UniProtKB-AC,ENSG_Uniprot,UniProtKB name,Gene Ontology (biological process),Gene Ontology (cellular component),Gene Ontology (molecular function),Post-translational modification,Domain [CC],Domain [FT],Beta strand,Helix,Turn,Taxonomic lineage,Reviewed,Gene Names,Protein names,Organism,Length,Mass,Sequence,MultiTaskProtDB,MoonProtDB,MoonDB,query,interpro_data,ELM,HPA,Catalytic activity,EC number,Activity regulation,Pathway,ENST,HGNC_g:Profiler,ENSG_g:Profiler,count,Gene symbol,RBP type,No. RBPome,disprot_disorder,disprot_id,curated_disorder,alphadb_disorder,mobidblite_disorder,Entrez
A5D8V6,ENSG00000167987,VP37C_HUMAN,macroautophagy [GO:0016236]; membrane fission [GO:0090148]; multivesicular body assembly [GO:0036258]; protein targeting to membrane [GO:0006612]; protein targeting to vacuole [GO:0006623]; protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043328]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; viral budding via host ESCRT complex [GO:0039702],endosome membrane [GO:0010008]; ESCRT I complex [GO:0000813]; extracellular exosome [GO:0070062]; late endosome membrane [GO:0031902],calcium-dependent protein binding [GO:0048306],PTM: Phosphorylated by TBK1. {ECO:0000269|PubMed:21270402}.,,"DOMAIN 78..167; /note=""VPS37 C-terminal""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00646""",,,,"cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,VPS37C PML39,Vacuolar protein sorting-associated protein 37C (hVps37C) (ESCRT-I complex subunit VPS37C),Homo sapiens (Human),355.0,38659.0,METLKDKTLQELEELQNDSEAIDQLALESPEVQDLQLEREMALATNRSLAERNLEFQGPLEISRSNLSDRYQELRKLVERCQEQKAKLEKFSSALQPGTLLDLLQVEGMKIEEESEAMAEKFLEGEVPLETFLENFSSMRMLSHLRRVRVEKLQEVVRKPRASQELAGDAPPPRPPPPVRPVPQGTPPVVEEQPQPPLAMPPYPLPYSPSPSLPVGPTAHGALPPAPFPVVSQPSFYSGPLGPTYPAAQLGPRGAAGYSWSPQRSMPPRPGYPGTPMGASGPGYPLRGGRAPSPGYPQQSPYPATGGKPPYPIQPQLPSFPGQPQPSVPLQPPYPPGPAPPYGFPPPPGPAWPGY,False,False,True,A5D8V6,"[('G3DSA:1.10.287.660', 'Helix hairpin bin'), ('IPR009851', 'Modifier of rudimentary, Modr'), ('IPR029012', 'Helix hairpin bin domain superfamily'), ('IPR037202', 'ESCRT assembly domain'), ('PF07200', 'Modifier of rudimentary (Mod(r)) protein'), ('PS51314', 'VPS37 C-terminal domain profile'), ('PTHR13678', 'VACUOLAR PROTEIN SORTING-ASSOCIATED PROTEIN 37'), ('SSF140111', 'Endosomal sorting complex assembly domain')]",,"""ENSG00000167987; Low tissue specificity."";",,,,,ENST00000301765.10;,VPS37C,ENSG00000167987,0.0,,,,,,,0.617,0.555,VPS37C
A7UKY0,,A7UKY0_HUMAN,negative regulation of apoptotic process [GO:0043066]; regulation of cell cycle [GO:0051726]; ubiquitin-dependent protein catabolic process [GO:0006511],nucleolus [GO:0005730],metal ion binding [GO:0046872],,,"DOMAIN 26..109; /note=""DM2""; /evidence=""ECO:0000259|PROSITE:PS51925""",,,,"cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",unreviewed,mdm2,Mdm2,Homo sapiens (Human),257.0,28775.0,MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSE,True,False,False,,,,,,,,,,,,,,,,,,,,,
O00204,ENSG00000088002,ST2B1_HUMAN,3'-phosphoadenosine 5'-phosphosulfate metabolic process [GO:0050427]; cholesterol metabolic process [GO:0008203]; negative regulation of cell population proliferation [GO:0008285]; positive regulation of epidermal cell differentiation [GO:0045606]; steroid metabolic process [GO:0008202]; sulfation [GO:0051923],cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; intracellular membrane-bounded organelle [GO:0043231]; nucleus [GO:0005634],cholesterol binding [GO:0015485]; cholesterol sulfotransferase activity [GO:0051922]; nucleic acid binding [GO:0003676]; small molecule binding [GO:0036094]; steroid hormone binding [GO:1990239]; steroid sulfotransferase activity [GO:0050294]; sulfotransferase activity [GO:0008146],PTM: Phosphorylated. {ECO:0000269|PubMed:16855051}.,"DOMAIN: The C-terminus, which contains a proline/serine-rich region is involved in nuclear translocation and enzymatic thermostability. {ECO:0000269|PubMed:16855051}.",,"STRAND 31..34; /evidence=""ECO:0007829|PDB:1Q20""; STRAND 37..41; /evidence=""ECO:0007829|PDB:1Q20""; STRAND 63..68; /evidence=""ECO:0007829|PDB:1Q20""; STRAND 103..106; /evidence=""ECO:0007829|PDB:1Q20""; STRAND 121..124; /evidence=""ECO:0007829|PDB:1Q20""; STRAND 141..146; /evidence=""ECO:0007829|PDB:1Q20""; STRAND 163..166; /evidence=""ECO:0007829|PDB:1Q1Z""; STRAND 205..209; /evidence=""ECO:0007829|PDB:1Q20""","HELIX 19..25; /evidence=""ECO:0007829|PDB:1Q20""; HELIX 46..54; /evidence=""ECO:0007829|PDB:1Q20""; HELIX 73..84; /evidence=""ECO:0007829|PDB:1Q20""; HELIX 90..94; /evidence=""ECO:0007829|PDB:1Q20""; HELIX 97..100; /evidence=""ECO:0007829|PDB:1Q20""; HELIX 110..112; /evidence=""ECO:0007829|PDB:1Q20""; HELIX 133..135; /evidence=""ECO:0007829|PDB:1Q20""; HELIX 149..162; /evidence=""ECO:0007829|PDB:1Q20""; HELIX 172..180; /evidence=""ECO:0007829|PDB:1Q20""; HELIX 189..196; /evidence=""ECO:0007829|PDB:1Q20""; HELIX 197..199; /evidence=""ECO:0007829|PDB:1Q20""; HELIX 210..215; /evidence=""ECO:0007829|PDB:1Q20""; HELIX 217..228; /evidence=""ECO:0007829|PDB:1Q20""; HELIX 234..244; /evidence=""ECO:0007829|PDB:1Q20""; HELIX 246..250; /evidence=""ECO:0007829|PDB:1Q20""; HELIX 280..283; /evidence=""ECO:0007829|PDB:1Q20""; HELIX 287..300; /evidence=""ECO:0007829|PDB:1Q20""","TURN 85..87; /evidence=""ECO:0007829|PDB:1Q20""; TURN 128..130; /evidence=""ECO:0007829|PDB:1Q20""; TURN 253..255; /evidence=""ECO:0007829|PDB:1Q20""; TURN 256..259; /evidence=""ECO:0007829|PDB:1Q1Z""; TURN 262..264; /evidence=""ECO:0007829|PDB:1Q20""; TURN 267..269; /evidence=""ECO:0007829|PDB:1Q20""; TURN 301..303; /evidence=""ECO:0007829|PDB:1Q20""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,SULT2B1 HSST2,Sulfotransferase 2B1 (EC 2.8.2.2) (Alcohol sulfotransferase) (Hydroxysteroid sulfotransferase 2) (Sulfotransferase family 2B member 1) (Sulfotransferase family cytosolic 2B member 1) (ST2B1),Homo sapiens (Human),365.0,41308.0,MDGPAEPQIPGLWDTYEDDISEISQKLPGEYFRYKGVPFPVGLYSLESISLAENTQDVRDDDIFIITYPKSGTTWMIEIICLILKEGDPSWIRSVPIWERAPWCETIVGAFSLPDQYSPRLMSSHLPIQIFTKAFFSSKAKVIYMGRNPRDVVVSLYHYSKIAGQLKDPGTPDQFLRDFLKGEVQFGSWFDHIKGWLRMKGKDNFLFITYEELQQDLQGSVERICGFLGRPLGKEALGSVVAHSTFSAMKANTMSNYTLLPPSLLDHRRGAFLRKGVCGDWKNHFTVAQSEAFDRAYRKQMRGMPTFPWDEDPEEDGSPDPEPSPEPEPKPSLEPNTSLEREPRPNSSPSPSPGQASETPHPRPS,False,False,True,O00204,"[('G3DSA:3.40.50.300', 'P-loop containing nucleotide triphosphate hydrolases'), ('IPR000863', 'Sulfotransferase domain'), ('IPR027417', 'P-loop containing nucleoside triphosphate hydrolase'), ('PF00685', 'Sulfotransferase domain'), ('PTHR11783', 'Cytosolic sulfotransferase 1'), ('SSF52540', 'P-loop containing nucleoside triphosphate hydrolases')]",,"""ENSG00000088002; Tissue enhanced (esophagus, skin, vagina)."";","CATALYTIC ACTIVITY: Reaction=an alcohol + 3'-phosphoadenylyl sulfate = an alkyl sulfate + adenosine 3',5'-bisphosphate + H(+); Xref=Rhea:RHEA:22552, ChEBI:CHEBI:15378, ChEBI:CHEBI:30879, ChEBI:CHEBI:58339, ChEBI:CHEBI:58343, ChEBI:CHEBI:83414; EC=2.8.2.2; Evidence={ECO:0000269|PubMed:12145317, ECO:0000269|PubMed:16855051, ECO:0000269|PubMed:19589875, ECO:0000269|PubMed:21855633, ECO:0000269|PubMed:9799594}; CATALYTIC ACTIVITY: Reaction=3beta-hydroxyandrost-5-en-17-one + 3'-phosphoadenylyl sulfate = dehydroepiandrosterone 3-sulfate + adenosine 3',5'-bisphosphate + H(+); Xref=Rhea:RHEA:51216, ChEBI:CHEBI:15378, ChEBI:CHEBI:28689, ChEBI:CHEBI:57905, ChEBI:CHEBI:58339, ChEBI:CHEBI:58343; Evidence={ECO:0000269|PubMed:12145317, ECO:0000269|PubMed:16855051, ECO:0000269|PubMed:21855633, ECO:0000269|PubMed:9799594}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:51217; Evidence={ECO:0000305}; CATALYTIC ACTIVITY: Reaction=(24S)-hydroxycholesterol + 3'-phosphoadenylyl sulfate = (24S)-hydroxycholesterol 3-sulfate + adenosine 3',5'-bisphosphate + H(+); Xref=Rhea:RHEA:52348, ChEBI:CHEBI:15378, ChEBI:CHEBI:34310, ChEBI:CHEBI:58339, ChEBI:CHEBI:58343, ChEBI:CHEBI:136567; Evidence={ECO:0000269|PubMed:19589875}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:52349; Evidence={ECO:0000305}; CATALYTIC ACTIVITY: Reaction=cholesterol + 3'-phosphoadenylyl sulfate = cholesterol sulfate + adenosine 3',5'-bisphosphate + H(+); Xref=Rhea:RHEA:52368, ChEBI:CHEBI:15378, ChEBI:CHEBI:16113, ChEBI:CHEBI:58339, ChEBI:CHEBI:58343, ChEBI:CHEBI:136579; Evidence={ECO:0000269|PubMed:12145317, ECO:0000269|PubMed:12923182}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:52369; Evidence={ECO:0000305}; CATALYTIC ACTIVITY: Reaction=pregnenolone + 3'-phosphoadenylyl sulfate = pregnenolone sulfate + adenosine 3',5'-bisphosphate + H(+); Xref=Rhea:RHEA:52356, ChEBI:CHEBI:15378, ChEBI:CHEBI:16581, ChEBI:CHEBI:58339, ChEBI:CHEBI:58343, ChEBI:CHEBI:133000; Evidence={ECO:0000269|PubMed:12145317, ECO:0000269|PubMed:12923182, ECO:0000269|PubMed:21855633}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:52357; Evidence={ECO:0000305};",2.8.2.2,,,ENST00000201586.7 [O00204-1];ENST00000323090.4 [O00204-2];,SULT2B1,ENSG00000088002,0.0,,,,3.84,DP00404,0.038,0.195,0.173,SULT2B1
O00291,ENSG00000127946,HIP1_HUMAN,actin filament organization [GO:0007015]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; cell differentiation [GO:0030154]; clathrin coat assembly [GO:0048268]; endocytosis [GO:0006897]; neurotransmitter receptor transport [GO:0099637]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of platelet-derived growth factor receptor-beta signaling pathway [GO:2000588]; positive regulation of receptor-mediated endocytosis [GO:0048260]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; protein stabilization [GO:0050821]; regulation of apoptotic process [GO:0042981]; regulation of endocytosis [GO:0030100]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149],clathrin-coated vesicle [GO:0030136]; clathrin-coated vesicle membrane [GO:0030665]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nucleus [GO:0005634]; postsynapse [GO:0098794]; postsynaptic membrane [GO:0045211]; presynapse [GO:0098793]; presynaptic membrane [GO:0042734]; Schaffer collateral - CA1 synapse [GO:0098685],"actin filament binding [GO:0051015]; AP-2 adaptor complex binding [GO:0035612]; clathrin adaptor activity [GO:0035615]; clathrin binding [GO:0030276]; clathrin light chain binding [GO:0032051]; epidermal growth factor receptor binding [GO:0005154]; glutamate receptor binding [GO:0035254]; phosphatidylinositol binding [GO:0035091]; phosphatidylinositol-3,4-bisphosphate binding [GO:0043325]; phosphatidylinositol-3,5-bisphosphate binding [GO:0080025]; phosphatidylinositol-3-phosphate binding [GO:0032266]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; structural constituent of cytoskeleton [GO:0005200]",,DOMAIN: The pseudo DED region (pDED) mediates the interaction with IFT57. {ECO:0000269|PubMed:11788820}.; DOMAIN: Binds F-actin via the talin-like I/LWEQ domain. {ECO:0000269|PubMed:11788820}.,"DOMAIN 32..160; /note=""ENTH""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00243""; DOMAIN 771..1012; /note=""I/LWEQ""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00292""",,"HELIX 373..441; /evidence=""ECO:0007829|PDB:3I00""; HELIX 462..465; /evidence=""ECO:0007829|PDB:2QA7""; HELIX 482..580; /evidence=""ECO:0007829|PDB:2NO2""","TURN 459..461; /evidence=""ECO:0007829|PDB:2QA7""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,HIP1,Huntingtin-interacting protein 1 (HIP-1) (Huntingtin-interacting protein I) (HIP-I),Homo sapiens (Human),1037.0,116221.0,MDRMASSMKQVPNPLPKVLSRRGVGAGLEAAERESFERTQTVSINKAINTQEVAVKEKHARTCILGTHHEKGAQTFWSVVNRLPLSSNAVLCWKFCHVFHKLLRDGHPNVLKDSLRYRNELSDMSRMWGHLSEGYGQLCSIYLKLLRTKMEYHTKNPRFPGNLQMSDRQLDEAGESDVNNFFQLTVEMFDYLECELNLFQTVFNSLDMSRSVSVTAAGQCRLAPLIQVILDCSHLYDYTVKLLFKLHSCLPADTLQGHRDRFMEQFTKLKDLFYRSSNLQYFKRLIQIPQLPENPPNFLRASALSEHISPVVVIPAEASSPDSEPVLEKDDLMDMDASQQNLFDNKFDDIFGSSFSSDPFNFNSQNGVNKDEKDHLIERLYREISGLKAQLENMKTESQRVVLQLKGHVSELEADLAEQQHLRQQAADDCEFLRAELDELRRQREDTEKAQRSLSEIERKAQANEQRYSKLKEKYSELVQNHADLLRKNAEVTKQVSMARQAQVDLEREKKELEDSLERISDQGQRKTQEQLEVLESLKQELATSQRELQVLQGSLETSAQSEANWAAEFAELEKERDSLVSGAAHREEELSALRKELQDTQLKLASTEESMCQLAKDQRKMLLVGSRKAAEQVIQDALNQLEEPPLISCAGSADHLLSTVTSISSCIEQLEKSWSQYLACPEDISGLLHSITLLAHLTSDAIAHGATTCLRAPPEPADSLTEACKQYGRETLAYLASLEEEGSLENADSTAMRNCLSKIKAIGEELLPRGLDIKQEELGDLVDKEMAATSAAIETATARIEEMLSKSRAGDTGVKLEVNERILGCCTSLMQAIQVLIVASKDLQREIVESGRGTASPKEFYAKNSRWTEGLISASKAVGWGATVMVDAADLVVQGRGKFEELMVCSHEIAASTAQLVAASKVKADKDSPNLAQLQQASRGVNQATAGVVASTISGKSQIEETDNMDFSSMTLTQIKRQEMDSQVRVLELENELQKERQKLGELRKKHYELAGVAEGWEEGTEASPPTLQEVVTEKE,False,False,True,O00291,"[('cd17013', 'ANTH (AP180 N-Terminal Homology) domain, N-terminal region, of Huntingtin-interacting protein 1'), ('G3DSA:1.20.1410.10', 'I/LWEQ domain'), ('G3DSA:1.20.5.1700', None), ('G3DSA:1.25.40.90', None), ('G3DSA:6.10.250.920', None), ('IPR002558', 'I/LWEQ domain'), ('IPR008942', 'ENTH/VHS'), ('IPR011417', 'AP180 N-terminal homology (ANTH) domain'), ('IPR013809', 'ENTH domain'), ('IPR030224', 'Sla2 family'), ('IPR032422', 'Huntingtin-interacting protein 1, clathrin-binding domain'), ('IPR035964', 'I/LWEQ domain superfamily'), ('PF01608', 'I/LWEQ domain'), ('PF07651', 'ANTH domain'), ('PF16515', 'Clathrin-binding domain of Huntingtin-interacting protein 1'), ('PS50942', 'ENTH domain profile'), ('PS50945', 'I/LWEQ domain profile'), ('PTHR10407', 'HUNTINGTIN INTERACTING PROTEIN 1'), ('SM00273', 'Epsin N-terminal homology (ENTH) domain'), ('SM00307', 'I/LWEQ domain')]",O00291;,"""ENSG00000127946; Low tissue specificity."";",,,,,ENST00000336926.11 [O00291-1];ENST00000434438.6 [O00291-3];ENST00000616821.4 [O00291-4];,HIP1,ENSG00000127946,0.0,,,,,,0.049,0.277,0.02,HIP1
O00308,ENSG00000198373,WWP2_HUMAN,extracellular transport [GO:0006858]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of gene expression [GO:0010629]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of protein transport [GO:0051224]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transporter activity [GO:0032410]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein K63-linked ubiquitination [GO:0070534]; protein modification process [GO:0036211]; protein ubiquitination [GO:0016567]; regulation of membrane potential [GO:0042391]; regulation of monoatomic ion transmembrane transport [GO:0034765]; regulation of potassium ion transmembrane transporter activity [GO:1901016]; symbiont entry into host cell [GO:0046718]; transcription by RNA polymerase II [GO:0006366],cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151],RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription factor binding [GO:0008134]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842],"PTM: Autoubiquitinated. Ubiquitinated by the SCF(FBXL15) complex, leading to its degradation by the proteasome. {ECO:0000269|PubMed:19343052, ECO:0000269|PubMed:21572392}.","DOMAIN: The C2 domain is involved in autoinhibition of the catalytic activity by interacting with the HECT domain. {ECO:0000250}.; DOMAIN: The WW domains mediate interaction with PPxY motif-containing proteins. {ECO:0000269|PubMed:21191027, ECO:0000269|PubMed:22315426}.","DOMAIN 1..117; /note=""C2""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00041""; DOMAIN 300..333; /note=""WW 1""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00224""; DOMAIN 330..363; /note=""WW 2""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00224""; DOMAIN 405..437; /note=""WW 3""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00224""; DOMAIN 444..477; /note=""WW 4""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00224""; DOMAIN 536..870; /note=""HECT""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00104""","STRAND 336..340; /evidence=""ECO:0007829|PDB:6J1Z""; STRAND 348..350; /evidence=""ECO:0007829|PDB:5TJ7""; STRAND 355..359; /evidence=""ECO:0007829|PDB:5TJ7""; STRAND 443..445; /evidence=""ECO:0007829|PDB:6RSS""; STRAND 450..454; /evidence=""ECO:0007829|PDB:6RSS""; STRAND 460..464; /evidence=""ECO:0007829|PDB:6RSS""; STRAND 469..471; /evidence=""ECO:0007829|PDB:6RSS""; STRAND 512..519; /evidence=""ECO:0007829|PDB:8EI7""; STRAND 542..548; /evidence=""ECO:0007829|PDB:8EI7""; STRAND 579..583; /evidence=""ECO:0007829|PDB:8EI7""; STRAND 587..591; /evidence=""ECO:0007829|PDB:8EI7""; STRAND 671..678; /evidence=""ECO:0007829|PDB:8EI7""; STRAND 681..688; /evidence=""ECO:0007829|PDB:8EI7""; STRAND 765..768; /evidence=""ECO:0007829|PDB:8EI7""; STRAND 800..802; /evidence=""ECO:0007829|PDB:8EI8""; STRAND 817..819; /evidence=""ECO:0007829|PDB:5TJ7""; STRAND 822..825; /evidence=""ECO:0007829|PDB:8EI7""; STRAND 829..831; /evidence=""ECO:0007829|PDB:5TJ8""; STRAND 834..836; /evidence=""ECO:0007829|PDB:8EI7""; STRAND 841..844; /evidence=""ECO:0007829|PDB:8EI7""","HELIX 363..386; /evidence=""ECO:0007829|PDB:5TJ8""; HELIX 477..479; /evidence=""ECO:0007829|PDB:6RSS""; HELIX 495..507; /evidence=""ECO:0007829|PDB:8EI7""; HELIX 521..523; /evidence=""ECO:0007829|PDB:5TJ8""; HELIX 524..533; /evidence=""ECO:0007829|PDB:8EI7""; HELIX 537..541; /evidence=""ECO:0007829|PDB:8EI7""; HELIX 556..570; /evidence=""ECO:0007829|PDB:8EI7""; HELIX 574..576; /evidence=""ECO:0007829|PDB:8EI7""; HELIX 595..597; /evidence=""ECO:0007829|PDB:8EI7""; HELIX 601..618; /evidence=""ECO:0007829|PDB:8EI7""; HELIX 628..634; /evidence=""ECO:0007829|PDB:8EI7""; HELIX 641..647; /evidence=""ECO:0007829|PDB:8EI7""; HELIX 649..660; /evidence=""ECO:0007829|PDB:8EI7""; HELIX 701..714; /evidence=""ECO:0007829|PDB:8EI7""; HELIX 718..731; /evidence=""ECO:0007829|PDB:8EI7""; HELIX 734..737; /evidence=""ECO:0007829|PDB:8EI7""; HELIX 742..750; /evidence=""ECO:0007829|PDB:8EI7""; HELIX 757..762; /evidence=""ECO:0007829|PDB:8EI7""; HELIX 774..785; /evidence=""ECO:0007829|PDB:8EI7""; HELIX 788..799; /evidence=""ECO:0007829|PDB:8EI7""; HELIX 809..811; /evidence=""ECO:0007829|PDB:8EI7""; HELIX 837..839; /evidence=""ECO:0007829|PDB:8EI7""; HELIX 850..863; /evidence=""ECO:0007829|PDB:8EI7""","TURN 351..354; /evidence=""ECO:0007829|PDB:5TJ7""; TURN 465..468; /evidence=""ECO:0007829|PDB:6RSS""; TURN 584..586; /evidence=""ECO:0007829|PDB:8EI7""; TURN 663..667; /evidence=""ECO:0007829|PDB:8EI7""; TURN 689..693; /evidence=""ECO:0007829|PDB:8EI7""; TURN 698..700; /evidence=""ECO:0007829|PDB:8EI7""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2 (EC 2.3.2.26) (Atrophin-1-interacting protein 2) (AIP2) (HECT-type E3 ubiquitin transferase WWP2) (WW domain-containing protein 2),Homo sapiens (Human),870.0,98912.0,MASASSSRAGVALPFEKSQLTLKVVSAKPKVHNRQPRINSYVEVAVDGLPSETKKTGKRIGSSELLWNEIIILNVTAQSHLDLKVWSCHTLRNELLGTASVNLSNVLKNNGGKMENMQLTLNLQTENKGSVVSGGELTIFLDGPTVDLGNVPNGSALTDGSQLPSRDSSGTAVAPENRHQPPSTNCFGGRSRTHRHSGASARTTPATGEQSPGARSRHRQPVKNSGHSGLANGTVNDEPTTATDPEEPSVVGVTSPPAAPLSVTPNPNTTSLPAPATPAEGEEPSTSGTQQLPAAAQAPDALPAGWEQRELPNGRVYYVDHNTKTTTWERPLPPGWEKRTDPRGRFYYVDHNTRTTTWQRPTAEYVRNYEQWQSQRNQLQGAMQHFSQRFLYQSSSASTDHDPLGPLPPGWEKRQDNGRVYYVNHNTRTTQWEDPRTQGMIQEPALPPGWEMKYTSEGVRYFVDHNTRTTTFKDPRPGFESGTKQGSPGAYDRSFRWKYHQFRFLCHSNALPSHVKISVSRQTLFEDSFQQIMNMKPYDLRRRLYIIMRGEEGLDYGGIAREWFFLLSHEVLNPMYCLFEYAGKNNYCLQINPASSINPDHLTYFRFIGRFIAMALYHGKFIDTGFTLPFYKRMLNKRPTLKDLESIDPEFYNSIVWIKENNLEECGLELYFIQDMEILGKVTTHELKEGGESIRVTEENKEEYIMLLTDWRFTRGVEEQTKAFLDGFNEVAPLEWLRYFDEKELELMLCGMQEIDMSDWQKSTIYRHYTKNSKQIQWFWQVVKEMDNEKRIRLLQFVTGTCRLPVGGFAELIGSNGPQKFCIDKVGKETWLPRSHTCFNRLDLPPYKSYEQLREKLLYAIEETEGFGQE,False,False,True,O00308,"[('cd00078', 'HECTc'), ('cd00201', 'WW'), ('cd04021', 'C2 domain present in E3 ubiquitin ligase'), ('G3DSA:2.20.70.10', None), ('G3DSA:2.60.40.150', 'C2 domain'), ('G3DSA:3.30.2160.10', 'Hect, E3 ligase catalytic domain'), ('G3DSA:3.30.2410.10', 'Hect, E3 ligase catalytic domain'), ('G3DSA:3.90.1750.10', 'Hect, E3 ligase catalytic domains'), ('IPR000008', 'C2 domain'), ('IPR000569', 'HECT domain'), ('IPR001202', 'WW domain'), ('IPR024928', 'E3 ubiquitin-protein ligase, SMURF1 type'), ('IPR035892', 'C2 domain superfamily'), ('IPR035983', 'HECT, E3 ligase catalytic domain'), ('IPR036020', 'WW domain superfamily'), ('IPR050409', 'E3 ubiquitin-protein ligase'), ('PF00397', 'WW domain'), ('PF00632', 'HECT-domain (ubiquitin-transferase)'), ('PIRSF001569', 'E3 ubiquitin-protein ligase, SMURF1 type'), ('PS01159', 'WW/rsp5/WWP domain signature')]",,"""ENSG00000198373; Low tissue specificity."";","CATALYTIC ACTIVITY: Reaction=S-ubiquitinyl-[E2 ubiquitin-conjugating enzyme]-L-cysteine + [acceptor protein]-L-lysine = [E2 ubiquitin-conjugating enzyme]-L-cysteine + N(6)-ubiquitinyl-[acceptor protein]-L-lysine.; EC=2.3.2.26; Evidence={ECO:0000269|PubMed:19274063, ECO:0000269|PubMed:19651900};",2.3.2.26,ACTIVITY REGULATION: Activated by NDFIP1- and NDFIP2-binding. {ECO:0000269|PubMed:19343052}.,"PATHWAY: Protein modification; protein ubiquitination. {ECO:0000269|PubMed:19274063, ECO:0000269|PubMed:19651900}.",ENST00000356003.6 [O00308-2];ENST00000359154.7 [O00308-1];ENST00000568684.1 [O00308-3];ENST00000569174.5 [O00308-4];,WWP2,ENSG00000198373,0.0,,,,4.71,DP03092,0.047,0.201,0.171,WWP2
O00337,ENSG00000156222,S28A1_HUMAN,azole transmembrane transport [GO:0045117]; cytidine transport [GO:0015861]; nucleoside import across plasma membrane [GO:0180015]; nucleoside transmembrane transport [GO:1901642]; purine nucleobase transmembrane transport [GO:1904823]; pyrimidine nucleobase transport [GO:0015855]; pyrimidine-containing compound transmembrane transport [GO:0072531]; uridine transmembrane transport [GO:0015862],apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; plasma membrane [GO:0005886],azole transmembrane transporter activity [GO:1901474]; cytidine transmembrane transporter activity [GO:0015212]; nucleoside:sodium symporter activity [GO:0005415]; purine nucleobase transmembrane transporter activity [GO:0005345]; pyrimidine- and adenosine-specific:sodium symporter activity [GO:0015389]; uridine transmembrane transporter activity [GO:0015213],PTM: N-glycosylated. N-glycosylation is required for localization to the plasma membrane and the transporter activity. {ECO:0000269|PubMed:30658162}.,,,,,,"cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,SLC28A1 CNT1,Sodium/nucleoside cotransporter 1 (Concentrative nucleoside transporter 1) (CNT 1) (hCNT1) (Na(+)/nucleoside cotransporter 1) (Sodium-coupled nucleoside transporter 1) (Solute carrier family 28 member 1),Homo sapiens (Human),649.0,71584.0,MENDPSRRRESISLTPVAKGLENMGADFLESLEEGQLPRSDLSPAEIRSSWSEAAPKPFSRWRNLQPALRARSFCREHMQLFRWIGTGLLCTGLSAFLLVACLLDFQRALALFVLTCVVLTFLGHRLLKRLLGPKLRRFLKPQGHPRLLLWFKRGLALAAFLGLVLWLSLDTSQRPEQLVSFAGICVFVALLFACSKHHCAVSWRAVSWGLGLQFVLGLLVIRTEPGFIAFEWLGEQIRIFLSYTKAGSSFVFGEALVKDVFAFQVLPIIVFFSCVISVLYHVGLMQWVILKIAWLMQVTMGTTATETLSVAGNIFVSQTEAPLLIRPYLADMTLSEVHVVMTGGYATIAGSLLGAYISFGIDATSLIAASVMAAPCALALSKLVYPEVEESKFRREEGVKLTYGDAQNLIEAASTGAAISVKVVANIAANLIAFLAVLDFINAALSWLGDMVDIQGLSFQLICSYILRPVAFLMGVAWEDCPVVAELLGIKLFLNEFVAYQDLSKYKQRRLAGAEEWVGDRKQWISVRAEVLTTFALCGFANFSSIGIMLGGLTSMVPQRKSDFSQIVLRALFTGACVSLVNACMAGILYMPRGAEVDCMSLLNTTLSSSSFEIYQCCREAFQSVNPEFSPEALDNCCRFYNHTICAQ,True,False,False,O00337,"[('IPR002668', 'Concentrative nucleoside transporter N-terminal domain'), ('IPR008276', 'Concentrative nucleoside transporter'), ('IPR011642', 'Nucleoside transporter/FeoB GTPase, Gate domain'), ('IPR011657', 'Concentrative nucleoside transporter C-terminal domain'), ('IPR018270', 'Concentrative nucleoside transporter, metazoan/bacterial'), ('PF01773', 'Na+ dependent nucleoside transporter N-terminus'), ('PF07662', 'Na+ dependent nucleoside transporter C-terminus'), ('PF07670', 'Nucleoside recognition'), ('PTHR10590', 'SODIUM/NUCLEOSIDE COTRANSPORTER'), ('TIGR00804', 'NupC/NupG family nucleoside CNT transporter')]",,"""ENSG00000156222; Group enriched (intestine, kidney, liver)."";","CATALYTIC ACTIVITY: Reaction=uridine(out) + Na(+)(out) = uridine(in) + Na(+)(in); Xref=Rhea:RHEA:69887, ChEBI:CHEBI:16704, ChEBI:CHEBI:29101; Evidence={ECO:0000269|PubMed:10455109, ECO:0000269|PubMed:14701834, ECO:0000269|PubMed:21795683, ECO:0000269|PubMed:21998139, ECO:0000269|PubMed:32126230, ECO:0000269|PubMed:9124315}; CATALYTIC ACTIVITY: Reaction=thymidine(out) + Na(+)(out) = thymidine(in) + Na(+)(in); Xref=Rhea:RHEA:69891, ChEBI:CHEBI:17748, ChEBI:CHEBI:29101; Evidence={ECO:0000269|PubMed:10455109, ECO:0000269|PubMed:21998139, ECO:0000269|PubMed:9124315}; CATALYTIC ACTIVITY: Reaction=cytidine(out) + Na(+)(out) = cytidine(in) + Na(+)(in); Xref=Rhea:RHEA:69895, ChEBI:CHEBI:17562, ChEBI:CHEBI:29101; Evidence={ECO:0000269|PubMed:10455109, ECO:0000269|PubMed:21998139, ECO:0000269|PubMed:30658162, ECO:0000269|PubMed:9124315}; CATALYTIC ACTIVITY: Reaction=adenosine(out) + Na(+)(out) = adenosine(in) + Na(+)(in); Xref=Rhea:RHEA:69927, ChEBI:CHEBI:16335, ChEBI:CHEBI:29101; Evidence={ECO:0000269|PubMed:10455109, ECO:0000269|PubMed:15194733, ECO:0000269|PubMed:21998139, ECO:0000269|PubMed:32126230, ECO:0000269|PubMed:9124315};",,"ACTIVITY REGULATION: Due to its high apparent affinity but slow transport, adenosine could act as a negative regulator of pyrimidine transport under some conditions. {ECO:0000269|PubMed:14701834, ECO:0000269|PubMed:32126230}.",,ENST00000286749.3 [O00337-1];ENST00000338602.6 [O00337-2];ENST00000394573.6 [O00337-1];,SLC28A1,ENSG00000156222,0.0,,,,,,,0.19,,SLC28A1
O00499,ENSG00000136717,BIN1_HUMAN,cytoskeleton organization [GO:0007010]; endocytosis [GO:0006897]; endosome to lysosome transport [GO:0008333]; lipid tube assembly [GO:0060988]; negative regulation of amyloid-beta formation [GO:1902430]; negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process [GO:1902960]; negative regulation of calcium ion transmembrane transport via high voltage-gated calcium channel [GO:1904878]; negative regulation of potassium ion transmembrane transport [GO:1901380]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of ventricular cardiac muscle cell action potential [GO:1903946]; nucleus localization [GO:0051647]; nucleus organization [GO:0006997]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of apoptotic process [GO:0043065]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of endocytosis [GO:0045807]; regulation of cell cycle process [GO:0010564]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of neuron differentiation [GO:0045664]; response to lipopolysaccharide [GO:0032496]; synaptic vesicle endocytosis [GO:0048488]; T-tubule organization [GO:0033292],actin cytoskeleton [GO:0015629]; axon [GO:0030424]; axon initial segment [GO:0043194]; axon terminus [GO:0043679]; cerebellar mossy fiber [GO:0044300]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; endosome [GO:0005768]; extrinsic component of synaptic vesicle membrane [GO:0098850]; glutamatergic synapse [GO:0098978]; I band [GO:0031674]; lipid tube [GO:0060987]; membrane [GO:0016020]; node of Ranvier [GO:0033268]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; RNA polymerase II transcription repressor complex [GO:0090571]; synaptic vesicle [GO:0008021]; T-tubule [GO:0030315]; varicosity [GO:0043196]; vesicle [GO:0031982]; Z disc [GO:0030018],actin filament binding [GO:0051015]; aspartic-type endopeptidase inhibitor activity [GO:0019828]; clathrin binding [GO:0030276]; GTPase binding [GO:0051020]; identical protein binding [GO:0042802]; lipid binding [GO:0008289]; phospholipid binding [GO:0005543]; protease binding [GO:0002020]; protein-folding chaperone binding [GO:0051087]; RNA polymerase binding [GO:0070063]; signaling adaptor activity [GO:0035591]; tau protein binding [GO:0048156],PTM: Phosphorylated by protein kinase C. {ECO:0000250}.,,"DOMAIN 29..276; /note=""BAR""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00361""; DOMAIN 520..593; /note=""SH3""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00192""","STRAND 163..165; /evidence=""ECO:0007829|PDB:2FIC""; STRAND 523..527; /evidence=""ECO:0007829|PDB:1MUZ""; STRAND 535..537; /evidence=""ECO:0007829|PDB:1MUZ""; STRAND 546..549; /evidence=""ECO:0007829|PDB:1MUZ""; STRAND 562..567; /evidence=""ECO:0007829|PDB:1MUZ""; STRAND 582..585; /evidence=""ECO:0007829|PDB:1MUZ""; STRAND 589..591; /evidence=""ECO:0007829|PDB:1MUZ""","HELIX 8..33; /evidence=""ECO:0007829|PDB:2RMY""; HELIX 43..89; /evidence=""ECO:0007829|PDB:2FIC""; HELIX 97..121; /evidence=""ECO:0007829|PDB:2FIC""; HELIX 123..131; /evidence=""ECO:0007829|PDB:2FIC""; HELIX 133..161; /evidence=""ECO:0007829|PDB:2FIC""; HELIX 205..268; /evidence=""ECO:0007829|PDB:2FIC""; HELIX 555..557; /evidence=""ECO:0007829|PDB:1MUZ""; HELIX 568..572; /evidence=""ECO:0007829|PDB:1MUZ""; HELIX 573..579; /evidence=""ECO:0007829|PDB:1MUZ""; HELIX 586..588; /evidence=""ECO:0007829|PDB:1MUZ""",,"cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,BIN1 AMPHL,Myc box-dependent-interacting protein 1 (Amphiphysin II) (Amphiphysin-like protein) (Box-dependent myc-interacting protein 1) (Bridging integrator 1),Homo sapiens (Human),593.0,64699.0,MAEMGSKGVTAGKIASNVQKKLTRAQEKVLQKLGKADETKDEQFEQCVQNFNKQLTEGTRLQKDLRTYLASVKAMHEASKKLNECLQEVYEPDWPGRDEANKIAENNDLLWMDYHQKLVDQALLTMDTYLGQFPDIKSRIAKRGRKLVDYDSARHHYESLQTAKKKDEAKIAKPVSLLEKAAPQWCQGKLQAHLVAQTNLLRNQAEEELIKAQKVFEEMNVDLQEELPSLWNSRVGFYVNTFQSIAGLEENFHKEMSKLNQNLNDVLVGLEKQHGSNTFTVKAQPSDNAPAKGNKSPSPPDGSPAATPEIRVNHEPEPAGGATPGATLPKSPSQLRKGPPVPPPPKHTPSKEVKQEQILSLFEDTFVPEISVTTPSQFEAPGPFSEQASLLDLDFDPLPPVTSPVKAPTPSGQSIPWDLWEPTESPAGSLPSGEPSAAEGTFAVSWPSQTAEPGPAQPAEASEVAGGTQPAAGAQEPGETAASEAASSSLPAVVVETFPATVNGTVEGGSGAGRLDLPPGFMFKVQAQHDYTATDTDELQLKAGDVVLVIPFQNPEEQDEGWLMGVKESDWNQHKELEKCRGVFPENFTERVP,False,False,True,O00499,"[('cd07611', 'The Bin/Amphiphysin/Rvs (BAR) domain of Amphiphysin I and II'), ('cd12139', 'Src Homology 3 domain of Bridging integrator 1 (Bin1), also called Amphiphysin-2'), ('G3DSA:1.20.1270.60', 'Arfaptin homology (AH) domain/BAR domain'), ('G3DSA:2.30.30.40', 'SH3 Domains'), ('IPR001452', 'SH3 domain'), ('IPR003005', 'Amphiphysin'), ('IPR003023', 'Amphiphysin 2'), ('IPR004148', 'BAR domain'), ('IPR027267', 'AH/BAR domain superfamily'), ('IPR035471', 'Amphiphysin 2, SH3 domain'), ('IPR036028', 'SH3-like domain superfamily'), ('PF03114', 'BAR domain'), ('PF14604', 'Variant SH3 domain'), ('PR00452', 'SH3DOMAIN'), ('PR01251', 'AMPHIPHYSIN'), ('PR01253', 'AMPHIPHYSIN2'), ('PS50002', 'Src homology 3 (SH3) domain profile'), ('PS51021', 'BAR domain profile'), ('PTHR46514', 'AMPHIPHYSIN'), ('SM00326', 'Src homology 3 domains')]",O00499;,"""ENSG00000136717; Group enriched (skeletal muscle, tongue)."";",,,,,ENST00000259238.8 [O00499-11];ENST00000316724.10 [O00499-1];ENST00000346226.7 [O00499-2];ENST00000348750.8 [O00499-9];ENST00000351659.7 [O00499-3];ENST00000352848.8 [O00499-8];ENST00000357970.7 [O00499-5];ENST00000376113.6 [O00499-10];ENST00000393040.7 [O00499-6];ENST00000393041.7 [O00499-4];ENST00000409400.1 [O00499-7];,BIN1,ENSG00000136717,0.0,,,,6.91,DP04169,0.069,0.442,0.277,BIN1
O00560,ENSG00000137575,SDCB1_HUMAN,"actin cytoskeleton organization [GO:0030036]; chemical synaptic transmission [GO:0007268]; intracellular signal transduction [GO:0035556]; negative regulation of receptor internalization [GO:0002091]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of extracellular exosome assembly [GO:1903553]; positive regulation of JNK cascade [GO:0046330]; positive regulation of phosphorylation [GO:0042327]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; presynapse assembly [GO:0099054]; protein targeting to membrane [GO:0006612]; Ras protein signal transduction [GO:0007265]; regulation of mitotic cell cycle [GO:0007346]; substrate-dependent cell migration, cell extension [GO:0006930]",adherens junction [GO:0005912]; azurophil granule lumen [GO:0035578]; blood microparticle [GO:0072562]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular vesicle [GO:1903561]; focal adhesion [GO:0005925]; interleukin-5 receptor complex [GO:0005895]; melanosome [GO:0042470]; membrane [GO:0016020]; membrane raft [GO:0045121]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; presynapse [GO:0098793],"cell adhesion molecule binding [GO:0050839]; cytoskeletal anchor activity [GO:0008093]; ephrin receptor binding [GO:0046875]; frizzled binding [GO:0005109]; growth factor binding [GO:0019838]; identical protein binding [GO:0042802]; interleukin-5 receptor binding [GO:0005137]; ionotropic glutamate receptor binding [GO:0035255]; neurexin family protein binding [GO:0042043]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; protein heterodimerization activity [GO:0046982]; protein sequestering activity [GO:0140311]; protein-containing complex binding [GO:0044877]; syndecan binding [GO:0045545]",PTM: Phosphorylated on tyrosine residues.,,"DOMAIN 114..193; /note=""PDZ 1""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00143""; DOMAIN 198..273; /note=""PDZ 2""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00143""","STRAND 111..117; /evidence=""ECO:0007829|PDB:8BLU""; STRAND 127..132; /evidence=""ECO:0007829|PDB:8BLU""; STRAND 135..142; /evidence=""ECO:0007829|PDB:8BLU""; STRAND 157..161; /evidence=""ECO:0007829|PDB:8BLU""; STRAND 186..191; /evidence=""ECO:0007829|PDB:8BLU""; STRAND 197..202; /evidence=""ECO:0007829|PDB:1R6J""; STRAND 205..208; /evidence=""ECO:0007829|PDB:1N99""; STRAND 211..214; /evidence=""ECO:0007829|PDB:1R6J""; STRAND 217..221; /evidence=""ECO:0007829|PDB:1R6J""; STRAND 223..225; /evidence=""ECO:0007829|PDB:7FSR""; STRAND 234..241; /evidence=""ECO:0007829|PDB:1R6J""; STRAND 247..249; /evidence=""ECO:0007829|PDB:7FTA""; STRAND 263..271; /evidence=""ECO:0007829|PDB:1R6J""; STRAND 280..282; /evidence=""ECO:0007829|PDB:7FSR""","HELIX 146..149; /evidence=""ECO:0007829|PDB:8BLU""; HELIX 171..180; /evidence=""ECO:0007829|PDB:8BLU""; HELIX 226..230; /evidence=""ECO:0007829|PDB:1R6J""; HELIX 251..260; /evidence=""ECO:0007829|PDB:1R6J""; HELIX 272..279; /evidence=""ECO:0007829|PDB:8BLU""; HELIX 284..290; /evidence=""ECO:0007829|PDB:8BLU""","TURN 121..123; /evidence=""ECO:0007829|PDB:8AAP""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,SDCBP MDA9 SYCL,Syntenin-1 (Melanoma differentiation-associated protein 9) (MDA-9) (Pro-TGF-alpha cytoplasmic domain-interacting protein 18) (TACIP18) (Scaffold protein Pbp1) (Syndecan-binding protein 1),Homo sapiens (Human),298.0,32444.0,MSLYPSLEDLKVDKVIQAQTAFSANPANPAILSEASAPIPHDGNLYPRLYPELSQYMGLSLNEEEIRANVAVVSGAPLQGQLVARPSSINYMVAPVTGNDVGIRRAEIKQGIREVILCKDQDGKIGLRLKSIDNGIFVQLVQANSPASLVGLRFGDQVLQINGENCAGWSSDKAHKVLKQAFGEKITMTIRDRPFERTITMHKDSTGHVGFIFKNGKITSIVKDSSAARNGLLTEHNICEINGQNVIGLKDSQIADILSTSGTVVTITIMPAFIFEHIIKRMAPSIMKSLMDHTIPEV,False,False,True,O00560,"[('cd00992', 'PDZ_signaling'), ('G3DSA:2.30.42.10', None), ('IPR001478', 'PDZ domain'), ('IPR036034', 'PDZ superfamily'), ('IPR051230', 'Amyloid-beta A4 Precursor Protein-Binding'), ('PF00595', 'PDZ domain'), ('PS50106', 'PDZ domain profile'), ('PTHR12345', 'Amyloid-beta A4 Precursor Protein-Binding'), ('SM00228', 'Domain present in PSD-95, Dlg, and ZO-1/2.'), ('SSF50156', 'PDZ domain-like')]",,"""ENSG00000137575; Low tissue specificity."";",,,,,ENST00000260130.9 [O00560-1];ENST00000413219.6 [O00560-1];ENST00000424270.6 [O00560-3];ENST00000447182.6 [O00560-2];,SDCBP,ENSG00000137575,0.0,,,,,,,0.232,,SDCBP
O14503,ENSG00000134107,BHE40_HUMAN,anterior/posterior pattern specification [GO:0009952]; circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; entrainment of circadian clock by photoperiod [GO:0043153]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of circadian rhythm [GO:0042752]; regulation of DNA-templated transcription [GO:0006355]; regulation of neurogenesis [GO:0050767]; regulation of transcription by RNA polymerase II [GO:0006357],chromatin [GO:0000785]; cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nucleus [GO:0005634],"bHLH transcription factor binding [GO:0043425]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; E-box binding [GO:0070888]; MRF binding [GO:0043426]; protein domain specific binding [GO:0019904]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific double-stranded DNA binding [GO:1990837]","PTM: Ubiquitinated; which may lead to proteasomal degradation. {ECO:0000269|PubMed:11278694}.; PTM: Sumoylation inhibits its ubiquitination and promotes its negative regulation of the CLOCK-BMAL1 heterodimer transcriptional activator activity. {ECO:0000269|PubMed:11278694, ECO:0000269|PubMed:21829689}.",,"DOMAIN 52..107; /note=""bHLH""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00981""; DOMAIN 142..175; /note=""Orange""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00380""",,,,"cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,BHLHE40 BHLHB2 DEC1 SHARP2 STRA13,Class E basic helix-loop-helix protein 40 (bHLHe40) (Class B basic helix-loop-helix protein 2) (bHLHb2) (Differentially expressed in chondrocytes protein 1) (DEC1) (Enhancer-of-split and hairy-related protein 2) (SHARP-2) (Stimulated by retinoic acid gene 13 protein),Homo sapiens (Human),412.0,45510.0,MERIPSAQPPPACLPKAPGLEHGDLPGMYPAHMYQVYKSRRGIKRSEDSKETYKLPHRLIEKKRRDRINECIAQLKDLLPEHLKLTTLGHLEKAVVLELTLKHVKALTNLIDQQQQKIIALQSGLQAGELSGRNVETGQEMFCSGFQTCAREVLQYLAKHENTRDLKSSQLVTHLHRVVSELLQGGTSRKPSDPAPKVMDFKEKPSSPAKGSEGPGKNCVPVIQRTFAHSSGEQSGSDTDTDSGYGGESEKGDLRSEQPCFKSDHGRRFTMGERIGAIKQESEEPPTKKNRMQLSDDEGHFTSSDLISSPFLGPHPHQPPFCLPFYLIPPSATAYLPMLEKCWYPTSVPVLYPGLNASAAALSSFMNPDKISAPLLMPQRLPSPLPAHPSVDSSVLLQALKPIPPLNLETKD,False,False,True,O14503,"[('cd19749', 'basic helix-loop-helix-orange (bHLH-O) domain found in differentially expressed in chondrocytes protein 1 (DEC1) and similar proteins'), ('G3DSA:4.10.280.10', 'Helix-loop-helix DNA-binding domain'), ('G3DSA:6.10.250.980', None), ('IPR003650', 'Orange domain'), ('IPR011598', 'Myc-type, basic helix-loop-helix (bHLH) domain'), ('IPR036638', 'Helix-loop-helix DNA-binding domain superfamily'), ('IPR050370', 'Hairy and Enhancer of Split/HEY-related'), ('PF00010', 'Helix-loop-helix DNA-binding domain'), ('PF07527', 'Hairy Orange'), ('PS50888', 'Myc-type, basic helix-loop-helix (bHLH) domain profile'), ('PS51054', 'Orange domain profile'), ('PTHR10985', 'Hairy and Enhancer of Split/HEY-related'), ('SM00353', 'helix loop helix domain'), ('SM00511', 'Orange domain'), ('SSF158457', 'Orange domain-like'), ('SSF47459', 'HLH, helix-loop-helix DNA-binding domain')]",,"""ENSG00000134107; Low tissue specificity."";",,,,,ENST00000256495.4;,BHLHE40,ENSG00000134107,0.0,,,,,,,0.711,0.296,BHLHE40
O14786,ENSG00000099250,NRP1_HUMAN,"angiogenesis [GO:0001525]; angiogenesis involved in coronary vascular morphogenesis [GO:0060978]; animal organ morphogenesis [GO:0009887]; artery morphogenesis [GO:0048844]; axon extension involved in axon guidance [GO:0048846]; axon guidance [GO:0007411]; axonal fasciculation [GO:0007413]; axonogenesis involved in innervation [GO:0060385]; basal dendrite arborization [GO:0150020]; basal dendrite development [GO:0150018]; branching involved in blood vessel morphogenesis [GO:0001569]; branchiomotor neuron axon guidance [GO:0021785]; cell migration involved in sprouting angiogenesis [GO:0002042]; cell-cell signaling [GO:0007267]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; commissural neuron axon guidance [GO:0071679]; coronary artery morphogenesis [GO:0060982]; dichotomous subdivision of terminal units involved in salivary gland branching [GO:0060666]; dorsal root ganglion morphogenesis [GO:1904835]; endothelial cell chemotaxis [GO:0035767]; endothelial tip cell fate specification [GO:0097102]; facial nerve structural organization [GO:0021612]; facioacoustic ganglion development [GO:1903375]; gonadotrophin-releasing hormone neuronal migration to the hypothalamus [GO:0021828]; hepatocyte growth factor receptor signaling pathway [GO:0048012]; integrin-mediated signaling pathway [GO:0007229]; motor neuron axon guidance [GO:0008045]; motor neuron migration [GO:0097475]; negative regulation of axon extension involved in axon guidance [GO:0048843]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of neuron apoptotic process [GO:0043524]; neural crest cell migration [GO:0001755]; neural crest cell migration involved in autonomic nervous system development [GO:1901166]; neuron migration [GO:0001764]; neuropilin signaling pathway [GO:0038189]; otic placode development [GO:1905040]; outflow tract septum morphogenesis [GO:0003148]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive chemotaxis [GO:0050918]; positive regulation of angiogenesis [GO:0045766]; positive regulation of axon extension involved in axon guidance [GO:0048842]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of smooth muscle cell migration [GO:0014911]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; postsynapse organization [GO:0099173]; protein localization to early endosome [GO:1902946]; regulation of Cdc42 protein signal transduction [GO:0032489]; regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030947]; regulation of vesicle-mediated transport [GO:0060627]; renal artery morphogenesis [GO:0061441]; response to wounding [GO:0009611]; retina vasculature morphogenesis in camera-type eye [GO:0061299]; retinal ganglion cell axon guidance [GO:0031290]; semaphorin-plexin signaling pathway [GO:0071526]; sensory neuron axon guidance [GO:0097374]; signal transduction [GO:0007165]; sprouting angiogenesis [GO:0002040]; substrate-dependent cell migration, cell extension [GO:0006930]; symbiont entry into host cell [GO:0046718]; sympathetic ganglion development [GO:0061549]; sympathetic neuron projection extension [GO:0097490]; sympathetic neuron projection guidance [GO:0097491]; trigeminal ganglion development [GO:0061551]; trigeminal nerve structural organization [GO:0021637]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; vasculogenesis [GO:0001570]; VEGF-activated neuropilin signaling pathway [GO:0038190]; ventral trunk neural crest cell migration [GO:0036486]; vestibulocochlear nerve structural organization [GO:0021649]",axon [GO:0030424]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; early endosome [GO:0005769]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; mitochondrial membrane [GO:0031966]; neurofilament [GO:0005883]; neuron projection [GO:0043005]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; receptor complex [GO:0043235]; semaphorin receptor complex [GO:0002116]; sorting endosome [GO:0097443],coreceptor activity [GO:0015026]; cytokine binding [GO:0019955]; growth factor binding [GO:0019838]; GTPase activator activity [GO:0005096]; heparin binding [GO:0008201]; metal ion binding [GO:0046872]; protein kinase binding [GO:0019901]; semaphorin receptor activity [GO:0017154]; vascular endothelial growth factor binding [GO:0038085]; vascular endothelial growth factor receptor activity [GO:0005021],,"DOMAIN: The tandem CUB domains mediate binding to semaphorin, while the tandem F5/8 domains are responsible for heparin and VEGF binding. F5/8 domains mediate the recognition and binding to R/KXXR/K CendR motifs (PubMed:19805273, PubMed:33082294). {ECO:0000269|PubMed:19805273, ECO:0000269|PubMed:33082294}.","DOMAIN 27..141; /note=""CUB 1""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00059""; DOMAIN 147..265; /note=""CUB 2""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00059""; DOMAIN 275..424; /note=""F5/8 type C 1""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00081""; DOMAIN 431..583; /note=""F5/8 type C 2""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00081""; DOMAIN 645..811; /note=""MAM""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00128""","STRAND 149..151; /evidence=""ECO:0007829|PDB:2QQM""; STRAND 153..159; /evidence=""ECO:0007829|PDB:2QQM""; STRAND 172..178; /evidence=""ECO:0007829|PDB:2QQM""; STRAND 185..193; /evidence=""ECO:0007829|PDB:2QQM""; STRAND 208..217; /evidence=""ECO:0007829|PDB:2QQM""; STRAND 223..227; /evidence=""ECO:0007829|PDB:2QQM""; STRAND 235..238; /evidence=""ECO:0007829|PDB:2QQM""; STRAND 240..248; /evidence=""ECO:0007829|PDB:2QQM""; STRAND 257..264; /evidence=""ECO:0007829|PDB:2QQM""; STRAND 284..286; /evidence=""ECO:0007829|PDB:5JGI""; STRAND 291..294; /evidence=""ECO:0007829|PDB:6FMC""; STRAND 318..321; /evidence=""ECO:0007829|PDB:6TKK""; STRAND 326..342; /evidence=""ECO:0007829|PDB:6FMC""; STRAND 352..368; /evidence=""ECO:0007829|PDB:6FMC""; STRAND 369..371; /evidence=""ECO:0007829|PDB:1KEX""; STRAND 373..378; /evidence=""ECO:0007829|PDB:5C7G""; STRAND 385..389; /evidence=""ECO:0007829|PDB:6FMC""; STRAND 391..414; /evidence=""ECO:0007829|PDB:6FMC""; STRAND 417..424; /evidence=""ECO:0007829|PDB:6FMC""; STRAND 447..449; /evidence=""ECO:0007829|PDB:2QQI""; STRAND 471..473; /evidence=""ECO:0007829|PDB:2QQM""; STRAND 485..502; /evidence=""ECO:0007829|PDB:2QQI""; STRAND 515..525; /evidence=""ECO:0007829|PDB:2QQI""; STRAND 534..537; /evidence=""ECO:0007829|PDB:2QQI""; STRAND 544..547; /evidence=""ECO:0007829|PDB:2QQI""; STRAND 550..566; /evidence=""ECO:0007829|PDB:2QQI""; STRAND 570..572; /evidence=""ECO:0007829|PDB:2QQI""; STRAND 576..584; /evidence=""ECO:0007829|PDB:2QQI""; STRAND 667..671; /evidence=""ECO:0007829|PDB:5L73""; STRAND 674..677; /evidence=""ECO:0007829|PDB:5L73""; STRAND 680..682; /evidence=""ECO:0007829|PDB:5L73""; STRAND 690..696; /evidence=""ECO:0007829|PDB:5L73""; STRAND 705..713; /evidence=""ECO:0007829|PDB:5L73""; STRAND 720..728; /evidence=""ECO:0007829|PDB:5L73""; STRAND 733..742; /evidence=""ECO:0007829|PDB:5L73""; STRAND 744..746; /evidence=""ECO:0007829|PDB:5L73""; STRAND 749..757; /evidence=""ECO:0007829|PDB:5L73""; STRAND 761..770; /evidence=""ECO:0007829|PDB:5L73""; STRAND 777..785; /evidence=""ECO:0007829|PDB:5L73""; STRAND 792..800; /evidence=""ECO:0007829|PDB:5L73""; STRAND 809..811; /evidence=""ECO:0007829|PDB:5L73""","HELIX 180..182; /evidence=""ECO:0007829|PDB:2QQM""; HELIX 288..290; /evidence=""ECO:0007829|PDB:6FMC""; HELIX 299..301; /evidence=""ECO:0007829|PDB:6FMC""; HELIX 303..306; /evidence=""ECO:0007829|PDB:6FMC""; HELIX 426..428; /evidence=""ECO:0007829|PDB:2QQI""; HELIX 444..446; /evidence=""ECO:0007829|PDB:2QQI""; HELIX 459..462; /evidence=""ECO:0007829|PDB:2QQI""; HELIX 643..645; /evidence=""ECO:0007829|PDB:5L73""; HELIX 699..701; /evidence=""ECO:0007829|PDB:5L73""","TURN 161..164; /evidence=""ECO:0007829|PDB:2QQM""; TURN 218..220; /evidence=""ECO:0007829|PDB:2QQM""; TURN 273..275; /evidence=""ECO:0007829|PDB:4RN5""; TURN 281..283; /evidence=""ECO:0007829|PDB:6FMC""; TURN 347..349; /evidence=""ECO:0007829|PDB:6FMC""; TURN 437..439; /evidence=""ECO:0007829|PDB:2QQI""; TURN 450..453; /evidence=""ECO:0007829|PDB:2QQI""; TURN 464..466; /evidence=""ECO:0007829|PDB:2QQM""; TURN 506..508; /evidence=""ECO:0007829|PDB:2QQM""; TURN 646..648; /evidence=""ECO:0007829|PDB:5L73""; TURN 686..689; /evidence=""ECO:0007829|PDB:5L73""; TURN 806..808; /evidence=""ECO:0007829|PDB:5L73""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,NRP1 NRP VEGF165R,Neuropilin-1 (Vascular endothelial cell growth factor 165 receptor) (CD antigen CD304),Homo sapiens (Human),923.0,103134.0,MERGLPLLCAVLALVLAPAGAFRNDKCGDTIKIESPGYLTSPGYPHSYHPSEKCEWLIQAPDPYQRIMINFNPHFDLEDRDCKYDYVEVFDGENENGHFRGKFCGKIAPPPVVSSGPFLFIKFVSDYETHGAGFSIRYEIFKRGPECSQNYTTPSGVIKSPGFPEKYPNSLECTYIVFVPKMSEIILEFESFDLEPDSNPPGGMFCRYDRLEIWDGFPDVGPHIGRYCGQKTPGRIRSSSGILSMVFYTDSAIAKEGFSANYSVLQSSVSEDFKCMEALGMESGEIHSDQITASSQYSTNWSAERSRLNYPENGWTPGEDSYREWIQVDLGLLRFVTAVGTQGAISKETKKKYYVKTYKIDVSSNGEDWITIKEGNKPVLFQGNTNPTDVVVAVFPKPLITRFVRIKPATWETGISMRFEVYGCKITDYPCSGMLGMVSGLISDSQITSSNQGDRNWMPENIRLVTSRSGWALPPAPHSYINEWLQIDLGEEKIVRGIIIQGGKHRENKVFMRKFKIGYSNNGSDWKMIMDDSKRKAKSFEGNNNYDTPELRTFPALSTRFIRIYPERATHGGLGLRMELLGCEVEAPTAGPTTPNGNLVDECDDDQANCHSGTGDDFQLTGGTTVLATEKPTVIDSTIQSEFPTYGFNCEFGWGSHKTFCHWEHDNHVQLKWSVLTSKTGPIQDHTGDGNFIYSQADENQKGKVARLVSPVVYSQNSAHCMTFWYHMSGSHVGTLRVKLRYQKPEEYDQLVWMAIGHQGDHWKEGRVLLHKSLKLYQVIFEGEIGKGNLGGIAVDDISINNHISQEDCAKPADLDKKNPEIKIDETGSTPGYEGEGEGDKNISRKPGNVLKTLDPILITIIAMSALGVLLGAVCGVVLYCACWHNGMSERNLSALENYNFELVDGVKLKKDKLNTQSTYSEA,True,False,False,O14786,"[('cd00041', 'CUB'), ('cd00057', 'FA58C'), ('cd06263', 'MAM'), ('G3DSA:2.60.120.200', None), ('G3DSA:2.60.120.260', 'Galactose-binding domain-like'), ('G3DSA:2.60.120.290', 'Spermadhesin, CUB domain'), ('IPR000421', 'Coagulation factor 5/8, C-terminal domain'), ('IPR000859', 'CUB domain'), ('IPR000998', 'MAM domain'), ('IPR008979', 'Galactose-binding-like domain superfamily'), ('IPR013320', 'Concanavalin A-like lectin/glucanase domain superfamily'), ('IPR014648', 'Neuropilin'), ('IPR022579', 'Neuropilin, C-terminal'), ('IPR035914', 'Spermadhesin, CUB domain superfamily'), ('IPR050633', 'Neuropilin/Multicopper Oxidase/Coagulation Factor'), ('PF00431', 'CUB domain'), ('PF00629', 'MAM domain, meprin/A5/mu'), ('PF00754', 'F5/8 type C domain'), ('PF11980', 'C-terminal domain of neuropilin glycoprotein'), ('PIRSF036960', 'Neuropilin')]",,"""ENSG00000099250; Low tissue specificity."";",,,,,ENST00000265371.8 [O14786-1];ENST00000374821.9 [O14786-3];ENST00000374822.8 [O14786-2];ENST00000374867.7 [O14786-1];,NRP1,ENSG00000099250,0.0,,,,,,,0.213,0.028,NRP1
O14788,ENSG00000120659,TNF11_HUMAN,bone resorption [GO:0045453]; calcium ion homeostasis [GO:0055074]; calcium-mediated signaling [GO:0019722]; cellular response to leukemia inhibitory factor [GO:1990830]; cytokine-mediated signaling pathway [GO:0019221]; ERK1 and ERK2 cascade [GO:0070371]; immune response [GO:0006955]; JNK cascade [GO:0007254]; mammary gland alveolus development [GO:0060749]; mammary gland epithelial cell proliferation [GO:0033598]; monocyte chemotaxis [GO:0002548]; negative regulation of transcription by RNA polymerase II [GO:0000122]; ossification [GO:0001503]; osteoclast development [GO:0036035]; osteoclast differentiation [GO:0030316]; osteoclast proliferation [GO:0002158]; paracrine signaling [GO:0038001]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; positive regulation of bone resorption [GO:0045780]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of corticotropin-releasing hormone secretion [GO:0051466]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fever generation by positive regulation of prostaglandin secretion [GO:0071812]; positive regulation of gene expression [GO:0010628]; positive regulation of homotypic cell-cell adhesion [GO:0034112]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of JNK cascade [GO:0046330]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of osteoclast development [GO:2001206]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of T cell activation [GO:0050870]; positive regulation of transcription by RNA polymerase II [GO:0045944]; tooth eruption [GO:0044691]; tumor necrosis factor-mediated signaling pathway [GO:0033209],cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; plasma membrane [GO:0005886],cytokine activity [GO:0005125]; identical protein binding [GO:0042802]; tumor necrosis factor receptor binding [GO:0005164]; tumor necrosis factor receptor superfamily binding [GO:0032813],PTM: The soluble form of isoform 1 derives from the membrane form by proteolytic processing (By similarity). The cleavage may be catalyzed by ADAM17. {ECO:0000250}.,,"DOMAIN 164..313; /note=""THD""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU01387""","STRAND 165..170; /evidence=""ECO:0007829|PDB:3URF""; STRAND 178..180; /evidence=""ECO:0007829|PDB:5BNQ""; STRAND 182..184; /evidence=""ECO:0007829|PDB:3URF""; STRAND 187..191; /evidence=""ECO:0007829|PDB:3URF""; STRAND 194..202; /evidence=""ECO:0007829|PDB:3URF""; STRAND 205..208; /evidence=""ECO:0007829|PDB:3URF""; STRAND 212..225; /evidence=""ECO:0007829|PDB:3URF""; STRAND 227..229; /evidence=""ECO:0007829|PDB:3URF""; STRAND 235..248; /evidence=""ECO:0007829|PDB:3URF""; STRAND 253..263; /evidence=""ECO:0007829|PDB:3URF""; STRAND 269..283; /evidence=""ECO:0007829|PDB:3URF""; STRAND 287..294; /evidence=""ECO:0007829|PDB:3URF""; STRAND 306..314; /evidence=""ECO:0007829|PDB:3URF""","HELIX 172..174; /evidence=""ECO:0007829|PDB:5BNQ""; HELIX 296..298; /evidence=""ECO:0007829|PDB:3URF""","TURN 303..305; /evidence=""ECO:0007829|PDB:3URF""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,TNFSF11 OPGL RANKL TRANCE,"Tumor necrosis factor ligand superfamily member 11 (Osteoclast differentiation factor) (ODF) (Osteoprotegerin ligand) (OPGL) (Receptor activator of nuclear factor kappa-B ligand) (RANKL) (TNF-related activation-induced cytokine) (TRANCE) (CD antigen CD254) [Cleaved into: Tumor necrosis factor ligand superfamily member 11, membrane form; Tumor necrosis factor ligand superfamily member 11, soluble form]",Homo sapiens (Human),317.0,35478.0,MRRASRDYTKYLRGSEEMGGGPGAPHEGPLHAPPPPAPHQPPAASRSMFVALLGLGLGQVVCSVALFFYFRAQMDPNRISEDGTHCIYRILRLHENADFQDTTLESQDTKLIPDSCRRIKQAFQGAVQKELQHIVGSQHIRAEKAMVDGSWLDLAKRSKLEAQPFAHLTINATDIPSGSHKVSLSSWYHDRGWAKISNMTFSNGKLIVNQDGFYYLYANICFRHHETSGDLATEYLQLMVYVTKTSIKIPSSHTLMKGGSTKYWSGNSEFHFYSINVGGFFKLRSGEEISIEVSNPSLLDPDQDATYFGAFKVRDID,False,False,True,O14788,"[('cd00184', 'TNF'), ('G3DSA:2.60.120.40', None), ('IPR006052', 'Tumour necrosis factor domain'), ('IPR008983', 'Tumour necrosis factor-like domain superfamily'), ('IPR017355', 'Tumour necrosis factor ligand 10/11'), ('PF00229', 'TNF(Tumour Necrosis Factor) family'), ('PIRSF038013', 'Tumor necrosis factor ligand superfamily member, 10/11 types'), ('PS50049', 'TNF family profile'), ('PTHR11471', 'Tumor Necrosis Factor'), ('SM00207', 'Tumour necrosis factor family.'), ('SSF49842', 'TNF-like')]",,"""ENSG00000120659; Tissue enhanced (liver, lymphoid tissue)."";",,,,,ENST00000358545.6 [O14788-2];ENST00000398795.7 [O14788-1];,TNFSF11,ENSG00000120659,0.0,,,,,,,0.404,0.136,TNFSF11
O15105,ENSG00000101665,SMAD7_HUMAN,adherens junction assembly [GO:0034333]; anatomical structure morphogenesis [GO:0009653]; artery morphogenesis [GO:0048844]; cell differentiation [GO:0030154]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to transforming growth factor beta stimulus [GO:0071560]; negative regulation of activin receptor signaling pathway [GO:0032926]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of cell migration [GO:0030336]; negative regulation of chondrocyte proliferation [GO:1902731]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of ossification [GO:0030279]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of SMAD protein signal transduction [GO:0060392]; negative regulation of T cell cytokine production [GO:0002725]; negative regulation of T-helper 17 cell differentiation [GO:2000320]; negative regulation of T-helper 17 type immune response [GO:2000317]; negative regulation of transcription by competitive promoter binding [GO:0010944]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of ubiquitin-protein transferase activity [GO:0051444]; positive regulation of cell-cell adhesion [GO:0022409]; positive regulation of chondrocyte hypertrophy [GO:1903043]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; protein stabilization [GO:0050821]; protein-containing complex localization [GO:0031503]; regulation of cardiac muscle contraction [GO:0055117]; regulation of epithelial to mesenchymal transition [GO:0010717]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of ventricular cardiac muscle cell membrane depolarization [GO:0060373]; response to laminar fluid shear stress [GO:0034616]; SMAD protein signal transduction [GO:0060395]; transforming growth factor beta receptor signaling pathway [GO:0007179]; ureteric bud development [GO:0001657]; ventricular cardiac muscle tissue morphogenesis [GO:0055010]; ventricular septum morphogenesis [GO:0060412],centrosome [GO:0005813]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; heteromeric SMAD protein complex [GO:0071144]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991],activin receptor binding [GO:0070697]; beta-catenin binding [GO:0008013]; collagen binding [GO:0005518]; I-SMAD binding [GO:0070411]; metal ion binding [GO:0046872]; transcription corepressor activity [GO:0003714]; transcription regulator inhibitor activity [GO:0140416]; type I transforming growth factor beta receptor binding [GO:0034713]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756],"PTM: Phosphorylation on Ser-249 does not affect its stability, nuclear localization or inhibitory function in TGFB signaling; however it affects its ability to regulate transcription (By similarity). Phosphorylated by PDPK1. {ECO:0000250|UniProtKB:O35253, ECO:0000269|PubMed:17327236}.; PTM: Ubiquitinated by WWP1 (By similarity). Polyubiquitinated by RNF111, which is enhanced by AXIN1 and promotes proteasomal degradation (PubMed:14657019, PubMed:16601693). In response to TGF-beta, ubiquitinated by SMURF1; which promotes its degradation (PubMed:11278251). {ECO:0000250|UniProtKB:O35253, ECO:0000269|PubMed:11278251, ECO:0000269|PubMed:14657019, ECO:0000269|PubMed:16601693}.; PTM: Acetylation prevents ubiquitination and degradation mediated by SMURF1. {ECO:0000269|PubMed:12408818}.",,"DOMAIN 64..207; /note=""MH1""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00438""; DOMAIN 261..426; /note=""MH2""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00439""","STRAND 204..206; /evidence=""ECO:0007829|PDB:2DJY""; STRAND 212..214; /evidence=""ECO:0007829|PDB:2DJY""",,,"cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,SMAD7 MADH7 MADH8,Mothers against decapentaplegic homolog 7 (MAD homolog 7) (Mothers against DPP homolog 7) (Mothers against decapentaplegic homolog 8) (MAD homolog 8) (Mothers against DPP homolog 8) (SMAD family member 7) (SMAD 7) (Smad7) (hSMAD7),Homo sapiens (Human),426.0,46426.0,MFRTKRSALVRRLWRSRAPGGEDEEEGAGGGGGGGELRGEGATDSRAHGAGGGGPGRAGCCLGKAVRGAKGHHHPHPPAAGAGAAGGAEADLKALTHSVLKKLKERQLELLLQAVESRGGTRTACLLLPGRLDCRLGPGAPAGAQPAQPPSSYSLPLLLCKVFRWPDLRHSSEVKRLCCCESYGKINPELVCCNPHHLSRLCELESPPPPYSRYPMDFLKPTADCPDAVPSSAETGGTNYLAPGGLSDSQLLLEPGDRSHWCVVAYWEEKTRVGRLYCVQEPSLDIFYDLPQGNGFCLGQLNSDNKSQLVQKVRSKIGCGIQLTREVDGVWVYNRSSYPIFIKSATLDNPDSRTLLVHKVFPGFSIKAFDYEKAYSLQRPNDHEFMQQPWTGFTVQISFVKGWGQCYTRQFISSCPCWLEVIFNSR,True,False,False,O15105,"[('cd10494', 'N-terminal Mad Homology 1 (MH1) domain in SMAD7'), ('cd10500', 'C-terminal Mad Homology 2 (MH2) domain in SMAD7'), ('G3DSA:2.60.200.10', None), ('G3DSA:3.90.520.10', 'SMAD MH1 domain'), ('IPR001132', 'SMAD domain, Dwarfin-type'), ('IPR003619', 'MAD homology 1, Dwarfin-type'), ('IPR008984', 'SMAD/FHA domain superfamily'), ('IPR013019', 'MAD homology, MH1'), ('IPR013790', 'Dwarfin'), ('IPR017855', 'SMAD-like domain superfamily'), ('IPR036578', 'SMAD MH1 domain superfamily'), ('PF03165', 'MH1 domain'), ('PF03166', 'MH2 domain'), ('PS51075', 'MAD homology domain 1 (MH1) profile'), ('PS51076', 'MAD homology domain 2 (MH2) profile'), ('PTHR13703', 'SMAD'), ('SM00523', 'Domain A in dwarfin family proteins'), ('SM00524', 'Domain B in dwarfin family proteins'), ('SSF49879', 'SMAD/FHA domain'), ('SSF56366', 'SMAD MH1 domain')]",,"""ENSG00000101665; Low tissue specificity."";",,,,,ENST00000262158.8 [O15105-1];ENST00000589634.1 [O15105-3];ENST00000591805.5 [O15105-2];,SMAD7,ENSG00000101665,0.0,SMAD7,Non-canonical_RBPs,2.0,,,,0.308,0.101,SMAD7
O15151,ENSG00000198625,MDM4_HUMAN,"atrial septum development [GO:0003283]; atrioventricular valve morphogenesis [GO:0003181]; cellular response to hypoxia [GO:0071456]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; endocardial cushion morphogenesis [GO:0003203]; heart valve development [GO:0003170]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein stabilization [GO:0050821]; protein ubiquitination [GO:0016567]; protein-containing complex assembly [GO:0065003]; regulation of cell cycle [GO:0051726]; ventricular septum development [GO:0003281]",nucleoplasm [GO:0005654]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053],enzyme binding [GO:0019899]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],"PTM: Phosphorylated. Phosphorylation at Ser-367 promotes interaction with YWHAG and subsequent ubiquitination and degradation. Phosphorylation at Ser-342 also induces ubiquitination and degradation but to a lower extent. {ECO:0000269|PubMed:16163388, ECO:0000269|PubMed:16511572, ECO:0000269|PubMed:19838211}.; PTM: Ubiquitinated and degraded by MDM2. Deubiquitination by USP2 on the other hand stabilizes the MDM4 protein. {ECO:0000269|PubMed:19838211}.",DOMAIN: Region I is sufficient for binding TP53 and inhibiting its G1 arrest and apoptosis functions. It also binds TP73. Region II contains most of a central acidic region and a putative C4-type zinc finger. The RING finger domain which coordinates two molecules of zinc mediates the heterooligomerization with MDM2.,"DOMAIN 25..108; /note=""SWIB/MDM2""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU01273""","STRAND 27..29; /evidence=""ECO:0007829|PDB:6Q9Y""; STRAND 68..70; /evidence=""ECO:0007829|PDB:4RXZ""; STRAND 73..75; /evidence=""ECO:0007829|PDB:6Q9Y""; STRAND 77..79; /evidence=""ECO:0007829|PDB:7KJN""; STRAND 88..91; /evidence=""ECO:0007829|PDB:6Q9Y""; STRAND 106..108; /evidence=""ECO:0007829|PDB:6Q9Y""; STRAND 307..309; /evidence=""ECO:0007829|PDB:2CR8""; STRAND 442..445; /evidence=""ECO:0007829|PDB:5MNJ""; STRAND 447..451; /evidence=""ECO:0007829|PDB:5MNJ""; STRAND 454..459; /evidence=""ECO:0007829|PDB:5MNJ""; STRAND 483..489; /evidence=""ECO:0007829|PDB:5MNJ""","HELIX 31..39; /evidence=""ECO:0007829|PDB:6Q9Y""; HELIX 49..62; /evidence=""ECO:0007829|PDB:6Q9Y""; HELIX 80..85; /evidence=""ECO:0007829|PDB:6Q9Y""; HELIX 96..105; /evidence=""ECO:0007829|PDB:6Q9Y""; HELIX 343..345; /evidence=""ECO:0007829|PDB:6YR7""; HELIX 429..434; /evidence=""ECO:0007829|PDB:5MNJ""; HELIX 461..469; /evidence=""ECO:0007829|PDB:5MNJ""","TURN 321..323; /evidence=""ECO:0007829|PDB:2CR8""; TURN 438..440; /evidence=""ECO:0007829|PDB:5MNJ""; TURN 475..477; /evidence=""ECO:0007829|PDB:5MNJ""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,MDM4 MDMX,Protein Mdm4 (Double minute 4 protein) (Mdm2-like p53-binding protein) (Protein Mdmx) (p53-binding protein Mdm4),Homo sapiens (Human),490.0,54864.0,MTSFSTSAQCSTSDSACRISPGQINQVRPKLPLLKILHAAGAQGEMFTVKEVMHYLGQYIMVKQLYDQQEQHMVYCGGDLLGELLGRQSFSVKDPSPLYDMLRKNLVTLATATTDAAQTLALAQDHSMDIPSQDQLKQSAEESSTSRKRTTEDDIPTLPTSEHKCIHSREDEDLIENLAQDETSRLDLGFEEWDVAGLPWWFLGNLRSNYTPRSNGSTDLQTNQDVGTAIVSDTTDDLWFLNESVSEQLGVGIKVEAADTEQTSEEVGKVSDKKVIEVGKNDDLEDSKSLSDDTDVEVTSEDEWQCTECKKFNSPSKRYCFRCWALRKDWYSDCSKLTHSLSTSDITAIPEKENEGNDVPDCRRTISAPVVRPKDAYIKKENSKLFDPCNSVEFLDLAHSSESQETISSMGEQLDNLSEQRTDTENMEDCQNLLKPCSLCEKRPRDGNIIHGRTGHLVTCFHCARRLKKAGASCPICKKEIQLVIKVFIA,False,False,True,O15151,"[('cd16784', 'Modified RING finger, HC subclass (C2H2C4-type), found in protein MDM4 and similar proteins'), ('cd17673', 'p53-binding domain found in MDM4 and similar proteins'), ('G3DSA:1.10.245.10', 'SWIB/MDM2 domain'), ('G3DSA:2.30.30.380', 'Zn-finger domain of Sec23/24'), ('G3DSA:3.30.40.10', 'Zinc/RING finger domain, C3HC4 (zinc finger)'), ('IPR001841', 'Zinc finger, RING-type'), ('IPR001876', 'Zinc finger, RanBP2-type'), ('IPR003121', 'SWIB/MDM2 domain'), ('IPR013083', 'Zinc finger, RING/FYVE/PHD-type'), ('IPR015458', 'MDM4'), ('IPR016495', 'p53 negative regulator Mdm2/Mdm4'), ('IPR036443', 'Zinc finger, RanBP2-type superfamily'), ('IPR036885', 'SWIB/MDM2 domain superfamily'), ('IPR051652', 'MDM2/MDM4 and MUL1'), ('PF00641', 'Zn-finger in Ran binding protein and others'), ('PF13920', 'Zinc finger, C3HC4 type (RING finger)'), ('PIRSF006748', 'p53 negative regulator Mdm2/Mdm4'), ('PIRSF500699', 'p53 negative regulator Mdm4'), ('PS01358', 'Zinc finger RanBP2-type signature'), ('PS50089', 'Zinc finger RING-type profile')]",,"""ENSG00000198625; Low tissue specificity."";",,,,,ENST00000367182.8 [O15151-1];ENST00000367183.7 [O15151-4];ENST00000454264.6 [O15151-5];,MDM4,ENSG00000198625,0.0,MDM4,Canonical_RBPs,1.0,24.49,DP03919,0.29,0.641,0.065,MDM4
O15287,ENSG00000221829,FANCG_HUMAN,DNA damage response [GO:0006974]; DNA repair [GO:0006281]; interstrand cross-link repair [GO:0036297]; mitochondrion organization [GO:0007005]; ovarian follicle development [GO:0001541]; response to radiation [GO:0009314]; spermatid development [GO:0007286],chromatin [GO:0000785]; cytosol [GO:0005829]; Fanconi anaemia nuclear complex [GO:0043240]; mitochondrion [GO:0005739]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886],damaged DNA binding [GO:0003684],,,,,,,"cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,FANCG XRCC9,Fanconi anemia group G protein (Protein FACG) (DNA repair protein XRCC9),Homo sapiens (Human),622.0,68554.0,MSRQTTSVGSSCLDLWREKNDRLVRQAKVAQNSGLTLRRQQLAQDALEGLRGLLHSLQGLPAAVPVLPLELTVTCNFIILRASLAQGFTEDQAQDIQRSLERVLETQEQQGPRLEQGLRELWDSVLRASCLLPELLSALHRLVGLQAALWLSADRLGDLALLLETLNGSQSGASKDLLLLLKTWSPPAEELDAPLTLQDAQGLKDVLLTAFAYRQGLQELITGNPDKALSSLHEAASGLCPRPVLVQVYTALGSCHRKMGNPQRALLYLVAALKEGSAWGPPLLEASRLYQQLGDTTAELESLELLVEALNVPCSSKAPQFLIEVELLLPPPDLASPLHCGTQSQTKHILASRCLQTGRAGDAAEHYLDLLALLLDSSEPRFSPPPSPPGPCMPEVFLEAAVALIQAGRAQDALTLCEELLSRTSSLLPKMSRLWEDARKGTKELPYCPLWVSATHLLQGQAWVQLGAQKVAISEFSRCLELLFRATPEEKEQGAAFNCEQGCKSDAALQQLRAAALISRGLEWVASGQDTKALQDFLLSVQMCPGNRDTYFHLLQTLKRLDRRDEATALWWRLEAQTKGSHEDALWSLPLYLESYLSWIRPSDRDAFLEEFRTSLPKSCDL,False,False,True,O15287,"[('G3DSA:1.25.40.10', 'Tetratricopeptide repeat domain'), ('IPR011990', 'Tetratricopeptide-like helical domain superfamily'), ('IPR019734', 'Tetratricopeptide repeat'), ('IPR039684', 'Fanconi anemia group G protein'), ('PTHR15254', 'FANCONI ANEMIA GROUP G PROTEIN FAMILY MEMBER'), ('SM00028', 'Tetratricopeptide repeats'), ('SSF48452', 'TPR-like')]",,"""ENSG00000221829; Low tissue specificity."";",,,,,ENST00000378643.8;ENST00000448890.2;,FANCG,ENSG00000221829,0.0,,,,,,,0.053,,FANCG
O15360,ENSG00000187741,FANCA_HUMAN,DNA repair [GO:0006281]; female gonad development [GO:0008585]; interstrand cross-link repair [GO:0036297]; male gonad development [GO:0008584]; male meiotic nuclear division [GO:0007140]; protein-containing complex assembly [GO:0065003]; regulation of CD40 signaling pathway [GO:2000348]; regulation of germ cell proliferation [GO:1905936]; regulation of inflammatory response [GO:0050727]; regulation of regulatory T cell differentiation [GO:0045589],chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Fanconi anaemia nuclear complex [GO:0043240]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],,"PTM: Phosphorylation is required for the formation of the nuclear complex. Not phosphorylated in cells derived from groups A, B, C, E, F, G, and H. {ECO:0000269|PubMed:9789045}.",,,,,,"cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,FANCA FAA FACA FANCH,Fanconi anemia group A protein (Protein FACA),Homo sapiens (Human),1455.0,162775.0,MSDSWVPNSASGQDPGGRRRAWAELLAGRVKREKYNPERAQKLKESAVRLLRSHQDLNALLLEVEGPLCKKLSLSKVIDCDSSEAYANHSSSFIGSALQDQASRLGVPVGILSAGMVASSVGQICTAPAETSHPVLLTVEQRKKLSSLLEFAQYLLAHSMFSRLSFCQELWKIQSSLLLEAVWHLHVQGIVSLQELLESHPDMHAVGSWLFRNLCCLCEQMEASCQHADVARAMLSDFVQMFVLRGFQKNSDLRRTVEPEKMPQVTVDVLQRMLIFALDALAAGVQEESSTHKIVRCWFGVFSGHTLGSVISTDPLKRFFSHTLTQILTHSPVLKASDAVQMQREWSFARTHPLLTSLYRRLFVMLSAEELVGHLQEVLETQEVHWQRVLSFVSALVVCFPEAQQLLEDWVARLMAQAFESCQLDSMVTAFLVVRQAALEGPSAFLSYADWFKASFGSTRGYHGCSKKALVFLFTFLSELVPFESPRYLQVHILHPPLVPGKYRSLLTDYISLAKTRLADLKVSIENMGLYEDLSSAGDITEPHSQALQDVEKAIMVFEHTGNIPVTVMEASIFRRPYYVSHFLPALLTPRVLPKVPDSRVAFIESLKRADKIPPSLYSTYCQACSAAEEKPEDAALGVRAEPNSAEEPLGQLTAALGELRASMTDPSQRDVISAQVAVISERLRAVLGHNEDDSSVEISKIQLSINTPRLEPREHMAVDLLLTSFCQNLMAASSVAPPERQGPWAALFVRTMCGRVLPAVLTRLCQLLRHQGPSLSAPHVLGLAALAVHLGESRSALPEVDVGPPAPGAGLPVPALFDSLLTCRTRDSLFFCLKFCTAAISYSLCKFSSQSRDTLCSCLSPGLIKKFQFLMFRLFSEARQPLSEEDVASLSWRPLHLPSADWQRAALSLWTHRTFREVLKEEDVHLTYQDWLHLELEIQPEADALSDTERQDFHQWAIHEHFLPESSASGGCDGDLQAACTILVNALMDFHQSSRSYDHSENSDLVFGGRTGNEDIISRLQEMVADLELQQDLIVPLGHTPSQEHFLFEIFRRRLQALTSGWSVAASLQRQRELLMYKRILLRLPSSVLCGSSFQAEQPITARCEQFFHLVNSEMRNFCSHGGALTQDITAHFFRGLLNACLRSRDPSLMVDFILAKCQTKCPLILTSALVWWPSLEPVLLCRWRRHCQSPLPRELQKLQEGRQFASDFLSPEAASPAPNPDWLSAAALHFAIQQVREENIRKQLKKLDCEREELLVFLFFFSLMGLLSSHLTSNSTTDLPKAFHVCAAILECLEKRKISWLALFQLTESDLRLGRLLLRVAPDQHTRLLPFAFYSLLSYFHEDAAIREEAFLHVAVDMYLKLVQLFVAGDTSTVSPPAGRSLELKGQGNPVELITKARLFLLQLIPRCPKKSFSHVAELLADRGDCDPEVSAALQSRQQAAPDADLSQEPHLF,False,False,True,O15360,"[('IPR003516', 'Fanconi anaemia group A protein'), ('IPR031729', 'Fanconi anaemia group A protein, N-terminal domain'), ('IPR055277', 'Fanconi anaemia group A protein, C-terminal'), ('IPR055386', 'Fanconi anaemia group A protein, helical domain'), ('IPR055387', 'Fanconi anaemia group A protein, arcN subdomain'), ('PF03511', 'Fanconi anaemia group A protein C-terminal domain'), ('PF15865', 'Fanconi anaemia group A protein N terminus'), ('PF24781', 'FANCA helical domain'), ('PF24783', 'FANCA arcN subdomain'), ('PR00826', 'FANCONIAGENE'), ('PTHR12047', 'FANCONI ANEMIA GROUP A PROTEIN')]",,"""ENSG00000187741; Tissue enhanced (testis)."";",,,,,ENST00000389301.8 [O15360-1];ENST00000389302.7 [O15360-2];ENST00000568369.6 [O15360-3];ENST00000696275.1 [O15360-2];,FANCA,ENSG00000187741,0.0,,,,,,,0.089,,FANCA
O15371,ENSG00000100353,EIF3D_HUMAN,cap-dependent translational initiation [GO:0002191]; formation of cytoplasmic translation initiation complex [GO:0001732]; IRES-dependent viral translational initiation [GO:0075522]; positive regulation of mRNA binding [GO:1902416]; positive regulation of translation [GO:0045727]; translational initiation [GO:0006413]; viral translational termination-reinitiation [GO:0075525],"cytosol [GO:0005829]; eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex, eIF3m [GO:0071541]; membrane [GO:0016020]; synapse [GO:0045202]",mRNA cap binding [GO:0098808]; RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743],,DOMAIN: The RNA gate region regulates mRNA cap recognition to prevent promiscuous mRNA-binding before assembly of EIF3D into the full eukaryotic translation initiation factor 3 (eIF-3) complex. {ECO:0000305|PubMed:27462815}.,,"STRAND 35..37; /evidence=""ECO:0007829|PDB:6YBD""; STRAND 169..175; /evidence=""ECO:0007829|PDB:6YBS""; STRAND 193..196; /evidence=""ECO:0007829|PDB:6YBS""; STRAND 244..246; /evidence=""ECO:0007829|PDB:6YBS""; STRAND 267..270; /evidence=""ECO:0007829|PDB:6YBS""; STRAND 276..280; /evidence=""ECO:0007829|PDB:6YBS""; STRAND 342..345; /evidence=""ECO:0007829|PDB:6YBS""; STRAND 357..361; /evidence=""ECO:0007829|PDB:6YBS""; STRAND 371..374; /evidence=""ECO:0007829|PDB:6YBS""; STRAND 390..395; /evidence=""ECO:0007829|PDB:6YBS""; STRAND 445..456; /evidence=""ECO:0007829|PDB:6YBS""; STRAND 463..471; /evidence=""ECO:0007829|PDB:6YBS""; STRAND 503..507; /evidence=""ECO:0007829|PDB:6YBS""; STRAND 516..521; /evidence=""ECO:0007829|PDB:6YBS""","HELIX 176..180; /evidence=""ECO:0007829|PDB:6YBS""; HELIX 204..207; /evidence=""ECO:0007829|PDB:6YBS""; HELIX 233..236; /evidence=""ECO:0007829|PDB:6YBS""; HELIX 309..322; /evidence=""ECO:0007829|PDB:6YBS""; HELIX 323..325; /evidence=""ECO:0007829|PDB:6YBS""; HELIX 409..412; /evidence=""ECO:0007829|PDB:6YBS""; HELIX 417..427; /evidence=""ECO:0007829|PDB:6YBS""; HELIX 430..441; /evidence=""ECO:0007829|PDB:6YBS""; HELIX 475..478; /evidence=""ECO:0007829|PDB:6YBS""; HELIX 484..497; /evidence=""ECO:0007829|PDB:6YBS""","TURN 229..231; /evidence=""ECO:0007829|PDB:6YBS""; TURN 237..241; /evidence=""ECO:0007829|PDB:6YBS""; TURN 253..256; /evidence=""ECO:0007829|PDB:6YBS""; TURN 258..260; /evidence=""ECO:0007829|PDB:6YBS""; TURN 401..405; /evidence=""ECO:0007829|PDB:6YBS""; TURN 413..415; /evidence=""ECO:0007829|PDB:6YBS""; TURN 479..481; /evidence=""ECO:0007829|PDB:6YBS""; TURN 512..515; /evidence=""ECO:0007829|PDB:6YBS""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,EIF3D EIF3S7,Eukaryotic translation initiation factor 3 subunit D (eIF3d) (Eukaryotic translation initiation factor 3 subunit 7) (eIF-3-zeta) (eIF3 p66),Homo sapiens (Human),548.0,63973.0,MAKFMTPVIQDNPSGWGPCAVPEQFRDMPYQPFSKGDRLGKVADWTGATYQDKRYTNKYSSQFGGGSQYAYFHEEDESSFQLVDTARTQKTAYQRNRMRFAQRNLRRDKDRRNMLQFNLQILPKSAKQKERERIRLQKKFQKQFGVRQKWDQKSQKPRDSSVEVRSDWEVKEEMDFPQLMKMRYLEVSEPQDIECCGALEYYDKAFDRITTRSEKPLRSIKRIFHTVTTTDDPVIRKLAKTQGNVFATDAILATLMSCTRSVYSWDIVVQRVGSKLFFDKRDNSDFDLLTVSETANEPPQDEGNSFNSPRNLAMEATYINHNFSQQCLRMGKERYNFPNPNPFVEDDMDKNEIASVAYRYRRWKLGDDIDLIVRCEHDGVMTGANGEVSFINIKTLNEWDSRHCNGVDWRQKLDSQRGAVIATELKNNSYKLARWTCCALLAGSEYLKLGYVSRYHVKDSSRHVILGTQQFKPNEFASQINLSVENAWGILRCVIDICMKLEEGKYLILKDPNKQVIRVYSLPDGTFSSDEDEEEEEEEEEEEEEEET,False,True,False,O15371,"[('IPR007783', 'Eukaryotic translation initiation factor 3 subunit D'), ('MF_03003', 'Eukaryotic translation initiation factor 3 subunit D [EIF3D]'), ('PF05091', 'Eukaryotic translation initiation factor 3 subunit 7 (eIF-3)'), ('PIRSF016281', 'Translation initiation factor eIF-3, subunit d'), ('PTHR12399', 'EUKARYOTIC TRANSLATION INITIATION FACTOR 3 SUBUNIT 7')]",,"""ENSG00000100353; Low tissue specificity."";",,,,,ENST00000216190.13 [O15371-1];ENST00000405442.5 [O15371-1];,EIF3D,ENSG00000100353,0.0,EIF3D,Canonical_RBPs,25.0,,,,0.321,0.047,EIF3D
O15530,ENSG00000140992,PDPK1_HUMAN,actin cytoskeleton organization [GO:0030036]; activation of protein kinase B activity [GO:0032148]; calcium-mediated signaling [GO:0019722]; cell migration [GO:0016477]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to insulin stimulus [GO:0032869]; epidermal growth factor receptor signaling pathway [GO:0007173]; extrinsic apoptotic signaling pathway [GO:0097191]; hyperosmotic response [GO:0006972]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; intracellular signal transduction [GO:0035556]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of phospholipase activity [GO:0010518]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; positive regulation of sprouting angiogenesis [GO:1903672]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of canonical NF-kappaB signal transduction [GO:0043122]; regulation of mast cell degranulation [GO:0043304]; T cell costimulation [GO:0031295]; type B pancreatic cell development [GO:0003323],cell projection [GO:0042995]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069],3-phosphoinositide-dependent protein kinase activity [GO:0004676]; ATP binding [GO:0005524]; histone H2AS1 kinase activity [GO:0044024]; phospholipase activator activity [GO:0016004]; phospholipase binding [GO:0043274]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],"PTM: Phosphorylation on Ser-241 in the activation loop is required for full activity. PDPK1 itself can autophosphorylate Ser-241, leading to its own activation. Autophosphorylation is inhibited by the apoptotic C-terminus cleavage product of PKN2 (By similarity). Tyr-9 phosphorylation is critical for stabilization of both PDPK1 and the PDPK1/SRC complex via HSP90-mediated protection of PDPK1 degradation. Angiotensin II stimulates the tyrosine phosphorylation of PDPK1 in vascular smooth muscle in a calcium- and SRC-dependent manner. Phosphorylated on Tyr-9, Tyr-373 and Tyr-376 by INSR in response to insulin. Palmitate negatively regulates autophosphorylation at Ser-241 and palmitate-induced phosphorylation at Ser-529 and Ser-501 by PKC/PRKCQ negatively regulates its ability to phosphorylate PKB/AKT1. Phosphorylation at Thr-354 by MELK partially inhibits kinase activity, the inhibition is cooperatively enhanced by phosphorylation at Ser-394 and Ser-398 by MAP3K5. {ECO:0000250, ECO:0000269|PubMed:10455013, ECO:0000269|PubMed:11481331, ECO:0000269|PubMed:14585963, ECO:0000269|PubMed:15743829, ECO:0000269|PubMed:16314505, ECO:0000269|PubMed:16780920, ECO:0000269|PubMed:22544756, ECO:0000269|Ref.8}.; PTM: Autophosphorylated; autophosphorylation is inhibited by the apoptotic C-terminus cleavage product of PKN2. {ECO:0000250}.; PTM: Monoubiquitinated in the kinase domain, deubiquitinated by USP4.",DOMAIN: The PH domain plays a pivotal role in the localization and nuclear import of PDPK1 and is also essential for its homodimerization.; DOMAIN: The PIF-pocket is a small lobe in the catalytic domain required by the enzyme for the binding to the hydrophobic motif of its substrates. It is an allosteric regulatory site that can accommodate small compounds acting as allosteric inhibitors. {ECO:0000305|PubMed:22999883}.,"DOMAIN 82..342; /note=""Protein kinase""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00159""; DOMAIN 459..550; /note=""PH""","STRAND 82..90; /evidence=""ECO:0007829|PDB:5LVO""; STRAND 95..101; /evidence=""ECO:0007829|PDB:5LVO""; STRAND 107..114; /evidence=""ECO:0007829|PDB:5LVO""; STRAND 145..150; /evidence=""ECO:0007829|PDB:5LVO""; STRAND 152..159; /evidence=""ECO:0007829|PDB:5LVO""; STRAND 163..166; /evidence=""ECO:0007829|PDB:3PWY""; STRAND 211..213; /evidence=""ECO:0007829|PDB:5LVO""; STRAND 219..221; /evidence=""ECO:0007829|PDB:5LVO""; STRAND 238..240; /evidence=""ECO:0007829|PDB:3OTU""; STRAND 303..305; /evidence=""ECO:0007829|PDB:3QD3""; STRAND 416..420; /evidence=""ECO:0007829|PDB:1W1G""; STRAND 423..426; /evidence=""ECO:0007829|PDB:1W1G""; STRAND 457..467; /evidence=""ECO:0007829|PDB:1W1G""; STRAND 470..479; /evidence=""ECO:0007829|PDB:1W1G""; STRAND 483..488; /evidence=""ECO:0007829|PDB:1W1G""; STRAND 493..498; /evidence=""ECO:0007829|PDB:1W1G""; STRAND 505..518; /evidence=""ECO:0007829|PDB:1W1G""; STRAND 521..526; /evidence=""ECO:0007829|PDB:1W1G""","HELIX 79..81; /evidence=""ECO:0007829|PDB:5LVO""; HELIX 115..120; /evidence=""ECO:0007829|PDB:5LVO""; HELIX 124..136; /evidence=""ECO:0007829|PDB:5LVO""; HELIX 167..174; /evidence=""ECO:0007829|PDB:5LVO""; HELIX 179..198; /evidence=""ECO:0007829|PDB:5LVO""; HELIX 208..210; /evidence=""ECO:0007829|PDB:5LVO""; HELIX 224..226; /evidence=""ECO:0007829|PDB:3ORX""; HELIX 246..248; /evidence=""ECO:0007829|PDB:5LVO""; HELIX 251..256; /evidence=""ECO:0007829|PDB:5LVO""; HELIX 261..277; /evidence=""ECO:0007829|PDB:5LVO""; HELIX 287..295; /evidence=""ECO:0007829|PDB:5LVO""; HELIX 307..316; /evidence=""ECO:0007829|PDB:5LVO""; HELIX 321..323; /evidence=""ECO:0007829|PDB:5LVO""; HELIX 328..330; /evidence=""ECO:0007829|PDB:5LVO""; HELIX 333..337; /evidence=""ECO:0007829|PDB:5LVO""; HELIX 340..342; /evidence=""ECO:0007829|PDB:5LVO""; HELIX 347..352; /evidence=""ECO:0007829|PDB:5LVO""; HELIX 412..415; /evidence=""ECO:0007829|PDB:1W1G""; HELIX 432..445; /evidence=""ECO:0007829|PDB:1W1G""; HELIX 449..451; /evidence=""ECO:0007829|PDB:1W1G""; HELIX 532..547; /evidence=""ECO:0007829|PDB:1W1G""","TURN 7..9; /evidence=""ECO:0007829|PDB:6WJQ""; TURN 102..104; /evidence=""ECO:0007829|PDB:5LVO""; TURN 232..235; /evidence=""ECO:0007829|PDB:5LVO""; TURN 452..454; /evidence=""ECO:0007829|PDB:1W1G""; TURN 480..482; /evidence=""ECO:0007829|PDB:1W1G""; TURN 489..492; /evidence=""ECO:0007829|PDB:1W1G""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,PDPK1 PDK1,3-phosphoinositide-dependent protein kinase 1 (hPDK1) (EC 2.7.11.1),Homo sapiens (Human),556.0,63152.0,MARTTSQLYDAVPIQSSVVLCSCPSPSMVRTQTESSTPPGIPGGSRQGPAMDGTAAEPRPGAGSLQHAQPPPQPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKLTAYLPAMSEDDEDCYGNYDNLLSQFGCMQVSSSSSSHSLSASDTGLPQRSGSNIEQYIHDLDSNSFELDLQFSEDEKRLLLEKQAGGNPWHQFVENNLILKMGPVDKRKGLFARRRQLLLTEGPHLYYVDPVNKVLKGEIPWSQELRPEAKNFKTFFVHTPNRTYYLMDPSGNAHKWCRKIQEVWRQRYQSHPDAAVQ,False,False,True,O15530,"[('cd01262', '3-Phosphoinositide dependent protein kinase 1 (PDK1) pleckstrin homology (PH) domain'), ('cd05581', 'Catalytic domain of the Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1'), ('G3DSA:1.10.510.10', 'Transferase(Phosphotransferase) domain 1'), ('G3DSA:2.30.29.30', 'Pleckstrin-homology domain (PH domain)/Phosphotyrosine-binding domain (PTB)'), ('G3DSA:3.30.200.20', 'Phosphorylase Kinase; domain 1'), ('IPR000719', 'Protein kinase domain'), ('IPR008271', 'Serine/threonine-protein kinase, active site'), ('IPR011009', 'Protein kinase-like domain superfamily'), ('IPR011993', 'PH-like domain superfamily'), ('IPR017441', 'Protein kinase, ATP binding site'), ('IPR033931', 'PDK1-type, PH domain'), ('IPR039046', 'PDPK1 family'), ('IPR050236', 'Serine/threonine-protein kinases, AGC'), ('PF00069', 'Protein kinase domain'), ('PF14593', 'PH domain'), ('PS00107', 'Protein kinases ATP-binding region signature'), ('PS00108', 'Serine/Threonine protein kinases active-site signature'), ('PS50011', 'Protein kinase domain profile'), ('PS51257', 'Prokaryotic membrane lipoprotein lipid attachment site profile'), ('PTHR24356', 'Serine/threonine-protein kinases, AGC')]",O15530;,"""ENSG00000140992; Low tissue specificity."";","CATALYTIC ACTIVITY: Reaction=L-seryl-[protein] + ATP = O-phospho-L-seryl-[protein] + ADP + H(+); Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616, ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.1; Evidence={ECO:0000269|PubMed:9368760}; CATALYTIC ACTIVITY: Reaction=L-threonyl-[protein] + ATP = O-phospho-L-threonyl-[protein] + ADP + H(+); Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060, Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013, ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216; EC=2.7.11.1; Evidence={ECO:0000269|PubMed:9368760};",2.7.11.1,"ACTIVITY REGULATION: Homodimerization regulates its activity by maintaining the kinase in an autoinhibitory conformation. NPRL2 down-regulates its activity by interfering with tyrosine phosphorylation at the Tyr-9, Tyr-373 and Tyr-376 residues. The 14-3-3 protein YWHAQ acts as a negative regulator by association with the residues surrounding the Ser-241 residue. STRAP positively regulates its activity by enhancing its autophosphorylation and by stimulating its dissociation from YWHAQ. SMAD2, SMAD3, SMAD4 and SMAD7 also positively regulate its activity by stimulating its dissociation from YWHAQ. Activated by phosphorylation on Tyr-9, Tyr-373 and Tyr-376 by INSR in response to insulin. {ECO:0000269|PubMed:12177059, ECO:0000269|PubMed:16251192, ECO:0000269|PubMed:18616680, ECO:0000269|PubMed:20978239}.",,ENST00000268673.11 [O15530-4];ENST00000342085.9 [O15530-1];ENST00000441549.7 [O15530-5];,PDPK1,ENSG00000140992,0.0,,,,,,,0.227,0.099,PDPK1
O43264,ENSG00000086827,ZW10_HUMAN,"cell division [GO:0051301]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; establishment of mitotic spindle orientation [GO:0000132]; Golgi organization [GO:0007030]; meiotic cell cycle [GO:0051321]; mitotic metaphase chromosome alignment [GO:0007080]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle assembly checkpoint signaling [GO:0007094]; protein localization to kinetochore [GO:0034501]; protein transport [GO:0015031]; protein-containing complex assembly [GO:0065003]; regulation of attachment of spindle microtubules to kinetochore [GO:0051988]; regulation of exit from mitosis [GO:0007096]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]",cytosol [GO:0005829]; Dsl1/NZR complex [GO:0070939]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; lipid droplet [GO:0005811]; membrane [GO:0016020]; nucleus [GO:0005634]; RZZ complex [GO:1990423]; spindle pole [GO:0000922],centromeric DNA binding [GO:0019237],,,,,,,"cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,ZW10,Centromere/kinetochore protein zw10 homolog,Homo sapiens (Human),779.0,88829.0,MASFVTEVLAHSGRLEKEDLGTRISRLTRRVEEIKGEVCNMISKKYSEFLPSMQSAQGLITQVDKLSEDIDLLKSRIESEVRRDLHVSTGEFTDLKQQLERDSVVLSLLKQLQEFSTAIEEYNCALTEKKYVTGAQRLEEAQKCLKLLKSRKCFDLKILKSLSMELTIQKQNILYHLGEEWQKLIVWKFPPSKDTSSLESYLQTELHLYTEQSHKEEKTPMPPISSVLLAFSVLGELHSKLKSFGQMLLKYILRPLASCPSLHAVIESQPNIVIIRFESIMTNLEYPSPSEVFTKIRLVLEVLQKQLLDLPLDTDLENEKTSTVPLAEMLGDMIWEDLSECLIKNCLVYSIPTNSSKLQQYEEIIQSTEEFENALKEMRFLKGDTTDLLKYARNINSHFANKKCQDVIVAARNLMTSEIHNTVKIIPDSKINVPELPTPDEDNKLEVQKVSNTQYHEVMNLEPENTLDQHSFSLPTCRISESVKKLMELAYQTLLEATTSSDQCAVQLFYSVRNIFHLFHDVVPTYHKENLQKLPQLAAIHHNNCMYIAHHLLTLGHQFRLRLAPILCDGTATFVDLVPGFRRLGTECFLAQMRAQKGELLERLSSARNFSNMDDEENYSAASKAVRQVLHQLKRLGIVWQDVLPVNIYCKAMGTLLNTAISEVIGKITALEDISTEDGDRLYSLCKTVMDEGPQVFAPLSEESKNKKYQEEVPVYVPKWMPFKELMMMLQASLQEIGDRWADGKGPLAAAFSSSEVKALIRALFQNTERRAAALAKIK,True,False,False,O43264,"[('G3DSA:1.10.357.150', None), ('IPR009361', 'Centromere/kinetochore protein zw10, N-terminal'), ('IPR046362', 'Zw10/DSL1, C-terminal'), ('IPR048343', 'Centromere/kinetochore protein zw10, C-terminal domain'), ('IPR048344', 'Centromere/kinetochore protein zw10, middle domain'), ('IPR055148', 'ZW10, C-terminal helical domain'), ('PF06248', 'Centromere/kinetochore Zw10 N-terminal'), ('PF20665', 'Centromere/kinetochore protein zw10, middle domain'), ('PF20666', 'Centromere/kinetochore protein zw10, C-terminal'), ('PF22766', 'ZW10 C-terminal helical domain'), ('PTHR12205', 'Centromere/kinetochore-associated protein')]",,"""ENSG00000086827; Low tissue specificity."";",,,,,ENST00000200135.8 [O43264-1];ENST00000535142.5 [O43264-2];,ZW10,ENSG00000086827,0.0,,,,,,,0.095,,ZW10
O43318,ENSG00000135341,M3K7_HUMAN,"anoikis [GO:0043276]; canonical NF-kappaB signal transduction [GO:0007249]; cellular response to angiotensin [GO:1904385]; cellular response to hypoxia [GO:0071456]; cellular response to tumor necrosis factor [GO:0071356]; cytoplasmic pattern recognition receptor signaling pathway [GO:0002753]; defense response to bacterium [GO:0042742]; Fc-epsilon receptor signaling pathway [GO:0038095]; I-kappaB phosphorylation [GO:0007252]; immune response [GO:0006955]; inflammatory response [GO:0006954]; interleukin-1-mediated signaling pathway [GO:0070498]; interleukin-17A-mediated signaling pathway [GO:0038173]; interleukin-33-mediated signaling pathway [GO:0038172]; JNK cascade [GO:0007254]; MAPK cascade [GO:0000165]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; negative regulation of gene expression [GO:0010629]; nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway [GO:0035872]; p38MAPK cascade [GO:0038066]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of cell cycle [GO:0045787]; positive regulation of cell size [GO:0045793]; positive regulation of cGAS/STING signaling pathway [GO:0141111]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of macroautophagy [GO:0016239]; positive regulation of non-canonical NF-kappaB signal transduction [GO:1901224]; positive regulation of T cell cytokine production [GO:0002726]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; stress-activated MAPK cascade [GO:0051403]; T cell receptor signaling pathway [GO:0050852]; toll-like receptor 3 signaling pathway [GO:0034138]; toll-like receptor 4 signaling pathway [GO:0034142]; transforming growth factor beta receptor signaling pathway [GO:0007179]; TRIF-dependent toll-like receptor signaling pathway [GO:0035666]",ATAC complex [GO:0140672]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; nucleus [GO:0005634]; plasma membrane [GO:0005886],ATP binding [GO:0005524]; DNA-binding transcription factor binding [GO:0140297]; histone kinase activity [GO:0035173]; identical protein binding [GO:0042802]; linear polyubiquitin binding [GO:1990450]; magnesium ion binding [GO:0000287]; MAP kinase activity [GO:0004707]; MAP kinase kinase kinase activity [GO:0004709]; MAP kinase kinase kinase kinase activity [GO:0008349]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine kinase binding [GO:0120283]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110]; transcription coactivator binding [GO:0001223]; type II transforming growth factor beta receptor binding [GO:0005114]; ubiquitin protein ligase binding [GO:0031625],"PTM: Association with TAB1/MAP3K7IP1 promotes autophosphorylation at Ser-192 and subsequent activation. Association with TAB2/MAP3K7IP2, itself associated with free unanchored Lys-63 polyubiquitin chain, promotes autophosphorylation and subsequent activation of MAP3K7. Dephosphorylation at Ser-192 by PPM1B/PP2CB and at Thr-187 by PP2A and PPP6C leads to inactivation. {ECO:0000269|PubMed:10702308, ECO:0000269|PubMed:10838074, ECO:0000269|PubMed:16845370, ECO:0000269|PubMed:17548520, ECO:0000269|PubMed:19675569, ECO:0000269|PubMed:21512573, ECO:0000269|PubMed:37832545}.; PTM: 'Lys-48'-linked polyubiquitination at Lys-72 is induced by TNFalpha, and leads to proteasomal degradation. Undergoes 'Lys-48'-linked polyubiquitination catalyzed by ITCH (By similarity). Requires 'Lys-63'-linked polyubiquitination for autophosphorylation and subsequent activation. 'Lys-63'-linked ubiquitination does not lead to proteasomal degradation. Deubiquitinated by CYLD, a protease that selectively cleaves 'Lys-63'-linked ubiquitin chains. Deubiquitinated by Y.enterocolitica YopP. {ECO:0000250|UniProtKB:Q62073, ECO:0000269|PubMed:17548520, ECO:0000269|PubMed:22406003}.; PTM: (Microbial infection) Cleaved and inactivated by the proteases 3C of coxsackievirus A16 and human enterovirus D68, allowing the virus to disrupt TRAF6-triggered NF-kappa-B induction. {ECO:0000269|PubMed:28424289}.; PTM: (Microbial infection) Acetylation of Thr-184 and Thr-187 by Yersinia YopJ prevents phosphorylation and activation, thus blocking the MAPK signaling pathway. {ECO:0000269|PubMed:22520462, ECO:0000269|PubMed:22802624}.",,"DOMAIN 36..291; /note=""Protein kinase""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00159""","STRAND 36..44; /evidence=""ECO:0007829|PDB:7NTH""; STRAND 46..57; /evidence=""ECO:0007829|PDB:7NTH""; STRAND 59..64; /evidence=""ECO:0007829|PDB:7NTH""; STRAND 92..96; /evidence=""ECO:0007829|PDB:7NTH""; STRAND 101..105; /evidence=""ECO:0007829|PDB:7NTH""; STRAND 108..111; /evidence=""ECO:0007829|PDB:7NTH""; STRAND 118..123; /evidence=""ECO:0007829|PDB:7NTH""; STRAND 148..150; /evidence=""ECO:0007829|PDB:7NTH""; STRAND 162..165; /evidence=""ECO:0007829|PDB:7NTH""; STRAND 170..173; /evidence=""ECO:0007829|PDB:7NTH""; STRAND 300..302; /evidence=""ECO:0007829|PDB:5JGA""","HELIX 33..35; /evidence=""ECO:0007829|PDB:7NTH""; HELIX 68..70; /evidence=""ECO:0007829|PDB:7NTH""; HELIX 71..83; /evidence=""ECO:0007829|PDB:7NTH""; HELIX 112..117; /evidence=""ECO:0007829|PDB:7NTH""; HELIX 127..145; /evidence=""ECO:0007829|PDB:7NTH""; HELIX 159..161; /evidence=""ECO:0007829|PDB:7NTH""; HELIX 182..186; /evidence=""ECO:0007829|PDB:5GJF""; HELIX 193..195; /evidence=""ECO:0007829|PDB:7NTH""; HELIX 198..201; /evidence=""ECO:0007829|PDB:7NTH""; HELIX 209..224; /evidence=""ECO:0007829|PDB:7NTH""; HELIX 236..244; /evidence=""ECO:0007829|PDB:7NTH""; HELIX 257..266; /evidence=""ECO:0007829|PDB:7NTH""; HELIX 271..273; /evidence=""ECO:0007829|PDB:7NTH""; HELIX 277..288; /evidence=""ECO:0007829|PDB:7NTH""","TURN 97..100; /evidence=""ECO:0007829|PDB:7NTH""; TURN 166..169; /evidence=""ECO:0007829|PDB:7NTH""; TURN 228..231; /evidence=""ECO:0007829|PDB:7NTH""; TURN 292..295; /evidence=""ECO:0007829|PDB:7NTH""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,MAP3K7 TAK1,Mitogen-activated protein kinase kinase kinase 7 (EC 2.7.11.25) (Transforming growth factor-beta-activated kinase 1) (TGF-beta-activated kinase 1),Homo sapiens (Human),606.0,67196.0,MSTASAASSSSSSSAGEMIEAPSQVLNFEEIDYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGACLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQYPCQYSDEGQSNSATSTGSFMDIASTNTSNKSDTNMEQVPATNDTIKRLESKLLKNQAKQQSESGRLSLGASRGSSVESLPPTSEGKRMSADMSEIEARIAATTAYSKPKRGHRKTASFGNILDVPEIVISGNGQPRRRSIQDLTVTGTEPGQVSSRSSSPSVRMITTSGPTSEKPTRSHPWTPDDSTDTNGSDNSIPMAYLTLDHQLQPLAPCPNSKESMAVFEQHCKMAQEYMKVQTEIALLLQRKQELVAELDQDEKDQQNTSRLVQEHKKLLDENKSLSTYYQQCKKQLEVIRSQQQKRQGTS,False,False,True,O43318,"[('cd14058', 'Catalytic domain of the Serine/Threonine Kinase, Transforming Growth Factor beta Activated Kinase-1'), ('G3DSA:1.10.510.10', 'Transferase(Phosphotransferase) domain 1'), ('G3DSA:3.30.200.20', 'Phosphorylase Kinase; domain 1'), ('IPR000719', 'Protein kinase domain'), ('IPR001245', 'Serine-threonine/tyrosine-protein kinase, catalytic domain'), ('IPR008271', 'Serine/threonine-protein kinase, active site'), ('IPR011009', 'Protein kinase-like domain superfamily'), ('IPR017441', 'Protein kinase, ATP binding site'), ('IPR049637', 'Mitogen-activated protein kinase kinase kinase 7'), ('PF07714', 'Protein tyrosine and serine/threonine kinase'), ('PIRSF038168', 'Mitogen-activated protein kinase kinase kinase 7'), ('PR00109', 'TYRKINASE'), ('PS00107', 'Protein kinases ATP-binding region signature'), ('PS00108', 'Serine/Threonine protein kinases active-site signature'), ('PS50011', 'Protein kinase domain profile'), ('PTHR46716', 'MITOGEN-ACTIVATED PROTEIN KINASE KINASE KINASE 7'), ('SM00220', 'Serine/Threonine protein kinases, catalytic domain'), ('SSF56112', 'Protein kinase-like (PK-like)')]",,"""ENSG00000135341; Low tissue specificity."";","CATALYTIC ACTIVITY: Reaction=L-seryl-[protein] + ATP = O-phospho-L-seryl-[protein] + ADP + H(+); Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616, ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.25; Evidence={ECO:0000269|PubMed:10094049, ECO:0000269|PubMed:10838074, ECO:0000269|PubMed:12589052, ECO:0000269|PubMed:37832545}; CATALYTIC ACTIVITY: Reaction=L-threonyl-[protein] + ATP = O-phospho-L-threonyl-[protein] + ADP + H(+); Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060, Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013, ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216; EC=2.7.11.25; Evidence={ECO:0000269|PubMed:10094049, ECO:0000269|PubMed:10838074, ECO:0000269|PubMed:12589052};",2.7.11.25,"ACTIVITY REGULATION: Activated by pro-inflammatory cytokines and in response to physical and chemical stresses, including osmotic stress, oxidative stress, arsenic and ultraviolet light irradiation (PubMed:16893890). Activated by 'Lys-63'-linked polyubiquitination and by autophosphorylation (PubMed:10702308, PubMed:11460167, PubMed:12242293, PubMed:29291351). Association with TAB1/MAP3K7IP1 and TAB2/MAP3K7IP2 promotes activation through autophosphorylation, whereas PPM1B/PP2CB, PP2A and PPP6C dephosphorylation leads to inactivation (PubMed:11104763, PubMed:17079228, PubMed:37832545). Ceramides are also able to activate MAP3K7/TAK1 (PubMed:9079627). {ECO:0000269|PubMed:10702308, ECO:0000269|PubMed:11104763, ECO:0000269|PubMed:11460167, ECO:0000269|PubMed:12242293, ECO:0000269|PubMed:16893890, ECO:0000269|PubMed:17079228, ECO:0000269|PubMed:29291351, ECO:0000269|PubMed:37832545, ECO:0000269|PubMed:9079627}.",,ENST00000369325.7 [O43318-3];ENST00000369327.7 [O43318-4];ENST00000369329.8 [O43318-1];ENST00000369332.7 [O43318-2];ENST00000700580.1 [O43318-2];,MAP3K7,ENSG00000135341,0.0,,,,4.62,DP03863,0.046,0.439,0.21,MAP3K7
O43464,ENSG00000115317,HTRA2_HUMAN,adult walking behavior [GO:0007628]; cellular response to growth factor stimulus [GO:0071363]; cellular response to heat [GO:0034605]; cellular response to interferon-beta [GO:0035458]; cellular response to oxidative stress [GO:0034599]; cellular response to retinoic acid [GO:0071300]; ceramide metabolic process [GO:0006672]; execution phase of apoptosis [GO:0097194]; forebrain development [GO:0030900]; intracellular signal transduction [GO:0035556]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; mitochondrial protein catabolic process [GO:0035694]; mitochondrion organization [GO:0007005]; negative regulation of cell cycle [GO:0045786]; negative regulation of mitophagy in response to mitochondrial depolarization [GO:1904924]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; neuron apoptotic process [GO:0051402]; neuron development [GO:0048666]; pentacyclic triterpenoid metabolic process [GO:0019742]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of execution phase of apoptosis [GO:1900119]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; positive regulation of protein targeting to mitochondrion [GO:1903955]; programmed cell death [GO:0012501]; protein autoprocessing [GO:0016540]; protein catabolic process [GO:0030163]; proteolysis [GO:0006508]; regulation of autophagy of mitochondrion [GO:1903146]; regulation of multicellular organism growth [GO:0040014]; response to herbicide [GO:0009635],CD40 receptor complex [GO:0035631]; chromatin [GO:0000785]; cytoplasmic side of plasma membrane [GO:0009898]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; membrane [GO:0016020]; mitochondrial intermembrane space [GO:0005758]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; serine-type endopeptidase complex [GO:1905370],identical protein binding [GO:0042802]; peptidase activity [GO:0008233]; protein serine/threonine kinase inhibitor activity [GO:0030291]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; ubiquitin ligase inhibitor activity [GO:1990948]; unfolded protein binding [GO:0051082],"PTM: Ubiquitinated by BIRC6; this activity is inhibited by DIABLO/SMAC. {ECO:0000269|PubMed:36758104, ECO:0000269|PubMed:36758105}.; PTM: Autoproteolytically activated. {ECO:0000269|PubMed:10873535}.",DOMAIN: The mature N-terminus is involved in the interaction with XIAP.; DOMAIN: The PDZ domain mediates interaction with MXI2.,"DOMAIN 364..445; /note=""PDZ""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00143""","STRAND 161..170; /evidence=""ECO:0007829|PDB:5M3N""; STRAND 175..188; /evidence=""ECO:0007829|PDB:5M3N""; STRAND 192..195; /evidence=""ECO:0007829|PDB:5M3N""; STRAND 204..209; /evidence=""ECO:0007829|PDB:5M3N""; STRAND 211..213; /evidence=""ECO:0007829|PDB:5TO0""; STRAND 215..224; /evidence=""ECO:0007829|PDB:5M3N""; STRAND 229..233; /evidence=""ECO:0007829|PDB:5M3N""; STRAND 256..259; /evidence=""ECO:0007829|PDB:5M3N""; STRAND 265..268; /evidence=""ECO:0007829|PDB:5FHT""; STRAND 271..275; /evidence=""ECO:0007829|PDB:5M3N""; STRAND 295..299; /evidence=""ECO:0007829|PDB:5M3N""; STRAND 308..311; /evidence=""ECO:0007829|PDB:5M3N""; STRAND 317..326; /evidence=""ECO:0007829|PDB:5M3N""; STRAND 329..334; /evidence=""ECO:0007829|PDB:5M3N""; STRAND 359..361; /evidence=""ECO:0007829|PDB:5M3N""; STRAND 364..368; /evidence=""ECO:0007829|PDB:5M3N""; STRAND 382..384; /evidence=""ECO:0007829|PDB:5WYN""; STRAND 391..396; /evidence=""ECO:0007829|PDB:5M3N""; STRAND 412..416; /evidence=""ECO:0007829|PDB:5M3N""; STRAND 435..443; /evidence=""ECO:0007829|PDB:5M3N""; STRAND 446..452; /evidence=""ECO:0007829|PDB:5M3N""; STRAND 455..457; /evidence=""ECO:0007829|PDB:5M3N""","HELIX 143..147; /evidence=""ECO:0007829|PDB:5M3N""; HELIX 149..157; /evidence=""ECO:0007829|PDB:5M3N""; HELIX 158..160; /evidence=""ECO:0007829|PDB:5M3N""; HELIX 198..200; /evidence=""ECO:0007829|PDB:5M3N""; HELIX 248..250; /evidence=""ECO:0007829|PDB:5M3N""; HELIX 335..342; /evidence=""ECO:0007829|PDB:5M3N""; HELIX 371..380; /evidence=""ECO:0007829|PDB:5M3N""; HELIX 401..405; /evidence=""ECO:0007829|PDB:5M3N""; HELIX 424..433; /evidence=""ECO:0007829|PDB:5M3N""","TURN 171..174; /evidence=""ECO:0007829|PDB:5M3N""; TURN 189..191; /evidence=""ECO:0007829|PDB:5M3N""; TURN 225..228; /evidence=""ECO:0007829|PDB:5M3N""; TURN 303..307; /evidence=""ECO:0007829|PDB:5M3N""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,HTRA2 OMI PRSS25,"Serine protease HTRA2, mitochondrial (EC 3.4.21.108) (High temperature requirement protein A2) (HtrA2) (Omi stress-regulated endoprotease) (Serine protease 25) (Serine proteinase OMI)",Homo sapiens (Human),458.0,48841.0,MAAPRAGRGAGWSLRAWRALGGIRWGRRPRLTPDLRALLTSGTSDPRARVTYGTPSLWARLSVGVTEPRACLTSGTPGPRAQLTAVTPDTRTREASENSGTRSRAWLAVALGAGGAVLLLLWGGGRGPPAVLAAVPSPPPASPRSQYNFIADVVEKTAPAVVYIEILDRHPFLGREVPISNGSGFVVAADGLIVTNAHVVADRRRVRVRLLSGDTYEAVVTAVDPVADIATLRIQTKEPLPTLPLGRSADVRQGEFVVAMGSPFALQNTITSGIVSSAQRPARDLGLPQTNVEYIQTDAAIDFGNSGGPLVNLDGEVIGVNTMKVTAGISFAIPSDRLREFLHRGEKKNSSSGISGSQRRYIGVMMLTLSPSILAELQLREPSFPDVQHGVLIHKVILGSPAHRAGLRPGDVILAIGEQMVQNAEDVYEAVRTQSQLAVQIRRGRETLTLYVTPEVTE,False,False,True,O43464,"[('cd00987', 'PDZ_serine_protease'), ('G3DSA:2.30.42.10', None), ('G3DSA:2.40.10.120', None), ('IPR001478', 'PDZ domain'), ('IPR001940', 'Peptidase S1C'), ('IPR009003', 'Peptidase S1, PA clan'), ('IPR036034', 'PDZ superfamily'), ('IPR041489', 'PDZ domain 6'), ('PF13365', 'Trypsin-like peptidase domain'), ('PF17820', 'PDZ domain'), ('PR00834', 'PROTEASES2C'), ('PS50106', 'PDZ domain profile'), ('PTHR22939', 'HtrA Serine Proteases'), ('SM00228', 'Domain present in PSD-95, Dlg, and ZO-1/2.'), ('SSF50156', 'PDZ domain-like'), ('SSF50494', 'Trypsin-like serine proteases')]",O43464;,"""ENSG00000115317; Low tissue specificity."";","CATALYTIC ACTIVITY: Reaction=Cleavage of non-polar aliphatic amino-acids at the P1 position, with a preference for Val, Ile and Met. At the P2 and P3 positions, Arg is selected most strongly with a secondary preference for other hydrophilic residues.; EC=3.4.21.108;",3.4.21.108,"ACTIVITY REGULATION: Inhibited by BIRC6. {ECO:0000269|PubMed:36758104, ECO:0000269|PubMed:36758105}.",,ENST00000258080.8 [O43464-1];ENST00000352222.7 [O43464-2];ENST00000437202.2 [O43464-3];,HTRA2,ENSG00000115317,0.0,,,,6.11,DP00315,0.061,0.314,,HTRA2
O43541,ENSG00000137834,SMAD6_HUMAN,anatomical structure morphogenesis [GO:0009653]; aorta development [GO:0035904]; aortic valve morphogenesis [GO:0003180]; BMP signaling pathway [GO:0030509]; cell differentiation [GO:0030154]; cell-substrate adhesion [GO:0031589]; coronary vasculature development [GO:0060976]; fat cell differentiation [GO:0045444]; immune response [GO:0006955]; mitral valve morphogenesis [GO:0003183]; negative regulation of activin receptor signaling pathway [GO:0032926]; negative regulation of apoptotic process [GO:0043066]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of SMAD protein signal transduction [GO:0060392]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of miRNA transcription [GO:1902895]; pulmonary valve morphogenesis [GO:0003184]; regulation of transcription by RNA polymerase II [GO:0006357]; response to estrogen [GO:0043627]; response to laminar fluid shear stress [GO:0034616]; response to lipopolysaccharide [GO:0032496]; SMAD protein signal transduction [GO:0060395]; transforming growth factor beta receptor signaling pathway [GO:0007179]; ureteric bud development [GO:0001657]; ventricular septum development [GO:0003281]; zygotic specification of dorsal/ventral axis [GO:0007352],chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; heteromeric SMAD protein complex [GO:0071144]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991],chromatin binding [GO:0003682]; co-SMAD binding [GO:0070410]; I-SMAD binding [GO:0070411]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein sequestering activity [GO:0140311]; R-SMAD binding [GO:0070412]; transcription cis-regulatory region binding [GO:0000976]; transcription regulator inhibitor activity [GO:0140416]; type I activin receptor binding [GO:0070698]; type I transforming growth factor beta receptor binding [GO:0034713]; ubiquitin protein ligase binding [GO:0031625],"PTM: Phosphorylated by BMP type 1 receptor kinase and by PRKX. {ECO:0000269|PubMed:16491121}.; PTM: Monoubiquitinated at Lys-173 by the E2/E3 hybrid ubiquitin-protein ligase UBE2O, leading to reduced binding affinity for the activated BMP type I receptor ACVR1/ALK2, thereby enhancing BMP7 and regulating adipocyte differentiation (PubMed:23455153). Ubiquitinated by WWP1 (By similarity). Ubiquitinated by ARK2C, promoting proteasomal degradation, leading to enhance the BMP-Smad signaling (By similarity). {ECO:0000250|UniProtKB:O35182, ECO:0000269|PubMed:23455153}.; PTM: Arginine methylation by PRMT1, which is recruited by BMPR2, initiates BMP-Induced signaling and induces dissociation from the BMPR1B receptor at the cell surface leading to derepress downstream Smad1/Smad5 signaling. {ECO:0000250|UniProtKB:O35182}.",,"DOMAIN 148..275; /note=""MH1""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00438""; DOMAIN 331..496; /note=""MH2""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00439""",,,,"cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,SMAD6 MADH6,Mothers against decapentaplegic homolog 6 (MAD homolog 6) (Mothers against DPP homolog 6) (SMAD family member 6) (SMAD 6) (Smad6) (hSMAD6),Homo sapiens (Human),496.0,53497.0,MFRSKRSGLVRRLWRSRVVPDREEGGSGGGGGGDEDGSLGSRAEPAPRAREGGGCGRSEVRPVAPRRPRDAVGQRGAQGAGRRRRAGGPPRPMSEPGAGAGSSLLDVAEPGGPGWLPESDCETVTCCLFSERDAAGAPRDASDPLAGAALEPAGGGRSREARSRLLLLEQELKTVTYSLLKRLKERSLDTLLEAVESRGGVPGGCVLVPRADLRLGGQPAPPQLLLGRLFRWPDLQHAVELKPLCGCHSFAAAADGPTVCCNPYHFSRLCGPESPPPPYSRLSPRDEYKPLDLSDSTLSYTETEATNSLITAPGEFSDASMSPDATKPSHWCSVAYWEHRTRVGRLYAVYDQAVSIFYDLPQGSGFCLGQLNLEQRSESVRRTRSKIGFGILLSKEPDGVWAYNRGEHPIFVNSPTLDAPGGRALVVRKVPPGYSIKVFDFERSGLQHAPEPDAADGPYDPNSVRISFAKGWGPCYSRQFITSCPCWLEILLNNPR,True,False,False,O43541,"[('cd10493', 'N-terminal Mad Homology 1 (MH1) domain in SMAD6'), ('cd10499', 'C-terminal Mad Homology 2 (MH2) domain in SMAD6'), ('G3DSA:2.60.200.10', None), ('G3DSA:3.90.520.10', 'SMAD MH1 domain'), ('IPR001132', 'SMAD domain, Dwarfin-type'), ('IPR003619', 'MAD homology 1, Dwarfin-type'), ('IPR008984', 'SMAD/FHA domain superfamily'), ('IPR013019', 'MAD homology, MH1'), ('IPR013790', 'Dwarfin'), ('IPR017855', 'SMAD-like domain superfamily'), ('IPR036578', 'SMAD MH1 domain superfamily'), ('PF03165', 'MH1 domain'), ('PF03166', 'MH2 domain'), ('PS51075', 'MAD homology domain 1 (MH1) profile'), ('PS51076', 'MAD homology domain 2 (MH2) profile'), ('PTHR13703', 'SMAD'), ('SM00523', 'Domain A in dwarfin family proteins'), ('SM00524', 'Domain B in dwarfin family proteins'), ('SSF49879', 'SMAD/FHA domain'), ('SSF56366', 'SMAD MH1 domain')]",,"""ENSG00000137834; Tissue enhanced (heart muscle, lung)."";",,,,,ENST00000288840.10 [O43541-1];ENST00000557916.5 [O43541-4];,SMAD6,ENSG00000137834,0.0,SMAD6,Non-canonical_RBPs,1.0,,,,0.381,0.276,SMAD6
O43639,ENSG00000071051,NCK2_HUMAN,actin filament organization [GO:0007015]; cell migration [GO:0016477]; dendritic spine development [GO:0060996]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; immunological synapse formation [GO:0001771]; lamellipodium assembly [GO:0030032]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation [GO:1903912]; negative regulation of PERK-mediated unfolded protein response [GO:1903898]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902237]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of translation in response to endoplasmic reticulum stress [GO:0036493]; signal complex assembly [GO:0007172]; signal transduction [GO:0007165]; T cell activation [GO:0042110],cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; postsynaptic density [GO:0014069]; vesicle membrane [GO:0012506],cytoskeletal anchor activity [GO:0008093]; phosphotyrosine residue binding [GO:0001784]; protein-containing complex binding [GO:0044877]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110]; signaling adaptor activity [GO:0035591]; signaling receptor complex adaptor activity [GO:0030159],PTM: Phosphorylated. {ECO:0000269|PubMed:10026169}.,,"DOMAIN 2..61; /note=""SH3 1""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00192""; DOMAIN 111..170; /note=""SH3 2""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00192""; DOMAIN 195..257; /note=""SH3 3""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00192""; DOMAIN 285..380; /note=""SH2""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00191""","STRAND 5..11; /evidence=""ECO:0007829|PDB:2B86""; STRAND 17..20; /evidence=""ECO:0007829|PDB:2JXB""; STRAND 28..33; /evidence=""ECO:0007829|PDB:2B86""; STRAND 35..38; /evidence=""ECO:0007829|PDB:2B86""; STRAND 40..42; /evidence=""ECO:0007829|PDB:2B86""; STRAND 48..50; /evidence=""ECO:0007829|PDB:2B86""; STRAND 55..58; /evidence=""ECO:0007829|PDB:2B86""; STRAND 115..118; /evidence=""ECO:0007829|PDB:4E6R""; STRAND 137..142; /evidence=""ECO:0007829|PDB:4E6R""; STRAND 147..153; /evidence=""ECO:0007829|PDB:4E6R""; STRAND 156..161; /evidence=""ECO:0007829|PDB:4E6R""; STRAND 165..167; /evidence=""ECO:0007829|PDB:4E6R""; STRAND 196..204; /evidence=""ECO:0007829|PDB:1U5S""; STRAND 210..213; /evidence=""ECO:0007829|PDB:1U5S""; STRAND 222..226; /evidence=""ECO:0007829|PDB:1U5S""; STRAND 234..239; /evidence=""ECO:0007829|PDB:1U5S""; STRAND 243..248; /evidence=""ECO:0007829|PDB:1U5S""; STRAND 251..254; /evidence=""ECO:0007829|PDB:1U5S""; STRAND 307..312; /evidence=""ECO:0007829|PDB:2CIA""; STRAND 314..316; /evidence=""ECO:0007829|PDB:2CIA""; STRAND 320..324; /evidence=""ECO:0007829|PDB:2CIA""; STRAND 327..329; /evidence=""ECO:0007829|PDB:2CIA""; STRAND 331..338; /evidence=""ECO:0007829|PDB:2CIA""; STRAND 341..344; /evidence=""ECO:0007829|PDB:2CIA""; STRAND 347..351; /evidence=""ECO:0007829|PDB:2CIA""; STRAND 364..366; /evidence=""ECO:0007829|PDB:2CIA""","HELIX 162..164; /evidence=""ECO:0007829|PDB:4E6R""; HELIX 292..302; /evidence=""ECO:0007829|PDB:2CIA""; HELIX 352..361; /evidence=""ECO:0007829|PDB:2CIA""","TURN 230..232; /evidence=""ECO:0007829|PDB:1U5S""; TURN 240..242; /evidence=""ECO:0007829|PDB:1U5S""; TURN 368..370; /evidence=""ECO:0007829|PDB:1Z3K""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,NCK2 GRB4,Cytoplasmic protein NCK2 (Growth factor receptor-bound protein 4) (NCK adaptor protein 2) (Nck-2) (SH2/SH3 adaptor protein NCK-beta),Homo sapiens (Human),380.0,42915.0,MTEEVIVIAKWDYTAQQDQELDIKKNERLWLLDDSKTWWRVRNAANRTGYVPSNYVERKNSLKKGSLVKNLKDTLGLGKTRRKTSARDASPTPSTDAEYPANGSGADRIYDLNIPAFVKFAYVAEREDELSLVKGSRVTVMEKCSDGWWRGSYNGQIGWFPSNYVLEEVDEAAAESPSFLSLRKGASLSNGQGSRVLHVVQTLYPFSSVTEEELNFEKGETMEVIEKPENDPEWWKCKNARGQVGLVPKNYVVVLSDGPALHPAHAPQISYTGPSSSGRFAGREWYYGNVTRHQAECALNERGVEGDFLIRDSESSPSDFSVSLKASGKNKHFKVQLVDNVYCIGQRRFHTMDELVEHYKKAPIFTSEHGEKLYLVRALQ,False,False,True,O43639,"[('cd10409', 'Src homology 2 (SH2) domain found in Nck'), ('cd11899', 'First Src Homology 3 domain of Nck2 adaptor protein'), ('cd11902', 'Second Src Homology 3 domain of Nck2 adaptor protein'), ('cd11903', 'Third Src Homology 3 domain of Nck2 adaptor protein'), ('G3DSA:2.30.30.40', 'SH3 Domains'), ('G3DSA:3.30.505.10', 'SH2 domain'), ('IPR000980', 'SH2 domain'), ('IPR001452', 'SH3 domain'), ('IPR017304', 'Cytoplasmic protein NCK'), ('IPR035559', 'Nck2, SH3 domain 1'), ('IPR035560', 'Nck2, SH3 domain 2'), ('IPR035561', 'Nck2, SH3 domain 3'), ('IPR035883', 'Nck2, SH2 domain'), ('IPR036028', 'SH3-like domain superfamily'), ('IPR036860', 'SH2 domain superfamily'), ('IPR051184', 'Tyrosine-phosphorylated adapter molecule'), ('PF00017', 'SH2 domain'), ('PF00018', 'SH3 domain'), ('PF14604', 'Variant SH3 domain'), ('PIRSF037874', 'Cytoplasmic protein NCK')]",,"""ENSG00000071051; Low tissue specificity."";",,,,,ENST00000233154.9;ENST00000393349.2;,NCK2,ENSG00000071051,0.0,,,,,,,0.239,0.063,NCK2
O60341,ENSG00000004487,KDM1A_HUMAN,"cellular response to cAMP [GO:0071320]; cellular response to gamma radiation [GO:0071480]; cellular response to UV [GO:0034644]; cerebral cortex development [GO:0021987]; chromatin remodeling [GO:0006338]; DNA repair-dependent chromatin remodeling [GO:0140861]; guanine metabolic process [GO:0046098]; muscle cell development [GO:0055001]; negative regulation of DNA binding [GO:0043392]; negative regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043518]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902166]; negative regulation of protein binding [GO:0032091]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neuron maturation [GO:0042551]; positive regulation of cell size [GO:0045793]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron projection development [GO:0010976]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein demethylation [GO:0006482]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of DNA methylation-dependent heterochromatin formation [GO:0090308]; regulation of double-strand break repair via homologous recombination [GO:0010569]; regulation of protein localization [GO:0032880]; regulation of transcription by RNA polymerase II [GO:0006357]; response to fungicide [GO:0060992]","chromatin [GO:0000785]; chromosome, telomeric region [GO:0000781]; DNA repair complex [GO:1990391]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; transcription regulator complex [GO:0005667]",chromatin binding [GO:0003682]; demethylase activity [GO:0032451]; DNA-binding transcription factor binding [GO:0140297]; enzyme binding [GO:0019899]; FAD-dependent H3K4me/H3K4me3 demethylase activity [GO:0140682]; flavin adenine dinucleotide binding [GO:0050660]; histone demethylase activity [GO:0032452]; histone H3K4 demethylase activity [GO:0032453]; histone H3K9 demethylase activity [GO:0032454]; identical protein binding [GO:0042802]; MRF binding [GO:0043426]; nuclear androgen receptor binding [GO:0050681]; nuclear receptor coactivator activity [GO:0030374]; oxidoreductase activity [GO:0016491]; p53 binding [GO:0002039]; promoter-specific chromatin binding [GO:1990841]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; telomeric repeat-containing RNA binding [GO:0061752]; transcription coactivator activity [GO:0003713],"PTM: Acetylated by KAT8 in epithelial but not in mesenchymal cells, thereby regulating the epithelial-to-mesenchymal transition (PubMed:27292636). Acetylation by KAT8 reduces KDM1A association with nucleosomes, thereby decreasing histone H3 demethylation, leading to transcription activatio of target genes (PubMed:27292636). {ECO:0000269|PubMed:27292636}.; PTM: Polyubiquitinated by JADE2; which leads to its proteasomal degradation (PubMed:25018020). Deubiquitinated by USP38; preventing it from degradation by the 26S proteasome (PubMed:30497519). {ECO:0000269|PubMed:25018020, ECO:0000269|PubMed:30497519}.",DOMAIN: The SWIRM domain may act as an anchor site for a histone tail. {ECO:0000269|PubMed:16531230}.,"DOMAIN 174..273; /note=""SWIRM""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00247""","STRAND 181..183; /evidence=""ECO:0007829|PDB:2COM""; STRAND 185..187; /evidence=""ECO:0007829|PDB:7XW8""; STRAND 261..263; /evidence=""ECO:0007829|PDB:5IT3""; STRAND 265..267; /evidence=""ECO:0007829|PDB:2COM""; STRAND 280..284; /evidence=""ECO:0007829|PDB:2Z3Y""; STRAND 303..307; /evidence=""ECO:0007829|PDB:2Z3Y""; STRAND 309..314; /evidence=""ECO:0007829|PDB:2Z3Y""; STRAND 319..322; /evidence=""ECO:0007829|PDB:2Z3Y""; STRAND 325..330; /evidence=""ECO:0007829|PDB:2Z3Y""; STRAND 333..335; /evidence=""ECO:0007829|PDB:6NQU""; STRAND 353..355; /evidence=""ECO:0007829|PDB:2Z3Y""; STRAND 362..364; /evidence=""ECO:0007829|PDB:6KGM""; STRAND 367..369; /evidence=""ECO:0007829|PDB:8Q1G""; STRAND 400..405; /evidence=""ECO:0007829|PDB:5H6Q""; STRAND 518..521; /evidence=""ECO:0007829|PDB:7VQT""; STRAND 565..567; /evidence=""ECO:0007829|PDB:2Z3Y""; STRAND 583..585; /evidence=""ECO:0007829|PDB:2Z3Y""; STRAND 588..596; /evidence=""ECO:0007829|PDB:2Z3Y""; STRAND 599..608; /evidence=""ECO:0007829|PDB:2Z3Y""; STRAND 613..623; /evidence=""ECO:0007829|PDB:2Z3Y""; STRAND 636..641; /evidence=""ECO:0007829|PDB:2Z3Y""; STRAND 654..656; /evidence=""ECO:0007829|PDB:2Z3Y""; STRAND 660..665; /evidence=""ECO:0007829|PDB:2Z3Y""; STRAND 676..680; /evidence=""ECO:0007829|PDB:2Z3Y""; STRAND 683..685; /evidence=""ECO:0007829|PDB:2Z3Y""; STRAND 690..695; /evidence=""ECO:0007829|PDB:2Z3Y""; STRAND 698..707; /evidence=""ECO:0007829|PDB:2Z3Y""; STRAND 744..748; /evidence=""ECO:0007829|PDB:2Z3Y""; STRAND 758..760; /evidence=""ECO:0007829|PDB:2Z3Y""; STRAND 765..767; /evidence=""ECO:0007829|PDB:6NQM""; STRAND 785..788; /evidence=""ECO:0007829|PDB:6S35""; STRAND 796..798; /evidence=""ECO:0007829|PDB:2Z3Y""; STRAND 805..807; /evidence=""ECO:0007829|PDB:5H6R""","HELIX 138..150; /evidence=""ECO:0007829|PDB:6WC6""; HELIX 173..180; /evidence=""ECO:0007829|PDB:2Z3Y""; HELIX 190..195; /evidence=""ECO:0007829|PDB:6E1F""; HELIX 197..200; /evidence=""ECO:0007829|PDB:6E1F""; HELIX 204..223; /evidence=""ECO:0007829|PDB:6E1F""; HELIX 231..236; /evidence=""ECO:0007829|PDB:6E1F""; HELIX 242..244; /evidence=""ECO:0007829|PDB:6E1F""; HELIX 246..258; /evidence=""ECO:0007829|PDB:6E1F""; HELIX 288..299; /evidence=""ECO:0007829|PDB:2Z3Y""; HELIX 341..349; /evidence=""ECO:0007829|PDB:2Z3Y""; HELIX 372..393; /evidence=""ECO:0007829|PDB:2Z3Y""; HELIX 408..456; /evidence=""ECO:0007829|PDB:2Z3Y""; HELIX 476..487; /evidence=""ECO:0007829|PDB:2Z3Y""; HELIX 491..497; /evidence=""ECO:0007829|PDB:2Z3Y""; HELIX 499..511; /evidence=""ECO:0007829|PDB:2Z3Y""; HELIX 523..539; /evidence=""ECO:0007829|PDB:2Z3Y""; HELIX 544..546; /evidence=""ECO:0007829|PDB:2Z3Y""; HELIX 556..558; /evidence=""ECO:0007829|PDB:2Z3Y""; HELIX 573..578; /evidence=""ECO:0007829|PDB:2Z3Y""; HELIX 627..631; /evidence=""ECO:0007829|PDB:2Z3Y""; HELIX 645..653; /evidence=""ECO:0007829|PDB:2Z3Y""; HELIX 710..715; /evidence=""ECO:0007829|PDB:2Z3Y""; HELIX 720..735; /evidence=""ECO:0007829|PDB:2Z3Y""; HELIX 737..739; /evidence=""ECO:0007829|PDB:6KGO""; HELIX 771..777; /evidence=""ECO:0007829|PDB:2Z3Y""; HELIX 801..803; /evidence=""ECO:0007829|PDB:2Z3Y""; HELIX 811..829; /evidence=""ECO:0007829|PDB:2Z3Y""; HELIX 833..835; /evidence=""ECO:0007829|PDB:5L3D""","TURN 394..396; /evidence=""ECO:0007829|PDB:2HKO""; TURN 457..461; /evidence=""ECO:0007829|PDB:2Z3Y""; TURN 488..490; /evidence=""ECO:0007829|PDB:2Z3Y""; TURN 549..555; /evidence=""ECO:0007829|PDB:2Z3Y""; TURN 579..581; /evidence=""ECO:0007829|PDB:2Z3Y""; TURN 686..689; /evidence=""ECO:0007829|PDB:2Z3Y""; TURN 751..753; /evidence=""ECO:0007829|PDB:2Z3Y""; TURN 755..757; /evidence=""ECO:0007829|PDB:2Z3Y""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,KDM1A AOF2 KDM1 KIAA0601 LSD1,Lysine-specific histone demethylase 1A (EC 1.14.99.66) (BRAF35-HDAC complex protein BHC110) (Flavin-containing amine oxidase domain-containing protein 2) ([histone H3]-dimethyl-L-lysine(4) FAD-dependent demethylase 1A),Homo sapiens (Human),852.0,92903.0,MLSGKKAAAAAAAAAAAATGTEAGPGTAGGSENGSEVAAQPAGLSGPAEVGPGAVGERTPRKKEPPRASPPGGLAEPPGSAGPQAGPTVVPGSATPMETGIAETPEGRRTSRRKRAKVEYREMDESLANLSEDEYYSEEERNAKAEKEKKLPPPPPQAPPEEENESEPEEPSGVEGAAFQSRLPHDRMTSQEAACFPDIISGPQQTQKVFLFIRNRTLQLWLDNPKIQLTFEATLQQLEAPYNSDTVLVHRVHSYLERHGLINFGIYKRIKPLPTKKTGKVIIIGSGVSGLAAARQLQSFGMDVTLLEARDRVGGRVATFRKGNYVADLGAMVVTGLGGNPMAVVSKQVNMELAKIKQKCPLYEANGQAVPKEKDEMVEQEFNRLLEATSYLSHQLDFNVLNNKPVSLGQALEVVIQLQEKHVKDEQIEHWKKIVKTQEELKELLNKMVNLKEKIKELHQQYKEASEVKPPRDITAEFLVKSKHRDLTALCKEYDELAETQGKLEEKLQELEANPPSDVYLSSRDRQILDWHFANLEFANATPLSTLSLKHWDQDDDFEFTGSHLTVRNGYSCVPVALAEGLDIKLNTAVRQVRYTASGCEVIAVNTRSTSQTFIYKCDAVLCTLPLGVLKQQPPAVQFVPPLPEWKTSAVQRMGFGNLNKVVLCFDRVFWDPSVNLFGHVGSTTASRGELFLFWNLYKAPILLALVAGEAAGIMENISDDVIVGRCLAILKGIFGSSAVPQPKETVVSRWRADPWARGSYSYVAAGSSGNDYDLMAQPITPGPSIPGAPQPIPRLFFAGEHTIRNYPATVHGALLSGLREAGRIADQFLGAMYTLPRQATPGVPAQQSPSM,False,False,True,O60341,"[('G3DSA:1.10.10.10', 'Winged helix-like DNA-binding domain superfamily/Winged helix DNA-binding domain'), ('G3DSA:1.10.287.80', 'ATP synthase, gamma subunit, helix hairpin domain'), ('G3DSA:3.50.50.60', 'FAD/NAD(P)-binding domain'), ('G3DSA:3.90.660.10', None), ('IPR002937', 'Amine oxidase'), ('IPR007526', 'SWIRM domain'), ('IPR009057', 'Homedomain-like superfamily'), ('IPR017366', 'Lysine-specific histone demethylase'), ('IPR036188', 'FAD/NAD(P)-binding domain superfamily'), ('IPR036388', 'Winged helix-like DNA-binding domain superfamily'), ('IPR050281', 'Flavin monoamine oxidase and related enzymes'), ('PF01593', 'Flavin containing amine oxidoreductase'), ('PF04433', 'SWIRM domain'), ('PIRSF038051', 'Lysine-specific histone demethylase'), ('PS50934', 'SWIRM domain profile'), ('PTHR10742', 'Flavin monoamine oxidase and related enzymes'), ('SSF46689', 'Homeodomain-like'), ('SSF51905', 'FAD/NAD(P)-binding domain'), ('SSF54373', 'FAD-linked reductases, C-terminal domain')]",,"""ENSG00000004487; Low tissue specificity."";","CATALYTIC ACTIVITY: Reaction=N(6),N(6)-dimethyl-L-lysyl(4)-[histone H3] + 2 A + 2 H2O = L-lysyl(4)-[histone H3] + 2 formaldehyde + 2 AH2; Xref=Rhea:RHEA:60244, Rhea:RHEA-COMP:15540, Rhea:RHEA-COMP:15547, ChEBI:CHEBI:13193, ChEBI:CHEBI:15377, ChEBI:CHEBI:16842, ChEBI:CHEBI:17499, ChEBI:CHEBI:29969, ChEBI:CHEBI:61976; EC=1.14.99.66; Evidence={ECO:0000269|PubMed:15620353, ECO:0000269|PubMed:15811342, ECO:0000269|PubMed:27292636};",1.14.99.66,"ACTIVITY REGULATION: The N-terminal sequences of INSM1 and SNAI1 compete with histone H3 for the same binding site and thereby inhibit histone demethylation (in vitro). {ECO:0000269|PubMed:21300290, ECO:0000269|PubMed:23721412}.",,ENST00000356634.7 [O60341-1];ENST00000400181.9 [O60341-2];,KDM1A,ENSG00000004487,0.0,KDM1A,Non-canonical_RBPs,3.0,,,0.256,0.19,0.207,KDM1A
O60568,ENSG00000106397,PLOD3_HUMAN,basement membrane assembly [GO:0070831]; collagen fibril organization [GO:0030199]; collagen metabolic process [GO:0032963]; endothelial cell morphogenesis [GO:0001886]; epidermis morphogenesis [GO:0048730]; hydroxylysine biosynthetic process [GO:0046947]; in utero embryonic development [GO:0001701]; lung morphogenesis [GO:0060425]; neural tube development [GO:0021915]; peptidyl-lysine hydroxylation [GO:0017185]; protein localization [GO:0008104]; protein O-linked glycosylation [GO:0006493]; vasodilation [GO:0042311],collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; rough endoplasmic reticulum [GO:0005791]; trans-Golgi network [GO:0005802],iron ion binding [GO:0005506]; L-ascorbic acid binding [GO:0031418]; metal ion binding [GO:0046872]; procollagen galactosyltransferase activity [GO:0050211]; procollagen glucosyltransferase activity [GO:0033823]; procollagen-lysine 5-dioxygenase activity [GO:0008475]; small molecule binding [GO:0036094],,DOMAIN: The N-terminal domain mediates glycosyltransferase activity. {ECO:0000269|PubMed:30089812}.; DOMAIN: The C-terminal domain that mediates lysyl hydroxylase activity is also important for homodimerization. {ECO:0000269|PubMed:30089812}.,"DOMAIN 647..738; /note=""Fe2OG dioxygenase""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00805""","STRAND 39..44; /evidence=""ECO:0007829|PDB:6WFV""; STRAND 66..69; /evidence=""ECO:0007829|PDB:6WFV""; STRAND 71..73; /evidence=""ECO:0007829|PDB:8ONE""; STRAND 107..113; /evidence=""ECO:0007829|PDB:6WFV""; STRAND 116..118; /evidence=""ECO:0007829|PDB:6WFV""; STRAND 135..143; /evidence=""ECO:0007829|PDB:6WFV""; STRAND 158..160; /evidence=""ECO:0007829|PDB:6FXM""; STRAND 163..172; /evidence=""ECO:0007829|PDB:6WFV""; STRAND 187..189; /evidence=""ECO:0007829|PDB:6FXK""; STRAND 210..212; /evidence=""ECO:0007829|PDB:6WFV""; STRAND 217..221; /evidence=""ECO:0007829|PDB:6WFV""; STRAND 229..234; /evidence=""ECO:0007829|PDB:6WFV""; STRAND 237..242; /evidence=""ECO:0007829|PDB:6WFV""; STRAND 250..253; /evidence=""ECO:0007829|PDB:6WFV""; STRAND 278..280; /evidence=""ECO:0007829|PDB:6FXM""; STRAND 291..293; /evidence=""ECO:0007829|PDB:6TEU""; STRAND 298..304; /evidence=""ECO:0007829|PDB:6FXM""; STRAND 321..323; /evidence=""ECO:0007829|PDB:8ONE""; STRAND 328..334; /evidence=""ECO:0007829|PDB:6FXM""; STRAND 354..360; /evidence=""ECO:0007829|PDB:6FXM""; STRAND 387..392; /evidence=""ECO:0007829|PDB:6FXM""; STRAND 395..397; /evidence=""ECO:0007829|PDB:6FXM""; STRAND 412..416; /evidence=""ECO:0007829|PDB:6FXM""; STRAND 418..420; /evidence=""ECO:0007829|PDB:6FXM""; STRAND 426..432; /evidence=""ECO:0007829|PDB:6FXM""; STRAND 436..439; /evidence=""ECO:0007829|PDB:6FXR""; STRAND 454..461; /evidence=""ECO:0007829|PDB:6FXM""; STRAND 463..468; /evidence=""ECO:0007829|PDB:6FXM""; STRAND 484..487; /evidence=""ECO:0007829|PDB:6FXM""; STRAND 504..507; /evidence=""ECO:0007829|PDB:6FXM""; STRAND 513..515; /evidence=""ECO:0007829|PDB:6FXM""; STRAND 525..527; /evidence=""ECO:0007829|PDB:6FXM""; STRAND 560..563; /evidence=""ECO:0007829|PDB:6FXM""; STRAND 566..570; /evidence=""ECO:0007829|PDB:6FXM""; STRAND 599..601; /evidence=""ECO:0007829|PDB:6FXR""; STRAND 602..604; /evidence=""ECO:0007829|PDB:6TES""; STRAND 610..613; /evidence=""ECO:0007829|PDB:6FXM""; STRAND 648..656; /evidence=""ECO:0007829|PDB:6FXM""; STRAND 658..660; /evidence=""ECO:0007829|PDB:6FXM""; STRAND 664..678; /evidence=""ECO:0007829|PDB:6FXM""; STRAND 686..688; /evidence=""ECO:0007829|PDB:6FXM""; STRAND 691..693; /evidence=""ECO:0007829|PDB:6FXM""; STRAND 698..700; /evidence=""ECO:0007829|PDB:6FXM""; STRAND 707..712; /evidence=""ECO:0007829|PDB:6FXM""; STRAND 714..716; /evidence=""ECO:0007829|PDB:6FXM""; STRAND 719..721; /evidence=""ECO:0007829|PDB:6FXM""; STRAND 724..727; /evidence=""ECO:0007829|PDB:6FXM""; STRAND 729..736; /evidence=""ECO:0007829|PDB:6FXM""","HELIX 36..38; /evidence=""ECO:0007829|PDB:6WFV""; HELIX 50..61; /evidence=""ECO:0007829|PDB:6WFV""; HELIX 87..97; /evidence=""ECO:0007829|PDB:6WFV""; HELIX 98..100; /evidence=""ECO:0007829|PDB:6WFV""; HELIX 122..132; /evidence=""ECO:0007829|PDB:6WFV""; HELIX 148..153; /evidence=""ECO:0007829|PDB:6WFV""; HELIX 173..180; /evidence=""ECO:0007829|PDB:6WFV""; HELIX 191..199; /evidence=""ECO:0007829|PDB:6WFV""; HELIX 202..208; /evidence=""ECO:0007829|PDB:6WFV""; HELIX 226..228; /evidence=""ECO:0007829|PDB:6WFV""; HELIX 256..264; /evidence=""ECO:0007829|PDB:6WFV""; HELIX 281..284; /evidence=""ECO:0007829|PDB:6FXM""; HELIX 311..318; /evidence=""ECO:0007829|PDB:6FXM""; HELIX 325..327; /evidence=""ECO:0007829|PDB:6FXM""; HELIX 337..339; /evidence=""ECO:0007829|PDB:6FXM""; HELIX 340..353; /evidence=""ECO:0007829|PDB:6FXM""; HELIX 362..364; /evidence=""ECO:0007829|PDB:6FXM""; HELIX 368..380; /evidence=""ECO:0007829|PDB:6FXM""; HELIX 402..408; /evidence=""ECO:0007829|PDB:6FXM""; HELIX 444..448; /evidence=""ECO:0007829|PDB:6FXM""; HELIX 469..474; /evidence=""ECO:0007829|PDB:6FXM""; HELIX 489..499; /evidence=""ECO:0007829|PDB:6FXM""; HELIX 528..531; /evidence=""ECO:0007829|PDB:6FXM""; HELIX 537..544; /evidence=""ECO:0007829|PDB:6FXM""; HELIX 549..554; /evidence=""ECO:0007829|PDB:6FXM""; HELIX 574..587; /evidence=""ECO:0007829|PDB:6FXM""; HELIX 614..617; /evidence=""ECO:0007829|PDB:6FXM""; HELIX 620..629; /evidence=""ECO:0007829|PDB:6FXM""; HELIX 631..638; /evidence=""ECO:0007829|PDB:6FXM""; HELIX 694..696; /evidence=""ECO:0007829|PDB:6FXM""","TURN 80..82; /evidence=""ECO:0007829|PDB:6FXR""; TURN 223..225; /evidence=""ECO:0007829|PDB:6WFV""; TURN 243..246; /evidence=""ECO:0007829|PDB:6WFV""; TURN 267..272; /evidence=""ECO:0007829|PDB:6FXM""; TURN 275..277; /evidence=""ECO:0007829|PDB:6FXM""; TURN 533..535; /evidence=""ECO:0007829|PDB:6FXM""; TURN 683..685; /evidence=""ECO:0007829|PDB:6FXM""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,PLOD3,"Multifunctional procollagen lysine hydroxylase and glycosyltransferase LH3 [Includes: Procollagen-lysine,2-oxoglutarate 5-dioxygenase 3 (EC 1.14.11.4) (Lysyl hydroxylase 3) (LH3); Procollagen glycosyltransferase (EC 2.4.1.50) (EC 2.4.1.66) (Galactosylhydroxylysine-glucosyltransferase) (Procollagen galactosyltransferase) (Procollagen glucosyltransferase)]",Homo sapiens (Human),738.0,84785.0,MTSSGPGPRFLLLLPLLLPPAASASDRPRGRDPVNPEKLLVITVATAETEGYLRFLRSAEFFNYTVRTLGLGEEWRGGDVARTVGGGQKVRWLKKEMEKYADREDMIIMFVDSYDVILAGSPTELLKKFVQSGSRLLFSAESFCWPEWGLAEQYPEVGTGKRFLNSGGFIGFATTIHQIVRQWKYKDDDDDQLFYTRLYLDPGLREKLSLNLDHKSRIFQNLNGALDEVVLKFDRNRVRIRNVAYDTLPIVVHGNGPTKLQLNYLGNYVPNGWTPEGGCGFCNQDRRTLPGGQPPPRVFLAVFVEQPTPFLPRFLQRLLLLDYPPDRVTLFLHNNEVFHEPHIADSWPQLQDHFSAVKLVGPEEALSPGEARDMAMDLCRQDPECEFYFSLDADAVLTNLQTLRILIEENRKVIAPMLSRHGKLWSNFWGALSPDEYYARSEDYVELVQRKRVGVWNVPYISQAYVIRGDTLRMELPQRDVFSGSDTDPDMAFCKSFRDKGIFLHLSNQHEFGRLLATSRYDTEHLHPDLWQIFDNPVDWKEQYIHENYSRALEGEGIVEQPCPDVYWFPLLSEQMCDELVAEMEHYGQWSGGRHEDSRLAGGYENVPTVDIHMKQVGYEDQWLQLLRTYVGPMTESLFPGYHTKARAVMNFVVRYRPDEQPSLRPHHDSSTFTLNVALNHKGLDYEGGGCRFLRYDCVISSPRKGWALLHPGRLTHYHEGLPTTWGTRYIMVSFVDP,True,True,True,O60568,"[('cd23002', 'catalytic glycosyltransferase (GT) domain found in lysyl hydroxylase 3 (LH3) and similar proteins'), ('G3DSA:2.60.120.620', 'q2cbj1_9rhob like domain'), ('IPR001006', 'Procollagen-lysine 5-dioxygenase, conserved site'), ('IPR005123', 'Oxoglutarate/iron-dependent dioxygenase domain'), ('IPR006620', 'Prolyl 4-hydroxylase, alpha subunit'), ('IPR029044', 'Nucleotide-diphospho-sugar transferases'), ('IPR044861', 'Isopenicillin N synthase-like, Fe(2+) 2OG dioxygenase domain'), ('IPR050757', 'Collagen-modifying Glycosyltransferase 25'), ('PF03171', '2OG-Fe(II) oxygenase superfamily'), ('PS01325', 'Lysyl hydroxylase signature'), ('PS51471', 'Fe(2+) 2-oxoglutarate dioxygenase domain profile'), ('PTHR10730', 'Collagen-modifying Glycosyltransferase 25'), ('SM00702', 'Prolyl 4-hydroxylase alpha subunit homologues.'), ('SSF53448', 'Nucleotide-diphospho-sugar transferases')]",,"""ENSG00000106397; Low tissue specificity."";","CATALYTIC ACTIVITY: Reaction=L-lysyl-[collagen] + 2-oxoglutarate + O2 = (5R)-5-hydroxy-L-lysyl-[collagen] + succinate + CO2; Xref=Rhea:RHEA:16569, Rhea:RHEA-COMP:12751, Rhea:RHEA-COMP:12752, ChEBI:CHEBI:15379, ChEBI:CHEBI:16526, ChEBI:CHEBI:16810, ChEBI:CHEBI:29969, ChEBI:CHEBI:30031, ChEBI:CHEBI:133442; EC=1.14.11.4; Evidence={ECO:0000269|PubMed:10934207, ECO:0000269|PubMed:11956192, ECO:0000269|PubMed:12475640, ECO:0000269|PubMed:18298658, ECO:0000269|PubMed:18834968, ECO:0000269|PubMed:30089812, ECO:0000269|PubMed:9582318, ECO:0000269|PubMed:9724729}; CATALYTIC ACTIVITY: Reaction=(5R)-5-hydroxy-L-lysyl-[collagen] + UDP-alpha-D-galactose = (5R)-5-O-(beta-D-galactosyl)-5-hydroxy-L-lysyl-[collagen] + UDP + H(+); Xref=Rhea:RHEA:12637, Rhea:RHEA-COMP:12752, Rhea:RHEA-COMP:12753, ChEBI:CHEBI:15378, ChEBI:CHEBI:58223, ChEBI:CHEBI:66914, ChEBI:CHEBI:133442, ChEBI:CHEBI:133443; EC=2.4.1.50; Evidence={ECO:0000269|PubMed:12475640, ECO:0000269|PubMed:18298658, ECO:0000269|PubMed:18834968, ECO:0000269|PubMed:30089812}; CATALYTIC ACTIVITY: Reaction=(5R)-5-O-(beta-D-galactosyl)-5-hydroxy-L-lysyl-[collagen] + UDP-alpha-D-glucose = (5R)-5-O-[alpha-D-glucosyl-(1->2)-beta-D-galactosyl]-5-hydroxy-L-lysyl-[collagen] + UDP + H(+); Xref=Rhea:RHEA:12576, Rhea:RHEA-COMP:12753, Rhea:RHEA-COMP:12754, ChEBI:CHEBI:15378, ChEBI:CHEBI:58223, ChEBI:CHEBI:58885, ChEBI:CHEBI:133443, ChEBI:CHEBI:133452; EC=2.4.1.66; Evidence={ECO:0000269|PubMed:10934207, ECO:0000269|PubMed:11896059, ECO:0000269|PubMed:11956192, ECO:0000269|PubMed:12475640, ECO:0000269|PubMed:18298658, ECO:0000269|PubMed:18834968, ECO:0000269|PubMed:30089812};",1.14.11.4; 2.4.1.50; 2.4.1.66,ACTIVITY REGULATION: Lysyl hydroxylase activity is strongly inhibited by imidazole. {ECO:0000269|PubMed:10934207}.,,ENST00000223127.8;,PLOD3,ENSG00000106397,0.0,PLOD3,Canonical_RBPs,6.0,3.93,DP03260,0.039,0.045,,PLOD3
O75330,ENSG00000072571,HMMR_HUMAN,hyaluronan catabolic process [GO:0030214]; receptor-mediated endocytosis [GO:0006898],cell surface [GO:0009986]; centrosome [GO:0005813]; cytosol [GO:0005829]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; plasma membrane [GO:0005886]; spindle [GO:0005819],cargo receptor activity [GO:0038024]; hyaluronic acid binding [GO:0005540],,,,,,,"cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,HMMR IHABP RHAMM,Hyaluronan mediated motility receptor (Intracellular hyaluronic acid-binding protein) (Receptor for hyaluronan-mediated motility) (CD antigen CD168),Homo sapiens (Human),724.0,84100.0,MSFPKAPLKRFNDPSGCAPSPGAYDVKTLEVLKGPVSFQKSQRFKQQKESKQNLNVDKDTTLPASARKVKSSESKESQKNDKDLKILEKEIRVLLQERGAQDRRIQDLETELEKMEARLNAALREKTSLSANNATLEKQLIELTRTNELLKSKFSENGNQKNLRILSLELMKLRNKRETKMRGMMAKQEGMEMKLQVTQRSLEESQGKIAQLEGKLVSIEKEKIDEKSETEKLLEYIEEISCASDQVEKYKLDIAQLEENLKEKNDEILSLKQSLEENIVILSKQVEDLNVKCQLLEKEKEDHVNRNREHNENLNAEMQNLKQKFILEQQEREKLQQKELQIDSLLQQEKELSSSLHQKLCSFQEEMVKEKNLFEEELKQTLDELDKLQQKEEQAERLVKQLEEEAKSRAEELKLLEEKLKGKEAELEKSSAAHTQATLLLQEKYDSMVQSLEDVTAQFESYKALTASEIEDLKLENSSLQEKAAKAGKNAEDVQHQILATESSNQEYVRMLLDLQTKSALKETEIKEITVSFLQKITDLQNQLKQQEEDFRKQLEDEEGRKAEKENTTAELTEEINKWRLLYEELYNKTKPFQLQLDAFEVEKQALLNEHGAAQEQLNKIRDSYAKLLGHQNLKQKIKHVVKLKDENSQLKSEVSKLRCQLAKKKQSETKLQEELNKVLGIKHFDPSKAFHHESKENFALKTPLKEGNTNCYRAPMECQESWK,False,False,True,O75330,"[('IPR026203', 'Intracellular hyaluronic acid binding protein'), ('IPR031794', 'Hyaluronan-mediated motility receptor, C-terminal'), ('PF15905', 'Hyaluronan mediated motility receptor N-terminal'), ('PF15908', 'Hyaluronan mediated motility receptor C-terminal'), ('PTHR18956', 'HYALURONAN MEDIATED MOTILITY RECEPTOR')]",,"""ENSG00000072571; Tissue enhanced (bone marrow, lymphoid tissue, testis)."";",,,,,ENST00000353866.7 [O75330-2];ENST00000358715.3 [O75330-1];ENST00000393915.9 [O75330-3];ENST00000432118.6 [O75330-4];,HMMR,ENSG00000072571,0.0,,,,,,,0.597,0.088,HMMR
O75390,ENSG00000062485,CISY_HUMAN,carbohydrate metabolic process [GO:0005975]; citrate metabolic process [GO:0006101]; tricarboxylic acid cycle [GO:0006099],extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634],citrate (Si)-synthase activity [GO:0004108]; identical protein binding [GO:0042802]; RNA binding [GO:0003723],"PTM: Methylated (PubMed:28391595, PubMed:28887308). Trimethylation at Lys-395 by CSKMT decreases citrate synthase activity (PubMed:28887308). {ECO:0000269|PubMed:28391595, ECO:0000269|PubMed:28887308}.; PTM: In response to mitochondrial stress, the precursor protein is ubiquitinated by the SIFI complex in the cytoplasm before mitochondrial import, leading to its degradation (PubMed:38297121). Within the SIFI complex, UBR4 initiates ubiquitin chain that are further elongated or branched by KCMF1 (PubMed:38297121). {ECO:0000269|PubMed:38297121}.",,,"STRAND 59..64; /evidence=""ECO:0007829|PDB:5UZP""; STRAND 76..79; /evidence=""ECO:0007829|PDB:5UZP""; STRAND 82..86; /evidence=""ECO:0007829|PDB:5UZQ""; STRAND 90..93; /evidence=""ECO:0007829|PDB:5UZQ""; STRAND 345..349; /evidence=""ECO:0007829|PDB:5UZQ""; STRAND 394..399; /evidence=""ECO:0007829|PDB:5UZQ""; STRAND 450..452; /evidence=""ECO:0007829|PDB:5UZP""","HELIX 33..55; /evidence=""ECO:0007829|PDB:5UZQ""; HELIX 65..69; /evidence=""ECO:0007829|PDB:5UZQ""; HELIX 98..104; /evidence=""ECO:0007829|PDB:5UZQ""; HELIX 116..125; /evidence=""ECO:0007829|PDB:5UZQ""; HELIX 131..144; /evidence=""ECO:0007829|PDB:5UZQ""; HELIX 149..157; /evidence=""ECO:0007829|PDB:5UZQ""; HELIX 164..174; /evidence=""ECO:0007829|PDB:5UZQ""; HELIX 175..178; /evidence=""ECO:0007829|PDB:5UZQ""; HELIX 180..187; /evidence=""ECO:0007829|PDB:5UZQ""; HELIX 191..193; /evidence=""ECO:0007829|PDB:5UZQ""; HELIX 194..221; /evidence=""ECO:0007829|PDB:5UZQ""; HELIX 236..244; /evidence=""ECO:0007829|PDB:5UZQ""; HELIX 249..261; /evidence=""ECO:0007829|PDB:5UZQ""; HELIX 270..279; /evidence=""ECO:0007829|PDB:5UZQ""; HELIX 285..296; /evidence=""ECO:0007829|PDB:5UZQ""; HELIX 299..302; /evidence=""ECO:0007829|PDB:5UZQ""; HELIX 304..319; /evidence=""ECO:0007829|PDB:5UZQ""; HELIX 325..337; /evidence=""ECO:0007829|PDB:5UZQ""; HELIX 355..367; /evidence=""ECO:0007829|PDB:5UZQ""; HELIX 372..391; /evidence=""ECO:0007829|PDB:5UZQ""; HELIX 401..403; /evidence=""ECO:0007829|PDB:5UZQ""; HELIX 405..411; /evidence=""ECO:0007829|PDB:5UZQ""; HELIX 417..419; /evidence=""ECO:0007829|PDB:5UZQ""; HELIX 420..441; /evidence=""ECO:0007829|PDB:5UZQ""; HELIX 454..462; /evidence=""ECO:0007829|PDB:5UZQ""","TURN 70..74; /evidence=""ECO:0007829|PDB:5UZQ""; TURN 87..89; /evidence=""ECO:0007829|PDB:5UZQ""; TURN 280..282; /evidence=""ECO:0007829|PDB:5UZQ""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,CS,"Citrate synthase, mitochondrial (EC 2.3.3.1) (Citrate (Si)-synthase)",Homo sapiens (Human),466.0,51712.0,MALLTAAARLLGTKNASCLVLAARHASASSTNLKDILADLIPKEQARIKTFRQQHGKTVVGQITVDMMYGGMRGMKGLVYETSVLDPDEGIRFRGFSIPECQKLLPKAKGGEEPLPEGLFWLLVTGHIPTEEQVSWLSKEWAKRAALPSHVVTMLDNFPTNLHPMSQLSAAVTALNSESNFARAYAQGISRTKYWELIYEDSMDLIAKLPCVAAKIYRNLYREGSGIGAIDSNLDWSHNFTNMLGYTDHQFTELTRLYLTIHSDHEGGNVSAHTSHLVGSALSDPYLSFAAAMNGLAGPLHGLANQEVLVWLTQLQKEVGKDVSDEKLRDYIWNTLNSGRVVPGYGHAVLRKTDPRYTCQREFALKHLPNDPMFKLVAQLYKIVPNVLLEQGKAKNPWPNVDAHSGVLLQYYGMTEMNYYTVLFGVSRALGVLAQLIWSRALGFPLERPKSMSTEGLMKFVDSKSG,True,False,False,O75390,"[('cd06105', 'ScCit1-2_like'), ('G3DSA:1.10.230.10', 'Cytochrome P450-Terp, domain 2'), ('G3DSA:1.10.580.10', 'Citrate Synthase, domain 1'), ('IPR002020', 'Citrate synthase'), ('IPR010109', 'Citrate synthase, eukaryotic-type'), ('IPR016142', 'Citrate synthase-like, large alpha subdomain'), ('IPR016143', 'Citrate synthase-like, small alpha subdomain'), ('IPR019810', 'Citrate synthase active site'), ('IPR036969', 'Citrate synthase superfamily'), ('PF00285', 'Citrate synthase, C-terminal domain'), ('PR00143', 'CITRTSNTHASE'), ('PS00480', 'Citrate synthase signature'), ('PTHR11739', 'CITRATE SYNTHASE'), ('SSF48256', 'Citrate synthase'), ('TIGR01793', 'citrate (Si)-synthase, eukaryotic')]",,"""ENSG00000062485; Tissue enhanced (skeletal muscle, tongue)."";","CATALYTIC ACTIVITY: Reaction=oxaloacetate + acetyl-CoA + H2O = citrate + CoA + H(+); Xref=Rhea:RHEA:16845, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:16452, ChEBI:CHEBI:16947, ChEBI:CHEBI:57287, ChEBI:CHEBI:57288; EC=2.3.3.1; Evidence={ECO:0000269|PubMed:31141475};",2.3.3.1,,PATHWAY: Carbohydrate metabolism; tricarboxylic acid cycle; isocitrate from oxaloacetate: step 1/2.,ENST00000351328.8;,CS,ENSG00000062485,0.0,CS,Non-canonical_RBPs,8.0,,,,0.097,,CS
O75400,ENSG00000196504,PR40A_HUMAN,"cell division [GO:0051301]; cell migration [GO:0016477]; cytoskeleton organization [GO:0007010]; mRNA cis splicing, via spliceosome [GO:0045292]; mRNA splicing, via spliceosome [GO:0000398]; regulation of cell shape [GO:0008360]; regulation of cytokinesis [GO:0032465]",membrane [GO:0016020]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; U1 snRNP [GO:0005685]; U2-type prespliceosome [GO:0071004],RNA binding [GO:0003723],,DOMAIN: The WW domains are essential for localization to nuclear speckles. {ECO:0000250}.,"DOMAIN 140..173; /note=""WW 1""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00224""; DOMAIN 181..214; /note=""WW 2""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00224""; DOMAIN 393..447; /note=""FF 1""; DOMAIN 460..514; /note=""FF 2""; DOMAIN 527..587; /note=""FF 3""; DOMAIN 607..667; /note=""FF 4""; DOMAIN 672..727; /note=""FF 5""; DOMAIN 742..799; /note=""FF 6""","STRAND 136..138; /evidence=""ECO:0007829|PDB:2L5F""; STRAND 146..151; /evidence=""ECO:0007829|PDB:1YWI""; STRAND 155..160; /evidence=""ECO:0007829|PDB:1YWI""; STRAND 165..169; /evidence=""ECO:0007829|PDB:1YWI""; STRAND 186..191; /evidence=""ECO:0007829|PDB:2L5F""; STRAND 193..195; /evidence=""ECO:0007829|PDB:8PXX""; STRAND 197..201; /evidence=""ECO:0007829|PDB:2L5F""; STRAND 206..209; /evidence=""ECO:0007829|PDB:2L5F""; STRAND 218..220; /evidence=""ECO:0007829|PDB:2L5F""; STRAND 411..413; /evidence=""ECO:0007829|PDB:2LKS""","HELIX 172..174; /evidence=""ECO:0007829|PDB:2L5F""; HELIX 177..183; /evidence=""ECO:0007829|PDB:2L5F""; HELIX 213..216; /evidence=""ECO:0007829|PDB:2L5F""; HELIX 230..232; /evidence=""ECO:0007829|PDB:8PXW""; HELIX 393..406; /evidence=""ECO:0007829|PDB:1UZC""; HELIX 415..423; /evidence=""ECO:0007829|PDB:1UZC""; HELIX 426..430; /evidence=""ECO:0007829|PDB:1UZC""; HELIX 434..447; /evidence=""ECO:0007829|PDB:1UZC""; HELIX 743..755; /evidence=""ECO:0007829|PDB:2CQN""; HELIX 767..774; /evidence=""ECO:0007829|PDB:2CQN""; HELIX 778..781; /evidence=""ECO:0007829|PDB:2CQN""; HELIX 786..804; /evidence=""ECO:0007829|PDB:2CQN""","TURN 142..145; /evidence=""ECO:0007829|PDB:2L5F""; TURN 152..154; /evidence=""ECO:0007829|PDB:1YWI""; TURN 161..164; /evidence=""ECO:0007829|PDB:1YWI""; TURN 202..205; /evidence=""ECO:0007829|PDB:2L5F""; TURN 226..228; /evidence=""ECO:0007829|PDB:8PXW""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,PRPF40A FBP11 FLAF1 FNBP3 HIP10 HYPA HSPC225,Pre-mRNA-processing factor 40 homolog A (Fas ligand-associated factor 1) (Formin-binding protein 11) (Formin-binding protein 3) (Huntingtin yeast partner A) (Huntingtin-interacting protein 10) (HIP-10) (Huntingtin-interacting protein A) (Renal carcinoma antigen NY-REN-6),Homo sapiens (Human),957.0,108805.0,MRPGTGAERGGLMVSEMESHPPSQGPGDGERRLSGSSLCSGSWVSADGFLRRRPSMGHPGMHYAPMGMHPMGQRANMPPVPHGMMPQMMPPMGGPPMGQMPGMMSSVMPGMMMSHMSQASMQPALPPGVNSMDVAAGTASGAKSMWTEHKSPDGRTYYYNTETKQSTWEKPDDLKTPAEQLLSKCPWKEYKSDSGKPYYYNSQTKESRWAKPKELEDLEGYQNTIVAGSLITKSNLHAMIKAEESSKQEECTTTSTAPVPTTEIPTTMSTMAAAEAAAAVVAAAAAAAAAAAAANANASTSASNTVSGTVPVVPEPEVTSIVATVVDNENTVTISTEEQAQLTSTPAIQDQSVEVSSNTGEETSKQETVADFTPKKEEEESQPAKKTYTWNTKEEAKQAFKELLKEKRVPSNASWEQAMKMIINDPRYSALAKLSEKKQAFNAYKVQTEKEEKEEARSKYKEAKESFQRFLENHEKMTSTTRYKKAEQMFGEMEVWNAISERDRLEIYEDVLFFLSKKEKEQAKQLRKRNWEALKNILDNMANVTYSTTWSEAQQYLMDNPTFAEDEELQNMDKEDALICFEEHIRALEKEEEEEKQKSLLRERRRQRKNRESFQIFLDELHEHGQLHSMSSWMELYPTISSDIRFTNMLGQPGSTALDLFKFYVEDLKARYHDEKKIIKDILKDKGFVVEVNTTFEDFVAIISSTKRSTTLDAGNIKLAFNSLLEKAEAREREREKEEARKMKRKESAFKSMLKQAAPPIELDAVWEDIRERFVKEPAFEDITLESERKRIFKDFMHVLEHECQHHHSKNKKHSKKSKKHHRKRSRSRSGSDSDDDDSHSKKKRQRSESRSASEHSSSAESERSYKKSKKHKKKSKKRRHKSDSPESDAEREKDKKEKDRESEKDRTRQRSESKHKSPKKKTGKDSGNWDTSGSELSEGELEKRRRTLLEQLDDDQ,False,False,True,O75400,"[('cd00201', 'WW'), ('G3DSA:1.10.10.440', 'FF domain'), ('G3DSA:2.20.70.10', None), ('IPR001202', 'WW domain'), ('IPR002713', 'FF domain'), ('IPR036020', 'WW domain superfamily'), ('IPR036517', 'FF domain superfamily'), ('IPR039726', 'Pre-mRNA-processing factor Prp40'), ('PF00397', 'WW domain'), ('PF01846', 'FF domain'), ('PS01159', 'WW/rsp5/WWP domain signature'), ('PS50020', 'WW/rsp5/WWP domain profile'), ('PS51676', 'FF domain profile'), ('PTHR11864', 'PRE-MRNA-PROCESSING PROTEIN PRP40'), ('SM00441', 'Contains two conserved F residues'), ('SM00456', 'Domain with 2 conserved Trp (W) residues'), ('SSF51045', 'WW domain'), ('SSF81698', 'FF domain')]",,,,,,,ENST00000354363.11 [O75400-5];ENST00000696381.1 [O75400-1];,PRPF40A,ENSG00000196504,0.0,PRPF40A,Canonical_RBPs,11.0,,,,0.486,0.274,PRPF40A
O75604,ENSG00000036672,UBP2_HUMAN,circadian behavior [GO:0048512]; circadian regulation of gene expression [GO:0032922]; entrainment of circadian clock by photoperiod [GO:0043153]; locomotor rhythm [GO:0045475]; muscle organ development [GO:0007517]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of mitotic cell cycle [GO:0045931]; protein deubiquitination [GO:0016579]; protein stabilization [GO:0050821]; proteolysis [GO:0006508]; regulation of signal transduction by p53 class mediator [GO:1901796],centrosome [GO:0005813]; cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471],cyclin binding [GO:0030332]; cysteine-type deubiquitinase activity [GO:0004843]; cysteine-type endopeptidase activity [GO:0004197]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; ubiquitin protein ligase binding [GO:0031625],,DOMAIN: The different N-terminus extensions of isoform 1 and isoform 4 determine their respective subcellular localization and differential effect on myoblast fusion and accumulation of muscle-specific proteins. The different N-terminus extensions of isoform 1 and isoform 4 are not essential for their catalytic activity. {ECO:0000250|UniProtKB:Q5U349}.,"DOMAIN 267..599; /note=""USP""","STRAND 272..274; /evidence=""ECO:0007829|PDB:3V6E""; STRAND 351..353; /evidence=""ECO:0007829|PDB:3NHE""; STRAND 417..425; /evidence=""ECO:0007829|PDB:5XVE""; STRAND 431..443; /evidence=""ECO:0007829|PDB:5XVE""; STRAND 450..454; /evidence=""ECO:0007829|PDB:5XVE""; STRAND 466..468; /evidence=""ECO:0007829|PDB:5XVE""; STRAND 485..493; /evidence=""ECO:0007829|PDB:5XVE""; STRAND 496..502; /evidence=""ECO:0007829|PDB:5XVE""; STRAND 505..508; /evidence=""ECO:0007829|PDB:6DGF""; STRAND 509..511; /evidence=""ECO:0007829|PDB:5XU8""; STRAND 518..520; /evidence=""ECO:0007829|PDB:6DGF""; STRAND 532..534; /evidence=""ECO:0007829|PDB:5XU8""; STRAND 540..551; /evidence=""ECO:0007829|PDB:5XVE""; STRAND 553..555; /evidence=""ECO:0007829|PDB:3V6C""; STRAND 556..563; /evidence=""ECO:0007829|PDB:5XVE""; STRAND 570..574; /evidence=""ECO:0007829|PDB:5XVE""; STRAND 577..581; /evidence=""ECO:0007829|PDB:5XVE""; STRAND 591..598; /evidence=""ECO:0007829|PDB:5XVE""","HELIX 276..286; /evidence=""ECO:0007829|PDB:5XVE""; HELIX 289..296; /evidence=""ECO:0007829|PDB:5XVE""; HELIX 299..302; /evidence=""ECO:0007829|PDB:5XVE""; HELIX 312..325; /evidence=""ECO:0007829|PDB:5XVE""; HELIX 337..346; /evidence=""ECO:0007829|PDB:5XVE""; HELIX 348..350; /evidence=""ECO:0007829|PDB:5XVE""; HELIX 358..373; /evidence=""ECO:0007829|PDB:5XVE""; HELIX 392..404; /evidence=""ECO:0007829|PDB:5XVE""; HELIX 410..415; /evidence=""ECO:0007829|PDB:5XVE""; HELIX 455..463; /evidence=""ECO:0007829|PDB:5XVE""; HELIX 470..472; /evidence=""ECO:0007829|PDB:5XVE""; HELIX 529..531; /evidence=""ECO:0007829|PDB:5XVE""; HELIX 583..585; /evidence=""ECO:0007829|PDB:5XVE""","TURN 426..428; /evidence=""ECO:0007829|PDB:5XVE""; TURN 477..480; /evidence=""ECO:0007829|PDB:5XVE""; TURN 565..567; /evidence=""ECO:0007829|PDB:5XVE""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,USP2 UBP41,Ubiquitin carboxyl-terminal hydrolase 2 (EC 3.4.19.12) (41 kDa ubiquitin-specific protease) (Deubiquitinating enzyme 2) (Ubiquitin thioesterase 2) (Ubiquitin-specific-processing protease 2),Homo sapiens (Human),605.0,68072.0,MSQLSSTLKRYTESARYTDAHYAKSGYGAYTPSSYGANLAASLLEKEKLGFKPVPTSSFLTRPRTYGPSSLLDYDRGRPLLRPDITGGGKRAESQTRGTERPLGSGLSGGSGFPYGVTNNCLSYLPINAYDQGVTLTQKLDSQSDLARDFSSLRTSDSYRIDPRNLGRSPMLARTRKELCTLQGLYQTASCPEYLVDYLENYGRKGSASQVPSQAPPSRVPEIISPTYRPIGRYTLWETGKGQAPGPSRSSSPGRDGMNSKSAQGLAGLRNLGNTCFMNSILQCLSNTRELRDYCLQRLYMRDLHHGSNAHTALVEEFAKLIQTIWTSSPNDVVSPSEFKTQIQRYAPRFVGYNQQDAQEFLRFLLDGLHNEVNRVTLRPKSNPENLDHLPDDEKGRQMWRKYLEREDSRIGDLFVGQLKSSLTCTDCGYCSTVFDPFWDLSLPIAKRGYPEVTLMDCMRLFTKEDVLDGDEKPTCCRCRGRKRCIKKFSIQRFPKILVLHLKRFSESRIRTSKLTTFVNFPLRDLDLREFASENTNHAVYNLYAVSNHSGTTMGGHYTAYCRSPGTGEWHTFNDSSVTPMSSSQVRTSDAYLLFYELASPPSRM,False,False,True,O75604,"[('cd02674', 'Peptidase_C19R'), ('G3DSA:3.90.70.10', 'Cysteine proteinases'), ('IPR001394', 'Peptidase C19, ubiquitin carboxyl-terminal hydrolase'), ('IPR018200', 'Ubiquitin specific protease, conserved site'), ('IPR028889', 'Ubiquitin specific protease domain'), ('IPR038765', 'Papain-like cysteine peptidase superfamily'), ('IPR050185', 'Ubiquitin carboxyl-terminal hydrolase'), ('PF00443', 'Ubiquitin carboxyl-terminal hydrolase'), ('PS00972', 'Ubiquitin specific protease (USP) domain signature 1'), ('PS00973', 'Ubiquitin specific protease (USP) domain signature 2'), ('PS50235', 'Ubiquitin specific protease (USP) domain profile'), ('PTHR21646', 'Ubiquitin carboxyl-terminal hydrolase'), ('SSF54001', 'Cysteine proteinases')]",,"""ENSG00000036672; Tissue enhanced (skeletal)."";","CATALYTIC ACTIVITY: Reaction=Thiol-dependent hydrolysis of ester, thioester, amide, peptide and isopeptide bonds formed by the C-terminal Gly of ubiquitin (a 76-residue protein attached to proteins as an intracellular targeting signal).; EC=3.4.19.12;",3.4.19.12,ACTIVITY REGULATION: Cleavage is inhibited by ubiquitin in a dosage-dependent manner. Cleavage is blocked by ubiquitin aldehyde. {ECO:0000269|PubMed:16905103}.,,ENST00000260187.7 [O75604-1];ENST00000455332.6 [O75604-3];ENST00000525735.1 [O75604-4];,USP2,ENSG00000036672,0.0,,,,,,,0.413,0.107,USP2
O75674,ENSG00000141198,TM1L1_HUMAN,activation of protein kinase activity [GO:0032147]; negative regulation of mitotic nuclear division [GO:0045839]; positive regulation of protein autophosphorylation [GO:0031954]; protein transport [GO:0015031]; signal transduction [GO:0007165]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162],cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; Golgi stack [GO:0005795]; lysosome [GO:0005764]; membrane [GO:0016020],clathrin binding [GO:0030276]; phosphatidylinositol binding [GO:0035091]; protein kinase activator activity [GO:0030295]; protein kinase binding [GO:0019901]; SH3 domain binding [GO:0017124]; ubiquitin binding [GO:0043130],PTM: Phosphorylated on tyrosines by FYN and LYN. {ECO:0000250}.,,"DOMAIN 22..154; /note=""VHS""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00218""; DOMAIN 200..288; /note=""GAT""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00373""","STRAND 131..133; /evidence=""ECO:0007829|PDB:3RRU""","HELIX 10..12; /evidence=""ECO:0007829|PDB:3RRU""; HELIX 14..22; /evidence=""ECO:0007829|PDB:3RRU""; HELIX 32..44; /evidence=""ECO:0007829|PDB:3RRU""; HELIX 48..60; /evidence=""ECO:0007829|PDB:3RRU""; HELIX 66..82; /evidence=""ECO:0007829|PDB:3RRU""; HELIX 85..91; /evidence=""ECO:0007829|PDB:3RRU""; HELIX 94..97; /evidence=""ECO:0007829|PDB:3RRU""; HELIX 102..105; /evidence=""ECO:0007829|PDB:3RRU""; HELIX 107..109; /evidence=""ECO:0007829|PDB:3RRU""; HELIX 113..127; /evidence=""ECO:0007829|PDB:3RRU""; HELIX 137..148; /evidence=""ECO:0007829|PDB:3RRU""","TURN 98..101; /evidence=""ECO:0007829|PDB:3RRU""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,TOM1L1 SRCASM,TOM1-like protein 1 (Src-activating and signaling molecule protein) (Target of Myb-like protein 1),Homo sapiens (Human),476.0,52989.0,MAFGKSHRDPYATSVGHLIEKATFAGVQTEDWGQFMHICDIINTTQDGPKDAVKALKKRISKNYNHKEIQLTLSLIDMCVQNCGPSFQSLIVKKEFVKENLVKLLNPRYNLPLDIQNRILNFIKTWSQGFPGGVDVSEVKEVYLDLVKKGVQFPPSEAEAETARQETAQISSNPPTSVPTAPALSSVIAPKNSTVTLVPEQIGKLHSELDMVKMNVRVMSAILMENTPGSENHEDIELLQKLYKTGREMQERIMDLLVVVENEDVTVELIQVNEDLNNAILGYERFTRNQQRILEQNKNQKEATNTTSEPSAPSQDLLDLSPSPRMPRATLGELNTMNNQLSGLNFSLPSSDVTNNLKPSLHPQMNLLALENTEIPPFAQRTSQNLTSSHAYDNFLEHSNSVFLQPVSLQTIAAAPSNQSLPPLPSNHPAMTKSDLQPPNYYEVMEFDPLAPAVTTEAIYEEIDAHQHKGAQNDGD,False,False,True,O75674,"[('cd14237', 'canonical GAT domain found in target of Myb-like protein 1 (Tom1L1)'), ('cd16997', 'VHS (Vps27/Hrs/STAM) domain of TOM1-like protein 1'), ('G3DSA:1.20.58.160', None), ('G3DSA:1.25.40.90', None), ('IPR002014', 'VHS domain'), ('IPR004152', 'GAT domain'), ('IPR008942', 'ENTH/VHS'), ('IPR014645', 'Target of Myb protein 1'), ('IPR027428', 'TOM1-like protein 1, GAT domain'), ('IPR038425', 'GAT domain superfamily'), ('IPR047013', 'TOM1-like protein 1, VHS domain'), ('PF00790', 'VHS domain'), ('PF03127', 'GAT domain'), ('PIRSF036948', 'Target of Myb protein 1'), ('PS50179', 'VHS domain profile'), ('PS50909', 'GAT domain profile'), ('PTHR13856', 'TOM1 and TOM1-like domain-containing protein'), ('SM00288', 'Domain present in VPS-27, Hrs and STAM'), ('SSF48464', 'ENTH/VHS domain'), ('SSF89009', 'GAT-like domain')]",O75674;,"""ENSG00000141198; Low tissue specificity."";",,,,,ENST00000348161.8 [O75674-3];ENST00000536554.5 [O75674-3];ENST00000570371.5 [O75674-2];ENST00000575333.5 [O75674-2];ENST00000575882.6 [O75674-1];,TOM1L1,ENSG00000141198,0.0,,,,,,,0.479,0.116,TOM1L1
O75821,ENSG00000130811,EIF3G_HUMAN,formation of cytoplasmic translation initiation complex [GO:0001732]; translational initiation [GO:0006413]; viral translational termination-reinitiation [GO:0075525],cytoplasm [GO:0005737]; cytosol [GO:0005829]; eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; perinuclear region of cytoplasm [GO:0048471],RNA binding [GO:0003723]; translation initiation factor activity [GO:0003743],"PTM: Phosphorylated. Phosphorylation is enhanced upon serum stimulation. {ECO:0000255|HAMAP-Rule:MF_03006, ECO:0000269|PubMed:17322308}.",,"DOMAIN 239..317; /note=""RRM""; /evidence=""ECO:0000255|HAMAP-Rule:MF_03006""","STRAND 158..160; /evidence=""ECO:0007829|PDB:2MJC""; STRAND 162..164; /evidence=""ECO:0007829|PDB:2MJC""; STRAND 241..245; /evidence=""ECO:0007829|PDB:6YBS""; STRAND 266..273; /evidence=""ECO:0007829|PDB:6YBS""; STRAND 276..286; /evidence=""ECO:0007829|PDB:6YBS""; STRAND 300..305; /evidence=""ECO:0007829|PDB:6YBS""; STRAND 308..310; /evidence=""ECO:0007829|PDB:6YBS""; STRAND 311..316; /evidence=""ECO:0007829|PDB:2CQ0""","HELIX 173..175; /evidence=""ECO:0007829|PDB:2MJC""; HELIX 252..259; /evidence=""ECO:0007829|PDB:6YBS""; HELIX 260..262; /evidence=""ECO:0007829|PDB:6YBS""; HELIX 292..296; /evidence=""ECO:0007829|PDB:6YBS""","TURN 297..299; /evidence=""ECO:0007829|PDB:6YBS""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,EIF3G EIF3S4,Eukaryotic translation initiation factor 3 subunit G (eIF3g) (Eukaryotic translation initiation factor 3 RNA-binding subunit) (eIF-3 RNA-binding subunit) (Eukaryotic translation initiation factor 3 subunit 4) (eIF-3-delta) (eIF3 p42) (eIF3 p44),Homo sapiens (Human),320.0,35611.0,MPTGDFDSKPSWADQVEEEGEDDKCVTSELLKGIPLATGDTSPEPELLPGAPLPPPKEVINGNIKTVTEYKIDEDGKKFKIVRTFRIETRKASKAVARRKNWKKFGNSEFDPPGPNVATTTVSDDVSMTFITSKEDLNCQEEEDPMNKLKGQKIVSCRICKGDHWTTRCPYKDTLGPMQKELAEQLGLSTGEKEKLPGELEPVQATQNKTGKYVPPSLRDGASRRGESMQPNRRADDNATIRVTNLSEDTRETDLQELFRPFGSISRIYLAKDKTTGQSKGFAFISFHRREDAARAIAGVSGFGYDHLILNVEWAKPSTN,False,True,False,O75821,"[('cd12408', 'RNA recognition motif (RRM) found in eukaryotic translation initiation factor 3 subunit G (eIF-3G) and similar proteins'), ('cd12933', 'eIF3G domain found in eukaryotic translation initiation factor 3 subunit G (eIF-3G) and similar proteins'), ('G3DSA:3.30.70.330', None), ('IPR000504', 'RNA recognition motif domain'), ('IPR012677', 'Nucleotide-binding alpha-beta plait domain superfamily'), ('IPR017334', 'Eukaryotic translation initiation factor 3 subunit G'), ('IPR024675', 'Eukaryotic translation initiation factor 3 subunit G, N-terminal'), ('IPR034240', 'eIF3G, RNA recognition motif'), ('IPR035979', 'RNA-binding domain superfamily'), ('MF_03006', 'Eukaryotic translation initiation factor 3 subunit G [EIF3G]'), ('PF00076', 'RNA recognition motif'), ('PF12353', 'Eukaryotic translation initiation factor 3 subunit G'), ('PIRSF037949', 'Translation initiation factor 3, RNA-binding subunit'), ('PS50102', 'Eukaryotic RNA Recognition Motif (RRM) profile'), ('PTHR10352', 'RNA Metabolism and Translation Regulatory Proteins'), ('SM00360', 'RNA recognition motif'), ('SSF54928', 'RNA-binding domain, RBD')]",O75821;,"""ENSG00000130811; Low tissue specificity."";",,,,,ENST00000253108.9;,EIF3G,ENSG00000130811,0.0,EIF3G,Canonical_RBPs,30.0,,,,0.566,0.266,EIF3G
O75925,ENSG00000033800,PIAS1_HUMAN,cell surface receptor signaling pathway via JAK-STAT [GO:0007259]; DNA damage response [GO:0006974]; fat cell differentiation [GO:0045444]; G1/S transition of mitotic cell cycle [GO:0000082]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein localization to cell periphery [GO:1904377]; positive regulation of protein sumoylation [GO:0033235]; positive regulation of smooth muscle cell differentiation [GO:0051152]; protein sumoylation [GO:0016925]; protein-DNA complex assembly [GO:0065004]; regulation of cell population proliferation [GO:0042127]; regulation of transcription by RNA polymerase II [GO:0006357]; spermatogenesis [GO:0007283]; visual learning [GO:0008542],chromatin [GO:0000785]; cytoskeleton [GO:0005856]; glutamatergic synapse [GO:0098978]; nuclear periphery [GO:0034399]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; postsynaptic cytosol [GO:0099524]; presynaptic cytosol [GO:0099523],DNA-binding transcription factor binding [GO:0140297]; enzyme binding [GO:0019899]; protein domain specific binding [GO:0019904]; SUMO ligase activity [GO:0061665]; SUMO transferase activity [GO:0019789]; transcription cis-regulatory region binding [GO:0000976]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270],"PTM: Sumoylated. {ECO:0000269|PubMed:11867732, ECO:0000269|PubMed:12393906}.",DOMAIN: The LXXLL motif is a transcriptional coregulator signature.; DOMAIN: The SP-RING-type domain is required for promoting EKLF sumoylation. {ECO:0000250}.,"DOMAIN 11..45; /note=""SAP""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00186""; DOMAIN 124..288; /note=""PINIT""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00799""",,"HELIX 6..11; /evidence=""ECO:0007829|PDB:1V66""; HELIX 16..24; /evidence=""ECO:0007829|PDB:1V66""; HELIX 34..46; /evidence=""ECO:0007829|PDB:1V66""; HELIX 51..63; /evidence=""ECO:0007829|PDB:1V66""",,"cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,PIAS1 DDXBP1,E3 SUMO-protein ligase PIAS1 (EC 2.3.2.-) (DEAD/H box-binding protein 1) (E3 SUMO-protein transferase PIAS1) (Gu-binding protein) (GBP) (Protein inhibitor of activated STAT protein 1) (RNA helicase II-binding protein),Homo sapiens (Human),651.0,71836.0,MADSAELKQMVMSLRVSELQVLLGYAGRNKHGRKHELLTKALHLLKAGCSPAVQMKIKELYRRRFPQKIMTPADLSIPNVHSSPMPATLSPSTIPQLTYDGHPASSPLLPVSLLGPKHELELPHLTSALHPVHPDIKLQKLPFYDLLDELIKPTSLASDNSQRFRETCFAFALTPQQVQQISSSMDISGTKCDFTVQVQLRFCLSETSCPQEDHFPPNLCVKVNTKPCSLPGYLPPTKNGVEPKRPSRPINITSLVRLSTTVPNTIVVSWTAEIGRNYSMAVYLVKQLSSTVLLQRLRAKGIRNPDHSRALIKEKLTADPDSEIATTSLRVSLLCPLGKMRLTIPCRALTCSHLQCFDATLYIQMNEKKPTWVCPVCDKKAPYEHLIIDGLFMEILKYCTDCDEIQFKEDGTWAPMRSKKEVQEVSASYNGVDGCLSSTLEHQVASHHQSSNKNKKVEVIDLTIDSSSDEEEEEPSAKRTCPSLSPTSPLNNKGILSLPHQASPVSRTPSLPAVDTSYINTSLIQDYRHPFHMTPMPYDLQGLDFFPFLSGDNQHYNTSLLAAAAAAVSDDQDLLHSSRFFPYTSSQMFLDQLSAGGSTSLPTTNGSSSGSNSSLVSSNSLRESHSHTVTNRSSTDTASIFGIIPDIISLD,True,False,False,O75925,"[('cd16818', 'SP-RING finger found in protein inhibitor of activated STAT protein 1 (PIAS1) and similar proteins'), ('G3DSA:1.10.720.30', 'SAP domain'), ('G3DSA:2.60.120.780', 'PINIT domain'), ('G3DSA:3.30.40.10', 'Zinc/RING finger domain, C3HC4 (zinc finger)'), ('IPR003034', 'SAP domain'), ('IPR004181', 'Zinc finger, MIZ-type'), ('IPR013083', 'Zinc finger, RING/FYVE/PHD-type'), ('IPR023321', 'PINIT domain'), ('IPR036361', 'SAP domain superfamily'), ('IPR038654', 'PINIT domain superfamily'), ('PF02891', 'MIZ/SP-RING zinc finger'), ('PF14324', 'PINIT domain'), ('PS50800', 'SAP motif profile'), ('PS51044', 'Zinc finger SP-RING-type profile'), ('PS51466', 'PINIT domain profile'), ('PTHR10782', 'Protein Inhibitor of Activated STAT (PIAS)'), ('SM00513', 'Putative DNA-binding (bihelical) motif predicted to be involved in chromosomal organisation'), ('SSF68906', 'SAP domain')]",O75925;,"""ENSG00000033800; Low tissue specificity."";",,2.3.2.-,,PATHWAY: Protein modification; protein sumoylation.,ENST00000249636.11 [O75925-1];ENST00000545237.1 [O75925-2];,PIAS1,ENSG00000033800,0.0,,,,,,,0.464,0.124,PIAS1
O94811,ENSG00000171368,TPPP_HUMAN,astral microtubule organization [GO:0030953]; cell division [GO:0051301]; microtubule bundle formation [GO:0001578]; microtubule nucleation by microtubule organizing center [GO:0051418]; microtubule polymerization [GO:0046785]; myelin assembly [GO:0032288]; negative regulation of tubulin deacetylation [GO:1904428]; oligodendrocyte development [GO:0014003]; oligodendrocyte differentiation [GO:0048709]; positive regulation of myelination [GO:0031643]; positive regulation of protein polymerization [GO:0032273]; positive regulation of protein-containing complex assembly [GO:0031334]; regulation of microtubule cytoskeleton organization [GO:0070507],cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; microtubule [GO:0005874]; microtubule organizing center [GO:0005815]; mitochondrion [GO:0005739]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic Golgi apparatus [GO:0150051],GTPase activity [GO:0003924]; magnesium ion binding [GO:0000287]; microtubule binding [GO:0008017]; microtubule nucleator activity [GO:0140490]; protein dimerization activity [GO:0046983]; protein homodimerization activity [GO:0042803]; tubulin binding [GO:0015631],"PTM: Phosphorylated by LIMK1 on serine residues; phosphorylation may alter the tubulin polymerization activity (PubMed:17693641, PubMed:18028908). Phosphorylation by LIMK2, but not LIMK1, regulates astral microtubule organization at early stage of mitosis (PubMed:22328514). Phosphorylation by ROCK1 at Ser-32, Ser-107 and Ser-159 inhibits interaction with HDAC6, resulting in decreased acetylation of tubulin, increased cell motility and entry into S-phase (PubMed:23093407, PubMed:23355470). Phosphorylation by CDK1 inhibits the microtubule polymerizing activity (PubMed:23355470). {ECO:0000269|PubMed:17693641, ECO:0000269|PubMed:18028908, ECO:0000269|PubMed:22328514, ECO:0000269|PubMed:23093407, ECO:0000269|PubMed:23355470}.; PTM: Degraded by the proteasome; zinc-binding inhibits degradation by the proteasome. {ECO:0000269|PubMed:25445539}.","DOMAIN: Most of the protein is composed of disordered regions (PubMed:21316364). Zinc-binding induces structural rearrangement by promoting molten globule state formation (PubMed:21995432). {ECO:0000269|PubMed:21316364, ECO:0000269|PubMed:21995432}.",,,,,"cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,TPPP TPPP1,Tubulin polymerization-promoting protein (TPPP) (EC 3.6.5.-) (25 kDa brain-specific protein) (TPPP/p25) (p24) (p25-alpha),Homo sapiens (Human),219.0,23694.0,MADKAKPAKAANRTPPKSPGDPSKDRAAKRLSLESEGAGEGAAASPELSALEEAFRRFAVHGDARATGREMHGKNWSKLCKDCQVIDGRNVTVTDVDIVFSKIKGKSCRTITFEQFQEALEELAKKRFKDKSSEEAVREVHRLIEGKAPIISGVTKAISSPTVSRLTDTTKFTGSHKERFDPSGKGKGKAGRVDLVDESGYVSGYKHAGTYDQKVQGGK,True,False,False,O94811,"[('G3DSA:1.10.238.10', 'EF-hand'), ('IPR008907', 'Tubulin polymerization-promoting protein'), ('IPR011992', 'EF-hand domain pair'), ('PF05517', 'p25-alpha'), ('PTHR12932', 'P25 ALPHA-RELATED'), ('SSF47473', 'EF-hand')]",,"""ENSG00000171368; Tissue enriched (brain)."";","CATALYTIC ACTIVITY: Reaction=GTP + H2O = GDP + phosphate + H(+); Xref=Rhea:RHEA:19669, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:37565, ChEBI:CHEBI:43474, ChEBI:CHEBI:58189; Evidence={ECO:0000269|PubMed:21316364, ECO:0000269|PubMed:21995432}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:19670; Evidence={ECO:0000269|PubMed:21316364, ECO:0000269|PubMed:21995432};",3.6.5.-,,,ENST00000360578.7;,TPPP,ENSG00000171368,0.0,,,,,,,0.434,0.311,TPPP
O94906,ENSG00000101161,PRP6_HUMAN,"mRNA splicing, via spliceosome [GO:0000398]; positive regulation of transcription by RNA polymerase II [GO:0045944]; RNA localization [GO:0006403]; RNA splicing [GO:0008380]; RNA splicing, via transesterification reactions [GO:0000375]; spliceosomal complex assembly [GO:0000245]; spliceosomal tri-snRNP complex assembly [GO:0000244]",catalytic step 2 spliceosome [GO:0071013]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U5 snRNP [GO:0005682],identical protein binding [GO:0042802]; protein-macromolecule adaptor activity [GO:0030674]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723],PTM: Phosphorylated by PRP4K during spliceosome assembly. {ECO:0000269|PubMed:20118938}.,,,"STRAND 32..35; /evidence=""ECO:0007829|PDB:8QOZ""; STRAND 83..86; /evidence=""ECO:0007829|PDB:8QP8""; STRAND 90..92; /evidence=""ECO:0007829|PDB:8QP8""; STRAND 872..874; /evidence=""ECO:0007829|PDB:8QOZ""","HELIX 75..77; /evidence=""ECO:0007829|PDB:8QP8""; HELIX 96..113; /evidence=""ECO:0007829|PDB:8Q91""; HELIX 117..126; /evidence=""ECO:0007829|PDB:8Q91""; HELIX 138..149; /evidence=""ECO:0007829|PDB:8Q91""; HELIX 154..156; /evidence=""ECO:0007829|PDB:8Q91""; HELIX 169..172; /evidence=""ECO:0007829|PDB:8QOZ""; HELIX 184..192; /evidence=""ECO:0007829|PDB:8QOZ""; HELIX 241..259; /evidence=""ECO:0007829|PDB:8QP8""; HELIX 270..280; /evidence=""ECO:0007829|PDB:8QP8""; HELIX 291..304; /evidence=""ECO:0007829|PDB:8QOZ""; HELIX 309..322; /evidence=""ECO:0007829|PDB:8QOZ""; HELIX 325..338; /evidence=""ECO:0007829|PDB:8QOZ""; HELIX 343..352; /evidence=""ECO:0007829|PDB:8QOZ""; HELIX 355..368; /evidence=""ECO:0007829|PDB:8QOZ""; HELIX 373..382; /evidence=""ECO:0007829|PDB:8QOZ""; HELIX 386..396; /evidence=""ECO:0007829|PDB:8QOZ""; HELIX 404..407; /evidence=""ECO:0007829|PDB:8QOZ""; HELIX 409..413; /evidence=""ECO:0007829|PDB:8QOZ""; HELIX 794..806; /evidence=""ECO:0007829|PDB:8QOZ""; HELIX 811..820; /evidence=""ECO:0007829|PDB:8QOZ""; HELIX 825..828; /evidence=""ECO:0007829|PDB:8QOZ""; HELIX 832..837; /evidence=""ECO:0007829|PDB:8QOZ""; HELIX 841..853; /evidence=""ECO:0007829|PDB:8QOZ""; HELIX 857..870; /evidence=""ECO:0007829|PDB:8QOZ""; HELIX 877..887; /evidence=""ECO:0007829|PDB:8QOZ""; HELIX 891..900; /evidence=""ECO:0007829|PDB:8QOZ""; HELIX 911..918; /evidence=""ECO:0007829|PDB:8QOZ""; HELIX 924..929; /evidence=""ECO:0007829|PDB:8QOZ""; HELIX 936..939; /evidence=""ECO:0007829|PDB:8QOZ""","TURN 21..24; /evidence=""ECO:0007829|PDB:8QOZ""; TURN 80..82; /evidence=""ECO:0007829|PDB:8QP8""; TURN 114..116; /evidence=""ECO:0007829|PDB:8QOZ""; TURN 157..159; /evidence=""ECO:0007829|PDB:8Q91""; TURN 397..399; /evidence=""ECO:0007829|PDB:8QOZ""; TURN 829..831; /evidence=""ECO:0007829|PDB:8QOZ""; TURN 905..907; /evidence=""ECO:0007829|PDB:8QOZ""; TURN 933..935; /evidence=""ECO:0007829|PDB:8QOZ""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,PRPF6 C20orf14,Pre-mRNA-processing factor 6 (Androgen receptor N-terminal domain-transactivating protein 1) (ANT-1) (PRP6 homolog) (U5 snRNP-associated 102 kDa protein) (U5-102 kDa protein),Homo sapiens (Human),941.0,106925.0,MNKKKKPFLGMPAPLGYVPGLGRGATGFTTRSDIGPARDANDPVDDRHAPPGKRTVGDQMKKNQAADDDDEDLNDTNYDEFNGYAGSLFSSGPYEKDDEEADAIYAALDKRMDERRKERREQREKEEIEKYRMERPKIQQQFSDLKRKLAEVTEEEWLSIPEVGDARNKRQRNPRYEKLTPVPDSFFAKHLQTGENHTSVDPRQTQFGGLNTPYPGGLNTPYPGGMTPGLMTPGTGELDMRKIGQARNTLMDMRLSQVSDSVSGQTVVDPKGYLTDLNSMIPTHGGDINDIKKARLLLKSVRETNPHHPPAWIASARLEEVTGKLQVARNLIMKGTEMCPKSEDVWLEAARLQPGDTAKAVVAQAVRHLPQSVRIYIRAAELETDIRAKKRVLRKALEHVPNSVRLWKAAVELEEPEDARIMLSRAVECCPTSVELWLALARLETYENARKVLNKARENIPTDRHIWITAAKLEEANGNTQMVEKIIDRAITSLRANGVEINREQWIQDAEECDRAGSVATCQAVMRAVIGIGIEEEDRKHTWMEDADSCVAHNALECARAIYAYALQVFPSKKSVWLRAAYFEKNHGTRESLEALLQRAVAHCPKAEVLWLMGAKSKWLAGDVPAARSILALAFQANPNSEEIWLAAVKLESENDEYERARRLLAKARSSAPTARVFMKSVKLEWVQDNIRAAQDLCEEALRHYEDFPKLWMMKGQIEEQKEMMEKAREAYNQGLKKCPHSTPLWLLLSRLEEKIGQLTRARAILEKSRLKNPKNPGLWLESVRLEYRAGLKNIANTLMAKALQECPNSGILWSEAIFLEARPQRRTKSVDALKKCEHDPHVLLAVAKLFWSQRKITKAREWFHRTVKIDSDLGDAWAFFYKFELQHGTEEQQEEVRKRCESAEPRHGELWCAVSKDIANWQKKIGDILRLVAGRIKNTF,False,False,True,O94906,"[('G3DSA:1.25.40.10', 'Tetratricopeptide repeat domain'), ('IPR003107', 'HAT (Half-A-TPR) repeat'), ('IPR010491', 'PRP1 splicing factor, N-terminal'), ('IPR011990', 'Tetratricopeptide-like helical domain superfamily'), ('IPR019734', 'Tetratricopeptide repeat'), ('IPR045075', 'Pre-mRNA-splicing factor Syf1-like'), ('PF06424', 'PRP1 splicing factor, N-terminal'), ('PF13432', 'Tetratricopeptide repeat'), ('PF14559', 'Tetratricopeptide repeat'), ('PTHR11246', 'PRE-MRNA SPLICING FACTOR'), ('SM00028', 'Tetratricopeptide repeats'), ('SM00386', 'HAT (Half-A-TPR) repeats'), ('SSF48452', 'TPR-like')]",,"""ENSG00000101161; Low tissue specificity."";",,,,,ENST00000266079.5 [O94906-1];,PRPF6,ENSG00000101161,0.0,PRPF6,Canonical_RBPs,11.0,,,,0.294,0.084,PRPF6
O95166,ENSG00000170296,GBRAP_HUMAN,autophagosome assembly [GO:0000045]; autophagosome maturation [GO:0097352]; autophagy of mitochondrion [GO:0000422]; cellular response to nitrogen starvation [GO:0006995]; chemical synaptic transmission [GO:0007268]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; microtubule cytoskeleton organization [GO:0000226]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein K48-linked ubiquitination [GO:1902524]; protein targeting [GO:0006605]; protein transport [GO:0015031]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; regulation of Rac protein signal transduction [GO:0035020],actin cytoskeleton [GO:0015629]; autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; axoneme [GO:0005930]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; GABA-ergic synapse [GO:0098982]; Golgi membrane [GO:0000139]; lysosome [GO:0005764]; microtubule [GO:0005874]; microtubule associated complex [GO:0005875]; plasma membrane [GO:0005886]; smooth endoplasmic reticulum [GO:0005790]; sperm midpiece [GO:0097225],beta-tubulin binding [GO:0048487]; GABA receptor binding [GO:0050811]; microtubule binding [GO:0008017]; phosphatidylethanolamine binding [GO:0008429]; ubiquitin protein ligase binding [GO:0031625],"PTM: The precursor molecule is cleaved by ATG4 (ATG4A, ATG4B, ATG4C or ATG4D) to expose the glycine at the C-terminus and form the cytosolic form, GABARAP-I (PubMed:15169837, PubMed:20818167, PubMed:30661429). The processed form is then activated by APG7L/ATG7, transferred to ATG3 and conjugated to phosphatidylethanolamine (PE) phospholipid to form the membrane-bound form, GABARAP-II (PubMed:15169837). During non-canonical autophagy, the processed form is conjugated to phosphatidylserine (PS) phospholipid (PubMed:33909989). ATG4 proteins also mediate the delipidation of PE-conjugated forms (PubMed:33909989). In addition, ATG4B and ATG4D mediate delipidation of ATG8 proteins conjugated to PS during non-canonical autophagy (PubMed:33909989). ATG4B constitutes the major protein for proteolytic activation (PubMed:30661429). ATG4D is the main enzyme for delipidation activity (By similarity). {ECO:0000250|UniProtKB:Q9DCD6, ECO:0000269|PubMed:15169837, ECO:0000269|PubMed:20818167, ECO:0000269|PubMed:30661429, ECO:0000269|PubMed:33909989}.; PTM: (Microbial infection) The Legionella effector RavZ is a deconjugating enzyme that hydrolyzes the amide bond between the C-terminal glycine residue and an adjacent aromatic residue in ATG8 proteins conjugated to phosphatidylethanolamine (PE), producing an ATG8 protein that is resistant to reconjugation by the host machinery due to the cleavage of the reactive C-terminal glycine (PubMed:31722778). RavZ is also able to mediate delipidation of ATG8 proteins conjugated to phosphatidylserine (PS) (PubMed:33909989). {ECO:0000269|PubMed:31722778, ECO:0000269|PubMed:33909989}.",,,"STRAND 28..35; /evidence=""ECO:0007829|PDB:6HYO""; STRAND 48..52; /evidence=""ECO:0007829|PDB:6HYO""; STRAND 72..74; /evidence=""ECO:0007829|PDB:8AFI""; STRAND 77..80; /evidence=""ECO:0007829|PDB:6HYO""; STRAND 87..90; /evidence=""ECO:0007829|PDB:7BV4""; STRAND 101..103; /evidence=""ECO:0007829|PDB:1KM7""; STRAND 105..114; /evidence=""ECO:0007829|PDB:6HYO""","HELIX 4..8; /evidence=""ECO:0007829|PDB:6HYO""; HELIX 11..24; /evidence=""ECO:0007829|PDB:6HYO""; HELIX 57..67; /evidence=""ECO:0007829|PDB:6HYO""; HELIX 91..98; /evidence=""ECO:0007829|PDB:6HYO""",,"cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,GABARAP FLC3B HT004,Gamma-aminobutyric acid receptor-associated protein (GABA(A) receptor-associated protein) (MM46),Homo sapiens (Human),117.0,13918.0,MKFVYKEEHPFEKRRSEGEKIRKKYPDRVPVIVEKAPKARIGDLDKKKYLVPSDLTVGQFYFLIRKRIHLRAEDALFFFVNNVIPPTSATMGQLYQEHHEEDFFLYIAYSDESVYGL,False,False,True,O95166,"[('cd17232', 'ubiquitin-like (Ubl) domain found in gamma-aminobutyric acid receptor-associated protein (GABARAP)'), ('G3DSA:3.10.20.90', 'Phosphatidylinositol 3-kinase Catalytic Subunit; Chain A, domain 1'), ('IPR004241', 'Autophagy protein Atg8 ubiquitin-like'), ('IPR029071', 'Ubiquitin-like domain superfamily'), ('PF02991', 'Autophagy protein Atg8 ubiquitin like'), ('PTHR10969', 'MICROTUBULE-ASSOCIATED PROTEINS 1A/1B LIGHT CHAIN 3-RELATED'), ('SSF54236', 'Ubiquitin-like')]",O95166;,"""ENSG00000170296; Low tissue specificity."";",,,,,ENST00000302386.10;,GABARAP,ENSG00000170296,0.0,,,,,,,,,GABARAP
O95396,ENSG00000124217,MOCS3_HUMAN,Mo-molybdopterin cofactor biosynthetic process [GO:0006777]; molybdopterin cofactor metabolic process [GO:0043545]; protein urmylation [GO:0032447]; tRNA thio-modification [GO:0034227]; tRNA wobble position uridine thiolation [GO:0002143]; tRNA wobble uridine modification [GO:0002098],cytoplasm [GO:0005737]; cytosol [GO:0005829],ATP binding [GO:0005524]; metal ion binding [GO:0046872]; molybdopterin-synthase adenylyltransferase activity [GO:0061605]; molybdopterin-synthase sulfurtransferase activity [GO:0061604]; nucleotidyltransferase activity [GO:0016779]; sulfurtransferase activity [GO:0016783]; thiosulfate sulfurtransferase activity [GO:0004792]; URM1 activating enzyme activity [GO:0042292],,,"DOMAIN 347..458; /note=""Rhodanese""; /evidence=""ECO:0000255|HAMAP-Rule:MF_03049""","STRAND 352..355; /evidence=""ECO:0007829|PDB:3I2V""; STRAND 370..372; /evidence=""ECO:0007829|PDB:3I2V""; STRAND 406..411; /evidence=""ECO:0007829|PDB:3I2V""; STRAND 413..416; /evidence=""ECO:0007829|PDB:3I2V""; STRAND 433..435; /evidence=""ECO:0007829|PDB:3I2V""; STRAND 437..442; /evidence=""ECO:0007829|PDB:3I2V""","HELIX 338..347; /evidence=""ECO:0007829|PDB:3I2V""; HELIX 359..364; /evidence=""ECO:0007829|PDB:3I2V""; HELIX 375..379; /evidence=""ECO:0007829|PDB:3I2V""; HELIX 383..397; /evidence=""ECO:0007829|PDB:3I2V""; HELIX 417..430; /evidence=""ECO:0007829|PDB:3I2V""; HELIX 445..452; /evidence=""ECO:0007829|PDB:3I2V""",,"cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,MOCS3 UBA4,Adenylyltransferase and sulfurtransferase MOCS3 (Molybdenum cofactor synthesis protein 3) (Molybdopterin synthase sulfurylase) (MPT synthase sulfurylase) [Includes: Molybdopterin-synthase adenylyltransferase (EC 2.7.7.80) (Adenylyltransferase MOCS3) (Sulfur carrier protein MOCS2A adenylyltransferase); Molybdopterin-synthase sulfurtransferase (EC 2.8.1.11) (Sulfur carrier protein MOCS2A sulfurtransferase) (Sulfurtransferase MOCS3)],Homo sapiens (Human),460.0,49669.0,MASREEVLALQAEVAQREEELNSLKQKLASALLAEQEPQPERLVPVSPLPPKAALSRDEILRYSRQLVLPELGVHGQLRLGTACVLIVGCGGLGCPLAQYLAAAGVGRLGLVDYDVVEMSNLARQVLHGEALAGQAKAFSAAASLRRLNSAVECVPYTQALTPATALDLVRRYDVVADCSDNVPTRYLVNDACVLAGRPLVSASALRFEGQITVYHYDGGPCYRCIFPQPPPAETVTNCADGGVLGVVTGVLGCLQALEVLKIAAGLGPSYSGSLLLFDALRGHFRSIRLRSRRLDCAACGERPTVTDLLDYEAFCGSSATDKCRSLQLLSPEERVSVTDYKRLLDSGAFHLLLDVRPQVEVDICRLPHALHIPLKHLERRDAESLKLLKEAIWEEKQGTQEGAAVPIYVICKLGNDSQKAVKILQSLSAAQELDPLTVRDVVGGLMAWAAKIDGTFPQY,True,False,False,O95396,"[('cd00757', 'ThiF_MoeB_HesA_family'), ('cd01526', 'RHOD_ThiF'), ('G3DSA:3.40.250.10', 'Rhodanese-like domain'), ('G3DSA:3.40.50.720', 'NAD(P)-binding Rossmann-like Domain'), ('IPR000594', 'THIF-type NAD/FAD binding fold'), ('IPR001763', 'Rhodanese-like domain'), ('IPR028885', 'Adenylyltransferase and sulfurtransferase MOCS3/Uba4'), ('IPR035985', 'Ubiquitin-activating enzyme'), ('IPR036873', 'Rhodanese-like domain superfamily'), ('IPR045886', 'ThiF/MoeB/HesA family'), ('MF_03049', 'Adenylyltransferase and sulfurtransferase MOCS3 [MOCS3]'), ('PF00581', 'Rhodanese-like domain'), ('PF00899', 'ThiF family'), ('PS50206', 'Rhodanese domain profile'), ('PTHR10953', 'UBIQUITIN-ACTIVATING ENZYME E1'), ('SM00450', 'Rhodanese Homology Domain'), ('SSF69572', 'Activating enzymes of the ubiquitin-like proteins')]",,"""ENSG00000124217; Low tissue specificity."";","CATALYTIC ACTIVITY: Reaction=[molybdopterin-synthase sulfur-carrier protein]-C-terminal Gly-Gly + ATP + H(+) = [molybdopterin-synthase sulfur-carrier protein]-C-terminal Gly-Gly-AMP + diphosphate; Xref=Rhea:RHEA:43616, Rhea:RHEA-COMP:12159, Rhea:RHEA-COMP:12202, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616, ChEBI:CHEBI:33019, ChEBI:CHEBI:90618, ChEBI:CHEBI:90778; EC=2.7.7.80; Evidence={ECO:0000255|HAMAP-Rule:MF_03049, ECO:0000269|PubMed:15073332, ECO:0000269|PubMed:17459099, ECO:0000269|PubMed:18650437}; CATALYTIC ACTIVITY: Reaction=[molybdopterin-synthase sulfur-carrier protein]-C-terminal Gly-Gly-AMP + S-sulfanyl-L-cysteinyl-[cysteine desulfurase] + AH2 = [molybdopterin-synthase sulfur-carrier protein]-C-terminal Gly-NH-CH2-C(O)SH + L-cysteinyl-[cysteine desulfurase] + A + AMP + H(+); Xref=Rhea:RHEA:48612, Rhea:RHEA-COMP:12157, Rhea:RHEA-COMP:12158, Rhea:RHEA-COMP:12159, Rhea:RHEA-COMP:12160, ChEBI:CHEBI:13193, ChEBI:CHEBI:15378, ChEBI:CHEBI:17499, ChEBI:CHEBI:29950, ChEBI:CHEBI:61963, ChEBI:CHEBI:90618, ChEBI:CHEBI:90619, ChEBI:CHEBI:456215; EC=2.8.1.11; Evidence={ECO:0000255|HAMAP-Rule:MF_03049, ECO:0000269|PubMed:15073332, ECO:0000269|PubMed:17459099, ECO:0000269|PubMed:18650437};",2.7.7.80; 2.8.1.11,,PATHWAY: tRNA modification; 5-methoxycarbonylmethyl-2-thiouridine-tRNA biosynthesis. {ECO:0000255|HAMAP-Rule:MF_03049}.; PATHWAY: Cofactor biosynthesis; molybdopterin biosynthesis. {ECO:0000255|HAMAP-Rule:MF_03049}.,ENST00000244051.3;,MOCS3,ENSG00000124217,0.0,MOCS3,Non-canonical_RBPs,8.0,,,,0.085,,MOCS3
O95400,ENSG00000169217,CD2B2_HUMAN,spliceosomal tri-snRNP complex assembly [GO:0000244],cytoplasm [GO:0005737]; cytosol [GO:0005829]; fibrillar center [GO:0001650]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; U5 snRNP [GO:0005682],ribonucleoprotein complex binding [GO:0043021],,,"DOMAIN 280..338; /note=""GYF""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00101""","STRAND 81..87; /evidence=""ECO:0007829|PDB:8Q91""; STRAND 90..92; /evidence=""ECO:0007829|PDB:8Q91""; STRAND 99..101; /evidence=""ECO:0007829|PDB:8Q7Q""; STRAND 107..109; /evidence=""ECO:0007829|PDB:8Q7Q""; STRAND 282..293; /evidence=""ECO:0007829|PDB:1SYX""; STRAND 296..300; /evidence=""ECO:0007829|PDB:1SYX""; STRAND 318..324; /evidence=""ECO:0007829|PDB:1SYX""","HELIX 68..71; /evidence=""ECO:0007829|PDB:8Q91""; HELIX 93..98; /evidence=""ECO:0007829|PDB:8Q91""; HELIX 118..121; /evidence=""ECO:0007829|PDB:8Q91""; HELIX 154..163; /evidence=""ECO:0007829|PDB:8Q91""; HELIX 171..178; /evidence=""ECO:0007829|PDB:8Q91""; HELIX 196..211; /evidence=""ECO:0007829|PDB:8Q91""; HELIX 217..219; /evidence=""ECO:0007829|PDB:8Q91""; HELIX 222..232; /evidence=""ECO:0007829|PDB:8Q91""; HELIX 301..309; /evidence=""ECO:0007829|PDB:1SYX""; HELIX 332..334; /evidence=""ECO:0007829|PDB:1SYX""; HELIX 337..340; /evidence=""ECO:0007829|PDB:1SYX""","TURN 124..126; /evidence=""ECO:0007829|PDB:8Q91""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,CD2BP2 KIAA1178,CD2 antigen cytoplasmic tail-binding protein 2 (CD2 cytoplasmic domain-binding protein 2) (CD2 tail-binding protein 2) (U5 snRNP 52K protein) (U5-52K),Homo sapiens (Human),341.0,37646.0,MPKRKVTFQGVGDEEDEDEIIVPKKKLVDPVAGSGGPGSRFKGKHSLDSDEEEDDDDGGSSKYDILASEDVEGQEAATLPSEGGVRITPFNLQEEMEEGHFDADGNYFLNRDAQIRDSWLDNIDWVKIRERPPGQRQASDSEEEDSLGQTSMSAQALLEGLLELLLPRETVAGALRRLGARGGGKGRKGPGQPSSPQRLDRLSGLADQMVARGNLGVYQETRERLAMRLKGLGCQTLGPHNPTPPPSLDMFAEELAEEELETPTPTQRGEAESRGDGLVDVMWEYKWENTGDAELYGPFTSAQMQTWVSEGYFPDGVYCRKLDPPGGQFYNSKRIDFDLYT,True,False,False,O95400,"[('cd00072', 'GYF'), ('G3DSA:3.30.1490.40', None), ('IPR003169', 'GYF domain'), ('IPR035445', 'GYF-like domain superfamily'), ('IPR039905', 'CD2 antigen cytoplasmic tail-binding protein 2/Lin1'), ('PF02213', 'GYF domain'), ('PS50829', 'GYF domain profile'), ('PTHR13138', 'PROTEIN LIN1'), ('SM00444', 'Contains conserved Gly-Tyr-Phe residues'), ('SSF55277', 'GYF domain')]",O95400;,"""ENSG00000169217; Low tissue specificity."";",,,,,ENST00000305596.8;ENST00000569466.1;,CD2BP2,ENSG00000169217,0.0,CD2BP2,Non-canonical_RBPs,1.0,7.33,DP02457,0.073,0.528,0.32,CD2BP2
O95835,ENSG00000131023,LATS1_HUMAN,cell division [GO:0051301]; cytoplasmic sequestering of protein [GO:0051220]; G1/S transition of mitotic cell cycle [GO:0000082]; G2/M transition of mitotic cell cycle [GO:0000086]; hippo signaling [GO:0035329]; hormone-mediated signaling pathway [GO:0009755]; inner cell mass cell fate commitment [GO:0001827]; inner cell mass cellular morphogenesis [GO:0001828]; keratinocyte differentiation [GO:0030216]; mammary gland epithelial cell differentiation [GO:0060644]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of protein localization to nucleus [GO:1900181]; positive regulation of apoptotic process [GO:0043065]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; protein phosphorylation [GO:0006468]; regulation of actin filament polymerization [GO:0030833]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of organ growth [GO:0046620]; regulation of postsynaptic density assembly [GO:0099151]; regulation of protein-containing complex assembly [GO:0043254]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]; regulation of ubiquitin-dependent protein catabolic process [GO:2000058]; sister chromatid segregation [GO:0000819],centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; midbody [GO:0030496]; nucleus [GO:0005634]; postsynapse [GO:0098794]; spindle pole [GO:0000922]; spindle pole body [GO:0005816],ATP binding [GO:0005524]; histone H2AS1 kinase activity [GO:0044024]; magnesium ion binding [GO:0000287]; nuclear estrogen receptor binding [GO:0030331]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],"PTM: Autophosphorylated and phosphorylated during M-phase of the cell cycle (PubMed:10518011, PubMed:15122335, PubMed:9988268). Phosphorylated by STK3/MST2 at Ser-909 and Thr-1079, which results in its activation (PubMed:15688006). Phosphorylated by MAP4Ks; in parallel to STK3/MST2 and resulting to its activation (PubMed:26437443). Phosphorylation at Ser-464 by NUAK1 and NUAK2 leads to decreased protein level and is required to regulate cellular senescence and cellular ploidy (PubMed:19927127). {ECO:0000269|PubMed:10518011, ECO:0000269|PubMed:15122335, ECO:0000269|PubMed:15688006, ECO:0000269|PubMed:19927127, ECO:0000269|PubMed:26437443, ECO:0000269|PubMed:9988268}.",,"DOMAIN 100..141; /note=""UBA""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00212""; DOMAIN 705..1010; /note=""Protein kinase""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00159""; DOMAIN 1011..1090; /note=""AGC-kinase C-terminal""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00618""",,"HELIX 72..74; /evidence=""ECO:0007829|PDB:7LWH""; HELIX 75..85; /evidence=""ECO:0007829|PDB:7LWH""; HELIX 86..88; /evidence=""ECO:0007829|PDB:7LWH""; HELIX 637..671; /evidence=""ECO:0007829|PDB:5BRK""; HELIX 675..697; /evidence=""ECO:0007829|PDB:5BRK""",,"cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,LATS1 WARTS,Serine/threonine-protein kinase LATS1 (EC 2.7.11.1) (Large tumor suppressor homolog 1) (WARTS protein kinase) (h-warts),Homo sapiens (Human),1130.0,126870.0,MKRSEKPEGYRQMRPKTFPASNYTVSSRQMLQEIRESLRNLSKPSDAAKAEHNMSKMSTEDPRQVRNPPKFGTHHKALQEIRNSLLPFANETNSSRSTSEVNPQMLQDLQAAGFDEDMVIQALQKTNNRSIEAAIEFISKMSYQDPRREQMAAAAARPINASMKPGNVQQSVNRKQSWKGSKESLVPQRHGPPLGESVAYHSESPNSQTDVGRPLSGSGISAFVQAHPSNGQRVNPPPPPQVRSVTPPPPPRGQTPPPRGTTPPPPSWEPNSQTKRYSGNMEYVISRISPVPPGAWQEGYPPPPLNTSPMNPPNQGQRGISSVPVGRQPIIMQSSSKFNFPSGRPGMQNGTGQTDFMIHQNVVPAGTVNRQPPPPYPLTAANGQSPSALQTGGSAAPSSYTNGSIPQSMMVPNRNSHNMELYNISVPGLQTNWPQSSSAPAQSSPSSGHEIPTWQPNIPVRSNSFNNPLGNRASHSANSQPSATTVTAITPAPIQQPVKSMRVLKPELQTALAPTHPSWIPQPIQTVQPSPFPEGTASNVTVMPPVAEAPNYQGPPPPYPKHLLHQNPSVPPYESISKPSKEDQPSLPKEDESEKSYENVDSGDKEKKQITTSPITVRKNKKDEERRESRIQSYSPQAFKFFMEQHVENVLKSHQQRLHRKKQLENEMMRVGLSQDAQDQMRKMLCQKESNYIRLKRAKMDKSMFVKIKTLGIGAFGEVCLARKVDTKALYATKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPESLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHPRQDSMDFSNEWGDPSSCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILFEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLCRGPEDRLGKNGADEIKAHPFFKTIDFSSDLRQQSASYIPKITHPTDTSNFDPVDPDKLWSDDNEEENVNDTLNGWYKNGKHPEHAFYEFTFRRFFDDNGYPYNYPKPIEYEYINSQGSEQQSDEDDQNTGSEIKNRDLVYV,False,True,False,O95835,"[('cd05625', 'Catalytic domain of the Serine/Threonine Kinase, Large Tumor Suppressor 1'), ('cd14397', 'UBA domain found in vertebrate serine/threonine-protein kinase LATS1'), ('cd21778', 'Mob-binding domain found in large tumor suppressor homolog 1 (LATS1) and similar proteins'), ('G3DSA:1.10.510.10', 'Transferase(Phosphotransferase) domain 1'), ('G3DSA:1.10.8.10', 'DNA helicase RuvA subunit, C-terminal domain'), ('G3DSA:3.30.200.20', 'Phosphorylase Kinase; domain 1'), ('IPR000719', 'Protein kinase domain'), ('IPR000961', 'AGC-kinase, C-terminal'), ('IPR008271', 'Serine/threonine-protein kinase, active site'), ('IPR009060', 'UBA-like superfamily'), ('IPR011009', 'Protein kinase-like domain superfamily'), ('IPR015940', 'Ubiquitin-associated domain'), ('IPR017892', 'Protein kinase, C-terminal'), ('IPR042706', 'Serine/threonine-protein kinase LATS1, catalytic domain'), ('IPR049761', 'Serine/threonine-protein kinase , Mob-binding domain'), ('IPR050236', 'Serine/threonine-protein kinases, AGC'), ('PF00069', 'Protein kinase domain'), ('PF00433', 'Protein kinase C terminal domain'), ('PF00627', 'UBA/TS-N domain'), ('PS00108', 'Serine/Threonine protein kinases active-site signature')]",,"""ENSG00000131023; Low tissue specificity."";","CATALYTIC ACTIVITY: Reaction=L-seryl-[protein] + ATP = O-phospho-L-seryl-[protein] + ADP + H(+); Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616, ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.1; Evidence={ECO:0000269|PubMed:10518011, ECO:0000269|PubMed:15122335}; CATALYTIC ACTIVITY: Reaction=L-threonyl-[protein] + ATP = O-phospho-L-threonyl-[protein] + ADP + H(+); Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060, Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013, ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216; EC=2.7.11.1; Evidence={ECO:0000269|PubMed:10518011, ECO:0000269|PubMed:15122335};",2.7.11.1,,,ENST00000253339.9 [O95835-1];ENST00000392273.7 [O95835-2];ENST00000543571.6 [O95835-1];,LATS1,ENSG00000131023,0.0,,,,19.56,DP03124,0.196,0.555,0.412,LATS1
O95997,ENSG00000164611,PTTG1_HUMAN,cell division [GO:0051301]; chromosome organization [GO:0051276]; DNA repair [GO:0006281]; homologous chromosome segregation [GO:0045143]; spermatogenesis [GO:0007283],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634],cysteine-type endopeptidase inhibitor activity [GO:0004869]; molecular function activator activity [GO:0140677]; SH3 domain binding [GO:0017124],"PTM: Phosphorylated at Ser-165 by CDK1 during mitosis. {ECO:0000269|PubMed:10656688}.; PTM: Phosphorylated in vitro by ds-DNA kinase. {ECO:0000269|PubMed:10656688}.; PTM: Ubiquitinated through 'Lys-11' linkage of ubiquitin moieties by the anaphase promoting complex (APC) at the onset of anaphase, conducting to its degradation. 'Lys-11'-linked ubiquitination is mediated by the E2 ligase UBE2C/UBCH10. {ECO:0000269|PubMed:10411507, ECO:0000269|PubMed:18485873}.",DOMAIN: The N-terminal destruction box (D-box) acts as a recognition signal for degradation via the ubiquitin-proteasome pathway. {ECO:0000250}.; DOMAIN: The TEK-boxes are required for 'Lys-11'-linked ubiquitination and facilitate the transfer of the first ubiquitin and ubiquitin chain nucleation. TEK-boxes may direct a catalytically competent orientation of the UBE2C/UBCH10-ubiquitin thioester with the acceptor lysine residue. {ECO:0000269|PubMed:18485873}.,,"STRAND 132..134; /evidence=""ECO:0007829|PDB:7NJ1""","HELIX 122..125; /evidence=""ECO:0007829|PDB:7NJ1""",,"cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,PTTG1 EAP1 PTTG TUTR1,Securin (Esp1-associated protein) (Pituitary tumor-transforming gene 1 protein) (Tumor-transforming protein 1) (hPTTG),Homo sapiens (Human),202.0,22024.0,MATLIYVDKENGEPGTRVVAKDGLKLGSGPSIKALDGRSQVSTPRFGKTFDAPPALPKATRKALGTVNRATEKSVKTKGPLKQKQPSFSAKKMTEKTVKAKSSVPASDDAYPEIEKFFPFNPLDFESFDLPEEHQIAHLPLSGVPLMILDEERELEKLFQLGPPSPVKMPSPPWESNLLQSPSSILSTLDVELPPVCCDIDI,True,False,False,O95997,"[('IPR006940', 'Securin sister-chromatid separation inhibitor'), ('PF04856', 'Securin sister-chromatid separation inhibitor'), ('PTHR10418', 'SECURIN-3')]",O95997;,"""ENSG00000164611; Tissue enhanced (bone marrow, lymphoid tissue, testis)."";",,,,,ENST00000352433.10;ENST00000393964.1;ENST00000520452.5;,PTTG1,ENSG00000164611,0.0,,,,100.0,DP00521,1.0,1.0,0.277,PTTG1
O96007,ENSG00000164172,MOC2B_HUMAN,Mo-molybdopterin cofactor biosynthetic process [GO:0006777]; molybdopterin cofactor biosynthetic process [GO:0032324],cytosol [GO:0005829]; molybdopterin synthase complex [GO:1990140]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654],molybdopterin synthase activity [GO:0030366],,,,"STRAND 45..52; /evidence=""ECO:0007829|PDB:5MPO""; STRAND 70..78; /evidence=""ECO:0007829|PDB:5MPO""; STRAND 80..82; /evidence=""ECO:0007829|PDB:5MPO""; STRAND 85..94; /evidence=""ECO:0007829|PDB:5MPO""; STRAND 116..124; /evidence=""ECO:0007829|PDB:5MPO""; STRAND 126..130; /evidence=""ECO:0007829|PDB:5MPO""; STRAND 132..143; /evidence=""ECO:0007829|PDB:5MPO""; STRAND 164..170; /evidence=""ECO:0007829|PDB:5MPO""","HELIX 56..63; /evidence=""ECO:0007829|PDB:5MPO""; HELIX 98..113; /evidence=""ECO:0007829|PDB:5MPO""; HELIX 144..161; /evidence=""ECO:0007829|PDB:5MPO""",,"cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,MOCS2 MCBPE MOCO1,Molybdopterin synthase catalytic subunit (EC 2.8.1.12) (MOCO1-B) (Molybdenum cofactor synthesis protein 2 large subunit) (Molybdenum cofactor synthesis protein 2B) (MOCS2B) (Molybdopterin-synthase large subunit) (MPT synthase large subunit),Homo sapiens (Human),188.0,20944.0,MSSLEISSSCFSLETKLPLSPPLVEDSAFEPSRKDMDEVEEKSKDVINFTAEKLSVDEVSQLVISPLCGAISLFVGTTRNNFEGKKVISLEYEAYLPMAENEVRKICSDIRQKWPVKHIAVFHRLGLVPVSEASIIIAVSSAHRAASLEAVSYAIDTLKAKVPIWKKEIYEESSTWKGNKECFWASNS,True,False,False,O96007,"[('cd00756', 'MoaE'), ('G3DSA:3.90.1170.40', 'Molybdopterin biosynthesis MoaE subunit'), ('IPR003448', 'Molybdopterin biosynthesis MoaE'), ('IPR028888', 'Molybdopterin synthase catalytic subunit, eukaryotes'), ('IPR036563', 'Molybdopterin biosynthesis MoaE subunit superfamily'), ('MF_03052', 'Molybdopterin synthase catalytic subunit [cnxH]'), ('PF02391', 'MoaE protein'), ('PTHR23404', 'Molybdopterin synthase MOCS2B subfamily'), ('SSF54690', 'Molybdopterin synthase subunit MoaE')]",,"""ENSG00000164172; Low tissue specificity."";","CATALYTIC ACTIVITY: Reaction=2 [molybdopterin-synthase sulfur-carrier protein]-C-terminal Gly-NH-CH2-C(O)SH + cyclic pyranopterin phosphate + H2O = molybdopterin + 2 [molybdopterin-synthase sulfur-carrier protein]-C-terminal Gly-Gly + 4 H(+); Xref=Rhea:RHEA:26333, Rhea:RHEA-COMP:12160, Rhea:RHEA-COMP:12202, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:58698, ChEBI:CHEBI:59648, ChEBI:CHEBI:90619, ChEBI:CHEBI:90778; EC=2.8.1.12; Evidence={ECO:0000255|HAMAP-Rule:MF_03052, ECO:0000269|PubMed:12732628, ECO:0000269|PubMed:15073332};",2.8.1.12,,PATHWAY: Cofactor biosynthesis; molybdopterin biosynthesis. {ECO:0000255|HAMAP-Rule:MF_03052}.,ENST00000396954.8;,MOCS2,ENSG00000164172,0.0,,,,,,,0.33,,MOCS2
P00338,ENSG00000134333|ENSG00000288299,LDHA_HUMAN,glycolytic process [GO:0006096]; lactate metabolic process [GO:0006089]; pyruvate metabolic process [GO:0006090]; substantia nigra development [GO:0021762],cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; oxidoreductase complex [GO:1990204],cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; L-lactate dehydrogenase activity [GO:0004459],PTM: ISGylated. {ECO:0000269|PubMed:16139798}.,,,"STRAND 9..11; /evidence=""ECO:0007829|PDB:5W8J""; STRAND 20..26; /evidence=""ECO:0007829|PDB:5W8J""; STRAND 46..51; /evidence=""ECO:0007829|PDB:5W8J""; STRAND 76..79; /evidence=""ECO:0007829|PDB:5W8J""; STRAND 90..94; /evidence=""ECO:0007829|PDB:5W8J""; STRAND 132..135; /evidence=""ECO:0007829|PDB:5W8J""; STRAND 137..139; /evidence=""ECO:0007829|PDB:5W8J""; STRAND 158..160; /evidence=""ECO:0007829|PDB:5W8J""; STRAND 189..194; /evidence=""ECO:0007829|PDB:5W8J""; STRAND 197..199; /evidence=""ECO:0007829|PDB:5W8I""; STRAND 220..222; /evidence=""ECO:0007829|PDB:6Q0D""; STRAND 269..276; /evidence=""ECO:0007829|PDB:5W8J""; STRAND 278..280; /evidence=""ECO:0007829|PDB:5ZJE""; STRAND 288..296; /evidence=""ECO:0007829|PDB:5W8J""; STRAND 299..304; /evidence=""ECO:0007829|PDB:5W8J""","HELIX 4..8; /evidence=""ECO:0007829|PDB:5W8J""; HELIX 30..41; /evidence=""ECO:0007829|PDB:5W8J""; HELIX 55..67; /evidence=""ECO:0007829|PDB:5W8J""; HELIX 68..71; /evidence=""ECO:0007829|PDB:5W8J""; HELIX 83..86; /evidence=""ECO:0007829|PDB:5W8J""; HELIX 106..127; /evidence=""ECO:0007829|PDB:5W8J""; HELIX 140..151; /evidence=""ECO:0007829|PDB:5W8J""; HELIX 155..157; /evidence=""ECO:0007829|PDB:5W8J""; HELIX 164..178; /evidence=""ECO:0007829|PDB:5W8J""; HELIX 182..184; /evidence=""ECO:0007829|PDB:5W8J""; HELIX 201..203; /evidence=""ECO:0007829|PDB:5W8J""; HELIX 211..214; /evidence=""ECO:0007829|PDB:5W8J""; HELIX 228..245; /evidence=""ECO:0007829|PDB:5W8J""; HELIX 250..264; /evidence=""ECO:0007829|PDB:5W8J""; HELIX 310..327; /evidence=""ECO:0007829|PDB:5W8J""","TURN 216..219; /evidence=""ECO:0007829|PDB:5W8J""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,LDHA PIG19,L-lactate dehydrogenase A chain (LDH-A) (EC 1.1.1.27) (Cell proliferation-inducing gene 19 protein) (LDH muscle subunit) (LDH-M) (Renal carcinoma antigen NY-REN-59),Homo sapiens (Human),332.0,36689.0,MATLKDQLIYNLLKEEQTPQNKITVVGVGAVGMACAISILMKDLADELALVDVIEDKLKGEMMDLQHGSLFLRTPKIVSGKDYNVTANSKLVIITAGARQQEGESRLNLVQRNVNIFKFIIPNVVKYSPNCKLLIVSNPVDILTYVAWKISGFPKNRVIGSGCNLDSARFRYLMGERLGVHPLSCHGWVLGEHGDSSVPVWSGMNVAGVSLKTLHPDLGTDKDKEQWKEVHKQVVESAYEVIKLKGYTSWAIGLSVADLAESIMKNLRRVHPVSTMIKGLYGIKDDVFLSVPCILGQNGISDLVKVTLTSEEEARLKKSADTLWGIQKELQF,True,False,False,P00338,"[('cd05293', 'A subgroup of L-lactate dehydrogenases'), ('G3DSA:3.40.50.720', 'NAD(P)-binding Rossmann-like Domain'), ('G3DSA:3.90.110.10', 'Lactate dehydrogenase/glycoside hydrolase, family 4, C-terminal'), ('IPR001236', 'Lactate/malate dehydrogenase, N-terminal'), ('IPR001557', 'L-lactate/malate dehydrogenase'), ('IPR011304', 'L-lactate dehydrogenase'), ('IPR015955', 'Lactate dehydrogenase/glycoside hydrolase, family 4, C-terminal'), ('IPR018177', 'L-lactate dehydrogenase, active site'), ('IPR022383', 'Lactate/malate dehydrogenase, C-terminal'), ('IPR036291', 'NAD(P)-binding domain superfamily'), ('MF_00488', 'L-lactate dehydrogenase [ldh]'), ('PF00056', 'lactate/malate dehydrogenase, NAD binding domain'), ('PF02866', 'lactate/malate dehydrogenase, alpha/beta C-terminal domain'), ('PIRSF000102', 'L-lactate/malate dehydrogenase'), ('PR00086', 'LLDHDRGNASE'), ('PS00064', 'L-lactate dehydrogenase active site'), ('PS51257', 'Prokaryotic membrane lipoprotein lipid attachment site profile'), ('PTHR43128', 'Lactate/Malate dehydrogenase superfamily'), ('SSF51735', 'NAD(P)-binding Rossmann-fold domains'), ('SSF56327', 'LDH C-terminal domain-like')]",,"""ENSG00000134333; Low tissue specificity."";","CATALYTIC ACTIVITY: Reaction=(S)-lactate + NAD(+) = pyruvate + NADH + H(+); Xref=Rhea:RHEA:23444, ChEBI:CHEBI:15361, ChEBI:CHEBI:15378, ChEBI:CHEBI:16651, ChEBI:CHEBI:57540, ChEBI:CHEBI:57945; EC=1.1.1.27; Evidence={ECO:0000269|PubMed:11276087}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:23445; Evidence={ECO:0000269|PubMed:11276087}; PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:23446; Evidence={ECO:0000269|PubMed:11276087};",1.1.1.27,"ACTIVITY REGULATION: Fermentation of pyruvate to lactate is inhibited when bound to folliculin FLCN, perhaps partly by FLCN preventing binding of cofactor NADH (PubMed:34381247). {ECO:0000269|PubMed:34381247}.",PATHWAY: Fermentation; pyruvate fermentation to lactate; (S)-lactate from pyruvate: step 1/1. {ECO:0000305|PubMed:11276087}.,ENST00000227157.8 [P00338-5];ENST00000379412.9 [P00338-3];ENST00000396222.6 [P00338-2];ENST00000422447.8 [P00338-1];ENST00000430553.6 [P00338-4];ENST00000542179.1 [P00338-1];ENST00000671981.1 [P00338-1];ENST00000672078.1 [P00338-5];ENST00000672405.1 [P00338-1];ENST00000672996.1 [P00338-4];ENST00000673007.1 [P00338-3];ENST00000673083.1 [P00338-2];ENST00000673204.1 [P00338-1];,LDHA,ENSG00000134333,1.0,LDHA,Non-canonical_RBPs,22.0,,,,0.036,,LDHA
P00374,ENSG00000228716,DYR_HUMAN,axon regeneration [GO:0031103]; dihydrofolate metabolic process [GO:0046452]; folic acid metabolic process [GO:0046655]; negative regulation of translation [GO:0017148]; one-carbon metabolic process [GO:0006730]; positive regulation of nitric-oxide synthase activity [GO:0051000]; regulation of removal of superoxide radicals [GO:2000121]; response to methotrexate [GO:0031427]; tetrahydrobiopterin biosynthetic process [GO:0006729]; tetrahydrofolate biosynthetic process [GO:0046654]; tetrahydrofolate metabolic process [GO:0046653],cytosol [GO:0005829]; mitochondrion [GO:0005739],dihydrofolate reductase activity [GO:0004146]; folic acid binding [GO:0005542]; mRNA binding [GO:0003729]; mRNA regulatory element binding translation repressor activity [GO:0000900]; NADP binding [GO:0050661]; NADPH binding [GO:0070402]; sequence-specific mRNA binding [GO:1990825],,,"DOMAIN 4..185; /note=""DHFR""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00660""","STRAND 5..11; /evidence=""ECO:0007829|PDB:1KMV""; STRAND 16..19; /evidence=""ECO:0007829|PDB:1KMV""; STRAND 24..26; /evidence=""ECO:0007829|PDB:5HVE""; STRAND 43..46; /evidence=""ECO:0007829|PDB:5HQY""; STRAND 48..54; /evidence=""ECO:0007829|PDB:1KMV""; STRAND 71..76; /evidence=""ECO:0007829|PDB:1KMV""; STRAND 88..93; /evidence=""ECO:0007829|PDB:1KMV""; STRAND 110..115; /evidence=""ECO:0007829|PDB:1KMV""; STRAND 128..130; /evidence=""ECO:0007829|PDB:4M6K""; STRAND 132..141; /evidence=""ECO:0007829|PDB:1KMV""; STRAND 146..148; /evidence=""ECO:0007829|PDB:1KMV""; STRAND 157..159; /evidence=""ECO:0007829|PDB:1KMS""; STRAND 161..163; /evidence=""ECO:0007829|PDB:3S7A""; STRAND 171..173; /evidence=""ECO:0007829|PDB:1KMV""; STRAND 176..185; /evidence=""ECO:0007829|PDB:1KMV""","HELIX 29..40; /evidence=""ECO:0007829|PDB:1KMV""; HELIX 55..60; /evidence=""ECO:0007829|PDB:1KMV""; HELIX 63..65; /evidence=""ECO:0007829|PDB:1KMV""; HELIX 94..101; /evidence=""ECO:0007829|PDB:1KMV""; HELIX 119..126; /evidence=""ECO:0007829|PDB:1KMV""","TURN 104..109; /evidence=""ECO:0007829|PDB:1KMV""; TURN 154..156; /evidence=""ECO:0007829|PDB:1KMV""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,DHFR,Dihydrofolate reductase (EC 1.5.1.3),Homo sapiens (Human),187.0,21453.0,MVGSLNCIVAVSQNMGIGKNGDLPWPPLRNEFRYFQRMTTTSSVEGKQNLVIMGKKTWFSIPEKNRPLKGRINLVLSRELKEPPQGAHFLSRSLDDALKLTEQPELANKVDMVWIVGGSSVYKEAMNHPGHLKLFVTRIMQDFESDTFFPEIDLEKYKLLPEYPGVLSDVQEEKGIKYKFEVYEKND,False,True,False,P00374,"[('cd00209', 'DHFR'), ('G3DSA:3.40.430.10', 'Dihydrofolate Reductase, subunit A'), ('IPR001796', 'Dihydrofolate reductase domain'), ('IPR012259', 'Dihydrofolate reductase'), ('IPR017925', 'Dihydrofolate reductase conserved site'), ('IPR024072', 'Dihydrofolate reductase-like domain superfamily'), ('PF00186', 'Dihydrofolate reductase'), ('PR00070', 'DHFR'), ('PS00075', 'Dihydrofolate reductase (DHFR) domain signature'), ('PS51330', 'Dihydrofolate reductase (DHFR) domain profile'), ('PTHR48069', 'DIHYDROFOLATE REDUCTASE'), ('SSF53597', 'Dihydrofolate reductase-like')]",,"""ENSG00000228716; Low tissue specificity."";","CATALYTIC ACTIVITY: Reaction=(6S)-5,6,7,8-tetrahydrofolate + NADP(+) = 7,8-dihydrofolate + NADPH + H(+); Xref=Rhea:RHEA:15009, ChEBI:CHEBI:15378, ChEBI:CHEBI:57451, ChEBI:CHEBI:57453, ChEBI:CHEBI:57783, ChEBI:CHEBI:58349; EC=1.5.1.3; Evidence={ECO:0000255|PROSITE-ProRule:PRU00660, ECO:0000269|PubMed:12096917, ECO:0000269|PubMed:15039552, ECO:0000269|PubMed:17569517, ECO:0000269|PubMed:19196009, ECO:0000269|PubMed:19478082, ECO:0000269|PubMed:21876184, ECO:0000269|PubMed:9719595};",1.5.1.3,,"PATHWAY: Cofactor biosynthesis; tetrahydrofolate biosynthesis; 5,6,7,8-tetrahydrofolate from 7,8-dihydrofolate: step 1/1.",ENST00000439211.7 [P00374-1];ENST00000504396.1 [P00374-2];ENST00000505337.5 [P00374-1];,DHFR,ENSG00000228716,0.0,DHFR,Non-canonical_RBPs,3.0,,,,,,DHFR
P00505,ENSG00000125166,AATM_HUMAN,2-oxoglutarate metabolic process [GO:0006103]; 4-hydroxyproline catabolic process [GO:0019470]; aspartate biosynthetic process [GO:0006532]; aspartate catabolic process [GO:0006533]; aspartate metabolic process [GO:0006531]; fatty acid transport [GO:0015908]; glutamate catabolic process to 2-oxoglutarate [GO:0019551]; glutamate catabolic process to aspartate [GO:0019550]; glutamate metabolic process [GO:0006536]; oxaloacetate metabolic process [GO:0006107]; response to ethanol [GO:0045471],extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886],kynurenine-oxoglutarate transaminase activity [GO:0016212]; L-aspartate:2-oxoglutarate aminotransferase activity [GO:0004069]; pyridoxal phosphate binding [GO:0030170]; RNA binding [GO:0003723],,,,"STRAND 72..74; /evidence=""ECO:0007829|PDB:8SKR""; STRAND 126..132; /evidence=""ECO:0007829|PDB:5AX8""; STRAND 153..159; /evidence=""ECO:0007829|PDB:5AX8""; STRAND 175..180; /evidence=""ECO:0007829|PDB:5AX8""; STRAND 206..213; /evidence=""ECO:0007829|PDB:5AX8""; STRAND 239..246; /evidence=""ECO:0007829|PDB:5AX8""; STRAND 272..276; /evidence=""ECO:0007829|PDB:5AX8""; STRAND 288..294; /evidence=""ECO:0007829|PDB:5AX8""; STRAND 316..318; /evidence=""ECO:0007829|PDB:5AX8""; STRAND 379..383; /evidence=""ECO:0007829|PDB:5AX8""; STRAND 406..409; /evidence=""ECO:0007829|PDB:5AX8""","HELIX 43..53; /evidence=""ECO:0007829|PDB:5AX8""; HELIX 78..88; /evidence=""ECO:0007829|PDB:5AX8""; HELIX 103..114; /evidence=""ECO:0007829|PDB:5AX8""; HELIX 119..123; /evidence=""ECO:0007829|PDB:5AX8""; HELIX 133..148; /evidence=""ECO:0007829|PDB:5AX8""; HELIX 165..172; /evidence=""ECO:0007829|PDB:5AX8""; HELIX 191..198; /evidence=""ECO:0007829|PDB:5AX8""; HELIX 223..236; /evidence=""ECO:0007829|PDB:5AX8""; HELIX 254..257; /evidence=""ECO:0007829|PDB:5AX8""; HELIX 259..266; /evidence=""ECO:0007829|PDB:5AX8""; HELIX 298..315; /evidence=""ECO:0007829|PDB:5AX8""; HELIX 321..332; /evidence=""ECO:0007829|PDB:5AX8""; HELIX 334..364; /evidence=""ECO:0007829|PDB:5AX8""; HELIX 372..376; /evidence=""ECO:0007829|PDB:5AX8""; HELIX 388..398; /evidence=""ECO:0007829|PDB:5AX8""; HELIX 410..412; /evidence=""ECO:0007829|PDB:5AX8""; HELIX 415..428; /evidence=""ECO:0007829|PDB:5AX8""","TURN 32..35; /evidence=""ECO:0007829|PDB:8SKR""; TURN 89..91; /evidence=""ECO:0007829|PDB:5AX8""; TURN 184..187; /evidence=""ECO:0007829|PDB:5AX8""; TURN 215..217; /evidence=""ECO:0007829|PDB:8SKR""; TURN 247..251; /evidence=""ECO:0007829|PDB:5AX8""; TURN 278..280; /evidence=""ECO:0007829|PDB:5AX8""; TURN 284..287; /evidence=""ECO:0007829|PDB:5AX8""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,GOT2 KYAT4,"Aspartate aminotransferase, mitochondrial (mAspAT) (EC 2.6.1.1) (EC 2.6.1.7) (Fatty acid-binding protein) (FABP-1) (Glutamate oxaloacetate transaminase 2) (Kynurenine aminotransferase 4) (Kynurenine aminotransferase IV) (Kynurenine--oxoglutarate transaminase 4) (Kynurenine--oxoglutarate transaminase IV) (Plasma membrane-associated fatty acid-binding protein) (FABPpm) (Transaminase A)",Homo sapiens (Human),430.0,47518.0,MALLHSGRVLPGIAAAFHPGLAAAASARASSWWTHVEMGPPDPILGVTEAFKRDTNSKKMNLGVGAYRDDNGKPYVLPSVRKAEAQIAAKNLDKEYLPIGGLAEFCKASAELALGENSEVLKSGRFVTVQTISGTGALRIGASFLQRFFKFSRDVFLPKPTWGNHTPIFRDAGMQLQGYRYYDPKTCGFDFTGAVEDISKIPEQSVLLLHACAHNPTGVDPRPEQWKEIATVVKKRNLFAFFDMAYQGFASGDGDKDAWAVRHFIEQGINVCLCQSYAKNMGLYGERVGAFTMVCKDADEAKRVESQLKILIRPMYSNPPLNGARIAAAILNTPDLRKQWLQEVKVMADRIIGMRTQLVSNLKKEGSTHNWQHITDQIGMFCFTGLKPEQVERLIKEFSIYMTKDGRISVAGVTSSNVGYLAHAIHQVTK,True,False,False,P00505,"[('cd00609', 'AAT_like'), ('G3DSA:3.40.640.10', 'Type I PLP-dependent aspartate aminotransferase-like (Major domain)'), ('G3DSA:3.90.1150.10', 'Aspartate Aminotransferase, domain 1'), ('IPR000796', 'Aspartate/other aminotransferase'), ('IPR004838', 'Aminotransferases, class-I, pyridoxal-phosphate-binding site'), ('IPR004839', 'Aminotransferase, class I/classII, large domain'), ('IPR015421', 'Pyridoxal phosphate-dependent transferase, major domain'), ('IPR015422', 'Pyridoxal phosphate-dependent transferase, small domain'), ('IPR015424', 'Pyridoxal phosphate-dependent transferase'), ('PF00155', 'Aminotransferase class I and II'), ('PR00799', 'Aspartate aminotransferase'), ('PS00105', 'Aminotransferases class-I pyridoxal-phosphate attachment site'), ('PTHR11879', 'ASPARTATE AMINOTRANSFERASE'), ('SSF53383', 'PLP-dependent transferases')]",,"""ENSG00000125166; Group enriched (choroid plexus, heart muscle, liver, skeletal muscle, tongue)."";","CATALYTIC ACTIVITY: Reaction=L-aspartate + 2-oxoglutarate = oxaloacetate + L-glutamate; Xref=Rhea:RHEA:21824, ChEBI:CHEBI:16452, ChEBI:CHEBI:16810, ChEBI:CHEBI:29985, ChEBI:CHEBI:29991; EC=2.6.1.1; Evidence={ECO:0000269|PubMed:26902786, ECO:0000269|PubMed:31422819}; CATALYTIC ACTIVITY: Reaction=L-kynurenine + 2-oxoglutarate = kynurenate + L-glutamate + H2O; Xref=Rhea:RHEA:65560, ChEBI:CHEBI:15377, ChEBI:CHEBI:16810, ChEBI:CHEBI:29985, ChEBI:CHEBI:57959, ChEBI:CHEBI:58454; EC=2.6.1.7; Evidence={ECO:0000250|UniProtKB:P00507};",2.6.1.1; 2.6.1.7,,,ENST00000245206.10 [P00505-1];ENST00000434819.2 [P00505-2];,GOT2,ENSG00000125166,0.0,GOT2,Non-canonical_RBPs,6.0,,,,0.107,,GOT2
P00519,ENSG00000097007,ABL1_HUMAN,"actin cytoskeleton organization [GO:0030036]; actin filament polymerization [GO:0030041]; activated T cell proliferation [GO:0050798]; activation of protein kinase C activity [GO:1990051]; alpha-beta T cell differentiation [GO:0046632]; associative learning [GO:0008306]; autophagy [GO:0006914]; B cell proliferation involved in immune response [GO:0002322]; B cell receptor signaling pathway [GO:0050853]; B-1 B cell homeostasis [GO:0001922]; Bergmann glial cell differentiation [GO:0060020]; BMP signaling pathway [GO:0030509]; canonical NF-kappaB signal transduction [GO:0007249]; cardiac muscle cell proliferation [GO:0060038]; cell-cell adhesion [GO:0098609]; cellular response to dopamine [GO:1903351]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to oxidative stress [GO:0034599]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular senescence [GO:0090398]; cerebellum morphogenesis [GO:0021587]; DN4 thymocyte differentiation [GO:1904157]; DNA conformation change [GO:0071103]; DNA damage response [GO:0006974]; endothelial cell migration [GO:0043542]; epidermal growth factor receptor signaling pathway [GO:0007173]; ERK1 and ERK2 cascade [GO:0070371]; establishment of localization in cell [GO:0051649]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; integrin-mediated signaling pathway [GO:0007229]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; microspike assembly [GO:0030035]; mismatch repair [GO:0006298]; mitochondrial depolarization [GO:0051882]; mitotic cell cycle [GO:0000278]; myoblast proliferation [GO:0051450]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of cell-cell adhesion [GO:0022408]; negative regulation of cellular senescence [GO:2000773]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of long-term synaptic potentiation [GO:1900272]; negative regulation of mitotic cell cycle [GO:0045930]; negative regulation of protein serine/threonine kinase activity [GO:0071901]; negative regulation of ubiquitin-protein transferase activity [GO:0051444]; neural tube closure [GO:0001843]; neuroepithelial cell differentiation [GO:0060563]; neuromuscular process controlling balance [GO:0050885]; neuron apoptotic process [GO:0051402]; neuron differentiation [GO:0030182]; neuropilin signaling pathway [GO:0038189]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; phospholipase C-inhibiting G protein-coupled receptor signaling pathway [GO:0030845]; platelet-derived growth factor receptor-beta signaling pathway [GO:0035791]; podocyte apoptotic process [GO:1903210]; positive regulation of actin filament binding [GO:1904531]; positive regulation of apoptotic process [GO:0043065]; positive regulation of blood vessel branching [GO:1905555]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of dendrite development [GO:1900006]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of establishment of T cell polarity [GO:1903905]; positive regulation of extracellular matrix organization [GO:1903055]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of microtubule binding [GO:1904528]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of osteoblast proliferation [GO:0033690]; positive regulation of oxidoreductase activity [GO:0051353]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; positive regulation of T cell migration [GO:2000406]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of type II interferon production [GO:0032729]; positive regulation of vasoconstriction [GO:0045907]; positive regulation of Wnt signaling pathway, planar cell polarity pathway [GO:2000096]; post-embryonic development [GO:0009791]; protein autophosphorylation [GO:0046777]; protein localization to cytoplasmic microtubule plus-end [GO:1904518]; protein modification process [GO:0036211]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of autophagy [GO:0010506]; regulation of axon extension [GO:0030516]; regulation of Cdc42 protein signal transduction [GO:0032489]; regulation of cell adhesion [GO:0030155]; regulation of cell cycle [GO:0051726]; regulation of cell motility [GO:2000145]; regulation of DNA-templated transcription [GO:0006355]; regulation of endocytosis [GO:0030100]; regulation of hematopoietic stem cell differentiation [GO:1902036]; regulation of microtubule polymerization [GO:0031113]; regulation of modification of synaptic structure [GO:1905244]; regulation of postsynaptic specialization assembly [GO:0099150]; regulation of T cell differentiation [GO:0045580]; response to endoplasmic reticulum stress [GO:0034976]; response to epinephrine [GO:0071871]; response to oxidative stress [GO:0006979]; response to xenobiotic stimulus [GO:0009410]; signal transduction in response to DNA damage [GO:0042770]; spleen development [GO:0048536]; substrate adhesion-dependent cell spreading [GO:0034446]; T cell receptor signaling pathway [GO:0050852]; thymus development [GO:0048538]; transitional one stage B cell differentiation [GO:0002333]",actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; growth cone [GO:0030426]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; nuclear body [GO:0016604]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; ruffle [GO:0001726],actin filament binding [GO:0051015]; actin monomer binding [GO:0003785]; ATP binding [GO:0005524]; bubble DNA binding [GO:0000405]; delta-catenin binding [GO:0070097]; DNA binding [GO:0003677]; ephrin receptor binding [GO:0046875]; four-way junction DNA binding [GO:0000400]; kinase activity [GO:0016301]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; mitogen-activated protein kinase binding [GO:0051019]; neuropilin binding [GO:0038191]; nicotinate-nucleotide adenylyltransferase activity [GO:0004515]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; phosphotyrosine residue binding [GO:0001784]; proline-rich region binding [GO:0070064]; protein kinase activity [GO:0004672]; protein kinase C binding [GO:0005080]; protein tyrosine kinase activity [GO:0004713]; sequence-specific double-stranded DNA binding [GO:1990837]; SH2 domain binding [GO:0042169]; SH3 domain binding [GO:0017124]; syntaxin binding [GO:0019905]; transcription coactivator activity [GO:0003713],"PTM: Acetylated at Lys-711 by EP300 which promotes the cytoplasmic translocation. {ECO:0000269|PubMed:16648821}.; PTM: Phosphorylation at Tyr-70 by members of the SRC family of kinases disrupts SH3 domain-based autoinhibitory interactions and intermolecular associations, such as that with ABI1, and also enhances kinase activity. Phosphorylation at Tyr-226 and Tyr-393 correlate with increased activity. DNA damage-induced activation of ABL1 requires the function of ATM and Ser-446 phosphorylation (By similarity). Phosphorylation at Ser-569 has been attributed to a CDC2-associated kinase and is coupled to cell division (By similarity). Phosphorylation at Ser-618 and Ser-619 by PAK2 increases binding to CRK and reduces binding to ABI1. Phosphorylation on Thr-735 is required for binding 14-3-3 proteins for cytoplasmic translocation. Phosphorylated by PRKDC (By similarity). {ECO:0000250}.; PTM: Polyubiquitinated. Polyubiquitination of ABL1 leads to degradation. {ECO:0000269|PubMed:12475393}.",,"DOMAIN 61..121; /note=""SH3""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00192""; DOMAIN 127..217; /note=""SH2""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00191""; DOMAIN 242..493; /note=""Protein kinase""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00159""","STRAND 26..32; /evidence=""ECO:0007829|PDB:6AMV""; STRAND 39..44; /evidence=""ECO:0007829|PDB:6AMV""; STRAND 65..70; /evidence=""ECO:0007829|PDB:5OAZ""; STRAND 76..79; /evidence=""ECO:0007829|PDB:7PW2""; STRAND 87..93; /evidence=""ECO:0007829|PDB:5OAZ""; STRAND 97..104; /evidence=""ECO:0007829|PDB:5OAZ""; STRAND 107..112; /evidence=""ECO:0007829|PDB:5OAZ""; STRAND 116..118; /evidence=""ECO:0007829|PDB:5OAZ""; STRAND 128..131; /evidence=""ECO:0007829|PDB:5DC4""; STRAND 148..153; /evidence=""ECO:0007829|PDB:5DC4""; STRAND 155..157; /evidence=""ECO:0007829|PDB:5DC4""; STRAND 161..167; /evidence=""ECO:0007829|PDB:5DC4""; STRAND 170..175; /evidence=""ECO:0007829|PDB:5DC4""; STRAND 177..179; /evidence=""ECO:0007829|PDB:4XEY""; STRAND 184..187; /evidence=""ECO:0007829|PDB:5DC4""; STRAND 190..194; /evidence=""ECO:0007829|PDB:5DC4""; STRAND 209..211; /evidence=""ECO:0007829|PDB:5DC4""; STRAND 226..228; /evidence=""ECO:0007829|PDB:5MO4""; STRAND 229..231; /evidence=""ECO:0007829|PDB:2GQG""; STRAND 242..247; /evidence=""ECO:0007829|PDB:5HU9""; STRAND 254..261; /evidence=""ECO:0007829|PDB:5HU9""; STRAND 266..271; /evidence=""ECO:0007829|PDB:5HU9""; STRAND 301..305; /evidence=""ECO:0007829|PDB:5HU9""; STRAND 307..310; /evidence=""ECO:0007829|PDB:5HU9""; STRAND 312..316; /evidence=""ECO:0007829|PDB:5HU9""; STRAND 319..322; /evidence=""ECO:0007829|PDB:2HZI""; STRAND 359..361; /evidence=""ECO:0007829|PDB:2G2H""; STRAND 369..371; /evidence=""ECO:0007829|PDB:5HU9""; STRAND 377..379; /evidence=""ECO:0007829|PDB:5HU9""; STRAND 393..396; /evidence=""ECO:0007829|PDB:3QRJ""; STRAND 399..401; /evidence=""ECO:0007829|PDB:5HU9""; STRAND 498..500; /evidence=""ECO:0007829|PDB:1OPL""; STRAND 1101..1104; /evidence=""ECO:0007829|PDB:1ZZP""; STRAND 1106..1108; /evidence=""ECO:0007829|PDB:1ZZP""","HELIX 49..53; /evidence=""ECO:0007829|PDB:2FO0""; HELIX 58..60; /evidence=""ECO:0007829|PDB:2FO0""; HELIX 113..115; /evidence=""ECO:0007829|PDB:5OAZ""; HELIX 122..124; /evidence=""ECO:0007829|PDB:5DC4""; HELIX 134..140; /evidence=""ECO:0007829|PDB:5DC4""; HELIX 195..202; /evidence=""ECO:0007829|PDB:5DC4""; HELIX 239..241; /evidence=""ECO:0007829|PDB:5HU9""; HELIX 248..251; /evidence=""ECO:0007829|PDB:5HU9""; HELIX 262..264; /evidence=""ECO:0007829|PDB:5HU9""; HELIX 280..290; /evidence=""ECO:0007829|PDB:5HU9""; HELIX 323..329; /evidence=""ECO:0007829|PDB:5HU9""; HELIX 337..356; /evidence=""ECO:0007829|PDB:5HU9""; HELIX 366..368; /evidence=""ECO:0007829|PDB:5HU9""; HELIX 373..375; /evidence=""ECO:0007829|PDB:5HU9""; HELIX 381..383; /evidence=""ECO:0007829|PDB:2G2F""; HELIX 384..387; /evidence=""ECO:0007829|PDB:2G1T""; HELIX 390..392; /evidence=""ECO:0007829|PDB:2G1T""; HELIX 403..405; /evidence=""ECO:0007829|PDB:5HU9""; HELIX 408..413; /evidence=""ECO:0007829|PDB:5HU9""; HELIX 418..433; /evidence=""ECO:0007829|PDB:5HU9""; HELIX 445..447; /evidence=""ECO:0007829|PDB:5HU9""; HELIX 448..453; /evidence=""ECO:0007829|PDB:5HU9""; HELIX 466..475; /evidence=""ECO:0007829|PDB:5HU9""; HELIX 480..482; /evidence=""ECO:0007829|PDB:5HU9""; HELIX 486..496; /evidence=""ECO:0007829|PDB:5HU9""; HELIX 503..506; /evidence=""ECO:0007829|PDB:2G1T""; HELIX 1029..1045; /evidence=""ECO:0007829|PDB:1ZZP""; HELIX 1053..1070; /evidence=""ECO:0007829|PDB:1ZZP""; HELIX 1071..1073; /evidence=""ECO:0007829|PDB:1ZZP""; HELIX 1080..1097; /evidence=""ECO:0007829|PDB:1ZZP""; HELIX 1115..1128; /evidence=""ECO:0007829|PDB:1ZZP""","TURN 45..47; /evidence=""ECO:0007829|PDB:6AMV""; TURN 141..143; /evidence=""ECO:0007829|PDB:5DC4""; TURN 180..182; /evidence=""ECO:0007829|PDB:4XEY""; TURN 233..235; /evidence=""ECO:0007829|PDB:2G1T""; TURN 275..277; /evidence=""ECO:0007829|PDB:5HU9""; TURN 332..334; /evidence=""ECO:0007829|PDB:5HU9""; TURN 510..512; /evidence=""ECO:0007829|PDB:2F4J""; TURN 1046..1048; /evidence=""ECO:0007829|PDB:1ZZP""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,ABL1 ABL JTK7,Tyrosine-protein kinase ABL1 (EC 2.7.10.2) (Abelson murine leukemia viral oncogene homolog 1) (Abelson tyrosine-protein kinase 1) (Proto-oncogene c-Abl) (p150),Homo sapiens (Human),1130.0,122873.0,MLEICLKLVGCKSKKGLSSSSSCYLEEALQRPVASDFEPQGLSEAARWNSKENLLAGPSENDPNLFVALYDFVASGDNTLSITKGEKLRVLGYNHNGEWCEAQTKNGQGWVPSNYITPVNSLEKHSWYHGPVSRNAAEYLLSSGINGSFLVRESESSPGQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTVYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKQGVRGAVSTLLQAPELPTKTRTSRRAAEHRDTTDVPEMPHSKGQGESDPLDHEPAVSPLLPRKERGPPEGGLNEDERLLPKDKKTNLFSALIKKKKKTAPTPPKRSSSFREMDGQPERRGAGEEEGRDISNGALAFTPLDTADPAKSPKPSNGAGVPNGALRESGGSGFRSPHLWKKSSTLTSSRLATGEEEGGGSSSKRFLRSCSASCVPHGAKDTEWRSVTLPRDLQSTGRQFDSSTFGGHKSEKPALPRKRAGENRSDQVTRGTVTPPPRLVKKNEEAADEVFKDIMESSPGSSPPNLTPKPLRRQVTVAPASGLPHKEEAGKGSALGTPAAAEPVTPTSKAGSGAPGGTSKGPAEESRVRRHKHSSESPGRDKGKLSRLKPAPPPPPAASAGKAGGKPSQSPSQEAAGEAVLGAKTKATSLVDAVNSDAAKPSQPGEGLKKPVLPATPKPQSAKPSGTPISPAPVPSTLPSASSALAGDQPSSTAFIPLISTRVSLRKTRQPPERIASGAITKGVVLDSTEALCLAISRNSEQMASHSAVLEAGKNLYTFCVSYVDSIQQMRNKFAFREAINKLENNLRELQICPATAGSGPAATQDFSKLLSSVKEISDIVQR,False,False,True,P00519,"[('cd05052', 'Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase'), ('cd09935', 'Src homology 2 (SH2) domain found in Abelson murine lymphosarcoma virus (ABL) proteins'), ('cd11850', 'Src homology 3 domain of the Protein Tyrosine Kinase, Abelson kinase'), ('G3DSA:1.10.510.10', 'Transferase(Phosphotransferase) domain 1'), ('G3DSA:1.20.120.330', 'Nucleotidyltransferases domain 2'), ('G3DSA:2.30.30.40', 'SH3 Domains'), ('G3DSA:3.30.200.20', 'Phosphorylase Kinase; domain 1'), ('G3DSA:3.30.505.10', 'SH2 domain'), ('IPR000719', 'Protein kinase domain'), ('IPR000980', 'SH2 domain'), ('IPR001245', 'Serine-threonine/tyrosine-protein kinase, catalytic domain'), ('IPR001452', 'SH3 domain'), ('IPR008266', 'Tyrosine-protein kinase, active site'), ('IPR011009', 'Protein kinase-like domain superfamily'), ('IPR015015', 'F-actin binding'), ('IPR017441', 'Protein kinase, ATP binding site'), ('IPR020635', 'Tyrosine-protein kinase, catalytic domain'), ('IPR035837', 'Tyrosine-protein kinase ABL, SH2 domain'), ('IPR036028', 'SH3-like domain superfamily'), ('IPR036860', 'SH2 domain superfamily')]",,"""ENSG00000097007; Low tissue specificity."";","CATALYTIC ACTIVITY: Reaction=L-tyrosyl-[protein] + ATP = O-phospho-L-tyrosyl-[protein] + ADP + H(+); Xref=Rhea:RHEA:10596, Rhea:RHEA-COMP:10136, Rhea:RHEA-COMP:10137, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616, ChEBI:CHEBI:46858, ChEBI:CHEBI:82620, ChEBI:CHEBI:456216; EC=2.7.10.2; Evidence={ECO:0000255|PROSITE-ProRule:PRU10028, ECO:0000269|PubMed:20357770, ECO:0000269|PubMed:28428613};",2.7.10.2,"ACTIVITY REGULATION: Stabilized in the inactive form by an association between the SH3 domain and the SH2-TK linker region, interactions of the N-terminal cap, and contributions from an N-terminal myristoyl group and phospholipids. Activated by autophosphorylation as well as by SRC-family kinase-mediated phosphorylation. Activated by RIN1 binding to the SH2 and SH3 domains. Also stimulated by cell death inducers and DNA-damage. Phosphatidylinositol 4,5-bisphosphate (PIP2), a highly abundant phosphoinositide known to regulate cytoskeletal and membrane proteins, inhibits also the tyrosine kinase activity (By similarity). Activated by 5-(1,3-diaryl-1H-pyrazol-4-yl)hydantoin, 5-[3-(4-fluorophenyl)-1-phenyl-1H-pyrazol-4-yl]-2,4-imidazolidinedione (DPH) (PubMed:28428613). Inhibited by ABI1, whose activity is controlled by ABL1 itself through tyrosine phosphorylation. Also inhibited by imatinib mesylate (Gleevec) which is used for the treatment of chronic myeloid leukemia (CML), and by VX-680, an inhibitor that acts also on imatinib-resistant mutants (PubMed:28428613). {ECO:0000250, ECO:0000269|PubMed:10391250, ECO:0000269|PubMed:12654251, ECO:0000269|PubMed:16424036, ECO:0000269|PubMed:16543148, ECO:0000269|PubMed:18328268, ECO:0000269|PubMed:28428613}.",,ENST00000318560.6 [P00519-1];ENST00000372348.9 [P00519-2];,ABL1,ENSG00000097007,0.0,,,,1.5,DP03166,0.25,0.499,0.424,ABL1
P00533,ENSG00000146648,EGFR_HUMAN,"astrocyte activation [GO:0048143]; cell surface receptor signaling pathway [GO:0007166]; cell-cell adhesion [GO:0098609]; cellular response to amino acid stimulus [GO:0071230]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to estradiol stimulus [GO:0071392]; cellular response to mechanical stimulus [GO:0071260]; cellular response to xenobiotic stimulus [GO:0071466]; cerebral cortex cell migration [GO:0021795]; circadian rhythm [GO:0007623]; digestive tract morphogenesis [GO:0048546]; diterpenoid metabolic process [GO:0016101]; embryonic placenta development [GO:0001892]; epidermal growth factor receptor signaling pathway [GO:0007173]; epithelial cell proliferation [GO:0050673]; ERBB2-EGFR signaling pathway [GO:0038134]; eyelid development in camera-type eye [GO:0061029]; hair follicle development [GO:0001942]; hydrogen peroxide metabolic process [GO:0042743]; learning or memory [GO:0007611]; liver regeneration [GO:0097421]; lung development [GO:0030324]; midgut development [GO:0007494]; morphogenesis of an epithelial fold [GO:0060571]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cardiocyte differentiation [GO:1905208]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of mitotic cell cycle [GO:0045930]; negative regulation of protein catabolic process [GO:0042177]; neurogenesis [GO:0022008]; neuron projection morphogenesis [GO:0048812]; ossification [GO:0001503]; ovulation cycle [GO:0042698]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of bone resorption [GO:0045780]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA replication [GO:0045740]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of mucus secretion [GO:0070257]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of phosphorylation [GO:0042327]; positive regulation of prolactin secretion [GO:1902722]; positive regulation of protein kinase C activity [GO:1900020]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of superoxide anion generation [GO:0032930]; positive regulation of synaptic transmission, glutamatergic [GO:0051968]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of vasoconstriction [GO:0045907]; protein insertion into membrane [GO:0051205]; regulation of peptidyl-tyrosine phosphorylation [GO:0050730]; response to calcium ion [GO:0051592]; response to cobalamin [GO:0033590]; response to hydroxyisoflavone [GO:0033594]; response to oxidative stress [GO:0006979]; response to UV-A [GO:0070141]; salivary gland morphogenesis [GO:0007435]; signal transduction [GO:0007165]; tongue development [GO:0043586]; translation [GO:0006412]; vasodilation [GO:0042311]","apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cell junction [GO:0030054]; cell surface [GO:0009986]; clathrin-coated endocytic vesicle membrane [GO:0030669]; cytoplasm [GO:0005737]; early endosome membrane [GO:0031901]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; intracellular vesicle [GO:0097708]; membrane [GO:0016020]; membrane raft [GO:0045121]; multivesicular body, internal vesicle lumen [GO:0097489]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; receptor complex [GO:0043235]; ruffle membrane [GO:0032587]; Shc-EGFR complex [GO:0070435]; synaptic membrane [GO:0097060]",actin filament binding [GO:0051015]; ATP binding [GO:0005524]; ATPase binding [GO:0051117]; cadherin binding [GO:0045296]; calmodulin binding [GO:0005516]; chromatin binding [GO:0003682]; double-stranded DNA binding [GO:0003690]; enzyme binding [GO:0019899]; epidermal growth factor binding [GO:0048408]; epidermal growth factor receptor activity [GO:0005006]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; kinase binding [GO:0019900]; MAP kinase kinase kinase activity [GO:0004709]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; protein tyrosine kinase activator activity [GO:0030296]; protein tyrosine kinase activity [GO:0004713]; transmembrane receptor protein tyrosine kinase activator activity [GO:0030297]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; transmembrane signaling receptor activity [GO:0004888]; ubiquitin protein ligase binding [GO:0031625]; virus receptor activity [GO:0001618],"PTM: Phosphorylated on Tyr residues in response to EGF (PubMed:20462955, PubMed:27153536). Phosphorylation at Ser-695 is partial and occurs only if Thr-693 is phosphorylated. Phosphorylation at Thr-678 and Thr-693 by PRKD1 inhibits EGF-induced MAPK8/JNK1 activation. Dephosphorylation by PTPRJ prevents endocytosis and stabilizes the receptor at the plasma membrane. Autophosphorylation at Tyr-1197 is stimulated by methylation at Arg-1199 and enhances interaction with PTPN6. Autophosphorylation at Tyr-1092 and/or Tyr-1110 recruits STAT3. Dephosphorylated by PTPN1 and PTPN2. {ECO:0000269|PubMed:10523301, ECO:0000269|PubMed:12873986, ECO:0000269|PubMed:16083266, ECO:0000269|PubMed:19563760, ECO:0000269|PubMed:19836242, ECO:0000269|PubMed:20462955, ECO:0000269|PubMed:21258366, ECO:0000269|PubMed:2543678, ECO:0000269|PubMed:27153536, ECO:0000269|PubMed:3138233}.; PTM: Monoubiquitinated and polyubiquitinated upon EGF stimulation; which does not affect tyrosine kinase activity or signaling capacity but may play a role in lysosomal targeting (PubMed:27153536). Polyubiquitin linkage is mainly through 'Lys-63', but linkage through 'Lys-48', 'Lys-11' and 'Lys-29' also occurs. Deubiquitination by OTUD7B prevents degradation. Ubiquitinated by RNF115 and RNF126 (By similarity). Ubiquitinated by ZNRF1 or CBL at different lysines in response to EGF stimulation; leading to recruitment of the ESCRT machinery and subsequent degradation in the lysosomes (PubMed:33996800). Deubiquitinated by UCHL1 leading to the inhibition of its degradation (By similarity). {ECO:0000250|UniProtKB:Q01279, ECO:0000269|PubMed:16543144, ECO:0000269|PubMed:22179831, ECO:0000269|PubMed:22298428, ECO:0000269|PubMed:27153536, ECO:0000269|PubMed:33996800}.; PTM: Palmitoylated on Cys residues by ZDHHC20. Palmitoylation inhibits internalization after ligand binding, and increases the persistence of tyrosine-phosphorylated EGFR at the cell membrane. Palmitoylation increases the amplitude and duration of EGFR signaling. {ECO:0000269|PubMed:27153536}.; PTM: Methylated. Methylation at Arg-1199 by PRMT5 stimulates phosphorylation at Tyr-1197. {ECO:0000269|PubMed:19563760, ECO:0000269|PubMed:19836242, ECO:0000269|PubMed:21258366}.",,"DOMAIN 712..979; /note=""Protein kinase""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00159""","STRAND 40..43; /evidence=""ECO:0007829|PDB:3QWQ""; STRAND 60..69; /evidence=""ECO:0007829|PDB:4UV7""; STRAND 84..87; /evidence=""ECO:0007829|PDB:4UV7""; STRAND 89..93; /evidence=""ECO:0007829|PDB:4UV7""; STRAND 117..122; /evidence=""ECO:0007829|PDB:4UV7""; STRAND 125..129; /evidence=""ECO:0007829|PDB:1MOX""; STRAND 145..152; /evidence=""ECO:0007829|PDB:4UV7""; STRAND 183..185; /evidence=""ECO:0007829|PDB:5XWD""; STRAND 199..204; /evidence=""ECO:0007829|PDB:4UV7""; STRAND 211..214; /evidence=""ECO:0007829|PDB:1MOX""; STRAND 217..221; /evidence=""ECO:0007829|PDB:5XWD""; STRAND 223..227; /evidence=""ECO:0007829|PDB:4UV7""; STRAND 236..238; /evidence=""ECO:0007829|PDB:4UV7""; STRAND 240..244; /evidence=""ECO:0007829|PDB:4UV7""; STRAND 248..256; /evidence=""ECO:0007829|PDB:4UV7""; STRAND 259..263; /evidence=""ECO:0007829|PDB:4UV7""; STRAND 267..271; /evidence=""ECO:0007829|PDB:4UV7""; STRAND 276..279; /evidence=""ECO:0007829|PDB:4UV7""; STRAND 285..287; /evidence=""ECO:0007829|PDB:4UV7""; STRAND 290..294; /evidence=""ECO:0007829|PDB:4UV7""; STRAND 299..301; /evidence=""ECO:0007829|PDB:7LEN""; STRAND 303..305; /evidence=""ECO:0007829|PDB:4KRP""; STRAND 306..310; /evidence=""ECO:0007829|PDB:4UV7""; STRAND 313..315; /evidence=""ECO:0007829|PDB:3B2V""; STRAND 318..320; /evidence=""ECO:0007829|PDB:3G5Y""; STRAND 323..325; /evidence=""ECO:0007829|PDB:3G5Y""; STRAND 330..332; /evidence=""ECO:0007829|PDB:4UV7""; STRAND 336..338; /evidence=""ECO:0007829|PDB:3P0Y""; STRAND 349..351; /evidence=""ECO:0007829|PDB:3P0Y""; STRAND 363..367; /evidence=""ECO:0007829|PDB:3P0Y""; STRAND 369..371; /evidence=""ECO:0007829|PDB:3P0Y""; STRAND 400..403; /evidence=""ECO:0007829|PDB:3P0Y""; STRAND 405..407; /evidence=""ECO:0007829|PDB:3P0Y""; STRAND 436..442; /evidence=""ECO:0007829|PDB:3P0Y""; STRAND 458..464; /evidence=""ECO:0007829|PDB:3P0Y""; STRAND 481..483; /evidence=""ECO:0007829|PDB:1YY9""; STRAND 488..494; /evidence=""ECO:0007829|PDB:3P0Y""; STRAND 508..510; /evidence=""ECO:0007829|PDB:5SX4""; STRAND 515..519; /evidence=""ECO:0007829|PDB:3P0Y""; STRAND 523..526; /evidence=""ECO:0007829|PDB:3P0Y""; STRAND 531..533; /evidence=""ECO:0007829|PDB:4KRL""; STRAND 534..537; /evidence=""ECO:0007829|PDB:8UKW""; STRAND 540..546; /evidence=""ECO:0007829|PDB:4UV7""; STRAND 548..551; /evidence=""ECO:0007829|PDB:4UV7""; STRAND 554..557; /evidence=""ECO:0007829|PDB:4UV7""; STRAND 560..562; /evidence=""ECO:0007829|PDB:4KRO""; STRAND 566..568; /evidence=""ECO:0007829|PDB:8UKW""; STRAND 570..575; /evidence=""ECO:0007829|PDB:4UV7""; STRAND 578..587; /evidence=""ECO:0007829|PDB:4UV7""; STRAND 590..594; /evidence=""ECO:0007829|PDB:4UV7""; STRAND 597..602; /evidence=""ECO:0007829|PDB:4UV7""; STRAND 606..611; /evidence=""ECO:0007829|PDB:4UV7""; STRAND 615..619; /evidence=""ECO:0007829|PDB:4UV7""; STRAND 622..624; /evidence=""ECO:0007829|PDB:7SYE""; STRAND 629..632; /evidence=""ECO:0007829|PDB:4UV7""; STRAND 643..646; /evidence=""ECO:0007829|PDB:2KS1""; STRAND 671..673; /evidence=""ECO:0007829|PDB:1Z9I""; STRAND 688..692; /evidence=""ECO:0007829|PDB:1Z9I""; STRAND 694..697; /evidence=""ECO:0007829|PDB:1Z9I""; STRAND 703..706; /evidence=""ECO:0007829|PDB:8A27""; STRAND 712..720; /evidence=""ECO:0007829|PDB:8A27""; STRAND 722..731; /evidence=""ECO:0007829|PDB:8A27""; STRAND 740..749; /evidence=""ECO:0007829|PDB:8A27""; STRAND 777..781; /evidence=""ECO:0007829|PDB:8A27""; STRAND 783..785; /evidence=""ECO:0007829|PDB:8A27""; STRAND 787..791; /evidence=""ECO:0007829|PDB:8A27""; STRAND 794..797; /evidence=""ECO:0007829|PDB:5ZWJ""; STRAND 843..847; /evidence=""ECO:0007829|PDB:8A27""; STRAND 850..853; /evidence=""ECO:0007829|PDB:8A27""; STRAND 871..873; /evidence=""ECO:0007829|PDB:6V66""; STRAND 875..877; /evidence=""ECO:0007829|PDB:5CZH""; STRAND 937..939; /evidence=""ECO:0007829|PDB:8PO0""; STRAND 951..953; /evidence=""ECO:0007829|PDB:5JEB""; STRAND 1004..1010; /evidence=""ECO:0007829|PDB:3W2S""; STRAND 1068..1070; /evidence=""ECO:0007829|PDB:3PFV""","HELIX 44..55; /evidence=""ECO:0007829|PDB:4UV7""; HELIX 77..81; /evidence=""ECO:0007829|PDB:4UV7""; HELIX 101..103; /evidence=""ECO:0007829|PDB:1IVO""; HELIX 159..161; /evidence=""ECO:0007829|PDB:4UV7""; HELIX 164..166; /evidence=""ECO:0007829|PDB:4UV7""; HELIX 170..173; /evidence=""ECO:0007829|PDB:1MOX""; HELIX 195..197; /evidence=""ECO:0007829|PDB:4UV7""; HELIX 228..230; /evidence=""ECO:0007829|PDB:4UV7""; HELIX 343..345; /evidence=""ECO:0007829|PDB:3P0Y""; HELIX 356..359; /evidence=""ECO:0007829|PDB:3P0Y""; HELIX 373..377; /evidence=""ECO:0007829|PDB:3P0Y""; HELIX 389..397; /evidence=""ECO:0007829|PDB:3P0Y""; HELIX 418..420; /evidence=""ECO:0007829|PDB:3P0Y""; HELIX 472..474; /evidence=""ECO:0007829|PDB:3P0Y""; HELIX 477..480; /evidence=""ECO:0007829|PDB:3P0Y""; HELIX 496..501; /evidence=""ECO:0007829|PDB:3P0Y""; HELIX 520..522; /evidence=""ECO:0007829|PDB:3P0Y""; HELIX 633..635; /evidence=""ECO:0007829|PDB:4UV7""; HELIX 648..669; /evidence=""ECO:0007829|PDB:2KS1""; HELIX 679..684; /evidence=""ECO:0007829|PDB:3GOP""; HELIX 685..687; /evidence=""ECO:0007829|PDB:3GOP""; HELIX 709..711; /evidence=""ECO:0007829|PDB:8A27""; HELIX 753..767; /evidence=""ECO:0007829|PDB:8A27""; HELIX 798..804; /evidence=""ECO:0007829|PDB:8A27""; HELIX 806..808; /evidence=""ECO:0007829|PDB:8A27""; HELIX 811..830; /evidence=""ECO:0007829|PDB:8A27""; HELIX 840..842; /evidence=""ECO:0007829|PDB:8A27""; HELIX 856..858; /evidence=""ECO:0007829|PDB:7VRA""; HELIX 866..868; /evidence=""ECO:0007829|PDB:8A2D""; HELIX 878..880; /evidence=""ECO:0007829|PDB:8A27""; HELIX 883..888; /evidence=""ECO:0007829|PDB:8A27""; HELIX 893..908; /evidence=""ECO:0007829|PDB:8A27""; HELIX 920..922; /evidence=""ECO:0007829|PDB:8A27""; HELIX 923..928; /evidence=""ECO:0007829|PDB:8A27""; HELIX 941..950; /evidence=""ECO:0007829|PDB:8A27""; HELIX 955..957; /evidence=""ECO:0007829|PDB:8A27""; HELIX 961..972; /evidence=""ECO:0007829|PDB:8A27""; HELIX 975..977; /evidence=""ECO:0007829|PDB:8A27""; HELIX 984..986; /evidence=""ECO:0007829|PDB:5HG8""; HELIX 1013..1016; /evidence=""ECO:0007829|PDB:8A2A""","TURN 114..116; /evidence=""ECO:0007829|PDB:4UV7""; TURN 245..247; /evidence=""ECO:0007829|PDB:4UV7""; TURN 272..275; /evidence=""ECO:0007829|PDB:4UV7""; TURN 296..298; /evidence=""ECO:0007829|PDB:3B2V""; TURN 340..342; /evidence=""ECO:0007829|PDB:3QWQ""; TURN 353..355; /evidence=""ECO:0007829|PDB:3P0Y""; TURN 380..383; /evidence=""ECO:0007829|PDB:3P0Y""; TURN 433..435; /evidence=""ECO:0007829|PDB:3P0Y""; TURN 734..736; /evidence=""ECO:0007829|PDB:5UG9""; TURN 771..773; /evidence=""ECO:0007829|PDB:8PO2""; TURN 859..865; /evidence=""ECO:0007829|PDB:8A2A""; TURN 909..911; /evidence=""ECO:0007829|PDB:7JXW""; TURN 914..917; /evidence=""ECO:0007829|PDB:8A27""; TURN 992..998; /evidence=""ECO:0007829|PDB:5HG8""; TURN 999..1003; /evidence=""ECO:0007829|PDB:6S89""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,EGFR ERBB ERBB1 HER1,Epidermal growth factor receptor (EC 2.7.10.1) (Proto-oncogene c-ErbB-1) (Receptor tyrosine-protein kinase erbB-1),Homo sapiens (Human),1210.0,134277.0,MRPSGTAGAALLALLAALCPASRALEEKKVCQGTSNKLTQLGTFEDHFLSLQRMFNNCEVVLGNLEITYVQRNYDLSFLKTIQEVAGYVLIALNTVERIPLENLQIIRGNMYYENSYALAVLSNYDANKTGLKELPMRNLQEILHGAVRFSNNPALCNVESIQWRDIVSSDFLSNMSMDFQNHLGSCQKCDPSCPNGSCWGAGEENCQKLTKIICAQQCSGRCRGKSPSDCCHNQCAAGCTGPRESDCLVCRKFRDEATCKDTCPPLMLYNPTTYQMDVNPEGKYSFGATCVKKCPRNYVVTDHGSCVRACGADSYEMEEDGVRKCKKCEGPCRKVCNGIGIGEFKDSLSINATNIKHFKNCTSISGDLHILPVAFRGDSFTHTPPLDPQELDILKTVKEITGFLLIQAWPENRTDLHAFENLEIIRGRTKQHGQFSLAVVSLNITSLGLRSLKEISDGDVIISGNKNLCYANTINWKKLFGTSGQKTKIISNRGENSCKATGQVCHALCSPEGCWGPEPRDCVSCRNVSRGRECVDKCNLLEGEPREFVENSECIQCHPECLPQAMNITCTGRGPDNCIQCAHYIDGPHCVKTCPAGVMGENNTLVWKYADAGHVCHLCHPNCTYGCTGPGLEGCPTNGPKIPSIATGMVGALLLLLVVALGIGLFMRRRHIVRKRTLRRLLQERELVEPLTPSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVVDADEYLIPQQGFFSSPSTSRTPLLSSLSATSNNSTVACIDRNGLQSCPIKEDSFLQRYSSDPTGALTEDSIDDTFLPVPEYINQSVPKRPAGSVQNPVYHNQPLNPAPSRDPHYQDPHSTAVGNPEYLNTVQPTCVNSTFDSPAHWAQKGSHQISLDNPDYQQDFFPKEAKPNGIFKGSTAENAEYLRVAPQSSEFIGA,True,False,True,P00533,"[('cd00064', 'FU'), ('cd05108', 'Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor'), ('cd12093', 'Transmembrane domain of Epidermal Growth Factor Receptor or ErbB1, a Protein Tyrosine Kinase'), ('G3DSA:1.10.510.10', 'Transferase(Phosphotransferase) domain 1'), ('G3DSA:1.20.5.420', 'Immunoglobulin FC, subunit C'), ('G3DSA:2.10.220.10', 'Hormone Receptor, Insulin-like Growth Factor Receptor 1; Chain A, domain 2'), ('G3DSA:3.30.200.20', 'Phosphorylase Kinase; domain 1'), ('G3DSA:3.80.20.20', 'Receptor L-domain'), ('IPR000494', 'Receptor L-domain'), ('IPR000719', 'Protein kinase domain'), ('IPR001245', 'Serine-threonine/tyrosine-protein kinase, catalytic domain'), ('IPR006211', 'Furin-like cysteine-rich domain'), ('IPR006212', 'Furin-like repeat'), ('IPR008266', 'Tyrosine-protein kinase, active site'), ('IPR009030', 'Growth factor receptor cysteine-rich domain superfamily'), ('IPR011009', 'Protein kinase-like domain superfamily'), ('IPR016245', 'Tyrosine protein kinase, EGF/ERB/XmrK receptor'), ('IPR017441', 'Protein kinase, ATP binding site'), ('IPR020635', 'Tyrosine-protein kinase, catalytic domain'), ('IPR032778', 'Growth factor receptor domain 4')]",P00533;,"""ENSG00000146648; Tissue enhanced (placenta)."";","CATALYTIC ACTIVITY: Reaction=L-tyrosyl-[protein] + ATP = O-phospho-L-tyrosyl-[protein] + ADP + H(+); Xref=Rhea:RHEA:10596, Rhea:RHEA-COMP:10136, Rhea:RHEA-COMP:10137, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616, ChEBI:CHEBI:46858, ChEBI:CHEBI:82620, ChEBI:CHEBI:456216; EC=2.7.10.1; Evidence={ECO:0000255|PROSITE-ProRule:PRU10028, ECO:0000269|PubMed:15374980, ECO:0000269|PubMed:17349580, ECO:0000269|PubMed:18046415, ECO:0000269|PubMed:18227510, ECO:0000269|PubMed:19560417, ECO:0000269|PubMed:19563760};",2.7.10.1,"ACTIVITY REGULATION: Endocytosis and inhibition of the activated EGFR by phosphatases like PTPRJ and PTPRK constitute immediate regulatory mechanisms. Upon EGF-binding phosphorylates EPS15 that regulates EGFR endocytosis and activity. Moreover, inducible feedback inhibitors including LRIG1, SOCS4, SOCS5 and ERRFI1 constitute alternative regulatory mechanisms for the EGFR signaling. Up-regulated by NEU3-mediated desialylation of N-linked glycan at Asn-528. {ECO:0000269|PubMed:15282549, ECO:0000269|PubMed:15590694, ECO:0000269|PubMed:17334392, ECO:0000269|PubMed:18046415, ECO:0000269|PubMed:19836242, ECO:0000269|PubMed:25922362}.",,ENST00000275493.7 [P00533-1];ENST00000342916.7 [P00533-4];ENST00000344576.7 [P00533-3];ENST00000420316.6 [P00533-2];,EGFR,ENSG00000146648,0.0,,,,2.31,DP00309,0.494,0.222,0.034,EGFR
P00558,ENSG00000102144,PGK1_HUMAN,canonical glycolysis [GO:0061621]; cellular response to hypoxia [GO:0071456]; epithelial cell differentiation [GO:0030855]; gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096]; negative regulation of angiogenesis [GO:0016525]; phosphorylation [GO:0016310]; plasminogen activation [GO:0031639],cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; membrane [GO:0016020]; membrane raft [GO:0045121],ADP binding [GO:0043531]; ATP binding [GO:0005524]; phosphoglycerate kinase activity [GO:0004618]; protein-disulfide reductase (NAD(P)H) activity [GO:0047134],,,,"STRAND 18..22; /evidence=""ECO:0007829|PDB:2WZB""; STRAND 29..32; /evidence=""ECO:0007829|PDB:5M6Z""; STRAND 33..35; /evidence=""ECO:0007829|PDB:2WZB""; STRAND 56..61; /evidence=""ECO:0007829|PDB:2WZB""; STRAND 94..97; /evidence=""ECO:0007829|PDB:3C3B""; STRAND 99..101; /evidence=""ECO:0007829|PDB:2WZB""; STRAND 115..118; /evidence=""ECO:0007829|PDB:2WZB""; STRAND 131..133; /evidence=""ECO:0007829|PDB:2XE8""; STRAND 135..137; /evidence=""ECO:0007829|PDB:3C3A""; STRAND 139..141; /evidence=""ECO:0007829|PDB:5M1R""; STRAND 159..163; /evidence=""ECO:0007829|PDB:2WZB""; STRAND 184..186; /evidence=""ECO:0007829|PDB:2WZB""; STRAND 206..212; /evidence=""ECO:0007829|PDB:2WZB""; STRAND 232..236; /evidence=""ECO:0007829|PDB:2WZB""; STRAND 279..281; /evidence=""ECO:0007829|PDB:2WZB""; STRAND 285..293; /evidence=""ECO:0007829|PDB:2WZB""; STRAND 298..302; /evidence=""ECO:0007829|PDB:2WZB""; STRAND 312..316; /evidence=""ECO:0007829|PDB:2WZB""; STRAND 332..338; /evidence=""ECO:0007829|PDB:2WZB""; STRAND 368..373; /evidence=""ECO:0007829|PDB:2WZB""; STRAND 388..394; /evidence=""ECO:0007829|PDB:2WZB""","HELIX 3..5; /evidence=""ECO:0007829|PDB:5M1R""; HELIX 9..11; /evidence=""ECO:0007829|PDB:2WZB""; HELIX 38..52; /evidence=""ECO:0007829|PDB:2WZB""; HELIX 73..76; /evidence=""ECO:0007829|PDB:2WZB""; HELIX 79..89; /evidence=""ECO:0007829|PDB:2WZB""; HELIX 102..109; /evidence=""ECO:0007829|PDB:2WZB""; HELIX 122..124; /evidence=""ECO:0007829|PDB:2WZB""; HELIX 144..156; /evidence=""ECO:0007829|PDB:2WZB""; HELIX 166..168; /evidence=""ECO:0007829|PDB:2WZB""; HELIX 174..177; /evidence=""ECO:0007829|PDB:2WZB""; HELIX 188..202; /evidence=""ECO:0007829|PDB:2WZB""; HELIX 217..220; /evidence=""ECO:0007829|PDB:2WZB""; HELIX 221..223; /evidence=""ECO:0007829|PDB:2WZB""; HELIX 224..227; /evidence=""ECO:0007829|PDB:2WZB""; HELIX 238..240; /evidence=""ECO:0007829|PDB:2WZB""; HELIX 241..249; /evidence=""ECO:0007829|PDB:2WZB""; HELIX 260..263; /evidence=""ECO:0007829|PDB:2WZB""; HELIX 266..275; /evidence=""ECO:0007829|PDB:2WZB""; HELIX 318..330; /evidence=""ECO:0007829|PDB:2WZB""; HELIX 346..348; /evidence=""ECO:0007829|PDB:2WZB""; HELIX 350..364; /evidence=""ECO:0007829|PDB:2WZB""; HELIX 376..382; /evidence=""ECO:0007829|PDB:2WZB""; HELIX 397..404; /evidence=""ECO:0007829|PDB:2WZB""; HELIX 409..412; /evidence=""ECO:0007829|PDB:2WZB""","TURN 126..130; /evidence=""ECO:0007829|PDB:2WZB""; TURN 228..230; /evidence=""ECO:0007829|PDB:2WZB""; TURN 303..305; /evidence=""ECO:0007829|PDB:2WZB""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,PGK1 PGKA MIG10 OK/SW-cl.110,Phosphoglycerate kinase 1 (EC 2.7.2.3) (Cell migration-inducing gene 10 protein) (Primer recognition protein 2) (PRP 2),Homo sapiens (Human),417.0,44615.0,MSLSNKLTLDKLDVKGKRVVMRVDFNVPMKNNQITNNQRIKAAVPSIKFCLDNGAKSVVLMSHLGRPDGVPMPDKYSLEPVAVELKSLLGKDVLFLKDCVGPEVEKACANPAAGSVILLENLRFHVEEEGKGKDASGNKVKAEPAKIEAFRASLSKLGDVYVNDAFGTAHRAHSSMVGVNLPQKAGGFLMKKELNYFAKALESPERPFLAILGGAKVADKIQLINNMLDKVNEMIIGGGMAFTFLKVLNNMEIGTSLFDEEGAKIVKDLMSKAEKNGVKITLPVDFVTADKFDENAKTGQATVASGIPAGWMGLDCGPESSKKYAEAVTRAKQIVWNGPVGVFEWEAFARGTKALMDEVVKATSRGCITIIGGGDTATCCAKWNTEDKVSHVSTGGGASLELLEGKVLPGVDALSNI,True,True,True,P00558,"[('cd00318', 'Phosphoglycerate_kinase'), ('G3DSA:3.40.50.1260', 'Phosphoglycerate kinase, N-terminal domain'), ('IPR001576', 'Phosphoglycerate kinase'), ('IPR015824', 'Phosphoglycerate kinase, N-terminal'), ('IPR015911', 'Phosphoglycerate kinase, conserved site'), ('IPR036043', 'Phosphoglycerate kinase superfamily'), ('MF_00145', 'Phosphoglycerate kinase [pgk]'), ('PF00162', 'Phosphoglycerate kinase'), ('PIRSF000724', 'Phosphoglycerate kinase'), ('PR00477', 'PHGLYCKINASE'), ('PS00111', 'Phosphoglycerate kinase signature'), ('PTHR11406', 'PHOSPHOGLYCERATE KINASE'), ('SSF53748', 'Phosphoglycerate kinase')]",,"""ENSG00000102144; Low tissue specificity."";","CATALYTIC ACTIVITY: Reaction=(2R)-3-phosphoglycerate + ATP = (2R)-3-phospho-glyceroyl phosphate + ADP; Xref=Rhea:RHEA:14801, ChEBI:CHEBI:30616, ChEBI:CHEBI:57604, ChEBI:CHEBI:58272, ChEBI:CHEBI:456216; EC=2.7.2.3; Evidence={ECO:0000269|PubMed:30323285, ECO:0000269|PubMed:7391028};",2.7.2.3,ACTIVITY REGULATION: Specifically inhibited by heterocyclic compound CBR-470-0. {ECO:0000269|PubMed:30323285}.,"PATHWAY: Carbohydrate degradation; glycolysis; pyruvate from D-glyceraldehyde 3-phosphate: step 2/5. {ECO:0000269|PubMed:30323285, ECO:0000269|PubMed:7391028}.",ENST00000373316.5 [P00558-1];ENST00000644362.1 [P00558-2];,PGK1,ENSG00000102144,0.0,PGK1,Non-canonical_RBPs,22.0,,,,,,PGK1
P00734,ENSG00000180210,THRB_HUMAN,acute-phase response [GO:0006953]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; blood coagulation [GO:0007596]; cell surface receptor signaling pathway [GO:0007166]; cytolysis by host of symbiont cells [GO:0051838]; fibrinolysis [GO:0042730]; G protein-coupled receptor signaling pathway [GO:0007186]; ligand-gated ion channel signaling pathway [GO:1990806]; negative regulation of astrocyte differentiation [GO:0048712]; negative regulation of blood coagulation [GO:0030195]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of fibrinolysis [GO:0051918]; negative regulation of platelet activation [GO:0010544]; negative regulation of proteolysis [GO:0045861]; neutrophil-mediated killing of gram-negative bacterium [GO:0070945]; platelet activation [GO:0030168]; positive regulation of blood coagulation [GO:0030194]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of insulin secretion [GO:0032024]; positive regulation of lipid kinase activity [GO:0090218]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of phospholipase C-activating G protein-coupled receptor signaling pathway [GO:1900738]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; proteolysis [GO:0006508]; regulation of blood coagulation [GO:0030193]; regulation of cell shape [GO:0008360]; regulation of cytosolic calcium ion concentration [GO:0051480]; response to wounding [GO:0009611],blood microparticle [GO:0072562]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi lumen [GO:0005796]; plasma membrane [GO:0005886],calcium ion binding [GO:0005509]; growth factor activity [GO:0008083]; heparin binding [GO:0008201]; lipopolysaccharide binding [GO:0001530]; receptor ligand activity [GO:0048018]; serine-type endopeptidase activity [GO:0004252]; signaling receptor binding [GO:0005102]; thrombospondin receptor activity [GO:0070053],"PTM: The gamma-carboxyglutamyl residues, which bind calcium ions, result from the carboxylation of glutamyl residues by a microsomal enzyme, the vitamin K-dependent carboxylase. The modified residues are necessary for the calcium-dependent interaction with a negatively charged phospholipid surface, which is essential for the conversion of prothrombin to thrombin. {ECO:0000269|PubMed:3759958, ECO:0000269|PubMed:6305407}.; PTM: N-glycosylated. N-glycan heterogeneity at Asn-121: Hex3HexNAc3 (minor), Hex4HexNAc3 (minor) and Hex5HexNAc4 (major). At Asn-143: Hex4HexNAc3 (minor) and Hex5HexNAc4 (major). {ECO:0000269|PubMed:14760718, ECO:0000269|PubMed:16335952, ECO:0000269|PubMed:19139490, ECO:0000269|PubMed:19159218, ECO:0000269|PubMed:19838169, ECO:0000269|PubMed:22171320, ECO:0000269|PubMed:873923}.; PTM: In the penultimate step of the coagulation cascade, prothrombin is converted to thrombin by the prothrombinase complex composed of factor Xa (F10), cofactor Va (F5), and phospholipids. This activation requires factor Xa-catalyzed sequential cleavage at 2 sites, Arg-314 and Arg-363, along 2 possible pathways. In the first pathway, the first cleavage occurs at Arg-314, leading to the formation of the inactive intermediate prethrombin-2. This pathway preferentially occurs on platelets and in the absence of cofactor Va. In the second pathway, the first cleavage occurs at Arg-363, which separates protease domain into 2 chains that remain connected through a disulfide bond and generates the active intermediate meizothrombin. The presence of cofactor Va directs activation along the meizothrombin pathway and greatly accelerates the rate of cleavage at Arg-363, but has a smaller effect on the cleavage of meizothrombin at Arg-314. Meizothrombin accumulates as an intermediate when prothrombinase is assembled on the membrane of red blood cells. {ECO:0000305|PubMed:34265300}.",,"DOMAIN 44..89; /note=""Gla""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00463""; DOMAIN 108..186; /note=""Kringle 1""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00121""; DOMAIN 213..291; /note=""Kringle 2""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00121""; DOMAIN 364..618; /note=""Peptidase S1""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00274""","STRAND 107..109; /evidence=""ECO:0007829|PDB:5EDM""; STRAND 124..126; /evidence=""ECO:0007829|PDB:5EDK""; STRAND 128..130; /evidence=""ECO:0007829|PDB:5EDK""; STRAND 136..138; /evidence=""ECO:0007829|PDB:8UF7""; STRAND 148..150; /evidence=""ECO:0007829|PDB:4NZQ""; STRAND 167..173; /evidence=""ECO:0007829|PDB:5EDM""; STRAND 177..180; /evidence=""ECO:0007829|PDB:5EDM""; STRAND 191..193; /evidence=""ECO:0007829|PDB:5EDM""; STRAND 211..214; /evidence=""ECO:0007829|PDB:5EDM""; STRAND 229..231; /evidence=""ECO:0007829|PDB:4HZH""; STRAND 233..235; /evidence=""ECO:0007829|PDB:4HZH""; STRAND 237..239; /evidence=""ECO:0007829|PDB:4NZQ""; STRAND 247..249; /evidence=""ECO:0007829|PDB:5EDK""; STRAND 253..255; /evidence=""ECO:0007829|PDB:5EDK""; STRAND 273..275; /evidence=""ECO:0007829|PDB:3K65""; STRAND 277..279; /evidence=""ECO:0007829|PDB:3K65""; STRAND 283..285; /evidence=""ECO:0007829|PDB:3K65""; STRAND 322..324; /evidence=""ECO:0007829|PDB:3BEI""; STRAND 367..369; /evidence=""ECO:0007829|PDB:3SQH""; STRAND 372..375; /evidence=""ECO:0007829|PDB:3QDZ""; STRAND 378..383; /evidence=""ECO:0007829|PDB:5AFY""; STRAND 388..395; /evidence=""ECO:0007829|PDB:5AFY""; STRAND 397..403; /evidence=""ECO:0007829|PDB:5AFY""; STRAND 408..410; /evidence=""ECO:0007829|PDB:4DY7""; STRAND 422..427; /evidence=""ECO:0007829|PDB:5AFY""; STRAND 430..433; /evidence=""ECO:0007829|PDB:5AFY""; STRAND 440..449; /evidence=""ECO:0007829|PDB:5AFY""; STRAND 464..470; /evidence=""ECO:0007829|PDB:5AFY""; STRAND 475..477; /evidence=""ECO:0007829|PDB:4O03""; STRAND 495..497; /evidence=""ECO:0007829|PDB:5EDM""; STRAND 498..504; /evidence=""ECO:0007829|PDB:5AFY""; STRAND 507..510; /evidence=""ECO:0007829|PDB:4UD9""; STRAND 516..518; /evidence=""ECO:0007829|PDB:4CH2""; STRAND 524..530; /evidence=""ECO:0007829|PDB:5AFY""; STRAND 540..542; /evidence=""ECO:0007829|PDB:1MH0""; STRAND 548..551; /evidence=""ECO:0007829|PDB:5AFY""; STRAND 571..575; /evidence=""ECO:0007829|PDB:5AFY""; STRAND 582..590; /evidence=""ECO:0007829|PDB:5AFY""; STRAND 592..595; /evidence=""ECO:0007829|PDB:5AFY""; STRAND 596..598; /evidence=""ECO:0007829|PDB:3K65""; STRAND 601..605; /evidence=""ECO:0007829|PDB:5AFY""","HELIX 47..60; /evidence=""ECO:0007829|PDB:5EDM""; HELIX 67..74; /evidence=""ECO:0007829|PDB:5EDM""; HELIX 77..89; /evidence=""ECO:0007829|PDB:5EDM""; HELIX 97..105; /evidence=""ECO:0007829|PDB:5EDM""; HELIX 216..218; /evidence=""ECO:0007829|PDB:3K65""; HELIX 240..246; /evidence=""ECO:0007829|PDB:3K65""; HELIX 295..297; /evidence=""ECO:0007829|PDB:5EDM""; HELIX 329..333; /evidence=""ECO:0007829|PDB:5NHU""; HELIX 343..345; /evidence=""ECO:0007829|PDB:5AFY""; HELIX 352..358; /evidence=""ECO:0007829|PDB:5AFY""; HELIX 405..407; /evidence=""ECO:0007829|PDB:5AFY""; HELIX 411..413; /evidence=""ECO:0007829|PDB:5AFY""; HELIX 419..421; /evidence=""ECO:0007829|PDB:5AFY""; HELIX 486..492; /evidence=""ECO:0007829|PDB:5AFY""; HELIX 533..538; /evidence=""ECO:0007829|PDB:5AFY""; HELIX 555..557; /evidence=""ECO:0007829|PDB:5AFY""; HELIX 607..609; /evidence=""ECO:0007829|PDB:5AFY""; HELIX 610..619; /evidence=""ECO:0007829|PDB:5AFY""","TURN 90..92; /evidence=""ECO:0007829|PDB:5EDM""; TURN 112..115; /evidence=""ECO:0007829|PDB:4HZH""; TURN 144..146; /evidence=""ECO:0007829|PDB:5EDM""; TURN 186..188; /evidence=""ECO:0007829|PDB:4NZQ""; TURN 326..328; /evidence=""ECO:0007829|PDB:4O03""; TURN 334..337; /evidence=""ECO:0007829|PDB:5AFY""; TURN 340..342; /evidence=""ECO:0007829|PDB:5AFY""; TURN 360..362; /evidence=""ECO:0007829|PDB:1NO9""; TURN 384..387; /evidence=""ECO:0007829|PDB:5AFY""; TURN 436..438; /evidence=""ECO:0007829|PDB:5AFY""; TURN 455..458; /evidence=""ECO:0007829|PDB:5AFY""; TURN 513..515; /evidence=""ECO:0007829|PDB:4CH2""; TURN 565..569; /evidence=""ECO:0007829|PDB:3U8O""; TURN 577..579; /evidence=""ECO:0007829|PDB:5AFY""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,F2,Prothrombin (EC 3.4.21.5) (Coagulation factor II) [Cleaved into: Activation peptide fragment 1; Activation peptide fragment 2; Thrombin light chain; Thrombin heavy chain],Homo sapiens (Human),622.0,70037.0,MAHVRGLQLPGCLALAALCSLVHSQHVFLAPQQARSLLQRVRRANTFLEEVRKGNLERECVEETCSYEEAFEALESSTATDVFWAKYTACETARTPRDKLAACLEGNCAEGLGTNYRGHVNITRSGIECQLWRSRYPHKPEINSTTHPGADLQENFCRNPDSSTTGPWCYTTDPTVRRQECSIPVCGQDQVTVAMTPRSEGSSVNLSPPLEQCVPDRGQQYQGRLAVTTHGLPCLAWASAQAKALSKHQDFNSAVQLVENFCRNPDGDEEGVWCYVAGKPGDFGYCDLNYCEEAVEEETGDGLDEDSDRAIEGRTATSEYQTFFNPRTFGSGEADCGLRPLFEKKSLEDKTERELLESYIDGRIVEGSDAEIGMSPWQVMLFRKSPQELLCGASLISDRWVLTAAHCLLYPPWDKNFTENDLLVRIGKHSRTRYERNIEKISMLEKIYIHPRYNWRENLDRDIALMKLKKPVAFSDYIHPVCLPDRETAASLLQAGYKGRVTGWGNLKETWTANVGKGQPSVLQVVNLPIVERPVCKDSTRIRITDNMFCAGYKPDEGKRGDACEGDSGGPFVMKSPFNNRWYQMGIVSWGEGCDRDGKYGFYTHVFRLKKWIQKVIDQFGE,True,False,True,P00734,"[('cd00108', 'KR'), ('cd00190', 'Tryp_SPc'), ('G3DSA:2.40.10.10', 'Trypsin-like serine proteases'), ('G3DSA:2.40.20.10', 'Plasminogen Kringle 4'), ('G3DSA:4.10.140.10', 'Thrombin light chain domain'), ('IPR000001', 'Kringle'), ('IPR000294', 'Gamma-carboxyglutamic acid-rich (GLA) domain'), ('IPR001254', 'Serine proteases, trypsin domain'), ('IPR001314', 'Peptidase S1A, chymotrypsin family'), ('IPR003966', 'Prothrombin/thrombin'), ('IPR009003', 'Peptidase S1, PA clan'), ('IPR013806', 'Kringle-like fold'), ('IPR018056', 'Kringle, conserved site'), ('IPR018114', 'Serine proteases, trypsin family, histidine active site'), ('IPR018992', 'Thrombin light chain'), ('IPR033116', 'Serine proteases, trypsin family, serine active site'), ('IPR035972', 'Gamma-carboxyglutamic acid-rich (GLA) domain superfamily'), ('IPR037111', 'Thrombin light chain domain superfamily'), ('IPR038178', 'Kringle superfamily'), ('IPR043504', 'Peptidase S1, PA clan, chymotrypsin-like fold')]",,"""ENSG00000180210; Tissue enriched (liver)."";",CATALYTIC ACTIVITY: Reaction=Selective cleavage of Arg-|-Gly bonds in fibrinogen to form fibrin and release fibrinopeptides A and B.; EC=3.4.21.5;,3.4.21.5,"ACTIVITY REGULATION: Activity is promoted in the presence of negatively charged surfaces, such as polyphosphate and dextran sulfate (PubMed:2019570, PubMed:21976677). Inhibited by SERPINA5 (PubMed:6323392). {ECO:0000269|PubMed:2019570, ECO:0000269|PubMed:21976677, ECO:0000269|PubMed:6323392}.",,ENST00000311907.10;,F2,ENSG00000180210,0.0,,,,10.45,DP03299,0.105,0.14,,F2
P00813,ENSG00000196839,ADA_HUMAN,adenosine catabolic process [GO:0006154]; adenosine metabolic process [GO:0046085]; allantoin metabolic process [GO:0000255]; alpha-beta T cell differentiation [GO:0046632]; amide catabolic process [GO:0043605]; AMP catabolic process [GO:0006196]; AMP salvage [GO:0044209]; B cell proliferation [GO:0042100]; calcium-mediated signaling [GO:0019722]; cell adhesion [GO:0007155]; dAMP catabolic process [GO:0046059]; dATP catabolic process [GO:0046061]; deoxyadenosine catabolic process [GO:0006157]; embryonic digestive tract development [GO:0048566]; germinal center B cell differentiation [GO:0002314]; germinal center formation [GO:0002467]; GMP salvage [GO:0032263]; hypoxanthine salvage [GO:0043103]; inosine biosynthetic process [GO:0046103]; leukocyte migration [GO:0050900]; liver development [GO:0001889]; lung alveolus development [GO:0048286]; mature B cell apoptotic process [GO:0002901]; mucus secretion [GO:0070254]; negative regulation of adenosine receptor signaling pathway [GO:0060169]; negative regulation of inflammatory response [GO:0050728]; negative regulation of leukocyte migration [GO:0002686]; negative regulation of mature B cell apoptotic process [GO:0002906]; negative regulation of mucus secretion [GO:0070256]; negative regulation of penile erection [GO:0060407]; negative regulation of thymocyte apoptotic process [GO:0070244]; penile erection [GO:0043084]; Peyer's patch development [GO:0048541]; placenta development [GO:0001890]; positive regulation of alpha-beta T cell differentiation [GO:0046638]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of calcium-mediated signaling [GO:0050850]; positive regulation of germinal center formation [GO:0002636]; positive regulation of heart rate [GO:0010460]; positive regulation of smooth muscle contraction [GO:0045987]; positive regulation of T cell differentiation in thymus [GO:0033089]; positive regulation of T cell receptor signaling pathway [GO:0050862]; purine nucleotide salvage [GO:0032261]; purine-containing compound salvage [GO:0043101]; regulation of cell-cell adhesion mediated by integrin [GO:0033632]; response to hypoxia [GO:0001666]; response to purine-containing compound [GO:0014074]; smooth muscle contraction [GO:0006939]; T cell activation [GO:0042110]; T cell differentiation in thymus [GO:0033077]; T cell receptor signaling pathway [GO:0050852]; thymocyte apoptotic process [GO:0070242]; trophectodermal cell differentiation [GO:0001829]; xanthine biosynthetic process [GO:0046111]; xenobiotic metabolic process [GO:0006805],anchoring junction [GO:0070161]; cell surface [GO:0009986]; cytoplasmic vesicle lumen [GO:0060205]; cytosol [GO:0005829]; external side of plasma membrane [GO:0009897]; lysosome [GO:0005764]; membrane [GO:0016020]; plasma membrane [GO:0005886],2'-deoxyadenosine deaminase activity [GO:0046936]; adenosine deaminase activity [GO:0004000]; deaminase activity [GO:0019239]; zinc ion binding [GO:0008270],,,,"STRAND 11..13; /evidence=""ECO:0007829|PDB:3IAR""; STRAND 95..102; /evidence=""ECO:0007829|PDB:3IAR""; STRAND 109..111; /evidence=""ECO:0007829|PDB:3IAR""; STRAND 147..155; /evidence=""ECO:0007829|PDB:3IAR""; STRAND 177..184; /evidence=""ECO:0007829|PDB:3IAR""; STRAND 210..219; /evidence=""ECO:0007829|PDB:3IAR""; STRAND 234..238; /evidence=""ECO:0007829|PDB:3IAR""; STRAND 258..261; /evidence=""ECO:0007829|PDB:3IAR""; STRAND 270..272; /evidence=""ECO:0007829|PDB:3IAR""; STRAND 290..292; /evidence=""ECO:0007829|PDB:3IAR""; STRAND 333..335; /evidence=""ECO:0007829|PDB:3IAR""","HELIX 18..20; /evidence=""ECO:0007829|PDB:3IAR""; HELIX 24..34; /evidence=""ECO:0007829|PDB:3IAR""; HELIX 43..50; /evidence=""ECO:0007829|PDB:3IAR""; HELIX 58..62; /evidence=""ECO:0007829|PDB:3IAR""; HELIX 63..67; /evidence=""ECO:0007829|PDB:3IAR""; HELIX 69..72; /evidence=""ECO:0007829|PDB:3IAR""; HELIX 76..91; /evidence=""ECO:0007829|PDB:3IAR""; HELIX 104..107; /evidence=""ECO:0007829|PDB:3IAR""; HELIX 116..118; /evidence=""ECO:0007829|PDB:3IAR""; HELIX 126..144; /evidence=""ECO:0007829|PDB:3IAR""; HELIX 159..161; /evidence=""ECO:0007829|PDB:3IAR""; HELIX 162..171; /evidence=""ECO:0007829|PDB:3IAR""; HELIX 191..193; /evidence=""ECO:0007829|PDB:3IAR""; HELIX 195..207; /evidence=""ECO:0007829|PDB:3IAR""; HELIX 221..229; /evidence=""ECO:0007829|PDB:3IAR""; HELIX 240..244; /evidence=""ECO:0007829|PDB:3IAR""; HELIX 246..254; /evidence=""ECO:0007829|PDB:3IAR""; HELIX 263..268; /evidence=""ECO:0007829|PDB:3IAR""; HELIX 279..285; /evidence=""ECO:0007829|PDB:3IAR""; HELIX 297..300; /evidence=""ECO:0007829|PDB:3IAR""; HELIX 304..315; /evidence=""ECO:0007829|PDB:3IAR""; HELIX 319..331; /evidence=""ECO:0007829|PDB:3IAR""; HELIX 337..351; /evidence=""ECO:0007829|PDB:3IAR""; HELIX 355..362; /evidence=""ECO:0007829|PDB:3IAR""","TURN 92..94; /evidence=""ECO:0007829|PDB:3IAR""; TURN 172..176; /evidence=""ECO:0007829|PDB:3IAR""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,ADA ADA1,Adenosine deaminase (EC 3.5.4.4) (Adenosine aminohydrolase),Homo sapiens (Human),363.0,40764.0,MAQTPAFDKPKVELHVHLDGSIKPETILYYGRRRGIALPANTAEGLLNVIGMDKPLTLPDFLAKFDYYMPAIAGCREAIKRIAYEFVEMKAKEGVVYVEVRYSPHLLANSKVEPIPWNQAEGDLTPDEVVALVGQGLQEGERDFGVKARSILCCMRHQPNWSPKVVELCKKYQQQTVVAIDLAGDETIPGSSLLPGHVQAYQEAVKSGIHRTVHAGEVGSAEVVKEAVDILKTERLGHGYHTLEDQALYNRLRQENMHFEICPWSSYLTGAWKPDTEHAVIRLKNDQANYSLNTDDPLIFKSTLDTDYQMTKRDMGFTEEEFKRLNINAAKSSFLPEDEKRELLDLLYKAYGMPPSASAGQNL,True,False,False,P00813,"[('cd01320', 'ADA'), ('G3DSA:3.20.20.140', 'Metal-dependent hydrolases'), ('IPR001365', 'Adenosine deaminase domain'), ('IPR006330', 'Adenosine/adenine deaminase'), ('IPR006650', 'Adenosine/AMP deaminase active site'), ('IPR028893', 'Adenosine deaminase'), ('IPR032466', 'Metal-dependent hydrolase'), ('MF_00540', 'Adenosine deaminase [add]'), ('PF00962', 'Adenosine deaminase'), ('PS00485', 'Adenosine and AMP deaminase signature'), ('PTHR11409', 'ADENOSINE DEAMINASE'), ('SSF51556', 'Metallo-dependent hydrolases'), ('TIGR01430', 'adenosine deaminase')]",,"""ENSG00000196839; Group enriched (intestine, lymphoid tissue)."";","CATALYTIC ACTIVITY: Reaction=adenosine + H2O + H(+) = inosine + NH4(+); Xref=Rhea:RHEA:24408, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:16335, ChEBI:CHEBI:17596, ChEBI:CHEBI:28938; EC=3.5.4.4; Evidence={ECO:0000269|PubMed:16670267, ECO:0000269|PubMed:23193172, ECO:0000269|PubMed:26166670, ECO:0000269|PubMed:8452534, ECO:0000269|PubMed:9361033}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:24409; Evidence={ECO:0000305|PubMed:9361033}; CATALYTIC ACTIVITY: Reaction=2'-deoxyadenosine + H2O + H(+) = 2'-deoxyinosine + NH4(+); Xref=Rhea:RHEA:28190, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:17256, ChEBI:CHEBI:28938, ChEBI:CHEBI:28997; EC=3.5.4.4; Evidence={ECO:0000269|PubMed:9361033}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:28191; Evidence={ECO:0000305|PubMed:9361033}; CATALYTIC ACTIVITY: Reaction=cordycepin + H2O + H(+) = 3'-deoxyinosine + NH4(+); Xref=Rhea:RHEA:79047, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:28938, ChEBI:CHEBI:29014, ChEBI:CHEBI:229694; Evidence={ECO:0000269|PubMed:26038697}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:79048; Evidence={ECO:0000269|PubMed:26038697};",3.5.4.4,"ACTIVITY REGULATION: Inhibited by Cu(2+) and Hg(2+), coformycin, deoxycoformycin (dCF), 2-deoxyadenosine, 6-methylaminopurine riboside, 2-3-iso-propylidene-adenosine, pentostatin, naringin and erythro-9-(2-hydroxy-3-nonyl)adenine (EHNA). {ECO:0000269|PubMed:16670267, ECO:0000269|PubMed:26038697, ECO:0000269|PubMed:8452534}.",,ENST00000372874.9;,ADA,ENSG00000196839,0.0,,,,,,,0.022,,ADA
P00966,ENSG00000130707,ASSY_HUMAN,acute-phase response [GO:0006953]; arginine biosynthetic process [GO:0006526]; argininosuccinate metabolic process [GO:0000053]; aspartate metabolic process [GO:0006531]; cellular response to amine stimulus [GO:0071418]; cellular response to amino acid stimulus [GO:0071230]; cellular response to ammonium ion [GO:0071242]; cellular response to cAMP [GO:0071320]; cellular response to dexamethasone stimulus [GO:0071549]; cellular response to glucagon stimulus [GO:0071377]; cellular response to laminar fluid shear stress [GO:0071499]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to oleic acid [GO:0071400]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to type II interferon [GO:0071346]; circadian rhythm [GO:0007623]; citrulline metabolic process [GO:0000052]; diaphragm development [GO:0060539]; kidney development [GO:0001822]; liver development [GO:0001889]; midgut development [GO:0007494]; negative regulation of leukocyte cell-cell adhesion [GO:1903038]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; response to estradiol [GO:0032355]; response to growth hormone [GO:0060416]; response to mycotoxin [GO:0010046]; response to nutrient [GO:0007584]; response to xenobiotic stimulus [GO:0009410]; response to zinc ion [GO:0010043]; urea cycle [GO:0000050],cell body fiber [GO:0070852]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrial outer membrane [GO:0005741]; nucleoplasm [GO:0005654]; perikaryon [GO:0043204],amino acid binding [GO:0016597]; argininosuccinate synthase activity [GO:0004055]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; toxic substance binding [GO:0015643],PTM: Acetylated by CLOCK in a circadian manner which negatively regulates its enzyme activity. Deacetylated by histone deacetylases. {ECO:0000269|PubMed:28985504}.,,,"STRAND 5..10; /evidence=""ECO:0007829|PDB:2NZ2""; STRAND 29..39; /evidence=""ECO:0007829|PDB:2NZ2""; STRAND 57..63; /evidence=""ECO:0007829|PDB:2NZ2""; STRAND 112..115; /evidence=""ECO:0007829|PDB:2NZ2""; STRAND 140..142; /evidence=""ECO:0007829|PDB:2NZ2""; STRAND 181..183; /evidence=""ECO:0007829|PDB:2NZ2""; STRAND 188..190; /evidence=""ECO:0007829|PDB:2NZ2""; STRAND 221..228; /evidence=""ECO:0007829|PDB:2NZ2""; STRAND 231..237; /evidence=""ECO:0007829|PDB:2NZ2""; STRAND 265..271; /evidence=""ECO:0007829|PDB:2NZ2""; STRAND 277..283; /evidence=""ECO:0007829|PDB:2NZ2""; STRAND 326..328; /evidence=""ECO:0007829|PDB:2NZ2""; STRAND 347..354; /evidence=""ECO:0007829|PDB:2NZ2""; STRAND 357..364; /evidence=""ECO:0007829|PDB:2NZ2""","HELIX 15..26; /evidence=""ECO:0007829|PDB:2NZ2""; HELIX 44..54; /evidence=""ECO:0007829|PDB:2NZ2""; HELIX 65..71; /evidence=""ECO:0007829|PDB:2NZ2""; HELIX 73..78; /evidence=""ECO:0007829|PDB:2NZ2""; HELIX 94..109; /evidence=""ECO:0007829|PDB:2NZ2""; HELIX 124..135; /evidence=""ECO:0007829|PDB:2NZ2""; HELIX 144..146; /evidence=""ECO:0007829|PDB:2NZ2""; HELIX 148..151; /evidence=""ECO:0007829|PDB:2NZ2""; HELIX 158..166; /evidence=""ECO:0007829|PDB:2NZ2""; HELIX 193..196; /evidence=""ECO:0007829|PDB:2NZ2""; HELIX 204..206; /evidence=""ECO:0007829|PDB:2NZ2""; HELIX 247..261; /evidence=""ECO:0007829|PDB:2NZ2""; HELIX 285..301; /evidence=""ECO:0007829|PDB:2NZ2""; HELIX 304..323; /evidence=""ECO:0007829|PDB:2NZ2""; HELIX 329..341; /evidence=""ECO:0007829|PDB:2NZ2""; HELIX 372..375; /evidence=""ECO:0007829|PDB:2NZ2""; HELIX 385..404; /evidence=""ECO:0007829|PDB:2NZ2""","TURN 84..86; /evidence=""ECO:0007829|PDB:2NZ2""; TURN 90..93; /evidence=""ECO:0007829|PDB:2NZ2""; TURN 213..215; /evidence=""ECO:0007829|PDB:2NZ2""; TURN 238..240; /evidence=""ECO:0007829|PDB:2NZ2""; TURN 342..344; /evidence=""ECO:0007829|PDB:2NZ2""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,ASS1 ASS,Argininosuccinate synthase (EC 6.3.4.5) (Citrulline--aspartate ligase),Homo sapiens (Human),412.0,46530.0,MSSKGSVVLAYSGGLDTSCILVWLKEQGYDVIAYLANIGQKEDFEEARKKALKLGAKKVFIEDVSREFVEEFIWPAIQSSALYEDRYLLGTSLARPCIARKQVEIAQREGAKYVSHGATGKGNDQVRFELSCYSLAPQIKVIAPWRMPEFYNRFKGRNDLMEYAKQHGIPIPVTPKNPWSMDENLMHISYEAGILENPKNQAPPGLYTKTQDPAKAPNTPDILEIEFKKGVPVKVTNVKDGTTHQTSLELFMYLNEVAGKHGVGRIDIVENRFIGMKSRGIYETPAGTILYHAHLDIEAFTMDREVRKIKQGLGLKFAELVYTGFWHSPECEFVRHCIAKSQERVEGKVQVSVLKGQVYILGRESPLSLYNEELVSMNVQGDYEPTDATGFININSLRLKEYHRLQSKVTAK,True,False,False,P00966,"[('cd01999', 'Argininosuccinate_Synthase'), ('G3DSA:1.20.5.470', 'Single helix bin'), ('G3DSA:3.40.50.620', 'HUPs'), ('G3DSA:3.90.1260.10', 'Argininosuccinate synthetase, chain A, domain 2'), ('IPR001518', 'Argininosuccinate synthase'), ('IPR014729', 'Rossmann-like alpha/beta/alpha sandwich fold'), ('IPR018223', 'Argininosuccinate synthase, conserved site'), ('IPR023434', 'Argininosuccinate synthase, type 1 subfamily'), ('IPR024074', 'Argininosuccinate synthetase, catalytic/multimerisation domain body'), ('IPR048267', 'Arginosuccinate synthase-like, N-terminal domain'), ('IPR048268', 'Arginosuccinate synthase C-terminal domain'), ('MF_00005', 'Argininosuccinate synthase [argG]'), ('PF00764', 'Arginosuccinate synthase N-terminal HUP domain'), ('PF20979', 'Arginosuccinate synthase C-terminal domain'), ('PS00564', 'Argininosuccinate synthase signature 1'), ('PS00565', 'Argininosuccinate synthase signature 2'), ('PTHR11587', 'ARGININOSUCCINATE SYNTHASE'), ('SSF52402', 'Adenine nucleotide alpha hydrolases-like'), ('SSF69864', 'Argininosuccinate synthetase, C-terminal domain'), ('TIGR00032', 'argininosuccinate synthase')]",,"""ENSG00000130707; Group enriched (kidney, liver)."";","CATALYTIC ACTIVITY: Reaction=L-citrulline + L-aspartate + ATP = 2-(N(omega)-L-arginino)succinate + AMP + diphosphate + H(+); Xref=Rhea:RHEA:10932, ChEBI:CHEBI:15378, ChEBI:CHEBI:29991, ChEBI:CHEBI:30616, ChEBI:CHEBI:33019, ChEBI:CHEBI:57472, ChEBI:CHEBI:57743, ChEBI:CHEBI:456215; EC=6.3.4.5; Evidence={ECO:0000269|PubMed:18473344, ECO:0000269|PubMed:27287393, ECO:0000269|PubMed:8792870};",6.3.4.5,,"PATHWAY: Amino-acid biosynthesis; L-arginine biosynthesis; L-arginine from L-ornithine and carbamoyl phosphate: step 2/3. {ECO:0000305|PubMed:18473344, ECO:0000305|PubMed:27287393, ECO:0000305|PubMed:8792870}.; PATHWAY: Nitrogen metabolism; urea cycle; (N(omega)-L-arginino)succinate from L-aspartate and L-citrulline: step 1/1. {ECO:0000305|PubMed:18473344, ECO:0000305|PubMed:27287393, ECO:0000305|PubMed:8792870}.",ENST00000352480.10;ENST00000372393.7;ENST00000372394.5;,ASS1,ENSG00000130707,0.0,ASS1,Non-canonical_RBPs,5.0,,,,0.075,,ASS1
P01023,ENSG00000175899,A2MG_HUMAN,"acute inflammatory response to antigenic stimulus [GO:0002438]; acute-phase response [GO:0006953]; embryonic liver development [GO:1990402]; luteinization [GO:0001553]; negative regulation of complement activation, lectin pathway [GO:0001869]; negative regulation of peptidase activity [GO:0010466]; response to carbon dioxide [GO:0010037]; response to glucocorticoid [GO:0051384]; response to nutrient [GO:0007584]; response to prostaglandin E [GO:0034695]; stem cell differentiation [GO:0048863]",blood microparticle [GO:0072562]; collagen-containing extracellular matrix [GO:0062023]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; platelet alpha granule lumen [GO:0031093],brain-derived neurotrophic factor binding [GO:0048403]; calcium-dependent protein binding [GO:0048306]; endopeptidase inhibitor activity [GO:0004866]; enzyme binding [GO:0019899]; growth factor binding [GO:0019838]; identical protein binding [GO:0042802]; interleukin-1 binding [GO:0019966]; interleukin-8 binding [GO:0019959]; nerve growth factor binding [GO:0048406]; protease binding [GO:0002020]; serine-type endopeptidase inhibitor activity [GO:0004867]; signaling receptor binding [GO:0005102]; tumor necrosis factor binding [GO:0043120],,,,"STRAND 128..134; /evidence=""ECO:0007829|PDB:2P9R""; STRAND 136..138; /evidence=""ECO:0007829|PDB:2P9R""; STRAND 143..151; /evidence=""ECO:0007829|PDB:2P9R""; STRAND 161..168; /evidence=""ECO:0007829|PDB:2P9R""; STRAND 174..182; /evidence=""ECO:0007829|PDB:2P9R""; STRAND 187..193; /evidence=""ECO:0007829|PDB:2P9R""; STRAND 201..208; /evidence=""ECO:0007829|PDB:2P9R""; STRAND 214..221; /evidence=""ECO:0007829|PDB:2P9R""; STRAND 1341..1347; /evidence=""ECO:0007829|PDB:1BV8""; STRAND 1360..1369; /evidence=""ECO:0007829|PDB:1BV8""; STRAND 1379..1384; /evidence=""ECO:0007829|PDB:1BV8""; STRAND 1389..1391; /evidence=""ECO:0007829|PDB:1BV8""; STRAND 1407..1410; /evidence=""ECO:0007829|PDB:1BV8""; STRAND 1412..1419; /evidence=""ECO:0007829|PDB:1BV8""; STRAND 1427..1434; /evidence=""ECO:0007829|PDB:1BV8""; STRAND 1445..1450; /evidence=""ECO:0007829|PDB:1BV8""; STRAND 1454..1456; /evidence=""ECO:0007829|PDB:1BV8""; STRAND 1459..1463; /evidence=""ECO:0007829|PDB:1BV8""","HELIX 153..155; /evidence=""ECO:0007829|PDB:2P9R""; HELIX 1355..1359; /evidence=""ECO:0007829|PDB:1BV8""; HELIX 1393..1400; /evidence=""ECO:0007829|PDB:1BV8""","TURN 1401..1403; /evidence=""ECO:0007829|PDB:1BV8""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,A2M CPAMD5 FWP007,Alpha-2-macroglobulin (Alpha-2-M) (C3 and PZP-like alpha-2-macroglobulin domain-containing protein 5),Homo sapiens (Human),1474.0,163291.0,MGKNKLLHPSLVLLLLVLLPTDASVSGKPQYMVLVPSLLHTETTEKGCVLLSYLNETVTVSASLESVRGNRSLFTDLEAENDVLHCVAFAVPKSSSNEEVMFLTVQVKGPTQEFKKRTTVMVKNEDSLVFVQTDKSIYKPGQTVKFRVVSMDENFHPLNELIPLVYIQDPKGNRIAQWQSFQLEGGLKQFSFPLSSEPFQGSYKVVVQKKSGGRTEHPFTVEEFVLPKFEVQVTVPKIITILEEEMNVSVCGLYTYGKPVPGHVTVSICRKYSDASDCHGEDSQAFCEKFSGQLNSHGCFYQQVKTKVFQLKRKEYEMKLHTEAQIQEEGTVVELTGRQSSEITRTITKLSFVKVDSHFRQGIPFFGQVRLVDGKGVPIPNKVIFIRGNEANYYSNATTDEHGLVQFSINTTNVMGTSLTVRVNYKDRSPCYGYQWVSEEHEEAHHTAYLVFSPSKSFVHLEPMSHELPCGHTQTVQAHYILNGGTLLGLKKLSFYYLIMAKGGIVRTGTHGLLVKQEDMKGHFSISIPVKSDIAPVARLLIYAVLPTGDVIGDSAKYDVENCLANKVDLSFSPSQSLPASHAHLRVTAAPQSVCALRAVDQSVLLMKPDAELSASSVYNLLPEKDLTGFPGPLNDQDNEDCINRHNVYINGITYTPVSSTNEKDMYSFLEDMGLKAFTNSKIRKPKMCPQLQQYEMHGPEGLRVGFYESDVMGRGHARLVHVEEPHTETVRKYFPETWIWDLVVVNSAGVAEVGVTVPDTITEWKAGAFCLSEDAGLGISSTASLRAFQPFFVELTMPYSVIRGEAFTLKATVLNYLPKCIRVSVQLEASPAFLAVPVEKEQAPHCICANGRQTVSWAVTPKSLGNVNFTVSAEALESQELCGTEVPSVPEHGRKDTVIKPLLVEPEGLEKETTFNSLLCPSGGEVSEELSLKLPPNVVEESARASVSVLGDILGSAMQNTQNLLQMPYGCGEQNMVLFAPNIYVLDYLNETQQLTPEIKSKAIGYLNTGYQRQLNYKHYDGSYSTFGERYGRNQGNTWLTAFVLKTFAQARAYIFIDEAHITQALIWLSQRQKDNGCFRSSGSLLNNAIKGGVEDEVTLSAYITIALLEIPLTVTHPVVRNALFCLESAWKTAQEGDHGSHVYTKALLAYAFALAGNQDKRKEVLKSLNEEAVKKDNSVHWERPQKPKAPVGHFYEPQAPSAEVEMTSYVLLAYLTAQPAPTSEDLTSATNIVKWITKQQNAQGGFSSTQDTVVALHALSKYGAATFTRTGKAAQVTIQSSGTFSSKFQVDNNNRLLLQQVSLPELPGEYSMKVTGEGCVYLQTSLKYNILPEKEEFPFALGVQTLPQTCDEPKAHTSFQISLSVSYTGSRSASNMAIVDVKMVSGFIPLKPTVKMLERSNHVSRTEVSSNHVLIYLDKVSNQTLSLFFTVLQDVPVRDLKPAIVKVYDYYETDEFAIAEYNAPCSKDLGNA,False,False,True,P01023,"[('cd02897', 'A2M_2'), ('G3DSA:1.50.10.20', None), ('G3DSA:2.20.130.20', None), ('G3DSA:2.60.120.1540', None), ('G3DSA:2.60.40.10', 'Immunoglobulins'), ('G3DSA:2.60.40.1930', None), ('G3DSA:2.60.40.1940', None), ('G3DSA:2.60.40.690', 'Alpha-macroglobulin, receptor-binding domain'), ('IPR001599', 'Alpha-2-macroglobulin'), ('IPR002890', 'Macroglobulin domain'), ('IPR008930', 'Terpenoid cyclases/protein prenyltransferase alpha-alpha toroid'), ('IPR009048', 'Alpha-macroglobulin, receptor-binding'), ('IPR010916', 'TonB box, conserved site'), ('IPR011625', 'Alpha-2-macroglobulin, bait region domain'), ('IPR011626', 'Alpha-macroglobulin-like, TED domain'), ('IPR013783', 'Immunoglobulin-like fold'), ('IPR014756', 'Immunoglobulin E-set'), ('IPR019742', 'Alpha-2-macroglobulin, conserved site'), ('IPR036595', 'Alpha-macroglobulin, receptor-binding domain superfamily'), ('IPR040839', 'Macroglobulin domain MG4')]",,"""ENSG00000175899; Tissue enhanced (liver, lung)."";",,,,,ENST00000318602.12;,A2M,ENSG00000175899,0.0,,,,3.12,DP02649,0.031,0.048,,A2M
P01033,ENSG00000102265,TIMP1_HUMAN,cartilage development [GO:0051216]; cellular response to peptide [GO:1901653]; cellular response to UV-A [GO:0071492]; connective tissue replacement involved in inflammatory response wound healing [GO:0002248]; negative regulation of apoptotic process [GO:0043066]; negative regulation of catalytic activity [GO:0043086]; negative regulation of endopeptidase activity [GO:0010951]; negative regulation of membrane protein ectodomain proteolysis [GO:0051045]; negative regulation of metallopeptidase activity [GO:1905049]; negative regulation of trophoblast cell migration [GO:1901164]; positive regulation of cell population proliferation [GO:0008284]; regulation of integrin-mediated signaling pathway [GO:2001044]; response to cytokine [GO:0034097]; response to hormone [GO:0009725]; response to peptide hormone [GO:0043434],basement membrane [GO:0005604]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; platelet alpha granule lumen [GO:0031093],cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; metalloendopeptidase inhibitor activity [GO:0008191]; peptidase inhibitor activity [GO:0030414]; protease binding [GO:0002020]; zinc ion binding [GO:0008270],"PTM: The activity of TIMP1 is dependent on the presence of disulfide bonds. {ECO:0000269|PubMed:10623524, ECO:0000269|PubMed:20545310, ECO:0000269|PubMed:2163605, ECO:0000269|PubMed:22427646, ECO:0000269|PubMed:3010309}.; PTM: N-glycosylated. {ECO:0000269|PubMed:16263699, ECO:0000269|PubMed:16335952, ECO:0000269|PubMed:16740002, ECO:0000269|PubMed:19139490, ECO:0000269|PubMed:3010309, ECO:0000269|PubMed:3839290, ECO:0000269|PubMed:3903517}.",,"DOMAIN 24..147; /note=""NTR""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00295""","STRAND 25..27; /evidence=""ECO:0007829|PDB:7S7L""; STRAND 39..46; /evidence=""ECO:0007829|PDB:3V96""; STRAND 57..70; /evidence=""ECO:0007829|PDB:3V96""; STRAND 83..89; /evidence=""ECO:0007829|PDB:3V96""; STRAND 105..113; /evidence=""ECO:0007829|PDB:3V96""; STRAND 116..118; /evidence=""ECO:0007829|PDB:3V96""; STRAND 121..123; /evidence=""ECO:0007829|PDB:7S7L""; STRAND 125..127; /evidence=""ECO:0007829|PDB:3V96""; STRAND 151..154; /evidence=""ECO:0007829|PDB:3V96""; STRAND 157..159; /evidence=""ECO:0007829|PDB:3V96""; STRAND 167..170; /evidence=""ECO:0007829|PDB:3V96""; STRAND 177..181; /evidence=""ECO:0007829|PDB:3V96""; STRAND 188..193; /evidence=""ECO:0007829|PDB:3V96""; STRAND 196..200; /evidence=""ECO:0007829|PDB:3V96""","HELIX 31..37; /evidence=""ECO:0007829|PDB:3V96""; HELIX 72..74; /evidence=""ECO:0007829|PDB:7S7L""; HELIX 90..92; /evidence=""ECO:0007829|PDB:3V96""; HELIX 128..130; /evidence=""ECO:0007829|PDB:3V96""; HELIX 133..140; /evidence=""ECO:0007829|PDB:3V96""; HELIX 143..145; /evidence=""ECO:0007829|PDB:3V96""; HELIX 172..176; /evidence=""ECO:0007829|PDB:3V96""; HELIX 182..186; /evidence=""ECO:0007829|PDB:3V96""","TURN 54..56; /evidence=""ECO:0007829|PDB:6MAV""; TURN 77..79; /evidence=""ECO:0007829|PDB:1UEA""; TURN 146..149; /evidence=""ECO:0007829|PDB:3V96""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,TIMP1 CLGI TIMP,Metalloproteinase inhibitor 1 (Erythroid-potentiating activity) (EPA) (Fibroblast collagenase inhibitor) (Collagenase inhibitor) (Tissue inhibitor of metalloproteinases 1) (TIMP-1),Homo sapiens (Human),207.0,23171.0,MAPFEPLASGILLLLWLIAPSRACTCVPPHPQTAFCNSDLVIRAKFVGTPEVNQTTLYQRYEIKMTKMYKGFQALGDAADIRFVYTPAMESVCGYFHRSHNRSEEFLIAGKLQDGLLHITTCSFVAPWNSLSLAQRRGFTKTYTVGCEECTVFPCLSIPCKLQSGTHCLWTDQLLQGSEKGFQSRHLACLPREPGLCTWQSLRSQIA,True,False,False,P01033,"[('cd03585', 'NTR_TIMP'), ('G3DSA:2.40.50.120', None), ('G3DSA:3.90.370.10', 'Tissue inhibitor of metalloproteinase-1. Chain B, domain 1'), ('IPR001134', 'Netrin domain'), ('IPR001820', 'Protease inhibitor I35 (TIMP)'), ('IPR008993', 'Tissue inhibitor of metalloproteinases-like, OB-fold'), ('IPR027465', 'Proteinase inhibitor I35b (TIMP), C-terminal'), ('IPR030490', 'Tissue inhibitor of metalloproteinase, conserved site'), ('PF00965', 'Tissue inhibitor of metalloproteinase'), ('PS00288', 'Tissue inhibitors of metalloproteinases signature'), ('PS50189', 'NTR domain profile'), ('PTHR11844', 'METALLOPROTEASE INHIBITOR'), ('SM00206', 'Tissue inhibitor of metalloproteinase family.'), ('SSF50242', 'TIMP-like')]",,"""ENSG00000102265; Tissue enhanced (urinary)."";",,,,,ENST00000218388.9;,TIMP1,ENSG00000102265,0.0,,,,,,,0.092,,TIMP1
P01583,ENSG00000115008,IL1A_HUMAN,apoptotic process [GO:0006915]; cellular response to heat [GO:0034605]; cellular response to lipopolysaccharide [GO:0071222]; connective tissue replacement involved in inflammatory response wound healing [GO:0002248]; cytokine-mediated signaling pathway [GO:0019221]; ectopic germ cell programmed cell death [GO:0035234]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; fever generation [GO:0001660]; heart development [GO:0007507]; immune response [GO:0006955]; inflammatory response [GO:0006954]; intracellular sodium ion homeostasis [GO:0006883]; keratinization [GO:0031424]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of establishment of Sertoli cell barrier [GO:1904445]; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001240]; positive regulation of angiogenesis [GO:0045766]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of cell division [GO:0051781]; positive regulation of cytokine production [GO:0001819]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of immature T cell proliferation in thymus [GO:0033092]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of JNK cascade [GO:0046330]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of neutrophil migration [GO:1902624]; positive regulation of prostaglandin secretion [GO:0032308]; positive regulation of protein secretion [GO:0050714]; positive regulation of steroid biosynthetic process [GO:0010893]; positive regulation of stress-activated MAPK cascade [GO:0032874]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of vascular endothelial growth factor production [GO:0010575]; regulation of actin cytoskeleton organization [GO:0032956]; response to copper ion [GO:0046688]; response to gamma radiation [GO:0010332]; response to hypoxia [GO:0001666]; response to L-ascorbic acid [GO:0033591]; response to ozone [GO:0010193]; spermatogenesis [GO:0007283],cell surface [GO:0009986]; cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nucleus [GO:0005634],copper ion binding [GO:0005507]; cytokine activity [GO:0005125]; interleukin-1 receptor binding [GO:0005149],"PTM: Acetylated within its nuclear localization sequence, which impacts subcellular localization. {ECO:0000269|PubMed:26439902}.; PTM: Proteolytic processed by CAPN1 in a calcium-dependent manner. Cleavage from 31 kDa precursor to 18 kDa biologically active molecules. {ECO:0000269|PubMed:2115174}.; PTM: Phosphorylated. Phosphorylation greatly enhances susceptibility to digestion and promotes the conversion of pre-IL1A alpha to the biologically active IL1A. {ECO:0000269|PubMed:3258335}.",DOMAIN: The similarity among the IL-1 precursors suggests that the amino ends of these proteins serve some as yet undefined function.,,"STRAND 123..138; /evidence=""ECO:0007829|PDB:5UC6""; STRAND 143..146; /evidence=""ECO:0007829|PDB:5UC6""; STRAND 148..150; /evidence=""ECO:0007829|PDB:5UC6""; STRAND 152..155; /evidence=""ECO:0007829|PDB:5UC6""; STRAND 166..175; /evidence=""ECO:0007829|PDB:5UC6""; STRAND 176..178; /evidence=""ECO:0007829|PDB:2KKI""; STRAND 181..186; /evidence=""ECO:0007829|PDB:5UC6""; STRAND 189..194; /evidence=""ECO:0007829|PDB:5UC6""; STRAND 198..200; /evidence=""ECO:0007829|PDB:2KKI""; STRAND 203..206; /evidence=""ECO:0007829|PDB:5UC6""; STRAND 212..215; /evidence=""ECO:0007829|PDB:5UC6""; STRAND 223..228; /evidence=""ECO:0007829|PDB:5UC6""; STRAND 231..239; /evidence=""ECO:0007829|PDB:5UC6""; STRAND 243..246; /evidence=""ECO:0007829|PDB:5UC6""; STRAND 248..251; /evidence=""ECO:0007829|PDB:2KKI""; STRAND 253..257; /evidence=""ECO:0007829|PDB:5UC6""; STRAND 259..261; /evidence=""ECO:0007829|PDB:2KKI""; STRAND 264..267; /evidence=""ECO:0007829|PDB:5UC6""","HELIX 160..162; /evidence=""ECO:0007829|PDB:5UC6""; HELIX 216..221; /evidence=""ECO:0007829|PDB:5UC6""",,"cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,IL1A IL1F1,Interleukin-1 alpha (IL-1 alpha) (Hematopoietin-1),Homo sapiens (Human),271.0,30607.0,MAKVPDMFEDLKNCYSENEEDSSSIDHLSLNQKSFYHVSYGPLHEGCMDQSVSLSISETSKTSKLTFKESMVVVATNGKVLKKRRLSLSQSITDDDLEAIANDSEEEIIKPRSAPFSFLSNVKYNFMRIIKYEFILNDALNQSIIRANDQYLTAAALHNLDEAVKFDMGAYKSSKDDAKITVILRISKTQLYVTAQDEDQPVLLKEMPEIPKTITGSETNLLFFWETHGTKNYFTSVAHPNLFIATKQDYWVCLAGGPPSITDFQILENQA,False,True,False,P01583,"[('cd00100', 'IL1'), ('G3DSA:2.80.10.50', None), ('IPR000975', 'Interleukin-1 family'), ('IPR003295', 'Interleukin-1 alpha'), ('IPR003502', 'Interleukin-1 propeptide'), ('IPR008996', 'Cytokine IL1/FGF'), ('IPR020877', 'Interleukin-1 conserved site'), ('PF00340', 'Interleukin-1 / 18'), ('PF02394', 'Interleukin-1 propeptide'), ('PR00264', 'INTERLEUKIN1'), ('PR01357', 'INTRLEUKN1AB'), ('PR01358', 'INTRLEUKIN1A'), ('PS00253', 'Interleukin-1 signature'), ('PTHR10078', 'INTERLEUKIN-1 FAMILY MEMBER'), ('SM00125', 'Interleukin-1 homologues'), ('SSF50353', 'Cytokine')]",,"""ENSG00000115008; Tissue enhanced (esophagus, testis, urinary bladder)."";",,,,,ENST00000263339.4;,IL1A,ENSG00000115008,0.0,,,,,,,0.432,,IL1A
P02489,ENSG00000160202,CRYAA_HUMAN,lens development in camera-type eye [GO:0002088]; negative regulation of apoptotic process [GO:0043066]; negative regulation of intracellular transport [GO:0032387]; protein refolding [GO:0042026]; protein stabilization [GO:0050821]; response to heat [GO:0009408]; visual perception [GO:0007601],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991],identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; structural constituent of eye lens [GO:0005212]; structural molecule activity [GO:0005198]; unfolded protein binding [GO:0051082],"PTM: O-glycosylated; contains N-acetylglucosamine side chains.; PTM: Deamidation of Asn-101 in lens occurs mostly during the first 30 years of age, followed by a small additional amount of deamidation (approximately 5%) during the next approximately 38 years, resulting in a maximum of approximately 50% deamidation during the lifetime of the individual. {ECO:0000269|PubMed:18754677, ECO:0000269|PubMed:8175657, ECO:0000269|PubMed:9068373, ECO:0000269|PubMed:9543632, ECO:0000269|PubMed:9655350}.; PTM: Phosphorylation on Ser-122 seems to be developmentally regulated. Absent in the first months of life, it appears during the first 12 years of human lifetime. The relative amount of phosphorylated form versus unphosphorylated form does not change over the lifetime of the individual. {ECO:0000269|PubMed:10930324, ECO:0000269|PubMed:8175657, ECO:0000269|PubMed:8759518, ECO:0000269|PubMed:9068373, ECO:0000269|PubMed:9655350}.; PTM: Acetylation at Lys-70 may increase chaperone activity. {ECO:0000269|PubMed:22120592, ECO:0000269|PubMed:817940, ECO:0000269|PubMed:9655350}.; PTM: Undergoes age-dependent proteolytical cleavage at the C-terminus. Alpha-crystallin A(1-172) is the most predominant form produced most rapidly during the first 12 years of age and after this age is present in approximately 50% of the lens molecules. {ECO:0000269|PubMed:10930324, ECO:0000269|PubMed:12356833, ECO:0000269|PubMed:8175657, ECO:0000269|PubMed:9068373, ECO:0000269|PubMed:9655350}.; PTM: In young individuals and during the first approximately 30 years of life, less than half molecules contain an intramolecular disulfide bond (oxidized form), while in the remaining fraction the cysteines are in the free sulfhydryl form (reduced form). With aging, the amount of oxidized form increases up to 90% and it becomes a major constituent of high molecular weight aggregates, concomitant with an age-dependent loss of its chaperone activity. The reduced form is undetectable in cataractous lenses. {ECO:0000305|PubMed:31792453}.",,"DOMAIN 52..164; /note=""sHSP""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00285""",,,,"cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,CRYAA CRYA1 HSPB4,Alpha-crystallin A chain (Heat shock protein beta-4) (HspB4) (Heat shock protein family B member 4) [Cleaved into: Alpha-crystallin A(1-172); Alpha-crystallin A(1-168); Alpha-crystallin A(1-162)],Homo sapiens (Human),173.0,19909.0,MDVTIQHPWFKRTLGPFYPSRLFDQFFGEGLFEYDLLPFLSSTISPYYRQSLFRTVLDSGISEVRSDRDKFVIFLDVKHFSPEDLTVKVQDDFVEIHGKHNERQDDHGYISREFHRRYRLPSNVDQSALSCSLSADGMLTFCGPKIQTGLDATHAERAIPVSREEKPTSAPSS,True,False,True,P02489,"[('cd06497', 'ACD_alphaA-crystallin_HspB4'), ('G3DSA:2.60.40.790', None), ('IPR001436', 'Alpha crystallin/Small heat shock protein, animal type'), ('IPR002068', 'Alpha crystallin/Hsp20 domain'), ('IPR003090', 'Alpha-crystallin, N-terminal'), ('IPR008978', 'HSP20-like chaperone'), ('IPR055269', 'Alpha crystallin/Heat shock protein Hsp-16.1/Hsp-16.2'), ('PF00011', 'Hsp20/alpha crystallin family'), ('PF00525', 'Alpha crystallin A chain, N terminal'), ('PIRSF036514', 'Small heat shock protein, beta-1 type'), ('PR00299', 'ACRYSTALLIN'), ('PS01031', 'Small heat shock protein (sHSP) domain profile'), ('PTHR45640', 'HEAT SHOCK PROTEIN HSP-12.2-RELATED'), ('SSF49764', 'HSP20-like chaperones')]",,"""ENSG00000160202; Group enriched (kidney, retina)."";",,,,,ENST00000291554.6;,CRYAA,ENSG00000160202,0.0,,,,,,,0.272,,CRYAA
P02511,ENSG00000109846,CRYAB_HUMAN,apoptotic process involved in morphogenesis [GO:0060561]; cellular response to gamma radiation [GO:0071480]; lens development in camera-type eye [GO:0002088]; microtubule polymerization or depolymerization [GO:0031109]; muscle contraction [GO:0006936]; muscle organ development [GO:0007517]; negative regulation of amyloid fibril formation [GO:1905907]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell growth [GO:0030308]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of gene expression [GO:0010629]; negative regulation of intracellular transport [GO:0032387]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; protein folding [GO:0006457]; protein refolding [GO:0042026]; protein stabilization [GO:0050821]; regulation of programmed cell death [GO:0043067]; response to estradiol [GO:0032355]; response to heat [GO:0009408]; response to hydrogen peroxide [GO:0042542]; response to hypoxia [GO:0001666]; stress-activated MAPK cascade [GO:0051403]; tubulin complex assembly [GO:0007021],actin filament bundle [GO:0032432]; axon [GO:0030424]; cardiac myofibril [GO:0097512]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; extracellular exosome [GO:0070062]; lysosome [GO:0005764]; M band [GO:0031430]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; protein-containing complex [GO:0032991]; synaptic membrane [GO:0097060]; Z disc [GO:0030018],amyloid-beta binding [GO:0001540]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; microtubule binding [GO:0008017]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; structural constituent of eye lens [GO:0005212]; structural molecule activity [GO:0005198]; unfolded protein binding [GO:0051082],,,"DOMAIN 56..164; /note=""sHSP""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00285""","STRAND 68..70; /evidence=""ECO:0007829|PDB:4M5S""; STRAND 72..80; /evidence=""ECO:0007829|PDB:4M5S""; STRAND 82..84; /evidence=""ECO:0007829|PDB:2N0K""; STRAND 89..94; /evidence=""ECO:0007829|PDB:4M5S""; STRAND 97..109; /evidence=""ECO:0007829|PDB:4M5S""; STRAND 112..123; /evidence=""ECO:0007829|PDB:4M5S""; STRAND 134..137; /evidence=""ECO:0007829|PDB:4M5S""; STRAND 141..148; /evidence=""ECO:0007829|PDB:4M5S""; STRAND 157..159; /evidence=""ECO:0007829|PDB:4M5T""; STRAND 161..163; /evidence=""ECO:0007829|PDB:4M5T""","HELIX 86..88; /evidence=""ECO:0007829|PDB:4M5S""; HELIX 130..132; /evidence=""ECO:0007829|PDB:4M5S""","TURN 125..127; /evidence=""ECO:0007829|PDB:2KLR""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,CRYAB CRYA2 HSPB5,Alpha-crystallin B chain (Alpha(B)-crystallin) (Heat shock protein beta-5) (HspB5) (Heat shock protein family B member 5) (Renal carcinoma antigen NY-REN-27) (Rosenthal fiber component),Homo sapiens (Human),175.0,20159.0,MDIAIHHPWIRRPFFPFHSPSRLFDQFFGEHLLESDLFPTSTSLSPFYLRPPSFLRAPSWFDTGLSEMRLEKDRFSVNLDVKHFSPEELKVKVLGDVIEVHGKHEERQDEHGFISREFHRKYRIPADVDPLTITSSLSSDGVLTVNGPRKQVSGPERTIPITREEKPAVTAAPKK,True,False,True,P02511,"[('cd06498', 'ACD_alphaB-crystallin_HspB5'), ('G3DSA:2.60.40.790', None), ('IPR001436', 'Alpha crystallin/Small heat shock protein, animal type'), ('IPR002068', 'Alpha crystallin/Hsp20 domain'), ('IPR003090', 'Alpha-crystallin, N-terminal'), ('IPR008978', 'HSP20-like chaperone'), ('IPR037882', 'Alpha-crystallin B chain, ACD domain'), ('IPR055269', 'Alpha crystallin/Heat shock protein Hsp-16.1/Hsp-16.2'), ('PF00011', 'Hsp20/alpha crystallin family'), ('PF00525', 'Alpha crystallin A chain, N terminal'), ('PIRSF036514', 'Small heat shock protein, beta-1 type'), ('PR00299', 'ACRYSTALLIN'), ('PS01031', 'Small heat shock protein (sHSP) domain profile'), ('PTHR45640', 'HEAT SHOCK PROTEIN HSP-12.2-RELATED'), ('SSF49764', 'HSP20-like chaperones')]",,"""ENSG00000109846; Tissue enhanced (heart muscle, skeletal muscle, tongue)."";",,,,,ENST00000227251.7;ENST00000526180.6;ENST00000527899.6;ENST00000527950.5;ENST00000531198.5;ENST00000533475.6;ENST00000533879.2;ENST00000616970.5;ENST00000650687.2;ENST00000651164.1;,CRYAB,ENSG00000109846,0.0,,,,14.29,DP00445,0.057,0.349,0.171,CRYAB
P02649,ENSG00000130203,APOE_HUMAN,"acylglycerol homeostasis [GO:0055090]; AMPA glutamate receptor clustering [GO:0097113]; amyloid precursor protein metabolic process [GO:0042982]; artery morphogenesis [GO:0048844]; cellular response to lipoprotein particle stimulus [GO:0071402]; cholesterol catabolic process [GO:0006707]; cholesterol efflux [GO:0033344]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; chylomicron remnant clearance [GO:0034382]; cytoskeleton organization [GO:0007010]; fatty acid homeostasis [GO:0055089]; G protein-coupled receptor signaling pathway [GO:0007186]; gene expression [GO:0010467]; high-density lipoprotein particle assembly [GO:0034380]; high-density lipoprotein particle clearance [GO:0034384]; high-density lipoprotein particle remodeling [GO:0034375]; intermediate-density lipoprotein particle clearance [GO:0071831]; intracellular calcium ion homeostasis [GO:0006874]; intracellular transport [GO:0046907]; lipid transport involved in lipid storage [GO:0010877]; lipoprotein biosynthetic process [GO:0042158]; lipoprotein catabolic process [GO:0042159]; locomotory exploration behavior [GO:0035641]; long-chain fatty acid transport [GO:0015909]; long-term memory [GO:0007616]; low-density lipoprotein particle remodeling [GO:0034374]; maintenance of location in cell [GO:0051651]; melanosome organization [GO:0032438]; negative regulation of amyloid fibril formation [GO:1905907]; negative regulation of amyloid-beta formation [GO:1902430]; negative regulation of blood coagulation [GO:0030195]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cholesterol biosynthetic process [GO:0045541]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of gene expression [GO:0010629]; negative regulation of inflammatory response [GO:0050728]; negative regulation of long-term synaptic potentiation [GO:1900272]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of neuron projection development [GO:0010977]; negative regulation of platelet activation [GO:0010544]; negative regulation of protein metabolic process [GO:0051248]; negative regulation of protein secretion [GO:0050709]; negative regulation of smooth muscle cell proliferation [GO:0048662]; negative regulation of triglyceride metabolic process [GO:0090209]; neuron projection development [GO:0031175]; nitric oxide-cGMP-mediated signaling [GO:0038060]; NMDA glutamate receptor clustering [GO:0097114]; phospholipid efflux [GO:0033700]; positive regulation by host of viral process [GO:0044794]; positive regulation of amyloid fibril formation [GO:1905908]; positive regulation of amyloid-beta clearance [GO:1900223]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of cholesterol metabolic process [GO:0090205]; positive regulation of CoA-transferase activity [GO:1905920]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of dendritic spine maintenance [GO:1902952]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endocytosis [GO:0045807]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of lipid biosynthetic process [GO:0046889]; positive regulation of lipid transport across blood-brain barrier [GO:1903002]; positive regulation of lipoprotein transport [GO:0140077]; positive regulation of low-density lipoprotein particle receptor catabolic process [GO:0032805]; positive regulation of membrane protein ectodomain proteolysis [GO:0051044]; positive regulation of neuron projection development [GO:0010976]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of phospholipid efflux [GO:1902995]; protein import [GO:0017038]; receptor-mediated endocytosis [GO:0006898]; regulation of amyloid fibril formation [GO:1905906]; regulation of amyloid precursor protein catabolic process [GO:1902991]; regulation of amyloid-beta clearance [GO:1900221]; regulation of apoptotic process [GO:0042981]; regulation of axon extension [GO:0030516]; regulation of behavioral fear response [GO:2000822]; regulation of Cdc42 protein signal transduction [GO:0032489]; regulation of cellular response to very-low-density lipoprotein particle stimulus [GO:1905890]; regulation of cholesterol metabolic process [GO:0090181]; regulation of innate immune response [GO:0045088]; regulation of neuronal synaptic plasticity [GO:0048168]; regulation of proteasomal protein catabolic process [GO:0061136]; regulation of protein metabolic process [GO:0051246]; regulation of protein-containing complex assembly [GO:0043254]; response to caloric restriction [GO:0061771]; response to dietary excess [GO:0002021]; response to reactive oxygen species [GO:0000302]; reverse cholesterol transport [GO:0043691]; synaptic transmission, cholinergic [GO:0007271]; triglyceride homeostasis [GO:0070328]; triglyceride metabolic process [GO:0006641]; triglyceride-rich lipoprotein particle clearance [GO:0071830]; vasodilation [GO:0042311]; very-low-density lipoprotein particle clearance [GO:0034447]; very-low-density lipoprotein particle remodeling [GO:0034372]; virion assembly [GO:0019068]","blood microparticle [GO:0072562]; chylomicron [GO:0042627]; chylomicron remnant [GO:0034360]; clathrin-coated endocytic vesicle membrane [GO:0030669]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; dendrite [GO:0030425]; discoidal high-density lipoprotein particle [GO:0034365]; early endosome [GO:0005769]; endocytic vesicle lumen [GO:0071682]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; extracellular vesicle [GO:1903561]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; high-density lipoprotein particle [GO:0034364]; intermediate-density lipoprotein particle [GO:0034363]; lipoprotein particle [GO:1990777]; low-density lipoprotein particle [GO:0034362]; melanosome [GO:0042470]; membrane [GO:0016020]; multivesicular body, internal vesicle [GO:0097487]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; synaptic cleft [GO:0043083]; very-low-density lipoprotein particle [GO:0034361]",amyloid-beta binding [GO:0001540]; antioxidant activity [GO:0016209]; cholesterol transfer activity [GO:0120020]; enzyme binding [GO:0019899]; heparan sulfate proteoglycan binding [GO:0043395]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; lipid binding [GO:0008289]; lipid transporter activity [GO:0005319]; lipoprotein particle binding [GO:0071813]; low-density lipoprotein particle receptor binding [GO:0050750]; metal chelating activity [GO:0046911]; phosphatidylcholine-sterol O-acyltransferase activator activity [GO:0060228]; phospholipid binding [GO:0005543]; protein dimerization activity [GO:0046983]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; receptor ligand activity [GO:0048018]; signaling receptor binding [GO:0005102]; structural molecule activity [GO:0005198]; tau protein binding [GO:0048156]; very-low-density lipoprotein particle receptor binding [GO:0070326],"PTM: APOE exists as multiple glycosylated and sialylated glycoforms within cells and in plasma (PubMed:29516132). The extent of glycosylation and sialylation are tissue and context specific (PubMed:29516132). Plasma APOE undergoes desialylation and is less glycosylated and sialylated than the cellular form (PubMed:19838169, PubMed:20511397, PubMed:23234360, PubMed:2498325). Glycosylation is not required for proper expression and secretion (PubMed:2498325). O-glycosylated with core 1 or possibly core 8 glycans. Thr-307 and Ser-314 are minor glycosylation sites compared to Ser-308 (PubMed:19838169, PubMed:23234360). {ECO:0000269|PubMed:19838169, ECO:0000269|PubMed:20511397, ECO:0000269|PubMed:23234360, ECO:0000269|PubMed:2498325, ECO:0000303|PubMed:29516132}.; PTM: Glycated in plasma VLDL of normal subjects, and of hyperglycemic diabetic patients at a higher level (2-3 fold). {ECO:0000269|PubMed:10452964}.; PTM: Phosphorylated by FAM20C in the extracellular medium. {ECO:0000269|PubMed:26091039}.; PTM: Undergoes C-terminal proteolytic processing in neurons. C-terminally truncated APOE has a tendency to form neurotoxic intracellular neurofibrillary tangle-like inclusions in neurons. {ECO:0000269|PubMed:11447277}.",,,"STRAND 22..24; /evidence=""ECO:0007829|PDB:2KC3""; STRAND 103..105; /evidence=""ECO:0007829|PDB:7UVJ""; STRAND 200..202; /evidence=""ECO:0007829|PDB:2L7B""; STRAND 307..309; /evidence=""ECO:0007829|PDB:2L7B""","HELIX 31..39; /evidence=""ECO:0007829|PDB:2KC3""; HELIX 43..60; /evidence=""ECO:0007829|PDB:7FCR""; HELIX 63..70; /evidence=""ECO:0007829|PDB:7FCR""; HELIX 73..96; /evidence=""ECO:0007829|PDB:7FCR""; HELIX 97..99; /evidence=""ECO:0007829|PDB:7FCR""; HELIX 107..142; /evidence=""ECO:0007829|PDB:7FCR""; HELIX 149..180; /evidence=""ECO:0007829|PDB:7FCR""; HELIX 193..198; /evidence=""ECO:0007829|PDB:2KC3""; HELIX 209..217; /evidence=""ECO:0007829|PDB:2L7B""; HELIX 228..241; /evidence=""ECO:0007829|PDB:2L7B""; HELIX 257..283; /evidence=""ECO:0007829|PDB:2L7B""; HELIX 286..303; /evidence=""ECO:0007829|PDB:1OEF""","TURN 40..42; /evidence=""ECO:0007829|PDB:2KC3""; TURN 143..145; /evidence=""ECO:0007829|PDB:7FCR""; TURN 187..190; /evidence=""ECO:0007829|PDB:2KC3""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,APOE,Apolipoprotein E (Apo-E),Homo sapiens (Human),317.0,36154.0,MKVLWAALLVTFLAGCQAKVEQAVETEPEPELRQQTEWQSGQRWELALGRFWDYLRWVQTLSEQVQEELLSSQVTQELRALMDETMKELKAYKSELEEQLTPVAEETRARLSKELQAAQARLGADMEDVCGRLVQYRGEVQAMLGQSTEELRVRLASHLRKLRKRLLRDADDLQKRLAVYQAGAREGAERGLSAIRERLGPLVEQGRVRAATVGSLAGQPLQERAQAWGERLRARMEEMGSRTRDRLDEVKEQVAEVRAKLEEQAQQIRLQAEAFQARLKSWFEPLVEDMQRQWAGLVEKVQAAVGTSAAPVPSDNH,False,False,True,P02649,"[('G3DSA:1.20.120.20', 'Apolipoprotein'), ('IPR000074', 'Apolipoprotein A/E'), ('IPR050163', 'Apolipoprotein A1/A4/E'), ('PF01442', 'Apolipoprotein A1/A4/E domain'), ('PS51257', 'Prokaryotic membrane lipoprotein lipid attachment site profile'), ('PTHR18976', 'Apolipoprotein A1/A4/E'), ('SSF58113', 'Apolipoprotein A-I')]",,"""ENSG00000130203; Group enriched (adrenal gland, brain, liver)."";",,,,,ENST00000252486.9;,APOE,ENSG00000130203,0.0,,,,29.34,DP04133,0.293,0.375,,APOE
P02730,ENSG00000004939,B3AT_HUMAN,bicarbonate transport [GO:0015701]; blood coagulation [GO:0007596]; chloride transmembrane transport [GO:1902476]; chloride transport [GO:0006821]; erythrocyte development [GO:0048821]; intracellular monoatomic ion homeostasis [GO:0006873]; monoatomic anion transport [GO:0006820]; negative regulation of glycolytic process through fructose-6-phosphate [GO:1904539]; negative regulation of urine volume [GO:0035811]; pH elevation [GO:0045852]; plasma membrane phospholipid scrambling [GO:0017121]; protein localization to plasma membrane [GO:0072659]; regulation of intracellular pH [GO:0051453]; transmembrane transport [GO:0055085],ankyrin-1 complex [GO:0170014]; basolateral plasma membrane [GO:0016323]; blood microparticle [GO:0072562]; cortical cytoskeleton [GO:0030863]; cytoplasmic side of plasma membrane [GO:0009898]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; plasma membrane [GO:0005886]; Z disc [GO:0030018],ankyrin binding [GO:0030506]; bicarbonate transmembrane transporter activity [GO:0015106]; chloride transmembrane transporter activity [GO:0015108]; chloride:bicarbonate antiporter activity [GO:0140900]; hemoglobin binding [GO:0030492]; monoatomic anion transmembrane transporter activity [GO:0008509]; protein homodimerization activity [GO:0042803]; protein-membrane adaptor activity [GO:0043495]; solute:inorganic anion antiporter activity [GO:0005452],"PTM: Phosphorylated on Tyr-8 and Tyr-21 most likely by SYK. PP1-resistant phosphorylation that precedes Tyr-359 and Tyr-904 phosphorylation. {ECO:0000269|PubMed:10942405, ECO:0000269|PubMed:1998697}.; PTM: Phosphorylated on Tyr-359 and Tyr-904 most likely by LYN. PP1-inhibited phosphorylation that follows Tyr-8 and Tyr-21 phosphorylation. {ECO:0000269|PubMed:10942405, ECO:0000269|PubMed:1998697}.; PTM: N-glycosylated. {ECO:0000269|PubMed:26542571}.",,,"STRAND 58..66; /evidence=""ECO:0007829|PDB:4KY9""; STRAND 68..70; /evidence=""ECO:0007829|PDB:4KY9""; STRAND 73..88; /evidence=""ECO:0007829|PDB:4KY9""; STRAND 90..92; /evidence=""ECO:0007829|PDB:4KY9""; STRAND 118..123; /evidence=""ECO:0007829|PDB:4KY9""; STRAND 173..175; /evidence=""ECO:0007829|PDB:7UZV""; STRAND 180..185; /evidence=""ECO:0007829|PDB:7UZV""; STRAND 188..190; /evidence=""ECO:0007829|PDB:4KY9""; STRAND 226..234; /evidence=""ECO:0007829|PDB:4KY9""; STRAND 241..251; /evidence=""ECO:0007829|PDB:4KY9""; STRAND 256..258; /evidence=""ECO:0007829|PDB:1HYN""; STRAND 262..270; /evidence=""ECO:0007829|PDB:4KY9""; STRAND 319..321; /evidence=""ECO:0007829|PDB:4KY9""; STRAND 350..352; /evidence=""ECO:0007829|PDB:7UZV""; STRAND 460..463; /evidence=""ECO:0007829|PDB:7TY4""; STRAND 560..562; /evidence=""ECO:0007829|PDB:7UZ3""; STRAND 594..597; /evidence=""ECO:0007829|PDB:7TY8""; STRAND 636..638; /evidence=""ECO:0007829|PDB:7UZ3""; STRAND 655..657; /evidence=""ECO:0007829|PDB:7UZ3""; STRAND 725..727; /evidence=""ECO:0007829|PDB:7TY4""; STRAND 739..741; /evidence=""ECO:0007829|PDB:7UZ3""; STRAND 753..756; /evidence=""ECO:0007829|PDB:7UZ3""","HELIX 5..7; /evidence=""ECO:0007829|PDB:7UZU""; HELIX 9..16; /evidence=""ECO:0007829|PDB:7UZU""; HELIX 18..21; /evidence=""ECO:0007829|PDB:7UZU""; HELIX 43..46; /evidence=""ECO:0007829|PDB:7UZV""; HELIX 104..115; /evidence=""ECO:0007829|PDB:4KY9""; HELIX 128..141; /evidence=""ECO:0007829|PDB:4KY9""; HELIX 147..149; /evidence=""ECO:0007829|PDB:4KY9""; HELIX 150..157; /evidence=""ECO:0007829|PDB:4KY9""; HELIX 164..169; /evidence=""ECO:0007829|PDB:4KY9""; HELIX 195..200; /evidence=""ECO:0007829|PDB:4KY9""; HELIX 212..219; /evidence=""ECO:0007829|PDB:1HYN""; HELIX 278..290; /evidence=""ECO:0007829|PDB:4KY9""; HELIX 292..300; /evidence=""ECO:0007829|PDB:4KY9""; HELIX 304..316; /evidence=""ECO:0007829|PDB:4KY9""; HELIX 329..332; /evidence=""ECO:0007829|PDB:4KY9""; HELIX 333..335; /evidence=""ECO:0007829|PDB:4KY9""; HELIX 336..347; /evidence=""ECO:0007829|PDB:4KY9""; HELIX 380..389; /evidence=""ECO:0007829|PDB:7UZ3""; HELIX 390..392; /evidence=""ECO:0007829|PDB:7UZ3""; HELIX 395..398; /evidence=""ECO:0007829|PDB:7UZ3""; HELIX 403..431; /evidence=""ECO:0007829|PDB:7UZ3""; HELIX 437..454; /evidence=""ECO:0007829|PDB:7UZ3""; HELIX 466..481; /evidence=""ECO:0007829|PDB:7UZ3""; HELIX 486..506; /evidence=""ECO:0007829|PDB:7UZ3""; HELIX 509..515; /evidence=""ECO:0007829|PDB:7UZ3""; HELIX 518..546; /evidence=""ECO:0007829|PDB:7UZ3""; HELIX 570..593; /evidence=""ECO:0007829|PDB:7UZ3""; HELIX 599..607; /evidence=""ECO:0007829|PDB:7UZ3""; HELIX 609..622; /evidence=""ECO:0007829|PDB:7UZ3""; HELIX 661..666; /evidence=""ECO:0007829|PDB:7UZ3""; HELIX 668..689; /evidence=""ECO:0007829|PDB:7UZ3""; HELIX 692..694; /evidence=""ECO:0007829|PDB:7UZ3""; HELIX 702..718; /evidence=""ECO:0007829|PDB:7UZ3""; HELIX 728..737; /evidence=""ECO:0007829|PDB:7UZ3""; HELIX 761..772; /evidence=""ECO:0007829|PDB:7UZ3""; HELIX 773..775; /evidence=""ECO:0007829|PDB:7UZ3""; HELIX 777..780; /evidence=""ECO:0007829|PDB:7UZ3""; HELIX 785..798; /evidence=""ECO:0007829|PDB:7UZ3""; HELIX 804..811; /evidence=""ECO:0007829|PDB:7UZ3""; HELIX 816..818; /evidence=""ECO:0007829|PDB:7UZ3""; HELIX 823..826; /evidence=""ECO:0007829|PDB:7UZ3""; HELIX 830..851; /evidence=""ECO:0007829|PDB:7UZ3""; HELIX 854..858; /evidence=""ECO:0007829|PDB:7UZ3""; HELIX 859..864; /evidence=""ECO:0007829|PDB:7UZ3""; HELIX 866..872; /evidence=""ECO:0007829|PDB:7UZ3""; HELIX 874..877; /evidence=""ECO:0007829|PDB:7UZ3""; HELIX 880..886; /evidence=""ECO:0007829|PDB:7UZ3""","TURN 643..645; /evidence=""ECO:0007829|PDB:7UZ3""; TURN 799..802; /evidence=""ECO:0007829|PDB:7UZ3""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,SLC4A1 AE1 DI EPB3,Band 3 anion transport protein (Anion exchange protein 1) (AE 1) (Anion exchanger 1) (Solute carrier family 4 member 1) (CD antigen CD233),Homo sapiens (Human),911.0,101792.0,MEELQDDYEDMMEENLEQEEYEDPDIPESQMEEPAAHDTEATATDYHTTSHPGTHKVYVELQELVMDEKNQELRWMEAARWVQLEENLGENGAWGRPHLSHLTFWSLLELRRVFTKGTVLLDLQETSLAGVANQLLDRFIFEDQIRPQDREELLRALLLKHSHAGELEALGGVKPAVLTRSGDPSQPLLPQHSSLETQLFCEQGDGGTEGHSPSGILEKIPPDSEATLVLVGRADFLEQPVLGFVRLQEAAELEAVELPVPIRFLFVLLGPEAPHIDYTQLGRAAATLMSERVFRIDAYMAQSRGELLHSLEGFLDCSLVLPPTDAPSEQALLSLVPVQRELLRRRYQSSPAKPDSSFYKGLDLNGGPDDPLQQTGQLFGGLVRDIRRRYPYYLSDITDAFSPQVLAAVIFIYFAALSPAITFGGLLGEKTRNQMGVSELLISTAVQGILFALLGAQPLLVVGFSGPLLVFEEAFFSFCETNGLEYIVGRVWIGFWLILLVVLVVAFEGSFLVRFISRYTQEIFSFLISLIFIYETFSKLIKIFQDHPLQKTYNYNVLMVPKPQGPLPNTALLSLVLMAGTFFFAMMLRKFKNSSYFPGKLRRVIGDFGVPISILIMVLVDFFIQDTYTQKLSVPDGFKVSNSSARGWVIHPLGLRSEFPIWMMFASALPALLVFILIFLESQITTLIVSKPERKMVKGSGFHLDLLLVVGMGGVAALFGMPWLSATTVRSVTHANALTVMGKASTPGAAAQIQEVKEQRISGLLVAVLVGLSILMEPILSRIPLAVLFGIFLYMGVTSLSGIQLFDRILLLFKPPKYHPDVPYVKRVKTWRMHLFTGIQIICLAVLWVVKSTPASLALPFVLILTVPLRRVLLPLIFRNVELQCLDADDAKATFDEEEGRDEYDEVAMPV,True,True,True,P02730,"[('G3DSA:1.10.287.570', 'Helical hairpin bin'), ('G3DSA:3.40.930.10', 'Mannitol-specific EII; Chain A'), ('IPR001717', 'Anion exchange protein'), ('IPR002977', 'Anion exchange protein 1'), ('IPR003020', 'Bicarbonate transporter, eukaryotic'), ('IPR011531', 'Bicarbonate transporter-like, transmembrane domain'), ('IPR013769', 'Band 3 cytoplasmic domain'), ('IPR016152', 'Phosphotransferase/anion transporter'), ('IPR018241', 'Anion exchange, conserved site'), ('PF00955', 'HCO3- transporter integral membrane domain'), ('PF07565', 'Band 3 cytoplasmic domain'), ('PR00165', 'ANIONEXCHNGR'), ('PR01187', 'ANIONEXHNGR1'), ('PR01231', 'HCO3TRNSPORT'), ('PS00219', 'Anion exchangers family signature 1'), ('PS00220', 'Anion exchangers family signature 2'), ('PTHR11453', 'ANION EXCHANGE PROTEIN'), ('SSF55804', 'Phoshotransferase/anion transport protein'), ('TIGR00834', 'anion exchange protein')]",P02730;,"""ENSG00000004939; Tissue enriched (bone)."";","CATALYTIC ACTIVITY: Reaction=hydrogencarbonate(in) + chloride(out) = hydrogencarbonate(out) + chloride(in); Xref=Rhea:RHEA:72363, ChEBI:CHEBI:17544, ChEBI:CHEBI:17996; Evidence={ECO:0000269|PubMed:10926824, ECO:0000269|PubMed:14734552, ECO:0000269|PubMed:16227998, ECO:0000269|PubMed:24121512, ECO:0000269|PubMed:28387307};",,ACTIVITY REGULATION: Phenyl isothiocyanate inhibits anion transport in vitro.,,ENST00000262418.12 [P02730-1];,SLC4A1,ENSG00000004939,0.0,,,,5.93,DP01167,0.059,0.075,0.044,SLC4A1
P03372,ENSG00000091831,ESR1_HUMAN,androgen metabolic process [GO:0008209]; antral ovarian follicle growth [GO:0001547]; cellular response to estradiol stimulus [GO:0071392]; cellular response to estrogen stimulus [GO:0071391]; chromatin remodeling [GO:0006338]; epithelial cell development [GO:0002064]; epithelial cell proliferation involved in mammary gland duct elongation [GO:0060750]; estrogen receptor signaling pathway [GO:0030520]; fibroblast proliferation [GO:0048144]; male gonad development [GO:0008584]; mammary gland alveolus development [GO:0060749]; mammary gland branching involved in pregnancy [GO:0060745]; negative regulation of canonical NF-kappaB signal transduction [GO:0043124]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of gene expression [GO:0010629]; negative regulation of miRNA transcription [GO:1902894]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nuclear receptor-mediated steroid hormone signaling pathway [GO:0030518]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of nitric-oxide synthase activity [GO:0051000]; positive regulation of transcription by RNA polymerase II [GO:0045944]; prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis [GO:0060527]; prostate epithelial cord elongation [GO:0060523]; protein localization to chromatin [GO:0071168]; regulation of branching involved in prostate gland morphogenesis [GO:0060687]; regulation of DNA-templated transcription [GO:0006355]; regulation of epithelial cell apoptotic process [GO:1904035]; regulation of inflammatory response [GO:0050727]; regulation of toll-like receptor signaling pathway [GO:0034121]; regulation of transcription by RNA polymerase II [GO:0006357]; response to estradiol [GO:0032355]; response to estrogen [GO:0043627]; RNA polymerase II preinitiation complex assembly [GO:0051123]; signal transduction [GO:0007165]; stem cell differentiation [GO:0048863]; steroid hormone receptor signaling pathway [GO:0043401]; uterus development [GO:0060065]; vagina development [GO:0060068],chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; euchromatin [GO:0000791]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; transcription regulator complex [GO:0005667],"14-3-3 protein binding [GO:0071889]; ATPase binding [GO:0051117]; beta-catenin binding [GO:0008013]; calmodulin binding [GO:0005516]; chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; enzyme binding [GO:0019899]; estrogen response element binding [GO:0034056]; G protein-coupled estrogen receptor activity [GO:0038054]; identical protein binding [GO:0042802]; nitric-oxide synthase regulator activity [GO:0030235]; nuclear estrogen receptor activity [GO:0030284]; nuclear estrogen receptor binding [GO:0030331]; nuclear receptor activity [GO:0004879]; protein kinase binding [GO:0019901]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; steroid binding [GO:0005496]; TBP-class protein binding [GO:0017025]; TFIIB-class transcription factor binding [GO:0001093]; transcription coactivator binding [GO:0001223]; transcription coregulator binding [GO:0001221]; transcription corepressor binding [GO:0001222]; zinc ion binding [GO:0008270]","PTM: Phosphorylated by cyclin A/CDK2 and CK1. Phosphorylation probably enhances transcriptional activity. Self-association induces phosphorylation. Dephosphorylation at Ser-118 by PPP5C inhibits its transactivation activity. Phosphorylated by LMTK3 in vitro. {ECO:0000269|PubMed:10428798, ECO:0000269|PubMed:14764652, ECO:0000269|PubMed:19339517, ECO:0000269|PubMed:21602804, ECO:0000269|PubMed:7476978, ECO:0000269|PubMed:7539106, ECO:0000269|PubMed:7838153}.; PTM: Glycosylated; contains N-acetylglucosamine, probably O-linked. {ECO:0000269|PubMed:8999954}.; PTM: Ubiquitinated; regulated by LATS1 via DCAF1 it leads to ESR1 proteasomal degradation (PubMed:21602804, PubMed:28068668). Deubiquitinated by OTUB1 (PubMed:19383985). Ubiquitinated by STUB1/CHIP; in the CA1 hippocampal region following loss of endogenous circulating estradiol (17-beta-estradiol/E2) (By similarity). Ubiquitinated by UBR5, leading to its degradation: UBR5 specifically recognizes and binds ligand-bound ESR1 when it is not associated with coactivators (NCOAs) (PubMed:37478846). In presence of NCOAs, the UBR5-degron is not accessible, preventing its ubiquitination and degradation (PubMed:37478846). {ECO:0000250|UniProtKB:P06211, ECO:0000269|PubMed:19383985, ECO:0000269|PubMed:21602804, ECO:0000269|PubMed:28068668, ECO:0000269|PubMed:37478846}.; PTM: Dimethylated by PRMT1 at Arg-260. The methylation may favor cytoplasmic localization (PubMed:18657504, PubMed:24498420). Demethylated by JMJD6 at Arg-260 (PubMed:24498420). {ECO:0000269|PubMed:18657504, ECO:0000269|PubMed:24498420}.; PTM: Palmitoylated (isoform 3). Not biotinylated (isoform 3). {ECO:0000269|PubMed:22031296}.; PTM: Palmitoylated by ZDHHC7 and ZDHHC21. Palmitoylation is required for plasma membrane targeting and for rapid intracellular signaling via ERK and AKT kinases and cAMP generation, but not for signaling mediated by the nuclear hormone receptor. {ECO:0000269|PubMed:22031296}.","DOMAIN: Composed of three domains: a modulating N-terminal domain, a DNA-binding domain and a C-terminal ligand-binding domain. The modulating domain, also known as A/B or AF-1 domain has a ligand-independent transactivation function. The C-terminus contains a ligand-dependent transactivation domain, also known as E/F or AF-2 domain which overlaps with the ligand binding domain. AF-1 and AF-2 activate transcription independently and synergistically and act in a promoter- and cell-specific manner. AF-1 seems to provide the major transactivation function in differentiated cells.","DOMAIN 311..547; /note=""NR LBD""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU01189""","STRAND 189..191; /evidence=""ECO:0007829|PDB:1HCP""; STRAND 194..196; /evidence=""ECO:0007829|PDB:1HCQ""; STRAND 199..201; /evidence=""ECO:0007829|PDB:1HCQ""; STRAND 222..225; /evidence=""ECO:0007829|PDB:1HCQ""; STRAND 330..332; /evidence=""ECO:0007829|PDB:7RRX""; STRAND 334..336; /evidence=""ECO:0007829|PDB:2QZO""; STRAND 396..398; /evidence=""ECO:0007829|PDB:2QE4""; STRAND 402..405; /evidence=""ECO:0007829|PDB:7NFB""; STRAND 408..410; /evidence=""ECO:0007829|PDB:7NFB""; STRAND 418..420; /evidence=""ECO:0007829|PDB:5KCW""","HELIX 203..213; /evidence=""ECO:0007829|PDB:1HCQ""; HELIX 238..248; /evidence=""ECO:0007829|PDB:1HCQ""; HELIX 288..291; /evidence=""ECO:0007829|PDB:2LLO""; HELIX 302..304; /evidence=""ECO:0007829|PDB:3Q95""; HELIX 307..309; /evidence=""ECO:0007829|PDB:7NFB""; HELIX 312..321; /evidence=""ECO:0007829|PDB:7NFB""; HELIX 339..363; /evidence=""ECO:0007829|PDB:7NFB""; HELIX 367..369; /evidence=""ECO:0007829|PDB:7NFB""; HELIX 372..395; /evidence=""ECO:0007829|PDB:7NFB""; HELIX 412..415; /evidence=""ECO:0007829|PDB:7NFB""; HELIX 421..438; /evidence=""ECO:0007829|PDB:7NFB""; HELIX 442..455; /evidence=""ECO:0007829|PDB:7NFB""; HELIX 466..492; /evidence=""ECO:0007829|PDB:7NFB""; HELIX 497..530; /evidence=""ECO:0007829|PDB:7NFB""; HELIX 531..533; /evidence=""ECO:0007829|PDB:7RS0""; HELIX 538..545; /evidence=""ECO:0007829|PDB:7NFB""; HELIX 547..549; /evidence=""ECO:0007829|PDB:7QVJ""; HELIX 588..590; /evidence=""ECO:0007829|PDB:5N10""","TURN 186..188; /evidence=""ECO:0007829|PDB:1HCQ""; TURN 231..236; /evidence=""ECO:0007829|PDB:1HCQ""; TURN 456..459; /evidence=""ECO:0007829|PDB:7UJO""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,ESR1 ESR NR3A1,Estrogen receptor (ER) (ER-alpha) (Estradiol receptor) (Nuclear receptor subfamily 3 group A member 1),Homo sapiens (Human),595.0,66216.0,MTMTLHTKASGMALLHQIQGNELEPLNRPQLKIPLERPLGEVYLDSSKPAVYNYPEGAAYEFNAAAAANAQVYGQTGLPYGPGSEAAAFGSNGLGGFPPLNSVSPSPLMLLHPPPQLSPFLQPHGQQVPYYLENEPSGYTVREAGPPAFYRPNSDNRRQGGRERLASTNDKGSMAMESAKETRYCAVCNDYASGYHYGVWSCEGCKAFFKRSIQGHNDYMCPATNQCTIDKNRRKSCQACRLRKCYEVGMMKGGIRKDRRGGRMLKHKRQRDDGEGRGEVGSAGDMRAANLWPSPLMIKRSKKNSLALSLTADQMVSALLDAEPPILYSEYDPTRPFSEASMMGLLTNLADRELVHMINWAKRVPGFVDLTLHDQVHLLECAWLEILMIGLVWRSMEHPGKLLFAPNLLLDRNQGKCVEGMVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSSTLKSLEEKDHIHRVLDKITDTLIHLMAKAGLTLQQQHQRLAQLLLILSHIRHMSNKGMEHLYSMKCKNVVPLYDLLLEMLDAHRLHAPTSRGGASVEETDQSHLATAGSTSSHSLQKYYITGEAEGFPATV,False,False,True,P03372,"[('cd06949', 'Ligand binding domain of Estrogen receptor, which are activated by the hormone 17beta-estradiol (estrogen)'), ('cd07171', 'DNA-binding domain of estrogen receptors (ER) is composed of two C4-type zinc fingers'), ('G3DSA:1.10.565.10', 'Retinoid X Receptor'), ('G3DSA:3.30.50.10', 'Erythroid Transcription Factor GATA-1, subunit A'), ('IPR000536', 'Nuclear hormone receptor, ligand-binding domain'), ('IPR001292', 'Estrogen receptor'), ('IPR001628', 'Zinc finger, nuclear hormone receptor-type'), ('IPR001723', 'Nuclear hormone receptor'), ('IPR013088', 'Zinc finger, NHR/GATA-type'), ('IPR024178', 'Estrogen receptor/oestrogen-related receptor'), ('IPR024736', 'Oestrogen-type nuclear receptor final C-terminal domain'), ('IPR035500', 'Nuclear hormone receptor-like domain superfamily'), ('IPR046944', 'Estrogen receptor, N-terminal'), ('IPR050200', 'Nuclear hormone receptor family NR3 subfamily'), ('PF00104', 'Ligand-binding domain of nuclear hormone receptor'), ('PF00105', 'Double treble clef zinc finger, C4 type'), ('PF02159', 'Oestrogen receptor'), ('PF12743', 'Oestrogen-type nuclear receptor final C-terminal'), ('PIRSF002527', 'Estrogen receptor-like nuclear receptor'), ('PIRSF500101', 'Estrogen receptor alpha')]",P03372;,"""ENSG00000091831; Tissue enhanced (cervix, endometrium, fallopian tube)."";",,,,,ENST00000206249.8 [P03372-1];ENST00000338799.9 [P03372-1];ENST00000427531.6 [P03372-4];ENST00000440973.5 [P03372-1];ENST00000443427.5 [P03372-1];,ESR1,ENSG00000091831,0.0,,,,39.66,DP00074,0.598,0.471,0.123,ESR1
P04049,ENSG00000132155,RAF1_HUMAN,activation of adenylate cyclase activity [GO:0007190]; apoptotic process [GO:0006915]; death-inducing signaling complex assembly [GO:0071550]; ERBB2-ERBB3 signaling pathway [GO:0038133]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; face development [GO:0060324]; insulin receptor signaling pathway [GO:0008286]; insulin secretion involved in cellular response to glucose stimulus [GO:0035773]; insulin-like growth factor receptor signaling pathway [GO:0048009]; intermediate filament cytoskeleton organization [GO:0045104]; MAPK cascade [GO:0000165]; myelination [GO:0042552]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of protein-containing complex assembly [GO:0031333]; neurotrophin TRK receptor signaling pathway [GO:0048011]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein phosphorylation [GO:0006468]; regulation of apoptotic process [GO:0042981]; regulation of cell differentiation [GO:0045595]; regulation of cell motility [GO:2000145]; regulation of Rho protein signal transduction [GO:0035023]; response to muscle stretch [GO:0035994]; Schwann cell development [GO:0014044]; signal transduction [GO:0007165]; somatic stem cell population maintenance [GO:0035019]; thymus development [GO:0048538]; thyroid gland development [GO:0030878]; type B pancreatic cell proliferation [GO:0044342]; type II interferon-mediated signaling pathway [GO:0060333]; wound healing [GO:0042060],cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; pseudopodium [GO:0031143],ATP binding [GO:0005524]; enzyme binding [GO:0019899]; histone H2AS1 kinase activity [GO:0044024]; identical protein binding [GO:0042802]; MAP kinase kinase kinase activity [GO:0004709]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],"PTM: Phosphorylation at Thr-269, Ser-338, Tyr-341, Thr-491 and Ser-494 results in its activation. Phosphorylation at Ser-29, Ser-43, Ser-289, Ser-296, Ser-301 and Ser-642 by MAPK1/ERK2 results in its inactivation. Phosphorylation at Ser-259 induces the interaction with YWHAZ and inactivates kinase activity. Dephosphorylation of Ser-259 by the SHOC2-MRAS-PP1c (SMP) complex consisting of SHOC2, GTP-bound M-Ras/MRAS and the catalytic subunit of protein phosphatase 1 (PPP1CA, PPP1CB or PPP1CC); this relieves inactivation and stimulates kinase activity (PubMed:35768504, PubMed:35831509, PubMed:35830882). Phosphorylation at Ser-338 by PAK1 and PAK5 and Ser-339 by PAK1 is required for its mitochondrial localization. Phosphorylation at Ser-621 in response to growth factor treatment stabilizes the protein, possibly by preventing proteasomal degradation. Phosphorylation at Ser-289, Ser-296, Ser-301, Ser-338 and Ser-621 are somehow linked to the methylation potential of cells. Treatment of cells with HGF in the presence of the methylation inhibitor 5'-methylthioadenosine (MTA) results in increased phosphorylation at Ser-338 and Ser-621 and decreased phosphorylation at Ser-296, Ser-301 and Ser-338. Dephosphorylation at Ser-338 by PPP5C results in an activity decrease. {ECO:0000269|PubMed:10576742, ECO:0000269|PubMed:10801873, ECO:0000269|PubMed:11447113, ECO:0000269|PubMed:11733498, ECO:0000269|PubMed:11756411, ECO:0000269|PubMed:15047712, ECO:0000269|PubMed:15849194, ECO:0000269|PubMed:16093354, ECO:0000269|PubMed:16630891, ECO:0000269|PubMed:16892053, ECO:0000269|PubMed:18465753, ECO:0000269|PubMed:21917714, ECO:0000269|PubMed:35768504, ECO:0000269|PubMed:35830882, ECO:0000269|PubMed:35831509, ECO:0000269|PubMed:7477354, ECO:0000269|PubMed:8349614, ECO:0000269|PubMed:9823899}.; PTM: Methylated at Arg-563 in response to EGF treatment. This modification leads to destabilization of the protein, possibly through proteasomal degradation. {ECO:0000269|PubMed:21917714}.",,"DOMAIN 56..131; /note=""RBD""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00262""; DOMAIN 349..609; /note=""Protein kinase""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00159""","STRAND 57..61; /evidence=""ECO:0007829|PDB:6VJJ""; STRAND 67..71; /evidence=""ECO:0007829|PDB:6VJJ""; STRAND 96..100; /evidence=""ECO:0007829|PDB:6VJJ""; STRAND 103..107; /evidence=""ECO:0007829|PDB:6VJJ""; STRAND 110..112; /evidence=""ECO:0007829|PDB:8T74""; STRAND 125..130; /evidence=""ECO:0007829|PDB:6VJJ""; STRAND 132..134; /evidence=""ECO:0007829|PDB:6PTW""; STRAND 135..137; /evidence=""ECO:0007829|PDB:6XGV""; STRAND 141..145; /evidence=""ECO:0007829|PDB:6XI7""; STRAND 160..165; /evidence=""ECO:0007829|PDB:6XI7""; STRAND 170..172; /evidence=""ECO:0007829|PDB:7JHP""; STRAND 182..185; /evidence=""ECO:0007829|PDB:6XGV""; STRAND 350..353; /evidence=""ECO:0007829|PDB:8CPD""; STRAND 363..376; /evidence=""ECO:0007829|PDB:8CPD""; STRAND 408..412; /evidence=""ECO:0007829|PDB:8CPD""; STRAND 414..416; /evidence=""ECO:0007829|PDB:8CPD""; STRAND 418..422; /evidence=""ECO:0007829|PDB:8CPD""; STRAND 429..431; /evidence=""ECO:0007829|PDB:7Z38""; STRAND 481..484; /evidence=""ECO:0007829|PDB:8GAE""; STRAND 510..512; /evidence=""ECO:0007829|PDB:7Z38""; STRAND 520..522; /evidence=""ECO:0007829|PDB:7Z38""","HELIX 78..88; /evidence=""ECO:0007829|PDB:6VJJ""; HELIX 93..95; /evidence=""ECO:0007829|PDB:6VJJ""; HELIX 118..121; /evidence=""ECO:0007829|PDB:6VJJ""; HELIX 174..179; /evidence=""ECO:0007829|PDB:6XI7""; HELIX 384..397; /evidence=""ECO:0007829|PDB:8CPD""; HELIX 442..461; /evidence=""ECO:0007829|PDB:7Z38""; HELIX 471..473; /evidence=""ECO:0007829|PDB:7Z38""; HELIX 514..518; /evidence=""ECO:0007829|PDB:7Z38""; HELIX 527..542; /evidence=""ECO:0007829|PDB:7Z38""; HELIX 554..563; /evidence=""ECO:0007829|PDB:7Z38""; HELIX 580..588; /evidence=""ECO:0007829|PDB:7Z38""; HELIX 599..611; /evidence=""ECO:0007829|PDB:7Z38""","TURN 63..65; /evidence=""ECO:0007829|PDB:8T74""; TURN 153..155; /evidence=""ECO:0007829|PDB:6XI7""; TURN 166..168; /evidence=""ECO:0007829|PDB:6XI7""; TURN 434..437; /evidence=""ECO:0007829|PDB:7Z38""; TURN 478..480; /evidence=""ECO:0007829|PDB:8GAE""; TURN 547..550; /evidence=""ECO:0007829|PDB:7Z38""; TURN 593..595; /evidence=""ECO:0007829|PDB:7Z38""; TURN 612..614; /evidence=""ECO:0007829|PDB:7Z38""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,RAF1 RAF,RAF proto-oncogene serine/threonine-protein kinase (EC 2.7.11.1) (Proto-oncogene c-RAF) (cRaf) (Raf-1),Homo sapiens (Human),648.0,73052.0,MEHIQGAWKTISNGFGFKDAVFDGSSCISPTIVQQFGYQRRASDDGKLTDPSKTSNTIRVFLPNKQRTVVNVRNGMSLHDCLMKALKVRGLQPECCAVFRLLHEHKGKKARLDWNTDAASLIGEELQVDFLDHVPLTTHNFARKTFLKLAFCDICQKFLLNGFRCQTCGYKFHEHCSTKVPTMCVDWSNIRQLLLFPNSTIGDSGVPALPSLTMRRMRESVSRMPVSSQHRYSTPHAFTFNTSSPSSEGSLSQRQRSTSTPNVHMVSTTLPVDSRMIEDAIRSHSESASPSALSSSPNNLSPTGWSQPKTPVPAQRERAPVSGTQEKNKIRPRGQRDSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPKINRSASEPSLHRAAHTEDINACTLTTSPRLPVF,False,False,True,P04049,"[('cd14149', 'Catalytic domain of the Serine/Threonine Kinase, C-Raf (Rapidly Accelerated Fibrosarcoma) kinase'), ('cd17135', 'Ras-binding domain (RBD) found in RAF proto-oncogene serine/threonine-protein kinase RAF1/CRAF'), ('cd20870', 'protein kinase C conserved region 1 (C1 domain) found in A- and C-Raf (Rapidly Accelerated Fibrosarcoma) kinases, and similar proteins'), ('G3DSA:1.10.510.10', 'Transferase(Phosphotransferase) domain 1'), ('G3DSA:3.10.20.90', 'Phosphatidylinositol 3-kinase Catalytic Subunit; Chain A, domain 1'), ('G3DSA:3.30.200.20', 'Phosphorylase Kinase; domain 1'), ('G3DSA:3.30.60.20', None), ('IPR000719', 'Protein kinase domain'), ('IPR002219', 'Protein kinase C-like, phorbol ester/diacylglycerol-binding domain'), ('IPR003116', 'Raf-like Ras-binding'), ('IPR008271', 'Serine/threonine-protein kinase, active site'), ('IPR011009', 'Protein kinase-like domain superfamily'), ('IPR017441', 'Protein kinase, ATP binding site'), ('IPR020454', 'Diacylglycerol/phorbol-ester binding'), ('IPR029071', 'Ubiquitin-like domain superfamily'), ('IPR046349', 'C1-like domain superfamily'), ('IPR051681', 'Serine/Threonine Kinases and Pseudokinases'), ('PF00069', 'Protein kinase domain'), ('PF00130', 'Phorbol esters/diacylglycerol binding domain (C1 domain)'), ('PF02196', 'Raf-like Ras-binding domain')]",,"""ENSG00000132155; Low tissue specificity."";","CATALYTIC ACTIVITY: Reaction=L-seryl-[protein] + ATP = O-phospho-L-seryl-[protein] + ADP + H(+); Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616, ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.1; Evidence={ECO:0000269|PubMed:17603483}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:17990; Evidence={ECO:0000269|PubMed:17603483}; CATALYTIC ACTIVITY: Reaction=L-threonyl-[protein] + ATP = O-phospho-L-threonyl-[protein] + ADP + H(+); Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060, Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013, ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216; EC=2.7.11.1; Evidence={ECO:0000269|PubMed:17603483}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:46609; Evidence={ECO:0000269|PubMed:17603483};",2.7.11.1,"ACTIVITY REGULATION: Regulation is a highly complex process involving membrane recruitment, protein-protein interactions, dimerization, and phosphorylation/dephosphorylation events. Ras-GTP recruits RAF1 to the membrane, thereby promoting its activation. The inactive conformation of RAF1 is maintained by autoinhibitory interactions occurring between the N-terminal regulatory and the C-terminal catalytic domains and by the binding of a 14-3-3 protein that contacts two phosphorylation sites, Ser-259 and Ser-621. Upon mitogenic stimulation, Ras and PPP2R1A cooperate to release autoinhibition and the subsequent phosphorylation of activating sites: Ser-338, Tyr-341, Thr-491, and Ser-494, yields a fully active kinase. Through a negative feedback mechanism involving MAPK1/ERK2, RAF1 is phosphorylated on Ser-29, Ser-43, Ser-289, Ser-296, Ser-301 and Ser-642 by MAPK1/ERK2, which yields an inactive, desensitized kinase. The signaling-competent conformation of RAF1 is finally re-established by the coordinated action of PIN1, a prolyl isomerase that converts pSer and pThr residues from the cis to the trans conformation, which is preferentially recognized and dephosphorylated by PPP2R1A. Activated by homodimerization and heterodimerization (with BRAF). Also regulated through association with other proteins such as KSR2, CNKSR1/CNK1, PEBP1/RKIP, PHB/prohibitin and SPRY4. PEBP1/RKIP acts by dissociating RAF1 from its substrates MAP2K1/MEK1 and MAP2K2/MEK2. PHB/prohibitin facilitates the displacement of 14-3-3 from RAF1 by activated Ras, thereby promoting cell membrane localization and phosphorylation of RAF1 at the activating Ser-338. SPRY4 inhibits Ras-independent, but not Ras-dependent, activation of RAF1. CNKSR1/CNK1 regulates Src-mediated RAF1 activation. {ECO:0000269|PubMed:10576742, ECO:0000269|PubMed:10801873, ECO:0000269|PubMed:11447113, ECO:0000269|PubMed:11733498, ECO:0000269|PubMed:12717443, ECO:0000269|PubMed:16892053, ECO:0000269|PubMed:18294816, ECO:0000269|PubMed:19710016}.",,ENST00000251849.9 [P04049-1];ENST00000442415.7 [P04049-2];ENST00000685653.1 [P04049-1];ENST00000691899.1 [P04049-1];,RAF1,ENSG00000132155,0.0,RAF1,Non-canonical_RBPs,11.0,3.09,DP00171,0.076,0.369,0.177,RAF1
P04075,ENSG00000149925,ALDOA_HUMAN,"actin filament organization [GO:0007015]; ATP biosynthetic process [GO:0006754]; binding of sperm to zona pellucida [GO:0007339]; fructose 1,6-bisphosphate metabolic process [GO:0030388]; fructose metabolic process [GO:0006000]; glycolytic process [GO:0006096]; muscle cell cellular homeostasis [GO:0046716]; protein homotetramerization [GO:0051289]; regulation of cell shape [GO:0008360]; striated muscle contraction [GO:0006941]",actin cytoskeleton [GO:0015629]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; I band [GO:0031674]; M band [GO:0031430]; membrane [GO:0016020]; nucleus [GO:0005634]; platelet alpha granule lumen [GO:0031093]; secretory granule lumen [GO:0034774]; sperm head [GO:0061827]; tertiary granule lumen [GO:1904724],actin binding [GO:0003779]; cadherin binding [GO:0045296]; cytoskeletal protein binding [GO:0008092]; fructose binding [GO:0070061]; fructose-bisphosphate aldolase activity [GO:0004332]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; tubulin binding [GO:0015631],,,,"STRAND 29..33; /evidence=""ECO:0007829|PDB:6XML""; STRAND 74..79; /evidence=""ECO:0007829|PDB:6XML""; STRAND 104..108; /evidence=""ECO:0007829|PDB:6XML""; STRAND 113..115; /evidence=""ECO:0007829|PDB:6XML""; STRAND 119..121; /evidence=""ECO:0007829|PDB:6XML""; STRAND 123..125; /evidence=""ECO:0007829|PDB:6XML""; STRAND 145..152; /evidence=""ECO:0007829|PDB:6XML""; STRAND 155..157; /evidence=""ECO:0007829|PDB:5KY6""; STRAND 184..191; /evidence=""ECO:0007829|PDB:6XML""; STRAND 267..271; /evidence=""ECO:0007829|PDB:6XML""; STRAND 296..303; /evidence=""ECO:0007829|PDB:6XML""; STRAND 348..350; /evidence=""ECO:0007829|PDB:1ALD""","HELIX 10..23; /evidence=""ECO:0007829|PDB:6XML""; HELIX 40..45; /evidence=""ECO:0007829|PDB:6XML""; HELIX 53..64; /evidence=""ECO:0007829|PDB:6XML""; HELIX 68..73; /evidence=""ECO:0007829|PDB:6XML""; HELIX 81..84; /evidence=""ECO:0007829|PDB:6XML""; HELIX 94..100; /evidence=""ECO:0007829|PDB:6XML""; HELIX 131..140; /evidence=""ECO:0007829|PDB:6XML""; HELIX 161..180; /evidence=""ECO:0007829|PDB:6XML""; HELIX 199..219; /evidence=""ECO:0007829|PDB:6XML""; HELIX 224..226; /evidence=""ECO:0007829|PDB:6XML""; HELIX 246..258; /evidence=""ECO:0007829|PDB:6XML""; HELIX 277..289; /evidence=""ECO:0007829|PDB:6XML""; HELIX 304..314; /evidence=""ECO:0007829|PDB:6XML""; HELIX 318..320; /evidence=""ECO:0007829|PDB:6XML""; HELIX 321..338; /evidence=""ECO:0007829|PDB:6XML""; HELIX 351..354; /evidence=""ECO:0007829|PDB:6XMH""; HELIX 357..359; /evidence=""ECO:0007829|PDB:5KY6""; HELIX 361..363; /evidence=""ECO:0007829|PDB:5KY6""","TURN 37..39; /evidence=""ECO:0007829|PDB:6XML""; TURN 46..48; /evidence=""ECO:0007829|PDB:6XML""; TURN 339..341; /evidence=""ECO:0007829|PDB:6XML""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,ALDOA ALDA,Fructose-bisphosphate aldolase A (EC 4.1.2.13) (Lung cancer antigen NY-LU-1) (Muscle-type aldolase),Homo sapiens (Human),364.0,39420.0,MPYQYPALTPEQKKELSDIAHRIVAPGKGILAADESTGSIAKRLQSIGTENTEENRRFYRQLLLTADDRVNPCIGGVILFHETLYQKADDGRPFPQVIKSKGGVVGIKVDKGVVPLAGTNGETTTQGLDGLSERCAQYKKDGADFAKWRCVLKIGEHTPSALAIMENANVLARYASICQQNGIVPIVEPEILPDGDHDLKRCQYVTEKVLAAVYKALSDHHIYLEGTLLKPNMVTPGHACTQKFSHEEIAMATVTALRRTVPPAVTGITFLSGGQSEEEASINLNAINKCPLLKPWALTFSYGRALQASALKAWGGKKENLKAAQEEYVKRALANSLACQGKYTPSGQAGAAASESLFVSNHAY,True,True,False,P04075,"[('cd00948', 'Fructose-1,6-bisphosphate aldolase'), ('G3DSA:3.20.20.70', 'Aldolase class I'), ('IPR000741', 'Fructose-bisphosphate aldolase, class-I'), ('IPR013785', 'Aldolase-type TIM barrel'), ('IPR029768', 'Fructose-bisphosphate aldolase class-I active site'), ('NF033379', 'class I fructose-bisphosphate aldolase'), ('PF00274', 'Fructose-bisphosphate aldolase class-I'), ('PS00158', 'Fructose-bisphosphate aldolase class-I active site'), ('PTHR11627', 'FRUCTOSE-BISPHOSPHATE ALDOLASE'), ('SSF51569', 'Aldolase')]",,"""ENSG00000149925; Group enriched (skeletal muscle, tongue)."";","CATALYTIC ACTIVITY: Reaction=beta-D-fructose 1,6-bisphosphate = D-glyceraldehyde 3-phosphate + dihydroxyacetone phosphate; Xref=Rhea:RHEA:14729, ChEBI:CHEBI:32966, ChEBI:CHEBI:57642, ChEBI:CHEBI:59776; EC=4.1.2.13; Evidence={ECO:0000269|PubMed:14766013, ECO:0000269|PubMed:2204832}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:14730; Evidence={ECO:0000305|PubMed:14766013};",4.1.2.13,,PATHWAY: Carbohydrate degradation; glycolysis; D-glyceraldehyde 3-phosphate and glycerone phosphate from D-glucose: step 4/4.,ENST00000412304.6 [P04075-1];ENST00000563060.6 [P04075-1];ENST00000569545.5 [P04075-1];ENST00000642816.3 [P04075-2];ENST00000643777.4 [P04075-1];,ALDOA,ENSG00000149925,0.0,ALDOA,Non-canonical_RBPs,24.0,,,,,,ALDOA
P04156,ENSG00000171867,PRIO_HUMAN,activation of protein kinase activity [GO:0032147]; cellular response to amyloid-beta [GO:1904646]; cellular response to copper ion [GO:0071280]; cellular response to xenobiotic stimulus [GO:0071466]; dendritic spine maintenance [GO:0097062]; intracellular copper ion homeostasis [GO:0006878]; learning or memory [GO:0007611]; long-term memory [GO:0007616]; negative regulation of activated T cell proliferation [GO:0046007]; negative regulation of amyloid precursor protein catabolic process [GO:1902992]; negative regulation of amyloid-beta formation [GO:1902430]; negative regulation of apoptotic process [GO:0043066]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of catalytic activity [GO:0043086]; negative regulation of dendritic spine maintenance [GO:1902951]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of interleukin-17 production [GO:0032700]; negative regulation of interleukin-2 production [GO:0032703]; negative regulation of long-term synaptic potentiation [GO:1900272]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein processing [GO:0010955]; negative regulation of T cell receptor signaling pathway [GO:0050860]; negative regulation of type II interferon production [GO:0032689]; neuron projection maintenance [GO:1990535]; positive regulation of calcium-mediated signaling [GO:0050850]; positive regulation of glutamate receptor signaling pathway [GO:1900451]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein targeting to membrane [GO:0090314]; protein destabilization [GO:0031648]; protein homooligomerization [GO:0051260]; regulation of calcium ion import across plasma membrane [GO:1905664]; regulation of cell cycle [GO:0051726]; regulation of glutamate receptor signaling pathway [GO:1900449]; regulation of peptidyl-tyrosine phosphorylation [GO:0050730]; regulation of potassium ion transmembrane transport [GO:1901379]; response to amyloid-beta [GO:1904645]; response to cadmium ion [GO:0046686]; response to oxidative stress [GO:0006979],cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extrinsic component of membrane [GO:0019898]; Golgi apparatus [GO:0005794]; inclusion body [GO:0016234]; intracellular membrane-bounded organelle [GO:0043231]; membrane raft [GO:0045121]; nuclear membrane [GO:0031965]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; terminal bouton [GO:0043195],amyloid-beta binding [GO:0001540]; aspartic-type endopeptidase inhibitor activity [GO:0019828]; ATP-dependent protein binding [GO:0043008]; copper ion binding [GO:0005507]; cupric ion binding [GO:1903135]; cuprous ion binding [GO:1903136]; glycosaminoglycan binding [GO:0005539]; identical protein binding [GO:0042802]; lamin binding [GO:0005521]; microtubule binding [GO:0008017]; molecular adaptor activity [GO:0060090]; molecular condensate scaffold activity [GO:0140693]; molecular function activator activity [GO:0140677]; protease binding [GO:0002020]; protein-containing complex binding [GO:0044877]; protein-folding chaperone binding [GO:0051087]; signaling receptor activity [GO:0038023]; transmembrane transporter binding [GO:0044325]; tubulin binding [GO:0015631]; type 5 metabotropic glutamate receptor binding [GO:0031802],"PTM: The glycosylation pattern (the amount of mono-, di- and non-glycosylated forms or glycoforms) seems to differ in normal and CJD prion. {ECO:0000269|PubMed:12214108}.","DOMAIN: The normal, monomeric form, PRPN(C), has a mainly alpha-helical structure. Misfolding of this form produces a disease-associated, protease-resistant form, PRPN (Sc), accompanied by a large increase of the beta-sheet content and formation of amyloid fibrils. These fibrils consist of a cross-beta spine, formed by a steric zipper of superposed beta-strands. Disease mutations may favor intermolecular contacts via short beta strands, and may thereby trigger oligomerization. In addition, the heparan-sulfate proteoglycan, GPC1, promotes the association of PRPN (C) to lipid rafts and appears to facilitate the conversion to PRPN (Sc). {ECO:0000269|PubMed:17468747, ECO:0000269|PubMed:19927125, ECO:0000269|PubMed:20564047}.; DOMAIN: Contains an N-terminal region composed of octamer repeats. At low copper concentrations, the sidechains of His residues from three or four repeats contribute to the binding of a single copper ion. Alternatively, a copper ion can be bound by interaction with the sidechain and backbone amide nitrogen of a single His residue. The observed copper binding stoichiometry suggests that two repeat regions cooperate to stabilize the binding of a single copper ion. At higher copper concentrations, each octamer can bind one copper ion by interactions with the His sidechain and Gly backbone atoms. A mixture of binding types may occur, especially in the case of octamer repeat expansion. Copper binding may stabilize the conformation of this region and may promote oligomerization. {ECO:0000269|PubMed:11524679, ECO:0000269|PubMed:11900542, ECO:0000269|PubMed:20375014}.",,"STRAND 63..67; /evidence=""ECO:0007829|PDB:1OEI""; STRAND 70..73; /evidence=""ECO:0007829|PDB:1OEI""; STRAND 79..82; /evidence=""ECO:0007829|PDB:1OEH""; STRAND 92..95; /evidence=""ECO:0007829|PDB:5YJ4""; STRAND 99..101; /evidence=""ECO:0007829|PDB:5L6R""; STRAND 109..112; /evidence=""ECO:0007829|PDB:7RL4""; STRAND 118..122; /evidence=""ECO:0007829|PDB:4KML""; STRAND 125..127; /evidence=""ECO:0007829|PDB:1H0L""; STRAND 128..131; /evidence=""ECO:0007829|PDB:3MD4""; STRAND 133..135; /evidence=""ECO:0007829|PDB:7RL4""; STRAND 138..140; /evidence=""ECO:0007829|PDB:7RL4""; STRAND 141..143; /evidence=""ECO:0007829|PDB:1E1S""; STRAND 159..163; /evidence=""ECO:0007829|PDB:1E1U""; STRAND 178..181; /evidence=""ECO:0007829|PDB:4E1H""; STRAND 182..185; /evidence=""ECO:0007829|PDB:6LNI""; STRAND 189..192; /evidence=""ECO:0007829|PDB:6LNI""; STRAND 196..202; /evidence=""ECO:0007829|PDB:6LNI""; STRAND 205..210; /evidence=""ECO:0007829|PDB:6LNI""; STRAND 212..215; /evidence=""ECO:0007829|PDB:4E1H""","HELIX 144..153; /evidence=""ECO:0007829|PDB:4KML""; HELIX 154..156; /evidence=""ECO:0007829|PDB:4KML""; HELIX 166..168; /evidence=""ECO:0007829|PDB:4KML""","TURN 74..76; /evidence=""ECO:0007829|PDB:1OEI""; TURN 114..117; /evidence=""ECO:0007829|PDB:7RL4""; TURN 171..173; /evidence=""ECO:0007829|PDB:1QM0""; TURN 193..195; /evidence=""ECO:0007829|PDB:3HAK""; TURN 223..225; /evidence=""ECO:0007829|PDB:3HER""; TURN 228..230; /evidence=""ECO:0007829|PDB:2LFT""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,PRNP ALTPRP PRIP PRP,Major prion protein (PrP) (ASCR) (PrP27-30) (PrP33-35C) (CD antigen CD230),Homo sapiens (Human),253.0,27661.0,MANLGCWMLVLFVATWSDLGLCKKRPKPGGWNTGGSRYPGQGSPGGNRYPPQGGGGWGQPHGGGWGQPHGGGWGQPHGGGWGQPHGGGWGQGGGTHSQWNKPSKPKTNMKHMAGAAAAGAVVGGLGGYMLGSAMSRPIIHFGSDYEDRYYRENMHRYPNQVYYRPMDEYSNQNNFVHDCVNITIKQHTVTTTTKGENFTETDVKMMERVVEQMCITQYERESQAYYQRGSSMVLFSSPPVILLISFLIFLIVG,False,False,True,P04156,"[('G3DSA:1.10.790.10', 'Prion/Doppel protein, beta-ribbon domain'), ('IPR000817', 'Prion protein'), ('IPR020949', 'Prion, copper binding octapeptide repeat region'), ('IPR022416', 'Prion/Doppel protein, beta-ribbon domain'), ('IPR025860', 'Major prion protein N-terminal'), ('IPR036924', 'Prion/Doppel beta-ribbon domain superfamily'), ('PF00377', 'Prion/Doppel alpha-helical domain'), ('PF03991', 'Copper binding octapeptide repeat region'), ('PF11587', 'Major prion protein bPrPp - N terminal'), ('PR00341', 'PRION'), ('PS00291', 'Prion protein signature 1'), ('PS00706', 'Prion protein signature 2'), ('PTHR15506', 'Major prion'), ('SM00157', 'Major prion protein'), ('SSF54098', 'Prion-like')]",P04156;,"""ENSG00000171867; Tissue enhanced (choroid)."";",,,,,ENST00000379440.9 [P04156-1];ENST00000424424.2 [P04156-1];ENST00000430350.2 [P04156-1];ENST00000457586.2 [P04156-1];,PRNP,ENSG00000171867,0.0,,,,40.32,DP00466,0.403,0.545,0.328,PRNP
P04278,ENSG00000129214,SHBG_HUMAN,,extracellular exosome [GO:0070062]; extracellular region [GO:0005576],androgen binding [GO:0005497]; steroid binding [GO:0005496],"PTM: Variant Asn-356 contains one N-linked (GlcNAc...) at position 356. {ECO:0000269|PubMed:1400872, ECO:0000269|PubMed:16335952, ECO:0000269|PubMed:19159218}.",,"DOMAIN 45..217; /note=""Laminin G-like 1""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00122""; DOMAIN 224..390; /note=""Laminin G-like 2""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00122""","STRAND 44..47; /evidence=""ECO:0007829|PDB:1D2S""; STRAND 50..52; /evidence=""ECO:0007829|PDB:6PYA""; STRAND 56..62; /evidence=""ECO:0007829|PDB:1D2S""; STRAND 70..78; /evidence=""ECO:0007829|PDB:1D2S""; STRAND 80..90; /evidence=""ECO:0007829|PDB:1D2S""; STRAND 94..101; /evidence=""ECO:0007829|PDB:1D2S""; STRAND 104..113; /evidence=""ECO:0007829|PDB:1D2S""; STRAND 115..119; /evidence=""ECO:0007829|PDB:1D2S""; STRAND 126..128; /evidence=""ECO:0007829|PDB:1D2S""; STRAND 130..137; /evidence=""ECO:0007829|PDB:1D2S""; STRAND 140..145; /evidence=""ECO:0007829|PDB:1D2S""; STRAND 148..153; /evidence=""ECO:0007829|PDB:1D2S""; STRAND 167..174; /evidence=""ECO:0007829|PDB:1D2S""; STRAND 182..184; /evidence=""ECO:0007829|PDB:1D2S""; STRAND 192..200; /evidence=""ECO:0007829|PDB:1D2S""; STRAND 205..209; /evidence=""ECO:0007829|PDB:1D2S""","HELIX 63..65; /evidence=""ECO:0007829|PDB:1D2S""; HELIX 160..162; /evidence=""ECO:0007829|PDB:6PYF""; HELIX 179..181; /evidence=""ECO:0007829|PDB:1D2S""; HELIX 202..204; /evidence=""ECO:0007829|PDB:1D2S""; HELIX 211..213; /evidence=""ECO:0007829|PDB:6PYA""","TURN 91..93; /evidence=""ECO:0007829|PDB:1D2S""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,SHBG,Sex hormone-binding globulin (SHBG) (Sex steroid-binding protein) (SBP) (Testis-specific androgen-binding protein) (ABP) (Testosterone-estradiol-binding globulin) (TeBG) (Testosterone-estrogen-binding globulin),Homo sapiens (Human),402.0,43779.0,MESRGPLATSRLLLLLLLLLLRHTRQGWALRPVLPTQSAHDPPAVHLSNGPGQEPIAVMTFDLTKITKTSSSFEVRTWDPEGVIFYGDTNPKDDWFMLGLRDGRPEIQLHNHWAQLTVGAGPRLDDGRWHQVEVKMEGDSVLLEVDGEEVLRLRQVSGPLTSKRHPIMRIALGGLLFPASNLRLPLVPALDGCLRRDSWLDKQAEISASAPTSLRSCDVESNPGIFLPPGTQAEFNLRDIPQPHAEPWAFSLDLGLKQAAGSGHLLALGTPENPSWLSLHLQDQKVVLSSGSGPGLDLPLVLGLPLQLKLSMSRVVLSQGSKMKALALPPLGLAPLLNLWAKPQGRLFLGALPGEDSSTSFCLNGLWAQGQRLDVDQALNRSHEIWTHSCPQSPGNGTDASH,False,False,True,P04278,"[('cd00110', 'LamG'), ('G3DSA:2.60.120.200', None), ('IPR001791', 'Laminin G domain'), ('IPR013320', 'Concanavalin A-like lectin/glucanase domain superfamily'), ('IPR051145', 'Growth Arrest-Specific/Sex Hormone-Binding/Vitamin K-Dependent'), ('PF00054', 'Laminin G domain'), ('PS50025', 'Laminin G domain profile'), ('PTHR24040', 'Growth Arrest-Specific/Sex Hormone-Binding/Vitamin K-Dependent'), ('SM00282', 'Laminin G domain'), ('SSF49899', 'Concanavalin A-like lectins/glucanases')]",,"""ENSG00000129214; Tissue enriched (liver)."";",,,,,ENST00000380450.9 [P04278-1];ENST00000416273.7 [P04278-3];ENST00000441599.6 [P04278-4];ENST00000574539.5 [P04278-2];ENST00000575903.5 [P04278-5];,SHBG,ENSG00000129214,0.0,,,,,,,0.117,,SHBG
P04406,ENSG00000111640,G3P_HUMAN,antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cellular response to type II interferon [GO:0071346]; defense response to fungus [GO:0050832]; glucose metabolic process [GO:0006006]; glycolytic process [GO:0006096]; killing by host of symbiont cells [GO:0051873]; killing of cells of another organism [GO:0031640]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of endopeptidase activity [GO:0010951]; negative regulation of translation [GO:0017148]; neuron apoptotic process [GO:0051402]; peptidyl-cysteine S-trans-nitrosylation [GO:0035606]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of cytokine production [GO:0001819]; positive regulation of type I interferon production [GO:0032481]; protein stabilization [GO:0050821]; regulation of macroautophagy [GO:0016241],cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; GAIT complex [GO:0097452]; intracellular membrane-bounded organelle [GO:0043231]; lipid droplet [GO:0005811]; membrane [GO:0016020]; microtubule cytoskeleton [GO:0015630]; nuclear membrane [GO:0031965]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ribonucleoprotein complex [GO:1990904]; vesicle [GO:0031982],aspartic-type endopeptidase inhibitor activity [GO:0019828]; disordered domain specific binding [GO:0097718]; glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity [GO:0004365]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; NAD binding [GO:0051287]; NADP binding [GO:0050661]; peptidyl-cysteine S-nitrosylase activity [GO:0035605],"PTM: S-nitrosylation of Cys-152 leads to interaction with SIAH1, followed by translocation to the nucleus (By similarity). S-nitrosylation of Cys-247 is induced by interferon-gamma and LDL(ox) implicating the iNOS-S100A8/9 transnitrosylase complex and seems to prevent interaction with phosphorylated RPL13A and to interfere with GAIT complex activity (PubMed:22771119, PubMed:25417112). {ECO:0000250|UniProtKB:P04797, ECO:0000269|PubMed:22771119, ECO:0000269|PubMed:25417112}.; PTM: ISGylated. {ECO:0000305|PubMed:16815975}.; PTM: Sulfhydration at Cys-152 increases catalytic activity. {ECO:0000250|UniProtKB:P16858}.; PTM: Oxidative stress can promote the formation of high molecular weight disulfide-linked GAPDH aggregates, through a process called nucleocytoplasmic coagulation. Such aggregates can be observed in vivo in the affected tissues of patients with Alzheimer disease or alcoholic liver cirrhosis, or in cell cultures during necrosis. Oxidation at Met-46 may play a pivotal role in the formation of these insoluble structures. This modification has been detected in vitro following treatment with free radical donor (+/-)-(E)-4-ethyl-2-[(E)-hydroxyimino]-5-nitro-3-hexenamide. It has been proposed to destabilize nearby residues, increasing the likelihood of secondary oxidative damages, including oxidation of Tyr-45 and Met-105. This cascade of oxidations may augment GAPDH misfolding, leading to intermolecular disulfide cross-linking and aggregation. {ECO:0000305|PubMed:25086035}.; PTM: Succination of Cys-152 and Cys-247 by the Krebs cycle intermediate fumarate, which leads to S-(2-succinyl)cysteine residues, inhibits glyceraldehyde-3-phosphate dehydrogenase activity. Fumarate concentration as well as succination of cysteine residues in GAPDH is significantly increased in muscle of diabetic mammals. It was proposed that the S-(2-succinyl)cysteine chemical modification may be a useful biomarker of mitochondrial and oxidative stress in diabetes and that succination of GAPDH and other thiol proteins by fumarate may contribute to the metabolic changes underlying the development of diabetes complications. {ECO:0000250|UniProtKB:P04797}.; PTM: (Microbial infection) Glycosylated by C.rodentium protein NleB, enteropathogenic E.coli protein NleB1 and S.typhimurium protein Ssek1: arginine GlcNAcylation prevents the interaction with TRAF2 and TRAF3 (PubMed:23332158, PubMed:27387501, PubMed:28522607). This leads to reduced ubiquitination of TRAF2 and TRAF3, and subsequent inhibition of NF-kappa-B signaling and type I interferon production, respectively (PubMed:23332158, PubMed:27387501). {ECO:0000269|PubMed:23332158, ECO:0000269|PubMed:27387501, ECO:0000269|PubMed:28522607}.",DOMAIN: The [IL]-x-C-x-x-[DE] motif is a proposed target motif for cysteine S-nitrosylation mediated by the iNOS-S100A8/A9 transnitrosylase complex. {ECO:0000305|PubMed:25417112}.,,"STRAND 5..9; /evidence=""ECO:0007829|PDB:6YND""; STRAND 27..34; /evidence=""ECO:0007829|PDB:6YND""; STRAND 36..38; /evidence=""ECO:0007829|PDB:6YND""; STRAND 60..63; /evidence=""ECO:0007829|PDB:6YND""; STRAND 66..69; /evidence=""ECO:0007829|PDB:6YND""; STRAND 72..77; /evidence=""ECO:0007829|PDB:6YND""; STRAND 94..97; /evidence=""ECO:0007829|PDB:6YND""; STRAND 99..101; /evidence=""ECO:0007829|PDB:6YND""; STRAND 117..123; /evidence=""ECO:0007829|PDB:6YND""; STRAND 126..128; /evidence=""ECO:0007829|PDB:6YND""; STRAND 146..148; /evidence=""ECO:0007829|PDB:6YND""; STRAND 170..179; /evidence=""ECO:0007829|PDB:6YND""; STRAND 185..189; /evidence=""ECO:0007829|PDB:6YND""; STRAND 207..210; /evidence=""ECO:0007829|PDB:6YND""; STRAND 227..234; /evidence=""ECO:0007829|PDB:6YND""; STRAND 241..251; /evidence=""ECO:0007829|PDB:6YND""; STRAND 274..277; /evidence=""ECO:0007829|PDB:6YND""; STRAND 292..296; /evidence=""ECO:0007829|PDB:6YND""; STRAND 301..304; /evidence=""ECO:0007829|PDB:6YND""; STRAND 307..314; /evidence=""ECO:0007829|PDB:6YND""","HELIX 13..25; /evidence=""ECO:0007829|PDB:6YND""; HELIX 40..48; /evidence=""ECO:0007829|PDB:6YND""; HELIX 82..84; /evidence=""ECO:0007829|PDB:6YND""; HELIX 88..90; /evidence=""ECO:0007829|PDB:6YND""; HELIX 105..108; /evidence=""ECO:0007829|PDB:6YND""; HELIX 110..113; /evidence=""ECO:0007829|PDB:6YND""; HELIX 137..139; /evidence=""ECO:0007829|PDB:6YND""; HELIX 152..168; /evidence=""ECO:0007829|PDB:6YND""; HELIX 196..199; /evidence=""ECO:0007829|PDB:6YND""; HELIX 213..220; /evidence=""ECO:0007829|PDB:6YND""; HELIX 222..224; /evidence=""ECO:0007829|PDB:6YND""; HELIX 255..267; /evidence=""ECO:0007829|PDB:6YND""; HELIX 283..286; /evidence=""ECO:0007829|PDB:6YND""; HELIX 318..333; /evidence=""ECO:0007829|PDB:6YND""","TURN 51..53; /evidence=""ECO:0007829|PDB:6YND""; TURN 133..135; /evidence=""ECO:0007829|PDB:6YND""; TURN 202..204; /evidence=""ECO:0007829|PDB:6YND""; TURN 268..273; /evidence=""ECO:0007829|PDB:6YND""; TURN 297..299; /evidence=""ECO:0007829|PDB:6YND""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,GAPDH GAPD CDABP0047 OK/SW-cl.12,Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (EC 1.2.1.12) (Peptidyl-cysteine S-nitrosylase GAPDH) (EC 2.6.99.-),Homo sapiens (Human),335.0,36053.0,MGKVKVGVNGFGRIGRLVTRAAFNSGKVDIVAINDPFIDLNYMVYMFQYDSTHGKFHGTVKAENGKLVINGNPITIFQERDPSKIKWGDAGAEYVVESTGVFTTMEKAGAHLQGGAKRVIISAPSADAPMFVMGVNHEKYDNSLKIISNASCTTNCLAPLAKVIHDNFGIVEGLMTTVHAITATQKTVDGPSGKLWRDGRGALQNIIPASTGAAKAVGKVIPELNGKLTGMAFRVPTANVSVVDLTCRLEKPAKYDDIKKVVKQASEGPLKGILGYTEHQVVSSDFNSDTHSSTFDAGAGIALNDHFVKLISWYDNEFGYSNRVVDLMAHMASKE,True,True,True,P04406,"[('G3DSA:3.30.360.10', 'Dihydrodipicolinate Reductase; domain 2'), ('G3DSA:3.40.50.720', 'NAD(P)-binding Rossmann-like Domain'), ('IPR006424', 'Glyceraldehyde-3-phosphate dehydrogenase, type I'), ('IPR020828', 'Glyceraldehyde 3-phosphate dehydrogenase, NAD(P) binding domain'), ('IPR020829', 'Glyceraldehyde 3-phosphate dehydrogenase, catalytic domain'), ('IPR020830', 'Glyceraldehyde 3-phosphate dehydrogenase, active site'), ('IPR020831', 'Glyceraldehyde/Erythrose phosphate dehydrogenase family'), ('IPR036291', 'NAD(P)-binding domain superfamily'), ('PF00044', 'Glyceraldehyde 3-phosphate dehydrogenase, NAD binding domain'), ('PF02800', 'Glyceraldehyde 3-phosphate dehydrogenase, C-terminal domain'), ('PIRSF000149', 'Glyceraldehyde-3-phosphate dehydrogenase'), ('PR00078', 'G3PDHDRGNASE'), ('PS00071', 'Glyceraldehyde 3-phosphate dehydrogenase active site'), ('PTHR10836', 'GLYCERALDEHYDE 3-PHOSPHATE DEHYDROGENASE'), ('SM00846', 'Glyceraldehyde 3-phosphate dehydrogenase, NAD binding domain'), ('SSF51735', 'NAD(P)-binding Rossmann-fold domains'), ('SSF55347', 'Glyceraldehyde-3-phosphate dehydrogenase-like, C-terminal domain'), ('TIGR01534', 'glyceraldehyde-3-phosphate dehydrogenase, type I')]",,"""ENSG00000111640; Group enriched (skeletal muscle, tongue)."";","CATALYTIC ACTIVITY: Reaction=D-glyceraldehyde 3-phosphate + phosphate + NAD(+) = (2R)-3-phospho-glyceroyl phosphate + NADH + H(+); Xref=Rhea:RHEA:10300, ChEBI:CHEBI:15378, ChEBI:CHEBI:43474, ChEBI:CHEBI:57540, ChEBI:CHEBI:57604, ChEBI:CHEBI:57945, ChEBI:CHEBI:59776; EC=1.2.1.12; Evidence={ECO:0000255|PROSITE-ProRule:PRU10009, ECO:0000269|PubMed:3170585}; CATALYTIC ACTIVITY: Reaction=S-nitroso-L-cysteinyl-[GAPDH] + L-cysteinyl-[protein] = L-cysteinyl-[GAPDH] + S-nitroso-L-cysteinyl-[protein]; Xref=Rhea:RHEA:66684, Rhea:RHEA-COMP:10131, Rhea:RHEA-COMP:17089, Rhea:RHEA-COMP:17090, Rhea:RHEA-COMP:17091, ChEBI:CHEBI:29950, ChEBI:CHEBI:149494; Evidence={ECO:0000250|UniProtKB:P04797}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:66685; Evidence={ECO:0000250|UniProtKB:P04797};",1.2.1.12; 2.6.99.-,"ACTIVITY REGULATION: Glyceraldehyde-3-phosphate dehydrogenase activity is inhibited by fumarate, via the formation of S-(2-succinyl)cysteine residues. {ECO:0000250|UniProtKB:P04797}.",PATHWAY: Carbohydrate degradation; glycolysis; pyruvate from D-glyceraldehyde 3-phosphate: step 1/5.,ENST00000229239.10 [P04406-1];ENST00000396858.5 [P04406-2];ENST00000396859.5 [P04406-1];ENST00000396861.5 [P04406-1];ENST00000619601.1 [P04406-2];,GAPDH,ENSG00000111640,0.0,GAPDH,Non-canonical_RBPs,16.0,,,,,,GAPDH
P04626,ENSG00000141736,ERBB2_HUMAN,cell population proliferation [GO:0008283]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; cell surface receptor signaling pathway [GO:0007166]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to growth factor stimulus [GO:0071363]; enzyme-linked receptor protein signaling pathway [GO:0007167]; ERBB2-EGFR signaling pathway [GO:0038134]; ERBB2-ERBB3 signaling pathway [GO:0038133]; ERBB2-ERBB4 signaling pathway [GO:0038135]; heart development [GO:0007507]; immature T cell proliferation in thymus [GO:0033080]; intracellular signal transduction [GO:0035556]; motor neuron axon guidance [GO:0008045]; myelination [GO:0042552]; negative regulation of apoptotic process [GO:0043066]; negative regulation of immature T cell proliferation in thymus [GO:0033088]; neurogenesis [GO:0022008]; neuromuscular junction development [GO:0007528]; neuron differentiation [GO:0030182]; neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0099645]; oligodendrocyte differentiation [GO:0048709]; peptidyl-tyrosine phosphorylation [GO:0018108]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of Rho protein signal transduction [GO:0035025]; positive regulation of transcription by RNA polymerase I [GO:0045943]; positive regulation of translation [GO:0045727]; protein phosphorylation [GO:0006468]; regulation of angiogenesis [GO:0045765]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of microtubule-based process [GO:0032886]; Schwann cell development [GO:0014044]; semaphorin-plexin signaling pathway [GO:0071526]; signal transduction [GO:0007165]; wound healing [GO:0042060],apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome membrane [GO:0010008]; ERBB3:ERBB2 complex [GO:0038143]; membrane [GO:0016020]; myelin sheath [GO:0043209]; neuromuscular junction [GO:0031594]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; presynaptic membrane [GO:0042734]; receptor complex [GO:0043235]; ruffle membrane [GO:0032587]; semaphorin receptor complex [GO:0002116],ATP binding [GO:0005524]; coreceptor activity [GO:0015026]; ErbB-3 class receptor binding [GO:0043125]; identical protein binding [GO:0042802]; protein heterodimerization activity [GO:0046982]; protein tyrosine kinase activity [GO:0004713]; receptor tyrosine kinase binding [GO:0030971]; RNA polymerase I core binding [GO:0001042]; signaling receptor binding [GO:0005102]; transmembrane receptor protein tyrosine kinase activity [GO:0004714]; transmembrane signaling receptor activity [GO:0004888],"PTM: Autophosphorylated. Autophosphorylation occurs in trans, i.e. one subunit of the dimeric receptor phosphorylates tyrosine residues on the other subunit (Probable). Ligand-binding increases phosphorylation on tyrosine residues (PubMed:27134172, PubMed:33497358). Signaling via SEMA4C promotes phosphorylation at Tyr-1248 (PubMed:17554007). Dephosphorylated by PTPN12 (PubMed:27134172). {ECO:0000269|PubMed:17554007, ECO:0000269|PubMed:27134172, ECO:0000269|PubMed:33497358, ECO:0000305}.",,"DOMAIN 720..987; /note=""Protein kinase""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00159""","STRAND 25..27; /evidence=""ECO:0007829|PDB:8JYR""; STRAND 55..64; /evidence=""ECO:0007829|PDB:8JYR""; STRAND 79..82; /evidence=""ECO:0007829|PDB:8JYR""; STRAND 84..88; /evidence=""ECO:0007829|PDB:8JYR""; STRAND 92..95; /evidence=""ECO:0007829|PDB:3H3B""; STRAND 112..117; /evidence=""ECO:0007829|PDB:8JYR""; STRAND 123..125; /evidence=""ECO:0007829|PDB:8PWH""; STRAND 139..141; /evidence=""ECO:0007829|PDB:3H3B""; STRAND 147..150; /evidence=""ECO:0007829|PDB:2A91""; STRAND 152..156; /evidence=""ECO:0007829|PDB:8JYR""; STRAND 182..184; /evidence=""ECO:0007829|PDB:8JYR""; STRAND 204..208; /evidence=""ECO:0007829|PDB:8JYR""; STRAND 217..219; /evidence=""ECO:0007829|PDB:1N8Z""; STRAND 227..231; /evidence=""ECO:0007829|PDB:5MY6""; STRAND 240..248; /evidence=""ECO:0007829|PDB:5MY6""; STRAND 251..260; /evidence=""ECO:0007829|PDB:5MY6""; STRAND 263..267; /evidence=""ECO:0007829|PDB:5MY6""; STRAND 271..274; /evidence=""ECO:0007829|PDB:5MY6""; STRAND 281..283; /evidence=""ECO:0007829|PDB:5MY6""; STRAND 289..291; /evidence=""ECO:0007829|PDB:5MY6""; STRAND 294..298; /evidence=""ECO:0007829|PDB:5MY6""; STRAND 303..305; /evidence=""ECO:0007829|PDB:1N8Z""; STRAND 309..314; /evidence=""ECO:0007829|PDB:5MY6""; STRAND 319..323; /evidence=""ECO:0007829|PDB:5MY6""; STRAND 325..327; /evidence=""ECO:0007829|PDB:3MZW""; STRAND 329..333; /evidence=""ECO:0007829|PDB:5MY6""; STRAND 335..337; /evidence=""ECO:0007829|PDB:2A91""; STRAND 368..376; /evidence=""ECO:0007829|PDB:5MY6""; STRAND 405..408; /evidence=""ECO:0007829|PDB:5MY6""; STRAND 410..413; /evidence=""ECO:0007829|PDB:5MY6""; STRAND 417..421; /evidence=""ECO:0007829|PDB:8PWH""; STRAND 430..435; /evidence=""ECO:0007829|PDB:3WLW""; STRAND 441..447; /evidence=""ECO:0007829|PDB:5MY6""; STRAND 463..469; /evidence=""ECO:0007829|PDB:5MY6""; STRAND 488..490; /evidence=""ECO:0007829|PDB:6J71""; STRAND 493..499; /evidence=""ECO:0007829|PDB:5MY6""; STRAND 520..524; /evidence=""ECO:0007829|PDB:5MY6""; STRAND 532..536; /evidence=""ECO:0007829|PDB:6LBX""; STRAND 539..542; /evidence=""ECO:0007829|PDB:6LBX""; STRAND 545..551; /evidence=""ECO:0007829|PDB:6LBX""; STRAND 553..556; /evidence=""ECO:0007829|PDB:6LBX""; STRAND 559..562; /evidence=""ECO:0007829|PDB:6LBX""; STRAND 565..567; /evidence=""ECO:0007829|PDB:3WSQ""; STRAND 571..573; /evidence=""ECO:0007829|PDB:6LBX""; STRAND 575..580; /evidence=""ECO:0007829|PDB:6LBX""; STRAND 583..592; /evidence=""ECO:0007829|PDB:6LBX""; STRAND 595..599; /evidence=""ECO:0007829|PDB:6LBX""; STRAND 602..604; /evidence=""ECO:0007829|PDB:6J71""; STRAND 605..608; /evidence=""ECO:0007829|PDB:8PWH""; STRAND 613..616; /evidence=""ECO:0007829|PDB:8JYQ""; STRAND 621..625; /evidence=""ECO:0007829|PDB:1N8Z""; STRAND 630..632; /evidence=""ECO:0007829|PDB:6J71""; STRAND 635..637; /evidence=""ECO:0007829|PDB:6J71""; STRAND 720..729; /evidence=""ECO:0007829|PDB:8U8X""; STRAND 732..739; /evidence=""ECO:0007829|PDB:8U8X""; STRAND 748..755; /evidence=""ECO:0007829|PDB:8U8X""; STRAND 787..799; /evidence=""ECO:0007829|PDB:8U8X""; STRAND 851..855; /evidence=""ECO:0007829|PDB:8U8X""; STRAND 858..861; /evidence=""ECO:0007829|PDB:8U8X""; STRAND 1140..1142; /evidence=""ECO:0007829|PDB:1MW4""","HELIX 39..50; /evidence=""ECO:0007829|PDB:8JYR""; HELIX 72..74; /evidence=""ECO:0007829|PDB:8JYR""; HELIX 164..166; /evidence=""ECO:0007829|PDB:8JYR""; HELIX 169..171; /evidence=""ECO:0007829|PDB:8JYR""; HELIX 175..177; /evidence=""ECO:0007829|PDB:1N8Z""; HELIX 200..202; /evidence=""ECO:0007829|PDB:8JYR""; HELIX 209..211; /evidence=""ECO:0007829|PDB:8JYR""; HELIX 221..223; /evidence=""ECO:0007829|PDB:5MY6""; HELIX 232..234; /evidence=""ECO:0007829|PDB:5MY6""; HELIX 348..350; /evidence=""ECO:0007829|PDB:5MY6""; HELIX 361..364; /evidence=""ECO:0007829|PDB:5MY6""; HELIX 378..382; /evidence=""ECO:0007829|PDB:5MY6""; HELIX 385..387; /evidence=""ECO:0007829|PDB:5MY6""; HELIX 394..400; /evidence=""ECO:0007829|PDB:5MY6""; HELIX 423..425; /evidence=""ECO:0007829|PDB:5MY6""; HELIX 482..485; /evidence=""ECO:0007829|PDB:5MY6""; HELIX 501..506; /evidence=""ECO:0007829|PDB:5MY6""; HELIX 516..518; /evidence=""ECO:0007829|PDB:5MY6""; HELIX 525..527; /evidence=""ECO:0007829|PDB:2A91""; HELIX 651..678; /evidence=""ECO:0007829|PDB:2JWA""; HELIX 684..690; /evidence=""ECO:0007829|PDB:2N2A""; HELIX 691..697; /evidence=""ECO:0007829|PDB:2N2A""; HELIX 717..719; /evidence=""ECO:0007829|PDB:8U8X""; HELIX 770..775; /evidence=""ECO:0007829|PDB:8U8X""; HELIX 806..813; /evidence=""ECO:0007829|PDB:8U8X""; HELIX 814..816; /evidence=""ECO:0007829|PDB:8U8X""; HELIX 819..838; /evidence=""ECO:0007829|PDB:8U8X""; HELIX 848..850; /evidence=""ECO:0007829|PDB:8U8X""; HELIX 866..870; /evidence=""ECO:0007829|PDB:8U8X""; HELIX 874..876; /evidence=""ECO:0007829|PDB:8U8X""; HELIX 878..880; /evidence=""ECO:0007829|PDB:8U8X""; HELIX 886..888; /evidence=""ECO:0007829|PDB:8U8X""; HELIX 891..896; /evidence=""ECO:0007829|PDB:8U8X""; HELIX 901..916; /evidence=""ECO:0007829|PDB:8U8X""; HELIX 928..930; /evidence=""ECO:0007829|PDB:8U8X""; HELIX 931..936; /evidence=""ECO:0007829|PDB:8U8X""; HELIX 949..958; /evidence=""ECO:0007829|PDB:8U8X""; HELIX 963..965; /evidence=""ECO:0007829|PDB:8U8X""; HELIX 969..980; /evidence=""ECO:0007829|PDB:8U8X""; HELIX 983..985; /evidence=""ECO:0007829|PDB:8U8X""; HELIX 989..992; /evidence=""ECO:0007829|PDB:3PP0""; HELIX 1003..1007; /evidence=""ECO:0007829|PDB:3PP0""; HELIX 1020..1022; /evidence=""ECO:0007829|PDB:8U8X""","TURN 109..111; /evidence=""ECO:0007829|PDB:8JYR""; TURN 130..132; /evidence=""ECO:0007829|PDB:3H3B""; TURN 276..278; /evidence=""ECO:0007829|PDB:5MY6""; TURN 284..286; /evidence=""ECO:0007829|PDB:6J71""; TURN 358..360; /evidence=""ECO:0007829|PDB:5MY6""; TURN 438..440; /evidence=""ECO:0007829|PDB:5MY6""; TURN 476..479; /evidence=""ECO:0007829|PDB:7MN5""; TURN 507..509; /evidence=""ECO:0007829|PDB:3N85""; TURN 762..765; /evidence=""ECO:0007829|PDB:3RCD""; TURN 922..925; /evidence=""ECO:0007829|PDB:8U8X""; TURN 1008..1011; /evidence=""ECO:0007829|PDB:8U8X""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,ERBB2 HER2 MLN19 NEU NGL,Receptor tyrosine-protein kinase erbB-2 (EC 2.7.10.1) (Metastatic lymph node gene 19 protein) (MLN 19) (Proto-oncogene Neu) (Proto-oncogene c-ErbB-2) (Tyrosine kinase-type cell surface receptor HER2) (p185erbB2) (CD antigen CD340),Homo sapiens (Human),1255.0,137910.0,MELAALCRWGLLLALLPPGAASTQVCTGTDMKLRLPASPETHLDMLRHLYQGCQVVQGNLELTYLPTNASLSFLQDIQEVQGYVLIAHNQVRQVPLQRLRIVRGTQLFEDNYALAVLDNGDPLNNTTPVTGASPGGLRELQLRSLTEILKGGVLIQRNPQLCYQDTILWKDIFHKNNQLALTLIDTNRSRACHPCSPMCKGSRCWGESSEDCQSLTRTVCAGGCARCKGPLPTDCCHEQCAAGCTGPKHSDCLACLHFNHSGICELHCPALVTYNTDTFESMPNPEGRYTFGASCVTACPYNYLSTDVGSCTLVCPLHNQEVTAEDGTQRCEKCSKPCARVCYGLGMEHLREVRAVTSANIQEFAGCKKIFGSLAFLPESFDGDPASNTAPLQPEQLQVFETLEEITGYLYISAWPDSLPDLSVFQNLQVIRGRILHNGAYSLTLQGLGISWLGLRSLRELGSGLALIHHNTHLCFVHTVPWDQLFRNPHQALLHTANRPEDECVGEGLACHQLCARGHCWGPGPTQCVNCSQFLRGQECVEECRVLQGLPREYVNARHCLPCHPECQPQNGSVTCFGPEADQCVACAHYKDPPFCVARCPSGVKPDLSYMPIWKFPDEEGACQPCPINCTHSCVDLDDKGCPAEQRASPLTSIISAVVGILLVVVLGVVFGILIKRRQQKIRKYTMRRLLQETELVEPLTPSGAMPNQAQMRILKETELRKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVSRLLGICLTSTVQLVTQLMPYGCLLDHVRENRGRLGSQDLLNWCMQIAKGMSYLEDVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILRRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVSEFSRMARDPQRFVVIQNEDLGPASPLDSTFYRSLLEDDDMGDLVDAEEYLVPQQGFFCPDPAPGAGGMVHHRHRSSSTRSGGGDLTLGLEPSEEEAPRSPLAPSEGAGSDVFDGDLGMGAAKGLQSLPTHDPSPLQRYSEDPTVPLPSETDGYVAPLTCSPQPEYVNQPDVRPQPPSPREGPLPAARPAGATLERPKTLSPGKNGVVKDVFAFGGAVENPEYLTPQGGAAPQPHPPPAFSPAFDNLYYWDQDPPERGAPPSTFKGTPTAENPEYLGLDVPV,False,False,True,P04626,"[('cd00064', 'FU'), ('cd05109', 'Catalytic domain of the Protein Tyrosine Kinase, HER2'), ('cd12094', 'Transmembrane domain of ErbB2, a Protein Tyrosine Kinase'), ('G3DSA:1.10.510.10', 'Transferase(Phosphotransferase) domain 1'), ('G3DSA:1.20.5.100', 'Cytochrome c1, transmembrane anchor, C-terminal'), ('G3DSA:2.10.220.10', 'Hormone Receptor, Insulin-like Growth Factor Receptor 1; Chain A, domain 2'), ('G3DSA:3.30.200.20', 'Phosphorylase Kinase; domain 1'), ('G3DSA:3.80.20.20', 'Receptor L-domain'), ('G3DSA:4.10.1140.10', 'membrane-bound form of the juxtamembrane domain of the epidermal growth factor receptor like domain'), ('IPR000494', 'Receptor L-domain'), ('IPR000719', 'Protein kinase domain'), ('IPR001245', 'Serine-threonine/tyrosine-protein kinase, catalytic domain'), ('IPR006211', 'Furin-like cysteine-rich domain'), ('IPR006212', 'Furin-like repeat'), ('IPR008266', 'Tyrosine-protein kinase, active site'), ('IPR009030', 'Growth factor receptor cysteine-rich domain superfamily'), ('IPR011009', 'Protein kinase-like domain superfamily'), ('IPR016245', 'Tyrosine protein kinase, EGF/ERB/XmrK receptor'), ('IPR017441', 'Protein kinase, ATP binding site'), ('IPR020635', 'Tyrosine-protein kinase, catalytic domain')]",P04626;,"""ENSG00000141736; Low tissue specificity."";","CATALYTIC ACTIVITY: Reaction=L-tyrosyl-[protein] + ATP = O-phospho-L-tyrosyl-[protein] + ADP + H(+); Xref=Rhea:RHEA:10596, Rhea:RHEA-COMP:10136, Rhea:RHEA-COMP:10137, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616, ChEBI:CHEBI:46858, ChEBI:CHEBI:82620, ChEBI:CHEBI:456216; EC=2.7.10.1; Evidence={ECO:0000255|PROSITE-ProRule:PRU10028, ECO:0000269|PubMed:21454582};",2.7.10.1,"ACTIVITY REGULATION: Activated by dimerization. Not activated by EGF, TGF-alpha and amphiregulin. Interaction with PTK6 increases its intrinsic kinase activity. {ECO:0000269|PubMed:18719096, ECO:0000269|PubMed:21454582}.",,ENST00000269571.10 [P04626-1];ENST00000406381.6 [P04626-5];ENST00000541774.5 [P04626-4];ENST00000584601.5 [P04626-5];,ERBB2,ENSG00000141736,0.0,,,,21.35,DP01484,0.305,0.232,0.163,ERBB2
P04637,ENSG00000141510,P53_HUMAN,"autophagy [GO:0006914]; B cell lineage commitment [GO:0002326]; bone marrow development [GO:0048539]; cardiac muscle cell apoptotic process [GO:0010659]; cardiac septum morphogenesis [GO:0060411]; cellular response to actinomycin D [GO:0072717]; cellular response to gamma radiation [GO:0071480]; cellular response to glucose starvation [GO:0042149]; cellular response to hypoxia [GO:0071456]; cellular response to ionizing radiation [GO:0071479]; cellular response to UV [GO:0034644]; cellular response to UV-C [GO:0071494]; cellular response to xenobiotic stimulus [GO:0071466]; cellular senescence [GO:0090398]; cerebellum development [GO:0021549]; chromosome organization [GO:0051276]; circadian behavior [GO:0048512]; determination of adult lifespan [GO:0008340]; DNA damage response [GO:0006974]; DNA damage response, signal transduction by p53 class mediator [GO:0030330]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator [GO:0006978]; double-strand break repair [GO:0006302]; embryonic organ development [GO:0048568]; entrainment of circadian clock by photoperiod [GO:0043153]; ER overload response [GO:0006983]; fibroblast proliferation [GO:0048144]; gastrulation [GO:0007369]; glial cell proliferation [GO:0014009]; glucose catabolic process to lactate via pyruvate [GO:0019661]; hematopoietic progenitor cell differentiation [GO:0002244]; hematopoietic stem cell differentiation [GO:0060218]; in utero embryonic development [GO:0001701]; intrinsic apoptotic signaling pathway [GO:0097193]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; intrinsic apoptotic signaling pathway in response to hypoxia [GO:1990144]; mitochondrial DNA repair [GO:0043504]; mitophagy [GO:0000423]; mitotic G1 DNA damage checkpoint signaling [GO:0031571]; mRNA transcription [GO:0009299]; multicellular organism growth [GO:0035264]; necroptotic process [GO:0070266]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA replication [GO:0008156]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of fibroblast proliferation [GO:0048147]; negative regulation of G1 to G0 transition [GO:1903451]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of glucose catabolic process to lactate via pyruvate [GO:1904024]; negative regulation of helicase activity [GO:0051097]; negative regulation of miRNA processing [GO:1903799]; negative regulation of mitophagy [GO:1901525]; negative regulation of neuroblast proliferation [GO:0007406]; negative regulation of pentose-phosphate shunt [GO:1905856]; negative regulation of proteolysis [GO:0045861]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; negative regulation of stem cell proliferation [GO:2000647]; negative regulation of telomere maintenance via telomerase [GO:0032211]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; neuroblast proliferation [GO:0007405]; neuron apoptotic process [GO:0051402]; nucleotide-excision repair [GO:0006289]; oligodendrocyte apoptotic process [GO:0097252]; oxidative stress-induced premature senescence [GO:0090403]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cardiac muscle cell apoptotic process [GO:0010666]; positive regulation of cellular senescence [GO:2000774]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of execution phase of apoptosis [GO:1900119]; positive regulation of gene expression [GO:0010628]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of mitochondrial membrane permeability [GO:0035794]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of programmed necrotic cell death [GO:0062100]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; positive regulation of release of cytochrome c from mitochondria [GO:0090200]; positive regulation of RNA polymerase II transcription preinitiation complex assembly [GO:0045899]; positive regulation of thymocyte apoptotic process [GO:0070245]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein import into nucleus [GO:0006606]; protein localization [GO:0008104]; protein stabilization [GO:0050821]; protein tetramerization [GO:0051262]; protein-containing complex assembly [GO:0065003]; Ras protein signal transduction [GO:0007265]; reactive oxygen species metabolic process [GO:0072593]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of cell cycle G2/M phase transition [GO:1902749]; regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043516]; regulation of DNA-templated transcription [GO:0006355]; regulation of fibroblast apoptotic process [GO:2000269]; regulation of intrinsic apoptotic signaling pathway by p53 class mediator [GO:1902253]; regulation of mitochondrial membrane permeability involved in apoptotic process [GO:1902108]; regulation of tissue remodeling [GO:0034103]; regulation of transcription by RNA polymerase II [GO:0006357]; release of cytochrome c from mitochondria [GO:0001836]; replicative senescence [GO:0090399]; response to antibiotic [GO:0046677]; response to gamma radiation [GO:0010332]; response to ischemia [GO:0002931]; response to salt stress [GO:0009651]; response to X-ray [GO:0010165]; rRNA transcription [GO:0009303]; signal transduction by p53 class mediator [GO:0072331]; somitogenesis [GO:0001756]; stem cell proliferation [GO:0072089]; T cell differentiation in thymus [GO:0033077]; T cell lineage commitment [GO:0002360]; T cell proliferation involved in immune response [GO:0002309]; thymocyte apoptotic process [GO:0070242]; transcription initiation-coupled chromatin remodeling [GO:0045815]; transforming growth factor beta receptor signaling pathway [GO:0007179]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; type II interferon-mediated signaling pathway [GO:0060333]; viral process [GO:0016032]",centrosome [GO:0005813]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; germ cell nucleus [GO:0043073]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; protein-containing complex [GO:0032991]; replication fork [GO:0005657]; site of double-strand break [GO:0035861]; transcription regulator complex [GO:0005667]; transcription repressor complex [GO:0017053],"14-3-3 protein binding [GO:0071889]; ATP-dependent DNA/DNA annealing activity [GO:0036310]; chromatin binding [GO:0003682]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; copper ion binding [GO:0005507]; core promoter sequence-specific DNA binding [GO:0001046]; disordered domain specific binding [GO:0097718]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; enzyme binding [GO:0019899]; general transcription initiation factor binding [GO:0140296]; histone deacetylase binding [GO:0042826]; histone deacetylase regulator activity [GO:0035033]; identical protein binding [GO:0042802]; MDM2/MDM4 family protein binding [GO:0097371]; molecular condensate scaffold activity [GO:0140693]; molecular function activator activity [GO:0140677]; mRNA 3'-UTR binding [GO:0003730]; p53 binding [GO:0002039]; promoter-specific chromatin binding [GO:1990841]; protease binding [GO:0002020]; protein heterodimerization activity [GO:0046982]; protein phosphatase 2A binding [GO:0051721]; protein-folding chaperone binding [GO:0051087]; receptor tyrosine kinase binding [GO:0030971]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; TFIID-class transcription factor complex binding [GO:0001094]; transcription cis-regulatory region binding [GO:0000976]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]","PTM: Acetylation of Lys-382 by CREBBP enhances transcriptional activity (PubMed:10656795, PubMed:15448695, PubMed:20228809, PubMed:23431171). Acetylation of Lys-382 by EP300 (PubMed:10656795, PubMed:15448695, PubMed:20228809, PubMed:23431171). Deacetylation of Lys-382 by SIRT1 impairs its ability to induce proapoptotic program and modulate cell senescence (PubMed:10656795, PubMed:15448695, PubMed:20228809, PubMed:23431171). Deacetylation by SIRT2 impairs its ability to induce transcription activation in a AKT-dependent manner (PubMed:10656795, PubMed:15448695, PubMed:20228809, PubMed:23431171, PubMed:29681526). Acetylation at Lys-381 increases stability (PubMed:29474172). Deacetylation at Lys-381 by SIRT6 decreases its stability, thereby regulating cell senescence (PubMed:29474172). Acetylated at Lys-120 by KAT5, KAT6A and KAT8; regulating its ability to induce proapoptotic program (PubMed:17189187, PubMed:19854137, PubMed:23431171). {ECO:0000269|PubMed:10656795, ECO:0000269|PubMed:15448695, ECO:0000269|PubMed:17189187, ECO:0000269|PubMed:19854137, ECO:0000269|PubMed:20228809, ECO:0000269|PubMed:23431171, ECO:0000269|PubMed:29474172, ECO:0000269|PubMed:29681526}.; PTM: Lactylation by AARS1 prevents ability to undergo liquid-liquid phase separation (LLPS), thereby inhibiting transcription factor activity. {ECO:0000269|PubMed:38653238}.; PTM: Phosphorylation on Ser residues mediates transcriptional activation. Phosphorylated by HIPK1 (By similarity). Phosphorylation at Ser-9 by HIPK4 increases repression activity on BIRC5 promoter. Phosphorylated on Thr-18 by VRK1, which may prevent the interaction with MDM2 (PubMed:10951572, PubMed:31527692). Phosphorylated on Ser-20 by CHEK2 in response to DNA damage, which prevents ubiquitination by MDM2. Phosphorylated on Ser-20 by PLK3 in response to reactive oxygen species (ROS), promoting p53/TP53-mediated apoptosis. Phosphorylated on Thr-55 by TAF1, which promotes MDM2-mediated degradation. Phosphorylated on Ser-33 by CDK7 in a CAK complex in response to DNA damage. Phosphorylated on Ser-46 by HIPK2 upon UV irradiation. Phosphorylation on Ser-46 is required for acetylation by CREBBP. Phosphorylated on Ser-392 following UV but not gamma irradiation. Phosphorylated by NUAK1 at Ser-15 and Ser-392; was initially thought to be mediated by STK11/LKB1 but it was later shown that it is indirect and that STK11/LKB1-dependent phosphorylation is probably mediated by downstream NUAK1 (PubMed:21317932). It is unclear whether AMP directly mediates phosphorylation at Ser-15. Phosphorylated on Thr-18 by isoform 1 and isoform 2 of VRK2. Phosphorylation on Thr-18 by isoform 2 of VRK2 results in a reduction in ubiquitination by MDM2 and an increase in acetylation by EP300. Stabilized by CDK5-mediated phosphorylation in response to genotoxic and oxidative stresses at Ser-15, Ser-33 and Ser-46, leading to accumulation of p53/TP53, particularly in the nucleus, thus inducing the transactivation of p53/TP53 target genes. Phosphorylated by DYRK2 at Ser-46 in response to genotoxic stress. Phosphorylated at Ser-315 and Ser-392 by CDK2 in response to DNA-damage. Phosphorylation at Ser-15 is required for interaction with DDX3X and gamma-tubulin (PubMed:28842590). Phosphorylation at Ser-392 regulates its ability to undergo liquid-liquid phase separation by increasing fluidity of TP53/p53 condensates (PubMed:35618207). {ECO:0000250, ECO:0000269|PubMed:10570149, ECO:0000269|PubMed:10606744, ECO:0000269|PubMed:10884347, ECO:0000269|PubMed:10951572, ECO:0000269|PubMed:11239457, ECO:0000269|PubMed:11447225, ECO:0000269|PubMed:11546806, ECO:0000269|PubMed:11551930, ECO:0000269|PubMed:11554766, ECO:0000269|PubMed:11740489, ECO:0000269|PubMed:11780126, ECO:0000269|PubMed:12810724, ECO:0000269|PubMed:14702041, ECO:0000269|PubMed:15053879, ECO:0000269|PubMed:15866171, ECO:0000269|PubMed:16377624, ECO:0000269|PubMed:16704422, ECO:0000269|PubMed:1705009, ECO:0000269|PubMed:17108107, ECO:0000269|PubMed:17254968, ECO:0000269|PubMed:17349958, ECO:0000269|PubMed:17591690, ECO:0000269|PubMed:17967874, ECO:0000269|PubMed:18022393, ECO:0000269|PubMed:20041275, ECO:0000269|PubMed:20124405, ECO:0000269|PubMed:20959462, ECO:0000269|PubMed:21317932, ECO:0000269|PubMed:2141171, ECO:0000269|PubMed:22214662, ECO:0000269|PubMed:28842590, ECO:0000269|PubMed:31527692, ECO:0000269|PubMed:9372954}.; PTM: Dephosphorylated by PP2A-PPP2R5C holoenzyme at Thr-55. SV40 small T antigen inhibits the dephosphorylation by the AC form of PP2A.; PTM: May be O-glycosylated in the C-terminal basic region. Studied in EB-1 cell line. {ECO:0000269|PubMed:8632915}.; PTM: Ubiquitinated by MDM2 and SYVN1, which leads to proteasomal degradation (PubMed:10722742, PubMed:12810724, PubMed:15340061, PubMed:17170702, PubMed:19880522, PubMed:29681526). Ubiquitinated by RFWD3, which works in cooperation with MDM2 and may catalyze the formation of short polyubiquitin chains on p53/TP53 that are not targeted to the proteasome (PubMed:10722742, PubMed:12810724, PubMed:20173098). Ubiquitinated by MKRN1 at Lys-291 and Lys-292, which leads to proteasomal degradation (PubMed:19536131). Deubiquitinated by USP10, leading to its stabilization (PubMed:20096447). Ubiquitinated by TRIM24, RFFL, RNF34 and RNF125, which leads to proteasomal degradation (PubMed:19556538). Ubiquitination by TOPORS induces degradation (PubMed:19473992). Deubiquitination by USP7, leading to stabilization (PubMed:15053880). Isoform 4 is monoubiquitinated in an MDM2-independent manner (PubMed:15340061). Ubiquitinated by COP1, which leads to proteasomal degradation (PubMed:19837670). Ubiquitination and subsequent proteasomal degradation is negatively regulated by CCAR2 (PubMed:25732823). Polyubiquitinated by C10orf90/FATS, polyubiquitination is 'Lys-48'-linkage independent and non-proteolytic, leading to TP53 stabilization (By similarity). Polyubiquitinated by MUL1 at Lys-24 which leads to proteasomal degradation (PubMed:21597459). Deubiquitinated by USP3, leading to stabilization (PubMed:28807825). Ubiquitinated by MSL2, promoting its cytoplasmic localization (PubMed:19033443). {ECO:0000250|UniProtKB:P02340, ECO:0000269|PubMed:10722742, ECO:0000269|PubMed:12810724, ECO:0000269|PubMed:15053880, ECO:0000269|PubMed:15340061, ECO:0000269|PubMed:17170702, ECO:0000269|PubMed:18206965, ECO:0000269|PubMed:19033443, ECO:0000269|PubMed:19473992, ECO:0000269|PubMed:19536131, ECO:0000269|PubMed:19556538, ECO:0000269|PubMed:19837670, ECO:0000269|PubMed:19880522, ECO:0000269|PubMed:20096447, ECO:0000269|PubMed:20173098, ECO:0000269|PubMed:21597459, ECO:0000269|PubMed:25591766, ECO:0000269|PubMed:25732823, ECO:0000269|PubMed:28807825, ECO:0000269|PubMed:29681526}.; PTM: Monomethylated at Lys-372 by SETD7, leading to stabilization and increased transcriptional activation (PubMed:15525938, PubMed:16415881). Monomethylated at Lys-370 by SMYD2, leading to decreased DNA-binding activity and subsequent transcriptional regulation activity (PubMed:17108971). Lys-372 monomethylation prevents interaction with SMYD2 and subsequent monomethylation at Lys-370 (PubMed:17108971). Dimethylated at Lys-373 by EHMT1 and EHMT2 (PubMed:20118233). Monomethylated at Lys-382 by KMT5A, promoting interaction with L3MBTL1 and leading to repress transcriptional activity (PubMed:17707234). Dimethylation at Lys-370 and Lys-382 diminishes p53 ubiquitination, through stabilizing association with the methyl reader PHF20 (PubMed:22864287). Demethylation of dimethylated Lys-370 by KDM1A prevents interaction with TP53BP1 and represses TP53-mediated transcriptional activation (PubMed:17805299). Monomethylated at Arg-333 and dimethylated at Arg-335 and Arg-337 by PRMT5; methylation is increased after DNA damage and might possibly affect TP53 target gene specificity (PubMed:19011621). {ECO:0000269|PubMed:15525938, ECO:0000269|PubMed:16415881, ECO:0000269|PubMed:17108971, ECO:0000269|PubMed:17707234, ECO:0000269|PubMed:17805299, ECO:0000269|PubMed:19011621, ECO:0000269|PubMed:20118233, ECO:0000269|PubMed:22864287}.; PTM: Sumoylated with SUMO1. Sumoylated at Lys-386 by UBC9. {ECO:0000269|PubMed:11124955, ECO:0000269|PubMed:22214662, ECO:0000269|Ref.37}.","DOMAIN: The N-terminal and C-terminal disordered regions undergo liquid-liquid phase separation (LLPS) following homotetramerization and activation (PubMed:31953488, PubMed:35618207, PubMed:36108750, PubMed:36634798, PubMed:38653238). Post-translational modifications, such as phosphorylation or lactylation affect the ability to undergo LLPS (PubMed:31953488, PubMed:35618207, PubMed:36634798, PubMed:38653238). {ECO:0000269|PubMed:31953488, ECO:0000269|PubMed:35618207, ECO:0000269|PubMed:36108750, ECO:0000269|PubMed:36634798, ECO:0000269|PubMed:38653238}.; DOMAIN: The nuclear export signal acts as a transcriptional repression domain. The TADI and TADII motifs (residues 17 to 25 and 48 to 56) correspond both to 9aaTAD motifs which are transactivation domains present in a large number of yeast and animal transcription factors. {ECO:0000269|PubMed:17467953}.",,"STRAND 29..31; /evidence=""ECO:0007829|PDB:2LY4""; STRAND 33..35; /evidence=""ECO:0007829|PDB:2L14""; STRAND 95..97; /evidence=""ECO:0007829|PDB:7B49""; STRAND 110..112; /evidence=""ECO:0007829|PDB:3D06""; STRAND 118..120; /evidence=""ECO:0007829|PDB:3Q05""; STRAND 124..127; /evidence=""ECO:0007829|PDB:3D06""; STRAND 132..135; /evidence=""ECO:0007829|PDB:3D06""; STRAND 141..146; /evidence=""ECO:0007829|PDB:3D06""; STRAND 148..150; /evidence=""ECO:0007829|PDB:5UN8""; STRAND 156..165; /evidence=""ECO:0007829|PDB:3D06""; STRAND 181..183; /evidence=""ECO:0007829|PDB:4KVP""; STRAND 187..189; /evidence=""ECO:0007829|PDB:6GGC""; STRAND 194..199; /evidence=""ECO:0007829|PDB:3D06""; STRAND 204..207; /evidence=""ECO:0007829|PDB:3D06""; STRAND 214..219; /evidence=""ECO:0007829|PDB:3D06""; STRAND 228..236; /evidence=""ECO:0007829|PDB:3D06""; STRAND 251..258; /evidence=""ECO:0007829|PDB:3D06""; STRAND 260..262; /evidence=""ECO:0007829|PDB:2ADY""; STRAND 264..274; /evidence=""ECO:0007829|PDB:3D06""; STRAND 327..334; /evidence=""ECO:0007829|PDB:3Q01""","HELIX 3..6; /evidence=""ECO:0007829|PDB:5HOU""; HELIX 19..21; /evidence=""ECO:0007829|PDB:6T58""; HELIX 22..27; /evidence=""ECO:0007829|PDB:6V4F""; HELIX 36..38; /evidence=""ECO:0007829|PDB:2B3G""; HELIX 41..44; /evidence=""ECO:0007829|PDB:2B3G""; HELIX 47..55; /evidence=""ECO:0007829|PDB:2B3G""; HELIX 166..168; /evidence=""ECO:0007829|PDB:3D06""; HELIX 177..180; /evidence=""ECO:0007829|PDB:3D06""; HELIX 240..242; /evidence=""ECO:0007829|PDB:3D07""; HELIX 278..287; /evidence=""ECO:0007829|PDB:3D06""; HELIX 288..290; /evidence=""ECO:0007829|PDB:4HJE""; HELIX 322..324; /evidence=""ECO:0007829|PDB:3Q01""; HELIX 335..354; /evidence=""ECO:0007829|PDB:1AIE""; HELIX 375..380; /evidence=""ECO:0007829|PDB:1YC5""","TURN 8..10; /evidence=""ECO:0007829|PDB:5HOU""; TURN 105..108; /evidence=""ECO:0007829|PDB:3D06""; TURN 121..123; /evidence=""ECO:0007829|PDB:3Q05""; TURN 128..131; /evidence=""ECO:0007829|PDB:3D06""; TURN 209..211; /evidence=""ECO:0007829|PDB:3D06""; TURN 225..227; /evidence=""ECO:0007829|PDB:2FEJ""; TURN 243..248; /evidence=""ECO:0007829|PDB:3D06""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,TP53 P53,Cellular tumor antigen p53 (Antigen NY-CO-13) (Phosphoprotein p53) (Tumor suppressor p53),Homo sapiens (Human),393.0,43653.0,MEEPQSDPSVEPPLSQETFSDLWKLLPENNVLSPLPSQAMDDLMLSPDDIEQWFTEDPGPDEAPRMPEAAPPVAPAPAAPTPAAPAPAPSWPLSSSVPSQKTYQGSYGFRLGFLHSGTAKSVTCTYSPALNKMFCQLAKTCPVQLWVDSTPPPGTRVRAMAIYKQSQHMTEVVRRCPHHERCSDSDGLAPPQHLIRVEGNLRVEYLDDRNTFRHSVVVPYEPPEVGSDCTTIHYNYMCNSSCMGGMNRRPILTIITLEDSSGNLLGRNSFEVRVCACPGRDRRTEEENLRKKGEPHHELPPGSTKRALPNNTSSSPQPKKKPLDGEYFTLQIRGRERFEMFRELNEALELKDAQAGKEPGGSRAHSSHLKSKKGQSTSRHKKLMFKTEGPDSD,True,False,True,P04637,"[('cd08367', 'P53 DNA-binding domain'), ('G3DSA:2.60.40.720', None), ('G3DSA:4.10.170.10', 'p53-like tetramerisation domain'), ('G3DSA:6.10.50.20', None), ('IPR002117', 'p53 tumour suppressor family'), ('IPR008967', 'p53-like transcription factor, DNA-binding domain superfamily'), ('IPR010991', 'p53, tetramerisation domain'), ('IPR011615', 'p53, DNA-binding domain'), ('IPR012346', 'p53/RUNT-type transcription factor, DNA-binding domain superfamily'), ('IPR013872', 'p53 transactivation domain'), ('IPR036674', 'p53-like tetramerisation domain superfamily'), ('IPR040926', 'Cellular tumor antigen p53, transactivation domain 2'), ('PF00870', 'P53 DNA-binding domain'), ('PF07710', 'P53 tetramerisation motif'), ('PF08563', 'P53 transactivation motif'), ('PF18521', 'Transactivation domain 2'), ('PR00386', 'P53SUPPRESSR'), ('PS00348', 'p53 family signature'), ('PTHR11447', 'CELLULAR TUMOR ANTIGEN P53'), ('SSF47719', 'p53 tetramerization domain')]",P04637;,"""ENSG00000141510; Low tissue specificity."";",,,,,ENST00000269305.9 [P04637-1];ENST00000420246.6 [P04637-2];ENST00000445888.6 [P04637-1];ENST00000455263.6 [P04637-3];ENST00000503591.2 [P04637-1];ENST00000504290.5 [P04637-9];ENST00000504937.5 [P04637-7];ENST00000508793.6 [P04637-1];ENST00000509690.6 [P04637-7];ENST00000510385.5 [P04637-8];ENST00000610292.4 [P04637-4];ENST00000610538.4 [P04637-6];ENST00000619485.4 [P04637-4];ENST00000620739.4 [P04637-4];ENST00000622645.4 [P04637-5];ENST00000714357.1 [P04637-1];ENST00000714359.1 [P04637-1];,TP53,ENSG00000141510,0.0,TP53,Non-canonical_RBPs,6.0,37.66,DP00086,0.392,0.483,0.341,TP53
P04792,ENSG00000106211,HSPB1_HUMAN,anterograde axonal protein transport [GO:0099641]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; chaperone-mediated protein folding [GO:0061077]; intracellular signal transduction [GO:0035556]; negative regulation of apoptotic process [GO:0043066]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein kinase activity [GO:0006469]; platelet aggregation [GO:0070527]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of tumor necrosis factor production [GO:0032760]; protein refolding [GO:0042026]; regulation of autophagy [GO:0010506]; regulation of canonical NF-kappaB signal transduction [GO:0043122]; regulation of protein phosphorylation [GO:0001932]; regulation of translational initiation [GO:0006446]; response to heat [GO:0009408]; response to unfolded protein [GO:0006986]; response to virus [GO:0009615]; vascular endothelial growth factor receptor signaling pathway [GO:0048010],axon cytoplasm [GO:1904115]; cornified envelope [GO:0001533]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; spindle [GO:0005819]; Z disc [GO:0030018],identical protein binding [GO:0042802]; protein folding chaperone [GO:0044183]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase C binding [GO:0005080]; protein kinase C inhibitor activity [GO:0008426]; RNA binding [GO:0003723]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; ubiquitin binding [GO:0043130]; unfolded protein binding [GO:0051082],"PTM: Phosphorylated upon exposure to protein kinase C activators and heat shock (PubMed:8325890). Phosphorylation by MAPKAPK2 and MAPKAPK3 in response to stress dissociates HSPB1 from large small heat-shock protein (sHsps) oligomers and impairs its chaperone activity and ability to protect against oxidative stress effectively. Phosphorylation by MAPKAPK5 in response to PKA stimulation induces F-actin rearrangement (PubMed:1332886, PubMed:19166925, PubMed:8093612). {ECO:0000269|PubMed:1332886, ECO:0000269|PubMed:19166925, ECO:0000269|PubMed:8093612, ECO:0000269|PubMed:8325890}.",,"DOMAIN 76..184; /note=""sHSP""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00285""","STRAND 86..88; /evidence=""ECO:0007829|PDB:4MJH""; STRAND 94..100; /evidence=""ECO:0007829|PDB:3Q9P""; STRAND 107..114; /evidence=""ECO:0007829|PDB:3Q9P""; STRAND 117..124; /evidence=""ECO:0007829|PDB:3Q9P""; STRAND 136..143; /evidence=""ECO:0007829|PDB:3Q9P""; STRAND 154..157; /evidence=""ECO:0007829|PDB:3Q9P""; STRAND 161..168; /evidence=""ECO:0007829|PDB:3Q9P""","HELIX 150..152; /evidence=""ECO:0007829|PDB:3Q9P""","TURN 102..104; /evidence=""ECO:0007829|PDB:3Q9P""; TURN 145..147; /evidence=""ECO:0007829|PDB:2N3J""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,HSPB1 HSP27 HSP28,Heat shock protein beta-1 (HspB1) (28 kDa heat shock protein) (Estrogen-regulated 24 kDa protein) (Heat shock 27 kDa protein) (HSP 27) (Heat shock protein family B member 1) (Stress-responsive protein 27) (SRP27),Homo sapiens (Human),205.0,22783.0,MTERRVPFSLLRGPSWDPFRDWYPHSRLFDQAFGLPRLPEEWSQWLGGSSWPGYVRPLPPAAIESPAVAAPAYSRALSRQLSSGVSEIRHTADRWRVSLDVNHFAPDELTVKTKDGVVEITGKHEERQDEHGYISRCFTRKYTLPPGVDPTQVSSSLSPEGTLTVEAPMPKLATQSNEITIPVTFESRAQLGGPEAAKSDETAAK,False,False,True,P04792,"[('cd06475', 'ACD_HspB1_like'), ('G3DSA:2.60.40.790', None), ('IPR001436', 'Alpha crystallin/Small heat shock protein, animal type'), ('IPR002068', 'Alpha crystallin/Hsp20 domain'), ('IPR008978', 'HSP20-like chaperone'), ('IPR037876', 'Heat shock protein beta-1, ACD domain'), ('PF00011', 'Hsp20/alpha crystallin family'), ('PR00299', 'ACRYSTALLIN'), ('PS01031', 'Small heat shock protein (sHSP) domain profile'), ('PTHR45640', 'HEAT SHOCK PROTEIN HSP-12.2-RELATED'), ('SSF49764', 'HSP20-like chaperones')]",,"""ENSG00000106211; Tissue enhanced (esophagus)."";",,,,,ENST00000248553.7;,HSPB1,ENSG00000106211,0.0,HSPB1,Non-canonical_RBPs,13.0,,,,0.537,,HSPB1
P04818,ENSG00000176890,TYSY_HUMAN,cartilage development [GO:0051216]; circadian rhythm [GO:0007623]; developmental growth [GO:0048589]; DNA biosynthetic process [GO:0071897]; dTMP biosynthetic process [GO:0006231]; dTTP biosynthetic process [GO:0006235]; intestinal epithelial cell maturation [GO:0060574]; liver regeneration [GO:0097421]; methylation [GO:0032259]; negative regulation of translation [GO:0017148]; response to cytokine [GO:0034097]; response to ethanol [GO:0045471]; response to folic acid [GO:0051593]; response to glucocorticoid [GO:0051384]; response to organophosphorus [GO:0046683]; response to progesterone [GO:0032570]; response to toxic substance [GO:0009636]; response to vitamin A [GO:0033189]; response to xenobiotic stimulus [GO:0009410]; tetrahydrofolate interconversion [GO:0035999]; uracil metabolic process [GO:0019860],cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634],folic acid binding [GO:0005542]; mRNA regulatory element binding translation repressor activity [GO:0000900]; protein homodimerization activity [GO:0042803]; sequence-specific mRNA binding [GO:1990825]; thymidylate synthase activity [GO:0004799],,,,"STRAND 45..48; /evidence=""ECO:0007829|PDB:3ED7""; STRAND 50..52; /evidence=""ECO:0007829|PDB:1YPV""; STRAND 54..66; /evidence=""ECO:0007829|PDB:3ED7""; STRAND 68..70; /evidence=""ECO:0007829|PDB:3EBU""; STRAND 128..130; /evidence=""ECO:0007829|PDB:6OJU""; STRAND 149..151; /evidence=""ECO:0007829|PDB:3ED7""; STRAND 156..158; /evidence=""ECO:0007829|PDB:3EHI""; STRAND 178..181; /evidence=""ECO:0007829|PDB:3ED7""; STRAND 190..192; /evidence=""ECO:0007829|PDB:3ED7""; STRAND 196..204; /evidence=""ECO:0007829|PDB:3ED7""; STRAND 207..218; /evidence=""ECO:0007829|PDB:3ED7""; STRAND 244..258; /evidence=""ECO:0007829|PDB:3ED7""; STRAND 278..281; /evidence=""ECO:0007829|PDB:3ED7""; STRAND 296..300; /evidence=""ECO:0007829|PDB:3ED7""","HELIX 30..43; /evidence=""ECO:0007829|PDB:3ED7""; HELIX 81..92; /evidence=""ECO:0007829|PDB:3ED7""; HELIX 98..101; /evidence=""ECO:0007829|PDB:3ED7""; HELIX 111..113; /evidence=""ECO:0007829|PDB:1HVY""; HELIX 117..120; /evidence=""ECO:0007829|PDB:3ED7""; HELIX 123..127; /evidence=""ECO:0007829|PDB:3ED7""; HELIX 136..141; /evidence=""ECO:0007829|PDB:3ED7""; HELIX 160..170; /evidence=""ECO:0007829|PDB:3ED7""; HELIX 184..186; /evidence=""ECO:0007829|PDB:3ED7""; HELIX 222..241; /evidence=""ECO:0007829|PDB:3ED7""; HELIX 259..261; /evidence=""ECO:0007829|PDB:3ED7""; HELIX 262..268; /evidence=""ECO:0007829|PDB:3ED7""; HELIX 288..290; /evidence=""ECO:0007829|PDB:3ED7""; HELIX 293..295; /evidence=""ECO:0007829|PDB:3ED7""","TURN 75..78; /evidence=""ECO:0007829|PDB:3ED7""; TURN 103..105; /evidence=""ECO:0007829|PDB:1HVY""; TURN 108..110; /evidence=""ECO:0007829|PDB:1HZW""; TURN 132..134; /evidence=""ECO:0007829|PDB:4E28""; TURN 187..189; /evidence=""ECO:0007829|PDB:3ED7""; TURN 219..221; /evidence=""ECO:0007829|PDB:3ED7""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,TYMS TS OK/SW-cl.29,Thymidylate synthase (TS) (TSase) (EC 2.1.1.45),Homo sapiens (Human),313.0,35716.0,MPVAGSELPRRPLPPAAQERDAEPRPPHGELQYLGQIQHILRCGVRKDDRTGTGTLSVFGMQARYSLRDEFPLLTTKRVFWKGVLEELLWFIKGSTNAKELSSKGVKIWDANGSRDFLDSLGFSTREEGDLGPVYGFQWRHFGAEYRDMESDYSGQGVDQLQRVIDTIKTNPDDRRIIMCAWNPRDLPLMALPPCHALCQFYVVNSELSCQLYQRSGDMGLGVPFNIASYALLTYMIAHITGLKPGDFIHTLGDAHIYLNHIEPLKIQLQREPRPFPKLRILRKVEKIDDFKAEDFQIEGYNPHPTIKMEMAV,True,True,False,P04818,"[('cd00351', 'TS_Pyrimidine_HMase'), ('G3DSA:3.30.572.10', 'Thymidylate synthase/dCMP hydroxymethylase domain'), ('IPR000398', 'Thymidylate synthase'), ('IPR020940', 'Thymidylate synthase, active site'), ('IPR023451', 'Thymidylate synthase/dCMP hydroxymethylase domain'), ('IPR036926', 'Thymidylate synthase/dCMP hydroxymethylase superfamily'), ('IPR045097', 'Thymidylate synthase/dCMP hydroxymethylase'), ('MF_00008', 'Thymidylate synthase [thyA]'), ('PF00303', 'Thymidylate synthase'), ('PR00108', 'THYMDSNTHASE'), ('PS00091', 'Thymidylate synthase active site'), ('PTHR11548', 'THYMIDYLATE SYNTHASE 1'), ('SSF55831', 'Thymidylate synthase/dCMP hydroxymethylase'), ('TIGR03284', 'thymidylate synthase')]",,"""ENSG00000176890; Tissue enhanced (bone marrow, lymphoid tissue)."";","CATALYTIC ACTIVITY: Reaction=dUMP + (6R)-5,10-methylene-5,6,7,8-tetrahydrofolate = 7,8-dihydrofolate + dTMP; Xref=Rhea:RHEA:12104, ChEBI:CHEBI:15636, ChEBI:CHEBI:57451, ChEBI:CHEBI:63528, ChEBI:CHEBI:246422; EC=2.1.1.45; Evidence={ECO:0000269|PubMed:11278511}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:12105; Evidence={ECO:0000305|PubMed:11278511};",2.1.1.45,,PATHWAY: Pyrimidine metabolism; dTTP biosynthesis. {ECO:0000305|PubMed:11278511}.,ENST00000323224.7 [P04818-2];ENST00000323250.9 [P04818-3];ENST00000323274.15 [P04818-1];,TYMS,ENSG00000176890,0.0,TYMS,Non-canonical_RBPs,5.0,15.65,DP00073,0.157,0.083,0.089,TYMS
P05062,ENSG00000136872,ALDOB_HUMAN,"fructose 1,6-bisphosphate metabolic process [GO:0030388]; fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate [GO:0061624]; fructose metabolic process [GO:0006000]; gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096]; NADH oxidation [GO:0006116]; negative regulation of pentose-phosphate shunt [GO:1905856]; positive regulation of ATP-dependent activity [GO:0032781]; vacuolar proton-transporting V-type ATPase complex assembly [GO:0070072]",centriolar satellite [GO:0034451]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; microtubule organizing center [GO:0005815],ATPase binding [GO:0051117]; cytoskeletal protein binding [GO:0008092]; fructose binding [GO:0070061]; fructose-1-phosphate aldolase activity [GO:0061609]; fructose-bisphosphate aldolase activity [GO:0004332]; identical protein binding [GO:0042802]; molecular adaptor activity [GO:0060090],,,,"STRAND 29..33; /evidence=""ECO:0007829|PDB:1QO5""; STRAND 74..79; /evidence=""ECO:0007829|PDB:1QO5""; STRAND 104..108; /evidence=""ECO:0007829|PDB:1QO5""; STRAND 113..115; /evidence=""ECO:0007829|PDB:1QO5""; STRAND 119..121; /evidence=""ECO:0007829|PDB:1QO5""; STRAND 123..125; /evidence=""ECO:0007829|PDB:1QO5""; STRAND 145..152; /evidence=""ECO:0007829|PDB:1QO5""; STRAND 184..191; /evidence=""ECO:0007829|PDB:1QO5""; STRAND 267..271; /evidence=""ECO:0007829|PDB:1QO5""; STRAND 290..292; /evidence=""ECO:0007829|PDB:1XDM""; STRAND 296..303; /evidence=""ECO:0007829|PDB:1QO5""","HELIX 10..23; /evidence=""ECO:0007829|PDB:1QO5""; HELIX 37..46; /evidence=""ECO:0007829|PDB:1QO5""; HELIX 53..64; /evidence=""ECO:0007829|PDB:1QO5""; HELIX 68..72; /evidence=""ECO:0007829|PDB:1QO5""; HELIX 83..85; /evidence=""ECO:0007829|PDB:1QO5""; HELIX 94..100; /evidence=""ECO:0007829|PDB:1QO5""; HELIX 131..140; /evidence=""ECO:0007829|PDB:1QO5""; HELIX 161..179; /evidence=""ECO:0007829|PDB:1QO5""; HELIX 199..219; /evidence=""ECO:0007829|PDB:1QO5""; HELIX 224..226; /evidence=""ECO:0007829|PDB:1QO5""; HELIX 246..260; /evidence=""ECO:0007829|PDB:1QO5""; HELIX 277..289; /evidence=""ECO:0007829|PDB:1QO5""; HELIX 304..306; /evidence=""ECO:0007829|PDB:1QO5""; HELIX 308..314; /evidence=""ECO:0007829|PDB:1QO5""; HELIX 318..320; /evidence=""ECO:0007829|PDB:1QO5""; HELIX 321..338; /evidence=""ECO:0007829|PDB:1QO5""; HELIX 351..354; /evidence=""ECO:0007829|PDB:1QO5""","TURN 24..26; /evidence=""ECO:0007829|PDB:8D44""; TURN 89..91; /evidence=""ECO:0007829|PDB:1XDM""; TURN 180..182; /evidence=""ECO:0007829|PDB:1QO5""; TURN 339..341; /evidence=""ECO:0007829|PDB:1QO5""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,ALDOB ALDB,Fructose-bisphosphate aldolase B (EC 4.1.2.13) (Liver-type aldolase),Homo sapiens (Human),364.0,39473.0,MAHRFPALTQEQKKELSEIAQSIVANGKGILAADESVGTMGNRLQRIKVENTEENRRQFREILFSVDSSINQSIGGVILFHETLYQKDSQGKLFRNILKEKGIVVGIKLDQGGAPLAGTNKETTIQGLDGLSERCAQYKKDGVDFGKWRAVLRIADQCPSSLAIQENANALARYASICQQNGLVPIVEPEVIPDGDHDLEHCQYVTEKVLAAVYKALNDHHVYLEGTLLKPNMVTAGHACTKKYTPEQVAMATVTALHRTVPAAVPGICFLSGGMSEEDATLNLNAINLCPLPKPWKLSFSYGRALQASALAAWGGKAANKEATQEAFMKRAMANCQAAKGQYVHTGSSGAASTQSLFTACYTY,False,False,True,P05062,"[('cd00948', 'Fructose-1,6-bisphosphate aldolase'), ('G3DSA:3.20.20.70', 'Aldolase class I'), ('IPR000741', 'Fructose-bisphosphate aldolase, class-I'), ('IPR013785', 'Aldolase-type TIM barrel'), ('IPR029768', 'Fructose-bisphosphate aldolase class-I active site'), ('NF033379', 'class I fructose-bisphosphate aldolase'), ('PF00274', 'Fructose-bisphosphate aldolase class-I'), ('PS00158', 'Fructose-bisphosphate aldolase class-I active site'), ('PTHR11627', 'FRUCTOSE-BISPHOSPHATE ALDOLASE'), ('SSF51569', 'Aldolase')]",,"""ENSG00000136872; Group enriched (intestine, kidney, liver)."";","CATALYTIC ACTIVITY: Reaction=beta-D-fructose 1,6-bisphosphate = D-glyceraldehyde 3-phosphate + dihydroxyacetone phosphate; Xref=Rhea:RHEA:14729, ChEBI:CHEBI:32966, ChEBI:CHEBI:57642, ChEBI:CHEBI:59776; EC=4.1.2.13; Evidence={ECO:0000269|PubMed:10970798, ECO:0000269|PubMed:12205126, ECO:0000269|PubMed:20848650}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:14730; Evidence={ECO:0000305|PubMed:10970798, ECO:0000305|PubMed:12205126, ECO:0000305|PubMed:20848650}; PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:14731; Evidence={ECO:0000305}; CATALYTIC ACTIVITY: Reaction=beta-D-fructose 1-phosphate = D-glyceraldehyde + dihydroxyacetone phosphate; Xref=Rhea:RHEA:30851, ChEBI:CHEBI:17378, ChEBI:CHEBI:57642, ChEBI:CHEBI:138881; Evidence={ECO:0000269|PubMed:10970798, ECO:0000269|PubMed:12205126, ECO:0000269|PubMed:20848650}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:30852; Evidence={ECO:0000305|PubMed:10970798, ECO:0000305|PubMed:12205126, ECO:0000305|PubMed:20848650}; PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:30853; Evidence={ECO:0000305};",4.1.2.13,,"PATHWAY: Carbohydrate degradation; glycolysis; D-glyceraldehyde 3-phosphate and glycerone phosphate from D-glucose: step 4/4. {ECO:0000305|PubMed:10970798, ECO:0000305|PubMed:12205126, ECO:0000305|PubMed:20848650}.; PATHWAY: Carbohydrate biosynthesis; gluconeogenesis. {ECO:0000305|PubMed:10970798, ECO:0000305|PubMed:12205126, ECO:0000305|PubMed:20848650}.; PATHWAY: Carbohydrate metabolism; fructose metabolism. {ECO:0000269|PubMed:10970798, ECO:0000269|PubMed:12205126, ECO:0000269|PubMed:20848650}.",ENST00000647789.2;ENST00000648064.1;ENST00000648758.1;,ALDOB,ENSG00000136872,0.0,,,,,,,,,ALDOB
P05089,ENSG00000118520,ARGI1_HUMAN,adaptive immune response [GO:0002250]; arginine catabolic process [GO:0006527]; arginine catabolic process to ornithine [GO:0019547]; defense response to protozoan [GO:0042832]; innate immune response [GO:0045087]; negative regulation of activated T cell proliferation [GO:0046007]; negative regulation of T cell proliferation [GO:0042130]; negative regulation of T-helper 2 cell cytokine production [GO:2000552]; negative regulation of type II interferon-mediated signaling pathway [GO:0060336]; positive regulation of neutrophil mediated killing of fungus [GO:0070965]; response to nematode [GO:0009624]; urea cycle [GO:0000050],azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nucleus [GO:0005634]; specific granule lumen [GO:0035580],arginase activity [GO:0004053]; manganese ion binding [GO:0030145],,,,"STRAND 7..13; /evidence=""ECO:0007829|PDB:2AEB""; STRAND 19..21; /evidence=""ECO:0007829|PDB:7KLK""; STRAND 46..52; /evidence=""ECO:0007829|PDB:2AEB""; STRAND 64..66; /evidence=""ECO:0007829|PDB:7LEY""; STRAND 67..69; /evidence=""ECO:0007829|PDB:3TH7""; STRAND 93..99; /evidence=""ECO:0007829|PDB:2AEB""; STRAND 119..126; /evidence=""ECO:0007829|PDB:2AEB""; STRAND 174..179; /evidence=""ECO:0007829|PDB:2AEB""; STRAND 196..199; /evidence=""ECO:0007829|PDB:2AEB""; STRAND 221..223; /evidence=""ECO:0007829|PDB:2AEB""; STRAND 227..232; /evidence=""ECO:0007829|PDB:2AEB""; STRAND 243..246; /evidence=""ECO:0007829|PDB:2AEB""; STRAND 270..276; /evidence=""ECO:0007829|PDB:2AEB""","HELIX 4..6; /evidence=""ECO:0007829|PDB:6Q92""; HELIX 22..26; /evidence=""ECO:0007829|PDB:2AEB""; HELIX 27..33; /evidence=""ECO:0007829|PDB:2AEB""; HELIX 36..42; /evidence=""ECO:0007829|PDB:2AEB""; HELIX 70..89; /evidence=""ECO:0007829|PDB:2AEB""; HELIX 101..103; /evidence=""ECO:0007829|PDB:2AEB""; HELIX 104..114; /evidence=""ECO:0007829|PDB:2AEB""; HELIX 140..142; /evidence=""ECO:0007829|PDB:2AEB""; HELIX 144..148; /evidence=""ECO:0007829|PDB:2AEB""; HELIX 150..152; /evidence=""ECO:0007829|PDB:2AEB""; HELIX 171..173; /evidence=""ECO:0007829|PDB:2AEB""; HELIX 184..193; /evidence=""ECO:0007829|PDB:2AEB""; HELIX 200..206; /evidence=""ECO:0007829|PDB:2AEB""; HELIX 208..220; /evidence=""ECO:0007829|PDB:2AEB""; HELIX 233..235; /evidence=""ECO:0007829|PDB:2AEB""; HELIX 254..267; /evidence=""ECO:0007829|PDB:2AEB""; HELIX 280..282; /evidence=""ECO:0007829|PDB:2AEB""; HELIX 286..303; /evidence=""ECO:0007829|PDB:2AEB""","TURN 132..134; /evidence=""ECO:0007829|PDB:2AEB""; TURN 153..155; /evidence=""ECO:0007829|PDB:2AEB""; TURN 238..240; /evidence=""ECO:0007829|PDB:2AEB""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,ARG1,Arginase-1 (EC 3.5.3.1) (Liver-type arginase) (Type I arginase),Homo sapiens (Human),322.0,34735.0,MSAKSRTIGIIGAPFSKGQPRGGVEEGPTVLRKAGLLEKLKEQECDVKDYGDLPFADIPNDSPFQIVKNPRSVGKASEQLAGKVAEVKKNGRISLVLGGDHSLAIGSISGHARVHPDLGVIWVDAHTDINTPLTTTSGNLHGQPVSFLLKELKGKIPDVPGFSWVTPCISAKDIVYIGLRDVDPGEHYILKTLGIKYFSMTEVDRLGIGKVMEETLSYLLGRKKRPIHLSFDVDGLDPSFTPATGTPVVGGLTYREGLYITEEIYKTGLLSGLDIMEVNPSLGKTPEEVTRTVNTAVAITLACFGLAREGNHKPIDYLNPPK,True,False,False,P05089,"[('cd11587', 'Arginase types I and II and arginase-like family'), ('G3DSA:3.40.800.10', 'Ureohydrolase domain'), ('IPR006035', 'Ureohydrolase'), ('IPR014033', 'Arginase'), ('IPR020855', 'Ureohydrolase, manganese-binding site'), ('IPR023696', 'Ureohydrolase domain superfamily'), ('PF00491', 'Arginase family'), ('PIRSF036979', 'Ureohydrolase/formiminoglutamase/proclavaminate amidino hydrolase'), ('PR00116', 'ARGINASE'), ('PS01053', 'Arginase family signature'), ('PS51409', 'Arginase family profile'), ('PTHR43782', 'ARGINASE'), ('SSF52768', 'Arginase/deacetylase'), ('TIGR01229', 'arginase')]",,"""ENSG00000118520; Tissue enriched (liver)."";","CATALYTIC ACTIVITY: Reaction=L-arginine + H2O = urea + L-ornithine; Xref=Rhea:RHEA:20569, ChEBI:CHEBI:15377, ChEBI:CHEBI:16199, ChEBI:CHEBI:32682, ChEBI:CHEBI:46911; EC=3.5.3.1; Evidence={ECO:0000269|PubMed:16141327, ECO:0000269|PubMed:17562323, ECO:0000269|PubMed:21728378};",3.5.3.1,,PATHWAY: Nitrogen metabolism; urea cycle; L-ornithine and urea from L-arginine: step 1/1. {ECO:0000305|PubMed:16141327}.,ENST00000356962.2 [P05089-2];ENST00000368087.8 [P05089-1];,ARG1,ENSG00000118520,0.0,,,,,,,0.025,,ARG1
P05141,ENSG00000005022,ADT2_HUMAN,adaptive thermogenesis [GO:1990845]; adenine nucleotide transport [GO:0051503]; B cell differentiation [GO:0030183]; cellular response to leukemia inhibitory factor [GO:1990830]; chromosome segregation [GO:0007059]; erythrocyte differentiation [GO:0030218]; mitochondrial ADP transmembrane transport [GO:0140021]; mitochondrial ATP transmembrane transport [GO:1990544]; negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901029]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of mitophagy [GO:1901526]; regulation of mitochondrial membrane permeability [GO:0046902],membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial nucleoid [GO:0042645]; mitochondrial permeability transition pore complex [GO:0005757]; mitochondrion [GO:0005739]; MMXD complex [GO:0071817]; nucleus [GO:0005634]; plasma membrane [GO:0005886],adenine nucleotide transmembrane transporter activity [GO:0000295]; adenine transmembrane transporter activity [GO:0015207]; ATP:ADP antiporter activity [GO:0005471]; oxidative phosphorylation uncoupler activity [GO:0017077]; proton transmembrane transporter activity [GO:0015078]; RNA binding [GO:0003723]; ubiquitin protein ligase binding [GO:0031625],PTM: Trimethylated by ANTKMT at Lys-52. {ECO:0000269|PubMed:31213526}.,"DOMAIN: The transmembrane helices are not perpendicular to the plane of the membrane, but cross the membrane at an angle. Odd-numbered transmembrane helices exhibit a sharp kink, due to the presence of a conserved proline residue. {ECO:0000250|UniProtKB:P02722}.",,,,,"cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,SLC25A5 AAC2 ANT2,"ADP/ATP translocase 2 (ADP,ATP carrier protein 2) (ADP,ATP carrier protein, fibroblast isoform) (Adenine nucleotide translocator 2) (ANT 2) (Solute carrier family 25 member 5) [Cleaved into: ADP/ATP translocase 2, N-terminally processed]",Homo sapiens (Human),298.0,32852.0,MTDAAVSFAKDFLAGGVAAAISKTAVAPIERVKLLLQVQHASKQITADKQYKGIIDCVVRIPKEQGVLSFWRGNLANVIRYFPTQALNFAFKDKYKQIFLGGVDKRTQFWLYFAGNLASGGAAGATSLCFVYPLDFARTRLAADVGKAGAEREFRGLGDCLVKIYKSDGIKGLYQGFNVSVQGIIIYRAAYFGIYDTAKGMLPDPKNTHIVISWMIAQTVTAVAGLTSYPFDTVRRRMMMQSGRKGTDIMYTGTLDCWRKIARDEGGKAFFKGAWSNVLRGMGGAFVLVLYDEIKKYT,False,True,False,P05141,"[('G3DSA:1.50.40.10', 'Mitochondrial carrier domain'), ('IPR002067', 'Mitochondrial carrier protein'), ('IPR002113', 'ADP/ATP carrier protein, eukaryotic type'), ('IPR018108', 'Mitochondrial substrate/solute carrier'), ('IPR023395', 'Mitochondrial carrier domain superfamily'), ('PF00153', 'Mitochondrial carrier protein'), ('PR00926', 'MITOCARRIER'), ('PR00927', 'Adenine nucleotide translocator'), ('PS50920', 'Solute carrier (Solcar) repeat profile'), ('PTHR45635', 'ADP,ATP CARRIER PROTEIN 1-RELATED-RELATED'), ('SSF103506', 'Mitochondrial carrier')]",,"""ENSG00000005022; Low tissue specificity."";","CATALYTIC ACTIVITY: Reaction=ADP(in) + ATP(out) = ADP(out) + ATP(in); Xref=Rhea:RHEA:34999, ChEBI:CHEBI:30616, ChEBI:CHEBI:456216; Evidence={ECO:0000250|UniProtKB:P51881}; CATALYTIC ACTIVITY: Reaction=H(+)(in) = H(+)(out); Xref=Rhea:RHEA:34979, ChEBI:CHEBI:15378; Evidence={ECO:0000250|UniProtKB:P51881};",,"ACTIVITY REGULATION: The matrix-open state (m-state) is inhibited by the membrane-permeable bongkrekic acid (BKA). The cytoplasmic-open state (c-state) is inhibited by the membrane-impermeable toxic inhibitor carboxyatractyloside (CATR) (By similarity). Proton transporter activity is inhibited by ADP:ATP antiporter activity (By similarity). {ECO:0000250|UniProtKB:G2QNH0, ECO:0000250|UniProtKB:P51881}.",,ENST00000317881.9;,SLC25A5,ENSG00000005022,0.0,SLC25A5,Non-canonical_RBPs,20.0,,,,,,SLC25A5
P05230,ENSG00000113578,FGF1_HUMAN,activation of protein kinase B activity [GO:0032148]; anatomical structure morphogenesis [GO:0009653]; angiogenesis [GO:0001525]; animal organ morphogenesis [GO:0009887]; branch elongation involved in ureteric bud branching [GO:0060681]; cell differentiation [GO:0030154]; cellular response to heat [GO:0034605]; epithelial cell proliferation [GO:0050673]; fibroblast growth factor receptor signaling pathway [GO:0008543]; lung development [GO:0030324]; mesonephric epithelium development [GO:0072163]; organ induction [GO:0001759]; positive regulation of angiogenesis [GO:0045766]; positive regulation of cell division [GO:0051781]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cholesterol biosynthetic process [GO:0045542]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of hepatocyte proliferation [GO:2000347]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of sprouting angiogenesis [GO:1903672]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of cell migration [GO:0030334]; regulation of endothelial cell chemotaxis to fibroblast growth factor [GO:2000544]; regulation of endothelial tube morphogenesis [GO:1901509]; signal transduction [GO:0007165]; wound healing [GO:0042060],cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],fibroblast growth factor receptor binding [GO:0005104]; growth factor activity [GO:0008083]; heparin binding [GO:0008201]; Hsp70 protein binding [GO:0030544]; integrin binding [GO:0005178]; S100 protein binding [GO:0044548],"PTM: In the nucleus, phosphorylated by PKC/PRKCD. {ECO:0000269|PubMed:22321063}.",,,"STRAND 23..25; /evidence=""ECO:0007829|PDB:1RG8""; STRAND 27..31; /evidence=""ECO:0007829|PDB:1RG8""; STRAND 36..40; /evidence=""ECO:0007829|PDB:1RG8""; STRAND 46..49; /evidence=""ECO:0007829|PDB:1RG8""; STRAND 59..65; /evidence=""ECO:0007829|PDB:1RG8""; STRAND 68..73; /evidence=""ECO:0007829|PDB:1RG8""; STRAND 79..82; /evidence=""ECO:0007829|PDB:1RG8""; STRAND 84..86; /evidence=""ECO:0007829|PDB:3OJ2""; STRAND 88..93; /evidence=""ECO:0007829|PDB:1RG8""; STRAND 100..105; /evidence=""ECO:0007829|PDB:1RG8""; STRAND 109..115; /evidence=""ECO:0007829|PDB:1RG8""; STRAND 123..126; /evidence=""ECO:0007829|PDB:3O3Q""; STRAND 130..132; /evidence=""ECO:0007829|PDB:4QC4""; STRAND 147..151; /evidence=""ECO:0007829|PDB:1RG8""","HELIX 55..57; /evidence=""ECO:0007829|PDB:3B9U""; HELIX 96..98; /evidence=""ECO:0007829|PDB:1RG8""; HELIX 118..120; /evidence=""ECO:0007829|PDB:1RG8""; HELIX 135..137; /evidence=""ECO:0007829|PDB:1RG8""; HELIX 143..145; /evidence=""ECO:0007829|PDB:3B9U""","TURN 11..13; /evidence=""ECO:0007829|PDB:3OJM""; TURN 32..35; /evidence=""ECO:0007829|PDB:1RG8""; TURN 42..44; /evidence=""ECO:0007829|PDB:1DZC""; TURN 74..76; /evidence=""ECO:0007829|PDB:1RG8""; TURN 106..108; /evidence=""ECO:0007829|PDB:1RG8""; TURN 138..141; /evidence=""ECO:0007829|PDB:2K43""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,FGF1 FGFA,Fibroblast growth factor 1 (FGF-1) (Acidic fibroblast growth factor) (aFGF) (Endothelial cell growth factor) (ECGF) (Heparin-binding growth factor 1) (HBGF-1),Homo sapiens (Human),155.0,17460.0,MAEGEITTFTALTEKFNLPPGNYKKPKLLYCSNGGHFLRILPDGTVDGTRDRSDQHIQLQLSAESVGEVYIKSTETGQYLAMDTDGLLYGSQTPNEECLFLERLEENHYNTYISKKHAEKNWFVGLKKNGSCKRGPRTHYGQKAILFLPLPVSSD,True,True,False,P05230,"[('cd00058', 'FGF'), ('G3DSA:2.80.10.50', None), ('IPR002209', 'Fibroblast growth factor family'), ('IPR008996', 'Cytokine IL1/FGF'), ('PF00167', 'Fibroblast growth factor'), ('PR00262', 'IL1HBGF'), ('PR00263', 'HBGFFGF'), ('PS00247', 'HBGF/FGF family signature'), ('PTHR11486', 'FIBROBLAST GROWTH FACTOR'), ('SM00442', 'Acidic and basic fibroblast growth factor family.'), ('SSF50353', 'Cytokine')]",,"""ENSG00000113578; Tissue enriched (brain)."";",,,,,ENST00000337706.7 [P05230-1];ENST00000359370.10 [P05230-1];ENST00000360966.9 [P05230-2];ENST00000378046.5 [P05230-1];ENST00000419524.6 [P05230-1];ENST00000441680.6 [P05230-1];ENST00000610990.4 [P05230-1];ENST00000612258.4 [P05230-1];ENST00000619447.4 [P05230-1];ENST00000621536.4 [P05230-1];,FGF1,ENSG00000113578,0.0,,,,,,,0.09,,FGF1
P05388,ENSG00000089157,RLA0_HUMAN,cytoplasmic translation [GO:0002181]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412],cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleus [GO:0005634]; postsynapse [GO:0098794]; postsynaptic density [GO:0014069]; ribonucleoprotein complex [GO:1990904],large ribosomal subunit rRNA binding [GO:0070180]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735],PTM: Ubiquitinated at Lys-264 by RNF14 and RNF25 in response to ribosome collisions (ribosome stalling). {ECO:0000269|PubMed:36638793}.,,,,,,"cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,RPLP0,Large ribosomal subunit protein uL10 (60S acidic ribosomal protein P0) (60S ribosomal protein L10E),Homo sapiens (Human),317.0,34274.0,MPREDRATWKSNYFLKIIQLLDDYPKCFIVGADNVGSKQMQQIRMSLRGKAVVLMGKNTMMRKAIRGHLENNPALEKLLPHIRGNVGFVFTKEDLTEIRDMLLANKVPAAARAGAIAPCEVTVPAQNTGLGPEKTSFFQALGITTKISRGTIEILSDVQLIKTGDKVGASEATLLNMLNISPFSFGLVIQQVFDNGSIYNPEVLDITEETLHSRFLEGVRNVASVCLQIGYPTVASVPHSIINGYKRVLALSVETDYTFPLAEKVKAFLADPSAFVAAAPVAAATTAAPAAAAAPAKVEAKEESEESDEDMGFGLFD,True,False,False,P05388,"[('cd05795', 'Ribosomal_P0_L10e'), ('G3DSA:3.30.70.1730', None), ('G3DSA:3.90.105.20', None), ('IPR001790', 'Large ribosomal subunit protein uL10'), ('IPR030670', 'Large ribosomal subunit protein uL10, eukaryotes'), ('IPR040637', 'Large ribosomal subunit protein uL10-like, insertion domain'), ('IPR043141', 'Large ribosomal subunit protein uL10-like domain superfamily'), ('IPR043164', 'Large ribosomal subunit protein uL10-like, insertion domain superfamily'), ('IPR050323', 'Universal ribosomal protein uL10'), ('PF00428', '60s Acidic ribosomal protein'), ('PF00466', 'Ribosomal protein L10'), ('PF17777', 'Insertion domain in 60S ribosomal protein L10P'), ('PIRSF039087', '60S acidic ribosomal protein P0'), ('PTHR45699', 'Universal ribosomal protein uL10'), ('SSF160369', 'Ribosomal protein L10-like')]",,"""ENSG00000089157; Low tissue specificity."";",,,,,ENST00000228306.8 [P05388-1];ENST00000313104.9 [P05388-2];ENST00000392514.9 [P05388-1];ENST00000551150.5 [P05388-1];,RPLP0,ENSG00000089157,0.0,RPLP0,Canonical_RBPs,25.0,,,,0.189,0.076,RPLP0
P05455,ENSG00000138385,LA_HUMAN,histone mRNA metabolic process [GO:0008334]; IRES-dependent viral translational initiation [GO:0075522]; nuclear histone mRNA catabolic process [GO:0071045]; positive regulation of translation [GO:0045727]; protein localization to cytoplasmic stress granule [GO:1903608]; tRNA 3'-end processing [GO:0042780]; tRNA 5'-leader removal [GO:0001682]; tRNA export from nucleus [GO:0006409]; tRNA modification [GO:0006400]; tRNA processing [GO:0008033],"chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]",mRNA binding [GO:0003729]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723]; sequence-specific mRNA binding [GO:1990825]; tRNA binding [GO:0000049],PTM: Phosphorylated. The phosphorylation sites are at the C-terminal part of the protein. {ECO:0000269|PubMed:9054510}.; PTM: The N-terminus is blocked.,,"DOMAIN 7..99; /note=""HTH La-type RNA-binding""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00332""; DOMAIN 111..187; /note=""RRM""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00176""; DOMAIN 227..348; /note=""xRRM""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU01288""","STRAND 46..48; /evidence=""ECO:0007829|PDB:2VON""; STRAND 80..82; /evidence=""ECO:0007829|PDB:2VOO""; STRAND 86..91; /evidence=""ECO:0007829|PDB:2VOO""; STRAND 112..116; /evidence=""ECO:0007829|PDB:2VOO""; STRAND 137..144; /evidence=""ECO:0007829|PDB:2VOO""; STRAND 146..148; /evidence=""ECO:0007829|PDB:2VOP""; STRAND 150..160; /evidence=""ECO:0007829|PDB:2VOO""; STRAND 174..177; /evidence=""ECO:0007829|PDB:2VOD""; STRAND 181..184; /evidence=""ECO:0007829|PDB:2VOO""; STRAND 233..239; /evidence=""ECO:0007829|PDB:1OWX""; STRAND 259..263; /evidence=""ECO:0007829|PDB:1OWX""; STRAND 269..277; /evidence=""ECO:0007829|PDB:1OWX""; STRAND 298..304; /evidence=""ECO:0007829|PDB:1OWX""","HELIX 11..24; /evidence=""ECO:0007829|PDB:2VOO""; HELIX 30..32; /evidence=""ECO:0007829|PDB:2VOO""; HELIX 34..42; /evidence=""ECO:0007829|PDB:2VOO""; HELIX 49..52; /evidence=""ECO:0007829|PDB:2VOO""; HELIX 56..61; /evidence=""ECO:0007829|PDB:2VOO""; HELIX 65..73; /evidence=""ECO:0007829|PDB:2VOO""; HELIX 102..110; /evidence=""ECO:0007829|PDB:2VOO""; HELIX 124..131; /evidence=""ECO:0007829|PDB:2VOO""; HELIX 132..134; /evidence=""ECO:0007829|PDB:1YTY""; HELIX 161..169; /evidence=""ECO:0007829|PDB:2VOO""; HELIX 246..252; /evidence=""ECO:0007829|PDB:1OWX""; HELIX 279..288; /evidence=""ECO:0007829|PDB:1OWX""; HELIX 308..326; /evidence=""ECO:0007829|PDB:1OWX""","TURN 27..29; /evidence=""ECO:0007829|PDB:2VOO""; TURN 43..45; /evidence=""ECO:0007829|PDB:2VOO""; TURN 185..187; /evidence=""ECO:0007829|PDB:2VOO""; TURN 289..291; /evidence=""ECO:0007829|PDB:1OWX""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,SSB,Lupus La protein (La autoantigen) (La ribonucleoprotein) (Sjoegren syndrome type B antigen) (SS-B),Homo sapiens (Human),408.0,46837.0,MAENGDNEKMAALEAKICHQIEYYFGDFNLPRDKFLKEQIKLDEGWVPLEIMIKFNRLNRLTTDFNVIVEALSKSKAELMEISEDKTKIRRSPSKPLPEVTDEYKNDVKNRSVYIKGFPTDATLDDIKEWLEDKGQVLNIQMRRTLHKAFKGSIFVVFDSIESAKKFVETPGQKYKETDLLILFKDDYFAKKNEERKQNKVEAKLRAKQEQEAKQKLEEDAEMKSLEEKIGCLLKFSGDLDDQTCREDLHILFSNHGEIKWIDFVRGAKEGIILFKEKAKEALGKAKDANNGNLQLRNKEVTWEVLEGEVEKEALKKIIEDQQESLNKWKSKGRRFKGKGKGNKAAQPGSGKGKVQFQGKKTKFASDDEHDEHDENGATGPVKRAREETDKEEPASKQQKTENGAGDQ,True,False,False,P05455,"[('cd08028', 'La RNA-binding domain of La-related protein 3'), ('cd12291', 'RNA recognition motif 1 in La autoantigen (La or LARP3) and similar proteins'), ('cd12541', 'RNA recognition motif 2 in La autoantigen (La or LARP3) and similar proteins'), ('G3DSA:1.10.10.10', 'Winged helix-like DNA-binding domain superfamily/Winged helix DNA-binding domain'), ('G3DSA:3.30.70.330', None), ('IPR000504', 'RNA recognition motif domain'), ('IPR002344', 'Lupus La protein'), ('IPR006630', 'La-type HTH domain'), ('IPR012677', 'Nucleotide-binding alpha-beta plait domain superfamily'), ('IPR014886', 'La protein, xRRM domain'), ('IPR035979', 'RNA-binding domain superfamily'), ('IPR036388', 'Winged helix-like DNA-binding domain superfamily'), ('IPR036390', 'Winged helix DNA-binding domain superfamily'), ('IPR045180', 'La domain containing protein'), ('PF00076', 'RNA recognition motif'), ('PF05383', 'La domain'), ('PF08777', 'RNA binding motif'), ('PR00302', 'LUPUSLA'), ('PS50102', 'Eukaryotic RNA Recognition Motif (RRM) profile'), ('PS50961', 'La-type HTH domain profile')]",,"""ENSG00000138385; Low tissue specificity."";",,,,,ENST00000260956.9;ENST00000409333.1;,SSB,ENSG00000138385,0.0,SSB,Canonical_RBPs,21.0,20.34,DP00229,0.203,0.228,0.196,SSB
P06241,ENSG00000010810,FYN_HUMAN,activated T cell proliferation [GO:0050798]; adaptive immune response [GO:0002250]; axon guidance [GO:0007411]; calcium ion transport [GO:0006816]; cell differentiation [GO:0030154]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; cellular response to amyloid-beta [GO:1904646]; cellular response to glycine [GO:1905430]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to L-glutamate [GO:1905232]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to transforming growth factor beta stimulus [GO:0071560]; dendrite morphogenesis [GO:0048813]; dendritic spine maintenance [GO:0097062]; detection of mechanical stimulus involved in sensory perception of pain [GO:0050966]; ephrin receptor signaling pathway [GO:0048013]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; feeding behavior [GO:0007631]; forebrain development [GO:0030900]; G protein-coupled glutamate receptor signaling pathway [GO:0007216]; gene expression [GO:0010467]; heart process [GO:0003015]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; learning [GO:0007612]; leukocyte migration [GO:0050900]; modulation of chemical synaptic transmission [GO:0050804]; natural killer cell activation [GO:0030101]; negative regulation of angiogenesis [GO:0016525]; negative regulation of dendritic spine maintenance [GO:1902951]; negative regulation of gene expression [GO:0010629]; negative regulation of hydrogen peroxide biosynthetic process [GO:0010730]; negative regulation of inflammatory response to antigenic stimulus [GO:0002862]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of protein ubiquitination [GO:0031397]; neuron migration [GO:0001764]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of neuron projection development [GO:0010976]; positive regulation of protein localization to membrane [GO:1905477]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein targeting to membrane [GO:0090314]; positive regulation of tyrosine phosphorylation of STAT protein [GO:0042531]; protein catabolic process [GO:0030163]; protein phosphorylation [GO:0006468]; protein ubiquitination [GO:0016567]; reelin-mediated signaling pathway [GO:0038026]; regulation of calcium ion import across plasma membrane [GO:1905664]; regulation of cell shape [GO:0008360]; regulation of glutamate receptor signaling pathway [GO:1900449]; regulation of peptidyl-tyrosine phosphorylation [GO:0050730]; response to amyloid-beta [GO:1904645]; response to ethanol [GO:0045471]; response to singlet oxygen [GO:0000304]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell costimulation [GO:0031295]; T cell receptor signaling pathway [GO:0050852]; vascular endothelial growth factor receptor signaling pathway [GO:0048010],actin filament [GO:0005884]; cell body [GO:0044297]; cytosol [GO:0005829]; dendrite [GO:0030425]; endosome [GO:0005768]; glial cell projection [GO:0097386]; membrane raft [GO:0045121]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear endoplasmic reticulum [GO:0097038]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; Schaffer collateral - CA1 synapse [GO:0098685],alpha-tubulin binding [GO:0043014]; ATP binding [GO:0005524]; disordered domain specific binding [GO:0097718]; enzyme binding [GO:0019899]; ephrin receptor binding [GO:0046875]; G protein-coupled receptor binding [GO:0001664]; growth factor receptor binding [GO:0070851]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; phospholipase activator activity [GO:0016004]; phospholipase binding [GO:0043274]; protein tyrosine kinase activity [GO:0004713]; scaffold protein binding [GO:0097110]; signaling receptor binding [GO:0005102]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321]; transmembrane transporter binding [GO:0044325]; type 5 metabotropic glutamate receptor binding [GO:0031802],"PTM: Autophosphorylated at Tyr-420 (By similarity). Phosphorylation on the C-terminal tail at Tyr-531 by CSK maintains the enzyme in an inactive state (PubMed:1699196). PTPRC/CD45 dephosphorylates Tyr-531 leading to activation (PubMed:1533589). Ultraviolet B (UVB) strongly increase phosphorylation at Thr-12 and kinase activity, and promotes translocation from the cytoplasm to the nucleus (PubMed:15537652). Dephosphorylation at Tyr-420 by PTPN2 negatively regulates T-cell receptor signaling (PubMed:22080863). Phosphorylated at tyrosine residues, which can be enhanced by NTN1 (By similarity). {ECO:0000250|UniProtKB:P39688, ECO:0000269|PubMed:10196263, ECO:0000269|PubMed:1533589, ECO:0000269|PubMed:15537652, ECO:0000269|PubMed:1699196, ECO:0000269|PubMed:22080863}.; PTM: Palmitoylated. Palmitoylation at Cys-3 and Cys-6, probably by ZDHHC21, regulates subcellular location. {ECO:0000250|UniProtKB:P39688}.",,"DOMAIN 82..143; /note=""SH3""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00192""; DOMAIN 149..246; /note=""SH2""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00191""; DOMAIN 271..524; /note=""Protein kinase""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00159""","STRAND 87..91; /evidence=""ECO:0007829|PDB:7A2P""; STRAND 97..100; /evidence=""ECO:0007829|PDB:7A2P""; STRAND 108..113; /evidence=""ECO:0007829|PDB:7A2P""; STRAND 115..124; /evidence=""ECO:0007829|PDB:7A2P""; STRAND 130..134; /evidence=""ECO:0007829|PDB:7A2P""; STRAND 138..140; /evidence=""ECO:0007829|PDB:7A2P""; STRAND 147..150; /evidence=""ECO:0007829|PDB:1G83""; STRAND 172..177; /evidence=""ECO:0007829|PDB:4U1P""; STRAND 179..181; /evidence=""ECO:0007829|PDB:4U1P""; STRAND 185..193; /evidence=""ECO:0007829|PDB:4U1P""; STRAND 197..207; /evidence=""ECO:0007829|PDB:4U1P""; STRAND 213..216; /evidence=""ECO:0007829|PDB:4U1P""; STRAND 219..223; /evidence=""ECO:0007829|PDB:4U1P""; STRAND 238..240; /evidence=""ECO:0007829|PDB:4U1P""; STRAND 263..265; /evidence=""ECO:0007829|PDB:2DQ7""; STRAND 271..278; /evidence=""ECO:0007829|PDB:2DQ7""; STRAND 285..290; /evidence=""ECO:0007829|PDB:2DQ7""; STRAND 294..299; /evidence=""ECO:0007829|PDB:2DQ7""; STRAND 329..333; /evidence=""ECO:0007829|PDB:2DQ7""; STRAND 335..337; /evidence=""ECO:0007829|PDB:2DQ7""; STRAND 339..343; /evidence=""ECO:0007829|PDB:2DQ7""; STRAND 355..357; /evidence=""ECO:0007829|PDB:2DQ7""; STRAND 396..399; /evidence=""ECO:0007829|PDB:2DQ7""; STRAND 403..406; /evidence=""ECO:0007829|PDB:2DQ7""; STRAND 416..418; /evidence=""ECO:0007829|PDB:2DQ7""","HELIX 135..137; /evidence=""ECO:0007829|PDB:7A2P""; HELIX 141..143; /evidence=""ECO:0007829|PDB:6IPY""; HELIX 144..146; /evidence=""ECO:0007829|PDB:1G83""; HELIX 156..163; /evidence=""ECO:0007829|PDB:4U1P""; HELIX 224..233; /evidence=""ECO:0007829|PDB:4U1P""; HELIX 268..270; /evidence=""ECO:0007829|PDB:2DQ7""; HELIX 308..318; /evidence=""ECO:0007829|PDB:2DQ7""; HELIX 350..354; /evidence=""ECO:0007829|PDB:2DQ7""; HELIX 364..383; /evidence=""ECO:0007829|PDB:2DQ7""; HELIX 393..395; /evidence=""ECO:0007829|PDB:2DQ7""; HELIX 435..438; /evidence=""ECO:0007829|PDB:2DQ7""; HELIX 445..460; /evidence=""ECO:0007829|PDB:2DQ7""; HELIX 472..481; /evidence=""ECO:0007829|PDB:2DQ7""; HELIX 496..502; /evidence=""ECO:0007829|PDB:2DQ7""; HELIX 507..509; /evidence=""ECO:0007829|PDB:2DQ7""; HELIX 513..521; /evidence=""ECO:0007829|PDB:2DQ7""","TURN 125..127; /evidence=""ECO:0007829|PDB:7A2P""; TURN 165..167; /evidence=""ECO:0007829|PDB:1AOT""; TURN 194..196; /evidence=""ECO:0007829|PDB:4U1P""; TURN 209..211; /evidence=""ECO:0007829|PDB:1AOT""; TURN 291..293; /evidence=""ECO:0007829|PDB:2DQ7""; TURN 303..305; /evidence=""ECO:0007829|PDB:2DQ7""; TURN 358..360; /evidence=""ECO:0007829|PDB:2DQ7""; TURN 400..402; /evidence=""ECO:0007829|PDB:2DQ7""; TURN 430..432; /evidence=""ECO:0007829|PDB:2DQ7""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,FYN,Tyrosine-protein kinase Fyn (EC 2.7.10.2) (Proto-oncogene Syn) (Proto-oncogene c-Fyn) (Src-like kinase) (SLK) (p59-Fyn),Homo sapiens (Human),537.0,60762.0,MGCVQCKDKEATKLTEERDGSLNQSSGYRYGTDPTPQHYPSFGVTSIPNYNNFHAAGGQGLTVFGGVNSSSHTGTLRTRGGTGVTLFVALYDYEARTEDDLSFHKGEKFQILNSSEGDWWEARSLTTGETGYIPSNYVAPVDSIQAEEWYFGKLGRKDAERQLLSFGNPRGTFLIRESETTKGAYSLSIRDWDDMKGDHVKHYKIRKLDNGGYYITTRAQFETLQQLVQHYSERAAGLCCRLVVPCHKGMPRLTDLSVKTKDVWEIPRESLQLIKRLGNGQFGEVWMGTWNGNTKVAIKTLKPGTMSPESFLEEAQIMKKLKHDKLVQLYAVVSEEPIYIVTEYMNKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGNGLICKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPISLHELMIHCWKKDPEERPTFEYLQSFLEDYFTATEPQYQPGENL,False,False,True,P06241,"[('cd05070', 'Catalytic domain of the Protein Tyrosine Kinase, Fyn'), ('cd10418', 'Src homology 2 (SH2) domain found in Fyn isoform a like proteins'), ('cd12006', 'Src homology 3 domain of Fyn and Yrk Protein Tyrosine Kinases'), ('G3DSA:1.10.510.10', 'Transferase(Phosphotransferase) domain 1'), ('G3DSA:2.30.30.40', 'SH3 Domains'), ('G3DSA:3.30.200.20', 'Phosphorylase Kinase; domain 1'), ('G3DSA:3.30.505.10', 'SH2 domain'), ('IPR000719', 'Protein kinase domain'), ('IPR000980', 'SH2 domain'), ('IPR001245', 'Serine-threonine/tyrosine-protein kinase, catalytic domain'), ('IPR001452', 'SH3 domain'), ('IPR008266', 'Tyrosine-protein kinase, active site'), ('IPR011009', 'Protein kinase-like domain superfamily'), ('IPR017441', 'Protein kinase, ATP binding site'), ('IPR020635', 'Tyrosine-protein kinase, catalytic domain'), ('IPR035750', 'Fyn/Yrk, SH3 domain'), ('IPR036028', 'SH3-like domain superfamily'), ('IPR036860', 'SH2 domain superfamily'), ('IPR047924', 'Fyn/Yrk, SH2 domain'), ('IPR050198', 'Non-receptor tyrosine kinases involved in cell signaling')]",P06241;,"""ENSG00000010810; Low tissue specificity."";","CATALYTIC ACTIVITY: Reaction=L-tyrosyl-[protein] + ATP = O-phospho-L-tyrosyl-[protein] + ADP + H(+); Xref=Rhea:RHEA:10596, Rhea:RHEA-COMP:10136, Rhea:RHEA-COMP:10137, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616, ChEBI:CHEBI:46858, ChEBI:CHEBI:82620, ChEBI:CHEBI:456216; EC=2.7.10.2; Evidence={ECO:0000255|PROSITE-ProRule:PRU10028, ECO:0000269|PubMed:11005864, ECO:0000269|PubMed:11162638, ECO:0000269|PubMed:12788081, ECO:0000269|PubMed:14707117, ECO:0000269|PubMed:14761972, ECO:0000269|PubMed:15536091, ECO:0000269|PubMed:16841086, ECO:0000269|PubMed:17194753, ECO:0000269|PubMed:18056706, ECO:0000269|PubMed:18258597, ECO:0000269|PubMed:19179337, ECO:0000269|PubMed:19652227, ECO:0000269|PubMed:7568038};",2.7.10.2,ACTIVITY REGULATION: Inhibited by phosphorylation of Tyr-531 by leukocyte common antigen and activated by dephosphorylation of this site. {ECO:0000269|PubMed:1699196}.,,ENST00000229471.8 [P06241-3];ENST00000354650.7 [P06241-1];ENST00000368667.6 [P06241-1];ENST00000368678.8 [P06241-2];ENST00000368682.8 [P06241-2];,FYN,ENSG00000010810,0.0,,,,,,0.05,0.156,0.041,FYN
P06396,ENSG00000148180,GELS_HUMAN,"actin filament capping [GO:0051693]; actin filament depolymerization [GO:0030042]; actin filament organization [GO:0007015]; actin filament polymerization [GO:0030041]; actin filament severing [GO:0051014]; actin polymerization or depolymerization [GO:0008154]; amyloid fibril formation [GO:1990000]; barbed-end actin filament capping [GO:0051016]; cardiac muscle cell contraction [GO:0086003]; cell projection assembly [GO:0030031]; cellular response to type II interferon [GO:0071346]; central nervous system development [GO:0007417]; cilium assembly [GO:0060271]; hepatocyte apoptotic process [GO:0097284]; negative regulation of viral entry into host cell [GO:0046597]; phagocytosis, engulfment [GO:0006911]; positive regulation of actin nucleation [GO:0051127]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway [GO:2001269]; positive regulation of gene expression [GO:0010628]; positive regulation of keratinocyte apoptotic process [GO:1902174]; positive regulation of protein processing in phagocytic vesicle [GO:1903923]; protein destabilization [GO:0031648]; regulation of establishment of T cell polarity [GO:1903903]; regulation of plasma membrane raft polarization [GO:1903906]; regulation of podosome assembly [GO:0071801]; regulation of receptor clustering [GO:1903909]; relaxation of cardiac muscle [GO:0055119]; renal protein absorption [GO:0097017]; response to muscle stretch [GO:0035994]; sequestering of actin monomers [GO:0042989]; striated muscle atrophy [GO:0014891]",actin cap [GO:0030478]; actin cytoskeleton [GO:0015629]; blood microparticle [GO:0072562]; cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; podosome [GO:0002102]; sarcoplasm [GO:0016528]; secretory granule lumen [GO:0034774],"actin binding [GO:0003779]; actin filament binding [GO:0051015]; calcium ion binding [GO:0005509]; myosin II binding [GO:0045159]; phosphatidylinositol 3-kinase catalytic subunit binding [GO:0036313]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]","PTM: Phosphorylation on Tyr-86, Tyr-409, Tyr-465, Tyr-603 and Tyr-651 in vitro is induced in presence of phospholipids. {ECO:0000269|PubMed:10210201}.","DOMAIN: Comprises six structurally related gelsolin-like (G1-G6) domains, that, in a calcium-free environment, are packed together to form a compact globular structure in which the putative actin-binding sequences are not sufficiently exposed to enable binding to occur (PubMed:19666512). Binding calcium may release the connections that join the N- and C-terminal halves of gelsolin, enabling each half to bind actin relatively independently (PubMed:12460571, PubMed:19666512). G1 and G4 bind two Ca(2+) in a type I and in a type II manner (PubMed:12460571, PubMed:19666512). G2, G3, G5 and G6 bind only one Ca(2+) in a type II manner (PubMed:12460571, PubMed:19666512). Type I Ca(2+) binding sites are shared between actin and gelsolin-like repeats G1 and G4 (PubMed:12460571, PubMed:19666512). Type I binding governs the strength of interactions between gelsolin and actin by direct participation at the binding interface (PubMed:12460571, PubMed:19666512). Ca(2+) binding to G2 and G6 disrupts the interactions between G2 and G6, releases the C-terminal tail, and induces large interdomain rearrangements that result in the exposure of the F-actin-binding site on G2 and contributes to the activation of gelsolin (PubMed:12460571, PubMed:19666512). Binding to phosphoinositides may inhibit the severing and capping properties of gelsolin (Probable). {ECO:0000269|PubMed:12460571, ECO:0000269|PubMed:19666512, ECO:0000305|PubMed:8599675}.",,"STRAND 52..55; /evidence=""ECO:0007829|PDB:3FFN""; STRAND 64..74; /evidence=""ECO:0007829|PDB:3CIP""; STRAND 77..80; /evidence=""ECO:0007829|PDB:3CIP""; STRAND 88..90; /evidence=""ECO:0007829|PDB:3CIP""; STRAND 94..102; /evidence=""ECO:0007829|PDB:3CIP""; STRAND 108..116; /evidence=""ECO:0007829|PDB:3CIP""; STRAND 143..149; /evidence=""ECO:0007829|PDB:3CIP""; STRAND 150..152; /evidence=""ECO:0007829|PDB:5H3M""; STRAND 166..169; /evidence=""ECO:0007829|PDB:3CIP""; STRAND 179..181; /evidence=""ECO:0007829|PDB:1SOL""; STRAND 188..193; /evidence=""ECO:0007829|PDB:5FAF""; STRAND 195..197; /evidence=""ECO:0007829|PDB:5FAF""; STRAND 199..203; /evidence=""ECO:0007829|PDB:5FAF""; STRAND 214..219; /evidence=""ECO:0007829|PDB:5FAF""; STRAND 221..228; /evidence=""ECO:0007829|PDB:5FAF""; STRAND 230..232; /evidence=""ECO:0007829|PDB:6JCO""; STRAND 256..262; /evidence=""ECO:0007829|PDB:5FAF""; STRAND 299..304; /evidence=""ECO:0007829|PDB:6LJE""; STRAND 306..309; /evidence=""ECO:0007829|PDB:3FFN""; STRAND 311..316; /evidence=""ECO:0007829|PDB:6LJE""; STRAND 318..321; /evidence=""ECO:0007829|PDB:6LJE""; STRAND 330..336; /evidence=""ECO:0007829|PDB:6LJE""; STRAND 341..346; /evidence=""ECO:0007829|PDB:6LJE""; STRAND 377..381; /evidence=""ECO:0007829|PDB:6LJE""; STRAND 393..395; /evidence=""ECO:0007829|PDB:6JEH""; STRAND 401..406; /evidence=""ECO:0007829|PDB:6Q9R""; STRAND 445..453; /evidence=""ECO:0007829|PDB:2FH1""; STRAND 456..459; /evidence=""ECO:0007829|PDB:2FH1""; STRAND 467..469; /evidence=""ECO:0007829|PDB:2FH1""; STRAND 472..482; /evidence=""ECO:0007829|PDB:2FH1""; STRAND 485..494; /evidence=""ECO:0007829|PDB:2FH1""; STRAND 521..527; /evidence=""ECO:0007829|PDB:2FH1""; STRAND 544..548; /evidence=""ECO:0007829|PDB:2FH1""; STRAND 562..570; /evidence=""ECO:0007829|PDB:2FH1""; STRAND 576..581; /evidence=""ECO:0007829|PDB:2FH1""; STRAND 592..597; /evidence=""ECO:0007829|PDB:2FH1""; STRAND 602..606; /evidence=""ECO:0007829|PDB:2FH1""; STRAND 630..633; /evidence=""ECO:0007829|PDB:2FH1""; STRAND 645..647; /evidence=""ECO:0007829|PDB:2FH4""; STRAND 668..673; /evidence=""ECO:0007829|PDB:2FH1""; STRAND 676..678; /evidence=""ECO:0007829|PDB:6JEH""; STRAND 680..684; /evidence=""ECO:0007829|PDB:2FH1""; STRAND 697..702; /evidence=""ECO:0007829|PDB:2FH1""; STRAND 707..711; /evidence=""ECO:0007829|PDB:2FH1""; STRAND 744..748; /evidence=""ECO:0007829|PDB:2FH1""; STRAND 760..762; /evidence=""ECO:0007829|PDB:2FH1""","HELIX 57..61; /evidence=""ECO:0007829|PDB:3CIP""; HELIX 83..85; /evidence=""ECO:0007829|PDB:3CIP""; HELIX 122..138; /evidence=""ECO:0007829|PDB:3CIP""; HELIX 155..158; /evidence=""ECO:0007829|PDB:3CIP""; HELIX 183..186; /evidence=""ECO:0007829|PDB:5H3M""; HELIX 207..209; /evidence=""ECO:0007829|PDB:5FAF""; HELIX 234..251; /evidence=""ECO:0007829|PDB:5FAF""; HELIX 268..274; /evidence=""ECO:0007829|PDB:5FAF""; HELIX 292..294; /evidence=""ECO:0007829|PDB:6Q9R""; HELIX 323..325; /evidence=""ECO:0007829|PDB:6LJE""; HELIX 337..339; /evidence=""ECO:0007829|PDB:6LJE""; HELIX 352..368; /evidence=""ECO:0007829|PDB:6LJE""; HELIX 387..390; /evidence=""ECO:0007829|PDB:6LJE""; HELIX 412..414; /evidence=""ECO:0007829|PDB:6Q9R""; HELIX 424..429; /evidence=""ECO:0007829|PDB:6Q9R""; HELIX 431..437; /evidence=""ECO:0007829|PDB:6Q9R""; HELIX 462..464; /evidence=""ECO:0007829|PDB:2FH1""; HELIX 500..516; /evidence=""ECO:0007829|PDB:2FH1""; HELIX 533..536; /evidence=""ECO:0007829|PDB:2FH1""; HELIX 537..539; /evidence=""ECO:0007829|PDB:2FH1""; HELIX 585..587; /evidence=""ECO:0007829|PDB:2FH1""; HELIX 612..624; /evidence=""ECO:0007829|PDB:2FH1""; HELIX 639..644; /evidence=""ECO:0007829|PDB:2FH1""; HELIX 655..658; /evidence=""ECO:0007829|PDB:2FH1""; HELIX 661..664; /evidence=""ECO:0007829|PDB:6Q9R""; HELIX 690..692; /evidence=""ECO:0007829|PDB:2FH1""; HELIX 717..732; /evidence=""ECO:0007829|PDB:2FH1""; HELIX 754..757; /evidence=""ECO:0007829|PDB:2FH1""; HELIX 767..769; /evidence=""ECO:0007829|PDB:6Q9R""; HELIX 772..778; /evidence=""ECO:0007829|PDB:6Q9R""","TURN 104..106; /evidence=""ECO:0007829|PDB:1P8Z""; TURN 139..141; /evidence=""ECO:0007829|PDB:3CIP""; TURN 172..175; /evidence=""ECO:0007829|PDB:6Q9R""; TURN 176..178; /evidence=""ECO:0007829|PDB:5H3M""; TURN 263..265; /evidence=""ECO:0007829|PDB:3FFK""; TURN 517..519; /evidence=""ECO:0007829|PDB:1P8X""; TURN 553..555; /evidence=""ECO:0007829|PDB:2FH1""; TURN 735..737; /evidence=""ECO:0007829|PDB:2FH1""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,GSN,Gelsolin (AGEL) (Actin-depolymerizing factor) (ADF) (Brevin),Homo sapiens (Human),782.0,85698.0,MAPHRPAPALLCALSLALCALSLPVRAATASRGASQAGAPQGRVPEARPNSMVVEHPEFLKAGKEPGLQIWRVEKFDLVPVPTNLYGDFFTGDAYVILKTVQLRNGNLQYDLHYWLGNECSQDESGAAAIFTVQLDDYLNGRAVQHREVQGFESATFLGYFKSGLKYKKGGVASGFKHVVPNEVVVQRLFQVKGRRVVRATEVPVSWESFNNGDCFILDLGNNIHQWCGSNSNRYERLKATQVSKGIRDNERSGRARVHVSEEGTEPEAMLQVLGPKPALPAGTEDTAKEDAANRKLAKLYKVSNGAGTMSVSLVADENPFAQGALKSEDCFILDHGKDGKIFVWKGKQANTEERKAALKTASDFITKMDYPKQTQVSVLPEGGETPLFKQFFKNWRDPDQTDGLGLSYLSSHIANVERVPFDAATLHTSTAMAAQHGMDDDGTGQKQIWRIEGSNKVPVDPATYGQFYGGDSYIILYNYRHGGRQGQIIYNWQGAQSTQDEVAASAILTAQLDEELGGTPVQSRVVQGKEPAHLMSLFGGKPMIIYKGGTSREGGQTAPASTRLFQVRANSAGATRAVEVLPKAGALNSNDAFVLKTPSAAYLWVGTGASEAEKTGAQELLRVLRAQPVQVAEGSEPDGFWEALGGKAAYRTSPRLKDKKMDAHPPRLFACSNKIGRFVIEEVPGELMQEDLATDDVMLLDTWDQVFVWVGKDSQEEEKTEALTSAKRYIETDPANRDRRTPITVVKQGFEPPSFVGWFLGWDDDYWSVDPLDRAMAELAA,True,False,False,P06396,"[('cd11288', 'Gelsolin sub-domain 5-like domain found in gelsolin, severin, villin, and related proteins'), ('cd11289', 'Gelsolin sub-domain 2-like domain found in gelsolin, severin, villin, and related proteins'), ('cd11290', 'Gelsolin sub-domain 1-like domain found in gelsolin, severin, villin, and related proteins'), ('cd11291', 'Gelsolin sub-domain 6-like domain found in gelsolin, severin, villin, and related proteins'), ('cd11292', 'Gelsolin sub-domain 3-like domain found in gelsolin, severin, villin, and related proteins'), ('cd11293', 'Gelsolin sub-domain 4-like domain found in gelsolin, severin, villin, and related proteins'), ('G3DSA:3.40.20.10', 'Severin'), ('IPR007122', 'Villin/Gelsolin'), ('IPR007123', 'Gelsolin-like domain'), ('IPR029006', 'ADF-H/Gelsolin-like domain superfamily'), ('PF00626', 'Gelsolin repeat'), ('PR00597', 'GELSOLIN'), ('PTHR11977', 'VILLIN'), ('SM00262', 'Gelsolin homology domain'), ('SSF55753', 'Actin depolymerizing proteins')]",,"""ENSG00000148180; Tissue enhanced (heart)."";",,,,,ENST00000373808.8 [P06396-3];ENST00000373818.8 [P06396-1];ENST00000373823.7 [P06396-2];ENST00000432226.7 [P06396-2];ENST00000545652.6 [P06396-4];,GSN,ENSG00000148180,0.0,,,,,,0.15,0.072,0.05,GSN
P06702,ENSG00000163220,S10A9_HUMAN,activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; apoptotic process [GO:0006915]; astrocyte development [GO:0014002]; autocrine signaling [GO:0035425]; autophagy [GO:0006914]; cell-cell signaling [GO:0007267]; chronic inflammatory response [GO:0002544]; defense response to bacterium [GO:0042742]; defense response to fungus [GO:0050832]; endothelial cell migration [GO:0043542]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; leukocyte migration involved in inflammatory response [GO:0002523]; modulation of process of another organism [GO:0035821]; neutrophil aggregation [GO:0070488]; neutrophil chemotaxis [GO:0030593]; peptidyl-cysteine S-trans-nitrosylation [GO:0035606]; positive regulation of cell growth [GO:0030307]; positive regulation of inflammatory response [GO:0050729]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of neuron projection development [GO:0010976]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; regulation of cytoskeleton organization [GO:0051493]; regulation of integrin biosynthetic process [GO:0045113]; regulation of respiratory burst involved in inflammatory response [GO:0060264]; regulation of toll-like receptor signaling pathway [GO:0034121]; response to lipopolysaccharide [GO:0032496]; sequestering of zinc ion [GO:0032119],calprotectin complex [GO:1990660]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; S100A9 complex [GO:1990662]; secretory granule lumen [GO:0034774],antioxidant activity [GO:0016209]; arachidonic acid binding [GO:0050544]; calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; microtubule binding [GO:0008017]; RAGE receptor binding [GO:0050786]; Toll-like receptor 4 binding [GO:0035662]; zinc ion binding [GO:0008270],"PTM: Phosphorylated. Phosphorylation inhibits activation of tubulin polymerization. {ECO:0000269|PubMed:15331440, ECO:0000269|PubMed:15905572, ECO:0000269|PubMed:2478889}.; PTM: S-nitrosylation of Cys-3 is implicated in LDL(ox)-induced S-nitrosylation of GAPDH at 'Cys-247' through a transnitrosylase mechanism involving a iNOS-S100A8/9 complex (PubMed:25417112). {ECO:0000305|PubMed:25417112}.; PTM: Methylation at His-105 by METTL9 reduces zinc-binding without affecting heterodimerization with S100A8. {ECO:0000250|UniProtKB:P31725}.",,"DOMAIN 12..47; /note=""EF-hand 1""; /evidence=""ECO:0000305""; DOMAIN 54..89; /note=""EF-hand 2""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00448""","STRAND 25..28; /evidence=""ECO:0007829|PDB:4GGF""; STRAND 71..74; /evidence=""ECO:0007829|PDB:4GGF""","HELIX 7..23; /evidence=""ECO:0007829|PDB:4GGF""; HELIX 34..44; /evidence=""ECO:0007829|PDB:4GGF""; HELIX 50..53; /evidence=""ECO:0007829|PDB:4GGF""; HELIX 56..66; /evidence=""ECO:0007829|PDB:4GGF""; HELIX 76..94; /evidence=""ECO:0007829|PDB:4GGF""","TURN 45..49; /evidence=""ECO:0007829|PDB:4GGF""; TURN 95..97; /evidence=""ECO:0007829|PDB:4GGF""; TURN 108..110; /evidence=""ECO:0007829|PDB:5I8N""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,S100A9 CAGB CFAG MRP14,Protein S100-A9 (Calgranulin-B) (Calprotectin L1H subunit) (Leukocyte L1 complex heavy chain) (Migration inhibitory factor-related protein 14) (MRP-14) (p14) (S100 calcium-binding protein A9),Homo sapiens (Human),114.0,13242.0,MTCKMSQLERNIETIINTFHQYSVKLGHPDTLNQGEFKELVRKDLQNFLKKENKNEKVIEHIMEDLDTNADKQLSFEEFIMLMARLTWASHEKMHEGDEGPGHHHKPGLGEGTP,False,True,False,P06702,"[('cd05030', 'calgranulins'), ('G3DSA:1.10.238.10', 'EF-hand'), ('IPR001751', 'S100/Calcium binding protein 7/8-like, conserved site'), ('IPR002048', 'EF-hand domain'), ('IPR011992', 'EF-hand domain pair'), ('IPR013787', 'S100/CaBP-9k-type, calcium binding, subdomain'), ('IPR018247', 'EF-Hand 1, calcium-binding site'), ('PF01023', 'S-100/ICaBP type calcium binding domain'), ('PS00018', 'EF-hand calcium-binding domain'), ('PS00303', 'S-100/ICaBP type calcium binding protein signature'), ('PS50222', 'EF-hand calcium-binding domain profile'), ('PTHR11639', 'S100 calcium-binding'), ('SM00054', 'EF-hand, calcium binding motif'), ('SM01394', 'S-100/ICaBP type calcium binding domain'), ('SSF47473', 'EF-hand')]",,"""ENSG00000163220; Tissue enhanced (bone marrow, esophagus, vagina)."";",,,,,ENST00000368738.4;,S100A9,ENSG00000163220,0.0,S100A9,Non-canonical_RBPs,7.0,24.56,DP04125,0.246,0.175,0.193,S100A9
P06733,ENSG00000074800,ENOA_HUMAN,canonical glycolysis [GO:0061621]; gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096]; negative regulation of cell growth [GO:0030308]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway [GO:1903298]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of ATP biosynthetic process [GO:2001171]; positive regulation of muscle contraction [GO:0045933]; positive regulation of plasminogen activation [GO:0010756]; response to virus [GO:0009615],cell cortex [GO:0005938]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; M band [GO:0031430]; membrane [GO:0016020]; nuclear outer membrane [GO:0005640]; nucleus [GO:0005634]; phosphopyruvate hydratase complex [GO:0000015]; plasma membrane [GO:0005886],"cadherin binding [GO:0045296]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; GTPase binding [GO:0051020]; magnesium ion binding [GO:0000287]; phosphopyruvate hydratase activity [GO:0004634]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; transcription corepressor activity [GO:0003714]; transcription corepressor binding [GO:0001222]","PTM: ISGylated. {ECO:0000269|PubMed:16139798, ECO:0000269|PubMed:16815975}.; PTM: Lysine 2-hydroxyisobutyrylation (Khib) by p300/EP300 activates the phosphopyruvate hydratase activity. {ECO:0000269|PubMed:29775581}.",,,"STRAND 5..12; /evidence=""ECO:0007829|PDB:2PSN""; STRAND 18..26; /evidence=""ECO:0007829|PDB:2PSN""; STRAND 29..34; /evidence=""ECO:0007829|PDB:2PSN""; STRAND 147..154; /evidence=""ECO:0007829|PDB:2PSN""; STRAND 159..162; /evidence=""ECO:0007829|PDB:2PSN""; STRAND 167..171; /evidence=""ECO:0007829|PDB:2PSN""; STRAND 241..245; /evidence=""ECO:0007829|PDB:2PSN""; STRAND 289..293; /evidence=""ECO:0007829|PDB:2PSN""; STRAND 313..318; /evidence=""ECO:0007829|PDB:2PSN""; STRAND 338..342; /evidence=""ECO:0007829|PDB:2PSN""; STRAND 366..370; /evidence=""ECO:0007829|PDB:2PSN""; STRAND 391..394; /evidence=""ECO:0007829|PDB:2PSN""","HELIX 57..59; /evidence=""ECO:0007829|PDB:2PSN""; HELIX 63..71; /evidence=""ECO:0007829|PDB:2PSN""; HELIX 73..79; /evidence=""ECO:0007829|PDB:2PSN""; HELIX 87..98; /evidence=""ECO:0007829|PDB:2PSN""; HELIX 108..125; /evidence=""ECO:0007829|PDB:2PSN""; HELIX 130..138; /evidence=""ECO:0007829|PDB:2PSN""; HELIX 156..158; /evidence=""ECO:0007829|PDB:2PSN""; HELIX 178..200; /evidence=""ECO:0007829|PDB:2PSN""; HELIX 202..204; /evidence=""ECO:0007829|PDB:2PSN""; HELIX 220..233; /evidence=""ECO:0007829|PDB:2PSN""; HELIX 248..250; /evidence=""ECO:0007829|PDB:2PSN""; HELIX 267..269; /evidence=""ECO:0007829|PDB:2PSN""; HELIX 273..286; /evidence=""ECO:0007829|PDB:2PSN""; HELIX 301..311; /evidence=""ECO:0007829|PDB:2PSN""; HELIX 325..334; /evidence=""ECO:0007829|PDB:2PSN""; HELIX 344..347; /evidence=""ECO:0007829|PDB:2PSN""; HELIX 350..362; /evidence=""ECO:0007829|PDB:2PSN""; HELIX 380..387; /evidence=""ECO:0007829|PDB:2PSN""; HELIX 401..417; /evidence=""ECO:0007829|PDB:2PSN""; HELIX 418..420; /evidence=""ECO:0007829|PDB:2PSN""; HELIX 425..427; /evidence=""ECO:0007829|PDB:2PSN""","TURN 104..106; /evidence=""ECO:0007829|PDB:2PSN""; TURN 237..239; /evidence=""ECO:0007829|PDB:2PSN""; TURN 259..262; /evidence=""ECO:0007829|PDB:2PSN""; TURN 319..323; /evidence=""ECO:0007829|PDB:2PSN""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,ENO1 ENO1L1 MBPB1 MPB1,Alpha-enolase (EC 4.2.1.11) (2-phospho-D-glycerate hydro-lyase) (C-myc promoter-binding protein) (Enolase 1) (MBP-1) (MPB-1) (Non-neural enolase) (NNE) (Phosphopyruvate hydratase) (Plasminogen-binding protein),Homo sapiens (Human),434.0,47169.0,MSILKIHAREIFDSRGNPTVEVDLFTSKGLFRAAVPSGASTGIYEALELRDNDKTRYMGKGVSKAVEHINKTIAPALVSKKLNVTEQEKIDKLMIEMDGTENKSKFGANAILGVSLAVCKAGAVEKGVPLYRHIADLAGNSEVILPVPAFNVINGGSHAGNKLAMQEFMILPVGAANFREAMRIGAEVYHNLKNVIKEKYGKDATNVGDEGGFAPNILENKEGLELLKTAIGKAGYTDKVVIGMDVAASEFFRSGKYDLDFKSPDDPSRYISPDQLADLYKSFIKDYPVVSIEDPFDQDDWGAWQKFTASAGIQVVGDDLTVTNPKRIAKAVNEKSCNCLLLKVNQIGSVTESLQACKLAQANGWGVMVSHRSGETEDTFIADLVVGLCTGQIKTGAPCRSERLAKYNQLLRIEEELGSKAKFAGRNFRNPLAK,True,True,True,P06733,"[('cd03313', 'enolase'), ('G3DSA:3.20.20.120', 'Enolase-like C-terminal domain'), ('G3DSA:3.30.390.10', 'Enolase-like, N-terminal domain'), ('IPR000941', 'Enolase'), ('IPR020809', 'Enolase, conserved site'), ('IPR020810', 'Enolase, C-terminal TIM barrel domain'), ('IPR020811', 'Enolase, N-terminal'), ('IPR029017', 'Enolase-like, N-terminal'), ('IPR036849', 'Enolase-like, C-terminal domain superfamily'), ('MF_00318', 'Enolase [eno]'), ('PF00113', 'Enolase, C-terminal TIM barrel domain'), ('PF03952', 'Enolase, N-terminal domain'), ('PIRSF001400', 'Enolase'), ('PR00148', 'ENOLASE'), ('PS00164', 'Enolase signature'), ('PTHR11902', 'ENOLASE'), ('SFLDF00002', 'enolase'), ('SFLDG00178', 'enolase'), ('SM01192', 'Enolase, C-terminal TIM barrel domain'), ('SM01193', 'Enolase, N-terminal domain')]",,"""ENSG00000074800; Low tissue specificity."";","CATALYTIC ACTIVITY: Reaction=(2R)-2-phosphoglycerate = phosphoenolpyruvate + H2O; Xref=Rhea:RHEA:10164, ChEBI:CHEBI:15377, ChEBI:CHEBI:58289, ChEBI:CHEBI:58702; EC=4.2.1.11; Evidence={ECO:0000269|PubMed:1369209, ECO:0000269|PubMed:29775581};",4.2.1.11,,PATHWAY: Carbohydrate degradation; glycolysis; pyruvate from D-glyceraldehyde 3-phosphate: step 4/5. {ECO:0000305|PubMed:1369209}.,ENST00000234590.10 [P06733-1];,ENO1,ENSG00000074800,0.0,ENO1,Non-canonical_RBPs,30.0,,,,,,ENO1
P06744,ENSG00000105220,G6PI_HUMAN,carbohydrate metabolic process [GO:0005975]; erythrocyte homeostasis [GO:0034101]; fructose 6-phosphate metabolic process [GO:0006002]; GDP-mannose biosynthetic process from glucose [GO:0141199]; gluconeogenesis [GO:0006094]; glucose 6-phosphate metabolic process [GO:0051156]; glucose homeostasis [GO:0042593]; glycolytic process [GO:0006096]; hemostasis [GO:0007599]; humoral immune response [GO:0006959]; in utero embryonic development [GO:0001701]; learning or memory [GO:0007611]; mesoderm formation [GO:0001707]; negative regulation of neuron apoptotic process [GO:0043524]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of immunoglobulin production [GO:0002639]; response to cadmium ion [GO:0046686]; response to estradiol [GO:0032355]; response to immobilization stress [GO:0035902]; response to muscle stretch [GO:0035994]; response to progesterone [GO:0032570]; response to testosterone [GO:0033574],ciliary membrane [GO:0060170]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; secretory granule lumen [GO:0034774],carbohydrate derivative binding [GO:0097367]; cytokine activity [GO:0005125]; glucose-6-phosphate isomerase activity [GO:0004347]; growth factor activity [GO:0008083]; monosaccharide binding [GO:0048029]; ubiquitin protein ligase binding [GO:0031625],"PTM: Phosphorylation at Ser-185 by CK2 has been shown to decrease enzymatic activity and may contribute to secretion by a non-classical secretory pathway. {ECO:0000269|PubMed:11004567, ECO:0000269|PubMed:15637053}.; PTM: ISGylated. {ECO:0000269|PubMed:16139798}.",,,"STRAND 41..45; /evidence=""ECO:0007829|PDB:1IAT""; STRAND 50..54; /evidence=""ECO:0007829|PDB:1IAT""; STRAND 57..59; /evidence=""ECO:0007829|PDB:1IAT""; STRAND 116..118; /evidence=""ECO:0007829|PDB:1IAT""; STRAND 151..155; /evidence=""ECO:0007829|PDB:1IAT""; STRAND 180..184; /evidence=""ECO:0007829|PDB:1IAT""; STRAND 204..209; /evidence=""ECO:0007829|PDB:1IAT""; STRAND 211..213; /evidence=""ECO:0007829|PDB:1IAT""; STRAND 243..248; /evidence=""ECO:0007829|PDB:1IAT""; STRAND 263..265; /evidence=""ECO:0007829|PDB:1IAT""; STRAND 335..341; /evidence=""ECO:0007829|PDB:1IAT""; STRAND 366..368; /evidence=""ECO:0007829|PDB:6XUH""; STRAND 378..380; /evidence=""ECO:0007829|PDB:1IAT""; STRAND 398..400; /evidence=""ECO:0007829|PDB:1JLH""; STRAND 404..411; /evidence=""ECO:0007829|PDB:1IAT""; STRAND 474..481; /evidence=""ECO:0007829|PDB:1IAT""; STRAND 530..532; /evidence=""ECO:0007829|PDB:1IAT""","HELIX 3..6; /evidence=""ECO:0007829|PDB:1IAT""; HELIX 8..20; /evidence=""ECO:0007829|PDB:1IAT""; HELIX 21..23; /evidence=""ECO:0007829|PDB:1IAT""; HELIX 26..32; /evidence=""ECO:0007829|PDB:1IAT""; HELIX 36..39; /evidence=""ECO:0007829|PDB:1IAT""; HELIX 62..74; /evidence=""ECO:0007829|PDB:1IAT""; HELIX 77..85; /evidence=""ECO:0007829|PDB:1IAT""; HELIX 100..103; /evidence=""ECO:0007829|PDB:1IAT""; HELIX 119..137; /evidence=""ECO:0007829|PDB:1IAT""; HELIX 158..160; /evidence=""ECO:0007829|PDB:1IAT""; HELIX 162..170; /evidence=""ECO:0007829|PDB:1IAT""; HELIX 172..174; /evidence=""ECO:0007829|PDB:1IAT""; HELIX 189..196; /evidence=""ECO:0007829|PDB:1IAT""; HELIX 201..203; /evidence=""ECO:0007829|PDB:1IAT""; HELIX 216..233; /evidence=""ECO:0007829|PDB:1IAT""; HELIX 236..238; /evidence=""ECO:0007829|PDB:1IAT""; HELIX 239..242; /evidence=""ECO:0007829|PDB:1IAT""; HELIX 250..256; /evidence=""ECO:0007829|PDB:1IAT""; HELIX 260..262; /evidence=""ECO:0007829|PDB:1IAT""; HELIX 272..274; /evidence=""ECO:0007829|PDB:1IAT""; HELIX 279..281; /evidence=""ECO:0007829|PDB:1IAT""; HELIX 282..288; /evidence=""ECO:0007829|PDB:1IAT""; HELIX 290..309; /evidence=""ECO:0007829|PDB:1IAT""; HELIX 312..314; /evidence=""ECO:0007829|PDB:1IAT""; HELIX 316..329; /evidence=""ECO:0007829|PDB:1IAT""; HELIX 343..345; /evidence=""ECO:0007829|PDB:1IAT""; HELIX 348..360; /evidence=""ECO:0007829|PDB:1IAT""; HELIX 386..389; /evidence=""ECO:0007829|PDB:1IAT""; HELIX 392..397; /evidence=""ECO:0007829|PDB:1IAT""; HELIX 416..419; /evidence=""ECO:0007829|PDB:1IAT""; HELIX 420..438; /evidence=""ECO:0007829|PDB:1IAT""; HELIX 442..451; /evidence=""ECO:0007829|PDB:1IAT""; HELIX 456..462; /evidence=""ECO:0007829|PDB:1IAT""; HELIX 463..466; /evidence=""ECO:0007829|PDB:1IAT""; HELIX 484..505; /evidence=""ECO:0007829|PDB:1IAT""; HELIX 513..515; /evidence=""ECO:0007829|PDB:1IAT""; HELIX 516..528; /evidence=""ECO:0007829|PDB:1IAT""; HELIX 540..552; /evidence=""ECO:0007829|PDB:1IAT""","TURN 92..95; /evidence=""ECO:0007829|PDB:1IAT""; TURN 276..278; /evidence=""ECO:0007829|PDB:1IAT""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,GPI,Glucose-6-phosphate isomerase (GPI) (EC 5.3.1.9) (Autocrine motility factor) (AMF) (Neuroleukin) (NLK) (Phosphoglucose isomerase) (PGI) (Phosphohexose isomerase) (PHI) (Sperm antigen 36) (SA-36),Homo sapiens (Human),558.0,63147.0,MAALTRDPQFQKLQQWYREHRSELNLRRLFDANKDRFNHFSLTLNTNHGHILVDYSKNLVTEDVMRMLVDLAKSRGVEAARERMFNGEKINYTEGRAVLHVALRNRSNTPILVDGKDVMPEVNKVLDKMKSFCQRVRSGDWKGYTGKTITDVINIGIGGSDLGPLMVTEALKPYSSGGPRVWYVSNIDGTHIAKTLAQLNPESSLFIIASKTFTTQETITNAETAKEWFLQAAKDPSAVAKHFVALSTNTTKVKEFGIDPQNMFEFWDWVGGRYSLWSAIGLSIALHVGFDNFEQLLSGAHWMDQHFRTTPLEKNAPVLLALLGIWYINCFGCETHAMLPYDQYLHRFAAYFQQGDMESNGKYITKSGTRVDHQTGPIVWGEPGTNGQHAFYQLIHQGTKMIPCDFLIPVQTQHPIRKGLHHKILLANFLAQTEALMRGKSTEEARKELQAAGKSPEDLERLLPHKVFEGNRPTNSIVFTKLTPFMLGALVAMYEHKIFVQGIIWDINSFDQWGVELGKQLAKKIEPELDGSAQVTSHDASTNGLINFIKQQREARVQ,True,False,True,P06744,"[('cd05015', 'SIS_PGI_1'), ('cd05016', 'SIS_PGI_2'), ('G3DSA:1.10.1390.10', None), ('G3DSA:3.40.50.10490', 'Glucose-6-phosphate isomerase like protein; domain 1'), ('IPR001672', 'Phosphoglucose isomerase (PGI)'), ('IPR018189', 'Phosphoglucose isomerase, conserved site'), ('IPR023096', 'Phosphoglucose isomerase, C-terminal'), ('IPR035476', 'Phosphoglucose isomerase, SIS domain 1'), ('IPR035482', 'Phosphoglucose isomerase, SIS domain 2'), ('IPR046348', 'SIS domain superfamily'), ('MF_00473', 'Glucose-6-phosphate isomerase [pgi]'), ('PF00342', 'Phosphoglucose isomerase'), ('PR00662', 'G6PISOMERASE'), ('PS00174', 'Phosphoglucose isomerase signature 2'), ('PS00765', 'Phosphoglucose isomerase signature 1'), ('PS51463', 'Glucose-6-phosphate isomerase family profile'), ('PTHR11469', 'GLUCOSE-6-PHOSPHATE ISOMERASE'), ('SSF53697', 'SIS domain')]",,"""ENSG00000105220; Low tissue specificity."";","CATALYTIC ACTIVITY: Reaction=alpha-D-glucose 6-phosphate = beta-D-fructose 6-phosphate; Xref=Rhea:RHEA:11816, ChEBI:CHEBI:57634, ChEBI:CHEBI:58225; EC=5.3.1.9; Evidence={ECO:0000269|PubMed:28803808};",5.3.1.9,ACTIVITY REGULATION: Strongly inhibited by erythrose 4-phosphate. {ECO:0000269|PubMed:12054796}.,PATHWAY: Carbohydrate degradation; glycolysis; D-glyceraldehyde 3-phosphate and glycerone phosphate from D-glucose: step 2/4. {ECO:0000269|PubMed:28803808}.,ENST00000356487.11 [P06744-1];ENST00000588991.7 [P06744-2];,GPI,ENSG00000105220,0.0,,,,,,,,,GPI
P07355,ENSG00000182718,ANXA2_HUMAN,angiogenesis [GO:0001525]; cell-matrix adhesion [GO:0007160]; collagen fibril organization [GO:0030199]; epithelial cell apoptotic process [GO:1904019]; fibrinolysis [GO:0042730]; lung development [GO:0030324]; membrane raft assembly [GO:0001765]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of low-density lipoprotein particle receptor catabolic process [GO:0032804]; negative regulation of receptor internalization [GO:0002091]; osteoclast development [GO:0036035]; positive regulation of exocytosis [GO:0045921]; positive regulation of low-density lipoprotein particle clearance [GO:1905581]; positive regulation of low-density lipoprotein particle receptor binding [GO:1905597]; positive regulation of low-density lipoprotein receptor activity [GO:1905599]; positive regulation of plasma membrane repair [GO:1905686]; positive regulation of plasminogen activation [GO:0010756]; positive regulation of receptor recycling [GO:0001921]; positive regulation of receptor-mediated endocytosis involved in cholesterol transport [GO:1905602]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of vacuole organization [GO:0044090]; positive regulation of vesicle fusion [GO:0031340]; regulation of neurogenesis [GO:0050767]; response to activity [GO:0014823]; vesicle budding from membrane [GO:0006900],adherens junction [GO:0005912]; AnxA2-p11 complex [GO:1990665]; azurophil granule lumen [GO:0035578]; basement membrane [GO:0005604]; basolateral plasma membrane [GO:0016323]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; cornified envelope [GO:0001533]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; late endosome membrane [GO:0031902]; lipid droplet [GO:0005811]; lysosomal membrane [GO:0005765]; melanosome [GO:0042470]; membrane [GO:0016020]; midbody [GO:0030496]; myelin sheath adaxonal region [GO:0035749]; nuclear matrix [GO:0016363]; nucleus [GO:0005634]; PCSK9-AnxA2 complex [GO:1990667]; plasma membrane [GO:0005886]; plasma membrane protein complex [GO:0098797]; RNA polymerase II transcription regulator complex [GO:0090575]; sarcolemma [GO:0042383]; Schmidt-Lanterman incisure [GO:0043220]; vesicle [GO:0031982]; vesicle membrane [GO:0012506],"cadherin binding involved in cell-cell adhesion [GO:0098641]; calcium ion binding [GO:0005509]; calcium-dependent phospholipid binding [GO:0005544]; calcium-dependent protein binding [GO:0048306]; cytoskeletal protein binding [GO:0008092]; identical protein binding [GO:0042802]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphatidylserine binding [GO:0001786]; phospholipase A2 inhibitor activity [GO:0019834]; protease binding [GO:0002020]; RNA binding [GO:0003723]; S100 protein binding [GO:0044548]; serine-type endopeptidase inhibitor activity [GO:0004867]","PTM: Phosphorylation of Tyr-24 enhances heat stress-induced translocation to the cell surface. {ECO:0000269|PubMed:15302870, ECO:0000269|PubMed:2946940}.; PTM: ISGylated. {ECO:0000269|PubMed:16139798}.",DOMAIN: A pair of annexin repeats may form one binding site for calcium and phospholipid.,,"STRAND 48..50; /evidence=""ECO:0007829|PDB:5N7D""; STRAND 120..122; /evidence=""ECO:0007829|PDB:1W7B""; STRAND 205..207; /evidence=""ECO:0007829|PDB:2HYV""; STRAND 236..238; /evidence=""ECO:0007829|PDB:7DTO""; STRAND 279..282; /evidence=""ECO:0007829|PDB:2HYV""","HELIX 4..12; /evidence=""ECO:0007829|PDB:5LPU""; HELIX 35..47; /evidence=""ECO:0007829|PDB:2HYV""; HELIX 53..60; /evidence=""ECO:0007829|PDB:2HYV""; HELIX 65..79; /evidence=""ECO:0007829|PDB:2HYV""; HELIX 83..90; /evidence=""ECO:0007829|PDB:2HYV""; HELIX 93..103; /evidence=""ECO:0007829|PDB:2HYV""; HELIX 106..117; /evidence=""ECO:0007829|PDB:2HYV""; HELIX 125..134; /evidence=""ECO:0007829|PDB:2HYV""; HELIX 137..151; /evidence=""ECO:0007829|PDB:2HYV""; HELIX 155..161; /evidence=""ECO:0007829|PDB:2HYV""; HELIX 165..175; /evidence=""ECO:0007829|PDB:2HYV""; HELIX 188..200; /evidence=""ECO:0007829|PDB:2HYV""; HELIX 210..219; /evidence=""ECO:0007829|PDB:2HYV""; HELIX 222..232; /evidence=""ECO:0007829|PDB:2HYV""; HELIX 240..247; /evidence=""ECO:0007829|PDB:2HYV""; HELIX 250..264; /evidence=""ECO:0007829|PDB:2HYV""; HELIX 266..278; /evidence=""ECO:0007829|PDB:2HYV""; HELIX 285..295; /evidence=""ECO:0007829|PDB:2HYV""; HELIX 300..311; /evidence=""ECO:0007829|PDB:2HYV""; HELIX 315..322; /evidence=""ECO:0007829|PDB:2HYV""; HELIX 325..335; /evidence=""ECO:0007829|PDB:2HYV""","TURN 24..27; /evidence=""ECO:0007829|PDB:7QQM""; TURN 201..204; /evidence=""ECO:0007829|PDB:2HYV""; TURN 233..235; /evidence=""ECO:0007829|PDB:2HYV""; TURN 296..298; /evidence=""ECO:0007829|PDB:2HYV""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,ANXA2 ANX2 ANX2L4 CAL1H LPC2D,Annexin A2 (Annexin II) (Annexin-2) (Calpactin I heavy chain) (Calpactin-1 heavy chain) (Chromobindin-8) (Lipocortin II) (Placental anticoagulant protein IV) (PAP-IV) (Protein I) (p36),Homo sapiens (Human),339.0,38604.0,MSTVHEILCKLSLEGDHSTPPSAYGSVKAYTNFDAERDALNIETAIKTKGVDEVTIVNILTNRSNAQRQDIAFAYQRRTKKELASALKSALSGHLETVILGLLKTPAQYDASELKASMKGLGTDEDSLIEIICSRTNQELQEINRVYKEMYKTDLEKDIISDTSGDFRKLMVALAKGRRAEDGSVIDYELIDQDARDLYDAGVKRKGTDVPKWISIMTERSVPHLQKVFDRYKSYSPYDMLESIRKEVKGDLENAFLNLVQCIQNKPLYFADRLYDSMKGKGTRDKVLIRIMVSRSEVDMLKIRSEFKRKYGKSLYYYIQQDTKGDYQKALLYLCGGDD,True,False,False,P07355,"[('G3DSA:1.10.220.10', 'Annexin'), ('IPR001464', 'Annexin'), ('IPR002389', 'Annexin A2'), ('IPR018252', 'Annexin repeat, conserved site'), ('IPR018502', 'Annexin repeat'), ('IPR037104', 'Annexin superfamily'), ('PF00191', 'Annexin'), ('PR00196', 'ANNEXIN'), ('PR00198', 'ANNEXINII'), ('PS00223', 'Annexin repeat signature'), ('PS51897', 'Annexin repeat profile'), ('PTHR10502', 'Annexin calcium/phospholipid-binding'), ('SM00335', 'Annexin repeats'), ('SSF47874', 'Annexin')]",,"""ENSG00000182718; Tissue enhanced (esophagus)."";",,,,,ENST00000332680.8 [P07355-2];ENST00000396024.7 [P07355-1];ENST00000421017.6 [P07355-1];ENST00000451270.7 [P07355-1];ENST00000557906.6 [P07355-1];ENST00000558558.6 [P07355-1];ENST00000559818.6 [P07355-1];ENST00000559956.6 [P07355-1];ENST00000560468.6 [P07355-1];ENST00000677968.1 [P07355-1];ENST00000678061.1 [P07355-1];ENST00000678450.1 [P07355-1];ENST00000678870.1 [P07355-1];ENST00000679109.1 [P07355-1];,ANXA2,ENSG00000182718,0.0,ANXA2,Non-canonical_RBPs,25.0,9.44,DP02735,0.097,0.065,,ANXA2
P07359,ENSG00000185245,GP1BA_HUMAN,"blood coagulation [GO:0007596]; blood coagulation, intrinsic pathway [GO:0007597]; cell adhesion [GO:0007155]; cell morphogenesis [GO:0000902]; cell surface receptor signaling pathway [GO:0007166]; fibrinolysis [GO:0042730]; megakaryocyte development [GO:0035855]; platelet activation [GO:0030168]; positive regulation of leukocyte tethering or rolling [GO:1903238]; positive regulation of platelet activation [GO:0010572]; regulation of blood coagulation [GO:0030193]; release of sequestered calcium ion into cytosol [GO:0051209]",cell surface [GO:0009986]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular space [GO:0005615]; glycoprotein Ib-IX-V complex [GO:1990779]; membrane [GO:0016020]; plasma membrane [GO:0005886],thrombin-activated receptor activity [GO:0015057],"PTM: Glycocalicin is the product of a proteolytic cleavage/shedding, catalyzed by ADAM17, which releases most of the extracellular domain. Binding sites for vWF and thrombin are in this part of the protein. {ECO:0000269|PubMed:17445093}.",,"DOMAIN 17..47; /note=""LRRNT""; DOMAIN 221..282; /note=""LRRCT""","STRAND 19..23; /evidence=""ECO:0007829|PDB:1P9A""; STRAND 30..32; /evidence=""ECO:0007829|PDB:1P9A""; STRAND 51..53; /evidence=""ECO:0007829|PDB:1P9A""; STRAND 60..63; /evidence=""ECO:0007829|PDB:1P9A""; STRAND 75..77; /evidence=""ECO:0007829|PDB:1P9A""; STRAND 85..87; /evidence=""ECO:0007829|PDB:1P9A""; STRAND 97..99; /evidence=""ECO:0007829|PDB:1P9A""; STRAND 120..122; /evidence=""ECO:0007829|PDB:1P9A""; STRAND 144..146; /evidence=""ECO:0007829|PDB:1P9A""; STRAND 168..170; /evidence=""ECO:0007829|PDB:1P9A""; STRAND 192..194; /evidence=""ECO:0007829|PDB:1P9A""; STRAND 214..217; /evidence=""ECO:0007829|PDB:1P9A""; STRAND 243..249; /evidence=""ECO:0007829|PDB:4C2A""; STRAND 262..264; /evidence=""ECO:0007829|PDB:1P9A""; STRAND 283..287; /evidence=""ECO:0007829|PDB:1OOK""; STRAND 291..293; /evidence=""ECO:0007829|PDB:1GWB""; STRAND 605..613; /evidence=""ECO:0007829|PDB:2BP3""","HELIX 64..67; /evidence=""ECO:0007829|PDB:1P9A""; HELIX 227..229; /evidence=""ECO:0007829|PDB:1P9A""; HELIX 230..238; /evidence=""ECO:0007829|PDB:1P9A""; HELIX 240..242; /evidence=""ECO:0007829|PDB:1P9A""; HELIX 252..254; /evidence=""ECO:0007829|PDB:3P72""; HELIX 259..261; /evidence=""ECO:0007829|PDB:1P9A""; HELIX 272..274; /evidence=""ECO:0007829|PDB:1P9A""; HELIX 297..299; /evidence=""ECO:0007829|PDB:6XFQ""; HELIX 507..509; /evidence=""ECO:0007829|PDB:4YR6""","TURN 112..114; /evidence=""ECO:0007829|PDB:1P9A""; TURN 135..138; /evidence=""ECO:0007829|PDB:1P9A""; TURN 157..162; /evidence=""ECO:0007829|PDB:1P9A""; TURN 181..186; /evidence=""ECO:0007829|PDB:1P9A""; TURN 205..210; /evidence=""ECO:0007829|PDB:1P9A""; TURN 265..268; /evidence=""ECO:0007829|PDB:1M0Z""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,GP1BA,Platelet glycoprotein Ib alpha chain (GP-Ib alpha) (GPIb-alpha) (GPIbA) (Glycoprotein Ibalpha) (Antigen CD42b-alpha) (CD antigen CD42b) [Cleaved into: Glycocalicin],Homo sapiens (Human),652.0,71540.0,MPLLLLLLLLPSPLHPHPICEVSKVASHLEVNCDKRNLTALPPDLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRCELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYTIPKGFFGSHLLPFAFLHGNPWLCNCEILYFRRWLQDNAENVYVWKQGVDVKAMTSNVASVQCDNSDKFPVYKYPGKGCPTLGDEGDTDLYDYYPEEDTEGDKVRATRTVVKFPTKAHTTPWGLFYSWSTASLDSQMPSSLHPTQESTKEQTTFPPRWTPNFTLHMESITFSKTPKSTTEPTPSPTTSEPVPEPAPNMTTLEPTPSPTTPEPTSEPAPSPTTPEPTSEPAPSPTTPEPTSEPAPSPTTPEPTPIPTIATSPTILVSATSLITPKSTFLTTTKPVSLLESTKKTIPELDQPPKLRGVLQGHLESSRNDPFLHPDFCCLLPLGFYVLGLFWLLFASVVLILLLSWVGHVKPQALDSGQGAALTTATQTTHLELQRGRQVTVPRAWLLFLRGSLPTFRSSLFLWVRPNGRVGPLVAGRRPSALSQGRGQDLLSTVSIRYSGHSL,False,False,True,P07359,"[('G3DSA:3.80.10.10', 'Ribonuclease Inhibitor'), ('IPR000372', 'Leucine-rich repeat N-terminal domain'), ('IPR000483', 'Cysteine-rich flanking region, C-terminal'), ('IPR001611', 'Leucine-rich repeat'), ('IPR003591', 'Leucine-rich repeat, typical subtype'), ('IPR032675', 'Leucine-rich repeat domain superfamily'), ('PF01462', 'Leucine rich repeat N-terminal domain'), ('PF13855', 'Leucine rich repeat'), ('PR00019', 'LEURICHRPT'), ('PR01217', 'PRICHEXTENSN'), ('PS51450', 'Leucine-rich repeat profile'), ('PTHR24366', 'IG(IMMUNOGLOBULIN) AND LRR(LEUCINE RICH REPEAT) DOMAINS'), ('SM00013', 'Leucine rich repeat N-terminal domain'), ('SM00082', 'Leucine rich repeat C-terminal domain'), ('SM00364', 'Leucine-rich repeats, bacterial type'), ('SM00369', 'Leucine-rich repeats, typical (most populated) subfamily'), ('SSF52058', 'L domain-like')]",,"""ENSG00000185245; Tissue enhanced (bone marrow, lymphoid tissue)."";",,,,,ENST00000329125.6;,GP1BA,ENSG00000185245,0.0,,,,,,,0.607,0.19,GP1BA
P07550,ENSG00000169252,ADRB2_HUMAN,activation of transmembrane receptor protein tyrosine kinase activity [GO:0007171]; adenylate cyclase-activating adrenergic receptor signaling pathway [GO:0071880]; adenylate cyclase-modulating G protein-coupled receptor signaling pathway [GO:0007188]; adrenergic receptor signaling pathway [GO:0071875]; AMPA selective glutamate receptor signaling pathway [GO:0098990]; bone resorption [GO:0045453]; brown fat cell differentiation [GO:0050873]; cell surface receptor signaling pathway [GO:0007166]; cellular response to amyloid-beta [GO:1904646]; diet induced thermogenesis [GO:0002024]; endosome to lysosome transport [GO:0008333]; heat generation [GO:0031649]; negative regulation of G protein-coupled receptor signaling pathway [GO:0045744]; negative regulation of multicellular organism growth [GO:0040015]; negative regulation of smooth muscle contraction [GO:0045986]; norepinephrine-epinephrine-mediated vasodilation involved in regulation of systemic arterial blood pressure [GO:0002025]; positive regulation of autophagosome maturation [GO:1901098]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cAMP/PKA signal transduction [GO:0141163]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of lipophagy [GO:1904504]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of mini excitatory postsynaptic potential [GO:0061885]; positive regulation of transcription by RNA polymerase II [GO:0045944]; receptor-mediated endocytosis [GO:0006898]; regulation of sodium ion transport [GO:0002028]; response to cold [GO:0009409]; response to psychosocial stress [GO:1990911]; smooth muscle contraction [GO:0006939]; transcription by RNA polymerase II [GO:0006366],apical plasma membrane [GO:0016324]; clathrin-coated endocytic vesicle membrane [GO:0030669]; early endosome [GO:0005769]; endosome [GO:0005768]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; lysosome [GO:0005764]; membrane [GO:0016020]; neuronal dense core vesicle [GO:0098992]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235],adenylate cyclase binding [GO:0008179]; amyloid-beta binding [GO:0001540]; beta2-adrenergic receptor activity [GO:0004941]; identical protein binding [GO:0042802]; norepinephrine binding [GO:0051380]; potassium channel regulator activity [GO:0015459]; protein homodimerization activity [GO:0042803],"PTM: Palmitoylated (PubMed:11146000, PubMed:17962520, PubMed:18547522, PubMed:2540197, PubMed:27481942). Mainly palmitoylated at Cys-341 (PubMed:17962520, PubMed:18547522, PubMed:2540197). Palmitoylation may reduce accessibility of phosphorylation sites by anchoring the receptor to the plasma membrane. Agonist stimulation promotes depalmitoylation and further allows Ser-345 and Ser-346 phosphorylation (PubMed:11146000). Also undergoes transient, ligand-induced palmitoylation at Cys-265 probably by ZDHHC9, ZDHHC14 and ZDHHC18 within the Golgi (PubMed:27481942). Palmitoylation at Cys-265 requires phosphorylation by PKA and receptor internalization and stabilizes the receptor (PubMed:27481942). Could be depalmitoylated by LYPLA1 at the plasma membrane (PubMed:27481942). {ECO:0000269|PubMed:11146000, ECO:0000269|PubMed:17962520, ECO:0000269|PubMed:18547522, ECO:0000269|PubMed:2540197, ECO:0000269|PubMed:27481942}.; PTM: Phosphorylated by PKA and BARK upon agonist stimulation, which mediates homologous desensitization of the receptor. PKA-mediated phosphorylation seems to facilitate phosphorylation by BARK.; PTM: Phosphorylation of Tyr-141 is induced by insulin and leads to supersensitization of the receptor. {ECO:0000269|PubMed:8521811}.; PTM: Polyubiquitinated (PubMed:23166351). Agonist-induced ubiquitination leads to sort internalized receptors to the lysosomes for degradation (PubMed:19424180, PubMed:20559325, PubMed:23166351). Deubiquitination by USP20 and USP33, leads to ADRB2 recycling and resensitization after prolonged agonist stimulation. USP20 and USP33 are constitutively associated and are dissociated immediately after agonist stimulation. Ubiquitination by the VHL-E3 ligase complex is oxygen-dependent. {ECO:0000269|PubMed:19424180, ECO:0000269|PubMed:20559325, ECO:0000269|PubMed:23166351}.; PTM: Hydroxylation by EGLN3 occurs only under normoxia and increases the interaction with VHL and the subsequent ubiquitination and degradation of ADRB2. {ECO:0000269|PubMed:19424180, ECO:0000269|PubMed:19584355}.",,,"STRAND 25..27; /evidence=""ECO:0007829|PDB:3P0G""; STRAND 137..139; /evidence=""ECO:0007829|PDB:2RH1""; STRAND 140..142; /evidence=""ECO:0007829|PDB:6PS2""; STRAND 187..189; /evidence=""ECO:0007829|PDB:8GFV""; STRAND 299..303; /evidence=""ECO:0007829|PDB:6PS4""","HELIX 31..60; /evidence=""ECO:0007829|PDB:2RH1""; HELIX 62..64; /evidence=""ECO:0007829|PDB:2RH1""; HELIX 67..85; /evidence=""ECO:0007829|PDB:2RH1""; HELIX 87..96; /evidence=""ECO:0007829|PDB:2RH1""; HELIX 102..136; /evidence=""ECO:0007829|PDB:2RH1""; HELIX 147..170; /evidence=""ECO:0007829|PDB:2RH1""; HELIX 179..186; /evidence=""ECO:0007829|PDB:2RH1""; HELIX 197..207; /evidence=""ECO:0007829|PDB:2RH1""; HELIX 209..229; /evidence=""ECO:0007829|PDB:2RH1""; HELIX 267..298; /evidence=""ECO:0007829|PDB:2RH1""; HELIX 305..317; /evidence=""ECO:0007829|PDB:2RH1""; HELIX 318..320; /evidence=""ECO:0007829|PDB:2RH1""; HELIX 322..325; /evidence=""ECO:0007829|PDB:2RH1""; HELIX 326..328; /evidence=""ECO:0007829|PDB:2RH1""; HELIX 330..339; /evidence=""ECO:0007829|PDB:2RH1""","TURN 171..174; /evidence=""ECO:0007829|PDB:2RH1""; TURN 238..240; /evidence=""ECO:0007829|PDB:8GG0""; TURN 340..342; /evidence=""ECO:0007829|PDB:5JQH""; TURN 345..347; /evidence=""ECO:0007829|PDB:2R4R""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,ADRB2 ADRB2R B2AR,Beta-2 adrenergic receptor (Beta-2 adrenoreceptor) (Beta-2 adrenoceptor),Homo sapiens (Human),413.0,46459.0,MGQPGNGSAFLLAPNGSHAPDHDVTQERDEVWVVGMGIVMSLIVLAIVFGNVLVITAIAKFERLQTVTNYFITSLACADLVMGLAVVPFGAAHILMKMWTFGNFWCEFWTSIDVLCVTASIETLCVIAVDRYFAITSPFKYQSLLTKNKARVIILMVWIVSGLTSFLPIQMHWYRATHQEAINCYANETCCDFFTNQAYAIASSIVSFYVPLVIMVFVYSRVFQEAKRQLQKIDKSEGRFHVQNLSQVEQDGRTGHGLRRSSKFCLKEHKALKTLGIIMGTFTLCWLPFFIVNIVHVIQDNLIRKEVYILLNWIGYVNSGFNPLIYCRSPDFRIAFQELLCLRRSSLKAYGNGYSSNGNTGEQSGYHVEQEKENKLLCEDLPGTEDFVGHQGTVPSDNIDSQGRNCSTNDSLL,False,False,True,P07550,"[('cd15957', 'beta-2 adrenergic receptors (adrenoceptors), member of the class A family of seven-transmembrane G protein-coupled receptors'), ('G3DSA:1.20.1070.10', 'Rhodopsin 7-helix transmembrane proteins'), ('IPR000276', 'G protein-coupled receptor, rhodopsin-like'), ('IPR000332', 'Beta 2 adrenoceptor'), ('IPR002233', 'Adrenoceptor family'), ('IPR017452', 'GPCR, rhodopsin-like, 7TM'), ('PF00001', '7 transmembrane receptor (rhodopsin family)'), ('PR00237', 'GPCRRHODOPSN'), ('PR00562', 'ADRENRGCB2AR'), ('PR01103', 'ADRENERGICR'), ('PS00237', 'G-protein coupled receptors family 1 signature'), ('PS50262', 'G-protein coupled receptors family 1 profile'), ('PTHR24248', 'G-protein coupled receptor 1'), ('SM01381', 'Serpentine type 7TM GPCR chemoreceptor Srsx'), ('SSF81321', 'Family A G protein-coupled receptor-like')]",P07550;,"""ENSG00000169252; Low tissue specificity."";",,,,,ENST00000305988.6;,ADRB2,ENSG00000169252,0.0,,,,17.43,DP03692,0.174,0.305,0.053,ADRB2
P07814,ENSG00000136628,SYEP_HUMAN,cellular response to insulin stimulus [GO:0032869]; cellular response to type II interferon [GO:0071346]; glutamyl-tRNA aminoacylation [GO:0006424]; negative regulation of translation [GO:0017148]; prolyl-tRNA aminoacylation [GO:0006433]; regulation of long-chain fatty acid import into cell [GO:0140212]; tRNA aminoacylation for protein translation [GO:0006418],aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; GAIT complex [GO:0097452]; membrane [GO:0016020]; plasma membrane [GO:0005886]; ribonucleoprotein complex [GO:1990904],ATP binding [GO:0005524]; glutamate-tRNA ligase activity [GO:0004818]; GTPase binding [GO:0051020]; identical protein binding [GO:0042802]; proline-tRNA ligase activity [GO:0004827]; protein homodimerization activity [GO:0042803]; RNA stem-loop binding [GO:0035613]; zinc ion binding [GO:0008270],"PTM: Phosphorylated at Ser-886 by CDK5 (PubMed:19647514, PubMed:21220307). Phosphorylated at Ser-999 by RPS6KB1; triggers EPRS1 release from the aminoacyl-tRNA synthetase multienzyme complex (PubMed:19647514, PubMed:21220307, PubMed:28178239). In monocytes, the IFN-gamma-induced sequential phosphorylation at Ser-886 and Ser-999 releases EPRS1 from the aminoacyl-tRNA synthetase multienzyme complex, allowing its association with the GAIT complex. Phosphorylation at Ser-999 is specifically required for the RPL13A-mediated interaction of the GAIT complex with eIF4G (PubMed:19647514, PubMed:21220307). Phosphorylation at Ser-999 by RPS6KB1, is also induced by insulin through activation of the mTORC1 signaling pathway and promotes the interaction of EPRS1 with SLC27A1 (PubMed:28178239). {ECO:0000269|PubMed:19647514, ECO:0000269|PubMed:21220307, ECO:0000269|PubMed:28178239}.",DOMAIN: The WHEP-TRS domains are involved in RNA binding. {ECO:0000250|UniProtKB:Q7SIA2}.,"DOMAIN 749..805; /note=""WHEP-TRS 1""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00531""; DOMAIN 822..878; /note=""WHEP-TRS 2""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00531""; DOMAIN 900..956; /note=""WHEP-TRS 3""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00531""","STRAND 4..7; /evidence=""ECO:0007829|PDB:5A1N""; STRAND 10..12; /evidence=""ECO:0007829|PDB:5A34""; STRAND 30..33; /evidence=""ECO:0007829|PDB:5A1N""; STRAND 39..43; /evidence=""ECO:0007829|PDB:5A1N""; STRAND 46..48; /evidence=""ECO:0007829|PDB:5A1N""; STRAND 110..113; /evidence=""ECO:0007829|PDB:5A1N""; STRAND 114..116; /evidence=""ECO:0007829|PDB:5BMU""; STRAND 1037..1040; /evidence=""ECO:0007829|PDB:7F99""; STRAND 1042..1045; /evidence=""ECO:0007829|PDB:4K86""; STRAND 1047..1049; /evidence=""ECO:0007829|PDB:7F99""; STRAND 1080..1082; /evidence=""ECO:0007829|PDB:7F99""; STRAND 1102..1107; /evidence=""ECO:0007829|PDB:7F99""; STRAND 1110..1118; /evidence=""ECO:0007829|PDB:7F99""; STRAND 1120..1122; /evidence=""ECO:0007829|PDB:7F99""; STRAND 1142..1151; /evidence=""ECO:0007829|PDB:7F99""; STRAND 1165..1178; /evidence=""ECO:0007829|PDB:7F99""; STRAND 1206..1209; /evidence=""ECO:0007829|PDB:7F99""; STRAND 1220..1229; /evidence=""ECO:0007829|PDB:7F99""; STRAND 1234..1245; /evidence=""ECO:0007829|PDB:7F99""; STRAND 1255..1257; /evidence=""ECO:0007829|PDB:7F99""; STRAND 1259..1261; /evidence=""ECO:0007829|PDB:7F99""; STRAND 1265..1267; /evidence=""ECO:0007829|PDB:7F99""; STRAND 1269..1276; /evidence=""ECO:0007829|PDB:7F99""; STRAND 1303..1308; /evidence=""ECO:0007829|PDB:7F99""; STRAND 1313..1315; /evidence=""ECO:0007829|PDB:7F98""; STRAND 1341..1343; /evidence=""ECO:0007829|PDB:7F99""; STRAND 1347..1349; /evidence=""ECO:0007829|PDB:7F99""; STRAND 1364..1369; /evidence=""ECO:0007829|PDB:7F99""; STRAND 1378..1383; /evidence=""ECO:0007829|PDB:7F99""; STRAND 1389..1393; /evidence=""ECO:0007829|PDB:7F99""; STRAND 1424..1426; /evidence=""ECO:0007829|PDB:7F99""; STRAND 1442..1447; /evidence=""ECO:0007829|PDB:7F99""; STRAND 1477..1484; /evidence=""ECO:0007829|PDB:7F99""; STRAND 1498..1501; /evidence=""ECO:0007829|PDB:7F99""; STRAND 1504..1509; /evidence=""ECO:0007829|PDB:7F99""","HELIX 15..24; /evidence=""ECO:0007829|PDB:5A1N""; HELIX 51..61; /evidence=""ECO:0007829|PDB:5A1N""; HELIX 63..65; /evidence=""ECO:0007829|PDB:5A1N""; HELIX 72..87; /evidence=""ECO:0007829|PDB:5A1N""; HELIX 95..106; /evidence=""ECO:0007829|PDB:5A1N""; HELIX 119..129; /evidence=""ECO:0007829|PDB:5A1N""; HELIX 132..139; /evidence=""ECO:0007829|PDB:5A1N""; HELIX 145..155; /evidence=""ECO:0007829|PDB:5A1N""; HELIX 158..167; /evidence=""ECO:0007829|PDB:5A1N""; HELIX 750..769; /evidence=""ECO:0007829|PDB:1FYJ""; HELIX 774..795; /evidence=""ECO:0007829|PDB:1FYJ""; HELIX 1024..1034; /evidence=""ECO:0007829|PDB:7F99""; HELIX 1051..1070; /evidence=""ECO:0007829|PDB:7F99""; HELIX 1084..1087; /evidence=""ECO:0007829|PDB:7F99""; HELIX 1091..1097; /evidence=""ECO:0007829|PDB:7F99""; HELIX 1098..1100; /evidence=""ECO:0007829|PDB:7F99""; HELIX 1123..1133; /evidence=""ECO:0007829|PDB:7F99""; HELIX 1137..1139; /evidence=""ECO:0007829|PDB:7F99""; HELIX 1179..1199; /evidence=""ECO:0007829|PDB:7F99""; HELIX 1212..1214; /evidence=""ECO:0007829|PDB:7F99""; HELIX 1249..1252; /evidence=""ECO:0007829|PDB:7F99""; HELIX 1278..1287; /evidence=""ECO:0007829|PDB:7F99""; HELIX 1317..1335; /evidence=""ECO:0007829|PDB:7F99""; HELIX 1351..1360; /evidence=""ECO:0007829|PDB:7F99""; HELIX 1371..1375; /evidence=""ECO:0007829|PDB:7F99""; HELIX 1394..1396; /evidence=""ECO:0007829|PDB:7F99""; HELIX 1397..1423; /evidence=""ECO:0007829|PDB:7F99""; HELIX 1430..1438; /evidence=""ECO:0007829|PDB:7F99""; HELIX 1451..1460; /evidence=""ECO:0007829|PDB:7F99""","TURN 25..27; /evidence=""ECO:0007829|PDB:5A1N""; TURN 88..90; /evidence=""ECO:0007829|PDB:5A1N""; TURN 1020..1022; /evidence=""ECO:0007829|PDB:7F99""; TURN 1088..1090; /evidence=""ECO:0007829|PDB:4K86""; TURN 1160..1162; /evidence=""ECO:0007829|PDB:7F99""; TURN 1230..1233; /evidence=""ECO:0007829|PDB:7F99""; TURN 1246..1248; /evidence=""ECO:0007829|PDB:7F99""; TURN 1297..1299; /evidence=""ECO:0007829|PDB:7F99""; TURN 1336..1338; /evidence=""ECO:0007829|PDB:7F99""; TURN 1384..1386; /evidence=""ECO:0007829|PDB:7F99""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,EPRS1 EPRS GLNS PARS QARS QPRS PIG32,Bifunctional glutamate/proline--tRNA ligase (Bifunctional aminoacyl-tRNA synthetase) (Cell proliferation-inducing gene 32 protein) (Glutamatyl-prolyl-tRNA synthetase) [Includes: Glutamate--tRNA ligase (EC 6.1.1.17) (Glutamyl-tRNA synthetase) (GluRS); Proline--tRNA ligase (EC 6.1.1.15) (Prolyl-tRNA synthetase)],Homo sapiens (Human),1512.0,170591.0,MATLSLTVNSGDPPLGALLAVEHVKDDVSISVEEGKENILHVSENVIFTDVNSILRYLARVATTAGLYGSNLMEHTEIDHWLEFSATKLSSCDSFTSTINELNHCLSLRTYLVGNSLSLADLCVWATLKGNAAWQEQLKQKKAPVHVKRWFGFLEAQQAFQSVGTKWDVSTTKARVAPEKKQDVGKFVELPGAEMGKVTVRFPPEASGYLHIGHAKAALLNQHYQVNFKGKLIMRFDDTNPEKEKEDFEKVILEDVAMLHIKPDQFTYTSDHFETIMKYAEKLIQEGKAYVDDTPAEQMKAEREQRIDSKHRKNPIEKNLQMWEEMKKGSQFGQSCCLRAKIDMSSNNGCMRDPTLYRCKIQPHPRTGNKYNVYPTYDFACPIVDSIEGVTHALRTTEYHDRDEQFYWIIEALGIRKPYIWEYSRLNLNNTVLSKRKLTWFVNEGLVDGWDDPRFPTVRGVLRRGMTVEGLKQFIAAQGSSRSVVNMEWDKIWAFNKKVIDPVAPRYVALLKKEVIPVNVPEAQEEMKEVAKHPKNPEVGLKPVWYSPKVFIEGADAETFSEGEMVTFINWGNLNITKIHKNADGKIISLDAKLNLENKDYKKTTKVTWLAETTHALPIPVICVTYEHLITKPVLGKDEDFKQYVNKNSKHEELMLGDPCLKDLKKGDIIQLQRRGFFICDQPYEPVSPYSCKEAPCVLIYIPDGHTKEMPTSGSKEKTKVEATKNETSAPFKERPTPSLNNNCTTSEDSLVLYNRVAVQGDVVRELKAKKAPKEDVDAAVKQLLSLKAEYKEKTGQEYKPGNPPAEIGQNISSNSSASILESKSLYDEVAAQGEVVRKLKAEKSPKAKINEAVECLLSLKAQYKEKTGKEYIPGQPPLSQSSDSSPTRNSEPAGLETPEAKVLFDKVASQGEVVRKLKTEKAPKDQVDIAVQELLQLKAQYKSLIGVEYKPVSATGAEDKDKKKKEKENKSEKQNKPQKQNDGQRKDPSKNQGGGLSSSGAGEGQGPKKQTRLGLEAKKEENLADWYSQVITKSEMIEYHDISGCYILRPWAYAIWEAIKDFFDAEIKKLGVENCYFPMFVSQSALEKEKTHVADFAPEVAWVTRSGKTELAEPIAIRPTSETVMYPAYAKWVQSHRDLPIKLNQWCNVVRWEFKHPQPFLRTREFLWQEGHSAFATMEEAAEEVLQILDLYAQVYEELLAIPVVKGRKTEKEKFAGGDYTTTIEAFISASGRAIQGGTSHHLGQNFSKMFEIVFEDPKIPGEKQFAYQNSWGLTTRTIGVMTMVHGDNMGLVLPPRVACVQVVIIPCGITNALSEEDKEALIAKCNDYRRRLLSVNIRVRADLRDNYSPGWKFNHWELKGVPIRLEVGPRDMKSCQFVAVRRDTGEKLTVAENEAETKLQAILEDIQVTLFTRASEDLKTHMVVANTMEDFQKILDSGKIVQIPFCGEIDCEDWIKKTTARDQDLEPGAPSMGAKSLCIPFKPLCELQPGAKCVCGKNPAKYYTLFGRSY,True,True,False,P07814,"[('cd00778', 'ProRS_core_arch_euk'), ('cd00807', 'catalytic core domain of glutaminyl-tRNA synthetase'), ('cd00862', 'ProRS_anticodon_zinc'), ('cd00936', 'WEPRS_RNA'), ('cd10309', 'Glutathione S-transferase C-terminal-like, alpha helical domain of bifunctional Glutamyl-Prolyl-tRNA synthetase'), ('G3DSA:1.10.287.10', 'S15/NS1, RNA-binding'), ('G3DSA:1.20.1050.130', None), ('G3DSA:2.40.240.10', 'Ribosomal Protein L25; Chain P'), ('G3DSA:3.30.110.30', 'C-terminal domain of ProRS'), ('G3DSA:3.30.930.10', 'Bira Bifunctional Protein; Domain 2'), ('G3DSA:3.40.50.620', 'HUPs'), ('G3DSA:3.40.50.800', 'Anticodon-binding domain'), ('IPR000738', 'WHEP-TRS domain'), ('IPR000924', 'Glutamyl/glutaminyl-tRNA synthetase'), ('IPR001412', 'Aminoacyl-tRNA synthetase, class I, conserved site'), ('IPR002314', 'Aminoacyl-tRNA synthetase, class II (G/ P/ S/T)'), ('IPR004154', 'Anticodon-binding'), ('IPR004499', 'Proline-tRNA ligase, class IIa, archaeal-type'), ('IPR004526', 'Glutamyl-tRNA synthetase, archaeal/eukaryotic cytosolic'), ('IPR006195', 'Aminoacyl-tRNA synthetase, class II')]",,"""ENSG00000136628; Low tissue specificity."";","CATALYTIC ACTIVITY: Reaction=tRNA(Glu) + L-glutamate + ATP = L-glutamyl-tRNA(Glu) + AMP + diphosphate; Xref=Rhea:RHEA:23540, Rhea:RHEA-COMP:9663, Rhea:RHEA-COMP:9680, ChEBI:CHEBI:29985, ChEBI:CHEBI:30616, ChEBI:CHEBI:33019, ChEBI:CHEBI:78442, ChEBI:CHEBI:78520, ChEBI:CHEBI:456215; EC=6.1.1.17; Evidence={ECO:0000269|PubMed:3290852}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:23541; Evidence={ECO:0000305|PubMed:3290852}; CATALYTIC ACTIVITY: Reaction=tRNA(Pro) + L-proline + ATP = L-prolyl-tRNA(Pro) + AMP + diphosphate; Xref=Rhea:RHEA:14305, Rhea:RHEA-COMP:9700, Rhea:RHEA-COMP:9702, ChEBI:CHEBI:30616, ChEBI:CHEBI:33019, ChEBI:CHEBI:60039, ChEBI:CHEBI:78442, ChEBI:CHEBI:78532, ChEBI:CHEBI:456215; EC=6.1.1.15; Evidence={ECO:0000269|PubMed:23263184, ECO:0000269|PubMed:24100331, ECO:0000269|PubMed:29576217, ECO:0000269|PubMed:37212275}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:14306; Evidence={ECO:0000305|PubMed:24100331};",6.1.1.15; 6.1.1.17,"ACTIVITY REGULATION: Inhibited by halofuginone (PubMed:23263184, PubMed:24100331). Can be activated by azetidine-2-carboxylic acid (Aze), a non-proteinogenic amino acids found in plants that mimics both proline and alanine, leading to misincorporation of Aze into proline positions of proteins (PubMed:29273753). {ECO:0000269|PubMed:23263184, ECO:0000269|PubMed:24100331, ECO:0000269|PubMed:29273753}.",,ENST00000366923.8;,EPRS1,ENSG00000136628,0.0,EPRS1,Canonical_RBPs,18.0,1.85,DP03841,0.019,0.104,0.083,EPRS1
P07900,ENSG00000080824,HS90A_HUMAN,activation of innate immune response [GO:0002218]; cardiac muscle cell apoptotic process [GO:0010659]; cellular response to heat [GO:0034605]; cellular response to virus [GO:0098586]; chaperone-mediated autophagy [GO:0061684]; chaperone-mediated protein complex assembly [GO:0051131]; mitochondrial transport [GO:0006839]; neuron migration [GO:0001764]; positive regulation of cardiac muscle contraction [GO:0060452]; positive regulation of cell size [GO:0045793]; positive regulation of defense response to virus by host [GO:0002230]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein polymerization [GO:0032273]; positive regulation of tau-protein kinase activity [GO:1902949]; positive regulation of telomere maintenance via telomerase [GO:0032212]; protein folding [GO:0006457]; protein insertion into mitochondrial outer membrane [GO:0045040]; protein refolding [GO:0042026]; protein stabilization [GO:0050821]; protein unfolding [GO:0043335]; regulation of apoptotic process [GO:0042981]; regulation of postsynaptic membrane neurotransmitter receptor levels [GO:0099072]; regulation of protein localization [GO:0032880]; regulation of protein ubiquitination [GO:0031396]; regulation of protein-containing complex assembly [GO:0043254]; response to antibiotic [GO:0046677]; response to cocaine [GO:0042220]; response to cold [GO:0009409]; response to estrogen [GO:0043627]; response to heat [GO:0009408]; response to salt stress [GO:0009651]; response to unfolded protein [GO:0006986]; response to xenobiotic stimulus [GO:0009410]; skeletal muscle contraction [GO:0003009]; telomerase holoenzyme complex assembly [GO:1905323]; telomere maintenance via telomerase [GO:0007004],apical plasma membrane [GO:0016324]; axonal growth cone [GO:0044295]; basolateral plasma membrane [GO:0016323]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic growth cone [GO:0044294]; endocytic vesicle lumen [GO:0071682]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; lysosomal lumen [GO:0043202]; melanosome [GO:0042470]; membrane [GO:0016020]; mitochondrion [GO:0005739]; myelin sheath [GO:0043209]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; secretory granule lumen [GO:0034774]; sperm mitochondrial sheath [GO:0097226]; sperm plasma membrane [GO:0097524],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent protein folding chaperone [GO:0140662]; CTP binding [GO:0002135]; dATP binding [GO:0032564]; disordered domain specific binding [GO:0097718]; DNA polymerase binding [GO:0070182]; GTP binding [GO:0005525]; GTPase binding [GO:0051020]; histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802]; MHC class II protein complex binding [GO:0023026]; mRNA binding [GO:0003729]; nitric-oxide synthase regulator activity [GO:0030235]; protein homodimerization activity [GO:0042803]; protein phosphatase binding [GO:0019903]; protein tyrosine kinase binding [GO:1990782]; Rho GDP-dissociation inhibitor binding [GO:0051022]; RNA binding [GO:0003723]; scaffold protein binding [GO:0097110]; sulfonylurea receptor binding [GO:0017098]; tau protein binding [GO:0048156]; TPR domain binding [GO:0030911]; transmembrane transporter binding [GO:0044325]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082]; UTP binding [GO:0002134],PTM: ISGylated. {ECO:0000269|PubMed:16139798}.; PTM: S-nitrosylated; negatively regulates the ATPase activity and the activation of eNOS by HSP90AA1. {ECO:0000269|PubMed:15937123}.; PTM: Ubiquitinated via 'Lys-63'-linked polyubiquitination by HECTD1. Ubiquitination promotes translocation into the cytoplasm away from the membrane and secretory pathways. {ECO:0000250|UniProtKB:P07901}.,DOMAIN: The TPR repeat-binding motif mediates interaction with TPR repeat-containing proteins like the co-chaperone STUB1. {ECO:0000269|PubMed:16307917}.,,"STRAND 18..21; /evidence=""ECO:0007829|PDB:5J80""; STRAND 78..83; /evidence=""ECO:0007829|PDB:5J80""; STRAND 88..93; /evidence=""ECO:0007829|PDB:5J80""; STRAND 145..153; /evidence=""ECO:0007829|PDB:5J80""; STRAND 155..157; /evidence=""ECO:0007829|PDB:2WI6""; STRAND 160..164; /evidence=""ECO:0007829|PDB:5J80""; STRAND 166..168; /evidence=""ECO:0007829|PDB:8FFV""; STRAND 169..174; /evidence=""ECO:0007829|PDB:5J80""; STRAND 181..190; /evidence=""ECO:0007829|PDB:5J80""; STRAND 212..216; /evidence=""ECO:0007829|PDB:3VHC""; STRAND 218..220; /evidence=""ECO:0007829|PDB:5J80""; STRAND 225..227; /evidence=""ECO:0007829|PDB:3T1K""; STRAND 284..289; /evidence=""ECO:0007829|PDB:7KRJ""; STRAND 324..331; /evidence=""ECO:0007829|PDB:7RY0""; STRAND 333..335; /evidence=""ECO:0007829|PDB:7RY0""; STRAND 337..343; /evidence=""ECO:0007829|PDB:7RY0""; STRAND 361..365; /evidence=""ECO:0007829|PDB:7RY0""; STRAND 368..372; /evidence=""ECO:0007829|PDB:7RY0""; STRAND 386..394; /evidence=""ECO:0007829|PDB:7RY0""; STRAND 465..467; /evidence=""ECO:0007829|PDB:7RY0""; STRAND 490..495; /evidence=""ECO:0007829|PDB:7RY0""; STRAND 518..521; /evidence=""ECO:0007829|PDB:7RY0""; STRAND 539..543; /evidence=""ECO:0007829|PDB:7RY0""; STRAND 546..548; /evidence=""ECO:0007829|PDB:7RY0""; STRAND 584..588; /evidence=""ECO:0007829|PDB:7RY0""; STRAND 593..601; /evidence=""ECO:0007829|PDB:7RY0""; STRAND 603..605; /evidence=""ECO:0007829|PDB:7KRJ""; STRAND 632..636; /evidence=""ECO:0007829|PDB:7RY0""; STRAND 728..730; /evidence=""ECO:0007829|PDB:4CGW""","HELIX 2..5; /evidence=""ECO:0007829|PDB:6GQS""; HELIX 24..35; /evidence=""ECO:0007829|PDB:5J80""; HELIX 43..65; /evidence=""ECO:0007829|PDB:5J80""; HELIX 67..70; /evidence=""ECO:0007829|PDB:5J80""; HELIX 100..104; /evidence=""ECO:0007829|PDB:5J80""; HELIX 111..123; /evidence=""ECO:0007829|PDB:5J80""; HELIX 128..134; /evidence=""ECO:0007829|PDB:5J80""; HELIX 137..143; /evidence=""ECO:0007829|PDB:5J80""; HELIX 192..198; /evidence=""ECO:0007829|PDB:5J80""; HELIX 200..210; /evidence=""ECO:0007829|PDB:5J80""; HELIX 228..230; /evidence=""ECO:0007829|PDB:2XJX""; HELIX 296..298; /evidence=""ECO:0007829|PDB:7RY0""; HELIX 301..303; /evidence=""ECO:0007829|PDB:6KSQ""; HELIX 306..316; /evidence=""ECO:0007829|PDB:7RY0""; HELIX 375..377; /evidence=""ECO:0007829|PDB:7RY0""; HELIX 380..382; /evidence=""ECO:0007829|PDB:7RY0""; HELIX 407..428; /evidence=""ECO:0007829|PDB:7RY0""; HELIX 431..451; /evidence=""ECO:0007829|PDB:7RY0""; HELIX 453..455; /evidence=""ECO:0007829|PDB:6KSQ""; HELIX 456..460; /evidence=""ECO:0007829|PDB:7RY0""; HELIX 477..482; /evidence=""ECO:0007829|PDB:7RY0""; HELIX 499..503; /evidence=""ECO:0007829|PDB:7RY0""; HELIX 506..508; /evidence=""ECO:0007829|PDB:7RY0""; HELIX 509..513; /evidence=""ECO:0007829|PDB:7RY0""; HELIX 524..529; /evidence=""ECO:0007829|PDB:7RY0""; HELIX 555..579; /evidence=""ECO:0007829|PDB:7RY0""; HELIX 580..582; /evidence=""ECO:0007829|PDB:3Q6M""; HELIX 608..613; /evidence=""ECO:0007829|PDB:7RY0""; HELIX 622..624; /evidence=""ECO:0007829|PDB:7KRJ""; HELIX 641..652; /evidence=""ECO:0007829|PDB:7RY0""; HELIX 657..673; /evidence=""ECO:0007829|PDB:7RY0""; HELIX 681..696; /evidence=""ECO:0007829|PDB:7RY0""","TURN 39..42; /evidence=""ECO:0007829|PDB:6GPF""; TURN 84..87; /evidence=""ECO:0007829|PDB:5J80""; TURN 105..108; /evidence=""ECO:0007829|PDB:5J80""; TURN 221..224; /evidence=""ECO:0007829|PDB:3T1K""; TURN 351..353; /evidence=""ECO:0007829|PDB:6KSQ""; TURN 400..405; /evidence=""ECO:0007829|PDB:7RY0""; TURN 468..472; /evidence=""ECO:0007829|PDB:7RY0""; TURN 530..532; /evidence=""ECO:0007829|PDB:7RY0""; TURN 625..629; /evidence=""ECO:0007829|PDB:7KRJ""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,HSP90AA1 HSP90A HSPC1 HSPCA,Heat shock protein HSP 90-alpha (EC 3.6.4.10) (Heat shock 86 kDa) (HSP 86) (HSP86) (Heat shock protein family C member 1) (Lipopolysaccharide-associated protein 2) (LAP-2) (LPS-associated protein 2) (Renal carcinoma antigen NY-REN-38),Homo sapiens (Human),732.0,84660.0,MPEETQTQDQPMEEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNSSDALDKIRYESLTDPSKLDSGKELHINLIPNKQDRTLTIVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVTVITKHNDDEQYAWESSAGGSFTVRTDTGEPMGRGTKVILHLKEDQTEYLEERRIKEIVKKHSQFIGYPITLFVEKERDKEVSDDEAEEKEDKEEEKEKEEKESEDKPEIEDVGSDEEEEKKDGDKKKKKKIKEKYIDQEELNKTKPIWTRNPDDITNEEYGEFYKSLTNDWEDHLAVKHFSVEGQLEFRALLFVPRRAPFDLFENRKKKNNIKLYVRRVFIMDNCEELIPEYLNFIRGVVDSEDLPLNISREMLQQSKILKVIRKNLVKKCLELFTELAEDKENYKKFYEQFSKNIKLGIHEDSQNRKKLSELLRYYTSASGDEMVSLKDYCTRMKENQKHIYYITGETKDQVANSAFVERLRKHGLEVIYMIEPIDEYCVQQLKEFEGKTLVSVTKEGLELPEDEEEKKKQEEKKTKFENLCKIMKDILEKKVEKVVVSNRLVTSPCCIVTSTYGWTANMERIMKAQALRDNSTMGYMAAKKHLEINPDHSIIETLRQKAEADKNDKSVKDLVILLYETALLSSGFSLEDPQTHANRIYRMIKLGLGIDEDDPTADDTSAAVTEEMPPLEGDDDTSRMEEVD,True,False,True,P07900,"[('cd16927', 'Histidine kinase-like ATPase domain of human cytosolic Hsp90 and its homologs including Escherichia coli HtpG, and related domains'), ('G3DSA:1.20.120.790', 'Heat shock protein 90, C-terminal domain'), ('G3DSA:3.30.230.80', None), ('G3DSA:3.30.565.10', 'Histidine kinase-like ATPase, C-terminal domain'), ('G3DSA:3.40.50.11260', None), ('IPR001404', 'Heat shock protein Hsp90 family'), ('IPR003594', 'Histidine kinase/HSP90-like ATPase domain'), ('IPR019805', 'Heat shock protein Hsp90, conserved site'), ('IPR020568', 'Ribosomal protein uS5 domain 2-type superfamily'), ('IPR020575', 'Heat shock protein Hsp90, N-terminal'), ('IPR036890', 'Histidine kinase/HSP90-like ATPase superfamily'), ('IPR037196', 'HSP90, C-terminal domain'), ('MF_00505', 'Chaperone protein HtpG [htpG]'), ('PF00183', 'Hsp90 protein'), ('PF13589', 'Histidine kinase-, DNA gyrase B-, and HSP90-like ATPase'), ('PIRSF002583', 'Heat shock protein, HSP90/HTPG types'), ('PR00775', 'HEATSHOCK90'), ('PS00298', 'Heat shock hsp90 proteins family signature'), ('PTHR11528', 'HEAT SHOCK PROTEIN 90 FAMILY MEMBER'), ('SM00387', 'Histidine kinase-like ATPases')]",,"""ENSG00000080824; Low tissue specificity."";","CATALYTIC ACTIVITY: Reaction=ATP + H2O = ADP + phosphate + H(+); Xref=Rhea:RHEA:13065, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616, ChEBI:CHEBI:43474, ChEBI:CHEBI:456216; EC=3.6.4.10; Evidence={ECO:0000269|PubMed:12526792};",3.6.4.10,"ACTIVITY REGULATION: In the resting state, through the dimerization of its C-terminal domain, HSP90 forms a homodimer which is defined as the open conformation (PubMed:18400751). Upon ATP-binding, the N-terminal domain undergoes significant conformational changes and comes in contact to form an active closed conformation (PubMed:18400751). After HSP90 finishes its chaperoning tasks of assisting the proper folding, stabilization and activation of client proteins under the active state, ATP molecule is hydrolyzed to ADP which then dissociates from HSP90 and directs the protein back to the resting state (PubMed:18400751). Co-chaperone TSC1 promotes ATP binding and inhibits HSP90AA1 ATPase activity (PubMed:29127155). Binding to phosphorylated AHSA1 promotes HSP90AA1 ATPase activity (PubMed:29127155). Inhibited by geldanamycin, Ganetespib (STA-9090) and SNX-2112 (PubMed:12526792, PubMed:29127155). {ECO:0000269|PubMed:18400751, ECO:0000269|PubMed:29127155}.",,ENST00000216281.13 [P07900-1];ENST00000334701.11 [P07900-2];,HSP90AA1,ENSG00000080824,0.0,HSP90AA1,Non-canonical_RBPs,22.0,,,,0.143,0.119,HSP90AA1
P07954,ENSG00000091483,FUMH_HUMAN,DNA damage response [GO:0006974]; DNA repair [GO:0006281]; fumarate metabolic process [GO:0006106]; homeostasis of number of cells within a tissue [GO:0048873]; malate metabolic process [GO:0006108]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of double-strand break repair via nonhomologous end joining [GO:2001034]; regulation of arginine metabolic process [GO:0000821]; tricarboxylic acid cycle [GO:0006099]; urea cycle [GO:0000050],chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; site of double-strand break [GO:0035861],fumarate hydratase activity [GO:0004333]; histone binding [GO:0042393],PTM: [Isoform Cytoplasmic]: Phosphorylation at Thr-236 by PRKDC in response to DNA damage promotes translocation to the nucleus and recruitment to DNA double-strand breaks (DSBs). {ECO:0000269|PubMed:26237645}.,,,"STRAND 50..55; /evidence=""ECO:0007829|PDB:5UPP""; STRAND 58..63; /evidence=""ECO:0007829|PDB:5UPP""; STRAND 139..142; /evidence=""ECO:0007829|PDB:5UPP""; STRAND 229..234; /evidence=""ECO:0007829|PDB:5UPP""; STRAND 237..243; /evidence=""ECO:0007829|PDB:5UPP""; STRAND 349..352; /evidence=""ECO:0007829|PDB:5UPP""; STRAND 366..368; /evidence=""ECO:0007829|PDB:3E04""; STRAND 506..508; /evidence=""ECO:0007829|PDB:5UPP""","HELIX 70..78; /evidence=""ECO:0007829|PDB:5UPP""; HELIX 84..86; /evidence=""ECO:0007829|PDB:5UPP""; HELIX 90..107; /evidence=""ECO:0007829|PDB:5UPP""; HELIX 108..110; /evidence=""ECO:0007829|PDB:5UPP""; HELIX 114..128; /evidence=""ECO:0007829|PDB:5UPP""; HELIX 133..135; /evidence=""ECO:0007829|PDB:5UPP""; HELIX 147..164; /evidence=""ECO:0007829|PDB:5UPP""; HELIX 177..181; /evidence=""ECO:0007829|PDB:5UPP""; HELIX 190..205; /evidence=""ECO:0007829|PDB:5UPP""; HELIX 207..224; /evidence=""ECO:0007829|PDB:5UPP""; HELIX 244..264; /evidence=""ECO:0007829|PDB:5UPP""; HELIX 289..301; /evidence=""ECO:0007829|PDB:5UPP""; HELIX 311..316; /evidence=""ECO:0007829|PDB:5UPP""; HELIX 319..345; /evidence=""ECO:0007829|PDB:5UPP""; HELIX 375..399; /evidence=""ECO:0007829|PDB:5UPP""; HELIX 409..433; /evidence=""ECO:0007829|PDB:5UPP""; HELIX 435..437; /evidence=""ECO:0007829|PDB:5UPP""; HELIX 442..451; /evidence=""ECO:0007829|PDB:5UPP""; HELIX 454..459; /evidence=""ECO:0007829|PDB:5UPP""; HELIX 460..463; /evidence=""ECO:0007829|PDB:5UPP""; HELIX 465..478; /evidence=""ECO:0007829|PDB:5UPP""; HELIX 482..488; /evidence=""ECO:0007829|PDB:5UPP""; HELIX 494..500; /evidence=""ECO:0007829|PDB:5UPP""; HELIX 503..505; /evidence=""ECO:0007829|PDB:5UPP""","TURN 129..132; /evidence=""ECO:0007829|PDB:6VBE""; TURN 182..184; /evidence=""ECO:0007829|PDB:5UPP""; TURN 187..189; /evidence=""ECO:0007829|PDB:5UPP""; TURN 225..227; /evidence=""ECO:0007829|PDB:5UPP""; TURN 267..270; /evidence=""ECO:0007829|PDB:5UPP""; TURN 277..279; /evidence=""ECO:0007829|PDB:5UPP""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,FH,"Fumarate hydratase, mitochondrial (Fumarase) (HsFH) (EC 4.2.1.2)",Homo sapiens (Human),510.0,54637.0,MYRALRLLARSRPLVRAPAAALASAPGLGGAAVPSFWPPNAARMASQNSFRIEYDTFGELKVPNDKYYGAQTVRSTMNFKIGGVTERMPTPVIKAFGILKRAAAEVNQDYGLDPKIANAIMKAADEVAEGKLNDHFPLVVWQTGSGTQTNMNVNEVISNRAIEMLGGELGSKIPVHPNDHVNKSQSSNDTFPTAMHIAAAIEVHEVLLPGLQKLHDALDAKSKEFAQIIKIGRTHTQDAVPLTLGQEFSGYVQQVKYAMTRIKAAMPRIYELAAGGTAVGTGLNTRIGFAEKVAAKVAALTGLPFVTAPNKFEALAAHDALVELSGAMNTTACSLMKIANDIRFLGSGPRSGLGELILPENEPGSSIMPGKVNPTQCEAMTMVAAQVMGNHVAVTVGGSNGHFELNVFKPMMIKNVLHSARLLGDASVSFTENCVVGIQANTERINKLMNESLMLVTALNPHIGYDKAAKIAKTAHKNGSTLKETAIELGYLTAEQFDEWVKPKDMLGPK,True,False,False,P07954,"[('cd01362', 'Class II fumarases'), ('G3DSA:1.10.275.10', 'Fumarase/aspartase (N-terminal domain)'), ('G3DSA:1.10.40.30', 'Fumarase/aspartase (C-terminal domain)'), ('G3DSA:1.20.200.10', 'Fumarase/aspartase (Central domain)'), ('IPR000362', 'Fumarate lyase family'), ('IPR005677', 'Fumarate hydratase, class II'), ('IPR008948', 'L-Aspartase-like'), ('IPR018951', 'Fumarase C, C-terminal'), ('IPR020557', 'Fumarate lyase, conserved site'), ('IPR022761', 'Fumarate lyase, N-terminal'), ('IPR024083', 'Fumarase/histidase, N-terminal'), ('MF_00743', 'Fumarate hydratase class II [fumC]'), ('PF00206', 'Lyase'), ('PF10415', 'Fumarase C C-terminus'), ('PR00149', 'FUMRATELYASE'), ('PS00163', 'Fumarate lyases signature'), ('PTHR11444', 'ASPARTATEAMMONIA/ARGININOSUCCINATE/ADENYLOSUCCINATE LYASE'), ('SSF48557', 'L-aspartase-like'), ('TIGR00979', 'class II fumarate hydratase')]",,"""ENSG00000091483; Tissue enhanced (liver)."";","CATALYTIC ACTIVITY: Reaction=(S)-malate = fumarate + H2O; Xref=Rhea:RHEA:12460, ChEBI:CHEBI:15377, ChEBI:CHEBI:15589, ChEBI:CHEBI:29806; EC=4.2.1.2; Evidence={ECO:0000269|PubMed:30761759, ECO:0000305|PubMed:30718813}; CATALYTIC ACTIVITY: [Isoform Mitochondrial]: Reaction=(S)-malate = fumarate + H2O; Xref=Rhea:RHEA:12460, ChEBI:CHEBI:15377, ChEBI:CHEBI:15589, ChEBI:CHEBI:29806; EC=4.2.1.2; Evidence={ECO:0000250|UniProtKB:P10173}; PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:12462; Evidence={ECO:0000250|UniProtKB:P10173}; CATALYTIC ACTIVITY: [Isoform Cytoplasmic]: Reaction=(S)-malate = fumarate + H2O; Xref=Rhea:RHEA:12460, ChEBI:CHEBI:15377, ChEBI:CHEBI:15589, ChEBI:CHEBI:29806; EC=4.2.1.2; Evidence={ECO:0000250|UniProtKB:P97807}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:12461; Evidence={ECO:0000250|UniProtKB:P97807};",4.2.1.2,,PATHWAY: Carbohydrate metabolism; tricarboxylic acid cycle; (S)-malate from fumarate: step 1/1. {ECO:0000250|UniProtKB:P10173}.,ENST00000366560.4 [P07954-1];,FH,ENSG00000091483,0.0,,,,,,,0.098,,FH
P07996,ENSG00000137801,TSP1_HUMAN,apoptotic process [GO:0006915]; behavioral response to pain [GO:0048266]; cell adhesion [GO:0007155]; cell migration [GO:0016477]; cellular response to growth factor stimulus [GO:0071363]; cellular response to heat [GO:0034605]; cellular response to tumor necrosis factor [GO:0071356]; chronic inflammatory response [GO:0002544]; engulfment of apoptotic cell [GO:0043652]; immune response [GO:0006955]; inflammatory response [GO:0006954]; negative regulation of angiogenesis [GO:0016525]; negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II [GO:0002581]; negative regulation of apoptotic process [GO:0043066]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:1903588]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of cGMP-mediated signaling [GO:0010754]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of dendritic cell antigen processing and presentation [GO:0002605]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of endothelial cell migration [GO:0010596]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of fibrinolysis [GO:0051918]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of interleukin-10 production [GO:0032693]; negative regulation of interleukin-12 production [GO:0032695]; negative regulation of long-chain fatty acid import across plasma membrane [GO:0010748]; negative regulation of nitric oxide mediated signal transduction [GO:0010751]; negative regulation of plasminogen activation [GO:0010757]; negative regulation of sprouting angiogenesis [GO:1903671]; negative regulation of tumor necrosis factor production [GO:0032720]; nitric oxide-cGMP-mediated signaling [GO:0038060]; peptide cross-linking [GO:0018149]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood coagulation [GO:0030194]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of chemotaxis [GO:0050921]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902043]; positive regulation of fibroblast migration [GO:0010763]; positive regulation of macrophage activation [GO:0043032]; positive regulation of macrophage chemotaxis [GO:0010759]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of phosphorylation [GO:0042327]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; positive regulation of transforming growth factor beta1 production [GO:0032914]; positive regulation of translation [GO:0045727]; positive regulation of tumor necrosis factor production [GO:0032760]; response to calcium ion [GO:0051592]; response to endoplasmic reticulum stress [GO:0034976]; response to glucose [GO:0009749]; response to hypoxia [GO:0001666]; response to magnesium ion [GO:0032026]; response to mechanical stimulus [GO:0009612]; response to progesterone [GO:0032570]; response to testosterone [GO:0033574]; response to unfolded protein [GO:0006986]; response to xenobiotic stimulus [GO:0009410]; sprouting angiogenesis [GO:0002040],cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; fibrinogen complex [GO:0005577]; platelet alpha granule [GO:0031091]; platelet alpha granule lumen [GO:0031093]; sarcoplasmic reticulum [GO:0016529]; secretory granule [GO:0030141],calcium ion binding [GO:0005509]; collagen V binding [GO:0070052]; endopeptidase inhibitor activity [GO:0004866]; extracellular matrix structural constituent [GO:0005201]; fibrinogen binding [GO:0070051]; fibroblast growth factor binding [GO:0017134]; fibronectin binding [GO:0001968]; heparin binding [GO:0008201]; integrin binding [GO:0005178]; laminin binding [GO:0043236]; low-density lipoprotein particle binding [GO:0030169]; phosphatidylserine binding [GO:0001786]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; proteoglycan binding [GO:0043394]; transforming growth factor beta binding [GO:0050431],,,"DOMAIN 65..270; /note=""Laminin G-like""; DOMAIN 316..373; /note=""VWFC""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00220""; DOMAIN 379..429; /note=""TSP type-1 1""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00210""; DOMAIN 435..490; /note=""TSP type-1 2""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00210""; DOMAIN 492..547; /note=""TSP type-1 3""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00210""; DOMAIN 547..587; /note=""EGF-like 1""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DOMAIN 646..690; /note=""EGF-like 2""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DOMAIN 958..1170; /note=""TSP C-terminal""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00635""","STRAND 30..32; /evidence=""ECO:0007829|PDB:2ERF""; STRAND 44..49; /evidence=""ECO:0007829|PDB:2ERF""; STRAND 58..62; /evidence=""ECO:0007829|PDB:2ERF""; STRAND 87..96; /evidence=""ECO:0007829|PDB:2ERF""; STRAND 101..109; /evidence=""ECO:0007829|PDB:2ERF""; STRAND 115..122; /evidence=""ECO:0007829|PDB:2ERF""; STRAND 127..134; /evidence=""ECO:0007829|PDB:2ERF""; STRAND 137..145; /evidence=""ECO:0007829|PDB:2ERF""; STRAND 150..161; /evidence=""ECO:0007829|PDB:2ERF""; STRAND 164..169; /evidence=""ECO:0007829|PDB:2ERF""; STRAND 173..178; /evidence=""ECO:0007829|PDB:2ERF""; STRAND 195..200; /evidence=""ECO:0007829|PDB:2ERF""; STRAND 210..218; /evidence=""ECO:0007829|PDB:2ERF""; STRAND 394..403; /evidence=""ECO:0007829|PDB:5FOE""; STRAND 417..424; /evidence=""ECO:0007829|PDB:5FOE""; STRAND 450..459; /evidence=""ECO:0007829|PDB:1LSL""; STRAND 469..471; /evidence=""ECO:0007829|PDB:7YYK""; STRAND 478..485; /evidence=""ECO:0007829|PDB:1LSL""; STRAND 507..509; /evidence=""ECO:0007829|PDB:1LSL""; STRAND 511..516; /evidence=""ECO:0007829|PDB:1LSL""; STRAND 535..541; /evidence=""ECO:0007829|PDB:1LSL""; STRAND 849..852; /evidence=""ECO:0007829|PDB:1UX6""; STRAND 865..867; /evidence=""ECO:0007829|PDB:1UX6""; STRAND 888..890; /evidence=""ECO:0007829|PDB:1UX6""; STRAND 901..903; /evidence=""ECO:0007829|PDB:1UX6""; STRAND 924..926; /evidence=""ECO:0007829|PDB:1UX6""; STRAND 937..939; /evidence=""ECO:0007829|PDB:1UX6""; STRAND 961..965; /evidence=""ECO:0007829|PDB:1UX6""; STRAND 986..988; /evidence=""ECO:0007829|PDB:1UX6""; STRAND 995..1014; /evidence=""ECO:0007829|PDB:1UX6""; STRAND 1022..1031; /evidence=""ECO:0007829|PDB:1UX6""; STRAND 1034..1043; /evidence=""ECO:0007829|PDB:1UX6""; STRAND 1051..1053; /evidence=""ECO:0007829|PDB:1UX6""; STRAND 1059..1067; /evidence=""ECO:0007829|PDB:1UX6""; STRAND 1082..1084; /evidence=""ECO:0007829|PDB:1UX6""; STRAND 1090..1095; /evidence=""ECO:0007829|PDB:1UX6""; STRAND 1107..1115; /evidence=""ECO:0007829|PDB:1UX6""; STRAND 1120..1127; /evidence=""ECO:0007829|PDB:1UX6""; STRAND 1130..1134; /evidence=""ECO:0007829|PDB:1UX6""; STRAND 1146..1154; /evidence=""ECO:0007829|PDB:1UX6""; STRAND 1156..1167; /evidence=""ECO:0007829|PDB:1UX6""","HELIX 33..37; /evidence=""ECO:0007829|PDB:2ERF""; HELIX 64..66; /evidence=""ECO:0007829|PDB:2ERF""; HELIX 72..85; /evidence=""ECO:0007829|PDB:2ERF""; HELIX 183..185; /evidence=""ECO:0007829|PDB:2ERF""; HELIX 191..194; /evidence=""ECO:0007829|PDB:2ERF""; HELIX 223..228; /evidence=""ECO:0007829|PDB:2ERF""; HELIX 869..871; /evidence=""ECO:0007829|PDB:1UX6""; HELIX 892..894; /evidence=""ECO:0007829|PDB:1UX6""; HELIX 905..907; /evidence=""ECO:0007829|PDB:1UX6""; HELIX 928..930; /evidence=""ECO:0007829|PDB:1UX6""; HELIX 1074..1081; /evidence=""ECO:0007829|PDB:1UX6""","TURN 38..41; /evidence=""ECO:0007829|PDB:2ERF""; TURN 123..126; /evidence=""ECO:0007829|PDB:2ERF""; TURN 170..172; /evidence=""ECO:0007829|PDB:2ERF""; TURN 203..205; /evidence=""ECO:0007829|PDB:2ERF""; TURN 229..231; /evidence=""ECO:0007829|PDB:2OUH""; TURN 408..410; /evidence=""ECO:0007829|PDB:5FOE""; TURN 838..840; /evidence=""ECO:0007829|PDB:1UX6""; TURN 854..856; /evidence=""ECO:0007829|PDB:1UX6""; TURN 909..912; /evidence=""ECO:0007829|PDB:1UX6""; TURN 941..943; /evidence=""ECO:0007829|PDB:1UX6""; TURN 1087..1089; /evidence=""ECO:0007829|PDB:1UX6""; TURN 1116..1119; /evidence=""ECO:0007829|PDB:1UX6""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,THBS1 TSP TSP1,Thrombospondin-1 (Glycoprotein G),Homo sapiens (Human),1170.0,129383.0,MGLAWGLGVLFLMHVCGTNRIPESGGDNSVFDIFELTGAARKGSGRRLVKGPDPSSPAFRIEDANLIPPVPDDKFQDLVDAVRAEKGFLLLASLRQMKKTRGTLLALERKDHSGQVFSVVSNGKAGTLDLSLTVQGKQHVVSVEEALLATGQWKSITLFVQEDRAQLYIDCEKMENAELDVPIQSVFTRDLASIARLRIAKGGVNDNFQGVLQNVRFVFGTTPEDILRNKGCSSSTSVLLTLDNNVVNGSSPAIRTNYIGHKTKDLQAICGISCDELSSMVLELRGLRTIVTTLQDSIRKVTEENKELANELRRPPLCYHNGVQYRNNEEWTVDSCTECHCQNSVTICKKVSCPIMPCSNATVPDGECCPRCWPSDSADDGWSPWSEWTSCSTSCGNGIQQRGRSCDSLNNRCEGSSVQTRTCHIQECDKRFKQDGGWSHWSPWSSCSVTCGDGVITRIRLCNSPSPQMNGKPCEGEARETKACKKDACPINGGWGPWSPWDICSVTCGGGVQKRSRLCNNPTPQFGGKDCVGDVTENQICNKQDCPIDGCLSNPCFAGVKCTSYPDGSWKCGACPPGYSGNGIQCTDVDECKEVPDACFNHNGEHRCENTDPGYNCLPCPPRFTGSQPFGQGVEHATANKQVCKPRNPCTDGTHDCNKNAKCNYLGHYSDPMYRCECKPGYAGNGIICGEDTDLDGWPNENLVCVANATYHCKKDNCPNLPNSGQEDYDKDGIGDACDDDDDNDKIPDDRDNCPFHYNPAQYDYDRDDVGDRCDNCPYNHNPDQADTDNNGEGDACAADIDGDGILNERDNCQYVYNVDQRDTDMDGVGDQCDNCPLEHNPDQLDSDSDRIGDTCDNNQDIDEDGHQNNLDNCPYVPNANQADHDKDGKGDACDHDDDNDGIPDDKDNCRLVPNPDQKDSDGDGRGDACKDDFDHDSVPDIDDICPENVDISETDFRRFQMIPLDPKGTSQNDPNWVVRHQGKELVQTVNCDPGLAVGYDEFNAVDFSGTFFINTERDDDYAGFVFGYQSSSRFYVVMWKQVTQSYWDTNPTRAQGYSGLSVKVVNSTTGPGEHLRNALWHTGNTPGQVRTLWHDPRHIGWKDFTAYRWRLSHRPKTGFIRVVMYEGKKIMADSGPIYDKTYAGGRLGLFVFSQEMVFFSDLKYECRDP,True,False,False,P07996,"[('cd00054', 'EGF_CA'), ('G3DSA:2.10.25.10', 'Laminin'), ('G3DSA:2.20.100.10', 'Thrombospondin type-1 (TSP1) repeat'), ('G3DSA:2.60.120.200', None), ('G3DSA:4.10.1080.10', 'TSP type-3 repeat'), ('G3DSA:6.20.200.20', None), ('IPR000742', 'EGF-like domain'), ('IPR000884', 'Thrombospondin type-1 (TSP1) repeat'), ('IPR001007', 'VWFC domain'), ('IPR001881', 'EGF-like calcium-binding domain'), ('IPR003367', 'Thrombospondin, type 3-like repeat'), ('IPR008859', 'Thrombospondin, C-terminal'), ('IPR013320', 'Concanavalin A-like lectin/glucanase domain superfamily'), ('IPR017897', 'Thrombospondin, type 3 repeat'), ('IPR028974', 'TSP type-3 repeat'), ('IPR036383', 'Thrombospondin type-1 (TSP1) repeat superfamily'), ('IPR048287', 'Thrombospondin-like, N-terminal domain'), ('PF00090', 'Thrombospondin type 1 domain'), ('PF00093', 'von Willebrand factor type C domain'), ('PF02412', 'Thrombospondin type 3 repeat')]",,"""ENSG00000137801; Low tissue specificity."";",,,,,ENST00000260356.6 [P07996-1];,THBS1,ENSG00000137801,0.0,,,,,,,0.121,0.082,THBS1
P08183,ENSG00000085563,MDR1_HUMAN,carboxylic acid transmembrane transport [GO:1905039]; ceramide translocation [GO:0099040]; export across plasma membrane [GO:0140115]; G2/M transition of mitotic cell cycle [GO:0000086]; phospholipid translocation [GO:0045332]; regulation of chloride transport [GO:2001225]; response to xenobiotic stimulus [GO:0009410]; stem cell proliferation [GO:0072089]; terpenoid transport [GO:0046865]; transepithelial transport [GO:0070633]; transmembrane transport [GO:0055085]; transport across blood-brain barrier [GO:0150104]; xenobiotic detoxification by transmembrane export across the plasma membrane [GO:1990961]; xenobiotic metabolic process [GO:0006805]; xenobiotic transport across blood-brain barrier [GO:1990962],apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; external side of apical plasma membrane [GO:0098591]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; plasma membrane [GO:0005886],ABC-type xenobiotic transporter activity [GO:0008559]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled transmembrane transporter activity [GO:0042626]; carboxylic acid transmembrane transporter activity [GO:0046943]; ceramide floppase activity [GO:0099038]; efflux transmembrane transporter activity [GO:0015562]; floppase activity [GO:0140328]; phosphatidylcholine floppase activity [GO:0090554]; phosphatidylethanolamine flippase activity [GO:0090555]; transmembrane transporter activity [GO:0022857]; ubiquitin protein ligase binding [GO:0031625]; xenobiotic transmembrane transporter activity [GO:0042910],,,"DOMAIN 51..357; /note=""ABC transmembrane type-1 1""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00441""; DOMAIN 392..628; /note=""ABC transporter 1""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00434""; DOMAIN 711..1000; /note=""ABC transmembrane type-1 2""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00441""; DOMAIN 1035..1273; /note=""ABC transporter 2""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00434""","STRAND 377..379; /evidence=""ECO:0007829|PDB:7A6F""; STRAND 392..398; /evidence=""ECO:0007829|PDB:7A69""; STRAND 402..404; /evidence=""ECO:0007829|PDB:7O9W""; STRAND 410..412; /evidence=""ECO:0007829|PDB:6C0V""; STRAND 415..417; /evidence=""ECO:0007829|PDB:7A69""; STRAND 422..426; /evidence=""ECO:0007829|PDB:7A69""; STRAND 447..457; /evidence=""ECO:0007829|PDB:7A69""; STRAND 470..473; /evidence=""ECO:0007829|PDB:7A69""; STRAND 481..483; /evidence=""ECO:0007829|PDB:7A69""; STRAND 516..518; /evidence=""ECO:0007829|PDB:7A69""; STRAND 550..556; /evidence=""ECO:0007829|PDB:7A69""; STRAND 559..561; /evidence=""ECO:0007829|PDB:6C0V""; STRAND 578..585; /evidence=""ECO:0007829|PDB:7A69""; STRAND 595..602; /evidence=""ECO:0007829|PDB:7A69""; STRAND 605..608; /evidence=""ECO:0007829|PDB:7A69""; STRAND 739..742; /evidence=""ECO:0007829|PDB:7A69""; STRAND 1035..1041; /evidence=""ECO:0007829|PDB:7A69""; STRAND 1045..1047; /evidence=""ECO:0007829|PDB:6C0V""; STRAND 1048..1052; /evidence=""ECO:0007829|PDB:7A69""; STRAND 1056..1060; /evidence=""ECO:0007829|PDB:7A69""; STRAND 1066..1069; /evidence=""ECO:0007829|PDB:7A69""; STRAND 1074..1077; /evidence=""ECO:0007829|PDB:7A69""; STRAND 1090..1096; /evidence=""ECO:0007829|PDB:7A69""; STRAND 1114..1116; /evidence=""ECO:0007829|PDB:7A69""; STRAND 1124..1126; /evidence=""ECO:0007829|PDB:6C0V""; STRAND 1161..1163; /evidence=""ECO:0007829|PDB:7A69""; STRAND 1195..1201; /evidence=""ECO:0007829|PDB:7A69""; STRAND 1225..1230; /evidence=""ECO:0007829|PDB:7A69""; STRAND 1240..1247; /evidence=""ECO:0007829|PDB:7A69""; STRAND 1250..1256; /evidence=""ECO:0007829|PDB:7A69""; STRAND 1272..1274; /evidence=""ECO:0007829|PDB:7O9W""","HELIX 45..80; /evidence=""ECO:0007829|PDB:7A69""; HELIX 107..156; /evidence=""ECO:0007829|PDB:7A69""; HELIX 162..165; /evidence=""ECO:0007829|PDB:7A69""; HELIX 168..186; /evidence=""ECO:0007829|PDB:7A69""; HELIX 188..210; /evidence=""ECO:0007829|PDB:7A69""; HELIX 212..236; /evidence=""ECO:0007829|PDB:7A69""; HELIX 241..257; /evidence=""ECO:0007829|PDB:7A69""; HELIX 261..267; /evidence=""ECO:0007829|PDB:7A69""; HELIX 270..322; /evidence=""ECO:0007829|PDB:7A69""; HELIX 328..346; /evidence=""ECO:0007829|PDB:7A69""; HELIX 349..370; /evidence=""ECO:0007829|PDB:7A69""; HELIX 433..440; /evidence=""ECO:0007829|PDB:7A69""; HELIX 458..460; /evidence=""ECO:0007829|PDB:7A69""; HELIX 463..468; /evidence=""ECO:0007829|PDB:7A69""; HELIX 484..489; /evidence=""ECO:0007829|PDB:7A69""; HELIX 497..506; /evidence=""ECO:0007829|PDB:7A69""; HELIX 511..515; /evidence=""ECO:0007829|PDB:7A69""; HELIX 526..528; /evidence=""ECO:0007829|PDB:7A69""; HELIX 533..545; /evidence=""ECO:0007829|PDB:7A69""; HELIX 563..573; /evidence=""ECO:0007829|PDB:7A69""; HELIX 612..618; /evidence=""ECO:0007829|PDB:7A69""; HELIX 621..629; /evidence=""ECO:0007829|PDB:7A69""; HELIX 700..703; /evidence=""ECO:0007829|PDB:7A69""; HELIX 708..736; /evidence=""ECO:0007829|PDB:7A69""; HELIX 745..797; /evidence=""ECO:0007829|PDB:7A69""; HELIX 801..804; /evidence=""ECO:0007829|PDB:7A69""; HELIX 812..853; /evidence=""ECO:0007829|PDB:7A69""; HELIX 855..861; /evidence=""ECO:0007829|PDB:7A69""; HELIX 865..880; /evidence=""ECO:0007829|PDB:7A69""; HELIX 887..902; /evidence=""ECO:0007829|PDB:7A69""; HELIX 904..910; /evidence=""ECO:0007829|PDB:7A69""; HELIX 914..965; /evidence=""ECO:0007829|PDB:7A69""; HELIX 971..981; /evidence=""ECO:0007829|PDB:7A69""; HELIX 986..994; /evidence=""ECO:0007829|PDB:7A69""; HELIX 999..1013; /evidence=""ECO:0007829|PDB:7A69""; HELIX 1078..1083; /evidence=""ECO:0007829|PDB:7A69""; HELIX 1106..1112; /evidence=""ECO:0007829|PDB:7A69""; HELIX 1128..1131; /evidence=""ECO:0007829|PDB:7A69""; HELIX 1142..1151; /evidence=""ECO:0007829|PDB:7A69""; HELIX 1155..1159; /evidence=""ECO:0007829|PDB:7A69""; HELIX 1164..1166; /evidence=""ECO:0007829|PDB:6C0V""; HELIX 1171..1173; /evidence=""ECO:0007829|PDB:7A69""; HELIX 1178..1190; /evidence=""ECO:0007829|PDB:7A69""; HELIX 1208..1222; /evidence=""ECO:0007829|PDB:7A69""; HELIX 1235..1238; /evidence=""ECO:0007829|PDB:7A69""; HELIX 1257..1262; /evidence=""ECO:0007829|PDB:7A69""; HELIX 1266..1271; /evidence=""ECO:0007829|PDB:7A69""","TURN 37..39; /evidence=""ECO:0007829|PDB:7A69""; TURN 40..42; /evidence=""ECO:0007829|PDB:7O9W""; TURN 507..510; /evidence=""ECO:0007829|PDB:7A6F""; TURN 519..521; /evidence=""ECO:0007829|PDB:7A69""; TURN 590..594; /evidence=""ECO:0007829|PDB:7A69""; TURN 704..706; /evidence=""ECO:0007829|PDB:7A69""; TURN 808..811; /evidence=""ECO:0007829|PDB:7A69""; TURN 862..864; /evidence=""ECO:0007829|PDB:7A69""; TURN 982..985; /evidence=""ECO:0007829|PDB:7A69""; TURN 1101..1103; /evidence=""ECO:0007829|PDB:7A69""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,ABCB1 MDR1 PGY1,ATP-dependent translocase ABCB1 (ATP-binding cassette sub-family B member 1) (Multidrug resistance protein 1) (EC 7.6.2.2) (P-glycoprotein 1) (Phospholipid transporter ABCB1) (EC 7.6.2.1) (CD antigen CD243),Homo sapiens (Human),1280.0,141479.0,MDLEGDRNGGAKKKNFFKLNNKSEKDKKEKKPTVSVFSMFRYSNWLDKLYMVVGTLAAIIHGAGLPLMMLVFGEMTDIFANAGNLEDLMSNITNRSDINDTGFFMNLEEDMTRYAYYYSGIGAGVLVAAYIQVSFWCLAAGRQIHKIRKQFFHAIMRQEIGWFDVHDVGELNTRLTDDVSKINEGIGDKIGMFFQSMATFFTGFIVGFTRGWKLTLVILAISPVLGLSAAVWAKILSSFTDKELLAYAKAGAVAEEVLAAIRTVIAFGGQKKELERYNKNLEEAKRIGIKKAITANISIGAAFLLIYASYALAFWYGTTLVLSGEYSIGQVLTVFFSVLIGAFSVGQASPSIEAFANARGAAYEIFKIIDNKPSIDSYSKSGHKPDNIKGNLEFRNVHFSYPSRKEVKILKGLNLKVQSGQTVALVGNSGCGKSTTVQLMQRLYDPTEGMVSVDGQDIRTINVRFLREIIGVVSQEPVLFATTIAENIRYGRENVTMDEIEKAVKEANAYDFIMKLPHKFDTLVGERGAQLSGGQKQRIAIARALVRNPKILLLDEATSALDTESEAVVQVALDKARKGRTTIVIAHRLSTVRNADVIAGFDDGVIVEKGNHDELMKEKGIYFKLVTMQTAGNEVELENAADESKSEIDALEMSSNDSRSSLIRKRSTRRSVRGSQAQDRKLSTKEALDESIPPVSFWRIMKLNLTEWPYFVVGVFCAIINGGLQPAFAIIFSKIIGVFTRIDDPETKRQNSNLFSLLFLALGIISFITFFLQGFTFGKAGEILTKRLRYMVFRSMLRQDVSWFDDPKNTTGALTTRLANDAAQVKGAIGSRLAVITQNIANLGTGIIISFIYGWQLTLLLLAIVPIIAIAGVVEMKMLSGQALKDKKELEGSGKIATEAIENFRTVVSLTQEQKFEHMYAQSLQVPYRNSLRKAHIFGITFSFTQAMMYFSYAGCFRFGAYLVAHKLMSFEDVLLVFSAVVFGAMAVGQVSSFAPDYAKAKISAAHIIMIIEKTPLIDSYSTEGLMPNTLEGNVTFGEVVFNYPTRPDIPVLQGLSLEVKKGQTLALVGSSGCGKSTVVQLLERFYDPLAGKVLLDGKEIKRLNVQWLRAHLGIVSQEPILFDCSIAENIAYGDNSRVVSQEEIVRAAKEANIHAFIESLPNKYSTKVGDKGTQLSGGQKQRIAIARALVRQPHILLLDEATSALDTESEKVVQEALDKAREGRTCIVIAHRLSTIQNADLIVVFQNGRVKEHGTHQQLLAQKGIYFSMVSVQAGTKRQ,True,True,True,P08183,"[('cd03249', 'ATP-binding cassette domain of a mitochondrial protein MTABC3 and related proteins'), ('cd18558', 'Six-transmembrane helical domain of P-glycoprotein 1 (Pgp) and related proteins'), ('cd18578', 'Six-transmembrane helical domain 2 (TMD2) of P-glycoprotein 1 (Pgp) and related proteins'), ('G3DSA:1.20.1560.10', 'ABC transporter type 1, transmembrane domain'), ('G3DSA:3.40.50.300', 'P-loop containing nucleotide triphosphate hydrolases'), ('IPR003439', 'ABC transporter-like, ATP-binding domain'), ('IPR003593', 'AAA+ ATPase domain'), ('IPR011527', 'ABC transporter type 1, transmembrane domain'), ('IPR017871', 'ABC transporter-like, conserved site'), ('IPR027417', 'P-loop containing nucleoside triphosphate hydrolase'), ('IPR036640', 'ABC transporter type 1, transmembrane domain superfamily'), ('IPR039421', 'Type 1 protein exporter'), ('PF00005', 'ABC transporter'), ('PF00664', 'ABC transporter transmembrane region'), ('PS00211', 'ABC transporters family signature'), ('PS50893', 'ATP-binding cassette, ABC transporter-type domain profile'), ('PS50929', 'ABC transporter integral membrane type-1 fused domain profile'), ('PTHR43394', 'ATP-DEPENDENT PERMEASE MDL1, MITOCHONDRIAL'), ('SM00382', 'ATPases associated with a variety of cellular activities'), ('SSF52540', 'P-loop containing nucleoside triphosphate hydrolases')]",,"""ENSG00000085563; Tissue enhanced (adrenal gland, intestine)."";","CATALYTIC ACTIVITY: Reaction=ATP + H2O + xenobioticSide 1 = ADP + phosphate + xenobioticSide 2.; EC=7.6.2.2; Evidence={ECO:0000269|PubMed:9038218}; CATALYTIC ACTIVITY: Reaction=ATP + H2O + phospholipidSide 1 = ADP + phosphate + phospholipidSide 2.; EC=7.6.2.1; Evidence={ECO:0000269|PubMed:8898203}; CATALYTIC ACTIVITY: Reaction=a 1,2-diacyl-sn-glycero-3-phosphoethanolamine(in) + ATP + H2O = a 1,2-diacyl-sn-glycero-3-phosphoethanolamine(out) + ADP + phosphate + H(+); Xref=Rhea:RHEA:36439, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616, ChEBI:CHEBI:43474, ChEBI:CHEBI:64612, ChEBI:CHEBI:456216; Evidence={ECO:0000269|PubMed:8898203}; CATALYTIC ACTIVITY: Reaction=a 1,2-diacyl-sn-glycero-3-phosphocholine(out) + ATP + H2O = a 1,2-diacyl-sn-glycero-3-phosphocholine(in) + ADP + phosphate + H(+); Xref=Rhea:RHEA:38583, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616, ChEBI:CHEBI:43474, ChEBI:CHEBI:57643, ChEBI:CHEBI:456216; Evidence={ECO:0000269|PubMed:8898203}; CATALYTIC ACTIVITY: Reaction=a beta-D-glucosyl-(1<->1')-N-acylsphing-4-enine(in) + ATP + H2O = a beta-D-glucosyl-(1<->1')-N-acylsphing-4-enine(out) + ADP + phosphate + H(+); Xref=Rhea:RHEA:38943, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:22801, ChEBI:CHEBI:30616, ChEBI:CHEBI:43474, ChEBI:CHEBI:456216; Evidence={ECO:0000269|PubMed:8898203}; CATALYTIC ACTIVITY: Reaction=a sphingomyelin(in) + ATP + H2O = a sphingomyelin(out) + ADP + phosphate + H(+); Xref=Rhea:RHEA:38903, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:17636, ChEBI:CHEBI:30616, ChEBI:CHEBI:43474, ChEBI:CHEBI:456216; Evidence={ECO:0000269|PubMed:8898203};",7.6.2.1; 7.6.2.2,"ACTIVITY REGULATION: Translocase activity is inhibited by verapamil and is sensitive to energy depletion (PubMed:8898203). C1orf115 regulates drug efflux through modulation of ABCB1 localization and activity (PubMed:35970996). {ECO:0000269|PubMed:35970996, ECO:0000269|PubMed:8898203}.",,ENST00000265724.8 [P08183-1];ENST00000543898.5 [P08183-2];ENST00000622132.5 [P08183-1];,ABCB1,ENSG00000085563,0.0,,,,,,,0.065,0.031,ABCB1
P08237,ENSG00000152556,PFKAM_HUMAN,"canonical glycolysis [GO:0061621]; fructose 1,6-bisphosphate metabolic process [GO:0030388]; fructose 6-phosphate metabolic process [GO:0006002]; glucose homeostasis [GO:0042593]; glycogen catabolic process [GO:0005980]; glycolysis from storage polysaccharide through glucose-1-phosphate [GO:0093001]; glycolytic process [GO:0006096]; glycolytic process through fructose-6-phosphate [GO:0061615]; muscle cell cellular homeostasis [GO:0046716]; positive regulation of insulin secretion [GO:0032024]; positive regulation of transcription by RNA polymerase II [GO:0045944]",6-phosphofructokinase complex [GO:0005945]; apical plasma membrane [GO:0016324]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; sperm principal piece [GO:0097228],6-phosphofructokinase activity [GO:0003872]; AMP binding [GO:0016208]; ATP binding [GO:0005524]; fructose binding [GO:0070061]; fructose-6-phosphate binding [GO:0070095]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; metal ion binding [GO:0046872]; monosaccharide binding [GO:0048029],PTM: GlcNAcylation decreases enzyme activity. {ECO:0000250}.,,,,,,"cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,PFKM PFKX,"ATP-dependent 6-phosphofructokinase, muscle type (ATP-PFK) (PFK-M) (EC 2.7.1.11) (6-phosphofructokinase type A) (Phosphofructo-1-kinase isozyme A) (PFK-A) (Phosphohexokinase)",Homo sapiens (Human),780.0,85183.0,MTHEEHHAAKTLGIGKAIAVLTSGGDAQGMNAAVRAVVRVGIFTGARVFFVHEGYQGLVDGGDHIKEATWESVSMMLQLGGTVIGSARCKDFREREGRLRAAYNLVKRGITNLCVIGGDGSLTGADTFRSEWSDLLSDLQKAGKITDEEATKSSYLNIVGLVGSIDNDFCGTDMTIGTDSALHRIMEIVDAITTTAQSHQRTFVLEVMGRHCGYLALVTSLSCGADWVFIPECPPDDDWEEHLCRRLSETRTRGSRLNIIIVAEGAIDKNGKPITSEDIKNLVVKRLGYDTRVTVLGHVQRGGTPSAFDRILGSRMGVEAVMALLEGTPDTPACVVSLSGNQAVRLPLMECVQVTKDVTKAMDEKKFDEALKLRGRSFMNNWEVYKLLAHVRPPVSKSGSHTVAVMNVGAPAAGMNAAVRSTVRIGLIQGNRVLVVHDGFEGLAKGQIEEAGWSYVGGWTGQGGSKLGTKRTLPKKSFEQISANITKFNIQGLVIIGGFEAYTGGLELMEGRKQFDELCIPFVVIPATVSNNVPGSDFSVGADTALNTICTTCDRIKQSAAGTKRRVFIIETMGGYCGYLATMAGLAAGADAAYIFEEPFTIRDLQANVEHLVQKMKTTVKRGLVLRNEKCNENYTTDFIFNLYSEEGKGIFDSRKNVLGHMQQGGSPTPFDRNFATKMGAKAMNWMSGKIKESYRNGRIFANTPDSGCVLGMRKRALVFQPVAELKDQTDFEHRIPKEQWWLKLRPILKILAKYEIDLDTSDHAHLEHITRKRSGEAAV,False,True,False,P08237,"[('cd00764', 'Eukaryotic_PFK'), ('G3DSA:3.40.50.450', None), ('G3DSA:3.40.50.460', 'Phosphofructokinase domain'), ('IPR000023', 'Phosphofructokinase domain'), ('IPR009161', 'ATP-dependent 6-phosphofructokinase, eukaryotic-type'), ('IPR015912', 'Phosphofructokinase, conserved site'), ('IPR022953', 'ATP-dependent 6-phosphofructokinase'), ('IPR035966', 'Phosphofructokinase superfamily'), ('IPR041914', 'ATP-dependent 6-phosphofructokinase, vertebrate-type'), ('MF_03184', 'ATP-dependent 6-phosphofructokinase'), ('PF00365', 'Phosphofructokinase'), ('PIRSF000533', 'ATP-dependent phosphofructokinase, eukaryotic type'), ('PR00476', 'PHFRCTKINASE'), ('PS00433', 'Phosphofructokinase signature'), ('PTHR13697', 'ATP-dependent 6-phosphofructokinase'), ('SSF53784', 'Phosphofructokinase'), ('TIGR02478', '6-phosphofructokinase')]",,"""ENSG00000152556; Group enriched (skeletal muscle, tongue)."";","CATALYTIC ACTIVITY: Reaction=beta-D-fructose 6-phosphate + ATP = beta-D-fructose 1,6-bisphosphate + ADP + H(+); Xref=Rhea:RHEA:16109, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616, ChEBI:CHEBI:32966, ChEBI:CHEBI:57634, ChEBI:CHEBI:456216; EC=2.7.1.11; Evidence={ECO:0000255|HAMAP-Rule:MF_03184};",2.7.1.11,"ACTIVITY REGULATION: Allosterically activated by ADP, AMP, or fructose 2,6-bisphosphate, and allosterically inhibited by ATP or citrate.",PATHWAY: Carbohydrate degradation; glycolysis; D-glyceraldehyde 3-phosphate and glycerone phosphate from D-glucose: step 3/4. {ECO:0000255|HAMAP-Rule:MF_03184}.,ENST00000312352.11 [P08237-1];ENST00000340802.12 [P08237-3];ENST00000359794.11 [P08237-1];ENST00000547587.5 [P08237-1];ENST00000550345.6 [P08237-1];ENST00000550924.6 [P08237-1];ENST00000551339.6 [P08237-1];ENST00000551804.5 [P08237-2];,PFKM,ENSG00000152556,0.0,,,,,,,0.013,,PFKM
P08238,ENSG00000096384,HS90B_HUMAN,cellular response to heat [GO:0034605]; cellular response to interleukin-4 [GO:0071353]; chaperone-mediated protein complex assembly [GO:0051131]; chaperone-mediated protein folding [GO:0061077]; negative regulation of apoptotic process [GO:0043066]; negative regulation of proteasomal protein catabolic process [GO:1901799]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; placenta development [GO:0001890]; positive regulation of cell differentiation [GO:0045597]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of phosphoprotein phosphatase activity [GO:0032516]; positive regulation of protein localization to cell surface [GO:2000010]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; regulation of cell cycle [GO:0051726]; regulation of protein localization [GO:0032880]; regulation of protein ubiquitination [GO:0031396]; response to unfolded protein [GO:0006986]; supramolecular fiber organization [GO:0097435]; telomerase holoenzyme complex assembly [GO:1905323]; telomere maintenance via telomerase [GO:0007004]; virion attachment to host cell [GO:0019062],aryl hydrocarbon receptor complex [GO:0034751]; axonal growth cone [GO:0044295]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic growth cone [GO:0044294]; dynein axonemal particle [GO:0120293]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; HSP90-CDC37 chaperone complex [GO:1990565]; melanosome [GO:0042470]; membrane [GO:0016020]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein folding chaperone complex [GO:0101031]; protein-containing complex [GO:0032991]; secretory granule lumen [GO:0034774],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent protein binding [GO:0043008]; ATP-dependent protein folding chaperone [GO:0140662]; cadherin binding [GO:0045296]; disordered domain specific binding [GO:0097718]; DNA polymerase binding [GO:0070182]; double-stranded RNA binding [GO:0003725]; heat shock protein binding [GO:0031072]; histone deacetylase binding [GO:0042826]; histone methyltransferase binding [GO:1990226]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; MHC class II protein complex binding [GO:0023026]; nitric-oxide synthase regulator activity [GO:0030235]; peptide binding [GO:0042277]; protein dimerization activity [GO:0046983]; protein folding chaperone [GO:0044183]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; receptor ligand inhibitor activity [GO:0141069]; RNA binding [GO:0003723]; tau protein binding [GO:0048156]; TPR domain binding [GO:0030911]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082],"PTM: Ubiquitinated in the presence of STUB1-UBE2D1 complex (in vitro). {ECO:0000269|PubMed:18042044}.; PTM: ISGylated. {ECO:0000269|PubMed:16139798}.; PTM: S-nitrosylated; negatively regulates the ATPase activity. {ECO:0000305|PubMed:19696785}.; PTM: Phosphorylation at Tyr-301 by SRC is induced by lipopolysaccharide (PubMed:23585225). Phosphorylation at Ser-226 and Ser-255 inhibits AHR interaction (PubMed:15581363). {ECO:0000269|PubMed:15581363, ECO:0000269|PubMed:23585225}.; PTM: Methylated by SMYD2; facilitates dimerization and chaperone complex formation; promotes cancer cell proliferation. {ECO:0000269|PubMed:24880080}.; PTM: Cleaved following oxidative stress resulting in HSP90AB1 protein radicals formation; disrupts the chaperoning function and the degradation of its client proteins. {ECO:0000269|PubMed:22848402}.",DOMAIN: The TPR repeat-binding motif mediates interaction with TPR repeat-containing proteins. {ECO:0000250|UniProtKB:P07900}.,,"STRAND 2..6; /evidence=""ECO:0007829|PDB:6N8W""; STRAND 13..16; /evidence=""ECO:0007829|PDB:6N8Y""; STRAND 73..78; /evidence=""ECO:0007829|PDB:6N8Y""; STRAND 83..88; /evidence=""ECO:0007829|PDB:6N8Y""; STRAND 140..148; /evidence=""ECO:0007829|PDB:6N8Y""; STRAND 150..152; /evidence=""ECO:0007829|PDB:8EOB""; STRAND 155..159; /evidence=""ECO:0007829|PDB:6N8Y""; STRAND 161..163; /evidence=""ECO:0007829|PDB:8GAE""; STRAND 164..169; /evidence=""ECO:0007829|PDB:6N8Y""; STRAND 176..185; /evidence=""ECO:0007829|PDB:6N8Y""; STRAND 206..208; /evidence=""ECO:0007829|PDB:7Z38""; STRAND 213..215; /evidence=""ECO:0007829|PDB:6N8Y""; STRAND 217..219; /evidence=""ECO:0007829|PDB:8EOB""; STRAND 277..282; /evidence=""ECO:0007829|PDB:8QMO""; STRAND 316..323; /evidence=""ECO:0007829|PDB:3PRY""; STRAND 325..327; /evidence=""ECO:0007829|PDB:3PRY""; STRAND 329..335; /evidence=""ECO:0007829|PDB:3PRY""; STRAND 346..348; /evidence=""ECO:0007829|PDB:8QMO""; STRAND 353..357; /evidence=""ECO:0007829|PDB:3PRY""; STRAND 360..364; /evidence=""ECO:0007829|PDB:3PRY""; STRAND 378..386; /evidence=""ECO:0007829|PDB:3PRY""; STRAND 456..459; /evidence=""ECO:0007829|PDB:3PRY""; STRAND 482..486; /evidence=""ECO:0007829|PDB:3PRY""; STRAND 510..512; /evidence=""ECO:0007829|PDB:3PRY""; STRAND 526..528; /evidence=""ECO:0007829|PDB:8GAE""; STRAND 531..535; /evidence=""ECO:0007829|PDB:3PRY""; STRAND 538..540; /evidence=""ECO:0007829|PDB:8QMO""; STRAND 576..580; /evidence=""ECO:0007829|PDB:8QMO""; STRAND 585..593; /evidence=""ECO:0007829|PDB:8QMO""; STRAND 595..598; /evidence=""ECO:0007829|PDB:8QMO""; STRAND 610..612; /evidence=""ECO:0007829|PDB:8QMO""; STRAND 624..628; /evidence=""ECO:0007829|PDB:8QMO""; STRAND 630..632; /evidence=""ECO:0007829|PDB:7ZR0""","HELIX 19..30; /evidence=""ECO:0007829|PDB:6N8Y""; HELIX 38..60; /evidence=""ECO:0007829|PDB:6N8Y""; HELIX 62..65; /evidence=""ECO:0007829|PDB:6N8Y""; HELIX 95..99; /evidence=""ECO:0007829|PDB:6N8Y""; HELIX 101..118; /evidence=""ECO:0007829|PDB:6N8Y""; HELIX 123..129; /evidence=""ECO:0007829|PDB:6N8Y""; HELIX 132..138; /evidence=""ECO:0007829|PDB:6N8Y""; HELIX 187..193; /evidence=""ECO:0007829|PDB:6N8Y""; HELIX 195..205; /evidence=""ECO:0007829|PDB:6N8Y""; HELIX 288..290; /evidence=""ECO:0007829|PDB:3PRY""; HELIX 293..295; /evidence=""ECO:0007829|PDB:3PRY""; HELIX 298..309; /evidence=""ECO:0007829|PDB:3PRY""; HELIX 367..369; /evidence=""ECO:0007829|PDB:3PRY""; HELIX 372..374; /evidence=""ECO:0007829|PDB:3PRY""; HELIX 395..420; /evidence=""ECO:0007829|PDB:3PRY""; HELIX 423..443; /evidence=""ECO:0007829|PDB:3PRY""; HELIX 445..447; /evidence=""ECO:0007829|PDB:3PRY""; HELIX 448..453; /evidence=""ECO:0007829|PDB:3PRY""; HELIX 469..474; /evidence=""ECO:0007829|PDB:3PRY""; HELIX 491..495; /evidence=""ECO:0007829|PDB:3PRY""; HELIX 498..504; /evidence=""ECO:0007829|PDB:3PRY""; HELIX 518..525; /evidence=""ECO:0007829|PDB:3PRY""; HELIX 547..570; /evidence=""ECO:0007829|PDB:8QMO""; HELIX 600..607; /evidence=""ECO:0007829|PDB:8QMO""; HELIX 614..616; /evidence=""ECO:0007829|PDB:7Z38""; HELIX 617..619; /evidence=""ECO:0007829|PDB:8QMO""; HELIX 633..644; /evidence=""ECO:0007829|PDB:8QMO""; HELIX 649..665; /evidence=""ECO:0007829|PDB:8QMO""; HELIX 673..688; /evidence=""ECO:0007829|PDB:8QMO""; HELIX 716..720; /evidence=""ECO:0007829|PDB:8QMO""","TURN 34..37; /evidence=""ECO:0007829|PDB:5UCH""; TURN 79..82; /evidence=""ECO:0007829|PDB:6N8Y""; TURN 341..344; /evidence=""ECO:0007829|PDB:8QMO""; TURN 460..464; /evidence=""ECO:0007829|PDB:3PRY""; TURN 505..507; /evidence=""ECO:0007829|PDB:3PRY""; TURN 571..574; /evidence=""ECO:0007829|PDB:8QMO""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB,Heat shock protein HSP 90-beta (HSP 90) (Heat shock 84 kDa) (HSP 84) (HSP84) (Heat shock protein family C member 3),Homo sapiens (Human),724.0,83264.0,MPEEVHHGEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNASDALDKIRYESLTDPSKLDSGKELKIDIIPNPQERTLTLVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVVVITKHNDDEQYAWESSAGGSFTVRADHGEPIGRGTKVILHLKEDQTEYLEERRVKEVVKKHSQFIGYPITLYLEKEREKEISDDEAEEEKGEKEEEDKDDEEKPKIEDVGSDEEDDSGKDKKKKTKKIKEKYIDQEELNKTKPIWTRNPDDITQEEYGEFYKSLTNDWEDHLAVKHFSVEGQLEFRALLFIPRRAPFDLFENKKKKNNIKLYVRRVFIMDSCDELIPEYLNFIRGVVDSEDLPLNISREMLQQSKILKVIRKNIVKKCLELFSELAEDKENYKKFYEAFSKNLKLGIHEDSTNRRRLSELLRYHTSQSGDEMTSLSEYVSRMKETQKSIYYITGESKEQVANSAFVERVRKRGFEVVYMTEPIDEYCVQQLKEFDGKSLVSVTKEGLELPEDEEEKKKMEESKAKFENLCKLMKEILDKKVEKVTISNRLVSSPCCIVTSTYGWTANMERIMKAQALRDNSTMGYMMAKKHLEINPDHPIVETLRQKAEADKNDKAVKDLVVLLFETALLSSGFSLEDPQTHSNRIYRMIKLGLGIDEDEVAAEEPNAAVPDEIPPLEGDEDASRMEEVD,True,False,True,P08238,"[('cd16927', 'Histidine kinase-like ATPase domain of human cytosolic Hsp90 and its homologs including Escherichia coli HtpG, and related domains'), ('G3DSA:1.20.120.790', 'Heat shock protein 90, C-terminal domain'), ('G3DSA:3.30.230.80', None), ('G3DSA:3.30.565.10', 'Histidine kinase-like ATPase, C-terminal domain'), ('G3DSA:3.40.50.11260', None), ('IPR001404', 'Heat shock protein Hsp90 family'), ('IPR003594', 'Histidine kinase/HSP90-like ATPase domain'), ('IPR019805', 'Heat shock protein Hsp90, conserved site'), ('IPR020568', 'Ribosomal protein uS5 domain 2-type superfamily'), ('IPR020575', 'Heat shock protein Hsp90, N-terminal'), ('IPR036890', 'Histidine kinase/HSP90-like ATPase superfamily'), ('IPR037196', 'HSP90, C-terminal domain'), ('MF_00505', 'Chaperone protein HtpG [htpG]'), ('PF00183', 'Hsp90 protein'), ('PF13589', 'Histidine kinase-, DNA gyrase B-, and HSP90-like ATPase'), ('PIRSF002583', 'Heat shock protein, HSP90/HTPG types'), ('PR00775', 'HEATSHOCK90'), ('PS00298', 'Heat shock hsp90 proteins family signature'), ('PTHR11528', 'HEAT SHOCK PROTEIN 90 FAMILY MEMBER'), ('SM00387', 'Histidine kinase-like ATPases')]",,"""ENSG00000096384; Low tissue specificity."";",,,"ACTIVITY REGULATION: In the resting state, through the dimerization of its C-terminal domain, HSP90 forms a homodimer which is defined as the open conformation. Upon ATP-binding, the N-terminal domain undergoes significant conformational changes and comes in contact to form an active closed conformation. After HSP90 finishes its chaperoning tasks of assisting the proper folding, stabilization and activation of client proteins under the active state, ATP molecule is hydrolyzed to ADP which then dissociates from HSP90 and directs the protein back to the resting state. {ECO:0000269|PubMed:18400751}.",,ENST00000353801.7;ENST00000371554.2;ENST00000371646.10;ENST00000620073.4;,HSP90AB1,ENSG00000096384,0.0,HSP90AB1,Non-canonical_RBPs,27.0,,,0.029,0.141,0.108,HSP90AB1
P08253,ENSG00000087245,MMP2_HUMAN,angiogenesis [GO:0001525]; blood vessel maturation [GO:0001955]; bone trabecula formation [GO:0060346]; cell migration [GO:0016477]; cellular response to amino acid stimulus [GO:0071230]; cellular response to estradiol stimulus [GO:0071392]; cellular response to fluid shear stress [GO:0071498]; cellular response to interleukin-1 [GO:0071347]; cellular response to reactive oxygen species [GO:0034614]; cellular response to UV-A [GO:0071492]; collagen catabolic process [GO:0030574]; embryo implantation [GO:0007566]; endodermal cell differentiation [GO:0035987]; ephrin receptor signaling pathway [GO:0048013]; extracellular matrix disassembly [GO:0022617]; extracellular matrix organization [GO:0030198]; face morphogenesis [GO:0060325]; heart development [GO:0007507]; intramembranous ossification [GO:0001957]; luteinization [GO:0001553]; macrophage chemotaxis [GO:0048246]; negative regulation of cell adhesion [GO:0007162]; negative regulation of vasoconstriction [GO:0045906]; ovarian follicle development [GO:0001541]; ovulation from ovarian follicle [GO:0001542]; parturition [GO:0007567]; peripheral nervous system axon regeneration [GO:0014012]; positive regulation of cell migration [GO:0030335]; positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903378]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; prostate gland epithelium morphogenesis [GO:0060740]; protein catabolic process [GO:0030163]; proteolysis [GO:0006508]; response to activity [GO:0014823]; response to amyloid-beta [GO:1904645]; response to electrical stimulus [GO:0051602]; response to estrogen [GO:0043627]; response to hydrogen peroxide [GO:0042542]; response to hyperoxia [GO:0055093]; response to hypoxia [GO:0001666]; response to mechanical stimulus [GO:0009612]; response to nicotine [GO:0035094]; response to retinoic acid [GO:0032526]; response to xenobiotic stimulus [GO:0009410]; tissue remodeling [GO:0048771],collagen-containing extracellular matrix [GO:0062023]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; sarcomere [GO:0030017],endopeptidase activity [GO:0004175]; fibronectin binding [GO:0001968]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; serine-type endopeptidase activity [GO:0004252]; zinc ion binding [GO:0008270],"PTM: Phosphorylation on multiple sites modulates enzymatic activity. Phosphorylated by PKC in vitro. {ECO:0000269|PubMed:17435175}.; PTM: The propeptide is processed by MMP14 (MT-MMP1) and MMP16 (MT-MMP3). Autocatalytic cleavage in the C-terminal produces the anti-angiogenic peptide, PEX. This processing appears to be facilitated by binding integrinv/beta3. {ECO:0000269|PubMed:12879005, ECO:0000269|PubMed:9119036}.","DOMAIN: The conserved cysteine present in the cysteine-switch motif binds the catalytic zinc ion, thus inhibiting the enzyme. The dissociation of the cysteine from the zinc ion upon the activation-peptide release activates the enzyme.","DOMAIN 228..276; /note=""Fibronectin type-II 1""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00479""; DOMAIN 286..334; /note=""Fibronectin type-II 2""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00479""; DOMAIN 344..392; /note=""Fibronectin type-II 3""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00479""","STRAND 86..88; /evidence=""ECO:0007829|PDB:1GXD""; STRAND 111..113; /evidence=""ECO:0007829|PDB:1CK7""; STRAND 120..128; /evidence=""ECO:0007829|PDB:3AYU""; STRAND 133..135; /evidence=""ECO:0007829|PDB:1HOV""; STRAND 154..156; /evidence=""ECO:0007829|PDB:3AYU""; STRAND 158..161; /evidence=""ECO:0007829|PDB:3AYU""; STRAND 163..165; /evidence=""ECO:0007829|PDB:3AYU""; STRAND 168..174; /evidence=""ECO:0007829|PDB:3AYU""; STRAND 179..181; /evidence=""ECO:0007829|PDB:3AYU""; STRAND 186..189; /evidence=""ECO:0007829|PDB:3AYU""; STRAND 192..195; /evidence=""ECO:0007829|PDB:3AYU""; STRAND 197..199; /evidence=""ECO:0007829|PDB:3AYU""; STRAND 205..208; /evidence=""ECO:0007829|PDB:3AYU""; STRAND 209..211; /evidence=""ECO:0007829|PDB:1HOV""; STRAND 213..216; /evidence=""ECO:0007829|PDB:3AYU""; STRAND 235..239; /evidence=""ECO:0007829|PDB:1EAK""; STRAND 242..246; /evidence=""ECO:0007829|PDB:1EAK""; STRAND 258..264; /evidence=""ECO:0007829|PDB:1EAK""; STRAND 271..273; /evidence=""ECO:0007829|PDB:1EAK""; STRAND 293..297; /evidence=""ECO:0007829|PDB:1EAK""; STRAND 300..304; /evidence=""ECO:0007829|PDB:1EAK""; STRAND 316..321; /evidence=""ECO:0007829|PDB:1EAK""; STRAND 329..331; /evidence=""ECO:0007829|PDB:1EAK""; STRAND 338..341; /evidence=""ECO:0007829|PDB:1GXD""; STRAND 351..355; /evidence=""ECO:0007829|PDB:1EAK""; STRAND 358..362; /evidence=""ECO:0007829|PDB:1EAK""; STRAND 369..371; /evidence=""ECO:0007829|PDB:1EAK""; STRAND 374..379; /evidence=""ECO:0007829|PDB:1EAK""; STRAND 387..389; /evidence=""ECO:0007829|PDB:1EAK""; STRAND 394..396; /evidence=""ECO:0007829|PDB:3AYU""; STRAND 422..424; /evidence=""ECO:0007829|PDB:3AYU""; STRAND 476..481; /evidence=""ECO:0007829|PDB:1GEN""; STRAND 484..489; /evidence=""ECO:0007829|PDB:1GEN""; STRAND 492..498; /evidence=""ECO:0007829|PDB:1GEN""; STRAND 504..508; /evidence=""ECO:0007829|PDB:1GEN""; STRAND 514..516; /evidence=""ECO:0007829|PDB:1GXD""; STRAND 521..526; /evidence=""ECO:0007829|PDB:1GEN""; STRAND 531..536; /evidence=""ECO:0007829|PDB:1GEN""; STRAND 539..544; /evidence=""ECO:0007829|PDB:1GEN""; STRAND 553..555; /evidence=""ECO:0007829|PDB:1GEN""; STRAND 569..573; /evidence=""ECO:0007829|PDB:1GEN""; STRAND 580..584; /evidence=""ECO:0007829|PDB:1GEN""; STRAND 587..592; /evidence=""ECO:0007829|PDB:1GEN""; STRAND 610..612; /evidence=""ECO:0007829|PDB:1GEN""; STRAND 618..622; /evidence=""ECO:0007829|PDB:1GEN""; STRAND 628..633; /evidence=""ECO:0007829|PDB:1GEN""; STRAND 636..641; /evidence=""ECO:0007829|PDB:1GEN""; STRAND 644..652; /evidence=""ECO:0007829|PDB:1GEN""","HELIX 46..56; /evidence=""ECO:0007829|PDB:1EAK""; HELIX 67..80; /evidence=""ECO:0007829|PDB:1EAK""; HELIX 91..97; /evidence=""ECO:0007829|PDB:1EAK""; HELIX 137..152; /evidence=""ECO:0007829|PDB:3AYU""; HELIX 226..228; /evidence=""ECO:0007829|PDB:1EAK""; HELIX 381..384; /evidence=""ECO:0007829|PDB:1EAK""; HELIX 397..408; /evidence=""ECO:0007829|PDB:3AYU""; HELIX 435..445; /evidence=""ECO:0007829|PDB:3AYU""; HELIX 509..511; /evidence=""ECO:0007829|PDB:1GEN""; HELIX 556..559; /evidence=""ECO:0007829|PDB:1GEN""; HELIX 606..609; /evidence=""ECO:0007829|PDB:1GEN""; HELIX 653..656; /evidence=""ECO:0007829|PDB:1GEN""","TURN 62..64; /evidence=""ECO:0007829|PDB:1CK7""; TURN 200..203; /evidence=""ECO:0007829|PDB:3AYU""; TURN 265..267; /evidence=""ECO:0007829|PDB:1EAK""; TURN 277..279; /evidence=""ECO:0007829|PDB:1EAK""; TURN 284..288; /evidence=""ECO:0007829|PDB:1EAK""; TURN 323..325; /evidence=""ECO:0007829|PDB:1EAK""; TURN 342..346; /evidence=""ECO:0007829|PDB:1EAK""; TURN 468..470; /evidence=""ECO:0007829|PDB:1GEN""; TURN 527..530; /evidence=""ECO:0007829|PDB:1GEN""; TURN 563..566; /evidence=""ECO:0007829|PDB:1GXD""; TURN 575..577; /evidence=""ECO:0007829|PDB:1GEN""; TURN 593..596; /evidence=""ECO:0007829|PDB:1GEN""; TURN 624..626; /evidence=""ECO:0007829|PDB:1GEN""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,MMP2 CLG4A,72 kDa type IV collagenase (EC 3.4.24.24) (72 kDa gelatinase) (Gelatinase A) (Matrix metalloproteinase-2) (MMP-2) (TBE-1) [Cleaved into: PEX],Homo sapiens (Human),660.0,73882.0,MEALMARGALTGPLRALCLLGCLLSHAAAAPSPIIKFPGDVAPKTDKELAVQYLNTFYGCPKESCNLFVLKDTLKKMQKFFGLPQTGDLDQNTIETMRKPRCGNPDVANYNFFPRKPKWDKNQITYRIIGYTPDLDPETVDDAFARAFQVWSDVTPLRFSRIHDGEADIMINFGRWEHGDGYPFDGKDGLLAHAFAPGTGVGGDSHFDDDELWTLGEGQVVRVKYGNADGEYCKFPFLFNGKEYNSCTDTGRSDGFLWCSTTYNFEKDGKYGFCPHEALFTMGGNAEGQPCKFPFRFQGTSYDSCTTEGRTDGYRWCGTTEDYDRDKKYGFCPETAMSTVGGNSEGAPCVFPFTFLGNKYESCTSAGRSDGKMWCATTANYDDDRKWGFCPDQGYSLFLVAAHEFGHAMGLEHSQDPGALMAPIYTYTKNFRLSQDDIKGIQELYGASPDIDLGTGPTPTLGPVTPEICKQDIVFDGIAQIRGEIFFFKDRFIWRTVTPRDKPMGPLLVATFWPELPEKIDAVYEAPQEEKAVFFAGNEYWIYSASTLERGYPKPLTSLGLPPDVQRVDAAFNWSKNKKTYIFAGDKFWRYNEVKKKMDPGFPKLIADAWNAIPDNLDAVVDLQGGGHSYFFKGAYYLKLENQSLKSVKFGSIKSDWLGC,True,False,False,P08253,"[('cd00062', 'FN2'), ('cd00094', 'HX'), ('cd04278', 'ZnMc_MMP'), ('G3DSA:2.10.10.10', 'Fibronectin, type II, collagen-binding'), ('G3DSA:2.110.10.10', 'Hemopexin-like domain'), ('G3DSA:3.40.390.10', 'Collagenase (Catalytic Domain)'), ('IPR000562', 'Fibronectin type II domain'), ('IPR000585', 'Hemopexin-like domain'), ('IPR001818', 'Peptidase M10, metallopeptidase'), ('IPR006026', 'Peptidase, metallopeptidase'), ('IPR013806', 'Kringle-like fold'), ('IPR018486', 'Hemopexin, conserved site'), ('IPR018487', 'Hemopexin-like repeats'), ('IPR021158', 'Peptidase M10A, cysteine switch, zinc binding site'), ('IPR021190', 'Peptidase M10A'), ('IPR024079', 'Metallopeptidase, catalytic domain superfamily'), ('IPR033739', 'Peptidase M10A, catalytic domain'), ('IPR036365', 'PGBD-like superfamily'), ('IPR036375', 'Hemopexin-like domain superfamily'), ('IPR036943', 'Fibronectin type II domain superfamily')]",,"""ENSG00000087245; Tissue enhanced (gallbladder)."";","CATALYTIC ACTIVITY: Reaction=Cleavage of gelatin type I and collagen types IV, V, VII, X. Cleaves the collagen-like sequence Pro-Gln-Gly-|-Ile-Ala-Gly-Gln.; EC=3.4.24.24; Evidence={ECO:0000305|PubMed:11179305, ECO:0000305|PubMed:11431697, ECO:0000305|PubMed:12147339, ECO:0000305|PubMed:2834383};",3.4.24.24,ACTIVITY REGULATION: Inhibited by histatin-3 1/24 (histatin-5). {ECO:0000269|PubMed:11179305}.,,ENST00000219070.9 [P08253-1];ENST00000437642.6 [P08253-3];ENST00000543485.5 [P08253-2];ENST00000570308.5 [P08253-2];,MMP2,ENSG00000087245,0.0,,,,1.67,DP03256,0.027,0.056,,MMP2
P08254,ENSG00000149968,MMP3_HUMAN,cellular response to amino acid stimulus [GO:0071230]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to nitric oxide [GO:0071732]; cellular response to reactive oxygen species [GO:0034614]; cellular response to UV-A [GO:0071492]; collagen catabolic process [GO:0030574]; extracellular matrix disassembly [GO:0022617]; extracellular matrix organization [GO:0030198]; innate immune response [GO:0045087]; negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051898]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; positive regulation of protein-containing complex assembly [GO:0031334]; protein catabolic process [GO:0030163]; proteolysis [GO:0006508]; regulation of cell migration [GO:0030334]; regulation of neuroinflammatory response [GO:0150077]; response to amyloid-beta [GO:1904645],cytosol [GO:0005829]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; mitochondrion [GO:0005739]; nucleus [GO:0005634],endopeptidase activity [GO:0004175]; metalloendopeptidase activity [GO:0004222]; metallopeptidase activity [GO:0008237]; peptidase activity [GO:0008233]; serine-type endopeptidase activity [GO:0004252]; zinc ion binding [GO:0008270],PTM: Directly cleaved by HTRA2 to produce active form. {ECO:0000269|PubMed:22265821}.,"DOMAIN: The conserved cysteine present in the cysteine-switch motif binds the catalytic zinc ion, thus inhibiting the enzyme. The dissociation of the cysteine from the zinc ion upon the activation-peptide release activates the enzyme.",,"STRAND 96..98; /evidence=""ECO:0007829|PDB:1SLM""; STRAND 102..104; /evidence=""ECO:0007829|PDB:7S7L""; STRAND 110..118; /evidence=""ECO:0007829|PDB:1HY7""; STRAND 123..125; /evidence=""ECO:0007829|PDB:1CAQ""; STRAND 144..146; /evidence=""ECO:0007829|PDB:2SRT""; STRAND 148..151; /evidence=""ECO:0007829|PDB:1HY7""; STRAND 153..155; /evidence=""ECO:0007829|PDB:1HY7""; STRAND 158..164; /evidence=""ECO:0007829|PDB:1HY7""; STRAND 169..171; /evidence=""ECO:0007829|PDB:1HY7""; STRAND 176..179; /evidence=""ECO:0007829|PDB:1HY7""; STRAND 182..184; /evidence=""ECO:0007829|PDB:1HY7""; STRAND 187..189; /evidence=""ECO:0007829|PDB:1HY7""; STRAND 195..198; /evidence=""ECO:0007829|PDB:1HY7""; STRAND 199..201; /evidence=""ECO:0007829|PDB:2SRT""; STRAND 203..211; /evidence=""ECO:0007829|PDB:1HY7""; STRAND 232..234; /evidence=""ECO:0007829|PDB:4JA1""; STRAND 237..239; /evidence=""ECO:0007829|PDB:1SLM""","HELIX 34..41; /evidence=""ECO:0007829|PDB:1SLM""; HELIX 58..70; /evidence=""ECO:0007829|PDB:1SLM""; HELIX 81..86; /evidence=""ECO:0007829|PDB:1SLM""; HELIX 127..142; /evidence=""ECO:0007829|PDB:1HY7""; HELIX 212..223; /evidence=""ECO:0007829|PDB:1HY7""; HELIX 240..243; /evidence=""ECO:0007829|PDB:1USN""; HELIX 246..248; /evidence=""ECO:0007829|PDB:1CIZ""; HELIX 253..263; /evidence=""ECO:0007829|PDB:1HY7""","TURN 190..193; /evidence=""ECO:0007829|PDB:1HY7""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,MMP3 STMY1,Stromelysin-1 (SL-1) (EC 3.4.24.17) (Matrix metalloproteinase-3) (MMP-3) (Transin-1),Homo sapiens (Human),477.0,53977.0,MKSLPILLLLCVAVCSAYPLDGAARGEDTSMNLVQKYLENYYDLKKDVKQFVRRKDSGPVVKKIREMQKFLGLEVTGKLDSDTLEVMRKPRCGVPDVGHFRTFPGIPKWRKTHLTYRIVNYTPDLPKDAVDSAVEKALKVWEEVTPLTFSRLYEGEADIMISFAVREHGDFYPFDGPGNVLAHAYAPGPGINGDAHFDDDEQWTKDTTGTNLFLVAAHEIGHSLGLFHSANTEALMYPLYHSLTDLTRFRLSQDDINGIQSLYGPPPDSPETPLVPTEPVPPEPGTPANCDPALSFDAVSTLRGEILIFKDRHFWRKSLRKLEPELHLISSFWPSLPSGVDAAYEVTSKDLVFIFKGNQFWAIRGNEVRAGYPRGIHTLGFPPTVRKIDAAISDKEKNKTYFFVEDKYWRFDEKRNSMEPGFPKQIAEDFPGIDSKIDAVFEEFGFFYFFTGSSQLEFDPNAKKVTHTLKSNSWLNC,False,True,False,P08254,"[('cd00094', 'HX'), ('cd04278', 'ZnMc_MMP'), ('G3DSA:2.110.10.10', 'Hemopexin-like domain'), ('G3DSA:3.40.390.10', 'Collagenase (Catalytic Domain)'), ('IPR000585', 'Hemopexin-like domain'), ('IPR001818', 'Peptidase M10, metallopeptidase'), ('IPR002477', 'Peptidoglycan binding-like'), ('IPR006026', 'Peptidase, metallopeptidase'), ('IPR018486', 'Hemopexin, conserved site'), ('IPR018487', 'Hemopexin-like repeats'), ('IPR021158', 'Peptidase M10A, cysteine switch, zinc binding site'), ('IPR021190', 'Peptidase M10A'), ('IPR024079', 'Metallopeptidase, catalytic domain superfamily'), ('IPR033739', 'Peptidase M10A, catalytic domain'), ('IPR036365', 'PGBD-like superfamily'), ('IPR036375', 'Hemopexin-like domain superfamily'), ('PF00045', 'Hemopexin'), ('PF00413', 'Matrixin'), ('PF01471', 'Putative peptidoglycan binding domain'), ('PIRSF001191', 'Matrix metalloproteinase, stromelysin type')]",,"""ENSG00000149968; Tissue enhanced (adipose tissue, salivary gland)."";","CATALYTIC ACTIVITY: Reaction=Preferential cleavage where P1', P2' and P3' are hydrophobic residues.; EC=3.4.24.17; Evidence={ECO:0000269|PubMed:1371271, ECO:0000269|PubMed:21330369};",3.4.24.17,ACTIVITY REGULATION: Enzymatic activity is activated by HTRA2 in dopaminergic cells upon mitochondrial stress. {ECO:0000269|PubMed:22265821}.,,ENST00000299855.10;,MMP3,ENSG00000149968,0.0,,,,,,,0.073,0.055,MMP3
P08621,ENSG00000104852,RU17_HUMAN,"mRNA splicing, via spliceosome [GO:0000398]; negative regulation of chaperone-mediated autophagy [GO:1904715]; negative regulation of protein refolding [GO:0061084]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; regulation of ATP-dependent activity [GO:0043462]; regulation of RNA splicing [GO:0043484]",nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U1 snRNP [GO:0005685]; U2-type prespliceosome [GO:0071004],mRNA binding [GO:0003729]; RNA binding [GO:0003723]; U1 snRNA binding [GO:0030619],PTM: The N-terminus is blocked.; PTM: Extensively phosphorylated on serine residues in the C-terminal region. {ECO:0000269|PubMed:8332490}.,"DOMAIN: The RRM domain mediates interaction with U1 RNA. {ECO:0000269|PubMed:2467746, ECO:0000269|PubMed:25555158}.","DOMAIN 103..181; /note=""RRM""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00176""","STRAND 104..109; /evidence=""ECO:0007829|PDB:4PKD""; STRAND 129..136; /evidence=""ECO:0007829|PDB:4PKD""; STRAND 143..153; /evidence=""ECO:0007829|PDB:4PKD""; STRAND 175..178; /evidence=""ECO:0007829|PDB:4PKD""","HELIX 7..10; /evidence=""ECO:0007829|PDB:7VPX""; HELIX 29..31; /evidence=""ECO:0007829|PDB:7VPX""; HELIX 42..44; /evidence=""ECO:0007829|PDB:7VPX""; HELIX 50..52; /evidence=""ECO:0007829|PDB:7VPX""; HELIX 63..86; /evidence=""ECO:0007829|PDB:4PKD""; HELIX 91..93; /evidence=""ECO:0007829|PDB:4PKD""; HELIX 101..103; /evidence=""ECO:0007829|PDB:4PKD""; HELIX 116..124; /evidence=""ECO:0007829|PDB:4PKD""; HELIX 154..163; /evidence=""ECO:0007829|PDB:4PKD""; HELIX 190..192; /evidence=""ECO:0007829|PDB:4PKD""","TURN 138..140; /evidence=""ECO:0007829|PDB:4PKD""; TURN 181..183; /evidence=""ECO:0007829|PDB:4PKD""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,SNRNP70 RNPU1Z RPU1 SNRP70 U1AP1,U1 small nuclear ribonucleoprotein 70 kDa (U1 snRNP 70 kDa) (U1-70K) (snRNP70),Homo sapiens (Human),437.0,51557.0,MTQFLPPNLLALFAPRDPIPYLPPLEKLPHEKHHNQPYCGIAPYIREFEDPRDAPPPTRAETREERMERKRREKIERRQQEVETELKMWDPHNDPNAQGDAFKTLFVARVNYDTTESKLRREFEVYGPIKRIHMVYSKRSGKPRGYAFIEYEHERDMHSAYKHADGKKIDGRRVLVDVERGRTVKGWRPRRLGGGLGGTRRGGADVNIRHSGRDDTSRYDERPGPSPLPHRDRDRDRERERRERSRERDKERERRRSRSRDRRRRSRSRDKEERRRSRERSKDKDRDRKRRSSRSRERARRERERKEELRGGGGDMAEPSEAGDAPPDDGPPGELGPDGPDGPEEKGRDRDRERRRSHRSERERRRDRDRDRDRDREHKRGERGSERGRDEARGGGGGQDNGLEGLGNDSRDMYMESEGGDGYLAPENGYLMEAAPE,False,False,True,P08621,"[('cd12236', 'RNA recognition motif (RRM) found in U1 small nuclear ribonucleoprotein 70 kDa (U1-70K) and similar proteins'), ('G3DSA:3.30.70.330', None), ('IPR000504', 'RNA recognition motif domain'), ('IPR012677', 'Nucleotide-binding alpha-beta plait domain superfamily'), ('IPR022023', 'U1 small nuclear ribonucleoprotein of 70kDa N-terminal'), ('IPR034143', 'snRNP70, RNA recognition motif'), ('IPR035979', 'RNA-binding domain superfamily'), ('IPR051183', 'U1 snRNP 70 kDa and U11/U12 snRNP 35 kDa'), ('PF00076', 'RNA recognition motif'), ('PF12220', 'U1 small nuclear ribonucleoprotein of 70kDa MW N terminal'), ('PS50102', 'Eukaryotic RNA Recognition Motif (RRM) profile'), ('PTHR13952', 'U1 snRNP 70 kDa and U11/U12 snRNP 35 kDa'), ('SM00360', 'RNA recognition motif'), ('SSF54928', 'RNA-binding domain, RBD')]",P08621;,"""ENSG00000104852; Low tissue specificity."";",,,,,ENST00000221448.9 [P08621-2];ENST00000401730.5 [P08621-3];ENST00000595231.5 [P08621-3];ENST00000598441.6 [P08621-1];ENST00000601065.5 [P08621-3];,SNRNP70,ENSG00000104852,0.0,SNRNP70,Canonical_RBPs,25.0,65.68,DP02171,0.76,0.648,0.648,SNRNP70
P08670,ENSG00000026025,VIME_HUMAN,astrocyte development [GO:0014002]; Bergmann glial cell differentiation [GO:0060020]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to muramyl dipeptide [GO:0071225]; cellular response to type II interferon [GO:0071346]; intermediate filament organization [GO:0045109]; lens fiber cell development [GO:0070307]; negative regulation of neuron projection development [GO:0010977]; neuron projection development [GO:0031175]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of gene expression [GO:0010628]; regulation of mRNA stability [GO:0043488],axon [GO:0030424]; cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; intermediate filament [GO:0005882]; intermediate filament cytoskeleton [GO:0045111]; microtubule organizing center [GO:0005815]; nuclear matrix [GO:0016363]; peroxisome [GO:0005777]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886],double-stranded RNA binding [GO:0003725]; identical protein binding [GO:0042802]; keratin filament binding [GO:1990254]; molecular adaptor activity [GO:0060090]; protein domain specific binding [GO:0019904]; scaffold protein binding [GO:0097110]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of eye lens [GO:0005212],"PTM: Filament disassembly during mitosis is promoted by phosphorylation at Ser-55 as well as by nestin (By similarity). One of the most prominent phosphoproteins in various cells of mesenchymal origin. Phosphorylation is enhanced during cell division, at which time vimentin filaments are significantly reorganized. Phosphorylation by PKN1 inhibits the formation of filaments. Phosphorylated at Ser-56 by CDK5 during neutrophil secretion in the cytoplasm (PubMed:21465480). Phosphorylated by STK33 (PubMed:18811945). Phosphorylated on tyrosine residues by SRMS (PubMed:29496907). {ECO:0000250|UniProtKB:P31000, ECO:0000269|PubMed:18811945, ECO:0000269|PubMed:21465480, ECO:0000269|PubMed:29496907, ECO:0000269|Ref.14}.; PTM: O-glycosylated during cytokinesis at sites identical or close to phosphorylation sites, this interferes with the phosphorylation status. {ECO:0000269|PubMed:20068230}.; PTM: S-nitrosylation is induced by interferon-gamma and oxidatively-modified low-densitity lipoprotein (LDL(ox)) possibly implicating the iNOS-S100A8/9 transnitrosylase complex. {ECO:0000305|PubMed:25417112}.",DOMAIN: The central alpha-helical coiled-coil IF rod domain mediates elementary homodimerization. {ECO:0000269|PubMed:20176112}.; DOMAIN: The [IL]-x-C-x-x-[DE] motif is a proposed target motif for cysteine S-nitrosylation mediated by the iNOS-S100A8/A9 transnitrosylase complex. {ECO:0000305|PubMed:25417112}.,"DOMAIN 103..411; /note=""IF rod""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU01188""","STRAND 238..241; /evidence=""ECO:0007829|PDB:4YPC""","HELIX 101..135; /evidence=""ECO:0007829|PDB:1GK7""; HELIX 167..235; /evidence=""ECO:0007829|PDB:4YPC""; HELIX 266..334; /evidence=""ECO:0007829|PDB:3TRT""; HELIX 385..405; /evidence=""ECO:0007829|PDB:1GK6""","TURN 244..248; /evidence=""ECO:0007829|PDB:3UF1""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,VIM,Vimentin,Homo sapiens (Human),466.0,53652.0,MSTRSVSSSSYRRMFGGPGTASRPSSSRSYVTTSTRTYSLGSALRPSTSRSLYASSPGGVYATRSSAVRLRSSVPGVRLLQDSVDFSLADAINTEFKNTRTNEKVELQELNDRFANYIDKVRFLEQQNKILLAELEQLKGQGKSRLGDLYEEEMRELRRQVDQLTNDKARVEVERDNLAEDIMRLREKLQEEMLQREEAENTLQSFRQDVDNASLARLDLERKVESLQEEIAFLKKLHEEEIQELQAQIQEQHVQIDVDVSKPDLTAALRDVRQQYESVAAKNLQEAEEWYKSKFADLSEAANRNNDALRQAKQESTEYRRQVQSLTCEVDALKGTNESLERQMREMEENFAVEAANYQDTIGRLQDEIQNMKEEMARHLREYQDLLNVKMALDIEIATYRKLLEGEESRISLPLPNFSSLNLRETNLDSLPLVDTHSKRTLLIKTVETRDGQVINETSQHHDDLE,False,False,True,P08670,"[('G3DSA:1.20.5.1160', 'Vasodilator-stimulated phosphoprotein'), ('G3DSA:1.20.5.170', None), ('G3DSA:1.20.5.500', 'Single helix bin'), ('IPR006821', 'Intermediate filament head, DNA-binding domain'), ('IPR018039', 'Intermediate filament protein, conserved site'), ('IPR039008', 'Intermediate filament, rod domain'), ('IPR050405', 'Intermediate filament structural protein'), ('PF00038', 'Intermediate filament protein'), ('PF04732', 'Intermediate filament head (DNA binding) region'), ('PS00226', 'Intermediate filament (IF) rod domain signature'), ('PS51842', 'Intermediate filament (IF) rod domain profile'), ('PTHR45652', 'Intermediate filament structural protein'), ('SM01391', 'Intermediate filament protein'), ('SSF64593', 'Intermediate filament protein, coiled coil region')]",,"""ENSG00000026025; Low tissue specificity."";",,,,,ENST00000224237.9;ENST00000544301.7;,VIM,ENSG00000026025,0.0,VIM,Non-canonical_RBPs,18.0,9.87,DP02862,0.099,0.433,0.069,VIM
P09038,ENSG00000138685,FGF2_HUMAN,angiogenesis involved in coronary vascular morphogenesis [GO:0060978]; animal organ morphogenesis [GO:0009887]; behavioral response to ethanol [GO:0048149]; branching involved in ureteric bud morphogenesis [GO:0001658]; canonical Wnt signaling pathway [GO:0060070]; cell differentiation [GO:0030154]; cell migration involved in sprouting angiogenesis [GO:0002042]; cellular response to mechanical stimulus [GO:0071260]; cerebellar granule cell precursor proliferation [GO:0021930]; chemotaxis [GO:0006935]; chondroblast differentiation [GO:0060591]; corticotropin hormone secreting cell differentiation [GO:0060128]; embryo development ending in birth or egg hatching [GO:0009792]; embryonic morphogenesis [GO:0048598]; endothelial cell proliferation [GO:0001935]; ERK1 and ERK2 cascade [GO:0070371]; fibroblast growth factor receptor signaling pathway [GO:0008543]; glial cell differentiation [GO:0010001]; growth factor dependent regulation of skeletal muscle satellite cell proliferation [GO:0014843]; hyaluronan catabolic process [GO:0030214]; inner ear auditory receptor cell differentiation [GO:0042491]; lung development [GO:0030324]; lymphatic endothelial cell migration [GO:1904977]; mammary gland epithelial cell differentiation [GO:0060644]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of fibroblast growth factor receptor signaling pathway [GO:0040037]; negative regulation of fibroblast migration [GO:0010764]; negative regulation of gene expression [GO:0010629]; negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903377]; negative regulation of stem cell proliferation [GO:2000647]; negative regulation of wound healing [GO:0061045]; nervous system development [GO:0007399]; neuroblast proliferation [GO:0007405]; organ induction [GO:0001759]; osteoblast differentiation [GO:0001649]; paracrine signaling [GO:0038001]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell division [GO:0051781]; positive regulation of cell fate specification [GO:0042660]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cerebellar granule cell precursor proliferation [GO:0021940]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis to fibroblast growth factor [GO:2000546]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of epithelial tube formation [GO:1905278]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of inner ear auditory receptor cell differentiation [GO:0045609]; positive regulation of lens fiber cell differentiation [GO:1902748]; positive regulation of MAP kinase activity [GO:0043406]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuroepithelial cell differentiation [GO:1902913]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of sprouting angiogenesis [GO:1903672]; positive regulation of stem cell differentiation [GO:2000738]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; Ras protein signal transduction [GO:0007265]; regulation of angiogenesis [GO:0045765]; regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:1903587]; regulation of cell cycle [GO:0051726]; regulation of cell migration [GO:0030334]; regulation of cell migration involved in sprouting angiogenesis [GO:0090049]; regulation of endothelial cell chemotaxis to fibroblast growth factor [GO:2000544]; regulation of retinal cell programmed cell death [GO:0046668]; release of sequestered calcium ion into cytosol [GO:0051209]; response to axon injury [GO:0048678]; signal transduction [GO:0007165]; stem cell development [GO:0048864]; stem cell proliferation [GO:0072089]; substantia nigra development [GO:0021762]; thyroid-stimulating hormone-secreting cell differentiation [GO:0060129]; transcription by RNA polymerase II [GO:0006366]; wound healing [GO:0042060],cytoplasm [GO:0005737]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; nucleus [GO:0005634],chemoattractant activity [GO:0042056]; chemokine binding [GO:0019956]; cytokine activity [GO:0005125]; fibroblast growth factor receptor binding [GO:0005104]; growth factor activity [GO:0008083]; H3K9me3 modified histone binding [GO:0062072]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; integrin binding [GO:0005178]; nuclear receptor coactivator activity [GO:0030374]; receptor-receptor interaction [GO:0090722],"PTM: Phosphorylation at Tyr-215 regulates FGF2 unconventional secretion. {ECO:0000269|PubMed:20230531}.; PTM: Several N-termini starting at positions 94, 125, 126, 132, 143 and 162 have been identified by direct sequencing.",,,"STRAND 136..139; /evidence=""ECO:0007829|PDB:1BLA""; STRAND 151..153; /evidence=""ECO:0007829|PDB:1BLA""; STRAND 163..167; /evidence=""ECO:0007829|PDB:8OM6""; STRAND 172..176; /evidence=""ECO:0007829|PDB:8OM6""; STRAND 182..186; /evidence=""ECO:0007829|PDB:8OM6""; STRAND 195..199; /evidence=""ECO:0007829|PDB:8OM6""; STRAND 201..203; /evidence=""ECO:0007829|PDB:1BLA""; STRAND 204..209; /evidence=""ECO:0007829|PDB:8OM6""; STRAND 214..218; /evidence=""ECO:0007829|PDB:8OM6""; STRAND 220..222; /evidence=""ECO:0007829|PDB:1BLA""; STRAND 224..229; /evidence=""ECO:0007829|PDB:8OM6""; STRAND 236..240; /evidence=""ECO:0007829|PDB:8OM6""; STRAND 246..253; /evidence=""ECO:0007829|PDB:8OM6""; STRAND 264..266; /evidence=""ECO:0007829|PDB:8OM6""; STRAND 281..285; /evidence=""ECO:0007829|PDB:8OM6""","HELIX 156..160; /evidence=""ECO:0007829|PDB:4OEE""; HELIX 191..193; /evidence=""ECO:0007829|PDB:8OM6""; HELIX 232..234; /evidence=""ECO:0007829|PDB:8OM6""; HELIX 242..244; /evidence=""ECO:0007829|PDB:2FGF""; HELIX 269..271; /evidence=""ECO:0007829|PDB:8OM6""; HELIX 277..279; /evidence=""ECO:0007829|PDB:8OM6""","TURN 168..171; /evidence=""ECO:0007829|PDB:8OM6""; TURN 210..213; /evidence=""ECO:0007829|PDB:8OM6""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,FGF2 FGFB,Fibroblast growth factor 2 (FGF-2) (Basic fibroblast growth factor) (bFGF) (Heparin-binding growth factor 2) (HBGF-2),Homo sapiens (Human),288.0,30770.0,MVGVGGGDVEDVTPRPGGCQISGRGARGCNGIPGAAAWEAALPRRRPRRHPSVNPRSRAAGSPRTRGRRTEERPSGSRLGDRGRGRALPGGRLGGRGRGRAPERVGGRGRGRGTAAPRAAPAARGSRPGPAGTMAAGSITTLPALPEDGGSGAFPPGHFKDPKRLYCKNGGFFLRIHPDGRVDGVREKSDPHIKLQLQAEERGVVSIKGVCANRYLAMKEDGRLLASKCVTDECFFFERLESNNYNTYRSRKYTSWYVALKRTGQYKLGSKTGPGQKAILFLPMSAKS,True,True,False,P09038,"[('cd00058', 'FGF'), ('G3DSA:2.80.10.50', None), ('IPR002209', 'Fibroblast growth factor family'), ('IPR008996', 'Cytokine IL1/FGF'), ('PF00167', 'Fibroblast growth factor'), ('PR00262', 'IL1HBGF'), ('PR00263', 'HBGFFGF'), ('PS00247', 'HBGF/FGF family signature'), ('PTHR11486', 'FIBROBLAST GROWTH FACTOR'), ('SM00442', 'Acidic and basic fibroblast growth factor family.'), ('SSF50353', 'Cytokine')]",,"""ENSG00000138685; Low tissue specificity."";",,,,,ENST00000264498.9 [P09038-4];ENST00000608478.1 [P09038-2];ENST00000644866.2 [P09038-2];,FGF2,ENSG00000138685,0.0,,,,6.25,DP01644,0.097,0.517,0.462,FGF2
P09104,ENSG00000111674,ENOG_HUMAN,canonical glycolysis [GO:0061621]; gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096],cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; membrane [GO:0016020]; perikaryon [GO:0043204]; phosphopyruvate hydratase complex [GO:0000015]; photoreceptor inner segment [GO:0001917]; plasma membrane [GO:0005886],magnesium ion binding [GO:0000287]; phosphopyruvate hydratase activity [GO:0004634],,,,"STRAND 5..12; /evidence=""ECO:0007829|PDB:2AKZ""; STRAND 18..26; /evidence=""ECO:0007829|PDB:2AKZ""; STRAND 29..34; /evidence=""ECO:0007829|PDB:2AKZ""; STRAND 43..45; /evidence=""ECO:0007829|PDB:5TD9""; STRAND 100..102; /evidence=""ECO:0007829|PDB:5TD9""; STRAND 147..154; /evidence=""ECO:0007829|PDB:2AKZ""; STRAND 159..162; /evidence=""ECO:0007829|PDB:2AKZ""; STRAND 167..171; /evidence=""ECO:0007829|PDB:2AKZ""; STRAND 211..213; /evidence=""ECO:0007829|PDB:3UJF""; STRAND 241..245; /evidence=""ECO:0007829|PDB:2AKZ""; STRAND 254..257; /evidence=""ECO:0007829|PDB:2AKM""; STRAND 289..293; /evidence=""ECO:0007829|PDB:2AKZ""; STRAND 312..318; /evidence=""ECO:0007829|PDB:2AKZ""; STRAND 338..342; /evidence=""ECO:0007829|PDB:2AKZ""; STRAND 366..370; /evidence=""ECO:0007829|PDB:2AKZ""; STRAND 391..394; /evidence=""ECO:0007829|PDB:2AKZ""","HELIX 57..59; /evidence=""ECO:0007829|PDB:2AKZ""; HELIX 63..71; /evidence=""ECO:0007829|PDB:2AKZ""; HELIX 73..80; /evidence=""ECO:0007829|PDB:2AKZ""; HELIX 87..98; /evidence=""ECO:0007829|PDB:2AKZ""; HELIX 108..126; /evidence=""ECO:0007829|PDB:2AKZ""; HELIX 130..138; /evidence=""ECO:0007829|PDB:2AKZ""; HELIX 156..158; /evidence=""ECO:0007829|PDB:2AKZ""; HELIX 178..200; /evidence=""ECO:0007829|PDB:2AKZ""; HELIX 202..205; /evidence=""ECO:0007829|PDB:2AKZ""; HELIX 220..234; /evidence=""ECO:0007829|PDB:2AKZ""; HELIX 248..251; /evidence=""ECO:0007829|PDB:2AKZ""; HELIX 267..269; /evidence=""ECO:0007829|PDB:2AKZ""; HELIX 273..286; /evidence=""ECO:0007829|PDB:2AKZ""; HELIX 301..309; /evidence=""ECO:0007829|PDB:2AKZ""; HELIX 325..333; /evidence=""ECO:0007829|PDB:2AKZ""; HELIX 344..347; /evidence=""ECO:0007829|PDB:2AKZ""; HELIX 350..362; /evidence=""ECO:0007829|PDB:2AKZ""; HELIX 380..388; /evidence=""ECO:0007829|PDB:2AKZ""; HELIX 401..417; /evidence=""ECO:0007829|PDB:2AKZ""; HELIX 418..420; /evidence=""ECO:0007829|PDB:2AKZ""; HELIX 425..427; /evidence=""ECO:0007829|PDB:2AKZ""; HELIX 431..433; /evidence=""ECO:0007829|PDB:2AKZ""","TURN 54..56; /evidence=""ECO:0007829|PDB:5TD9""; TURN 104..106; /evidence=""ECO:0007829|PDB:2AKZ""; TURN 237..239; /evidence=""ECO:0007829|PDB:2AKZ""; TURN 259..262; /evidence=""ECO:0007829|PDB:2AKZ""; TURN 319..323; /evidence=""ECO:0007829|PDB:2AKZ""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,ENO2,Gamma-enolase (EC 4.2.1.11) (2-phospho-D-glycerate hydro-lyase) (Enolase 2) (Neural enolase) (Neuron-specific enolase) (NSE),Homo sapiens (Human),434.0,47269.0,MSIEKIWAREILDSRGNPTVEVDLYTAKGLFRAAVPSGASTGIYEALELRDGDKQRYLGKGVLKAVDHINSTIAPALISSGLSVVEQEKLDNLMLELDGTENKSKFGANAILGVSLAVCKAGAAERELPLYRHIAQLAGNSDLILPVPAFNVINGGSHAGNKLAMQEFMILPVGAESFRDAMRLGAEVYHTLKGVIKDKYGKDATNVGDEGGFAPNILENSEALELVKEAIDKAGYTEKIVIGMDVAASEFYRDGKYDLDFKSPTDPSRYITGDQLGALYQDFVRDYPVVSIEDPFDQDDWAAWSKFTANVGIQIVGDDLTVTNPKRIERAVEEKACNCLLLKVNQIGSVTEAIQACKLAQENGWGVMVSHRSGETEDTFIADLVVGLCTGQIKTGAPCRSERLAKYNQLMRIEEELGDEARFAGHNFRNPSVL,True,False,False,P09104,"[('cd03313', 'enolase'), ('G3DSA:3.20.20.120', 'Enolase-like C-terminal domain'), ('G3DSA:3.30.390.10', 'Enolase-like, N-terminal domain'), ('IPR000941', 'Enolase'), ('IPR020809', 'Enolase, conserved site'), ('IPR020810', 'Enolase, C-terminal TIM barrel domain'), ('IPR020811', 'Enolase, N-terminal'), ('IPR029017', 'Enolase-like, N-terminal'), ('IPR036849', 'Enolase-like, C-terminal domain superfamily'), ('MF_00318', 'Enolase [eno]'), ('PF00113', 'Enolase, C-terminal TIM barrel domain'), ('PF03952', 'Enolase, N-terminal domain'), ('PIRSF001400', 'Enolase'), ('PR00148', 'ENOLASE'), ('PS00164', 'Enolase signature'), ('PTHR11902', 'ENOLASE'), ('SFLDF00002', 'enolase'), ('SFLDS00001', 'Enolase'), ('SM01192', 'Enolase, C-terminal TIM barrel domain'), ('SM01193', 'Enolase, N-terminal domain')]",,"""ENSG00000111674; Group enriched (brain, retina)."";","CATALYTIC ACTIVITY: Reaction=(2R)-2-phosphoglycerate = phosphoenolpyruvate + H2O; Xref=Rhea:RHEA:10164, ChEBI:CHEBI:15377, ChEBI:CHEBI:58289, ChEBI:CHEBI:58702; EC=4.2.1.11;",4.2.1.11,,PATHWAY: Carbohydrate degradation; glycolysis; pyruvate from D-glyceraldehyde 3-phosphate: step 4/5.,ENST00000229277.6 [P09104-1];ENST00000535366.5 [P09104-1];ENST00000538763.5 [P09104-2];ENST00000541477.5 [P09104-1];,ENO2,ENSG00000111674,0.0,,,,,,,,,ENO2
P09382,ENSG00000100097,LEG1_HUMAN,apoptotic process [GO:0006915]; cell-cell adhesion [GO:0098609]; myoblast differentiation [GO:0045445]; negative regulation of T-helper 17 cell lineage commitment [GO:2000329]; plasma cell differentiation [GO:0002317]; positive regulation of apoptotic process [GO:0043065]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of inflammatory response [GO:0050729]; positive regulation of viral entry into host cell [GO:0046598]; regulation of apoptotic process [GO:0042981]; T cell costimulation [GO:0031295],collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; galectin complex [GO:1990724]; plasma membrane [GO:0005886],lactose binding [GO:0030395]; laminin binding [GO:0043236]; receptor ligand activity [GO:0048018]; RNA binding [GO:0003723],,,"DOMAIN 4..135; /note=""Galectin""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00639""","STRAND 3..12; /evidence=""ECO:0007829|PDB:4Q27""; STRAND 18..24; /evidence=""ECO:0007829|PDB:4Q27""; STRAND 30..38; /evidence=""ECO:0007829|PDB:4Q27""; STRAND 41..52; /evidence=""ECO:0007829|PDB:4Q27""; STRAND 55..65; /evidence=""ECO:0007829|PDB:4Q27""; STRAND 73..76; /evidence=""ECO:0007829|PDB:4Y1U""; STRAND 84..92; /evidence=""ECO:0007829|PDB:4Q27""; STRAND 94..100; /evidence=""ECO:0007829|PDB:4Q27""; STRAND 106..110; /evidence=""ECO:0007829|PDB:4Q27""; STRAND 116..133; /evidence=""ECO:0007829|PDB:4Q27""","HELIX 102..104; /evidence=""ECO:0007829|PDB:4Q27""",,"cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,LGALS1,Galectin-1 (Gal-1) (14 kDa laminin-binding protein) (HLBP14) (14 kDa lectin) (Beta-galactoside-binding lectin L-14-I) (Galaptin) (HBL) (HPL) (Lactose-binding lectin 1) (Lectin galactoside-binding soluble 1) (Putative MAPK-activating protein PM12) (S-Lac lectin 1),Homo sapiens (Human),135.0,14716.0,MACGLVASNLNLKPGECLRVRGEVAPDAKSFVLNLGKDSNNLCLHFNPRFNAHGDANTIVCNSKDGGAWGTEQREAVFPFQPGSVAEVCITFDQANLTVKLPDGYEFKFPNRLNLEAINYMAADGDFKIKCVAFD,True,False,True,P09382,"[('cd00070', 'GLECT'), ('G3DSA:2.60.120.200', None), ('IPR001079', 'Galectin, carbohydrate recognition domain'), ('IPR013320', 'Concanavalin A-like lectin/glucanase domain superfamily'), ('IPR044156', 'Galectin-like'), ('PF00337', 'Galactoside-binding lectin'), ('PS51304', 'Galactoside-binding lectin (galectin) domain profile'), ('PTHR11346', 'GALECTIN'), ('SM00276', 'Galectin'), ('SM00908', 'Galactoside-binding lectin'), ('SSF49899', 'Concanavalin A-like lectins/glucanases')]",,"""ENSG00000100097; Low tissue specificity."";",,,,,ENST00000215909.10;,LGALS1,ENSG00000100097,0.0,LGALS1,Non-canonical_RBPs,8.0,,,,,,LGALS1
P09429,ENSG00000189403,HMGB1_HUMAN,"activation of innate immune response [GO:0002218]; apoptotic cell clearance [GO:0043277]; autophagy [GO:0006914]; cellular response to lipopolysaccharide [GO:0071222]; dendritic cell chemotaxis [GO:0002407]; DNA geometric change [GO:0032392]; DNA recombination [GO:0006310]; DNA topological change [GO:0006265]; double-strand break repair via nonhomologous end joining [GO:0006303]; heterochromatin formation [GO:0031507]; inflammatory response [GO:0006954]; inflammatory response to antigenic stimulus [GO:0002437]; innate immune response [GO:0045087]; myeloid dendritic cell activation [GO:0001773]; negative regulation of apoptotic cell clearance [GO:2000426]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of CD4-positive, alpha-beta T cell differentiation [GO:0043371]; negative regulation of RNA polymerase II transcription preinitiation complex assembly [GO:0017055]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of type II interferon production [GO:0032689]; neuron projection development [GO:0031175]; neutrophil clearance [GO:0097350]; positive regulation of activated T cell proliferation [GO:0042104]; positive regulation of apoptotic process [GO:0043065]; positive regulation of autophagy [GO:0010508]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of chemokine (C-X-C motif) ligand 2 production [GO:2000343]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of dendritic cell differentiation [GO:2001200]; positive regulation of DNA binding [GO:0043388]; positive regulation of DNA ligation [GO:0051106]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of interleukin-1 production [GO:0032732]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of JNK cascade [GO:0046330]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of mismatch repair [GO:0032425]; positive regulation of monocyte chemotaxis [GO:0090026]; positive regulation of toll-like receptor 9 signaling pathway [GO:0034165]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; positive regulation of viral entry into host cell [GO:0046598]; regulation of restriction endodeoxyribonuclease activity [GO:0032072]; regulation of T cell mediated immune response to tumor cell [GO:0002840]; regulation of tolerance induction [GO:0002643]; regulation of transcription by RNA polymerase II [GO:0006357]; T-helper 1 cell activation [GO:0035711]; T-helper 1 cell differentiation [GO:0045063]; V(D)J recombination [GO:0033151]",alphav-beta3 integrin-HMGB1 complex [GO:0035868]; cell surface [GO:0009986]; condensed chromosome [GO:0000793]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; endosome [GO:0005768]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; secretory granule lumen [GO:0034774]; transcription repressor complex [GO:0017053],"bubble DNA binding [GO:0000405]; C-X-C chemokine binding [GO:0019958]; chemoattractant activity [GO:0042056]; cytokine activity [GO:0005125]; damaged DNA binding [GO:0003684]; DNA binding, bending [GO:0008301]; DNA polymerase binding [GO:0070182]; DNA-binding transcription factor binding [GO:0140297]; double-stranded DNA binding [GO:0003690]; four-way junction DNA binding [GO:0000400]; integrin binding [GO:0005178]; lipopolysaccharide binding [GO:0001530]; lyase activity [GO:0016829]; phosphatidylserine binding [GO:0001786]; RAGE receptor binding [GO:0050786]; receptor ligand activity [GO:0048018]; RNA binding [GO:0003723]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; single-stranded DNA binding [GO:0003697]; supercoiled DNA binding [GO:0097100]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]","PTM: Phosphorylated at serine residues. Phosphorylation in both NLS regions is required for cytoplasmic translocation followed by secretion (PubMed:17114460). {ECO:0000269|PubMed:17114460}.; PTM: Acetylated on multiple sites upon stimulation with LPS (PubMed:22801494). Acetylation on lysine residues in the nuclear localization signals (NLS 1 and NLS 2) leads to cytoplasmic localization and subsequent secretion (By similarity). Acetylation on Lys-3 results in preferential binding to DNA ends and impairs DNA bending activity (By similarity). {ECO:0000250|UniProtKB:P10103, ECO:0000250|UniProtKB:P63159, ECO:0000269|PubMed:22801494}.; PTM: Reduction/oxidation of cysteine residues Cys-23, Cys-45 and Cys-106 and a possible intramolecular disulfide bond involving Cys-23 and Cys-45 give rise to different redox forms with specific functional activities in various cellular compartments: 1- fully reduced HMGB1 (HMGB1C23hC45hC106h), 2- disulfide HMGB1 (HMGB1C23-C45C106h) and 3- sulfonyl HMGB1 (HMGB1C23soC45soC106so). {ECO:0000269|PubMed:16962095, ECO:0000269|PubMed:19811284, ECO:0000269|PubMed:22869893, ECO:0000305|PubMed:24531895}.; PTM: Poly-ADP-ribosylated by PARP1 when secreted following stimulation with LPS (By similarity). {ECO:0000250|UniProtKB:P63158}.; PTM: In vitro cleavage by CASP1 is liberating a HMG box 1-containing peptide which may mediate immunogenic activity; the peptide antagonizes apoptosis-induced immune tolerance (PubMed:24474694). Can be proteolytically cleaved by a thrombin:thrombomodulin complex; reduces binding to heparin and pro-inflammatory activities (By similarity). {ECO:0000250|UniProtKB:P10103, ECO:0000269|PubMed:24474694}.; PTM: Forms covalent cross-links mediated by transglutaminase TGM2, between a glutamine and the epsilon-amino group of a lysine residue, forming homopolymers and heteropolymers. {ECO:0000269|PubMed:29618516}.","DOMAIN: HMG box 2 mediates pro-inflammatory cytokine-stimulating activity and binding to TLR4 (PubMed:12765338, PubMed:20547845). However, not involved in mediating immunogenic activity in the context of apoptosis-induced immune tolerance (PubMed:24474694). {ECO:0000269|PubMed:12765338, ECO:0000269|PubMed:20547845, ECO:0000269|PubMed:24474694}.; DOMAIN: The acidic C-terminal domain forms a flexible structure which can reversibly interact intramolecularily with the HMG boxes and modulate binding to DNA and other proteins (PubMed:23063560). {ECO:0000250|UniProtKB:P63159, ECO:0000305|PubMed:23063560}.",,"STRAND 1..3; /evidence=""ECO:0007829|PDB:2YRQ""; STRAND 6..8; /evidence=""ECO:0007829|PDB:2YRQ""; STRAND 31..33; /evidence=""ECO:0007829|PDB:6CIK""; STRAND 92..94; /evidence=""ECO:0007829|PDB:2YRQ""; STRAND 118..120; /evidence=""ECO:0007829|PDB:2YRQ""","HELIX 20..30; /evidence=""ECO:0007829|PDB:6CIK""; HELIX 38..47; /evidence=""ECO:0007829|PDB:6CIK""; HELIX 54..76; /evidence=""ECO:0007829|PDB:2LY4""; HELIX 101..116; /evidence=""ECO:0007829|PDB:6CIK""; HELIX 122..135; /evidence=""ECO:0007829|PDB:6CIK""; HELIX 138..140; /evidence=""ECO:0007829|PDB:2YRQ""; HELIX 142..157; /evidence=""ECO:0007829|PDB:6CIK""",,"cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,HMGB1 HMG1,High mobility group protein B1 (High mobility group protein 1) (HMG-1),Homo sapiens (Human),215.0,24894.0,MGKGDPKKPRGKMSSYAFFVQTCREEHKKKHPDASVNFSEFSKKCSERWKTMSAKEKGKFEDMAKADKARYEREMKTYIPPKGETKKKFKDPNAPKRPPSAFFLFCSEYRPKIKGEHPGLSIGDVAKKLGEMWNNTAADDKQPYEKKAAKLKEKYEKDIAAYRAKGKPDAAKKGVVKAEKSKKKKEEEEDEEDEEDEEEEEDEEDEDEEEDDDDE,True,True,False,P09429,"[('cd21978', 'first high mobility group (HMG)-box found in the high mobility group protein B (HMGB) family'), ('cd21979', 'second high mobility group (HMG)-box found in the high mobility group protein B (HMGB) family'), ('G3DSA:1.10.30.10', 'High mobility group box domain'), ('IPR009071', 'High mobility group box domain'), ('IPR017967', 'HMG box A DNA-binding domain, conserved site'), ('IPR036910', 'High mobility group box domain superfamily'), ('IPR050342', 'High Mobility Group Box (HMGB)'), ('PF00505', 'HMG (high mobility group) box'), ('PF09011', 'HMG-box domain'), ('PR00886', 'HIGHMOBLTY12'), ('PS00353', 'HMG box A DNA-binding domain signature'), ('PS50118', 'HMG boxes A and B DNA-binding domains profile'), ('PTHR48112', 'High Mobility Group Box (HMGB)'), ('SM00398', 'high mobility group'), ('SSF47095', 'HMG-box')]",,"""ENSG00000189403; Low tissue specificity."";",,,,,ENST00000339872.8;ENST00000341423.10;ENST00000399494.5;ENST00000405805.5;,HMGB1,ENSG00000189403,0.0,HMGB1,Non-canonical_RBPs,12.0,22.79,DP01493,0.228,0.33,0.349,HMGB1
P09467,ENSG00000165140,F16P1_HUMAN,"cellular hyperosmotic salinity response [GO:0071475]; cellular hypotonic salinity response [GO:0071477]; cellular response to cAMP [GO:0071320]; cellular response to insulin stimulus [GO:0032869]; cellular response to magnesium ion [GO:0071286]; cellular response to phorbol 13-acetate 12-myristate [GO:1904628]; cellular response to raffinose [GO:0097403]; cellular response to xenobiotic stimulus [GO:0071466]; dephosphorylation [GO:0016311]; fructose 1,6-bisphosphate metabolic process [GO:0030388]; fructose 6-phosphate metabolic process [GO:0006002]; fructose metabolic process [GO:0006000]; gluconeogenesis [GO:0006094]; negative regulation of cell growth [GO:0030308]; negative regulation of glycolytic process [GO:0045820]; negative regulation of Ras protein signal transduction [GO:0046580]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of gluconeogenesis [GO:0006111]; response to nutrient levels [GO:0031667]; sucrose biosynthetic process [GO:0005986]",cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634],"AMP binding [GO:0016208]; fructose 1,6-bisphosphate 1-phosphatase activity [GO:0042132]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; monosaccharide binding [GO:0048029]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]",,,,"STRAND 92..97; /evidence=""ECO:0007829|PDB:7WJV""; STRAND 100..102; /evidence=""ECO:0007829|PDB:7CWE""; STRAND 111..119; /evidence=""ECO:0007829|PDB:7WJV""; STRAND 133..141; /evidence=""ECO:0007829|PDB:7WJV""; STRAND 145..147; /evidence=""ECO:0007829|PDB:5PZW""; STRAND 161..178; /evidence=""ECO:0007829|PDB:7WJV""; STRAND 181..187; /evidence=""ECO:0007829|PDB:7WJV""; STRAND 194..198; /evidence=""ECO:0007829|PDB:7WJV""; STRAND 208..211; /evidence=""ECO:0007829|PDB:7WJV""; STRAND 235..237; /evidence=""ECO:0007829|PDB:7CVH""; STRAND 262..265; /evidence=""ECO:0007829|PDB:7WJV""; STRAND 269..271; /evidence=""ECO:0007829|PDB:7C9Q""; STRAND 275..277; /evidence=""ECO:0007829|PDB:7WJV""; STRAND 295..297; /evidence=""ECO:0007829|PDB:7WJV""; STRAND 299..302; /evidence=""ECO:0007829|PDB:7WJV""; STRAND 317..320; /evidence=""ECO:0007829|PDB:7WJV""","HELIX 14..25; /evidence=""ECO:0007829|PDB:7WJV""; HELIX 30..49; /evidence=""ECO:0007829|PDB:7WJV""; HELIX 54..57; /evidence=""ECO:0007829|PDB:7WJV""; HELIX 71..87; /evidence=""ECO:0007829|PDB:7WJV""; HELIX 108..110; /evidence=""ECO:0007829|PDB:7WJV""; HELIX 150..153; /evidence=""ECO:0007829|PDB:7WJV""; HELIX 157..159; /evidence=""ECO:0007829|PDB:7WJV""; HELIX 214..219; /evidence=""ECO:0007829|PDB:7WJV""; HELIX 222..232; /evidence=""ECO:0007829|PDB:7WJV""; HELIX 249..259; /evidence=""ECO:0007829|PDB:7WJV""; HELIX 282..291; /evidence=""ECO:0007829|PDB:7WJV""; HELIX 303..305; /evidence=""ECO:0007829|PDB:7WJV""; HELIX 322..334; /evidence=""ECO:0007829|PDB:7WJV""","TURN 50..53; /evidence=""ECO:0007829|PDB:7WJV""; TURN 58..61; /evidence=""ECO:0007829|PDB:7WJV""; TURN 88..90; /evidence=""ECO:0007829|PDB:7WJV""; TURN 124..130; /evidence=""ECO:0007829|PDB:7WJV""; TURN 189..191; /evidence=""ECO:0007829|PDB:7WJV""; TURN 278..281; /evidence=""ECO:0007829|PDB:7WJV""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,FBP1 FBP,"Fructose-1,6-bisphosphatase 1 (FBPase 1) (EC 3.1.3.11) (D-fructose-1,6-bisphosphate 1-phosphohydrolase 1) (Liver FBPase)",Homo sapiens (Human),338.0,36842.0,MADQAPFDTDVNTLTRFVMEEGRKARGTGELTQLLNSLCTAVKAISSAVRKAGIAHLYGIAGSTNVTGDQVKKLDVLSNDLVMNMLKSSFATCVLVSEEDKHAIIVEPEKRGKYVVCFDPLDGSSNIDCLVSVGTIFGIYRKKSTDEPSEKDALQPGRNLVAAGYALYGSATMLVLAMDCGVNCFMLDPAIGEFILVDKDVKIKKKGKIYSLNEGYARDFDPAVTEYIQRKKFPPDNSAPYGARYVGSMVADVHRTLVYGGIFLYPANKKSPNGKLRLLYECNPMAYVMEKAGGMATTGKEAVLDVIPTDIHQRAPVILGSPDDVLEFLKVYEKHSAQ,False,True,False,P09467,"[('cd00354', 'FBPase'), ('G3DSA:3.30.540.10', 'Fructose-1,6-Bisphosphatase, subunit A, domain 1'), ('G3DSA:3.40.190.80', None), ('IPR000146', 'Fructose-1,6-bisphosphatase class 1'), ('IPR020548', 'Fructose-1,6-bisphosphatase, active site'), ('IPR028343', 'Fructose-1,6-bisphosphatase'), ('IPR033391', 'Fructose-1-6-bisphosphatase class I, N-terminal'), ('IPR044015', 'Fructose-1-6-bisphosphatase class 1, C-terminal'), ('MF_01855', 'Fructose-1,6-bisphosphatase class 1 [fbp]'), ('PF00316', 'Fructose-1-6-bisphosphatase, N-terminal domain'), ('PF18913', 'Fructose-1-6-bisphosphatase, C-terminal domain'), ('PIRSF000904', 'Fructose-1,6-bisphosphatase/sedoheptulose-1,7-bisphosphatase'), ('PIRSF500210', 'Fructose-1,6-bisphosphatase'), ('PR00115', 'F16BPHPHTASE'), ('PS00124', 'Fructose-1-6-bisphosphatase active site'), ('PTHR11556', 'FRUCTOSE-1,6-BISPHOSPHATASE-RELATED'), ('SSF56655', 'Carbohydrate phosphatase')]",,"""ENSG00000165140; Tissue enhanced (intestine, kidney, liver)."";","CATALYTIC ACTIVITY: Reaction=beta-D-fructose 1,6-bisphosphate + H2O = beta-D-fructose 6-phosphate + phosphate; Xref=Rhea:RHEA:11064, ChEBI:CHEBI:15377, ChEBI:CHEBI:32966, ChEBI:CHEBI:43474, ChEBI:CHEBI:57634; EC=3.1.3.11; Evidence={ECO:0000269|PubMed:17350621, ECO:0000269|PubMed:8387495};",3.1.3.11,"ACTIVITY REGULATION: Subject to complex allosteric regulation. The enzyme can assume an active R-state, or an inactive T-state. Intermediate conformations may exist. AMP acts as an allosteric inhibitor. AMP binding affects the turnover of bound substrate and not the affinity for substrate. Fructose 2,6-bisphosphate acts as a competitive inhibitor. Fructose 2,6-bisphosphate and AMP have synergistic effects. {ECO:0000269|PubMed:16442285, ECO:0000269|PubMed:16446092, ECO:0000269|PubMed:17350621, ECO:0000269|PubMed:18650089, ECO:0000269|PubMed:7809062}.",PATHWAY: Carbohydrate biosynthesis; gluconeogenesis.,ENST00000375326.9;ENST00000415431.5;,FBP1,ENSG00000165140,0.0,,,,,,,0.033,,FBP1
P09622,ENSG00000091140,DLDH_HUMAN,"acetyl-CoA biosynthetic process from pyruvate [GO:0006086]; branched-chain amino acid catabolic process [GO:0009083]; gastrulation [GO:0007369]; mitochondrial electron transport, NADH to ubiquinone [GO:0006120]; proteolysis [GO:0006508]; regulation of membrane potential [GO:0042391]; sperm capacitation [GO:0048240]",acetyltransferase complex [GO:1902493]; acrosomal matrix [GO:0043159]; branched-chain alpha-ketoacid dehydrogenase complex [GO:0160157]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; motile cilium [GO:0031514]; nucleus [GO:0005634]; oxoadipate dehydrogenase complex [GO:0160167]; oxoglutarate dehydrogenase complex [GO:0045252]; pyruvate dehydrogenase complex [GO:0045254],dihydrolipoyl dehydrogenase activity [GO:0004148]; flavin adenine dinucleotide binding [GO:0050660],PTM: Tyrosine phosphorylated. {ECO:0000250|UniProtKB:Q811C4}.,,,"STRAND 40..47; /evidence=""ECO:0007829|PDB:6I4R""; STRAND 67..71; /evidence=""ECO:0007829|PDB:6I4R""; STRAND 73..77; /evidence=""ECO:0007829|PDB:6I4R""; STRAND 111..114; /evidence=""ECO:0007829|PDB:6I4R""; STRAND 116..118; /evidence=""ECO:0007829|PDB:6I4R""; STRAND 148..158; /evidence=""ECO:0007829|PDB:6I4R""; STRAND 161..165; /evidence=""ECO:0007829|PDB:6I4R""; STRAND 171..181; /evidence=""ECO:0007829|PDB:6I4R""; STRAND 185..187; /evidence=""ECO:0007829|PDB:6I4R""; STRAND 197..201; /evidence=""ECO:0007829|PDB:6I4R""; STRAND 214..219; /evidence=""ECO:0007829|PDB:6I4R""; STRAND 238..242; /evidence=""ECO:0007829|PDB:6I4R""; STRAND 244..249; /evidence=""ECO:0007829|PDB:6I4R""; STRAND 271..273; /evidence=""ECO:0007829|PDB:6I4R""; STRAND 275..283; /evidence=""ECO:0007829|PDB:6I4R""; STRAND 289..295; /evidence=""ECO:0007829|PDB:6I4R""; STRAND 302..311; /evidence=""ECO:0007829|PDB:6I4R""; STRAND 315..317; /evidence=""ECO:0007829|PDB:6I4R""; STRAND 350..352; /evidence=""ECO:0007829|PDB:6I4R""; STRAND 357..359; /evidence=""ECO:0007829|PDB:6I4R""; STRAND 391..393; /evidence=""ECO:0007829|PDB:6I4R""; STRAND 395..403; /evidence=""ECO:0007829|PDB:6I4R""; STRAND 416..422; /evidence=""ECO:0007829|PDB:6I4R""; STRAND 438..444; /evidence=""ECO:0007829|PDB:6I4R""; STRAND 449..457; /evidence=""ECO:0007829|PDB:6I4R""","HELIX 51..62; /evidence=""ECO:0007829|PDB:6I4R""; HELIX 78..83; /evidence=""ECO:0007829|PDB:6I4R""; HELIX 85..102; /evidence=""ECO:0007829|PDB:6I4R""; HELIX 105..108; /evidence=""ECO:0007829|PDB:6I4R""; HELIX 120..144; /evidence=""ECO:0007829|PDB:6I4R""; HELIX 203..206; /evidence=""ECO:0007829|PDB:6I4R""; HELIX 223..235; /evidence=""ECO:0007829|PDB:6I4R""; HELIX 255..268; /evidence=""ECO:0007829|PDB:6I4R""; HELIX 324..327; /evidence=""ECO:0007829|PDB:6I4R""; HELIX 354..356; /evidence=""ECO:0007829|PDB:6I4R""; HELIX 363..377; /evidence=""ECO:0007829|PDB:6I4R""; HELIX 386..388; /evidence=""ECO:0007829|PDB:6I4R""; HELIX 406..412; /evidence=""ECO:0007829|PDB:6I4R""; HELIX 423..425; /evidence=""ECO:0007829|PDB:6I4R""; HELIX 427..432; /evidence=""ECO:0007829|PDB:6I4R""; HELIX 460..473; /evidence=""ECO:0007829|PDB:6I4R""; HELIX 477..482; /evidence=""ECO:0007829|PDB:6I4R""; HELIX 491..503; /evidence=""ECO:0007829|PDB:6I4R""","TURN 445..447; /evidence=""ECO:0007829|PDB:6I4R""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,DLD GCSL LAD PHE3,"Dihydrolipoyl dehydrogenase, mitochondrial (EC 1.8.1.4) (Dihydrolipoamide dehydrogenase) (Glycine cleavage system L protein)",Homo sapiens (Human),509.0,54177.0,MQSWSRVYCSLAKRGHFNRISHGLQGLSAVPLRTYADQPIDADVTVIGSGPGGYVAAIKAAQLGFKTVCIEKNETLGGTCLNVGCIPSKALLNNSHYYHMAHGKDFASRGIEMSEVRLNLDKMMEQKSTAVKALTGGIAHLFKQNKVVHVNGYGKITGKNQVTATKADGGTQVIDTKNILIATGSEVTPFPGITIDEDTIVSSTGALSLKKVPEKMVVIGAGVIGVELGSVWQRLGADVTAVEFLGHVGGVGIDMEISKNFQRILQKQGFKFKLNTKVTGATKKSDGKIDVSIEAASGGKAEVITCDVLLVCIGRRPFTKNLGLEELGIELDPRGRIPVNTRFQTKIPNIYAIGDVVAGPMLAHKAEDEGIICVEGMAGGAVHIDYNCVPSVIYTHPEVAWVGKSEEQLKEEGIEYKVGKFPFAANSRAKTNADTDGMVKILGQKSTDRVLGAHILGPGAGEMVNEAALALEYGASCEDIARVCHAHPTLSEAFREANLAASFGKSINF,True,False,False,P09622,"[('G3DSA:3.30.390.30', None), ('G3DSA:3.50.50.60', 'FAD/NAD(P)-binding domain'), ('IPR001100', 'Pyridine nucleotide-disulphide oxidoreductase, class I'), ('IPR004099', 'Pyridine nucleotide-disulphide oxidoreductase, dimerisation domain'), ('IPR006258', 'Dihydrolipoamide dehydrogenase'), ('IPR012999', 'Pyridine nucleotide-disulphide oxidoreductase, class I, active site'), ('IPR016156', 'FAD/NAD-linked reductase, dimerisation domain superfamily'), ('IPR023753', 'FAD/NAD(P)-binding domain'), ('IPR036188', 'FAD/NAD(P)-binding domain superfamily'), ('IPR050151', 'Class-I pyridine nucleotide-disulfide oxidoreductase'), ('PF02852', 'Pyridine nucleotide-disulphide oxidoreductase, dimerisation domain'), ('PF07992', 'Pyridine nucleotide-disulphide oxidoreductase'), ('PIRSF000350', 'Mercury(II) reductase, MerA type'), ('PR00368', 'FAD-dependent pyridine nucleotide reductase'), ('PR00411', 'PNDRDTASEI'), ('PS00076', 'Pyridine nucleotide-disulphide oxidoreductases class-I active site'), ('PTHR22912', 'Class-I pyridine nucleotide-disulfide oxidoreductase'), ('SSF51905', 'FAD/NAD(P)-binding domain'), ('SSF55424', 'FAD/NAD-linked reductases, dimerisation (C-terminal) domain'), ('TIGR01350', 'dihydrolipoyl dehydrogenase')]",,"""ENSG00000091140; Tissue enhanced (skeletal muscle, tongue)."";","CATALYTIC ACTIVITY: Reaction=N(6)-[(R)-dihydrolipoyl]-L-lysyl-[protein] + NAD(+) = N(6)-[(R)-lipoyl]-L-lysyl-[protein] + NADH + H(+); Xref=Rhea:RHEA:15045, Rhea:RHEA-COMP:10474, Rhea:RHEA-COMP:10475, ChEBI:CHEBI:15378, ChEBI:CHEBI:57540, ChEBI:CHEBI:57945, ChEBI:CHEBI:83099, ChEBI:CHEBI:83100; EC=1.8.1.4; Evidence={ECO:0000269|PubMed:15712224, ECO:0000269|PubMed:16442803, ECO:0000269|PubMed:16770810, ECO:0000269|PubMed:17404228, ECO:0000269|PubMed:20160912, ECO:0000269|PubMed:20385101};",1.8.1.4,ACTIVITY REGULATION: Disruption of native heterodimer state inhibits primary dihydrolipoamide dehydrogenase activity and induces serine protease activity. {ECO:0000269|PubMed:17404228}.,,ENST00000205402.10 [P09622-1];ENST00000417551.5 [P09622-1];ENST00000437604.6 [P09622-3];,DLD,ENSG00000091140,0.0,DLD,Non-canonical_RBPs,12.0,,,,0.069,,DLD
P09874,ENSG00000143799,PARP1_HUMAN,"apoptotic process [GO:0006915]; ATP generation from poly-ADP-D-ribose [GO:1990966]; carbohydrate biosynthetic process [GO:0016051]; cellular response to amyloid-beta [GO:1904646]; cellular response to insulin stimulus [GO:0032869]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to oxidative stress [GO:0034599]; cellular response to UV [GO:0034644]; cellular response to zinc ion [GO:0071294]; decidualization [GO:0046697]; DNA ADP-ribosylation [GO:0030592]; DNA damage response [GO:0006974]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; innate immune response [GO:0045087]; macrophage differentiation [GO:0030225]; mitochondrial DNA metabolic process [GO:0032042]; mitochondrial DNA repair [GO:0043504]; mitochondrion organization [GO:0007005]; negative regulation of adipose tissue development [GO:1904178]; negative regulation of ATP biosynthetic process [GO:2001170]; negative regulation of cGAS/STING signaling pathway [GO:0160049]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of innate immune response [GO:0045824]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transcription elongation by RNA polymerase II [GO:0034244]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of DNA-templated transcription, elongation [GO:0032786]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of mitochondrial depolarization [GO:0051901]; positive regulation of myofibroblast differentiation [GO:1904762]; positive regulation of necroptotic process [GO:0060545]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of single strand break repair [GO:1903518]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein auto-ADP-ribosylation [GO:0070213]; protein autoprocessing [GO:0016540]; protein localization to chromatin [GO:0071168]; protein modification process [GO:0036211]; protein poly-ADP-ribosylation [GO:0070212]; regulation of base-excision repair [GO:1905051]; regulation of catalytic activity [GO:0050790]; regulation of circadian sleep/wake cycle, non-REM sleep [GO:0045188]; regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903376]; regulation of protein localization [GO:0032880]; replication fork reversal [GO:0071932]; response to aldosterone [GO:1904044]; response to gamma radiation [GO:0010332]; signal transduction involved in regulation of gene expression [GO:0023019]; telomere maintenance [GO:0000723]; transcription by RNA polymerase II [GO:0006366]; transforming growth factor beta receptor signaling pathway [GO:0007179]","chromatin [GO:0000785]; chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nuclear body [GO:0016604]; nuclear envelope [GO:0005635]; nuclear replication fork [GO:0043596]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; protein-DNA complex [GO:0032993]; site of DNA damage [GO:0090734]; site of double-strand break [GO:0035861]; transcription regulator complex [GO:0005667]",chromatin binding [GO:0003682]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; enzyme binding [GO:0019899]; histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802]; NAD binding [GO:0051287]; NAD DNA ADP-ribosyltransferase activity [GO:0140294]; NAD+-histone H2BE35 glutamate ADP-ribosyltransferase activity [GO:0140822]; NAD+-histone H2BS6 serine ADP-ribosyltransferase activity [GO:0140816]; NAD+-histone H3S10 serine ADP-ribosyltransferase activity [GO:0140817]; NAD+-protein ADP-ribosyltransferase activity [GO:1990404]; NAD+-protein poly-ADP-ribosyltransferase activity [GO:0003950]; NAD+-protein-aspartate ADP-ribosyltransferase activity [GO:0140806]; NAD+-protein-glutamate ADP-ribosyltransferase activity [GO:0140807]; NAD+-protein-histidine ADP-ribosyltransferase activity [GO:0140815]; NAD+-protein-serine ADP-ribosyltransferase activity [GO:0140805]; NAD+-protein-tyrosine ADP-ribosyltransferase activity [GO:0140808]; nuclear estrogen receptor binding [GO:0030331]; nucleosome binding [GO:0031491]; nucleotidyltransferase activity [GO:0016779]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; R-SMAD binding [GO:0070412]; RNA binding [GO:0003723]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription regulator activator activity [GO:0140537]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270],"PTM: Poly-ADP-ribosylated on serine, glutamate and aspartate residues by autocatalysis (PubMed:19764761, PubMed:20388712, PubMed:22582261). Auto-ADP-ribosylation on serine takes place following interaction with HPF1 (PubMed:28190768, PubMed:34625544). Auto poly-ADP-ribosylation on serine residues promotes its dissociation from chromatin (PubMed:15607977, PubMed:30675909, PubMed:32358582, PubMed:34210965, PubMed:34625544). Poly-ADP-ribosylated by PARP2; poly-ADP-ribosylation mediates the recruitment of CHD1L to DNA damage sites (PubMed:19661379). Mono-ADP-ribosylated at Lys-521 by SIRT6 in response to oxidative stress, promoting recruitment to double-strand breaks (DSBs) sites (PubMed:21680843, PubMed:22753495, PubMed:27568560). {ECO:0000269|PubMed:15607977, ECO:0000269|PubMed:19661379, ECO:0000269|PubMed:19764761, ECO:0000269|PubMed:20388712, ECO:0000269|PubMed:21680843, ECO:0000269|PubMed:22582261, ECO:0000269|PubMed:22753495, ECO:0000269|PubMed:27568560, ECO:0000269|PubMed:28190768, ECO:0000269|PubMed:30675909, ECO:0000269|PubMed:32358582, ECO:0000269|PubMed:34210965, ECO:0000269|PubMed:34625544}.; PTM: Phosphorylated at Thr-594 by PRKDC in response to DNA damage following virus infection, promoting its translocation to the cytosol (PubMed:10467406, PubMed:35460603). Phosphorylated by TXK (PubMed:17177976). {ECO:0000269|PubMed:10467406, ECO:0000269|PubMed:17177976, ECO:0000269|PubMed:35460603}.; PTM: S-nitrosylated, leading to inhibit transcription regulation activity. {ECO:0000250|UniProtKB:P11103}.; PTM: Proteolytically cleaved by caspase-3 (CASP3) and caspase-7 (CASP7) in response to apoptosis to generate the Poly [ADP-ribose] polymerase 1, processed N-terminus and Poly [ADP-ribose] polymerase 1, processed C-terminus forms (PubMed:10497198, PubMed:16374543, PubMed:22451931, PubMed:22464733, PubMed:33168626, PubMed:35104452, PubMed:7596430). CASP3-mediated cleavage is promoted by the TP53/p53-induced long non-coding RNA SPARCLE, which binds PARP1 in response to genotoxic stress (PubMed:35104452). {ECO:0000269|PubMed:10497198, ECO:0000269|PubMed:16374543, ECO:0000269|PubMed:22451931, ECO:0000269|PubMed:22464733, ECO:0000269|PubMed:33168626, ECO:0000269|PubMed:35104452, ECO:0000269|PubMed:7596430}.; PTM: Sumoylated with SUMO1 or SUMO2 by PIAS4 following prolonged residence (trapping) to chromatin (PubMed:35013556). Sumoylation promotes ubiquitination by RNF4 and removal from chromatin by VCP/p97 (PubMed:35013556). {ECO:0000269|PubMed:35013556}.; PTM: Ubiquitinated by RNF4 following sumoylation by PIAS4 in response to prolonged residence (trapping) to chromatin (PubMed:35013556). Ubiquitination promotes removal from chromatin by VCP/p97 (PubMed:35013556). {ECO:0000269|PubMed:35013556}.","DOMAIN: The two PARP-type zinc-fingers (also named Zn1 and Zn2) specifically recognize DNA strand breaks: PARP-type zinc-finger 1 binds PARP-type zinc-finger 2 from a separate PARP1 molecule to form a dimeric module that specifically recognizes DNA strand breaks. {ECO:0000269|PubMed:22683995}.; DOMAIN: The PADR1-type (also named Zn3) zinc-finger mediates an interdomain contact and is required for the ability of PARP1 to regulate chromatin structure. {ECO:0000269|PubMed:20068231}.; DOMAIN: The BRCT domain is able to bind intact DNA without activating the poly-ADP-ribosyltransferase activity (PubMed:34919819). The BRCT domain mediates DNA intrastrand transfer (named 'monkey-bar mechanism') that allows rapid movements of PARP1 through the nucleus (PubMed:34919819). {ECO:0000269|PubMed:34919819}.; DOMAIN: The WGR domain bridges two nucleosomes, with the broken DNA aligned in a position suitable for ligation. The bridging induces structural changes in PARP1 that signal the recognition of a DNA break to the catalytic domain of PARP1, promoting HPF1 recruitment and subsequent activation of PARP1, licensing serine ADP-ribosylation of target proteins. {ECO:0000250|UniProtKB:Q9UGN5}.; DOMAIN: The PARP alpha-helical domain (also named HD region) prevents effective NAD(+)-binding in absence of activation signal (PubMed:26626479, PubMed:26626480). Binding to damaged DNA unfolds the PARP alpha-helical domain, relieving autoinhibition (PubMed:26626479, PubMed:26626480). {ECO:0000269|PubMed:26626479, ECO:0000269|PubMed:26626480}.","DOMAIN 225..359; /note=""PADR1 zinc-binding""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU01351""; DOMAIN 385..476; /note=""BRCT""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00033""; DOMAIN 542..638; /note=""WGR""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU01321""; DOMAIN 662..779; /note=""PARP alpha-helical""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00398""; DOMAIN 788..1014; /note=""PARP catalytic""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00397""","STRAND 8..13; /evidence=""ECO:0007829|PDB:3OD8""; STRAND 15..17; /evidence=""ECO:0007829|PDB:3OD8""; STRAND 25..27; /evidence=""ECO:0007829|PDB:2L30""; STRAND 32..40; /evidence=""ECO:0007829|PDB:3OD8""; STRAND 42..53; /evidence=""ECO:0007829|PDB:3OD8""; STRAND 102..105; /evidence=""ECO:0007829|PDB:2N8A""; STRAND 113..117; /evidence=""ECO:0007829|PDB:3ODC""; STRAND 119..121; /evidence=""ECO:0007829|PDB:3ODC""; STRAND 137..145; /evidence=""ECO:0007829|PDB:3ODC""; STRAND 148..158; /evidence=""ECO:0007829|PDB:3ODC""; STRAND 209..211; /evidence=""ECO:0007829|PDB:2N8A""; STRAND 302..305; /evidence=""ECO:0007829|PDB:2RIQ""; STRAND 308..311; /evidence=""ECO:0007829|PDB:2RIQ""; STRAND 314..316; /evidence=""ECO:0007829|PDB:2RIQ""; STRAND 324..327; /evidence=""ECO:0007829|PDB:2RIQ""; STRAND 394..397; /evidence=""ECO:0007829|PDB:7SCZ""; STRAND 418..420; /evidence=""ECO:0007829|PDB:7SCZ""; STRAND 427..431; /evidence=""ECO:0007829|PDB:7SCZ""; STRAND 452..455; /evidence=""ECO:0007829|PDB:7SCZ""; STRAND 543..545; /evidence=""ECO:0007829|PDB:7S6H""; STRAND 548..550; /evidence=""ECO:0007829|PDB:7S68""; STRAND 554..561; /evidence=""ECO:0007829|PDB:7S6H""; STRAND 566..581; /evidence=""ECO:0007829|PDB:7S6H""; STRAND 583..591; /evidence=""ECO:0007829|PDB:7S6H""; STRAND 597..606; /evidence=""ECO:0007829|PDB:7S6H""; STRAND 639..641; /evidence=""ECO:0007829|PDB:7S6H""; STRAND 745..747; /evidence=""ECO:0007829|PDB:7ONS""; STRAND 752..754; /evidence=""ECO:0007829|PDB:1UK0""; STRAND 785..787; /evidence=""ECO:0007829|PDB:4R6E""; STRAND 799..803; /evidence=""ECO:0007829|PDB:6NRH""; STRAND 806..808; /evidence=""ECO:0007829|PDB:2RCW""; STRAND 829..841; /evidence=""ECO:0007829|PDB:6NRH""; STRAND 853..855; /evidence=""ECO:0007829|PDB:3GN7""; STRAND 857..863; /evidence=""ECO:0007829|PDB:6NRH""; STRAND 882..884; /evidence=""ECO:0007829|PDB:8FZ1""; STRAND 889..891; /evidence=""ECO:0007829|PDB:1WOK""; STRAND 893..900; /evidence=""ECO:0007829|PDB:6NRH""; STRAND 912..914; /evidence=""ECO:0007829|PDB:7KK5""; STRAND 916..925; /evidence=""ECO:0007829|PDB:6NRH""; STRAND 928..934; /evidence=""ECO:0007829|PDB:6NRH""; STRAND 938..940; /evidence=""ECO:0007829|PDB:6VKK""; STRAND 947..950; /evidence=""ECO:0007829|PDB:6NRH""; STRAND 952..956; /evidence=""ECO:0007829|PDB:6NRH""; STRAND 962..964; /evidence=""ECO:0007829|PDB:6NRH""; STRAND 967..969; /evidence=""ECO:0007829|PDB:6NRH""; STRAND 974..976; /evidence=""ECO:0007829|PDB:6NRH""; STRAND 983..986; /evidence=""ECO:0007829|PDB:6NRH""; STRAND 988..993; /evidence=""ECO:0007829|PDB:6NRH""; STRAND 997..1009; /evidence=""ECO:0007829|PDB:6NRH""","HELIX 54..59; /evidence=""ECO:0007829|PDB:3OD8""; HELIX 67..70; /evidence=""ECO:0007829|PDB:3OD8""; HELIX 74..76; /evidence=""ECO:0007829|PDB:3OD8""; HELIX 79..90; /evidence=""ECO:0007829|PDB:3OD8""; HELIX 160..165; /evidence=""ECO:0007829|PDB:3ODC""; HELIX 167..170; /evidence=""ECO:0007829|PDB:3ODC""; HELIX 177..180; /evidence=""ECO:0007829|PDB:3ODC""; HELIX 184..186; /evidence=""ECO:0007829|PDB:3ODC""; HELIX 189..198; /evidence=""ECO:0007829|PDB:3ODC""; HELIX 226..255; /evidence=""ECO:0007829|PDB:2RIQ""; HELIX 258..267; /evidence=""ECO:0007829|PDB:2RIQ""; HELIX 276..289; /evidence=""ECO:0007829|PDB:2RIQ""; HELIX 337..340; /evidence=""ECO:0007829|PDB:2RIQ""; HELIX 342..347; /evidence=""ECO:0007829|PDB:2RIQ""; HELIX 405..414; /evidence=""ECO:0007829|PDB:7SCZ""; HELIX 434..438; /evidence=""ECO:0007829|PDB:7SCZ""; HELIX 441..448; /evidence=""ECO:0007829|PDB:7SCZ""; HELIX 458..464; /evidence=""ECO:0007829|PDB:7SCZ""; HELIX 469..472; /evidence=""ECO:0007829|PDB:7SCZ""; HELIX 535..537; /evidence=""ECO:0007829|PDB:7S6H""; HELIX 607..622; /evidence=""ECO:0007829|PDB:7S6H""; HELIX 667..676; /evidence=""ECO:0007829|PDB:7AAC""; HELIX 679..688; /evidence=""ECO:0007829|PDB:7AAC""; HELIX 698..700; /evidence=""ECO:0007829|PDB:7AAC""; HELIX 703..721; /evidence=""ECO:0007829|PDB:7AAC""; HELIX 726..739; /evidence=""ECO:0007829|PDB:7AAC""; HELIX 755..779; /evidence=""ECO:0007829|PDB:7AAC""; HELIX 790..796; /evidence=""ECO:0007829|PDB:6NRH""; HELIX 809..820; /evidence=""ECO:0007829|PDB:6NRH""; HELIX 824..826; /evidence=""ECO:0007829|PDB:7AAC""; HELIX 844..848; /evidence=""ECO:0007829|PDB:6NRH""; HELIX 849..851; /evidence=""ECO:0007829|PDB:6NRH""; HELIX 866..868; /evidence=""ECO:0007829|PDB:6NRH""; HELIX 869..875; /evidence=""ECO:0007829|PDB:6NRH""; HELIX 886..888; /evidence=""ECO:0007829|PDB:7AAC""; HELIX 901..905; /evidence=""ECO:0007829|PDB:6NRH""; HELIX 906..908; /evidence=""ECO:0007829|PDB:6NRH""; HELIX 958..960; /evidence=""ECO:0007829|PDB:6NRH""; HELIX 994..996; /evidence=""ECO:0007829|PDB:6NRH""","TURN 2..5; /evidence=""ECO:0007829|PDB:2L30""; TURN 22..24; /evidence=""ECO:0007829|PDB:3OD8""; TURN 126..128; /evidence=""ECO:0007829|PDB:3ODC""; TURN 174..176; /evidence=""ECO:0007829|PDB:3ODC""; TURN 204..206; /evidence=""ECO:0007829|PDB:2L31""; TURN 273..275; /evidence=""ECO:0007829|PDB:2JVN""; TURN 296..298; /evidence=""ECO:0007829|PDB:2RIQ""; TURN 389..392; /evidence=""ECO:0007829|PDB:7SCZ""; TURN 473..475; /evidence=""ECO:0007829|PDB:7SCZ""; TURN 540..542; /evidence=""ECO:0007829|PDB:7S6H""; TURN 562..565; /evidence=""ECO:0007829|PDB:7S6H""; TURN 693..695; /evidence=""ECO:0007829|PDB:7AAC""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,PARP1 ADPRT PPOL,"Poly [ADP-ribose] polymerase 1 (PARP-1) (EC 2.4.2.30) (ADP-ribosyltransferase diphtheria toxin-like 1) (ARTD1) (DNA ADP-ribosyltransferase PARP1) (EC 2.4.2.-) (NAD(+) ADP-ribosyltransferase 1) (ADPRT 1) (Poly[ADP-ribose] synthase 1) (Protein poly-ADP-ribosyltransferase PARP1) (EC 2.4.2.-) [Cleaved into: Poly [ADP-ribose] polymerase 1, processed C-terminus (Poly [ADP-ribose] polymerase 1, 89-kDa form); Poly [ADP-ribose] polymerase 1, processed N-terminus (NT-PARP-1) (Poly [ADP-ribose] polymerase 1, 24-kDa form) (Poly [ADP-ribose] polymerase 1, 28-kDa form)]",Homo sapiens (Human),1014.0,113084.0,MAESSDKLYRVEYAKSGRASCKKCSESIPKDSLRMAIMVQSPMFDGKVPHWYHFSCFWKVGHSIRHPDVEVDGFSELRWDDQQKVKKTAEAGGVTGKGQDGIGSKAEKTLGDFAAEYAKSNRSTCKGCMEKIEKGQVRLSKKMVDPEKPQLGMIDRWYHPGCFVKNREELGFRPEYSASQLKGFSLLATEDKEALKKQLPGVKSEGKRKGDEVDGVDEVAKKKSKKEKDKDSKLEKALKAQNDLIWNIKDELKKVCSTNDLKELLIFNKQQVPSGESAILDRVADGMVFGALLPCEECSGQLVFKSDAYYCTGDVTAWTKCMVKTQTPNRKEWVTPKEFREISYLKKLKVKKQDRIFPPETSASVAATPPPSTASAPAAVNSSASADKPLSNMKILTLGKLSRNKDEVKAMIEKLGGKLTGTANKASLCISTKKEVEKMNKKMEEVKEANIRVVSEDFLQDVSASTKSLQELFLAHILSPWGAEVKAEPVEVVAPRGKSGAALSKKSKGQVKEEGINKSEKRMKLTLKGGAAVDPDSGLEHSAHVLEKGGKVFSATLGLVDIVKGTNSYYKLQLLEDDKENRYWIFRSWGRVGTVIGSNKLEQMPSKEDAIEHFMKLYEEKTGNAWHSKNFTKYPKKFYPLEIDYGQDEEAVKKLTVNPGTKSKLPKPVQDLIKMIFDVESMKKAMVEYEIDLQKMPLGKLSKRQIQAAYSILSEVQQAVSQGSSDSQILDLSNRFYTLIPHDFGMKKPPLLNNADSVQAKVEMLDNLLDIEVAYSLLRGGSDDSSKDPIDVNYEKLKTDIKVVDRDSEEAEIIRKYVKNTHATTHNAYDLEVIDIFKIEREGECQRYKPFKQLHNRRLLWHGSRTTNFAGILSQGLRIAPPEAPVTGYMFGKGIYFADMVSKSANYCHTSQGDPIGLILLGEVALGNMYELKHASHISKLPKGKHSVKGLGKTTPDPSANISLDGVDVPLGTGISSGVNDTSLLYNEYIVYDIAQVNLKYLLKLKFNFKTSLW,False,True,False,P09874,"[('cd01437', 'parp_like'), ('cd08001', 'WGR domain of poly(ADP-ribose) polymerase 1 and similar proteins'), ('cd17747', 'BRCT domain of poly [ADP-ribose] polymerase 1 (PARP-1) and similar proteins'), ('G3DSA:1.10.20.130', None), ('G3DSA:1.20.142.10', 'Poly(ADP-ribose) polymerase, regulatory domain'), ('G3DSA:2.20.25.630', None), ('G3DSA:3.30.1740.10', 'Zinc finger, PARP-type'), ('G3DSA:3.40.50.10190', 'BRCT domain'), ('G3DSA:3.90.228.10', None), ('IPR001357', 'BRCT domain'), ('IPR001510', 'Zinc finger, PARP-type'), ('IPR004102', 'Poly(ADP-ribose) polymerase, regulatory domain'), ('IPR008288', 'Poly [ADP-ribose] polymerase'), ('IPR008893', 'WGR domain'), ('IPR012317', 'Poly(ADP-ribose) polymerase, catalytic domain'), ('IPR012982', 'PARP1-like, PADR1 domain, zinc ribbon fold'), ('IPR036420', 'BRCT domain superfamily'), ('IPR036616', 'Poly(ADP-ribose) polymerase, regulatory domain superfamily'), ('IPR036930', 'WGR domain superfamily'), ('IPR036957', 'Zinc finger, PARP-type superfamily')]",P09874;,"""ENSG00000143799; Low tissue specificity."";","CATALYTIC ACTIVITY: Reaction=NAD(+) + (ADP-D-ribosyl)n-acceptor = nicotinamide + (ADP-D-ribosyl)n+1-acceptor + H(+).; EC=2.4.2.30; Evidence={ECO:0000269|PubMed:18172500, ECO:0000269|PubMed:19764761, ECO:0000269|PubMed:25043379, ECO:0000269|PubMed:26344098, ECO:0000269|PubMed:28190768, ECO:0000269|PubMed:32358582, ECO:0000269|PubMed:33683197, ECO:0000269|PubMed:7852410}; CATALYTIC ACTIVITY: Reaction=L-seryl-[protein] + NAD(+) = O-(ADP-D-ribosyl)-L-seryl-[protein] + nicotinamide + H(+); Xref=Rhea:RHEA:58232, Rhea:RHEA-COMP:9863, Rhea:RHEA-COMP:15091, ChEBI:CHEBI:15378, ChEBI:CHEBI:17154, ChEBI:CHEBI:29999, ChEBI:CHEBI:57540, ChEBI:CHEBI:142556; Evidence={ECO:0000269|PubMed:27067600, ECO:0000269|PubMed:27256882, ECO:0000269|PubMed:32028527, ECO:0000269|PubMed:33186521, ECO:0000269|PubMed:33683197, ECO:0000269|PubMed:34210965, ECO:0000269|PubMed:34625544, ECO:0000305|PubMed:29954836}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:58233; Evidence={ECO:0000269|PubMed:27067600, ECO:0000269|PubMed:27256882, ECO:0000269|PubMed:32028527, ECO:0000269|PubMed:33186521, ECO:0000269|PubMed:33683197, ECO:0000269|PubMed:34210965, ECO:0000269|PubMed:34625544, ECO:0000305|PubMed:29954836}; CATALYTIC ACTIVITY: Reaction=L-aspartyl-[protein] + NAD(+) = 4-O-(ADP-D-ribosyl)-L-aspartyl-[protein] + nicotinamide; Xref=Rhea:RHEA:54424, Rhea:RHEA-COMP:9867, Rhea:RHEA-COMP:13832, ChEBI:CHEBI:17154, ChEBI:CHEBI:29961, ChEBI:CHEBI:57540, ChEBI:CHEBI:138102; Evidence={ECO:0000269|PubMed:19764761, ECO:0000269|PubMed:25043379, ECO:0000269|PubMed:35460603}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:54425; Evidence={ECO:0000269|PubMed:19764761, ECO:0000269|PubMed:25043379, ECO:0000269|PubMed:35460603}; CATALYTIC ACTIVITY: Reaction=L-glutamyl-[protein] + NAD(+) = 5-O-(ADP-D-ribosyl)-L-glutamyl-[protein] + nicotinamide; Xref=Rhea:RHEA:58224, Rhea:RHEA-COMP:10208, Rhea:RHEA-COMP:15089, ChEBI:CHEBI:17154, ChEBI:CHEBI:29973, ChEBI:CHEBI:57540, ChEBI:CHEBI:142540; Evidence={ECO:0000269|PubMed:19764761, ECO:0000269|PubMed:25043379, ECO:0000269|PubMed:27256882}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:58225; Evidence={ECO:0000269|PubMed:19764761, ECO:0000269|PubMed:25043379, ECO:0000269|PubMed:27256882}; CATALYTIC ACTIVITY: Reaction=L-tyrosyl-[protein] + NAD(+) = O-(ADP-D-ribosyl)-L-tyrosyl-[protein] + nicotinamide + H(+); Xref=Rhea:RHEA:58236, Rhea:RHEA-COMP:10136, Rhea:RHEA-COMP:15092, ChEBI:CHEBI:15378, ChEBI:CHEBI:17154, ChEBI:CHEBI:46858, ChEBI:CHEBI:57540, ChEBI:CHEBI:142557; Evidence={ECO:0000305|PubMed:29954836, ECO:0000305|PubMed:30257210}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:58237; Evidence={ECO:0000305|PubMed:29954836, ECO:0000305|PubMed:30257210}; CATALYTIC ACTIVITY: Reaction=L-histidyl-[protein] + NAD(+) = N(tele)-(ADP-D-ribosyl)-L-histidyl-[protein] + nicotinamide + H(+); Xref=Rhea:RHEA:72071, Rhea:RHEA-COMP:9745, Rhea:RHEA-COMP:18085, ChEBI:CHEBI:15378, ChEBI:CHEBI:17154, ChEBI:CHEBI:29979, ChEBI:CHEBI:57540, ChEBI:CHEBI:191398; Evidence={ECO:0000269|PubMed:35393539}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:72072; Evidence={ECO:0000269|PubMed:35393539};",2.4.2.-; 2.4.2.30,"ACTIVITY REGULATION: ADP-ribosyltransferase activity is regulated via an allosteric activation mechanism (PubMed:22582261, PubMed:26626479, PubMed:26626480, PubMed:32241924, PubMed:32358582). In absence of activation signal, PARP1 is autoinhibited by the PARP alpha-helical domain (also named HD region), which prevents effective NAD(+)-binding (PubMed:26626479, PubMed:26626480, PubMed:32241924). Activity is highly stimulated by signals, such as DNA strand breaks (PubMed:20388712, PubMed:32241924, PubMed:32358582). Binding to damaged DNA unfolds the PARP alpha-helical domain, relieving autoinhibition (PubMed:22582261, PubMed:26626479, PubMed:26626480, PubMed:32241924). Poly-ADP-ribosyltransferase activity is tightly regulated and PARP1 is removed from damaged chromatin following initial poly-ADP-ribosylation of chromatin to avoid prolonged residence (trapping) that has cytotoxic consequences (PubMed:34210965, PubMed:34625544, PubMed:35013556). A number of factors (VCP/p97) or post-translational modifications (auto-poly-ADP-ribosylation or ubiquitination) promote PARP1 removal from chromatin (PubMed:34210965, PubMed:34625544, PubMed:35013556). ADP-ribosyltransferase activity is inhibited by a number of PARP inhibitors (PARPi) compounds, that are used the treatment of breast or ovarian cancers that have defects in DNA repair by homologous recombination (PubMed:29487285, PubMed:32241924, PubMed:32358582). PARPi molecules can be classified in three categories: type I compounds (EB-47, UKTT15 and BAD) that promote allosteric retention of PARP1 on DNA, type II inhibitors (talazoparib and olaparib) that mediate a non-allosteric inhibition, and type III inhibitors (rucaparib, niraparib, and veliparib) that promote allosteric release from DNA (PubMed:29487285, PubMed:32241924, PubMed:33361107). Trapping to chromatin by PARPi molecules triggers activation of the cGAS-STING pathway (PubMed:32844745). {ECO:0000269|PubMed:20388712, ECO:0000269|PubMed:22582261, ECO:0000269|PubMed:26626479, ECO:0000269|PubMed:26626480, ECO:0000269|PubMed:29487285, ECO:0000269|PubMed:32241924, ECO:0000269|PubMed:32358582, ECO:0000269|PubMed:32844745, ECO:0000269|PubMed:33361107, ECO:0000269|PubMed:34210965, ECO:0000269|PubMed:34625544, ECO:0000269|PubMed:35013556}.",,ENST00000366794.10;,PARP1,ENSG00000143799,0.0,PARP1,Canonical_RBPs,18.0,,,,0.123,0.06,PARP1
P09960,ENSG00000111144,LKHA4_HUMAN,leukotriene biosynthetic process [GO:0019370]; lipid metabolic process [GO:0006629]; peptide catabolic process [GO:0043171]; protein metabolic process [GO:0019538]; proteolysis [GO:0006508]; response to peptide hormone [GO:0043434]; response to zinc ion [GO:0010043]; type I pneumocyte differentiation [GO:0060509],cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; tertiary granule lumen [GO:1904724],aminopeptidase activity [GO:0004177]; epoxide hydrolase activity [GO:0004301]; leukotriene-A4 hydrolase activity [GO:0004463]; metalloaminopeptidase activity [GO:0070006]; peptidase activity [GO:0008233]; RNA binding [GO:0003723]; tripeptide aminopeptidase activity [GO:0045148]; zinc ion binding [GO:0008270],PTM: Phosphorylation at Ser-416 inhibits leukotriene-A4 hydrolase activity. {ECO:0000269|PubMed:9395533}.,,,"STRAND 17..29; /evidence=""ECO:0007829|PDB:3U9W""; STRAND 34..45; /evidence=""ECO:0007829|PDB:3U9W""; STRAND 50..59; /evidence=""ECO:0007829|PDB:3U9W""; STRAND 61..67; /evidence=""ECO:0007829|PDB:3U9W""; STRAND 74..76; /evidence=""ECO:0007829|PDB:3U9W""; STRAND 85..95; /evidence=""ECO:0007829|PDB:3U9W""; STRAND 100..108; /evidence=""ECO:0007829|PDB:3U9W""; STRAND 116..119; /evidence=""ECO:0007829|PDB:3U9W""; STRAND 124..129; /evidence=""ECO:0007829|PDB:3U9W""; STRAND 131..134; /evidence=""ECO:0007829|PDB:3U9W""; STRAND 155..164; /evidence=""ECO:0007829|PDB:3U9W""; STRAND 167..180; /evidence=""ECO:0007829|PDB:3U9W""; STRAND 182..184; /evidence=""ECO:0007829|PDB:2VJ8""; STRAND 187..198; /evidence=""ECO:0007829|PDB:3U9W""; STRAND 205..209; /evidence=""ECO:0007829|PDB:3U9W""; STRAND 211..216; /evidence=""ECO:0007829|PDB:3U9W""; STRAND 219..223; /evidence=""ECO:0007829|PDB:3U9W""; STRAND 253..255; /evidence=""ECO:0007829|PDB:5NIE""; STRAND 258..261; /evidence=""ECO:0007829|PDB:3U9W""; STRAND 267..271; /evidence=""ECO:0007829|PDB:3U9W""; STRAND 276..279; /evidence=""ECO:0007829|PDB:3U9W""; STRAND 286..288; /evidence=""ECO:0007829|PDB:3U9W""; STRAND 307..311; /evidence=""ECO:0007829|PDB:3U9W""; STRAND 365..367; /evidence=""ECO:0007829|PDB:3U9W""; STRAND 418..420; /evidence=""ECO:0007829|PDB:3U9W""","HELIX 81..83; /evidence=""ECO:0007829|PDB:3U9W""; HELIX 121..123; /evidence=""ECO:0007829|PDB:3U9W""; HELIX 141..143; /evidence=""ECO:0007829|PDB:3U9W""; HELIX 200..202; /evidence=""ECO:0007829|PDB:3U9W""; HELIX 225..227; /evidence=""ECO:0007829|PDB:3U9W""; HELIX 228..234; /evidence=""ECO:0007829|PDB:3U9W""; HELIX 238..249; /evidence=""ECO:0007829|PDB:3U9W""; HELIX 281..283; /evidence=""ECO:0007829|PDB:3U9W""; HELIX 292..299; /evidence=""ECO:0007829|PDB:3U9W""; HELIX 312..314; /evidence=""ECO:0007829|PDB:3U9W""; HELIX 315..334; /evidence=""ECO:0007829|PDB:3U9W""; HELIX 336..357; /evidence=""ECO:0007829|PDB:3U9W""; HELIX 362..364; /evidence=""ECO:0007829|PDB:3U9W""; HELIX 375..378; /evidence=""ECO:0007829|PDB:3U9W""; HELIX 382..398; /evidence=""ECO:0007829|PDB:3U9W""; HELIX 401..415; /evidence=""ECO:0007829|PDB:3U9W""; HELIX 422..432; /evidence=""ECO:0007829|PDB:3U9W""; HELIX 434..436; /evidence=""ECO:0007829|PDB:3U9W""; HELIX 437..441; /evidence=""ECO:0007829|PDB:3U9W""; HELIX 445..450; /evidence=""ECO:0007829|PDB:3U9W""; HELIX 467..478; /evidence=""ECO:0007829|PDB:3U9W""; HELIX 481..486; /evidence=""ECO:0007829|PDB:3U9W""; HELIX 489..492; /evidence=""ECO:0007829|PDB:3U9W""; HELIX 497..508; /evidence=""ECO:0007829|PDB:3U9W""; HELIX 515..525; /evidence=""ECO:0007829|PDB:3U9W""; HELIX 527..529; /evidence=""ECO:0007829|PDB:3U9W""; HELIX 533..545; /evidence=""ECO:0007829|PDB:3U9W""; HELIX 551..561; /evidence=""ECO:0007829|PDB:3U9W""; HELIX 565..577; /evidence=""ECO:0007829|PDB:3U9W""; HELIX 579..592; /evidence=""ECO:0007829|PDB:3U9W""; HELIX 593..595; /evidence=""ECO:0007829|PDB:3U9W""; HELIX 598..608; /evidence=""ECO:0007829|PDB:3U9W""","TURN 14..16; /evidence=""ECO:0007829|PDB:3U9W""; TURN 30..33; /evidence=""ECO:0007829|PDB:3U9W""; TURN 137..140; /evidence=""ECO:0007829|PDB:3U9W""; TURN 235..237; /evidence=""ECO:0007829|PDB:3U9W""; TURN 289..291; /evidence=""ECO:0007829|PDB:3U9W""; TURN 300..302; /evidence=""ECO:0007829|PDB:3U9W""; TURN 304..306; /evidence=""ECO:0007829|PDB:3U9W""; TURN 464..466; /evidence=""ECO:0007829|PDB:3U9W""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,LTA4H LTA4,Leukotriene A-4 hydrolase (LTA-4 hydrolase) (EC 3.3.2.6) (Leukotriene A(4) hydrolase) (Tripeptide aminopeptidase LTA4H) (EC 3.4.11.4),Homo sapiens (Human),611.0,69285.0,MPEIVDTCSLASPASVCRTKHLHLRCSVDFTRRTLTGTAALTVQSQEDNLRSLVLDTKDLTIEKVVINGQEVKYALGERQSYKGSPMEISLPIALSKNQEIVIEISFETSPKSSALQWLTPEQTSGKEHPYLFSQCQAIHCRAILPCQDTPSVKLTYTAEVSVPKELVALMSAIRDGETPDPEDPSRKIYKFIQKVPIPCYLIALVVGALESRQIGPRTLVWSEKEQVEKSAYEFSETESMLKIAEDLGGPYVWGQYDLLVLPPSFPYGGMENPCLTFVTPTLLAGDKSLSNVIAHEISHSWTGNLVTNKTWDHFWLNEGHTVYLERHICGRLFGEKFRHFNALGGWGELQNSVKTFGETHPFTKLVVDLTDIDPDVAYSSVPYEKGFALLFYLEQLLGGPEIFLGFLKAYVEKFSYKSITTDDWKDFLYSYFKDKVDVLNQVDWNAWLYSPGLPPIKPNYDMTLTNACIALSQRWITAKEDDLNSFNATDLKDLSSHQLNEFLAQTLQRAPLPLGHIKRMQEVYNFNAINNSEIRFRWLRLCIQSKWEDAIPLALKMATEQGRMKFTRPLFKDLAAFDKSHDQAVRTYQEHKASMHPVTAMLVGKDLKVD,True,True,False,P09960,"[('cd09599', 'Peptidase M1 family including Leukotriene A4 hydrolase catalytic domain'), ('G3DSA:1.10.390.10', 'Neutral Protease Domain 2'), ('G3DSA:1.25.40.320', 'Peptidase M1, leukotriene A4 hydrolase/aminopeptidase C-terminal domain'), ('G3DSA:2.60.40.1730', 'tricorn interacting facor f3 domain'), ('G3DSA:3.30.2010.30', None), ('IPR001930', 'Peptidase M1, alanine aminopeptidase/leukotriene A4 hydrolase'), ('IPR012777', 'Leukotriene A4 hydrolase/leucine aminopeptidase'), ('IPR014782', 'Peptidase M1, membrane alanine aminopeptidase'), ('IPR015211', 'Peptidase M1, leukotriene A4 hydrolase/aminopeptidase C-terminal'), ('IPR016024', 'Armadillo-type fold'), ('IPR027268', 'Peptidase M4/M1, CTD superfamily'), ('IPR034015', 'Aminopeptidase, leukotriene A4 hydrolase-like'), ('IPR038502', 'Peptidase M1, LTA-4 hydrolase/aminopeptidase, C-terminal domain superfamily'), ('IPR042097', 'Aminopeptidase N-like , N-terminal domain superfamliy'), ('IPR045357', 'Aminopeptidase N-like , N-terminal domain'), ('IPR049980', 'Leukotriene A4 hydrolase-like, catalytic domain'), ('PF01433', 'Peptidase family M1 domain'), ('PF09127', 'Leukotriene A4 hydrolase, C-terminal'), ('PF17900', 'Peptidase M1 N-terminal domain'), ('PR00756', 'ALADIPTASE')]",,"""ENSG00000111144; Low tissue specificity."";","CATALYTIC ACTIVITY: Reaction=leukotriene A4 + H2O = leukotriene B4; Xref=Rhea:RHEA:22324, ChEBI:CHEBI:15377, ChEBI:CHEBI:57461, ChEBI:CHEBI:57463; EC=3.3.2.6; Evidence={ECO:0000269|PubMed:11675384, ECO:0000269|PubMed:11917124, ECO:0000269|PubMed:12207002, ECO:0000269|PubMed:15078870, ECO:0000269|PubMed:18804029, ECO:0000269|PubMed:1897988, ECO:0000269|PubMed:24591641, ECO:0000269|PubMed:6490615, ECO:0000269|PubMed:7667299, ECO:0000269|PubMed:9395533}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:22325; Evidence={ECO:0000305|PubMed:11917124}; CATALYTIC ACTIVITY: Reaction=(5S,6S)-epoxy-(18R)-hydroxy-(7E,9E,11Z,14Z,16E)-eicosapentaenoate + H2O = resolvin E1; Xref=Rhea:RHEA:50272, ChEBI:CHEBI:15377, ChEBI:CHEBI:91000, ChEBI:CHEBI:132219; Evidence={ECO:0000269|PubMed:21206090}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:50273; Evidence={ECO:0000305|PubMed:21206090}; CATALYTIC ACTIVITY: Reaction=(5S,6S)-epoxy-(18S)-hydroxy-(7E,9E,11Z,14Z,16E)-eicosapentaenoate + H2O = 18S-resolvin E1; Xref=Rhea:RHEA:51988, ChEBI:CHEBI:15377, ChEBI:CHEBI:134661, ChEBI:CHEBI:136057; Evidence={ECO:0000269|PubMed:21206090}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:51989; Evidence={ECO:0000305|PubMed:21206090}; CATALYTIC ACTIVITY: Reaction=Release of the N-terminal residue from a tripeptide.; EC=3.4.11.4; Evidence={ECO:0000269|PubMed:11675384, ECO:0000269|PubMed:11917124, ECO:0000269|PubMed:20813919, ECO:0000269|PubMed:24591641, ECO:0000269|PubMed:9395533};",3.3.2.6; 3.4.11.4,"ACTIVITY REGULATION: Inhibited by bestatin (PubMed:11175901). The epoxide hydrolase activity is restrained by suicide inactivation that involves binding of LTA4 to Tyr-379 (PubMed:7667299). 4-(4-benzylphenyl)thiazol-2-amine (ARM1) selectively inhibits the epoxide hydrolase activity (PubMed:24591641). {ECO:0000269|PubMed:11175901, ECO:0000269|PubMed:24591641, ECO:0000269|PubMed:7667299}.",PATHWAY: Lipid metabolism; leukotriene B4 biosynthesis. {ECO:0000269|PubMed:11917124}.,ENST00000228740.7 [P09960-1];ENST00000413268.6 [P09960-3];ENST00000552789.5 [P09960-4];,LTA4H,ENSG00000111144,0.0,LTA4H,Non-canonical_RBPs,11.0,,,,,,LTA4H
P0C0L4,ENSG00000206340|ENSG00000227746|ENSG00000244731,CO4A_HUMAN,"complement activation [GO:0006956]; complement activation, classical pathway [GO:0006958]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; positive regulation of apoptotic cell clearance [GO:2000427]",axon [GO:0030424]; blood microparticle [GO:0072562]; dendrite [GO:0030425]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; neuronal cell body [GO:0043025]; plasma membrane [GO:0005886]; synapse [GO:0045202],complement component C1q complex binding [GO:0001849]; endopeptidase inhibitor activity [GO:0004866],"PTM: Prior to secretion, the single-chain precursor is enzymatically cleaved to yield non-identical chains alpha, beta and gamma. During activation, the alpha chain is cleaved by C1 into C4a and C4b, and C4b stays linked to the beta and gamma chains. Further degradation of C4b by C1 into the inactive fragments C4c and C4d blocks the generation of C3 convertase. The proteolytic cleavages often are incomplete so that many structural forms can be found in plasma.; PTM: N- and O-glycosylated. O-glycosylated with a core 1 or possibly core 8 glycan. {ECO:0000269|PubMed:12754519, ECO:0000269|PubMed:14760718, ECO:0000269|PubMed:16335952, ECO:0000269|PubMed:18780401, ECO:0000269|PubMed:19139490, ECO:0000269|PubMed:19159218, ECO:0000269|PubMed:19838169, ECO:0000269|PubMed:23234360}.",,"DOMAIN 702..736; /note=""Anaphylatoxin-like""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00022""; DOMAIN 1595..1742; /note=""NTR""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00295""","STRAND 22..32; /evidence=""ECO:0007829|PDB:5JTW""; STRAND 37..45; /evidence=""ECO:0007829|PDB:5JTW""; STRAND 51..59; /evidence=""ECO:0007829|PDB:5JTW""; STRAND 67..69; /evidence=""ECO:0007829|PDB:5JTW""; STRAND 72..77; /evidence=""ECO:0007829|PDB:5JTW""; STRAND 82..87; /evidence=""ECO:0007829|PDB:5JTW""; STRAND 107..113; /evidence=""ECO:0007829|PDB:5JTW""; STRAND 126..135; /evidence=""ECO:0007829|PDB:5JTW""; STRAND 139..146; /evidence=""ECO:0007829|PDB:5JTW""; STRAND 148..150; /evidence=""ECO:0007829|PDB:5JTW""; STRAND 155..163; /evidence=""ECO:0007829|PDB:5JTW""; STRAND 167..169; /evidence=""ECO:0007829|PDB:5JTW""; STRAND 174..179; /evidence=""ECO:0007829|PDB:5JTW""; STRAND 181..183; /evidence=""ECO:0007829|PDB:5JTW""; STRAND 185..191; /evidence=""ECO:0007829|PDB:5JTW""; STRAND 194..203; /evidence=""ECO:0007829|PDB:5JTW""; STRAND 210..221; /evidence=""ECO:0007829|PDB:5JTW""; STRAND 228..233; /evidence=""ECO:0007829|PDB:5JTW""; STRAND 240..253; /evidence=""ECO:0007829|PDB:5JTW""; STRAND 262..270; /evidence=""ECO:0007829|PDB:5JTW""; STRAND 278..287; /evidence=""ECO:0007829|PDB:5JTW""; STRAND 289..291; /evidence=""ECO:0007829|PDB:5JTW""; STRAND 293..295; /evidence=""ECO:0007829|PDB:5JTW""; STRAND 301..304; /evidence=""ECO:0007829|PDB:5JTW""; STRAND 309..314; /evidence=""ECO:0007829|PDB:5JTW""; STRAND 337..346; /evidence=""ECO:0007829|PDB:5JTW""; STRAND 352..357; /evidence=""ECO:0007829|PDB:5JTW""; STRAND 361..364; /evidence=""ECO:0007829|PDB:5JTW""; STRAND 366..370; /evidence=""ECO:0007829|PDB:5JTW""; STRAND 372..374; /evidence=""ECO:0007829|PDB:5JTW""; STRAND 382..392; /evidence=""ECO:0007829|PDB:5JTW""; STRAND 395..397; /evidence=""ECO:0007829|PDB:5JTW""; STRAND 402..409; /evidence=""ECO:0007829|PDB:5JTW""; STRAND 412..414; /evidence=""ECO:0007829|PDB:5JTW""; STRAND 417..424; /evidence=""ECO:0007829|PDB:5JTW""; STRAND 430..436; /evidence=""ECO:0007829|PDB:5JTW""; STRAND 442..450; /evidence=""ECO:0007829|PDB:5JTW""; STRAND 452..454; /evidence=""ECO:0007829|PDB:5JTW""; STRAND 456..463; /evidence=""ECO:0007829|PDB:5JTW""; STRAND 472..476; /evidence=""ECO:0007829|PDB:5JTW""; STRAND 488..498; /evidence=""ECO:0007829|PDB:5JTW""; STRAND 504..511; /evidence=""ECO:0007829|PDB:5JTW""; STRAND 514..522; /evidence=""ECO:0007829|PDB:5JTW""; STRAND 527..532; /evidence=""ECO:0007829|PDB:5JTW""; STRAND 539..549; /evidence=""ECO:0007829|PDB:5JTW""; STRAND 552..561; /evidence=""ECO:0007829|PDB:5JTW""; STRAND 571..575; /evidence=""ECO:0007829|PDB:5JTW""; STRAND 586..605; /evidence=""ECO:0007829|PDB:5JTW""; STRAND 652..655; /evidence=""ECO:0007829|PDB:5JTW""; STRAND 657..660; /evidence=""ECO:0007829|PDB:5JTW""; STRAND 780..782; /evidence=""ECO:0007829|PDB:6YSQ""; STRAND 786..798; /evidence=""ECO:0007829|PDB:6YSQ""; STRAND 804..814; /evidence=""ECO:0007829|PDB:6YSQ""; STRAND 818..821; /evidence=""ECO:0007829|PDB:6YSQ""; STRAND 825..829; /evidence=""ECO:0007829|PDB:6YSQ""; STRAND 832..837; /evidence=""ECO:0007829|PDB:6YSQ""; STRAND 849..851; /evidence=""ECO:0007829|PDB:6YSQ""; STRAND 853..857; /evidence=""ECO:0007829|PDB:6YSQ""; STRAND 859..861; /evidence=""ECO:0007829|PDB:6YSQ""; STRAND 863..869; /evidence=""ECO:0007829|PDB:6YSQ""; STRAND 875..877; /evidence=""ECO:0007829|PDB:5JTW""; STRAND 885..889; /evidence=""ECO:0007829|PDB:6YSQ""; STRAND 894..896; /evidence=""ECO:0007829|PDB:6YSQ""; STRAND 899..903; /evidence=""ECO:0007829|PDB:6YSQ""; STRAND 906..921; /evidence=""ECO:0007829|PDB:6YSQ""; STRAND 924..934; /evidence=""ECO:0007829|PDB:6YSQ""; STRAND 936..948; /evidence=""ECO:0007829|PDB:6YSQ""; STRAND 954..960; /evidence=""ECO:0007829|PDB:6YSQ""; STRAND 973..981; /evidence=""ECO:0007829|PDB:6YSQ""; STRAND 1035..1037; /evidence=""ECO:0007829|PDB:6YSQ""; STRAND 1068..1072; /evidence=""ECO:0007829|PDB:6YSQ""; STRAND 1113..1115; /evidence=""ECO:0007829|PDB:6YSQ""; STRAND 1225..1228; /evidence=""ECO:0007829|PDB:5JTW""; STRAND 1276..1278; /evidence=""ECO:0007829|PDB:6YSQ""; STRAND 1326..1335; /evidence=""ECO:0007829|PDB:6YSQ""; STRAND 1338..1350; /evidence=""ECO:0007829|PDB:6YSQ""; STRAND 1354..1356; /evidence=""ECO:0007829|PDB:6YSQ""; STRAND 1362..1364; /evidence=""ECO:0007829|PDB:6YSQ""; STRAND 1366..1370; /evidence=""ECO:0007829|PDB:6YSQ""; STRAND 1372..1374; /evidence=""ECO:0007829|PDB:6YSQ""; STRAND 1376..1386; /evidence=""ECO:0007829|PDB:6YSQ""; STRAND 1395..1405; /evidence=""ECO:0007829|PDB:6YSQ""; STRAND 1409..1411; /evidence=""ECO:0007829|PDB:5JTW""; STRAND 1465..1475; /evidence=""ECO:0007829|PDB:5JTW""; STRAND 1484..1489; /evidence=""ECO:0007829|PDB:5JTW""; STRAND 1494..1496; /evidence=""ECO:0007829|PDB:5JTW""; STRAND 1511..1518; /evidence=""ECO:0007829|PDB:5JTW""; STRAND 1521..1527; /evidence=""ECO:0007829|PDB:5JTW""; STRAND 1534..1544; /evidence=""ECO:0007829|PDB:5JTW""; STRAND 1552..1560; /evidence=""ECO:0007829|PDB:5JTW""; STRAND 1564..1570; /evidence=""ECO:0007829|PDB:5JTW""; STRAND 1573..1575; /evidence=""ECO:0007829|PDB:5JTW""; STRAND 1581..1584; /evidence=""ECO:0007829|PDB:5JTW""; STRAND 1587..1590; /evidence=""ECO:0007829|PDB:5JTW""; STRAND 1624..1637; /evidence=""ECO:0007829|PDB:5JTW""; STRAND 1640..1652; /evidence=""ECO:0007829|PDB:5JTW""; STRAND 1664..1670; /evidence=""ECO:0007829|PDB:5JTW""; STRAND 1681..1687; /evidence=""ECO:0007829|PDB:5JTW""; STRAND 1708..1711; /evidence=""ECO:0007829|PDB:5JTW""","HELIX 91..97; /evidence=""ECO:0007829|PDB:5JTW""; HELIX 99..101; /evidence=""ECO:0007829|PDB:5JTW""; HELIX 116..119; /evidence=""ECO:0007829|PDB:5JTW""; HELIX 316..325; /evidence=""ECO:0007829|PDB:5JTW""; HELIX 330..332; /evidence=""ECO:0007829|PDB:5JTW""; HELIX 607..611; /evidence=""ECO:0007829|PDB:5JTW""; HELIX 621..628; /evidence=""ECO:0007829|PDB:5JTW""; HELIX 629..631; /evidence=""ECO:0007829|PDB:5JTW""; HELIX 643..650; /evidence=""ECO:0007829|PDB:5JTW""; HELIX 878..880; /evidence=""ECO:0007829|PDB:6YSQ""; HELIX 997..1001; /evidence=""ECO:0007829|PDB:1HZF""; HELIX 1011..1030; /evidence=""ECO:0007829|PDB:1HZF""; HELIX 1041..1057; /evidence=""ECO:0007829|PDB:1HZF""; HELIX 1076..1089; /evidence=""ECO:0007829|PDB:1HZF""; HELIX 1090..1092; /evidence=""ECO:0007829|PDB:1HZF""; HELIX 1097..1107; /evidence=""ECO:0007829|PDB:1HZF""; HELIX 1108..1110; /evidence=""ECO:0007829|PDB:1HZF""; HELIX 1126..1132; /evidence=""ECO:0007829|PDB:1HZF""; HELIX 1137..1153; /evidence=""ECO:0007829|PDB:1HZF""; HELIX 1162..1185; /evidence=""ECO:0007829|PDB:1HZF""; HELIX 1190..1202; /evidence=""ECO:0007829|PDB:1HZF""; HELIX 1207..1218; /evidence=""ECO:0007829|PDB:1HZF""; HELIX 1259..1275; /evidence=""ECO:0007829|PDB:1HZF""; HELIX 1280..1292; /evidence=""ECO:0007829|PDB:1HZF""; HELIX 1294..1297; /evidence=""ECO:0007829|PDB:5JTW""; HELIX 1302..1319; /evidence=""ECO:0007829|PDB:1HZF""; HELIX 1498..1506; /evidence=""ECO:0007829|PDB:5JTW""; HELIX 1613..1618; /evidence=""ECO:0007829|PDB:5JTW""; HELIX 1716..1719; /evidence=""ECO:0007829|PDB:5JTW""; HELIX 1721..1723; /evidence=""ECO:0007829|PDB:5JTW""; HELIX 1726..1740; /evidence=""ECO:0007829|PDB:5JTW""","TURN 347..349; /evidence=""ECO:0007829|PDB:5JTW""; TURN 535..537; /evidence=""ECO:0007829|PDB:5JTW""; TURN 666..668; /evidence=""ECO:0007829|PDB:5JTW""; TURN 815..817; /evidence=""ECO:0007829|PDB:6YSQ""; TURN 950..953; /evidence=""ECO:0007829|PDB:6YSQ""; TURN 1062..1064; /evidence=""ECO:0007829|PDB:5JTW""; TURN 1158..1161; /evidence=""ECO:0007829|PDB:1HZF""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,C4A CO4 CPAMD2,Complement C4-A (Acidic complement C4) (C3 and PZP-like alpha-2-macroglobulin domain-containing protein 2) [Cleaved into: Complement C4 beta chain; Complement C4-A alpha chain; C4a anaphylatoxin; C4b-A; C4d-A; Complement C4 gamma chain],Homo sapiens (Human),1744.0,192785.0,MRLLWGLIWASSFFTLSLQKPRLLLFSPSVVHLGVPLSVGVQLQDVPRGQVVKGSVFLRNPSRNNVPCSPKVDFTLSSERDFALLSLQVPLKDAKSCGLHQLLRGPEVQLVAHSPWLKDSLSRTTNIQGINLLFSSRRGHLFLQTDQPIYNPGQRVRYRVFALDQKMRPSTDTITVMVENSHGLRVRKKEVYMPSSIFQDDFVIPDISEPGTWKISARFSDGLESNSSTQFEVKKYVLPNFEVKITPGKPYILTVPGHLDEMQLDIQARYIYGKPVQGVAYVRFGLLDEDGKKTFFRGLESQTKLVNGQSHISLSKAEFQDALEKLNMGITDLQGLRLYVAAAIIESPGGEMEEAELTSWYFVSSPFSLDLSKTKRHLVPGAPFLLQALVREMSGSPASGIPVKVSATVSSPGSVPEVQDIQQNTDGSGQVSIPIIIPQTISELQLSVSAGSPHPAIARLTVAAPPSGGPGFLSIERPDSRPPRVGDTLNLNLRAVGSGATFSHYYYMILSRGQIVFMNREPKRTLTSVSVFVDHHLAPSFYFVAFYYHGDHPVANSLRVDVQAGACEGKLELSVDGAKQYRNGESVKLHLETDSLALVALGALDTALYAAGSKSHKPLNMGKVFEAMNSYDLGCGPGGGDSALQVFQAAGLAFSDGDQWTLSRKRLSCPKEKTTRKKRNVNFQKAINEKLGQYASPTAKRCCQDGVTRLPMMRSCEQRAARVQQPDCREPFLSCCQFAESLRKKSRDKGQAGLQRALEILQEEDLIDEDDIPVRSFFPENWLWRVETVDRFQILTLWLPDSLTTWEIHGLSLSKTKGLCVATPVQLRVFREFHLHLRLPMSVRRFEQLELRPVLYNYLDKNLTVSVHVSPVEGLCLAGGGGLAQQVLVPAGSARPVAFSVVPTAAAAVSLKVVARGSFEFPVGDAVSKVLQIEKEGAIHREELVYELNPLDHRGRTLEIPGNSDPNMIPDGDFNSYVRVTASDPLDTLGSEGALSPGGVASLLRLPRGCGEQTMIYLAPTLAASRYLDKTEQWSTLPPETKDHAVDLIQKGYMRIQQFRKADGSYAAWLSRDSSTWLTAFVLKVLSLAQEQVGGSPEKLQETSNWLLSQQQADGSFQDPCPVLDRSMQGGLVGNDETVALTAFVTIALHHGLAVFQDEGAEPLKQRVEASISKANSFLGEKASAGLLGAHAAAITAYALTLTKAPVDLLGVAHNNLMAMAQETGDNLYWGSVTGSQSNAVSPTPAPRNPSDPMPQAPALWIETTAYALLHLLLHEGKAEMADQASAWLTRQGSFQGGFRSTQDTVIALDALSAYWIASHTTEERGLNVTLSSTGRNGFKSHALQLNNRQIRGLEEELQFSLGSKINVKVGGNSKGTLKVLRTYNVLDMKNTTCQDLQIEVTVKGHVEYTMEANEDYEDYEYDELPAKDDPDAPLQPVTPLQLFEGRRNRRRREAPKVVEEQESRVHYTVCIWRNGKVGLSGMAIADVTLLSGFHALRADLEKLTSLSDRYVSHFETEGPHVLLYFDSVPTSRECVGFEAVQEVPVGLVQPASATLYDYYNPERRCSVFYGAPSKSRLLATLCSAEVCQCAEGKCPRQRRALERGLQDEDGYRMKFACYYPRVEYGFQVKVLREDSRAAFRLFETKITQVLHFTKDVKAAANQMRNFLVRASCRLRLEPGKEYLIMGLDGATYDLEGHPQYLLDSNSWIEEMPSERLCRSTRQRAACAQLNDFLQEYGTQGCQV,True,False,False,P0C0L4,"[('cd00017', 'ANATO'), ('cd02896', 'complement_C3_C4_C5'), ('cd03584', 'NTR_complement_C4'), ('G3DSA:1.20.91.20', 'Anaphylotoxins (complement system)'), ('G3DSA:1.50.10.20', None), ('G3DSA:2.20.130.20', None), ('G3DSA:2.40.50.120', None), ('G3DSA:2.60.120.1540', None), ('G3DSA:2.60.40.10', 'Immunoglobulins'), ('G3DSA:2.60.40.1930', None), ('G3DSA:2.60.40.1940', None), ('G3DSA:2.60.40.690', 'Alpha-macroglobulin, receptor-binding domain'), ('G3DSA:6.20.50.160', None), ('IPR000020', 'Anaphylatoxin/fibulin'), ('IPR001134', 'Netrin domain'), ('IPR001599', 'Alpha-2-macroglobulin'), ('IPR001840', 'Anaphylatoxin, complement system domain'), ('IPR002890', 'Macroglobulin domain'), ('IPR008930', 'Terpenoid cyclases/protein prenyltransferase alpha-alpha toroid'), ('IPR008993', 'Tissue inhibitor of metalloproteinases-like, OB-fold')]",,"""ENSG00000244731; Tissue enhanced (adrenal gland, liver)."";",,,,,ENST00000383325.8;ENST00000421274.7;ENST00000428956.7 [P0C0L4-1];ENST00000498271.1 [P0C0L4-2];,C4A,ENSG00000244731,2.0,,,,,,,0.061,,C4A
P0CG47,ENSG00000170315,UBB_HUMAN,energy homeostasis [GO:0097009]; fat pad development [GO:0060613]; female gonad development [GO:0008585]; female meiosis I [GO:0007144]; hypothalamus gonadotrophin-releasing hormone neuron development [GO:0021888]; male meiosis I [GO:0007141]; mitochondrion transport along microtubule [GO:0047497]; modification-dependent protein catabolic process [GO:0019941]; neuron projection morphogenesis [GO:0048812]; positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator [GO:1902255]; positive regulation of protein monoubiquitination [GO:1902527]; positive regulation of protein ubiquitination [GO:0031398]; protein ubiquitination [GO:0016567]; regulation of mitochondrial membrane potential [GO:0051881]; regulation of neuron apoptotic process [GO:0043523]; regulation of proteasomal protein catabolic process [GO:0061136]; seminiferous tubule development [GO:0072520],cytosol [GO:0005829]; endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; vesicle [GO:0031982],protein tag activity [GO:0031386]; ubiquitin protein ligase binding [GO:0031625],"PTM: [Ubiquitin]: Phosphorylated at Ser-65 by PINK1 during mitophagy (PubMed:24660806, PubMed:24751536, PubMed:24784582, PubMed:25527291, PubMed:26161729). Phosphorylated ubiquitin specifically binds and activates parkin (PRKN), triggering mitophagy (PubMed:24660806, PubMed:24751536, PubMed:24784582, PubMed:25527291, PubMed:26161729). Phosphorylation does not affect E1-mediated E2 charging of ubiquitin but affects discharging of E2 enzymes to form polyubiquitin chains. It also affects deubiquitination by deubiquitinase enzymes such as USP30 (PubMed:25527291). {ECO:0000269|PubMed:24660806, ECO:0000269|PubMed:24751536, ECO:0000269|PubMed:24784582, ECO:0000269|PubMed:25527291, ECO:0000269|PubMed:26161729}.; PTM: [Ubiquitin]: Mono-ADP-ribosylated at the C-terminus by PARP9, a component of the PPAR9-DTX3L complex. ADP-ribosylation requires processing by E1 and E2 enzymes and prevents ubiquitin conjugation to substrates such as histones. {ECO:0000269|PubMed:28525742}.; PTM: [Ubiquitin]: (Microbial infection) Mono-ADP-ribosylated at Thr-66 by the C.violaceum CteC virulence factor. ADP-ribosylation causes the shutdown of polyubiquitin synthesis and disrupts the recognition and reversal of polyubiquitin. {ECO:0000269|PubMed:32330457}.",,"DOMAIN 1..76; /note=""Ubiquitin-like 1""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00214""; DOMAIN 77..152; /note=""Ubiquitin-like 2""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00214""; DOMAIN 153..228; /note=""Ubiquitin-like 3""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00214""","STRAND 78..82; /evidence=""ECO:0007829|PDB:7RBR""; STRAND 84..86; /evidence=""ECO:0007829|PDB:7MYH""; STRAND 88..92; /evidence=""ECO:0007829|PDB:7RBR""; STRAND 117..121; /evidence=""ECO:0007829|PDB:7RBR""; STRAND 142..147; /evidence=""ECO:0007829|PDB:7RBR""; STRAND 154..159; /evidence=""ECO:0007829|PDB:5NVG""; STRAND 160..162; /evidence=""ECO:0007829|PDB:7NBB""; STRAND 164..168; /evidence=""ECO:0007829|PDB:5NVG""; STRAND 171..174; /evidence=""ECO:0007829|PDB:5XPK""; STRAND 193..197; /evidence=""ECO:0007829|PDB:5NVG""; STRAND 200..202; /evidence=""ECO:0007829|PDB:7UV5""; STRAND 206..208; /evidence=""ECO:0007829|PDB:5GO7""; STRAND 218..223; /evidence=""ECO:0007829|PDB:5NVG""; STRAND 226..228; /evidence=""ECO:0007829|PDB:8EFW""","HELIX 99..110; /evidence=""ECO:0007829|PDB:7RBR""; HELIX 114..116; /evidence=""ECO:0007829|PDB:7RBR""; HELIX 133..135; /evidence=""ECO:0007829|PDB:7RBR""; HELIX 175..186; /evidence=""ECO:0007829|PDB:5NVG""; HELIX 190..192; /evidence=""ECO:0007829|PDB:5NVG""; HELIX 209..211; /evidence=""ECO:0007829|PDB:5NVG""",,"cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,UBB,Polyubiquitin-B [Cleaved into: Ubiquitin],Homo sapiens (Human),229.0,25762.0,MQIFVKTLTGKTITLEVEPSDTIENVKAKIQDKEGIPPDQQRLIFAGKQLEDGRTLSDYNIQKESTLHLVLRLRGGMQIFVKTLTGKTITLEVEPSDTIENVKAKIQDKEGIPPDQQRLIFAGKQLEDGRTLSDYNIQKESTLHLVLRLRGGMQIFVKTLTGKTITLEVEPSDTIENVKAKIQDKEGIPPDQQRLIFAGKQLEDGRTLSDYNIQKESTLHLVLRLRGGC,False,False,True,P0CG47,"[('cd01803', 'ubiquitin-like (Ubl) domain found in ubiquitin'), ('G3DSA:3.10.20.90', 'Phosphatidylinositol 3-kinase Catalytic Subunit; Chain A, domain 1'), ('IPR000626', 'Ubiquitin-like domain'), ('IPR019954', 'Ubiquitin conserved site'), ('IPR019956', 'Ubiquitin domain'), ('IPR029071', 'Ubiquitin-like domain superfamily'), ('IPR050158', 'Ubiquitin and ubiquitin-like'), ('PF00240', 'Ubiquitin family'), ('PR00348', 'UBIQUITIN'), ('PS00299', 'Ubiquitin domain signature'), ('PS50053', 'Ubiquitin domain profile'), ('PTHR10666', 'Ubiquitin and ubiquitin-like'), ('SM00213', 'Ubiquitin homologues'), ('SSF54236', 'Ubiquitin-like')]",,"""ENSG00000170315; Low tissue specificity."";",,,,,ENST00000302182.8;ENST00000395837.1;ENST00000395839.5;ENST00000614404.1;,UBB,ENSG00000170315,0.0,,,,,,,,,UBB
P0CG48,ENSG00000150991,UBC_HUMAN,modification-dependent protein catabolic process [GO:0019941]; protein ubiquitination [GO:0016567],cytosol [GO:0005829]; endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; mitochondrial outer membrane [GO:0005741]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; vesicle [GO:0031982],protein tag activity [GO:0031386]; RNA binding [GO:0003723]; ubiquitin protein ligase binding [GO:0031625],"PTM: [Ubiquitin]: Phosphorylated at Ser-65 by PINK1 during mitophagy. Phosphorylated ubiquitin specifically binds and activates parkin (PRKN), triggering mitophagy (PubMed:24660806, PubMed:24751536, PubMed:24784582, PubMed:25527291). Phosphorylation does not affect E1-mediated E2 charging of ubiquitin but affects discharging of E2 enzymes to form polyubiquitin chains. It also affects deubiquitination by deubiquitinase enzymes such as USP30 (PubMed:25527291). {ECO:0000269|PubMed:24660806, ECO:0000269|PubMed:24751536, ECO:0000269|PubMed:24784582, ECO:0000269|PubMed:25527291}.; PTM: [Ubiquitin]: Mono-ADP-ribosylated at the C-terminus by PARP9, a component of the PPAR9-DTX3L complex. ADP-ribosylation requires processing by E1 and E2 enzymes and prevents ubiquitin conjugation to substrates such as histones. {ECO:0000269|PubMed:28525742}.; PTM: [Ubiquitin]: (Microbial infection) Mono-ADP-ribosylated at Thr-66 by the C.violaceum CteC virulence factor. ADP-ribosylation causes the shutdown of polyubiquitin synthesis and disrupts the recognition and reversal of polyubiquitin. {ECO:0000269|PubMed:32330457}.",,"DOMAIN 1..76; /note=""Ubiquitin-like 1""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00214""; DOMAIN 77..152; /note=""Ubiquitin-like 2""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00214""; DOMAIN 153..228; /note=""Ubiquitin-like 3""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00214""; DOMAIN 229..304; /note=""Ubiquitin-like 4""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00214""; DOMAIN 305..380; /note=""Ubiquitin-like 5""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00214""; DOMAIN 381..456; /note=""Ubiquitin-like 6""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00214""; DOMAIN 457..532; /note=""Ubiquitin-like 7""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00214""; DOMAIN 533..608; /note=""Ubiquitin-like 8""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00214""; DOMAIN 609..684; /note=""Ubiquitin-like 9""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00214""","STRAND 381..386; /evidence=""ECO:0007829|PDB:7YUI""; STRAND 392..397; /evidence=""ECO:0007829|PDB:7YUI""; STRAND 421..425; /evidence=""ECO:0007829|PDB:7YUI""; STRAND 428..430; /evidence=""ECO:0007829|PDB:5B83""; STRAND 446..451; /evidence=""ECO:0007829|PDB:7YUI""; STRAND 458..463; /evidence=""ECO:0007829|PDB:5H07""; STRAND 468..472; /evidence=""ECO:0007829|PDB:5H07""; STRAND 497..501; /evidence=""ECO:0007829|PDB:5H07""; STRAND 522..527; /evidence=""ECO:0007829|PDB:5H07""; STRAND 534..539; /evidence=""ECO:0007829|PDB:3B08""; STRAND 540..542; /evidence=""ECO:0007829|PDB:6N6R""; STRAND 544..548; /evidence=""ECO:0007829|PDB:3B08""; STRAND 573..577; /evidence=""ECO:0007829|PDB:3B08""; STRAND 579..581; /evidence=""ECO:0007829|PDB:3N3K""; STRAND 586..588; /evidence=""ECO:0007829|PDB:6N6R""; STRAND 598..603; /evidence=""ECO:0007829|PDB:3B08""; STRAND 610..615; /evidence=""ECO:0007829|PDB:6Q00""; STRAND 616..618; /evidence=""ECO:0007829|PDB:4K1R""; STRAND 620..624; /evidence=""ECO:0007829|PDB:6Q00""; STRAND 627..630; /evidence=""ECO:0007829|PDB:1G6J""; STRAND 649..653; /evidence=""ECO:0007829|PDB:6Q00""; STRAND 656..658; /evidence=""ECO:0007829|PDB:6TUV""; STRAND 662..664; /evidence=""ECO:0007829|PDB:3VUX""; STRAND 671..673; /evidence=""ECO:0007829|PDB:6EQI""; STRAND 674..679; /evidence=""ECO:0007829|PDB:6Q00""; STRAND 681..683; /evidence=""ECO:0007829|PDB:6TUV""","HELIX 403..414; /evidence=""ECO:0007829|PDB:7YUI""; HELIX 418..420; /evidence=""ECO:0007829|PDB:7YUI""; HELIX 479..490; /evidence=""ECO:0007829|PDB:5H07""; HELIX 494..496; /evidence=""ECO:0007829|PDB:5H07""; HELIX 513..515; /evidence=""ECO:0007829|PDB:5H07""; HELIX 555..566; /evidence=""ECO:0007829|PDB:3B08""; HELIX 570..572; /evidence=""ECO:0007829|PDB:3B08""; HELIX 589..591; /evidence=""ECO:0007829|PDB:3B08""; HELIX 631..642; /evidence=""ECO:0007829|PDB:6Q00""; HELIX 646..648; /evidence=""ECO:0007829|PDB:6Q00""; HELIX 665..667; /evidence=""ECO:0007829|PDB:6Q00""","TURN 436..440; /evidence=""ECO:0007829|PDB:7YUI""; TURN 529..531; /evidence=""ECO:0007829|PDB:7EB9""; TURN 668..670; /evidence=""ECO:0007829|PDB:5OXH""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,UBC,Polyubiquitin-C [Cleaved into: Ubiquitin],Homo sapiens (Human),685.0,77039.0,MQIFVKTLTGKTITLEVEPSDTIENVKAKIQDKEGIPPDQQRLIFAGKQLEDGRTLSDYNIQKESTLHLVLRLRGGMQIFVKTLTGKTITLEVEPSDTIENVKAKIQDKEGIPPDQQRLIFAGKQLEDGRTLSDYNIQKESTLHLVLRLRGGMQIFVKTLTGKTITLEVEPSDTIENVKAKIQDKEGIPPDQQRLIFAGKQLEDGRTLSDYNIQKESTLHLVLRLRGGMQIFVKTLTGKTITLEVEPSDTIENVKAKIQDKEGIPPDQQRLIFAGKQLEDGRTLSDYNIQKESTLHLVLRLRGGMQIFVKTLTGKTITLEVEPSDTIENVKAKIQDKEGIPPDQQRLIFAGKQLEDGRTLSDYNIQKESTLHLVLRLRGGMQIFVKTLTGKTITLEVEPSDTIENVKAKIQDKEGIPPDQQRLIFAGKQLEDGRTLSDYNIQKESTLHLVLRLRGGMQIFVKTLTGKTITLEVEPSDTIENVKAKIQDKEGIPPDQQRLIFAGKQLEDGRTLSDYNIQKESTLHLVLRLRGGMQIFVKTLTGKTITLEVEPSDTIENVKAKIQDKEGIPPDQQRLIFAGKQLEDGRTLSDYNIQKESTLHLVLRLRGGMQIFVKTLTGKTITLEVEPSDTIENVKAKIQDKEGIPPDQQRLIFAGKQLEDGRTLSDYNIQKESTLHLVLRLRGGV,False,False,True,P0CG48,"[('cd01803', 'ubiquitin-like (Ubl) domain found in ubiquitin'), ('G3DSA:3.10.20.90', 'Phosphatidylinositol 3-kinase Catalytic Subunit; Chain A, domain 1'), ('IPR000626', 'Ubiquitin-like domain'), ('IPR019954', 'Ubiquitin conserved site'), ('IPR019956', 'Ubiquitin domain'), ('IPR029071', 'Ubiquitin-like domain superfamily'), ('IPR050158', 'Ubiquitin and ubiquitin-like'), ('PF00240', 'Ubiquitin family'), ('PR00348', 'UBIQUITIN'), ('PS00299', 'Ubiquitin domain signature'), ('PS50053', 'Ubiquitin domain profile'), ('PTHR10666', 'Ubiquitin and ubiquitin-like'), ('SM00213', 'Ubiquitin homologues'), ('SSF54236', 'Ubiquitin-like')]",,"""ENSG00000150991; Low tissue specificity."";",,,,,ENST00000339647.6;ENST00000536769.1;,UBC,ENSG00000150991,0.0,UBC,Non-canonical_RBPs,3.0,,,,,,UBC
P0DP23,ENSG00000198668,CALM1_HUMAN,autophagosome membrane docking [GO:0016240]; cellular response to interferon-beta [GO:0035458]; cellular response to type II interferon [GO:0071346]; detection of calcium ion [GO:0005513]; G protein-coupled receptor signaling pathway [GO:0007186]; G2/M transition of mitotic cell cycle [GO:0000086]; mitochondrion-endoplasmic reticulum membrane tethering [GO:1990456]; negative regulation of calcium ion export across plasma membrane [GO:1905913]; negative regulation of high voltage-gated calcium channel activity [GO:1901842]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; negative regulation of ryanodine-sensitive calcium-release channel activity [GO:0060315]; organelle localization by membrane tethering [GO:0140056]; positive regulation of cyclic-nucleotide phosphodiesterase activity [GO:0051343]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of phosphoprotein phosphatase activity [GO:0032516]; positive regulation of protein autophosphorylation [GO:0031954]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of ryanodine-sensitive calcium-release channel activity [GO:0060316]; presynaptic endocytosis [GO:0140238]; regulation of calcium-mediated signaling [GO:0050848]; regulation of cardiac muscle cell action potential [GO:0098901]; regulation of cardiac muscle contraction [GO:0055117]; regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion [GO:0010881]; regulation of cell communication by electrical coupling involved in cardiac conduction [GO:1901844]; regulation of cytokinesis [GO:0032465]; regulation of heart rate [GO:0002027]; regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum [GO:0010880]; regulation of ryanodine-sensitive calcium-release channel activity [GO:0060314]; response to calcium ion [GO:0051592]; substantia nigra development [GO:0021762],calcium channel complex [GO:0034704]; calyx of Held [GO:0044305]; catalytic complex [GO:1902494]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular region [GO:0005576]; myelin sheath [GO:0043209]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; presynaptic cytosol [GO:0099523]; protein-containing complex [GO:0032991]; sarcomere [GO:0030017]; sperm midpiece [GO:0097225]; spindle microtubule [GO:0005876]; spindle pole [GO:0000922]; vesicle [GO:0031982]; voltage-gated potassium channel complex [GO:0008076],adenylate cyclase activator activity [GO:0010856]; calcium channel inhibitor activity [GO:0019855]; calcium ion binding [GO:0005509]; calcium-dependent protein binding [GO:0048306]; protein kinase binding [GO:0019901]; protein phosphatase activator activity [GO:0072542]; protein serine/threonine kinase activator activity [GO:0043539]; titin binding [GO:0031432]; transmembrane transporter binding [GO:0044325],PTM: Ubiquitination results in a strongly decreased activity. {ECO:0000250}.; PTM: Phosphorylation results in a decreased activity. {ECO:0000250}.,"DOMAIN: The N-terminal and C-terminal lobes of CALM bind to the C-terminus of KCNQ1 in a clamp-like conformation. Binding of CALM C-terminus to KCNQ1 is calcium-independent but is essential for assembly of the structure. Binding of CALM N-terminus to KCNQ1 is calcium-dependent and regulates electrophysiological activity of the channel (PubMed:25441029). The C-lobe interacts with KCNN4 channels in a calcium-independent manner, whereas the N-lobe interacts with the S4-S5 linker of KCNN4 in a calcium-dependent manner playing a role as calcium sensor and gating the channel (PubMed:29724949). {ECO:0000269|PubMed:25441029, ECO:0000269|PubMed:29724949}.","DOMAIN 8..43; /note=""EF-hand 1""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00448""; DOMAIN 44..79; /note=""EF-hand 2""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00448""; DOMAIN 81..116; /note=""EF-hand 3""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00448""; DOMAIN 117..149; /note=""EF-hand 4""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00448""","STRAND 21..23; /evidence=""ECO:0007829|PDB:2M0J""; STRAND 25..28; /evidence=""ECO:0007829|PDB:4DJC""; STRAND 61..65; /evidence=""ECO:0007829|PDB:4DJC""; STRAND 94..96; /evidence=""ECO:0007829|PDB:1WRZ""; STRAND 97..101; /evidence=""ECO:0007829|PDB:4DJC""; STRAND 113..115; /evidence=""ECO:0007829|PDB:4LZX""; STRAND 133..138; /evidence=""ECO:0007829|PDB:4DJC""","HELIX 2..4; /evidence=""ECO:0007829|PDB:4DJC""; HELIX 7..20; /evidence=""ECO:0007829|PDB:4DJC""; HELIX 30..39; /evidence=""ECO:0007829|PDB:4DJC""; HELIX 46..56; /evidence=""ECO:0007829|PDB:4DJC""; HELIX 57..59; /evidence=""ECO:0007829|PDB:4LZX""; HELIX 66..93; /evidence=""ECO:0007829|PDB:4DJC""; HELIX 103..112; /evidence=""ECO:0007829|PDB:4DJC""; HELIX 119..129; /evidence=""ECO:0007829|PDB:4DJC""; HELIX 139..146; /evidence=""ECO:0007829|PDB:4DJC""","TURN 130..132; /evidence=""ECO:0007829|PDB:4DCK""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,CALM1 CALM CAM CAM1,Calmodulin-1,Homo sapiens (Human),149.0,16838.0,MADQLTEEQIAEFKEAFSLFDKDGDGTITTKELGTVMRSLGQNPTEAELQDMINEVDADGNGTIDFPEFLTMMARKMKDTDSEEEIREAFRVFDKDGNGYISAAELRHVMTNLGEKLTDEEVDEMIREADIDGDGQVNYEEFVQMMTAK,False,False,True,P0DP23,"[('cd00051', 'EFh'), ('G3DSA:1.10.238.10', 'EF-hand'), ('IPR002048', 'EF-hand domain'), ('IPR011992', 'EF-hand domain pair'), ('IPR018247', 'EF-Hand 1, calcium-binding site'), ('IPR050230', 'Calmodulin/Myosin light chain/Troponin C-like'), ('PF13499', 'EF-hand domain pair'), ('PR00450', 'RECOVERIN'), ('PS00018', 'EF-hand calcium-binding domain'), ('PS50222', 'EF-hand calcium-binding domain profile'), ('PTHR23048', 'Calcium-Regulated Muscle Contraction and Cellular Process'), ('SM00054', 'EF-hand, calcium binding motif'), ('SSF47473', 'EF-hand')]",,"""ENSG00000198668; Low tissue specificity."";",,,"ACTIVITY REGULATION: (Microbial infection) Inactivated by S.flexneri OspC1 and OspC3 proteins, which specifically bind the apo-form of calmodulin, thereby preventing calcium-binding and activity. {ECO:0000269|PubMed:35568036}.",,ENST00000356978.9;,CALM1,ENSG00000198668,0.0,,,,6.71,DP02013,0.57,,,CALM1
P10275,ENSG00000169083,ANDR_HUMAN,activation of prostate induction by androgen receptor signaling pathway [GO:0060520]; androgen receptor signaling pathway [GO:0030521]; animal organ formation [GO:0048645]; cell-cell signaling [GO:0007267]; cellular response to estrogen stimulus [GO:0071391]; cellular response to steroid hormone stimulus [GO:0071383]; cellular response to testosterone stimulus [GO:0071394]; epithelial cell differentiation involved in prostate gland development [GO:0060742]; epithelial cell morphogenesis [GO:0003382]; epithelial cell proliferation [GO:0050673]; estrogen receptor signaling pathway [GO:0030520]; in utero embryonic development [GO:0001701]; insulin-like growth factor receptor signaling pathway [GO:0048009]; intracellular receptor signaling pathway [GO:0030522]; lateral sprouting involved in mammary gland duct morphogenesis [GO:0060599]; Leydig cell differentiation [GO:0033327]; male genitalia morphogenesis [GO:0048808]; male gonad development [GO:0008584]; male somatic sex determination [GO:0019102]; mammary gland alveolus development [GO:0060749]; MAPK cascade [GO:0000165]; morphogenesis of an epithelial fold [GO:0060571]; multicellular organism growth [GO:0035264]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of integrin biosynthetic process [GO:0045720]; negative regulation of transcription by RNA polymerase II [GO:0000122]; non-membrane-bounded organelle assembly [GO:0140694]; nuclear receptor-mediated steroid hormone signaling pathway [GO:0030518]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of epithelial cell proliferation involved in prostate gland development [GO:0060769]; positive regulation of gene expression [GO:0010628]; positive regulation of insulin-like growth factor receptor signaling pathway [GO:0043568]; positive regulation of integrin biosynthetic process [GO:0045726]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of phosphorylation [GO:0042327]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription by RNA polymerase III [GO:0045945]; prostate gland epithelium morphogenesis [GO:0060740]; prostate gland growth [GO:0060736]; regulation of developmental growth [GO:0048638]; regulation of protein localization to plasma membrane [GO:1903076]; regulation of systemic arterial blood pressure [GO:0003073]; seminiferous tubule development [GO:0072520]; signal transduction [GO:0007165]; single fertilization [GO:0007338]; spermatogenesis [GO:0007283]; tertiary branching involved in mammary gland duct morphogenesis [GO:0060748]; transcription by RNA polymerase II [GO:0006366],chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991],"androgen binding [GO:0005497]; ATPase binding [GO:0051117]; beta-catenin binding [GO:0008013]; chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; enzyme binding [GO:0019899]; estrogen response element binding [GO:0034056]; G protein-coupled receptor activity [GO:0004930]; molecular adaptor activity [GO:0060090]; molecular condensate scaffold activity [GO:0140693]; nuclear receptor activity [GO:0004879]; POU domain binding [GO:0070974]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II general transcription initiation factor binding [GO:0001091]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; signaling receptor binding [GO:0005102]; steroid binding [GO:0005496]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator binding [GO:0001223]; zinc ion binding [GO:0008270]","PTM: Sumoylated on Lys-388 (major) and Lys-521. Ubiquitinated. Deubiquitinated by USP26. 'Lys-6' and 'Lys-27'-linked polyubiquitination by RNF6 modulates AR transcriptional activity and specificity. {ECO:0000269|PubMed:11121022, ECO:0000269|PubMed:19345326, ECO:0000269|PubMed:20501646}.; PTM: Phosphorylated in prostate cancer cells in response to several growth factors including EGF. Phosphorylation is induced by c-Src kinase (CSK). Tyr-535 is one of the major phosphorylation sites and an increase in phosphorylation and Src kinase activity is associated with prostate cancer progression. Phosphorylation by TNK2 enhances the DNA-binding and transcriptional activity and may be responsible for androgen-independent progression of prostate cancer. Phosphorylation at Ser-83 by CDK9 regulates AR promoter selectivity and cell growth. Phosphorylation by PAK6 leads to AR-mediated transcription inhibition. {ECO:0000269|PubMed:14573606, ECO:0000269|PubMed:17045208, ECO:0000269|PubMed:17494760, ECO:0000269|PubMed:20623637, ECO:0000269|PubMed:20980437, ECO:0000269|PubMed:21512132}.; PTM: Palmitoylated by ZDHHC7 and ZDHHC21. Palmitoylation is required for plasma membrane targeting and for rapid intracellular signaling via ERK and AKT kinases and cAMP generation. {ECO:0000269|PubMed:22031296}.","DOMAIN: Composed of three domains: a modulating N-terminal domain, a DNA-binding domain and a C-terminal ligand-binding domain. In the presence of bound steroid the ligand-binding domain interacts with the N-terminal modulating domain, and thereby activates AR transcription factor activity. Agonist binding is required for dimerization and binding to target DNA. The transcription factor activity of the complex formed by ligand-activated AR and DNA is modulated by interactions with coactivator and corepressor proteins (PubMed:25091737). Interaction with RANBP9 is mediated by both the N-terminal domain and the DNA-binding domain. Interaction with EFCAB6/DJBP is mediated by the DNA-binding domain. {ECO:0000269|PubMed:25091737}.","DOMAIN 669..900; /note=""NR LBD""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU01189""","STRAND 667..669; /evidence=""ECO:0007829|PDB:1XJ7""; STRAND 692..694; /evidence=""ECO:0007829|PDB:5VO4""; STRAND 761..766; /evidence=""ECO:0007829|PDB:8E1A""; STRAND 769..771; /evidence=""ECO:0007829|PDB:8E1A""; STRAND 815..818; /evidence=""ECO:0007829|PDB:8E1A""; STRAND 911..914; /evidence=""ECO:0007829|PDB:8E1A""","HELIX 22..29; /evidence=""ECO:0007829|PDB:3V49""; HELIX 673..681; /evidence=""ECO:0007829|PDB:8E1A""; HELIX 698..721; /evidence=""ECO:0007829|PDB:8E1A""; HELIX 726..728; /evidence=""ECO:0007829|PDB:8E1A""; HELIX 731..758; /evidence=""ECO:0007829|PDB:8E1A""; HELIX 773..778; /evidence=""ECO:0007829|PDB:8E1A""; HELIX 782..797; /evidence=""ECO:0007829|PDB:8E1A""; HELIX 802..813; /evidence=""ECO:0007829|PDB:8E1A""; HELIX 825..844; /evidence=""ECO:0007829|PDB:8E1A""; HELIX 850..883; /evidence=""ECO:0007829|PDB:8E1A""; HELIX 885..888; /evidence=""ECO:0007829|PDB:8E1A""; HELIX 894..902; /evidence=""ECO:0007829|PDB:8E1A""; HELIX 904..908; /evidence=""ECO:0007829|PDB:8E1A""",,"cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,AR DHTR NR3C4,Androgen receptor (Dihydrotestosterone receptor) (Nuclear receptor subfamily 3 group C member 4),Homo sapiens (Human),920.0,99188.0,MEVQLGLGRVYPRPPSKTYRGAFQNLFQSVREVIQNPGPRHPEAASAAPPGASLLLLQQQQQQQQQQQQQQQQQQQQQQQETSPRQQQQQQGEDGSPQAHRRGPTGYLVLDEEQQPSQPQSALECHPERGCVPEPGAAVAASKGLPQQLPAPPDEDDSAAPSTLSLLGPTFPGLSSCSADLKDILSEASTMQLLQQQQQEAVSEGSSSGRAREASGAPTSSKDNYLGGTSTISDNAKELCKAVSVSMGLGVEALEHLSPGEQLRGDCMYAPLLGVPPAVRPTPCAPLAECKGSLLDDSAGKSTEDTAEYSPFKGGYTKGLEGESLGCSGSAAAGSSGTLELPSTLSLYKSGALDEAAAYQSRDYYNFPLALAGPPPPPPPPHPHARIKLENPLDYGSAWAAAAAQCRYGDLASLHGAGAAGPGSGSPSAAASSSWHTLFTAEEGQLYGPCGGGGGGGGGGGGGGGGGGGGGGGEAGAVAPYGYTRPPQGLAGQESDFTAPDVWYPGGMVSRVPYPSPTCVKSEMGPWMDSYSGPYGDMRLETARDHVLPIDYYFPPQKTCLICGDEASGCHYGALTCGSCKVFFKRAAEGKQKYLCASRNDCTIDKFRRKNCPSCRLRKCYEAGMTLGARKLKKLGNLKLQEEGEASSTTSPTEETTQKLTVSHIEGYECQPIFLNVLEAIEPGVVCAGHDNNQPDSFAALLSSLNELGERQLVHVVKWAKALPGFRNLHVDDQMAVIQYSWMGLMVFAMGWRSFTNVNSRMLYFAPDLVFNEYRMHKSRMYSQCVRMRHLSQEFGWLQITPQEFLCMKALLLFSIIPVDGLKNQKFFDELRMNYIKELDRIIACKRKNPTSCSRRFYQLTKLLDSVQPIARELHQFTFDLLIKSHMVSVDFPEMMAEIISVQVPKILSGKVKPIYFHTQ,False,False,True,P10275,"[('cd07073', 'Ligand binding domain of the nuclear receptor androgen receptor, ligand activated transcription regulator'), ('cd07173', 'DNA-binding domain of androgen receptor (AR) is composed of two C4-type zinc fingers'), ('G3DSA:1.10.565.10', 'Retinoid X Receptor'), ('G3DSA:3.30.50.10', 'Erythroid Transcription Factor GATA-1, subunit A'), ('IPR000536', 'Nuclear hormone receptor, ligand-binding domain'), ('IPR001103', 'Androgen receptor'), ('IPR001628', 'Zinc finger, nuclear hormone receptor-type'), ('IPR013088', 'Zinc finger, NHR/GATA-type'), ('IPR035500', 'Nuclear hormone receptor-like domain superfamily'), ('IPR050200', 'Nuclear hormone receptor family NR3 subfamily'), ('PF00104', 'Ligand-binding domain of nuclear hormone receptor'), ('PF00105', 'Double treble clef zinc finger, C4 type'), ('PF02166', 'Androgen receptor'), ('PR00047', 'STROIDFINGER'), ('PR00521', 'ANDROGENR'), ('PS00031', 'Nuclear hormones receptors DNA-binding region signature'), ('PS51030', 'Nuclear hormone receptors DNA-binding domain profile'), ('PS51843', 'Nuclear receptor (NR) ligand-binding (LBD) domain profile'), ('PTHR48092', 'Nuclear hormone receptor family NR3 subfamily'), ('SM00399', 'c4 zinc finger in nuclear hormone receptors')]",P10275;,"""ENSG00000169083; Tissue enhanced (liver)."";",,,"ACTIVITY REGULATION: AIM-100 (4-amino-5,6-biaryl-furo[2,3-d]pyrimidine) suppresses TNK2-mediated phosphorylation at Tyr-269. Inhibits the binding of the Tyr-269 phosphorylated form to androgen-responsive enhancers (AREs) and its transcriptional activity. {ECO:0000269|PubMed:20623637}.",,ENST00000374690.9 [P10275-1];ENST00000504326.5 [P10275-3];ENST00000612452.5 [P10275-1];,AR,ENSG00000169083;ENSG00000235610,0.0,,,,58.37,DP00492,0.617,0.62,0.18,AR
P10276,ENSG00000131759,RARA_HUMAN,apoptotic cell clearance [GO:0043277]; cell differentiation [GO:0030154]; cellular response to estrogen stimulus [GO:0071391]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to retinoic acid [GO:0071300]; chondroblast differentiation [GO:0060591]; embryonic camera-type eye development [GO:0031076]; face development [GO:0060324]; female pregnancy [GO:0007565]; germ cell development [GO:0007281]; glandular epithelial cell development [GO:0002068]; growth plate cartilage development [GO:0003417]; hippocampus development [GO:0021766]; hormone-mediated signaling pathway [GO:0009755]; limb development [GO:0060173]; liver development [GO:0001889]; mRNA transcription by RNA polymerase II [GO:0042789]; multicellular organism growth [GO:0035264]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cartilage development [GO:0061037]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of granulocyte differentiation [GO:0030853]; negative regulation of miRNA transcription [GO:1902894]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of tumor necrosis factor production [GO:0032720]; negative regulation of type II interferon production [GO:0032689]; neural tube closure [GO:0001843]; outflow tract septum morphogenesis [GO:0003148]; positive regulation of binding [GO:0051099]; positive regulation of cell cycle [GO:0045787]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of interleukin-13 production [GO:0032736]; positive regulation of interleukin-4 production [GO:0032753]; positive regulation of interleukin-5 production [GO:0032754]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of T-helper 2 cell differentiation [GO:0045630]; positive regulation of transcription by RNA polymerase II [GO:0045944]; prostate gland development [GO:0030850]; protein phosphorylation [GO:0006468]; regulation of hematopoietic progenitor cell differentiation [GO:1901532]; regulation of myelination [GO:0031641]; regulation of synaptic plasticity [GO:0048167]; response to cytokine [GO:0034097]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to retinoic acid [GO:0032526]; response to vitamin A [GO:0033189]; retinoic acid receptor signaling pathway [GO:0048384]; Sertoli cell fate commitment [GO:0060010]; spermatogenesis [GO:0007283]; trachea cartilage development [GO:0060534]; ureteric bud development [GO:0001657]; ventricular cardiac muscle cell differentiation [GO:0055012],actin cytoskeleton [GO:0015629]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; RNA polymerase II transcription regulator complex [GO:0090575]; transcription regulator complex [GO:0005667],"alpha-actinin binding [GO:0051393]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity [GO:0001217]; enzyme binding [GO:0019899]; heterocyclic compound binding [GO:1901363]; histone deacetylase binding [GO:0042826]; mRNA 5'-UTR binding [GO:0048027]; mRNA regulatory element binding translation repressor activity [GO:0000900]; nuclear receptor activity [GO:0004879]; protein domain specific binding [GO:0019904]; protein kinase A binding [GO:0051018]; protein kinase B binding [GO:0043422]; retinoic acid binding [GO:0001972]; retinoic acid-responsive element binding [GO:0044323]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; signaling receptor binding [GO:0005102]; transcription coactivator binding [GO:0001223]; zinc ion binding [GO:0008270]","PTM: Phosphorylated on serine and threonine residues. Phosphorylation does not change during cell cycle. Phosphorylation on Ser-77 is crucial for transcriptional activity (By similarity). Phosphorylation by AKT1 is required for the repressor activity but has no effect on DNA binding, protein stability nor subcellular localization. Phosphorylated by PKA in vitro. This phosphorylation on Ser-219 and Ser-369 is critical for ligand binding, nuclear localization and transcriptional activity in response to FSH signaling. {ECO:0000250, ECO:0000269|PubMed:16417524, ECO:0000269|PubMed:20215566}.; PTM: Sumoylated with SUMO2, mainly on Lys-399 which is also required for SENP6 binding. On all-trans retinoic acid (ATRA) binding, a conformational change may occur that allows sumoylation on two additional site, Lys-166 and Lys-171. Probably desumoylated by SENP6. Sumoylation levels determine nuclear localization and regulate ATRA-mediated transcriptional activity. {ECO:0000269|PubMed:15809060, ECO:0000269|PubMed:19850744}.; PTM: Trimethylation enhances heterodimerization with RXRA and positively modulates the transcriptional activation.; PTM: Ubiquitinated by UBR5, leading to its degradation: UBR5 specifically recognizes and binds ligand-bound RARA when it is not associated with coactivators (NCOAs) (PubMed:37478846). In presence of NCOAs, the UBR5-degron is not accessible, preventing its ubiquitination and degradation (PubMed:37478846). {ECO:0000269|PubMed:37478846}.; PTM: Acetylated; acetylation is increased upon pulsatile shear stress and decreased upon oscillatory shear stress. {ECO:0000269|PubMed:28167758}.","DOMAIN: Composed of three domains: a modulating N-terminal domain, a DNA-binding domain and a C-terminal ligand-binding domain.; DOMAIN: The 9aaTAD motif is a transactivation domain present in a large number of yeast and animal transcription factors. {ECO:0000305|PubMed:30468856}.","DOMAIN 183..417; /note=""NR LBD""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU01189""","STRAND 97..99; /evidence=""ECO:0007829|PDB:1DSZ""; STRAND 102..104; /evidence=""ECO:0007829|PDB:6XWG""; STRAND 214..216; /evidence=""ECO:0007829|PDB:5K13""; STRAND 283..285; /evidence=""ECO:0007829|PDB:3KMR""; STRAND 289..293; /evidence=""ECO:0007829|PDB:3KMR""; STRAND 402..404; /evidence=""ECO:0007829|PDB:3KMR""","HELIX 106..117; /evidence=""ECO:0007829|PDB:1DSZ""; HELIX 137..139; /evidence=""ECO:0007829|PDB:1DSZ""; HELIX 141..150; /evidence=""ECO:0007829|PDB:1DSZ""; HELIX 155..157; /evidence=""ECO:0007829|PDB:1DSZ""; HELIX 183..196; /evidence=""ECO:0007829|PDB:3KMR""; HELIX 202..204; /evidence=""ECO:0007829|PDB:3KMR""; HELIX 222..244; /evidence=""ECO:0007829|PDB:3KMR""; HELIX 249..251; /evidence=""ECO:0007829|PDB:3KMR""; HELIX 254..275; /evidence=""ECO:0007829|PDB:3KMR""; HELIX 294..300; /evidence=""ECO:0007829|PDB:3KMR""; HELIX 303..305; /evidence=""ECO:0007829|PDB:3KMR""; HELIX 306..316; /evidence=""ECO:0007829|PDB:3KMR""; HELIX 317..319; /evidence=""ECO:0007829|PDB:3KMR""; HELIX 323..334; /evidence=""ECO:0007829|PDB:3KMR""; HELIX 345..366; /evidence=""ECO:0007829|PDB:3KMR""; HELIX 373..401; /evidence=""ECO:0007829|PDB:3KMR""; HELIX 408..414; /evidence=""ECO:0007829|PDB:3KMR""","TURN 89..91; /evidence=""ECO:0007829|PDB:1DSZ""; TURN 134..136; /evidence=""ECO:0007829|PDB:1DSZ""; TURN 279..282; /evidence=""ECO:0007829|PDB:3KMR""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,RARA NR1B1,Retinoic acid receptor alpha (RAR-alpha) (Nuclear receptor subfamily 1 group B member 1),Homo sapiens (Human),462.0,50771.0,MASNSSSCPTPGGGHLNGYPVPPYAFFFPPMLGGLSPPGALTTLQHQLPVSGYSTPSPATIETQSSSSEEIVPSPPSPPPLPRIYKPCFVCQDKSSGYHYGVSACEGCKGFFRRSIQKNMVYTCHRDKNCIINKVTRNRCQYCRLQKCFEVGMSKESVRNDRNKKKKEVPKPECSESYTLTPEVGELIEKVRKAHQETFPALCQLGKYTTNNSSEQRVSLDIDLWDKFSELSTKCIIKTVEFAKQLPGFTTLTIADQITLLKAACLDILILRICTRYTPEQDTMTFSDGLTLNRTQMHNAGFGPLTDLVFAFANQLLPLEMDDAETGLLSAICLICGDRQDLEQPDRVDMLQEPLLEALKVYVRKRRPSRPHMFPKMLMKITDLRSISAKGAERVITLKMEIPGSMPPLIQEMLENSEGLDTLSGQPGGGGRDGGGLAPPPGSCSPSLSPSSNRSSPATHSP,False,False,True,P10276,"[('cd06937', 'The ligand binding domain (LBD) of retinoic acid receptor (RAR), a members of the nuclear receptor superfamily'), ('cd06964', 'DNA-binding domain of retinoic acid receptor (RAR) is composed of two C4-type zinc fingers'), ('G3DSA:1.10.565.10', 'Retinoid X Receptor'), ('G3DSA:3.30.50.10', 'Erythroid Transcription Factor GATA-1, subunit A'), ('IPR000536', 'Nuclear hormone receptor, ligand-binding domain'), ('IPR001628', 'Zinc finger, nuclear hormone receptor-type'), ('IPR001723', 'Nuclear hormone receptor'), ('IPR003078', 'Retinoic acid receptor'), ('IPR013088', 'Zinc finger, NHR/GATA-type'), ('IPR035500', 'Nuclear hormone receptor-like domain superfamily'), ('IPR047158', 'Retinoic acid receptor, ligand-binding domain'), ('IPR047159', 'Retinoic acid receptor, DNA-binding domain'), ('PF00104', 'Ligand-binding domain of nuclear hormone receptor'), ('PF00105', 'Double treble clef zinc finger, C4 type'), ('PR00047', 'STROIDFINGER'), ('PR00398', 'STRDHORMONER'), ('PR01292', 'RETNOICACIDR'), ('PS00031', 'Nuclear hormones receptors DNA-binding region signature'), ('PS51030', 'Nuclear hormone receptors DNA-binding domain profile'), ('PS51843', 'Nuclear receptor (NR) ligand-binding (LBD) domain profile')]",,"""ENSG00000131759; Low tissue specificity."";",,,,,ENST00000254066.10 [P10276-1];ENST00000394081.7 [P10276-2];ENST00000394089.6 [P10276-1];ENST00000425707.7 [P10276-3];,RARA;NYAP2,ENSG00000131759;ENSG00000144460,0.0,RARA,Non-canonical_RBPs,0.0,,,0.117,0.338,0.152,RARA
P10809,ENSG00000144381,CH60_HUMAN,'de novo' protein folding [GO:0006458]; activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; apoptotic mitochondrial changes [GO:0008637]; B cell activation [GO:0042113]; B cell proliferation [GO:0042100]; biological process involved in interaction with symbiont [GO:0051702]; cellular response to interleukin-7 [GO:0098761]; chaperone-mediated protein complex assembly [GO:0051131]; isotype switching to IgG isotypes [GO:0048291]; mitochondrial unfolded protein response [GO:0034514]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; negative regulation of apoptotic process [GO:0043066]; positive regulation of apoptotic process [GO:0043065]; positive regulation of interferon-alpha production [GO:0032727]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of macrophage activation [GO:0043032]; positive regulation of T cell activation [GO:0050870]; positive regulation of T cell mediated immune response to tumor cell [GO:0002842]; positive regulation of type II interferon production [GO:0032729]; protein folding [GO:0006457]; protein import into mitochondrial intermembrane space [GO:0045041]; protein maturation [GO:0051604]; protein refolding [GO:0042026]; protein stabilization [GO:0050821]; response to cold [GO:0009409]; response to unfolded protein [GO:0006986]; T cell activation [GO:0042110],cell surface [GO:0009986]; clathrin-coated pit [GO:0005905]; coated vesicle [GO:0030135]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; lipopolysaccharide receptor complex [GO:0046696]; membrane [GO:0016020]; migrasome [GO:0140494]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; secretory granule [GO:0030141]; sperm midpiece [GO:0097225]; sperm plasma membrane [GO:0097524],apolipoprotein A-I binding [GO:0034186]; apolipoprotein binding [GO:0034185]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent protein folding chaperone [GO:0140662]; DNA replication origin binding [GO:0003688]; double-stranded RNA binding [GO:0003725]; enzyme binding [GO:0019899]; high-density lipoprotein particle binding [GO:0008035]; isomerase activity [GO:0016853]; lipopolysaccharide binding [GO:0001530]; p53 binding [GO:0002039]; protein-folding chaperone binding [GO:0051087]; RNA binding [GO:0003723]; single-stranded DNA binding [GO:0003697]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082],,,,"STRAND 28..32; /evidence=""ECO:0007829|PDB:8G7L""; STRAND 56..58; /evidence=""ECO:0007829|PDB:7L7S""; STRAND 61..64; /evidence=""ECO:0007829|PDB:8G7L""; STRAND 67..70; /evidence=""ECO:0007829|PDB:8G7L""; STRAND 72..74; /evidence=""ECO:0007829|PDB:8G7L""; STRAND 109..111; /evidence=""ECO:0007829|PDB:7L7S""; STRAND 197..203; /evidence=""ECO:0007829|PDB:8G7L""; STRAND 205..208; /evidence=""ECO:0007829|PDB:8G7L""; STRAND 210..214; /evidence=""ECO:0007829|PDB:8G7L""; STRAND 216..218; /evidence=""ECO:0007829|PDB:8G7N""; STRAND 223..225; /evidence=""ECO:0007829|PDB:8G7O""; STRAND 232..235; /evidence=""ECO:0007829|PDB:8G7L""; STRAND 237..249; /evidence=""ECO:0007829|PDB:8G7L""; STRAND 271..276; /evidence=""ECO:0007829|PDB:8G7L""; STRAND 297..301; /evidence=""ECO:0007829|PDB:8G7L""; STRAND 303..305; /evidence=""ECO:0007829|PDB:8G7L""; STRAND 324..326; /evidence=""ECO:0007829|PDB:8G7N""; STRAND 342..350; /evidence=""ECO:0007829|PDB:8G7L""; STRAND 355..357; /evidence=""ECO:0007829|PDB:8G7L""; STRAND 401..406; /evidence=""ECO:0007829|PDB:8G7L""; STRAND 436..438; /evidence=""ECO:0007829|PDB:8G7L""; STRAND 501..504; /evidence=""ECO:0007829|PDB:8G7L""; STRAND 509..512; /evidence=""ECO:0007829|PDB:8G7L""; STRAND 519..521; /evidence=""ECO:0007829|PDB:8G7L""; STRAND 542..548; /evidence=""ECO:0007829|PDB:8G7L""","HELIX 34..52; /evidence=""ECO:0007829|PDB:8G7L""; HELIX 77..82; /evidence=""ECO:0007829|PDB:8G7L""; HELIX 89..108; /evidence=""ECO:0007829|PDB:8G7L""; HELIX 113..128; /evidence=""ECO:0007829|PDB:8G7L""; HELIX 137..158; /evidence=""ECO:0007829|PDB:8G7L""; HELIX 165..175; /evidence=""ECO:0007829|PDB:8G7L""; HELIX 180..193; /evidence=""ECO:0007829|PDB:8G7L""; HELIX 226..228; /evidence=""ECO:0007829|PDB:8G7L""; HELIX 254..266; /evidence=""ECO:0007829|PDB:8G7L""; HELIX 280..293; /evidence=""ECO:0007829|PDB:8G7L""; HELIX 306..320; /evidence=""ECO:0007829|PDB:8G7L""; HELIX 334..336; /evidence=""ECO:0007829|PDB:8G7N""; HELIX 339..341; /evidence=""ECO:0007829|PDB:8G7L""; HELIX 364..380; /evidence=""ECO:0007829|PDB:8G7L""; HELIX 384..398; /evidence=""ECO:0007829|PDB:8G7L""; HELIX 411..433; /evidence=""ECO:0007829|PDB:8G7L""; HELIX 442..445; /evidence=""ECO:0007829|PDB:8G7L""; HELIX 446..453; /evidence=""ECO:0007829|PDB:8G7L""; HELIX 459..471; /evidence=""ECO:0007829|PDB:8G7L""; HELIX 474..482; /evidence=""ECO:0007829|PDB:8G7L""; HELIX 487..495; /evidence=""ECO:0007829|PDB:8G7L""; HELIX 513..516; /evidence=""ECO:0007829|PDB:8G7L""; HELIX 522..539; /evidence=""ECO:0007829|PDB:8G7L""","TURN 132..134; /evidence=""ECO:0007829|PDB:7L7S""; TURN 176..178; /evidence=""ECO:0007829|PDB:4PJ1""; TURN 328..330; /evidence=""ECO:0007829|PDB:6MRC""; TURN 439..441; /evidence=""ECO:0007829|PDB:8G7L""; TURN 505..508; /evidence=""ECO:0007829|PDB:8G7L""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,HSPD1 HSP60,"60 kDa heat shock protein, mitochondrial (EC 5.6.1.7) (60 kDa chaperonin) (Chaperonin 60) (CPN60) (Heat shock protein 60) (HSP-60) (Hsp60) (Heat shock protein family D member 1) (HuCHA60) (Mitochondrial matrix protein P1) (P60 lymphocyte protein)",Homo sapiens (Human),573.0,61055.0,MLRLPTVFRQMRPVSRVLAPHLTRAYAKDVKFGADARALMLQGVDLLADAVAVTMGPKGRTVIIEQSWGSPKVTKDGVTVAKSIDLKDKYKNIGAKLVQDVANNTNEEAGDGTTTATVLARSIAKEGFEKISKGANPVEIRRGVMLAVDAVIAELKKQSKPVTTPEEIAQVATISANGDKEIGNIISDAMKKVGRKGVITVKDGKTLNDELEIIEGMKFDRGYISPYFINTSKGQKCEFQDAYVLLSEKKISSIQSIVPALEIANAHRKPLVIIAEDVDGEALSTLVLNRLKVGLQVVAVKAPGFGDNRKNQLKDMAIATGGAVFGEEGLTLNLEDVQPHDLGKVGEVIVTKDDAMLLKGKGDKAQIEKRIQEIIEQLDVTTSEYEKEKLNERLAKLSDGVAVLKVGGTSDVEVNEKKDRVTDALNATRAAVEEGIVLGGGCALLRCIPALDSLTPANEDQKIGIEIIKRTLKIPAMTIAKNAGVEGSLIVEKIMQSSSEVGYDAMAGDFVNMVEKGIIDPTKVVRTALLDAAGVASLLTTAEVVVTEIPKEEKDPGMGAMGGMGGGMGGGMF,True,True,False,P10809,"[('cd03344', 'GroEL'), ('G3DSA:1.10.560.10', 'GroEL-like equatorial domain'), ('G3DSA:3.30.260.10', 'TCP-1-like chaperonin intermediate domain'), ('G3DSA:3.50.7.10', 'GroEL'), ('IPR001844', 'Chaperonin Cpn60/GroEL'), ('IPR002423', 'Chaperonin Cpn60/GroEL/TCP-1 family'), ('IPR018370', 'Chaperonin Cpn60, conserved site'), ('IPR027409', 'GroEL-like apical domain superfamily'), ('IPR027410', 'TCP-1-like chaperonin intermediate domain superfamily'), ('IPR027413', 'GroEL-like equatorial domain superfamily'), ('MF_00600', 'Chaperonin GroEL [groEL]'), ('PF00118', 'TCP-1/cpn60 chaperonin family'), ('PR00298', 'CHAPERONIN60'), ('PS00296', 'Chaperonins cpn60 signature'), ('PTHR45633', '60 KDA HEAT SHOCK PROTEIN, MITOCHONDRIAL'), ('SSF48592', 'GroEL equatorial domain-like'), ('SSF52029', 'GroEL apical domain-like'), ('SSF54849', 'GroEL-intermediate domain like'), ('TIGR02348', 'chaperonin GroEL')]",,"""ENSG00000144381; Tissue enhanced (adrenal)."";",CATALYTIC ACTIVITY: Reaction=ATP + H2O + a folded polypeptide = ADP + phosphate + an unfolded polypeptide.; EC=5.6.1.7; Evidence={ECO:0000305};,5.6.1.7,,,ENST00000345042.6 [P10809-1];ENST00000388968.8 [P10809-1];ENST00000418022.2 [P10809-1];ENST00000426480.2 [P10809-1];ENST00000428204.6 [P10809-1];ENST00000439605.2 [P10809-1];ENST00000452200.6 [P10809-1];ENST00000677913.1 [P10809-1];ENST00000678761.1 [P10809-1];,HSPD1,ENSG00000144381;ENSG00000230233,0.0,HSPD1,Non-canonical_RBPs,18.0,,,,0.091,,HSPD1
P11142,ENSG00000109971,HSP7C_HUMAN,"ATP metabolic process [GO:0046034]; cellular response to cadmium ion [GO:0071276]; cellular response to heat [GO:0034605]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to starvation [GO:0009267]; cellular response to steroid hormone stimulus [GO:0071383]; cerebellum development [GO:0021549]; chaperone cofactor-dependent protein refolding [GO:0051085]; chaperone-mediated autophagy [GO:0061684]; chaperone-mediated autophagy translocation complex disassembly [GO:1904764]; clathrin coat disassembly [GO:0072318]; estrous cycle [GO:0044849]; forebrain development [GO:0030900]; G1/S transition of mitotic cell cycle [GO:0000082]; kidney development [GO:0001822]; late endosomal microautophagy [GO:0061738]; maintenance of postsynaptic specialization structure [GO:0098880]; membrane organization [GO:0061024]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of NLRP3 inflammasome complex assembly [GO:1900226]; negative regulation of supramolecular fiber organization [GO:1902904]; positive regulation by host of viral genome replication [GO:0044829]; positive regulation of cell migration [GO:0030335]; positive regulation of lysosomal membrane permeability [GO:0097214]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; positive regulation of phagocytosis [GO:0050766]; positive regulation of protein refolding [GO:1904592]; positive regulation of proteolysis [GO:0045862]; positive regulation of T cell mediated cytotoxicity [GO:0001916]; protein folding [GO:0006457]; protein import into nucleus [GO:0006606]; protein refolding [GO:0042026]; protein targeting to lysosome involved in chaperone-mediated autophagy [GO:0061740]; protein transmembrane import into intracellular organelle [GO:0044743]; regulation of cell cycle [GO:0051726]; regulation of postsynapse organization [GO:0099175]; regulation of protein complex stability [GO:0061635]; regulation of protein import [GO:1904589]; regulation of protein stability [GO:0031647]; regulation of protein-containing complex assembly [GO:0043254]; response to activity [GO:0014823]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to nickel cation [GO:0010045]; response to odorant [GO:1990834]; response to progesterone [GO:0032570]; response to unfolded protein [GO:0006986]; response to xenobiotic stimulus [GO:0009410]; skeletal muscle tissue development [GO:0007519]; slow axonal transport [GO:1990832]",autophagosome [GO:0005776]; blood microparticle [GO:0072562]; cell surface [GO:0009986]; clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane [GO:0061202]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic shaft [GO:0043198]; dendritic spine [GO:0043197]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; glycinergic synapse [GO:0098690]; intermediate filament [GO:0005882]; late endosome [GO:0005770]; lumenal side of lysosomal membrane [GO:0098575]; lysosomal lumen [GO:0043202]; lysosomal matrix [GO:1990836]; lysosomal membrane [GO:0005765]; melanosome [GO:0042470]; membrane [GO:0016020]; microtubule [GO:0005874]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; photoreceptor inner segment [GO:0001917]; photoreceptor ribbon synapse [GO:0098684]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic specialization membrane [GO:0099634]; protein folding chaperone complex [GO:0101031]; Prp19 complex [GO:0000974]; ribonucleoprotein complex [GO:1990904]; secretory granule lumen [GO:0034774]; spliceosomal complex [GO:0005681]; synaptic vesicle [GO:0008021]; terminal bouton [GO:0043195],A1 adenosine receptor binding [GO:0031686]; ADP binding [GO:0043531]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent protein disaggregase activity [GO:0140545]; ATP-dependent protein folding chaperone [GO:0140662]; C3HC4-type RING finger domain binding [GO:0055131]; cadherin binding [GO:0045296]; clathrin-uncoating ATPase activity [GO:1990833]; enzyme binding [GO:0019899]; G protein-coupled receptor binding [GO:0001664]; heat shock protein binding [GO:0031072]; MHC class II protein complex binding [GO:0023026]; peptide binding [GO:0042277]; phosphatidylserine binding [GO:0001786]; prostaglandin binding [GO:1904593]; protein carrier chaperone [GO:0140597]; protein folding chaperone [GO:0044183]; protein-folding chaperone binding [GO:0051087]; protein-macromolecule adaptor activity [GO:0030674]; receptor ligand activity [GO:0048018]; RNA binding [GO:0003723]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082],"PTM: Acetylated. {ECO:0000269|Ref.5, ECO:0000269|Ref.6}.; PTM: ISGylated. {ECO:0000269|PubMed:16139798, ECO:0000269|PubMed:16815975}.; PTM: Trimethylation at Lys-561 reduces fibrillar SNCA binding.","DOMAIN: The N-terminal nucleotide binding domain (NBD) (also known as the ATPase domain) is responsible for binding and hydrolyzing ATP. The C-terminal substrate-binding domain (SBD) (also known as peptide-binding domain) binds to the client/substrate proteins. The two domains are allosterically coupled so that, when ATP is bound to the NBD, the SBD binds relatively weakly to clients. When ADP is bound in the NBD, a conformational change enhances the affinity of the SBD for client proteins. {ECO:0000269|PubMed:9305631}.",,"STRAND 7..10; /evidence=""ECO:0007829|PDB:5AQM""; STRAND 13..22; /evidence=""ECO:0007829|PDB:5AQM""; STRAND 25..28; /evidence=""ECO:0007829|PDB:5AQM""; STRAND 36..39; /evidence=""ECO:0007829|PDB:5AQM""; STRAND 42..44; /evidence=""ECO:0007829|PDB:5AQM""; STRAND 49..51; /evidence=""ECO:0007829|PDB:5AQM""; STRAND 91..97; /evidence=""ECO:0007829|PDB:5AQM""; STRAND 100..107; /evidence=""ECO:0007829|PDB:5AQM""; STRAND 110..114; /evidence=""ECO:0007829|PDB:5AQM""; STRAND 136..138; /evidence=""ECO:0007829|PDB:5AQF""; STRAND 141..146; /evidence=""ECO:0007829|PDB:5AQM""; STRAND 168..174; /evidence=""ECO:0007829|PDB:5AQM""; STRAND 188..191; /evidence=""ECO:0007829|PDB:5AQL""; STRAND 193..201; /evidence=""ECO:0007829|PDB:5AQM""; STRAND 204..213; /evidence=""ECO:0007829|PDB:5AQM""; STRAND 216..225; /evidence=""ECO:0007829|PDB:5AQM""; STRAND 278..288; /evidence=""ECO:0007829|PDB:5AQM""; STRAND 291..298; /evidence=""ECO:0007829|PDB:5AQM""; STRAND 333..338; /evidence=""ECO:0007829|PDB:5AQM""; STRAND 357..360; /evidence=""ECO:0007829|PDB:3FZF""; STRAND 641..644; /evidence=""ECO:0007829|PDB:3AGY""","HELIX 53..57; /evidence=""ECO:0007829|PDB:5AQM""; HELIX 63..65; /evidence=""ECO:0007829|PDB:5AQM""; HELIX 70..72; /evidence=""ECO:0007829|PDB:5AQM""; HELIX 81..87; /evidence=""ECO:0007829|PDB:5AQM""; HELIX 116..135; /evidence=""ECO:0007829|PDB:5AQM""; HELIX 152..164; /evidence=""ECO:0007829|PDB:5AQM""; HELIX 175..182; /evidence=""ECO:0007829|PDB:5AQM""; HELIX 185..187; /evidence=""ECO:0007829|PDB:5AQM""; HELIX 230..249; /evidence=""ECO:0007829|PDB:5AQM""; HELIX 253..255; /evidence=""ECO:0007829|PDB:3LDQ""; HELIX 257..276; /evidence=""ECO:0007829|PDB:5AQM""; HELIX 299..305; /evidence=""ECO:0007829|PDB:5AQM""; HELIX 307..312; /evidence=""ECO:0007829|PDB:5AQM""; HELIX 314..324; /evidence=""ECO:0007829|PDB:5AQM""; HELIX 328..330; /evidence=""ECO:0007829|PDB:5AQM""; HELIX 339..342; /evidence=""ECO:0007829|PDB:5AQM""; HELIX 344..353; /evidence=""ECO:0007829|PDB:5AQM""; HELIX 368..380; /evidence=""ECO:0007829|PDB:5AQM""; HELIX 541..556; /evidence=""ECO:0007829|PDB:4KBQ""; HELIX 564..582; /evidence=""ECO:0007829|PDB:4KBQ""; HELIX 594..612; /evidence=""ECO:0007829|PDB:4KBQ""; HELIX 613..616; /evidence=""ECO:0007829|PDB:4KBQ""","TURN 58..61; /evidence=""ECO:0007829|PDB:5AQM""; TURN 73..75; /evidence=""ECO:0007829|PDB:5AQM""; TURN 354..356; /evidence=""ECO:0007829|PDB:5AQM""; TURN 365..367; /evidence=""ECO:0007829|PDB:5AQM""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,HSPA8 HSC70 HSP73 HSPA10,Heat shock cognate 71 kDa protein (EC 3.6.4.10) (Heat shock 70 kDa protein 8) (Heat shock protein family A member 8) (Lipopolysaccharide-associated protein 1) (LAP-1) (LPS-associated protein 1),Homo sapiens (Human),646.0,70898.0,MSKGPAVGIDLGTTYSCVGVFQHGKVEIIANDQGNRTTPSYVAFTDTERLIGDAAKNQVAMNPTNTVFDAKRLIGRRFDDAVVQSDMKHWPFMVVNDAGRPKVQVEYKGETKSFYPEEVSSMVLTKMKEIAEAYLGKTVTNAVVTVPAYFNDSQRQATKDAGTIAGLNVLRIINEPTAAAIAYGLDKKVGAERNVLIFDLGGGTFDVSILTIEDGIFEVKSTAGDTHLGGEDFDNRMVNHFIAEFKRKHKKDISENKRAVRRLRTACERAKRTLSSSTQASIEIDSLYEGIDFYTSITRARFEELNADLFRGTLDPVEKALRDAKLDKSQIHDIVLVGGSTRIPKIQKLLQDFFNGKELNKSINPDEAVAYGAAVQAAILSGDKSENVQDLLLLDVTPLSLGIETAGGVMTVLIKRNTTIPTKQTQTFTTYSDNQPGVLIQVYEGERAMTKDNNLLGKFELTGIPPAPRGVPQIEVTFDIDANGILNVSAVDKSTGKENKITITNDKGRLSKEDIERMVQEAEKYKAEDEKQRDKVSSKNSLESYAFNMKATVEDEKLQGKINDEDKQKILDKCNEIINWLDKNQTAEKEEFEHQQKELEKVCNPIITKLYQSAGGMPGGMPGGFPGGGAPPSGGASSGPTIEEVD,False,False,True,P11142,"[('cd10233', 'Nucleotide-binding domain of HSPA1-A, -B, -L, HSPA-2, -6, -7, -8, and similar proteins'), ('G3DSA:1.20.1270.10', None), ('G3DSA:2.60.34.10', 'Substrate Binding Domain Of DNAk; Chain A, domain 1'), ('G3DSA:3.30.30.30', None), ('G3DSA:3.30.420.40', None), ('G3DSA:3.90.640.10', 'Actin; Chain A, domain 4'), ('IPR013126', 'Heat shock protein 70 family'), ('IPR018181', 'Heat shock protein 70, conserved site'), ('IPR029047', 'Heat shock protein 70kD, peptide-binding domain superfamily'), ('IPR029048', 'Heat shock protein 70kD, C-terminal domain superfamily'), ('IPR043129', 'ATPase, nucleotide binding domain'), ('PF00012', 'Hsp70 protein'), ('PR00301', 'HEATSHOCK70'), ('PS00297', 'Heat shock hsp70 proteins family signature 1'), ('PS00329', 'Heat shock hsp70 proteins family signature 2'), ('PS01036', 'Heat shock hsp70 proteins family signature 3'), ('PTHR19375', 'HEAT SHOCK PROTEIN 70KDA'), ('SSF100920', 'Heat shock protein 70kD (HSP70), peptide-binding domain'), ('SSF100934', 'Heat shock protein 70kD (HSP70), C-terminal subdomain'), ('SSF53067', 'Actin-like ATPase domain')]",,"""ENSG00000109971; Low tissue specificity."";","CATALYTIC ACTIVITY: Reaction=ATP + H2O = ADP + phosphate + H(+); Xref=Rhea:RHEA:13065, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616, ChEBI:CHEBI:43474, ChEBI:CHEBI:456216; EC=3.6.4.10; Evidence={ECO:0000269|PubMed:12526792};",3.6.4.10,,,ENST00000227378.7 [P11142-1];ENST00000453788.6 [P11142-2];ENST00000532636.5 [P11142-1];ENST00000534624.6 [P11142-1];,HSPA8,ENSG00000109971;ENSG00000238195,0.0,HSPA8,Non-canonical_RBPs,29.0,,,0.037,0.054,0.051,HSPA8
P11473,ENSG00000111424,VDR_HUMAN,apoptotic process involved in mammary gland involution [GO:0060057]; calcium ion transport [GO:0006816]; cell differentiation [GO:0030154]; cell morphogenesis [GO:0000902]; decidualization [GO:0046697]; intestinal absorption [GO:0050892]; intracellular calcium ion homeostasis [GO:0006874]; lactation [GO:0007595]; mammary gland branching involved in pregnancy [GO:0060745]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of keratinocyte proliferation [GO:0010839]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nuclear receptor-mediated bile acid signaling pathway [GO:0038185]; phosphate ion transmembrane transport [GO:0035435]; positive regulation of apoptotic process involved in mammary gland involution [GO:0060058]; positive regulation of bone mineralization [GO:0030501]; positive regulation of gene expression [GO:0010628]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of vitamin D 24-hydroxylase activity [GO:0010980]; positive regulation of vitamin D receptor signaling pathway [GO:0070564]; regulation of calcidiol 1-monooxygenase activity [GO:0060558]; response to bile acid [GO:1903412]; retinoic acid receptor signaling pathway [GO:0048384]; skeletal system development [GO:0001501]; vitamin D receptor signaling pathway [GO:0070561],chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; receptor complex [GO:0043235]; RNA polymerase II transcription regulator complex [GO:0090575],"bile acid nuclear receptor activity [GO:0038186]; calcitriol binding [GO:1902098]; DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; lithocholic acid binding [GO:1902121]; nuclear receptor activity [GO:0004879]; nuclear retinoid X receptor binding [GO:0046965]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]","PTM: Ubiquitinated by UBR5, leading to its degradation: UBR5 specifically recognizes and binds ligand-bound VDR when it is not associated with coactivators (NCOAs) (PubMed:37478846). In presence of NCOAs, the UBR5-degron is not accessible, preventing its ubiquitination and degradation (PubMed:37478846). {ECO:0000269|PubMed:37478846}.","DOMAIN: Composed of three domains: a modulating N-terminal domain, a DNA-binding domain and a C-terminal ligand-binding domain. {ECO:0000269|PubMed:10678179}.; DOMAIN: The 9aaTAD motif is a transactivation domain present in a large number of yeast and animal transcription factors. {ECO:0000305|PubMed:30468856}.","DOMAIN 127..423; /note=""NR LBD""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU01189""","STRAND 33..35; /evidence=""ECO:0007829|PDB:1KB2""; STRAND 38..40; /evidence=""ECO:0007829|PDB:1KB6""; STRAND 61..64; /evidence=""ECO:0007829|PDB:1KB4""; STRAND 108..110; /evidence=""ECO:0007829|PDB:1KB6""; STRAND 285..287; /evidence=""ECO:0007829|PDB:3B0T""; STRAND 341..343; /evidence=""ECO:0007829|PDB:3AUQ""","HELIX 42..53; /evidence=""ECO:0007829|PDB:1KB2""; HELIX 77..86; /evidence=""ECO:0007829|PDB:1KB2""; HELIX 91..93; /evidence=""ECO:0007829|PDB:1KB2""; HELIX 97..107; /evidence=""ECO:0007829|PDB:1KB2""; HELIX 115..119; /evidence=""ECO:0007829|PDB:1KB6""; HELIX 126..142; /evidence=""ECO:0007829|PDB:3B0T""; HELIX 150..152; /evidence=""ECO:0007829|PDB:3B0T""; HELIX 217..223; /evidence=""ECO:0007829|PDB:3B0T""; HELIX 227..247; /evidence=""ECO:0007829|PDB:3B0T""; HELIX 251..253; /evidence=""ECO:0007829|PDB:3B0T""; HELIX 256..274; /evidence=""ECO:0007829|PDB:3B0T""; HELIX 275..277; /evidence=""ECO:0007829|PDB:3B0T""; HELIX 291..293; /evidence=""ECO:0007829|PDB:3B0T""; HELIX 297..301; /evidence=""ECO:0007829|PDB:3B0T""; HELIX 307..321; /evidence=""ECO:0007829|PDB:3B0T""; HELIX 327..338; /evidence=""ECO:0007829|PDB:3B0T""; HELIX 349..370; /evidence=""ECO:0007829|PDB:3B0T""; HELIX 379..404; /evidence=""ECO:0007829|PDB:3B0T""; HELIX 410..413; /evidence=""ECO:0007829|PDB:3B0T""; HELIX 416..422; /evidence=""ECO:0007829|PDB:3B0T""","TURN 25..27; /evidence=""ECO:0007829|PDB:1KB2""; TURN 70..75; /evidence=""ECO:0007829|PDB:1KB2""; TURN 111..113; /evidence=""ECO:0007829|PDB:1KB6""; TURN 162..164; /evidence=""ECO:0007829|PDB:5V39""; TURN 281..284; /evidence=""ECO:0007829|PDB:3B0T""; TURN 302..304; /evidence=""ECO:0007829|PDB:3B0T""; TURN 322..324; /evidence=""ECO:0007829|PDB:2HAR""; TURN 373..378; /evidence=""ECO:0007829|PDB:3B0T""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,VDR NR1I1,"Vitamin D3 receptor (VDR) (1,25-dihydroxyvitamin D3 receptor) (Nuclear receptor subfamily 1 group I member 1)",Homo sapiens (Human),427.0,48289.0,MEAMAASTSLPDPGDFDRNVPRICGVCGDRATGFHFNAMTCEGCKGFFRRSMKRKALFTCPFNGDCRITKDNRRHCQACRLKRCVDIGMMKEFILTDEEVQRKREMILKRKEEEALKDSLRPKLSEEQQRIIAILLDAHHKTYDPTYSDFCQFRPPVRVNDGGGSHPSRPNSRHTPSFSGDSSSSCSDHCITSSDMMDSSSFSNLDLSEEDSDDPSVTLELSQLSMLPHLADLVSYSIQKVIGFAKMIPGFRDLTSEDQIVLLKSSAIEVIMLRSNESFTMDDMSWTCGNQDYKYRVSDVTKAGHSLELIEPLIKFQVGLKKLNLHEEEHVLLMAICIVSPDRPGVQDAALIEAIQDRLSNTLQTYIRCRHPPPGSHLLYAKMIQKLADLRSLNEEHSKQYRCLSFQPECSMKLTPLVLEVFGNEIS,False,False,True,P11473,"[('cd06933', 'The ligand binding domain of vitamin D receptors, a member of the nuclear receptor superfamily'), ('cd06955', 'DNA-binding domain of vitamin D receptors (VDR) is composed of two C4-type zinc fingers'), ('G3DSA:1.10.565.10', 'Retinoid X Receptor'), ('G3DSA:3.30.50.10', 'Erythroid Transcription Factor GATA-1, subunit A'), ('IPR000324', 'Vitamin D receptor'), ('IPR000536', 'Nuclear hormone receptor, ligand-binding domain'), ('IPR001628', 'Zinc finger, nuclear hormone receptor-type'), ('IPR001723', 'Nuclear hormone receptor'), ('IPR013088', 'Zinc finger, NHR/GATA-type'), ('IPR035500', 'Nuclear hormone receptor-like domain superfamily'), ('IPR042153', 'VDR, DNA-binding domain'), ('IPR050234', 'Nuclear hormone receptor family NR1 subfamily'), ('PF00104', 'Ligand-binding domain of nuclear hormone receptor'), ('PF00105', 'Double treble clef zinc finger, C4 type'), ('PR00047', 'STROIDFINGER'), ('PR00350', 'Vitamin D receptor'), ('PR00398', 'STRDHORMONER'), ('PS00031', 'Nuclear hormones receptors DNA-binding region signature'), ('PS51030', 'Nuclear hormone receptors DNA-binding domain profile'), ('PS51843', 'Nuclear receptor (NR) ligand-binding (LBD) domain profile')]",P11473;,"""ENSG00000111424; Tissue enriched (parathyroid)."";",,,,,ENST00000395324.6 [P11473-1];ENST00000549336.6 [P11473-1];ENST00000550325.5 [P11473-2];,VDR,ENSG00000111424;ENSG00000241219,0.0,,,,11.94,DP00184,0.119,0.187,0.077,VDR
P11940,ENSG00000070756,PABP1_HUMAN,"CRD-mediated mRNA stabilization [GO:0070934]; mRNA splicing, via spliceosome [GO:0000398]; mRNA stabilization [GO:0048255]; negative regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900152]; negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:2000623]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]; positive regulation of cytoplasmic translation [GO:2000767]; positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900153]; positive regulation of nuclear-transcribed mRNA poly(A) tail shortening [GO:0060213]; positive regulation of viral genome replication [GO:0045070]; regulatory ncRNA-mediated gene silencing [GO:0031047]",catalytic step 2 spliceosome [GO:0071013]; cell leading edge [GO:0031252]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; lamellipodium [GO:0030027]; mCRD-mediated mRNA stability complex [GO:0106002]; membrane [GO:0016020]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904],mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; poly(A) binding [GO:0008143]; poly(U) RNA binding [GO:0008266]; RNA binding [GO:0003723]; translation activator activity [GO:0008494],"PTM: Phosphorylated by MAPKAPK2. {ECO:0000269|PubMed:12565831}.; PTM: Methylated by CARM1. Arg-493 is dimethylated, probably to asymmetric dimethylarginine. {ECO:0000269|PubMed:11850402, ECO:0000269|Ref.6, ECO:0000269|Ref.7}.","DOMAIN: The RNA-binding domains RRM1 and RRM2 and the C-terminus (last 138 amino acids) regions interact with the PABPC1-interacting motif-1 (PAM1) and -2 (PAM2) of PAIP1, respectively. {ECO:0000269|PubMed:11287632, ECO:0000269|PubMed:11997512}.; DOMAIN: The RNA-binding domains RRM2 and RRM3 and the C-terminus (last 138 amino acids) regions interact with the PABPC1-interacting motif-1 (PAM1) and -2 (PAM2) of PAIP2, respectively. {ECO:0000269|PubMed:11287632, ECO:0000269|PubMed:20096703}.","DOMAIN 11..89; /note=""RRM 1""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00176""; DOMAIN 99..175; /note=""RRM 2""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00176""; DOMAIN 191..268; /note=""RRM 3""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00176""; DOMAIN 294..370; /note=""RRM 4""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00176""; DOMAIN 542..619; /note=""PABC""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00641""","STRAND 12..17; /evidence=""ECO:0007829|PDB:4F02""; STRAND 37..44; /evidence=""ECO:0007829|PDB:4F02""; STRAND 51..61; /evidence=""ECO:0007829|PDB:4F02""; STRAND 83..86; /evidence=""ECO:0007829|PDB:4F02""; STRAND 100..105; /evidence=""ECO:0007829|PDB:4F25""; STRAND 125..133; /evidence=""ECO:0007829|PDB:4F25""; STRAND 136..146; /evidence=""ECO:0007829|PDB:4F25""; STRAND 161..163; /evidence=""ECO:0007829|PDB:2K8G""; STRAND 169..174; /evidence=""ECO:0007829|PDB:4F25""; STRAND 628..630; /evidence=""ECO:0007829|PDB:1G9L""","HELIX 24..31; /evidence=""ECO:0007829|PDB:4F02""; HELIX 32..34; /evidence=""ECO:0007829|PDB:4F02""; HELIX 62..72; /evidence=""ECO:0007829|PDB:4F02""; HELIX 92..96; /evidence=""ECO:0007829|PDB:4F02""; HELIX 112..119; /evidence=""ECO:0007829|PDB:4F25""; HELIX 120..122; /evidence=""ECO:0007829|PDB:4F25""; HELIX 148..158; /evidence=""ECO:0007829|PDB:4F25""; HELIX 176..183; /evidence=""ECO:0007829|PDB:4F02""; HELIX 547..551; /evidence=""ECO:0007829|PDB:3KUJ""; HELIX 555..557; /evidence=""ECO:0007829|PDB:3KUJ""; HELIX 558..573; /evidence=""ECO:0007829|PDB:3KUJ""; HELIX 578..585; /evidence=""ECO:0007829|PDB:3KUJ""; HELIX 590..598; /evidence=""ECO:0007829|PDB:3KUJ""; HELIX 600..619; /evidence=""ECO:0007829|PDB:3KUJ""","TURN 46..48; /evidence=""ECO:0007829|PDB:4F02""; TURN 575..577; /evidence=""ECO:0007829|PDB:3KUJ""; TURN 623..625; /evidence=""ECO:0007829|PDB:1JGN""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,PABPC1 PAB1 PABP PABP1 PABPC2,Polyadenylate-binding protein 1 (PABP-1) (Poly(A)-binding protein 1),Homo sapiens (Human),636.0,70671.0,MNPSAPSYPMASLYVGDLHPDVTEAMLYEKFSPAGPILSIRVCRDMITRRSLGYAYVNFQQPADAERALDTMNFDVIKGKPVRIMWSQRDPSLRKSGVGNIFIKNLDKSIDNKALYDTFSAFGNILSCKVVCDENGSKGYGFVHFETQEAAERAIEKMNGMLLNDRKVFVGRFKSRKEREAELGARAKEFTNVYIKNFGEDMDDERLKDLFGKFGPALSVKVMTDESGKSKGFGFVSFERHEDAQKAVDEMNGKELNGKQIYVGRAQKKVERQTELKRKFEQMKQDRITRYQGVNLYVKNLDDGIDDERLRKEFSPFGTITSAKVMMEGGRSKGFGFVCFSSPEEATKAVTEMNGRIVATKPLYVALAQRKEERQAHLTNQYMQRMASVRAVPNPVINPYQPAPPSGYFMAAIPQTQNRAAYYPPSQIAQLRPSPRWTAQGARPHPFQNMPGAIRPAAPRPPFSTMRPASSQVPRVMSTQRVANTSTQTMGPRPAAAAAAATPAVRTVPQYKYAAGVRNPQQHLNAQPQVTMQQPAVHVQGQEPLTASMLASAPPQEQKQMLGERLFPLIQAMHPTLAGKITGMLLEIDNSELLHMLESPESLRSKVDEAVAVLQAHQAKEAAQKAVNSATGVPTV,False,False,True,P11940,"[('cd12378', 'RNA recognition motif 1 (RRM1) found in type I polyadenylate-binding proteins'), ('cd12379', 'RNA recognition motif 2 (RRM2) found found in type I polyadenylate-binding proteins'), ('cd12380', 'RNA recognition motif 3 (RRM3) found found in type I polyadenylate-binding proteins'), ('cd12381', 'RNA recognition motif 4 (RRM4) found in type I polyadenylate-binding proteins'), ('G3DSA:1.10.1900.10', 'c-terminal domain of poly(a) binding protein'), ('G3DSA:3.30.70.330', None), ('IPR000504', 'RNA recognition motif domain'), ('IPR002004', 'Polyadenylate-binding protein/Hyperplastic disc protein, C-terminal'), ('IPR003954', 'RNA recognition motif domain, eukaryotes'), ('IPR006515', 'Polyadenylate binding protein, human types 1, 2, 3, 4'), ('IPR012677', 'Nucleotide-binding alpha-beta plait domain superfamily'), ('IPR034364', 'PABP, RNA recognition motif 1'), ('IPR035979', 'RNA-binding domain superfamily'), ('IPR036053', 'PABC (PABP) domain'), ('IPR045305', 'PABP, RNA recognition motif 2'), ('PF00076', 'RNA recognition motif'), ('PF00658', 'MLLE domain'), ('PS50102', 'Eukaryotic RNA Recognition Motif (RRM) profile'), ('PS51309', 'Poly(A)-binding protein C-terminal (PABC) domain profile'), ('PTHR24012', 'Polyadenylate-binding/CELF RNA-binding')]",P11940;,"""ENSG00000070756; Low tissue specificity."";",,,,,ENST00000318607.10 [P11940-1];ENST00000520142.2 [P11940-1];ENST00000520804.2 [P11940-1];ENST00000521865.6 [P11940-1];ENST00000522658.6 [P11940-1];ENST00000522720.2 [P11940-1];ENST00000523555.6 [P11940-1];,PABPC1;GSK3B-DT,ENSG00000070756;ENSG00000242622,0.0,PABPC1,Canonical_RBPs,31.0,4.87,DP03230,0.16,0.277,,PABPC1
P12004,ENSG00000132646,PCNA_HUMAN,"base-excision repair, gap-filling [GO:0006287]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to UV [GO:0034644]; cellular response to xenobiotic stimulus [GO:0071466]; epithelial cell differentiation [GO:0030855]; estrous cycle [GO:0044849]; heart development [GO:0007507]; leading strand elongation [GO:0006272]; liver regeneration [GO:0097421]; mismatch repair [GO:0006298]; mitotic telomere maintenance via semi-conservative replication [GO:1902990]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of deoxyribonuclease activity [GO:0032077]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA replication [GO:0045740]; positive regulation of DNA-directed DNA polymerase activity [GO:1900264]; replication fork processing [GO:0031297]; response to cadmium ion [GO:0046686]; response to dexamethasone [GO:0071548]; response to estradiol [GO:0032355]; response to L-glutamate [GO:1902065]; translesion synthesis [GO:0019985]","centrosome [GO:0005813]; chromatin [GO:0000785]; chromosome, telomeric region [GO:0000781]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; extracellular exosome [GO:0070062]; male germ cell nucleus [GO:0001673]; nuclear body [GO:0016604]; nuclear lamina [GO:0005652]; nuclear replication fork [GO:0043596]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PCNA complex [GO:0043626]; PCNA-p21 complex [GO:0070557]; replication fork [GO:0005657]; replisome [GO:0030894]",chromatin binding [GO:0003682]; damaged DNA binding [GO:0003684]; dinucleotide insertion or deletion binding [GO:0032139]; DNA polymerase binding [GO:0070182]; DNA polymerase processivity factor activity [GO:0030337]; enzyme binding [GO:0019899]; histone acetyltransferase binding [GO:0035035]; identical protein binding [GO:0042802]; MutLalpha complex binding [GO:0032405]; nuclear estrogen receptor binding [GO:0030331]; protein-containing complex binding [GO:0044877]; purine-specific mismatch base pair DNA N-glycosylase activity [GO:0000701]; receptor tyrosine kinase binding [GO:0030971],"PTM: Phosphorylated. Phosphorylation at Tyr-211 by EGFR stabilizes chromatin-associated PCNA. {ECO:0000269|PubMed:17115032}.; PTM: Acetylated by CREBBP and p300/EP300; preferentially acetylated by CREBBP on Lys-80, Lys-13 and Lys-14 and on Lys-77 by p300/EP300 upon loading on chromatin in response to UV irradiation (PubMed:19419956, PubMed:24939902). Lysine acetylation disrupts association with chromatin, hence promoting PCNA ubiquitination and proteasomal degradation in response to UV damage in a CREBBP- and EP300-dependent manner (PubMed:24939902). Acetylation disrupts interaction with NUDT15 and promotes degradation (PubMed:19419956). {ECO:0000269|PubMed:24939902}.; PTM: Ubiquitinated (PubMed:20227374, PubMed:24939902). Following DNA damage, can be either monoubiquitinated to stimulate direct bypass of DNA lesions by specialized DNA polymerases or polyubiquitinated to promote recombination-dependent DNA synthesis across DNA lesions by template switching mechanisms. Following induction of replication stress, monoubiquitinated by the UBE2B-RAD18 complex on Lys-164, leading to recruit translesion (TLS) polymerases, which are able to synthesize across DNA lesions in a potentially error-prone manner. An error-free pathway also exists and requires non-canonical polyubiquitination on Lys-164 through 'Lys-63' linkage of ubiquitin moieties by the E2 complex UBE2N-UBE2V2 and the E3 ligases, HLTF, RNF8 and SHPRH. This error-free pathway, also known as template switching, employs recombination mechanisms to synthesize across the lesion, using as a template the undamaged, newly synthesized strand of the sister chromatid. Monoubiquitination at Lys-164 also takes place in undamaged proliferating cells, and is mediated by the DCX(DTL) complex, leading to enhance PCNA-dependent translesion DNA synthesis. Sumoylated during S phase. {ECO:0000269|PubMed:15149598, ECO:0000269|PubMed:17108083, ECO:0000269|PubMed:17130289, ECO:0000269|PubMed:18316726, ECO:0000269|PubMed:18719106, ECO:0000269|PubMed:18948756, ECO:0000269|PubMed:20129063, ECO:0000269|PubMed:20227374, ECO:0000269|PubMed:22153967, ECO:0000269|PubMed:24939902}.; PTM: Methylated on glutamate residues by ARMT1/C6orf211. {ECO:0000269|PubMed:25732820}.",,,"STRAND 2..7; /evidence=""ECO:0007829|PDB:1U7B""; STRAND 24..31; /evidence=""ECO:0007829|PDB:1U7B""; STRAND 34..40; /evidence=""ECO:0007829|PDB:1U7B""; STRAND 44..53; /evidence=""ECO:0007829|PDB:1U7B""; STRAND 57..64; /evidence=""ECO:0007829|PDB:1U7B""; STRAND 66..71; /evidence=""ECO:0007829|PDB:1U7B""; STRAND 84..86; /evidence=""ECO:0007829|PDB:8UN0""; STRAND 87..92; /evidence=""ECO:0007829|PDB:1U7B""; STRAND 94..96; /evidence=""ECO:0007829|PDB:1VYM""; STRAND 97..104; /evidence=""ECO:0007829|PDB:1U7B""; STRAND 106..108; /evidence=""ECO:0007829|PDB:8F5Q""; STRAND 111..117; /evidence=""ECO:0007829|PDB:1U7B""; STRAND 121..126; /evidence=""ECO:0007829|PDB:5E0U""; STRAND 134..140; /evidence=""ECO:0007829|PDB:1U7B""; STRAND 156..163; /evidence=""ECO:0007829|PDB:1U7B""; STRAND 166..173; /evidence=""ECO:0007829|PDB:1U7B""; STRAND 176..182; /evidence=""ECO:0007829|PDB:1U7B""; STRAND 187..189; /evidence=""ECO:0007829|PDB:8UMY""; STRAND 196..201; /evidence=""ECO:0007829|PDB:1U7B""; STRAND 203..208; /evidence=""ECO:0007829|PDB:1U7B""; STRAND 223..229; /evidence=""ECO:0007829|PDB:1U7B""; STRAND 231..233; /evidence=""ECO:0007829|PDB:1VYM""; STRAND 235..241; /evidence=""ECO:0007829|PDB:1U7B""; STRAND 245..251; /evidence=""ECO:0007829|PDB:1U7B""; STRAND 254..256; /evidence=""ECO:0007829|PDB:8UMY""","HELIX 10..20; /evidence=""ECO:0007829|PDB:1U7B""; HELIX 54..56; /evidence=""ECO:0007829|PDB:1U7B""; HELIX 72..79; /evidence=""ECO:0007829|PDB:1U7B""; HELIX 141..152; /evidence=""ECO:0007829|PDB:1U7B""; HELIX 191..193; /evidence=""ECO:0007829|PDB:5E0U""; HELIX 209..215; /evidence=""ECO:0007829|PDB:1U7B""; HELIX 216..221; /evidence=""ECO:0007829|PDB:1U7B""","TURN 242..244; /evidence=""ECO:0007829|PDB:1U7B""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,PCNA,Proliferating cell nuclear antigen (PCNA) (Cyclin),Homo sapiens (Human),261.0,28769.0,MFEARLVQGSILKKVLEALKDLINEACWDISSSGVNLQSMDSSHVSLVQLTLRSEGFDTYRCDRNLAMGVNLTSMSKILKCAGNEDIITLRAEDNADTLALVFEAPNQEKVSDYEMKLMDLDVEQLGIPEQEYSCVVKMPSGEFARICRDLSHIGDAVVISCAKDGVKFSASGELGNGNIKLSQTSNVDKEEEAVTIEMNEPVQLTFALRYLNFFTKATPLSSTVTLSMSADVPLVVEYKIADMGHLKYYLAPKIEDEEGS,False,False,True,P12004,"[('cd00577', 'PCNA'), ('G3DSA:3.70.10.10', None), ('IPR000730', 'Proliferating cell nuclear antigen, PCNA'), ('IPR022648', 'Proliferating cell nuclear antigen, PCNA, N-terminal'), ('IPR022649', 'Proliferating cell nuclear antigen, PCNA, C-terminal'), ('IPR022659', 'Proliferating cell nuclear antigen, PCNA, conserved site'), ('IPR046938', 'DNA clamp superfamily'), ('MF_00317', 'DNA polymerase sliding clamp [pcn]'), ('PF00705', 'Proliferating cell nuclear antigen, N-terminal domain'), ('PF02747', 'Proliferating cell nuclear antigen, C-terminal domain'), ('PR00339', 'PCNACYCLIN'), ('PS00293', 'Proliferating cell nuclear antigen signature 2'), ('PS01251', 'Proliferating cell nuclear antigen signature 1'), ('PTHR11352', 'PROLIFERATING CELL NUCLEAR ANTIGEN'), ('SSF55979', 'DNA clamp'), ('TIGR00590', 'proliferating cell nuclear antigen (pcna)')]",P12004;,"""ENSG00000132646; Tissue enhanced (bone)."";",,,,,ENST00000379143.10;ENST00000379160.3;,PCNA,ENSG00000132646;ENSG00000243415,0.0,PCNA,Non-canonical_RBPs,12.0,,,0.042,,,PCNA
P12235,ENSG00000151729,ADT1_HUMAN,adaptive thermogenesis [GO:1990845]; ADP transport [GO:0015866]; apoptotic mitochondrial changes [GO:0008637]; generation of precursor metabolites and energy [GO:0006091]; mitochondrial ADP transmembrane transport [GO:0140021]; mitochondrial ATP transmembrane transport [GO:1990544]; mitochondrial genome maintenance [GO:0000002]; negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901029]; negative regulation of necroptotic process [GO:0060546]; positive regulation of mitophagy [GO:1901526]; regulation of mitochondrial membrane permeability [GO:0046902],membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial membrane [GO:0031966]; mitochondrial permeability transition pore complex [GO:0005757]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886],adenine transmembrane transporter activity [GO:0015207]; ATP:ADP antiporter activity [GO:0005471]; oxidative phosphorylation uncoupler activity [GO:0017077]; proton transmembrane transporter activity [GO:0015078],"PTM: Under cell death induction, transglutaminated by TGM2. Transglutamination leads to formation of covalent cross-links between a glutamine and the epsilon-amino group of a lysine residue, forming polymers. {ECO:0000250|UniProtKB:P48962}.","DOMAIN: The transmembrane helices are not perpendicular to the plane of the membrane, but cross the membrane at an angle. Odd-numbered transmembrane helices exhibit a sharp kink, due to the presence of a conserved proline residue. {ECO:0000250|UniProtKB:P02722}.",,,,,"cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,SLC25A4 AAC1 ANT1,"ADP/ATP translocase 1 (ADP,ATP carrier protein 1) (ADP,ATP carrier protein, heart/skeletal muscle isoform T1) (Adenine nucleotide translocator 1) (ANT 1) (Solute carrier family 25 member 4)",Homo sapiens (Human),298.0,33064.0,MGDHAWSFLKDFLAGGVAAAVSKTAVAPIERVKLLLQVQHASKQISAEKQYKGIIDCVVRIPKEQGFLSFWRGNLANVIRYFPTQALNFAFKDKYKQLFLGGVDRHKQFWRYFAGNLASGGAAGATSLCFVYPLDFARTRLAADVGKGAAQREFHGLGDCIIKIFKSDGLRGLYQGFNVSVQGIIIYRAAYFGVYDTAKGMLPDPKNVHIFVSWMIAQSVTAVAGLVSYPFDTVRRRMMMQSGRKGADIMYTGTVDCWRKIAKDEGAKAFFKGAWSNVLRGMGGAFVLVLYDEIKKYV,False,True,False,P12235,"[('G3DSA:1.50.40.10', 'Mitochondrial carrier domain'), ('IPR002067', 'Mitochondrial carrier protein'), ('IPR002113', 'ADP/ATP carrier protein, eukaryotic type'), ('IPR018108', 'Mitochondrial substrate/solute carrier'), ('IPR023395', 'Mitochondrial carrier domain superfamily'), ('PF00153', 'Mitochondrial carrier protein'), ('PR00926', 'MITOCARRIER'), ('PR00927', 'Adenine nucleotide translocator'), ('PS50920', 'Solute carrier (Solcar) repeat profile'), ('PTHR45635', 'ADP,ATP CARRIER PROTEIN 1-RELATED-RELATED'), ('SSF103506', 'Mitochondrial carrier')]",,"""ENSG00000151729; Group enriched (heart muscle, skeletal muscle, tongue)."";","CATALYTIC ACTIVITY: Reaction=ADP(in) + ATP(out) = ADP(out) + ATP(in); Xref=Rhea:RHEA:34999, ChEBI:CHEBI:30616, ChEBI:CHEBI:456216; Evidence={ECO:0000269|PubMed:21586654}; CATALYTIC ACTIVITY: Reaction=H(+)(in) = H(+)(out); Xref=Rhea:RHEA:34979, ChEBI:CHEBI:15378; Evidence={ECO:0000250|UniProtKB:P48962};",,"ACTIVITY REGULATION: The matrix-open state (m-state) is inhibited by the membrane-permeable bongkrekic acid (BKA) (By similarity). The cytoplasmic-open state (c-state) is inhibited by the membrane-impermeable toxic inhibitor carboxyatractyloside (CATR) (PubMed:21586654). Proton transporter activity is inhibited by ADP:ATP antiporter activity (By similarity). {ECO:0000250|UniProtKB:G2QNH0, ECO:0000250|UniProtKB:P48962, ECO:0000269|PubMed:21586654}.",,ENST00000281456.11;,SLC25A4;LINC02447,ENSG00000151729;ENSG00000245468,0.0,,,,,,,,,SLC25A4
P12830,ENSG00000039068,CADH1_HUMAN,"adherens junction organization [GO:0034332]; calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules [GO:0016339]; cell migration [GO:0016477]; cell morphogenesis [GO:0000902]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by cadherin [GO:0044331]; cell-cell junction assembly [GO:0007043]; cellular response to indole-3-methanol [GO:0071681]; cellular response to lithium ion [GO:0071285]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; negative regulation of axon extension [GO:0030517]; negative regulation of cell migration [GO:0030336]; negative regulation of cell-cell adhesion [GO:0022408]; neuron projection development [GO:0031175]; pituitary gland development [GO:0021983]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of protein import into nucleus [GO:0042307]; protein localization to plasma membrane [GO:0072659]; regulation of gene expression [GO:0010468]; regulation of protein catabolic process at postsynapse, modulating synaptic transmission [GO:0099576]; response to Gram-positive bacterium [GO:0140459]; response to heparin [GO:0071503]; response to toxic substance [GO:0009636]; response to xenobiotic stimulus [GO:0009410]; synapse assembly [GO:0007416]",actin cytoskeleton [GO:0015629]; adherens junction [GO:0005912]; apical junction complex [GO:0043296]; catenin complex [GO:0016342]; cell junction [GO:0030054]; cytoplasmic side of plasma membrane [GO:0009898]; desmosome [GO:0030057]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; flotillin complex [GO:0016600]; glutamatergic synapse [GO:0098978]; lamellipodium [GO:0030027]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; trans-Golgi network [GO:0005802],ankyrin binding [GO:0030506]; beta-catenin binding [GO:0008013]; cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839]; gamma-catenin binding [GO:0045295]; GTPase activating protein binding [GO:0032794]; identical protein binding [GO:0042802]; protein tyrosine kinase binding [GO:1990782],"PTM: During apoptosis or with calcium influx, cleaved by a membrane-bound metalloproteinase (ADAM10), PS1/gamma-secretase and caspase-3 (PubMed:10597309, PubMed:11076937, PubMed:11953314). Processing by the metalloproteinase, induced by calcium influx, causes disruption of cell-cell adhesion and the subsequent release of beta-catenin into the cytoplasm (PubMed:10597309). The residual membrane-tethered cleavage product is rapidly degraded via an intracellular proteolytic pathway (PubMed:10597309). Cleavage by caspase-3 releases the cytoplasmic tail resulting in disintegration of the actin microfilament system (PubMed:11076937). The gamma-secretase-mediated cleavage promotes disassembly of adherens junctions (PubMed:11953314). During development of the cochlear organ of Corti, cleavage by ADAM10 at adherens junctions promotes pillar cell separation (By similarity). {ECO:0000250|UniProtKB:P09803, ECO:0000269|PubMed:10597309, ECO:0000269|PubMed:11076937, ECO:0000269|PubMed:11953314}.; PTM: N-glycosylation at Asn-637 is essential for expression, folding and trafficking. Addition of bisecting N-acetylglucosamine by MGAT3 modulates its cell membrane location (PubMed:19403558). {ECO:0000269|PubMed:18491227, ECO:0000269|PubMed:19403558}.; PTM: Ubiquitinated by a SCF complex containing SKP2, which requires prior phosphorylation by CK1/CSNK1A1. Ubiquitinated by CBLL1/HAKAI, requires prior phosphorylation at Tyr-754. {ECO:0000269|PubMed:21283129, ECO:0000269|PubMed:22252131, ECO:0000269|PubMed:22770219}.; PTM: O-glycosylated. O-manosylated by TMTC1, TMTC2, TMTC3 or TMTC4. Thr-285 and Thr-509 are O-mannosylated by TMTC2 or TMTC4 but not TMTC1 or TMTC3. {ECO:0000250|UniProtKB:P09803}.; PTM: (Microbial infection) Cleaved by S.pyogenes SpeB protease; leading to its degradation (PubMed:23532847). Degradation by SpeB promotes bacterial translocation across the host epithelial barrier (PubMed:23532847). {ECO:0000269|PubMed:23532847}.","DOMAIN: Three calcium ions are usually bound at the interface of each cadherin domain and strengthen the connections, imparting a strong curvature to the full-length ectodomain. {ECO:0000269|PubMed:2349235}.","DOMAIN 155..262; /note=""Cadherin 1""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00043""; DOMAIN 263..375; /note=""Cadherin 2""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00043""; DOMAIN 376..486; /note=""Cadherin 3""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00043""; DOMAIN 487..593; /note=""Cadherin 4""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00043""; DOMAIN 594..697; /note=""Cadherin 5""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00043""","STRAND 163..166; /evidence=""ECO:0007829|PDB:2OMZ""; STRAND 169..177; /evidence=""ECO:0007829|PDB:2OMZ""; STRAND 189..195; /evidence=""ECO:0007829|PDB:2OMZ""; STRAND 199..201; /evidence=""ECO:0007829|PDB:2OMZ""; STRAND 204..207; /evidence=""ECO:0007829|PDB:2OMZ""; STRAND 213..216; /evidence=""ECO:0007829|PDB:2OMZ""; STRAND 227..235; /evidence=""ECO:0007829|PDB:2OMZ""; STRAND 241..243; /evidence=""ECO:0007829|PDB:2OMZ""; STRAND 246..253; /evidence=""ECO:0007829|PDB:2OMZ""; STRAND 261..263; /evidence=""ECO:0007829|PDB:8H62""; STRAND 265..272; /evidence=""ECO:0007829|PDB:8H62""; STRAND 280..283; /evidence=""ECO:0007829|PDB:8H62""; STRAND 301..309; /evidence=""ECO:0007829|PDB:8H62""; STRAND 316..319; /evidence=""ECO:0007829|PDB:8H62""; STRAND 325..328; /evidence=""ECO:0007829|PDB:8H62""; STRAND 340..348; /evidence=""ECO:0007829|PDB:8H62""; STRAND 356..366; /evidence=""ECO:0007829|PDB:8H62""; STRAND 374..384; /evidence=""ECO:0007829|PDB:7STZ""; STRAND 394..396; /evidence=""ECO:0007829|PDB:7STZ""; STRAND 410..417; /evidence=""ECO:0007829|PDB:7STZ""; STRAND 423..428; /evidence=""ECO:0007829|PDB:7STZ""; STRAND 433..440; /evidence=""ECO:0007829|PDB:7STZ""; STRAND 448..460; /evidence=""ECO:0007829|PDB:7STZ""; STRAND 470..477; /evidence=""ECO:0007829|PDB:7STZ""; STRAND 485..498; /evidence=""ECO:0007829|PDB:7STZ""; STRAND 504..507; /evidence=""ECO:0007829|PDB:7STZ""; STRAND 522..527; /evidence=""ECO:0007829|PDB:7STZ""; STRAND 533..535; /evidence=""ECO:0007829|PDB:7STZ""; STRAND 541..544; /evidence=""ECO:0007829|PDB:7STZ""; STRAND 557..568; /evidence=""ECO:0007829|PDB:7STZ""; STRAND 571..573; /evidence=""ECO:0007829|PDB:7STZ""; STRAND 576..586; /evidence=""ECO:0007829|PDB:7STZ""; STRAND 594..596; /evidence=""ECO:0007829|PDB:7STZ""; STRAND 599..607; /evidence=""ECO:0007829|PDB:7STZ""; STRAND 610..615; /evidence=""ECO:0007829|PDB:7STZ""; STRAND 622..625; /evidence=""ECO:0007829|PDB:7STZ""; STRAND 627..633; /evidence=""ECO:0007829|PDB:7STZ""; STRAND 638..644; /evidence=""ECO:0007829|PDB:7STZ""; STRAND 648..656; /evidence=""ECO:0007829|PDB:7STZ""; STRAND 660..673; /evidence=""ECO:0007829|PDB:7STZ""; STRAND 675..691; /evidence=""ECO:0007829|PDB:7STZ""","HELIX 181..184; /evidence=""ECO:0007829|PDB:2OMZ""; HELIX 350..352; /evidence=""ECO:0007829|PDB:8H62""; HELIX 769..771; /evidence=""ECO:0007829|PDB:3L6X""","TURN 196..198; /evidence=""ECO:0007829|PDB:2OMZ""; TURN 209..211; /evidence=""ECO:0007829|PDB:2OMZ""; TURN 222..224; /evidence=""ECO:0007829|PDB:2OMZ""; TURN 292..294; /evidence=""ECO:0007829|PDB:8H62""; TURN 321..323; /evidence=""ECO:0007829|PDB:8H62""; TURN 335..337; /evidence=""ECO:0007829|PDB:8H62""; TURN 407..409; /evidence=""ECO:0007829|PDB:7STZ""; TURN 429..432; /evidence=""ECO:0007829|PDB:7STZ""; TURN 444..446; /evidence=""ECO:0007829|PDB:7STZ""; TURN 537..539; /evidence=""ECO:0007829|PDB:7STZ""; TURN 553..555; /evidence=""ECO:0007829|PDB:7STZ""; TURN 635..637; /evidence=""ECO:0007829|PDB:7STZ""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,CDH1 CDHE UVO,Cadherin-1 (CAM 120/80) (Epithelial cadherin) (E-cadherin) (Uvomorulin) (CD antigen CD324) [Cleaved into: E-Cad/CTF1; E-Cad/CTF2; E-Cad/CTF3],Homo sapiens (Human),882.0,97456.0,MGPWSRSLSALLLLLQVSSWLCQEPEPCHPGFDAESYTFTVPRRHLERGRVLGRVNFEDCTGRQRTAYFSLDTRFKVGTDGVITVKRPLRFHNPQIHFLVYAWDSTYRKFSTKVTLNTVGHHHRPPPHQASVSGIQAELLTFPNSSPGLRRQKRDWVIPPISCPENEKGPFPKNLVQIKSNKDKEGKVFYSITGQGADTPPVGVFIIERETGWLKVTEPLDRERIATYTLFSHAVSSNGNAVEDPMEILITVTDQNDNKPEFTQEVFKGSVMEGALPGTSVMEVTATDADDDVNTYNAAIAYTILSQDPELPDKNMFTINRNTGVISVVTTGLDRESFPTYTLVVQAADLQGEGLSTTATAVITVTDTNDNPPIFNPTTYKGQVPENEANVVITTLKVTDADAPNTPAWEAVYTILNDDGGQFVVTTNPVNNDGILKTAKGLDFEAKQQYILHVAVTNVVPFEVSLTTSTATVTVDVLDVNEAPIFVPPEKRVEVSEDFGVGQEITSYTAQEPDTFMEQKITYRIWRDTANWLEINPDTGAISTRAELDREDFEHVKNSTYTALIIATDNGSPVATGTGTLLLILSDVNDNAPIPEPRTIFFCERNPKPQVINIIDADLPPNTSPFTAELTHGASANWTIQYNDPTQESIILKPKMALEVGDYKINLKLMDNQNKDQVTTLEVSVCDCEGAAGVCRKAQPVEAGLQIPAILGILGGILALLILILLLLLFLRRRAVVKEPLLPPEDDTRDNVYYYDEEGGGEEDQDFDLSQLHRGLDARPEVTRNDVAPTLMSVPRYLPRPANPDEIGNFIDENLKAADTDPTAPPYDSLLVFDYEGSGSEAASLSSLNSSESDKDQDYDYLNEWGNRFKKLADMYGGGEDD,True,False,False,P12830,"[('cd00031', 'Cadherin repeat-like domain'), ('cd11304', 'Cadherin tandem repeat domain'), ('G3DSA:2.60.40.60', 'Cadherins'), ('G3DSA:4.10.900.10', 'TCF3-CBD (Catenin binding domain)'), ('IPR000233', 'Cadherin, Y-type LIR-motif'), ('IPR002126', 'Cadherin-like'), ('IPR014868', 'Cadherin prodomain'), ('IPR015919', 'Cadherin-like superfamily'), ('IPR020894', 'Cadherin conserved site'), ('IPR027397', 'Catenin binding domain superfamily'), ('IPR039808', 'Cadherin'), ('PF00028', 'Cadherin domain'), ('PF01049', 'Cadherin, Y-type LIR-motif'), ('PF08758', 'Cadherin prodomain like'), ('PR00205', 'CADHERIN'), ('PS00232', 'Cadherin domain signature'), ('PS50268', 'Cadherins domain profile'), ('PTHR24027', 'CADHERIN-23'), ('SM00112', 'Cadherin repeats.'), ('SM01055', 'Cadherin prodomain like')]",P12830;,"""ENSG00000039068; Tissue enhanced (parathyroid)."";",,,,,ENST00000261769.10 [P12830-1];ENST00000422392.6 [P12830-2];,CDH1;ARHGEF38,ENSG00000039068;ENSG00000236699,0.0,,,,,,,0.287,0.024,CDH1
P12931,ENSG00000197122|ENSG00000291971,SRC_HUMAN,adherens junction organization [GO:0034332]; angiotensin-activated signaling pathway [GO:0038166]; bone resorption [GO:0045453]; branching involved in mammary gland duct morphogenesis [GO:0060444]; cell adhesion [GO:0007155]; cell differentiation [GO:0030154]; cell-cell adhesion [GO:0098609]; cellular response to fatty acid [GO:0071398]; cellular response to fluid shear stress [GO:0071498]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to hypoxia [GO:0071456]; cellular response to insulin stimulus [GO:0032869]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to peptide hormone stimulus [GO:0071375]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; cellular response to progesterone stimulus [GO:0071393]; cellular response to prolactin [GO:1990646]; cellular response to reactive oxygen species [GO:0034614]; DNA biosynthetic process [GO:0071897]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; ERBB2 signaling pathway [GO:0038128]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; focal adhesion assembly [GO:0048041]; forebrain development [GO:0030900]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; interleukin-6-mediated signaling pathway [GO:0070102]; intestinal epithelial cell development [GO:0060576]; intracellular signal transduction [GO:0035556]; learning or memory [GO:0007611]; leukocyte migration [GO:0050900]; macroautophagy [GO:0016236]; myoblast proliferation [GO:0051450]; negative regulation of anoikis [GO:2000811]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of focal adhesion assembly [GO:0051895]; negative regulation of gene expression [GO:0010629]; negative regulation of hippo signaling [GO:0035331]; negative regulation of inflammatory response to antigenic stimulus [GO:0002862]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of mitochondrial depolarization [GO:0051902]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of telomere maintenance [GO:0032205]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neurotrophin TRK receptor signaling pathway [GO:0048011]; odontogenesis [GO:0042476]; oogenesis [GO:0048477]; osteoclast development [GO:0036035]; peptidyl-tyrosine autophosphorylation [GO:0038083]; peptidyl-tyrosine phosphorylation [GO:0018108]; platelet activation [GO:0030168]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of apoptotic process [GO:0043065]; positive regulation of bone resorption [GO:0045780]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cytokine production [GO:0001819]; positive regulation of dephosphorylation [GO:0035306]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of glucose metabolic process [GO:0010907]; positive regulation of glycolytic process [GO:0045821]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of integrin activation [GO:0033625]; positive regulation of lamellipodium morphogenesis [GO:2000394]; positive regulation of male germ cell proliferation [GO:2000256]; positive regulation of non-membrane spanning protein tyrosine kinase activity [GO:1903997]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of ovarian follicle development [GO:2000386]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of platelet-derived growth factor receptor-beta signaling pathway [GO:2000588]; positive regulation of podosome assembly [GO:0071803]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of protein processing [GO:0010954]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; positive regulation of protein transport [GO:0051222]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of small GTPase mediated signal transduction [GO:0051057]; positive regulation of smooth muscle cell migration [GO:0014911]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; primary ovarian follicle growth [GO:0001545]; progesterone receptor signaling pathway [GO:0050847]; protein autophosphorylation [GO:0046777]; protein destabilization [GO:0031648]; regulation of bone resorption [GO:0045124]; regulation of caveolin-mediated endocytosis [GO:2001286]; regulation of cell projection assembly [GO:0060491]; regulation of cell-cell adhesion [GO:0022407]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of epithelial cell migration [GO:0010632]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of intracellular estrogen receptor signaling pathway [GO:0033146]; regulation of toll-like receptor 3 signaling pathway [GO:0034139]; regulation of vascular permeability [GO:0043114]; response to acidic pH [GO:0010447]; response to electrical stimulus [GO:0051602]; response to interleukin-1 [GO:0070555]; response to mechanical stimulus [GO:0009612]; response to mineralocorticoid [GO:0051385]; response to nutrient levels [GO:0031667]; response to xenobiotic stimulus [GO:0009410]; signal complex assembly [GO:0007172]; signal transduction [GO:0007165]; skeletal muscle cell proliferation [GO:0014856]; spermatogenesis [GO:0007283]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; stress fiber assembly [GO:0043149]; substrate adhesion-dependent cell spreading [GO:0034446]; symbiont entry into host cell [GO:0046718]; T cell costimulation [GO:0031295]; transcytosis [GO:0045056]; transforming growth factor beta receptor signaling pathway [GO:0007179]; uterus development [GO:0060065]; vascular endothelial growth factor receptor signaling pathway [GO:0048010],"actin filament [GO:0005884]; caveola [GO:0005901]; cell junction [GO:0030054]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic filopodium [GO:1902737]; dendritic growth cone [GO:0044294]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; late endosome [GO:0005770]; lysosome [GO:0005764]; membrane raft [GO:0045121]; mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739]; neuronal cell body [GO:0043025]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; podosome [GO:0002102]; postsynaptic specialization, intracellular component [GO:0099091]; ruffle membrane [GO:0032587]; synaptic membrane [GO:0097060]",ATP binding [GO:0005524]; ATPase binding [GO:0051117]; BMP receptor binding [GO:0070700]; cadherin binding [GO:0045296]; connexin binding [GO:0071253]; enzyme binding [GO:0019899]; ephrin receptor binding [GO:0046875]; heme binding [GO:0020037]; insulin receptor binding [GO:0005158]; integrin binding [GO:0005178]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; nuclear estrogen receptor binding [GO:0030331]; phospholipase activator activity [GO:0016004]; phospholipase binding [GO:0043274]; phosphoprotein binding [GO:0051219]; protein kinase activity [GO:0004672]; protein kinase C binding [GO:0005080]; protein tyrosine kinase activity [GO:0004713]; scaffold protein binding [GO:0097110]; SH2 domain binding [GO:0042169]; signaling receptor binding [GO:0005102]; transmembrane transporter binding [GO:0044325],"PTM: Myristoylated at Gly-2, and this is essential for targeting to membranes. {ECO:0000269|PubMed:7525268}.; PTM: Dephosphorylated at Tyr-530 by PTPRJ (By similarity). Phosphorylated on Tyr-530 by c-Src kinase (CSK). The phosphorylated form is termed pp60c-src. Dephosphorylated by PTPRJ at Tyr-419. Normally maintained in an inactive conformation with the SH2 domain engaged with Tyr-530, the SH3 domain engaged with the SH2-kinase linker, and Tyr-419 dephosphorylated. Dephosphorylation of Tyr-530 as a result of protein tyrosine phosphatase (PTP) action disrupts the intramolecular interaction between the SH2 domain and Tyr-530, Tyr-419 can then become autophosphorylated, resulting in SRC activation. Phosphorylation of Tyr-530 by CSK allows this interaction to reform, resulting in SRC inactivation. CDK5-mediated phosphorylation at Ser-75 targets SRC to ubiquitin-dependent degradation and thus leads to cytoskeletal reorganization. Phosphorylated by PTK2/FAK1; this enhances kinase activity. Phosphorylated by PTK2B/PYK2; this enhances kinase activity. Upon activation of IL6ST by IL6, Tyr-419 is phosphorylated and Tyr-530 dephosphorylated (PubMed:25731159). {ECO:0000250, ECO:0000269|PubMed:14661060, ECO:0000269|PubMed:18936167, ECO:0000269|PubMed:21442427, ECO:0000269|PubMed:22888118, ECO:0000269|PubMed:25731159, ECO:0000269|PubMed:6273838, ECO:0000269|PubMed:7525268}.; PTM: [Isoform 1]: Displays reduced levels of autophosphorylation at Tyr-419 compared to isoforms 2 and 3. {ECO:0000250|UniProtKB:Q9WUD9}.; PTM: [Isoform 2]: Displays enhanced levels of autophosphorylation at Tyr-419 compared to isoform 1. {ECO:0000250|UniProtKB:Q9WUD9}.; PTM: [Isoform 3]: Displays enhanced levels of autophosphorylation at Tyr-419 compared to isoform 1 (By similarity). Shows reduced phosphorylation at Tyr-527 compared to isoforms 1 and 2 (By similarity). {ECO:0000250|UniProtKB:Q9WUD9}.; PTM: S-nitrosylation is important for activation of its kinase activity. {ECO:0000250}.; PTM: Ubiquitinated in response to CDK5-mediated phosphorylation. Ubiquitination mediated by CBLC requires SRC autophosphorylation at Tyr-419 and may lead to lysosomal degradation. {ECO:0000269|PubMed:14661060, ECO:0000269|PubMed:18936167, ECO:0000269|PubMed:22888118, ECO:0000269|PubMed:6273838}.","DOMAIN: The SH2 and SH3 domains are important for the intramolecular and intermolecular interactions that regulate catalytic activity, localization, and substrate recruitment.","DOMAIN 84..145; /note=""SH3""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00192""; DOMAIN 151..248; /note=""SH2""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00191""; DOMAIN 270..523; /note=""Protein kinase""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00159""","STRAND 87..93; /evidence=""ECO:0007829|PDB:1FMK""; STRAND 99..102; /evidence=""ECO:0007829|PDB:1FMK""; STRAND 110..114; /evidence=""ECO:0007829|PDB:1FMK""; STRAND 118..126; /evidence=""ECO:0007829|PDB:1FMK""; STRAND 132..136; /evidence=""ECO:0007829|PDB:1FMK""; STRAND 140..142; /evidence=""ECO:0007829|PDB:1FMK""; STRAND 152..154; /evidence=""ECO:0007829|PDB:1FMK""; STRAND 167..170; /evidence=""ECO:0007829|PDB:1SHD""; STRAND 174..179; /evidence=""ECO:0007829|PDB:1FMK""; STRAND 181..183; /evidence=""ECO:0007829|PDB:1FMK""; STRAND 187..195; /evidence=""ECO:0007829|PDB:1FMK""; STRAND 199..209; /evidence=""ECO:0007829|PDB:1FMK""; STRAND 211..213; /evidence=""ECO:0007829|PDB:2SRC""; STRAND 215..218; /evidence=""ECO:0007829|PDB:1FMK""; STRAND 221..225; /evidence=""ECO:0007829|PDB:1FMK""; STRAND 240..242; /evidence=""ECO:0007829|PDB:1FMK""; STRAND 256..259; /evidence=""ECO:0007829|PDB:1FMK""; STRAND 270..278; /evidence=""ECO:0007829|PDB:1FMK""; STRAND 280..282; /evidence=""ECO:0007829|PDB:6ATE""; STRAND 283..289; /evidence=""ECO:0007829|PDB:1FMK""; STRAND 293..299; /evidence=""ECO:0007829|PDB:1FMK""; STRAND 328..332; /evidence=""ECO:0007829|PDB:1FMK""; STRAND 334..336; /evidence=""ECO:0007829|PDB:1FMK""; STRAND 338..341; /evidence=""ECO:0007829|PDB:1FMK""; STRAND 345..348; /evidence=""ECO:0007829|PDB:6ATE""; STRAND 395..397; /evidence=""ECO:0007829|PDB:1FMK""; STRAND 403..405; /evidence=""ECO:0007829|PDB:1FMK""","HELIX 137..139; /evidence=""ECO:0007829|PDB:1FMK""; HELIX 146..148; /evidence=""ECO:0007829|PDB:1FMK""; HELIX 158..165; /evidence=""ECO:0007829|PDB:1FMK""; HELIX 226..233; /evidence=""ECO:0007829|PDB:1FMK""; HELIX 267..269; /evidence=""ECO:0007829|PDB:1FMK""; HELIX 307..319; /evidence=""ECO:0007829|PDB:1FMK""; HELIX 349..353; /evidence=""ECO:0007829|PDB:1FMK""; HELIX 355..358; /evidence=""ECO:0007829|PDB:1FMK""; HELIX 363..382; /evidence=""ECO:0007829|PDB:1FMK""; HELIX 392..394; /evidence=""ECO:0007829|PDB:1FMK""; HELIX 399..401; /evidence=""ECO:0007829|PDB:1FMK""; HELIX 410..413; /evidence=""ECO:0007829|PDB:2SRC""; HELIX 417..420; /evidence=""ECO:0007829|PDB:2SRC""; HELIX 429..431; /evidence=""ECO:0007829|PDB:1FMK""; HELIX 434..439; /evidence=""ECO:0007829|PDB:1FMK""; HELIX 444..459; /evidence=""ECO:0007829|PDB:1FMK""; HELIX 471..479; /evidence=""ECO:0007829|PDB:1FMK""; HELIX 492..501; /evidence=""ECO:0007829|PDB:1FMK""; HELIX 506..508; /evidence=""ECO:0007829|PDB:1FMK""; HELIX 512..520; /evidence=""ECO:0007829|PDB:1FMK""","TURN 127..129; /evidence=""ECO:0007829|PDB:1FMK""; TURN 196..198; /evidence=""ECO:0007829|PDB:1FMK""; TURN 290..292; /evidence=""ECO:0007829|PDB:1FMK""; TURN 302..304; /evidence=""ECO:0007829|PDB:2BDF""; TURN 423..426; /evidence=""ECO:0007829|PDB:1Y57""; TURN 460..462; /evidence=""ECO:0007829|PDB:1FMK""; TURN 521..523; /evidence=""ECO:0007829|PDB:1FMK""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,SRC SRC1,Proto-oncogene tyrosine-protein kinase Src (EC 2.7.10.2) (Proto-oncogene c-Src) (pp60c-src) (p60-Src),Homo sapiens (Human),536.0,59835.0,MGSNKSKPKDASQRRRSLEPAENVHGAGGGAFPASQTPSKPASADGHRGPSAAFAPAAAEPKLFGGFNSSDTVTSPQRAGPLAGGVTTFVALYDYESRTETDLSFKKGERLQIVNNTEGDWWLAHSLSTGQTGYIPSNYVAPSDSIQAEEWYFGKITRRESERLLLNAENPRGTFLVRESETTKGAYCLSVSDFDNAKGLNVKHYKIRKLDSGGFYITSRTQFNSLQQLVAYYSKHADGLCHRLTTVCPTSKPQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPGENL,False,False,True,P12931,"[('cd05071', 'Catalytic domain of the Protein Tyrosine Kinase, Src'), ('cd10365', 'Src homology 2 (SH2) domain found in tyrosine kinase sarcoma (Src)'), ('cd12008', 'Src homology 3 domain of Src Protein Tyrosine Kinase'), ('G3DSA:1.10.510.10', 'Transferase(Phosphotransferase) domain 1'), ('G3DSA:2.30.30.40', 'SH3 Domains'), ('G3DSA:3.30.200.20', 'Phosphorylase Kinase; domain 1'), ('G3DSA:3.30.505.10', 'SH2 domain'), ('IPR000719', 'Protein kinase domain'), ('IPR000980', 'SH2 domain'), ('IPR001245', 'Serine-threonine/tyrosine-protein kinase, catalytic domain'), ('IPR001452', 'SH3 domain'), ('IPR008266', 'Tyrosine-protein kinase, active site'), ('IPR011009', 'Protein kinase-like domain superfamily'), ('IPR017441', 'Protein kinase, ATP binding site'), ('IPR020635', 'Tyrosine-protein kinase, catalytic domain'), ('IPR036028', 'SH3-like domain superfamily'), ('IPR036860', 'SH2 domain superfamily'), ('IPR050198', 'Non-receptor tyrosine kinases involved in cell signaling'), ('PF00017', 'SH2 domain'), ('PF00018', 'SH3 domain')]",P12931;,"""ENSG00000197122; Low tissue specificity."";","CATALYTIC ACTIVITY: Reaction=L-tyrosyl-[protein] + ATP = O-phospho-L-tyrosyl-[protein] + ADP + H(+); Xref=Rhea:RHEA:10596, Rhea:RHEA-COMP:10136, Rhea:RHEA-COMP:10137, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616, ChEBI:CHEBI:46858, ChEBI:CHEBI:82620, ChEBI:CHEBI:456216; EC=2.7.10.2; Evidence={ECO:0000255|PROSITE-ProRule:PRU10028, ECO:0000269|PubMed:14632929, ECO:0000269|PubMed:19307596, ECO:0000269|PubMed:21036157, ECO:0000269|PubMed:25501895, ECO:0000269|PubMed:34234773, ECO:0000269|PubMed:35927303, ECO:0000269|PubMed:7929427, ECO:0000269|PubMed:8759729, ECO:0000269|PubMed:9571170}; CATALYTIC ACTIVITY: [Isoform 1]: Reaction=L-tyrosyl-[protein] + ATP = O-phospho-L-tyrosyl-[protein] + ADP + H(+); Xref=Rhea:RHEA:10596, Rhea:RHEA-COMP:10136, Rhea:RHEA-COMP:10137, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616, ChEBI:CHEBI:46858, ChEBI:CHEBI:82620, ChEBI:CHEBI:456216; EC=2.7.10.2; Evidence={ECO:0000250|UniProtKB:Q9WUD9}; CATALYTIC ACTIVITY: [Isoform 2]: Reaction=L-tyrosyl-[protein] + ATP = O-phospho-L-tyrosyl-[protein] + ADP + H(+); Xref=Rhea:RHEA:10596, Rhea:RHEA-COMP:10136, Rhea:RHEA-COMP:10137, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616, ChEBI:CHEBI:46858, ChEBI:CHEBI:82620, ChEBI:CHEBI:456216; EC=2.7.10.2; Evidence={ECO:0000250|UniProtKB:Q9WUD9}; CATALYTIC ACTIVITY: [Isoform 3]: Reaction=L-tyrosyl-[protein] + ATP = O-phospho-L-tyrosyl-[protein] + ADP + H(+); Xref=Rhea:RHEA:10596, Rhea:RHEA-COMP:10136, Rhea:RHEA-COMP:10137, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616, ChEBI:CHEBI:46858, ChEBI:CHEBI:82620, ChEBI:CHEBI:456216; EC=2.7.10.2; Evidence={ECO:0000250|UniProtKB:Q9WUD9};",2.7.10.2,"ACTIVITY REGULATION: Phosphorylation by CSK at Tyr-530 inhibits kinase activity. Inhibitory phosphorylation at Tyr-530 is enhanced by heme. Further phosphorylation by CDK1 partially reactivates CSK-inactivated SRC and facilitates complete reactivation by protein tyrosine phosphatase PTPRC. Integrin engagement stimulates kinase activity. Phosphorylation by PTK2/FAK1 enhances kinase activity. Butein and pseudosubstrate-based peptide inhibitors like CIYKYYF act as inhibitors. Phosphorylation at Tyr-419 increases kinase activity. {ECO:0000269|PubMed:14632929, ECO:0000269|PubMed:21036157, ECO:0000269|PubMed:7929427, ECO:0000269|PubMed:8759729, ECO:0000269|PubMed:9571170}.",,ENST00000358208.9 [P12931-3];ENST00000373558.2 [P12931-2];ENST00000373567.6 [P12931-1];ENST00000373578.7 [P12931-1];ENST00000692112.1 [P12931-1];ENST00000692423.1 [P12931-1];ENST00000709392.1 [P12931-1];ENST00000709394.1 [P12931-1];ENST00000709395.1 [P12931-1];ENST00000709396.1 [P12931-1];ENST00000709397.1 [P12931-2];ENST00000709398.1 [P12931-3];,SRC,ENSG00000197122;ENSG00000249184,1.0,,,,15.67,DP01570,0.289,0.149,0.099,SRC
P12956,ENSG00000196419,XRCC6_HUMAN,activation of innate immune response [GO:0002218]; cellular hyperosmotic salinity response [GO:0071475]; cellular response to gamma radiation [GO:0071480]; cellular response to X-ray [GO:0071481]; DNA ligation [GO:0006266]; double-strand break repair via classical nonhomologous end joining [GO:0097680]; double-strand break repair via nonhomologous end joining [GO:0006303]; innate immune response [GO:0045087]; negative regulation of DNA-templated transcription [GO:0045892]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of lymphocyte differentiation [GO:0045621]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of transcription by RNA polymerase II [GO:0045944]; recombinational repair [GO:0000725]; regulation of smooth muscle cell proliferation [GO:0048660]; telomere maintenance [GO:0000723],"chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; DNA-dependent protein kinase complex [GO:0070418]; DNA-dependent protein kinase-DNA ligase 4 complex [GO:0005958]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; Ku70:Ku80 complex [GO:0043564]; membrane [GO:0016020]; nonhomologous end joining complex [GO:0070419]; nuclear telomere cap complex [GO:0000783]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; protein-DNA complex [GO:0032993]; secretory granule lumen [GO:0034774]; transcription regulator complex [GO:0005667]","5'-deoxyribose-5-phosphate lyase activity [GO:0051575]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent activity, acting on DNA [GO:0008094]; cyclin binding [GO:0030332]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; DNA helicase activity [GO:0003678]; double-stranded DNA binding [GO:0003690]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; scaffold protein binding [GO:0097110]; telomeric DNA binding [GO:0042162]; transcription cis-regulatory region binding [GO:0000976]","PTM: Phosphorylation by PRKDC may enhance helicase activity. Phosphorylation of Ser-51 does not affect DNA repair. {ECO:0000269|PubMed:10026262, ECO:0000269|PubMed:12547193, ECO:0000269|PubMed:9362500}.; PTM: ADP-ribosylated by PARP3. {ECO:0000269|PubMed:24598253}.",,"DOMAIN 261..468; /note=""Ku""; DOMAIN 573..607; /note=""SAP""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00186""","STRAND 37..43; /evidence=""ECO:0007829|PDB:8AG4""; STRAND 53..56; /evidence=""ECO:0007829|PDB:1JEY""; STRAND 82..91; /evidence=""ECO:0007829|PDB:8AG4""; STRAND 94..97; /evidence=""ECO:0007829|PDB:7ZYG""; STRAND 100..109; /evidence=""ECO:0007829|PDB:8AG4""; STRAND 164..169; /evidence=""ECO:0007829|PDB:8AG4""; STRAND 198..202; /evidence=""ECO:0007829|PDB:8AG4""; STRAND 207..210; /evidence=""ECO:0007829|PDB:7Z87""; STRAND 218..221; /evidence=""ECO:0007829|PDB:8AG4""; STRAND 232..234; /evidence=""ECO:0007829|PDB:7SGL""; STRAND 260..266; /evidence=""ECO:0007829|PDB:8AG4""; STRAND 268..274; /evidence=""ECO:0007829|PDB:8AG4""; STRAND 286..289; /evidence=""ECO:0007829|PDB:1JEY""; STRAND 290..292; /evidence=""ECO:0007829|PDB:8AG4""; STRAND 295..297; /evidence=""ECO:0007829|PDB:7ZT6""; STRAND 300..304; /evidence=""ECO:0007829|PDB:8AG4""; STRAND 308..310; /evidence=""ECO:0007829|PDB:7ZT6""; STRAND 315..322; /evidence=""ECO:0007829|PDB:8AG4""; STRAND 325..329; /evidence=""ECO:0007829|PDB:8AG4""; STRAND 343..352; /evidence=""ECO:0007829|PDB:8AG4""; STRAND 366..370; /evidence=""ECO:0007829|PDB:8AG4""; STRAND 394..401; /evidence=""ECO:0007829|PDB:8AG4""; STRAND 403..405; /evidence=""ECO:0007829|PDB:1JEY""; STRAND 409..416; /evidence=""ECO:0007829|PDB:8AG4""; STRAND 426..428; /evidence=""ECO:0007829|PDB:8AG4""; STRAND 430..436; /evidence=""ECO:0007829|PDB:8AG4""; STRAND 506..508; /evidence=""ECO:0007829|PDB:7ZWA""","HELIX 46..49; /evidence=""ECO:0007829|PDB:8AG4""; HELIX 59..77; /evidence=""ECO:0007829|PDB:8AG4""; HELIX 113..121; /evidence=""ECO:0007829|PDB:8AG4""; HELIX 124..134; /evidence=""ECO:0007829|PDB:8AG4""; HELIX 143..155; /evidence=""ECO:0007829|PDB:8AG4""; HELIX 180..196; /evidence=""ECO:0007829|PDB:8AG4""; HELIX 239..250; /evidence=""ECO:0007829|PDB:8AG4""; HELIX 331..336; /evidence=""ECO:0007829|PDB:8AG4""; HELIX 353..355; /evidence=""ECO:0007829|PDB:8AG4""; HELIX 358..360; /evidence=""ECO:0007829|PDB:1JEY""; HELIX 378..392; /evidence=""ECO:0007829|PDB:8AG4""; HELIX 440..442; /evidence=""ECO:0007829|PDB:8AG4""; HELIX 456..468; /evidence=""ECO:0007829|PDB:8AG4""; HELIX 481..494; /evidence=""ECO:0007829|PDB:8AG4""; HELIX 511..518; /evidence=""ECO:0007829|PDB:8AG4""; HELIX 521..529; /evidence=""ECO:0007829|PDB:8AG4""; HELIX 561..569; /evidence=""ECO:0007829|PDB:1JEQ""; HELIX 573..575; /evidence=""ECO:0007829|PDB:1JEQ""; HELIX 578..587; /evidence=""ECO:0007829|PDB:1JEQ""; HELIX 596..607; /evidence=""ECO:0007829|PDB:1JEQ""","TURN 175..178; /evidence=""ECO:0007829|PDB:8AG4""; TURN 213..216; /evidence=""ECO:0007829|PDB:8AG4""; TURN 225..228; /evidence=""ECO:0007829|PDB:8AG4""; TURN 305..307; /evidence=""ECO:0007829|PDB:8AG4""; TURN 372..374; /evidence=""ECO:0007829|PDB:8AG4""; TURN 422..424; /evidence=""ECO:0007829|PDB:7SGL""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,XRCC6 G22P1,X-ray repair cross-complementing protein 6 (EC 3.6.4.-) (EC 4.2.99.-) (5'-deoxyribose-5-phosphate lyase Ku70) (5'-dRP lyase Ku70) (70 kDa subunit of Ku antigen) (ATP-dependent DNA helicase 2 subunit 1) (ATP-dependent DNA helicase II 70 kDa subunit) (CTC box-binding factor 75 kDa subunit) (CTC75) (CTCBF) (DNA repair protein XRCC6) (Lupus Ku autoantigen protein p70) (Ku70) (Thyroid-lupus autoantigen) (TLAA) (X-ray repair complementing defective repair in Chinese hamster cells 6),Homo sapiens (Human),609.0,69843.0,MSGWESYYKTEGDEEAEEEQEENLEASGDYKYSGRDSLIFLVDASKAMFESQSEDELTPFDMSIQCIQSVYISKIISSDRDLLAVVFYGTEKDKNSVNFKNIYVLQELDNPGAKRILELDQFKGQQGQKRFQDMMGHGSDYSLSEVLWVCANLFSDVQFKMSHKRIMLFTNEDNPHGNDSAKASRARTKAGDLRDTGIFLDLMHLKKPGGFDISLFYRDIISIAEDEDLRVHFEESSKLEDLLRKVRAKETRKRALSRLKLKLNKDIVISVGIYNLVQKALKPPPIKLYRETNEPVKTKTRTFNTSTGGLLLPSDTKRSQIYGSRQIILEKEETEELKRFDDPGLMLMGFKPLVLLKKHHYLRPSLFVYPEESLVIGSSTLFSALLIKCLEKEVAALCRYTPRRNIPPYFVALVPQEEELDDQKIQVTPPGFQLVFLPFADDKRKMPFTEKIMATPEQVGKMKAIVEKLRFTYRSDSFENPVLQQHFRNLEALALDLMEPEQAVDLTLPKVEAMNKRLGSLVDEFKELVYPPDYNPEGKVTKRKHDNEGSGSKRPKVEYSEEELKTHISKGTLGKFTVPMLKEACRAYGLKSGLKKQELLEALTKHFQD,False,False,True,P12956,"[('cd00788', 'KU70'), ('cd01458', 'vWA_ku'), ('G3DSA:1.10.1600.10', None), ('G3DSA:1.10.720.30', 'SAP domain'), ('G3DSA:2.40.290.10', None), ('G3DSA:3.40.50.410', 'von Willebrand factor, type A domain'), ('G3DSA:4.10.970.10', 'Ku70, bridge and pillars'), ('IPR003034', 'SAP domain'), ('IPR005160', 'Ku70/Ku80 C-terminal arm'), ('IPR005161', 'Ku70/Ku80, N-terminal alpha/beta'), ('IPR006164', 'Ku70/Ku80 beta-barrel domain'), ('IPR006165', 'Ku70'), ('IPR016194', 'SPOC-like, C-terminal domain superfamily'), ('IPR027388', 'Ku70, bridge and pillars domain superfamily'), ('IPR036361', 'SAP domain superfamily'), ('IPR036465', 'von Willebrand factor A-like domain superfamily'), ('IPR047087', 'Ku70, core domain'), ('PF02037', 'SAP domain'), ('PF02735', 'Ku70/Ku80 beta-barrel domain'), ('PF03730', 'Ku70/Ku80 C-terminal arm')]",P12956;,"""ENSG00000196419; Low tissue specificity."";",,3.6.4.-; 4.2.99.-,,,ENST00000359308.8 [P12956-1];ENST00000360079.8 [P12956-1];ENST00000402580.7 [P12956-2];ENST00000405878.5 [P12956-1];,XRCC6;MAP9-AS1,ENSG00000196419;ENSG00000250910,0.0,XRCC6,Canonical_RBPs,26.0,12.64,DP01254,0.182,0.182,0.09,XRCC6
P13010,ENSG00000079246,XRCC5_HUMAN,"activation of innate immune response [GO:0002218]; cellular hyperosmotic salinity response [GO:0071475]; cellular response to fatty acid [GO:0071398]; cellular response to gamma radiation [GO:0071480]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to X-ray [GO:0071481]; DNA damage response [GO:0006974]; DNA recombination [GO:0006310]; double-strand break repair [GO:0006302]; double-strand break repair via nonhomologous end joining [GO:0006303]; hematopoietic stem cell differentiation [GO:0060218]; hematopoietic stem cell proliferation [GO:0071425]; innate immune response [GO:0045087]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of t-circle formation [GO:1904430]; neurogenesis [GO:0022008]; positive regulation of neurogenesis [GO:0050769]; positive regulation of protein kinase activity [GO:0045860]; protein localization to chromosome, telomeric region [GO:0070198]; recombinational repair [GO:0000725]; regulation of smooth muscle cell proliferation [GO:0048660]; regulation of telomere maintenance [GO:0032204]; response to xenobiotic stimulus [GO:0009410]; small-subunit processome assembly [GO:0034462]; telomere maintenance [GO:0000723]; telomere maintenance via telomerase [GO:0007004]","chromosome, telomeric region [GO:0000781]; cytosol [GO:0005829]; DNA-dependent protein kinase complex [GO:0070418]; DNA-dependent protein kinase-DNA ligase 4 complex [GO:0005958]; extracellular region [GO:0005576]; Ku70:Ku80 complex [GO:0043564]; membrane [GO:0016020]; nonhomologous end joining complex [GO:0070419]; nuclear telomere cap complex [GO:0000783]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; protein-DNA complex [GO:0032993]; ribonucleoprotein complex [GO:1990904]; secretory granule lumen [GO:0034774]; site of DNA damage [GO:0090734]; small-subunit processome [GO:0032040]","ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent activity, acting on DNA [GO:0008094]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; DNA end binding [GO:0045027]; DNA helicase activity [GO:0003678]; double-stranded DNA binding [GO:0003690]; enzyme activator activity [GO:0008047]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; telomeric DNA binding [GO:0042162]; transcription cis-regulatory region binding [GO:0000976]; U3 snoRNA binding [GO:0034511]; ubiquitin protein ligase binding [GO:0031625]","PTM: ADP-ribosylated by PARP3. {ECO:0000269|PubMed:24598253}.; PTM: Phosphorylated on serine residues. Phosphorylation by PRKDC may enhance helicase activity. {ECO:0000269|PubMed:10026262}.; PTM: Sumoylated. {ECO:0000269|PubMed:15561718}.; PTM: Ubiquitinated by RNF8 via 'Lys-48'-linked ubiquitination following DNA damage, leading to its degradation and removal from DNA damage sites (PubMed:22266820). Ubiquitinated by RNF138, leading to remove the Ku complex from DNA breaks (PubMed:26502055). {ECO:0000269|PubMed:22266820, ECO:0000269|PubMed:26502055}.",DOMAIN: The EEXXXDDL motif is required for the interaction with catalytic subunit PRKDC and its recruitment to sites of DNA damage. {ECO:0000269|PubMed:15758953}.; DOMAIN: The VWFA domain interacts with the KBM (Ku-binding motif) found in a number of DNA repair proteins. {ECO:0000250|UniProtKB:Q6DDS9}.; DOMAIN: The N-terminal and C-terminal regions are not required for binding to DNA or for degradation of the protein with only the central region being required for these processes. {ECO:0000250|UniProtKB:Q6DDS9}.,"DOMAIN 9..231; /note=""VWFA""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00219""; DOMAIN 253..452; /note=""Ku""; /evidence=""ECO:0000255""","STRAND 8..15; /evidence=""ECO:0007829|PDB:8AG4""; STRAND 25..27; /evidence=""ECO:0007829|PDB:7Z87""; STRAND 53..60; /evidence=""ECO:0007829|PDB:8AG4""; STRAND 70..74; /evidence=""ECO:0007829|PDB:8AG4""; STRAND 76..84; /evidence=""ECO:0007829|PDB:8AG4""; STRAND 122..125; /evidence=""ECO:0007829|PDB:8AG4""; STRAND 128..135; /evidence=""ECO:0007829|PDB:8AG4""; STRAND 159..167; /evidence=""ECO:0007829|PDB:8AG4""; STRAND 187..189; /evidence=""ECO:0007829|PDB:7SGL""; STRAND 224..226; /evidence=""ECO:0007829|PDB:8AG4""; STRAND 247..256; /evidence=""ECO:0007829|PDB:8AG4""; STRAND 258..267; /evidence=""ECO:0007829|PDB:8AG4""; STRAND 277..280; /evidence=""ECO:0007829|PDB:8AG4""; STRAND 289..293; /evidence=""ECO:0007829|PDB:8AG4""; STRAND 298..300; /evidence=""ECO:0007829|PDB:8AG4""; STRAND 310..312; /evidence=""ECO:0007829|PDB:7Z88""; STRAND 313..315; /evidence=""ECO:0007829|PDB:8AG4""; STRAND 320..322; /evidence=""ECO:0007829|PDB:8AG4""; STRAND 338..347; /evidence=""ECO:0007829|PDB:8AG4""; STRAND 357..366; /evidence=""ECO:0007829|PDB:8AG4""; STRAND 368..370; /evidence=""ECO:0007829|PDB:7Z88""; STRAND 389..401; /evidence=""ECO:0007829|PDB:8AG4""; STRAND 404..412; /evidence=""ECO:0007829|PDB:8AG4""; STRAND 417..424; /evidence=""ECO:0007829|PDB:8AG4""; STRAND 438..440; /evidence=""ECO:0007829|PDB:1JEQ""; STRAND 442..444; /evidence=""ECO:0007829|PDB:1JEY""; STRAND 462..465; /evidence=""ECO:0007829|PDB:7ZVT""; STRAND 474..476; /evidence=""ECO:0007829|PDB:8AG4""; STRAND 501..503; /evidence=""ECO:0007829|PDB:1JEQ""; STRAND 540..542; /evidence=""ECO:0007829|PDB:7SGL""; STRAND 581..586; /evidence=""ECO:0007829|PDB:1RW2""; STRAND 588..592; /evidence=""ECO:0007829|PDB:1RW2""; STRAND 607..609; /evidence=""ECO:0007829|PDB:7Z87""; STRAND 688..692; /evidence=""ECO:0007829|PDB:7Z87""","HELIX 18..21; /evidence=""ECO:0007829|PDB:1JEY""; HELIX 30..48; /evidence=""ECO:0007829|PDB:8AG4""; HELIX 88..96; /evidence=""ECO:0007829|PDB:8AG4""; HELIX 107..121; /evidence=""ECO:0007829|PDB:8AG4""; HELIX 144..146; /evidence=""ECO:0007829|PDB:1JEQ""; HELIX 147..157; /evidence=""ECO:0007829|PDB:8AG4""; HELIX 170..174; /evidence=""ECO:0007829|PDB:8ASC""; HELIX 199..215; /evidence=""ECO:0007829|PDB:8AG4""; HELIX 218..223; /evidence=""ECO:0007829|PDB:8AG4""; HELIX 227..230; /evidence=""ECO:0007829|PDB:8AG4""; HELIX 235..237; /evidence=""ECO:0007829|PDB:8AG4""; HELIX 238..240; /evidence=""ECO:0007829|PDB:1JEY""; HELIX 286..288; /evidence=""ECO:0007829|PDB:8AG4""; HELIX 307..309; /evidence=""ECO:0007829|PDB:8AG4""; HELIX 323..325; /evidence=""ECO:0007829|PDB:8AG4""; HELIX 348..350; /evidence=""ECO:0007829|PDB:8AG4""; HELIX 353..355; /evidence=""ECO:0007829|PDB:8AG4""; HELIX 371..387; /evidence=""ECO:0007829|PDB:8AG4""; HELIX 427..429; /evidence=""ECO:0007829|PDB:8AG4""; HELIX 448..460; /evidence=""ECO:0007829|PDB:8AG4""; HELIX 467..469; /evidence=""ECO:0007829|PDB:8AG4""; HELIX 479..481; /evidence=""ECO:0007829|PDB:8AG4""; HELIX 485..499; /evidence=""ECO:0007829|PDB:8AG4""; HELIX 510..515; /evidence=""ECO:0007829|PDB:8AG4""; HELIX 520..536; /evidence=""ECO:0007829|PDB:8AG4""; HELIX 550..553; /evidence=""ECO:0007829|PDB:7Z87""; HELIX 578..580; /evidence=""ECO:0007829|PDB:7SU3""; HELIX 597..604; /evidence=""ECO:0007829|PDB:7Z87""; HELIX 613..625; /evidence=""ECO:0007829|PDB:7Z87""; HELIX 629..648; /evidence=""ECO:0007829|PDB:7Z87""; HELIX 652..668; /evidence=""ECO:0007829|PDB:7Z87""; HELIX 673..681; /evidence=""ECO:0007829|PDB:7Z87""; HELIX 700..704; /evidence=""ECO:0007829|PDB:7Z87""; HELIX 725..730; /evidence=""ECO:0007829|PDB:7Z87""","TURN 194..196; /evidence=""ECO:0007829|PDB:1JEY""; TURN 281..283; /evidence=""ECO:0007829|PDB:8AG4""; TURN 328..330; /evidence=""ECO:0007829|PDB:8AG4""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,XRCC5 G22P2,X-ray repair cross-complementing protein 5 (EC 3.6.4.-) (86 kDa subunit of Ku antigen) (ATP-dependent DNA helicase 2 subunit 2) (ATP-dependent DNA helicase II 80 kDa subunit) (CTC box-binding factor 85 kDa subunit) (CTC85) (CTCBF) (DNA repair protein XRCC5) (Ku80) (Ku86) (Lupus Ku autoantigen protein p86) (Nuclear factor IV) (Thyroid-lupus autoantigen) (TLAA) (X-ray repair complementing defective repair in Chinese hamster cells 5 (double-strand-break rejoining)),Homo sapiens (Human),732.0,82705.0,MVRSGNKAAVVLCMDVGFTMSNSIPGIESPFEQAKKVITMFVQRQVFAENKDEIALVLFGTDGTDNPLSGGDQYQNITVHRHLMLPDFDLLEDIESKIQPGSQQADFLDALIVSMDVIQHETIGKKFEKRHIEIFTDLSSRFSKSQLDIIIHSLKKCDISLQFFLPFSLGKEDGSGDRGDGPFRLGGHGPSFPLKGITEQQKEGLEIVKMVMISLEGEDGLDEIYSFSESLRKLCVFKKIERHSIHWPCRLTIGSNLSIRIAAYKSILQERVKKTWTVVDAKTLKKEDIQKETVYCLNDDDETEVLKEDIIQGFRYGSDIVPFSKVDEEQMKYKSEGKCFSVLGFCKSSQVQRRFFMGNQVLKVFAARDDEAAAVALSSLIHALDDLDMVAIVRYAYDKRANPQVGVAFPHIKHNYECLVYVQLPFMEDLRQYMFSSLKNSKKYAPTEAQLNAVDALIDSMSLAKKDEKTDTLEDLFPTTKIPNPRFQRLFQCLLHRALHPREPLPPIQQHIWNMLNPPAEVTTKSQIPLSKIKTLFPLIEAKKKDQVTAQEIFQDNHEDGPTAKKLKTEQGGAHFSVSSLAEGSVTSVGSVNPAENFRVLVKQKKASFEEASNQLINHIEQFLDTNETPYFMKSIDCIRAFREEAIKFSEEQRFNNFLKALQEKVEIKQLNHFWEIVVQDGITLITKEEASGSSVTAEEAKKFLAPKDKPSGDTAAVFEEGGDVDDLLDMI,True,False,True,P13010,"[('cd00873', 'KU80'), ('cd01458', 'vWA_ku'), ('G3DSA:1.10.1600.10', None), ('G3DSA:1.25.40.240', 'Ku, C-terminal domain'), ('G3DSA:2.40.290.10', None), ('G3DSA:3.40.50.410', 'von Willebrand factor, type A domain'), ('IPR002035', 'von Willebrand factor, type A'), ('IPR005160', 'Ku70/Ku80 C-terminal arm'), ('IPR005161', 'Ku70/Ku80, N-terminal alpha/beta'), ('IPR006164', 'Ku70/Ku80 beta-barrel domain'), ('IPR014893', 'Ku, C-terminal'), ('IPR016194', 'SPOC-like, C-terminal domain superfamily'), ('IPR024193', 'Ku80'), ('IPR036465', 'von Willebrand factor A-like domain superfamily'), ('IPR036494', 'Ku, C-terminal domain superfamily'), ('PF02735', 'Ku70/Ku80 beta-barrel domain'), ('PF03730', 'Ku70/Ku80 C-terminal arm'), ('PF03731', 'Ku70/Ku80 N-terminal alpha/beta domain'), ('PF08785', 'Ku C terminal domain like'), ('PIRSF016570', 'Ku DNA-binding complex, Ku80 subunit')]",P13010;,"""ENSG00000079246; Low tissue specificity."";",,3.6.4.-,,,ENST00000392132.7;ENST00000392133.7;,XRCC5;LINC02436,ENSG00000079246;ENSG00000250754,0.0,XRCC5,Non-canonical_RBPs,28.0,2.73,DP01255,0.126,0.202,,XRCC5
P13569,ENSG00000001626,CFTR_HUMAN,amelogenesis [GO:0097186]; bicarbonate transport [GO:0015701]; cellular response to cAMP [GO:0071320]; cellular response to forskolin [GO:1904322]; chloride transmembrane transport [GO:1902476]; cholesterol biosynthetic process [GO:0006695]; cholesterol transport [GO:0030301]; establishment of localization in cell [GO:0051649]; intracellular pH elevation [GO:0051454]; membrane hyperpolarization [GO:0060081]; multicellular organismal-level water homeostasis [GO:0050891]; positive regulation of cyclic nucleotide-gated ion channel activity [GO:1902161]; positive regulation of enamel mineralization [GO:0070175]; positive regulation of exocytosis [GO:0045921]; positive regulation of insulin secretion involved in cellular response to glucose stimulus [GO:0035774]; positive regulation of voltage-gated chloride channel activity [GO:1902943]; response to endoplasmic reticulum stress [GO:0034976]; sperm capacitation [GO:0048240]; transepithelial water transport [GO:0035377]; transmembrane transport [GO:0055085]; vesicle docking involved in exocytosis [GO:0006904],apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; chloride channel complex [GO:0034707]; clathrin-coated endocytic vesicle membrane [GO:0030669]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; Golgi-associated vesicle membrane [GO:0030660]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; recycling endosome [GO:0055037]; recycling endosome membrane [GO:0055038],14-3-3 protein binding [GO:0071889]; ABC-type transporter activity [GO:0140359]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATPase-coupled inorganic anion transmembrane transporter activity [GO:0043225]; ATPase-coupled transmembrane transporter activity [GO:0042626]; bicarbonate transmembrane transporter activity [GO:0015106]; chloride channel activity [GO:0005254]; chloride channel inhibitor activity [GO:0019869]; chloride channel regulator activity [GO:0017081]; chloride transmembrane transporter activity [GO:0015108]; enzyme binding [GO:0019899]; intracellularly ATP-gated chloride channel activity [GO:0005260]; isomerase activity [GO:0016853]; PDZ domain binding [GO:0030165]; protein-folding chaperone binding [GO:0051087]; Sec61 translocon complex binding [GO:0106138],"PTM: N-glycosylated. {ECO:0000269|PubMed:12529365, ECO:0000269|PubMed:1699669, ECO:0000269|PubMed:20008117, ECO:0000269|PubMed:21884936, ECO:0000269|PubMed:28067262}.; PTM: Phosphorylated; cAMP treatment promotes phosphorylation and activates the channel (PubMed:12588899, PubMed:17036051, PubMed:8910473). Dephosphorylation decreases the ATPase activity (in vitro) (PubMed:8910473). Phosphorylation at PKA sites activates the channel (PubMed:10792060, PubMed:12519745, PubMed:12588899, PubMed:25330774). Phosphorylation at PKC sites enhances the response to phosphorylation by PKA (PubMed:12588899). Phosphorylated by AMPK; this inhibits channel activity (PubMed:12519745). {ECO:0000269|PubMed:10792060, ECO:0000269|PubMed:12519745, ECO:0000269|PubMed:12588899, ECO:0000269|PubMed:1377674, ECO:0000269|PubMed:17036051, ECO:0000269|PubMed:22119790, ECO:0000269|PubMed:25330774, ECO:0000269|PubMed:8910473, ECO:0000269|PubMed:9385646}.; PTM: Ubiquitinated, leading to its degradation in the lysosome (PubMed:19398555, PubMed:23818989). Deubiquitination by USP10 in early endosomes enhances its endocytic recycling to the cell membrane (PubMed:19398555). Ubiquitinated by RNF185 during ER stress (PubMed:24019521). Ubiquitinated by MARCHF2 (PubMed:23818989). {ECO:0000269|PubMed:19398555, ECO:0000269|PubMed:22119790, ECO:0000269|PubMed:23818989, ECO:0000269|PubMed:24019521}.","DOMAIN: Binds and hydrolyzes ATP via the two cytoplasmic ABC transporter nucleotide-binding domains (PubMed:15284228). The two ATP-binding domains interact with each other, forming a head-to-tail dimer (PubMed:17036051). Normal ATPase activity requires interaction between the two domains (PubMed:15284228). The first ABC transporter nucleotide-binding domain has no ATPase activity by itself (By similarity). {ECO:0000250|UniProtKB:P26361, ECO:0000269|PubMed:15284228, ECO:0000269|PubMed:17036051}.; DOMAIN: The PDZ-binding motif mediates interactions with GOPC and with the SLC4A7, NHERF1/EBP50 complex. {ECO:0000269|PubMed:11304524, ECO:0000269|PubMed:11707463, ECO:0000269|PubMed:16331976}.; DOMAIN: The R region is intrinsically disordered (PubMed:10792060, PubMed:17660831). It mediates channel activation when it is phosphorylated, but not in the absence of phosphorylation (PubMed:10792060). {ECO:0000269|PubMed:10792060, ECO:0000269|PubMed:17660831}.","DOMAIN 81..365; /note=""ABC transmembrane type-1 1""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00441""; DOMAIN 423..646; /note=""ABC transporter 1""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00434""; DOMAIN 859..1155; /note=""ABC transmembrane type-1 2""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00441""; DOMAIN 1210..1443; /note=""ABC transporter 2""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00434""","STRAND 386..388; /evidence=""ECO:0007829|PDB:8UBR""; STRAND 390..399; /evidence=""ECO:0007829|PDB:2PZE""; STRAND 440..449; /evidence=""ECO:0007829|PDB:2PZE""; STRAND 450..452; /evidence=""ECO:0007829|PDB:6MSM""; STRAND 453..457; /evidence=""ECO:0007829|PDB:2PZE""; STRAND 478..484; /evidence=""ECO:0007829|PDB:2PZE""; STRAND 488..491; /evidence=""ECO:0007829|PDB:2PZE""; STRAND 499..501; /evidence=""ECO:0007829|PDB:2PZG""; STRAND 533..535; /evidence=""ECO:0007829|PDB:2PZF""; STRAND 540..545; /evidence=""ECO:0007829|PDB:5TFJ""; STRAND 567..573; /evidence=""ECO:0007829|PDB:2PZE""; STRAND 598..603; /evidence=""ECO:0007829|PDB:2PZE""; STRAND 614..620; /evidence=""ECO:0007829|PDB:2PZE""; STRAND 623..628; /evidence=""ECO:0007829|PDB:2PZE""; STRAND 904..906; /evidence=""ECO:0007829|PDB:7SVD""; STRAND 1204..1207; /evidence=""ECO:0007829|PDB:3GD7""; STRAND 1210..1220; /evidence=""ECO:0007829|PDB:6UK1""; STRAND 1226..1234; /evidence=""ECO:0007829|PDB:6UK1""; STRAND 1239..1243; /evidence=""ECO:0007829|PDB:6UK1""; STRAND 1261..1269; /evidence=""ECO:0007829|PDB:6UK1""; STRAND 1286..1290; /evidence=""ECO:0007829|PDB:6UK1""; STRAND 1297..1299; /evidence=""ECO:0007829|PDB:6UK1""; STRAND 1331..1333; /evidence=""ECO:0007829|PDB:7SVD""; STRAND 1365..1371; /evidence=""ECO:0007829|PDB:6UK1""; STRAND 1395..1403; /evidence=""ECO:0007829|PDB:6UK1""; STRAND 1411..1415; /evidence=""ECO:0007829|PDB:6UK1""; STRAND 1422..1427; /evidence=""ECO:0007829|PDB:6UK1""; STRAND 1478..1480; /evidence=""ECO:0007829|PDB:2LOB""","HELIX 5..8; /evidence=""ECO:0007829|PDB:8UBR""; HELIX 11..16; /evidence=""ECO:0007829|PDB:7SVD""; HELIX 18..20; /evidence=""ECO:0007829|PDB:7SVD""; HELIX 21..27; /evidence=""ECO:0007829|PDB:7SVD""; HELIX 34..36; /evidence=""ECO:0007829|PDB:7SVD""; HELIX 42..44; /evidence=""ECO:0007829|PDB:7SVD""; HELIX 46..63; /evidence=""ECO:0007829|PDB:7SVD""; HELIX 70..97; /evidence=""ECO:0007829|PDB:7SVD""; HELIX 99..107; /evidence=""ECO:0007829|PDB:7SVD""; HELIX 114..118; /evidence=""ECO:0007829|PDB:8EIO""; HELIX 120..164; /evidence=""ECO:0007829|PDB:7SVD""; HELIX 177..185; /evidence=""ECO:0007829|PDB:7SVD""; HELIX 190..193; /evidence=""ECO:0007829|PDB:7SVD""; HELIX 194..196; /evidence=""ECO:0007829|PDB:7SVD""; HELIX 200..216; /evidence=""ECO:0007829|PDB:7SVD""; HELIX 223..249; /evidence=""ECO:0007829|PDB:7SVD""; HELIX 252..266; /evidence=""ECO:0007829|PDB:7SVD""; HELIX 269..275; /evidence=""ECO:0007829|PDB:7SVD""; HELIX 278..312; /evidence=""ECO:0007829|PDB:7SVD""; HELIX 314..328; /evidence=""ECO:0007829|PDB:7SVD""; HELIX 333..351; /evidence=""ECO:0007829|PDB:7SVD""; HELIX 354..375; /evidence=""ECO:0007829|PDB:7SVD""; HELIX 403..411; /evidence=""ECO:0007829|PDB:2BBS""; HELIX 414..417; /evidence=""ECO:0007829|PDB:2BBT""; HELIX 433..436; /evidence=""ECO:0007829|PDB:1XMI""; HELIX 460..462; /evidence=""ECO:0007829|PDB:6ZE1""; HELIX 464..471; /evidence=""ECO:0007829|PDB:2PZE""; HELIX 502..507; /evidence=""ECO:0007829|PDB:2PZE""; HELIX 514..523; /evidence=""ECO:0007829|PDB:2PZE""; HELIX 527..530; /evidence=""ECO:0007829|PDB:2PZE""; HELIX 536..538; /evidence=""ECO:0007829|PDB:2PZE""; HELIX 550..563; /evidence=""ECO:0007829|PDB:2PZE""; HELIX 580..589; /evidence=""ECO:0007829|PDB:2PZE""; HELIX 590..594; /evidence=""ECO:0007829|PDB:2PZE""; HELIX 607..612; /evidence=""ECO:0007829|PDB:2PZE""; HELIX 630..634; /evidence=""ECO:0007829|PDB:2PZE""; HELIX 640..644; /evidence=""ECO:0007829|PDB:2PZE""; HELIX 650..652; /evidence=""ECO:0007829|PDB:2BBS""; HELIX 655..669; /evidence=""ECO:0007829|PDB:2BBS""; HELIX 849..853; /evidence=""ECO:0007829|PDB:7SVD""; HELIX 857..882; /evidence=""ECO:0007829|PDB:7SVD""; HELIX 914..926; /evidence=""ECO:0007829|PDB:7SVD""; HELIX 931..956; /evidence=""ECO:0007829|PDB:7SVD""; HELIX 961..965; /evidence=""ECO:0007829|PDB:7SVD""; HELIX 969..1011; /evidence=""ECO:0007829|PDB:7SVD""; HELIX 1015..1046; /evidence=""ECO:0007829|PDB:7SVD""; HELIX 1049..1060; /evidence=""ECO:0007829|PDB:7SVD""; HELIX 1062..1068; /evidence=""ECO:0007829|PDB:7SVD""; HELIX 1071..1121; /evidence=""ECO:0007829|PDB:7SVD""; HELIX 1128..1136; /evidence=""ECO:0007829|PDB:7SVD""; HELIX 1140..1167; /evidence=""ECO:0007829|PDB:7SVD""; HELIX 1250..1257; /evidence=""ECO:0007829|PDB:6UK1""; HELIX 1274..1276; /evidence=""ECO:0007829|PDB:7SVD""; HELIX 1279..1283; /evidence=""ECO:0007829|PDB:6UK1""; HELIX 1300..1304; /evidence=""ECO:0007829|PDB:6UK1""; HELIX 1312..1321; /evidence=""ECO:0007829|PDB:6UK1""; HELIX 1325..1329; /evidence=""ECO:0007829|PDB:6UK1""; HELIX 1334..1336; /evidence=""ECO:0007829|PDB:6UK1""; HELIX 1348..1361; /evidence=""ECO:0007829|PDB:6UK1""; HELIX 1372..1375; /evidence=""ECO:0007829|PDB:6UK1""; HELIX 1378..1387; /evidence=""ECO:0007829|PDB:6UK1""; HELIX 1404..1406; /evidence=""ECO:0007829|PDB:6UK1""; HELIX 1435..1439; /evidence=""ECO:0007829|PDB:7SVD""; HELIX 1443..1449; /evidence=""ECO:0007829|PDB:7SVD""","TURN 169..173; /evidence=""ECO:0007829|PDB:7SVD""; TURN 220..222; /evidence=""ECO:0007829|PDB:7SVD""; TURN 574..577; /evidence=""ECO:0007829|PDB:2PZE""; TURN 595..597; /evidence=""ECO:0007829|PDB:2PZE""; TURN 883..886; /evidence=""ECO:0007829|PDB:7SVD""; TURN 910..913; /evidence=""ECO:0007829|PDB:7SVD""; TURN 1137..1139; /evidence=""ECO:0007829|PDB:7SVD""; TURN 1341..1345; /evidence=""ECO:0007829|PDB:6UK1""; TURN 1388..1394; /evidence=""ECO:0007829|PDB:6UK1""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,CFTR ABCC7,Cystic fibrosis transmembrane conductance regulator (CFTR) (ATP-binding cassette sub-family C member 7) (Channel conductance-controlling ATPase) (EC 5.6.1.6) (cAMP-dependent chloride channel),Homo sapiens (Human),1480.0,168142.0,MQRSPLEKASVVSKLFFSWTRPILRKGYRQRLELSDIYQIPSVDSADNLSEKLEREWDRELASKKNPKLINALRRCFFWRFMFYGIFLYLGEVTKAVQPLLLGRIIASYDPDNKEERSIAIYLGIGLCLLFIVRTLLLHPAIFGLHHIGMQMRIAMFSLIYKKTLKLSSRVLDKISIGQLVSLLSNNLNKFDEGLALAHFVWIAPLQVALLMGLIWELLQASAFCGLGFLIVLALFQAGLGRMMMKYRDQRAGKISERLVITSEMIENIQSVKAYCWEEAMEKMIENLRQTELKLTRKAAYVRYFNSSAFFFSGFFVVFLSVLPYALIKGIILRKIFTTISFCIVLRMAVTRQFPWAVQTWYDSLGAINKIQDFLQKQEYKTLEYNLTTTEVVMENVTAFWEEGFGELFEKAKQNNNNRKTSNGDDSLFFSNFSLLGTPVLKDINFKIERGQLLAVAGSTGAGKTSLLMVIMGELEPSEGKIKHSGRISFCSQFSWIMPGTIKENIIFGVSYDEYRYRSVIKACQLEEDISKFAEKDNIVLGEGGITLSGGQRARISLARAVYKDADLYLLDSPFGYLDVLTEKEIFESCVCKLMANKTRILVTSKMEHLKKADKILILHEGSSYFYGTFSELQNLQPDFSSKLMGCDSFDQFSAERRNSILTETLHRFSLEGDAPVSWTETKKQSFKQTGEFGEKRKNSILNPINSIRKFSIVQKTPLQMNGIEEDSDEPLERRLSLVPDSEQGEAILPRISVISTGPTLQARRRQSVLNLMTHSVNQGQNIHRKTTASTRKVSLAPQANLTELDIYSRRLSQETGLEISEEINEEDLKECFFDDMESIPAVTTWNTYLRYITVHKSLIFVLIWCLVIFLAEVAASLVVLWLLGNTPLQDKGNSTHSRNNSYAVIITSTSSYYVFYIYVGVADTLLAMGFFRGLPLVHTLITVSKILHHKMLHSVLQAPMSTLNTLKAGGILNRFSKDIAILDDLLPLTIFDFIQLLLIVIGAIAVVAVLQPYIFVATVPVIVAFIMLRAYFLQTSQQLKQLESEGRSPIFTHLVTSLKGLWTLRAFGRQPYFETLFHKALNLHTANWFLYLSTLRWFQMRIEMIFVIFFIAVTFISILTTGEGEGRVGIILTLAMNIMSTLQWAVNSSIDVDSLMRSVSRVFKFIDMPTEGKPTKSTKPYKNGQLSKVMIIENSHVKKDDIWPSGGQMTVKDLTAKYTEGGNAILENISFSISPGQRVGLLGRTGSGKSTLLSAFLRLLNTEGEIQIDGVSWDSITLQQWRKAFGVIPQKVFIFSGTFRKNLDPYEQWSDQEIWKVADEVGLRSVIEQFPGKLDFVLVDGGCVLSHGHKQLMCLARSVLSKAKILLLDEPSAHLDPVTYQIIRRTLKQAFADCTVILCEHRIEAMLECQQFLVIEENKVRQYDSIQKLLNERSLFRQAISPSDRVKLFPHRNSSKCKSKPQIAALKEETEEEVQDTRL,True,True,False,P13569,"[('cd03289', 'ATP-binding cassette domain 2 of CFTR,subfamily C'), ('cd03291', 'ATP-binding cassette domain of the cystic fibrosis transmembrane regulator, subfamily C'), ('cd18594', 'Six-transmembrane helical domain 1 of Cystic Fibrosis Transmembrane Conductance Regulator'), ('cd18600', 'Six-transmembrane helical domain 2 of Cystic Fibrosis Transmembrane Conductance Regulator'), ('G3DSA:1.20.1560.10', 'ABC transporter type 1, transmembrane domain'), ('G3DSA:3.40.50.300', 'P-loop containing nucleotide triphosphate hydrolases'), ('IPR003439', 'ABC transporter-like, ATP-binding domain'), ('IPR003593', 'AAA+ ATPase domain'), ('IPR009147', 'Cystic fibrosis transmembrane conductance regulator'), ('IPR011527', 'ABC transporter type 1, transmembrane domain'), ('IPR017871', 'ABC transporter-like, conserved site'), ('IPR025837', 'CFTR regulator domain'), ('IPR027417', 'P-loop containing nucleoside triphosphate hydrolase'), ('IPR036640', 'ABC transporter type 1, transmembrane domain superfamily'), ('IPR047082', 'Cystic fibrosis transmembrane conductance regulator, ATP-binding cassette domain 1'), ('IPR050173', 'ATP-binding cassette transporter C-like'), ('PF00005', 'ABC transporter'), ('PF00664', 'ABC transporter transmembrane region'), ('PF14396', 'Cystic fibrosis TM conductance regulator (CFTR), regulator domain'), ('PR01851', 'CYSFIBREGLTR')]",,"""ENSG00000001626; Tissue enhanced (gallbladder, intestine, pancreas)."";","CATALYTIC ACTIVITY: Reaction=ATP + H2O + closed Cl(-) channel = ADP + phosphate + open Cl(-) channel.; EC=5.6.1.6; Evidence={ECO:0000269|PubMed:11524016, ECO:0000269|PubMed:15284228, ECO:0000269|PubMed:26627831, ECO:0000269|PubMed:8910473}; CATALYTIC ACTIVITY: Reaction=chloride(in) = chloride(out); Xref=Rhea:RHEA:29823, ChEBI:CHEBI:17996; Evidence={ECO:0000269|PubMed:10792060, ECO:0000269|PubMed:11524016, ECO:0000269|PubMed:11707463, ECO:0000269|PubMed:12519745, ECO:0000269|PubMed:12529365, ECO:0000269|PubMed:12588899, ECO:0000269|PubMed:12727866, ECO:0000269|PubMed:15010471, ECO:0000269|PubMed:17036051, ECO:0000269|PubMed:1712898, ECO:0000269|PubMed:17182731, ECO:0000269|PubMed:19398555, ECO:0000269|PubMed:19621064, ECO:0000269|PubMed:22178883, ECO:0000269|PubMed:25330774, ECO:0000269|PubMed:26846474, ECO:0000269|PubMed:28087700, ECO:0000269|PubMed:8910473, ECO:0000269|PubMed:9804160}; CATALYTIC ACTIVITY: Reaction=hydrogencarbonate(in) = hydrogencarbonate(out); Xref=Rhea:RHEA:28695, ChEBI:CHEBI:17544; Evidence={ECO:0000269|PubMed:15010471, ECO:0000269|PubMed:19019741}; CATALYTIC ACTIVITY: Reaction=ATP + H2O = ADP + phosphate + H(+); Xref=Rhea:RHEA:13065, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616, ChEBI:CHEBI:43474, ChEBI:CHEBI:456216; Evidence={ECO:0000269|PubMed:11524016, ECO:0000269|PubMed:15284228, ECO:0000269|PubMed:26627831, ECO:0000269|PubMed:8910473}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:13066; Evidence={ECO:0000269|PubMed:8910473};",5.6.1.6,,,ENST00000003084.11 [P13569-1];ENST00000649781.2 [P13569-2];,CFTR;LINC02162,ENSG00000001626;ENSG00000249830,0.0,,,,12.5,DP00012,0.178,0.171,0.02,CFTR
P13639,ENSG00000167658,EF2_HUMAN,hematopoietic progenitor cell differentiation [GO:0002244]; positive regulation of translation [GO:0045727]; translational elongation [GO:0006414],aggresome [GO:0016235]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ribonucleoprotein complex [GO:1990904]; ribosome [GO:0005840]; secretory granule lumen [GO:0034774]; synapse [GO:0045202],cadherin binding [GO:0045296]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; protein kinase binding [GO:0019901]; ribosome binding [GO:0043022]; RNA binding [GO:0003723]; translation elongation factor activity [GO:0003746],"PTM: Phosphorylation by EF-2 kinase completely inactivates EF-2; it requires prior phosphorylation by CDK2 at Ser-595 during mitotic prometaphase. Phosphorylation by CSK promotes SUMOylation, proteolytic cleavage, and nuclear translocation if the C-terminal fragment. {ECO:0000269|PubMed:23184662, ECO:0000269|PubMed:24648518}.; PTM: Diphthamide is 2-[3-carboxyamido-3-(trimethyl-ammonio)propyl]histidine (By similarity). {ECO:0000250|UniProtKB:P05197}.; PTM: (Microbial infection) Diphthamide can be ADP-ribosylated by diphtheria toxin and by Pseudomonas exotoxin A, thus arresting protein synthesis. {ECO:0000269|PubMed:16901746}.; PTM: ISGylated. {ECO:0000269|PubMed:16139798}.; PTM: Proteolytically processed at two sites following phosphorylation by CSK. {ECO:0000269|PubMed:24648518}.; PTM: SUMOylated following phosphorylation by CSK, promotes proteolytic cleavage. {ECO:0000269|PubMed:24648518}.",,"DOMAIN 17..362; /note=""tr-type G""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU01059""",,,,"cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,EEF2 EF2,Elongation factor 2 (EF-2) (EC 3.6.5.-),Homo sapiens (Human),858.0,95338.0,MVNFTVDQIRAIMDKKANIRNMSVIAHVDHGKSTLTDSLVCKAGIIASARAGETRFTDTRKDEQERCITIKSTAISLFYELSENDLNFIKQSKDGAGFLINLIDSPGHVDFSSEVTAALRVTDGALVVVDCVSGVCVQTETVLRQAIAERIKPVLMMNKMDRALLELQLEPEELYQTFQRIVENVNVIISTYGEGESGPMGNIMIDPVLGTVGFGSGLHGWAFTLKQFAEMYVAKFAAKGEGQLGPAERAKKVEDMMKKLWGDRYFDPANGKFSKSATSPEGKKLPRTFCQLILDPIFKVFDAIMNFKKEETAKLIEKLDIKLDSEDKDKEGKPLLKAVMRRWLPAGDALLQMITIHLPSPVTAQKYRCELLYEGPPDDEAAMGIKSCDPKGPLMMYISKMVPTSDKGRFYAFGRVFSGLVSTGLKVRIMGPNYTPGKKEDLYLKPIQRTILMMGRYVEPIEDVPCGNIVGLVGVDQFLVKTGTITTFEHAHNMRVMKFSVSPVVRVAVEAKNPADLPKLVEGLKRLAKSDPMVQCIIEESGEHIIAGAGELHLEICLKDLEEDHACIPIKKSDPVVSYRETVSEESNVLCLSKSPNKHNRLYMKARPFPDGLAEDIDKGEVSARQELKQRARYLAEKYEWDVAEARKIWCFGPDGTGPNILTDITKGVQYLNEIKDSVVAGFQWATKEGALCEENMRGVRFDVHDVTLHADAIHRGGGQIIPTARRCLYASVLTAQPRLMEPIYLVEIQCPEQVVGGIYGVLNRKRGHVFEESQVAGTPMFVVKAYLPVNESFGFTADLRSNTGGQAFPQCVFDHWQILPGDPFDNSSRPSQVVAETRKRKGLKEGIPALDNFLDKL,False,True,False,P13639,"[('cd01681', 'aeEF2_snRNP_like_IV'), ('cd01885', 'Elongation Factor 2 (EF2) in archaea and eukarya'), ('cd03700', 'Domain II of elongation factor 2 and C-terminal domain of the spliceosomal human 116kD U5 small nuclear ribonucleoprotein (snRNP) protein'), ('cd04096', 'eEF2_snRNP_like_C'), ('cd16261', 'Domain III of Elongation Factor 2 (EF2)'), ('G3DSA:2.40.30.10', 'Translation factors'), ('G3DSA:3.30.230.10', None), ('G3DSA:3.30.70.240', None), ('G3DSA:3.30.70.870', 'Elongation Factor G (Translational Gtpase), domain 3'), ('G3DSA:3.40.50.300', 'P-loop containing nucleotide triphosphate hydrolases'), ('IPR000640', 'Elongation factor EFG, domain V-like'), ('IPR000795', 'Translational (tr)-type GTP-binding domain'), ('IPR004161', 'Translation elongation factor EFTu-like, domain 2'), ('IPR005225', 'Small GTP-binding domain'), ('IPR005517', 'Translation elongation factor EFG/EF2, domain IV'), ('IPR009000', 'Translation protein, beta-barrel domain superfamily'), ('IPR014721', 'Small ribosomal subunit protein uS5 domain 2-type fold, subgroup'), ('IPR020568', 'Ribosomal protein uS5 domain 2-type superfamily'), ('IPR027417', 'P-loop containing nucleoside triphosphate hydrolase'), ('IPR031157', 'Tr-type G domain, conserved site')]",,"""ENSG00000167658; Low tissue specificity."";","CATALYTIC ACTIVITY: Reaction=GTP + H2O = GDP + phosphate + H(+); Xref=Rhea:RHEA:19669, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:37565, ChEBI:CHEBI:43474, ChEBI:CHEBI:58189; Evidence={ECO:0000305|PubMed:26593721}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:19670; Evidence={ECO:0000305|PubMed:26593721};",3.6.5.-,,,ENST00000309311.7;,EEF2,ENSG00000167658;ENSG00000249688,0.0,EEF2,Canonical_RBPs,34.0,,,,,,EEF2
P13716,ENSG00000148218,HEM2_HUMAN,cellular response to interleukin-4 [GO:0071353]; cellular response to lead ion [GO:0071284]; heme A biosynthetic process [GO:0006784]; heme B biosynthetic process [GO:0006785]; heme biosynthetic process [GO:0006783]; heme O biosynthetic process [GO:0048034]; negative regulation of proteasomal protein catabolic process [GO:1901799]; protein homooligomerization [GO:0051260]; protoporphyrinogen IX biosynthetic process [GO:0006782]; response to activity [GO:0014823]; response to aluminum ion [GO:0010044]; response to amino acid [GO:0043200]; response to arsenic-containing substance [GO:0046685]; response to cadmium ion [GO:0046686]; response to cobalt ion [GO:0032025]; response to ethanol [GO:0045471]; response to fatty acid [GO:0070542]; response to glucocorticoid [GO:0051384]; response to herbicide [GO:0009635]; response to hypoxia [GO:0001666]; response to ionizing radiation [GO:0010212]; response to iron ion [GO:0010039]; response to lipopolysaccharide [GO:0032496]; response to mercury ion [GO:0046689]; response to methylmercury [GO:0051597]; response to oxidative stress [GO:0006979]; response to platinum ion [GO:0070541]; response to selenium ion [GO:0010269]; response to vitamin B1 [GO:0010266]; response to vitamin E [GO:0033197]; response to xenobiotic stimulus [GO:0009410]; response to zinc ion [GO:0010043],cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; nucleus [GO:0005634]; secretory granule lumen [GO:0034774],catalytic activity [GO:0003824]; identical protein binding [GO:0042802]; porphobilinogen synthase activity [GO:0004655]; proteasome core complex binding [GO:1904854]; zinc ion binding [GO:0008270],,,,"STRAND 11..13; /evidence=""ECO:0007829|PDB:5HMS""; STRAND 31..37; /evidence=""ECO:0007829|PDB:1PV8""; STRAND 44..46; /evidence=""ECO:0007829|PDB:1PV8""; STRAND 48..50; /evidence=""ECO:0007829|PDB:1PV8""; STRAND 54..56; /evidence=""ECO:0007829|PDB:1PV8""; STRAND 75..80; /evidence=""ECO:0007829|PDB:1PV8""; STRAND 83..85; /evidence=""ECO:0007829|PDB:5HMS""; STRAND 88..90; /evidence=""ECO:0007829|PDB:5HMS""; STRAND 115..121; /evidence=""ECO:0007829|PDB:1PV8""; STRAND 127..129; /evidence=""ECO:0007829|PDB:5HMS""; STRAND 131..133; /evidence=""ECO:0007829|PDB:5HNR""; STRAND 137..139; /evidence=""ECO:0007829|PDB:5HMS""; STRAND 163..167; /evidence=""ECO:0007829|PDB:1PV8""; STRAND 192..194; /evidence=""ECO:0007829|PDB:1PV8""; STRAND 198..200; /evidence=""ECO:0007829|PDB:5HMS""; STRAND 217..219; /evidence=""ECO:0007829|PDB:5HMS""; STRAND 247..253; /evidence=""ECO:0007829|PDB:1PV8""; STRAND 273..277; /evidence=""ECO:0007829|PDB:1PV8""; STRAND 313..317; /evidence=""ECO:0007829|PDB:1PV8""","HELIX 8..10; /evidence=""ECO:0007829|PDB:5HMS""; HELIX 14..20; /evidence=""ECO:0007829|PDB:1PV8""; HELIX 28..30; /evidence=""ECO:0007829|PDB:1PV8""; HELIX 58..71; /evidence=""ECO:0007829|PDB:1PV8""; HELIX 92..94; /evidence=""ECO:0007829|PDB:5HMS""; HELIX 100..111; /evidence=""ECO:0007829|PDB:1PV8""; HELIX 124..126; /evidence=""ECO:0007829|PDB:5HMS""; HELIX 141..160; /evidence=""ECO:0007829|PDB:1PV8""; HELIX 174..184; /evidence=""ECO:0007829|PDB:1PV8""; HELIX 203..205; /evidence=""ECO:0007829|PDB:1PV8""; HELIX 206..210; /evidence=""ECO:0007829|PDB:1PV8""; HELIX 231..243; /evidence=""ECO:0007829|PDB:1PV8""; HELIX 255..257; /evidence=""ECO:0007829|PDB:1PV8""; HELIX 258..267; /evidence=""ECO:0007829|PDB:1PV8""; HELIX 279..290; /evidence=""ECO:0007829|PDB:1PV8""; HELIX 296..310; /evidence=""ECO:0007829|PDB:1PV8""; HELIX 320..326; /evidence=""ECO:0007829|PDB:1PV8""","TURN 21..24; /evidence=""ECO:0007829|PDB:1PV8""; TURN 188..190; /evidence=""ECO:0007829|PDB:1PV8""; TURN 222..224; /evidence=""ECO:0007829|PDB:5HMS""; TURN 327..329; /evidence=""ECO:0007829|PDB:1PV8""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,ALAD,Delta-aminolevulinic acid dehydratase (ALADH) (EC 4.2.1.24) (Porphobilinogen synthase),Homo sapiens (Human),330.0,36295.0,MQPQSVLHSGYFHPLLRAWQTATTTLNASNLIYPIFVTDVPDDIQPITSLPGVARYGVKRLEEMLRPLVEEGLRCVLIFGVPSRVPKDERGSAADSEESPAIEAIHLLRKTFPNLLVACDVCLCPYTSHGHCGLLSENGAFRAEESRQRLAEVALAYAKAGCQVVAPSDMMDGRVEAIKEALMAHGLGNRVSVMSYSAKFASCFYGPFRDAAKSSPAFGDRRCYQLPPGARGLALRAVDRDVREGADMLMVKPGMPYLDIVREVKDKHPDLPLAVYHVSGEFAMLWHGAQAGAFDLKAAVLEAMTAFRRAGADIIITYYTPQLLQWLKEE,True,True,True,P13716,"[('cd04824', 'eu_ALAD_PBGS_cysteine_rich'), ('G3DSA:3.20.20.70', 'Aldolase class I'), ('IPR001731', 'Delta-aminolevulinic acid dehydratase'), ('IPR013785', 'Aldolase-type TIM barrel'), ('IPR030656', 'Delta-aminolevulinic acid dehydratase, active site'), ('PF00490', 'Delta-aminolevulinic acid dehydratase'), ('PIRSF001415', 'Porphobilinogen synthase'), ('PR00144', 'DALDHYDRTASE'), ('PS00169', 'Delta-aminolevulinic acid dehydratase active site'), ('PTHR11458', 'DELTA-AMINOLEVULINIC ACID DEHYDRATASE'), ('SM01004', 'Delta-aminolevulinic acid dehydratase'), ('SSF51569', 'Aldolase')]",,"""ENSG00000148218; Tissue enhanced (liver)."";","CATALYTIC ACTIVITY: Reaction=2 5-aminolevulinate = porphobilinogen + 2 H2O + H(+); Xref=Rhea:RHEA:24064, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:58126, ChEBI:CHEBI:356416; EC=4.2.1.24; Evidence={ECO:0000269|PubMed:11032836, ECO:0000269|PubMed:12897770, ECO:0000269|PubMed:19812033};",4.2.1.24,"ACTIVITY REGULATION: Can alternate between a fully active homooctamer and a low-activity homohexamer. A bound magnesium ion may promote the assembly of the fully active homooctamer. The magnesium-binding site is absent in the low-activity homohexamer. Inhibited by compounds that favor the hexameric state. Inhibited by divalent lead ions. The lead ions partially displace the zinc cofactor. {ECO:0000269|PubMed:11032836, ECO:0000269|PubMed:12897770, ECO:0000269|PubMed:19812033}.",PATHWAY: Porphyrin-containing compound metabolism; protoporphyrin-IX biosynthesis; coproporphyrinogen-III from 5-aminolevulinate: step 1/4.,ENST00000409155.8 [P13716-1];,ALAD,ENSG00000148218;ENSG00000249149;ENSG00000293193,0.0,ALAD,Non-canonical_RBPs,9.0,,,,0.039,,ALAD
P14324,ENSG00000160752,FPPS_HUMAN,cholesterol biosynthetic process [GO:0006695]; farnesyl diphosphate biosynthetic process [GO:0045337]; geranyl diphosphate biosynthetic process [GO:0033384],cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; nucleoplasm [GO:0005654]; peroxisome [GO:0005777],dimethylallyltranstransferase activity [GO:0004161]; geranyltranstransferase activity [GO:0004337]; metal ion binding [GO:0046872]; RNA binding [GO:0003723],,,,"STRAND 119..122; /evidence=""ECO:0007829|PDB:4NUA""; STRAND 176..178; /evidence=""ECO:0007829|PDB:4QXS""; STRAND 246..248; /evidence=""ECO:0007829|PDB:4JVJ""","HELIX 76..85; /evidence=""ECO:0007829|PDB:4NUA""; HELIX 87..94; /evidence=""ECO:0007829|PDB:4NUA""; HELIX 97..100; /evidence=""ECO:0007829|PDB:4DEM""; HELIX 102..104; /evidence=""ECO:0007829|PDB:4NUA""; HELIX 105..118; /evidence=""ECO:0007829|PDB:4NUA""; HELIX 125..137; /evidence=""ECO:0007829|PDB:4NUA""; HELIX 140..142; /evidence=""ECO:0007829|PDB:4NUA""; HELIX 145..172; /evidence=""ECO:0007829|PDB:4NUA""; HELIX 184..186; /evidence=""ECO:0007829|PDB:4NUA""; HELIX 191..193; /evidence=""ECO:0007829|PDB:4NUA""; HELIX 194..213; /evidence=""ECO:0007829|PDB:4NUA""; HELIX 219..243; /evidence=""ECO:0007829|PDB:4NUA""; HELIX 251..253; /evidence=""ECO:0007829|PDB:4NUA""; HELIX 256..266; /evidence=""ECO:0007829|PDB:4NUA""; HELIX 268..271; /evidence=""ECO:0007829|PDB:4NUA""; HELIX 273..282; /evidence=""ECO:0007829|PDB:4NUA""; HELIX 288..315; /evidence=""ECO:0007829|PDB:4NUA""; HELIX 318..321; /evidence=""ECO:0007829|PDB:4NUA""; HELIX 335..343; /evidence=""ECO:0007829|PDB:4NUA""; HELIX 346..355; /evidence=""ECO:0007829|PDB:4NUA""; HELIX 361..373; /evidence=""ECO:0007829|PDB:4NUA""; HELIX 376..398; /evidence=""ECO:0007829|PDB:4NUA""; HELIX 404..414; /evidence=""ECO:0007829|PDB:4NUA""","TURN 188..190; /evidence=""ECO:0007829|PDB:4NUA""; TURN 327..331; /evidence=""ECO:0007829|PDB:4NUA""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,FDPS FPS KIAA1293,"Farnesyl pyrophosphate synthase (FPP synthase) (FPS) (EC 2.5.1.10) ((2E,6E)-farnesyl diphosphate synthase) (Dimethylallyltranstransferase) (EC 2.5.1.1) (Farnesyl diphosphate synthase) (Geranyltranstransferase)",Homo sapiens (Human),419.0,48275.0,MPLSRWLRSVGVFLLPAPYWAPRERWLGSLRRPSLVHGYPVLAWHSARCWCQAWTEEPRALCSSLRMNGDQNSDVYAQEKQDFVQHFSQIVRVLTEDEMGHPEIGDAIARLKEVLEYNAIGGKYNRGLTVVVAFRELVEPRKQDADSLQRAWTVGWCVELLQAFFLVADDIMDSSLTRRGQICWYQKPGVGLDAINDANLLEACIYRLLKLYCREQPYYLNLIELFLQSSYQTEIGQTLDLLTAPQGNVDLVRFTEKRYKSIVKYKTAFYSFYLPIAAAMYMAGIDGEKEHANAKKILLEMGEFFQIQDDYLDLFGDPSVTGKIGTDIQDNKCSWLVVQCLQRATPEQYQILKENYGQKEAEKVARVKALYEELDLPAVFLQYEEDSYSHIMALIEQYAAPLPPAVFLGLARKIYKRRK,True,False,False,P14324,"[('cd00685', 'Trans-Isoprenyl Diphosphate Synthases, head-to-tail'), ('G3DSA:1.10.600.10', 'Farnesyl Diphosphate Synthase'), ('IPR000092', 'Polyprenyl synthetase-like'), ('IPR008949', 'Isoprenoid synthase domain superfamily'), ('IPR033749', 'Polyprenyl synthetase, conserved site'), ('IPR039702', 'Farnesyl pyrophosphate synthase-like'), ('PF00348', 'Polyprenyl synthetase'), ('PS00444', 'Polyprenyl synthases signature 2'), ('PS00723', 'Polyprenyl synthases signature 1'), ('PTHR11525', 'FARNESYL-PYROPHOSPHATE SYNTHETASE'), ('SFLDG01017', 'Polyprenyl Transferase Like'), ('SFLDS00005', 'Isoprenoid Synthase Type I'), ('SSF48576', 'Terpenoid synthases')]",,"""ENSG00000160752; Tissue enhanced (liver)."";","CATALYTIC ACTIVITY: Reaction=isopentenyl diphosphate + dimethylallyl diphosphate = (2E)-geranyl diphosphate + diphosphate; Xref=Rhea:RHEA:22408, ChEBI:CHEBI:33019, ChEBI:CHEBI:57623, ChEBI:CHEBI:58057, ChEBI:CHEBI:128769; EC=2.5.1.1; Evidence={ECO:0000269|PubMed:16684881}; CATALYTIC ACTIVITY: Reaction=isopentenyl diphosphate + (2E)-geranyl diphosphate = (2E,6E)-farnesyl diphosphate + diphosphate; Xref=Rhea:RHEA:19361, ChEBI:CHEBI:33019, ChEBI:CHEBI:58057, ChEBI:CHEBI:128769, ChEBI:CHEBI:175763; EC=2.5.1.10; Evidence={ECO:0000269|PubMed:16684881};",2.5.1.1; 2.5.1.10,"ACTIVITY REGULATION: Inactivated by interferon-induced RSAD2. This inactivation may result of disruption of lipid rafts at the plasma membrane, and thus have an antiviral effect since many enveloped viruses need lipid rafts to bud efficiently out of the cell. {ECO:0000269|PubMed:18005724}.",PATHWAY: Isoprenoid biosynthesis; farnesyl diphosphate biosynthesis; farnesyl diphosphate from geranyl diphosphate and isopentenyl diphosphate: step 1/1.; PATHWAY: Isoprenoid biosynthesis; geranyl diphosphate biosynthesis; geranyl diphosphate from dimethylallyl diphosphate and isopentenyl diphosphate: step 1/1.,ENST00000356657.10 [P14324-1];ENST00000368356.9 [P14324-1];ENST00000447866.5 [P14324-2];ENST00000467076.5 [P14324-2];ENST00000612683.1 [P14324-2];,FDPS;MYB-AS1,ENSG00000160752;ENSG00000236703,0.0,FDPS,Non-canonical_RBPs,7.0,,,,0.177,,FDPS
P14373,ENSG00000204713|ENSG00000215641|ENSG00000234495|ENSG00000237071|ENSG00000229006,TRI27_HUMAN,"Arp2/3 complex-mediated actin nucleation [GO:0034314]; innate immune response [GO:0045087]; negative regulation of adaptive immune response [GO:0002820]; negative regulation of autophagy [GO:0010507]; negative regulation of calcium ion import [GO:0090281]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of interleukin-2 production [GO:0032703]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of tumor necrosis factor production [GO:0032720]; negative regulation of type I interferon production [GO:0032480]; negative regulation of viral transcription [GO:0032897]; positive regulation of actin nucleation [GO:0051127]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of type II interferon production [GO:0032729]; protein K63-linked ubiquitination [GO:0070534]; protein sumoylation [GO:0016925]; retrograde transport, endosome to Golgi [GO:0042147]; spermatogenesis [GO:0007283]; suppression of viral release by host [GO:0044790]",cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome [GO:0005768]; fibrillar center [GO:0001650]; mitochondrion [GO:0005739]; nuclear membrane [GO:0031965]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605],DNA binding [GO:0003677]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; nucleic acid binding [GO:0003676]; SUMO transferase activity [GO:0019789]; transcription coactivator activity [GO:0003713]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],,DOMAIN: The coiled-coil region mediates interaction with EPC1 and CHD4. The B box and coiled-coil domains mediate interaction with PML. The B box and the distal coiled-coil domains mediate homomultimerisation. The B30.2 domain mediates interaction with EIF3S6.,"DOMAIN 298..492; /note=""B30.2/SPRY""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00548""",,,,"cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,TRIM27 RFP RNF76,Zinc finger protein RFP (EC 2.3.2.27) (RING finger protein 76) (Ret finger protein) (Tripartite motif-containing protein 27),Homo sapiens (Human),513.0,58490.0,MASGSVAECLQQETTCPVCLQYFAEPMMLDCGHNICCACLARCWGTAETNVSCPQCRETFPQRHMRPNRHLANVTQLVKQLRTERPSGPGGEMGVCEKHREPLKLYCEEDQMPICVVCDRSREHRGHSVLPLEEAVEGFKEQIQNQLDHLKRVKDLKKRRRAQGEQARAELLSLTQMEREKIVWEFEQLYHSLKEHEYRLLARLEELDLAIYNSINGAITQFSCNISHLSSLIAQLEEKQQQPTRELLQDIGDTLSRAERIRIPEPWITPPDLQEKIHIFAQKCLFLTESLKQFTEKMQSDMEKIQELREAQLYSVDVTLDPDTAYPSLILSDNLRQVRYSYLQQDLPDNPERFNLFPCVLGSPCFIAGRHYWEVEVGDKAKWTIGVCEDSVCRKGGVTSAPQNGFWAVSLWYGKEYWALTSPMTALPLRTPLQRVGIFLDYDAGEVSFYNVTERCHTFTFSHATFCGPVRPYFSLSYSGGKSAAPLIICPMSGIDGFSGHVGNHGHSMETSP,False,False,True,P14373,"[('cd15814', 'PRY/SPRY domain in tripartite motif-containing protein 27 (TRIM27), also known as RING finger protein 76 (RNF76)'), ('cd16594', 'RING finger, HC subclass, found in tripartite motif-containing proteins, TRIM7, TRIM11 and TRIM27, and similar proteins'), ('cd19762', 'B-box-type 2 zinc finger found in tripartite motif-containing proteins TRIM7, TRIM27 and similar proteins'), ('G3DSA:2.60.120.920', None), ('G3DSA:3.30.160.60', 'Classic Zinc Finger'), ('G3DSA:3.30.40.10', 'Zinc/RING finger domain, C3HC4 (zinc finger)'), ('IPR000315', 'B-box-type zinc finger'), ('IPR001841', 'Zinc finger, RING-type'), ('IPR001870', 'B30.2/SPRY domain'), ('IPR003877', 'SPRY domain'), ('IPR003879', 'Butyrophylin-like, SPRY domain'), ('IPR006574', 'SPRY-associated'), ('IPR013083', 'Zinc finger, RING/FYVE/PHD-type'), ('IPR013320', 'Concanavalin A-like lectin/glucanase domain superfamily'), ('IPR017907', 'Zinc finger, RING-type, conserved site'), ('IPR020457', 'Zinc finger, B-box, chordata'), ('IPR035791', 'TRIM27, PRY/SPRY domain'), ('IPR043136', 'B30.2/SPRY domain superfamily'), ('IPR050143', 'Tripartite motif-containing'), ('PF00622', 'SPRY domain')]",,"""ENSG00000204713; Low tissue specificity."";","CATALYTIC ACTIVITY: Reaction=S-ubiquitinyl-[E2 ubiquitin-conjugating enzyme]-L-cysteine + [acceptor protein]-L-lysine = [E2 ubiquitin-conjugating enzyme]-L-cysteine + N(6)-ubiquitinyl-[acceptor protein]-L-lysine.; EC=2.3.2.27; Evidence={ECO:0000269|PubMed:22829933, ECO:0000269|PubMed:24144979, ECO:0000269|PubMed:26358190, ECO:0000269|PubMed:35670107};",2.3.2.27,,"PATHWAY: Protein modification; protein ubiquitination. {ECO:0000269|PubMed:22128329, ECO:0000269|PubMed:22829933, ECO:0000269|PubMed:26358190, ECO:0000269|PubMed:35670107}.",ENST00000377194.7 [P14373-2];ENST00000377199.4 [P14373-1];ENST00000400720.7 [P14373-1];ENST00000412687.6 [P14373-2];ENST00000417660.6 [P14373-2];ENST00000427689.6 [P14373-2];ENST00000431123.6 [P14373-1];ENST00000435528.6 [P14373-1];ENST00000437160.6 [P14373-1];ENST00000452265.6 [P14373-2];,TRIM27;TAB2-AS1,ENSG00000204713;ENSG00000225924,4.0,TRIM27,Canonical_RBPs,3.0,,,,0.058,,TRIM27
P14618,ENSG00000067225,KPYM_HUMAN,canonical glycolysis [GO:0061621]; cellular response to insulin stimulus [GO:0032869]; glycolytic process [GO:0006096]; phosphorylation [GO:0016310]; positive regulation of cytoplasmic translation [GO:2000767]; positive regulation of sprouting angiogenesis [GO:1903672]; positive regulation of transcription by RNA polymerase II [GO:0045944]; programmed cell death [GO:0012501],cilium [GO:0005929]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular vesicle [GO:1903561]; ficolin-1-rich granule lumen [GO:1904813]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; rough endoplasmic reticulum [GO:0005791]; secretory granule lumen [GO:0034774]; vesicle [GO:0031982],ATP binding [GO:0005524]; cadherin binding [GO:0045296]; histone H3T11 kinase activity [GO:0035402]; magnesium ion binding [GO:0000287]; MHC class II protein complex binding [GO:0023026]; mRNA binding [GO:0003729]; potassium ion binding [GO:0030955]; protein homodimerization activity [GO:0042803]; protein tyrosine kinase activity [GO:0004713]; pyruvate kinase activity [GO:0004743]; RNA binding [GO:0003723]; transcription coactivator activity [GO:0003713],"PTM: ISGylated. {ECO:0000269|PubMed:16139798}.; PTM: Under hypoxia, hydroxylated by EGLN3. {ECO:0000269|PubMed:21620138}.; PTM: Acetylation at Lys-305 is stimulated by high glucose concentration, it decreases enzyme activity and promotes its lysosomal-dependent degradation via chaperone-mediated autophagy. {ECO:0000269|PubMed:21700219, ECO:0000269|Ref.11}.; PTM: [Isoform M2]: Acetylated at Lys-433 by EP300, leading to impair phosphoenolpyruvate substrate-binding and promote its homodimerization and subsequent translocation to the nucleus (PubMed:24120661). Deacetylation at Lys-433 by SIRT6 promotes its nuclear export into the cytoplasm, leading to suppress its nuclear localization and oncogenic function (PubMed:26787900). {ECO:0000269|PubMed:24120661, ECO:0000269|PubMed:26787900}.; PTM: [Isoform M2]: S-nitrosylation at Cys-423 and Cys-424 inhibits homotetramerization and pyruvate kinase activity (PubMed:30487609). S-nitrosylation is indirectly inhibited by AKR1A1 which degrades S-nitroso-CoA, a cofactor required to S-nitrosylate proteins (PubMed:30487609). {ECO:0000269|PubMed:30487609}.; PTM: FGFR1-dependent tyrosine phosphorylation is reduced by interaction with TRIM35. {ECO:0000269|PubMed:25263439}.",,,"STRAND 23..25; /evidence=""ECO:0007829|PDB:6WP4""; STRAND 35..37; /evidence=""ECO:0007829|PDB:4QGC""; STRAND 45..50; /evidence=""ECO:0007829|PDB:6B6U""; STRAND 71..75; /evidence=""ECO:0007829|PDB:6B6U""; STRAND 109..113; /evidence=""ECO:0007829|PDB:6B6U""; STRAND 119..121; /evidence=""ECO:0007829|PDB:6B6U""; STRAND 128..130; /evidence=""ECO:0007829|PDB:4WJ8""; STRAND 132..134; /evidence=""ECO:0007829|PDB:6B6U""; STRAND 139..143; /evidence=""ECO:0007829|PDB:6B6U""; STRAND 154..160; /evidence=""ECO:0007829|PDB:6B6U""; STRAND 173..176; /evidence=""ECO:0007829|PDB:6B6U""; STRAND 181..188; /evidence=""ECO:0007829|PDB:6B6U""; STRAND 190..199; /evidence=""ECO:0007829|PDB:6B6U""; STRAND 201..203; /evidence=""ECO:0007829|PDB:6B6U""; STRAND 204..206; /evidence=""ECO:0007829|PDB:4B2D""; STRAND 208..210; /evidence=""ECO:0007829|PDB:6B6U""; STRAND 212..214; /evidence=""ECO:0007829|PDB:5X1V""; STRAND 238..242; /evidence=""ECO:0007829|PDB:6B6U""; STRAND 265..271; /evidence=""ECO:0007829|PDB:6B6U""; STRAND 287..293; /evidence=""ECO:0007829|PDB:6B6U""; STRAND 324..329; /evidence=""ECO:0007829|PDB:6B6U""; STRAND 337..339; /evidence=""ECO:0007829|PDB:6NU5""; STRAND 357..362; /evidence=""ECO:0007829|PDB:6B6U""; STRAND 367..369; /evidence=""ECO:0007829|PDB:1ZJH""; STRAND 428..431; /evidence=""ECO:0007829|PDB:6B6U""; STRAND 433..435; /evidence=""ECO:0007829|PDB:6B6U""; STRAND 450..455; /evidence=""ECO:0007829|PDB:6B6U""; STRAND 469..473; /evidence=""ECO:0007829|PDB:6B6U""; STRAND 508..512; /evidence=""ECO:0007829|PDB:6B6U""; STRAND 525..529; /evidence=""ECO:0007829|PDB:6B6U""","HELIX 9..11; /evidence=""ECO:0007829|PDB:6B6U""; HELIX 18..21; /evidence=""ECO:0007829|PDB:6B6U""; HELIX 26..31; /evidence=""ECO:0007829|PDB:6B6U""; HELIX 58..67; /evidence=""ECO:0007829|PDB:6B6U""; HELIX 81..96; /evidence=""ECO:0007829|PDB:6B6U""; HELIX 146..148; /evidence=""ECO:0007829|PDB:6B6U""; HELIX 164..167; /evidence=""ECO:0007829|PDB:6B6U""; HELIX 223..234; /evidence=""ECO:0007829|PDB:6B6U""; HELIX 248..257; /evidence=""ECO:0007829|PDB:6B6U""; HELIX 274..278; /evidence=""ECO:0007829|PDB:6B6U""; HELIX 280..286; /evidence=""ECO:0007829|PDB:6B6U""; HELIX 294..300; /evidence=""ECO:0007829|PDB:6B6U""; HELIX 303..305; /evidence=""ECO:0007829|PDB:6B6U""; HELIX 306..320; /evidence=""ECO:0007829|PDB:6B6U""; HELIX 332..335; /evidence=""ECO:0007829|PDB:6B6U""; HELIX 342..354; /evidence=""ECO:0007829|PDB:6B6U""; HELIX 363..366; /evidence=""ECO:0007829|PDB:6B6U""; HELIX 371..388; /evidence=""ECO:0007829|PDB:6B6U""; HELIX 391..400; /evidence=""ECO:0007829|PDB:6B6U""; HELIX 408..423; /evidence=""ECO:0007829|PDB:6B6U""; HELIX 436..442; /evidence=""ECO:0007829|PDB:6B6U""; HELIX 457..462; /evidence=""ECO:0007829|PDB:6B6U""; HELIX 463..465; /evidence=""ECO:0007829|PDB:6B6U""; HELIX 482..499; /evidence=""ECO:0007829|PDB:6B6U""","TURN 15..17; /evidence=""ECO:0007829|PDB:6V74""; TURN 53..55; /evidence=""ECO:0007829|PDB:6B6U""; TURN 76..78; /evidence=""ECO:0007829|PDB:6GG6""; TURN 97..100; /evidence=""ECO:0007829|PDB:6B6U""; TURN 102..104; /evidence=""ECO:0007829|PDB:6B6U""; TURN 125..127; /evidence=""ECO:0007829|PDB:6B6U""; TURN 177..180; /evidence=""ECO:0007829|PDB:6B6U""; TURN 258..264; /evidence=""ECO:0007829|PDB:6B6U""; TURN 402..404; /evidence=""ECO:0007829|PDB:3SRF""; TURN 517..519; /evidence=""ECO:0007829|PDB:3G2G""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,PKM OIP3 PK2 PK3 PKM2,Pyruvate kinase PKM (EC 2.7.1.40) (Cytosolic thyroid hormone-binding protein) (CTHBP) (Opa-interacting protein 3) (OIP-3) (Pyruvate kinase 2/3) (Pyruvate kinase muscle isozyme) (Threonine-protein kinase PKM2) (EC 2.7.11.1) (Thyroid hormone-binding protein 1) (THBP1) (Tumor M2-PK) (Tyrosine-protein kinase PKM2) (EC 2.7.10.2) (p58),Homo sapiens (Human),531.0,57937.0,MSKPHSEAGTAFIQTQQLHAAMADTFLEHMCRLDIDSPPITARNTGIICTIGPASRSVETLKEMIKSGMNVARLNFSHGTHEYHAETIKNVRTATESFASDPILYRPVAVALDTKGPEIRTGLIKGSGTAEVELKKGATLKITLDNAYMEKCDENILWLDYKNICKVVEVGSKIYVDDGLISLQVKQKGADFLVTEVENGGSLGSKKGVNLPGAAVDLPAVSEKDIQDLKFGVEQDVDMVFASFIRKASDVHEVRKVLGEKGKNIKIISKIENHEGVRRFDEILEASDGIMVARGDLGIEIPAEKVFLAQKMMIGRCNRAGKPVICATQMLESMIKKPRPTRAEGSDVANAVLDGADCIMLSGETAKGDYPLEAVRMQHLIAREAEAAIYHLQLFEELRRLAPITSDPTEATAVGAVEASFKCCSGAIIVLTKSGRSAHQVARYRPRAPIIAVTRNPQTARQAHLYRGIFPVLCKDPVQEAWAEDVDLRVNFAMNVGKARGFFKKGDVVIVLTGWRPGSGFTNTMRVVPVP,True,True,True,P14618,"[('cd00288', 'Pyruvate_Kinase'), ('G3DSA:2.40.33.10', 'PK beta-barrel domain-like'), ('G3DSA:3.20.20.60', 'Phosphoenolpyruvate-binding domains'), ('G3DSA:3.40.1380.20', 'Pyruvate kinase, C-terminal domain'), ('IPR001697', 'Pyruvate kinase'), ('IPR011037', 'Pyruvate kinase-like, insert domain superfamily'), ('IPR015793', 'Pyruvate kinase, barrel'), ('IPR015795', 'Pyruvate kinase, C-terminal'), ('IPR015806', 'Pyruvate kinase, insert domain superfamily'), ('IPR015813', 'Pyruvate/Phosphoenolpyruvate kinase-like domain superfamily'), ('IPR018209', 'Pyruvate kinase, active site'), ('IPR036918', 'Pyruvate kinase, C-terminal domain superfamily'), ('IPR040442', 'Pyruvate kinase-like domain superfamily'), ('PF00224', 'Pyruvate kinase, barrel domain'), ('PF02887', 'Pyruvate kinase, alpha/beta domain'), ('PR01050', 'PYRUVTKNASE'), ('PS00110', 'Pyruvate kinase active site signature'), ('PTHR11817', 'PYRUVATE KINASE'), ('SSF50800', 'PK beta-barrel domain-like'), ('SSF51621', 'Phosphoenolpyruvate/pyruvate domain')]",,"""ENSG00000067225; Tissue enhanced (skeletal muscle, tongue)."";","CATALYTIC ACTIVITY: [Isoform M2]: Reaction=pyruvate + ATP = phosphoenolpyruvate + ADP + H(+); Xref=Rhea:RHEA:18157, ChEBI:CHEBI:15361, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616, ChEBI:CHEBI:58702, ChEBI:CHEBI:456216; EC=2.7.1.40; Evidence={ECO:0000269|PubMed:15996096, ECO:0000269|PubMed:1854723, ECO:0000269|PubMed:20847263}; PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:18159; Evidence={ECO:0000269|PubMed:15996096, ECO:0000269|PubMed:1854723, ECO:0000269|PubMed:20847263}; CATALYTIC ACTIVITY: [Isoform M2]: Reaction=L-tyrosyl-[protein] + ATP = O-phospho-L-tyrosyl-[protein] + ADP + H(+); Xref=Rhea:RHEA:10596, Rhea:RHEA-COMP:10136, Rhea:RHEA-COMP:10137, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616, ChEBI:CHEBI:46858, ChEBI:CHEBI:82620, ChEBI:CHEBI:456216; EC=2.7.10.2; Evidence={ECO:0000269|PubMed:22306293, ECO:0000269|PubMed:24120661}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:10597; Evidence={ECO:0000269|PubMed:22306293, ECO:0000269|PubMed:24120661}; CATALYTIC ACTIVITY: [Isoform M2]: Reaction=L-threonyl-[protein] + ATP = O-phospho-L-threonyl-[protein] + ADP + H(+); Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060, Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013, ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216; EC=2.7.11.1; Evidence={ECO:0000269|PubMed:22901803, ECO:0000269|PubMed:24120661}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:46609; Evidence={ECO:0000269|PubMed:22901803, ECO:0000269|PubMed:24120661}; CATALYTIC ACTIVITY: [Isoform M1]: Reaction=pyruvate + ATP = phosphoenolpyruvate + ADP + H(+); Xref=Rhea:RHEA:18157, ChEBI:CHEBI:15361, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616, ChEBI:CHEBI:58702, ChEBI:CHEBI:456216; EC=2.7.1.40; Evidence={ECO:0000269|PubMed:20847263};",2.7.1.40; 2.7.10.2; 2.7.11.1,"ACTIVITY REGULATION: [Isoform M2]: Isoform M2 is allosterically activated by D-fructose 1,6-bisphosphate (FBP) (PubMed:15996096, PubMed:18337815, PubMed:1854723, PubMed:2813362). Inhibited by oxalate and 3,3',5-triiodo-L-thyronine (T3) (PubMed:15996096). The activity of the tetrameric form is inhibited by PML (PubMed:18298799). Selective binding to tyrosine-phosphorylated peptides releases the allosteric activator FBP, leading to inhibition of PKM enzymatic activity, this diverts glucose metabolites from energy production to anabolic processes when cells are stimulated by certain growth factors (PubMed:18337815). Glycolytic flux are highly dependent on de novo biosynthesis of serine and glycine, and serine is a natural ligand and allosteric activator of isoform M2 (PubMed:23064226). Acetylation at Lys-433 promotes its translocation into the nucleus and homodimerization, promoting the protein kinase activity (PubMed:24120661). {ECO:0000269|PubMed:15996096, ECO:0000269|PubMed:18298799, ECO:0000269|PubMed:18337815, ECO:0000269|PubMed:1854723, ECO:0000269|PubMed:23064226, ECO:0000269|PubMed:24120661, ECO:0000269|PubMed:2813362}.; ACTIVITY REGULATION: [Isoform M1]: Has high pyruvate kinase activity by itself and does not require allosteric activation by D-fructose 1,6-bisphosphate (FBP) for activity. {ECO:0000269|PubMed:20847263}.","PATHWAY: Carbohydrate degradation; glycolysis; pyruvate from D-glyceraldehyde 3-phosphate: step 5/5. {ECO:0000269|PubMed:15996096, ECO:0000269|PubMed:1854723}.",ENST00000319622.10 [P14618-2];ENST00000335181.10 [P14618-1];ENST00000568459.5 [P14618-2];,PKM,ENSG00000067225;ENSG00000231143,0.0,PKM,Non-canonical_RBPs,22.0,,,,0.017,,PKM
P14859,ENSG00000143190,PO2F1_HUMAN,negative regulation of DNA-templated transcription [GO:0045892]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357],chromatin [GO:0000785]; endoplasmic reticulum [GO:0005783]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575],"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II core promoter sequence-specific DNA binding [GO:0000979]; sequence-specific DNA binding [GO:0043565]","PTM: Phosphorylated by PRKDC. {ECO:0000269|PubMed:14612514, ECO:0000269|PubMed:1684878}.",,"DOMAIN 280..354; /note=""POU-specific""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00530""",,"HELIX 285..301; /evidence=""ECO:0007829|PDB:1E3O""; HELIX 306..317; /evidence=""ECO:0007829|PDB:1E3O""; HELIX 323..331; /evidence=""ECO:0007829|PDB:1E3O""; HELIX 336..353; /evidence=""ECO:0007829|PDB:1E3O""; HELIX 388..400; /evidence=""ECO:0007829|PDB:1E3O""; HELIX 406..416; /evidence=""ECO:0007829|PDB:1E3O""; HELIX 420..434; /evidence=""ECO:0007829|PDB:1E3O""",,"cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,POU2F1 OCT1 OTF1,"POU domain, class 2, transcription factor 1 (NF-A1) (Octamer-binding protein 1) (Oct-1) (Octamer-binding transcription factor 1) (OTF-1)",Homo sapiens (Human),743.0,76472.0,MNNPSETSKPSMESGDGNTGTQTNGLDFQKQPVPVGGAISTAQAQAFLGHLHQVQLAGTSLQAAAQSLNVQSKSNEESGDSQQPSQPSQQPSVQAAIPQTQLMLAGGQITGLTLTPAQQQLLLQQAQAQAQLLAAAVQQHSASQQHSAAGATISASAATPMTQIPLSQPIQIAQDLQQLQQLQQQNLNLQQFVLVHPTTNLQPAQFIISQTPQGQQGLLQAQNLLTQLPQQSQANLLQSQPSITLTSQPATPTRTIAATPIQTLPQSQSTPKRIDTPSLEEPSDLEELEQFAKTFKQRRIKLGFTQGDVGLAMGKLYGNDFSQTTISRFEALNLSFKNMCKLKPLLEKWLNDAENLSSDSSLSSPSALNSPGIEGLSRRRKKRTSIETNIRVALEKSFLENQKPTSEEITMIADQLNMEKEVIRVWFCNRRQKEKRINPPSSGGTSSSPIKAIFPSPTSLVATTPSLVTSSAATTLTVSPVLPLTSAAVTNLSVTGTSDTTSNNTATVISTAPPASSAVTSPSLSPSPSASASTSEASSASETSTTQTTSTPLSSPLGTSQVMVTASGLQTAAAAALQGAAQLPANASLAAMAAAAGLNPSLMAPSQFAAGGALLSLNPGTLSGALSPALMSNSTLATIQALASGGSLPITSLDATGNLVFANAGGAPNIVTAPLFLNPQNLSLLTSNPVSLVSAAAASAGNSAPVASLHATSTSAESIQNSLFTVASASGAASTTTTASKAQ,False,True,False,P14859,"[('cd00086', 'homeodomain'), ('G3DSA:1.10.10.60', 'Homeodomain-like'), ('G3DSA:1.10.260.40', 'lambda repressor-like DNA-binding domains'), ('IPR000327', 'POU-specific domain'), ('IPR000972', 'Octamer-binding transcription factor'), ('IPR001356', 'Homeodomain'), ('IPR009057', 'Homedomain-like superfamily'), ('IPR010982', 'Lambda repressor-like, DNA-binding domain superfamily'), ('IPR013847', 'POU domain'), ('IPR017970', 'Homeobox, conserved site'), ('IPR045703', 'POU domain, class 2, transcription factor 1, C-terminal'), ('IPR050255', 'POU domain transcription factor'), ('PF00046', 'Homeodomain'), ('PF00157', 'Pou domain - N-terminal to homeobox domain'), ('PF19536', 'POU domain, class 2, transcription factor 1 C-terminal'), ('PR00028', 'POUDOMAIN'), ('PR00029', 'OCTAMER'), ('PS00027', 'Homeobox domain signature'), ('PS00035', 'POU-specific (POUs) domain signature 1'), ('PS00465', 'POU-specific (POUs) domain signature 2')]",,"""ENSG00000143190; Low tissue specificity."";",,,,,ENST00000367862.9 [P14859-2];ENST00000367866.7 [P14859-6];ENST00000429375.6 [P14859-5];ENST00000541643.7 [P14859-1];,POU2F1,ENSG00000143190;ENSG00000260951,0.0,,,,30.28,DP00231,0.31,0.83,0.24,POU2F1
P14921,ENSG00000134954,ETS1_HUMAN,cell motility [GO:0048870]; immune response [GO:0006955]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell population proliferation [GO:0008285]; PML body organization [GO:0030578]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of gene expression [GO:0010628]; positive regulation of inflammatory response [GO:0050729]; positive regulation of leukocyte adhesion to vascular endothelial cell [GO:1904996]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of angiogenesis [GO:0045765]; regulation of apoptotic process [GO:0042981]; regulation of transcription by RNA polymerase II [GO:0006357]; response to antibiotic [GO:0046677]; transcription by RNA polymerase II [GO:0006366],chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; nuclear receptor coactivator activity [GO:0030374]; nucleic acid binding [GO:0003676]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription cis-regulatory region binding [GO:0000976]; transcription corepressor binding [GO:0001222]","PTM: Sumoylated on Lys-15 and Lys-227, preferentially with SUMO2; which inhibits transcriptional activity. {ECO:0000250|UniProtKB:P27577}.; PTM: Ubiquitinated; which induces proteasomal degradation. {ECO:0000250|UniProtKB:P27577}.; PTM: Phosphorylation at Ser-251, Ser-282 and Ser-285 by CaMK2/CaMKII in response to calcium signaling decreases affinity for DNA: an increasing number of phosphoserines causes DNA-binding to become progressively weaker. {ECO:0000250|UniProtKB:P27577}.",,"DOMAIN 51..136; /note=""PNT""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00762""","STRAND 331..334; /evidence=""ECO:0007829|PDB:3WTS""; STRAND 354..356; /evidence=""ECO:0007829|PDB:1GVJ""; STRAND 358..361; /evidence=""ECO:0007829|PDB:2STT""; STRAND 362..364; /evidence=""ECO:0007829|PDB:1GVJ""; STRAND 401..404; /evidence=""ECO:0007829|PDB:1GVJ""; STRAND 408..414; /evidence=""ECO:0007829|PDB:1GVJ""","HELIX 304..313; /evidence=""ECO:0007829|PDB:1GVJ""; HELIX 323..330; /evidence=""ECO:0007829|PDB:1GVJ""; HELIX 337..345; /evidence=""ECO:0007829|PDB:1GVJ""; HELIX 348..350; /evidence=""ECO:0007829|PDB:1GVJ""; HELIX 368..379; /evidence=""ECO:0007829|PDB:1GVJ""; HELIX 386..395; /evidence=""ECO:0007829|PDB:1GVJ""; HELIX 418..422; /evidence=""ECO:0007829|PDB:1GVJ""; HELIX 426..432; /evidence=""ECO:0007829|PDB:1GVJ""","TURN 351..353; /evidence=""ECO:0007829|PDB:1GVJ""; TURN 396..400; /evidence=""ECO:0007829|PDB:1GVJ""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,ETS1 EWSR2,Protein C-ets-1 (p54),Homo sapiens (Human),441.0,50408.0,MKAAVDLKPTLTIIKTEKVDLELFPSPDMECADVPLLTPSSKEMMSQALKATFSGFTKEQQRLGIPKDPRQWTETHVRDWVMWAVNEFSLKGVDFQKFCMNGAALCALGKDCFLELAPDFVGDILWEHLEILQKEDVKPYQVNGVNPAYPESRYTSDYFISYGIEHAQCVPPSEFSEPSFITESYQTLHPISSEELLSLKYENDYPSVILRDPLQTDTLQNDYFAIKQEVVTPDNMCMGRTSRGKLGGQDSFESIESYDSCDRLTQSWSSQSSFNSLQRVPSYDSFDSEDYPAALPNHKPKGTFKDYVRDRADLNKDKPVIPAAALAGYTGSGPIQLWQFLLELLTDKSCQSFISWTGDGWEFKLSDPDEVARRWGKRKNKPKMNYEKLSRGLRYYYDKNIIHKTAGKRYVYRFVCDLQSLLGYTPEELHAMLDVKPDADE,False,False,True,P14921,"[('cd08542', 'Sterile alpha motif (SAM)/Pointed domain of ETS-1'), ('G3DSA:1.10.10.10', 'Winged helix-like DNA-binding domain superfamily/Winged helix DNA-binding domain'), ('G3DSA:1.10.150.50', 'Transcription Factor, Ets-1'), ('IPR000418', 'Ets domain'), ('IPR003118', 'Pointed domain'), ('IPR013761', 'Sterile alpha motif/pointed domain superfamily'), ('IPR016311', 'Transforming protein C-ets'), ('IPR036388', 'Winged helix-like DNA-binding domain superfamily'), ('IPR036390', 'Winged helix DNA-binding domain superfamily'), ('IPR041886', 'Protein C-ets-1, pointed domain'), ('IPR045688', 'Ets1, N-terminal flanking region of Ets domain'), ('IPR046328', 'ETS family'), ('PF00178', 'Ets-domain'), ('PF02198', 'Sterile alpha motif (SAM)/Pointed domain'), ('PF19525', 'Ets1 N-terminal flanking region of Ets domain'), ('PIRSF001698', 'Transforming factor C-ets'), ('PR00454', 'ETSDOMAIN'), ('PS00345', 'Ets-domain signature 1'), ('PS00346', 'Ets-domain signature 2'), ('PS50061', 'Ets-domain profile')]",,"""ENSG00000134954; Tissue enhanced (lymphoid)."";",,,"ACTIVITY REGULATION: Autoinhibited by a module composed of four alpha helices (HI-1, HI-2, H4, and H5) that flank the DNA-binding ETS domain, reducing the affinity for DNA. Phosphorylation by CaMK2/CaMKII in response to calcium signaling decreases affinity for DNA. {ECO:0000250|UniProtKB:P27577}.",,ENST00000319397.7 [P14921-1];ENST00000392668.8 [P14921-3];ENST00000526145.6 [P14921-2];ENST00000531611.5 [P14921-5];ENST00000535549.5 [P14921-4];,ETS1;LINC01448,ENSG00000134954;ENSG00000238284,0.0,,,,9.75,DP01441,0.168,0.481,,ETS1
P15144,ENSG00000166825,AMPN_HUMAN,angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; peptide catabolic process [GO:0043171]; proteolysis [GO:0006508],cytoplasm [GO:0005737]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667],aminopeptidase activity [GO:0004177]; metalloaminopeptidase activity [GO:0070006]; metallopeptidase activity [GO:0008237]; peptide binding [GO:0042277]; signaling receptor activity [GO:0038023]; virus receptor activity [GO:0001618]; zinc ion binding [GO:0008270],"PTM: Sulfated. {ECO:0000250|UniProtKB:P15145}.; PTM: N- and O-glycosylated. {ECO:0000269|PubMed:15084671, ECO:0000269|PubMed:16335952, ECO:0000269|PubMed:1705556, ECO:0000269|PubMed:19159218, ECO:0000269|PubMed:22932899, ECO:0000269|PubMed:9056417}.; PTM: May undergo proteolysis and give rise to a soluble form. {ECO:0000269|PubMed:7902291}.",,,"STRAND 73..75; /evidence=""ECO:0007829|PDB:4FYT""; STRAND 78..91; /evidence=""ECO:0007829|PDB:4FYT""; STRAND 102..115; /evidence=""ECO:0007829|PDB:4FYT""; STRAND 118..123; /evidence=""ECO:0007829|PDB:4FYT""; STRAND 126..129; /evidence=""ECO:0007829|PDB:5LHD""; STRAND 135..142; /evidence=""ECO:0007829|PDB:4FYT""; STRAND 150..156; /evidence=""ECO:0007829|PDB:4FYT""; STRAND 161..168; /evidence=""ECO:0007829|PDB:4FYT""; STRAND 175..185; /evidence=""ECO:0007829|PDB:4FYT""; STRAND 188..200; /evidence=""ECO:0007829|PDB:4FYT""; STRAND 203..211; /evidence=""ECO:0007829|PDB:4FYT""; STRAND 231..240; /evidence=""ECO:0007829|PDB:4FYT""; STRAND 243..249; /evidence=""ECO:0007829|PDB:4FYT""; STRAND 251..253; /evidence=""ECO:0007829|PDB:4FYT""; STRAND 256..258; /evidence=""ECO:0007829|PDB:4FYT""; STRAND 261..269; /evidence=""ECO:0007829|PDB:4FYT""; STRAND 282..285; /evidence=""ECO:0007829|PDB:4FYT""; STRAND 288..293; /evidence=""ECO:0007829|PDB:4FYT""; STRAND 299..304; /evidence=""ECO:0007829|PDB:4FYT""; STRAND 338..348; /evidence=""ECO:0007829|PDB:4FYT""; STRAND 350..354; /evidence=""ECO:0007829|PDB:4FYT""; STRAND 359..363; /evidence=""ECO:0007829|PDB:4FYT""; STRAND 399..403; /evidence=""ECO:0007829|PDB:4FYT""; STRAND 510..512; /evidence=""ECO:0007829|PDB:4FYT""; STRAND 550..555; /evidence=""ECO:0007829|PDB:4FYT""; STRAND 560..565; /evidence=""ECO:0007829|PDB:4FYT""; STRAND 586..588; /evidence=""ECO:0007829|PDB:4FYT""; STRAND 590..592; /evidence=""ECO:0007829|PDB:4FYT""; STRAND 600..602; /evidence=""ECO:0007829|PDB:4FYT""; STRAND 604..608; /evidence=""ECO:0007829|PDB:4FYT""; STRAND 620..623; /evidence=""ECO:0007829|PDB:4FYT""; STRAND 631..634; /evidence=""ECO:0007829|PDB:4FYT""; STRAND 742..746; /evidence=""ECO:0007829|PDB:7VPQ""","HELIX 70..72; /evidence=""ECO:0007829|PDB:4FYT""; HELIX 217..219; /evidence=""ECO:0007829|PDB:4FYT""; HELIX 277..279; /evidence=""ECO:0007829|PDB:4FYT""; HELIX 306..310; /evidence=""ECO:0007829|PDB:4FYT""; HELIX 315..331; /evidence=""ECO:0007829|PDB:4FYT""; HELIX 364..367; /evidence=""ECO:0007829|PDB:4FYT""; HELIX 376..394; /evidence=""ECO:0007829|PDB:4FYT""; HELIX 404..407; /evidence=""ECO:0007829|PDB:4FYT""; HELIX 408..425; /evidence=""ECO:0007829|PDB:4FYT""; HELIX 427..429; /evidence=""ECO:0007829|PDB:4FYT""; HELIX 431..434; /evidence=""ECO:0007829|PDB:4FYT""; HELIX 435..438; /evidence=""ECO:0007829|PDB:4FYT""; HELIX 440..447; /evidence=""ECO:0007829|PDB:4FYT""; HELIX 459..461; /evidence=""ECO:0007829|PDB:4FYT""; HELIX 465..470; /evidence=""ECO:0007829|PDB:4FYT""; HELIX 474..491; /evidence=""ECO:0007829|PDB:4FYT""; HELIX 493..507; /evidence=""ECO:0007829|PDB:4FYT""; HELIX 514..527; /evidence=""ECO:0007829|PDB:4FYT""; HELIX 536..544; /evidence=""ECO:0007829|PDB:4FYT""; HELIX 610..612; /evidence=""ECO:0007829|PDB:4FYT""; HELIX 624..626; /evidence=""ECO:0007829|PDB:4FYT""; HELIX 636..649; /evidence=""ECO:0007829|PDB:4FYT""; HELIX 650..652; /evidence=""ECO:0007829|PDB:4FYT""; HELIX 655..670; /evidence=""ECO:0007829|PDB:4FYT""; HELIX 676..681; /evidence=""ECO:0007829|PDB:4FYT""; HELIX 682..688; /evidence=""ECO:0007829|PDB:4FYT""; HELIX 692..709; /evidence=""ECO:0007829|PDB:4FYT""; HELIX 715..736; /evidence=""ECO:0007829|PDB:4FYT""; HELIX 747..762; /evidence=""ECO:0007829|PDB:4FYT""; HELIX 766..781; /evidence=""ECO:0007829|PDB:4FYT""; HELIX 790..792; /evidence=""ECO:0007829|PDB:4FYT""; HELIX 793..803; /evidence=""ECO:0007829|PDB:4FYT""; HELIX 806..817; /evidence=""ECO:0007829|PDB:4FYT""; HELIX 822..832; /evidence=""ECO:0007829|PDB:4FYT""; HELIX 838..848; /evidence=""ECO:0007829|PDB:4FYT""; HELIX 856..858; /evidence=""ECO:0007829|PDB:4FYT""; HELIX 859..868; /evidence=""ECO:0007829|PDB:4FYT""; HELIX 872..882; /evidence=""ECO:0007829|PDB:4FYT""; HELIX 884..890; /evidence=""ECO:0007829|PDB:4FYT""; HELIX 898..906; /evidence=""ECO:0007829|PDB:4FYT""; HELIX 912..924; /evidence=""ECO:0007829|PDB:4FYT""; HELIX 931..933; /evidence=""ECO:0007829|PDB:4FYT""; HELIX 934..965; /evidence=""ECO:0007829|PDB:4FYT""","TURN 157..160; /evidence=""ECO:0007829|PDB:4FYT""; TURN 213..216; /evidence=""ECO:0007829|PDB:4FYT""; TURN 311..314; /evidence=""ECO:0007829|PDB:4FYT""; TURN 371..373; /evidence=""ECO:0007829|PDB:4FYT""; TURN 396..398; /evidence=""ECO:0007829|PDB:4FYT""; TURN 556..559; /evidence=""ECO:0007829|PDB:4FYT""; TURN 579..582; /evidence=""ECO:0007829|PDB:4FYT""; TURN 737..741; /evidence=""ECO:0007829|PDB:4FYT""; TURN 851..853; /evidence=""ECO:0007829|PDB:4FYT""; TURN 891..894; /evidence=""ECO:0007829|PDB:4FYT""; TURN 925..928; /evidence=""ECO:0007829|PDB:4FYT""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,ANPEP APN CD13 PEPN,Aminopeptidase N (AP-N) (hAPN) (EC 3.4.11.2) (Alanyl aminopeptidase) (Aminopeptidase M) (AP-M) (Microsomal aminopeptidase) (Myeloid plasma membrane glycoprotein CD13) (gp150) (CD antigen CD13),Homo sapiens (Human),967.0,109540.0,MAKGFYISKSLGILGILLGVAAVCTIIALSVVYSQEKNKNANSSPVASTTPSASATTNPASATTLDQSKAWNRYRLPNTLKPDSYRVTLRPYLTPNDRGLYVFKGSSTVRFTCKEATDVIIIHSKKLNYTLSQGHRVVLRGVGGSQPPDIDKTELVEPTEYLVVHLKGSLVKDSQYEMDSEFEGELADDLAGFYRSEYMEGNVRKVVATTQMQAADARKSFPCFDEPAMKAEFNITLIHPKDLTALSNMLPKGPSTPLPEDPNWNVTEFHTTPKMSTYLLAFIVSEFDYVEKQASNGVLIRIWARPSAIAAGHGDYALNVTGPILNFFAGHYDTPYPLPKSDQIGLPDFNAGAMENWGLVTYRENSLLFDPLSSSSSNKERVVTVIAHELAHQWFGNLVTIEWWNDLWLNEGFASYVEYLGADYAEPTWNLKDLMVLNDVYRVMAVDALASSHPLSTPASEINTPAQISELFDAISYSKGASVLRMLSSFLSEDVFKQGLASYLHTFAYQNTIYLNLWDHLQEAVNNRSIQLPTTVRDIMNRWTLQMGFPVITVDTSTGTLSQEHFLLDPDSNVTRPSEFNYVWIVPITSIRDGRQQQDYWLIDVRAQNDLFSTSGNEWVLLNLNVTGYYRVNYDEENWRKIQTQLQRDHSAIPVINRAQIINDAFNLASAHKVPVTLALNNTLFLIEERQYMPWEAALSSLSYFKLMFDRSEVYGPMKNYLKKQVTPLFIHFRNNTNNWREIPENLMDQYSEVNAISTACSNGVPECEEMVSGLFKQWMENPNNNPIHPNLRSTVYCNAIAQGGEEEWDFAWEQFRNATLVNEADKLRAALACSKELWILNRYLSYTLNPDLIRKQDATSTIISITNNVIGQGLVWDFVQSNWKKLFNDYGGGSFSFSNLIQAVTRRFSTEYELQQLEQFKKDNEETGFGSGTRALEQALEKTKANIKWVKENKEVVLQWFTENSK,True,False,False,P15144,"[('cd09601', 'Peptidase M1 aminopeptidase N catalytic domain family which includes aminopeptidase N (APN), aminopeptidase Q (APQ), tricorn interacting factor F3, and endoplasmic reticulum aminopeptidase 1 (ERAP1)'), ('G3DSA:1.10.390.10', 'Neutral Protease Domain 2'), ('G3DSA:1.25.50.20', None), ('G3DSA:2.60.40.1730', 'tricorn interacting facor f3 domain'), ('G3DSA:2.60.40.1910', None), ('IPR001930', 'Peptidase M1, alanine aminopeptidase/leukotriene A4 hydrolase'), ('IPR014782', 'Peptidase M1, membrane alanine aminopeptidase'), ('IPR024571', 'ERAP1-like C-terminal domain'), ('IPR027268', 'Peptidase M4/M1, CTD superfamily'), ('IPR034016', 'Aminopeptidase N-type'), ('IPR042097', 'Aminopeptidase N-like , N-terminal domain superfamliy'), ('IPR045357', 'Aminopeptidase N-like , N-terminal domain'), ('IPR050344', 'Peptidase M1 family aminopeptidases'), ('PF01433', 'Peptidase family M1 domain'), ('PF11838', 'ERAP1-like C-terminal domain'), ('PF17900', 'Peptidase M1 N-terminal domain'), ('PR00756', 'ALADIPTASE'), ('PTHR11533', 'Peptidase M1 family aminopeptidases'), ('SSF55486', 'Metalloproteases (""zincins""), catalytic domain'), ('SSF63737', 'Leukotriene A4 hydrolase N-terminal domain')]",,"""ENSG00000166825; Group enriched (intestine, pancreas)."";","CATALYTIC ACTIVITY: Reaction=Release of an N-terminal amino acid, Xaa-|-Yaa- from a peptide, amide or arylamide. Xaa is preferably Ala, but may be most amino acids including Pro (slow action). When a terminal hydrophobic residue is followed by a prolyl residue, the two may be released as an intact Xaa-Pro dipeptide.; EC=3.4.11.2; Evidence={ECO:0000269|PubMed:22932899, ECO:0000269|PubMed:6149934, ECO:0000269|PubMed:7576235, ECO:0000269|PubMed:8887485};",3.4.11.2,,,ENST00000300060.7;ENST00000559874.2;ENST00000560137.2;ENST00000679248.1;,ANPEP,ENSG00000166825;ENSG00000284644;ENSG00000290816;ENSG00000290818,0.0,,,,,,,0.058,0.024,ANPEP
P15291,ENSG00000086062,B4GT1_HUMAN,acute inflammatory response [GO:0002526]; angiogenesis involved in wound healing [GO:0060055]; binding of sperm to zona pellucida [GO:0007339]; cell adhesion [GO:0007155]; development of secondary sexual characteristics [GO:0045136]; epithelial cell development [GO:0002064]; epithelial cell proliferation [GO:0050673]; extracellular matrix organization [GO:0030198]; galactose metabolic process [GO:0006012]; lactose biosynthetic process [GO:0005989]; lipid metabolic process [GO:0006629]; macrophage migration [GO:1905517]; negative regulation of epithelial cell proliferation [GO:0050680]; oligosaccharide biosynthetic process [GO:0009312]; penetration of zona pellucida [GO:0007341]; positive regulation of apoptotic process [GO:0043065]; positive regulation of circulating fibrinogen levels [GO:0061755]; positive regulation of epithelial cell proliferation involved in wound healing [GO:0060054]; protein N-linked glycosylation [GO:0006487]; regulation of acrosome reaction [GO:0060046],azurophil granule membrane [GO:0035577]; basolateral plasma membrane [GO:0016323]; brush border membrane [GO:0031526]; desmosome [GO:0030057]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; filopodium [GO:0030175]; Golgi apparatus [GO:0005794]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; Golgi trans cisterna [GO:0000138]; membrane [GO:0016020]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; secretory granule membrane [GO:0030667],"alpha-tubulin binding [GO:0043014]; beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity [GO:0003831]; beta-tubulin binding [GO:0048487]; cytoskeletal protein binding [GO:0008092]; galactosyltransferase activity [GO:0008378]; identical protein binding [GO:0042802]; lactose synthase activity [GO:0004461]; manganese ion binding [GO:0030145]; N-acetyllactosamine synthase activity [GO:0003945]; UDP-galactosyltransferase activity [GO:0035250]",PTM: The soluble form derives from the membrane forms by proteolytic processing.,,,"STRAND 170..173; /evidence=""ECO:0007829|PDB:2FY7""; STRAND 177..186; /evidence=""ECO:0007829|PDB:2FY7""; STRAND 208..216; /evidence=""ECO:0007829|PDB:2FY7""; STRAND 218..220; /evidence=""ECO:0007829|PDB:2FY7""; STRAND 243..247; /evidence=""ECO:0007829|PDB:2FY7""; STRAND 251..255; /evidence=""ECO:0007829|PDB:2FY7""; STRAND 288..293; /evidence=""ECO:0007829|PDB:2FY7""; STRAND 309..312; /evidence=""ECO:0007829|PDB:2AGD""; STRAND 337..340; /evidence=""ECO:0007829|PDB:2FY7""; STRAND 377..384; /evidence=""ECO:0007829|PDB:2FY7""; STRAND 387..393; /evidence=""ECO:0007829|PDB:2FY7""","HELIX 151..157; /evidence=""ECO:0007829|PDB:2FY7""; HELIX 188..204; /evidence=""ECO:0007829|PDB:2FY7""; HELIX 224..238; /evidence=""ECO:0007829|PDB:2FY7""; HELIX 274..276; /evidence=""ECO:0007829|PDB:2FY7""; HELIX 280..283; /evidence=""ECO:0007829|PDB:6FWU""; HELIX 294..299; /evidence=""ECO:0007829|PDB:2FY7""; HELIX 313..323; /evidence=""ECO:0007829|PDB:2FY7""; HELIX 344..346; /evidence=""ECO:0007829|PDB:6FWT""; HELIX 347..349; /evidence=""ECO:0007829|PDB:4L41""; HELIX 359..365; /evidence=""ECO:0007829|PDB:2FY7""; HELIX 371..373; /evidence=""ECO:0007829|PDB:2FY7""","TURN 163..165; /evidence=""ECO:0007829|PDB:2FY7""; TURN 284..286; /evidence=""ECO:0007829|PDB:6FWU""; TURN 333..335; /evidence=""ECO:0007829|PDB:2FY7""; TURN 366..368; /evidence=""ECO:0007829|PDB:2FY7""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,B4GALT1 GGTB2,"Beta-1,4-galactosyltransferase 1 (Beta-1,4-GalTase 1) (Beta4Gal-T1) (b4Gal-T1) (EC 2.4.1.-) (Beta-N-acetylglucosaminyl-glycolipid beta-1,4-galactosyltransferase) (Beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase) (EC 2.4.1.38) (Lactose synthase A protein) (EC 2.4.1.22) (N-acetyllactosamine synthase) (EC 2.4.1.90) (Nal synthase) (Neolactotriaosylceramide beta-1,4-galactosyltransferase) (EC 2.4.1.275) (UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1) (UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1) [Cleaved into: Processed beta-1,4-galactosyltransferase 1]",Homo sapiens (Human),398.0,43920.0,MRLREPLLSGSAAMPGASLQRACRLLVAVCALHLGVTLVYYLAGRDLSRLPQLVGVSTPLQGGSNSAAAIGQSSGELRTGGARPPPPLGASSQPRPGGDSSPVVDSGPGPASNLTSVPVPHTTALSLPACPEESPLLVGPMLIEFNMPVDLELVAKQNPNVKMGGRYAPRDCVSPHKVAIIIPFRNRQEHLKYWLYYLHPVLQRQQLDYGIYVINQAGDTIFNRAKLLNVGFQEALKDYDYTCFVFSDVDLIPMNDHNAYRCFSQPRHISVAMDKFGFSLPYVQYFGGVSALSKQQFLTINGFPNNYWGWGGEDDDIFNRLVFRGMSISRPNAVVGRCRMIRHSRDKKNEPNPQRFDRIAHTKETMLSDGLNSLTYQVLDVQRYPLYTQITVDIGTPS,True,True,False,P15291,"[('cd00899', 'Beta-4-Galactosyltransferase is involved in the formation of the poly-N-acetyllactosamine core structures present in glycoproteins and glycosphingolipids'), ('G3DSA:3.90.550.10', 'Spore Coat Polysaccharide Biosynthesis Protein SpsA; Chain A'), ('IPR003859', 'Beta-1,4-galactosyltransferase'), ('IPR027791', 'Galactosyltransferase, C-terminal'), ('IPR027995', 'Galactosyltransferase, N-terminal'), ('IPR029044', 'Nucleotide-diphospho-sugar transferases'), ('PF02709', 'N-terminal domain of galactosyltransferase'), ('PF13733', 'N-terminal region of glycosyl transferase group 7'), ('PR02050', 'Beta-1,4-galactosyltransferase family'), ('PTHR19300', 'BETA-1,4-GALACTOSYLTRANSFERASE'), ('SSF53448', 'Nucleotide-diphospho-sugar transferases')]",,"""ENSG00000086062; Low tissue specificity."";","CATALYTIC ACTIVITY: Reaction=UDP-alpha-D-galactose + D-glucose = lactose + UDP + H(+); Xref=Rhea:RHEA:12404, ChEBI:CHEBI:4167, ChEBI:CHEBI:15378, ChEBI:CHEBI:17716, ChEBI:CHEBI:58223, ChEBI:CHEBI:66914; EC=2.4.1.22; Evidence={ECO:0000269|PubMed:16157350}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:12405; Evidence={ECO:0000269|PubMed:16157350}; CATALYTIC ACTIVITY: Reaction=an N-acetyl-beta-D-glucosaminyl derivative + UDP-alpha-D-galactose = a beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl derivative + UDP + H(+); Xref=Rhea:RHEA:22932, ChEBI:CHEBI:15378, ChEBI:CHEBI:58223, ChEBI:CHEBI:61631, ChEBI:CHEBI:66914, ChEBI:CHEBI:133507; EC=2.4.1.38; Evidence={ECO:0000269|PubMed:16157350}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:22933; Evidence={ECO:0000269|PubMed:16157350}; CATALYTIC ACTIVITY: Reaction=N-acetyl-D-glucosamine + UDP-alpha-D-galactose = beta-D-galactosyl-(1->4)-N-acetyl-D-glucosamine + UDP + H(+); Xref=Rhea:RHEA:17745, ChEBI:CHEBI:15378, ChEBI:CHEBI:58223, ChEBI:CHEBI:60152, ChEBI:CHEBI:66914, ChEBI:CHEBI:506227; EC=2.4.1.90; Evidence={ECO:0000269|PubMed:16157350}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:17746; Evidence={ECO:0000269|PubMed:16157350}; CATALYTIC ACTIVITY: Reaction=a beta-D-GlcNAc-(1->3)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1)-Cer(d18:1(4E)) + UDP-alpha-D-galactose = a neolactoside nLc4Cer(d18:1(4E)) + UDP + H(+); Xref=Rhea:RHEA:31499, ChEBI:CHEBI:15378, ChEBI:CHEBI:17006, ChEBI:CHEBI:17103, ChEBI:CHEBI:58223, ChEBI:CHEBI:66914; EC=2.4.1.275; Evidence={ECO:0000250|UniProtKB:P08037}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:31500; Evidence={ECO:0000250|UniProtKB:P08037}; CATALYTIC ACTIVITY: Reaction=a beta-D-glucosylceramide + UDP-alpha-D-galactose = a beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1)-ceramide + UDP + H(+); Xref=Rhea:RHEA:62552, ChEBI:CHEBI:15378, ChEBI:CHEBI:58223, ChEBI:CHEBI:66914, ChEBI:CHEBI:79208, ChEBI:CHEBI:83264; Evidence={ECO:0000250|UniProtKB:P08037}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:62553; Evidence={ECO:0000250|UniProtKB:P08037}; CATALYTIC ACTIVITY: Reaction=a neolactoside IV(3)-beta-GlcNAc-nLc4Cer + UDP-alpha-D-galactose = a neolactoside nLc6Cer + UDP + H(+); Xref=Rhea:RHEA:62548, ChEBI:CHEBI:15378, ChEBI:CHEBI:58223, ChEBI:CHEBI:66914, ChEBI:CHEBI:90357, ChEBI:CHEBI:144378; Evidence={ECO:0000250|UniProtKB:P08037}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:62549; Evidence={ECO:0000250|UniProtKB:P08037};",2.4.1.-; 2.4.1.22; 2.4.1.275; 2.4.1.38; 2.4.1.90,,PATHWAY: Protein modification; protein glycosylation. {ECO:0000269|PubMed:16157350}.,ENST00000379731.5 [P15291-1];,B4GALT1;HOXA10-AS,ENSG00000086062;ENSG00000253187,0.0,,,,,,,0.329,0.143,B4GALT1
P15336,ENSG00000115966,ATF2_HUMAN,abducens nucleus development [GO:0021742]; adipose tissue development [GO:0060612]; apoptotic process involved in development [GO:1902742]; BMP signaling pathway [GO:0030509]; brainstem development [GO:0003360]; cellular lipid metabolic process [GO:0044255]; cellular response to anisomycin [GO:0072740]; cellular response to leucine starvation [GO:1990253]; cellular response to oxidative stress [GO:0034599]; cellular response to virus [GO:0098586]; detection of cell density [GO:0060245]; DNA damage response [GO:0006974]; facial nucleus development [GO:0021754]; growth plate cartilage chondrocyte differentiation [GO:0003418]; growth plate cartilage chondrocyte proliferation [GO:0003419]; hematopoietic progenitor cell differentiation [GO:0002244]; hepatocyte apoptotic process [GO:0097284]; hypoglossal nucleus development [GO:0021743]; in utero embryonic development [GO:0001701]; intrinsic apoptotic signaling pathway in response to hypoxia [GO:1990144]; JNK cascade [GO:0007254]; liver development [GO:0001889]; mitotic intra-S DNA damage checkpoint signaling [GO:0031573]; motor neuron apoptotic process [GO:0097049]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of angiogenesis [GO:0016525]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neurofilament cytoskeleton organization [GO:0060052]; NK T cell differentiation [GO:0001865]; outflow tract morphogenesis [GO:0003151]; p38MAPK cascade [GO:0038066]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of cardiac muscle myoblast proliferation [GO:0110024]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of gene expression [GO:0010628]; positive regulation of mitochondrial membrane permeability involved in apoptotic process [GO:1902110]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta2 production [GO:0032915]; protein import into nucleus [GO:0006606]; regulation of DNA-templated transcription [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; response to organic cyclic compound [GO:0014070]; response to osmotic stress [GO:0006970]; transcription initiation-coupled chromatin remodeling [GO:0045815]; vacuole organization [GO:0007033]; white fat cell differentiation [GO:0050872],chromatin [GO:0000785]; cytoplasm [GO:0005737]; H4 histone acetyltransferase complex [GO:1902562]; mitochondrial outer membrane [GO:0005741]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575]; site of double-strand break [GO:0035861],"cAMP response element binding [GO:0035497]; cAMP response element binding protein binding [GO:0008140]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; histone acetyltransferase activity [GO:0004402]; histone H2B acetyltransferase activity [GO:0044013]; histone H4 acetyltransferase activity [GO:0010485]; identical protein binding [GO:0042802]; leucine zipper domain binding [GO:0043522]; metal ion binding [GO:0046872]; promoter-specific chromatin binding [GO:1990841]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific double-stranded DNA binding [GO:1990837]","PTM: Phosphorylation of Thr-69 by MAPK14 and MAPK11, and at Thr-71 by MAPK1/ERK2, MAPK3/ERK1, MAPK11, MAPK12 and MAPK14 in response to external stimulus like insulin causes increased transcriptional activity (PubMed:12110590, PubMed:9430721). Phosphorylated by PLK3 following hyperosmotic stress (PubMed:21098032). Also phosphorylated and activated by JNK and CaMK4 (PubMed:8855261). ATM-mediated phosphorylation at Ser-490 and Ser-498 stimulates its function in DNA damage response (PubMed:15916964). Phosphorylation at Ser-62, Thr-73 and Ser-121 activates its transcriptional activity (PubMed:15105425). Phosphorylation at Thr-69 or Thr-71 enhances acetylation of histones H2B and H4 (PubMed:10821277). {ECO:0000269|PubMed:10821277, ECO:0000269|PubMed:12110590, ECO:0000269|PubMed:15105425, ECO:0000269|PubMed:15916964, ECO:0000269|PubMed:21098032, ECO:0000269|PubMed:8855261, ECO:0000269|PubMed:9430721}.",DOMAIN: The nuclear export signal 1 (N-NES) negatively regulates its nuclear localization and transcriptional activity.,"DOMAIN 352..415; /note=""bZIP""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00978""","STRAND 35..38; /evidence=""ECO:0007829|PDB:6ZR5""","HELIX 39..49; /evidence=""ECO:0007829|PDB:6ZR5""; HELIX 91..100; /evidence=""ECO:0007829|PDB:6ZQS""; HELIX 355..412; /evidence=""ECO:0007829|PDB:1T2K""","TURN 30..32; /evidence=""ECO:0007829|PDB:1BHI""; TURN 51..55; /evidence=""ECO:0007829|PDB:1BHI""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,ATF2 CREB2 CREBP1,Cyclic AMP-dependent transcription factor ATF-2 (cAMP-dependent transcription factor ATF-2) (Activating transcription factor 2) (Cyclic AMP-responsive element-binding protein 2) (CREB-2) (cAMP-responsive element-binding protein 2) (HB16) (cAMP response element-binding protein CRE-BP1),Homo sapiens (Human),505.0,54537.0,MKFKLHVNSARQYKDLWNMSDDKPFLCTAPGCGQRFTNEDHLAVHKHKHEMTLKFGPARNDSVIVADQTPTPTRFLKNCEEVGLFNELASPFENEFKKASEDDIKKMPLDLSPLATPIIRSKIEEPSVVETTHQDSPLPHPESTTSDEKEVPLAQTAQPTSAIVRPASLQVPNVLLTSSDSSVIIQQAVPSPTSSTVITQAPSSNRPIVPVPGPFPLLLHLPNGQTMPVAIPASITSSNVHVPAAVPLVRPVTMVPSVPGIPGPSSPQPVQSEAKMRLKAALTQQHPPVTNGDTVKGHGSGLVRTQSEESRPQSLQQPATSTTETPASPAHTTPQTQSTSGRRRRAANEDPDEKRRKFLERNRAAASRCRQKRKVWVQSLEKKAEDLSSLNGQLQSEVTLLRNEVAQLKQLLLAHKDCPVTAMQKKSGYHTADKDDSSEDISVPSSPHTEAIQHSSVSTSNGVSSTSKAEAVATSVLTQMADQSTEPALSQIVMAPSSQSQPSGS,True,True,False,P15336,"[('cd12192', 'GCN4 central activation domain-like acidic activation domain'), ('cd14687', 'Basic leucine zipper (bZIP) domain of Activating Transcription Factor-2 (ATF-2) and similar proteins: a DNA-binding and dimerization domain'), ('G3DSA:1.20.5.170', None), ('G3DSA:3.30.160.60', 'Classic Zinc Finger'), ('IPR004827', 'Basic-leucine zipper domain'), ('IPR013087', 'Zinc finger C2H2-type'), ('IPR016378', 'Transcription factor cyclic AMP-dependent, CRE-BP1-type'), ('IPR036236', 'Zinc finger C2H2 superfamily'), ('IPR046347', 'Basic-leucine zipper domain superfamily'), ('IPR051027', 'Basic leucine zipper (bZIP) transcription factors'), ('PF00170', 'bZIP transcription factor'), ('PIRSF003153', 'Cyclic AMP-dependent transcription factor, CRE-BP1 type'), ('PS00028', 'Zinc finger C2H2 type domain signature'), ('PS00036', 'Basic-leucine zipper (bZIP) domain signature'), ('PS50157', 'Zinc finger C2H2 type domain profile'), ('PS50217', 'Basic-leucine zipper (bZIP) domain profile'), ('PTHR19304', 'Basic leucine zipper (bZIP) transcription factors'), ('SM00338', 'basic region leucin zipper'), ('SSF57667', 'beta-beta-alpha zinc fingers'), ('SSF57959', 'Leucine zipper domain')]",P15336;,"""ENSG00000115966; Low tissue specificity."";",,,,,ENST00000264110.7 [P15336-1];ENST00000345739.9 [P15336-4];ENST00000392544.5 [P15336-1];ENST00000409499.5 [P15336-8];ENST00000409635.5 [P15336-4];ENST00000409833.5 [P15336-3];ENST00000426833.7 [P15336-5];,ATF2,ENSG00000115966;ENSG00000229459,0.0,,,,,,0.099,0.929,0.384,ATF2
P15531,ENSG00000239672,NDKA_HUMAN,cell differentiation [GO:0030154]; CTP biosynthetic process [GO:0006241]; endocytosis [GO:0006897]; GTP biosynthetic process [GO:0006183]; lactation [GO:0007595]; negative regulation of cell population proliferation [GO:0008285]; nervous system development [GO:0007399]; phosphorylation [GO:0016310]; positive regulation of DNA binding [GO:0043388]; positive regulation of epithelial cell proliferation [GO:0050679]; regulation of apoptotic process [GO:0042981]; UTP biosynthetic process [GO:0006228],cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleus [GO:0005634]; ruffle membrane [GO:0032587],3'-5' exonuclease activity [GO:0008408]; ATP binding [GO:0005524]; DNA nuclease activity [GO:0004536]; GTP binding [GO:0005525]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; nucleoside diphosphate kinase activity [GO:0004550]; ribosomal small subunit binding [GO:0043024]; RNA binding [GO:0003723],,,,"STRAND 6..11; /evidence=""ECO:0007829|PDB:8OOV""; STRAND 34..41; /evidence=""ECO:0007829|PDB:8OOV""; STRAND 56..58; /evidence=""ECO:0007829|PDB:4ENO""; STRAND 73..80; /evidence=""ECO:0007829|PDB:8OOV""; STRAND 117..119; /evidence=""ECO:0007829|PDB:8OOV""","HELIX 2..4; /evidence=""ECO:0007829|PDB:8OOV""; HELIX 13..17; /evidence=""ECO:0007829|PDB:8OOV""; HELIX 21..31; /evidence=""ECO:0007829|PDB:8OOV""; HELIX 45..51; /evidence=""ECO:0007829|PDB:8OOV""; HELIX 53..55; /evidence=""ECO:0007829|PDB:8OOV""; HELIX 61..69; /evidence=""ECO:0007829|PDB:8OOV""; HELIX 83..91; /evidence=""ECO:0007829|PDB:8OOV""; HELIX 96..98; /evidence=""ECO:0007829|PDB:8OOV""; HELIX 104..108; /evidence=""ECO:0007829|PDB:8OOV""; HELIX 112..114; /evidence=""ECO:0007829|PDB:1UCN""; HELIX 123..133; /evidence=""ECO:0007829|PDB:8OOV""; HELIX 136..138; /evidence=""ECO:0007829|PDB:8OOV""; HELIX 147..150; /evidence=""ECO:0007829|PDB:8OOV""",,"cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,NME1 NDPKA NM23,Nucleoside diphosphate kinase A (NDK A) (NDP kinase A) (EC 2.7.4.6) (Granzyme A-activated DNase) (GAAD) (Metastasis inhibition factor nm23) (NM23-H1) (Tumor metastatic process-associated protein),Homo sapiens (Human),152.0,17149.0,MANCERTFIAIKPDGVQRGLVGEIIKRFEQKGFRLVGLKFMQASEDLLKEHYVDLKDRPFFAGLVKYMHSGPVVAMVWEGLNVVKTGRVMLGETNPADSKPGTIRGDFCIQVGRNIIHGSDSVESAEKEIGLWFHPEELVDYTSCAQNWIYE,True,False,False,P15531,"[('cd04413', 'NDPk_I'), ('G3DSA:3.30.70.141', 'Nucleoside diphosphate kinase-like domain'), ('IPR001564', 'Nucleoside diphosphate kinase'), ('IPR023005', 'Nucleoside diphosphate kinase, active site'), ('IPR034907', 'Nucleoside diphosphate kinase-like domain'), ('IPR036850', 'Nucleoside diphosphate kinase-like domain superfamily'), ('MF_00451', 'Nucleoside diphosphate kinase [ndk]'), ('PF00334', 'Nucleoside diphosphate kinase'), ('PR01243', 'NUCDPKINASE'), ('PS00469', 'Nucleoside diphosphate kinases active site'), ('PTHR11349', 'Nucleoside diphosphate kinase'), ('SM00562', 'NDK'), ('SSF54919', 'Nucleoside diphosphate kinase, NDK')]",,"""ENSG00000239672; Low tissue specificity."";","CATALYTIC ACTIVITY: Reaction=a 2'-deoxyribonucleoside 5'-diphosphate + ATP = a 2'-deoxyribonucleoside 5'-triphosphate + ADP; Xref=Rhea:RHEA:44640, ChEBI:CHEBI:30616, ChEBI:CHEBI:61560, ChEBI:CHEBI:73316, ChEBI:CHEBI:456216; EC=2.7.4.6; CATALYTIC ACTIVITY: Reaction=a ribonucleoside 5'-diphosphate + ATP = a ribonucleoside 5'-triphosphate + ADP; Xref=Rhea:RHEA:18113, ChEBI:CHEBI:30616, ChEBI:CHEBI:57930, ChEBI:CHEBI:61557, ChEBI:CHEBI:456216; EC=2.7.4.6;",2.7.4.6,ACTIVITY REGULATION: Autophosphorylation at His-118 increases serine/threonine protein kinase activity of the enzyme. Interaction with the SET complex inhibits the endonuclease activity. {ECO:0000269|PubMed:12628186}.,,ENST00000013034.3 [P15531-2];ENST00000336097.7 [P15531-2];ENST00000393196.8 [P15531-1];,NME1,ENSG00000227365;ENSG00000239672,0.0,NME1,Non-canonical_RBPs,8.0,,,,,,NME1
P15559,ENSG00000181019,NQO1_HUMAN,"cell redox homeostasis [GO:0045454]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to metal ion [GO:0071248]; cellular response to oxidative stress [GO:0034599]; innate immune response [GO:0045087]; NADH oxidation [GO:0006116]; NADPH oxidation [GO:0070995]; negative regulation of apoptotic process [GO:0043066]; negative regulation of ferroptosis [GO:0110076]; negative regulation of protein catabolic process [GO:0042177]; nitric oxide biosynthetic process [GO:0006809]; positive regulation of neuron apoptotic process [GO:0043525]; protein catabolic process [GO:0030163]; protein polyubiquitination [GO:0000209]; removal of superoxide radicals [GO:0019430]; response to alkaloid [GO:0043279]; response to amine [GO:0014075]; response to carbohydrate [GO:0009743]; response to electrical stimulus [GO:0051602]; response to estradiol [GO:0032355]; response to ethanol [GO:0045471]; response to flavonoid [GO:1905395]; response to hormone [GO:0009725]; response to hydrogen sulfide [GO:1904880]; response to ischemia [GO:0002931]; response to L-glutamine [GO:1904844]; response to lipopolysaccharide [GO:0032496]; response to nutrient [GO:0007584]; response to oxidative stress [GO:0006979]; response to testosterone [GO:0033574]; response to tetrachloromethane [GO:1904772]; response to toxic substance [GO:0009636]; synaptic transmission, cholinergic [GO:0007271]; ubiquinone metabolic process [GO:0006743]; vitamin E metabolic process [GO:0042360]; vitamin K metabolic process [GO:0042373]; xenobiotic metabolic process [GO:0006805]",cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; synapse [GO:0045202],"cytochrome-b5 reductase activity, acting on NAD(P)H [GO:0004128]; identical protein binding [GO:0042802]; NAD(P)H dehydrogenase (quinone) activity [GO:0003955]; NADH:ubiquinone reductase (non-electrogenic) activity [GO:0050136]; NADPH dehydrogenase (quinone) activity [GO:0008753]; RNA binding [GO:0003723]; superoxide dismutase activity [GO:0004784]",,,,"STRAND 5..10; /evidence=""ECO:0007829|PDB:8OK0""; STRAND 15..17; /evidence=""ECO:0007829|PDB:1QBG""; STRAND 36..41; /evidence=""ECO:0007829|PDB:8OK0""; STRAND 56..58; /evidence=""ECO:0007829|PDB:5EA2""; STRAND 96..103; /evidence=""ECO:0007829|PDB:8OK0""; STRAND 106..108; /evidence=""ECO:0007829|PDB:4CET""; STRAND 142..148; /evidence=""ECO:0007829|PDB:8OK0""; STRAND 160..162; /evidence=""ECO:0007829|PDB:1H69""; STRAND 188..190; /evidence=""ECO:0007829|PDB:8OK0""; STRAND 254..256; /evidence=""ECO:0007829|PDB:8OK0""","HELIX 18..32; /evidence=""ECO:0007829|PDB:8OK0""; HELIX 53..55; /evidence=""ECO:0007829|PDB:8OK0""; HELIX 63..65; /evidence=""ECO:0007829|PDB:5EA2""; HELIX 68..78; /evidence=""ECO:0007829|PDB:8OK0""; HELIX 83..94; /evidence=""ECO:0007829|PDB:8OK0""; HELIX 111..120; /evidence=""ECO:0007829|PDB:8OK0""; HELIX 129..131; /evidence=""ECO:0007829|PDB:8OK0""; HELIX 133..135; /evidence=""ECO:0007829|PDB:8OK0""; HELIX 153..156; /evidence=""ECO:0007829|PDB:8OK0""; HELIX 165..173; /evidence=""ECO:0007829|PDB:8OK0""; HELIX 178..180; /evidence=""ECO:0007829|PDB:8OK0""; HELIX 193..195; /evidence=""ECO:0007829|PDB:8OK0""; HELIX 198..212; /evidence=""ECO:0007829|PDB:8OK0""; HELIX 213..217; /evidence=""ECO:0007829|PDB:8OK0""; HELIX 226..228; /evidence=""ECO:0007829|PDB:8OK0""; HELIX 241..247; /evidence=""ECO:0007829|PDB:8OK0""","TURN 42..46; /evidence=""ECO:0007829|PDB:8OK0""; TURN 124..126; /evidence=""ECO:0007829|PDB:8OK0""; TURN 137..140; /evidence=""ECO:0007829|PDB:8OK0""; TURN 174..177; /evidence=""ECO:0007829|PDB:8OK0""; TURN 233..237; /evidence=""ECO:0007829|PDB:8OK0""; TURN 266..270; /evidence=""ECO:0007829|PDB:8OK0""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,NQO1 DIA4 NMOR1,NAD(P)H dehydrogenase [quinone] 1 (EC 1.6.5.2) (Azoreductase) (DT-diaphorase) (DTD) (Menadione reductase) (NAD(P)H:quinone oxidoreductase 1) (Phylloquinone reductase) (Quinone reductase 1) (QR1),Homo sapiens (Human),274.0,30868.0,MVGRRALIVLAHSERTSFNYAMKEAAAAALKKKGWEVVESDLYAMNFNPIISRKDITGKLKDPANFQYPAESVLAYKEGHLSPDIVAEQKKLEAADLVIFQFPLQWFGVPAILKGWFERVFIGEFAYTYAAMYDKGPFRSKKAVLSITTGGSGSMYSLQGIHGDMNVILWPIQSGILHFCGFQVLEPQLTYSIGHTPADARIQILEGWKKRLENIWDETPLYFAPSSLFDLNFQAGFLMKKEVQDEEKNKKFGLSVGHHLGKSIPTDNQIKARK,True,False,False,P15559,"[('G3DSA:3.40.50.360', None), ('IPR003680', 'Flavodoxin-like fold'), ('IPR029039', 'Flavoprotein-like superfamily'), ('IPR051545', 'NAD(P)H dehydrogenase (quinone)'), ('PF02525', 'Flavodoxin-like fold'), ('PTHR10204', 'NAD(P)H dehydrogenase (quinone)'), ('SSF52218', 'Flavoproteins')]",,"""ENSG00000181019; Tissue enhanced (stomach)."";","CATALYTIC ACTIVITY: Reaction=a quinone + NADH + H(+) = a quinol + NAD(+); Xref=Rhea:RHEA:46160, ChEBI:CHEBI:15378, ChEBI:CHEBI:24646, ChEBI:CHEBI:57540, ChEBI:CHEBI:57945, ChEBI:CHEBI:132124; EC=1.6.5.2; Evidence={ECO:0000269|PubMed:8999809, ECO:0000269|PubMed:9271353}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:46161; Evidence={ECO:0000305|PubMed:8999809, ECO:0000305|PubMed:9271353}; CATALYTIC ACTIVITY: Reaction=a quinone + NADPH + H(+) = a quinol + NADP(+); Xref=Rhea:RHEA:46164, ChEBI:CHEBI:15378, ChEBI:CHEBI:24646, ChEBI:CHEBI:57783, ChEBI:CHEBI:58349, ChEBI:CHEBI:132124; EC=1.6.5.2; Evidence={ECO:0000269|PubMed:9271353}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:46165; Evidence={ECO:0000305|PubMed:9271353}; CATALYTIC ACTIVITY: Reaction=ubiquinone-10 + NADH + H(+) = ubiquinol-10 + NAD(+); Xref=Rhea:RHEA:61984, ChEBI:CHEBI:15378, ChEBI:CHEBI:46245, ChEBI:CHEBI:57540, ChEBI:CHEBI:57945, ChEBI:CHEBI:64183; Evidence={ECO:0000269|PubMed:9271353}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:61985; Evidence={ECO:0000305|PubMed:9271353}; CATALYTIC ACTIVITY: Reaction=menadione + NADH + H(+) = menadiol + NAD(+); Xref=Rhea:RHEA:69695, ChEBI:CHEBI:6746, ChEBI:CHEBI:15378, ChEBI:CHEBI:28869, ChEBI:CHEBI:57540, ChEBI:CHEBI:57945; Evidence={ECO:0000269|PubMed:8999809}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:69696; Evidence={ECO:0000305|PubMed:8999809};",1.6.5.2,"ACTIVITY REGULATION: Inhibited by dicoumarol. {ECO:0000269|PubMed:15687255, ECO:0000269|PubMed:9271353}.",,ENST00000320623.10 [P15559-1];ENST00000379046.6 [P15559-3];ENST00000379047.7 [P15559-2];,NQO1;KBTBD11-AS1,ENSG00000181019;ENSG00000253764,0.0,NQO1,Non-canonical_RBPs,5.0,,,,,,NQO1
P15692,ENSG00000112715,VEGFA_HUMAN,angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; artery morphogenesis [GO:0048844]; basophil chemotaxis [GO:0002575]; bone trabecula formation [GO:0060346]; branching involved in blood vessel morphogenesis [GO:0001569]; camera-type eye morphogenesis [GO:0048593]; cardiac muscle cell development [GO:0055013]; cardiac vascular smooth muscle cell development [GO:0060948]; cell maturation [GO:0048469]; cell migration involved in sprouting angiogenesis [GO:0002042]; cell-cell adhesion [GO:0098609]; cellular response to hypoxia [GO:0071456]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; cellular stress response to acid chemical [GO:0097533]; commissural neuron axon guidance [GO:0071679]; coronary artery morphogenesis [GO:0060982]; coronary vein morphogenesis [GO:0003169]; dopaminergic neuron differentiation [GO:0071542]; endothelial cell chemotaxis [GO:0035767]; endothelial cell proliferation [GO:0001935]; epithelial cell differentiation [GO:0030855]; epithelial cell maturation [GO:0002070]; eye photoreceptor cell development [GO:0042462]; heart morphogenesis [GO:0003007]; homeostasis of number of cells within a tissue [GO:0048873]; in utero embryonic development [GO:0001701]; induction of positive chemotaxis [GO:0050930]; kidney development [GO:0001822]; lactation [GO:0007595]; lung development [GO:0030324]; lung vasculature development [GO:0060426]; lymph vessel morphogenesis [GO:0036303]; lymphangiogenesis [GO:0001946]; macrophage differentiation [GO:0030225]; mammary gland alveolus development [GO:0060749]; mesoderm development [GO:0007498]; monocyte differentiation [GO:0030224]; motor neuron migration [GO:0097475]; negative regulation of adherens junction organization [GO:1903392]; negative regulation of apoptotic process [GO:0043066]; negative regulation of blood-brain barrier permeability [GO:1905604]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of establishment of endothelial barrier [GO:1903141]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of gene expression [GO:0010629]; negative regulation of miRNA transcription [GO:1902894]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; neuroblast proliferation [GO:0007405]; outflow tract morphogenesis [GO:0003151]; ovarian follicle development [GO:0001541]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive chemotaxis [GO:0050918]; positive regulation of angiogenesis [GO:0045766]; positive regulation of axon extension involved in axon guidance [GO:0048842]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis [GO:1903589]; positive regulation of branching involved in ureteric bud morphogenesis [GO:0090190]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of cell adhesion [GO:0045785]; positive regulation of cell division [GO:0051781]; positive regulation of cell migration [GO:0030335]; positive regulation of cell migration involved in sprouting angiogenesis [GO:0090050]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway [GO:0038091]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of DNA biosynthetic process [GO:2000573]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway [GO:0038033]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of epithelial tube formation [GO:1905278]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of gene expression [GO:0010628]; positive regulation of leukocyte migration [GO:0002687]; positive regulation of lymphangiogenesis [GO:1901492]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of mast cell chemotaxis [GO:0060754]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of p38MAPK cascade [GO:1900745]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of positive chemotaxis [GO:0050927]; positive regulation of protein autophosphorylation [GO:0031954]; positive regulation of protein localization to early endosome [GO:1902966]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of receptor internalization [GO:0002092]; positive regulation of sprouting angiogenesis [GO:1903672]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of trophoblast cell migration [GO:1901165]; positive regulation of vascular endothelial growth factor signaling pathway [GO:1900748]; positive regulation of vascular permeability [GO:0043117]; post-embryonic camera-type eye development [GO:0031077]; primitive erythrocyte differentiation [GO:0060319]; regulation of cell shape [GO:0008360]; regulation of hematopoietic progenitor cell differentiation [GO:1901532]; regulation of nitric oxide mediated signal transduction [GO:0010749]; regulation of transcription by RNA polymerase II [GO:0006357]; response to hypoxia [GO:0001666]; retinal ganglion cell axon guidance [GO:0031290]; sprouting angiogenesis [GO:0002040]; surfactant homeostasis [GO:0043129]; tube formation [GO:0035148]; vascular endothelial growth factor receptor signaling pathway [GO:0048010]; vascular endothelial growth factor receptor-2 signaling pathway [GO:0036324]; vascular endothelial growth factor signaling pathway [GO:0038084]; vascular wound healing [GO:0061042]; vasculogenesis [GO:0001570]; vasodilation [GO:0042311]; VEGF-activated neuropilin signaling pathway [GO:0038190],adherens junction [GO:0005912]; cell surface [GO:0009986]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; extracellular matrix [GO:0031012]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; nucleus [GO:0005634]; platelet alpha granule lumen [GO:0031093]; secretory granule [GO:0030141]; VEGF-A complex [GO:1990150],chemoattractant activity [GO:0042056]; cytokine activity [GO:0005125]; extracellular matrix binding [GO:0050840]; fibronectin binding [GO:0001968]; growth factor activity [GO:0008083]; heparin binding [GO:0008201]; identical protein binding [GO:0042802]; neuropilin binding [GO:0038191]; platelet-derived growth factor receptor binding [GO:0005161]; protein homodimerization activity [GO:0042803]; receptor ligand activity [GO:0048018]; transmembrane receptor protein tyrosine kinase activator activity [GO:0030297]; vascular endothelial growth factor receptor 1 binding [GO:0043183]; vascular endothelial growth factor receptor 2 binding [GO:0043184]; vascular endothelial growth factor receptor binding [GO:0005172],"PTM: [Vascular endothelial growth factor A, long form]: Produced by use of an alternative upstream CUG codon and post-translationally processed into the N-terminal N-VEGF form and the C-terminal secreted VEGFA form. {ECO:0000269|PubMed:11731620}.",,,"STRAND 231..240; /evidence=""ECO:0007829|PDB:1MKK""; STRAND 251..264; /evidence=""ECO:0007829|PDB:1MKK""; STRAND 273..289; /evidence=""ECO:0007829|PDB:1MKK""; STRAND 296..311; /evidence=""ECO:0007829|PDB:1MKK""; STRAND 352..354; /evidence=""ECO:0007829|PDB:4DEQ""; STRAND 357..360; /evidence=""ECO:0007829|PDB:4DEQ""; STRAND 367..371; /evidence=""ECO:0007829|PDB:4DEQ""; STRAND 382..384; /evidence=""ECO:0007829|PDB:1KMX""; STRAND 389..391; /evidence=""ECO:0007829|PDB:1KMX""","HELIX 223..230; /evidence=""ECO:0007829|PDB:1MKK""; HELIX 241..244; /evidence=""ECO:0007829|PDB:1MKK""; HELIX 246..248; /evidence=""ECO:0007829|PDB:1MKK""; HELIX 373..377; /evidence=""ECO:0007829|PDB:4DEQ""","TURN 291..293; /evidence=""ECO:0007829|PDB:4GLN""; TURN 362..364; /evidence=""ECO:0007829|PDB:4DEQ""; TURN 378..380; /evidence=""ECO:0007829|PDB:4DEQ""; TURN 385..387; /evidence=""ECO:0007829|PDB:4DEQ""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,VEGFA VEGF,"Vascular endothelial growth factor A, long form (L-VEGF) (Vascular permeability factor) (VPF) [Cleaved into: N-VEGF; VEGFA]",Homo sapiens (Human),395.0,43597.0,MTDRQTDTAPSPSYHLLPGRRRTVDAAASRGQGPEPAPGGGVEGVGARGVALKLFVQLLGCSRFGGAVVRAGEAEPSGAARSASSGREEPQPEEGEEEEEKEEERGPQWRLGARKPGSWTGEAAVCADSAPAARAPQALARASGRGGRVARRGAEESGPPHSPSRRGSASRAGPGRASETMNFLLSWVHWSLALLLYLHHAKWSQAAPMAEGGGQNHHEVVKFMDVYQRSYCHPIETLVDIFQEYPDEIEYIFKPSCVPLMRCGGCCNDEGLECVPTEESNITMQIMRIKPHQGQHIGEMSFLQHNKCECRPKKDRARQEKKSVRGKGKGQKRKRKKSRYKSWSVPCGPCSERRKHLFVQDPQTCKCSCKNTDSRCKARQLELNERTCRCDKPRR,False,False,True,P15692,"[('cd00135', 'PDGF'), ('G3DSA:2.10.160.10', 'Vascular endothelial growth factor, heparin-binding domain'), ('G3DSA:2.10.90.10', 'Cystine-knot cytokines'), ('IPR000072', 'PDGF/VEGF domain'), ('IPR023581', 'Platelet-derived growth factor, conserved site'), ('IPR027928', 'Vascular endothelial growth factor, heparin-binding domain'), ('IPR029034', 'Cystine-knot cytokine'), ('IPR036841', 'Vascular endothelial growth factor, heparin-binding domain superfamily'), ('IPR050507', 'Platelet-derived/Vascular endothelial growth factor'), ('PF00341', 'PDGF/VEGF domain'), ('PF14554', 'VEGF heparin-binding domain'), ('PS00249', 'Platelet-derived growth factor (PDGF) family signature'), ('PS50278', 'Platelet-derived growth factor (PDGF) family profile'), ('PTHR12025', 'Platelet-derived/Vascular endothelial growth factor'), ('SM00141', 'Platelet-derived and vascular endothelial growth factors (PDGF, VEGF) family'), ('SSF57501', 'Cystine-knot cytokines'), ('SSF57593', 'Heparin-binding domain from vascular endothelial growth factor')]",,"""ENSG00000112715; Low tissue specificity."";",,,,,ENST00000324450.11 [P15692-18];ENST00000372055.9 [P15692-14];ENST00000372064.9 [P15692-12];ENST00000372067.8 [P15692-11];ENST00000372077.8 [P15692-9];ENST00000413642.8 [P15692-16];ENST00000417285.7 [P15692-17];ENST00000457104.6 [P15692-10];ENST00000482630.7 [P15692-15];ENST00000518689.5 [P15692-3];ENST00000518824.5 [P15692-8];ENST00000520948.5 [P15692-2];ENST00000523125.5 [P15692-5];ENST00000523873.5 [P15692-1];ENST00000523950.5 [P15692-4];ENST00000672860.3 [P15692-13];,VEGFA,ENSG00000112715;ENSG00000253484,0.0,,,,,,,0.461,0.453,VEGFA
P15822,ENSG00000095951,ZEP1_HUMAN,BMP signaling pathway [GO:0030509]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357],cytosol [GO:0005829]; mitochondrion [GO:0005739]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]",,"DOMAIN: Contains two sets of 2 zinc-fingers, which are widely separated and recognize the same DNA sequence. There is a fifth zinc-finger in-between.",,"STRAND 2119..2122; /evidence=""ECO:0007829|PDB:1BBO""; STRAND 2124..2127; /evidence=""ECO:0007829|PDB:1BBO""; STRAND 2137..2140; /evidence=""ECO:0007829|PDB:1BBO""","HELIX 2100..2109; /evidence=""ECO:0007829|PDB:1BBO""; HELIX 2128..2136; /evidence=""ECO:0007829|PDB:1BBO""","TURN 2091..2093; /evidence=""ECO:0007829|PDB:1BBO""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,HIVEP1 ZNF40,Zinc finger protein 40 (Cirhin interaction protein) (CIRIP) (Gate keeper of apoptosis-activating protein) (GAAP) (Human immunodeficiency virus type I enhancer-binding protein 1) (HIV-EP1) (Major histocompatibility complex-binding protein 1) (MBP-1) (Positive regulatory domain II-binding factor 1) (PRDII-BF1),Homo sapiens (Human),2718.0,296835.0,MPRTKQIHPRNLRDKIEEAQKELNGAEVSKKEILQAGVKGTSESLKGVKRKKIVAENHLKKIPKSPLRNPLQAKHKQNTEESSFAVLHSASESHKKQNYIPVKNGKQFTKQNGETPGIIAEASKSEESVSPKKPLFLQQPSELRRWRSEGADPAKFSDLDEQCDSSSLSSKTRTDNSECISSHCGTTSPSYTNTAFDVLLKAMEPELSTLSQKGSPCAIKTEKLRPNKTARSPPKLKNSSMDAPNQTSQELVAESQSSCTSYTVHMSAAQKNEQGAMQSASHLYHQHEHFVPKSNQHNQQLPGCSGFTGSLTNLQNQENAKLEQVYNIAVTSSVGLTSPSSRSQVTPQNQQMDSASPLSISPANSTQSPPMPIYNSTHVASVVNQSVEQMCNLLLKDQKPKKQGKYICEYCNRACAKPSVLLKHIRSHTGERPYPCVTCGFSFKTKSNLYKHKKSHAHTIKLGLVLQPDAGGLFLSHESPKALSIHSDVEDSGESEEEGATDERQHDLGAMELQPVHIIKRMSNAETLLKSSFTPSSPENVIGDFLLQDRSAESQAVTELPKVVVHHVTVSPLRTDSPKAMDPKPELSSAQKQKDLQVTNVQPLSANMSQGGVSRLETNENSHQKGDMNPLEGKQDSHVGTVHAQLQRQQATDYSQEQQGKLLSPRSLGSTDSGYFSRSESADQTVSPPTPFARRLPSTEQDSGRSNGPSAALVTTSTPSALPTGEKALLLPGQMRPPLATKTLEERISKLISDNEALVDDKQLDSVKPRRTSLSRRGSIDSPKSYIFKDSFQFDLKPVGRRTSSSSDIPKSPFTPTEKSKQVFLLSVPSLDCLPITRSNSMPTTGYSAVPANIIPPPHPLRGSQSFDDKIGAFYDDVFVSGPNAPVPQSGHPRTLVRQAAIEDSSANESHVLGTGQSLDESHQGCHAAGEAMSVRSKALAQGPHIEKKKSHQGRGTMFECETCRNRYRKLENFENHKKFYCSELHGPKTKVAMREPEHSPVPGGLQPQILHYRVAGSSGIWEQTPQIRKRRKMKSVGDDEELQQNESGTSPKSSEGLQFQNALGCNPSLPKHNVTIRSDQQHKNIQLQNSHIHLVARGPEQTMDPKLSTIMEQQISSAAQDKIELQRHGTGISVIQHTNSLSRPNSFDKPEPFERASPVSFQELNRTGKSGSLKVIGISQEESHPSRDGSHPHQLALSDALRGELQESSRKSPSERHVLGQPSRLVRQHNIQVPEILVTEEPDRDLEAQCHDQEKSEKFSWPQRSETLSKLPTEKLPPKKKRLRLAEIEHSSTESSFDSTLSRSLSRESSLSHTSSFSASLDIEDVSKTEASPKIDFLNKAEFLMIPAGLNTLNVPGCHREMRRTASEQINCTQTSMEVSDLRSKSFDCGSITPPQTTPLTELQPPSSPSRVGVTGHVPLLERRRGPLVRQISLNIAPDSHLSPVHPTSFQNTALPSVNAVPYQGPQLTSTSLAEFSANTLHSQTQVKDLQAETSNSSSTNVFPVQQLCDINLLNQIHAPPSHQSTQLSLQVSTQGSKPDKNSVLSGSSKSEDCFAPKYQLHCQVFTSGPSCSSNPVHSLPNQVISDPVGTDHCVTSATLPTKLIDSMSNSHPLLPPELRPLGSQVQKVPSSFMLPIRLQSSVPAYCFATLTSLPQILVTQDLPNQPICQTNHSVVPISEEQNSVPTLQKGHQNALPNPEKEFLCENVFSEMSQNSSLSESLPITQKISVGRLSPQQESSASSKRMLSPANSLDIAMEKHQKRAKDENGAVCATDVRPLEALSSRVNEASKQKKPILVRQVCTTEPLDGVMLEKDVFSQPEISNEAVNLTNVLPADNSSTGCSKFVVIEPISELQEFENIKSSTSLTLTVRSSPAPSENTHISPLKCTDNNQERKSPGVKNQGDKVNIQEQSQQPVTSLSLFNIKDTQQLAFPSLKTTTNFTWCYLLRQKSLHLPQKDQKTSAYTDWTVSASNPNPLGLPTKVALALLNSKQNTGKSLYCQAITTHSKSDLLVYSSKWKSSLSKRALGNQKSTVVEFSNKDASEINSEQDKENSLIKSEPRRIKIFDGGYKSNEEYVYVRGRGRGKYICEECGIRCKKPSMLKKHIRTHTDVRPYHCTYCNFSFKTKGNLTKHMKSKAHSKKCVDLGVSVGLIDEQDTEESDEKQRFSYERSGYDLEESDGPDEDDNENEDDDEDSQAESVLSATPSVTASPQHLPSRSSLQDPVSTDEDVRITDCFSGVHTDPMDVLPRALLTRMTVLSTAQSDYNRKTLSPGKARQRAARDENDTIPSVDTSRSPCHQMSVDYPESEEILRSSMAGKAVAITQSPSSVRLPPAAAEHSPQTAAGMPSVASPHPDPQEQKQQITLQPTPGLPSPHTHLFSHLPLHSQQQSRTPYNMVPVGGIHVVPAGLTYSTFVPLQAGPVQLTIPAVSVVHRTLGTHRNTVTEVSGTTNPAGVAELSSVVPCIPIGQIRVPGLQNLSTPGLQSLPSLSMETVNIVGLANTNMAPQVHPPGLALNAVGLQVLTANPSSQSSPAPQAHIPGLQILNIALPTLIPSVSQVAVDAQGAPEMPASQSKACETQPKQTSVASANQVSRTESPQGLPTVQRENAKKVLNPPAPAGDHARLDGLSKMDTEKAASANHVKPKPELTSIQGQPASTSQPLLKAHSEVFTKPSGQQTLSPDRQVPRPTALPRRQPTVHFSDVSSDDDEDRLVIAT,False,False,True,P15822,"[('G3DSA:3.30.160.60', 'Classic Zinc Finger'), ('IPR013087', 'Zinc finger C2H2-type'), ('IPR034729', 'Zinc finger CCHC HIVEP-type'), ('IPR036236', 'Zinc finger C2H2 superfamily'), ('IPR051969', 'Zinc-finger DNA-binding transcription regulators'), ('PF00096', 'Zinc finger, C2H2 type'), ('PS00028', 'Zinc finger C2H2 type domain signature'), ('PS50157', 'Zinc finger C2H2 type domain profile'), ('PS51811', 'Zinc finger CCHC HIVEP-type profile'), ('PTHR45944', 'Zinc-finger DNA-binding transcription regulators'), ('SM00355', 'zinc finger'), ('SSF57667', 'beta-beta-alpha zinc fingers')]",P15822;,"""ENSG00000095951; Low tissue specificity."";",,,,,ENST00000379388.7 [P15822-1];ENST00000478545.2 [P15822-1];ENST00000487103.6 [P15822-1];ENST00000491710.6 [P15822-1];,HIVEP1,ENSG00000095951;ENSG00000254219,0.0,,,,,,,,0.353,HIVEP1
P16333,ENSG00000158092,NCK1_HUMAN,"actin filament organization [GO:0007015]; antiviral innate immune response [GO:0140374]; cell migration [GO:0016477]; ephrin receptor signaling pathway [GO:0048013]; lamellipodium assembly [GO:0030032]; negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation [GO:1903912]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of peptidyl-serine phosphorylation [GO:0033137]; negative regulation of PERK-mediated unfolded protein response [GO:1903898]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of cap-dependent translational initiation [GO:1903676]; positive regulation of cap-independent translational initiation [GO:1903679]; positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902237]; positive regulation of neuron projection development [GO:0010976]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of translation in response to endoplasmic reticulum stress [GO:0036493]; regulation of cell migration [GO:0030334]; response to endoplasmic reticulum stress [GO:0034976]; signal complex assembly [GO:0007172]; substrate-dependent cell migration, cell extension [GO:0006930]; T cell activation [GO:0042110]",cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein phosphatase type 1 complex [GO:0000164]; ribosome [GO:0005840]; vesicle membrane [GO:0012506],cadherin binding [GO:0045296]; cytoskeletal anchor activity [GO:0008093]; ephrin receptor binding [GO:0046875]; eukaryotic initiation factor eIF2 binding [GO:0071074]; molecular condensate scaffold activity [GO:0140693]; protein domain specific binding [GO:0019904]; protein kinase inhibitor activity [GO:0004860]; protein-macromolecule adaptor activity [GO:0030674]; receptor tyrosine kinase binding [GO:0030971]; signaling adaptor activity [GO:0035591]; signaling receptor binding [GO:0005102]; signaling receptor complex adaptor activity [GO:0030159],"PTM: Phosphorylated on Ser and Tyr residues. Phosphorylated in response to activation of EGFR and FcERI. Phosphorylated by activated PDGFRB. {ECO:0000269|PubMed:10026169, ECO:0000269|PubMed:1333046, ECO:0000269|PubMed:1448108, ECO:0000269|PubMed:18835251, ECO:0000269|PubMed:7692233}.",DOMAIN: Only the first and third SH3 domains seem to be involved in RASA1-binding; the second SH3 domain and the SH2 domains do not seem to be involved.,"DOMAIN 2..61; /note=""SH3 1""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00192""; DOMAIN 106..165; /note=""SH3 2""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00192""; DOMAIN 190..252; /note=""SH3 3""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00192""; DOMAIN 282..376; /note=""SH2""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00191""","STRAND 5..8; /evidence=""ECO:0007829|PDB:5QU8""; STRAND 28..31; /evidence=""ECO:0007829|PDB:5QU8""; STRAND 38..42; /evidence=""ECO:0007829|PDB:5QU8""; STRAND 48..52; /evidence=""ECO:0007829|PDB:5QU8""; STRAND 56..58; /evidence=""ECO:0007829|PDB:5QU2""; STRAND 99..101; /evidence=""ECO:0007829|PDB:2CUB""; STRAND 109..115; /evidence=""ECO:0007829|PDB:2CUB""; STRAND 131..138; /evidence=""ECO:0007829|PDB:2CUB""; STRAND 142..148; /evidence=""ECO:0007829|PDB:2CUB""; STRAND 151..156; /evidence=""ECO:0007829|PDB:2CUB""; STRAND 160..162; /evidence=""ECO:0007829|PDB:2CUB""; STRAND 168..170; /evidence=""ECO:0007829|PDB:2CUB""; STRAND 304..309; /evidence=""ECO:0007829|PDB:2CI9""; STRAND 311..313; /evidence=""ECO:0007829|PDB:2CI9""; STRAND 316..321; /evidence=""ECO:0007829|PDB:2CI9""; STRAND 324..326; /evidence=""ECO:0007829|PDB:2CI9""; STRAND 328..335; /evidence=""ECO:0007829|PDB:2CI9""; STRAND 338..341; /evidence=""ECO:0007829|PDB:2CI9""; STRAND 344..348; /evidence=""ECO:0007829|PDB:2CI9""; STRAND 361..363; /evidence=""ECO:0007829|PDB:2CI9""","HELIX 33..35; /evidence=""ECO:0007829|PDB:5QU8""; HELIX 53..55; /evidence=""ECO:0007829|PDB:5QU8""; HELIX 157..159; /evidence=""ECO:0007829|PDB:2CUB""; HELIX 289..299; /evidence=""ECO:0007829|PDB:2CI9""; HELIX 349..358; /evidence=""ECO:0007829|PDB:2CI9""",,"cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,NCK1 NCK,SH2/SH3 adapter protein NCK1 (Cytoplasmic protein NCK1) (NCK adapter protein 1) (Nck-1) (SH2/SH3 adapter protein NCK-alpha),Homo sapiens (Human),377.0,42864.0,MAEEVVVVAKFDYVAQQEQELDIKKNERLWLLDDSKSWWRVRNSMNKTGFVPSNYVERKNSARKASIVKNLKDTLGIGKVKRKPSVPDSASPADDSFVDPGERLYDLNMPAYVKFNYMAEREDELSLIKGTKVIVMEKCSDGWWRGSYNGQVGWFPSNYVTEEGDSPLGDHVGSLSEKLAAVVNNLNTGQVLHVVQALYPFSSSNDEELNFEKGDVMDVIEKPENDPEWWKCRKINGMVGLVPKNYVTVMQNNPLTSGLEPSPPQCDYIRPSLTGKFAGNPWYYGKVTRHQAEMALNERGHEGDFLIRDSESSPNDFSVSLKAQGKNKHFKVQLKETVYCIGQRKFSTMEELVEHYKKAPIFTSEQGEKLYLVKHLS,False,False,True,P16333,"[('cd10408', 'Src homology 2 (SH2) domain found in Nck'), ('cd11900', 'First Src Homology 3 domain of Nck1 adaptor protein'), ('cd11901', 'Second Src Homology 3 domain of Nck1 adaptor protein'), ('cd11904', 'Third Src Homology 3 domain of Nck1 adaptor protein'), ('G3DSA:2.30.30.40', 'SH3 Domains'), ('G3DSA:3.30.505.10', 'SH2 domain'), ('IPR000980', 'SH2 domain'), ('IPR001452', 'SH3 domain'), ('IPR017304', 'Cytoplasmic protein NCK'), ('IPR035562', 'Nck1, SH3 domain 1'), ('IPR035564', 'Nck1, SH3 domain 2'), ('IPR035565', 'Nck1, SH3 domain 3'), ('IPR035882', 'Nck1, SH2 domain'), ('IPR036028', 'SH3-like domain superfamily'), ('IPR036860', 'SH2 domain superfamily'), ('IPR051184', 'Tyrosine-phosphorylated adapter molecule'), ('PF00017', 'SH2 domain'), ('PF00018', 'SH3 domain'), ('PIRSF037874', 'Cytoplasmic protein NCK'), ('PR00401', 'SH2DOMAIN')]",P16333;,"""ENSG00000158092; Low tissue specificity."";",,,,,ENST00000288986.6 [P16333-1];ENST00000469404.1 [P16333-2];ENST00000481752.6 [P16333-1];,NCK1;LINC02237,ENSG00000158092;ENSG00000253434,0.0,NCK1,Non-canonical_RBPs,5.0,13.26,DP01114,0.133,0.257,,NCK1
P16402,ENSG00000124575,H13_HUMAN,chromosome condensation [GO:0030261]; negative regulation of DNA recombination [GO:0045910]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nucleosome assembly [GO:0006334],chromatin [GO:0000785]; euchromatin [GO:0000791]; nucleosome [GO:0000786]; nucleus [GO:0005634],chromatin DNA binding [GO:0031490]; double-stranded DNA binding [GO:0003690]; nucleosomal DNA binding [GO:0031492]; RNA binding [GO:0003723]; structural constituent of chromatin [GO:0030527],"PTM: H1 histones are progressively phosphorylated during the cell cycle, becoming maximally phosphorylated during late G2 phase and M phase, and being dephosphorylated sharply thereafter. {ECO:0000250|UniProtKB:P43275}.; PTM: Citrullination at Arg-55 (H1R54ci) by PADI4 takes place within the DNA-binding site of H1 and results in its displacement from chromatin and global chromatin decondensation, thereby promoting pluripotency and stem cell maintenance. {ECO:0000250|UniProtKB:P43277}.",DOMAIN: The C-terminal domain is required for high-affinity binding to chromatin. {ECO:0000250}.,"DOMAIN 37..110; /note=""H15""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00837""","STRAND 53..55; /evidence=""ECO:0007829|PDB:7XX5""; STRAND 95..98; /evidence=""ECO:0007829|PDB:7XX5""; STRAND 100..102; /evidence=""ECO:0007829|PDB:7XX5""; STRAND 105..107; /evidence=""ECO:0007829|PDB:7XX5""","HELIX 43..52; /evidence=""ECO:0007829|PDB:7XX5""; HELIX 59..67; /evidence=""ECO:0007829|PDB:7XX5""; HELIX 78..90; /evidence=""ECO:0007829|PDB:7XX5""",,"cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,H1-3 H1F3 HIST1H1D,Histone H1.3 (Histone H1c) (Histone H1s-2),Homo sapiens (Human),221.0,22350.0,MSETAPLAPTIPAPAEKTPVKKKAKKAGATAGKRKASGPPVSELITKAVAASKERSGVSLAALKKALAAAGYDVEKNNSRIKLGLKSLVSKGTLVQTKGTGASGSFKLNKKAASGEGKPKAKKAGAAKPRKPAGAAKKPKKVAGAATPKKSIKKTPKKVKKPATAAGTKKVAKSAKKVKTPQPKKAAKSPAKAKAPKPKAAKPKSGKPKVTKAKKAAPKKK,True,False,False,P16402,"[('cd00073', 'H15'), ('G3DSA:1.10.10.10', 'Winged helix-like DNA-binding domain superfamily/Winged helix DNA-binding domain'), ('IPR005818', 'Linker histone H1/H5, domain H15'), ('IPR005819', 'Linker histone H1/H5'), ('IPR036388', 'Winged helix-like DNA-binding domain superfamily'), ('IPR036390', 'Winged helix DNA-binding domain superfamily'), ('PF00538', 'linker histone H1 and H5 family'), ('PR00624', 'HISTONEH5'), ('PS51504', 'Linker histone H1/H5 globular (H15) domain profile'), ('SM00526', 'Domain in histone families 1 and 5'), ('SSF46785', '""Winged helix"" DNA-binding domain')]",,"""ENSG00000124575; Tissue enhanced (bone marrow, choroid plexus)."";",,,,,ENST00000244534.7;,H1-3;LINC02055,ENSG00000124575;ENSG00000254101,0.0,H1-3,Non-canonical_RBPs,12.0,,,,0.679,0.792,H1-3
P16885,ENSG00000197943,PLCG2_HUMAN,"antifungal innate immune response [GO:0061760]; B cell activation [GO:0042113]; B cell differentiation [GO:0030183]; B cell receptor signaling pathway [GO:0050853]; calcium-mediated signaling [GO:0019722]; cell activation [GO:0001775]; cellular response to calcium ion [GO:0071277]; cellular response to lectin [GO:1990858]; cellular response to lipid [GO:0071396]; Fc-epsilon receptor signaling pathway [GO:0038095]; follicular B cell differentiation [GO:0002316]; inositol trisphosphate biosynthetic process [GO:0032959]; intracellular signal transduction [GO:0035556]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; macrophage activation involved in immune response [GO:0002281]; negative regulation of programmed cell death [GO:0043069]; phosphatidylinositol biosynthetic process [GO:0006661]; phosphatidylinositol metabolic process [GO:0046488]; phosphatidylinositol-mediated signaling [GO:0048015]; phospholipid catabolic process [GO:0009395]; platelet activation [GO:0030168]; positive regulation of calcium-mediated signaling [GO:0050850]; positive regulation of cell cycle G1/S phase transition [GO:1902808]; positive regulation of dendritic cell cytokine production [GO:0002732]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of gene expression [GO:0010628]; positive regulation of I-kappaB phosphorylation [GO:1903721]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of interleukin-23 production [GO:0032747]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of macrophage cytokine production [GO:0060907]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of neuroinflammatory response [GO:0150078]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of NLRP3 inflammasome complex assembly [GO:1900227]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of phagocytosis, engulfment [GO:0060100]; positive regulation of reactive oxygen species biosynthetic process [GO:1903428]; positive regulation of receptor internalization [GO:0002092]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of type I interferon production [GO:0032481]; programmed cell death [GO:0012501]; regulation of calcineurin-NFAT signaling cascade [GO:0070884]; regulation of canonical NF-kappaB signal transduction [GO:0043122]; regulation of lipid metabolic process [GO:0019216]; release of sequestered calcium ion into cytosol [GO:0051209]; response to axon injury [GO:0048678]; response to yeast [GO:0001878]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell receptor signaling pathway [GO:0050852]; toll-like receptor signaling pathway [GO:0002224]; Wnt signaling pathway [GO:0016055]",cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intracellular vesicle [GO:0097708]; membrane raft [GO:0045121]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; ruffle membrane [GO:0032587],phosphatidylinositol phospholipase C activity [GO:0004435]; phospholipase C activity [GO:0004629]; phosphorylation-dependent protein binding [GO:0140031]; phosphotyrosine residue binding [GO:0001784]; protein kinase binding [GO:0019901]; protein tyrosine kinase binding [GO:1990782]; scaffold protein binding [GO:0097110],"PTM: Phosphorylated on tyrosine residues by CSF1R (By similarity). Phosphorylated on tyrosine residues by BTK and SYK; upon ligand-induced activation of a variety of growth factor receptors and immune system receptors. Phosphorylation leads to increased phospholipase activity. {ECO:0000250|UniProtKB:Q8CIH5, ECO:0000269|PubMed:11606584, ECO:0000269|PubMed:12181444}.",,"DOMAIN 20..131; /note=""PH""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00145""; DOMAIN 312..456; /note=""PI-PLC X-box""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00270""; DOMAIN 532..635; /note=""SH2 1""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00191""; DOMAIN 646..735; /note=""SH2 2""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00191""; DOMAIN 769..829; /note=""SH3""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00192""; DOMAIN 930..1044; /note=""PI-PLC Y-box""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00271""; DOMAIN 1038..1169; /note=""C2""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00041""","STRAND 478..485; /evidence=""ECO:0007829|PDB:2W2X""; STRAND 818..825; /evidence=""ECO:0007829|PDB:2W2X""; STRAND 828..831; /evidence=""ECO:0007829|PDB:2W2X""; STRAND 850..854; /evidence=""ECO:0007829|PDB:2W2X""; STRAND 858..862; /evidence=""ECO:0007829|PDB:2W2X""; STRAND 867..869; /evidence=""ECO:0007829|PDB:2K2J""; STRAND 870..882; /evidence=""ECO:0007829|PDB:2W2X""; STRAND 886..892; /evidence=""ECO:0007829|PDB:2W2X""","HELIX 835..840; /evidence=""ECO:0007829|PDB:2W2X""; HELIX 855..857; /evidence=""ECO:0007829|PDB:2W2X""; HELIX 893..907; /evidence=""ECO:0007829|PDB:2W2X""","TURN 815..817; /evidence=""ECO:0007829|PDB:2W2X""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,PLCG2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-2 (EC 3.1.4.11) (Phosphoinositide phospholipase C-gamma-2) (Phospholipase C-IV) (PLC-IV) (Phospholipase C-gamma-2) (PLC-gamma-2)",Homo sapiens (Human),1265.0,147870.0,MSTTVNVDSLAEYEKSQIKRALELGTVMTVFSFRKSTPERRTVQVIMETRQVAWSKTADKIEGFLDIMEIKEIRPGKNSKDFERAKAVRQKEDCCFTILYGTQFVLSTLSLAADSKEDAVNWLSGLKILHQEAMNASTPTIIESWLRKQIYSVDQTRRNSISLRELKTILPLINFKVSSAKFLKDKFVEIGAHKDELSFEQFHLFYKKLMFEQQKSILDEFKKDSSVFILGNTDRPDASAVYLHDFQRFLIHEQQEHWAQDLNKVRERMTKFIDDTMRETAEPFLFVDEFLTYLFSRENSIWDEKYDAVDMQDMNNPLSHYWISSSHNTYLTGDQLRSESSPEAYIRCLRMGCRCIELDCWDGPDGKPVIYHGWTRTTKIKFDDVVQAIKDHAFVTSSFPVILSIEEHCSVEQQRHMAKAFKEVFGDLLLTKPTEASADQLPSPSQLREKIIIKHKKLGPRGDVDVNMEDKKDEHKQQGELYMWDSIDQKWTRHYCAIADAKLSFSDDIEQTMEEEVPQDIPPTELHFGEKWFHKKVEKRTSAEKLLQEYCMETGGKDGTFLVRESETFPNDYTLSFWRSGRVQHCRIRSTMEGGTLKYYLTDNLTFSSIYALIQHYRETHLRCAEFELRLTDPVPNPNPHESKPWYYDSLSRGEAEDMLMRIPRDGAFLIRKREGSDSYAITFRARGKVKHCRINRDGRHFVLGTSAYFESLVELVSYYEKHSLYRKMRLRYPVTPELLERYNMERDINSLYDVSRMYVDPSEINPSMPQRTVKALYDYKAKRSDELSFCRGALIHNVSKEPGGWWKGDYGTRIQQYFPSNYVEDISTADFEELEKQIIEDNPLGSLCRGILDLNTYNVVKAPQGKNQKSFVFILEPKQQGDPPVEFATDRVEELFEWFQSIREITWKIDTKENNMKYWEKNQSIAIELSDLVVYCKPTSKTKDNLENPDFREIRSFVETKADSIIRQKPVDLLKYNQKGLTRVYPKGQRVDSSNYDPFRLWLCGSQMVALNFQTADKYMQMNHALFSLNGRTGYVLQPESMRTEKYDPMPPESQRKILMTLTVKVLGARHLPKLGRSIACPFVEVEICGAEYDNNKFKTTVVNDNGLSPIWAPTQEKVTFEIYDPNLAFLRFVVYEEDMFSDPNFLAHATYPIKAVKSGFRSVPLKNGYSEDIELASLLVFCEMRPVLESEEELYSSCRQLRRRQEELNNQLFLYDTHQNLRNANRDALVKEFSVNENQLQLYQEKCNKRLREKRVSNSKFYS,False,False,True,P16885,"[('cd00275', 'C2 domain present in Phosphoinositide-specific phospholipases C (PLC)'), ('cd08592', 'Catalytic domain of metazoan phosphoinositide-specific phospholipase C-gamma'), ('cd09932', 'C-terminal Src homology 2 (C-SH2) domain in Phospholipase C gamma'), ('cd10341', 'N-terminal Src homology 2 (N-SH2) domain in Phospholipase C gamma'), ('cd11969', 'Src homology 3 domain of Phospholipase C (PLC) gamma 2'), ('cd13234', 'Phospholipase C-gamma Split pleckstrin homology (PH) domain'), ('cd13362', 'Phospholipase C-gamma (PLC-gamma) pleckstrin homology (PH) domain'), ('cd16215', '1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-2'), ('G3DSA:2.30.29.30', 'Pleckstrin-homology domain (PH domain)/Phosphotyrosine-binding domain (PTB)'), ('G3DSA:2.30.30.40', 'SH3 Domains'), ('G3DSA:2.60.40.150', 'C2 domain'), ('G3DSA:3.20.20.190', 'Phosphatidylinositol (PI) phosphodiesterase'), ('G3DSA:3.30.505.10', 'SH2 domain'), ('IPR000008', 'C2 domain'), ('IPR000909', 'Phosphatidylinositol-specific phospholipase C, X domain'), ('IPR000980', 'SH2 domain'), ('IPR001192', 'Phosphoinositide phospholipase C family'), ('IPR001452', 'SH3 domain'), ('IPR001711', 'Phospholipase C, phosphatidylinositol-specific, Y domain'), ('IPR001849', 'Pleckstrin homology domain')]",,"""ENSG00000197943; Tissue enhanced (lymphoid)."";","CATALYTIC ACTIVITY: Reaction=a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-4,5-bisphosphate) + H2O = 1D-myo-inositol 1,4,5-trisphosphate + a 1,2-diacyl-sn-glycerol + H(+); Xref=Rhea:RHEA:33179, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:17815, ChEBI:CHEBI:58456, ChEBI:CHEBI:203600; EC=3.1.4.11; Evidence={ECO:0000269|PubMed:23000145}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:33180; Evidence={ECO:0000305|PubMed:23000145};",3.1.4.11,,,ENST00000564138.6;,PLCG2,ENSG00000197943;ENSG00000224644,0.0,,,,,,,0.038,,PLCG2
P17050,ENSG00000198951,NAGAB_HUMAN,carbohydrate catabolic process [GO:0016052]; glycolipid catabolic process [GO:0019377]; glycoside catabolic process [GO:0016139]; oligosaccharide metabolic process [GO:0009311],cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; lysosome [GO:0005764],alpha-galactosidase activity [GO:0004557]; alpha-N-acetylgalactosaminidase activity [GO:0008456]; protein homodimerization activity [GO:0042803],,,,"STRAND 28..32; /evidence=""ECO:0007829|PDB:4DO4""; STRAND 49..51; /evidence=""ECO:0007829|PDB:4DO4""; STRAND 74..76; /evidence=""ECO:0007829|PDB:4DO4""; STRAND 82..85; /evidence=""ECO:0007829|PDB:4DO4""; STRAND 91..93; /evidence=""ECO:0007829|PDB:4DO4""; STRAND 115..125; /evidence=""ECO:0007829|PDB:4DO4""; STRAND 152..156; /evidence=""ECO:0007829|PDB:4DO4""; STRAND 184..187; /evidence=""ECO:0007829|PDB:4DO4""; STRAND 210..213; /evidence=""ECO:0007829|PDB:4DO4""; STRAND 247..250; /evidence=""ECO:0007829|PDB:4DO4""; STRAND 258..260; /evidence=""ECO:0007829|PDB:4DO4""; STRAND 280..282; /evidence=""ECO:0007829|PDB:4DO4""; STRAND 315..319; /evidence=""ECO:0007829|PDB:4DO4""; STRAND 323..330; /evidence=""ECO:0007829|PDB:4DO4""; STRAND 336..342; /evidence=""ECO:0007829|PDB:4DO4""; STRAND 345..347; /evidence=""ECO:0007829|PDB:4DO4""; STRAND 349..354; /evidence=""ECO:0007829|PDB:4DO4""; STRAND 365..370; /evidence=""ECO:0007829|PDB:4DO4""; STRAND 376..380; /evidence=""ECO:0007829|PDB:4DO4""; STRAND 385..390; /evidence=""ECO:0007829|PDB:4DO4""; STRAND 395..403; /evidence=""ECO:0007829|PDB:4DO4""","HELIX 33..36; /evidence=""ECO:0007829|PDB:4DO4""; HELIX 52..64; /evidence=""ECO:0007829|PDB:4DO4""; HELIX 67..70; /evidence=""ECO:0007829|PDB:4DO4""; HELIX 102..111; /evidence=""ECO:0007829|PDB:4DO4""; HELIX 135..137; /evidence=""ECO:0007829|PDB:4DO4""; HELIX 138..147; /evidence=""ECO:0007829|PDB:4DO4""; HELIX 162..178; /evidence=""ECO:0007829|PDB:4DO4""; HELIX 189..192; /evidence=""ECO:0007829|PDB:4DO4""; HELIX 202..208; /evidence=""ECO:0007829|PDB:4DO4""; HELIX 222..234; /evidence=""ECO:0007829|PDB:4DO4""; HELIX 236..239; /evidence=""ECO:0007829|PDB:4DO4""; HELIX 240..242; /evidence=""ECO:0007829|PDB:4DO4""; HELIX 263..275; /evidence=""ECO:0007829|PDB:4DO4""; HELIX 291..297; /evidence=""ECO:0007829|PDB:4DO4""; HELIX 300..306; /evidence=""ECO:0007829|PDB:4DO4""; HELIX 332..334; /evidence=""ECO:0007829|PDB:4DO4""; HELIX 355..358; /evidence=""ECO:0007829|PDB:4DO4""; HELIX 405..408; /evidence=""ECO:0007829|PDB:4DO4""","TURN 42..44; /evidence=""ECO:0007829|PDB:4DO4""; TURN 46..48; /evidence=""ECO:0007829|PDB:4DO4""; TURN 95..97; /evidence=""ECO:0007829|PDB:4DO4""; TURN 197..199; /evidence=""ECO:0007829|PDB:4DO4""; TURN 286..288; /evidence=""ECO:0007829|PDB:4DO4""; TURN 371..373; /evidence=""ECO:0007829|PDB:4DO4""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,NAGA,Alpha-N-acetylgalactosaminidase (EC 3.2.1.49) (Alpha-galactosidase B),Homo sapiens (Human),411.0,46565.0,MLLKTVLLLGHVAQVLMLDNGLLQTPPMGWLAWERFRCNINCDEDPKNCISEQLFMEMADRMAQDGWRDMGYTYLNIDDCWIGGRDASGRLMPDPKRFPHGIPFLADYVHSLGLKLGIYADMGNFTCMGYPGTTLDKVVQDAQTFAEWKVDMLKLDGCFSTPEERAQGYPKMAAALNATGRPIAFSCSWPAYEGGLPPRVNYSLLADICNLWRNYDDIQDSWWSVLSILNWFVEHQDILQPVAGPGHWNDPDMLLIGNFGLSLEQSRAQMALWTVLAAPLLMSTDLRTISAQNMDILQNPLMIKINQDPLGIQGRRIHKEKSLIEVYMRPLSNKASALVFFSCRTDMPYRYHSSLGQLNFTGSVIYEAQDVYSGDIISGLRDETNFTVIINPSGVVMWYLYPIKNLEMSQQ,True,False,False,P17050,"[('cd14792', 'glycosyl hydrolase family 27 (GH27)'), ('G3DSA:2.60.40.1180', 'Golgi alpha-mannosidase II'), ('G3DSA:3.20.20.70', 'Aldolase class I'), ('IPR000111', 'Glycoside hydrolase family 27/36, conserved site'), ('IPR002241', 'Glycoside hydrolase, family 27'), ('IPR013780', 'Glycosyl hydrolase, all-beta'), ('IPR013785', 'Aldolase-type TIM barrel'), ('IPR017853', 'Glycoside hydrolase superfamily'), ('IPR035373', 'Alpha galactosidase A, C-terminal beta-sandwich domain'), ('PF16499', 'Alpha galactosidase A'), ('PF17450', 'Alpha galactosidase A C-terminal beta sandwich domain'), ('PR00740', 'GLHYDRLASE27'), ('PS00512', 'Alpha-galactosidase signature'), ('PTHR11452', 'ALPHA-GALACTOSIDASE/ALPHA-N-ACETYLGALACTOSAMINIDASE'), ('SSF51011', 'Glycosyl hydrolase domain'), ('SSF51445', '(Trans)glycosidases')]",,"""ENSG00000198951; Low tissue specificity."";","CATALYTIC ACTIVITY: Reaction=Cleavage of non-reducing alpha-(1->3)-N-acetylgalactosamine residues from human blood group A and AB mucin glycoproteins, Forssman hapten and blood group A lacto series glycolipids.; EC=3.2.1.49; Evidence={ECO:0000269|PubMed:19683538}; CATALYTIC ACTIVITY: Reaction=a neolactoside IV(3)-alpha-GalNAc,IV(2)-alpha-Fuc-nLc4Cer(d18:1(4E)) + H2O = a neolactoside IV(2)-alpha-Fuc-nLc4Cer(d18:1(4E)) + N-acetyl-alpha-D-galactosamine; Xref=Rhea:RHEA:48212, ChEBI:CHEBI:15377, ChEBI:CHEBI:28471, ChEBI:CHEBI:28691, ChEBI:CHEBI:40356; Evidence={ECO:0000269|PubMed:9741689}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:48213; Evidence={ECO:0000269|PubMed:9741689}; CATALYTIC ACTIVITY: Reaction=a neolactoside IV(3)-alpha-GalNAc,IV(2)-alpha-Fuc-nLc4Cer(d18:0) + H2O = a neolactoside IV(2)-alpha-Fuc-nLc4Cer(d18:0) + N-acetyl-alpha-D-galactosamine; Xref=Rhea:RHEA:49304, ChEBI:CHEBI:15377, ChEBI:CHEBI:40356, ChEBI:CHEBI:91118, ChEBI:CHEBI:91119; Evidence={ECO:0000269|PubMed:9741689}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:49305; Evidence={ECO:0000269|PubMed:9741689}; CATALYTIC ACTIVITY: Reaction=a globoside IV3GalNAc-Gb4Cer + H2O = N-acetyl-alpha-D-galactosamine + a globoside Gb4Cer; Xref=Rhea:RHEA:48412, ChEBI:CHEBI:15377, ChEBI:CHEBI:40356, ChEBI:CHEBI:88167, ChEBI:CHEBI:90400; Evidence={ECO:0000269|PubMed:1418679}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:48413; Evidence={ECO:0000269|PubMed:1418679};",3.2.1.49,,,ENST00000396398.8;ENST00000402937.1;ENST00000403363.5;,NAGA;FTX,ENSG00000198951;ENSG00000230590,0.0,,,,,,,0.039,,NAGA
P17931,ENSG00000131981,LEG3_HUMAN,eosinophil chemotaxis [GO:0048245]; epithelial cell differentiation [GO:0030855]; innate immune response [GO:0045087]; macrophage chemotaxis [GO:0048246]; monocyte chemotaxis [GO:0002548]; mononuclear cell migration [GO:0071674]; mRNA processing [GO:0006397]; negative regulation of endocytosis [GO:0045806]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of immunological synapse formation [GO:2000521]; negative regulation of NK T cell activation [GO:0051134]; negative regulation of protein tyrosine phosphatase activity [GO:1903614]; negative regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell [GO:2001189]; negative regulation of T cell receptor signaling pathway [GO:0050860]; neutrophil chemotaxis [GO:0030593]; positive chemotaxis [GO:0050918]; positive regulation of calcium ion import [GO:0090280]; positive regulation of mononuclear cell migration [GO:0071677]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of protein-containing complex assembly [GO:0031334]; regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902041]; regulation of T cell apoptotic process [GO:0070232]; regulation of T cell proliferation [GO:0042129]; RNA splicing [GO:0008380],cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule membrane [GO:0101003]; immunological synapse [GO:0001772]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; secretory granule membrane [GO:0030667]; spliceosomal complex [GO:0005681],carbohydrate binding [GO:0030246]; chemoattractant activity [GO:0042056]; disaccharide binding [GO:0048030]; IgE binding [GO:0019863]; laminin binding [GO:0043236]; molecular condensate scaffold activity [GO:0140693]; protein phosphatase binding [GO:0019903]; protein phosphatase inhibitor activity [GO:0004864]; receptor ligand inhibitor activity [GO:0141069]; RNA binding [GO:0003723]; signaling receptor inhibitor activity [GO:0030547],,,"DOMAIN 118..248; /note=""Galectin""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00639""","STRAND 6..8; /evidence=""ECO:0007829|PDB:6FOF""; STRAND 13..15; /evidence=""ECO:0007829|PDB:6FOF""; STRAND 116..121; /evidence=""ECO:0007829|PDB:3ZSJ""; STRAND 130..138; /evidence=""ECO:0007829|PDB:3ZSJ""; STRAND 144..151; /evidence=""ECO:0007829|PDB:3ZSJ""; STRAND 154..165; /evidence=""ECO:0007829|PDB:3ZSJ""; STRAND 168..177; /evidence=""ECO:0007829|PDB:3ZSJ""; STRAND 185..187; /evidence=""ECO:0007829|PDB:3ZSJ""; STRAND 197..204; /evidence=""ECO:0007829|PDB:3ZSJ""; STRAND 206..213; /evidence=""ECO:0007829|PDB:3ZSJ""; STRAND 216..222; /evidence=""ECO:0007829|PDB:3ZSJ""; STRAND 233..249; /evidence=""ECO:0007829|PDB:3ZSJ""","HELIX 60..62; /evidence=""ECO:0007829|PDB:6ZVF""; HELIX 228..230; /evidence=""ECO:0007829|PDB:3ZSJ""",,"cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,LGALS3 MAC2,Galectin-3 (Gal-3) (35 kDa lectin) (Carbohydrate-binding protein 35) (CBP 35) (Galactose-specific lectin 3) (Galactoside-binding protein) (GALBP) (IgE-binding protein) (L-31) (Laminin-binding protein) (Lectin L-29) (Mac-2 antigen),Homo sapiens (Human),250.0,26152.0,MADNFSLHDALSGSGNPNPQGWPGAWGNQPAGAGGYPGASYPGAYPGQAPPGAYPGQAPPGAYPGAPGAYPGAPAPGVYPGPPSGPGAYPSSGQPSATGAYPATGPYGAPAGPLIVPYNLPLPGGVVPRMLITILGTVKPNANRIALDFQRGNDVAFHFNPRFNENNRRVIVCNTKLDNNWGREERQSVFPFESGKPFKIQVLVEPDHFKVAVNDAHLLQYNHRVKKLNEISKLGISGDIDLTSASYTMI,False,False,True,P17931,"[('cd00070', 'GLECT'), ('G3DSA:2.60.120.200', None), ('IPR001079', 'Galectin, carbohydrate recognition domain'), ('IPR013320', 'Concanavalin A-like lectin/glucanase domain superfamily'), ('IPR044156', 'Galectin-like'), ('PF00337', 'Galactoside-binding lectin'), ('PS51304', 'Galactoside-binding lectin (galectin) domain profile'), ('PTHR11346', 'GALECTIN'), ('SM00276', 'Galectin'), ('SM00908', 'Galactoside-binding lectin'), ('SSF49899', 'Concanavalin A-like lectins/glucanases')]",,"""ENSG00000131981; Tissue enhanced (intestine)."";",,,,,ENST00000254301.14;,LGALS3,ENSG00000131981,0.0,LGALS3,Non-canonical_RBPs,4.0,46.0,DP01332,0.46,0.46,0.24,LGALS3
P18074,ENSG00000104884,ERCC2_HUMAN,"apoptotic process [GO:0006915]; bone mineralization [GO:0030282]; central nervous system myelin formation [GO:0032289]; chromosome segregation [GO:0007059]; determination of adult lifespan [GO:0008340]; embryonic cleavage [GO:0040016]; embryonic organ development [GO:0048568]; erythrocyte maturation [GO:0043249]; extracellular matrix organization [GO:0030198]; hair cell differentiation [GO:0035315]; hair follicle maturation [GO:0048820]; hematopoietic stem cell differentiation [GO:0060218]; hematopoietic stem cell proliferation [GO:0071425]; in utero embryonic development [GO:0001701]; insulin-like growth factor receptor signaling pathway [GO:0048009]; intrinsic apoptotic signaling pathway by p53 class mediator [GO:0072332]; maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000462]; multicellular organism growth [GO:0035264]; nucleotide-excision repair [GO:0006289]; positive regulation of mitotic recombination [GO:0045951]; post-embryonic development [GO:0009791]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of transcription by RNA polymerase II [GO:0006357]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; spinal cord development [GO:0021510]; transcription by RNA polymerase II [GO:0006366]; transcription elongation by RNA polymerase I [GO:0006362]; transcription initiation at RNA polymerase II promoter [GO:0006367]; transcription-coupled nucleotide-excision repair [GO:0006283]; UV protection [GO:0009650]",CAK-ERCC2 complex [GO:0070516]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; MMXD complex [GO:0071817]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spindle [GO:0005819]; transcription factor TFIID complex [GO:0005669]; transcription factor TFIIH core complex [GO:0000439]; transcription factor TFIIH holo complex [GO:0005675],"4 iron, 4 sulfur cluster binding [GO:0051539]; 5'-3' DNA helicase activity [GO:0043139]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; damaged DNA binding [GO:0003684]; DNA helicase activity [GO:0003678]; isomerase activity [GO:0016853]; metal ion binding [GO:0046872]; protein-macromolecule adaptor activity [GO:0030674]",PTM: ISGylated. {ECO:0000305|PubMed:16884686}.,"DOMAIN: Interacts with GTF2H2/p44 via the C-terminus of this protein; mutations in the C-terminal region of XPD do not alter its helicase activity, but prevent its interaction with and helicase stimulation by GTF2H2/p44 (PubMed:9771713). {ECO:0000269|PubMed:9771713}.","DOMAIN 7..283; /note=""Helicase ATP-binding""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00541""","STRAND 2..5; /evidence=""ECO:0007829|PDB:8EBU""; STRAND 8..11; /evidence=""ECO:0007829|PDB:8EBU""; STRAND 13..15; /evidence=""ECO:0007829|PDB:8EBU""; STRAND 38..41; /evidence=""ECO:0007829|PDB:8EBU""; STRAND 69..76; /evidence=""ECO:0007829|PDB:8EBU""; STRAND 106..108; /evidence=""ECO:0007829|PDB:8EBU""; STRAND 151..153; /evidence=""ECO:0007829|PDB:7AD8""; STRAND 203..206; /evidence=""ECO:0007829|PDB:8EBU""; STRAND 222..225; /evidence=""ECO:0007829|PDB:8EBU""; STRAND 227..234; /evidence=""ECO:0007829|PDB:8EBU""; STRAND 249..252; /evidence=""ECO:0007829|PDB:6TUN""; STRAND 323..325; /evidence=""ECO:0007829|PDB:6TUN""; STRAND 350..352; /evidence=""ECO:0007829|PDB:6TUN""; STRAND 414..421; /evidence=""ECO:0007829|PDB:6TUN""; STRAND 427..429; /evidence=""ECO:0007829|PDB:8EBU""; STRAND 432..437; /evidence=""ECO:0007829|PDB:6TUN""; STRAND 455..459; /evidence=""ECO:0007829|PDB:8EBU""; STRAND 490..495; /evidence=""ECO:0007829|PDB:8EBU""; STRAND 535..540; /evidence=""ECO:0007829|PDB:8EBU""; STRAND 565..569; /evidence=""ECO:0007829|PDB:8EBU""; STRAND 590..592; /evidence=""ECO:0007829|PDB:6RO4""; STRAND 594..599; /evidence=""ECO:0007829|PDB:8EBU""; STRAND 616..622; /evidence=""ECO:0007829|PDB:8EBU""; STRAND 670..672; /evidence=""ECO:0007829|PDB:8EBU""; STRAND 675..680; /evidence=""ECO:0007829|PDB:8EBU""; STRAND 705..708; /evidence=""ECO:0007829|PDB:8EBU""","HELIX 19..34; /evidence=""ECO:0007829|PDB:8EBU""; HELIX 48..62; /evidence=""ECO:0007829|PDB:8EBU""; HELIX 77..98; /evidence=""ECO:0007829|PDB:8EBU""; HELIX 130..137; /evidence=""ECO:0007829|PDB:8EBU""; HELIX 140..146; /evidence=""ECO:0007829|PDB:8EBU""; HELIX 157..164; /evidence=""ECO:0007829|PDB:8EBU""; HELIX 177..187; /evidence=""ECO:0007829|PDB:8EBU""; HELIX 191..198; /evidence=""ECO:0007829|PDB:8EBU""; HELIX 210..213; /evidence=""ECO:0007829|PDB:8EBU""; HELIX 215..221; /evidence=""ECO:0007829|PDB:8EBU""; HELIX 239..246; /evidence=""ECO:0007829|PDB:8EBU""; HELIX 253..276; /evidence=""ECO:0007829|PDB:6TUN""; HELIX 278..290; /evidence=""ECO:0007829|PDB:6TUN""; HELIX 326..343; /evidence=""ECO:0007829|PDB:6TUN""; HELIX 354..365; /evidence=""ECO:0007829|PDB:6TUN""; HELIX 369..373; /evidence=""ECO:0007829|PDB:6TUN""; HELIX 375..385; /evidence=""ECO:0007829|PDB:6TUN""; HELIX 392..394; /evidence=""ECO:0007829|PDB:6TUN""; HELIX 395..409; /evidence=""ECO:0007829|PDB:6TUN""; HELIX 445..448; /evidence=""ECO:0007829|PDB:8EBU""; HELIX 467..470; /evidence=""ECO:0007829|PDB:8EBU""; HELIX 508..510; /evidence=""ECO:0007829|PDB:8EBU""; HELIX 514..527; /evidence=""ECO:0007829|PDB:8EBU""; HELIX 542..554; /evidence=""ECO:0007829|PDB:8EBU""; HELIX 558..562; /evidence=""ECO:0007829|PDB:8EBU""; HELIX 574..589; /evidence=""ECO:0007829|PDB:8EBU""; HELIX 603..607; /evidence=""ECO:0007829|PDB:8EBU""; HELIX 633..643; /evidence=""ECO:0007829|PDB:8EBU""; HELIX 648..664; /evidence=""ECO:0007829|PDB:8EBU""; HELIX 665..667; /evidence=""ECO:0007829|PDB:8EBU""; HELIX 682..685; /evidence=""ECO:0007829|PDB:8EBU""; HELIX 687..690; /evidence=""ECO:0007829|PDB:8EBU""; HELIX 695..698; /evidence=""ECO:0007829|PDB:8EBU""; HELIX 710..724; /evidence=""ECO:0007829|PDB:8EBU""","TURN 64..66; /evidence=""ECO:0007829|PDB:8EBU""; TURN 112..114; /evidence=""ECO:0007829|PDB:8EBU""; TURN 119..121; /evidence=""ECO:0007829|PDB:8EBU""; TURN 127..129; /evidence=""ECO:0007829|PDB:8EBU""; TURN 147..149; /evidence=""ECO:0007829|PDB:8EBU""; TURN 165..167; /evidence=""ECO:0007829|PDB:8EBU""; TURN 410..412; /evidence=""ECO:0007829|PDB:6TUN""; TURN 440..444; /evidence=""ECO:0007829|PDB:8EBU""; TURN 464..466; /evidence=""ECO:0007829|PDB:8EBU""; TURN 528..530; /evidence=""ECO:0007829|PDB:8EBU""; TURN 555..557; /evidence=""ECO:0007829|PDB:8EBU""; TURN 630..632; /evidence=""ECO:0007829|PDB:8EBU""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,ERCC2 XPD XPDC,General transcription and DNA repair factor IIH helicase subunit XPD (TFIIH subunit XPD) (EC 5.6.2.3) (Basic transcription factor 2 80 kDa subunit) (BTF2 p80) (CXPD) (DNA 5'-3' helicase XPD) (DNA excision repair protein ERCC-2) (DNA repair protein complementing XP-D cells) (TFIIH basal transcription factor complex 80 kDa subunit) (TFIIH 80 kDa subunit) (TFIIH p80) (Xeroderma pigmentosum group D-complementing protein),Homo sapiens (Human),760.0,86909.0,MKLNVDGLLVYFPYDYIYPEQFSYMRELKRTLDAKGHGVLEMPSGTGKTVSLLALIMAYQRAYPLEVTKLIYCSRTVPEIEKVIEELRKLLNFYEKQEGEKLPFLGLALSSRKNLCIHPEVTPLRFGKDVDGKCHSLTASYVRAQYQHDTSLPHCRFYEEFDAHGREVPLPAGIYNLDDLKALGRRQGWCPYFLARYSILHANVVVYSYHYLLDPKIADLVSKELARKAVVVFDEAHNIDNVCIDSMSVNLTRRTLDRCQGNLETLQKTVLRIKETDEQRLRDEYRRLVEGLREASAARETDAHLANPVLPDEVLQEAVPGSIRTAEHFLGFLRRLLEYVKWRLRVQHVVQESPPAFLSGLAQRVCIQRKPLRFCAERLRSLLHTLEITDLADFSPLTLLANFATLVSTYAKGFTIIIEPFDDRTPTIANPILHFSCMDASLAIKPVFERFQSVIITSGTLSPLDIYPKILDFHPVTMATFTMTLARVCLCPMIIGRGNDQVAISSKFETREDIAVIRNYGNLLLEMSAVVPDGIVAFFTSYQYMESTVASWYEQGILENIQRNKLLFIETQDGAETSVALEKYQEACENGRGAILLSVARGKVSEGIDFVHHYGRAVIMFGVPYVYTQSRILKARLEYLRDQFQIRENDFLTFDAMRHAAQCVGRAIRGKTDYGLMVFADKRFARGDKRGKLPRWIQEHLTDANLNLTVDEGVQVAKYFLRQMAQPFHREDQLGLSLLSLEQLESEETLKRIEQIAQQL,True,False,False,P18074,"[('cd17969', 'DEAH-box helicase domain of TFIIH basal transcription factor complex helicase XPD subunit'), ('cd18788', 'C-terminal helicase domain of xeroderma pigmentosum group D (XPD) family DEAD-like helicases'), ('G3DSA:3.40.50.300', 'P-loop containing nucleotide triphosphate hydrolases'), ('IPR001945', 'RAD3/XPD'), ('IPR002464', 'DNA/RNA helicase, ATP-dependent, DEAH-box type, conserved site'), ('IPR006554', 'Helicase-like, DEXD box c2 type'), ('IPR006555', 'ATP-dependent helicase, C-terminal'), ('IPR010614', 'RAD3-like helicase, DEAD'), ('IPR010643', 'Helical and beta-bridge domain'), ('IPR013020', 'ATP-dependent helicase Rad3/Chl1-like'), ('IPR014013', 'Helicase superfamily 1/2, ATP-binding domain, DinG/Rad3-type'), ('IPR027417', 'P-loop containing nucleoside triphosphate hydrolase'), ('IPR045028', 'Helicase superfamily 1/2, DinG/Rad3-like'), ('PF06733', 'DEAD_2'), ('PF06777', 'Helical and beta-bridge domain'), ('PF13307', 'Helicase C-terminal domain'), ('PR00852', 'XRODRMPGMNTD'), ('PS00690', 'DEAH-box subfamily ATP-dependent helicases signature'), ('PS51193', 'Superfamilies 1 and 2 helicase ATP-binding type-2 domain profile'), ('PTHR11472', 'DNA REPAIR DEAD HELICASE RAD3/XP-D SUBFAMILY MEMBER')]",,"""ENSG00000104884; Low tissue specificity."";","CATALYTIC ACTIVITY: Reaction=Couples ATP hydrolysis with the unwinding of duplex DNA at the replication fork by translocating in the 5'-3' direction. This creates two antiparallel DNA single strands (ssDNA). The leading ssDNA polymer is the template for DNA polymerase III holoenzyme which synthesizes a continuous strand.; EC=5.6.2.3; Evidence={ECO:0000269|PubMed:31253769, ECO:0000269|PubMed:8413672}; CATALYTIC ACTIVITY: Reaction=ATP + H2O = ADP + phosphate + H(+); Xref=Rhea:RHEA:13065, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616, ChEBI:CHEBI:43474, ChEBI:CHEBI:456216; EC=5.6.2.3; Evidence={ECO:0000269|PubMed:8413672, ECO:0000269|PubMed:9771713};",5.6.2.3,"ACTIVITY REGULATION: Interaction with GTF2H2 (p44) results in stimulation of the 5'-3' helicase activity of this subunit (PubMed:9771713). DNA unwinding by this subunit in TFIIH is stimulated 4-fold by XPA and 20-fold by ERCC5/XPG (PubMed:31253769). {ECO:0000269|PubMed:31253769, ECO:0000269|PubMed:9771713}.",,ENST00000391945.10 [P18074-1];ENST00000485403.6 [P18074-2];ENST00000682414.1 [P18074-1];,ERCC2,ENSG00000104884,0.0,ERCC2,Canonical_RBPs,0.0,,,,,,ERCC2
P18124,ENSG00000147604,RL7_HUMAN,"cytoplasmic translation [GO:0002181]; maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000463]; ribosomal large subunit biogenesis [GO:0042273]; rRNA processing [GO:0006364]; translation [GO:0006412]",cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; ribonucleoprotein complex [GO:1990904],DNA binding [GO:0003677]; identical protein binding [GO:0042802]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735],,,,,,,"cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,RPL7,Large ribosomal subunit protein uL30 (60S ribosomal protein L7),Homo sapiens (Human),248.0,29226.0,MEGVEEKKKEVPAVPETLKKKRRNFAELKIKRLRKKFAQKMLRKARRKLIYEKAKHYHKEYRQMYRTEIRMARMARKAGNFYVPAEPKLAFVIRIRGINGVSPKVRKVLQLLRLRQIFNGTFVKLNKASINMLRIVEPYIAWGYPNLKSVNELIYKRGYGKINKKRIALTDNALIARSLGKYGIICMEDLIHEIYTVGKRFKEANNFLWPFKLSSPRGGMKKKTTHFVEGGDAGNREDQINRLIRRMN,True,False,False,P18124,"[('cd01657', 'Ribosomal_L7_archeal_euk'), ('G3DSA:3.30.1390.20', 'Ribosomal protein L30, ferredoxin-like fold domain'), ('IPR005998', 'Large ribosomal subunit protein uL30, eukaryotic'), ('IPR012988', 'Large ribosomal subunit protein uL30, N-terminal, eukaryotes'), ('IPR016082', 'Large ribosomal subunit protein uL30-like, ferredoxin-like fold domain'), ('IPR018038', 'Large ribosomal subunit protein uL30, conserved site'), ('IPR035808', 'Large ribosomal subunit protein uL30, eukaryotic/archaeal'), ('IPR036919', 'Large ribosomal subunit protein uL30, ferredoxin-like fold domain superfamily'), ('IPR039699', 'Large ribosomal subunit protein uL30'), ('PF00327', 'Ribosomal protein L30p/L7e'), ('PF08079', 'Ribosomal L30 N-terminal domain'), ('PS00634', 'Ribosomal protein L30 signature'), ('PTHR11524', '60S RIBOSOMAL PROTEIN L7'), ('SSF55129', 'Ribosomal protein L30p/L7e'), ('TIGR01310', '60S ribosomal protein uL30')]",,"""ENSG00000147604; Low tissue specificity."";",,,,,ENST00000352983.7;,RPL7,ENSG00000147604;ENSG00000290535,0.0,RPL7,Canonical_RBPs,30.0,,,,0.194,,RPL7
P18754,ENSG00000180198,RCC1_HUMAN,cell division [GO:0051301]; chromosome segregation [GO:0007059]; G1/S transition of mitotic cell cycle [GO:0000082]; mitotic nuclear membrane reassembly [GO:0007084]; mitotic spindle organization [GO:0007052]; regulation of mitotic nuclear division [GO:0007088]; spindle assembly [GO:0051225]; viral process [GO:0016032],chromatin [GO:0000785]; chromosome [GO:0005694]; condensed nuclear chromosome [GO:0000794]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991],chromatin binding [GO:0003682]; guanyl-nucleotide exchange factor activity [GO:0005085]; histone binding [GO:0042393]; nucleosomal DNA binding [GO:0031492]; nucleosome binding [GO:0031491]; protein heterodimerization activity [GO:0046982]; small GTPase binding [GO:0031267]; sulfate binding [GO:0043199],"PTM: N-terminal methylation by METTL11A/NTM1 is required for binding double-stranded DNA and stable chromatin association. Di- and trimethylation produce a permanent positive charge on the amino group, which facilitates electrostatic binding to the phosphate groups on DNA, while inhibiting histone-binding. Methylated tail helps retain RCC1 on chromosomes during nucleotide exchange on Ran. {ECO:0000269|PubMed:17435751, ECO:0000269|PubMed:18762580, ECO:0000269|PubMed:20668449}.",,,"STRAND 35..42; /evidence=""ECO:0007829|PDB:1A12""; STRAND 48..50; /evidence=""ECO:0007829|PDB:8UX1""; STRAND 56..63; /evidence=""ECO:0007829|PDB:1A12""; STRAND 69..74; /evidence=""ECO:0007829|PDB:1A12""; STRAND 76..83; /evidence=""ECO:0007829|PDB:1A12""; STRAND 88..92; /evidence=""ECO:0007829|PDB:1A12""; STRAND 95..97; /evidence=""ECO:0007829|PDB:8UX1""; STRAND 121..126; /evidence=""ECO:0007829|PDB:1A12""; STRAND 128..135; /evidence=""ECO:0007829|PDB:1A12""; STRAND 140..144; /evidence=""ECO:0007829|PDB:1A12""; STRAND 146..148; /evidence=""ECO:0007829|PDB:1A12""; STRAND 151..158; /evidence=""ECO:0007829|PDB:1A12""; STRAND 162..168; /evidence=""ECO:0007829|PDB:1A12""; STRAND 174..179; /evidence=""ECO:0007829|PDB:1A12""; STRAND 181..188; /evidence=""ECO:0007829|PDB:1A12""; STRAND 193..197; /evidence=""ECO:0007829|PDB:1A12""; STRAND 205..207; /evidence=""ECO:0007829|PDB:1I2M""; STRAND 212..214; /evidence=""ECO:0007829|PDB:1A12""; STRAND 242..248; /evidence=""ECO:0007829|PDB:1A12""; STRAND 251..256; /evidence=""ECO:0007829|PDB:1A12""; STRAND 261..265; /evidence=""ECO:0007829|PDB:1A12""; STRAND 280..285; /evidence=""ECO:0007829|PDB:1A12""; STRAND 292..294; /evidence=""ECO:0007829|PDB:8UX1""; STRAND 296..301; /evidence=""ECO:0007829|PDB:1A12""; STRAND 303..310; /evidence=""ECO:0007829|PDB:1A12""; STRAND 315..319; /evidence=""ECO:0007829|PDB:1A12""; STRAND 328..331; /evidence=""ECO:0007829|PDB:5TBK""; STRAND 335..340; /evidence=""ECO:0007829|PDB:1A12""; STRAND 343..352; /evidence=""ECO:0007829|PDB:1A12""; STRAND 354..361; /evidence=""ECO:0007829|PDB:1A12""; STRAND 366..370; /evidence=""ECO:0007829|PDB:1A12""; STRAND 379..381; /evidence=""ECO:0007829|PDB:1A12""; STRAND 385..390; /evidence=""ECO:0007829|PDB:1A12""; STRAND 399..406; /evidence=""ECO:0007829|PDB:1A12""; STRAND 408..417; /evidence=""ECO:0007829|PDB:1A12""","HELIX 108..110; /evidence=""ECO:0007829|PDB:1A12""; HELIX 208..210; /evidence=""ECO:0007829|PDB:1A12""; HELIX 216..219; /evidence=""ECO:0007829|PDB:1A12""; HELIX 220..224; /evidence=""ECO:0007829|PDB:1A12""; HELIX 287..289; /evidence=""ECO:0007829|PDB:1A12""; HELIX 322..324; /evidence=""ECO:0007829|PDB:1A12""","TURN 232..234; /evidence=""ECO:0007829|PDB:8UX1""; TURN 394..398; /evidence=""ECO:0007829|PDB:1A12""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,RCC1 CHC1,Regulator of chromosome condensation (Cell cycle regulatory protein) (Chromosome condensation protein 1),Homo sapiens (Human),421.0,44969.0,MSPKRIAKRRSPPADAIPKSKKVKVSHRSHSTEPGLVLTLGQGDVGQLGLGENVMERKKPALVSIPEDVVQAEAGGMHTVCLSKSGQVYSFGCNDEGALGRDTSVEGSEMVPGKVELQEKVVQVSAGDSHTAALTDDGRVFLWGSFRDNNGVIGLLEPMKKSMVPVQVQLDVPVVKVASGNDHLVMLTADGDLYTLGCGEQGQLGRVPELFANRGGRQGLERLLVPKCVMLKSRGSRGHVRFQDAFCGAYFTFAISHEGHVYGFGLSNYHQLGTPGTESCFIPQNLTSFKNSTKSWVGFSGGQHHTVCMDSEGKAYSLGRAEYGRLGLGEGAEEKSIPTLISRLPAVSSVACGASVGYAVTKDGRVFAWGMGTNYQLGTGQDEDAWSPVEMMGKQLENRVVLSVSSGGQHTVLLVKDKEQS,True,False,False,P18754,"[('G3DSA:2.130.10.30', 'Regulator of chromosome condensation 1/beta-lactamase-inhibitor protein II'), ('IPR000408', 'Regulator of chromosome condensation, RCC1'), ('IPR009091', 'Regulator of chromosome condensation 1/beta-lactamase-inhibitor protein II'), ('IPR051553', 'Ran GTPase-activating'), ('PF00415', 'Regulator of chromosome condensation (RCC1) repeat'), ('PR00633', 'RCCNDNSATION'), ('PS00625', 'Regulator of chromosome condensation (RCC1) signature 1'), ('PS00626', 'Regulator of chromosome condensation (RCC1) signature 2'), ('PS50012', 'Regulator of chromosome condensation (RCC1) repeat profile'), ('PTHR45982', 'Ran GTPase-activating'), ('SSF50985', 'RCC1/BLIP-II')]",,"""ENSG00000180198; Low tissue specificity."";",,,,,ENST00000373831.7 [P18754-2];ENST00000373832.5 [P18754-1];ENST00000373833.10 [P18754-1];ENST00000398958.6 [P18754-1];ENST00000649185.1 [P18754-2];ENST00000683442.1 [P18754-1];,RCC1,ENSG00000180198,0.0,RCC1,Non-canonical_RBPs,11.0,,,,0.059,0.086,RCC1
P19174,ENSG00000124181,PLCG1_HUMAN,calcium-mediated signaling [GO:0019722]; cell migration [GO:0016477]; cellular response to epidermal growth factor stimulus [GO:0071364]; epidermal growth factor receptor signaling pathway [GO:0007173]; Fc-epsilon receptor signaling pathway [GO:0038095]; in utero embryonic development [GO:0001701]; modulation of chemical synaptic transmission [GO:0050804]; negative regulation of inflammatory response to antigenic stimulus [GO:0002862]; phosphatidylinositol metabolic process [GO:0046488]; phosphatidylinositol-mediated signaling [GO:0048015]; phospholipid catabolic process [GO:0009395]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell apoptotic process [GO:2000353]; positive regulation of epithelial cell migration [GO:0010634]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; release of sequestered calcium ion into cytosol [GO:0051209]; T cell receptor signaling pathway [GO:0050852],cell projection [GO:0042995]; cell-cell junction [GO:0005911]; COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]; Schaffer collateral - CA1 synapse [GO:0098685],calcium ion binding [GO:0005509]; calcium-dependent phospholipase C activity [GO:0050429]; glutamate receptor binding [GO:0035254]; guanyl-nucleotide exchange factor activity [GO:0005085]; neurotrophin TRKA receptor binding [GO:0005168]; phosphatidylinositol phospholipase C activity [GO:0004435]; phospholipase C activity [GO:0004629]; protein kinase binding [GO:0019901]; receptor tyrosine kinase binding [GO:0030971],"PTM: Tyrosine phosphorylated in response to signaling via activated FLT3, KIT and PDGFRA (By similarity). Tyrosine phosphorylated by activated FGFR1, FGFR2, FGFR3 and FGFR4. Tyrosine phosphorylated by activated FLT1 and KDR. Tyrosine phosphorylated by activated PDGFRB. The receptor-mediated activation of PLCG1 involves its phosphorylation by tyrosine kinases, in response to ligation of a variety of growth factor receptors and immune system receptors. For instance, SYK phosphorylates and activates PLCG1 in response to ligation of the B-cell receptor. May be dephosphorylated by PTPRJ. Phosphorylated by ITK and TXK on Tyr-783 upon TCR activation in T-cells. {ECO:0000250, ECO:0000269|PubMed:10102632, ECO:0000269|PubMed:11564877, ECO:0000269|PubMed:1370476, ECO:0000269|PubMed:15215251, ECO:0000269|PubMed:16081816, ECO:0000269|PubMed:16844695, ECO:0000269|PubMed:17561467, ECO:0000269|PubMed:20494825, ECO:0000269|PubMed:2167438, ECO:0000269|PubMed:21765395, ECO:0000269|PubMed:8657103}.; PTM: Ubiquitinated by CBLB in activated T-cells. {ECO:0000250|UniProtKB:Q62077}.","DOMAIN: The SH3 domain mediates interaction with CLNK (By similarity). The SH3 domain also mediates interaction with RALGPS1 (PubMed:10747847). {ECO:0000250|UniProtKB:Q62077, ECO:0000269|PubMed:10747847}.","DOMAIN 27..142; /note=""PH 1""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00145""; DOMAIN 152..187; /note=""EF-hand""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00448""; DOMAIN 320..464; /note=""PI-PLC X-box""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00270""; DOMAIN 489..523; /note=""PH 2; first part""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00145""; DOMAIN 550..657; /note=""SH2 1""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00191""; DOMAIN 668..756; /note=""SH2 2""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00191""; DOMAIN 791..851; /note=""SH3""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00192""; DOMAIN 895..931; /note=""PH 2; second part""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00145""; DOMAIN 953..1070; /note=""PI-PLC Y-box""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00271""; DOMAIN 1071..1194; /note=""C2""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00041""","STRAND 551..554; /evidence=""ECO:0007829|PDB:7NXE""; STRAND 556..558; /evidence=""ECO:0007829|PDB:4EY0""; STRAND 583..587; /evidence=""ECO:0007829|PDB:7NXE""; STRAND 589..591; /evidence=""ECO:0007829|PDB:7NXE""; STRAND 595..601; /evidence=""ECO:0007829|PDB:7NXE""; STRAND 604..612; /evidence=""ECO:0007829|PDB:7NXE""; STRAND 621..624; /evidence=""ECO:0007829|PDB:7NXE""; STRAND 628..631; /evidence=""ECO:0007829|PDB:7NXE""; STRAND 644..646; /evidence=""ECO:0007829|PDB:4EY0""; STRAND 649..651; /evidence=""ECO:0007829|PDB:4EY0""; STRAND 669..672; /evidence=""ECO:0007829|PDB:7NXE""; STRAND 690..695; /evidence=""ECO:0007829|PDB:7NXE""; STRAND 701..708; /evidence=""ECO:0007829|PDB:7NXE""; STRAND 711..720; /evidence=""ECO:0007829|PDB:7NXE""; STRAND 723..726; /evidence=""ECO:0007829|PDB:7NXE""; STRAND 729..733; /evidence=""ECO:0007829|PDB:7NXE""; STRAND 792..794; /evidence=""ECO:0007829|PDB:1HSQ""; STRAND 805..809; /evidence=""ECO:0007829|PDB:1HSQ""; STRAND 817..820; /evidence=""ECO:0007829|PDB:2HSP""; STRAND 834..836; /evidence=""ECO:0007829|PDB:1HSQ""","HELIX 561..576; /evidence=""ECO:0007829|PDB:7NXE""; HELIX 615..617; /evidence=""ECO:0007829|PDB:4FBN""; HELIX 632..641; /evidence=""ECO:0007829|PDB:7NXE""; HELIX 662..665; /evidence=""ECO:0007829|PDB:7NXE""; HELIX 675..683; /evidence=""ECO:0007829|PDB:7NXE""; HELIX 734..741; /evidence=""ECO:0007829|PDB:7NXE""; HELIX 758..764; /evidence=""ECO:0007829|PDB:7NXE""","TURN 825..827; /evidence=""ECO:0007829|PDB:1HSQ""; TURN 843..845; /evidence=""ECO:0007829|PDB:1HSQ""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,PLCG1 PLC1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 (EC 3.1.4.11) (PLC-148) (Phosphoinositide phospholipase C-gamma-1) (Phospholipase C-II) (PLC-II) (Phospholipase C-gamma-1) (PLC-gamma-1)",Homo sapiens (Human),1290.0,148532.0,MAGAASPCANGCGPGAPSDAEVLHLCRSLEVGTVMTLFYSKKSQRPERKTFQVKLETRQITWSRGADKIEGAIDIREIKEIRPGKTSRDFDRYQEDPAFRPDQSHCFVILYGMEFRLKTLSLQATSEDEVNMWIKGLTWLMEDTLQAPTPLQIERWLRKQFYSVDRNREDRISAKDLKNMLSQVNYRVPNMRFLRERLTDLEQRSGDITYGQFAQLYRSLMYSAQKTMDLPFLEASTLRAGERPELCRVSLPEFQQFLLDYQGELWAVDRLQVQEFMLSFLRDPLREIEEPYFFLDEFVTFLFSKENSVWNSQLDAVCPDTMNNPLSHYWISSSHNTYLTGDQFSSESSLEAYARCLRMGCRCIELDCWDGPDGMPVIYHGHTLTTKIKFSDVLHTIKEHAFVASEYPVILSIEDHCSIAQQRNMAQYFKKVLGDTLLTKPVEISADGLPSPNQLKRKILIKHKKLAEGSAYEEVPTSMMYSENDISNSIKNGILYLEDPVNHEWYPHYFVLTSSKIYYSEETSSDQGNEDEEEPKEVSSSTELHSNEKWFHGKLGAGRDGRHIAERLLTEYCIETGAPDGSFLVRESETFVGDYTLSFWRNGKVQHCRIHSRQDAGTPKFFLTDNLVFDSLYDLITHYQQVPLRCNEFEMRLSEPVPQTNAHESKEWYHASLTRAQAEHMLMRVPRDGAFLVRKRNEPNSYAISFRAEGKIKHCRVQQEGQTVMLGNSEFDSLVDLISYYEKHPLYRKMKLRYPINEEALEKIGTAEPDYGALYEGRNPGFYVEANPMPTFKCAVKALFDYKAQREDELTFIKSAIIQNVEKQEGGWWRGDYGGKKQLWFPSNYVEEMVNPVALEPEREHLDENSPLGDLLRGVLDVPACQIAIRPEGKNNRLFVFSISMASVAHWSLDVAADSQEELQDWVKKIREVAQTADARLTEGKIMERRKKIALELSELVVYCRPVPFDEEKIGTERACYRDMSSFPETKAEKYVNKAKGKKFLQYNRLQLSRIYPKGQRLDSSNYDPLPMWICGSQLVALNFQTPDKPMQMNQALFMTGRHCGYVLQPSTMRDEAFDPFDKSSLRGLEPCAISIEVLGARHLPKNGRGIVCPFVEIEVAGAEYDSTKQKTEFVVDNGLNPVWPAKPFHFQISNPEFAFLRFVVYEEDMFSDQNFLAQATFPVKGLKTGYRAVPLKNNYSEDLELASLLIKIDIFPAKENGDLSPFSGTSLRERGSDASGQLFHGRAREGSFESRYQQPFEDFRISQEHLADHFDSRERRAPRRTRVNGDNRL,False,False,True,P19174,"[('cd00275', 'C2 domain present in Phosphoinositide-specific phospholipases C (PLC)'), ('cd08592', 'Catalytic domain of metazoan phosphoinositide-specific phospholipase C-gamma'), ('cd09932', 'C-terminal Src homology 2 (C-SH2) domain in Phospholipase C gamma'), ('cd10341', 'N-terminal Src homology 2 (N-SH2) domain in Phospholipase C gamma'), ('cd11970', 'Src homology 3 domain of Phospholipase C (PLC) gamma 1'), ('cd13234', 'Phospholipase C-gamma Split pleckstrin homology (PH) domain'), ('cd13362', 'Phospholipase C-gamma (PLC-gamma) pleckstrin homology (PH) domain'), ('cd16214', 'EF-hand motif found in phosphoinositide phospholipase C gamma 1 (PI-PLC-gamma1)'), ('G3DSA:2.30.29.30', 'Pleckstrin-homology domain (PH domain)/Phosphotyrosine-binding domain (PTB)'), ('G3DSA:2.30.30.40', 'SH3 Domains'), ('G3DSA:2.60.40.150', 'C2 domain'), ('G3DSA:3.20.20.190', 'Phosphatidylinositol (PI) phosphodiesterase'), ('G3DSA:3.30.505.10', 'SH2 domain'), ('IPR000008', 'C2 domain'), ('IPR000909', 'Phosphatidylinositol-specific phospholipase C, X domain'), ('IPR000980', 'SH2 domain'), ('IPR001192', 'Phosphoinositide phospholipase C family'), ('IPR001452', 'SH3 domain'), ('IPR001711', 'Phospholipase C, phosphatidylinositol-specific, Y domain'), ('IPR001849', 'Pleckstrin homology domain')]",,"""ENSG00000124181; Low tissue specificity."";","CATALYTIC ACTIVITY: Reaction=a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-4,5-bisphosphate) + H2O = 1D-myo-inositol 1,4,5-trisphosphate + a 1,2-diacyl-sn-glycerol + H(+); Xref=Rhea:RHEA:33179, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:17815, ChEBI:CHEBI:58456, ChEBI:CHEBI:203600; EC=3.1.4.11; Evidence={ECO:0000250|UniProtKB:P10686}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:33180; Evidence={ECO:0000250|UniProtKB:P10686}; CATALYTIC ACTIVITY: Reaction=a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol) + H2O = 1D-myo-inositol 1-phosphate + a 1,2-diacyl-sn-glycerol + H(+); Xref=Rhea:RHEA:43484, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:17815, ChEBI:CHEBI:57880, ChEBI:CHEBI:58433; Evidence={ECO:0000250|UniProtKB:P10686}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:43485; Evidence={ECO:0000250|UniProtKB:P10686};",3.1.4.11,ACTIVITY REGULATION: Activated by phosphorylation on tyrosine residues. {ECO:0000269|PubMed:1370476}.,,ENST00000244007.7 [P19174-2];ENST00000373271.5 [P19174-1];ENST00000685551.1 [P19174-2];,PLCG1,ENSG00000124181,0.0,,,,,,,0.102,0.033,PLCG1
P19338,ENSG00000115053,NUCL_HUMAN,"angiogenesis [GO:0001525]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to leukemia inhibitory factor [GO:1990830]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of translation [GO:0017148]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901838]",cell cortex [GO:0005938]; chromosome [GO:0005694]; cornified envelope [GO:0001533]; cytoplasmic ribonucleoprotein granule [GO:0036464]; extracellular exosome [GO:0070062]; macropinosome membrane [GO:0160056]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ribonucleoprotein complex [GO:1990904]; spliceosomal complex [GO:0005681],DNA topoisomerase binding [GO:0044547]; identical protein binding [GO:0042802]; insulin receptor substrate binding [GO:0043560]; mRNA 5'-UTR binding [GO:0048027]; PH domain binding [GO:0042731]; RNA binding [GO:0003723]; telomeric DNA binding [GO:0042162],PTM: Some glutamate residues are glycylated by TTLL8. This modification occurs exclusively on glutamate residues and results in a glycine chain on the gamma-carboxyl group (By similarity). {ECO:0000250}.; PTM: Symmetrically methylated by PRMT5. {ECO:0000269|PubMed:21081503}.,,"DOMAIN 307..383; /note=""RRM 1""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00176""; DOMAIN 393..466; /note=""RRM 2""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00176""; DOMAIN 486..560; /note=""RRM 3""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00176""; DOMAIN 572..647; /note=""RRM 4""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00176""","STRAND 304..306; /evidence=""ECO:0007829|PDB:2KRR""; STRAND 308..312; /evidence=""ECO:0007829|PDB:2KRR""; STRAND 316..318; /evidence=""ECO:0007829|PDB:2KRR""; STRAND 338..343; /evidence=""ECO:0007829|PDB:2KRR""; STRAND 345..356; /evidence=""ECO:0007829|PDB:2KRR""; STRAND 377..379; /evidence=""ECO:0007829|PDB:2KRR""; STRAND 394..399; /evidence=""ECO:0007829|PDB:2KRR""; STRAND 416..424; /evidence=""ECO:0007829|PDB:2KRR""; STRAND 427..435; /evidence=""ECO:0007829|PDB:2KRR""; STRAND 460..463; /evidence=""ECO:0007829|PDB:2KRR""; STRAND 486..492; /evidence=""ECO:0007829|PDB:2FC9""; STRAND 510..513; /evidence=""ECO:0007829|PDB:2FC9""; STRAND 518..520; /evidence=""ECO:0007829|PDB:2FC9""; STRAND 524..529; /evidence=""ECO:0007829|PDB:2FC9""; STRAND 544..548; /evidence=""ECO:0007829|PDB:2FC9""; STRAND 551..557; /evidence=""ECO:0007829|PDB:2FC9""; STRAND 565..568; /evidence=""ECO:0007829|PDB:2FC8""; STRAND 572..577; /evidence=""ECO:0007829|PDB:2FC8""; STRAND 596..602; /evidence=""ECO:0007829|PDB:2FC8""; STRAND 604..606; /evidence=""ECO:0007829|PDB:2FC8""; STRAND 608..616; /evidence=""ECO:0007829|PDB:2FC8""; STRAND 641..644; /evidence=""ECO:0007829|PDB:2FC8""; STRAND 650..652; /evidence=""ECO:0007829|PDB:2FC8""","HELIX 321..333; /evidence=""ECO:0007829|PDB:2KRR""; HELIX 357..365; /evidence=""ECO:0007829|PDB:2KRR""; HELIX 388..391; /evidence=""ECO:0007829|PDB:2KRR""; HELIX 406..413; /evidence=""ECO:0007829|PDB:2KRR""; HELIX 439..442; /evidence=""ECO:0007829|PDB:2KRR""; HELIX 446..449; /evidence=""ECO:0007829|PDB:2KRR""; HELIX 499..505; /evidence=""ECO:0007829|PDB:2FC9""; HELIX 533..542; /evidence=""ECO:0007829|PDB:2FC9""; HELIX 585..590; /evidence=""ECO:0007829|PDB:2FC8""; HELIX 620..630; /evidence=""ECO:0007829|PDB:2FC8""","TURN 443..445; /evidence=""ECO:0007829|PDB:2KRR""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,NCL,Nucleolin (Protein C23),Homo sapiens (Human),710.0,76614.0,MVKLAKAGKNQGDPKKMAPPPKEVEEDSEDEEMSEDEEDDSSGEEVVIPQKKGKKAAATSAKKVVVSPTKKVAVATPAKKAAVTPGKKAAATPAKKTVTPAKAVTTPGKKGATPGKALVATPGKKGAAIPAKGAKNGKNAKKEDSDEEEDDDSEEDEEDDEDEDEDEDEIEPAAMKAAAAAPASEDEDDEDDEDDEDDDDDEEDDSEEEAMETTPAKGKKAAKVVPVKAKNVAEDEDEEEDDEDEDDDDDEDDEDDDDEDDEEEEEEEEEEPVKEAPGKRKKEMAKQKAAPEAKKQKVEGTEPTTAFNLFVGNLNFNKSAPELKTGISDVFAKNDLAVVDVRIGMTRKFGYVDFESAEDLEKALELTGLKVFGNEIKLEKPKGKDSKKERDARTLLAKNLPYKVTQDELKEVFEDAAEIRLVSKDGKSKGIAYIEFKTEADAEKTFEEKQGTEIDGRSISLYYTGEKGQNQDYRGGKNSTWSGESKTLVLSNLSYSATEETLQEVFEKATFIKVPQNQNGKSKGYAFIEFASFEDAKEALNSCNKREIEGRAIRLELQGPRGSPNARSQPSKTLFVKGLSEDTTEETLKESFDGSVRARIVTDRETGSSKGFGFVDFNSEEDAKAAKEAMEDGEIDGNKVTLDWAKPKGEGGFGGRGGGRGGFGGRGGGRGGRGGFGGRGRGGFGGRGGFRGGRGGGGDHKPQGKKTKFE,True,True,False,P19338,"[('cd12403', 'RNA recognition motif 1 (RRM1) found in vertebrate nucleolin'), ('cd12404', 'RNA recognition motif 2 (RRM2) found in vertebrate nucleolin'), ('cd12405', 'RNA recognition motif 3 (RRM3) found in vertebrate nucleolin'), ('cd12406', 'RNA recognition motif 4 (RRM4) found in vertebrate nucleolin'), ('G3DSA:3.30.70.330', None), ('IPR000504', 'RNA recognition motif domain'), ('IPR003954', 'RNA recognition motif domain, eukaryotes'), ('IPR012677', 'Nucleotide-binding alpha-beta plait domain superfamily'), ('IPR034230', 'Nucleolin, RNA recognition motif 1'), ('IPR034233', 'Nucleolin, RNA recognition motif 2'), ('IPR034234', 'Nucleolin, RNA recognition motif 3'), ('IPR034235', 'Nucleolin, RNA recognition motif 4'), ('IPR035979', 'RNA-binding domain superfamily'), ('PF00076', 'RNA recognition motif'), ('PS50102', 'Eukaryotic RNA Recognition Motif (RRM) profile'), ('PTHR23236', 'Polyadenylate-binding'), ('SM00360', 'RNA recognition motif'), ('SM00361', 'RNA recognition motif'), ('SSF54928', 'RNA-binding domain, RBD')]",P19338;,"""ENSG00000115053; Low tissue specificity."";",,,,,ENST00000322723.9;,NCL,ENSG00000115053,0.0,NCL,Canonical_RBPs,37.0,,,,0.518,0.527,NCL
P19367,ENSG00000156515,HXK1_HUMAN,canonical glycolysis [GO:0061621]; carbohydrate phosphorylation [GO:0046835]; establishment of protein localization to mitochondrion [GO:0072655]; fructose 6-phosphate metabolic process [GO:0006002]; GDP-mannose biosynthetic process [GO:0009298]; GDP-mannose biosynthetic process from glucose [GO:0141199]; GDP-mannose biosynthetic process from mannose [GO:0061728]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glycolytic process [GO:0006096]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; intracellular glucose homeostasis [GO:0001678]; maintenance of protein location in mitochondrion [GO:0072656]; mannose metabolic process [GO:0006013]; positive regulation of cytokine production involved in immune response [GO:0002720]; positive regulation of interleukin-1 beta production [GO:0032731],cytosol [GO:0005829]; membrane raft [GO:0045121]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739],ATP binding [GO:0005524]; D-glucose binding [GO:0005536]; fructokinase activity [GO:0008865]; glucokinase activity [GO:0004340]; glucosamine kinase activity [GO:0047931]; hexokinase activity [GO:0004396]; mannokinase activity [GO:0019158]; peptidoglycan binding [GO:0042834],,"DOMAIN: The N- and C-terminal halves of this hexokinase contain a hexokinase domain (PubMed:10574795, PubMed:9493266, PubMed:9735292). The catalytic activity is associated with the C-terminus while regulatory function is associated with the N-terminus (PubMed:10574795, PubMed:9493266, PubMed:9735292). Each domain can bind a single D-glucose and D-glucose 6-phosphate molecule (PubMed:9493266). {ECO:0000269|PubMed:10574795, ECO:0000269|PubMed:9493266, ECO:0000269|PubMed:9735292}.","DOMAIN 16..458; /note=""Hexokinase 1""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU01084""; DOMAIN 464..906; /note=""Hexokinase 2""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU01084""","STRAND 78..100; /evidence=""ECO:0007829|PDB:1CZA""; STRAND 103..112; /evidence=""ECO:0007829|PDB:1CZA""; STRAND 120..122; /evidence=""ECO:0007829|PDB:1CZA""; STRAND 144..146; /evidence=""ECO:0007829|PDB:4FOI""; STRAND 150..154; /evidence=""ECO:0007829|PDB:1CZA""; STRAND 161..164; /evidence=""ECO:0007829|PDB:4FPB""; STRAND 203..207; /evidence=""ECO:0007829|PDB:1CZA""; STRAND 224..241; /evidence=""ECO:0007829|PDB:1CZA""; STRAND 252..258; /evidence=""ECO:0007829|PDB:1CZA""; STRAND 285..287; /evidence=""ECO:0007829|PDB:1CZA""; STRAND 404..413; /evidence=""ECO:0007829|PDB:1CZA""; STRAND 438..444; /evidence=""ECO:0007829|PDB:1CZA""; STRAND 526..546; /evidence=""ECO:0007829|PDB:1CZA""; STRAND 548..550; /evidence=""ECO:0007829|PDB:1QHA""; STRAND 552..560; /evidence=""ECO:0007829|PDB:1CZA""; STRAND 568..570; /evidence=""ECO:0007829|PDB:4F9O""; STRAND 597..602; /evidence=""ECO:0007829|PDB:1CZA""; STRAND 606..610; /evidence=""ECO:0007829|PDB:1CZA""; STRAND 613..616; /evidence=""ECO:0007829|PDB:1CZA""; STRAND 650..655; /evidence=""ECO:0007829|PDB:1CZA""; STRAND 672..689; /evidence=""ECO:0007829|PDB:1CZA""; STRAND 700..706; /evidence=""ECO:0007829|PDB:1CZA""; STRAND 852..861; /evidence=""ECO:0007829|PDB:1CZA""; STRAND 886..892; /evidence=""ECO:0007829|PDB:1CZA""","HELIX 17..25; /evidence=""ECO:0007829|PDB:1CZA""; HELIX 27..29; /evidence=""ECO:0007829|PDB:1CZA""; HELIX 33..51; /evidence=""ECO:0007829|PDB:1CZA""; HELIX 56..58; /evidence=""ECO:0007829|PDB:1CZA""; HELIX 116..119; /evidence=""ECO:0007829|PDB:1CZA""; HELIX 123..141; /evidence=""ECO:0007829|PDB:1CZA""; HELIX 185..196; /evidence=""ECO:0007829|PDB:1CZA""; HELIX 209..220; /evidence=""ECO:0007829|PDB:1CZA""; HELIX 242..244; /evidence=""ECO:0007829|PDB:1CZA""; HELIX 261..263; /evidence=""ECO:0007829|PDB:1CZA""; HELIX 276..283; /evidence=""ECO:0007829|PDB:1CZA""; HELIX 294..297; /evidence=""ECO:0007829|PDB:1CZA""; HELIX 299..315; /evidence=""ECO:0007829|PDB:1CZA""; HELIX 320..322; /evidence=""ECO:0007829|PDB:1CZA""; HELIX 336..342; /evidence=""ECO:0007829|PDB:1CZA""; HELIX 348..358; /evidence=""ECO:0007829|PDB:1CZA""; HELIX 365..401; /evidence=""ECO:0007829|PDB:1CZA""; HELIX 415..419; /evidence=""ECO:0007829|PDB:1CZA""; HELIX 423..434; /evidence=""ECO:0007829|PDB:1CZA""; HELIX 449..475; /evidence=""ECO:0007829|PDB:1CZA""; HELIX 481..499; /evidence=""ECO:0007829|PDB:1CZA""; HELIX 501..504; /evidence=""ECO:0007829|PDB:1CZA""; HELIX 564..567; /evidence=""ECO:0007829|PDB:1CZA""; HELIX 571..589; /evidence=""ECO:0007829|PDB:1CZA""; HELIX 633..644; /evidence=""ECO:0007829|PDB:1CZA""; HELIX 657..666; /evidence=""ECO:0007829|PDB:1CZA""; HELIX 709..711; /evidence=""ECO:0007829|PDB:1CZA""; HELIX 724..731; /evidence=""ECO:0007829|PDB:1CZA""; HELIX 742..744; /evidence=""ECO:0007829|PDB:1CZA""; HELIX 750..763; /evidence=""ECO:0007829|PDB:1CZA""; HELIX 768..770; /evidence=""ECO:0007829|PDB:1CZA""; HELIX 784..790; /evidence=""ECO:0007829|PDB:1CZA""; HELIX 797..807; /evidence=""ECO:0007829|PDB:1CZA""; HELIX 813..848; /evidence=""ECO:0007829|PDB:1CZA""; HELIX 863..867; /evidence=""ECO:0007829|PDB:1CZA""; HELIX 871..882; /evidence=""ECO:0007829|PDB:1CZA""; HELIX 898..912; /evidence=""ECO:0007829|PDB:1CZA""","TURN 53..55; /evidence=""ECO:0007829|PDB:1CZA""; TURN 179..182; /evidence=""ECO:0007829|PDB:4FPB""; TURN 264..273; /evidence=""ECO:0007829|PDB:1CZA""; TURN 326..329; /evidence=""ECO:0007829|PDB:1CZA""; TURN 345..347; /evidence=""ECO:0007829|PDB:1CZA""; TURN 690..692; /evidence=""ECO:0007829|PDB:1CZA""; TURN 712..715; /evidence=""ECO:0007829|PDB:1CZA""; TURN 717..721; /evidence=""ECO:0007829|PDB:1CZA""; TURN 734..737; /evidence=""ECO:0007829|PDB:1CZA""; TURN 747..749; /evidence=""ECO:0007829|PDB:1CZA""; TURN 774..777; /evidence=""ECO:0007829|PDB:1CZA""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,HK1,Hexokinase-1 (EC 2.7.1.1) (Brain form hexokinase) (Hexokinase type I) (HK I) (Hexokinase-A),Homo sapiens (Human),917.0,102486.0,MIAAQLLAYYFTELKDDQVKKIDKYLYAMRLSDETLIDIMTRFRKEMKNGLSRDFNPTATVKMLPTFVRSIPDGSEKGDFIALDLGGSSFRILRVQVNHEKNQNVHMESEVYDTPENIVHGSGSQLFDHVAECLGDFMEKRKIKDKKLPVGFTFSFPCQQSKIDEAILITWTKRFKASGVEGADVVKLLNKAIKKRGDYDANIVAVVNDTVGTMMTCGYDDQHCEVGLIIGTGTNACYMEELRHIDLVEGDEGRMCINTEWGAFGDDGSLEDIRTEFDREIDRGSLNPGKQLFEKMVSGMYLGELVRLILVKMAKEGLLFEGRITPELLTRGKFNTSDVSAIEKNKEGLHNAKEILTRLGVEPSDDDCVSVQHVCTIVSFRSANLVAATLGAILNRLRDNKGTPRLRTTVGVDGSLYKTHPQYSRRFHKTLRRLVPDSDVRFLLSESGSGKGAAMVTAVAYRLAEQHRQIEETLAHFHLTKDMLLEVKKRMRAEMELGLRKQTHNNAVVKMLPSFVRRTPDGTENGDFLALDLGGTNFRVLLVKIRSGKKRTVEMHNKIYAIPIEIMQGTGEELFDHIVSCISDFLDYMGIKGPRMPLGFTFSFPCQQTSLDAGILITWTKGFKATDCVGHDVVTLLRDAIKRREEFDLDVVAVVNDTVGTMMTCAYEEPTCEVGLIVGTGSNACYMEEMKNVEMVEGDQGQMCINMEWGAFGDNGCLDDIRTHYDRLVDEYSLNAGKQRYEKMISGMYLGEIVRNILIDFTKKGFLFRGQISETLKTRGIFETKFLSQIESDRLALLQVRAILQQLGLNSTCDDSILVKTVCGVVSRRAAQLCGAGMAAVVDKIRENRGLDRLNVTVGVDGTLYKLHPHFSRIMHQTVKELSPKCNVSFLLSEDGSGKGAALITAVGVRLRTEASS,True,False,False,P19367,"[('cd00012', 'Nucleotide-Binding Domain of the sugar kinase/HSP70/actin superfamily'), ('G3DSA:3.30.420.40', None), ('G3DSA:3.40.367.20', None), ('IPR001312', 'Hexokinase'), ('IPR019807', 'Hexokinase, binding site'), ('IPR022672', 'Hexokinase, N-terminal'), ('IPR022673', 'Hexokinase, C-terminal'), ('IPR043129', 'ATPase, nucleotide binding domain'), ('PF00349', 'Hexokinase'), ('PF03727', 'Hexokinase'), ('PR00475', 'HEXOKINASE'), ('PS00378', 'Hexokinase domain signature'), ('PS51748', 'Hexokinase domain profile'), ('PTHR19443', 'HEXOKINASE'), ('SSF53067', 'Actin-like ATPase domain')]",,"""ENSG00000156515; Low tissue specificity."";","CATALYTIC ACTIVITY: Reaction=a D-hexose + ATP = a D-hexose 6-phosphate + ADP + H(+); Xref=Rhea:RHEA:22740, ChEBI:CHEBI:4194, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616, ChEBI:CHEBI:229467, ChEBI:CHEBI:456216; EC=2.7.1.1; Evidence={ECO:0000269|PubMed:1637300, ECO:0000269|PubMed:27374331}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:22741; Evidence={ECO:0000269|PubMed:1637300, ECO:0000269|PubMed:27374331}; CATALYTIC ACTIVITY: Reaction=D-fructose + ATP = D-fructose 6-phosphate + ADP + H(+); Xref=Rhea:RHEA:16125, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616, ChEBI:CHEBI:37721, ChEBI:CHEBI:61527, ChEBI:CHEBI:456216; EC=2.7.1.1; Evidence={ECO:0000250|UniProtKB:P05708}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:16126; Evidence={ECO:0000250|UniProtKB:P05708}; CATALYTIC ACTIVITY: Reaction=D-glucose + ATP = D-glucose 6-phosphate + ADP + H(+); Xref=Rhea:RHEA:17825, ChEBI:CHEBI:4167, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616, ChEBI:CHEBI:61548, ChEBI:CHEBI:456216; EC=2.7.1.1; Evidence={ECO:0000250|UniProtKB:P05708}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:17826; Evidence={ECO:0000250|UniProtKB:P05708}; CATALYTIC ACTIVITY: Reaction=D-mannose + ATP = D-mannose 6-phosphate + ADP + H(+); Xref=Rhea:RHEA:11028, ChEBI:CHEBI:4208, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616, ChEBI:CHEBI:58735, ChEBI:CHEBI:456216; EC=2.7.1.1; Evidence={ECO:0000250|UniProtKB:P05708}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:11029; Evidence={ECO:0000250|UniProtKB:P05708}; CATALYTIC ACTIVITY: Reaction=D-glucosamine + ATP = D-glucosamine 6-phosphate + ADP + H(+); Xref=Rhea:RHEA:10948, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616, ChEBI:CHEBI:58723, ChEBI:CHEBI:58725, ChEBI:CHEBI:456216; EC=2.7.1.1; Evidence={ECO:0000269|PubMed:27374331}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:10949; Evidence={ECO:0000269|PubMed:27374331};",2.7.1.1,"ACTIVITY REGULATION: Hexokinase is an allosteric enzyme inhibited by its product D-glucose 6-phosphate (PubMed:1637300). Hexokinase activity is inhibited by N-acetyl-D-glucosamine (PubMed:27374331). {ECO:0000269|PubMed:1637300, ECO:0000269|PubMed:27374331}.","PATHWAY: Carbohydrate metabolism; hexose metabolism. {ECO:0000305|PubMed:1637300, ECO:0000305|PubMed:27374331}.; PATHWAY: Carbohydrate degradation; glycolysis; D-glyceraldehyde 3-phosphate and glycerone phosphate from D-glucose: step 1/4. {ECO:0000250|UniProtKB:P05708}.",ENST00000298649.8 [P19367-2];ENST00000359426.7 [P19367-1];ENST00000436817.6 [P19367-3];ENST00000643399.2 [P19367-3];,HK1;SNHG10,ENSG00000156515;ENSG00000247092,0.0,,,,,,,0.01,,HK1
P19447,ENSG00000163161,ERCC3_HUMAN,"apoptotic process [GO:0006915]; DNA repair [GO:0006281]; DNA topological change [GO:0006265]; embryonic organ development [GO:0048568]; hair cell differentiation [GO:0035315]; nucleotide-excision repair [GO:0006289]; nucleotide-excision repair, DNA duplex unwinding [GO:0000717]; positive regulation of apoptotic process [GO:0043065]; protein localization [GO:0008104]; regulation of mitotic cell cycle phase transition [GO:1901990]; response to hypoxia [GO:0001666]; response to oxidative stress [GO:0006979]; response to UV [GO:0009411]; transcription by RNA polymerase II [GO:0006366]; transcription elongation by RNA polymerase II [GO:0006368]; transcription initiation at RNA polymerase II promoter [GO:0006367]; transcription-coupled nucleotide-excision repair [GO:0006283]; UV protection [GO:0009650]",nucleoplasm [GO:0005654]; nucleotide-excision repair factor 3 complex [GO:0000112]; nucleus [GO:0005634]; transcription factor TFIID complex [GO:0005669]; transcription factor TFIIH core complex [GO:0000439]; transcription factor TFIIH holo complex [GO:0005675]; transcription preinitiation complex [GO:0097550],3'-5' DNA helicase activity [GO:0043138]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; isomerase activity [GO:0016853]; promoter-specific chromatin binding [GO:1990841],PTM: Phosphorylation on Ser-751 by CK2 controls the 5'-excision activity of ERCC1-XPF endonuclease; phosphorylated protein inhibits the excision activity and thus NER (PubMed:15549133). Dephosphorylation reactivates the 5'-excision step (PubMed:15549133). Phosphorylation has no effect on transcription or the 3'-5' helicase activity (PubMed:15549133). {ECO:0000269|PubMed:15549133}.,,"DOMAIN 327..488; /note=""Helicase ATP-binding""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00541""; DOMAIN 542..702; /note=""Helicase C-terminal""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00542""","STRAND 55..60; /evidence=""ECO:0007829|PDB:8EBU""; STRAND 76..78; /evidence=""ECO:0007829|PDB:7NVV""; STRAND 82..87; /evidence=""ECO:0007829|PDB:7NVV""; STRAND 104..108; /evidence=""ECO:0007829|PDB:7NVV""; STRAND 111..117; /evidence=""ECO:0007829|PDB:7NVV""; STRAND 144..146; /evidence=""ECO:0007829|PDB:7NVV""; STRAND 163..171; /evidence=""ECO:0007829|PDB:7NVV""; STRAND 174..180; /evidence=""ECO:0007829|PDB:7NVV""; STRAND 267..272; /evidence=""ECO:0007829|PDB:7NVV""; STRAND 301..303; /evidence=""ECO:0007829|PDB:8EBU""; STRAND 329..334; /evidence=""ECO:0007829|PDB:7NVV""; STRAND 336..339; /evidence=""ECO:0007829|PDB:7NVV""; STRAND 342..344; /evidence=""ECO:0007829|PDB:8EBU""; STRAND 361..367; /evidence=""ECO:0007829|PDB:7NVV""; STRAND 389..392; /evidence=""ECO:0007829|PDB:7NVV""; STRAND 393..395; /evidence=""ECO:0007829|PDB:6RO4""; STRAND 404..409; /evidence=""ECO:0007829|PDB:7NVV""; STRAND 434..442; /evidence=""ECO:0007829|PDB:7NVV""; STRAND 458..461; /evidence=""ECO:0007829|PDB:7NVV""; STRAND 463..468; /evidence=""ECO:0007829|PDB:7NVV""; STRAND 473..475; /evidence=""ECO:0007829|PDB:7NVV""; STRAND 486..490; /evidence=""ECO:0007829|PDB:7NVV""; STRAND 505..512; /evidence=""ECO:0007829|PDB:4ERN""; STRAND 558..561; /evidence=""ECO:0007829|PDB:4ERN""; STRAND 582..584; /evidence=""ECO:0007829|PDB:8EBU""; STRAND 604..607; /evidence=""ECO:0007829|PDB:4ERN""; STRAND 620..626; /evidence=""ECO:0007829|PDB:4ERN""; STRAND 629..631; /evidence=""ECO:0007829|PDB:7AD8""; STRAND 651..654; /evidence=""ECO:0007829|PDB:4ERN""; STRAND 656..664; /evidence=""ECO:0007829|PDB:4ERN""; STRAND 686..692; /evidence=""ECO:0007829|PDB:4ERN""","HELIX 93..103; /evidence=""ECO:0007829|PDB:7NVV""; HELIX 120..129; /evidence=""ECO:0007829|PDB:7NVV""; HELIX 133..143; /evidence=""ECO:0007829|PDB:7NVV""; HELIX 150..158; /evidence=""ECO:0007829|PDB:7NVV""; HELIX 182..190; /evidence=""ECO:0007829|PDB:7NVV""; HELIX 192..196; /evidence=""ECO:0007829|PDB:7NVV""; HELIX 200..202; /evidence=""ECO:0007829|PDB:8EBU""; HELIX 274..276; /evidence=""ECO:0007829|PDB:7NVV""; HELIX 277..286; /evidence=""ECO:0007829|PDB:7NVV""; HELIX 297..299; /evidence=""ECO:0007829|PDB:7NVV""; HELIX 318..327; /evidence=""ECO:0007829|PDB:7NVV""; HELIX 346..357; /evidence=""ECO:0007829|PDB:7NVV""; HELIX 368..381; /evidence=""ECO:0007829|PDB:7NVV""; HELIX 410..414; /evidence=""ECO:0007829|PDB:7NVV""; HELIX 421..431; /evidence=""ECO:0007829|PDB:7NVV""; HELIX 443..445; /evidence=""ECO:0007829|PDB:7NVV""; HELIX 453..457; /evidence=""ECO:0007829|PDB:7NVV""; HELIX 477..479; /evidence=""ECO:0007829|PDB:7NVV""; HELIX 480..483; /evidence=""ECO:0007829|PDB:7NVV""; HELIX 493..498; /evidence=""ECO:0007829|PDB:7NVV""; HELIX 516..524; /evidence=""ECO:0007829|PDB:4ERN""; HELIX 528..530; /evidence=""ECO:0007829|PDB:4ERN""; HELIX 531..536; /evidence=""ECO:0007829|PDB:4ERN""; HELIX 538..552; /evidence=""ECO:0007829|PDB:4ERN""; HELIX 565..574; /evidence=""ECO:0007829|PDB:4ERN""; HELIX 586..598; /evidence=""ECO:0007829|PDB:4ERN""; HELIX 609..611; /evidence=""ECO:0007829|PDB:4ERN""; HELIX 633..643; /evidence=""ECO:0007829|PDB:4ERN""; HELIX 668..670; /evidence=""ECO:0007829|PDB:4ERN""; HELIX 671..682; /evidence=""ECO:0007829|PDB:4ERN""; HELIX 696..698; /evidence=""ECO:0007829|PDB:4ERN""; HELIX 706..718; /evidence=""ECO:0007829|PDB:4ERN""; HELIX 721..724; /evidence=""ECO:0007829|PDB:4ERN""","TURN 62..64; /evidence=""ECO:0007829|PDB:7NVV""; TURN 69..73; /evidence=""ECO:0007829|PDB:7NVV""; TURN 159..162; /evidence=""ECO:0007829|PDB:7NVV""; TURN 386..388; /evidence=""ECO:0007829|PDB:7NVV""; TURN 449..452; /evidence=""ECO:0007829|PDB:7NVV""; TURN 553..555; /evidence=""ECO:0007829|PDB:4ERN""; TURN 612..614; /evidence=""ECO:0007829|PDB:4ERN""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,ERCC3 XPB XPBC,General transcription and DNA repair factor IIH helicase/translocase subunit XPB (TFIIH subunit XPB) (EC 5.6.2.4) (Basic transcription factor 2 89 kDa subunit) (BTF2 p89) (DNA 3'-5' helicase/translocase XPB) (DNA excision repair protein ERCC-3) (DNA repair protein complementing XP-B cells) (TFIIH basal transcription factor complex 89 kDa subunit) (TFIIH 89 kDa subunit) (TFIIH p89) (Xeroderma pigmentosum group B-complementing protein),Homo sapiens (Human),782.0,89278.0,MGKRDRADRDKKKSRKRHYEDEEDDEEDAPGNDPQEAVPSAAGKQVDESGTKVDEYGAKDYRLQMPLKDDHTSRPLWVAPDGHIFLEAFSPVYKYAQDFLVAIAEPVCRPTHVHEYKLTAYSLYAAVSVGLQTSDITEYLRKLSKTGVPDGIMQFIKLCTVSYGKVKLVLKHNRYFVESCHPDVIQHLLQDPVIRECRLRNSEGEATELITETFTSKSAISKTAESSGGPSTSRVTDPQGKSDIPMDLFDFYEQMDKDEEEEEETQTVSFEVKQEMIEELQKRCIHLEYPLLAEYDFRNDSVNPDINIDLKPTAVLRPYQEKSLRKMFGNGRARSGVIVLPCGAGKSLVGVTAACTVRKRCLVLGNSAVSVEQWKAQFKMWSTIDDSQICRFTSDAKDKPIGCSVAISTYSMLGHTTKRSWEAERVMEWLKTQEWGLMILDEVHTIPAKMFRRVLTIVQAHCKLGLTATLVREDDKIVDLNFLIGPKLYEANWMELQNNGYIAKVQCAEVWCPMSPEFYREYVAIKTKKRILLYTMNPNKFRACQFLIKFHERRNDKIIVFADNVFALKEYAIRLNKPYIYGPTSQGERMQILQNFKHNPKINTIFISKVGDTSFDLPEANVLIQISSHGGSRRQEAQRLGRVLRAKKGMVAEEYNAFFYSLVSQDTQEMAYSTKRQRFLVDQGYSFKVITKLAGMEEEDLAFSTKEEQQQLLQKVLAATDLDAEEEVVAGEFGSRSSQASRRFGTMSSMSGADDTVYMEYHSSRSKAPSKHVHPLFKRFRK,False,True,False,P19447,"[('cd18029', 'DEXH-box helicase domain of TFIIH XPB subunit and similar proteins'), ('cd18789', 'C-terminal helicase domain of XPB-like helicases'), ('G3DSA:3.40.50.300', 'P-loop containing nucleotide triphosphate hydrolases'), ('IPR001161', 'Helicase XPB/Ssl2'), ('IPR001650', 'Helicase, C-terminal domain-like'), ('IPR006935', 'Helicase/UvrB, N-terminal'), ('IPR014001', 'Helicase superfamily 1/2, ATP-binding domain'), ('IPR027417', 'P-loop containing nucleoside triphosphate hydrolase'), ('IPR032438', 'ERCC3/RAD25/XPB helicase, C-terminal domain'), ('IPR032830', 'Helicase XPB/Ssl2, N-terminal domain'), ('IPR050615', 'ATP-dependent DNA Helicase'), ('PF04851', 'Type III restriction enzyme, res subunit'), ('PF13625', 'Helicase conserved C-terminal domain'), ('PF16203', 'ERCC3/RAD25/XPB C-terminal helicase'), ('PR00851', 'XRODRMPGMNTB'), ('PS51192', 'Superfamilies 1 and 2 helicase ATP-binding type-1 domain profile'), ('PS51194', 'Superfamilies 1 and 2 helicase C-terminal domain profile'), ('PTHR11274', 'ATP-dependent DNA Helicase'), ('SM00487', 'DEAD-like helicases superfamily'), ('SM00490', 'helicase superfamily c-terminal domain')]",,"""ENSG00000163161; Low tissue specificity."";","CATALYTIC ACTIVITY: Reaction=Couples ATP hydrolysis with the unwinding of duplex DNA by translocating in the 3'-5' direction.; EC=5.6.2.4; Evidence={ECO:0000269|PubMed:8663148, ECO:0000305|PubMed:8465201}; CATALYTIC ACTIVITY: Reaction=ATP + H2O = ADP + phosphate + H(+); Xref=Rhea:RHEA:13065, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616, ChEBI:CHEBI:43474, ChEBI:CHEBI:456216; EC=5.6.2.4; Evidence={ECO:0000269|PubMed:17466626, ECO:0000269|PubMed:8663148, ECO:0000305|PubMed:8465201};",5.6.2.4,"ACTIVITY REGULATION: Phosphorylation on Ser-751 by CK2 controls the 5'-excision activity of ERCC1-XPF endonuclease; phosphorylated protein inhibits the excision activity and thus NER (PubMed:15549133). ATPase activity is stimulated by TFIIH subunit p52 (GTF2H4) (PubMed:17466626). DNA translocase activity by this subunit in TFIIH is stimulated by XPA, ERCC5/XPG and XFP plus ERCC1; translocase activity is sensitive to triptolide which targets this enzyme (PubMed:31253769). {ECO:0000269|PubMed:15549133, ECO:0000269|PubMed:17466626, ECO:0000269|PubMed:31253769}.",,ENST00000285398.7;,ERCC3,ENSG00000163161,0.0,ERCC3,Canonical_RBPs,5.0,,,,0.16,0.096,ERCC3
P19544,ENSG00000184937,WT1_HUMAN,adrenal cortex formation [GO:0035802]; adrenal gland development [GO:0030325]; branching involved in ureteric bud morphogenesis [GO:0001658]; camera-type eye development [GO:0043010]; cardiac muscle cell fate commitment [GO:0060923]; cellular response to cAMP [GO:0071320]; cellular response to gonadotropin stimulus [GO:0071371]; diaphragm development [GO:0060539]; epithelial cell differentiation [GO:0030855]; germ cell development [GO:0007281]; glomerular basement membrane development [GO:0032836]; glomerulus development [GO:0032835]; gonad development [GO:0008406]; heart development [GO:0007507]; kidney development [GO:0001822]; male genitalia development [GO:0030539]; male gonad development [GO:0008584]; mesenchymal to epithelial transition [GO:0060231]; metanephric epithelium development [GO:0072207]; metanephric mesenchyme development [GO:0072075]; metanephric S-shaped body morphogenesis [GO:0072284]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of female gonad development [GO:2000195]; negative regulation of gene expression via chromosomal CpG island methylation [GO:0044027]; negative regulation of metanephric glomerular mesangial cell proliferation [GO:0072302]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translation [GO:0017148]; podocyte differentiation [GO:0072112]; positive regulation of apoptotic process [GO:0043065]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of gene expression [GO:0010628]; positive regulation of heart growth [GO:0060421]; positive regulation of male gonad development [GO:2000020]; positive regulation of metanephric ureteric bud development [GO:2001076]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of transcription by RNA polymerase II [GO:0045944]; posterior mesonephric tubule development [GO:0072166]; regulation of animal organ formation [GO:0003156]; regulation of DNA-templated transcription [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; RNA splicing [GO:0008380]; sex determination [GO:0007530]; thorax and anterior abdomen determination [GO:0007356]; tissue development [GO:0009888]; ureteric bud development [GO:0001657]; vasculogenesis [GO:0001570]; visceral serous pericardium development [GO:0061032],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],"C2H2 zinc finger domain binding [GO:0070742]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; double-stranded methylated DNA binding [GO:0010385]; hemi-methylated DNA-binding [GO:0044729]; RNA binding [GO:0003723]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; transcription cis-regulatory region binding [GO:0000976]; zinc ion binding [GO:0008270]",,"DOMAIN: Binds to DNA motifs with the sequence 5'-GCG(T/G)GGGCG-3' via its C2H2-type zinc fingers. Starting from the N-terminus, the second zinc finger binds to the 3'-GCG motif, the middle zinc finger interacts with the central TGG motif, and the C-terminal zinc finger binds to the 5'-GCG motif. Binds double-stranded target DNA, irrespective of the cytosine methylation status. Has reduced affinity for target DNA where the cytosines have been oxidized to 5-hydroxymethylcytosine, 5-formylcytosine or 5-carboxylcytosine. {ECO:0000269|PubMed:25258363}.; DOMAIN: The 9aaTAD motif is a transactivation domain present in a large number of yeast and animal transcription factors. {ECO:0000269|PubMed:31375868}.",,"STRAND 322..324; /evidence=""ECO:0007829|PDB:6B0Q""; STRAND 333..336; /evidence=""ECO:0007829|PDB:6B0O""; STRAND 352..354; /evidence=""ECO:0007829|PDB:6WLH""; STRAND 357..359; /evidence=""ECO:0007829|PDB:6B0R""; STRAND 363..366; /evidence=""ECO:0007829|PDB:5KL3""; STRAND 391..393; /evidence=""ECO:0007829|PDB:5KL3""; STRAND 418..420; /evidence=""ECO:0007829|PDB:6BLW""; STRAND 424..427; /evidence=""ECO:0007829|PDB:5KL3""","HELIX 337..348; /evidence=""ECO:0007829|PDB:6B0O""; HELIX 367..378; /evidence=""ECO:0007829|PDB:5KL3""; HELIX 395..401; /evidence=""ECO:0007829|PDB:5KL3""; HELIX 403..406; /evidence=""ECO:0007829|PDB:5KL3""; HELIX 428..438; /evidence=""ECO:0007829|PDB:5KL3""","TURN 328..330; /evidence=""ECO:0007829|PDB:6B0R""; TURN 386..388; /evidence=""ECO:0007829|PDB:5KL3""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,WT1,Wilms tumor protein (WT33),Homo sapiens (Human),449.0,49188.0,MGSDVRDLNALLPAVPSLGGGGGCALPVSGAAQWAPVLDFAPPGASAYGSLGGPAPPPAPPPPPPPPPHSFIKQEPSWGGAEPHEEQCLSAFTVHFSGQFTGTAGACRYGPFGPPPPSQASSGQARMFPNAPYLPSCLESQPAIRNQGYSTVTFDGTPSYGHTPSHHAAQFPNHSFKHEDPMGQQGSLGEQQYSVPPPVYGCHTPTDSCTGSQALLLRTPYSSDNLYQMTSQLECMTWNQMNLGATLKGVAAGSSSSVKWTEGQSNHSTGYESDNHTTPILCGAQYRIHTHGVFRGIQDVRRVPGVAPTLVRSASETSEKRPFMCAYPGCNKRYFKLSHLQMHSRKHTGEKPYQCDFKDCERRFSRSDQLKRHQRRHTGVKPFQCKTCQRKFSRSDHLKTHTRTHTGKTSEKPFSCRWPSCQKKFARSDELVRHHNMHQRNMTKLQLAL,False,True,False,P19544,"[('G3DSA:3.30.160.60', 'Classic Zinc Finger'), ('IPR000976', ""Wilm's tumour protein, N-terminal""), ('IPR013087', 'Zinc finger C2H2-type'), ('IPR036236', 'Zinc finger C2H2 superfamily'), ('PF00096', 'Zinc finger, C2H2 type'), ('PF02165', ""Wilm's tumour protein""), ('PR00049', 'WILMSTUMOUR'), ('PS00028', 'Zinc finger C2H2 type domain signature'), ('PS50157', 'Zinc finger C2H2 type domain profile'), ('PS51257', 'Prokaryotic membrane lipoprotein lipid attachment site profile'), ('PTHR23235', 'KRUEPPEL-LIKE TRANSCRIPTION FACTOR'), ('SM00355', 'zinc finger'), ('SSF57667', 'beta-beta-alpha zinc fingers')]",,"""ENSG00000184937; Tissue enhanced (endometrium, fallopian tube, ovary)."";",,,,,ENST00000379079.8 [P19544-6];ENST00000452863.10 [P19544-7];ENST00000530998.5 [P19544-9];ENST00000639563.3 [P19544-8];,WT1,ENSG00000184937,0.0,WT1,Canonical_RBPs,0.0,,,,0.728,0.082,WT1
P19793,ENSG00000186350,RXRA_HUMAN,cell differentiation [GO:0030154]; hormone-mediated signaling pathway [GO:0009755]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of transcription by RNA polymerase II [GO:0000122]; peroxisome proliferator activated receptor signaling pathway [GO:0035357]; positive regulation of bone mineralization [GO:0030501]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of thyroid hormone receptor signaling pathway [GO:0002157]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transporter activity [GO:0032411]; positive regulation of vitamin D receptor signaling pathway [GO:0070564]; response to retinoic acid [GO:0032526]; retinoic acid receptor signaling pathway [GO:0048384],chromatin [GO:0000785]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; receptor complex [GO:0043235]; RNA polymerase II transcription regulator complex [GO:0090575]; transcription regulator complex [GO:0005667],"DNA binding domain binding [GO:0050692]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; double-stranded DNA binding [GO:0003690]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; LBD domain binding [GO:0050693]; nuclear receptor activity [GO:0004879]; nuclear steroid receptor activity [GO:0003707]; nuclear vitamin D receptor binding [GO:0042809]; peptide binding [GO:0042277]; retinoic acid binding [GO:0001972]; retinoic acid-responsive element binding [GO:0044323]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription cis-regulatory region binding [GO:0000976]; transcription coregulator binding [GO:0001221]; zinc ion binding [GO:0008270]","PTM: Acetylated by EP300; acetylation enhances DNA binding and transcriptional activity. {ECO:0000269|PubMed:17761950}.; PTM: Phosphorylated on serine and threonine residues mainly in the N-terminal modulating domain (By similarity). Constitutively phosphorylated on Ser-21 in the presence or absence of ligand (By similarity). Under stress conditions, hyperphosphorylated by activated JNK on Ser-56, Ser-70, Thr-82 and Ser-260 (By similarity). Phosphorylated on Ser-27, in vitro, by PKA (PubMed:11162439). This phosphorylation is required for repression of cAMP-mediated transcriptional activity of RARA (PubMed:11162439). {ECO:0000250|UniProtKB:P28700, ECO:0000269|PubMed:11162439}.; PTM: Ubiquitinated by UBR5, leading to its degradation: UBR5 specifically recognizes and binds ligand-bound RXRA when it is not associated with coactivators (NCOAs) (PubMed:37478846). In presence of NCOAs, the UBR5-degron is not accessible, preventing its ubiquitination and degradation (PubMed:37478846). {ECO:0000269|PubMed:37478846}.; PTM: Sumoylation negatively regulates transcriptional activity. Desumoylated specifically by SENP6. {ECO:0000269|PubMed:16912044}.","DOMAIN: Composed of three domains: a modulating N-terminal domain (AF1 domain), a DNA-binding domain and a C-terminal ligand-binding domain (AF2 domain).","DOMAIN 227..458; /note=""NR LBD""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU01189""","STRAND 131..134; /evidence=""ECO:0007829|PDB:4CN5""; STRAND 141..146; /evidence=""ECO:0007829|PDB:6FBQ""; STRAND 149..151; /evidence=""ECO:0007829|PDB:6FBQ""; STRAND 172..175; /evidence=""ECO:0007829|PDB:2NLL""; STRAND 258..261; /evidence=""ECO:0007829|PDB:1XVP""; STRAND 321..325; /evidence=""ECO:0007829|PDB:6LB4""; STRAND 329..333; /evidence=""ECO:0007829|PDB:6LB4""; STRAND 380..382; /evidence=""ECO:0007829|PDB:3DZU""; STRAND 444..447; /evidence=""ECO:0007829|PDB:4ZO1""","HELIX 153..164; /evidence=""ECO:0007829|PDB:6FBQ""; HELIX 188..198; /evidence=""ECO:0007829|PDB:6FBQ""; HELIX 202..204; /evidence=""ECO:0007829|PDB:6FBQ""; HELIX 226..229; /evidence=""ECO:0007829|PDB:7A77""; HELIX 232..242; /evidence=""ECO:0007829|PDB:6LB4""; HELIX 246..250; /evidence=""ECO:0007829|PDB:1MZN""; HELIX 264..284; /evidence=""ECO:0007829|PDB:6LB4""; HELIX 289..291; /evidence=""ECO:0007829|PDB:6LB4""; HELIX 294..316; /evidence=""ECO:0007829|PDB:6LB4""; HELIX 317..319; /evidence=""ECO:0007829|PDB:6LB4""; HELIX 334..339; /evidence=""ECO:0007829|PDB:6LB4""; HELIX 343..352; /evidence=""ECO:0007829|PDB:6LB4""; HELIX 354..360; /evidence=""ECO:0007829|PDB:6LB4""; HELIX 364..375; /evidence=""ECO:0007829|PDB:6LB4""; HELIX 386..407; /evidence=""ECO:0007829|PDB:6LB4""; HELIX 414..419; /evidence=""ECO:0007829|PDB:6LB4""; HELIX 422..442; /evidence=""ECO:0007829|PDB:6LB4""; HELIX 449..454; /evidence=""ECO:0007829|PDB:6LB4""; HELIX 457..459; /evidence=""ECO:0007829|PDB:3NSQ""","TURN 136..138; /evidence=""ECO:0007829|PDB:6FBQ""; TURN 181..185; /evidence=""ECO:0007829|PDB:6FBQ""; TURN 251..253; /evidence=""ECO:0007829|PDB:1FM9""; TURN 340..342; /evidence=""ECO:0007829|PDB:3UVV""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,RXRA NR2B1,Retinoic acid receptor RXR-alpha (Nuclear receptor subfamily 2 group B member 1) (Retinoid X receptor alpha),Homo sapiens (Human),462.0,50811.0,MDTKHFLPLDFSTQVNSSLTSPTGRGSMAAPSLHPSLGPGIGSPGQLHSPISTLSSPINGMGPPFSVISSPMGPHSMSVPTTPTLGFSTGSPQLSSPMNPVSSSEDIKPPLGLNGVLKVPAHPSGNMASFTKHICAICGDRSSGKHYGVYSCEGCKGFFKRTVRKDLTYTCRDNKDCLIDKRQRNRCQYCRYQKCLAMGMKREAVQEERQRGKDRNENEVESTSSANEDMPVERILEAELAVEPKTETYVEANMGLNPSSPNDPVTNICQAADKQLFTLVEWAKRIPHFSELPLDDQVILLRAGWNELLIASFSHRSIAVKDGILLATGLHVHRNSAHSAGVGAIFDRVLTELVSKMRDMQMDKTELGCLRAIVLFNPDSKGLSNPAEVEALREKVYASLEAYCKHKYPEQPGRFAKLLLRLPALRSIGLKCLEHLFFFKLIGDTPIDTFLMEMLEAPHQMT,False,False,True,P19793,"[('cd06943', 'The ligand binding domain of the retinoid X receptor and Ultraspiracle, members of nuclear receptor superfamily'), ('cd06956', 'DNA-binding domain of retinoid X receptor (RXR) is composed of two C4-type zinc fingers'), ('G3DSA:1.10.565.10', 'Retinoid X Receptor'), ('G3DSA:3.30.50.10', 'Erythroid Transcription Factor GATA-1, subunit A'), ('IPR000003', 'Retinoid X receptor/HNF4'), ('IPR000536', 'Nuclear hormone receptor, ligand-binding domain'), ('IPR001628', 'Zinc finger, nuclear hormone receptor-type'), ('IPR001723', 'Nuclear hormone receptor'), ('IPR013088', 'Zinc finger, NHR/GATA-type'), ('IPR021780', 'Nuclear/hormone receptor activator site AF-1'), ('IPR035500', 'Nuclear hormone receptor-like domain superfamily'), ('IPR050274', 'Nuclear hormone receptor family NR2 subfamily'), ('PF00104', 'Ligand-binding domain of nuclear hormone receptor'), ('PF00105', 'Double treble clef zinc finger, C4 type'), ('PF11825', 'Nuclear/hormone receptor activator site AF-1'), ('PR00047', 'STROIDFINGER'), ('PR00398', 'STRDHORMONER'), ('PR00545', 'Retinoid X receptor'), ('PS00031', 'Nuclear hormones receptors DNA-binding region signature'), ('PS51030', 'Nuclear hormone receptors DNA-binding domain profile')]",P19793;,"""ENSG00000186350; Tissue enhanced (skeletal)."";",,,,,ENST00000481739.2 [P19793-1];,RXRA;UBL7-DT,ENSG00000186350;ENSG00000247240,0.0,,,,32.68,DP00062,0.519,0.331,0.281,RXRA
P19971,ENSG00000025708,TYPH_HUMAN,angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; chemotaxis [GO:0006935]; dTMP catabolic process [GO:0046074]; mitochondrial genome maintenance [GO:0000002]; pyrimidine nucleobase metabolic process [GO:0006206]; pyrimidine nucleoside metabolic process [GO:0006213]; regulation of gastric motility [GO:1905333]; regulation of myelination [GO:0031641]; regulation of transmission of nerve impulse [GO:0051969],cytosol [GO:0005829],"1,4-alpha-oligoglucan phosphorylase activity [GO:0004645]; growth factor activity [GO:0008083]; protein homodimerization activity [GO:0042803]; thymidine phosphorylase activity [GO:0009032]",,,,"STRAND 112..118; /evidence=""ECO:0007829|PDB:1UOU""; STRAND 139..143; /evidence=""ECO:0007829|PDB:1UOU""; STRAND 181..185; /evidence=""ECO:0007829|PDB:1UOU""; STRAND 189..192; /evidence=""ECO:0007829|PDB:1UOU""; STRAND 228..236; /evidence=""ECO:0007829|PDB:1UOU""; STRAND 240..244; /evidence=""ECO:0007829|PDB:2J0F""; STRAND 266..272; /evidence=""ECO:0007829|PDB:1UOU""; STRAND 280..283; /evidence=""ECO:0007829|PDB:1UOU""; STRAND 319..322; /evidence=""ECO:0007829|PDB:2J0F""; STRAND 376..382; /evidence=""ECO:0007829|PDB:1UOU""; STRAND 387..392; /evidence=""ECO:0007829|PDB:1UOU""; STRAND 409..412; /evidence=""ECO:0007829|PDB:2WK5""; STRAND 420..423; /evidence=""ECO:0007829|PDB:1UOU""; STRAND 436..446; /evidence=""ECO:0007829|PDB:1UOU""; STRAND 459..464; /evidence=""ECO:0007829|PDB:1UOU""; STRAND 475..477; /evidence=""ECO:0007829|PDB:1UOU""","HELIX 36..44; /evidence=""ECO:0007829|PDB:1UOU""; HELIX 51..63; /evidence=""ECO:0007829|PDB:1UOU""; HELIX 68..81; /evidence=""ECO:0007829|PDB:1UOU""; HELIX 85..96; /evidence=""ECO:0007829|PDB:1UOU""; HELIX 106..111; /evidence=""ECO:0007829|PDB:1UOU""; HELIX 125..134; /evidence=""ECO:0007829|PDB:1UOU""; HELIX 154..158; /evidence=""ECO:0007829|PDB:1UOU""; HELIX 170..180; /evidence=""ECO:0007829|PDB:1UOU""; HELIX 193..204; /evidence=""ECO:0007829|PDB:1UOU""; HELIX 211..224; /evidence=""ECO:0007829|PDB:1UOU""; HELIX 245..261; /evidence=""ECO:0007829|PDB:1UOU""; HELIX 284..294; /evidence=""ECO:0007829|PDB:1UOU""; HELIX 300..316; /evidence=""ECO:0007829|PDB:1UOU""; HELIX 323..335; /evidence=""ECO:0007829|PDB:1UOU""; HELIX 338..349; /evidence=""ECO:0007829|PDB:1UOU""; HELIX 354..362; /evidence=""ECO:0007829|PDB:1UOU""; HELIX 365..371; /evidence=""ECO:0007829|PDB:1UOU""; HELIX 394..405; /evidence=""ECO:0007829|PDB:1UOU""; HELIX 449..458; /evidence=""ECO:0007829|PDB:1UOU""","TURN 135..137; /evidence=""ECO:0007829|PDB:1UOU""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,TYMP ECGF1,Thymidine phosphorylase (TP) (EC 2.4.2.4) (Gliostatin) (Platelet-derived endothelial cell growth factor) (PD-ECGF) (TdRPase),Homo sapiens (Human),482.0,49955.0,MAALMTPGTGAPPAPGDFSGEGSQGLPDPSPEPKQLPELIRMKRDGGRLSEADIRGFVAAVVNGSAQGAQIGAMLMAIRLRGMDLEETSVLTQALAQSGQQLEWPEAWRQQLVDKHSTGGVGDKVSLVLAPALAACGCKVPMISGRGLGHTGGTLDKLESIPGFNVIQSPEQMQVLLDQAGCCIVGQSEQLVPADGILYAARDVTATVDSLPLITASILSKKLVEGLSALVVDVKFGGAAVFPNQEQARELAKTLVGVGASLGLRVAAALTAMDKPLGRCVGHALEVEEALLCMDGAGPPDLRDLVTTLGGALLWLSGHAGTQAQGAARVAAALDDGSALGRFERMLAAQGVDPGLARALCSGSPAERRQLLPRAREQEELLAPADGTVELVRALPLALVLHELGAGRSRAGEPLRLGVGAELLVDVGQRLRRGTPWLRVHRDGPALSGPQSRALQEALVLSDRAPFAAPSPFAELVLPPQQ,True,True,True,P19971,"[('G3DSA:1.20.970.10', 'Transferase, Pyrimidine Nucleoside Phosphorylase; Chain C'), ('G3DSA:3.40.1030.10', 'Nucleoside phosphorylase/phosphoribosyltransferase catalytic domain'), ('G3DSA:3.90.1170.30', 'Pyrimidine nucleoside phosphorylase-like, C-terminal domain'), ('IPR000053', 'Thymidine/pyrimidine-nucleoside phosphorylase'), ('IPR000312', 'Glycosyl transferase, family 3'), ('IPR013102', 'Pyrimidine nucleoside phosphorylase, C-terminal'), ('IPR017459', 'Glycosyl transferase family 3, N-terminal domain'), ('IPR017872', 'Pyrimidine-nucleoside phosphorylase, conserved site'), ('IPR018090', 'Pyrimidine-nucleoside phosphorylase, bacterial/eukaryotic'), ('IPR035902', 'Nucleoside phosphorylase/phosphoribosyltransferase catalytic domain superfamily'), ('IPR036320', 'Glycosyl transferase family 3, N-terminal domain superfamily'), ('IPR036566', 'Pyrimidine nucleoside phosphorylase-like, C-terminal domain superfamily'), ('PF00591', 'Glycosyl transferase family, a/b domain'), ('PF02885', 'Glycosyl transferase family, helical bundle domain'), ('PF07831', 'Pyrimidine nucleoside phosphorylase C-terminal domain'), ('PIRSF000478', 'Thymidine phosphorylase/pyrimidine-nucleoside phosphorylase'), ('PS00647', 'Thymidine and pyrimidine-nucleoside phosphorylases signature'), ('PTHR10515', 'THYMIDINE PHOSPHORYLASE'), ('SM00941', 'Pyrimidine nucleoside phosphorylase C-terminal domain'), ('SSF47648', 'Nucleoside phosphorylase/phosphoribosyltransferase N-terminal domain')]",,"""ENSG00000025708; Low tissue specificity."";","CATALYTIC ACTIVITY: Reaction=thymidine + phosphate = 2-deoxy-alpha-D-ribose 1-phosphate + thymine; Xref=Rhea:RHEA:16037, ChEBI:CHEBI:17748, ChEBI:CHEBI:17821, ChEBI:CHEBI:43474, ChEBI:CHEBI:57259; EC=2.4.2.4; Evidence={ECO:0000269|PubMed:1590793}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:16038; Evidence={ECO:0000305|PubMed:1590793};",2.4.2.4,,PATHWAY: Pyrimidine metabolism; dTMP biosynthesis via salvage pathway; dTMP from thymine: step 1/2. {ECO:0000269|PubMed:1590793}.,ENST00000252029.8 [P19971-1];ENST00000395678.7 [P19971-1];ENST00000395680.6 [P19971-1];ENST00000395681.6 [P19971-2];ENST00000487577.5 [P19971-1];,TYMP;LINC02189,ENSG00000025708;ENSG00000260026,0.0,,,,,,,0.073,0.075,TYMP
P20338,ENSG00000168118,RAB4A_HUMAN,antigen processing and presentation [GO:0019882]; neurotransmitter receptor transport postsynaptic membrane to endosome [GO:0098968]; Rab protein signal transduction [GO:0032482]; regulation of endocytosis [GO:0030100]; vesicle-mediated transport [GO:0016192]; vesicle-mediated transport in synapse [GO:0099003],cytoplasmic vesicle membrane [GO:0030659]; early endosome membrane [GO:0031901]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; insulin-responsive compartment [GO:0032593]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic recycling endosome [GO:0098837]; recycling endosome membrane [GO:0055038]; vesicle [GO:0031982],G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924],"PTM: Phosphorylated by CDK1 kinase during mitosis. {ECO:0000269|PubMed:1425574, ECO:0000269|PubMed:1902553}.; PTM: Serotonylation of Gln-72 by TGM2 during activation and aggregation of platelets leads to constitutive activation of GTPase activity. {ECO:0000250|UniProtKB:P56371}.",,,"STRAND 11..21; /evidence=""ECO:0007829|PDB:2BME""; STRAND 46..57; /evidence=""ECO:0007829|PDB:2BME""; STRAND 60..69; /evidence=""ECO:0007829|PDB:2BME""; STRAND 87..94; /evidence=""ECO:0007829|PDB:2BME""; STRAND 120..126; /evidence=""ECO:0007829|PDB:2BME""; STRAND 151..154; /evidence=""ECO:0007829|PDB:2BME""","HELIX 26..35; /evidence=""ECO:0007829|PDB:2BME""; HELIX 73..75; /evidence=""ECO:0007829|PDB:2BME""; HELIX 76..80; /evidence=""ECO:0007829|PDB:2BME""; HELIX 98..102; /evidence=""ECO:0007829|PDB:2BME""; HELIX 104..114; /evidence=""ECO:0007829|PDB:2BME""; HELIX 128..133; /evidence=""ECO:0007829|PDB:2BME""; HELIX 138..147; /evidence=""ECO:0007829|PDB:2BME""; HELIX 163..179; /evidence=""ECO:0007829|PDB:2BME""","TURN 157..159; /evidence=""ECO:0007829|PDB:2BME""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,RAB4A RAB4,Ras-related protein Rab-4A (EC 3.6.5.2),Homo sapiens (Human),218.0,24390.0,MSQTAMSETYDFLFKFLVIGNAGTGKSCLLHQFIEKKFKDDSNHTIGVEFGSKIINVGGKYVKLQIWDTAGQERFRSVTRSYYRGAAGALLVYDITSRETYNALTNWLTDARMLASQNIVIILCGNKKDLDADREVTFLEASRFAQENELMFLETSALTGENVEEAFVQCARKILNKIESGELDPERMGSGIQYGDAALRQLRSPRRAQAPNAQECGC,False,False,True,P20338,"[('cd04113', 'Rab GTPase family 4 (Rab4)'), ('G3DSA:3.40.50.300', 'P-loop containing nucleotide triphosphate hydrolases'), ('IPR001806', 'Small GTPase'), ('IPR005225', 'Small GTP-binding domain'), ('IPR027417', 'P-loop containing nucleoside triphosphate hydrolase'), ('IPR041819', 'Rab4'), ('IPR050209', 'Rab GTPases family involved in membrane trafficking'), ('PF00071', 'Ras family'), ('PR00449', 'RASTRNSFRMNG'), ('PS51419', 'small GTPase Rab1 family profile'), ('PS51421', 'small GTPase Ras family profile'), ('PTHR47979', 'Rab GTPases family involved in membrane trafficking'), ('SM00173', 'Ras subfamily of RAS small GTPases'), ('SM00174', 'Rho (Ras homology) subfamily of Ras-like small GTPases'), ('SM00175', 'Rab subfamily of small GTPases'), ('SM00176', 'Ran (Ras-related nuclear proteins) /TC4 subfamily of small GTPases'), ('SM00177', 'ARF-like small GTPases; ARF, ADP-ribosylation factor'), ('SSF52540', 'P-loop containing nucleoside triphosphate hydrolases'), ('TIGR00231', 'small GTP-binding protein domain')]",,"""ENSG00000168118; Low tissue specificity."";","CATALYTIC ACTIVITY: Reaction=GTP + H2O = GDP + phosphate + H(+); Xref=Rhea:RHEA:19669, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:37565, ChEBI:CHEBI:43474, ChEBI:CHEBI:58189; EC=3.6.5.2; Evidence={ECO:0000269|PubMed:15907487, ECO:0000269|PubMed:16034420}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:19670; Evidence={ECO:0000269|PubMed:15907487, ECO:0000269|PubMed:16034420};",3.6.5.2,,,ENST00000366690.5;,RAB4A;LINC01482,ENSG00000168118;ENSG00000267659,0.0,,,,,,,0.078,,RAB4A
P21266,ENSG00000134202,GSTM3_HUMAN,cellular detoxification of nitrogen compound [GO:0070458]; establishment of blood-nerve barrier [GO:0008065]; glutathione metabolic process [GO:0006749]; nitrobenzene metabolic process [GO:0018916]; response to estrogen [GO:0043627]; xenobiotic catabolic process [GO:0042178],cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; intercellular bridge [GO:0045171]; nucleus [GO:0005634]; sperm fibrous sheath [GO:0035686],enzyme binding [GO:0019899]; glutathione binding [GO:0043295]; glutathione transferase activity [GO:0004364]; identical protein binding [GO:0042802]; protein homodimerization activity [GO:0042803],PTM: The N-terminus is blocked.,,"DOMAIN 5..92; /note=""GST N-terminal""; DOMAIN 94..212; /note=""GST C-terminal""","STRAND 7..15; /evidence=""ECO:0007829|PDB:3GTU""; STRAND 32..37; /evidence=""ECO:0007829|PDB:3GTU""; STRAND 42..44; /evidence=""ECO:0007829|PDB:3GTU""; STRAND 64..69; /evidence=""ECO:0007829|PDB:3GTU""; STRAND 72..76; /evidence=""ECO:0007829|PDB:3GTU""; STRAND 154..156; /evidence=""ECO:0007829|PDB:3GTU""; STRAND 211..213; /evidence=""ECO:0007829|PDB:3GTU""; STRAND 217..220; /evidence=""ECO:0007829|PDB:3GTU""","HELIX 16..18; /evidence=""ECO:0007829|PDB:3GTU""; HELIX 19..27; /evidence=""ECO:0007829|PDB:3GTU""; HELIX 48..54; /evidence=""ECO:0007829|PDB:3GTU""; HELIX 77..87; /evidence=""ECO:0007829|PDB:3GTU""; HELIX 95..120; /evidence=""ECO:0007829|PDB:3GTU""; HELIX 124..146; /evidence=""ECO:0007829|PDB:3GTU""; HELIX 159..174; /evidence=""ECO:0007829|PDB:3GTU""; HELIX 176..179; /evidence=""ECO:0007829|PDB:3GTU""; HELIX 183..193; /evidence=""ECO:0007829|PDB:3GTU""; HELIX 196..203; /evidence=""ECO:0007829|PDB:3GTU""; HELIX 205..208; /evidence=""ECO:0007829|PDB:3GTU""",,"cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,GSTM3 GST5,Glutathione S-transferase Mu 3 (EC 2.5.1.18) (GST class-mu 3) (GSTM3-3) (hGSTM3-3),Homo sapiens (Human),225.0,26560.0,MSCESSMVLGYWDIRGLAHAIRLLLEFTDTSYEEKRYTCGEAPDYDRSQWLDVKFKLDLDFPNLPYLLDGKNKITQSNAILRYIARKHNMCGETEEEKIRVDIIENQVMDFRTQLIRLCYSSDHEKLKPQYLEELPGQLKQFSMFLGKFSWFAGEKLTFVDFLTYDILDQNRIFDPKCLDEFPNLKAFMCRFEALEKIAAYLQSDQFCKMPINNKMAQWGNKPVC,False,True,False,P21266,"[('cd03075', 'GST_N_Mu'), ('cd03209', 'C-terminal, alpha helical domain of Class Mu Glutathione S-transferases'), ('G3DSA:1.20.1050.10', None), ('G3DSA:3.40.30.10', 'Glutaredoxin'), ('IPR003081', 'Glutathione S-transferase, Mu class'), ('IPR004045', 'Glutathione S-transferase, N-terminal'), ('IPR004046', 'Glutathione S-transferase, C-terminal'), ('IPR010987', 'Glutathione S-transferase, C-terminal-like'), ('IPR036249', 'Thioredoxin-like superfamily'), ('IPR036282', 'Glutathione S-transferase, C-terminal domain superfamily'), ('IPR040079', 'Glutathione transferase family'), ('IPR050213', 'Glutathione S-transferase superfamily'), ('PF00043', 'Glutathione S-transferase, C-terminal domain'), ('PF02798', 'Glutathione S-transferase, N-terminal domain'), ('PR01267', 'GSTRNSFRASEM'), ('PS50404', 'Soluble glutathione S-transferase N-terminal domain profile'), ('PS50405', 'Soluble glutathione S-transferase C-terminal domain profile'), ('PTHR11571', 'Glutathione S-transferase superfamily'), ('SFLDG01205', 'AMPS.1'), ('SFLDS00019', 'Glutathione Transferase (cytosolic)')]",,"""ENSG00000134202; Tissue enhanced (choroid)."";","CATALYTIC ACTIVITY: Reaction=RX + glutathione = an S-substituted glutathione + a halide anion + H(+); Xref=Rhea:RHEA:16437, ChEBI:CHEBI:15378, ChEBI:CHEBI:16042, ChEBI:CHEBI:17792, ChEBI:CHEBI:57925, ChEBI:CHEBI:90779; EC=2.5.1.18; Evidence={ECO:0000269|PubMed:10587441};",2.5.1.18,,,ENST00000256594.7;ENST00000361066.7;,GSTM3,ENSG00000134202,0.0,,,,,,,,,GSTM3
P21333,ENSG00000196924,FLNA_HUMAN,"actin crosslink formation [GO:0051764]; actin cytoskeleton organization [GO:0030036]; adenylate cyclase-inhibiting dopamine receptor signaling pathway [GO:0007195]; angiogenesis [GO:0001525]; blood coagulation, intrinsic pathway [GO:0007597]; blood vessel remodeling [GO:0001974]; cell-cell junction organization [GO:0045216]; cerebral cortex development [GO:0021987]; cilium assembly [GO:0060271]; cytoplasmic sequestering of protein [GO:0051220]; early endosome to late endosome transport [GO:0045022]; epithelial to mesenchymal transition [GO:0001837]; establishment of protein localization [GO:0045184]; establishment of Sertoli cell barrier [GO:0097368]; formation of radial glial scaffolds [GO:0021943]; heart morphogenesis [GO:0003007]; megakaryocyte development [GO:0035855]; mitotic spindle assembly [GO:0090307]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of neuron projection development [GO:0010977]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transcription by RNA polymerase I [GO:0016479]; platelet aggregation [GO:0070527]; positive regulation of actin filament bundle assembly [GO:0032233]; positive regulation of axon regeneration [GO:0048680]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of integrin-mediated signaling pathway [GO:2001046]; positive regulation of neural precursor cell proliferation [GO:2000179]; positive regulation of neuron migration [GO:2001224]; positive regulation of platelet activation [GO:0010572]; positive regulation of potassium ion transmembrane transport [GO:1901381]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein localization to bicellular tight junction [GO:1902396]; protein localization to cell surface [GO:0034394]; protein localization to plasma membrane [GO:0072659]; protein stabilization [GO:0050821]; receptor clustering [GO:0043113]; regulation of cell migration [GO:0030334]; regulation of membrane repolarization during atrial cardiac muscle cell action potential [GO:1905000]; regulation of membrane repolarization during cardiac muscle cell action potential [GO:1905031]; release of sequestered calcium ion into cytosol [GO:0051209]; semaphorin-plexin signaling pathway [GO:0071526]; synapse organization [GO:0050808]; tubulin deacetylation [GO:0090042]; wound healing, spreading of cells [GO:0044319]",actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; actin filament bundle [GO:0032432]; apical dendrite [GO:0097440]; axonal growth cone [GO:0044295]; brush border [GO:0005903]; cell-cell junction [GO:0005911]; cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic shaft [GO:0043198]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; glycoprotein Ib-IX-V complex [GO:1990779]; membrane [GO:0016020]; Myb complex [GO:0031523]; nucleolus [GO:0005730]; nucleus [GO:0005634]; perikaryon [GO:0043204]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; podosome [GO:0002102]; postsynapse [GO:0098794]; trans-Golgi network [GO:0005802]; Z disc [GO:0030018],actin filament binding [GO:0051015]; cadherin binding [GO:0045296]; DNA-binding transcription factor binding [GO:0140297]; Fc-gamma receptor I complex binding [GO:0034988]; G protein-coupled receptor binding [GO:0001664]; GTPase binding [GO:0051020]; kinase binding [GO:0019900]; potassium channel regulator activity [GO:0015459]; protein homodimerization activity [GO:0042803]; protein kinase C binding [GO:0005080]; RNA binding [GO:0003723]; SMAD binding [GO:0046332]; small GTPase binding [GO:0031267]; transmembrane transporter binding [GO:0044325],"PTM: Phosphorylation at Ser-2152 is negatively regulated by the autoinhibited conformation of filamin repeats 19-21. Ligand binding induces a conformational switch triggering phosphorylation at Ser-2152 by PKA. {ECO:0000269|PubMed:25666618}.; PTM: Phosphorylation extent changes in response to cell activation.; PTM: Polyubiquitination in the CH1 domain by a SCF-like complex containing ASB2 leads to proteasomal degradation. Prior dissociation from actin may be required to expose the target lysines (PubMed:24052262). Ubiquitinated in endothelial cells by RNF213 downstream of the non-canonical Wnt signaling pathway, leading to its degradation by the proteasome (PubMed:26766444). {ECO:0000269|PubMed:24052262, ECO:0000269|PubMed:26766444}.","DOMAIN: Comprised of a NH2-terminal actin-binding domain, 24 immunoglobulin-like internally homologous repeats and two hinge regions. Repeat 24 and the second hinge domain are important for dimer formation. Filamin repeat 20 interacts with filamin repeat 21 masking the ligand binding site on filamin repeat 21, resulting in an autoinhibited conformation (PubMed:17690686). The autoinhibition can be relieved by ligands like ITGB7 or FBLIM1 (PubMed:21524097). Filamin repeats 19 and 21 can simultaneously engage ligands (PubMed:21524097). {ECO:0000269|PubMed:17690686, ECO:0000269|PubMed:21524097}.","DOMAIN 43..149; /note=""Calponin-homology (CH) 1""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00044""; DOMAIN 166..269; /note=""Calponin-homology (CH) 2""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00044""","STRAND 157..159; /evidence=""ECO:0007829|PDB:3HOP""; STRAND 181..183; /evidence=""ECO:0007829|PDB:3HOR""; STRAND 193..195; /evidence=""ECO:0007829|PDB:3HOR""; STRAND 484..487; /evidence=""ECO:0007829|PDB:4M9P""; STRAND 501..506; /evidence=""ECO:0007829|PDB:4M9P""; STRAND 515..521; /evidence=""ECO:0007829|PDB:4M9P""; STRAND 529..534; /evidence=""ECO:0007829|PDB:4M9P""; STRAND 537..542; /evidence=""ECO:0007829|PDB:4M9P""; STRAND 548..556; /evidence=""ECO:0007829|PDB:4M9P""; STRAND 565..571; /evidence=""ECO:0007829|PDB:4M9P""; STRAND 579..583; /evidence=""ECO:0007829|PDB:4M9P""; STRAND 588..590; /evidence=""ECO:0007829|PDB:4M9P""; STRAND 595..604; /evidence=""ECO:0007829|PDB:4M9P""; STRAND 609..617; /evidence=""ECO:0007829|PDB:4M9P""; STRAND 620..625; /evidence=""ECO:0007829|PDB:4M9P""; STRAND 627..636; /evidence=""ECO:0007829|PDB:4M9P""; STRAND 639..649; /evidence=""ECO:0007829|PDB:4M9P""; STRAND 658..664; /evidence=""ECO:0007829|PDB:4M9P""; STRAND 676..679; /evidence=""ECO:0007829|PDB:4M9P""; STRAND 683..685; /evidence=""ECO:0007829|PDB:4M9P""; STRAND 693..698; /evidence=""ECO:0007829|PDB:4M9P""; STRAND 707..712; /evidence=""ECO:0007829|PDB:4M9P""; STRAND 714..716; /evidence=""ECO:0007829|PDB:4M9P""; STRAND 721..725; /evidence=""ECO:0007829|PDB:4M9P""; STRAND 727..735; /evidence=""ECO:0007829|PDB:4M9P""; STRAND 739..749; /evidence=""ECO:0007829|PDB:4M9P""; STRAND 758..762; /evidence=""ECO:0007829|PDB:4M9P""; STRAND 1164..1167; /evidence=""ECO:0007829|PDB:3RGH""; STRAND 1172..1174; /evidence=""ECO:0007829|PDB:3RGH""; STRAND 1179..1184; /evidence=""ECO:0007829|PDB:3RGH""; STRAND 1193..1198; /evidence=""ECO:0007829|PDB:3RGH""; STRAND 1206..1211; /evidence=""ECO:0007829|PDB:3RGH""; STRAND 1213..1222; /evidence=""ECO:0007829|PDB:3RGH""; STRAND 1225..1235; /evidence=""ECO:0007829|PDB:3RGH""; STRAND 1244..1250; /evidence=""ECO:0007829|PDB:3RGH""; STRAND 1791..1796; /evidence=""ECO:0007829|PDB:2K7P""; STRAND 1804..1809; /evidence=""ECO:0007829|PDB:2K7P""; STRAND 1819..1822; /evidence=""ECO:0007829|PDB:2K7P""; STRAND 1824..1832; /evidence=""ECO:0007829|PDB:2K7P""; STRAND 1838..1846; /evidence=""ECO:0007829|PDB:2K7P""; STRAND 1855..1860; /evidence=""ECO:0007829|PDB:2K7P""; STRAND 1865..1867; /evidence=""ECO:0007829|PDB:2K7P""; STRAND 1869..1872; /evidence=""ECO:0007829|PDB:2BP3""; STRAND 1877..1879; /evidence=""ECO:0007829|PDB:2BP3""; STRAND 1884..1889; /evidence=""ECO:0007829|PDB:2BP3""; STRAND 1895..1906; /evidence=""ECO:0007829|PDB:2BP3""; STRAND 1909..1914; /evidence=""ECO:0007829|PDB:2BP3""; STRAND 1916..1925; /evidence=""ECO:0007829|PDB:2BP3""; STRAND 1930..1938; /evidence=""ECO:0007829|PDB:2BP3""; STRAND 1947..1953; /evidence=""ECO:0007829|PDB:2BP3""; STRAND 1959..1967; /evidence=""ECO:0007829|PDB:2K7Q""; STRAND 1980..1988; /evidence=""ECO:0007829|PDB:2K7Q""; STRAND 1998..2001; /evidence=""ECO:0007829|PDB:2K7Q""; STRAND 2007..2010; /evidence=""ECO:0007829|PDB:2K7Q""; STRAND 2014..2025; /evidence=""ECO:0007829|PDB:2K7Q""; STRAND 2034..2039; /evidence=""ECO:0007829|PDB:2K7Q""; STRAND 2051..2054; /evidence=""ECO:0007829|PDB:2J3S""; STRAND 2059..2061; /evidence=""ECO:0007829|PDB:2J3S""; STRAND 2066..2071; /evidence=""ECO:0007829|PDB:2J3S""; STRAND 2075..2077; /evidence=""ECO:0007829|PDB:2J3S""; STRAND 2080..2088; /evidence=""ECO:0007829|PDB:2J3S""; STRAND 2091..2096; /evidence=""ECO:0007829|PDB:2J3S""; STRAND 2100..2107; /evidence=""ECO:0007829|PDB:2J3S""; STRAND 2112..2120; /evidence=""ECO:0007829|PDB:2J3S""; STRAND 2129..2136; /evidence=""ECO:0007829|PDB:2J3S""; STRAND 2139..2148; /evidence=""ECO:0007829|PDB:2J3S""; STRAND 2161..2165; /evidence=""ECO:0007829|PDB:4P3W""; STRAND 2174..2179; /evidence=""ECO:0007829|PDB:4P3W""; STRAND 2185..2187; /evidence=""ECO:0007829|PDB:4P3W""; STRAND 2189..2192; /evidence=""ECO:0007829|PDB:4P3W""; STRAND 2194..2201; /evidence=""ECO:0007829|PDB:4P3W""; STRAND 2208..2216; /evidence=""ECO:0007829|PDB:4P3W""; STRAND 2225..2229; /evidence=""ECO:0007829|PDB:4P3W""; STRAND 2234..2236; /evidence=""ECO:0007829|PDB:4P3W""; STRAND 2242..2245; /evidence=""ECO:0007829|PDB:7SC4""; STRAND 2251..2253; /evidence=""ECO:0007829|PDB:5XR1""; STRAND 2257..2262; /evidence=""ECO:0007829|PDB:7SC4""; STRAND 2268..2279; /evidence=""ECO:0007829|PDB:7SC4""; STRAND 2282..2287; /evidence=""ECO:0007829|PDB:7SC4""; STRAND 2289..2298; /evidence=""ECO:0007829|PDB:7SC4""; STRAND 2303..2311; /evidence=""ECO:0007829|PDB:7SC4""; STRAND 2320..2326; /evidence=""ECO:0007829|PDB:7SC4""; STRAND 2433..2436; /evidence=""ECO:0007829|PDB:2K3T""; STRAND 2441..2443; /evidence=""ECO:0007829|PDB:2K3T""; STRAND 2448..2453; /evidence=""ECO:0007829|PDB:2K3T""; STRAND 2462..2470; /evidence=""ECO:0007829|PDB:2K3T""; STRAND 2472..2479; /evidence=""ECO:0007829|PDB:2K3T""; STRAND 2482..2489; /evidence=""ECO:0007829|PDB:2K3T""; STRAND 2491..2506; /evidence=""ECO:0007829|PDB:2K3T""; STRAND 2511..2518; /evidence=""ECO:0007829|PDB:2K3T""; STRAND 2561..2564; /evidence=""ECO:0007829|PDB:3CNK""; STRAND 2576..2581; /evidence=""ECO:0007829|PDB:3CNK""; STRAND 2590..2595; /evidence=""ECO:0007829|PDB:3CNK""; STRAND 2597..2599; /evidence=""ECO:0007829|PDB:3CNK""; STRAND 2602..2610; /evidence=""ECO:0007829|PDB:3CNK""; STRAND 2613..2619; /evidence=""ECO:0007829|PDB:3CNK""; STRAND 2624..2632; /evidence=""ECO:0007829|PDB:3CNK""; STRAND 2641..2646; /evidence=""ECO:0007829|PDB:3CNK""","HELIX 40..43; /evidence=""ECO:0007829|PDB:3HOC""; HELIX 44..57; /evidence=""ECO:0007829|PDB:3HOC""; HELIX 58..60; /evidence=""ECO:0007829|PDB:3HOC""; HELIX 75..85; /evidence=""ECO:0007829|PDB:3HOC""; HELIX 100..116; /evidence=""ECO:0007829|PDB:3HOC""; HELIX 126..130; /evidence=""ECO:0007829|PDB:3HOC""; HELIX 134..149; /evidence=""ECO:0007829|PDB:3HOC""; HELIX 168..179; /evidence=""ECO:0007829|PDB:3HOC""; HELIX 190..192; /evidence=""ECO:0007829|PDB:3HOC""; HELIX 196..205; /evidence=""ECO:0007829|PDB:3HOC""; HELIX 213..215; /evidence=""ECO:0007829|PDB:3HOC""; HELIX 221..236; /evidence=""ECO:0007829|PDB:3HOC""; HELIX 244..247; /evidence=""ECO:0007829|PDB:3HOC""; HELIX 254..261; /evidence=""ECO:0007829|PDB:3HOC""; HELIX 263..266; /evidence=""ECO:0007829|PDB:3HOP""; HELIX 480..482; /evidence=""ECO:0007829|PDB:4M9P""; HELIX 488..490; /evidence=""ECO:0007829|PDB:4M9P""; HELIX 584..586; /evidence=""ECO:0007829|PDB:4M9P""; HELIX 672..674; /evidence=""ECO:0007829|PDB:4M9P""; HELIX 680..682; /evidence=""ECO:0007829|PDB:4M9P""; HELIX 1160..1162; /evidence=""ECO:0007829|PDB:3RGH""; HELIX 1168..1170; /evidence=""ECO:0007829|PDB:3RGH""; HELIX 1873..1875; /evidence=""ECO:0007829|PDB:2BP3""; HELIX 2041..2043; /evidence=""ECO:0007829|PDB:2K7Q""; HELIX 2047..2049; /evidence=""ECO:0007829|PDB:2J3S""; HELIX 2055..2057; /evidence=""ECO:0007829|PDB:2J3S""; HELIX 2171..2173; /evidence=""ECO:0007829|PDB:4P3W""; HELIX 2238..2240; /evidence=""ECO:0007829|PDB:7SC4""; HELIX 2246..2248; /evidence=""ECO:0007829|PDB:7SC4""; HELIX 2437..2439; /evidence=""ECO:0007829|PDB:2K3T""; HELIX 2565..2567; /evidence=""ECO:0007829|PDB:3CNK""","TURN 67..73; /evidence=""ECO:0007829|PDB:3HOC""; TURN 1785..1787; /evidence=""ECO:0007829|PDB:2K7P""; TURN 1891..1893; /evidence=""ECO:0007829|PDB:2AAV""; TURN 2264..2266; /evidence=""ECO:0007829|PDB:7SC4""; TURN 2316..2318; /evidence=""ECO:0007829|PDB:5XR1""; TURN 2429..2431; /evidence=""ECO:0007829|PDB:2K3T""; TURN 2455..2457; /evidence=""ECO:0007829|PDB:2K3T""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,FLNA FLN FLN1,Filamin-A (FLN-A) (Actin-binding protein 280) (ABP-280) (Alpha-filamin) (Endothelial actin-binding protein) (Filamin-1) (Non-muscle filamin),Homo sapiens (Human),2647.0,280739.0,MSSSHSRAGQSAAGAAPGGGVDTRDAEMPATEKDLAEDAPWKKIQQNTFTRWCNEHLKCVSKRIANLQTDLSDGLRLIALLEVLSQKKMHRKHNQRPTFRQMQLENVSVALEFLDRESIKLVSIDSKAIVDGNLKLILGLIWTLILHYSISMPMWDEEEDEEAKKQTPKQRLLGWIQNKLPQLPITNFSRDWQSGRALGALVDSCAPGLCPDWDSWDASKPVTNAREAMQQADDWLGIPQVITPEEIVDPNVDEHSVMTYLSQFPKAKLKPGAPLRPKLNPKKARAYGPGIEPTGNMVKKRAEFTVETRSAGQGEVLVYVEDPAGHQEEAKVTANNDKNRTFSVWYVPEVTGTHKVTVLFAGQHIAKSPFEVYVDKSQGDASKVTAQGPGLEPSGNIANKTTYFEIFTAGAGTGEVEVVIQDPMGQKGTVEPQLEARGDSTYRCSYQPTMEGVHTVHVTFAGVPIPRSPYTVTVGQACNPSACRAVGRGLQPKGVRVKETADFKVYTKGAGSGELKVTVKGPKGEERVKQKDLGDGVYGFEYYPMVPGTYIVTITWGGQNIGRSPFEVKVGTECGNQKVRAWGPGLEGGVVGKSADFVVEAIGDDVGTLGFSVEGPSQAKIECDDKGDGSCDVRYWPQEAGEYAVHVLCNSEDIRLSPFMADIRDAPQDFHPDRVKARGPGLEKTGVAVNKPAEFTVDAKHGGKAPLRVQVQDNEGCPVEALVKDNGNGTYSCSYVPRKPVKHTAMVSWGGVSIPNSPFRVNVGAGSHPNKVKVYGPGVAKTGLKAHEPTYFTVDCAEAGQGDVSIGIKCAPGVVGPAEADIDFDIIRNDNDTFTVKYTPRGAGSYTIMVLFADQATPTSPIRVKVEPSHDASKVKAEGPGLSRTGVELGKPTHFTVNAKAAGKGKLDVQFSGLTKGDAVRDVDIIDHHDNTYTVKYTPVQQGPVGVNVTYGGDPIPKSPFSVAVSPSLDLSKIKVSGLGEKVDVGKDQEFTVKSKGAGGQGKVASKIVGPSGAAVPCKVEPGLGADNSVVRFLPREEGPYEVEVTYDGVPVPGSPFPLEAVAPTKPSKVKAFGPGLQGGSAGSPARFTIDTKGAGTGGLGLTVEGPCEAQLECLDNGDGTCSVSYVPTEPGDYNINILFADTHIPGSPFKAHVVPCFDASKVKCSGPGLERATAGEVGQFQVDCSSAGSAELTIEICSEAGLPAEVYIQDHGDGTHTITYIPLCPGAYTVTIKYGGQPVPNFPSKLQVEPAVDTSGVQCYGPGIEGQGVFREATTEFSVDARALTQTGGPHVKARVANPSGNLTETYVQDRGDGMYKVEYTPYEEGLHSVDVTYDGSPVPSSPFQVPVTEGCDPSRVRVHGPGIQSGTTNKPNKFTVETRGAGTGGLGLAVEGPSEAKMSCMDNKDGSCSVEYIPYEAGTYSLNVTYGGHQVPGSPFKVPVHDVTDASKVKCSGPGLSPGMVRANLPQSFQVDTSKAGVAPLQVKVQGPKGLVEPVDVVDNADGTQTVNYVPSREGPYSISVLYGDEEVPRSPFKVKVLPTHDASKVKASGPGLNTTGVPASLPVEFTIDAKDAGEGLLAVQITDPEGKPKKTHIQDNHDGTYTVAYVPDVTGRYTILIKYGGDEIPFSPYRVRAVPTGDASKCTVTVSIGGHGLGAGIGPTIQIGEETVITVDTKAAGKGKVTCTVCTPDGSEVDVDVVENEDGTFDIFYTAPQPGKYVICVRFGGEHVPNSPFQVTALAGDQPSVQPPLRSQQLAPQYTYAQGGQQTWAPERPLVGVNGLDVTSLRPFDLVIPFTIKKGEITGEVRMPSGKVAQPTITDNKDGTVTVRYAPSEAGLHEMDIRYDNMHIPGSPLQFYVDYVNCGHVTAYGPGLTHGVVNKPATFTVNTKDAGEGGLSLAIEGPSKAEISCTDNQDGTCSVSYLPVLPGDYSILVKYNEQHVPGSPFTARVTGDDSMRMSHLKVGSAADIPINISETDLSLLTATVVPPSGREEPCLLKRLRNGHVGISFVPKETGEHLVHVKKNGQHVASSPIPVVISQSEIGDASRVRVSGQGLHEGHTFEPAEFIIDTRDAGYGGLSLSIEGPSKVDINTEDLEDGTCRVTYCPTEPGNYIINIKFADQHVPGSPFSVKVTGEGRVKESITRRRRAPSVANVGSHCDLSLKIPEISIQDMTAQVTSPSGKTHEAEIVEGENHTYCIRFVPAEMGTHTVSVKYKGQHVPGSPFQFTVGPLGEGGAHKVRAGGPGLERAEAGVPAEFSIWTREAGAGGLAIAVEGPSKAEISFEDRKDGSCGVAYVVQEPGDYEVSVKFNEEHIPDSPFVVPVASPSGDARRLTVSSLQESGLKVNQPASFAVSLNGAKGAIDAKVHSPSGALEECYVTEIDQDKYAVRFIPRENGVYLIDVKFNGTHIPGSPFKIRVGEPGHGGDPGLVSAYGAGLEGGVTGNPAEFVVNTSNAGAGALSVTIDGPSKVKMDCQECPEGYRVTYTPMAPGSYLISIKYGGPYHIGGSPFKAKVTGPRLVSNHSLHETSSVFVDSLTKATCAPQHGAPGPGPADASKVVAKGLGLSKAYVGQKSSFTVDCSKAGNNMLLVGVHGPRTPCEEILVKHVGSRLYSVSYLLKDKGEYTLVVKWGDEHIPGSPYRVVVP,False,False,True,P21333,"[('cd21308', 'first calponin homology (CH) domain found in filamin-A (FLN-A) and similar proteins'), ('cd21312', 'second calponin homology (CH) domain found in filamin-A (FLN-A) and similar proteins'), ('G3DSA:1.10.418.10', 'Calponin-like domain'), ('G3DSA:2.60.40.10', 'Immunoglobulins'), ('IPR001298', 'Filamin/ABP280 repeat'), ('IPR001589', 'Actinin-type actin-binding domain, conserved site'), ('IPR001715', 'Calponin homology domain'), ('IPR013783', 'Immunoglobulin-like fold'), ('IPR014756', 'Immunoglobulin E-set'), ('IPR017868', 'Filamin/ABP280 repeat-like'), ('IPR036872', 'CH domain superfamily'), ('IPR044801', 'Filamin family'), ('PF00307', 'Calponin homology (CH) domain'), ('PF00630', 'Filamin/ABP280 repeat'), ('PS00019', 'Actinin-type actin-binding domain signature 1'), ('PS00020', 'Actinin-type actin-binding domain signature 2'), ('PS50021', 'Calponin homology (CH) domain profile'), ('PS50194', 'Filamin/ABP280 repeat profile'), ('PTHR38537', 'JITTERBUG, ISOFORM N'), ('SM00033', 'Calponin homology domain')]",,"""ENSG00000196924; Tissue enhanced (endometrium, intestine)."";",,,,,ENST00000360319.9 [P21333-2];ENST00000369850.10 [P21333-1];,FLNA,ENSG00000196924;ENSG00000234446,0.0,FLNA,Non-canonical_RBPs,27.0,1.36,DP01950,0.014,0.04,0.032,FLNA
P21399,ENSG00000122729,ACOHC_HUMAN,citrate metabolic process [GO:0006101]; intestinal absorption [GO:0050892]; intracellular iron ion homeostasis [GO:0006879]; post-embryonic development [GO:0009791]; response to iron(II) ion [GO:0010040]; tricarboxylic acid cycle [GO:0006099],cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; mitochondrion [GO:0005739],"3 iron, 4 sulfur cluster binding [GO:0051538]; 4 iron, 4 sulfur cluster binding [GO:0051539]; aconitate hydratase activity [GO:0003994]; iron-responsive element binding [GO:0030350]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; mRNA regulatory element binding translation repressor activity [GO:0000900]; RNA binding [GO:0003723]",,,,"STRAND 9..12; /evidence=""ECO:0007829|PDB:2B3Y""; STRAND 20..22; /evidence=""ECO:0007829|PDB:2B3Y""; STRAND 52..55; /evidence=""ECO:0007829|PDB:2B3Y""; STRAND 75..78; /evidence=""ECO:0007829|PDB:2B3Y""; STRAND 81..86; /evidence=""ECO:0007829|PDB:2B3Y""; STRAND 120..123; /evidence=""ECO:0007829|PDB:2B3Y""; STRAND 167..170; /evidence=""ECO:0007829|PDB:2B3Y""; STRAND 188..192; /evidence=""ECO:0007829|PDB:2B3Y""; STRAND 195..198; /evidence=""ECO:0007829|PDB:2B3Y""; STRAND 200..205; /evidence=""ECO:0007829|PDB:2B3Y""; STRAND 217..220; /evidence=""ECO:0007829|PDB:2B3Y""; STRAND 235..238; /evidence=""ECO:0007829|PDB:2B3Y""; STRAND 242..249; /evidence=""ECO:0007829|PDB:2B3Y""; STRAND 277..282; /evidence=""ECO:0007829|PDB:2B3Y""; STRAND 306..309; /evidence=""ECO:0007829|PDB:2B3Y""; STRAND 356..362; /evidence=""ECO:0007829|PDB:2B3Y""; STRAND 368..371; /evidence=""ECO:0007829|PDB:2B3Y""; STRAND 379..381; /evidence=""ECO:0007829|PDB:2B3Y""; STRAND 412..417; /evidence=""ECO:0007829|PDB:2B3Y""; STRAND 420..425; /evidence=""ECO:0007829|PDB:2B3Y""; STRAND 428..434; /evidence=""ECO:0007829|PDB:2B3Y""; STRAND 467..471; /evidence=""ECO:0007829|PDB:2B3Y""; STRAND 501..503; /evidence=""ECO:0007829|PDB:2B3X""; STRAND 529..535; /evidence=""ECO:0007829|PDB:2B3Y""; STRAND 547..551; /evidence=""ECO:0007829|PDB:2B3Y""; STRAND 564..566; /evidence=""ECO:0007829|PDB:2B3X""; STRAND 575..578; /evidence=""ECO:0007829|PDB:2B3Y""; STRAND 582..584; /evidence=""ECO:0007829|PDB:2B3Y""; STRAND 662..671; /evidence=""ECO:0007829|PDB:2B3Y""; STRAND 688..690; /evidence=""ECO:0007829|PDB:2B3Y""; STRAND 735..737; /evidence=""ECO:0007829|PDB:2B3Y""; STRAND 739..742; /evidence=""ECO:0007829|PDB:2B3Y""; STRAND 749..751; /evidence=""ECO:0007829|PDB:2B3Y""; STRAND 766..769; /evidence=""ECO:0007829|PDB:2B3Y""; STRAND 772..774; /evidence=""ECO:0007829|PDB:2B3Y""; STRAND 792..798; /evidence=""ECO:0007829|PDB:2B3Y""; STRAND 814..818; /evidence=""ECO:0007829|PDB:2B3Y""; STRAND 835..837; /evidence=""ECO:0007829|PDB:2B3Y""; STRAND 848..853; /evidence=""ECO:0007829|PDB:2B3Y""; STRAND 858..863; /evidence=""ECO:0007829|PDB:2B3Y""","HELIX 6..8; /evidence=""ECO:0007829|PDB:2B3Y""; HELIX 24..27; /evidence=""ECO:0007829|PDB:2B3Y""; HELIX 32..34; /evidence=""ECO:0007829|PDB:2B3Y""; HELIX 37..48; /evidence=""ECO:0007829|PDB:2B3Y""; HELIX 57..64; /evidence=""ECO:0007829|PDB:2B3Y""; HELIX 66..69; /evidence=""ECO:0007829|PDB:2B3Y""; HELIX 87..106; /evidence=""ECO:0007829|PDB:2B3Y""; HELIX 111..113; /evidence=""ECO:0007829|PDB:2B3Y""; HELIX 138..163; /evidence=""ECO:0007829|PDB:2B3Y""; HELIX 177..183; /evidence=""ECO:0007829|PDB:2B3Y""; HELIX 206..214; /evidence=""ECO:0007829|PDB:2B3Y""; HELIX 223..230; /evidence=""ECO:0007829|PDB:2B3Y""; HELIX 257..271; /evidence=""ECO:0007829|PDB:2B3Y""; HELIX 283..285; /evidence=""ECO:0007829|PDB:2B3Y""; HELIX 290..298; /evidence=""ECO:0007829|PDB:2B3Y""; HELIX 300..303; /evidence=""ECO:0007829|PDB:2B3Y""; HELIX 314..322; /evidence=""ECO:0007829|PDB:2B3Y""; HELIX 327..340; /evidence=""ECO:0007829|PDB:2B3Y""; HELIX 349..351; /evidence=""ECO:0007829|PDB:2B3Y""; HELIX 363..365; /evidence=""ECO:0007829|PDB:2B3Y""; HELIX 382..384; /evidence=""ECO:0007829|PDB:2B3Y""; HELIX 385..394; /evidence=""ECO:0007829|PDB:2B3Y""; HELIX 406..408; /evidence=""ECO:0007829|PDB:2B3Y""; HELIX 437..440; /evidence=""ECO:0007829|PDB:2B3Y""; HELIX 443..458; /evidence=""ECO:0007829|PDB:2B3Y""; HELIX 476..484; /evidence=""ECO:0007829|PDB:2B3Y""; HELIX 488..493; /evidence=""ECO:0007829|PDB:2B3Y""; HELIX 504..507; /evidence=""ECO:0007829|PDB:2B3Y""; HELIX 515..524; /evidence=""ECO:0007829|PDB:2B3Y""; HELIX 554..563; /evidence=""ECO:0007829|PDB:2B3Y""; HELIX 586..589; /evidence=""ECO:0007829|PDB:2B3Y""; HELIX 593..603; /evidence=""ECO:0007829|PDB:2B3Y""; HELIX 606..613; /evidence=""ECO:0007829|PDB:2B3Y""; HELIX 621..625; /evidence=""ECO:0007829|PDB:2B3Y""; HELIX 647..649; /evidence=""ECO:0007829|PDB:2B3Y""; HELIX 677..680; /evidence=""ECO:0007829|PDB:2B3Y""; HELIX 691..698; /evidence=""ECO:0007829|PDB:2B3Y""; HELIX 703..705; /evidence=""ECO:0007829|PDB:2B3Y""; HELIX 710..712; /evidence=""ECO:0007829|PDB:2B3Y""; HELIX 716..721; /evidence=""ECO:0007829|PDB:2B3Y""; HELIX 752..761; /evidence=""ECO:0007829|PDB:2B3Y""; HELIX 782..789; /evidence=""ECO:0007829|PDB:2B3Y""; HELIX 802..810; /evidence=""ECO:0007829|PDB:2B3Y""; HELIX 824..827; /evidence=""ECO:0007829|PDB:2B3Y""; HELIX 868..876; /evidence=""ECO:0007829|PDB:2B3Y""; HELIX 879..888; /evidence=""ECO:0007829|PDB:2B3Y""","TURN 70..73; /evidence=""ECO:0007829|PDB:2B3Y""; TURN 539..541; /evidence=""ECO:0007829|PDB:2B3X""; TURN 570..572; /evidence=""ECO:0007829|PDB:2B3Y""; TURN 579..581; /evidence=""ECO:0007829|PDB:2B3Y""; TURN 614..618; /evidence=""ECO:0007829|PDB:2B3Y""; TURN 722..724; /evidence=""ECO:0007829|PDB:2B3Y""; TURN 732..734; /evidence=""ECO:0007829|PDB:2B3Y""; TURN 744..746; /evidence=""ECO:0007829|PDB:2B3Y""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,ACO1 IREB1,Cytoplasmic aconitate hydratase (Aconitase) (EC 4.2.1.3) (Citrate hydro-lyase) (Ferritin repressor protein) (Iron regulatory protein 1) (IRP1) (Iron-responsive element-binding protein 1) (IRE-BP 1),Homo sapiens (Human),889.0,98399.0,MSNPFAHLAEPLDPVQPGKKFFNLNKLEDSRYGRLPFSIRVLLEAAIRNCDEFLVKKQDIENILHWNVTQHKNIEVPFKPARVILQDFTGVPAVVDFAAMRDAVKKLGGDPEKINPVCPADLVIDHSIQVDFNRRADSLQKNQDLEFERNRERFEFLKWGSQAFHNMRIIPPGSGIIHQVNLEYLARVVFDQDGYYYPDSLVGTDSHTTMIDGLGILGWGVGGIEAEAVMLGQPISMVLPQVIGYRLMGKPHPLVTSTDIVLTITKHLRQVGVVGKFVEFFGPGVAQLSIADRATIANMCPEYGATAAFFPVDEVSITYLVQTGRDEEKLKYIKKYLQAVGMFRDFNDPSQDPDFTQVVELDLKTVVPCCSGPKRPQDKVAVSDMKKDFESCLGAKQGFKGFQVAPEHHNDHKTFIYDNTEFTLAHGSVVIAAITSCTNTSNPSVMLGAGLLAKKAVDAGLNVMPYIKTSLSPGSGVVTYYLQESGVMPYLSQLGFDVVGYGCMTCIGNSGPLPEPVVEAITQGDLVAVGVLSGNRNFEGRVHPNTRANYLASPPLVIAYAIAGTIRIDFEKEPLGVNAKGQQVFLKDIWPTRDEIQAVERQYVIPGMFKEVYQKIETVNESWNALATPSDKLFFWNSKSTYIKSPPFFENLTLDLQPPKSIVDAYVLLNLGDSVTTDHISPAGNIARNSPAARYLTNRGLTPREFNSYGSRRGNDAVMARGTFANIRLLNRFLNKQAPQTIHLPSGEILDVFDAAERYQQAGLPLIVLAGKEYGAGSSRDWAAKGPFLLGIKAVLAESYERIHRSNLVGMGVIPLEYLPGENADALGLTGQERYTIIIPENLKPQMKVQVKLDTGKTFQAVMRFDTDVELTYFLNGGILNYMIRKMAK,True,True,True,P21399,"[('cd01580', 'AcnA_IRP_Swivel'), ('cd01586', 'Aconitase A catalytic domain'), ('G3DSA:3.20.19.10', 'Aconitase, domain 4'), ('G3DSA:3.30.499.10', 'Aconitase, domain 3'), ('G3DSA:6.10.190.10', None), ('IPR000573', 'Aconitase A/isopropylmalate dehydratase small subunit, swivel domain'), ('IPR001030', 'Aconitase/3-isopropylmalate dehydratase large subunit, alpha/beta/alpha domain'), ('IPR006249', 'Aconitase/Iron-responsive element-binding protein 2'), ('IPR015928', 'Aconitase/3-isopropylmalate dehydratase, swivel'), ('IPR015931', 'Aconitase/3-isopropylmalate dehydratase large subunit, alpha/beta/alpha, subdomain 1/3'), ('IPR018136', 'Aconitase family, 4Fe-4S cluster binding site'), ('IPR036008', 'Aconitase, iron-sulfur domain'), ('IPR044137', 'Aconitase A, swivel domain'), ('PF00330', 'Aconitase family (aconitate hydratase)'), ('PF00694', 'Aconitase C-terminal domain'), ('PR00415', 'ACONITASE'), ('PS00450', 'Aconitase family signature 1'), ('PS01244', 'Aconitase family signature 2'), ('PTHR11670', 'ACONITASE/IRON-RESPONSIVE ELEMENT FAMILY MEMBER'), ('SSF52016', 'LeuD/IlvD-like')]",,"""ENSG00000122729; Tissue enhanced (liver)."";","CATALYTIC ACTIVITY: Reaction=citrate = D-threo-isocitrate; Xref=Rhea:RHEA:10336, ChEBI:CHEBI:15562, ChEBI:CHEBI:16947; EC=4.2.1.3; Evidence={ECO:0000269|PubMed:1281544, ECO:0000269|PubMed:1946430, ECO:0000269|PubMed:8041788};",4.2.1.3,,,ENST00000309951.8;ENST00000379923.5;ENST00000541043.5;,ACO1,ENSG00000122729,0.0,ACO1,Canonical_RBPs,4.0,,,,,,ACO1
P21860,ENSG00000065361,ERBB3_HUMAN,cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; cranial nerve development [GO:0021545]; endocardial cushion development [GO:0003197]; ERBB2-ERBB3 signaling pathway [GO:0038133]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; heart development [GO:0007507]; motor neuron apoptotic process [GO:0097049]; myelination [GO:0042552]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell adhesion [GO:0007162]; negative regulation of motor neuron apoptotic process [GO:2000672]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of secretion [GO:0051048]; negative regulation of signal transduction [GO:0009968]; neurogenesis [GO:0022008]; neuron apoptotic process [GO:0051402]; peripheral nervous system development [GO:0007422]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; positive regulation of cardiac muscle tissue development [GO:0055025]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; protein phosphorylation [GO:0006468]; regulation of cell population proliferation [GO:0042127]; Schwann cell development [GO:0014044]; Schwann cell differentiation [GO:0014037]; signal transduction [GO:0007165]; wound healing [GO:0042060],apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; basolateral plasma membrane [GO:0016323]; ERBB3:ERBB2 complex [GO:0038143]; extracellular space [GO:0005615]; lateral plasma membrane [GO:0016328]; plasma membrane [GO:0005886]; receptor complex [GO:0043235],ATP binding [GO:0005524]; ErbB-3 class receptor binding [GO:0043125]; growth factor binding [GO:0019838]; identical protein binding [GO:0042802]; neuregulin binding [GO:0038132]; neuregulin receptor activity [GO:0038131]; protein heterodimerization activity [GO:0046982]; protein tyrosine kinase activator activity [GO:0030296]; transmembrane signaling receptor activity [GO:0004888]; ubiquitin protein ligase binding [GO:0031625],"PTM: Autophosphorylated (PubMed:20351256). Ligand-binding increases phosphorylation on tyrosine residues and promotes its association with the p85 subunit of phosphatidylinositol 3-kinase (PubMed:20682778). {ECO:0000269|PubMed:20351256, ECO:0000269|PubMed:20682778, ECO:0000269|PubMed:33497358}.",DOMAIN: The cytoplasmic part of the receptor may interact with the SH2 or SH3 domains of many signal-transducing proteins.,"DOMAIN 709..966; /note=""Protein kinase""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00159""","STRAND 28..30; /evidence=""ECO:0007829|PDB:4LEO""; STRAND 38..41; /evidence=""ECO:0007829|PDB:7MN5""; STRAND 58..61; /evidence=""ECO:0007829|PDB:1M6B""; STRAND 63..67; /evidence=""ECO:0007829|PDB:1M6B""; STRAND 82..85; /evidence=""ECO:0007829|PDB:1M6B""; STRAND 87..91; /evidence=""ECO:0007829|PDB:1M6B""; STRAND 95..98; /evidence=""ECO:0007829|PDB:1M6B""; STRAND 115..120; /evidence=""ECO:0007829|PDB:1M6B""; STRAND 125..128; /evidence=""ECO:0007829|PDB:4LEO""; STRAND 133..135; /evidence=""ECO:0007829|PDB:1M6B""; STRAND 141..144; /evidence=""ECO:0007829|PDB:7MN6""; STRAND 146..150; /evidence=""ECO:0007829|PDB:1M6B""; STRAND 174..178; /evidence=""ECO:0007829|PDB:1M6B""; STRAND 194..198; /evidence=""ECO:0007829|PDB:1M6B""; STRAND 214..216; /evidence=""ECO:0007829|PDB:1M6B""; STRAND 218..222; /evidence=""ECO:0007829|PDB:1M6B""; STRAND 231..233; /evidence=""ECO:0007829|PDB:1M6B""; STRAND 235..239; /evidence=""ECO:0007829|PDB:1M6B""; STRAND 243..251; /evidence=""ECO:0007829|PDB:1M6B""; STRAND 254..258; /evidence=""ECO:0007829|PDB:1M6B""; STRAND 262..265; /evidence=""ECO:0007829|PDB:1M6B""; STRAND 270..274; /evidence=""ECO:0007829|PDB:1M6B""; STRAND 280..282; /evidence=""ECO:0007829|PDB:1M6B""; STRAND 285..289; /evidence=""ECO:0007829|PDB:1M6B""; STRAND 295..297; /evidence=""ECO:0007829|PDB:1M6B""; STRAND 300..304; /evidence=""ECO:0007829|PDB:1M6B""; STRAND 309..314; /evidence=""ECO:0007829|PDB:1M6B""; STRAND 317..322; /evidence=""ECO:0007829|PDB:1M6B""; STRAND 324..326; /evidence=""ECO:0007829|PDB:4LEO""; STRAND 330..332; /evidence=""ECO:0007829|PDB:7D85""; STRAND 338..342; /evidence=""ECO:0007829|PDB:5CUS""; STRAND 355..363; /evidence=""ECO:0007829|PDB:7D85""; STRAND 392..395; /evidence=""ECO:0007829|PDB:7D85""; STRAND 397..399; /evidence=""ECO:0007829|PDB:7D85""; STRAND 428..433; /evidence=""ECO:0007829|PDB:7D85""; STRAND 451..457; /evidence=""ECO:0007829|PDB:7D85""; STRAND 481..488; /evidence=""ECO:0007829|PDB:7D85""; STRAND 509..513; /evidence=""ECO:0007829|PDB:7BHF""; STRAND 517..522; /evidence=""ECO:0007829|PDB:7BHF""; STRAND 528..531; /evidence=""ECO:0007829|PDB:7BHE""; STRAND 534..540; /evidence=""ECO:0007829|PDB:7BHF""; STRAND 542..545; /evidence=""ECO:0007829|PDB:7BHF""; STRAND 548..551; /evidence=""ECO:0007829|PDB:7BHF""; STRAND 560..562; /evidence=""ECO:0007829|PDB:7BHF""; STRAND 564..569; /evidence=""ECO:0007829|PDB:7BHF""; STRAND 572..581; /evidence=""ECO:0007829|PDB:7BHF""; STRAND 584..588; /evidence=""ECO:0007829|PDB:7BHF""; STRAND 591..595; /evidence=""ECO:0007829|PDB:7BHF""; STRAND 598..604; /evidence=""ECO:0007829|PDB:7BHF""; STRAND 608..612; /evidence=""ECO:0007829|PDB:7BHF""; STRAND 621..625; /evidence=""ECO:0007829|PDB:7BHF""; STRAND 709..717; /evidence=""ECO:0007829|PDB:6OP9""; STRAND 722..728; /evidence=""ECO:0007829|PDB:6OP9""; STRAND 731..733; /evidence=""ECO:0007829|PDB:3LMG""; STRAND 737..744; /evidence=""ECO:0007829|PDB:6OP9""; STRAND 753..755; /evidence=""ECO:0007829|PDB:4RIY""; STRAND 774..778; /evidence=""ECO:0007829|PDB:6OP9""; STRAND 780..788; /evidence=""ECO:0007829|PDB:6OP9""; STRAND 840..846; /evidence=""ECO:0007829|PDB:6OP9""; STRAND 848..850; /evidence=""ECO:0007829|PDB:6OP9""; STRAND 980..983; /evidence=""ECO:0007829|PDB:3KEX""","HELIX 43..53; /evidence=""ECO:0007829|PDB:4LEO""; HELIX 75..79; /evidence=""ECO:0007829|PDB:1M6B""; HELIX 163..166; /evidence=""ECO:0007829|PDB:1M6B""; HELIX 188..190; /evidence=""ECO:0007829|PDB:4LEO""; HELIX 199..201; /evidence=""ECO:0007829|PDB:7MN5""; HELIX 223..225; /evidence=""ECO:0007829|PDB:5CUS""; HELIX 240..242; /evidence=""ECO:0007829|PDB:1M6B""; HELIX 348..351; /evidence=""ECO:0007829|PDB:7D85""; HELIX 365..369; /evidence=""ECO:0007829|PDB:7D85""; HELIX 381..389; /evidence=""ECO:0007829|PDB:7D85""; HELIX 410..412; /evidence=""ECO:0007829|PDB:7D85""; HELIX 465..467; /evidence=""ECO:0007829|PDB:4LEO""; HELIX 470..474; /evidence=""ECO:0007829|PDB:7D85""; HELIX 490..495; /evidence=""ECO:0007829|PDB:7D85""; HELIX 514..516; /evidence=""ECO:0007829|PDB:7BHF""; HELIX 626..628; /evidence=""ECO:0007829|PDB:7BHF""; HELIX 641..670; /evidence=""ECO:0007829|PDB:2L9U""; HELIX 706..708; /evidence=""ECO:0007829|PDB:6OP9""; HELIX 758..764; /evidence=""ECO:0007829|PDB:6OP9""; HELIX 795..802; /evidence=""ECO:0007829|PDB:6OP9""; HELIX 803..806; /evidence=""ECO:0007829|PDB:6OP9""; HELIX 808..827; /evidence=""ECO:0007829|PDB:6OP9""; HELIX 837..839; /evidence=""ECO:0007829|PDB:6OP9""; HELIX 856..858; /evidence=""ECO:0007829|PDB:6OP9""; HELIX 865..868; /evidence=""ECO:0007829|PDB:4RIY""; HELIX 875..877; /evidence=""ECO:0007829|PDB:6OP9""; HELIX 880..885; /evidence=""ECO:0007829|PDB:6OP9""; HELIX 890..905; /evidence=""ECO:0007829|PDB:6OP9""; HELIX 917..919; /evidence=""ECO:0007829|PDB:6OP9""; HELIX 920..925; /evidence=""ECO:0007829|PDB:6OP9""; HELIX 938..947; /evidence=""ECO:0007829|PDB:6OP9""; HELIX 958..969; /evidence=""ECO:0007829|PDB:6OP9""; HELIX 972..974; /evidence=""ECO:0007829|PDB:6OP9""","TURN 112..114; /evidence=""ECO:0007829|PDB:1M6B""; TURN 158..160; /evidence=""ECO:0007829|PDB:1M6B""; TURN 267..269; /evidence=""ECO:0007829|PDB:1M6B""; TURN 345..347; /evidence=""ECO:0007829|PDB:7D85""; TURN 372..375; /evidence=""ECO:0007829|PDB:7D85""; TURN 425..427; /evidence=""ECO:0007829|PDB:7D85""; TURN 747..749; /evidence=""ECO:0007829|PDB:6OP9""; TURN 870..872; /evidence=""ECO:0007829|PDB:4RIY""; TURN 911..914; /evidence=""ECO:0007829|PDB:6OP9""; TURN 952..954; /evidence=""ECO:0007829|PDB:6OP9""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,ERBB3 HER3,Receptor tyrosine-protein kinase erbB-3 (EC 2.7.10.1) (Proto-oncogene-like protein c-ErbB-3) (Tyrosine kinase-type cell surface receptor HER3),Homo sapiens (Human),1342.0,148098.0,MRANDALQVLGLLFSLARGSEVGNSQAVCPGTLNGLSVTGDAENQYQTLYKLYERCEVVMGNLEIVLTGHNADLSFLQWIREVTGYVLVAMNEFSTLPLPNLRVVRGTQVYDGKFAIFVMLNYNTNSSHALRQLRLTQLTEILSGGVYIEKNDKLCHMDTIDWRDIVRDRDAEIVVKDNGRSCPPCHEVCKGRCWGPGSEDCQTLTKTICAPQCNGHCFGPNPNQCCHDECAGGCSGPQDTDCFACRHFNDSGACVPRCPQPLVYNKLTFQLEPNPHTKYQYGGVCVASCPHNFVVDQTSCVRACPPDKMEVDKNGLKMCEPCGGLCPKACEGTGSGSRFQTVDSSNIDGFVNCTKILGNLDFLITGLNGDPWHKIPALDPEKLNVFRTVREITGYLNIQSWPPHMHNFSVFSNLTTIGGRSLYNRGFSLLIMKNLNVTSLGFRSLKEISAGRIYISANRQLCYHHSLNWTKVLRGPTEERLDIKHNRPRRDCVAEGKVCDPLCSSGGCWGPGPGQCLSCRNYSRGGVCVTHCNFLNGEPREFAHEAECFSCHPECQPMEGTATCNGSGSDTCAQCAHFRDGPHCVSSCPHGVLGAKGPIYKYPDVQNECRPCHENCTQGCKGPELQDCLGQTLVLIGKTHLTMALTVIAGLVVIFMMLGGTFLYWRGRRIQNKRAMRRYLERGESIEPLDPSEKANKVLARIFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARDPPRYLVIKRESGPGIAPGPEPHGLTNKKLEEVELEPELDLDLDLEAEEDNLATTTLGSALSLPVGTLNRPRGSQSLLSPSSGYMPMNQGNLGESCQESAVSGSSERCPRPVSLHPMPRGCLASESSEGHVTGSEAELQEKVSMCRSRSRSRSPRPRGDSAYHSQRHSLLTPVTPLSPPGLEEEDVNGYVMPDTHLKGTPSSREGTLSSVGLSSVLGTEEEDEDEEYEYMNRRRRHSPPHPPRPSSLEELGYEYMDVGSDLSASLGSTQSCPLHPVPIMPTAGTTPDEDYEYMNRQRDGGGPGGDYAAMGACPASEQGYEEMRAFQGPGHQAPHVHYARLKTLRSLEATDSAFDNPDYWHSRLFPKANAQRT,False,False,True,P21860,"[('cd00064', 'FU'), ('cd05111', 'Pseudokinase domain of the Protein Tyrosine Kinase, HER3'), ('cd12095', 'Transmembrane domain of ErbB3, a Protein Tyrosine Kinase'), ('G3DSA:1.10.510.10', 'Transferase(Phosphotransferase) domain 1'), ('G3DSA:1.20.890.10', 'cAMP-dependent protein kinase regulatory subunit, dimerization-anchoring domain'), ('G3DSA:2.10.220.10', 'Hormone Receptor, Insulin-like Growth Factor Receptor 1; Chain A, domain 2'), ('G3DSA:3.30.200.20', 'Phosphorylase Kinase; domain 1'), ('G3DSA:3.80.20.20', 'Receptor L-domain'), ('IPR000494', 'Receptor L-domain'), ('IPR000719', 'Protein kinase domain'), ('IPR001245', 'Serine-threonine/tyrosine-protein kinase, catalytic domain'), ('IPR006211', 'Furin-like cysteine-rich domain'), ('IPR006212', 'Furin-like repeat'), ('IPR009030', 'Growth factor receptor cysteine-rich domain superfamily'), ('IPR011009', 'Protein kinase-like domain superfamily'), ('IPR016245', 'Tyrosine protein kinase, EGF/ERB/XmrK receptor'), ('IPR032778', 'Growth factor receptor domain 4'), ('IPR036941', 'Receptor L-domain superfamily'), ('IPR050122', 'Receptor Tyrosine Kinase'), ('PF00757', 'Furin-like cysteine rich region')]",P21860;,"""ENSG00000065361; Low tissue specificity."";","CATALYTIC ACTIVITY: Reaction=L-tyrosyl-[protein] + ATP = O-phospho-L-tyrosyl-[protein] + ADP + H(+); Xref=Rhea:RHEA:10596, Rhea:RHEA-COMP:10136, Rhea:RHEA-COMP:10137, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616, ChEBI:CHEBI:46858, ChEBI:CHEBI:82620, ChEBI:CHEBI:456216; EC=2.7.10.1; Evidence={ECO:0000269|PubMed:20351256};",2.7.10.1,,,ENST00000267101.8 [P21860-1];ENST00000411731.6 [P21860-2];ENST00000415288.6 [P21860-4];ENST00000551242.5 [P21860-3];ENST00000683018.1 [P21860-4];ENST00000683059.1 [P21860-4];ENST00000683164.1 [P21860-4];,ERBB3,ENSG00000065361,0.0,,,,,,,0.314,0.104,ERBB3
P21912,ENSG00000117118,SDHB_HUMAN,"aerobic respiration [GO:0009060]; mitochondrial electron transport, succinate to ubiquinone [GO:0006121]; proton motive force-driven mitochondrial ATP synthesis [GO:0042776]; respiratory electron transport chain [GO:0022904]; tricarboxylic acid cycle [GO:0006099]",mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrial membrane [GO:0031966]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; respiratory chain complex II (succinate dehydrogenase) [GO:0045273],"2 iron, 2 sulfur cluster binding [GO:0051537]; 3 iron, 4 sulfur cluster binding [GO:0051538]; 4 iron, 4 sulfur cluster binding [GO:0051539]; electron transfer activity [GO:0009055]; metal ion binding [GO:0046872]; succinate dehydrogenase (quinone) activity [GO:0008177]; ubiquinone binding [GO:0048039]",,,"DOMAIN 40..133; /note=""2Fe-2S ferredoxin-type""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00465""; DOMAIN 176..206; /note=""4Fe-4S ferredoxin-type""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00711""","STRAND 39..46; /evidence=""ECO:0007829|PDB:8GS8""; STRAND 49..51; /evidence=""ECO:0007829|PDB:8GS8""; STRAND 57..68; /evidence=""ECO:0007829|PDB:8GS8""; STRAND 94..98; /evidence=""ECO:0007829|PDB:8GS8""; STRAND 101..105; /evidence=""ECO:0007829|PDB:8GS8""; STRAND 108..111; /evidence=""ECO:0007829|PDB:8GS8""; STRAND 121..123; /evidence=""ECO:0007829|PDB:7KCM""; STRAND 124..128; /evidence=""ECO:0007829|PDB:8GS8""; STRAND 130..132; /evidence=""ECO:0007829|PDB:7KCM""; STRAND 133..137; /evidence=""ECO:0007829|PDB:8GS8""","HELIX 72..82; /evidence=""ECO:0007829|PDB:8GS8""; HELIX 144..152; /evidence=""ECO:0007829|PDB:8GS8""; HELIX 174..177; /evidence=""ECO:0007829|PDB:8GS8""; HELIX 178..180; /evidence=""ECO:0007829|PDB:8GS8""; HELIX 193..195; /evidence=""ECO:0007829|PDB:8GS8""; HELIX 197..201; /evidence=""ECO:0007829|PDB:8GS8""; HELIX 208..219; /evidence=""ECO:0007829|PDB:8GS8""; HELIX 232..234; /evidence=""ECO:0007829|PDB:8GS8""; HELIX 248..252; /evidence=""ECO:0007829|PDB:8GS8""; HELIX 259..271; /evidence=""ECO:0007829|PDB:8GS8""","TURN 112..114; /evidence=""ECO:0007829|PDB:8GS8""; TURN 163..167; /evidence=""ECO:0007829|PDB:8GS8""; TURN 181..185; /evidence=""ECO:0007829|PDB:8GS8""; TURN 203..205; /evidence=""ECO:0007829|PDB:8GS8""; TURN 227..231; /evidence=""ECO:0007829|PDB:8GS8""; TURN 237..242; /evidence=""ECO:0007829|PDB:8GS8""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,SDHB SDH SDH1,"Succinate dehydrogenase [ubiquinone] iron-sulfur subunit, mitochondrial (EC 1.3.5.1) (Iron-sulfur subunit of complex II) (Ip) (Malate dehydrogenase [quinone] iron-sulfur subunit) (EC 1.1.5.-)",Homo sapiens (Human),280.0,31630.0,MAAVVALSLRRRLPATTLGGACLQASRGAQTAAATAPRIKKFAIYRWDPDKAGDKPHMQTYEVDLNKCGPMVLDALIKIKNEVDSTLTFRRSCREGICGSCAMNINGGNTLACTRRIDTNLNKVSKIYPLPHMYVIKDLVPDLSNFYAQYKSIEPYLKKKDESQEGKQQYLQSIEEREKLDGLYECILCACCSTSCPSYWWNGDKYLGPAVLMQAYRWMIDSRDDFTEERLAKLQDPFSLYRCHTIMNCTRTCPKGLNPGKAIAEIKKMMATYKEKKASV,True,False,False,P21912,"[('cd00207', 'fer2'), ('G3DSA:1.10.1060.10', 'Alpha-helical ferredoxin'), ('G3DSA:3.10.20.30', None), ('IPR001041', '2Fe-2S ferredoxin-type iron-sulfur binding domain'), ('IPR004489', 'Succinate dehydrogenase/fumarate reductase iron-sulphur protein'), ('IPR006058', '2Fe-2S ferredoxin, iron-sulphur binding site'), ('IPR009051', 'Alpha-helical ferredoxin'), ('IPR012675', 'Beta-grasp domain superfamily'), ('IPR017896', '4Fe-4S ferredoxin-type, iron-sulphur binding domain'), ('IPR017900', '4Fe-4S ferredoxin, iron-sulphur binding, conserved site'), ('IPR025192', 'Succinate dehydogenase/fumarate reductase N-terminal'), ('IPR036010', '2Fe-2S ferredoxin-like superfamily'), ('IPR050573', 'Succinate Dehydrogenase/Fumarate Reductase Iron-Sulfur'), ('PF13085', '2Fe-2S iron-sulfur cluster binding domain'), ('PF13534', '4Fe-4S dicluster domain'), ('PS00197', '2Fe-2S ferredoxin-type iron-sulfur binding region signature'), ('PS00198', '4Fe-4S ferredoxin-type iron-sulfur binding region signature'), ('PS51085', '2Fe-2S ferredoxin-type iron-sulfur binding domain profile'), ('PS51379', '4Fe-4S ferredoxin-type iron-sulfur binding domain profile'), ('PTHR11921', 'Succinate Dehydrogenase/Fumarate Reductase Iron-Sulfur')]",,"""ENSG00000117118; Tissue enhanced (skeletal muscle, tongue)."";","CATALYTIC ACTIVITY: Reaction=a quinone + succinate = fumarate + a quinol; Xref=Rhea:RHEA:40523, ChEBI:CHEBI:24646, ChEBI:CHEBI:29806, ChEBI:CHEBI:30031, ChEBI:CHEBI:132124; EC=1.3.5.1; Evidence={ECO:0000269|PubMed:26925370, ECO:0000269|PubMed:27604842}; CATALYTIC ACTIVITY: Reaction=(R)-malate + a quinone = enol-oxaloacetate + a quinol; Xref=Rhea:RHEA:79827, ChEBI:CHEBI:15588, ChEBI:CHEBI:17479, ChEBI:CHEBI:24646, ChEBI:CHEBI:132124; Evidence={ECO:0000250|UniProtKB:Q3T189}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:79828; Evidence={ECO:0000250|UniProtKB:Q3T189}; CATALYTIC ACTIVITY: Reaction=(S)-malate + a quinone = enol-oxaloacetate + a quinol; Xref=Rhea:RHEA:79831, ChEBI:CHEBI:15589, ChEBI:CHEBI:17479, ChEBI:CHEBI:24646, ChEBI:CHEBI:132124; Evidence={ECO:0000250|UniProtKB:Q3T189}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:79832; Evidence={ECO:0000250|UniProtKB:Q3T189};",1.1.5.-; 1.3.5.1,ACTIVITY REGULATION: Enol-oxaloacetate inhibits the succinate dehydrogenase activity. {ECO:0000250|UniProtKB:Q3T189}.,"PATHWAY: Carbohydrate metabolism; tricarboxylic acid cycle; fumarate from succinate (eukaryal route): step 1/1. {ECO:0000269|PubMed:26925370, ECO:0000269|PubMed:27604842}.",ENST00000375499.8;,SDHB;LINC02024,ENSG00000117118;ENSG00000241213,0.0,,,,,,,0.125,,SDHB
P21980,ENSG00000198959,TGM2_HUMAN,apoptotic cell clearance [GO:0043277]; bone development [GO:0060348]; branching involved in salivary gland morphogenesis [GO:0060445]; cellular response to cocaine [GO:0071314]; cellular response to dopamine [GO:1903351]; cellular response to serotonin [GO:1904015]; dopamine secretion [GO:0014046]; gene expression [GO:0010467]; negative regulation of endoplasmic reticulum calcium ion concentration [GO:0032471]; peptide cross-linking [GO:0018149]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cell adhesion [GO:0045785]; positive regulation of GTPase activity [GO:0043547]; positive regulation of mitochondrial calcium ion concentration [GO:0051561]; positive regulation of neurogenesis [GO:0050769]; positive regulation of small GTPase mediated signal transduction [GO:0051057]; positive regulation of sprouting angiogenesis [GO:1903672]; protein deamination [GO:0018277]; protein homooligomerization [GO:0051260]; proteolysis [GO:0006508]; regulation of apoptotic cell clearance [GO:2000425]; regulation of apoptotic process [GO:0042981]; salivary gland cavitation [GO:0060662],chromatin [GO:0000785]; collagen-containing extracellular matrix [GO:0062023]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular matrix [GO:0031012]; focal adhesion [GO:0005925]; mitochondrion [GO:0005739]; nucleosome [GO:0000786]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886],calcium ion binding [GO:0005509]; GTP binding [GO:0005525]; histone dopaminyltransferase activity [GO:0120297]; histone serotonyltransferase activity [GO:0120295]; peptidase activity [GO:0008233]; peptide histaminyltransferase activity [GO:0120299]; peptide noradrenalinyltransferase activity [GO:0120298]; protein-glutamine gamma-glutamyltransferase activity [GO:0003810]; protein-glutamine glutaminase activity [GO:0050568],"PTM: Disulfide bond formation inactivates the calcium-dependent acyltransferase activity (PubMed:20547769). Cys-370 can form disulfide bonds with both Cys-230 and Cys-371: formation of a disulfide bond between Cys-230 and Cys-370 facilitates formation of the disulfide between Cys-370 and Cys-371, which promotes inactivation of the acyltransferase activity (PubMed:20547769). May also form interchain disulfids between Cys-230 and Cys-370 (PubMed:25192068). Ca(2+) protects against disulfide bond formation and inactivation (PubMed:20547769). {ECO:0000269|PubMed:20547769, ECO:0000269|PubMed:25192068}.; PTM: Auto-transglutaminated: Forms covalent cross-links mediated by transglutaminase between Gln-633 and the epsilon-amino group of a lysine residue of itself or HMGB1, forming homopolymers and heteropolymers, respectively. {ECO:0000250|UniProtKB:P08587}.; PTM: S-nitrosylated, leading to inactivation of the acyltransferase activity. {ECO:0000250|UniProtKB:P21981}.",,,"STRAND 7..11; /evidence=""ECO:0007829|PDB:2Q3Z""; STRAND 28..30; /evidence=""ECO:0007829|PDB:2Q3Z""; STRAND 32..34; /evidence=""ECO:0007829|PDB:2Q3Z""; STRAND 39..48; /evidence=""ECO:0007829|PDB:2Q3Z""; STRAND 55..66; /evidence=""ECO:0007829|PDB:2Q3Z""; STRAND 73..79; /evidence=""ECO:0007829|PDB:2Q3Z""; STRAND 85..87; /evidence=""ECO:0007829|PDB:4PYG""; STRAND 89..95; /evidence=""ECO:0007829|PDB:2Q3Z""; STRAND 97..105; /evidence=""ECO:0007829|PDB:2Q3Z""; STRAND 113..123; /evidence=""ECO:0007829|PDB:2Q3Z""; STRAND 126..138; /evidence=""ECO:0007829|PDB:2Q3Z""; STRAND 164..170; /evidence=""ECO:0007829|PDB:2Q3Z""; STRAND 172..181; /evidence=""ECO:0007829|PDB:2Q3Z""; STRAND 235..239; /evidence=""ECO:0007829|PDB:2Q3Z""; STRAND 255..257; /evidence=""ECO:0007829|PDB:4PYG""; STRAND 272..275; /evidence=""ECO:0007829|PDB:2Q3Z""; STRAND 295..304; /evidence=""ECO:0007829|PDB:2Q3Z""; STRAND 306..309; /evidence=""ECO:0007829|PDB:1KV3""; STRAND 332..342; /evidence=""ECO:0007829|PDB:2Q3Z""; STRAND 347..350; /evidence=""ECO:0007829|PDB:3LY6""; STRAND 353..357; /evidence=""ECO:0007829|PDB:2Q3Z""; STRAND 365..369; /evidence=""ECO:0007829|PDB:2Q3Z""; STRAND 400..404; /evidence=""ECO:0007829|PDB:2Q3Z""; STRAND 412..414; /evidence=""ECO:0007829|PDB:6A8P""; STRAND 419..429; /evidence=""ECO:0007829|PDB:2Q3Z""; STRAND 433..438; /evidence=""ECO:0007829|PDB:2Q3Z""; STRAND 447..449; /evidence=""ECO:0007829|PDB:3LY6""; STRAND 473..478; /evidence=""ECO:0007829|PDB:2Q3Z""; STRAND 489..497; /evidence=""ECO:0007829|PDB:2Q3Z""; STRAND 499..501; /evidence=""ECO:0007829|PDB:2Q3Z""; STRAND 503..514; /evidence=""ECO:0007829|PDB:2Q3Z""; STRAND 520..534; /evidence=""ECO:0007829|PDB:2Q3Z""; STRAND 538..546; /evidence=""ECO:0007829|PDB:2Q3Z""; STRAND 560..569; /evidence=""ECO:0007829|PDB:2Q3Z""; STRAND 574..583; /evidence=""ECO:0007829|PDB:2Q3Z""; STRAND 590..595; /evidence=""ECO:0007829|PDB:2Q3Z""; STRAND 598..601; /evidence=""ECO:0007829|PDB:2Q3Z""; STRAND 603..610; /evidence=""ECO:0007829|PDB:2Q3Z""; STRAND 613..615; /evidence=""ECO:0007829|PDB:2Q3Z""; STRAND 619..625; /evidence=""ECO:0007829|PDB:2Q3Z""; STRAND 634..638; /evidence=""ECO:0007829|PDB:2Q3Z""; STRAND 647..654; /evidence=""ECO:0007829|PDB:2Q3Z""; STRAND 658..660; /evidence=""ECO:0007829|PDB:2Q3Z""; STRAND 662..669; /evidence=""ECO:0007829|PDB:2Q3Z""; STRAND 671..673; /evidence=""ECO:0007829|PDB:2Q3Z""; STRAND 676..682; /evidence=""ECO:0007829|PDB:2Q3Z""","HELIX 14..20; /evidence=""ECO:0007829|PDB:2Q3Z""; HELIX 24..26; /evidence=""ECO:0007829|PDB:2Q3Z""; HELIX 153..159; /evidence=""ECO:0007829|PDB:2Q3Z""; HELIX 189..198; /evidence=""ECO:0007829|PDB:2Q3Z""; HELIX 201..205; /evidence=""ECO:0007829|PDB:2Q3Z""; HELIX 207..213; /evidence=""ECO:0007829|PDB:2Q3Z""; HELIX 217..226; /evidence=""ECO:0007829|PDB:2Q3Z""; HELIX 258..266; /evidence=""ECO:0007829|PDB:2Q3Z""; HELIX 277..291; /evidence=""ECO:0007829|PDB:2Q3Z""; HELIX 311..317; /evidence=""ECO:0007829|PDB:2Q3Z""; HELIX 376..380; /evidence=""ECO:0007829|PDB:2Q3Z""; HELIX 390..397; /evidence=""ECO:0007829|PDB:2Q3Z""; HELIX 440..443; /evidence=""ECO:0007829|PDB:2Q3Z""; HELIX 450..460; /evidence=""ECO:0007829|PDB:2Q3Z""; HELIX 548..551; /evidence=""ECO:0007829|PDB:2Q3Z""","TURN 52..54; /evidence=""ECO:0007829|PDB:2Q3Z""; TURN 69..72; /evidence=""ECO:0007829|PDB:2Q3Z""; TURN 227..229; /evidence=""ECO:0007829|PDB:2Q3Z""; TURN 231..234; /evidence=""ECO:0007829|PDB:2Q3Z""; TURN 251..253; /evidence=""ECO:0007829|PDB:2Q3Z""; TURN 267..269; /evidence=""ECO:0007829|PDB:2Q3Z""; TURN 387..389; /evidence=""ECO:0007829|PDB:2Q3Z""; TURN 468..471; /evidence=""ECO:0007829|PDB:3LY6""; TURN 552..554; /evidence=""ECO:0007829|PDB:2Q3Z""; TURN 570..573; /evidence=""ECO:0007829|PDB:2Q3Z""; TURN 627..629; /evidence=""ECO:0007829|PDB:2Q3Z""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,TGM2,Protein-glutamine gamma-glutamyltransferase 2 (EC 2.3.2.13) (Erythrocyte transglutaminase) (Heart G alpha(h)) (hhG alpha(h)) (Isopeptidase TGM2) (EC 3.4.-.-) (Protein G alpha(h)) (G(h)) (Protein-glutamine deamidase TGM2) (EC 3.5.1.44) (Protein-glutamine dopaminyltransferase TGM2) (EC 2.3.1.-) (Protein-glutamine histaminyltransferase TGM2) (EC 2.3.1.-) (Protein-glutamine noradrenalinyltransferase TGM2) (EC 2.3.1.-) (Protein-glutamine serotonyltransferase TGM2) (EC 2.3.1.-) (Tissue transglutaminase) (tTG) (tTgase) (Transglutaminase C) (TG(C)) (TGC) (TGase C) (Transglutaminase H) (TGase H) (Transglutaminase II) (TGase II) (Transglutaminase-2) (TG2) (TGase-2) (hTG2),Homo sapiens (Human),687.0,77329.0,MAEELVLERCDLELETNGRDHHTADLCREKLVVRRGQPFWLTLHFEGRNYEASVDSLTFSVVTGPAPSQEAGTKARFPLRDAVEEGDWTATVVDQQDCTLSLQLTTPANAPIGLYRLSLEASTGYQGSSFVLGHFILLFNAWCPADAVYLDSEEERQEYVLTQQGFIYQGSAKFIKNIPWNFGQFEDGILDICLILLDVNPKFLKNAGRDCSRRSSPVYVGRVVSGMVNCNDDQGVLLGRWDNNYGDGVSPMSWIGSVDILRRWKNHGCQRVKYGQCWVFAAVACTVLRCLGIPTRVVTNYNSAHDQNSNLLIEYFRNEFGEIQGDKSEMIWNFHCWVESWMTRPDLQPGYEGWQALDPTPQEKSEGTYCCGPVPVRAIKEGDLSTKYDAPFVFAEVNADVVDWIQQDDGSVHKSINRSLIVGLKISTKSVGRDEREDITHTYKYPEGSSEEREAFTRANHLNKLAEKEETGMAMRIRVGQSMNMGSDFDVFAHITNNTAEEYVCRLLLCARTVSYNGILGPECGTKYLLNLNLEPFSEKSVPLCILYEKYRDCLTESNLIKVRALLVEPVINSYLLAERDLYLENPEIKIRILGEPKQKRKLVAEVSLQNPLPVALEGCTFTVEGAGLTEEQKTVEIPDPVEAGEEVKVRMDLLPLHMGLHKLVVNFESDKLKAVKGFRNVIIGPA,True,True,False,P21980,"[('G3DSA:2.60.40.10', 'Immunoglobulins'), ('G3DSA:3.90.260.10', 'Transglutaminase-like'), ('IPR001102', 'Transglutaminase, N-terminal'), ('IPR002931', 'Transglutaminase-like'), ('IPR008958', 'Transglutaminase, C-terminal'), ('IPR013783', 'Immunoglobulin-like fold'), ('IPR013808', 'Transglutaminase, active site'), ('IPR014756', 'Immunoglobulin E-set'), ('IPR023608', 'Protein-glutamine gamma-glutamyltransferase, animal'), ('IPR036238', 'Transglutaminase, C-terminal domain superfamily'), ('IPR036985', 'Transglutaminase-like superfamily'), ('IPR038765', 'Papain-like cysteine peptidase superfamily'), ('IPR050779', 'Protein-glutamine gamma-glutamyltransferases'), ('PF00868', 'Transglutaminase family'), ('PF00927', 'Transglutaminase family, C-terminal ig like domain'), ('PF01841', 'Transglutaminase-like superfamily'), ('PIRSF000459', 'Protein-glutamine gamma-glutamyltransferase/erythrocyte membrane protein band 4.2'), ('PS00547', 'Transglutaminases active site'), ('PTHR11590', 'Protein-glutamine gamma-glutamyltransferases'), ('SM00460', 'Transglutaminase/protease-like homologues')]",,"""ENSG00000198959; Tissue enhanced (cervix)."";","CATALYTIC ACTIVITY: Reaction=L-glutaminyl-[protein] + L-lysyl-[protein] = [protein]-L-lysyl-N(6)-5-L-glutamyl-[protein] + NH4(+); Xref=Rhea:RHEA:54816, Rhea:RHEA-COMP:9752, Rhea:RHEA-COMP:10207, Rhea:RHEA-COMP:14005, ChEBI:CHEBI:28938, ChEBI:CHEBI:29969, ChEBI:CHEBI:30011, ChEBI:CHEBI:138370; EC=2.3.2.13; Evidence={ECO:0000255|PROSITE-ProRule:PRU10024, ECO:0000269|PubMed:23941696, ECO:0000269|PubMed:24349085, ECO:0000269|PubMed:31991788}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:54817; Evidence={ECO:0000269|PubMed:23941696, ECO:0000269|PubMed:24349085, ECO:0000269|PubMed:31991788}; CATALYTIC ACTIVITY: Reaction=L-glutaminyl-[protein] + serotonin = 5-serotonyl-L-glutamyl-[protein] + NH4(+); Xref=Rhea:RHEA:66552, Rhea:RHEA-COMP:10207, Rhea:RHEA-COMP:17052, ChEBI:CHEBI:28938, ChEBI:CHEBI:30011, ChEBI:CHEBI:167174, ChEBI:CHEBI:350546; Evidence={ECO:0000269|PubMed:30867594}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:66553; Evidence={ECO:0000269|PubMed:30867594}; CATALYTIC ACTIVITY: Reaction=L-glutaminyl-[protein] + dopamine = 5-dopaminyl-L-glutamyl-[protein] + NH4(+); Xref=Rhea:RHEA:66556, Rhea:RHEA-COMP:10207, Rhea:RHEA-COMP:17053, ChEBI:CHEBI:28938, ChEBI:CHEBI:30011, ChEBI:CHEBI:59905, ChEBI:CHEBI:167175; Evidence={ECO:0000269|PubMed:32273471}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:66557; Evidence={ECO:0000269|PubMed:32273471}; CATALYTIC ACTIVITY: Reaction=L-glutaminyl-[protein] + histamine = 5-histaminyl-L-glutamyl-[protein] + NH4(+); Xref=Rhea:RHEA:66564, Rhea:RHEA-COMP:10207, Rhea:RHEA-COMP:17056, ChEBI:CHEBI:28938, ChEBI:CHEBI:30011, ChEBI:CHEBI:58432, ChEBI:CHEBI:167179; Evidence={ECO:0000269|PubMed:23797785}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:66565; Evidence={ECO:0000269|PubMed:23797785}; CATALYTIC ACTIVITY: Reaction=L-glutaminyl-[protein] + (R)-noradrenaline = 5-(R)-noradrenalinyl-L-glutamyl-[protein] + NH4(+); Xref=Rhea:RHEA:66560, Rhea:RHEA-COMP:10207, Rhea:RHEA-COMP:17054, ChEBI:CHEBI:28938, ChEBI:CHEBI:30011, ChEBI:CHEBI:72587, ChEBI:CHEBI:167178; Evidence={ECO:0000250|UniProtKB:P08587}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:66561; Evidence={ECO:0000250|UniProtKB:P08587}; CATALYTIC ACTIVITY: Reaction=L-glutaminyl-[protein] + H2O = L-glutamyl-[protein] + NH4(+); Xref=Rhea:RHEA:16441, Rhea:RHEA-COMP:10207, Rhea:RHEA-COMP:10208, ChEBI:CHEBI:15377, ChEBI:CHEBI:28938, ChEBI:CHEBI:29973, ChEBI:CHEBI:30011; EC=3.5.1.44; Evidence={ECO:0000269|PubMed:20547769, ECO:0000269|PubMed:9623982}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:16442; Evidence={ECO:0000269|PubMed:20547769, ECO:0000269|PubMed:9623982};",2.3.1.-; 2.3.2.13; 3.4.-.-; 3.5.1.44,"ACTIVITY REGULATION: Acyltransferase activity is regulated by the binding of GTP and Ca(2+): inactivated by GTP, which stabilizes its closed structure, thereby obstructing the accessibility of substrates to the active sites (PubMed:18092889, PubMed:2903073, PubMed:31991788, PubMed:7592956). In contrast, Ca(2+) acts as a cofactor by inducing conformational change to the active open form (PubMed:18092889, PubMed:2903073, PubMed:31991788). In absence of Ca(2+), Mg(2+) may bind Ca(2+)-binding sites, promoting GTP-binding and subsequent inhibition of the acyltransferase activity (PubMed:31991788). Extracellularly reduced and activated by CLIC3 (PubMed:28198360). Specifically inhibited by compound VA4 ((S)-Benzyl (6-Acrylamido-1-(4-((5-(dimethylamino)naphthalen-1-yl)sulfonyl)piperazin-1-yl)-1-oxohexan-2-yl)carbamate), which specifically abolishes both the transamidation and GTP-binding activities (PubMed:28858494). {ECO:0000269|PubMed:18092889, ECO:0000269|PubMed:28198360, ECO:0000269|PubMed:28858494, ECO:0000269|PubMed:2903073, ECO:0000269|PubMed:31991788, ECO:0000269|PubMed:7592956}.",,ENST00000361475.7 [P21980-1];,TGM2,ENSG00000198959,0.0,,,,,,,,,TGM2
P22090,ENSG00000129824,RS4Y1_HUMAN,translation [GO:0006412],cytosol [GO:0005829]; cytosolic small ribosomal subunit [GO:0022627]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribosome [GO:0005840],RNA binding [GO:0003723]; rRNA binding [GO:0019843]; structural constituent of ribosome [GO:0003735],,,"DOMAIN 42..104; /note=""S4 RNA-binding""",,,,"cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,RPS4Y1 RPS4Y PRO2646,"Small ribosomal subunit protein eS4, Y isoform 1 (40S ribosomal protein S4)",Homo sapiens (Human),263.0,29456.0,MARGPKKHLKRVAAPKHWMLDKLTGVFAPRPSTGPHKLRECLPLIVFLRNRLKYALTGDEVKKICMQRFIKIDGKVRVDVTYPAGFMDVISIEKTGEHFRLVYDTKGRFAVHRITVEEAKYKLCKVRKITVGVKGIPHLVTHDARTIRYPDPVIKVNDTVQIDLGTGKIINFIKFDTGNLCMVIGGANLGRVGVITNRERHPGSFDVVHVKDANGNSFATRLSNIFVIGNGNKPWISLPRGKGIRLTVAEERDKRLATKQSSG,True,False,False,P22090,"[('cd00165', 'S4'), ('cd06087', 'KOW motif of Ribosomal Protein S4 (RPS4)'), ('G3DSA:2.30.30.30', None), ('G3DSA:2.40.50.740', None), ('G3DSA:3.10.290.10', 'RNA-binding S4 domain'), ('IPR000876', 'Small ribosomal subunit protein eS4'), ('IPR002942', 'RNA-binding S4 domain'), ('IPR005824', 'KOW'), ('IPR013843', 'Small ribosomal subunit protein eS4, N-terminal'), ('IPR013845', 'Small ribosomal subunit protein eS4, central region'), ('IPR014722', 'Large ribosomal subunit protein uL2, domain 2'), ('IPR018199', 'Small ribosomal subunit protein eS4, N-terminal, conserved site'), ('IPR032277', 'Small ribosomal subunit protein eS4, C-terminal domain'), ('IPR036986', 'RNA-binding S4 domain superfamily'), ('IPR038237', 'Small ribosomal subunit protein eS4, central domain superfamily'), ('IPR041982', 'Small ribosomal subunit protein eS4, KOW domain'), ('MF_00485', 'Small ribosomal subunit protein eS4 [rps4e]'), ('PF00467', 'KOW motif'), ('PF00900', 'Ribosomal family S4e'), ('PF08071', 'RS4NT (NUC023) domain')]",,"""ENSG00000129824; Low tissue specificity."";",,,,,ENST00000250784.13;,RPS4Y1,ENSG00000129824,0.0,RPS4Y1,Canonical_RBPs,4.0,,,,0.068,,RPS4Y1
P22736,ENSG00000123358,NR4A1_HUMAN,apoptotic process [GO:0006915]; cell migration involved in sprouting angiogenesis [GO:0002042]; cellular response to corticotropin-releasing hormone stimulus [GO:0071376]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; detection of lipopolysaccharide [GO:0032497]; endothelial cell chemotaxis [GO:0035767]; fat cell differentiation [GO:0045444]; inflammatory response [GO:0006954]; negative regulation of cell cycle [GO:0045786]; neurotransmitter secretion involved in regulation of skeletal muscle contraction [GO:0014860]; non-canonical inflammasome complex assembly [GO:0160075]; positive regulation of apoptotic process [GO:0043065]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of type B pancreatic cell proliferation [GO:0061469]; response to amphetamine [GO:0001975]; response to electrical stimulus [GO:0051602]; signal transduction [GO:0007165]; skeletal muscle cell differentiation [GO:0035914]; transcription by RNA polymerase II [GO:0006366],chromatin [GO:0000785]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; presynapse [GO:0098793]; transcription regulator complex [GO:0005667],"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; identical protein binding [GO:0042802]; lipopolysaccharide binding [GO:0001530]; nuclear glucocorticoid receptor binding [GO:0035259]; nuclear receptor activity [GO:0004879]; protein heterodimerization activity [GO:0046982]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270]","PTM: Phosphorylated at Ser-351 by RPS6KA1 and RPS6KA3 in response to mitogenic or stress stimuli. {ECO:0000269|PubMed:17360704}.; PTM: Acetylated by p300/CBP, acetylation increases stability. Deacetylated by HDAC1. {ECO:0000269|PubMed:20438716}.",DOMAIN: The NR LBD domain binds the lipid A moiety of lipopolysaccharide (LPS) in the cytosol. {ECO:0000269|PubMed:37001519}.,"DOMAIN 360..595; /note=""NR LBD""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU01189""","STRAND 276..278; /evidence=""ECO:0007829|PDB:6LC1""; STRAND 281..283; /evidence=""ECO:0007829|PDB:6LC1""; STRAND 395..397; /evidence=""ECO:0007829|PDB:4REF""; STRAND 461..463; /evidence=""ECO:0007829|PDB:4RZF""; STRAND 467..471; /evidence=""ECO:0007829|PDB:4RZF""","HELIX 286..297; /evidence=""ECO:0007829|PDB:6LC1""; HELIX 320..329; /evidence=""ECO:0007829|PDB:6LC1""; HELIX 364..373; /evidence=""ECO:0007829|PDB:4RZF""; HELIX 379..381; /evidence=""ECO:0007829|PDB:4RZF""; HELIX 400..422; /evidence=""ECO:0007829|PDB:4RZF""; HELIX 427..429; /evidence=""ECO:0007829|PDB:4RZF""; HELIX 432..454; /evidence=""ECO:0007829|PDB:4RZF""; HELIX 457..459; /evidence=""ECO:0007829|PDB:4RZF""; HELIX 472..479; /evidence=""ECO:0007829|PDB:4RZF""; HELIX 482..495; /evidence=""ECO:0007829|PDB:4RZF""; HELIX 500..511; /evidence=""ECO:0007829|PDB:4RZF""; HELIX 521..541; /evidence=""ECO:0007829|PDB:4RZF""; HELIX 550..556; /evidence=""ECO:0007829|PDB:4RZF""; HELIX 558..579; /evidence=""ECO:0007829|PDB:4RZF""; HELIX 586..594; /evidence=""ECO:0007829|PDB:4RZF""","TURN 268..270; /evidence=""ECO:0007829|PDB:6LC1""; TURN 314..317; /evidence=""ECO:0007829|PDB:6LC1""; TURN 544..546; /evidence=""ECO:0007829|PDB:3V3Q""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,NR4A1 GFRP1 HMR NAK1,Nuclear receptor subfamily 4immunitygroup A member 1 (Early response protein NAK1) (Nuclear hormone receptor NUR/77) (Nur77) (Orphan nuclear receptor HMR) (Orphan nuclear receptor TR3) (ST-59) (Testicular receptor 3),Homo sapiens (Human),598.0,64463.0,MPCIQAQYGTPAPSPGPRDHLASDPLTPEFIKPTMDLASPEAAPAAPTALPSFSTFMDGYTGEFDTFLYQLPGTVQPCSSASSSASSTSSSSATSPASASFKFEDFQVYGCYPGPLSGPVDEALSSSGSDYYGSPCSAPSPSTPSFQPPQLSPWDGSFGHFSPSQTYEGLRAWTEQLPKASGPPQPPAFFSFSPPTGPSPSLAQSPLKLFPSQATHQLGEGESYSMPTAFPGLAPTSPHLEGSGILDTPVTSTKARSGAPGGSEGRCAVCGDNASCQHYGVRTCEGCKGFFKRTVQKNAKYICLANKDCPVDKRRRNRCQFCRFQKCLAVGMVKEVVRTDSLKGRRGRLPSKPKQPPDASPANLLTSLVRAHLDSGPSTAKLDYSKFQELVLPHFGKEDAGDVQQFYDLLSGSLEVIRKWAEKIPGFAELSPADQDLLLESAFLELFILRLAYRSKPGEGKLIFCSGLVLHRLQCARGFGDWIDSILAFSRSLHSLLVDVPAFACLSALVLITDRHGLQEPRRVEELQNRIASCLKEHVAAVAGEPQPASCLSRLLGKLPELRTLCTQGLQRIFYLKLEDLVPPPPIIDKIFMDTLPF,False,False,True,P22736,"[('cd06969', 'DNA-binding domain of the orphan nuclear receptor, nerve growth factor-induced-B'), ('cd07348', 'The ligand binding domain of Nurr1, a member of conserved family of nuclear receptors'), ('G3DSA:1.10.565.10', 'Retinoid X Receptor'), ('G3DSA:3.30.50.10', 'Erythroid Transcription Factor GATA-1, subunit A'), ('IPR000536', 'Nuclear hormone receptor, ligand-binding domain'), ('IPR001628', 'Zinc finger, nuclear hormone receptor-type'), ('IPR001723', 'Nuclear hormone receptor'), ('IPR003070', 'Nuclear receptor subfamily 4 group A member 1-3'), ('IPR003071', 'Nuclear receptor subfamily 4 group A member 1'), ('IPR013088', 'Zinc finger, NHR/GATA-type'), ('IPR035500', 'Nuclear hormone receptor-like domain superfamily'), ('PF00104', 'Ligand-binding domain of nuclear hormone receptor'), ('PF00105', 'Double treble clef zinc finger, C4 type'), ('PR00047', 'STROIDFINGER'), ('PR00398', 'STRDHORMONER'), ('PR01284', 'NUCLEARECPTR'), ('PR01285', 'HMRNUCRECPTR'), ('PS00031', 'Nuclear hormones receptors DNA-binding region signature'), ('PS51030', 'Nuclear hormone receptors DNA-binding domain profile'), ('PS51843', 'Nuclear receptor (NR) ligand-binding (LBD) domain profile')]",,"""ENSG00000123358; Low tissue specificity."";",,,"ACTIVITY REGULATION: Its transcription factor activity is activated by binding cytosporone B (Csn-B) via its ligand-binding (NR LBD) domain and stimulates recruitment of coactivators NCOA1 and NCOA2, but not NCOA3, to promoters (PubMed:18690216). Csn-B-binding is also accompanied by its translocation to the mitochondrion (PubMed:18690216). Its transcription factor activity is activated by corticotropin-releasing hormone (CRH) and forskolin (PubMed:9315652). Not activated by binding cytosporone C (Csn-C) (PubMed:18690216). {ECO:0000269|PubMed:18690216, ECO:0000269|PubMed:9315652}.",,ENST00000243050.5 [P22736-1];ENST00000360284.7 [P22736-2];ENST00000394824.2 [P22736-1];ENST00000394825.6 [P22736-1];ENST00000548232.1 [P22736-3];ENST00000550082.5 [P22736-2];,NR4A1;LINC02229,ENSG00000123358;ENSG00000250313,0.0,,,,,,,0.487,0.281,NR4A1
P23219,ENSG00000095303,PGH1_HUMAN,cyclooxygenase pathway [GO:0019371]; prostaglandin biosynthetic process [GO:0001516]; regulation of blood pressure [GO:0008217]; regulation of cell population proliferation [GO:0042127]; response to oxidative stress [GO:0006979],cytoplasm [GO:0005737]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; neuron projection [GO:0043005]; photoreceptor outer segment [GO:0001750],"heme binding [GO:0020037]; metal ion binding [GO:0046872]; oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen [GO:0016702]; peroxidase activity [GO:0004601]; prostaglandin-endoperoxide synthase activity [GO:0004666]",,,"DOMAIN 31..69; /note=""EGF-like""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""","STRAND 45..49; /evidence=""ECO:0007829|PDB:6Y3C""; STRAND 53..57; /evidence=""ECO:0007829|PDB:6Y3C""; STRAND 61..64; /evidence=""ECO:0007829|PDB:6Y3C""; STRAND 129..132; /evidence=""ECO:0007829|PDB:6Y3C""; STRAND 148..151; /evidence=""ECO:0007829|PDB:6Y3C""; STRAND 158..160; /evidence=""ECO:0007829|PDB:6Y3C""; STRAND 163..166; /evidence=""ECO:0007829|PDB:6Y3C""; STRAND 217..221; /evidence=""ECO:0007829|PDB:6Y3C""; STRAND 235..237; /evidence=""ECO:0007829|PDB:6Y3C""; STRAND 254..256; /evidence=""ECO:0007829|PDB:6Y3C""; STRAND 259..261; /evidence=""ECO:0007829|PDB:6Y3C""; STRAND 287..290; /evidence=""ECO:0007829|PDB:6Y3C""; STRAND 366..368; /evidence=""ECO:0007829|PDB:6Y3C""; STRAND 392..394; /evidence=""ECO:0007829|PDB:6Y3C""; STRAND 427..429; /evidence=""ECO:0007829|PDB:6Y3C""; STRAND 475..477; /evidence=""ECO:0007829|PDB:6Y3C""; STRAND 516..518; /evidence=""ECO:0007829|PDB:6Y3C""; STRAND 570..573; /evidence=""ECO:0007829|PDB:6Y3C""; STRAND 578..580; /evidence=""ECO:0007829|PDB:6Y3C""","HELIX 34..37; /evidence=""ECO:0007829|PDB:6Y3C""; HELIX 73..79; /evidence=""ECO:0007829|PDB:6Y3C""; HELIX 85..91; /evidence=""ECO:0007829|PDB:6Y3C""; HELIX 96..103; /evidence=""ECO:0007829|PDB:6Y3C""; HELIX 107..120; /evidence=""ECO:0007829|PDB:6Y3C""; HELIX 138..142; /evidence=""ECO:0007829|PDB:6Y3C""; HELIX 173..179; /evidence=""ECO:0007829|PDB:6Y3C""; HELIX 195..205; /evidence=""ECO:0007829|PDB:6Y3C""; HELIX 230..233; /evidence=""ECO:0007829|PDB:6Y3C""; HELIX 238..243; /evidence=""ECO:0007829|PDB:6Y3C""; HELIX 291..293; /evidence=""ECO:0007829|PDB:6Y3C""; HELIX 295..318; /evidence=""ECO:0007829|PDB:6Y3C""; HELIX 324..345; /evidence=""ECO:0007829|PDB:6Y3C""; HELIX 347..352; /evidence=""ECO:0007829|PDB:6Y3C""; HELIX 362..365; /evidence=""ECO:0007829|PDB:6Y3C""; HELIX 378..383; /evidence=""ECO:0007829|PDB:6Y3C""; HELIX 387..389; /evidence=""ECO:0007829|PDB:6Y3C""; HELIX 403..406; /evidence=""ECO:0007829|PDB:6Y3C""; HELIX 412..425; /evidence=""ECO:0007829|PDB:6Y3C""; HELIX 441..443; /evidence=""ECO:0007829|PDB:6Y3C""; HELIX 444..456; /evidence=""ECO:0007829|PDB:6Y3C""; HELIX 462..468; /evidence=""ECO:0007829|PDB:6Y3C""; HELIX 478..481; /evidence=""ECO:0007829|PDB:6Y3C""; HELIX 484..494; /evidence=""ECO:0007829|PDB:6Y3C""; HELIX 497..499; /evidence=""ECO:0007829|PDB:6Y3C""; HELIX 502..507; /evidence=""ECO:0007829|PDB:6Y3C""; HELIX 519..533; /evidence=""ECO:0007829|PDB:6Y3C""; HELIX 537..539; /evidence=""ECO:0007829|PDB:6Y3C""; HELIX 552..558; /evidence=""ECO:0007829|PDB:6Y3C""; HELIX 564..567; /evidence=""ECO:0007829|PDB:6Y3C""","TURN 50..52; /evidence=""ECO:0007829|PDB:6Y3C""; TURN 65..68; /evidence=""ECO:0007829|PDB:6Y3C""; TURN 206..208; /evidence=""ECO:0007829|PDB:6Y3C""; TURN 213..215; /evidence=""ECO:0007829|PDB:6Y3C""; TURN 265..267; /evidence=""ECO:0007829|PDB:6Y3C""; TURN 280..282; /evidence=""ECO:0007829|PDB:6Y3C""; TURN 541..543; /evidence=""ECO:0007829|PDB:6Y3C""; TURN 546..550; /evidence=""ECO:0007829|PDB:6Y3C""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,PTGS1 COX1,Prostaglandin G/H synthase 1 (EC 1.14.99.1) (Cyclooxygenase-1) (COX-1) (Prostaglandin H2 synthase 1) (PGH synthase 1) (PGHS-1) (PHS 1) (Prostaglandin-endoperoxide synthase 1),Homo sapiens (Human),599.0,68686.0,MSRSLLLWFLLFLLLLPPLPVLLADPGAPTPVNPCCYYPCQHQGICVRFGLDRYQCDCTRTGYSGPNCTIPGLWTWLRNSLRPSPSFTHFLLTHGRWFWEFVNATFIREMLMRLVLTVRSNLIPSPPTYNSAHDYISWESFSNVSYYTRILPSVPKDCPTPMGTKGKKQLPDAQLLARRFLLRRKFIPDPQGTNLMFAFFAQHFTHQFFKTSGKMGPGFTKALGHGVDLGHIYGDNLERQYQLRLFKDGKLKYQVLDGEMYPPSVEEAPVLMHYPRGIPPQSQMAVGQEVFGLLPGLMLYATLWLREHNRVCDLLKAEHPTWGDEQLFQTTRLILIGETIKIVIEEYVQQLSGYFLQLKFDPELLFGVQFQYRNRIAMEFNHLYHWHPLMPDSFKVGSQEYSYEQFLFNTSMLVDYGVEALVDAFSRQIAGRIGGGRNMDHHILHVAVDVIRESREMRLQPFNEYRKRFGMKPYTSFQELVGEKEMAAELEELYGDIDALEFYPGLLLEKCHPNSIFGESMIEIGAPFSLKGLLGNPICSPEYWKPSTFGGEVGFNIVKTATLKKLVCLNTKTCPYVSFRVPDASQDDGPAVERPSTEL,True,False,True,P23219,"[('cd00054', 'EGF_CA'), ('cd09816', 'Animal prostaglandin endoperoxide synthase and related bacterial proteins'), ('G3DSA:1.10.640.10', 'Haem peroxidase domain superfamily, animal type'), ('G3DSA:2.10.25.10', 'Laminin'), ('IPR000742', 'EGF-like domain'), ('IPR010255', 'Haem peroxidase superfamily'), ('IPR019791', 'Haem peroxidase, animal-type'), ('IPR037120', 'Haem peroxidase domain superfamily, animal type'), ('IPR050783', 'Oxylipin biosynthesis and metabolism'), ('PF03098', 'Animal haem peroxidase'), ('PR00457', 'ANPEROXIDASE'), ('PS50026', 'EGF-like domain profile'), ('PS50292', 'Animal heme peroxidase superfamily profile'), ('PTHR11903', 'Oxylipin biosynthesis and metabolism'), ('SSF48113', 'Heme-dependent peroxidases'), ('SSF57196', 'EGF/Laminin')]",,"""ENSG00000095303; Tissue enhanced (intestine, skin, urinary bladder)."";","CATALYTIC ACTIVITY: Reaction=(5Z,8Z,11Z,14Z)-eicosatetraenoate + AH2 + 2 O2 = prostaglandin H2 + A + H2O; Xref=Rhea:RHEA:23728, ChEBI:CHEBI:13193, ChEBI:CHEBI:15377, ChEBI:CHEBI:15379, ChEBI:CHEBI:17499, ChEBI:CHEBI:32395, ChEBI:CHEBI:57405; EC=1.14.99.1; Evidence={ECO:0000269|PubMed:7947975}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:23729; Evidence={ECO:0000305|PubMed:7947975}; CATALYTIC ACTIVITY: Reaction=(5Z,8Z,11Z,14Z)-eicosatetraenoate + 2 O2 = prostaglandin G2; Xref=Rhea:RHEA:42596, ChEBI:CHEBI:15379, ChEBI:CHEBI:32395, ChEBI:CHEBI:82629; Evidence={ECO:0000269|PubMed:7947975}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:42597; Evidence={ECO:0000305|PubMed:7947975}; CATALYTIC ACTIVITY: Reaction=prostaglandin G2 + AH2 = prostaglandin H2 + A + H2O; Xref=Rhea:RHEA:42600, ChEBI:CHEBI:13193, ChEBI:CHEBI:15377, ChEBI:CHEBI:17499, ChEBI:CHEBI:57405, ChEBI:CHEBI:82629; Evidence={ECO:0000269|PubMed:7947975}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:42601; Evidence={ECO:0000305|PubMed:7947975}; CATALYTIC ACTIVITY: Reaction=(9Z,12Z)-octadecadienoate + AH2 + O2 = (9R)-hydroxy-(10E,12Z)-octadecadienoate + A + H2O; Xref=Rhea:RHEA:75447, ChEBI:CHEBI:13193, ChEBI:CHEBI:15377, ChEBI:CHEBI:15379, ChEBI:CHEBI:17499, ChEBI:CHEBI:30245, ChEBI:CHEBI:77895; Evidence={ECO:0000250|UniProtKB:P05979}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:75448; Evidence={ECO:0000250|UniProtKB:P05979}; CATALYTIC ACTIVITY: Reaction=(9Z,12Z)-octadecadienoate + AH2 + O2 = (9S)-hydroxy-(10E,12Z)-octadecadienoate + A + H2O; Xref=Rhea:RHEA:75459, ChEBI:CHEBI:13193, ChEBI:CHEBI:15377, ChEBI:CHEBI:15379, ChEBI:CHEBI:17499, ChEBI:CHEBI:30245, ChEBI:CHEBI:77852; Evidence={ECO:0000250|UniProtKB:P05979}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:75460; Evidence={ECO:0000250|UniProtKB:P05979}; CATALYTIC ACTIVITY: Reaction=(9Z,12Z)-octadecadienoate + AH2 + O2 = (13S)-hydroxy-(9Z,11E)-octadecadienoate + A + H2O; Xref=Rhea:RHEA:75451, ChEBI:CHEBI:13193, ChEBI:CHEBI:15377, ChEBI:CHEBI:15379, ChEBI:CHEBI:17499, ChEBI:CHEBI:30245, ChEBI:CHEBI:90850; Evidence={ECO:0000250|UniProtKB:P05979}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:75452; Evidence={ECO:0000250|UniProtKB:P05979}; CATALYTIC ACTIVITY: Reaction=(9Z,12Z)-octadecadienoate + AH2 + O2 = (13R)-hydroxy-(9Z,11E)-octadecadienoate + A + H2O; Xref=Rhea:RHEA:75455, ChEBI:CHEBI:13193, ChEBI:CHEBI:15377, ChEBI:CHEBI:15379, ChEBI:CHEBI:17499, ChEBI:CHEBI:30245, ChEBI:CHEBI:136655; Evidence={ECO:0000250|UniProtKB:P05979}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:75456; Evidence={ECO:0000250|UniProtKB:P05979};",1.14.99.1,"ACTIVITY REGULATION: The cyclooxygenase activity is inhibited by nonsteroidal anti-inflammatory drugs (NSAIDs) including ibuprofen, flurbiprofen, ketoprofen, naproxen, flurbiprofen, anirolac, fenclofenac and diclofenac. {ECO:0000269|PubMed:7947975}.",PATHWAY: Lipid metabolism; prostaglandin biosynthesis. {ECO:0000269|PubMed:7947975}.,ENST00000223423.8 [P23219-2];ENST00000362012.7 [P23219-1];ENST00000373698.7 [P23219-4];ENST00000540753.6 [P23219-3];,PTGS1;LINC02537,ENSG00000095303;ENSG00000223469;ENSG00000283215,0.0,,,,,,,0.067,,PTGS1
P23381,ENSG00000140105,SYWC_HUMAN,angiogenesis [GO:0001525]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of protein kinase activity [GO:0006469]; positive regulation of gene expression [GO:0010628]; positive regulation of protein-containing complex assembly [GO:0031334]; regulation of angiogenesis [GO:0045765]; translation [GO:0006412]; tryptophanyl-tRNA aminoacylation [GO:0006436],cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; protein-containing complex [GO:0032991],ATP binding [GO:0005524]; kinase inhibitor activity [GO:0019210]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; tryptophan-tRNA ligase activity [GO:0004830],PTM: Proteolytic cleavage generates 2 forms; T1-TrpRS and T2-TrpRS. {ECO:0000269|PubMed:11773626}.,,"DOMAIN 8..64; /note=""WHEP-TRS""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00531""","STRAND 54..56; /evidence=""ECO:0007829|PDB:1R6T""; STRAND 84..86; /evidence=""ECO:0007829|PDB:1R6U""; STRAND 89..91; /evidence=""ECO:0007829|PDB:1R6U""; STRAND 136..142; /evidence=""ECO:0007829|PDB:1R6U""; STRAND 156..162; /evidence=""ECO:0007829|PDB:1R6U""; STRAND 166..168; /evidence=""ECO:0007829|PDB:5UJJ""; STRAND 191..195; /evidence=""ECO:0007829|PDB:1R6U""; STRAND 232..236; /evidence=""ECO:0007829|PDB:1R6U""; STRAND 271..274; /evidence=""ECO:0007829|PDB:1ULH""; STRAND 304..310; /evidence=""ECO:0007829|PDB:1R6U""; STRAND 333..337; /evidence=""ECO:0007829|PDB:1R6U""; STRAND 345..349; /evidence=""ECO:0007829|PDB:1R6U""; STRAND 354..357; /evidence=""ECO:0007829|PDB:1R6U""; STRAND 360..362; /evidence=""ECO:0007829|PDB:2AZX""; STRAND 379..381; /evidence=""ECO:0007829|PDB:5UJI""; STRAND 423..425; /evidence=""ECO:0007829|PDB:1R6U""","HELIX 8..28; /evidence=""ECO:0007829|PDB:1R6T""; HELIX 33..53; /evidence=""ECO:0007829|PDB:1R6T""; HELIX 103..106; /evidence=""ECO:0007829|PDB:1R6U""; HELIX 114..124; /evidence=""ECO:0007829|PDB:1R6U""; HELIX 130..133; /evidence=""ECO:0007829|PDB:1R6U""; HELIX 143..150; /evidence=""ECO:0007829|PDB:1R6U""; HELIX 171..187; /evidence=""ECO:0007829|PDB:1R6U""; HELIX 197..203; /evidence=""ECO:0007829|PDB:1R6U""; HELIX 208..223; /evidence=""ECO:0007829|PDB:1R6U""; HELIX 229..231; /evidence=""ECO:0007829|PDB:1R6U""; HELIX 237..240; /evidence=""ECO:0007829|PDB:1R6U""; HELIX 241..243; /evidence=""ECO:0007829|PDB:1R6U""; HELIX 247..256; /evidence=""ECO:0007829|PDB:1R6U""; HELIX 260..267; /evidence=""ECO:0007829|PDB:1R6U""; HELIX 275..285; /evidence=""ECO:0007829|PDB:1R6U""; HELIX 286..288; /evidence=""ECO:0007829|PDB:1R6U""; HELIX 290..292; /evidence=""ECO:0007829|PDB:1R6U""; HELIX 294..297; /evidence=""ECO:0007829|PDB:1R6U""; HELIX 311..313; /evidence=""ECO:0007829|PDB:1R6U""; HELIX 314..323; /evidence=""ECO:0007829|PDB:1R6U""; HELIX 324..327; /evidence=""ECO:0007829|PDB:1R6U""; HELIX 365..374; /evidence=""ECO:0007829|PDB:1R6U""; HELIX 384..390; /evidence=""ECO:0007829|PDB:1R6U""; HELIX 398..406; /evidence=""ECO:0007829|PDB:1R6U""; HELIX 410..422; /evidence=""ECO:0007829|PDB:1R6U""; HELIX 430..450; /evidence=""ECO:0007829|PDB:1R6U""; HELIX 454..460; /evidence=""ECO:0007829|PDB:1R6U""","TURN 100..102; /evidence=""ECO:0007829|PDB:1R6U""; TURN 151..153; /evidence=""ECO:0007829|PDB:1R6U""; TURN 224..226; /evidence=""ECO:0007829|PDB:1R6U""; TURN 394..396; /evidence=""ECO:0007829|PDB:1R6U""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,WARS1 IFI53 WARS WRS,"Tryptophan--tRNA ligase, cytoplasmic (EC 6.1.1.2) (Interferon-induced protein 53) (IFP53) (Tryptophanyl-tRNA synthetase) (TrpRS) (hWRS) [Cleaved into: T1-TrpRS; T2-TrpRS]",Homo sapiens (Human),471.0,53165.0,MPNSEPASLLELFNSIATQGELVRSLKAGNASKDEIDSAVKMLVSLKMSYKAAAGEDYKADCPPGNPAPTSNHGPDATEAEEDFVDPWTVQTSSAKGIDYDKLIVRFGSSKIDKELINRIERATGQRPHHFLRRGIFFSHRDMNQVLDAYENKKPFYLYTGRGPSSEAMHVGHLIPFIFTKWLQDVFNVPLVIQMTDDEKYLWKDLTLDQAYSYAVENAKDIIACGFDINKTFIFSDLDYMGMSSGFYKNVVKIQKHVTFNQVKGIFGFTDSDCIGKISFPAIQAAPSFSNSFPQIFRDRTDIQCLIPCAIDQDPYFRMTRDVAPRIGYPKPALLHSTFFPALQGAQTKMSASDPNSSIFLTDTAKQIKTKVNKHAFSGGRDTIEEHRQFGGNCDVDVSFMYLTFFLEDDDKLEQIRKDYTSGAMLTGELKKALIEVLQPLIAEHQARRKEVTDEIVKEFMTPRKLSFDFQ,True,True,False,P23381,"[('cd00806', 'catalytic core domain of tryptophanyl-tRNA synthetase'), ('cd00936', 'WEPRS_RNA'), ('G3DSA:1.10.240.10', 'Tyrosyl-Transfer RNA Synthetase'), ('G3DSA:1.10.287.10', 'S15/NS1, RNA-binding'), ('G3DSA:3.40.50.620', 'HUPs'), ('IPR000738', 'WHEP-TRS domain'), ('IPR001412', 'Aminoacyl-tRNA synthetase, class I, conserved site'), ('IPR002305', 'Aminoacyl-tRNA synthetase, class Ic'), ('IPR002306', 'Tryptophan-tRNA ligase'), ('IPR009068', 'uS15/NS1, RNA-binding domain superfamily'), ('IPR014729', 'Rossmann-like alpha/beta/alpha sandwich fold'), ('PF00458', 'WHEP-TRS domain'), ('PF00579', 'tRNA synthetases class I (W and Y)'), ('PR01039', 'TRNASYNTHTRP'), ('PS00178', 'Aminoacyl-transfer RNA synthetases class-I signature'), ('PS00762', 'WHEP-TRS domain signature'), ('PS51185', 'WHEP-TRS domain profile'), ('PTHR10055', 'Tryptophan--tRNA ligase'), ('SM00991', 'WHEP-TRS'), ('SSF47060', 'S15/NS1 RNA-binding domain')]",,"""ENSG00000140105; Tissue enhanced (placenta)."";","CATALYTIC ACTIVITY: Reaction=tRNA(Trp) + L-tryptophan + ATP = L-tryptophanyl-tRNA(Trp) + AMP + diphosphate + H(+); Xref=Rhea:RHEA:24080, Rhea:RHEA-COMP:9671, Rhea:RHEA-COMP:9705, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616, ChEBI:CHEBI:33019, ChEBI:CHEBI:57912, ChEBI:CHEBI:78442, ChEBI:CHEBI:78535, ChEBI:CHEBI:456215; EC=6.1.1.2; Evidence={ECO:0000269|PubMed:1761529, ECO:0000269|PubMed:28369220}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:24081; Evidence={ECO:0000269|PubMed:28369220};",6.1.1.2,,,ENST00000344102.9 [P23381-2];ENST00000355338.6 [P23381-1];ENST00000358655.8 [P23381-2];ENST00000392882.7 [P23381-1];ENST00000556645.5 [P23381-2];ENST00000557135.5 [P23381-1];,HIVEP1;WARS1,ENSG00000095951;ENSG00000140105;ENSG00000229896,0.0,WARS1,Canonical_RBPs,4.0,,,,0.072,0.045,HIVEP1
P23396,ENSG00000149273,RS3_HUMAN,apoptotic process [GO:0006915]; base-excision repair [GO:0006284]; cell division [GO:0051301]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to reactive oxygen species [GO:0034614]; cellular response to tumor necrosis factor [GO:0071356]; chromosome segregation [GO:0007059]; cytoplasmic translation [GO:0002181]; DNA damage response [GO:0006974]; DNA repair [GO:0006281]; negative regulation of DNA repair [GO:0045738]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of translation [GO:0017148]; positive regulation of activated T cell proliferation [GO:0042104]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of base-excision repair [GO:1905053]; positive regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis [GO:2001272]; positive regulation of DNA repair [GO:0045739]; positive regulation of endodeoxyribonuclease activity [GO:0032079]; positive regulation of gene expression [GO:0010628]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage [GO:1902231]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of non-canonical NF-kappaB signal transduction [GO:1901224]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of T cell receptor signaling pathway [GO:0050862]; regulation of apoptotic process [GO:0042981]; response to TNF agonist [GO:0061481]; spindle assembly [GO:0051225]; translation [GO:0006412]; translational initiation [GO:0006413],cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; membrane [GO:0016020]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitotic spindle [GO:0072686]; NF-kappaB complex [GO:0071159]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; ribonucleoprotein complex [GO:1990904]; ribosome [GO:0005840]; ruffle membrane [GO:0032587],class I DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0140078]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; DNA endonuclease activity [GO:0004520]; DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0003906]; DNA-binding transcription factor binding [GO:0140297]; enzyme binding [GO:0019899]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; iron-sulfur cluster binding [GO:0051536]; kinase binding [GO:0019900]; microtubule binding [GO:0008017]; mRNA binding [GO:0003729]; oxidized purine DNA binding [GO:0032357]; oxidized pyrimidine DNA binding [GO:0032358]; protein kinase A binding [GO:0051018]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; small ribosomal subunit rRNA binding [GO:0070181]; structural constituent of ribosome [GO:0003735]; supercoiled DNA binding [GO:0097100]; tubulin binding [GO:0015631]; ubiquitin-like protein conjugating enzyme binding [GO:0044390],"PTM: Methylation by PRMT1 is required for import into the nucleolus and for ribosome assembly. {ECO:0000269|PubMed:19460357}.; PTM: Sumoylation by SUMO1 enhances protein stability through increased resistance to proteolysis. Sumoylation occurs at one or more of the three consensus sites, Lys-18, Lys-214 and Lys-230. {ECO:0000269|PubMed:21968017}.; PTM: Phosphorylation at Thr-221 by CDK1 occurs mainly in G2/M phase (PubMed:21871177). Phosphorylation by PRKCD occurs on a non-ribosomal-associated form which results in translocation of RPS3 to the nucleus and enhances its endonuclease activity (PubMed:19059439). Phosphorylated on Ser-209 by IKKB in response to activation of the NF-kappa-B p65-p50 complex which enhances the association of RPS3 with importin-alpha and mediates the nuclear translocation of RPS3 (PubMed:21399639). Phosphorylation by MAPK is required for translocation to the nucleus following exposure of cells to DNA damaging agents such as hydrogen peroxide (PubMed:17560175). Phosphorylation by PKB/AKT mediates RPS3 nuclear translocation, enhances RPS3 endonuclease activity and suppresses RPS3-induced neuronal apoptosis (PubMed:20605787). {ECO:0000269|PubMed:17560175, ECO:0000269|PubMed:19059439, ECO:0000269|PubMed:20605787, ECO:0000269|PubMed:21399639, ECO:0000269|PubMed:21871177}.; PTM: Ubiquitinated; ubiquitination is prevented by interaction with HSP90 which stabilizes the protein (PubMed:16314389). Monoubiquitinated at Lys-214 by RNF10 and ZNF598 when a ribosome has stalled during translation of poly(A) sequences, leading to preclude synthesis of a long poly-lysine tail and initiate the ribosome quality control (RQC) pathway to degrade the potentially detrimental aberrant nascent polypeptide (PubMed:28065601, PubMed:28132843, PubMed:32011234, PubMed:34348161, PubMed:34469731). Deubiquitinated at Lys-214 by USP10, preventing degradation by the proteasome and promoting 40S ribosome subunit recycling following ribosome dissociation (PubMed:31981475, PubMed:34469731). {ECO:0000269|PubMed:16314389, ECO:0000269|PubMed:28065601, ECO:0000269|PubMed:28132843, ECO:0000269|PubMed:31981475, ECO:0000269|PubMed:32011234, ECO:0000269|PubMed:34348161, ECO:0000269|PubMed:34469731}.; PTM: Ufmylated by UFL1. {ECO:0000250|UniProtKB:P62908}.",,"DOMAIN 21..92; /note=""KH type-2""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00118""","STRAND 34..41; /evidence=""ECO:0007829|PDB:7R4X""; STRAND 46..53; /evidence=""ECO:0007829|PDB:7R4X""; STRAND 83..89; /evidence=""ECO:0007829|PDB:7R4X""; STRAND 132..140; /evidence=""ECO:0007829|PDB:7R4X""; STRAND 142..146; /evidence=""ECO:0007829|PDB:7R4X""; STRAND 148..155; /evidence=""ECO:0007829|PDB:7R4X""; STRAND 160..162; /evidence=""ECO:0007829|PDB:6ZXG""; STRAND 168..177; /evidence=""ECO:0007829|PDB:7R4X""; STRAND 180..189; /evidence=""ECO:0007829|PDB:7R4X""; STRAND 194..199; /evidence=""ECO:0007829|PDB:7R4X""; STRAND 223..226; /evidence=""ECO:0007829|PDB:6ZLW""","HELIX 7..29; /evidence=""ECO:0007829|PDB:7R4X""; HELIX 30..32; /evidence=""ECO:0007829|PDB:7R4X""; HELIX 55..59; /evidence=""ECO:0007829|PDB:7R4X""; HELIX 61..63; /evidence=""ECO:0007829|PDB:7R4X""; HELIX 64..77; /evidence=""ECO:0007829|PDB:7R4X""; HELIX 94..96; /evidence=""ECO:0007829|PDB:7R4X""; HELIX 98..109; /evidence=""ECO:0007829|PDB:7R4X""; HELIX 115..128; /evidence=""ECO:0007829|PDB:7R4X""; HELIX 163..167; /evidence=""ECO:0007829|PDB:7R4X""","TURN 110..112; /evidence=""ECO:0007829|PDB:7R4X""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,RPS3 OK/SW-cl.26,Small ribosomal subunit protein uS3 (40S ribosomal protein S3) (EC 4.2.99.18),Homo sapiens (Human),243.0,26688.0,MAVQISKKRKFVADGIFKAELNEFLTRELAEDGYSGVEVRVTPTRTEIIILATRTQNVLGEKGRRIRELTAVVQKRFGFPEGSVELYAEKVATRGLCAIAQAESLRYKLLGGLAVRRACYGVLRFIMESGAKGCEVVVSGKLRGQRAKSMKFVDGLMIHSGDPVNYYVDTAVRHVLLRQGVLGIKVKIMLPWDPTGKIGPKKPLPDHVSIVEPKDEILPTTPISEQKGGKPEPPAMPQPVPTA,True,True,False,P23396,"[('cd02413', 'type II K-homology (KH) RNA-binding domain found in 40S ribosomal protein S3 and similar proteins'), ('G3DSA:3.30.1140.32', 'Ribosomal protein S3, C-terminal domain'), ('G3DSA:3.30.300.20', None), ('IPR001351', 'Small ribosomal subunit protein uS3, C-terminal'), ('IPR004044', 'K Homology domain, type 2'), ('IPR005703', 'Small ribosomal subunit protein uS3, eukaryotic/archaeal'), ('IPR009019', 'K homology domain superfamily, prokaryotic type'), ('IPR015946', 'K homology domain-like, alpha/beta'), ('IPR018280', 'Small ribosomal subunit protein uS3, conserved site'), ('IPR036419', 'Ribosomal protein S3, C-terminal domain superfamily'), ('PF00189', 'Ribosomal protein S3, C-terminal domain'), ('PF07650', 'KH domain'), ('PS00548', 'Ribosomal protein S3 signature'), ('PS50823', 'Type-2 KH domain profile'), ('PTHR11760', 'Universal ribosomal protein uS3'), ('SSF54814', 'Prokaryotic type KH domain (KH-domain type II)'), ('SSF54821', 'Ribosomal protein S3 C-terminal domain'), ('TIGR01008', '30S ribosomal protein S3')]",P23396;,"""ENSG00000149273; Low tissue specificity."";","CATALYTIC ACTIVITY: Reaction=2'-deoxyribonucleotide-(2'-deoxyribose 5'-phosphate)-2'-deoxyribonucleotide-DNA = a 3'-end 2'-deoxyribonucleotide-(2,3-dehydro-2,3-deoxyribose 5'-phosphate)-DNA + a 5'-end 5'-phospho-2'-deoxyribonucleoside-DNA + H(+); Xref=Rhea:RHEA:66592, Rhea:RHEA-COMP:13180, Rhea:RHEA-COMP:16897, Rhea:RHEA-COMP:17067, ChEBI:CHEBI:15378, ChEBI:CHEBI:136412, ChEBI:CHEBI:157695, ChEBI:CHEBI:167181; EC=4.2.99.18; Evidence={ECO:0000269|PubMed:7775413};",4.2.99.18,ACTIVITY REGULATION: Endonuclease activity is inhibited by MgCl2 on apurinic/apyrimidinic DNA but not on UV-irradiated DNA. {ECO:0000269|PubMed:15707971}.,,ENST00000278572.10 [P23396-2];ENST00000524851.5 [P23396-1];ENST00000527446.5 [P23396-1];ENST00000531188.6 [P23396-1];,RPS3,ENSG00000149273,0.0,RPS3,Canonical_RBPs,32.0,,,,0.218,0.123,RPS3
P24278,ENSG00000089775,ZBT25_HUMAN,negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of cytokine production [GO:0001817]; regulation of immune system process [GO:0002682],nucleoplasm [GO:0005654],"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]",,,"DOMAIN 1..107; /note=""BTB""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00037""",,,,"cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,ZBTB25 C14orf51 KUP ZNF46,Zinc finger and BTB domain-containing protein 25 (Zinc finger protein 46) (Zinc finger protein KUP),Homo sapiens (Human),435.0,48990.0,MDTASHSLVLLQQLNMQREFGFLCDCTVAIGDVYFKAHRAVLAAFSNYFKMIFIHQTSECIKIQPTDIQPDIFSYLLHIMYTGKGPKQIVDHSRLEEGIRFLHADYLSHIATEMNQVFSPETVQSSNLYGIQISTTQKTVVKQGLEVKEAPSSNSGNRAAVQGDHPQLQLSLAIGLDDGTADQQRACPATQALEEHQKPPVSIKQERCDPESVISQSHPSPSSEVTGPTFTENSVKIHLCHYCGERFDSRSNLRQHLHTHVSGSLPFGVPASILESNDLGEVHPLNENSEALECRRLSSFIVKENEQQPDHTNRGTTEPLQISQVSLISKDTEPVELNCNFSFSRKRKMSCTICGHKFPRKSQLLEHMYTHKGKSYRYNRCQRFGNALAQRFQPYCDSWSDVSLKSSRLSQEHLDLPCALESELTQENVDTILVE,False,False,True,P24278,"[('cd18213', 'BTB (Broad-Complex, Tramtrack and Bric a brac)/POZ (poxvirus and zinc finger) domain found in zinc finger and BTB domain-containing protein 25 (ZBTB25)'), ('G3DSA:3.30.160.60', 'Classic Zinc Finger'), ('G3DSA:3.30.710.10', 'Potassium Channel Kv1.1; Chain A'), ('IPR000210', 'BTB/POZ domain'), ('IPR011333', 'SKP1/BTB/POZ domain superfamily'), ('IPR013087', 'Zinc finger C2H2-type'), ('IPR036236', 'Zinc finger C2H2 superfamily'), ('PF00096', 'Zinc finger, C2H2 type'), ('PF00651', 'BTB/POZ domain'), ('PS00028', 'Zinc finger C2H2 type domain signature'), ('PS50097', 'BTB domain profile'), ('PS50157', 'Zinc finger C2H2 type domain profile'), ('PTHR24394', 'Krppel C2H2-type zinc-finger'), ('SM00225', 'Broad-Complex, Tramtrack and Bric a brac'), ('SM00355', 'zinc finger'), ('SSF54695', 'POZ domain'), ('SSF57667', 'beta-beta-alpha zinc fingers')]",,"""ENSG00000089775; Low tissue specificity."";",,,,,ENST00000394715.1;ENST00000608382.6;,ZBTB25,ENSG00000089775,0.0,,,,,,,0.621,,ZBTB25
P25788,ENSG00000100567,PSA3_HUMAN,proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of endopeptidase activity [GO:0052548],"cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome complex [GO:0000502]; proteasome core complex [GO:0005839]; proteasome core complex, alpha-subunit complex [GO:0019773]; synapse [GO:0045202]",ubiquitin protein ligase binding [GO:0031625],,,,"STRAND 6..10; /evidence=""ECO:0007829|PDB:6KWY""; STRAND 11..14; /evidence=""ECO:0007829|PDB:5A0Q""; STRAND 17..19; /evidence=""ECO:0007829|PDB:5VFO""; STRAND 37..42; /evidence=""ECO:0007829|PDB:5LE5""; STRAND 45..53; /evidence=""ECO:0007829|PDB:5LE5""; STRAND 57..59; /evidence=""ECO:0007829|PDB:8QYO""; STRAND 67..71; /evidence=""ECO:0007829|PDB:5LE5""; STRAND 74..80; /evidence=""ECO:0007829|PDB:5LE5""; STRAND 125..129; /evidence=""ECO:0007829|PDB:8UD9""; STRAND 133..142; /evidence=""ECO:0007829|PDB:5LE5""; STRAND 146..152; /evidence=""ECO:0007829|PDB:5LE5""; STRAND 158..167; /evidence=""ECO:0007829|PDB:5LE5""; STRAND 178..180; /evidence=""ECO:0007829|PDB:8QZ9""; STRAND 210..218; /evidence=""ECO:0007829|PDB:5LE5""; STRAND 225..227; /evidence=""ECO:0007829|PDB:6RGQ""","HELIX 22..32; /evidence=""ECO:0007829|PDB:5LE5""; HELIX 82..103; /evidence=""ECO:0007829|PDB:5LE5""; HELIX 109..122; /evidence=""ECO:0007829|PDB:5LE5""; HELIX 170..177; /evidence=""ECO:0007829|PDB:5LE5""; HELIX 182..184; /evidence=""ECO:0007829|PDB:5LE5""; HELIX 187..201; /evidence=""ECO:0007829|PDB:5LE5""; HELIX 219..221; /evidence=""ECO:0007829|PDB:5LE5""; HELIX 230..244; /evidence=""ECO:0007829|PDB:5LE5""","TURN 61..64; /evidence=""ECO:0007829|PDB:5LE5""; TURN 143..145; /evidence=""ECO:0007829|PDB:5LE5""; TURN 204..206; /evidence=""ECO:0007829|PDB:5LE5""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,PSMA3 HC8 PSC8,Proteasome subunit alpha type-3 (Macropain subunit C8) (Multicatalytic endopeptidase complex subunit C8) (Proteasome component C8) (Proteasome subunit alpha-7) (alpha-7),Homo sapiens (Human),255.0,28433.0,MSSIGTGYDLSASTFSPDGRVFQVEYAMKAVENSSTAIGIRCKDGVVFGVEKLVLSKLYEEGSNKRLFNVDRHVGMAVAGLLADARSLADIAREEASNFRSNFGYNIPLKHLADRVAMYVHAYTLYSAVRPFGCSFMLGSYSVNDGAQLYMIDPSGVSYGYWGCAIGKARQAAKTEIEKLQMKEMTCRDIVKEVAKIIYIVHDEVKDKAFELELSWVGELTNGRHEIVPKDIREEAEKYAKESLKEEDESDDDNM,False,False,True,P25788,"[('cd03751', 'proteasome_alpha_type_3'), ('G3DSA:3.60.20.10', 'Glutamine Phosphoribosylpyrophosphate, subunit 1, domain 1'), ('IPR000426', 'Proteasome alpha-subunit, N-terminal domain'), ('IPR001353', 'Proteasome, subunit alpha/beta'), ('IPR023332', 'Proteasome alpha-type subunit'), ('IPR029055', 'Nucleophile aminohydrolases, N-terminal'), ('IPR050115', 'Proteasome subunit alpha'), ('PF00227', 'Proteasome subunit'), ('PF10584', 'Proteasome subunit A N-terminal signature'), ('PS00388', 'Proteasome alpha-type subunits signature'), ('PS51475', 'Proteasome alpha-type subunit profile'), ('PTHR11599', 'Proteasome subunit alpha'), ('SM00948', 'Proteasome subunit A N-terminal signature Add an annotation'), ('SSF56235', 'N-terminal nucleophile aminohydrolases (Ntn hydrolases)')]",,"""ENSG00000100567; Low tissue specificity."";",,,,,ENST00000216455.9 [P25788-1];ENST00000412908.6 [P25788-2];,PSMA3;OR8B2,ENSG00000100567;ENSG00000284680,0.0,PSMA3,Non-canonical_RBPs,11.0,,,,,,PSMA3
P26639,ENSG00000113407,SYTC_HUMAN,threonyl-tRNA aminoacylation [GO:0006435],cytosol [GO:0005829]; extracellular exosome [GO:0070062],ATP binding [GO:0005524]; identical protein binding [GO:0042802]; threonine-tRNA ligase activity [GO:0004829]; tRNA binding [GO:0000049]; zinc ion binding [GO:0008270],PTM: ISGylated. {ECO:0000269|PubMed:16139798}.,,"DOMAIN 79..143; /note=""TGS""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU01228""","STRAND 82..86; /evidence=""ECO:0007829|PDB:1WWT""; STRAND 92..96; /evidence=""ECO:0007829|PDB:1WWT""; STRAND 120..127; /evidence=""ECO:0007829|PDB:1WWT""; STRAND 129..131; /evidence=""ECO:0007829|PDB:1WWT""; STRAND 135..141; /evidence=""ECO:0007829|PDB:1WWT""; STRAND 332..334; /evidence=""ECO:0007829|PDB:4HWT""; STRAND 376..379; /evidence=""ECO:0007829|PDB:4HWT""; STRAND 398..401; /evidence=""ECO:0007829|PDB:4HWT""; STRAND 404..408; /evidence=""ECO:0007829|PDB:4HWT""; STRAND 431..436; /evidence=""ECO:0007829|PDB:4HWT""; STRAND 439..441; /evidence=""ECO:0007829|PDB:4HWT""; STRAND 456..459; /evidence=""ECO:0007829|PDB:4HWT""; STRAND 462..467; /evidence=""ECO:0007829|PDB:4HWT""; STRAND 493..499; /evidence=""ECO:0007829|PDB:4HWT""; STRAND 530..533; /evidence=""ECO:0007829|PDB:4HWT""; STRAND 543..549; /evidence=""ECO:0007829|PDB:4HWT""; STRAND 555..565; /evidence=""ECO:0007829|PDB:4HWT""; STRAND 587..595; /evidence=""ECO:0007829|PDB:4HWT""; STRAND 621..627; /evidence=""ECO:0007829|PDB:4HWT""; STRAND 648..650; /evidence=""ECO:0007829|PDB:4HWT""; STRAND 671..676; /evidence=""ECO:0007829|PDB:4HWT""; STRAND 685..690; /evidence=""ECO:0007829|PDB:4HWT""; STRAND 695..700; /evidence=""ECO:0007829|PDB:4HWT""","HELIX 57..69; /evidence=""ECO:0007829|PDB:5XLN""; HELIX 102..108; /evidence=""ECO:0007829|PDB:1WWT""; HELIX 114..116; /evidence=""ECO:0007829|PDB:1WWT""; HELIX 323..329; /evidence=""ECO:0007829|PDB:4HWT""; HELIX 347..366; /evidence=""ECO:0007829|PDB:4HWT""; HELIX 380..385; /evidence=""ECO:0007829|PDB:4HWT""; HELIX 388..391; /evidence=""ECO:0007829|PDB:4HWT""; HELIX 393..395; /evidence=""ECO:0007829|PDB:4HWT""; HELIX 413..421; /evidence=""ECO:0007829|PDB:4HWT""; HELIX 427..429; /evidence=""ECO:0007829|PDB:4HWT""; HELIX 446..448; /evidence=""ECO:0007829|PDB:4HWT""; HELIX 469..471; /evidence=""ECO:0007829|PDB:4HWT""; HELIX 472..490; /evidence=""ECO:0007829|PDB:4HWT""; HELIX 509..525; /evidence=""ECO:0007829|PDB:4HWT""; HELIX 566..570; /evidence=""ECO:0007829|PDB:4HWT""; HELIX 597..607; /evidence=""ECO:0007829|PDB:4HWT""; HELIX 614..616; /evidence=""ECO:0007829|PDB:4HWT""; HELIX 628..630; /evidence=""ECO:0007829|PDB:4HWT""; HELIX 631..642; /evidence=""ECO:0007829|PDB:4HWT""; HELIX 658..667; /evidence=""ECO:0007829|PDB:4HWT""; HELIX 678..683; /evidence=""ECO:0007829|PDB:4HWT""; HELIX 701..713; /evidence=""ECO:0007829|PDB:4HWT""; HELIX 719..722; /evidence=""ECO:0007829|PDB:4P3N""","TURN 97..99; /evidence=""ECO:0007829|PDB:1WWT""; TURN 111..113; /evidence=""ECO:0007829|PDB:1WWT""; TURN 451..453; /evidence=""ECO:0007829|PDB:4HWT""; TURN 608..610; /evidence=""ECO:0007829|PDB:4HWT""; TURN 643..645; /evidence=""ECO:0007829|PDB:4HWT""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,TARS1 TARS,"Threonine--tRNA ligase 1, cytoplasmic (EC 6.1.1.3) (Threonyl-tRNA synthetase) (ThrRS) (Threonyl-tRNA synthetase 1)",Homo sapiens (Human),723.0,83435.0,MFEEKASSPSGKMGGEEKPIGAGEEKQKEGGKKKNKEGSGDGGRAELNPWPEYIYTRLEMYNILKAEHDSILAEKAEKDSKPIKVTLPDGKQVDAESWKTTPYQIACGISQGLADNTVIAKVNNVVWDLDRPLEEDCTLELLKFEDEEAQAVYWHSSAHIMGEAMERVYGGCLCYGPPIENGFYYDMYLEEGGVSSNDFSSLEALCKKIIKEKQAFERLEVKKETLLAMFKYNKFKCRILNEKVNTPTTTVYRCGPLIDLCRGPHVRHTGKIKALKIHKNSSTYWEGKADMETLQRIYGISFPDPKMLKEWEKFQEEAKNRDHRKIGRDQELYFFHELSPGSCFFLPKGAYIYNALIEFIRSEYRKRGFQEVVTPNIFNSRLWMTSGHWQHYSENMFSFEVEKELFALKPMNCPGHCLMFDHRPRSWRELPLRLADFGVLHRNELSGALTGLTRVRRFQQDDAHIFCAMEQIEDEIKGCLDFLRTVYSVFGFSFKLNLSTRPEKFLGDIEVWDQAEKQLENSLNEFGEKWELNSGDGAFYGPKIDIQIKDAIGRYHQCATIQLDFQLPIRFNLTYVSHDGDDKKRPVIVHRAILGSVERMIAILTENYGGKWPFWLSPRQVMVVPVGPTCDEYAQKVRQQFHDAKFMADIDLDPGCTLNKKIRNAQLAQYNFILVVGEKEKISGTVNIRTRDNKVHGERTISETIERLQQLKEFRSKQAEEEF,False,True,False,P26639,"[('cd00771', 'ThrRS_core'), ('cd00860', 'ThrRS_anticodon'), ('cd01667', 'TGS (ThrRS, GTPase and SpoT) domain found in threonyl-tRNA synthetase (ThrRS) and similar proteins'), ('G3DSA:3.10.20.30', None), ('G3DSA:3.30.930.10', 'Bira Bifunctional Protein; Domain 2'), ('G3DSA:3.30.980.10', 'Threonyl-trna Synthetase; Chain A, domain 2'), ('G3DSA:3.40.50.800', 'Anticodon-binding domain'), ('IPR002314', 'Aminoacyl-tRNA synthetase, class II (G/ P/ S/T)'), ('IPR002320', 'Threonine-tRNA ligase, class IIa'), ('IPR004095', 'TGS'), ('IPR004154', 'Anticodon-binding'), ('IPR006195', 'Aminoacyl-tRNA synthetase, class II'), ('IPR012675', 'Beta-grasp domain superfamily'), ('IPR012676', 'TGS-like'), ('IPR012947', 'Threonyl/alanyl tRNA synthetase, SAD'), ('IPR018163', 'Threonyl/alanyl tRNA synthetase, class II-like, putative editing domain superfamily'), ('IPR033728', 'Threonine-tRNA ligase catalytic core domain'), ('IPR036621', 'Anticodon-binding domain superfamily'), ('IPR045864', 'Class II Aminoacyl-tRNA synthetase/Biotinyl protein ligase (BPL) and lipoyl protein ligase (LPL)'), ('IPR047246', 'Threonine-tRNA ligase, class IIa, anticodon-binding domain')]",,"""ENSG00000113407; Low tissue specificity."";","CATALYTIC ACTIVITY: Reaction=tRNA(Thr) + L-threonine + ATP = L-threonyl-tRNA(Thr) + AMP + diphosphate + H(+); Xref=Rhea:RHEA:24624, Rhea:RHEA-COMP:9670, Rhea:RHEA-COMP:9704, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616, ChEBI:CHEBI:33019, ChEBI:CHEBI:57926, ChEBI:CHEBI:78442, ChEBI:CHEBI:78534, ChEBI:CHEBI:456215; EC=6.1.1.3; Evidence={ECO:0000269|PubMed:25824639};",6.1.1.3,"ACTIVITY REGULATION: Inhibited by borrelidin (BN, IC 50 is 7 nM), which binds to 4 distinct subsites in the protein, preventing binding of all 3 substrates (PubMed:25824639). {ECO:0000269|PubMed:25824639}.",,ENST00000265112.8 [P26639-1];ENST00000455217.6 [P26639-2];ENST00000502553.5 [P26639-1];,TARS1;NEAT1,ENSG00000113407;ENSG00000245532;ENSG00000277599;ENSG00000278050;ENSG00000278144,0.0,TARS1,Canonical_RBPs,13.0,,,,0.062,0.064,TARS1
P27361,ENSG00000102882,MK03_HUMAN,apoptotic process [GO:0006915]; Bergmann glial cell differentiation [GO:0060020]; BMP signaling pathway [GO:0030509]; cardiac neural crest cell development involved in heart development [GO:0061308]; cartilage development [GO:0051216]; caveolin-mediated endocytosis [GO:0072584]; cellular response to amino acid starvation [GO:0034198]; cellular response to mechanical stimulus [GO:0071260]; cellular response to tumor necrosis factor [GO:0071356]; DNA-templated transcription [GO:0006351]; ERBB2-ERBB3 signaling pathway [GO:0038133]; ERK1 and ERK2 cascade [GO:0070371]; face development [GO:0060324]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; interleukin-1-mediated signaling pathway [GO:0070498]; intracellular signal transduction [GO:0035556]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; lung morphogenesis [GO:0060425]; MAPK cascade [GO:0000165]; modulation of chemical synaptic transmission [GO:0050804]; myelination [GO:0042552]; negative regulation of TORC1 signaling [GO:1904262]; outer ear morphogenesis [GO:0042473]; peptidyl-tyrosine autophosphorylation [GO:0038083]; phosphorylation [GO:0016310]; positive regulation of cyclase activity [GO:0031281]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of macrophage chemotaxis [GO:0010759]; positive regulation of macrophage proliferation [GO:0120041]; positive regulation of telomere maintenance [GO:0032206]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of xenophagy [GO:1904417]; protein phosphorylation [GO:0006468]; regulation of cellular pH [GO:0030641]; regulation of cytoskeleton organization [GO:0051493]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of Golgi inheritance [GO:0090170]; regulation of ossification [GO:0030278]; regulation of stress-activated MAPK cascade [GO:0032872]; response to epidermal growth factor [GO:0070849]; response to exogenous dsRNA [GO:0043330]; Schwann cell development [GO:0014044]; sensory perception of pain [GO:0019233]; signal transduction in response to DNA damage [GO:0042770]; stress-activated MAPK cascade [GO:0051403]; thymus development [GO:0048538]; thyroid gland development [GO:0030878]; trachea formation [GO:0060440]; xenophagy [GO:0098792],caveola [GO:0005901]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; early endosome [GO:0005769]; endoplasmic reticulum lumen [GO:0005788]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; Golgi apparatus [GO:0005794]; late endosome [GO:0005770]; mitochondrion [GO:0005739]; nuclear envelope [GO:0005635]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; pseudopodium [GO:0031143],ATP binding [GO:0005524]; DNA-binding transcription factor binding [GO:0140297]; identical protein binding [GO:0042802]; MAP kinase activity [GO:0004707]; phosphatase binding [GO:0019902]; phosphotyrosine residue binding [GO:0001784]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],"PTM: Phosphorylated upon KIT and FLT3 signaling (By similarity). Dually phosphorylated on Thr-202 and Tyr-204, which activates the enzyme. Ligand-activated ALK induces tyrosine phosphorylation. Dephosphorylated by PTPRJ at Tyr-204. {ECO:0000250, ECO:0000269|PubMed:17274988, ECO:0000269|PubMed:18983981, ECO:0000269|PubMed:19060905, ECO:0000269|PubMed:19265199, ECO:0000269|PubMed:19494114}.; PTM: Ubiquitinated by TRIM15 via 'Lys-63'-linked ubiquitination; leading to activation. Deubiquitinated by CYLD. {ECO:0000269|PubMed:34497368}.",DOMAIN: The TXY motif contains the threonine and tyrosine residues whose phosphorylation activates the MAP kinases. {ECO:0000269|PubMed:10521408}.,"DOMAIN 42..330; /note=""Protein kinase""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00159""","STRAND 29..31; /evidence=""ECO:0007829|PDB:4QTB""; STRAND 34..36; /evidence=""ECO:0007829|PDB:4QTB""; STRAND 42..51; /evidence=""ECO:0007829|PDB:4QTB""; STRAND 54..61; /evidence=""ECO:0007829|PDB:4QTB""; STRAND 66..73; /evidence=""ECO:0007829|PDB:4QTB""; STRAND 105..107; /evidence=""ECO:0007829|PDB:4QTB""; STRAND 118..122; /evidence=""ECO:0007829|PDB:4QTB""; STRAND 126..128; /evidence=""ECO:0007829|PDB:4QTB""; STRAND 172..174; /evidence=""ECO:0007829|PDB:4QTB""; STRAND 180..182; /evidence=""ECO:0007829|PDB:4QTB""","HELIX 79..94; /evidence=""ECO:0007829|PDB:4QTB""; HELIX 129..135; /evidence=""ECO:0007829|PDB:4QTB""; HELIX 140..159; /evidence=""ECO:0007829|PDB:4QTB""; HELIX 169..171; /evidence=""ECO:0007829|PDB:4QTB""; HELIX 193..195; /evidence=""ECO:0007829|PDB:4QTB""; HELIX 208..210; /evidence=""ECO:0007829|PDB:4QTB""; HELIX 213..215; /evidence=""ECO:0007829|PDB:4QTB""; HELIX 225..240; /evidence=""ECO:0007829|PDB:4QTB""; HELIX 250..261; /evidence=""ECO:0007829|PDB:4QTB""; HELIX 266..269; /evidence=""ECO:0007829|PDB:4QTB""; HELIX 275..282; /evidence=""ECO:0007829|PDB:4QTB""; HELIX 292..295; /evidence=""ECO:0007829|PDB:4QTB""; HELIX 301..310; /evidence=""ECO:0007829|PDB:4QTB""; HELIX 315..317; /evidence=""ECO:0007829|PDB:4QTB""; HELIX 321..325; /evidence=""ECO:0007829|PDB:4QTB""; HELIX 328..330; /evidence=""ECO:0007829|PDB:4QTB""; HELIX 336..338; /evidence=""ECO:0007829|PDB:4QTB""; HELIX 350..354; /evidence=""ECO:0007829|PDB:4QTB""; HELIX 357..368; /evidence=""ECO:0007829|PDB:4QTB""; HELIX 369..371; /evidence=""ECO:0007829|PDB:4QTB""","TURN 39..41; /evidence=""ECO:0007829|PDB:4QTB""; TURN 62..65; /evidence=""ECO:0007829|PDB:4QTB""; TURN 112..114; /evidence=""ECO:0007829|PDB:4QTB""; TURN 216..218; /evidence=""ECO:0007829|PDB:4QTB""; TURN 331..333; /evidence=""ECO:0007829|PDB:4QTB""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,MAPK3 ERK1 PRKM3,Mitogen-activated protein kinase 3 (MAP kinase 3) (MAPK 3) (EC 2.7.11.24) (ERT2) (Extracellular signal-regulated kinase 1) (ERK-1) (Insulin-stimulated MAP2 kinase) (MAP kinase isoform p44) (p44-MAPK) (Microtubule-associated protein 2 kinase) (p44-ERK1),Homo sapiens (Human),379.0,43136.0,MAAAAAQGGGGGEPRRTEGVGPGVPGEVEMVKGQPFDVGPRYTQLQYIGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYCQRTLREIQILLRFRHENVIGIRDILRASTLEAMRDVYIVQDLMETDLYKLLKSQQLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINMKARNYLQSLPSKTKVAWAKLFPKSDSKALDLLDRMLTFNPNKRITVEEALAHPYLEQYYDPTDEPVAEEPFTFAMELDDLPKERLKELIFQETARFQPGVLEAP,False,False,True,P27361,"[('cd07849', 'Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases'), ('G3DSA:1.10.510.10', 'Transferase(Phosphotransferase) domain 1'), ('G3DSA:3.30.200.20', 'Phosphorylase Kinase; domain 1'), ('IPR000719', 'Protein kinase domain'), ('IPR003527', 'Mitogen-activated protein (MAP) kinase, conserved site'), ('IPR008271', 'Serine/threonine-protein kinase, active site'), ('IPR008349', 'Mitogen-activated protein (MAP) kinase, ERK1/2'), ('IPR011009', 'Protein kinase-like domain superfamily'), ('IPR017441', 'Protein kinase, ATP binding site'), ('IPR050117', 'Mitogen-activated protein kinase'), ('PF00069', 'Protein kinase domain'), ('PR01770', 'ERK1ERK2MAPK'), ('PS00107', 'Protein kinases ATP-binding region signature'), ('PS00108', 'Serine/Threonine protein kinases active-site signature'), ('PS01351', 'MAP kinase signature'), ('PS50011', 'Protein kinase domain profile'), ('PTHR24055', 'Mitogen-activated protein kinase'), ('SM00220', 'Serine/Threonine protein kinases, catalytic domain'), ('SSF56112', 'Protein kinase-like (PK-like)')]",P27361;,"""ENSG00000102882; Low tissue specificity."";","CATALYTIC ACTIVITY: Reaction=L-seryl-[protein] + ATP = O-phospho-L-seryl-[protein] + ADP + H(+); Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616, ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.24; Evidence={ECO:0000269|PubMed:35216969}; CATALYTIC ACTIVITY: Reaction=L-threonyl-[protein] + ATP = O-phospho-L-threonyl-[protein] + ADP + H(+); Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060, Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013, ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216; EC=2.7.11.24;",2.7.11.24,"ACTIVITY REGULATION: Phosphorylated by MAP2K1/MEK1 and MAP2K2/MEK2 on Thr-202 and Tyr-204 in response to external stimuli like insulin or NGF. Both phosphorylations are required for activity. This phosphorylation causes dramatic conformational changes, which enable full activation and interaction of MAPK1/ERK2 with its substrates. Dephosphorylated and inactivated by DUSP3, DUSP6 and DUSP9. {ECO:0000269|PubMed:12356731, ECO:0000269|PubMed:19060905}.",,ENST00000263025.9 [P27361-1];ENST00000322266.9 [P27361-2];ENST00000395199.7 [P27361-3];ENST00000395202.5 [P27361-2];,MAPK3,ENSG00000102882,0.0,,,,6.07,DP03497,0.061,0.084,0.069,MAPK3
P27487,ENSG00000197635,DPP4_HUMAN,behavioral fear response [GO:0001662]; cell adhesion [GO:0007155]; endothelial cell migration [GO:0043542]; glucagon processing [GO:0120116]; locomotory exploration behavior [GO:0035641]; membrane fusion [GO:0061025]; negative regulation of extracellular matrix disassembly [GO:0010716]; negative regulation of neutrophil chemotaxis [GO:0090024]; peptide hormone processing [GO:0016486]; positive regulation of cell population proliferation [GO:0008284]; proteolysis [GO:0006508]; psychomotor behavior [GO:0036343]; receptor-mediated endocytosis of virus by host cell [GO:0019065]; receptor-mediated virion attachment to host cell [GO:0046813]; regulation of cell-cell adhesion mediated by integrin [GO:0033632]; response to hypoxia [GO:0001666]; symbiont entry into host cell [GO:0046718]; T cell activation [GO:0042110]; T cell costimulation [GO:0031295],apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; endocytic vesicle [GO:0030139]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; focal adhesion [GO:0005925]; intercellular canaliculus [GO:0046581]; lamellipodium [GO:0030027]; lamellipodium membrane [GO:0031258]; lysosomal membrane [GO:0005765]; membrane [GO:0016020]; membrane raft [GO:0045121]; plasma membrane [GO:0005886],aminopeptidase activity [GO:0004177]; chemorepellent activity [GO:0045499]; dipeptidyl-peptidase activity [GO:0008239]; identical protein binding [GO:0042802]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; serine-type endopeptidase activity [GO:0004252]; serine-type peptidase activity [GO:0008236]; signaling receptor binding [GO:0005102]; virus receptor activity [GO:0001618],"PTM: The soluble form (Dipeptidyl peptidase 4 soluble form also named SDPP) derives from the membrane form (Dipeptidyl peptidase 4 membrane form also named MDPP) by proteolytic processing.; PTM: N- and O-Glycosylated. {ECO:0000269|PubMed:10900005, ECO:0000269|PubMed:11773049, ECO:0000269|PubMed:12483204, ECO:0000269|PubMed:12646248, ECO:0000269|PubMed:12906826, ECO:0000269|PubMed:16335952, ECO:0000269|PubMed:19159218, ECO:0000269|PubMed:20684603}.; PTM: Phosphorylated. Mannose 6-phosphate residues in the carbohydrate moiety are necessary for interaction with IGF2R in activated T-cells. Mannose 6-phosphorylation is induced during T-cell activation. {ECO:0000269|PubMed:10900005}.","DOMAIN: The extracellular cysteine-rich region is necessary for association with collagen, dimer formation and optimal dipeptidyl peptidase activity.",,"STRAND 40..42; /evidence=""ECO:0007829|PDB:3VJM""; STRAND 60..62; /evidence=""ECO:0007829|PDB:4A5S""; STRAND 64..72; /evidence=""ECO:0007829|PDB:4A5S""; STRAND 75..80; /evidence=""ECO:0007829|PDB:4A5S""; STRAND 86..90; /evidence=""ECO:0007829|PDB:4A5S""; STRAND 98..100; /evidence=""ECO:0007829|PDB:5T4B""; STRAND 104..107; /evidence=""ECO:0007829|PDB:4A5S""; STRAND 111..122; /evidence=""ECO:0007829|PDB:4A5S""; STRAND 124..126; /evidence=""ECO:0007829|PDB:4A5S""; STRAND 128..136; /evidence=""ECO:0007829|PDB:4A5S""; STRAND 141..143; /evidence=""ECO:0007829|PDB:3F8S""; STRAND 152..157; /evidence=""ECO:0007829|PDB:4A5S""; STRAND 159..162; /evidence=""ECO:0007829|PDB:4A5S""; STRAND 164..168; /evidence=""ECO:0007829|PDB:4A5S""; STRAND 171..177; /evidence=""ECO:0007829|PDB:4A5S""; STRAND 194..198; /evidence=""ECO:0007829|PDB:4A5S""; STRAND 208..212; /evidence=""ECO:0007829|PDB:4A5S""; STRAND 214..216; /evidence=""ECO:0007829|PDB:4A5S""; STRAND 220..229; /evidence=""ECO:0007829|PDB:4A5S""; STRAND 235..240; /evidence=""ECO:0007829|PDB:4A5S""; STRAND 250..255; /evidence=""ECO:0007829|PDB:4A5S""; STRAND 265..272; /evidence=""ECO:0007829|PDB:4A5S""; STRAND 278..280; /evidence=""ECO:0007829|PDB:4A5S""; STRAND 284..287; /evidence=""ECO:0007829|PDB:4A5S""; STRAND 298..307; /evidence=""ECO:0007829|PDB:4A5S""; STRAND 310..319; /evidence=""ECO:0007829|PDB:4A5S""; STRAND 322..330; /evidence=""ECO:0007829|PDB:4A5S""; STRAND 337..339; /evidence=""ECO:0007829|PDB:4A5S""; STRAND 345..348; /evidence=""ECO:0007829|PDB:4A5S""; STRAND 350..352; /evidence=""ECO:0007829|PDB:4A5S""; STRAND 354..358; /evidence=""ECO:0007829|PDB:4A5S""; STRAND 362..364; /evidence=""ECO:0007829|PDB:1NU8""; STRAND 368..376; /evidence=""ECO:0007829|PDB:4A5S""; STRAND 378..380; /evidence=""ECO:0007829|PDB:2G5P""; STRAND 382..388; /evidence=""ECO:0007829|PDB:4A5S""; STRAND 391..393; /evidence=""ECO:0007829|PDB:3SWW""; STRAND 395..397; /evidence=""ECO:0007829|PDB:4A5S""; STRAND 400..402; /evidence=""ECO:0007829|PDB:4A5S""; STRAND 404..410; /evidence=""ECO:0007829|PDB:4A5S""; STRAND 412..420; /evidence=""ECO:0007829|PDB:4A5S""; STRAND 429..435; /evidence=""ECO:0007829|PDB:4A5S""; STRAND 438..446; /evidence=""ECO:0007829|PDB:4A5S""; STRAND 456..461; /evidence=""ECO:0007829|PDB:4A5S""; STRAND 465..472; /evidence=""ECO:0007829|PDB:4A5S""; STRAND 474..477; /evidence=""ECO:0007829|PDB:4A5S""; STRAND 479..484; /evidence=""ECO:0007829|PDB:4A5S""; STRAND 489..495; /evidence=""ECO:0007829|PDB:4A5S""; STRAND 506..508; /evidence=""ECO:0007829|PDB:3G0B""; STRAND 511..519; /evidence=""ECO:0007829|PDB:4A5S""; STRAND 522..530; /evidence=""ECO:0007829|PDB:4A5S""; STRAND 536..538; /evidence=""ECO:0007829|PDB:1PFQ""; STRAND 540..545; /evidence=""ECO:0007829|PDB:4A5S""; STRAND 574..578; /evidence=""ECO:0007829|PDB:4A5S""; STRAND 584..586; /evidence=""ECO:0007829|PDB:4A5S""; STRAND 619..629; /evidence=""ECO:0007829|PDB:4A5S""; STRAND 648..654; /evidence=""ECO:0007829|PDB:4A5S""; STRAND 698..705; /evidence=""ECO:0007829|PDB:4A5S""; STRAND 709..711; /evidence=""ECO:0007829|PDB:4A5S""; STRAND 731..735; /evidence=""ECO:0007829|PDB:4A5S""","HELIX 45..50; /evidence=""ECO:0007829|PDB:4A5S""; HELIX 201..206; /evidence=""ECO:0007829|PDB:4A5S""; HELIX 273..275; /evidence=""ECO:0007829|PDB:4N8D""; HELIX 291..294; /evidence=""ECO:0007829|PDB:4A5S""; HELIX 341..343; /evidence=""ECO:0007829|PDB:4A5S""; HELIX 422..424; /evidence=""ECO:0007829|PDB:4A5S""; HELIX 498..504; /evidence=""ECO:0007829|PDB:4A5S""; HELIX 563..569; /evidence=""ECO:0007829|PDB:4A5S""; HELIX 588..591; /evidence=""ECO:0007829|PDB:4A5S""; HELIX 592..594; /evidence=""ECO:0007829|PDB:4A5S""; HELIX 601..614; /evidence=""ECO:0007829|PDB:4A5S""; HELIX 631..640; /evidence=""ECO:0007829|PDB:4A5S""; HELIX 659..661; /evidence=""ECO:0007829|PDB:4A5S""; HELIX 664..671; /evidence=""ECO:0007829|PDB:4A5S""; HELIX 680..685; /evidence=""ECO:0007829|PDB:4A5S""; HELIX 689..697; /evidence=""ECO:0007829|PDB:4A5S""; HELIX 714..725; /evidence=""ECO:0007829|PDB:4A5S""; HELIX 745..762; /evidence=""ECO:0007829|PDB:4A5S""","TURN 81..83; /evidence=""ECO:0007829|PDB:4A5S""; TURN 92..97; /evidence=""ECO:0007829|PDB:4A5S""; TURN 137..140; /evidence=""ECO:0007829|PDB:4A5S""; TURN 191..193; /evidence=""ECO:0007829|PDB:4A5S""; TURN 332..334; /evidence=""ECO:0007829|PDB:4A5S""; TURN 447..449; /evidence=""ECO:0007829|PDB:1PFQ""; TURN 451..453; /evidence=""ECO:0007829|PDB:4A5S""; TURN 485..488; /evidence=""ECO:0007829|PDB:4A5S""; TURN 598..600; /evidence=""ECO:0007829|PDB:5Y7J""; TURN 615..617; /evidence=""ECO:0007829|PDB:3VJK""; TURN 641..643; /evidence=""ECO:0007829|PDB:4A5S""; TURN 676..679; /evidence=""ECO:0007829|PDB:4A5S""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,DPP4 ADCP2 CD26,Dipeptidyl peptidase 4 (EC 3.4.14.5) (ADABP) (Adenosine deaminase complexing protein 2) (ADCP-2) (Dipeptidyl peptidase IV) (DPP IV) (T-cell activation antigen CD26) (TP103) (CD antigen CD26) [Cleaved into: Dipeptidyl peptidase 4 membrane form (Dipeptidyl peptidase IV membrane form); Dipeptidyl peptidase 4 soluble form (Dipeptidyl peptidase IV soluble form)],Homo sapiens (Human),766.0,88279.0,MKTPWKVLLGLLGAAALVTIITVPVVLLNKGTDDATADSRKTYTLTDYLKNTYRLKLYSLRWISDHEYLYKQENNILVFNAEYGNSSVFLENSTFDEFGHSINDYSISPDGQFILLEYNYVKQWRHSYTASYDIYDLNKRQLITEERIPNNTQWVTWSPVGHKLAYVWNNDIYVKIEPNLPSYRITWTGKEDIIYNGITDWVYEEEVFSAYSALWWSPNGTFLAYAQFNDTEVPLIEYSFYSDESLQYPKTVRVPYPKAGAVNPTVKFFVVNTDSLSSVTNATSIQITAPASMLIGDHYLCDVTWATQERISLQWLRRIQNYSVMDICDYDESSGRWNCLVARQHIEMSTTGWVGRFRPSEPHFTLDGNSFYKIISNEEGYRHICYFQIDKKDCTFITKGTWEVIGIEALTSDYLYYISNEYKGMPGGRNLYKIQLSDYTKVTCLSCELNPERCQYYSVSFSKEAKYYQLRCSGPGLPLYTLHSSVNDKGLRVLEDNSALDKMLQNVQMPSKKLDFIILNETKFWYQMILPPHFDKSKKYPLLLDVYAGPCSQKADTVFRLNWATYLASTENIIVASFDGRGSGYQGDKIMHAINRRLGTFEVEDQIEAARQFSKMGFVDNKRIAIWGWSYGGYVTSMVLGSGSGVFKCGIAVAPVSRWEYYDSVYTERYMGLPTPEDNLDHYRNSTVMSRAENFKQVEYLLIHGTADDNVHFQQSAQISKALVDVGVDFQAMWYTDEDHGIASSTAHQHIYTHMSHFIKQCFSLP,True,True,False,P27487,"[('G3DSA:2.140.10.30', 'Dipeptidylpeptidase IV, N-terminal domain'), ('G3DSA:3.40.50.1820', 'alpha/beta hydrolase'), ('IPR001375', 'Peptidase S9, prolyl oligopeptidase, catalytic domain'), ('IPR002469', 'Dipeptidylpeptidase IV, N-terminal domain'), ('IPR002471', 'Peptidase S9, serine active site'), ('IPR029058', 'Alpha/Beta hydrolase fold'), ('IPR050278', 'Serine protease S9B/DPPIV'), ('PF00326', 'Prolyl oligopeptidase family'), ('PF00930', 'Dipeptidyl peptidase IV (DPP IV) N-terminal region'), ('PS00708', 'Prolyl endopeptidase family serine active site'), ('PTHR11731', 'Serine Protease S9B/DPPIV Subfamily'), ('SSF53474', 'alpha/beta-Hydrolases'), ('SSF82171', 'DPP6 N-terminal domain-like')]",,"""ENSG00000197635; Tissue enhanced (intestine, parathyroid gland, placenta, prostate)."";","CATALYTIC ACTIVITY: Reaction=Release of an N-terminal dipeptide, Xaa-Yaa-|-Zaa-, from a polypeptide, preferentially when Yaa is Pro, provided Zaa is neither Pro nor hydroxyproline.; EC=3.4.14.5; Evidence={ECO:0000255|PROSITE-ProRule:PRU10084, ECO:0000269|PubMed:10593948};",3.4.14.5,"ACTIVITY REGULATION: Inhibited by GPC3 and diprotin A. {ECO:0000269|PubMed:17549790, ECO:0000269|PubMed:18708048}.",,ENST00000360534.8;,DPP4,ENSG00000197635,0.0,,,,,,,0.044,,DPP4
P27540,ENSG00000143437,ARNT_HUMAN,cell differentiation [GO:0030154]; cellular response to oxidative stress [GO:0034599]; embryonic placenta development [GO:0001892]; negative regulation of inflammatory response [GO:0050728]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of glycolytic process [GO:0045821]; positive regulation of hormone biosynthetic process [GO:0046886]; positive regulation of protein sumoylation [GO:0033235]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of vascular endothelial growth factor production [GO:0010575]; positive regulation of vascular endothelial growth factor receptor signaling pathway [GO:0030949]; regulation of transcription by RNA polymerase II [GO:0006357]; response to hypoxia [GO:0001666],aryl hydrocarbon receptor complex [GO:0034751]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; nuclear aryl hydrocarbon receptor complex [GO:0034753]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575],"aryl hydrocarbon receptor binding [GO:0017162]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; nuclear receptor activity [GO:0004879]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]",,,"DOMAIN 89..142; /note=""bHLH""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00981""; DOMAIN 161..235; /note=""PAS 1""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00140""; DOMAIN 349..419; /note=""PAS 2""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00140""; DOMAIN 424..467; /note=""PAC""","STRAND 356..358; /evidence=""ECO:0007829|PDB:2K7S""; STRAND 362..367; /evidence=""ECO:0007829|PDB:3F1P""; STRAND 371..376; /evidence=""ECO:0007829|PDB:3F1P""; STRAND 423..430; /evidence=""ECO:0007829|PDB:3F1P""; STRAND 436..446; /evidence=""ECO:0007829|PDB:3F1P""; STRAND 456..463; /evidence=""ECO:0007829|PDB:3F1P""","HELIX 380..384; /evidence=""ECO:0007829|PDB:3F1P""; HELIX 388..390; /evidence=""ECO:0007829|PDB:3F1P""; HELIX 396..399; /evidence=""ECO:0007829|PDB:3F1P""; HELIX 405..415; /evidence=""ECO:0007829|PDB:3F1P""","TURN 391..393; /evidence=""ECO:0007829|PDB:3F1P""; TURN 402..404; /evidence=""ECO:0007829|PDB:3F1P""; TURN 416..420; /evidence=""ECO:0007829|PDB:3F1N""; TURN 449..451; /evidence=""ECO:0007829|PDB:2B02""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,ARNT BHLHE2,"Aryl hydrocarbon receptor nuclear translocator (ARNT protein) (Class E basic helix-loop-helix protein 2) (bHLHe2) (Dioxin receptor, nuclear translocator) (Hypoxia-inducible factor 1-beta) (HIF-1-beta) (HIF1-beta)",Homo sapiens (Human),789.0,86636.0,MAATTANPEMTSDVPSLGPAIASGNSGPGIQGGGAIVQRAIKRRPGLDFDDDGEGNSKFLRCDDDQMSNDKERFARSDDEQSSADKERLARENHSEIERRRRNKMTAYITELSDMVPTCSALARKPDKLTILRMAVSHMKSLRGTGNTSTDGSYKPSFLTDQELKHLILEAADGFLFIVSCETGRVVYVSDSVTPVLNQPQSEWFGSTLYDQVHPDDVDKLREQLSTSENALTGRILDLKTGTVKKEGQQSSMRMCMGSRRSFICRMRCGSSSVDPVSVNRLSFVRNRCRNGLGSVKDGEPHFVVVHCTGYIKAWPPAGVSLPDDDPEAGQGSKFCLVAIGRLQVTSSPNCTDMSNVCQPTEFISRHNIEGIFTFVDHRCVATVGYQPQELLGKNIVEFCHPEDQQLLRDSFQQVVKLKGQVLSVMFRFRSKNQEWLWMRTSSFTFQNPYSDEIEYIICTNTNVKNSSQEPRPTLSNTIQRPQLGPTANLPLEMGSGQLAPRQQQQQTELDMVPGRDGLASYNHSQVVQPVTTTGPEHSKPLEKSDGLFAQDRDPRFSEIYHNINADQSKGISSSTVPATQQLFSQGNTFPPTPRPAENFRNSGLAPPVTIVQPSASAGQMLAQISRHSNPTQGATPTWTPTTRSGFSAQQVATQATAKTRTSQFGVGSFQTPSSFSSMSLPGAPTASPGAAAYPSLTNRGSNFAPETGQTAGQFQTRTAEGVGVWPQWQGQQPHHRSSSSEQHVQQPPAQQPGQPEVFQEMLSMLGDQSNSYNNEEFPDLTMFPPFSE,False,False,True,P27540,"[('cd00130', 'PAS'), ('cd18947', 'basic helix-loop-helix-Per-ARNT-Sim (bHLH-PAS) domain found in aryl hydrocarbon receptor nuclear translocator (ARNT) and similar proteins'), ('G3DSA:3.30.450.20', 'PAS domain'), ('G3DSA:4.10.280.10', 'Helix-loop-helix DNA-binding domain'), ('IPR000014', 'PAS domain'), ('IPR001067', 'Nuclear translocator'), ('IPR001610', 'PAC motif'), ('IPR011598', 'Myc-type, basic helix-loop-helix (bHLH) domain'), ('IPR013767', 'PAS fold'), ('IPR035965', 'PAS domain superfamily'), ('IPR036638', 'Helix-loop-helix DNA-binding domain superfamily'), ('IPR050933', 'Circadian Clock Transcription Factors'), ('PF00010', 'Helix-loop-helix DNA-binding domain'), ('PF00989', 'PAS fold'), ('PF14598', 'PAS domain'), ('PR00785', 'NCTRNSLOCATR'), ('PS50112', 'PAS repeat profile'), ('PS50888', 'Myc-type, basic helix-loop-helix (bHLH) domain profile'), ('PTHR23042', 'Circadian Clock Transcription Factors'), ('SM00086', 'Motif C-terminal to PAS motifs (likely to contribute to PAS structural domain)')]",P27540;,"""ENSG00000143437; Low tissue specificity."";",,,,,ENST00000354396.6 [P27540-4];ENST00000358595.10 [P27540-1];ENST00000505755.5 [P27540-2];ENST00000515192.5 [P27540-3];,ARNT;MBNL1,ENSG00000143437;ENSG00000152601,0.0,,,,,,,0.597,0.308,ARNT
P27635,ENSG00000147403,RL10_HUMAN,cytoplasmic translation [GO:0002181]; embryonic brain development [GO:1990403]; negative regulation of apoptotic process [GO:0043066]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of translation [GO:0006417]; ribosomal large subunit assembly [GO:0000027]; translation [GO:0006412],cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; endoplasmic reticulum [GO:0005783]; membrane [GO:0016020]; nucleus [GO:0005634]; protein-containing complex [GO:0032991],RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; translation regulator activity [GO:0045182],PTM: Citrullinated by PADI4. {ECO:0000250|UniProtKB:Q6ZWV3}.; PTM: Ufmylated by UFL1. {ECO:0000250|UniProtKB:Q6ZWV3}.,,,"STRAND 48..54; /evidence=""ECO:0007829|PDB:2PA2""; STRAND 58..61; /evidence=""ECO:0007829|PDB:2PA2""; STRAND 84..89; /evidence=""ECO:0007829|PDB:2PA2""; STRAND 126..129; /evidence=""ECO:0007829|PDB:2PA2""; STRAND 133..140; /evidence=""ECO:0007829|PDB:2PA2""; STRAND 159..161; /evidence=""ECO:0007829|PDB:2PA2""; STRAND 163..169; /evidence=""ECO:0007829|PDB:2PA2""","HELIX 62..80; /evidence=""ECO:0007829|PDB:2PA2""; HELIX 142..144; /evidence=""ECO:0007829|PDB:2PA2""; HELIX 145..155; /evidence=""ECO:0007829|PDB:2PA2""; HELIX 156..158; /evidence=""ECO:0007829|PDB:2PA2""","TURN 43..45; /evidence=""ECO:0007829|PDB:2PA2""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,RPL10 DXS648E QM,Large ribosomal subunit protein uL16 (60S ribosomal protein L10) (Laminin receptor homolog) (Protein QM) (Ribosomal protein L10) (Tumor suppressor QM),Homo sapiens (Human),214.0,24577.0,MGRRPARCYRYCKNKPYPKSRFCRGVPDAKIRIFDLGRKKAKVDEFPLCGHMVSDEYEQLSSEALEAARICANKYMVKSCGKDGFHIRVRLHPFHVIRINKMLSCAGADRLQTGMRGAFGKPQGTVARVHIGQVIMSIRTKLQNKEHVIEALRRAKFKFPGRQKIHISKKWGFTKFNADEFEDMVAEKRLIPDGCGVKYIPSRGPLDKWRALHS,True,True,False,P27635,"[('cd01433', 'Ribosomal_L16_L10e'), ('G3DSA:3.30.60.300', None), ('G3DSA:3.90.1170.10', 'Ribosomal protein L10e/L16'), ('IPR001197', 'Large ribosomal subunit protein uL16, eukaryotes/archaea'), ('IPR016180', 'Large ribosomal subunit protein uL16 domain'), ('IPR018255', 'Large ribosomal subunit protein uL16, conserved site, eukaryotes/archaea'), ('IPR036920', 'Large ribosomal subunit protein uL16 superfamily'), ('IPR047873', 'Large ribosomal subunit protein uL16'), ('PF00252', 'Ribosomal protein L16p/L10e'), ('PIRSF005590', 'Ribosomal protein L10a/L10e types'), ('PS01257', 'Ribosomal protein L10e signature'), ('PTHR11726', '60S RIBOSOMAL PROTEIN L10'), ('SSF54686', 'Ribosomal protein L16p/L10e'), ('TIGR00279', '50S ribosomal protein L16')]",,"""ENSG00000147403; Low tissue specificity."";",,,,,ENST00000344746.8;ENST00000369817.7;,RPL10,ENSG00000147403,0.0,RPL10,Canonical_RBPs,26.0,13.55,DP03456,,0.023,,RPL10
P27695,ENSG00000100823|ENSG00000291796,APEX1_HUMAN,"base-excision repair [GO:0006284]; base-excision repair, gap-filling [GO:0006287]; cell redox homeostasis [GO:0045454]; DNA catabolic process [GO:0006308]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; positive regulation of gene expression via chromosomal CpG island demethylation [GO:0044029]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of apoptotic process [GO:0042981]; regulation of mRNA stability [GO:0043488]; telomere maintenance [GO:0000723]; telomere maintenance via base-excision repair [GO:0097698]","centrosome [GO:0005813]; chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; ribosome [GO:0005840]","3'-5' exonuclease activity [GO:0008408]; 3'-5'-DNA exonuclease activity [GO:0008296]; chromatin DNA binding [GO:0031490]; class II DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0052720]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; DNA endonuclease activity [GO:0004520]; DNA-(abasic site) binding [GO:0140431]; DNA-(apurinic or apyrimidinic site) endonuclease activity [GO:0003906]; double-stranded DNA 3'-5' DNA exonuclease activity [GO:0008311]; double-stranded DNA exodeoxyribonuclease activity [GO:0008309]; double-stranded telomeric DNA binding [GO:0003691]; endonuclease activity [GO:0004519]; metal ion binding [GO:0046872]; oxidoreductase activity [GO:0016491]; phosphodiesterase activity, acting on 3'-phosphoglycolate-terminated DNA strands [GO:0090580]; phosphodiesterase I activity [GO:0004528]; phosphoric diester hydrolase activity [GO:0008081]; RNA binding [GO:0003723]; RNA-DNA hybrid ribonuclease activity [GO:0004523]; site-specific endodeoxyribonuclease activity, specific for altered base [GO:0016890]; transcription coactivator activity [GO:0003713]; transcription corepressor activity [GO:0003714]; uracil DNA N-glycosylase activity [GO:0004844]","PTM: Phosphorylated. Phosphorylation by kinase PKC or casein kinase CK2 results in enhanced redox activity that stimulates binding of the FOS/JUN AP-1 complex to its cognate binding site. AP-endodeoxyribonuclease activity is not affected by CK2-mediated phosphorylation. Phosphorylation of Thr-233 by CDK5 reduces AP-endodeoxyribonuclease activity resulting in accumulation of DNA damage and contributing to neuronal death. {ECO:0000269|PubMed:10023679, ECO:0000269|PubMed:11452037}.; PTM: Acetylated on Lys-6 and Lys-7. Acetylation is increased by the transcriptional coactivator EP300 acetyltransferase, genotoxic agents like H(2)O(2) and methyl methanesulfonate (MMS). Acetylation increases its binding affinity to the negative calcium response element (nCaRE) DNA promoter. The acetylated form induces a stronger binding of YBX1 to the Y-box sequence in the MDR1 promoter than the unacetylated form. Deacetylated on lysines. Lys-6 and Lys-7 are deacetylated by SIRT1. {ECO:0000269|PubMed:14633989, ECO:0000269|PubMed:20699270}.; PTM: Cleaved at Lys-31 by granzyme A to create the mitochondrial form; leading to reduction of binding to DNA, AP endodeoxynuclease activity, redox activation of transcription factors and to enhanced cell death. Cleaved by granzyme K; leading to intracellular ROS accumulation and enhanced cell death after oxidative stress. {ECO:0000269|PubMed:12524539}.; PTM: Cys-65 and Cys-93 are nitrosylated in response to nitric oxide (NO) and lead to the exposure of the nuclear export signal (NES). {ECO:0000269|PubMed:17403694}.; PTM: Ubiquitinated by MDM2; leading to translocation to the cytoplasm and proteasomal degradation. {ECO:0000269|PubMed:19219073}.","DOMAIN: The N-terminus contains the redox activity while the C-terminus exerts the DNA AP-endodeoxyribonuclease activity; both functions are independent in their actions. An unconventional mitochondrial targeting sequence (MTS) is harbored within the C-terminus, that appears to be masked by the N-terminal sequence containing the nuclear localization signal (NLS), that probably blocks the interaction between the MTS and Tom proteins.",,"STRAND 62..68; /evidence=""ECO:0007829|PDB:7TC3""; STRAND 90..95; /evidence=""ECO:0007829|PDB:7TC3""; STRAND 116..120; /evidence=""ECO:0007829|PDB:7TC3""; STRAND 122..124; /evidence=""ECO:0007829|PDB:7MEV""; STRAND 127..129; /evidence=""ECO:0007829|PDB:4QHE""; STRAND 131..137; /evidence=""ECO:0007829|PDB:7TC3""; STRAND 140..145; /evidence=""ECO:0007829|PDB:7TC3""; STRAND 152..155; /evidence=""ECO:0007829|PDB:7TC3""; STRAND 157..161; /evidence=""ECO:0007829|PDB:7TC3""; STRAND 166..171; /evidence=""ECO:0007829|PDB:7TC3""; STRAND 205..210; /evidence=""ECO:0007829|PDB:7TC3""; STRAND 249..251; /evidence=""ECO:0007829|PDB:7MCR""; STRAND 257..259; /evidence=""ECO:0007829|PDB:1DE9""; STRAND 265..267; /evidence=""ECO:0007829|PDB:7U50""; STRAND 283..287; /evidence=""ECO:0007829|PDB:7TC3""; STRAND 295..300; /evidence=""ECO:0007829|PDB:7TC3""; STRAND 306..309; /evidence=""ECO:0007829|PDB:7TC3""; STRAND 312..316; /evidence=""ECO:0007829|PDB:7TC3""","HELIX 72..77; /evidence=""ECO:0007829|PDB:7TC3""; HELIX 80..87; /evidence=""ECO:0007829|PDB:7TC3""; HELIX 101..103; /evidence=""ECO:0007829|PDB:5DFF""; HELIX 106..110; /evidence=""ECO:0007829|PDB:7TC3""; HELIX 112..114; /evidence=""ECO:0007829|PDB:4QHE""; HELIX 149..151; /evidence=""ECO:0007829|PDB:7TC3""; HELIX 177..179; /evidence=""ECO:0007829|PDB:7TC3""; HELIX 182..200; /evidence=""ECO:0007829|PDB:7TC3""; HELIX 217..219; /evidence=""ECO:0007829|PDB:7TC3""; HELIX 234..246; /evidence=""ECO:0007829|PDB:7TC3""; HELIX 252..256; /evidence=""ECO:0007829|PDB:7TC3""; HELIX 270..272; /evidence=""ECO:0007829|PDB:6BOW""; HELIX 273..276; /evidence=""ECO:0007829|PDB:7TC3""; HELIX 289..294; /evidence=""ECO:0007829|PDB:7TC3""","TURN 224..228; /evidence=""ECO:0007829|PDB:7TC3""; TURN 230..232; /evidence=""ECO:0007829|PDB:7LPI""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,APEX1 APE APE1 APEX APX HAP1 REF1,"DNA repair nuclease/redox regulator APEX1 (EC 3.1.11.2) (EC 3.1.21.-) (APEX nuclease) (APEN) (Apurinic-apyrimidinic endonuclease 1) (AP endonuclease 1) (APE-1) (DNA-(apurinic or apyrimidinic site) endonuclease) (Redox factor-1) (REF-1) [Cleaved into: DNA repair nuclease/redox regulator APEX1, mitochondrial]",Homo sapiens (Human),318.0,35555.0,MPKRGKKGAVAEDGDELRTEPEAKKSKTAAKKNDKEAAGEGPALYEDPPDQKTSPSGKPATLKICSWNVDGLRAWIKKKGLDWVKEEAPDILCLQETKCSENKLPAELQELPGLSHQYWSAPSDKEGYSGVGLLSRQCPLKVSYGIGDEEHDQEGRVIVAEFDSFVLVTAYVPNAGRGLVRLEYRQRWDEAFRKFLKGLASRKPLVLCGDLNVAHEEIDLRNPKGNKKNAGFTPQERQGFGELLQAVPLADSFRHLYPNTPYAYTFWTYMMNARSKNVGWRLDYFLLSHSLLPALCDSKIRSKALGSDHCPITLYLAL,False,True,False,P27695,"[('cd09087', 'Human Ape1-like subfamily of the ExoIII family apurinic/apyrimidinic (AP) endonucleases'), ('G3DSA:3.60.10.10', 'Endonuclease/exonuclease/phosphatase'), ('IPR004808', 'AP endonuclease 1'), ('IPR005135', 'Endonuclease/exonuclease/phosphatase'), ('IPR020847', 'AP endonuclease 1, binding site'), ('IPR020848', 'AP endonuclease 1, conserved site'), ('IPR036691', 'Endonuclease/exonuclease/phosphatase superfamily'), ('PF03372', 'Endonuclease/Exonuclease/phosphatase family'), ('PS00726', 'AP endonucleases family 1 signature 1'), ('PS00727', 'AP endonucleases family 1 signature 2'), ('PS00728', 'AP endonucleases family 1 signature 3'), ('PS51435', 'AP endonucleases family 1 profile'), ('PTHR22748', 'AP ENDONUCLEASE'), ('SSF56219', 'DNase I-like'), ('TIGR00195', 'exodeoxyribonuclease III'), ('TIGR00633', 'exodeoxyribonuclease III')]",,"""ENSG00000100823; Low tissue specificity."";","CATALYTIC ACTIVITY: Reaction=Exonucleolytic cleavage in the 3'- to 5'-direction to yield nucleoside 5'-phosphates.; EC=3.1.11.2; Evidence={ECO:0000269|PubMed:11286553, ECO:0000269|PubMed:15380100, ECO:0000269|PubMed:19123919, ECO:0000269|PubMed:21762700};",3.1.11.2; 3.1.21.-,"ACTIVITY REGULATION: NPM1 stimulates endodeoxyribonuclease activity on double-stranded DNA with AP sites, but inhibits endoribonuclease activity on single-stranded RNA containing AP sites. {ECO:0000269|PubMed:19188445}.",,ENST00000216714.8;ENST00000398030.8;ENST00000555414.5;ENST00000708787.1;ENST00000708794.1;ENST00000708795.1;,APEX1,ENSG00000100823;ENSG00000240973,1.0,APEX1,Canonical_RBPs,15.0,13.52,DP00007,0.135,0.151,0.189,APEX1
P27797,ENSG00000179218,CALR_HUMAN,cardiac muscle cell differentiation [GO:0055007]; cellular response to electrical stimulus [GO:0071257]; cellular response to lithium ion [GO:0071285]; cellular response to virus [GO:0098586]; cellular senescence [GO:0090398]; cortical actin cytoskeleton organization [GO:0030866]; ERAD pathway [GO:0036503]; intracellular calcium ion homeostasis [GO:0006874]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of intracellular steroid hormone receptor signaling pathway [GO:0033144]; negative regulation of neuron differentiation [GO:0045665]; negative regulation of retinoic acid receptor signaling pathway [GO:0048387]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translation [GO:0017148]; negative regulation of trophoblast cell migration [GO:1901164]; nuclear receptor-mediated glucocorticoid signaling pathway [GO:0042921]; peptide antigen assembly with MHC class I protein complex [GO:0002502]; positive regulation of cell cycle [GO:0045787]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of dendritic cell chemotaxis [GO:2000510]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of gene expression [GO:0010628]; positive regulation of non-canonical NF-kappaB signal transduction [GO:1901224]; positive regulation of phagocytosis [GO:0050766]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; protein export from nucleus [GO:0006611]; protein folding [GO:0006457]; protein folding in endoplasmic reticulum [GO:0034975]; protein localization to nucleus [GO:0034504]; protein maturation by protein folding [GO:0022417]; protein stabilization [GO:0050821]; regulation of apoptotic process [GO:0042981]; regulation of DNA-templated transcription [GO:0006355]; regulation of meiotic nuclear division [GO:0040020]; response to biphenyl [GO:1904614]; response to estradiol [GO:0032355]; response to glycoside [GO:1903416]; response to peptide [GO:1901652]; response to testosterone [GO:0033574]; response to xenobiotic stimulus [GO:0009410]; sequestering of calcium ion [GO:0051208]; spermatogenesis [GO:0007283],acrosomal vesicle [GO:0001669]; cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; cortical granule [GO:0060473]; cytolytic granule [GO:0044194]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endocytic vesicle lumen [GO:0071682]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum lumen [GO:0005788]; endoplasmic reticulum membrane [GO:0005789]; endoplasmic reticulum quality control compartment [GO:0044322]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; external side of plasma membrane [GO:0009897]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; lumenal side of endoplasmic reticulum membrane [GO:0098553]; membrane [GO:0016020]; MHC class I peptide loading complex [GO:0042824]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; phagocytic vesicle membrane [GO:0030670]; postsynapse [GO:0098794]; ribosome [GO:0005840]; sarcoplasmic reticulum lumen [GO:0033018]; smooth endoplasmic reticulum [GO:0005790],calcium ion binding [GO:0005509]; carbohydrate binding [GO:0030246]; complement component C1q complex binding [GO:0001849]; DNA binding [GO:0003677]; hormone binding [GO:0042562]; integrin binding [GO:0005178]; iron ion binding [GO:0005506]; molecular sequestering activity [GO:0140313]; mRNA binding [GO:0003729]; nuclear androgen receptor binding [GO:0050681]; nuclear export signal receptor activity [GO:0005049]; peptide binding [GO:0042277]; protein folding chaperone [GO:0044183]; protein-folding chaperone binding [GO:0051087]; RNA binding [GO:0003723]; ubiquitin protein ligase binding [GO:0031625]; unfolded protein binding [GO:0051082]; zinc ion binding [GO:0008270],,"DOMAIN: Can be divided into a N-terminal globular domain, a proline-rich P-domain forming an elongated arm-like structure and a C-terminal acidic domain. The P-domain binds one molecule of calcium with high affinity, whereas the acidic C-domain binds multiple calcium ions with low affinity.; DOMAIN: The interaction with glycans occurs through a binding site in the globular lectin domain.; DOMAIN: The zinc binding sites are localized to the N-domain.; DOMAIN: Associates with PDIA3 through the tip of the extended arm formed by the P-domain.",,"STRAND 20..25; /evidence=""ECO:0007829|PDB:3POW""; STRAND 37..39; /evidence=""ECO:0007829|PDB:3POW""; STRAND 42..44; /evidence=""ECO:0007829|PDB:3POW""; STRAND 49..52; /evidence=""ECO:0007829|PDB:3POW""; STRAND 65..68; /evidence=""ECO:0007829|PDB:3POW""; STRAND 70..84; /evidence=""ECO:0007829|PDB:3POW""; STRAND 91..98; /evidence=""ECO:0007829|PDB:3POW""; STRAND 104..107; /evidence=""ECO:0007829|PDB:3POW""; STRAND 110..113; /evidence=""ECO:0007829|PDB:3POW""; STRAND 129..138; /evidence=""ECO:0007829|PDB:3POW""; STRAND 142..150; /evidence=""ECO:0007829|PDB:3POW""; STRAND 153..156; /evidence=""ECO:0007829|PDB:3POW""; STRAND 166..176; /evidence=""ECO:0007829|PDB:3POW""; STRAND 180..186; /evidence=""ECO:0007829|PDB:3POW""; STRAND 189..195; /evidence=""ECO:0007829|PDB:3POW""; STRAND 201..203; /evidence=""ECO:0007829|PDB:3DOW""; STRAND 311..322; /evidence=""ECO:0007829|PDB:3POW""; STRAND 326..334; /evidence=""ECO:0007829|PDB:3POW""","HELIX 30..35; /evidence=""ECO:0007829|PDB:3POW""; HELIX 119..121; /evidence=""ECO:0007829|PDB:3POW""; HELIX 196..199; /evidence=""ECO:0007829|PDB:3POW""; HELIX 336..345; /evidence=""ECO:0007829|PDB:3POW""; HELIX 347..366; /evidence=""ECO:0007829|PDB:3POW""","TURN 60..63; /evidence=""ECO:0007829|PDB:3POW""; TURN 255..257; /evidence=""ECO:0007829|PDB:5V90""; TURN 303..306; /evidence=""ECO:0007829|PDB:5LK5""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,CALR CRTC,Calreticulin (CRP55) (Calregulin) (Endoplasmic reticulum resident protein 60) (ERp60) (HACBP) (grp60),Homo sapiens (Human),417.0,48142.0,MLLSVPLLLGLLGLAVAEPAVYFKEQFLDGDGWTSRWIESKHKSDFGKFVLSSGKFYGDEEKDKGLQTSQDARFYALSASFEPFSNKGQTLVVQFTVKHEQNIDCGGGYVKLFPNSLDQTDMHGDSEYNIMFGPDICGPGTKKVHVIFNYKGKNVLINKDIRCKDDEFTHLYTLIVRPDNTYEVKIDNSQVESGSLEDDWDFLPPKKIKDPDASKPEDWDERAKIDDPTDSKPEDWDKPEHIPDPDAKKPEDWDEEMDGEWEPPVIQNPEYKGEWKPRQIDNPDYKGTWIHPEIDNPEYSPDPSIYAYDNFGVLGLDLWQVKSGTIFDNFLITNDEAYAEEFGNETWGVTKAAEKQMKDKQDEEQRLKEEEEDKKRKEEEEAEDKEDDEDKDEDEEDEEDKEEDEEEDVPGQAKDEL,True,True,False,P27797,"[('G3DSA:2.10.250.10', 'Calreticulin/calnexin, P domain'), ('G3DSA:2.60.120.200', None), ('IPR001580', 'Calreticulin/calnexin'), ('IPR009033', 'Calreticulin/calnexin, P domain superfamily'), ('IPR009169', 'Calreticulin'), ('IPR013320', 'Concanavalin A-like lectin/glucanase domain superfamily'), ('IPR018124', 'Calreticulin/calnexin, conserved site'), ('PF00262', 'Calreticulin family'), ('PIRSF002356', 'Calreticulin'), ('PR00626', 'CALRETICULIN'), ('PS00803', 'Calreticulin family signature 1'), ('PS00804', 'Calreticulin family signature 2'), ('PS00805', 'Calreticulin family repeated motif signature'), ('PTHR11073', 'CALRETICULIN AND CALNEXIN'), ('SSF49899', 'Concanavalin A-like lectins/glucanases'), ('SSF63887', 'P-domain of calnexin/calreticulin')]",,"""ENSG00000179218; Low tissue specificity."";",,,,,ENST00000316448.10;ENST00000586967.2;,CALR,ENSG00000179218,0.0,CALR,Canonical_RBPs,5.0,95.92,DP00333,0.959,0.158,0.369,CALR
P27986,ENSG00000145675,P85A_HUMAN,B cell differentiation [GO:0030183]; cellular response to insulin stimulus [GO:0032869]; cellular response to UV [GO:0034644]; cytokine-mediated signaling pathway [GO:0019221]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; growth hormone receptor signaling pathway [GO:0060396]; immune response [GO:0006955]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; interleukin-18-mediated signaling pathway [GO:0035655]; intracellular glucose homeostasis [GO:0001678]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; myeloid leukocyte migration [GO:0097529]; natural killer cell mediated cytotoxicity [GO:0042267]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of osteoclast differentiation [GO:0045671]; negative regulation of stress fiber assembly [GO:0051497]; osteoclast differentiation [GO:0030316]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; positive regulation of endoplasmic reticulum unfolded protein response [GO:1900103]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of focal adhesion disassembly [GO:0120183]; positive regulation of glucose import [GO:0046326]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of leukocyte migration [GO:0002687]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of RNA splicing [GO:0033120]; positive regulation of smooth muscle cell proliferation [GO:0048661]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; protein import into nucleus [GO:0006606]; protein stabilization [GO:0050821]; regulation of toll-like receptor 4 signaling pathway [GO:0034143]; response to endoplasmic reticulum stress [GO:0034976]; substrate adhesion-dependent cell spreading [GO:0034446]; T cell differentiation [GO:0030217]; transcription by RNA polymerase II [GO:0006366],"cell-cell junction [GO:0005911]; cis-Golgi network [GO:0005801]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; perinuclear endoplasmic reticulum membrane [GO:1990578]; perinuclear region of cytoplasm [GO:0048471]; phosphatidylinositol 3-kinase complex [GO:0005942]; phosphatidylinositol 3-kinase complex, class IA [GO:0005943]; plasma membrane [GO:0005886]",1-phosphatidylinositol-3-kinase regulator activity [GO:0046935]; enzyme-substrate adaptor activity [GO:0140767]; ErbB-3 class receptor binding [GO:0043125]; insulin binding [GO:0043559]; insulin receptor binding [GO:0005158]; insulin receptor substrate binding [GO:0043560]; insulin-like growth factor receptor binding [GO:0005159]; kinase activator activity [GO:0019209]; neurotrophin TRKA receptor binding [GO:0005168]; phosphatidylinositol 3-kinase activator activity [GO:0141038]; phosphatidylinositol 3-kinase binding [GO:0043548]; phosphatidylinositol 3-kinase regulator activity [GO:0035014]; phosphatidylinositol 3-kinase regulatory subunit binding [GO:0036312]; phosphatidylinositol kinase activity [GO:0052742]; phosphotyrosine residue binding [GO:0001784]; protein heterodimerization activity [GO:0046982]; protein phosphatase binding [GO:0019903]; transmembrane receptor protein tyrosine kinase adaptor activity [GO:0005068],"PTM: Polyubiquitinated in T-cells by CBLB; which does not promote proteasomal degradation but impairs association with CD28 and CD3Z upon T-cell activation. {ECO:0000269|PubMed:11087752, ECO:0000269|PubMed:11526404}.; PTM: In adipose tissue, polyubiquitinated by the BCR(KBTBD2) E3 ubiquitin ligase complex; recognized by KBTBD2 through the SH2 domains, undergoes 'Lys-48'-linked polyubiquitination leading to its degradation. {ECO:0000269|PubMed:27708159}.; PTM: Phosphorylated. Tyrosine phosphorylated in response to signaling by FGFR1, FGFR2, FGFR3 and FGFR4. Phosphorylated by CSF1R. Phosphorylated by ERBB4. Phosphorylated on tyrosine residues by TEK/TIE2. Dephosphorylated by PTPRJ. Phosphorylated by PIK3CA at Ser-608; phosphorylation is stimulated by insulin and PDGF. The relevance of phosphorylation by PIK3CA is however unclear (By similarity). Phosphorylated in response to KIT and KITLG/SCF. Phosphorylated by FGR. {ECO:0000250, ECO:0000269|PubMed:15561106, ECO:0000269|PubMed:18348712}.","DOMAIN: The SH3 domain mediates the binding to CBLB, and to HIV-1 Nef.","DOMAIN 3..79; /note=""SH3""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00192""; DOMAIN 113..301; /note=""Rho-GAP""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00172""; DOMAIN 333..428; /note=""SH2 1""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00191""; DOMAIN 624..718; /note=""SH2 2""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00191""","STRAND 4..10; /evidence=""ECO:0007829|PDB:3I5R""; STRAND 29..33; /evidence=""ECO:0007829|PDB:3I5R""; STRAND 55..60; /evidence=""ECO:0007829|PDB:3I5R""; STRAND 65..70; /evidence=""ECO:0007829|PDB:3I5R""; STRAND 74..81; /evidence=""ECO:0007829|PDB:3I5R""; STRAND 167..170; /evidence=""ECO:0007829|PDB:1PBW""; STRAND 193..195; /evidence=""ECO:0007829|PDB:1PBW""; STRAND 334..337; /evidence=""ECO:0007829|PDB:4WAF""; STRAND 354..359; /evidence=""ECO:0007829|PDB:5GJI""; STRAND 361..363; /evidence=""ECO:0007829|PDB:8V8V""; STRAND 368..374; /evidence=""ECO:0007829|PDB:5GJI""; STRAND 377..386; /evidence=""ECO:0007829|PDB:5GJI""; STRAND 389..395; /evidence=""ECO:0007829|PDB:5GJI""; STRAND 398..400; /evidence=""ECO:0007829|PDB:5GJI""; STRAND 425..427; /evidence=""ECO:0007829|PDB:4YKN""; STRAND 625..629; /evidence=""ECO:0007829|PDB:1PIC""; STRAND 645..650; /evidence=""ECO:0007829|PDB:5AUL""; STRAND 652..655; /evidence=""ECO:0007829|PDB:1PIC""; STRAND 657..663; /evidence=""ECO:0007829|PDB:5AUL""; STRAND 666..675; /evidence=""ECO:0007829|PDB:5AUL""; STRAND 678..682; /evidence=""ECO:0007829|PDB:5AUL""; STRAND 688..690; /evidence=""ECO:0007829|PDB:5AUL""; STRAND 716..719; /evidence=""ECO:0007829|PDB:1PIC""","HELIX 34..40; /evidence=""ECO:0007829|PDB:3I5R""; HELIX 46..48; /evidence=""ECO:0007829|PDB:3I5R""; HELIX 50..53; /evidence=""ECO:0007829|PDB:3I5R""; HELIX 71..73; /evidence=""ECO:0007829|PDB:3I5R""; HELIX 118..121; /evidence=""ECO:0007829|PDB:1PBW""; HELIX 130..143; /evidence=""ECO:0007829|PDB:1PBW""; HELIX 160..164; /evidence=""ECO:0007829|PDB:1PBW""; HELIX 174..176; /evidence=""ECO:0007829|PDB:1PBW""; HELIX 179..191; /evidence=""ECO:0007829|PDB:1PBW""; HELIX 200..209; /evidence=""ECO:0007829|PDB:1PBW""; HELIX 210..212; /evidence=""ECO:0007829|PDB:1PBW""; HELIX 216..227; /evidence=""ECO:0007829|PDB:1PBW""; HELIX 234..252; /evidence=""ECO:0007829|PDB:1PBW""; HELIX 254..257; /evidence=""ECO:0007829|PDB:1PBW""; HELIX 261..273; /evidence=""ECO:0007829|PDB:1PBW""; HELIX 280..295; /evidence=""ECO:0007829|PDB:1PBW""; HELIX 323..325; /evidence=""ECO:0007829|PDB:4L23""; HELIX 328..330; /evidence=""ECO:0007829|PDB:5GJI""; HELIX 340..347; /evidence=""ECO:0007829|PDB:5GJI""; HELIX 364..366; /evidence=""ECO:0007829|PDB:7RNS""; HELIX 401..409; /evidence=""ECO:0007829|PDB:5GJI""; HELIX 413..415; /evidence=""ECO:0007829|PDB:5GJI""; HELIX 418..420; /evidence=""ECO:0007829|PDB:5GJI""; HELIX 433..436; /evidence=""ECO:0007829|PDB:4WAF""; HELIX 442..515; /evidence=""ECO:0007829|PDB:4JPS""; HELIX 518..587; /evidence=""ECO:0007829|PDB:4JPS""; HELIX 591..597; /evidence=""ECO:0007829|PDB:6PYR""; HELIX 617..619; /evidence=""ECO:0007829|PDB:5AUL""; HELIX 621..623; /evidence=""ECO:0007829|PDB:5AUL""; HELIX 631..638; /evidence=""ECO:0007829|PDB:5AUL""; HELIX 691..698; /evidence=""ECO:0007829|PDB:5AUL""; HELIX 703..705; /evidence=""ECO:0007829|PDB:5AUL""","TURN 43..45; /evidence=""ECO:0007829|PDB:3I5R""; TURN 61..64; /evidence=""ECO:0007829|PDB:3I5R""; TURN 100..102; /evidence=""ECO:0007829|PDB:1AZG""; TURN 147..150; /evidence=""ECO:0007829|PDB:1PBW""; TURN 331..333; /evidence=""ECO:0007829|PDB:6NCT""; TURN 430..432; /evidence=""ECO:0007829|PDB:2IUG""; TURN 708..710; /evidence=""ECO:0007829|PDB:1PIC""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,PIK3R1 GRB1,Phosphatidylinositol 3-kinase regulatory subunit alpha (PI3-kinase regulatory subunit alpha) (PI3K regulatory subunit alpha) (PtdIns-3-kinase regulatory subunit alpha) (Phosphatidylinositol 3-kinase 85 kDa regulatory subunit alpha) (PI3-kinase subunit p85-alpha) (PtdIns-3-kinase regulatory subunit p85-alpha),Homo sapiens (Human),724.0,83598.0,MSAEGYQYRALYDYKKEREEDIDLHLGDILTVNKGSLVALGFSDGQEARPEEIGWLNGYNETTGERGDFPGTYVEYIGRKKISPPTPKPRPPRPLPVAPGSSKTEADVEQQALTLPDLAEQFAPPDIAPPLLIKLVEAIEKKGLECSTLYRTQSSSNLAELRQLLDCDTPSVDLEMIDVHVLADAFKRYLLDLPNPVIPAAVYSEMISLAPEVQSSEEYIQLLKKLIRSPSIPHQYWLTLQYLLKHFFKLSQTSSKNLLNARVLSEIFSPMLFRFSAASSDNTENLIKVIEILISTEWNERQPAPALPPKPPKPTTVANNGMNNNMSLQDAEWYWGDISREEVNEKLRDTADGTFLVRDASTKMHGDYTLTLRKGGNNKLIKIFHRDGKYGFSDPLTFSSVVELINHYRNESLAQYNPKLDVKLLYPVSKYQQDQVVKEDNIEAVGKKLHEYNTQFQEKSREYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCQTQERYSKEYIEKFKREGNEKEIQRIMHNYDKLKSRISEIIDSRRRLEEDLKKQAAEYREIDKRMNSIKPDLIQLRKTRDQYLMWLTQKGVRQKKLNEWLGNENTEDQYSLVEDDEDLPHHDEKTWNVGSSNRNKAENLLRGKRDGTFLVRESSKQGCYACSVVVDGEVKHCVINKTATGYGFAEPYNLYSSLKELVLHYQHTSLVQHNDSLNVTLAYPVYAQQRR,False,False,True,P27986,"[('cd04388', 'RhoGAP_p85'), ('cd09930', 'C-terminal Src homology 2 (cSH2) domain found in p85'), ('cd09942', 'N-terminal Src homology 2 (nSH2) domain found in p85'), ('cd11910', 'Src Homology 3 domain of the p85alpha regulatory subunit of Class IA Phosphatidylinositol 3-kinases'), ('cd12924', 'Inter-Src homology 2 (iSH2) helical domain of Class IA Phosphoinositide 3-kinase Regulatory subunit 1, PIK3R1, also called p85alpha'), ('G3DSA:1.10.287.1490', None), ('G3DSA:1.10.555.10', 'Rho GTPase activation protein'), ('G3DSA:2.30.30.40', 'SH3 Domains'), ('G3DSA:3.30.505.10', 'SH2 domain'), ('IPR000198', 'Rho GTPase-activating protein domain'), ('IPR000980', 'SH2 domain'), ('IPR001452', 'SH3 domain'), ('IPR008936', 'Rho GTPase activation protein'), ('IPR032498', 'PI3K regulatory subunit p85-related , inter-SH2 domain'), ('IPR035020', 'PI3K p85 subunit, C-terminal SH2 domain'), ('IPR035022', 'PI3K p85 subunit, N-terminal SH2 domain'), ('IPR035591', 'Phosphatidylinositol 3-kinase regulatory subunit alpha, SH3 domain'), ('IPR036028', 'SH3-like domain superfamily'), ('IPR036860', 'SH2 domain superfamily'), ('IPR044124', 'PIK3R1, inter-SH2 domain')]",,"""ENSG00000145675; Low tissue specificity."";",,,,,ENST00000320694.13 [P27986-3];ENST00000336483.10 [P27986-2];ENST00000517643.2 [P27986-1];ENST00000521381.6 [P27986-1];ENST00000521657.6 [P27986-1];ENST00000523872.1 [P27986-5];ENST00000697458.1 [P27986-1];ENST00000697461.1 [P27986-4];ENST00000697467.1 [P27986-5];,PIK3R1,ENSG00000145675,0.0,,,,1.93,DP01112,0.838,0.095,0.04,PIK3R1
P28482,ENSG00000100030,MK01_HUMAN,androgen receptor signaling pathway [GO:0030521]; apoptotic process [GO:0006915]; B cell receptor signaling pathway [GO:0050853]; Bergmann glial cell differentiation [GO:0060020]; cardiac neural crest cell development involved in heart development [GO:0061308]; caveolin-mediated endocytosis [GO:0072584]; cell surface receptor signaling pathway [GO:0007166]; cellular response to amino acid starvation [GO:0034198]; cellular response to tumor necrosis factor [GO:0071356]; chemical synaptic transmission [GO:0007268]; chemotaxis [GO:0006935]; cytosine metabolic process [GO:0019858]; DNA damage response [GO:0006974]; ERBB signaling pathway [GO:0038127]; ERBB2-ERBB3 signaling pathway [GO:0038133]; ERK1 and ERK2 cascade [GO:0070371]; face development [GO:0060324]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; intracellular signal transduction [GO:0035556]; labyrinthine layer blood vessel development [GO:0060716]; learning or memory [GO:0007611]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; long-term synaptic potentiation [GO:0060291]; lung morphogenesis [GO:0060425]; mammary gland epithelial cell proliferation [GO:0033598]; myelination [GO:0042552]; negative regulation of cell differentiation [GO:0045596]; outer ear morphogenesis [GO:0042473]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of cholesterol biosynthetic process [GO:0045542]; positive regulation of macrophage chemotaxis [GO:0010759]; positive regulation of macrophage proliferation [GO:0120041]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of telomere maintenance [GO:0032206]; progesterone receptor signaling pathway [GO:0050847]; protein phosphorylation [GO:0006468]; regulation of cellular pH [GO:0030641]; regulation of cytoskeleton organization [GO:0051493]; regulation of early endosome to late endosome transport [GO:2000641]; regulation of Golgi inheritance [GO:0090170]; regulation of ossification [GO:0030278]; regulation of protein stability [GO:0031647]; regulation of stress-activated MAPK cascade [GO:0032872]; response to epidermal growth factor [GO:0070849]; response to exogenous dsRNA [GO:0043330]; response to nicotine [GO:0035094]; Schwann cell development [GO:0014044]; signal transduction [GO:0007165]; steroid hormone receptor signaling pathway [GO:0043401]; stress-activated MAPK cascade [GO:0051403]; T cell receptor signaling pathway [GO:0050852]; thymus development [GO:0048538]; thyroid gland development [GO:0030878]; trachea formation [GO:0060440],azurophil granule lumen [GO:0035578]; caveola [GO:0005901]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; early endosome [GO:0005769]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; late endosome [GO:0005770]; mitochondrion [GO:0005739]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; pseudopodium [GO:0031143]; synapse [GO:0045202],ATP binding [GO:0005524]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; MAP kinase activity [GO:0004707]; phosphatase binding [GO:0019902]; phosphotyrosine residue binding [GO:0001784]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; RNA polymerase II CTD heptapeptide repeat kinase activity [GO:0008353],"PTM: Phosphorylated upon KIT and FLT3 signaling (By similarity). Dually phosphorylated on Thr-185 and Tyr-187, which activates the enzyme. Undergoes regulatory phosphorylation on additional residues such as Ser-246 and Ser-248 in the kinase insert domain (KID) These phosphorylations, which are probably mediated by more than one kinase, are important for binding of MAPK1/ERK2 to importin-7 (IPO7) and its nuclear translocation. In addition, autophosphorylation of Thr-190 was shown to affect the subcellular localization of MAPK1/ERK2 as well. Ligand-activated ALK induces tyrosine phosphorylation. Dephosphorylated by PTPRJ at Tyr-187. Phosphorylation on Ser-29 by SGK1 results in its activation by enhancing its interaction with MAP2K1/MEK1 and MAP2K2/MEK2. DUSP3 and DUSP6 dephosphorylate specifically MAPK1/ERK2 and MAPK3/ERK1 whereas DUSP9 dephosphorylates a broader range of MAPKs. Dephosphorylated by DUSP1 and DUSP2 at Thr-185 and Tyr-187 (By similarity) (PubMed:16288922). {ECO:0000250, ECO:0000250|UniProtKB:P63085, ECO:0000269|PubMed:16288922, ECO:0000269|PubMed:17274988, ECO:0000269|PubMed:18760948, ECO:0000269|PubMed:19053285, ECO:0000269|PubMed:19060905, ECO:0000269|PubMed:19265199, ECO:0000269|PubMed:19447520, ECO:0000269|PubMed:19494114}.; PTM: ISGylated. {ECO:0000250}.; PTM: Ubiquitinated by TRIM15 via 'Lys-63'-linked ubiquitination; leading to activation. Deubiquitinated by CYLD. {ECO:0000269|PubMed:34497368}.",DOMAIN: The TXY motif contains the threonine and tyrosine residues whose phosphorylation activates the MAP kinases.,"DOMAIN 25..313; /note=""Protein kinase""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00159""","STRAND 12..14; /evidence=""ECO:0007829|PDB:4QTA""; STRAND 17..19; /evidence=""ECO:0007829|PDB:4QTA""; STRAND 25..34; /evidence=""ECO:0007829|PDB:8AOJ""; STRAND 37..44; /evidence=""ECO:0007829|PDB:8AOJ""; STRAND 49..56; /evidence=""ECO:0007829|PDB:8AOJ""; STRAND 59..61; /evidence=""ECO:0007829|PDB:6G92""; STRAND 81..83; /evidence=""ECO:0007829|PDB:5AX3""; STRAND 88..90; /evidence=""ECO:0007829|PDB:8AOJ""; STRAND 101..106; /evidence=""ECO:0007829|PDB:8AOJ""; STRAND 109..111; /evidence=""ECO:0007829|PDB:8AOJ""; STRAND 155..157; /evidence=""ECO:0007829|PDB:8AOJ""; STRAND 163..165; /evidence=""ECO:0007829|PDB:8AOJ""; STRAND 201..203; /evidence=""ECO:0007829|PDB:5K4I""; STRAND 280..282; /evidence=""ECO:0007829|PDB:5NHO""; STRAND 355..357; /evidence=""ECO:0007829|PDB:7X4U""","HELIX 2..7; /evidence=""ECO:0007829|PDB:7OPM""; HELIX 62..77; /evidence=""ECO:0007829|PDB:8AOJ""; HELIX 112..118; /evidence=""ECO:0007829|PDB:8AOJ""; HELIX 123..142; /evidence=""ECO:0007829|PDB:8AOJ""; HELIX 152..154; /evidence=""ECO:0007829|PDB:8AOJ""; HELIX 168..170; /evidence=""ECO:0007829|PDB:3I5Z""; HELIX 176..178; /evidence=""ECO:0007829|PDB:8AOJ""; HELIX 191..193; /evidence=""ECO:0007829|PDB:8AOJ""; HELIX 196..200; /evidence=""ECO:0007829|PDB:8AOJ""; HELIX 208..223; /evidence=""ECO:0007829|PDB:8AOJ""; HELIX 233..244; /evidence=""ECO:0007829|PDB:8AOJ""; HELIX 249..253; /evidence=""ECO:0007829|PDB:8AOJ""; HELIX 258..266; /evidence=""ECO:0007829|PDB:8AOJ""; HELIX 275..278; /evidence=""ECO:0007829|PDB:8AOJ""; HELIX 284..293; /evidence=""ECO:0007829|PDB:8AOJ""; HELIX 304..308; /evidence=""ECO:0007829|PDB:8AOJ""; HELIX 311..313; /evidence=""ECO:0007829|PDB:8AOJ""; HELIX 319..321; /evidence=""ECO:0007829|PDB:8AOJ""; HELIX 331..334; /evidence=""ECO:0007829|PDB:5V62""; HELIX 335..337; /evidence=""ECO:0007829|PDB:8AOG""; HELIX 340..350; /evidence=""ECO:0007829|PDB:8AOJ""; HELIX 352..354; /evidence=""ECO:0007829|PDB:8AOJ""","TURN 22..24; /evidence=""ECO:0007829|PDB:4ZZN""; TURN 45..48; /evidence=""ECO:0007829|PDB:8AOJ""; TURN 95..97; /evidence=""ECO:0007829|PDB:8AOJ""; TURN 159..161; /evidence=""ECO:0007829|PDB:4IZ5""; TURN 181..185; /evidence=""ECO:0007829|PDB:2Y9Q""; TURN 298..300; /evidence=""ECO:0007829|PDB:8AOJ""; TURN 314..316; /evidence=""ECO:0007829|PDB:8AOJ""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,MAPK1 ERK2 PRKM1 PRKM2,Mitogen-activated protein kinase 1 (MAP kinase 1) (MAPK 1) (EC 2.7.11.24) (ERT1) (Extracellular signal-regulated kinase 2) (ERK-2) (MAP kinase isoform p42) (p42-MAPK) (Mitogen-activated protein kinase 2) (MAP kinase 2) (MAPK 2),Homo sapiens (Human),360.0,41390.0,MAAAAAAGAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYRS,True,True,True,P28482,"[('cd07849', 'Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases'), ('G3DSA:1.10.510.10', 'Transferase(Phosphotransferase) domain 1'), ('G3DSA:3.30.200.20', 'Phosphorylase Kinase; domain 1'), ('IPR000719', 'Protein kinase domain'), ('IPR003527', 'Mitogen-activated protein (MAP) kinase, conserved site'), ('IPR008271', 'Serine/threonine-protein kinase, active site'), ('IPR008349', 'Mitogen-activated protein (MAP) kinase, ERK1/2'), ('IPR011009', 'Protein kinase-like domain superfamily'), ('IPR017441', 'Protein kinase, ATP binding site'), ('IPR050117', 'Mitogen-activated protein kinase'), ('PF00069', 'Protein kinase domain'), ('PR01770', 'ERK1ERK2MAPK'), ('PS00107', 'Protein kinases ATP-binding region signature'), ('PS00108', 'Serine/Threonine protein kinases active-site signature'), ('PS01351', 'MAP kinase signature'), ('PS50011', 'Protein kinase domain profile'), ('PTHR24055', 'Mitogen-activated protein kinase'), ('SM00220', 'Serine/Threonine protein kinases, catalytic domain'), ('SSF56112', 'Protein kinase-like (PK-like)')]",P28482;,"""ENSG00000100030; Low tissue specificity."";","CATALYTIC ACTIVITY: Reaction=L-seryl-[protein] + ATP = O-phospho-L-seryl-[protein] + ADP + H(+); Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616, ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.24; CATALYTIC ACTIVITY: Reaction=L-threonyl-[protein] + ATP = O-phospho-L-threonyl-[protein] + ADP + H(+); Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060, Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013, ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216; EC=2.7.11.24;",2.7.11.24,"ACTIVITY REGULATION: Phosphorylated by MAP2K1/MEK1 and MAP2K2/MEK2 on Thr-185 and Tyr-187 in response to external stimuli like insulin or NGF. Both phosphorylations are required for activity. This phosphorylation causes dramatic conformational changes, which enable full activation and interaction of MAPK1/ERK2 with its substrates. Phosphorylation on Ser-29 by SGK1 results in its activation by enhancing its interaction with MAP2K1/MEK1 and MAP2K2/MEK2. Dephosphorylated and inactivated by DUSP1, DUSP3, DUSP6 and DUSP9. Inactivated by pyrimidylpyrrole inhibitors. {ECO:0000269|PubMed:12356731, ECO:0000269|PubMed:19060905}.",,ENST00000215832.11 [P28482-1];ENST00000398822.7 [P28482-1];ENST00000544786.1 [P28482-2];,MAPK1;GPSM2,ENSG00000100030;ENSG00000121957,0.0,MAPK1,Non-canonical_RBPs,13.0,8.33,DP03864,0.083,0.039,,MAPK1
P28702,ENSG00000204231|ENSG00000206289|ENSG00000228333|ENSG00000235712|ENSG00000231321|ENSG00000227322,RXRB_HUMAN,cell differentiation [GO:0030154]; hormone-mediated signaling pathway [GO:0009755]; mRNA transcription by RNA polymerase II [GO:0042789]; positive regulation of bone mineralization [GO:0030501]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of vitamin D receptor signaling pathway [GO:0070564]; response to retinoic acid [GO:0032526]; retinoic acid receptor signaling pathway [GO:0048384],chromatin [GO:0000785]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575],"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; nuclear receptor activity [GO:0004879]; nuclear steroid receptor activity [GO:0003707]; retinoic acid-responsive element binding [GO:0044323]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific double-stranded DNA binding [GO:1990837]; zinc ion binding [GO:0008270]",,"DOMAIN: Composed of three domains: a modulating N-terminal domain, a DNA-binding domain and a C-terminal ligand-binding domain. {ECO:0000305}.","DOMAIN 296..529; /note=""NR LBD""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU01189, ECO:0000269|PubMed:11782480""","STRAND 391..396; /evidence=""ECO:0007829|PDB:7A78""; STRAND 402..404; /evidence=""ECO:0007829|PDB:7A78""","HELIX 301..310; /evidence=""ECO:0007829|PDB:7A78""; HELIX 335..355; /evidence=""ECO:0007829|PDB:7A78""; HELIX 360..362; /evidence=""ECO:0007829|PDB:7A78""; HELIX 365..387; /evidence=""ECO:0007829|PDB:7A78""; HELIX 405..410; /evidence=""ECO:0007829|PDB:7A78""; HELIX 414..423; /evidence=""ECO:0007829|PDB:7A78""; HELIX 425..431; /evidence=""ECO:0007829|PDB:7A78""; HELIX 435..446; /evidence=""ECO:0007829|PDB:7A78""; HELIX 457..478; /evidence=""ECO:0007829|PDB:7A78""; HELIX 485..490; /evidence=""ECO:0007829|PDB:7A78""; HELIX 493..513; /evidence=""ECO:0007829|PDB:7A78""; HELIX 520..525; /evidence=""ECO:0007829|PDB:7A78""","TURN 388..390; /evidence=""ECO:0007829|PDB:7A78""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,RXRB NR2B2,Retinoic acid receptor RXR-beta (Nuclear receptor subfamily 2 group B member 2) (Retinoid X receptor beta),Homo sapiens (Human),533.0,56922.0,MSWAARPPFLPQRHAAGQCGPVGVRKEMHCGVASRWRRRRPWLDPAAAAAAAVAGGEQQTPEPEPGEAGRDGMGDSGRDSRSPDSSSPNPLPQGVPPPSPPGPPLPPSTAPSLGGSGAPPPPPMPPPPLGSPFPVISSSMGSPGLPPPAPPGFSGPVSSPQINSTVSLPGGGSGPPEDVKPPVLGVRGLHCPPPPGGPGAGKRLCAICGDRSSGKHYGVYSCEGCKGFFKRTIRKDLTYSCRDNKDCTVDKRQRNRCQYCRYQKCLATGMKREAVQEERQRGKDKDGDGEGAGGAPEEMPVDRILEAELAVEQKSDQGVEGPGGTGGSGSSPNDPVTNICQAADKQLFTLVEWAKRIPHFSSLPLDDQVILLRAGWNELLIASFSHRSIDVRDGILLATGLHVHRNSAHSAGVGAIFDRVLTELVSKMRDMRMDKTELGCLRAIILFNPDAKGLSNPSEVEVLREKVYASLETYCKQKYPEQQGRFAKLLLRLPALRSIGLKCLEHLFFFKLIGDTPIDTFLMEMLEAPHQLA,False,False,True,P28702,"[('cd06943', 'The ligand binding domain of the retinoid X receptor and Ultraspiracle, members of nuclear receptor superfamily'), ('cd06956', 'DNA-binding domain of retinoid X receptor (RXR) is composed of two C4-type zinc fingers'), ('G3DSA:1.10.565.10', 'Retinoid X Receptor'), ('G3DSA:3.30.50.10', 'Erythroid Transcription Factor GATA-1, subunit A'), ('IPR000003', 'Retinoid X receptor/HNF4'), ('IPR000536', 'Nuclear hormone receptor, ligand-binding domain'), ('IPR001628', 'Zinc finger, nuclear hormone receptor-type'), ('IPR001723', 'Nuclear hormone receptor'), ('IPR013088', 'Zinc finger, NHR/GATA-type'), ('IPR035500', 'Nuclear hormone receptor-like domain superfamily'), ('IPR050274', 'Nuclear hormone receptor family NR2 subfamily'), ('PF00104', 'Ligand-binding domain of nuclear hormone receptor'), ('PF00105', 'Double treble clef zinc finger, C4 type'), ('PR00047', 'STROIDFINGER'), ('PR00398', 'STRDHORMONER'), ('PR00545', 'Retinoid X receptor'), ('PS00031', 'Nuclear hormones receptors DNA-binding region signature'), ('PS51030', 'Nuclear hormone receptors DNA-binding domain profile'), ('PS51843', 'Nuclear receptor (NR) ligand-binding (LBD) domain profile'), ('PTHR24083', 'Nuclear hormone receptor family NR2 subfamily')]",,"""ENSG00000204231; Low tissue specificity."";",,,,,ENST00000374680.4 [P28702-1];ENST00000374685.8 [P28702-3];ENST00000383216.8 [P28702-3];ENST00000383217.8 [P28702-1];ENST00000415157.6 [P28702-1];ENST00000415909.6 [P28702-1];ENST00000431161.6 [P28702-3];ENST00000431820.6 [P28702-1];ENST00000436753.6 [P28702-1];ENST00000443603.6 [P28702-3];ENST00000455462.6 [P28702-3];ENST00000456244.6 [P28702-3];,RXRB,ENSG00000204231,5.0,,,,,,0.045,0.456,0.407,RXRB
P29350,ENSG00000111679,PTN6_HUMAN,B cell receptor signaling pathway [GO:0050853]; CD27 signaling pathway [GO:0160162]; cell differentiation [GO:0030154]; cytokine-mediated signaling pathway [GO:0019221]; epididymis development [GO:1905867]; G protein-coupled receptor signaling pathway [GO:0007186]; hematopoietic progenitor cell differentiation [GO:0002244]; intracellular signal transduction [GO:0035556]; MAPK cascade [GO:0000165]; megakaryocyte development [GO:0035855]; mitotic cell cycle [GO:0000278]; natural killer cell mediated cytotoxicity [GO:0042267]; negative regulation of angiogenesis [GO:0016525]; negative regulation of B cell receptor signaling pathway [GO:0050859]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of humoral immune response mediated by circulating immunoglobulin [GO:0002924]; negative regulation of inflammatory response to wounding [GO:0106015]; negative regulation of innate immune response [GO:0045824]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of mast cell activation involved in immune response [GO:0033007]; negative regulation of peptidyl-tyrosine phosphorylation [GO:0050732]; negative regulation of T cell proliferation [GO:0042130]; negative regulation of T cell receptor signaling pathway [GO:0050860]; negative regulation of tumor necrosis factor production [GO:0032720]; peptidyl-tyrosine dephosphorylation [GO:0035335]; peptidyl-tyrosine phosphorylation [GO:0018108]; platelet aggregation [GO:0070527]; platelet formation [GO:0030220]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; protein dephosphorylation [GO:0006470]; regulation of apoptotic process [GO:0042981]; regulation of B cell differentiation [GO:0045577]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of release of sequestered calcium ion into cytosol [GO:0051279]; regulation of type I interferon-mediated signaling pathway [GO:0060338]; T cell activation [GO:0042110]; T cell costimulation [GO:0031295]; T cell proliferation [GO:0042098]; T cell receptor signaling pathway [GO:0050852],alpha-beta T cell receptor complex [GO:0042105]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; specific granule lumen [GO:0035580]; tertiary granule lumen [GO:1904724],cell adhesion molecule binding [GO:0050839]; non-membrane spanning protein tyrosine phosphatase activity [GO:0004726]; phosphorylation-dependent protein binding [GO:0140031]; phosphotyrosine residue binding [GO:0001784]; protein kinase binding [GO:0019901]; protein tyrosine phosphatase activity [GO:0004725]; SH2 domain binding [GO:0042169]; SH3 domain binding [GO:0017124]; transmembrane receptor protein tyrosine phosphatase activity [GO:0005001],"PTM: Phosphorylated on tyrosine residues. Binding of KITLG/SCF to KIT increases tyrosine phosphorylation (By similarity). Phosphorylation at Tyr-564 by LYN enhances phosphatase activity. Phosphorylation at Thr-394 by TAOK3 leads to polyubiquitination and subsequent proteasomal degradation (PubMed:38166031). {ECO:0000250|UniProtKB:P29351, ECO:0000269|PubMed:10574931, ECO:0000269|PubMed:38166031, ECO:0000269|PubMed:38532423, ECO:0000269|PubMed:7781604}.; PTM: Ubiquitinated after phosphorylation by TAOK3 (PubMed:38166031). Ubiquitinated by a cooperation between ITCH and WWP2 via 'Lys-27'-mediated polyubiquitin chains resulting in the reduction of its association with LCK (PubMed:29925997). {ECO:0000269|PubMed:29925997, ECO:0000269|PubMed:38166031}.","DOMAIN: The N-terminal SH2 domain functions as an auto-inhibitory domain, blocking the catalytic domain in the ligand-free close conformation. {ECO:0000269|PubMed:12482860, ECO:0000269|PubMed:21465528}.","DOMAIN 4..100; /note=""SH2 1""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00191""; DOMAIN 110..213; /note=""SH2 2""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00191""; DOMAIN 244..515; /note=""Tyrosine-protein phosphatase""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00160""","STRAND 26..31; /evidence=""ECO:0007829|PDB:2B3O""; STRAND 33..45; /evidence=""ECO:0007829|PDB:2B3O""; STRAND 48..55; /evidence=""ECO:0007829|PDB:2B3O""; STRAND 57..59; /evidence=""ECO:0007829|PDB:2B3O""; STRAND 61..63; /evidence=""ECO:0007829|PDB:2B3O""; STRAND 68..70; /evidence=""ECO:0007829|PDB:2B3O""; STRAND 89..91; /evidence=""ECO:0007829|PDB:2B3O""; STRAND 111..114; /evidence=""ECO:0007829|PDB:6SM5""; STRAND 132..137; /evidence=""ECO:0007829|PDB:6SM5""; STRAND 139..141; /evidence=""ECO:0007829|PDB:6SM5""; STRAND 145..157; /evidence=""ECO:0007829|PDB:6SM5""; STRAND 162..172; /evidence=""ECO:0007829|PDB:6SM5""; STRAND 175..177; /evidence=""ECO:0007829|PDB:6SM5""; STRAND 184..186; /evidence=""ECO:0007829|PDB:6SM5""; STRAND 199..202; /evidence=""ECO:0007829|PDB:6SM5""; STRAND 205..207; /evidence=""ECO:0007829|PDB:6SM5""; STRAND 236..238; /evidence=""ECO:0007829|PDB:3PS5""; STRAND 275..278; /evidence=""ECO:0007829|PDB:1GWZ""; STRAND 286..288; /evidence=""ECO:0007829|PDB:4GRZ""; STRAND 290..292; /evidence=""ECO:0007829|PDB:4GS0""; STRAND 294..296; /evidence=""ECO:0007829|PDB:3PS5""; STRAND 301..307; /evidence=""ECO:0007829|PDB:4GRZ""; STRAND 309..312; /evidence=""ECO:0007829|PDB:1GWZ""; STRAND 321..324; /evidence=""ECO:0007829|PDB:4GRZ""; STRAND 346..349; /evidence=""ECO:0007829|PDB:4GRZ""; STRAND 353..355; /evidence=""ECO:0007829|PDB:4GRZ""; STRAND 356..358; /evidence=""ECO:0007829|PDB:1FPR""; STRAND 371..374; /evidence=""ECO:0007829|PDB:4GRZ""; STRAND 377..386; /evidence=""ECO:0007829|PDB:4GRZ""; STRAND 388..399; /evidence=""ECO:0007829|PDB:4GRZ""; STRAND 403..405; /evidence=""ECO:0007829|PDB:1FPR""; STRAND 407..414; /evidence=""ECO:0007829|PDB:4GRZ""; STRAND 419..421; /evidence=""ECO:0007829|PDB:2B3O""; STRAND 424..426; /evidence=""ECO:0007829|PDB:4GRZ""; STRAND 443..445; /evidence=""ECO:0007829|PDB:4HJQ""; STRAND 449..452; /evidence=""ECO:0007829|PDB:4GRZ""; STRAND 454..457; /evidence=""ECO:0007829|PDB:4GRZ""","HELIX 11..21; /evidence=""ECO:0007829|PDB:2B3O""; HELIX 72..80; /evidence=""ECO:0007829|PDB:2B3O""; HELIX 105..107; /evidence=""ECO:0007829|PDB:2B3O""; HELIX 117..126; /evidence=""ECO:0007829|PDB:6SM5""; HELIX 187..197; /evidence=""ECO:0007829|PDB:6SM5""; HELIX 221..223; /evidence=""ECO:0007829|PDB:2B3O""; HELIX 244..256; /evidence=""ECO:0007829|PDB:4GRZ""; HELIX 263..266; /evidence=""ECO:0007829|PDB:4GRZ""; HELIX 268..273; /evidence=""ECO:0007829|PDB:4GRZ""; HELIX 314..316; /evidence=""ECO:0007829|PDB:1FPR""; HELIX 329..331; /evidence=""ECO:0007829|PDB:4GRZ""; HELIX 332..341; /evidence=""ECO:0007829|PDB:4GRZ""; HELIX 400..402; /evidence=""ECO:0007829|PDB:2B3O""; HELIX 427..442; /evidence=""ECO:0007829|PDB:4GRZ""; HELIX 458..476; /evidence=""ECO:0007829|PDB:4GRZ""; HELIX 484..492; /evidence=""ECO:0007829|PDB:4GRZ""; HELIX 502..523; /evidence=""ECO:0007829|PDB:4GRZ""","TURN 257..259; /evidence=""ECO:0007829|PDB:4HJP""; TURN 283..285; /evidence=""ECO:0007829|PDB:4GRZ""; TURN 297..300; /evidence=""ECO:0007829|PDB:4GRZ""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,PTPN6 HCP PTP1C,Tyrosine-protein phosphatase non-receptor type 6 (EC 3.1.3.48) (Hematopoietic cell protein-tyrosine phosphatase) (Protein-tyrosine phosphatase 1C) (PTP-1C) (Protein-tyrosine phosphatase SHP-1) (SH-PTP1),Homo sapiens (Human),595.0,67561.0,MVRWFHRDLSGLDAETLLKGRGVHGSFLARPSRKNQGDFSLSVRVGDQVTHIRIQNSGDFYDLYGGEKFATLTELVEYYTQQQGVLQDRDGTIIHLKYPLNCSDPTSERWYHGHMSGGQAETLLQAKGEPWTFLVRESLSQPGDFVLSVLSDQPKAGPGSPLRVTHIKVMCEGGRYTVGGLETFDSLTDLVEHFKKTGIEEASGAFVYLRQPYYATRVNAADIENRVLELNKKQESEDTAKAGFWEEFESLQKQEVKNLHQRLEGQRPENKGKNRYKNILPFDHSRVILQGRDSNIPGSDYINANYIKNQLLGPDENAKTYIASQGCLEATVNDFWQMAWQENSRVIVMTTREVEKGRNKCVPYWPEVGMQRAYGPYSVTNCGEHDTTEYKLRTLQVSPLDNGDLIREIWHYQYLSWPDHGVPSEPGGVLSFLDQINQRQESLPHAGPIIVHCSAGIGRTGTIIVIDMLMENISTKGLDCDIDIQKTIQMVRAQRSGMVQTEAQYKFIYVAIAQFIETTKKKLEVLQSQKGQESEYGNITYPPAMKNAHAKASRTSSKHKEDVYENLHTKNKREEKVKKQRSADKEKSKGSLKRK,False,False,True,P29350,"[('cd09931', 'C-terminal Src homology 2 (C-SH2) domain found in SH2 domain Phosphatases (SHP) proteins'), ('cd10340', 'N-terminal Src homology 2 (N-SH2) domain found in SH2 domain Phosphatases (SHP) proteins'), ('cd14606', 'catalytic domain of tyrosine-protein phosphatase non-receptor type 6'), ('G3DSA:3.30.505.10', 'SH2 domain'), ('G3DSA:3.90.190.10', 'Protein tyrosine phosphatase superfamily'), ('IPR000242', 'Tyrosine-specific protein phosphatase, PTPase domain'), ('IPR000387', 'Tyrosine-specific protein phosphatases domain'), ('IPR000980', 'SH2 domain'), ('IPR003595', 'Protein-tyrosine phosphatase, catalytic'), ('IPR012152', 'Protein-tyrosine phosphatase, non-receptor type-6, -11'), ('IPR016130', 'Protein-tyrosine phosphatase, active site'), ('IPR029021', 'Protein-tyrosine phosphatase-like'), ('IPR036860', 'SH2 domain superfamily'), ('IPR052123', 'Non-receptor Tyrosine Phosphatase'), ('PF00017', 'SH2 domain'), ('PF00102', 'Protein-tyrosine phosphatase'), ('PIRSF000929', 'Non-receptor tyrosine-protein phosphatase, 6/11 types'), ('PR00401', 'SH2DOMAIN'), ('PR00700', 'PRTYPHPHTASE'), ('PS00383', 'Tyrosine specific protein phosphatases active site')]",,"""ENSG00000111679; Tissue enhanced (bone marrow, lymphoid tissue)."";","CATALYTIC ACTIVITY: Reaction=O-phospho-L-tyrosyl-[protein] + H2O = L-tyrosyl-[protein] + phosphate; Xref=Rhea:RHEA:10684, Rhea:RHEA-COMP:10136, Rhea:RHEA-COMP:10137, ChEBI:CHEBI:15377, ChEBI:CHEBI:43474, ChEBI:CHEBI:46858, ChEBI:CHEBI:82620; EC=3.1.3.48; Evidence={ECO:0000255|PROSITE-ProRule:PRU10044, ECO:0000269|PubMed:29925997, ECO:0000269|PubMed:38532423};",3.1.3.48,,,ENST00000318974.14 [P29350-1];ENST00000399448.5 [P29350-3];ENST00000456013.5 [P29350-4];,PTPN6;OPA1-AS1,ENSG00000111679;ENSG00000224855,0.0,,,,,,,0.114,0.103,PTPN6
P29474,ENSG00000164867,NOS3_HUMAN,angiogenesis [GO:0001525]; aortic valve morphogenesis [GO:0003180]; arginine catabolic process [GO:0006527]; blood vessel diameter maintenance [GO:0097746]; blood vessel remodeling [GO:0001974]; calcium ion transport [GO:0006816]; cell redox homeostasis [GO:0045454]; endocardial cushion morphogenesis [GO:0003203]; endothelial cell migration [GO:0043542]; establishment of localization in cell [GO:0051649]; homeostasis of number of cells within a tissue [GO:0048873]; in utero embryonic development [GO:0001701]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; lung development [GO:0030324]; mitochondrion organization [GO:0007005]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of blood pressure [GO:0045776]; negative regulation of calcium ion transport [GO:0051926]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of muscle hyperplasia [GO:0014740]; negative regulation of platelet activation [GO:0010544]; negative regulation of potassium ion transport [GO:0043267]; negative regulation of smooth muscle cell proliferation [GO:0048662]; nitric oxide biosynthetic process [GO:0006809]; nitric oxide mediated signal transduction [GO:0007263]; ovulation from ovarian follicle [GO:0001542]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of gene expression [GO:0010628]; positive regulation of guanylate cyclase activity [GO:0031284]; positive regulation of Notch signaling pathway [GO:0045747]; potassium ion transport [GO:0006813]; pulmonary valve morphogenesis [GO:0003184]; regulation of blood pressure [GO:0008217]; regulation of nervous system process [GO:0031644]; regulation of sodium ion transport [GO:0002028]; regulation of systemic arterial blood pressure by endothelin [GO:0003100]; regulation of the force of heart contraction by chemical signal [GO:0003057]; removal of superoxide radicals [GO:0019430]; response to fluid shear stress [GO:0034405]; response to heat [GO:0009408]; response to hormone [GO:0009725]; response to lipopolysaccharide [GO:0032496]; smooth muscle hyperplasia [GO:0014806]; vasodilation [GO:0042311]; ventricular septum morphogenesis [GO:0060412],caveola [GO:0005901]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endocytic vesicle membrane [GO:0030666]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; nucleus [GO:0005634]; plasma membrane [GO:0005886],actin monomer binding [GO:0003785]; arginine binding [GO:0034618]; cadmium ion binding [GO:0046870]; calmodulin binding [GO:0005516]; flavin adenine dinucleotide binding [GO:0050660]; FMN binding [GO:0010181]; heme binding [GO:0020037]; NADP binding [GO:0050661]; nitric-oxide synthase activity [GO:0004517]; scaffold protein binding [GO:0097110]; tetrahydrobiopterin binding [GO:0034617],"PTM: Phosphorylation by AMPK at Ser-1177 in the presence of Ca(2+)-calmodulin (CaM) activates activity. In absence of Ca(2+)-calmodulin, AMPK also phosphorylates Thr-495, resulting in inhibition of activity (By similarity). Phosphorylation of Ser-114 by CDK5 reduces activity. {ECO:0000250, ECO:0000269|PubMed:16126727, ECO:0000269|PubMed:20213743}.",,"DOMAIN 520..703; /note=""Flavodoxin-like""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00088""; DOMAIN 756..1002; /note=""FAD-binding FR-type""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00716""","STRAND 70..73; /evidence=""ECO:0007829|PDB:4D1P""; STRAND 79..81; /evidence=""ECO:0007829|PDB:4D1P""; STRAND 88..90; /evidence=""ECO:0007829|PDB:3NOS""; STRAND 104..107; /evidence=""ECO:0007829|PDB:6NH3""; STRAND 141..143; /evidence=""ECO:0007829|PDB:6NH7""; STRAND 194..197; /evidence=""ECO:0007829|PDB:4D1P""; STRAND 227..230; /evidence=""ECO:0007829|PDB:4D1P""; STRAND 236..238; /evidence=""ECO:0007829|PDB:6NH7""; STRAND 245..249; /evidence=""ECO:0007829|PDB:4D1P""; STRAND 253..255; /evidence=""ECO:0007829|PDB:4D1P""; STRAND 257..259; /evidence=""ECO:0007829|PDB:6AV6""; STRAND 261..263; /evidence=""ECO:0007829|PDB:4D1P""; STRAND 284..286; /evidence=""ECO:0007829|PDB:4D1P""; STRAND 291..294; /evidence=""ECO:0007829|PDB:4D1P""; STRAND 296..298; /evidence=""ECO:0007829|PDB:8UFT""; STRAND 301..303; /evidence=""ECO:0007829|PDB:4D1P""; STRAND 312..314; /evidence=""ECO:0007829|PDB:4D1P""; STRAND 329..332; /evidence=""ECO:0007829|PDB:4D1P""; STRAND 340..343; /evidence=""ECO:0007829|PDB:4D1P""; STRAND 346..349; /evidence=""ECO:0007829|PDB:4D1P""; STRAND 451..453; /evidence=""ECO:0007829|PDB:4D1P""; STRAND 465..467; /evidence=""ECO:0007829|PDB:7UAO""; STRAND 470..474; /evidence=""ECO:0007829|PDB:4D1P""","HELIX 84..87; /evidence=""ECO:0007829|PDB:4D1P""; HELIX 120..137; /evidence=""ECO:0007829|PDB:4D1P""; HELIX 144..160; /evidence=""ECO:0007829|PDB:4D1P""; HELIX 167..179; /evidence=""ECO:0007829|PDB:4D1P""; HELIX 187..189; /evidence=""ECO:0007829|PDB:4D1P""; HELIX 204..219; /evidence=""ECO:0007829|PDB:4D1P""; HELIX 220..222; /evidence=""ECO:0007829|PDB:4D1P""; HELIX 265..267; /evidence=""ECO:0007829|PDB:4D1P""; HELIX 268..276; /evidence=""ECO:0007829|PDB:4D1P""; HELIX 307..309; /evidence=""ECO:0007829|PDB:4D1P""; HELIX 323..326; /evidence=""ECO:0007829|PDB:4D1P""; HELIX 359..363; /evidence=""ECO:0007829|PDB:4D1P""; HELIX 365..368; /evidence=""ECO:0007829|PDB:4D1P""; HELIX 376..382; /evidence=""ECO:0007829|PDB:4D1P""; HELIX 390..392; /evidence=""ECO:0007829|PDB:4D1P""; HELIX 394..412; /evidence=""ECO:0007829|PDB:4D1P""; HELIX 420..438; /evidence=""ECO:0007829|PDB:4D1P""; HELIX 445..448; /evidence=""ECO:0007829|PDB:4D1P""; HELIX 454..456; /evidence=""ECO:0007829|PDB:4D1P""; HELIX 458..461; /evidence=""ECO:0007829|PDB:4D1P""; HELIX 496..506; /evidence=""ECO:0007829|PDB:1NIW""; HELIX 507..509; /evidence=""ECO:0007829|PDB:1NIW""","TURN 74..76; /evidence=""ECO:0007829|PDB:4D1P""; TURN 370..373; /evidence=""ECO:0007829|PDB:4D1P""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,NOS3,"Nitric oxide synthase 3 (EC 1.14.13.39) (Constitutive NOS) (cNOS) (EC-NOS) (NOS type III) (NOSIII) (Nitric oxide synthase, endothelial) (Endothelial NOS) (eNOS)",Homo sapiens (Human),1203.0,133275.0,MGNLKSVAQEPGPPCGLGLGLGLGLCGKQGPATPAPEPSRAPASLLPPAPEHSPPSSPLTQPPEGPKFPRVKNWEVGSITYDTLSAQAQQDGPCTPRRCLGSLVFPRKLQGRPSPGPPAPEQLLSQARDFINQYYSSIKRSGSQAHEQRLQEVEAEVAATGTYQLRESELVFGAKQAWRNAPRCVGRIQWGKLQVFDARDCRSAQEMFTYICNHIKYATNRGNLRSAITVFPQRCPGRGDFRIWNSQLVRYAGYRQQDGSVRGDPANVEITELCIQHGWTPGNGRFDVLPLLLQAPDDPPELFLLPPELVLEVPLEHPTLEWFAALGLRWYALPAVSNMLLEIGGLEFPAAPFSGWYMSTEIGTRNLCDPHRYNILEDVAVCMDLDTRTTSSLWKDKAAVEINVAVLHSYQLAKVTIVDHHAATASFMKHLENEQKARGGCPADWAWIVPPISGSLTPVFHQEMVNYFLSPAFRYQPDPWKGSAAKGTGITRKKTFKEVANAVKISASLMGTVMAKRVKATILYGSETGRAQSYAQQLGRLFRKAFDPRVLCMDEYDVVSLEHETLVLVVTSTFGNGDPPENGESFAAALMEMSGPYNSSPRPEQHKSYKIRFNSISCSDPLVSSWRRKRKESSNTDSAGALGTLRFCVFGLGSRAYPHFCAFARAVDTRLEELGGERLLQLGQGDELCGQEEAFRGWAQAAFQAACETFCVGEDAKAAARDIFSPKRSWKRQRYRLSAQAEGLQLLPGLIHVHRRKMFQATIRSVENLQSSKSTRATILVRLDTGGQEGLQYQPGDHIGVCPPNRPGLVEALLSRVEDPPAPTEPVAVEQLEKGSPGGPPPGWVRDPRLPPCTLRQALTFFLDITSPPSPQLLRLLSTLAEEPREQQELEALSQDPRRYEEWKWFRCPTLLEVLEQFPSVALPAPLLLTQLPLLQPRYYSVSSAPSTHPGEIHLTVAVLAYRTQDGLGPLHYGVCSTWLSQLKPGDPVPCFIRGAPSFRLPPDPSLPCILVGPGTGIAPFRGFWQERLHDIESKGLQPTPMTLVFGCRCSQLDHLYRDEVQNAQQRGVFGRVLTAFSREPDNPKTYVQDILRTELAAEVHRVLCLERGHMFVCGDVTMATNVLQTVQRILATEGDMELDEAGDVIGVLRDQQRYHEDIFGLTLRTQEVTSRIRTQSFSLQERQLRGAVPWAFDPPGSDTNSP,True,False,False,P29474,"[('cd00795', 'NOS_oxygenase_euk'), ('G3DSA:1.20.990.10', 'NADPH-cytochrome p450 Reductase; Chain A, domain 3'), ('G3DSA:2.40.30.10', 'Translation factors'), ('G3DSA:3.40.50.360', None), ('G3DSA:3.40.50.80', 'Nucleotide-binding domain of ferredoxin-NADP reductase (FNR) module'), ('G3DSA:3.90.1230.10', 'Nitric Oxide Synthase; Chain A, domain 3'), ('G3DSA:3.90.340.10', 'Nitric Oxide Synthase; Chain A, domain 1'), ('G3DSA:3.90.440.10', 'Nitric Oxide Synthase;Heme Domain;Chain A domain 2'), ('IPR001094', 'Flavodoxin-like'), ('IPR001433', 'Oxidoreductase FAD/NAD(P)-binding'), ('IPR001709', 'Flavoprotein pyridine nucleotide cytochrome reductase'), ('IPR003097', 'Sulfite reductase [NADPH] flavoprotein alpha-component-like, FAD-binding'), ('IPR004030', 'Nitric oxide synthase, N-terminal'), ('IPR008254', 'Flavodoxin/nitric oxide synthase'), ('IPR012144', 'Nitric-oxide synthase, eukaryote'), ('IPR017927', 'FAD-binding domain, ferredoxin reductase-type'), ('IPR017938', 'Riboflavin synthase-like beta-barrel'), ('IPR023173', 'NADPH-cytochrome p450 reductase, FAD-binding, alpha-helical domain superfamily'), ('IPR029039', 'Flavoprotein-like superfamily'), ('IPR036119', 'Nitric oxide synthase, N-terminal domain superfamily')]",,"""ENSG00000164867; Tissue enhanced (lymphoid)."";","CATALYTIC ACTIVITY: Reaction=2 L-arginine + 3 NADPH + 4 O2 + H(+) = 2 L-citrulline + 2 nitric oxide + 3 NADP(+) + 4 H2O; Xref=Rhea:RHEA:19897, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:15379, ChEBI:CHEBI:16480, ChEBI:CHEBI:32682, ChEBI:CHEBI:57743, ChEBI:CHEBI:57783, ChEBI:CHEBI:58349; EC=1.14.13.39; Evidence={ECO:0000269|PubMed:1378832, ECO:0000269|PubMed:35772285}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:19898; Evidence={ECO:0000305|PubMed:1378832};",1.14.13.39,"ACTIVITY REGULATION: Stimulated by calcium/calmodulin. Inhibited by NOSIP and NOSTRIN. {ECO:0000269|PubMed:11149895, ECO:0000269|PubMed:12446846}.",,ENST00000297494.8 [P29474-1];ENST00000467517.1 [P29474-3];ENST00000484524.5 [P29474-2];,DBNL;NOS3,ENSG00000136279;ENSG00000164867;ENSG00000239775,0.0,,,,,,,0.091,0.059,DBNL
P30041,ENSG00000117592,PRDX6_HUMAN,"cell redox homeostasis [GO:0045454]; cellular oxidant detoxification [GO:0098869]; glycerophospholipid catabolic process [GO:0046475]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; response to oxidative stress [GO:0006979]",azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471],1-acylglycerophosphocholine O-acyltransferase activity [GO:0047184]; cadherin binding [GO:0045296]; calcium-independent phospholipase A2 activity [GO:0047499]; glutathione peroxidase activity [GO:0004602]; identical protein binding [GO:0042802]; peroxiredoxin activity [GO:0051920]; phospholipase A2 activity [GO:0004623]; ubiquitin protein ligase binding [GO:0031625],"PTM: Irreversibly inactivated by overoxidation of Cys-47 to sulfinic acid (Cys-SO(2)H) and sulfonic acid (Cys-SO(3)H) forms upon oxidative stress. {ECO:0000269|PubMed:12059788, ECO:0000269|PubMed:27353378}.; PTM: Phosphorylation at Thr-177 by MAP kinases increases the phospholipase activity of the enzyme (By similarity). The phosphorylated form exhibits a greater lysophosphatidylcholine acyltransferase activity compared to the non-phosphorylated form (PubMed:26830860). {ECO:0000250|UniProtKB:O35244, ECO:0000269|PubMed:26830860}.",,"DOMAIN 5..169; /note=""Thioredoxin""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00691""","STRAND 15..18; /evidence=""ECO:0007829|PDB:1PRX""; STRAND 21..24; /evidence=""ECO:0007829|PDB:1PRX""; STRAND 32..40; /evidence=""ECO:0007829|PDB:1PRX""; STRAND 66..74; /evidence=""ECO:0007829|PDB:1PRX""; STRAND 102..104; /evidence=""ECO:0007829|PDB:1PRX""; STRAND 117..122; /evidence=""ECO:0007829|PDB:5B6M""; STRAND 124..126; /evidence=""ECO:0007829|PDB:1PRX""; STRAND 128..130; /evidence=""ECO:0007829|PDB:5B6M""; STRAND 133..137; /evidence=""ECO:0007829|PDB:1PRX""; STRAND 141..148; /evidence=""ECO:0007829|PDB:1PRX""; STRAND 151..153; /evidence=""ECO:0007829|PDB:5B6N""; STRAND 175..177; /evidence=""ECO:0007829|PDB:1PRX""; STRAND 187..189; /evidence=""ECO:0007829|PDB:1PRX""; STRAND 219..221; /evidence=""ECO:0007829|PDB:1PRX""","HELIX 25..29; /evidence=""ECO:0007829|PDB:1PRX""; HELIX 45..62; /evidence=""ECO:0007829|PDB:1PRX""; HELIX 76..89; /evidence=""ECO:0007829|PDB:1PRX""; HELIX 109..113; /evidence=""ECO:0007829|PDB:1PRX""; HELIX 157..173; /evidence=""ECO:0007829|PDB:1PRX""; HELIX 195..201; /evidence=""ECO:0007829|PDB:1PRX""","TURN 63..65; /evidence=""ECO:0007829|PDB:1PRX""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,PRDX6 AOP2 KIAA0106,Peroxiredoxin-6 (EC 1.11.1.27) (1-Cys peroxiredoxin) (1-Cys PRX) (24 kDa protein) (Acidic calcium-independent phospholipase A2) (aiPLA2) (EC 3.1.1.4) (Antioxidant protein 2) (Glutathione-dependent peroxiredoxin) (Liver 2D page spot 40) (Lysophosphatidylcholine acyltransferase 5) (LPC acyltransferase 5) (LPCAT-5) (Lyso-PC acyltransferase 5) (EC 2.3.1.23) (Non-selenium glutathione peroxidase) (NSGPx) (Red blood cells page spot 12),Homo sapiens (Human),224.0,25035.0,MPGGLLLGDVAPNFEANTTVGRIRFHDFLGDSWGILFSHPRDFTPVCTTELGRAAKLAPEFAKRNVKLIALSIDSVEDHLAWSKDINAYNCEEPTEKLPFPIIDDRNRELAILLGMLDPAEKDEKGMPVTARVVFVFGPDKKLKLSILYPATTGRNFDEILRVVISLQLTAEKRVATPVDWKDGDSVMVLPTIPEEEAKKLFPKGVFTKELPSGKKYLRYTPQP,True,True,True,P30041,"[('cd03016', 'PRX_1cys'), ('G3DSA:3.30.1020.10', 'Antioxidant, Horf6; Chain A, domain2'), ('G3DSA:3.40.30.10', 'Glutaredoxin'), ('IPR000866', 'Alkyl hydroperoxide reductase subunit C/ Thiol specific antioxidant'), ('IPR013766', 'Thioredoxin domain'), ('IPR019479', 'Peroxiredoxin, C-terminal'), ('IPR024706', 'Peroxiredoxin, AhpC-type'), ('IPR036249', 'Thioredoxin-like superfamily'), ('IPR045020', '1-Cys peroxiredoxin'), ('PF00578', 'AhpC/TSA family'), ('PF10417', 'C-terminal domain of 1-Cys peroxiredoxin'), ('PIRSF000239', 'Peroxiredoxin, AhpC type'), ('PS51352', 'Thioredoxin domain profile'), ('PTHR43503', 'Peroxiredoxin family, Prx6 subfamily'), ('SSF52833', 'Thioredoxin-like')]",,"""ENSG00000117592; Low tissue specificity."";","CATALYTIC ACTIVITY: Reaction=a hydroperoxide + 2 glutathione = an alcohol + glutathione disulfide + H2O; Xref=Rhea:RHEA:62632, ChEBI:CHEBI:15377, ChEBI:CHEBI:30879, ChEBI:CHEBI:35924, ChEBI:CHEBI:57925, ChEBI:CHEBI:58297; EC=1.11.1.27; Evidence={ECO:0000269|PubMed:10893423, ECO:0000269|PubMed:9497358}; CATALYTIC ACTIVITY: Reaction=a 1,2-diacyl-sn-glycero-3-phosphocholine + H2O = a 1-acyl-sn-glycero-3-phosphocholine + a fatty acid + H(+); Xref=Rhea:RHEA:15801, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:28868, ChEBI:CHEBI:57643, ChEBI:CHEBI:58168; EC=3.1.1.4; Evidence={ECO:0000269|PubMed:10893423, ECO:0000269|PubMed:26830860}; CATALYTIC ACTIVITY: Reaction=a 1-acyl-sn-glycero-3-phosphocholine + an acyl-CoA = a 1,2-diacyl-sn-glycero-3-phosphocholine + CoA; Xref=Rhea:RHEA:12937, ChEBI:CHEBI:57287, ChEBI:CHEBI:57643, ChEBI:CHEBI:58168, ChEBI:CHEBI:58342; EC=2.3.1.23; Evidence={ECO:0000269|PubMed:26830860}; CATALYTIC ACTIVITY: Reaction=1-hexadecanoyl-sn-glycero-3-phosphocholine + hexadecanoyl-CoA = 1,2-dihexadecanoyl-sn-glycero-3-phosphocholine + CoA; Xref=Rhea:RHEA:35983, ChEBI:CHEBI:57287, ChEBI:CHEBI:57379, ChEBI:CHEBI:72998, ChEBI:CHEBI:72999; Evidence={ECO:0000269|PubMed:26830860}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:35984; Evidence={ECO:0000305|PubMed:26830860}; CATALYTIC ACTIVITY: Reaction=1,2-dihexadecanoyl-sn-glycero-3-phosphocholine + H2O = 1-hexadecanoyl-sn-glycero-3-phosphocholine + hexadecanoate + H(+); Xref=Rhea:RHEA:41223, ChEBI:CHEBI:7896, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:72998, ChEBI:CHEBI:72999; Evidence={ECO:0000269|PubMed:26830860}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:41224; Evidence={ECO:0000305|PubMed:26830860};",1.11.1.27; 2.3.1.23; 3.1.1.4,"ACTIVITY REGULATION: MJ33 or lithium;[(2R)-1-hexadecoxy-3-(2,2,2-trifluoroethoxy)propan-2-yl] methyl phosphate inhibits its phospholipase A2 activity (PubMed:26830860). CI-976 or 2,2-Dimethyl-N-(2,4,6-trimethoxyphenyl)dodecanamide inhibits its lysophosphatidylcholine acyltransferase activity (PubMed:26830860). {ECO:0000269|PubMed:26830860}.",,ENST00000340385.6;,PRDX6;LINC01132,ENSG00000117592;ENSG00000227630,0.0,PRDX6,Non-canonical_RBPs,19.0,,,,,,PRDX6
P32121,ENSG00000141480,ARRB2_HUMAN,"adult walking behavior [GO:0007628]; cell chemotaxis [GO:0060326]; desensitization of G protein-coupled receptor signaling pathway [GO:0002029]; excitatory postsynaptic potential [GO:0060079]; G protein-coupled dopamine receptor signaling pathway [GO:0007212]; G protein-coupled receptor internalization [GO:0002031]; negative regulation of canonical NF-kappaB signal transduction [GO:0043124]; negative regulation of interleukin-1 beta production [GO:0032691]; negative regulation of interleukin-12 production [GO:0032695]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of natural killer cell mediated cytotoxicity [GO:0045953]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051898]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; negative regulation of tumor necrosis factor production [GO:0032720]; positive regulation of cardiac muscle cell differentiation [GO:2000727]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of receptor internalization [GO:0002092]; positive regulation of synaptic transmission, dopaminergic [GO:0032226]; postsynaptic signal transduction [GO:0098926]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein transport [GO:0015031]; protein ubiquitination [GO:0016567]; receptor internalization [GO:0031623]; transcription by RNA polymerase II [GO:0006366]; transforming growth factor beta receptor signaling pathway [GO:0007179]",clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endocytic vesicle [GO:0030139]; endocytic vesicle membrane [GO:0030666]; glutamatergic synapse [GO:0098978]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynapse [GO:0098794],angiotensin receptor binding [GO:0031701]; D1 dopamine receptor binding [GO:0031748]; enzyme binding [GO:0019899]; G protein-coupled receptor binding [GO:0001664]; molecular adaptor activity [GO:0060090]; protein kinase B binding [GO:0043422]; signaling receptor binding [GO:0005102]; ubiquitin protein ligase binding [GO:0031625],"PTM: Phosphorylated at Thr-382 in the cytoplasm; probably dephosphorylated at the plasma membrane. The phosphorylation does not regulate internalization and recycling of ADRB2, interaction with clathrin or AP2B1. {ECO:0000269|PubMed:11877451}.; PTM: The ubiquitination status appears to regulate the formation and trafficking of beta-arrestin-GPCR complexes and signaling. Ubiquitination appears to occur GPCR-specific. Ubiquitinated by MDM2; the ubiquitination is required for rapid internalization of ADRB2. Deubiquitinated by USP33; the deubiquitination leads to a dissociation of the beta-arrestin-GPCR complex. Stimulation of a class A GPCR, such as ADRB2, induces transient ubiquitination and subsequently promotes association with USP33. Stimulation of a class B GPCR promotes a sustained ubiquitination. Deubiquitinated by USP20; allowing USP20 to deubiquitinate TRAF6 leading to inhibition of NF-kappa-B signaling (PubMed:26839314). {ECO:0000269|PubMed:19363159, ECO:0000269|PubMed:26839314}.; PTM: Hydroxylation by PHD2 modulates the rate of internalization by slowing down recruitment to the plasma membrane and inhibiting subsequent co-internalization with class A receptors. {ECO:0000269|PubMed:21255264}.","DOMAIN: The [DE]-X(1,2)-F-X-X-[FL]-X-X-X-R motif mediates interaction the AP-2 complex subunit AP2B1. {ECO:0000250}.",,,,,"cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,ARRB2 ARB2 ARR2,Beta-arrestin-2 (Arrestin beta-2) (Non-visual arrestin-3),Homo sapiens (Human),409.0,46106.0,MGEKPGTRVFKKSSPNCKLTVYLGKRDFVDHLDKVDPVDGVVLVDPDYLKDRKVFVTLTCAFRYGREDLDVLGLSFRKDLFIATYQAFPPVPNPPRPPTRLQDRLLRKLGQHAHPFFFTIPQNLPCSVTLQPGPEDTGKACGVDFEIRAFCAKSLEEKSHKRNSVRLVIRKVQFAPEKPGPQPSAETTRHFLMSDRSLHLEASLDKELYYHGEPLNVNVHVTNNSTKTVKKIKVSVRQYADICLFSTAQYKCPVAQLEQDDQVSPSSTFCKVYTITPLLSDNREKRGLALDGKLKHEDTNLASSTIVKEGANKEVLGILVSYRVKVKLVVSRGGDVSVELPFVLMHPKPHDHIPLPRPQSAAPETDVPVDTNLIEFDTNYATDDDIVFEDFARLRLKGMKDDDYDDQLC,False,True,True,P32121,"[('G3DSA:2.60.40.640', None), ('G3DSA:2.60.40.840', None), ('IPR000698', 'Arrestin'), ('IPR011021', 'Arrestin-like, N-terminal'), ('IPR011022', 'Arrestin C-terminal-like domain'), ('IPR014752', 'Arrestin-like, C-terminal'), ('IPR014753', 'Arrestin, N-terminal'), ('IPR014756', 'Immunoglobulin E-set'), ('IPR017864', 'Arrestin, conserved site'), ('PF00339', 'Arrestin (or S-antigen), N-terminal domain'), ('PF02752', 'Arrestin (or S-antigen), C-terminal domain'), ('PR00309', 'ARRESTIN'), ('PS00295', 'Arrestins signature'), ('PTHR11792', 'ARRESTIN'), ('SM01017', 'Arrestin (or S-antigen), C-terminal domain'), ('SSF81296', 'E set domains')]",,"""ENSG00000141480; Tissue enhanced (bone marrow, lymphoid tissue)."";",,,,,ENST00000269260.7 [P32121-1];ENST00000346341.6 [P32121-2];ENST00000381488.10 [P32121-5];ENST00000412477.7 [P32121-4];,ARRB2,ENSG00000141480,0.0,,,,,,,0.112,,ARRB2
P32189,ENSG00000198814,GLPK_HUMAN,glycerol catabolic process [GO:0019563]; glycerol metabolic process [GO:0006071]; glycerol-3-phosphate biosynthetic process [GO:0046167]; phosphorylation [GO:0016310]; triglyceride biosynthetic process [GO:0019432]; triglyceride metabolic process [GO:0006641],cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleus [GO:0005634],ATP binding [GO:0005524]; glycerol kinase activity [GO:0004370]; metal ion binding [GO:0046872],,,,,,,"cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,GK,Glycerol kinase (Glycerokinase) (EC 2.7.1.30) (ATP:glycerol 3-phosphotransferase),Homo sapiens (Human),559.0,61245.0,MAASKKAVLGPLVGAVDQGTSSTRFLVFNSKTAELLSHHQVEIKQEFPREGWVEQDPKEILHSVYECIEKTCEKLGQLNIDISNIKAIGVSNQRETTVVWDKITGEPLYNAVVWLDLRTQSTVESLSKRIPGNNNFVKSKTGLPLSTYFSAVKLRWLLDNVRKVQKAVEEKRALFGTIDSWLIWSLTGGVNGGVHCTDVTNASRTMLFNIHSLEWDKQLCEFFGIPMEILPNVRSSSEIYGLMKISHSVKAGALEGVPISGCLGDQSAALVGQMCFQIGQAKNTYGTGCFLLCNTGHKCVFSDHGLLTTVAYKLGRDKPVYYALEGSVAIAGAVIRWLRDNLGIIKTSEEIEKLAKEVGTSYGCYFVPAFSGLYAPYWEPSARGIICGLTQFTNKCHIAFAALEAVCFQTREILDAMNRDCGIPLSHLQVDGGMTSNKILMQLQADILYIPVVKPSMPETTALGAAMAAGAAEGVGVWSLEPEDLSAVTMERFEPQINAEESEIRYSTWKKAVMKSMGWVTTQSPESGDPSIFCSLPLGFFIVSSMVMLIGARYISGIP,True,False,True,P32189,"[('cd07792', 'Metazoan glycerol kinase 1 and 3-like proteins; belongs to the FGGY family of carbohydrate kinases'), ('G3DSA:3.30.420.40', None), ('IPR000577', 'Carbohydrate kinase, FGGY'), ('IPR005999', 'Glycerol kinase'), ('IPR018483', 'Carbohydrate kinase, FGGY, conserved site'), ('IPR018484', 'Carbohydrate kinase FGGY, N-terminal'), ('IPR018485', 'Carbohydrate kinase FGGY, C-terminal'), ('IPR042018', 'Glycerol kinase, metazoa'), ('IPR043129', 'ATPase, nucleotide binding domain'), ('PF00370', 'FGGY family of carbohydrate kinases, N-terminal domain'), ('PF02782', 'FGGY family of carbohydrate kinases, C-terminal domain'), ('PIRSF000538', 'Keto-sugar kinase'), ('PS00445', 'FGGY family of carbohydrate kinases signature 2'), ('PS00933', 'FGGY family of carbohydrate kinases signature 1'), ('PTHR10196', 'FGGY carbohydrate kinase'), ('SSF53067', 'Actin-like ATPase domain'), ('TIGR01311', 'glycerol kinase GlpK')]",,"""ENSG00000198814; Tissue enhanced (intestine, kidney, liver)."";","CATALYTIC ACTIVITY: Reaction=glycerol + ATP = sn-glycerol 3-phosphate + ADP + H(+); Xref=Rhea:RHEA:21644, ChEBI:CHEBI:15378, ChEBI:CHEBI:17754, ChEBI:CHEBI:30616, ChEBI:CHEBI:57597, ChEBI:CHEBI:456216; EC=2.7.1.30; Evidence={ECO:0000269|PubMed:15845384, ECO:0000269|PubMed:37021775}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:21645; Evidence={ECO:0000305|PubMed:37021775};",2.7.1.30,ACTIVITY REGULATION: Potassium and magnesium-dependent. {ECO:0000269|PubMed:37021775}.,"PATHWAY: Polyol metabolism; glycerol degradation via glycerol kinase pathway; sn-glycerol 3-phosphate from glycerol: step 1/1. {ECO:0000305|PubMed:15845384, ECO:0000305|PubMed:37021775}.",ENST00000378943.7 [P32189-2];ENST00000378945.7 [P32189-1];ENST00000378946.7 [P32189-4];ENST00000427190.6 [P32189-3];,GK,ENSG00000198814,0.0,,,,,,,0.07,,GK
P32243,ENSG00000165588,OTX2_HUMAN,axon guidance [GO:0007411]; dopaminergic neuron differentiation [GO:0071542]; forebrain development [GO:0030900]; midbrain development [GO:0030901]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of embryonic development [GO:0040019]; positive regulation of gastrulation [GO:2000543]; positive regulation of transcription by RNA polymerase II [GO:0045944]; primitive streak formation [GO:0090009]; protein-containing complex assembly [GO:0065003]; regulation of fibroblast growth factor receptor signaling pathway [GO:0040036]; regulation of smoothened signaling pathway [GO:0008589]; regulation of transcription by RNA polymerase II [GO:0006357],chromatin [GO:0000785]; growth cone [GO:0030426]; nucleus [GO:0005634]; protein-containing complex [GO:0032991],"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; eukaryotic initiation factor 4E binding [GO:0008190]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]",,,,,,,"cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,OTX2,Homeobox protein OTX2 (Orthodenticle homolog 2),Homo sapiens (Human),289.0,31636.0,MMSYLKQPPYAVNGLSLTTSGMDLLHPSVGYPATPRKQRRERTTFTRAQLDVLEALFAKTRYPDIFMREEVALKINLPESRVQVWFKNRRAKCRQQQQQQQNGGQNKVRPAKKKTSPAREVSSESGTSGQFTPPSSTSVPTIASSSAPVSIWSPASISPLSDPLSTSSSCMQRSYPMTYTQASGYSQGYAGSTSYFGGMDCGSYLTPMHHQLPGPGATLSPMGTNAVTSHLNQSPASLSTQGYGASSLGFNSTTDCLDYKDQTASWKLNFNADCLDYKDQTSSWKFQVL,False,False,True,P32243,"[('cd00086', 'homeodomain'), ('G3DSA:1.10.10.60', 'Homeodomain-like'), ('IPR001356', 'Homeodomain'), ('IPR003022', 'Transcription factor Otx2'), ('IPR003025', 'Transcription factor Otx'), ('IPR009057', 'Homedomain-like superfamily'), ('IPR013851', 'Transcription factor Otx, C-terminal'), ('IPR017970', 'Homeobox, conserved site'), ('PF00046', 'Homeodomain'), ('PF03529', 'Otx1 transcription factor'), ('PR01255', 'OTXHOMEOBOX'), ('PR01257', 'OTX2HOMEOBOX'), ('PS00027', 'Homeobox domain signature'), ('PS50071', 'Homeobox domain profile'), ('PTHR45793', 'Paired homeobox transcription factors'), ('SM00389', 'Homeodomain'), ('SSF46689', 'Homeodomain-like')]",,"""ENSG00000165588; Group enriched (choroid plexus, retina)."";",,,,,ENST00000339475.10 [P32243-1];ENST00000408990.8 [P32243-1];ENST00000554845.2 [P32243-2];ENST00000555006.5 [P32243-1];ENST00000555804.2 [P32243-1];ENST00000672264.2 [P32243-2];ENST00000673035.1 [P32243-1];ENST00000673481.1 [P32243-2];ENST00000685244.1 [P32243-1];,OTX2,ENSG00000165588,0.0,,,,,,,0.82,0.176,OTX2
P32856,ENSG00000111450,STX2_HUMAN,acrosome reaction [GO:0007340]; animal organ morphogenesis [GO:0009887]; cellular response to oxidative stress [GO:0034599]; cornified envelope assembly [GO:1903575]; ectoderm development [GO:0007398]; exocytosis [GO:0006887]; intracellular protein transport [GO:0006886]; signal transduction [GO:0007165]; synaptic vesicle fusion to presynaptic active zone membrane [GO:0031629]; vesicle docking [GO:0048278],basolateral plasma membrane [GO:0016323]; endomembrane system [GO:0012505]; extracellular space [GO:0005615]; intracellular membrane-bounded organelle [GO:0043231]; lamellipodium [GO:0030027]; plasma membrane [GO:0005886]; presynaptic active zone membrane [GO:0048787]; protein-containing complex [GO:0032991]; SNARE complex [GO:0031201]; synaptic vesicle [GO:0008021],calcium-dependent protein binding [GO:0048306]; identical protein binding [GO:0042802]; SNAP receptor activity [GO:0005484]; SNARE binding [GO:0000149]; structural molecule activity [GO:0005198],,,"DOMAIN 191..253; /note=""t-SNARE coiled-coil homology""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00202""",,,,"cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,STX2 EPIM STX2A STX2B STX2C,Syntaxin-2 (Epimorphin),Homo sapiens (Human),288.0,33341.0,MRDRLPDLTACRKNDDGDTVVVVEKDHFMDDFFHQVEEIRNSIDKITQYVEEVKKNHSIILSAPNPEGKIKEELEDLNKEIKKTANKIRAKLKAIEQSFDQDESGNRTSVDLRIRRTQHSVLSRKFVEAMAEYNEAQTLFRERSKGRIQRQLEITGRTTTDDELEEMLESGKPSIFTSDIISDSQITRQALNEIESRHKDIMKLETSIRELHEMFMDMAMFVETQGEMINNIERNVMNATDYVEHAKEETKKAIKYQSKARRKKWIIIAVSVVLVAIIALIIGLSVGK,True,True,True,P32856,"[('cd00179', 'SynN'), ('cd15882', 'SNARE motif of syntaxin 2'), ('G3DSA:1.20.5.110', None), ('G3DSA:1.20.58.70', None), ('IPR000727', 'Target SNARE coiled-coil homology domain'), ('IPR006011', 'Syntaxin, N-terminal domain'), ('IPR006012', 'Syntaxin/epimorphin, conserved site'), ('IPR010989', 'SNARE'), ('IPR028671', 'Syntaxin-2, SNARE motif'), ('IPR045242', 'Syntaxin'), ('PF00804', 'Syntaxin'), ('PF05739', 'SNARE domain'), ('PS00914', 'Syntaxin / epimorphin family signature'), ('PS50192', 't-SNARE coiled-coil homology domain profile'), ('PTHR19957', 'SYNTAXIN'), ('SM00397', 'Helical region found in SNAREs'), ('SM00503', 'Syntaxin N-terminal domain'), ('SSF47661', 't-snare proteins')]",,"""ENSG00000111450; Low tissue specificity."";",,,,,ENST00000261653.11 [P32856-2];ENST00000392373.7 [P32856-1];,STX2,ENSG00000111450,0.0,,,,,,,0.194,,STX2
P33316,ENSG00000128951,DUT_HUMAN,DNA replication [GO:0006260]; dTMP biosynthetic process [GO:0006231]; dUMP biosynthetic process [GO:0006226]; dUTP catabolic process [GO:0046081]; nucleobase-containing compound metabolic process [GO:0006139],extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],dUTP diphosphatase activity [GO:0004170]; magnesium ion binding [GO:0000287]; RNA binding [GO:0003723],"PTM: Nuclear isoform 2 is phosphorylated in vivo on Ser-11, a reaction that can be catalyzed in vitro by CDC2. Phosphorylation in mature T-cells occurs in a cell cycle-dependent manner. Isoform 3 is not phosphorylated. {ECO:0000269|PubMed:8389461}.",,,"STRAND 113..120; /evidence=""ECO:0007829|PDB:3ARA""; STRAND 127..130; /evidence=""ECO:0007829|PDB:3EHW""; STRAND 134..139; /evidence=""ECO:0007829|PDB:3ARA""; STRAND 144..146; /evidence=""ECO:0007829|PDB:3ARA""; STRAND 150..155; /evidence=""ECO:0007829|PDB:3ARA""; STRAND 158..161; /evidence=""ECO:0007829|PDB:3ARA""; STRAND 166..171; /evidence=""ECO:0007829|PDB:3ARA""; STRAND 182..185; /evidence=""ECO:0007829|PDB:3ARA""; STRAND 198..203; /evidence=""ECO:0007829|PDB:3ARA""; STRAND 205..207; /evidence=""ECO:0007829|PDB:3ARA""; STRAND 209..211; /evidence=""ECO:0007829|PDB:3ARA""; STRAND 216..226; /evidence=""ECO:0007829|PDB:3ARA""; STRAND 229..232; /evidence=""ECO:0007829|PDB:3ARA""; STRAND 240..242; /evidence=""ECO:0007829|PDB:3EHW""","HELIX 174..180; /evidence=""ECO:0007829|PDB:3ARA""","TURN 246..249; /evidence=""ECO:0007829|PDB:3EHW""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial (dUTPase) (EC 3.6.1.23) (dUTP pyrophosphatase)",Homo sapiens (Human),252.0,26563.0,MTPLCPRPALCYHFLTSLLRSAMQNARGARQRAEAAVLSGPGPPLGRAAQHGIPRPLSSAGRLSQGCRGASTVGAAGWKGELPKAGGSPAPGPETPAISPSKRARPAEVGGMQLRFARLSEHATAPTRGSARAAGYDLYSAYDYTIPPMEKAVVKTDIQIALPSGCYGRVAPRSGLAAKHFIDVGAGVIDEDYRGNVGVVLFNFGKEKFEVKKGDRIAQLICERIFYPEIEEVQALDDTERGSGGFGSTGKN,True,False,False,P33316,"[('cd07557', 'Trimeric dUTP diphosphatases'), ('G3DSA:2.70.40.10', None), ('IPR008181', 'Deoxyuridine triphosphate nucleotidohydrolase'), ('IPR029054', 'dUTPase-like'), ('IPR033704', 'dUTPase, trimeric'), ('IPR036157', 'dUTPase-like superfamily'), ('PF00692', 'dUTPase'), ('PTHR11241', ""DEOXYURIDINE 5'-TRIPHOSPHATE NUCLEOTIDOHYDROLASE""), ('SSF51283', 'dUTPase-like'), ('TIGR00576', 'dUTP diphosphatase')]",,"""ENSG00000128951; Low tissue specificity."";","CATALYTIC ACTIVITY: Reaction=dUTP + H2O = dUMP + diphosphate + H(+); Xref=Rhea:RHEA:10248, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:33019, ChEBI:CHEBI:61555, ChEBI:CHEBI:246422; EC=3.6.1.23; Evidence={ECO:0000269|PubMed:17880943, ECO:0000269|PubMed:8631816, ECO:0000269|PubMed:8805593};",3.6.1.23,ACTIVITY REGULATION: Phosphorylation is necessary for activity.,"PATHWAY: Pyrimidine metabolism; dUMP biosynthesis; dUMP from dCTP (dUTP route): step 2/2. {ECO:0000269|PubMed:8631816, ECO:0000269|PubMed:8805593}.",ENST00000331200.8 [P33316-3];ENST00000455976.6 [P33316-2];,DUT,ENSG00000128951,0.0,DUT,Non-canonical_RBPs,7.0,,,,0.556,0.107,DUT
P34896,ENSG00000176974|ENSG00000284320,GLYC_HUMAN,carnitine biosynthetic process [GO:0045329]; cellular response to leukemia inhibitory factor [GO:1990830]; cellular response to tetrahydrofolate [GO:1904482]; dTMP biosynthetic process [GO:0006231]; folic acid metabolic process [GO:0046655]; glycine biosynthetic process from serine [GO:0019264]; glycine metabolic process [GO:0006544]; L-serine catabolic process [GO:0006565]; L-serine metabolic process [GO:0006563]; negative regulation of translation [GO:0017148]; protein homotetramerization [GO:0051289]; purine nucleobase biosynthetic process [GO:0009113]; tetrahydrofolate interconversion [GO:0035999]; tetrahydrofolate metabolic process [GO:0046653],cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],aldehyde-lyase activity [GO:0016832]; glycine hydroxymethyltransferase activity [GO:0004372]; identical protein binding [GO:0042802]; mRNA 5'-UTR binding [GO:0048027]; mRNA regulatory element binding translation repressor activity [GO:0000900]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; serine binding [GO:0070905]; small molecule binding [GO:0036094],,,,"STRAND 47..49; /evidence=""ECO:0007829|PDB:6M5W""; STRAND 80..83; /evidence=""ECO:0007829|PDB:6M5W""; STRAND 111..114; /evidence=""ECO:0007829|PDB:6M5W""; STRAND 137..139; /evidence=""ECO:0007829|PDB:6M5W""; STRAND 167..169; /evidence=""ECO:0007829|PDB:6M5W""; STRAND 196..201; /evidence=""ECO:0007829|PDB:6M5W""; STRAND 224..228; /evidence=""ECO:0007829|PDB:6M5W""; STRAND 249..256; /evidence=""ECO:0007829|PDB:6M5W""; STRAND 265..270; /evidence=""ECO:0007829|PDB:6M5W""; STRAND 355..362; /evidence=""ECO:0007829|PDB:6M5W""; STRAND 385..387; /evidence=""ECO:0007829|PDB:6M5W""; STRAND 400..405; /evidence=""ECO:0007829|PDB:6M5W""","HELIX 15..23; /evidence=""ECO:0007829|PDB:6M5W""; HELIX 26..29; /evidence=""ECO:0007829|PDB:6M5W""; HELIX 31..45; /evidence=""ECO:0007829|PDB:6M5W""; HELIX 59..65; /evidence=""ECO:0007829|PDB:6M5W""; HELIX 68..70; /evidence=""ECO:0007829|PDB:6M5W""; HELIX 88..103; /evidence=""ECO:0007829|PDB:6M5W""; HELIX 120..131; /evidence=""ECO:0007829|PDB:6M5W""; HELIX 149..151; /evidence=""ECO:0007829|PDB:6M5W""; HELIX 162..166; /evidence=""ECO:0007829|PDB:6M5W""; HELIX 183..193; /evidence=""ECO:0007829|PDB:6M5W""; HELIX 211..221; /evidence=""ECO:0007829|PDB:6M5W""; HELIX 229..231; /evidence=""ECO:0007829|PDB:6M5W""; HELIX 233..238; /evidence=""ECO:0007829|PDB:6M5W""; HELIX 244..246; /evidence=""ECO:0007829|PDB:6M5W""; HELIX 257..259; /evidence=""ECO:0007829|PDB:6M5W""; HELIX 288..296; /evidence=""ECO:0007829|PDB:6M5W""; HELIX 306..319; /evidence=""ECO:0007829|PDB:6M5W""; HELIX 322..344; /evidence=""ECO:0007829|PDB:6M5W""; HELIX 363..365; /evidence=""ECO:0007829|PDB:6M5W""; HELIX 370..379; /evidence=""ECO:0007829|PDB:6M5W""; HELIX 406..409; /evidence=""ECO:0007829|PDB:6M5W""; HELIX 415..439; /evidence=""ECO:0007829|PDB:6M5W""; HELIX 445..453; /evidence=""ECO:0007829|PDB:6M5W""; HELIX 455..472; /evidence=""ECO:0007829|PDB:6M5W""","TURN 84..87; /evidence=""ECO:0007829|PDB:6M5W""; TURN 108..110; /evidence=""ECO:0007829|PDB:6M5W""; TURN 143..146; /evidence=""ECO:0007829|PDB:6M5W""; TURN 176..178; /evidence=""ECO:0007829|PDB:6M5W""; TURN 278..280; /evidence=""ECO:0007829|PDB:6M5W""; TURN 297..300; /evidence=""ECO:0007829|PDB:6M5W""; TURN 410..412; /evidence=""ECO:0007829|PDB:6M5W""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,SHMT1,"Serine hydroxymethyltransferase, cytosolic (SHMT) (EC 2.1.2.1) (Glycine hydroxymethyltransferase) (Serine methylase)",Homo sapiens (Human),483.0,53083.0,MTMPVNGAHKDADLWSSHDKMLAQPLKDSDVEVYNIIKKESNRQRVGLELIASENFASRAVLEALGSCLNNKYSEGYPGQRYYGGTEFIDELETLCQKRALQAYKLDPQCWGVNVQPYSGSPANFAVYTALVEPHGRIMGLDLPDGGHLTHGFMTDKKKISATSIFFESMPYKVNPDTGYINYDQLEENARLFHPKLIIAGTSCYSRNLEYARLRKIADENGAYLMADMAHISGLVAAGVVPSPFEHCHVVTTTTHKTLRGCRAGMIFYRKGVKSVDPKTGKEILYNLESLINSAVFPGLQGGPHNHAIAGVAVALKQAMTLEFKVYQHQVVANCRALSEALTELGYKIVTGGSDNHLILVDLRSKGTDGGRAEKVLEACSIACNKNTCPGDRSALRPSGLRLGTPALTSRGLLEKDFQKVAHFIHRGIELTLQIQSDTGVRATLKEFKERLAGDKYQAAVQALREEVESFASLFPLPGLPDF,True,True,False,P34896,"[('cd00378', 'SHMT'), ('G3DSA:3.40.640.10', 'Type I PLP-dependent aspartate aminotransferase-like (Major domain)'), ('G3DSA:3.90.1150.10', 'Aspartate Aminotransferase, domain 1'), ('IPR001085', 'Serine hydroxymethyltransferase'), ('IPR015421', 'Pyridoxal phosphate-dependent transferase, major domain'), ('IPR015422', 'Pyridoxal phosphate-dependent transferase, small domain'), ('IPR015424', 'Pyridoxal phosphate-dependent transferase'), ('IPR019798', 'Serine hydroxymethyltransferase, pyridoxal phosphate binding site'), ('IPR039429', 'Serine hydroxymethyltransferase-like domain'), ('IPR049943', 'Serine hydroxymethyltransferase-like'), ('MF_00051', 'Serine hydroxymethyltransferase [glyA]'), ('PF00464', 'Serine hydroxymethyltransferase'), ('PIRSF000412', 'Serine/glycine hydroxymethyltransferase'), ('PS00096', 'Serine hydroxymethyltransferase pyridoxal-phosphate attachment site'), ('PTHR11680', 'SERINE HYDROXYMETHYLTRANSFERASE'), ('SSF53383', 'PLP-dependent transferases')]",,"""ENSG00000176974; Tissue enhanced (kidney, liver)."";","CATALYTIC ACTIVITY: Reaction=(6R)-5,10-methylene-5,6,7,8-tetrahydrofolate + glycine + H2O = (6S)-5,6,7,8-tetrahydrofolate + L-serine; Xref=Rhea:RHEA:15481, ChEBI:CHEBI:15377, ChEBI:CHEBI:15636, ChEBI:CHEBI:33384, ChEBI:CHEBI:57305, ChEBI:CHEBI:57453; EC=2.1.2.1; Evidence={ECO:0000269|PubMed:24698160, ECO:0000269|PubMed:8505317};",2.1.2.1,ACTIVITY REGULATION: Inhibited by tetrahydrofolate concentrations above 40 uM. {ECO:0000269|PubMed:24698160}.,PATHWAY: One-carbon metabolism; tetrahydrofolate interconversion. {ECO:0000305|PubMed:24698160}.,ENST00000316694.8 [P34896-1];ENST00000354098.7 [P34896-2];ENST00000583780.2 [P34896-1];ENST00000640392.2 [P34896-1];ENST00000711529.1 [P34896-1];ENST00000711531.1 [P34896-2];,SHMT1,ENSG00000176974,1.0,,,,,,,0.043,,SHMT1
P35222,ENSG00000168036,CTNB1_HUMAN,"acinar cell differentiation [GO:0090425]; adherens junction assembly [GO:0034333]; anterior/posterior axis specification [GO:0009948]; apoptotic signaling pathway [GO:0097190]; astrocyte-dopaminergic neuron signaling [GO:0036520]; bone resorption [GO:0045453]; branching involved in blood vessel morphogenesis [GO:0001569]; branching involved in ureteric bud morphogenesis [GO:0001658]; canonical Wnt signaling pathway [GO:0060070]; canonical Wnt signaling pathway involved in mesenchymal stem cell differentiation [GO:0044338]; cell adhesion [GO:0007155]; cell fate specification [GO:0001708]; cell maturation [GO:0048469]; cell-cell adhesion [GO:0098609]; cell-matrix adhesion [GO:0007160]; cellular response to growth factor stimulus [GO:0071363]; cellular response to indole-3-methanol [GO:0071681]; central nervous system vasculogenesis [GO:0022009]; chemical synaptic transmission [GO:0007268]; chondrocyte differentiation [GO:0002062]; cranial ganglion development [GO:0061550]; cranial skeletal system development [GO:1904888]; detection of muscle stretch [GO:0035995]; dorsal root ganglion development [GO:1990791]; dorsal/ventral axis specification [GO:0009950]; ectoderm development [GO:0007398]; embryonic axis specification [GO:0000578]; embryonic brain development [GO:1990403]; embryonic digit morphogenesis [GO:0042733]; embryonic foregut morphogenesis [GO:0048617]; embryonic forelimb morphogenesis [GO:0035115]; embryonic heart tube development [GO:0035050]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic skeletal limb joint morphogenesis [GO:0036023]; endodermal cell fate commitment [GO:0001711]; endothelial tube morphogenesis [GO:0061154]; epithelial cell differentiation involved in prostate gland development [GO:0060742]; epithelial cell proliferation involved in prostate gland development [GO:0060767]; epithelial to mesenchymal transition [GO:0001837]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; establishment of blood-brain barrier [GO:0060856]; establishment of blood-retinal barrier [GO:1990963]; fibroblast growth factor receptor signaling pathway [GO:0008543]; fungiform papilla formation [GO:0061198]; gastrulation with mouth forming second [GO:0001702]; genitalia morphogenesis [GO:0035112]; glial cell fate determination [GO:0007403]; hair cell differentiation [GO:0035315]; hair follicle morphogenesis [GO:0031069]; hair follicle placode formation [GO:0060789]; hindbrain development [GO:0030902]; hypothalamus development [GO:0021854]; in utero embryonic development [GO:0001701]; layer formation in cerebral cortex [GO:0021819]; lens morphogenesis in camera-type eye [GO:0002089]; lung epithelial cell differentiation [GO:0060487]; lung induction [GO:0060492]; lung-associated mesenchyme development [GO:0060484]; male genitalia development [GO:0030539]; MAPK cascade [GO:0000165]; mesenchymal cell proliferation involved in lung development [GO:0060916]; mesenchymal stem cell differentiation [GO:0072497]; metanephros morphogenesis [GO:0003338]; midbrain dopaminergic neuron differentiation [GO:1904948]; myoblast proliferation [GO:0051450]; negative regulation of angiogenesis [GO:0016525]; negative regulation of apoptotic process [GO:0043066]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of chondrocyte differentiation [GO:0032331]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of gene expression [GO:0010629]; negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis [GO:0003340]; negative regulation of mitotic cell cycle, embryonic [GO:0045976]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of osteoclast differentiation [GO:0045671]; negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway [GO:1903377]; negative regulation of protein sumoylation [GO:0033234]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nephron tubule formation [GO:0072079]; neural plate development [GO:0001840]; neuroblast proliferation [GO:0007405]; neuron fate determination [GO:0048664]; neuron migration [GO:0001764]; neuron projection extension [GO:1990138]; odontogenesis of dentin-containing tooth [GO:0042475]; oligodendrocyte differentiation [GO:0048709]; oocyte development [GO:0048599]; osteoblast differentiation [GO:0001649]; osteoclast differentiation [GO:0030316]; outflow tract morphogenesis [GO:0003151]; oviduct development [GO:0060066]; pancreas development [GO:0031016]; positive regulation of apoptotic process [GO:0043065]; positive regulation of branching involved in lung morphogenesis [GO:0061047]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of determination of dorsal identity [GO:2000017]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of epithelial cell proliferation involved in prostate gland development [GO:0060769]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of fibroblast growth factor receptor signaling pathway [GO:0045743]; positive regulation of gene expression [GO:0010628]; positive regulation of heparan sulfate proteoglycan biosynthetic process [GO:0010909]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of mesenchymal cell proliferation [GO:0002053]; positive regulation of myoblast proliferation [GO:2000288]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of odontoblast differentiation [GO:1901331]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of skeletal muscle tissue development [GO:0048643]; positive regulation of stem cell proliferation [GO:2000648]; positive regulation of telomere maintenance via telomerase [GO:0032212]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription elongation by RNA polymerase II [GO:0032968]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein localization to cell surface [GO:0034394]; protein polyubiquitination [GO:0000209]; proximal/distal pattern formation [GO:0009954]; regulation of angiogenesis [GO:0045765]; regulation of calcium ion import [GO:0090279]; regulation of centriole-centriole cohesion [GO:0030997]; regulation of centromeric sister chromatid cohesion [GO:0070602]; regulation of fibroblast proliferation [GO:0048145]; regulation of myelination [GO:0031641]; regulation of nephron tubule epithelial cell differentiation [GO:0072182]; regulation of neurogenesis [GO:0050767]; regulation of protein localization to cell surface [GO:2000008]; regulation of protein ubiquitination [GO:0031396]; regulation of secondary heart field cardioblast proliferation [GO:0003266]; regulation of smooth muscle cell proliferation [GO:0048660]; regulation of synapse assembly [GO:0051963]; regulation of T cell proliferation [GO:0042129]; regulation of timing of anagen [GO:0051884]; renal inner medulla development [GO:0072053]; renal outer medulla development [GO:0072054]; renal vesicle formation [GO:0072033]; response to estradiol [GO:0032355]; response to xenobiotic stimulus [GO:0009410]; smooth muscle cell differentiation [GO:0051145]; stem cell population maintenance [GO:0019827]; stem cell proliferation [GO:0072089]; sympathetic ganglion development [GO:0061549]; synapse organization [GO:0050808]; synaptic vesicle clustering [GO:0097091]; synaptic vesicle transport [GO:0048489]; T cell differentiation in thymus [GO:0033077]; thymus development [GO:0048538]; trachea formation [GO:0060440]; transcription by RNA polymerase II [GO:0006366]","adherens junction [GO:0005912]; apical part of cell [GO:0045177]; apicolateral plasma membrane [GO:0016327]; basolateral plasma membrane [GO:0016323]; beta-catenin destruction complex [GO:0030877]; beta-catenin-ICAT complex [GO:1990711]; beta-catenin-TCF complex [GO:1990907]; beta-catenin-TCF7L2 complex [GO:0070369]; bicellular tight junction [GO:0005923]; catenin complex [GO:0016342]; cell cortex [GO:0005938]; cell junction [GO:0030054]; cell periphery [GO:0071944]; cell-cell junction [GO:0005911]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; euchromatin [GO:0000791]; extracellular exosome [GO:0070062]; fascia adherens [GO:0005916]; flotillin complex [GO:0016600]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; lamellipodium [GO:0030027]; lateral plasma membrane [GO:0016328]; membrane [GO:0016020]; microvillus membrane [GO:0031528]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density, intracellular component [GO:0099092]; postsynaptic membrane [GO:0045211]; presynaptic active zone cytoplasmic component [GO:0098831]; presynaptic membrane [GO:0042734]; protein-containing complex [GO:0032991]; protein-DNA complex [GO:0032993]; Schaffer collateral - CA1 synapse [GO:0098685]; Scrib-APC-beta-catenin complex [GO:0034750]; spindle pole [GO:0000922]; synapse [GO:0045202]; transcription regulator complex [GO:0005667]; Wnt signalosome [GO:1990909]; Z disc [GO:0030018]",alpha-catenin binding [GO:0045294]; cadherin binding [GO:0045296]; chromatin binding [GO:0003682]; disordered domain specific binding [GO:0097718]; DNA-binding transcription factor binding [GO:0140297]; enzyme binding [GO:0019899]; histone methyltransferase binding [GO:1990226]; I-SMAD binding [GO:0070411]; kinase binding [GO:0019900]; nuclear estrogen receptor binding [GO:0030331]; nuclear receptor binding [GO:0016922]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; signaling receptor binding [GO:0005102]; SMAD binding [GO:0046332]; transcription coactivator activity [GO:0003713]; transcription coregulator binding [GO:0001221]; transcription corepressor binding [GO:0001222]; transmembrane transporter binding [GO:0044325]; ubiquitin protein ligase binding [GO:0031625],"PTM: Phosphorylation at Ser-552 by AMPK promotes stabilization of the protein, enhancing TCF/LEF-mediated transcription (By similarity). Phosphorylation by GSK3B requires prior phosphorylation of Ser-45 by another kinase (PubMed:10966653, PubMed:12027456, PubMed:12051714). Phosphorylation proceeds then from Thr-41 to Ser-37 and Ser-33 (PubMed:12077367, PubMed:25169422). Phosphorylated by NEK2 (PubMed:18086858). EGF stimulates tyrosine phosphorylation (PubMed:10187801). Phosphorylated on Ser-33 and Ser-37 by HIPK2 and GSK3B, this phosphorylation triggers proteasomal degradation (PubMed:20307497). Phosphorylation on Ser-191 and Ser-246 by CDK5 (PubMed:17009320). Phosphorylation by CDK2 regulates insulin internalization (PubMed:21262353). Phosphorylation by PTK6 at Tyr-64, Tyr-142, Tyr-331 and/or Tyr-333 with the predominant site at Tyr-64 is not essential for inhibition of transcriptional activity (PubMed:20026641). Phosphorylation by SRC at Tyr-333 promotes interaction with isoform M2 of PKM (PKM2); promoting transcription activation (PubMed:22056988). {ECO:0000250|UniProtKB:Q02248, ECO:0000269|PubMed:10187801, ECO:0000269|PubMed:10966653, ECO:0000269|PubMed:12027456, ECO:0000269|PubMed:12051714, ECO:0000269|PubMed:12077367, ECO:0000269|PubMed:17009320, ECO:0000269|PubMed:18086858, ECO:0000269|PubMed:20026641, ECO:0000269|PubMed:20307497, ECO:0000269|PubMed:21262353, ECO:0000269|PubMed:22056988, ECO:0000269|PubMed:25169422}.; PTM: Ubiquitinated by the SCF(BTRC) E3 ligase complex when phosphorylated by GSK3B, leading to its degradation (PubMed:12077367). Ubiquitinated by a E3 ubiquitin ligase complex containing UBE2D1, SIAH1, CACYBP/SIP, SKP1, APC and TBL1X, leading to its subsequent proteasomal degradation (PubMed:11389839, PubMed:11389840, PubMed:20307497). Ubiquitinated and degraded following interaction with SOX9 (By similarity). Ubiquitinated via 'Lys-11'- and 'Lys-29'-linked ubiquitin chains by UBR5, leading to its stabilization (PubMed:21118991). {ECO:0000250|UniProtKB:Q02248, ECO:0000269|PubMed:11389839, ECO:0000269|PubMed:11389840, ECO:0000269|PubMed:12077367, ECO:0000269|PubMed:20307497, ECO:0000269|PubMed:21118991}.; PTM: S-nitrosylation at Cys-619 within adherens junctions promotes VEGF-induced, NO-dependent endothelial cell permeability by disrupting interaction with E-cadherin, thus mediating disassembly adherens junctions. {ECO:0000250|UniProtKB:Q02248}.; PTM: O-glycosylation at Ser-23 decreases nuclear localization and transcriptional activity, and increases localization to the plasma membrane and interaction with E-cadherin CDH1. {ECO:0000269|PubMed:24342833}.; PTM: Deacetylated at Lys-49 by SIRT1. {ECO:0000269|PubMed:24824780}.; PTM: Phosphorylated at Thr-556 by herpes virus 1/HHV-1 leading to CTNNB1 inhibition. {ECO:0000269|PubMed:24824780}.",,,"STRAND 161..164; /evidence=""ECO:0007829|PDB:7UWO""; STRAND 473..475; /evidence=""ECO:0007829|PDB:1JDH""; STRAND 499..501; /evidence=""ECO:0007829|PDB:4DJS""; STRAND 550..552; /evidence=""ECO:0007829|PDB:1QZ7""; STRAND 554..557; /evidence=""ECO:0007829|PDB:1QZ7""; STRAND 561..563; /evidence=""ECO:0007829|PDB:1T08""; STRAND 778..780; /evidence=""ECO:0007829|PDB:3DIW""","HELIX 145..160; /evidence=""ECO:0007829|PDB:7AFW""; HELIX 165..179; /evidence=""ECO:0007829|PDB:7AFW""; HELIX 182..189; /evidence=""ECO:0007829|PDB:7AFW""; HELIX 192..204; /evidence=""ECO:0007829|PDB:7AFW""; HELIX 208..221; /evidence=""ECO:0007829|PDB:7AFW""; HELIX 225..233; /evidence=""ECO:0007829|PDB:7AFW""; HELIX 236..243; /evidence=""ECO:0007829|PDB:7AFW""; HELIX 249..265; /evidence=""ECO:0007829|PDB:7AFW""; HELIX 269..275; /evidence=""ECO:0007829|PDB:7AFW""; HELIX 278..284; /evidence=""ECO:0007829|PDB:7AFW""; HELIX 285..287; /evidence=""ECO:0007829|PDB:7AFW""; HELIX 291..303; /evidence=""ECO:0007829|PDB:7AFW""; HELIX 309..317; /evidence=""ECO:0007829|PDB:1JDH""; HELIX 320..330; /evidence=""ECO:0007829|PDB:1JDH""; HELIX 334..347; /evidence=""ECO:0007829|PDB:1JDH""; HELIX 353..359; /evidence=""ECO:0007829|PDB:1JDH""; HELIX 362..367; /evidence=""ECO:0007829|PDB:1JDH""; HELIX 375..389; /evidence=""ECO:0007829|PDB:1JDH""; HELIX 392..394; /evidence=""ECO:0007829|PDB:7ZRB""; HELIX 399..408; /evidence=""ECO:0007829|PDB:1JDH""; HELIX 414..427; /evidence=""ECO:0007829|PDB:1JDH""; HELIX 432..440; /evidence=""ECO:0007829|PDB:1JDH""; HELIX 443..454; /evidence=""ECO:0007829|PDB:1JDH""; HELIX 458..471; /evidence=""ECO:0007829|PDB:1JDH""; HELIX 478..487; /evidence=""ECO:0007829|PDB:1JDH""; HELIX 491..496; /evidence=""ECO:0007829|PDB:1JDH""; HELIX 504..517; /evidence=""ECO:0007829|PDB:1JDH""; HELIX 521..523; /evidence=""ECO:0007829|PDB:1JDH""; HELIX 524..529; /evidence=""ECO:0007829|PDB:1JDH""; HELIX 532..547; /evidence=""ECO:0007829|PDB:1JDH""; HELIX 566..580; /evidence=""ECO:0007829|PDB:1JDH""; HELIX 584..592; /evidence=""ECO:0007829|PDB:1JDH""; HELIX 596..601; /evidence=""ECO:0007829|PDB:1JDH""; HELIX 602..604; /evidence=""ECO:0007829|PDB:1JDH""; HELIX 608..621; /evidence=""ECO:0007829|PDB:1JDH""; HELIX 625..633; /evidence=""ECO:0007829|PDB:1JDH""; HELIX 637..642; /evidence=""ECO:0007829|PDB:1JDH""; HELIX 643..645; /evidence=""ECO:0007829|PDB:1JDH""; HELIX 649..662; /evidence=""ECO:0007829|PDB:1JDH""; HELIX 668..682; /evidence=""ECO:0007829|PDB:2Z6H""; HELIX 688..690; /evidence=""ECO:0007829|PDB:2Z6H""","TURN 368..371; /evidence=""ECO:0007829|PDB:1JDH""; TURN 428..430; /evidence=""ECO:0007829|PDB:1JDH""; TURN 634..636; /evidence=""ECO:0007829|PDB:8Y0G""; TURN 663..665; /evidence=""ECO:0007829|PDB:2Z6H""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,CTNNB1 CTNNB OK/SW-cl.35 PRO2286,Catenin beta-1 (Beta-catenin),Homo sapiens (Human),781.0,85497.0,MATQADLMELDMAMEPDRKAAVSHWQQQSYLDSGIHSGATTTAPSLSGKGNPEEEDVDTSQVLYEWEQGFSQSFTQEQVADIDGQYAMTRAQRVRAAMFPETLDEGMQIPSTQFDAAHPTNVQRLAEPSQMLKHAVVNLINYQDDAELATRAIPELTKLLNDEDQVVVNKAAVMVHQLSKKEASRHAIMRSPQMVSAIVRTMQNTNDVETARCTAGTLHNLSHHREGLLAIFKSGGIPALVKMLGSPVDSVLFYAITTLHNLLLHQEGAKMAVRLAGGLQKMVALLNKTNVKFLAITTDCLQILAYGNQESKLIILASGGPQALVNIMRTYTYEKLLWTTSRVLKVLSVCSSNKPAIVEAGGMQALGLHLTDPSQRLVQNCLWTLRNLSDAATKQEGMEGLLGTLVQLLGSDDINVVTCAAGILSNLTCNNYKNKMMVCQVGGIEALVRTVLRAGDREDITEPAICALRHLTSRHQEAEMAQNAVRLHYGLPVVVKLLHPPSHWPLIKATVGLIRNLALCPANHAPLREQGAIPRLVQLLVRAHQDTQRRTSMGGTQQQFVEGVRMEEIVEGCTGALHILARDVHNRIVIRGLNTIPLFVQLLYSPIENIQRVAAGVLCELAQDKEAAEAIEAEGATAPLTELLHSRNEGVATYAAAVLFRMSEDKPQDYKKRLSVELTSSLFRTEPMAWNETADLGLDIGAQGEPLGYRQDDPSYRSFHSGGYGQDALGMDPMMEHEMGGHHPGADYPVDGLPDLGHAQDLMDGLPPGDSNQLAWFDTDL,True,False,False,P35222,"[('cd21724', 'alpha-catenin binding domain found in catenin beta-1 (CTNNB1) and similar proteins'), ('G3DSA:1.25.10.10', 'Leucine-rich Repeat Variant'), ('IPR000225', 'Armadillo'), ('IPR011989', 'Armadillo-like helical'), ('IPR013284', 'Beta-catenin'), ('IPR016024', 'Armadillo-type fold'), ('PF00514', 'Armadillo/beta-catenin-like repeat'), ('PR01869', 'Beta-catenin'), ('PS50176', 'Armadillo/plakoglobin ARM repeat profile'), ('PTHR45976', 'ARMADILLO SEGMENT POLARITY PROTEIN'), ('SM00185', 'Armadillo/beta-catenin-like repeats'), ('SSF48371', 'ARM repeat')]",,"""ENSG00000168036; Low tissue specificity."";",,,,,ENST00000349496.11;ENST00000396183.7;ENST00000396185.8;ENST00000405570.6;ENST00000431914.6;ENST00000433400.6;ENST00000441708.2;ENST00000450969.6;ENST00000642248.1;ENST00000642315.1;ENST00000642426.1;ENST00000642992.1;ENST00000643031.1;ENST00000643297.1;ENST00000643541.1;ENST00000643977.1;ENST00000643992.1;ENST00000644867.1;ENST00000645210.1;ENST00000645320.1;ENST00000645982.1;ENST00000646369.1;ENST00000646725.1;ENST00000647390.1;ENST00000647413.2;,CTNNB1,ENSG00000168036,0.0,CTNNB1,Non-canonical_RBPs,9.0,29.71,DP01119,0.456,0.233,0.129,CTNNB1
P35268,ENSG00000116251,RL22_HUMAN,alpha-beta T cell differentiation [GO:0046632]; cytoplasmic translation [GO:0002181]; translation [GO:0006412]; translation at presynapse [GO:0140236],cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; nucleus [GO:0005634]; presynapse [GO:0098793]; ribonucleoprotein complex [GO:1990904],heparin binding [GO:0008201]; identical protein binding [GO:0042802]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735],,,,,,,"cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,RPL22,Large ribosomal subunit protein eL22 (60S ribosomal protein L22) (EBER-associated protein) (EAP) (Epstein-Barr virus small RNA-associated protein) (Heparin-binding protein HBp15),Homo sapiens (Human),128.0,14787.0,MAPVKKLVVKGGKKKKQVLKFTLDCTHPVEDGIMDAANFEQFLQERIKVNGKAGNLGGGVVTIERSKSKITVTSEVPFSKRYLKYLTKKYLKKNNLRDWLRVVANSKESYELRYFQINQDEEEEEDED,True,False,False,P35268,"[('G3DSA:3.30.1360.210', None), ('IPR002671', 'Large ribosomal subunit protein eL22'), ('IPR038526', 'Large ribosomal subunit protein eL22 superfamily'), ('PF01776', 'Ribosomal L22e protein family'), ('PTHR10064', '60S RIBOSOMAL PROTEIN L22')]",,"""ENSG00000116251; Low tissue specificity."";",,,,,ENST00000234875.9;,RPL22,ENSG00000116251,0.0,RPL22,Canonical_RBPs,30.0,,,,0.242,,RPL22
P36776,ENSG00000196365,LONM_HUMAN,cellular response to oxidative stress [GO:0034599]; chaperone-mediated protein complex assembly [GO:0051131]; mitochondrial DNA metabolic process [GO:0032042]; mitochondrial genome maintenance [GO:0000002]; mitochondrial protein catabolic process [GO:0035694]; mitochondrion organization [GO:0007005]; negative regulation of insulin receptor signaling pathway [GO:0046627]; oxidation-dependent protein catabolic process [GO:0070407]; protein catabolic process [GO:0030163]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; proteolysis involved in protein catabolic process [GO:0051603]; response to hypoxia [GO:0001666],cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654],ADP binding [GO:0043531]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent peptidase activity [GO:0004176]; DNA polymerase binding [GO:0070182]; G-quadruplex DNA binding [GO:0051880]; identical protein binding [GO:0042802]; insulin receptor substrate binding [GO:0043560]; PH domain binding [GO:0042731]; sequence-specific DNA binding [GO:0043565]; serine-type endopeptidase activity [GO:0004252]; single-stranded DNA binding [GO:0003697]; single-stranded RNA binding [GO:0003727],,"DOMAIN: The Lon N-terminal domains are crucial for the overall structure of the protein, maintaining it in a conformation allowing its proper functioning. {ECO:0000269|PubMed:27632940}.; DOMAIN: The AP-domain (ATP-binding and proteolytic domains) has a closed-ring conformation in the presence of AMP-PNP and its N-terminal entry gate appears closed. Upon ADP binding, it switches to a lock-washer conformation and its N-terminal gate opens. {ECO:0000269|PubMed:27632940}.; DOMAIN: The proteolytic site is connected to the ATP binding site through the GG loop (Gly-893 and Gly-894) and the loop containing Trp-770. Binding of a protein substrate such as beta-casein appears to trigger movement of both these loops as part of the conformational changes which lead to enhanced ATPase and peptidase activities. {ECO:0000305|PubMed:24520911}.","DOMAIN 124..370; /note=""Lon N-terminal""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU01123""; DOMAIN 759..949; /note=""Lon proteolytic""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU01122""","STRAND 140..142; /evidence=""ECO:0007829|PDB:8OJL""; STRAND 156..161; /evidence=""ECO:0007829|PDB:8OJL""; STRAND 167..169; /evidence=""ECO:0007829|PDB:8OJL""; STRAND 184..193; /evidence=""ECO:0007829|PDB:8OJL""; STRAND 200..203; /evidence=""ECO:0007829|PDB:8OJL""; STRAND 206..208; /evidence=""ECO:0007829|PDB:8OJL""; STRAND 212..215; /evidence=""ECO:0007829|PDB:8OJL""; STRAND 450..452; /evidence=""ECO:0007829|PDB:7KSL""; STRAND 518..522; /evidence=""ECO:0007829|PDB:7P09""; STRAND 525..528; /evidence=""ECO:0007829|PDB:8OJL""; STRAND 544..548; /evidence=""ECO:0007829|PDB:7P09""; STRAND 565..567; /evidence=""ECO:0007829|PDB:7KSL""; STRAND 582..584; /evidence=""ECO:0007829|PDB:8OJL""; STRAND 586..590; /evidence=""ECO:0007829|PDB:7P09""; STRAND 599..601; /evidence=""ECO:0007829|PDB:7P09""; STRAND 617..619; /evidence=""ECO:0007829|PDB:7P09""; STRAND 626..628; /evidence=""ECO:0007829|PDB:7P0M""; STRAND 634..640; /evidence=""ECO:0007829|PDB:7P09""; STRAND 653..657; /evidence=""ECO:0007829|PDB:7P09""; STRAND 706..709; /evidence=""ECO:0007829|PDB:7P09""; STRAND 733..736; /evidence=""ECO:0007829|PDB:7P09""; STRAND 750..753; /evidence=""ECO:0007829|PDB:7KSL""; STRAND 754..756; /evidence=""ECO:0007829|PDB:8OJL""; STRAND 764..786; /evidence=""ECO:0007829|PDB:2X36""; STRAND 799..804; /evidence=""ECO:0007829|PDB:2X36""; STRAND 839..843; /evidence=""ECO:0007829|PDB:2X36""; STRAND 877..879; /evidence=""ECO:0007829|PDB:2X36""; STRAND 887..890; /evidence=""ECO:0007829|PDB:2X36""; STRAND 909..913; /evidence=""ECO:0007829|PDB:2X36""; STRAND 932..938; /evidence=""ECO:0007829|PDB:2X36""","HELIX 148..155; /evidence=""ECO:0007829|PDB:8OJL""; HELIX 175..180; /evidence=""ECO:0007829|PDB:8OJL""; HELIX 291..306; /evidence=""ECO:0007829|PDB:8OJL""; HELIX 313..317; /evidence=""ECO:0007829|PDB:8OJL""; HELIX 320..322; /evidence=""ECO:0007829|PDB:8OJL""; HELIX 328..337; /evidence=""ECO:0007829|PDB:8OJL""; HELIX 343..351; /evidence=""ECO:0007829|PDB:8OJL""; HELIX 355..406; /evidence=""ECO:0007829|PDB:8OJL""; HELIX 413..427; /evidence=""ECO:0007829|PDB:7P09""; HELIX 432..447; /evidence=""ECO:0007829|PDB:7P09""; HELIX 453..467; /evidence=""ECO:0007829|PDB:7P09""; HELIX 480..490; /evidence=""ECO:0007829|PDB:7P09""; HELIX 495..511; /evidence=""ECO:0007829|PDB:7P09""; HELIX 529..540; /evidence=""ECO:0007829|PDB:7P09""; HELIX 556..559; /evidence=""ECO:0007829|PDB:7P09""; HELIX 572..580; /evidence=""ECO:0007829|PDB:7P09""; HELIX 592..594; /evidence=""ECO:0007829|PDB:7P09""; HELIX 603..611; /evidence=""ECO:0007829|PDB:7P09""; HELIX 613..616; /evidence=""ECO:0007829|PDB:7P09""; HELIX 642..644; /evidence=""ECO:0007829|PDB:7KRZ""; HELIX 647..651; /evidence=""ECO:0007829|PDB:7P09""; HELIX 663..672; /evidence=""ECO:0007829|PDB:7P09""; HELIX 674..682; /evidence=""ECO:0007829|PDB:7P09""; HELIX 693..702; /evidence=""ECO:0007829|PDB:7P09""; HELIX 712..728; /evidence=""ECO:0007829|PDB:7P09""; HELIX 739..741; /evidence=""ECO:0007829|PDB:7P09""; HELIX 742..746; /evidence=""ECO:0007829|PDB:7P09""; HELIX 808..828; /evidence=""ECO:0007829|PDB:2X36""; HELIX 834..837; /evidence=""ECO:0007829|PDB:2X36""; HELIX 853..856; /evidence=""ECO:0007829|PDB:2X36""; HELIX 857..869; /evidence=""ECO:0007829|PDB:2X36""; HELIX 895..904; /evidence=""ECO:0007829|PDB:2X36""; HELIX 914..916; /evidence=""ECO:0007829|PDB:2X36""; HELIX 917..921; /evidence=""ECO:0007829|PDB:2X36""; HELIX 925..928; /evidence=""ECO:0007829|PDB:2X36""; HELIX 939..946; /evidence=""ECO:0007829|PDB:2X36""; HELIX 948..951; /evidence=""ECO:0007829|PDB:6WZV""; HELIX 952..956; /evidence=""ECO:0007829|PDB:6X27""","TURN 622..624; /evidence=""ECO:0007829|PDB:7P0M""; TURN 686..688; /evidence=""ECO:0007829|PDB:7P09""; TURN 850..852; /evidence=""ECO:0007829|PDB:2X36""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,LONP1 PRSS15,"Lon protease homolog, mitochondrial (EC 3.4.21.53) (LONHs) (Lon protease-like protein) (LONP) (Mitochondrial ATP-dependent protease Lon) (Serine protease 15)",Homo sapiens (Human),959.0,106489.0,MAASTGYVRLWGAARCWVLRRPMLAAAGGRVPTAAGAWLLRGQRTCDASPPWALWGRGPAIGGQWRGFWEASSRGGGAFSGGEDASEGGAEEGAGGAGGSAGAGEGPVITALTPMTIPDVFPHLPLIAITRNPVFPRFIKIIEVKNKKLVELLRRKVRLAQPYVGVFLKRDDSNESDVVESLDEIYHTGTFAQIHEMQDLGDKLRMIVMGHRRVHISRQLEVEPEEPEAENKHKPRRKSKRGKKEAEDELSARHPAELAMEPTPELPAEVLMVEVENVVHEDFQVTEEVKALTAEIVKTIRDIIALNPLYRESVLQMMQAGQRVVDNPIYLSDMGAALTGAESHELQDVLEETNIPKRLYKALSLLKKEFELSKLQQRLGREVEEKIKQTHRKYLLQEQLKIIKKELGLEKDDKDAIEEKFRERLKELVVPKHVMDVVDEELSKLGLLDNHSSEFNVTRNYLDWLTSIPWGKYSNENLDLARAQAVLEEDHYGMEDVKKRILEFIAVSQLRGSTQGKILCFYGPPGVGKTSIARSIARALNREYFRFSVGGMTDVAEIKGHRRTYVGAMPGKIIQCLKKTKTENPLILIDEVDKIGRGYQGDPSSALLELLDPEQNANFLDHYLDVPVDLSKVLFICTANVTDTIPEPLRDRMEMINVSGYVAQEKLAIAERYLVPQARALCGLDESKAKLSSDVLTLLIKQYCRESGVRNLQKQVEKVLRKSAYKIVSGEAESVEVTPENLQDFVGKPVFTVERMYDVTPPGVVMGLAWTAMGGSTLFVETSLRRPQDKDAKGDKDGSLEVTGQLGEVMKESARIAYTFARAFLMQHAPANDYLVTSHIHLHVPEGATPKDGPSAGCTIVTALLSLAMGRPVRQNLAMTGEVSLTGKILPVGGIKEKTIAAKRAGVTCIVLPAENKKDFYDLAAFITEGLEVHFVEHYREIFDIAFPDEQAEALAVER,False,False,True,P36776,"[('cd19500', 'lon protease homolog 2 peroxisomal'), ('G3DSA:1.10.8.60', None), ('G3DSA:1.20.5.5270', None), ('G3DSA:1.20.58.1480', None), ('G3DSA:2.30.130.40', 'LON domain-like'), ('G3DSA:3.30.230.10', None), ('G3DSA:3.40.50.300', 'P-loop containing nucleotide triphosphate hydrolases'), ('IPR003111', 'Lon protease, N-terminal domain'), ('IPR003593', 'AAA+ ATPase domain'), ('IPR003959', 'ATPase, AAA-type, core'), ('IPR004815', 'Lon protease, bacterial/eukaryotic-type'), ('IPR008268', 'Peptidase S16, active site'), ('IPR008269', 'Peptidase S16, Lon proteolytic domain'), ('IPR014721', 'Small ribosomal subunit protein uS5 domain 2-type fold, subgroup'), ('IPR015947', 'PUA-like superfamily'), ('IPR020568', 'Ribosomal protein uS5 domain 2-type superfamily'), ('IPR027065', 'Lon protease'), ('IPR027417', 'P-loop containing nucleoside triphosphate hydrolase'), ('IPR027503', 'Lon protease homologue, chloroplastic/mitochondrial'), ('IPR046336', 'Lon protease, N-terminal domain superfamily')]",,"""ENSG00000196365; Tissue enhanced (adrenal)."";","CATALYTIC ACTIVITY: Reaction=Hydrolysis of proteins in presence of ATP.; EC=3.4.21.53; Evidence={ECO:0000255|HAMAP-Rule:MF_03120, ECO:0000269|PubMed:14739292, ECO:0000269|PubMed:17420247};",3.4.21.53,ACTIVITY REGULATION: Peptidase activity is subject to substrate inhibition by ATP. {ECO:0000269|PubMed:24520911}.,,ENST00000360614.8 [P36776-1];ENST00000540670.6 [P36776-3];ENST00000593119.5 [P36776-2];,LONP1,ENSG00000196365,0.0,LONP1,Non-canonical_RBPs,11.0,17.94,DP03861,0.179,0.182,0.069,LONP1
P36873,ENSG00000186298,PP1G_HUMAN,blastocyst development [GO:0001824]; cell division [GO:0051301]; circadian regulation of gene expression [GO:0032922]; entrainment of circadian clock by photoperiod [GO:0043153]; glycogen metabolic process [GO:0005977]; MAPK cascade [GO:0000165]; mitotic sister chromatid segregation [GO:0000070]; neuron differentiation [GO:0030182]; positive regulation of glial cell proliferation [GO:0060252]; protein dephosphorylation [GO:0006470]; regulation of circadian rhythm [GO:0042752]; regulation of nucleocytoplasmic transport [GO:0046822]; spermatogenesis [GO:0007283],cleavage furrow [GO:0032154]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; kinetochore [GO:0000776]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleus [GO:0005634]; presynapse [GO:0098793]; protein-containing complex [GO:0032991]; PTW/PP1 phosphatase complex [GO:0072357],lamin binding [GO:0005521]; metal ion binding [GO:0046872]; myosin phosphatase activity [GO:0017018]; phosphatase activity [GO:0016791]; phosphoprotein phosphatase activity [GO:0004721]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; protein phosphatase 1 binding [GO:0008157]; protein serine/threonine phosphatase activity [GO:0004722]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723],PTM: Phosphorylated by NEK2. {ECO:0000269|PubMed:15659832}.,,,"STRAND 51..55; /evidence=""ECO:0007829|PDB:5INB""; STRAND 57..62; /evidence=""ECO:0007829|PDB:5INB""; STRAND 87..89; /evidence=""ECO:0007829|PDB:5INB""; STRAND 94..98; /evidence=""ECO:0007829|PDB:5INB""; STRAND 118..120; /evidence=""ECO:0007829|PDB:5INB""; STRAND 162..165; /evidence=""ECO:0007829|PDB:5INB""; STRAND 169..174; /evidence=""ECO:0007829|PDB:5INB""; STRAND 197..199; /evidence=""ECO:0007829|PDB:5INB""; STRAND 214..218; /evidence=""ECO:0007829|PDB:5INB""; STRAND 222..227; /evidence=""ECO:0007829|PDB:5INB""; STRAND 243..246; /evidence=""ECO:0007829|PDB:5INB""; STRAND 254..258; /evidence=""ECO:0007829|PDB:5INB""; STRAND 263..267; /evidence=""ECO:0007829|PDB:5INB""; STRAND 280..285; /evidence=""ECO:0007829|PDB:5INB""; STRAND 290..298; /evidence=""ECO:0007829|PDB:5INB""","HELIX 9..17; /evidence=""ECO:0007829|PDB:5INB""; HELIX 18..21; /evidence=""ECO:0007829|PDB:5INB""; HELIX 32..48; /evidence=""ECO:0007829|PDB:5INB""; HELIX 69..79; /evidence=""ECO:0007829|PDB:5INB""; HELIX 100..113; /evidence=""ECO:0007829|PDB:5INB""; HELIX 124..126; /evidence=""ECO:0007829|PDB:7SD0""; HELIX 128..131; /evidence=""ECO:0007829|PDB:5INB""; HELIX 136..143; /evidence=""ECO:0007829|PDB:5INB""; HELIX 146..156; /evidence=""ECO:0007829|PDB:5INB""; HELIX 183..187; /evidence=""ECO:0007829|PDB:5INB""; HELIX 200..206; /evidence=""ECO:0007829|PDB:5INB""; HELIX 229..239; /evidence=""ECO:0007829|PDB:5INB""; HELIX 272..274; /evidence=""ECO:0007829|PDB:5INB""","TURN 115..117; /evidence=""ECO:0007829|PDB:5INB""; TURN 132..135; /evidence=""ECO:0007829|PDB:4UT3""; TURN 166..168; /evidence=""ECO:0007829|PDB:5INB""; TURN 259..262; /evidence=""ECO:0007829|PDB:5INB""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit (PP-1G) (EC 3.1.3.16) (Protein phosphatase 1C catalytic subunit),Homo sapiens (Human),323.0,36984.0,MADLDKLNIDSIIQRLLEVRGSKPGKNVQLQENEIRGLCLKSREIFLSQPILLELEAPLKICGDIHGQYYDLLRLFEYGGFPPESNYLFLGDYVDRGKQSLETICLLLAYKIKYPENFFLLRGNHECASINRIYGFYDECKRRYNIKLWKTFTDCFNCLPIAAIVDEKIFCCHGGLSPDLQSMEQIRRIMRPTDVPDQGLLCDLLWSDPDKDVLGWGENDRGVSFTFGAEVVAKFLHKHDLDLICRAHQVVEDGYEFFAKRQLVTLFSAPNYCGEFDNAGAMMSVDETLMCSFQILKPAEKKKPNATRPVTPPRGMITKQAKK,True,False,True,P36873,"[('cd07414', 'PP1, PPKL (PP1 and kelch-like) enzymes, and related proteins, metallophosphatase domain'), ('G3DSA:3.60.21.10', None), ('IPR004843', 'Calcineurin-like phosphoesterase domain, ApaH type'), ('IPR006186', 'Serine/threonine-specific protein phosphatase/bis(5-nucleosyl)-tetraphosphatase'), ('IPR029052', 'Metallo-dependent phosphatase-like'), ('IPR031675', 'Serine-threonine protein phosphatase, N-terminal'), ('IPR050341', 'Serine/threonine-protein phosphatase PP1 catalytic subunit'), ('PF00149', 'Calcineurin-like phosphoesterase'), ('PF16891', 'Serine-threonine protein phosphatase N-terminal domain'), ('PR00114', 'STPHPHTASE'), ('PS00125', 'Serine/threonine specific protein phosphatases signature'), ('PTHR11668', 'Serine/threonine-protein phosphatase PP1 catalytic subunit'), ('SM00156', 'Protein phosphatase 2A homologues, catalytic domain.'), ('SSF56300', 'Metallo-dependent phosphatases')]",,"""ENSG00000186298; Low tissue specificity."";","CATALYTIC ACTIVITY: Reaction=O-phospho-L-seryl-[protein] + H2O = L-seryl-[protein] + phosphate; Xref=Rhea:RHEA:20629, Rhea:RHEA-COMP:9863, Rhea:RHEA-COMP:11604, ChEBI:CHEBI:15377, ChEBI:CHEBI:29999, ChEBI:CHEBI:43474, ChEBI:CHEBI:83421; EC=3.1.3.16; Evidence={ECO:0000269|PubMed:15280359, ECO:0000269|PubMed:35768504, ECO:0000269|PubMed:35831509}; CATALYTIC ACTIVITY: Reaction=O-phospho-L-threonyl-[protein] + H2O = L-threonyl-[protein] + phosphate; Xref=Rhea:RHEA:47004, Rhea:RHEA-COMP:11060, Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15377, ChEBI:CHEBI:30013, ChEBI:CHEBI:43474, ChEBI:CHEBI:61977; EC=3.1.3.16; Evidence={ECO:0000269|PubMed:15280359};",3.1.3.16,"ACTIVITY REGULATION: Inactivated by binding to URI1. The phosphatase activity of the PPP1R15A-PP1 complex toward EIF2S1 is specifically inhibited by Salubrinal, a drug that protects cells from endoplasmic reticulum stress. {ECO:0000269|PubMed:15705855, ECO:0000269|PubMed:17936702}.",,ENST00000335007.10 [P36873-1];ENST00000340766.9 [P36873-2];,PPP1CC,ENSG00000186298,0.0,PPP1CC,Non-canonical_RBPs,8.0,,,,0.084,0.068,PPP1CC
P36897,ENSG00000106799,TGFR1_HUMAN,activin receptor signaling pathway [GO:0032924]; angiogenesis involved in coronary vascular morphogenesis [GO:0060978]; anterior/posterior pattern specification [GO:0009952]; apoptotic process [GO:0006915]; artery morphogenesis [GO:0048844]; blastocyst development [GO:0001824]; cardiac epithelial to mesenchymal transition [GO:0060317]; cell motility [GO:0048870]; cellular response to growth factor stimulus [GO:0071363]; cellular response to transforming growth factor beta stimulus [GO:0071560]; collagen fibril organization [GO:0030199]; coronary artery morphogenesis [GO:0060982]; embryonic cranial skeleton morphogenesis [GO:0048701]; endothelial cell activation [GO:0042118]; endothelial cell migration [GO:0043542]; endothelial cell proliferation [GO:0001935]; epicardium morphogenesis [GO:1905223]; epithelial to mesenchymal transition [GO:0001837]; extracellular structure organization [GO:0043062]; filopodium assembly [GO:0046847]; germ cell migration [GO:0008354]; heart development [GO:0007507]; in utero embryonic development [GO:0001701]; intracellular signal transduction [GO:0035556]; kidney development [GO:0001822]; lens development in camera-type eye [GO:0002088]; male gonad development [GO:0008584]; mesenchymal cell differentiation [GO:0048762]; myofibroblast differentiation [GO:0036446]; negative regulation of cell migration [GO:0030336]; negative regulation of chondrocyte differentiation [GO:0032331]; negative regulation of endothelial cell proliferation [GO:0001937]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; nervous system development [GO:0007399]; neuron fate commitment [GO:0048663]; parathyroid gland development [GO:0060017]; peptidyl-serine phosphorylation [GO:0018105]; pharyngeal system development [GO:0060037]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endothelial cell proliferation [GO:0001938]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation [GO:1905007]; positive regulation of extracellular matrix assembly [GO:1901203]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of gene expression [GO:0010628]; positive regulation of mesenchymal stem cell proliferation [GO:1902462]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of tight junction disassembly [GO:1905075]; positive regulation of vasculature development [GO:1904018]; post-embryonic development [GO:0009791]; regulation of cardiac muscle cell proliferation [GO:0060043]; regulation of cell cycle [GO:0051726]; regulation of DNA-templated transcription [GO:0006355]; regulation of epithelial to mesenchymal transition [GO:0010717]; regulation of gene expression [GO:0010468]; regulation of protein ubiquitination [GO:0031396]; response to cholesterol [GO:0070723]; roof of mouth development [GO:0060021]; signal transduction [GO:0007165]; skeletal system development [GO:0001501]; skeletal system morphogenesis [GO:0048705]; thymus development [GO:0048538]; transforming growth factor beta receptor signaling pathway [GO:0007179]; ventricular compact myocardium morphogenesis [GO:0003223]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222]; wound healing [GO:0042060],activin receptor complex [GO:0048179]; bicellular tight junction [GO:0005923]; cell surface [GO:0009986]; endosome [GO:0005768]; membrane [GO:0016020]; membrane raft [GO:0045121]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; transforming growth factor beta ligand-receptor complex [GO:0070021],"activin binding [GO:0048185]; activin receptor activity, type I [GO:0016361]; ATP binding [GO:0005524]; I-SMAD binding [GO:0070411]; metal ion binding [GO:0046872]; protein kinase activity [GO:0004672]; protein serine/threonine kinase activity [GO:0004674]; SMAD binding [GO:0046332]; transforming growth factor beta binding [GO:0050431]; transforming growth factor beta receptor activity [GO:0005024]; transforming growth factor beta receptor activity, type I [GO:0005025]; transmembrane receptor protein serine/threonine kinase activity [GO:0004675]; type II transforming growth factor beta receptor binding [GO:0005114]; ubiquitin protein ligase binding [GO:0031625]","PTM: Phosphorylated at basal levels in the absence of ligand. Activated upon phosphorylation by TGFBR2, mainly in the GS domain. Phosphorylation in the GS domain abrogates FKBP1A-binding. {ECO:0000269|PubMed:11583628, ECO:0000269|PubMed:7774578}.; PTM: N-Glycosylated. {ECO:0000269|PubMed:9661882}.; PTM: Ubiquitinated; undergoes ubiquitination catalyzed by several E3 ubiquitin ligases including SMURF1, SMURF2 and NEDD4L2. Results in the proteasomal and/or lysosomal degradation of the receptor thereby negatively regulating its activity. Deubiquitinated by USP15, leading to stabilization of the protein and enhanced TGF-beta signal. Its ubiquitination and proteasome-mediated degradation is negatively regulated by SDCBP (PubMed:25893292). {ECO:0000269|PubMed:15496141, ECO:0000269|PubMed:22344298, ECO:0000269|PubMed:25893292}.",,"DOMAIN 175..204; /note=""GS""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00585""; DOMAIN 205..495; /note=""Protein kinase""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00159""","STRAND 35..37; /evidence=""ECO:0007829|PDB:6MAC""; STRAND 47..49; /evidence=""ECO:0007829|PDB:6MAC""; STRAND 51..63; /evidence=""ECO:0007829|PDB:6MAC""; STRAND 65..72; /evidence=""ECO:0007829|PDB:6MAC""; STRAND 77..79; /evidence=""ECO:0007829|PDB:6MAC""; STRAND 89..91; /evidence=""ECO:0007829|PDB:6MAC""; STRAND 94..101; /evidence=""ECO:0007829|PDB:6MAC""; STRAND 102..105; /evidence=""ECO:0007829|PDB:3KFD""; STRAND 187..190; /evidence=""ECO:0007829|PDB:3KCF""; STRAND 191..193; /evidence=""ECO:0007829|PDB:1B6C""; STRAND 205..213; /evidence=""ECO:0007829|PDB:5E8S""; STRAND 215..224; /evidence=""ECO:0007829|PDB:5E8S""; STRAND 227..234; /evidence=""ECO:0007829|PDB:5E8S""; STRAND 251..253; /evidence=""ECO:0007829|PDB:3KCF""; STRAND 262..269; /evidence=""ECO:0007829|PDB:5E8S""; STRAND 271..281; /evidence=""ECO:0007829|PDB:5E8S""; STRAND 322..324; /evidence=""ECO:0007829|PDB:5E8X""; STRAND 328..330; /evidence=""ECO:0007829|PDB:5E8Z""; STRAND 339..341; /evidence=""ECO:0007829|PDB:5E8S""; STRAND 347..349; /evidence=""ECO:0007829|PDB:5E8S""; STRAND 356..359; /evidence=""ECO:0007829|PDB:5E8S""; STRAND 364..367; /evidence=""ECO:0007829|PDB:5E8S""; STRAND 368..371; /evidence=""ECO:0007829|PDB:5E8X""; STRAND 417..419; /evidence=""ECO:0007829|PDB:3KCF""","HELIX 74..76; /evidence=""ECO:0007829|PDB:6MAC""; HELIX 107..109; /evidence=""ECO:0007829|PDB:2L5S""; HELIX 177..183; /evidence=""ECO:0007829|PDB:1B6C""; HELIX 202..204; /evidence=""ECO:0007829|PDB:5E8S""; HELIX 236..238; /evidence=""ECO:0007829|PDB:5E8S""; HELIX 239..249; /evidence=""ECO:0007829|PDB:5E8S""; HELIX 288..294; /evidence=""ECO:0007829|PDB:5E8S""; HELIX 299..317; /evidence=""ECO:0007829|PDB:5E8S""; HELIX 336..338; /evidence=""ECO:0007829|PDB:5E8S""; HELIX 352..354; /evidence=""ECO:0007829|PDB:5E8S""; HELIX 376..378; /evidence=""ECO:0007829|PDB:5E8S""; HELIX 381..384; /evidence=""ECO:0007829|PDB:5E8S""; HELIX 393..413; /evidence=""ECO:0007829|PDB:5E8S""; HELIX 438..445; /evidence=""ECO:0007829|PDB:5E8S""; HELIX 456..460; /evidence=""ECO:0007829|PDB:5E8S""; HELIX 462..474; /evidence=""ECO:0007829|PDB:5E8S""; HELIX 479..481; /evidence=""ECO:0007829|PDB:5E8S""; HELIX 485..497; /evidence=""ECO:0007829|PDB:5E8S""","TURN 42..46; /evidence=""ECO:0007829|PDB:6MAC""; TURN 84..86; /evidence=""ECO:0007829|PDB:3KFD""; TURN 360..363; /evidence=""ECO:0007829|PDB:5E8S""; TURN 427..431; /evidence=""ECO:0007829|PDB:5E8S""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,TGFBR1 ALK5 SKR4,TGF-beta receptor type-1 (TGFR-1) (EC 2.7.11.30) (Activin A receptor type II-like protein kinase of 53kD) (Activin receptor-like kinase 5) (ALK-5) (ALK5) (Serine/threonine-protein kinase receptor R4) (SKR4) (TGF-beta type I receptor) (Transforming growth factor-beta receptor type I) (TGF-beta receptor type I) (TbetaR-I),Homo sapiens (Human),503.0,55960.0,MEAAVAAPRPRLLLLVLAAAAAAAAALLPGATALQCFCHLCTKDNFTCVTDGLCFVSVTETTDKVIHNSMCIAEIDLIPRDRPFVCAPSSKTGSVTTTYCCNQDHCNKIELPTTVKSSPGLGPVELAAVIAGPVCFVCISLMLMVYICHNRTVIHHRVPNEEDPSLDRPFISEGTTLKDLIYDMTTSGSGSGLPLLVQRTIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGIKM,True,False,False,P36897,"[('cd14143', 'Catalytic domain of the Serine/Threonine Kinases, Transforming Growth Factor beta Type I Receptor and Activin Type IB/IC Receptors'), ('G3DSA:1.10.510.10', 'Transferase(Phosphotransferase) domain 1'), ('G3DSA:2.10.60.10', 'CD59'), ('G3DSA:3.30.200.20', 'Phosphorylase Kinase; domain 1'), ('IPR000333', 'Ser/Thr protein kinase, TGFB receptor'), ('IPR000472', 'Activin types I and II receptor domain'), ('IPR000719', 'Protein kinase domain'), ('IPR003605', 'GS domain'), ('IPR008271', 'Serine/threonine-protein kinase, active site'), ('IPR011009', 'Protein kinase-like domain superfamily'), ('IPR017441', 'Protein kinase, ATP binding site'), ('IPR045860', 'Snake toxin-like superfamily'), ('PF00069', 'Protein kinase domain'), ('PF01064', 'Activin types I and II receptor domain'), ('PF08515', 'Transforming growth factor beta type I GS-motif'), ('PS00107', 'Protein kinases ATP-binding region signature'), ('PS00108', 'Serine/Threonine protein kinases active-site signature'), ('PS50011', 'Protein kinase domain profile'), ('PS51256', 'GS domain profile'), ('PTHR23255', 'TRANSFORMING GROWTH FACTOR-BETA RECEPTOR TYPE I AND II')]",,"""ENSG00000106799; Low tissue specificity."";","CATALYTIC ACTIVITY: Reaction=L-threonyl-[receptor-protein] + ATP = O-phospho-L-threonyl-[receptor-protein] + ADP + H(+); Xref=Rhea:RHEA:44880, Rhea:RHEA-COMP:11024, Rhea:RHEA-COMP:11025, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013, ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216; EC=2.7.11.30; CATALYTIC ACTIVITY: Reaction=L-seryl-[receptor-protein] + ATP = O-phospho-L-seryl-[receptor-protein] + ADP + H(+); Xref=Rhea:RHEA:18673, Rhea:RHEA-COMP:11022, Rhea:RHEA-COMP:11023, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616, ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.30;",2.7.11.30,ACTIVITY REGULATION: Kept in an inactive conformation by FKBP1A preventing receptor activation in absence of ligand. CD109 is another inhibitor of the receptor. {ECO:0000269|PubMed:9233797}.,,ENST00000374990.6 [P36897-3];ENST00000374994.9 [P36897-1];ENST00000552516.5 [P36897-2];,TGFBR1,ENSG00000106799,0.0,,,,,,0.076,0.179,,TGFBR1
P36969,ENSG00000167468,GPX4_HUMAN,apoptotic process [GO:0006915]; arachidonic acid metabolic process [GO:0019369]; cerebellum development [GO:0021549]; chromatin organization [GO:0006325]; dendrite development [GO:0016358]; lipoxygenase pathway [GO:0019372]; long-chain fatty acid biosynthetic process [GO:0042759]; multicellular organism growth [GO:0035264]; negative regulation of ferroptosis [GO:0110076]; phospholipid metabolic process [GO:0006644]; protein polymerization [GO:0051258]; response to estradiol [GO:0032355]; response to lipopolysaccharide [GO:0032496]; response to oxidative stress [GO:0006979]; spermatogenesis [GO:0007283],cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; nuclear envelope [GO:0005635]; nucleus [GO:0005634]; protein-containing complex [GO:0032991],glutathione peroxidase activity [GO:0004602]; identical protein binding [GO:0042802]; phospholipid-hydroperoxide glutathione peroxidase activity [GO:0047066]; selenium binding [GO:0008430],,,,"STRAND 45..48; /evidence=""ECO:0007829|PDB:6HN3""; STRAND 53..55; /evidence=""ECO:0007829|PDB:6HN3""; STRAND 62..69; /evidence=""ECO:0007829|PDB:6HN3""; STRAND 71..73; /evidence=""ECO:0007829|PDB:6HN3""; STRAND 95..101; /evidence=""ECO:0007829|PDB:6HN3""; STRAND 127..130; /evidence=""ECO:0007829|PDB:6HN3""; STRAND 135..137; /evidence=""ECO:0007829|PDB:7U4J""; STRAND 158..160; /evidence=""ECO:0007829|PDB:6HN3""; STRAND 167..170; /evidence=""ECO:0007829|PDB:6HN3""; STRAND 176..180; /evidence=""ECO:0007829|PDB:6HN3""","HELIX 41..43; /evidence=""ECO:0007829|PDB:6HN3""; HELIX 56..59; /evidence=""ECO:0007829|PDB:6HN3""; HELIX 76..90; /evidence=""ECO:0007829|PDB:6HN3""; HELIX 91..93; /evidence=""ECO:0007829|PDB:6HN3""; HELIX 113..121; /evidence=""ECO:0007829|PDB:6HN3""; HELIX 142..149; /evidence=""ECO:0007829|PDB:6HN3""; HELIX 151..153; /evidence=""ECO:0007829|PDB:6HN3""; HELIX 186..192; /evidence=""ECO:0007829|PDB:6HN3""; HELIX 195..197; /evidence=""ECO:0007829|PDB:6HN3""","TURN 35..37; /evidence=""ECO:0007829|PDB:6HN3""; TURN 104..107; /evidence=""ECO:0007829|PDB:6HN3""; TURN 122..124; /evidence=""ECO:0007829|PDB:6HN3""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,GPX4,Phospholipid hydroperoxide glutathione peroxidase GPX4 (PHGPx) (EC 1.11.1.12) (Glutathione peroxidase 4) (GPx-4) (GSHPx-4) (EC 1.11.1.9),Homo sapiens (Human),197.0,22175.0,MSLGRLCRLLKPALLCGALAAPGLAGTMCASRDDWRCARSMHEFSAKDIDGHMVNLDKYRGFVCIVTNVASQUGKTEVNYTQLVDLHARYAECGLRILAFPCNQFGKQEPGSNEEIKEFAAGYNVKFDMFSKICVNGDDAHPLWKWMKIQPKGKGILGNAIKWNFTKFLIDKNGCVVKRYGPMEEPLVIEKDLPHYF,True,True,False,P36969,"[('cd00340', 'GSH_Peroxidase'), ('G3DSA:3.40.30.10', 'Glutaredoxin'), ('IPR000889', 'Glutathione peroxidase'), ('IPR029759', 'Glutathione peroxidase active site'), ('IPR029760', 'Glutathione peroxidase conserved site'), ('IPR036249', 'Thioredoxin-like superfamily'), ('PF00255', 'Glutathione peroxidase'), ('PIRSF000303', 'Glutathione peroxidase'), ('PS00460', 'Glutathione peroxidases active site'), ('PS00763', 'Glutathione peroxidases signature 2'), ('PS51355', 'Glutathione peroxidase profile'), ('PTHR11592', 'GLUTATHIONE PEROXIDASE'), ('SSF52833', 'Thioredoxin-like')]",,"""ENSG00000167468; Low tissue specificity."";","CATALYTIC ACTIVITY: Reaction=a hydroperoxy polyunsaturated fatty acid + 2 glutathione = a hydroxy polyunsaturated fatty acid + glutathione disulfide + H2O; Xref=Rhea:RHEA:19057, ChEBI:CHEBI:15377, ChEBI:CHEBI:57925, ChEBI:CHEBI:58297, ChEBI:CHEBI:131871, ChEBI:CHEBI:134019; EC=1.11.1.12; Evidence={ECO:0000269|PubMed:11115402, ECO:0000269|PubMed:36608588}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:19058; Evidence={ECO:0000305|PubMed:36608588}; CATALYTIC ACTIVITY: Reaction=2 glutathione + H2O2 = glutathione disulfide + 2 H2O; Xref=Rhea:RHEA:16833, ChEBI:CHEBI:15377, ChEBI:CHEBI:16240, ChEBI:CHEBI:57925, ChEBI:CHEBI:58297; EC=1.11.1.9; Evidence={ECO:0000269|PubMed:36608588}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:16834; Evidence={ECO:0000269|PubMed:36608588}; CATALYTIC ACTIVITY: Reaction=tert-butyl hydroperoxide + 2 glutathione = tert-butanol + glutathione disulfide + H2O; Xref=Rhea:RHEA:69412, ChEBI:CHEBI:15377, ChEBI:CHEBI:45895, ChEBI:CHEBI:57925, ChEBI:CHEBI:58297, ChEBI:CHEBI:64090; Evidence={ECO:0000269|PubMed:17630701, ECO:0000269|PubMed:36608588}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:69413; Evidence={ECO:0000269|PubMed:36608588}; CATALYTIC ACTIVITY: Reaction=cumene hydroperoxide + 2 glutathione = 2-phenylpropan-2-ol + glutathione disulfide + H2O; Xref=Rhea:RHEA:69651, ChEBI:CHEBI:15377, ChEBI:CHEBI:57925, ChEBI:CHEBI:58297, ChEBI:CHEBI:78673, ChEBI:CHEBI:131607; Evidence={ECO:0000269|PubMed:36608588}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:69652; Evidence={ECO:0000269|PubMed:36608588}; CATALYTIC ACTIVITY: Reaction=(9S)-hydroperoxy-(10E,12Z)-octadecadienoate + 2 glutathione = (9S)-hydroxy-(10E,12Z)-octadecadienoate + glutathione disulfide + H2O; Xref=Rhea:RHEA:76687, ChEBI:CHEBI:15377, ChEBI:CHEBI:57925, ChEBI:CHEBI:58297, ChEBI:CHEBI:60955, ChEBI:CHEBI:77852; Evidence={ECO:0000269|PubMed:36608588}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:76688; Evidence={ECO:0000305|PubMed:36608588}; CATALYTIC ACTIVITY: Reaction=(13S)-hydroperoxy-(9Z,11E)-octadecadienoate + 2 glutathione = (13S)-hydroxy-(9Z,11E)-octadecadienoate + glutathione disulfide + H2O; Xref=Rhea:RHEA:48888, ChEBI:CHEBI:15377, ChEBI:CHEBI:57466, ChEBI:CHEBI:57925, ChEBI:CHEBI:58297, ChEBI:CHEBI:90850; Evidence={ECO:0000269|PubMed:36608588}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:48889; Evidence={ECO:0000305|PubMed:36608588}; CATALYTIC ACTIVITY: Reaction=(5S)-hydroperoxy-(6E,8Z,11Z,14Z)-eicosatetraenoate + 2 glutathione = (5S)-hydroxy-(6E,8Z,11Z,14Z)-eicosatetraenoate + glutathione disulfide + H2O; Xref=Rhea:RHEA:48620, ChEBI:CHEBI:15377, ChEBI:CHEBI:57450, ChEBI:CHEBI:57925, ChEBI:CHEBI:58297, ChEBI:CHEBI:90632; Evidence={ECO:0000269|PubMed:36608588}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:48621; Evidence={ECO:0000305|PubMed:36608588}; CATALYTIC ACTIVITY: Reaction=(12R)-hydroperoxy-(5Z,8Z,10E,14Z)-eicosatetraenoate + 2 glutathione = (12R)-hydroxy-(5Z,8Z,10E,14Z)-eicosatetraenoate + glutathione disulfide + H2O; Xref=Rhea:RHEA:76691, ChEBI:CHEBI:15377, ChEBI:CHEBI:57925, ChEBI:CHEBI:58297, ChEBI:CHEBI:75230, ChEBI:CHEBI:83343; Evidence={ECO:0000269|PubMed:36608588}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:76692; Evidence={ECO:0000305|PubMed:36608588}; CATALYTIC ACTIVITY: Reaction=(12S)-hydroperoxy-(5Z,8Z,10E,14Z)-eicosatetraenoate + 2 glutathione = (12S)-hydroxy-(5Z,8Z,10E,14Z)-eicosatetraenoate + glutathione disulfide + H2O; Xref=Rhea:RHEA:50708, ChEBI:CHEBI:15377, ChEBI:CHEBI:57444, ChEBI:CHEBI:57925, ChEBI:CHEBI:58297, ChEBI:CHEBI:90680; Evidence={ECO:0000269|PubMed:11115402, ECO:0000269|PubMed:36608588}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:50709; Evidence={ECO:0000305|PubMed:11115402}; CATALYTIC ACTIVITY: Reaction=(15S)-hydroperoxy-(5Z,8Z,11Z,13E)-eicosatetraenoate + 2 glutathione = (15S)-hydroxy-(5Z,8Z,11Z,13E)-eicosatetraenoate + glutathione disulfide + H2O; Xref=Rhea:RHEA:76695, ChEBI:CHEBI:15377, ChEBI:CHEBI:57409, ChEBI:CHEBI:57446, ChEBI:CHEBI:57925, ChEBI:CHEBI:58297; Evidence={ECO:0000269|PubMed:36608588}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:76696; Evidence={ECO:0000305|PubMed:36608588}; CATALYTIC ACTIVITY: Reaction=(5S)-hydroperoxy-(6E,8Z,11Z,14Z,17Z)-eicosapentaenoate + 2 glutathione = (5S)-hydroxy-(6E,8Z,11Z,14Z,17Z)-eicosapentaenoate + glutathione disulfide + H2O; Xref=Rhea:RHEA:76699, ChEBI:CHEBI:15377, ChEBI:CHEBI:57925, ChEBI:CHEBI:58297, ChEBI:CHEBI:195399, ChEBI:CHEBI:195400; Evidence={ECO:0000269|PubMed:36608588}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:76700; Evidence={ECO:0000305|PubMed:36608588}; CATALYTIC ACTIVITY: Reaction=(12S)-hydroperoxy-(5Z,8Z,10E,14Z,17Z)-eicosapentaenoate + 2 glutathione = (12S)-hydroxy-(5Z,8Z,10E,14Z,17Z)-eicosapentaenoate + glutathione disulfide + H2O; Xref=Rhea:RHEA:76703, ChEBI:CHEBI:15377, ChEBI:CHEBI:57925, ChEBI:CHEBI:58297, ChEBI:CHEBI:90772, ChEBI:CHEBI:195401; Evidence={ECO:0000269|PubMed:36608588}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:76704; Evidence={ECO:0000305|PubMed:36608588}; CATALYTIC ACTIVITY: Reaction=(15S)-hydroperoxy-(5Z,8Z,11Z,13E,17Z)-eicosapentaenoate + 2 glutathione = (15S)-hydroxy-(5Z,8Z,11Z,13E,17Z)-eicosapentaenoate + glutathione disulfide + H2O; Xref=Rhea:RHEA:76707, ChEBI:CHEBI:15377, ChEBI:CHEBI:57925, ChEBI:CHEBI:58297, ChEBI:CHEBI:132087, ChEBI:CHEBI:194369; Evidence={ECO:0000269|PubMed:36608588}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:76708; Evidence={ECO:0000305|PubMed:36608588}; CATALYTIC ACTIVITY: Reaction=(15S)-hydroperoxy-(11Z,13E)-eicosadienoate + 2 glutathione = (15S)-hydroxy-(11Z,13E)-eicosadienoate + glutathione disulfide + H2O; Xref=Rhea:RHEA:76711, ChEBI:CHEBI:15377, ChEBI:CHEBI:57925, ChEBI:CHEBI:58297, ChEBI:CHEBI:144832, ChEBI:CHEBI:195402; Evidence={ECO:0000269|PubMed:36608588}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:76712; Evidence={ECO:0000305|PubMed:36608588}; CATALYTIC ACTIVITY: Reaction=(17S)-hydroperoxy-(4Z,7Z,10Z,13Z,15E,19Z)-docosahexaenoate + 2 glutathione = (17S)-hydroxy-(4Z,7Z,10Z,13Z,15E,19Z)-docosahexaenoate + glutathione disulfide + H2O; Xref=Rhea:RHEA:76715, ChEBI:CHEBI:15377, ChEBI:CHEBI:57925, ChEBI:CHEBI:58297, ChEBI:CHEBI:133795, ChEBI:CHEBI:195403; Evidence={ECO:0000269|PubMed:36608588}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:76716; Evidence={ECO:0000305|PubMed:36608588}; CATALYTIC ACTIVITY: Reaction=a hydroperoxy-1,2-diacyl-glycero-3-phosphocholine + 2 glutathione = a hydroxy-1,2-diacyl-glycero-3-phosphocholine + glutathione disulfide + H2O; Xref=Rhea:RHEA:76731, ChEBI:CHEBI:15377, ChEBI:CHEBI:57925, ChEBI:CHEBI:58297, ChEBI:CHEBI:195423, ChEBI:CHEBI:195424; Evidence={ECO:0000269|PubMed:36608588}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:76732; Evidence={ECO:0000305|PubMed:36608588};",1.11.1.12; 1.11.1.9,,,ENST00000354171.13 [P36969-1];ENST00000611653.4 [P36969-2];,GPX4,ENSG00000167468,0.0,,,,,,,,,GPX4
P37198,ENSG00000213024,NUP62_HUMAN,cell surface receptor signaling pathway [GO:0007166]; cellular senescence [GO:0090398]; centriole assembly [GO:0098534]; centrosome cycle [GO:0007098]; mitotic centrosome separation [GO:0007100]; mitotic metaphase chromosome alignment [GO:0007080]; mRNA transport [GO:0051028]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of MAP kinase activity [GO:0043407]; negative regulation of programmed cell death [GO:0043069]; negative regulation of Ras protein signal transduction [GO:0046580]; nucleocytoplasmic transport [GO:0006913]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of centriole replication [GO:0046601]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of epidermal growth factor receptor signaling pathway [GO:0045742]; positive regulation of mitotic cytokinetic process [GO:1903438]; positive regulation of mitotic nuclear division [GO:0045840]; positive regulation of protein localization to centrosome [GO:1904781]; protein import into nucleus [GO:0006606]; regulation of mitotic spindle organization [GO:0060236]; regulation of Ras protein signal transduction [GO:0046578]; regulation of signal transduction [GO:0009966]; RNA export from nucleus [GO:0006405],centrosome [GO:0005813]; cytoplasm [GO:0005737]; Flemming body [GO:0090543]; mitotic spindle [GO:0072686]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore central transport channel [GO:0044613]; nucleoplasm [GO:0005654]; ribonucleoprotein complex [GO:1990904]; spindle pole [GO:0000922],chromatin binding [GO:0003682]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; phospholipid binding [GO:0005543]; PTB domain binding [GO:0051425]; SH2 domain binding [GO:0042169]; signaling receptor complex adaptor activity [GO:0030159]; structural constituent of nuclear pore [GO:0017056]; ubiquitin binding [GO:0043130],"PTM: O-glycosylated. Contains about 10 N-acetylglucosamine side chain sites predicted for the entire protein, among which only one in the C-terminal. {ECO:0000305}.; PTM: The inner channel of the NPC has a different redox environment from the cytoplasm and allows the formation of interchain disulfide bonds between some nucleoporins, the significant increase of these linkages upon oxidative stress reduces the permeability of the NPC. {ECO:0000250}.",DOMAIN: Contains FG repeats.,,,,,"cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,NUP62,Nuclear pore glycoprotein p62 (62 kDa nucleoporin) (Nucleoporin Nup62),Homo sapiens (Human),522.0,53255.0,MSGFNFGGTGAPTGGFTFGTAKTATTTPATGFSFSTSGTGGFNFGAPFQPATSTPSTGLFSLATQTPATQTTGFTFGTATLASGGTGFSLGIGASKLNLSNTAATPAMANPSGFGLGSSNLTNAISSTVTSSQGTAPTGFVFGPSTTSVAPATTSGGFSFTGGSTAQPSGFNIGSAGNSAQPTAPATLPFTPATPAATTAGATQPAAPTPTATITSTGPSLFASIATAPTSSATTGLSLCTPVTTAGAPTAGTQGFSLKAPGAASGTSTTTSTAATATATTTSSSSTTGFALNLKPLAPAGIPSNTAAAVTAPPGPGAAAGAAASSAMTYAQLESLINKWSLELEDQERHFLQQATQVNAWDRTLIENGEKITSLHREVEKVKLDQKRLDQELDFILSQQKELEDLLSPLEELVKEQSGTIYLQHADEEREKTYKLAENIDAQLKRMAQDLKDIIEHLNTSGAPADTSDPLQQICKILNAHMDSLQWIDQNSALLQRKVEEVTKVCEGRRKEQERSFRITFD,True,False,False,P37198,"[('G3DSA:1.20.5.170', None), ('IPR007758', 'Nucleoporin, NSP1-like, C-terminal'), ('IPR026010', 'Nucleoporin NSP1/NUP62'), ('PF05064', 'Nsp1-like C-terminal region'), ('PTHR12084', 'NUCLEAR PORE GLYCOPROTEIN P62-RELATED')]",,"""ENSG00000213024; Low tissue specificity."";",,,,,ENST00000352066.8;ENST00000422090.2;ENST00000596217.1;ENST00000596437.6;ENST00000597029.6;ENST00000598301.2;ENST00000599560.6;ENST00000599788.2;ENST00000600583.6;ENST00000600935.2;ENST00000700473.1;ENST00000700474.1;ENST00000700475.1;ENST00000700476.1;ENST00000700477.1;ENST00000700478.1;,NUP62,ENSG00000213024,0.0,NUP62,Non-canonical_RBPs,1.0,,,,0.699,0.146,NUP62
P37231,ENSG00000132170,PPARG_HUMAN,BMP signaling pathway [GO:0030509]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; cell maturation [GO:0048469]; cellular response to hypoxia [GO:0071456]; cellular response to insulin stimulus [GO:0032869]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; epithelial cell differentiation [GO:0030855]; fatty acid metabolic process [GO:0006631]; glucose homeostasis [GO:0042593]; hormone-mediated signaling pathway [GO:0009755]; innate immune response [GO:0045087]; lipid homeostasis [GO:0055088]; lipid metabolic process [GO:0006629]; lipoprotein transport [GO:0042953]; long-chain fatty acid transport [GO:0015909]; monocyte differentiation [GO:0030224]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of angiogenesis [GO:0016525]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of cardiac muscle hypertrophy in response to stress [GO:1903243]; negative regulation of cellular response to transforming growth factor beta stimulus [GO:1903845]; negative regulation of cholesterol storage [GO:0010887]; negative regulation of connective tissue replacement involved in inflammatory response wound healing [GO:1904597]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of extracellular matrix assembly [GO:1901202]; negative regulation of gene expression [GO:0010629]; negative regulation of inflammatory response [GO:0050728]; negative regulation of lipid storage [GO:0010888]; negative regulation of macrophage derived foam cell differentiation [GO:0010745]; negative regulation of MAPK cascade [GO:0043409]; negative regulation of miRNA transcription [GO:1902894]; negative regulation of mitochondrial fission [GO:0090258]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of receptor signaling pathway via STAT [GO:1904893]; negative regulation of sequestering of triglyceride [GO:0010891]; negative regulation of signaling receptor activity [GO:2000272]; negative regulation of SMAD protein signal transduction [GO:0060392]; negative regulation of smooth muscle cell proliferation [GO:0048662]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; negative regulation of type II interferon-mediated signaling pathway [GO:0060336]; negative regulation of vascular associated smooth muscle cell proliferation [GO:1904706]; negative regulation of vascular endothelial cell proliferation [GO:1905563]; peroxisome proliferator activated receptor signaling pathway [GO:0035357]; placenta development [GO:0001890]; positive regulation of adiponectin secretion [GO:0070165]; positive regulation of adipose tissue development [GO:1904179]; positive regulation of apoptotic signaling pathway [GO:2001235]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of cholesterol transport [GO:0032376]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of fatty acid metabolic process [GO:0045923]; positive regulation of gene expression [GO:0010628]; positive regulation of low-density lipoprotein receptor activity [GO:1905599]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of vascular associated smooth muscle cell apoptotic process [GO:1905461]; regulation of blood pressure [GO:0008217]; regulation of cellular response to insulin stimulus [GO:1900076]; regulation of circadian rhythm [GO:0042752]; regulation of transcription by RNA polymerase II [GO:0006357]; response to lipid [GO:0033993]; response to nutrient [GO:0007584]; retinoic acid receptor signaling pathway [GO:0048384]; rhythmic process [GO:0048511]; signal transduction [GO:0007165]; white fat cell differentiation [GO:0050872],chromatin [GO:0000785]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; receptor complex [GO:0043235]; RNA polymerase II transcription regulator complex [GO:0090575],"alpha-actinin binding [GO:0051393]; arachidonic acid binding [GO:0050544]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA binding domain binding [GO:0050692]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; double-stranded DNA binding [GO:0003690]; E-box binding [GO:0070888]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; LBD domain binding [GO:0050693]; nuclear receptor activity [GO:0004879]; nuclear retinoid X receptor binding [GO:0046965]; nucleic acid binding [GO:0003676]; peptide binding [GO:0042277]; prostaglandin receptor activity [GO:0004955]; R-SMAD binding [GO:0070412]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; STAT family protein binding [GO:0097677]; transcription cis-regulatory region binding [GO:0000976]; transcription coregulator binding [GO:0001221]; WW domain binding [GO:0050699]; zinc ion binding [GO:0008270]","PTM: O-GlcNAcylation at Thr-84 reduces transcriptional activity in adipocytes. {ECO:0000250|UniProtKB:P37238}.; PTM: Phosphorylated in basal conditions and dephosphorylated when treated with the ligand. May be dephosphorylated by PPP5C. The phosphorylated form may be inactive and dephosphorylation at Ser-112 induces adipogenic activity (By similarity). {ECO:0000250}.; PTM: Ubiquitinated by E3 ubiquitin-protein ligase complex containing FBXO9; leading to proteasomal degradation (By similarity). Ubiquitinated at Lys-252 by TRIM55 leading to proteasomal degradation (PubMed:36737649). Ubiquitinated by E3 ubiquitin-protein ligase STUB1/CHIP; leading to proteasomal degradation (By similarity). {ECO:0000250|UniProtKB:P37238, ECO:0000269|PubMed:36737649}.",DOMAIN: The 9aaTAD motif is a transactivation domain present in a large number of yeast and animal transcription factors. {ECO:0000305|PubMed:30468856}.,"DOMAIN 238..503; /note=""NR LBD""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU01189""","STRAND 140..142; /evidence=""ECO:0007829|PDB:3DZY""; STRAND 148..150; /evidence=""ECO:0007829|PDB:3DZU""; STRAND 151..154; /evidence=""ECO:0007829|PDB:3DZY""; STRAND 254..256; /evidence=""ECO:0007829|PDB:7WGO""; STRAND 266..268; /evidence=""ECO:0007829|PDB:6ZLY""; STRAND 269..271; /evidence=""ECO:0007829|PDB:3U9Q""; STRAND 275..277; /evidence=""ECO:0007829|PDB:8BF1""; STRAND 291..293; /evidence=""ECO:0007829|PDB:3NOA""; STRAND 294..296; /evidence=""ECO:0007829|PDB:1ZGY""; STRAND 297..299; /evidence=""ECO:0007829|PDB:6T1S""; STRAND 361..363; /evidence=""ECO:0007829|PDB:3DZU""; STRAND 366..369; /evidence=""ECO:0007829|PDB:8BF1""; STRAND 374..377; /evidence=""ECO:0007829|PDB:8BF1""; STRAND 383..385; /evidence=""ECO:0007829|PDB:6FZP""; STRAND 423..427; /evidence=""ECO:0007829|PDB:8CPJ""; STRAND 453..455; /evidence=""ECO:0007829|PDB:4R2U""; STRAND 456..458; /evidence=""ECO:0007829|PDB:7CXK""","HELIX 157..167; /evidence=""ECO:0007829|PDB:3DZY""; HELIX 186..188; /evidence=""ECO:0007829|PDB:3DZY""; HELIX 191..200; /evidence=""ECO:0007829|PDB:3DZY""; HELIX 205..207; /evidence=""ECO:0007829|PDB:3DZY""; HELIX 218..220; /evidence=""ECO:0007829|PDB:3DZY""; HELIX 235..253; /evidence=""ECO:0007829|PDB:8BF1""; HELIX 258..265; /evidence=""ECO:0007829|PDB:8BF1""; HELIX 280..290; /evidence=""ECO:0007829|PDB:8BF1""; HELIX 302..304; /evidence=""ECO:0007829|PDB:8DKV""; HELIX 305..329; /evidence=""ECO:0007829|PDB:8BF1""; HELIX 334..336; /evidence=""ECO:0007829|PDB:6MS7""; HELIX 339..360; /evidence=""ECO:0007829|PDB:8BF1""; HELIX 378..382; /evidence=""ECO:0007829|PDB:8BF1""; HELIX 393..403; /evidence=""ECO:0007829|PDB:8BF1""; HELIX 409..420; /evidence=""ECO:0007829|PDB:8BF1""; HELIX 431..452; /evidence=""ECO:0007829|PDB:8BF1""; HELIX 459..487; /evidence=""ECO:0007829|PDB:8BF1""; HELIX 491..493; /evidence=""ECO:0007829|PDB:4L98""; HELIX 495..501; /evidence=""ECO:0007829|PDB:8BF1""","TURN 168..170; /evidence=""ECO:0007829|PDB:3DZY""; TURN 214..217; /evidence=""ECO:0007829|PDB:3DZY""; TURN 226..229; /evidence=""ECO:0007829|PDB:6IJR""; TURN 370..373; /evidence=""ECO:0007829|PDB:8BF1""; TURN 386..390; /evidence=""ECO:0007829|PDB:8BF1""; TURN 488..490; /evidence=""ECO:0007829|PDB:7AWC""; TURN 502..504; /evidence=""ECO:0007829|PDB:6IJS""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,PPARG NR1C3,Peroxisome proliferator-activated receptor gamma (PPAR-gamma) (Nuclear receptor subfamily 1 group C member 3),Homo sapiens (Human),505.0,57620.0,MGETLGDSPIDPESDSFTDTLSANISQEMTMVDTEMPFWPTNFGISSVDLSVMEDHSHSFDIKPFTTVDFSSISTPHYEDIPFTRTDPVVADYKYDLKLQEYQSAIKVEPASPPYYSEKTQLYNKPHEEPSNSLMAIECRVCGDKASGFHYGVHACEGCKGFFRRTIRLKLIYDRCDLNCRIHKKSRNKCQYCRFQKCLAVGMSHNAIRFGRMPQAEKEKLLAEISSDIDQLNPESADLRALAKHLYDSYIKSFPLTKAKARAILTGKTTDKSPFVIYDMNSLMMGEDKIKFKHITPLQEQSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLASLMNKDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIFIAVIILSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQLLQVIKKTETDMSLHPLLQEIYKDLY,False,False,True,P37231,"[('cd06932', 'The ligand binding domain of peroxisome proliferator-activated receptors'), ('cd06965', 'DNA-binding domain of peroxisome proliferator-activated receptors (PPAR) is composed of two C4-type zinc fingers'), ('G3DSA:1.10.565.10', 'Retinoid X Receptor'), ('G3DSA:3.30.50.10', 'Erythroid Transcription Factor GATA-1, subunit A'), ('IPR000536', 'Nuclear hormone receptor, ligand-binding domain'), ('IPR001628', 'Zinc finger, nuclear hormone receptor-type'), ('IPR001723', 'Nuclear hormone receptor'), ('IPR003074', 'Peroxisome proliferator-activated receptor'), ('IPR003077', 'Peroxisome proliferator-activated receptor gamma'), ('IPR013088', 'Zinc finger, NHR/GATA-type'), ('IPR022590', 'Peroxisome proliferator-activated receptor gamma, N-terminal'), ('IPR035500', 'Nuclear hormone receptor-like domain superfamily'), ('IPR050234', 'Nuclear hormone receptor family NR1 subfamily'), ('PF00104', 'Ligand-binding domain of nuclear hormone receptor'), ('PF00105', 'Double treble clef zinc finger, C4 type'), ('PF12577', 'PPAR gamma N-terminal region'), ('PR00047', 'STROIDFINGER'), ('PR00398', 'STRDHORMONER'), ('PR01288', 'PROXISOMEPAR'), ('PR01291', 'PROXISOMPAGR')]",P37231;,"""ENSG00000132170; Tissue enhanced (adipose)."";",,,ACTIVITY REGULATION: PDPK1 activates its transcriptional activity independently of its kinase activity. {ECO:0000269|PubMed:16150867}.,,ENST00000287820.10 [P37231-1];,PPARG,ENSG00000132170,0.0,,,,59.21,DP00718,0.691,0.267,,PPARG
P38398,ENSG00000012048,BRCA1_HUMAN,cellular response to indole-3-methanol [GO:0071681]; cellular response to ionizing radiation [GO:0071479]; cellular response to tumor necrosis factor [GO:0071356]; centrosome cycle [GO:0007098]; chordate embryonic development [GO:0043009]; chromosome segregation [GO:0007059]; DNA damage response [GO:0006974]; DNA repair [GO:0006281]; DNA strand resection involved in replication fork processing [GO:0110025]; double-strand break repair [GO:0006302]; double-strand break repair via homologous recombination [GO:0000724]; fatty acid biosynthetic process [GO:0006633]; homologous recombination [GO:0035825]; intrinsic apoptotic signaling pathway in response to DNA damage [GO:0008630]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; mitotic G2/M transition checkpoint [GO:0044818]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell growth [GO:0030308]; negative regulation of centriole replication [GO:0046600]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of fatty acid biosynthetic process [GO:0045717]; negative regulation of gene expression via chromosomal CpG island methylation [GO:0044027]; negative regulation of intracellular estrogen receptor signaling pathway [GO:0033147]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; positive regulation of angiogenesis [GO:0045766]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of vascular endothelial growth factor production [GO:0010575]; postreplication repair [GO:0006301]; protein autoubiquitination [GO:0051865]; protein K6-linked ubiquitination [GO:0085020]; protein ubiquitination [GO:0016567]; random inactivation of X chromosome [GO:0060816]; regulation of cell cycle [GO:0051726]; regulation of DNA damage checkpoint [GO:2000001]; regulation of DNA repair [GO:0006282]; regulation of transcription by RNA polymerase II [GO:0006357]; response to ionizing radiation [GO:0010212]; sex-chromosome dosage compensation [GO:0007549],BRCA1-A complex [GO:0070531]; BRCA1-B complex [GO:0070532]; BRCA1-BARD1 complex [GO:0031436]; BRCA1-C complex [GO:0070533]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; DNA repair complex [GO:1990391]; gamma-tubulin ring complex [GO:0000931]; intracellular non-membrane-bounded organelle [GO:0043232]; lateral element [GO:0000800]; male germ cell nucleus [GO:0001673]; nuclear body [GO:0016604]; nuclear ubiquitin ligase complex [GO:0000152]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]; ubiquitin ligase complex [GO:0000151]; XY body [GO:0001741],damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; DNA-binding transcription activator activity [GO:0001216]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; p53 binding [GO:0002039]; RNA binding [GO:0003723]; RNA polymerase binding [GO:0070063]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator activity [GO:0003713]; tubulin binding [GO:0015631]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],"PTM: Phosphorylated in response to IR, UV, and various stimuli that cause checkpoint activation, probably by ATM or ATR (PubMed:11114888, PubMed:12183412, PubMed:21144835). Phosphorylation at Ser-988 by CHEK2 regulates mitotic spindle assembly (PubMed:10724175, PubMed:20364141). Phosphorylation by AURKA regulates centrosomal microtubule nucleation (PubMed:18056443). {ECO:0000269|PubMed:10724175, ECO:0000269|PubMed:11114888, ECO:0000269|PubMed:12183412, ECO:0000269|PubMed:18056443, ECO:0000269|PubMed:20364141, ECO:0000269|PubMed:21144835}.; PTM: Autoubiquitinated, undergoes 'Lys-6'-linked polyubiquitination. 'Lys-6'-linked polyubiquitination does not promote degradation. {ECO:0000269|PubMed:12890688, ECO:0000269|PubMed:20351172}.","DOMAIN: The BRCT domains recognize and bind phosphorylated pSXXF motif on proteins. The interaction with the phosphorylated pSXXF motif of ABRAXAS1, recruits BRCA1 at DNA damage sites. {ECO:0000269|PubMed:20159462}.; DOMAIN: The RING-type zinc finger domain interacts with BAP1. {ECO:0000269|PubMed:20159462}.","DOMAIN 1642..1736; /note=""BRCT 1""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00033""; DOMAIN 1756..1855; /note=""BRCT 2""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00033""","STRAND 25..27; /evidence=""ECO:0007829|PDB:7LYB""; STRAND 54..58; /evidence=""ECO:0007829|PDB:1JM7""; STRAND 62..64; /evidence=""ECO:0007829|PDB:7LYB""; STRAND 66..68; /evidence=""ECO:0007829|PDB:7LYB""; STRAND 1651..1656; /evidence=""ECO:0007829|PDB:4IGK""; STRAND 1675..1679; /evidence=""ECO:0007829|PDB:1T29""; STRAND 1686..1689; /evidence=""ECO:0007829|PDB:4IGK""; STRAND 1695..1697; /evidence=""ECO:0007829|PDB:4IGK""; STRAND 1712..1715; /evidence=""ECO:0007829|PDB:4IGK""; STRAND 1743..1745; /evidence=""ECO:0007829|PDB:1T29""; STRAND 1765..1768; /evidence=""ECO:0007829|PDB:4IGK""; STRAND 1770..1772; /evidence=""ECO:0007829|PDB:1T2V""; STRAND 1773..1775; /evidence=""ECO:0007829|PDB:4IGK""; STRAND 1790..1794; /evidence=""ECO:0007829|PDB:4IGK""; STRAND 1801..1803; /evidence=""ECO:0007829|PDB:4IGK""; STRAND 1806..1810; /evidence=""ECO:0007829|PDB:4IGK""; STRAND 1817..1819; /evidence=""ECO:0007829|PDB:1OQA""; STRAND 1828..1830; /evidence=""ECO:0007829|PDB:3PXE""; STRAND 1832..1834; /evidence=""ECO:0007829|PDB:4IGK""","HELIX 8..21; /evidence=""ECO:0007829|PDB:7LYB""; HELIX 49..52; /evidence=""ECO:0007829|PDB:7LYB""; HELIX 80..96; /evidence=""ECO:0007829|PDB:7LYB""; HELIX 1659..1671; /evidence=""ECO:0007829|PDB:4IGK""; HELIX 1701..1708; /evidence=""ECO:0007829|PDB:4IGK""; HELIX 1717..1725; /evidence=""ECO:0007829|PDB:4IGK""; HELIX 1731..1734; /evidence=""ECO:0007829|PDB:4IGK""; HELIX 1748..1754; /evidence=""ECO:0007829|PDB:4IGK""; HELIX 1777..1786; /evidence=""ECO:0007829|PDB:4IGK""; HELIX 1795..1797; /evidence=""ECO:0007829|PDB:4IGK""; HELIX 1812..1814; /evidence=""ECO:0007829|PDB:4IGK""; HELIX 1820..1822; /evidence=""ECO:0007829|PDB:4IGK""; HELIX 1824..1827; /evidence=""ECO:0007829|PDB:4IGK""; HELIX 1835..1844; /evidence=""ECO:0007829|PDB:4IGK""; HELIX 1851..1853; /evidence=""ECO:0007829|PDB:4IGK""","TURN 5..7; /evidence=""ECO:0007829|PDB:7LYB""; TURN 70..72; /evidence=""ECO:0007829|PDB:7LYB""; TURN 1740..1742; /evidence=""ECO:0007829|PDB:4IGK""; TURN 1755..1757; /evidence=""ECO:0007829|PDB:1T29""; TURN 1760..1763; /evidence=""ECO:0007829|PDB:4IGK""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,BRCA1 RNF53,Breast cancer type 1 susceptibility protein (EC 2.3.2.27) (RING finger protein 53) (RING-type E3 ubiquitin transferase BRCA1),Homo sapiens (Human),1863.0,207721.0,MDLSALRVEEVQNVINAMQKILECPICLELIKEPVSTKCDHIFCKFCMLKLLNQKKGPSQCPLCKNDITKRSLQESTRFSQLVEELLKIICAFQLDTGLEYANSYNFAKKENNSPEHLKDEVSIIQSMGYRNRAKRLLQSEPENPSLQETSLSVQLSNLGTVRTLRTKQRIQPQKTSVYIELGSDSSEDTVNKATYCSVGDQELLQITPQGTRDEISLDSAKKAACEFSETDVTNTEHHQPSNNDLNTTEKRAAERHPEKYQGSSVSNLHVEPCGTNTHASSLQHENSSLLLTKDRMNVEKAEFCNKSKQPGLARSQHNRWAGSKETCNDRRTPSTEKKVDLNADPLCERKEWNKQKLPCSENPRDTEDVPWITLNSSIQKVNEWFSRSDELLGSDDSHDGESESNAKVADVLDVLNEVDEYSGSSEKIDLLASDPHEALICKSERVHSKSVESNIEDKIFGKTYRKKASLPNLSHVTENLIIGAFVTEPQIIQERPLTNKLKRKRRPTSGLHPEDFIKKADLAVQKTPEMINQGTNQTEQNGQVMNITNSGHENKTKGDSIQNEKNPNPIESLEKESAFKTKAEPISSSISNMELELNIHNSKAPKKNRLRRKSSTRHIHALELVVSRNLSPPNCTELQIDSCSSSEEIKKKKYNQMPVRHSRNLQLMEGKEPATGAKKSNKPNEQTSKRHDSDTFPELKLTNAPGSFTKCSNTSELKEFVNPSLPREEKEEKLETVKVSNNAEDPKDLMLSGERVLQTERSVESSSISLVPGTDYGTQESISLLEVSTLGKAKTEPNKCVSQCAAFENPKGLIHGCSKDNRNDTEGFKYPLGHEVNHSRETSIEMEESELDAQYLQNTFKVSKRQSFAPFSNPGNAEEECATFSAHSGSLKKQSPKVTFECEQKEENQGKNESNIKPVQTVNITAGFPVVGQKDKPVDNAKCSIKGGSRFCLSSQFRGNETGLITPNKHGLLQNPYRIPPLFPIKSFVKTKCKKNLLEENFEEHSMSPEREMGNENIPSTVSTISRNNIRENVFKEASSSNINEVGSSTNEVGSSINEIGSSDENIQAELGRNRGPKLNAMLRLGVLQPEVYKQSLPGSNCKHPEIKKQEYEEVVQTVNTDFSPYLISDNLEQPMGSSHASQVCSETPDDLLDDGEIKEDTSFAENDIKESSAVFSKSVQKGELSRSPSPFTHTHLAQGYRRGAKKLESSEENLSSEDEELPCFQHLLFGKVNNIPSQSTRHSTVATECLSKNTEENLLSLKNSLNDCSNQVILAKASQEHHLSEETKCSASLFSSQCSELEDLTANTNTQDPFLIGSSKQMRHQSESQGVGLSDKELVSDDEERGTGLEENNQEEQSMDSNLGEAASGCESETSVSEDCSGLSSQSDILTTQQRDTMQHNLIKLQQEMAELEAVLEQHGSQPSNSYPSIISDSSALEDLRNPEQSTSEKAVLTSQKSSEYPISQNPEGLSADKFEVSADSSTSKNKEPGVERSSPSKCPSLDDRWYMHSCSGSLQNRNYPSQEELIKVVDVEEQQLEESGPHDLTETSYLPRQDLEGTPYLESGISLFSDDPESDPSEDRAPESARVGNIPSSTSALKVPQLKVAESAQSPAAAHTTDTAGYNAMEESVSREKPELTASTERVNKRMSMVVSGLTPEEFMLVYKFARKHHITLTNLITEETTHVVMKTDAEFVCERTLKYFLGIAGGKWVVSYFWVTQSIKERKMLNEHDFEVRGDVVNGRNHQGPKRARESQDRKIFRGLEICCYGPFTNMPTDQLEWMVQLCGASVVKELSSFTLGTGVHPIVVVQPDAWTEDNGFHAIGQMCEAPVVTREWVLDSVALYQCQELDTYLIPQIPHSHY,False,True,False,P38398,"[('cd16498', 'RING finger, HC subclass, found in breast cancer type 1 susceptibility protein (BRCA1) and similar proteins'), ('cd17721', 'second (C-terminal) BRCT domain of breast cancer type 1 susceptibility protein (BRCA1) and similar proteins'), ('cd17735', 'first BRCT domain of breast cancer type 1 susceptibility protein (BRCA1) and similar proteins'), ('G3DSA:3.30.40.10', 'Zinc/RING finger domain, C3HC4 (zinc finger)'), ('G3DSA:3.40.50.10190', 'BRCT domain'), ('IPR001357', 'BRCT domain'), ('IPR001841', 'Zinc finger, RING-type'), ('IPR011364', 'Breast cancer type 1 susceptibility protein (BRCA1)'), ('IPR013083', 'Zinc finger, RING/FYVE/PHD-type'), ('IPR017907', 'Zinc finger, RING-type, conserved site'), ('IPR018957', 'Zinc finger, C3HC4 RING-type'), ('IPR025994', 'BRCA1, serine-rich domain'), ('IPR031099', 'BRCA1-associated'), ('IPR036420', 'BRCT domain superfamily'), ('PF00097', 'Zinc finger, C3HC4 type (RING finger)'), ('PF00533', 'BRCA1 C Terminus (BRCT) domain'), ('PF12820', 'Serine-rich domain associated with BRCT'), ('PIRSF001734', 'Transcriptional regulator, BRCA1 type'), ('PR00493', 'BRSTCANCERI'), ('PS00518', 'Zinc finger RING-type signature')]",,"""ENSG00000012048; Low tissue specificity."";","CATALYTIC ACTIVITY: Reaction=S-ubiquitinyl-[E2 ubiquitin-conjugating enzyme]-L-cysteine + [acceptor protein]-L-lysine = [E2 ubiquitin-conjugating enzyme]-L-cysteine + N(6)-ubiquitinyl-[acceptor protein]-L-lysine.; EC=2.3.2.27; Evidence={ECO:0000269|PubMed:10500182, ECO:0000269|PubMed:12887909, ECO:0000269|PubMed:12890688, ECO:0000269|PubMed:16818604, ECO:0000269|PubMed:18056443, ECO:0000269|PubMed:20351172};",2.3.2.27,ACTIVITY REGULATION: The E3 ubiquitin-protein ligase activity is inhibited by phosphorylation by AURKA. Activity is increased by phosphatase treatment. {ECO:0000269|PubMed:18056443}.,PATHWAY: Protein modification; protein ubiquitination.,ENST00000352993.7 [P38398-5];ENST00000357654.9 [P38398-1];ENST00000461221.5 [P38398-2];ENST00000461798.5 [P38398-2];ENST00000468300.5 [P38398-6];ENST00000470026.6 [P38398-1];ENST00000471181.7 [P38398-7];ENST00000491747.6 [P38398-3];ENST00000493795.5 [P38398-8];ENST00000494123.6 [P38398-1];ENST00000618469.2 [P38398-1];ENST00000652672.2 [P38398-8];ENST00000713676.1 [P38398-1];,BRCA1,ENSG00000012048,0.0,BRCA1,Non-canonical_RBPs,6.0,83.2,DP00238,0.832,0.823,0.197,BRCA1
P38936,ENSG00000124762,CDN1A_HUMAN,"animal organ regeneration [GO:0031100]; cellular response to amino acid starvation [GO:0034198]; cellular response to cell-matrix adhesion [GO:0071460]; cellular response to gamma radiation [GO:0071480]; cellular response to heat [GO:0034605]; cellular response to ionizing radiation [GO:0071479]; cellular response to UV-B [GO:0071493]; cellular senescence [GO:0090398]; DNA damage response [GO:0006974]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator [GO:0006978]; fibroblast proliferation [GO:0048144]; G1/S transition of mitotic cell cycle [GO:0000082]; heart development [GO:0007507]; import into nucleus [GO:0051170]; in utero embryonic development [GO:0001701]; intestinal epithelial cell maturation [GO:0060574]; intrinsic apoptotic signaling pathway [GO:0097193]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; keratinocyte differentiation [GO:0030216]; keratinocyte proliferation [GO:0043616]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cardiac muscle tissue regeneration [GO:1905179]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cyclin-dependent protein kinase activity [GO:1904030]; negative regulation of DNA biosynthetic process [GO:2000279]; negative regulation of G1/S transition of mitotic cell cycle [GO:2000134]; negative regulation of gene expression [GO:0010629]; negative regulation of phosphorylation [GO:0042326]; negative regulation of protein binding [GO:0032091]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of vascular associated smooth muscle cell proliferation [GO:1904706]; oncogene-induced cell senescence [GO:0090402]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of DNA replication [GO:0045740]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of programmed cell death [GO:0043068]; positive regulation of protein kinase activity [GO:0045860]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; protein import into nucleus [GO:0006606]; Ras protein signal transduction [GO:0007265]; regulation of cell cycle [GO:0051726]; regulation of cell cycle G1/S phase transition [GO:1902806]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; replicative senescence [GO:0090399]; response to aldosterone [GO:1904044]; response to arsenic-containing substance [GO:0046685]; response to corticosterone [GO:0051412]; response to hyperoxia [GO:0055093]; response to toxic substance [GO:0009636]; response to X-ray [GO:0010165]; response to xenobiotic stimulus [GO:0009410]; stress-induced premature senescence [GO:0090400]; tissue regeneration [GO:0042246]; wound healing [GO:0042060]",cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PCNA-p21 complex [GO:0070557]; perinuclear region of cytoplasm [GO:0048471]; protein-containing complex [GO:0032991],cyclin binding [GO:0030332]; cyclin-dependent protein kinase activating kinase activity [GO:0019912]; cyclin-dependent protein serine/threonine kinase inhibitor activity [GO:0004861]; metal ion binding [GO:0046872]; molecular function activator activity [GO:0140677]; molecular function inhibitor activity [GO:0140678]; protein kinase binding [GO:0019901]; protein kinase inhibitor activity [GO:0004860]; protein sequestering activity [GO:0140311]; protein serine/threonine kinase binding [GO:0120283]; protein-containing complex binding [GO:0044877]; ubiquitin protein ligase binding [GO:0031625],"PTM: Phosphorylation of Thr-145 by Akt or of Ser-146 by PKC impairs binding to PCNA. Phosphorylation at Ser-114 by GSK3-beta enhances ubiquitination by the DCX(DTL) complex. Phosphorylation of Thr-145 by PIM2 enhances CDKN1A stability and inhibits cell proliferation. Phosphorylation of Thr-145 by PIM1 results in the relocation of CDKN1A to the cytoplasm and enhanced CDKN1A protein stability. UV radiation-induced phosphorylation at Thr-80 by LKB1 and at Ser-146 by NUAK1 leads to its degradation. {ECO:0000269|PubMed:10753973, ECO:0000269|PubMed:11463845, ECO:0000269|PubMed:12431783, ECO:0000269|PubMed:16982699, ECO:0000269|PubMed:18794347, ECO:0000269|PubMed:20307683, ECO:0000269|PubMed:25329316}.; PTM: Ubiquitinated by MKRN1; leading to polyubiquitination and 26S proteasome-dependent degradation. Ubiquitinated by the DCX(DTL) complex, also named CRL4(CDT2) complex, leading to its degradation during S phase or following UV irradiation. Ubiquitination by the DCX(DTL) complex is essential to control replication licensing and is PCNA-dependent: interacts with PCNA via its PIP-box, while the presence of the containing the 'K+4' motif in the PIP box, recruit the DCX(DTL) complex, leading to its degradation. Ubiquitination at Ser-2 leads to degradation by the proteasome pathway. Ubiquitinated by RNF114; leading to proteasomal degradation. {ECO:0000269|PubMed:15226418, ECO:0000269|PubMed:23213251}.; PTM: Acetylation leads to protein stability. Acetylated in vitro on Lys-141, Lys-154, Lys-161 and Lys-163. Deacetylation by HDAC1 is prevented by competitive binding of C10orf90/FATS to HDAC1 (By similarity). {ECO:0000250}.","DOMAIN: The PIP-box K+4 motif mediates both the interaction with PCNA and the recruitment of the DCX(DTL) complex: while the PIP-box interacts with PCNA, the presence of the K+4 submotif, recruits the DCX(DTL) complex, leading to its ubiquitination.; DOMAIN: The C-terminal is required for nuclear localization of the cyclin D-CDK4 complex.",,"STRAND 21..23; /evidence=""ECO:0007829|PDB:6P8H""; STRAND 49..51; /evidence=""ECO:0007829|PDB:6P8H""; STRAND 142..144; /evidence=""ECO:0007829|PDB:7KQ1""; STRAND 153..158; /evidence=""ECO:0007829|PDB:5E0U""","HELIX 27..46; /evidence=""ECO:0007829|PDB:6P8H""; HELIX 147..149; /evidence=""ECO:0007829|PDB:5E0U""","TURN 53..56; /evidence=""ECO:0007829|PDB:6P8H""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,CDKN1A CAP20 CDKN1 CIP1 MDA6 PIC1 SDI1 WAF1,Cyclin-dependent kinase inhibitor 1 (CDK-interacting protein 1) (Melanoma differentiation-associated protein 6) (MDA-6) (p21),Homo sapiens (Human),164.0,18119.0,MSEPAGDVRQNPCGSKACRRLFGPVDSEQLSRDCDALMAGCIQEARERWNFDFVTETPLEGDFAWERVRGLGLPKLYLPTGPRRGRDELGGGRRPGTSPALLQGTAEEDHVDLSLSCTLVPRSGEQAEGSPGGPGDSQGRKRRQTSMTDFYHSKRRLIFSKRKP,True,False,True,P38936,"[('G3DSA:4.10.365.10', 'p27'), ('IPR003175', 'Cyclin-dependent kinase inhibitor domain'), ('IPR029841', 'Cyclin-dependent kinase inhibitor 1'), ('IPR044898', 'Cyclin-dependent kinase inhibitor domain superfamily'), ('PF02234', 'Cyclin-dependent kinase inhibitor'), ('PTHR46778', 'CYCLIN-DEPENDENT KINASE INHIBITOR 1-RELATED')]",,"""ENSG00000124762; Low tissue specificity."";",,,,,ENST00000244741.10;ENST00000373711.3;ENST00000405375.5;ENST00000448526.6;ENST00000615513.4;,CDKN1A,ENSG00000124762,0.0,,,,100.0,DP00016,1.0,0.841,0.543,CDKN1A
P40429,ENSG00000142541,RL13A_HUMAN,cellular response to type II interferon [GO:0071346]; cytoplasmic translation [GO:0002181]; homeostatic process [GO:0042592]; lung morphogenesis [GO:0060425]; macrophage chemotaxis [GO:0048246]; negative regulation of formation of translation preinitiation complex [GO:1901194]; negative regulation of translation [GO:0017148]; response to lipopolysaccharide [GO:0032496]; translation [GO:0006412],cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; focal adhesion [GO:0005925]; GAIT complex [GO:0097452]; large ribosomal subunit [GO:0015934]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleus [GO:0005634]; ribonucleoprotein complex [GO:1990904]; ribosome [GO:0005840]; synapse [GO:0045202],mRNA binding [GO:0003729]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735],"PTM: Phosphorylation at Ser-77 upon interferon-gamma treatment in monocytes involves a DAPK1-DAPK3 kinase cascade and is causing release from the ribosome, association with the GAIT complex and subsequent involvement in transcript-selective translation inhibition. {ECO:0000269|PubMed:14567916, ECO:0000269|PubMed:18995835}.; PTM: Citrullinated by PADI4. {ECO:0000250|UniProtKB:P19253}.",,,,,,"cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,RPL13A,Large ribosomal subunit protein uL13 (23 kDa highly basic protein) (60S ribosomal protein L13a),Homo sapiens (Human),203.0,23577.0,MAEVQVLVLDGRGHLLGRLAAIVAKQVLLGRKVVVVRCEGINISGNFYRNKLKYLAFLRKRMNTNPSRGPYHFRAPSRIFWRTVRGMLPHKTKRGQAALDRLKVFDGIPPPYDKKKRMVVPAALKVVRLKPTRKFAYLGRLAHEVGWKYQAVTATLEEKRKEKAKIHYRKKKQLMRLRKQAEKNVEKKIDKYTEVLKTHGLLV,True,True,False,P40429,"[('cd00392', 'Ribosomal_L13'), ('G3DSA:3.90.1180.10', 'Ribosomal protein L13'), ('G3DSA:6.10.250.3250', None), ('IPR005755', 'Large ribosomal subunit protein uL13, eukaryotic/archaeal'), ('IPR005822', 'Large ribosomal subunit protein uL13'), ('IPR023563', 'Large ribosomal subunit protein uL13, conserved site'), ('IPR036899', 'Large ribosomal subunit protein uL13 superfamily'), ('MF_01366', 'Large ribosomal subunit protein uL13 [rplM]'), ('PF00572', 'Ribosomal protein L13'), ('PS00783', 'Ribosomal protein L13 signature'), ('PTHR11545', 'RIBOSOMAL PROTEIN L13'), ('SSF52161', 'Ribosomal protein L13'), ('TIGR01077', '50S ribosomal protein L13')]",,"""ENSG00000142541; Low tissue specificity."";",,,,,ENST00000391857.9;,RPL13A,ENSG00000142541,0.0,RPL13A,Canonical_RBPs,26.0,,,,0.158,,RPL13A
P40763,ENSG00000168610,STAT3_HUMAN,astrocyte differentiation [GO:0048708]; cell differentiation [GO:0030154]; cell population proliferation [GO:0008283]; cell surface receptor signaling pathway via JAK-STAT [GO:0007259]; cell surface receptor signaling pathway via STAT [GO:0097696]; cellular response to hormone stimulus [GO:0032870]; cellular response to interleukin-17 [GO:0097398]; cellular response to leptin stimulus [GO:0044320]; cytokine-mediated signaling pathway [GO:0019221]; defense response [GO:0006952]; eating behavior [GO:0042755]; energy homeostasis [GO:0097009]; eye photoreceptor cell differentiation [GO:0001754]; glucose homeostasis [GO:0042593]; growth hormone receptor signaling pathway [GO:0060396]; growth hormone receptor signaling pathway via JAK-STAT [GO:0060397]; inflammatory response [GO:0006954]; interleukin-10-mediated signaling pathway [GO:0140105]; interleukin-11-mediated signaling pathway [GO:0038154]; interleukin-15-mediated signaling pathway [GO:0035723]; interleukin-2-mediated signaling pathway [GO:0038110]; interleukin-23-mediated signaling pathway [GO:0038155]; interleukin-6-mediated signaling pathway [GO:0070102]; interleukin-9-mediated signaling pathway [GO:0038113]; intracellular receptor signaling pathway [GO:0030522]; leptin-mediated signaling pathway [GO:0033210]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of autophagy [GO:0010507]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of gene expression [GO:0010629]; negative regulation of glycolytic process [GO:0045820]; negative regulation of inflammatory response [GO:0050728]; negative regulation of inflammatory response to wounding [GO:0106015]; negative regulation of neuron migration [GO:2001223]; negative regulation of primary miRNA processing [GO:2000635]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; phosphorylation [GO:0016310]; positive regulation of angiogenesis [GO:0045766]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of cell migration [GO:0030335]; positive regulation of cytokine production involved in inflammatory response [GO:1900017]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of erythrocyte differentiation [GO:0045648]; positive regulation of gene expression [GO:0010628]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of metalloendopeptidase activity [GO:1904685]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of vascular endothelial cell proliferation [GO:1905564]; positive regulation of vascular endothelial growth factor production [GO:0010575]; protein import into nucleus [GO:0006606]; radial glial cell differentiation [GO:0060019]; regulation of cell cycle [GO:0051726]; regulation of cell population proliferation [GO:0042127]; regulation of DNA-templated transcription [GO:0006355]; regulation of feeding behavior [GO:0060259]; regulation of multicellular organism growth [GO:0040014]; regulation of transcription by RNA polymerase II [GO:0006357]; response to estradiol [GO:0032355]; response to leptin [GO:0044321]; response to peptide hormone [GO:0043434]; retinal rod cell differentiation [GO:0060221]; sexual reproduction [GO:0019953]; signal transduction [GO:0007165]; somatic stem cell population maintenance [GO:0035019]; T-helper 17 cell lineage commitment [GO:0072540]; T-helper 17 type immune response [GO:0072538]; temperature homeostasis [GO:0001659]; transforming growth factor beta receptor signaling pathway [GO:0007179],chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; RNA polymerase II transcription regulator complex [GO:0090575]; transcription regulator complex [GO:0005667],"chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; identical protein binding [GO:0042802]; lncRNA binding [GO:0106222]; nuclear receptor activity [GO:0004879]; primary miRNA binding [GO:0070878]; protein dimerization activity [GO:0046983]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; RNA sequestering activity [GO:0140610]; signaling adaptor activity [GO:0035591]; signaling receptor binding [GO:0005102]; transcription cis-regulatory region binding [GO:0000976]","PTM: Tyrosine phosphorylated upon stimulation with EGF. Tyrosine phosphorylated in response to constitutively activated FGFR1, FGFR2, FGFR3 and FGFR4 (By similarity). Activated through tyrosine phosphorylation by BMX. Tyrosine phosphorylated in response to IL6, IL11, LIF, CNTF, KITLG/SCF, CSF1, EGF, PDGF, IFN-alpha, LEP and OSM. Activated KIT promotes phosphorylation on tyrosine residues and subsequent translocation to the nucleus. Phosphorylated on serine upon DNA damage, probably by ATM or ATR. Serine phosphorylation is important for the formation of stable DNA-binding STAT3 homodimers and maximal transcriptional activity. ARL2BP may participate in keeping the phosphorylated state of STAT3 within the nucleus. Upon LPS challenge, phosphorylated within the nucleus by IRAK1. Upon erythropoietin treatment, phosphorylated on Ser-727 by RPS6KA5. Dephosphorylation on tyrosine residues by PTPN2 negatively regulates IL6/interleukin-6 signaling (By similarity). Phosphorylation at Tyr-705 by PTK6, isoform M2 of PKM (PKM2) or FER leads to an increase of its transcriptional activity (PubMed:12763138, PubMed:16568091, PubMed:21135090, PubMed:22306293, PubMed:32929201). Phosphorylation at Tyr-705 is increased in the presence of calcineurin (By similarity). Phosphorylation at Tyr-640 by TYK2 negatively regulates transcriptional activity (PubMed:29162862). {ECO:0000250|UniProtKB:P42227, ECO:0000269|PubMed:10688651, ECO:0000269|PubMed:12359225, ECO:0000269|PubMed:12763138, ECO:0000269|PubMed:15465816, ECO:0000269|PubMed:16219639, ECO:0000269|PubMed:16568091, ECO:0000269|PubMed:17344214, ECO:0000269|PubMed:17875724, ECO:0000269|PubMed:18234692, ECO:0000269|PubMed:18599021, ECO:0000269|PubMed:19147545, ECO:0000269|PubMed:21135090, ECO:0000269|PubMed:22306293, ECO:0000269|PubMed:29162862, ECO:0000269|PubMed:32929201, ECO:0000269|PubMed:7701321}.; PTM: Acetylated on lysine residues by EP300/p300, promoting its activation (PubMed:15653507, PubMed:16285960, PubMed:18782771). Acetylation at Lys-49 and Lys-87 by EP300/p300 promotes its activation (PubMed:15653507, PubMed:16285960, PubMed:28262505). Acetylation at Lys-87 by EP300/p300 promotes its association with BRD2 and recruitment to chromatin (PubMed:28262505). Deacetylated at Lys-49 and Lys-87 by HDAC1 (PubMed:16285960). Acetylation at Lys-685 by EP300/p300 promotes its homodimerization and activation (PubMed:15653507). Deacetylated at Lys-685 by HDAC3 (PubMed:15653507). Acetylated on lysine residues by CREBBP (PubMed:28065600). Deacetylation by LOXL3 leads to disrupt STAT3 dimerization and inhibit STAT3 transcription activity (PubMed:28065600). Oxidation of lysine residues to allysine on STAT3 preferentially takes place on lysine residues that are acetylated (PubMed:28065600). {ECO:0000269|PubMed:15653507, ECO:0000269|PubMed:16285960, ECO:0000269|PubMed:18782771, ECO:0000269|PubMed:28065600, ECO:0000269|PubMed:28262505}.; PTM: Some lysine residues are oxidized to allysine by LOXL3, leading to disrupt STAT3 dimerization and inhibit STAT3 transcription activity (PubMed:28065600). Oxidation of lysine residues to allysine on STAT3 preferentially takes place on lysine residues that are acetylated (PubMed:28065600). {ECO:0000269|PubMed:28065600}.; PTM: (Microbial infection) Phosphorylated on Tyr-705 in the presence of S.typhimurium SarA. {ECO:0000269|PubMed:29924996}.",,"DOMAIN 580..670; /note=""SH2""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00191""","STRAND 321..328; /evidence=""ECO:0007829|PDB:6NJS""; STRAND 338..340; /evidence=""ECO:0007829|PDB:6NJS""; STRAND 345..353; /evidence=""ECO:0007829|PDB:6NJS""; STRAND 363..368; /evidence=""ECO:0007829|PDB:6NJS""; STRAND 373..376; /evidence=""ECO:0007829|PDB:6QHD""; STRAND 384..388; /evidence=""ECO:0007829|PDB:6NJS""; STRAND 391..393; /evidence=""ECO:0007829|PDB:6NJS""; STRAND 404..415; /evidence=""ECO:0007829|PDB:6NJS""; STRAND 439..447; /evidence=""ECO:0007829|PDB:6NJS""; STRAND 450..457; /evidence=""ECO:0007829|PDB:6NJS""; STRAND 461..466; /evidence=""ECO:0007829|PDB:6NJS""; STRAND 514..517; /evidence=""ECO:0007829|PDB:6TLC""; STRAND 557..559; /evidence=""ECO:0007829|PDB:6NJS""; STRAND 605..610; /evidence=""ECO:0007829|PDB:6NJS""; STRAND 619..626; /evidence=""ECO:0007829|PDB:6NJS""; STRAND 632..636; /evidence=""ECO:0007829|PDB:6NJS""","HELIX 139..177; /evidence=""ECO:0007829|PDB:6NJS""; HELIX 194..237; /evidence=""ECO:0007829|PDB:6NJS""; HELIX 239..251; /evidence=""ECO:0007829|PDB:6NJS""; HELIX 261..290; /evidence=""ECO:0007829|PDB:6NJS""; HELIX 297..320; /evidence=""ECO:0007829|PDB:6NJS""; HELIX 356..358; /evidence=""ECO:0007829|PDB:6NJS""; HELIX 432..434; /evidence=""ECO:0007829|PDB:6NJS""; HELIX 467..469; /evidence=""ECO:0007829|PDB:6NJS""; HELIX 470..483; /evidence=""ECO:0007829|PDB:6NJS""; HELIX 501..513; /evidence=""ECO:0007829|PDB:6NJS""; HELIX 522..533; /evidence=""ECO:0007829|PDB:6NJS""; HELIX 546..549; /evidence=""ECO:0007829|PDB:6NJS""; HELIX 561..574; /evidence=""ECO:0007829|PDB:6NJS""; HELIX 577..582; /evidence=""ECO:0007829|PDB:6NJS""; HELIX 591..600; /evidence=""ECO:0007829|PDB:6NJS""; HELIX 642..645; /evidence=""ECO:0007829|PDB:6NJS""; HELIX 650..656; /evidence=""ECO:0007829|PDB:6NJS""; HELIX 679..683; /evidence=""ECO:0007829|PDB:6NJS""; HELIX 684..686; /evidence=""ECO:0007829|PDB:6NJS""","TURN 359..361; /evidence=""ECO:0007829|PDB:6NJS""; TURN 398..401; /evidence=""ECO:0007829|PDB:6NJS""; TURN 490..494; /evidence=""ECO:0007829|PDB:6NJS""; TURN 674..676; /evidence=""ECO:0007829|PDB:6NJS""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,STAT3 APRF,Signal transducer and activator of transcription 3 (Acute-phase response factor),Homo sapiens (Human),770.0,88068.0,MAQWNQLQQLDTRYLEQLHQLYSDSFPMELRQFLAPWIESQDWAYAASKESHATLVFHNLLGEIDQQYSRFLQESNVLYQHNLRRIKQFLQSRYLEKPMEIARIVARCLWEESRLLQTAATAAQQGGQANHPTAAVVTEKQQMLEQHLQDVRKRVQDLEQKMKVVENLQDDFDFNYKTLKSQGDMQDLNGNNQSVTRQKMQQLEQMLTALDQMRRSIVSELAGLLSAMEYVQKTLTDEELADWKRRQQIACIGGPPNICLDRLENWITSLAESQLQTRQQIKKLEELQQKVSYKGDPIVQHRPMLEERIVELFRNLMKSAFVVERQPCMPMHPDRPLVIKTGVQFTTKVRLLVKFPELNYQLKIKVCIDKDSGDVAALRGSRKFNILGTNTKVMNMEESNNGSLSAEFKHLTLREQRCGNGGRANCDASLIVTEELHLITFETEVYHQGLKIDLETHSLPVVVISNICQMPNAWASILWYNMLTNNPKNVNFFTKPPIGTWDQVAEVLSWQFSSTTKRGLSIEQLTTLAEKLLGPGVNYSGCQITWAKFCKENMAGKGFSFWVWLDNIIDLVKKYILALWNEGYIMGFISKERERAILSTKPPGTFLLRFSESSKEGGVTFTWVEKDISGKTQIQSVEPYTKQQLNNMSFAEIIMGYKIMDATNILVSPLVYLYPDIPKEEAFGKYCRPESQEHPEADPGSAAPYLKTKFICVTPTTCSNTIDLPMSPRTLDSLMQFGNNGEGAEPSAGGQFESLTFDMELTSECATSPM,False,False,True,P40763,"[('cd10374', 'Src homology 2 (SH2) domain found in signal transducer and activator of transcription (STAT) 3 proteins'), ('cd16847', 'DNA-binding domain of Signal Transducer and Activator of Transcription 3 (STAT3)'), ('cd16853', 'Coiled-coil domain of Signal Transducer and Activator of Transcription 3 (STAT3)'), ('G3DSA:1.10.238.10', 'EF-hand'), ('G3DSA:1.10.532.10', 'STAT transcription factor, N-terminal domain'), ('G3DSA:1.20.1050.20', 'STAT transcription factor, all-alpha domain'), ('G3DSA:2.60.40.630', 'STAT transcription factor, DNA-binding domain'), ('G3DSA:3.30.505.10', 'SH2 domain'), ('IPR000980', 'SH2 domain'), ('IPR001217', 'Transcription factor STAT'), ('IPR008967', 'p53-like transcription factor, DNA-binding domain superfamily'), ('IPR012345', 'STAT transcription factor, DNA-binding, N-terminal'), ('IPR013799', 'STAT transcription factor, protein interaction'), ('IPR013800', 'STAT transcription factor, all-alpha domain'), ('IPR013801', 'STAT transcription factor, DNA-binding'), ('IPR015988', 'STAT transcription factor, coiled coil'), ('IPR035855', 'STAT3, SH2 domain'), ('IPR036535', 'STAT transcription factor, N-terminal domain superfamily'), ('IPR036860', 'SH2 domain superfamily'), ('IPR048988', 'Signal transducer and activator of transcription, linker domain')]",P40763;,"""ENSG00000168610; Low tissue specificity."";",,,,,ENST00000264657.10 [P40763-1];ENST00000404395.3 [P40763-2];ENST00000585517.5 [P40763-3];ENST00000588969.5 [P40763-1];ENST00000677030.1 [P40763-3];ENST00000677723.1 [P40763-2];ENST00000678044.1 [P40763-1];ENST00000678827.1 [P40763-3];ENST00000678906.1 [P40763-1];ENST00000678960.1 [P40763-1];ENST00000679014.1 [P40763-2];ENST00000715205.1 [P40763-1];,STAT3,ENSG00000168610,0.0,STAT3,Non-canonical_RBPs,5.0,4.42,DP03428,0.044,0.135,,STAT3
P40926,ENSG00000146701,MDHM_HUMAN,aerobic respiration [GO:0009060]; gluconeogenesis [GO:0006094]; malate metabolic process [GO:0006108]; malate-aspartate shuttle [GO:0043490]; NADH metabolic process [GO:0006734]; tricarboxylic acid cycle [GO:0006099],cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleus [GO:0005634],identical protein binding [GO:0042802]; L-malate dehydrogenase (NAD+) activity [GO:0030060]; L-malate dehydrogenase (NADP+) activity [GO:0046554]; RNA binding [GO:0003723],PTM: Acetylation is enhanced by up to 67% after treatment either with trichostin A (TSA) or with nicotinamide (NAM) with the appearance of tri- and tetraacetylations. Glucose also increases acetylation by about 60%. {ECO:0000269|PubMed:20167786}.,,,"STRAND 25..30; /evidence=""ECO:0007829|PDB:2DFD""; STRAND 50..60; /evidence=""ECO:0007829|PDB:2DFD""; STRAND 71..74; /evidence=""ECO:0007829|PDB:2DFD""; STRAND 76..82; /evidence=""ECO:0007829|PDB:2DFD""; STRAND 94..98; /evidence=""ECO:0007829|PDB:2DFD""; STRAND 135..139; /evidence=""ECO:0007829|PDB:2DFD""; STRAND 165..168; /evidence=""ECO:0007829|PDB:2DFD""; STRAND 196..198; /evidence=""ECO:0007829|PDB:2DFD""; STRAND 205..207; /evidence=""ECO:0007829|PDB:2DFD""; STRAND 273..279; /evidence=""ECO:0007829|PDB:2DFD""; STRAND 282..295; /evidence=""ECO:0007829|PDB:2DFD""; STRAND 298..302; /evidence=""ECO:0007829|PDB:2DFD""","HELIX 37..45; /evidence=""ECO:0007829|PDB:2DFD""; HELIX 61..69; /evidence=""ECO:0007829|PDB:2DFD""; HELIX 86..90; /evidence=""ECO:0007829|PDB:2DFD""; HELIX 110..113; /evidence=""ECO:0007829|PDB:2DFD""; HELIX 114..131; /evidence=""ECO:0007829|PDB:2DFD""; HELIX 144..157; /evidence=""ECO:0007829|PDB:2DFD""; HELIX 171..185; /evidence=""ECO:0007829|PDB:2DFD""; HELIX 189..191; /evidence=""ECO:0007829|PDB:2DFD""; HELIX 202..204; /evidence=""ECO:0007829|PDB:2DFD""; HELIX 209..211; /evidence=""ECO:0007829|PDB:2DFD""; HELIX 220..241; /evidence=""ECO:0007829|PDB:2DFD""; HELIX 249..266; /evidence=""ECO:0007829|PDB:2DFD""; HELIX 310..335; /evidence=""ECO:0007829|PDB:2DFD""","TURN 31..33; /evidence=""ECO:0007829|PDB:2DFD""; TURN 83..85; /evidence=""ECO:0007829|PDB:2DFD""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,MDH2,"Malate dehydrogenase, mitochondrial (EC 1.1.1.37)",Homo sapiens (Human),338.0,35503.0,MLSALARPASAALRRSFSTSAQNNAKVAVLGASGGIGQPLSLLLKNSPLVSRLTLYDIAHTPGVAADLSHIETKAAVKGYLGPEQLPDCLKGCDVVVIPAGVPRKPGMTRDDLFNTNATIVATLTAACAQHCPEAMICVIANPVNSTIPITAEVFKKHGVYNPNKIFGVTTLDIVRANTFVAELKGLDPARVNVPVIGGHAGKTIIPLISQCTPKVDFPQDQLTALTGRIQEAGTEVVKAKAGAGSATLSMAYAGARFVFSLVDAMNGKEGVVECSFVKSQETECTYFSTPLLLGKKGIEKNLGIGKVSSFEEKMISDAIPELKASIKKGEDFVKTLK,True,False,False,P40926,"[('cd01337', 'Glyoxysomal and mitochondrial malate dehydrogenases'), ('G3DSA:3.40.50.720', 'NAD(P)-binding Rossmann-like Domain'), ('G3DSA:3.90.110.10', 'Lactate dehydrogenase/glycoside hydrolase, family 4, C-terminal'), ('IPR001236', 'Lactate/malate dehydrogenase, N-terminal'), ('IPR001252', 'Malate dehydrogenase, active site'), ('IPR001557', 'L-lactate/malate dehydrogenase'), ('IPR010097', 'Malate dehydrogenase, type 1'), ('IPR015955', 'Lactate dehydrogenase/glycoside hydrolase, family 4, C-terminal'), ('IPR022383', 'Lactate/malate dehydrogenase, C-terminal'), ('IPR036291', 'NAD(P)-binding domain superfamily'), ('PF00056', 'lactate/malate dehydrogenase, NAD binding domain'), ('PF02866', 'lactate/malate dehydrogenase, alpha/beta C-terminal domain'), ('PIRSF000102', 'L-lactate/malate dehydrogenase'), ('PS00068', 'Malate dehydrogenase active site signature'), ('PTHR11540', 'Malate Dehydrogenase Type 1'), ('SSF51735', 'NAD(P)-binding Rossmann-fold domains'), ('SSF56327', 'LDH C-terminal domain-like'), ('TIGR01772', 'malate dehydrogenase')]",,"""ENSG00000146701; Tissue enhanced (skeletal muscle, tongue)."";","CATALYTIC ACTIVITY: Reaction=(S)-malate + NAD(+) = oxaloacetate + NADH + H(+); Xref=Rhea:RHEA:21432, ChEBI:CHEBI:15378, ChEBI:CHEBI:15589, ChEBI:CHEBI:16452, ChEBI:CHEBI:57540, ChEBI:CHEBI:57945; EC=1.1.1.37; Evidence={ECO:0000269|PubMed:27989324};",1.1.1.37,ACTIVITY REGULATION: Enzyme activity is enhanced by acetylation. {ECO:0000269|PubMed:20167786}.,,ENST00000315758.10 [P40926-1];ENST00000432020.2 [P40926-2];,MDH2,ENSG00000146701,0.0,MDH2,Non-canonical_RBPs,14.0,,,,0.056,,MDH2
P41182,ENSG00000113916,BCL6_HUMAN,actin cytoskeleton organization [GO:0030036]; B cell proliferation [GO:0042100]; cell morphogenesis [GO:0000902]; cell motility [GO:0048870]; cell-matrix adhesion [GO:0007160]; DNA damage response [GO:0006974]; erythrocyte development [GO:0048821]; germinal center formation [GO:0002467]; heterochromatin formation [GO:0031507]; inflammatory response [GO:0006954]; isotype switching to IgE isotypes [GO:0048289]; negative regulation of B cell apoptotic process [GO:0002903]; negative regulation of cell growth [GO:0030308]; negative regulation of cell-matrix adhesion [GO:0001953]; negative regulation of cellular senescence [GO:2000773]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of isotype switching to IgE isotypes [GO:0048294]; negative regulation of mast cell cytokine production [GO:0032764]; negative regulation of mitotic cell cycle DNA replication [GO:1903464]; negative regulation of mononuclear cell proliferation [GO:0032945]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of plasma cell differentiation [GO:1900099]; negative regulation of Rho protein signal transduction [GO:0035024]; negative regulation of T-helper 2 cell differentiation [GO:0045629]; negative regulation of transcription by RNA polymerase II [GO:0000122]; plasma cell differentiation [GO:0002317]; positive regulation of apoptotic process [GO:0043065]; positive regulation of B cell proliferation [GO:0030890]; positive regulation of cell motility [GO:2000147]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of regulatory T cell differentiation [GO:0045591]; protein localization [GO:0008104]; pyramidal neuron differentiation [GO:0021859]; regulation of cell differentiation [GO:0045595]; regulation of cell population proliferation [GO:0042127]; regulation of cytokine production [GO:0001817]; regulation of germinal center formation [GO:0002634]; regulation of immune response [GO:0050776]; regulation of immune system process [GO:0002682]; regulation of inflammatory response [GO:0050727]; regulation of memory T cell differentiation [GO:0043380]; regulation of T cell proliferation [GO:0042129]; Rho protein signal transduction [GO:0007266]; spermatogenesis [GO:0007283]; T-helper 2 cell differentiation [GO:0045064]; transcription by RNA polymerase II [GO:0006366]; type 2 immune response [GO:0042092],Golgi apparatus [GO:0005794]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; paraspeckles [GO:0042382],"chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor binding [GO:0140297]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; identical protein binding [GO:0042802]; intronic transcription regulatory region sequence-specific DNA binding [GO:0001161]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; transcription corepressor binding [GO:0001222]","PTM: Phosphorylated by MAPK1 in response to antigen receptor activation at Ser-333 and Ser-343. Phosphorylated by ATM in response to genotoxic stress. Phosphorylation induces its degradation by ubiquitin/proteasome pathway. {ECO:0000269|PubMed:17828269, ECO:0000269|PubMed:22113614, ECO:0000269|PubMed:9649500}.; PTM: Polyubiquitinated (PubMed:22113614, PubMed:30190310, PubMed:9649500). Polyubiquitinated by SCF(FBXO11), leading to its degradation by the proteasome (PubMed:22113614). Ubiquitinated by the SCF(FBXL17) complex, leading to its degradation by the proteasome: ubiquitination by the SCF(FBXL17) complex takes place when aberrant BTB domain dimers are formed (PubMed:30190310). {ECO:0000269|PubMed:22113614, ECO:0000269|PubMed:30190310, ECO:0000269|PubMed:9649500}.; PTM: Acetylated at Lys-379 by EP300 which inhibits the interaction with NuRD complex and the transcriptional repressor function. Deacetylated by HDAC- and SIR2-dependent pathways. {ECO:0000269|PubMed:12402037, ECO:0000269|PubMed:15454082}.","DOMAIN: The BTB domain mediates homodimerization. Its dimer interface mediates peptide binding such as to corepressors BCOR and NCOR2 (PubMed:18212045). Interaction with corepressors through the BTB domain is needed to facilitate the rapid proliferation and survival of GC B-cells but is not involved in the T(FH) formation and BCL6-mediated suppression of T(H)2 and T(H)17 differentiationrequired for GC formation (By similarity). {ECO:0000250, ECO:0000269|PubMed:18212045}.","DOMAIN 32..99; /note=""BTB""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00037""","STRAND 8..10; /evidence=""ECO:0007829|PDB:6C3L""; STRAND 34..38; /evidence=""ECO:0007829|PDB:7LWE""; STRAND 41..45; /evidence=""ECO:0007829|PDB:7LWE""; STRAND 70..73; /evidence=""ECO:0007829|PDB:7LWE""; STRAND 93..95; /evidence=""ECO:0007829|PDB:7LWG""; STRAND 521..523; /evidence=""ECO:0007829|PDB:2YRM""; STRAND 527..529; /evidence=""ECO:0007829|PDB:2YRM""; STRAND 573..575; /evidence=""ECO:0007829|PDB:2LCE""; STRAND 582..584; /evidence=""ECO:0007829|PDB:2LCE""; STRAND 601..603; /evidence=""ECO:0007829|PDB:2EN2""; STRAND 610..613; /evidence=""ECO:0007829|PDB:2EN2""; STRAND 633..635; /evidence=""ECO:0007829|PDB:2EOS""; STRAND 639..641; /evidence=""ECO:0007829|PDB:2EOS""","HELIX 5..7; /evidence=""ECO:0007829|PDB:7LWE""; HELIX 14..27; /evidence=""ECO:0007829|PDB:7LWE""; HELIX 47..53; /evidence=""ECO:0007829|PDB:7LWE""; HELIX 55..62; /evidence=""ECO:0007829|PDB:7LWE""; HELIX 80..92; /evidence=""ECO:0007829|PDB:7LWE""; HELIX 102..112; /evidence=""ECO:0007829|PDB:7LWE""; HELIX 115..127; /evidence=""ECO:0007829|PDB:7LWE""; HELIX 530..540; /evidence=""ECO:0007829|PDB:2YRM""; HELIX 558..568; /evidence=""ECO:0007829|PDB:2LCE""; HELIX 586..596; /evidence=""ECO:0007829|PDB:2LCE""; HELIX 614..620; /evidence=""ECO:0007829|PDB:2EN2""; HELIX 622..625; /evidence=""ECO:0007829|PDB:2EN2""; HELIX 642..648; /evidence=""ECO:0007829|PDB:2EOS""","TURN 29..31; /evidence=""ECO:0007829|PDB:3E4U""; TURN 64..68; /evidence=""ECO:0007829|PDB:7LWE""; TURN 99..101; /evidence=""ECO:0007829|PDB:7LWE""; TURN 577..579; /evidence=""ECO:0007829|PDB:2LCE""; TURN 605..607; /evidence=""ECO:0007829|PDB:2EN2""; TURN 649..652; /evidence=""ECO:0007829|PDB:2EOS""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,BCL6 BCL5 LAZ3 ZBTB27 ZNF51,B-cell lymphoma 6 protein (BCL-6) (B-cell lymphoma 5 protein) (BCL-5) (Protein LAZ-3) (Zinc finger and BTB domain-containing protein 27) (Zinc finger protein 51),Homo sapiens (Human),706.0,78846.0,MASPADSCIQFTRHASDVLLNLNRLRSRDILTDVVIVVSREQFRAHKTVLMACSGLFYSIFTDQLKCNLSVINLDPEINPEGFCILLDFMYTSRLNLREGNIMAVMATAMYLQMEHVVDTCRKFIKASEAEMVSAIKPPREEFLNSRMLMPQDIMAYRGREVVENNLPLRSAPGCESRAFAPSLYSGLSTPPASYSMYSHLPVSSLLFSDEEFRDVRMPVANPFPKERALPCDSARPVPGEYSRPTLEVSPNVCHSNIYSPKETIPEEARSDMHYSVAEGLKPAAPSARNAPYFPCDKASKEEERPSSEDEIALHFEPPNAPLNRKGLVSPQSPQKSDCQPNSPTESCSSKNACILQASGSPPAKSPTDPKACNWKKYKFIVLNSLNQNAKPEGPEQAELGRLSPRAYTAPPACQPPMEPENLDLQSPTKLSASGEDSTIPQASRLNNIVNRSMTGSPRSSSESHSPLYMHPPKCTSCGSQSPQHAEMCLHTAGPTFPEEMGETQSEYSDSSCENGAFFCNECDCRFSEEASLKRHTLQTHSDKPYKCDRCQASFRYKGNLASHKTVHTGEKPYRCNICGAQFNRPANLKTHTRIHSGEKPYKCETCGARFVQVAHLRAHVLIHTGEKPYPCEICGTRFRHLQTLKSHLRIHTGEKPYHCEKCNLHFRHKSQLRLHLRQKHGAITNTKVQYRVSATDLPPELPKAC,True,False,False,P41182,"[('cd18331', 'BTB (Broad-Complex, Tramtrack and Bric a brac)/POZ (poxvirus and zinc finger) domain found in B-cell lymphoma 6 protein (BCL-6)'), ('G3DSA:3.30.160.60', 'Classic Zinc Finger'), ('G3DSA:3.30.710.10', 'Potassium Channel Kv1.1; Chain A'), ('IPR000210', 'BTB/POZ domain'), ('IPR011333', 'SKP1/BTB/POZ domain superfamily'), ('IPR013087', 'Zinc finger C2H2-type'), ('IPR036236', 'Zinc finger C2H2 superfamily'), ('PF00096', 'Zinc finger, C2H2 type'), ('PF00651', 'BTB/POZ domain'), ('PS00028', 'Zinc finger C2H2 type domain signature'), ('PS50097', 'BTB domain profile'), ('PS50157', 'Zinc finger C2H2 type domain profile'), ('PTHR24394', 'Krppel C2H2-type zinc-finger'), ('SM00225', 'Broad-Complex, Tramtrack and Bric a brac'), ('SM00355', 'zinc finger'), ('SSF54695', 'POZ domain'), ('SSF57667', 'beta-beta-alpha zinc fingers')]",,"""ENSG00000113916; Tissue enhanced (skeletal)."";",,,,,ENST00000232014.8 [P41182-1];ENST00000406870.7 [P41182-1];ENST00000450123.6 [P41182-2];ENST00000621333.4 [P41182-2];,BCL6,ENSG00000113916,0.0,BCL6,Canonical_RBPs,0.0,,,,0.589,0.133,BCL6
P41250,ENSG00000106105,GARS_HUMAN,diadenosine tetraphosphate biosynthetic process [GO:0015966]; mitochondrial glycyl-tRNA aminoacylation [GO:0070150]; tRNA aminoacylation for protein translation [GO:0006418],axon [GO:0030424]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; secretory granule [GO:0030141],ATP binding [GO:0005524]; ATP:ATP adenylyltransferase activity [GO:0141192]; bis(5'-nucleosyl)-tetraphosphatase (asymmetrical) activity [GO:0004081]; glycine-tRNA ligase activity [GO:0004820]; identical protein binding [GO:0042802]; protein dimerization activity [GO:0046983],,,"DOMAIN 63..119; /note=""WHEP-TRS""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00531""","STRAND 133..136; /evidence=""ECO:0007829|PDB:2ZT5""; STRAND 148..150; /evidence=""ECO:0007829|PDB:2ZT5""; STRAND 182..185; /evidence=""ECO:0007829|PDB:2ZT5""; STRAND 199..208; /evidence=""ECO:0007829|PDB:2ZT5""; STRAND 211..213; /evidence=""ECO:0007829|PDB:2ZT5""; STRAND 229..231; /evidence=""ECO:0007829|PDB:2Q5I""; STRAND 266..268; /evidence=""ECO:0007829|PDB:2ZT5""; STRAND 276..279; /evidence=""ECO:0007829|PDB:2ZT5""; STRAND 283..285; /evidence=""ECO:0007829|PDB:2ZT5""; STRAND 287..296; /evidence=""ECO:0007829|PDB:2ZT5""; STRAND 298..300; /evidence=""ECO:0007829|PDB:2ZXF""; STRAND 321..330; /evidence=""ECO:0007829|PDB:2ZT5""; STRAND 344..355; /evidence=""ECO:0007829|PDB:2ZT5""; STRAND 372..376; /evidence=""ECO:0007829|PDB:2ZT5""; STRAND 388..391; /evidence=""ECO:0007829|PDB:2ZT5""; STRAND 400..402; /evidence=""ECO:0007829|PDB:2PME""; STRAND 427..431; /evidence=""ECO:0007829|PDB:2ZT5""; STRAND 442..451; /evidence=""ECO:0007829|PDB:2ZT5""; STRAND 454..462; /evidence=""ECO:0007829|PDB:2ZT5""; STRAND 482..484; /evidence=""ECO:0007829|PDB:2ZT5""; STRAND 541..544; /evidence=""ECO:0007829|PDB:4KQE""; STRAND 547..550; /evidence=""ECO:0007829|PDB:4KQE""; STRAND 552..554; /evidence=""ECO:0007829|PDB:4KQE""; STRAND 562..564; /evidence=""ECO:0007829|PDB:2PMF""; STRAND 568..570; /evidence=""ECO:0007829|PDB:2ZT5""; STRAND 573..580; /evidence=""ECO:0007829|PDB:2ZT5""; STRAND 593..595; /evidence=""ECO:0007829|PDB:2ZT5""; STRAND 597..600; /evidence=""ECO:0007829|PDB:4KQE""; STRAND 603..605; /evidence=""ECO:0007829|PDB:2ZT5""; STRAND 615..621; /evidence=""ECO:0007829|PDB:2ZT5""; STRAND 645..647; /evidence=""ECO:0007829|PDB:2ZT5""; STRAND 650..652; /evidence=""ECO:0007829|PDB:5E6M""; STRAND 668..672; /evidence=""ECO:0007829|PDB:2ZT5""; STRAND 679..681; /evidence=""ECO:0007829|PDB:2ZT5""; STRAND 683..688; /evidence=""ECO:0007829|PDB:2ZT5""; STRAND 694..698; /evidence=""ECO:0007829|PDB:2ZT5""; STRAND 712..714; /evidence=""ECO:0007829|PDB:4KR3""","HELIX 65..80; /evidence=""ECO:0007829|PDB:5E6M""; HELIX 95..112; /evidence=""ECO:0007829|PDB:5E6M""; HELIX 121..130; /evidence=""ECO:0007829|PDB:2ZT5""; HELIX 139..141; /evidence=""ECO:0007829|PDB:2ZT5""; HELIX 152..168; /evidence=""ECO:0007829|PDB:2ZT5""; HELIX 170..173; /evidence=""ECO:0007829|PDB:2ZT5""; HELIX 186..191; /evidence=""ECO:0007829|PDB:2ZT5""; HELIX 194..197; /evidence=""ECO:0007829|PDB:2ZT5""; HELIX 214..227; /evidence=""ECO:0007829|PDB:2ZT5""; HELIX 233..243; /evidence=""ECO:0007829|PDB:2ZT5""; HELIX 251..260; /evidence=""ECO:0007829|PDB:2ZT5""; HELIX 301..305; /evidence=""ECO:0007829|PDB:2ZT5""; HELIX 308..314; /evidence=""ECO:0007829|PDB:2ZT5""; HELIX 339..341; /evidence=""ECO:0007829|PDB:2ZT5""; HELIX 357..359; /evidence=""ECO:0007829|PDB:4KQE""; HELIX 365..367; /evidence=""ECO:0007829|PDB:2ZT5""; HELIX 378..382; /evidence=""ECO:0007829|PDB:2ZT5""; HELIX 392..397; /evidence=""ECO:0007829|PDB:2ZT5""; HELIX 404..420; /evidence=""ECO:0007829|PDB:2ZT5""; HELIX 424..426; /evidence=""ECO:0007829|PDB:2ZT5""; HELIX 434..436; /evidence=""ECO:0007829|PDB:2ZT5""; HELIX 467..476; /evidence=""ECO:0007829|PDB:2ZT5""; HELIX 501..507; /evidence=""ECO:0007829|PDB:4KQE""; HELIX 512..519; /evidence=""ECO:0007829|PDB:4KQE""; HELIX 524..535; /evidence=""ECO:0007829|PDB:4KQE""; HELIX 581..592; /evidence=""ECO:0007829|PDB:2ZT5""; HELIX 628..640; /evidence=""ECO:0007829|PDB:2ZT5""; HELIX 654..663; /evidence=""ECO:0007829|PDB:2ZT5""; HELIX 674..677; /evidence=""ECO:0007829|PDB:2ZT5""; HELIX 702..710; /evidence=""ECO:0007829|PDB:2ZT5""; HELIX 716..722; /evidence=""ECO:0007829|PDB:2ZT5""","TURN 62..64; /evidence=""ECO:0007829|PDB:5E6M""; TURN 81..83; /evidence=""ECO:0007829|PDB:5E6M""; TURN 244..248; /evidence=""ECO:0007829|PDB:2ZT5""; TURN 315..317; /evidence=""ECO:0007829|PDB:2ZT5""; TURN 368..370; /evidence=""ECO:0007829|PDB:2ZT5""; TURN 565..567; /evidence=""ECO:0007829|PDB:2PMF""; TURN 609..611; /evidence=""ECO:0007829|PDB:2ZT5""; TURN 625..627; /evidence=""ECO:0007829|PDB:2ZT5""; TURN 689..691; /evidence=""ECO:0007829|PDB:2ZT5""; TURN 699..701; /evidence=""ECO:0007829|PDB:2ZT5""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,GARS1 GARS,Glycine--tRNA ligase (EC 6.1.1.14) (Diadenosine tetraphosphate synthetase) (Ap4A synthetase) (EC 2.7.7.-) (Glycyl-tRNA synthetase) (GlyRS) (Glycyl-tRNA synthetase 1),Homo sapiens (Human),739.0,83166.0,MPSPRPVLLRGARAALLLLLPPRLLARPSLLLRRSLSAASCPPISLPAAASRSSMDGAGAEEVLAPLRLAVRQQGDLVRKLKEDKAPQVDVDKAVAELKARKRVLEAKELALQPKDDIVDRAKMEDTLKRRFFYDQAFAIYGGVSGLYDFGPVGCALKNNIIQTWRQHFIQEEQILEIDCTMLTPEPVLKTSGHVDKFADFMVKDVKNGECFRADHLLKAHLQKLMSDKKCSVEKKSEMESVLAQLDNYGQQELADLFVNYNVKSPITGNDLSPPVSFNLMFKTFIGPGGNMPGYLRPETAQGIFLNFKRLLEFNQGKLPFAAAQIGNSFRNEISPRSGLIRVREFTMAEIEHFVDPSEKDHPKFQNVADLHLYLYSAKAQVSGQSARKMRLGDAVEQGVINNTVLGYFIGRIYLYLTKVGISPDKLRFRQHMENEMAHYACDCWDAESKTSYGWIEIVGCADRSCYDLSCHARATKVPLVAEKPLKEPKTVNVVQFEPSKGAIGKAYKKDAKLVMEYLAICDECYITEMEMLLNEKGEFTIETEGKTFQLTKDMINVKRFQKTLYVEEVVPNVIEPSFGLGRIMYTVFEHTFHVREGDEQRTFFSFPAVVAPFKCSVLPLSQNQEFMPFVKELSEALTRHGVSHKVDDSSGSIGRRYARTDEIGVAFGVTIDFDTVNKTPHTATLRDRDSMRQIRAEISELPSIVQDLANGNITWADVEARYPLFEGQETGKKETIEE,False,True,False,P41250,"[('cd00774', 'GlyRS-like_core'), ('cd00858', 'GlyRS_anticodon'), ('cd00935', 'GlyRS_RNA'), ('G3DSA:1.10.287.10', 'S15/NS1, RNA-binding'), ('G3DSA:3.30.40.230', None), ('G3DSA:3.30.720.200', None), ('G3DSA:3.30.930.10', 'Bira Bifunctional Protein; Domain 2'), ('G3DSA:3.40.50.800', 'Anticodon-binding domain'), ('IPR000738', 'WHEP-TRS domain'), ('IPR002314', 'Aminoacyl-tRNA synthetase, class II (G/ P/ S/T)'), ('IPR002315', 'Glycyl-tRNA synthetase'), ('IPR004154', 'Anticodon-binding'), ('IPR006195', 'Aminoacyl-tRNA synthetase, class II'), ('IPR009068', 'uS15/NS1, RNA-binding domain superfamily'), ('IPR027031', 'Glycyl-tRNA synthetase/DNA polymerase subunit gamma-2'), ('IPR033731', 'Glycyl-tRNA synthetase-like core domain'), ('IPR036621', 'Anticodon-binding domain superfamily'), ('IPR045864', 'Class II Aminoacyl-tRNA synthetase/Biotinyl protein ligase (BPL) and lipoyl protein ligase (LPL)'), ('PF00458', 'WHEP-TRS domain'), ('PF00587', 'tRNA synthetase class II core domain (G, H, P, S and T)')]",,"""ENSG00000106105; Low tissue specificity."";","CATALYTIC ACTIVITY: Reaction=tRNA(Gly) + glycine + ATP = glycyl-tRNA(Gly) + AMP + diphosphate; Xref=Rhea:RHEA:16013, Rhea:RHEA-COMP:9664, Rhea:RHEA-COMP:9683, ChEBI:CHEBI:30616, ChEBI:CHEBI:33019, ChEBI:CHEBI:57305, ChEBI:CHEBI:78442, ChEBI:CHEBI:78522, ChEBI:CHEBI:456215; EC=6.1.1.14; Evidence={ECO:0000269|PubMed:17544401, ECO:0000269|PubMed:24898252, ECO:0000269|PubMed:28675565}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:16014; Evidence={ECO:0000305|PubMed:24898252}; CATALYTIC ACTIVITY: Reaction=2 ATP + H(+) = P(1),P(4)-bis(5'-adenosyl) tetraphosphate + diphosphate; Xref=Rhea:RHEA:34935, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616, ChEBI:CHEBI:33019, ChEBI:CHEBI:58141; Evidence={ECO:0000269|PubMed:19710017}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:34936; Evidence={ECO:0000305|PubMed:19710017};",2.7.7.-; 6.1.1.14,"ACTIVITY REGULATION: Ap4A synthesis is inhibited by tRNA, via the disruption of the second ATP-binding site by direct blocking and/or by tRNA-induced conformational change. {ECO:0000269|PubMed:19710017}.",,ENST00000389266.8 [P41250-1];,GARS1,ENSG00000106105,0.0,GARS1,Canonical_RBPs,13.0,,,,0.096,,GARS1
P42566,ENSG00000085832,EPS15_HUMAN,clathrin coat assembly [GO:0048268]; endocytic recycling [GO:0032456]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; Golgi to endosome transport [GO:0006895]; positive regulation of receptor recycling [GO:0001921]; postsynaptic neurotransmitter receptor internalization [GO:0098884]; protein transport [GO:0015031]; receptor-mediated endocytosis of virus by host cell [GO:0019065]; regulation of cell population proliferation [GO:0042127]; symbiont entry into host cell [GO:0046718]; vesicle organization [GO:0016050],aggresome [GO:0016235]; apical plasma membrane [GO:0016324]; basal plasma membrane [GO:0009925]; clathrin coat of coated pit [GO:0030132]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; glutamatergic synapse [GO:0098978]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; plasma membrane [GO:0005886]; postsynaptic endocytic zone [GO:0098843],cadherin binding [GO:0045296]; calcium ion binding [GO:0005509]; polyubiquitin modification-dependent protein binding [GO:0031593]; SH3 domain binding [GO:0017124],"PTM: Phosphorylation on Tyr-849 is involved in the internalization of EGFR. Not required for membrane translocation after EGF treatment or for targeting to coated pits, but essential for a subsequent step in EGFR endocytosis (By similarity). Phosphorylated on serine upon DNA damage, probably by ATM or ATR. {ECO:0000250}.; PTM: Ubiquitinated. {ECO:0000250|UniProtKB:P42567}.","DOMAIN: The EH domain interacts with Asn-Pro-Phe (NPF) motifs of target proteins. {ECO:0000269|PubMed:11062555}.; DOMAIN: The UIM (ubiquitin-interacting motif) repeats specifically bind 'Lys-33'-linked ubiquitin. {ECO:0000269|PubMed:11062555, ECO:0000269|PubMed:24768539}.","DOMAIN 15..104; /note=""EH 1""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00077""; DOMAIN 48..83; /note=""EF-hand 1""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00448""; DOMAIN 128..216; /note=""EH 2""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00077""; DOMAIN 160..195; /note=""EF-hand 2""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00448""; DOMAIN 223..258; /note=""EF-hand 3""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00448""; DOMAIN 224..314; /note=""EH 3""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00077""; DOMAIN 262..292; /note=""EF-hand 4""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00448""; DOMAIN 851..870; /note=""UIM 1""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00213""; DOMAIN 877..896; /note=""UIM 2""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00213""","STRAND 142..144; /evidence=""ECO:0007829|PDB:1EH2""; STRAND 145..147; /evidence=""ECO:0007829|PDB:2JXC""; STRAND 177..179; /evidence=""ECO:0007829|PDB:1EH2""; STRAND 240..243; /evidence=""ECO:0007829|PDB:1C07""; STRAND 274..278; /evidence=""ECO:0007829|PDB:1C07""","HELIX 126..136; /evidence=""ECO:0007829|PDB:1EH2""; HELIX 148..156; /evidence=""ECO:0007829|PDB:1EH2""; HELIX 162..172; /evidence=""ECO:0007829|PDB:1EH2""; HELIX 182..197; /evidence=""ECO:0007829|PDB:1EH2""; HELIX 212..214; /evidence=""ECO:0007829|PDB:1F8H""; HELIX 223..235; /evidence=""ECO:0007829|PDB:1C07""; HELIX 245..253; /evidence=""ECO:0007829|PDB:1C07""; HELIX 259..269; /evidence=""ECO:0007829|PDB:1C07""; HELIX 282..293; /evidence=""ECO:0007829|PDB:1C07""; HELIX 723..726; /evidence=""ECO:0007829|PDB:2IV9""","TURN 157..159; /evidence=""ECO:0007829|PDB:1EH2""; TURN 207..209; /evidence=""ECO:0007829|PDB:1EH2""; TURN 254..256; /evidence=""ECO:0007829|PDB:1C07""; TURN 279..281; /evidence=""ECO:0007829|PDB:1C07""; TURN 305..307; /evidence=""ECO:0007829|PDB:1C07""; TURN 624..627; /evidence=""ECO:0007829|PDB:5JP2""; TURN 630..633; /evidence=""ECO:0007829|PDB:5JP2""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,EPS15 AF1P,Epidermal growth factor receptor substrate 15 (Protein Eps15) (Protein AF-1p),Homo sapiens (Human),896.0,98656.0,MAAAAQLSLTQLSSGNPVYEKYYRQVDTGNTGRVLASDAAAFLKKSGLPDLILGKIWDLADTDGKGILNKQEFFVALRLVACAQNGLEVSLSSLNLAVPPPRFHDTSSPLLISGTSAAELPWAVKPEDKAKYDAIFDSLSPVNGFLSGDKVKPVLLNSKLPVDILGRVWELSDIDHDGMLDRDEFAVAMFLVYCALEKEPVPMSLPPALVPPSKRKTWVVSPAEKAKYDEIFLKTDKDMDGFVSGLEVREIFLKTGLPSTLLAHIWSLCDTKDCGKLSKDQFALAFHLISQKLIKGIDPPHVLTPEMIPPSDRASLQKNIIGSSPVADFSAIKELDTLNNEIVDLQREKNNVEQDLKEKEDTIKQRTSEVQDLQDEVQRENTNLQKLQAQKQQVQELLDELDEQKAQLEEQLKEVRKKCAEEAQLISSLKAELTSQESQISTYEEELAKAREELSRLQQETAELEESVESGKAQLEPLQQHLQDSQQEISSMQMKLMEMKDLENHNSQLNWCSSPHSILVNGATDYCSLSTSSSETANLNEHVEGQSNLESEPIHQESPARSSPELLPSGVTDENEVTTAVTEKVCSELDNNRHSKEEDPFNVDSSSLTGPVADTNLDFFQSDPFVGSDPFKDDPFGKIDPFGGDPFKGSDPFASDCFFRQSTDPFATSSTDPFSAANNSSITSVETLKHNDPFAPGGTVVAASDSATDPFASVFGNESFGGGFADFSTLSKVNNEDPFRSATSSSVSNVVITKNVFEETSVKSEDEPPALPPKIGTPTRPCPLPPGKRSINKLDSPDPFKLNDPFQPFPGNDSPKEKDPEIFCDPFTSATTTTNKEADPSNFANFSAYPSEEDMIEWAKRESEREEEQRLARLNQQEQEDLELAIALSKSEISEA,False,True,True,P42566,"[('cd00052', 'EH'), ('G3DSA:1.10.238.10', 'EF-hand'), ('G3DSA:1.10.287.1490', None), ('IPR000261', 'EH domain'), ('IPR002048', 'EF-hand domain'), ('IPR003903', 'Ubiquitin interacting motif'), ('IPR011992', 'EF-hand domain pair'), ('IPR018247', 'EF-Hand 1, calcium-binding site'), ('PF12763', 'Cytoskeletal-regulatory complex EF hand'), ('PS00018', 'EF-hand calcium-binding domain'), ('PS50031', 'EH domain profile'), ('PS50222', 'EF-hand calcium-binding domain profile'), ('PS50330', 'Ubiquitin-interacting motif (UIM) domain profile'), ('PTHR11216', 'PAN1/END3 actin cytoskeleton-regulatory complex'), ('SM00027', 'Eps15 homology domain'), ('SM00054', 'EF-hand, calcium binding motif'), ('SM00726', 'Ubiquitin-interacting motif.'), ('SSF47473', 'EF-hand'), ('SSF90257', 'Myosin rod fragments')]",P42566;,"""ENSG00000085832; Low tissue specificity."";",,,,,ENST00000371733.8 [P42566-1];ENST00000493793.2 [P42566-2];,EPS15,ENSG00000085832,0.0,,,,,,,0.501,0.172,EPS15
P42684,ENSG00000143322,ABL2_HUMAN,cell adhesion [GO:0007155]; cellular response to retinoic acid [GO:0071300]; epidermal growth factor receptor signaling pathway [GO:0007173]; exploration behavior [GO:0035640]; negative regulation of Rho protein signal transduction [GO:0035024]; peptidyl-tyrosine phosphorylation [GO:0018108]; phospholipase C-activating G protein-coupled receptor signaling pathway [GO:0007200]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of establishment of T cell polarity [GO:1903905]; positive regulation of neuron projection development [GO:0010976]; positive regulation of oxidoreductase activity [GO:0051353]; positive regulation of T cell migration [GO:2000406]; protein modification process [GO:0036211]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of autophagy [GO:0010506]; regulation of cell adhesion [GO:0030155]; regulation of cell motility [GO:2000145]; regulation of endocytosis [GO:0030100]; signal transduction [GO:0007165],actin cytoskeleton [GO:0015629]; cytosol [GO:0005829]; plasma membrane [GO:0005886],actin filament binding [GO:0051015]; actin monomer binding [GO:0003785]; ATP binding [GO:0005524]; magnesium ion binding [GO:0000287]; manganese ion binding [GO:0030145]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; phosphotyrosine residue binding [GO:0001784]; protein kinase activity [GO:0004672]; protein tyrosine kinase activity [GO:0004713],PTM: Phosphorylated at Tyr-261 by ABL1 in response to oxidative stress. Phosphorylated by PDGFRB (By similarity). {ECO:0000250}.; PTM: Polyubiquitinated. Polyubiquitination of ABL2 leads to degradation. {ECO:0000269|PubMed:15735735}.,"DOMAIN: Contains two distinct classes of F-actin-binding domains. Although both can bind F-actin, the 2 are required to bundle actin filaments (By similarity). {ECO:0000250}.","DOMAIN 107..167; /note=""SH3""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00192""; DOMAIN 173..263; /note=""SH2""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00191""; DOMAIN 288..539; /note=""Protein kinase""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00159""","STRAND 111..116; /evidence=""ECO:0007829|PDB:5NP5""; STRAND 133..139; /evidence=""ECO:0007829|PDB:5NP5""; STRAND 141..150; /evidence=""ECO:0007829|PDB:5NP5""; STRAND 153..158; /evidence=""ECO:0007829|PDB:5NP5""; STRAND 162..164; /evidence=""ECO:0007829|PDB:5NP5""; STRAND 174..177; /evidence=""ECO:0007829|PDB:4EIH""; STRAND 194..199; /evidence=""ECO:0007829|PDB:4EIH""; STRAND 207..213; /evidence=""ECO:0007829|PDB:4EIH""; STRAND 216..221; /evidence=""ECO:0007829|PDB:4EIH""; STRAND 226..228; /evidence=""ECO:0007829|PDB:2ECD""; STRAND 230..233; /evidence=""ECO:0007829|PDB:4EIH""; STRAND 236..240; /evidence=""ECO:0007829|PDB:4EIH""; STRAND 255..257; /evidence=""ECO:0007829|PDB:4EIH""; STRAND 280..282; /evidence=""ECO:0007829|PDB:3GVU""; STRAND 288..293; /evidence=""ECO:0007829|PDB:3HMI""; STRAND 300..307; /evidence=""ECO:0007829|PDB:3HMI""; STRAND 312..318; /evidence=""ECO:0007829|PDB:3HMI""; STRAND 347..351; /evidence=""ECO:0007829|PDB:3HMI""; STRAND 353..356; /evidence=""ECO:0007829|PDB:3HMI""; STRAND 358..362; /evidence=""ECO:0007829|PDB:3HMI""; STRAND 415..417; /evidence=""ECO:0007829|PDB:3HMI""; STRAND 423..425; /evidence=""ECO:0007829|PDB:3HMI""; STRAND 435..437; /evidence=""ECO:0007829|PDB:2XYN""; STRAND 438..440; /evidence=""ECO:0007829|PDB:3GVU""; STRAND 1155..1158; /evidence=""ECO:0007829|PDB:2KK1""","HELIX 159..161; /evidence=""ECO:0007829|PDB:5NP5""; HELIX 168..170; /evidence=""ECO:0007829|PDB:4EIH""; HELIX 180..187; /evidence=""ECO:0007829|PDB:4EIH""; HELIX 241..248; /evidence=""ECO:0007829|PDB:4EIH""; HELIX 285..287; /evidence=""ECO:0007829|PDB:3HMI""; HELIX 294..297; /evidence=""ECO:0007829|PDB:3HMI""; HELIX 308..310; /evidence=""ECO:0007829|PDB:3HMI""; HELIX 326..337; /evidence=""ECO:0007829|PDB:3HMI""; HELIX 369..375; /evidence=""ECO:0007829|PDB:3HMI""; HELIX 383..402; /evidence=""ECO:0007829|PDB:3HMI""; HELIX 412..414; /evidence=""ECO:0007829|PDB:3HMI""; HELIX 419..421; /evidence=""ECO:0007829|PDB:3HMI""; HELIX 449..451; /evidence=""ECO:0007829|PDB:3HMI""; HELIX 454..459; /evidence=""ECO:0007829|PDB:3HMI""; HELIX 464..479; /evidence=""ECO:0007829|PDB:3HMI""; HELIX 491..493; /evidence=""ECO:0007829|PDB:3HMI""; HELIX 494..499; /evidence=""ECO:0007829|PDB:3HMI""; HELIX 512..521; /evidence=""ECO:0007829|PDB:3HMI""; HELIX 526..528; /evidence=""ECO:0007829|PDB:3HMI""; HELIX 532..545; /evidence=""ECO:0007829|PDB:3HMI""; HELIX 1069..1071; /evidence=""ECO:0007829|PDB:2KK1""; HELIX 1080..1083; /evidence=""ECO:0007829|PDB:2KK1""; HELIX 1086..1099; /evidence=""ECO:0007829|PDB:2KK1""; HELIX 1106..1123; /evidence=""ECO:0007829|PDB:2KK1""; HELIX 1124..1126; /evidence=""ECO:0007829|PDB:2KK1""; HELIX 1130..1152; /evidence=""ECO:0007829|PDB:2KK1""; HELIX 1165..1181; /evidence=""ECO:0007829|PDB:2KK1""","TURN 378..380; /evidence=""ECO:0007829|PDB:3HMI""; TURN 1076..1078; /evidence=""ECO:0007829|PDB:2KK1""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,ABL2 ABLL ARG,Tyrosine-protein kinase ABL2 (EC 2.7.10.2) (Abelson murine leukemia viral oncogene homolog 2) (Abelson tyrosine-protein kinase 2) (Abelson-related gene protein) (Tyrosine-protein kinase ARG),Homo sapiens (Human),1182.0,128343.0,MGQQVGRVGEAPGLQQPQPRGIRGSSAARPSGRRRDPAGRTTETGFNIFTQHDHFASCVEDGFEGDKTGGSSPEALHRPYGCDVEPQALNEAIRWSSKENLLGATESDPNLFVALYDFVASGDNTLSITKGEKLRVLGYNQNGEWSEVRSKNGQGWVPSNYITPVNSLEKHSWYHGPVSRSAAEYLLSSLINGSFLVRESESSPGQLSISLRYEGRVYHYRINTTADGKVYVTAESRFSTLAELVHHHSTVADGLVTTLHYPAPKCNKPTVYGVSPIHDKWEMERTDITMKHKLGGGQYGEVYVGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTLEPPFYIVTEYMPYGNLLDYLRECNREEVTAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHVVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYDLLEKGYRMEQPEGCPPKVYELMRACWKWSPADRPSFAETHQAFETMFHDSSISEEVAEELGRAASSSSVVPYLPRLPILPSKTRTLKKQVENKENIEGAQDATENSASSLAPGFIRGAQASSGSPALPRKQRDKSPSSLLEDAKETCFTRDRKGGFFSSFMKKRNAPTPPKRSSSFREMENQPHKKYELTGNFSSVASLQHADGFSFTPAQQEANLVPPKCYGGSFAQRNLCNDDGGGGGGSGTAGGGWSGITGFFTPRLIKKTLGLRAGKPTASDDTSKPFPRSNSTSSMSSGLPEQDRMAMTLPRNCQRSKLQLERTVSTSSQPEENVDRANDMLPKKSEESAAPSRERPKAKLLPRGATALPLRTPSGDLAITEKDPPGVGVAGVAAAPKGKEKNGGARLGMAGVPEDGEQPGWPSPAKAAPVLPTTHNHKVPVLISPTLKHTPADVQLIGTDSQGNKFKLLSEHQVTSSGDKDRPRRVKPKCAPPPPPVMRLLQHPSICSDPTEEPTALTAGQSTSETQEGGKKAALGAVPISGKAGRPVMPPPQVPLPTSSISPAKMANGTAGTKVALRKTKQAAEKISADKISKEALLECADLLSSALTEPVPNSQLVDTGHQLLDYCSGYVDCIPQTRNKFAFREAVSKLELSLQELQVSSAAAGVPGTNPVLNNLLSCVQEISDVVQR,False,False,True,P42684,"[('cd05052', 'Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase'), ('cd09935', 'Src homology 2 (SH2) domain found in Abelson murine lymphosarcoma virus (ABL) proteins'), ('cd11850', 'Src homology 3 domain of the Protein Tyrosine Kinase, Abelson kinase'), ('G3DSA:1.10.510.10', 'Transferase(Phosphotransferase) domain 1'), ('G3DSA:1.20.120.330', 'Nucleotidyltransferases domain 2'), ('G3DSA:2.30.30.40', 'SH3 Domains'), ('G3DSA:3.30.200.20', 'Phosphorylase Kinase; domain 1'), ('G3DSA:3.30.505.10', 'SH2 domain'), ('IPR000719', 'Protein kinase domain'), ('IPR000980', 'SH2 domain'), ('IPR001245', 'Serine-threonine/tyrosine-protein kinase, catalytic domain'), ('IPR001452', 'SH3 domain'), ('IPR008266', 'Tyrosine-protein kinase, active site'), ('IPR011009', 'Protein kinase-like domain superfamily'), ('IPR015015', 'F-actin binding'), ('IPR017441', 'Protein kinase, ATP binding site'), ('IPR020635', 'Tyrosine-protein kinase, catalytic domain'), ('IPR035837', 'Tyrosine-protein kinase ABL, SH2 domain'), ('IPR036028', 'SH3-like domain superfamily'), ('IPR036860', 'SH2 domain superfamily')]",,"""ENSG00000143322; Low tissue specificity."";","CATALYTIC ACTIVITY: Reaction=L-tyrosyl-[protein] + ATP = O-phospho-L-tyrosyl-[protein] + ADP + H(+); Xref=Rhea:RHEA:10596, Rhea:RHEA-COMP:10136, Rhea:RHEA-COMP:10137, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616, ChEBI:CHEBI:46858, ChEBI:CHEBI:82620, ChEBI:CHEBI:456216; EC=2.7.10.2; Evidence={ECO:0000255|PROSITE-ProRule:PRU10028};",2.7.10.2,"ACTIVITY REGULATION: Stabilized in the inactive form by an association between the SH3 domain and the SH2-TK linker region, interactions of the N-terminal cap, and contributions from an N-terminal myristoyl group and phospholipids. Activated by autophosphorylation as well as by SRC-family kinase-mediated phosphorylation. Activated by RIN1 binding to the SH2 and SH3 domains. Inhibited by imatinib mesylate (Gleevec) which is used for the treatment of chronic myeloid leukemia (CML). Phosphatidylinositol 4,5-bisphosphate (PIP2), a highly abundant phosphoinositide known to regulate cytoskeletal and membrane proteins, inhibits the tyrosine kinase activity (By similarity). {ECO:0000250}.",,ENST00000344730.8 [P42684-10];ENST00000367623.8 [P42684-6];ENST00000502732.6 [P42684-1];ENST00000504405.5 [P42684-4];ENST00000507173.5 [P42684-7];ENST00000511413.5 [P42684-5];ENST00000512653.5 [P42684-3];,ABL2,ENSG00000143322,0.0,,,,,,,0.525,0.218,ABL2
P42858,ENSG00000197386,HD_HUMAN,"apoptotic process [GO:0006915]; establishment of mitotic spindle orientation [GO:0000132]; Golgi organization [GO:0007030]; microtubule-based transport [GO:0099111]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; positive regulation of aggrephagy [GO:1905337]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cilium assembly [GO:0045724]; positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity [GO:0031587]; positive regulation of lipophagy [GO:1904504]; positive regulation of mitophagy [GO:1901526]; protein destabilization [GO:0031648]; regulation of CAMKK-AMPK signaling cascade [GO:1905289]; regulation of cAMP-dependent protein kinase activity [GO:2000479]; retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum [GO:0006890]; vesicle transport along microtubule [GO:0047496]; vocal learning [GO:0042297]",autophagosome [GO:0005776]; axon [GO:0030424]; centriole [GO:0005814]; cytoplasm [GO:0005737]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; dendrite [GO:0030425]; early endosome [GO:0005769]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; inclusion body [GO:0016234]; late endosome [GO:0005770]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic cytosol [GO:0099524]; presynaptic cytosol [GO:0099523]; protein-containing complex [GO:0032991],beta-tubulin binding [GO:0048487]; dynactin binding [GO:0034452]; dynein intermediate chain binding [GO:0045505]; heat shock protein binding [GO:0031072]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; p53 binding [GO:0002039]; phosphoprotein phosphatase activity [GO:0004721]; profilin binding [GO:0005522]; transmembrane transporter binding [GO:0044325],"PTM: [Huntingtin]: Cleaved by caspases downstream of the polyglutamine stretch (PubMed:10770929, PubMed:29802276, PubMed:8696339, PubMed:9535906). The resulting N-terminal fragments are cytotoxic and provokes apoptosis (PubMed:10770929). {ECO:0000269|PubMed:10770929, ECO:0000269|PubMed:29802276, ECO:0000269|PubMed:8696339, ECO:0000269|PubMed:9535906}.; PTM: [Huntingtin]: Forms with expanded polyglutamine expansion are specifically ubiquitinated by SYVN1, which promotes their proteasomal degradation. {ECO:0000269|PubMed:17141218}.; PTM: [Huntingtin]: Phosphorylation at Ser-1179 and Ser-1199 by CDK5 in response to DNA damage in nuclei of neurons protects neurons against polyglutamine expansion as well as DNA damage mediated toxicity. {ECO:0000269|PubMed:17611284}.; PTM: [Huntingtin, myristoylated N-terminal fragment]: Myristoylated at Gly-551, following proteolytic cleavage at Asp-550. {ECO:0000269|PubMed:24459296, ECO:0000269|PubMed:29802276}.","DOMAIN: The N-terminal Gln-rich and Pro-rich domain has great conformational flexibility and is likely to exist in a fluctuating equilibrium of alpha-helical, random coil, and extended conformations. {ECO:0000269|PubMed:19748341}.",,"STRAND 13..15; /evidence=""ECO:0007829|PDB:4RAV""; STRAND 139..141; /evidence=""ECO:0007829|PDB:6X9O""; STRAND 281..283; /evidence=""ECO:0007829|PDB:6X9O""; STRAND 302..304; /evidence=""ECO:0007829|PDB:6X9O""; STRAND 397..399; /evidence=""ECO:0007829|PDB:6X9O""; STRAND 676..678; /evidence=""ECO:0007829|PDB:6X9O""; STRAND 696..699; /evidence=""ECO:0007829|PDB:6X9O""; STRAND 732..734; /evidence=""ECO:0007829|PDB:6X9O""; STRAND 1076..1078; /evidence=""ECO:0007829|PDB:6X9O""; STRAND 1467..1469; /evidence=""ECO:0007829|PDB:6X9O""; STRAND 1508..1515; /evidence=""ECO:0007829|PDB:6X9O""; STRAND 1530..1532; /evidence=""ECO:0007829|PDB:6X9O""; STRAND 1663..1665; /evidence=""ECO:0007829|PDB:6X9O""; STRAND 1789..1791; /evidence=""ECO:0007829|PDB:6X9O""; STRAND 1808..1812; /evidence=""ECO:0007829|PDB:6X9O""; STRAND 2192..2194; /evidence=""ECO:0007829|PDB:8SAH""; STRAND 2196..2198; /evidence=""ECO:0007829|PDB:8SAH""; STRAND 2267..2269; /evidence=""ECO:0007829|PDB:6X9O""; STRAND 2386..2388; /evidence=""ECO:0007829|PDB:6X9O""; STRAND 2426..2429; /evidence=""ECO:0007829|PDB:6X9O""; STRAND 2516..2518; /evidence=""ECO:0007829|PDB:6X9O""; STRAND 2537..2542; /evidence=""ECO:0007829|PDB:6X9O""; STRAND 2663..2666; /evidence=""ECO:0007829|PDB:6X9O""; STRAND 2736..2738; /evidence=""ECO:0007829|PDB:6X9O""; STRAND 2757..2760; /evidence=""ECO:0007829|PDB:6X9O""; STRAND 2821..2824; /evidence=""ECO:0007829|PDB:6X9O""; STRAND 3040..3042; /evidence=""ECO:0007829|PDB:6X9O""","HELIX 4..10; /evidence=""ECO:0007829|PDB:4RAV""; HELIX 23..26; /evidence=""ECO:0007829|PDB:3IOT""; HELIX 97..109; /evidence=""ECO:0007829|PDB:6X9O""; HELIX 119..132; /evidence=""ECO:0007829|PDB:6X9O""; HELIX 135..137; /evidence=""ECO:0007829|PDB:6X9O""; HELIX 142..157; /evidence=""ECO:0007829|PDB:6X9O""; HELIX 159..175; /evidence=""ECO:0007829|PDB:6X9O""; HELIX 180..191; /evidence=""ECO:0007829|PDB:6X9O""; HELIX 192..196; /evidence=""ECO:0007829|PDB:6X9O""; HELIX 202..217; /evidence=""ECO:0007829|PDB:6X9O""; HELIX 222..239; /evidence=""ECO:0007829|PDB:6X9O""; HELIX 240..242; /evidence=""ECO:0007829|PDB:6X9O""; HELIX 245..256; /evidence=""ECO:0007829|PDB:6X9O""; HELIX 257..260; /evidence=""ECO:0007829|PDB:6X9O""; HELIX 264..279; /evidence=""ECO:0007829|PDB:6X9O""; HELIX 284..297; /evidence=""ECO:0007829|PDB:6X9O""; HELIX 309..321; /evidence=""ECO:0007829|PDB:6X9O""; HELIX 322..324; /evidence=""ECO:0007829|PDB:6X9O""; HELIX 351..364; /evidence=""ECO:0007829|PDB:6X9O""; HELIX 370..385; /evidence=""ECO:0007829|PDB:6X9O""; HELIX 389..396; /evidence=""ECO:0007829|PDB:6X9O""; HELIX 400..403; /evidence=""ECO:0007829|PDB:6X9O""; HELIX 680..692; /evidence=""ECO:0007829|PDB:6X9O""; HELIX 709..725; /evidence=""ECO:0007829|PDB:6X9O""; HELIX 727..731; /evidence=""ECO:0007829|PDB:6X9O""; HELIX 750..758; /evidence=""ECO:0007829|PDB:6X9O""; HELIX 765..782; /evidence=""ECO:0007829|PDB:6X9O""; HELIX 787..797; /evidence=""ECO:0007829|PDB:6X9O""; HELIX 804..806; /evidence=""ECO:0007829|PDB:6X9O""; HELIX 808..815; /evidence=""ECO:0007829|PDB:6X9O""; HELIX 820..838; /evidence=""ECO:0007829|PDB:6X9O""; HELIX 843..853; /evidence=""ECO:0007829|PDB:6X9O""; HELIX 854..858; /evidence=""ECO:0007829|PDB:6X9O""; HELIX 862..873; /evidence=""ECO:0007829|PDB:6X9O""; HELIX 877..886; /evidence=""ECO:0007829|PDB:6X9O""; HELIX 894..896; /evidence=""ECO:0007829|PDB:6X9O""; HELIX 903..910; /evidence=""ECO:0007829|PDB:6X9O""; HELIX 914..917; /evidence=""ECO:0007829|PDB:6X9O""; HELIX 921..934; /evidence=""ECO:0007829|PDB:6X9O""; HELIX 935..937; /evidence=""ECO:0007829|PDB:6X9O""; HELIX 949..961; /evidence=""ECO:0007829|PDB:6X9O""; HELIX 996..1014; /evidence=""ECO:0007829|PDB:6X9O""; HELIX 1019..1035; /evidence=""ECO:0007829|PDB:6X9O""; HELIX 1065..1074; /evidence=""ECO:0007829|PDB:6X9O""; HELIX 1079..1081; /evidence=""ECO:0007829|PDB:6X9O""; HELIX 1083..1098; /evidence=""ECO:0007829|PDB:6X9O""; HELIX 1101..1103; /evidence=""ECO:0007829|PDB:6X9O""; HELIX 1135..1156; /evidence=""ECO:0007829|PDB:6X9O""; HELIX 1234..1250; /evidence=""ECO:0007829|PDB:6X9O""; HELIX 1262..1277; /evidence=""ECO:0007829|PDB:6X9O""; HELIX 1278..1280; /evidence=""ECO:0007829|PDB:6X9O""; HELIX 1283..1286; /evidence=""ECO:0007829|PDB:6X9O""; HELIX 1290..1300; /evidence=""ECO:0007829|PDB:6X9O""; HELIX 1305..1319; /evidence=""ECO:0007829|PDB:6X9O""; HELIX 1360..1372; /evidence=""ECO:0007829|PDB:6X9O""; HELIX 1422..1425; /evidence=""ECO:0007829|PDB:6X9O""; HELIX 1426..1438; /evidence=""ECO:0007829|PDB:6X9O""; HELIX 1442..1457; /evidence=""ECO:0007829|PDB:6X9O""; HELIX 1462..1465; /evidence=""ECO:0007829|PDB:6X9O""; HELIX 1470..1484; /evidence=""ECO:0007829|PDB:6X9O""; HELIX 1494..1506; /evidence=""ECO:0007829|PDB:6X9O""; HELIX 1517..1529; /evidence=""ECO:0007829|PDB:6X9O""; HELIX 1538..1550; /evidence=""ECO:0007829|PDB:6X9O""; HELIX 1563..1577; /evidence=""ECO:0007829|PDB:6X9O""; HELIX 1582..1598; /evidence=""ECO:0007829|PDB:6X9O""; HELIX 1602..1620; /evidence=""ECO:0007829|PDB:6X9O""; HELIX 1628..1640; /evidence=""ECO:0007829|PDB:6X9O""; HELIX 1643..1646; /evidence=""ECO:0007829|PDB:6X9O""; HELIX 1650..1656; /evidence=""ECO:0007829|PDB:6X9O""; HELIX 1666..1686; /evidence=""ECO:0007829|PDB:6X9O""; HELIX 1689..1698; /evidence=""ECO:0007829|PDB:6X9O""; HELIX 1703..1706; /evidence=""ECO:0007829|PDB:6X9O""; HELIX 1708..1715; /evidence=""ECO:0007829|PDB:6X9O""; HELIX 1736..1756; /evidence=""ECO:0007829|PDB:6X9O""; HELIX 1766..1788; /evidence=""ECO:0007829|PDB:6X9O""; HELIX 1793..1803; /evidence=""ECO:0007829|PDB:6X9O""; HELIX 1815..1823; /evidence=""ECO:0007829|PDB:6X9O""; HELIX 1830..1842; /evidence=""ECO:0007829|PDB:6X9O""; HELIX 1851..1854; /evidence=""ECO:0007829|PDB:6X9O""; HELIX 1889..1908; /evidence=""ECO:0007829|PDB:6X9O""; HELIX 1914..1929; /evidence=""ECO:0007829|PDB:6X9O""; HELIX 1934..1944; /evidence=""ECO:0007829|PDB:6X9O""; HELIX 1947..1958; /evidence=""ECO:0007829|PDB:6X9O""; HELIX 1967..1978; /evidence=""ECO:0007829|PDB:6X9O""; HELIX 1982..1984; /evidence=""ECO:0007829|PDB:6X9O""; HELIX 1987..1994; /evidence=""ECO:0007829|PDB:6X9O""; HELIX 2002..2021; /evidence=""ECO:0007829|PDB:6X9O""; HELIX 2024..2030; /evidence=""ECO:0007829|PDB:6X9O""; HELIX 2033..2045; /evidence=""ECO:0007829|PDB:6X9O""; HELIX 2048..2051; /evidence=""ECO:0007829|PDB:6X9O""; HELIX 2053..2066; /evidence=""ECO:0007829|PDB:6X9O""; HELIX 2097..2108; /evidence=""ECO:0007829|PDB:6X9O""; HELIX 2116..2123; /evidence=""ECO:0007829|PDB:6X9O""; HELIX 2128..2130; /evidence=""ECO:0007829|PDB:6X9O""; HELIX 2142..2144; /evidence=""ECO:0007829|PDB:6X9O""; HELIX 2145..2156; /evidence=""ECO:0007829|PDB:6X9O""; HELIX 2163..2181; /evidence=""ECO:0007829|PDB:6X9O""; HELIX 2201..2208; /evidence=""ECO:0007829|PDB:6X9O""; HELIX 2215..2217; /evidence=""ECO:0007829|PDB:6X9O""; HELIX 2218..2229; /evidence=""ECO:0007829|PDB:6X9O""; HELIX 2232..2234; /evidence=""ECO:0007829|PDB:6X9O""; HELIX 2237..2239; /evidence=""ECO:0007829|PDB:6X9O""; HELIX 2245..2266; /evidence=""ECO:0007829|PDB:6X9O""; HELIX 2272..2285; /evidence=""ECO:0007829|PDB:6X9O""; HELIX 2289..2295; /evidence=""ECO:0007829|PDB:6X9O""; HELIX 2301..2319; /evidence=""ECO:0007829|PDB:6X9O""; HELIX 2354..2368; /evidence=""ECO:0007829|PDB:6X9O""; HELIX 2379..2381; /evidence=""ECO:0007829|PDB:6X9O""; HELIX 2389..2400; /evidence=""ECO:0007829|PDB:6X9O""; HELIX 2403..2409; /evidence=""ECO:0007829|PDB:6X9O""; HELIX 2413..2417; /evidence=""ECO:0007829|PDB:6X9O""; HELIX 2437..2439; /evidence=""ECO:0007829|PDB:6X9O""; HELIX 2443..2456; /evidence=""ECO:0007829|PDB:6X9O""; HELIX 2461..2475; /evidence=""ECO:0007829|PDB:6X9O""; HELIX 2498..2512; /evidence=""ECO:0007829|PDB:6X9O""; HELIX 2543..2562; /evidence=""ECO:0007829|PDB:6X9O""; HELIX 2594..2596; /evidence=""ECO:0007829|PDB:6X9O""; HELIX 2619..2625; /evidence=""ECO:0007829|PDB:6X9O""; HELIX 2668..2680; /evidence=""ECO:0007829|PDB:6X9O""; HELIX 2694..2707; /evidence=""ECO:0007829|PDB:6X9O""; HELIX 2714..2730; /evidence=""ECO:0007829|PDB:6X9O""; HELIX 2739..2752; /evidence=""ECO:0007829|PDB:6X9O""; HELIX 2763..2771; /evidence=""ECO:0007829|PDB:6X9O""; HELIX 2776..2790; /evidence=""ECO:0007829|PDB:6X9O""; HELIX 2795..2798; /evidence=""ECO:0007829|PDB:8SAH""; HELIX 2802..2816; /evidence=""ECO:0007829|PDB:6X9O""; HELIX 2826..2842; /evidence=""ECO:0007829|PDB:6X9O""; HELIX 2854..2863; /evidence=""ECO:0007829|PDB:6X9O""; HELIX 2872..2887; /evidence=""ECO:0007829|PDB:6X9O""; HELIX 2897..2900; /evidence=""ECO:0007829|PDB:6X9O""; HELIX 2912..2928; /evidence=""ECO:0007829|PDB:6X9O""; HELIX 2952..2967; /evidence=""ECO:0007829|PDB:6X9O""; HELIX 2970..2987; /evidence=""ECO:0007829|PDB:6X9O""; HELIX 2990..2992; /evidence=""ECO:0007829|PDB:6X9O""; HELIX 2994..3001; /evidence=""ECO:0007829|PDB:6X9O""; HELIX 3009..3023; /evidence=""ECO:0007829|PDB:6X9O""; HELIX 3031..3037; /evidence=""ECO:0007829|PDB:6X9O""; HELIX 3049..3062; /evidence=""ECO:0007829|PDB:6X9O""; HELIX 3070..3072; /evidence=""ECO:0007829|PDB:6X9O""; HELIX 3073..3077; /evidence=""ECO:0007829|PDB:6X9O""; HELIX 3085..3100; /evidence=""ECO:0007829|PDB:6X9O""; HELIX 3106..3116; /evidence=""ECO:0007829|PDB:6X9O""; HELIX 3117..3119; /evidence=""ECO:0007829|PDB:6X9O""; HELIX 3127..3135; /evidence=""ECO:0007829|PDB:6X9O""","TURN 30..32; /evidence=""ECO:0007829|PDB:3IOT""; TURN 704..706; /evidence=""ECO:0007829|PDB:6X9O""; TURN 741..743; /evidence=""ECO:0007829|PDB:6X9O""; TURN 762..764; /evidence=""ECO:0007829|PDB:6X9O""; TURN 890..893; /evidence=""ECO:0007829|PDB:6X9O""; TURN 911..913; /evidence=""ECO:0007829|PDB:6X9O""; TURN 1038..1040; /evidence=""ECO:0007829|PDB:6X9O""; TURN 1042..1045; /evidence=""ECO:0007829|PDB:6X9O""; TURN 1287..1289; /evidence=""ECO:0007829|PDB:6X9O""; TURN 1301..1303; /evidence=""ECO:0007829|PDB:6X9O""; TURN 1324..1326; /evidence=""ECO:0007829|PDB:6X9O""; TURN 1356..1359; /evidence=""ECO:0007829|PDB:6X9O""; TURN 1491..1493; /evidence=""ECO:0007829|PDB:6X9O""; TURN 1534..1537; /evidence=""ECO:0007829|PDB:6X9O""; TURN 1578..1580; /evidence=""ECO:0007829|PDB:6X9O""; TURN 1760..1763; /evidence=""ECO:0007829|PDB:6X9O""; TURN 1824..1828; /evidence=""ECO:0007829|PDB:6X9O""; TURN 1848..1850; /evidence=""ECO:0007829|PDB:6X9O""; TURN 1930..1932; /evidence=""ECO:0007829|PDB:6X9O""; TURN 1959..1965; /evidence=""ECO:0007829|PDB:6X9O""; TURN 2131..2136; /evidence=""ECO:0007829|PDB:6X9O""; TURN 2157..2159; /evidence=""ECO:0007829|PDB:6X9O""; TURN 2369..2374; /evidence=""ECO:0007829|PDB:6X9O""; TURN 2522..2524; /evidence=""ECO:0007829|PDB:6X9O""; TURN 2598..2600; /evidence=""ECO:0007829|PDB:6X9O""; TURN 2708..2710; /evidence=""ECO:0007829|PDB:6X9O""; TURN 2844..2846; /evidence=""ECO:0007829|PDB:6X9O""; TURN 2851..2853; /evidence=""ECO:0007829|PDB:6X9O""; TURN 2867..2869; /evidence=""ECO:0007829|PDB:6X9O""; TURN 2893..2895; /evidence=""ECO:0007829|PDB:8SAH""; TURN 2904..2906; /evidence=""ECO:0007829|PDB:6X9O""; TURN 3024..3027; /evidence=""ECO:0007829|PDB:6X9O""; TURN 3067..3069; /evidence=""ECO:0007829|PDB:6X9O""; TURN 3101..3103; /evidence=""ECO:0007829|PDB:6X9O""; TURN 3122..3126; /evidence=""ECO:0007829|PDB:6X9O""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,HTT HD IT15,"Huntingtin (Huntington disease protein) (HD protein) [Cleaved into: Huntingtin, myristoylated N-terminal fragment]",Homo sapiens (Human),3142.0,347603.0,MATLEKLMKAFESLKSFQQQQQQQQQQQQQQQQQQQQQPPPPPPPPPPPQLPQPPPQAQPLLPQPQPPPPPPPPPPGPAVAEEPLHRPKKELSATKKDRVNHCLTICENIVAQSVRNSPEFQKLLGIAMELFLLCSDDAESDVRMVADECLNKVIKALMDSNLPRLQLELYKEIKKNGAPRSLRAALWRFAELAHLVRPQKCRPYLVNLLPCLTRTSKRPEESVQETLAAAVPKIMASFGNFANDNEIKVLLKAFIANLKSSSPTIRRTAAGSAVSICQHSRRTQYFYSWLLNVLLGLLVPVEDEHSTLLILGVLLTLRYLVPLLQQQVKDTSLKGSFGVTRKEMEVSPSAEQLVQVYELTLHHTQHQDHNVVTGALELLQQLFRTPPPELLQTLTAVGGIGQLTAAKEESGGRSRSGSIVELIAGGGSSCSPVLSRKQKGKVLLGEEEALEDDSESRSDVSSSALTASVKDEISGELAASSGVSTPGSAGHDIITEQPRSQHTLQADSVDLASCDLTSSATDGDEEDILSHSSSQVSAVPSDPAMDLNDGTQASSPISDSSQTTTEGPDSAVTPSDSSEIVLDGTDNQYLGLQIGQPQDEDEEATGILPDEASEAFRNSSMALQQAHLLKNMSHCRQPSDSSVDKFVLRDEATEPGDQENKPCRIKGDIGQSTDDDSAPLVHCVRLLSASFLLTGGKNVLVPDRDVRVSVKALALSCVGAAVALHPESFFSKLYKVPLDTTEYPEEQYVSDILNYIDHGDPQVRGATAILCGTLICSILSRSRFHVGDWMGTIRTLTGNTFSLADCIPLLRKTLKDESSVTCKLACTAVRNCVMSLCSSSYSELGLQLIIDVLTLRNSSYWLVRTELLETLAEIDFRLVSFLEAKAENLHRGAHHYTGLLKLQERVLNNVVIHLLGDEDPRVRHVAAASLIRLVPKLFYKCDQGQADPVVAVARDQSSVYLKLLMHETQPPSHFSVSTITRIYRGYNLLPSITDVTMENNLSRVIAAVSHELITSTTRALTFGCCEALCLLSTAFPVCIWSLGWHCGVPPLSASDESRKSCTVGMATMILTLLSSAWFPLDLSAHQDALILAGNLLAASAPKSLRSSWASEEEANPAATKQEEVWPALGDRALVPMVEQLFSHLLKVINICAHVLDDVAPGPAIKAALPSLTNPPSLSPIRRKGKEKEPGEQASVPLSPKKGSEASAASRQSDTSGPVTTSKSSSLGSFYHLPSYLKLHDVLKATHANYKVTLDLQNSTEKFGGFLRSALDVLSQILELATLQDIGKCVEEILGYLKSCFSREPMMATVCVQQLLKTLFGTNLASQFDGLSSNPSKSQGRAQRLGSSSVRPGLYHYCFMAPYTHFTQALADASLRNMVQAEQENDTSGWFDVLQKVSTQLKTNLTSVTKNRADKNAIHNHIRLFEPLVIKALKQYTTTTCVQLQKQVLDLLAQLVQLRVNYCLLDSDQVFIGFVLKQFEYIEVGQFRESEAIIPNIFFFLVLLSYERYHSKQIIGIPKIIQLCDGIMASGRKAVTHAIPALQPIVHDLFVLRGTNKADAGKELETQKEVVVSMLLRLIQYHQVLEMFILVLQQCHKENEDKWKRLSRQIADIILPMLAKQQMHIDSHEALGVLNTLFEILAPSSLRPVDMLLRSMFVTPNTMASVSTVQLWISGILAILRVLISQSTEDIVLSRIQELSFSPYLISCTVINRLRDGDSTSTLEEHSEGKQIKNLPEETFSRFLLQLVGILLEDIVTKQLKVEMSEQQHTFYCQELGTLLMCLIHIFKSGMFRRITAAATRLFRSDGCGGSFYTLDSLNLRARSMITTHPALVLLWCQILLLVNHTDYRWWAEVQQTPKRHSLSSTKLLSPQMSGEEEDSDLAAKLGMCNREIVRRGALILFCDYVCQNLHDSEHLTWLIVNHIQDLISLSHEPPVQDFISAVHRNSAASGLFIQAIQSRCENLSTPTMLKKTLQCLEGIHLSQSGAVLTLYVDRLLCTPFRVLARMVDILACRRVEMLLAANLQSSMAQLPMEELNRIQEYLQSSGLAQRHQRLYSLLDRFRLSTMQDSLSPSPPVSSHPLDGDGHVSLETVSPDKDWYVHLVKSQCWTRSDSALLEGAELVNRIPAEDMNAFMMNSEFNLSLLAPCLSLGMSEISGGQKSALFEAAREVTLARVSGTVQQLPAVHHVFQPELPAEPAAYWSKLNDLFGDAALYQSLPTLARALAQYLVVVSKLPSHLHLPPEKEKDIVKFVVATLEALSWHLIHEQIPLSLDLQAGLDCCCLALQLPGLWSVVSSTEFVTHACSLIYCVHFILEAVAVQPGEQLLSPERRTNTPKAISEEEEEVDPNTQNPKYITAACEMVAEMVESLQSVLALGHKRNSGVPAFLTPLLRNIIISLARLPLVNSYTRVPPLVWKLGWSPKPGGDFGTAFPEIPVEFLQEKEVFKEFIYRINTLGWTSRTQFEETWATLLGVLVTQPLVMEQEESPPEEDTERTQINVLAVQAITSLVLSAMTVPVAGNPAVSCLEQQPRNKPLKALDTRFGRKLSIIRGIVEQEIQAMVSKRENIATHHLYQAWDPVPSLSPATTGALISHEKLLLQINPERELGSMSYKLGQVSIHSVWLGNSITPLREEEWDEEEEEEADAPAPSSPPTSPVNSRKHRAGVDIHSCSQFLLELYSRWILPSSSARRTPAILISEVVRSLLVVSDLFTERNQFELMYVTLTELRRVHPSEDEILAQYLVPATCKAAAVLGMDKAVAEPVSRLLESTLRSSHLPSRVGALHGVLYVLECDLLDDTAKQLIPVISDYLLSNLKGIAHCVNIHSQQHVLVMCATAFYLIENYPLDVGPEFSASIIQMCGVMLSGSEESTPSIIYHCALRGLERLLLSEQLSRLDAESLVKLSVDRVNVHSPHRAMAALGLMLTCMYTGKEKVSPGRTSDPNPAAPDSESVIVAMERVSVLFDRIRKGFPCEARVVARILPQFLDDFFPPQDIMNKVIGEFLSNQQPYPQFMATVVYKVFQTLHSTGQSSMVRDWVMLSLSNFTQRAPVAMATWSLSCFFVSASTSPWVAAILPHVISRMGKLEQVDVNLFCLVATDFYRHQIEEELDRRAFQSVLEVVAAPGSPYHRLLTCLRNVHKVTTC,False,False,True,P42858,"[('G3DSA:1.25.10.10', 'Leucine-rich Repeat Variant'), ('IPR000091', 'Huntingtin'), ('IPR011989', 'Armadillo-like helical'), ('IPR016024', 'Armadillo-type fold'), ('IPR024613', 'Huntingtin, N-terminal, HEAT repeats 2'), ('IPR028426', 'Huntingtin family'), ('IPR048411', 'Huntingtin, N-terminal, HEAT repeats 1'), ('IPR048412', 'Huntingtin, bridge'), ('IPR048413', 'Huntingtin, C-terminal HEAT repeats'), ('PF12372', 'Huntingtin, N-terminal HEAT'), ('PF20925', 'Huntingtin, bridge'), ('PF20926', 'Huntingtin, N-terminal HEAT 1'), ('PF20927', 'Huntingtin, C-terminal HEAT'), ('PR00375', 'HUNTINGTIN'), ('PTHR10170', 'HUNTINGTON DISEASE PROTEIN'), ('SSF48371', 'ARM repeat'), ('SSF81995', 'beta-sandwich domain of Sec23/24')]",P42858;,"""ENSG00000197386; Low tissue specificity."";",,,,,ENST00000355072.11;,HTT,ENSG00000197386,0.0,HTT,Non-canonical_RBPs,11.0,24.03,DP04129,0.24,,0.084,HTT
P43364,ENSG00000185247,MAGAB_HUMAN,negative regulation of transcription by RNA polymerase II [GO:0000122],cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],histone deacetylase binding [GO:0042826],,,"DOMAIN 222..421; /note=""MAGE""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00127""","STRAND 277..283; /evidence=""ECO:0007829|PDB:6WJH""; STRAND 288..293; /evidence=""ECO:0007829|PDB:6WJH""; STRAND 368..373; /evidence=""ECO:0007829|PDB:6WJH""; STRAND 382..386; /evidence=""ECO:0007829|PDB:6WJH""","HELIX 221..238; /evidence=""ECO:0007829|PDB:6WJH""; HELIX 245..251; /evidence=""ECO:0007829|PDB:6WJH""; HELIX 254..259; /evidence=""ECO:0007829|PDB:6WJH""; HELIX 260..275; /evidence=""ECO:0007829|PDB:6WJH""; HELIX 294..296; /evidence=""ECO:0007829|PDB:6WJH""; HELIX 312..324; /evidence=""ECO:0007829|PDB:6WJH""; HELIX 331..338; /evidence=""ECO:0007829|PDB:6WJH""; HELIX 339..341; /evidence=""ECO:0007829|PDB:6WJH""; HELIX 355..360; /evidence=""ECO:0007829|PDB:6WJH""; HELIX 362..365; /evidence=""ECO:0007829|PDB:6WJH""; HELIX 388..393; /evidence=""ECO:0007829|PDB:6WJH""; HELIX 396..406; /evidence=""ECO:0007829|PDB:6WJH""; HELIX 411..413; /evidence=""ECO:0007829|PDB:6WJH""; HELIX 415..422; /evidence=""ECO:0007829|PDB:6WJH""","TURN 284..287; /evidence=""ECO:0007829|PDB:6WJH""; TURN 350..352; /evidence=""ECO:0007829|PDB:6WJH""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,MAGEA11 MAGE11,Melanoma-associated antigen 11 (Cancer/testis antigen 1.11) (CT1.11) (MAGE-11 antigen),Homo sapiens (Human),429.0,48129.0,METQFRRGGLGCSPASIKRKKKREDSGDFGLQVSTMFSEDDFQSTERAPYGPQLQWSQDLPRVQVFREQANLEDRSPRRTQRITGGEQVLWGPITQIFPTVRPADLTRVIMPLEQRSQHCKPEEGLQAQEEDLGLVGAQALQAEEQEAAFFSSTLNVGTLEELPAAESPSPPQSPQEESFSPTAMDAIFGSLSDEGSGSQEKEGPSTSPDLIDPESFSQDILHDKIIDLVHLLLRKYRVKGLITKAEMLGSVIKNYEDYFPEIFREASVCMQLLFGIDVKEVDPTSHSYVLVTSLNLSYDGIQCNEQSMPKSGLLIIVLGVIFMEGNCIPEEVMWEVLSIMGVYAGREHFLFGEPKRLLTQNWVQEKYLVYRQVPGTDPACYEFLWGPRAHAETSKMKVLEYIANANGRDPTSYPSLYEDALREEGEGV,False,False,True,P43364,"[('G3DSA:1.10.10.1200', 'MAGE homology domain, winged helix WH1 motif'), ('G3DSA:1.10.10.1210', 'MAGE homology domain, winged helix WH2 motif'), ('IPR002190', 'MAGE homology domain'), ('IPR021072', 'Melanoma associated antigen, N-terminal'), ('IPR037445', 'Melanoma-associated antigen'), ('IPR041898', 'MAGE homology domain, winged helix WH1 motif'), ('IPR041899', 'MAGE homology domain, winged helix WH2 motif'), ('PF01454', 'MAGE homology domain'), ('PF12440', 'Melanoma associated antigen family N terminal'), ('PS50838', 'MAGE conserved domain profile'), ('PTHR11736', 'MELANOMA-ASSOCIATED ANTIGEN MAGE ANTIGEN'), ('SM01373', 'Melanoma-associated antigen'), ('SM01392', 'Melanoma associated antigen family N terminal')]",,"""ENSG00000185247; Tissue enriched (epididymis)."";",,,,,ENST00000355220.6 [P43364-1];,MAGEA11,ENSG00000185247,0.0,,,,,,,0.478,0.135,MAGEA11
P43405,ENSG00000165025,KSYK_HUMAN,adaptive immune response [GO:0002250]; amyloid-beta clearance [GO:0097242]; angiogenesis [GO:0001525]; animal organ morphogenesis [GO:0009887]; B cell differentiation [GO:0030183]; B cell receptor signaling pathway [GO:0050853]; beta selection [GO:0043366]; blood vessel morphogenesis [GO:0048514]; calcium-mediated signaling [GO:0019722]; cell activation [GO:0001775]; cell differentiation [GO:0030154]; cell surface receptor protein tyrosine kinase signaling pathway [GO:0007169]; cellular response to amyloid-beta [GO:1904646]; cellular response to lectin [GO:1990858]; cellular response to lipid [GO:0071396]; cellular response to low-density lipoprotein particle stimulus [GO:0071404]; cellular response to molecule of fungal origin [GO:0071226]; collagen-activated tyrosine kinase receptor signaling pathway [GO:0038063]; defense response to bacterium [GO:0042742]; Fc-epsilon receptor signaling pathway [GO:0038095]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; gamma-delta T cell differentiation [GO:0042492]; innate immune response [GO:0045087]; integrin-mediated signaling pathway [GO:0007229]; interleukin-3-mediated signaling pathway [GO:0038156]; intracellular signal transduction [GO:0035556]; leukocyte activation involved in immune response [GO:0002366]; leukocyte cell-cell adhesion [GO:0007159]; leukotriene biosynthetic process [GO:0019370]; lymph vessel development [GO:0001945]; macrophage activation involved in immune response [GO:0002281]; mast cell degranulation [GO:0043303]; negative regulation of inflammatory response to antigenic stimulus [GO:0002862]; neutrophil activation involved in immune response [GO:0002283]; neutrophil chemotaxis [GO:0030593]; peptidyl-tyrosine phosphorylation [GO:0018108]; platelet activation [GO:0030168]; positive regulation of alpha-beta T cell differentiation [GO:0046638]; positive regulation of alpha-beta T cell proliferation [GO:0046641]; positive regulation of B cell differentiation [GO:0045579]; positive regulation of bone resorption [GO:0045780]; positive regulation of calcium-mediated signaling [GO:0050850]; positive regulation of cell adhesion mediated by integrin [GO:0033630]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043280]; positive regulation of gamma-delta T cell differentiation [GO:0045588]; positive regulation of granulocyte macrophage colony-stimulating factor production [GO:0032725]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-3 production [GO:0032752]; positive regulation of interleukin-4 production [GO:0032753]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of interleukin-8 production [GO:0032757]; positive regulation of killing of cells of another organism [GO:0051712]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of mast cell cytokine production [GO:0032765]; positive regulation of mast cell degranulation [GO:0043306]; positive regulation of monocyte chemotactic protein-1 production [GO:0071639]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of protein-containing complex assembly [GO:0031334]; positive regulation of receptor internalization [GO:0002092]; positive regulation of superoxide anion generation [GO:0032930]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of tumor necrosis factor production [GO:0032760]; positive regulation of type I interferon production [GO:0032481]; protein import into nucleus [GO:0006606]; protein phosphorylation [GO:0006468]; receptor internalization [GO:0031623]; regulation of arachidonic acid secretion [GO:0090237]; regulation of DNA-binding transcription factor activity [GO:0051090]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of neutrophil degranulation [GO:0043313]; regulation of phagocytosis [GO:0050764]; regulation of platelet activation [GO:0010543]; regulation of platelet aggregation [GO:0090330]; regulation of superoxide anion generation [GO:0032928]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]; serotonin secretion by platelet [GO:0002554]; stimulatory C-type lectin receptor signaling pathway [GO:0002223],B cell receptor complex [GO:0019815]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early phagosome [GO:0032009]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; T cell receptor complex [GO:0042101],ATP binding [GO:0005524]; integrin binding [GO:0005178]; interleukin-15 receptor binding [GO:0016170]; kinase activity [GO:0016301]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; phosphatase binding [GO:0019902]; phospholipase binding [GO:0043274]; phosphotyrosine residue binding [GO:0001784]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; scaffold protein binding [GO:0097110]; SH2 domain binding [GO:0042169]; signaling receptor binding [GO:0005102]; Toll-like receptor binding [GO:0035325],"PTM: Ubiquitinated by CBLB after BCR activation; which promotes proteasomal degradation. {ECO:0000250}.; PTM: Autophosphorylated. Phosphorylated on tyrosine residues by LYN following receptors engagement. Phosphorylation on Tyr-323 creates a binding site for CBL, an adapter protein that serves as a negative regulator of BCR-stimulated calcium ion signaling. Phosphorylation at Tyr-348 creates a binding site for VAV1. Phosphorylation on Tyr-348 and Tyr-352 enhances the phosphorylation and activation of phospholipase C-gamma and the early phase of calcium ion mobilization via a phosphoinositide 3-kinase-independent pathway (By similarity). Phosphorylated on tyrosine residues in response to IL15 (PubMed:15123770). Phosphorylation on Ser-297 is very common, it peaks 5 minutes after BCR stimulation, and creates a binding site for YWHAG. Phosphorylation at Tyr-630 creates a binding site for BLNK. Dephosphorylated by PTPN6. {ECO:0000250, ECO:0000269|PubMed:10458769, ECO:0000269|PubMed:15123770, ECO:0000269|PubMed:18369315, ECO:0000269|PubMed:21469132}.",DOMAIN: The SH2 domains mediate the interaction of SYK with the phosphorylated ITAM domains of transmembrane proteins. Some proteins like CLEC1B have a partial ITAM domain (also called hemITAM) containing a single YxxL motif. The interaction with SYK requires CLEC1B homodimerization.,"DOMAIN 15..107; /note=""SH2 1""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00191""; DOMAIN 168..259; /note=""SH2 2""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00191""; DOMAIN 371..631; /note=""Protein kinase""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00159""","STRAND 38..43; /evidence=""ECO:0007829|PDB:4FL3""; STRAND 47..49; /evidence=""ECO:0007829|PDB:4FL3""; STRAND 51..57; /evidence=""ECO:0007829|PDB:4FL3""; STRAND 60..68; /evidence=""ECO:0007829|PDB:4FL3""; STRAND 74..76; /evidence=""ECO:0007829|PDB:4FL3""; STRAND 82..84; /evidence=""ECO:0007829|PDB:4FL3""; STRAND 99..101; /evidence=""ECO:0007829|PDB:4FL3""; STRAND 169..172; /evidence=""ECO:0007829|PDB:1A81""; STRAND 184..186; /evidence=""ECO:0007829|PDB:4FL3""; STRAND 187..189; /evidence=""ECO:0007829|PDB:1CSY""; STRAND 192..201; /evidence=""ECO:0007829|PDB:4FL3""; STRAND 203..209; /evidence=""ECO:0007829|PDB:4FL3""; STRAND 212..220; /evidence=""ECO:0007829|PDB:4FL3""; STRAND 221..224; /evidence=""ECO:0007829|PDB:1CSY""; STRAND 226..228; /evidence=""ECO:0007829|PDB:4FL3""; STRAND 229..231; /evidence=""ECO:0007829|PDB:1CSY""; STRAND 234..236; /evidence=""ECO:0007829|PDB:4FL3""; STRAND 251..253; /evidence=""ECO:0007829|PDB:4FL3""; STRAND 370..372; /evidence=""ECO:0007829|PDB:4YJR""; STRAND 377..380; /evidence=""ECO:0007829|PDB:6ZCS""; STRAND 384..391; /evidence=""ECO:0007829|PDB:4YJR""; STRAND 393..409; /evidence=""ECO:0007829|PDB:4YJR""; STRAND 435..449; /evidence=""ECO:0007829|PDB:4YJR""; STRAND 500..504; /evidence=""ECO:0007829|PDB:4YJR""; STRAND 507..510; /evidence=""ECO:0007829|PDB:4YJR""; STRAND 524..527; /evidence=""ECO:0007829|PDB:4YJR""; STRAND 548..550; /evidence=""ECO:0007829|PDB:4YJR""; STRAND 589..591; /evidence=""ECO:0007829|PDB:3SRV""","HELIX 10..12; /evidence=""ECO:0007829|PDB:7SA7""; HELIX 22..31; /evidence=""ECO:0007829|PDB:4FL3""; HELIX 85..92; /evidence=""ECO:0007829|PDB:4FL3""; HELIX 119..136; /evidence=""ECO:0007829|PDB:4FL3""; HELIX 140..158; /evidence=""ECO:0007829|PDB:4FL3""; HELIX 163..165; /evidence=""ECO:0007829|PDB:4FL3""; HELIX 175..183; /evidence=""ECO:0007829|PDB:4FL3""; HELIX 237..244; /evidence=""ECO:0007829|PDB:4FL3""; HELIX 342..344; /evidence=""ECO:0007829|PDB:4FL3""; HELIX 346..348; /evidence=""ECO:0007829|PDB:4FL2""; HELIX 351..353; /evidence=""ECO:0007829|PDB:4FL2""; HELIX 360..363; /evidence=""ECO:0007829|PDB:5TT7""; HELIX 367..369; /evidence=""ECO:0007829|PDB:4YJR""; HELIX 411..424; /evidence=""ECO:0007829|PDB:4YJR""; HELIX 456..462; /evidence=""ECO:0007829|PDB:4YJR""; HELIX 468..487; /evidence=""ECO:0007829|PDB:4YJR""; HELIX 497..499; /evidence=""ECO:0007829|PDB:4YJR""; HELIX 513..515; /evidence=""ECO:0007829|PDB:4RX7""; HELIX 536..538; /evidence=""ECO:0007829|PDB:4YJR""; HELIX 541..546; /evidence=""ECO:0007829|PDB:4YJR""; HELIX 551..566; /evidence=""ECO:0007829|PDB:4YJR""; HELIX 578..586; /evidence=""ECO:0007829|PDB:4YJR""; HELIX 599..608; /evidence=""ECO:0007829|PDB:4YJR""; HELIX 613..615; /evidence=""ECO:0007829|PDB:4YJR""; HELIX 619..624; /evidence=""ECO:0007829|PDB:4YJR""","TURN 567..569; /evidence=""ECO:0007829|PDB:4YJR""; TURN 572..575; /evidence=""ECO:0007829|PDB:4YJR""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,SYK,Tyrosine-protein kinase SYK (EC 2.7.10.2) (Spleen tyrosine kinase) (p72-Syk),Homo sapiens (Human),635.0,72066.0,MASSGMADSANHLPFFFGNITREEAEDYLVQGGMSDGLYLLRQSRNYLGGFALSVAHGRKAHHYTIERELNGTYAIAGGRTHASPADLCHYHSQESDGLVCLLKKPFNRPQGVQPKTGPFEDLKENLIREYVKQTWNLQGQALEQAIISQKPQLEKLIATTAHEKMPWFHGKISREESEQIVLIGSKTNGKFLIRARDNNGSYALCLLHEGKVLHYRIDKDKTGKLSIPEGKKFDTLWQLVEHYSYKADGLLRVLTVPCQKIGTQGNVNFGGRPQLPGSHPATWSAGGIISRIKSYSFPKPGHRKSSPAQGNRQESTVSFNPYEPELAPWAADKGPQREALPMDTEVYESPYADPEEIRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVN,False,False,True,P43405,"[('cd05116', 'Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase'), ('cd09938', 'N-terminal Src homology 2 (SH2) domain found in Zeta-chain-associated protein kinase 70 (ZAP-70) and Spleen tyrosine kinase (Syk) proteins'), ('cd10401', 'C-terminal Src homology 2 (SH2) domain found in Spleen tyrosine kinase (Syk) proteins'), ('G3DSA:1.10.510.10', 'Transferase(Phosphotransferase) domain 1'), ('G3DSA:1.10.930.10', 'Syk Kinase; Chain A, domain 2'), ('G3DSA:3.30.200.20', 'Phosphorylase Kinase; domain 1'), ('G3DSA:3.30.505.10', 'SH2 domain'), ('IPR000719', 'Protein kinase domain'), ('IPR000980', 'SH2 domain'), ('IPR001245', 'Serine-threonine/tyrosine-protein kinase, catalytic domain'), ('IPR008266', 'Tyrosine-protein kinase, active site'), ('IPR011009', 'Protein kinase-like domain superfamily'), ('IPR012234', 'Tyrosine-protein kinase, non-receptor SYK/ZAP-70'), ('IPR017441', 'Protein kinase, ATP binding site'), ('IPR020635', 'Tyrosine-protein kinase, catalytic domain'), ('IPR023420', 'Tyrosine-protein kinase SYK/ZAP-70, inter-SH2 domain superfamily'), ('IPR035838', 'SYK/ZAP-70, N-terminal SH2 domain'), ('IPR036860', 'SH2 domain superfamily'), ('IPR050198', 'Non-receptor tyrosine kinases involved in cell signaling'), ('PF00017', 'SH2 domain')]",P43405;,"""ENSG00000165025; Tissue enhanced (lymphoid tissue, parathyroid gland)."";","CATALYTIC ACTIVITY: Reaction=L-tyrosyl-[protein] + ATP = O-phospho-L-tyrosyl-[protein] + ADP + H(+); Xref=Rhea:RHEA:10596, Rhea:RHEA-COMP:10136, Rhea:RHEA-COMP:10137, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616, ChEBI:CHEBI:46858, ChEBI:CHEBI:82620, ChEBI:CHEBI:456216; EC=2.7.10.2; Evidence={ECO:0000255|PROSITE-ProRule:PRU10028, ECO:0000269|PubMed:33782605, ECO:0000269|PubMed:34634301};",2.7.10.2,"ACTIVITY REGULATION: Autoinhibited. Intramolecular binding of the interdomains A and B (also called linker region) to parts of the catalytic domain keep the catalytic center in an inactive conformation. The phosphorylation of the interdomains or the binding of the SH2 domains with dually phosphorylated ITAM domains on transmembrane proteins disrupt those intramolecular interactions allowing the kinase domain to adopt an active conformation. The phosphorylation of SYK and of the ITAM domains which is responsible for SYK activation is essentially mediated by SRC subfamily kinases, like LYN, upon transmembrane receptors engagement. May also be negatively regulated by PTPN6 through dephosphorylation. Downstream signaling adapters and intermediates like BLNK or RHOH may mediate positive and/or negative feedback regulation. Negatively regulated by CBL and CBLB through ubiquitination and probable degradation. Phosphorylates SH3BP2 which in turn may regulate SYK through LYN (By similarity). {ECO:0000250}.",,ENST00000375746.1 [P43405-1];ENST00000375747.5 [P43405-2];ENST00000375751.8 [P43405-2];ENST00000375754.9 [P43405-1];,SYK,ENSG00000165025,0.0,,,,,,0.241,0.101,,SYK
P45880,ENSG00000165637,VDAC2_HUMAN,binding of sperm to zona pellucida [GO:0007339]; mitochondrial outer membrane permeabilization [GO:0097345]; mitochondrial transmembrane transport [GO:1990542]; monoatomic anion transport [GO:0006820]; negative regulation of intrinsic apoptotic signaling pathway [GO:2001243]; negative regulation of protein polymerization [GO:0032272]; phospholipid translocation [GO:0045332],acrosomal vesicle [GO:0001669]; membrane [GO:0016020]; membrane raft [GO:0045121]; mitochondrial membrane [GO:0031966]; mitochondrial nucleoid [GO:0042645]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; pore complex [GO:0046930]; sperm midpiece [GO:0097225],ATP binding [GO:0005524]; ceramide binding [GO:0097001]; cholesterol binding [GO:0015485]; oxysterol binding [GO:0008142]; phosphatidylcholine binding [GO:0031210]; phospholipid scramblase activity [GO:0017128]; porin activity [GO:0015288]; voltage-gated monoatomic anion channel activity [GO:0008308],"PTM: Ubiquitinated by PRKN during mitophagy, leading to its degradation and enhancement of mitophagy. Deubiquitinated by USP30. {ECO:0000269|PubMed:25621951}.",DOMAIN: Consists mainly of a membrane-spanning beta-barrel formed by 19 beta-strands. {ECO:0000250}.,,,,,"cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,VDAC2,Voltage-dependent anion-selective channel protein 2 (VDAC-2) (hVDAC2) (Outer mitochondrial membrane protein porin 2),Homo sapiens (Human),294.0,31567.0,MATHGQTCARPMCIPPSYADLGKAARDIFNKGFGFGLVKLDVKTKSCSGVEFSTSGSSNTDTGKVTGTLETKYKWCEYGLTFTEKWNTDNTLGTEIAIEDQICQGLKLTFDTTFSPNTGKKSGKIKSSYKRECINLGCDVDFDFAGPAIHGSAVFGYEGWLAGYQMTFDSAKSKLTRNNFAVGYRTGDFQLHTNVNDGTEFGGSIYQKVCEDLDTSVNLAWTSGTNCTRFGIAAKYQLDPTASISAKVNNSSLIGVGYTQTLRPGVKLTLSALVDGKSINAGGHKVGLALELEA,True,True,False,P45880,"[('cd07306', 'Voltage-dependent anion channel of the outer mitochondrial membrane'), ('G3DSA:2.40.160.10', 'Porin'), ('IPR001925', 'Porin, eukaryotic type'), ('IPR023614', 'Porin domain superfamily'), ('IPR027246', 'Eukaryotic porin/Tom40'), ('PF01459', 'Eukaryotic porin'), ('PR00185', 'EUKARYTPORIN'), ('PS00558', 'Eukaryotic mitochondrial porin signature'), ('PTHR11743', 'VOLTAGE-DEPENDENT ANION-SELECTIVE CHANNEL')]",,"""ENSG00000165637; Low tissue specificity."";",,,,,ENST00000313132.8 [P45880-1];ENST00000332211.11 [P45880-3];ENST00000543351.5 [P45880-3];,VDAC2,ENSG00000165637,0.0,,,,,,,0.041,,VDAC2
P45973,ENSG00000094916,CBX5_HUMAN,DNA damage response [GO:0006974]; heterochromatin formation [GO:0031507]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122],"chromocenter [GO:0010369]; chromosome, telomeric region [GO:0000781]; heterochromatin [GO:0000792]; histone deacetylase complex [GO:0000118]; histone methyltransferase complex [GO:0035097]; kinetochore [GO:0000776]; nuclear envelope [GO:0005635]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; pericentric heterochromatin [GO:0005721]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]; site of DNA damage [GO:0090734]; transcription repressor complex [GO:0017053]",chromatin binding [GO:0003682]; DNA-binding transcription factor binding [GO:0140297]; histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802]; methylated histone binding [GO:0035064]; protein-containing complex binding [GO:0044877]; protein-macromolecule adaptor activity [GO:0030674]; ribonucleoprotein complex binding [GO:0043021],"PTM: Phosphorylation of HP1 and LBR may be responsible for some of the alterations in chromatin organization and nuclear structure which occur at various times during the cell cycle (By similarity). Phosphorylated during interphase and possibly hyper-phosphorylated during mitosis. {ECO:0000250, ECO:0000269|PubMed:10460410}.; PTM: Ubiquitinated. {ECO:0000269|PubMed:20498703}.",,"DOMAIN 20..78; /note=""Chromo 1""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00053""; DOMAIN 121..179; /note=""Chromo 2; shadow subtype""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00053""","STRAND 19..31; /evidence=""ECO:0007829|PDB:3FDT""; STRAND 34..41; /evidence=""ECO:0007829|PDB:3FDT""; STRAND 50..53; /evidence=""ECO:0007829|PDB:3FDT""; STRAND 123..130; /evidence=""ECO:0007829|PDB:3I3C""; STRAND 137..142; /evidence=""ECO:0007829|PDB:3I3C""; STRAND 148..152; /evidence=""ECO:0007829|PDB:3I3C""","HELIX 46..48; /evidence=""ECO:0007829|PDB:3FDT""; HELIX 54..56; /evidence=""ECO:0007829|PDB:3FDT""; HELIX 60..67; /evidence=""ECO:0007829|PDB:3FDT""; HELIX 116..119; /evidence=""ECO:0007829|PDB:3I3C""; HELIX 153..159; /evidence=""ECO:0007829|PDB:3I3C""; HELIX 161..168; /evidence=""ECO:0007829|PDB:3I3C""",,"cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,CBX5 HP1A,Chromobox protein homolog 5 (Antigen p25) (Heterochromatin protein 1 homolog alpha) (HP1 alpha),Homo sapiens (Human),191.0,22225.0,MGKKTKRTADSSSSEDEEEYVVEKVLDRRVVKGQVEYLLKWKGFSEEHNTWEPEKNLDCPELISEFMKKYKKMKEGENNKPREKSESNKRKSNFSNSADDIKSKKKREQSNDIARGFERGLEPEKIIGATDSCGDLMFLMKWKDTDEADLVLAKEANVKCPQIVIAFYEERLTWHAYPEDAENKEKETAKS,False,False,True,P45973,"[('cd18651', 'chromodomain of heterochromatin protein 1 homolog alpha'), ('cd18655', 'chromo shadow domain of heterochromatin protein 1 homolog alpha'), ('G3DSA:2.40.50.40', None), ('IPR000953', 'Chromo/chromo shadow domain'), ('IPR008251', 'Chromo shadow domain'), ('IPR016197', 'Chromo-like domain superfamily'), ('IPR017984', 'Chromo domain subgroup'), ('IPR023779', 'Chromo domain, conserved site'), ('IPR023780', 'Chromo domain'), ('IPR051219', 'Heterochromatin-associated chromo domain-containing protein'), ('PF00385', 'Chromo (CHRromatin Organisation MOdifier) domain'), ('PF01393', 'Chromo shadow domain'), ('PR00504', 'CHROMODOMAIN'), ('PS00598', 'Chromo domain signature'), ('PS50013', 'Chromo and chromo shadow domain profile'), ('PTHR22812', 'Heterochromatin-associated chromo domain-containing protein'), ('SM00298', 'Chromatin organization modifier domain'), ('SM00300', 'Chromo Shadow Domain'), ('SSF54160', 'Chromo domain-like')]",,"""ENSG00000094916; Tissue enhanced (choroid)."";",,,,,ENST00000209875.9;ENST00000439541.6;ENST00000550411.5;,CBX5,ENSG00000094916,0.0,,,,41.88,DP04242,,0.445,0.251,CBX5
P46060,ENSG00000100401,RAGP1_HUMAN,activation of GTPase activity [GO:0090630]; cellular response to vasopressin [GO:1904117]; negative regulation of protein export from nucleus [GO:0046826]; nuclear export [GO:0051168]; nucleocytoplasmic transport [GO:0006913]; protein sumoylation [GO:0016925]; response to axon injury [GO:0048678]; signal transduction [GO:0007165],aggresome [GO:0016235]; axon cytoplasm [GO:1904115]; cytoplasm [GO:0005737]; cytoplasmic periphery of the nuclear pore complex [GO:1990723]; cytosol [GO:0005829]; dendrite [GO:0030425]; intracellular membrane-bounded organelle [GO:0043231]; kinetochore [GO:0000776]; mitotic spindle [GO:0072686]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore cytoplasmic filaments [GO:0044614]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; SUMO ligase complex [GO:0106068],cadherin binding [GO:0045296]; GTPase activator activity [GO:0005096]; RNA binding [GO:0003723]; small GTPase binding [GO:0031267]; ubiquitin protein ligase binding [GO:0031625],"PTM: Phosphorylation occurs before nuclear envelope breakdown and continues throughout mitosis. Phosphorylated by the M-phase kinase cyclin B/Cdk1, in vitro. Differential timimg of dephosphorylation occurs during phases of mitosis. The phosphorylated form remains associated with RANBP2/NUP358 and the SUMO E2-conjugating enzyme, UBE2I, on nuclear pore complex (NPC) diassembly and during mitosis. {ECO:0000269|PubMed:15037602}.; PTM: Sumoylated (PubMed:11854305, PubMed:15037602, PubMed:26304119, PubMed:27160050). Sumoylation is necessary for targeting to the nuclear envelope (NE), and for association with mitotic spindles and kinetochores during mitosis (PubMed:11854305). Also required for interaction with RANBP2 and is mediated by UBE2I (PubMed:27160050). Desumoylated by HINT1 (By similarity). {ECO:0000250|UniProtKB:P46061, ECO:0000269|PubMed:11854305, ECO:0000269|PubMed:15037602, ECO:0000269|PubMed:16428860, ECO:0000269|PubMed:20388717, ECO:0000269|PubMed:26304119, ECO:0000305|PubMed:27160050}.",,,"STRAND 503..507; /evidence=""ECO:0007829|PDB:1Z5S""; STRAND 522..526; /evidence=""ECO:0007829|PDB:2IO2""; STRAND 548..551; /evidence=""ECO:0007829|PDB:1Z5S""","HELIX 434..439; /evidence=""ECO:0007829|PDB:2GRR""; HELIX 443..448; /evidence=""ECO:0007829|PDB:2GRR""; HELIX 450..452; /evidence=""ECO:0007829|PDB:2IO2""; HELIX 453..459; /evidence=""ECO:0007829|PDB:2GRR""; HELIX 466..477; /evidence=""ECO:0007829|PDB:2GRR""; HELIX 484..502; /evidence=""ECO:0007829|PDB:2GRR""; HELIX 509..519; /evidence=""ECO:0007829|PDB:2GRR""; HELIX 536..545; /evidence=""ECO:0007829|PDB:2GRR""; HELIX 553..555; /evidence=""ECO:0007829|PDB:2GRR""; HELIX 556..564; /evidence=""ECO:0007829|PDB:2GRR""; HELIX 568..571; /evidence=""ECO:0007829|PDB:2GRR""; HELIX 574..586; /evidence=""ECO:0007829|PDB:2GRR""",,"cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,RANGAP1 KIAA1835 SD,Ran GTPase-activating protein 1 (RanGAP1),Homo sapiens (Human),587.0,63542.0,MASEDIAKLAETLAKTQVAGGQLSFKGKSLKLNTAEDAKDVIKEIEDFDSLEALRLEGNTVGVEAARVIAKALEKKSELKRCHWSDMFTGRLRTEIPPALISLGEGLITAGAQLVELDLSDNAFGPDGVQGFEALLKSSACFTLQELKLNNCGMGIGGGKILAAALTECHRKSSAQGKPLALKVFVAGRNRLENDGATALAEAFRVIGTLEEVHMPQNGINHPGITALAQAFAVNPLLRVINLNDNTFTEKGAVAMAETLKTLRQVEVINFGDCLVRSKGAVAIADAIRGGLPKLKELNLSFCEIKRDAALAVAEAMADKAELEKLDLNGNTLGEEGCEQLQEVLEGFNMAKVLASLSDDEDEEEEEEGEEEEEEAEEEEEEDEEEEEEEEEEEEEEPQQRGQGEKSATPSRKILDPNTGEPAPVLSSPPPADVSTFLAFPSPEKLLRLGPKSSVLIAQQTDTSDPEKVVSAFLKVSSVFKDEATVRMAVQDAVDALMQKAFNSSSFNSNTFLTRLLVHMGLLKSEDKVKAIANLYGPLMALNHMVQQDYFPKALAPLLLAFVTKPNSALESCSFARHSLLQTLYKV,True,False,False,P46060,"[('cd00116', 'LRR_RI'), ('G3DSA:1.25.40.200', 'Ran-GTPase activating protein 1, C-terminal domain'), ('G3DSA:3.80.10.10', 'Ribonuclease Inhibitor'), ('IPR001611', 'Leucine-rich repeat'), ('IPR009109', 'Ran-GTPase activating protein 1, C-terminal'), ('IPR027038', 'Ran GTPase-activating protein'), ('IPR032675', 'Leucine-rich repeat domain superfamily'), ('IPR036720', 'Ran-GTPase activating protein 1, C-terminal domain superfamily'), ('PF07834', 'RanGAP1 C-terminal domain'), ('PF13516', 'Leucine Rich repeat'), ('PTHR24113', 'RAN GTPASE-ACTIVATING PROTEIN 1'), ('SM00368', 'Leucine rich repeat, ribonuclease inhibitor type'), ('SSF52047', 'RNI-like'), ('SSF69099', 'Ran-GTPase activating protein 1 (RanGAP1), C-terminal domain')]",,"""ENSG00000100401; Low tissue specificity."";",,,,,ENST00000356244.8;ENST00000405486.5;ENST00000455915.6;ENST00000705116.1;,RANGAP1,ENSG00000100401,0.0,RANGAP1,Non-canonical_RBPs,16.0,,,,0.135,0.126,RANGAP1
P46108,ENSG00000167193,CRK_HUMAN,actin cytoskeleton organization [GO:0030036]; cell chemotaxis [GO:0060326]; cell migration [GO:0016477]; cell population proliferation [GO:0008283]; cellular response to endothelin [GO:1990859]; cellular response to insulin-like growth factor stimulus [GO:1990314]; cellular response to nerve growth factor stimulus [GO:1990090]; cellular response to nitric oxide [GO:0071732]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cerebellar neuron development [GO:0098749]; cerebral cortex development [GO:0021987]; dendrite development [GO:0016358]; enzyme-linked receptor protein signaling pathway [GO:0007167]; ephrin receptor signaling pathway [GO:0048013]; establishment of cell polarity [GO:0030010]; helper T cell diapedesis [GO:0035685]; hippocampus development [GO:0021766]; lipid metabolic process [GO:0006629]; negative regulation of cell motility [GO:2000146]; negative regulation of natural killer cell mediated cytotoxicity [GO:0045953]; negative regulation of wound healing [GO:0061045]; neuron migration [GO:0001764]; positive regulation of cell growth [GO:0030307]; positive regulation of JNK cascade [GO:0046330]; positive regulation of Rac protein signal transduction [GO:0035022]; positive regulation of skeletal muscle acetylcholine-gated channel clustering [GO:1904395]; positive regulation of smooth muscle cell migration [GO:0014911]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; postsynaptic specialization assembly [GO:0098698]; protein localization to membrane [GO:0072657]; reelin-mediated signaling pathway [GO:0038026]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of cell adhesion mediated by integrin [GO:0033628]; regulation of cell shape [GO:0008360]; regulation of dendrite development [GO:0050773]; regulation of GTPase activity [GO:0043087]; regulation of intracellular signal transduction [GO:1902531]; regulation of signal transduction [GO:0009966]; regulation of T cell migration [GO:2000404]; regulation of transcription by RNA polymerase II [GO:0006357]; response to cholecystokinin [GO:0061847]; response to hepatocyte growth factor [GO:0035728]; response to hydrogen peroxide [GO:0042542]; response to peptide [GO:1901652]; response to yeast [GO:0001878],actin cytoskeleton [GO:0015629]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; neuromuscular junction [GO:0031594]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991],cytoskeletal protein binding [GO:0008092]; ephrin receptor binding [GO:0046875]; insulin-like growth factor receptor binding [GO:0005159]; kinase binding [GO:0019900]; phosphotyrosine residue binding [GO:0001784]; protein phosphorylated amino acid binding [GO:0045309]; protein tyrosine kinase binding [GO:1990782]; receptor tyrosine kinase binding [GO:0030971]; scaffold protein binding [GO:0097110]; SH2 domain binding [GO:0042169]; SH3 domain binding [GO:0017124]; signaling adaptor activity [GO:0035591]; signaling receptor complex adaptor activity [GO:0030159]; ubiquitin protein ligase binding [GO:0031625],"PTM: Phosphorylated on Tyr-221 upon cell adhesion. Results in the negative regulation of the association with SH2- and SH3-binding partners, possibly by the formation of an intramolecular interaction of phosphorylated Tyr-221 with the SH2 domain. This leads finally to the down-regulation of the Crk signaling pathway (PubMed:17515907). Isoform Crk-II: Phosphorylated by KIT (By similarity). {ECO:0000250|UniProtKB:Q64010, ECO:0000269|PubMed:17515907}.; PTM: Proline isomerization at Pro-237 by PPIA acts as a switch between two conformations: an autoinhibitory conformation in the cis form, where the tandem SH3 domains interact intramolecularly, and an activated conformation in the trans form. {ECO:0000250}.",DOMAIN: The C-terminal SH3 domain function as a negative modulator for transformation and the N-terminal SH3 domain appears to function as a positive regulator for transformation. {ECO:0000250}.; DOMAIN: The SH2 domain mediates interaction with tyrosine phosphorylated proteins. Mediates interaction with SHB.,"DOMAIN 13..118; /note=""SH2""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00191""; DOMAIN 132..192; /note=""SH3 1""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00192""; DOMAIN 235..296; /note=""SH3 2""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00192""","STRAND 7..13; /evidence=""ECO:0007829|PDB:2DVJ""; STRAND 14..16; /evidence=""ECO:0007829|PDB:2EYY""; STRAND 30..33; /evidence=""ECO:0007829|PDB:2DVJ""; STRAND 34..39; /evidence=""ECO:0007829|PDB:1JU5""; STRAND 41..43; /evidence=""ECO:0007829|PDB:1JU5""; STRAND 46..52; /evidence=""ECO:0007829|PDB:1JU5""; STRAND 54..56; /evidence=""ECO:0007829|PDB:2DVJ""; STRAND 57..63; /evidence=""ECO:0007829|PDB:1JU5""; STRAND 66..69; /evidence=""ECO:0007829|PDB:1JU5""; STRAND 70..77; /evidence=""ECO:0007829|PDB:2DVJ""; STRAND 87..89; /evidence=""ECO:0007829|PDB:1JU5""; STRAND 92..96; /evidence=""ECO:0007829|PDB:1JU5""; STRAND 109..112; /evidence=""ECO:0007829|PDB:1JU5""; STRAND 116..118; /evidence=""ECO:0007829|PDB:1JU5""; STRAND 120..123; /evidence=""ECO:0007829|PDB:2EYV""; STRAND 135..141; /evidence=""ECO:0007829|PDB:5UL6""; STRAND 146..150; /evidence=""ECO:0007829|PDB:2DVJ""; STRAND 158..163; /evidence=""ECO:0007829|PDB:5UL6""; STRAND 165..173; /evidence=""ECO:0007829|PDB:5UL6""; STRAND 179..183; /evidence=""ECO:0007829|PDB:5UL6""; STRAND 187..190; /evidence=""ECO:0007829|PDB:5UL6""; STRAND 208..210; /evidence=""ECO:0007829|PDB:2DVJ""; STRAND 224..227; /evidence=""ECO:0007829|PDB:2EYZ""; STRAND 229..231; /evidence=""ECO:0007829|PDB:2EYZ""; STRAND 239..242; /evidence=""ECO:0007829|PDB:2EYX""; STRAND 253..255; /evidence=""ECO:0007829|PDB:2EYX""; STRAND 260..269; /evidence=""ECO:0007829|PDB:2EYX""; STRAND 273..279; /evidence=""ECO:0007829|PDB:2EYX""; STRAND 282..287; /evidence=""ECO:0007829|PDB:2EYX""","HELIX 20..27; /evidence=""ECO:0007829|PDB:1JU5""; HELIX 97..106; /evidence=""ECO:0007829|PDB:1JU5""; HELIX 126..128; /evidence=""ECO:0007829|PDB:2EYY""; HELIX 184..186; /evidence=""ECO:0007829|PDB:5UL6""; HELIX 288..290; /evidence=""ECO:0007829|PDB:2EYX""","TURN 78..80; /evidence=""ECO:0007829|PDB:2DVJ""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,CRK,Adapter molecule crk (Proto-oncogene c-Crk) (p38),Homo sapiens (Human),304.0,33831.0,MAGNFDSEERSSWYWGRLSRQEAVALLQGQRHGVFLVRDSSTSPGDYVLSVSENSRVSHYIINSSGPRPPVPPSPAQPPPGVSPSRLRIGDQEFDSLPALLEFYKIHYLDTTTLIEPVSRSRQGSGVILRQEEAEYVRALFDFNGNDEEDLPFKKGDILRIRDKPEEQWWNAEDSEGKRGMIPVPYVEKYRPASASVSALIGGNQEGSHPQPLGGPEPGPYAQPSVNTPLPNLQNGPIYARVIQKRVPNAYDKTALALEVGELVKVTKINVSGQWEGECNGKRGHFPFTHVRLLDQQNPDEDFS,False,False,True,P46108,"[('cd09926', 'Src homology 2 domain found in cancer-related signaling adaptor protein CRK'), ('cd11758', 'N-terminal Src Homology 3 domain of Ct10 Regulator of Kinase adaptor proteins'), ('cd11759', 'C-terminal Src Homology 3 domain of Ct10 Regulator of Kinase adaptor proteins'), ('G3DSA:2.30.30.40', 'SH3 Domains'), ('G3DSA:3.30.505.10', 'SH2 domain'), ('IPR000980', 'SH2 domain'), ('IPR001452', 'SH3 domain'), ('IPR035457', 'CRK, N-terminal SH3 domain'), ('IPR035458', 'CRK, C-terminal SH3 domain'), ('IPR036028', 'SH3-like domain superfamily'), ('IPR036860', 'SH2 domain superfamily'), ('IPR051184', 'Tyrosine-phosphorylated adapter molecule'), ('PF00017', 'SH2 domain'), ('PF00018', 'SH3 domain'), ('PF07653', 'Variant SH3 domain'), ('PR00401', 'SH2DOMAIN'), ('PR00452', 'SH3DOMAIN'), ('PS50001', 'Src homology 2 (SH2) domain profile'), ('PS50002', 'Src homology 3 (SH3) domain profile'), ('PTHR19969', 'Tyrosine-phosphorylated adapter molecule')]",,"""ENSG00000167193; Low tissue specificity."";",,,,,ENST00000300574.3 [P46108-1];ENST00000398970.5 [P46108-2];,CRK,ENSG00000167193,0.0,,,,28.95,DP00748,0.289,0.25,0.178,CRK
P46527,ENSG00000111276,CDN1B_HUMAN,"autophagic cell death [GO:0048102]; cellular response to antibiotic [GO:0071236]; cellular response to hypoxia [GO:0071456]; cellular response to lithium ion [GO:0071285]; cellular response to organic cyclic compound [GO:0071407]; cellular senescence [GO:0090398]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; epithelial cell apoptotic process [GO:1904019]; epithelial cell proliferation involved in prostate gland development [GO:0060767]; G1/S transition of mitotic cell cycle [GO:0000082]; heart development [GO:0007507]; inner ear development [GO:0048839]; negative regulation of cardiac muscle tissue regeneration [GO:1905179]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cyclin-dependent protein kinase activity [GO:1904030]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of epithelial cell apoptotic process [GO:1904036]; negative regulation of epithelial cell proliferation involved in prostate gland development [GO:0060770]; negative regulation of kinase activity [GO:0033673]; negative regulation of mitotic cell cycle [GO:0045930]; negative regulation of phosphorylation [GO:0042326]; negative regulation of vascular associated smooth muscle cell proliferation [GO:1904706]; Notch signaling pathway [GO:0007219]; nuclear export [GO:0051168]; placenta development [GO:0001890]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA replication [GO:0045740]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of protein catabolic process [GO:0045732]; potassium ion transport [GO:0006813]; regulation of cell cycle [GO:0051726]; regulation of cell cycle G1/S phase transition [GO:1902806]; regulation of cell migration [GO:0030334]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of exit from mitosis [GO:0007096]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of lens fiber cell differentiation [GO:1902746]; response to amino acid [GO:0043200]; response to cadmium ion [GO:0046686]; response to estradiol [GO:0032355]; response to glucose [GO:0009749]; response to peptide hormone [GO:0043434]; response to xenobiotic stimulus [GO:0009410]; sensory perception of sound [GO:0007605]",Cul4A-RING E3 ubiquitin ligase complex [GO:0031464]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],cyclin binding [GO:0030332]; cyclin-dependent protein kinase activating kinase regulator activity [GO:0019914]; cyclin-dependent protein serine/threonine kinase inhibitor activity [GO:0004861]; Hsp70 protein binding [GO:0030544]; molecular adaptor activity [GO:0060090]; molecular function inhibitor activity [GO:0140678]; protein kinase binding [GO:0019901]; protein kinase inhibitor activity [GO:0004860]; protein phosphatase binding [GO:0019903]; protein-containing complex binding [GO:0044877]; protein-folding chaperone binding [GO:0051087]; ubiquitin ligase activator activity [GO:1990757]; ubiquitin protein ligase binding [GO:0031625],"PTM: Phosphorylated; phosphorylation occurs on serine, threonine and tyrosine residues. Phosphorylation on Ser-10 is the major site of phosphorylation in resting cells, takes place at the G(0)-G(1) phase and leads to protein stability. Phosphorylation on other sites is greatly enhanced by mitogens, growth factors, cMYC and in certain cancer cell lines. The phosphorylated form found in the cytoplasm is inactivate. Phosphorylation on Thr-198 is required for interaction with 14-3-3 proteins. Phosphorylation on Thr-187, by CDK1 and CDK2 leads to protein ubiquitination and proteasomal degradation. Tyrosine phosphorylation promotes this process. Phosphorylation by PKB/AKT1 can be suppressed by LY294002, an inhibitor of the catalytic subunit of PI3K. Phosphorylation on Tyr-88 and Tyr-89 has no effect on binding CDK2, but is required for binding CDK4. Dephosphorylated on tyrosine residues by G-CSF. {ECO:0000269|PubMed:10323868, ECO:0000269|PubMed:10831586, ECO:0000269|PubMed:12042314, ECO:0000269|PubMed:12093740, ECO:0000269|PubMed:14504289, ECO:0000269|PubMed:15280662, ECO:0000269|PubMed:16195327, ECO:0000269|PubMed:16209941, ECO:0000269|PubMed:17254966, ECO:0000269|PubMed:17254967, ECO:0000269|PubMed:18593906, ECO:0000269|PubMed:21423214, ECO:0000269|PubMed:23478441, ECO:0000269|PubMed:23707388}.; PTM: Ubiquitinated; in the cytoplasm by the KPC complex (composed of RNF123/KPC1 and UBAC1/KPC2) and, in the nucleus, by SCF(SKP2). The latter requires prior phosphorylation on Thr-187. Ubiquitinated; by a TRIM21-containing SCF(SKP2)-like complex; leads to its degradation. {ECO:0000269|PubMed:10323868, ECO:0000269|PubMed:12042314, ECO:0000269|PubMed:16209941, ECO:0000269|PubMed:23478441}.; PTM: Subject to degradation in the lysosome. Interaction with SNX6 promotes lysosomal degradation (By similarity). {ECO:0000250}.",DOMAIN: A peptide sequence containing only AA 28-79 retains substantial Kip1 cyclin A/CDK2 inhibitory activity.,,"STRAND 71..78; /evidence=""ECO:0007829|PDB:6ATH""","HELIX 26..28; /evidence=""ECO:0007829|PDB:8BYA""; HELIX 38..47; /evidence=""ECO:0007829|PDB:6ATH""; HELIX 55..60; /evidence=""ECO:0007829|PDB:6ATH""; HELIX 86..89; /evidence=""ECO:0007829|PDB:1JSU""","TURN 50..53; /evidence=""ECO:0007829|PDB:1JSU""; TURN 64..67; /evidence=""ECO:0007829|PDB:6ATH""; TURN 81..83; /evidence=""ECO:0007829|PDB:8BYA""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,CDKN1B KIP1 p27,Cyclin-dependent kinase inhibitor 1B (Cyclin-dependent kinase inhibitor p27) (p27Kip1),Homo sapiens (Human),198.0,22073.0,MSNVRVSNGSPSLERMDARQAEHPKPSACRNLFGPVDHEELTRDLEKHCRDMEEASQRKWNFDFQNHKPLEGKYEWQEVEKGSLPEFYYRPPRPPKGACKVPAQESQDVSGSRPAAPLIGAPANSEDTHLVDPKTDPSDSQTGLAEQCAGIRKRPATDDSSTQNKRANRTEENVSDGSPNAGSVEQTPKKPGLRRRQT,False,False,True,P46527,"[('G3DSA:4.10.365.10', 'p27'), ('IPR003175', 'Cyclin-dependent kinase inhibitor domain'), ('IPR044898', 'Cyclin-dependent kinase inhibitor domain superfamily'), ('PF02234', 'Cyclin-dependent kinase inhibitor'), ('PTHR10265', 'Cyclin-dependent kinase inhibitor')]",,"""ENSG00000111276; Low tissue specificity."";",,,,,ENST00000228872.9;ENST00000614874.2;,CDKN1B,ENSG00000111276,0.0,,,,100.0,DP00018,1.0,0.874,0.747,CDKN1B
P46531,ENSG00000148400,NOTC1_HUMAN,"animal organ regeneration [GO:0031100]; aortic valve morphogenesis [GO:0003180]; apoptotic process involved in embryonic digit morphogenesis [GO:1902263]; arterial endothelial cell differentiation [GO:0060842]; astrocyte differentiation [GO:0048708]; atrioventricular node development [GO:0003162]; atrioventricular valve morphogenesis [GO:0003181]; auditory receptor cell fate commitment [GO:0009912]; axon guidance [GO:0007411]; branching morphogenesis of an epithelial tube [GO:0048754]; calcium-ion regulated exocytosis [GO:0017156]; cardiac atrium morphogenesis [GO:0003209]; cardiac chamber formation [GO:0003207]; cardiac epithelial to mesenchymal transition [GO:0060317]; cardiac left ventricle morphogenesis [GO:0003214]; cardiac muscle cell myoblast differentiation [GO:0060379]; cardiac muscle cell proliferation [GO:0060038]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac right atrium morphogenesis [GO:0003213]; cardiac right ventricle formation [GO:0003219]; cardiac septum morphogenesis [GO:0060411]; cardiac vascular smooth muscle cell development [GO:0060948]; cardiac ventricle morphogenesis [GO:0003208]; cell differentiation in spinal cord [GO:0021515]; cell migration involved in endocardial cushion formation [GO:0003273]; cellular response to follicle-stimulating hormone stimulus [GO:0071372]; cellular response to hypoxia [GO:0071456]; cellular response to tumor cell [GO:0071228]; cellular response to vascular endothelial growth factor stimulus [GO:0035924]; chemical synaptic transmission, postsynaptic [GO:0099565]; cilium assembly [GO:0060271]; collecting duct development [GO:0072044]; compartment pattern specification [GO:0007386]; coronary artery morphogenesis [GO:0060982]; coronary sinus valve morphogenesis [GO:0003182]; coronary vein morphogenesis [GO:0003169]; determination of left/right symmetry [GO:0007368]; distal tubule development [GO:0072017]; embryonic hindlimb morphogenesis [GO:0035116]; endocardial cell differentiation [GO:0060956]; endocardial cushion morphogenesis [GO:0003203]; endocardium development [GO:0003157]; endocardium morphogenesis [GO:0003160]; endoderm development [GO:0007492]; epidermal cell fate specification [GO:0009957]; epithelial cell fate commitment [GO:0072148]; epithelial cell proliferation [GO:0050673]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; forebrain development [GO:0030900]; foregut morphogenesis [GO:0007440]; glomerular mesangial cell development [GO:0072144]; growth involved in heart morphogenesis [GO:0003241]; hair follicle morphogenesis [GO:0031069]; heart development [GO:0007507]; heart looping [GO:0001947]; heart trabecula morphogenesis [GO:0061384]; homeostasis of number of cells within a tissue [GO:0048873]; humoral immune response [GO:0006959]; immune response [GO:0006955]; in utero embryonic development [GO:0001701]; inflammatory response to antigenic stimulus [GO:0002437]; inhibition of neuroepithelial cell differentiation [GO:0002085]; interleukin-17-mediated signaling pathway [GO:0097400]; keratinocyte differentiation [GO:0030216]; left/right axis specification [GO:0070986]; liver development [GO:0001889]; lung development [GO:0030324]; luteolysis [GO:0001554]; mesenchymal cell development [GO:0014031]; mitral valve formation [GO:0003192]; negative regulation of anoikis [GO:2000811]; negative regulation of biomineral tissue development [GO:0070168]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of calcium ion-dependent exocytosis [GO:0045955]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of catalytic activity [GO:0043086]; negative regulation of cell adhesion molecule production [GO:0060354]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cell proliferation involved in heart valve morphogenesis [GO:0003252]; negative regulation of cell-cell adhesion mediated by cadherin [GO:2000048]; negative regulation of cell-substrate adhesion [GO:0010812]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of collagen biosynthetic process [GO:0032966]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of endothelial cell chemotaxis [GO:2001027]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of extracellular matrix constituent secretion [GO:0003332]; negative regulation of gene expression [GO:0010629]; negative regulation of glial cell proliferation [GO:0060253]; negative regulation of inner ear auditory receptor cell differentiation [GO:0045608]; negative regulation of myoblast differentiation [GO:0045662]; negative regulation of myotube differentiation [GO:0010832]; negative regulation of neurogenesis [GO:0050768]; negative regulation of oligodendrocyte differentiation [GO:0048715]; negative regulation of ossification [GO:0030279]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of photoreceptor cell differentiation [GO:0046533]; negative regulation of pro-B cell differentiation [GO:2000974]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube development [GO:0021915]; neuroendocrine cell differentiation [GO:0061101]; neuronal stem cell population maintenance [GO:0097150]; Notch signaling pathway [GO:0007219]; Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation [GO:0003270]; oligodendrocyte differentiation [GO:0048709]; outflow tract morphogenesis [GO:0003151]; pericardium morphogenesis [GO:0003344]; positive regulation of aorta morphogenesis [GO:1903849]; positive regulation of apoptotic process involved in morphogenesis [GO:1902339]; positive regulation of astrocyte differentiation [GO:0048711]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of cardiac epithelial to mesenchymal transition [GO:0062043]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of endothelial cell differentiation [GO:0045603]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of gene expression [GO:0010628]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of Ras protein signal transduction [GO:0046579]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of smooth muscle cell differentiation [GO:0051152]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription of Notch receptor target [GO:0007221]; positive regulation of viral genome replication [GO:0045070]; prostate gland epithelium morphogenesis [GO:0060740]; protein catabolic process [GO:0030163]; protein import into nucleus [GO:0006606]; pulmonary valve morphogenesis [GO:0003184]; regulation of cell adhesion involved in heart morphogenesis [GO:0061344]; regulation of DNA-templated transcription [GO:0006355]; regulation of epithelial cell proliferation involved in prostate gland development [GO:0060768]; regulation of extracellular matrix assembly [GO:1901201]; regulation of somitogenesis [GO:0014807]; regulation of stem cell proliferation [GO:0072091]; regulation of transcription by RNA polymerase II [GO:0006357]; response to lipopolysaccharide [GO:0032496]; response to muramyl dipeptide [GO:0032495]; retinal cone cell differentiation [GO:0042670]; secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development [GO:0060528]; skeletal muscle cell differentiation [GO:0035914]; somatic stem cell division [GO:0048103]; spermatogenesis [GO:0007283]; sprouting angiogenesis [GO:0002040]; T-helper 17 type immune response [GO:0072538]; tissue regeneration [GO:0042246]; transcription by RNA polymerase II [GO:0006366]; tube formation [GO:0035148]; vasculogenesis involved in coronary vascular morphogenesis [GO:0060979]; venous endothelial cell differentiation [GO:0060843]; ventricular septum morphogenesis [GO:0060412]; ventricular trabecula myocardium morphogenesis [GO:0003222]",acrosomal vesicle [GO:0001669]; adherens junction [GO:0005912]; apical plasma membrane [GO:0016324]; cell surface [GO:0009986]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; extracellular region [GO:0005576]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; MAML1-RBP-Jkappa- ICN1 complex [GO:0002193]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density membrane [GO:0098839]; receptor complex [GO:0043235]; Schaffer collateral - CA1 synapse [GO:0098685],"calcium ion binding [GO:0005509]; chromatin DNA binding [GO:0031490]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; enzyme binding [GO:0019899]; enzyme inhibitor activity [GO:0004857]; identical protein binding [GO:0042802]; Notch binding [GO:0005112]; transcription coactivator activity [GO:0003713]; transcription regulator activator activity [GO:0140537]; transmembrane signaling receptor activity [GO:0004888]","PTM: Synthesized in the endoplasmic reticulum as an inactive form which is proteolytically cleaved by a furin-like convertase in the trans-Golgi network before it reaches the plasma membrane to yield an active, ligand-accessible form (By similarity). Cleavage results in a C-terminal fragment N(TM) and a N-terminal fragment N(EC). Following ligand binding, it is cleaved by ADAM17 to yield a membrane-associated intermediate fragment called notch extracellular truncation (NEXT) (PubMed:24226769). Following endocytosis, this fragment is then cleaved by one of the catalytic subunits of gamma-secretase (PSEN1 or PSEN2), to release a Notch-derived peptide containing the intracellular domain (NICD) from the membrane (PubMed:30598546). {ECO:0000250|UniProtKB:Q01705, ECO:0000269|PubMed:24226769, ECO:0000269|PubMed:30598546}.; PTM: Phosphorylated. {ECO:0000250}.; PTM: O-glycosylated on the EGF-like domains (PubMed:24226769). O-glucosylated at Ser-435 by KDELC1 and KDELC2 (PubMed:30127001). Contains both O-linked fucose and O-linked glucose in the EGF-like domains 11, 12 and 13, which are interacting with the residues on DLL4 (By similarity). O-linked glycosylation by GALNT11 is involved in determination of left/right symmetry: glycosylation promotes activation of NOTCH1, possibly by promoting cleavage by ADAM17, modulating the balance between motile and immotile (sensory) cilia at the left-right organiser (LRO) (PubMed:24226769). MFNG-, RFNG- and LFNG-mediated modification of O-fucose residues at specific EGF-like domains results in inhibition of its activation by JAG1 and enhancement of its activation by DLL1 via an increased binding to DLL1 (By similarity). {ECO:0000250|UniProtKB:Q01705, ECO:0000250|UniProtKB:Q07008, ECO:0000269|PubMed:24226769, ECO:0000269|PubMed:30127001}.; PTM: Ubiquitinated. Undergoes 'Lys-29'-linked polyubiquitination by ITCH; promotes the lysosomal degradation of non-activated internalized NOTCH1 (PubMed:18628966, PubMed:23886940). Deubiquitination by USP12 is required for transport of internalized non-activated receptor from late endosomes to lysosomes for degradation (PubMed:22778262). Monoubiquitination at Lys-1759 is required for activation by gamma-secretase cleavage, it promotes interaction with AAK1, which stabilizes it. Deubiquitination by EIF3F is necessary for nuclear import of activated Notch (PubMed:24226769). {ECO:0000269|PubMed:18628966, ECO:0000269|PubMed:22778262, ECO:0000269|PubMed:23886940, ECO:0000269|PubMed:24226769}.; PTM: Hydroxylated at Asn-1955 by HIF1AN. Hydroxylated at Asn-2022 by HIF1AN (By similarity). Hydroxylation reduces affinity for HI1AN and may thus indirectly modulate negative regulation of NICD (By similarity). {ECO:0000250}.","DOMAIN: Interaction with PSEN1 causes partial unwinding of the transmembrane helix, facilitating access to the scissile peptide bond. {ECO:0000269|PubMed:30598546}.","DOMAIN 20..58; /note=""EGF-like 1""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DOMAIN 59..99; /note=""EGF-like 2""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DOMAIN 102..139; /note=""EGF-like 3""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DOMAIN 140..176; /note=""EGF-like 4""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DOMAIN 178..216; /note=""EGF-like 5; calcium-binding""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DOMAIN 218..255; /note=""EGF-like 6""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DOMAIN 257..293; /note=""EGF-like 7; calcium-binding""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DOMAIN 295..333; /note=""EGF-like 8; calcium-binding""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DOMAIN 335..371; /note=""EGF-like 9; calcium-binding""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DOMAIN 372..410; /note=""EGF-like 10""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DOMAIN 412..450; /note=""EGF-like 11; calcium-binding""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DOMAIN 452..488; /note=""EGF-like 12; calcium-binding""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DOMAIN 490..526; /note=""EGF-like 13; calcium-binding""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DOMAIN 528..564; /note=""EGF-like 14; calcium-binding""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DOMAIN 566..601; /note=""EGF-like 15; calcium-binding""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DOMAIN 603..639; /note=""EGF-like 16; calcium-binding""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DOMAIN 641..676; /note=""EGF-like 17; calcium-binding""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DOMAIN 678..714; /note=""EGF-like 18; calcium-binding""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DOMAIN 716..751; /note=""EGF-like 19; calcium-binding""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DOMAIN 753..789; /note=""EGF-like 20""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DOMAIN 791..827; /note=""EGF-like 21; calcium-binding""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DOMAIN 829..867; /note=""EGF-like 22""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DOMAIN 869..905; /note=""EGF-like 23; calcium-binding""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DOMAIN 907..943; /note=""EGF-like 24""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DOMAIN 945..981; /note=""EGF-like 25; calcium-binding""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DOMAIN 983..1019; /note=""EGF-like 26""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DOMAIN 1021..1057; /note=""EGF-like 27""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DOMAIN 1059..1095; /note=""EGF-like 28""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DOMAIN 1097..1143; /note=""EGF-like 29""; /evidence=""ECO:0000305""; DOMAIN 1145..1181; /note=""EGF-like 30""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DOMAIN 1183..1219; /note=""EGF-like 31; calcium-binding""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DOMAIN 1221..1265; /note=""EGF-like 32; calcium-binding""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DOMAIN 1267..1305; /note=""EGF-like 33""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DOMAIN 1307..1346; /note=""EGF-like 34""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DOMAIN 1348..1384; /note=""EGF-like 35""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""; DOMAIN 1387..1426; /note=""EGF-like 36""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00076""","STRAND 154..157; /evidence=""ECO:0007829|PDB:5FMA""; STRAND 162..165; /evidence=""ECO:0007829|PDB:5FMA""; STRAND 170..175; /evidence=""ECO:0007829|PDB:5FMA""; STRAND 194..198; /evidence=""ECO:0007829|PDB:5FMA""; STRAND 201..205; /evidence=""ECO:0007829|PDB:5FMA""; STRAND 210..212; /evidence=""ECO:0007829|PDB:5FMA""; STRAND 232..235; /evidence=""ECO:0007829|PDB:5FMA""; STRAND 237..239; /evidence=""ECO:0007829|PDB:5FMA""; STRAND 241..244; /evidence=""ECO:0007829|PDB:5FMA""; STRAND 249..254; /evidence=""ECO:0007829|PDB:5FMA""; STRAND 271..274; /evidence=""ECO:0007829|PDB:5FMA""; STRAND 279..282; /evidence=""ECO:0007829|PDB:5FMA""; STRAND 289..292; /evidence=""ECO:0007829|PDB:5FMA""; STRAND 418..420; /evidence=""ECO:0007829|PDB:4D0E""; STRAND 422..424; /evidence=""ECO:0007829|PDB:4D0E""; STRAND 428..432; /evidence=""ECO:0007829|PDB:4D0E""; STRAND 435..439; /evidence=""ECO:0007829|PDB:4D0E""; STRAND 444..446; /evidence=""ECO:0007829|PDB:4D0E""; STRAND 466..470; /evidence=""ECO:0007829|PDB:5L0R""; STRAND 473..477; /evidence=""ECO:0007829|PDB:5L0R""; STRAND 482..484; /evidence=""ECO:0007829|PDB:5L0R""; STRAND 504..507; /evidence=""ECO:0007829|PDB:4D0E""; STRAND 512..515; /evidence=""ECO:0007829|PDB:4D0E""; STRAND 520..522; /evidence=""ECO:0007829|PDB:4D0E""; STRAND 1460..1462; /evidence=""ECO:0007829|PDB:3ETO""; STRAND 1502..1504; /evidence=""ECO:0007829|PDB:3ETO""; STRAND 1542..1544; /evidence=""ECO:0007829|PDB:3ETO""; STRAND 1563..1565; /evidence=""ECO:0007829|PDB:3L95""; STRAND 1571..1580; /evidence=""ECO:0007829|PDB:3ETO""; STRAND 1602..1606; /evidence=""ECO:0007829|PDB:3ETO""; STRAND 1616..1620; /evidence=""ECO:0007829|PDB:3ETO""; STRAND 1672..1681; /evidence=""ECO:0007829|PDB:3ETO""; STRAND 1714..1716; /evidence=""ECO:0007829|PDB:3ETO""; STRAND 1718..1724; /evidence=""ECO:0007829|PDB:3ETO""; STRAND 1733..1735; /evidence=""ECO:0007829|PDB:6IDF""; STRAND 1755..1760; /evidence=""ECO:0007829|PDB:6IDF""; STRAND 1767..1769; /evidence=""ECO:0007829|PDB:5KZO""; STRAND 1983..1985; /evidence=""ECO:0007829|PDB:2F8X""","HELIX 143..146; /evidence=""ECO:0007829|PDB:5FMA""; HELIX 181..184; /evidence=""ECO:0007829|PDB:5FMA""; HELIX 415..417; /evidence=""ECO:0007829|PDB:4D0E""; HELIX 455..458; /evidence=""ECO:0007829|PDB:5L0R""; HELIX 1448..1450; /evidence=""ECO:0007829|PDB:3L95""; HELIX 1452..1457; /evidence=""ECO:0007829|PDB:3ETO""; HELIX 1465..1467; /evidence=""ECO:0007829|PDB:3ETO""; HELIX 1470..1472; /evidence=""ECO:0007829|PDB:3ETO""; HELIX 1473..1476; /evidence=""ECO:0007829|PDB:3ETO""; HELIX 1492..1494; /evidence=""ECO:0007829|PDB:3ETO""; HELIX 1496..1498; /evidence=""ECO:0007829|PDB:3ETO""; HELIX 1507..1509; /evidence=""ECO:0007829|PDB:3ETO""; HELIX 1512..1519; /evidence=""ECO:0007829|PDB:3ETO""; HELIX 1533..1539; /evidence=""ECO:0007829|PDB:3ETO""; HELIX 1547..1549; /evidence=""ECO:0007829|PDB:3ETO""; HELIX 1552..1559; /evidence=""ECO:0007829|PDB:3ETO""; HELIX 1582..1587; /evidence=""ECO:0007829|PDB:3ETO""; HELIX 1589..1600; /evidence=""ECO:0007829|PDB:3ETO""; HELIX 1685..1688; /evidence=""ECO:0007829|PDB:3ETO""; HELIX 1696..1708; /evidence=""ECO:0007829|PDB:3ETO""; HELIX 1736..1741; /evidence=""ECO:0007829|PDB:6IDF""; HELIX 1743..1746; /evidence=""ECO:0007829|PDB:6IDF""; HELIX 1884..1890; /evidence=""ECO:0007829|PDB:2F8X""; HELIX 1909..1914; /evidence=""ECO:0007829|PDB:2F8X""; HELIX 1931..1937; /evidence=""ECO:0007829|PDB:2F8Y""; HELIX 1941..1949; /evidence=""ECO:0007829|PDB:2F8Y""; HELIX 1964..1970; /evidence=""ECO:0007829|PDB:2F8Y""; HELIX 1974..1982; /evidence=""ECO:0007829|PDB:2F8Y""; HELIX 1998..2005; /evidence=""ECO:0007829|PDB:2F8Y""; HELIX 2008..2016; /evidence=""ECO:0007829|PDB:2F8Y""; HELIX 2031..2037; /evidence=""ECO:0007829|PDB:2F8Y""; HELIX 2041..2049; /evidence=""ECO:0007829|PDB:2F8Y""; HELIX 2064..2071; /evidence=""ECO:0007829|PDB:2F8Y""; HELIX 2074..2082; /evidence=""ECO:0007829|PDB:2F8Y""; HELIX 2097..2103; /evidence=""ECO:0007829|PDB:2F8Y""; HELIX 2107..2115; /evidence=""ECO:0007829|PDB:2F8Y""","TURN 190..192; /evidence=""ECO:0007829|PDB:5FMA""; TURN 493..496; /evidence=""ECO:0007829|PDB:4D0E""; TURN 500..502; /evidence=""ECO:0007829|PDB:2VJ3""; TURN 1477..1482; /evidence=""ECO:0007829|PDB:3ETO""; TURN 1486..1489; /evidence=""ECO:0007829|PDB:3ETO""; TURN 1499..1501; /evidence=""ECO:0007829|PDB:3ETO""; TURN 1530..1532; /evidence=""ECO:0007829|PDB:3ETO""; TURN 1747..1752; /evidence=""ECO:0007829|PDB:6IDF""; TURN 1925..1927; /evidence=""ECO:0007829|PDB:2F8Y""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,NOTCH1 TAN1,Neurogenic locus notch homolog protein 1 (Notch 1) (hN1) (Translocation-associated notch protein TAN-1) [Cleaved into: Notch 1 extracellular truncation (NEXT); Notch 1 intracellular domain (NICD)],Homo sapiens (Human),2555.0,272505.0,MPPLLAPLLCLALLPALAARGPRCSQPGETCLNGGKCEAANGTEACVCGGAFVGPRCQDPNPCLSTPCKNAGTCHVVDRRGVADYACSCALGFSGPLCLTPLDNACLTNPCRNGGTCDLLTLTEYKCRCPPGWSGKSCQQADPCASNPCANGGQCLPFEASYICHCPPSFHGPTCRQDVNECGQKPGLCRHGGTCHNEVGSYRCVCRATHTGPNCERPYVPCSPSPCQNGGTCRPTGDVTHECACLPGFTGQNCEENIDDCPGNNCKNGGACVDGVNTYNCRCPPEWTGQYCTEDVDECQLMPNACQNGGTCHNTHGGYNCVCVNGWTGEDCSENIDDCASAACFHGATCHDRVASFYCECPHGRTGLLCHLNDACISNPCNEGSNCDTNPVNGKAICTCPSGYTGPACSQDVDECSLGANPCEHAGKCINTLGSFECQCLQGYTGPRCEIDVNECVSNPCQNDATCLDQIGEFQCICMPGYEGVHCEVNTDECASSPCLHNGRCLDKINEFQCECPTGFTGHLCQYDVDECASTPCKNGAKCLDGPNTYTCVCTEGYTGTHCEVDIDECDPDPCHYGSCKDGVATFTCLCRPGYTGHHCETNINECSSQPCRHGGTCQDRDNAYLCFCLKGTTGPNCEINLDDCASSPCDSGTCLDKIDGYECACEPGYTGSMCNINIDECAGNPCHNGGTCEDGINGFTCRCPEGYHDPTCLSEVNECNSNPCVHGACRDSLNGYKCDCDPGWSGTNCDINNNECESNPCVNGGTCKDMTSGYVCTCREGFSGPNCQTNINECASNPCLNQGTCIDDVAGYKCNCLLPYTGATCEVVLAPCAPSPCRNGGECRQSEDYESFSCVCPTGWQGQTCEVDINECVLSPCRHGASCQNTHGGYRCHCQAGYSGRNCETDIDDCRPNPCHNGGSCTDGINTAFCDCLPGFRGTFCEEDINECASDPCRNGANCTDCVDSYTCTCPAGFSGIHCENNTPDCTESSCFNGGTCVDGINSFTCLCPPGFTGSYCQHDVNECDSQPCLHGGTCQDGCGSYRCTCPQGYTGPNCQNLVHWCDSSPCKNGGKCWQTHTQYRCECPSGWTGLYCDVPSVSCEVAAQRQGVDVARLCQHGGLCVDAGNTHHCRCQAGYTGSYCEDLVDECSPSPCQNGATCTDYLGGYSCKCVAGYHGVNCSEEIDECLSHPCQNGGTCLDLPNTYKCSCPRGTQGVHCEINVDDCNPPVDPVSRSPKCFNNGTCVDQVGGYSCTCPPGFVGERCEGDVNECLSNPCDARGTQNCVQRVNDFHCECRAGHTGRRCESVINGCKGKPCKNGGTCAVASNTARGFICKCPAGFEGATCENDARTCGSLRCLNGGTCISGPRSPTCLCLGPFTGPECQFPASSPCLGGNPCYNQGTCEPTSESPFYRCLCPAKFNGLLCHILDYSFGGGAGRDIPPPLIEEACELPECQEDAGNKVCSLQCNNHACGWDGGDCSLNFNDPWKNCTQSLQCWKYFSDGHCDSQCNSAGCLFDGFDCQRAEGQCNPLYDQYCKDHFSDGHCDQGCNSAECEWDGLDCAEHVPERLAAGTLVVVVLMPPEQLRNSSFHFLRELSRVLHTNVVFKRDAHGQQMIFPYYGREEELRKHPIKRAAEGWAAPDALLGQVKASLLPGGSEGGRRRRELDPMDVRGSIVYLEIDNRQCVQASSQCFQSATDVAAFLGALASLGSLNIPYKIEAVQSETVEPPPPAQLHFMYVAAAAFVLLFFVGCGVLLSRKRRRQHGQLWFPEGFKVSEASKKKRREPLGEDSVGLKPLKNASDGALMDDNQNEWGDEDLETKKFRFEEPVVLPDLDDQTDHRQWTQQHLDAADLRMSAMAPTPPQGEVDADCMDVNVRGPDGFTPLMIASCSGGGLETGNSEEEEDAPAVISDFIYQGASLHNQTDRTGETALHLAARYSRSDAAKRLLEASADANIQDNMGRTPLHAAVSADAQGVFQILIRNRATDLDARMHDGTTPLILAARLAVEGMLEDLINSHADVNAVDDLGKSALHWAAAVNNVDAAVVLLKNGANKDMQNNREETPLFLAAREGSYETAKVLLDHFANRDITDHMDRLPRDIAQERMHHDIVRLLDEYNLVRSPQLHGAPLGGTPTLSPPLCSPNGYLGSLKPGVQGKKVRKPSSKGLACGSKEAKDLKARRKKSQDGKGCLLDSSGMLSPVDSLESPHGYLSDVASPPLLPSPFQQSPSVPLNHLPGMPDTHLGIGHLNVAAKPEMAALGGGGRLAFETGPPRLSHLPVASGTSTVLGSSSGGALNFTVGGSTSLNGQCEWLSRLQSGMVPNQYNPLRGSVAPGPLSTQAPSLQHGMVGPLHSSLAASALSQMMSYQGLPSTRLATQPHLVQTQQVQPQNLQMQQQNLQPANIQQQQSLQPPPPPPQPHLGVSSAASGHLGRSFLSGEPSQADVQPLGPSSLAVHTILPQESPALPTSLPSSLVPPVTAAQFLTPPSQHSYSSPVDNTPSHQLQVPEHPFLTPSPESPDQWSSSSPHSNVSDWSEGVSSPPTSMQSQIARIPEAFK,True,False,False,P46531,"[('cd00054', 'EGF_CA'), ('cd21702', 'juxtamembrane and transmembrane (JMTM) domain found in neurogenic locus notch homolog protein 1 (Notch1) and similar proteins'), ('G3DSA:1.25.40.20', 'Ankyrin repeat-containing domain'), ('G3DSA:2.10.25.10', 'Laminin'), ('G3DSA:3.30.300.320', None), ('G3DSA:3.30.70.3310', None), ('IPR000152', 'EGF-type aspartate/asparagine hydroxylation site'), ('IPR000742', 'EGF-like domain'), ('IPR000800', 'Notch domain'), ('IPR001881', 'EGF-like calcium-binding domain'), ('IPR002110', 'Ankyrin repeat'), ('IPR008297', 'Notch'), ('IPR009030', 'Growth factor receptor cysteine-rich domain superfamily'), ('IPR010660', 'Notch, NOD domain'), ('IPR011656', 'Notch, NODP domain'), ('IPR013032', 'EGF-like, conserved site'), ('IPR018097', 'EGF-like calcium-binding, conserved site'), ('IPR022362', 'Neurogenic locus notch homolog protein 1'), ('IPR024600', 'Notch, C-terminal'), ('IPR035993', 'Notch-like domain superfamily')]",,"""ENSG00000148400; Low tissue specificity."";",,,,,ENST00000651671.1;,NOTCH1,ENSG00000148400,0.0,,,,5.13,DP01104,0.094,0.247,0.084,NOTCH1
P46777,ENSG00000122406,RL5_HUMAN,cytoplasmic translation [GO:0002181]; negative regulation of protein neddylation [GO:2000435]; negative regulation of ubiquitin protein ligase activity [GO:1904667]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; positive regulation of gene expression [GO:0010628]; positive regulation of translation [GO:0045727]; protein stabilization [GO:0050821]; regulation of signal transduction by p53 class mediator [GO:1901796]; ribosomal large subunit assembly [GO:0000027]; ribosomal large subunit biogenesis [GO:0042273]; rRNA processing [GO:0006364]; translation [GO:0006412],cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904],5S rRNA binding [GO:0008097]; mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; ubiquitin ligase inhibitor activity [GO:1990948]; ubiquitin protein ligase binding [GO:0031625],,,,,,,"cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,RPL5 MSTP030,Large ribosomal subunit protein uL18 (60S ribosomal protein L5),Homo sapiens (Human),297.0,34363.0,MGFVKVVKNKAYFKRYQVKFRRRREGKTDYYARKRLVIQDKNKYNTPKYRMIVRVTNRDIICQIAYARIEGDMIVCAAYAHELPKYGVKVGLTNYAAAYCTGLLLARRLLNRFGMDKIYEGQVEVTGDEYNVESIDGQPGAFTCYLDAGLARTTTGNKVFGALKGAVDGGLSIPHSTKRFPGYDSESKEFNAEVHRKHIMGQNVADYMRYLMEEDEDAYKKQFSQYIKNSVTPDMMEEMYKKAHAAIRENPVYEKKPKKEVKKKRWNRPKMSLAQKKDRVAQKKASFLRAQERAAES,True,True,False,P46777,"[('cd00432', 'Ribosomal_L18_L5e'), ('G3DSA:3.30.420.100', None), ('IPR005485', 'Large ribosomal subunit protein uL18 eukaryotic/archaeal'), ('IPR025607', 'Large ribosomal subunit protein uL18, C-terminal, eukaryotes'), ('MF_01337_A', 'Large ribosomal subunit protein uL18 [rplR]'), ('PF14204', 'Ribosomal L18 C-terminal region'), ('PF17144', 'Ribosomal large subunit proteins 60S L5, and 50S L18'), ('PR00058', 'RIBOSOMALL5'), ('PTHR23410', 'RIBOSOMAL PROTEIN L5-RELATED'), ('SSF53137', 'Translational machinery components')]",,"""ENSG00000122406; Low tissue specificity."";",,,,,ENST00000370321.8;,RPL5,ENSG00000122406,0.0,RPL5,Canonical_RBPs,19.0,,,,0.209,0.152,RPL5
P46937,ENSG00000137693,YAP1_HUMAN,bud elongation involved in lung branching [GO:0060449]; canonical Wnt signaling pathway [GO:0060070]; cardiac muscle tissue regeneration [GO:0061026]; cell morphogenesis [GO:0000902]; cellular response to gamma radiation [GO:0071480]; cellular response to retinoic acid [GO:0071300]; DNA damage response [GO:0006974]; embryonic heart tube morphogenesis [GO:0003143]; enterocyte differentiation [GO:1903703]; epithelial cell proliferation [GO:0050673]; extrinsic apoptotic signaling pathway [GO:0097191]; glandular epithelial cell differentiation [GO:0002067]; heart process [GO:0003015]; hippo signaling [GO:0035329]; interleukin-6-mediated signaling pathway [GO:0070102]; intestinal epithelial cell development [GO:0060576]; keratinocyte differentiation [GO:0030216]; lateral mesoderm development [GO:0048368]; lung epithelial cell differentiation [GO:0060487]; negative regulation of cilium assembly [GO:1902018]; negative regulation of epithelial cell apoptotic process [GO:1904036]; negative regulation of epithelial cell differentiation [GO:0030857]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of gene expression [GO:0010629]; negative regulation of stem cell differentiation [GO:2000737]; negative regulation of transcription by RNA polymerase II [GO:0000122]; notochord development [GO:0030903]; organ growth [GO:0035265]; paraxial mesoderm development [GO:0048339]; polarized epithelial cell differentiation [GO:0030859]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cardiac muscle cell proliferation [GO:0060045]; positive regulation of cell growth [GO:0030307]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of epithelial cell proliferation [GO:0050679]; positive regulation of gene expression [GO:0010628]; positive regulation of Notch signaling pathway [GO:0045747]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein-containing complex assembly [GO:0065003]; regulation of keratinocyte proliferation [GO:0010837]; regulation of metanephric nephron tubule epithelial cell differentiation [GO:0072307]; regulation of neurogenesis [GO:0050767]; regulation of stem cell proliferation [GO:0072091]; response to progesterone [GO:0032570]; somatic stem cell population maintenance [GO:0035019]; tissue homeostasis [GO:0001894]; trophectodermal cell differentiation [GO:0001829]; vasculogenesis [GO:0001570]; wound healing [GO:0042060],bicellular tight junction [GO:0005923]; cell junction [GO:0030054]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; female germ cell nucleus [GO:0001674]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; TEAD-YAP complex [GO:0140552],chromatin binding [GO:0003682]; DNA-binding transcription factor binding [GO:0140297]; proline-rich region binding [GO:0070064]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714],"PTM: Phosphorylated by LATS1 and LATS2; leading to cytoplasmic translocation and inactivation (PubMed:18158288, PubMed:20048001). Phosphorylated by ABL1; leading to YAP1 stabilization, enhanced interaction with TP73 and recruitment onto proapoptotic genes; in response to DNA damage (PubMed:18280240). Phosphorylation at Ser-400 and Ser-403 by CK1 is triggered by previous phosphorylation at Ser-397 by LATS proteins and leads to YAP1 ubiquitination by SCF(beta-TRCP) E3 ubiquitin ligase and subsequent degradation (PubMed:20048001). Phosphorylated at Thr-119, Ser-138, Thr-154, Ser-367 and Thr-412 by MAPK8/JNK1 and MAPK9/JNK2, which is required for the regulation of apoptosis by YAP1 (PubMed:21364637). Phosphorylated in the nucleus by PRP4K; phosphorylation leads to nuclear exclusion (PubMed:29695716). {ECO:0000269|PubMed:18158288, ECO:0000269|PubMed:18280240, ECO:0000269|PubMed:20048001, ECO:0000269|PubMed:21364637, ECO:0000269|PubMed:29695716}.; PTM: Lactylation by AARS1 promotes nuclear localization and stabilization of YAP1, leading to increased Hippo signaling pathway (PubMed:38512451). Delactylated by SIRT1 (PubMed:38512451). {ECO:0000269|PubMed:38512451}.; PTM: Ubiquitinated by SCF(beta-TRCP) E3 ubiquitin ligase. {ECO:0000269|PubMed:20048001}.",DOMAIN: The first coiled-coil region mediates most of the interaction with TEAD transcription factors. {ECO:0000269|PubMed:20123905}.,"DOMAIN 171..204; /note=""WW 1""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00224""; DOMAIN 230..263; /note=""WW 2""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00224""","STRAND 52..54; /evidence=""ECO:0007829|PDB:8A8Q""; STRAND 169..171; /evidence=""ECO:0007829|PDB:1K9Q""; STRAND 177..181; /evidence=""ECO:0007829|PDB:4REX""; STRAND 183..185; /evidence=""ECO:0007829|PDB:1K9Q""; STRAND 187..191; /evidence=""ECO:0007829|PDB:4REX""; STRAND 196..200; /evidence=""ECO:0007829|PDB:4REX""; STRAND 233..235; /evidence=""ECO:0007829|PDB:2LAW""; STRAND 238..241; /evidence=""ECO:0007829|PDB:2LAW""; STRAND 245..250; /evidence=""ECO:0007829|PDB:2LAW""; STRAND 255..259; /evidence=""ECO:0007829|PDB:2LAW""; STRAND 261..263; /evidence=""ECO:0007829|PDB:5YDY""","HELIX 61..73; /evidence=""ECO:0007829|PDB:8A8Q""; HELIX 75..77; /evidence=""ECO:0007829|PDB:6GEI""; HELIX 86..88; /evidence=""ECO:0007829|PDB:8A8Q""; HELIX 93..96; /evidence=""ECO:0007829|PDB:8A8Q""; HELIX 202..206; /evidence=""ECO:0007829|PDB:4REX""","TURN 192..195; /evidence=""ECO:0007829|PDB:4REX""; TURN 242..244; /evidence=""ECO:0007829|PDB:2LAW""; TURN 251..254; /evidence=""ECO:0007829|PDB:2LAW""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,YAP1 YAP65,Transcriptional coactivator YAP1 (Yes-associated protein 1) (Protein yorkie homolog) (Yes-associated protein YAP65 homolog),Homo sapiens (Human),504.0,54462.0,MDPGQQPPPQPAPQGQGQPPSQPPQGQGPPSGPGQPAPAATQAAPQAPPAGHQIVHVRGDSETDLEALFNAVMNPKTANVPQTVPMRLRKLPDSFFKPPEPKSHSRQASTDAGTAGALTPQHVRAHSSPASLQLGAVSPGTLTPTGVVSGPAATPTAQHLRQSSFEIPDDVPLPAGWEMAKTSSGQRYFLNHIDQTTTWQDPRKAMLSQMNVTAPTSPPVQQNMMNSASGPLPDGWEQAMTQDGEIYYINHKNKTTSWLDPRLDPRFAMNQRISQSAPVKQPPPLAPQSPQGGVMGGSNSNQQQQMRLQQLQMEKERLRLKQQELLRQAMRNINPSTANSPKCQELALRSQLPTLEQDGGTQNPVSSPGMSQELRTMTTNSSDPFLNSGTYHSRDESTDSGLSMSSYSVPRTPDDFLNSVDEMDTGDTINQSTLPSQQNRFPDYLEAIPGTNVDLGTLEGDGMNIEGEELMPSLQEALSSDILNDMESVLAATKLDKESFLTWL,False,True,False,P46937,"[('cd00201', 'WW'), ('G3DSA:2.20.70.10', None), ('G3DSA:6.20.430.10', None), ('IPR001202', 'WW domain'), ('IPR036020', 'WW domain superfamily'), ('IPR051583', 'Yes-associated protein 1'), ('IPR053819', 'TEAD interating region 3, omega loop'), ('PF00397', 'WW domain'), ('PF15238', 'Omega loop, TEAD interating region 3'), ('PS01159', 'WW/rsp5/WWP domain signature'), ('PS50020', 'WW/rsp5/WWP domain profile'), ('PTHR17616', 'Yes-associated protein 1'), ('SM00456', 'Domain with 2 conserved Trp (W) residues'), ('SSF51045', 'WW domain')]",P46937;,"""ENSG00000137693; Low tissue specificity."";",,,,,ENST00000282441.10 [P46937-1];ENST00000345877.6 [P46937-7];ENST00000524575.5 [P46937-4];ENST00000526343.5 [P46937-5];ENST00000531439.5 [P46937-2];ENST00000537274.5 [P46937-8];ENST00000615667.4 [P46937-9];ENST00000629586.2 [P46937-3];,YAP1,ENSG00000137693,0.0,,,,24.21,DP00702,0.242,0.857,0.391,YAP1
P47897,ENSG00000172053,SYQ_HUMAN,brain development [GO:0007420]; glutaminyl-tRNA aminoacylation [GO:0006425]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of stress-activated MAPK cascade [GO:0032873]; tRNA aminoacylation for protein translation [GO:0006418],aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrial matrix [GO:0005759]; protein-containing complex [GO:0032991],ATP binding [GO:0005524]; glutamine-tRNA ligase activity [GO:0004819]; protein kinase binding [GO:0019901]; protein kinase inhibitor activity [GO:0004860],,,,"STRAND 265..268; /evidence=""ECO:0007829|PDB:4YE6""; STRAND 297..302; /evidence=""ECO:0007829|PDB:4YE6""; STRAND 330..334; /evidence=""ECO:0007829|PDB:4YE6""; STRAND 354..358; /evidence=""ECO:0007829|PDB:4YE6""; STRAND 401..404; /evidence=""ECO:0007829|PDB:4YE6""; STRAND 416..420; /evidence=""ECO:0007829|PDB:4YE6""; STRAND 433..436; /evidence=""ECO:0007829|PDB:4YE6""; STRAND 452..457; /evidence=""ECO:0007829|PDB:4YE6""; STRAND 480..484; /evidence=""ECO:0007829|PDB:4YE6""; STRAND 487..489; /evidence=""ECO:0007829|PDB:4YE6""; STRAND 507..510; /evidence=""ECO:0007829|PDB:4YE6""; STRAND 546..548; /evidence=""ECO:0007829|PDB:4YE6""; STRAND 570..576; /evidence=""ECO:0007829|PDB:4YE6""; STRAND 578..581; /evidence=""ECO:0007829|PDB:4YE6""; STRAND 592..594; /evidence=""ECO:0007829|PDB:4YE6""; STRAND 603..606; /evidence=""ECO:0007829|PDB:4YE9""; STRAND 613..615; /evidence=""ECO:0007829|PDB:4YE6""; STRAND 647..650; /evidence=""ECO:0007829|PDB:4YE6""; STRAND 654..656; /evidence=""ECO:0007829|PDB:4YE6""; STRAND 661..663; /evidence=""ECO:0007829|PDB:4YE6""; STRAND 681..683; /evidence=""ECO:0007829|PDB:4YE6""; STRAND 685..692; /evidence=""ECO:0007829|PDB:4YE6""; STRAND 695..700; /evidence=""ECO:0007829|PDB:4YE6""; STRAND 720..722; /evidence=""ECO:0007829|PDB:4YE6""; STRAND 725..728; /evidence=""ECO:0007829|PDB:4YE6""; STRAND 732..734; /evidence=""ECO:0007829|PDB:4YE6""; STRAND 740..743; /evidence=""ECO:0007829|PDB:4YE6""; STRAND 747..751; /evidence=""ECO:0007829|PDB:4YE6""; STRAND 757..759; /evidence=""ECO:0007829|PDB:4YE6""; STRAND 761..766; /evidence=""ECO:0007829|PDB:4YE6""","HELIX 6..12; /evidence=""ECO:0007829|PDB:4YE6""; HELIX 17..25; /evidence=""ECO:0007829|PDB:4YE6""; HELIX 27..42; /evidence=""ECO:0007829|PDB:4YE6""; HELIX 50..62; /evidence=""ECO:0007829|PDB:4YE6""; HELIX 66..68; /evidence=""ECO:0007829|PDB:4YE6""; HELIX 69..77; /evidence=""ECO:0007829|PDB:4YE6""; HELIX 84..94; /evidence=""ECO:0007829|PDB:4YE6""; HELIX 104..110; /evidence=""ECO:0007829|PDB:4YE6""; HELIX 119..140; /evidence=""ECO:0007829|PDB:4YE6""; HELIX 141..143; /evidence=""ECO:0007829|PDB:4YE6""; HELIX 147..154; /evidence=""ECO:0007829|PDB:4YE6""; HELIX 162..177; /evidence=""ECO:0007829|PDB:4YE6""; HELIX 220..223; /evidence=""ECO:0007829|PDB:4YE6""; HELIX 226..229; /evidence=""ECO:0007829|PDB:4YE6""; HELIX 237..239; /evidence=""ECO:0007829|PDB:4YE6""; HELIX 249..260; /evidence=""ECO:0007829|PDB:4YE6""; HELIX 278..293; /evidence=""ECO:0007829|PDB:4YE6""; HELIX 312..324; /evidence=""ECO:0007829|PDB:4YE6""; HELIX 335..338; /evidence=""ECO:0007829|PDB:4YE6""; HELIX 339..351; /evidence=""ECO:0007829|PDB:4YE6""; HELIX 380..391; /evidence=""ECO:0007829|PDB:4YE6""; HELIX 438..448; /evidence=""ECO:0007829|PDB:4YE6""; HELIX 464..473; /evidence=""ECO:0007829|PDB:4YE6""; HELIX 496..504; /evidence=""ECO:0007829|PDB:4YE6""; HELIX 519..524; /evidence=""ECO:0007829|PDB:4YE6""; HELIX 529..539; /evidence=""ECO:0007829|PDB:4YE6""; HELIX 551..564; /evidence=""ECO:0007829|PDB:4YE6""; HELIX 599..601; /evidence=""ECO:0007829|PDB:4YE6""","TURN 43..45; /evidence=""ECO:0007829|PDB:4YE6""; TURN 374..377; /evidence=""ECO:0007829|PDB:4YE6""; TURN 426..428; /evidence=""ECO:0007829|PDB:4YE6""; TURN 616..618; /evidence=""ECO:0007829|PDB:4YE6""; TURN 702..705; /evidence=""ECO:0007829|PDB:4YE6""; TURN 711..714; /evidence=""ECO:0007829|PDB:4YE6""; TURN 744..746; /evidence=""ECO:0007829|PDB:4YE6""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,QARS1 QARS,Glutamine--tRNA ligase (EC 6.1.1.18) (Glutaminyl-tRNA synthetase) (GlnRS),Homo sapiens (Human),775.0,87799.0,MAALDSLSLFTSLGLSEQKARETLKNSALSAQLREAATQAQQTLGSTIDKATGILLYGLASRLRDTRRLSFLVSYIASKKIHTEPQLSAALEYVRSHPLDPIDTVDFERECGVGVIVTPEQIEEAVEAAINRHRPQLLVERYHFNMGLLMGEARAVLKWADGKMIKNEVDMQVLHLLGPKLEADLEKKFKVAKARLEETDRRTAKDVVENGETADQTLSLMEQLRGEALKFHKPGENYKTPGYVVTPHTMNLLKQHLEITGGQVRTRFPPEPNGILHIGHAKAINFNFGYAKANNGICFLRFDDTNPEKEEAKFFTAICDMVAWLGYTPYKVTYASDYFDQLYAWAVELIRRGLAYVCHQRGEELKGHNTLPSPWRDRPMEESLLLFEAMRKGKFSEGEATLRMKLVMEDGKMDPVAYRVKYTPHHRTGDKWCIYPTYDYTHCLCDSIEHITHSLCTKEFQARRSSYFWLCNALDVYCPVQWEYGRLNLHYAVVSKRKILQLVATGAVRDWDDPRLFTLTALRRRGFPPEAINNFCARVGVTVAQTTMEPHLLEACVRDVLNDTAPRAMAVLESLRVIITNFPAAKSLDIQVPNFPADETKGFHQVPFAPIVFIERTDFKEEPEPGFKRLAWGQPVGLRHTGYVIELQHVVKGPSGCVESLEVTCRRADAGEKPKAFIHWVSQPLMCEVRLYERLFQHKNPEDPTEVPGGFLSDLNLASLHVVDAALVDCSVALAKPFDKFQFERLGYFSVDPDSHQGKLVFNRTVTLKEDPGKV,True,True,False,P47897,"[('cd00807', 'catalytic core domain of glutaminyl-tRNA synthetase'), ('G3DSA:1.10.10.2420', None), ('G3DSA:1.10.8.1290', 'Glutaminyl-tRNA synthetase, non-specific RNA binding region part 1, domain 1'), ('G3DSA:2.40.240.10', 'Ribosomal Protein L25; Chain P'), ('G3DSA:3.40.50.620', 'HUPs'), ('IPR000924', 'Glutamyl/glutaminyl-tRNA synthetase'), ('IPR001412', 'Aminoacyl-tRNA synthetase, class I, conserved site'), ('IPR004514', 'Glutamine-tRNA synthetase'), ('IPR007638', 'Glutaminyl-tRNA synthetase, class Ib, non-specific RNA-binding domain 2'), ('IPR007639', 'Glutaminyl-tRNA synthetase, class Ib, non-specific RNA-binding domain, N-terminal'), ('IPR011035', 'Large ribosomal subunit protein bL25/Gln-tRNA synthetase, anti-codon-binding domain superfamily'), ('IPR014729', 'Rossmann-like alpha/beta/alpha sandwich fold'), ('IPR020056', 'Large ribosomal subunit protein bL25/Gln-tRNA synthetase, N-terminal'), ('IPR020058', 'Glutamyl/glutaminyl-tRNA synthetase, class Ib, catalytic domain'), ('IPR020059', 'Glutamyl/glutaminyl-tRNA synthetase, class Ib, anti-codon binding domain'), ('IPR042558', 'Glutaminyl-tRNA synthetase, class Ib, non-specific RNA-binding domain, N-terminal, subdomain 1'), ('IPR042559', 'Glutaminyl-tRNA synthetase, class Ib, non-specific RNA-binding domain, N-terminal, subdomain 2'), ('IPR049437', 'tRNA synthetases class I (E and Q), anti-codon binding domain'), ('IPR050132', 'Glutamine/Glutamate--tRNA Ligase'), ('PF00749', 'tRNA synthetases class I (E and Q), catalytic domain')]",,"""ENSG00000172053; Low tissue specificity."";","CATALYTIC ACTIVITY: Reaction=tRNA(Gln) + L-glutamine + ATP = L-glutaminyl-tRNA(Gln) + AMP + diphosphate; Xref=Rhea:RHEA:20121, Rhea:RHEA-COMP:9662, Rhea:RHEA-COMP:9681, ChEBI:CHEBI:30616, ChEBI:CHEBI:33019, ChEBI:CHEBI:58359, ChEBI:CHEBI:78442, ChEBI:CHEBI:78521, ChEBI:CHEBI:456215; EC=6.1.1.18; Evidence={ECO:0000269|PubMed:24656866};",6.1.1.18,,,ENST00000306125.12 [P47897-1];ENST00000414533.5 [P47897-2];,QARS1,ENSG00000172053,0.0,QARS1,Canonical_RBPs,2.0,4.39,DP03589,0.044,0.049,,QARS1
P47992,ENSG00000143184,XCL1_HUMAN,"antimicrobial humoral immune response mediated by antimicrobial peptide [GO:0061844]; cell-cell signaling [GO:0007267]; cellular response to interleukin-4 [GO:0071353]; cellular response to transforming growth factor beta stimulus [GO:0071560]; chemokine-mediated signaling pathway [GO:0070098]; eosinophil chemotaxis [GO:0048245]; inflammatory response [GO:0006954]; mature natural killer cell chemotaxis [GO:0035782]; negative regulation of CD4-positive, alpha-beta T cell proliferation [GO:2000562]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of interleukin-2 production [GO:0032703]; negative regulation of T cell cytokine production [GO:0002725]; negative regulation of T-helper 1 cell activation [GO:2000518]; negative regulation of T-helper 1 type immune response [GO:0002826]; negative regulation of type II interferon production [GO:0032689]; neutrophil chemotaxis [GO:0030593]; positive regulation of B cell chemotaxis [GO:2000538]; positive regulation of CD4-positive, alpha-beta T cell proliferation [GO:2000563]; positive regulation of CD8-positive, alpha-beta T cell proliferation [GO:2000566]; positive regulation of cell migration [GO:0030335]; positive regulation of granzyme A production [GO:2000513]; positive regulation of granzyme B production [GO:0071663]; positive regulation of immunoglobulin production in mucosal tissue [GO:2000558]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of leukocyte chemotaxis [GO:0002690]; positive regulation of natural killer cell chemotaxis [GO:2000503]; positive regulation of neutrophil chemotaxis [GO:0090023]; positive regulation of release of sequestered calcium ion into cytosol [GO:0051281]; positive regulation of T cell chemotaxis [GO:0010820]; positive regulation of T cell cytokine production [GO:0002726]; positive regulation of T cell mediated cytotoxicity [GO:0001916]; positive regulation of T-helper 1 cell cytokine production [GO:2000556]; positive regulation of T-helper 2 cell cytokine production [GO:2000553]; positive regulation of thymocyte migration [GO:2000412]; positive regulation of transforming growth factor beta production [GO:0071636]; regulation of inflammatory response [GO:0050727]; release of sequestered calcium ion into cytosol [GO:0051209]; response to virus [GO:0009615]; signal transduction [GO:0007165]",extracellular region [GO:0005576]; extracellular space [GO:0005615],CCR chemokine receptor binding [GO:0048020]; chemokine activity [GO:0008009]; chemokine receptor binding [GO:0042379]; protein homodimerization activity [GO:0042803],,,,"STRAND 33..35; /evidence=""ECO:0007829|PDB:1J8I""; STRAND 45..50; /evidence=""ECO:0007829|PDB:1J8I""; STRAND 53..55; /evidence=""ECO:0007829|PDB:2NYZ""; STRAND 57..62; /evidence=""ECO:0007829|PDB:2NYZ""; STRAND 65..70; /evidence=""ECO:0007829|PDB:2NYZ""; STRAND 72..74; /evidence=""ECO:0007829|PDB:2NYZ""","HELIX 42..44; /evidence=""ECO:0007829|PDB:2NYZ""; HELIX 75..82; /evidence=""ECO:0007829|PDB:2NYZ""; HELIX 85..87; /evidence=""ECO:0007829|PDB:2NYZ""","TURN 88..91; /evidence=""ECO:0007829|PDB:1J8I""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,XCL1 LTN SCYC1,Lymphotactin (ATAC) (C motif chemokine 1) (Cytokine SCM-1) (Lymphotaxin) (SCM-1-alpha) (Small-inducible cytokine C1) (XC chemokine ligand 1),Homo sapiens (Human),114.0,12517.0,MRLLILALLGICSLTAYIVEGVGSEVSDKRTCVSLTTQRLPVSRIKTYTITEGSLRAVIFITKRGLKVCADPQATWVRDVVRSMDRKSNTRNNMIQTKPTGTQQSTNTAVTLTG,True,True,True,P47992,"[('cd00271', 'Chemokine_C'), ('G3DSA:2.40.50.40', None), ('IPR001811', 'Chemokine interleukin-8-like domain'), ('IPR008105', 'C chemokine'), ('IPR036048', 'Chemokine interleukin-8-like superfamily'), ('IPR039809', 'Chemokine beta/gamma/delta'), ('PF00048', 'Small cytokines (intecrine/chemokine), interleukin-8 like'), ('PR01731', 'LYMPHOTACTIN'), ('PTHR12015', 'SMALL INDUCIBLE CYTOKINE A'), ('SM00199', 'Intercrine alpha family (small cytokine C-X-C) (chemokine CXC).'), ('SSF54117', 'Interleukin 8-like chemokines')]",,"""ENSG00000143184; Tissue enhanced (lymphoid)."";",,,,,ENST00000367818.4;,XCL1,ENSG00000143184,0.0,,,,28.95,DP02957,0.289,0.526,0.211,XCL1
P49327,ENSG00000169710,FAS_HUMAN,cellular response to interleukin-4 [GO:0071353]; establishment of endothelial intestinal barrier [GO:0090557]; ether lipid biosynthetic process [GO:0008611]; fatty acid biosynthetic process [GO:0006633]; fatty acid metabolic process [GO:0006631]; fatty-acyl-CoA biosynthetic process [GO:0046949]; glandular epithelial cell development [GO:0002068]; inflammatory response [GO:0006954]; mammary gland development [GO:0030879]; modulation by host of viral process [GO:0044788]; monocyte differentiation [GO:0030224]; neutrophil differentiation [GO:0030223]; osteoblast differentiation [GO:0001649],cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; glycogen granule [GO:0042587]; Golgi apparatus [GO:0005794]; melanosome [GO:0042470]; membrane [GO:0016020]; plasma membrane [GO:0005886],(3R)-hydroxyacyl-[acyl-carrier-protein] dehydratase activity [GO:0019171]; 3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activity [GO:0004316]; 3-oxoacyl-[acyl-carrier-protein] synthase activity [GO:0004315]; [acyl-carrier-protein] S-acetyltransferase activity [GO:0004313]; [acyl-carrier-protein] S-malonyltransferase activity [GO:0004314]; cadherin binding [GO:0045296]; enoyl-[acyl-carrier-protein] reductase (NADPH) activity [GO:0141148]; fatty acid synthase activity [GO:0004312]; fatty acyl-[ACP] hydrolase activity [GO:0016297]; phosphopantetheine binding [GO:0031177]; RNA binding [GO:0003723],"PTM: S-nitrosylation of Fatty acid synthase at cysteine residues Cys-1471 or Cys-2091 is important for the enzyme dimerization. In adipocytes, S-nitrosylation of Fatty acid synthase occurs under physiological conditions and gradually increases during adipogenesis. {ECO:0000269|PubMed:26851298}.",,"DOMAIN 1..406; /note=""Ketosynthase family 3 (KS3)""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU01348""; DOMAIN 838..1108; /note=""PKS/mFAS DH""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU01363""; DOMAIN 2121..2198; /note=""Carrier""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00258""","STRAND 4..13; /evidence=""ECO:0007829|PDB:3HHD""; STRAND 16..18; /evidence=""ECO:0007829|PDB:3HHD""; STRAND 36..40; /evidence=""ECO:0007829|PDB:3HHD""; STRAND 106..110; /evidence=""ECO:0007829|PDB:3HHD""; STRAND 154..158; /evidence=""ECO:0007829|PDB:3HHD""; STRAND 181..189; /evidence=""ECO:0007829|PDB:3HHD""; STRAND 227..235; /evidence=""ECO:0007829|PDB:3HHD""; STRAND 243..253; /evidence=""ECO:0007829|PDB:3HHD""; STRAND 287..291; /evidence=""ECO:0007829|PDB:3HHD""; STRAND 320..323; /evidence=""ECO:0007829|PDB:3HHD""; STRAND 373..376; /evidence=""ECO:0007829|PDB:3HHD""; STRAND 387..393; /evidence=""ECO:0007829|PDB:3HHD""; STRAND 397..406; /evidence=""ECO:0007829|PDB:3HHD""; STRAND 422..430; /evidence=""ECO:0007829|PDB:3HHD""; STRAND 467..477; /evidence=""ECO:0007829|PDB:3HHD""; STRAND 481..484; /evidence=""ECO:0007829|PDB:3HHD""; STRAND 492..496; /evidence=""ECO:0007829|PDB:3HHD""; STRAND 575..579; /evidence=""ECO:0007829|PDB:3HHD""; STRAND 618..625; /evidence=""ECO:0007829|PDB:3HHD""; STRAND 639..645; /evidence=""ECO:0007829|PDB:3HHD""; STRAND 648..654; /evidence=""ECO:0007829|PDB:3HHD""; STRAND 672..675; /evidence=""ECO:0007829|PDB:3HHD""; STRAND 677..679; /evidence=""ECO:0007829|PDB:2JFD""; STRAND 702..704; /evidence=""ECO:0007829|PDB:2JFD""; STRAND 715..717; /evidence=""ECO:0007829|PDB:3HHD""; STRAND 757..764; /evidence=""ECO:0007829|PDB:3HHD""; STRAND 780..783; /evidence=""ECO:0007829|PDB:3HHD""; STRAND 858..865; /evidence=""ECO:0007829|PDB:8G7X""; STRAND 867..870; /evidence=""ECO:0007829|PDB:8EYI""; STRAND 878..880; /evidence=""ECO:0007829|PDB:8GKC""; STRAND 883..885; /evidence=""ECO:0007829|PDB:8G7X""; STRAND 912..919; /evidence=""ECO:0007829|PDB:8G7X""; STRAND 927..938; /evidence=""ECO:0007829|PDB:8G7X""; STRAND 943..948; /evidence=""ECO:0007829|PDB:8G7X""; STRAND 951..960; /evidence=""ECO:0007829|PDB:8G7X""; STRAND 981..983; /evidence=""ECO:0007829|PDB:8EYI""; STRAND 984..986; /evidence=""ECO:0007829|PDB:8G7X""; STRAND 999..1001; /evidence=""ECO:0007829|PDB:8GKC""; STRAND 1008..1012; /evidence=""ECO:0007829|PDB:8G7X""; STRAND 1015..1021; /evidence=""ECO:0007829|PDB:8G7X""; STRAND 1047..1057; /evidence=""ECO:0007829|PDB:8G7X""; STRAND 1074..1081; /evidence=""ECO:0007829|PDB:8G7X""; STRAND 1086..1089; /evidence=""ECO:0007829|PDB:8G7X""; STRAND 1092..1101; /evidence=""ECO:0007829|PDB:8G7X""; STRAND 1113..1127; /evidence=""ECO:0007829|PDB:6NNA""; STRAND 1236..1246; /evidence=""ECO:0007829|PDB:6NNA""; STRAND 1263..1265; /evidence=""ECO:0007829|PDB:5C37""; STRAND 1267..1276; /evidence=""ECO:0007829|PDB:6NNA""; STRAND 1293..1296; /evidence=""ECO:0007829|PDB:6NNA""; STRAND 1309..1316; /evidence=""ECO:0007829|PDB:6NNA""; STRAND 1336..1347; /evidence=""ECO:0007829|PDB:6NNA""; STRAND 1387..1394; /evidence=""ECO:0007829|PDB:6NNA""; STRAND 1397..1404; /evidence=""ECO:0007829|PDB:6NNA""; STRAND 1413..1416; /evidence=""ECO:0007829|PDB:6NNA""; STRAND 1441..1445; /evidence=""ECO:0007829|PDB:6NNA""; STRAND 1469..1474; /evidence=""ECO:0007829|PDB:6NNA""; STRAND 1479..1482; /evidence=""ECO:0007829|PDB:8EYI""; STRAND 1502..1507; /evidence=""ECO:0007829|PDB:6NNA""; STRAND 1510..1518; /evidence=""ECO:0007829|PDB:6NNA""; STRAND 1525..1529; /evidence=""ECO:0007829|PDB:8GKC""; STRAND 1531..1537; /evidence=""ECO:0007829|PDB:4W82""; STRAND 1544..1548; /evidence=""ECO:0007829|PDB:4W82""; STRAND 1562..1570; /evidence=""ECO:0007829|PDB:4W82""; STRAND 1602..1606; /evidence=""ECO:0007829|PDB:4W82""; STRAND 1612..1616; /evidence=""ECO:0007829|PDB:4W82""; STRAND 1622..1628; /evidence=""ECO:0007829|PDB:4W82""; STRAND 1633..1635; /evidence=""ECO:0007829|PDB:4W82""; STRAND 1670..1675; /evidence=""ECO:0007829|PDB:4W82""; STRAND 1694..1701; /evidence=""ECO:0007829|PDB:4W82""; STRAND 1720..1722; /evidence=""ECO:0007829|PDB:4W82""; STRAND 1723..1726; /evidence=""ECO:0007829|PDB:4W9N""; STRAND 1741..1746; /evidence=""ECO:0007829|PDB:4W82""; STRAND 1760..1769; /evidence=""ECO:0007829|PDB:4W82""; STRAND 1779..1781; /evidence=""ECO:0007829|PDB:8GKC""; STRAND 1790..1794; /evidence=""ECO:0007829|PDB:4W82""; STRAND 1828..1832; /evidence=""ECO:0007829|PDB:4W82""; STRAND 1849..1857; /evidence=""ECO:0007829|PDB:4W82""; STRAND 1873..1876; /evidence=""ECO:0007829|PDB:8GKC""; STRAND 1885..1890; /evidence=""ECO:0007829|PDB:6NNA""; STRAND 1911..1915; /evidence=""ECO:0007829|PDB:6NNA""; STRAND 1938..1942; /evidence=""ECO:0007829|PDB:6NNA""; STRAND 1963..1970; /evidence=""ECO:0007829|PDB:6NNA""; STRAND 2015..2021; /evidence=""ECO:0007829|PDB:6NNA""; STRAND 2056..2060; /evidence=""ECO:0007829|PDB:6NNA""; STRAND 2065..2067; /evidence=""ECO:0007829|PDB:6NNA""; STRAND 2075..2077; /evidence=""ECO:0007829|PDB:5C37""; STRAND 2104..2111; /evidence=""ECO:0007829|PDB:6NNA""; STRAND 2230..2233; /evidence=""ECO:0007829|PDB:3TJM""; STRAND 2239..2241; /evidence=""ECO:0007829|PDB:3TJM""; STRAND 2244..2247; /evidence=""ECO:0007829|PDB:3TJM""; STRAND 2268..2271; /evidence=""ECO:0007829|PDB:3TJM""; STRAND 2303..2307; /evidence=""ECO:0007829|PDB:3TJM""; STRAND 2333..2338; /evidence=""ECO:0007829|PDB:3TJM""; STRAND 2390..2392; /evidence=""ECO:0007829|PDB:3TJM""; STRAND 2443..2447; /evidence=""ECO:0007829|PDB:3TJM""; STRAND 2453..2458; /evidence=""ECO:0007829|PDB:4Z49""; STRAND 2468..2470; /evidence=""ECO:0007829|PDB:7MHD""; STRAND 2472..2476; /evidence=""ECO:0007829|PDB:3TJM""","HELIX 19..27; /evidence=""ECO:0007829|PDB:3HHD""; HELIX 44..46; /evidence=""ECO:0007829|PDB:3HHD""; HELIX 69..73; /evidence=""ECO:0007829|PDB:3HHD""; HELIX 77..92; /evidence=""ECO:0007829|PDB:3HHD""; HELIX 97..100; /evidence=""ECO:0007829|PDB:3HHD""; HELIX 115..120; /evidence=""ECO:0007829|PDB:3HHD""; HELIX 130..135; /evidence=""ECO:0007829|PDB:3HHD""; HELIX 139..148; /evidence=""ECO:0007829|PDB:3HHD""; HELIX 160..162; /evidence=""ECO:0007829|PDB:3HHD""; HELIX 163..176; /evidence=""ECO:0007829|PDB:3HHD""; HELIX 194..202; /evidence=""ECO:0007829|PDB:3HHD""; HELIX 236..238; /evidence=""ECO:0007829|PDB:3HHD""; HELIX 266..279; /evidence=""ECO:0007829|PDB:3HHD""; HELIX 284..286; /evidence=""ECO:0007829|PDB:3HHD""; HELIX 300..312; /evidence=""ECO:0007829|PDB:3HHD""; HELIX 326..329; /evidence=""ECO:0007829|PDB:3HHD""; HELIX 333..335; /evidence=""ECO:0007829|PDB:3HHD""; HELIX 336..350; /evidence=""ECO:0007829|PDB:3HHD""; HELIX 367..370; /evidence=""ECO:0007829|PDB:3HHD""; HELIX 416..419; /evidence=""ECO:0007829|PDB:3HHD""; HELIX 431..443; /evidence=""ECO:0007829|PDB:3HHD""; HELIX 448..457; /evidence=""ECO:0007829|PDB:3HHD""; HELIX 510..512; /evidence=""ECO:0007829|PDB:3HHD""; HELIX 514..527; /evidence=""ECO:0007829|PDB:3HHD""; HELIX 528..530; /evidence=""ECO:0007829|PDB:3HHD""; HELIX 534..539; /evidence=""ECO:0007829|PDB:3HHD""; HELIX 545..547; /evidence=""ECO:0007829|PDB:3HHD""; HELIX 549..569; /evidence=""ECO:0007829|PDB:3HHD""; HELIX 583..590; /evidence=""ECO:0007829|PDB:3HHD""; HELIX 596..611; /evidence=""ECO:0007829|PDB:3HHD""; HELIX 627..633; /evidence=""ECO:0007829|PDB:3HHD""; HELIX 655..667; /evidence=""ECO:0007829|PDB:3HHD""; HELIX 685..690; /evidence=""ECO:0007829|PDB:3HHD""; HELIX 691..701; /evidence=""ECO:0007829|PDB:3HHD""; HELIX 719..721; /evidence=""ECO:0007829|PDB:3HHD""; HELIX 725..728; /evidence=""ECO:0007829|PDB:3HHD""; HELIX 732..740; /evidence=""ECO:0007829|PDB:3HHD""; HELIX 745..749; /evidence=""ECO:0007829|PDB:3HHD""; HELIX 768..774; /evidence=""ECO:0007829|PDB:3HHD""; HELIX 792..805; /evidence=""ECO:0007829|PDB:3HHD""; HELIX 812..815; /evidence=""ECO:0007829|PDB:3HHD""; HELIX 831..833; /evidence=""ECO:0007829|PDB:3HHD""; HELIX 847..849; /evidence=""ECO:0007829|PDB:3HHD""; HELIX 873..877; /evidence=""ECO:0007829|PDB:8G7X""; HELIX 888..903; /evidence=""ECO:0007829|PDB:8G7X""; HELIX 907..909; /evidence=""ECO:0007829|PDB:8G7X""; HELIX 966..969; /evidence=""ECO:0007829|PDB:8G7X""; HELIX 987..996; /evidence=""ECO:0007829|PDB:8G7X""; HELIX 1003..1005; /evidence=""ECO:0007829|PDB:8G7X""; HELIX 1026..1039; /evidence=""ECO:0007829|PDB:8G7X""; HELIX 1059..1065; /evidence=""ECO:0007829|PDB:8G7X""; HELIX 1132..1149; /evidence=""ECO:0007829|PDB:6NNA""; HELIX 1173..1175; /evidence=""ECO:0007829|PDB:5C37""; HELIX 1177..1187; /evidence=""ECO:0007829|PDB:6NNA""; HELIX 1200..1205; /evidence=""ECO:0007829|PDB:6NNA""; HELIX 1206..1211; /evidence=""ECO:0007829|PDB:6NNA""; HELIX 1218..1220; /evidence=""ECO:0007829|PDB:6NNA""; HELIX 1222..1233; /evidence=""ECO:0007829|PDB:6NNA""; HELIX 1247..1250; /evidence=""ECO:0007829|PDB:6NNA""; HELIX 1256..1260; /evidence=""ECO:0007829|PDB:6NNA""; HELIX 1277..1283; /evidence=""ECO:0007829|PDB:6NNA""; HELIX 1284..1289; /evidence=""ECO:0007829|PDB:6NNA""; HELIX 1305..1307; /evidence=""ECO:0007829|PDB:6NNA""; HELIX 1325..1334; /evidence=""ECO:0007829|PDB:6NNA""; HELIX 1352..1360; /evidence=""ECO:0007829|PDB:6NNA""; HELIX 1374..1383; /evidence=""ECO:0007829|PDB:6NNA""; HELIX 1424..1433; /evidence=""ECO:0007829|PDB:6NNA""; HELIX 1453..1460; /evidence=""ECO:0007829|PDB:6NNA""; HELIX 1466..1468; /evidence=""ECO:0007829|PDB:6NNA""; HELIX 1491..1499; /evidence=""ECO:0007829|PDB:6NNA""; HELIX 1541..1543; /evidence=""ECO:0007829|PDB:4W82""; HELIX 1550..1553; /evidence=""ECO:0007829|PDB:8GKC""; HELIX 1573..1579; /evidence=""ECO:0007829|PDB:4W82""; HELIX 1585..1587; /evidence=""ECO:0007829|PDB:4W82""; HELIX 1589..1592; /evidence=""ECO:0007829|PDB:4W82""; HELIX 1630..1632; /evidence=""ECO:0007829|PDB:4W82""; HELIX 1642..1645; /evidence=""ECO:0007829|PDB:4W82""; HELIX 1649..1659; /evidence=""ECO:0007829|PDB:4W82""; HELIX 1679..1690; /evidence=""ECO:0007829|PDB:4W82""; HELIX 1702..1711; /evidence=""ECO:0007829|PDB:4W82""; HELIX 1717..1719; /evidence=""ECO:0007829|PDB:4W82""; HELIX 1728..1735; /evidence=""ECO:0007829|PDB:4W82""; HELIX 1753..1757; /evidence=""ECO:0007829|PDB:4W82""; HELIX 1772..1775; /evidence=""ECO:0007829|PDB:8GKC""; HELIX 1796..1799; /evidence=""ECO:0007829|PDB:4W82""; HELIX 1805..1819; /evidence=""ECO:0007829|PDB:4W82""; HELIX 1833..1835; /evidence=""ECO:0007829|PDB:4W82""; HELIX 1836..1845; /evidence=""ECO:0007829|PDB:4W82""; HELIX 1895..1906; /evidence=""ECO:0007829|PDB:6NNA""; HELIX 1923..1934; /evidence=""ECO:0007829|PDB:6NNA""; HELIX 1949..1962; /evidence=""ECO:0007829|PDB:6NNA""; HELIX 1980..1982; /evidence=""ECO:0007829|PDB:6NNA""; HELIX 1985..2009; /evidence=""ECO:0007829|PDB:6NNA""; HELIX 2022..2025; /evidence=""ECO:0007829|PDB:6NNA""; HELIX 2032..2050; /evidence=""ECO:0007829|PDB:6NNA""; HELIX 2088..2099; /evidence=""ECO:0007829|PDB:6NNA""; HELIX 2127..2134; /evidence=""ECO:0007829|PDB:2CG5""; HELIX 2156..2170; /evidence=""ECO:0007829|PDB:2CG5""; HELIX 2176..2180; /evidence=""ECO:0007829|PDB:2CG5""; HELIX 2184..2192; /evidence=""ECO:0007829|PDB:2CG5""; HELIX 2219..2222; /evidence=""ECO:0007829|PDB:3TJM""; HELIX 2255..2257; /evidence=""ECO:0007829|PDB:3TJM""; HELIX 2258..2263; /evidence=""ECO:0007829|PDB:3TJM""; HELIX 2282..2293; /evidence=""ECO:0007829|PDB:3TJM""; HELIX 2309..2325; /evidence=""ECO:0007829|PDB:3TJM""; HELIX 2343..2352; /evidence=""ECO:0007829|PDB:3TJM""; HELIX 2360..2375; /evidence=""ECO:0007829|PDB:3TJM""; HELIX 2380..2387; /evidence=""ECO:0007829|PDB:3TJM""; HELIX 2393..2407; /evidence=""ECO:0007829|PDB:3TJM""; HELIX 2413..2432; /evidence=""ECO:0007829|PDB:3TJM""; HELIX 2464..2466; /evidence=""ECO:0007829|PDB:3TJM""; HELIX 2483..2485; /evidence=""ECO:0007829|PDB:3TJM""; HELIX 2487..2499; /evidence=""ECO:0007829|PDB:3TJM""","TURN 62..66; /evidence=""ECO:0007829|PDB:3HHD""; TURN 124..126; /evidence=""ECO:0007829|PDB:3HHD""; TURN 444..446; /evidence=""ECO:0007829|PDB:3HHD""; TURN 462..464; /evidence=""ECO:0007829|PDB:3HHD""; TURN 504..509; /evidence=""ECO:0007829|PDB:3HHD""; TURN 939..942; /evidence=""ECO:0007829|PDB:8G7X""; TURN 1082..1085; /evidence=""ECO:0007829|PDB:8G7X""; TURN 1128..1130; /evidence=""ECO:0007829|PDB:6NNA""; TURN 1213..1217; /evidence=""ECO:0007829|PDB:6NNA""; TURN 1253..1255; /evidence=""ECO:0007829|PDB:6NNA""; TURN 1317..1319; /evidence=""ECO:0007829|PDB:6NNA""; TURN 1660..1663; /evidence=""ECO:0007829|PDB:4W82""; TURN 1736..1738; /evidence=""ECO:0007829|PDB:4W82""; TURN 1747..1751; /evidence=""ECO:0007829|PDB:4W9N""; TURN 1784..1788; /evidence=""ECO:0007829|PDB:4W82""; TURN 1801..1803; /evidence=""ECO:0007829|PDB:4W9N""; TURN 1891..1893; /evidence=""ECO:0007829|PDB:6NNA""; TURN 2068..2070; /evidence=""ECO:0007829|PDB:6NNA""; TURN 2149..2153; /evidence=""ECO:0007829|PDB:2CG5""; TURN 2294..2296; /evidence=""ECO:0007829|PDB:3TJM""; TURN 2459..2463; /evidence=""ECO:0007829|PDB:3TJM""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,FASN FAS,Fatty acid synthase (EC 2.3.1.85) (Type I fatty acid synthase) [Includes: [Acyl-carrier-protein] S-acetyltransferase (EC 2.3.1.38); [Acyl-carrier-protein] S-malonyltransferase (EC 2.3.1.39); 3-oxoacyl-[acyl-carrier-protein] synthase (EC 2.3.1.41); 3-oxoacyl-[acyl-carrier-protein] reductase (EC 1.1.1.100); 3-hydroxyacyl-[acyl-carrier-protein] dehydratase (EC 4.2.1.59); Enoyl-[acyl-carrier-protein] reductase (EC 1.3.1.39); Acyl-[acyl-carrier-protein] hydrolase (EC 3.1.2.14)],Homo sapiens (Human),2511.0,273427.0,MEEVVIAGMSGKLPESENLQEFWDNLIGGVDMVTDDDRRWKAGLYGLPRRSGKLKDLSRFDASFFGVHPKQAHTMDPQLRLLLEVTYEAIVDGGINPDSLRGTHTGVWVGVSGSETSEALSRDPETLVGYSMVGCQRAMMANRLSFFFDFRGPSIALDTACSSSLMALQNAYQAIHSGQCPAAIVGGINVLLKPNTSVQFLRLGMLSPEGTCKAFDTAGNGYCRSEGVVAVLLTKKSLARRVYATILNAGTNTDGFKEQGVTFPSGDIQEQLIRSLYQSAGVAPESFEYIEAHGTGTKVGDPQELNGITRALCATRQEPLLIGSTKSNMGHPEPASGLAALAKVLLSLEHGLWAPNLHFHSPNPEIPALLDGRLQVVDQPLPVRGGNVGINSFGFGGSNVHIILRPNTQPPPAPAPHATLPRLLRASGRTPEAVQKLLEQGLRHSQDLAFLSMLNDIAAVPATAMPFRGYAVLGGERGGPEVQQVPAGERPLWFICSGMGTQWRGMGLSLMRLDRFRDSILRSDEAVKPFGLKVSQLLLSTDESTFDDIVHSFVSLTAIQIGLIDLLSCMGLRPDGIVGHSLGEVACGYADGCLSQEEAVLAAYWRGQCIKEAHLPPGAMAAVGLSWEECKQRCPPGVVPACHNSKDTVTISGPQAPVFEFVEQLRKEGVFAKEVRTGGMAFHSYFMEAIAPPLLQELKKVIREPKPRSARWLSTSIPEAQWHSSLARTSSAEYNVNNLVSPVLFQEALWHVPEHAVVLEIAPHALLQAVLKRGLKPSCTIIPLMKKDHRDNLEFFLAGIGRLHLSGIDANPNALFPPVEFPAPRGTPLISPLIKWDHSLAWDVPAAEDFPNGSGSPSAAIYNIDTSSESPDHYLVDHTLDGRVLFPATGYLSIVWKTLARALGLGVEQLPVVFEDVVLHQATILPKTGTVSLEVRLLEASRAFEVSENGNLVVSGKVYQWDDPDPRLFDHPESPTPNPTEPLFLAQAEVYKELRLRGYDYGPHFQGILEASLEGDSGRLLWKDNWVSFMDTMLQMSILGSAKHGLYLPTRVTAIHIDPATHRQKLYTLQDKAQVADVVVSRWLRVTVAGGVHISGLHTESAPRRQQEQQVPILEKFCFTPHTEEGCLSERAALQEELQLCKGLVQALQTKVTQQGLKMVVPGLDGAQIPRDPSQQELPRLLSAACRLQLNGNLQLELAQVLAQERPKLPEDPLLSGLLDSPALKACLDTAVENMPSLKMKVVEVLAGHGHLYSRIPGLLSPHPLLQLSYTATDRHPQALEAAQAELQQHDVAQGQWDPADPAPSALGSADLLVCNCAVAALGDPASALSNMVAALREGGFLLLHTLLRGHPLGDIVAFLTSTEPQYGQGILSQDAWESLFSRVSLRLVGLKKSFYGSTLFLCRRPTPQDSPIFLPVDDTSFRWVESLKGILADEDSSRPVWLKAINCATSGVVGLVNCLRREPGGNRLRCVLLSNLSSTSHVPEVDPGSAELQKVLQGDLVMNVYRDGAWGAFRHFLLEEDKPEEPTAHAFVSTLTRGDLSSIRWVCSSLRHAQPTCPGAQLCTVYYASLNFRDIMLATGKLSPDAIPGKWTSQDSLLGMEFSGRDASGKRVMGLVPAKGLATSVLLSPDFLWDVPSNWTLEEAASVPVVYSTAYYALVVRGRVRPGETLLIHSGSGGVGQAAIAIALSLGCRVFTTVGSAEKRAYLQARFPQLDSTSFANSRDTSFEQHVLWHTGGKGVDLVLNSLAEEKLQASVRCLATHGRFLEIGKFDLSQNHPLGMAIFLKNVTFHGVLLDAFFNESSADWREVWALVQAGIRDGVVRPLKCTVFHGAQVEDAFRYMAQGKHIGKVVVQVLAEEPEAVLKGAKPKLMSAISKTFCPAHKSYIIAGGLGGFGLELAQWLIQRGVQKLVLTSRSGIRTGYQAKQVRRWRRQGVQVQVSTSNISSLEGARGLIAEAAQLGPVGGVFNLAVVLRDGLLENQTPEFFQDVCKPKYSGTLNLDRVTREACPELDYFVVFSSVSCGRGNAGQSNYGFANSAMERICEKRRHEGLPGLAVQWGAIGDVGILVETMSTNDTIVSGTLPQRMASCLEVLDLFLNQPHMVLSSFVLAEKAAAYRDRDSQRDLVEAVAHILGIRDLAAVNLDSSLADLGLDSLMSVEVRQTLERELNLVLSVREVRQLTLRKLQELSSKADEASELACPTPKEDGLAQQQTQLNLRSLLVNPEGPTLMRLNSVQSSERPLFLVHPIEGSTTVFHSLASRLSIPTYGLQCTRAAPLDSIHSLAAYYIDCIRQVQPEGPYRVAGYSYGACVAFEMCSQLQAQQSPAPTHNSLFLFDGSPTYVLAYTQSYRAKLTPGCEAEAETEAICFFVQQFTDMEHNRVLEALLPLKGLEERVAAAVDLIIKSHQGLDRQELSFAARSFYYKLRAAEQYTPKAKYHGNVMLLRAKTGGAYGEDLGADYNLSQVCDGKVSVHVIEGDHRTLLEGSGLESIISIIHSSLAEPRVSVREG,True,False,False,P49327,"[('cd00833', 'PKS'), ('cd05195', 'enoyl reductase of polyketide synthase'), ('cd08954', 'beta-ketoacyl reductase (KR) domain of fatty acid synthase (FAS), subgroup 1, complex (x) SDRs'), ('G3DSA:1.10.1200.10', 'ACP-like'), ('G3DSA:3.10.129.110', 'Polyketide synthase dehydratase'), ('G3DSA:3.30.70.3290', None), ('G3DSA:3.40.366.10', 'Malonyl-Coenzyme A Acyl Carrier Protein, domain 2'), ('G3DSA:3.40.47.10', None), ('G3DSA:3.40.50.150', 'Vaccinia Virus protein VP39'), ('G3DSA:3.40.50.1820', 'alpha/beta hydrolase'), ('G3DSA:3.40.50.720', 'NAD(P)-binding Rossmann-like Domain'), ('G3DSA:3.90.180.10', 'Medium-chain alcohol dehydrogenases, catalytic domain'), ('IPR001031', 'Thioesterase'), ('IPR001227', 'Acyl transferase domain superfamily'), ('IPR006162', 'Phosphopantetheine attachment site'), ('IPR009081', 'Phosphopantetheine binding ACP domain'), ('IPR011032', 'GroES-like superfamily'), ('IPR013149', 'Alcohol dehydrogenase-like, C-terminal'), ('IPR013217', 'Methyltransferase type 12'), ('IPR013968', 'Polyketide synthase, ketoreductase domain')]",,"""ENSG00000169710; Tissue enhanced (adipose tissue, breast)."";","CATALYTIC ACTIVITY: Reaction=acetyl-CoA + n malonyl-CoA + 2n NADPH + 2n H(+) = a long-chain fatty acid + (n+1) CoA + n CO2 + 2n NADP(+).; EC=2.3.1.85; Evidence={ECO:0000269|PubMed:16215233, ECO:0000269|PubMed:26851298, ECO:0000269|PubMed:7567999, ECO:0000269|PubMed:8962082, ECO:0000269|PubMed:9356448}; CATALYTIC ACTIVITY: Reaction=holo-[ACP] + acetyl-CoA = acetyl-[ACP] + CoA; Xref=Rhea:RHEA:41788, Rhea:RHEA-COMP:9621, Rhea:RHEA-COMP:9685, ChEBI:CHEBI:57287, ChEBI:CHEBI:57288, ChEBI:CHEBI:64479, ChEBI:CHEBI:78446; EC=2.3.1.38; Evidence={ECO:0000269|PubMed:26851298, ECO:0000269|PubMed:7567999, ECO:0000269|PubMed:8962082, ECO:0000269|PubMed:9356448}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:41789; Evidence={ECO:0000269|PubMed:26851298, ECO:0000269|PubMed:7567999, ECO:0000269|PubMed:8962082, ECO:0000269|PubMed:9356448}; CATALYTIC ACTIVITY: Reaction=holo-[ACP] + malonyl-CoA = malonyl-[ACP] + CoA; Xref=Rhea:RHEA:41792, Rhea:RHEA-COMP:9623, Rhea:RHEA-COMP:9685, ChEBI:CHEBI:57287, ChEBI:CHEBI:57384, ChEBI:CHEBI:64479, ChEBI:CHEBI:78449; EC=2.3.1.39; Evidence={ECO:0000269|PubMed:26851298, ECO:0000269|PubMed:7567999, ECO:0000269|PubMed:8962082, ECO:0000269|PubMed:9356448}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:41793; Evidence={ECO:0000269|PubMed:26851298, ECO:0000269|PubMed:7567999, ECO:0000269|PubMed:8962082, ECO:0000269|PubMed:9356448}; CATALYTIC ACTIVITY: Reaction=a fatty acyl-[ACP] + malonyl-[ACP] + H(+) = a 3-oxoacyl-[ACP] + holo-[ACP] + CO2; Xref=Rhea:RHEA:22836, Rhea:RHEA-COMP:9623, Rhea:RHEA-COMP:9685, Rhea:RHEA-COMP:9916, Rhea:RHEA-COMP:14125, ChEBI:CHEBI:15378, ChEBI:CHEBI:16526, ChEBI:CHEBI:64479, ChEBI:CHEBI:78449, ChEBI:CHEBI:78776, ChEBI:CHEBI:138651; EC=2.3.1.41; Evidence={ECO:0000269|PubMed:26851298, ECO:0000269|PubMed:7567999, ECO:0000269|PubMed:8962082, ECO:0000269|PubMed:9356448}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:22837; Evidence={ECO:0000269|PubMed:26851298, ECO:0000269|PubMed:7567999, ECO:0000269|PubMed:8962082, ECO:0000269|PubMed:9356448}; CATALYTIC ACTIVITY: Reaction=a (3R)-hydroxyacyl-[ACP] + NADP(+) = a 3-oxoacyl-[ACP] + NADPH + H(+); Xref=Rhea:RHEA:17397, Rhea:RHEA-COMP:9916, Rhea:RHEA-COMP:9945, ChEBI:CHEBI:15378, ChEBI:CHEBI:57783, ChEBI:CHEBI:58349, ChEBI:CHEBI:78776, ChEBI:CHEBI:78827; EC=1.1.1.100; Evidence={ECO:0000269|PubMed:26851298, ECO:0000269|PubMed:7567999, ECO:0000269|PubMed:8962082, ECO:0000269|PubMed:9356448}; PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:17399; Evidence={ECO:0000269|PubMed:26851298, ECO:0000269|PubMed:7567999, ECO:0000269|PubMed:8962082, ECO:0000269|PubMed:9356448}; CATALYTIC ACTIVITY: Reaction=a (3R)-hydroxyacyl-[ACP] = a (2E)-enoyl-[ACP] + H2O; Xref=Rhea:RHEA:13097, Rhea:RHEA-COMP:9925, Rhea:RHEA-COMP:9945, ChEBI:CHEBI:15377, ChEBI:CHEBI:78784, ChEBI:CHEBI:78827; EC=4.2.1.59; Evidence={ECO:0000269|PubMed:26851298, ECO:0000269|PubMed:7567999, ECO:0000269|PubMed:8962082, ECO:0000269|PubMed:9356448}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:13098; Evidence={ECO:0000269|PubMed:26851298, ECO:0000269|PubMed:7567999, ECO:0000269|PubMed:8962082, ECO:0000269|PubMed:9356448}; CATALYTIC ACTIVITY: Reaction=a 2,3-saturated acyl-[ACP] + NADP(+) = a (2E)-enoyl-[ACP] + NADPH + H(+); Xref=Rhea:RHEA:22564, Rhea:RHEA-COMP:9925, Rhea:RHEA-COMP:9926, ChEBI:CHEBI:15378, ChEBI:CHEBI:57783, ChEBI:CHEBI:58349, ChEBI:CHEBI:78784, ChEBI:CHEBI:78785; EC=1.3.1.39; Evidence={ECO:0000269|PubMed:26851298, ECO:0000269|PubMed:7567999, ECO:0000269|PubMed:8962082, ECO:0000269|PubMed:9356448}; PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:22566; Evidence={ECO:0000269|PubMed:26851298, ECO:0000269|PubMed:7567999, ECO:0000269|PubMed:8962082, ECO:0000269|PubMed:9356448}; CATALYTIC ACTIVITY: Reaction=hexadecanoyl-[ACP] + H2O = hexadecanoate + holo-[ACP] + H(+); Xref=Rhea:RHEA:41932, Rhea:RHEA-COMP:9652, Rhea:RHEA-COMP:9685, ChEBI:CHEBI:7896, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:64479, ChEBI:CHEBI:78483; EC=3.1.2.14; Evidence={ECO:0000269|PubMed:15507492, ECO:0000269|PubMed:7567999, ECO:0000269|PubMed:8962082, ECO:0000269|PubMed:9356448}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:41933; Evidence={ECO:0000269|PubMed:15507492, ECO:0000269|PubMed:7567999, ECO:0000269|PubMed:8962082, ECO:0000269|PubMed:9356448}; CATALYTIC ACTIVITY: Reaction=acetyl-[ACP] + malonyl-[ACP] + H(+) = 3-oxobutanoyl-[ACP] + holo-[ACP] + CO2; Xref=Rhea:RHEA:41800, Rhea:RHEA-COMP:9621, Rhea:RHEA-COMP:9623, Rhea:RHEA-COMP:9625, Rhea:RHEA-COMP:9685, ChEBI:CHEBI:15378, ChEBI:CHEBI:16526, ChEBI:CHEBI:64479, ChEBI:CHEBI:78446, ChEBI:CHEBI:78449, ChEBI:CHEBI:78450; Evidence={ECO:0000269|PubMed:7567999, ECO:0000269|PubMed:8962082, ECO:0000269|PubMed:9356448}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:41801; Evidence={ECO:0000269|PubMed:7567999, ECO:0000269|PubMed:8962082, ECO:0000269|PubMed:9356448}; CATALYTIC ACTIVITY: Reaction=3-oxobutanoyl-[ACP] + NADPH + H(+) = (3R)-hydroxybutanoyl-[ACP] + NADP(+); Xref=Rhea:RHEA:41804, Rhea:RHEA-COMP:9625, Rhea:RHEA-COMP:9626, ChEBI:CHEBI:15378, ChEBI:CHEBI:57783, ChEBI:CHEBI:58349, ChEBI:CHEBI:78450, ChEBI:CHEBI:78451; Evidence={ECO:0000269|PubMed:7567999, ECO:0000269|PubMed:8962082, ECO:0000269|PubMed:9356448}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:41805; Evidence={ECO:0000269|PubMed:7567999, ECO:0000269|PubMed:8962082, ECO:0000269|PubMed:9356448}; CATALYTIC ACTIVITY: Reaction=(3R)-hydroxybutanoyl-[ACP] = (2E)-butenoyl-[ACP] + H2O; Xref=Rhea:RHEA:41808, Rhea:RHEA-COMP:9626, Rhea:RHEA-COMP:9627, ChEBI:CHEBI:15377, ChEBI:CHEBI:78451, ChEBI:CHEBI:78453; Evidence={ECO:0000269|PubMed:7567999, ECO:0000269|PubMed:8962082, ECO:0000269|PubMed:9356448}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:41809; Evidence={ECO:0000269|PubMed:7567999, ECO:0000269|PubMed:8962082, ECO:0000269|PubMed:9356448}; CATALYTIC ACTIVITY: Reaction=(2E)-butenoyl-[ACP] + NADPH + H(+) = butanoyl-[ACP] + NADP(+); Xref=Rhea:RHEA:41812, Rhea:RHEA-COMP:9627, Rhea:RHEA-COMP:9628, ChEBI:CHEBI:15378, ChEBI:CHEBI:57783, ChEBI:CHEBI:58349, ChEBI:CHEBI:78453, ChEBI:CHEBI:78454; Evidence={ECO:0000269|PubMed:7567999, ECO:0000269|PubMed:8962082, ECO:0000269|PubMed:9356448}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:41813; Evidence={ECO:0000269|PubMed:7567999, ECO:0000269|PubMed:8962082, ECO:0000269|PubMed:9356448}; CATALYTIC ACTIVITY: Reaction=butanoyl-[ACP] + malonyl-[ACP] + H(+) = 3-oxohexanoyl-[ACP] + holo-[ACP] + CO2; Xref=Rhea:RHEA:41820, Rhea:RHEA-COMP:9623, Rhea:RHEA-COMP:9628, Rhea:RHEA-COMP:9629, Rhea:RHEA-COMP:9685, ChEBI:CHEBI:15378, ChEBI:CHEBI:16526, ChEBI:CHEBI:64479, ChEBI:CHEBI:78449, ChEBI:CHEBI:78454, ChEBI:CHEBI:78456; Evidence={ECO:0000269|PubMed:7567999, ECO:0000269|PubMed:8962082, ECO:0000269|PubMed:9356448}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:41821; Evidence={ECO:0000269|PubMed:7567999, ECO:0000269|PubMed:8962082, ECO:0000269|PubMed:9356448}; CATALYTIC ACTIVITY: Reaction=3-oxohexanoyl-[ACP] + NADPH + H(+) = (3R)-hydroxyhexanoyl-[ACP] + NADP(+); Xref=Rhea:RHEA:41824, Rhea:RHEA-COMP:9629, Rhea:RHEA-COMP:9630, ChEBI:CHEBI:15378, ChEBI:CHEBI:57783, ChEBI:CHEBI:58349, ChEBI:CHEBI:78456, ChEBI:CHEBI:78457; Evidence={ECO:0000269|PubMed:7567999, ECO:0000269|PubMed:8962082, ECO:0000269|PubMed:9356448}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:41825; Evidence={ECO:0000269|PubMed:7567999, ECO:0000269|PubMed:8962082, ECO:0000269|PubMed:9356448}; CATALYTIC ACTIVITY: Reaction=(3R)-hydroxyhexanoyl-[ACP] = (2E)-hexenoyl-[ACP] + H2O; Xref=Rhea:RHEA:41828, Rhea:RHEA-COMP:9630, Rhea:RHEA-COMP:9631, ChEBI:CHEBI:15377, ChEBI:CHEBI:78457, ChEBI:CHEBI:78458; Evidence={ECO:0000269|PubMed:7567999, ECO:0000269|PubMed:8962082, ECO:0000269|PubMed:9356448}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:41829; Evidence={ECO:0000269|PubMed:7567999, ECO:0000269|PubMed:8962082, ECO:0000269|PubMed:9356448}; CATALYTIC ACTIVITY: Reaction=(2E)-hexenoyl-[ACP] + NADPH + H(+) = hexanoyl-[ACP] + NADP(+); Xref=Rhea:RHEA:41832, Rhea:RHEA-COMP:9631, Rhea:RHEA-COMP:9632, ChEBI:CHEBI:15378, ChEBI:CHEBI:57783, ChEBI:CHEBI:58349, ChEBI:CHEBI:78458, ChEBI:CHEBI:78459; Evidence={ECO:0000269|PubMed:7567999, ECO:0000269|PubMed:8962082, ECO:0000269|PubMed:9356448}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:41833; Evidence={ECO:0000269|PubMed:7567999, ECO:0000269|PubMed:8962082, ECO:0000269|PubMed:9356448}; CATALYTIC ACTIVITY: Reaction=hexanoyl-[ACP] + malonyl-[ACP] + H(+) = 3-oxooctanoyl-[ACP] + holo-[ACP] + CO2; Xref=Rhea:RHEA:41836, Rhea:RHEA-COMP:9623, Rhea:RHEA-COMP:9632, Rhea:RHEA-COMP:9633, Rhea:RHEA-COMP:9685, ChEBI:CHEBI:15378, ChEBI:CHEBI:16526, ChEBI:CHEBI:64479, ChEBI:CHEBI:78449, ChEBI:CHEBI:78459, ChEBI:CHEBI:78460; Evidence={ECO:0000269|PubMed:7567999, ECO:0000269|PubMed:8962082, ECO:0000269|PubMed:9356448}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:41837; Evidence={ECO:0000269|PubMed:7567999, ECO:0000269|PubMed:8962082, ECO:0000269|PubMed:9356448}; CATALYTIC ACTIVITY: Reaction=3-oxooctanoyl-[ACP] + NADPH + H(+) = (3R)-hydroxyoctanoyl-[ACP] + NADP(+); Xref=Rhea:RHEA:41840, Rhea:RHEA-COMP:9633, Rhea:RHEA-COMP:9634, ChEBI:CHEBI:15378, ChEBI:CHEBI:57783, ChEBI:CHEBI:58349, ChEBI:CHEBI:78460, ChEBI:CHEBI:78461; Evidence={ECO:0000269|PubMed:7567999, ECO:0000269|PubMed:8962082, ECO:0000269|PubMed:9356448}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:41841; Evidence={ECO:0000269|PubMed:7567999, ECO:0000269|PubMed:8962082, ECO:0000269|PubMed:9356448}; CATALYTIC ACTIVITY: Reaction=(3R)-hydroxyoctanoyl-[ACP] = (2E)-octenoyl-[ACP] + H2O; Xref=Rhea:RHEA:41844, Rhea:RHEA-COMP:9634, Rhea:RHEA-COMP:9635, ChEBI:CHEBI:15377, ChEBI:CHEBI:78461, ChEBI:CHEBI:78462; Evidence={ECO:0000269|PubMed:7567999, ECO:0000269|PubMed:8962082, ECO:0000269|PubMed:9356448}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:41845; Evidence={ECO:0000269|PubMed:7567999, ECO:0000269|PubMed:8962082, ECO:0000269|PubMed:9356448}; CATALYTIC ACTIVITY: Reaction=(2E)-octenoyl-[ACP] + NADPH + H(+) = octanoyl-[ACP] + NADP(+); Xref=Rhea:RHEA:41848, Rhea:RHEA-COMP:9635, Rhea:RHEA-COMP:9636, ChEBI:CHEBI:15378, ChEBI:CHEBI:57783, ChEBI:CHEBI:58349, ChEBI:CHEBI:78462, ChEBI:CHEBI:78463; Evidence={ECO:0000269|PubMed:7567999, ECO:0000269|PubMed:8962082, ECO:0000269|PubMed:9356448}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:41849; Evidence={ECO:0000269|PubMed:7567999, ECO:0000269|PubMed:8962082, ECO:0000269|PubMed:9356448}; CATALYTIC ACTIVITY: Reaction=octanoyl-[ACP] + malonyl-[ACP] + H(+) = 3-oxodecanoyl-[ACP] + holo-[ACP] + CO2; Xref=Rhea:RHEA:41852, Rhea:RHEA-COMP:9623, Rhea:RHEA-COMP:9636, Rhea:RHEA-COMP:9637, Rhea:RHEA-COMP:9685, ChEBI:CHEBI:15378, ChEBI:CHEBI:16526, ChEBI:CHEBI:64479, ChEBI:CHEBI:78449, ChEBI:CHEBI:78463, ChEBI:CHEBI:78464; Evidence={ECO:0000269|PubMed:7567999, ECO:0000269|PubMed:8962082, ECO:0000269|PubMed:9356448}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:41853; Evidence={ECO:0000269|PubMed:7567999, ECO:0000269|PubMed:8962082, ECO:0000269|PubMed:9356448}; CATALYTIC ACTIVITY: Reaction=3-oxodecanoyl-[ACP] + NADPH + H(+) = (3R)-hydroxydecanoyl-[ACP] + NADP(+); Xref=Rhea:RHEA:41856, Rhea:RHEA-COMP:9637, Rhea:RHEA-COMP:9638, ChEBI:CHEBI:15378, ChEBI:CHEBI:57783, ChEBI:CHEBI:58349, ChEBI:CHEBI:78464, ChEBI:CHEBI:78466; Evidence={ECO:0000269|PubMed:7567999, ECO:0000269|PubMed:8962082, ECO:0000269|PubMed:9356448}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:41857; Evidence={ECO:0000269|PubMed:7567999, ECO:0000269|PubMed:8962082, ECO:0000269|PubMed:9356448}; CATALYTIC ACTIVITY: Reaction=(3R)-hydroxydecanoyl-[ACP] = (2E)-decenoyl-[ACP] + H2O; Xref=Rhea:RHEA:41860, Rhea:RHEA-COMP:9638, Rhea:RHEA-COMP:9639, ChEBI:CHEBI:15377, ChEBI:CHEBI:78466, ChEBI:CHEBI:78467; Evidence={ECO:0000269|PubMed:7567999, ECO:0000269|PubMed:8962082, ECO:0000269|PubMed:9356448}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:41861; Evidence={ECO:0000269|PubMed:7567999, ECO:0000269|PubMed:8962082, ECO:0000269|PubMed:9356448}; CATALYTIC ACTIVITY: Reaction=(2E)-decenoyl-[ACP] + NADPH + H(+) = decanoyl-[ACP] + NADP(+); Xref=Rhea:RHEA:41864, Rhea:RHEA-COMP:9639, Rhea:RHEA-COMP:9640, ChEBI:CHEBI:15378, ChEBI:CHEBI:57783, ChEBI:CHEBI:58349, ChEBI:CHEBI:78467, ChEBI:CHEBI:78468; Evidence={ECO:0000269|PubMed:7567999, ECO:0000269|PubMed:8962082, ECO:0000269|PubMed:9356448}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:41865; Evidence={ECO:0000269|PubMed:7567999, ECO:0000269|PubMed:8962082, ECO:0000269|PubMed:9356448}; CATALYTIC ACTIVITY: Reaction=decanoyl-[ACP] + malonyl-[ACP] + H(+) = 3-oxododecanoyl-[ACP] + holo-[ACP] + CO2; Xref=Rhea:RHEA:41868, Rhea:RHEA-COMP:9623, Rhea:RHEA-COMP:9640, Rhea:RHEA-COMP:9641, Rhea:RHEA-COMP:9685, ChEBI:CHEBI:15378, ChEBI:CHEBI:16526, ChEBI:CHEBI:64479, ChEBI:CHEBI:78449, ChEBI:CHEBI:78468, ChEBI:CHEBI:78469; Evidence={ECO:0000269|PubMed:7567999, ECO:0000269|PubMed:8962082, ECO:0000269|PubMed:9356448}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:41869; Evidence={ECO:0000269|PubMed:7567999, ECO:0000269|PubMed:8962082, ECO:0000269|PubMed:9356448}; CATALYTIC ACTIVITY: Reaction=3-oxododecanoyl-[ACP] + NADPH + H(+) = (3R)-hydroxydodecanoyl-[ACP] + NADP(+); Xref=Rhea:RHEA:41872, Rhea:RHEA-COMP:9641, Rhea:RHEA-COMP:9642, ChEBI:CHEBI:15378, ChEBI:CHEBI:57783, ChEBI:CHEBI:58349, ChEBI:CHEBI:78469, ChEBI:CHEBI:78470; Evidence={ECO:0000269|PubMed:7567999, ECO:0000269|PubMed:8962082, ECO:0000269|PubMed:9356448}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:41873; Evidence={ECO:0000269|PubMed:7567999, ECO:0000269|PubMed:8962082, ECO:0000269|PubMed:9356448}; CATALYTIC ACTIVITY: Reaction=(3R)-hydroxydodecanoyl-[ACP] = (2E)-dodecenoyl-[ACP] + H2O; Xref=Rhea:RHEA:41876, Rhea:RHEA-COMP:9642, Rhea:RHEA-COMP:9643, ChEBI:CHEBI:15377, ChEBI:CHEBI:78470, ChEBI:CHEBI:78472; Evidence={ECO:0000269|PubMed:7567999, ECO:0000269|PubMed:8962082, ECO:0000269|PubMed:9356448}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:41877; Evidence={ECO:0000269|PubMed:7567999, ECO:0000269|PubMed:8962082, ECO:0000269|PubMed:9356448}; CATALYTIC ACTIVITY: Reaction=(2E)-dodecenoyl-[ACP] + NADPH + H(+) = dodecanoyl-[ACP] + NADP(+); Xref=Rhea:RHEA:41880, Rhea:RHEA-COMP:9643, Rhea:RHEA-COMP:9644, ChEBI:CHEBI:15378, ChEBI:CHEBI:57783, ChEBI:CHEBI:58349, ChEBI:CHEBI:65264, ChEBI:CHEBI:78472; Evidence={ECO:0000269|PubMed:7567999, ECO:0000269|PubMed:8962082, ECO:0000269|PubMed:9356448}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:41881; Evidence={ECO:0000269|PubMed:7567999, ECO:0000269|PubMed:8962082, ECO:0000269|PubMed:9356448}; CATALYTIC ACTIVITY: Reaction=dodecanoyl-[ACP] + malonyl-[ACP] + H(+) = 3-oxotetradecanoyl-[ACP] + holo-[ACP] + CO2; Xref=Rhea:RHEA:41884, Rhea:RHEA-COMP:9623, Rhea:RHEA-COMP:9644, Rhea:RHEA-COMP:9645, Rhea:RHEA-COMP:9685, ChEBI:CHEBI:15378, ChEBI:CHEBI:16526, ChEBI:CHEBI:64479, ChEBI:CHEBI:65264, ChEBI:CHEBI:78449, ChEBI:CHEBI:78473; Evidence={ECO:0000269|PubMed:7567999, ECO:0000269|PubMed:8962082, ECO:0000269|PubMed:9356448}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:41885; Evidence={ECO:0000269|PubMed:7567999, ECO:0000269|PubMed:8962082, ECO:0000269|PubMed:9356448}; CATALYTIC ACTIVITY: Reaction=3-oxotetradecanoyl-[ACP] + NADPH + H(+) = (3R)-hydroxytetradecanoyl-[ACP] + NADP(+); Xref=Rhea:RHEA:41888, Rhea:RHEA-COMP:9645, Rhea:RHEA-COMP:9646, ChEBI:CHEBI:15378, ChEBI:CHEBI:57783, ChEBI:CHEBI:58349, ChEBI:CHEBI:78473, ChEBI:CHEBI:78474; Evidence={ECO:0000269|PubMed:7567999, ECO:0000269|PubMed:8962082, ECO:0000269|PubMed:9356448}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:41889; Evidence={ECO:0000269|PubMed:7567999, ECO:0000269|PubMed:8962082, ECO:0000269|PubMed:9356448}; CATALYTIC ACTIVITY: Reaction=(3R)-hydroxytetradecanoyl-[ACP] = (2E)-tetradecenoyl-[ACP] + H2O; Xref=Rhea:RHEA:41892, Rhea:RHEA-COMP:9646, Rhea:RHEA-COMP:9647, ChEBI:CHEBI:15377, ChEBI:CHEBI:78474, ChEBI:CHEBI:78475; Evidence={ECO:0000269|PubMed:7567999, ECO:0000269|PubMed:8962082, ECO:0000269|PubMed:9356448}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:41893; Evidence={ECO:0000269|PubMed:7567999, ECO:0000269|PubMed:8962082, ECO:0000269|PubMed:9356448}; CATALYTIC ACTIVITY: Reaction=(2E)-tetradecenoyl-[ACP] + NADPH + H(+) = tetradecanoyl-[ACP] + NADP(+); Xref=Rhea:RHEA:41896, Rhea:RHEA-COMP:9647, Rhea:RHEA-COMP:9648, ChEBI:CHEBI:15378, ChEBI:CHEBI:57783, ChEBI:CHEBI:58349, ChEBI:CHEBI:78475, ChEBI:CHEBI:78477; Evidence={ECO:0000269|PubMed:7567999, ECO:0000269|PubMed:8962082, ECO:0000269|PubMed:9356448}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:41897; Evidence={ECO:0000269|PubMed:7567999, ECO:0000269|PubMed:8962082, ECO:0000269|PubMed:9356448}; CATALYTIC ACTIVITY: Reaction=tetradecanoyl-[ACP] + malonyl-[ACP] + H(+) = 3-oxohexadecanoyl-[ACP] + holo-[ACP] + CO2; Xref=Rhea:RHEA:41900, Rhea:RHEA-COMP:9623, Rhea:RHEA-COMP:9648, Rhea:RHEA-COMP:9649, Rhea:RHEA-COMP:9685, ChEBI:CHEBI:15378, ChEBI:CHEBI:16526, ChEBI:CHEBI:64479, ChEBI:CHEBI:78449, ChEBI:CHEBI:78477, ChEBI:CHEBI:78478; Evidence={ECO:0000269|PubMed:7567999, ECO:0000269|PubMed:8962082, ECO:0000269|PubMed:9356448}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:41901; Evidence={ECO:0000269|PubMed:7567999, ECO:0000269|PubMed:8962082, ECO:0000269|PubMed:9356448}; CATALYTIC ACTIVITY: Reaction=3-oxohexadecanoyl-[ACP] + NADPH + H(+) = (3R)-hydroxyhexadecanoyl-[ACP] + NADP(+); Xref=Rhea:RHEA:41904, Rhea:RHEA-COMP:9649, Rhea:RHEA-COMP:9650, ChEBI:CHEBI:15378, ChEBI:CHEBI:57783, ChEBI:CHEBI:58349, ChEBI:CHEBI:78478, ChEBI:CHEBI:78480; Evidence={ECO:0000269|PubMed:7567999, ECO:0000269|PubMed:8962082, ECO:0000269|PubMed:9356448}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:41905; Evidence={ECO:0000269|PubMed:7567999, ECO:0000269|PubMed:8962082, ECO:0000269|PubMed:9356448}; CATALYTIC ACTIVITY: Reaction=(3R)-hydroxyhexadecanoyl-[ACP] = (2E)-hexadecenoyl-[ACP] + H2O; Xref=Rhea:RHEA:41908, Rhea:RHEA-COMP:9650, Rhea:RHEA-COMP:9651, ChEBI:CHEBI:15377, ChEBI:CHEBI:78480, ChEBI:CHEBI:78481; Evidence={ECO:0000269|PubMed:7567999, ECO:0000269|PubMed:8962082, ECO:0000269|PubMed:9356448}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:41909; Evidence={ECO:0000269|PubMed:7567999, ECO:0000269|PubMed:8962082, ECO:0000269|PubMed:9356448}; CATALYTIC ACTIVITY: Reaction=(2E)-hexadecenoyl-[ACP] + NADPH + H(+) = hexadecanoyl-[ACP] + NADP(+); Xref=Rhea:RHEA:41912, Rhea:RHEA-COMP:9651, Rhea:RHEA-COMP:9652, ChEBI:CHEBI:15378, ChEBI:CHEBI:57783, ChEBI:CHEBI:58349, ChEBI:CHEBI:78481, ChEBI:CHEBI:78483; Evidence={ECO:0000269|PubMed:7567999, ECO:0000269|PubMed:8962082, ECO:0000269|PubMed:9356448}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:41913; Evidence={ECO:0000269|PubMed:7567999, ECO:0000269|PubMed:8962082, ECO:0000269|PubMed:9356448}; CATALYTIC ACTIVITY: Reaction=hexadecanoyl-[ACP] + malonyl-[ACP] + H(+) = 3-oxooctadecanoyl-[ACP] + holo-[ACP] + CO2; Xref=Rhea:RHEA:41916, Rhea:RHEA-COMP:9623, Rhea:RHEA-COMP:9652, Rhea:RHEA-COMP:9653, Rhea:RHEA-COMP:9685, ChEBI:CHEBI:15378, ChEBI:CHEBI:16526, ChEBI:CHEBI:64479, ChEBI:CHEBI:78449, ChEBI:CHEBI:78483, ChEBI:CHEBI:78487; Evidence={ECO:0000269|PubMed:7567999, ECO:0000269|PubMed:8962082}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:41917; Evidence={ECO:0000269|PubMed:7567999, ECO:0000269|PubMed:8962082}; CATALYTIC ACTIVITY: Reaction=3-oxooctadecanoyl-[ACP] + NADPH + H(+) = (3R)-hydroxyoctadecanoyl-[ACP] + NADP(+); Xref=Rhea:RHEA:41920, Rhea:RHEA-COMP:9653, Rhea:RHEA-COMP:9654, ChEBI:CHEBI:15378, ChEBI:CHEBI:57783, ChEBI:CHEBI:58349, ChEBI:CHEBI:78487, ChEBI:CHEBI:78488; Evidence={ECO:0000269|PubMed:7567999, ECO:0000269|PubMed:8962082}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:41921; Evidence={ECO:0000269|PubMed:7567999, ECO:0000269|PubMed:8962082}; CATALYTIC ACTIVITY: Reaction=(3R)-hydroxyoctadecanoyl-[ACP] = (2E)-octadecenoyl-[ACP] + H2O; Xref=Rhea:RHEA:41924, Rhea:RHEA-COMP:9654, Rhea:RHEA-COMP:9655, ChEBI:CHEBI:15377, ChEBI:CHEBI:78488, ChEBI:CHEBI:78489; Evidence={ECO:0000269|PubMed:7567999, ECO:0000269|PubMed:8962082}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:41925; Evidence={ECO:0000269|PubMed:7567999, ECO:0000269|PubMed:8962082}; CATALYTIC ACTIVITY: Reaction=(2E)-octadecenoyl-[ACP] + NADPH + H(+) = octadecanoyl-[ACP] + NADP(+); Xref=Rhea:RHEA:41928, Rhea:RHEA-COMP:9655, Rhea:RHEA-COMP:9656, ChEBI:CHEBI:15378, ChEBI:CHEBI:57783, ChEBI:CHEBI:58349, ChEBI:CHEBI:78489, ChEBI:CHEBI:78495; Evidence={ECO:0000269|PubMed:7567999, ECO:0000269|PubMed:8962082}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:41929; Evidence={ECO:0000269|PubMed:7567999, ECO:0000269|PubMed:8962082}; CATALYTIC ACTIVITY: Reaction=tetradecanoyl-[ACP] + H2O = tetradecanoate + holo-[ACP] + H(+); Xref=Rhea:RHEA:30123, Rhea:RHEA-COMP:9648, Rhea:RHEA-COMP:9685, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:30807, ChEBI:CHEBI:64479, ChEBI:CHEBI:78477; EC=3.1.2.14; Evidence={ECO:0000269|PubMed:8962082, ECO:0000269|PubMed:9356448}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:30124; Evidence={ECO:0000269|PubMed:7567999, ECO:0000269|PubMed:8962082}; CATALYTIC ACTIVITY: Reaction=octadecanoyl-[ACP] + H2O = octadecanoate + holo-[ACP] + H(+); Xref=Rhea:RHEA:63204, Rhea:RHEA-COMP:9656, Rhea:RHEA-COMP:9685, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:25629, ChEBI:CHEBI:64479, ChEBI:CHEBI:78495; Evidence={ECO:0000269|PubMed:15507492, ECO:0000269|PubMed:7567999, ECO:0000269|PubMed:8962082}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:63205; Evidence={ECO:0000269|PubMed:15507492, ECO:0000269|PubMed:7567999, ECO:0000269|PubMed:8962082};",1.1.1.100; 1.3.1.39; 2.3.1.38; 2.3.1.39; 2.3.1.41; 2.3.1.85; 3.1.2.14; 4.2.1.59,"ACTIVITY REGULATION: Activated by S-nitrosylation which promotes enzyme dimerization (PubMed:26851298). Cerulenin, a potent non-competitive pharmacological inhibitor of FAS, binds covalently to the active site of the condensing enzyme region, inactivating a key enzyme step in fatty acid synthesis (PubMed:16969344). {ECO:0000269|PubMed:16969344, ECO:0000269|PubMed:26851298}.","PATHWAY: Lipid metabolism; fatty acid biosynthesis. {ECO:0000269|PubMed:7567999, ECO:0000269|PubMed:8962082, ECO:0000269|PubMed:9356448}.",ENST00000306749.4;,FASN,ENSG00000169710,0.0,FASN,Non-canonical_RBPs,22.0,1.51,DP03143,0.015,0.014,,FASN
P49407,ENSG00000137486,ARRB1_HUMAN,G protein-coupled receptor internalization [GO:0002031]; negative regulation of interleukin-6 production [GO:0032715]; negative regulation of interleukin-8 production [GO:0032717]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of Notch signaling pathway [GO:0045746]; negative regulation of protein ubiquitination [GO:0031397]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of receptor internalization [GO:0002092]; positive regulation of Rho protein signal transduction [GO:0035025]; positive regulation of transcription by RNA polymerase II [GO:0045944]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein transport [GO:0015031]; protein ubiquitination [GO:0016567]; regulation of transcription by RNA polymerase II [GO:0006357]; signal transduction [GO:0007165]; stress fiber assembly [GO:0043149]; ubiquitin-dependent protein catabolic process [GO:0006511]; visual perception [GO:0007601],chromatin [GO:0000785]; clathrin-coated pit [GO:0005905]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytoplasmic vesicle membrane [GO:0030659]; cytosol [GO:0005829]; endocytic vesicle membrane [GO:0030666]; Golgi membrane [GO:0000139]; lysosomal membrane [GO:0005765]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; pseudopodium [GO:0031143],angiotensin receptor binding [GO:0031701]; arrestin family protein binding [GO:1990763]; enzyme inhibitor activity [GO:0004857]; G protein-coupled receptor binding [GO:0001664]; GTPase activator activity [GO:0005096]; insulin-like growth factor receptor binding [GO:0005159]; transcription coactivator activity [GO:0003713]; ubiquitin protein ligase binding [GO:0031625],"PTM: Constitutively phosphorylated at Ser-412 in the cytoplasm. At the plasma membrane, is rapidly dephosphorylated, a process that is required for clathrin binding and ADRB2 endocytosis but not for ADRB2 binding and desensitization. Once internalized, is rephosphorylated. {ECO:0000269|PubMed:19661922}.; PTM: The ubiquitination status appears to regulate the formation and trafficking of beta-arrestin-GPCR complexes and signaling. Ubiquitination appears to occur GPCR-specific. Ubiquitinated by MDM2; the ubiquitination is required for rapid internalization of ADRB2. Deubiquitinated by USP33; the deubiquitination leads to a dissociation of the beta-arrestin-GPCR complex. Stimulation of a class A GPCR, such as ADRB2, induces transient ubiquitination and subsequently promotes association with USP33. {ECO:0000269|PubMed:19363159}.","DOMAIN: The [DE]-X(1,2)-F-X-X-[FL]-X-X-X-R motif mediates interaction the AP-2 complex subunit AP2B1 (By similarity). Binding to phosphorylated GPCRs induces a conformationanl change that exposes the motif to the surface. {ECO:0000250}.; DOMAIN: The N-terminus binds InsP6 with low affinity. {ECO:0000250}.; DOMAIN: The C-terminus binds InsP6 with high affinity. {ECO:0000250}.",,"STRAND 7..12; /evidence=""ECO:0007829|PDB:8AS4""; STRAND 16..23; /evidence=""ECO:0007829|PDB:8AS4""; STRAND 25..29; /evidence=""ECO:0007829|PDB:8AS4""; STRAND 31..33; /evidence=""ECO:0007829|PDB:6TKO""; STRAND 37..43; /evidence=""ECO:0007829|PDB:8AS4""; STRAND 52..64; /evidence=""ECO:0007829|PDB:8AS4""; STRAND 74..87; /evidence=""ECO:0007829|PDB:8AS4""; STRAND 112..117; /evidence=""ECO:0007829|PDB:8AS4""; STRAND 127..130; /evidence=""ECO:0007829|PDB:8AS4""; STRAND 140..152; /evidence=""ECO:0007829|PDB:8AS4""; STRAND 154..156; /evidence=""ECO:0007829|PDB:8AS4""; STRAND 163..166; /evidence=""ECO:0007829|PDB:8AS4""; STRAND 169..172; /evidence=""ECO:0007829|PDB:8AS4""; STRAND 185..189; /evidence=""ECO:0007829|PDB:8AS4""; STRAND 191..195; /evidence=""ECO:0007829|PDB:8AS4""; STRAND 197..204; /evidence=""ECO:0007829|PDB:8AS4""; STRAND 206..209; /evidence=""ECO:0007829|PDB:8AS4""; STRAND 214..222; /evidence=""ECO:0007829|PDB:8AS4""; STRAND 224..226; /evidence=""ECO:0007829|PDB:6TKO""; STRAND 228..241; /evidence=""ECO:0007829|PDB:8AS4""; STRAND 243..245; /evidence=""ECO:0007829|PDB:8AS4""; STRAND 247..258; /evidence=""ECO:0007829|PDB:8AS4""; STRAND 266..274; /evidence=""ECO:0007829|PDB:8AS4""; STRAND 285..291; /evidence=""ECO:0007829|PDB:8AS4""; STRAND 293..295; /evidence=""ECO:0007829|PDB:8AS2""; STRAND 316..329; /evidence=""ECO:0007829|PDB:8AS4""; STRAND 341..352; /evidence=""ECO:0007829|PDB:8AS4""; STRAND 365..367; /evidence=""ECO:0007829|PDB:7SRS""; STRAND 387..392; /evidence=""ECO:0007829|PDB:8AS4""","HELIX 45..48; /evidence=""ECO:0007829|PDB:8AS4""; HELIX 66..70; /evidence=""ECO:0007829|PDB:7SRS""; HELIX 99..108; /evidence=""ECO:0007829|PDB:8AS4""; HELIX 160..162; /evidence=""ECO:0007829|PDB:8AS4""; HELIX 278..281; /evidence=""ECO:0007829|PDB:8AS4""; HELIX 313..315; /evidence=""ECO:0007829|PDB:8AS4""; HELIX 333..335; /evidence=""ECO:0007829|PDB:8AS2""","TURN 91..93; /evidence=""ECO:0007829|PDB:6TKO""; TURN 336..338; /evidence=""ECO:0007829|PDB:8AS3""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,ARRB1 ARR1,Beta-arrestin-1 (Arrestin beta-1) (Non-visual arrestin-2),Homo sapiens (Human),418.0,47066.0,MGDKGTRVFKKASPNGKLTVYLGKRDFVDHIDLVDPVDGVVLVDPEYLKERRVYVTLTCAFRYGREDLDVLGLTFRKDLFVANVQSFPPAPEDKKPLTRLQERLIKKLGEHAYPFTFEIPPNLPCSVTLQPGPEDTGKACGVDYEVKAFCAENLEEKIHKRNSVRLVIRKVQYAPERPGPQPTAETTRQFLMSDKPLHLEASLDKEIYYHGEPISVNVHVTNNTNKTVKKIKISVRQYADICLFNTAQYKCPVAMEEADDTVAPSSTFCKVYTLTPFLANNREKRGLALDGKLKHEDTNLASSTLLREGANREILGIIVSYKVKVKLVVSRGGLLGDLASSDVAVELPFTLMHPKPKEEPPHREVPENETPVDTNLIELDTNDDDIVFEDFARQRLKGMKDDKEEEEDGTGSPQLNNR,False,True,True,P49407,"[('G3DSA:2.60.40.640', None), ('G3DSA:2.60.40.840', None), ('IPR000698', 'Arrestin'), ('IPR011021', 'Arrestin-like, N-terminal'), ('IPR011022', 'Arrestin C-terminal-like domain'), ('IPR014752', 'Arrestin-like, C-terminal'), ('IPR014753', 'Arrestin, N-terminal'), ('IPR014756', 'Immunoglobulin E-set'), ('IPR017864', 'Arrestin, conserved site'), ('PF00339', 'Arrestin (or S-antigen), N-terminal domain'), ('PF02752', 'Arrestin (or S-antigen), C-terminal domain'), ('PR00309', 'ARRESTIN'), ('PS00295', 'Arrestins signature'), ('PTHR11792', 'ARRESTIN'), ('SM01017', 'Arrestin (or S-antigen), C-terminal domain'), ('SSF81296', 'E set domains')]",P49407;,"""ENSG00000137486; Low tissue specificity."";",,,,,ENST00000360025.7 [P49407-2];ENST00000420843.7 [P49407-1];,ARRB1,ENSG00000137486,0.0,,,,,,,0.12,0.108,ARRB1
P49759,ENSG00000013441,CLK1_HUMAN,protein phosphorylation [GO:0006468]; regulation of RNA splicing [GO:0043484],nucleus [GO:0005634],ATP binding [GO:0005524]; non-membrane spanning protein tyrosine kinase activity [GO:0004715]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein serine/threonine/tyrosine kinase activity [GO:0004712]; protein tyrosine kinase activity [GO:0004713],PTM: Autophosphorylates on all three types of residues. {ECO:0000250|UniProtKB:P22518}.,,"DOMAIN 161..477; /note=""Protein kinase""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00159""","STRAND 161..170; /evidence=""ECO:0007829|PDB:6FT8""; STRAND 173..180; /evidence=""ECO:0007829|PDB:6FT8""; STRAND 187..193; /evidence=""ECO:0007829|PDB:6FT8""; STRAND 222..224; /evidence=""ECO:0007829|PDB:6Z50""; STRAND 227..233; /evidence=""ECO:0007829|PDB:6FT8""; STRAND 236..242; /evidence=""ECO:0007829|PDB:6FT8""; STRAND 294..297; /evidence=""ECO:0007829|PDB:6FT8""; STRAND 301..306; /evidence=""ECO:0007829|PDB:6FT8""; STRAND 311..317; /evidence=""ECO:0007829|PDB:6FT8""; STRAND 321..323; /evidence=""ECO:0007829|PDB:6FT8""; STRAND 330..334; /evidence=""ECO:0007829|PDB:6YTE""; STRAND 421..423; /evidence=""ECO:0007829|PDB:6YTI""","HELIX 148..150; /evidence=""ECO:0007829|PDB:6FT8""; HELIX 197..216; /evidence=""ECO:0007829|PDB:6FT8""; HELIX 248..254; /evidence=""ECO:0007829|PDB:6FT8""; HELIX 262..281; /evidence=""ECO:0007829|PDB:6FT8""; HELIX 291..293; /evidence=""ECO:0007829|PDB:6FT8""; HELIX 343..345; /evidence=""ECO:0007829|PDB:6FT8""; HELIX 348..351; /evidence=""ECO:0007829|PDB:6FT8""; HELIX 359..374; /evidence=""ECO:0007829|PDB:6FT8""; HELIX 384..395; /evidence=""ECO:0007829|PDB:6FT8""; HELIX 400..405; /evidence=""ECO:0007829|PDB:6FT8""; HELIX 409..411; /evidence=""ECO:0007829|PDB:6FT8""; HELIX 424..432; /evidence=""ECO:0007829|PDB:6FT8""; HELIX 436..439; /evidence=""ECO:0007829|PDB:6FT8""; HELIX 445..457; /evidence=""ECO:0007829|PDB:6FT8""; HELIX 468..471; /evidence=""ECO:0007829|PDB:6FT8""; HELIX 475..481; /evidence=""ECO:0007829|PDB:6FT8""","TURN 158..160; /evidence=""ECO:0007829|PDB:6FT8""; TURN 181..185; /evidence=""ECO:0007829|PDB:6FT8""; TURN 255..257; /evidence=""ECO:0007829|PDB:6FT8""; TURN 307..310; /evidence=""ECO:0007829|PDB:6FT8""; TURN 462..464; /evidence=""ECO:0007829|PDB:6FT8""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,CLK1 CLK,Dual specificity protein kinase CLK1 (EC 2.7.12.1) (CDC-like kinase 1),Homo sapiens (Human),484.0,57291.0,MRHSKRTYCPDWDDKDWDYGKWRSSSSHKRRKRSHSSAQENKRCKYNHSKMCDSHYLESRSINEKDYHSRRYIDEYRNDYTQGCEPGHRQRDHESRYQNHSSKSSGRSGRSSYKSKHRIHHSTSHRRSHGKSHRRKRTRSVEDDEEGHLICQSGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRRCKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDLLKKSI,True,False,False,P49759,"[('cd14213', 'Catalytic domain of the Dual-specificity protein kinases, CDC-like kinases 1 and 4'), ('G3DSA:1.10.510.10', 'Transferase(Phosphotransferase) domain 1'), ('G3DSA:3.30.200.20', 'Phosphorylase Kinase; domain 1'), ('IPR000719', 'Protein kinase domain'), ('IPR008271', 'Serine/threonine-protein kinase, active site'), ('IPR011009', 'Protein kinase-like domain superfamily'), ('IPR017441', 'Protein kinase, ATP binding site'), ('IPR051175', 'Dual specificity CLK kinases'), ('PF00069', 'Protein kinase domain'), ('PS00107', 'Protein kinases ATP-binding region signature'), ('PS00108', 'Serine/Threonine protein kinases active-site signature'), ('PS50011', 'Protein kinase domain profile'), ('PTHR45646', 'Dual specificity CLK kinases'), ('SM00220', 'Serine/Threonine protein kinases, catalytic domain'), ('SSF56112', 'Protein kinase-like (PK-like)')]",,"""ENSG00000013441; Low tissue specificity."";","CATALYTIC ACTIVITY: Reaction=L-seryl-[protein] + ATP = O-phospho-L-seryl-[protein] + ADP + H(+); Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616, ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.12.1; Evidence={ECO:0000269|PubMed:10480872}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:17990; Evidence={ECO:0000269|PubMed:10480872}; CATALYTIC ACTIVITY: Reaction=L-threonyl-[protein] + ATP = O-phospho-L-threonyl-[protein] + ADP + H(+); Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060, Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013, ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216; EC=2.7.12.1; Evidence={ECO:0000250|UniProtKB:P22518}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:46609; Evidence={ECO:0000250|UniProtKB:P22518}; CATALYTIC ACTIVITY: Reaction=L-tyrosyl-[protein] + ATP = O-phospho-L-tyrosyl-[protein] + ADP + H(+); Xref=Rhea:RHEA:10596, Rhea:RHEA-COMP:10136, Rhea:RHEA-COMP:10137, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616, ChEBI:CHEBI:46858, ChEBI:CHEBI:82620, ChEBI:CHEBI:456216; EC=2.7.12.1; Evidence={ECO:0000250|UniProtKB:P22518}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:10597; Evidence={ECO:0000250|UniProtKB:P22518};",2.7.12.1,ACTIVITY REGULATION: Regulates splicing of its own pre-mRNA according to its kinase activity; increased expression of the catalytically active form influences splicing to generate the catalytically inactive splicing variant lacking the kinase domain. Leucettine L41 inhibits its kinase activity and affects the regulation of alternative splicing mediated by phosphorylation of SR proteins. {ECO:0000250|UniProtKB:P22518}.,,ENST00000321356.9 [P49759-1];ENST00000432425.5 [P49759-2];ENST00000434813.3 [P49759-3];,CLK1,ENSG00000013441,0.0,CLK1,Non-canonical_RBPs,3.0,,,,0.244,0.227,CLK1
P49790,ENSG00000124789,NU153_HUMAN,amyloid fibril formation [GO:1990000]; mRNA transport [GO:0051028]; negative regulation of RNA export from nucleus [GO:0046832]; nuclear pore complex assembly [GO:0051292]; nucleocytoplasmic transport [GO:0006913]; protein import into nucleus [GO:0006606]; RNA export from nucleus [GO:0006405]; symbiont entry into host cell [GO:0046718]; viral penetration into host nucleus [GO:0075732],cytosol [GO:0005829]; host cell [GO:0043657]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear inclusion body [GO:0042405]; nuclear membrane [GO:0031965]; nuclear periphery [GO:0034399]; nuclear pore [GO:0005643]; nuclear pore nuclear basket [GO:0044615]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654],DNA binding [GO:0003677]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; molecular condensate scaffold activity [GO:0140693]; nuclear localization sequence binding [GO:0008139]; protein-membrane adaptor activity [GO:0043495]; structural constituent of nuclear pore [GO:0017056],"PTM: Phosphorylated in interphase, hyperphosphorylated during mitosis. May play a role in the reversible disassembly of the nuclear pore complex during mitosis (By similarity). {ECO:0000250}.; PTM: Proteolytically degraded after poliovirus (PV) infection; degradation is partial and NCP- and TPR-binding domains withstand degradation.; PTM: O-glycosylated during cytokinesis at sites identical or close to phosphorylation sites, this interferes with the phosphorylation status. {ECO:0000269|PubMed:20068230}.","DOMAIN: Contains FG repeats. FG repeats are interaction sites for karyopherins (importins, exportins) and form probably an affinity gradient, guiding the transport proteins unidirectionally with their cargo through the NPC. FG repeat regions are highly flexible and lack ordered secondary structure. The overall conservation of FG repeats regarding exact sequence, spacing, and repeat unit length is limited. {ECO:0000305}.; DOMAIN: (Microbial infection) FG repeats mediates interaction with HIV-1 capsid protein p24 (CA). {ECO:0000269|PubMed:24130490, ECO:0000269|PubMed:29997211}.",,"STRAND 723..727; /evidence=""ECO:0007829|PDB:2EBQ""; STRAND 729..731; /evidence=""ECO:0007829|PDB:2EBQ""; STRAND 743..745; /evidence=""ECO:0007829|PDB:2EBQ""; STRAND 794..796; /evidence=""ECO:0007829|PDB:2EBV""; STRAND 800..802; /evidence=""ECO:0007829|PDB:2EBV""; STRAND 814..816; /evidence=""ECO:0007829|PDB:2EBV""; STRAND 858..860; /evidence=""ECO:0007829|PDB:2EBR""; STRAND 872..874; /evidence=""ECO:0007829|PDB:2EBR""; STRAND 1416..1418; /evidence=""ECO:0007829|PDB:8CL0""","HELIX 755..757; /evidence=""ECO:0007829|PDB:2EBQ""",,"cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,NUP153,Nuclear pore complex protein Nup153 (153 kDa nucleoporin) (Nucleoporin Nup153),Homo sapiens (Human),1475.0,153938.0,MASGAGGVGGGGGGKIRTRRCHQGPIKPYQQGRQQHQGILSRVTESVKNIVPGWLQRYFNKNEDVCSCSTDTSEVPRWPENKEDHLVYADEESSNITDGRITPEPAVSNTEEPSTTSTASNYPDVLTRPSLHRSHLNFSMLESPALHCQPSTSSAFPIGSSGFSLVKEIKDSTSQHDDDNISTTSGFSSRASDKDITVSKNTSLPPLWSPEAERSHSLSQHTATSSKKPAFNLSAFGTLSPSLGNSSILKTSQLGDSPFYPGKTTYGGAAAAVRQSKLRNTPYQAPVRRQMKAKQLSAQSYGVTSSTARRILQSLEKMSSPLADAKRIPSIVSSPLNSPLDRSGIDITDFQAKREKVDSQYPPVQRLMTPKPVSIATNRSVYFKPSLTPSGEFRKTNQRIDNKCSTGYEKNMTPGQNREQRESGFSYPNFSLPAANGLSSGVGGGGGKMRRERTRFVASKPLEEEEMEVPVLPKISLPITSSSLPTFNFSSPEITTSSPSPINSSQALTNKVQMTSPSSTGSPMFKFSSPIVKSTEANVLPPSSIGFTFSVPVAKTAELSGSSSTLEPIISSSAHHVTTVNSTNCKKTPPEDCEGPFRPAEILKEGSVLDILKSPGFASPKIDSVAAQPTATSPVVYTRPAISSFSSSGIGFGESLKAGSSWQCDTCLLQNKVTDNKCIACQAAKLSPRDTAKQTGIETPNKSGKTTLSASGTGFGDKFKPVIGTWDCDTCLVQNKPEAIKCVACETPKPGTCVKRALTLTVVSESAETMTASSSSCTVTTGTLGFGDKFKRPIGSWECSVCCVSNNAEDNKCVSCMSEKPGSSVPASSSSTVPVSLPSGGSLGLEKFKKPEGSWDCELCLVQNKADSTKCLACESAKPGTKSGFKGFDTSSSSSNSAASSSFKFGVSSSSSGPSQTLTSTGNFKFGDQGGFKIGVSSDSGSINPMSEGFKFSKPIGDFKFGVSSESKPEEVKKDSKNDNFKFGLSSGLSNPVSLTPFQFGVSNLGQEEKKEELPKSSSAGFSFGTGVINSTPAPANTIVTSENKSSFNLGTIETKSASVAPFTCKTSEAKKEEMPATKGGFSFGNVEPASLPSASVFVLGRTEEKQQEPVTSTSLVFGKKADNEEPKCQPVFSFGNSEQTKDENSSKSTFSFSMTKPSEKESEQPAKATFAFGAQTSTTADQGAAKPVFSFLNNSSSSSSTPATSAGGGIFGSSTSSSNPPVATFVFGQSSNPVSSSAFGNTAESSTSQSLLFSQDSKLATTSSTGTAVTPFVFGPGASSNNTTTSGFGFGATTTSSSAGSSFVFGTGPSAPSASPAFGANQTPTFGQSQGASQPNPPGFGSISSSTALFPTGSQPAPPTFGTVSSSSQPPVFGQQPSQSAFGSGTTPNSSSAFQFGSSTTNFNFTNNSPSGVFTFGANSSTPAASAQPSGSGGFPFNQSPAAFTVGSNGKNVFSSSGTSFSGRKIKTAVRRRK,True,False,False,P49790,"[('G3DSA:4.10.1060.10', 'Zinc finger, RanBP2-type'), ('IPR001876', 'Zinc finger, RanBP2-type'), ('IPR013913', 'Nucleoporin Nup153, N-terminal'), ('IPR018892', 'Retro-transposon transporting motif'), ('IPR026054', 'Nuclear pore complex protein'), ('IPR036443', 'Zinc finger, RanBP2-type superfamily'), ('PF00641', 'Zn-finger in Ran binding protein and others'), ('PF08604', 'Nucleoporin Nup153-like'), ('PF10599', 'Retro-transposon transporting motif'), ('PS01358', 'Zinc finger RanBP2-type signature'), ('PS50199', 'Zinc finger RanBP2 type profile'), ('PTHR23193', 'NUCLEAR PORE COMPLEX PROTEIN NUP'), ('SM00547', 'Zinc finger domain'), ('SSF90209', 'Ran binding protein zinc finger-like')]",,"""ENSG00000124789; Low tissue specificity."";",,,,,ENST00000262077.3 [P49790-1];ENST00000537253.5 [P49790-3];ENST00000613258.4 [P49790-2];,NUP153,ENSG00000124789,0.0,NUP153,Canonical_RBPs,2.0,40.75,DP01799,0.407,0.942,0.214,NUP153
P49792,ENSG00000153201,RBP2_HUMAN,centrosome localization [GO:0051642]; mRNA transport [GO:0051028]; NLS-bearing protein import into nucleus [GO:0006607]; nuclear export [GO:0051168]; nucleocytoplasmic transport [GO:0006913]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]; protein sumoylation [GO:0016925]; regulation of gluconeogenesis [GO:0006111]; response to amphetamine [GO:0001975],annulate lamellae [GO:0005642]; cytoplasm [GO:0005737]; cytoplasmic periphery of the nuclear pore complex [GO:1990723]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; nuclear envelope [GO:0005635]; nuclear inclusion body [GO:0042405]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear pore cytoplasmic filaments [GO:0044614]; nuclear pore nuclear basket [GO:0044615]; nucleoplasm [GO:0005654]; SUMO ligase complex [GO:0106068],metal ion binding [GO:0046872]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723]; small GTPase binding [GO:0031267]; SUMO ligase activity [GO:0061665]; SUMO transferase activity [GO:0019789],"PTM: Polyubiquitinated by PRKN, which leads to proteasomal degradation. {ECO:0000269|PubMed:16332688}.; PTM: The inner channel of the NPC has a different redox environment from the cytoplasm and allows the formation of interchain disulfide bonds between some nucleoporins, the significant increase of these linkages upon oxidative stress reduces the permeability of the NPC. {ECO:0000250|UniProtKB:Q9ERU9}.","DOMAIN: Contains FG repeats. FG repeats are interaction sites for karyopherins (importins, exportins) and form probably an affinity gradient, guiding the transport proteins unidirectionally with their cargo through the NPC. FG repeat regions are highly flexible and lack ordered secondary structure. The overall conservation of FG repeats regarding exact sequence, spacing, and repeat unit length is limited. {ECO:0000305}.; DOMAIN: The PPIase cyclophilin-type domain has high structural similarity with PPIA, but has extremely low and barely detectable proline isomerase activity (in vitro) (PubMed:23353830). Only about half of the residues that surround the PPIA active site cleft are conserved. {ECO:0000269|PubMed:23353830}.","DOMAIN 1171..1307; /note=""RanBD1 1""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00164""; DOMAIN 2012..2148; /note=""RanBD1 2""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00164""; DOMAIN 2309..2445; /note=""RanBD1 3""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00164""; DOMAIN 2911..3046; /note=""RanBD1 4""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00164""; DOMAIN 3067..3223; /note=""PPIase cyclophilin-type""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00156""","STRAND 1191..1205; /evidence=""ECO:0007829|PDB:7MNW""; STRAND 1210..1224; /evidence=""ECO:0007829|PDB:7MNW""; STRAND 1230..1235; /evidence=""ECO:0007829|PDB:7MNW""; STRAND 1242..1247; /evidence=""ECO:0007829|PDB:7MNW""; STRAND 1255..1257; /evidence=""ECO:0007829|PDB:7MNW""; STRAND 1261..1270; /evidence=""ECO:0007829|PDB:7MNW""; STRAND 1277..1284; /evidence=""ECO:0007829|PDB:7MNW""; STRAND 2028..2030; /evidence=""ECO:0007829|PDB:1XKE""; STRAND 2032..2046; /evidence=""ECO:0007829|PDB:7MNX""; STRAND 2051..2065; /evidence=""ECO:0007829|PDB:7MNX""; STRAND 2071..2076; /evidence=""ECO:0007829|PDB:7MNX""; STRAND 2083..2088; /evidence=""ECO:0007829|PDB:7MNX""; STRAND 2095..2097; /evidence=""ECO:0007829|PDB:1XKE""; STRAND 2102..2111; /evidence=""ECO:0007829|PDB:7MNX""; STRAND 2113..2115; /evidence=""ECO:0007829|PDB:1XKE""; STRAND 2118..2125; /evidence=""ECO:0007829|PDB:7MNX""; STRAND 2329..2343; /evidence=""ECO:0007829|PDB:7MNY""; STRAND 2348..2362; /evidence=""ECO:0007829|PDB:7MNY""; STRAND 2368..2373; /evidence=""ECO:0007829|PDB:7MNY""; STRAND 2380..2385; /evidence=""ECO:0007829|PDB:7MNY""; STRAND 2399..2408; /evidence=""ECO:0007829|PDB:7MNY""; STRAND 2415..2422; /evidence=""ECO:0007829|PDB:7MNY""; STRAND 2632..2637; /evidence=""ECO:0007829|PDB:3UIP""; STRAND 2663..2665; /evidence=""ECO:0007829|PDB:3UIN""; STRAND 2710..2712; /evidence=""ECO:0007829|PDB:2LAS""; STRAND 2930..2944; /evidence=""ECO:0007829|PDB:7MNZ""; STRAND 2949..2963; /evidence=""ECO:0007829|PDB:7MNZ""; STRAND 2969..2975; /evidence=""ECO:0007829|PDB:7MNZ""; STRAND 2981..2986; /evidence=""ECO:0007829|PDB:7MNZ""; STRAND 2994..2996; /evidence=""ECO:0007829|PDB:4L6E""; STRAND 2999..3009; /evidence=""ECO:0007829|PDB:7MNZ""; STRAND 3016..3026; /evidence=""ECO:0007829|PDB:7MNZ""; STRAND 3065..3072; /evidence=""ECO:0007829|PDB:4I9Y""; STRAND 3075..3084; /evidence=""ECO:0007829|PDB:4I9Y""; STRAND 3112..3117; /evidence=""ECO:0007829|PDB:4I9Y""; STRAND 3121..3124; /evidence=""ECO:0007829|PDB:4I9Y""; STRAND 3130..3133; /evidence=""ECO:0007829|PDB:4I9Y""; STRAND 3157..3160; /evidence=""ECO:0007829|PDB:4I9Y""; STRAND 3168..3170; /evidence=""ECO:0007829|PDB:4LQW""; STRAND 3172..3177; /evidence=""ECO:0007829|PDB:4I9Y""; STRAND 3188..3194; /evidence=""ECO:0007829|PDB:4I9Y""; STRAND 3216..3223; /evidence=""ECO:0007829|PDB:4I9Y""","HELIX 5..18; /evidence=""ECO:0007829|PDB:4GA0""; HELIX 22..26; /evidence=""ECO:0007829|PDB:4GA0""; HELIX 29..38; /evidence=""ECO:0007829|PDB:4GA0""; HELIX 42..55; /evidence=""ECO:0007829|PDB:4GA0""; HELIX 60..72; /evidence=""ECO:0007829|PDB:4GA0""; HELIX 76..89; /evidence=""ECO:0007829|PDB:4GA0""; HELIX 94..107; /evidence=""ECO:0007829|PDB:4GA0""; HELIX 112..124; /evidence=""ECO:0007829|PDB:4GA0""; HELIX 129..141; /evidence=""ECO:0007829|PDB:4GA0""; HELIX 805..831; /evidence=""ECO:0007829|PDB:7MNK""; HELIX 1288..1302; /evidence=""ECO:0007829|PDB:7MNW""; HELIX 1472..1475; /evidence=""ECO:0007829|PDB:7MNR""; HELIX 2129..2147; /evidence=""ECO:0007829|PDB:7MNX""; HELIX 2426..2442; /evidence=""ECO:0007829|PDB:7MNY""; HELIX 2642..2650; /evidence=""ECO:0007829|PDB:3UIP""; HELIX 2657..2661; /evidence=""ECO:0007829|PDB:3UIP""; HELIX 2677..2682; /evidence=""ECO:0007829|PDB:3UIP""; HELIX 3027..3042; /evidence=""ECO:0007829|PDB:7MNZ""; HELIX 3090..3101; /evidence=""ECO:0007829|PDB:4I9Y""; HELIX 3180..3182; /evidence=""ECO:0007829|PDB:4I9Y""; HELIX 3196..3203; /evidence=""ECO:0007829|PDB:4I9Y""","TURN 1206..1209; /evidence=""ECO:0007829|PDB:7MNW""; TURN 1225..1227; /evidence=""ECO:0007829|PDB:7MNW""; TURN 1237..1239; /evidence=""ECO:0007829|PDB:7MNW""; TURN 1422..1424; /evidence=""ECO:0007829|PDB:7MNP""; TURN 1436..1438; /evidence=""ECO:0007829|PDB:7MNP""; TURN 1486..1488; /evidence=""ECO:0007829|PDB:7MNR""; TURN 1500..1502; /evidence=""ECO:0007829|PDB:7MNR""; TURN 1550..1552; /evidence=""ECO:0007829|PDB:7MNS""; TURN 1564..1566; /evidence=""ECO:0007829|PDB:7MNS""; TURN 1659..1662; /evidence=""ECO:0007829|PDB:7MNT""; TURN 1672..1674; /evidence=""ECO:0007829|PDB:7MNT""; TURN 1686..1688; /evidence=""ECO:0007829|PDB:7MNT""; TURN 1718..1721; /evidence=""ECO:0007829|PDB:7MNU""; TURN 1731..1733; /evidence=""ECO:0007829|PDB:7MNU""; TURN 1745..1747; /evidence=""ECO:0007829|PDB:7MNU""; TURN 1788..1790; /evidence=""ECO:0007829|PDB:7MNV""; TURN 1802..1804; /evidence=""ECO:0007829|PDB:7MNV""; TURN 2047..2050; /evidence=""ECO:0007829|PDB:7MNX""; TURN 2066..2068; /evidence=""ECO:0007829|PDB:7MNX""; TURN 2078..2080; /evidence=""ECO:0007829|PDB:7MNX""; TURN 2344..2347; /evidence=""ECO:0007829|PDB:7MNY""; TURN 2363..2365; /evidence=""ECO:0007829|PDB:7MNY""; TURN 2375..2377; /evidence=""ECO:0007829|PDB:7MNY""; TURN 2683..2686; /evidence=""ECO:0007829|PDB:3UIP""; TURN 2926..2929; /evidence=""ECO:0007829|PDB:4L6E""; TURN 2945..2948; /evidence=""ECO:0007829|PDB:7MNZ""; TURN 2964..2966; /evidence=""ECO:0007829|PDB:7MNZ""; TURN 2976..2978; /evidence=""ECO:0007829|PDB:7MNZ""; TURN 3086..3088; /evidence=""ECO:0007829|PDB:4I9Y""; TURN 3102..3104; /evidence=""ECO:0007829|PDB:4I9Y""; TURN 3118..3120; /evidence=""ECO:0007829|PDB:4I9Y""; TURN 3127..3129; /evidence=""ECO:0007829|PDB:4I9Y""; TURN 3183..3185; /evidence=""ECO:0007829|PDB:4I9Y""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,RANBP2 NUP358,E3 SUMO-protein ligase RanBP2 (EC 2.3.2.-) (358 kDa nucleoporin) (Nuclear pore complex protein Nup358) (Nucleoporin Nup358) (Ran-binding protein 2) (RanBP2) (p270),Homo sapiens (Human),3224.0,358199.0,MRRSKADVERYIASVQGSTPSPRQKSMKGFYFAKLYYEAKEYDLAKKYICTYINVQERDPKAHRFLGLLYELEENTDKAVECYRRSVELNPTQKDLVLKIAELLCKNDVTDGRAKYWLERAAKLFPGSPAIYKLKEQLLDCEGEDGWNKLFDLIQSELYVRPDDVHVNIRLVEVYRSTKRLKDAVAHCHEAERNIALRSSLEWNSCVVQTLKEYLESLQCLESDKSDWRATNTDLLLAYANLMLLTLSTRDVQESRELLQSFDSALQSVKSLGGNDELSATFLEMKGHFYMHAGSLLLKMGQHSSNVQWRALSELAALCYLIAFQVPRPKIKLIKGEAGQNLLEMMACDRLSQSGHMLLNLSRGKQDFLKEIVETFANKSGQSALYDALFSSQSPKDTSFLGSDDIGNIDVREPELEDLTRYDVGAIRAHNGSLQHLTWLGLQWNSLPALPGIRKWLKQLFHHLPHETSRLETNAPESICILDLEVFLLGVVYTSHLQLKEKCNSHHSSYQPLCLPLPVCKQLCTERQKSWWDAVCTLIHRKAVPGNVAKLRLLVQHEINTLRAQEKHGLQPALLVHWAECLQKTGSGLNSFYDQREYIGRSVHYWKKVLPLLKIIKKKNSIPEPIDPLFKHFHSVDIQASEIVEYEEDAHITFAILDAVNGNIEDAVTAFESIKSVVSYWNLALIFHRKAEDIENDALSPEEQEECKNYLRKTRDYLIKIIDDSDSNLSVVKKLPVPLESVKEMLNSVMQELEDYSEGGPLYKNGSLRNADSEIKHSTPSPTRYSLSPSKSYKYSPKTPPRWAEDQNSLLKMICQQVEAIKKEMQELKLNSSNSASPHRWPTENYGPDSVPDGYQGSQTFHGAPLTVATTGPSVYYSQSPAYNSQYLLRPAANVTPTKGPVYGMNRLPPQQHIYAYPQQMHTPPVQSSSACMFSQEMYGPPALRFESPATGILSPRGDDYFNYNVQQTSTNPPLPEPGYFTKPPIAAHASRSAESKTIEFGKTNFVQPMPGEGLRPSLPTQAHTTQPTPFKFNSNFKSNDGDFTFSSPQVVTQPPPAAYSNSESLLGLLTSDKPLQGDGYSGAKPIPGGQTIGPRNTFNFGSKNVSGISFTENMGSSQQKNSGFRRSDDMFTFHGPGKSVFGTPTLETANKNHETDGGSAHGDDDDDGPHFEPVVPLPDKIEVKTGEEDEEEFFCNRAKLFRFDVESKEWKERGIGNVKILRHKTSGKIRLLMRREQVLKICANHYISPDMKLTPNAGSDRSFVWHALDYADELPKPEQLAIRFKTPEEAALFKCKFEEAQSILKAPGTNVAMASNQAVRIVKEPTSHDNKDICKSDAGNLNFEFQVAKKEGSWWHCNSCSLKNASTAKKCVSCQNLNPSNKELVGPPLAETVFTPKTSPENVQDRFALVTPKKEGHWDCSICLVRNEPTVSRCIACQNTKSANKSGSSFVHQASFKFGQGDLPKPINSDFRSVFSTKEGQWDCSACLVQNEGSSTKCAACQNPRKQSLPATSIPTPASFKFGTSETSKTLKSGFEDMFAKKEGQWDCSSCLVRNEANATRCVACQNPDKPSPSTSVPAPASFKFGTSETSKAPKSGFEGMFTKKEGQWDCSVCLVRNEASATKCIACQNPGKQNQTTSAVSTPASSETSKAPKSGFEGMFTKKEGQWDCSVCLVRNEASATKCIACQNPGKQNQTTSAVSTPASSETSKAPKSGFEGMFTKKEGQWDCSVCLVRNEASATKCIACQCPSKQNQTTAISTPASSEISKAPKSGFEGMFIRKGQWDCSVCCVQNESSSLKCVACDASKPTHKPIAEAPSAFTLGSEMKLHDSSGSQVGTGFKSNFSEKASKFGNTEQGFKFGHVDQENSPSFMFQGSSNTEFKSTKEGFSIPVSADGFKFGISEPGNQEKKSEKPLENGTGFQAQDISGQKNGRGVIFGQTSSTFTFADLAKSTSGEGFQFGKKDPNFKGFSGAGEKLFSSQYGKMANKANTSGDFEKDDDAYKTEDSDDIHFEPVVQMPEKVELVTGEEDEKVLYSQRVKLFRFDAEVSQWKERGLGNLKILKNEVNGKLRMLMRREQVLKVCANHWITTTMNLKPLSGSDRAWMWLASDFSDGDAKLEQLAAKFKTPELAEEFKQKFEECQRLLLDIPLQTPHKLVDTGRAAKLIQRAEEMKSGLKDFKTFLTNDQTKVTEEENKGSGTGAAGASDTTIKPNPENTGPTLEWDNYDLREDALDDSVSSSSVHASPLASSPVRKNLFRFGESTTGFNFSFKSALSPSKSPAKLNQSGTSVGTDEESDVTQEEERDGQYFEPVVPLPDLVEVSSGEENEQVVFSHRAKLYRYDKDVGQWKERGIGDIKILQNYDNKQVRIVMRRDQVLKLCANHRITPDMTLQNMKGTERVWLWTACDFADGERKVEHLAVRFKLQDVADSFKKIFDEAKTAQEKDSLITPHVSRSSTPRESPCGKIAVAVLEETTRERTDVIQGDDVADATSEVEVSSTSETTPKAVVSPPKFVFGSESVKSIFSSEKSKPFAFGNSSATGSLFGFSFNAPLKSNNSETSSVAQSGSESKVEPKKCELSKNSDIEQSSDSKVKNLFASFPTEESSINYTFKTPEKAKEKKKPEDSPSDDDVLIVYELTPTAEQKALATKLKLPPTFFCYKNRPDYVSEEEEDDEDFETAVKKLNGKLYLDGSEKCRPLEENTADNEKECIIVWEKKPTVEEKAKADTLKLPPTFFCGVCSDTDEDNGNGEDFQSELQKVQEAQKSQTEEITSTTDSVYTGGTEVMVPSFCKSEEPDSITKSISSPSVSSETMDKPVDLSTRKEIDTDSTSQGESKIVSFGFGSSTGLSFADLASSNSGDFAFGSKDKNFQWANTGAAVFGTQSVGTQSAGKVGEDEDGSDEEVVHNEDIHFEPIVSLPEVEVKSGEEDEEILFKERAKLYRWDRDVSQWKERGVGDIKILWHTMKNYYRILMRRDQVFKVCANHVITKTMELKPLNVSNNALVWTASDYADGEAKVEQLAVRFKTKEVADCFKKTFEECQQNLMKLQKGHVSLAAELSKETNPVVFFDVCADGEPLGRITMELFSNIVPRTAENFRALCTGEKGFGFKNSIFHRVIPDFVCQGGDITKHDGTGGQSIYGDKFEDENFDVKHTGPGLLSMANQGQNTNNSQFVITLKKAEHLDFKHVVFGFVKDGMDTVKKIESFGSPKGSVCRRITITECGQI,True,False,False,P49792,"[('cd01926', 'cyclophilin_ABH_like'), ('cd13177', 'Ran-binding protein 2, Ran binding domain repeat 2'), ('cd13178', 'Ran-binding protein 2, Ran binding domain repeat 4'), ('cd14684', 'Ran-binding protein 2, Ran binding domain repeat 1'), ('cd14685', 'Ran-binding protein 2, Ran binding domain repeat 3'), ('G3DSA:1.25.40.10', 'Tetratricopeptide repeat domain'), ('G3DSA:2.30.29.30', 'Pleckstrin-homology domain (PH domain)/Phosphotyrosine-binding domain (PTB)'), ('G3DSA:2.40.100.10', 'Cyclophilin-like'), ('G3DSA:4.10.1060.10', 'Zinc finger, RanBP2-type'), ('IPR000156', 'Ran binding domain'), ('IPR001876', 'Zinc finger, RanBP2-type'), ('IPR002130', 'Cyclophilin-type peptidyl-prolyl cis-trans isomerase domain'), ('IPR011990', 'Tetratricopeptide-like helical domain superfamily'), ('IPR011993', 'PH-like domain superfamily'), ('IPR019734', 'Tetratricopeptide repeat'), ('IPR020892', 'Cyclophilin-type peptidyl-prolyl cis-trans isomerase, conserved site'), ('IPR022011', 'Nup358/RanBP2 E3 ligase domain'), ('IPR029000', 'Cyclophilin-like domain superfamily'), ('IPR036443', 'Zinc finger, RanBP2-type superfamily'), ('IPR045255', 'Ran binding protein RanBP1-like')]",,"""ENSG00000153201; Low tissue specificity."";",,2.3.2.-,,PATHWAY: Protein modification; protein sumoylation.,ENST00000283195.11;,RANBP2,ENSG00000153201,0.0,RANBP2,Canonical_RBPs,10.0,,,0.038,,0.104,RANBP2
P49841,ENSG00000082701,GSK3B_HUMAN,beta-catenin destruction complex disassembly [GO:1904886]; canonical Wnt signaling pathway [GO:0060070]; cell differentiation [GO:0030154]; cellular response to amyloid-beta [GO:1904646]; cellular response to interleukin-3 [GO:0036016]; cellular response to retinoic acid [GO:0071300]; circadian rhythm [GO:0007623]; epithelial to mesenchymal transition [GO:0001837]; ER overload response [GO:0006983]; establishment of cell polarity [GO:0030010]; excitatory postsynaptic potential [GO:0060079]; extrinsic apoptotic signaling pathway [GO:0097191]; extrinsic apoptotic signaling pathway in absence of ligand [GO:0097192]; G protein-coupled dopamine receptor signaling pathway [GO:0007212]; glycogen metabolic process [GO:0005977]; heart valve development [GO:0003170]; hippocampus development [GO:0021766]; insulin receptor signaling pathway [GO:0008286]; intracellular signal transduction [GO:0035556]; maintenance of cell polarity [GO:0030011]; mitochondrion organization [GO:0007005]; negative regulation of apoptotic process [GO:0043066]; negative regulation of calcineurin-NFAT signaling cascade [GO:0070885]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cell migration [GO:0030336]; negative regulation of dopaminergic neuron differentiation [GO:1904339]; negative regulation of epithelial to mesenchymal transition [GO:0010719]; negative regulation of extrinsic apoptotic signaling pathway via death domain receptors [GO:1902042]; negative regulation of gene expression [GO:0010629]; negative regulation of glycogen (starch) synthase activity [GO:2000466]; negative regulation of glycogen biosynthetic process [GO:0045719]; negative regulation of mesenchymal stem cell differentiation [GO:2000740]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of phosphoprotein phosphatase activity [GO:0032515]; negative regulation of protein acetylation [GO:1901984]; negative regulation of protein localization to nucleus [GO:1900181]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of TOR signaling [GO:0032007]; negative regulation of type B pancreatic cell development [GO:2000077]; neuron projection development [GO:0031175]; neuron projection organization [GO:0106027]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of autophagy [GO:0010508]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of cilium assembly [GO:0045724]; positive regulation of gene expression [GO:0010628]; positive regulation of GTPase activity [GO:0043547]; positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901030]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein binding [GO:0032092]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of protein localization to centrosome [GO:1904781]; positive regulation of protein localization to cilium [GO:1903566]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of protein-containing complex assembly [GO:0031334]; presynaptic modulation of chemical synaptic transmission [GO:0099171]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of axon extension [GO:0030516]; regulation of axonogenesis [GO:0050770]; regulation of cellular response to heat [GO:1900034]; regulation of circadian rhythm [GO:0042752]; regulation of dendrite morphogenesis [GO:0048814]; regulation of long-term synaptic potentiation [GO:1900271]; regulation of microtubule anchoring at centrosome [GO:0150101]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of microtubule-based process [GO:0032886]; regulation of neuron projection development [GO:0010975]; regulation of protein export from nucleus [GO:0046825]; superior temporal gyrus development [GO:0071109]; viral protein processing [GO:0019082],axon [GO:0030424]; beta-catenin destruction complex [GO:0030877]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; glutamatergic synapse [GO:0098978]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynapse [GO:0098793]; Wnt signalosome [GO:1990909],ATP binding [GO:0005524]; beta-catenin binding [GO:0008013]; dynactin binding [GO:0034452]; histone H2AS1 kinase activity [GO:0044024]; kinase activity [GO:0016301]; NF-kappaB binding [GO:0051059]; p53 binding [GO:0002039]; protease binding [GO:0002020]; protein kinase A catalytic subunit binding [GO:0034236]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; tau protein binding [GO:0048156]; tau-protein kinase activity [GO:0050321]; ubiquitin protein ligase binding [GO:0031625],"PTM: Phosphorylated by AKT1 and ILK1. Upon insulin-mediated signaling, the activated PKB/AKT1 protein kinase phosphorylates and deactivates GSK3B, resulting in the dephosphorylation and activation of GYS1. Activated by phosphorylation at Tyr-216 (PubMed:25169422). Inactivated by phosphorylation at Ser-9 (Probable). Phosphorylated in a circadian manner in the hippocampus (By similarity). {ECO:0000250|UniProtKB:Q9WV60, ECO:0000269|PubMed:12054501, ECO:0000269|PubMed:12554650, ECO:0000269|PubMed:16484495, ECO:0000269|PubMed:20937854, ECO:0000269|PubMed:21029237, ECO:0000269|PubMed:25169422, ECO:0000269|PubMed:8250835, ECO:0000305|PubMed:25169422}.; PTM: Mono-ADP-ribosylation by PARP10 negatively regulates kinase activity. {ECO:0000269|PubMed:23332125}.; PTM: Palmitoylated. Palmitoylation by ZDHHC4 prevents AKT1-mediated phosphorylation. {ECO:0000269|PubMed:35606353}.",,"DOMAIN 56..340; /note=""Protein kinase""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00159""","STRAND 10..12; /evidence=""ECO:0007829|PDB:2JDO""; STRAND 26..30; /evidence=""ECO:0007829|PDB:1J1B""; STRAND 32..34; /evidence=""ECO:0007829|PDB:4NM5""; STRAND 38..48; /evidence=""ECO:0007829|PDB:1J1B""; STRAND 52..64; /evidence=""ECO:0007829|PDB:1J1B""; STRAND 66..75; /evidence=""ECO:0007829|PDB:1J1B""; STRAND 81..88; /evidence=""ECO:0007829|PDB:1J1B""; STRAND 91..93; /evidence=""ECO:0007829|PDB:1Q5K""; STRAND 112..120; /evidence=""ECO:0007829|PDB:1J1B""; STRAND 125..133; /evidence=""ECO:0007829|PDB:1J1B""; STRAND 136..138; /evidence=""ECO:0007829|PDB:7SXJ""; STRAND 187..190; /evidence=""ECO:0007829|PDB:1J1B""; STRAND 195..198; /evidence=""ECO:0007829|PDB:1J1B""; STRAND 209..211; /evidence=""ECO:0007829|PDB:6HK4""; STRAND 289..291; /evidence=""ECO:0007829|PDB:4ACC""; STRAND 345..347; /evidence=""ECO:0007829|PDB:1UV5""; STRAND 353..355; /evidence=""ECO:0007829|PDB:6HK4""","HELIX 96..102; /evidence=""ECO:0007829|PDB:1J1B""; HELIX 139..148; /evidence=""ECO:0007829|PDB:1J1B""; HELIX 155..173; /evidence=""ECO:0007829|PDB:1J1B""; HELIX 184..186; /evidence=""ECO:0007829|PDB:1J1B""; HELIX 201..203; /evidence=""ECO:0007829|PDB:7SXJ""; HELIX 220..222; /evidence=""ECO:0007829|PDB:7SXJ""; HELIX 225..228; /evidence=""ECO:0007829|PDB:1J1B""; HELIX 237..252; /evidence=""ECO:0007829|PDB:1J1B""; HELIX 262..273; /evidence=""ECO:0007829|PDB:1J1B""; HELIX 278..284; /evidence=""ECO:0007829|PDB:1J1B""; HELIX 286..288; /evidence=""ECO:0007829|PDB:7B6F""; HELIX 301..304; /evidence=""ECO:0007829|PDB:1J1B""; HELIX 311..320; /evidence=""ECO:0007829|PDB:1J1B""; HELIX 325..327; /evidence=""ECO:0007829|PDB:1J1B""; HELIX 331..335; /evidence=""ECO:0007829|PDB:1J1B""; HELIX 338..344; /evidence=""ECO:0007829|PDB:1J1B""; HELIX 364..367; /evidence=""ECO:0007829|PDB:1J1B""; HELIX 371..373; /evidence=""ECO:0007829|PDB:1J1B""; HELIX 374..377; /evidence=""ECO:0007829|PDB:1J1B""","TURN 76..78; /evidence=""ECO:0007829|PDB:1J1B""; TURN 121..124; /evidence=""ECO:0007829|PDB:1J1B""; TURN 174..176; /evidence=""ECO:0007829|PDB:1J1B""; TURN 191..194; /evidence=""ECO:0007829|PDB:1J1B""; TURN 380..383; /evidence=""ECO:0007829|PDB:1J1B""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,GSK3B,Glycogen synthase kinase-3 beta (GSK-3 beta) (EC 2.7.11.26) (Serine/threonine-protein kinase GSK3B) (EC 2.7.11.1),Homo sapiens (Human),420.0,46744.0,MSGRPRTTSFAESCKPVQQPSAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNPPLATILIPPHARIQAAASTPTNATAASDANTGDRGQTNNAASASASNST,True,False,False,P49841,"[('cd14137', 'The catalytic domain of the Serine/Threonine Kinase, Glycogen Synthase Kinase 3'), ('G3DSA:1.10.510.10', 'Transferase(Phosphotransferase) domain 1'), ('G3DSA:3.30.200.20', 'Phosphorylase Kinase; domain 1'), ('IPR000719', 'Protein kinase domain'), ('IPR008271', 'Serine/threonine-protein kinase, active site'), ('IPR011009', 'Protein kinase-like domain superfamily'), ('IPR017441', 'Protein kinase, ATP binding site'), ('IPR039192', 'Glycogen synthase kinase 3, catalytic domain'), ('IPR050591', 'Glycogen Synthase Kinase-3'), ('PF00069', 'Protein kinase domain'), ('PS00107', 'Protein kinases ATP-binding region signature'), ('PS00108', 'Serine/Threonine protein kinases active-site signature'), ('PS50011', 'Protein kinase domain profile'), ('PTHR24057', 'Glycogen Synthase Kinase-3'), ('SM00220', 'Serine/Threonine protein kinases, catalytic domain'), ('SSF56112', 'Protein kinase-like (PK-like)')]",P49841;,"""ENSG00000082701; Low tissue specificity."";","CATALYTIC ACTIVITY: Reaction=L-seryl-[tau protein] + ATP = O-phospho-L-seryl-[tau protein] + ADP + H(+); Xref=Rhea:RHEA:12801, Rhea:RHEA-COMP:13701, Rhea:RHEA-COMP:13702, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616, ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.26; Evidence={ECO:0000269|PubMed:14690523}; CATALYTIC ACTIVITY: Reaction=L-threonyl-[tau protein] + ATP = O-phospho-L-threonyl-[tau protein] + ADP + H(+); Xref=Rhea:RHEA:53904, Rhea:RHEA-COMP:13703, Rhea:RHEA-COMP:13704, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013, ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216; EC=2.7.11.26; Evidence={ECO:0000269|PubMed:14690523}; CATALYTIC ACTIVITY: Reaction=L-seryl-[protein] + ATP = O-phospho-L-seryl-[protein] + ADP + H(+); Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616, ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.1; Evidence={ECO:0000269|PubMed:17050006, ECO:0000269|PubMed:22539723, ECO:0000269|PubMed:25827072, ECO:0000269|PubMed:28992046, ECO:0000269|PubMed:29059170}; CATALYTIC ACTIVITY: Reaction=L-threonyl-[protein] + ATP = O-phospho-L-threonyl-[protein] + ADP + H(+); Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060, Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013, ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216; EC=2.7.11.1; Evidence={ECO:0000269|PubMed:17050006};",2.7.11.1; 2.7.11.26,"ACTIVITY REGULATION: Activated by phosphorylation at Tyr-216. In response to insulin, inhibited by phosphorylation at Ser-9 by PKB/AKT1 and RPS6KA3; phosphorylation at this site causes a conformational change, preventing access of substrates to the active site. Inhibited by IL22 treatment which also triggers phosphorylation at Ser-9, promoting inactivation (By similarity). Inhibited by lithium. {ECO:0000250|UniProtKB:Q9WV60, ECO:0000269|PubMed:11749387, ECO:0000269|PubMed:12554650, ECO:0000269|PubMed:19366350, ECO:0000269|PubMed:8524413}.",,ENST00000264235.13 [P49841-1];ENST00000316626.6 [P49841-2];,GSK3B,ENSG00000082701,0.0,GSK3B,Non-canonical_RBPs,6.0,20.24,DP00385,0.217,0.148,0.21,GSK3B
P50222,ENSG00000106511,MEOX2_HUMAN,angiogenesis [GO:0001525]; limb development [GO:0060173]; negative regulation of cell migration involved in sprouting angiogenesis [GO:0090051]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357]; roof of mouth development [GO:0060021]; skeletal muscle tissue development [GO:0007519]; somite development [GO:0061053]; somite specification [GO:0001757],chromatin [GO:0000785]; cytoplasm [GO:0005737]; nuclear speck [GO:0016607]; nucleus [GO:0005634],"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]",,DOMAIN: The polyhistidine repeat may act as a targeting signal to nuclear speckles. {ECO:0000269|PubMed:19266028}.,,,,,"cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,MEOX2 GAX MOX2,Homeobox protein MOX-2 (Growth arrest-specific homeobox) (Mesenchyme homeobox 2),Homo sapiens (Human),304.0,33594.0,MEHPLFGCLRSPHATAQGLHPFSQSSLALHGRSDHMSYPELSTSSSSCIIAGYPNEEGMFASQHHRGHHHHHHHHHHHHHQQQQHQALQTNWHLPQMSSPPSAARHSLCLQPDSGGPPELGSSPPVLCSNSSSLGSSTPTGAACAPGDYGRQALSPAEAEKRSGGKRKSDSSDSQEGNYKSEVNSKPRKERTAFTKEQIRELEAEFAHHNYLTRLRRYEIAVNLDLTERQVKVWFQNRRMKWKRVKGGQQGAAAREKELVNVKKGTLLPSELSGIGAATLQQTGDSIANEDSHDSDHSSEHAHL,False,False,True,P50222,"[('cd00086', 'homeodomain'), ('G3DSA:1.10.10.60', 'Homeodomain-like'), ('IPR001356', 'Homeodomain'), ('IPR009057', 'Homedomain-like superfamily'), ('IPR017970', 'Homeobox, conserved site'), ('IPR020479', 'Homeodomain, metazoa'), ('IPR042634', 'Homeobox protein MOX-1/MOX-2'), ('PF00046', 'Homeodomain'), ('PR00024', 'HOMEOBOX'), ('PS00027', 'Homeobox domain signature'), ('PS50071', 'Homeobox domain profile'), ('PTHR24328', 'HOMEOBOX PROTEIN MOX'), ('SM00389', 'Homeodomain'), ('SSF46689', 'Homeodomain-like')]",,"""ENSG00000106511; Tissue enhanced (adipose tissue, placenta)."";",,,,,ENST00000262041.6;,MEOX2,ENSG00000106511,0.0,,,,,,,0.836,0.428,MEOX2
P50552,ENSG00000125753,VASP_HUMAN,actin cytoskeleton organization [GO:0030036]; actin polymerization or depolymerization [GO:0008154]; axon guidance [GO:0007411]; neural tube closure [GO:0001843]; positive regulation of actin filament polymerization [GO:0030838]; protein homotetramerization [GO:0051289],actin cytoskeleton [GO:0015629]; bicellular tight junction [GO:0005923]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; filopodium membrane [GO:0031527]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; lamellipodium membrane [GO:0031258]; plasma membrane [GO:0005886]; postsynapse [GO:0098794],actin binding [GO:0003779]; cadherin binding [GO:0045296]; profilin binding [GO:0005522]; SH3 domain binding [GO:0017124],"PTM: Major substrate for cAMP-dependent (PKA) and cGMP-dependent protein kinase (PKG) in platelets. The preferred site for PKA is Ser-157, the preferred site for PKG/PRKG1, Ser-239. In ADP-activated platelets, phosphorylation by PKA or PKG on Ser-157 leads to fibrinogen receptor inhibition. Phosphorylation on Thr-278 requires prior phosphorylation on Ser-157 and Ser-239. In response to phorbol ester (PMA) stimulation, phosphorylated by PKC/PRKCA. In response to thrombin, phosphorylated by both PKC and ROCK1. Phosphorylation at Thr-278 by AMPK does not require prior phosphorylation at Ser-157 or Ser-239. Phosphorylation at Ser-157 by PKA is required for localization to the tight junctions in epithelial cells. Phosphorylation modulates F-actin binding, actin filament elongation and platelet activation. Phosphorylation at Ser-322 by AMPK also alters actin filament binding. Carbon monoxide (CO) promotes phosphorylation at Ser-157, while nitric oxide (NO) promotes phosphorylation at Ser-157, but also at Ser-239. Response to NO and CO is blunted in platelets from diabetic patients, and VASP is not phosphorylated efficiently at Ser-157 and Ser-239. {ECO:0000269|PubMed:14706852, ECO:0000269|PubMed:16197368, ECO:0000269|PubMed:17082196, ECO:0000269|PubMed:18559661, ECO:0000269|PubMed:7925440, ECO:0000269|PubMed:8182057}.","DOMAIN: The EVH2 domain is comprised of 3 regions. Block A is a thymosin-like domain required for G-actin binding. The KLKR motif within this block is essential for the G-actin binding and for actin polymerization. Block B is required for F-actin binding and subcellular location, and Block C for tetramerization.; DOMAIN: The WH1 domain mediates interaction with XIRP1.","DOMAIN 2..113; /note=""WH1""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00410""","STRAND 5..12; /evidence=""ECO:0007829|PDB:1EGX""; STRAND 14..16; /evidence=""ECO:0007829|PDB:1EGX""; STRAND 25..27; /evidence=""ECO:0007829|PDB:1EGX""; STRAND 34..41; /evidence=""ECO:0007829|PDB:1EGX""; STRAND 46..55; /evidence=""ECO:0007829|PDB:1EGX""; STRAND 60..66; /evidence=""ECO:0007829|PDB:1EGX""; STRAND 79..86; /evidence=""ECO:0007829|PDB:1EGX""; STRAND 88..95; /evidence=""ECO:0007829|PDB:1EGX""","HELIX 96..114; /evidence=""ECO:0007829|PDB:1EGX""; HELIX 226..231; /evidence=""ECO:0007829|PDB:2PBD""; HELIX 341..376; /evidence=""ECO:0007829|PDB:1USE""","TURN 18..20; /evidence=""ECO:0007829|PDB:1EGX""; TURN 42..45; /evidence=""ECO:0007829|PDB:1EGX""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,VASP,Vasodilator-stimulated phosphoprotein (VASP),Homo sapiens (Human),380.0,39830.0,MSETVICSSRATVMLYDDGNKRWLPAGTGPQAFSRVQIYHNPTANSFRVVGRKMQPDQQVVINCAIVRGVKYNQATPNFHQWRDARQVWGLNFGSKEDAAQFAAGMASALEALEGGGPPPPPALPTWSVPNGPSPEEVEQQKRQQPGPSEHIERRVSNAGGPPAPPAGGPPPPPGPPPPPGPPPPPGLPPSGVPAAAHGAGGGPPPAPPLPAAQGPGGGGAGAPGLAAAIAGAKLRKVSKQEEASGGPTAPKAESGRSGGGGLMEEMNAMLARRRKATQVGEKTPKDESANQEEPEARVPAQSESVRRPWEKNSTTLPRMKSSSSVTTSETQPCTPSSSDYSDLQRVKQELLEEVKKELQKVKEEIIEAFVQELRKRGSP,False,False,True,P50552,"[('cd01207', 'Enabled/VASP family EVH1 domain'), ('cd22185', 'Wiskott-Aldrich syndrome protein (WASP)-homology domain 2 (WH2) of human Vasodilator-stimulated phosphoprotein and related proteins'), ('G3DSA:1.20.5.1160', 'Vasodilator-stimulated phosphoprotein'), ('G3DSA:2.30.29.30', 'Pleckstrin-homology domain (PH domain)/Phosphotyrosine-binding domain (PTB)'), ('IPR000697', 'WH1/EVH1 domain'), ('IPR011993', 'PH-like domain superfamily'), ('IPR014885', 'VASP tetramerisation'), ('IPR017354', 'Vasodilator-stimulated phosphoprotein/ENA/VASP-like'), ('IPR038023', 'VASP tetramerisation domain superfamily'), ('PF00568', 'WH1 domain'), ('PF08776', 'VASP tetramerisation domain'), ('PIRSF038010', 'Vasodilator-stimulated phosphoprotein'), ('PS50229', 'WH1 domain profile'), ('PTHR11202', 'Actin cytoskeleton regulatory domain-containing protein'), ('SM00461', 'WASP homology region 1'), ('SSF118370', 'Vasodilator-stimulated phosphoprotein, VASP, tetramerisation domain'), ('SSF50729', 'PH domain-like')]",P50552;,"""ENSG00000125753; Low tissue specificity."";",,,,,ENST00000245932.11;,VASP,ENSG00000125753,0.0,,,,,,,0.65,0.613,VASP
P50570,ENSG00000079805,DYN2_HUMAN,actin filament bundle organization [GO:0061572]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; autophagy [GO:0006914]; centrosome cycle [GO:0007098]; endocytosis [GO:0006897]; G2/M transition of mitotic cell cycle [GO:0000086]; membrane organization [GO:0061024]; membrane tubulation [GO:0097749]; negative regulation of membrane tubulation [GO:1903526]; neuron projection morphogenesis [GO:0048812]; phagocytosis [GO:0006909]; positive regulation of apoptotic process [GO:0043065]; positive regulation of DNA-templated transcription [GO:0045893]; post-Golgi vesicle-mediated transport [GO:0006892]; protein polymerization [GO:0051258]; receptor internalization [GO:0031623]; receptor-mediated endocytosis [GO:0006898]; regulation of axon extension [GO:0030516]; regulation of DNA-templated transcription [GO:0006355]; signal transduction [GO:0007165]; stress fiber assembly [GO:0043149]; synaptic vesicle budding from presynaptic endocytic zone membrane [GO:0016185]; synaptic vesicle transport [GO:0048489]; transferrin transport [GO:0033572]; vesicle scission [GO:0099050],centriole [GO:0005814]; centrosome [GO:0005813]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endocytic vesicle membrane [GO:0030666]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139]; microtubule [GO:0005874]; midbody [GO:0030496]; neuron projection [GO:0043005]; phagocytic cup [GO:0001891]; phagocytic vesicle membrane [GO:0030670]; plasma membrane [GO:0005886]; podosome [GO:0002102]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; presynapse [GO:0098793]; recycling endosome [GO:0055037]; synapse [GO:0045202]; uropod [GO:0001931],"enzyme binding [GO:0019899]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; microtubule binding [GO:0008017]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; SH3 domain binding [GO:0017124]","PTM: Phosphorylation at Ser-848 by GSK3-alpha relieves the inhibition of BIN1 and promotes endocytosis (PubMed:36445308). Phosphorylation at Ser-764 by CDK1 is greatly increased upon mitotic entry (PubMed:20496096). It regulates cytokinesis downstream of calcineurin, and does not affect clathrin-mediated endocytosis (By similarity). Dephosphorylated by calcineurin/PP2 during cytokinesis in a Ca(2+)- and calmodulin-dependent manner (PubMed:20496096). Phosphorylated on tyrosine residues by EGFR and after activation of SRC (By similarity). {ECO:0000250|UniProtKB:P39052, ECO:0000250|UniProtKB:P39054, ECO:0000269|PubMed:20496096, ECO:0000269|PubMed:36445308}.",,"DOMAIN 28..294; /note=""Dynamin-type G""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU01055""; DOMAIN 519..625; /note=""PH""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00145""; DOMAIN 653..744; /note=""GED""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00720""","STRAND 522..530; /evidence=""ECO:0007829|PDB:2YS1""; STRAND 533..535; /evidence=""ECO:0007829|PDB:2YS1""; STRAND 540..545; /evidence=""ECO:0007829|PDB:2YS1""; STRAND 550..555; /evidence=""ECO:0007829|PDB:2YS1""; STRAND 560..565; /evidence=""ECO:0007829|PDB:2YS1""; STRAND 567..573; /evidence=""ECO:0007829|PDB:2YS1""; STRAND 585..590; /evidence=""ECO:0007829|PDB:2YS1""; STRAND 596..599; /evidence=""ECO:0007829|PDB:2YS1""; STRAND 601..606; /evidence=""ECO:0007829|PDB:2YS1""","HELIX 610..623; /evidence=""ECO:0007829|PDB:2YS1""",,"cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,DNM2 DYN2,Dynamin-2 (EC 3.6.5.5) (Dynamin 2) (Dynamin II),Homo sapiens (Human),870.0,98064.0,MGNRGMEELIPLVNKLQDAFSSIGQSCHLDLPQIAVVGGQSAGKSSVLENFVGRDFLPRGSGIVTRRPLILQLIFSKTEHAEFLHCKSKKFTDFDEVRQEIEAETDRVTGTNKGISPVPINLRVYSPHVLNLTLIDLPGITKVPVGDQPPDIEYQIKDMILQFISRESSLILAVTPANMDLANSDALKLAKEVDPQGLRTIGVITKLDLMDEGTDARDVLENKLLPLRRGYIGVVNRSQKDIEGKKDIRAALAAERKFFLSHPAYRHMADRMGTPHLQKTLNQQLTNHIRESLPALRSKLQSQLLSLEKEVEEYKNFRPDDPTRKTKALLQMVQQFGVDFEKRIEGSGDQVDTLELSGGARINRIFHERFPFELVKMEFDEKDLRREISYAIKNIHGVRTGLFTPDLAFEAIVKKQVVKLKEPCLKCVDLVIQELINTVRQCTSKLSSYPRLREETERIVTTYIREREGRTKDQILLLIDIEQSYINTNHEDFIGFANAQQRSTQLNKKRAIPNQGEILVIRRGWLTINNISLMKGGSKEYWFVLTAESLSWYKDEEEKEKKYMLPLDNLKIRDVEKGFMSNKHVFAIFNTEQRNVYKDLRQIELACDSQEDVDSWKASFLRAGVYPEKDQAENEDGAQENTFSMDPQLERQVETIRNLVDSYVAIINKSIRDLMPKTIMHLMINNTKAFIHHELLAYLYSSADQSSLMEESADQAQRRDDMLRMYHALKEALNIIGDISTSTVSTPVPPPVDDTWLQSASSHSPTPQRRPVSSIHPPGRPPAVRGPTPGPPLIPVPVGAAASFSAPPIPSRPGPQSVFANSDLFPAPPQIPSRPVRIPPGIPPGVPSRRPPAAPSRPTIIRPAEPSLLD,True,False,True,P50570,"[('cd01256', 'Dynamin pleckstrin homology (PH) domain'), ('cd08771', 'Dynamin_like protein family includes dynamins and Mx proteins'), ('G3DSA:1.20.120.1240', 'Dynamin, middle domain'), ('G3DSA:2.30.29.30', 'Pleckstrin-homology domain (PH domain)/Phosphotyrosine-binding domain (PTB)'), ('G3DSA:3.40.50.300', 'P-loop containing nucleotide triphosphate hydrolases'), ('IPR000375', 'Dynamin stalk domain'), ('IPR001401', 'Dynamin, GTPase domain'), ('IPR001849', 'Pleckstrin homology domain'), ('IPR003130', 'Dynamin GTPase effector'), ('IPR011993', 'PH-like domain superfamily'), ('IPR019762', 'Dynamin, GTPase region, conserved site'), ('IPR020850', 'GTPase effector domain'), ('IPR022812', 'Dynamin'), ('IPR027417', 'P-loop containing nucleoside triphosphate hydrolase'), ('IPR030381', 'Dynamin-type guanine nucleotide-binding (G) domain'), ('IPR045063', 'Dynamin, N-terminal'), ('PF00169', 'PH domain'), ('PF00350', 'Dynamin family'), ('PF01031', 'Dynamin central region'), ('PF02212', 'Dynamin GTPase effector domain')]",P50570;,"""ENSG00000079805; Low tissue specificity."";","CATALYTIC ACTIVITY: Reaction=GTP + H2O = GDP + phosphate + H(+); Xref=Rhea:RHEA:19669, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:37565, ChEBI:CHEBI:43474, ChEBI:CHEBI:58189; EC=3.6.5.5; Evidence={ECO:0000269|PubMed:34744632}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:19670; Evidence={ECO:0000269|PubMed:34744632};",3.6.5.5,,,ENST00000355667.11 [P50570-1];ENST00000359692.10 [P50570-2];ENST00000389253.9 [P50570-4];ENST00000408974.8 [P50570-3];ENST00000585892.5 [P50570-5];,DNM2,ENSG00000079805,0.0,,,,,,,0.174,0.149,DNM2
P50747,ENSG00000159267,BPL1_HUMAN,biotin metabolic process [GO:0006768]; post-translational protein modification [GO:0043687]; response to biotin [GO:0070781],chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nuclear lamina [GO:0005652]; nuclear matrix [GO:0016363],ATP binding [GO:0005524]; biotin binding [GO:0009374]; biotin--[biotin carboxyl-carrier protein] ligase activity [GO:0004077]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802],,,"DOMAIN 463..652; /note=""BPL/LPL catalytic""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU01067""",,,,"cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,HLCS,Biotin--protein ligase (EC 6.3.4.-) (Biotin apo-protein ligase) [Includes: Biotin--[methylmalonyl-CoA-carboxytransferase] ligase (EC 6.3.4.9); Biotin--[propionyl-CoA-carboxylase [ATP-hydrolyzing]] ligase (EC 6.3.4.10) (Holocarboxylase synthetase) (HCS); Biotin--[methylcrotonoyl-CoA-carboxylase] ligase (EC 6.3.4.11); Biotin--[acetyl-CoA-carboxylase] ligase (EC 6.3.4.15)],Homo sapiens (Human),726.0,80760.0,MEDRLHMDNGLVPQKIVSVHLQDSTLKEVKDQVSNKQAQILEPKPEPSLEIKPEQDGMEHVGRDDPKALGEEPKQRRGSASGSEPAGDSDRGGGPVEHYHLHLSSCHECLELENSTIESVKFASAENIPDLPYDYSSSLESVADETSPEREGRRVNLTGKAPNILLYVGSDSQEALGRFHEVRSVLADCVDIDSYILYHLLEDSALRDPWTDNCLLLVIATRESIPEDLYQKFMAYLSQGGKVLGLSSSFTFGGFQVTSKGALHKTVQNLVFSKADQSEVKLSVLSSGCRYQEGPVRLSPGRLQGHLENEDKDRMIVHVPFGTRGGEAVLCQVHLELPPSSNIVQTPEDFNLLKSSNFRRYEVLREILTTLGLSCDMKQVPALTPLYLLSAAEEIRDPLMQWLGKHVDSEGEIKSGQLSLRFVSSYVSEVEITPSCIPVVTNMEAFSSEHFNLEIYRQNLQTKQLGKVILFAEVTPTTMRLLDGLMFQTPQEMGLIVIAARQTEGKGRGGNVWLSPVGCALSTLLISIPLRSQLGQRIPFVQHLMSVAVVEAVRSIPEYQDINLRVKWPNDIYYSDLMKIGGVLVNSTLMGETFYILIGCGFNVTNSNPTICINDLITEYNKQHKAELKPLRADYLIARVVTVLEKLIKEFQDKGPNSVLPLYYRYWVHSGQQVHLGSAEGPKVSIVGLDDSGFLQVHQEGGEVVTVHPDGNSFDMLRNLILPKRR,True,False,False,P50747,"[('cd16442', 'biotin protein ligase'), ('G3DSA:3.30.930.10', 'Bira Bifunctional Protein; Domain 2'), ('IPR003142', 'Biotin protein ligase, C-terminal'), ('IPR004143', 'Biotinyl protein ligase (BPL) and lipoyl protein ligase (LPL), catalytic domain'), ('IPR004408', 'Biotin--acetyl-CoA-carboxylase ligase'), ('IPR045864', 'Class II Aminoacyl-tRNA synthetase/Biotinyl protein ligase (BPL) and lipoyl protein ligase (LPL)'), ('PF02237', 'Biotin protein ligase C terminal domain'), ('PF03099', 'Biotin/lipoate A/B protein ligase family'), ('PS51733', 'Biotinyl protein ligase (BPL) and lipoyl protein ligase (LPL) catalytic domain profile'), ('PTHR12835', 'Biotin--protein ligase'), ('SSF55681', 'Class II aaRS and biotin synthetases'), ('TIGR00121', 'biotin--[acetyl-CoA-carboxylase] ligase')]",,"""ENSG00000159267; Low tissue specificity."";","CATALYTIC ACTIVITY: Reaction=apo-[methylmalonyl-CoA:pyruvate carboxytransferase] + biotin + ATP = holo-[methylmalonyl-CoA:pyruvate carboxytransferase] + AMP + diphosphate + H(+); Xref=Rhea:RHEA:23668, Rhea:RHEA-COMP:10508, Rhea:RHEA-COMP:10509, ChEBI:CHEBI:15378, ChEBI:CHEBI:29969, ChEBI:CHEBI:30616, ChEBI:CHEBI:33019, ChEBI:CHEBI:57586, ChEBI:CHEBI:83144, ChEBI:CHEBI:456215; EC=6.3.4.9; Evidence={ECO:0000305|PubMed:10590022}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:23669; Evidence={ECO:0000305|PubMed:10590022}; CATALYTIC ACTIVITY: Reaction=apo-[propionyl-CoA:carbon-dioxide ligase (ADP-forming)] + biotin + ATP = holo-[propionyl-CoA:carbon-dioxide ligase (ADP-forming)] + AMP + diphosphate + H(+); Xref=Rhea:RHEA:11204, Rhea:RHEA-COMP:10511, Rhea:RHEA-COMP:10512, ChEBI:CHEBI:15378, ChEBI:CHEBI:29969, ChEBI:CHEBI:30616, ChEBI:CHEBI:33019, ChEBI:CHEBI:57586, ChEBI:CHEBI:83144, ChEBI:CHEBI:456215; EC=6.3.4.10; Evidence={ECO:0000269|PubMed:7753853}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:11205; Evidence={ECO:0000269|PubMed:7753853}; CATALYTIC ACTIVITY: Reaction=apo-[3-methylcrotonoyl-CoA:carbon-dioxide ligase (ADP-forming)] + biotin + ATP = holo-[3-methylcrotonoyl-CoA:carbon-dioxide ligase (ADP-forming)] + AMP + diphosphate + H(+); Xref=Rhea:RHEA:24376, Rhea:RHEA-COMP:10514, Rhea:RHEA-COMP:10515, ChEBI:CHEBI:15378, ChEBI:CHEBI:29969, ChEBI:CHEBI:30616, ChEBI:CHEBI:33019, ChEBI:CHEBI:57586, ChEBI:CHEBI:83144, ChEBI:CHEBI:456215; EC=6.3.4.11; Evidence={ECO:0000305|PubMed:10590022}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:24377; Evidence={ECO:0000269|PubMed:7753853}; CATALYTIC ACTIVITY: Reaction=biotin + L-lysyl-[protein] + ATP = N(6)-biotinyl-L-lysyl-[protein] + AMP + diphosphate + H(+); Xref=Rhea:RHEA:11756, Rhea:RHEA-COMP:9752, Rhea:RHEA-COMP:10505, ChEBI:CHEBI:15378, ChEBI:CHEBI:29969, ChEBI:CHEBI:30616, ChEBI:CHEBI:33019, ChEBI:CHEBI:57586, ChEBI:CHEBI:83144, ChEBI:CHEBI:456215; EC=6.3.4.15; Evidence={ECO:0000305|PubMed:10590022}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:11757; Evidence={ECO:0000269|PubMed:7753853};",6.3.4.-; 6.3.4.10; 6.3.4.11; 6.3.4.15; 6.3.4.9,,,ENST00000336648.8 [P50747-1];ENST00000399120.5 [P50747-1];ENST00000612277.4 [P50747-1];ENST00000674895.3 [P50747-2];ENST00000675307.1 [P50747-1];,HLCS,ENSG00000159267,0.0,,,,,,,0.187,0.098,HLCS
P51608,ENSG00000169057,MECP2_HUMAN,adult locomotory behavior [GO:0008344]; behavioral fear response [GO:0001662]; biogenic amine metabolic process [GO:0006576]; cardiolipin metabolic process [GO:0032048]; catecholamine secretion [GO:0050432]; cellular response to isoquinoline alkaloid [GO:0071317]; cellular response to potassium ion [GO:0035865]; cerebellum development [GO:0021549]; cerebral cortex development [GO:0021987]; dendrite development [GO:0016358]; excitatory postsynaptic potential [GO:0060079]; gene expression [GO:0010467]; genomic imprinting [GO:0071514]; glial cell proliferation [GO:0014009]; glucocorticoid metabolic process [GO:0008211]; glutamine metabolic process [GO:0006541]; heterochromatin formation [GO:0031507]; hippocampus development [GO:0021766]; inositol metabolic process [GO:0006020]; long-term memory [GO:0007616]; long-term synaptic potentiation [GO:0060291]; lung alveolus development [GO:0048286]; negative regulation of angiogenesis [GO:0016525]; negative regulation of astrocyte differentiation [GO:0048712]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of dendrite extension [GO:1903860]; negative regulation of dendritic spine development [GO:0061000]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of gene expression [GO:0010629]; negative regulation of gene expression via chromosomal CpG island methylation [GO:0044027]; negative regulation of locomotion involved in locomotory behavior [GO:0090327]; negative regulation of neuron apoptotic process [GO:0043524]; negative regulation of primary miRNA processing [GO:2000635]; negative regulation of respiratory gaseous exchange [GO:1903941]; negative regulation of smooth muscle cell differentiation [GO:0051151]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system process involved in regulation of systemic arterial blood pressure [GO:0001976]; neuron maturation [GO:0042551]; Notch signaling pathway [GO:0007219]; olfactory bulb development [GO:0021772]; oligodendrocyte development [GO:0014003]; phosphatidylcholine metabolic process [GO:0046470]; positive regulation of anterograde dense core granule transport [GO:1901953]; positive regulation of branching morphogenesis of a nerve [GO:1905492]; positive regulation of dendrite extension [GO:1903861]; positive regulation of dendritic spine development [GO:0060999]; positive regulation of glial cell proliferation [GO:0060252]; positive regulation of microtubule nucleation [GO:0090063]; positive regulation of retrograde dense core granule transport [GO:1901956]; positive regulation of synaptic plasticity [GO:0031915]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-embryonic development [GO:0009791]; principal sensory nucleus of trigeminal nerve development [GO:0021740]; proprioception [GO:0019230]; protein localization [GO:0008104]; regulation of action potential firing threshold [GO:0099611]; regulation of respiratory gaseous exchange by nervous system process [GO:0002087]; regulation of synapse organization [GO:0050807]; respiratory gaseous exchange by respiratory system [GO:0007585]; response to alcohol [GO:0097305]; response to cocaine [GO:0042220]; response to estradiol [GO:0032355]; response to hypoxia [GO:0001666]; response to ionizing radiation [GO:0010212]; response to lead ion [GO:0010288]; response to other organism [GO:0051707]; sensory perception of pain [GO:0019233]; social behavior [GO:0035176]; spinal cord development [GO:0021510]; startle response [GO:0001964]; striatum development [GO:0021756]; synapse assembly [GO:0007416]; thalamus development [GO:0021794]; trans-synaptic signaling by BDNF [GO:0099191]; ventricular cardiac muscle tissue development [GO:0003229]; ventricular system development [GO:0021591]; visual learning [GO:0008542],centrosome [GO:0005813]; cytosol [GO:0005829]; extracellular space [GO:0005615]; glutamatergic synapse [GO:0098978]; heterochromatin [GO:0000792]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynapse [GO:0098794]; protein-containing complex [GO:0032991],chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; double-stranded methylated DNA binding [GO:0010385]; four-way junction DNA binding [GO:0000400]; histone deacetylase binding [GO:0042826]; histone reader activity [GO:0140566]; identical protein binding [GO:0042802]; methyl-CpG binding [GO:0008327]; molecular adaptor activity [GO:0060090]; molecular condensate scaffold activity [GO:0140693]; mRNA binding [GO:0003729]; nucleic acid binding [GO:0003676]; promoter-specific chromatin binding [GO:1990841]; protein domain specific binding [GO:0019904]; RNA binding [GO:0003723]; siRNA binding [GO:0035197]; transcription corepressor activity [GO:0003714]; unmethylated CpG binding [GO:0045322],"PTM: Phosphorylated on Ser-423 in brain upon synaptic activity, which attenuates its repressor activity and seems to regulate dendritic growth and spine maturation. {ECO:0000250}.",,"DOMAIN 90..162; /note=""MBD""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00338""","STRAND 95..97; /evidence=""ECO:0007829|PDB:1QK9""; STRAND 100..103; /evidence=""ECO:0007829|PDB:1QK9""; STRAND 105..110; /evidence=""ECO:0007829|PDB:6OGK""; STRAND 120..125; /evidence=""ECO:0007829|PDB:6OGK""; STRAND 130..134; /evidence=""ECO:0007829|PDB:1QK9""; STRAND 148..150; /evidence=""ECO:0007829|PDB:8ALQ""; STRAND 179..181; /evidence=""ECO:0007829|PDB:8AJR""","HELIX 135..144; /evidence=""ECO:0007829|PDB:6OGK""; HELIX 152..154; /evidence=""ECO:0007829|PDB:6OGK""; HELIX 158..160; /evidence=""ECO:0007829|PDB:8AJR""","TURN 88..91; /evidence=""ECO:0007829|PDB:6OGJ""; TURN 115..118; /evidence=""ECO:0007829|PDB:6OGK""; TURN 127..129; /evidence=""ECO:0007829|PDB:1QK9""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,MECP2,Methyl-CpG-binding protein 2 (MeCp-2 protein) (MeCp2),Homo sapiens (Human),486.0,52441.0,MVAGMLGLREEKSEDQDLQGLKDKPLKFKKVKKDKKEEKEGKHEPVQPSAHHSAEPAEAGKAETSEGSGSAPAVPEASASPKQRRSIIRDRGPMYDDPTLPEGWTRKLKQRKSGRSAGKYDVYLINPQGKAFRSKVELIAYFEKVGDTSLDPNDFDFTVTGRGSPSRREQKPPKKPKSPKAPGTGRGRGRPKGSGTTRPKAATSEGVQVKRVLEKSPGKLLVKMPFQTSPGGKAEGGGATTSTQVMVIKRPGRKRKAEADPQAIPKKRGRKPGSVVAAAAAEAKKKAVKESSIRSVQETVLPIKKRKTRETVSIEVKEVVKPLLVSTLGEKSGKGLKTCKSPGRKSKESSPKGRSSSASSPPKKEHHHHHHHSESPKAPVPLLPPLPPPPPEPESSEDPTSPPEPQDLSSSVCKEEKMPRGGSLESDGCPKEPAKTQPAVATAATAAEKYKHRGEGERKDIVSSSMPRPNREEPVDSRTPVTERVS,True,False,False,P51608,"[('cd01396', 'MeCP2_MBD'), ('G3DSA:3.30.890.10', 'Methyl-cpg-binding Protein 2; Chain A'), ('IPR001739', 'Methyl-CpG DNA binding'), ('IPR016177', 'DNA-binding domain superfamily'), ('IPR017353', 'Methyl-CpG binding protein MeCP2'), ('IPR045138', 'Methyl-CpG binding protein MeCP2/MBD4'), ('PF01429', 'Methyl-CpG binding domain'), ('PIRSF038006', 'Methyl-CpG binding protein MeCP2'), ('PS50982', 'Methyl-CpG-binding domain (MBD) profile'), ('PTHR15074', 'METHYL-CPG-BINDING PROTEIN'), ('SM00391', 'Methyl-CpG binding domain'), ('SSF54171', 'DNA-binding domain')]",,"""ENSG00000169057; Low tissue specificity."";",,,,,ENST00000303391.11 [P51608-1];ENST00000453960.7 [P51608-2];ENST00000630151.3 [P51608-1];,MECP2,ENSG00000169057,0.0,MECP2,Canonical_RBPs,3.0,80.86,DP00539,0.846,0.854,0.846,MECP2
P51668,ENSG00000072401,UB2D1_HUMAN,negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of TORC1 signaling [GO:1904262]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of protein polyubiquitination [GO:1902916]; positive regulation of protein ubiquitination [GO:0031398]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; ubiquitin ligase complex [GO:0000151],ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842],PTM: Autoubiquitinated in vitro. {ECO:0000269|PubMed:22496338}.,,"DOMAIN 1..147; /note=""UBC core""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00388""","STRAND 21..26; /evidence=""ECO:0007829|PDB:4QPL""; STRAND 29..38; /evidence=""ECO:0007829|PDB:4QPL""; STRAND 41..43; /evidence=""ECO:0007829|PDB:4AP4""; STRAND 49..55; /evidence=""ECO:0007829|PDB:4QPL""; STRAND 66..69; /evidence=""ECO:0007829|PDB:4QPL""; STRAND 115..117; /evidence=""ECO:0007829|PDB:5FER""","HELIX 1..15; /evidence=""ECO:0007829|PDB:4QPL""; HELIX 87..89; /evidence=""ECO:0007829|PDB:4QPL""; HELIX 99..111; /evidence=""ECO:0007829|PDB:4QPL""; HELIX 121..129; /evidence=""ECO:0007829|PDB:4QPL""; HELIX 131..146; /evidence=""ECO:0007829|PDB:4QPL""","TURN 44..47; /evidence=""ECO:0007829|PDB:4QPL""; TURN 58..61; /evidence=""ECO:0007829|PDB:4QPL""; TURN 90..92; /evidence=""ECO:0007829|PDB:4QPL""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,UBE2D1 SFT UBC5A UBCH5 UBCH5A,Ubiquitin-conjugating enzyme E2 D1 (EC 2.3.2.23) ((E3-independent) E2 ubiquitin-conjugating enzyme D1) (EC 2.3.2.24) (E2 ubiquitin-conjugating enzyme D1) (Stimulator of Fe transport) (SFT) (UBC4/5 homolog) (UbcH5) (Ubiquitin carrier protein D1) (Ubiquitin-conjugating enzyme E2(17)KB 1) (Ubiquitin-conjugating enzyme E2-17 kDa 1) (Ubiquitin-protein ligase D1),Homo sapiens (Human),147.0,16602.0,MALKRIQKELSDLQRDPPAHCSAGPVGDDLFHWQATIMGPPDSAYQGGVFFLTVHFPTDYPFKPPKIAFTTKIYHPNINSNGSICLDILRSQWSPALTVSKVLLSICSLLCDPNPDDPLVPDIAQIYKSDKEKYNRHAREWTQKYAM,False,False,True,P51668,"[('cd00195', 'UBCc'), ('G3DSA:3.10.110.10', 'Ubiquitin Conjugating Enzyme'), ('IPR000608', 'Ubiquitin-conjugating enzyme E2'), ('IPR016135', 'Ubiquitin-conjugating enzyme/RWD-like'), ('IPR023313', 'Ubiquitin-conjugating enzyme, active site'), ('PF00179', 'Ubiquitin-conjugating enzyme'), ('PS00183', 'Ubiquitin-conjugating (UBC) active site signature'), ('PS50127', 'Ubiquitin-conjugating (UBC) core domain profile'), ('PTHR24068', 'Ubiquitin-conjugating enzyme'), ('SM00212', 'Ubiquitin-conjugating enzyme E2, catalytic domain homologues'), ('SSF54495', 'UBC-like')]",,"""ENSG00000072401; Tissue enhanced (skeletal muscle, tongue)."";","CATALYTIC ACTIVITY: Reaction=S-ubiquitinyl-[E1 ubiquitin-activating enzyme]-L-cysteine + [E2 ubiquitin-conjugating enzyme]-L-cysteine = [E1 ubiquitin-activating enzyme]-L-cysteine + S-ubiquitinyl-[E2 ubiquitin-conjugating enzyme]-L-cysteine.; EC=2.3.2.23; Evidence={ECO:0000255|PROSITE-ProRule:PRU00388, ECO:0000255|PROSITE-ProRule:PRU10133, ECO:0000269|PubMed:18042044, ECO:0000269|PubMed:19854139, ECO:0000269|PubMed:20061386}; CATALYTIC ACTIVITY: Reaction=S-ubiquitinyl-[E1 ubiquitin-activating enzyme]-L-cysteine + [acceptor protein]-L-lysine = [E1 ubiquitin-activating enzyme]-L-cysteine + N(6)-monoubiquitinyl-[acceptor protein]-L-lysine.; EC=2.3.2.24; Evidence={ECO:0000269|PubMed:17588522};",2.3.2.23; 2.3.2.24,,PATHWAY: Protein modification; protein ubiquitination. {ECO:0000255|PROSITE-ProRule:PRU00388}.,ENST00000373910.9;,UBE2D1,ENSG00000072401,0.0,,,,,,,,,UBE2D1
P51948,ENSG00000020426,MAT1_HUMAN,adult heart development [GO:0007512]; DNA repair [GO:0006281]; G1/S transition of mitotic cell cycle [GO:0000082]; negative regulation of apoptotic process [GO:0043066]; nucleotide-excision repair [GO:0006289]; positive regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045737]; positive regulation of smooth muscle cell proliferation [GO:0048661]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of transcription by RNA polymerase II [GO:0006357]; response to calcium ion [GO:0051592]; transcription initiation at RNA polymerase II promoter [GO:0006367]; ventricular system development [GO:0021591],CAK-ERCC2 complex [GO:0070516]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; nucleoplasm [GO:0005654]; transcription factor TFIIH core complex [GO:0000439]; transcription factor TFIIH holo complex [GO:0005675]; transcription factor TFIIK complex [GO:0070985],cyclin-dependent protein serine/threonine kinase activator activity [GO:0061575]; zinc ion binding [GO:0008270],,,"DOMAIN 142..161; /note=""UIM""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00213""","STRAND 21..23; /evidence=""ECO:0007829|PDB:1G25""; STRAND 43..45; /evidence=""ECO:0007829|PDB:1G25""; STRAND 59..61; /evidence=""ECO:0007829|PDB:1G25""; STRAND 89..91; /evidence=""ECO:0007829|PDB:6TUN""; STRAND 256..258; /evidence=""ECO:0007829|PDB:8P73""","HELIX 12..15; /evidence=""ECO:0007829|PDB:1G25""; HELIX 32..40; /evidence=""ECO:0007829|PDB:1G25""; HELIX 68..81; /evidence=""ECO:0007829|PDB:6TUN""; HELIX 86..88; /evidence=""ECO:0007829|PDB:6TUN""; HELIX 92..110; /evidence=""ECO:0007829|PDB:6TUN""; HELIX 115..128; /evidence=""ECO:0007829|PDB:6TUN""; HELIX 263..265; /evidence=""ECO:0007829|PDB:8P79""; HELIX 271..274; /evidence=""ECO:0007829|PDB:8P79""; HELIX 280..284; /evidence=""ECO:0007829|PDB:8P79""; HELIX 289..301; /evidence=""ECO:0007829|PDB:8P79""","TURN 8..11; /evidence=""ECO:0007829|PDB:1G25""; TURN 47..49; /evidence=""ECO:0007829|PDB:1G25""; TURN 266..270; /evidence=""ECO:0007829|PDB:8P79""; TURN 302..305; /evidence=""ECO:0007829|PDB:8P79""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,MNAT1 CAP35 MAT1 RNF66,CDK-activating kinase assembly factor MAT1 (CDK7/cyclin-H assembly factor) (Cyclin-G1-interacting protein) (Menage a trois) (RING finger protein 66) (RING finger protein MAT1) (p35) (p36),Homo sapiens (Human),309.0,35823.0,MDDQGCPRCKTTKYRNPSLKLMVNVCGHTLCESCVDLLFVRGAGNCPECGTPLRKSNFRVQLFEDPTVDKEVEIRKKVLKIYNKREEDFPSLREYNDFLEEVEEIVFNLTNNVDLDNTKKKMEIYQKENKDVIQKNKLKLTREQEELEEALEVERQENEQRRLFIQKEEQLQQILKRKNKQAFLDELESSDLPVALLLAQHKDRSTQLEMQLEKPKPVKPVTFSTGIKMGQHISLAPIHKLEEALYEYQPLQIETYGPHVPELEMLGRLGYLNHVRAASPQDLAGGYTSSLACHRALQDAFSGLFWQPS,False,False,True,P51948,"[('cd16517', 'RING finger, HC subclass, found in RING finger protein MAT1'), ('G3DSA:3.30.40.10', 'Zinc/RING finger domain, C3HC4 (zinc finger)'), ('IPR001841', 'Zinc finger, RING-type'), ('IPR003903', 'Ubiquitin interacting motif'), ('IPR004575', 'Cdk-activating kinase assembly factor MAT1/Tfb3'), ('IPR013083', 'Zinc finger, RING/FYVE/PHD-type'), ('IPR015877', 'Cdk-activating kinase assembly factor MAT1, centre'), ('IPR017907', 'Zinc finger, RING-type, conserved site'), ('PF06391', 'CDK-activating kinase assembly factor MAT1'), ('PF17121', 'Zinc finger, C3HC4 type (RING finger)'), ('PIRSF003338', 'CDK-activating kinase assembly factor MAT1'), ('PS00518', 'Zinc finger RING-type signature'), ('PS50089', 'Zinc finger RING-type profile'), ('PS50330', 'Ubiquitin-interacting motif (UIM) domain profile'), ('PTHR12683', 'RNA Pol II TF B subunit 3/MAT1'), ('SM00184', 'Ring finger'), ('SSF57850', 'RING/U-box'), ('TIGR00570', 'CDK-activating kinase assembly factor MAT1')]",,"""ENSG00000020426; Low tissue specificity."";",,,,,ENST00000261245.9 [P51948-1];ENST00000539616.6 [P51948-2];,MNAT1,ENSG00000020426,0.0,,,,,,,0.162,,MNAT1
P51965,ENSG00000170142,UB2E1_HUMAN,ISG15-protein conjugation [GO:0032020]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511],cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151],ATP binding [GO:0005524]; ISG15 transferase activity [GO:0042296]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842],PTM: ISGylation suppresses ubiquitin E2 enzyme activity. {ECO:0000269|PubMed:16428300}.; PTM: Autoubiquitinated in vitro. {ECO:0000269|PubMed:22496338}.,,"DOMAIN 47..193; /note=""UBC core""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00388""","STRAND 67..74; /evidence=""ECO:0007829|PDB:5LBN""; STRAND 78..84; /evidence=""ECO:0007829|PDB:5LBN""; STRAND 95..101; /evidence=""ECO:0007829|PDB:5LBN""; STRAND 112..117; /evidence=""ECO:0007829|PDB:5LBN""","HELIX 22..24; /evidence=""ECO:0007829|PDB:3BZH""; HELIX 42..44; /evidence=""ECO:0007829|PDB:5LBN""; HELIX 47..61; /evidence=""ECO:0007829|PDB:5LBN""; HELIX 133..135; /evidence=""ECO:0007829|PDB:5LBN""; HELIX 145..157; /evidence=""ECO:0007829|PDB:5LBN""; HELIX 167..175; /evidence=""ECO:0007829|PDB:5LBN""; HELIX 177..191; /evidence=""ECO:0007829|PDB:5LBN""","TURN 90..93; /evidence=""ECO:0007829|PDB:5LBN""; TURN 104..107; /evidence=""ECO:0007829|PDB:5LBN""; TURN 136..138; /evidence=""ECO:0007829|PDB:3BZH""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,UBE2E1 UBCH6,Ubiquitin-conjugating enzyme E2 E1 (EC 2.3.2.23) ((E3-independent) E2 ubiquitin-conjugating enzyme E1) (EC 2.3.2.24) (E2 ubiquitin-conjugating enzyme E1) (UbcH6) (Ubiquitin carrier protein E1) (Ubiquitin-protein ligase E1),Homo sapiens (Human),193.0,21404.0,MSDDDSRASTSSSSSSSSNQQTEKETNTPKKKESKVSMSKNSKLLSTSAKRIQKELADITLDPPPNCSAGPKGDNIYEWRSTILGPPGSVYEGGVFFLDITFTPEYPFKPPKVTFRTRIYHCNINSQGVICLDILKDNWSPALTISKVLLSICSLLTDCNPADPLVGSIATQYMTNRAEHDRMARQWTKRYAT,False,False,True,P51965,"[('cd00195', 'UBCc'), ('G3DSA:3.10.110.10', 'Ubiquitin Conjugating Enzyme'), ('IPR000608', 'Ubiquitin-conjugating enzyme E2'), ('IPR016135', 'Ubiquitin-conjugating enzyme/RWD-like'), ('IPR023313', 'Ubiquitin-conjugating enzyme, active site'), ('PF00179', 'Ubiquitin-conjugating enzyme'), ('PS00183', 'Ubiquitin-conjugating (UBC) active site signature'), ('PS50127', 'Ubiquitin-conjugating (UBC) core domain profile'), ('PTHR24068', 'Ubiquitin-conjugating enzyme'), ('SM00212', 'Ubiquitin-conjugating enzyme E2, catalytic domain homologues'), ('SSF54495', 'UBC-like')]",,"""ENSG00000170142; Low tissue specificity."";","CATALYTIC ACTIVITY: Reaction=S-ubiquitinyl-[E1 ubiquitin-activating enzyme]-L-cysteine + [E2 ubiquitin-conjugating enzyme]-L-cysteine = [E1 ubiquitin-activating enzyme]-L-cysteine + S-ubiquitinyl-[E2 ubiquitin-conjugating enzyme]-L-cysteine.; EC=2.3.2.23; Evidence={ECO:0000255|PROSITE-ProRule:PRU00388, ECO:0000255|PROSITE-ProRule:PRU10133, ECO:0000269|PubMed:20061386}; CATALYTIC ACTIVITY: Reaction=S-ubiquitinyl-[E1 ubiquitin-activating enzyme]-L-cysteine + [acceptor protein]-L-lysine = [E1 ubiquitin-activating enzyme]-L-cysteine + N(6)-monoubiquitinyl-[acceptor protein]-L-lysine.; EC=2.3.2.24; Evidence={ECO:0000269|PubMed:17588522};",2.3.2.23; 2.3.2.24,,PATHWAY: Protein modification; protein ubiquitination. {ECO:0000255|PROSITE-ProRule:PRU00388}.,ENST00000306627.8 [P51965-1];ENST00000346855.7 [P51965-3];ENST00000424381.5 [P51965-2];,UBE2E1,ENSG00000170142,0.0,,,,20.73,DP02191,0.207,0.218,0.233,UBE2E1
P52735,ENSG00000160293,VAV2_HUMAN,angiogenesis [GO:0001525]; cell migration [GO:0016477]; cellular response to xenobiotic stimulus [GO:0071466]; Fc-epsilon receptor signaling pathway [GO:0038095]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; lamellipodium assembly [GO:0030032]; platelet activation [GO:0030168]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; regulation of cell size [GO:0008361]; regulation of GTPase activity [GO:0043087]; regulation of small GTPase mediated signal transduction [GO:0051056]; signal transduction [GO:0007165]; small GTPase-mediated signal transduction [GO:0007264]; vascular endothelial growth factor receptor signaling pathway [GO:0048010],cytoplasm [GO:0005737]; cytosol [GO:0005829]; plasma membrane [GO:0005886],epidermal growth factor receptor binding [GO:0005154]; guanyl-nucleotide exchange factor activity [GO:0005085]; metal ion binding [GO:0046872]; phosphotyrosine residue binding [GO:0001784],"PTM: Phosphorylated on tyrosine residues in response to FGR activation. {ECO:0000269|PubMed:12454019, ECO:0000269|PubMed:15561106}.",,"DOMAIN 1..120; /note=""Calponin-homology (CH)""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00044""; DOMAIN 198..376; /note=""DH""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00062""; DOMAIN 405..512; /note=""PH""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00145""; DOMAIN 586..652; /note=""SH3 1""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00192""; DOMAIN 673..767; /note=""SH2""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00191""; DOMAIN 816..877; /note=""SH3 2""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00192""","STRAND 661..664; /evidence=""ECO:0007829|PDB:2LNX""; STRAND 674..677; /evidence=""ECO:0007829|PDB:7RNV""; STRAND 694..699; /evidence=""ECO:0007829|PDB:4ROJ""; STRAND 703..705; /evidence=""ECO:0007829|PDB:4ROJ""; STRAND 707..713; /evidence=""ECO:0007829|PDB:4ROJ""; STRAND 716..725; /evidence=""ECO:0007829|PDB:4ROJ""; STRAND 728..732; /evidence=""ECO:0007829|PDB:4ROJ""; STRAND 735..739; /evidence=""ECO:0007829|PDB:4ROJ""; STRAND 765..767; /evidence=""ECO:0007829|PDB:7RNV""; STRAND 819..825; /evidence=""ECO:0007829|PDB:2DM1""; STRAND 842..844; /evidence=""ECO:0007829|PDB:2DM1""; STRAND 847..854; /evidence=""ECO:0007829|PDB:2DM1""; STRAND 856..860; /evidence=""ECO:0007829|PDB:2DM1""; STRAND 863..867; /evidence=""ECO:0007829|PDB:2DM1""; STRAND 869..874; /evidence=""ECO:0007829|PDB:2DM1""","HELIX 668..670; /evidence=""ECO:0007829|PDB:7RNV""; HELIX 680..687; /evidence=""ECO:0007829|PDB:4ROJ""; HELIX 740..749; /evidence=""ECO:0007829|PDB:4ROJ""; HELIX 752..754; /evidence=""ECO:0007829|PDB:4ROJ""",,"cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,VAV2,Guanine nucleotide exchange factor VAV2 (VAV-2),Homo sapiens (Human),878.0,101289.0,MEQWRQCGRWLIDCKVLPPNHRVVWPSAVVFDLAQALRDGVLLCQLLHNLSPGSIDLKDINFRPQMSQFLCLKNIRTFLKVCHDKFGLRNSELFDPFDLFDVRDFGKVISAVSRLSLHSIAQNKGIRPFPSEETTENDDDVYRSLEELADEHDLGEDIYDCVPCEDGGDDIYEDIIKVEVQQPMIRYMQKMGMTEDDKRNCCLLEIQETEAKYYRTLEDIEKNYMSPLRLVLSPADMAAVFINLEDLIKVHHSFLRAIDVSVMVGGSTLAKVFLDFKERLLIYGEYCSHMEHAQNTLNQLLASREDFRQKVEECTLKVQDGKFKLQDLLVVPMQRVLKYHLLLKELLSHSAERPERQQLKEALEAMQDLAMYINEVKRDKETLRKISEFQSSIENLQVKLEEFGRPKIDGELKVRSIVNHTKQDRYLFLFDKVVIVCKRKGYSYELKEIIELLFHKMTDDPMNNKDVKKSHGKMWSYGFYLIHLQGKQGFQFFCKTEDMKRKWMEQFEMAMSNIKPDKANANHHSFQMYTFDKTTNCKACKMFLRGTFYQGYMCTKCGVGAHKECLEVIPPCKFTSPADLDASGAGPGPKMVAMQNYHGNPAPPGKPVLTFQTGDVLELLRGDPESPWWEGRLVQTRKSGYFPSSSVKPCPVDGRPPISRPPSREIDYTAYPWFAGNMERQQTDNLLKSHASGTYLIRERPAEAERFAISIKFNDEVKHIKVVEKDNWIHITEAKKFDSLLELVEYYQCHSLKESFKQLDTTLKYPYKSRERSASRASSRSPASCASYNFSFLSPQGLSFASQGPSAPFWSVFTPRVIGTAVARYNFAARDMRELSLREGDVVRIYSRIGGDQGWWKGETNGRIGWFPSTYVEEEGIQ,False,False,True,P52735,"[('cd00160', 'RhoGEF'), ('cd01223', 'Vav pleckstrin homology (PH) domain'), ('cd10406', 'Src homology 2 (SH2) domain found in the Vav2 proteins'), ('cd11977', 'C-terminal (or second) Src homology 3 domain of VAV2 protein'), ('cd11980', 'First Src homology 3 domain of VAV2 protein'), ('cd20868', 'protein kinase C conserved region 1 (C1 domain) found in VAV2 protein'), ('cd21263', 'calponin homology (CH) domain found in VAV2 protein and similar proteins'), ('G3DSA:1.10.418.10', 'Calponin-like domain'), ('G3DSA:1.20.900.10', 'Dbl homology (DH) domain'), ('G3DSA:2.30.29.30', 'Pleckstrin-homology domain (PH domain)/Phosphotyrosine-binding domain (PTB)'), ('G3DSA:2.30.30.40', 'SH3 Domains'), ('G3DSA:3.30.505.10', 'SH2 domain'), ('G3DSA:3.30.60.20', None), ('IPR000219', 'Dbl homology (DH) domain'), ('IPR000980', 'SH2 domain'), ('IPR001331', 'Guanine-nucleotide dissociation stimulator, CDC24, conserved site'), ('IPR001452', 'SH3 domain'), ('IPR001715', 'Calponin homology domain'), ('IPR001849', 'Pleckstrin homology domain'), ('IPR002219', 'Protein kinase C-like, phorbol ester/diacylglycerol-binding domain')]",,"""ENSG00000160293; Low tissue specificity."";",,,,,ENST00000371850.8 [P52735-1];ENST00000371851.1 [P52735-2];ENST00000406606.7 [P52735-3];,VAV2,ENSG00000160293,0.0,,,,,,,0.075,,VAV2
P52789,ENSG00000159399,HXK2_HUMAN,apoptotic mitochondrial changes [GO:0008637]; canonical glycolysis [GO:0061621]; carbohydrate phosphorylation [GO:0046835]; cellular response to leukemia inhibitory factor [GO:1990830]; establishment of protein localization to mitochondrion [GO:0072655]; fructose 6-phosphate metabolic process [GO:0006002]; glucose 6-phosphate metabolic process [GO:0051156]; glucose metabolic process [GO:0006006]; glycolytic process [GO:0006096]; intracellular glucose homeostasis [GO:0001678]; lactation [GO:0007595]; maintenance of protein location in mitochondrion [GO:0072656]; negative regulation of mitochondrial membrane permeability [GO:0035795]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; positive regulation of angiogenesis [GO:0045766]; positive regulation of autophagy of mitochondrion in response to mitochondrial depolarization [GO:1904925]; regulation of glucose import [GO:0046324]; response to hypoxia [GO:0001666]; response to ischemia [GO:0002931],centrosome [GO:0005813]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739]; sarcoplasmic reticulum [GO:0016529],ATP binding [GO:0005524]; D-glucose binding [GO:0005536]; fructokinase activity [GO:0008865]; glucokinase activity [GO:0004340]; hexokinase activity [GO:0004396],,"DOMAIN: The N- and C-terminal halves of the protein contain a hexokinase domain (PubMed:29298880). In contrast to hexokinase-1 and -3 (HK1 and HK3, respectively), both hexokinase domains display catalytic activity (PubMed:29298880). The region connecting the two hexokinase domains is required for the catalytic activity of the N-terminal hexokinase domain (PubMed:29298880). The N-terminal half regulates stability of the whole enzyme (PubMed:29298880). {ECO:0000269|PubMed:29298880}.","DOMAIN 16..458; /note=""Hexokinase 1""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU01084""; DOMAIN 464..906; /note=""Hexokinase 2""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU01084""","STRAND 78..97; /evidence=""ECO:0007829|PDB:2NZT""; STRAND 100..102; /evidence=""ECO:0007829|PDB:5HEX""; STRAND 106..112; /evidence=""ECO:0007829|PDB:2NZT""; STRAND 148..154; /evidence=""ECO:0007829|PDB:2NZT""; STRAND 161..164; /evidence=""ECO:0007829|PDB:5HEX""; STRAND 165..168; /evidence=""ECO:0007829|PDB:5HFU""; STRAND 201..207; /evidence=""ECO:0007829|PDB:2NZT""; STRAND 224..241; /evidence=""ECO:0007829|PDB:2NZT""; STRAND 252..258; /evidence=""ECO:0007829|PDB:2NZT""; STRAND 285..287; /evidence=""ECO:0007829|PDB:2NZT""; STRAND 345..347; /evidence=""ECO:0007829|PDB:2NZT""; STRAND 404..413; /evidence=""ECO:0007829|PDB:2NZT""; STRAND 420..422; /evidence=""ECO:0007829|PDB:2NZT""; STRAND 438..444; /evidence=""ECO:0007829|PDB:2NZT""; STRAND 527..536; /evidence=""ECO:0007829|PDB:2NZT""; STRAND 539..545; /evidence=""ECO:0007829|PDB:2NZT""; STRAND 548..550; /evidence=""ECO:0007829|PDB:5HEX""; STRAND 553..559; /evidence=""ECO:0007829|PDB:2NZT""; STRAND 597..602; /evidence=""ECO:0007829|PDB:2NZT""; STRAND 606..610; /evidence=""ECO:0007829|PDB:2NZT""; STRAND 613..616; /evidence=""ECO:0007829|PDB:2NZT""; STRAND 650..655; /evidence=""ECO:0007829|PDB:2NZT""; STRAND 672..689; /evidence=""ECO:0007829|PDB:2NZT""; STRAND 699..706; /evidence=""ECO:0007829|PDB:2NZT""; STRAND 733..735; /evidence=""ECO:0007829|PDB:2NZT""; STRAND 852..861; /evidence=""ECO:0007829|PDB:2NZT""; STRAND 868..870; /evidence=""ECO:0007829|PDB:5HG1""; STRAND 886..892; /evidence=""ECO:0007829|PDB:2NZT""","HELIX 19..25; /evidence=""ECO:0007829|PDB:2NZT""; HELIX 27..29; /evidence=""ECO:0007829|PDB:2NZT""; HELIX 33..51; /evidence=""ECO:0007829|PDB:2NZT""; HELIX 56..58; /evidence=""ECO:0007829|PDB:2NZT""; HELIX 116..119; /evidence=""ECO:0007829|PDB:2NZT""; HELIX 123..141; /evidence=""ECO:0007829|PDB:2NZT""; HELIX 143..145; /evidence=""ECO:0007829|PDB:5HG1""; HELIX 185..194; /evidence=""ECO:0007829|PDB:2NZT""; HELIX 209..218; /evidence=""ECO:0007829|PDB:2NZT""; HELIX 242..244; /evidence=""ECO:0007829|PDB:2NZT""; HELIX 261..263; /evidence=""ECO:0007829|PDB:2NZT""; HELIX 276..283; /evidence=""ECO:0007829|PDB:2NZT""; HELIX 292..295; /evidence=""ECO:0007829|PDB:2NZT""; HELIX 302..315; /evidence=""ECO:0007829|PDB:2NZT""; HELIX 320..322; /evidence=""ECO:0007829|PDB:2NZT""; HELIX 326..329; /evidence=""ECO:0007829|PDB:2NZT""; HELIX 336..344; /evidence=""ECO:0007829|PDB:2NZT""; HELIX 348..358; /evidence=""ECO:0007829|PDB:2NZT""; HELIX 365..401; /evidence=""ECO:0007829|PDB:2NZT""; HELIX 415..419; /evidence=""ECO:0007829|PDB:2NZT""; HELIX 423..434; /evidence=""ECO:0007829|PDB:2NZT""; HELIX 449..474; /evidence=""ECO:0007829|PDB:2NZT""; HELIX 475..477; /evidence=""ECO:0007829|PDB:2NZT""; HELIX 481..499; /evidence=""ECO:0007829|PDB:2NZT""; HELIX 501..504; /evidence=""ECO:0007829|PDB:2NZT""; HELIX 564..568; /evidence=""ECO:0007829|PDB:2NZT""; HELIX 571..588; /evidence=""ECO:0007829|PDB:2NZT""; HELIX 633..642; /evidence=""ECO:0007829|PDB:2NZT""; HELIX 657..666; /evidence=""ECO:0007829|PDB:2NZT""; HELIX 709..711; /evidence=""ECO:0007829|PDB:2NZT""; HELIX 724..731; /evidence=""ECO:0007829|PDB:2NZT""; HELIX 742..744; /evidence=""ECO:0007829|PDB:2NZT""; HELIX 750..763; /evidence=""ECO:0007829|PDB:2NZT""; HELIX 768..770; /evidence=""ECO:0007829|PDB:2NZT""; HELIX 785..788; /evidence=""ECO:0007829|PDB:2NZT""; HELIX 797..806; /evidence=""ECO:0007829|PDB:2NZT""; HELIX 813..848; /evidence=""ECO:0007829|PDB:2NZT""; HELIX 863..867; /evidence=""ECO:0007829|PDB:2NZT""; HELIX 871..882; /evidence=""ECO:0007829|PDB:2NZT""; HELIX 897..911; /evidence=""ECO:0007829|PDB:2NZT""","TURN 53..55; /evidence=""ECO:0007829|PDB:2NZT""; TURN 264..267; /evidence=""ECO:0007829|PDB:2NZT""; TURN 269..273; /evidence=""ECO:0007829|PDB:2NZT""; TURN 299..301; /evidence=""ECO:0007829|PDB:2NZT""; TURN 690..692; /evidence=""ECO:0007829|PDB:2NZT""; TURN 712..715; /evidence=""ECO:0007829|PDB:2NZT""; TURN 717..721; /evidence=""ECO:0007829|PDB:2NZT""; TURN 747..749; /evidence=""ECO:0007829|PDB:2NZT""; TURN 774..776; /evidence=""ECO:0007829|PDB:2NZT""; TURN 789..791; /evidence=""ECO:0007829|PDB:2NZT""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,HK2,Hexokinase-2 (EC 2.7.1.1) (Hexokinase type II) (HK II) (Hexokinase-B) (Muscle form hexokinase),Homo sapiens (Human),917.0,102380.0,MIASHLLAYFFTELNHDQVQKVDQYLYHMRLSDETLLEISKRFRKEMEKGLGATTHPTAAVKMLPTFVRSTPDGTEHGEFLALDLGGTNFRVLWVKVTDNGLQKVEMENQIYAIPEDIMRGSGTQLFDHIAECLANFMDKLQIKDKKLPLGFTFSFPCHQTKLDESFLVSWTKGFKSSGVEGRDVVALIRKAIQRRGDFDIDIVAVVNDTVGTMMTCGYDDHNCEIGLIVGTGSNACYMEEMRHIDMVEGDEGRMCINMEWGAFGDDGSLNDIRTEFDQEIDMGSLNPGKQLFEKMISGMYMGELVRLILVKMAKEELLFGGKLSPELLNTGRFETKDISDIEGEKDGIRKAREVLMRLGLDPTQEDCVATHRICQIVSTRSASLCAATLAAVLQRIKENKGEERLRSTIGVDGSVYKKHPHFAKRLHKTVRRLVPGCDVRFLRSEDGSGKGAAMVTAVAYRLADQHRARQKTLEHLQLSHDQLLEVKRRMKVEMERGLSKETHASAPVKMLPTYVCATPDGTEKGDFLALDLGGTNFRVLLVRVRNGKWGGVEMHNKIYAIPQEVMHGTGDELFDHIVQCIADFLEYMGMKGVSLPLGFTFSFPCQQNSLDESILLKWTKGFKASGCEGEDVVTLLKEAIHRREEFDLDVVAVVNDTVGTMMTCGFEDPHCEVGLIVGTGSNACYMEEMRNVELVEGEEGRMCVNMEWGAFGDNGCLDDFRTEFDVAVDELSLNPGKQRFEKMISGMYLGEIVRNILIDFTKRGLLFRGRISERLKTRGIFETKFLSQIESDCLALLQVRAILQHLGLESTCDDSIIVKEVCTVVARRAAQLCGAGMAAVVDRIRENRGLDALKVTVGVDGTLYKLHPHFAKVMHETVKDLAPKCDVSFLQSEDGSGKGAALITAVACRIREAGQR,True,False,False,P52789,"[('cd00012', 'Nucleotide-Binding Domain of the sugar kinase/HSP70/actin superfamily'), ('G3DSA:3.30.420.40', None), ('G3DSA:3.40.367.20', None), ('IPR001312', 'Hexokinase'), ('IPR019807', 'Hexokinase, binding site'), ('IPR022672', 'Hexokinase, N-terminal'), ('IPR022673', 'Hexokinase, C-terminal'), ('IPR043129', 'ATPase, nucleotide binding domain'), ('PF00349', 'Hexokinase'), ('PF03727', 'Hexokinase'), ('PR00475', 'HEXOKINASE'), ('PS00378', 'Hexokinase domain signature'), ('PS51748', 'Hexokinase domain profile'), ('PTHR19443', 'HEXOKINASE'), ('SSF53067', 'Actin-like ATPase domain')]",,"""ENSG00000159399; Tissue enhanced (retina)."";","CATALYTIC ACTIVITY: Reaction=a D-hexose + ATP = a D-hexose 6-phosphate + ADP + H(+); Xref=Rhea:RHEA:22740, ChEBI:CHEBI:4194, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616, ChEBI:CHEBI:229467, ChEBI:CHEBI:456216; EC=2.7.1.1; Evidence={ECO:0000269|PubMed:23185017, ECO:0000269|PubMed:26985301, ECO:0000269|PubMed:29298880}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:22741; Evidence={ECO:0000269|PubMed:23185017, ECO:0000269|PubMed:29298880}; CATALYTIC ACTIVITY: Reaction=D-fructose + ATP = D-fructose 6-phosphate + ADP + H(+); Xref=Rhea:RHEA:16125, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616, ChEBI:CHEBI:37721, ChEBI:CHEBI:61527, ChEBI:CHEBI:456216; EC=2.7.1.1; Evidence={ECO:0000250|UniProtKB:P27881}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:16126; Evidence={ECO:0000250|UniProtKB:P27881}; CATALYTIC ACTIVITY: Reaction=D-glucose + ATP = D-glucose 6-phosphate + ADP + H(+); Xref=Rhea:RHEA:17825, ChEBI:CHEBI:4167, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616, ChEBI:CHEBI:61548, ChEBI:CHEBI:456216; EC=2.7.1.1; Evidence={ECO:0000269|PubMed:29298880}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:17826; Evidence={ECO:0000269|PubMed:29298880};",2.7.1.1,"ACTIVITY REGULATION: Hexokinase activity is specifically inhibited by 2,6-disubstituted glucosamines. {ECO:0000269|PubMed:26985301}.",PATHWAY: Carbohydrate metabolism; hexose metabolism. {ECO:0000305|PubMed:29298880}.; PATHWAY: Carbohydrate degradation; glycolysis; D-glyceraldehyde 3-phosphate and glycerone phosphate from D-glucose: step 1/4. {ECO:0000305|PubMed:29298880}.,ENST00000290573.7;,HK2,ENSG00000159399,0.0,,,,,,,0.007,,HK2
P52948,ENSG00000110713,NUP98_HUMAN,"mRNA transport [GO:0051028]; nuclear pore complex assembly [GO:0051292]; nuclear pore organization [GO:0006999]; nucleocytoplasmic transport [GO:0006913]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; post-transcriptional tethering of RNA polymerase II gene DNA at nuclear periphery [GO:0000973]; protein import into nucleus [GO:0006606]; proteolysis [GO:0006508]; RNA export from nucleus [GO:0006405]; telomere tethering at nuclear periphery [GO:0034398]",cytosol [GO:0005829]; nuclear body [GO:0016604]; nuclear envelope [GO:0005635]; nuclear inclusion body [GO:0042405]; nuclear membrane [GO:0031965]; nuclear periphery [GO:0034399]; nuclear pore [GO:0005643]; nuclear pore cytoplasmic filaments [GO:0044614]; nuclear pore nuclear basket [GO:0044615]; nuclear pore outer ring [GO:0031080]; nucleoplasm [GO:0005654]; ribonucleoprotein complex [GO:1990904],molecular condensate scaffold activity [GO:0140693]; mRNA binding [GO:0003729]; nuclear localization sequence binding [GO:0008139]; promoter-specific chromatin binding [GO:1990841]; RNA binding [GO:0003723]; serine-type peptidase activity [GO:0008236]; structural constituent of nuclear pore [GO:0017056]; transcription coactivator activity [GO:0003713],"PTM: Isoform 1 to isoform 4 are autoproteolytically cleaved to yield Nup98 and Nup96 or Nup98 only, respectively (PubMed:10087256, PubMed:12191480, PubMed:18287282, PubMed:20407419). Cleaved Nup98 is necessary for the targeting of Nup98 to the nuclear pore and the interaction with Nup96 (PubMed:12191480, PubMed:20407419). {ECO:0000269|PubMed:10087256, ECO:0000269|PubMed:12191480, ECO:0000269|PubMed:18287282, ECO:0000269|PubMed:20407419}.; PTM: Proteolytically degraded after poliovirus (PV) infection; degradation is partial and NCP- and TPR-binding domains withstand degradation.",DOMAIN: Contains G-L-F-G repeats. The FG repeat domains in Nup98 have a direct role in the transport.,"DOMAIN 738..880; /note=""Peptidase S59""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00765""","STRAND 91..96; /evidence=""ECO:0007829|PDB:7Q64""; STRAND 100..104; /evidence=""ECO:0007829|PDB:7Q64""; STRAND 105..113; /evidence=""ECO:0007829|PDB:7Q66""; STRAND 120..123; /evidence=""ECO:0007829|PDB:7Q64""; STRAND 168..172; /evidence=""ECO:0007829|PDB:3MMY""; STRAND 181..186; /evidence=""ECO:0007829|PDB:3MMY""; STRAND 306..309; /evidence=""ECO:0007829|PDB:8CI8""; STRAND 312..316; /evidence=""ECO:0007829|PDB:8CI8""; STRAND 318..320; /evidence=""ECO:0007829|PDB:8CI8""; STRAND 322..325; /evidence=""ECO:0007829|PDB:8CI8""; STRAND 741..745; /evidence=""ECO:0007829|PDB:2Q5X""; STRAND 761..769; /evidence=""ECO:0007829|PDB:2Q5X""; STRAND 773..782; /evidence=""ECO:0007829|PDB:2Q5X""; STRAND 792..795; /evidence=""ECO:0007829|PDB:2Q5X""; STRAND 798..801; /evidence=""ECO:0007829|PDB:2Q5X""; STRAND 819..823; /evidence=""ECO:0007829|PDB:2Q5X""; STRAND 862..867; /evidence=""ECO:0007829|PDB:2Q5X""; STRAND 872..879; /evidence=""ECO:0007829|PDB:2Q5X""","HELIX 189..191; /evidence=""ECO:0007829|PDB:3MMY""; HELIX 200..209; /evidence=""ECO:0007829|PDB:3MMY""; HELIX 747..753; /evidence=""ECO:0007829|PDB:2Q5X""; HELIX 788..791; /evidence=""ECO:0007829|PDB:2Q5X""; HELIX 805..807; /evidence=""ECO:0007829|PDB:2Q5Y""; HELIX 840..845; /evidence=""ECO:0007829|PDB:2Q5X""; HELIX 848..858; /evidence=""ECO:0007829|PDB:2Q5X""","TURN 193..197; /evidence=""ECO:0007829|PDB:3MMY""; TURN 770..772; /evidence=""ECO:0007829|PDB:2Q5X""; TURN 831..833; /evidence=""ECO:0007829|PDB:2Q5X""; TURN 868..871; /evidence=""ECO:0007829|PDB:2Q5X""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,NUP98 ADAR2,Nuclear pore complex protein Nup98-Nup96 (EC 3.4.21.-) [Cleaved into: Nuclear pore complex protein Nup98 (98 kDa nucleoporin) (Nucleoporin Nup98) (Nup98); Nuclear pore complex protein Nup96 (96 kDa nucleoporin) (Nucleoporin Nup96) (Nup96)],Homo sapiens (Human),1817.0,197579.0,MFNKSFGTPFGGGTGGFGTTSTFGQNTGFGTTSGGAFGTSAFGSSNNTGGLFGNSQTKPGGLFGTSSFSQPATSTSTGFGFGTSTGTANTLFGTASTGTSLFSSQNNAFAQNKPTGFGNFGTSTSSGGLFGTTNTTSNPFGSTSGSLFGPSSFTAAPTGTTIKFNPPTGTDTMVKAGVSTNISTKHQCITAMKEYESKSLEELRLEDYQANRKGPQNQVGAGTTTGLFGSSPATSSATGLFSSSTTNSGFAYGQNKTAFGTSTTGFGTNPGGLFGQQNQQTTSLFSKPFGQATTTQNTGFSFGNTSTIGQPSTNTMGLFGVTQASQPGGLFGTATNTSTGTAFGTGTGLFGQTNTGFGAVGSTLFGNNKLTTFGSSTTSAPSFGTTSGGLFGNKPTLTLGTNTNTSNFGFGTNTSGNSIFGSKPAPGTLGTGLGAGFGTALGAGQASLFGNNQPKIGGPLGTGAFGAPGFNTTTATLGFGAPQAPVALTDPNASAAQQAVLQQHINSLTYSPFGDSPLFRNPMSDPKKKEERLKPTNPAAQKALTTPTHYKLTPRPATRVRPKALQTTGTAKSHLFDGLDDDEPSLANGAFMPKKSIKKLVLKNLNNSNLFSPVNRDSENLASPSEYPENGERFSFLSKPVDENHQQDGDEDSLVSHFYTNPIAKPIPQTPESAGNKHSNSNSVDDTIVALNMRAALRNGLEGSSEETSFHDESLQDDREEIENNSYHMHPAGIILTKVGYYTIPSMDDLAKITNEKGECIVSDFTIGRKGYGSIYFEGDVNLTNLNLDDIVHIRRKEVVVYLDDNQKPPVGEGLNRKAEVTLDGVWPTDKTSRCLIKSPDRLADINYEGRLEAVSRKQGAQFKEYRPETGSWVFKVSHFSKYGLQDSDEEEEEHPSKTSTKKLKTAPLPPASQTTPLQMALNGKPAPPPQSQSPEVEQLGRVVELDSDMVDITQEPVLDTMLEESMPEDQEPVSASTHIASSLGINPHVLQIMKASLLTDEEDVDMALDQRFSRLPSKADTSQEICSPRLPISASHSSKTRSLVGGLLQSKFTSGAFLSPSVSVQECRTPRAASLMNIPSTSSWSVPPPLTSVFTMPSPAPEVPLKTVGTRRQLGLVPREKSVTYGKGKLLMDMALFMGRSFRVGWGPNWTLANSGEQLNGSHELENHQIADSMEFGFLPNPVAVKPLTESPFKVHLEKLSLRQRKPDEDMKLYQTPLELKLKHSTVHVDELCPLIVPNLGVAVIHDYADWVKEASGDLPEAQIVKHWSLTWTLCEALWGHLKELDSQLNEPREYIQILERRRAFSRWLSCTATPQIEEEVSLTQKNSPVEAVFSYLTGKRISEACSLAQQSGDHRLALLLSQFVGSQSVRELLTMQLVDWHQLQADSFIQDERLRIFALLAGKPVWQLSEKKQINVCSQLDWKRSLAIHLWYLLPPTASISRALSMYEEAFQNTSDSDRYACSPLPSYLEGSGCVIAEEQNSQTPLRDVCFHLLKLYSDRHYDLNQLLEPRSITADPLDYRLSWHLWEVLRALNYTHLSAQCEGVLQASYAGQLESEGLWEWAIFVLLHIDNSGIREKAVRELLTRHCQLLETPESWAKETFLTQKLRVPAKWIHEAKAVRAHMESDKHLEALCLFKAEHWNRCHKLIIRHLASDAIINENYDYLKGFLEDLAPPERSSLIQDWETSGLVYLDYIRVIEMLRHIQQVDCSGNDLEQLHIKVTSLCSRIEQIQCYSAKDRLAQSDMAKRVANLLRVVLSLHHPPDRTSDSTPDPQRVPLRLLAPHIGRLPMPEDYAMDELRSLTQSYLRELAVGSL,True,False,False,P52948,"[('G3DSA:1.10.10.2360', None), ('G3DSA:1.25.40.690', None), ('G3DSA:3.30.1610.10', 'Peptidase S59, nucleoporin'), ('IPR007230', 'Nuclear pore complex protein Nup98-Nup96-like, autopeptidase S59 domain'), ('IPR021967', 'Nuclear pore complex protein NUP96, C-terminal domain'), ('IPR036903', 'Nuclear pore complex protein Nup98-Nup96-like, autopeptidase S59 domain superfamily'), ('IPR037665', 'Nucleoporin peptidase S59-like'), ('PF04096', 'Nup98-96 autopeptidase S59'), ('PF12110', 'Nuclear protein 96'), ('PF21240', 'Nup98, Gle2-binding sequence'), ('PS51434', 'NUP C-terminal domain profile'), ('PTHR23198', 'NUCLEOPORIN'), ('SSF82215', 'C-terminal autoproteolytic domain of nucleoporin nup98')]",,"""ENSG00000110713; Low tissue specificity."";",,3.4.21.-,,,ENST00000324932.12 [P52948-5];ENST00000355260.8 [P52948-2];ENST00000359171.8 [P52948-1];ENST00000397004.9 [P52948-4];ENST00000397007.10 [P52948-3];ENST00000700606.1 [P52948-4];,NUP98,ENSG00000110713,0.0,NUP98,Non-canonical_RBPs,8.0,54.71,DP02123,0.547,0.537,0.064,NUP98
P53350,ENSG00000166851,PLK1_HUMAN,centrosome cycle [GO:0007098]; double-strand break repair [GO:0006302]; double-strand break repair via alternative nonhomologous end joining [GO:0097681]; establishment of mitotic spindle orientation [GO:0000132]; establishment of protein localization [GO:0045184]; female meiosis chromosome segregation [GO:0016321]; G2/M transition of mitotic cell cycle [GO:0000086]; Golgi inheritance [GO:0048313]; homologous chromosome segregation [GO:0045143]; metaphase/anaphase transition of mitotic cell cycle [GO:0007091]; microtubule bundle formation [GO:0001578]; mitotic cell cycle [GO:0000278]; mitotic chromosome condensation [GO:0007076]; mitotic cytokinesis [GO:0000281]; mitotic G2 DNA damage checkpoint signaling [GO:0007095]; mitotic nuclear membrane disassembly [GO:0007077]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle assembly checkpoint signaling [GO:0007094]; mitotic spindle organization [GO:0007052]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nuclear membrane disassembly [GO:0051081]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein localization to nucleus [GO:1900182]; positive regulation of proteolysis [GO:0045862]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; protein destabilization [GO:0031648]; protein localization to chromatin [GO:0071168]; protein localization to nuclear envelope [GO:0090435]; protein phosphorylation [GO:0006468]; protein ubiquitination [GO:0016567]; regulation of anaphase-promoting complex-dependent catabolic process [GO:1905784]; regulation of cell cycle [GO:0051726]; regulation of cytokinesis [GO:0032465]; regulation of mitotic cell cycle [GO:0007346]; regulation of mitotic cell cycle phase transition [GO:1901990]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of mitotic spindle assembly [GO:1901673]; regulation of protein binding [GO:0043393]; regulation of protein localization to cell cortex [GO:1904776]; sister chromatid cohesion [GO:0007062]; synaptonemal complex disassembly [GO:0070194],centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; kinetochore [GO:0000776]; microtubule cytoskeleton [GO:0015630]; midbody [GO:0030496]; mitotic spindle pole [GO:0097431]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; outer kinetochore [GO:0000940]; spindle [GO:0005819]; spindle midzone [GO:0051233]; spindle pole [GO:0000922]; synaptonemal complex [GO:0000795],anaphase-promoting complex binding [GO:0010997]; ATP binding [GO:0005524]; identical protein binding [GO:0042802]; magnesium ion binding [GO:0000287]; microtubule binding [GO:0008017]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],"PTM: Catalytic activity is enhanced by phosphorylation of Thr-210. Phosphorylation at Thr-210 is first detected on centrosomes in the G2 phase of the cell cycle, peaks in prometaphase and gradually disappears from centrosomes during anaphase. Dephosphorylation at Thr-210 at centrosomes is probably mediated by protein phosphatase 1C (PP1C), via interaction with PPP1R12A/MYPT1. Autophosphorylation and phosphorylation of Ser-137 may not be significant for the activation of PLK1 during mitosis, but may enhance catalytic activity during recovery after DNA damage checkpoint. Phosphorylated in vitro by STK10. {ECO:0000269|PubMed:12207013, ECO:0000269|PubMed:12442251, ECO:0000269|PubMed:12639966, ECO:0000269|PubMed:18477460, ECO:0000269|PubMed:18615013}.; PTM: Ubiquitinated by the anaphase promoting complex/cyclosome (APC/C) in anaphase and following DNA damage, leading to its degradation by the proteasome. Ubiquitination is mediated via its interaction with FZR1/CDH1. Ubiquitination and subsequent degradation prevents entry into mitosis and is essential to maintain an efficient G2 DNA damage checkpoint. Monoubiquitination at Lys-492 by the BCR(KLHL22) ubiquitin ligase complex does not lead to degradation: it promotes PLK1 dissociation from phosphoreceptor proteins and subsequent removal from kinetochores, allowing silencing of the spindle assembly checkpoint (SAC) and chromosome segregation. {ECO:0000269|PubMed:18662541, ECO:0000269|PubMed:23455478}.","DOMAIN: The POLO box domains act as phosphopeptide-binding module that recognizes and binds serine-[phosphothreonine/phosphoserine]-(proline/X) motifs. PLK1 recognizes and binds docking proteins that are already phosphorylated on these motifs, and then phosphorylates them. PLK1 can also create its own docking sites by mediating phosphorylation of serine-[phosphothreonine/phosphoserine]-(proline/X) motifs subsequently recognized by the POLO box domains. {ECO:0000269|PubMed:12939256, ECO:0000269|PubMed:14532005, ECO:0000269|PubMed:14734534, ECO:0000269|PubMed:17351640}.","DOMAIN 53..305; /note=""Protein kinase""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00159""; DOMAIN 410..488; /note=""POLO box 1""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00154""; DOMAIN 510..592; /note=""POLO box 2""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00154""","STRAND 42..46; /evidence=""ECO:0007829|PDB:2RKU""; STRAND 51..62; /evidence=""ECO:0007829|PDB:2RKU""; STRAND 65..72; /evidence=""ECO:0007829|PDB:2RKU""; STRAND 78..85; /evidence=""ECO:0007829|PDB:2RKU""; STRAND 116..121; /evidence=""ECO:0007829|PDB:2RKU""; STRAND 123..131; /evidence=""ECO:0007829|PDB:2RKU""; STRAND 182..184; /evidence=""ECO:0007829|PDB:2RKU""; STRAND 190..192; /evidence=""ECO:0007829|PDB:2RKU""; STRAND 224..226; /evidence=""ECO:0007829|PDB:2V5Q""; STRAND 392..394; /evidence=""ECO:0007829|PDB:3P34""; STRAND 411..417; /evidence=""ECO:0007829|PDB:4X9R""; STRAND 422..427; /evidence=""ECO:0007829|PDB:4X9R""; STRAND 432..436; /evidence=""ECO:0007829|PDB:4X9R""; STRAND 441..444; /evidence=""ECO:0007829|PDB:4X9R""; STRAND 448..454; /evidence=""ECO:0007829|PDB:4X9R""; STRAND 460..464; /evidence=""ECO:0007829|PDB:4X9R""; STRAND 511..516; /evidence=""ECO:0007829|PDB:4X9R""; STRAND 518..525; /evidence=""ECO:0007829|PDB:4X9R""; STRAND 530..534; /evidence=""ECO:0007829|PDB:4X9R""; STRAND 540..544; /evidence=""ECO:0007829|PDB:4X9R""; STRAND 549..553; /evidence=""ECO:0007829|PDB:4X9R""; STRAND 559..563; /evidence=""ECO:0007829|PDB:4X9R""; STRAND 593..595; /evidence=""ECO:0007829|PDB:4O56""; STRAND 598..602; /evidence=""ECO:0007829|PDB:4O56""","HELIX 86..88; /evidence=""ECO:0007829|PDB:2RKU""; HELIX 92..106; /evidence=""ECO:0007829|PDB:2RKU""; HELIX 138..145; /evidence=""ECO:0007829|PDB:2RKU""; HELIX 150..169; /evidence=""ECO:0007829|PDB:2RKU""; HELIX 179..181; /evidence=""ECO:0007829|PDB:2RKU""; HELIX 220..223; /evidence=""ECO:0007829|PDB:2RKU""; HELIX 231..246; /evidence=""ECO:0007829|PDB:2RKU""; HELIX 256..264; /evidence=""ECO:0007829|PDB:2RKU""; HELIX 276..285; /evidence=""ECO:0007829|PDB:2RKU""; HELIX 290..292; /evidence=""ECO:0007829|PDB:2RKU""; HELIX 296..301; /evidence=""ECO:0007829|PDB:2RKU""; HELIX 303..306; /evidence=""ECO:0007829|PDB:2RKU""; HELIX 316..319; /evidence=""ECO:0007829|PDB:2RKU""; HELIX 367..370; /evidence=""ECO:0007829|PDB:5J19""; HELIX 374..386; /evidence=""ECO:0007829|PDB:4X9R""; HELIX 389..391; /evidence=""ECO:0007829|PDB:4X9R""; HELIX 397..400; /evidence=""ECO:0007829|PDB:4X9R""; HELIX 403..405; /evidence=""ECO:0007829|PDB:4X9R""; HELIX 470..472; /evidence=""ECO:0007829|PDB:4X9R""; HELIX 473..488; /evidence=""ECO:0007829|PDB:4X9R""; HELIX 564..570; /evidence=""ECO:0007829|PDB:4X9R""; HELIX 574..591; /evidence=""ECO:0007829|PDB:4X9R""","TURN 47..50; /evidence=""ECO:0007829|PDB:2RKU""; TURN 73..75; /evidence=""ECO:0007829|PDB:2RKU""; TURN 418..421; /evidence=""ECO:0007829|PDB:4X9R""; TURN 465..467; /evidence=""ECO:0007829|PDB:3Q1I""; TURN 493..496; /evidence=""ECO:0007829|PDB:4X9R""; TURN 503..505; /evidence=""ECO:0007829|PDB:3P34""; TURN 526..528; /evidence=""ECO:0007829|PDB:4WHL""; TURN 535..537; /evidence=""ECO:0007829|PDB:4X9R""; TURN 545..548; /evidence=""ECO:0007829|PDB:4X9R""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,PLK1 PLK,Serine/threonine-protein kinase PLK1 (EC 2.7.11.21) (Polo-like kinase 1) (PLK-1) (Serine/threonine-protein kinase 13) (STPK13),Homo sapiens (Human),603.0,68255.0,MSAAVTAGKLARAPADPGKAGVPGVAAPGAPAAAPPAKEIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPARLPITCLTIPPRFSIAPSSLDPSNRKPLTVLNKGLENPLPERPREKEEPVVRETGEVVDCHLSDMLQQLHSVNASKPSERGLVRQEEAEDPACIPIFWVSKWVDYSDKYGLGYQLCDNSVGVLFNDSTRLILYNDGDSLQYIERDGTESYLTVSSHPNSLMKKITLLKYFRNYMSEHLLKAGANITPREGDELARLPYLRTWFRTRSAIILHLSNGSVQINFFQDHTKLILCPLMAAVTYIDEKRDFRTYRLSLLEEYGCCKELASRLRYARTMVDKLLSSRSASNRLKAS,True,False,True,P53350,"[('cd13117', 'Second polo-box domain (PBD) of polo-like kinases Plk1, Plk2, Plk3, and Plk5'), ('cd13118', 'First polo-box domain (PBD) of polo-like kinases Plk1, Plk2, Plk3, and Plk5'), ('cd14187', 'Catalytic domain of the Serine/Threonine Kinase, Polo-like kinase 1'), ('G3DSA:1.10.510.10', 'Transferase(Phosphotransferase) domain 1'), ('G3DSA:3.30.1120.30', 'POLO box domain'), ('G3DSA:3.30.200.20', 'Phosphorylase Kinase; domain 1'), ('IPR000719', 'Protein kinase domain'), ('IPR000959', 'POLO box domain'), ('IPR008271', 'Serine/threonine-protein kinase, active site'), ('IPR011009', 'Protein kinase-like domain superfamily'), ('IPR017441', 'Protein kinase, ATP binding site'), ('IPR033695', 'Second polo-box domain'), ('IPR033701', 'First polo-box domain'), ('IPR033702', 'Polo-like kinase 1, catalytic domain'), ('IPR036947', 'POLO box domain superfamily'), ('PF00069', 'Protein kinase domain'), ('PF00659', 'POLO box duplicated region'), ('PS00107', 'Protein kinases ATP-binding region signature'), ('PS00108', 'Serine/Threonine protein kinases active-site signature'), ('PS50011', 'Protein kinase domain profile')]",P53350;,"""ENSG00000166851; Tissue enhanced (bone marrow, lymphoid tissue, testis)."";","CATALYTIC ACTIVITY: Reaction=L-seryl-[protein] + ATP = O-phospho-L-seryl-[protein] + ADP + H(+); Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616, ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.21; Evidence={ECO:0000269|PubMed:11202906, ECO:0000269|PubMed:12207013, ECO:0000269|PubMed:21880710, ECO:0000269|PubMed:22325354, ECO:0000269|PubMed:28512243, ECO:0000269|PubMed:37440612, ECO:0000269|PubMed:37674080}; CATALYTIC ACTIVITY: Reaction=L-threonyl-[protein] + ATP = O-phospho-L-threonyl-[protein] + ADP + H(+); Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060, Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013, ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216; EC=2.7.11.21; Evidence={ECO:0000269|PubMed:11202906, ECO:0000269|PubMed:12207013, ECO:0000269|PubMed:21880710, ECO:0000269|PubMed:37674080};",2.7.11.21,"ACTIVITY REGULATION: Activated by phosphorylation of Thr-210 by AURKA; phosphorylation by AURKA is enhanced by BORA (PubMed:17307877, PubMed:18615013). Once activated, activity is stimulated by binding target proteins (PubMed:17307877, PubMed:18615013). Binding of target proteins has no effect on the non-activated kinase (PubMed:17307877, PubMed:18615013). Several inhibitors targeting PLKs are currently in development and are under investigation in a growing number of clinical trials, such as BI 2536, an ATP-competitive PLK1 inhibitor or BI 6727, a dihydropteridinone that specifically inhibits the catalytic activity of PLK1 (PubMed:18005335). {ECO:0000269|PubMed:17307877, ECO:0000269|PubMed:18005335, ECO:0000269|PubMed:18615013}.",,ENST00000300093.9;,PLK1,ENSG00000166851,0.0,,,,2.99,DP00428,0.209,0.128,0.103,PLK1
P53384,ENSG00000103274,NUBP1_HUMAN,cell projection organization [GO:0030030]; centrosome localization [GO:0051642]; intracellular iron ion homeostasis [GO:0006879]; iron-sulfur cluster assembly [GO:0016226]; negative regulation of centrosome duplication [GO:0010826]; protein localization to cell cortex [GO:0072697]; regulation of cell growth [GO:0001558],centriole [GO:0005814]; centrosome [GO:0005813]; cilium [GO:0005929]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886],"4 iron, 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent FeS chaperone activity [GO:0140663]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]",,,,,,,"cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,NUBP1 NBP NBP1,Cytosolic Fe-S cluster assembly factor NUBP1 (Nucleotide-binding protein 1) (NBP 1),Homo sapiens (Human),320.0,34534.0,MEEVPHDCPGADSAQAGRGASCQGCPNQRLCASGAGATPDTAIEEIKEKMKTVKHKILVLSGKGGVGKSTFSAHLAHGLAEDENTQIALLDIDICGPSIPKIMGLEGEQVHQSGSGWSPVYVEDNLGVMSVGFLLSSPDDAVIWRGPKKNGMIKQFLRDVDWGEVDYLIVDTPPGTSDEHLSVVRYLATAHIDGAVIITTPQEVSLQDVRKEINFCRKVKLPIIGVVENMSGFICPKCKKESQIFPPTTGGAELMCQDLEVPLLGRVPLDPLIGKNCDKGQSFFIDAPDSPATLAYRSIIQRIQEFCNLHQSKEENLISS,True,False,False,P53384,"[('cd02037', 'Mrp/NBP35 ATP-binding protein family'), ('G3DSA:3.40.50.300', 'P-loop containing nucleotide triphosphate hydrolases'), ('IPR000808', 'Iron-sulfur cluster carrier protein-like, conserved site'), ('IPR003593', 'AAA+ ATPase domain'), ('IPR019591', 'Mrp/NBP35 ATP-binding protein'), ('IPR027417', 'P-loop containing nucleoside triphosphate hydrolase'), ('IPR028601', 'Cytosolic Fe-S cluster assembly factor NUBP1/Nbp35'), ('IPR033756', 'Flagellum site-determining protein YlxH/ Fe-S cluster assembling factor NBP35'), ('MF_02040', 'Iron-sulfur cluster carrier protein'), ('MF_03038', 'Cytosolic Fe-S cluster assembly factor NUBP1 [NUBP1]'), ('PF10609', 'NUBPL iron-transfer P-loop NTPase'), ('PS01215', 'Mrp family signature'), ('PTHR23264', 'NUCLEOTIDE-BINDING PROTEIN NBP35 YEAST -RELATED'), ('SM00382', 'ATPases associated with a variety of cellular activities'), ('SSF52540', 'P-loop containing nucleoside triphosphate hydrolases')]",,"""ENSG00000103274; Low tissue specificity."";",,,,,ENST00000283027.10 [P53384-1];ENST00000433392.6 [P53384-2];,NUBP1,ENSG00000103274,0.0,,,,,,,0.041,,NUBP1
P53597,ENSG00000163541,SUCA_HUMAN,succinyl-CoA catabolic process [GO:1901289]; tricarboxylic acid cycle [GO:0006099],mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; succinate-CoA ligase complex (ADP-forming) [GO:0009361]; succinate-CoA ligase complex (GDP-forming) [GO:0045244],nucleotide binding [GO:0000166]; RNA binding [GO:0003723]; succinate-CoA ligase (ADP-forming) activity [GO:0004775]; succinate-CoA ligase (GDP-forming) activity [GO:0004776],,,,"STRAND 58..61; /evidence=""ECO:0007829|PDB:6WCV""; STRAND 82..86; /evidence=""ECO:0007829|PDB:6WCV""; STRAND 98..102; /evidence=""ECO:0007829|PDB:6WCV""; STRAND 115..118; /evidence=""ECO:0007829|PDB:6WCV""; STRAND 138..142; /evidence=""ECO:0007829|PDB:6WCV""; STRAND 166..168; /evidence=""ECO:0007829|PDB:6WCV""; STRAND 170..172; /evidence=""ECO:0007829|PDB:7MSR""; STRAND 174..177; /evidence=""ECO:0007829|PDB:6WCV""; STRAND 181..186; /evidence=""ECO:0007829|PDB:6WCV""; STRAND 193..201; /evidence=""ECO:0007829|PDB:6WCV""; STRAND 220..225; /evidence=""ECO:0007829|PDB:6WCV""; STRAND 251..261; /evidence=""ECO:0007829|PDB:6WCV""; STRAND 274..276; /evidence=""ECO:0007829|PDB:6WCV""; STRAND 282..287; /evidence=""ECO:0007829|PDB:6WCV""; STRAND 298..301; /evidence=""ECO:0007829|PDB:7MSS""","HELIX 43..50; /evidence=""ECO:0007829|PDB:6WCV""; HELIX 66..78; /evidence=""ECO:0007829|PDB:6WCV""; HELIX 104..111; /evidence=""ECO:0007829|PDB:6WCV""; HELIX 122..134; /evidence=""ECO:0007829|PDB:6WCV""; HELIX 149..160; /evidence=""ECO:0007829|PDB:6WCV""; HELIX 188..190; /evidence=""ECO:0007829|PDB:6WCV""; HELIX 203..215; /evidence=""ECO:0007829|PDB:6WCV""; HELIX 236..245; /evidence=""ECO:0007829|PDB:6WCV""; HELIX 262..273; /evidence=""ECO:0007829|PDB:6WCV""; HELIX 311..320; /evidence=""ECO:0007829|PDB:6WCV""; HELIX 329..331; /evidence=""ECO:0007829|PDB:6WCV""; HELIX 332..342; /evidence=""ECO:0007829|PDB:6WCV""","TURN 62..64; /evidence=""ECO:0007829|PDB:6WCV""; TURN 178..180; /evidence=""ECO:0007829|PDB:6WCV""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,SUCLG1,"Succinate--CoA ligase [ADP/GDP-forming] subunit alpha, mitochondrial (EC 6.2.1.4) (EC 6.2.1.5) (Succinyl-CoA synthetase subunit alpha) (SCS-alpha)",Homo sapiens (Human),346.0,36250.0,MTATLAAAADIATMVSGSSGLAAARLLSRSFLLPQNGIRHCSYTASRQHLYVDKNTKIICQGFTGKQGTFHSQQALEYGTKLVGGTTPGKGGQTHLGLPVFNTVKEAKEQTGATASVIYVPPPFAAAAINEAIEAEIPLVVCITEGIPQQDMVRVKHKLLRQEKTRLIGPNCPGVINPGECKIGIMPGHIHKKGRIGIVSRSGTLTYEAVHQTTQVGLGQSLCVGIGGDPFNGTDFIDCLEIFLNDSATEGIILIGEIGGNAEENAAEFLKQHNSGPNSKPVVSFIAGLTAPPGRRMGHAGAIIAGGKGGAKEKISALQSAGVVVSMSPAQLGTTIYKEFEKRKML,True,False,False,P53597,"[('G3DSA:3.40.50.261', 'Succinyl-CoA synthetase domains'), ('G3DSA:3.40.50.720', 'NAD(P)-binding Rossmann-like Domain'), ('IPR003781', 'CoA-binding'), ('IPR005810', 'Succinyl-CoA ligase, alpha subunit'), ('IPR005811', 'ATP-citrate synthase/succinyl-CoA ligase, C-terminal domain'), ('IPR016102', 'Succinyl-CoA synthetase-like'), ('IPR017440', 'ATP-citrate lyase/succinyl-CoA ligase, active site'), ('IPR033847', 'ATP-citrate lyase/succinyl-CoA ligase, conserved site'), ('IPR036291', 'NAD(P)-binding domain superfamily'), ('MF_01988', 'Succinate--CoA ligase [ADP-forming] subunit alpha [sucD]'), ('PF00549', 'CoA-ligase'), ('PF02629', 'CoA binding domain'), ('PIRSF001553', 'Succinyl-CoA synthetase, alpha subunit'), ('PR01798', 'SCOASYNTHASE'), ('PS00399', 'ATP-citrate lyase / succinyl-CoA ligases family active site'), ('PS01216', 'ATP-citrate lyase / succinyl-CoA ligases family signature 1'), ('PTHR11117', 'Succinate/malate CoA ligase alpha subunit'), ('SM00881', 'CoA binding domain'), ('SSF51735', 'NAD(P)-binding Rossmann-fold domains'), ('SSF52210', 'Succinyl-CoA synthetase domains')]",,"""ENSG00000163541; Tissue enhanced (kidney)."";","CATALYTIC ACTIVITY: Reaction=succinate + ATP + CoA = succinyl-CoA + ADP + phosphate; Xref=Rhea:RHEA:17661, ChEBI:CHEBI:30031, ChEBI:CHEBI:30616, ChEBI:CHEBI:43474, ChEBI:CHEBI:57287, ChEBI:CHEBI:57292, ChEBI:CHEBI:456216; EC=6.2.1.5; Evidence={ECO:0000255|HAMAP-Rule:MF_03222}; CATALYTIC ACTIVITY: Reaction=GTP + succinate + CoA = succinyl-CoA + GDP + phosphate; Xref=Rhea:RHEA:22120, ChEBI:CHEBI:30031, ChEBI:CHEBI:37565, ChEBI:CHEBI:43474, ChEBI:CHEBI:57287, ChEBI:CHEBI:57292, ChEBI:CHEBI:58189; EC=6.2.1.4; Evidence={ECO:0000255|HAMAP-Rule:MF_03222};",6.2.1.4; 6.2.1.5,,PATHWAY: Carbohydrate metabolism; tricarboxylic acid cycle; succinate from succinyl-CoA (ligase route): step 1/1. {ECO:0000255|HAMAP-Rule:MF_03222}.,ENST00000393868.7;,SUCLG1,ENSG00000163541,0.0,SUCLG1,Non-canonical_RBPs,8.0,,,,0.116,,SUCLG1
P53675,ENSG00000070371,CLH2_HUMAN,"anatomical structure morphogenesis [GO:0009653]; intracellular protein transport [GO:0006886]; mitotic cell cycle [GO:0000278]; positive regulation of glucose import [GO:0046326]; receptor-mediated endocytosis [GO:0006898]; retrograde transport, endosome to Golgi [GO:0042147]",clathrin coat of trans-Golgi network vesicle [GO:0030130]; clathrin complex [GO:0071439]; clathrin-coated endocytic vesicle [GO:0045334]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; coated vesicle [GO:0030135]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; late endosome [GO:0005770]; membrane [GO:0016020]; sorting endosome [GO:0097443]; spindle [GO:0005819]; trans-Golgi network [GO:0005802],clathrin light chain binding [GO:0032051]; structural molecule activity [GO:0005198],,"DOMAIN: The C-terminal third of the heavy chains forms the hub of the triskelion. This region contains the trimerization domain and the light-chain binding domain involved in the assembly of the clathrin lattice.; DOMAIN: The N-terminal seven-bladed beta-propeller is formed by WD40-like repeats, and projects inward from the polyhedral outer clathrin coat. It constitutes a major protein-protein interaction node (By similarity). {ECO:0000250}.",,,,,"cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,CLTCL1 CLH22 CLTCL CLTD,Clathrin heavy chain 2 (Clathrin heavy chain on chromosome 22) (CLH-22),Homo sapiens (Human),1640.0,187030.0,MAQILPVRFQEHFQLQNLGINPANIGFSTLTMESDKFICIREKVGEQAQVTIIDMSDPMAPIRRPISAESAIMNPASKVIALKAGKTLQIFNIEMKSKMKAHTMAEEVIFWKWVSVNTVALVTETAVYHWSMEGDSQPMKMFDRHTSLVGCQVIHYRTDEYQKWLLLVGISAQQNRVVGAMQLYSVDRKVSQPIEGHAAAFAEFKMEGNAKPATLFCFAVRNPTGGKLHIIEVGQPAAGNQPFVKKAVDVFFPPEAQNDFPVAMQIGAKHGVIYLITKYGYLHLYDLESGVCICMNRISADTIFVTAPHKPTSGIIGVNKKGQVLSVCVEEDNIVNYATNVLQNPDLGLRLAVRSNLAGAEKLFVRKFNTLFAQGSYAEAAKVAASAPKGILRTRETVQKFQSIPAQSGQASPLLQYFGILLDQGQLNKLESLELCHLVLQQGRKQLLEKWLKEDKLECSEELGDLVKTTDPMLALSVYLRANVPSKVIQCFAETGQFQKIVLYAKKVGYTPDWIFLLRGVMKISPEQGLQFSRMLVQDEEPLANISQIVDIFMENSLIQQCTSFLLDALKNNRPAEGLLQTWLLEMNLVHAPQVADAILGNKMFTHYDRAHIAQLCEKAGLLQQALEHYTDLYDIKRAVVHTHLLNPEWLVNFFGSLSVEDSVECLHAMLSANIRQNLQLCVQVASKYHEQLGTQALVELFESFKSYKGLFYFLGSIVNFSQDPDVHLKYIQAACKTGQIKEVERICRESSCYNPERVKNFLKEAKLTDQLPLIIVCDRFGFVHDLVLYLYRNNLQRYIEIYVQKVNPSRTPAVIGGLLDVDCSEEVIKHLIMAVRGQFSTDELVAEVEKRNRLKLLLPWLESQIQEGCEEPATHNALAKIYIDSNNSPECFLRENAYYDSSVVGRYCEKRDPHLACVAYERGQCDLELIKVCNENSLFKSEARYLVCRKDPELWAHVLEETNPSRRQLIDQVVQTALSETRDPEEISVTVKAFMTADLPNELIELLEKIVLDNSVFSEHRNLQNLLILTAIKADRTRVMEYISRLDNYDALDIASIAVSSALYEEAFTVFHKFDMNASAIQVLIEHIGNLDRAYEFAERCNEPAVWSQLAQAQLQKDLVKEAINSYIRGDDPSSYLEVVQSASRSNNWEDLVKFLQMARKKGRESYIETELIFALAKTSRVSELEDFINGPNNAHIQQVGDRCYEEGMYEAAKLLYSNVSNFARLASTLVHLGEYQAAVDNSRKASSTRTWKEVCFACMDGQEFRFAQLCGLHIVIHADELEELMCYYQDRGYFEELILLLEAALGLERAHMGMFTELAILYSKFKPQKMLEHLELFWSRVNIPKVLRAAEQAHLWAELVFLYDKYEEYDNAVLTMMSHPTEAWKEGQFKDIITKVANVELCYRALQFYLDYKPLLINDLLLVLSPRLDHTWTVSFFSKAGQLPLVKPYLRSVQSHNNKSVNEALNHLLTEEEDYQGLRASIDAYDNFDNISLAQQLEKHQLMEFRCIAAYLYKGNNWWAQSVELCKKDHLYKDAMQHAAESRDAELAQKLLQWFLEEGKRECFAACLFTCYDLLRPDMVLELAWRHNLVDLAMPYFIQVMREYLSKVDKLDALESLRKQEEHVTEPAPLVFDFDGHE,False,False,True,P53675,"[('G3DSA:1.25.40.10', 'Tetratricopeptide repeat domain'), ('G3DSA:1.25.40.730', None), ('G3DSA:2.130.10.110', 'Clathrin heavy-chain terminal domain'), ('IPR000547', 'Clathrin, heavy chain/VPS, 7-fold repeat'), ('IPR011990', 'Tetratricopeptide-like helical domain superfamily'), ('IPR015348', 'Clathrin, heavy chain, linker, core motif'), ('IPR016024', 'Armadillo-type fold'), ('IPR016025', 'Clathrin heavy chain, N-terminal'), ('IPR016341', 'Clathrin, heavy chain'), ('IPR022365', 'Clathrin, heavy chain, propeller repeat'), ('IPR055358', 'Clathrin heavy-chain repeat'), ('PF00637', 'Region in Clathrin and VPS'), ('PF01394', 'Clathrin propeller repeat'), ('PF09268', 'Clathrin, heavy-chain linker'), ('PF13838', 'Clathrin-H-link'), ('PIRSF002290', 'Clathrin heavy chain'), ('PS50236', 'Clathrin heavy-chain (CHCR) repeat profile'), ('PTHR10292', 'Clathrin heavy chain'), ('SM00299', 'Clathrin heavy chain repeat homology'), ('SSF48371', 'ARM repeat')]",,"""ENSG00000070371; Group enriched (skeletal muscle, testis, tongue)."";",,,,,ENST00000427926.6 [P53675-1];ENST00000621271.4 [P53675-2];,CLTCL1,ENSG00000070371,0.0,,,,,,,0.016,,CLTCL1
P54253,ENSG00000124788,ATX1_HUMAN,brain development [GO:0007420]; learning [GO:0007612]; memory [GO:0007613]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; nuclear export [GO:0051168]; RNA processing [GO:0006396]; social behavior [GO:0035176],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear inclusion body [GO:0042405]; nuclear matrix [GO:0016363]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],DNA binding [GO:0003677]; identical protein binding [GO:0042802]; poly(G) binding [GO:0034046]; poly(U) RNA binding [GO:0008266],"PTM: Ubiquitinated by UBE3A, leading to its degradation by the proteasome. The presence of expanded poly-Gln repeats in spinocerebellar ataxia 1 (SCA1) patients impairs ubiquitination and degradation, leading to accumulation of ATXN1 in neurons and subsequent toxicity. {ECO:0000250|UniProtKB:P54254}.; PTM: Phosphorylation at Ser-775 increases the pathogenicity of proteins with an expanded polyglutamine tract. {ECO:0000269|PubMed:12741986}.; PTM: Sumoylation is dependent on nuclear localization and phosphorylation at Ser-775. It is reduced in the presence of an expanded polyglutamine tract. {ECO:0000269|PubMed:12741986, ECO:0000269|PubMed:15824120}.",DOMAIN: The AXH domain is required for interaction with CIC. {ECO:0000250|UniProtKB:P54254}.,"DOMAIN 562..693; /note=""AXH""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00496""","STRAND 568..570; /evidence=""ECO:0007829|PDB:2M41""; STRAND 579..581; /evidence=""ECO:0007829|PDB:1OA8""; STRAND 587..589; /evidence=""ECO:0007829|PDB:1OA8""; STRAND 606..620; /evidence=""ECO:0007829|PDB:1OA8""; STRAND 626..633; /evidence=""ECO:0007829|PDB:1OA8""; STRAND 638..645; /evidence=""ECO:0007829|PDB:1OA8""; STRAND 650..652; /evidence=""ECO:0007829|PDB:1OA8""; STRAND 656..660; /evidence=""ECO:0007829|PDB:1OA8""; STRAND 673..675; /evidence=""ECO:0007829|PDB:4J2L""; STRAND 681..687; /evidence=""ECO:0007829|PDB:1OA8""","HELIX 572..574; /evidence=""ECO:0007829|PDB:1OA8""; HELIX 590..592; /evidence=""ECO:0007829|PDB:1OA8""; HELIX 595..604; /evidence=""ECO:0007829|PDB:1OA8""; HELIX 662..669; /evidence=""ECO:0007829|PDB:1OA8""","TURN 634..637; /evidence=""ECO:0007829|PDB:1OA8""; TURN 653..655; /evidence=""ECO:0007829|PDB:1OA8""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,ATXN1 ATX1 SCA1,Ataxin-1 (Spinocerebellar ataxia type 1 protein),Homo sapiens (Human),815.0,86923.0,MKSNQERSNECLPPKKREIPATSRSSEEKAPTLPSDNHRVEGTAWLPGNPGGRGHGGGRHGPAGTSVELGLQQGIGLHKALSTGLDYSPPSAPRSVPVATTLPAAYATPQPGTPVSPVQYAHLPHTFQFIGSSQYSGTYASFIPSQLIPPTANPVTSAVASAAGATTPSQRSQLEAYSTLLANMGSLSQTPGHKAEQQQQQQQQQQQQHQHQQQQQQQQQQQQQQHLSRAPGLITPGSPPPAQQNQYVHISSSPQNTGRTASPPAIPVHLHPHQTMIPHTLTLGPPSQVVMQYADSGSHFVPREATKKAESSRLQQAIQAKEVLNGEMEKSRRYGAPSSADLGLGKAGGKSVPHPYESRHVVVHPSPSDYSSRDPSGVRASVMVLPNSNTPAADLEVQQATHREASPSTLNDKSGLHLGKPGHRSYALSPHTVIQTTHSASEPLPVGLPATAFYAGTQPPVIGYLSGQQQAITYAGSLPQHLVIPGTQPLLIPVGSTDMEASGAAPAIVTSSPQFAAVPHTFVTTALPKSENFNPEALVTQAAYPAMVQAQIHLPVVQSVASPAAAPPTLPPYFMKGSIIQLANGELKKVEDLKTEDFIQSAEISNDLKIDSSTVERIEDSHSPGVAVIQFAVGEHRAQVSVEVLVEYPFFVFGQGWSSCCPERTSQLFDLPCSKLSVGDVCISLTLKNLKNGSVKKGQPVDPASVLLKHSKADGLAGSRHRYAEQENGINQGSAQMLSENGELKFPEKMGLPAAPFLTKIEPSKPAATRKRRWSAPESRKLEKSEDEPPLTLPKPSLIPQEVKICIEGRSNVGK,False,False,True,P54253,"[('IPR003652', 'Ataxin, AXH domain'), ('IPR020997', 'Ataxin-1, N-terminal'), ('IPR036096', 'Ataxin, AXH domain superfamily'), ('IPR043404', 'ATAXIN1-like'), ('PF08517', 'Ataxin-1 and HBP1 module (AXH)'), ('PF12547', 'Ataxin-1 like family'), ('PS51148', 'AXH domain profile'), ('PTHR13392', 'ATAXIN 1'), ('SM00536', 'domain in Ataxins and HMG containing proteins'), ('SSF102031', 'AXH domain')]",,"""ENSG00000124788; Low tissue specificity."";",,,,,ENST00000244769.8 [P54253-1];ENST00000436367.6 [P54253-1];,ATXN1,ENSG00000124788,0.0,ATXN1,Canonical_RBPs,0.0,,,,0.856,0.296,ATXN1
P54886,ENSG00000059573,P5CS_HUMAN,citrulline biosynthetic process [GO:0019240]; glutamate metabolic process [GO:0006536]; L-proline biosynthetic process [GO:0055129]; ornithine biosynthetic process [GO:0006592]; phosphorylation [GO:0016310]; proline biosynthetic process [GO:0006561]; response to temperature stimulus [GO:0009266],mitochondrial inner membrane [GO:0005743]; mitochondrion [GO:0005739],ATP binding [GO:0005524]; glutamate 5-kinase activity [GO:0004349]; glutamate-5-semialdehyde dehydrogenase activity [GO:0004350]; identical protein binding [GO:0042802]; RNA binding [GO:0003723],,,,"STRAND 454..461; /evidence=""ECO:0007829|PDB:2H5G""; STRAND 464..472; /evidence=""ECO:0007829|PDB:2H5G""; STRAND 475..482; /evidence=""ECO:0007829|PDB:2H5G""; STRAND 500..504; /evidence=""ECO:0007829|PDB:2H5G""; STRAND 533..535; /evidence=""ECO:0007829|PDB:2H5G""; STRAND 553..559; /evidence=""ECO:0007829|PDB:2H5G""; STRAND 572..574; /evidence=""ECO:0007829|PDB:2H5G""; STRAND 584..588; /evidence=""ECO:0007829|PDB:2H5G""; STRAND 614..621; /evidence=""ECO:0007829|PDB:2H5G""; STRAND 643..646; /evidence=""ECO:0007829|PDB:2H5G""; STRAND 670..680; /evidence=""ECO:0007829|PDB:2H5G""; STRAND 694..700; /evidence=""ECO:0007829|PDB:2H5G""; STRAND 716..723; /evidence=""ECO:0007829|PDB:2H5G""; STRAND 745..747; /evidence=""ECO:0007829|PDB:2H5G""; STRAND 758..765; /evidence=""ECO:0007829|PDB:2H5G""","HELIX 363..379; /evidence=""ECO:0007829|PDB:2H5G""; HELIX 382..398; /evidence=""ECO:0007829|PDB:2H5G""; HELIX 400..414; /evidence=""ECO:0007829|PDB:2H5G""; HELIX 420..424; /evidence=""ECO:0007829|PDB:2H5G""; HELIX 430..446; /evidence=""ECO:0007829|PDB:2H5G""; HELIX 486..497; /evidence=""ECO:0007829|PDB:2H5G""; HELIX 507..509; /evidence=""ECO:0007829|PDB:2H5G""; HELIX 510..525; /evidence=""ECO:0007829|PDB:2H5G""; HELIX 530..532; /evidence=""ECO:0007829|PDB:2H5G""; HELIX 561..570; /evidence=""ECO:0007829|PDB:2H5G""; HELIX 597..606; /evidence=""ECO:0007829|PDB:2H5G""; HELIX 622..624; /evidence=""ECO:0007829|PDB:2H5G""; HELIX 628..639; /evidence=""ECO:0007829|PDB:2H5G""; HELIX 648..651; /evidence=""ECO:0007829|PDB:2H5G""; HELIX 681..691; /evidence=""ECO:0007829|PDB:2H5G""; HELIX 704..713; /evidence=""ECO:0007829|PDB:2H5G""; HELIX 725..727; /evidence=""ECO:0007829|PDB:2H5G""; HELIX 754..757; /evidence=""ECO:0007829|PDB:2H5G""; HELIX 771..774; /evidence=""ECO:0007829|PDB:2H5G""","TURN 415..417; /evidence=""ECO:0007829|PDB:2H5G""; TURN 526..528; /evidence=""ECO:0007829|PDB:2H5G""; TURN 594..596; /evidence=""ECO:0007829|PDB:2H5G""; TURN 730..734; /evidence=""ECO:0007829|PDB:2H5G""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,ALDH18A1 GSAS P5CS PYCS,Delta-1-pyrroline-5-carboxylate synthase (P5CS) (Aldehyde dehydrogenase family 18 member A1) [Includes: Glutamate 5-kinase (GK) (EC 2.7.2.11) (Gamma-glutamyl kinase); Gamma-glutamyl phosphate reductase (GPR) (EC 1.2.1.41) (Glutamate-5-semialdehyde dehydrogenase) (Glutamyl-gamma-semialdehyde dehydrogenase)],Homo sapiens (Human),795.0,87302.0,MLSQVYRCGFQPFNQHLLPWVKCTTVFRSHCIQPSVIRHVRSWSNIPFITVPLSRTHGKSFAHRSELKHAKRIVVKLGSAVVTRGDECGLALGRLASIVEQVSVLQNQGREMMLVTSGAVAFGKQRLRHEILLSQSVRQALHSGQNQLKEMAIPVLEARACAAAGQSGLMALYEAMFTQYSICAAQILVTNLDFHDEQKRRNLNGTLHELLRMNIVPIVNTNDAVVPPAEPNSDLQGVNVISVKDNDSLAARLAVEMKTDLLIVLSDVEGLFDSPPGSDDAKLIDIFYPGDQQSVTFGTKSRVGMGGMEAKVKAALWALQGGTSVVIANGTHPKVSGHVITDIVEGKKVGTFFSEVKPAGPTVEQQGEMARSGGRMLATLEPEQRAEIIHHLADLLTDQRDEILLANKKDLEEAEGRLAAPLLKRLSLSTSKLNSLAIGLRQIAASSQDSVGRVLRRTRIAKNLELEQVTVPIGVLLVIFESRPDCLPQVAALAIASGNGLLLKGGKEAAHSNRILHLLTQEALSIHGVKEAVQLVNTREEVEDLCRLDKMIDLIIPRGSSQLVRDIQKAAKGIPVMGHSEGICHMYVDSEASVDKVTRLVRDSKCEYPAACNALETLLIHRDLLRTPLFDQIIDMLRVEQVKIHAGPKFASYLTFSPSEVKSLRTEYGDLELCIEVVDNVQDAIDHIHKYGSSHTDVIVTEDENTAEFFLQHVDSACVFWNASTRFSDGYRFGLGAEVGISTSRIHARGPVGLEGLLTTKWLLRGKDHVVSDFSEHGSLKYLHENLPIPQRNTN,True,False,False,P54886,"[('cd04256', 'AAK_P5CS_ProBA'), ('cd07079', 'Gamma-glutamyl phosphate reductase (GPR), aldehyde dehydrogenase families 18 and 19'), ('G3DSA:3.40.1160.10', 'Acetylglutamate kinase-like'), ('G3DSA:3.40.309.10', 'Aldehyde Dehydrogenase; Chain A, domain 2'), ('G3DSA:3.40.605.10', 'Aldehyde Dehydrogenase; Chain A, domain 1'), ('IPR000965', 'GPR domain'), ('IPR001048', 'Aspartate/glutamate/uridylate kinase'), ('IPR001057', 'Glutamate/acetylglutamate kinase'), ('IPR005715', 'Glutamate 5-kinase/delta-1-pyrroline-5-carboxylate synthase'), ('IPR005766', 'Delta l-pyrroline-5-carboxylate synthetase'), ('IPR015590', 'Aldehyde dehydrogenase domain'), ('IPR016161', 'Aldehyde/histidinol dehydrogenase'), ('IPR016162', 'Aldehyde dehydrogenase, N-terminal'), ('IPR016163', 'Aldehyde dehydrogenase, C-terminal'), ('IPR019797', 'Glutamate 5-kinase, conserved site'), ('IPR020593', 'Gamma-glutamyl phosphate reductase GPR, conserved site'), ('IPR036393', 'Acetylglutamate kinase-like superfamily'), ('IPR041744', 'Bifunctional delta 1-pyrroline-5-carboxylate synthetase, glutamate-5-kinase domain'), ('MF_00412', 'Gamma-glutamyl phosphate reductase [proA]'), ('MF_00456', 'Glutamate 5-kinase [proB]')]",,"""ENSG00000059573; Tissue enhanced (salivary)."";","CATALYTIC ACTIVITY: Reaction=L-glutamate + ATP = L-glutamyl 5-phosphate + ADP; Xref=Rhea:RHEA:14877, ChEBI:CHEBI:29985, ChEBI:CHEBI:30616, ChEBI:CHEBI:58274, ChEBI:CHEBI:456216; EC=2.7.2.11; Evidence={ECO:0000269|PubMed:26297558}; CATALYTIC ACTIVITY: Reaction=L-glutamate 5-semialdehyde + phosphate + NADP(+) = L-glutamyl 5-phosphate + NADPH + H(+); Xref=Rhea:RHEA:19541, ChEBI:CHEBI:15378, ChEBI:CHEBI:43474, ChEBI:CHEBI:57783, ChEBI:CHEBI:58066, ChEBI:CHEBI:58274, ChEBI:CHEBI:58349; EC=1.2.1.41; Evidence={ECO:0000269|PubMed:26297558};",1.2.1.41; 2.7.2.11,ACTIVITY REGULATION: Isoform Short: Inhibited by L-ornithine with a Ki of approximately 0.25 mm. Isoform Long: Insensitive to ornithine inhibition. This is due to the two amino acid insert which abolishes feedback inhibition of P5CS activity by L-ornithine. {ECO:0000269|PubMed:10037775}.,PATHWAY: Amino-acid biosynthesis; L-proline biosynthesis; L-glutamate 5-semialdehyde from L-glutamate: step 1/2. {ECO:0000269|PubMed:26297558}.; PATHWAY: Amino-acid biosynthesis; L-proline biosynthesis; L-glutamate 5-semialdehyde from L-glutamate: step 2/2. {ECO:0000269|PubMed:26297558}.,ENST00000371221.3 [P54886-2];ENST00000371224.7 [P54886-1];,ALDH18A1,ENSG00000059573,0.0,ALDH18A1,Non-canonical_RBPs,17.0,,,,0.113,,ALDH18A1
P55055,ENSG00000131408,NR1H2_HUMAN,cell differentiation [GO:0030154]; cholesterol homeostasis [GO:0042632]; hormone-mediated signaling pathway [GO:0009755]; mRNA transcription by RNA polymerase II [GO:0042789]; negative regulation of cholesterol storage [GO:0010887]; negative regulation of cold-induced thermogenesis [GO:0120163]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of lipid transport [GO:0032369]; negative regulation of macrophage derived foam cell differentiation [GO:0010745]; negative regulation of pinocytosis [GO:0048550]; negative regulation of proteolysis [GO:0045861]; negative regulation of response to endoplasmic reticulum stress [GO:1903573]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of type II interferon-mediated signaling pathway [GO:0060336]; phosphatidylcholine acyl-chain remodeling [GO:0036151]; positive regulation of cholesterol efflux [GO:0010875]; positive regulation of cholesterol transport [GO:0032376]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of fatty acid biosynthetic process [GO:0045723]; positive regulation of high-density lipoprotein particle assembly [GO:0090108]; positive regulation of lipid storage [GO:0010884]; positive regulation of lipoprotein lipase activity [GO:0051006]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of pancreatic juice secretion [GO:0090187]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of secretion of lysosomal enzymes [GO:0090340]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of triglyceride biosynthetic process [GO:0010867],chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575],"apolipoprotein A-I receptor binding [GO:0034191]; ATPase binding [GO:0051117]; chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; nuclear receptor activity [GO:0004879]; nuclear retinoid X receptor binding [GO:0046965]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; zinc ion binding [GO:0008270]","PTM: Sumoylated by SUMO2 at Lys-409 and Lys-447 during the hepatic acute phase response, leading to promote interaction with GPS2 and prevent N-Cor corepressor complex dissociation. {ECO:0000269|PubMed:20159957}.",,"DOMAIN 222..460; /note=""NR LBD""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU01189""","STRAND 88..90; /evidence=""ECO:0007829|PDB:4NQA""; STRAND 99..103; /evidence=""ECO:0007829|PDB:4NQA""; STRAND 183..185; /evidence=""ECO:0007829|PDB:4NQA""; STRAND 212..214; /evidence=""ECO:0007829|PDB:4NQA""; STRAND 318..320; /evidence=""ECO:0007829|PDB:4NQA""; STRAND 325..331; /evidence=""ECO:0007829|PDB:6S5K""; STRAND 332..334; /evidence=""ECO:0007829|PDB:6S4N""","HELIX 105..116; /evidence=""ECO:0007829|PDB:4NQA""; HELIX 137..139; /evidence=""ECO:0007829|PDB:4NQA""; HELIX 142..151; /evidence=""ECO:0007829|PDB:4NQA""; HELIX 162..165; /evidence=""ECO:0007829|PDB:4NQA""; HELIX 170..173; /evidence=""ECO:0007829|PDB:4NQA""; HELIX 221..242; /evidence=""ECO:0007829|PDB:6S5K""; HELIX 245..247; /evidence=""ECO:0007829|PDB:6S4N""; HELIX 263..286; /evidence=""ECO:0007829|PDB:6S5K""; HELIX 291..293; /evidence=""ECO:0007829|PDB:6S5K""; HELIX 296..317; /evidence=""ECO:0007829|PDB:6S5K""; HELIX 336..341; /evidence=""ECO:0007829|PDB:6S5K""; HELIX 346..362; /evidence=""ECO:0007829|PDB:6S5K""; HELIX 366..377; /evidence=""ECO:0007829|PDB:6S5K""; HELIX 388..409; /evidence=""ECO:0007829|PDB:6S5K""; HELIX 416..440; /evidence=""ECO:0007829|PDB:6S5K""; HELIX 450..456; /evidence=""ECO:0007829|PDB:6S5K""","TURN 167..169; /evidence=""ECO:0007829|PDB:4NQA""; TURN 176..178; /evidence=""ECO:0007829|PDB:4NQA""; TURN 321..324; /evidence=""ECO:0007829|PDB:6S5K""; TURN 411..413; /evidence=""ECO:0007829|PDB:4RAK""; TURN 441..445; /evidence=""ECO:0007829|PDB:6S5K""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,NR1H2 LXRB NER UNR,Oxysterols receptor LXR-beta (Liver X receptor beta) (Nuclear receptor NER) (Nuclear receptor subfamily 1 group H member 2) (Ubiquitously-expressed nuclear receptor),Homo sapiens (Human),460.0,50974.0,MSSPTTSSLDTPLPGNGPPQPGAPSSSPTVKEEGPEPWPGGPDPDVPGTDEASSACSTDWVIPDPEEEPERKRKKGPAPKMLGHELCRVCGDKASGFHYNVLSCEGCKGFFRRSVVRGGARRYACRGGGTCQMDAFMRRKCQQCRLRKCKEAGMREQCVLSEEQIRKKKIRKQQQESQSQSQSPVGPQGSSSSASGPGASPGGSEAGSQGSGEGEGVQLTAAQELMIQQLVAAQLQCNKRSFSDQPKVTPWPLGADPQSRDARQQRFAHFTELAIISVQEIVDFAKQVPGFLQLGREDQIALLKASTIEIMLLETARRYNHETECITFLKDFTYSKDDFHRAGLQVEFINPIFEFSRAMRRLGLDDAEYALLIAINIFSADRPNVQEPGRVEALQQPYVEALLSYTRIKRPQDQLRFPRMLMKLVSLRTLSSVHSEQVFALRLQDKKLPPLLSEIWDVHE,False,False,True,P55055,"[('cd06954', 'The ligand binding domain of Liver X receptors, a family of nuclear receptors of ligand-activated transcription factors'), ('cd07160', 'DNA-binding domain of Liver X receptors (LXRs) family is composed of two C4-type zinc fingers'), ('G3DSA:1.10.565.10', 'Retinoid X Receptor'), ('G3DSA:3.30.50.10', 'Erythroid Transcription Factor GATA-1, subunit A'), ('IPR000536', 'Nuclear hormone receptor, ligand-binding domain'), ('IPR001628', 'Zinc finger, nuclear hormone receptor-type'), ('IPR001723', 'Nuclear hormone receptor'), ('IPR013088', 'Zinc finger, NHR/GATA-type'), ('IPR023257', 'Liver X receptor'), ('IPR035500', 'Nuclear hormone receptor-like domain superfamily'), ('IPR050234', 'Nuclear hormone receptor family NR1 subfamily'), ('PF00104', 'Ligand-binding domain of nuclear hormone receptor'), ('PF00105', 'Double treble clef zinc finger, C4 type'), ('PR00047', 'STROIDFINGER'), ('PR00398', 'STRDHORMONER'), ('PR02034', 'Liver X receptor'), ('PS00031', 'Nuclear hormones receptors DNA-binding region signature'), ('PS51030', 'Nuclear hormone receptors DNA-binding domain profile'), ('PS51843', 'Nuclear receptor (NR) ligand-binding (LBD) domain profile'), ('PTHR24082', 'Nuclear hormone receptor family NR1 subfamily')]",,"""ENSG00000131408; Low tissue specificity."";",,,,,ENST00000253727.10 [P55055-1];ENST00000411902.6 [P55055-2];ENST00000593926.5 [P55055-1];ENST00000652203.1 [P55055-1];,NR1H2,ENSG00000131408,0.0,,,,,,0.174,0.287,0.274,NR1H2
P55072,ENSG00000165280,TERA_HUMAN,"activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; aggresome assembly [GO:0070842]; ATP metabolic process [GO:0046034]; autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; cellular response to arsenite ion [GO:1903843]; cellular response to heat [GO:0034605]; cellular response to misfolded protein [GO:0071218]; cytoplasm protein quality control [GO:0140455]; DNA damage response [GO:0006974]; DNA repair [GO:0006281]; double-strand break repair [GO:0006302]; endoplasmic reticulum stress-induced pre-emptive quality control [GO:0061857]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; endoplasmic reticulum unfolded protein response [GO:0030968]; endosome to lysosome transport via multivesicular body sorting pathway [GO:0032510]; ERAD pathway [GO:0036503]; establishment of protein localization [GO:0045184]; flavin adenine dinucleotide catabolic process [GO:0072389]; interstrand cross-link repair [GO:0036297]; macroautophagy [GO:0016236]; mitotic spindle disassembly [GO:0051228]; NADH metabolic process [GO:0006734]; negative regulation of hippo signaling [GO:0035331]; negative regulation of protein localization to chromatin [GO:0120186]; negative regulation of smoothened signaling pathway [GO:0045879]; positive regulation of ATP biosynthetic process [GO:2001171]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of Lys63-specific deubiquitinase activity [GO:1903007]; positive regulation of mitochondrial membrane potential [GO:0010918]; positive regulation of non-canonical NF-kappaB signal transduction [GO:1901224]; positive regulation of oxidative phosphorylation [GO:1903862]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of protein K63-linked deubiquitination [GO:1903006]; positive regulation of protein-containing complex assembly [GO:0031334]; proteasomal protein catabolic process [GO:0010498]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; protein-DNA covalent cross-linking repair [GO:0106300]; regulation of aerobic respiration [GO:1903715]; regulation of apoptotic process [GO:0042981]; regulation of protein localization to chromatin [GO:1905634]; regulation of synapse organization [GO:0050807]; retrograde protein transport, ER to cytosol [GO:0030970]; stress granule disassembly [GO:0035617]; translesion synthesis [GO:0019985]; ubiquitin-dependent protein catabolic process [GO:0006511]; viral genome replication [GO:0019079]",ATPase complex [GO:1904949]; azurophil granule lumen [GO:0035578]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; Derlin-1 retrotranslocation complex [GO:0036513]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; glutamatergic synapse [GO:0098978]; intracellular membrane-bounded organelle [GO:0043231]; lipid droplet [GO:0005811]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; proteasome complex [GO:0000502]; protein-containing complex [GO:0032991]; secretory granule lumen [GO:0034774]; site of double-strand break [GO:0035861]; VCP-NPL4-UFD1 AAA ATPase complex [GO:0034098]; VCP-NSFL1C complex [GO:1990730],ADP binding [GO:0043531]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; BAT3 complex binding [GO:1904288]; deubiquitinase activator activity [GO:0035800]; identical protein binding [GO:0042802]; K48-linked polyubiquitin modification-dependent protein binding [GO:0036435]; lipid binding [GO:0008289]; MHC class I protein binding [GO:0042288]; polyubiquitin modification-dependent protein binding [GO:0031593]; protein domain specific binding [GO:0019904]; protein phosphatase binding [GO:0019903]; RNA binding [GO:0003723]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-like protein ligase binding [GO:0044389]; ubiquitin-modified protein reader activity [GO:0140036]; ubiquitin-specific protease binding [GO:1990381],"PTM: Phosphorylated by tyrosine kinases in response to T-cell antigen receptor activation. Phosphorylated in mitotic cells. {ECO:0000250|UniProtKB:P46462}.; PTM: ISGylated. {ECO:0000269|PubMed:16139798}.; PTM: Methylation at Lys-315 catalyzed by VCPKMT is increased in the presence of ASPSCR1. Lys-315 methylation may decrease ATPase activity. {ECO:0000269|PubMed:22948820, ECO:0000269|PubMed:23349634}.",DOMAIN: The PIM (PUB-interaction motif) motif mediates interaction with the PUB domain of RNF31. {ECO:0000269|PubMed:24726327}.,,"STRAND 25..29; /evidence=""ECO:0007829|PDB:5B6C""; STRAND 32..37; /evidence=""ECO:0007829|PDB:8R0E""; STRAND 38..41; /evidence=""ECO:0007829|PDB:5B6C""; STRAND 53..55; /evidence=""ECO:0007829|PDB:5FTN""; STRAND 56..60; /evidence=""ECO:0007829|PDB:5B6C""; STRAND 66..73; /evidence=""ECO:0007829|PDB:5B6C""; STRAND 75..77; /evidence=""ECO:0007829|PDB:8OOI""; STRAND 81..83; /evidence=""ECO:0007829|PDB:5B6C""; STRAND 94..97; /evidence=""ECO:0007829|PDB:8R0E""; STRAND 99..104; /evidence=""ECO:0007829|PDB:5B6C""; STRAND 112..119; /evidence=""ECO:0007829|PDB:5B6C""; STRAND 126..128; /evidence=""ECO:0007829|PDB:5IFS""; STRAND 144..147; /evidence=""ECO:0007829|PDB:5B6C""; STRAND 151..154; /evidence=""ECO:0007829|PDB:5B6C""; STRAND 157..159; /evidence=""ECO:0007829|PDB:4KDI""; STRAND 161..176; /evidence=""ECO:0007829|PDB:5B6C""; STRAND 181..183; /evidence=""ECO:0007829|PDB:5B6C""; STRAND 198..200; /evidence=""ECO:0007829|PDB:5FTJ""; STRAND 240..244; /evidence=""ECO:0007829|PDB:7PUX""; STRAND 246..250; /evidence=""ECO:0007829|PDB:4KLN""; STRAND 265..270; /evidence=""ECO:0007829|PDB:7PUX""; STRAND 298..304; /evidence=""ECO:0007829|PDB:7PUX""; STRAND 341..348; /evidence=""ECO:0007829|PDB:7PUX""; STRAND 365..368; /evidence=""ECO:0007829|PDB:7PUX""; STRAND 388..390; /evidence=""ECO:0007829|PDB:5DYG""; STRAND 432..436; /evidence=""ECO:0007829|PDB:3HU1""; STRAND 458..461; /evidence=""ECO:0007829|PDB:4KO8""; STRAND 513..519; /evidence=""ECO:0007829|PDB:6G2V""; STRAND 520..523; /evidence=""ECO:0007829|PDB:8RSB""; STRAND 538..543; /evidence=""ECO:0007829|PDB:6G2V""; STRAND 550..553; /evidence=""ECO:0007829|PDB:7LN0""; STRAND 571..577; /evidence=""ECO:0007829|PDB:6G2V""; STRAND 588..590; /evidence=""ECO:0007829|PDB:5FTJ""; STRAND 592..594; /evidence=""ECO:0007829|PDB:8OOI""; STRAND 617..624; /evidence=""ECO:0007829|PDB:6G2V""; STRAND 635..639; /evidence=""ECO:0007829|PDB:5FTK""; STRAND 641..644; /evidence=""ECO:0007829|PDB:6G2V""; STRAND 662..664; /evidence=""ECO:0007829|PDB:7LN0""; STRAND 718..721; /evidence=""ECO:0007829|PDB:7VCU""; STRAND 722..724; /evidence=""ECO:0007829|PDB:5IFW""; STRAND 729..731; /evidence=""ECO:0007829|PDB:7LMY""; STRAND 767..770; /evidence=""ECO:0007829|PDB:7RLI""","HELIX 15..17; /evidence=""ECO:0007829|PDB:7LMY""; HELIX 43..48; /evidence=""ECO:0007829|PDB:5B6C""; HELIX 62..64; /evidence=""ECO:0007829|PDB:3QQ8""; HELIX 86..92; /evidence=""ECO:0007829|PDB:5B6C""; HELIX 120..123; /evidence=""ECO:0007829|PDB:5B6C""; HELIX 130..133; /evidence=""ECO:0007829|PDB:5B6C""; HELIX 135..139; /evidence=""ECO:0007829|PDB:5B6C""; HELIX 191..193; /evidence=""ECO:0007829|PDB:7PUX""; HELIX 203..205; /evidence=""ECO:0007829|PDB:7PUX""; HELIX 210..225; /evidence=""ECO:0007829|PDB:7PUX""; HELIX 229..232; /evidence=""ECO:0007829|PDB:7PUX""; HELIX 251..262; /evidence=""ECO:0007829|PDB:7PUX""; HELIX 271..275; /evidence=""ECO:0007829|PDB:7PUX""; HELIX 281..295; /evidence=""ECO:0007829|PDB:7PUX""; HELIX 306..308; /evidence=""ECO:0007829|PDB:7PUX""; HELIX 313..315; /evidence=""ECO:0007829|PDB:7PUX""; HELIX 319..334; /evidence=""ECO:0007829|PDB:7PUX""; HELIX 335..337; /evidence=""ECO:0007829|PDB:7PUX""; HELIX 350..352; /evidence=""ECO:0007829|PDB:7PUX""; HELIX 355..358; /evidence=""ECO:0007829|PDB:7PUX""; HELIX 374..384; /evidence=""ECO:0007829|PDB:7PUX""; HELIX 392..394; /evidence=""ECO:0007829|PDB:8PQX""; HELIX 396..402; /evidence=""ECO:0007829|PDB:7PUX""; HELIX 408..427; /evidence=""ECO:0007829|PDB:7PUX""; HELIX 439..444; /evidence=""ECO:0007829|PDB:7PUX""; HELIX 449..456; /evidence=""ECO:0007829|PDB:7PUX""; HELIX 476..478; /evidence=""ECO:0007829|PDB:6G2V""; HELIX 483..498; /evidence=""ECO:0007829|PDB:6G2V""; HELIX 500..505; /evidence=""ECO:0007829|PDB:6G2V""; HELIX 524..534; /evidence=""ECO:0007829|PDB:6G2V""; HELIX 544..547; /evidence=""ECO:0007829|PDB:6G2V""; HELIX 557..568; /evidence=""ECO:0007829|PDB:6G2V""; HELIX 579..581; /evidence=""ECO:0007829|PDB:6G2V""; HELIX 597..609; /evidence=""ECO:0007829|PDB:6G2V""; HELIX 613..615; /evidence=""ECO:0007829|PDB:6G2V""; HELIX 626..628; /evidence=""ECO:0007829|PDB:6G2V""; HELIX 631..634; /evidence=""ECO:0007829|PDB:6G2V""; HELIX 650..661; /evidence=""ECO:0007829|PDB:6G2V""; HELIX 672..677; /evidence=""ECO:0007829|PDB:6G2V""; HELIX 684..711; /evidence=""ECO:0007829|PDB:6G2V""; HELIX 733..739; /evidence=""ECO:0007829|PDB:6G2V""; HELIX 740..742; /evidence=""ECO:0007829|PDB:6G2V""; HELIX 749..761; /evidence=""ECO:0007829|PDB:6G2V""; HELIX 763..765; /evidence=""ECO:0007829|PDB:7JY5""","TURN 21..23; /evidence=""ECO:0007829|PDB:7BPA""; TURN 140..142; /evidence=""ECO:0007829|PDB:5B6C""; TURN 278..280; /evidence=""ECO:0007829|PDB:8OOI""; TURN 338..340; /evidence=""ECO:0007829|PDB:8HRZ""; TURN 360..362; /evidence=""ECO:0007829|PDB:8OOI""; TURN 385..387; /evidence=""ECO:0007829|PDB:7PUX""; TURN 403..405; /evidence=""ECO:0007829|PDB:5FTJ""; TURN 428..430; /evidence=""ECO:0007829|PDB:7PUX""; TURN 462..468; /evidence=""ECO:0007829|PDB:4KO8""; TURN 584..586; /evidence=""ECO:0007829|PDB:5FTN""; TURN 678..681; /evidence=""ECO:0007829|PDB:6G2V""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,VCP HEL-220 HEL-S-70,Transitional endoplasmic reticulum ATPase (TER ATPase) (EC 3.6.4.6) (15S Mg(2+)-ATPase p97 subunit) (Valosin-containing protein) (VCP),Homo sapiens (Human),806.0,89322.0,MASGADSKGDDLSTAILKQKNRPNRLIVDEAINEDNSVVSLSQPKMDELQLFRGDTVLLKGKKRREAVCIVLSDDTCSDEKIRMNRVVRNNLRVRLGDVISIQPCPDVKYGKRIHVLPIDDTVEGITGNLFEVYLKPYFLEAYRPIRKGDIFLVRGGMRAVEFKVVETDPSPYCIVAPDTVIHCEGEPIKREDEEESLNEVGYDDIGGCRKQLAQIKEMVELPLRHPALFKAIGVKPPRGILLYGPPGTGKTLIARAVANETGAFFFLINGPEIMSKLAGESESNLRKAFEEAEKNAPAIIFIDELDAIAPKREKTHGEVERRIVSQLLTLMDGLKQRAHVIVMAATNRPNSIDPALRRFGRFDREVDIGIPDATGRLEILQIHTKNMKLADDVDLEQVANETHGHVGADLAALCSEAALQAIRKKMDLIDLEDETIDAEVMNSLAVTMDDFRWALSQSNPSALRETVVEVPQVTWEDIGGLEDVKRELQELVQYPVEHPDKFLKFGMTPSKGVLFYGPPGCGKTLLAKAIANECQANFISIKGPELLTMWFGESEANVREIFDKARQAAPCVLFFDELDSIAKARGGNIGDGGGAADRVINQILTEMDGMSTKKNVFIIGATNRPDIIDPAILRPGRLDQLIYIPLPDEKSRVAILKANLRKSPVAKDVDLEFLAKMTNGFSGADLTEICQRACKLAIRESIESEIRRERERQTNPSAMEVEEDDPVPEIRRDHFEEAMRFARRSVSDNDIRKYEMFAQTLQQSRGFGSFRFPSGNQGGAGPSQGSGGGTGGSVYTEDNDDDLYG,False,False,True,P55072,"[('cd19519', 'first of two ATPase domains of CDC48 and similar ATPase domains'), ('cd19528', 'second of two ATPase domains of CDC48 and similar ATPase domains'), ('G3DSA:1.10.8.60', None), ('G3DSA:2.40.40.20', None), ('G3DSA:3.10.330.10', None), ('G3DSA:3.40.50.300', 'P-loop containing nucleotide triphosphate hydrolases'), ('G3DSA:6.10.20.150', None), ('IPR003338', 'CDC48, N-terminal subdomain'), ('IPR003593', 'AAA+ ATPase domain'), ('IPR003959', 'ATPase, AAA-type, core'), ('IPR003960', 'ATPase, AAA-type, conserved site'), ('IPR004201', 'CDC48, domain 2'), ('IPR005938', 'AAA ATPase, CDC48 family'), ('IPR009010', 'Aspartate decarboxylase-like domain superfamily'), ('IPR027417', 'P-loop containing nucleoside triphosphate hydrolase'), ('IPR029067', 'CDC48 domain 2-like superfamily'), ('IPR041569', 'AAA ATPase, AAA+ lid domain'), ('IPR050168', 'AAA ATPase domain-containing protein'), ('PF00004', 'ATPase family associated with various cellular activities (AAA)'), ('PF02359', 'Cell division protein 48 (CDC48), N-terminal domain')]",,"""ENSG00000165280; Low tissue specificity."";","CATALYTIC ACTIVITY: Reaction=ATP + H2O = ADP + phosphate + H(+); Xref=Rhea:RHEA:13065, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616, ChEBI:CHEBI:43474, ChEBI:CHEBI:456216; EC=3.6.4.6; Evidence={ECO:0000269|PubMed:26471729};",3.6.4.6,,,ENST00000358901.11;,VCP,ENSG00000165280,0.0,VCP,Non-canonical_RBPs,19.0,9.43,DP03238,0.406,0.096,0.073,VCP
P55084,ENSG00000138029,ECHB_HUMAN,cellular response to lipopolysaccharide [GO:0071222]; fatty acid beta-oxidation [GO:0006635]; gene expression [GO:0010467],endoplasmic reticulum [GO:0005783]; mitochondrial envelope [GO:0005740]; mitochondrial fatty acid beta-oxidation multienzyme complex [GO:0016507]; mitochondrial inner membrane [GO:0005743]; mitochondrial nucleoid [GO:0042645]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739],3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; acetyl-CoA C-acetyltransferase activity [GO:0003985]; acetyl-CoA C-acyltransferase activity [GO:0003988]; acetyl-CoA C-myristoyltransferase activity [GO:0050633]; enoyl-CoA hydratase activity [GO:0004300]; lncRNA binding [GO:0106222]; RNA binding [GO:0003723],,,,,,,"cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,HADHB MSTP029,"Trifunctional enzyme subunit beta, mitochondrial (TP-beta) [Includes: 3-ketoacyl-CoA thiolase (EC 2.3.1.155) (EC 2.3.1.16) (Acetyl-CoA acyltransferase) (Beta-ketothiolase)]",Homo sapiens (Human),474.0,51294.0,MTILTYPFKNLPTASKWALRFSIRPLSCSSQLRAAPAVQTKTKKTLAKPNIRNVVVVDGVRTPFLLSGTSYKDLMPHDLARAALTGLLHRTSVPKEVVDYIIFGTVIQEVKTSNVAREAALGAGFSDKTPAHTVTMACISANQAMTTGVGLIASGQCDVIVAGGVELMSDVPIRHSRKMRKLMLDLNKAKSMGQRLSLISKFRFNFLAPELPAVSEFSTSETMGHSADRLAAAFAVSRLEQDEYALRSHSLAKKAQDEGLLSDVVPFKVPGKDTVTKDNGIRPSSLEQMAKLKPAFIKPYGTVTAANSSFLTDGASAMLIMAEEKALAMGYKPKAYLRDFMYVSQDPKDQLLLGPTYATPKVLEKAGLTMNDIDAFEFHEAFSGQILANFKAMDSDWFAENYMGRKTKVGLPPLEKFNNWGGSLSLGHPFGATGCRLVMAAANRLRKEGGQYGLVAACAAGGQGHAMIVEAYPK,True,True,False,P55084,"[('cd00751', 'thiolase'), ('G3DSA:3.40.47.10', None), ('IPR002155', 'Thiolase'), ('IPR016039', 'Thiolase-like'), ('IPR020610', 'Thiolase, active site'), ('IPR020613', 'Thiolase, conserved site'), ('IPR020615', 'Thiolase, acyl-enzyme intermediate active site'), ('IPR020616', 'Thiolase, N-terminal'), ('IPR020617', 'Thiolase, C-terminal'), ('PF00108', 'Thiolase, N-terminal domain'), ('PF02803', 'Thiolase, C-terminal domain'), ('PS00098', 'Thiolases acyl-enzyme intermediate signature'), ('PS00099', 'Thiolases active site'), ('PS00737', 'Thiolases signature 2'), ('PTHR18919', 'Acetyl-CoA acetyltransferase/thiolase'), ('SSF53901', 'Thiolase-like'), ('TIGR01930', 'acetyl-CoA C-acyltransferase')]",,"""ENSG00000138029; Tissue enhanced (heart muscle, skeletal muscle, tongue)."";","CATALYTIC ACTIVITY: Reaction=an acyl-CoA + acetyl-CoA = a 3-oxoacyl-CoA + CoA; Xref=Rhea:RHEA:21564, ChEBI:CHEBI:57287, ChEBI:CHEBI:57288, ChEBI:CHEBI:58342, ChEBI:CHEBI:90726; EC=2.3.1.16; Evidence={ECO:0000269|PubMed:7958339, ECO:0000269|PubMed:8135828, ECO:0000269|PubMed:8163672, ECO:0000269|PubMed:8651282}; PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:21566; Evidence={ECO:0000269|PubMed:8135828}; CATALYTIC ACTIVITY: Reaction=butanoyl-CoA + acetyl-CoA = 3-oxohexanoyl-CoA + CoA; Xref=Rhea:RHEA:31111, ChEBI:CHEBI:57287, ChEBI:CHEBI:57288, ChEBI:CHEBI:57371, ChEBI:CHEBI:62418; Evidence={ECO:0000269|PubMed:1550553}; PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:31113; Evidence={ECO:0000269|PubMed:8135828}; CATALYTIC ACTIVITY: Reaction=hexanoyl-CoA + acetyl-CoA = 3-oxooctanoyl-CoA + CoA; Xref=Rhea:RHEA:31203, ChEBI:CHEBI:57287, ChEBI:CHEBI:57288, ChEBI:CHEBI:62619, ChEBI:CHEBI:62620; Evidence={ECO:0000269|PubMed:8163672}; PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:31205; Evidence={ECO:0000269|PubMed:8135828}; CATALYTIC ACTIVITY: Reaction=octanoyl-CoA + acetyl-CoA = 3-oxodecanoyl-CoA + CoA; Xref=Rhea:RHEA:31087, ChEBI:CHEBI:57287, ChEBI:CHEBI:57288, ChEBI:CHEBI:57386, ChEBI:CHEBI:62548; Evidence={ECO:0000269|PubMed:1550553}; PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:31089; Evidence={ECO:0000269|PubMed:8135828}; CATALYTIC ACTIVITY: Reaction=decanoyl-CoA + acetyl-CoA = 3-oxododecanoyl-CoA + CoA; Xref=Rhea:RHEA:31183, ChEBI:CHEBI:57287, ChEBI:CHEBI:57288, ChEBI:CHEBI:61430, ChEBI:CHEBI:62615; Evidence={ECO:0000269|PubMed:8163672}; PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:31185; Evidence={ECO:0000269|PubMed:8135828}; CATALYTIC ACTIVITY: Reaction=dodecanoyl-CoA + acetyl-CoA = 3-oxotetradecanoyl-CoA + CoA; Xref=Rhea:RHEA:31091, ChEBI:CHEBI:57287, ChEBI:CHEBI:57288, ChEBI:CHEBI:57375, ChEBI:CHEBI:62543; Evidence={ECO:0000269|PubMed:1550553}; PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:31093; Evidence={ECO:0000269|PubMed:8135828}; CATALYTIC ACTIVITY: Reaction=tetradecanoyl-CoA + acetyl-CoA = 3-oxohexadecanoyl-CoA + CoA; Xref=Rhea:RHEA:18161, ChEBI:CHEBI:57287, ChEBI:CHEBI:57288, ChEBI:CHEBI:57349, ChEBI:CHEBI:57385; EC=2.3.1.155; Evidence={ECO:0000269|PubMed:1550553, ECO:0000269|PubMed:7958339, ECO:0000269|PubMed:8135828, ECO:0000269|PubMed:8163672, ECO:0000269|PubMed:8651282}; PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:18163; Evidence={ECO:0000269|PubMed:8135828};",2.3.1.155; 2.3.1.16,,PATHWAY: Lipid metabolism; fatty acid beta-oxidation. {ECO:0000269|PubMed:8135828}.,ENST00000317799.10 [P55084-1];ENST00000545822.2 [P55084-2];,HADHB,ENSG00000138029,0.0,HADHB,Non-canonical_RBPs,12.0,,,,0.095,,HADHB
P55263,ENSG00000156110,ADK_HUMAN,AMP salvage [GO:0044209]; dAMP salvage [GO:0106383]; dATP biosynthetic process [GO:0006175]; GMP salvage [GO:0032263]; phosphorylation [GO:0016310]; purine nucleobase metabolic process [GO:0006144]; purine ribonucleoside salvage [GO:0006166]; ribonucleoside monophosphate biosynthetic process [GO:0009156],cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886],adenosine kinase activity [GO:0004001]; ATP binding [GO:0005524]; deoxyadenosine kinase activity [GO:0004136]; metal ion binding [GO:0046872]; RNA binding [GO:0003723],,,,"STRAND 26..29; /evidence=""ECO:0007829|PDB:1BX4""; STRAND 33..39; /evidence=""ECO:0007829|PDB:1BX4""; STRAND 52..57; /evidence=""ECO:0007829|PDB:1BX4""; STRAND 76..80; /evidence=""ECO:0007829|PDB:1BX4""; STRAND 96..99; /evidence=""ECO:0007829|PDB:2I6B""; STRAND 101..110; /evidence=""ECO:0007829|PDB:1BX4""; STRAND 126..135; /evidence=""ECO:0007829|PDB:1BX4""; STRAND 139..145; /evidence=""ECO:0007829|PDB:1BX4""; STRAND 148..154; /evidence=""ECO:0007829|PDB:1BX4""; STRAND 180..185; /evidence=""ECO:0007829|PDB:1BX4""; STRAND 209..213; /evidence=""ECO:0007829|PDB:1BX4""; STRAND 235..240; /evidence=""ECO:0007829|PDB:1BX4""; STRAND 278..283; /evidence=""ECO:0007829|PDB:1BX4""; STRAND 286..291; /evidence=""ECO:0007829|PDB:1BX4""; STRAND 296..299; /evidence=""ECO:0007829|PDB:1BX4""; STRAND 350..353; /evidence=""ECO:0007829|PDB:1BX4""","HELIX 42..47; /evidence=""ECO:0007829|PDB:1BX4""; HELIX 60..62; /evidence=""ECO:0007829|PDB:1BX4""; HELIX 63..72; /evidence=""ECO:0007829|PDB:1BX4""; HELIX 82..94; /evidence=""ECO:0007829|PDB:1BX4""; HELIX 111..122; /evidence=""ECO:0007829|PDB:1BX4""; HELIX 156..160; /evidence=""ECO:0007829|PDB:1BX4""; HELIX 163..165; /evidence=""ECO:0007829|PDB:1BX4""; HELIX 170..178; /evidence=""ECO:0007829|PDB:1BX4""; HELIX 186..190; /evidence=""ECO:0007829|PDB:1BX4""; HELIX 193..205; /evidence=""ECO:0007829|PDB:1BX4""; HELIX 217..222; /evidence=""ECO:0007829|PDB:1BX4""; HELIX 224..230; /evidence=""ECO:0007829|PDB:1BX4""; HELIX 231..233; /evidence=""ECO:0007829|PDB:1BX4""; HELIX 241..250; /evidence=""ECO:0007829|PDB:1BX4""; HELIX 258..266; /evidence=""ECO:0007829|PDB:1BX4""; HELIX 312..327; /evidence=""ECO:0007829|PDB:1BX4""; HELIX 333..347; /evidence=""ECO:0007829|PDB:1BX4""","TURN 166..168; /evidence=""ECO:0007829|PDB:1BX4""; TURN 328..330; /evidence=""ECO:0007829|PDB:1BX4""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,ADK,Adenosine kinase (AK) (EC 2.7.1.20) (Adenosine 5'-phosphotransferase),Homo sapiens (Human),362.0,40545.0,MAAAEEEPKPKKLKVEAPQALRENILFGMGNPLLDISAVVDKDFLDKYSLKPNDQILAEDKHKELFDELVKKFKVEYHAGGSTQNSIKVAQWMIQQPHKAATFFGCIGIDKFGEILKRKAAEAHVDAHYYEQNEQPTGTCAACITGDNRSLIANLAAANCYKKEKHLDLEKNWMLVEKARVCYIAGFFLTVSPESVLKVAHHASENNRIFTLNLSAPFISQFYKESLMKVMPYVDILFGNETEAATFAREQGFETKDIKEIAKKTQALPKMNSKRQRIVIFTQGRDDTIMATESEVTAFAVLDQDQKEIIDTNGAGDAFVGGFLSQLVSDKPLTECIRAGHYAASIIIRRTGCTFPEKPDFH,True,False,False,P55263,"[('cd01168', 'adenosine_kinase'), ('G3DSA:3.40.1190.20', None), ('IPR001805', 'Adenosine kinase'), ('IPR002173', 'Carbohydrate/purine kinase, PfkB, conserved site'), ('IPR011611', 'Carbohydrate kinase PfkB'), ('IPR029056', 'Ribokinase-like'), ('PF00294', 'pfkB family carbohydrate kinase'), ('PR00989', 'ADENOKINASE'), ('PS00584', 'pfkB family of carbohydrate kinases signature 2'), ('PTHR45769', 'ADENOSINE KINASE'), ('SSF53613', 'Ribokinase-like')]",,"""ENSG00000156110; Tissue enhanced (liver)."";","CATALYTIC ACTIVITY: Reaction=adenosine + ATP = AMP + ADP + H(+); Xref=Rhea:RHEA:20824, ChEBI:CHEBI:15378, ChEBI:CHEBI:16335, ChEBI:CHEBI:30616, ChEBI:CHEBI:456215, ChEBI:CHEBI:456216; EC=2.7.1.20; Evidence={ECO:0000269|PubMed:21963049, ECO:0000269|PubMed:8577746, ECO:0000269|PubMed:9070863}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:20825; Evidence={ECO:0000305|PubMed:8577746};",2.7.1.20,ACTIVITY REGULATION: Activity is inhibited by 5-iodotubercidin and 5'-amino-5'-deoxyadenosine. {ECO:0000269|PubMed:9070863}.,PATHWAY: Purine metabolism; AMP biosynthesis via salvage pathway; AMP from adenosine: step 1/1.,ENST00000372734.5 [P55263-2];ENST00000539909.6 [P55263-1];ENST00000672429.1 [P55263-3];ENST00000673027.1 [P55263-4];,ADK,ENSG00000156110,0.0,ADK,Non-canonical_RBPs,3.0,4.14,DP03960,0.041,0.047,,ADK
P56192,ENSG00000166986,SYMC_HUMAN,cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to platelet-derived growth factor stimulus [GO:0036120]; methionyl-tRNA aminoacylation [GO:0006431]; positive regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901838]; rRNA transcription [GO:0009303]; tRNA aminoacylation for protein translation [GO:0006418],aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleolus [GO:0005730],ATP binding [GO:0005524]; methionine-tRNA ligase activity [GO:0004825]; tRNA binding [GO:0000049],,,"DOMAIN 74..198; /note=""GST C-terminal""; DOMAIN 841..897; /note=""WHEP-TRS""","STRAND 2..5; /evidence=""ECO:0007829|PDB:4BVX""; STRAND 29..32; /evidence=""ECO:0007829|PDB:4BVX""; STRAND 48..52; /evidence=""ECO:0007829|PDB:4BVX""; STRAND 131..140; /evidence=""ECO:0007829|PDB:4BVX""; STRAND 265..270; /evidence=""ECO:0007829|PDB:5GL7""; STRAND 304..312; /evidence=""ECO:0007829|PDB:5GL7""; STRAND 352..357; /evidence=""ECO:0007829|PDB:5GL7""; STRAND 379..389; /evidence=""ECO:0007829|PDB:5GL7""; STRAND 401..404; /evidence=""ECO:0007829|PDB:5GL7""; STRAND 413..417; /evidence=""ECO:0007829|PDB:5GL7""; STRAND 431..435; /evidence=""ECO:0007829|PDB:5GL7""; STRAND 443..452; /evidence=""ECO:0007829|PDB:5GL7""; STRAND 496..498; /evidence=""ECO:0007829|PDB:5GL7""; STRAND 500..502; /evidence=""ECO:0007829|PDB:5GL7""; STRAND 546..553; /evidence=""ECO:0007829|PDB:5GL7""; STRAND 578..584; /evidence=""ECO:0007829|PDB:5GL7""; STRAND 587..589; /evidence=""ECO:0007829|PDB:5GL7""; STRAND 627..629; /evidence=""ECO:0007829|PDB:5GL7""; STRAND 631..633; /evidence=""ECO:0007829|PDB:5GL7""; STRAND 817..819; /evidence=""ECO:0007829|PDB:5GOY""; STRAND 893..895; /evidence=""ECO:0007829|PDB:2DJV""; STRAND 897..899; /evidence=""ECO:0007829|PDB:2DJV""","HELIX 12..18; /evidence=""ECO:0007829|PDB:4BVX""; HELIX 19..22; /evidence=""ECO:0007829|PDB:4BVX""; HELIX 62..72; /evidence=""ECO:0007829|PDB:4BVX""; HELIX 79..90; /evidence=""ECO:0007829|PDB:4BVX""; HELIX 92..104; /evidence=""ECO:0007829|PDB:4BVX""; HELIX 111..114; /evidence=""ECO:0007829|PDB:4BVX""; HELIX 115..117; /evidence=""ECO:0007829|PDB:4BVX""; HELIX 118..130; /evidence=""ECO:0007829|PDB:4BVX""; HELIX 143..156; /evidence=""ECO:0007829|PDB:4BVX""; HELIX 159..161; /evidence=""ECO:0007829|PDB:4BVX""; HELIX 167..177; /evidence=""ECO:0007829|PDB:4BVX""; HELIX 180..190; /evidence=""ECO:0007829|PDB:4BVX""; HELIX 194..198; /evidence=""ECO:0007829|PDB:4BVX""; HELIX 199..202; /evidence=""ECO:0007829|PDB:4BVX""; HELIX 230..241; /evidence=""ECO:0007829|PDB:5GL7""; HELIX 243..246; /evidence=""ECO:0007829|PDB:5GL7""; HELIX 281..286; /evidence=""ECO:0007829|PDB:5GL7""; HELIX 288..300; /evidence=""ECO:0007829|PDB:5GL7""; HELIX 316..324; /evidence=""ECO:0007829|PDB:5GL7""; HELIX 329..346; /evidence=""ECO:0007829|PDB:5GL7""; HELIX 360..374; /evidence=""ECO:0007829|PDB:5GL7""; HELIX 398..400; /evidence=""ECO:0007829|PDB:5GL7""; HELIX 427..429; /evidence=""ECO:0007829|PDB:5GL7""; HELIX 454..468; /evidence=""ECO:0007829|PDB:5GL7""; HELIX 476..488; /evidence=""ECO:0007829|PDB:5GL7""; HELIX 517..520; /evidence=""ECO:0007829|PDB:5GL7""; HELIX 524..532; /evidence=""ECO:0007829|PDB:5GL7""; HELIX 537..540; /evidence=""ECO:0007829|PDB:5GL7""; HELIX 554..556; /evidence=""ECO:0007829|PDB:5GL7""; HELIX 557..561; /evidence=""ECO:0007829|PDB:5GL7""; HELIX 563..571; /evidence=""ECO:0007829|PDB:5GL7""; HELIX 607..610; /evidence=""ECO:0007829|PDB:5GL7""; HELIX 614..623; /evidence=""ECO:0007829|PDB:5GL7""; HELIX 635..645; /evidence=""ECO:0007829|PDB:5GL7""; HELIX 650..664; /evidence=""ECO:0007829|PDB:5GL7""; HELIX 676..696; /evidence=""ECO:0007829|PDB:5GL7""; HELIX 701..722; /evidence=""ECO:0007829|PDB:5GL7""; HELIX 724..727; /evidence=""ECO:0007829|PDB:5GL7""; HELIX 732..755; /evidence=""ECO:0007829|PDB:5GL7""; HELIX 761..771; /evidence=""ECO:0007829|PDB:5GL7""; HELIX 775..778; /evidence=""ECO:0007829|PDB:5GL7""; HELIX 807..816; /evidence=""ECO:0007829|PDB:5GL7""; HELIX 838..861; /evidence=""ECO:0007829|PDB:2DJV""; HELIX 866..887; /evidence=""ECO:0007829|PDB:2DJV""","TURN 23..25; /evidence=""ECO:0007829|PDB:4BVX""; TURN 375..377; /evidence=""ECO:0007829|PDB:5GL7""; TURN 390..393; /evidence=""ECO:0007829|PDB:5GL7""; TURN 406..408; /evidence=""ECO:0007829|PDB:5GL7""; TURN 419..421; /evidence=""ECO:0007829|PDB:5GL7""; TURN 436..438; /evidence=""ECO:0007829|PDB:5GL7""; TURN 521..523; /evidence=""ECO:0007829|PDB:5GL7""; TURN 534..536; /evidence=""ECO:0007829|PDB:5GL7""; TURN 543..545; /evidence=""ECO:0007829|PDB:5GL7""; TURN 596..599; /evidence=""ECO:0007829|PDB:5GL7""; TURN 604..606; /evidence=""ECO:0007829|PDB:5GL7""; TURN 646..649; /evidence=""ECO:0007829|PDB:5GL7""; TURN 697..699; /evidence=""ECO:0007829|PDB:5GL7""; TURN 756..759; /evidence=""ECO:0007829|PDB:5GL7""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,MARS1 MARS,"Methionine--tRNA ligase, cytoplasmic (EC 6.1.1.10) (Methionyl-tRNA synthetase) (MetRS)",Homo sapiens (Human),900.0,101116.0,MRLFVSDGVPGCLPVLAAAGRARGRAEVLISTVGPEDCVVPFLTRPKVPVLQLDSGNYLFSTSAICRYFFLLSGWEQDDLTNQWLEWEATELQPALSAALYYLVVQGKKGEDVLGSVRRALTHIDHSLSRQNCPFLAGETESLADIVLWGALYPLLQDPAYLPEELSALHSWFQTLSTQEPCQRAAETVLKQQGVLALRPYLQKQPQPSPAEGRAVTNEPEEEELATLSEEEIAMAVTAWEKGLESLPPLRPQQNPVLPVAGERNVLITSALPYVNNVPHLGNIIGCVLSADVFARYSRLRQWNTLYLCGTDEYGTATETKALEEGLTPQEICDKYHIIHADIYRWFNISFDIFGRTTTPQQTKITQDIFQQLLKRGFVLQDTVEQLRCEHCARFLADRFVEGVCPFCGYEEARGDQCDKCGKLINAVELKKPQCKVCRSCPVVQSSQHLFLDLPKLEKRLEEWLGRTLPGSDWTPNAQFITRSWLRDGLKPRCITRDLKWGTPVPLEGFEDKVFYVWFDATIGYLSITANYTDQWERWWKNPEQVDLYQFMAKDNVPFHSLVFPCSALGAEDNYTLVSHLIATEYLNYEDGKFSKSRGVGVFGDMAQDTGIPADIWRFYLLYIRPEGQDSAFSWTDLLLKNNSELLNNLGNFINRAGMFVSKFFGGYVPEMVLTPDDQRLLAHVTLELQHYHQLLEKVRIRDALRSILTISRHGNQYIQVNEPWKRIKGSEADRQRAGTVTGLAVNIAALLSVMLQPYMPTVSATIQAQLQLPPPACSILLTNFLCTLPAGHQIGTVSPLFQKLENDQIESLRQRFGGGQAKTSPKPAVVETVTTAKPQQIQALMDEVTKQGNIVRELKAQKADKNEVAAEVAKLLDLKKQLAVAEGKPPEAPKGKKKK,False,True,False,P56192,"[('cd00814', 'catalytic core domain of methioninyl-tRNA synthetases'), ('cd00939', 'MetRS_RNA'), ('cd07957', 'Anticodon-binding domain of methionyl tRNA synthetases'), ('cd10307', 'Glutathione S-transferase C-terminal-like, alpha helical domain of Methionyl-tRNA synthetase from higher eukaryotes'), ('G3DSA:1.10.287.10', 'S15/NS1, RNA-binding'), ('G3DSA:1.10.730.10', 'Isoleucyl-tRNA Synthetase; Domain 1'), ('G3DSA:1.20.1050.10', None), ('G3DSA:2.20.28.20', 'Methionyl-tRNA synthetase, Zn-domain'), ('G3DSA:3.40.30.10', 'Glutaredoxin'), ('G3DSA:3.40.50.620', 'HUPs'), ('IPR000738', 'WHEP-TRS domain'), ('IPR001412', 'Aminoacyl-tRNA synthetase, class I, conserved site'), ('IPR004046', 'Glutathione S-transferase, C-terminal'), ('IPR009068', 'uS15/NS1, RNA-binding domain superfamily'), ('IPR009080', 'Aminoacyl-tRNA synthetase, class Ia, anticodon-binding'), ('IPR010987', 'Glutathione S-transferase, C-terminal-like'), ('IPR014729', 'Rossmann-like alpha/beta/alpha sandwich fold'), ('IPR014758', 'Methionyl-tRNA synthetase'), ('IPR015413', 'Methionyl/Leucyl tRNA synthetase'), ('IPR023458', 'Methionine-tRNA ligase, type 1')]",,"""ENSG00000166986; Low tissue specificity."";","CATALYTIC ACTIVITY: Reaction=tRNA(Met) + L-methionine + ATP = L-methionyl-tRNA(Met) + AMP + diphosphate; Xref=Rhea:RHEA:13481, Rhea:RHEA-COMP:9667, Rhea:RHEA-COMP:9698, ChEBI:CHEBI:30616, ChEBI:CHEBI:33019, ChEBI:CHEBI:57844, ChEBI:CHEBI:78442, ChEBI:CHEBI:78530, ChEBI:CHEBI:456215; EC=6.1.1.10; Evidence={ECO:0000269|PubMed:11714285};",6.1.1.10,"ACTIVITY REGULATION: Enzyme activity is increased by spermidine, EEF1A1, and when the Mg(2+) concentration is increased from 5 mM to 13 mM (in vitro), possibly by promoting the dissociation of the complex between the enzyme and its product. {ECO:0000269|PubMed:11714285}.",,ENST00000262027.10 [P56192-1];ENST00000537638.6 [P56192-2];,MARS1,ENSG00000166986,0.0,MARS1,Canonical_RBPs,13.0,,,,0.067,,MARS1
P57086,ENSG00000171222,SCND1_HUMAN,positive regulation of DNA-templated transcription [GO:0045893],nucleus [GO:0005634],,,,"DOMAIN 108..166; /note=""SCAN box""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00187""",,,,"cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,SCAND1 SDP1,SCAN domain-containing protein 1,Homo sapiens (Human),179.0,19082.0,MAATEPILAATGSPAAVPPEKLEGAGSSSAPERNCVGSSLPEASPPAPEPSSPNAAVPEAIPTPRAAASAALELPLGPAPVSVAPQAEAEARSTPGPAGSRLGPETFRQRFRQFRYQDAAGPREAFRQLRELSRQWLRPDIRTKEQIVEMLVQEQLLAILPEAARARRIRRRTDVRITG,False,False,True,P57086,"[('cd07936', 'SCAN oligomerization domain'), ('G3DSA:1.10.4020.10', 'DNA breaking-rejoining enzymes'), ('IPR003309', 'SCAN domain'), ('IPR038269', 'SCAN domain superfamily'), ('IPR050916', 'SCAN domain and C2H2-type zinc finger'), ('PF02023', 'SCAN domain'), ('PS50804', 'SCAN box profile'), ('PTHR45935', 'SCAN domain and C2H2-type zinc finger'), ('SM00431', 'leucine rich region'), ('SSF47353', 'Retrovirus capsid dimerization domain-like')]",,"""ENSG00000171222; Low tissue specificity."";",,,,,ENST00000305978.7;ENST00000373991.3;ENST00000615116.1;,SCAND1,ENSG00000171222,0.0,,,,,,,0.654,0.581,SCAND1
P58340,ENSG00000178053,MLF1_HUMAN,DNA-templated transcription [GO:0006351]; myeloid progenitor cell differentiation [GO:0002318]; regulation of cell cycle G1/S phase transition [GO:1902806]; regulation of DNA-templated transcription [GO:0006355]; regulation of signal transduction by p53 class mediator [GO:1901796],ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471],DNA binding [GO:0003677]; protein domain specific binding [GO:0019904],PTM: Phosphorylation is required for binding to YWHAZ. {ECO:0000250}.,,,,,,"cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,MLF1,Myeloid leukemia factor 1 (Myelodysplasia-myeloid leukemia factor 1),Homo sapiens (Human),268.0,30627.0,MFRMLNSSFEDDPFFSESILAHRENMRQMIRSFSEPFGRDLLSISDGRGRAHNRRGHNDGEDSLTHTDVSSFQTMDQMVSNMRNYMQKLERNFGQLSVDPNGHSFCSSSVMTYSKIGDEPPKVFQASTQTRRAPGGIKETRKAMRDSDSGLEKMAIGHHIHDRAHVIKKSKNKKTGDEEVNQEFINMNESDAHAFDEEWQSEVLKYKPGRHNLGNTRMRSVGHENPGSRELKRREKPQQSPAIEHGRRSNVLGDKLHIKGSSVKSNKK,False,False,True,P58340,"[('IPR019376', 'Myeloid leukemia factor'), ('PF10248', 'Myelodysplasia-myeloid leukemia factor 1-interacting protein'), ('PTHR13105', 'MYELOID LEUKEMIA FACTOR')]",P58340;,"""ENSG00000178053; Tissue enhanced (skeletal muscle, testis)."";",,,,,ENST00000355893.11 [P58340-1];ENST00000359117.9 [P58340-5];ENST00000469452.5 [P58340-2];ENST00000471745.5 [P58340-4];ENST00000477042.6 [P58340-4];ENST00000478894.7 [P58340-4];ENST00000482628.5 [P58340-5];ENST00000484955.5 [P58340-5];ENST00000618075.4 [P58340-2];ENST00000651874.1 [P58340-5];ENST00000651984.1 [P58340-5];,MLF1,ENSG00000178053,0.0,,,,,,,0.396,0.31,MLF1
P60174,ENSG00000111669,TPIS_HUMAN,canonical glycolysis [GO:0061621]; gluconeogenesis [GO:0006094]; glyceraldehyde-3-phosphate biosynthetic process [GO:0046166]; glycerol catabolic process [GO:0019563]; glycolytic process [GO:0006096]; methylglyoxal biosynthetic process [GO:0019242],cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; nucleus [GO:0005634],methylglyoxal synthase activity [GO:0008929]; protein homodimerization activity [GO:0042803]; triose-phosphate isomerase activity [GO:0004807]; ubiquitin protein ligase binding [GO:0031625],,,,"STRAND 7..12; /evidence=""ECO:0007829|PDB:7RDE""; STRAND 38..43; /evidence=""ECO:0007829|PDB:7RDE""; STRAND 60..65; /evidence=""ECO:0007829|PDB:7RDE""; STRAND 69..74; /evidence=""ECO:0007829|PDB:7RDE""; STRAND 91..95; /evidence=""ECO:0007829|PDB:7RDE""; STRAND 123..128; /evidence=""ECO:0007829|PDB:7RDE""; STRAND 161..165; /evidence=""ECO:0007829|PDB:7RDE""; STRAND 207..209; /evidence=""ECO:0007829|PDB:7RDE""; STRAND 229..233; /evidence=""ECO:0007829|PDB:7RDE""","HELIX 19..32; /evidence=""ECO:0007829|PDB:7RDE""; HELIX 46..48; /evidence=""ECO:0007829|PDB:7RDE""; HELIX 49..55; /evidence=""ECO:0007829|PDB:7RDE""; HELIX 81..86; /evidence=""ECO:0007829|PDB:7RDE""; HELIX 97..101; /evidence=""ECO:0007829|PDB:7RDE""; HELIX 107..119; /evidence=""ECO:0007829|PDB:7RDE""; HELIX 132..136; /evidence=""ECO:0007829|PDB:7RDE""; HELIX 140..152; /evidence=""ECO:0007829|PDB:7RDE""; HELIX 158..160; /evidence=""ECO:0007829|PDB:7RDE""; HELIX 168..170; /evidence=""ECO:0007829|PDB:4UNL""; HELIX 181..196; /evidence=""ECO:0007829|PDB:7RDE""; HELIX 199..204; /evidence=""ECO:0007829|PDB:7RDE""; HELIX 218..222; /evidence=""ECO:0007829|PDB:7RDE""; HELIX 234..237; /evidence=""ECO:0007829|PDB:7RDE""; HELIX 241..245; /evidence=""ECO:0007829|PDB:7RDE""","TURN 137..139; /evidence=""ECO:0007829|PDB:6UP8""; TURN 171..173; /evidence=""ECO:0007829|PDB:4UNL""; TURN 215..217; /evidence=""ECO:0007829|PDB:7RDE""; TURN 246..248; /evidence=""ECO:0007829|PDB:7RDE""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,TPI1 TPI,Triosephosphate isomerase (TIM) (EC 5.3.1.1) (Methylglyoxal synthase) (EC 4.2.3.3) (Triose-phosphate isomerase),Homo sapiens (Human),249.0,26669.0,MAPSRKFFVGGNWKMNGRKQSLGELIGTLNAAKVPADTEVVCAPPTAYIDFARQKLDPKIAVAAQNCYKVTNGAFTGEISPGMIKDCGATWVVLGHSERRHVFGESDELIGQKVAHALAEGLGVIACIGEKLDEREAGITEKVVFEQTKVIADNVKDWSKVVLAYEPVWAIGTGKTATPQQAQEVHEKLRGWLKSNVSDAVAQSTRIIYGGSVTGATCKELASQPDVDGFLVGGASLKPEFVDIINAKQ,True,True,False,P60174,"[('cd00311', 'TIM'), ('G3DSA:3.20.20.70', 'Aldolase class I'), ('IPR000652', 'Triosephosphate isomerase'), ('IPR013785', 'Aldolase-type TIM barrel'), ('IPR020861', 'Triosephosphate isomerase, active site'), ('IPR022896', 'Triosephosphate isomerase, bacterial/eukaryotic'), ('IPR035990', 'Triosephosphate isomerase superfamily'), ('MF_00147_B', 'Triosephosphate isomerase [tpiA]'), ('PF00121', 'Triosephosphate isomerase'), ('PS00171', 'Triosephosphate isomerase active site'), ('PS51440', 'Triosephosphate isomerase (TIM) family profile'), ('PTHR21139', 'TRIOSEPHOSPHATE ISOMERASE'), ('SSF51351', 'Triosephosphate isomerase (TIM)'), ('TIGR00419', 'triose-phosphate isomerase')]",,"""ENSG00000111669; Tissue enhanced (skeletal)."";","CATALYTIC ACTIVITY: Reaction=D-glyceraldehyde 3-phosphate = dihydroxyacetone phosphate; Xref=Rhea:RHEA:18585, ChEBI:CHEBI:57642, ChEBI:CHEBI:59776; EC=5.3.1.1; Evidence={ECO:0000269|PubMed:18562316}; CATALYTIC ACTIVITY: Reaction=dihydroxyacetone phosphate = methylglyoxal + phosphate; Xref=Rhea:RHEA:17937, ChEBI:CHEBI:17158, ChEBI:CHEBI:43474, ChEBI:CHEBI:57642; EC=4.2.3.3; Evidence={ECO:0000250|UniProtKB:P00939};",4.2.3.3; 5.3.1.1,,PATHWAY: Carbohydrate degradation; glycolysis; D-glyceraldehyde 3-phosphate from glycerone phosphate: step 1/1. {ECO:0000255|PROSITE-ProRule:PRU10127}.; PATHWAY: Carbohydrate biosynthesis; gluconeogenesis. {ECO:0000255|PROSITE-ProRule:PRU10127}.,ENST00000229270.8 [P60174-3];ENST00000396705.10 [P60174-1];ENST00000488464.6 [P60174-4];ENST00000535434.5 [P60174-4];ENST00000613953.4 [P60174-3];,TPI1,ENSG00000111669,0.0,TPI1,Non-canonical_RBPs,15.0,,,,,,TPI1
P60411,ENSG00000221837,KR109_HUMAN,,cytosol [GO:0005829]; keratin filament [GO:0045095],,,,,,,,"cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,KRTAP10-9 KAP10.9 KAP18-9 KRTAP10.9 KRTAP18-9 KRTAP18.9,Keratin-associated protein 10-9 (High sulfur keratin-associated protein 10.9) (Keratin-associated protein 10.9) (Keratin-associated protein 18-9) (Keratin-associated protein 18.9),Homo sapiens (Human),292.0,30037.0,MAASTMSIRSSAYSDSWQVDDCPESCCEPPCCATSCCAPAPCLTLVCTPVSRVSSPCCQVTCEPSPCQSGCTSSCTPSCCQQSSCQPAYCTSSPCQQACCVPVCCKPVCCVPVCCGASSCCQQSSYQPACCASSSCQPACCVPVCCKPVCCAPTCSEDSYSCCQQSSCQPACCTSSPCQQSYCVPVCCKPVCCKPICCVPVCSGASSLCCQQSGCQPACCTTSCCRPSSSVSLLCRPVCRPACCVPVSSCCAPTSSRQPSYCRQASCVSLLCRPVCSRPACYSFSSGQKSSC,False,False,True,P60411,"[('IPR002494', 'Keratin-associated protein'), ('PF13885', 'Keratin, high sulfur B2 protein'), ('PTHR23262', 'Keratin-associated')]",,"""ENSG00000221837; Tissue enriched (skin)."";",,,,,ENST00000397911.5 [P60411-1];,KRTAP10-9,ENSG00000221837,0.0,,,,,,,1.0,,KRTAP10-9
P60520,ENSG00000034713,GBRL2_HUMAN,autophagosome assembly [GO:0000045]; autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; autophagy of mitochondrion [GO:0000422]; cellular response to nitrogen starvation [GO:0006995]; intra-Golgi vesicle-mediated transport [GO:0006891]; negative regulation of proteasomal protein catabolic process [GO:1901799]; positive regulation of ATP-dependent activity [GO:0032781]; protein localization to endoplasmic reticulum [GO:0070972]; protein transport [GO:0015031],autophagosome [GO:0005776]; autophagosome membrane [GO:0000421]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endoplasmic reticulum membrane [GO:0005789]; Golgi apparatus [GO:0005794]; Golgi membrane [GO:0000139],ATPase binding [GO:0051117]; beta-tubulin binding [GO:0048487]; GABA receptor binding [GO:0050811]; microtubule binding [GO:0008017]; phosphatidylethanolamine binding [GO:0008429]; SNARE binding [GO:0000149]; ubiquitin protein ligase binding [GO:0031625],"PTM: The precursor molecule is cleaved by ATG4 (ATG4A, ATG4B, ATG4C or ATG4D) to expose the glycine at the C-terminus and form the cytosolic form, GABARAPL2-I (PubMed:15169837, PubMed:20818167, PubMed:30661429, PubMed:31709703). The processed form is then activated by APG7L/ATG7, transferred to ATG3 and conjugated to phosphatidylethanolamine (PE) phospholipid to form the membrane-bound form, GABARAPL2-II (PubMed:15169837, PubMed:31709703). During non-canonical autophagy, the processed form is conjugated to phosphatidylserine (PS) phospholipid (PubMed:33909989). ATG4 proteins also mediate the delipidation of PE-conjugated forms required for GABARAPL2 recycling when autophagosomes fuse with lysosomes (PubMed:29458288, PubMed:31709703, PubMed:33909989). In addition, ATG4B and ATG4D mediate delipidation of ATG8 proteins conjugated to PS during non-canonical autophagy (PubMed:33909989). ATG4B constitutes the major protein for proteolytic activation (PubMed:30661429). ATG4D is the main enzyme for delipidation activity (By similarity). {ECO:0000250|UniProtKB:P60521, ECO:0000269|PubMed:15169837, ECO:0000269|PubMed:20818167, ECO:0000269|PubMed:29458288, ECO:0000269|PubMed:30661429, ECO:0000269|PubMed:31709703, ECO:0000269|PubMed:33909989}.; PTM: (Microbial infection) The Legionella effector RavZ is a deconjugating enzyme that hydrolyzes the amide bond between the C-terminal glycine residue and an adjacent aromatic residue in ATG8 proteins conjugated to phosphatidylethanolamine (PE), producing an ATG8 protein that is resistant to reconjugation by the host machinery due to the cleavage of the reactive C-terminal glycine (PubMed:31722778). RavZ is also able to mediate delipidation of ATG8 proteins conjugated to phosphatidylserine (PS) (PubMed:33909989). {ECO:0000269|PubMed:31722778, ECO:0000269|PubMed:33909989}.; PTM: Phosphorylation at Ser-87 and Ser-88 by TBK1 prevents interaction with ATG4 (ATG4A, ATG4B, ATG4C or ATG4D) (PubMed:31709703). Phosphorylation by TBK1 on autophagosomes prevents their delipidation by ATG4 and premature removal from nascent autophagosomes (PubMed:31709703). {ECO:0000269|PubMed:31709703}.",,,"STRAND 28..35; /evidence=""ECO:0007829|PDB:7YO8""; STRAND 39..41; /evidence=""ECO:0007829|PDB:6H8C""; STRAND 48..52; /evidence=""ECO:0007829|PDB:7YO8""; STRAND 77..80; /evidence=""ECO:0007829|PDB:7YO8""; STRAND 105..110; /evidence=""ECO:0007829|PDB:7YO8""","HELIX 5..8; /evidence=""ECO:0007829|PDB:7YO8""; HELIX 11..24; /evidence=""ECO:0007829|PDB:7YO8""; HELIX 57..68; /evidence=""ECO:0007829|PDB:7YO8""; HELIX 91..98; /evidence=""ECO:0007829|PDB:7YO8""",,"cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,GABARAPL2 FLC3A GEF2,Gamma-aminobutyric acid receptor-associated protein-like 2 (GABA(A) receptor-associated protein-like 2) (Ganglioside expression factor 2) (GEF-2) (General protein transport factor p16) (Golgi-associated ATPase enhancer of 16 kDa) (GATE-16) (MAP1 light chain 3-related protein),Homo sapiens (Human),117.0,13667.0,MKWMFKEDHSLEHRCVESAKIRAKYPDRVPVIVEKVSGSQIVDIDKRKYLVPSDITVAQFMWIIRKRIQLPSEKAIFLFVDKTVPQSSLTMGQLYEKEKDEDGFLYVAYSGENTFGF,False,False,True,P60520,"[('cd17163', 'ubiquitin-like (Ubl) domain found in GABA type A receptor associated protein like 2 (GABARAPL2, also known as GATE16)'), ('G3DSA:3.10.20.90', 'Phosphatidylinositol 3-kinase Catalytic Subunit; Chain A, domain 1'), ('IPR004241', 'Autophagy protein Atg8 ubiquitin-like'), ('IPR029071', 'Ubiquitin-like domain superfamily'), ('PF02991', 'Autophagy protein Atg8 ubiquitin like'), ('PTHR10969', 'MICROTUBULE-ASSOCIATED PROTEINS 1A/1B LIGHT CHAIN 3-RELATED'), ('SSF54236', 'Ubiquitin-like')]",P60520;,"""ENSG00000034713; Low tissue specificity."";",,,,,ENST00000037243.7;,GABARAPL2,ENSG00000034713,0.0,,,,,,,,,GABARAPL2
P60709,ENSG00000075624,ACTB_HUMAN,adherens junction assembly [GO:0034333]; apical protein localization [GO:0045176]; axonogenesis [GO:0007409]; cell motility [GO:0048870]; cellular response to cytochalasin B [GO:0072749]; chromatin remodeling [GO:0006338]; establishment or maintenance of cell polarity [GO:0007163]; maintenance of blood-brain barrier [GO:0035633]; morphogenesis of a polarized epithelium [GO:0001738]; negative regulation of cell differentiation [GO:0045596]; negative regulation of protein binding [GO:0032091]; platelet aggregation [GO:0070527]; positive regulation of cell differentiation [GO:0045597]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of double-strand break repair via homologous recombination [GO:1905168]; positive regulation of myoblast differentiation [GO:0045663]; positive regulation of norepinephrine uptake [GO:0051623]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of T cell differentiation [GO:0045582]; protein localization to adherens junction [GO:0071896]; regulation of apoptotic process [GO:0042981]; regulation of cell cycle [GO:0051726]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of double-strand break repair [GO:2000779]; regulation of G0 to G1 transition [GO:0070316]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of mitotic metaphase/anaphase transition [GO:0030071]; regulation of norepinephrine uptake [GO:0051621]; regulation of nucleotide-excision repair [GO:2000819]; regulation of protein localization to plasma membrane [GO:1903076]; regulation of synaptic vesicle endocytosis [GO:1900242]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transepithelial transport [GO:0150111]; regulation of transmembrane transporter activity [GO:0022898]; substantia nigra development [GO:0021762],actin cytoskeleton [GO:0015629]; actin filament [GO:0005884]; adherens junction [GO:0005912]; apical junction complex [GO:0043296]; axon [GO:0030424]; bBAF complex [GO:0140092]; blood microparticle [GO:0072562]; brahma complex [GO:0035060]; brush border [GO:0005903]; calyx of Held [GO:0044305]; cell-cell junction [GO:0005911]; chromatin [GO:0000785]; cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dense body [GO:0097433]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; GBAF complex [GO:0140288]; glutamatergic synapse [GO:0098978]; kinetochore [GO:0000776]; lamellipodium [GO:0030027]; membrane [GO:0016020]; nBAF complex [GO:0071565]; npBAF complex [GO:0071564]; NuA4 histone acetyltransferase complex [GO:0035267]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic actin cytoskeleton [GO:0098871]; presynapse [GO:0098793]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]; RSC-type complex [GO:0016586]; Schaffer collateral - CA1 synapse [GO:0098685]; SWI/SNF complex [GO:0016514]; synapse [GO:0045202]; tight junction [GO:0070160]; vesicle [GO:0031982],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; identical protein binding [GO:0042802]; kinesin binding [GO:0019894]; nitric-oxide synthase binding [GO:0050998]; protein kinase binding [GO:0019901]; structural constituent of cytoskeleton [GO:0005200]; structural constituent of postsynaptic actin cytoskeleton [GO:0098973]; Tat protein binding [GO:0030957]; tau protein binding [GO:0048156],"PTM: ISGylated. {ECO:0000269|PubMed:16139798}.; PTM: Oxidation of Met-44 and Met-47 by MICALs (MICAL1, MICAL2 or MICAL3) to form methionine sulfoxide promotes actin filament depolymerization. MICAL1 and MICAL2 produce the (R)-S-oxide form. The (R)-S-oxide form is reverted by MSRB1 and MSRB2, which promote actin repolymerization. {ECO:0000269|PubMed:29343822}.; PTM: Monomethylation at Lys-84 (K84me1) regulates actin-myosin interaction and actomyosin-dependent processes (PubMed:23673617). Demethylation by ALKBH4 is required for maintaining actomyosin dynamics supporting normal cleavage furrow ingression during cytokinesis and cell migration (PubMed:23673617). {ECO:0000269|PubMed:23673617}.; PTM: Methylated at His-73 by SETD3 (PubMed:30526847, PubMed:30626964, PubMed:30785395, PubMed:31388018). Methylation at His-73 is required for smooth muscle contraction of the laboring uterus during delivery (By similarity). {ECO:0000250|UniProtKB:P60710, ECO:0000269|PubMed:30526847, ECO:0000269|PubMed:30626964, ECO:0000269|PubMed:30785395, ECO:0000269|PubMed:31388018}.; PTM: [Actin, cytoplasmic 1]: N-terminal cleavage of acetylated methionine of immature cytoplasmic actin by ACTMAP. {ECO:0000269|PubMed:36173861}.; PTM: [Actin, cytoplasmic 1, N-terminally processed]: N-terminal acetylation by NAA80 affects actin filament depolymerization and elongation, including elongation driven by formins (PubMed:29581253). In contrast, filament nucleation by the Arp2/3 complex is not affected (PubMed:29581253). {ECO:0000269|PubMed:29581253}.; PTM: (Microbial infection) Monomeric actin is cross-linked by V.cholerae toxins RtxA and VgrG1 in case of infection: bacterial toxins mediate the cross-link between Lys-50 of one monomer and Glu-270 of another actin monomer, resulting in formation of highly toxic actin oligomers that cause cell rounding (PubMed:19015515). The toxin can be highly efficient at very low concentrations by acting on formin homology family proteins: toxic actin oligomers bind with high affinity to formins and adversely affect both nucleation and elongation abilities of formins, causing their potent inhibition in both profilin-dependent and independent manners (PubMed:26228148). {ECO:0000305|PubMed:19015515, ECO:0000305|PubMed:26228148}.",,,"STRAND 8..12; /evidence=""ECO:0007829|PDB:8OI8""; STRAND 14..21; /evidence=""ECO:0007829|PDB:8OI8""; STRAND 24..26; /evidence=""ECO:0007829|PDB:8COG""; STRAND 28..32; /evidence=""ECO:0007829|PDB:8OI8""; STRAND 35..38; /evidence=""ECO:0007829|PDB:8OI8""; STRAND 40..42; /evidence=""ECO:0007829|PDB:8OI8""; STRAND 44..47; /evidence=""ECO:0007829|PDB:8DNH""; STRAND 51..54; /evidence=""ECO:0007829|PDB:8RU2""; STRAND 68..70; /evidence=""ECO:0007829|PDB:6MBK""; STRAND 75..77; /evidence=""ECO:0007829|PDB:8OI8""; STRAND 103..107; /evidence=""ECO:0007829|PDB:8OI8""; STRAND 130..136; /evidence=""ECO:0007829|PDB:8OI8""; STRAND 148..155; /evidence=""ECO:0007829|PDB:8OI8""; STRAND 160..166; /evidence=""ECO:0007829|PDB:8OI8""; STRAND 176..179; /evidence=""ECO:0007829|PDB:8OI8""; STRAND 234..236; /evidence=""ECO:0007829|PDB:8COG""; STRAND 238..241; /evidence=""ECO:0007829|PDB:8OI8""; STRAND 243..246; /evidence=""ECO:0007829|PDB:7VDV""; STRAND 247..251; /evidence=""ECO:0007829|PDB:8OI8""; STRAND 297..301; /evidence=""ECO:0007829|PDB:8OI8""; STRAND 323..325; /evidence=""ECO:0007829|PDB:8DNH""; STRAND 356..358; /evidence=""ECO:0007829|PDB:8COG""","HELIX 56..60; /evidence=""ECO:0007829|PDB:8OI8""; HELIX 62..64; /evidence=""ECO:0007829|PDB:8OI8""; HELIX 113..125; /evidence=""ECO:0007829|PDB:8OI8""; HELIX 137..144; /evidence=""ECO:0007829|PDB:8OI8""; HELIX 172..174; /evidence=""ECO:0007829|PDB:8OI8""; HELIX 182..193; /evidence=""ECO:0007829|PDB:8OI8""; HELIX 194..196; /evidence=""ECO:0007829|PDB:8OI8""; HELIX 203..216; /evidence=""ECO:0007829|PDB:8OI8""; HELIX 223..230; /evidence=""ECO:0007829|PDB:8OI8""; HELIX 253..259; /evidence=""ECO:0007829|PDB:8OI8""; HELIX 264..267; /evidence=""ECO:0007829|PDB:8OI8""; HELIX 274..283; /evidence=""ECO:0007829|PDB:8OI8""; HELIX 287..289; /evidence=""ECO:0007829|PDB:8OI8""; HELIX 290..294; /evidence=""ECO:0007829|PDB:8OI8""; HELIX 302..304; /evidence=""ECO:0007829|PDB:8OI8""; HELIX 309..320; /evidence=""ECO:0007829|PDB:8OI8""; HELIX 335..337; /evidence=""ECO:0007829|PDB:8OI8""; HELIX 338..346; /evidence=""ECO:0007829|PDB:8OI8""; HELIX 350..352; /evidence=""ECO:0007829|PDB:8OI8""; HELIX 359..365; /evidence=""ECO:0007829|PDB:8OI8""; HELIX 366..370; /evidence=""ECO:0007829|PDB:8OI8""","TURN 3..5; /evidence=""ECO:0007829|PDB:8DNH""; TURN 81..83; /evidence=""ECO:0007829|PDB:6OX3""; TURN 92..94; /evidence=""ECO:0007829|PDB:8OI8""; TURN 98..100; /evidence=""ECO:0007829|PDB:8OID""; TURN 231..233; /evidence=""ECO:0007829|PDB:7VDV""; TURN 260..262; /evidence=""ECO:0007829|PDB:8OI8""; TURN 353..355; /evidence=""ECO:0007829|PDB:8OI8""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,ACTB,"Actin, cytoplasmic 1 (EC 3.6.4.-) (Beta-actin) [Cleaved into: Actin, cytoplasmic 1, N-terminally processed]",Homo sapiens (Human),375.0,41737.0,MDDDIAALVVDNGSGMCKAGFAGDDAPRAVFPSIVGRPRHQGVMVGMGQKDSYVGDEAQSKRGILTLKYPIEHGIVTNWDDMEKIWHHTFYNELRVAPEEHPVLLTEAPLNPKANREKMTQIMFETFNTPAMYVAIQAVLSLYASGRTTGIVMDSGDGVTHTVPIYEGYALPHAILRLDLAGRDLTDYLMKILTERGYSFTTTAEREIVRDIKEKLCYVALDFEQEMATAASSSSLEKSYELPDGQVITIGNERFRCPEALFQPSFLGMESCGIHETTFNSIMKCDVDIRKDLYANTVLSGGTTMYPGIADRMQKEITALAPSTMKIKIIAPPERKYSVWIGGSILASLSTFQQMWISKQEYDESGPSIVHRKCF,True,False,False,P60709,"[('cd00012', 'Nucleotide-Binding Domain of the sugar kinase/HSP70/actin superfamily'), ('G3DSA:3.30.420.40', None), ('G3DSA:3.90.640.10', 'Actin; Chain A, domain 4'), ('IPR004000', 'Actin family'), ('IPR004001', 'Actin, conserved site'), ('IPR020902', 'Actin/actin-like conserved site'), ('IPR043129', 'ATPase, nucleotide binding domain'), ('PF00022', 'Actin'), ('PR00190', 'ACTIN'), ('PS00406', 'Actins signature 1'), ('PS00432', 'Actins signature 2'), ('PS01132', 'Actins and actin-related proteins signature'), ('PTHR11937', 'ACTIN'), ('SM00268', 'Actin'), ('SSF53067', 'Actin-like ATPase domain')]",,"""ENSG00000075624; Low tissue specificity."";","CATALYTIC ACTIVITY: Reaction=ATP + H2O = ADP + phosphate + H(+); Xref=Rhea:RHEA:13065, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616, ChEBI:CHEBI:43474, ChEBI:CHEBI:456216; Evidence={ECO:0000269|PubMed:25255767};",3.6.4.-,,,ENST00000493945.6;ENST00000642480.2;ENST00000646664.1;ENST00000674681.1;ENST00000675515.1;,ACTB,ENSG00000075624,0.0,ACTB,Non-canonical_RBPs,1.0,12.27,DP03957,0.123,,,ACTB
P60953,ENSG00000070831,CDC42_HUMAN,"actin cytoskeleton organization [GO:0030036]; actin filament branching [GO:0090135]; actin filament organization [GO:0007015]; adherens junction organization [GO:0034332]; cardiac conduction system development [GO:0003161]; cardiac neural crest cell migration involved in outflow tract morphogenesis [GO:0003253]; Cdc42 protein signal transduction [GO:0032488]; cell junction assembly [GO:0034329]; cellular response to type II interferon [GO:0071346]; dendritic cell migration [GO:0036336]; dendritic spine morphogenesis [GO:0060997]; embryonic heart tube development [GO:0035050]; endocytosis [GO:0006897]; endothelin receptor signaling pathway involved in heart process [GO:0086101]; establishment of epithelial cell apical/basal polarity [GO:0045198]; establishment of Golgi localization [GO:0051683]; establishment or maintenance of cell polarity [GO:0007163]; filopodium assembly [GO:0046847]; Golgi organization [GO:0007030]; heart contraction [GO:0060047]; integrin-mediated signaling pathway [GO:0007229]; macrophage differentiation [GO:0030225]; modulation by host of viral process [GO:0044788]; negative regulation of protein-containing complex assembly [GO:0031333]; neuron fate determination [GO:0048664]; neuropilin signaling pathway [GO:0038189]; nuclear migration [GO:0007097]; organelle transport along microtubule [GO:0072384]; phagocytosis, engulfment [GO:0006911]; positive regulation of cell growth [GO:0030307]; positive regulation of cell migration [GO:0030335]; positive regulation of cytokinesis [GO:0032467]; positive regulation of DNA replication [GO:0045740]; positive regulation of epithelial cell proliferation involved in lung morphogenesis [GO:0060501]; positive regulation of filopodium assembly [GO:0051491]; positive regulation of intracellular protein transport [GO:0090316]; positive regulation of JNK cascade [GO:0046330]; positive regulation of lamellipodium assembly [GO:0010592]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of pinocytosis [GO:0048549]; positive regulation of pseudopodium assembly [GO:0031274]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of substrate adhesion-dependent cell spreading [GO:1900026]; positive regulation of synapse structural plasticity [GO:0051835]; protein localization [GO:0008104]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of attachment of spindle microtubules to kinetochore [GO:0051988]; regulation of filopodium assembly [GO:0051489]; regulation of lamellipodium assembly [GO:0010591]; regulation of mitotic nuclear division [GO:0007088]; regulation of modification of postsynaptic structure [GO:0099159]; regulation of postsynapse organization [GO:0099175]; regulation of stress fiber assembly [GO:0051492]; sprouting angiogenesis [GO:0002040]; submandibular salivary gland formation [GO:0060661]; substantia nigra development [GO:0021762]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]",apical part of cell [GO:0045177]; cell-cell junction [GO:0005911]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; endoplasmic reticulum membrane [GO:0005789]; extracellular exosome [GO:0070062]; filopodium [GO:0030175]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; Golgi membrane [GO:0000139]; Golgi transport complex [GO:0017119]; leading edge membrane [GO:0031256]; membrane [GO:0016020]; midbody [GO:0030496]; mitotic spindle [GO:0072686]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; phagocytic vesicle [GO:0045335]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; Schaffer collateral - CA1 synapse [GO:0098685]; secretory granule [GO:0030141]; spindle midzone [GO:0051233]; storage vacuole [GO:0000322],apolipoprotein A-I receptor binding [GO:0034191]; G protein activity [GO:0003925]; GBD domain binding [GO:0032427]; GTP binding [GO:0005525]; GTP-dependent protein binding [GO:0030742]; GTPase activity [GO:0003924]; identical protein binding [GO:0042802]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; protein kinase binding [GO:0019901]; thioesterase binding [GO:0031996]; ubiquitin protein ligase activity [GO:0061630],"PTM: (Microbial infection) AMPylation at Tyr-32 and Thr-35 are mediated by bacterial enzymes in case of infection by H.somnus and V.parahaemolyticus, respectively. AMPylation occurs in the effector region and leads to inactivation of the GTPase activity by preventing the interaction with downstream effectors, thereby inhibiting actin assembly in infected cells. It is unclear whether some human enzyme mediates AMPylation; FICD has such ability in vitro but additional experiments remain to be done to confirm results in vivo. {ECO:0000269|PubMed:19039103, ECO:0000269|PubMed:19362538, ECO:0000269|PubMed:20622875}.; PTM: Phosphorylated by SRC in an EGF-dependent manner, this stimulates the binding of the Rho-GDP dissociation inhibitor RhoGDI. {ECO:0000269|PubMed:14506284}.; PTM: (Microbial infection) Glycosylated at Tyr-32 by Photorhabdus asymbiotica toxin PAU_02230. Mono-O-GlcNAcylation by PAU_02230 inhibits downstream signaling by an impaired interaction with diverse regulator and effector proteins of CDC42 and leads to actin disassembly. {ECO:0000269|PubMed:24141704}.; PTM: (Microbial infection) Glucosylated at Thr-35 by C.difficile toxins TcdA and TcdB in the colonic epithelium (PubMed:24905543, PubMed:7775453, PubMed:7777059). Monoglucosylation completely prevents the recognition of the downstream effector, blocking the GTPases in their inactive form, leading to actin cytoskeleton disruption and cell death, resulting in the loss of colonic epithelial barrier function (PubMed:7775453, PubMed:7777059). {ECO:0000269|PubMed:24905543, ECO:0000269|PubMed:7775453, ECO:0000269|PubMed:7777059}.; PTM: (Microbial infection) Glycosylated (O-GlcNAcylated) at Thr-35 by C.novyi toxin TcdA (PubMed:8810274). O-GlcNAcylation completely prevents the recognition of the downstream effector, blocking the GTPases in their inactive form, leading to actin cytoskeleton disruption (PubMed:8810274). {ECO:0000269|PubMed:8810274}.",,,"STRAND 2..11; /evidence=""ECO:0007829|PDB:2NGR""; STRAND 36..46; /evidence=""ECO:0007829|PDB:2NGR""; STRAND 49..58; /evidence=""ECO:0007829|PDB:2NGR""; STRAND 72..74; /evidence=""ECO:0007829|PDB:3QBV""; STRAND 76..83; /evidence=""ECO:0007829|PDB:2NGR""; STRAND 105..107; /evidence=""ECO:0007829|PDB:2WMN""; STRAND 110..115; /evidence=""ECO:0007829|PDB:2NGR""; STRAND 154..156; /evidence=""ECO:0007829|PDB:2NGR""; STRAND 179..181; /evidence=""ECO:0007829|PDB:1NF3""","HELIX 12..14; /evidence=""ECO:0007829|PDB:6TKY""; HELIX 16..25; /evidence=""ECO:0007829|PDB:2NGR""; HELIX 29..31; /evidence=""ECO:0007829|PDB:3VHL""; HELIX 62..64; /evidence=""ECO:0007829|PDB:2NGR""; HELIX 68..71; /evidence=""ECO:0007829|PDB:2NGR""; HELIX 87..95; /evidence=""ECO:0007829|PDB:2NGR""; HELIX 97..104; /evidence=""ECO:0007829|PDB:2NGR""; HELIX 117..121; /evidence=""ECO:0007829|PDB:2NGR""; HELIX 123..130; /evidence=""ECO:0007829|PDB:2NGR""; HELIX 139..148; /evidence=""ECO:0007829|PDB:2NGR""; HELIX 165..176; /evidence=""ECO:0007829|PDB:2NGR""","TURN 65..67; /evidence=""ECO:0007829|PDB:2NGR""; TURN 131..133; /evidence=""ECO:0007829|PDB:2NGR""; TURN 159..161; /evidence=""ECO:0007829|PDB:2NGR""; TURN 162..164; /evidence=""ECO:0007829|PDB:2KB0""; TURN 184..186; /evidence=""ECO:0007829|PDB:1NF3""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,CDC42,Cell division control protein 42 homolog (EC 3.6.5.2) (G25K GTP-binding protein),Homo sapiens (Human),191.0,21259.0,MQTIKCVVVGDGAVGKTCLLISYTTNKFPSEYVPTVFDNYAVTVMIGGEPYTLGLFDTAGQEDYDRLRPLSYPQTDVFLVCFSVVSPSSFENVKEKWVPEITHHCPKTPFLLVGTQIDLRDDPSTIEKLAKNKQKPITPETAEKLARDLKAVKYVECSALTQKGLKNVFDEAILAALEPPEPKKSRRCVLL,False,False,True,P60953,"[('cd01874', 'cell division cycle 42 (Cdc42) is a small GTPase of the Rho family'), ('G3DSA:3.40.50.300', 'P-loop containing nucleotide triphosphate hydrolases'), ('IPR001806', 'Small GTPase'), ('IPR003578', 'Small GTPase Rho'), ('IPR005225', 'Small GTP-binding domain'), ('IPR027417', 'P-loop containing nucleoside triphosphate hydrolase'), ('IPR037874', 'Cdc42'), ('PF00071', 'Ras family'), ('PR00449', 'RASTRNSFRMNG'), ('PS51419', 'small GTPase Rab1 family profile'), ('PS51420', 'small GTPase Rho family profile'), ('PS51421', 'small GTPase Ras family profile'), ('PTHR24072', 'RHO FAMILY GTPASE'), ('SM00173', 'Ras subfamily of RAS small GTPases'), ('SM00174', 'Rho (Ras homology) subfamily of Ras-like small GTPases'), ('SM00175', 'Rab subfamily of small GTPases'), ('SSF52540', 'P-loop containing nucleoside triphosphate hydrolases'), ('TIGR00231', 'small GTP-binding protein domain')]",P60953;,"""ENSG00000070831; Low tissue specificity."";","CATALYTIC ACTIVITY: Reaction=GTP + H2O = GDP + phosphate + H(+); Xref=Rhea:RHEA:19669, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:37565, ChEBI:CHEBI:43474, ChEBI:CHEBI:58189; EC=3.6.5.2; Evidence={ECO:0000269|PubMed:21565175, ECO:0000269|PubMed:23940119}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:19670; Evidence={ECO:0000305|PubMed:21565175, ECO:0000305|PubMed:23940119};",3.6.5.2,"ACTIVITY REGULATION: Regulated by guanine nucleotide exchange factors (GEFs) which promote the exchange of bound GDP for free GTP, GTPase activating proteins (GAPs) which increase the GTP hydrolysis activity, and GDP dissociation inhibitors which inhibit the dissociation of the nucleotide from the GTPase. {ECO:0000269|PubMed:12172552}.",,ENST00000315554.15 [P60953-1];ENST00000344548.8 [P60953-2];ENST00000400259.5 [P60953-2];ENST00000411827.2 [P60953-2];ENST00000656825.1 [P60953-2];ENST00000662562.2 [P60953-2];ENST00000695796.1 [P60953-2];ENST00000695797.1 [P60953-2];ENST00000695798.1 [P60953-2];ENST00000695799.1 [P60953-2];ENST00000695800.1 [P60953-2];ENST00000695802.1 [P60953-2];ENST00000695857.1 [P60953-1];ENST00000695860.1 [P60953-1];,CDC42,ENSG00000070831,0.0,CDC42,Non-canonical_RBPs,5.0,,,0.073,0.063,,CDC42
P61077,ENSG00000109332,UB2D3_HUMAN,apoptotic process [GO:0006915]; DNA repair [GO:0006281]; negative regulation of BMP signaling pathway [GO:0030514]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of protein targeting to mitochondrion [GO:1903955]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein K11-linked ubiquitination [GO:0070979]; protein K48-linked ubiquitination [GO:0070936]; protein K6-linked ubiquitination [GO:0085020]; protein modification process [GO:0036211]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511],cytosol [GO:0005829]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ubiquitin ligase complex [GO:0000151],ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842],PTM: Phosphorylated by AURKB. {ECO:0000250|UniProtKB:P61079}.,,"DOMAIN 1..147; /note=""UBC core""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00388""","STRAND 19..21; /evidence=""ECO:0007829|PDB:2FUH""; STRAND 22..28; /evidence=""ECO:0007829|PDB:5EGG""; STRAND 32..38; /evidence=""ECO:0007829|PDB:5EGG""; STRAND 41..43; /evidence=""ECO:0007829|PDB:4S3O""; STRAND 49..55; /evidence=""ECO:0007829|PDB:5EGG""; STRAND 66..71; /evidence=""ECO:0007829|PDB:5EGG""; STRAND 76..78; /evidence=""ECO:0007829|PDB:8SMZ""; STRAND 80..84; /evidence=""ECO:0007829|PDB:4R8P""; STRAND 115..117; /evidence=""ECO:0007829|PDB:6CP0""","HELIX 1..15; /evidence=""ECO:0007829|PDB:5EGG""; HELIX 87..89; /evidence=""ECO:0007829|PDB:5EGG""; HELIX 99..111; /evidence=""ECO:0007829|PDB:5EGG""; HELIX 121..129; /evidence=""ECO:0007829|PDB:5EGG""; HELIX 131..145; /evidence=""ECO:0007829|PDB:5EGG""","TURN 44..47; /evidence=""ECO:0007829|PDB:5EGG""; TURN 58..61; /evidence=""ECO:0007829|PDB:5EGG""; TURN 90..92; /evidence=""ECO:0007829|PDB:5EGG""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,UBE2D3 UBC5C UBCH5C,Ubiquitin-conjugating enzyme E2 D3 (EC 2.3.2.23) ((E3-independent) E2 ubiquitin-conjugating enzyme D3) (EC 2.3.2.24) (E2 ubiquitin-conjugating enzyme D3) (Ubiquitin carrier protein D3) (Ubiquitin-conjugating enzyme E2(17)KB 3) (Ubiquitin-conjugating enzyme E2-17 kDa 3) (Ubiquitin-protein ligase D3),Homo sapiens (Human),147.0,16687.0,MALKRINKELSDLARDPPAQCSAGPVGDDMFHWQATIMGPNDSPYQGGVFFLTIHFPTDYPFKPPKVAFTTRIYHPNINSNGSICLDILRSQWSPALTISKVLLSICSLLCDPNPDDPLVPEIARIYKTDRDKYNRISREWTQKYAM,False,False,True,P61077,"[('cd00195', 'UBCc'), ('G3DSA:3.10.110.10', 'Ubiquitin Conjugating Enzyme'), ('IPR000608', 'Ubiquitin-conjugating enzyme E2'), ('IPR016135', 'Ubiquitin-conjugating enzyme/RWD-like'), ('IPR023313', 'Ubiquitin-conjugating enzyme, active site'), ('PF00179', 'Ubiquitin-conjugating enzyme'), ('PS00183', 'Ubiquitin-conjugating (UBC) active site signature'), ('PS50127', 'Ubiquitin-conjugating (UBC) core domain profile'), ('PTHR24068', 'Ubiquitin-conjugating enzyme'), ('SM00212', 'Ubiquitin-conjugating enzyme E2, catalytic domain homologues'), ('SSF54495', 'UBC-like')]",,"""ENSG00000109332; Low tissue specificity."";","CATALYTIC ACTIVITY: Reaction=S-ubiquitinyl-[E1 ubiquitin-activating enzyme]-L-cysteine + [E2 ubiquitin-conjugating enzyme]-L-cysteine = [E1 ubiquitin-activating enzyme]-L-cysteine + S-ubiquitinyl-[E2 ubiquitin-conjugating enzyme]-L-cysteine.; EC=2.3.2.23; Evidence={ECO:0000255|PROSITE-ProRule:PRU00388, ECO:0000255|PROSITE-ProRule:PRU10133, ECO:0000269|PubMed:20061386, ECO:0000269|PubMed:28685749}; CATALYTIC ACTIVITY: Reaction=S-ubiquitinyl-[E1 ubiquitin-activating enzyme]-L-cysteine + [acceptor protein]-L-lysine = [E1 ubiquitin-activating enzyme]-L-cysteine + N(6)-monoubiquitinyl-[acceptor protein]-L-lysine.; EC=2.3.2.24; Evidence={ECO:0000269|PubMed:17588522};",2.3.2.23; 2.3.2.24,,"PATHWAY: Protein modification; protein ubiquitination. {ECO:0000255|PROSITE-ProRule:PRU00388, ECO:0000269|PubMed:28685749}.",ENST00000321805.11 [P61077-1];ENST00000338145.7 [P61077-1];ENST00000343106.9 [P61077-2];ENST00000349311.12 [P61077-1];ENST00000357194.10 [P61077-3];ENST00000394801.8 [P61077-1];ENST00000394803.9 [P61077-1];ENST00000394804.6 [P61077-1];ENST00000453744.7 [P61077-1];,UBE2D3,ENSG00000109332,0.0,,,,,,,,,UBE2D3
P61086,ENSG00000078140,UBE2K_HUMAN,cellular response to interferon-beta [GO:0035458]; free ubiquitin chain polymerization [GO:0010994]; positive regulation of peptidyl-threonine phosphorylation [GO:0010800]; positive regulation of tumor necrosis factor-mediated signaling pathway [GO:1903265]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032434]; ubiquitin-dependent protein catabolic process [GO:0006511],cytoplasm [GO:0005737]; cytosol [GO:0005829]; filopodium tip [GO:0032433]; nucleus [GO:0005634],ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; ubiquitin-ubiquitin ligase activity [GO:0034450],PTM: Sumoylation at Lys-14 impairs catalytic activity. {ECO:0000250|UniProtKB:P61085}.,,"DOMAIN 4..154; /note=""UBC core""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00388""; DOMAIN 160..200; /note=""UBA""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00212""","STRAND 26..31; /evidence=""ECO:0007829|PDB:3K9O""; STRAND 33..35; /evidence=""ECO:0007829|PDB:2O25""; STRAND 36..44; /evidence=""ECO:0007829|PDB:3K9O""; STRAND 47..49; /evidence=""ECO:0007829|PDB:1YLA""; STRAND 55..61; /evidence=""ECO:0007829|PDB:3K9O""; STRAND 72..77; /evidence=""ECO:0007829|PDB:3K9O""","HELIX 6..17; /evidence=""ECO:0007829|PDB:3K9O""; HELIX 20..23; /evidence=""ECO:0007829|PDB:3K9O""; HELIX 94..96; /evidence=""ECO:0007829|PDB:3K9O""; HELIX 106..118; /evidence=""ECO:0007829|PDB:3K9O""; HELIX 128..136; /evidence=""ECO:0007829|PDB:3K9O""; HELIX 138..153; /evidence=""ECO:0007829|PDB:3K9O""; HELIX 160..170; /evidence=""ECO:0007829|PDB:3K9O""; HELIX 176..185; /evidence=""ECO:0007829|PDB:3K9O""; HELIX 190..199; /evidence=""ECO:0007829|PDB:3K9O""","TURN 50..53; /evidence=""ECO:0007829|PDB:3K9O""; TURN 64..68; /evidence=""ECO:0007829|PDB:3K9O""; TURN 86..88; /evidence=""ECO:0007829|PDB:3K9O""; TURN 97..99; /evidence=""ECO:0007829|PDB:3K9O""; TURN 171..173; /evidence=""ECO:0007829|PDB:3K9O""; TURN 186..188; /evidence=""ECO:0007829|PDB:3K9O""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,UBE2K HIP2 LIG,Ubiquitin-conjugating enzyme E2 K (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme K) (Huntingtin-interacting protein 2) (HIP-2) (Ubiquitin carrier protein) (Ubiquitin-conjugating enzyme E2-25 kDa) (Ubiquitin-conjugating enzyme E2(25K)) (Ubiquitin-conjugating enzyme E2-25K) (Ubiquitin-protein ligase),Homo sapiens (Human),200.0,22407.0,MANIAVQRIKREFKEVLKSEETSKNQIKVDLVDENFTELRGEIAGPPDTPYEGGRYQLEIKIPETYPFNPPKVRFITKIWHPNISSVTGAICLDILKDQWAAAMTLRTVLLSLQALLAAAEPDDPQDAVVANQYKQNPEMFKQTARLWAHVYAGAPVSSPEYTKKIENLCAMGFDRNAVIVALSSKSWDVETATELLLSN,False,False,True,P61086,"[('cd00195', 'UBCc'), ('cd14390', 'UBA domain of vertebrate ubiquitin-conjugating enzyme E2 K (UBE2K)'), ('G3DSA:1.10.8.10', 'DNA helicase RuvA subunit, C-terminal domain'), ('G3DSA:3.10.110.10', 'Ubiquitin Conjugating Enzyme'), ('IPR000608', 'Ubiquitin-conjugating enzyme E2'), ('IPR009060', 'UBA-like superfamily'), ('IPR015940', 'Ubiquitin-associated domain'), ('IPR016135', 'Ubiquitin-conjugating enzyme/RWD-like'), ('IPR023313', 'Ubiquitin-conjugating enzyme, active site'), ('IPR042599', 'Vertebrate ubiquitin-conjugating enzyme E2 K, UBA domain'), ('PF00179', 'Ubiquitin-conjugating enzyme'), ('PF00627', 'UBA/TS-N domain'), ('PS00183', 'Ubiquitin-conjugating (UBC) active site signature'), ('PS50030', 'Ubiquitin-associated domain (UBA) profile'), ('PS50127', 'Ubiquitin-conjugating (UBC) core domain profile'), ('PTHR24068', 'Ubiquitin-conjugating enzyme'), ('SM00165', 'Ubiquitin associated domain'), ('SM00212', 'Ubiquitin-conjugating enzyme E2, catalytic domain homologues'), ('SSF46934', 'UBA-like'), ('SSF54495', 'UBC-like')]",,"""ENSG00000078140; Low tissue specificity."";","CATALYTIC ACTIVITY: Reaction=S-ubiquitinyl-[E1 ubiquitin-activating enzyme]-L-cysteine + [E2 ubiquitin-conjugating enzyme]-L-cysteine = [E1 ubiquitin-activating enzyme]-L-cysteine + S-ubiquitinyl-[E2 ubiquitin-conjugating enzyme]-L-cysteine.; EC=2.3.2.23; Evidence={ECO:0000255|PROSITE-ProRule:PRU00388, ECO:0000255|PROSITE-ProRule:PRU10133, ECO:0000269|PubMed:20061386};",2.3.2.23,,PATHWAY: Protein modification; protein ubiquitination. {ECO:0000255|PROSITE-ProRule:PRU00388}.,ENST00000261427.10 [P61086-1];ENST00000445950.2 [P61086-3];ENST00000503368.5 [P61086-2];,UBE2K,ENSG00000078140,0.0,,,,,,,,,UBE2K
P61088,ENSG00000177889,UBE2N_HUMAN,antiviral innate immune response [GO:0140374]; DNA double-strand break processing [GO:0000729]; double-strand break repair via homologous recombination [GO:0000724]; negative regulation of TORC1 signaling [GO:1904262]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of DNA repair [GO:0045739]; positive regulation of double-strand break repair [GO:2000781]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein K63-linked ubiquitination [GO:1902523]; postreplication repair [GO:0006301]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K63-linked ubiquitination [GO:0070534]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of DNA repair [GO:0006282]; T cell receptor signaling pathway [GO:0050852],cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; UBC13-MMS2 complex [GO:0031372]; ubiquitin conjugating enzyme complex [GO:0031371]; ubiquitin ligase complex [GO:0000151],ATP binding [GO:0005524]; RNA binding [GO:0003723]; ubiquitin binding [GO:0043130]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activator activity [GO:0097027]; ubiquitin-protein transferase activity [GO:0004842],PTM: Conjugation to ISG15 impairs formation of the thioester bond with ubiquitin but not interaction with UBE2V2. {ECO:0000269|PubMed:16112642}.,,"DOMAIN 3..149; /note=""UBC core""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00388""","STRAND 23..27; /evidence=""ECO:0007829|PDB:4ONL""; STRAND 29..31; /evidence=""ECO:0007829|PDB:6KFP""; STRAND 34..40; /evidence=""ECO:0007829|PDB:4ONL""; STRAND 43..45; /evidence=""ECO:0007829|PDB:7BBF""; STRAND 51..57; /evidence=""ECO:0007829|PDB:4ONL""; STRAND 68..71; /evidence=""ECO:0007829|PDB:4ONL""; STRAND 78..80; /evidence=""ECO:0007829|PDB:5AIT""; STRAND 84..86; /evidence=""ECO:0007829|PDB:6LP2""; STRAND 121..123; /evidence=""ECO:0007829|PDB:4ONL""; STRAND 148..150; /evidence=""ECO:0007829|PDB:5YWR""","HELIX 6..17; /evidence=""ECO:0007829|PDB:4ONL""; HELIX 89..91; /evidence=""ECO:0007829|PDB:4ONL""; HELIX 101..113; /evidence=""ECO:0007829|PDB:4ONL""; HELIX 124..131; /evidence=""ECO:0007829|PDB:4ONL""; HELIX 133..147; /evidence=""ECO:0007829|PDB:4ONL""","TURN 46..49; /evidence=""ECO:0007829|PDB:4ONL""; TURN 60..64; /evidence=""ECO:0007829|PDB:4ONL""; TURN 92..94; /evidence=""ECO:0007829|PDB:4ONM""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,UBE2N BLU,Ubiquitin-conjugating enzyme E2 N (EC 2.3.2.23) (Bendless-like ubiquitin-conjugating enzyme) (E2 ubiquitin-conjugating enzyme N) (Ubc13) (UbcH13) (Ubiquitin carrier protein N) (Ubiquitin-protein ligase N),Homo sapiens (Human),152.0,17138.0,MAGLPRRIIKETQRLLAEPVPGIKAEPDESNARYFHVVIAGPQDSPFEGGTFKLELFLPEEYPMAAPKVRFMTKIYHPNVDKLGRICLDILKDKWSPALQIRTVLLSIQALLSAPNPDDPLANDVAEQWKTNEAQAIETARAWTRLYAMNNI,False,False,True,P61088,"[('cd00195', 'UBCc'), ('G3DSA:3.10.110.10', 'Ubiquitin Conjugating Enzyme'), ('IPR000608', 'Ubiquitin-conjugating enzyme E2'), ('IPR016135', 'Ubiquitin-conjugating enzyme/RWD-like'), ('IPR023313', 'Ubiquitin-conjugating enzyme, active site'), ('PF00179', 'Ubiquitin-conjugating enzyme'), ('PS00183', 'Ubiquitin-conjugating (UBC) active site signature'), ('PS50127', 'Ubiquitin-conjugating (UBC) core domain profile'), ('PTHR24068', 'Ubiquitin-conjugating enzyme'), ('SM00212', 'Ubiquitin-conjugating enzyme E2, catalytic domain homologues'), ('SSF54495', 'UBC-like')]",,"""ENSG00000177889; Low tissue specificity."";","CATALYTIC ACTIVITY: Reaction=S-ubiquitinyl-[E1 ubiquitin-activating enzyme]-L-cysteine + [E2 ubiquitin-conjugating enzyme]-L-cysteine = [E1 ubiquitin-activating enzyme]-L-cysteine + S-ubiquitinyl-[E2 ubiquitin-conjugating enzyme]-L-cysteine.; EC=2.3.2.23; Evidence={ECO:0000255|PROSITE-ProRule:PRU00388, ECO:0000255|PROSITE-ProRule:PRU10133, ECO:0000269|PubMed:20061386};",2.3.2.23,"ACTIVITY REGULATION: Activity is inhibited by binding to OTUB1, which prevents 'Lys-63'-linked polyubiquitination (PubMed:20725033, PubMed:22325355, PubMed:22367539). Activity is inhibited by GPS2, leading to prevent 'Lys-63'-linked polyubiquitination (By similarity). {ECO:0000250|UniProtKB:P61089, ECO:0000269|PubMed:20725033, ECO:0000269|PubMed:22325355, ECO:0000269|PubMed:22367539}.",PATHWAY: Protein modification; protein ubiquitination. {ECO:0000255|PROSITE-ProRule:PRU00388}.,ENST00000318066.7;,UBE2N,ENSG00000177889,0.0,UBE2N,Non-canonical_RBPs,8.0,,,,,,UBE2N
P61254,ENSG00000161970,RL26_HUMAN,"cellular response to gamma radiation [GO:0071480]; cellular response to UV [GO:0034644]; cytoplasmic translation [GO:0002181]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator [GO:1902164]; positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902167]; positive regulation of translation [GO:0045727]; regulation of translation involved in cellular response to UV [GO:1904803]; ribosomal large subunit biogenesis [GO:0042273]; rRNA processing [GO:0006364]; translation [GO:0006412]",cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; ribonucleoprotein complex [GO:1990904]; synapse [GO:0045202],mRNA 5'-UTR binding [GO:0048027]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735],"PTM: Ufmylated by UFL1 in response to endoplasmic reticulum stress, promoting reticulophagy of endoplasmic reticulum sheets. {ECO:0000269|PubMed:32160526}.",,,,,,"cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,RPL26,Large ribosomal subunit protein uL24 (60S ribosomal protein L26),Homo sapiens (Human),145.0,17258.0,MKFNPFVTSDRSKNRKRHFNAPSHIRRKIMSSPLSKELRQKYNVRSMPIRKDDEVQVVRGHYKGQQIGKVVQVYRKKYVIYIERVQREKANGTTVHVGIHPSKVVITRLKLDKDRKKILERKAKSRQVGKEKGKYKEETIEKMQE,True,True,False,P61254,"[('cd06089', 'KOW motif of Ribosomal Protein L26'), ('G3DSA:2.30.30.30', None), ('IPR005756', 'Large ribosomal subunit protein uL24, eukaryotic/archaeal'), ('IPR005824', 'KOW'), ('IPR005825', 'Large ribosomal subunit protein uL24, conserved site'), ('IPR008991', 'Translation protein SH3-like domain superfamily'), ('IPR014722', 'Large ribosomal subunit protein uL2, domain 2'), ('IPR041988', 'Large ribosomal subunit protein uL24, KOW domain'), ('MF_01326_A', 'Large ribosomal subunit protein uL24 [rplX]'), ('PF00467', 'KOW motif'), ('PF16906', 'Ribosomal proteins L26 eukaryotic, L24P archaeal'), ('PS01108', 'Ribosomal protein L24 signature'), ('PTHR11143', '60S RIBOSOMAL PROTEIN L26 FAMILY MEMBER'), ('SM00739', 'KOW (Kyprides, Ouzounis, Woese) motif.'), ('SSF50104', 'Translation proteins SH3-like domain'), ('TIGR01080', '50S ribosomal protein L24')]",,"""ENSG00000161970; Low tissue specificity."";",,,,,ENST00000582556.5;ENST00000583011.6;ENST00000584164.6;ENST00000648839.1;,RPL26,ENSG00000161970,0.0,RPL26,Canonical_RBPs,21.0,,,,0.186,0.31,RPL26
P61457,ENSG00000166228,PHS_HUMAN,tetrahydrobiopterin biosynthetic process [GO:0006729],cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654],4-alpha-hydroxytetrahydrobiopterin dehydratase activity [GO:0008124]; identical protein binding [GO:0042802]; phenylalanine 4-monooxygenase activity [GO:0004505]; transcription coactivator activity [GO:0003713],,,,,,,"cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,PCBD1 DCOH PCBD,Pterin-4-alpha-carbinolamine dehydratase (PHS) (EC 4.2.1.96) (4-alpha-hydroxy-tetrahydropterin dehydratase) (Dimerization cofactor of hepatocyte nuclear factor 1-alpha) (DCoH) (Dimerization cofactor of HNF1) (Phenylalanine hydroxylase-stimulating protein) (Pterin carbinolamine dehydratase) (PCD),Homo sapiens (Human),104.0,12000.0,MAGKAHRLSAEERDQLLPNLRAVGWNELEGRDAIFKQFHFKDFNRAFGFMTRVALQAEKLDHHPEWFNVYNKVHITLSTHECAGLSERDINLASFIEQVAVSMT,False,False,True,P61457,"[('cd00914', 'PCD_DCoH_subfamily_b'), ('G3DSA:3.30.1360.20', 'Transcriptional coactivator/pterin dehydratase'), ('IPR001533', 'Pterin 4 alpha carbinolamine dehydratase'), ('IPR036428', 'Pterin 4 alpha carbinolamine dehydratase superfamily'), ('MF_00434', 'Putative pterin-4-alpha-carbinolamine dehydratase'), ('PF01329', 'Pterin 4 alpha carbinolamine dehydratase'), ('PTHR12599', 'PTERIN-4-ALPHA-CARBINOLAMINE DEHYDRATASE'), ('SSF55248', 'PCD-like')]",,"""ENSG00000166228; Tissue enhanced (liver)."";","CATALYTIC ACTIVITY: Reaction=(4aS,6R)-4a-hydroxy-L-erythro-5,6,7,8-tetrahydrobiopterin = (6R)-L-erythro-6,7-dihydrobiopterin + H2O; Xref=Rhea:RHEA:11920, ChEBI:CHEBI:15377, ChEBI:CHEBI:15642, ChEBI:CHEBI:43120; EC=4.2.1.96; Evidence={ECO:0000250|UniProtKB:P61459};",4.2.1.96,,,ENST00000299299.4;,PCBD1,ENSG00000166228,0.0,,,,,,,,,PCBD1
P61604,ENSG00000115541,CH10_HUMAN,activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; chaperone cofactor-dependent protein refolding [GO:0051085]; osteoblast differentiation [GO:0001649]; protein folding [GO:0006457]; response to unfolded protein [GO:0006986],extracellular exosome [GO:0070062]; membrane [GO:0016020]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739],ATP binding [GO:0005524]; metal ion binding [GO:0046872]; protein folding chaperone [GO:0044183]; protein-folding chaperone binding [GO:0051087]; RNA binding [GO:0003723]; unfolded protein binding [GO:0051082],,,,"STRAND 9..11; /evidence=""ECO:0007829|PDB:8G7N""; STRAND 15..20; /evidence=""ECO:0007829|PDB:8G7N""; STRAND 28..30; /evidence=""ECO:0007829|PDB:8G7N""; STRAND 43..49; /evidence=""ECO:0007829|PDB:8G7N""; STRAND 53..59; /evidence=""ECO:0007829|PDB:8G7N""; STRAND 70..72; /evidence=""ECO:0007829|PDB:8G7N""; STRAND 79..83; /evidence=""ECO:0007829|PDB:8G7N""; STRAND 86..92; /evidence=""ECO:0007829|PDB:8G7N""; STRAND 98..100; /evidence=""ECO:0007829|PDB:8G7N""",,"TURN 35..37; /evidence=""ECO:0007829|PDB:8G7N""; TURN 93..95; /evidence=""ECO:0007829|PDB:8G7N""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,HSPE1,"10 kDa heat shock protein, mitochondrial (Hsp10) (10 kDa chaperonin) (Chaperonin 10) (CPN10) (Early-pregnancy factor) (EPF) (Heat shock protein family E member 1)",Homo sapiens (Human),102.0,10932.0,MAGQAFRKFLPLFDRVLVERSAAETVTKGGIMLPEKSQGKVLQATVVAVGSGSKGKGGEIQPVSVKVGDKVLLPEYGGTKVVLDDKDYFLFRDGDILGKYVD,True,False,False,P61604,"[('cd00320', 'cpn10'), ('G3DSA:2.30.33.40', 'GroES chaperonin'), ('IPR011032', 'GroES-like superfamily'), ('IPR018369', 'Chaperonin GroES, conserved site'), ('IPR020818', 'GroES chaperonin family'), ('IPR037124', 'GroES chaperonin superfamily'), ('MF_00580', 'Co-chaperonin GroES [groES]'), ('PF00166', 'Chaperonin 10 Kd subunit'), ('PR00297', 'CHAPERONIN10'), ('PS00681', 'Chaperonins cpn10 signature'), ('PTHR10772', '10 KDA HEAT SHOCK PROTEIN'), ('SM00883', 'Chaperonin 10 Kd subunit'), ('SSF50129', 'GroES-like')]",,"""ENSG00000115541; Low tissue specificity."";",,,,,ENST00000233893.10;,HSPE1,ENSG00000115541,0.0,HSPE1,Non-canonical_RBPs,5.0,,,,,,HSPE1
P61964,ENSG00000196363,WDR5_HUMAN,gluconeogenesis [GO:0006094]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of gluconeogenesis [GO:0045722]; regulation of cell cycle [GO:0051726]; regulation of cell division [GO:0051302]; regulation of DNA-templated transcription [GO:0006355]; regulation of embryonic development [GO:0045995]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of tubulin deacetylation [GO:0090043]; skeletal system development [GO:0001501]; transcription initiation-coupled chromatin remodeling [GO:0045815],ATAC complex [GO:0140672]; histone acetyltransferase complex [GO:0000123]; histone methyltransferase complex [GO:0035097]; mitotic spindle [GO:0072686]; MLL1 complex [GO:0071339]; MLL1/2 complex [GO:0044665]; MLL3/4 complex [GO:0044666]; NSL complex [GO:0044545]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Set1C/COMPASS complex [GO:0048188],histone binding [GO:0042393]; histone H3K4 methyltransferase activity [GO:0042800]; methylated histone binding [GO:0035064],,,,"STRAND 25..27; /evidence=""ECO:0007829|PDB:5EAP""; STRAND 31..33; /evidence=""ECO:0007829|PDB:8Q1N""; STRAND 36..41; /evidence=""ECO:0007829|PDB:6E1Z""; STRAND 48..53; /evidence=""ECO:0007829|PDB:6E1Z""; STRAND 57..64; /evidence=""ECO:0007829|PDB:6E1Z""; STRAND 67..73; /evidence=""ECO:0007829|PDB:6E1Z""; STRAND 79..84; /evidence=""ECO:0007829|PDB:6E1Z""; STRAND 90..95; /evidence=""ECO:0007829|PDB:6E1Z""; STRAND 99..106; /evidence=""ECO:0007829|PDB:6E1Z""; STRAND 109..115; /evidence=""ECO:0007829|PDB:6E1Z""; STRAND 121..126; /evidence=""ECO:0007829|PDB:6E1Z""; STRAND 132..137; /evidence=""ECO:0007829|PDB:6E1Z""; STRAND 141..148; /evidence=""ECO:0007829|PDB:6E1Z""; STRAND 153..157; /evidence=""ECO:0007829|PDB:6E1Z""; STRAND 163..167; /evidence=""ECO:0007829|PDB:6E1Z""; STRAND 174..179; /evidence=""ECO:0007829|PDB:6E1Z""; STRAND 183..190; /evidence=""ECO:0007829|PDB:6E1Z""; STRAND 193..199; /evidence=""ECO:0007829|PDB:6E1Z""; STRAND 205..211; /evidence=""ECO:0007829|PDB:6E1Z""; STRAND 213..215; /evidence=""ECO:0007829|PDB:6E1Z""; STRAND 217..222; /evidence=""ECO:0007829|PDB:6E1Z""; STRAND 226..233; /evidence=""ECO:0007829|PDB:6E1Z""; STRAND 237..242; /evidence=""ECO:0007829|PDB:6E1Z""; STRAND 247..252; /evidence=""ECO:0007829|PDB:6E1Z""; STRAND 258..260; /evidence=""ECO:0007829|PDB:6E1Z""; STRAND 264..267; /evidence=""ECO:0007829|PDB:6E1Z""; STRAND 269..271; /evidence=""ECO:0007829|PDB:6E1Z""; STRAND 273..276; /evidence=""ECO:0007829|PDB:6E1Z""; STRAND 279..281; /evidence=""ECO:0007829|PDB:2G9A""; STRAND 283..287; /evidence=""ECO:0007829|PDB:6E1Z""; STRAND 293..297; /evidence=""ECO:0007829|PDB:6E1Z""; STRAND 304..309; /evidence=""ECO:0007829|PDB:6E1Z""; STRAND 311..320; /evidence=""ECO:0007829|PDB:6E1Z""; STRAND 327..331; /evidence=""ECO:0007829|PDB:6E1Z""","HELIX 13..15; /evidence=""ECO:0007829|PDB:7BED""","TURN 74..76; /evidence=""ECO:0007829|PDB:6E1Z""; TURN 116..118; /evidence=""ECO:0007829|PDB:6E1Z""; TURN 158..160; /evidence=""ECO:0007829|PDB:6E1Z""; TURN 200..202; /evidence=""ECO:0007829|PDB:6E1Z""; TURN 234..236; /evidence=""ECO:0007829|PDB:6E1Z""; TURN 243..246; /evidence=""ECO:0007829|PDB:6E1Z""; TURN 288..290; /evidence=""ECO:0007829|PDB:6E1Z""; TURN 322..324; /evidence=""ECO:0007829|PDB:6E1Z""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,WDR5 BIG3,WD repeat-containing protein 5 (BMP2-induced 3-kb gene protein),Homo sapiens (Human),334.0,36588.0,MATEEKKPETEAARAQPTPSSSATQSKPTPVKPNYALKFTLAGHTKAVSSVKFSPNGEWLASSSADKLIKIWGAYDGKFEKTISGHKLGISDVAWSSDSNLLVSASDDKTLKIWDVSSGKCLKTLKGHSNYVFCCNFNPQSNLIVSGSFDESVRIWDVKTGKCLKTLPAHSDPVSAVHFNRDGSLIVSSSYDGLCRIWDTASGQCLKTLIDDDNPPVSFVKFSPNGKYILAATLDNTLKLWDYSKGKCLKTYTGHKNEKYCIFANFSVTGGKWIVSGSEDNLVYIWNLQTKEIVQKLQGHTDVVISTACHPTENIIASAALENDKTIKLWKSDC,False,True,False,P61964,"[('cd00200', 'WD40'), ('G3DSA:2.130.10.10', 'YVTN repeat-like/Quinoprotein amine dehydrogenase'), ('IPR001680', 'WD40 repeat'), ('IPR015943', 'WD40/YVTN repeat-like-containing domain superfamily'), ('IPR019775', 'WD40 repeat, conserved site'), ('IPR020472', 'G-protein beta WD-40 repeat'), ('IPR036322', 'WD40-repeat-containing domain superfamily'), ('PF00400', 'WD domain, G-beta repeat'), ('PIRSF002394', 'Guanine nucleotide-binding protein, beta subunit'), ('PR00320', 'GPROTEINBRPT'), ('PS00678', 'Trp-Asp (WD) repeats signature'), ('PS50082', 'Trp-Asp (WD) repeats profile'), ('PS50294', 'Trp-Asp (WD) repeats circular profile'), ('PTHR22847', 'WD repeat-containing protein'), ('SM00320', 'WD40 repeats'), ('SSF50978', 'WD40 repeat-like')]",P61964;,"""ENSG00000196363; Low tissue specificity."";",,,,,ENST00000358625.4;,WDR5,ENSG00000196363,0.0,WDR5,Canonical_RBPs,4.0,,,0.072,0.102,0.093,WDR5
P61978,ENSG00000165119,HNRPK_HUMAN,"mRNA splicing, via spliceosome [GO:0000398]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; positive regulation of low-density lipoprotein receptor activity [GO:1905599]; positive regulation of receptor-mediated endocytosis [GO:0048260]; positive regulation of transcription by RNA polymerase II [GO:0045944]; random inactivation of X chromosome [GO:0060816]; regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:1902165]; regulation of low-density lipoprotein particle clearance [GO:0010988]; regulation of mRNA splicing, via spliceosome [GO:0048024]; regulation of transcription by RNA polymerase II [GO:0006357]; regulatory ncRNA-mediated heterochromatin formation [GO:0031048]; RNA processing [GO:0006396]; signal transduction [GO:0007165]",catalytic step 2 spliceosome [GO:0071013]; cell projection [GO:0042995]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; podosome [GO:0002102]; ribonucleoprotein complex [GO:1990904],cadherin binding [GO:0045296]; DNA binding [GO:0003677]; identical protein binding [GO:0042802]; mRNA binding [GO:0003729]; protein domain specific binding [GO:0019904]; RNA binding [GO:0003723],"PTM: Arg-296 and Arg-299 are dimethylated, probably to asymmetric dimethylarginine.; PTM: Sumoylated by CBX4. Sumoylation is increased upon DNA damage, such as that produced by doxorubicin, etoposide, UV light and camptothecin, due to enhanced CBX4 phosphorylation by HIPK2 under these conditions. {ECO:0000269|PubMed:16564677, ECO:0000269|PubMed:22825850, ECO:0000269|PubMed:8107114}.; PTM: Ubiquitinated by MDM2. Doxorubicin treatment does not affect monoubiquitination, but slightly decreases HNRNPK poly-ubiquitination. {ECO:0000269|PubMed:16360036, ECO:0000269|PubMed:22825850}.; PTM: O-glycosylated (O-GlcNAcylated), in a cell cycle-dependent manner. {ECO:0000269|PubMed:22967762}.",,"DOMAIN 42..104; /note=""KH 1""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00117""; DOMAIN 144..209; /note=""KH 2""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00117""; DOMAIN 387..451; /note=""KH 3""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00117""","STRAND 377..380; /evidence=""ECO:0007829|PDB:1KHM""; STRAND 388..395; /evidence=""ECO:0007829|PDB:1ZZK""; STRAND 420..423; /evidence=""ECO:0007829|PDB:1ZZK""; STRAND 430..439; /evidence=""ECO:0007829|PDB:1ZZK""","HELIX 381..384; /evidence=""ECO:0007829|PDB:1KHM""; HELIX 399..402; /evidence=""ECO:0007829|PDB:1ZZK""; HELIX 405..407; /evidence=""ECO:0007829|PDB:1ZZK""; HELIX 408..417; /evidence=""ECO:0007829|PDB:1ZZK""; HELIX 441..459; /evidence=""ECO:0007829|PDB:1ZZK""","TURN 396..398; /evidence=""ECO:0007829|PDB:1ZZK""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,HNRNPK HNRPK,Heterogeneous nuclear ribonucleoprotein K (hnRNP K) (Transformation up-regulated nuclear protein) (TUNP),Homo sapiens (Human),463.0,50976.0,METEQPEETFPNTETNGEFGKRPAEDMEEEQAFKRSRNTDEMVELRILLQSKNAGAVIGKGGKNIKALRTDYNASVSVPDSSGPERILSISADIETIGEILKKIIPTLEEGLQLPSPTATSQLPLESDAVECLNYQHYKGSDFDCELRLLIHQSLAGGIIGVKGAKIKELRENTQTTIKLFQECCPHSTDRVVLIGGKPDRVVECIKIILDLISESPIKGRAQPYDPNFYDETYDYGGFTMMFDDRRGRPVGFPMRGRGGFDRMPPGRGGRPMPPSRRDYDDMSPRRGPPPPPPGRGGRGGSRARNLPLPPPPPPRGGDLMAYDRRGRPGDRYDGMVGFSADETWDSAIDTWSPSEWQMAYEPQGGSGYDYSYAGGRGSYGDLGGPIITTQVTIPKDLAGSIIGKGGQRIKQIRHESGASIKIDEPLEGSEDRIITITGTQDQIQNAQYLLQNSVKQYSGKFF,False,False,True,P61978,"[('cd22432', 'first type I K homology (KH) RNA-binding domain found in heterogeneous nuclear ribonucleoprotein K (hnRNP K) and similar proteins'), ('cd22433', 'second type I K homology (KH) RNA-binding domain found in heterogeneous nuclear ribonucleoprotein K (hnRNP K) and similar proteins'), ('cd22434', 'third type I K homology (KH) RNA-binding domain found in heterogeneous nuclear ribonucleoprotein K (hnRNP K) and similar proteins'), ('G3DSA:3.30.1370.10', 'K Homology domain, type 1'), ('IPR004087', 'K Homology domain'), ('IPR004088', 'K Homology domain, type 1'), ('IPR012987', 'ROK, N-terminal'), ('IPR036612', 'K Homology domain, type 1 superfamily'), ('PF00013', 'KH domain'), ('PF08067', 'ROKNT (NUC014) domain'), ('PS50084', 'Type-1 KH domain profile'), ('PTHR10288', 'KH domain-containing RNA-binding protein'), ('SM00322', 'K homology RNA-binding domain'), ('SSF54791', 'Eukaryotic type KH-domain (KH-domain type I)')]",,"""ENSG00000165119; Low tissue specificity."";",,,,,ENST00000351839.7 [P61978-1];ENST00000360384.9 [P61978-1];ENST00000376263.8 [P61978-2];ENST00000376281.8 [P61978-2];ENST00000457156.6 [P61978-3];ENST00000704004.1 [P61978-3];ENST00000704005.1 [P61978-2];ENST00000704006.1 [P61978-1];ENST00000704011.1 [P61978-2];ENST00000704051.1 [P61978-1];ENST00000704052.1 [P61978-1];ENST00000704053.1 [P61978-1];ENST00000704057.1 [P61978-2];ENST00000704058.1 [P61978-1];ENST00000704059.1 [P61978-2];,HNRNPK,ENSG00000165119,0.0,HNRNPK,Canonical_RBPs,25.0,,,,0.467,0.253,HNRNPK
P62081,ENSG00000171863,RS7_HUMAN,cytoplasmic translation [GO:0002181]; negative regulation of ubiquitin protein ligase activity [GO:1904667]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; neural crest cell differentiation [GO:0014033]; neural tube closure [GO:0001843]; positive regulation of gene expression [GO:0010628]; positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator [GO:1902255]; protein stabilization [GO:0050821]; ribosomal small subunit biogenesis [GO:0042274]; rRNA processing [GO:0006364]; translation [GO:0006412],centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; endoplasmic reticulum [GO:0005783]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; ribonucleoprotein complex [GO:1990904]; ribosome [GO:0005840]; small-subunit processome [GO:0032040]; synapse [GO:0045202],mRNA 3'-UTR binding [GO:0003730]; mRNA 5'-UTR binding [GO:0048027]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; ubiquitin ligase inhibitor activity [GO:1990948],"PTM: Phosphorylated by NEK6. {ECO:0000269|PubMed:20873783}.; PTM: Ubiquitinated. Deubiquitinated by DESI2, leading to its stabilization. {ECO:0000269|PubMed:28483520}.",,,"STRAND 13..15; /evidence=""ECO:0007829|PDB:7R4X""; STRAND 40..42; /evidence=""ECO:0007829|PDB:6ZXG""; STRAND 46..49; /evidence=""ECO:0007829|PDB:7R4X""; STRAND 57..64; /evidence=""ECO:0007829|PDB:7R4X""; STRAND 91..96; /evidence=""ECO:0007829|PDB:7R4X""; STRAND 139..146; /evidence=""ECO:0007829|PDB:7R4X""; STRAND 148..150; /evidence=""ECO:0007829|PDB:6ZVH""; STRAND 152..158; /evidence=""ECO:0007829|PDB:7R4X""; STRAND 184..188; /evidence=""ECO:0007829|PDB:7R4X""","HELIX 30..33; /evidence=""ECO:0007829|PDB:6ZLW""; HELIX 66..68; /evidence=""ECO:0007829|PDB:6ZXH""; HELIX 69..86; /evidence=""ECO:0007829|PDB:7R4X""; HELIX 106..108; /evidence=""ECO:0007829|PDB:8PPK""; HELIX 110..112; /evidence=""ECO:0007829|PDB:6ZOJ""; HELIX 118..120; /evidence=""ECO:0007829|PDB:7R4X""; HELIX 122..133; /evidence=""ECO:0007829|PDB:7R4X""; HELIX 160..162; /evidence=""ECO:0007829|PDB:7R4X""; HELIX 163..166; /evidence=""ECO:0007829|PDB:7R4X""; HELIX 167..169; /evidence=""ECO:0007829|PDB:7R4X""; HELIX 170..181; /evidence=""ECO:0007829|PDB:7R4X""","TURN 18..21; /evidence=""ECO:0007829|PDB:7R4X""; TURN 23..28; /evidence=""ECO:0007829|PDB:7R4X""; TURN 34..37; /evidence=""ECO:0007829|PDB:7R4X""; TURN 54..56; /evidence=""ECO:0007829|PDB:7R4X""; TURN 87..89; /evidence=""ECO:0007829|PDB:7R4X""; TURN 134..136; /evidence=""ECO:0007829|PDB:7R4X""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,RPS7,Small ribosomal subunit protein eS7 (40S ribosomal protein S7),Homo sapiens (Human),194.0,22127.0,MFSSSAKIVKPNGEKPDEFESGISQALLELEMNSDLKAQLRELNITAAKEIEVGGGRKAIIIFVPVPQLKSFQKIQVRLVRELEKKFSGKHVVFIAQRRILPKPTRKSRTKNKQKRPRSRTLTAVHDAILEDLVFPSEIVGKRIRVKLDGSRLIKVHLDKAQQNNVEHKVETFSGVYKKLTGKDVNFEFPEFQL,True,True,False,P62081,"[('IPR000554', 'Small ribosomal subunit protein eS7'), ('IPR047861', 'Small ribosomal subunit protein eS7, conserved site'), ('PF01251', 'Ribosomal protein S7e'), ('PS00948', 'Ribosomal protein S7e signature'), ('PTHR11278', '40S RIBOSOMAL PROTEIN S7')]",,"""ENSG00000171863; Low tissue specificity."";",,,,,ENST00000403564.5;ENST00000406376.1;ENST00000462576.5;ENST00000645674.2;ENST00000646909.1;,RPS7,ENSG00000171863,0.0,RPS7,Canonical_RBPs,29.0,,,,0.093,,RPS7
P62136,ENSG00000172531,PP1A_HUMAN,branching morphogenesis of an epithelial tube [GO:0048754]; cell division [GO:0051301]; circadian regulation of gene expression [GO:0032922]; dephosphorylation [GO:0016311]; entrainment of circadian clock by photoperiod [GO:0043153]; glycogen metabolic process [GO:0005977]; lung development [GO:0030324]; positive regulation of extrinsic apoptotic signaling pathway in absence of ligand [GO:2001241]; positive regulation of glycogen biosynthetic process [GO:0045725]; protein dephosphorylation [GO:0006470]; regulation of canonical Wnt signaling pathway [GO:0060828]; regulation of circadian rhythm [GO:0042752]; regulation of glycogen catabolic process [GO:0005981]; regulation of translational initiation in response to stress [GO:0043558]; response to lead ion [GO:0010288]; telomere maintenance in response to DNA damage [GO:0043247],adherens junction [GO:0005912]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; glycogen granule [GO:0042587]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; presynapse [GO:0098793]; PTW/PP1 phosphatase complex [GO:0072357],cadherin binding involved in cell-cell adhesion [GO:0098641]; iron ion binding [GO:0005506]; myosin phosphatase activity [GO:0017018]; phosphatase activity [GO:0016791]; phosphoprotein phosphatase activity [GO:0004721]; protein phosphatase 1 binding [GO:0008157]; protein serine/threonine phosphatase activity [GO:0004722]; ribonucleoprotein complex binding [GO:0043021]; transition metal ion binding [GO:0046914],PTM: Phosphorylated. Dephosphorylated at Thr-320 in the presence of ionizing radiation. {ECO:0000269|PubMed:16732323}.,,,"STRAND 51..55; /evidence=""ECO:0007829|PDB:6ZEG""; STRAND 57..62; /evidence=""ECO:0007829|PDB:6ZEG""; STRAND 87..89; /evidence=""ECO:0007829|PDB:6ZEG""; STRAND 94..98; /evidence=""ECO:0007829|PDB:6ZEG""; STRAND 118..120; /evidence=""ECO:0007829|PDB:6ZEG""; STRAND 162..165; /evidence=""ECO:0007829|PDB:6ZEG""; STRAND 169..171; /evidence=""ECO:0007829|PDB:6ZEG""; STRAND 197..199; /evidence=""ECO:0007829|PDB:6ZEG""; STRAND 214..218; /evidence=""ECO:0007829|PDB:6ZEG""; STRAND 222..227; /evidence=""ECO:0007829|PDB:6ZEG""; STRAND 242..246; /evidence=""ECO:0007829|PDB:6ZEG""; STRAND 248..251; /evidence=""ECO:0007829|PDB:8DWL""; STRAND 254..258; /evidence=""ECO:0007829|PDB:6ZEG""; STRAND 263..267; /evidence=""ECO:0007829|PDB:6ZEG""; STRAND 280..285; /evidence=""ECO:0007829|PDB:6ZEG""; STRAND 290..297; /evidence=""ECO:0007829|PDB:6ZEG""","HELIX 9..18; /evidence=""ECO:0007829|PDB:6ZEG""; HELIX 19..21; /evidence=""ECO:0007829|PDB:6ZEG""; HELIX 32..48; /evidence=""ECO:0007829|PDB:6ZEG""; HELIX 69..79; /evidence=""ECO:0007829|PDB:6ZEG""; HELIX 100..113; /evidence=""ECO:0007829|PDB:6ZEG""; HELIX 124..126; /evidence=""ECO:0007829|PDB:6ALZ""; HELIX 128..131; /evidence=""ECO:0007829|PDB:6ZEG""; HELIX 136..143; /evidence=""ECO:0007829|PDB:6ZEG""; HELIX 146..156; /evidence=""ECO:0007829|PDB:6ZEG""; HELIX 183..187; /evidence=""ECO:0007829|PDB:6ZEG""; HELIX 200..206; /evidence=""ECO:0007829|PDB:6ZEG""; HELIX 229..239; /evidence=""ECO:0007829|PDB:6ZEG""; HELIX 272..274; /evidence=""ECO:0007829|PDB:6ZEG""","TURN 115..117; /evidence=""ECO:0007829|PDB:6ZEG""; TURN 132..135; /evidence=""ECO:0007829|PDB:7QM2""; TURN 166..168; /evidence=""ECO:0007829|PDB:6ZEG""; TURN 259..262; /evidence=""ECO:0007829|PDB:6ZEG""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,PPP1CA PPP1A,Serine/threonine-protein phosphatase PP1-alpha catalytic subunit (PP-1A) (EC 3.1.3.16),Homo sapiens (Human),330.0,37512.0,MSDSEKLNLDSIIGRLLEVQGSRPGKNVQLTENEIRGLCLKSREIFLSQPILLELEAPLKICGDIHGQYYDLLRLFEYGGFPPESNYLFLGDYVDRGKQSLETICLLLAYKIKYPENFFLLRGNHECASINRIYGFYDECKRRYNIKLWKTFTDCFNCLPIAAIVDEKIFCCHGGLSPDLQSMEQIRRIMRPTDVPDQGLLCDLLWSDPDKDVQGWGENDRGVSFTFGAEVVAKFLHKHDLDLICRAHQVVEDGYEFFAKRQLVTLFSAPNYCGEFDNAGAMMSVDETLMCSFQILKPADKNKGKYGQFSGLNPGGRPITPPRNSAKAKK,False,False,True,P62136,"[('cd07414', 'PP1, PPKL (PP1 and kelch-like) enzymes, and related proteins, metallophosphatase domain'), ('G3DSA:3.60.21.10', None), ('IPR004843', 'Calcineurin-like phosphoesterase domain, ApaH type'), ('IPR006186', 'Serine/threonine-specific protein phosphatase/bis(5-nucleosyl)-tetraphosphatase'), ('IPR029052', 'Metallo-dependent phosphatase-like'), ('IPR031675', 'Serine-threonine protein phosphatase, N-terminal'), ('IPR050341', 'Serine/threonine-protein phosphatase PP1 catalytic subunit'), ('PF00149', 'Calcineurin-like phosphoesterase'), ('PF16891', 'Serine-threonine protein phosphatase N-terminal domain'), ('PR00114', 'STPHPHTASE'), ('PS00125', 'Serine/threonine specific protein phosphatases signature'), ('PTHR11668', 'Serine/threonine-protein phosphatase PP1 catalytic subunit'), ('SM00156', 'Protein phosphatase 2A homologues, catalytic domain.'), ('SSF56300', 'Metallo-dependent phosphatases')]",P62136;,"""ENSG00000172531; Low tissue specificity."";","CATALYTIC ACTIVITY: Reaction=O-phospho-L-seryl-[protein] + H2O = L-seryl-[protein] + phosphate; Xref=Rhea:RHEA:20629, Rhea:RHEA-COMP:9863, Rhea:RHEA-COMP:11604, ChEBI:CHEBI:15377, ChEBI:CHEBI:29999, ChEBI:CHEBI:43474, ChEBI:CHEBI:83421; EC=3.1.3.16; Evidence={ECO:0000269|PubMed:26083323, ECO:0000269|PubMed:28216226, ECO:0000269|PubMed:35768504, ECO:0000269|PubMed:35830882, ECO:0000269|PubMed:35831509, ECO:0000269|PubMed:36175670}; CATALYTIC ACTIVITY: Reaction=O-phospho-L-threonyl-[protein] + H2O = L-threonyl-[protein] + phosphate; Xref=Rhea:RHEA:47004, Rhea:RHEA-COMP:11060, Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15377, ChEBI:CHEBI:30013, ChEBI:CHEBI:43474, ChEBI:CHEBI:61977; EC=3.1.3.16; Evidence={ECO:0000269|PubMed:26083323};",3.1.3.16,"ACTIVITY REGULATION: The phosphatase activity of the PPP1R15A-PP1 complex toward EIF2S1 is specifically inhibited by Salubrinal, a drug that protects cells from endoplasmic reticulum stress. {ECO:0000269|PubMed:15705855}.",,ENST00000312989.11 [P62136-2];ENST00000358239.8 [P62136-3];ENST00000376745.9 [P62136-1];,PPP1CA,ENSG00000172531,0.0,PPP1CA,Non-canonical_RBPs,13.0,,,0.1,0.109,0.076,PPP1CA
P62256,ENSG00000186591,UBE2H_HUMAN,proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K11-linked ubiquitination [GO:0070979]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent protein catabolic process [GO:0006511],cytosol [GO:0005829]; nucleus [GO:0005634],ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842],PTM: Autoubiquitinated in vitro in the presence of NEDD4L. {ECO:0000269|PubMed:22496338}.,,"DOMAIN 1..150; /note=""UBC core""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00388""","STRAND 21..23; /evidence=""ECO:0007829|PDB:2Z5D""; STRAND 25..30; /evidence=""ECO:0007829|PDB:2Z5D""; STRAND 33..39; /evidence=""ECO:0007829|PDB:2Z5D""; STRAND 42..44; /evidence=""ECO:0007829|PDB:8PJN""; STRAND 50..56; /evidence=""ECO:0007829|PDB:2Z5D""; STRAND 67..72; /evidence=""ECO:0007829|PDB:2Z5D""","HELIX 6..20; /evidence=""ECO:0007829|PDB:2Z5D""; HELIX 88..94; /evidence=""ECO:0007829|PDB:2Z5D""; HELIX 103..106; /evidence=""ECO:0007829|PDB:2Z5D""; HELIX 108..114; /evidence=""ECO:0007829|PDB:2Z5D""; HELIX 124..132; /evidence=""ECO:0007829|PDB:2Z5D""; HELIX 134..148; /evidence=""ECO:0007829|PDB:2Z5D""; HELIX 151..154; /evidence=""ECO:0007829|PDB:2Z5D""","TURN 45..48; /evidence=""ECO:0007829|PDB:2Z5D""; TURN 59..63; /evidence=""ECO:0007829|PDB:2Z5D""; TURN 81..83; /evidence=""ECO:0007829|PDB:2Z5D""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,UBE2H,Ubiquitin-conjugating enzyme E2 H (EC 2.3.2.23) ((E3-independent) E2 ubiquitin-conjugating enzyme H) (EC 2.3.2.24) (E2 ubiquitin-conjugating enzyme H) (UbcH2) (Ubiquitin carrier protein H) (Ubiquitin-conjugating enzyme E2-20K) (Ubiquitin-protein ligase H),Homo sapiens (Human),183.0,20655.0,MSSPSPGKRRMDTDVVKLIESKHEVTILGGLNEFVVKFYGPQGTPYEGGVWKVRVDLPDKYPFKSPSIGFMNKIFHPNIDEASGTVCLDVINQTWTALYDLTNIFESFLPQLLAYPNPIDPLNGDAAAMYLHRPEEYKQKIKEYIQKYATEEALKEQEEGTGDSSSESSMSDFSEDEAQDMEL,False,False,True,P62256,"[('cd00195', 'UBCc'), ('G3DSA:3.10.110.10', 'Ubiquitin Conjugating Enzyme'), ('IPR000608', 'Ubiquitin-conjugating enzyme E2'), ('IPR016135', 'Ubiquitin-conjugating enzyme/RWD-like'), ('IPR023313', 'Ubiquitin-conjugating enzyme, active site'), ('PF00179', 'Ubiquitin-conjugating enzyme'), ('PS00183', 'Ubiquitin-conjugating (UBC) active site signature'), ('PS50127', 'Ubiquitin-conjugating (UBC) core domain profile'), ('PTHR24068', 'Ubiquitin-conjugating enzyme'), ('SM00212', 'Ubiquitin-conjugating enzyme E2, catalytic domain homologues'), ('SSF54495', 'UBC-like')]",,"""ENSG00000186591; Low tissue specificity."";","CATALYTIC ACTIVITY: Reaction=S-ubiquitinyl-[E1 ubiquitin-activating enzyme]-L-cysteine + [E2 ubiquitin-conjugating enzyme]-L-cysteine = [E1 ubiquitin-activating enzyme]-L-cysteine + S-ubiquitinyl-[E2 ubiquitin-conjugating enzyme]-L-cysteine.; EC=2.3.2.23; Evidence={ECO:0000255|PROSITE-ProRule:PRU00388, ECO:0000255|PROSITE-ProRule:PRU10133, ECO:0000269|PubMed:17588522, ECO:0000269|PubMed:20061386, ECO:0000269|PubMed:22496338, ECO:0000269|PubMed:29911972, ECO:0000269|PubMed:8132613}; CATALYTIC ACTIVITY: Reaction=S-ubiquitinyl-[E1 ubiquitin-activating enzyme]-L-cysteine + [acceptor protein]-L-lysine = [E1 ubiquitin-activating enzyme]-L-cysteine + N(6)-monoubiquitinyl-[acceptor protein]-L-lysine.; EC=2.3.2.24; Evidence={ECO:0000269|PubMed:17588522, ECO:0000269|PubMed:8132613};",2.3.2.23; 2.3.2.24,,"PATHWAY: Protein modification; protein ubiquitination. {ECO:0000255|PROSITE-ProRule:PRU00388, ECO:0000269|PubMed:17588522, ECO:0000269|PubMed:29911972, ECO:0000269|PubMed:8132613}.",ENST00000355621.8 [P62256-1];ENST00000473814.6 [P62256-2];,UBE2H,ENSG00000186591,0.0,,,,,,,0.142,0.175,UBE2H
P62258,ENSG00000108953|ENSG00000274474,1433E_HUMAN,cellular response to heat [GO:0034605]; cerebral cortex development [GO:0021987]; cytoplasmic pattern recognition receptor signaling pathway [GO:0002753]; cytoplasmic sequestering of protein [GO:0051220]; hippocampus development [GO:0021766]; intracellular signal transduction [GO:0035556]; MAPK cascade [GO:0000165]; membrane repolarization during cardiac muscle cell action potential [GO:0086013]; negative regulation of calcium ion export across plasma membrane [GO:1905913]; negative regulation of peptidyl-serine dephosphorylation [GO:1902309]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; neuron migration [GO:0001764]; positive regulation of hippo signaling [GO:0035332]; positive regulation of protein export from nucleus [GO:0046827]; protein localization [GO:0008104]; protein localization to endoplasmic reticulum [GO:0070972]; protein localization to nucleus [GO:0034504]; protein targeting [GO:0006605]; regulation of cytosolic calcium ion concentration [GO:0051480]; regulation of heart rate by cardiac conduction [GO:0086091]; regulation of heart rate by hormone [GO:0003064]; regulation of membrane repolarization [GO:0060306]; regulation of mitotic cell cycle [GO:0007346]; regulation of potassium ion transmembrane transporter activity [GO:1901016]; signal transduction [GO:0007165]; substantia nigra development [GO:0021762],cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; melanosome [GO:0042470]; membrane [GO:0016020]; mitochondrial membrane [GO:0031966]; nucleus [GO:0005634],cadherin binding [GO:0045296]; calcium channel inhibitor activity [GO:0019855]; calcium channel regulator activity [GO:0005246]; enzyme binding [GO:0019899]; histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802]; MHC class II protein complex binding [GO:0023026]; phosphoprotein binding [GO:0051219]; phosphoserine residue binding [GO:0050815]; potassium channel regulator activity [GO:0015459]; protein domain specific binding [GO:0019904]; protein heterodimerization activity [GO:0046982]; protein phosphatase binding [GO:0019903]; protein sequestering activity [GO:0140311]; RNA binding [GO:0003723]; scaffold protein binding [GO:0097110]; signaling adaptor activity [GO:0035591]; transmembrane transporter binding [GO:0044325]; ubiquitin protein ligase binding [GO:0031625],"PTM: (Microbial infection) Cleaved by poliovirus protease 3C, leading to disruption of the interaction with RIGI. {ECO:0000269|PubMed:37555661}.",,,"STRAND 33..35; /evidence=""ECO:0007829|PDB:8Q1S""","HELIX 4..17; /evidence=""ECO:0007829|PDB:2BR9""; HELIX 20..31; /evidence=""ECO:0007829|PDB:2BR9""; HELIX 39..73; /evidence=""ECO:0007829|PDB:2BR9""; HELIX 76..106; /evidence=""ECO:0007829|PDB:2BR9""; HELIX 108..111; /evidence=""ECO:0007829|PDB:2BR9""; HELIX 115..135; /evidence=""ECO:0007829|PDB:2BR9""; HELIX 138..162; /evidence=""ECO:0007829|PDB:2BR9""; HELIX 168..183; /evidence=""ECO:0007829|PDB:2BR9""; HELIX 188..204; /evidence=""ECO:0007829|PDB:2BR9""; HELIX 205..208; /evidence=""ECO:0007829|PDB:2BR9""; HELIX 214..231; /evidence=""ECO:0007829|PDB:2BR9""","TURN 211..213; /evidence=""ECO:0007829|PDB:2BR9""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,YWHAE,14-3-3 protein epsilon (14-3-3E),Homo sapiens (Human),255.0,29174.0,MDDREDLVYQAKLAEQAERYDEMVESMKKVAGMDVELTVEERNLLSVAYKNVIGARRASWRIISSIEQKEENKGGEDKLKMIREYRQMVETELKLICCDILDVLDKHLIPAANTGESKVFYYKMKGDYHRYLAEFATGNDRKEAAENSLVAYKAASDIAMTELPPTHPIRLGLALNFSVFYYEILNSPDRACRLAKAAFDDAIAELDTLSEESYKDSTLIMQLLRDNLTLWTSDMQGDGEEQNKEALQDVEDENQ,False,False,True,P62258,"[('cd10020', '14-3-3 epsilon, an isoform of 14-3-3 protein'), ('G3DSA:1.20.190.20', '14-3-3 domain'), ('IPR000308', '14-3-3 protein'), ('IPR023409', '14-3-3 protein, conserved site'), ('IPR023410', '14-3-3 domain'), ('IPR036815', '14-3-3 domain superfamily'), ('PF00244', '14-3-3 protein'), ('PIRSF000868', '14-3-3 protein'), ('PR00305', '1433ZETA'), ('PS00796', '14-3-3 proteins signature 1'), ('PS00797', '14-3-3 proteins signature 2'), ('PTHR18860', '14-3-3 PROTEIN'), ('SM00101', '14-3-3 homologues'), ('SSF48445', '14-3-3 protein')]",P62258;,"""ENSG00000108953; Low tissue specificity."";",,,,,ENST00000264335.13 [P62258-1];ENST00000571732.5 [P62258-2];ENST00000616643.3 [P62258-2];ENST00000627231.2 [P62258-1];,YWHAE,ENSG00000108953,1.0,YWHAE,Non-canonical_RBPs,20.0,,,,,0.086,YWHAE
P62263,ENSG00000164587,RS14_HUMAN,cytoplasmic translation [GO:0002181]; erythrocyte differentiation [GO:0030218]; maturation of SSU-rRNA [GO:0030490]; negative regulation of transcription by RNA polymerase II [GO:0000122]; ribosomal small subunit assembly [GO:0000028]; ribosomal small subunit biogenesis [GO:0042274]; translation [GO:0006412],cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; postsynaptic density [GO:0014069]; small-subunit processome [GO:0032040],mRNA 5'-UTR binding [GO:0048027]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; translation regulator activity [GO:0045182],,,,"STRAND 15..18; /evidence=""ECO:0007829|PDB:6ZVH""; STRAND 23..25; /evidence=""ECO:0007829|PDB:6ZOJ""; STRAND 28..35; /evidence=""ECO:0007829|PDB:7R4X""; STRAND 40..45; /evidence=""ECO:0007829|PDB:7R4X""; STRAND 51..57; /evidence=""ECO:0007829|PDB:7R4X""; STRAND 92..98; /evidence=""ECO:0007829|PDB:7R4X""; STRAND 125..131; /evidence=""ECO:0007829|PDB:7R4X""","HELIX 58..61; /evidence=""ECO:0007829|PDB:7R4X""; HELIX 65..69; /evidence=""ECO:0007829|PDB:7R4X""; HELIX 71..87; /evidence=""ECO:0007829|PDB:7R4X""; HELIX 111..121; /evidence=""ECO:0007829|PDB:7R4X""","TURN 102..104; /evidence=""ECO:0007829|PDB:6YBW""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,RPS14 PRO2640,Small ribosomal subunit protein uS11 (40S ribosomal protein S14),Homo sapiens (Human),151.0,16273.0,MAPRKGKEKKEEQVISLGPQVAEGENVFGVCHIFASFNDTFVHVTDLSGKETICRVTGGMKVKADRDESSPYAAMLAAQDVAQRCKELGITALHIKLRATGGNRTKTPGPGAQSALRALARSGMKIGRIEDVTPIPSDSTRRKGGRRGRRL,True,True,False,P62263,"[('G3DSA:3.30.420.80', 'Ribosomal protein S11'), ('IPR001971', 'Small ribosomal subunit protein uS11'), ('IPR018102', 'Small ribosomal subunit protein uS11, conserved site'), ('IPR036967', 'Small ribosomal subunit protein uS11 superfamily'), ('MF_01310', 'Small ribosomal subunit protein uS11 [rpsK]'), ('PF00411', 'Ribosomal protein S11'), ('PIRSF002131', 'Ribosomal protein, S11p/S11a/S14e/organellar S11 types'), ('PS00054', 'Ribosomal protein S11 signature'), ('PTHR11759', '40S RIBOSOMAL PROTEIN S14/30S RIBOSOMAL PROTEIN S11'), ('SSF53137', 'Translational machinery components')]",,"""ENSG00000164587; Low tissue specificity."";",,,,,ENST00000312037.6;ENST00000401695.8;ENST00000407193.7;ENST00000521466.5;,RPS14,ENSG00000164587,0.0,RPS14,Canonical_RBPs,29.0,,,,0.252,0.139,RPS14
P62277,ENSG00000110700,RS13_HUMAN,cytoplasmic translation [GO:0002181]; negative regulation of RNA splicing [GO:0033119]; ribosomal small subunit biogenesis [GO:0042274]; translation [GO:0006412],cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; cytosolic small ribosomal subunit [GO:0022627]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; ribosome [GO:0005840]; small-subunit processome [GO:0032040],mRNA 5'-UTR binding [GO:0048027]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; small ribosomal subunit rRNA binding [GO:0070181]; structural constituent of ribosome [GO:0003735],PTM: Ubiquitinated at Lys-27 by RNF14 and RNF25 in response to ribosome collisions (ribosome stalling). {ECO:0000269|PubMed:36638793}.,,,"STRAND 4..7; /evidence=""ECO:0007829|PDB:7R4X""; STRAND 133..135; /evidence=""ECO:0007829|PDB:7JQB""","HELIX 30..41; /evidence=""ECO:0007829|PDB:7R4X""; HELIX 47..57; /evidence=""ECO:0007829|PDB:7R4X""; HELIX 63..67; /evidence=""ECO:0007829|PDB:7R4X""; HELIX 71..77; /evidence=""ECO:0007829|PDB:7R4X""; HELIX 86..103; /evidence=""ECO:0007829|PDB:7R4X""; HELIX 109..131; /evidence=""ECO:0007829|PDB:7R4X""; HELIX 146..149; /evidence=""ECO:0007829|PDB:6ZLW""","TURN 42..44; /evidence=""ECO:0007829|PDB:7R4X""; TURN 143..145; /evidence=""ECO:0007829|PDB:6ZXG""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,RPS13,Small ribosomal subunit protein uS15 (40S ribosomal protein S13),Homo sapiens (Human),151.0,17222.0,MGRMHAPGKGLSQSALPYRRSVPTWLKLTSDDVKEQIYKLAKKGLTPSQIGVILRDSHGVAQVRFVTGNKILRILKSKGLAPDLPEDLYHLIKKAVAVRKHLERNRKDKDAKFRLILIESRIHRLARYYKTKRVLPPNWKYESSTASALVA,True,True,False,P62277,"[('cd00353', 'Ribosomal_S15p_S13e'), ('G3DSA:1.10.287.10', 'S15/NS1, RNA-binding'), ('G3DSA:4.10.860.130', None), ('IPR000589', 'Small ribosomal subunit protein uS15'), ('IPR009068', 'uS15/NS1, RNA-binding domain superfamily'), ('IPR012606', 'Small ribosomal subunit protein uS15, N-terminal'), ('IPR023029', 'Small ribosomal subunit protein uS15, archaea/eukaryotes'), ('MF_01343_A', 'Small ribosomal subunit protein uS15 [rpsO]'), ('PF00312', 'Ribosomal protein S15'), ('PF08069', 'Ribosomal S13/S15 N-terminal domain'), ('PS00362', 'Ribosomal protein S15 signature'), ('PTHR11885', 'RIBOSOMAL PROTEIN S15P/S13E'), ('SM01386', 'Ribosomal S13/S15 N-terminal domain'), ('SM01387', 'Ribosomal_S15'), ('SSF47060', 'S15/NS1 RNA-binding domain')]",,"""ENSG00000110700; Low tissue specificity."";",,,,,ENST00000525634.6;,RPS13,ENSG00000110700,0.0,RPS13,Canonical_RBPs,29.0,,,,0.152,,RPS13
P62310,ENSG00000170860,LSM3_HUMAN,"mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; P-body assembly [GO:0033962]",catalytic step 2 spliceosome [GO:0071013]; cytosol [GO:0005829]; Lsm1-7-Pat1 complex [GO:1990726]; Lsm2-8 complex [GO:0120115]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; precatalytic spliceosome [GO:0071011]; U2-type precatalytic spliceosome [GO:0071005]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U6 snRNP [GO:0005688],RNA binding [GO:0003723]; U6 snRNA 3'-end binding [GO:0030629],,,"DOMAIN 16..101; /note=""Sm""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU01346""",,,,"cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,LSM3 MDS017,U6 snRNA-associated Sm-like protein LSm3,Homo sapiens (Human),102.0,11845.0,MADDVDQQQTTNTVEEPLDLIRLSLDERIYVKMRNDRELRGRLHAYDQHLNMILGDVEETVTTIEIDEETYEEIYKSTKRNIPMLFVRGDGVVLVAPPLRVG,False,False,True,P62310,"[('cd01730', 'Like-Sm protein 3'), ('G3DSA:2.30.30.100', None), ('IPR001163', 'Sm domain, eukaryotic/archaea-type'), ('IPR010920', 'LSM domain superfamily'), ('IPR034105', 'Sm-like protein Lsm3'), ('IPR040002', 'U6 snRNA-associated Sm-like protein Lsm3'), ('IPR047575', 'Sm domain'), ('PF01423', 'LSM domain'), ('PS52002', 'Sm domain profile'), ('PTHR13110', 'U6 SNRNA-ASSOCIATED SM-LIKE PROTEIN LSM3'), ('SM00651', 'snRNP Sm proteins'), ('SSF50182', 'Sm-like ribonucleoproteins')]",,"""ENSG00000170860; Low tissue specificity."";",,,,,ENST00000306024.4;,LSM3,ENSG00000170860,0.0,LSM3,Canonical_RBPs,11.0,,,,0.137,,LSM3
P62328,ENSG00000205542,TYB4_HUMAN,"actin filament organization [GO:0007015]; negative regulation of canonical NF-kappaB signal transduction [GO:0043124]; negative regulation of inflammatory response [GO:0050728]; positive regulation of ATP biosynthetic process [GO:2001171]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of endothelial cell chemotaxis [GO:2001028]; positive regulation of proton-transporting ATP synthase activity, rotational mechanism [GO:1905273]; regulation of cell migration [GO:0030334]; sequestering of actin monomers [GO:0042989]; tumor necrosis factor-mediated signaling pathway [GO:0033209]",cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; extracellular region [GO:0005576]; nucleus [GO:0005634]; platelet alpha granule lumen [GO:0031093],actin monomer binding [GO:0003785]; enzyme binding [GO:0019899]; protein sequestering activity [GO:0140311]; RNA binding [GO:0003723],"PTM: [Hemoregulatory peptide AcSDKP]: AcSDKP is inactivated by ACE, which removes the dipeptide Lys-Pro from its C-terminus. {ECO:0000269|PubMed:7876104, ECO:0000269|PubMed:8257427}.",,,,"HELIX 6..11; /evidence=""ECO:0007829|PDB:4PL8""; HELIX 15..17; /evidence=""ECO:0007829|PDB:4PL8""; HELIX 32..39; /evidence=""ECO:0007829|PDB:4PL7""",,"cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,TMSB4X TB4X THYB4 TMSB4,Thymosin beta-4 (T beta-4) (Fx) [Cleaved into: Hemoregulatory peptide AcSDKP (Ac-Ser-Asp-Lys-Pro) (N-acetyl-SDKP) (AcSDKP) (Seraspenide)],Homo sapiens (Human),44.0,5053.0,MSDKPDMAEIEKFDKSKLKKTETQEKNPLPSKETIEQEKQAGES,True,True,True,P62328,"[('cd22059', 'Wiskott Aldrich syndrome homology region 2 (WH2 motif) found in beta-Thymosin, and similar proteins'), ('G3DSA:1.20.5.520', 'Single helix bin'), ('IPR001152', 'Beta-thymosin'), ('IPR038386', 'Beta-thymosin superfamily'), ('PF01290', 'Thymosin beta-4 family'), ('PIRSF001828', 'Thymosin beta'), ('PS00500', 'Thymosin beta-4 family signature'), ('PTHR12021', 'THYMOSIN BETA'), ('SM00152', 'Thymosin beta actin-binding motif.')]",,"""ENSG00000205542; Low tissue specificity."";",,,,,ENST00000380633.1;ENST00000380635.5;ENST00000380636.1;ENST00000451311.7;,TMSB4X,ENSG00000205542,0.0,TMSB4X,Non-canonical_RBPs,8.0,100.0,DP00357,1.0,1.0,1.0,TMSB4X
P62826,ENSG00000132341,RAN_HUMAN,actin cytoskeleton organization [GO:0030036]; cell division [GO:0051301]; cellular response to mineralocorticoid stimulus [GO:0071389]; DNA metabolic process [GO:0006259]; GTP metabolic process [GO:0046039]; hippocampus development [GO:0021766]; mitotic cell cycle [GO:0000278]; mitotic sister chromatid segregation [GO:0000070]; mitotic spindle organization [GO:0007052]; positive regulation of protein binding [GO:0032092]; positive regulation of protein import into nucleus [GO:0042307]; pre-miRNA export from nucleus [GO:0035281]; protein export from nucleus [GO:0006611]; protein import into nucleus [GO:0006606]; protein localization to nucleolus [GO:1902570]; ribosomal large subunit export from nucleus [GO:0000055]; ribosomal small subunit export from nucleus [GO:0000056]; ribosomal subunit export from nucleus [GO:0000054]; snRNA import into nucleus [GO:0061015]; spermatid development [GO:0007286]; viral process [GO:0016032],centriole [GO:0005814]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; male germ cell nucleus [GO:0001673]; manchette [GO:0002177]; melanosome [GO:0042470]; membrane [GO:0016020]; midbody [GO:0030496]; nuclear envelope [GO:0005635]; nuclear pore [GO:0005643]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; recycling endosome [GO:0055037]; RNA nuclear export complex [GO:0042565]; sperm flagellum [GO:0036126],cadherin binding [GO:0045296]; chromatin binding [GO:0003682]; dynein intermediate chain binding [GO:0045505]; G protein activity [GO:0003925]; GDP binding [GO:0019003]; GTP binding [GO:0005525]; GTPase activity [GO:0003924]; importin-alpha family protein binding [GO:0061676]; magnesium ion binding [GO:0000287]; protein domain specific binding [GO:0019904]; protein heterodimerization activity [GO:0046982]; protein-containing complex binding [GO:0044877]; RNA binding [GO:0003723],"PTM: Acetylation by KAT5 at Lys-134 is increased during mitosis, impairs RANGRF binding and enhances RCC1 binding (PubMed:29040603). Acetylation at Lys-37 enhances the association with nuclear export components (PubMed:31075303). Deacetylation of Lys-37 by SIRT7 regulates the nuclear export of NF-kappa-B subunit RELA/p65 (PubMed:31075303). {ECO:0000269|PubMed:29040603, ECO:0000269|PubMed:31075303}.",,,"STRAND 10..17; /evidence=""ECO:0007829|PDB:3GJ0""; STRAND 18..22; /evidence=""ECO:0007829|PDB:1QBK""; STRAND 38..40; /evidence=""ECO:0007829|PDB:3GJ0""; STRAND 45..54; /evidence=""ECO:0007829|PDB:3GJ0""; STRAND 57..66; /evidence=""ECO:0007829|PDB:3GJ0""; STRAND 85..91; /evidence=""ECO:0007829|PDB:3GJ0""; STRAND 92..94; /evidence=""ECO:0007829|PDB:1RRP""; STRAND 112..114; /evidence=""ECO:0007829|PDB:5CJ2""; STRAND 117..122; /evidence=""ECO:0007829|PDB:3GJ0""; STRAND 126..128; /evidence=""ECO:0007829|PDB:3GJ0""; STRAND 145..148; /evidence=""ECO:0007829|PDB:3GJ0""; STRAND 176..178; /evidence=""ECO:0007829|PDB:3GJ0""","HELIX 23..27; /evidence=""ECO:0007829|PDB:3GJ0""; HELIX 31..35; /evidence=""ECO:0007829|PDB:3GJ0""; HELIX 69..71; /evidence=""ECO:0007829|PDB:3GJ0""; HELIX 74..76; /evidence=""ECO:0007829|PDB:1K5D""; HELIX 77..80; /evidence=""ECO:0007829|PDB:3GJ0""; HELIX 95..99; /evidence=""ECO:0007829|PDB:3GJ0""; HELIX 101..111; /evidence=""ECO:0007829|PDB:3GJ0""; HELIX 133..135; /evidence=""ECO:0007829|PDB:3GJ0""; HELIX 138..142; /evidence=""ECO:0007829|PDB:3GJ0""; HELIX 159..169; /evidence=""ECO:0007829|PDB:3GJ0""; HELIX 191..205; /evidence=""ECO:0007829|PDB:3GJ0""; HELIX 210..212; /evidence=""ECO:0007829|PDB:7MNX""","TURN 2..5; /evidence=""ECO:0007829|PDB:2MMG""; TURN 28..30; /evidence=""ECO:0007829|PDB:8UX1""; TURN 41..44; /evidence=""ECO:0007829|PDB:3GJ0""; TURN 151..154; /evidence=""ECO:0007829|PDB:3GJ0""; TURN 156..158; /evidence=""ECO:0007829|PDB:3GJ0""; TURN 185..187; /evidence=""ECO:0007829|PDB:1QBK""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,RAN ARA24 OK/SW-cl.81,GTP-binding nuclear protein Ran (EC 3.6.5.-) (Androgen receptor-associated protein 24) (GTPase Ran) (Ras-like protein TC4) (Ras-related nuclear protein),Homo sapiens (Human),216.0,24423.0,MAAQGEPQVQFKLVLVGDGGTGKTTFVKRHLTGEFEKKYVATLGVEVHPLVFHTNRGPIKFNVWDTAGQEKFGGLRDGYYIQAQCAIIMFDVTSRVTYKNVPNWHRDLVRVCENIPIVLCGNKVDIKDRKVKAKSIVFHRKKNLQYYDISAKSNYNFEKPFLWLARKLIGDPNLEFVAMPALAPPEVVMDPALAAQYEHDLEVAQTTALPDEDDDL,True,False,False,P62826,"[('cd00877', 'Ras-related nuclear proteins (Ran)/TC4 family of small GTPases'), ('G3DSA:3.40.50.300', 'P-loop containing nucleotide triphosphate hydrolases'), ('IPR001806', 'Small GTPase'), ('IPR002041', 'Ran GTPase'), ('IPR005225', 'Small GTP-binding domain'), ('IPR027417', 'P-loop containing nucleoside triphosphate hydrolase'), ('PF00071', 'Ras family'), ('PR00627', 'GTPRANTC4'), ('PS51418', 'small GTPase Ran family profile'), ('PS51419', 'small GTPase Rab1 family profile'), ('PS51421', 'small GTPase Ras family profile'), ('PTHR24071', 'RAN GTPASE'), ('SM00173', 'Ras subfamily of RAS small GTPases'), ('SM00174', 'Rho (Ras homology) subfamily of Ras-like small GTPases'), ('SM00175', 'Rab subfamily of small GTPases'), ('SM00176', 'Ran (Ras-related nuclear proteins) /TC4 subfamily of small GTPases'), ('SSF52540', 'P-loop containing nucleoside triphosphate hydrolases'), ('TIGR00231', 'small GTP-binding protein domain')]",,"""ENSG00000132341; Low tissue specificity."";","CATALYTIC ACTIVITY: Reaction=GTP + H2O = GDP + phosphate + H(+); Xref=Rhea:RHEA:19669, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:37565, ChEBI:CHEBI:43474, ChEBI:CHEBI:58189; Evidence={ECO:0000269|PubMed:26272610, ECO:0000269|PubMed:8636225}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:19670; Evidence={ECO:0000269|PubMed:26272610, ECO:0000269|PubMed:8636225};",3.6.5.-,,,ENST00000392369.6;ENST00000543796.6;,RAN,ENSG00000132341,0.0,RAN,Non-canonical_RBPs,30.0,29.17,DP01364,0.384,0.185,,RAN
P62829,ENSG00000125691,RL23_HUMAN,cellular response to actinomycin D [GO:0072717]; cytoplasmic translation [GO:0002181]; G1 to G0 transition [GO:0070314]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of ubiquitin protein ligase activity [GO:1904667]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of signal transduction by p53 class mediator [GO:1901798]; protein stabilization [GO:0050821]; protein-DNA complex disassembly [GO:0032986]; regulation of G1 to G0 transition [GO:1903450]; ribosomal protein import into nucleus [GO:0006610]; translation [GO:0006412],cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; extracellular exosome [GO:0070062]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991]; ribosome [GO:0005840]; synapse [GO:0045202],large ribosomal subunit rRNA binding [GO:0070180]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; transcription coactivator binding [GO:0001223]; ubiquitin ligase inhibitor activity [GO:1990948]; ubiquitin protein ligase binding [GO:0031625],,,,,,,"cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,RPL23,Large ribosomal subunit protein uL14 (60S ribosomal protein L17) (60S ribosomal protein L23),Homo sapiens (Human),140.0,14865.0,MSKRGRGGSSGAKFRISLGLPVGAVINCADNTGAKNLYIISVKGIKGRLNRLPAAGVGDMVMATVKKGKPELRKKVHPAVVIRQRKSYRRKDGVFLYFEDNAGVIVNNKGEMKGSAITGPVAKECADLWPRIASNAGSIA,True,True,False,P62829,"[('G3DSA:2.40.150.20', 'Ribosomal protein L14'), ('IPR000218', 'Large ribosomal subunit protein uL14'), ('IPR019972', 'Large ribosomal subunit protein uL14, conserved site'), ('IPR036853', 'Large ribosomal subunit protein uL14 superfamily'), ('MF_01367', 'Large ribosomal subunit protein uL14 [rplN]'), ('PF00238', 'Ribosomal protein L14p/L23e'), ('PS00049', 'Ribosomal protein L14 signature'), ('PTHR11761', '50S/60S RIBOSOMAL PROTEIN L14/L23'), ('SM01374', 'Ribosomal protein L14p/L23e'), ('SSF50193', 'Ribosomal protein L14')]",,"""ENSG00000125691; Low tissue specificity."";",,,,,ENST00000394332.5;ENST00000479035.7;,RPL23,ENSG00000125691,0.0,RPL23,Canonical_RBPs,18.0,,,,0.079,,RPL23
P62837,ENSG00000131508,UB2D2_HUMAN,protein autoubiquitination [GO:0051865]; protein K48-linked ubiquitination [GO:0070936]; protein modification process [GO:0036211]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511],cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; ubiquitin ligase complex [GO:0000151],ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842],,,"DOMAIN 1..147; /note=""UBC core""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00388""","STRAND 19..28; /evidence=""ECO:0007829|PDB:2ESK""; STRAND 32..38; /evidence=""ECO:0007829|PDB:2ESK""; STRAND 41..43; /evidence=""ECO:0007829|PDB:6SQO""; STRAND 49..55; /evidence=""ECO:0007829|PDB:2ESK""; STRAND 66..71; /evidence=""ECO:0007829|PDB:2ESK""; STRAND 76..78; /evidence=""ECO:0007829|PDB:4A4B""; STRAND 82..84; /evidence=""ECO:0007829|PDB:6M2C""; STRAND 115..117; /evidence=""ECO:0007829|PDB:4V3L""","HELIX 1..15; /evidence=""ECO:0007829|PDB:2ESK""; HELIX 87..89; /evidence=""ECO:0007829|PDB:2ESK""; HELIX 99..111; /evidence=""ECO:0007829|PDB:2ESK""; HELIX 121..129; /evidence=""ECO:0007829|PDB:2ESK""; HELIX 131..145; /evidence=""ECO:0007829|PDB:2ESK""","TURN 44..47; /evidence=""ECO:0007829|PDB:2ESK""; TURN 58..61; /evidence=""ECO:0007829|PDB:2ESK""; TURN 90..92; /evidence=""ECO:0007829|PDB:2ESK""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,UBE2D2 PUBC1 UBC4 UBC5B UBCH4 UBCH5B,Ubiquitin-conjugating enzyme E2 D2 (EC 2.3.2.23) ((E3-independent) E2 ubiquitin-conjugating enzyme D2) (EC 2.3.2.24) (E2 ubiquitin-conjugating enzyme D2) (Ubiquitin carrier protein D2) (Ubiquitin-conjugating enzyme E2(17)KB 2) (Ubiquitin-conjugating enzyme E2-17 kDa 2) (Ubiquitin-protein ligase D2) (p53-regulated ubiquitin-conjugating enzyme 1),Homo sapiens (Human),147.0,16735.0,MALKRIHKELNDLARDPPAQCSAGPVGDDMFHWQATIMGPNDSPYQGGVFFLTIHFPTDYPFKPPKVAFTTRIYHPNINSNGSICLDILRSQWSPALTISKVLLSICSLLCDPNPDDPLVPEIARIYKTDREKYNRIAREWTQKYAM,False,False,True,P62837,"[('cd00195', 'UBCc'), ('G3DSA:3.10.110.10', 'Ubiquitin Conjugating Enzyme'), ('IPR000608', 'Ubiquitin-conjugating enzyme E2'), ('IPR016135', 'Ubiquitin-conjugating enzyme/RWD-like'), ('IPR023313', 'Ubiquitin-conjugating enzyme, active site'), ('PF00179', 'Ubiquitin-conjugating enzyme'), ('PS00183', 'Ubiquitin-conjugating (UBC) active site signature'), ('PS50127', 'Ubiquitin-conjugating (UBC) core domain profile'), ('PTHR24068', 'Ubiquitin-conjugating enzyme'), ('SM00212', 'Ubiquitin-conjugating enzyme E2, catalytic domain homologues'), ('SSF54495', 'UBC-like')]",,"""ENSG00000131508; Low tissue specificity."";","CATALYTIC ACTIVITY: Reaction=S-ubiquitinyl-[E1 ubiquitin-activating enzyme]-L-cysteine + [E2 ubiquitin-conjugating enzyme]-L-cysteine = [E1 ubiquitin-activating enzyme]-L-cysteine + S-ubiquitinyl-[E2 ubiquitin-conjugating enzyme]-L-cysteine.; EC=2.3.2.23; Evidence={ECO:0000255|PROSITE-ProRule:PRU00388, ECO:0000255|PROSITE-ProRule:PRU10133, ECO:0000269|PubMed:18042044, ECO:0000269|PubMed:18703417, ECO:0000269|PubMed:19854139, ECO:0000269|PubMed:20061386}; CATALYTIC ACTIVITY: Reaction=S-ubiquitinyl-[E1 ubiquitin-activating enzyme]-L-cysteine + [acceptor protein]-L-lysine = [E1 ubiquitin-activating enzyme]-L-cysteine + N(6)-monoubiquitinyl-[acceptor protein]-L-lysine.; EC=2.3.2.24; Evidence={ECO:0000269|PubMed:17588522};",2.3.2.23; 2.3.2.24,,PATHWAY: Protein modification; protein ubiquitination. {ECO:0000269|PubMed:26475854}.,ENST00000398733.8 [P62837-1];ENST00000398734.8 [P62837-1];ENST00000505548.5 [P62837-2];ENST00000511725.5 [P62837-2];ENST00000698321.1 [P62837-2];ENST00000698322.1 [P62837-2];,UBE2D2,ENSG00000131508,0.0,,,,,,,,,UBE2D2
P62913,ENSG00000142676,RL11_HUMAN,cytoplasmic translation [GO:0002181]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of protein neddylation [GO:2000435]; negative regulation of ubiquitin protein ligase activity [GO:1904667]; negative regulation of ubiquitin-dependent protein catabolic process [GO:2000059]; positive regulation of gene expression [GO:0010628]; positive regulation of protein binding [GO:0032092]; positive regulation of signal transduction by p53 class mediator [GO:1901798]; protein localization to nucleus [GO:0034504]; protein stabilization [GO:0050821]; protein targeting [GO:0006605]; regulation of signal transduction by p53 class mediator [GO:1901796]; ribosomal large subunit assembly [GO:0000027]; ribosomal large subunit biogenesis [GO:0042273]; rRNA processing [GO:0006364]; translation [GO:0006412],cytoplasm [GO:0005737]; cytosol [GO:0005829]; cytosolic large ribosomal subunit [GO:0022625]; cytosolic ribosome [GO:0022626]; extracellular exosome [GO:0070062]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; protein-containing complex [GO:0032991],5S rRNA binding [GO:0008097]; RNA binding [GO:0003723]; structural constituent of ribosome [GO:0003735]; ubiquitin ligase inhibitor activity [GO:1990948]; ubiquitin protein ligase binding [GO:0031625],,,,"STRAND 16..25; /evidence=""ECO:0007829|PDB:4XXB""; STRAND 27..30; /evidence=""ECO:0007829|PDB:4XXB""; STRAND 49..52; /evidence=""ECO:0007829|PDB:4XXB""; STRAND 67..74; /evidence=""ECO:0007829|PDB:4XXB""; STRAND 93..95; /evidence=""ECO:0007829|PDB:4XXB""; STRAND 105..110; /evidence=""ECO:0007829|PDB:4XXB""; STRAND 128..135; /evidence=""ECO:0007829|PDB:4XXB""; STRAND 173..175; /evidence=""ECO:0007829|PDB:4XXB""","HELIX 31..44; /evidence=""ECO:0007829|PDB:4XXB""; HELIX 58..60; /evidence=""ECO:0007829|PDB:4XXB""; HELIX 76..89; /evidence=""ECO:0007829|PDB:4XXB""; HELIX 96..98; /evidence=""ECO:0007829|PDB:4XXB""; HELIX 112..115; /evidence=""ECO:0007829|PDB:4XXB""; HELIX 159..169; /evidence=""ECO:0007829|PDB:4XXB""","TURN 90..92; /evidence=""ECO:0007829|PDB:4XXB""; TURN 121..123; /evidence=""ECO:0007829|PDB:4XXB""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,RPL11,Large ribosomal subunit protein uL5 (60S ribosomal protein L11) (CLL-associated antigen KW-12),Homo sapiens (Human),178.0,20252.0,MAQDQGEKENPMRELRIRKLCLNICVGESGDRLTRAAKVLEQLTGQTPVFSKARYTVRSFGIRRNEKIAVHCTVRGAKAEEILEKGLKVREYELRKNNFSDTGNFGFGIQEHIDLGIKYDPSIGIYGLDFYVVLGRPGFSIADKKRRTGCIGAKHRISKEEAMRWFQQKYDGIILPGK,True,True,False,P62913,"[('G3DSA:3.30.1440.10', None), ('IPR002132', 'Large ribosomal subunit protein uL5'), ('IPR020929', 'Large ribosomal subunit protein uL5, conserved site'), ('IPR022803', 'Large ribosomal subunit protein uL5 domain superfamily'), ('IPR031309', 'Large ribosomal subunit protein uL5, C-terminal'), ('IPR031310', 'Large ribosomal subunit protein uL5, N-terminal'), ('PF00281', 'Ribosomal protein L5'), ('PF00673', 'ribosomal L5P family C-terminus'), ('PIRSF002161', 'Ribosomal protein, L5p/L5a/L11e/organellar L5 types'), ('PS00358', 'Ribosomal protein L5 signature'), ('PTHR11994', '60S RIBOSOMAL PROTEIN L11-RELATED'), ('SSF55282', 'RL5-like')]",,"""ENSG00000142676; Low tissue specificity."";",,,,,ENST00000374550.8 [P62913-2];ENST00000643754.2 [P62913-1];,RPL11,ENSG00000142676,0.0,RPL11,Canonical_RBPs,22.0,,,,0.062,,RPL11
P62937,ENSG00000196262,PPIA_HUMAN,activation of protein kinase B activity [GO:0032148]; apoptotic process [GO:0006915]; cell adhesion molecule production [GO:0060352]; cellular response to oxidative stress [GO:0034599]; endothelial cell activation [GO:0042118]; leukocyte chemotaxis [GO:0030595]; lipid droplet organization [GO:0034389]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of protein K48-linked ubiquitination [GO:0061944]; negative regulation of protein kinase activity [GO:0006469]; negative regulation of protein phosphorylation [GO:0001933]; negative regulation of stress-activated MAPK cascade [GO:0032873]; negative regulation of viral life cycle [GO:1903901]; neuron differentiation [GO:0030182]; neutrophil chemotaxis [GO:0030593]; platelet activation [GO:0030168]; platelet aggregation [GO:0070527]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein dephosphorylation [GO:0035307]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of protein secretion [GO:0050714]; positive regulation of viral genome replication [GO:0045070]; protein folding [GO:0006457]; protein peptidyl-prolyl isomerization [GO:0000413]; regulation of apoptotic signaling pathway [GO:2001233]; regulation of viral genome replication [GO:0045069]; viral release from host cell [GO:0019076],cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; focal adhesion [GO:0005925]; membrane [GO:0016020]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; secretory granule lumen [GO:0034774]; vesicle [GO:0031982],cyclosporin A binding [GO:0016018]; heparan sulfate binding [GO:1904399]; integrin binding [GO:0005178]; peptidyl-prolyl cis-trans isomerase activity [GO:0003755]; RNA binding [GO:0003723]; unfolded protein binding [GO:0051082]; virion binding [GO:0046790],"PTM: Acetylation at Lys-125 markedly inhibits catalysis of cis to trans isomerization and stabilizes cis rather than trans forms of the HIV-1 capsid. PPIA acetylation also antagonizes the immunosuppressive effects of cyclosporine by inhibiting the sequential steps of cyclosporine binding and calcineurin inhibition (PubMed:20364129, Ref.12). Acetylation at Lys-125 favors its interaction with TARDBP (PubMed:25678563). {ECO:0000269|PubMed:20364129, ECO:0000269|PubMed:25678563, ECO:0000269|Ref.12}.",,"DOMAIN 7..163; /note=""PPIase cyclophilin-type""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00156""","STRAND 5..12; /evidence=""ECO:0007829|PDB:4N1M""; STRAND 15..24; /evidence=""ECO:0007829|PDB:4N1M""; STRAND 55..57; /evidence=""ECO:0007829|PDB:4N1M""; STRAND 61..64; /evidence=""ECO:0007829|PDB:4N1M""; STRAND 70..73; /evidence=""ECO:0007829|PDB:4N1M""; STRAND 74..77; /evidence=""ECO:0007829|PDB:2MS4""; STRAND 78..81; /evidence=""ECO:0007829|PDB:4YUI""; STRAND 97..100; /evidence=""ECO:0007829|PDB:4N1M""; STRAND 102..104; /evidence=""ECO:0007829|PDB:6I42""; STRAND 108..110; /evidence=""ECO:0007829|PDB:7ABT""; STRAND 112..117; /evidence=""ECO:0007829|PDB:4N1M""; STRAND 128..134; /evidence=""ECO:0007829|PDB:4N1M""; STRAND 148..150; /evidence=""ECO:0007829|PDB:7UXN""; STRAND 152..154; /evidence=""ECO:0007829|PDB:2MS4""; STRAND 156..164; /evidence=""ECO:0007829|PDB:4N1M""","HELIX 30..41; /evidence=""ECO:0007829|PDB:4N1M""; HELIX 120..122; /evidence=""ECO:0007829|PDB:4N1M""; HELIX 136..143; /evidence=""ECO:0007829|PDB:4N1M""","TURN 26..28; /evidence=""ECO:0007829|PDB:4N1M""; TURN 42..44; /evidence=""ECO:0007829|PDB:4N1M""; TURN 58..60; /evidence=""ECO:0007829|PDB:4N1M""; TURN 67..69; /evidence=""ECO:0007829|PDB:4N1M""; TURN 123..125; /evidence=""ECO:0007829|PDB:4N1M""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,PPIA CYPA,"Peptidyl-prolyl cis-trans isomerase A (PPIase A) (EC 5.2.1.8) (Cyclophilin A) (Cyclosporin A-binding protein) (Rotamase A) [Cleaved into: Peptidyl-prolyl cis-trans isomerase A, N-terminally processed]",Homo sapiens (Human),165.0,18012.0,MVNPTVFFDIAVDGEPLGRVSFELFADKVPKTAENFRALSTGEKGFGYKGSCFHRIIPGFMCQGGDFTRHNGTGGKSIYGEKFEDENFILKHTGPGILSMANAGPNTNGSQFFICTAKTEWLDGKHVVFGKVKEGMNIVEAMERFGSRNGKTSKKITIADCGQLE,True,False,False,P62937,"[('cd01926', 'cyclophilin_ABH_like'), ('G3DSA:2.40.100.10', 'Cyclophilin-like'), ('IPR002130', 'Cyclophilin-type peptidyl-prolyl cis-trans isomerase domain'), ('IPR020892', 'Cyclophilin-type peptidyl-prolyl cis-trans isomerase, conserved site'), ('IPR024936', 'Cyclophilin-type peptidyl-prolyl cis-trans isomerase'), ('IPR029000', 'Cyclophilin-like domain superfamily'), ('PF00160', 'Cyclophilin type peptidyl-prolyl cis-trans isomerase/CLD'), ('PIRSF001467', 'Peptidyl-prolyl cis-trans isomerase'), ('PR00153', 'CSAPPISMRASE'), ('PS00170', 'Cyclophilin-type peptidyl-prolyl cis-trans isomerase signature'), ('PS50072', 'Cyclophilin-type peptidyl-prolyl cis-trans isomerase domain profile'), ('PTHR11071', 'Cyclophilin-type Peptidyl-prolyl Cis-trans Isomerase'), ('SSF50891', 'Cyclophilin-like')]",,"""ENSG00000196262; Low tissue specificity."";","CATALYTIC ACTIVITY: Reaction=[protein]-peptidylproline (omega=180) = [protein]-peptidylproline (omega=0); Xref=Rhea:RHEA:16237, Rhea:RHEA-COMP:10747, Rhea:RHEA-COMP:10748, ChEBI:CHEBI:83833, ChEBI:CHEBI:83834; EC=5.2.1.8; Evidence={ECO:0000269|PubMed:2001362, ECO:0000269|PubMed:20676357, ECO:0000269|PubMed:21245143, ECO:0000269|PubMed:21593166, ECO:0000269|PubMed:25678563, ECO:0000305|PubMed:19207730, ECO:0000305|PubMed:26095851};",5.2.1.8,ACTIVITY REGULATION: Binds cyclosporin A (CsA). CsA mediates some of its effects via an inhibitory action on PPIase. {ECO:0000269|PubMed:2001362}.,,ENST00000355968.10 [P62937-2];ENST00000468812.6 [P62937-1];ENST00000489459.5 [P62937-2];ENST00000677022.1 [P62937-2];ENST00000677107.1 [P62937-2];ENST00000678789.1 [P62937-2];ENST00000678805.1 [P62937-2];,PPIA,ENSG00000196262,0.0,PPIA,Non-canonical_RBPs,29.0,,,,,,PPIA
P62993,ENSG00000177885,GRB2_HUMAN,actin cytoskeleton organization [GO:0030036]; B cell receptor signaling pathway [GO:0050853]; branching involved in labyrinthine layer morphogenesis [GO:0060670]; cellular response to ionizing radiation [GO:0071479]; endodermal cell differentiation [GO:0035987]; epidermal growth factor receptor signaling pathway [GO:0007173]; fibroblast growth factor receptor signaling pathway [GO:0008543]; insulin receptor signaling pathway [GO:0008286]; insulin-like growth factor receptor signaling pathway [GO:0048009]; myelination [GO:0042552]; natural killer cell mediated cytotoxicity [GO:0042267]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; Ras protein signal transduction [GO:0007265]; receptor internalization [GO:0031623]; regulation of MAPK cascade [GO:0043408]; Schwann cell development [GO:0014044]; signal transduction [GO:0007165]; signal transduction in response to DNA damage [GO:0042770]; T cell activation [GO:0042110],cell cortex [GO:0005938]; cell-cell junction [GO:0005911]; COP9 signalosome [GO:0008180]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; Grb2-EGFR complex [GO:0070436]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; vesicle membrane [GO:0012506],ephrin receptor binding [GO:0046875]; epidermal growth factor receptor binding [GO:0005154]; guanyl-nucleotide exchange factor adaptor activity [GO:0005091]; identical protein binding [GO:0042802]; insulin receptor substrate binding [GO:0043560]; neurotrophin TRKA receptor binding [GO:0005168]; phosphotyrosine residue binding [GO:0001784]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; protein-macromolecule adaptor activity [GO:0030674]; RNA binding [GO:0003723]; SH3 domain binding [GO:0017124]; transmembrane receptor protein tyrosine kinase adaptor activity [GO:0005068],"PTM: Phosphorylation of Tyr-209 in the C-terminal SH3 domain reduces its binding to SOS1. {ECO:0000269|PubMed:11726515}.; PTM: Ubiquitinated by RNF173, leading to proteasomal degradation and inhibition of the RAF/MEK/ERK pathway (PubMed:37328606). In the nucleus, polyubiquitinated by RBBP6 at Lys-109 at DNA damage sites (PubMed:34348893). {ECO:0000269|PubMed:34348893, ECO:0000269|PubMed:37328606}.",DOMAIN: The SH3 domains mediate interaction with RALGPS1 and SHB.,"DOMAIN 1..58; /note=""SH3 1""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00192""; DOMAIN 60..152; /note=""SH2""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00191""; DOMAIN 156..215; /note=""SH3 2""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00192""","STRAND 1..7; /evidence=""ECO:0007829|PDB:8DGO""; STRAND 13..15; /evidence=""ECO:0007829|PDB:1GRI""; STRAND 24..27; /evidence=""ECO:0007829|PDB:8DGO""; STRAND 36..41; /evidence=""ECO:0007829|PDB:8DGO""; STRAND 44..49; /evidence=""ECO:0007829|PDB:8DGO""; STRAND 53..55; /evidence=""ECO:0007829|PDB:8DGO""; STRAND 61..64; /evidence=""ECO:0007829|PDB:3IMD""; STRAND 78..80; /evidence=""ECO:0007829|PDB:1FHS""; STRAND 82..87; /evidence=""ECO:0007829|PDB:6ICG""; STRAND 89..91; /evidence=""ECO:0007829|PDB:6ICG""; STRAND 95..101; /evidence=""ECO:0007829|PDB:6ICG""; STRAND 104..112; /evidence=""ECO:0007829|PDB:6ICG""; STRAND 114..116; /evidence=""ECO:0007829|PDB:1GRI""; STRAND 118..122; /evidence=""ECO:0007829|PDB:6ICG""; STRAND 124..127; /evidence=""ECO:0007829|PDB:6ICG""; STRAND 142..144; /evidence=""ECO:0007829|PDB:6ICG""; STRAND 149..152; /evidence=""ECO:0007829|PDB:1FHS""; STRAND 155..157; /evidence=""ECO:0007829|PDB:1QG1""; STRAND 160..165; /evidence=""ECO:0007829|PDB:2VWF""; STRAND 171..174; /evidence=""ECO:0007829|PDB:1IO6""; STRAND 182..187; /evidence=""ECO:0007829|PDB:2VWF""; STRAND 190..198; /evidence=""ECO:0007829|PDB:2VWF""; STRAND 201..206; /evidence=""ECO:0007829|PDB:2VWF""; STRAND 210..212; /evidence=""ECO:0007829|PDB:2VWF""","HELIX 50..52; /evidence=""ECO:0007829|PDB:8DGO""; HELIX 67..75; /evidence=""ECO:0007829|PDB:6ICG""; HELIX 128..135; /evidence=""ECO:0007829|PDB:6ICG""; HELIX 207..209; /evidence=""ECO:0007829|PDB:2VWF""",,"cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,GRB2 ASH,Growth factor receptor-bound protein 2 (Adapter protein GRB2) (Protein Ash) (SH2/SH3 adapter GRB2),Homo sapiens (Human),217.0,25206.0,MEAIAKYDFKATADDELSFKRGDILKVLNEECDQNWYKAELNGKDGFIPKNYIEMKPHPWFFGKIPRAKAEEMLSKQRHDGAFLIRESESAPGDFSLSVKFGNDVQHFKVLRDGAGKYFLWVVKFNSLNELVDYHRSTSVSRNQQIFLRDIEQVPQQPTYVQALFDFDPQEDGELGFRRGDFIHVMDNSDPNWWKGACHGQTGMFPRNYVTPVNRNV,False,False,True,P62993,"[('cd09941', 'Src homology 2 domain found in Growth factor receptor-bound protein 2 (Grb2) and similar proteins'), ('cd11946', 'N-terminal Src homology 3 domain of Growth factor receptor-bound protein 2'), ('cd11949', 'C-terminal Src homology 3 domain of Growth factor receptor-bound protein 2'), ('G3DSA:2.30.30.40', 'SH3 Domains'), ('G3DSA:3.30.505.10', 'SH2 domain'), ('IPR000980', 'SH2 domain'), ('IPR001452', 'SH3 domain'), ('IPR035641', 'GRB2, N-terminal SH3 domain'), ('IPR035643', 'GRB2, C-terminal SH3 domain'), ('IPR036028', 'SH3-like domain superfamily'), ('IPR036860', 'SH2 domain superfamily'), ('IPR043539', 'Grb2-like'), ('PF00017', 'SH2 domain'), ('PF00018', 'SH3 domain'), ('PR00401', 'SH2DOMAIN'), ('PR00452', 'SH3DOMAIN'), ('PR00499', 'P67PHOX'), ('PS50001', 'Src homology 2 (SH2) domain profile'), ('PS50002', 'Src homology 3 (SH3) domain profile'), ('PTHR46037', 'PROTEIN ENHANCER OF SEVENLESS 2B')]",P62993;,"""ENSG00000177885; Low tissue specificity."";",,,,,ENST00000316615.9 [P62993-2];ENST00000316804.10 [P62993-1];ENST00000392562.5 [P62993-1];ENST00000392563.5 [P62993-2];ENST00000392564.5 [P62993-1];ENST00000648046.1 [P62993-1];,GRB2,ENSG00000177885,0.0,GRB2,Non-canonical_RBPs,7.0,,,0.175,,,GRB2
P63104,ENSG00000164924,1433Z_HUMAN,angiogenesis [GO:0001525]; cellular response to glucose starvation [GO:0042149]; ERK1 and ERK2 cascade [GO:0070371]; establishment of Golgi localization [GO:0051683]; Golgi reassembly [GO:0090168]; lung development [GO:0030324]; negative regulation of apoptotic process [GO:0043066]; negative regulation of innate immune response [GO:0045824]; negative regulation of protein localization to nucleus [GO:1900181]; negative regulation of TORC1 signaling [GO:1904262]; negative regulation of transcription by RNA polymerase II [GO:0000122]; protein localization [GO:0008104]; protein phosphorylation [GO:0006468]; protein targeting [GO:0006605]; regulation of ERK1 and ERK2 cascade [GO:0070372]; regulation of protein stability [GO:0031647]; regulation of synapse maturation [GO:0090128]; respiratory system process [GO:0003016]; signal transduction [GO:0007165]; synaptic target recognition [GO:0008039]; tube formation [GO:0035148],blood microparticle [GO:0072562]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular space [GO:0005615]; focal adhesion [GO:0005925]; glutamatergic synapse [GO:0098978]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; melanosome [GO:0042470]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; vesicle [GO:0031982],cadherin binding [GO:0045296]; DNA-binding transcription factor binding [GO:0140297]; identical protein binding [GO:0042802]; phosphoserine residue binding [GO:0050815]; protein domain specific binding [GO:0019904]; protein kinase binding [GO:0019901]; protein sequestering activity [GO:0140311]; RNA binding [GO:0003723]; transmembrane transporter binding [GO:0044325]; ubiquitin protein ligase binding [GO:0031625],"PTM: The delta, brain-specific form differs from the zeta form in being phosphorylated (Probable). Phosphorylation on Ser-184 by MAPK8; promotes dissociation of BAX and translocation of BAX to mitochondria (PubMed:15071501, PubMed:15696159). Phosphorylation on Thr-232; inhibits binding of RAF1 (PubMed:9360956). Phosphorylated on Ser-58 by PKA and protein kinase C delta type catalytic subunit in a sphingosine-dependent fashion (PubMed:11956222, PubMed:12865427, PubMed:15883165, PubMed:16376338). Phosphorylation on Ser-58 by PKA; disrupts homodimerization and heterodimerization with YHAE and TP53 (PubMed:11956222, PubMed:12865427, PubMed:15883165, PubMed:16376338). {ECO:0000269|PubMed:11956222, ECO:0000269|PubMed:12865427, ECO:0000269|PubMed:15071501, ECO:0000269|PubMed:15696159, ECO:0000269|PubMed:15883165, ECO:0000269|PubMed:16376338, ECO:0000269|PubMed:9360956, ECO:0000305}.",,,,"HELIX 3..15; /evidence=""ECO:0007829|PDB:2O02""; HELIX 19..31; /evidence=""ECO:0007829|PDB:2O02""; HELIX 38..67; /evidence=""ECO:0007829|PDB:2O02""; HELIX 76..103; /evidence=""ECO:0007829|PDB:2O02""; HELIX 105..108; /evidence=""ECO:0007829|PDB:2O02""; HELIX 112..131; /evidence=""ECO:0007829|PDB:2O02""; HELIX 135..159; /evidence=""ECO:0007829|PDB:2O02""; HELIX 165..180; /evidence=""ECO:0007829|PDB:2O02""; HELIX 185..200; /evidence=""ECO:0007829|PDB:2O02""; HELIX 201..205; /evidence=""ECO:0007829|PDB:2O02""; HELIX 211..228; /evidence=""ECO:0007829|PDB:2O02""","TURN 69..71; /evidence=""ECO:0007829|PDB:2O02""; TURN 208..210; /evidence=""ECO:0007829|PDB:2O02""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,YWHAZ,14-3-3 protein zeta/delta (Protein kinase C inhibitor protein 1) (KCIP-1),Homo sapiens (Human),245.0,27745.0,MDKNELVQKAKLAEQAERYDDMAACMKSVTEQGAELSNEERNLLSVAYKNVVGARRSSWRVVSSIEQKTEGAEKKQQMAREYREKIETELRDICNDVLSLLEKFLIPNASQAESKVFYLKMKGDYYRYLAEVAAGDDKKGIVDQSQQAYQEAFEISKKEMQPTHPIRLGLALNFSVFYYEILNSPEKACSLAKTAFDEAIAELDTLSEESYKDSTLIMQLLRDNLTLWTSDTQGDEAEAGEGGEN,True,False,True,P63104,"[('cd10022', '14-3-3 beta and zeta isoforms of 14-3-3 protein'), ('G3DSA:1.20.190.20', '14-3-3 domain'), ('IPR000308', '14-3-3 protein'), ('IPR023409', '14-3-3 protein, conserved site'), ('IPR023410', '14-3-3 domain'), ('IPR036815', '14-3-3 domain superfamily'), ('PF00244', '14-3-3 protein'), ('PIRSF000868', '14-3-3 protein'), ('PR00305', '1433ZETA'), ('PS00796', '14-3-3 proteins signature 1'), ('PS00797', '14-3-3 proteins signature 2'), ('PTHR18860', '14-3-3 PROTEIN'), ('SM00101', '14-3-3 homologues'), ('SSF48445', '14-3-3 protein')]",P63104;,"""ENSG00000164924; Low tissue specificity."";",,,,,ENST00000353245.7 [P63104-1];ENST00000395951.7 [P63104-1];ENST00000395953.6 [P63104-1];ENST00000395956.7 [P63104-1];ENST00000395957.6 [P63104-1];ENST00000395958.6 [P63104-1];ENST00000419477.6 [P63104-1];ENST00000457309.2 [P63104-1];ENST00000522542.5 [P63104-2];,YWHAZ,ENSG00000164924,0.0,YWHAZ,Non-canonical_RBPs,20.0,4.9,DP03654,0.151,0.049,,YWHAZ
P63165,ENSG00000116030,SUMO1_HUMAN,cellular response to cadmium ion [GO:0071276]; cellular response to heat [GO:0034605]; DNA repair [GO:0006281]; negative regulation of action potential [GO:0045759]; negative regulation of delayed rectifier potassium channel activity [GO:1902260]; negative regulation of DNA binding [GO:0043392]; negative regulation of DNA-binding transcription factor activity [GO:0043433]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of protein import into nucleus [GO:0042308]; negative regulation of transcription by transcription factor localization [GO:0010621]; PML body organization [GO:0030578]; positive regulation of ATPase-coupled calcium transmembrane transporter activity [GO:1901896]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein-containing complex assembly [GO:0031334]; protein localization to nuclear pore [GO:0090204]; protein stabilization [GO:0050821]; protein sumoylation [GO:0016925]; regulation of cardiac muscle cell contraction [GO:0086004]; regulation of protein localization [GO:0032880]; roof of mouth development [GO:0060021],cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; nuclear body [GO:0016604]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nuclear speck [GO:0016607]; nuclear stress granule [GO:0097165]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; PML body [GO:0016605]; postsynaptic cytosol [GO:0099524]; presynaptic cytosol [GO:0099523]; XY body [GO:0001741],enzyme binding [GO:0019899]; potassium channel regulator activity [GO:0015459]; protein tag activity [GO:0031386]; RNA binding [GO:0003723]; small protein activating enzyme binding [GO:0044388]; transcription factor binding [GO:0008134]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-like protein ligase binding [GO:0044389]; ubiquitin-specific protease binding [GO:1990381],PTM: Cleavage of precursor form by SENP1 or SENP2 is necessary for function. {ECO:0000269|PubMed:15487983}.; PTM: Polymeric SUMO1 chains undergo polyubiquitination by RNF4. {ECO:0000269|PubMed:18408734}.,,"DOMAIN 20..97; /note=""Ubiquitin-like""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00214""","STRAND 22..27; /evidence=""ECO:0007829|PDB:6UYR""; STRAND 29..31; /evidence=""ECO:0007829|PDB:1Z5S""; STRAND 33..38; /evidence=""ECO:0007829|PDB:6UYR""; STRAND 40..42; /evidence=""ECO:0007829|PDB:2PE6""; STRAND 62..66; /evidence=""ECO:0007829|PDB:6UYR""; STRAND 69..71; /evidence=""ECO:0007829|PDB:5B7A""; STRAND 87..92; /evidence=""ECO:0007829|PDB:6UYR""; STRAND 96..99; /evidence=""ECO:0007829|PDB:2N1A""","HELIX 4..6; /evidence=""ECO:0007829|PDB:6WW3""; HELIX 11..17; /evidence=""ECO:0007829|PDB:8DJH""; HELIX 48..55; /evidence=""ECO:0007829|PDB:6UYR""; HELIX 59..61; /evidence=""ECO:0007829|PDB:6UYR""; HELIX 77..80; /evidence=""ECO:0007829|PDB:6UYR""","TURN 45..47; /evidence=""ECO:0007829|PDB:6XOG""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,SUMO1 SMT3C SMT3H3 UBL1 OK/SW-cl.43,Small ubiquitin-related modifier 1 (SUMO-1) (GAP-modifying protein 1) (GMP1) (SMT3 homolog 3) (Sentrin) (Ubiquitin-homology domain protein PIC1) (Ubiquitin-like protein SMT3C) (Smt3C) (Ubiquitin-like protein UBL1),Homo sapiens (Human),101.0,11557.0,MSDQEAKPSTEDLGDKKEGEYIKLKVIGQDSSEIHFKVKMTTHLKKLKESYCQRQGVPMNSLRFLFEGQRIADNHTPKELGMEEEDVIEVYQEQTGGHSTV,False,False,True,P63165,"[('cd16114', 'ubiquitin-like (Ubl) domain found in small ubiquitin-related modifier 1 (SUMO-1) and similar proteins'), ('G3DSA:3.10.20.90', 'Phosphatidylinositol 3-kinase Catalytic Subunit; Chain A, domain 1'), ('IPR000626', 'Ubiquitin-like domain'), ('IPR022617', 'Rad60/SUMO-like domain'), ('IPR029071', 'Ubiquitin-like domain superfamily'), ('IPR046332', 'Small ubiquitin-related modifier 1, Ubl domain'), ('PF11976', 'Ubiquitin-2 like Rad60 SUMO-like'), ('PS50053', 'Ubiquitin domain profile'), ('PTHR10562', 'Small Ubiquitin-related Modifier (SUMO)'), ('SM00213', 'Ubiquitin homologues'), ('SSF54236', 'Ubiquitin-like')]",,"""ENSG00000116030; Low tissue specificity."";",,,,,ENST00000392244.7 [P63165-2];ENST00000392245.5 [P63165-1];ENST00000392246.7 [P63165-1];,SUMO1,ENSG00000116030,0.0,SUMO1,Non-canonical_RBPs,15.0,17.82,DP02294,0.218,0.287,,SUMO1
P63208,ENSG00000113558,SKP1_HUMAN,chromatin remodeling [GO:0006338]; maintenance of protein location in nucleus [GO:0051457]; positive regulation of ubiquitin protein ligase activity [GO:1904668]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K48-linked ubiquitination [GO:0070936]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; SCF-dependent proteasomal ubiquitin-dependent protein catabolic process [GO:0031146],centrosome [GO:0005813]; Cul7-RING ubiquitin ligase complex [GO:0031467]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; SCF ubiquitin ligase complex [GO:0019005],beta-catenin binding [GO:0008013]; cullin family protein binding [GO:0097602]; F-box domain binding [GO:1990444]; molecular function activator activity [GO:0140677]; protein domain specific binding [GO:0019904]; ubiquitin ligase complex scaffold activity [GO:0160072]; ubiquitin-like ligase-substrate adaptor activity [GO:1990756],PTM: Undergoes autophagy-mediated degradation in the liver in a time-dependent manner. {ECO:0000250|UniProtKB:Q9WTX5}.,,,"STRAND 3..7; /evidence=""ECO:0007829|PDB:1FS1""; STRAND 9..11; /evidence=""ECO:0007829|PDB:6M90""; STRAND 13..17; /evidence=""ECO:0007829|PDB:1FS1""; STRAND 38..40; /evidence=""ECO:0007829|PDB:6O60""; STRAND 44..46; /evidence=""ECO:0007829|PDB:1FS1""; STRAND 47..50; /evidence=""ECO:0007829|PDB:1LDK""; STRAND 80..82; /evidence=""ECO:0007829|PDB:5XYL""; STRAND 83..85; /evidence=""ECO:0007829|PDB:6WNX""; STRAND 128..130; /evidence=""ECO:0007829|PDB:1FQV""","HELIX 18..22; /evidence=""ECO:0007829|PDB:1FS1""; HELIX 25..33; /evidence=""ECO:0007829|PDB:1FS1""; HELIX 52..65; /evidence=""ECO:0007829|PDB:1FS1""; HELIX 70..73; /evidence=""ECO:0007829|PDB:8BYL""; HELIX 75..79; /evidence=""ECO:0007829|PDB:8BYL""; HELIX 87..92; /evidence=""ECO:0007829|PDB:1FS1""; HELIX 97..110; /evidence=""ECO:0007829|PDB:1FS1""; HELIX 113..127; /evidence=""ECO:0007829|PDB:1FS1""; HELIX 132..138; /evidence=""ECO:0007829|PDB:1FS1""; HELIX 147..155; /evidence=""ECO:0007829|PDB:6M90""","TURN 157..159; /evidence=""ECO:0007829|PDB:2AST""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,SKP1 EMC19 OCP2 SKP1A TCEB1L,S-phase kinase-associated protein 1 (Cyclin-A/CDK2-associated protein p19) (p19A) (Organ of Corti protein 2) (OCP-2) (Organ of Corti protein II) (OCP-II) (RNA polymerase II elongation factor-like protein) (SIII) (Transcription elongation factor B polypeptide 1-like) (p19skp1),Homo sapiens (Human),163.0,18658.0,MPSIKLQSSDGEIFEVDVEIAKQSVTIKTMLEDLGMDDEGDDDPVPLPNVNAAILKKVIQWCTHHKDDPPPPEDDENKEKRTDDIPVWDQEFLKVDQGTLFELILAANYLDIKGLLDVTCKTVANMIKGKTPEEIRKTFNIKNDFTEEEEAQVRKENQWCEEK,False,False,True,P63208,"[('cd18322', 'BTB (Broad-Complex, Tramtrack and Bric a brac) /POZ (poxvirus and zinc finger) domain found in S-phase kinase-associated protein 1 (SKP1) and similar proteins'), ('G3DSA:3.30.710.10', 'Potassium Channel Kv1.1; Chain A'), ('IPR001232', 'S-phase kinase-associated protein 1-like'), ('IPR011333', 'SKP1/BTB/POZ domain superfamily'), ('IPR016072', 'SKP1 component, dimerisation'), ('IPR016073', 'SKP1 component, POZ domain'), ('IPR016897', 'S-phase kinase-associated protein 1'), ('IPR036296', 'SKP1-like, dimerisation domain superfamily'), ('PF01466', 'Skp1 family, dimerisation domain'), ('PF03931', 'Skp1 family, tetramerisation domain'), ('PIRSF028729', 'E3 ubiquitin ligase SCF complex, Skp subunit'), ('PTHR11165', 'SKP1'), ('SM00512', 'Found in Skp1 protein family'), ('SSF54695', 'POZ domain'), ('SSF81382', 'Skp1 dimerisation domain-like')]",,"""ENSG00000113558; Low tissue specificity."";",,,,PATHWAY: Protein modification; protein ubiquitination.,ENST00000353411.11 [P63208-1];ENST00000517625.5 [P63208-1];ENST00000522552.5 [P63208-2];ENST00000522855.5 [P63208-1];,SKP1,ENSG00000113558,0.0,,,,,,,0.092,0.129,SKP1
P63279,ENSG00000103275,UBC9_HUMAN,cell division [GO:0051301]; chromosome segregation [GO:0007059]; mitotic nuclear membrane reassembly [GO:0007084]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nuclear export [GO:0051168]; positive regulation of cell migration [GO:0030335]; positive regulation of SUMO transferase activity [GO:1903755]; protein modification process [GO:0036211]; protein sumoylation [GO:0016925]; ubiquitin-dependent protein catabolic process [GO:0006511],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear envelope [GO:0005635]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; PML body [GO:0016605]; SUMO ligase complex [GO:0106068]; synaptonemal complex [GO:0000795]; transferase complex [GO:1990234],ATP binding [GO:0005524]; enzyme binding [GO:0019899]; RING-like zinc finger domain binding [GO:0071535]; RNA binding [GO:0003723]; small protein activating enzyme binding [GO:0044388]; SUMO conjugating enzyme activity [GO:0061656]; SUMO transferase activity [GO:0019789]; transcription coregulator binding [GO:0001221]; transcription factor binding [GO:0008134],PTM: Phosphorylation at Ser-71 significantly enhances SUMOylation activity. {ECO:0000269|PubMed:22509284}.,,"DOMAIN 4..157; /note=""UBC core""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00388""","STRAND 25..30; /evidence=""ECO:0007829|PDB:5F6E""; STRAND 32..34; /evidence=""ECO:0007829|PDB:2PE6""; STRAND 36..46; /evidence=""ECO:0007829|PDB:5F6E""; STRAND 57..63; /evidence=""ECO:0007829|PDB:5F6E""; STRAND 74..79; /evidence=""ECO:0007829|PDB:5F6E""; STRAND 90..92; /evidence=""ECO:0007829|PDB:5F6E""","HELIX 3..18; /evidence=""ECO:0007829|PDB:5F6E""; HELIX 95..97; /evidence=""ECO:0007829|PDB:5F6E""; HELIX 109..121; /evidence=""ECO:0007829|PDB:5F6E""; HELIX 131..139; /evidence=""ECO:0007829|PDB:5F6E""; HELIX 141..154; /evidence=""ECO:0007829|PDB:5F6E""","TURN 52..55; /evidence=""ECO:0007829|PDB:5F6E""; TURN 66..69; /evidence=""ECO:0007829|PDB:5F6E""; TURN 99..102; /evidence=""ECO:0007829|PDB:5F6E""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,UBE2I UBC9 UBCE9,SUMO-conjugating enzyme UBC9 (EC 2.3.2.-) (RING-type E3 SUMO transferase UBC9) (SUMO-protein ligase) (Ubiquitin carrier protein 9) (Ubiquitin carrier protein I) (Ubiquitin-conjugating enzyme E2 I) (Ubiquitin-protein ligase I) (p18),Homo sapiens (Human),158.0,18007.0,MSGIALSRLAQERKAWRKDHPFGFVAVPTKNPDGTMNLMNWECAIPGKKGTPWEGGLFKLRMLFKDDYPSSPPKCKFEPPLFHPNVYPSGTVCLSILEEDKDWRPAITIKQILLGIQELLNEPNIQDPAQAEAYTIYCQNRVEYEKRVRAQAKKFAPS,False,False,True,P63279,"[('cd00195', 'UBCc'), ('G3DSA:3.10.110.10', 'Ubiquitin Conjugating Enzyme'), ('IPR000608', 'Ubiquitin-conjugating enzyme E2'), ('IPR016135', 'Ubiquitin-conjugating enzyme/RWD-like'), ('IPR023313', 'Ubiquitin-conjugating enzyme, active site'), ('IPR050113', 'Ubiquitin-conjugating enzyme'), ('PF00179', 'Ubiquitin-conjugating enzyme'), ('PS00183', 'Ubiquitin-conjugating (UBC) active site signature'), ('PS50127', 'Ubiquitin-conjugating (UBC) core domain profile'), ('PTHR24067', 'Ubiquitin-conjugating enzyme'), ('SM00212', 'Ubiquitin-conjugating enzyme E2, catalytic domain homologues'), ('SSF54495', 'UBC-like')]",P63279;,"""ENSG00000103275; Low tissue specificity."";",,2.3.2.-,,PATHWAY: Protein modification; protein sumoylation. {ECO:0000269|PubMed:26524494}.,ENST00000325437.10;ENST00000355803.9;ENST00000397514.8;ENST00000397515.7;ENST00000403747.7;ENST00000406620.6;ENST00000562470.4;ENST00000566587.6;ENST00000567074.7;ENST00000567383.7;ENST00000711297.1;ENST00000711300.1;ENST00000711306.1;ENST00000711307.1;ENST00000711309.1;ENST00000711310.1;ENST00000711311.1;ENST00000711316.1;ENST00000711317.1;ENST00000711319.1;ENST00000711323.1;ENST00000711330.1;ENST00000711332.1;ENST00000711336.1;ENST00000711343.1;ENST00000711344.1;ENST00000711346.1;ENST00000711348.1;ENST00000711350.1;ENST00000713916.1;ENST00000713920.1;ENST00000713921.1;,UBE2I,ENSG00000103275,0.0,UBE2I,Non-canonical_RBPs,9.0,,,,,,UBE2I
P67809,ENSG00000065978,YBOX1_HUMAN,"cellular response to interleukin-7 [GO:0098761]; CRD-mediated mRNA stabilization [GO:0070934]; embryonic morphogenesis [GO:0048598]; epidermis development [GO:0008544]; in utero embryonic development [GO:0001701]; miRNA transport [GO:1990428]; mRNA processing [GO:0006397]; mRNA stabilization [GO:0048255]; negative regulation of cellular senescence [GO:2000773]; negative regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900152]; negative regulation of striated muscle cell differentiation [GO:0051154]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of translation [GO:0017148]; positive regulation of cell division [GO:0051781]; positive regulation of cytoplasmic translation [GO:2000767]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein localization to cytoplasmic stress granule [GO:1903608]; regulation of DNA-templated transcription [GO:0006355]; regulation of gene expression [GO:0010468]; RNA splicing [GO:0008380]; RNA transport [GO:0050658]; tRNA transport [GO:0051031]",CRD-mediated mRNA stability complex [GO:0070937]; cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; histone pre-mRNA 3'end processing complex [GO:0071204]; intracellular membrane-bounded organelle [GO:0043231]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932]; plasma membrane [GO:0005886]; ribonucleoprotein complex [GO:1990904]; synapse [GO:0045202]; U12-type spliceosomal complex [GO:0005689],C5-methylcytidine-containing RNA reader activity [GO:0062153]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; double-stranded DNA binding [GO:0003690]; GTPase binding [GO:0051020]; miRNA binding [GO:0035198]; mRNA binding [GO:0003729]; nucleic acid binding [GO:0003676]; RNA binding [GO:0003723]; sequence-specific double-stranded DNA binding [GO:1990837]; single-stranded DNA binding [GO:0003697],"PTM: Ubiquitinated by RBBP6; leading to a decrease of YBX1 transactivational ability. {ECO:0000269|PubMed:18851979}.; PTM: Phosphorylated; increased by TGFB1 treatment (Ref.6). Phosphorylation by PKB/AKT1 reduces interaction with cytoplasmic mRNA (By similarity). In the absence of phosphorylation the protein is retained in the cytoplasm (PubMed:15806160). {ECO:0000250|UniProtKB:Q28618, ECO:0000269|PubMed:15806160, ECO:0000269|Ref.6}.; PTM: Cleaved by a 20S proteasomal protease in response to agents that damage DNA. Cleavage takes place in the absence of ubiquitination and ATP. The resulting N-terminal fragment accumulates in the nucleus (By similarity). {ECO:0000250|UniProtKB:Q28618}.","DOMAIN: In the CSD domain, Trp-65 specifically recognizes C5-methylcytosine (m5C) modification through its indole ring. {ECO:0000269|PubMed:31358969}.","DOMAIN 61..125; /note=""CSD""","STRAND 54..67; /evidence=""ECO:0007829|PDB:6KUG""; STRAND 72..77; /evidence=""ECO:0007829|PDB:6KUG""; STRAND 83..87; /evidence=""ECO:0007829|PDB:6KUG""; STRAND 96..98; /evidence=""ECO:0007829|PDB:6LMS""; STRAND 108..116; /evidence=""ECO:0007829|PDB:6KUG""; STRAND 119..126; /evidence=""ECO:0007829|PDB:6KUG""","HELIX 88..90; /evidence=""ECO:0007829|PDB:6KUG""; HELIX 128..130; /evidence=""ECO:0007829|PDB:6LMR""","TURN 68..71; /evidence=""ECO:0007829|PDB:6KUG""; TURN 78..80; /evidence=""ECO:0007829|PDB:6KUG""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,YBX1 NSEP1 YB1,Y-box-binding protein 1 (YB-1) (CCAAT-binding transcription factor I subunit A) (CBF-A) (DNA-binding protein B) (DBPB) (Enhancer factor I subunit A) (EFI-A) (Nuclease-sensitive element-binding protein 1) (Y-box transcription factor),Homo sapiens (Human),324.0,35924.0,MSSEAETQQPPAAPPAAPALSAADTKPGTTGSGAGSGGPGGLTSAAPAGGDKKVIATKVLGTVKWFNVRNGYGFINRNDTKEDVFVHQTAIKKNNPRKYLRSVGDGETVEFDVVEGEKGAEAANVTGPGGVPVQGSKYAADRNHYRRYPRRRGPPRNYQQNYQNSESGEKNEGSESAPEGQAQQRRPYRRRRFPPYYMRRPYGRRPQYSNPPVQGEVMEGADNQGAGEQGRPVRQNMYRGYRPRFRRGPPRQRQPREDGNEEDKENQGDETQGQQPPQRRYRRNFNYRRRRPENPKPQDGKETKAADPPAENSSAPEAEQGGAE,False,True,False,P67809,"[('cd04458', 'CSP_CDS'), ('G3DSA:2.40.50.140', 'Nucleic acid-binding proteins'), ('IPR002059', 'Cold-shock protein Csp, DNA-binding'), ('IPR011129', 'Cold-shock domain'), ('IPR012340', 'Nucleic acid-binding, OB-fold'), ('IPR019844', 'Cold-shock domain, conserved site'), ('IPR050181', 'Cold shock domain-containing protein'), ('PF00313', ""'Cold-shock' DNA-binding domain""), ('PR00050', 'COLDSHOCK'), ('PS00352', 'Cold-shock (CSD) domain signature'), ('PS51857', 'Cold-shock (CSD) domain profile'), ('PTHR11544', 'Cold shock domain-containing protein'), ('SM00357', 'Cold shock protein domain'), ('SSF50249', 'Nucleic acid-binding proteins')]",,"""ENSG00000065978; Tissue enhanced (skeletal)."";",,,,,ENST00000321358.12;,YBX1,ENSG00000065978,0.0,YBX1,Canonical_RBPs,35.0,,,,0.738,0.784,YBX1
P67870,ENSG00000204435|ENSG00000206406|ENSG00000224774|ENSG00000228875|ENSG00000224398|ENSG00000230700|ENSG00000232960,CSK2B_HUMAN,adiponectin-activated signaling pathway [GO:0033211]; endothelial tube morphogenesis [GO:0061154]; negative regulation of blood vessel endothelial cell migration [GO:0043537]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of viral life cycle [GO:1903901]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of activin receptor signaling pathway [GO:0032927]; positive regulation of SMAD protein signal transduction [GO:0060391]; protein-containing complex assembly [GO:0065003]; regulation of DNA binding [GO:0051101]; signal transduction [GO:0007165]; symbiont-mediated disruption of host cell PML body [GO:0075342]; Wnt signaling pathway [GO:0016055],chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; protein kinase CK2 complex [GO:0005956]; secretory granule lumen [GO:0034774],chromatin binding [GO:0003682]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein domain specific binding [GO:0019904]; protein kinase regulator activity [GO:0019887]; protein serine/threonine kinase activity [GO:0004674]; protein-macromolecule adaptor activity [GO:0030674]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; signaling receptor binding [GO:0005102],"PTM: Phosphorylated by alpha subunit. {ECO:0000269|PubMed:11574463, ECO:0000269|PubMed:2300566}.",DOMAIN: The KSSR motif is part of a protein interaction pocket that mediates interaction with cellular and viral proteins. {ECO:0000269|PubMed:24216761}.,,"STRAND 43..45; /evidence=""ECO:0007829|PDB:4DGL""; STRAND 59..61; /evidence=""ECO:0007829|PDB:4NH1""; STRAND 120..122; /evidence=""ECO:0007829|PDB:1QF8""; STRAND 134..136; /evidence=""ECO:0007829|PDB:1QF8""; STRAND 142..144; /evidence=""ECO:0007829|PDB:3EED""; STRAND 152..155; /evidence=""ECO:0007829|PDB:4MD7""; STRAND 187..189; /evidence=""ECO:0007829|PDB:4MD9""; STRAND 190..192; /evidence=""ECO:0007829|PDB:4DGL""","HELIX 9..15; /evidence=""ECO:0007829|PDB:1QF8""; HELIX 27..31; /evidence=""ECO:0007829|PDB:1QF8""; HELIX 33..36; /evidence=""ECO:0007829|PDB:1QF8""; HELIX 39..41; /evidence=""ECO:0007829|PDB:1QF8""; HELIX 46..53; /evidence=""ECO:0007829|PDB:1QF8""; HELIX 67..87; /evidence=""ECO:0007829|PDB:1QF8""; HELIX 91..102; /evidence=""ECO:0007829|PDB:1QF8""; HELIX 112..114; /evidence=""ECO:0007829|PDB:1QF8""; HELIX 149..151; /evidence=""ECO:0007829|PDB:1QF8""; HELIX 156..158; /evidence=""ECO:0007829|PDB:1QF8""; HELIX 163..170; /evidence=""ECO:0007829|PDB:1QF8""; HELIX 172..174; /evidence=""ECO:0007829|PDB:1QF8""; HELIX 195..198; /evidence=""ECO:0007829|PDB:4DGL""; HELIX 202..205; /evidence=""ECO:0007829|PDB:4DGL""","TURN 17..20; /evidence=""ECO:0007829|PDB:1JWH""; TURN 103..106; /evidence=""ECO:0007829|PDB:1QF8""; TURN 138..140; /evidence=""ECO:0007829|PDB:1QF8""; TURN 159..162; /evidence=""ECO:0007829|PDB:4DGL""; TURN 199..201; /evidence=""ECO:0007829|PDB:4DGL""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,CSNK2B CK2N G5A,Casein kinase II subunit beta (CK II beta) (Phosvitin) (Protein G5a),Homo sapiens (Human),215.0,24942.0,MSSSEEVSWISWFCGLRGNEFFCEVDEDYIQDKFNLTGLNEQVPHYRQALDMILDLEPDEELEDNPNQSDLIEQAAEMLYGLIHARYILTNRGIAQMLEKYQQGDFGYCPRVYCENQPMLPIGLSDIPGEAMVKLYCPKCMDVYTPKSSRHHHTDGAYFGTGFPHMLFMVHPEYRPKRPANQFVPRLYGFKIHPMAYQLQLQAASNFKSPVKTIR,False,False,True,P67870,"[('G3DSA:1.10.1820.10', 'protein kinase ck2 holoenzyme, chain C, domain 1'), ('G3DSA:2.20.25.20', None), ('IPR000704', 'Casein kinase II, regulatory subunit'), ('IPR016149', 'Casein kinase II, regulatory subunit, N-terminal'), ('IPR035991', 'Casein kinase II subunit beta-like'), ('PF01214', 'Casein kinase II regulatory subunit'), ('PR00472', 'CASNKINASEII'), ('PS01101', 'Casein kinase II regulatory subunit signature'), ('PTHR11740', 'CASEIN KINASE II SUBUNIT BETA'), ('SM01085', 'Casein kinase II regulatory subunit'), ('SSF57798', 'Casein kinase II beta subunit')]",,"""ENSG00000204435; Low tissue specificity."";",,,,,ENST00000375865.6;ENST00000375866.2;ENST00000375882.7;ENST00000383427.6;ENST00000383433.8;ENST00000400110.5;ENST00000412802.5;ENST00000418230.5;ENST00000422567.6;ENST00000429633.5;ENST00000431476.5;ENST00000436169.5;ENST00000443673.6;ENST00000448596.1;ENST00000451917.6;ENST00000452985.6;ENST00000453234.5;ENST00000454382.6;ENST00000454511.5;ENST00000455161.1;ENST00000458330.5;,CSNK2B,ENSG00000204435,6.0,,,,,,,0.158,,CSNK2B
P68036,ENSG00000185651,UB2L3_HUMAN,cell cycle phase transition [GO:0044770]; cell population proliferation [GO:0008283]; cellular response to glucocorticoid stimulus [GO:0071385]; cellular response to steroid hormone stimulus [GO:0071383]; positive regulation of protein targeting to mitochondrion [GO:1903955]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; protein K11-linked ubiquitination [GO:0070979]; protein modification process [GO:0036211]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; regulation of DNA-templated transcription [GO:0006355]; ubiquitin-dependent protein catabolic process [GO:0006511],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; presynapse [GO:0098793]; ubiquitin ligase complex [GO:0000151],ATP binding [GO:0005524]; enzyme binding [GO:0019899]; RNA binding [GO:0003723]; transcription coactivator activity [GO:0003713]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activator activity [GO:0097027]; ubiquitin-protein transferase activity [GO:0004842],"PTM: Ubiquitinated. The alteration of UBE2L3 protein levels during the S-phase of the cell cycle is due to ubiquitin-dependent proteasomal degradation. Autoubiquitinated in vitro (PubMed:22496338). {ECO:0000269|PubMed:18946090, ECO:0000269|PubMed:22496338}.","DOMAIN: In contrast to other ubiquitin-conjugating enzymes E2, residues essential for lysine reactivity are absent: Pro and a His residues are present instead of an Asp and an Asp residues in positions 88 and 119, respectively. {ECO:0000269|PubMed:21532592}.","DOMAIN 2..149; /note=""UBC core""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00388""","STRAND 20..27; /evidence=""ECO:0007829|PDB:7V8F""; STRAND 34..39; /evidence=""ECO:0007829|PDB:7V8F""; STRAND 50..56; /evidence=""ECO:0007829|PDB:7V8F""; STRAND 67..72; /evidence=""ECO:0007829|PDB:7V8F""; STRAND 77..79; /evidence=""ECO:0007829|PDB:1FBV""; STRAND 83..85; /evidence=""ECO:0007829|PDB:4Q5E""; STRAND 117..119; /evidence=""ECO:0007829|PDB:3SQV""","HELIX 2..16; /evidence=""ECO:0007829|PDB:7V8F""; HELIX 88..90; /evidence=""ECO:0007829|PDB:7V8F""; HELIX 101..113; /evidence=""ECO:0007829|PDB:7V8F""; HELIX 123..131; /evidence=""ECO:0007829|PDB:7V8F""; HELIX 133..147; /evidence=""ECO:0007829|PDB:7V8F""","TURN 29..31; /evidence=""ECO:0007829|PDB:1FBV""; TURN 44..48; /evidence=""ECO:0007829|PDB:4Q5E""; TURN 59..62; /evidence=""ECO:0007829|PDB:7V8F""; TURN 92..94; /evidence=""ECO:0007829|PDB:7V8F""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,UBE2L3 UBCE7 UBCH7,Ubiquitin-conjugating enzyme E2 L3 (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme L3) (L-UBC) (UbcH7) (Ubiquitin carrier protein L3) (Ubiquitin-conjugating enzyme E2-F1) (Ubiquitin-protein ligase L3),Homo sapiens (Human),154.0,17862.0,MAASRRLMKELEEIRKCGMKNFRNIQVDEANLLTWQGLIVPDNPPYDKGAFRIEINFPAEYPFKPPKITFKTKIYHPNIDEKGQVCLPVISAENWKPATKTDQVIQSLIALVNDPQPEHPLRADLAEEYSKDRKKFCKNAEEFTKKYGEKRPVD,False,False,True,P68036,"[('cd00195', 'UBCc'), ('G3DSA:3.10.110.10', 'Ubiquitin Conjugating Enzyme'), ('IPR000608', 'Ubiquitin-conjugating enzyme E2'), ('IPR016135', 'Ubiquitin-conjugating enzyme/RWD-like'), ('IPR023313', 'Ubiquitin-conjugating enzyme, active site'), ('IPR050113', 'Ubiquitin-conjugating enzyme'), ('PF00179', 'Ubiquitin-conjugating enzyme'), ('PS00183', 'Ubiquitin-conjugating (UBC) active site signature'), ('PS50127', 'Ubiquitin-conjugating (UBC) core domain profile'), ('PTHR24067', 'Ubiquitin-conjugating enzyme'), ('SM00212', 'Ubiquitin-conjugating enzyme E2, catalytic domain homologues'), ('SSF54495', 'UBC-like')]",,"""ENSG00000185651; Low tissue specificity."";","CATALYTIC ACTIVITY: Reaction=S-ubiquitinyl-[E1 ubiquitin-activating enzyme]-L-cysteine + [E2 ubiquitin-conjugating enzyme]-L-cysteine = [E1 ubiquitin-activating enzyme]-L-cysteine + S-ubiquitinyl-[E2 ubiquitin-conjugating enzyme]-L-cysteine.; EC=2.3.2.23; Evidence={ECO:0000255|PROSITE-ProRule:PRU00388, ECO:0000255|PROSITE-ProRule:PRU10133, ECO:0000269|PubMed:20061386, ECO:0000269|PubMed:38605244};",2.3.2.23,,PATHWAY: Protein modification; protein ubiquitination. {ECO:0000255|PROSITE-ProRule:PRU00388}.,ENST00000342192.9 [P68036-1];ENST00000458578.6 [P68036-3];ENST00000545681.2 [P68036-2];,UBE2L3,ENSG00000185651,0.0,UBE2L3,Non-canonical_RBPs,7.0,,,,,,UBE2L3
P68104,ENSG00000156508,EF1A1_HUMAN,cellular response to epidermal growth factor stimulus [GO:0071364]; positive regulation by host of viral genome replication [GO:0044829]; regulation of chaperone-mediated autophagy [GO:1904714]; regulation of D-erythro-sphingosine kinase activity [GO:1900022]; translation [GO:0006412]; translational elongation [GO:0006414],cortical actin cytoskeleton [GO:0030864]; cytoplasm [GO:0005737]; cytoplasmic side of lysosomal membrane [GO:0098574]; cytosol [GO:0005829]; cytosolic ribosome [GO:0022626]; eukaryotic translation elongation factor 1 complex [GO:0005853]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; nucleolus [GO:0005730]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ribosome [GO:0005840]; ruffle membrane [GO:0032587]; secretory granule lumen [GO:0034774],GTP binding [GO:0005525]; GTPase activity [GO:0003924]; kinase binding [GO:0019900]; molecular adaptor activity [GO:0060090]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723]; translation elongation factor activity [GO:0003746]; tRNA binding [GO:0000049],"PTM: ISGylated. {ECO:0000269|PubMed:16139798}.; PTM: Phosphorylated by TXK (PubMed:17177976). Phosphorylation by PASK increases translation efficiency (PubMed:17595531). Phosphorylated by ROCK2 (PubMed:26497934). Phosphorylation by TGFBR1 inhibits translation elongation (PubMed:20832312). {ECO:0000269|PubMed:17177976, ECO:0000269|PubMed:17595531, ECO:0000269|PubMed:20832312, ECO:0000269|PubMed:26497934}.; PTM: Trimethylated at Lys-79 by EEF1AKMT1 (PubMed:26545399). Methylated at Lys-165 by EEF1AKMT3, methylation by EEF1AKMT3 is dynamic as well as inducible by stress conditions, such as ER-stress, and plays a regulatory role on mRNA translation (PubMed:28108655). Trimethylated at Lys-318 by EEF1AKMT2 (PubMed:25144183). Mono-, di-, and trimethylated at Lys-36 by EEF1AKMT4; trimethylated form is predominant. Methylation by EEF1AKMT4 contributes to the fine-tuning of translation rates for a subset of tRNAs (PubMed:28520920). Trimethylated at Gly-2 by METTL13 (PubMed:30143613). Mono- and dimethylated at Lys-55 by METTL13; dimethylated form is predominant (PubMed:30143613, PubMed:30612740). {ECO:0000269|PubMed:25144183, ECO:0000269|PubMed:26545399, ECO:0000269|PubMed:28108655, ECO:0000269|PubMed:28520920, ECO:0000269|PubMed:30143613, ECO:0000269|PubMed:30612740}.; PTM: Ubiquitinated at Lys-385 by RNF14 in response to ribosome collisions (ribosome stalling), leading to its degradation by the proteasome and rescue of stalled ribosomes. {ECO:0000269|PubMed:36638793}.",,"DOMAIN 5..242; /note=""tr-type G""",,,,"cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,EEF1A1 EEF1A EF1A LENG7,Elongation factor 1-alpha 1 (EF-1-alpha-1) (EC 3.6.5.-) (Elongation factor Tu) (EF-Tu) (Eukaryotic elongation factor 1 A-1) (eEF1A-1) (Leukocyte receptor cluster member 7),Homo sapiens (Human),462.0,50141.0,MGKEKTHINIVVIGHVDSGKSTTTGHLIYKCGGIDKRTIEKFEKEAAEMGKGSFKYAWVLDKLKAERERGITIDISLWKFETSKYYVTIIDAPGHRDFIKNMITGTSQADCAVLIVAAGVGEFEAGISKNGQTREHALLAYTLGVKQLIVGVNKMDSTEPPYSQKRYEEIVKEVSTYIKKIGYNPDTVAFVPISGWNGDNMLEPSANMPWFKGWKVTRKDGNASGTTLLEALDCILPPTRPTDKPLRLPLQDVYKIGGIGTVPVGRVETGVLKPGMVVTFAPVNVTTEVKSVEMHHEALSEALPGDNVGFNVKNVSVKDVRRGNVAGDSKNDPPMEAAGFTAQVIILNHPGQISAGYAPVLDCHTAHIACKFAELKEKIDRRSGKKLEDGPKFLKSGDAAIVDMVPGKPMCVESFSDYPPLGRFAVRDMRQTVAVGVIKAVDKKAAGAGKVTKSAQKAQKAK,True,True,False,P68104,"[('cd01883', 'Elongation Factor 1-alpha (EF1-alpha) protein family'), ('cd03693', 'Domain II of elongation factor 1-alpha'), ('cd03705', 'Domain III of Elongation Factor 1'), ('G3DSA:2.40.30.10', 'Translation factors'), ('G3DSA:3.40.50.300', 'P-loop containing nucleotide triphosphate hydrolases'), ('IPR000795', 'Translational (tr)-type GTP-binding domain'), ('IPR004161', 'Translation elongation factor EFTu-like, domain 2'), ('IPR004539', 'Translation elongation factor EF1A, eukaryotic/archaeal'), ('IPR009000', 'Translation protein, beta-barrel domain superfamily'), ('IPR009001', 'Translation elongation factor EF1A/initiation factor IF2gamma, C-terminal'), ('IPR027417', 'P-loop containing nucleoside triphosphate hydrolase'), ('IPR031157', 'Tr-type G domain, conserved site'), ('IPR050100', 'Translation factor GTPase superfamily members'), ('IPR054696', 'GTP-eEF1A, C-terminal domain'), ('MF_00118_A', 'Elongation factor Tu [tuf]'), ('PF00009', 'Elongation factor Tu GTP binding domain'), ('PF03144', 'Elongation factor Tu domain 2'), ('PF22594', 'GTP-eEF1A C-terminal domain-like'), ('PR00315', 'ELONGATNFCT'), ('PS00301', 'Translational (tr)-type guanine nucleotide-binding (G) domain signature')]",,"""ENSG00000156508; Low tissue specificity."";","CATALYTIC ACTIVITY: Reaction=GTP + H2O = GDP + phosphate + H(+); Xref=Rhea:RHEA:19669, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:37565, ChEBI:CHEBI:43474, ChEBI:CHEBI:58189; Evidence={ECO:0000305|PubMed:26593721}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:19670; Evidence={ECO:0000305|PubMed:26593721};",3.6.5.-,"ACTIVITY REGULATION: Inhibited by plitidepsin, a chemical compound extracted from the ascidian Aplidium albicans (PubMed:33495306). Specifically inhibited by didemnin B, a natural product that triggers ribosome stalling by preventing aminoacyl-tRNA (aa-tRNA) release from EEF1A1 on the ribosome (PubMed:26651998, PubMed:36264623). Specifically inhibited by ternatin-4, a small-molecule inhibitor that triggers ribosome stalling by traping EEF1A1 on the ribosome and preventing aminoacyl-tRNA (aa-tRNA) accommodation (PubMed:26651998, PubMed:36123449, PubMed:36264623, PubMed:36638793). Ribosome stalling by ternatin-4 causes ubiquitination and degradation of EEF1A1 (PubMed:36638793). Specifically inhibited by ternatin SR-A3, which differs from ternatin-4 by the addition of a single oxygen atom into the side chain of N-Me-Leu (PubMed:36123449). Inhibition by ternatin-4 can be reversed, while it is not the case for didemnin B (PubMed:36264623). {ECO:0000269|PubMed:26651998, ECO:0000269|PubMed:33495306, ECO:0000269|PubMed:36123449, ECO:0000269|PubMed:36264623, ECO:0000269|PubMed:36638793}.",,ENST00000309268.11;ENST00000316292.13;ENST00000331523.7;ENST00000356303.7;ENST00000455918.2;ENST00000615060.5;ENST00000676710.1;ENST00000677236.1;ENST00000678508.1;ENST00000678702.1;,EEF1A1,ENSG00000156508,0.0,EEF1A1,Canonical_RBPs,25.0,,,,,,EEF1A1
P68400,ENSG00000101266,CSK21_HUMAN,apoptotic process [GO:0006915]; chaperone-mediated protein folding [GO:0061077]; DNA damage response [GO:0006974]; double-strand break repair [GO:0006302]; negative regulation of apoptotic signaling pathway [GO:2001234]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of double-strand break repair via homologous recombination [GO:2000042]; negative regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032435]; negative regulation of translation [GO:0017148]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of aggrephagy [GO:1905337]; positive regulation of cell growth [GO:0030307]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of protein catabolic process [GO:0045732]; positive regulation of Wnt signaling pathway [GO:0030177]; protein phosphorylation [GO:0006468]; protein stabilization [GO:0050821]; regulation of cell cycle [GO:0051726]; regulation of chromosome separation [GO:1905818]; rhythmic process [GO:0048511]; signal transduction [GO:0007165]; symbiont-mediated disruption of host cell PML body [GO:0075342]; Wnt signaling pathway [GO:0016055],cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; PML body [GO:0016605]; protein kinase CK2 complex [GO:0005956]; Sin3-type complex [GO:0070822],ATP binding [GO:0005524]; histone H2AS1 kinase activity [GO:0044024]; Hsp90 protein binding [GO:0051879]; identical protein binding [GO:0042802]; kinase activity [GO:0016301]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],"PTM: Phosphorylated at Thr-344, Thr-360, Ser-362 and Ser-370 by CDK1 in prophase and metaphase and dephosphorylated during anaphase. Phosphorylation does not directly affect casein kinase 2 activity, but may contribute to its regulation by forming binding sites for interacting proteins and/or targeting it to different compartments. {ECO:0000269|PubMed:7592773}.",,"DOMAIN 39..324; /note=""Protein kinase""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00159""","STRAND 10..12; /evidence=""ECO:0007829|PDB:3WAR""; STRAND 29..32; /evidence=""ECO:0007829|PDB:6YZH""; STRAND 39..47; /evidence=""ECO:0007829|PDB:3WAR""; STRAND 49..58; /evidence=""ECO:0007829|PDB:3WAR""; STRAND 64..70; /evidence=""ECO:0007829|PDB:3WAR""; STRAND 97..102; /evidence=""ECO:0007829|PDB:3WAR""; STRAND 107..114; /evidence=""ECO:0007829|PDB:3WAR""; STRAND 162..165; /evidence=""ECO:0007829|PDB:3WAR""; STRAND 170..173; /evidence=""ECO:0007829|PDB:3WAR""; STRAND 230..233; /evidence=""ECO:0007829|PDB:3WAR""; STRAND 333..335; /evidence=""ECO:0007829|PDB:1JWH""","HELIX 21..24; /evidence=""ECO:0007829|PDB:3WAR""; HELIX 26..28; /evidence=""ECO:0007829|PDB:3WAR""; HELIX 36..38; /evidence=""ECO:0007829|PDB:3WAR""; HELIX 72..74; /evidence=""ECO:0007829|PDB:7ZYK""; HELIX 75..88; /evidence=""ECO:0007829|PDB:3WAR""; HELIX 121..124; /evidence=""ECO:0007829|PDB:3WAR""; HELIX 125..127; /evidence=""ECO:0007829|PDB:3WAR""; HELIX 130..149; /evidence=""ECO:0007829|PDB:3WAR""; HELIX 159..161; /evidence=""ECO:0007829|PDB:3WAR""; HELIX 166..168; /evidence=""ECO:0007829|PDB:3WAR""; HELIX 176..178; /evidence=""ECO:0007829|PDB:5ZN2""; HELIX 195..197; /evidence=""ECO:0007829|PDB:3WAR""; HELIX 200..203; /evidence=""ECO:0007829|PDB:3WAR""; HELIX 212..227; /evidence=""ECO:0007829|PDB:3WAR""; HELIX 238..249; /evidence=""ECO:0007829|PDB:3WAR""; HELIX 251..261; /evidence=""ECO:0007829|PDB:3WAR""; HELIX 267..269; /evidence=""ECO:0007829|PDB:3WAR""; HELIX 281..284; /evidence=""ECO:0007829|PDB:3WAR""; HELIX 290..292; /evidence=""ECO:0007829|PDB:3WAR""; HELIX 295..304; /evidence=""ECO:0007829|PDB:3WAR""; HELIX 309..311; /evidence=""ECO:0007829|PDB:3WAR""; HELIX 315..318; /evidence=""ECO:0007829|PDB:3WAR""; HELIX 322..324; /evidence=""ECO:0007829|PDB:3WAR""; HELIX 325..331; /evidence=""ECO:0007829|PDB:3WAR""","TURN 13..18; /evidence=""ECO:0007829|PDB:3WAR""; TURN 59..61; /evidence=""ECO:0007829|PDB:3WAR""; TURN 104..106; /evidence=""ECO:0007829|PDB:3WAR""; TURN 118..120; /evidence=""ECO:0007829|PDB:5CVG""; TURN 270..272; /evidence=""ECO:0007829|PDB:3WAR""; TURN 287..289; /evidence=""ECO:0007829|PDB:3WAR""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,CSNK2A1 CK2A1,Casein kinase II subunit alpha (CK II alpha) (EC 2.7.11.1),Homo sapiens (Human),391.0,45144.0,MSGPVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKDQARMGSSSMPGGSTPVSSANMMSGISSVPTPSPLGPLAGSPVIAAANPLGMPVPAAAGAQQ,False,False,True,P68400,"[('cd14132', 'Catalytic subunit (alpha) of the Serine/Threonine Kinase, Casein Kinase 2'), ('G3DSA:1.10.510.10', 'Transferase(Phosphotransferase) domain 1'), ('G3DSA:3.30.200.20', 'Phosphorylase Kinase; domain 1'), ('IPR000719', 'Protein kinase domain'), ('IPR008271', 'Serine/threonine-protein kinase, active site'), ('IPR011009', 'Protein kinase-like domain superfamily'), ('IPR017441', 'Protein kinase, ATP binding site'), ('IPR045216', 'Casein Kinase 2, subunit alpha'), ('PF00069', 'Protein kinase domain'), ('PS00107', 'Protein kinases ATP-binding region signature'), ('PS00108', 'Serine/Threonine protein kinases active-site signature'), ('PS50011', 'Protein kinase domain profile'), ('PTHR24054', 'CASEIN KINASE II SUBUNIT ALPHA'), ('SM00220', 'Serine/Threonine protein kinases, catalytic domain'), ('SSF56112', 'Protein kinase-like (PK-like)')]",,"""ENSG00000101266; Low tissue specificity."";","CATALYTIC ACTIVITY: Reaction=L-seryl-[protein] + ATP = O-phospho-L-seryl-[protein] + ADP + H(+); Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616, ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.1; Evidence={ECO:0000269|PubMed:18411307, ECO:0000269|PubMed:18583988, ECO:0000269|PubMed:18678890, ECO:0000269|PubMed:20545769, ECO:0000269|PubMed:20625391, ECO:0000269|PubMed:21482717, ECO:0000269|PubMed:22017874, ECO:0000269|PubMed:22184066, ECO:0000269|PubMed:23123191, ECO:0000269|PubMed:28512243, ECO:0000269|PubMed:30699359, ECO:0000269|PubMed:30898438, ECO:0000269|PubMed:31439799}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:17990; Evidence={ECO:0000269|PubMed:18411307, ECO:0000269|PubMed:18583988, ECO:0000269|PubMed:18678890, ECO:0000269|PubMed:20545769, ECO:0000269|PubMed:21482717, ECO:0000269|PubMed:23123191, ECO:0000269|PubMed:28512243, ECO:0000269|PubMed:30699359, ECO:0000269|PubMed:30898438, ECO:0000269|PubMed:31439799, ECO:0000269|PubMed:35597237}; CATALYTIC ACTIVITY: Reaction=L-threonyl-[protein] + ATP = O-phospho-L-threonyl-[protein] + ADP + H(+); Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060, Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013, ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216; EC=2.7.11.1; Evidence={ECO:0000269|PubMed:18411307, ECO:0000269|PubMed:18583988, ECO:0000269|PubMed:18678890, ECO:0000269|PubMed:20625391, ECO:0000269|PubMed:22325354, ECO:0000269|PubMed:31439799}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:46609; Evidence={ECO:0000269|PubMed:18411307, ECO:0000269|PubMed:18583988, ECO:0000269|PubMed:18678890, ECO:0000269|PubMed:31439799};",2.7.11.1,ACTIVITY REGULATION: Constitutively active protein kinase whose activity is not directly affected by phosphorylation. Seems to be regulated by level of expression and localization.,,ENST00000217244.9 [P68400-1];ENST00000349736.10 [P68400-2];ENST00000400217.7 [P68400-1];ENST00000643660.1 [P68400-1];ENST00000644003.1 [P68400-2];ENST00000645623.1 [P68400-1];ENST00000646305.1 [P68400-1];ENST00000646477.1 [P68400-2];ENST00000646561.1 [P68400-1];ENST00000646814.1 [P68400-1];ENST00000647348.1 [P68400-1];,CSNK2A1,ENSG00000101266,0.0,,,,,,,0.148,,CSNK2A1
P78352,ENSG00000132535,DLG4_HUMAN,AMPA glutamate receptor clustering [GO:0097113]; cell-cell adhesion [GO:0098609]; cellular response to potassium ion [GO:0035865]; chemical synaptic transmission [GO:0007268]; dendritic spine morphogenesis [GO:0060997]; establishment of protein localization [GO:0045184]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; learning [GO:0007612]; locomotory exploration behavior [GO:0035641]; negative regulation of receptor internalization [GO:0002091]; nervous system development [GO:0007399]; neuromuscular process controlling balance [GO:0050885]; neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0099645]; NMDA selective glutamate receptor signaling pathway [GO:0098989]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of neuron projection arborization [GO:0150012]; positive regulation of synaptic transmission [GO:0050806]; postsynaptic neurotransmitter receptor diffusion trapping [GO:0098970]; protein localization to synapse [GO:0035418]; protein-containing complex assembly [GO:0065003]; receptor localization to synapse [GO:0097120]; regulation of grooming behavior [GO:2000821]; regulation of long-term neuronal synaptic plasticity [GO:0048169]; signal transduction [GO:0007165]; social behavior [GO:0035176]; synaptic vesicle maturation [GO:0016188]; vocalization behavior [GO:0071625],adherens junction [GO:0005912]; AMPA glutamate receptor complex [GO:0032281]; basolateral plasma membrane [GO:0016323]; cell junction [GO:0030054]; cerebellar mossy fiber [GO:0044300]; cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite cytoplasm [GO:0032839]; dendritic spine [GO:0043197]; endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum [GO:0005783]; excitatory synapse [GO:0060076]; glutamatergic synapse [GO:0098978]; juxtaparanode region of axon [GO:0044224]; neuromuscular junction [GO:0031594]; neuron projection [GO:0043005]; neuron projection terminus [GO:0044306]; neuron spine [GO:0044309]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic density membrane [GO:0098839]; postsynaptic membrane [GO:0045211]; synapse [GO:0045202]; synaptic membrane [GO:0097060]; synaptic vesicle [GO:0008021],acetylcholine receptor binding [GO:0033130]; beta-1 adrenergic receptor binding [GO:0031697]; D1 dopamine receptor binding [GO:0031748]; ionotropic glutamate receptor binding [GO:0035255]; kinase binding [GO:0019900]; neuroligin family protein binding [GO:0097109]; P2Y1 nucleotide receptor binding [GO:0031812]; PDZ domain binding [GO:0030165]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; protein-containing complex binding [GO:0044877]; scaffold protein binding [GO:0097110],"PTM: Palmitoylated (PubMed:26701913). Palmitoylation is required for targeting to postsynaptic density, plasma membrane and synapses (By similarity). Palmitoylation by ZDHHC2 occurs when the synaptic activity decreases and induces DLG4 synaptic clustering (By similarity). Palmitoylation by ZDHHC15 regulates trafficking to the postsynaptic density and function in synaptogenesis (By similarity). Palmitoylation may play a role in glutamate receptor GRIA1 synapse clustering (By similarity). Depalmitoylated by ABHD17A and ABHD17B and to a lesser extent by ABHD17C, ABHD12, ABHD13, LYPLA1 and LYPLA2 (PubMed:26701913). Undergoes rapid synaptic palmitoylation/depalmitoylation cycles during neuronal development which slow down in mature neurons (By similarity). {ECO:0000250|UniProtKB:P31016, ECO:0000269|PubMed:26701913}.; PTM: Ubiquitinated by MDM2 in response to NMDA receptor activation, leading to proteasome-mediated degradation of DLG4 which is required for AMPA receptor endocytosis. {ECO:0000250|UniProtKB:P31016}.",DOMAIN: The PDZ domain 3 mediates interaction with ADR1B.; DOMAIN: The L27 domain near the N-terminus of isoform 2 is required for HGS/HRS-dependent targeting to postsynaptic density.,"DOMAIN 65..151; /note=""PDZ 1""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00143""; DOMAIN 160..246; /note=""PDZ 2""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00143""; DOMAIN 313..393; /note=""PDZ 3""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00143""; DOMAIN 428..498; /note=""SH3""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00192""; DOMAIN 534..709; /note=""Guanylate kinase-like""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00100""","STRAND 61..69; /evidence=""ECO:0007829|PDB:6SPV""; STRAND 72..74; /evidence=""ECO:0007829|PDB:1KEF""; STRAND 76..85; /evidence=""ECO:0007829|PDB:6SPV""; STRAND 87..90; /evidence=""ECO:0007829|PDB:1KEF""; STRAND 94..99; /evidence=""ECO:0007829|PDB:6SPV""; STRAND 116..120; /evidence=""ECO:0007829|PDB:6SPV""; STRAND 126..128; /evidence=""ECO:0007829|PDB:1KEF""; STRAND 142..151; /evidence=""ECO:0007829|PDB:6SPV""; STRAND 157..164; /evidence=""ECO:0007829|PDB:6SPV""; STRAND 171..176; /evidence=""ECO:0007829|PDB:6SPV""; STRAND 178..180; /evidence=""ECO:0007829|PDB:3ZRT""; STRAND 189..194; /evidence=""ECO:0007829|PDB:6SPV""; STRAND 211..215; /evidence=""ECO:0007829|PDB:6SPV""; STRAND 237..245; /evidence=""ECO:0007829|PDB:6SPV""; STRAND 308..310; /evidence=""ECO:0007829|PDB:8AH5""; STRAND 312..317; /evidence=""ECO:0007829|PDB:6QJL""; STRAND 324..331; /evidence=""ECO:0007829|PDB:6QJL""; STRAND 334..341; /evidence=""ECO:0007829|PDB:6QJL""; STRAND 343..345; /evidence=""ECO:0007829|PDB:5JXB""; STRAND 357..362; /evidence=""ECO:0007829|PDB:6QJL""; STRAND 384..392; /evidence=""ECO:0007829|PDB:6QJL""","HELIX 2..15; /evidence=""ECO:0007829|PDB:2MES""; HELIX 104..108; /evidence=""ECO:0007829|PDB:6SPV""; HELIX 130..138; /evidence=""ECO:0007829|PDB:6SPV""; HELIX 199..203; /evidence=""ECO:0007829|PDB:6SPV""; HELIX 225..233; /evidence=""ECO:0007829|PDB:6SPV""; HELIX 346..350; /evidence=""ECO:0007829|PDB:6QJL""; HELIX 372..380; /evidence=""ECO:0007829|PDB:6QJL""; HELIX 394..400; /evidence=""ECO:0007829|PDB:6QJL""","TURN 302..305; /evidence=""ECO:0007829|PDB:8AH7""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,DLG4 PSD95,Disks large homolog 4 (Postsynaptic density protein 95) (PSD-95) (Synapse-associated protein 90) (SAP-90) (SAP90),Homo sapiens (Human),724.0,80495.0,MDCLCIVTTKKYRYQDEDTPPLEHSPAHLPNQANSPPVIVNTDTLEAPGYELQVNGTEGEMEYEEITLERGNSGLGFSIAGGTDNPHIGDDPSIFITKIIPGGAAAQDGRLRVNDSILFVNEVDVREVTHSAAVEALKEAGSIVRLYVMRRKPPAEKVMEIKLIKGPKGLGFSIAGGVGNQHIPGDNSIYVTKIIEGGAAHKDGRLQIGDKILAVNSVGLEDVMHEDAVAALKNTYDVVYLKVAKPSNAYLSDSYAPPDITTSYSQHLDNEISHSSYLGTDYPTAMTPTSPRRYSPVAKDLLGEEDIPREPRRIVIHRGSTGLGFNIVGGEDGEGIFISFILAGGPADLSGELRKGDQILSVNGVDLRNASHEQAAIALKNAGQTVTIIAQYKPEEYSRFEAKIHDLREQLMNSSLGSGTASLRSNPKRGFYIRALFDYDKTKDCGFLSQALSFRFGDVLHVIDASDEEWWQARRVHSDSETDDIGFIPSKRRVERREWSRLKAKDWGSSSGSQGREDSVLSYETVTQMEVHYARPIIILGPTKDRANDDLLSEFPDKFGSCVPHTTRPKREYEIDGRDYHFVSSREKMEKDIQAHKFIEAGQYNSHLYGTSVQSVREVAEQGKHCILDVSANAVRRLQAAHLHPIAIFIRPRSLENVLEINKRITEEQARKAFDRATKLEQEFTECFSAIVEGDSFEEIYHKVKRVIEDLSGPYIWVPARERL,False,False,True,P78352,"[('cd00071', 'GMPK'), ('cd00992', 'PDZ_signaling'), ('cd12030', 'Src Homology 3 domain of Disks Large homolog 4'), ('G3DSA:2.30.30.40', 'SH3 Domains'), ('G3DSA:2.30.42.10', None), ('G3DSA:3.30.63.10', 'Guanylate Kinase phosphate binding domain'), ('G3DSA:3.40.50.300', 'P-loop containing nucleotide triphosphate hydrolases'), ('IPR001452', 'SH3 domain'), ('IPR001478', 'PDZ domain'), ('IPR008144', 'Guanylate kinase-like domain'), ('IPR008145', 'Guanylate kinase/L-type calcium channel beta subunit'), ('IPR016313', 'Disks large 1-like'), ('IPR019583', 'Disks large homolog 1-4, PDZ-associated domain'), ('IPR019590', 'Disks large homologue 1, N-terminal PEST domain'), ('IPR020590', 'Guanylate kinase, conserved site'), ('IPR027417', 'P-loop containing nucleoside triphosphate hydrolase'), ('IPR036028', 'SH3-like domain superfamily'), ('IPR036034', 'PDZ superfamily'), ('IPR050614', 'Synaptic Scaffolding LAP/MAGUK Families'), ('PF00018', 'SH3 domain')]",,"""ENSG00000132535; Group enriched (brain, pituitary gland, retina)."";",,,,,ENST00000302955.11 [P78352-3];ENST00000399506.9 [P78352-1];ENST00000648172.9 [P78352-2];,DLG4,ENSG00000132535,0.0,,,,9.81,DP03924,0.098,0.221,0.029,DLG4
P78362,ENSG00000135250,SRPK2_HUMAN,"angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; negative regulation of viral genome replication [GO:0045071]; nuclear speck organization [GO:0035063]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of cell cycle [GO:0045787]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of viral genome replication [GO:0045070]; protein phosphorylation [GO:0006468]; R-loop processing [GO:0062176]; regulation of mRNA processing [GO:0050684]; regulation of mRNA splicing, via spliceosome [GO:0048024]; RNA splicing [GO:0008380]; spliceosomal complex assembly [GO:0000245]",chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; presynapse [GO:0098793],14-3-3 protein binding [GO:0071889]; ATP binding [GO:0005524]; histone H2AS1 kinase activity [GO:0044024]; magnesium ion binding [GO:0000287]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; RNA binding [GO:0003723],"PTM: Phosphorylation at Thr-492 by PKB/AKT1 enhances its stimulatory activity in triggering cyclin-D1 (CCND1) expression and promoting apoptosis in neurons, which can be blocked by YWHAB. It also enhances its protein kinase activity toward ACIN1 and SRSF2, promotes its nuclear translocation and prevents its proteolytic cleavage. {ECO:0000269|PubMed:19592491}.; PTM: Proteolytically cleaved at Asp-139 and Asp-403 by caspase-3 during apoptotic cell death. Cleavage at Asp-139 which is the major site of cleavage, produces a small N-terminal fragment that translocates into nucleus and promotes VP16-induced apoptosis. {ECO:0000269|PubMed:21056976}.",,"DOMAIN 81..684; /note=""Protein kinase""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00159""","STRAND 81..89; /evidence=""ECO:0007829|PDB:7ZKX""; STRAND 91..100; /evidence=""ECO:0007829|PDB:7ZKX""; STRAND 105..112; /evidence=""ECO:0007829|PDB:7ZKX""; STRAND 150..154; /evidence=""ECO:0007829|PDB:7ZKX""; STRAND 161..166; /evidence=""ECO:0007829|PDB:7ZKX""; STRAND 220..222; /evidence=""ECO:0007829|PDB:7ZKX""; STRAND 526..528; /evidence=""ECO:0007829|PDB:7ZKX""; STRAND 630..632; /evidence=""ECO:0007829|PDB:7ZKX""","HELIX 116..134; /evidence=""ECO:0007829|PDB:7ZKX""; HELIX 140..144; /evidence=""ECO:0007829|PDB:7ZKX""; HELIX 173..179; /evidence=""ECO:0007829|PDB:7ZKX""; HELIX 187..206; /evidence=""ECO:0007829|PDB:7ZKX""; HELIX 217..219; /evidence=""ECO:0007829|PDB:7ZKX""; HELIX 226..234; /evidence=""ECO:0007829|PDB:7ZKX""; HELIX 518..523; /evidence=""ECO:0007829|PDB:7ZKX""; HELIX 531..533; /evidence=""ECO:0007829|PDB:7ZKX""; HELIX 548..550; /evidence=""ECO:0007829|PDB:7ZKX""; HELIX 553..557; /evidence=""ECO:0007829|PDB:7ZKX""; HELIX 564..579; /evidence=""ECO:0007829|PDB:7ZKX""; HELIX 594..606; /evidence=""ECO:0007829|PDB:7ZKX""; HELIX 611..614; /evidence=""ECO:0007829|PDB:7ZKX""; HELIX 620..623; /evidence=""ECO:0007829|PDB:7ZKX""; HELIX 641..647; /evidence=""ECO:0007829|PDB:7ZKX""; HELIX 653..663; /evidence=""ECO:0007829|PDB:7ZKX""; HELIX 664..667; /evidence=""ECO:0007829|PDB:7ZKX""; HELIX 671..673; /evidence=""ECO:0007829|PDB:7ZKX""; HELIX 677..681; /evidence=""ECO:0007829|PDB:7ZKX""; HELIX 684..686; /evidence=""ECO:0007829|PDB:7ZKX""","TURN 78..80; /evidence=""ECO:0007829|PDB:7ZKX""; TURN 101..104; /evidence=""ECO:0007829|PDB:7ZKX""; TURN 180..182; /evidence=""ECO:0007829|PDB:7ZKX""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,SRPK2,SRSF protein kinase 2 (EC 2.7.11.1) (SFRS protein kinase 2) (Serine/arginine-rich protein-specific kinase 2) (SR-protein-specific kinase 2) [Cleaved into: SRSF protein kinase 2 N-terminal; SRSF protein kinase 2 C-terminal],Homo sapiens (Human),688.0,77527.0,MSVNSEKSSSSERPEPQQKAPLVPPPPPPPPPPPPPLPDPTPPEPEEEILGSDDEEQEDPADYCKGGYHPVKIGDLFNGRYHVIRKLGWGHFSTVWLCWDMQGKRFVAMKVVKSAQHYTETALDEIKLLKCVRESDPSDPNKDMVVQLIDDFKISGMNGIHVCMVFEVLGHHLLKWIIKSNYQGLPVRCVKSIIRQVLQGLDYLHSKCKIIHTDIKPENILMCVDDAYVRRMAAEATEWQKAGAPPPSGSAVSTAPQQKPIGKISKNKKKKLKKKQKRQAELLEKRLQEIEELEREAERKIIEENITSAAPSNDQDGEYCPEVKLKTTGLEEAAEAETAKDNGEAEDQEEKEDAEKENIEKDEDDVDQELANIDPTWIESPKTNGHIENGPFSLEQQLDDEDDDEEDCPNPEEYNLDEPNAESDYTYSSSYEQFNGELPNGRHKIPESQFPEFSTSLFSGSLEPVACGSVLSEGSPLTEQEESSPSHDRSRTVSASSTGDLPKAKTRAADLLVNPLDPRNADKIRVKIADLGNACWVHKHFTEDIQTRQYRSIEVLIGAGYSTPADIWSTACMAFELATGDYLFEPHSGEDYSRDEDHIAHIIELLGSIPRHFALSGKYSREFFNRRGELRHITKLKPWSLFDVLVEKYGWPHEDAAQFTDFLIPMLEMVPEKRASAGECLRHPWLNS,False,False,True,P78362,"[('G3DSA:1.10.510.10', 'Transferase(Phosphotransferase) domain 1'), ('G3DSA:3.30.200.20', 'Phosphorylase Kinase; domain 1'), ('IPR000719', 'Protein kinase domain'), ('IPR008271', 'Serine/threonine-protein kinase, active site'), ('IPR011009', 'Protein kinase-like domain superfamily'), ('IPR017441', 'Protein kinase, ATP binding site'), ('IPR051334', 'Serine/Arginine-Rich Protein Kinases'), ('PF00069', 'Protein kinase domain'), ('PS00107', 'Protein kinases ATP-binding region signature'), ('PS00108', 'Serine/Threonine protein kinases active-site signature'), ('PS50011', 'Protein kinase domain profile'), ('PTHR47634', 'Serine/Arginine-Rich Protein Kinases'), ('SM00220', 'Serine/Threonine protein kinases, catalytic domain'), ('SSF101447', 'Formin homology 2 domain (FH2 domain)'), ('SSF56112', 'Protein kinase-like (PK-like)')]",,"""ENSG00000135250; Tissue enhanced (testis)."";","CATALYTIC ACTIVITY: Reaction=L-seryl-[protein] + ATP = O-phospho-L-seryl-[protein] + ADP + H(+); Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616, ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.1; Evidence={ECO:0000269|PubMed:12134018, ECO:0000269|PubMed:18559500, ECO:0000269|PubMed:9472028, ECO:0000305|PubMed:21157427}; CATALYTIC ACTIVITY: Reaction=L-threonyl-[protein] + ATP = O-phospho-L-threonyl-[protein] + ADP + H(+); Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060, Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013, ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216; EC=2.7.11.1; Evidence={ECO:0000269|PubMed:12134018, ECO:0000269|PubMed:9472028, ECO:0000305|PubMed:21157427};",2.7.11.1,ACTIVITY REGULATION: Activated by phosphorylation on Ser-52 and Ser-588. {ECO:0000250|UniProtKB:Q96SB4}.,,ENST00000357311.7 [P78362-1];ENST00000393651.8 [P78362-2];ENST00000489828.5 [P78362-1];,SRPK2,ENSG00000135250,0.0,SRPK2,Non-canonical_RBPs,11.0,52.47,DP02591,0.525,0.398,0.368,SRPK2
P78545,ENSG00000163435,ELF3_HUMAN,blastocyst development [GO:0001824]; cell differentiation [GO:0030154]; extracellular matrix organization [GO:0030198]; inflammatory response [GO:0006954]; mammary gland involution [GO:0060056]; negative regulation of DNA-templated transcription [GO:0045892]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of transcription by RNA polymerase II [GO:0006357],chromatin [GO:0000785]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],"DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; sequence-specific double-stranded DNA binding [GO:1990837]",,DOMAIN: The 9aaTAD motif is a transactivation domain present in a large number of yeast and animal transcription factors. {ECO:0000269|PubMed:17467953}.,"DOMAIN 46..132; /note=""PNT""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00762""","STRAND 60..62; /evidence=""ECO:0007829|PDB:2E8P""","HELIX 64..66; /evidence=""ECO:0007829|PDB:2E8P""; HELIX 69..82; /evidence=""ECO:0007829|PDB:2E8P""; HELIX 100..104; /evidence=""ECO:0007829|PDB:2E8P""; HELIX 107..113; /evidence=""ECO:0007829|PDB:2E8P""; HELIX 115..117; /evidence=""ECO:0007829|PDB:2E8P""; HELIX 118..130; /evidence=""ECO:0007829|PDB:2E8P""","TURN 92..94; /evidence=""ECO:0007829|PDB:2E8P""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,ELF3 ERT ESX JEN,ETS-related transcription factor Elf-3 (E74-like factor 3) (Epithelial-restricted with serine box) (Epithelium-restricted Ets protein ESX) (Epithelium-specific Ets transcription factor 1) (ESE-1),Homo sapiens (Human),371.0,41454.0,MAATCEISNIFSNYFSAMYSSEDSTLASVPPAATFGADDLVLTLSNPQMSLEGTEKASWLGEQPQFWSKTQVLDWISYQVEKNKYDASAIDFSRCDMDGATLCNCALEELRLVFGPLGDQLHAQLRDLTSSSSDELSWIIELLEKDGMAFQEALDPGPFDQGSPFAQELLDDGQQASPYHPGSCGAGAPSPGSSDVSTAGTGASRSSHSSDSGGSDVDLDPTDGKLFPSDGFRDCKKGDPKHGKRKRGRPRKLSKEYWDCLEGKKSKHAPRGTHLWEFIRDILIHPELNEGLMKWENRHEGVFKFLRSEAVAQLWGQKKKNSNMTYEKLSRAMRYYYKREILERVDGRRLVYKFGKNSSGWKEEEVLQSRN,True,False,False,P78545,"[('cd08537', 'Sterile alpha motif (SAM)/Pointed domain of ESE-1 like ETS transcriptional regulators'), ('G3DSA:1.10.10.10', 'Winged helix-like DNA-binding domain superfamily/Winged helix DNA-binding domain'), ('G3DSA:1.10.150.50', 'Transcription Factor, Ets-1'), ('IPR000418', 'Ets domain'), ('IPR003118', 'Pointed domain'), ('IPR013761', 'Sterile alpha motif/pointed domain superfamily'), ('IPR036388', 'Winged helix-like DNA-binding domain superfamily'), ('IPR036390', 'Winged helix DNA-binding domain superfamily'), ('IPR042693', 'ETS-related transcription factor Elf-3, pointed domain'), ('IPR046328', 'ETS family'), ('PF00178', 'Ets-domain'), ('PF02198', 'Sterile alpha motif (SAM)/Pointed domain'), ('PR00454', 'ETSDOMAIN'), ('PS50061', 'Ets-domain profile'), ('PS51433', 'Pointed (PNT) domain profile'), ('PTHR11849', 'ETS'), ('SM00251', 'SAM / Pointed domain'), ('SM00413', 'erythroblast transformation specific domain'), ('SSF46785', '""Winged helix"" DNA-binding domain'), ('SSF47769', 'SAM/Pointed domain')]",,"""ENSG00000163435; Tissue enhanced (esophagus)."";",,,,,ENST00000359651.7 [P78545-1];ENST00000367283.7 [P78545-1];ENST00000367284.10 [P78545-1];,ELF3,ENSG00000163435,0.0,,,,,,,0.439,0.213,ELF3
P80188,ENSG00000148346,NGAL_HUMAN,apoptotic process [GO:0006915]; defense response to bacterium [GO:0042742]; innate immune response [GO:0045087]; positive regulation of cold-induced thermogenesis [GO:0120162]; siderophore transport [GO:0015891],extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; specific granule lumen [GO:0035580],enterobactin binding [GO:1903981]; identical protein binding [GO:0042802]; iron ion binding [GO:0005506]; iron ion sequestering activity [GO:0140315],,,,"STRAND 49..60; /evidence=""ECO:0007829|PDB:6GQZ""; STRAND 64..66; /evidence=""ECO:0007829|PDB:4MVK""; STRAND 73..78; /evidence=""ECO:0007829|PDB:6GQZ""; STRAND 84..92; /evidence=""ECO:0007829|PDB:6GQZ""; STRAND 95..105; /evidence=""ECO:0007829|PDB:6GQZ""; STRAND 111..114; /evidence=""ECO:0007829|PDB:6GQZ""; STRAND 123..133; /evidence=""ECO:0007829|PDB:6GQZ""; STRAND 135..147; /evidence=""ECO:0007829|PDB:6GQZ""; STRAND 150..162; /evidence=""ECO:0007829|PDB:6GQZ""; STRAND 193..195; /evidence=""ECO:0007829|PDB:6GQZ""","HELIX 33..35; /evidence=""ECO:0007829|PDB:6GQZ""; HELIX 44..47; /evidence=""ECO:0007829|PDB:6GQZ""; HELIX 67..70; /evidence=""ECO:0007829|PDB:6Z2C""; HELIX 117..119; /evidence=""ECO:0007829|PDB:6GQZ""; HELIX 166..178; /evidence=""ECO:0007829|PDB:6GQZ""; HELIX 183..185; /evidence=""ECO:0007829|PDB:6GQZ""","TURN 80..82; /evidence=""ECO:0007829|PDB:1NGL""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,LCN2 HNL NGAL,Neutrophil gelatinase-associated lipocalin (NGAL) (25 kDa alpha-2-microglobulin-related subunit of MMP-9) (Lipocalin-2) (Oncogene 24p3) (Siderocalin) (p25),Homo sapiens (Human),198.0,22588.0,MPLGLLWLGLALLGALHAQAQDSTSDLIPAPPLSKVPLQQNFQDNQFQGKWYVVGLAGNAILREDKDPQKMYATIYELKEDKSYNVTSVLFRKKKCDYWIRTFVPGCQPGEFTLGNIKSYPGLTSYLVRVVSTNYNQHAMVFFKKVSQNREYFKITLYGRTKELTSELKENFIRFSKSLGLPENHIVFPVPIDQCIDG,False,False,True,P80188,"[('cd19457', 'lipocalin 2 and similar proteins'), ('G3DSA:2.40.128.20', None), ('IPR000566', 'Lipocalin/cytosolic fatty-acid binding domain'), ('IPR002345', 'Lipocalin'), ('IPR003087', 'Neutrophil gelatinase-associated lipocalin/epididymal-specific lipocalin-12'), ('IPR012674', 'Calycin'), ('IPR022272', 'Lipocalin family conserved site'), ('PF00061', 'Lipocalin / cytosolic fatty-acid binding protein family'), ('PR00179', 'LIPOCALIN'), ('PR01275', 'NGELATINASE'), ('PS00213', 'Lipocalin signature'), ('PTHR11430', 'LIPOCALIN'), ('SSF50814', 'Lipocalins')]",,"""ENSG00000148346; Tissue enhanced (bone marrow, gallbladder, salivary gland)."";",,,,,ENST00000277480.7 [P80188-1];ENST00000373017.5 [P80188-1];,LCN2,ENSG00000148346,0.0,,,,,,,0.126,,LCN2
P84022,ENSG00000166949,SMAD3_HUMAN,activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; activin receptor signaling pathway [GO:0032924]; adrenal gland development [GO:0030325]; anatomical structure morphogenesis [GO:0009653]; cell differentiation [GO:0030154]; cell population proliferation [GO:0008283]; cell-cell junction organization [GO:0045216]; cellular response to glucose stimulus [GO:0071333]; cellular response to transforming growth factor beta stimulus [GO:0071560]; cellular response to virus [GO:0098586]; developmental growth [GO:0048589]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic foregut morphogenesis [GO:0048617]; embryonic pattern specification [GO:0009880]; endoderm development [GO:0007492]; extrinsic apoptotic signaling pathway [GO:0097191]; heart looping [GO:0001947]; immune response [GO:0006955]; immune system development [GO:0002520]; in utero embryonic development [GO:0001701]; JNK cascade [GO:0007254]; lens fiber cell differentiation [GO:0070306]; liver development [GO:0001889]; mesoderm formation [GO:0001707]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cardiac muscle hypertrophy in response to stress [GO:1903243]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cytosolic calcium ion concentration [GO:0051481]; negative regulation of fat cell differentiation [GO:0045599]; negative regulation of gene expression [GO:0010629]; negative regulation of inflammatory response [GO:0050728]; negative regulation of lung blood pressure [GO:0061767]; negative regulation of miRNA transcription [GO:1902894]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of osteoblast proliferation [GO:0033689]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of wound healing [GO:0061045]; nodal signaling pathway [GO:0038092]; osteoblast development [GO:0002076]; paraxial mesoderm morphogenesis [GO:0048340]; pericardium development [GO:0060039]; positive regulation of bone mineralization [GO:0030501]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of cell migration [GO:0030335]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of extracellular matrix assembly [GO:1901203]; positive regulation of focal adhesion assembly [GO:0051894]; positive regulation of gene expression [GO:0010628]; positive regulation of interleukin-1 beta production [GO:0032731]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of nitric oxide biosynthetic process [GO:0045429]; positive regulation of positive chemotaxis [GO:0050927]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of stress fiber assembly [GO:0051496]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta3 production [GO:0032916]; primary miRNA processing [GO:0031053]; protein stabilization [GO:0050821]; regulation of DNA-templated transcription [GO:0006355]; regulation of epithelial cell proliferation [GO:0050678]; regulation of immune response [GO:0050776]; regulation of miRNA transcription [GO:1902893]; regulation of striated muscle tissue development [GO:0016202]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]; regulation of transforming growth factor beta2 production [GO:0032909]; response to angiotensin [GO:1990776]; response to hypoxia [GO:0001666]; signal transduction involved in regulation of gene expression [GO:0023019]; SMAD protein signal transduction [GO:0060395]; somitogenesis [GO:0001756]; T cell activation [GO:0042110]; thyroid gland development [GO:0030878]; transdifferentiation [GO:0060290]; transforming growth factor beta receptor signaling pathway [GO:0007179]; ureteric bud development [GO:0001657]; wound healing [GO:0042060],chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; heteromeric SMAD protein complex [GO:0071144]; nuclear inner membrane [GO:0005637]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; receptor complex [GO:0043235]; SMAD protein complex [GO:0071141]; transcription regulator complex [GO:0005667],"beta-catenin binding [GO:0008013]; bHLH transcription factor binding [GO:0043425]; chromatin DNA binding [GO:0031490]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; co-SMAD binding [GO:0070410]; collagen binding [GO:0005518]; DEAD/H-box RNA helicase binding [GO:0017151]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; DNA-binding transcription repressor activity [GO:0001217]; I-SMAD binding [GO:0070411]; identical protein binding [GO:0042802]; nuclear glucocorticoid receptor binding [GO:0035259]; nuclear mineralocorticoid receptor binding [GO:0031962]; nuclear receptor binding [GO:0016922]; phosphatase binding [GO:0019902]; promoter-specific chromatin binding [GO:1990841]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; R-SMAD binding [GO:0070412]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific DNA binding [GO:0043565]; sterol response element binding [GO:0032810]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator binding [GO:0001223]; transcription corepressor binding [GO:0001222]; transforming growth factor beta receptor binding [GO:0005160]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; zinc ion binding [GO:0008270]","PTM: Phosphorylated on serine and threonine residues. Enhanced phosphorylation in the linker region on Thr-179, Ser-204 and Ser-208 on EGF and TGF-beta treatment. Ser-208 is the main site of MAPK-mediated phosphorylation. CDK-mediated phosphorylation occurs in a cell-cycle dependent manner and inhibits both the transcriptional activity and antiproliferative functions of SMAD3. This phosphorylation is inhibited by flavopiridol. Maximum phosphorylation at the G(1)/S junction. Also phosphorylated on serine residues in the C-terminal SXS motif by TGFBR1 and ACVR1. TGFBR1-mediated phosphorylation at these C-terminal sites is required for interaction with SMAD4, nuclear location and transactivational activity, and appears to be a prerequisite for the TGF-beta mediated phosphorylation in the linker region. Dephosphorylated in the C-terminal SXS motif by PPM1A. This dephosphorylation disrupts the interaction with SMAD4, promotes nuclear export and terminates TGF-beta-mediated signaling. Phosphorylation at Ser-418 by CSNK1G2/CK1 promotes ligand-dependent ubiquitination and subsequent proteasome degradation, thus inhibiting SMAD3-mediated TGF-beta responses. Phosphorylated by PDPK1. {ECO:0000269|PubMed:11224571, ECO:0000269|PubMed:15241418, ECO:0000269|PubMed:15588252, ECO:0000269|PubMed:16156666, ECO:0000269|PubMed:17327236, ECO:0000269|PubMed:18794808, ECO:0000269|PubMed:19218245, ECO:0000269|PubMed:21947082, ECO:0000269|PubMed:8774881, ECO:0000269|PubMed:9843571}.; PTM: Acetylation in the nucleus by EP300 in the MH2 domain regulates positively its transcriptional activity and is enhanced by TGF-beta. {ECO:0000269|PubMed:16862174}.; PTM: Poly-ADP-ribosylated by PARP1 and PARP2. ADP-ribosylation negatively regulates SMAD3 transcriptional responses during the course of TGF-beta signaling. {ECO:0000269|PubMed:25133494}.; PTM: Ubiquitinated. Monoubiquitinated, leading to prevent DNA-binding (PubMed:21947082). Deubiquitination by USP15 alleviates inhibition and promotes activation of TGF-beta target genes (PubMed:21947082). Ubiquitinated by RNF111, leading to its degradation: only SMAD3 proteins that are 'in use' are targeted by RNF111, RNF111 playing a key role in activating SMAD3 and regulating its turnover (By similarity). Undergoes STUB1-mediated ubiquitination and degradation (PubMed:24613385). {ECO:0000250|UniProtKB:Q8BUN5, ECO:0000269|PubMed:21947082, ECO:0000269|PubMed:24613385}.",DOMAIN: The MH1 domain is required for DNA binding. Also binds zinc ions which are necessary for the DNA binding.; DOMAIN: The MH2 domain is required for both homomeric and heteromeric interactions and for transcriptional regulation. Sufficient for nuclear import.; DOMAIN: The linker region is required for the TGFbeta-mediated transcriptional activity and acts synergistically with the MH2 domain.,"DOMAIN 10..136; /note=""MH1""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00438""; DOMAIN 232..425; /note=""MH2""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00439""","STRAND 60..62; /evidence=""ECO:0007829|PDB:5OD6""; STRAND 66..68; /evidence=""ECO:0007829|PDB:5OD6""; STRAND 71..73; /evidence=""ECO:0007829|PDB:6ZMN""; STRAND 75..77; /evidence=""ECO:0007829|PDB:5OD6""; STRAND 80..82; /evidence=""ECO:0007829|PDB:5OD6""; STRAND 103..105; /evidence=""ECO:0007829|PDB:5OD6""; STRAND 118..121; /evidence=""ECO:0007829|PDB:5OD6""; STRAND 127..129; /evidence=""ECO:0007829|PDB:5OD6""; STRAND 221..225; /evidence=""ECO:0007829|PDB:1MK2""; STRAND 231..239; /evidence=""ECO:0007829|PDB:1MJS""; STRAND 242..250; /evidence=""ECO:0007829|PDB:1MJS""; STRAND 252..258; /evidence=""ECO:0007829|PDB:1MJS""; STRAND 268..270; /evidence=""ECO:0007829|PDB:1MJS""; STRAND 294..299; /evidence=""ECO:0007829|PDB:1MJS""; STRAND 302..307; /evidence=""ECO:0007829|PDB:1MJS""; STRAND 309..311; /evidence=""ECO:0007829|PDB:1MJS""; STRAND 313..316; /evidence=""ECO:0007829|PDB:1MJS""; STRAND 332..334; /evidence=""ECO:0007829|PDB:1MJS""; STRAND 339..343; /evidence=""ECO:0007829|PDB:1MJS""; STRAND 371..377; /evidence=""ECO:0007829|PDB:1MJS""; STRAND 384..386; /evidence=""ECO:0007829|PDB:1MK2""; STRAND 392..400; /evidence=""ECO:0007829|PDB:1MJS""","HELIX 11..17; /evidence=""ECO:0007829|PDB:5OD6""; HELIX 25..44; /evidence=""ECO:0007829|PDB:5OD6""; HELIX 48..57; /evidence=""ECO:0007829|PDB:5OD6""; HELIX 84..92; /evidence=""ECO:0007829|PDB:5OD6""; HELIX 100..102; /evidence=""ECO:0007829|PDB:5OD6""; HELIX 113..115; /evidence=""ECO:0007829|PDB:5OD6""; HELIX 124..126; /evidence=""ECO:0007829|PDB:5OD6""; HELIX 271..273; /evidence=""ECO:0007829|PDB:1U7F""; HELIX 281..290; /evidence=""ECO:0007829|PDB:1MJS""; HELIX 318..321; /evidence=""ECO:0007829|PDB:1MJS""; HELIX 323..325; /evidence=""ECO:0007829|PDB:1MK2""; HELIX 345..358; /evidence=""ECO:0007829|PDB:1MJS""; HELIX 360..364; /evidence=""ECO:0007829|PDB:1MJS""; HELIX 365..370; /evidence=""ECO:0007829|PDB:1MJS""; HELIX 389..391; /evidence=""ECO:0007829|PDB:5XOC""; HELIX 401..413; /evidence=""ECO:0007829|PDB:1MJS""",,"cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,SMAD3 MADH3,Mothers against decapentaplegic homolog 3 (MAD homolog 3) (Mad3) (Mothers against DPP homolog 3) (hMAD-3) (JV15-2) (SMAD family member 3) (SMAD 3) (Smad3) (hSMAD3),Homo sapiens (Human),425.0,48081.0,MSSILPFTPPIVKRLLGWKKGEQNGQEEKWCEKAVKSLVKKLKKTGQLDELEKAITTQNVNTKCITIPRSLDGRLQVSHRKGLPHVIYCRLWRWPDLHSHHELRAMELCEFAFNMKKDEVCVNPYHYQRVETPVLPPVLVPRHTEIPAEFPPLDDYSHSIPENTNFPAGIEPQSNIPETPPPGYLSEDGETSDHQMNHSMDAGSPNLSPNPMSPAHNNLDLQPVTYCEPAFWCSISYYELNQRVGETFHASQPSMTVDGFTDPSNSERFCLGLLSNVNRNAAVELTRRHIGRGVRLYYIGGEVFAECLSDSAIFVQSPNCNQRYGWHPATVCKIPPGCNLKIFNNQEFAALLAQSVNQGFEAVYQLTRMCTIRMSFVKGWGAEYRRQTVTSTPCWIELHLNGPLQWLDKVLTQMGSPSIRCSSVS,True,False,True,P84022,"[('cd10491', 'N-terminal Mad Homology 1 (MH1) domain in SMAD2 and SMAD3'), ('cd10985', 'C-terminal Mad Homology 2 (MH2) domain in SMAD2 and SMAD3'), ('G3DSA:2.60.200.10', None), ('G3DSA:3.90.520.10', 'SMAD MH1 domain'), ('IPR001132', 'SMAD domain, Dwarfin-type'), ('IPR003619', 'MAD homology 1, Dwarfin-type'), ('IPR008984', 'SMAD/FHA domain superfamily'), ('IPR013019', 'MAD homology, MH1'), ('IPR013790', 'Dwarfin'), ('IPR017855', 'SMAD-like domain superfamily'), ('IPR036578', 'SMAD MH1 domain superfamily'), ('PF03165', 'MH1 domain'), ('PF03166', 'MH2 domain'), ('PS51075', 'MAD homology domain 1 (MH1) profile'), ('PS51076', 'MAD homology domain 2 (MH2) profile'), ('PTHR13703', 'SMAD'), ('SM00523', 'Domain A in dwarfin family proteins'), ('SM00524', 'Domain B in dwarfin family proteins'), ('SSF49879', 'SMAD/FHA domain'), ('SSF56366', 'SMAD MH1 domain')]",,"""ENSG00000166949; Low tissue specificity."";",,,,,ENST00000327367.9 [P84022-1];ENST00000439724.7 [P84022-2];ENST00000537194.6 [P84022-4];ENST00000540846.6 [P84022-3];ENST00000558428.6 [P84022-4];ENST00000558739.2 [P84022-3];ENST00000558827.2 [P84022-4];ENST00000559460.6 [P84022-3];ENST00000679624.1 [P84022-3];ENST00000681239.1 [P84022-3];,SMAD3,ENSG00000166949,0.0,SMAD3,Non-canonical_RBPs,2.0,5.18,DP01648,0.249,0.235,0.104,SMAD3
P98170,ENSG00000101966,XIAP_HUMAN,"copper ion homeostasis [GO:0055070]; defense response to bacterium [GO:0042742]; DNA damage response [GO:0006974]; inhibition of cysteine-type endopeptidase activity [GO:0097340]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0043154]; negative regulation of tumor necrosis factor-mediated signaling pathway [GO:0010804]; neuron apoptotic process [GO:0051402]; nucleotide-binding oligomerization domain containing 1 signaling pathway [GO:0070427]; nucleotide-binding oligomerization domain containing 2 signaling pathway [GO:0070431]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of JNK cascade [GO:0046330]; positive regulation of protein linear polyubiquitination [GO:1902530]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of type I interferon production [GO:0032481]; protein K63-linked ubiquitination [GO:0070534]; regulation of apoptosis involved in tissue homeostasis [GO:0060785]; regulation of apoptotic process [GO:0042981]; regulation of BMP signaling pathway [GO:0030510]; regulation of cell cycle [GO:0051726]; regulation of cell population proliferation [GO:0042127]; regulation of inflammatory response [GO:0050727]; regulation of innate immune response [GO:0045088]; regulation of nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway [GO:0070424]; response to lipopolysaccharide [GO:0032496]; Wnt signaling pathway [GO:0016055]",cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],cysteine-type endopeptidase inhibitor activity [GO:0004869]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; endopeptidase regulator activity [GO:0061135]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein serine/threonine kinase binding [GO:0120283]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842],"PTM: S-Nitrosylation down-regulates its E3 ubiquitin-protein ligase activity. {ECO:0000269|PubMed:20670888}.; PTM: Autoubiquitinated (PubMed:12747801). Ubiquitinated by TRIM32; leading to proteasomal degradation (PubMed:21628460). {ECO:0000269|PubMed:12747801, ECO:0000269|PubMed:21628460}.","DOMAIN: The first BIR domain is involved in interaction with TAB1/MAP3K7IP1 and is important for dimerization (PubMed:17560374). The second BIR domain is sufficient to inhibit CASP3 and CASP7, while the third BIR is involved in CASP9 inhibition (PubMed:11257231, PubMed:12620238). The interactions with DIABLO/SMAC and HTRA2/PRSS25 are mediated by the second and third BIR domains. {ECO:0000269|PubMed:11257231, ECO:0000269|PubMed:12620238, ECO:0000269|PubMed:17560374}.",,"STRAND 40..42; /evidence=""ECO:0007829|PDB:2POI""; STRAND 52..54; /evidence=""ECO:0007829|PDB:2POI""; STRAND 61..63; /evidence=""ECO:0007829|PDB:2POI""; STRAND 189..191; /evidence=""ECO:0007829|PDB:4J44""; STRAND 198..200; /evidence=""ECO:0007829|PDB:4J44""; STRAND 206..208; /evidence=""ECO:0007829|PDB:4J44""; STRAND 249..251; /evidence=""ECO:0007829|PDB:1F9X""; STRAND 254..256; /evidence=""ECO:0007829|PDB:5C3K""; STRAND 277..279; /evidence=""ECO:0007829|PDB:8GH7""; STRAND 289..291; /evidence=""ECO:0007829|PDB:8GH7""; STRAND 293..296; /evidence=""ECO:0007829|PDB:2OPZ""; STRAND 298..300; /evidence=""ECO:0007829|PDB:8GH7""; STRAND 306..309; /evidence=""ECO:0007829|PDB:8GH7""; STRAND 311..313; /evidence=""ECO:0007829|PDB:1F9X""; STRAND 454..457; /evidence=""ECO:0007829|PDB:8W59""; STRAND 460..463; /evidence=""ECO:0007829|PDB:8W59""; STRAND 489..493; /evidence=""ECO:0007829|PDB:8W59""","HELIX 22..24; /evidence=""ECO:0007829|PDB:6GJW""; HELIX 26..30; /evidence=""ECO:0007829|PDB:2POI""; HELIX 31..33; /evidence=""ECO:0007829|PDB:2POI""; HELIX 44..49; /evidence=""ECO:0007829|PDB:2POI""; HELIX 79..86; /evidence=""ECO:0007829|PDB:2POI""; HELIX 136..142; /evidence=""ECO:0007829|PDB:1I4O""; HELIX 150..152; /evidence=""ECO:0007829|PDB:1I3O""; HELIX 158..161; /evidence=""ECO:0007829|PDB:4J44""; HELIX 163..168; /evidence=""ECO:0007829|PDB:4J44""; HELIX 175..177; /evidence=""ECO:0007829|PDB:4WVT""; HELIX 181..186; /evidence=""ECO:0007829|PDB:4J44""; HELIX 216..223; /evidence=""ECO:0007829|PDB:4J44""; HELIX 228..232; /evidence=""ECO:0007829|PDB:4J44""; HELIX 244..246; /evidence=""ECO:0007829|PDB:1F9X""; HELIX 260..262; /evidence=""ECO:0007829|PDB:8GH7""; HELIX 265..271; /evidence=""ECO:0007829|PDB:8GH7""; HELIX 281..286; /evidence=""ECO:0007829|PDB:8GH7""; HELIX 316..323; /evidence=""ECO:0007829|PDB:8GH7""; HELIX 328..333; /evidence=""ECO:0007829|PDB:3HL5""; HELIX 336..342; /evidence=""ECO:0007829|PDB:3UW5""; HELIX 346..353; /evidence=""ECO:0007829|PDB:1G73""; HELIX 354..356; /evidence=""ECO:0007829|PDB:1G73""; HELIX 368..372; /evidence=""ECO:0007829|PDB:2KNA""; HELIX 375..381; /evidence=""ECO:0007829|PDB:2KNA""; HELIX 386..400; /evidence=""ECO:0007829|PDB:2KNA""; HELIX 407..419; /evidence=""ECO:0007829|PDB:2KNA""; HELIX 437..447; /evidence=""ECO:0007829|PDB:8W59""; HELIX 472..475; /evidence=""ECO:0007829|PDB:8W59""","TURN 64..66; /evidence=""ECO:0007829|PDB:2POI""; TURN 91..97; /evidence=""ECO:0007829|PDB:2POI""; TURN 128..130; /evidence=""ECO:0007829|PDB:1I3O""; TURN 169..172; /evidence=""ECO:0007829|PDB:4J44""; TURN 201..203; /evidence=""ECO:0007829|PDB:4J44""; TURN 272..274; /evidence=""ECO:0007829|PDB:8GH7""; TURN 301..303; /evidence=""ECO:0007829|PDB:8GH7""; TURN 343..345; /evidence=""ECO:0007829|PDB:3HL5""; TURN 451..453; /evidence=""ECO:0007829|PDB:8W59""; TURN 482..484; /evidence=""ECO:0007829|PDB:8W59""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,XIAP API3 BIRC4 IAP3,E3 ubiquitin-protein ligase XIAP (EC 2.3.2.27) (Baculoviral IAP repeat-containing protein 4) (IAP-like protein) (ILP) (hILP) (Inhibitor of apoptosis protein 3) (IAP-3) (hIAP-3) (hIAP3) (RING-type E3 ubiquitin transferase XIAP) (X-linked inhibitor of apoptosis protein) (X-linked IAP),Homo sapiens (Human),497.0,56685.0,MTFNSFEGSKTCVPADINKEEEFVEEFNRLKTFANFPSGSPVSASTLARAGFLYTGEGDTVRCFSCHAAVDRWQYGDSAVGRHRKVSPNCRFINGFYLENSATQSTNSGIQNGQYKVENYLGSRDHFALDRPSETHADYLLRTGQVVDISDTIYPRNPAMYSEEARLKSFQNWPDYAHLTPRELASAGLYYTGIGDQVQCFCCGGKLKNWEPCDRAWSEHRRHFPNCFFVLGRNLNIRSESDAVSSDRNFPNSTNLPRNPSMADYEARIFTFGTWIYSVNKEQLARAGFYALGEGDKVKCFHCGGGLTDWKPSEDPWEQHAKWYPGCKYLLEQKGQEYINNIHLTHSLEECLVRTTEKTPSLTRRIDDTIFQNPMVQEAIRMGFSFKDIKKIMEEKIQISGSNYKSLEVLVADLVNAQKDSMQDESSQTSLQKEISTEEQLRRLQEEKLCKICMDRNIAIVFVPCGHLVTCKQCAEAVDKCPMCYTVITFKQKIFMS,False,False,True,P98170,"[('cd00022', 'BIR'), ('cd14395', 'UBA domain found in E3 ubiquitin-protein ligase XIAP, baculoviral IAP repeat-containing protein 8 (BIRC8) and similar proteins'), ('cd16714', 'RING finger, HC subclass, found in E3 ubiquitin-protein ligase XIAP, baculoviral IAP repeat-containing protein 8 (BIRC8) and similar proteins'), ('G3DSA:1.10.1170.10', 'Inhibitor Of Apoptosis Protein (2mihbC-IAP-1); Chain A'), ('G3DSA:1.10.533.10', 'Death Domain, Fas'), ('G3DSA:1.10.8.10', 'DNA helicase RuvA subunit, C-terminal domain'), ('IPR001370', 'BIR repeat'), ('IPR001841', 'Zinc finger, RING-type'), ('IPR011029', 'Death-like domain superfamily'), ('IPR042579', 'XIAP/BIRC8, UBA domain'), ('IPR048875', 'BIRC2/3-like, UBA domain'), ('IPR050784', 'Inhibitor of Apoptosis'), ('PF00653', 'Inhibitor of Apoptosis domain'), ('PF13920', 'Zinc finger, C3HC4 type (RING finger)'), ('PF21290', 'BIRC2/3-like, UBA domain'), ('PS01282', 'BIR repeat'), ('PS50089', 'Zinc finger RING-type profile'), ('PS50143', 'BIR repeat profile'), ('PTHR10044', 'Inhibitor of Apoptosis'), ('SM00184', 'Ring finger')]",,"""ENSG00000101966; Low tissue specificity."";","CATALYTIC ACTIVITY: Reaction=S-ubiquitinyl-[E2 ubiquitin-conjugating enzyme]-L-cysteine + [acceptor protein]-L-lysine = [E2 ubiquitin-conjugating enzyme]-L-cysteine + N(6)-ubiquitinyl-[acceptor protein]-L-lysine.; EC=2.3.2.27; Evidence={ECO:0000269|PubMed:19473982, ECO:0000269|PubMed:20154138, ECO:0000269|PubMed:21931591, ECO:0000269|PubMed:22304967, ECO:0000269|PubMed:22607974, ECO:0000269|PubMed:30026309};",2.3.2.27,,,ENST00000355640.3;ENST00000371199.8;ENST00000422098.6;,XIAP,ENSG00000101966,0.0,,,,5.23,DP01773,0.052,0.227,,XIAP
P98175,ENSG00000182872,RBM10_HUMAN,"3'-UTR-mediated mRNA stabilization [GO:0070935]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of mRNA splicing, via spliceosome [GO:0048025]; negative regulation of transcription by RNA polymerase II [GO:0000122]; negative regulation of vascular associated smooth muscle cell proliferation [GO:1904706]; positive regulation of vascular associated smooth muscle cell apoptotic process [GO:1905461]; vascular associated smooth muscle cell apoptotic process [GO:1905288]; vascular associated smooth muscle cell proliferation [GO:1990874]",nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991],identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; miRNA binding [GO:0035198]; RNA binding [GO:0003723],,,"DOMAIN 129..209; /note=""RRM 1""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00176""; DOMAIN 300..384; /note=""RRM 2""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00176""; DOMAIN 858..904; /note=""G-patch""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00092""","STRAND 130..134; /evidence=""ECO:0007829|PDB:2LXI""; STRAND 161..163; /evidence=""ECO:0007829|PDB:2LXI""; STRAND 165..167; /evidence=""ECO:0007829|PDB:2LXI""; STRAND 171..177; /evidence=""ECO:0007829|PDB:2LXI""; STRAND 194..197; /evidence=""ECO:0007829|PDB:2LXI""; STRAND 200..205; /evidence=""ECO:0007829|PDB:2LXI""; STRAND 220..222; /evidence=""ECO:0007829|PDB:2MXV""; STRAND 234..236; /evidence=""ECO:0007829|PDB:2MXV""; STRAND 301..304; /evidence=""ECO:0007829|PDB:2M2B""; STRAND 337..342; /evidence=""ECO:0007829|PDB:2M2B""; STRAND 346..349; /evidence=""ECO:0007829|PDB:2M2B""; STRAND 366..368; /evidence=""ECO:0007829|PDB:5ZSW""; STRAND 378..381; /evidence=""ECO:0007829|PDB:5ZSW""; STRAND 572..574; /evidence=""ECO:0007829|PDB:2MXW""; STRAND 597..599; /evidence=""ECO:0007829|PDB:2MXW""; STRAND 604..608; /evidence=""ECO:0007829|PDB:2MXW""; STRAND 614..617; /evidence=""ECO:0007829|PDB:2MXW""; STRAND 622..624; /evidence=""ECO:0007829|PDB:2MXW""; STRAND 627..630; /evidence=""ECO:0007829|PDB:2MXW""","HELIX 142..152; /evidence=""ECO:0007829|PDB:2LXI""; HELIX 181..189; /evidence=""ECO:0007829|PDB:2LXI""; HELIX 314..320; /evidence=""ECO:0007829|PDB:2M2B""; HELIX 321..323; /evidence=""ECO:0007829|PDB:2M2B""; HELIX 355..363; /evidence=""ECO:0007829|PDB:2M2B""; HELIX 372..374; /evidence=""ECO:0007829|PDB:2M2B""; HELIX 569..571; /evidence=""ECO:0007829|PDB:2MXW""","TURN 190..193; /evidence=""ECO:0007829|PDB:2LXI""; TURN 328..330; /evidence=""ECO:0007829|PDB:2M2B""; TURN 576..578; /evidence=""ECO:0007829|PDB:2MXW""; TURN 584..586; /evidence=""ECO:0007829|PDB:2MXW""; TURN 600..603; /evidence=""ECO:0007829|PDB:2MXW""; TURN 610..612; /evidence=""ECO:0007829|PDB:2MXW""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,RBM10 DXS8237E GPATC9 GPATCH9 KIAA0122,RNA-binding protein 10 (G patch domain-containing protein 9) (RNA-binding motif protein 10) (RNA-binding protein S1-1) (S1-1),Homo sapiens (Human),930.0,103533.0,MEYERRGGRGDRTGRYGATDRSQDDGGENRSRDHDYRDMDYRSYPREYGSQEGKHDYDDSSEEQSAEDSYEASPGSETQRRRRRRHRHSPTGPPGFPRDGDYRDQDYRTEQGEEEEEEEDEEEEEKASNIVMLRMLPQAATEDDIRGQLQSHGVQAREVRLMRNKSSGQSRGFAFVEFSHLQDATRWMEANQHSLNILGQKVSMHYSDPKPKINEDWLCNKCGVQNFKRREKCFKCGVPKSEAEQKLPLGTRLDQQTLPLGGRELSQGLLPLPQPYQAQGVLASQALSQGSEPSSENANDTIILRNLNPHSTMDSILGALAPYAVLSSSNVRVIKDKQTQLNRGFAFIQLSTIVEAAQLLQILQALHPPLTIDGKTINVEFAKGSKRDMASNEGSRISAASVASTAIAAAQWAISQASQGGEGTWATSEEPPVDYSYYQQDEGYGNSQGTESSLYAHGYLKGTKGPGITGTKGDPTGAGPEASLEPGADSVSMQAFSRAQPGAAPGIYQQSAEASSSQGTAANSQSYTIMSPAVLKSELQSPTHPSSALPPATSPTAQESYSQYPVPDVSTYQYDETSGYYYDPQTGLYYDPNSQYYYNAQSQQYLYWDGERRTYVPALEQSADGHKETGAPSKEGKEKKEKHKTKTAQQIAKDMERWARSLNKQKENFKNSFQPISSLRDDERRESATADAGYAILEKKGALAERQHTSMDLPKLASDDRPSPPRGLVAAYSGESDSEEEQERGGPEREEKLTDWQKLACLLCRRQFPSKEALIRHQQLSGLHKQNLEIHRRAHLSENELEALEKNDMEQMKYRDRAAERREKYGIPEPPEPKRRKYGGISTASVDFEQPTRDGLGSDNIGSRMLQAMGWKEGSGLGRKKQGIVTPIEAQTRVRGSGLGARGSSYGVTSTESYKETLHKTMVTRFNEAQ,False,False,True,P98175,"[('cd12753', 'RNA recognition motif 1 (RRM1) found in vertebrate RNA-binding protein 10 (RBM10)'), ('cd12754', 'RNA recognition motif 2 (RRM2) found in vertebrate RNA-binding protein 10 (RBM10)'), ('cd16167', 'OCRE domain found in RNA-binding protein 10 (RBM10) and similar proteins'), ('G3DSA:3.30.70.330', None), ('G3DSA:4.10.1060.10', 'Zinc finger, RanBP2-type'), ('IPR000467', 'G-patch domain'), ('IPR000504', 'RNA recognition motif domain'), ('IPR001876', 'Zinc finger, RanBP2-type'), ('IPR012677', 'Nucleotide-binding alpha-beta plait domain superfamily'), ('IPR013087', 'Zinc finger C2H2-type'), ('IPR034992', 'RNA-binding protein 10, RNA recognition motif 2'), ('IPR035618', 'RBM10, OCRE domain'), ('IPR035979', 'RNA-binding domain superfamily'), ('IPR036443', 'Zinc finger, RanBP2-type superfamily'), ('IPR041591', 'OCRE domain'), ('PF00076', 'RNA recognition motif'), ('PF00641', 'Zn-finger in Ran binding protein and others'), ('PF01585', 'G-patch domain'), ('PF17780', 'OCRE domain'), ('PS01358', 'Zinc finger RanBP2-type signature')]",,"""ENSG00000182872; Low tissue specificity."";",,,,,ENST00000329236.8 [P98175-5];ENST00000345781.10 [P98175-3];ENST00000377604.8 [P98175-1];ENST00000628161.2 [P98175-4];,RBM10,ENSG00000182872,0.0,RBM10,Canonical_RBPs,32.0,,,,0.604,0.415,RBM10
P99999,ENSG00000172115,CYC_HUMAN,"cellular respiration [GO:0045333]; execution phase of apoptosis [GO:0097194]; intrinsic apoptotic signaling pathway [GO:0097193]; mitochondrial electron transport, cytochrome c to oxygen [GO:0006123]; mitochondrial electron transport, ubiquinol to cytochrome c [GO:0006122]",apoptosome [GO:0043293]; cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739]; nucleus [GO:0005634],electron transfer activity [GO:0009055]; heme binding [GO:0020037]; metal ion binding [GO:0046872],"PTM: Binds 1 heme c group covalently per subunit.; PTM: Phosphorylation at Tyr-49 and Tyr-98 both reduce by half the turnover in the reaction with cytochrome c oxidase, down-regulating mitochondrial respiration. {ECO:0000250}.",,,"STRAND 23..25; /evidence=""ECO:0007829|PDB:1J3S""; STRAND 28..30; /evidence=""ECO:0007829|PDB:1J3S""; STRAND 39..42; /evidence=""ECO:0007829|PDB:2N9I""; STRAND 56..58; /evidence=""ECO:0007829|PDB:2N3Y""; STRAND 76..78; /evidence=""ECO:0007829|PDB:2N3Y""","HELIX 4..14; /evidence=""ECO:0007829|PDB:5TY3""; HELIX 51..55; /evidence=""ECO:0007829|PDB:5TY3""; HELIX 62..70; /evidence=""ECO:0007829|PDB:5TY3""; HELIX 72..75; /evidence=""ECO:0007829|PDB:5TY3""; HELIX 89..102; /evidence=""ECO:0007829|PDB:5TY3""","TURN 15..18; /evidence=""ECO:0007829|PDB:5TY3""; TURN 36..38; /evidence=""ECO:0007829|PDB:1J3S""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,CYCS CYC,Cytochrome c,Homo sapiens (Human),105.0,11749.0,MGDVEKGKKIFIMKCSQCHTVEKGGKHKTGPNLHGLFGRKTGQAPGYSYTAANKNKGIIWGEDTLMEYLENPKKYIPGTKMIFVGIKKKEERADLIAYLKKATNE,True,False,True,P99999,"[('G3DSA:1.10.760.10', 'Cytochrome c-like domain'), ('IPR002327', 'Cytochrome c, class IA/ IB'), ('IPR009056', 'Cytochrome c-like domain'), ('IPR036909', 'Cytochrome c-like domain superfamily'), ('PF00034', 'Cytochrome c'), ('PR00604', 'CYTCHRMECIAB'), ('PS51007', 'Cytochrome c family profile'), ('PTHR11961', 'CYTOCHROME C'), ('SSF46626', 'Cytochrome c')]",,"""ENSG00000172115; Tissue enhanced (tongue)."";",,,,,ENST00000305786.7;ENST00000409409.5;ENST00000409764.5;,CYCS,ENSG00000172115,0.0,CYCS,Non-canonical_RBPs,10.0,,,,,,CYCS
Q00534,ENSG00000105810,CDK6_HUMAN,astrocyte development [GO:0014002]; cell dedifferentiation [GO:0043697]; cell division [GO:0051301]; dentate gyrus development [GO:0021542]; G1/S transition of mitotic cell cycle [GO:0000082]; generation of neurons [GO:0048699]; gliogenesis [GO:0042063]; hematopoietic stem cell differentiation [GO:0060218]; lateral ventricle development [GO:0021670]; negative regulation of cell cycle [GO:0045786]; negative regulation of cell differentiation [GO:0045596]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of cellular senescence [GO:2000773]; negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of monocyte differentiation [GO:0045656]; negative regulation of myeloid cell differentiation [GO:0045638]; negative regulation of osteoblast differentiation [GO:0045668]; negative regulation of transcription by RNA polymerase II [GO:0000122]; Notch signaling pathway [GO:0007219]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of fibroblast proliferation [GO:0048146]; positive regulation of gene expression [GO:0010628]; protein phosphorylation [GO:0006468]; regulation of cell cycle [GO:0051726]; regulation of cell motility [GO:2000145]; regulation of erythrocyte differentiation [GO:0045646]; regulation of G2/M transition of mitotic cell cycle [GO:0010389]; regulation of gene expression [GO:0010468]; regulation of hematopoietic stem cell differentiation [GO:1902036]; response to virus [GO:0009615]; signal transduction [GO:0007165]; T cell differentiation in thymus [GO:0033077]; type B pancreatic cell development [GO:0003323],centrosome [GO:0005813]; cyclin D1-CDK6 complex [GO:0097131]; cyclin D2-CDK6 complex [GO:0097132]; cyclin D3-CDK6 complex [GO:0097133]; cyclin-dependent protein kinase holoenzyme complex [GO:0000307]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ruffle [GO:0001726],ATP binding [GO:0005524]; cyclin binding [GO:0030332]; cyclin-dependent protein serine/threonine kinase activity [GO:0004693]; FBXO family protein binding [GO:0098770]; protein serine kinase activity [GO:0106310],PTM: Thr-177 phosphorylation and Tyr-24 dephosphorylation promotes kinase activity. {ECO:0000269|PubMed:11828325}.,,"DOMAIN 13..300; /note=""Protein kinase""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00159""","STRAND 13..22; /evidence=""ECO:0007829|PDB:1BLX""; STRAND 25..32; /evidence=""ECO:0007829|PDB:1BLX""; STRAND 39..49; /evidence=""ECO:0007829|PDB:1BLX""; STRAND 79..87; /evidence=""ECO:0007829|PDB:1BLX""; STRAND 89..99; /evidence=""ECO:0007829|PDB:1BLX""; STRAND 102..104; /evidence=""ECO:0007829|PDB:6OQO""; STRAND 151..153; /evidence=""ECO:0007829|PDB:1BLX""; STRAND 159..161; /evidence=""ECO:0007829|PDB:1BLX""; STRAND 180..182; /evidence=""ECO:0007829|PDB:1BI8""; STRAND 245..249; /evidence=""ECO:0007829|PDB:1XO2""; STRAND 266..268; /evidence=""ECO:0007829|PDB:1XO2""","HELIX 9..11; /evidence=""ECO:0007829|PDB:1BLX""; HELIX 58..70; /evidence=""ECO:0007829|PDB:1BLX""; HELIX 105..111; /evidence=""ECO:0007829|PDB:1BLX""; HELIX 119..138; /evidence=""ECO:0007829|PDB:1BLX""; HELIX 148..150; /evidence=""ECO:0007829|PDB:1BLX""; HELIX 172..176; /evidence=""ECO:0007829|PDB:1BLX""; HELIX 183..185; /evidence=""ECO:0007829|PDB:2F2C""; HELIX 188..191; /evidence=""ECO:0007829|PDB:1BLX""; HELIX 199..214; /evidence=""ECO:0007829|PDB:1BLX""; HELIX 224..235; /evidence=""ECO:0007829|PDB:1BLX""; HELIX 240..242; /evidence=""ECO:0007829|PDB:1BLX""; HELIX 251..253; /evidence=""ECO:0007829|PDB:1BLX""; HELIX 262..264; /evidence=""ECO:0007829|PDB:1BLX""; HELIX 271..280; /evidence=""ECO:0007829|PDB:1BLX""; HELIX 291..295; /evidence=""ECO:0007829|PDB:1BLX""; HELIX 298..300; /evidence=""ECO:0007829|PDB:1BLX""","TURN 33..37; /evidence=""ECO:0007829|PDB:1BLX""; TURN 113..115; /evidence=""ECO:0007829|PDB:4TTH""; TURN 285..287; /evidence=""ECO:0007829|PDB:1BLX""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,CDK6 CDKN6,Cyclin-dependent kinase 6 (EC 2.7.11.22) (Cell division protein kinase 6) (Serine/threonine-protein kinase PLSTIRE),Homo sapiens (Human),326.0,36938.0,MEKDGLCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERCKENLDSHLPPSQNTSELNTA,False,False,True,Q00534,"[('cd07862', 'Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6'), ('G3DSA:1.10.510.10', 'Transferase(Phosphotransferase) domain 1'), ('G3DSA:3.30.200.20', 'Phosphorylase Kinase; domain 1'), ('IPR000719', 'Protein kinase domain'), ('IPR008271', 'Serine/threonine-protein kinase, active site'), ('IPR011009', 'Protein kinase-like domain superfamily'), ('IPR017441', 'Protein kinase, ATP binding site'), ('IPR028788', 'Cyclin-dependent kinase 6'), ('IPR050108', 'Cyclin-dependent kinase'), ('PF00069', 'Protein kinase domain'), ('PS00107', 'Protein kinases ATP-binding region signature'), ('PS00108', 'Serine/Threonine protein kinases active-site signature'), ('PS50011', 'Protein kinase domain profile'), ('PTHR24056', 'Cyclin-dependent kinase'), ('SM00220', 'Serine/Threonine protein kinases, catalytic domain'), ('SSF56112', 'Protein kinase-like (PK-like)')]",,"""ENSG00000105810; Tissue enhanced (lymphoid)."";","CATALYTIC ACTIVITY: Reaction=L-seryl-[protein] + ATP = O-phospho-L-seryl-[protein] + ADP + H(+); Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616, ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.22; CATALYTIC ACTIVITY: Reaction=L-threonyl-[protein] + ATP = O-phospho-L-threonyl-[protein] + ADP + H(+); Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060, Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013, ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216; EC=2.7.11.22;",2.7.11.22,"ACTIVITY REGULATION: Inhibited by INK4 proteins (CDKN2C/p18-INK4c), aminopurvalanol, PD0332991, 4-(Pyrazol-4-yl)-pyrimidines and fisetin, a flavonol inhibitor. Activated by Thr-177 phosphorylation and Tyr-24 dephosphorylation (By similarity). Stimulated by cyclin from herpesvirus saimiri (V-cyclin/ECLF2). Rapidly down-regulated prior to cell differentiation (e.g. erythroid and osteoblast). {ECO:0000250, ECO:0000269|PubMed:12833137}.",,ENST00000265734.8;ENST00000424848.3;,CDK6,ENSG00000105810,0.0,,,,11.66,DP03829,0.117,0.064,,CDK6
Q00610,ENSG00000141367,CLH1_HUMAN,"amyloid-beta clearance by transcytosis [GO:0150093]; autophagy [GO:0006914]; cell division [GO:0051301]; clathrin coat assembly [GO:0048268]; clathrin coat disassembly [GO:0072318]; clathrin-dependent endocytosis [GO:0072583]; intracellular protein transport [GO:0006886]; mitotic cell cycle [GO:0000278]; negative regulation of hyaluronan biosynthetic process [GO:1900126]; negative regulation of protein localization to plasma membrane [GO:1903077]; osteoblast differentiation [GO:0001649]; receptor internalization [GO:0031623]; receptor-mediated endocytosis [GO:0006898]; regulation of mitotic spindle organization [GO:0060236]; retrograde transport, endosome to Golgi [GO:0042147]; transferrin transport [GO:0033572]",clathrin coat [GO:0030118]; clathrin coat of coated pit [GO:0030132]; clathrin coat of trans-Golgi network vesicle [GO:0030130]; clathrin complex [GO:0071439]; clathrin-coated endocytic vesicle [GO:0045334]; clathrin-coated endocytic vesicle membrane [GO:0030669]; clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; endolysosome membrane [GO:0036020]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; extracellular vesicle [GO:1903561]; focal adhesion [GO:0005925]; lysosome [GO:0005764]; melanosome [GO:0042470]; membrane [GO:0016020]; mitotic spindle [GO:0072686]; mitotic spindle microtubule [GO:1990498]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; spindle [GO:0005819]; trans-Golgi network membrane [GO:0032588],clathrin light chain binding [GO:0032051]; disordered domain specific binding [GO:0097718]; double-stranded RNA binding [GO:0003725]; low-density lipoprotein particle receptor binding [GO:0050750]; protein kinase binding [GO:0019901]; RNA binding [GO:0003723]; structural molecule activity [GO:0005198]; ubiquitin-specific protease binding [GO:1990381],,"DOMAIN: The N-terminal seven-bladed beta-propeller is formed by WD40-like repeats, and projects inward from the polyhedral outer clathrin coat. It constitutes a major protein-protein interaction node.",,"STRAND 6..14; /evidence=""ECO:0007829|PDB:6E4L""; STRAND 30..34; /evidence=""ECO:0007829|PDB:6E4L""; STRAND 37..44; /evidence=""ECO:0007829|PDB:6E4L""; STRAND 47..54; /evidence=""ECO:0007829|PDB:6E4L""; STRAND 62..64; /evidence=""ECO:0007829|PDB:6E4L""; STRAND 69..73; /evidence=""ECO:0007829|PDB:6E4L""; STRAND 75..84; /evidence=""ECO:0007829|PDB:6E4L""; STRAND 87..92; /evidence=""ECO:0007829|PDB:6E4L""; STRAND 97..103; /evidence=""ECO:0007829|PDB:6E4L""; STRAND 108..113; /evidence=""ECO:0007829|PDB:6E4L""; STRAND 115..135; /evidence=""ECO:0007829|PDB:6E4L""; STRAND 139..143; /evidence=""ECO:0007829|PDB:6E4L""; STRAND 152..158; /evidence=""ECO:0007829|PDB:6E4L""; STRAND 164..173; /evidence=""ECO:0007829|PDB:6E4L""; STRAND 176..185; /evidence=""ECO:0007829|PDB:6E4L""; STRAND 190..194; /evidence=""ECO:0007829|PDB:6E4L""; STRAND 197..204; /evidence=""ECO:0007829|PDB:6E4L""; STRAND 213..222; /evidence=""ECO:0007829|PDB:6E4L""; STRAND 225..232; /evidence=""ECO:0007829|PDB:6E4L""; STRAND 246..249; /evidence=""ECO:0007829|PDB:6E4L""; STRAND 261..267; /evidence=""ECO:0007829|PDB:6E4L""; STRAND 272..277; /evidence=""ECO:0007829|PDB:6E4L""; STRAND 280..286; /evidence=""ECO:0007829|PDB:6E4L""; STRAND 292..297; /evidence=""ECO:0007829|PDB:6E4L""; STRAND 303..309; /evidence=""ECO:0007829|PDB:6E4L""; STRAND 314..319; /evidence=""ECO:0007829|PDB:6E4L""; STRAND 323..329; /evidence=""ECO:0007829|PDB:6E4L""","HELIX 15..18; /evidence=""ECO:0007829|PDB:6E4L""; HELIX 22..24; /evidence=""ECO:0007829|PDB:6E4L""; HELIX 146..148; /evidence=""ECO:0007829|PDB:6E4L""; HELIX 254..256; /evidence=""ECO:0007829|PDB:6E4L""; HELIX 334..340; /evidence=""ECO:0007829|PDB:6E4L""; HELIX 345..354; /evidence=""ECO:0007829|PDB:6E4L""","TURN 27..29; /evidence=""ECO:0007829|PDB:6E4L""; TURN 93..96; /evidence=""ECO:0007829|PDB:6E4L""; TURN 186..189; /evidence=""ECO:0007829|PDB:6E4L""; TURN 268..271; /evidence=""ECO:0007829|PDB:6E4L""; TURN 287..289; /evidence=""ECO:0007829|PDB:6E4L""; TURN 310..313; /evidence=""ECO:0007829|PDB:6E4L""; TURN 331..333; /evidence=""ECO:0007829|PDB:6E4L""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,CLTC CLH17 CLTCL2 KIAA0034,Clathrin heavy chain 1 (Clathrin heavy chain on chromosome 17) (CLH-17),Homo sapiens (Human),1675.0,191615.0,MAQILPIRFQEHLQLQNLGINPANIGFSTLTMESDKFICIREKVGEQAQVVIIDMNDPSNPIRRPISADSAIMNPASKVIALKAGKTLQIFNIEMKSKMKAHTMTDDVTFWKWISLNTVALVTDNAVYHWSMEGESQPVKMFDRHSSLAGCQIINYRTDAKQKWLLLTGISAQQNRVVGAMQLYSVDRKVSQPIEGHAASFAQFKMEGNAEESTLFCFAVRGQAGGKLHIIEVGTPPTGNQPFPKKAVDVFFPPEAQNDFPVAMQISEKHDVVFLITKYGYIHLYDLETGTCIYMNRISGETIFVTAPHEATAGIIGVNRKGQVLSVCVEEENIIPYITNVLQNPDLALRMAVRNNLAGAEELFARKFNALFAQGNYSEAAKVAANAPKGILRTPDTIRRFQSVPAQPGQTSPLLQYFGILLDQGQLNKYESLELCRPVLQQGRKQLLEKWLKEDKLECSEELGDLVKSVDPTLALSVYLRANVPNKVIQCFAETGQVQKIVLYAKKVGYTPDWIFLLRNVMRISPDQGQQFAQMLVQDEEPLADITQIVDVFMEYNLIQQCTAFLLDALKNNRPSEGPLQTRLLEMNLMHAPQVADAILGNQMFTHYDRAHIAQLCEKAGLLQRALEHFTDLYDIKRAVVHTHLLNPEWLVNYFGSLSVEDSLECLRAMLSANIRQNLQICVQVASKYHEQLSTQSLIELFESFKSFEGLFYFLGSIVNFSQDPDVHFKYIQAACKTGQIKEVERICRESNCYDPERVKNFLKEAKLTDQLPLIIVCDRFDFVHDLVLYLYRNNLQKYIEIYVQKVNPSRLPVVIGGLLDVDCSEDVIKNLILVVRGQFSTDELVAEVEKRNRLKLLLPWLEARIHEGCEEPATHNALAKIYIDSNNNPERFLRENPYYDSRVVGKYCEKRDPHLACVAYERGQCDLELINVCNENSLFKSLSRYLVRRKDPELWGSVLLESNPYRRPLIDQVVQTALSETQDPEEVSVTVKAFMTADLPNELIELLEKIVLDNSVFSEHRNLQNLLILTAIKADRTRVMEYINRLDNYDAPDIANIAISNELFEEAFAIFRKFDVNTSAVQVLIEHIGNLDRAYEFAERCNEPAVWSQLAKAQLQKGMVKEAIDSYIKADDPSSYMEVVQAANTSGNWEELVKYLQMARKKARESYVETELIFALAKTNRLAELEEFINGPNNAHIQQVGDRCYDEKMYDAAKLLYNNVSNFGRLASTLVHLGEYQAAVDGARKANSTRTWKEVCFACVDGKEFRLAQMCGLHIVVHADELEELINYYQDRGYFEELITMLEAALGLERAHMGMFTELAILYSKFKPQKMREHLELFWSRVNIPKVLRAAEQAHLWAELVFLYDKYEEYDNAIITMMNHPTDAWKEGQFKDIITKVANVELYYRAIQFYLEFKPLLLNDLLMVLSPRLDHTRAVNYFSKVKQLPLVKPYLRSVQNHNNKSVNESLNNLFITEEDYQALRTSIDAYDNFDNISLAQRLEKHELIEFRRIAAYLFKGNNRWKQSVELCKKDSLYKDAMQYASESKDTELAEELLQWFLQEEKRECFGACLFTCYDLLRPDVVLETAWRHNIMDFAMPYFIQVMKEYLTKVDKLDASESLRKEEEQATETQPIVYGQPQLMLTAGPSVAVPPQAPFGYGYTAPPYGQPQPGFGYSM,True,False,True,Q00610,"[('G3DSA:1.25.40.10', 'Tetratricopeptide repeat domain'), ('G3DSA:1.25.40.730', None), ('G3DSA:2.130.10.110', 'Clathrin heavy-chain terminal domain'), ('IPR000547', 'Clathrin, heavy chain/VPS, 7-fold repeat'), ('IPR011990', 'Tetratricopeptide-like helical domain superfamily'), ('IPR015348', 'Clathrin, heavy chain, linker, core motif'), ('IPR016024', 'Armadillo-type fold'), ('IPR016025', 'Clathrin heavy chain, N-terminal'), ('IPR016341', 'Clathrin, heavy chain'), ('IPR022365', 'Clathrin, heavy chain, propeller repeat'), ('IPR055358', 'Clathrin heavy-chain repeat'), ('PF00637', 'Region in Clathrin and VPS'), ('PF01394', 'Clathrin propeller repeat'), ('PF09268', 'Clathrin, heavy-chain linker'), ('PF13838', 'Clathrin-H-link'), ('PIRSF002290', 'Clathrin heavy chain'), ('PS50236', 'Clathrin heavy-chain (CHCR) repeat profile'), ('PTHR10292', 'Clathrin heavy chain'), ('SM00299', 'Clathrin heavy chain repeat homology'), ('SSF48371', 'ARM repeat')]",Q00610;,"""ENSG00000141367; Low tissue specificity."";",,,,,ENST00000269122.8 [Q00610-1];ENST00000393043.5 [Q00610-2];ENST00000700707.1 [Q00610-1];,CLTC,ENSG00000141367,0.0,CLTC,Non-canonical_RBPs,21.0,,,,0.037,,CLTC
Q00613,ENSG00000185122|ENSG00000284774,HSF1_HUMAN,cellular response to angiotensin [GO:1904385]; cellular response to cadmium ion [GO:0071276]; cellular response to copper ion [GO:0071280]; cellular response to diamide [GO:0072738]; cellular response to estradiol stimulus [GO:0071392]; cellular response to gamma radiation [GO:0071480]; cellular response to heat [GO:0034605]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to L-glutamine [GO:1904845]; cellular response to lipopolysaccharide [GO:0071222]; cellular response to nitroglycerin [GO:1904843]; cellular response to potassium ion [GO:0035865]; cellular response to sodium arsenite [GO:1903936]; cellular response to unfolded protein [GO:0034620]; cellular response to xenobiotic stimulus [GO:0071466]; defense response [GO:0006952]; DNA repair [GO:0006281]; MAPK cascade [GO:0000165]; mRNA processing [GO:0006397]; mRNA transport [GO:0051028]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of double-strand break repair via nonhomologous end joining [GO:2001033]; negative regulation of gene expression [GO:0010629]; negative regulation of inclusion body assembly [GO:0090084]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of apoptotic DNA fragmentation [GO:1902512]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of gene expression [GO:0010628]; positive regulation of inclusion body assembly [GO:0090261]; positive regulation of macrophage differentiation [GO:0045651]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of stress granule assembly [GO:0062029]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein-containing complex assembly [GO:0065003]; regulation of cellular response to heat [GO:1900034]; regulation of transcription by RNA polymerase II [GO:0006357]; response to activity [GO:0014823]; response to hypobaric hypoxia [GO:1990910]; response to nutrient [GO:0007584]; response to peptide [GO:1901652]; response to psychosocial stress [GO:1990911]; response to testosterone [GO:0033574],centrosome [GO:0005813]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; euchromatin [GO:0000791]; heterochromatin [GO:0000792]; kinetochore [GO:0000776]; mitotic spindle pole [GO:0097431]; nuclear stress granule [GO:0097165]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; PML body [GO:0016605]; protein folding chaperone complex [GO:0101031]; ribonucleoprotein complex [GO:1990904],"chromatin DNA binding [GO:0031490]; DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; general transcription initiation factor binding [GO:0140296]; heat shock protein binding [GO:0031072]; Hsp90 protein binding [GO:0051879]; identical protein binding [GO:0042802]; promoter-specific chromatin binding [GO:1990841]; protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding [GO:0001162]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]; sequence-specific single stranded DNA binding [GO:0098847]; STAT family protein binding [GO:0097677]; transcription cis-regulatory region binding [GO:0000976]; translation elongation factor binding [GO:0061770]","PTM: Phosphorylated (PubMed:10359787, PubMed:11583998, PubMed:26159920, PubMed:9499401). Phosphorylated in unstressed cells; this phosphorylation is constitutive and implicated in the repression of HSF1 transcriptional activity (PubMed:16278218, PubMed:8940068, PubMed:8946918, PubMed:9121459). Phosphorylated on Ser-121 by MAPKAPK2; this phosphorylation promotes interaction with HSP90 proteins and inhibits HSF1 homotrimerization, DNA-binding and transactivation activities (PubMed:16278218). Phosphorylation on Ser-303 by GSK3B/GSK3-beta and on Ser-307 by MAPK3 within the regulatory domain is involved in the repression of HSF1 transcriptional activity and occurs in a RAF1-dependent manner (PubMed:10747973, PubMed:12646186, PubMed:8940068, PubMed:8946918, PubMed:9121459, PubMed:9535852). Phosphorylation on Ser-303 and Ser-307 increases HSF1 nuclear export in a YWHAE- and XPO1/CRM1-dependent manner (PubMed:12917326). Phosphorylation on Ser-307 is a prerequisite for phosphorylation on Ser-303 (PubMed:8940068). According to PubMed:9535852, Ser-303 is not phosphorylated in unstressed cells. Phosphorylated on Ser-419 by PLK1; phosphorylation promotes nuclear translocation upon heat shock (PubMed:15661742). Hyperphosphorylated upon heat shock and during the attenuation and recovery phase period of the heat shock response (PubMed:11447121, PubMed:12659875, PubMed:24581496). Phosphorylated on Thr-142; this phosphorylation increases HSF1 transactivation activity upon heat shock (PubMed:12659875). Phosphorylation on Ser-230 by CAMK2A; this phosphorylation enhances HSF1 transactivation activity upon heat shock (PubMed:11447121). Phosphorylation on Ser-326 by MAPK12; this phosphorylation enhances HSF1 nuclear translocation, homotrimerization and transactivation activities upon heat shock (PubMed:15760475, PubMed:27354066). Phosphorylated on Ser-320 by PRKACA/PKA; this phosphorylation promotes nuclear localization and transcriptional activity upon heat shock (PubMed:21085490). Phosphorylated on Ser-363 by MAPK8; this phosphorylation occurs upon heat shock, induces HSF1 translocation into nuclear stress bodies and negatively regulates transactivation activity (PubMed:10747973). Neither basal nor stress-inducible phosphorylation on Ser-230, Ser-292, Ser-303, Ser-307, Ser-314, Ser-319, Ser-320, Thr-323, Ser-326, Ser-338, Ser-344, Ser-363, Thr-367, Ser-368 and Thr-369 within the regulatory domain is involved in the regulation of HSF1 subcellular localization or DNA-binding activity; however, it negatively regulates HSF1 transactivation activity (PubMed:25963659). Phosphorylated on Ser-216 by PLK1 in the early mitotic period; this phosphorylation regulates HSF1 localization to the spindle pole, the recruitment of the SCF(BTRC) ubiquitin ligase complex inducing HSF1 degradation, and hence mitotic progression (PubMed:18794143). Dephosphorylated on Ser-121, Ser-307, Ser-314, Thr-323 and Thr-367 by phosphatase PPP2CA in an IER5-dependent manner, leading to HSF1-mediated transactivation activity (PubMed:26754925). {ECO:0000269|PubMed:10359787, ECO:0000269|PubMed:10747973, ECO:0000269|PubMed:11447121, ECO:0000269|PubMed:11583998, ECO:0000269|PubMed:12646186, ECO:0000269|PubMed:12659875, ECO:0000269|PubMed:12917326, ECO:0000269|PubMed:15760475, ECO:0000269|PubMed:16278218, ECO:0000269|PubMed:18794143, ECO:0000269|PubMed:21085490, ECO:0000269|PubMed:24581496, ECO:0000269|PubMed:25963659, ECO:0000269|PubMed:26159920, ECO:0000269|PubMed:26754925, ECO:0000269|PubMed:27354066, ECO:0000269|PubMed:8940068, ECO:0000269|PubMed:8946918, ECO:0000269|PubMed:9121459, ECO:0000269|PubMed:9499401, ECO:0000269|PubMed:9535852}.; PTM: Sumoylated with SUMO1 and SUMO2 upon heat shock in a ERK2-dependent manner (PubMed:12646186, PubMed:12665592). Sumoylated by SUMO1 on Lys-298; sumoylation occurs upon heat shock and promotes its localization to nuclear stress bodies and DNA-binding activity (PubMed:11514557). Phosphorylation on Ser-303 and Ser-307 is probably a prerequisite for sumoylation (PubMed:12646186, PubMed:12665592). {ECO:0000269|PubMed:11514557, ECO:0000269|PubMed:12646186, ECO:0000269|PubMed:12665592}.; PTM: Acetylated on Lys-118; this acetylation is decreased in a IER5-dependent manner (PubMed:26754925). Acetylated on Lys-118, Lys-208 and Lys-298; these acetylations occur in a EP300-dependent manner (PubMed:24581496, PubMed:27189267). Acetylated on Lys-80; this acetylation inhibits DNA-binding activity upon heat shock (PubMed:19229036). Deacetylated on Lys-80 by SIRT1; this deacetylation increases DNA-binding activity (PubMed:19229036). {ECO:0000269|PubMed:19229036, ECO:0000269|PubMed:24581496, ECO:0000269|PubMed:26754925, ECO:0000269|PubMed:27189267}.; PTM: Ubiquitinated by SCF(BTRC) and degraded following stimulus-dependent phosphorylation at Ser-216 by PLK1 in mitosis (PubMed:18794143). Polyubiquitinated (PubMed:24581496). Undergoes proteasomal degradation upon heat shock and during the attenuation and recovery phase period of the heat shock response (PubMed:24581496). {ECO:0000269|PubMed:18794143, ECO:0000269|PubMed:24581496}.","DOMAIN: In unstressed cells, spontaneous homotrimerization is inhibited (PubMed:7760831, PubMed:7935471). Intramolecular interactions between the hydrophobic repeat HR-A/B and HR-C regions are necessary to maintain HSF1 in the inactive, monomeric conformation (PubMed:7623826, PubMed:7935471). Furthermore, intramolecular interactions between the regulatory domain and the nonadjacent transactivation domain prevents transcriptional activation, a process that is relieved upon heat shock (PubMed:7760831). The regulatory domain is necessary for full repression of the transcriptional activation domain in unstressed cells through its phosphorylation on Ser-303 and Ser-307 (PubMed:8946918, PubMed:9121459). In heat stressed cells, HSF1 homotrimerization occurs through formation of a three-stranded coiled-coil structure generated by intermolecular interactions between HR-A/B regions allowing DNA-binding activity (PubMed:7935471). The D domain is necessary for translocation to the nucleus, interaction with JNK1 and MAPK3 and efficient JNK1- and MAPK3-dependent phosphorylation (PubMed:10747973). The regulatory domain confers heat shock inducibility on the transcriptional transactivation domain (PubMed:7760831). The regulatory domain is necessary for transcriptional activation through its phosphorylation on Ser-230 upon heat shock (PubMed:11447121). 9aaTAD is a transactivation motif present in a large number of yeast and animal transcription factors (PubMed:17467953). {ECO:0000269|PubMed:10747973, ECO:0000269|PubMed:11447121, ECO:0000269|PubMed:17467953, ECO:0000269|PubMed:7623826, ECO:0000269|PubMed:7760831, ECO:0000269|PubMed:7935471, ECO:0000269|PubMed:8946918, ECO:0000269|PubMed:9121459}.",,"STRAND 35..37; /evidence=""ECO:0007829|PDB:5HDN""; STRAND 39..42; /evidence=""ECO:0007829|PDB:5D5U""; STRAND 44..47; /evidence=""ECO:0007829|PDB:5HDN""; STRAND 79..83; /evidence=""ECO:0007829|PDB:5HDN""; STRAND 87..89; /evidence=""ECO:0007829|PDB:7DCJ""; STRAND 96..100; /evidence=""ECO:0007829|PDB:5HDN""","HELIX 17..27; /evidence=""ECO:0007829|PDB:5HDN""; HELIX 29..31; /evidence=""ECO:0007829|PDB:5HDN""; HELIX 49..55; /evidence=""ECO:0007829|PDB:5HDN""; HELIX 57..60; /evidence=""ECO:0007829|PDB:5HDN""; HELIX 66..75; /evidence=""ECO:0007829|PDB:5HDN""; HELIX 109..114; /evidence=""ECO:0007829|PDB:5HDN""","TURN 32..34; /evidence=""ECO:0007829|PDB:5HDN""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,HSF1 HSTF1,Heat shock factor protein 1 (HSF 1) (Heat shock transcription factor 1) (HSTF 1),Homo sapiens (Human),529.0,57260.0,MDLPVGPGAAGPSNVPAFLTKLWTLVSDPDTDALICWSPSGNSFHVFDQGQFAKEVLPKYFKHNNMASFVRQLNMYGFRKVVHIEQGGLVKPERDDTEFQHPCFLRGQEQLLENIKRKVTSVSTLKSEDIKIRQDSVTKLLTDVQLMKGKQECMDSKLLAMKHENEALWREVASLRQKHAQQQKVVNKLIQFLISLVQSNRILGVKRKIPLMLNDSGSAHSMPKYSRQFSLEHVHGSGPYSAPSPAYSSSSLYAPDAVASSGPIISDITELAPASPMASPGGSIDERPLSSSPLVRVKEEPPSPPQSPRVEEASPGRPSSVDTLLSPTALIDSILRESEPAPASVTALTDARGHTDTEGRPPSPPPTSTPEKCLSVACLDKNELSDHLDAMDSNLDNLQTMLSSHGFSVDTSALLDLFSPSVTVPDMSLPDLDSSLASIQELLSPQEPPRPPEAENSSPDSGKQLVHYTAQPLFLLDPGSVDTGSNDLPVLFELGEGSYFSEGDGFAEDPTISLLTGSEPPKAKDPTVS,False,False,True,Q00613,"[('G3DSA:1.10.10.10', 'Winged helix-like DNA-binding domain superfamily/Winged helix DNA-binding domain'), ('IPR000232', 'Heat shock factor (HSF)-type, DNA-binding'), ('IPR010542', 'Vertebrate heat shock transcription factor, C-terminal domain'), ('IPR036388', 'Winged helix-like DNA-binding domain superfamily'), ('IPR036390', 'Winged helix DNA-binding domain superfamily'), ('PF00447', 'HSF-type DNA-binding'), ('PF06546', 'Vertebrate heat shock transcription factor'), ('PR00056', 'HSFDOMAIN'), ('PS00434', 'HSF-type DNA-binding domain signature'), ('PTHR10015', 'HEAT SHOCK TRANSCRIPTION FACTOR'), ('SM00415', 'heat shock factor'), ('SSF46785', '""Winged helix"" DNA-binding domain')]",,"""ENSG00000185122; Low tissue specificity."";",,,,,ENST00000528838.6 [Q00613-1];ENST00000646252.2 [Q00613-1];,HSF1,ENSG00000185122,1.0,HSF1,Non-canonical_RBPs,0.0,,,0.595,0.711,0.217,HSF1
Q00987,ENSG00000135679,MDM2_HUMAN,"amyloid fibril formation [GO:1990000]; apoptotic process [GO:0006915]; atrial septum development [GO:0003283]; atrioventricular valve morphogenesis [GO:0003181]; blood vessel development [GO:0001568]; blood vessel remodeling [GO:0001974]; cardiac septum morphogenesis [GO:0060411]; cellular response to actinomycin D [GO:0072717]; cellular response to alkaloid [GO:0071312]; cellular response to estrogen stimulus [GO:0071391]; cellular response to gamma radiation [GO:0071480]; cellular response to growth factor stimulus [GO:0071363]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to hypoxia [GO:0071456]; cellular response to peptide hormone stimulus [GO:0071375]; cellular response to UV-C [GO:0071494]; cellular response to vitamin B1 [GO:0071301]; DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest [GO:0006977]; endocardial cushion morphogenesis [GO:0003203]; establishment of protein localization [GO:0045184]; fibroblast activation [GO:0072537]; negative regulation of apoptotic process [GO:0043066]; negative regulation of DNA damage response, signal transduction by p53 class mediator [GO:0043518]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator [GO:1902254]; negative regulation of neuron projection development [GO:0010977]; negative regulation of protein processing [GO:0010955]; negative regulation of signal transduction by p53 class mediator [GO:1901797]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of gene expression [GO:0010628]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of muscle cell differentiation [GO:0051149]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein export from nucleus [GO:0046827]; positive regulation of vascular associated smooth muscle cell migration [GO:1904754]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein destabilization [GO:0031648]; protein localization to nucleus [GO:0034504]; protein polyubiquitination [GO:0000209]; protein sumoylation [GO:0016925]; protein ubiquitination [GO:0016567]; protein-containing complex assembly [GO:0065003]; proteolysis involved in protein catabolic process [GO:0051603]; regulation of cell cycle [GO:0051726]; regulation of gene expression [GO:0010468]; regulation of heart rate [GO:0002027]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; regulation of protein catabolic process [GO:0042176]; regulation of protein catabolic process at postsynapse, modulating synaptic transmission [GO:0099576]; response to antibiotic [GO:0046677]; response to cocaine [GO:0042220]; response to ether [GO:0045472]; response to formaldehyde [GO:1904404]; response to iron ion [GO:0010039]; response to magnesium ion [GO:0032026]; response to steroid hormone [GO:0048545]; response to toxic substance [GO:0009636]; response to water-immersion restraint stress [GO:1990785]; response to xenobiotic stimulus [GO:0009410]; traversing start control point of mitotic cell cycle [GO:0007089]; ubiquitin-dependent protein catabolic process [GO:0006511]; ventricular septum development [GO:0003281]",cytoplasm [GO:0005737]; cytosol [GO:0005829]; endocytic vesicle membrane [GO:0030666]; glutamatergic synapse [GO:0098978]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991]; transcription repressor complex [GO:0017053],5S rRNA binding [GO:0008097]; disordered domain specific binding [GO:0097718]; enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; ligase activity [GO:0016874]; NEDD8 ligase activity [GO:0061663]; p53 binding [GO:0002039]; peroxisome proliferator activated receptor binding [GO:0042975]; protein domain specific binding [GO:0019904]; receptor serine/threonine kinase binding [GO:0033612]; ribonucleoprotein complex binding [GO:0043021]; SUMO transferase activity [GO:0019789]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],"PTM: Phosphorylation on Ser-166 by SGK1 activates ubiquitination of p53/TP53. Phosphorylated at multiple sites near the RING domain by ATM upon DNA damage; this prevents oligomerization and E3 ligase processivity and impedes constitutive p53/TP53 degradation. {ECO:0000269|PubMed:10611322, ECO:0000269|PubMed:12167711, ECO:0000269|PubMed:18382127, ECO:0000269|PubMed:19756449, ECO:0000269|PubMed:19816404}.; PTM: Autoubiquitination leads to proteasomal degradation; resulting in p53/TP53 activation it may be regulated by SFN. Also ubiquitinated by TRIM13. Deubiquitinated by USP2 leads to its accumulation and increases deubiquitination and degradation of p53/TP53. Deubiquitinated by USP7 leading to its stabilization. {ECO:0000269|PubMed:18382127, ECO:0000269|PubMed:30879903}.",DOMAIN: Region I is sufficient for binding p53 and inhibiting its G1 arrest and apoptosis functions. It also binds p73 and E2F1. Region II contains most of a central acidic region required for interaction with ribosomal protein L5 and a putative C4-type zinc finger. The RING finger domain which coordinates two molecules of zinc interacts specifically with RNA whether or not zinc is present and mediates the heterooligomerization with MDM4. It is also essential for its ubiquitin ligase E3 activity toward p53 and itself.,"DOMAIN 26..109; /note=""SWIB/MDM2""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU01273""","STRAND 7..10; /evidence=""ECO:0007829|PDB:4WT2""; STRAND 13..15; /evidence=""ECO:0007829|PDB:4WT2""; STRAND 17..19; /evidence=""ECO:0007829|PDB:2LZG""; STRAND 27..30; /evidence=""ECO:0007829|PDB:6Q9L""; STRAND 46..49; /evidence=""ECO:0007829|PDB:6Q9L""; STRAND 69..71; /evidence=""ECO:0007829|PDB:6Q9L""; STRAND 74..76; /evidence=""ECO:0007829|PDB:6Q9L""; STRAND 78..80; /evidence=""ECO:0007829|PDB:3LBK""; STRAND 89..92; /evidence=""ECO:0007829|PDB:6Q9L""; STRAND 107..109; /evidence=""ECO:0007829|PDB:6Q9L""; STRAND 295..297; /evidence=""ECO:0007829|PDB:2C6A""; STRAND 314..318; /evidence=""ECO:0007829|PDB:4XXB""; STRAND 442..444; /evidence=""ECO:0007829|PDB:6SQO""; STRAND 448..452; /evidence=""ECO:0007829|PDB:6SQO""; STRAND 455..460; /evidence=""ECO:0007829|PDB:6SQO""; STRAND 484..489; /evidence=""ECO:0007829|PDB:6SQO""","HELIX 21..24; /evidence=""ECO:0007829|PDB:6Q9L""; HELIX 32..39; /evidence=""ECO:0007829|PDB:6Q9L""; HELIX 50..63; /evidence=""ECO:0007829|PDB:6Q9L""; HELIX 81..86; /evidence=""ECO:0007829|PDB:6Q9L""; HELIX 96..104; /evidence=""ECO:0007829|PDB:6Q9L""; HELIX 299..301; /evidence=""ECO:0007829|PDB:4XXB""; HELIX 432..435; /evidence=""ECO:0007829|PDB:6SQO""; HELIX 462..470; /evidence=""ECO:0007829|PDB:6SQO""","TURN 40..42; /evidence=""ECO:0007829|PDB:6Q9L""; TURN 64..67; /evidence=""ECO:0007829|PDB:4ODF""; TURN 306..308; /evidence=""ECO:0007829|PDB:4XXB""; TURN 320..322; /evidence=""ECO:0007829|PDB:4XXB""; TURN 439..441; /evidence=""ECO:0007829|PDB:6SQO""; TURN 476..478; /evidence=""ECO:0007829|PDB:6SQO""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,MDM2,E3 ubiquitin-protein ligase Mdm2 (EC 2.3.2.27) (Double minute 2 protein) (Hdm2) (Oncoprotein Mdm2) (RING-type E3 ubiquitin transferase Mdm2) (p53-binding protein Mdm2),Homo sapiens (Human),491.0,55233.0,MCNTNMSVPTDGAVTTSQIPASEQETLVRPKPLLLKLLKSVGAQKDTYTMKEVLFYLGQYIMTKRLYDEKQQHIVYCSNDLLGDLFGVPSFSVKEHRKIYTMIYRNLVVVNQQESSDSGTSVSENRCHLEGGSDQKDLVQELQEEKPSSSHLVSRPSTSSRRRAISETEENSDELSGERQRKRHKSDSISLSFDESLALCVIREICCERSSSSESTGTPSNPDLDAGVSEHSGDWLDQDSVSDQFSVEFEVESLDSEDYSLSEEGQELSDEDDEVYQVTVYQAGESDTDSFEEDPEISLADYWKCTSCNEMNPPLPSHCNRCWALRENWLPEDKGKDKGEISEKAKLENSTQAEEGFDVPDCKKTIVNDSRESCVEENDDKITQASQSQESEDYSQPSTSSSIIYSSQEDVKEFEREETQDKEESVESSLPLNAIEPCVICQGRPKNGCIVHGKTGHLMACFTCAKKLKKRNKPCPVCRQPIQMIVLTYFP,False,False,True,Q00987,"[('cd16783', 'Modified RING finger, HC subclass (C2H2C4-type), found in E3 ubiquitin-protein ligase MDM2 and similar proteins'), ('cd17672', 'p53-binding domain found in E3 ubiquitin-protein ligase MDM2 and similar proteins'), ('G3DSA:1.10.245.10', 'SWIB/MDM2 domain'), ('G3DSA:2.30.30.380', 'Zn-finger domain of Sec23/24'), ('G3DSA:3.30.40.10', 'Zinc/RING finger domain, C3HC4 (zinc finger)'), ('IPR001841', 'Zinc finger, RING-type'), ('IPR001876', 'Zinc finger, RanBP2-type'), ('IPR003121', 'SWIB/MDM2 domain'), ('IPR013083', 'Zinc finger, RING/FYVE/PHD-type'), ('IPR016495', 'p53 negative regulator Mdm2/Mdm4'), ('IPR028340', 'E3 ubiquitin-protein ligase Mdm2'), ('IPR036443', 'Zinc finger, RanBP2-type superfamily'), ('IPR036885', 'SWIB/MDM2 domain superfamily'), ('IPR044080', 'MDM2, modified RING finger, HC subclass'), ('PF00641', 'Zn-finger in Ran binding protein and others'), ('PF02201', 'SWIB/MDM2 domain'), ('PF13920', 'Zinc finger, C3HC4 type (RING finger)'), ('PIRSF006748', 'p53 negative regulator Mdm2/Mdm4'), ('PIRSF500700', 'p53 negative regulator Mdm2'), ('PS01358', 'Zinc finger RanBP2-type signature')]",Q00987;,"""ENSG00000135679; Low tissue specificity."";",CATALYTIC ACTIVITY: Reaction=S-ubiquitinyl-[E2 ubiquitin-conjugating enzyme]-L-cysteine + [acceptor protein]-L-lysine = [E2 ubiquitin-conjugating enzyme]-L-cysteine + N(6)-ubiquitinyl-[acceptor protein]-L-lysine.; EC=2.3.2.27; Evidence={ECO:0000269|PubMed:12821780};,2.3.2.27,,,ENST00000258149.11 [Q00987-11];ENST00000299252.8 [Q00987-5];ENST00000360430.6 [Q00987-2];ENST00000393413.7 [Q00987-4];ENST00000539479.6 [Q00987-1];,MDM2,ENSG00000135679,0.0,MDM2,Canonical_RBPs,0.0,45.21,DP00334,0.55,0.654,0.312,MDM2
Q02252,ENSG00000119711,MMSA_HUMAN,branched-chain amino acid catabolic process [GO:0009083]; brown fat cell differentiation [GO:0050873]; thymine catabolic process [GO:0006210]; thymine metabolic process [GO:0019859]; valine catabolic process [GO:0006574]; valine metabolic process [GO:0006573],mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654],"malonate-semialdehyde dehydrogenase (acetylating) activity [GO:0018478]; methylmalonate-semialdehyde dehydrogenase (acylating, NAD) activity [GO:0004491]; RNA binding [GO:0003723]",,,,,,,"cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,ALDH6A1 MMSDH,"Methylmalonate-semialdehyde/malonate-semialdehyde dehydrogenase [acylating], mitochondrial (MMSDH) (EC 1.2.1.27) (Aldehyde dehydrogenase family 6 member A1) (Malonate-semialdehyde dehydrogenase [acylating])",Homo sapiens (Human),535.0,57840.0,MAALLAAAAVRARILQVSSKVKSSPTWYSASSFSSSVPTVKLFIGGKFVESKSDKWIDIHNPATNEVIGRVPQATKAEMDAAIASCKRAFPAWADTSVLSRQQVLLRYQQLIKENLKEIAKLITLEQGKTLADAEGDVFRGLQVVEHACSVTSLMMGETMPSITKDMDLYSYRLPLGVCAGIAPFNFPAMIPLWMFPMAMVCGNTFLMKPSERVPGATMLLAKLLQDSGAPDGTLNIIHGQHEAVNFICDHPDIKAISFVGSNKAGEYIFERGSRHGKRVQANMGAKNHGVVMPDANKENTLNQLVGAAFGAAGQRCMALSTAVLVGEAKKWLPELVEHAKNLRVNAGDQPGADLGPLITPQAKERVCNLIDSGTKEGASILLDGRKIKVKGYENGNFVGPTIISNVKPNMTCYKEEIFGPVLVVLETETLDEAIQIVNNNPYGNGTAIFTTNGATARKYAHLVDVGQVGVNVPIPVPLPMFSFTGSRSSFRGDTNFYGKQGIQFYTQLKTITSQWKEEDATLSSPAVVMPTMGR,True,False,False,Q02252,"[('cd07085', 'Methylmalonate semialdehyde dehydrogenase and ALDH family members 6A1 and 6B2'), ('G3DSA:3.40.309.10', 'Aldehyde Dehydrogenase; Chain A, domain 2'), ('G3DSA:3.40.605.10', 'Aldehyde Dehydrogenase; Chain A, domain 1'), ('IPR010061', 'Methylmalonate-semialdehyde dehydrogenase'), ('IPR015590', 'Aldehyde dehydrogenase domain'), ('IPR016160', 'Aldehyde dehydrogenase, cysteine active site'), ('IPR016161', 'Aldehyde/histidinol dehydrogenase'), ('IPR016162', 'Aldehyde dehydrogenase, N-terminal'), ('IPR016163', 'Aldehyde dehydrogenase, C-terminal'), ('PF00171', 'Aldehyde dehydrogenase family'), ('PS00070', 'Aldehyde dehydrogenases cysteine active site'), ('PTHR43866', 'MALONATE-SEMIALDEHYDE DEHYDROGENASE'), ('SSF53720', 'ALDH-like'), ('TIGR01722', 'CoA-acylating methylmalonate-semialdehyde dehydrogenase')]",,"""ENSG00000119711; Group enriched (kidney, liver)."";","CATALYTIC ACTIVITY: Reaction=3-oxopropanoate + NAD(+) + CoA + H2O = hydrogencarbonate + acetyl-CoA + NADH + H(+); Xref=Rhea:RHEA:76615, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:17544, ChEBI:CHEBI:33190, ChEBI:CHEBI:57287, ChEBI:CHEBI:57288, ChEBI:CHEBI:57540, ChEBI:CHEBI:57945; EC=1.2.1.27; Evidence={ECO:0000250|UniProtKB:Q02253}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:76616; Evidence={ECO:0000250|UniProtKB:Q02253}; CATALYTIC ACTIVITY: Reaction=2-methyl-3-oxopropanoate + NAD(+) + CoA + H2O = propanoyl-CoA + hydrogencarbonate + NADH + H(+); Xref=Rhea:RHEA:20804, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:17544, ChEBI:CHEBI:57287, ChEBI:CHEBI:57392, ChEBI:CHEBI:57540, ChEBI:CHEBI:57700, ChEBI:CHEBI:57945; EC=1.2.1.27; Evidence={ECO:0000269|PubMed:23835272}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:20805; Evidence={ECO:0000269|PubMed:23835272}; CATALYTIC ACTIVITY: Reaction=(R)-2-methyl-3-oxopropanoate + NAD(+) + CoA + H2O = propanoyl-CoA + hydrogencarbonate + NADH + H(+); Xref=Rhea:RHEA:76623, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:17544, ChEBI:CHEBI:57287, ChEBI:CHEBI:57392, ChEBI:CHEBI:57540, ChEBI:CHEBI:57945, ChEBI:CHEBI:141212; Evidence={ECO:0000250|UniProtKB:Q02253}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:76624; Evidence={ECO:0000250|UniProtKB:Q02253}; CATALYTIC ACTIVITY: Reaction=(S)-2-methyl-3-oxopropanoate + NAD(+) + CoA + H2O = propanoyl-CoA + hydrogencarbonate + NADH + H(+); Xref=Rhea:RHEA:76627, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:17544, ChEBI:CHEBI:57287, ChEBI:CHEBI:57392, ChEBI:CHEBI:57540, ChEBI:CHEBI:57945, ChEBI:CHEBI:62413; Evidence={ECO:0000250|UniProtKB:Q02253}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:76628; Evidence={ECO:0000250|UniProtKB:Q02253};",1.2.1.27,,,ENST00000350259.8 [Q02252-2];ENST00000553458.6 [Q02252-1];,ALDH6A1,ENSG00000119711,0.0,ALDH6A1,Non-canonical_RBPs,5.0,,,,0.084,,ALDH6A1
Q04637,ENSG00000114867,IF4G1_HUMAN,behavioral fear response [GO:0001662]; cap-dependent translational initiation [GO:0002191]; cellular response to nutrient levels [GO:0031669]; energy homeostasis [GO:0097009]; lung development [GO:0030324]; macromolecule biosynthetic process [GO:0009059]; miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; negative regulation of autophagy [GO:0010507]; negative regulation of peptidyl-threonine phosphorylation [GO:0010801]; neuron differentiation [GO:0030182]; positive regulation of cell growth [GO:0030307]; positive regulation of eukaryotic translation initiation factor 4F complex assembly [GO:1905537]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of mRNA cap binding [GO:1905612]; positive regulation of neuron differentiation [GO:0045666]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein localization to cell periphery [GO:1904377]; positive regulation of protein metabolic process [GO:0051247]; positive regulation of translation in response to endoplasmic reticulum stress [GO:0036493]; regulation of cellular response to stress [GO:0080135]; regulation of presynapse assembly [GO:1905606]; regulation of translational initiation [GO:0006446]; response to ethanol [GO:0045471]; translation [GO:0006412]; translational initiation [GO:0006413],cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; eukaryotic translation initiation factor 4F complex [GO:0016281]; membrane [GO:0016020]; nucleus [GO:0005634]; postsynapse [GO:0098794]; ribosome [GO:0005840],"ATP binding [GO:0005524]; eukaryotic initiation factor 4E binding [GO:0008190]; molecular adaptor activity [GO:0060090]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; translation factor activity, RNA binding [GO:0008135]; translation initiation factor activity [GO:0003743]; translation initiation factor binding [GO:0031369]","PTM: Phosphorylated at multiple sites in vivo. Phosphorylation at Ser-1185 by PRKCA induces binding to MKNK1. {ECO:0000269|PubMed:21576361}.; PTM: Following infection by certain enteroviruses, rhinoviruses and aphthoviruses, EIF4G1 is cleaved by the viral protease 2A, or the leader protease in the case of aphthoviruses. This shuts down the capped cellular mRNA transcription. {ECO:0000269|PubMed:11034318, ECO:0000269|PubMed:8396129, ECO:0000269|PubMed:9755863}.",,"DOMAIN 565..792; /note=""MIF4G""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00698""; DOMAIN 1241..1363; /note=""MI""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00698""; DOMAIN 1433..1599; /note=""W2""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00695""","STRAND 181..183; /evidence=""ECO:0007829|PDB:1LJ2""; STRAND 1494..1496; /evidence=""ECO:0007829|PDB:1UG3""","HELIX 185..187; /evidence=""ECO:0007829|PDB:4F02""; HELIX 193..197; /evidence=""ECO:0007829|PDB:4F02""; HELIX 614..618; /evidence=""ECO:0007829|PDB:5T46""; HELIX 624..627; /evidence=""ECO:0007829|PDB:5T46""; HELIX 1234..1256; /evidence=""ECO:0007829|PDB:1UG3""; HELIX 1259..1267; /evidence=""ECO:0007829|PDB:1UG3""; HELIX 1272..1274; /evidence=""ECO:0007829|PDB:1UG3""; HELIX 1275..1286; /evidence=""ECO:0007829|PDB:1UG3""; HELIX 1291..1306; /evidence=""ECO:0007829|PDB:1UG3""; HELIX 1312..1329; /evidence=""ECO:0007829|PDB:1UG3""; HELIX 1336..1344; /evidence=""ECO:0007829|PDB:1UG3""; HELIX 1345..1348; /evidence=""ECO:0007829|PDB:1UG3""; HELIX 1355..1362; /evidence=""ECO:0007829|PDB:1UG3""; HELIX 1366..1369; /evidence=""ECO:0007829|PDB:1UG3""; HELIX 1372..1387; /evidence=""ECO:0007829|PDB:1UG3""; HELIX 1389..1398; /evidence=""ECO:0007829|PDB:1UG3""; HELIX 1403..1405; /evidence=""ECO:0007829|PDB:1UG3""; HELIX 1413..1419; /evidence=""ECO:0007829|PDB:1UG3""; HELIX 1423..1425; /evidence=""ECO:0007829|PDB:1UG3""; HELIX 1439..1452; /evidence=""ECO:0007829|PDB:1UG3""; HELIX 1457..1467; /evidence=""ECO:0007829|PDB:1UG3""; HELIX 1470..1473; /evidence=""ECO:0007829|PDB:1UG3""; HELIX 1476..1489; /evidence=""ECO:0007829|PDB:1UG3""; HELIX 1501..1514; /evidence=""ECO:0007829|PDB:1UG3""; HELIX 1518..1534; /evidence=""ECO:0007829|PDB:1UG3""; HELIX 1541..1551; /evidence=""ECO:0007829|PDB:1UG3""; HELIX 1557..1563; /evidence=""ECO:0007829|PDB:1UG3""","TURN 619..622; /evidence=""ECO:0007829|PDB:5T46""; TURN 637..639; /evidence=""ECO:0007829|PDB:5T46""; TURN 1287..1289; /evidence=""ECO:0007829|PDB:1UG3""; TURN 1330..1332; /evidence=""ECO:0007829|PDB:1UG3""; TURN 1363..1365; /evidence=""ECO:0007829|PDB:1UG3""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,EIF4G1 EIF4F EIF4G EIF4GI,Eukaryotic translation initiation factor 4 gamma 1 (eIF-4-gamma 1) (eIF-4G 1) (eIF-4G1) (p220),Homo sapiens (Human),1599.0,175491.0,MNKAPQSTGPPPAPSPGLPQPAFPPGQTAPVVFSTPQATQMNTPSQPRQHFYPSRAQPPSSAASRVQSAAPARPGPAAHVYPAGSQVMMIPSQISYPASQGAYYIPGQGRSTYVVPTQQYPVQPGAPGFYPGASPTEFGTYAGAYYPAQGVQQFPTGVAPTPVLMNQPPQIAPKRERKTIRIRDPNQGGKDITEEIMSGARTASTPTPPQTGGGLEPQANGETPQVAVIVRPDDRSQGAIIADRPGLPGPEHSPSESQPSSPSPTPSPSPVLEPGSEPNLAVLSIPGDTMTTIQMSVEESTPISRETGEPYRLSPEPTPLAEPILEVEVTLSKPVPESEFSSSPLQAPTPLASHTVEIHEPNGMVPSEDLEPEVESSPELAPPPACPSESPVPIAPTAQPEELLNGAPSPPAVDLSPVSEPEEQAKEVTASMAPPTIPSATPATAPSATSPAQEEEMEEEEEEEEGEAGEAGEAESEKGGEELLPPESTPIPANLSQNLEAAAATQVAVSVPKRRRKIKELNKKEAVGDLLDAFKEANPAVPEVENQPPAGSNPGPESEGSGVPPRPEEADETWDSKEDKIHNAENIQPGEQKYEYKSDQWKPLNLEEKKRYDREFLLGFQFIFASMQKPEGLPHISDVVLDKANKTPLRPLDPTRLQGINCGPDFTPSFANLGRTTLSTRGPPRGGPGGELPRGPAGLGPRRSQQGPRKEPRKIIATVLMTEDIKLNKAEKAWKPSSKRTAADKDRGEEDADGSKTQDLFRRVRSILNKLTPQMFQQLMKQVTQLAIDTEERLKGVIDLIFEKAISEPNFSVAYANMCRCLMALKVPTTEKPTVTVNFRKLLLNRCQKEFEKDKDDDEVFEKKQKEMDEAATAEERGRLKEELEEARDIARRRSLGNIKFIGELFKLKMLTEAIMHDCVVKLLKNHDEESLECLCRLLTTIGKDLDFEKAKPRMDQYFNQMEKIIKEKKTSSRIRFMLQDVLDLRGSNWVPRRGDQGPKTIDQIHKEAEMEEHREHIKVQQLMAKGSDKRRGGPPGPPISRGLPLVDDGGWNTVPISKGSRPIDTSRLTKITKPGSIDSNNQLFAPGGRLSWGKGSSGGSGAKPSDAASEAARPATSTLNRFSALQQAVPTESTDNRRVVQRSSLSRERGEKAGDRGDRLERSERGGDRGDRLDRARTPATKRSFSKEVEERSRERPSQPEGLRKAASLTEDRDRGRDAVKREAALPPVSPLKAALSEEELEKKSKAIIEEYLHLNDMKEAVQCVQELASPSLLFIFVRHGVESTLERSAIAREHMGQLLHQLLCAGHLSTAQYYQGLYEILELAEDMEIDIPHVWLYLAELVTPILQEGGVPMGELFREITKPLRPLGKAASLLLEILGLLCKSMGPKKVGTLWREAGLSWKEFLPEGQDIGAFVAEQKVEYTLGEESEAPGQRALPSEELNRQLEKLLKEGSSNQRVFDWIEANLSEQQIVSNTLVRALMTAVCYSAIIFETPLRVDVAVLKARAKLLQKYLCDEQKELQALYALQALVVTLEQPPNLLRMFFDALYDEDVVKEDAFYSWESSKDPAEQQGKGVALKSVTAFFKWLREAEEESDHN,False,True,False,Q04637,"[('cd11559', 'C-terminal W2 domain of eukaryotic translation initiation factor 4 gamma 1 and similar proteins'), ('G3DSA:1.25.40.180', None), ('IPR003307', 'W2 domain'), ('IPR003890', 'MIF4G-like, type 3'), ('IPR003891', 'Initiation factor eIF-4 gamma, MA3'), ('IPR016024', 'Armadillo-type fold'), ('PF02020', 'eIF4-gamma/eIF5/eIF2-epsilon'), ('PF02847', 'MA3 domain'), ('PF02854', 'MIF4G domain'), ('PS51363', 'W2 domain profile'), ('PS51366', 'MI domain profile'), ('PTHR23253', 'EUKARYOTIC TRANSLATION INITIATION FACTOR 4 GAMMA'), ('SM00515', 'Domain at the C-termini of GCD6, eIF-2B epsilon, eIF-4 gamma and eIF-5'), ('SM00543', 'Middle domain of eukaryotic initiation factor 4G (eIF4G)'), ('SM00544', 'Domain in DAP-5, eIF4G, MA-3 and other proteins.'), ('SSF48371', 'ARM repeat')]",Q04637;,"""ENSG00000114867; Tissue enhanced (skeletal)."";",,,,,ENST00000342981.8 [Q04637-8];ENST00000346169.7 [Q04637-1];ENST00000350481.9 [Q04637-5];ENST00000352767.7 [Q04637-9];ENST00000382330.7 [Q04637-9];ENST00000392537.6 [Q04637-4];ENST00000414031.5 [Q04637-3];ENST00000424196.5 [Q04637-9];ENST00000434061.6 [Q04637-7];,EIF4G1,ENSG00000114867,0.0,EIF4G1,Canonical_RBPs,30.0,70.61,DP02398,0.706,0.607,0.477,EIF4G1
Q05086,ENSG00000114062,UBE3A_HUMAN,androgen receptor signaling pathway [GO:0030521]; brain development [GO:0007420]; cellular response to brain-derived neurotrophic factor stimulus [GO:1990416]; locomotory exploration behavior [GO:0035641]; motor learning [GO:0061743]; negative regulation of dendritic spine morphogenesis [GO:0061002]; negative regulation of TORC1 signaling [GO:1904262]; ovarian follicle development [GO:0001541]; positive regulation of Golgi lumen acidification [GO:1905528]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of transcription by RNA polymerase II [GO:0045944]; progesterone receptor signaling pathway [GO:0050847]; prostate gland growth [GO:0060736]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein K48-linked ubiquitination [GO:0070936]; protein polyubiquitination [GO:0000209]; proteolysis [GO:0006508]; regulation of circadian rhythm [GO:0042752]; regulation of synaptic plasticity [GO:0048167]; regulation of ubiquitin-dependent protein catabolic process [GO:2000058]; response to cocaine [GO:0042220]; response to hydrogen peroxide [GO:0042542]; response to progesterone [GO:0032570]; rhythmic process [GO:0048511]; sperm entry [GO:0035037]; ubiquitin-dependent protein catabolic process [GO:0006511],cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; nucleus [GO:0005634]; postsynaptic cytosol [GO:0099524]; proteasome complex [GO:0000502]; synaptic vesicle [GO:0008021],metal ion binding [GO:0046872]; transcription coactivator activity [GO:0003713]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842],PTM: Phosphorylation at Tyr-659 by ABL1 impairs E3 ligase activity and protects p53/TP53 from degradation in (HPV)-infected cells. {ECO:0000269|PubMed:23581475}.,,"DOMAIN 776..875; /note=""HECT""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00104""","STRAND 52..54; /evidence=""ECO:0007829|PDB:8EPT""; STRAND 55..57; /evidence=""ECO:0007829|PDB:8ENP""; STRAND 58..60; /evidence=""ECO:0007829|PDB:8EPT""; STRAND 199..203; /evidence=""ECO:0007829|PDB:6SJV""; STRAND 525..527; /evidence=""ECO:0007829|PDB:1C4Z""; STRAND 529..531; /evidence=""ECO:0007829|PDB:1C4Z""; STRAND 557..559; /evidence=""ECO:0007829|PDB:1C4Z""; STRAND 589..592; /evidence=""ECO:0007829|PDB:1C4Z""; STRAND 599..601; /evidence=""ECO:0007829|PDB:1C4Z""; STRAND 679..684; /evidence=""ECO:0007829|PDB:1C4Z""; STRAND 692..697; /evidence=""ECO:0007829|PDB:1C4Z""; STRAND 742..744; /evidence=""ECO:0007829|PDB:1C4Z""; STRAND 775..777; /evidence=""ECO:0007829|PDB:6TGK""; STRAND 811..814; /evidence=""ECO:0007829|PDB:6TGK""; STRAND 826..828; /evidence=""ECO:0007829|PDB:6TGK""; STRAND 831..833; /evidence=""ECO:0007829|PDB:7QPB""; STRAND 839..841; /evidence=""ECO:0007829|PDB:7QPB""; STRAND 846..849; /evidence=""ECO:0007829|PDB:7QPB""","HELIX 18..25; /evidence=""ECO:0007829|PDB:8EPT""; HELIX 27..41; /evidence=""ECO:0007829|PDB:2KR1""; HELIX 65..78; /evidence=""ECO:0007829|PDB:2KR1""; HELIX 130..142; /evidence=""ECO:0007829|PDB:8GCR""; HELIX 147..156; /evidence=""ECO:0007829|PDB:8GCR""; HELIX 160..165; /evidence=""ECO:0007829|PDB:8GCR""; HELIX 171..180; /evidence=""ECO:0007829|PDB:6SJV""; HELIX 185..194; /evidence=""ECO:0007829|PDB:6SJV""; HELIX 205..208; /evidence=""ECO:0007829|PDB:6SJV""; HELIX 212..219; /evidence=""ECO:0007829|PDB:6SJV""; HELIX 223..226; /evidence=""ECO:0007829|PDB:6SJV""; HELIX 232..247; /evidence=""ECO:0007829|PDB:6SJV""; HELIX 252..259; /evidence=""ECO:0007829|PDB:6SJV""; HELIX 265..271; /evidence=""ECO:0007829|PDB:8GCR""; HELIX 281..288; /evidence=""ECO:0007829|PDB:8GCR""; HELIX 294..296; /evidence=""ECO:0007829|PDB:8GCR""; HELIX 299..301; /evidence=""ECO:0007829|PDB:8GCR""; HELIX 305..314; /evidence=""ECO:0007829|PDB:8GCR""; HELIX 318..329; /evidence=""ECO:0007829|PDB:8GCR""; HELIX 333..353; /evidence=""ECO:0007829|PDB:8GCR""; HELIX 362..364; /evidence=""ECO:0007829|PDB:8GCR""; HELIX 366..385; /evidence=""ECO:0007829|PDB:8GCR""; HELIX 405..412; /evidence=""ECO:0007829|PDB:6SJV""; HELIX 446..449; /evidence=""ECO:0007829|PDB:8GCR""; HELIX 452..455; /evidence=""ECO:0007829|PDB:8GCR""; HELIX 460..468; /evidence=""ECO:0007829|PDB:8GCR""; HELIX 481..483; /evidence=""ECO:0007829|PDB:8GCR""; HELIX 486..513; /evidence=""ECO:0007829|PDB:8GCR""; HELIX 532..545; /evidence=""ECO:0007829|PDB:1C4Z""; HELIX 548..552; /evidence=""ECO:0007829|PDB:1C4Z""; HELIX 569..582; /evidence=""ECO:0007829|PDB:1C4Z""; HELIX 585..587; /evidence=""ECO:0007829|PDB:1C4Z""; HELIX 609..624; /evidence=""ECO:0007829|PDB:1C4Z""; HELIX 635..641; /evidence=""ECO:0007829|PDB:1C4Z""; HELIX 648..654; /evidence=""ECO:0007829|PDB:1C4Z""; HELIX 656..667; /evidence=""ECO:0007829|PDB:1C4Z""; HELIX 672..675; /evidence=""ECO:0007829|PDB:1C4Z""; HELIX 710..722; /evidence=""ECO:0007829|PDB:1C4Z""; HELIX 727..741; /evidence=""ECO:0007829|PDB:1C4Z""; HELIX 746..749; /evidence=""ECO:0007829|PDB:8GCR""; HELIX 753..760; /evidence=""ECO:0007829|PDB:1C4Z""; HELIX 767..773; /evidence=""ECO:0007829|PDB:6TGK""; HELIX 785..795; /evidence=""ECO:0007829|PDB:6TGK""; HELIX 799..810; /evidence=""ECO:0007829|PDB:6TGK""; HELIX 820..822; /evidence=""ECO:0007829|PDB:6TGK""; HELIX 855..867; /evidence=""ECO:0007829|PDB:6TGK""","TURN 181..183; /evidence=""ECO:0007829|PDB:6SJV""; TURN 277..279; /evidence=""ECO:0007829|PDB:8GCR""; TURN 302..304; /evidence=""ECO:0007829|PDB:8GCR""; TURN 594..596; /evidence=""ECO:0007829|PDB:1C4Z""; TURN 687..689; /evidence=""ECO:0007829|PDB:1C4Z""; TURN 698..702; /evidence=""ECO:0007829|PDB:1C4Z""; TURN 707..709; /evidence=""ECO:0007829|PDB:1C4Z""; TURN 723..726; /evidence=""ECO:0007829|PDB:8GCR""; TURN 842..845; /evidence=""ECO:0007829|PDB:7QPB""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,UBE3A E6AP EPVE6AP HPVE6A,Ubiquitin-protein ligase E3A (EC 2.3.2.26) (E6AP ubiquitin-protein ligase) (HECT-type ubiquitin transferase E3A) (Human papillomavirus E6-associated protein) (Oncogenic protein-associated protein E6-AP) (Renal carcinoma antigen NY-REN-54),Homo sapiens (Human),875.0,100688.0,MEKLHQCYWKSGEPQSDDIEASRMKRAAAKHLIERYYHQLTEGCGNEACTNEFCASCPTFLRMDNNAAAIKALELYKINAKLCDPHPSKKGASSAYLENSKGAPNNSCSEIKMNKKGARIDFKDVTYLTEEKVYEILELCREREDYSPLIRVIGRVFSSAEALVQSFRKVKQHTKEELKSLQAKDEDKDEDEKEKAACSAAAMEEDSEASSSRIGDSSQGDNNLQKLGPDDVSVDIDAIRRVYTRLLSNEKIETAFLNALVYLSPNVECDLTYHNVYSRDPNYLNLFIIVMENRNLHSPEYLEMALPLFCKAMSKLPLAAQGKLIRLWSKYNADQIRRMMETFQQLITYKVISNEFNSRNLVNDDDAIVAASKCLKMVYYANVVGGEVDTNHNEEDDEEPIPESSELTLQELLGEERRNKKGPRVDPLETELGVKTLDCRKPLIPFEEFINEPLNEVLEMDKDYTFFKVETENKFSFMTCPFILNAVTKNLGLYYDNRIRMYSERRITVLYSLVQGQQLNPYLRLKVRRDHIIDDALVRLEMIAMENPADLKKQLYVEFEGEQGVDEGGVSKEFFQLVVEEIFNPDIGMFTYDESTKLFWFNPSSFETEGQFTLIGIVLGLAIYNNCILDVHFPMVVYRKLMGKKGTFRDLGDSHPVLYQSLKDLLEYEGNVEDDMMITFQISQTDLFGNPMMYDLKENGDKIPITNENRKEFVNLYSDYILNKSVEKQFKAFRRGFHMVTNESPLKYLFRPEEIELLICGSRNLDFQALEETTEYDGGYTRDSVLIREFWEIVHSFTDEQKRLFLQFTTGTDRAPVGGLGKLKMIIAKNGPDTERLPTSHTCFNVLLLPEYSSKEKLKERLLKAITYAKGFGML,False,False,True,Q05086,"[('cd00078', 'HECTc'), ('G3DSA:3.30.2160.10', 'Hect, E3 ligase catalytic domain'), ('G3DSA:3.30.2410.10', 'Hect, E3 ligase catalytic domain'), ('G3DSA:3.90.1750.10', 'Hect, E3 ligase catalytic domains'), ('G3DSA:6.10.130.10', 'Ubiquitin-protein ligase E3A, N-terminal zinc-binding domain (AZUL)'), ('IPR000569', 'HECT domain'), ('IPR017134', 'Ubiquitin-protein ligase E3A'), ('IPR032353', 'Ubiquitin-protein ligase E3A, N-terminal zinc-binding domain'), ('IPR035983', 'HECT, E3 ligase catalytic domain'), ('IPR042556', 'Ubiquitin-protein ligase E3A, N-terminal zinc-binding domain superfamily'), ('IPR044611', 'Ubiquitin-protein ligase E3A/B/C-like'), ('PF00632', 'HECT-domain (ubiquitin-transferase)'), ('PF16558', 'Amino-terminal Zinc-binding domain of ubiquitin ligase E3A'), ('PIRSF037201', 'Ubiquitin-protein ligase E6-AP'), ('PS50237', 'HECT domain profile'), ('PTHR45700', 'UBIQUITIN-PROTEIN LIGASE E3C'), ('SM00119', 'Domain Homologous to E6-AP Carboxyl Terminus with'), ('SSF56204', 'Hect, E3 ligase catalytic domain')]",,"""ENSG00000114062; Low tissue specificity."";",CATALYTIC ACTIVITY: Reaction=S-ubiquitinyl-[E2 ubiquitin-conjugating enzyme]-L-cysteine + [acceptor protein]-L-lysine = [E2 ubiquitin-conjugating enzyme]-L-cysteine + N(6)-ubiquitinyl-[acceptor protein]-L-lysine.; EC=2.3.2.26; Evidence={ECO:0000269|PubMed:24273172};,2.3.2.26,,PATHWAY: Protein modification; protein ubiquitination. {ECO:0000269|PubMed:24273172}.,ENST00000428984.6 [Q05086-2];ENST00000438097.6 [Q05086-2];ENST00000566215.5 [Q05086-2];ENST00000630424.2 [Q05086-2];ENST00000637886.1 [Q05086-3];ENST00000638011.1 [Q05086-2];ENST00000638155.1 [Q05086-2];ENST00000648336.2 [Q05086-3];ENST00000649550.1 [Q05086-2];ENST00000650110.1 [Q05086-1];,UBE3A,ENSG00000114062,0.0,,,,,,0.021,0.141,0.059,UBE3A
Q05513,ENSG00000067606,KPCZ_HUMAN,cell migration [GO:0016477]; cell surface receptor signaling pathway [GO:0007166]; cellular response to insulin stimulus [GO:0032869]; establishment of cell polarity [GO:0030010]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; inflammatory response [GO:0006954]; intracellular signal transduction [GO:0035556]; long-term memory [GO:0007616]; long-term synaptic potentiation [GO:0060291]; membrane depolarization [GO:0051899]; membrane hyperpolarization [GO:0060081]; microtubule cytoskeleton organization [GO:0000226]; negative regulation of apoptotic process [GO:0043066]; negative regulation of insulin receptor signaling pathway [GO:0046627]; negative regulation of peptidyl-tyrosine phosphorylation [GO:0050732]; negative regulation of protein-containing complex assembly [GO:0031333]; neuron projection extension [GO:1990138]; peptidyl-serine phosphorylation [GO:0018105]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of excitatory postsynaptic potential [GO:2000463]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of interleukin-10 production [GO:0032733]; positive regulation of interleukin-13 production [GO:0032736]; positive regulation of interleukin-4 production [GO:0032753]; positive regulation of interleukin-5 production [GO:0032754]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein transport [GO:0051222]; positive regulation of T-helper 2 cell cytokine production [GO:2000553]; positive regulation of T-helper 2 cell differentiation [GO:0045630]; protein kinase C signaling [GO:0070528]; protein localization to plasma membrane [GO:0072659]; protein phosphorylation [GO:0006468]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; signal transduction [GO:0007165]; vesicle transport along microtubule [GO:0047496],apical cortex [GO:0045179]; apical plasma membrane [GO:0016324]; axon hillock [GO:0043203]; bicellular tight junction [GO:0005923]; cell junction [GO:0030054]; cell leading edge [GO:0031252]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; microtubule organizing center [GO:0005815]; myelin sheath abaxonal region [GO:0035748]; nuclear envelope [GO:0005635]; nuclear matrix [GO:0016363]; PAR polarity complex [GO:0120157]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; Schaffer collateral - CA1 synapse [GO:0098685]; stress fiber [GO:0001725]; tight junction [GO:0070160]; vesicle [GO:0031982],14-3-3 protein binding [GO:0071889]; ATP binding [GO:0005524]; diacylglycerol-dependent serine/threonine kinase activity [GO:0004697]; insulin receptor substrate binding [GO:0043560]; metal ion binding [GO:0046872]; phospholipase binding [GO:0043274]; potassium channel regulator activity [GO:0015459]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein-containing complex binding [GO:0044877],"PTM: CDH5 is required for its phosphorylation at Thr-410. Phosphorylated by protein kinase PDPK1; phosphorylation is inhibited by the apoptotic C-terminal cleavage product of PKN2. Phosphorylation at Thr-410 by PI3K activates the kinase. {ECO:0000269|PubMed:11781095, ECO:0000269|PubMed:15314172, ECO:0000269|PubMed:20332120, ECO:0000269|PubMed:9768361}.",DOMAIN: The PB1 domain mediate mutually exclusive interactions with SQSTM1 and PARD6B. {ECO:0000269|PubMed:12887891}.; DOMAIN: The C1 domain does not bind the diacylglycerol (DAG). {ECO:0000269|PubMed:12887891}.,"DOMAIN 15..98; /note=""PB1""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU01081""; DOMAIN 252..518; /note=""Protein kinase""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00159""; DOMAIN 519..590; /note=""AGC-kinase C-terminal""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00618""",,,,"cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,PRKCZ PKC2,Protein kinase C zeta type (EC 2.7.11.13) (nPKC-zeta),Homo sapiens (Human),592.0,67660.0,MPSRTGPKMEGSGGRVRLKAHYGGDIFITSVDAATTFEELCEEVRDMCRLHQQHPLTLKWVDSEGDPCTVSSQMELEEAFRLARQCRDEGLIIHVFPSTPEQPGLPCPGEDKSIYRRGARRWRKLYRANGHLFQAKRFNRRAYCGQCSERIWGLARQGYRCINCKLLVHKRCHGLVPLTCRKHMDSVMPSQEPPVDDKNEDADLPSEETDGIAYISSSRKHDSIKDDSEDLKPVIDGMDGIKISQGLGLQDFDLIRVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDWDLLEKKQALPPFQPQITDDYGLDNFDTQFTSEPVQLTPDDEDAIKRIDQSEFEGFEYINPLLLSTEESV,False,False,True,Q05513,"[('cd05617', 'Catalytic domain of the Serine/Threonine Kinase, Atypical Protein Kinase C zeta'), ('cd06404', 'PB1_aPKC'), ('cd21095', 'protein kinase C conserved region 1 (C1 domain) found in the atypical protein kinase C (aPKC) zeta type'), ('G3DSA:1.10.510.10', 'Transferase(Phosphotransferase) domain 1'), ('G3DSA:3.10.20.90', 'Phosphatidylinositol 3-kinase Catalytic Subunit; Chain A, domain 1'), ('G3DSA:3.30.200.20', 'Phosphorylase Kinase; domain 1'), ('G3DSA:3.30.60.20', None), ('IPR000270', 'PB1 domain'), ('IPR000719', 'Protein kinase domain'), ('IPR000961', 'AGC-kinase, C-terminal'), ('IPR002219', 'Protein kinase C-like, phorbol ester/diacylglycerol-binding domain'), ('IPR008271', 'Serine/threonine-protein kinase, active site'), ('IPR011009', 'Protein kinase-like domain superfamily'), ('IPR012233', 'Protein kinase C'), ('IPR017441', 'Protein kinase, ATP binding site'), ('IPR017892', 'Protein kinase, C-terminal'), ('IPR020454', 'Diacylglycerol/phorbol-ester binding'), ('IPR034662', 'Atypical Protein Kinase C zeta, catalytic domain'), ('IPR034877', 'Protein kinase C, PB1 domain'), ('IPR046349', 'C1-like domain superfamily')]",Q05513;,"""ENSG00000067606; Tissue enhanced (brain)."";","CATALYTIC ACTIVITY: Reaction=L-seryl-[protein] + ATP = O-phospho-L-seryl-[protein] + ADP + H(+); Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616, ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.13; Evidence={ECO:0000269|PubMed:15084291, ECO:0000269|PubMed:15324659, ECO:0000269|PubMed:36040231}; CATALYTIC ACTIVITY: Reaction=L-threonyl-[protein] + ATP = O-phospho-L-threonyl-[protein] + ADP + H(+); Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060, Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013, ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216; EC=2.7.11.13; Evidence={ECO:0000269|PubMed:15084291, ECO:0000269|PubMed:15324659, ECO:0000269|PubMed:36040231};",2.7.11.13,"ACTIVITY REGULATION: Atypical PKCs (PRKCI and PRKCZ) exhibit an elevated basal enzymatic activity (that may be due to the interaction with SMG1 or SQSTM1) and are not regulated by diacylglycerol, phosphatidylserine, phorbol esters or calcium ions. Two specific sites, Thr-410 (activation loop of the kinase domain) and Thr-560 (turn motif), need to be phosphorylated for its full activation. Phosphatidylinositol 3,4,5-trisphosphate might be a physiological activator (By similarity). Isoform 2: Constitutively active (By similarity). {ECO:0000250|UniProtKB:Q02956}.",,ENST00000378567.8 [Q05513-1];ENST00000400921.6 [Q05513-2];ENST00000461106.6 [Q05513-3];,PRKCZ,ENSG00000067606,0.0,,,,,,,0.135,,PRKCZ
Q05516,ENSG00000109906,ZBT16_HUMAN,anterior/posterior pattern specification [GO:0009952]; apoptotic process [GO:0006915]; cartilage development [GO:0051216]; cell population proliferation [GO:0008283]; central nervous system development [GO:0007417]; embryonic digit morphogenesis [GO:0042733]; embryonic hindlimb morphogenesis [GO:0035116]; embryonic pattern specification [GO:0009880]; forelimb morphogenesis [GO:0035136]; hemopoiesis [GO:0030097]; male germ-line stem cell asymmetric division [GO:0048133]; mesonephros development [GO:0001823]; myeloid cell differentiation [GO:0030099]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of myeloid cell differentiation [GO:0045638]; negative regulation of transcription by RNA polymerase II [GO:0000122]; ossification involved in bone maturation [GO:0043931]; positive regulation of apoptotic process [GO:0043065]; positive regulation of cartilage development [GO:0061036]; positive regulation of chondrocyte differentiation [GO:0032332]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of fat cell differentiation [GO:0045600]; positive regulation of NK T cell differentiation [GO:0051138]; positive regulation of ossification [GO:0045778]; protein localization to nucleus [GO:0034504]; protein ubiquitination [GO:0016567]; regulation of transcription by RNA polymerase II [GO:0006357],cytosol [GO:0005829]; male germ cell nucleus [GO:0001673]; nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; PML body [GO:0016605]; protein-containing complex [GO:0032991]; transcription repressor complex [GO:0017053],"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription corepressor binding [GO:0001222]; type 2 angiotensin receptor binding [GO:0031703]",,,"DOMAIN 34..96; /note=""BTB""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00037""","STRAND 36..42; /evidence=""ECO:0007829|PDB:1BUO""; STRAND 44..47; /evidence=""ECO:0007829|PDB:1BUO""; STRAND 68..72; /evidence=""ECO:0007829|PDB:1BUO""","HELIX 16..30; /evidence=""ECO:0007829|PDB:1BUO""; HELIX 49..55; /evidence=""ECO:0007829|PDB:1BUO""; HELIX 57..62; /evidence=""ECO:0007829|PDB:1BUO""; HELIX 63..65; /evidence=""ECO:0007829|PDB:1CS3""; HELIX 77..89; /evidence=""ECO:0007829|PDB:1BUO""; HELIX 96..98; /evidence=""ECO:0007829|PDB:1BUO""; HELIX 99..109; /evidence=""ECO:0007829|PDB:1BUO""; HELIX 112..125; /evidence=""ECO:0007829|PDB:1BUO""","TURN 31..33; /evidence=""ECO:0007829|PDB:1BUO""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,ZBTB16 PLZF ZNF145,Zinc finger and BTB domain-containing protein 16 (Promyelocytic leukemia zinc finger protein) (Zinc finger protein 145) (Zinc finger protein PLZF),Homo sapiens (Human),673.0,74274.0,MDLTKMGMIQLQNPSHPTGLLCKANQMRLAGTLCDVVIMVDSQEFHAHRTVLACTSKMFEILFHRNSQHYTLDFLSPKTFQQILEYAYTATLQAKAEDLDDLLYAAEILEIEYLEEQCLKMLETIQASDDNDTEATMADGGAEEEEDRKARYLKNIFISKHSSEESGYASVAGQSLPGPMVDQSPSVSTSFGLSAMSPTKAAVDSLMTIGQSLLQGTLQPPAGPEEPTLAGGGRHPGVAEVKTEMMQVDEVPSQDSPGAAESSISGGMGDKVEERGKEGPGTPTRSSVITSARELHYGREESAEQVPPPAEAGQAPTGRPEHPAPPPEKHLGIYSVLPNHKADAVLSMPSSVTSGLHVQPALAVSMDFSTYGGLLPQGFIQRELFSKLGELAVGMKSESRTIGEQCSVCGVELPDNEAVEQHRKLHSGMKTYGCELCGKRFLDSLRLRMHLLAHSAGAKAFVCDQCGAQFSKEDALETHRQTHTGTDMAVFCLLCGKRFQAQSALQQHMEVHAGVRSYICSECNRTFPSHTALKRHLRSHTGDHPYECEFCGSCFRDESTLKSHKRIHTGEKPYECNGCGKKFSLKHQLETHYRVHTGEKPFECKLCHQRSRDYSAMIKHLRTHNGASPYQCTICTEYCPSLSSMQKHMKGHKPEEIPPDWRIEKTYLYLCYV,False,False,True,Q05516,"[('cd18205', 'BTB (Broad-Complex, Tramtrack and Bric a brac)/POZ (poxvirus and zinc finger) domain found in zinc finger and BTB domain-containing protein 16 (ZBTB16)'), ('G3DSA:3.30.160.60', 'Classic Zinc Finger'), ('G3DSA:3.30.710.10', 'Potassium Channel Kv1.1; Chain A'), ('IPR000210', 'BTB/POZ domain'), ('IPR011333', 'SKP1/BTB/POZ domain superfamily'), ('IPR013087', 'Zinc finger C2H2-type'), ('IPR036236', 'Zinc finger C2H2 superfamily'), ('PF00096', 'Zinc finger, C2H2 type'), ('PF00651', 'BTB/POZ domain'), ('PF13912', 'C2H2-type zinc finger'), ('PS00028', 'Zinc finger C2H2 type domain signature'), ('PS50097', 'BTB domain profile'), ('PS50157', 'Zinc finger C2H2 type domain profile'), ('PTHR24390', 'Krueppel C2H2-type zinc-finger'), ('SM00225', 'Broad-Complex, Tramtrack and Bric a brac'), ('SM00355', 'zinc finger'), ('SSF54695', 'POZ domain'), ('SSF57667', 'beta-beta-alpha zinc fingers')]",,"""ENSG00000109906; Low tissue specificity."";",,,,PATHWAY: Protein modification; protein ubiquitination.,ENST00000335953.9 [Q05516-1];ENST00000392996.2 [Q05516-1];ENST00000682278.1 [Q05516-1];ENST00000682697.1 [Q05516-1];ENST00000682971.1 [Q05516-1];ENST00000683318.1 [Q05516-1];ENST00000683554.1 [Q05516-1];ENST00000684295.1 [Q05516-1];,ZBTB16,ENSG00000109906,0.0,ZBTB16,Canonical_RBPs,0.0,,,,0.456,0.158,ZBTB16
Q06124,ENSG00000179295,PTN11_HUMAN,atrioventricular canal development [GO:0036302]; axonogenesis [GO:0007409]; Bergmann glial cell differentiation [GO:0060020]; brain development [GO:0007420]; cellular response to epidermal growth factor stimulus [GO:0071364]; cerebellar cortex formation [GO:0021697]; cytokine-mediated signaling pathway [GO:0019221]; DNA damage checkpoint signaling [GO:0000077]; ephrin receptor signaling pathway [GO:0048013]; epidermal growth factor receptor signaling pathway [GO:0007173]; ERBB signaling pathway [GO:0038127]; face morphogenesis [GO:0060325]; fibroblast growth factor receptor signaling pathway [GO:0008543]; genitalia development [GO:0048806]; glucose homeostasis [GO:0042593]; heart development [GO:0007507]; homeostasis of number of cells within a tissue [GO:0048873]; hormone metabolic process [GO:0042445]; hormone-mediated signaling pathway [GO:0009755]; inner ear development [GO:0048839]; integrin-mediated signaling pathway [GO:0007229]; intestinal epithelial cell migration [GO:0061582]; megakaryocyte development [GO:0035855]; microvillus organization [GO:0032528]; multicellular organism growth [GO:0035264]; negative regulation of cell adhesion mediated by integrin [GO:0033629]; negative regulation of chondrocyte differentiation [GO:0032331]; negative regulation of cortisol secretion [GO:0051463]; negative regulation of growth hormone secretion [GO:0060125]; negative regulation of insulin secretion [GO:0046676]; negative regulation of type I interferon production [GO:0032480]; neurotrophin TRK receptor signaling pathway [GO:0048011]; organ growth [GO:0035265]; peptidyl-tyrosine dephosphorylation [GO:0035335]; platelet formation [GO:0030220]; platelet-derived growth factor receptor signaling pathway [GO:0048008]; positive regulation of ERK1 and ERK2 cascade [GO:0070374]; positive regulation of glucose import [GO:0046326]; positive regulation of hormone secretion [GO:0046887]; positive regulation of insulin receptor signaling pathway [GO:0046628]; positive regulation of interferon-beta production [GO:0032728]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of mitotic cell cycle [GO:0045931]; positive regulation of ossification [GO:0045778]; positive regulation of peptidyl-tyrosine phosphorylation [GO:0050731]; positive regulation of tumor necrosis factor production [GO:0032760]; regulation of cell adhesion mediated by integrin [GO:0033628]; regulation of protein export from nucleus [GO:0046825]; regulation of protein-containing complex assembly [GO:0043254]; regulation of type I interferon-mediated signaling pathway [GO:0060338]; T cell costimulation [GO:0031295]; triglyceride metabolic process [GO:0006641],cytoplasm [GO:0005737]; cytosol [GO:0005829]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991],cadherin binding [GO:0045296]; cell adhesion molecule binding [GO:0050839]; insulin receptor binding [GO:0005158]; molecular adaptor activity [GO:0060090]; non-membrane spanning protein tyrosine phosphatase activity [GO:0004726]; peptide hormone receptor binding [GO:0051428]; phosphoprotein phosphatase activity [GO:0004721]; phosphotyrosine residue binding [GO:0001784]; protein kinase binding [GO:0019901]; protein tyrosine kinase binding [GO:1990782]; protein tyrosine phosphatase activity [GO:0004725]; receptor tyrosine kinase binding [GO:0030971]; signaling receptor complex adaptor activity [GO:0030159],"PTM: Phosphorylated on Tyr-542 and Tyr-580 upon receptor protein tyrosine kinase activation; which creates a binding site for GRB2 and other SH2-containing proteins. Phosphorylated upon activation of the receptor-type kinase FLT3. Phosphorylated upon activation of the receptor-type kinase PDGFRA (By similarity). Phosphorylated by activated PDGFRB. {ECO:0000250, ECO:0000269|PubMed:20494825, ECO:0000269|PubMed:34310951, ECO:0000269|PubMed:7681217, ECO:0000269|PubMed:7691811, ECO:0000269|PubMed:8041791}.","DOMAIN: The SH2 domains repress phosphatase activity. Binding of these domains to phosphotyrosine-containing proteins relieves this auto-inhibition, possibly by inducing a conformational change in the enzyme.","DOMAIN 6..102; /note=""SH2 1""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00191""; DOMAIN 112..216; /note=""SH2 2""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00191""; DOMAIN 247..517; /note=""Tyrosine-protein phosphatase""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00160""","STRAND 28..33; /evidence=""ECO:0007829|PDB:5EHR""; STRAND 35..37; /evidence=""ECO:0007829|PDB:5EHR""; STRAND 41..47; /evidence=""ECO:0007829|PDB:5EHR""; STRAND 50..57; /evidence=""ECO:0007829|PDB:5EHR""; STRAND 59..61; /evidence=""ECO:0007829|PDB:5EHR""; STRAND 63..65; /evidence=""ECO:0007829|PDB:5EHR""; STRAND 70..73; /evidence=""ECO:0007829|PDB:5EHR""; STRAND 83..85; /evidence=""ECO:0007829|PDB:4OHD""; STRAND 87..90; /evidence=""ECO:0007829|PDB:3TKZ""; STRAND 91..93; /evidence=""ECO:0007829|PDB:5BK8""; STRAND 113..116; /evidence=""ECO:0007829|PDB:6CMP""; STRAND 134..139; /evidence=""ECO:0007829|PDB:5EHR""; STRAND 141..143; /evidence=""ECO:0007829|PDB:5DF6""; STRAND 147..153; /evidence=""ECO:0007829|PDB:5EHR""; STRAND 154..156; /evidence=""ECO:0007829|PDB:5DF6""; STRAND 157..159; /evidence=""ECO:0007829|PDB:6CMP""; STRAND 161..164; /evidence=""ECO:0007829|PDB:6CMP""; STRAND 166..175; /evidence=""ECO:0007829|PDB:5EHR""; STRAND 178..184; /evidence=""ECO:0007829|PDB:5EHR""; STRAND 187..189; /evidence=""ECO:0007829|PDB:5EHR""; STRAND 202..204; /evidence=""ECO:0007829|PDB:5DF6""; STRAND 205..207; /evidence=""ECO:0007829|PDB:7R7D""; STRAND 208..210; /evidence=""ECO:0007829|PDB:4JEG""; STRAND 218..222; /evidence=""ECO:0007829|PDB:4OHD""; STRAND 235..237; /evidence=""ECO:0007829|PDB:6CMQ""; STRAND 277..279; /evidence=""ECO:0007829|PDB:6CMP""; STRAND 289..291; /evidence=""ECO:0007829|PDB:3ZM1""; STRAND 299..301; /evidence=""ECO:0007829|PDB:7RCT""; STRAND 304..310; /evidence=""ECO:0007829|PDB:3ZM1""; STRAND 319..321; /evidence=""ECO:0007829|PDB:4RDD""; STRAND 327..331; /evidence=""ECO:0007829|PDB:3ZM1""; STRAND 352..355; /evidence=""ECO:0007829|PDB:3ZM1""; STRAND 359..361; /evidence=""ECO:0007829|PDB:3ZM1""; STRAND 364..366; /evidence=""ECO:0007829|PDB:3ZM0""; STRAND 376..380; /evidence=""ECO:0007829|PDB:3ZM1""; STRAND 383..392; /evidence=""ECO:0007829|PDB:3ZM1""; STRAND 394..405; /evidence=""ECO:0007829|PDB:3ZM1""; STRAND 413..420; /evidence=""ECO:0007829|PDB:3ZM1""; STRAND 425..427; /evidence=""ECO:0007829|PDB:3ZM1""; STRAND 430..432; /evidence=""ECO:0007829|PDB:3ZM1""; STRAND 449..451; /evidence=""ECO:0007829|PDB:7R7I""; STRAND 455..463; /evidence=""ECO:0007829|PDB:3ZM1""; STRAND 484..488; /evidence=""ECO:0007829|PDB:5EHR""; STRAND 581..585; /evidence=""ECO:0007829|PDB:4JMG""","HELIX 13..23; /evidence=""ECO:0007829|PDB:5EHR""; HELIX 74..82; /evidence=""ECO:0007829|PDB:5EHR""; HELIX 107..109; /evidence=""ECO:0007829|PDB:4DGX""; HELIX 119..129; /evidence=""ECO:0007829|PDB:5EHR""; HELIX 190..199; /evidence=""ECO:0007829|PDB:5EHR""; HELIX 223..225; /evidence=""ECO:0007829|PDB:5EHR""; HELIX 226..234; /evidence=""ECO:0007829|PDB:5EHR""; HELIX 251..253; /evidence=""ECO:0007829|PDB:3ZM1""; HELIX 256..258; /evidence=""ECO:0007829|PDB:4PVG""; HELIX 259..262; /evidence=""ECO:0007829|PDB:3B7O""; HELIX 266..269; /evidence=""ECO:0007829|PDB:3ZM1""; HELIX 271..276; /evidence=""ECO:0007829|PDB:3ZM1""; HELIX 286..288; /evidence=""ECO:0007829|PDB:3ZM1""; HELIX 323..325; /evidence=""ECO:0007829|PDB:5EHP""; HELIX 335..337; /evidence=""ECO:0007829|PDB:3ZM1""; HELIX 338..347; /evidence=""ECO:0007829|PDB:3ZM1""; HELIX 409..411; /evidence=""ECO:0007829|PDB:5I6V""; HELIX 433..447; /evidence=""ECO:0007829|PDB:3ZM1""; HELIX 464..482; /evidence=""ECO:0007829|PDB:3ZM1""; HELIX 490..498; /evidence=""ECO:0007829|PDB:3ZM1""; HELIX 508..524; /evidence=""ECO:0007829|PDB:3ZM1""","TURN 4..6; /evidence=""ECO:0007829|PDB:5X7B""; TURN 239..241; /evidence=""ECO:0007829|PDB:8WFY""; TURN 312..315; /evidence=""ECO:0007829|PDB:6CMP""; TURN 406..408; /evidence=""ECO:0007829|PDB:7R7D""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,PTPN11 PTP2C SHPTP2,Tyrosine-protein phosphatase non-receptor type 11 (EC 3.1.3.48) (Protein-tyrosine phosphatase 1D) (PTP-1D) (Protein-tyrosine phosphatase 2C) (PTP-2C) (SH-PTP2) (SHP-2) (Shp2) (SH-PTP3),Homo sapiens (Human),593.0,68011.0,MTSRRWFHPNITGVEAENLLLTRGVDGSFLARPSKSNPGDFTLSVRRNGAVTHIKIQNTGDYYDLYGGEKFATLAELVQYYMEHHGQLKEKNGDVIELKYPLNCADPTSERWFHGHLSGKEAEKLLTEKGKHGSFLVRESQSHPGDFVLSVRTGDDKGESNDGKSKVTHVMIRCQELKYDVGGGERFDSLTDLVEHYKKNPMVETLGTVLQLKQPLNTTRINAAEIESRVRELSKLAETTDKVKQGFWEEFETLQQQECKLLYSRKEGQRQENKNKNRYKNILPFDHTRVVLHDGDPNEPVSDYINANIIMPEFETKCNNSKPKKSYIATQGCLQNTVNDFWRMVFQENSRVIVMTTKEVERGKSKCVKYWPDEYALKEYGVMRVRNVKESAAHDYTLRELKLSKVGQGNTERTVWQYHFRTWPDHGVPSDPGGVLDFLEEVHHKQESIMDAGPVVVHCSAGIGRTGTFIVIDILIDIIREKGVDCDIDVPKTIQMVRSQRSGMVQTEAQYRFIYMAVQHYIETLQRRIEEEQKSKRKGHEYTNIKYSLADQTSGDQSPLPPCTPTPPCAEMREDSARVYENVGLMQQQKSFR,False,False,True,Q06124,"[('cd09931', 'C-terminal Src homology 2 (C-SH2) domain found in SH2 domain Phosphatases (SHP) proteins'), ('cd10340', 'N-terminal Src homology 2 (N-SH2) domain found in SH2 domain Phosphatases (SHP) proteins'), ('cd14605', 'catalytic domain of tyrosine-protein phosphatase non-receptor type 11'), ('G3DSA:3.30.505.10', 'SH2 domain'), ('G3DSA:3.90.190.10', 'Protein tyrosine phosphatase superfamily'), ('IPR000242', 'Tyrosine-specific protein phosphatase, PTPase domain'), ('IPR000387', 'Tyrosine-specific protein phosphatases domain'), ('IPR000980', 'SH2 domain'), ('IPR003595', 'Protein-tyrosine phosphatase, catalytic'), ('IPR012152', 'Protein-tyrosine phosphatase, non-receptor type-6, -11'), ('IPR016130', 'Protein-tyrosine phosphatase, active site'), ('IPR029021', 'Protein-tyrosine phosphatase-like'), ('IPR036860', 'SH2 domain superfamily'), ('PF00017', 'SH2 domain'), ('PF00102', 'Protein-tyrosine phosphatase'), ('PIRSF000929', 'Non-receptor tyrosine-protein phosphatase, 6/11 types'), ('PR00401', 'SH2DOMAIN'), ('PR00700', 'PRTYPHPHTASE'), ('PS00383', 'Tyrosine specific protein phosphatases active site'), ('PS50001', 'Src homology 2 (SH2) domain profile')]",Q06124;,"""ENSG00000179295; Low tissue specificity."";","CATALYTIC ACTIVITY: Reaction=O-phospho-L-tyrosyl-[protein] + H2O = L-tyrosyl-[protein] + phosphate; Xref=Rhea:RHEA:10684, Rhea:RHEA-COMP:10136, Rhea:RHEA-COMP:10137, ChEBI:CHEBI:15377, ChEBI:CHEBI:43474, ChEBI:CHEBI:46858, ChEBI:CHEBI:82620; EC=3.1.3.48; Evidence={ECO:0000255|PROSITE-ProRule:PRU10044, ECO:0000269|PubMed:20170098, ECO:0000269|PubMed:26742426, ECO:0000269|PubMed:28074573};",3.1.3.48,,,ENST00000351677.7 [Q06124-2];ENST00000392597.5 [Q06124-3];ENST00000635625.1 [Q06124-1];,PTPN11,ENSG00000179295,0.0,PTPN11,Non-canonical_RBPs,11.0,,,,0.099,0.04,PTPN11
Q08117,ENSG00000104964,TLE5_HUMAN,negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of gene expression [GO:0010629]; negative regulation of protein binding [GO:0032091]; negative regulation of response to cytokine stimulus [GO:0060761]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of anoikis [GO:2000210]; regulation of growth [GO:0040008]; response to interleukin-1 [GO:0070555]; skeletal system development [GO:0001501]; Wnt signaling pathway [GO:0016055],nucleus [GO:0005634],identical protein binding [GO:0042802]; transcription corepressor activity [GO:0003714],PTM: Ubiquitinated by XIAP/BIRC4. {ECO:0000269|PubMed:22304967}.,DOMAIN: Lacks the C-terminal WD repeats.,,,,,"cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,TLE5 AES GRG GRG5,"TLE family member 5 (Amino-terminal enhancer of split) (Amino enhancer of split) (Gp130-associated protein GAM) (Grg-5) (Groucho-related protein 5) (Protein ESP1) (Protein GRG) (TLE family member 5, transcriptional modulator)",Homo sapiens (Human),197.0,21970.0,MMFPQSRHSGSSHLPQQLKFTTSDSCDRIKDEFQLLQAQYHSLKLECDKLASEKSEMQRHYVMYYEMSYGLNIEMHKQAEIVKRLNGICAQVLPYLSQEHQQQVLGAIERAKQVTAPELNSIIRQQLQAHQLSQLQALALPLTPLPVGLQPPSLPAVSAGTGLLSLSALGSQAHLSKEDKNGHDGDTHQEDDGEKSD,False,False,True,Q08117,"[('IPR005617', 'Groucho/TLE, N-terminal Q-rich domain'), ('IPR009146', 'Groucho/transducin-like enhancer'), ('PF03920', 'Groucho/TLE N-terminal Q-rich domain'), ('PTHR10814', 'TRANSDUCIN-LIKE ENHANCER PROTEIN')]",,"""ENSG00000104964; Low tissue specificity."";",,,,,ENST00000221561.12 [Q08117-2];ENST00000327141.9 [Q08117-1];,TLE5,ENSG00000104964,0.0,,,,,,,0.569,0.122,TLE5
Q08379,ENSG00000167110,GOGA2_HUMAN,asymmetric cell division [GO:0008356]; centrosome cycle [GO:0007098]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi disassembly [GO:0090166]; Golgi organization [GO:0007030]; Golgi ribbon formation [GO:0090161]; meiotic spindle assembly [GO:0090306]; microtubule nucleation [GO:0007020]; mitotic spindle assembly [GO:0090307]; negative regulation of autophagy [GO:0010507]; negative regulation of protein binding [GO:0032091]; positive regulation of protein glycosylation [GO:0060050]; protein glycosylation [GO:0006486]; protein homotetramerization [GO:0051289]; protein transport [GO:0015031]; spindle assembly [GO:0051225],cis-Golgi network [GO:0005801]; COPII-coated ER to Golgi transport vesicle [GO:0030134]; endoplasmic reticulum-Golgi intermediate compartment membrane [GO:0033116]; Golgi apparatus [GO:0005794]; Golgi cis cisterna [GO:0000137]; Golgi cisterna membrane [GO:0032580]; Golgi membrane [GO:0000139]; microtubule [GO:0005874]; mitotic spindle [GO:0072686]; spindle pole [GO:0000922],cadherin binding [GO:0045296]; identical protein binding [GO:0042802]; importin-alpha family protein binding [GO:0061676]; microtubule binding [GO:0008017]; protein kinase binding [GO:0019901]; syntaxin binding [GO:0019905],"PTM: Cleaved by caspases at the onset of apoptosis. {ECO:0000269|PubMed:15003503}.; PTM: Methylation by PRMT5 is required for Golgi ribbon formation. While dimethylation at Arg-30 and Arg-35 are confirmed in vivo, it is unclear whether Arg-18 is methylated in vivo. {ECO:0000269|PubMed:20421892}.; PTM: Phosphorylated at Ser-37 by CDK1 at the onset of mitosis, inhibiting the interaction with p115/USO1 and triggering Golgi disassembly (PubMed:20421892, PubMed:26165940). Phosphorylated at Ser-37 in prophase as the Golgi complex starts to break down, and remains phosphorylated during further breakdown and partitioning of the Golgi fragments in metaphase and anaphase. In telophase, GM130 is dephosphorylated by PP2A as the Golgi fragments start to reassemble (By similarity). {ECO:0000250|UniProtKB:Q62839, ECO:0000269|PubMed:20421892, ECO:0000269|PubMed:26165940}.","DOMAIN: Extended rod-like protein with long coiled-coil domains. {ECO:0000250|UniProtKB:Q62839}.; DOMAIN: The nuclear localization signal (cNLS) mediates interaction with importin-alpha, recruiting importin-alpha to the Golgi membrane and liberating TPX2. {ECO:0000269|PubMed:26165940}.",,,"HELIX 29..36; /evidence=""ECO:0007829|PDB:6K06""",,"cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,GOLGA2,Golgin subfamily A member 2 (130 kDa cis-Golgi matrix protein) (GM130) (GM130 autoantigen) (Golgin-95),Homo sapiens (Human),1002.0,113086.0,MWPQPRLPPRPAMSEETRQSKLAAAKKKLREYQQRNSPGVPTGAKKKKKIKNGSNPETTTSGGCHSPEDTPKDNAATLQPSDDTVLPGGVPSPGASLTSMAASQNHDADNVPNLMDETKTFSSTESLRQLSQQLNGLVCESATCVNGEGPASSANLKDLESRYQQLAVALDSSYVTNKQLNITIEKLKQQNQEITDQLEEEKKECHQKQGALREQLQVHIQTIGILVSEKAELQTALAHTQHAARQKEGESEDLASRLQYSRRRVGELERALSAVSTQQKKADRYNKELTKERDALRLELYKNTQSNEDLKQEKSELEEKLRVLVTEKAGMQLNLEELQKKLEMTELLLQQFSSRCEAPDANQQLQQAMEERAQLEAHLGQVMESVRQLQMERDKYAENLKGESAMWRQRMQQMSEQVHTLREEKECSMSRVQELETSLAELRNQMAEPPPPEPPAGPSEVEQQLQAEAEHLRKELEGLAGQLQAQVQDNEGLSRLNREQEERLLELERAAELWGEQAEARRQILETMQNDRTTISRALSQNRELKEQLAELQSGFVKLTNENMEITSALQSEQHVKRELGKKLGELQEKLSELKETVELKSQEAQSLQQQRDQYLGHLQQYVAAYQQLTSEKEVLHNQLLLQTQLVDQLQQQEAQGKAVAEMARQELQETQERLEAATQQNQQLRAQLSLMAHPGEGDGLDREEEEDEEEEEEEAVAVPQPMPSIPEDLESREAMVAFFNSAVASAEEEQARLRGQLKEQRVRCRRLAHLLASAQKEPEAAAPAPGTGGDSVCGETHRALQGAMEKLQSRFMELMQEKADLKERVEELEHRCIQLSGETDTIGEYIALYQSQRAVLKERHREKEEYISRLAQDKEEMKVKLLELQELVLRLVGDRNEWHGRFLAAAQNPADEPTSGAPAPQELGAANQQGDLCEVSLAGSVEPAQGEAREGSPRDNPTAQQIMQLLREMQNPRERPGLGSNPCIPFFYRADENDEVKITVI,False,False,True,Q08379,"[('IPR024858', 'Golgin subfamily A'), ('IPR043937', 'Golgin subfamily A member 2, C-terminal binding motif'), ('IPR043976', 'Golgin subfamily A, conserved domain'), ('PF15070', 'Putative golgin subfamily A member 2-like protein 5'), ('PF19046', 'GM130 C-terminal binding motif'), ('PTHR10881', 'GOLGIN SUBFAMILY A MEMBER-RELATED')]",,"""ENSG00000167110; Low tissue specificity."";",,,,,ENST00000421699.8 [Q08379-1];,GOLGA2,ENSG00000167110,0.0,,,,,,,0.505,0.138,GOLGA2
Q09472,ENSG00000100393,EP300_HUMAN,animal organ morphogenesis [GO:0009887]; apoptotic process [GO:0006915]; B cell differentiation [GO:0030183]; behavioral defense response [GO:0002209]; canonical NF-kappaB signal transduction [GO:0007249]; cellular response to L-leucine [GO:0071233]; cellular response to nutrient levels [GO:0031669]; cellular response to UV [GO:0034644]; circadian rhythm [GO:0007623]; face morphogenesis [GO:0060325]; fat cell differentiation [GO:0045444]; heart development [GO:0007507]; internal peptidyl-lysine acetylation [GO:0018393]; internal protein amino acid acetylation [GO:0006475]; intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator [GO:0042771]; learning or memory [GO:0007611]; lung development [GO:0030324]; megakaryocyte development [GO:0035855]; multicellular organism growth [GO:0035264]; N-terminal peptidyl-lysine acetylation [GO:0018076]; negative regulation of autophagy [GO:0010507]; negative regulation of gluconeogenesis [GO:0045721]; negative regulation of protein-containing complex assembly [GO:0031333]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nervous system development [GO:0007399]; peptidyl-lysine acetylation [GO:0018394]; peptidyl-lysine butyrylation [GO:0140067]; peptidyl-lysine crotonylation [GO:0140066]; peptidyl-lysine propionylation [GO:0061921]; platelet formation [GO:0030220]; positive regulation by host of viral transcription [GO:0043923]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of neuron projection development [GO:0010976]; positive regulation of protein import into nucleus [GO:0042307]; positive regulation of receptor signaling pathway via JAK-STAT [GO:0046427]; positive regulation of T-helper 17 cell lineage commitment [GO:2000330]; positive regulation of TORC1 signaling [GO:1904263]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; protein acetylation [GO:0006473]; protein destabilization [GO:0031648]; protein stabilization [GO:0050821]; regulation of androgen receptor signaling pathway [GO:0060765]; regulation of autophagy [GO:0010506]; regulation of cellular response to heat [GO:1900034]; regulation of glycolytic process [GO:0006110]; regulation of mitochondrion organization [GO:0010821]; regulation of signal transduction by p53 class mediator [GO:1901796]; regulation of tubulin deacetylation [GO:0090043]; response to estrogen [GO:0043627]; response to hypoxia [GO:0001666]; skeletal muscle tissue development [GO:0007519]; somitogenesis [GO:0001756]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; swimming [GO:0036268]; thigmotaxis [GO:0001966]; transcription initiation-coupled chromatin remodeling [GO:0045815],chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; histone acetyltransferase complex [GO:0000123]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-DNA complex [GO:0032993]; transcription regulator complex [GO:0005667],"acetylation-dependent protein binding [GO:0140033]; acetyltransferase activity [GO:0016407]; acyltransferase activity [GO:0016746]; beta-catenin binding [GO:0008013]; chromatin binding [GO:0003682]; chromatin DNA binding [GO:0031490]; damaged DNA binding [GO:0003684]; DNA binding [GO:0003677]; DNA-binding transcription factor binding [GO:0140297]; histone acetyltransferase activity [GO:0004402]; histone butyryltransferase activity [GO:0140069]; histone crotonyltransferase activity [GO:0140068]; histone H2B acetyltransferase activity [GO:0044013]; histone H3 acetyltransferase activity [GO:0010484]; histone H3K122 acetyltransferase activity [GO:0140908]; histone H3K18 acetyltransferase activity [GO:0043993]; histone H3K27 acetyltransferase activity [GO:0044017]; histone H4 acetyltransferase activity [GO:0010485]; histone lactyltransferase (CoA-dependent) activity [GO:0120301]; lysine N-acetyltransferase activity, acting on acetyl phosphate as donor [GO:0004468]; NF-kappaB binding [GO:0051059]; nuclear androgen receptor binding [GO:0050681]; nuclear receptor binding [GO:0016922]; p53 binding [GO:0002039]; peptide 2-hydroxyisobutyryltransferase activity [GO:0106226]; peptide butyryltransferase activity [GO:0140065]; peptide N-acetyltransferase activity [GO:0034212]; peptide-lysine-N-acetyltransferase activity [GO:0061733]; pre-mRNA intronic binding [GO:0097157]; protein propionyltransferase activity [GO:0061920]; protein-containing complex binding [GO:0044877]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; STAT family protein binding [GO:0097677]; tau protein binding [GO:0048156]; transcription coactivator activity [GO:0003713]; transcription coactivator binding [GO:0001223]; transcription coregulator binding [GO:0001221]; zinc ion binding [GO:0008270]","PTM: Acetylated on Lys at up to 17 positions by intermolecular autocatalysis. Deacetylated in the transcriptional repression domain (CRD1) by SIRT1, preferentially at Lys-1020. Deacetylated by SIRT2, preferentially at Lys-418, Lys-423, Lys-1542, Lys-1546, Lys-1549, Lys-1699, Lys-1704 and Lys-1707. {ECO:0000269|PubMed:15004546, ECO:0000269|PubMed:15632193, ECO:0000269|PubMed:17065153, ECO:0000269|PubMed:18995842, ECO:0000269|PubMed:23934153, ECO:0000269|PubMed:24177535}.; PTM: Citrullinated at Arg-2142 by PADI4, which impairs methylation by CARM1 and promotes interaction with NCOA2/GRIP1. {ECO:0000269|PubMed:11701890, ECO:0000269|PubMed:15731352}.; PTM: Methylated at Arg-580 and Arg-604 in the KIX domain by CARM1, which blocks association with CREB, inhibits CREB signaling and activates apoptotic response. Also methylated at Arg-2142 by CARM1, which impairs interaction with NCOA2/GRIP1. {ECO:0000269|PubMed:11701890, ECO:0000269|PubMed:15731352}.; PTM: Sumoylated; sumoylation in the transcriptional repression domain (CRD1) mediates transcriptional repression. Desumoylated by SENP3 through the removal of SUMO2 and SUMO3. {ECO:0000269|PubMed:12718889, ECO:0000269|PubMed:19680224}.; PTM: Probable target of ubiquitination by FBXO3, leading to rapid proteasome-dependent degradation.; PTM: Phosphorylated by HIPK2 in a RUNX1-dependent manner. This phosphorylation that activates EP300 happens when RUNX1 is associated with DNA and CBFB. Phosphorylated by ROCK2 and this enhances its activity. Phosphorylation at Ser-89 by AMPK reduces interaction with nuclear receptors, such as PPARG. {ECO:0000269|PubMed:11518699, ECO:0000269|PubMed:12446687, ECO:0000269|PubMed:16574662, ECO:0000269|PubMed:18695000}.",DOMAIN: The CRD1 domain (cell cycle regulatory domain 1) mediates transcriptional repression of a subset of p300 responsive genes; it can be de-repressed by CDKN1A/p21WAF1 at least at some promoters. It contains sumoylation and acetylation sites and the same lysine residues may be targeted for the respective modifications. It is proposed that deacetylation by SIRT1 allows sumoylation leading to suppressed activity.,"DOMAIN 566..645; /note=""KIX""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00311""; DOMAIN 1067..1139; /note=""Bromo""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00035""; DOMAIN 1287..1663; /note=""CBP/p300-type HAT""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU01065""","STRAND 408..410; /evidence=""ECO:0007829|PDB:1P4Q""; STRAND 1175..1177; /evidence=""ECO:0007829|PDB:6GYR""; STRAND 1178..1180; /evidence=""ECO:0007829|PDB:7VHZ""; STRAND 1181..1185; /evidence=""ECO:0007829|PDB:6GYR""; STRAND 1190..1194; /evidence=""ECO:0007829|PDB:7VHZ""; STRAND 1198..1201; /evidence=""ECO:0007829|PDB:7VHZ""; STRAND 1208..1215; /evidence=""ECO:0007829|PDB:7VHZ""; STRAND 1218..1221; /evidence=""ECO:0007829|PDB:4BHW""; STRAND 1224..1227; /evidence=""ECO:0007829|PDB:7VHZ""; STRAND 1231..1236; /evidence=""ECO:0007829|PDB:7VHZ""; STRAND 1244..1246; /evidence=""ECO:0007829|PDB:7VHZ""; STRAND 1253..1255; /evidence=""ECO:0007829|PDB:7VHZ""; STRAND 1321..1334; /evidence=""ECO:0007829|PDB:3BIY""; STRAND 1351..1366; /evidence=""ECO:0007829|PDB:3BIY""; STRAND 1369..1381; /evidence=""ECO:0007829|PDB:3BIY""; STRAND 1383..1385; /evidence=""ECO:0007829|PDB:6PF1""; STRAND 1392..1400; /evidence=""ECO:0007829|PDB:3BIY""; STRAND 1432..1436; /evidence=""ECO:0007829|PDB:3BIY""; STRAND 1442..1444; /evidence=""ECO:0007829|PDB:7VHZ""; STRAND 1446..1450; /evidence=""ECO:0007829|PDB:3BIY""; STRAND 1482..1485; /evidence=""ECO:0007829|PDB:3BIY""; STRAND 1595..1601; /evidence=""ECO:0007829|PDB:3BIY""; STRAND 1625..1627; /evidence=""ECO:0007829|PDB:3BIY""; STRAND 1676..1688; /evidence=""ECO:0007829|PDB:6DS6""; STRAND 1705..1708; /evidence=""ECO:0007829|PDB:6DS6""; STRAND 1750..1752; /evidence=""ECO:0007829|PDB:6FGN""; STRAND 1799..1802; /evidence=""ECO:0007829|PDB:2MZD""","HELIX 332..357; /evidence=""ECO:0007829|PDB:7QGS""; HELIX 369..381; /evidence=""ECO:0007829|PDB:7QGS""; HELIX 385..387; /evidence=""ECO:0007829|PDB:7QGS""; HELIX 393..405; /evidence=""ECO:0007829|PDB:7QGS""; HELIX 415..418; /evidence=""ECO:0007829|PDB:7QGS""; HELIX 1051..1066; /evidence=""ECO:0007829|PDB:5BT3""; HELIX 1073..1075; /evidence=""ECO:0007829|PDB:5BT3""; HELIX 1081..1084; /evidence=""ECO:0007829|PDB:5BT3""; HELIX 1089..1092; /evidence=""ECO:0007829|PDB:5BT3""; HELIX 1099..1107; /evidence=""ECO:0007829|PDB:5BT3""; HELIX 1114..1131; /evidence=""ECO:0007829|PDB:5BT3""; HELIX 1137..1160; /evidence=""ECO:0007829|PDB:5BT3""; HELIX 1202..1206; /evidence=""ECO:0007829|PDB:7VHZ""; HELIX 1228..1230; /evidence=""ECO:0007829|PDB:7VHZ""; HELIX 1256..1259; /evidence=""ECO:0007829|PDB:7VHZ""; HELIX 1273..1277; /evidence=""ECO:0007829|PDB:7VHZ""; HELIX 1297..1313; /evidence=""ECO:0007829|PDB:3BIY""; HELIX 1339..1342; /evidence=""ECO:0007829|PDB:3BIY""; HELIX 1407..1409; /evidence=""ECO:0007829|PDB:3BIY""; HELIX 1410..1428; /evidence=""ECO:0007829|PDB:3BIY""; HELIX 1460..1476; /evidence=""ECO:0007829|PDB:3BIY""; HELIX 1486..1493; /evidence=""ECO:0007829|PDB:3BIY""; HELIX 1498..1500; /evidence=""ECO:0007829|PDB:3BIY""; HELIX 1508..1517; /evidence=""ECO:0007829|PDB:3BIY""; HELIX 1582..1590; /evidence=""ECO:0007829|PDB:3BIY""; HELIX 1592..1594; /evidence=""ECO:0007829|PDB:3BIY""; HELIX 1603..1606; /evidence=""ECO:0007829|PDB:3BIY""; HELIX 1622..1624; /evidence=""ECO:0007829|PDB:3BIY""; HELIX 1628..1636; /evidence=""ECO:0007829|PDB:3BIY""; HELIX 1644..1662; /evidence=""ECO:0007829|PDB:3BIY""; HELIX 1693..1696; /evidence=""ECO:0007829|PDB:6DS6""; HELIX 1730..1747; /evidence=""ECO:0007829|PDB:3T92""; HELIX 1756..1770; /evidence=""ECO:0007829|PDB:3T92""; HELIX 1780..1793; /evidence=""ECO:0007829|PDB:3T92""; HELIX 1806..1818; /evidence=""ECO:0007829|PDB:3T92""","TURN 412..414; /evidence=""ECO:0007829|PDB:7QGS""; TURN 1069..1072; /evidence=""ECO:0007829|PDB:5BT3""; TURN 1195..1197; /evidence=""ECO:0007829|PDB:7VHZ""; TURN 1248..1250; /evidence=""ECO:0007829|PDB:7VHZ""; TURN 1263..1265; /evidence=""ECO:0007829|PDB:7VHZ""; TURN 1278..1280; /evidence=""ECO:0007829|PDB:7VHZ""; TURN 1290..1292; /evidence=""ECO:0007829|PDB:6V8K""; TURN 1343..1347; /evidence=""ECO:0007829|PDB:3BIY""; TURN 1671..1673; /evidence=""ECO:0007829|PDB:6DS6""; TURN 1726..1728; /evidence=""ECO:0007829|PDB:2MZD""; TURN 1774..1778; /evidence=""ECO:0007829|PDB:3T92""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,EP300 P300,Histone acetyltransferase p300 (p300 HAT) (EC 2.3.1.48) (E1A-associated protein p300) (Histone butyryltransferase p300) (EC 2.3.1.-) (Histone crotonyltransferase p300) (EC 2.3.1.-) (Protein 2-hydroxyisobutyryltransferase p300) (EC 2.3.1.-) (Protein lactyltransferas p300) (EC 2.3.1.-) (Protein propionyltransferase p300) (EC 2.3.1.-),Homo sapiens (Human),2414.0,264161.0,MAENVVEPGPPSAKRPKLSSPALSASASDGTDFGSLFDLEHDLPDELINSTELGLTNGGDINQLQTSLGMVQDAASKHKQLSELLRSGSSPNLNMGVGGPGQVMASQAQQSSPGLGLINSMVKSPMTQAGLTSPNMGMGTSGPNQGPTQSTGMMNSPVNQPAMGMNTGMNAGMNPGMLAAGNGQGIMPNQVMNGSIGAGRGRQNMQYPNPGMGSAGNLLTEPLQQGSPQMGGQTGLRGPQPLKMGMMNNPNPYGSPYTQNPGQQIGASGLGLQIQTKTVLSNNLSPFAMDKKAVPGGGMPNMGQQPAPQVQQPGLVTPVAQGMGSGAHTADPEKRKLIQQQLVLLLHAHKCQRREQANGEVRQCNLPHCRTMKNVLNHMTHCQSGKSCQVAHCASSRQIISHWKNCTRHDCPVCLPLKNAGDKRNQQPILTGAPVGLGNPSSLGVGQQSAPNLSTVSQIDPSSIERAYAALGLPYQVNQMPTQPQVQAKNQQNQQPGQSPQGMRPMSNMSASPMGVNGGVGVQTPSLLSDSMLHSAINSQNPMMSENASVPSLGPMPTAAQPSTTGIRKQWHEDITQDLRNHLVHKLVQAIFPTPDPAALKDRRMENLVAYARKVEGDMYESANNRAEYYHLLAEKIYKIQKELEEKRRTRLQKQNMLPNAAGMVPVSMNPGPNMGQPQPGMTSNGPLPDPSMIRGSVPNQMMPRITPQSGLNQFGQMSMAQPPIVPRQTPPLQHHGQLAQPGALNPPMGYGPRMQQPSNQGQFLPQTQFPSQGMNVTNIPLAPSSGQAPVSQAQMSSSSCPVNSPIMPPGSQGSHIHCPQLPQPALHQNSPSPVPSRTPTPHHTPPSIGAQQPPATTIPAPVPTPPAMPPGPQSQALHPPPRQTPTPPTTQLPQQVQPSLPAAPSADQPQQQPRSQQSTAASVPTPTAPLLPPQPATPLSQPAVSIEGQVSNPPSTSSTEVNSQAIAEKQPSQEVKMEAKMEVDQPEPADTQPEDISESKVEDCKMESTETEERSTELKTEIKEEEDQPSTSATQSSPAPGQSKKKIFKPEELRQALMPTLEALYRQDPESLPFRQPVDPQLLGIPDYFDIVKSPMDLSTIKRKLDTGQYQEPWQYVDDIWLMFNNAWLYNRKTSRVYKYCSKLSEVFEQEIDPVMQSLGYCCGRKLEFSPQTLCCYGKQLCTIPRDATYYSYQNRYHFCEKCFNEIQGESVSLGDDPSQPQTTINKEQFSKRKNDTLDPELFVECTECGRKMHQICVLHHEIIWPAGFVCDGCLKKSARTRKENKFSAKRLPSTRLGTFLENRVNDFLRRQNHPESGEVTVRVVHASDKTVEVKPGMKARFVDSGEMAESFPYRTKALFAFEEIDGVDLCFFGMHVQEYGSDCPPPNQRRVYISYLDSVHFFRPKCLRTAVYHEILIGYLEYVKKLGYTTGHIWACPPSEGDDYIFHCHPPDQKIPKPKRLQEWYKKMLDKAVSERIVHDYKDIFKQATEDRLTSAKELPYFEGDFWPNVLEESIKELEQEEEERKREENTSNESTDVTKGDSKNAKKKNNKKTSKNKSSLSRGNKKKPGMPNVSNDLSQKLYATMEKHKEVFFVIRLIAGPAANSLPPIVDPDPLIPCDLMDGRDAFLTLARDKHLEFSSLRRAQWSTMCMLVELHTQSQDRFVYTCNECKHHVETRWHCTVCEDYDLCITCYNTKNHDHKMEKLGLGLDDESNNQQAAATQSPGDSRRLSIQRCIQSLVHACQCRNANCSLPSCQKMKRVVQHTKGCKRKTNGGCPICKQLIALCCYHAKHCQENKCPVPFCLNIKQKLRQQQLQHRLQQAQMLRRRMASMQRTGVVGQQQGLPSPTPATPTTPTGQQPTTPQTPQPTSQPQPTPPNSMPPYLPRTQAAGPVSQGKAAGQVTPPTPPQTAQPPLPGPPPAAVEMAMQIQRAAETQRQMAHVQIFQRPIQHQMPPMTPMAPMGMNPPPMTRGPSGHLEPGMGPTGMQQQPPWSQGGLPQPQQLQSGMPRPAMMSVAQHGQPLNMAPQPGLGQVGISPLKPGTVSQQALQNLLRTLRSPSSPLQQQQVLSILHANPQLLAAFIKQRAAKYANSNPQPIPGQPGMPQGQPGLQPPTMPGQQGVHSNPAMQNMNPMQAGVQRAGLPQQQPQQQLQPPMGGMSPQAQQMNMNHNTMPSQFRDILRRQQMMQQQQQQGAGPGIGPGMANHNQFQQPQGVGYPPQQQQRMQHHMQQMQQGNMGQIGQLPQALGAEAGASLQAYQQRLLQQQMGSPVQPNPMSPQQHMLPNQAQSPHLQGQQIPNSLSNQVRSPQPVPSPRPQSQPPHSSPSPRMQPQPSPHHVSPQTSSPHPGLVAAQANPMEQGHFASPDQNSMLSQLASNPGMANLHGASATDLGLSTDNSDLNSNLSQSTLDIH,False,False,True,Q09472,"[('cd02337', 'ZZ_CBP'), ('cd05495', 'Bromo_cbp_like'), ('cd15646', 'PHD finger found in histone acetyltransferase p300'), ('cd15802', 'atypical RING domain found in CREB-binding protein and p300 histone acetyltransferases'), ('cd20910', 'Nuclear Coactivator Binding Domain (NCBD) of CREB (cyclic AMP response element binding protein) binding protein (CREBBP, also known as CBP) and its paralog p300'), ('G3DSA:1.10.1630.10', 'Nuclear receptor coactivator, CREB-bp-like, interlocking domain'), ('G3DSA:1.10.246.20', 'Coactivator CBP, KIX domain'), ('G3DSA:1.20.1020.10', 'TAZ domain'), ('G3DSA:1.20.920.10', 'Bromodomain-like'), ('G3DSA:2.10.110.40', None), ('G3DSA:3.30.40.10', 'Zinc/RING finger domain, C3HC4 (zinc finger)'), ('G3DSA:3.30.60.90', None), ('IPR000197', 'Zinc finger, TAZ-type'), ('IPR000433', 'Zinc finger, ZZ-type'), ('IPR001487', 'Bromodomain'), ('IPR003101', 'Coactivator CBP, KIX domain'), ('IPR009110', 'Nuclear receptor coactivator, interlocking'), ('IPR010303', 'CREB-binding protein/p300, atypical RING domain'), ('IPR013083', 'Zinc finger, RING/FYVE/PHD-type'), ('IPR013178', 'Histone acetyltransferase Rtt109/CBP')]",,"""ENSG00000100393; Low tissue specificity."";","CATALYTIC ACTIVITY: Reaction=L-lysyl-[histone] + acetyl-CoA = N(6)-acetyl-L-lysyl-[histone] + CoA + H(+); Xref=Rhea:RHEA:21992, Rhea:RHEA-COMP:9845, Rhea:RHEA-COMP:11338, ChEBI:CHEBI:15378, ChEBI:CHEBI:29969, ChEBI:CHEBI:57287, ChEBI:CHEBI:57288, ChEBI:CHEBI:61930; EC=2.3.1.48; Evidence={ECO:0000269|PubMed:14645221, ECO:0000269|PubMed:21131905, ECO:0000269|PubMed:23415232, ECO:0000269|PubMed:23934153, ECO:0000269|PubMed:25818647, ECO:0000269|PubMed:8945521}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:21993; Evidence={ECO:0000269|PubMed:14645221, ECO:0000269|PubMed:21131905, ECO:0000269|PubMed:23415232, ECO:0000269|PubMed:23934153, ECO:0000269|PubMed:25818647, ECO:0000269|PubMed:8945521}; CATALYTIC ACTIVITY: Reaction=L-lysyl-[protein] + acetyl-CoA = N(6)-acetyl-L-lysyl-[protein] + CoA + H(+); Xref=Rhea:RHEA:45948, Rhea:RHEA-COMP:9752, Rhea:RHEA-COMP:10731, ChEBI:CHEBI:15378, ChEBI:CHEBI:29969, ChEBI:CHEBI:57287, ChEBI:CHEBI:57288, ChEBI:CHEBI:61930; Evidence={ECO:0000269|PubMed:15448695, ECO:0000269|PubMed:15653507, ECO:0000269|PubMed:16285960, ECO:0000269|PubMed:17761950, ECO:0000269|PubMed:24120661, ECO:0000269|PubMed:26990986, ECO:0000269|PubMed:30197302, ECO:0000269|PubMed:32561715}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:45949; Evidence={ECO:0000269|PubMed:15653507, ECO:0000269|PubMed:16285960, ECO:0000305|PubMed:15448695, ECO:0000305|PubMed:30197302, ECO:0000305|PubMed:32561715}; CATALYTIC ACTIVITY: Reaction=N(6)-methyl-L-lysyl-[histone] + acetyl-CoA = N(6)-acetyl-N(6)-methyl-L-lysyl-[histone] + CoA + H(+); Xref=Rhea:RHEA:77775, Rhea:RHEA-COMP:9846, Rhea:RHEA-COMP:18984, ChEBI:CHEBI:15378, ChEBI:CHEBI:57287, ChEBI:CHEBI:57288, ChEBI:CHEBI:61929, ChEBI:CHEBI:197459; Evidence={ECO:0000269|PubMed:37731000}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:77776; Evidence={ECO:0000269|PubMed:37731000}; CATALYTIC ACTIVITY: Reaction=(2E)-butenoyl-CoA + L-lysyl-[protein] = N(6)-(2E)-butenoyl-L-lysyl-[protein] + CoA + H(+); Xref=Rhea:RHEA:53908, Rhea:RHEA-COMP:9752, Rhea:RHEA-COMP:13707, ChEBI:CHEBI:15378, ChEBI:CHEBI:29969, ChEBI:CHEBI:57287, ChEBI:CHEBI:57332, ChEBI:CHEBI:137954; Evidence={ECO:0000269|PubMed:25818647}; CATALYTIC ACTIVITY: Reaction=butanoyl-CoA + L-lysyl-[protein] = N(6)-butanoyl-L-lysyl-[protein] + CoA + H(+); Xref=Rhea:RHEA:53912, Rhea:RHEA-COMP:9752, Rhea:RHEA-COMP:13708, ChEBI:CHEBI:15378, ChEBI:CHEBI:29969, ChEBI:CHEBI:57287, ChEBI:CHEBI:57371, ChEBI:CHEBI:137955; Evidence={ECO:0000250|UniProtKB:B2RWS6}; CATALYTIC ACTIVITY: Reaction=propanoyl-CoA + L-lysyl-[protein] = N(6)-propanoyl-L-lysyl-[protein] + CoA + H(+); Xref=Rhea:RHEA:54020, Rhea:RHEA-COMP:9752, Rhea:RHEA-COMP:13758, ChEBI:CHEBI:15378, ChEBI:CHEBI:29969, ChEBI:CHEBI:57287, ChEBI:CHEBI:57392, ChEBI:CHEBI:138019; Evidence={ECO:0000269|PubMed:17267393}; CATALYTIC ACTIVITY: Reaction=2-hydroxyisobutanoyl-CoA + L-lysyl-[protein] = N(6)-(2-hydroxyisobutanoyl)-L-lysyl-[protein] + CoA + H(+); Xref=Rhea:RHEA:24180, Rhea:RHEA-COMP:9752, Rhea:RHEA-COMP:15921, ChEBI:CHEBI:15378, ChEBI:CHEBI:29969, ChEBI:CHEBI:57287, ChEBI:CHEBI:131780, ChEBI:CHEBI:144968; Evidence={ECO:0000269|PubMed:29775581}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:24181; Evidence={ECO:0000269|PubMed:29775581}; CATALYTIC ACTIVITY: Reaction=(S)-lactoyl-CoA + L-lysyl-[protein] = N(6)-[(S)-lactoyl]-L-lysyl-[protein] + CoA + H(+); Xref=Rhea:RHEA:61996, Rhea:RHEA-COMP:9752, Rhea:RHEA-COMP:19466, ChEBI:CHEBI:15378, ChEBI:CHEBI:29969, ChEBI:CHEBI:57287, ChEBI:CHEBI:231527, ChEBI:CHEBI:231528; Evidence={ECO:0000269|PubMed:31645732}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:61997; Evidence={ECO:0000269|PubMed:31645732};",2.3.1.-; 2.3.1.48,,,ENST00000263253.9;ENST00000715703.1;,EP300,ENSG00000100393,0.0,EP300,Canonical_RBPs,2.0,76.93,DP00633,0.772,0.6,0.363,EP300
Q10589,ENSG00000130303,BST2_HUMAN,B cell activation [GO:0042113]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; negative regulation of cell growth [GO:0030308]; negative regulation of cell migration [GO:0030336]; negative regulation of intracellular transport of viral material [GO:1901253]; negative regulation of plasmacytoid dendritic cell cytokine production [GO:0002737]; negative regulation of viral genome replication [GO:0045071]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of leukocyte proliferation [GO:0070665]; regulation of actin cytoskeleton organization [GO:0032956]; response to interferon-alpha [GO:0035455]; response to interferon-beta [GO:0035456]; response to type II interferon [GO:0034341]; response to virus [GO:0009615],apical plasma membrane [GO:0016324]; azurophil granule membrane [GO:0035577]; cell surface [GO:0009986]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; membrane raft [GO:0045121]; multivesicular body [GO:0005771]; plasma membrane [GO:0005886]; side of membrane [GO:0098552],identical protein binding [GO:0042802]; metalloendopeptidase inhibitor activity [GO:0008191]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723],"PTM: Monoubiquitinated by KSHV E3 ubiquitin-protein ligase K5, leading to its targeting to late endosomes and degradation. {ECO:0000269|PubMed:20419159}.; PTM: The GPI anchor is essential for its antiviral activity.",DOMAIN: The extracellular coiled coil domain forms an extended 170 A long semi-flexible rod-like structure important for virion retention at the cell surface and prevention of virus spreading. {ECO:0000269|PubMed:20399176}.,,"STRAND 25..28; /evidence=""ECO:0007829|PDB:7Q9A""; STRAND 152..154; /evidence=""ECO:0007829|PDB:3MQB""","HELIX 52..148; /evidence=""ECO:0007829|PDB:3MQ7""",,"cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,BST2,Bone marrow stromal antigen 2 (BST-2) (HM1.24 antigen) (Tetherin) (CD antigen CD317),Homo sapiens (Human),180.0,19769.0,MASTSYDYCRVPMEDGDKRCKLLLGIGILVLLIIVILGVPLIIFTIKANSEACRDGLRAVMECRNVTHLLQQELTEAQKGFQDVEAQAATCNHTVMALMASLDAEKAQGQKKVEELEGEITTLNHKLQDASAEVERLRRENQVLSVRIADKKYYPSSQDSSSAAAPQLLIVLLGLSALLQ,True,False,False,Q10589,"[('G3DSA:1.20.5.1700', None), ('IPR024886', 'Bone marrow stromal antigen 2'), ('PF16716', 'Bone marrow stromal antigen 2'), ('PTHR15190', 'BONE MARROW STROMAL ANTIGEN 2')]",,"""ENSG00000130303; Tissue enhanced (ovary)."";",,,,,ENST00000252593.7 [Q10589-1];,BST2,ENSG00000130303,0.0,BST2,Non-canonical_RBPs,5.0,6.11,DP02885,0.061,0.794,,BST2
Q12873,ENSG00000170004,CHD3_HUMAN,centrosome cycle [GO:0007098]; chromatin remodeling [GO:0006338]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of cell fate specification [GO:0042659]; regulation of DNA-templated transcription [GO:0006355]; regulation of stem cell differentiation [GO:2000736]; spindle organization [GO:0007051],centriolar satellite [GO:0034451]; centrosome [GO:0005813]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; NuRD complex [GO:0016581]; PML body [GO:0016605],ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; ATP-dependent chromatin remodeler activity [GO:0140658]; chromatin binding [GO:0003682]; DNA binding [GO:0003677]; helicase activity [GO:0004386]; histone binding [GO:0042393]; RNA binding [GO:0003723]; transcription cis-regulatory region binding [GO:0000976]; zinc ion binding [GO:0008270],PTM: Sumoylation at Lys-1971 results in dissociation from chromatin and suppression of transcriptional repression. {ECO:0000269|PubMed:27068747}.,,"DOMAIN 494..594; /note=""Chromo 1""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00053""; DOMAIN 631..673; /note=""Chromo 2""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00053""; DOMAIN 748..932; /note=""Helicase ATP-binding""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00541""; DOMAIN 1064..1229; /note=""Helicase C-terminal""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00542""",,,,"cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,CHD3,Chromodomain-helicase-DNA-binding protein 3 (CHD-3) (EC 3.6.4.12) (ATP-dependent helicase CHD3) (Mi-2 autoantigen 240 kDa protein) (Mi2-alpha) (Zinc finger helicase) (hZFH),Homo sapiens (Human),2000.0,226592.0,MKAADTVILWARSKNDQLRISFPPGLCWGDRMPDKDDIRLLPSALGVKKRKRGPKKQKENKPGKPRKRKKRDSEEEFGSERDEYREKSESGGSEYGTGPGRKRRRKHREKKEKKTKRRKKGEGDGGQKQVEQKSSATLLLTWGLEDVEHVFSEEDYHTLTNYKAFSQFMRPLIAKKNPKIPMSKMMTILGAKWREFSANNPFKGSAAAVAAAAAAAAAAVAEQVSAAVSSATPIAPSGPPALPPPPAADIQPPPIRRAKTKEGKGPGHKRRSKSPRVPDGRKKLRGKKMAPLKIKLGLLGGKRKKGGSYVFQSDEGPEPEAEESDLDSGSVHSASGRPDGPVRTKKLKRGRPGRKKKKVLGCPAVAGEEEVDGYETDHQDYCEVCQQGGEIILCDTCPRAYHLVCLDPELDRAPEGKWSCPHCEKEGVQWEAKEEEEEYEEEGEEEGEKEEEDDHMEYCRVCKDGGELLCCDACISSYHIHCLNPPLPDIPNGEWLCPRCTCPVLKGRVQKILHWRWGEPPVAVPAPQQADGNPDVPPPRPLQGRSEREFFVKWVGLSYWHCSWAKELQLEIFHLVMYRNYQRKNDMDEPPPLDYGSGEDDGKSDKRKVKDPHYAEMEEKYYRFGIKPEWMTVHRIINHSVDKKGNYHYLVKWRDLPYDQSTWEEDEMNIPEYEEHKQSYWRHRELIMGEDPAQPRKYKKKKKELQGDGPPSSPTNDPTVKYETQPRFITATGGTLHMYQLEGLNWLRFSWAQGTDTILADEMGLGKTIQTIVFLYSLYKEGHTKGPFLVSAPLSTIINWEREFQMWAPKFYVVTYTGDKDSRAIIRENEFSFEDNAIKGGKKAFKMKREAQVKFHVLLTSYELITIDQAALGSIRWACLVVDEAHRLKNNQSKFFRVLNGYKIDHKLLLTGTPLQNNLEELFHLLNFLTPERFNNLEGFLEEFADISKEDQIKKLHDLLGPHMLRRLKADVFKNMPAKTELIVRVELSPMQKKYYKYILTRNFEALNSRGGGNQVSLLNIMMDLKKCCNHPYLFPVAAMESPKLPSGAYEGGALIKSSGKLMLLQKMLRKLKEQGHRVLIFSQMTKMLDLLEDFLDYEGYKYERIDGGITGALRQEAIDRFNAPGAQQFCFLLSTRAGGLGINLATADTVIIFDSDWNPHNDIQAFSRAHRIGQANKVMIYRFVTRASVEERITQVAKRKMMLTHLVVRPGLGSKAGSMSKQELDDILKFGTEELFKDENEGENKEEDSSVIHYDNEAIARLLDRNQDATEDTDVQNMNEYLSSFKVAQYVVREEDKIEEIEREIIKQEENVDPDYWEKLLRHHYEQQQEDLARNLGKGKRVRKQVNYNDAAQEDQDNQSEYSVGSEEEDEDFDERPEGRRQSKRQLRNEKDKPLPPLLARVGGNIEVLGFNTRQRKAFLNAVMRWGMPPQDAFTTQWLVRDLRGKTEKEFKAYVSLFMRHLCEPGADGSETFADGVPREGLSRQQVLTRIGVMSLVKKKVQEFEHINGRWSMPELMPDPSADSKRSSRASSPTKTSPTTPEASATNSPCTSKPATPAPSEKGEGIRTPLEKEEAENQEEKPEKNSRIGEKMETEADAPSPAPSLGERLEPRKIPLEDEVPGVPGEMEPEPGYRGDREKSATESTPGERGEEKPLDGQEHRERPEGETGDLGKREDVKGDRELRPGPRDEPRSNGRREEKTEKPRFMFNIADGGFTELHTLWQNEERAAISSGKLNEIWHRRHDYWLLAGIVLHGYARWQDIQNDAQFAIINEPFKTEANKGNFLEMKNKFLARRFKLLEQALVIEEQLRRAAYLNLSQEPAHPAMALHARFAEAECLAESHQHLSKESLAGNKPANAVLHKVLNQLEELLSDMKADVTRLPATLSRIPPIAARLQMSERSILSRLASKGTEPHPTPAYPPGPYATPPGYGAAFSAAPVGALAAAGANYSQMPAGSFITAATNGPPVLVKKEKEMVGALVSDGLDRKEPRAGEVICIDD,False,False,True,Q12873,"[('cd00084', 'high mobility group (HMG)-box domain superfamily'), ('cd15531', 'PHD finger 1 found in class II Chromodomain-Helicase-DNA binding (CHD) proteins'), ('cd15532', 'PHD finger 2 found in class II Chromodomain-Helicase-DNA binding (CHD) proteins'), ('cd18055', 'DEAH-box helicase domain of the chromodomain helicase DNA binding protein 3'), ('cd18662', 'repeat 2 of the paired tandem chromodomains of chromodomain helicase DNA-binding protein 3 and 4, and similar proteins'), ('cd18667', 'repeat 1 of the paired tandem chromodomains of chromodomain helicase DNA-binding protein 3 and 4, and similar proteins'), ('cd18793', 'C-terminal helicase domain of the SNF family helicases'), ('G3DSA:1.10.10.60', 'Homeodomain-like'), ('G3DSA:1.10.30.10', 'High mobility group box domain'), ('G3DSA:2.40.50.40', None), ('G3DSA:3.30.40.10', 'Zinc/RING finger domain, C3HC4 (zinc finger)'), ('G3DSA:3.40.50.10810', 'Tandem AAA-ATPase domain'), ('G3DSA:3.40.50.300', 'P-loop containing nucleotide triphosphate hydrolases'), ('IPR000330', 'SNF2, N-terminal'), ('IPR000953', 'Chromo/chromo shadow domain'), ('IPR001650', 'Helicase, C-terminal domain-like'), ('IPR001965', 'Zinc finger, PHD-type'), ('IPR002464', 'DNA/RNA helicase, ATP-dependent, DEAH-box type, conserved site'), ('IPR009462', 'CHD subfamily II, SANT-like domain'), ('IPR009463', 'Domain of unknown function DUF1087')]",Q12873;,"""ENSG00000170004; Low tissue specificity."";","CATALYTIC ACTIVITY: Reaction=ATP + H2O = ADP + phosphate + H(+); Xref=Rhea:RHEA:13065, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616, ChEBI:CHEBI:43474, ChEBI:CHEBI:456216; EC=3.6.4.12; Evidence={ECO:0000269|PubMed:28977666, ECO:0000269|PubMed:30397230};",3.6.4.12,,,ENST00000330494.12 [Q12873-1];ENST00000358181.8 [Q12873-2];ENST00000380358.9 [Q12873-3];,CHD3,ENSG00000170004,0.0,CHD3,Canonical_RBPs,10.0,,,,0.403,0.291,CHD3
Q12904,ENSG00000164022,AIMP1_HUMAN,angiogenesis [GO:0001525]; apoptotic process [GO:0006915]; cell-cell signaling [GO:0007267]; defense response to virus [GO:0051607]; inflammatory response [GO:0006954]; leukocyte migration [GO:0050900]; negative regulation of endothelial cell proliferation [GO:0001937]; positive regulation of glucagon secretion [GO:0070094]; translation [GO:0006412],aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cell surface [GO:0009986]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; membrane [GO:0016020]; nucleus [GO:0005634],cytokine activity [GO:0005125]; GTPase binding [GO:0051020]; protein homodimerization activity [GO:0042803]; tRNA binding [GO:0000049],"PTM: Cleaved by caspase-7 in response to apoptosis to produce EMAP-II. {ECO:0000269|PubMed:10850427, ECO:0000269|PubMed:11306575}.",,"DOMAIN 151..252; /note=""tRNA-binding""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00209""","STRAND 157..168; /evidence=""ECO:0007829|PDB:1FL0""; STRAND 171..180; /evidence=""ECO:0007829|PDB:1FL0""; STRAND 182..185; /evidence=""ECO:0007829|PDB:1FL0""; STRAND 187..191; /evidence=""ECO:0007829|PDB:1FL0""; STRAND 205..210; /evidence=""ECO:0007829|PDB:1FL0""; STRAND 216..220; /evidence=""ECO:0007829|PDB:1FL0""; STRAND 221..223; /evidence=""ECO:0007829|PDB:1EUJ""; STRAND 229..232; /evidence=""ECO:0007829|PDB:1FL0""; STRAND 235..238; /evidence=""ECO:0007829|PDB:1FL0""; STRAND 262..264; /evidence=""ECO:0007829|PDB:1EUJ""; STRAND 278..280; /evidence=""ECO:0007829|PDB:1FL0""; STRAND 284..288; /evidence=""ECO:0007829|PDB:1FL0""; STRAND 310..312; /evidence=""ECO:0007829|PDB:1E7Z""","HELIX 152..154; /evidence=""ECO:0007829|PDB:1FL0""; HELIX 199..202; /evidence=""ECO:0007829|PDB:1FL0""; HELIX 271..274; /evidence=""ECO:0007829|PDB:1FL0""; HELIX 275..277; /evidence=""ECO:0007829|PDB:1FL0""","TURN 194..196; /evidence=""ECO:0007829|PDB:1FL0""; TURN 266..268; /evidence=""ECO:0007829|PDB:1FL0""; TURN 296..298; /evidence=""ECO:0007829|PDB:1FL0""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,AIMP1 EMAP2 SCYE1,Aminoacyl tRNA synthase complex-interacting multifunctional protein 1 (Multisynthase complex auxiliary component p43) [Cleaved into: Endothelial monocyte-activating polypeptide 2 (EMAP-2) (Endothelial monocyte-activating polypeptide II) (EMAP-II) (Small inducible cytokine subfamily E member 1)],Homo sapiens (Human),312.0,34353.0,MANNDAVLKRLEQKGAEADQIIEYLKQQVSLLKEKAILQATLREEKKLRVENAKLKKEIEELKQELIQAEIQNGVKQIPFPSGTPLHANSMVSENVIQSTAVTTVSSGTKEQIKGGTGDEKKAKEKIEKKGEKKEKKQQSIAGSADSKPIDVSRLDLRIGCIITARKHPDADSLYVEEVDVGEIAPRTVVSGLVNHVPLEQMQNRMVILLCNLKPAKMRGVLSQAMVMCASSPEKIEILAPPNGSVPGDRITFDAFPGEPDKELNPKKKIWEQIQPDLHTNDECVATYKGVPFEVKGKGVCRAQTMSNSGIK,True,True,False,Q12904,"[('cd02799', 'tRNA_bind_EMAP-II_like'), ('G3DSA:2.40.50.140', 'Nucleic acid-binding proteins'), ('IPR002547', 'tRNA-binding domain'), ('IPR012340', 'Nucleic acid-binding, OB-fold'), ('IPR051270', 'Tyrosine-tRNA ligase and regulatory protein'), ('PF01588', 'Putative tRNA binding domain'), ('PS50886', 'tRNA-binding domain profile'), ('PTHR11586', 'Tyrosine-tRNA ligase and regulatory protein'), ('SSF50249', 'Nucleic acid-binding proteins')]",,"""ENSG00000164022; Low tissue specificity."";",,,,,ENST00000358008.7 [Q12904-1];ENST00000671868.1 [Q12904-1];ENST00000671960.1 [Q12904-1];ENST00000672285.1 [Q12904-1];ENST00000672328.1 [Q12904-1];ENST00000672337.1 [Q12904-1];ENST00000672341.1 [Q12904-1];ENST00000672911.1 [Q12904-1];ENST00000673018.1 [Q12904-1];ENST00000673123.1 [Q12904-1];,AIMP1,ENSG00000164022,0.0,AIMP1,Canonical_RBPs,13.0,,,,0.385,0.131,AIMP1
Q13064,ENSG00000179455,MKRN3_HUMAN,protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567],ribonucleoprotein complex [GO:1990904],identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; RNA binding [GO:0003723]; ubiquitin protein ligase activity [GO:0061630],,,,,,,"cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,MKRN3 D15S9 RNF63 ZNF127,Probable E3 ubiquitin-protein ligase makorin-3 (EC 2.3.2.27) (RING finger protein 63) (RING-type E3 ubiquitin transferase makorin-3) (Zinc finger protein 127),Homo sapiens (Human),507.0,55645.0,MEEPAAPSEAHEAAGAQAGAEAAREGVSGPDLPVCEPSGESAAPDSALPHAARGWAPFPVAPVPAHLRRGGLRPAPASGGGAWPSPLPSRSSGIWTKQIICRYYIHGQCKEGENCRYSHDLSGRKMATEGGVSPPGASAGGGPSTAAHIEPPTQEVAEAPPAASSLSLPVIGSAAERGFFEAERDNADRGAAGGAGVESWADAIEFVPGQPYRGRWVASAPEAPLQSSETERKQMAVGSGLRFCYYASRGVCFRGESCMYLHGDICDMCGLQTLHPMDAAQREEHMRACIEAHEKDMELSFAVQRGMDKVCGICMEVVYEKANPNDRRFGILSNCNHSFCIRCIRRWRSARQFENRIVKSCPQCRVTSELVIPSEFWVEEEEEKQKLIQQYKEAMSNKACRYFAEGRGNCPFGDTCFYKHEYPEGWGDEPPGPGGGSFSAYWHQLVEPVRMGEGNMLYKSIKKELVVLRLASLLFKRFLSLRDELPFSEDQWDLLHYELEEYFNLIL,False,False,True,Q13064,"[('cd16730', 'RING finger, HC subclass, found in makorin-1 (MKRN1), makorin-3 (MKRN3), and similar proteins'), ('G3DSA:3.30.40.10', 'Zinc/RING finger domain, C3HC4 (zinc finger)'), ('G3DSA:4.10.1000.10', 'Zinc finger, CCCH-type'), ('IPR000571', 'Zinc finger, CCCH-type'), ('IPR001841', 'Zinc finger, RING-type'), ('IPR013083', 'Zinc finger, RING/FYVE/PHD-type'), ('IPR017907', 'Zinc finger, RING-type, conserved site'), ('IPR018957', 'Zinc finger, C3HC4 RING-type'), ('IPR031644', 'E3 ubiquitin-protein ligase makorin 1, C-terminal'), ('IPR036855', 'Zinc finger, CCCH-type superfamily'), ('IPR041367', 'E3 ligase, CCCH-type zinc finger'), ('IPR045072', 'MKRN-like'), ('PF00097', 'Zinc finger, C3HC4 type (RING finger)'), ('PF14608', 'RNA-binding, Nab2-type zinc finger'), ('PF15815', 'E3 ubiquitin-protein ligase makorin, C-terminal'), ('PF18044', 'CCCH-type zinc finger'), ('PS00518', 'Zinc finger RING-type signature'), ('PS50089', 'Zinc finger RING-type profile'), ('PS50103', 'Zinc finger C3H1-type profile'), ('PTHR11224', 'MAKORIN-RELATED')]",,"""ENSG00000179455; Tissue enhanced (retina)."";",CATALYTIC ACTIVITY: Reaction=S-ubiquitinyl-[E2 ubiquitin-conjugating enzyme]-L-cysteine + [acceptor protein]-L-lysine = [E2 ubiquitin-conjugating enzyme]-L-cysteine + N(6)-ubiquitinyl-[acceptor protein]-L-lysine.; EC=2.3.2.27;,2.3.2.27,,PATHWAY: Protein modification; protein ubiquitination.,ENST00000314520.6;,MKRN3,ENSG00000179455,0.0,MKRN3,Canonical_RBPs,8.0,,,,0.578,0.183,MKRN3
Q13114,ENSG00000131323,TRAF3_HUMAN,apoptotic process [GO:0006915]; defense response to virus [GO:0051607]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; positive regulation of type I interferon production [GO:0032481]; protein K63-linked ubiquitination [GO:0070534]; regulation of apoptotic process [GO:0042981]; regulation of canonical NF-kappaB signal transduction [GO:0043122]; regulation of cytokine production [GO:0001817]; regulation of defense response to virus [GO:0050688]; regulation of interferon-beta production [GO:0032648]; regulation of proteolysis [GO:0030162]; signal transduction [GO:0007165]; Toll signaling pathway [GO:0008063]; toll-like receptor 4 signaling pathway [GO:0034142]; toll-like receptor signaling pathway [GO:0002224]; TRIF-dependent toll-like receptor signaling pathway [GO:0035666]; tumor necrosis factor-mediated signaling pathway [GO:0033209]; type I interferon-mediated signaling pathway [GO:0060337],CD40 receptor complex [GO:0035631]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; endosome [GO:0005768]; endosome membrane [GO:0010008]; mitochondrion [GO:0005739]; serine/threonine protein kinase complex [GO:1902554]; ubiquitin ligase complex [GO:0000151],identical protein binding [GO:0042802]; protein kinase binding [GO:0019901]; protein phosphatase binding [GO:0019903]; thioesterase binding [GO:0031996]; tumor necrosis factor receptor binding [GO:0005164]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],"PTM: Undergoes 'Lys-48'-linked polyubiquitination, leading to its proteasomal degradation in response to signaling by TNFSF13B, TLR4 or through CD40. 'Lys-48'-linked polyubiquitinated form is deubiquitinated by OTUD7B, preventing TRAF3 proteolysis and over-activation of non-canonical NF-kappa-B. Undergoes 'Lys-63'-linked ubiquitination during early stages of virus infection, and 'Lys-48'-linked ubiquitination during later stages. Undergoes both 'Lys-48'-linked and 'Lys-63'-linked ubiquitination in response to TLR3 and TLR4 signaling. 'Lys-63'-linked ubiquitination can be mediated by TRIM35. Deubiquitinated by OTUB1, OTUB2 and OTUD5. Undergoes 'Lys-63'-linked deubiquitination by MYSM1 to terminate the pattern-recognition receptors/PRRs pathways (By similarity). Undergoes also 'Lys-29'-linked ubiquitination on Cys-56 and Cys-124 by NEDD4L; leading to increased 'Lys-48'- and 'Lys-63'-linked ubiquitination as well as increased binding to TBK1 (PubMed:33608556). TLR4 signals emanating from bacteria containing vesicles trigger 'Lys-33'-linked polyubiquitination that promotes the assembly of the exocyst complex thereby connecting innate immune signaling to the cellular trafficking apparatus (PubMed:27438768). Deubiquitinated by USP25 during viral infection, leading to TRAF3 stabilization and type I interferon production (By similarity). Ubiquitinated at Lys-329 by the SCF(FBXL2) complex, leading to its degradation by the proteasome (By similarity). 'Lys-63'-linked ubiquitination by FBXO11 in a NEDD8-dependent manner promotes the amplification of IFN-I signaling (PubMed:36897010). {ECO:0000250|UniProtKB:Q60803, ECO:0000269|PubMed:17991829, ECO:0000269|PubMed:19893624, ECO:0000269|PubMed:19937093, ECO:0000269|PubMed:19996094, ECO:0000269|PubMed:20097753, ECO:0000269|PubMed:27438768, ECO:0000269|PubMed:27980081, ECO:0000269|PubMed:32562145, ECO:0000269|PubMed:33608556, ECO:0000269|PubMed:34011520, ECO:0000269|PubMed:36897010}.; PTM: (Microbial infection) Cleaved by enterovirus D68 protease 2A; leading to inhibition of NF-kappa-B or IFN-beta triggered by TRAF3. {ECO:0000269|PubMed:33148796}.",DOMAIN: The MATH/TRAF domain binds to receptor cytoplasmic domains.; DOMAIN: The Ring-type zinc finger domain is required for its function in down-regulation of NFKB2 proteolytic processing. {ECO:0000250|UniProtKB:Q60803}.,"DOMAIN 415..560; /note=""MATH""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00129""","STRAND 59..62; /evidence=""ECO:0007829|PDB:2ECY""; STRAND 67..69; /evidence=""ECO:0007829|PDB:2ECY""; STRAND 415..423; /evidence=""ECO:0007829|PDB:8T5P""; STRAND 438..441; /evidence=""ECO:0007829|PDB:1L0A""; STRAND 445..448; /evidence=""ECO:0007829|PDB:8T5P""; STRAND 453..459; /evidence=""ECO:0007829|PDB:8T5P""; STRAND 470..478; /evidence=""ECO:0007829|PDB:8T5P""; STRAND 494..498; /evidence=""ECO:0007829|PDB:8T5P""; STRAND 502..504; /evidence=""ECO:0007829|PDB:1FLK""; STRAND 508..512; /evidence=""ECO:0007829|PDB:8T5P""; STRAND 525..528; /evidence=""ECO:0007829|PDB:8T5P""; STRAND 532..539; /evidence=""ECO:0007829|PDB:8T5P""; STRAND 553..560; /evidence=""ECO:0007829|PDB:8T5P""; STRAND 563..565; /evidence=""ECO:0007829|PDB:1ZMS""","HELIX 74..81; /evidence=""ECO:0007829|PDB:2ECY""; HELIX 379..410; /evidence=""ECO:0007829|PDB:8T5P""; HELIX 425..433; /evidence=""ECO:0007829|PDB:8T5P""; HELIX 464..466; /evidence=""ECO:0007829|PDB:8T5P""; HELIX 483..485; /evidence=""ECO:0007829|PDB:8T5P""; HELIX 519..521; /evidence=""ECO:0007829|PDB:8T5P""; HELIX 540..545; /evidence=""ECO:0007829|PDB:8T5P""","TURN 54..56; /evidence=""ECO:0007829|PDB:2ECY""; TURN 89..91; /evidence=""ECO:0007829|PDB:2ECY""; TURN 97..99; /evidence=""ECO:0007829|PDB:2ECY""; TURN 365..373; /evidence=""ECO:0007829|PDB:1FLK""; TURN 375..377; /evidence=""ECO:0007829|PDB:1FLL""; TURN 467..469; /evidence=""ECO:0007829|PDB:8T5P""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,TRAF3 CAP-1 CRAF1 TRAFAMN,TNF receptor-associated factor 3 (EC 2.3.2.27) (CD40 receptor-associated factor 1) (CRAF1) (CD40-binding protein) (CD40BP) (LMP1-associated protein 1) (LAP1) (RING-type E3 ubiquitin transferase TRAF3),Homo sapiens (Human),568.0,64490.0,MESSKKMDSPGALQTNPPLKLHTDRSAGTPVFVPEQGGYKEKFVKTVEDKYKCEKCHLVLCSPKQTECGHRFCESCMAALLSSSSPKCTACQESIVKDKVFKDNCCKREILALQIYCRNESRGCAEQLMLGHLLVHLKNDCHFEELPCVRPDCKEKVLRKDLRDHVEKACKYREATCSHCKSQVPMIALQKHEDTDCPCVVVSCPHKCSVQTLLRSELSAHLSECVNAPSTCSFKRYGCVFQGTNQQIKAHEASSAVQHVNLLKEWSNSLEKKVSLLQNESVEKNKSIQSLHNQICSFEIEIERQKEMLRNNESKILHLQRVIDSQAEKLKELDKEIRPFRQNWEEADSMKSSVESLQNRVTELESVDKSAGQVARNTGLLESQLSRHDQMLSVHDIRLADMDLRFQVLETASYNGVLIWKIRDYKRRKQEAVMGKTLSLYSQPFYTGYFGYKMCARVYLNGDGMGKGTHLSLFFVIMRGEYDALLPWPFKQKVTLMLMDQGSSRRHLGDAFKPDPNSSSFKKPTGEMNIASGCPVFVAQTVLENGTYIKDDTIFIKVIVDTSDLPDP,False,False,True,Q13114,"[('cd03777', 'MATH_TRAF3'), ('cd16640', 'RING finger, HC subclass, found in tumor necrosis factor (TNF) receptor-associated factor 3 (TRAF3) and similar proteins'), ('G3DSA:2.60.210.10', 'Apoptosis, Tumor Necrosis Factor Receptor Associated Protein 2; Chain A'), ('G3DSA:3.30.40.10', 'Zinc/RING finger domain, C3HC4 (zinc finger)'), ('IPR001293', 'Zinc finger, TRAF-type'), ('IPR001841', 'Zinc finger, RING-type'), ('IPR002083', 'MATH/TRAF domain'), ('IPR008974', 'TRAF-like'), ('IPR012227', 'TNF receptor-associated factor TRAF, metazoa'), ('IPR013083', 'Zinc finger, RING/FYVE/PHD-type'), ('IPR017907', 'Zinc finger, RING-type, conserved site'), ('IPR027128', 'TNF receptor-associated factor 3, C3HC3D-type RING zinc finger'), ('IPR037304', 'TNF receptor-associated factor 3, MATH domain'), ('IPR049342', 'TRAF1-6, MATH domain'), ('IPR049440', 'TNF receptor-associated factor 3/5, RING domain'), ('PF02176', 'TRAF-type zinc finger'), ('PF21355', 'TRAF/meprin, MATH domain'), ('PF21363', 'TNF receptor-associated factor 2/3/5, RING domain'), ('PIRSF015614', 'TNF receptor-associated factor (TRAF)'), ('PS00518', 'Zinc finger RING-type signature')]",,"""ENSG00000131323; Low tissue specificity."";",CATALYTIC ACTIVITY: Reaction=S-ubiquitinyl-[E2 ubiquitin-conjugating enzyme]-L-cysteine + [acceptor protein]-L-lysine = [E2 ubiquitin-conjugating enzyme]-L-cysteine + N(6)-ubiquitinyl-[acceptor protein]-L-lysine.; EC=2.3.2.27; Evidence={ECO:0000269|PubMed:25847972};,2.3.2.27,,,ENST00000392745.8 [Q13114-1];ENST00000539721.5 [Q13114-2];ENST00000560371.5 [Q13114-1];ENST00000699894.1 [Q13114-1];,TRAF3,ENSG00000131323,0.0,,,,,,,0.121,0.049,TRAF3
Q13153,ENSG00000149269,PAK1_HUMAN,actin cytoskeleton organization [GO:0030036]; apoptotic process [GO:0006915]; branching morphogenesis of an epithelial tube [GO:0048754]; cell migration [GO:0016477]; chromatin remodeling [GO:0006338]; DNA damage response [GO:0006974]; ephrin receptor signaling pathway [GO:0048013]; exocytosis [GO:0006887]; Fc-gamma receptor signaling pathway involved in phagocytosis [GO:0038096]; hepatocyte growth factor receptor signaling pathway [GO:0048012]; intracellular signal transduction [GO:0035556]; negative regulation of cell proliferation involved in contact inhibition [GO:0060244]; neuron projection morphogenesis [GO:0048812]; phosphorylation [GO:0016310]; positive regulation of cell migration [GO:0030335]; positive regulation of cell population proliferation [GO:0008284]; positive regulation of intracellular estrogen receptor signaling pathway [GO:0033148]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of microtubule nucleation [GO:0090063]; positive regulation of microtubule polymerization [GO:0031116]; positive regulation of peptidyl-serine phosphorylation [GO:0033138]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of stress fiber assembly [GO:0051496]; protein autophosphorylation [GO:0046777]; protein localization to cytoplasmic stress granule [GO:1903608]; protein phosphorylation [GO:0006468]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of axonogenesis [GO:0050770]; regulation of MAPK cascade [GO:0043408]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; wound healing [GO:0042060],actin filament [GO:0005884]; axon [GO:0030424]; cell-cell junction [GO:0005911]; centrosome [GO:0005813]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; dendrite [GO:0030425]; focal adhesion [GO:0005925]; intercalated disc [GO:0014704]; lamellipodium [GO:0030027]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]; Z disc [GO:0030018],ATP binding [GO:0005524]; collagen binding [GO:0005518]; gamma-tubulin binding [GO:0043015]; histone H2AS1 kinase activity [GO:0044024]; identical protein binding [GO:0042802]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],"PTM: Autophosphorylated in trans, meaning that in a dimer, one kinase molecule phosphorylates the other one (PubMed:20417602, PubMed:22153498, PubMed:23633677). Activated by autophosphorylation at Thr-423 in response to a conformation change, triggered by interaction with GTP-bound CDC42 or RAC1 (PubMed:10551809). Activated by phosphorylation at Thr-423 by BRSK2 and by PDPK1 (PubMed:10995762, PubMed:22669945). Phosphorylated by JAK2 in response to PRL; this increases PAK1 kinase activity. Phosphorylated at Ser-21 by PKB/AKT; this reduces interaction with NCK1 and association with focal adhesion sites (PubMed:14585966). Upon DNA damage, phosphorylated at Thr-212 and translocates to the nucleoplasm (PubMed:23260667). Phosphorylated at tyrosine residues, which can be enhanced by NTN1 (By similarity). {ECO:0000250|UniProtKB:O88643, ECO:0000269|PubMed:10551809, ECO:0000269|PubMed:10995762, ECO:0000269|PubMed:14585966, ECO:0000269|PubMed:20417602, ECO:0000269|PubMed:22153498, ECO:0000269|PubMed:22669945, ECO:0000269|PubMed:23260667, ECO:0000269|PubMed:23633677}.",,"DOMAIN 75..88; /note=""CRIB""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00057""; DOMAIN 270..521; /note=""Protein kinase""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00159""","STRAND 79..87; /evidence=""ECO:0007829|PDB:2QME""; STRAND 95..98; /evidence=""ECO:0007829|PDB:1F3M""; STRAND 195..198; /evidence=""ECO:0007829|PDB:1ZSG""; STRAND 214..219; /evidence=""ECO:0007829|PDB:3DVP""; STRAND 261..264; /evidence=""ECO:0007829|PDB:3FXZ""; STRAND 270..272; /evidence=""ECO:0007829|PDB:3Q4Z""; STRAND 274..279; /evidence=""ECO:0007829|PDB:3FXZ""; STRAND 282..289; /evidence=""ECO:0007829|PDB:3FXZ""; STRAND 295..302; /evidence=""ECO:0007829|PDB:3FXZ""; STRAND 330..336; /evidence=""ECO:0007829|PDB:3FXZ""; STRAND 339..345; /evidence=""ECO:0007829|PDB:3FXZ""; STRAND 349..351; /evidence=""ECO:0007829|PDB:4ZJI""; STRAND 395..397; /evidence=""ECO:0007829|PDB:3FXZ""; STRAND 403..405; /evidence=""ECO:0007829|PDB:3FXZ""; STRAND 408..410; /evidence=""ECO:0007829|PDB:1F3M""; STRAND 416..418; /evidence=""ECO:0007829|PDB:3Q52""","HELIX 101..108; /evidence=""ECO:0007829|PDB:1F3M""; HELIX 114..119; /evidence=""ECO:0007829|PDB:1F3M""; HELIX 121..135; /evidence=""ECO:0007829|PDB:1F3M""; HELIX 250..260; /evidence=""ECO:0007829|PDB:3FXZ""; HELIX 266..268; /evidence=""ECO:0007829|PDB:3FXZ""; HELIX 303..305; /evidence=""ECO:0007829|PDB:3FXZ""; HELIX 309..321; /evidence=""ECO:0007829|PDB:3FXZ""; HELIX 352..358; /evidence=""ECO:0007829|PDB:3FXZ""; HELIX 363..382; /evidence=""ECO:0007829|PDB:3FXZ""; HELIX 392..394; /evidence=""ECO:0007829|PDB:3FXZ""; HELIX 428..430; /evidence=""ECO:0007829|PDB:3FXZ""; HELIX 433..437; /evidence=""ECO:0007829|PDB:3FXZ""; HELIX 444..459; /evidence=""ECO:0007829|PDB:3FXZ""; HELIX 469..479; /evidence=""ECO:0007829|PDB:3FXZ""; HELIX 487..489; /evidence=""ECO:0007829|PDB:3FXZ""; HELIX 492..501; /evidence=""ECO:0007829|PDB:3FXZ""; HELIX 512..515; /evidence=""ECO:0007829|PDB:3FXZ""; HELIX 519..523; /evidence=""ECO:0007829|PDB:3FXZ""; HELIX 527..530; /evidence=""ECO:0007829|PDB:3FXZ""; HELIX 531..540; /evidence=""ECO:0007829|PDB:3FXZ""","TURN 91..94; /evidence=""ECO:0007829|PDB:2QME""; TURN 290..292; /evidence=""ECO:0007829|PDB:3FXZ""; TURN 463..466; /evidence=""ECO:0007829|PDB:3FXZ""; TURN 506..508; /evidence=""ECO:0007829|PDB:3FXZ""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,PAK1,Serine/threonine-protein kinase PAK 1 (EC 2.7.11.1) (Alpha-PAK) (p21-activated kinase 1) (PAK-1) (p65-PAK),Homo sapiens (Human),545.0,60647.0,MSNNGLDIQDKPPAPPMRNTSTMIGAGSKDAGTLNHGSKPLPPNPEEKKKKDRFYRSILPGDKTNKKKEKERPEISLPSDFEHTIHVGFDAVTGEFTGMPEQWARLLQTSNITKSEQKKNPQAVLDVLEFYNSKKTSNSQKYMSFTDKSAEDYNSSNALNVKAVSETPAVPPVSEDEDDDDDDATPPPVIAPRPEHTKSVYTRSVIEPLPVTPTRDVATSPISPTENNTTPPDALTRNTEKQKKKPKMSDEEILEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIAKPLSSLTPLIAAAKEATKNNH,False,False,True,Q13153,"[('cd01093', 'CRIB_PAK_like'), ('cd06654', 'Catalytic domain of the Serine/Threonine Kinase, p21-activated kinase 1'), ('G3DSA:1.10.510.10', 'Transferase(Phosphotransferase) domain 1'), ('G3DSA:3.30.200.20', 'Phosphorylase Kinase; domain 1'), ('G3DSA:3.90.810.10', 'CRIB domain'), ('IPR000095', 'CRIB domain'), ('IPR000719', 'Protein kinase domain'), ('IPR008271', 'Serine/threonine-protein kinase, active site'), ('IPR011009', 'Protein kinase-like domain superfamily'), ('IPR017441', 'Protein kinase, ATP binding site'), ('IPR033923', 'p21 activated kinase binding domain'), ('IPR036936', 'CRIB domain superfamily'), ('IPR051931', 'Serine/threonine-protein kinase PAK 3-like'), ('PF00069', 'Protein kinase domain'), ('PF00786', 'P21-Rho-binding domain'), ('PS00107', 'Protein kinases ATP-binding region signature'), ('PS00108', 'Serine/Threonine protein kinases active-site signature'), ('PS50011', 'Protein kinase domain profile'), ('PS50108', 'CRIB domain profile'), ('PTHR45832', 'Serine/Threonine and Tyrosine Kinase')]",Q13153;,"""ENSG00000149269; Tissue enhanced (brain)."";","CATALYTIC ACTIVITY: Reaction=L-seryl-[protein] + ATP = O-phospho-L-seryl-[protein] + ADP + H(+); Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616, ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.1; Evidence={ECO:0000269|PubMed:10551809, ECO:0000269|PubMed:17420447, ECO:0000269|PubMed:20417602, ECO:0000269|PubMed:22153498, ECO:0000269|PubMed:9032240}; CATALYTIC ACTIVITY: Reaction=L-threonyl-[protein] + ATP = O-phospho-L-threonyl-[protein] + ADP + H(+); Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060, Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013, ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216; EC=2.7.11.1; Evidence={ECO:0000269|PubMed:10551809, ECO:0000269|PubMed:17420447, ECO:0000269|PubMed:22153498, ECO:0000269|PubMed:9032240};",2.7.11.1,"ACTIVITY REGULATION: Activated by binding small G proteins. Binding of GTP-bound CDC42 or RAC1 to the autoregulatory region releases monomers from the autoinhibited dimer, and enables activation by phosphorylation of Thr-423 (PubMed:10995762, PubMed:11804587, PubMed:15893667, PubMed:9032240). Phosphorylation of Thr-84 by OXSR1 inhibits activation (By similarity). {ECO:0000250|UniProtKB:P35465, ECO:0000269|PubMed:10995762, ECO:0000269|PubMed:11804587, ECO:0000269|PubMed:15893667, ECO:0000269|PubMed:9032240}.",,ENST00000278568.8 [Q13153-2];ENST00000356341.8 [Q13153-1];,PAK1,ENSG00000149269,0.0,,,,48.44,DP03433,0.56,0.352,0.29,PAK1
Q13200,ENSG00000175166,PSMD2_HUMAN,proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; regulation of protein catabolic process [GO:0042176],"cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; ficolin-1-rich granule lumen [GO:1904813]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; proteasome accessory complex [GO:0022624]; proteasome complex [GO:0000502]; proteasome regulatory particle [GO:0005838]; proteasome regulatory particle, base subcomplex [GO:0008540]; proteasome storage granule [GO:0034515]; secretory granule lumen [GO:0034774]",enzyme regulator activity [GO:0030234],,,,"STRAND 389..391; /evidence=""ECO:0007829|PDB:7UJD""; STRAND 490..492; /evidence=""ECO:0007829|PDB:7UIH""; STRAND 780..782; /evidence=""ECO:0007829|PDB:7UJD""; STRAND 829..833; /evidence=""ECO:0007829|PDB:7UJD""; STRAND 843..847; /evidence=""ECO:0007829|PDB:7UJD""; STRAND 866..873; /evidence=""ECO:0007829|PDB:7UJD""; STRAND 879..884; /evidence=""ECO:0007829|PDB:7UJD""; STRAND 888..892; /evidence=""ECO:0007829|PDB:7UJD""; STRAND 895..901; /evidence=""ECO:0007829|PDB:7UJD""","HELIX 262..272; /evidence=""ECO:0007829|PDB:7UJD""; HELIX 275..282; /evidence=""ECO:0007829|PDB:7UJD""; HELIX 288..301; /evidence=""ECO:0007829|PDB:7UJD""; HELIX 314..321; /evidence=""ECO:0007829|PDB:7UJD""; HELIX 326..337; /evidence=""ECO:0007829|PDB:7UJD""; HELIX 345..348; /evidence=""ECO:0007829|PDB:7UJD""; HELIX 368..381; /evidence=""ECO:0007829|PDB:7UJD""; HELIX 396..399; /evidence=""ECO:0007829|PDB:7UJD""; HELIX 405..417; /evidence=""ECO:0007829|PDB:7UJD""; HELIX 422..429; /evidence=""ECO:0007829|PDB:7UJD""; HELIX 430..434; /evidence=""ECO:0007829|PDB:7UJD""; HELIX 438..450; /evidence=""ECO:0007829|PDB:7UJD""; HELIX 461..466; /evidence=""ECO:0007829|PDB:7UJD""; HELIX 475..488; /evidence=""ECO:0007829|PDB:7UJD""; HELIX 495..501; /evidence=""ECO:0007829|PDB:7UJD""; HELIX 502..505; /evidence=""ECO:0007829|PDB:7UJD""; HELIX 512..525; /evidence=""ECO:0007829|PDB:7UJD""; HELIX 532..544; /evidence=""ECO:0007829|PDB:7UJD""; HELIX 553..556; /evidence=""ECO:0007829|PDB:7UJD""; HELIX 557..565; /evidence=""ECO:0007829|PDB:7UJD""; HELIX 570..573; /evidence=""ECO:0007829|PDB:7UJD""; HELIX 574..579; /evidence=""ECO:0007829|PDB:7UJD""; HELIX 580..582; /evidence=""ECO:0007829|PDB:7UJD""; HELIX 585..599; /evidence=""ECO:0007829|PDB:7UJD""; HELIX 606..612; /evidence=""ECO:0007829|PDB:7UJD""; HELIX 650..661; /evidence=""ECO:0007829|PDB:7UJD""; HELIX 665..681; /evidence=""ECO:0007829|PDB:7UJD""; HELIX 686..689; /evidence=""ECO:0007829|PDB:7UJD""; HELIX 690..697; /evidence=""ECO:0007829|PDB:7UJD""; HELIX 704..713; /evidence=""ECO:0007829|PDB:7UJD""; HELIX 719..732; /evidence=""ECO:0007829|PDB:7UJD""; HELIX 739..751; /evidence=""ECO:0007829|PDB:7UJD""; HELIX 756..769; /evidence=""ECO:0007829|PDB:7UJD""; HELIX 771..774; /evidence=""ECO:0007829|PDB:7UJD""; HELIX 790..803; /evidence=""ECO:0007829|PDB:7UJD""; HELIX 809..813; /evidence=""ECO:0007829|PDB:7UJD""; HELIX 815..824; /evidence=""ECO:0007829|PDB:7UJD""","TURN 322..325; /evidence=""ECO:0007829|PDB:7UJD""; TURN 382..384; /evidence=""ECO:0007829|PDB:7UJD""; TURN 418..420; /evidence=""ECO:0007829|PDB:7UJD""; TURN 451..455; /evidence=""ECO:0007829|PDB:7UJD""; TURN 526..528; /evidence=""ECO:0007829|PDB:7UJD""; TURN 547..551; /evidence=""ECO:0007829|PDB:7UJD""; TURN 566..568; /evidence=""ECO:0007829|PDB:7UJD""; TURN 600..603; /evidence=""ECO:0007829|PDB:7UJD""; TURN 698..700; /evidence=""ECO:0007829|PDB:7UJD""; TURN 733..735; /evidence=""ECO:0007829|PDB:7UJD""; TURN 752..754; /evidence=""ECO:0007829|PDB:7UJD""; TURN 783..786; /evidence=""ECO:0007829|PDB:7UJD""; TURN 804..808; /evidence=""ECO:0007829|PDB:7UJD""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,PSMD2 TRAP2,26S proteasome non-ATPase regulatory subunit 2 (26S proteasome regulatory subunit RPN1) (26S proteasome regulatory subunit S2) (26S proteasome subunit p97) (Protein 55.11) (Tumor necrosis factor type 1 receptor-associated protein 2),Homo sapiens (Human),908.0,100200.0,MEEGGRDKAPVQPQQSPAAAPGGTDEKPSGKERRDAGDKDKEQELSEEDKQLQDELEMLVERLGEKDTSLYRPALEELRRQIRSSTTSMTSVPKPLKFLRPHYGKLKEIYENMAPGENKRFAADIISVLAMTMSGERECLKYRLVGSQEELASWGHEYVRHLAGEVAKEWQELDDAEKVQREPLLTLVKEIVPYNMAHNAEHEACDLLMEIEQVDMLEKDIDENAYAKVCLYLTSCVNYVPEPENSALLRCALGVFRKFSRFPEALRLALMLNDMELVEDIFTSCKDVVVQKQMAFMLGRHGVFLELSEDVEEYEDLTEIMSNVQLNSNFLALARELDIMEPKVPDDIYKTHLENNRFGGSGSQVDSARMNLASSFVNGFVNAAFGQDKLLTDDGNKWLYKNKDHGMLSAAASLGMILLWDVDGGLTQIDKYLYSSEDYIKSGALLACGIVNSGVRNECDPALALLSDYVLHNSNTMRLGSIFGLGLAYAGSNREDVLTLLLPVMGDSKSSMEVAGVTALACGMIAVGSCNGDVTSTILQTIMEKSETELKDTYARWLPLGLGLNHLGKGEAIEAILAALEVVSEPFRSFANTLVDVCAYAGSGNVLKVQQLLHICSEHFDSKEKEEDKDKKEKKDKDKKEAPADMGAHQGVAVLGIALIAMGEEIGAEMALRTFGHLLRYGEPTLRRAVPLALALISVSNPRLNILDTLSKFSHDADPEVSYNSIFAMGMVGSGTNNARLAAMLRQLAQYHAKDPNNLFMVRLAQGLTHLGKGTLTLCPYHSDRQLMSQVAVAGLLTVLVSFLDVRNIILGKSHYVLYGLVAAMQPRMLVTFDEELRPLPVSVRVGQAVDVVGQAGKPKTITGFQTHTTPVLLAHGERAELATEEFLPVTPILEGFVILRKNPNYDL,False,False,True,Q13200,"[('G3DSA:1.25.10.10', 'Leucine-rich Repeat Variant'), ('IPR002015', 'Proteasome/cyclosome repeat'), ('IPR011989', 'Armadillo-like helical'), ('IPR016024', 'Armadillo-type fold'), ('IPR016643', '26S proteasome regulatory complex, non-ATPase subcomplex, Rpn1 subunit'), ('IPR040892', 'RPN1, N-terminal'), ('IPR041433', '26S proteasome non-ATPase regulatory subunit RPN1, C-terminal'), ('PF01851', 'Proteasome/cyclosome repeat'), ('PF17781', 'RPN1 N-terminal domain'), ('PF18051', '26S proteasome non-ATPase regulatory subunit RPN1 C-terminal'), ('PIRSF015965', '26S proteasome regulatory complex, non-ATPase subcomplex, Rpn1 subunit'), ('PTHR10943', '26S Proteasome Regulatory Non-ATPase Subunits'), ('SSF48371', 'ARM repeat')]",,"""ENSG00000175166; Tissue enhanced (skeletal)."";",,,,,ENST00000310118.9 [Q13200-1];ENST00000435761.5 [Q13200-2];ENST00000439383.5 [Q13200-3];,PSMD2,ENSG00000175166,0.0,,,,,,,0.087,0.083,PSMD2
Q13387,ENSG00000008735,JIP2_HUMAN,"behavioral fear response [GO:0001662]; dendrite morphogenesis [GO:0048813]; excitatory postsynaptic potential [GO:0060079]; JNK cascade [GO:0007254]; MAPK cascade [GO:0000165]; mating behavior [GO:0007617]; negative regulation of apoptotic signaling pathway [GO:2001234]; nonassociative learning [GO:0046958]; positive regulation of stress-activated MAPK cascade [GO:0032874]; regulation of AMPA receptor activity [GO:2000311]; regulation of JNK cascade [GO:0046328]; regulation of NMDA receptor activity [GO:2000310]; regulation of signaling receptor activity [GO:0010469]; regulation of synaptic transmission, glutamatergic [GO:0051966]; signal complex assembly [GO:0007172]; social behavior [GO:0035176]",cytoplasm [GO:0005737]; neuronal cell body [GO:0043025]; postsynaptic density [GO:0014069]; protein-containing complex [GO:0032991],amyloid-beta binding [GO:0001540]; JUN kinase binding [GO:0008432]; kinesin binding [GO:0019894]; MAP-kinase scaffold activity [GO:0005078]; protein kinase activator activity [GO:0030295]; protein kinase binding [GO:0019901]; protein-containing complex binding [GO:0044877]; structural molecule activity [GO:0005198],,,"DOMAIN 604..665; /note=""SH3""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00192""; DOMAIN 677..813; /note=""PID""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00148""",,,,"cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,MAPK8IP2 IB2 JIP2 PRKM8IPL,C-Jun-amino-terminal kinase-interacting protein 2 (JIP-2) (JNK-interacting protein 2) (Islet-brain-2) (IB-2) (JNK MAP kinase scaffold protein 2) (Mitogen-activated protein kinase 8-interacting protein 2),Homo sapiens (Human),824.0,87975.0,MADRAEMFSLSTFHSLSPPGCRPPQDISLEEFDDEDLSEITDDCGLGLSYDSDHCEKDSLSLGRSEQPHPICSFQDDFQEFEMIDDNEEEDDEDEEEEEEEEEGDGEGQEGGDPGSEAPAPGPLIPSPSVEEPHKHRPTTLRLTTLGAQDSLNNNGGFDLVRPASWQETALCSPAPEALRELPGPLPATDTGPGGAQSPVRPGCDCEGNRPAEPPAPGGTSPSSDPGIEADLRSRSSGGRGGRRSSQELSSPGSDSEDAGGARLGRMISSISETELELSSDGGSSSSGRSSHLTNSIEEASSPASEPEPPREPPRRPAFLPVGPDDTNSEYESGSESEPDLSEDADSPWLLSNLVSRMISEGSSPIRCPGQCLSPAPRPPGEPVSPAGGAAQDSQDPEAAAGPGGVELVDMETLCAPPPPAPAAPRPGPAQPGPCLFLSNPTRDTITPLWAAPGRAARPGRACSAACSEEEDEEDDEEEEDAEDSAGSPGGRGTGPSAPRDASLVYDAVKYTLVVDEHTQLELVSLRRCAGLGHDSEEDSGGEASEEEAGAALLGGGQVSGDTSPDSPDLTFSKKFLNVFVNSTSRSSSTESFGLFSCLVNGEEREQTHRAVFRFIPRHPDELELDVDDPVLVEAEEDDFWFRGFNMRTGERGVFPAFYAHAVPGPAKDLLGSKRSPCWVERFDVQFLGSVEVPCHQGNGILCAAMQKIATARKLTVHLRPPASCDLEISLRGVKLSLSGGGPEFQRCSHFFQMKNISFCGCHPRNSCYFGFITKHPLLSRFACHVFVSQESMRPVAQSVGRAFLEYYQEHLAYACPTEDIYLE,False,False,True,Q13387,"[('cd01212', 'JNK-interacting protein-like (JIP) Phosphotyrosine-binding (PTB) domain'), ('cd11942', 'Src homology 3 domain of JNK-interacting protein 2'), ('G3DSA:2.30.29.30', 'Pleckstrin-homology domain (PH domain)/Phosphotyrosine-binding domain (PTB)'), ('G3DSA:2.30.30.40', 'SH3 Domains'), ('IPR001452', 'SH3 domain'), ('IPR006020', 'PTB/PI domain'), ('IPR011993', 'PH-like domain superfamily'), ('IPR035637', 'JIP2, SH3 domain'), ('IPR047178', 'JNK-interacting protein 1'), ('PF00640', 'Phosphotyrosine interaction domain (PTB/PID)'), ('PF14604', 'Variant SH3 domain'), ('PS01179', 'Phosphotyrosine interaction domain (PID) profile'), ('PS50002', 'Src homology 3 (SH3) domain profile'), ('PTHR47437', 'JNK-INTERACTING PROTEIN 1-LIKE PROTEIN'), ('SM00326', 'Src homology 3 domains'), ('SM00462', 'Phosphotyrosine-binding domain, phosphotyrosine-interaction (PI) domain'), ('SSF50729', 'PH domain-like')]",,"""ENSG00000008735; Tissue enriched (brain)."";",,,,,ENST00000329492.6 [Q13387-1];,MAPK8IP2,ENSG00000008735,0.0,,,,,,,0.748,0.568,MAPK8IP2
Q13404,ENSG00000244687,UB2V1_HUMAN,cell differentiation [GO:0030154]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of intracellular signal transduction [GO:1902533]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein K63-linked ubiquitination [GO:1902523]; postreplication repair [GO:0006301]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; regulation of DNA repair [GO:0006282]; regulation of DNA-templated transcription [GO:0006355],cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; UBC13-MMS2 complex [GO:0031372]; ubiquitin conjugating enzyme complex [GO:0031371]; ubiquitin ligase complex [GO:0000151],,,,"DOMAIN 12..147; /note=""UBC core""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00388""","STRAND 31..39; /evidence=""ECO:0007829|PDB:2A4D""; STRAND 47..53; /evidence=""ECO:0007829|PDB:2A4D""; STRAND 56..58; /evidence=""ECO:0007829|PDB:2HLW""; STRAND 64..70; /evidence=""ECO:0007829|PDB:2A4D""; STRAND 81..86; /evidence=""ECO:0007829|PDB:2A4D""; STRAND 91..93; /evidence=""ECO:0007829|PDB:2HLW""","HELIX 11..25; /evidence=""ECO:0007829|PDB:2A4D""; HELIX 102..104; /evidence=""ECO:0007829|PDB:2A4D""; HELIX 106..109; /evidence=""ECO:0007829|PDB:2A4D""; HELIX 117..128; /evidence=""ECO:0007829|PDB:2A4D""","TURN 59..62; /evidence=""ECO:0007829|PDB:2A4D""; TURN 73..77; /evidence=""ECO:0007829|PDB:2A4D""; TURN 95..97; /evidence=""ECO:0007829|PDB:2A4D""; TURN 131..135; /evidence=""ECO:0007829|PDB:2A4D""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,UBE2V1 CROC1 UBE2V UEV1 P/OKcl.19,Ubiquitin-conjugating enzyme E2 variant 1 (UEV-1) (CROC-1) (TRAF6-regulated IKK activator 1 beta Uev1A),Homo sapiens (Human),147.0,16495.0,MAATTGSGVKVPRNFRLLEELEEGQKGVGDGTVSWGLEDDEDMTLTRWTGMIIGPPRTIYENRIYSLKIECGPKYPEAPPFVRFVTKINMNGVNSSNGVVDPRAISVLAKWQNSYSIKVVLQELRRLMMSKENMKLPQPPEGQCYSN,False,False,True,Q13404,"[('G3DSA:3.10.110.10', 'Ubiquitin Conjugating Enzyme'), ('IPR000608', 'Ubiquitin-conjugating enzyme E2'), ('IPR016135', 'Ubiquitin-conjugating enzyme/RWD-like'), ('PF00179', 'Ubiquitin-conjugating enzyme'), ('PS50127', 'Ubiquitin-conjugating (UBC) core domain profile'), ('PTHR24068', 'Ubiquitin-conjugating enzyme'), ('SM00212', 'Ubiquitin-conjugating enzyme E2, catalytic domain homologues'), ('SSF54495', 'UBC-like')]",,"""ENSG00000244687; Low tissue specificity."";",,,,,ENST00000340309.7 [Q13404-7];ENST00000371657.9 [Q13404-8];ENST00000371674.8 [Q13404-4];ENST00000371677.7 [Q13404-7];ENST00000415862.6 [Q13404-6];,UBE2V1,ENSG00000244687,0.0,,,,,,,0.082,,UBE2V1
Q13480,ENSG00000109458,GAB1_HUMAN,angiogenesis [GO:0001525]; endothelial cell chemotaxis [GO:0035767]; epidermal growth factor receptor signaling pathway [GO:0007173]; insulin receptor signaling pathway [GO:0008286]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; response to hepatocyte growth factor [GO:0035728]; signal transduction [GO:0007165]; vascular endothelial growth factor signaling pathway [GO:0038084],cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; cytosol [GO:0005829],signaling adaptor activity [GO:0035591],PTM: Phosphorylated in response to FGFR1 activation. Phosphorylated on tyrosine residue(s) by the epidermal growth factor receptor (EGFR) and the insulin receptor (INSR). Tyrosine phosphorylation of GAB1 mediates interaction with several proteins that contain SH2 domains. Phosphorylated on tyrosine residues by HCK upon IL6 signaling. {ECO:0000269|PubMed:15010462}.,,"DOMAIN 5..116; /note=""PH""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00145""",,,,"cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,GAB1,GRB2-associated-binding protein 1 (GRB2-associated binder 1) (Growth factor receptor bound protein 2-associated protein 1),Homo sapiens (Human),694.0,76616.0,MSGGEVVCSGWLRKSPPEKKLKRYAWKRRWFVLRSGRLTGDPDVLEYYKNDHAKKPIRIIDLNLCQQVDAGLTFNKKEFENSYIFDINTIDRIFYLVADSEEEMNKWVRCICDICGFNPTEEDPVKPPGSSLQAPADLPLAINTAPPSTQADSSSATLPPPYQLINVPPHLETLGIQEDPQDYLLLINCQSKKPEPTRTHADSAKSTSSETDCNDNVPSHKNPASSQSKHGMNGFFQQQMIYDSPPSRAPSASVDSSLYNLPRSYSHDVLPKVSPSSTEADGELYVFNTPSGTSSVETQMRHVSISYDIPPTPGNTYQIPRTFPEGTLGQTSKLDTIPDIPPPRPPKPHPAHDRSPVETCSIPRTASDTDSSYCIPTAGMSPSRSNTISTVDLNKLRKDASSQDCYDIPRAFPSDRSSSLEGFHNHFKVKNVLTVGSVSSEELDENYVPMNPNSPPRQHSSSFTEPIQEANYVPMTPGTFDFSSFGMQVPPPAHMGFRSSPKTPPRRPVPVADCEPPPVDRNLKPDRKVKPAPLEIKPLPEWEELQAPVRSPITRSFARDSSRFPMSPRPDSVHSTTSSSDSHDSEENYVPMNPNLSSEDPNLFGSNSLDGGSSPMIKPKGDKQVEYLDLDLDSGKSTPPRKQKSSGSGSSVADERVDYVVVDQQKTLALKSTREAWTDGRQSTESETPAKSVK,False,False,True,Q13480,"[('cd01266', 'Grb2-associated binding proteins 1 and 2 pleckstrin homology (PH) domain'), ('G3DSA:2.30.29.30', 'Pleckstrin-homology domain (PH domain)/Phosphotyrosine-binding domain (PTB)'), ('IPR001849', 'Pleckstrin homology domain'), ('IPR011993', 'PH-like domain superfamily'), ('IPR046355', 'GRB2-associated-binding protein 1-4-like'), ('PF00169', 'PH domain'), ('PS50003', 'PH domain profile'), ('PTHR45960', 'GRB2-ASSOCIATED-BINDING PROTEIN'), ('SM00233', 'Pleckstrin homology domain.'), ('SSF50729', 'PH domain-like')]",Q13480;,"""ENSG00000109458; Low tissue specificity."";",,,,,ENST00000262994.9 [Q13480-1];ENST00000262995.9 [Q13480-2];,GAB1,ENSG00000109458,0.0,,,,83.29,DP03706,0.833,0.827,0.464,GAB1
Q13485,ENSG00000141646,SMAD4_HUMAN,activin receptor signaling pathway [GO:0032924]; adrenal gland development [GO:0030325]; anatomical structure morphogenesis [GO:0009653]; atrioventricular canal development [GO:0036302]; atrioventricular valve formation [GO:0003190]; axon guidance [GO:0007411]; BMP signaling pathway [GO:0030509]; brainstem development [GO:0003360]; branching involved in ureteric bud morphogenesis [GO:0001658]; cardiac conduction system development [GO:0003161]; cardiac muscle hypertrophy in response to stress [GO:0014898]; cell differentiation [GO:0030154]; cell population proliferation [GO:0008283]; cellular response to BMP stimulus [GO:0071773]; cellular response to glucose stimulus [GO:0071333]; cellular response to transforming growth factor beta stimulus [GO:0071560]; developmental growth [GO:0048589]; DNA-templated transcription [GO:0006351]; embryonic digit morphogenesis [GO:0042733]; endocardial cell differentiation [GO:0060956]; endothelial cell activation [GO:0042118]; epithelial cell migration [GO:0010631]; epithelial to mesenchymal transition [GO:0001837]; epithelial to mesenchymal transition involved in endocardial cushion formation [GO:0003198]; ERK1 and ERK2 cascade [GO:0070371]; extrinsic apoptotic signaling pathway [GO:0097191]; female gonad morphogenesis [GO:0061040]; formation of anatomical boundary [GO:0048859]; gastrulation with mouth forming second [GO:0001702]; in utero embryonic development [GO:0001701]; interleukin-6-mediated signaling pathway [GO:0070102]; intracellular iron ion homeostasis [GO:0006879]; intracellular signal transduction [GO:0035556]; left ventricular cardiac muscle tissue morphogenesis [GO:0003220]; mesendoderm development [GO:0048382]; metanephric mesenchyme morphogenesis [GO:0072133]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of cardiac muscle hypertrophy [GO:0010614]; negative regulation of cardiac myofibril assembly [GO:1905305]; negative regulation of cell growth [GO:0030308]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of protein catabolic process [GO:0042177]; negative regulation of transcription by RNA polymerase II [GO:0000122]; nephrogenic mesenchyme morphogenesis [GO:0072134]; neural crest cell differentiation [GO:0014033]; neuron fate specification [GO:0048665]; osteoblast differentiation [GO:0001649]; outflow tract septum morphogenesis [GO:0003148]; ovarian follicle development [GO:0001541]; positive regulation of cardiac muscle cell apoptotic process [GO:0010666]; positive regulation of cell proliferation involved in heart valve morphogenesis [GO:0003251]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of extracellular matrix assembly [GO:1901203]; positive regulation of follicle-stimulating hormone secretion [GO:0046881]; positive regulation of gene expression [GO:0010628]; positive regulation of luteinizing hormone secretion [GO:0033686]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of SMAD protein signal transduction [GO:0060391]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; regulation of DNA-templated transcription [GO:0006355]; regulation of hair follicle development [GO:0051797]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of transforming growth factor beta2 production [GO:0032909]; response to hypoxia [GO:0001666]; response to transforming growth factor beta [GO:0071559]; sebaceous gland development [GO:0048733]; secondary palate development [GO:0062009]; seminiferous tubule development [GO:0072520]; single fertilization [GO:0007338]; SMAD protein signal transduction [GO:0060395]; somite rostral/caudal axis specification [GO:0032525]; spermatogenesis [GO:0007283]; transcription by RNA polymerase II [GO:0006366]; transforming growth factor beta receptor signaling pathway [GO:0007179]; uterus development [GO:0060065]; ventricular septum morphogenesis [GO:0060412],activin responsive factor complex [GO:0032444]; centrosome [GO:0005813]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; heteromeric SMAD protein complex [GO:0071144]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; SMAD protein complex [GO:0071141]; transcription regulator complex [GO:0005667],"chromatin binding [GO:0003682]; collagen binding [GO:0005518]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; filamin binding [GO:0031005]; I-SMAD binding [GO:0070411]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; R-SMAD binding [GO:0070412]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific DNA binding [GO:0043565]; sulfate binding [GO:0043199]; transcription cis-regulatory region binding [GO:0000976]; transcription coactivator binding [GO:0001223]; transcription corepressor binding [GO:0001222]",PTM: Phosphorylated by PDPK1. {ECO:0000269|PubMed:17327236}.; PTM: Monoubiquitinated on Lys-519 by E3 ubiquitin-protein ligase TRIM33. Monoubiquitination hampers its ability to form a stable complex with activated SMAD2/3 resulting in inhibition of TGF-beta/BMP signaling cascade. Deubiquitination by USP9X restores its competence to mediate TGF-beta signaling. {ECO:0000269|PubMed:19135894}.,DOMAIN: The MH1 domain is required for DNA binding.; DOMAIN: The MH2 domain is required for both homomeric and heteromeric interactions and for transcriptional regulation. Sufficient for nuclear import.,"DOMAIN 18..142; /note=""MH1""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00438""; DOMAIN 323..552; /note=""MH2""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00439""","STRAND 29..31; /evidence=""ECO:0007829|PDB:5MEY""; STRAND 73..75; /evidence=""ECO:0007829|PDB:5MEY""; STRAND 78..80; /evidence=""ECO:0007829|PDB:5MEY""; STRAND 82..84; /evidence=""ECO:0007829|PDB:5MEY""; STRAND 87..89; /evidence=""ECO:0007829|PDB:5MEY""; STRAND 109..111; /evidence=""ECO:0007829|PDB:5MEY""; STRAND 124..127; /evidence=""ECO:0007829|PDB:5MEY""; STRAND 133..135; /evidence=""ECO:0007829|PDB:5MEY""; STRAND 288..291; /evidence=""ECO:0007829|PDB:1DD1""; STRAND 321..330; /evidence=""ECO:0007829|PDB:1YGS""; STRAND 333..342; /evidence=""ECO:0007829|PDB:1YGS""; STRAND 346..353; /evidence=""ECO:0007829|PDB:1YGS""; STRAND 359..363; /evidence=""ECO:0007829|PDB:1YGS""; STRAND 387..392; /evidence=""ECO:0007829|PDB:1YGS""; STRAND 396..401; /evidence=""ECO:0007829|PDB:1YGS""; STRAND 403..405; /evidence=""ECO:0007829|PDB:1YGS""; STRAND 407..410; /evidence=""ECO:0007829|PDB:1YGS""; STRAND 427..429; /evidence=""ECO:0007829|PDB:1YGS""; STRAND 434..438; /evidence=""ECO:0007829|PDB:1YGS""; STRAND 500..506; /evidence=""ECO:0007829|PDB:1YGS""; STRAND 521..529; /evidence=""ECO:0007829|PDB:1YGS""","HELIX 16..24; /evidence=""ECO:0007829|PDB:5MEY""; HELIX 33..47; /evidence=""ECO:0007829|PDB:5MEY""; HELIX 51..62; /evidence=""ECO:0007829|PDB:5MEY""; HELIX 91..99; /evidence=""ECO:0007829|PDB:5MEY""; HELIX 119..121; /evidence=""ECO:0007829|PDB:5MEY""; HELIX 130..132; /evidence=""ECO:0007829|PDB:5MEY""; HELIX 143..145; /evidence=""ECO:0007829|PDB:5UWU""; HELIX 364..366; /evidence=""ECO:0007829|PDB:1U7F""; HELIX 374..380; /evidence=""ECO:0007829|PDB:1YGS""; HELIX 412..416; /evidence=""ECO:0007829|PDB:1YGS""; HELIX 440..454; /evidence=""ECO:0007829|PDB:1YGS""; HELIX 461..464; /evidence=""ECO:0007829|PDB:1DD1""; HELIX 493..497; /evidence=""ECO:0007829|PDB:1YGS""; HELIX 518..520; /evidence=""ECO:0007829|PDB:1YGS""; HELIX 530..541; /evidence=""ECO:0007829|PDB:1YGS""","TURN 63..65; /evidence=""ECO:0007829|PDB:5MEY""; TURN 381..385; /evidence=""ECO:0007829|PDB:1YGS""; TURN 393..395; /evidence=""ECO:0007829|PDB:1YGS""; TURN 417..419; /evidence=""ECO:0007829|PDB:1YGS""; TURN 455..458; /evidence=""ECO:0007829|PDB:1DD1""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,SMAD4 DPC4 MADH4,Mothers against decapentaplegic homolog 4 (MAD homolog 4) (Mothers against DPP homolog 4) (Deletion target in pancreatic carcinoma 4) (SMAD family member 4) (SMAD 4) (Smad4) (hSMAD4),Homo sapiens (Human),552.0,60439.0,MDNMSITNTPTSNDACLSIVHSLMCHRQGGESETFAKRAIESLVKKLKEKKDELDSLITAITTNGAHPSKCVTIQRTLDGRLQVAGRKGFPHVIYARLWRWPDLHKNELKHVKYCQYAFDLKCDSVCVNPYHYERVVSPGIDLSGLTLQSNAPSSMMVKDEYVHDFEGQPSLSTEGHSIQTIQHPPSNRASTETYSTPALLAPSESNATSTANFPNIPVASTSQPASILGGSHSEGLLQIASGPQPGQQQNGFTGQPATYHHNSTTTWTGSRTAPYTPNLPHHQNGHLQHHPPMPPHPGHYWPVHNELAFQPPISNHPAPEYWCSIAYFEMDVQVGETFKVPSSCPIVTVDGYVDPSGGDRFCLGQLSNVHRTEAIERARLHIGKGVQLECKGEGDVWVRCLSDHAVFVQSYYLDREAGRAPGDAVHKIYPSAYIKVFDLRQCHRQMQQQAATAQAAAAAQAAAVAGNIPGPGSVGGIAPAISLSAAAGIGVDDLRRLCILRMSFVKGWGPDYPRQSIKETPCWIEIHLHRALQLLDEVLHTMPIADPQPLD,True,False,False,Q13485,"[('cd10492', 'N-terminal Mad Homology 1 (MH1) domain in SMAD4'), ('cd10498', 'C-terminal Mad Homology 2 (MH2) domain in SMAD4'), ('G3DSA:2.60.200.10', None), ('G3DSA:3.90.520.10', 'SMAD MH1 domain'), ('IPR001132', 'SMAD domain, Dwarfin-type'), ('IPR003619', 'MAD homology 1, Dwarfin-type'), ('IPR008984', 'SMAD/FHA domain superfamily'), ('IPR013019', 'MAD homology, MH1'), ('IPR013790', 'Dwarfin'), ('IPR017855', 'SMAD-like domain superfamily'), ('IPR036578', 'SMAD MH1 domain superfamily'), ('PF03165', 'MH1 domain'), ('PF03166', 'MH2 domain'), ('PS51075', 'MAD homology domain 1 (MH1) profile'), ('PS51076', 'MAD homology domain 2 (MH2) profile'), ('PTHR13703', 'SMAD'), ('SM00523', 'Domain A in dwarfin family proteins'), ('SM00524', 'Domain B in dwarfin family proteins'), ('SSF49879', 'SMAD/FHA domain'), ('SSF56366', 'SMAD MH1 domain')]",,"""ENSG00000141646; Low tissue specificity."";",,,,,ENST00000342988.8;ENST00000398417.6;ENST00000588860.6;ENST00000589076.6;ENST00000589941.2;ENST00000590061.2;,SMAD4,ENSG00000141646,0.0,SMAD4,Non-canonical_RBPs,7.0,0.0,DP00464,0.143,0.373,0.087,SMAD4
Q13492,ENSG00000073921,PICAL_HUMAN,amyloid-beta clearance by transcytosis [GO:0150093]; axonogenesis [GO:0007409]; clathrin coat assembly [GO:0048268]; clathrin-dependent endocytosis [GO:0072583]; dendrite morphogenesis [GO:0048813]; endocytosis [GO:0006897]; endosomal transport [GO:0016197]; hemopoiesis [GO:0030097]; intracellular iron ion homeostasis [GO:0006879]; learning or memory [GO:0007611]; membrane bending [GO:0097753]; multicellular organismal-level iron ion homeostasis [GO:0060586]; negative regulation of gene expression [GO:0010629]; negative regulation of protein localization to cell surface [GO:2000009]; negative regulation of protein localization to plasma membrane [GO:1903077]; negative regulation of receptor-mediated endocytosis [GO:0048261]; positive regulation of amyloid precursor protein catabolic process [GO:1902993]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of Ras protein signal transduction [GO:0046579]; protein-containing complex assembly [GO:0065003]; receptor internalization [GO:0031623]; receptor-mediated endocytosis [GO:0006898]; regulation of amyloid precursor protein catabolic process [GO:1902991]; regulation of endocytosis [GO:0030100]; regulation of protein localization [GO:0032880]; regulation of vesicle size [GO:0097494]; synaptic vesicle budding from presynaptic endocytic zone membrane [GO:0016185]; synaptic vesicle maturation [GO:0016188]; vesicle budding from membrane [GO:0006900]; vesicle cargo loading [GO:0035459]; vesicle-mediated transport [GO:0016192],cell surface [GO:0009986]; clathrin coat of coated pit [GO:0030132]; clathrin-coated endocytic vesicle [GO:0045334]; clathrin-coated pit [GO:0005905]; clathrin-coated vesicle [GO:0030136]; cytosol [GO:0005829]; early endosome [GO:0005769]; endosome to plasma membrane transport vesicle [GO:0070381]; extrinsic component of presynaptic endocytic zone membrane [GO:0098894]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; membrane [GO:0016020]; neurofibrillary tangle [GO:0097418]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic membrane [GO:0045211]; presynaptic membrane [GO:0042734]; synaptic vesicle [GO:0008021]; vesicle [GO:0031982],"1-phosphatidylinositol binding [GO:0005545]; amyloid-beta binding [GO:0001540]; cadherin binding [GO:0045296]; clathrin binding [GO:0030276]; clathrin heavy chain binding [GO:0032050]; low-density lipoprotein particle receptor binding [GO:0050750]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; small GTPase binding [GO:0031267]; SNARE binding [GO:0000149]; tau protein binding [GO:0048156]",,,"DOMAIN 14..145; /note=""ENTH""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00243""",,,,"cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,PICALM CALM,Phosphatidylinositol-binding clathrin assembly protein (Clathrin assembly lymphoid myeloid leukemia protein),Homo sapiens (Human),652.0,70755.0,MSGQSLTDRITAAQHSVTGSAVSKTVCKATTHEIMGPKKKHLDYLIQCTNEMNVNIPQLADSLFERTTNSSWVVVFKSLITTHHLMVYGNERFIQYLASRNTLFNLSNFLDKSGLQGYDMSTFIRRYSRYLNEKAVSYRQVAFDFTKVKRGADGVMRTMNTEKLLKTVPIIQNQMDALLDFNVNSNELTNGVINAAFMLLFKDAIRLFAAYNEGIINLLEKYFDMKKNQCKEGLDIYKKFLTRMTRISEFLKVAEQVGIDRGDIPDLSQAPSSLLDALEQHLASLEGKKIKDSTAASRATTLSNAVSSLASTGLSLTKVDEREKQAALEEEQARLKALKEQRLKELAKKPHTSLTTAASPVSTSAGGIMTAPAIDIFSTPSSSNSTSKLPNDLLDLQQPTFHPSVHPMSTASQVASTWGDPFSATVDAVDDAIPSLNPFLTKSSGDVHLSISSDVSTFTTRTPTHEMFVGFTPSPVAQPHPSAGLNVDFESVFGNKSTNVIVDSGGFDELGGLLKPTVASQNQNLPVAKLPPSKLVSDDLDSSLANLVGNLGIGNGTTKNDVNWSQPGEKKLTGGSNWQPKVAPTTAWNAATMAPPVMAYPATTPTGMIGYGIPPQMGSVPVMTQPTLIYSQPVMRPPNPFGPVSGAQIQFM,False,True,True,Q13492,"[('cd16985', 'ANTH (AP180 N-Terminal Homology) domain, N-terminal region, of adaptor protein 180 (AP180) subfamily'), ('G3DSA:1.20.58.150', 'ANTH domain'), ('G3DSA:1.25.40.90', None), ('IPR008942', 'ENTH/VHS'), ('IPR011417', 'AP180 N-terminal homology (ANTH) domain'), ('IPR013809', 'ENTH domain'), ('IPR014712', 'ANTH domain superfamily'), ('IPR045192', 'Clathrin coat assembly protein AP180-like'), ('PF07651', 'ANTH domain'), ('PS50942', 'ENTH domain profile'), ('PTHR22951', 'CLATHRIN ASSEMBLY PROTEIN'), ('SM00273', 'Epsin N-terminal homology (ENTH) domain'), ('SSF48464', 'ENTH/VHS domain'), ('SSF89009', 'GAT-like domain')]",Q13492;,"""ENSG00000073921; Low tissue specificity."";",,,,,ENST00000356360.9 [Q13492-2];ENST00000393346.8 [Q13492-1];ENST00000526033.5 [Q13492-5];ENST00000528398.5 [Q13492-4];ENST00000532317.5 [Q13492-3];,PICALM,ENSG00000073921,0.0,,,,,,,0.502,0.034,PICALM
Q13501,ENSG00000161011|ENSG00000284099,SQSTM_HUMAN,aggrephagy [GO:0035973]; apoptotic process [GO:0006915]; autophagy [GO:0006914]; autophagy of mitochondrion [GO:0000422]; brown fat cell proliferation [GO:0070342]; cell differentiation [GO:0030154]; cellular response to stress [GO:0033554]; endosomal transport [GO:0016197]; endosome organization [GO:0007032]; energy homeostasis [GO:0097009]; immune system process [GO:0002376]; intracellular signal transduction [GO:0035556]; macroautophagy [GO:0016236]; mitophagy [GO:0000423]; negative regulation of ferroptosis [GO:0110076]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of toll-like receptor 4 signaling pathway [GO:0034144]; negative regulation of transcription by RNA polymerase II [GO:0000122]; non-membrane-bounded organelle assembly [GO:0140694]; pexophagy [GO:0000425]; positive regulation of apoptotic process [GO:0043065]; positive regulation of autophagy [GO:0010508]; positive regulation of long-term synaptic potentiation [GO:1900273]; positive regulation of protein localization to plasma membrane [GO:1903078]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein catabolic process [GO:0030163]; protein import into nucleus [GO:0006606]; protein localization [GO:0008104]; protein localization to perinuclear region of cytoplasm [GO:1905719]; protein targeting to vacuole involved in autophagy [GO:0071211]; regulation of canonical NF-kappaB signal transduction [GO:0043122]; regulation of mitochondrion organization [GO:0010821]; regulation of protein complex stability [GO:0061635]; regulation of Ras protein signal transduction [GO:0046578]; response to ischemia [GO:0002931]; response to mitochondrial depolarisation [GO:0098780]; temperature homeostasis [GO:0001659]; transcription by RNA polymerase II [GO:0006366]; ubiquitin-dependent protein catabolic process [GO:0006511],aggresome [GO:0016235]; amphisome [GO:0044753]; autolysosome [GO:0044754]; autophagosome [GO:0005776]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; inclusion body [GO:0016234]; intracellular membrane-bounded organelle [GO:0043231]; intracellular non-membrane-bounded organelle [GO:0043232]; late endosome [GO:0005770]; Lewy body [GO:0097413]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; P-body [GO:0000932]; phagophore assembly site [GO:0000407]; PML body [GO:0016605]; sarcomere [GO:0030017]; sperm midpiece [GO:0097225],enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; ionotropic glutamate receptor binding [GO:0035255]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; molecular condensate scaffold activity [GO:0140693]; molecular sequestering activity [GO:0140313]; protein kinase binding [GO:0019901]; protein kinase C binding [GO:0005080]; protein sequestering activity [GO:0140311]; protein-containing complex binding [GO:0044877]; protein-macromolecule adaptor activity [GO:0030674]; receptor tyrosine kinase binding [GO:0030971]; SH2 domain binding [GO:0042169]; signaling adaptor activity [GO:0035591]; signaling receptor activity [GO:0038023]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-modified protein reader activity [GO:0140036]; zinc ion binding [GO:0008270],"PTM: Phosphorylation at Ser-407 by ULK1 destabilizes the UBA dimer interface and increases binding affinity to ubiquitinated proteins (By similarity). Phosphorylation at Ser-407 also primes for subsequent phosphorylation at Ser-403 (By similarity). Phosphorylation at Ser-403 by CK2 or ULK1 promotes binding to ubiquitinated proteins by increasing the affinity between the UBA domain and polyubiquitin chains (PubMed:22017874, PubMed:25040165). Phosphorylation at Ser-403 by ULK1 is stimulated by SESN2 (PubMed:25040165). Phosphorylated at Ser-403 by TBK1, leading to promote relocalization of 'Lys-63'-linked ubiquitinated STING1 to autophagosomes (PubMed:29496741). Phosphorylation at Ser-349 by ULK1 promotes interaction with KEAP1 and inactivation of the BCR(KEAP1) complex, promoting NFE2L2/NRF2 nuclear accumulation and expression of phase II detoxifying enzymes (PubMed:37306101). Phosphorylated in vitro by TTN (PubMed:15802564). {ECO:0000250|UniProtKB:Q64337, ECO:0000269|PubMed:15802564, ECO:0000269|PubMed:22017874, ECO:0000269|PubMed:25040165, ECO:0000269|PubMed:29496741, ECO:0000269|PubMed:37306101}.; PTM: Ubiquitinated by UBE2J1 and RNF26 at Lys-435: ubiquitinated SQSTM1 attracts specific vesicle-associated adapters, forming a molecular bridge that restrains cognate vesicles in the perinuclear region and organizes the endosomal pathway for efficient cargo transport (PubMed:27368102, PubMed:33472082). Ubiquitination by UBE2D2 and UBE2D3 increases its ability to bind polyubiquitin chains by destabilizing the UBA dimer interface (PubMed:28322253). Deubiquitination by USP15 releases target vesicles for fast transport into the cell periphery (PubMed:27368102). Ubiquitinated by the BCR(KEAP1) complex at Lys-420, increasing SQSTM1 sequestering activity and promoting its degradation (PubMed:28380357). Ubiquitinated via 'Lys-29' and 'Lys-33'-linked polyubiquitination leading to xenophagic targeting of bacteria and inhibition of their replication (PubMed:27880896). {ECO:0000269|PubMed:27368102, ECO:0000269|PubMed:27880896, ECO:0000269|PubMed:28322253, ECO:0000269|PubMed:28380357, ECO:0000269|PubMed:33472082}.; PTM: Acetylated at Lys-420 and Lys-435 by KAT5/TIP60, promotes activity by destabilizing the UBA dimer interface and increases binding affinity to ubiquitinated proteins (PubMed:31857589). Deacetylated by HDAC6 (PubMed:31857589). {ECO:0000269|PubMed:31857589}.; PTM: Palmitoylation at Cys-289 and Cys-290 by ZDHHC19 is required for efficient autophagic degradation of SQSTM1-cargo complexes by promoting affinity for ATG8 proteins and recruitment of p62 bodies to autophagosomes (PubMed:37802024). Dealmitoylated at Cys-289 and Cys-290 by LYPLA1 (PubMed:37802024). {ECO:0000269|PubMed:37802024}.; PTM: (Microbial infection) Cleaved by S.pyogenes SpeB protease; leading to its degradation (PubMed:24331465). Degradation by SpeB prevents autophagy, promoting to S.pyogenes intracellular replication (PubMed:24331465). {ECO:0000269|PubMed:24331465}.; PTM: (Microbial infection) Deubiquitinated by Epstein-Barr virus BPLF1; leading to inhibition of the recruitment of MAP1LC3A/LC3 to SQSTM1-positive structures. {ECO:0000269|PubMed:33509017}.","DOMAIN: The UBA domain binds specifically 'Lys-63'-linked polyubiquitin chains of polyubiquitinated substrates (PubMed:12857745, PubMed:15340068, PubMed:28322253, PubMed:31857589). Mediates the interaction with TRIM55 (PubMed:15802564). Both the UBA and PB1 domains are necessary and sufficient for the localization into the ubiquitin-containing inclusion bodies (PubMed:15802564). {ECO:0000269|PubMed:12857745, ECO:0000269|PubMed:15340068, ECO:0000269|PubMed:15802564, ECO:0000269|PubMed:28322253, ECO:0000269|PubMed:31857589}.; DOMAIN: The PB1 domain mediates homooligomerization and interactions with FHOD3, MAP2K5, NBR1, PRKCI, PRKCZ and WDR81 (PubMed:12813044, PubMed:12887891, PubMed:15802564, PubMed:28404643). Both the PB1 and UBA domains are necessary and sufficient for the localization into the ubiquitin-containing inclusion bodies (PubMed:15802564). {ECO:0000269|PubMed:12813044, ECO:0000269|PubMed:12887891, ECO:0000269|PubMed:15802564, ECO:0000269|PubMed:28404643}.; DOMAIN: The ZZ-type zinc finger mediates the interaction with RIPK1. {ECO:0000269|PubMed:10747026}.; DOMAIN: The LIR (LC3-interacting region) motif mediates the interaction with ATG8 family proteins. {ECO:0000269|PubMed:23908376}.","DOMAIN 3..102; /note=""PB1""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU01081""; DOMAIN 389..434; /note=""UBA""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00212""","STRAND 5..10; /evidence=""ECO:0007829|PDB:4MJS""; STRAND 13..15; /evidence=""ECO:0007829|PDB:6TGY""; STRAND 19..24; /evidence=""ECO:0007829|PDB:4MJS""; STRAND 36..39; /evidence=""ECO:0007829|PDB:6TGY""; STRAND 62..64; /evidence=""ECO:0007829|PDB:4MJS""; STRAND 66..68; /evidence=""ECO:0007829|PDB:4MJS""; STRAND 74..76; /evidence=""ECO:0007829|PDB:4MJS""; STRAND 92..101; /evidence=""ECO:0007829|PDB:4MJS""; STRAND 120..122; /evidence=""ECO:0007829|PDB:6MJ7""; STRAND 132..134; /evidence=""ECO:0007829|PDB:6KHZ""; STRAND 139..147; /evidence=""ECO:0007829|PDB:6MJ7""; STRAND 165..168; /evidence=""ECO:0007829|PDB:6MJ7""; STRAND 388..390; /evidence=""ECO:0007829|PDB:2JY7""; STRAND 409..411; /evidence=""ECO:0007829|PDB:2JY7""; STRAND 432..434; /evidence=""ECO:0007829|PDB:2JY8""","HELIX 43..54; /evidence=""ECO:0007829|PDB:4MJS""; HELIX 80..88; /evidence=""ECO:0007829|PDB:4MJS""; HELIX 152..156; /evidence=""ECO:0007829|PDB:6MJ7""; HELIX 392..402; /evidence=""ECO:0007829|PDB:1Q02""; HELIX 412..419; /evidence=""ECO:0007829|PDB:1Q02""; HELIX 424..431; /evidence=""ECO:0007829|PDB:1Q02""","TURN 129..131; /evidence=""ECO:0007829|PDB:6MJ7""; TURN 157..162; /evidence=""ECO:0007829|PDB:6MJ7""; TURN 403..405; /evidence=""ECO:0007829|PDB:2JY7""; TURN 420..422; /evidence=""ECO:0007829|PDB:1Q02""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,SQSTM1 ORCA OSIL,Sequestosome-1 (EBI3-associated protein of 60 kDa) (EBIAP) (p60) (Phosphotyrosine-independent ligand for the Lck SH2 domain of 62 kDa) (Ubiquitin-binding protein p62) (p62),Homo sapiens (Human),440.0,47687.0,MASLTVKAYLLGKEDAAREIRRFSFCCSPEPEAEAEAAAGPGPCERLLSRVAALFPALRPGGFQAHYRDEDGDLVAFSSDEELTMAMSYVKDDIFRIYIKEKKECRRDHRPPCAQEAPRNMVHPNVICDGCNGPVVGTRYKCSVCPDYDLCSVCEGKGLHRGHTKLAFPSPFGHLSEGFSHSRWLRKVKHGHFGWPGWEMGPPGNWSPRPPRAGEARPGPTAESASGPSEDPSVNFLKNVGESVAAALSPLGIEVDIDVEHGGKRSRLTPVSPESSSTEEKSSSQPSSCCSDPSKPGGNVEGATQSLAEQMRKIALESEGRPEEQMESDNCSGGDDDWTHLSSKEVDPSTGELQSLQMPESEGPSSLDPSQEGPTGLKEAALYPHLPPEADPRLIESLSQMLSMGFSDEGGWLTRLLQTKNYDIGAALDTIQYSKHPPPL,False,False,True,Q13501,"[('cd02340', 'ZZ_NBR1_like'), ('cd06402', 'PB1_p62'), ('cd14320', 'UBA domain of sequestosome-1 (SQSTM) and similar proteins'), ('G3DSA:1.10.8.10', 'DNA helicase RuvA subunit, C-terminal domain'), ('G3DSA:3.10.20.90', 'Phosphatidylinositol 3-kinase Catalytic Subunit; Chain A, domain 1'), ('G3DSA:3.30.60.90', None), ('IPR000270', 'PB1 domain'), ('IPR000433', 'Zinc finger, ZZ-type'), ('IPR009060', 'UBA-like superfamily'), ('IPR015940', 'Ubiquitin-associated domain'), ('IPR033741', 'Sequestosome-1, UBA domain'), ('IPR034866', 'Sequestosome-1, PB1 domain'), ('IPR043145', 'Zinc finger, ZZ-type superfamily'), ('IPR052260', 'Autophagy Receptor and Signaling Regulator'), ('IPR053793', 'PB1-like domain'), ('PF00564', 'PB1 domain'), ('PF00569', 'Zinc finger, ZZ type'), ('PF16577', 'UBA domain'), ('PS01357', 'Zinc finger ZZ-type signature'), ('PS50030', 'Ubiquitin-associated domain (UBA) profile')]",Q13501;,"""ENSG00000161011; Tissue enhanced (skeletal)."";",,,,,ENST00000360718.5 [Q13501-2];ENST00000389805.9 [Q13501-1];ENST00000640444.2 [Q13501-1];ENST00000643389.2 [Q13501-1];,SQSTM1,ENSG00000161011,1.0,SQSTM1,Non-canonical_RBPs,8.0,10.45,DP01111,0.141,0.511,0.38,SQSTM1
Q13584,,Q13584_HUMAN,glyoxylate cycle [GO:0006097]; isocitrate metabolic process [GO:0006102]; tricarboxylic acid cycle [GO:0006099],mitochondrion [GO:0005739],isocitrate dehydrogenase (NADP+) activity [GO:0004450]; magnesium ion binding [GO:0000287]; NAD binding [GO:0051287],,,"DOMAIN 21..408; /note=""Isopropylmalate dehydrogenase-like""; /evidence=""ECO:0000259|SMART:SM01329""",,,,"cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",unreviewed,,Isocitrate dehydrogenase [NADP] (EC 1.1.1.42),Homo sapiens (Human),419.0,46815.0,MSSLRTSGTASWSGSLGDLEHVEAHCLAQRPALAHCDDVTDLDVQLKYFDLGLPNRDQTDDQVTIDSALATQKYSVAVKCATITPDEARVEEFKLKKMWKSPNGTIRNIHGGTVFREPIICKNIPRLVPGWTKPITIGRHAHGDQYKATDFVADRAGTFKMVFTPKDGSGVKEWEVYNFPAGGVGMGMYNTDESISGFAHSCFQYAIQKKWPLYMSTKNTILKAYDGRFKDIFQEIFDKHYKTDFDKNKIWYEHRLIDDMVAQVLKSSGGFVWACKNYDGDVQSDILAQGFGSLGLMTSVLVCPDGKTIEAEAAHGTVTRHYREHQKGRPTSTNPIASIFAWTRGLEHRGKLDGNQDLIRFAQMLEKVCVETVESGAMTKDLAGCIHGLSNVKLNEHFLNTTDFLDTIKSNLDRALGRQ,True,False,False,,,,,,,,,,,,,,,,,,,,,
Q13596,ENSG00000028528,SNX1_HUMAN,"early endosome to Golgi transport [GO:0034498]; intracellular protein transport [GO:0006886]; lamellipodium morphogenesis [GO:0072673]; receptor internalization [GO:0031623]; retrograde transport, endosome to Golgi [GO:0042147]","cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; endosome membrane [GO:0010008]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; lamellipodium [GO:0030027]; lysosome [GO:0005764]; membrane [GO:0016020]; protein-containing complex [GO:0032991]; retromer complex [GO:0030904]; retromer, tubulation complex [GO:0030905]; vesicle [GO:0031982]",cadherin binding [GO:0045296]; epidermal growth factor receptor binding [GO:0005154]; identical protein binding [GO:0042802]; insulin receptor binding [GO:0005158]; leptin receptor binding [GO:1990460]; phosphatidylinositol binding [GO:0035091]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; transferrin receptor binding [GO:1990459],,"DOMAIN: The BAR domain is able to sense membrane curvature upon dimerization (PubMed:19816406). Membrane remodeling seems to implicate insertion of a N-terminal amphipathic helix (AH) in the membrane (Probable). {ECO:0000269|PubMed:19816406, ECO:0000303|PubMed:23085988}.","DOMAIN 143..272; /note=""PX""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00147""; DOMAIN 302..522; /note=""BAR""","STRAND 173..176; /evidence=""ECO:0007829|PDB:2I4K""; STRAND 202..205; /evidence=""ECO:0007829|PDB:2I4K""; STRAND 210..213; /evidence=""ECO:0007829|PDB:2I4K""; STRAND 216..221; /evidence=""ECO:0007829|PDB:2I4K""; STRAND 439..441; /evidence=""ECO:0007829|PDB:8A1G""","HELIX 187..199; /evidence=""ECO:0007829|PDB:2I4K""; HELIX 234..251; /evidence=""ECO:0007829|PDB:2I4K""; HELIX 253..256; /evidence=""ECO:0007829|PDB:2I4K""; HELIX 259..262; /evidence=""ECO:0007829|PDB:2I4K""; HELIX 307..357; /evidence=""ECO:0007829|PDB:8A1G""; HELIX 361..438; /evidence=""ECO:0007829|PDB:8A1G""; HELIX 443..519; /evidence=""ECO:0007829|PDB:8A1G""","TURN 263..266; /evidence=""ECO:0007829|PDB:2I4K""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,SNX1,Sorting nexin-1,Homo sapiens (Human),522.0,59070.0,MASGGGGCSASERLPPPFPGLEPESEGAAGGSEPEAGDSDTEGEDIFTGAAVVSKHQSPKITTSLLPINNGSKENGIHEEQDQEPQDLFADATVELSLDSTQNNQKKVLAKTLISLPPQEATNSSKPQPTYEELEEEEQEDQFDLTVGITDPEKIGDGMNAYVAYKVTTQTSLPLFRSKQFAVKRRFSDFLGLYEKLSEKHSQNGFIVPPPPEKSLIGMTKVKVGKEDSSSAEFLEKRRAALERYLQRIVNHPTMLQDPDVREFLEKEELPRAVGTQTLSGAGLLKMFNKATDAVSKMTIKMNESDIWFEEKLQEVECEEQRLRKLHAVVETLVNHRKELALNTAQFAKSLAMLGSSEDNTALSRALSQLAEVEEKIEQLHQEQANNDFFLLAELLSDYIRLLAIVRAAFDQRMKTWQRWQDAQATLQKKREAEARLLWANKPDKLQQAKDEILEWESRVTQYERDFERISTVVRKEVIRFEKEKSKDFKNHVIKYLETLLYSQQQLAKYWEAFLPEAKAIS,False,False,True,Q13596,"[('cd07281', 'The phosphoinositide binding Phox Homology domain of Sorting Nexin 1'), ('cd07665', 'The Bin/Amphiphysin/Rvs (BAR) domain of Sorting Nexin 1'), ('G3DSA:1.20.1270.60', 'Arfaptin homology (AH) domain/BAR domain'), ('G3DSA:3.30.1520.10', 'Phox-like domain'), ('IPR001683', 'Phox homology'), ('IPR005329', 'Sorting nexin, N-terminal'), ('IPR015404', 'Sorting nexin/Vps5-like, C-terminal'), ('IPR027267', 'AH/BAR domain superfamily'), ('IPR028660', 'Sorting nexin-1, BAR domain'), ('IPR034901', 'Sorting Nexin 1, PX domain'), ('IPR036871', 'PX domain superfamily'), ('PF00787', 'PX domain'), ('PF03700', 'Sorting nexin, N-terminal domain'), ('PF09325', 'Vps5 C terminal like'), ('PS50195', 'PX domain profile'), ('PTHR10555', 'SORTING NEXIN'), ('SM00312', 'PhoX homologous domain, present in p47phox and p40phox.'), ('SSF103657', 'BAR/IMD domain-like'), ('SSF64268', 'PX domain')]",,"""ENSG00000028528; Low tissue specificity."";",,,,,ENST00000261889.9 [Q13596-3];ENST00000559844.6 [Q13596-1];ENST00000561026.5 [Q13596-2];,SNX1,ENSG00000028528,0.0,,,,,,,0.261,0.215,SNX1
Q13825,ENSG00000148090,AUHM_HUMAN,fatty acid beta-oxidation [GO:0006635]; L-leucine catabolic process [GO:0006552],mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739],enoyl-CoA hydratase activity [GO:0004300]; itaconyl-CoA hydratase activity [GO:0050011]; methylglutaconyl-CoA hydratase activity [GO:0004490]; mRNA 3'-UTR binding [GO:0003730],,,,"STRAND 76..81; /evidence=""ECO:0007829|PDB:1HZD""; STRAND 89..94; /evidence=""ECO:0007829|PDB:1HZD""; STRAND 125..133; /evidence=""ECO:0007829|PDB:1HZD""; STRAND 135..138; /evidence=""ECO:0007829|PDB:1HZD""; STRAND 175..184; /evidence=""ECO:0007829|PDB:1HZD""; STRAND 194..200; /evidence=""ECO:0007829|PDB:1HZD""; STRAND 204..206; /evidence=""ECO:0007829|PDB:1HZD""; STRAND 242..244; /evidence=""ECO:0007829|PDB:1HZD""; STRAND 255..258; /evidence=""ECO:0007829|PDB:1HZD""","HELIX 84..86; /evidence=""ECO:0007829|PDB:1HZD""; HELIX 97..99; /evidence=""ECO:0007829|PDB:1HZD""; HELIX 107..120; /evidence=""ECO:0007829|PDB:1HZD""; HELIX 143..146; /evidence=""ECO:0007829|PDB:1HZD""; HELIX 151..169; /evidence=""ECO:0007829|PDB:1HZD""; HELIX 186..193; /evidence=""ECO:0007829|PDB:1HZD""; HELIX 209..212; /evidence=""ECO:0007829|PDB:1HZD""; HELIX 220..228; /evidence=""ECO:0007829|PDB:1HZD""; HELIX 230..239; /evidence=""ECO:0007829|PDB:1HZD""; HELIX 245..250; /evidence=""ECO:0007829|PDB:1HZD""; HELIX 266..276; /evidence=""ECO:0007829|PDB:1HZD""; HELIX 283..297; /evidence=""ECO:0007829|PDB:1HZD""; HELIX 301..313; /evidence=""ECO:0007829|PDB:1HZD""; HELIX 319..328; /evidence=""ECO:0007829|PDB:1HZD""","TURN 277..280; /evidence=""ECO:0007829|PDB:1HZD""; TURN 314..317; /evidence=""ECO:0007829|PDB:1HZD""; TURN 329..331; /evidence=""ECO:0007829|PDB:1HZD""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,AUH,"Methylglutaconyl-CoA hydratase, mitochondrial (3-MG-CoA hydratase) (EC 4.2.1.18) (AU-specific RNA-binding enoyl-CoA hydratase) (AU-binding protein/enoyl-CoA hydratase) (Itaconyl-CoA hydratase) (EC 4.2.1.56)",Homo sapiens (Human),339.0,35609.0,MAAAVAAAPGALGSLHAGGARLVAACSAWLCPGLRLPGSLAGRRAGPAIWAQGWVPAAGGPAPKRGYSSEMKTEDELRVRHLEEENRGIVVLGINRAYGKNSLSKNLIKMLSKAVDALKSDKKVRTIIIRSEVPGIFCAGADLKERAKMSSSEVGPFVSKIRAVINDIANLPVPTIAAIDGLALGGGLELALACDIRVAASSAKMGLVETKLAIIPGGGGTQRLPRAIGMSLAKELIFSARVLDGKEAKAVGLISHVLEQNQEGDAAYRKALDLAREFLPQGPVAMRVAKLAINQGMEVDLVTGLAIEEACYAQTIPTKDRLEGLLAFKEKRPPRYKGE,False,True,False,Q13825,"[('cd06558', 'crotonase-like'), ('G3DSA:1.10.12.10', 'Lyase 2-enoyl-coa Hydratase, Chain A, domain 2'), ('G3DSA:3.90.226.10', '2-enoyl-CoA Hydratase; Chain A, domain 1'), ('IPR001753', 'Enoyl-CoA hydratase/isomerase'), ('IPR014748', 'Enoyl-CoA hydratase, C-terminal'), ('IPR018376', 'Enoyl-CoA hydratase/isomerase, conserved site'), ('IPR029045', 'ClpP/crotonase-like domain superfamily'), ('PF00378', 'Enoyl-CoA hydratase/isomerase'), ('PS00166', 'Enoyl-CoA hydratase/isomerase signature'), ('PTHR11941', 'Enoyl-CoA hydratase/isomerase'), ('SSF52096', 'ClpP/crotonase')]",,"""ENSG00000148090; Low tissue specificity."";","CATALYTIC ACTIVITY: Reaction=(3S)-hydroxy-3-methylglutaryl-CoA = 3-methyl-(2E)-glutaconyl-CoA + H2O; Xref=Rhea:RHEA:21536, ChEBI:CHEBI:15377, ChEBI:CHEBI:43074, ChEBI:CHEBI:57346; EC=4.2.1.18; Evidence={ECO:0000269|PubMed:12434311, ECO:0000269|PubMed:16640564}; PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:21538; Evidence={ECO:0000269|PubMed:16640564, ECO:0000305|PubMed:12434311}; CATALYTIC ACTIVITY: Reaction=(3S)-citramalyl-CoA = itaconyl-CoA + H2O; Xref=Rhea:RHEA:13785, ChEBI:CHEBI:15377, ChEBI:CHEBI:57381, ChEBI:CHEBI:58668; EC=4.2.1.56; Evidence={ECO:0000303|PubMed:29056341}; PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:13787; Evidence={ECO:0000303|PubMed:29056341}; CATALYTIC ACTIVITY: Reaction=3-hydroxyisovaleryl-CoA = 3-methyl-(2E)-butenoyl-CoA + H2O; Xref=Rhea:RHEA:31079, ChEBI:CHEBI:15377, ChEBI:CHEBI:57344, ChEBI:CHEBI:62555; Evidence={ECO:0000269|PubMed:16640564}; PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:31081; Evidence={ECO:0000269|PubMed:16640564}; CATALYTIC ACTIVITY: Reaction=(S)-3-hydroxyglutaryl-CoA = (2E)-glutaconyl-CoA + H2O; Xref=Rhea:RHEA:68456, ChEBI:CHEBI:15377, ChEBI:CHEBI:57353, ChEBI:CHEBI:177916; Evidence={ECO:0000269|PubMed:16640564}; PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:68458; Evidence={ECO:0000269|PubMed:16640564};",4.2.1.18; 4.2.1.56,,"PATHWAY: Amino-acid degradation; L-leucine degradation; (S)-3-hydroxy-3-methylglutaryl-CoA from 3-isovaleryl-CoA: step 3/3. {ECO:0000305|PubMed:12434311, ECO:0000305|PubMed:16640564}.",ENST00000303617.5 [Q13825-2];ENST00000375731.9 [Q13825-1];,AUH,ENSG00000148090,0.0,AUH,Non-canonical_RBPs,1.0,,,,0.224,,AUH
Q13951,ENSG00000067955,PEBB_HUMAN,"cell maturation [GO:0048469]; definitive hemopoiesis [GO:0060216]; lymphocyte differentiation [GO:0030098]; myeloid cell differentiation [GO:0030099]; negative regulation of CD4-positive, alpha-beta T cell differentiation [GO:0043371]; negative regulation of transcription by RNA polymerase II [GO:0000122]; osteoblast differentiation [GO:0001649]; positive regulation of CD8-positive, alpha-beta T cell differentiation [GO:0043378]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein polyubiquitination [GO:0000209]; regulation of transcription by RNA polymerase II [GO:0006357]; transcription by RNA polymerase II [GO:0006366]",core-binding factor complex [GO:0016513]; membrane [GO:0016020]; nucleoplasm [GO:0005654],sequence-specific DNA binding [GO:0043565]; transcription coactivator activity [GO:0003713],,,,"STRAND 26..29; /evidence=""ECO:0007829|PDB:8J62""; STRAND 55..59; /evidence=""ECO:0007829|PDB:8J62""; STRAND 62..70; /evidence=""ECO:0007829|PDB:8J62""; STRAND 85..88; /evidence=""ECO:0007829|PDB:8J62""; STRAND 89..91; /evidence=""ECO:0007829|PDB:1H9D""; STRAND 94..103; /evidence=""ECO:0007829|PDB:8J62""; STRAND 106..115; /evidence=""ECO:0007829|PDB:8J62""; STRAND 120..127; /evidence=""ECO:0007829|PDB:8J62""","HELIX 8..14; /evidence=""ECO:0007829|PDB:1E50""; HELIX 18..23; /evidence=""ECO:0007829|PDB:8J62""; HELIX 37..49; /evidence=""ECO:0007829|PDB:8J62""; HELIX 71..73; /evidence=""ECO:0007829|PDB:8J62""; HELIX 129..134; /evidence=""ECO:0007829|PDB:1E50""; HELIX 137..148; /evidence=""ECO:0007829|PDB:8CX0""","TURN 31..34; /evidence=""ECO:0007829|PDB:8J62""; TURN 116..119; /evidence=""ECO:0007829|PDB:8J62""; TURN 152..154; /evidence=""ECO:0007829|PDB:6P59""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,CBFB,Core-binding factor subunit beta (CBF-beta) (Polyomavirus enhancer-binding protein 2 beta subunit) (PEA2-beta) (PEBP2-beta) (SL3-3 enhancer factor 1 subunit beta) (SL3/AKV core-binding factor beta subunit),Homo sapiens (Human),182.0,21508.0,MPRVVPDQRSKFENEEFFRKLSRECEIKYTGFRDRPHEERQARFQNACRDGRSEIAFVATGTNLSLQFFPASWQGEQRQTPSREYVDLEREAGKVYLKAPMILNGVCVIWKGWIDLQRLDGMGCLEFDEERAQQEDALAQQAFEEARRRTREFEDRDRSHREEMEVRVSQLLAVTGKKTTRP,False,True,False,Q13951,"[('G3DSA:2.40.250.10', 'Core binding factor, beta subunit'), ('IPR003417', 'Core-binding factor, beta subunit'), ('IPR036552', 'Core-binding factor, beta subunit superfamily'), ('PF02312', 'Core binding factor beta subunit'), ('PTHR10276', 'CORE-BINDING FACTOR, BETA SUBUNIT'), ('SSF50723', 'Core binding factor beta, CBF')]",,"""ENSG00000067955; Low tissue specificity."";",,,,,ENST00000290858.11 [Q13951-1];ENST00000412916.7 [Q13951-2];,CBFB,ENSG00000067955,0.0,,,,,,,0.104,,CBFB
Q14103,ENSG00000138668,HNRPD_HUMAN,"3'-UTR-mediated mRNA destabilization [GO:0061158]; cellular response to amino acid stimulus [GO:0071230]; cellular response to estradiol stimulus [GO:0071392]; cellular response to nitric oxide [GO:0071732]; cellular response to putrescine [GO:1904586]; cerebellum development [GO:0021549]; circadian regulation of translation [GO:0097167]; CRD-mediated mRNA stabilization [GO:0070934]; hepatocyte dedifferentiation [GO:1990828]; liver development [GO:0001889]; negative regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:1900152]; positive regulation of cytoplasmic translation [GO:2000767]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of telomere capping [GO:1904355]; positive regulation of telomere maintenance via telomerase [GO:0032212]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of translation [GO:0045727]; regulation of circadian rhythm [GO:0042752]; regulation of DNA-templated transcription [GO:0006355]; regulation of gene expression [GO:0010468]; response to calcium ion [GO:0051592]; response to electrical stimulus [GO:0051602]; response to rapamycin [GO:1901355]; response to sodium phosphate [GO:1904383]; RNA catabolic process [GO:0006401]; RNA processing [GO:0006396]",chromatin [GO:0000785]; cytosol [GO:0005829]; glutamatergic synapse [GO:0098978]; mCRD-mediated mRNA stability complex [GO:0106002]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; postsynaptic density [GO:0014069]; ribonucleoprotein complex [GO:1990904],chromatin binding [GO:0003682]; histone deacetylase binding [GO:0042826]; minor groove of adenine-thymine-rich DNA binding [GO:0003680]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; RNA binding [GO:0003723]; telomeric DNA binding [GO:0042162],"PTM: Arg-345 is dimethylated, probably to asymmetric dimethylarginine.; PTM: Methylated by PRMT1, in an insulin-dependent manner. The PRMT1-mediated methylation regulates tyrosine phosphorylation (By similarity). {ECO:0000250}.",,"DOMAIN 97..179; /note=""RRM 1""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00176""; DOMAIN 182..261; /note=""RRM 2""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00176""","STRAND 97..102; /evidence=""ECO:0007829|PDB:5IM0""; STRAND 123..130; /evidence=""ECO:0007829|PDB:5IM0""; STRAND 137..147; /evidence=""ECO:0007829|PDB:5IM0""; STRAND 160..162; /evidence=""ECO:0007829|PDB:5IM0""; STRAND 165..171; /evidence=""ECO:0007829|PDB:5IM0""; STRAND 184..187; /evidence=""ECO:0007829|PDB:1IQT""; STRAND 209..211; /evidence=""ECO:0007829|PDB:1IQT""; STRAND 220..222; /evidence=""ECO:0007829|PDB:1IQT""; STRAND 226..229; /evidence=""ECO:0007829|PDB:1IQT""; STRAND 231..233; /evidence=""ECO:0007829|PDB:1IQT""; STRAND 244..247; /evidence=""ECO:0007829|PDB:1WTB""; STRAND 250..253; /evidence=""ECO:0007829|PDB:1WTB""; STRAND 254..256; /evidence=""ECO:0007829|PDB:1IQT""; STRAND 349..351; /evidence=""ECO:0007829|PDB:2Z5N""","HELIX 110..117; /evidence=""ECO:0007829|PDB:5IM0""; HELIX 118..120; /evidence=""ECO:0007829|PDB:5IM0""; HELIX 149..155; /evidence=""ECO:0007829|PDB:5IM0""; HELIX 172..174; /evidence=""ECO:0007829|PDB:5IM0""; HELIX 195..205; /evidence=""ECO:0007829|PDB:1IQT""; HELIX 234..240; /evidence=""ECO:0007829|PDB:1IQT""","TURN 132..134; /evidence=""ECO:0007829|PDB:5IM0""; TURN 217..219; /evidence=""ECO:0007829|PDB:1X0F""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,HNRNPD AUF1 HNRPD,Heterogeneous nuclear ribonucleoprotein D0 (hnRNP D0) (AU-rich element RNA-binding protein 1),Homo sapiens (Human),355.0,38434.0,MSEEQFGGDGAAAAATAAVGGSAGEQEGAMVAATQGAAAAAGSGAGTGGGTASGGTEGGSAESEGAKIDASKNEEDEGHSNSSPRHSEAATAQREEWKMFIGGLSWDTTKKDLKDYFSKFGEVVDCTLKLDPITGRSRGFGFVLFKESESVDKVMDQKEHKLNGKVIDPKRAKAMKTKEPVKKIFVGGLSPDTPEEKIREYFGGFGEVESIELPMDNKTNKRRGFCFITFKEEEPVKKIMEKKYHNVGLSKCEIKVAMSKEQYQQQQQWGSRGGFAGRARGRGGGPSQNWNQGYSNYWNQGYGNYGYNSQGYGGYGGYDYTGYNNYYGYGDYSNQQSGYGKVSRRGGHQNSYKPY,False,False,True,Q14103,"[('cd12583', 'RNA recognition motif 2 (RRM2) found in heterogeneous nuclear ribonucleoprotein D0 (hnRNP D0) and similar proteins'), ('cd12756', 'RNA recognition motif 1 (RRM1) found in heterogeneous nuclear ribonucleoprotein D0 (hnRNP D0) and similar proteins'), ('G3DSA:3.30.70.330', None), ('IPR000504', 'RNA recognition motif domain'), ('IPR012677', 'Nucleotide-binding alpha-beta plait domain superfamily'), ('IPR012956', 'CARG-binding factor, N-terminal'), ('IPR035979', 'RNA-binding domain superfamily'), ('PF00076', 'RNA recognition motif'), ('PF08143', 'CBFNT (NUC161) domain'), ('PS50102', 'Eukaryotic RNA Recognition Motif (RRM) profile'), ('PTHR48033', 'RNA-binding and regulatory protein'), ('SM00360', 'RNA recognition motif'), ('SSF54928', 'RNA-binding domain, RBD')]",,"""ENSG00000138668; Low tissue specificity."";",,,,,ENST00000313899.12 [Q14103-1];ENST00000352301.8 [Q14103-2];ENST00000353341.8 [Q14103-3];ENST00000503822.2 [Q14103-4];ENST00000507010.6 [Q14103-1];ENST00000703971.1 [Q14103-2];,HNRNPD,ENSG00000138668,0.0,HNRNPD,Canonical_RBPs,22.0,,,0.079,0.504,0.259,HNRNPD
Q14152,ENSG00000107581,EIF3A_HUMAN,formation of cytoplasmic translation initiation complex [GO:0001732]; IRES-dependent viral translational initiation [GO:0075522]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; translation reinitiation [GO:0002188]; translational initiation [GO:0006413]; viral translational termination-reinitiation [GO:0075525],"cytoplasm [GO:0005737]; cytosol [GO:0005829]; eukaryotic 43S preinitiation complex [GO:0016282]; eukaryotic 48S preinitiation complex [GO:0033290]; eukaryotic translation initiation factor 3 complex [GO:0005852]; eukaryotic translation initiation factor 3 complex, eIF3e [GO:0071540]; eukaryotic translation initiation factor 3 complex, eIF3m [GO:0071541]; membrane [GO:0016020]; microtubule [GO:0005874]; multi-eIF complex [GO:0043614]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; postsynaptic density [GO:0014069]",mRNA binding [GO:0003729]; receptor tyrosine kinase binding [GO:0030971]; RNA binding [GO:0003723]; structural molecule activity [GO:0005198]; translation initiation factor activity [GO:0003743],"PTM: Phosphorylated. Phosphorylation is enhanced upon serum stimulation. {ECO:0000255|HAMAP-Rule:MF_03000, ECO:0000269|PubMed:17322308}.",,"DOMAIN 315..498; /note=""PCI""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU01185""","STRAND 333..336; /evidence=""ECO:0007829|PDB:6YBD""; STRAND 416..421; /evidence=""ECO:0007829|PDB:6YBD""; STRAND 476..478; /evidence=""ECO:0007829|PDB:6YBD""; STRAND 482..485; /evidence=""ECO:0007829|PDB:6YBD""; STRAND 490..494; /evidence=""ECO:0007829|PDB:6YBD""","HELIX 9..15; /evidence=""ECO:0007829|PDB:6YBD""; HELIX 24..35; /evidence=""ECO:0007829|PDB:6YBD""; HELIX 47..60; /evidence=""ECO:0007829|PDB:6YBD""; HELIX 65..76; /evidence=""ECO:0007829|PDB:6YBD""; HELIX 84..102; /evidence=""ECO:0007829|PDB:6YBD""; HELIX 106..115; /evidence=""ECO:0007829|PDB:6YBD""; HELIX 129..131; /evidence=""ECO:0007829|PDB:6YBD""; HELIX 140..143; /evidence=""ECO:0007829|PDB:6YBD""; HELIX 147..162; /evidence=""ECO:0007829|PDB:6YBD""; HELIX 171..187; /evidence=""ECO:0007829|PDB:6YBD""; HELIX 192..203; /evidence=""ECO:0007829|PDB:6YBD""; HELIX 208..210; /evidence=""ECO:0007829|PDB:6YBD""; HELIX 223..241; /evidence=""ECO:0007829|PDB:6YBD""; HELIX 248..259; /evidence=""ECO:0007829|PDB:6YBD""; HELIX 272..285; /evidence=""ECO:0007829|PDB:6YBD""; HELIX 289..306; /evidence=""ECO:0007829|PDB:6YBD""; HELIX 312..326; /evidence=""ECO:0007829|PDB:6YBD""; HELIX 339..344; /evidence=""ECO:0007829|PDB:6YBD""; HELIX 352..358; /evidence=""ECO:0007829|PDB:6YBD""; HELIX 371..375; /evidence=""ECO:0007829|PDB:6YBD""; HELIX 379..381; /evidence=""ECO:0007829|PDB:6YBD""; HELIX 390..395; /evidence=""ECO:0007829|PDB:6YBD""; HELIX 400..402; /evidence=""ECO:0007829|PDB:6YBD""; HELIX 403..415; /evidence=""ECO:0007829|PDB:6YBD""; HELIX 422..427; /evidence=""ECO:0007829|PDB:6YBD""; HELIX 429..443; /evidence=""ECO:0007829|PDB:6YBD""; HELIX 452..458; /evidence=""ECO:0007829|PDB:6YBD""; HELIX 464..475; /evidence=""ECO:0007829|PDB:6YBD""; HELIX 519..522; /evidence=""ECO:0007829|PDB:6YBD""; HELIX 526..535; /evidence=""ECO:0007829|PDB:6YBD""; HELIX 540..559; /evidence=""ECO:0007829|PDB:6YBD""; HELIX 560..563; /evidence=""ECO:0007829|PDB:6YBD""; HELIX 565..571; /evidence=""ECO:0007829|PDB:6YBD""","TURN 16..22; /evidence=""ECO:0007829|PDB:6YBD""; TURN 44..46; /evidence=""ECO:0007829|PDB:6YBD""; TURN 103..105; /evidence=""ECO:0007829|PDB:6YBD""; TURN 124..128; /evidence=""ECO:0007829|PDB:6YBD""; TURN 204..207; /evidence=""ECO:0007829|PDB:6YBD""; TURN 211..214; /evidence=""ECO:0007829|PDB:6YBD""; TURN 242..244; /evidence=""ECO:0007829|PDB:6YBD""; TURN 269..271; /evidence=""ECO:0007829|PDB:6YBD""; TURN 367..370; /evidence=""ECO:0007829|PDB:6YBD""; TURN 444..446; /evidence=""ECO:0007829|PDB:6YBD""; TURN 486..489; /evidence=""ECO:0007829|PDB:6YBD""; TURN 523..525; /evidence=""ECO:0007829|PDB:6YBD""; TURN 536..539; /evidence=""ECO:0007829|PDB:6YBD""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,EIF3A EIF3S10 KIAA0139,Eukaryotic translation initiation factor 3 subunit A (eIF3a) (Eukaryotic translation initiation factor 3 subunit 10) (eIF-3-theta) (eIF3 p167) (eIF3 p180) (eIF3 p185),Homo sapiens (Human),1382.0,166569.0,MPAYFQRPENALKRANEFLEVGKKQPALDVLYDVMKSKKHRTWQKIHEPIMLKYLELCVDLRKSHLAKEGLYQYKNICQQVNIKSLEDVVRAYLKMAEEKTEAAKEESQQMVLDIEDLDNIQTPESVLLSAVSGEDTQDRTDRLLLTPWVKFLWESYRQCLDLLRNNSRVERLYHDIAQQAFKFCLQYTRKAEFRKLCDNLRMHLSQIQRHHNQSTAINLNNPESQSMHLETRLVQLDSAISMELWQEAFKAVEDIHGLFSLSKKPPKPQLMANYYNKVSTVFWKSGNALFHASTLHRLYHLSREMRKNLTQDEMQRMSTRVLLATLSIPITPERTDIARLLDMDGIIVEKQRRLATLLGLQAPPTRIGLINDMVRFNVLQYVVPEVKDLYNWLEVEFNPLKLCERVTKVLNWVREQPEKEPELQQYVPQLQNNTILRLLQQVSQIYQSIEFSRLTSLVPFVDAFQLERAIVDAARHCDLQVRIDHTSRTLSFGSDLNYATREDAPIGPHLQSMPSEQIRNQLTAMSSVLAKALEVIKPAHILQEKEEQHQLAVTAYLKNSRKEHQRILARRQTIEERKERLESLNIQREKEELEQREAELQKVRKAEEERLRQEAKEREKERILQEHEQIKKKTVRERLEQIKKTELGAKAFKDIDIEDLEELDPDFIMAKQVEQLEKEKKELQERLKNQEKKIDYFERAKRLEEIPLIKSAYEEQRIKDMDLWEQQEEERITTMQLEREKALEHKNRMSRMLEDRDLFVMRLKAARQSVYEEKLKQFEERLAEERHNRLEERKRQRKEERRITYYREKEEEEQRRAEEQMLKEREERERAERAKREEELREYQERVKKLEEVERKKRQRELEIEERERRREEERRLGDSSLSRKDSRWGDRDSEGTWRKGPEADSEWRRGPPEKEWRRGEGRDEDRSHRRDEERPRRLGDDEDREPSLRPDDDRVPRRGMDDDRGPRRGPEEDRFSRRGADDDRPSWRNTDDDRPPRRIADEDRGNWRHADDDRPPRRGLDEDRGSWRTADEDRGPRRGMDDDRGPRRGGADDERSSWRNADDDRGPRRGLDDDRGPRRGMDDDRGPRRGMDDDRGPRRGMDDDRGPRRGLDDDRGPWRNADDDRIPRRGAEDDRGPWRNMDDDRLSRRADDDRFPRRGDDSRPGPWRPLVKPGGWREKEKAREESWGPPRESRPSEEREWDREKERDRDNQDREENDKDPERERDRERDVDREDRFRRPRDEGGWRRGPAEESSSWRDSSRRDDRDRDDRRRERDDRRDLRERRDLRDDRDRRGPPLRSEREEVSSWRRADDRKDDRVEERDPPRRVPPPALSRDRERDRDREREGEKEKASWRAEKDRESLRRTKNETDEDGWTTVRR,False,True,False,Q14152,"[('G3DSA:1.25.40.860', None), ('G3DSA:4.10.860.10', 'UVR domain'), ('IPR000717', 'Proteasome component (PCI) domain'), ('IPR027512', 'Eukaryotic translation initiation factor 3 subunit A'), ('IPR054711', 'eIF3a, PCI domain, TPR-like region'), ('MF_03000', 'Eukaryotic translation initiation factor 3 subunit A [EIF3A]'), ('PF01399', 'PCI domain'), ('PF22591', 'eIF3a, PCI domain, TPR-like region'), ('PS50250', 'PCI domain profile'), ('PTHR14005', 'EUKARYOTIC TRANSLATION INITIATION FACTOR 3, THETA SUBUNIT'), ('SM00088', 'motif in proteasome subunits, Int-6, Nip-1 and TRIP-15')]",,"""ENSG00000107581; Low tissue specificity."";",,,,,ENST00000369144.8 [Q14152-1];,EIF3A,ENSG00000107581,0.0,EIF3A,Non-canonical_RBPs,31.0,,,,0.492,0.399,EIF3A
Q14160,ENSG00000180900|ENSG00000274287,SCRIB_HUMAN,"activation of GTPase activity [GO:0090630]; apoptotic process involved in morphogenesis [GO:0060561]; astrocyte cell migration [GO:0043615]; auditory receptor cell stereocilium organization [GO:0060088]; cell migration [GO:0016477]; cell population proliferation [GO:0008283]; cell-cell adhesion [GO:0098609]; cochlear nucleus development [GO:0021747]; epithelial structure maintenance [GO:0010669]; establishment of apical/basal cell polarity [GO:0035089]; establishment of T cell polarity [GO:0001768]; establishment or maintenance of epithelial cell apical/basal polarity [GO:0045197]; mammary gland duct morphogenesis [GO:0060603]; negative regulation of activated T cell proliferation [GO:0046007]; negative regulation of mitotic cell cycle [GO:0045930]; neural tube closure [GO:0001843]; neurotransmitter receptor transport postsynaptic membrane to endosome [GO:0098968]; neurotransmitter receptor transport, endosome to postsynaptic membrane [GO:0098887]; polarized epithelial cell differentiation [GO:0030859]; positive chemotaxis [GO:0050918]; positive regulation of apoptotic process [GO:0043065]; positive regulation of receptor recycling [GO:0001921]; positive regulation of type II interferon production [GO:0032729]; post-anal tail morphogenesis [GO:0036342]; protein localization to adherens junction [GO:0071896]; receptor clustering [GO:0043113]; regulation of postsynaptic neurotransmitter receptor internalization [GO:0099149]; synaptic vesicle endocytosis [GO:0048488]; synaptic vesicle targeting [GO:0016080]; wound healing [GO:0042060]",adherens junction [GO:0005912]; basolateral plasma membrane [GO:0016323]; cell junction [GO:0030054]; cell-cell contact zone [GO:0044291]; cell-cell junction [GO:0005911]; cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extrinsic component of postsynaptic density membrane [GO:0099147]; glutamatergic synapse [GO:0098978]; immunological synapse [GO:0001772]; lamellipodium [GO:0030027]; myelin sheath abaxonal region [GO:0035748]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; Scrib-APC-beta-catenin complex [GO:0034750],cadherin binding [GO:0045296]; protein kinase binding [GO:0019901]; signaling adaptor activity [GO:0035591],"PTM: Ubiquitinated; targeted for UBE3A-dependent multiubiquitination in the presence of high-risk HPV E6 proteins and degraded. {ECO:0000269|PubMed:11027293}.; PTM: Palmitoylated (PubMed:27380321). Could be depalmitoylated by LYPLA1 and/or LYPLA2 (PubMed:27380321). Palmitoylation of SCRIB by ZDHHC7 is required for its localization to cell-cell junctions, function in the establishement of epithelial cell polarity and the regulation of downstream signaling pathways important for epithelial cell differentiation (PubMed:27380321). {ECO:0000269|PubMed:27380321}.",,"DOMAIN 728..815; /note=""PDZ 1""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00143""; DOMAIN 862..950; /note=""PDZ 2""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00143""; DOMAIN 1004..1093; /note=""PDZ 3""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00143""; DOMAIN 1100..1194; /note=""PDZ 4""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00143""","STRAND 710..712; /evidence=""ECO:0007829|PDB:8B82""; STRAND 715..717; /evidence=""ECO:0007829|PDB:8B82""; STRAND 725..732; /evidence=""ECO:0007829|PDB:6MYE""; STRAND 734..736; /evidence=""ECO:0007829|PDB:7QS9""; STRAND 740..744; /evidence=""ECO:0007829|PDB:6MYE""; STRAND 751..754; /evidence=""ECO:0007829|PDB:5VWC""; STRAND 757..763; /evidence=""ECO:0007829|PDB:6MYE""; STRAND 765..767; /evidence=""ECO:0007829|PDB:7QTP""; STRAND 779..783; /evidence=""ECO:0007829|PDB:6MYE""; STRAND 805..814; /evidence=""ECO:0007829|PDB:6MYE""; STRAND 815..818; /evidence=""ECO:0007829|PDB:6ESP""; STRAND 860..866; /evidence=""ECO:0007829|PDB:7QRT""; STRAND 874..878; /evidence=""ECO:0007829|PDB:7QRT""; STRAND 892..898; /evidence=""ECO:0007829|PDB:7QRT""; STRAND 914..918; /evidence=""ECO:0007829|PDB:7QRT""; STRAND 940..947; /evidence=""ECO:0007829|PDB:7QRT""; STRAND 997..1000; /evidence=""ECO:0007829|PDB:4WYU""; STRAND 1002..1008; /evidence=""ECO:0007829|PDB:5VWI""; STRAND 1010..1012; /evidence=""ECO:0007829|PDB:4WYU""; STRAND 1016..1020; /evidence=""ECO:0007829|PDB:5VWI""; STRAND 1022..1024; /evidence=""ECO:0007829|PDB:4WYT""; STRAND 1031..1033; /evidence=""ECO:0007829|PDB:4WYU""; STRAND 1036..1041; /evidence=""ECO:0007829|PDB:5VWI""; STRAND 1043..1045; /evidence=""ECO:0007829|PDB:8B8O""; STRAND 1057..1061; /evidence=""ECO:0007829|PDB:5VWI""; STRAND 1080..1090; /evidence=""ECO:0007829|PDB:5VWI""; STRAND 1099..1104; /evidence=""ECO:0007829|PDB:6EEY""; STRAND 1113..1117; /evidence=""ECO:0007829|PDB:6EEY""; STRAND 1119..1122; /evidence=""ECO:0007829|PDB:1UJU""; STRAND 1126..1128; /evidence=""ECO:0007829|PDB:4WYT""; STRAND 1134..1139; /evidence=""ECO:0007829|PDB:6EEY""; STRAND 1141..1143; /evidence=""ECO:0007829|PDB:4WYT""; STRAND 1156..1160; /evidence=""ECO:0007829|PDB:6EEY""; STRAND 1181..1189; /evidence=""ECO:0007829|PDB:6EEY""","HELIX 768..772; /evidence=""ECO:0007829|PDB:6MYE""; HELIX 793..801; /evidence=""ECO:0007829|PDB:6MYE""; HELIX 820..823; /evidence=""ECO:0007829|PDB:6ESP""; HELIX 902..906; /evidence=""ECO:0007829|PDB:7QRT""; HELIX 928..936; /evidence=""ECO:0007829|PDB:7QRT""; HELIX 1046..1049; /evidence=""ECO:0007829|PDB:5VWI""; HELIX 1071..1078; /evidence=""ECO:0007829|PDB:5VWI""; HELIX 1129..1131; /evidence=""ECO:0007829|PDB:6EEY""; HELIX 1144..1148; /evidence=""ECO:0007829|PDB:6EEY""; HELIX 1170..1177; /evidence=""ECO:0007829|PDB:6EEY""","TURN 1027..1030; /evidence=""ECO:0007829|PDB:4WYU""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,SCRIB CRIB1 KIAA0147 LAP4 SCRB1 VARTUL,Protein scribble homolog (Scribble) (hScrib) (Protein LAP4),Homo sapiens (Human),1655.0,177724.0,MLKCIPLWRCNRHVESVDKRHCSLQAVPEEIYRYSRSLEELLLDANQLRELPKPFFRLLNLRKLGLSDNEIQRLPPEVANFMQLVELDVSRNDIPEIPESIKFCKALEIADFSGNPLSRLPDGFTQLRSLAHLALNDVSLQALPGDVGNLANLVTLELRENLLKSLPASLSFLVKLEQLDLGGNDLEVLPDTLGALPNLRELWLDRNQLSALPPELGNLRRLVCLDVSENRLEELPAELGGLVLLTDLLLSQNLLRRLPDGIGQLKQLSILKVDQNRLCEVTEAIGDCENLSELILTENLLMALPRSLGKLTKLTNLNVDRNHLEALPPEIGGCVALSVLSLRDNRLAVLPPELAHTTELHVLDVAGNRLQSLPFALTHLNLKALWLAENQAQPMLRFQTEDDARTGEKVLTCYLLPQQPPPSLEDAGQQGSLSETWSDAPPSRVSVIQFLEAPIGDEDAEEAAAEKRGLQRRATPHPSELKVMKRSIEGRRSEACPCQPDSGSPLPAEEEKRLSAESGLSEDSRPSASTVSEAEPEGPSAEAQGGSQQEATTAGGEEDAEEDYQEPTVHFAEDALLPGDDREIEEGQPEAPWTLPGGRQRLIRKDTPHYKKHFKISKLPQPEAVVALLQGMQPDGEGPVAPGGWHNGPHAPWAPRAQKEEEEEEEGSPQEEEEEEEEENRAEEEEASTEEEDKEGAVVSAPSVKGVSFDQANNLLIEPARIEEEELTLTILRQTGGLGISIAGGKGSTPYKGDDEGIFISRVSEEGPAARAGVRVGDKLLEVNGVALQGAEHHEAVEALRGAGTAVQMRVWRERMVEPENAVTITPLRPEDDYSPRERRGGGLRLPLLPPESPGPLRQRHVACLARSERGLGFSIAGGKGSTPYRAGDAGIFVSRIAEGGAAHRAGTLQVGDRVLSINGVDVTEARHDHAVSLLTAASPTIALLLEREAGGPLPPSPLPHSSPPTAAVATTSITTATPGVPGLPSLAPSLLAAALEGPYPVEEIRLPRAGGPLGLSIVGGSDHSSHPFGVQEPGVFISKVLPRGLAARSGLRVGDRILAVNGQDVRDATHQEAVSALLRPCLELSLLVRRDPAPPGLRELCIQKAPGERLGISIRGGARGHAGNPRDPTDEGIFISKVSPTGAAGRDGRLRVGLRLLEVNQQSLLGLTHGEAVQLLRSVGDTLTVLVCDGFEASTDAALEVSPGVIANPFAAGIGHRNSLESISSIDRELSPEGPGKEKELPGQTLHWGPEATEAAGRGLQPLKLDYRALAAVPSAGSVQRVPSGAAGGKMAESPCSPSGQQPPSPPSPDELPANVKQAYRAFAAVPTSHPPEDAPAQPPTPGPAASPEQLSFRERQKYFELEVRVPQAEGPPKRVSLVGADDLRKMQEEEARKLQQKRAQMLREAAEAGAEARLALDGETLGEEEQEDEQPPWASPSPTSRQSPASPPPLGGGAPVRTAKAERRHQERLRVQSPEPPAPERALSPAELRALEAEKRALWRAARMKSLEQDALRAQMVLSRSQEGRGTRGPLERLAEAPSPAPTPSPTPVEDLGPQTSTSPGRLPLSGKKFDYRAFAALPSSRPVYDIQSPDFAEELRSLEPSPSPGPQEEDGEVALVLLGRPSPGAVGPEDVALCSSRRPVRPGRRGLGPVPS,False,False,True,Q14160,"[('cd00992', 'PDZ_signaling'), ('G3DSA:2.30.42.10', None), ('G3DSA:3.80.10.10', 'Ribonuclease Inhibitor'), ('IPR001478', 'PDZ domain'), ('IPR001611', 'Leucine-rich repeat'), ('IPR003591', 'Leucine-rich repeat, typical subtype'), ('IPR032675', 'Leucine-rich repeat domain superfamily'), ('IPR036034', 'PDZ superfamily'), ('IPR050614', 'Synaptic Scaffolding LAP/MAGUK Families'), ('IPR055414', 'Disease resistance R13L4/SHOC-2-like, LRR domain'), ('PF00595', 'PDZ domain'), ('PF13855', 'Leucine rich repeat'), ('PF23598', 'Leucine-rich repeat region'), ('PS50106', 'PDZ domain profile'), ('PS51450', 'Leucine-rich repeat profile'), ('PTHR23119', 'Synaptic Scaffolding LAP/MAGUK Families'), ('SM00228', 'Domain present in PSD-95, Dlg, and ZO-1/2.'), ('SM00364', 'Leucine-rich repeats, bacterial type'), ('SM00369', 'Leucine-rich repeats, typical (most populated) subfamily'), ('SSF50156', 'PDZ domain-like')]",Q14160;,"""ENSG00000180900; Low tissue specificity."";",,,,,ENST00000320476.7 [Q14160-1];ENST00000356994.7 [Q14160-3];ENST00000377533.7 [Q14160-2];ENST00000611528.2 [Q14160-2];ENST00000612204.4 [Q14160-3];ENST00000622455.4 [Q14160-1];,SCRIB,ENSG00000180900,1.0,,,,,,,0.506,0.379,SCRIB
Q14247,ENSG00000085733|ENSG00000288401,SRC8_HUMAN,"actin cytoskeleton organization [GO:0030036]; cell motility [GO:0048870]; dendritic spine maintenance [GO:0097062]; extrinsic apoptotic signaling pathway [GO:0097191]; focal adhesion assembly [GO:0048041]; intracellular protein transport [GO:0006886]; lamellipodium organization [GO:0097581]; negative regulation of extrinsic apoptotic signaling pathway [GO:2001237]; neuron projection morphogenesis [GO:0048812]; positive regulation of actin filament polymerization [GO:0030838]; positive regulation of smooth muscle contraction [GO:0045987]; receptor-mediated endocytosis [GO:0006898]; regulation of axon extension [GO:0030516]; regulation of mitophagy [GO:1901524]; signal transduction [GO:0007165]; substrate-dependent cell migration, cell extension [GO:0006930]",cell cortex [GO:0005938]; clathrin-coated pit [GO:0005905]; cortical cytoskeleton [GO:0030863]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; endocytic vesicle [GO:0030139]; endoplasmic reticulum [GO:0005783]; focal adhesion [GO:0005925]; Golgi apparatus [GO:0005794]; intracellular membrane-bounded organelle [GO:0043231]; lamellipodium [GO:0030027]; mitotic spindle midzone [GO:1990023]; plasma membrane [GO:0005886]; podosome [GO:0002102]; ruffle [GO:0001726]; voltage-gated potassium channel complex [GO:0008076],cadherin binding [GO:0045296]; profilin binding [GO:0005522],"PTM: Phosphorylated by PKN2 at both serine and threonine residues in a GTP-bound Rac1-dependent manner in hyaluronan-induced astrocytes and hence down-regulated CTTN ability to associates with filamentous actin (By similarity). Phosphorylated on tyrosine residues in response to CHRM1 activation (By similarity). Phosphorylated by PTK2/FAK1 in response to cell adhesion (By similarity). Phosphorylated by FER. Tyrosine phosphorylation in transformed cells may contribute to cellular growth regulation and transformation. Phosphorylated in response to FGR activation. Phosphorylation by SRC promotes MYLK binding. {ECO:0000250, ECO:0000250|UniProtKB:Q66HL2, ECO:0000269|PubMed:12408982, ECO:0000269|PubMed:15561106, ECO:0000269|PubMed:9722593}.; PTM: Acetylated. {ECO:0000269|PubMed:24574519}.",DOMAIN: The SH3 motif may mediate binding to the cytoskeleton. {ECO:0000305}.,"DOMAIN 492..550; /note=""SH3""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00192""","STRAND 497..499; /evidence=""ECO:0007829|PDB:2D1X""; STRAND 506..510; /evidence=""ECO:0007829|PDB:1X69""; STRAND 518..523; /evidence=""ECO:0007829|PDB:2D1X""; STRAND 526..534; /evidence=""ECO:0007829|PDB:2D1X""; STRAND 537..542; /evidence=""ECO:0007829|PDB:2D1X""; STRAND 546..548; /evidence=""ECO:0007829|PDB:2D1X""","HELIX 543..545; /evidence=""ECO:0007829|PDB:2D1X""",,"cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,CTTN EMS1,Src substrate cortactin (Amplaxin) (Oncogene EMS1),Homo sapiens (Human),550.0,61586.0,MWKASAGHAVSIAQDDAGADDWETDPDFVNDVSEKEQRWGAKTVQGSGHQEHINIHKLRENVFQEHQTLKEKELETGPKASHGYGGKFGVEQDRMDKSAVGHEYQSKLSKHCSQVDSVRGFGGKFGVQMDRVDQSAVGFEYQGKTEKHASQKDYSSGFGGKYGVQADRVDKSAVGFDYQGKTEKHESQRDYSKGFGGKYGIDKDKVDKSAVGFEYQGKTEKHESQKDYVKGFGGKFGVQTDRQDKCALGWDHQEKLQLHESQKDYKTGFGGKFGVQSERQDSAAVGFDYKEKLAKHESQQDYSKGFGGKYGVQKDRMDKNASTFEDVTQVSSAYQKTVPVEAVTSKTSNIRANFENLAKEKEQEDRRKAEAERAQRMAKERQEQEEARRKLEEQARAKTQTPPVSPAPQPTEERLPSSPVYEDAASFKAELSYRGPVSGTEPEPVYSMEAADYREASSQQGLAYATEAVYESAEAPGHYPAEDSTYDEYENDLGITAVALYDYQAAGDDEISFDPDDIITNIEMIDDGWWRGVCKGRYGLFPANYVELRQ,False,False,True,Q14247,"[('cd11959', 'Src homology 3 domain of Cortactin'), ('G3DSA:2.30.30.40', 'SH3 Domains'), ('IPR001452', 'SH3 domain'), ('IPR003134', 'Hs1/Cortactin'), ('IPR035716', 'Cortactin, SH3 domain'), ('IPR036028', 'SH3-like domain superfamily'), ('PF02218', 'Repeat in HS1/Cortactin'), ('PF14604', 'Variant SH3 domain'), ('PR00452', 'SH3DOMAIN'), ('PR00499', 'P67PHOX'), ('PS50002', 'Src homology 3 (SH3) domain profile'), ('PS51090', 'Cortactin repeat profile'), ('PTHR10829', 'Actin-Binding Protein 1'), ('SM00326', 'Src homology 3 domains'), ('SSF50044', 'SH3-domain')]",,"""ENSG00000085733; Low tissue specificity."";",,,,,ENST00000301843.13 [Q14247-1];ENST00000346329.7 [Q14247-3];ENST00000376561.7 [Q14247-2];ENST00000671805.1 [Q14247-1];ENST00000671849.1 [Q14247-2];ENST00000672198.1 [Q14247-3];,CTTN,ENSG00000085733,1.0,CTTN,Non-canonical_RBPs,18.0,,,,0.898,0.187,CTTN
Q14457,ENSG00000126581,BECN1_HUMAN,amyloid-beta metabolic process [GO:0050435]; apoptotic process [GO:0006915]; autophagosome assembly [GO:0000045]; autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; cell division [GO:0051301]; cellular defense response [GO:0006968]; cellular response to aluminum ion [GO:0071275]; cellular response to amino acid starvation [GO:0034198]; cellular response to copper ion [GO:0071280]; cellular response to epidermal growth factor stimulus [GO:0071364]; cellular response to glucose starvation [GO:0042149]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to nitrogen starvation [GO:0006995]; cellular response to oxygen-glucose deprivation [GO:0090650]; cytoplasmic pattern recognition receptor signaling pathway [GO:0002753]; defense response to virus [GO:0051607]; early endosome to late endosome transport [GO:0045022]; engulfment of apoptotic cell [GO:0043652]; JNK cascade [GO:0007254]; late endosome to vacuole transport [GO:0045324]; lysosome organization [GO:0007040]; macroautophagy [GO:0016236]; mitophagy [GO:0000423]; mitotic metaphase chromosome alignment [GO:0007080]; negative regulation of apoptotic process [GO:0043066]; negative regulation of autophagosome assembly [GO:1902902]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of lysosome organization [GO:1905672]; negative regulation of programmed cell death [GO:0043069]; negative regulation of reactive oxygen species metabolic process [GO:2000378]; neuron development [GO:0048666]; p38MAPK cascade [GO:0038066]; phosphatidylinositol-3-phosphate biosynthetic process [GO:0036092]; positive regulation of attachment of mitotic spindle microtubules to kinetochore [GO:1902425]; positive regulation of autophagosome assembly [GO:2000786]; positive regulation of autophagy [GO:0010508]; positive regulation of cardiac muscle hypertrophy [GO:0010613]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; positive regulation of stress granule assembly [GO:0062029]; protein targeting to lysosome [GO:0006622]; protein-containing complex assembly [GO:0065003]; receptor catabolic process [GO:0032801]; regulation of autophagy [GO:0010506]; regulation of cytokinesis [GO:0032465]; regulation of macroautophagy [GO:0016241]; response to hypoxia [GO:0001666]; response to iron(II) ion [GO:0010040]; response to lead ion [GO:0010288]; response to mitochondrial depolarisation [GO:0098780]; response to vitamin E [GO:0033197]; response to xenobiotic stimulus [GO:0009410]; SMAD protein signal transduction [GO:0060395]; suppression by virus of host autophagy [GO:0039521],"autophagosome [GO:0005776]; cytoplasm [GO:0005737]; cytoplasmic side of mitochondrial outer membrane [GO:0032473]; cytosol [GO:0005829]; dendrite [GO:0030425]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome [GO:0005768]; endosome membrane [GO:0010008]; nuclear body [GO:0016604]; phagocytic vesicle [GO:0045335]; phagophore assembly site [GO:0000407]; phosphatidylinositol 3-kinase complex, class III [GO:0035032]; phosphatidylinositol 3-kinase complex, class III, type I [GO:0034271]; phosphatidylinositol 3-kinase complex, class III, type II [GO:0034272]; trans-Golgi network [GO:0005802]",GTPase binding [GO:0051020]; identical protein binding [GO:0042802]; molecular adaptor activity [GO:0060090]; phosphatidylinositol 3-kinase binding [GO:0043548]; protein kinase binding [GO:0019901]; protein-macromolecule adaptor activity [GO:0030674]; ubiquitin protein ligase binding [GO:0031625],"PTM: Phosphorylation at Thr-119 by DAPK1 reduces its interaction with BCL2 and BCL2L1 and promotes induction of autophagy (PubMed:19180116). In response to autophagic stimuli, phosphorylated at serine residues by AMPK in an ATG14-dependent manner, and this phosphorylation is critical for maximally efficient autophagy (PubMed:23878393, PubMed:25891078). {ECO:0000269|PubMed:19180116, ECO:0000269|PubMed:23878393, ECO:0000269|PubMed:25891078}.; PTM: Polyubiquitinated by NEDD4, both with 'Lys-11'- and 'Lys-63'-linkages (PubMed:21936852). 'Lys-11'-linked polyubiquitination leads to degradation and is enhanced when the stabilizing interaction partner VPS34 is depleted (PubMed:21936852). Deubiquitinated by USP10 and USP13, leading to stabilize the PIK3C3/VPS34-containing complexes (PubMed:21962518). Polyubiquitinated at Lys-402 with 'Lys-48'-linkages (PubMed:28445460). 'Lys-48'-linked polyubiquitination of Lys-402 leads to degradation (PubMed:28445460). Deubiquitinated by ATXN3, leading to stabilization (PubMed:28445460). Ubiquitinated at Lys-437 via 'Lys-63'-linkage by the DCX(AMBRA1) complex, thereby increasing the association between BECN1 and PIK3C3 to promote PIK3C3 activity (PubMed:23974797). 'Lys-48'-linked ubiquitination by RNF216 leads to proteasomal degradation and autophagy inhibition (PubMed:25484083). {ECO:0000269|PubMed:21936852, ECO:0000269|PubMed:21962518, ECO:0000269|PubMed:23974797, ECO:0000269|PubMed:25484083, ECO:0000269|PubMed:28445460}.; PTM: Proteolytically processed by caspases including CASP8 and CASP3; the C-terminal fragments lack autophagy-inducing capacity and are proposed to induce apoptosis. Thus the cleavage is proposed to be an determinant to switch from autophagy to apoptosis pathways affecting cellular homeostasis including viral infections and survival of tumor cells. {ECO:0000305|PubMed:19713971, ECO:0000305|PubMed:21364619}.","DOMAIN: The coiled coil domain can form antiparallel homodimers and mediates dimerization with the coiled coil domains of ATG14 or UVRAG involved in the formation of PI3K complexes. {ECO:0000250|UniProtKB:Q91XJ1}.; DOMAIN: The C-terminal evolutionary conserved domain (ECD) contains poly-Gln-binding domains such as the ATXN3 poly-Gln motif, consistent with structural docking models revealing two highly scored poly-Gln-binding pockets in the ECD (PubMed:28445460). As some binding is observed with BECN1 lacking the ECD, other domains of BECN1 may also interact with ATXN3 (PubMed:28445460). {ECO:0000269|PubMed:28445460}.",,"STRAND 276..279; /evidence=""ECO:0007829|PDB:4DDP""; STRAND 282..285; /evidence=""ECO:0007829|PDB:4DDP""; STRAND 326..331; /evidence=""ECO:0007829|PDB:4DDP""; STRAND 338..343; /evidence=""ECO:0007829|PDB:4DDP""; STRAND 349..351; /evidence=""ECO:0007829|PDB:4DDP""; STRAND 402..404; /evidence=""ECO:0007829|PDB:4DDP""; STRAND 412..415; /evidence=""ECO:0007829|PDB:4DDP""","HELIX 110..127; /evidence=""ECO:0007829|PDB:5VAU""; HELIX 160..169; /evidence=""ECO:0007829|PDB:5EFM""; HELIX 176..265; /evidence=""ECO:0007829|PDB:5HHE""; HELIX 300..321; /evidence=""ECO:0007829|PDB:4DDP""; HELIX 334..336; /evidence=""ECO:0007829|PDB:4DDP""; HELIX 358..360; /evidence=""ECO:0007829|PDB:4DDP""; HELIX 364..384; /evidence=""ECO:0007829|PDB:4DDP""; HELIX 422..446; /evidence=""ECO:0007829|PDB:4DDP""","TURN 398..401; /evidence=""ECO:0007829|PDB:4DDP""; TURN 406..409; /evidence=""ECO:0007829|PDB:4DDP""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,BECN1 GT197,Beclin-1 (Coiled-coil myosin-like BCL2-interacting protein) (Protein GT197) [Cleaved into: Beclin-1-C 35 kDa; Beclin-1-C 37 kDa],Homo sapiens (Human),450.0,51896.0,MEGSKTSNNSTMQVSFVCQRCSQPLKLDTSFKILDRVTIQELTAPLLTTAQAKPGETQEEETNSGEEPFIETPRQDGVSRRFIPPARMMSTESANSFTLIGEASDGGTMENLSRRLKVTGDLFDIMSGQTDVDHPLCEECTDTLLDQLDTQLNVTENECQNYKRCLEILEQMNEDDSEQLQMELKELALEEERLIQELEDVEKNRKIVAENLEKVQAEAERLDQEEAQYQREYSEFKRQQLELDDELKSVENQMRYAQTQLDKLKKTNVFNATFHIWHSGQFGTINNFRLGRLPSVPVEWNEINAAWGQTVLLLHALANKMGLKFQRYRLVPYGNHSYLESLTDKSKELPLYCSGGLRFFWDNKFDHAMVAFLDCVQQFKEEVEKGETRFCLPYRMDVEKGKIEDTGGSGGSYSIKTQFNSEEQWTKALKFMLTNLKWGLAWVSSQFYNK,False,False,True,Q14457,"[('G3DSA:1.10.418.40', 'Autophagy protein 6/Beclin 1'), ('G3DSA:6.10.250.3110', None), ('IPR007243', 'Atg6/Beclin'), ('IPR029318', 'Beclin-1, BH3 domain'), ('IPR038274', 'Atg6/Beclin C-terminal domain superfamily'), ('IPR040455', 'Atg6, BARA domain'), ('IPR041691', 'Atg6/beclin, coiled-coil domain'), ('PF04111', 'Apg6 BARA domain'), ('PF15285', 'Beclin-1 BH3 domain, Bcl-2-interacting'), ('PF17675', 'Apg6 coiled-coil region'), ('PTHR12768', 'BECLIN 1')]",Q14457;,"""ENSG00000126581; Low tissue specificity."";",,,,,ENST00000361523.8;ENST00000590099.6;,BECN1,ENSG00000126581,0.0,,,,34.67,DP01149,0.347,0.262,0.056,BECN1
Q15024,ENSG00000075914,EXOS7_HUMAN,"exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) [GO:0000467]; nuclear mRNA surveillance [GO:0071028]; nuclear polyadenylation-dependent rRNA catabolic process [GO:0071035]; nuclear-transcribed mRNA catabolic process [GO:0000956]; nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay [GO:0000288]; RNA catabolic process [GO:0006401]; RNA processing [GO:0006396]; rRNA processing [GO:0006364]; TRAMP-dependent tRNA surveillance pathway [GO:0071038]; U1 snRNA 3'-end processing [GO:0034473]; U4 snRNA 3'-end processing [GO:0034475]; U5 snRNA 3'-end processing [GO:0034476]",cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; exosome (RNase complex) [GO:0000178]; nuclear exosome (RNase complex) [GO:0000176]; nucleolar exosome (RNase complex) [GO:0101019]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],3'-5'-RNA exonuclease activity [GO:0000175]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; RNA binding [GO:0003723],,,,"STRAND 24..26; /evidence=""ECO:0007829|PDB:2NN6""; STRAND 36..39; /evidence=""ECO:0007829|PDB:2NN6""; STRAND 45..53; /evidence=""ECO:0007829|PDB:2NN6""; STRAND 56..61; /evidence=""ECO:0007829|PDB:2NN6""; STRAND 71..73; /evidence=""ECO:0007829|PDB:2NN6""; STRAND 79..82; /evidence=""ECO:0007829|PDB:2NN6""; STRAND 116..119; /evidence=""ECO:0007829|PDB:6D6Q""; STRAND 121..124; /evidence=""ECO:0007829|PDB:2NN6""; STRAND 125..127; /evidence=""ECO:0007829|PDB:6D6Q""; STRAND 135..141; /evidence=""ECO:0007829|PDB:2NN6""; STRAND 167..171; /evidence=""ECO:0007829|PDB:2NN6""; STRAND 180..186; /evidence=""ECO:0007829|PDB:2NN6""; STRAND 188..190; /evidence=""ECO:0007829|PDB:6D6Q""; STRAND 201..213; /evidence=""ECO:0007829|PDB:2NN6""; STRAND 223..228; /evidence=""ECO:0007829|PDB:2NN6""; STRAND 232..234; /evidence=""ECO:0007829|PDB:2NN6""; STRAND 238..245; /evidence=""ECO:0007829|PDB:2NN6""","HELIX 8..19; /evidence=""ECO:0007829|PDB:2NN6""; HELIX 99..115; /evidence=""ECO:0007829|PDB:2NN6""; HELIX 148..158; /evidence=""ECO:0007829|PDB:2NN6""; HELIX 216..219; /evidence=""ECO:0007829|PDB:2NN6""; HELIX 249..278; /evidence=""ECO:0007829|PDB:2NN6""; HELIX 282..284; /evidence=""ECO:0007829|PDB:6D6Q""","TURN 87..89; /evidence=""ECO:0007829|PDB:2NN6""; TURN 95..97; /evidence=""ECO:0007829|PDB:6D6Q""; TURN 128..130; /evidence=""ECO:0007829|PDB:2NN6""; TURN 159..162; /evidence=""ECO:0007829|PDB:2NN6""; TURN 174..176; /evidence=""ECO:0007829|PDB:6D6Q""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,EXOSC7 KIAA0116 RRP42,Exosome complex component RRP42 (Exosome component 7) (Ribosomal RNA-processing protein 42) (p8),Homo sapiens (Human),291.0,31821.0,MASVTLSEAEKVYIVHGVQEDLRVDGRGCEDYRCVEVETDVVSNTSGSARVKLGHTDILVGVKAEMGTPKLEKPNEGYLEFFVDCSASATPEFEGRGGDDLGTEIANTLYRIFNNKSSVDLKTLCISPREHCWVLYVDVLLLECGGNLFDAISIAVKAALFNTRIPRVRVLEDEEGSKDIELSDDPYDCIRLSVENVPCIVTLCKIGYRHVVDATLQEEACSLASLLVSVTSKGVVTCMRKVGKGSLDPESIFEMMETGKRVGKVLHASLQSVVHKEESLGPKRQKVGFLG,False,False,True,Q15024,"[('cd11367', 'RRP42 subunit of eukaryotic exosome'), ('G3DSA:3.30.230.70', 'GHMP Kinase, N-terminal domain'), ('IPR001247', 'Exoribonuclease, phosphorolytic domain 1'), ('IPR015847', 'Exoribonuclease, phosphorolytic domain 2'), ('IPR020568', 'Ribosomal protein uS5 domain 2-type superfamily'), ('IPR027408', 'PNPase/RNase PH domain superfamily'), ('IPR036345', 'Exoribonuclease, PH domain 2 superfamily'), ('IPR050590', 'Exosome complex component Rrp42 subfamily'), ('PF01138', ""3' exoribonuclease family, domain 1""), ('PF03725', ""3' exoribonuclease family, domain 2""), ('PTHR11097', 'Exosome complex component Rrp42 subfamily'), ('SSF54211', 'Ribosomal protein S5 domain 2-like'), ('SSF55666', 'Ribonuclease PH domain 2-like')]",,"""ENSG00000075914; Low tissue specificity."";",,,,,ENST00000265564.8;,EXOSC7,ENSG00000075914,0.0,EXOSC7,Canonical_RBPs,1.0,,,,0.041,,EXOSC7
Q15038,ENSG00000183283,DAZP2_HUMAN,positive regulation of RNA polymerase II regulatory region sequence-specific DNA binding [GO:1905636]; protein destabilization [GO:0031648]; stress granule assembly [GO:0034063],cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; nuclear body [GO:0016604]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; protein-containing complex [GO:0032991],DNA-binding transcription factor binding [GO:0140297]; identical protein binding [GO:0042802]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; p53 binding [GO:0002039]; protein serine/threonine kinase activator activity [GO:0043539]; protein serine/threonine kinase binding [GO:0120283]; receptor tyrosine kinase binding [GO:0030971]; ubiquitin protein ligase binding [GO:0031625]; WW domain binding [GO:0050699],"PTM: Ubiquitinated (PubMed:11342538, PubMed:21274613, PubMed:22070932). Ubiquitinated by SMURF2, leading to proteasomal degradation (PubMed:22070932). Ubiquitinated by NEDD4, leading to proteasomal degradation (PubMed:11342538). {ECO:0000269|PubMed:11342538, ECO:0000269|PubMed:21274613, ECO:0000269|PubMed:22070932}.; PTM: Following DNA damage, phosphorylated by HIPK2 which promotes DAZAP2 localization to the nucleus, reduces interaction of DAZAP2 with HIPK2 and SIAH1, and prevents DAZAP2-dependent ubiquitination of HIPK2 by E3 ubiquitin-protein ligase SIAH1 and subsequent HIPK2 proteasomal degradation. {ECO:0000269|PubMed:33591310}.",,,,,,"cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,DAZAP2 KIAA0058 PRTB,DAZ-associated protein 2 (Deleted in azoospermia-associated protein 2) (Proline-rich transcript in brain protein),Homo sapiens (Human),168.0,17319.0,MNSKGQYPTQPTYPVQPPGNPVYPQTLHLPQAPPYTDAPPAYSELYRPSFVHPGAATVPTMSAAFPGASLYLPMAQSVAVGPLGSTIPMAYYPVGPIYPPGSTVLVEGGYDAGARFGAGATAGNIPPPPPGCPPNAAQLAVMQGANVLVTQRKGNFFMGGSDGGYTIW,False,False,True,Q15038,"[('IPR022730', 'DAZ associated protein 2'), ('PF11029', 'DAZ associated protein 2 (DAZAP2)'), ('PTHR31638', 'DAZ-ASSOCIATED PROTEIN 2')]",,"""ENSG00000183283; Low tissue specificity."";",,,,,ENST00000412716.8 [Q15038-1];ENST00000425012.6 [Q15038-2];ENST00000439799.6 [Q15038-4];ENST00000449723.7 [Q15038-6];ENST00000549555.5 [Q15038-5];ENST00000549732.6 [Q15038-3];,DAZAP2,ENSG00000183283,0.0,,,,,,,0.565,0.149,DAZAP2
Q15046,ENSG00000065427,SYK_HUMAN,basophil activation involved in immune response [GO:0002276]; diadenosine tetraphosphate biosynthetic process [GO:0015966]; ERK1 and ERK2 cascade [GO:0070371]; lysyl-tRNA aminoacylation [GO:0006430]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of inflammatory response to antigenic stimulus [GO:0002863]; positive regulation of macrophage activation [GO:0043032]; response to X-ray [GO:0010165]; tRNA processing [GO:0008033],aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytosol [GO:0005829]; extracellular space [GO:0005615]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886],amino acid binding [GO:0016597]; ATP binding [GO:0005524]; ATP:ADP adenylyltransferase activity [GO:0003877]; identical protein binding [GO:0042802]; lysine-tRNA ligase activity [GO:0004824]; protein homodimerization activity [GO:0042803]; tRNA binding [GO:0000049],PTM: Phosphorylated on a serine residue after mast cell stimulation with immunoglobulin E (IgE). {ECO:0000250|UniProtKB:Q5XIM7}.,"DOMAIN: The N-terminal domain (1-65) of the cytoplasmic isoform is a functional tRNA-binding domain, is required for nuclear localization, is involved in the interaction with DARS, but has a repulsive role in the binding to EEF1A1. A central domain (208-259) is involved in homodimerization and is required for interaction with HIV-1 GAG and incorporation into virions. The C-terminal domain (452-597) is not required for interaction with AIMP2. {ECO:0000269|PubMed:15220430, ECO:0000269|PubMed:18029264}.",,"STRAND 126..137; /evidence=""ECO:0007829|PDB:6ILD""; STRAND 139..149; /evidence=""ECO:0007829|PDB:6ILD""; STRAND 152..159; /evidence=""ECO:0007829|PDB:6ILD""; STRAND 181..190; /evidence=""ECO:0007829|PDB:6ILD""; STRAND 196..207; /evidence=""ECO:0007829|PDB:6ILD""; STRAND 270..274; /evidence=""ECO:0007829|PDB:6ILD""; STRAND 277..279; /evidence=""ECO:0007829|PDB:3BJU""; STRAND 284..287; /evidence=""ECO:0007829|PDB:6ILD""; STRAND 292..296; /evidence=""ECO:0007829|PDB:6ILD""; STRAND 314..322; /evidence=""ECO:0007829|PDB:6ILD""; STRAND 328..330; /evidence=""ECO:0007829|PDB:4DPG""; STRAND 333..343; /evidence=""ECO:0007829|PDB:6ILD""; STRAND 367..373; /evidence=""ECO:0007829|PDB:6ILD""; STRAND 383..386; /evidence=""ECO:0007829|PDB:6ILD""; STRAND 392..395; /evidence=""ECO:0007829|PDB:6ILD""; STRAND 460..463; /evidence=""ECO:0007829|PDB:6ILD""; STRAND 477..479; /evidence=""ECO:0007829|PDB:6ILD""; STRAND 482..490; /evidence=""ECO:0007829|PDB:6ILD""; STRAND 493..501; /evidence=""ECO:0007829|PDB:6ILD""; STRAND 524..526; /evidence=""ECO:0007829|PDB:4YCW""; STRAND 543..550; /evidence=""ECO:0007829|PDB:6ILD""; STRAND 568..570; /evidence=""ECO:0007829|PDB:6CHD""","HELIX 73..89; /evidence=""ECO:0007829|PDB:6ILD""; HELIX 105..112; /evidence=""ECO:0007829|PDB:6ILD""; HELIX 160..162; /evidence=""ECO:0007829|PDB:6ILD""; HELIX 166..175; /evidence=""ECO:0007829|PDB:6ILD""; HELIX 223..228; /evidence=""ECO:0007829|PDB:6ILD""; HELIX 230..236; /evidence=""ECO:0007829|PDB:6ILD""; HELIX 238..260; /evidence=""ECO:0007829|PDB:6ILD""; HELIX 301..309; /evidence=""ECO:0007829|PDB:6ILD""; HELIX 347..366; /evidence=""ECO:0007829|PDB:6ILD""; HELIX 396..404; /evidence=""ECO:0007829|PDB:6ILD""; HELIX 411..413; /evidence=""ECO:0007829|PDB:3BJU""; HELIX 417..429; /evidence=""ECO:0007829|PDB:6ILD""; HELIX 440..451; /evidence=""ECO:0007829|PDB:6ILD""; HELIX 453..455; /evidence=""ECO:0007829|PDB:6ILD""; HELIX 467..469; /evidence=""ECO:0007829|PDB:6ILD""; HELIX 505..520; /evidence=""ECO:0007829|PDB:6ILD""; HELIX 531..538; /evidence=""ECO:0007829|PDB:6ILD""; HELIX 551..558; /evidence=""ECO:0007829|PDB:6ILD""; HELIX 564..567; /evidence=""ECO:0007829|PDB:6ILD""","TURN 216..218; /evidence=""ECO:0007829|PDB:4YCU""; TURN 288..291; /evidence=""ECO:0007829|PDB:6ILD""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,KARS1 KARS KIAA0070,Lysine--tRNA ligase (EC 2.7.7.-) (EC 6.1.1.6) (Lysyl-tRNA synthetase) (LysRS),Homo sapiens (Human),597.0,68048.0,MAAVQAAEVKVDGSEPKLSKNELKRRLKAEKKVAEKEAKQKELSEKQLSQATAAATNHTTDNGVGPEEESVDPNQYYKIRSQAIHQLKVNGEDPYPHKFHVDISLTDFIQKYSHLQPGDHLTDITLKVAGRIHAKRASGGKLIFYDLRGEGVKLQVMANSRNYKSEEEFIHINNKLRRGDIIGVQGNPGKTKKGELSIIPYEITLLSPCLHMLPHLHFGLKDKETRYRQRYLDLILNDFVRQKFIIRSKIITYIRSFLDELGFLEIETPMMNIIPGGAVAKPFITYHNELDMNLYMRIAPELYHKMLVVGGIDRVYEIGRQFRNEGIDLTHNPEFTTCEFYMAYADYHDLMEITEKMVSGMVKHITGSYKVTYHPDGPEGQAYDVDFTPPFRRINMVEELEKALGMKLPETNLFETEETRKILDDICVAKAVECPPPRTTARLLDKLVGEFLEVTCINPTFICDHPQIMSPLAKWHRSKEGLTERFELFVMKKEICNAYTELNDPMRQRQLFEEQAKAKAAGDDEAMFIDENFCTALEYGLPPTAGWGMGIDRVAMFLTDSNNIKEVLLFPAMKPEDKKENVATTDTLESTTVGTSV,True,True,False,Q15046,"[('cd00775', 'LysRS_core'), ('cd04322', 'LysRS_N'), ('G3DSA:2.40.50.140', 'Nucleic acid-binding proteins'), ('G3DSA:3.30.930.10', 'Bira Bifunctional Protein; Domain 2'), ('IPR002313', 'Lysine-tRNA ligase, class II'), ('IPR004364', 'Aminoacyl-tRNA synthetase, class II (D/K/N)'), ('IPR004365', 'OB-fold nucleic acid binding domain, AA-tRNA synthetase-type'), ('IPR006195', 'Aminoacyl-tRNA synthetase, class II'), ('IPR012340', 'Nucleic acid-binding, OB-fold'), ('IPR018149', 'Lysyl-tRNA synthetase, class II, C-terminal'), ('IPR034762', 'Bacterial/eukaryotic lysine-tRNA ligase, class II'), ('IPR044136', 'Lysine-tRNA ligase, class II, N-terminal'), ('IPR045864', 'Class II Aminoacyl-tRNA synthetase/Biotinyl protein ligase (BPL) and lipoyl protein ligase (LPL)'), ('MF_00252', 'Lysine--tRNA ligase [lysS]'), ('PF00152', 'tRNA synthetases class II (D, K and N)'), ('PF01336', 'OB-fold nucleic acid binding domain'), ('PIRSF039101', 'Lysine--tRNA ligase, class II'), ('PR00982', 'TRNASYNTHLYS'), ('PS50862', 'Aminoacyl-transfer RNA synthetases class-II family profile'), ('PTHR42918', 'Lysine--tRNA ligase')]",,"""ENSG00000065427; Low tissue specificity."";","CATALYTIC ACTIVITY: Reaction=tRNA(Lys) + L-lysine + ATP = L-lysyl-tRNA(Lys) + AMP + diphosphate; Xref=Rhea:RHEA:20792, Rhea:RHEA-COMP:9696, Rhea:RHEA-COMP:9697, ChEBI:CHEBI:30616, ChEBI:CHEBI:32551, ChEBI:CHEBI:33019, ChEBI:CHEBI:78442, ChEBI:CHEBI:78529, ChEBI:CHEBI:456215; EC=6.1.1.6; Evidence={ECO:0000269|PubMed:18029264, ECO:0000269|PubMed:23159739, ECO:0000269|PubMed:9278442};",2.7.7.-; 6.1.1.6,"ACTIVITY REGULATION: Up-regulated by DARS and EEF1A1, but not by AIMP2. {ECO:0000269|PubMed:18029264}.",,ENST00000302445.8 [Q15046-1];ENST00000319410.9 [Q15046-2];,KARS1,ENSG00000065427,0.0,KARS1,Canonical_RBPs,14.0,11.73,DP02382,0.117,0.157,0.119,KARS1
Q15118,ENSG00000152256,PDK1_HUMAN,cell population proliferation [GO:0008283]; glucose metabolic process [GO:0006006]; hypoxia-inducible factor-1alpha signaling pathway [GO:0097411]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; phosphorylation [GO:0016310]; regulation of acetyl-CoA biosynthetic process from pyruvate [GO:0010510]; regulation of glucose metabolic process [GO:0010906],mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; pyruvate dehydrogenase complex [GO:0045254],ATP binding [GO:0005524]; protein kinase activity [GO:0004672]; pyruvate dehydrogenase (acetyl-transferring) kinase activity [GO:0004740],"PTM: Phosphorylated by constitutively activated ABL1, FGFR1, FLT3 and JAK2 (in vitro), and this may also occur in cancer cells that express constitutively activated ABL1, FGFR1, FLT3 and JAK2. Phosphorylation at Tyr-243 and Tyr-244 strongly increases kinase activity, while phosphorylation at Tyr-136 has a lesser effect. {ECO:0000269|PubMed:22195962}.",,"DOMAIN 163..393; /note=""Histidine kinase""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00107""","STRAND 125..127; /evidence=""ECO:0007829|PDB:2Q8G""; STRAND 219..224; /evidence=""ECO:0007829|PDB:2Q8G""; STRAND 250..259; /evidence=""ECO:0007829|PDB:2Q8G""; STRAND 265..268; /evidence=""ECO:0007829|PDB:2Q8G""; STRAND 301..307; /evidence=""ECO:0007829|PDB:2Q8G""; STRAND 309..318; /evidence=""ECO:0007829|PDB:2Q8G""; STRAND 352..354; /evidence=""ECO:0007829|PDB:2Q8H""; STRAND 372..378; /evidence=""ECO:0007829|PDB:2Q8G""; STRAND 382..392; /evidence=""ECO:0007829|PDB:2Q8G""","HELIX 42..50; /evidence=""ECO:0007829|PDB:2Q8G""; HELIX 59..67; /evidence=""ECO:0007829|PDB:2Q8G""; HELIX 72..94; /evidence=""ECO:0007829|PDB:2Q8G""; HELIX 99..102; /evidence=""ECO:0007829|PDB:2Q8G""; HELIX 105..122; /evidence=""ECO:0007829|PDB:2Q8G""; HELIX 132..148; /evidence=""ECO:0007829|PDB:2Q8G""; HELIX 152..166; /evidence=""ECO:0007829|PDB:2Q8G""; HELIX 171..202; /evidence=""ECO:0007829|PDB:2Q8G""; HELIX 225..244; /evidence=""ECO:0007829|PDB:2Q8G""; HELIX 270..291; /evidence=""ECO:0007829|PDB:2Q8G""; HELIX 325..328; /evidence=""ECO:0007829|PDB:2Q8G""; HELIX 329..332; /evidence=""ECO:0007829|PDB:2Q8G""; HELIX 358..368; /evidence=""ECO:0007829|PDB:2Q8G""; HELIX 405..411; /evidence=""ECO:0007829|PDB:2Q8G""","TURN 149..151; /evidence=""ECO:0007829|PDB:2Q8G""; TURN 293..295; /evidence=""ECO:0007829|PDB:2Q8G""; TURN 334..337; /evidence=""ECO:0007829|PDB:2Q8G""; TURN 379..381; /evidence=""ECO:0007829|PDB:2Q8G""; TURN 393..395; /evidence=""ECO:0007829|PDB:2Q8G""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,PDK1 PDHK1,"[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial (EC 2.7.11.2) (Pyruvate dehydrogenase kinase isoform 1) (PDH kinase 1)",Homo sapiens (Human),436.0,49244.0,MRLARLLRGAALAGPGPGLRAAGFSRSFSSDSGSSPASERGVPGQVDFYARFSPSPLSMKQFLDFGSVNACEKTSFMFLRQELPVRLANIMKEISLLPDNLLRTPSVQLVQSWYIQSLQELLDFKDKSAEDAKAIYDFTDTVIRIRNRHNDVIPTMAQGVIEYKESFGVDPVTSQNVQYFLDRFYMSRISIRMLLNQHSLLFGGKGKGSPSHRKHIGSINPNCNVLEVIKDGYENARRLCDLYYINSPELELEELNAKSPGQPIQVVYVPSHLYHMVFELFKNAMRATMEHHANRGVYPPIQVHVTLGNEDLTVKMSDRGGGVPLRKIDRLFNYMYSTAPRPRVETSRAVPLAGFGYGLPISRLYAQYFQGDLKLYSLEGYGTDAVIYIKALSTDSIERLPVYNKAAWKHYNTNHEADDWCVPSREPKDMTTFRSA,True,False,False,Q15118,"[('cd16929', 'Histidine kinase-like ATPase domain of pyruvate dehydrogenase kinase, branched-chain alpha-ketoacid dehydrogenase kinase and related domains'), ('G3DSA:1.20.140.20', 'Alpha-ketoacid/pyruvate dehydrogenase kinase, N-terminal domain'), ('G3DSA:3.30.565.10', 'Histidine kinase-like ATPase, C-terminal domain'), ('IPR003594', 'Histidine kinase/HSP90-like ATPase domain'), ('IPR005467', 'Histidine kinase domain'), ('IPR018955', 'Branched-chain alpha-ketoacid dehydrogenase kinase/Pyruvate dehydrogenase kinase, N-terminal'), ('IPR036784', 'Alpha-ketoacid/pyruvate dehydrogenase kinase, N-terminal domain superfamily'), ('IPR036890', 'Histidine kinase/HSP90-like ATPase superfamily'), ('IPR039028', 'PDK/BCKDK protein kinase'), ('PF02518', 'Histidine kinase-, DNA gyrase B-, and HSP90-like ATPase'), ('PF10436', 'Mitochondrial branched-chain alpha-ketoacid dehydrogenase kinase'), ('PS50109', 'Histidine kinase domain profile'), ('PTHR11947', 'PYRUVATE DEHYDROGENASE KINASE'), ('SM00387', 'Histidine kinase-like ATPases'), ('SSF55874', 'ATPase domain of HSP90 chaperone/DNA topoisomerase II/histidine kinase'), ('SSF69012', 'alpha-ketoacid dehydrogenase kinase, N-terminal domain')]",,"""ENSG00000152256; Low tissue specificity."";","CATALYTIC ACTIVITY: Reaction=L-seryl-[pyruvate dehydrogenase E1 alpha subunit] + ATP = O-phospho-L-seryl-[pyruvate dehydrogenase E1 alpha subunit] + ADP + H(+); Xref=Rhea:RHEA:23052, Rhea:RHEA-COMP:13689, Rhea:RHEA-COMP:13690, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616, ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.2; Evidence={ECO:0000269|PubMed:17683942, ECO:0000269|PubMed:22195962, ECO:0000269|PubMed:7499431};",2.7.11.2,ACTIVITY REGULATION: Activity is enhanced by binding to the pyruvate dehydrogenase subunit DLAT. Inhibited by AZD7545; this compound interferes with DLAT binding and thereby inhibits kinase activity. Inhibited by dichloroacetate and radicicol. {ECO:0000269|PubMed:17683942}.,,ENST00000282077.8 [Q15118-1];ENST00000392571.6 [Q15118-2];ENST00000410055.5 [Q15118-1];,PDK1,ENSG00000152256,0.0,,,,,,,0.133,,PDK1
Q15154,ENSG00000078674,PCM1_HUMAN,centrosome cycle [GO:0007098]; cilium assembly [GO:0060271]; cytoplasmic microtubule organization [GO:0031122]; interkinetic nuclear migration [GO:0022027]; intraciliary transport involved in cilium assembly [GO:0035735]; microtubule anchoring [GO:0034453]; microtubule anchoring at centrosome [GO:0034454]; negative regulation of neurogenesis [GO:0050768]; neuron migration [GO:0001764]; neuronal stem cell population maintenance [GO:0097150]; non-motile cilium assembly [GO:1905515]; positive regulation of intracellular protein transport [GO:0090316]; protein localization to centrosome [GO:0071539]; protein-containing complex localization to centriolar satellite [GO:0140706]; regulation of protein complex stability [GO:0061635]; social behavior [GO:0035176],apical part of cell [GO:0045177]; centriolar satellite [GO:0034451]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary transition zone [GO:0035869]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nuclear membrane [GO:0031965]; nucleoplasm [GO:0005654]; pericentriolar material [GO:0000242]; protein-containing complex [GO:0032991],identical protein binding [GO:0042802]; molecular adaptor activity [GO:0060090],"PTM: Ubiquitinated. Undergoes monoubiquitination catalyzed by the E3 ubiquitin-protein ligase MIB1 in proliferating cells, preventing cilia formation (PubMed:24121310). Monoubiquitination by MIB1 is inhibited in response to cellular stress, such as ultraviolet light (UV) radiation or heat shock, resulting in cilia formation initiation (PubMed:24121310). {ECO:0000269|PubMed:24121310}.; PTM: Variant Ser-159 is phosphorylated. {ECO:0007744|PubMed:23186163}.; PTM: Phosphorylated on multiple serine and threonine residues by DYRK3 during the G2-to-M transition, after the nuclear-envelope breakdown (PubMed:29973724). Phosphorylation by DYRK3 promotes disassembly of pericentriolar material (PubMed:29973724). Phosphorylation at Ser-372 mediated by PLK4 is required to maintain the integrity of centriolar satellites (PubMed:30804208). {ECO:0000269|PubMed:29973724, ECO:0000269|PubMed:30804208}.",,,,,,"cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,PCM1,Pericentriolar material 1 protein (PCM-1) (hPCM-1),Homo sapiens (Human),2024.0,228560.0,MATGGGPFEDGMNDQDLPNWSNENVDDRLNNMDWGAQQKKANRSSEKNKKKFGVESDKRVTNDISPESSPGVGRRRTKTPHTFPHSRYMSQMSVPEQAELEKLKQRINFSDLDQRSIGSDSQGRATAANNKRQLSENRKPFNFLPMQINTNKSKDASTNPPNRETIGSAQCKELFASALSNDLLQNCQVSEEDGRGEPAMESSQIVSRLVQIRDYITKASSMREDLVEKNERSANVERLTHLIDHLKEQEKSYMKFLKKILARDPQQEPMEEIENLKKQHDLLKRMLQQQEQLRALQGRQAALLALQHKAEQAIAVMDDSVVAETAGSLSGVSITSELNEELNDLIQRFHNQLRDSQPPAVPDNRRQAESLSLTREVSQSRKPSASERLPDEKVELFSKMRVLQEKKQKMDKLLGELHTLRDQHLNNSSSSPQRSVDQRSTSAPSASVGLAPVVNGESNSLTSSVPYPTASLVSQNESENEGHLNPSEKLQKLNEVRKRLNELRELVHYYEQTSDMMTDAVNENRKDEETEESEYDSEHENSEPVTNIRNPQVASTWNEVNSHSNAQCVSNNRDGRTVNSNCEINNRSAANIRALNMPPSLDCRYNREGEQEIHVAQGEDDEEEEEEAEEEGVSGASLSSHRSSLVDEHPEDAEFEQKINRLMAAKQKLRQLQDLVAMVQDDDAAQGVISASASNLDDFYPAEEDTKQNSNNTRGNANKTQKDTGVNEKAREKFYEAKLQQQQRELKQLQEERKKLIDIQEKIQALQTACPDLQLSAASVGNCPTKKYMPAVTSTPTVNQHETSTSKSVFEPEDSSIVDNELWSEMRRHEMLREELRQRRKQLEALMAEHQRRQGLAETASPVAVSLRSDGSENLCTPQQSRTEKTMATWGGSTQCALDEEGDEDGYLSEGIVRTDEEEEEEQDASSNDNFSVCPSNSVNHNSYNGKETKNRWKNNCPFSADENYRPLAKTRQQNISMQRQENLRWVSELSYVEEKEQWQEQINQLKKQLDFSVSICQTLMQDQQTLSCLLQTLLTGPYSVMPSNVASPQVHFIMHQLNQCYTQLTWQQNNVQRLKQMLNELMRQQNQHPEKPGGKERGSSASHPPSPSLFCPFSFPTQPVNLFNIPGFTNFSSFAPGMNFSPLFPSNFGDFSQNISTPSEQQQPLAQNSSGKTEYMAFPKPFESSSSIGAEKPRNKKLPEEEVESSRTPWLYEQEGEVEKPFIKTGFSVSVEKSTSSNRKNQLDTNGRRRQFDEESLESFSSMPDPVDPTTVTKTFKTRKASAQASLASKDKTPKSKSKKRNSTQLKSRVKNIRYESASMSSTCEPCKSRNRHSAQTEEPVQAKVFSRKNHEQLEKIIKCNRSTEISSETGSDFSMFEALRDTIYSEVATLISQNESRPHFLIELFHELQLLNTDYLRQRALYALQDIVSRHISESHEKGENVKSVNSGTWIASNSELTPSESLATTDDETFEKNFERETHKISEQNDADNASVLSVSSNFEPFATDDLGNTVIHLDQALARMREYERMKTEAESNSNMRCTCRIIEDGDGAGAGTTVNNLEETPVIENRSSQQPVSEVSTIPCPRIDTQQLDRQIKAIMKEVIPFLKEHMDEVCSSQLLTSVRRMVLTLTQQNDESKEFVKFFHKQLGSILQDSLAKFAGRKLKDCGEDLLVEISEVLFNELAFFKLMQDLDNNSITVKQRCKRKIEATGVIQSCAKEAKRILEDHGSPAGEIDDEDKDKDETETVKQTQTSEVYDGPKNVRSDISDQEEDEESEGCPVSINLSKAETQALTNYGSGEDENEDEEMEEFEEGPVDVQTSLQANTEATEENEHDEQVLQRDFKKTAESKNVPLEREATSKNDQNNCPVKPCYLNILEDEQPLNSAAHKESPPTVDSTQQPNPLPLRLPEMEPLVPRVKEVKSAQETPESSLAGSPDTESPVLVNDYEAESGNISQKSDEEDFVKVEDLPLKLTIYSEADLRKKMVEEEQKNHLSGEICEMQTEELAGNSETLKEPETVGAQSI,False,False,True,Q15154,"[('IPR024138', 'Pericentriolar material 1 protein'), ('IPR031446', 'Pericentriolar material 1 protein, C-terminal'), ('PF15717', 'Pericentriolar material 1 C terminus'), ('PTHR14164', 'PERICENTRIOLAR MATERIAL 1-RELATED')]",,"""ENSG00000078674; Low tissue specificity."";",,,,,ENST00000325083.13 [Q15154-1];ENST00000518537.5 [Q15154-3];ENST00000519253.5 [Q15154-5];ENST00000524226.5 [Q15154-4];,PCM1,ENSG00000078674,0.0,,,,,,,0.819,0.399,PCM1
Q15311,ENSG00000017797,RBP1_HUMAN,chemotaxis [GO:0006935]; doxorubicin transport [GO:1900753]; endocytosis [GO:0006897]; positive regulation of GTPase activity [GO:0043547]; positive regulation of mitochondrial fission [GO:0090141]; positive regulation of protein phosphorylation [GO:0001934]; regulation of Cdc42 protein signal transduction [GO:0032489]; regulation of GTPase activity [GO:0043087]; regulation of small GTPase mediated signal transduction [GO:0051056]; small GTPase-mediated signal transduction [GO:0007264]; transmembrane transport [GO:0055085]; xenobiotic detoxification by transmembrane export across the plasma membrane [GO:1990961],cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrion [GO:0005739]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886]; spindle pole [GO:0000922],ABC-type glutathione S-conjugate transporter activity [GO:0015431]; ABC-type xenobiotic transporter activity [GO:0008559]; ATP binding [GO:0005524]; ATPase-coupled transmembrane transporter activity [GO:0042626]; GTPase activator activity [GO:0005096]; small GTPase binding [GO:0031267]; transmembrane transporter activity [GO:0022857]; xenobiotic transmembrane transporter activity [GO:0042910],PTM: Tyrosine-phosphorylated upon stimulation of cells with EGF. {ECO:0000250|UniProtKB:Q62172}.; PTM: May undergo proteolytic cleavage to give peptides which reassemble to form a transporter complex. {ECO:0000305|PubMed:11300797}.,DOMAIN: The Rho-GAP domain mediates the GTPase activator activity toward CDC42. {ECO:0000250|UniProtKB:Q62796}.,"DOMAIN 192..380; /note=""Rho-GAP""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00172""","STRAND 184..187; /evidence=""ECO:0007829|PDB:2MBG""; STRAND 384..386; /evidence=""ECO:0007829|PDB:2MBG""","HELIX 194..200; /evidence=""ECO:0007829|PDB:2MBG""; HELIX 211..222; /evidence=""ECO:0007829|PDB:2MBG""; HELIX 237..248; /evidence=""ECO:0007829|PDB:2MBG""; HELIX 255..257; /evidence=""ECO:0007829|PDB:2MBG""; HELIX 260..273; /evidence=""ECO:0007829|PDB:2MBG""; HELIX 280..291; /evidence=""ECO:0007829|PDB:2MBG""; HELIX 296..309; /evidence=""ECO:0007829|PDB:2MBG""; HELIX 312..334; /evidence=""ECO:0007829|PDB:2MBG""; HELIX 339..350; /evidence=""ECO:0007829|PDB:2MBG""; HELIX 354..367; /evidence=""ECO:0007829|PDB:2MBG""; HELIX 396..416; /evidence=""ECO:0007829|PDB:6ZRN""; HELIX 423..443; /evidence=""ECO:0007829|PDB:6ZRN""","TURN 223..225; /evidence=""ECO:0007829|PDB:2MBG""; TURN 228..232; /evidence=""ECO:0007829|PDB:2MBG""; TURN 417..419; /evidence=""ECO:0007829|PDB:2MBG""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,RALBP1 RLIP RLIP1 RLIP76,"RalA-binding protein 1 (RalBP1) (76 kDa Ral-interacting protein) (Dinitrophenyl S-glutathione ATPase) (DNP-SG ATPase) (EC 7.6.2.2, EC 7.6.2.3) (Ral-interacting protein 1)",Homo sapiens (Human),655.0,76063.0,MTECFLPPTSSPSEHRRVEHGSGLTRTPSSEEISPTKFPGLYRTGEPSPPHDILHEPPDVVSDDEKDHGKKKGKFKKKEKRTEGYAAFQEDSSGDEAESPSKMKRSKGIHVFKKPSFSKKKEKDFKIKEKPKEEKHKEEKHKEEKHKEKKSKDLTAADVVKQWKEKKKKKKPIQEPEVPQIDVPNLKPIFGIPLADAVERTMMYDGIRLPAVFRECIDYVEKYGMKCEGIYRVSGIKSKVDELKAAYDREESTNLEDYEPNTVASLLKQYLRDLPENLLTKELMPRFEEACGRTTETEKVQEFQRLLKELPECNYLLISWLIVHMDHVIAKELETKMNIQNISIVLSPTVQISNRVLYVFFTHVQELFGNVVLKQVMKPLRWSNMATMPTLPETQAGIKEEIRRQEFLLNCLHRDLQGGIKDLSKEERLWEVQRILTALKRKLREAKRQECETKIAQEIASLSKEDVSKEEMNENEEVINILLAQENEILTEQEELLAMEQFLRRQIASEKEEIERLRAEIAEIQSRQQHGRSETEEYSSESESESEDEEELQIILEDLQRQNEELEIKNNHLNQAIHEEREAIIELRVQLRLLQMQRAKAEQQAQEDEEPEWRGGAVQPPRDGVLEPKAAKEQPKAGKEPAKPSPSRDRKETSI,True,False,False,Q15311,"[('cd04381', 'RhoGap_RalBP1'), ('G3DSA:1.10.555.10', 'Rho GTPase activation protein'), ('G3DSA:1.20.58.90', None), ('IPR000198', 'Rho GTPase-activating protein domain'), ('IPR008936', 'Rho GTPase activation protein'), ('IPR039767', 'RalA-binding protein 1'), ('IPR049041', 'RalA-binding protein 1-like, Ral binding domain'), ('PF00620', 'RhoGAP domain'), ('PF20924', 'RLIP76, Ral binding domain'), ('PS50238', 'Rho GTPase-activating proteins domain profile'), ('PTHR12783', 'RALA BINDING PROTEIN 1 RALBP1'), ('SM00324', 'GTPase-activator protein for Rho-like GTPases'), ('SSF48350', 'GTPase activation domain, GAP')]",,"""ENSG00000017797; Low tissue specificity."";","CATALYTIC ACTIVITY: Reaction=an S-substituted glutathione(in) + ATP + H2O = an S-substituted glutathione(out) + ADP + phosphate + H(+); Xref=Rhea:RHEA:19121, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616, ChEBI:CHEBI:43474, ChEBI:CHEBI:90779, ChEBI:CHEBI:456216; EC=7.6.2.3; Evidence={ECO:0000269|PubMed:10924126, ECO:0000269|PubMed:11437348, ECO:0000269|PubMed:9548755}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:19122; Evidence={ECO:0000305|PubMed:10924126}; CATALYTIC ACTIVITY: Reaction=ATP + H2O + xenobioticSide 1 = ADP + phosphate + xenobioticSide 2.; EC=7.6.2.2; Evidence={ECO:0000269|PubMed:10924126, ECO:0000269|PubMed:11437348}; CATALYTIC ACTIVITY: Reaction=leukotriene C4(in) + ATP + H2O = leukotriene C4(out) + ADP + phosphate + H(+); Xref=Rhea:RHEA:38963, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616, ChEBI:CHEBI:43474, ChEBI:CHEBI:57973, ChEBI:CHEBI:456216; Evidence={ECO:0000269|PubMed:11437348}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:38964; Evidence={ECO:0000305|PubMed:11437348};",7.6.2.2; 7.6.2.3,,,ENST00000019317.8;ENST00000383432.8;,RALBP1,ENSG00000017797,0.0,,,,,,,0.46,0.366,RALBP1
Q15428,ENSG00000104897,SF3A2_HUMAN,"mRNA 3'-splice site recognition [GO:0000389]; mRNA processing [GO:0006397]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of neuron projection development [GO:0010976]; spliceosomal complex assembly [GO:0000245]; U2-type prespliceosome assembly [GO:1903241]",catalytic step 2 spliceosome [GO:0071013]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2 snRNP [GO:0005686]; U2-type precatalytic spliceosome [GO:0071005]; U2-type prespliceosome [GO:0071004]; U2-type spliceosomal complex [GO:0005684],RNA binding [GO:0003723]; zinc ion binding [GO:0008270],,,,"STRAND 3..6; /evidence=""ECO:0007829|PDB:6FF4""; STRAND 45..48; /evidence=""ECO:0007829|PDB:7Q4O""; STRAND 54..56; /evidence=""ECO:0007829|PDB:7Q4O""; STRAND 61..65; /evidence=""ECO:0007829|PDB:7Q4O""; STRAND 118..121; /evidence=""ECO:0007829|PDB:7EVO""; STRAND 134..137; /evidence=""ECO:0007829|PDB:7EVO""; STRAND 148..155; /evidence=""ECO:0007829|PDB:7EVO""; STRAND 167..172; /evidence=""ECO:0007829|PDB:7EVO""; STRAND 174..176; /evidence=""ECO:0007829|PDB:7EVO""; STRAND 179..183; /evidence=""ECO:0007829|PDB:7EVO""; STRAND 196..200; /evidence=""ECO:0007829|PDB:7EVO""; STRAND 205..208; /evidence=""ECO:0007829|PDB:7EVO""","HELIX 19..41; /evidence=""ECO:0007829|PDB:7QTT""; HELIX 66..73; /evidence=""ECO:0007829|PDB:7Q4O""; HELIX 76..82; /evidence=""ECO:0007829|PDB:7Q4O""; HELIX 105..108; /evidence=""ECO:0007829|PDB:7EVO""","TURN 57..60; /evidence=""ECO:0007829|PDB:7Q4O""; TURN 193..195; /evidence=""ECO:0007829|PDB:7EVO""; TURN 201..204; /evidence=""ECO:0007829|PDB:7EVO""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,SF3A2 SAP62,Splicing factor 3A subunit 2 (SF3a66) (Spliceosome-associated protein 62) (SAP 62),Homo sapiens (Human),464.0,49256.0,MDFQHRPGGKTGSGGVASSSESNRDRRERLRQLALETIDINKDPYFMKNHLGSYECKLCLTLHNNEGSYLAHTQGKKHQTNLARRAAKEAKEAPAQPAPEKVKVEVKKFVKIGRPGYKVTKQRDSEMGQQSLLFQIDYPEIAEGIMPRHRFMSAYEQRIEPPDRRWQYLLMAAEPYETIAFKVPSREIDKAEGKFWTHWNRETKQFFLQFHFKMEKPPAPPSLPAGPPGVKRPPPPLMNGLPPRPPLPESLPPPPPGGLPLPPMPPTGPAPSGPPGPPQLPPPAPGVHPPAPVVHPPASGVHPPAPGVHPPAPGVHPPAPGVHPPTSGVHPPAPGVHPPAPGVHPPAPGVHPPAPGVHPPAPGVHPPPSAGVHPQAPGVHPAAPAVHPQAPGVHPPAPGMHPQAPGVHPQPPGVHPSAPGVHPQPPGVHPSNPGVHPPTPMPPMLRPPLPSEGPGNIPPPPPTN,False,True,False,Q15428,"[('G3DSA:2.60.40.2690', None), ('IPR000690', 'Matrin/U1-C, C2H2-type zinc finger'), ('IPR003604', 'Matrin/U1-C-like, C2H2-type zinc finger'), ('IPR013087', 'Zinc finger C2H2-type'), ('IPR031781', 'SF3A2 domain'), ('IPR036236', 'Zinc finger C2H2 superfamily'), ('IPR052092', 'Splicing Factor 3A Subunit 2'), ('PF12874', 'Zinc-finger of C2H2 type'), ('PF16835', 'Pre-mRNA-splicing factor SF3a complex subunit 2 (Prp11)'), ('PS50171', 'Zinc finger matrin-type profile'), ('PTHR23205', 'Splicing Factor 3A Subunit 2'), ('SM00451', 'U1-like zinc finger'), ('SM01050', 'Cactus-binding C-terminus of cactin protein'), ('SSF57667', 'beta-beta-alpha zinc fingers')]",,"""ENSG00000104897; Low tissue specificity."";",,,,,ENST00000221494.10;,SF3A2,ENSG00000104897,0.0,SF3A2,Canonical_RBPs,17.0,,,,0.655,0.593,SF3A2
Q15477,ENSG00000204351|ENSG00000206353|ENSG00000232616|ENSG00000228896|ENSG00000223493|ENSG00000225737,SKI2_HUMAN,"nuclear-transcribed mRNA catabolic process, 3'-5' exonucleolytic nonsense-mediated decay [GO:0070478]; rescue of stalled ribosome [GO:0072344]",cytosol [GO:0005829]; nucleus [GO:0005634]; Ski complex [GO:0055087],3'-5' RNA helicase activity [GO:0034458]; ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; RNA binding [GO:0003723]; RNA helicase activity [GO:0003724],,,"DOMAIN 319..475; /note=""Helicase ATP-binding""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00541""; DOMAIN 585..755; /note=""Helicase C-terminal""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00542""","STRAND 10..12; /evidence=""ECO:0007829|PDB:7QDY""; STRAND 14..16; /evidence=""ECO:0007829|PDB:7QDY""; STRAND 20..23; /evidence=""ECO:0007829|PDB:7QDY""; STRAND 25..28; /evidence=""ECO:0007829|PDB:7QDY""; STRAND 30..35; /evidence=""ECO:0007829|PDB:7QDY""; STRAND 73..77; /evidence=""ECO:0007829|PDB:7QDY""; STRAND 108..110; /evidence=""ECO:0007829|PDB:7QDY""; STRAND 140..142; /evidence=""ECO:0007829|PDB:7QDY""; STRAND 179..182; /evidence=""ECO:0007829|PDB:7QDY""; STRAND 283..286; /evidence=""ECO:0007829|PDB:7QDY""; STRAND 289..292; /evidence=""ECO:0007829|PDB:7QDY""; STRAND 296..299; /evidence=""ECO:0007829|PDB:7QDY""; STRAND 327..331; /evidence=""ECO:0007829|PDB:7QDY""; STRAND 355..359; /evidence=""ECO:0007829|PDB:7QDY""; STRAND 393..398; /evidence=""ECO:0007829|PDB:7QDY""; STRAND 417..422; /evidence=""ECO:0007829|PDB:7QDY""; STRAND 449..452; /evidence=""ECO:0007829|PDB:7QDY""; STRAND 475..479; /evidence=""ECO:0007829|PDB:7QDY""; STRAND 487..492; /evidence=""ECO:0007829|PDB:7QDY""; STRAND 503..507; /evidence=""ECO:0007829|PDB:7QDY""; STRAND 569..572; /evidence=""ECO:0007829|PDB:7QDY""; STRAND 632..635; /evidence=""ECO:0007829|PDB:7QDY""; STRAND 637..639; /evidence=""ECO:0007829|PDB:7QDY""; STRAND 658..661; /evidence=""ECO:0007829|PDB:7QDY""; STRAND 674..677; /evidence=""ECO:0007829|PDB:7QDY""; STRAND 681..683; /evidence=""ECO:0007829|PDB:7QDY""; STRAND 707..711; /evidence=""ECO:0007829|PDB:7QDY""; STRAND 713..717; /evidence=""ECO:0007829|PDB:7QDY""; STRAND 756..759; /evidence=""ECO:0007829|PDB:7QDY""; STRAND 843..851; /evidence=""ECO:0007829|PDB:7QDY""; STRAND 853..862; /evidence=""ECO:0007829|PDB:7QDY""; STRAND 866..868; /evidence=""ECO:0007829|PDB:7QDY""; STRAND 871..875; /evidence=""ECO:0007829|PDB:7QDY""; STRAND 901..903; /evidence=""ECO:0007829|PDB:7QDY""; STRAND 916..920; /evidence=""ECO:0007829|PDB:7QDY""; STRAND 925..930; /evidence=""ECO:0007829|PDB:7QDY""; STRAND 1189..1191; /evidence=""ECO:0007829|PDB:7QDY""","HELIX 54..63; /evidence=""ECO:0007829|PDB:7QDY""; HELIX 70..72; /evidence=""ECO:0007829|PDB:7QDY""; HELIX 87..90; /evidence=""ECO:0007829|PDB:7QDY""; HELIX 253..262; /evidence=""ECO:0007829|PDB:7QDY""; HELIX 313..322; /evidence=""ECO:0007829|PDB:7QDY""; HELIX 335..352; /evidence=""ECO:0007829|PDB:7QDY""; HELIX 365..376; /evidence=""ECO:0007829|PDB:7QDY""; HELIX 400..408; /evidence=""ECO:0007829|PDB:7QDY""; HELIX 414..416; /evidence=""ECO:0007829|PDB:7QDY""; HELIX 425..427; /evidence=""ECO:0007829|PDB:7QDY""; HELIX 434..443; /evidence=""ECO:0007829|PDB:7QDY""; HELIX 464..470; /evidence=""ECO:0007829|PDB:7QDY""; HELIX 515..528; /evidence=""ECO:0007829|PDB:7QDY""; HELIX 547..562; /evidence=""ECO:0007829|PDB:7QDY""; HELIX 576..586; /evidence=""ECO:0007829|PDB:7QDY""; HELIX 594..608; /evidence=""ECO:0007829|PDB:7QDY""; HELIX 614..616; /evidence=""ECO:0007829|PDB:7QDY""; HELIX 619..630; /evidence=""ECO:0007829|PDB:7QDY""; HELIX 641..651; /evidence=""ECO:0007829|PDB:7QDY""; HELIX 663..667; /evidence=""ECO:0007829|PDB:7QDY""; HELIX 694..702; /evidence=""ECO:0007829|PDB:7QDY""; HELIX 726..733; /evidence=""ECO:0007829|PDB:7QDY""; HELIX 748..755; /evidence=""ECO:0007829|PDB:7QDY""; HELIX 762..767; /evidence=""ECO:0007829|PDB:7QDY""; HELIX 770..772; /evidence=""ECO:0007829|PDB:7QDY""; HELIX 773..776; /evidence=""ECO:0007829|PDB:7QDY""; HELIX 779..793; /evidence=""ECO:0007829|PDB:7QDY""; HELIX 808..830; /evidence=""ECO:0007829|PDB:7QDY""; HELIX 833..838; /evidence=""ECO:0007829|PDB:7QDY""; HELIX 885..887; /evidence=""ECO:0007829|PDB:7QDY""; HELIX 922..924; /evidence=""ECO:0007829|PDB:7QDY""; HELIX 937..947; /evidence=""ECO:0007829|PDB:7QDY""; HELIX 959..973; /evidence=""ECO:0007829|PDB:7QDY""; HELIX 993..1009; /evidence=""ECO:0007829|PDB:7QDY""; HELIX 1014..1016; /evidence=""ECO:0007829|PDB:7QDY""; HELIX 1020..1043; /evidence=""ECO:0007829|PDB:7QDY""; HELIX 1052..1064; /evidence=""ECO:0007829|PDB:7QDY""; HELIX 1076..1082; /evidence=""ECO:0007829|PDB:7QDY""; HELIX 1088..1096; /evidence=""ECO:0007829|PDB:7QDY""; HELIX 1105..1112; /evidence=""ECO:0007829|PDB:7QDY""; HELIX 1113..1115; /evidence=""ECO:0007829|PDB:7QDY""; HELIX 1129..1150; /evidence=""ECO:0007829|PDB:7QDY""; HELIX 1158..1162; /evidence=""ECO:0007829|PDB:7QDY""; HELIX 1170..1176; /evidence=""ECO:0007829|PDB:7QDY""; HELIX 1182..1188; /evidence=""ECO:0007829|PDB:7QDY""; HELIX 1193..1204; /evidence=""ECO:0007829|PDB:7QDY""; HELIX 1209..1217; /evidence=""ECO:0007829|PDB:7QDY""; HELIX 1220..1229; /evidence=""ECO:0007829|PDB:7QDY""; HELIX 1237..1239; /evidence=""ECO:0007829|PDB:7QDY""","TURN 128..130; /evidence=""ECO:0007829|PDB:7QDY""; TURN 323..325; /evidence=""ECO:0007829|PDB:7QDY""; TURN 411..413; /evidence=""ECO:0007829|PDB:7QDY""; TURN 431..433; /evidence=""ECO:0007829|PDB:7QDY""; TURN 460..463; /evidence=""ECO:0007829|PDB:7QDY""; TURN 497..499; /evidence=""ECO:0007829|PDB:7QDY""; TURN 563..565; /evidence=""ECO:0007829|PDB:7QDY""; TURN 652..654; /evidence=""ECO:0007829|PDB:7QDY""; TURN 804..807; /evidence=""ECO:0007829|PDB:7QDY""; TURN 898..900; /evidence=""ECO:0007829|PDB:7QDY""; TURN 950..954; /evidence=""ECO:0007829|PDB:7QDY""; TURN 984..989; /evidence=""ECO:0007829|PDB:7QDY""; TURN 1065..1067; /evidence=""ECO:0007829|PDB:7QDY""; TURN 1097..1102; /evidence=""ECO:0007829|PDB:7QDY""; TURN 1151..1153; /evidence=""ECO:0007829|PDB:7QDY""; TURN 1177..1179; /evidence=""ECO:0007829|PDB:7QDY""; TURN 1205..1208; /evidence=""ECO:0007829|PDB:7QDY""; TURN 1230..1233; /evidence=""ECO:0007829|PDB:7QDY""; TURN 1243..1245; /evidence=""ECO:0007829|PDB:7QDY""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,SKIC2 DDX13 SKI2W SKIV2 SKIV2L W,Superkiller complex protein 2 (Ski2) (EC 3.6.4.13) (Helicase-like protein) (HLP),Homo sapiens (Human),1246.0,137755.0,MMETERLVLPPPDPLDLPLRAVELGCTGHWELLNLPGAPESSLPHGLPPCAPDLQQEAEQLFLSSPAWLPLHGVEHSARKWQRKTDPWSLLAVLGAPVPSDLQAQRHPTTGQILGYKEVLLENTNLSATTSLSLRRPPGPASQSLWGNPTQYPFWPGGMDEPTITDLNTREEAEEEIDFEKDLLTIPPGFKKGMDFAPKDCPTPAPGLLSLSCMLEPLDLGGGDEDENEAVGQPGGPRGDTVSASPCSAPLARASSLEDLVLKEASTAVSTPEAPEPPSQEQWAIPVDATSPVGDFYRLIPQPAFQWAFEPDVFQKQAILHLERHDSVFVAAHTSAGKTVVAEYAIALAQKHMTRTIYTSPIKALSNQKFRDFRNTFGDVGLLTGDVQLHPEASCLIMTTEILRSMLYSGSDVIRDLEWVIFDEVHYINDVERGVVWEEVLIMLPDHVSIILLSATVPNALEFADWIGRLKRRQIYVISTVTRPVPLEHYLFTGNSSKTQGELFLLLDSRGAFHTKGYYAAVEAKKERMSKHAQTFGAKQPTHQGGPAQDRGVYLSLLASLRTRAQLPVVVFTFSRGRCDEQASGLTSLDLTTSSEKSEIHLFLQRCLARLRGSDRQLPQVLHMSELLNRGLGVHHSGILPILKEIVEMLFSRGLVKVLFATETFAMGVNMPARTVVFDSMRKHDGSTFRDLLPGEYVQMAGRAGRRGLDPTGTVILLCKGRVPEMADLHRMMMGKPSQLQSQFRLTYTMILNLLRVDALRVEDMMKRSFSEFPSRKDSKAHEQALAELTKRLGALEEPDMTGQLVDLPEYYSWGEELTETQHMIQRRIMESVNGLKSLSAGRVVVVKNQEHHNALGVILQVSSNSTSRVFTTLVLCDKPLSQDPQDRGPATAEVPYPDDLVGFKLFLPEGPCDHTVVKLQPGDMAAITTKVLRVNGEKILEDFSKRQQPKFKKDPPLAAVTTAVQELLRLAQAHPAGPPTLDPVNDLQLKDMSVVEGGLRARKLEELIQGAQCVHSPRFPAQYLKLRERMQIQKEMERLRFLLSDQSLLLLPEYHQRVEVLRTLGYVDEAGTVKLAGRVACAMSSHELLLTELMFDNALSTLRPEEIAALLSGLVCQSPGDAGDQLPNTLKQGIERVRAVAKRIGEVQVACGLNQTVEEFVGELNFGLVEVVYEWARGMPFSELAGLSGTPEGLVVRCIQRLAEMCRSLRGAARLVGEPVLGAKMETAATLLRRDIVFAASLYTQ,False,False,True,Q15477,"[('cd18027', 'DEXH-box helicase domain of SKIV2L'), ('cd18795', 'C-terminal helicase domain of the Ski2 family helicases'), ('G3DSA:1.10.3380.30', None), ('G3DSA:3.40.50.300', 'P-loop containing nucleotide triphosphate hydrolases'), ('IPR001650', 'Helicase, C-terminal domain-like'), ('IPR011545', 'DEAD/DEAH box helicase domain'), ('IPR012961', 'ATP-dependent RNA helicase Ski2/MTR4, C-terminal'), ('IPR014001', 'Helicase superfamily 1/2, ATP-binding domain'), ('IPR016438', 'ATP-dependent RNA helicase SKI2-like'), ('IPR025696', 'Exosome RNA helicase MTR4-like, beta-barrel domain'), ('IPR027417', 'P-loop containing nucleoside triphosphate hydrolase'), ('IPR040801', 'Ski2, N-terminal domain'), ('IPR048392', 'Exosome RNA helicase MTR4-like, stalk'), ('IPR050699', 'RNA/DNA Helicase'), ('PF00270', 'DEAD/DEAH box helicase'), ('PF00271', 'Helicase conserved C-terminal domain'), ('PF08148', 'DSHCT (NUC185) domain'), ('PF13234', 'Mtr4-like, beta-barrel domain'), ('PF17911', 'Ski2 N-terminal region'), ('PF21408', 'Exosome RNA helicase MTR4-like, stalk')]",,"""ENSG00000204351; Low tissue specificity."";","CATALYTIC ACTIVITY: Reaction=ATP + H2O = ADP + phosphate + H(+); Xref=Rhea:RHEA:13065, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616, ChEBI:CHEBI:43474, ChEBI:CHEBI:456216; EC=3.6.4.13; Evidence={ECO:0000269|PubMed:35120588, ECO:0000269|PubMed:7610041};",3.6.4.13,,,ENST00000375394.7;ENST00000383336.6;ENST00000412823.4;ENST00000421789.4;ENST00000429465.4;ENST00000448219.4;,SKIC2,ENSG00000204351,5.0,SKIC2,Canonical_RBPs,8.0,,,,0.189,0.022,SKIC2
Q15637,ENSG00000168066,SF01_HUMAN,"Leydig cell differentiation [GO:0033327]; male sex determination [GO:0030238]; mRNA 3'-splice site recognition [GO:0000389]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of smooth muscle cell proliferation [GO:0048662]; nuclear body organization [GO:0030575]; regulation of mRNA splicing, via spliceosome [GO:0048024]; regulation of steroid biosynthetic process [GO:0050810]; spliceosomal complex assembly [GO:0000245]",nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; ribosome [GO:0005840]; spliceosomal complex [GO:0005681]; U2AF complex [GO:0089701],identical protein binding [GO:0042802]; mRNA binding [GO:0003729]; RNA binding [GO:0003723]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270],PTM: Phosphorylation on Ser-20 interferes with U2AF2 binding and spliceosome assembly. Isoform 6 is phosphorylated on Ser-463. {ECO:0000269|PubMed:10449420}.,,"DOMAIN 141..222; /note=""KH""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00117""","STRAND 15..17; /evidence=""ECO:0007829|PDB:1O0P""; STRAND 93..95; /evidence=""ECO:0007829|PDB:4FXW""; STRAND 136..141; /evidence=""ECO:0007829|PDB:7VPX""; STRAND 173..178; /evidence=""ECO:0007829|PDB:7VPX""; STRAND 204..211; /evidence=""ECO:0007829|PDB:7VPX""","HELIX 27..30; /evidence=""ECO:0007829|PDB:4FXX""; HELIX 46..67; /evidence=""ECO:0007829|PDB:4FXW""; HELIX 76..79; /evidence=""ECO:0007829|PDB:2M09""; HELIX 97..115; /evidence=""ECO:0007829|PDB:4FXW""; HELIX 116..118; /evidence=""ECO:0007829|PDB:4FXW""; HELIX 152..157; /evidence=""ECO:0007829|PDB:7VPX""; HELIX 159..161; /evidence=""ECO:0007829|PDB:7VPX""; HELIX 162..171; /evidence=""ECO:0007829|PDB:7VPX""; HELIX 212..228; /evidence=""ECO:0007829|PDB:7VPX""; HELIX 238..244; /evidence=""ECO:0007829|PDB:1K1G""; HELIX 245..248; /evidence=""ECO:0007829|PDB:1K1G""; HELIX 305..320; /evidence=""ECO:0007829|PDB:7VH9""","TURN 144..146; /evidence=""ECO:0007829|PDB:7VPX""; TURN 249..252; /evidence=""ECO:0007829|PDB:1K1G""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,SF1 ZFM1 ZNF162,Splicing factor 1 (Mammalian branch point-binding protein) (BBP) (mBBP) (Transcription factor ZFM1) (Zinc finger gene in MEN1 locus) (Zinc finger protein 162),Homo sapiens (Human),639.0,68330.0,MATGANATPLDFPSKKRKRSRWNQDTMEQKTVIPGMPTVIPPGLTREQERAYIVQLQIEDLTRKLRTGDLGIPPNPEDRSPSPEPIYNSEGKRLNTREFRTRKKLEEERHNLITEMVALNPDFKPPADYKPPATRVSDKVMIPQDEYPEINFVGLLIGPRGNTLKNIEKECNAKIMIRGKGSVKEGKVGRKDGQMLPGEDEPLHALVTANTMENVKKAVEQIRNILKQGIETPEDQNDLRKMQLRELARLNGTLREDDNRILRPWQSSETRSITNTTVCTKCGGAGHIASDCKFQRPGDPQSAQDKARMDKEYLSLMAELGEAPVPASVGSTSGPATTPLASAPRPAAPANNPPPPSLMSTTQSRPPWMNSGPSESRPYHGMHGGGPGGPGGGPHSFPHPLPSLTGGHGGHPMQHNPNGPPPPWMQPPPPPMNQGPHPPGHHGPPPMDQYLGSTPVGSGVYRLHQGKGMMPPPPMGMMPPPPPPPSGQPPPPPSGPLPPWQQQQQQPPPPPPPSSSMASSTPLPWQQNTTTTTTSAGTGSIPPWQQQQAAAAASPGAPQMQGNPTMVPLPPGVQPPLPPGAPPPPPPPPPGSAGMMYAPPPPPPPPMDPSNFVTMMGMGVAGMPPFGMPPAPPPPPPQN,False,False,True,Q15637,"[('cd22382', 'type I K homology (KH) RNA-binding domain found in splicing factor 1 (SF1) and similar proteins'), ('G3DSA:3.30.1370.10', 'K Homology domain, type 1'), ('G3DSA:6.10.140.1790', None), ('IPR001878', 'Zinc finger, CCHC-type'), ('IPR004087', 'K Homology domain'), ('IPR032570', 'Splicing factor 1, helix-hairpin domain'), ('IPR036612', 'K Homology domain, type 1 superfamily'), ('IPR045071', 'KH domain-containing BBP-like'), ('IPR047086', 'Splicing factor 1, helix-hairpin domain superfamily'), ('IPR055256', 'KHDC4/BBP-like, KH-domain type I'), ('PF00098', 'Zinc knuckle'), ('PF16275', 'Splicing factor 1 helix-hairpin domain'), ('PF22675', 'KHDC4/BBP-like, KH-domain type I'), ('PS50084', 'Type-1 KH domain profile'), ('PS50158', 'Zinc finger CCHC-type profile'), ('PTHR11208', 'RNA-BINDING PROTEIN RELATED'), ('SM00322', 'K homology RNA-binding domain'), ('SM00343', 'zinc finger'), ('SSF54791', 'Eukaryotic type KH-domain (KH-domain type I)')]",Q15637;,"""ENSG00000168066; Low tissue specificity."";",,,,,ENST00000227503.13 [Q15637-4];ENST00000334944.9 [Q15637-2];ENST00000377387.5 [Q15637-5];ENST00000377390.8 [Q15637-1];ENST00000377394.7 [Q15637-6];ENST00000433274.6 [Q15637-7];,SF1,ENSG00000168066,0.0,SF1,Canonical_RBPs,33.0,8.14,DP01449,0.097,0.676,0.606,SF1
Q15723,ENSG00000109381,ELF2_HUMAN,negative regulation of DNA-templated transcription [GO:0045892]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of transcription by RNA polymerase II [GO:0006357],chromatin [GO:0000785]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; sequence-specific DNA binding [GO:0043565]; sequence-specific double-stranded DNA binding [GO:1990837]",,,,,,,"cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,ELF2 NERF,ETS-related transcription factor Elf-2 (E74-like factor 2) (New ETS-related factor),Homo sapiens (Human),593.0,63967.0,MTSAVVDSGGTILELSSNGVENQEESEKVSEYPAVIVEPVPSARLEQGYAAQVLVYDDETYMMQDVAEEQEVETENVETVEASVHSSNAHCTDKTIEAAEALLHMESPTCLRDSRSPVEVFVPPCVSTPEFIHAAMRPDVITETVVEVSTEESEPMDTSPIPTSPDSHEPMKKKKVGRKPKTQQSPISNGSPELGIKKKPREGKGNTTYLWEFLLDLLQDKNTCPRYIKWTQREKGIFKLVDSKAVSKLWGKHKNKPDMNYETMGRALRYYYQRGILAKVEGQRLVYQFKDMPKNIVVIDDDKSETCNEDLAGTTDEKSLERVSLSAESLLKAASSVRSGKNSSPINCSRAEKGVARVVNITSPGHDASSRSPTTTASVSATAAPRTVRVAMQVPVVMTSLGQKISTVAVQSVNAGAPLITSTSPTTATSPKVVIQTIPTVMPASTENGDKITMQPAKIITIPATQLAQCQLQTKSNLTGSGSINIVGTPLAVRALTPVSIAHGTPVMRLSMPTQQASGQTPPRVISAVIKGPEVKSEAVAKKQEHDVKTLQLVEEKPADGNKTVTHVVVVSAPSAIALPVTMKTEGLVTCEK,True,False,False,Q15723,"[('G3DSA:1.10.10.10', 'Winged helix-like DNA-binding domain superfamily/Winged helix DNA-binding domain'), ('IPR000418', 'Ets domain'), ('IPR022084', 'Transcription factor Elf, N-terminal'), ('IPR036388', 'Winged helix-like DNA-binding domain superfamily'), ('IPR036390', 'Winged helix DNA-binding domain superfamily'), ('IPR046328', 'ETS family'), ('PF00178', 'Ets-domain'), ('PF12310', 'Transcription factor protein N terminal'), ('PR00454', 'ETSDOMAIN'), ('PS00345', 'Ets-domain signature 1'), ('PS00346', 'Ets-domain signature 2'), ('PS50061', 'Ets-domain profile'), ('PTHR11849', 'ETS'), ('SM00413', 'erythroblast transformation specific domain'), ('SSF46785', '""Winged helix"" DNA-binding domain')]",,"""ENSG00000109381; Low tissue specificity."";",,,,,ENST00000358635.7 [Q15723-3];ENST00000379549.7 [Q15723-4];ENST00000379550.5 [Q15723-5];ENST00000394235.6 [Q15723-1];ENST00000510408.5 [Q15723-2];ENST00000686138.1 [Q15723-5];,ELF2,ENSG00000109381,0.0,,,,,,,0.696,0.094,ELF2
Q15750,ENSG00000100324,TAB1_HUMAN,aorta development [GO:0035904]; cardiac septum development [GO:0003279]; coronary vasculature development [GO:0060976]; heart morphogenesis [GO:0003007]; in utero embryonic development [GO:0001701]; lung development [GO:0030324]; non-canonical NF-kappaB signal transduction [GO:0038061]; positive regulation of cGAS/STING signaling pathway [GO:0141111]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of protein serine/threonine kinase activity [GO:0071902]; protein dephosphorylation [GO:0006470]; transforming growth factor beta receptor signaling pathway [GO:0007179],cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789]; endosome membrane [GO:0010008]; nuclear speck [GO:0016607]; protein-containing complex [GO:0032991],mitogen-activated protein kinase p38 binding [GO:0048273]; molecular adaptor activity [GO:0060090]; protein serine/threonine kinase activator activity [GO:0043539]; protein serine/threonine phosphatase activity [GO:0004722]; protein-containing complex binding [GO:0044877],"PTM: Phosphorylated at all three sites Ser-423, Thr-431 and Ser-438 by MAPK14 when cells were exposed to cellular stresses, or stimulated with TNF-alpha, IL1 or LPS (PubMed:14592977). These phosphorylations inhibit TAK1 activation by a feedback control mechanism (PubMed:14592977). Dephosphorylated by DUSP14 at Ser-438, leading to TAB1-MAP3K7/TAK1 complex inactivation in T-cells (PubMed:24403530). {ECO:0000269|PubMed:14592977, ECO:0000269|PubMed:24403530}.; PTM: Ubiquitinated by MAP3K1 with 'Lys-63'-linked polyubiquitin; leading to activation of TAK1 and of JNK and p38 MAP kinases following EGF and TGF-beta stimulation (PubMed:25260751). Ubiquitinated by ITCH with 'Lys-48'-linked polyubiquitin; leading to proteasomal degradation (PubMed:25714464). Ubiquitinated by RNF114 during maternal-to-zygotic transition; leading to degradation (By similarity). {ECO:0000250|UniProtKB:Q8CF89, ECO:0000269|PubMed:25260751, ECO:0000269|PubMed:25714464}.; PTM: (Microbial infection) Deubiquitinated by Y.enterocolitica YopP. {ECO:0000269|PubMed:16845370}.; PTM: O-GlcNAcylated at Ser-395 by OGT is required for full MAP3K7/TAK1 activation upon stimulation with IL-1 or osmotic stress (PubMed:22307082). Deglycosylated at Ser-395 by OGA (PubMed:28939839). {ECO:0000269|PubMed:22307082, ECO:0000269|PubMed:28939839}.",,"DOMAIN 28..365; /note=""PPM-type phosphatase""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU01082""","STRAND 27..32; /evidence=""ECO:0007829|PDB:2J4O""; STRAND 35..37; /evidence=""ECO:0007829|PDB:2J4O""; STRAND 39..42; /evidence=""ECO:0007829|PDB:2J4O""; STRAND 44..46; /evidence=""ECO:0007829|PDB:5NZZ""; STRAND 51..58; /evidence=""ECO:0007829|PDB:2J4O""; STRAND 62..74; /evidence=""ECO:0007829|PDB:2J4O""; STRAND 89..92; /evidence=""ECO:0007829|PDB:2J4O""; STRAND 94..96; /evidence=""ECO:0007829|PDB:2POP""; STRAND 165..174; /evidence=""ECO:0007829|PDB:2J4O""; STRAND 177..185; /evidence=""ECO:0007829|PDB:2J4O""; STRAND 187..193; /evidence=""ECO:0007829|PDB:2J4O""; STRAND 195..202; /evidence=""ECO:0007829|PDB:2J4O""; STRAND 234..236; /evidence=""ECO:0007829|PDB:2POM""; STRAND 239..241; /evidence=""ECO:0007829|PDB:2POM""; STRAND 265..267; /evidence=""ECO:0007829|PDB:2J4O""; STRAND 271..277; /evidence=""ECO:0007829|PDB:2J4O""; STRAND 283..288; /evidence=""ECO:0007829|PDB:2J4O""; STRAND 302..304; /evidence=""ECO:0007829|PDB:2POP""; STRAND 353..355; /evidence=""ECO:0007829|PDB:2J4O""; STRAND 358..366; /evidence=""ECO:0007829|PDB:2J4O""; STRAND 475..478; /evidence=""ECO:0007829|PDB:7NTH""","HELIX 75..86; /evidence=""ECO:0007829|PDB:2J4O""; HELIX 99..133; /evidence=""ECO:0007829|PDB:2J4O""; HELIX 141..143; /evidence=""ECO:0007829|PDB:2POM""; HELIX 146..148; /evidence=""ECO:0007829|PDB:2J4O""; HELIX 149..162; /evidence=""ECO:0007829|PDB:2J4O""; HELIX 212..219; /evidence=""ECO:0007829|PDB:2J4O""; HELIX 225..231; /evidence=""ECO:0007829|PDB:2J4O""; HELIX 246..250; /evidence=""ECO:0007829|PDB:2J4O""; HELIX 252..254; /evidence=""ECO:0007829|PDB:2J4O""; HELIX 290..300; /evidence=""ECO:0007829|PDB:2J4O""; HELIX 305..319; /evidence=""ECO:0007829|PDB:2J4O""; HELIX 323..343; /evidence=""ECO:0007829|PDB:2J4O""; HELIX 348..351; /evidence=""ECO:0007829|PDB:2J4O""; HELIX 485..494; /evidence=""ECO:0007829|PDB:7NTH""","TURN 18..20; /evidence=""ECO:0007829|PDB:2J4O""; TURN 59..61; /evidence=""ECO:0007829|PDB:2J4O""; TURN 220..222; /evidence=""ECO:0007829|PDB:2J4O""; TURN 256..260; /evidence=""ECO:0007829|PDB:2J4O""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,TAB1 MAP3K7IP1,TGF-beta-activated kinase 1 and MAP3K7-binding protein 1 (Mitogen-activated protein kinase kinase kinase 7-interacting protein 1) (TGF-beta-activated kinase 1-binding protein 1) (TAK1-binding protein 1),Homo sapiens (Human),504.0,54644.0,MAAQRRSLLQSEQQPSWTDDLPLCHLSGVGSASNRSYSADGKGTESHPPEDSWLKFRSENNCFLYGVFNGYDGNRVTNFVAQRLSAELLLGQLNAEHAEADVRRVLLQAFDVVERSFLESIDDALAEKASLQSQLPEGVPQHQLPPQYQKILERLKTLEREISGGAMAVVAVLLNNKLYVANVGTNRALLCKSTVDGLQVTQLNVDHTTENEDELFRLSQLGLDAGKIKQVGIICGQESTRRIGDYKVKYGYTDIDLLSAAKSKPIIAEPEIHGAQPLDGVTGFLVLMSEGLYKALEAAHGPGQANQEIAAMIDTEFAKQTSLDAVAQAVVDRVKRIHSDTFASGGERARFCPRHEDMTLLVRNFGYPLGEMSQPTPSPAPAAGGRVYPVSVPYSSAQSTSKTSVTLSLVMPSQGQMVNGAHSASTLDEATPTLTNQSPTLTLQSTNTHTQSSSSSSDGGLFRSRPAHSLPPGEDGRVEPYVDFAEFYRLWSVDHGEQSVVTAP,False,False,True,Q15750,"[('cd00143', 'PP2Cc'), ('G3DSA:3.60.40.10', 'PPM-type phosphatase domain'), ('IPR001932', 'PPM-type phosphatase-like domain'), ('IPR015655', 'Protein phosphatase 2C'), ('IPR036457', 'PPM-type phosphatase-like domain superfamily'), ('PF00481', 'Protein phosphatase 2C'), ('PS51746', 'PPM-type phosphatase domain profile'), ('PTHR13832', 'PROTEIN PHOSPHATASE 2C'), ('SM00332', 'Serine/threonine phosphatases, family 2C, catalytic domain'), ('SSF81606', 'PP2C-like')]",Q15750;,"""ENSG00000100324; Low tissue specificity."";",,,,,ENST00000216160.11 [Q15750-1];ENST00000331454.3 [Q15750-2];,TAB1,ENSG00000100324,0.0,,,,,,,0.296,0.141,TAB1
Q15773,ENSG00000089693,MLF2_HUMAN,regulation of DNA-templated transcription [GO:0006355],cytoplasm [GO:0005737]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; nucleus [GO:0005634],,,,,,,,"cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,MLF2,Myeloid leukemia factor 2 (Myelodysplasia-myeloid leukemia factor 2),Homo sapiens (Human),248.0,28147.0,MFRFMRDVEPEDPMFLMDPFAIHRQHMSRMLSGGFGYSPFLSITDGNMPGTRPASRRMQQAGAVSPFGMLGMSGGFMDMFGMMNDMIGNMEHMTAGGNCQTFSSSTVISYSNTGDGAPKVYQETSEMRSAPGGIRETRRTVRDSDSGLEQMSIGHHIRDRAHILQRSRNHRTGDQEERQDYINLDESEAAAFDDEWRRETSRFRQQRPLEFRRLESSGAGGRRAEGPPRLAIQGPEDSPSRQSRRYDW,False,False,True,Q15773,"[('IPR019376', 'Myeloid leukemia factor'), ('PF10248', 'Myelodysplasia-myeloid leukemia factor 1-interacting protein'), ('PTHR13105', 'MYELOID LEUKEMIA FACTOR')]",,"""ENSG00000089693; Low tissue specificity."";",,,,,ENST00000203630.10;ENST00000435120.5;ENST00000539187.5;,MLF2,ENSG00000089693,0.0,,,,,,,0.476,0.335,MLF2
Q15796,ENSG00000175387,SMAD2_HUMAN,activin receptor signaling pathway [GO:0032924]; adrenal gland development [GO:0030325]; anatomical structure morphogenesis [GO:0009653]; anterior/posterior pattern specification [GO:0009952]; aortic valve morphogenesis [GO:0003180]; cell differentiation [GO:0030154]; cell fate commitment [GO:0045165]; cell population proliferation [GO:0008283]; cellular response to glucose stimulus [GO:0071333]; determination of left/right asymmetry in lateral mesoderm [GO:0003140]; DNA-templated transcription [GO:0006351]; embryonic cranial skeleton morphogenesis [GO:0048701]; embryonic foregut morphogenesis [GO:0048617]; endocardial cushion morphogenesis [GO:0003203]; endoderm formation [GO:0001706]; gastrulation [GO:0007369]; in utero embryonic development [GO:0001701]; insulin secretion [GO:0030073]; intracellular signal transduction [GO:0035556]; lung development [GO:0030324]; mesoderm formation [GO:0001707]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA-templated transcription [GO:0045892]; nodal signaling pathway [GO:0038092]; odontoblast differentiation [GO:0071895]; organ growth [GO:0035265]; pancreas development [GO:0031016]; paraxial mesoderm morphogenesis [GO:0048340]; pericardium development [GO:0060039]; positive regulation of BMP signaling pathway [GO:0030513]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of epithelial to mesenchymal transition [GO:0010718]; positive regulation of gene expression [GO:0010628]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-embryonic development [GO:0009791]; primary miRNA processing [GO:0031053]; pulmonary valve morphogenesis [GO:0003184]; regulation of binding [GO:0051098]; regulation of DNA-templated transcription [GO:0006355]; regulation of transforming growth factor beta receptor signaling pathway [GO:0017015]; response to cholesterol [GO:0070723]; secondary palate development [GO:0062009]; signal transduction involved in regulation of gene expression [GO:0023019]; SMAD protein signal transduction [GO:0060395]; transforming growth factor beta receptor signaling pathway [GO:0007179]; ureteric bud development [GO:0001657]; zygotic specification of dorsal/ventral axis [GO:0007352],activin responsive factor complex [GO:0032444]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; heteromeric SMAD protein complex [GO:0071144]; homomeric SMAD protein complex [GO:0071142]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; SMAD protein complex [GO:0071141]; transcription regulator complex [GO:0005667],"chromatin binding [GO:0003682]; cis-regulatory region sequence-specific DNA binding [GO:0000987]; co-SMAD binding [GO:0070410]; disordered domain specific binding [GO:0097718]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; DNA-binding transcription factor binding [GO:0140297]; double-stranded DNA binding [GO:0003690]; I-SMAD binding [GO:0070411]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; phosphatase binding [GO:0019902]; R-SMAD binding [GO:0070412]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; SMAD binding [GO:0046332]; tau protein binding [GO:0048156]; transforming growth factor beta receptor binding [GO:0005160]; type I transforming growth factor beta receptor binding [GO:0034713]; ubiquitin protein ligase binding [GO:0031625]","PTM: Phosphorylated on one or several of Thr-220, Ser-245, Ser-250, and Ser-255. In response to TGF-beta, phosphorylated on Ser-465/467 by TGF-beta and activin type 1 receptor kinases. TGF-beta-induced Ser-465/467 phosphorylation declines progressively in a KMT5A-dependent manner. Able to interact with SMURF2 when phosphorylated on Ser-465/467, recruiting other proteins, such as SNON, for degradation. In response to decorin, the naturally occurring inhibitor of TGF-beta signaling, phosphorylated on Ser-240 by CaMK2. Phosphorylated by MAPK3 upon EGF stimulation; which increases transcriptional activity and stability, and is blocked by calmodulin. Phosphorylated by PDPK1. {ECO:0000269|PubMed:11879191, ECO:0000269|PubMed:12193595, ECO:0000269|PubMed:17327236, ECO:0000269|PubMed:23478445, ECO:0000269|PubMed:8752209, ECO:0000269|PubMed:8980228, ECO:0000269|PubMed:9136927, ECO:0000269|PubMed:9346908}.; PTM: In response to TGF-beta, ubiquitinated by NEDD4L; which promotes its degradation. Monoubiquitinated, leading to prevent DNA-binding (By similarity). Deubiquitination by USP15 alleviates inhibition and promotes activation of TGF-beta target genes (PubMed:21947082). Ubiquitinated by RNF111, leading to its degradation: only SMAD2 proteins that are 'in use' are targeted by RNF111, RNF111 playing a key role in activating SMAD2 and regulating its turnover (By similarity). {ECO:0000250|UniProtKB:Q62432, ECO:0000269|PubMed:21947082}.; PTM: Acetylated on Lys-19 by coactivators in response to TGF-beta signaling, which increases transcriptional activity. Isoform short: Acetylation increases DNA binding activity in vitro and enhances its association with target promoters in vivo. Acetylation in the nucleus by EP300 is enhanced by TGF-beta. {ECO:0000269|PubMed:16862174, ECO:0000269|PubMed:17074756, ECO:0000269|Ref.7}.",,"DOMAIN 10..176; /note=""MH1""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00438""; DOMAIN 274..467; /note=""MH2""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00439""","STRAND 264..267; /evidence=""ECO:0007829|PDB:1DEV""; STRAND 272..281; /evidence=""ECO:0007829|PDB:6M64""; STRAND 290..292; /evidence=""ECO:0007829|PDB:6M64""; STRAND 294..302; /evidence=""ECO:0007829|PDB:6M64""; STRAND 305..307; /evidence=""ECO:0007829|PDB:1U7V""; STRAND 310..312; /evidence=""ECO:0007829|PDB:6M64""; STRAND 336..341; /evidence=""ECO:0007829|PDB:6M64""; STRAND 344..349; /evidence=""ECO:0007829|PDB:6M64""; STRAND 351..353; /evidence=""ECO:0007829|PDB:6M64""; STRAND 355..358; /evidence=""ECO:0007829|PDB:6M64""; STRAND 374..376; /evidence=""ECO:0007829|PDB:6M64""; STRAND 381..386; /evidence=""ECO:0007829|PDB:6M64""; STRAND 413..419; /evidence=""ECO:0007829|PDB:6M64""; STRAND 423..427; /evidence=""ECO:0007829|PDB:1KHX""; STRAND 434..442; /evidence=""ECO:0007829|PDB:6M64""","HELIX 313..315; /evidence=""ECO:0007829|PDB:6M64""; HELIX 323..329; /evidence=""ECO:0007829|PDB:6M64""; HELIX 360..366; /evidence=""ECO:0007829|PDB:6M64""; HELIX 387..398; /evidence=""ECO:0007829|PDB:6M64""; HELIX 402..406; /evidence=""ECO:0007829|PDB:6M64""; HELIX 407..412; /evidence=""ECO:0007829|PDB:6M64""; HELIX 431..433; /evidence=""ECO:0007829|PDB:6M64""; HELIX 443..453; /evidence=""ECO:0007829|PDB:6M64""","TURN 330..334; /evidence=""ECO:0007829|PDB:1KHX""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,SMAD2 MADH2 MADR2,Mothers against decapentaplegic homolog 2 (MAD homolog 2) (Mothers against DPP homolog 2) (JV18-1) (Mad-related protein 2) (hMAD-2) (SMAD family member 2) (SMAD 2) (Smad2) (hSMAD2),Homo sapiens (Human),467.0,52306.0,MSSILPFTPPVVKRLLGWKKSAGGSGGAGGGEQNGQEEKWCEKAVKSLVKKLKKTGRLDELEKAITTQNCNTKCVTIPSTCSEIWGLSTPNTIDQWDTTGLYSFSEQTRSLDGRLQVSHRKGLPHVIYCRLWRWPDLHSHHELKAIENCEYAFNLKKDEVCVNPYHYQRVETPVLPPVLVPRHTEILTELPPLDDYTHSIPENTNFPAGIEPQSNYIPETPPPGYISEDGETSDQQLNQSMDTGSPAELSPTTLSPVNHSLDLQPVTYSEPAFWCSIAYYELNQRVGETFHASQPSLTVDGFTDPSNSERFCLGLLSNVNRNATVEMTRRHIGRGVRLYYIGGEVFAECLSDSAIFVQSPNCNQRYGWHPATVCKIPPGCNLKIFNNQEFAALLAQSVNQGFEAVYQLTRMCTIRMSFVKGWGAEYRRQTVTSTPCWIELHLNGPLQWLDKVLTQMGSPSVRCSSMS,True,False,False,Q15796,"[('cd10491', 'N-terminal Mad Homology 1 (MH1) domain in SMAD2 and SMAD3'), ('cd10985', 'C-terminal Mad Homology 2 (MH2) domain in SMAD2 and SMAD3'), ('G3DSA:2.60.200.10', None), ('G3DSA:3.90.520.10', 'SMAD MH1 domain'), ('IPR001132', 'SMAD domain, Dwarfin-type'), ('IPR003619', 'MAD homology 1, Dwarfin-type'), ('IPR008984', 'SMAD/FHA domain superfamily'), ('IPR013019', 'MAD homology, MH1'), ('IPR013790', 'Dwarfin'), ('IPR017855', 'SMAD-like domain superfamily'), ('IPR036578', 'SMAD MH1 domain superfamily'), ('PF03165', 'MH1 domain'), ('PF03166', 'MH2 domain'), ('PS51075', 'MAD homology domain 1 (MH1) profile'), ('PS51076', 'MAD homology domain 2 (MH2) profile'), ('PTHR13703', 'SMAD'), ('SM00523', 'Domain A in dwarfin family proteins'), ('SM00524', 'Domain B in dwarfin family proteins'), ('SSF49879', 'SMAD/FHA domain'), ('SSF56366', 'SMAD MH1 domain')]",,"""ENSG00000175387; Low tissue specificity."";",,,,,ENST00000262160.11 [Q15796-1];ENST00000356825.8 [Q15796-2];ENST00000402690.6 [Q15796-1];ENST00000586040.5 [Q15796-2];,SMAD2,ENSG00000175387,0.0,SMAD2,Non-canonical_RBPs,3.0,10.92,DP01319,0.109,0.332,0.096,SMAD2
Q15797,ENSG00000170365,SMAD1_HUMAN,anatomical structure morphogenesis [GO:0009653]; BMP signaling pathway [GO:0030509]; bone development [GO:0060348]; cardiac conduction system development [GO:0003161]; cardiac muscle cell proliferation [GO:0060038]; cartilage development [GO:0051216]; cell differentiation [GO:0030154]; cellular response to organic cyclic compound [GO:0071407]; DNA-templated transcription [GO:0006351]; embryonic pattern specification [GO:0009880]; gamete generation [GO:0007276]; hindbrain development [GO:0030902]; homeostatic process [GO:0042592]; inflammatory response [GO:0006954]; MAPK cascade [GO:0000165]; mesodermal cell fate commitment [GO:0001710]; midbrain development [GO:0030901]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of muscle cell differentiation [GO:0051148]; ossification [GO:0001503]; osteoblast fate commitment [GO:0002051]; positive regulation of cartilage development [GO:0061036]; positive regulation of gene expression [GO:0010628]; positive regulation of miRNA transcription [GO:1902895]; positive regulation of osteoblast differentiation [GO:0045669]; positive regulation of sprouting angiogenesis [GO:1903672]; positive regulation of transcription by RNA polymerase II [GO:0045944]; primary miRNA processing [GO:0031053]; regulation of transcription by RNA polymerase II [GO:0006357]; signal transduction [GO:0007165]; SMAD protein signal transduction [GO:0060395]; transcription by RNA polymerase II [GO:0006366]; transforming growth factor beta receptor signaling pathway [GO:0007179]; ureteric bud development [GO:0001657],chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; heteromeric SMAD protein complex [GO:0071144]; homomeric SMAD protein complex [GO:0071142]; membrane [GO:0016020]; nuclear inner membrane [GO:0005637]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; SMAD protein complex [GO:0071141],"co-SMAD binding [GO:0070410]; DEAD/H-box RNA helicase binding [GO:0017151]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; I-SMAD binding [GO:0070411]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; primary miRNA binding [GO:0070878]; protein kinase binding [GO:0019901]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; ubiquitin protein ligase binding [GO:0031625]","PTM: Phosphorylation of the C-terminal SVS motif by BMP type 1 receptor kinase activates SMAD1 by promoting dissociation from the receptor and trimerization with SMAD4. Phosphorylation by ERK2 MAP kinase in response to EGF or HGF prevents SMAD1 nuclear accumulation and transcriptional activity in response to BMP (PubMed:9335504). Dephosphorylation, probably by PPM1A, induces its export from the nucleus to the cytoplasm (By similarity). Dephosphorylation is inhibited by association with EGR1 (By similarity). Phosphorylation by CDK8/9 creates binding sites for YAP1, and subsequent phosphorylation by GSK3 switches off YAP1 binding and adds binding sites for SMURF1 (PubMed:21685363). {ECO:0000250|UniProtKB:P70340, ECO:0000269|PubMed:11779505, ECO:0000269|PubMed:21685363, ECO:0000269|PubMed:21690388, ECO:0000269|PubMed:9136927, ECO:0000269|PubMed:9335504}.; PTM: Ubiquitinated by SMAD-specific E3 ubiquitin ligase SMURF1, leading to its degradation. Monoubiquitinated, leading to prevent DNA-binding. Deubiquitination by USP15 alleviates inhibition and promotes activation of TGF-beta target genes. Dephosphorylation, probably by PPM1A, induces its export from the nucleus to the cytoplasm (By similarity). Phospho-SMAD1 is ubiquitinated by CHIP leading to disruption of the SMAD1-SMAD4 complex (PubMed:21454478). {ECO:0000250|UniProtKB:P70340, ECO:0000269|PubMed:21454478, ECO:0000269|PubMed:21947082}.",DOMAIN: The MH2 domain mediates phosphorylation-dependent trimerization through L3 loop binding of phosphoserines in the adjacent subunit. {ECO:0000269|PubMed:11779505}.,"DOMAIN 12..136; /note=""MH1""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00438""; DOMAIN 271..465; /note=""MH2""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00439""","STRAND 272..278; /evidence=""ECO:0007829|PDB:1KHU""; STRAND 281..288; /evidence=""ECO:0007829|PDB:5ZOK""; STRAND 291..299; /evidence=""ECO:0007829|PDB:1KHU""; STRAND 305..310; /evidence=""ECO:0007829|PDB:1KHU""; STRAND 334..338; /evidence=""ECO:0007829|PDB:1KHU""; STRAND 340..347; /evidence=""ECO:0007829|PDB:1KHU""; STRAND 349..351; /evidence=""ECO:0007829|PDB:1KHU""; STRAND 353..356; /evidence=""ECO:0007829|PDB:1KHU""; STRAND 372..374; /evidence=""ECO:0007829|PDB:1KHU""; STRAND 379..384; /evidence=""ECO:0007829|PDB:1KHU""; STRAND 411..417; /evidence=""ECO:0007829|PDB:1KHU""; STRAND 421..425; /evidence=""ECO:0007829|PDB:5ZOK""; STRAND 432..440; /evidence=""ECO:0007829|PDB:1KHU""; STRAND 461..463; /evidence=""ECO:0007829|PDB:3Q47""","HELIX 321..327; /evidence=""ECO:0007829|PDB:1KHU""; HELIX 358..363; /evidence=""ECO:0007829|PDB:1KHU""; HELIX 385..393; /evidence=""ECO:0007829|PDB:1KHU""; HELIX 400..404; /evidence=""ECO:0007829|PDB:1KHU""; HELIX 405..410; /evidence=""ECO:0007829|PDB:1KHU""; HELIX 429..431; /evidence=""ECO:0007829|PDB:1KHU""; HELIX 441..451; /evidence=""ECO:0007829|PDB:1KHU""","TURN 328..332; /evidence=""ECO:0007829|PDB:5ZOK""; TURN 394..398; /evidence=""ECO:0007829|PDB:1KHU""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,SMAD1 BSP1 MADH1 MADR1,Mothers against decapentaplegic homolog 1 (MAD homolog 1) (Mothers against DPP homolog 1) (JV4-1) (Mad-related protein 1) (SMAD family member 1) (SMAD 1) (Smad1) (hSMAD1) (Transforming growth factor-beta-signaling protein 1) (BSP-1),Homo sapiens (Human),465.0,52260.0,MNVTSLFSFTSPAVKRLLGWKQGDEEEKWAEKAVDALVKKLKKKKGAMEELEKALSCPGQPSNCVTIPRSLDGRLQVSHRKGLPHVIYCRVWRWPDLQSHHELKPLECCEFPFGSKQKEVCINPYHYKRVESPVLPPVLVPRHSEYNPQHSLLAQFRNLGQNEPHMPLNATFPDSFQQPNSHPFPHSPNSSYPNSPGSSSSTYPHSPTSSDPGSPFQMPADTPPPAYLPPEDPMTQDGSQPMDTNMMAPPLPSEINRGDVQAVAYEEPKHWCSIVYYELNNRVGEAFHASSTSVLVDGFTDPSNNKNRFCLGLLSNVNRNSTIENTRRHIGKGVHLYYVGGEVYAECLSDSSIFVQSRNCNYHHGFHPTTVCKIPSGCSLKIFNNQEFAQLLAQSVNHGFETVYELTKMCTIRMSFVKGWGAEYHRQDVTSTPCWIEIHLHGPLQWLDKVLTQMGSPHNPISSVS,True,False,True,Q15797,"[('cd10490', 'N-terminal Mad Homology 1 (MH1) domain in SMAD1, SMAD5 and SMAD9 (also known as SMAD8)'), ('cd10497', 'C-terminal Mad Homology 2 (MH2) domain in SMAD1, SMAD5 and SMAD9'), ('G3DSA:2.60.200.10', None), ('G3DSA:3.90.520.10', 'SMAD MH1 domain'), ('IPR001132', 'SMAD domain, Dwarfin-type'), ('IPR003619', 'MAD homology 1, Dwarfin-type'), ('IPR008984', 'SMAD/FHA domain superfamily'), ('IPR013019', 'MAD homology, MH1'), ('IPR013790', 'Dwarfin'), ('IPR017855', 'SMAD-like domain superfamily'), ('IPR036578', 'SMAD MH1 domain superfamily'), ('PF03165', 'MH1 domain'), ('PF03166', 'MH2 domain'), ('PS51075', 'MAD homology domain 1 (MH1) profile'), ('PS51076', 'MAD homology domain 2 (MH2) profile'), ('PTHR13703', 'SMAD'), ('SM00523', 'Domain A in dwarfin family proteins'), ('SM00524', 'Domain B in dwarfin family proteins'), ('SSF49879', 'SMAD/FHA domain'), ('SSF56366', 'SMAD MH1 domain')]",,"""ENSG00000170365; Low tissue specificity."";",,,,,ENST00000302085.9 [Q15797-1];ENST00000394092.6 [Q15797-1];ENST00000515385.1 [Q15797-1];,SMAD1,ENSG00000170365,0.0,SMAD1,Non-canonical_RBPs,1.0,10.97,DP01206,0.14,0.245,0.187,SMAD1
Q15843,ENSG00000129559|ENSG00000285246,NEDD8_HUMAN,anatomical structure morphogenesis [GO:0009653]; modification-dependent protein catabolic process [GO:0019941]; protein localization [GO:0008104]; protein modification process [GO:0036211]; protein neddylation [GO:0045116]; proteolysis [GO:0006508]; regulation of postsynapse assembly [GO:0150052]; regulation of proteolysis [GO:0030162]; regulation of transcription by RNA polymerase II [GO:0006357]; ubiquitin-dependent protein catabolic process [GO:0006511],cytosol [GO:0005829]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],protein tag activity [GO:0031386]; ubiquitin protein ligase binding [GO:0031625],"PTM: Cleavage of precursor form by UCHL3 or SENP8 is necessary for function. {ECO:0000269|PubMed:12730221, ECO:0000269|PubMed:12759363, ECO:0000269|PubMed:9353319, ECO:0000269|PubMed:9790970}.; PTM: (Microbial infection) Deamidated at Gln-40 by bacterial cyclomodulin Cif produced by enteropathogenic E.coli, Y.pseudotuberculosis or B.pseudomallei, leading to impair NEDD8 ability to activate cullin-RING-based E3 ubiquitin-protein ligase complexes (CRL complexes) (PubMed:20688984, PubMed:21903097, PubMed:23175788, PubMed:23589306, PubMed:26632597). Deamidation occurs on NEDD8-modified cullins (PubMed:20850415, PubMed:21903097). NEDD8 deamidation prevents switching from the inactive to active state by maintaining the 'closed' structure of the CRL complexes (PubMed:23589306, PubMed:26632597). Deamidation may also impair its deconjugation by the COP9 signalosome; However this result needs additional evidences (PubMed:20850415, PubMed:21903097). {ECO:0000269|PubMed:20688984, ECO:0000269|PubMed:20850415, ECO:0000269|PubMed:21903097, ECO:0000269|PubMed:23175788, ECO:0000269|PubMed:23589306, ECO:0000269|PubMed:26632597}.",,,"STRAND 2..6; /evidence=""ECO:0007829|PDB:1NDD""; STRAND 8..10; /evidence=""ECO:0007829|PDB:4P5O""; STRAND 12..16; /evidence=""ECO:0007829|PDB:1NDD""; STRAND 41..45; /evidence=""ECO:0007829|PDB:1NDD""; STRAND 52..55; /evidence=""ECO:0007829|PDB:2NVU""; STRAND 66..71; /evidence=""ECO:0007829|PDB:1NDD""; STRAND 73..75; /evidence=""ECO:0007829|PDB:1XT9""","HELIX 23..34; /evidence=""ECO:0007829|PDB:1NDD""; HELIX 38..40; /evidence=""ECO:0007829|PDB:1NDD""; HELIX 56..59; /evidence=""ECO:0007829|PDB:1NDD""",,"cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,NEDD8,Ubiquitin-like protein NEDD8 (Neddylin) (Neural precursor cell expressed developmentally down-regulated protein 8) (NEDD-8),Homo sapiens (Human),81.0,9072.0,MLIKVKTLTGKEIEIDIEPTDKVERIKERVEEKEGIPPQQQRLIYSGKQMNDEKTAADYKILGGSVLHLVLALRGGGGLRQ,False,False,True,Q15843,"[('cd01806', 'ubiquitin-like (Ubl) domain found in neural precursor cell expressed developmentally down-regulated protein 8 (NEDD8) and similar proteins'), ('G3DSA:3.10.20.90', 'Phosphatidylinositol 3-kinase Catalytic Subunit; Chain A, domain 1'), ('IPR000626', 'Ubiquitin-like domain'), ('IPR019954', 'Ubiquitin conserved site'), ('IPR019956', 'Ubiquitin domain'), ('IPR029071', 'Ubiquitin-like domain superfamily'), ('IPR038738', 'Nedd8-like ubiquitin'), ('IPR050158', 'Ubiquitin and ubiquitin-like'), ('PF00240', 'Ubiquitin family'), ('PR00348', 'UBIQUITIN'), ('PS00299', 'Ubiquitin domain signature'), ('PS50053', 'Ubiquitin domain profile'), ('PTHR10666', 'Ubiquitin and ubiquitin-like'), ('SM00213', 'Ubiquitin homologues'), ('SSF54236', 'Ubiquitin-like')]",,"""ENSG00000129559; Low tissue specificity."";",,,,,ENST00000250495.10;ENST00000643069.2;,NEDD8,ENSG00000129559,1.0,,,,16.05,DP02302,0.16,0.16,,NEDD8
Q16236,ENSG00000116044,NF2L2_HUMAN,aflatoxin catabolic process [GO:0046223]; cell redox homeostasis [GO:0045454]; cellular response to angiotensin [GO:1904385]; cellular response to copper ion [GO:0071280]; cellular response to fluid shear stress [GO:0071498]; cellular response to glucose starvation [GO:0042149]; cellular response to hydrogen peroxide [GO:0070301]; cellular response to hypoxia [GO:0071456]; cellular response to laminar fluid shear stress [GO:0071499]; cellular response to methionine [GO:0061431]; cellular response to oxidative stress [GO:0034599]; cellular response to tumor necrosis factor [GO:0071356]; cellular response to xenobiotic stimulus [GO:0071466]; endoplasmic reticulum unfolded protein response [GO:0030968]; inflammatory response [GO:0006954]; integrated stress response signaling [GO:0140467]; negative regulation of cardiac muscle cell apoptotic process [GO:0010667]; negative regulation of cellular response to hypoxia [GO:1900038]; negative regulation of endothelial cell apoptotic process [GO:2000352]; negative regulation of ferroptosis [GO:0110076]; negative regulation of hematopoietic stem cell differentiation [GO:1902037]; negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway [GO:1902176]; negative regulation of vascular associated smooth muscle cell migration [GO:1904753]; PERK-mediated unfolded protein response [GO:0036499]; positive regulation of angiogenesis [GO:0045766]; positive regulation of blood coagulation [GO:0030194]; positive regulation of blood vessel endothelial cell migration [GO:0043536]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of ERAD pathway [GO:1904294]; positive regulation of gene expression [GO:0010628]; positive regulation of glucose import [GO:0046326]; positive regulation of glutathione biosynthetic process [GO:1903788]; positive regulation of neuron projection development [GO:0010976]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; proteasomal ubiquitin-independent protein catabolic process [GO:0010499]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; reactive oxygen species metabolic process [GO:0072593]; regulation of cellular response to oxidative stress [GO:1900407]; regulation of embryonic development [GO:0045995]; regulation of innate immune response [GO:0045088]; regulation of removal of superoxide radicals [GO:2000121]; regulation of transcription by RNA polymerase II [GO:0006357]; response to ischemia [GO:0002931]; response to oxidative stress [GO:0006979],centrosome [GO:0005813]; chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; Golgi apparatus [GO:0005794]; mediator complex [GO:0016592]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; protein-DNA complex [GO:0032993]; RNA polymerase II transcription regulator complex [GO:0090575],"DNA binding [GO:0003677]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; molecular condensate scaffold activity [GO:0140693]; protein domain specific binding [GO:0019904]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; sequence-specific DNA binding [GO:0043565]; transcription cis-regulatory region binding [GO:0000976]; transcription coregulator binding [GO:0001221]; ubiquitin protein ligase binding [GO:0031625]","PTM: Ubiquitinated in the cytoplasm by the BCR(KEAP1) E3 ubiquitin ligase complex leading to its degradation (PubMed:15601839, PubMed:15983046, PubMed:19489739). In response to oxidative stress, electrophile metabolites, such as sulforaphane, modify KEAP1, leading to inhibit activity of the BCR(KEAP1) complex, promoting NFE2L2/NRF2 nuclear accumulation and activity (PubMed:19489739, PubMed:29590092). In response to autophagy, the BCR(KEAP1) complex is inactivated (By similarity). {ECO:0000250|UniProtKB:Q60795, ECO:0000269|PubMed:15601839, ECO:0000269|PubMed:15983046, ECO:0000269|PubMed:19489739, ECO:0000269|PubMed:29590092}.; PTM: Phosphorylated by EIF2AK3/PERK following unfolded protein response (UPR), promoting dissociation from its cytoplasmic inhibitor KEAP1, followed by its translocation into the nucleus (By similarity). Phosphorylation of Ser-40 by PKC in response to oxidative stress dissociates NFE2L2 from its cytoplasmic inhibitor KEAP1, promoting its translocation into the nucleus (By similarity). {ECO:0000250|UniProtKB:O54968, ECO:0000250|UniProtKB:Q60795}.; PTM: Acetylation at Lys-596 and Lys-599 increases nuclear localization whereas deacetylation by SIRT1 enhances cytoplasmic presence. {ECO:0000269|PubMed:21196497}.; PTM: Glycation impairs transcription factor activity by preventing heterodimerization with small Maf proteins (PubMed:31398338). Deglycation by FN3K restores activity (PubMed:31398338). {ECO:0000269|PubMed:31398338}.","DOMAIN: The ETGE motif, and to a lower extent the DLG motif, mediate interaction with KEAP1. {ECO:0000269|PubMed:15601839}.","DOMAIN 497..560; /note=""bZIP""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00978""","STRAND 449..455; /evidence=""ECO:0007829|PDB:7O7B""","HELIX 456..463; /evidence=""ECO:0007829|PDB:7X5E""; HELIX 470..475; /evidence=""ECO:0007829|PDB:7X5E""; HELIX 478..485; /evidence=""ECO:0007829|PDB:7X5E""; HELIX 492..556; /evidence=""ECO:0007829|PDB:7X5E""","TURN 78..80; /evidence=""ECO:0007829|PDB:2FLU""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,NFE2L2 NRF2,"Nuclear factor erythroid 2-related factor 2 (NF-E2-related factor 2) (NFE2-related factor 2) (Nrf-2) (Nuclear factor, erythroid derived 2, like 2)",Homo sapiens (Human),605.0,67827.0,MMDLELPPPGLPSQQDMDLIDILWRQDIDLGVSREVFDFSQRRKEYELEKQKKLEKERQEQLQKEQEKAFFAQLQLDEETGEFLPIQPAQHIQSETSGSANYSQVAHIPKSDALYFDDCMQLLAQTFPFVDDNEVSSATFQSLVPDIPGHIESPVFIATNQAQSPETSVAQVAPVDLDGMQQDIEQVWEELLSIPELQCLNIENDKLVETTMVPSPEAKLTEVDNYHFYSSIPSMEKEVGNCSPHFLNAFEDSFSSILSTEDPNQLTVNSLNSDATVNTDFGDEFYSAFIAEPSISNSMPSPATLSHSLSELLNGPIDVSDLSLCKAFNQNHPESTAEFNDSDSGISLNTSPSVASPEHSVESSSYGDTLLGLSDSEVEELDSAPGSVKQNGPKTPVHSSGDMVQPLSPSQGQSTHVHDAQCENTPEKELPVSPGHRKTPFTKDKHSSRLEAHLTRDELRAKALHIPFPVEKIINLPVVDFNEMMSKEQFNEAQLALIRDIRRRGKNKVAAQNCRKRKLENIVELEQDLDHLKDEKEKLLKEKGENDKSLHLLKKQLSTLYLEVFSMLRDEDGKPYSPSEYSLQQTRDGNVFLVPKSKKPDVKKN,True,False,False,Q16236,"[('cd14720', 'Basic leucine zipper (bZIP) domain of Nuclear Factor, Erythroid-derived 2 (NFE2) and similar proteins: a DNA-binding and dimerization domain'), ('cd22249', 'UDM1 (ubiquitin-dependent DSB recruitment module 1) found in RING finger proteins RNF168, RNF169 and similar proteins'), ('G3DSA:1.10.880.10', 'Transcription factor, Skn-1-like, DNA-binding domain'), ('IPR004826', 'Basic leucine zipper domain, Maf-type'), ('IPR004827', 'Basic-leucine zipper domain'), ('IPR008917', 'Transcription factor, Skn-1-like, DNA-binding domain superfamily'), ('IPR046347', 'Basic-leucine zipper domain superfamily'), ('IPR047167', 'Nuclear Factor Erythroid-derived 2-like'), ('PF03131', 'bZIP Maf transcription factor'), ('PS00036', 'Basic-leucine zipper (bZIP) domain signature'), ('PS50217', 'Basic-leucine zipper (bZIP) domain profile'), ('PTHR24411', 'NUCLEAR FACTOR ERYTHROID 2-RELATED FACTOR'), ('SM00338', 'basic region leucin zipper'), ('SSF47454', 'A DNA-binding domain in eukaryotic transcription factors'), ('SSF57959', 'Leucine zipper domain')]",Q16236;,"""ENSG00000116044; Low tissue specificity."";",,,"ACTIVITY REGULATION: Activated by cell derived metabolites including itaconate and fumarate. {ECO:0000269|PubMed:29590092, ECO:0000269|PubMed:33009401}.; ACTIVITY REGULATION: (Microbial infection) Transcription factor activity on antioxidant target genes is significantly inhibited by SARS coronavirus-2/SARS-COV-2. {ECO:0000269|PubMed:29018201}.",,ENST00000397062.8 [Q16236-1];ENST00000397063.9 [Q16236-2];ENST00000421929.6 [Q16236-2];ENST00000446151.6 [Q16236-3];ENST00000448782.6 [Q16236-2];ENST00000464747.5 [Q16236-2];ENST00000699328.1 [Q16236-2];ENST00000699330.1 [Q16236-2];ENST00000699343.1 [Q16236-2];ENST00000699351.1 [Q16236-2];ENST00000699408.1 [Q16236-2];ENST00000699409.1 [Q16236-2];ENST00000699434.1 [Q16236-2];,NFE2L2,ENSG00000116044,0.0,,,,100.0,DP01115,1.0,0.721,0.25,NFE2L2
Q16543,ENSG00000105401,CDC37_HUMAN,positive regulation of mitophagy in response to mitochondrial depolarization [GO:0098779]; post-transcriptional regulation of gene expression [GO:0010608]; protein folding [GO:0006457]; protein stabilization [GO:0050821]; protein targeting [GO:0006605]; regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0000079]; regulation of type I interferon-mediated signaling pathway [GO:0060338]; regulation of type II interferon-mediated signaling pathway [GO:0060334],cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; HSP90-CDC37 chaperone complex [GO:1990565]; protein folding chaperone complex [GO:0101031],heat shock protein binding [GO:0031072]; Hsp90 protein binding [GO:0051879]; kinase binding [GO:0019900]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein-folding chaperone binding [GO:0051087]; scaffold protein binding [GO:0097110]; unfolded protein binding [GO:0051082],PTM: Constitutively sumoylated by UBE2I. {ECO:0000269|PubMed:17709345}.,,,"STRAND 6..8; /evidence=""ECO:0007829|PDB:7Z38""; STRAND 120..122; /evidence=""ECO:0007829|PDB:7Z38""; STRAND 126..129; /evidence=""ECO:0007829|PDB:7Z38""; STRAND 325..327; /evidence=""ECO:0007829|PDB:1US7""; STRAND 345..347; /evidence=""ECO:0007829|PDB:2N5X""; STRAND 365..367; /evidence=""ECO:0007829|PDB:2N5X""","HELIX 16..18; /evidence=""ECO:0007829|PDB:8GAE""; HELIX 25..73; /evidence=""ECO:0007829|PDB:7Z38""; HELIX 78..111; /evidence=""ECO:0007829|PDB:7Z38""; HELIX 116..119; /evidence=""ECO:0007829|PDB:7Z38""; HELIX 149..163; /evidence=""ECO:0007829|PDB:2W0G""; HELIX 168..177; /evidence=""ECO:0007829|PDB:2W0G""; HELIX 179..181; /evidence=""ECO:0007829|PDB:2W0G""; HELIX 184..199; /evidence=""ECO:0007829|PDB:2W0G""; HELIX 203..226; /evidence=""ECO:0007829|PDB:2W0G""; HELIX 230..241; /evidence=""ECO:0007829|PDB:2W0G""; HELIX 247..272; /evidence=""ECO:0007829|PDB:2W0G""; HELIX 294..300; /evidence=""ECO:0007829|PDB:1US7""; HELIX 303..310; /evidence=""ECO:0007829|PDB:2N5X""; HELIX 317..321; /evidence=""ECO:0007829|PDB:1US7""; HELIX 328..338; /evidence=""ECO:0007829|PDB:1US7""","TURN 13..15; /evidence=""ECO:0007829|PDB:2NCA""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,CDC37 CDC37A,"Hsp90 co-chaperone Cdc37 (Hsp90 chaperone protein kinase-targeting subunit) (p50Cdc37) [Cleaved into: Hsp90 co-chaperone Cdc37, N-terminally processed]",Homo sapiens (Human),378.0,44468.0,MVDYSVWDHIEVSDDEDETHPNIDTASLFRWRHQARVERMEQFQKEKEELDRGCRECKRKVAECQRKLKELEVAEGGKAELERLQAEAQQLRKEERSWEQKLEEMRKKEKSMPWNVDTLSKDGFSKSMVNTKPEKTEEDSEEVREQKHKTFVEKYEKQIKHFGMLRRWDDSQKYLSDNVHLVCEETANYLVIWCIDLEVEEKCALMEQVAHQTIVMQFILELAKSLKVDPRACFRQFFTKIKTADRQYMEGFNDELEAFKERVRGRAKLRIEKAMKEYEEEERKKRLGPGGLDPVEVYESLPEELQKCFDVKDVQMLQDAISKMDPTDAKYHMQRCIDSGLWVPNSKASEAKEGEEAGPGDPLLEAVPKTGDEKDVSV,False,False,True,Q16543,"[('G3DSA:1.20.58.610', 'Cdc37, Hsp90 binding domain'), ('G3DSA:6.10.140.250', None), ('IPR004918', 'Cdc37'), ('IPR013855', 'Cdc37, N-terminal domain'), ('IPR013873', 'Cdc37, C-terminal'), ('IPR013874', 'Cdc37, Hsp90 binding'), ('IPR038189', 'Cdc37, Hsp90-binding domain superfamily'), ('PF03234', 'Cdc37 N terminal kinase binding'), ('PF08564', 'Cdc37 C terminal domain'), ('PF08565', 'Cdc37 Hsp90 binding domain'), ('PTHR12800', 'CDC37-RELATED'), ('SM01069', 'Cdc37 C terminal domain'), ('SM01070', 'Cdc37 Hsp90 binding domain'), ('SM01071', 'Cdc37 N terminal kinase binding'), ('SSF101391', 'Hsp90 co-chaperone CDC37')]",,"""ENSG00000105401; Low tissue specificity."";",,,,,ENST00000222005.7;,CDC37,ENSG00000105401,0.0,,,,19.84,DP01420,0.201,0.206,0.146,CDC37
Q16637,ENSG00000172062|ENSG00000205571|ENSG00000277773|ENSG00000273772|ENSG00000275349,SMN_HUMAN,DNA-templated transcription termination [GO:0006353]; nervous system development [GO:0007399]; spliceosomal complex assembly [GO:0000245]; spliceosomal snRNP assembly [GO:0000387],axon [GO:0030424]; Cajal body [GO:0015030]; cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; Gemini of coiled bodies [GO:0097504]; neuron projection [GO:0043005]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204]; SMN complex [GO:0032797]; SMN-Sm protein complex [GO:0034719]; Z disc [GO:0030018],identical protein binding [GO:0042802]; RNA binding [GO:0003723],,"DOMAIN: The Tudor domain mediates association with dimethylarginines, which are common in snRNP proteins. {ECO:0000269|PubMed:12628254, ECO:0000269|PubMed:22101937, ECO:0000269|PubMed:26700805}.","DOMAIN 91..151; /note=""Tudor""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00211""","STRAND 97..102; /evidence=""ECO:0007829|PDB:7W2P""; STRAND 107..117; /evidence=""ECO:0007829|PDB:7W2P""; STRAND 122..127; /evidence=""ECO:0007829|PDB:7W2P""; STRAND 133..137; /evidence=""ECO:0007829|PDB:7W2P""","HELIX 38..48; /evidence=""ECO:0007829|PDB:5XJL""; HELIX 87..89; /evidence=""ECO:0007829|PDB:7W2P""; HELIX 103..105; /evidence=""ECO:0007829|PDB:7W2P""; HELIX 138..140; /evidence=""ECO:0007829|PDB:7W2P""; HELIX 263..280; /evidence=""ECO:0007829|PDB:4GLI""","TURN 118..121; /evidence=""ECO:0007829|PDB:7W2P""; TURN 128..130; /evidence=""ECO:0007829|PDB:7W2P""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,SMN1 SMN SMNT; SMN2 SMNC,Survival motor neuron protein (Component of gems 1) (Gemin-1),Homo sapiens (Human),294.0,31849.0,MAMSSGGSGGGVPEQEDSVLFRRGTGQSDDSDIWDDTALIKAYDKAVASFKHALKNGDICETSGKPKTTPKRKPAKKNKSQKKNTAASLQQWKVGDKCSAIWSEDGCIYPATIASIDFKRETCVVVYTGYGNREEQNLSDLLSPICEVANNIEQNAQENENESQVSTDESENSRSPGNKSDNIKPKSAPWNSFLPPPPPMPGPRLGPGKPGLKFNGPPPPPPPPPPHLLSCWLPPFPSGPPIIPPPPPICPDSLDDADALGSMLISWYMSGYHTGYYMGFRQNQKEGRCSHSLN,True,False,False,Q16637,"[('cd20398', 'Tudor domain found in survival motor neuron protein (SMN) and similar proteins'), ('cd22851', 'N-terminal Gemin2-binding domain of the Survival Motor Neuron family'), ('cd22852', 'C-terminal oligomerization domain of the Survival Motor Neuron family'), ('G3DSA:2.30.30.140', None), ('G3DSA:3.40.190.10', 'Periplasmic binding protein-like II'), ('IPR002999', 'Tudor domain'), ('IPR010304', 'Survival motor neuron, Tudor domain'), ('IPR040424', 'SMN complex subunit Smn1'), ('IPR047298', 'Survival motor neuron protein, Tudor domain, eumetazoa'), ('IPR047313', 'Survival motor neuron protein, C-terminal oligomerization domain'), ('IPR049481', 'Survival Motor Neuron, Gemin2-binding domain'), ('PF06003', 'Survival motor neuron protein (SMN), Tudor domain'), ('PF20635', 'Survival Motor Neuron, YG-box'), ('PF20636', 'Survival Motor Neuron, Gemin2-binding domain'), ('PS50304', 'Tudor domain profile'), ('PTHR39267', 'SURVIVAL MOTOR NEURON-LIKE PROTEIN 1'), ('SM00333', 'Tudor domain'), ('SSF63748', 'Tudor/PWWP/MBT')]",,"""ENSG00000172062; Low tissue specificity."";""ENSG00000205571; Low tissue specificity."";",,,,,ENST00000351205.8 [Q16637-1];ENST00000380707.9 [Q16637-1];ENST00000380741.8 [Q16637-1];ENST00000380742.8 [Q16637-2];ENST00000380743.9 [Q16637-1];ENST00000503079.6 [Q16637-2];ENST00000506163.5 [Q16637-3];ENST00000611442.4 [Q16637-2];ENST00000614240.4 [Q16637-2];ENST00000614610.2 [Q16637-1];ENST00000614773.4 [Q16637-2];ENST00000618251.4 [Q16637-1];ENST00000618661.2 [Q16637-1];ENST00000622158.4 [Q16637-2];ENST00000622739.2 [Q16637-1];ENST00000624634.3 [Q16637-2];ENST00000626847.2 [Q16637-3];ENST00000627341.2 [Q16637-1];ENST00000628353.2 [Q16637-3];ENST00000628642.2 [Q16637-3];ENST00000629122.2 [Q16637-1];,SMN1;SMN2,ENSG00000172062;ENSG00000205571,4.0,SMN1,Canonical_RBPs,9.0,,,0.126,0.745,0.439,SMN1
Q16659,ENSG00000069956,MK06_HUMAN,intracellular signal transduction [GO:0035556]; positive regulation of dendritic spine development [GO:0060999]; protein phosphorylation [GO:0006468]; signal transduction [GO:0007165],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; septin cytoskeleton [GO:0032156],ATP binding [GO:0005524]; MAP kinase activity [GO:0004707]; protein heterodimerization activity [GO:0046982]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],"PTM: Phosphorylated at Ser-189 by PAK1, PAK2 and PAK3 resulting in catalytic activation. Phosphorylated by MAPKAPK5 at other sites. {ECO:0000269|PubMed:21177870}.; PTM: Ubiquitination at Met-1 leads to degradation by the proteasome pathway. {ECO:0000269|PubMed:15226418}.","DOMAIN: In contrast to classical MAPKs, the TXY motif within the activation loop is replaced by the SEG motif, whose phosphorylation activates the MAP kinases. {ECO:0000250}.","DOMAIN 20..316; /note=""Protein kinase""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00159""","STRAND 14..16; /evidence=""ECO:0007829|PDB:7AQB""; STRAND 20..25; /evidence=""ECO:0007829|PDB:7AQB""; STRAND 34..39; /evidence=""ECO:0007829|PDB:7AQB""; STRAND 45..52; /evidence=""ECO:0007829|PDB:7AQB""; STRAND 80..84; /evidence=""ECO:0007829|PDB:7AQB""; STRAND 86..88; /evidence=""ECO:0007829|PDB:6YLC""; STRAND 102..109; /evidence=""ECO:0007829|PDB:7AQB""; STRAND 112..114; /evidence=""ECO:0007829|PDB:7AQB""; STRAND 148..150; /evidence=""ECO:0007829|PDB:6YLC""; STRAND 158..161; /evidence=""ECO:0007829|PDB:7AQB""; STRAND 166..169; /evidence=""ECO:0007829|PDB:7AQB""; STRAND 174..176; /evidence=""ECO:0007829|PDB:6YLC""; STRAND 271..273; /evidence=""ECO:0007829|PDB:6YLL""; STRAND 282..285; /evidence=""ECO:0007829|PDB:6YLC""","HELIX 56..70; /evidence=""ECO:0007829|PDB:7AQB""; HELIX 115..120; /evidence=""ECO:0007829|PDB:7AQB""; HELIX 126..145; /evidence=""ECO:0007829|PDB:7AQB""; HELIX 155..157; /evidence=""ECO:0007829|PDB:7AQB""; HELIX 180..182; /evidence=""ECO:0007829|PDB:6YLC""; HELIX 190..192; /evidence=""ECO:0007829|PDB:7AQB""; HELIX 200..204; /evidence=""ECO:0007829|PDB:7AQB""; HELIX 211..227; /evidence=""ECO:0007829|PDB:7AQB""; HELIX 237..247; /evidence=""ECO:0007829|PDB:7AQB""; HELIX 253..260; /evidence=""ECO:0007829|PDB:7AQB""; HELIX 265..270; /evidence=""ECO:0007829|PDB:7AQB""; HELIX 278..281; /evidence=""ECO:0007829|PDB:7AQB""; HELIX 287..294; /evidence=""ECO:0007829|PDB:7AQB""; HELIX 301..303; /evidence=""ECO:0007829|PDB:7AQB""; HELIX 307..312; /evidence=""ECO:0007829|PDB:7AQB""; HELIX 314..317; /evidence=""ECO:0007829|PDB:7AQB""","TURN 17..19; /evidence=""ECO:0007829|PDB:7AQB""; TURN 40..42; /evidence=""ECO:0007829|PDB:7AQB""; TURN 162..165; /evidence=""ECO:0007829|PDB:7AQB""; TURN 183..186; /evidence=""ECO:0007829|PDB:6YKY""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,MAPK6 ERK3 PRKM6,Mitogen-activated protein kinase 6 (MAP kinase 6) (MAPK 6) (EC 2.7.11.24) (Extracellular signal-regulated kinase 3) (ERK-3) (MAP kinase isoform p97) (p97-MAPK),Homo sapiens (Human),721.0,82681.0,MAEKFESLMNIHGFDLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREALDFLEQILTFSPMDRLTAEEALSHPYMSIYSFPMDEPISSHPFHIEDEVDDILLMDETHSHIYNWERYHDCQFSEHDWPVHNNFDIDEVQLDPRALSDVTDEEEVQVDPRKYLDGDREKYLEDPAFDTNYSTEPCWQYSDHHENKYCDLECSHTCNYKTRSSSYLDNLVWRESEVNHYYEPKLIIDLSNWKEQSKEKSDKKGKSKCERNGLVKAQIALEEASQQLAGKEREKNQGFDFDSFIAGTIQLSSQHEPTDVVDKLNDLNSSVSQLELKSLISKSVSQEKQEKGMANLAQLEALYQSSWDSQFVSGGEDCFFINQFCEVRKDEQVEKENTYTSYLDKFFSRKEDTEMLETEPVEDGKLGERGHEEGFLNNSGEFLFNKQLESIGIPQFHSPVGSPLKSIQATLTPSAMKSSPQIPHQTYSSILKHLN,False,False,True,Q16659,"[('cd07854', 'Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 (also called ERK4) and 6 (also called ERK3)'), ('G3DSA:1.10.510.10', 'Transferase(Phosphotransferase) domain 1'), ('G3DSA:3.30.200.20', 'Phosphorylase Kinase; domain 1'), ('IPR000719', 'Protein kinase domain'), ('IPR008271', 'Serine/threonine-protein kinase, active site'), ('IPR008350', 'Mitogen-activated protein (MAP) kinase, ERK3/4'), ('IPR011009', 'Protein kinase-like domain superfamily'), ('IPR017441', 'Protein kinase, ATP binding site'), ('IPR050117', 'Mitogen-activated protein kinase'), ('PF00069', 'Protein kinase domain'), ('PR01771', 'ERK3ERK4MAPK'), ('PS00107', 'Protein kinases ATP-binding region signature'), ('PS00108', 'Serine/Threonine protein kinases active-site signature'), ('PS50011', 'Protein kinase domain profile'), ('PTHR24055', 'Mitogen-activated protein kinase'), ('SM00220', 'Serine/Threonine protein kinases, catalytic domain'), ('SSF56112', 'Protein kinase-like (PK-like)')]",,"""ENSG00000069956; Low tissue specificity."";","CATALYTIC ACTIVITY: Reaction=L-seryl-[protein] + ATP = O-phospho-L-seryl-[protein] + ADP + H(+); Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616, ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.24; CATALYTIC ACTIVITY: Reaction=L-threonyl-[protein] + ATP = O-phospho-L-threonyl-[protein] + ADP + H(+); Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060, Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013, ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216; EC=2.7.11.24;",2.7.11.24,ACTIVITY REGULATION: Activated by phosphorylation at Ser-189.,,ENST00000261845.7;ENST00000680066.1;ENST00000680652.1;ENST00000680777.1;ENST00000681888.1;ENST00000691380.1;,MAPK6,ENSG00000069956,0.0,,,,,,,0.521,0.029,MAPK6
Q5BJF6,ENSG00000136811,ODFP2_HUMAN,cell differentiation [GO:0030154]; centriole-centriole cohesion [GO:0010457]; cilium organization [GO:0044782]; protein localization [GO:0008104]; regulation of cilium assembly [GO:1902017]; spermatogenesis [GO:0007283],centriolar subdistal appendage [GO:0120103]; centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytosol [GO:0005829]; intracellular membrane-bounded organelle [GO:0043231]; microtubule [GO:0005874]; nucleus [GO:0005634]; sperm flagellum [GO:0036126]; sperm midpiece [GO:0097225]; sperm principal piece [GO:0097228]; spindle pole [GO:0000922],small GTPase binding [GO:0031267]; structural molecule activity [GO:0005198],"PTM: Tyrosine phosphorylated. Phosphorylated by TSSK4 on Ser-95. {ECO:0000250|UniProtKB:A3KGV1, ECO:0000250|UniProtKB:Q2MJU7}.",,,,,,"cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,ODF2,Outer dense fiber protein 2 (Cenexin) (Outer dense fiber of sperm tails protein 2),Homo sapiens (Human),829.0,95401.0,MSASSSGGSPRFPSCGKNGVTSLTQKKVLRAPCGAPSVTVTKSHKRGMKGDTVNVRRSVRVKTKVPWMPPGKSSARPVGCKWENPPHCLEITPPSSEKLVSVMRLSDLSTEDDDSGHCKMNRYDKKIDSLMNAVGCLKSEVKMQKGERQMAKRFLEERKEELEEVAHELAETEHENTVLRHNIERMKEEKDFTILQKKHLQQEKECLMSKLVEAEMDGAAAAKQVMALKDTIGKLKTEKQMTCTDINTLTRQKELLLQKLSTFEETNRTLRDLLREQHCKEDSERLMEQQGALLKRLAEADSEKARLLLLLQDKDKEVEELLQEIQCEKAQAKTASELSKSMESMRGHLQAQLRSKEAENSRLCMQIKNLERSGNQHKAEVEAIMEQLKELKQKGDRDKESLKKAIRAQKERAEKSEEYAEQLHVQLADKDLYVAEALSTLESWRSRYNQVVKEKGDLELEIIVLNDRVTDLVNQQQTLEEKMREDRDSLVERLHRQTAEYSAFKLENERLKASFAPMEDKLNQAHLEVQQLKASVKNYEGMIDNYKSQVMKTRLEADEVAAQLERCDKENKILKDEMNKEIEAARRQFQSQLADLQQLPDILKITEAKLAECQDQLQGYERKNIDLTAIISDLRSRIEHQGDKLEMAREKHQASQKENKQLSLKVDELERKLEATSAQNIEFLQVIAKREEAIHQSQLRLEEKTRECGTLARQLESAIEDARRQVEQTKEHALSKERAAQNKILDLETQLSRTKTELSQLRRSRDDADRRYQSRLQDLKDRLEQSESTNRSMQNYVQFLKSSYANVFGDGPYSTFLTSSPIRSRSPPA,True,True,False,Q5BJF6,"[('IPR026099', 'Outer dense fibre protein 2-related'), ('PTHR23162', 'OUTER DENSE FIBER OF SPERM TAILS 2')]",,"""ENSG00000136811; Tissue enriched (testis)."";",,,,,ENST00000372791.8 [Q5BJF6-5];ENST00000372807.10 [Q5BJF6-4];ENST00000372814.7 [Q5BJF6-7];ENST00000393533.6 [Q5BJF6-10];ENST00000434106.7 [Q5BJF6-1];ENST00000448249.8 [Q5BJF6-9];ENST00000546203.5 [Q5BJF6-8];ENST00000604420.5 [Q5BJF6-1];,ODF2,ENSG00000136811,0.0,,,,,,,0.361,0.027,ODF2
Q5SW96,ENSG00000157978,ARH_HUMAN,amyloid precursor protein metabolic process [GO:0042982]; cellular response to cytokine stimulus [GO:0071345]; cholesterol homeostasis [GO:0042632]; cholesterol metabolic process [GO:0008203]; cholesterol transport [GO:0030301]; low-density lipoprotein particle clearance [GO:0034383]; positive regulation of cholesterol metabolic process [GO:0090205]; positive regulation of low-density lipoprotein particle clearance [GO:1905581]; positive regulation of receptor-mediated endocytosis [GO:0048260]; positive regulation of receptor-mediated endocytosis involved in cholesterol transport [GO:1905602]; positive regulation of vascular associated smooth muscle cell proliferation [GO:1904707]; receptor internalization [GO:0031623]; receptor-mediated endocytosis [GO:0006898]; receptor-mediated endocytosis involved in cholesterol transport [GO:0090118]; regulation of protein binding [GO:0043393]; regulation of protein localization to plasma membrane [GO:1903076],axon [GO:0030424]; basal plasma membrane [GO:0009925]; clathrin-coated endocytic vesicle membrane [GO:0030669]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; early endosome [GO:0005769]; neurofilament [GO:0005883]; plasma membrane [GO:0005886]; recycling endosome [GO:0055037],"amyloid-beta binding [GO:0001540]; AP-1 adaptor complex binding [GO:0035650]; AP-2 adaptor complex binding [GO:0035612]; clathrin adaptor activity [GO:0035615]; clathrin binding [GO:0030276]; low-density lipoprotein particle receptor binding [GO:0050750]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phosphotyrosine residue binding [GO:0001784]; signaling adaptor activity [GO:0035591]; signaling receptor complex adaptor activity [GO:0030159]",,"DOMAIN: The [DE]-X(1,2)-F-X-X-[FL]-X-X-X-R motif mediates interaction the AP-2 complex subunit AP2B1. {ECO:0000269|PubMed:16516836}.; DOMAIN: The PID domain mediates interaction with the NPXY internalization motif of LDLR. {ECO:0000250|UniProtKB:D3ZAR1}.","DOMAIN 42..196; /note=""PID""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00148""",,"HELIX 256..266; /evidence=""ECO:0007829|PDB:2G30""",,"cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,LDLRAP1 ARH,Low density lipoprotein receptor adapter protein 1 (Autosomal recessive hypercholesterolemia protein),Homo sapiens (Human),308.0,33885.0,MDALKSAGRALIRSPSLAKQSWGGGGRHRKLPENWTDTRETLLEGMLFSLKYLGMTLVEQPKGEELSAAAIKRIVATAKASGKKLQKVTLKVSPRGIILTDNLTNQLIENVSIYRISYCTADKMHDKVFAYIAQSQHNQSLECHAFLCTKRKMAQAVTLTVAQAFKVAFEFWQVSKEEKEKRDKASQEGGDVLGARQDCTPSLKSLVATGNLLDLEETAKAPLSTVSANTTNMDEVPRPQALSGSSVVWELDDGLDEAFSRLAQSRTNPQVLDTGLTAQDMHYAQCLSPVDWDKPDSSGTEQDDLFSF,True,False,True,Q5SW96,"[('cd13159', 'Low Density Lipoprotein Receptor Adaptor Protein 1 (LDLRAP1) in mammals and similar proteins Phosphotyrosine-binding (PTB) PH-like fold'), ('G3DSA:2.30.29.30', 'Pleckstrin-homology domain (PH domain)/Phosphotyrosine-binding domain (PTB)'), ('IPR006020', 'PTB/PI domain'), ('IPR011993', 'PH-like domain superfamily'), ('IPR051133', 'Adapter and Engulfment Domain-Containing Protein'), ('PF00640', 'Phosphotyrosine interaction domain (PTB/PID)'), ('PS01179', 'Phosphotyrosine interaction domain (PID) profile'), ('PTHR11232', 'Adapter and Engulfment Domain-Containing Protein'), ('SM00462', 'Phosphotyrosine-binding domain, phosphotyrosine-interaction (PI) domain'), ('SSF50729', 'PH domain-like')]",Q5SW96;,"""ENSG00000157978; Tissue enhanced (brain)."";",,,,,ENST00000374338.5;,LDLRAP1,ENSG00000157978,0.0,,,,,,,0.416,,LDLRAP1
Q5VVX9,ENSG00000177414,UBE2U_HUMAN,protein ubiquitination [GO:0016567],,ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631],PTM: Autoubiquitinated in vitro in the presence of UBR5. {ECO:0000269|PubMed:22496338}.,,"DOMAIN 4..153; /note=""UBC core""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00388""","STRAND 24..28; /evidence=""ECO:0007829|PDB:1YRV""; STRAND 35..41; /evidence=""ECO:0007829|PDB:1YRV""; STRAND 52..58; /evidence=""ECO:0007829|PDB:1YRV""; STRAND 69..74; /evidence=""ECO:0007829|PDB:1YRV""","HELIX 4..19; /evidence=""ECO:0007829|PDB:1YRV""; HELIX 91..94; /evidence=""ECO:0007829|PDB:1YRV""; HELIX 96..98; /evidence=""ECO:0007829|PDB:1YRV""; HELIX 105..116; /evidence=""ECO:0007829|PDB:1YRV""; HELIX 127..134; /evidence=""ECO:0007829|PDB:1YRV""; HELIX 137..147; /evidence=""ECO:0007829|PDB:1YRV""","TURN 47..50; /evidence=""ECO:0007829|PDB:1YRV""; TURN 83..85; /evidence=""ECO:0007829|PDB:1YRV""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,UBE2U,Ubiquitin-conjugating enzyme E2 U (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme U) (Ubiquitin carrier protein U) (Ubiquitin-protein ligase U),Homo sapiens (Human),321.0,37741.0,MHGRAYLLLHRDFCDLKENNYKGITAKPVSEDMMEWEVEIEGLQNSVWQGLVFQLTIHFTSEYNYAPPVVKFITIPFHPNVDPHTGQPCIDFLDNPEKWNTNYTLSSILLALQVMLSNPVLENPVNLEAARILVKDESLYRTILRLFNRPLQMKDDSQELPKDPRKCIRPIKTTSFSDYYQTWSRIATSKATEYYRTPLLKVPNFIGQYYKWKKMDLQHQKEWNLKYSVIKCWLARKRMPHEVTHSMEEIKLCPTLIPTTDEIFLESPTAINSITDIYETEEEGWKSDTSLYENDTDEPREEEVEDLISWTNTLNTNTSED,False,False,True,Q5VVX9,"[('cd00195', 'UBCc'), ('G3DSA:3.10.110.10', 'Ubiquitin Conjugating Enzyme'), ('IPR000608', 'Ubiquitin-conjugating enzyme E2'), ('IPR016135', 'Ubiquitin-conjugating enzyme/RWD-like'), ('IPR023313', 'Ubiquitin-conjugating enzyme, active site'), ('IPR050113', 'Ubiquitin-conjugating enzyme'), ('PF00179', 'Ubiquitin-conjugating enzyme'), ('PS00183', 'Ubiquitin-conjugating (UBC) active site signature'), ('PS50127', 'Ubiquitin-conjugating (UBC) core domain profile'), ('PTHR24067', 'Ubiquitin-conjugating enzyme'), ('SM00212', 'Ubiquitin-conjugating enzyme E2, catalytic domain homologues'), ('SSF54495', 'UBC-like')]",,"""ENSG00000177414; Tissue enriched (testis)."";","CATALYTIC ACTIVITY: Reaction=S-ubiquitinyl-[E1 ubiquitin-activating enzyme]-L-cysteine + [E2 ubiquitin-conjugating enzyme]-L-cysteine = [E1 ubiquitin-activating enzyme]-L-cysteine + S-ubiquitinyl-[E2 ubiquitin-conjugating enzyme]-L-cysteine.; EC=2.3.2.23; Evidence={ECO:0000255|PROSITE-ProRule:PRU00388, ECO:0000255|PROSITE-ProRule:PRU10133};",2.3.2.23,,PATHWAY: Protein modification; protein ubiquitination. {ECO:0000255|PROSITE-ProRule:PRU00388}.,ENST00000371076.7 [Q5VVX9-2];ENST00000611228.4 [Q5VVX9-1];,UBE2U,ENSG00000177414,0.0,,,,,,,0.551,0.115,UBE2U
Q63HR2,ENSG00000111077,TENS2_HUMAN,cellular homeostasis [GO:0019725]; collagen metabolic process [GO:0032963]; kidney development [GO:0001822]; multicellular organism growth [GO:0035264]; multicellular organismal-level homeostasis [GO:0048871]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of insulin receptor signaling pathway [GO:0046627]; peptidyl-tyrosine dephosphorylation [GO:0035335]; response to muscle activity [GO:0014850],cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; plasma membrane [GO:0005886],identical protein binding [GO:0042802]; kinase binding [GO:0019900]; lipid binding [GO:0008289]; metal ion binding [GO:0046872]; protein tyrosine phosphatase activity [GO:0004725],"PTM: Ubiquitinated following sequestration in cytoplasmic aggregates with SQSTM1, leading to proteasomal degradation. {ECO:0000269|PubMed:25101860}.","DOMAIN: The SH3 domain mediates binding to phosphatidylinositol-3,4,5-triphosphate (PtdIns(3,4,5)P3) (PubMed:30092354). It is also required to ensure podocyte integrity while the phosphatase domain is dispensible for podocyte maintenance (By similarity). {ECO:0000250|UniProtKB:Q8CGB6, ECO:0000269|PubMed:30092354}.","DOMAIN 122..294; /note=""Phosphatase tensin-type""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00590""; DOMAIN 299..425; /note=""C2 tensin-type""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00589""; DOMAIN 1140..1247; /note=""SH2""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00191""; DOMAIN 1275..1408; /note=""PTB""; /evidence=""ECO:0000255""","STRAND 1141..1144; /evidence=""ECO:0007829|PDB:2L6K""; STRAND 1161..1166; /evidence=""ECO:0007829|PDB:2KNO""; STRAND 1168..1170; /evidence=""ECO:0007829|PDB:2KNO""; STRAND 1173..1179; /evidence=""ECO:0007829|PDB:2KNO""; STRAND 1184..1189; /evidence=""ECO:0007829|PDB:2KNO""; STRAND 1190..1192; /evidence=""ECO:0007829|PDB:2L6K""; STRAND 1199..1205; /evidence=""ECO:0007829|PDB:2KNO""; STRAND 1210..1213; /evidence=""ECO:0007829|PDB:2L6K""; STRAND 1222..1224; /evidence=""ECO:0007829|PDB:2L6K""; STRAND 1237..1241; /evidence=""ECO:0007829|PDB:2L6K""; STRAND 1274..1285; /evidence=""ECO:0007829|PDB:3HQC""; STRAND 1305..1307; /evidence=""ECO:0007829|PDB:2DKQ""; STRAND 1312..1319; /evidence=""ECO:0007829|PDB:3HQC""; STRAND 1322..1329; /evidence=""ECO:0007829|PDB:3HQC""; STRAND 1332..1339; /evidence=""ECO:0007829|PDB:3HQC""; STRAND 1343..1348; /evidence=""ECO:0007829|PDB:3HQC""; STRAND 1350..1352; /evidence=""ECO:0007829|PDB:2LOZ""; STRAND 1354..1356; /evidence=""ECO:0007829|PDB:3HQC""; STRAND 1362..1372; /evidence=""ECO:0007829|PDB:3HQC""; STRAND 1375..1385; /evidence=""ECO:0007829|PDB:3HQC""; STRAND 1389..1391; /evidence=""ECO:0007829|PDB:2DKQ""","HELIX 1137..1140; /evidence=""ECO:0007829|PDB:2KNO""; HELIX 1147..1154; /evidence=""ECO:0007829|PDB:2KNO""; HELIX 1194..1198; /evidence=""ECO:0007829|PDB:2KNO""; HELIX 1225..1230; /evidence=""ECO:0007829|PDB:2KNO""; HELIX 1266..1272; /evidence=""ECO:0007829|PDB:3HQC""; HELIX 1291..1304; /evidence=""ECO:0007829|PDB:3HQC""; HELIX 1340..1342; /evidence=""ECO:0007829|PDB:3HQC""; HELIX 1393..1405; /evidence=""ECO:0007829|PDB:3HQC""","TURN 1231..1234; /evidence=""ECO:0007829|PDB:2KNO""; TURN 1358..1360; /evidence=""ECO:0007829|PDB:2DKQ""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,TNS2 KIAA1075 TENC1,Tensin-2 (EC 3.1.3.48) (C1 domain-containing phosphatase and tensin homolog) (C1-TEN) (Tensin-like C1 domain-containing phosphatase),Homo sapiens (Human),1409.0,152580.0,MKSSGPVERLLRALGRRDSSRAASRPRKAEPHSFREKVFRKKPPVCAVCKVTIDGTGVSCRVCKVATHRKCEAKVTSACQALPPVELRRNTAPVRRIEHLGSTKSLNHSKQRSTLPRSFSLDPLMERRWDLDLTYVTERILAAAFPARPDEQRHRGHLRELAHVLQSKHRDKYLLFNLSEKRHDLTRLNPKVQDFGWPELHAPPLDKLCSICKAMETWLSADPQHVVVLYCKGNKGKLGVIVSAYMHYSKISAGADQALATLTMRKFCEDKVATELQPSQRRYISYFSGLLSGSIRMNSSPLFLHYVLIPMLPAFEPGTGFQPFLKIYQSMQLVYTSGVYHIAGPGPQQLCISLEPALLLKGDVMVTCYHKGGRGTDRTLVFRVQFHTCTIHGPQLTFPKDQLDEAWTDERFPFQASVEFVFSSSPEKIKGSTPRNDPSVSVDYNTTEPAVRWDSYENFNQHHEDSVDGSLTHTRGPLDGSPYAQVQRPPRQTPPAPSPEPPPPPMLSVSSDSGHSSTLTTEPAAESPGRPPPTAAERQELDRLLGGCGVASGGRGAGRETAILDDEEQPTVGGGPHLGVYPGHRPGLSRHCSCRQGYREPCGVPNGGYYRPEGTLERRRLAYGGYEGSPQGYAEASMEKRRLCRSLSEGLYPYPPEMGKPATGDFGYRAPGYREVVILEDPGLPALYPCPACEEKLALPTAALYGLRLEREAGEGWASEAGKPLLHPVRPGHPLPLLLPACGHHHAPMPDYSCLKPPKAGEEGHEGCSYTMCPEGRYGHPGYPALVTYSYGGAVPSYCPAYGRVPHSCGSPGEGRGYPSPGAHSPRAGSISPGSPPYPQSRKLSYEIPTEEGGDRYPLPGHLASAGPLASAESLEPVSWREGPSGHSTLPRSPRDAPCSASSELSGPSTPLHTSSPVQGKESTRRQDTRSPTSAPTQRLSPGEALPPVSQAGTGKAPELPSGSGPEPLAPSPVSPTFPPSSPSDWPQERSPGGHSDGASPRSPVPTTLPGLRHAPWQGPRGPPDSPDGSPLTPVPSQMPWLVASPEPPQSSPTPAFPLAASYDTNGLSQPPLPEKRHLPGPGQQPGPWGPEQASSPARGISHHVTFAPLLSDNVPQTPEPPTQESQSNVKFVQDTSKFWYKPHLSRDQAIALLKDKDPGAFLIRDSHSFQGAYGLALKVATPPPSAQPWKGDPVEQLVRHFLIETGPKGVKIKGCPSEPYFGSLSALVSQHSISPISLPCCLRIPSKDPLEETPEAPVPTNMSTAADLLRQGAACSVLYLTSVETESLTGPQAVARASSAALSCSPRPTPAVVHFKVSAQGITLTDNQRKLFFRRHYPVNSITFSSTDPQDRRWTNPDGTTSKIFGFVAKKPGSPWENVCHLFAELDPDQPAGAIVTFITKVLLGQRK,False,False,True,Q63HR2,"[('cd01213', 'Tensin Phosphotyrosine-binding (PTB) domain'), ('cd09927', 'Src homology 2 domain found in Tensin-like proteins'), ('cd14562', 'protein tyrosine phosphatase-like domain of tensin-2'), ('cd20887', 'protein kinase C conserved region 1 (C1 domain) found in tensin-2 and similar proteins'), ('G3DSA:2.30.29.30', 'Pleckstrin-homology domain (PH domain)/Phosphotyrosine-binding domain (PTB)'), ('G3DSA:2.60.40.1110', None), ('G3DSA:3.30.505.10', 'SH2 domain'), ('G3DSA:3.30.60.20', None), ('G3DSA:3.90.190.10', 'Protein tyrosine phosphatase superfamily'), ('IPR000980', 'SH2 domain'), ('IPR002219', 'Protein kinase C-like, phorbol ester/diacylglycerol-binding domain'), ('IPR006020', 'PTB/PI domain'), ('IPR011993', 'PH-like domain superfamily'), ('IPR013625', 'Tensin/EPS8 phosphotyrosine-binding domain'), ('IPR014020', 'Tensin phosphatase, C2 domain'), ('IPR029021', 'Protein-tyrosine phosphatase-like'), ('IPR029023', 'Tensin-type phosphatase domain'), ('IPR033929', 'Tensin, phosphotyrosine-binding domain'), ('IPR035012', 'Tensin-like, SH2 domain'), ('IPR035892', 'C2 domain superfamily')]",,"""ENSG00000111077; Low tissue specificity."";","CATALYTIC ACTIVITY: Reaction=O-phospho-L-tyrosyl-[protein] + H2O = L-tyrosyl-[protein] + phosphate; Xref=Rhea:RHEA:10684, Rhea:RHEA-COMP:10136, Rhea:RHEA-COMP:10137, ChEBI:CHEBI:15377, ChEBI:CHEBI:43474, ChEBI:CHEBI:46858, ChEBI:CHEBI:82620; EC=3.1.3.48; Evidence={ECO:0000269|PubMed:23401856, ECO:0000269|PubMed:28955049, ECO:0000269|PubMed:30092354};",3.1.3.48,,,ENST00000314250.11 [Q63HR2-1];ENST00000314276.7 [Q63HR2-4];ENST00000379902.7 [Q63HR2-5];ENST00000546602.5 [Q63HR2-2];ENST00000552570.5 [Q63HR2-6];,TNS2,ENSG00000111077,0.0,,,,,,,0.534,0.311,TNS2
Q66GS9,ENSG00000174799,CP135_HUMAN,centriole replication [GO:0007099]; centriole-centriole cohesion [GO:0010457]; positive regulation of establishment of protein localization [GO:1904951]; positive regulation of non-motile cilium assembly [GO:1902857],centriole [GO:0005814]; centrosome [GO:0005813]; cytosol [GO:0005829],identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; protein homodimerization activity [GO:0042803]; tubulin binding [GO:0015631],,DOMAIN: Coiled-coil domains are critical for microtubule binding via the formation of a two-stranded coiled-coil structure in homodimers. {ECO:0000269|PubMed:27477386}.,,,"HELIX 82..131; /evidence=""ECO:0007829|PDB:5FCN""",,"cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,CEP135 CEP4 KIAA0635,Centrosomal protein of 135 kDa (Cep135) (Centrosomal protein 4),Homo sapiens (Human),1140.0,133490.0,MTTAVERKYINIRKRLDQLGYRQTLTVECLPLVEKLFSDLVHTTESLRQSKLSAVKAEKESANFDFVLEPYKLENARLSRENNELYLELMKLREHSDQHVKELKTSLKKCARETADLKFLNNQYAHKLKLLEKESKAKNERIQQLQEKNLHAVVQTPGGKKRSIAFRRQRMQIDEPVPPSEVSSYPVPQPDDPYIADLLQVADNRIQELQQEVHQLQEKLAMMESGVRDYSKQIELREREIERLSVALDGGRSPDVLSLESRNKTNEKLIAHLNIQVDFLQQANKDLEKRIRELMETKETVTSEVVNLSNKNEKLCQELTEIDQLAQQLERHKEEVLETADKELGEAKKEIKRKLSEMQDLEETMAKLQLELNLCQKEKERLSDELLVKSDLETVVHQLEQEKQRLSKKVESFAVTERQLTLEVERMRLEHGIKRRDRSPSRLDTFLKGIEEERDYYKKELERLQHIIQRRSCSTSYSAREKSSIFRTPEKGDYNSEIHQITRERDELQRMLERFEKYMEDIQSNVKLLTAERDKLSVLYNEAQEELSALRKESTQTTAPHNIVSLMEKEKELALSDLRRIMAEKEALREKLEHIEEVSLFGKSELEKTIEHLTCVNHQLESEKYELKSKVLIMKETIESLENKLKVQAQKFSHVAGDSSHQKTEVNSLRIVNEQLQRSVDDYQHRLSIKRGELESAQAQIKILEEKIDELNLKMTSQDEEAHVMKKTIGVIDKEKDFLQETVDEKTEKIANLQENLANKEKAVAQMKIMISECESSVNQLKETLVNRDREINSLRRQLDAAHKELDEVGRSREIAFKENRRLQDDLATMARENQEISLELEAAVQEKEEMKSRVHKYITEVSRWESLMAAKEKENQDLLDRFQMLHNRAEDWEVKAHQAEGESSSVRLELLSIDTERRHLRERVELLEKEIQEHINAHHAYESQISSMAKAMSRLEEELRHQEDEKATVLNDLSSLRELCIKLDSGKDIMTQQLNSKNLEFERVVVELENVKSESDLLKKQLSNERHTVKNLESLLATNRDKEFHSHLTSHEKDTEIQLLKEKLTLSESKLTSQSRENTMLRAKVAQLQTDYDALKRQISTERYERERAIQEMRRHGLATPPLSSTLRSPSHSPEHRNV,False,False,True,Q66GS9,"[('cd22292', 'coiled-coil microtubule binding domain of centrosomal protein of 135 kDa (Cep135) and similar proteins'), ('G3DSA:1.10.287.1490', None), ('IPR051877', 'Centriole and Basal Body Structural Protein'), ('PTHR20544', 'Centriole and Basal Body Structural Protein')]",,"""ENSG00000174799; Low tissue specificity."";",,,,,ENST00000257287.5 [Q66GS9-1];ENST00000422247.6 [Q66GS9-2];,CEP135,ENSG00000174799,0.0,,,,,,,0.325,0.024,CEP135
Q6FGJ9,,Q6FGJ9_HUMAN,glutathione metabolic process [GO:0006749],cytosol [GO:0005829]; intercellular bridge [GO:0045171]; sperm fibrous sheath [GO:0035686],glutathione transferase activity [GO:0004364]; identical protein binding [GO:0042802],,,"DOMAIN 5..92; /note=""GST N-terminal""; /evidence=""ECO:0000259|PROSITE:PS50404""; DOMAIN 94..212; /note=""GST C-terminal""; /evidence=""ECO:0000259|PROSITE:PS50405""",,,,"cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",unreviewed,GSTM3 hCG_40244,Glutathione S-transferase (EC 2.5.1.18),Homo sapiens (Human),225.0,26560.0,MSCESSMVLGYWDIRGLAHAIRLLLEFTDTSYEEKRYTCGEAPDYDRSQWLDVKFKLDLDFPNLPYLLDGKNKITQSNAILRYIARKHNMCGETEEEKIRVDIIENQVMDFRTQLIRLCYSSDHEKLKPQYLEELPGQLKQFSMFLGKFSWFAGEKLTFVDFLTYDILDQNRIFDPKCLDEFPNLKAFMCRFEALEKIAAYLQSDQFCKMPINNKMAQWGNKPVC,True,False,False,,,,,,,,,,GSTM3,ENSG00000134202,,,,,,,,,,GSTM3
Q6FGX3,,Q6FGX3_HUMAN,,,GTP binding [GO:0005525]; GTPase activity [GO:0003924],,,,,,,"cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",unreviewed,RAB6A,RAB6A protein,Homo sapiens (Human),208.0,23550.0,MSTGGDFGNPLRKFKLVFLGEQSVGKTSLITRFMYDSFDNTYQATIGIDFLSKTMYLEDRTIRLQLWDTAGQERFRSLIPSYIRDSAAAVVVYDITNVNSFQQTTKWIDDVRTERGSDVIIMLVGNKTDLADKRQVSIEEGERKAKELNVMFIETSAKAGYDVKQLFRRVAAALPGMESTQDRSREDMIDIKLEKPQEQPVSEGGCSC,True,False,False,,,,,,,,,,,,,,,,,,,,,
Q6NUS6,ENSG00000119977,TECT3_HUMAN,apoptotic process [GO:0006915]; cilium assembly [GO:0060271]; positive regulation of apoptotic process [GO:0043065]; smoothened signaling pathway [GO:0007224],ciliary membrane [GO:0060170]; nucleus [GO:0005634],,,,,,,,"cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,TCTN3 C10orf61 TECT3 PSEC0041 UNQ1881/PRO4324,Tectonic-3,Homo sapiens (Human),607.0,66157.0,MRTPQLALLQVFFLVFPDGVRPQPSSSPSGAVPTSLELQRGTDGGTLQSPSEATATRPAVPGLPTVVPTLVTPSAPGNRTVDLFPVLPICVCDLTPGACDINCCCDRDCYLLHPRTVFSFCLPGSVRSSSWVCVDNSVIFRSNSPFPSRVFMDSNGIRQFCVHVNNSNLNYFQKLQKVNATNFQALAAEFGGESFTSTFQTQSPPSFYRAGDPILTYFPKWSVISLLRQPAGVGAGGLCAESNPAGFLESKSTTCTRFFKNLASSCTLDSALNAASYYNFTVLKVPRSMTDPQNMEFQVPVILTSQANAPLLAGNTCQNVVSQVTYEIETNGTFGIQKVSVSLGQTNLTVEPGASLQQHFILRFRAFQQSTAASLTSPRSGNPGYIVGKPLLALTDDISYSMTLLQSQGNGSCSVKRHEVQFGVNAISGCKLRLKKADCSHLQQEIYQTLHGRPRPEYVAIFGNADPAQKGGWTRILNRHCSISAINCTSCCLIPVSLEIQVLWAYVGLLSNPQAHVSGVRFLYQCQSIQDSQQVTEVSLTTLVNFVDITQKPQPPRGQPKMDWKWPFDFFPFKVAFSRGVFSQKCSVSPILILCLLLLGVLNLETM,False,False,True,Q6NUS6,"[('IPR011677', 'Tectonic domain'), ('IPR040354', 'Tectonic'), ('PF07773', 'Tectonic domain DUF1619'), ('PTHR14611', 'TECTONIC FAMILY MEMBER')]",,"""ENSG00000119977; Low tissue specificity."";",,,,,ENST00000371209.5 [Q6NUS6-2];ENST00000371217.10 [Q6NUS6-1];ENST00000430368.6 [Q6NUS6-5];ENST00000679984.1 [Q6NUS6-4];,TCTN3,ENSG00000119977,0.0,,,,,,,0.3,0.066,TCTN3
Q6NVH9,,Q6NVH9_HUMAN,RNA splicing [GO:0008380],extracellular region [GO:0005576]; spliceosomal complex [GO:0005681],carbohydrate binding [GO:0030246]; IgE binding [GO:0019863],,,"DOMAIN 118..248; /note=""Galectin""; /evidence=""ECO:0000259|PROSITE:PS51304""",,,,"cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",unreviewed,LGALS3,Galectin,Homo sapiens (Human),250.0,26197.0,MADNFSLHDALSGSGNPNPQGWPGAWGNQPAGAGGYPGASYPGAYPGQAPPGAYPGQAPPGAYHGAPGAYPGAPAPGVYPGPPSGPGAYPSSGQPSAPGAYPATGPYGAPAGPLIVPYNLPLPGGVVPRMLITILGTVKPNANRIALDFQRGNDVAFHFNPRFNENNRRVIVCNTKLDNNWGREERQSVFPFESGKPFKIHVLVEPDHFKVAVNDAHLLQYNHRVKKLNEISKLGISGDIDLTSASYTMI,True,False,False,,,,,,,,,,,,,,,,,,,,,
Q6PJ79,,Q6PJ79_HUMAN,,cytoplasm [GO:0005737],calcium ion binding [GO:0005509],,,"DOMAIN 21..109; /note=""EH""; /evidence=""ECO:0000259|PROSITE:PS50031""; DOMAIN 53..88; /note=""EF-hand""; /evidence=""ECO:0000259|PROSITE:PS50222""; DOMAIN 243..332; /note=""EH""; /evidence=""ECO:0000259|PROSITE:PS50031""; DOMAIN 276..311; /note=""EF-hand""; /evidence=""ECO:0000259|PROSITE:PS50222""",,,,"cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",unreviewed,,ITSN2 protein,Homo sapiens (Human),560.0,63669.0,MAQFPTAMNGGPNMWAITSEERTKHDRQFDNLKPSGGYITGDQARNFFLQSGLPAPVLAEIWALSDLNKDGKMDQQEFSIAMKLIKLKLQGQQLPVVLPPIMKQPPMFSPLISARFGMGSMPNLSIPQPLPPAAPITSLSSATSGTNLPPLMMPTPLVPSVSTSSLPNGTASLIQPLPIPYSSSTLPHGSSYSLMMGGFGGASIQKAQSLIDLGSSSSTSSTASLSGNSPKTGTSEWAVPQPTRLKYRQKFNTLDKSMSGYLSGFQARNALLQSNLSQTQLATIWTLADIDGDGQLKAEEFILAMHLTDMAKAGQPLPLTLPPELVPPSFRGGKQIDSINGTLPSYQKMQEEEPQKKLPVTFEDKRKANYERGNMELEKRRQALMEQQQREAERKAQKEKEEWERKQRELQEQEWKKQLELEKRLEKQRELERQREEERRKDIERREAAKQELERQRRLEWERIRRQELLNQKNREQEEIVRLNSKKKNLHLELEALNGKHQQISGRLQDVRLKKQTQKTELEVLDKQCDLEIMEIKQLQQELQEYQNKLIYLVPEKQLL,True,False,False,,,,,,,,,,,,,,,,,,,,,
Q6UWE0,ENSG00000148356,LRSM1_HUMAN,autophagy [GO:0006914]; negative regulation of endocytosis [GO:0045806]; positive regulation of autophagosome assembly [GO:2000786]; positive regulation of xenophagy [GO:1904417]; protein autoubiquitination [GO:0051865]; protein catabolic process [GO:0030163]; protein polyubiquitination [GO:0000209]; ubiquitin-dependent endocytosis [GO:0070086]; viral budding [GO:0046755],cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020],metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842],PTM: Ubiquitination promoted by PHF23 leads to proteasomal degradation. {ECO:0000269|PubMed:25484098}.,DOMAIN: The coiled coil domains interact with the SB domain of TSG101. {ECO:0000269|PubMed:15256501}.; DOMAIN: The PTAP motifs mediate the binding to UEV domains. {ECO:0000269|PubMed:15256501}.; DOMAIN: The LRR domain is necessary and sufficient for localization to bacterial targets. {ECO:0000269|PubMed:23245322}.; DOMAIN: The RING domain is required for ubiquitination. {ECO:0000269|PubMed:23245322}.,"DOMAIN 569..632; /note=""SAM""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00184""",,,,"cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,LRSAM1 TAL UNQ6496/PRO21356,E3 ubiquitin-protein ligase LRSAM1 (EC 2.3.2.27) (Leucine-rich repeat and sterile alpha motif-containing protein 1) (RING-type E3 ubiquitin transferase LRSAM1) (Tsg101-associated ligase) (hTAL),Homo sapiens (Human),723.0,83594.0,MPLFFRKRKPSEEARKRLEYQMCLAKEAGADDILDISKCELSEIPFGAFATCKVLQKKVLIVHTNHLTSLLPKSCSLLSLATIKVLDLHDNQLTALPDDLGQLTALQVLNVERNQLMQLPRSIGNLTQLQTLNVKDNKLKELPDTVGELRSLRTLNISGNEIQRLPQMLAHVRTLEMLSLDASAMVYPPREVCGAGTAAILQFLCKESGLEYYPPSQYLLPILEQDGIENSRDSPDGPTDRFSREELEWQNRFSDYEKRKEQKMLEKLEFERRLELGQREHTQLLQQSSSQKDEILQTVKEEQSRLEQGLSEHQRHLNAERQRLQEQLKQTEQNISSRIQKLLQDNQRQKKSSEILKSLENERIRMEQLMSITQEETESLRRRDVASAMQQMLTESCKNRLIQMAYESQRQNLVQQACSSMAEMDERFQQILSWQQMDQNKAISQILQESAMQKAAFEALQVKKDLMHRQIRSQIKLIETELLQLTQLELKRKSLDTESLQEMISEQRWALSSLLQQLLKEKQQREEELREILTELEAKSETRQENYWLIQYQRLLNQKPLSLKLQEEGMERQLVALLEELSAEHYLPIFAHHRLSLDLLSQMSPGDLAKVGVSEAGLQHEILRRVQELLDAARIQPELKPPMGEVVTPTAPQEPPESVRPSAPPAELEVQASECVVCLEREAQMIFLNCGHVCCCQQCCQPLRTCPLCRQDIAQRLRIYHSS,False,False,True,Q6UWE0,"[('cd09523', 'SAM domain of TAL subfamily'), ('cd16515', 'RING finger, HC subclass, found in leucine-rich repeat and sterile alpha motif-containing protein 1 (LRSAM1) and similar proteins'), ('G3DSA:1.10.150.50', 'Transcription Factor, Ets-1'), ('G3DSA:3.30.40.10', 'Zinc/RING finger domain, C3HC4 (zinc finger)'), ('G3DSA:3.80.10.10', 'Ribonuclease Inhibitor'), ('IPR001611', 'Leucine-rich repeat'), ('IPR001660', 'Sterile alpha motif domain'), ('IPR001841', 'Zinc finger, RING-type'), ('IPR003591', 'Leucine-rich repeat, typical subtype'), ('IPR013083', 'Zinc finger, RING/FYVE/PHD-type'), ('IPR013761', 'Sterile alpha motif/pointed domain superfamily'), ('IPR032675', 'Leucine-rich repeat domain superfamily'), ('IPR050216', 'Leucine-rich repeat domain-containing protein'), ('IPR055414', 'Disease resistance R13L4/SHOC-2-like, LRR domain'), ('PF07647', 'SAM domain (Sterile alpha motif)'), ('PF13920', 'Zinc finger, C3HC4 type (RING finger)'), ('PF23598', 'Leucine-rich repeat region'), ('PS50089', 'Zinc finger RING-type profile'), ('PS50105', 'SAM domain profile'), ('PS51450', 'Leucine-rich repeat profile')]",Q6UWE0;,"""ENSG00000148356; Low tissue specificity."";","CATALYTIC ACTIVITY: Reaction=S-ubiquitinyl-[E2 ubiquitin-conjugating enzyme]-L-cysteine + [acceptor protein]-L-lysine = [E2 ubiquitin-conjugating enzyme]-L-cysteine + N(6)-ubiquitinyl-[acceptor protein]-L-lysine.; EC=2.3.2.27; Evidence={ECO:0000269|PubMed:15256501, ECO:0000269|PubMed:23245322};",2.3.2.27,,"PATHWAY: Protein modification; protein ubiquitination. {ECO:0000269|PubMed:15256501, ECO:0000269|PubMed:23245322}.",ENST00000300417.11 [Q6UWE0-1];ENST00000323301.8 [Q6UWE0-1];ENST00000373322.1 [Q6UWE0-1];ENST00000373324.8 [Q6UWE0-2];ENST00000675448.1 [Q6UWE0-1];ENST00000675883.1 [Q6UWE0-2];,LRSAM1,ENSG00000148356,0.0,LRSAM1,Non-canonical_RBPs,9.0,,,,0.259,0.079,LRSAM1
Q6YP21,ENSG00000137944,KAT3_HUMAN,2-oxoglutarate metabolic process [GO:0006103]; amino acid metabolic process [GO:0006520]; biosynthetic process [GO:0009058]; kynurenine metabolic process [GO:0070189]; L-kynurenine catabolic process [GO:0097053],cytoplasm [GO:0005737]; mitochondrion [GO:0005739],cysteine-S-conjugate beta-lyase activity [GO:0047804]; kynurenine-glyoxylate transaminase activity [GO:0047315]; kynurenine-oxoglutarate transaminase activity [GO:0016212]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170]; RNA binding [GO:0003723],,,,,,,"cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,KYAT3 CCBL2 KAT3,Kynurenine--oxoglutarate transaminase 3 (EC 2.6.1.7) (Cysteine-S-conjugate beta-lyase 2) (EC 4.4.1.13) (Kynurenine aminotransferase 3) (Kynurenine aminotransferase III) (KATIII) (Kynurenine--glyoxylate transaminase) (EC 2.6.1.63) (Kynurenine--oxoglutarate transaminase III),Homo sapiens (Human),454.0,51400.0,MFLAQRSLCSLSGRAKFLKTISSSKILGFSTSAKMSLKFTNAKRIEGLDSNVWIEFTKLAADPSVVNLGQGFPDISPPTYVKEELSKIAAIDSLNQYTRGFGHPSLVKALSYLYEKLYQKQIDSNKEILVTVGAYGSLFNTIQALIDEGDEVILIVPFYDCYEPMVRMAGATPVFIPLRSKPVYGKRWSSSDWTLDPQELESKFNSKTKAIILNTPHNPLGKVYNREELQVIADLCIKYDTLCISDEVYEWLVYSGNKHLKIATFPGMWERTITIGSAGKTFSVTGWKLGWSIGPNHLIKHLQTVQQNTIYTCATPLQEALAQAFWIDIKRMDDPECYFNSLPKELEVKRDRMVRLLESVGLKPIVPDGGYFIIADVSLLDPDLSDMKNNEPYDYKFVKWMTKHKKLSAIPVSAFCNSETKSQFEKFVRFCFIKKDSTLDAAEEIIKAWSVQKS,True,False,False,Q6YP21,"[('cd00609', 'AAT_like'), ('G3DSA:3.40.640.10', 'Type I PLP-dependent aspartate aminotransferase-like (Major domain)'), ('G3DSA:3.90.1150.10', 'Aspartate Aminotransferase, domain 1'), ('IPR004839', 'Aminotransferase, class I/classII, large domain'), ('IPR015421', 'Pyridoxal phosphate-dependent transferase, major domain'), ('IPR015422', 'Pyridoxal phosphate-dependent transferase, small domain'), ('IPR015424', 'Pyridoxal phosphate-dependent transferase'), ('IPR051326', 'Kynurenine--oxoglutarate transaminase'), ('PF00155', 'Aminotransferase class I and II'), ('PTHR43807', 'Kynurenine--oxoglutarate transaminase'), ('SSF53383', 'PLP-dependent transferases')]",,"""ENSG00000137944; Low tissue specificity."";","CATALYTIC ACTIVITY: Reaction=L-kynurenine + 2-oxoglutarate = kynurenate + L-glutamate + H2O; Xref=Rhea:RHEA:65560, ChEBI:CHEBI:15377, ChEBI:CHEBI:16810, ChEBI:CHEBI:29985, ChEBI:CHEBI:57959, ChEBI:CHEBI:58454; EC=2.6.1.7; Evidence={ECO:0000250|UniProtKB:Q71RI9}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:65561; Evidence={ECO:0000250|UniProtKB:Q71RI9}; CATALYTIC ACTIVITY: Reaction=L-kynurenine + glyoxylate = kynurenate + glycine + H2O; Xref=Rhea:RHEA:65896, ChEBI:CHEBI:15377, ChEBI:CHEBI:36655, ChEBI:CHEBI:57305, ChEBI:CHEBI:57959, ChEBI:CHEBI:58454; EC=2.6.1.63; Evidence={ECO:0000250|UniProtKB:Q71RI9}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:65897; Evidence={ECO:0000250|UniProtKB:Q71RI9}; CATALYTIC ACTIVITY: Reaction=3-hydroxy-L-kynurenine + glyoxylate = xanthurenate + glycine + H2O; Xref=Rhea:RHEA:65900, ChEBI:CHEBI:15377, ChEBI:CHEBI:36655, ChEBI:CHEBI:57305, ChEBI:CHEBI:58125, ChEBI:CHEBI:71201; EC=2.6.1.63; Evidence={ECO:0000250|UniProtKB:Q71RI9}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:65901; Evidence={ECO:0000250|UniProtKB:Q71RI9}; CATALYTIC ACTIVITY: Reaction=an S-substituted L-cysteine + H2O = a thiol + pyruvate + NH4(+); Xref=Rhea:RHEA:18121, ChEBI:CHEBI:15361, ChEBI:CHEBI:15377, ChEBI:CHEBI:28938, ChEBI:CHEBI:29256, ChEBI:CHEBI:58717; EC=4.4.1.13; Evidence={ECO:0000250|UniProtKB:Q71RI9}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:18122; Evidence={ECO:0000250|UniProtKB:Q71RI9};",2.6.1.63; 2.6.1.7; 4.4.1.13,,PATHWAY: Amino-acid degradation; L-kynurenine degradation; kynurenate from L-kynurenine: step 1/2. {ECO:0000250|UniProtKB:Q71RI9}.,ENST00000260508.9 [Q6YP21-1];ENST00000370491.7 [Q6YP21-3];,KYAT3,ENSG00000137944,0.0,KYAT3,Non-canonical_RBPs,7.0,,,,0.095,,KYAT3
Q6ZNA4,ENSG00000157450,RN111_HUMAN,global genome nucleotide-excision repair [GO:0070911]; pattern specification process [GO:0007389]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of transforming growth factor beta receptor signaling pathway [GO:0030511]; protein polyubiquitination [GO:0000209]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PML body [GO:0016605]; protein-containing complex [GO:0032991],metal ion binding [GO:0046872]; SMAD binding [GO:0046332]; SUMO polymer binding [GO:0032184]; ubiquitin protein ligase activity [GO:0061630],,"DOMAIN: The SUMO interaction motifs (SIMs) mediates the binding to polysumoylated substrate. {ECO:0000269|PubMed:23086935, ECO:0000269|PubMed:23751493}.; DOMAIN: The RING-type zinc finger mediates the E3 ubiquitin-protein ligase activity and binds directly to free ubiquitin (PubMed:26656854). Non-covalent ubiquitin-binding stabilizes the ubiquitin-conjugating enzyme E2 (donor ubiquitin) in the 'closed' conformation and stimulates ubiquitin transfer (By similarity). {ECO:0000250|UniProtKB:Q6ZSG1, ECO:0000305|PubMed:26656854}.",,"STRAND 938..942; /evidence=""ECO:0007829|PDB:5LG0""; STRAND 951..953; /evidence=""ECO:0007829|PDB:2KIZ""; STRAND 955..957; /evidence=""ECO:0007829|PDB:2KIZ""; STRAND 963..965; /evidence=""ECO:0007829|PDB:2KIZ""; STRAND 984..986; /evidence=""ECO:0007829|PDB:2KIZ""","HELIX 966..975; /evidence=""ECO:0007829|PDB:2KIZ""","TURN 943..946; /evidence=""ECO:0007829|PDB:2KIZ""; TURN 959..961; /evidence=""ECO:0007829|PDB:5LG0""; TURN 980..982; /evidence=""ECO:0007829|PDB:2KIZ""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,RNF111,E3 ubiquitin-protein ligase Arkadia (EC 2.3.2.27) (RING finger protein 111) (hRNF111) (RING-type E3 ubiquitin transferase Arkadia),Homo sapiens (Human),994.0,108862.0,MSQWTPEYNELYTLKVDMKSEIPSDAPKTQESLKGILLHPEPIGAAKSFPAGVEMINSKVGNEFSHLCDDSQKQEKEMNGNQQEQEKSLVVRKKRKSQQAGPSYVQNCVKENQGILGLRQHLGTPSDEDNDSSFSDCLSSPSSSLHFGDSDTVTSDEDKEVSVRHSQTILNAKSRSHSARSHKWPRTETESVSGLLMKRPCLHGSSLRRLPCRKRFVKNNSSQRTQKQKERILMQRKKREVLARRKYALLPSSSSSSENDLSSESSSSSSTEGEEDLFVSASENHQNNPAVPSGSIDEDVVVIEASSTPQVTANEEINVTSTDSEVEIVTVGESYRSRSTLGHSRSHWSQGSSSHASRPQEPRNRSRISTVIQPLRQNAAEVVDLTVDEDEPTVVPTTSARMESQATSASINNSNPSTSEQASDTASAVTSSQPSTVSETSATLTSNSTTGTSIGDDSRRTTSSAVTETGPPAMPRLPSCCPQHSPCGGSSQNHHALGHPHTSCFQQHGHHFQHHHHHHHTPHPAVPVSPSFSDPACPVERPPQVQAPCGANSSSGTSYHEQQALPVDLSNSGIRSHGSGSFHGASAFDPCCPVSSSRAAIFGHQAAAAAPSQPLSSIDGYGSSMVAQPQPQPPPQPSLSSCRHYMPPPYASLTRPLHHQASACPHSHGNPPPQTQPPPQVDYVIPHPVHAFHSQISSHATSHPVAPPPPTHLASTAAPIPQHLPPTHQPISHHIPATAPPAQRLHPHEVMQRMEVQRRRMMQHPTRAHERPPPHPHRMHPNYGHGHHIHVPQTMSSHPRQAPERSAWELGIEAGVTAATYTPGALHPHLAHYHAPPRLHHLQLGALPLMVPDMAGYPHIRYISSGLDGTSFRGPFRGNFEELIHLEERLGNVNRGASQGTIERCTYPHKYKKVTTDWFSQRKLHCKQDGEEGTEEDTEEKCTICLSILEEGEDVRRLPCMHLFHQVCVDQWLITNKKCPICRVDIEAQLPSES,False,False,True,Q6ZNA4,"[('cd16681', 'RING finger, H2 subclass, found in RING finger protein 111 (RNF111) and similar proteins'), ('G3DSA:3.30.40.10', 'Zinc/RING finger domain, C3HC4 (zinc finger)'), ('IPR001841', 'Zinc finger, RING-type'), ('IPR013083', 'Zinc finger, RING/FYVE/PHD-type'), ('IPR029306', 'E3 ubiquitin-protein ligase Arkadia, N-terminal'), ('IPR051073', 'ZNRF3/Arkadia E3 ubiquitin-protein ligases'), ('PF13639', 'Ring finger domain'), ('PF15303', 'E3 ubiquitin-protein ligase Arkadia N-terminus'), ('PS50089', 'Zinc finger RING-type profile'), ('PTHR16200', 'ZNRF3/Arkadia E3 ubiquitin-protein ligases'), ('SM00184', 'Ring finger'), ('SSF57850', 'RING/U-box')]",,"""ENSG00000157450; Low tissue specificity."";",CATALYTIC ACTIVITY: Reaction=S-ubiquitinyl-[E2 ubiquitin-conjugating enzyme]-L-cysteine + [acceptor protein]-L-lysine = [E2 ubiquitin-conjugating enzyme]-L-cysteine + N(6)-ubiquitinyl-[acceptor protein]-L-lysine.; EC=2.3.2.27; Evidence={ECO:0000269|PubMed:23751493};,2.3.2.27,ACTIVITY REGULATION: Binds free ubiquitin non-covalently via its RING-type zinc finger. Ubiquitin-binding leads to enhance the E3 ubiquitin-protein ligase activity by stabilizing the ubiquitin-conjugating enzyme E2 (donor ubiquitin) in the 'closed' conformation and activating ubiquitin transfer. {ECO:0000250|UniProtKB:Q6ZSG1}.,"PATHWAY: Protein modification; protein ubiquitination. {ECO:0000269|PubMed:14657019, ECO:0000269|PubMed:16601693, ECO:0000269|PubMed:17591695, ECO:0000269|PubMed:22411132, ECO:0000269|PubMed:23751493, ECO:0000269|PubMed:26656854}.",ENST00000348370.9 [Q6ZNA4-2];ENST00000557998.5 [Q6ZNA4-1];ENST00000559209.5 [Q6ZNA4-4];ENST00000561186.5 [Q6ZNA4-3];,RNF111,ENSG00000157450,0.0,,,,9.86,DP03113,0.099,0.919,0.458,RNF111
Q6ZU80,ENSG00000100629,CE128_HUMAN,protein localization [GO:0008104]; regulation of gene expression [GO:0010468]; sperm flagellum assembly [GO:0120316],centriolar subdistal appendage [GO:0120103]; centriole [GO:0005814]; centrosome [GO:0005813]; Golgi apparatus [GO:0005794]; nuclear membrane [GO:0031965]; spindle pole [GO:0000922],,,,,,,,"cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,CEP128 C14orf145 C14orf61,Centrosomal protein of 128 kDa (Cep128),Homo sapiens (Human),1094.0,128015.0,MAESSSESDHFRCRDRLSPWAARSTHRGTRSLPTVEVTEKVNTITSTLQDTSRNLRQVDQMLGRYREYSNGQAGAIEHLKESLEQSIDQLRSQRLLRNSGGRSISVTSLSASDLDGGTGSELHHFPPTSPLKDYGDPQGIKRMRSRTGVRFVQETDDMTQLHGFHQSLRDLSSEQIRLGDDFNRELSRRSRSDAETKRALEELTEKLNEAQKQEVVSDRVERRLQELEREMRTERELVERRQDQLGLMSLQLQEALKKQEAKADEHEGAIKNKLRQTETEKNQLEQELELSRRLLNQSEGSRETLLHQVEELRTQLTKAEGDRKGLQHQVSQISKQQSNYQDEQGEDWRFRRGVEREKQDLEKQMSDLRVQLNFSAMASELEEVKRCMERKDKEKAHLASQVENLTRELENGEKQQLQMLDRLKEIQNHFDTCEAERKHADLQISELTRHAEDATKQAERYLSELQQSEALKEEAEKRREDLKLKAQESIRQWKLKHKKLERALEKQSETVDELTGKNNQILKEKDELKTQLYAALQQIENLRKELNDVLTKRALQEEELHSKEEKLRDIKSHQADLELEVKNSLDTIHRLESELKKQSKIQSQMKVEKAHLEEEIAELKKSQAQDKAKLLEMQESIKDLSAIRADLANKLAEEERAKKAVLKDLSDLTAQAKSRDEETATIITQLKLERDVHQRELKDLTSSLQSVKTKHEQNIQELMKHFKKEKSEAENHIRTLKAESLEEKNMAKIHRGQLEKLKSQCDRLTEELTQNENENKKLKLKYQCLKDQLEEREKHISIEEEHLRRMEEARLQLKDQLLCLETEQESILGVIGKEIDAACKTFSKDSVEKLKVFSSGPDIHYDPHRWLAESKTKLQWLCEELKERENREKNLRHQLMLCRQQLRNLTENKESELQCLFQQIERQEQLLDEIHREKRDLLEETQRKDEEMGSLQDRVIALETSTQVALDHLESVPEKLSLLEDFKDFRDSCSSSERTDGRYSKYRVRRNSLQHHQDDTKYRTKSFKGDRTFLEGSHTRGLDHSSSWQDHSRFLSSPRFSYVNSFTKRTVAPDSASNKEDATMNGTSSQPKKEEYGS,False,False,True,Q6ZU80,"[('IPR026652', 'Centrosomal protein of 128kDa'), ('PTHR46657', 'CENTROSOMAL PROTEIN OF 128 KDA')]",,"""ENSG00000100629; Tissue enhanced (lymphoid)."";",,,,,ENST00000216517.10 [Q6ZU80-3];ENST00000281129.7 [Q6ZU80-2];ENST00000555265.6 [Q6ZU80-2];,CEP128,ENSG00000100629,0.0,,,,,,,0.353,0.13,CEP128
Q71UF1,,Q71UF1_HUMAN,tricarboxylic acid cycle [GO:0006099],mitochondrion [GO:0005739],"4 iron, 4 sulfur cluster binding [GO:0051539]; aconitate hydratase activity [GO:0003994]; metal ion binding [GO:0046872]",,,"DOMAIN 67..503; /note=""Aconitase/3-isopropylmalate dehydratase large subunit alpha/beta/alpha""; /evidence=""ECO:0000259|Pfam:PF00330""; DOMAIN 583..711; /note=""Aconitase A/isopropylmalate dehydratase small subunit swivel""; /evidence=""ECO:0000259|Pfam:PF00694""",,,,"cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",unreviewed,ACO2,"Aconitate hydratase, mitochondrial (Aconitase) (EC 4.2.1.3)",Homo sapiens (Human),780.0,85617.0,MAPYSLLVTRLQKALGVRQYHVASVLCQRAKVAMTHFEPNEYIHYDLLEKNINIVRKRLNRPLTLSEKIVYGHLDDPASQEIERGKSYLRLRPDRVAMQDATAQMAMLQFISSGLSKVAVPSTIHCDHLIEAQVGDEKDLRRAKDINQEVYNFLATAGDKYGVGFWSPGSGIIHQIILENYAYPGVLLIGTDSHTPNGGGLGGICIGVGGADAVDVMAGIPWELKCPKVIGVKLTGSLSGWTSPKDVILKVAGILTVKGGTGAIVEYHGPGVDSMSCTGMATICNMGAEIGATTSVFPYNHRMKKYLSKTGREDIANLADEFKDHLVPDPGCHYDQLIEINLSELKPHINGPFTPDLAHPVAEVGKVAEKEGWPLDIRVGLIGSCTNSSYEDMGRSAAVAKQALAHGLKCKSQFTITPGSEQIRATIERDGYRQILRDLGGIVLANACGPCIGQWDRKDIKKGEKNTIVTSYNRNFTGRNDANPETHAFVTSPEIVTALAIAGTLKFNPETNYLTGTDGKKFRLEAPDADELPKGEFDPGQDTYQHPPKDSSGQHVDVSPTSQRLQLLEPFDKWDGKDLEDLQILIKVKGKCTTDHISAAGPWLKFRGHLDNISNNLLIGAINIENGKANSVRNAVTQEFGPVPDTARYYKKHGIRWVVIGDENYGEGSSREHAALEPRHLGGRAIITKSFARIHETNLKKQGLLPLTFADPADYNKIHPVDKLTIQGLKDFTPGKPLKCIIKHPNGTQETILLNHTFNETQIEWFRAGSALNRMKELQQ,True,False,False,,,,,,,,,,,,,,,,,,,,,
Q7L0Y3,ENSG00000174173,TM10C_HUMAN,mitochondrial RNA 5'-end processing [GO:0000964]; mitochondrial tRNA 3'-end processing [GO:1990180]; mitochondrial tRNA 5'-end processing [GO:0097745]; mitochondrial tRNA methylation [GO:0070901]; mitochondrial tRNA processing [GO:0090646]; mRNA processing [GO:0006397]; positive regulation of mitochondrial translation [GO:0070131],mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrial ribonuclease P complex [GO:0030678]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; tRNA methyltransferase complex [GO:0043527],identical protein binding [GO:0042802]; RNA binding [GO:0003723]; tRNA (adenine(9)-N1)-methyltransferase activity [GO:0160106]; tRNA (guanosine(9)-N1)-methyltransferase activity [GO:0052905]; tRNA binding [GO:0000049],,,"DOMAIN 191..383; /note=""SAM-dependent MTase TRM10-type""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU01012""","STRAND 204..208; /evidence=""ECO:0007829|PDB:5NFJ""; STRAND 237..239; /evidence=""ECO:0007829|PDB:7ONU""; STRAND 242..247; /evidence=""ECO:0007829|PDB:5NFJ""; STRAND 271..273; /evidence=""ECO:0007829|PDB:5NFJ""; STRAND 287..290; /evidence=""ECO:0007829|PDB:5NFJ""; STRAND 295..297; /evidence=""ECO:0007829|PDB:5NFJ""; STRAND 306..310; /evidence=""ECO:0007829|PDB:5NFJ""; STRAND 316..318; /evidence=""ECO:0007829|PDB:7ONU""; STRAND 333..335; /evidence=""ECO:0007829|PDB:5NFJ""; STRAND 342..344; /evidence=""ECO:0007829|PDB:5NFJ""; STRAND 381..384; /evidence=""ECO:0007829|PDB:7ONU""","HELIX 93..103; /evidence=""ECO:0007829|PDB:7ONU""; HELIX 114..121; /evidence=""ECO:0007829|PDB:7ONU""; HELIX 126..155; /evidence=""ECO:0007829|PDB:7ONU""; HELIX 183..201; /evidence=""ECO:0007829|PDB:7ONU""; HELIX 212..214; /evidence=""ECO:0007829|PDB:5NFJ""; HELIX 217..236; /evidence=""ECO:0007829|PDB:5NFJ""; HELIX 253..261; /evidence=""ECO:0007829|PDB:5NFJ""; HELIX 263..268; /evidence=""ECO:0007829|PDB:5NFJ""; HELIX 278..281; /evidence=""ECO:0007829|PDB:5NFJ""; HELIX 284..286; /evidence=""ECO:0007829|PDB:5NFJ""; HELIX 321..327; /evidence=""ECO:0007829|PDB:5NFJ""; HELIX 338..341; /evidence=""ECO:0007829|PDB:5NFJ""; HELIX 353..364; /evidence=""ECO:0007829|PDB:5NFJ""; HELIX 369..372; /evidence=""ECO:0007829|PDB:5NFJ""; HELIX 373..375; /evidence=""ECO:0007829|PDB:5NFJ""","TURN 328..330; /evidence=""ECO:0007829|PDB:5NFJ""; TURN 378..380; /evidence=""ECO:0007829|PDB:7ONU""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,TRMT10C MRPP1 RG9MTD1,tRNA methyltransferase 10 homolog C (HBV pre-S2 trans-regulated protein 2) (Mitochondrial ribonuclease P protein 1) (Mitochondrial RNase P protein 1) (RNA (guanine-9-)-methyltransferase domain-containing protein 1) (Renal carcinoma antigen NY-REN-49) (mRNA methyladenosine-N(1)-methyltransferase) (EC 2.1.1.-) (tRNA (adenine(9)-N(1))-methyltransferase) (EC 2.1.1.218) (tRNA (guanine(9)-N(1))-methyltransferase) (EC 2.1.1.221),Homo sapiens (Human),403.0,47347.0,MAAFLKMSVSVNFFRPFTRFLVPFTLHRKRNNLTILQRYMSSKIPAVTYPKNESTPPSEELELDKWKTTMKSSVQEECVSTISSSKDEDPLAATREFIEMWRLLGREVPEHITEEELKTLMECVSNTAKKKYLKYLYTKEKVKKARQIKKEMKAAAREEAKNIKLLETTEEDKQKNFLFLRLWDRNMDIAMGWKGAQAMQFGQPLVFDMAYENYMKRKELQNTVSQLLESEGWNRRNVDPFHIYFCNLKIDGALHRELVKRYQEKWDKLLLTSTEKSHVDLFPKDSIIYLTADSPNVMTTFRHDKVYVIGSFVDKSMQPGTSLAKAKRLNLATECLPLDKYLQWEIGNKNLTLDQMIRILLCLKNNGNWQEALQFVPKRKHTGFLEISQHSQEFINRLKKAKT,True,True,False,Q7L0Y3,"[('cd18102', 'Mitochondrial ribonuclease P protein 1'), ('G3DSA:3.40.1280.30', None), ('IPR007356', 'tRNA (guanine(9)-N1)-methyltransferase, eukaryotic'), ('IPR016009', 'tRNA methyltransferase TRMD/TRM10-type domain'), ('IPR025812', 'tRNA methyltransferase 10 homolog C, TRM10-type domain'), ('IPR028564', 'tRNA methyltransferase TRM10-type domain'), ('IPR038459', 'tRNA methyltransferase TRM10-type domain superfamily'), ('PF01746', 'tRNA (Guanine-1)-methyltransferase'), ('PS51675', 'SAM-dependent methyltransferase TRM10-type domain profile'), ('PTHR13563', 'TRNA (GUANINE-9-) METHYLTRANSFERASE')]",,"""ENSG00000174173; Low tissue specificity."";","CATALYTIC ACTIVITY: Reaction=adenosine(9) in tRNA + S-adenosyl-L-methionine = N(1)-methyladenosine(9) in tRNA + S-adenosyl-L-homocysteine + H(+); Xref=Rhea:RHEA:43148, Rhea:RHEA-COMP:10363, Rhea:RHEA-COMP:10364, ChEBI:CHEBI:15378, ChEBI:CHEBI:57856, ChEBI:CHEBI:59789, ChEBI:CHEBI:74411, ChEBI:CHEBI:74491; EC=2.1.1.218; Evidence={ECO:0000269|PubMed:23042678}; CATALYTIC ACTIVITY: Reaction=guanosine(9) in tRNA + S-adenosyl-L-methionine = N(1)-methylguanosine(9) in tRNA + S-adenosyl-L-homocysteine + H(+); Xref=Rhea:RHEA:43156, Rhea:RHEA-COMP:10367, Rhea:RHEA-COMP:10368, ChEBI:CHEBI:15378, ChEBI:CHEBI:57856, ChEBI:CHEBI:59789, ChEBI:CHEBI:73542, ChEBI:CHEBI:74269; EC=2.1.1.221; Evidence={ECO:0000269|PubMed:23042678}; CATALYTIC ACTIVITY: Reaction=an adenosine in mRNA + S-adenosyl-L-methionine = an N(1)-methyladenosine in mRNA + S-adenosyl-L-homocysteine + H(+); Xref=Rhea:RHEA:55392, Rhea:RHEA-COMP:12414, Rhea:RHEA-COMP:12415, ChEBI:CHEBI:15378, ChEBI:CHEBI:57856, ChEBI:CHEBI:59789, ChEBI:CHEBI:74411, ChEBI:CHEBI:74491; Evidence={ECO:0000269|PubMed:29072297};",2.1.1.-; 2.1.1.218; 2.1.1.221,,,ENST00000309922.7;,TRMT10C,ENSG00000174173,0.0,TRMT10C,Canonical_RBPs,22.0,,,,0.337,,TRMT10C
Q7L5D6,ENSG00000239857,GET4_HUMAN,cytoplasmic sequestering of protein [GO:0051220]; ERAD pathway [GO:0036503]; maintenance of unfolded protein [GO:0036506]; post-translational protein targeting to endoplasmic reticulum membrane [GO:0006620]; protein insertion into ER membrane [GO:0045048]; regulation of protein stability [GO:0031647]; tail-anchored membrane protein insertion into ER membrane [GO:0071816]; ubiquitin-dependent protein catabolic process [GO:0006511],BAT3 complex [GO:0071818]; chromosome [GO:0005694]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654],protein-folding chaperone binding [GO:0051087],"PTM: Ubiquitinated by RNF12, leading to proteasomal degradation. When unassembled from BAG6; ubiquitinylation is modulated by BAG6 quality control role and effectuated by RNF126. {ECO:0000269|PubMed:29042515}.",,,"STRAND 228..231; /evidence=""ECO:0007829|PDB:7RU9""","HELIX 26..35; /evidence=""ECO:0007829|PDB:6AU8""; HELIX 39..55; /evidence=""ECO:0007829|PDB:6AU8""; HELIX 59..75; /evidence=""ECO:0007829|PDB:6AU8""; HELIX 79..95; /evidence=""ECO:0007829|PDB:6AU8""; HELIX 102..114; /evidence=""ECO:0007829|PDB:6AU8""; HELIX 120..133; /evidence=""ECO:0007829|PDB:6AU8""; HELIX 143..155; /evidence=""ECO:0007829|PDB:6AU8""; HELIX 159..167; /evidence=""ECO:0007829|PDB:6AU8""; HELIX 172..186; /evidence=""ECO:0007829|PDB:6AU8""; HELIX 189..191; /evidence=""ECO:0007829|PDB:6AU8""; HELIX 192..205; /evidence=""ECO:0007829|PDB:6AU8""; HELIX 209..222; /evidence=""ECO:0007829|PDB:6AU8""; HELIX 235..248; /evidence=""ECO:0007829|PDB:6AU8""; HELIX 252..261; /evidence=""ECO:0007829|PDB:6AU8""; HELIX 263..266; /evidence=""ECO:0007829|PDB:6AU8""; HELIX 272..284; /evidence=""ECO:0007829|PDB:6AU8""; HELIX 294..298; /evidence=""ECO:0007829|PDB:6AU8""; HELIX 301..303; /evidence=""ECO:0007829|PDB:6AU8""",,"cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,GET4 C7orf20 CEE TRC35 CGI-20,Golgi to ER traffic protein 4 homolog (Conserved edge-expressed protein) (Transmembrane domain recognition complex 35 kDa subunit) (TRC35),Homo sapiens (Human),327.0,36504.0,MAAAAAMAEQESARNGGRNRGGVQRVEGKLRASVEKGDYYEAHQMYRTLFFRYMSQSKHTEARELMYSGALLFFSHGQQNSAADLSMLVLESLEKAEVEVADELLENLAKVFSLMDPNSPERVTFVSRALKWSSGGSGKLGHPRLHQLLALTLWKEQNYCESRYHFLHSADGEGCANMLVEYSTSRGFRSEVDMFVAQAVLQFLCLKNKSSASVVFTTYTQKHPSIEDGPPFVEPLLNFIWFLLLAVDGGKLTVFTVLCEQYQPSLRRDPMYNEYLDRIGQLFFGVPPKQTSSYGGLLGNLLTSLMGSSEQEDGEESPSDGSPIELD,False,False,True,Q7L5D6,"[('G3DSA:1.25.40.10', 'Tetratricopeptide repeat domain'), ('IPR007317', 'Golgi to ER traffic protein 4'), ('IPR011990', 'Tetratricopeptide-like helical domain superfamily'), ('PF04190', 'Golgi to ER traffic protein 4'), ('PTHR12875', 'GOLGI TO ER TRAFFIC PROTEIN 4 HOMOLOG')]",,"""ENSG00000239857; Low tissue specificity."";",,,,,ENST00000265857.8 [Q7L5D6-1];ENST00000407192.5 [Q7L5D6-2];,GET4,ENSG00000239857,0.0,,,,,,,0.147,0.064,GET4
Q7Z3B3,ENSG00000120071,KANL1_HUMAN,chromatin organization [GO:0006325]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of mitochondrial transcription [GO:1903108],histone acetyltransferase complex [GO:0000123]; kinetochore [GO:0000776]; mitochondrion [GO:0005739]; MLL1 complex [GO:0071339]; NSL complex [GO:0044545]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],histone acetyltransferase binding [GO:0035035],,,,,"HELIX 591..593; /evidence=""ECO:0007829|PDB:4CY1""",,"cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,KANSL1 CENP-36 KIAA1267 MSL1V1 NSL1,KAT8 regulatory NSL complex subunit 1 (MLL1/MLL complex subunit KANSL1) (MSL1 homolog 1) (hMSL1v1) (NSL complex protein NSL1) (Non-specific lethal 1 homolog),Homo sapiens (Human),1105.0,120966.0,MAAMAPALTDAAAEAHHIRFKLAPPSSTLSPGSAENNGNANILIAANGTKRKAIAAEDPSLDFRNNPTKEDLGKLQPLVASYLCSDVTSVPSKESLKLQGVFSKQTVLKSHPLLSQSYELRAELLGRQPVLEFSLENLRTMNTSGQTALPQAPVNGLAKKLTKSSTHSDHDNSTSLNGGKRALTSSALHGGEMGGSESGDLKGGMTNCTLPHRSLDVEHTTLYSNNSTANKSSVNSMEQPALQGSSRLSPGTDSSSNLGGVKLEGKKSPLSSILFSALDSDTRITALLRRQADIESRARRLQKRLQVVQAKQVERHIQHQLGGFLEKTLSKLPNLESLRPRSQLMLTRKAEAALRKAASETTTSEGLSNFLKSNSISEELERFTASGIANLRCSEQAFDSDVTDSSSGGESDIEEEELTRADPEQRHVPLRRRSEWKWAADRAAIVSRWNWLQAHVSDLEYRIRQQTDIYKQIRANKGLIVLGEVPPPEHTTDLFLPLSSEVKTDHGTDKLIESVSQPLENHGAPIIGHISESLSTKSCGALRPVNGVINTLQPVLADHIPGDSSDAEEQLHKKQRLNLVSSSSDGTCVAARTRPVLSCKKRRLVRPNSIVPLSKKVHRNSTIRPGCDVNPSCALCGSGSINTMPPEIHYEAPLLERLSQLDSCVHPVLAFPDDVPTSLHFQSMLKSQWQNKPFDKIKPPKKLSLKHRAPMPGSLPDSARKDRHKLVSSFLTTAKLSHHQTRPDRTHRQHLDDVGAVPMVERVTAPKAERLLNPPPPVHDPNHSKMRLRDHSSERSEVLKHHTDMSSSSYLAATHHPPHSPLVRQLSTSSDSPAPASSSSQVTASTSQQPVRRRRGESSFDINNIVIPMSVAATTRVEKLQYKEILTPSWREVDLQSLKGSPDEENEEIEDLSDAAFAALHAKCEEMERARWLWTTSVPPQRRGSRSYRSSDGRTTPQLGSANPSTPQPASPDVSSSHSLSEYSHGQSPRSPISPELHSAPLTPVARDTPRHLASEDTRCSTPELGLDEQSVQPWERRTFPLAHSPQAECEDQLDAQERAARCTRRTSGSKTGRETEAAPTSPPIVPLKSRHLVAAATAQRPTHR,False,True,False,Q7Z3B3,"[('G3DSA:6.10.250.3170', None), ('IPR026180', 'KAT8 regulatory NSL complex subunit 1'), ('IPR029332', 'PEHE domain'), ('PF15275', 'PEHE domain'), ('PTHR22443', 'NON-SPECIFIC LETHAL 1, ISOFORM M'), ('SM01300', 'PEHE')]",Q7Z3B3;,"""ENSG00000120071; Low tissue specificity."";",,,,,ENST00000262419.10 [Q7Z3B3-1];ENST00000432791.7 [Q7Z3B3-1];ENST00000572904.6 [Q7Z3B3-1];,KANSL1,ENSG00000120071,0.0,,,,,,,0.834,0.366,KANSL1
Q7Z4W1,ENSG00000169738,DCXR_HUMAN,D-glucuronate catabolic process to D-xylulose 5-phosphate [GO:0019640]; D-xylose metabolic process [GO:0042732]; glucose metabolic process [GO:0006006]; NADP metabolic process [GO:0006739]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; xylulose metabolic process [GO:0005997],brush border [GO:0005903]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; microvillus [GO:0005902]; mitochondrion [GO:0005739]; nucleus [GO:0005634]; plasma membrane [GO:0005886],"carbonyl reductase (NADPH) activity [GO:0004090]; identical protein binding [GO:0042802]; L-xylulose reductase (NADPH) activity [GO:0050038]; oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor [GO:0016655]",,,,"STRAND 9..14; /evidence=""ECO:0007829|PDB:1PR9""; STRAND 33..39; /evidence=""ECO:0007829|PDB:1PR9""; STRAND 55..58; /evidence=""ECO:0007829|PDB:1PR9""; STRAND 79..82; /evidence=""ECO:0007829|PDB:1PR9""; STRAND 129..134; /evidence=""ECO:0007829|PDB:1PR9""; STRAND 172..179; /evidence=""ECO:0007829|PDB:1PR9""; STRAND 234..238; /evidence=""ECO:0007829|PDB:1PR9""","HELIX 18..29; /evidence=""ECO:0007829|PDB:1PR9""; HELIX 41..50; /evidence=""ECO:0007829|PDB:1PR9""; HELIX 64..71; /evidence=""ECO:0007829|PDB:1PR9""; HELIX 92..94; /evidence=""ECO:0007829|PDB:1PR9""; HELIX 97..107; /evidence=""ECO:0007829|PDB:1PR9""; HELIX 109..125; /evidence=""ECO:0007829|PDB:1PR9""; HELIX 137..139; /evidence=""ECO:0007829|PDB:1PR9""; HELIX 147..167; /evidence=""ECO:0007829|PDB:1PR9""; HELIX 168..170; /evidence=""ECO:0007829|PDB:1PR9""; HELIX 185..188; /evidence=""ECO:0007829|PDB:1PR9""; HELIX 194..201; /evidence=""ECO:0007829|PDB:1PR9""; HELIX 212..223; /evidence=""ECO:0007829|PDB:1PR9""; HELIX 225..227; /evidence=""ECO:0007829|PDB:1PR9""; HELIX 241..243; /evidence=""ECO:0007829|PDB:1PR9""",,"cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,DCXR SDR20C1,L-xylulose reductase (XR) (EC 1.1.1.10) (Carbonyl reductase II) (Dicarbonyl/L-xylulose reductase) (Kidney dicarbonyl reductase) (kiDCR) (Short chain dehydrogenase/reductase family 20C member 1) (Sperm surface protein P34H),Homo sapiens (Human),244.0,25913.0,MELFLAGRRVLVTGAGKGIGRGTVQALHATGARVVAVSRTQADLDSLVRECPGIEPVCVDLGDWEATERALGSVGPVDLLVNNAAVALLQPFLEVTKEAFDRSFEVNLRAVIQVSQIVARGLIARGVPGAIVNVSSQCSQRAVTNHSVYCSTKGALDMLTKVMALELGPHKIRVNAVNPTVVMTSMGQATWSDPHKAKTMLNRIPLGKFAEVEHVVNAILFLLSDRSGMTTGSTLPVEGGFWAC,True,False,False,Q7Z4W1,"[('cd05351', 'xylulose reductase-like, classical (c) SDRs'), ('G3DSA:3.40.50.720', 'NAD(P)-binding Rossmann-like Domain'), ('IPR002347', 'Short-chain dehydrogenase/reductase SDR'), ('IPR020904', 'Short-chain dehydrogenase/reductase, conserved site'), ('IPR036291', 'NAD(P)-binding domain superfamily'), ('IPR051737', 'L-xylulose reductase/Carbonyl reductase'), ('PF13561', 'Enoyl-(Acyl carrier protein) reductase'), ('PR00080', 'SDRFAMILY'), ('PR00081', 'GDHRDH'), ('PS00061', 'Short-chain dehydrogenases/reductases family signature'), ('PTHR44252', 'L-xylulose reductase/Carbonyl reductase'), ('SSF51735', 'NAD(P)-binding Rossmann-fold domains')]",,"""ENSG00000169738; Tissue enriched (liver)."";","CATALYTIC ACTIVITY: Reaction=xylitol + NADP(+) = L-xylulose + NADPH + H(+); Xref=Rhea:RHEA:17025, ChEBI:CHEBI:15378, ChEBI:CHEBI:17151, ChEBI:CHEBI:17399, ChEBI:CHEBI:57783, ChEBI:CHEBI:58349; EC=1.1.1.10; Evidence={ECO:0000269|PubMed:11882650};",1.1.1.10,,,ENST00000306869.7;,DCXR,ENSG00000169738,0.0,,,,,,,,,DCXR
Q86U72,,Q86U72_HUMAN,phosphorylation [GO:0016310],,kinase activity [GO:0016301],,,"DOMAIN 352..416; /note=""J""; /evidence=""ECO:0000259|PROSITE:PS50076""",,,,"cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",unreviewed,,Cyclin G associated kinase,Homo sapiens (Human),416.0,43977.0,MSLLQSALDFLAGPGSLGGASGRDQSDFVGQTVELGELRLLLASPAPPLSVQSTPRGGPPAAADPFGPLLPSSGNNSQPCSNPDLFGEFLNSDSVTVPPSFPSAHSSPPPSCSADFLHLGDLPGEPSKMTASSSNPDLLGGWAAWTETAASAVAPTPATEGPLFSPGGQPAPCGSQASWTKSQNPDPFADLGDLSSGLQGSPAGFPPGGFIPKTATTPKGSSSWQTSRPPAQGASWPPQAKPPPKACTQPRPNYASNFSVIGAREERGVRAPSFAQKPKVSENDFEDLLSNQGFSSRSDKKGPKTIAEMRKQDLAKDTDPLKLKLLDWIEGKERNIRALLSTLHTVLWDGESRWTPVGMADLVAPEQVKKHYRRAVLAVHPDKAAGQPYEQHAKMIFMELNDAWSEFENQGSRPLF,True,False,False,,,,,,,,,,,,,,,,,,,,,
Q86VP1,ENSG00000106052,TAXB1_HUMAN,apoptotic process [GO:0006915]; autophagy [GO:0006914]; innate immune response [GO:0045087]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cytoplasmic pattern recognition receptor signaling pathway [GO:0039532]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of toll-like receptor 4 signaling pathway [GO:0034144]; protein localization to phagocytic vesicle [GO:1905161],autophagosome [GO:0005776]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; mitochondrion [GO:0005739]; phagophore assembly site [GO:0000407],kinase binding [GO:0019900]; metal ion binding [GO:0046872]; protein-macromolecule adaptor activity [GO:0030674],PTM: Phosphorylated in the C-terminal region by CHUK/IKKA leading to NF-kappa-B signaling down-regulation. {ECO:0000269|PubMed:21765415}.,DOMAIN: The C-terminal UBZ-type zinc fingers function as ubiquitin-binding domains. {ECO:0000269|PubMed:24239949}.,,"STRAND 16..21; /evidence=""ECO:0007829|PDB:4NLH""; STRAND 24..26; /evidence=""ECO:0007829|PDB:4NLH""; STRAND 32..38; /evidence=""ECO:0007829|PDB:4NLH""; STRAND 49..54; /evidence=""ECO:0007829|PDB:4NLH""; STRAND 63..68; /evidence=""ECO:0007829|PDB:4NLH""; STRAND 81..87; /evidence=""ECO:0007829|PDB:4NLH""; STRAND 100..105; /evidence=""ECO:0007829|PDB:4NLH""; STRAND 111..114; /evidence=""ECO:0007829|PDB:4NLH""; STRAND 118..121; /evidence=""ECO:0007829|PDB:4NLH""; STRAND 727..729; /evidence=""ECO:0007829|PDB:4BMJ""; STRAND 731..734; /evidence=""ECO:0007829|PDB:4BMJ""; STRAND 754..756; /evidence=""ECO:0007829|PDB:4BMJ""","HELIX 13..15; /evidence=""ECO:0007829|PDB:5Z7G""; HELIX 60..62; /evidence=""ECO:0007829|PDB:4NLH""; HELIX 89..91; /evidence=""ECO:0007829|PDB:4NLH""; HELIX 743..751; /evidence=""ECO:0007829|PDB:4BMJ""; HELIX 770..779; /evidence=""ECO:0007829|PDB:5YT6""","TURN 758..760; /evidence=""ECO:0007829|PDB:5YT6""; TURN 780..782; /evidence=""ECO:0007829|PDB:5YT6""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,TAX1BP1 T6BP PRO0105,Tax1-binding protein 1 (TRAF6-binding protein),Homo sapiens (Human),789.0,90877.0,MTSFQEVPLQTSNFAHVIFQNVAKSYLPNAHLECHYTLTPYIHPHPKDWVGIFKVGWSTARDYYTFLWSPMPEHYVEGSTVNCVLAFQGYYLPNDDGEFYQFCYVTHKGEIRGASTPFQFRASSPVEELLTMEDEGNSDMLVVTTKAGLLELKIEKTMKEKEELLKLIAVLEKETAQLREQVGRMERELNHEKERCDQLQAEQKGLTEVTQSLKMENEEFKKRFSDATSKAHQLEEDIVSVTHKAIEKETELDSLKDKLKKAQHEREQLECQLKTEKDEKELYKVHLKNTEIENTKLMSEVQTLKNLDGNKESVITHFKEEIGRLQLCLAEKENLQRTFLLTTSSKEDTCFLKEQLRKAEEQVQATRQEVVFLAKELSDAVNVRDRTMADLHTARLENEKVKKQLADAVAELKLNAMKKDQDKTDTLEHELRREVEDLKLRLQMAADHYKEKFKECQRLQKQINKLSDQSANNNNVFTKKTGNQQKVNDASVNTDPATSASTVDVKPSPSAAEADFDIVTKGQVCEMTKEIADKTEKYNKCKQLLQDEKAKCNKYADELAKMELKWKEQVKIAENVKLELAEVQDNYKELKRSLENPAERKMEGQNSQSPQCFKTCSEQNGYVLTLSNAQPVLQYGNPYASQETRDGADGAFYPDEIQRPPVRVPSWGLEDNVVCSQPARNFSRPDGLEDSEDSKEDENVPTAPDPPSQHLRGHGTGFCFDSSFDVHKKCPLCELMFPPNYDQSKFEEHVESHWKVCPMCSEQFPPDYDQQVFERHVQTHFDQNVLNFD,False,False,True,Q86VP1,"[('cd21969', 'first C2H2-type zinc binding domain found in tax1-binding protein 1 (TAX1BP1) and similar proteins'), ('cd21970', 'second C2H2-type zinc binding domain found in tax1-binding protein 1 (TAX1BP1) and similar proteins'), ('G3DSA:2.60.40.2840', None), ('G3DSA:6.20.250.40', None), ('IPR012852', 'Calcium binding and coiled-coil domain-like'), ('IPR041611', 'SKICH domain'), ('IPR041641', 'CALCOCO1/2, zinc finger UBZ1-type'), ('IPR051002', 'Ubiquitin-binding and autophagy-associated domain-containing protein'), ('PF07888', 'Calcium binding and coiled-coil domain (CALCOCO1) like'), ('PF17751', 'SKICH domain'), ('PF18112', 'Autophagy receptor zinc finger-C2H2 domain'), ('PS51905', 'Zinc finger UBZ1-type profile'), ('PTHR31915', 'Ubiquitin-binding and autophagy-associated domain-containing protein')]",,"""ENSG00000106052; Low tissue specificity."";",,,,,ENST00000265393.10 [Q86VP1-2];ENST00000396319.7 [Q86VP1-1];ENST00000433216.6 [Q86VP1-4];ENST00000543117.5 [Q86VP1-2];,TAX1BP1,ENSG00000106052,0.0,,,,,,,0.508,0.108,TAX1BP1
Q86X19,ENSG00000186889,TMM17_HUMAN,cilium assembly [GO:0060271]; non-motile cilium assembly [GO:1905515]; smoothened signaling pathway [GO:0007224],ciliary membrane [GO:0060170]; ciliary transition zone [GO:0035869]; MKS complex [GO:0036038],,,,,,,,"cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,TMEM17,Transmembrane protein 17,Homo sapiens (Human),198.0,23046.0,MELPDPVRQRLGNFSRAVFSDSNRTGPESNEGPENEMVSSLALQMSLYFNTYYFPLWWVSSIMMLHMKYSILPDYYKFIVITVIILITLIEAIRLYLGYVGNLQEKVPELAGFWLLSLLLQLPLILFLLFNEGLTNLPLEKAIHIIFTLFLAFQVVAAFLTLRKMVNQLAVRFHLQDFDRLSANRGDMRRMRSCIEEI,False,False,True,Q86X19,"[('IPR019184', 'Uncharacterised protein family, transmembrane-17'), ('PF09799', 'Predicted membrane protein'), ('PTHR13531', 'GEO07735P1-RELATED-RELATED')]",,"""ENSG00000186889; Low tissue specificity."";",,,,,ENST00000335390.6;,TMEM17,ENSG00000186889,0.0,,,,,,,0.258,,TMEM17
Q86XF0,ENSG00000178700,DYR2_HUMAN,dihydrofolate metabolic process [GO:0046452]; folic acid metabolic process [GO:0046655]; one-carbon metabolic process [GO:0006730]; tetrahydrofolate biosynthetic process [GO:0046654]; tetrahydrofolate metabolic process [GO:0046653]; thymidine biosynthetic process [GO:0046105],cytosol [GO:0005829]; mitochondrial inner membrane [GO:0005743]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739],dihydrofolate reductase activity [GO:0004146]; folate reductase activity [GO:0033560]; mRNA binding [GO:0003729]; NADP binding [GO:0050661],,,"DOMAIN 4..185; /note=""DHFR""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00660""",,,,"cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,DHFR2 DHFRL1 DHFRP4,"Dihydrofolate reductase 2, mitochondrial (Dihydrofolate reductase, mitochondrial) (EC 1.5.1.3) (Dihydrofolate reductase-like protein 1)",Homo sapiens (Human),187.0,21620.0,MFLLLNCIVAVSQNMGIGKNGDLPRPPLRNEFRYFQRMTTTSSVEGKQNLVIMGRKTWFSIPEKNRPLKDRINLVLSRELKEPPQGAHFLARSLDDALKLTERPELANKVDMIWIVGGSSVYKEAMNHLGHLKLFVTRIMQDFESDTFFSEIDLEKYKLLPEYPGVLSDVQEGKHIKYKFEVCEKDD,True,False,False,Q86XF0,"[('cd00209', 'DHFR'), ('G3DSA:3.40.430.10', 'Dihydrofolate Reductase, subunit A'), ('IPR001796', 'Dihydrofolate reductase domain'), ('IPR012259', 'Dihydrofolate reductase'), ('IPR024072', 'Dihydrofolate reductase-like domain superfamily'), ('PF00186', 'Dihydrofolate reductase'), ('PR00070', 'DHFR'), ('PS51330', 'Dihydrofolate reductase (DHFR) domain profile'), ('PTHR48069', 'DIHYDROFOLATE REDUCTASE'), ('SSF53597', 'Dihydrofolate reductase-like')]",,"""ENSG00000178700; Low tissue specificity."";","CATALYTIC ACTIVITY: Reaction=(6S)-5,6,7,8-tetrahydrofolate + NADP(+) = 7,8-dihydrofolate + NADPH + H(+); Xref=Rhea:RHEA:15009, ChEBI:CHEBI:15378, ChEBI:CHEBI:57451, ChEBI:CHEBI:57453, ChEBI:CHEBI:57783, ChEBI:CHEBI:58349; EC=1.5.1.3; Evidence={ECO:0000255|PROSITE-ProRule:PRU00660, ECO:0000269|PubMed:21876184};",1.5.1.3,,"PATHWAY: Cofactor biosynthesis; tetrahydrofolate biosynthesis; 5,6,7,8-tetrahydrofolate from 7,8-dihydrofolate: step 1/1.",ENST00000314636.3;ENST00000394221.3;ENST00000461173.5;ENST00000619045.1;,DHFR2,ENSG00000178700,0.0,DHFR2,Non-canonical_RBPs,0.0,,,,,,DHFR2
Q8IUQ4,ENSG00000196470,SIAH1_HUMAN,amyloid fibril formation [GO:1990000]; anatomical structure morphogenesis [GO:0009653]; apoptotic process [GO:0006915]; axon guidance [GO:0007411]; canonical Wnt signaling pathway [GO:0060070]; nervous system development [GO:0007399]; neuron apoptotic process [GO:0051402]; positive regulation of apoptotic process [GO:0043065]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein catabolic process [GO:0030163]; protein ubiquitination [GO:0016567]; spermatogenesis [GO:0007283]; ubiquitin-dependent protein catabolic process [GO:0006511],beta-catenin destruction complex [GO:0030877]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634],identical protein binding [GO:0042802]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],"PTM: Phosphorylated on Ser-19 by ATM and ATR. This phosphorylation disrupts SIAH1 interaction with HIPK2, and subsequent proteasomal degradation of HIPK2. {ECO:0000269|PubMed:18536714}.",DOMAIN: The RING-type zinc finger domain is essential for ubiquitin ligase activity.; DOMAIN: The SBD domain (substrate-binding domain) mediates the homodimerization and the interaction with substrate proteins. It is related to the TRAF family. {ECO:0000250|UniProtKB:P61092}.,,"STRAND 95..97; /evidence=""ECO:0007829|PDB:4X3G""; STRAND 108..110; /evidence=""ECO:0007829|PDB:4X3G""; STRAND 122..124; /evidence=""ECO:0007829|PDB:4I7B""; STRAND 130..134; /evidence=""ECO:0007829|PDB:4CA1""; STRAND 156..167; /evidence=""ECO:0007829|PDB:4CA1""; STRAND 172..184; /evidence=""ECO:0007829|PDB:4CA1""; STRAND 187..197; /evidence=""ECO:0007829|PDB:4CA1""; STRAND 199..201; /evidence=""ECO:0007829|PDB:5WZZ""; STRAND 203..213; /evidence=""ECO:0007829|PDB:4CA1""; STRAND 221..229; /evidence=""ECO:0007829|PDB:4CA1""; STRAND 232..238; /evidence=""ECO:0007829|PDB:4CA1""; STRAND 256..260; /evidence=""ECO:0007829|PDB:4CA1""; STRAND 272..281; /evidence=""ECO:0007829|PDB:4CA1""","HELIX 101..103; /evidence=""ECO:0007829|PDB:4CA1""; HELIX 111..120; /evidence=""ECO:0007829|PDB:4CA1""; HELIX 141..143; /evidence=""ECO:0007829|PDB:4CA1""; HELIX 144..151; /evidence=""ECO:0007829|PDB:4CA1""; HELIX 215..218; /evidence=""ECO:0007829|PDB:4CA1""; HELIX 248..252; /evidence=""ECO:0007829|PDB:4CA1""; HELIX 261..267; /evidence=""ECO:0007829|PDB:4CA1""","TURN 243..245; /evidence=""ECO:0007829|PDB:4CA1""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,SIAH1 HUMSIAH,E3 ubiquitin-protein ligase SIAH1 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase SIAH1) (Seven in absentia homolog 1) (Siah-1) (Siah-1a),Homo sapiens (Human),282.0,31123.0,MSRQTATALPTGTSKCPPSQRVPALTGTTASNNDLASLFECPVCFDYVLPPILQCQSGHLVCSNCRPKLTCCPTCRGPLGSIRNLAMEKVANSVLFPCKYASSGCEITLPHTEKADHEELCEFRPYSCPCPGASCKWQGSLDAVMPHLMHQHKSITTLQGEDIVFLATDINLPGAVDWVMMQSCFGFHFMLVLEKQEKYDGHQQFFAIVQLIGTRKQAENFAYRLELNGHRRRLTWEATPRSIHEGIATAIMNSDCLVFDTSIAQLFAENGNLGINVTISMC,False,False,True,Q8IUQ4,"[('cd03829', 'Sina'), ('G3DSA:2.60.210.10', 'Apoptosis, Tumor Necrosis Factor Receptor Associated Protein 2; Chain A'), ('G3DSA:3.30.40.10', 'Zinc/RING finger domain, C3HC4 (zinc finger)'), ('IPR001841', 'Zinc finger, RING-type'), ('IPR004162', 'E3 ubiquitin-protein ligase SINA-like, animal'), ('IPR008974', 'TRAF-like'), ('IPR013010', 'Zinc finger, SIAH-type'), ('IPR013083', 'Zinc finger, RING/FYVE/PHD-type'), ('IPR018121', 'Seven-in-absentia protein, TRAF-like domain'), ('IPR049548', 'E3 ubiquitin-protein ligase Sina-like, RING finger'), ('PF03145', 'Sina, TRAF-like domain'), ('PF21361', 'Sina, zinc finger'), ('PF21362', 'E3 ubiquitin-protein ligase sina/sinah, RING finger'), ('PS50089', 'Zinc finger RING-type profile'), ('PS51081', 'Zinc finger SIAH-type profile'), ('PTHR45877', 'E3 UBIQUITIN-PROTEIN LIGASE SIAH2'), ('SSF49599', 'TRAF domain-like'), ('SSF57850', 'RING/U-box')]",,"""ENSG00000196470; Low tissue specificity."";","CATALYTIC ACTIVITY: Reaction=S-ubiquitinyl-[E2 ubiquitin-conjugating enzyme]-L-cysteine + [acceptor protein]-L-lysine = [E2 ubiquitin-conjugating enzyme]-L-cysteine + N(6)-ubiquitinyl-[acceptor protein]-L-lysine.; EC=2.3.2.27; Evidence={ECO:0000269|PubMed:19224863, ECO:0000269|PubMed:28546513};",2.3.2.27,"ACTIVITY REGULATION: Inhibited by interaction with SNCAIP (isoform 2, but not isoform 1). May be inhibited by interaction with PEG10. {ECO:0000269|PubMed:19224863}.","PATHWAY: Protein modification; protein ubiquitination. {ECO:0000269|PubMed:19224863, ECO:0000269|PubMed:28546513}.",ENST00000356721.3 [Q8IUQ4-2];ENST00000380006.2 [Q8IUQ4-1];ENST00000394725.3 [Q8IUQ4-1];ENST00000568007.5 [Q8IUQ4-1];,SIAH1,ENSG00000196470,0.0,,,,12.41,DP02608,0.124,0.117,0.078,SIAH1
Q8IWX2,,Q8IWX2_HUMAN,cell adhesion [GO:0007155],,hyaluronic acid binding [GO:0005540],,,"DOMAIN 50..153; /note=""Ig-like""; /evidence=""ECO:0000259|PROSITE:PS50835""; DOMAIN 85..193; /note=""Link""; /evidence=""ECO:0000259|PROSITE:PS50963""; DOMAIN 198..295; /note=""Link""; /evidence=""ECO:0000259|PROSITE:PS50963""",,,,"cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",unreviewed,HABP2,Brevican core protein,Homo sapiens (Human),516.0,55879.0,MAQLFLPLLAALVLAQAPAALADVLEGDSSEDRAFRVRIAGDAPLQGVLGGALTIPCHVHYLRPPPSRRAVLGSPRVKWTFLSRGREAEVLVARGVRVKVNEAYRFRVALPAYPASLTDVSLALSELRPNDSGIYRCEVQHGIDDSSDAVESSQRYPIQTPREACYGDMDGFPGVRNYGVVDPDDLYDVYCYAEDLNGELFLGDPPEKLTLEEARAYCQERGAEIATTGQLYAAWDGGLDHCSPGWLADGSVRYPIVTPSQRCGGGLPGVKTLFLFPNQTGFPNKHSRFNVYCFRDSAQLLPSLRPPTQPPTQLDGLEAIVTVTETLEELQLPQEATESESRGAIYSIPIMEDGGGGSSTPEDPAEAPRTLLEFETQSMVPPTGFSEEEGKALEEEEKYEDEEEKEEEEEEEEVEDEALWAWPSELSSPGPEASLPTEPAAQEESLSQAPARAVLQPGASPLPDGESEASRPPRVHGPPTETLPTPRERNLASPSPSTLVEAREVGEATGGPELSG,True,False,False,,,,,,,,,,,,,,,,,,,,,
Q8IWX8,ENSG00000085872,CHERP_HUMAN,intracellular calcium ion homeostasis [GO:0006874]; negative regulation of cell population proliferation [GO:0008285]; nervous system development [GO:0007399]; positive regulation of calcineurin-NFAT signaling cascade [GO:0070886]; release of sequestered calcium ion into cytosol [GO:0051209]; RNA processing [GO:0006396],cytoplasm [GO:0005737]; membrane [GO:0016020]; nucleoplasm [GO:0005654]; perinuclear region of cytoplasm [GO:0048471]; sarcoplasmic reticulum membrane [GO:0033017],RNA binding [GO:0003723]; transmembrane transporter binding [GO:0044325],,,"DOMAIN 149..289; /note=""CID""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00724""; DOMAIN 841..891; /note=""G-patch""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00092""",,,,"cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,CHERP DAN26 SCAF6,Calcium homeostasis endoplasmic reticulum protein (ERPROT 213-21) (SR-related CTD-associated factor 6),Homo sapiens (Human),916.0,103702.0,MEMPLPPDDQELRNVIDKLAQFVARNGPEFEKMTMEKQKDNPKFSFLFGGEFYSYYKCKLALEQQQLICKQQTPELEPAATMPPLPQPPLAPAAPIPPAQGAPSMDELIQQSQWNLQQQEQHLLALRQEQVTAAVAHAVEQQMQKLLEETQLDMNEFDNLLQPIIDTCTKDAISAGKNWMFSNAKSPPHCELMAGHLRNRITADGAHFELRLHLIYLINDVLHHCQRKQARELLAALQKVVVPIYCTSFLAVEEDKQQKIARLLQLWEKNGYFDDSIIQQLQSPALGLGQYQATLINEYSSVVQPVQLAFQQQIQTLKTQHEEFVTSLAQQQQQQQQQQQQLQMPQMEAEVKATPPPPAPPPAPAPAPAIPPTTQPDDSKPPIQMPGSSEYEAPGGVQDPAAAGPRGPGPHDQIPPNKPPWFDQPHPVAPWGQQQPPEQPPYPHHQGGPPHCPPWNNSHEGMWGEQRGDPGWNGQRDAPWNNQPDAAWNSQFEGPWNSQHEQPPWGGGQREPPFRMQRPPHFRGPFPPHQQHPQFNQPPHPHNFNRFPPRFMQDDFPPRHPFERPPYPHRFDYPQGDFPAEMGPPHHHPGHRMPHPGINEHPPWAGPQHPDFGPPPHGFNGQPPHMRRQGPPHINHDDPSLVPNVPYFDLPAGLMAPLVKLEDHEYKPLDPKDIRLPPPMPPSERLLAAVEAFYSPPSHDRPRNSEGWEQNGLYEFFRAKMRARRRKGQEKRNSGPSRSRSRSKSRGRSSSRSNSRSSKSSGSYSRSRSRSCSRSYSRSRSRSRSRSRSSRSRSRSQSRSRSKSYSPGRRRRSRSRSPTPPSSAGLGSNSAPPIPDSRLGEENKGHQMLVKMGWSGSGGLGAKEQGIQDPIKGGDVRDKWDQYKGVGVALDDPYENYRRNKSYSFIARMKARDECK,False,False,True,Q8IWX8,"[('G3DSA:1.10.10.790', 'Surp module'), ('G3DSA:1.25.40.90', None), ('IPR000061', 'SWAP/Surp'), ('IPR000467', 'G-patch domain'), ('IPR006569', 'CID domain'), ('IPR008942', 'ENTH/VHS'), ('IPR035967', 'SWAP/Surp superfamily'), ('PF01585', 'G-patch domain'), ('PF01805', 'Surp module'), ('PF04818', 'CID domain'), ('PS50128', 'SURP motif repeat profile'), ('PS50174', 'G-patch domain profile'), ('PS51391', 'CID domain profile'), ('PTHR12323', 'SR-RELATED CTD ASSOCIATED FACTOR 6'), ('SM00443', 'glycine rich nucleic binding domain'), ('SM00648', 'Suppressor-of-White-APricot splicing regulator'), ('SSF109905', 'Surp module (SWAP domain)'), ('SSF48464', 'ENTH/VHS domain')]",,"""ENSG00000085872; Low tissue specificity."";",,,,,ENST00000546361.7;,CHERP,ENSG00000085872,0.0,CHERP,Canonical_RBPs,27.0,,,,0.582,0.443,CHERP
Q8IXK0,ENSG00000134686,PHC2_HUMAN,negative regulation of DNA-templated transcription [GO:0045892]; spermatogenesis [GO:0007283],heterochromatin [GO:0000792]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; PcG protein complex [GO:0031519]; PRC1 complex [GO:0035102],chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone binding [GO:0042393]; identical protein binding [GO:0042802]; zinc ion binding [GO:0008270],,DOMAIN: HD1 motif interacts with SAM domain of PHC1.,"DOMAIN 794..858; /note=""SAM""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00184""",,,,"cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,PHC2 EDR2 PH2,Polyhomeotic-like protein 2 (hPH2) (Early development regulatory protein 2),Homo sapiens (Human),858.0,90713.0,MENELPVPHTSSSACATSSTSGASSSSGCNNSSSGGSGRPTGPQISVYSGIPDRQTVQVIQQALHRQPSTAAQYLQQMYAAQQQHLMLQTAALQQQHLSSAQLQSLAAVQQASLVSNRQGSTSGSNVSAQAPAQSSSINLAASPAAAQLLNRAQSVNSAAASGIAQQAVLLGNTSSPALTASQAQMYLRAQMLIFTPTATVATVQPELGTGSPARPPTPAQVQNLTLRTQQTPAAAASGPTPTQPVLPSLALKPTPGGSQPLPTPAQSRNTAQASPAGAKPGIADSVMEPHKKGDGNSSVPGSMEGRAGLSRTVPAVAAHPLIAPAYAQLQPHQLLPQPSSKHLQPQFVIQQQPQPQQQQPPPQQSRPVLQAEPHPQLASVSPSVALQPSSEAHAMPLGPVTPALPLQCPTANLHKPGGSQQCHPPTPDTGPQNGHPEGVPHTPQRRFQHTSAVILQLQPASPPQQCVPDDWKEVAPGEKSVPETRSGPSPHQQAIVTAMPGGLPVPTSPNIQPSPAHETGQGIVHALTDLSSPGMTSGNGNSASSIAGTAPQNGENKPPQAIVKPQILTHVIEGFVIQEGAEPFPVGRSSLLVGNLKKKYAQGFLPEKLPQQDHTTTTDSEMEEPYLQESKEEGAPLKLKCELCGRVDFAYKFKRSKRFCSMACAKRYNVGCTKRVGLFHSDRSKLQKAGAATHNRRRASKASLPPLTKDTKKQPTGTVPLSVTAALQLTHSQEDSSRCSDNSSYEEPLSPISASSSTSRRRQGQRDLELPDMHMRDLVGMGHHFLPSEPTKWNVEDVYEFIRSLPGCQEIAEEFRAQEIDGQALLLLKEDHLMSAMNIKLGPALKIYARISMLKDS,False,False,True,Q8IXK0,"[('cd09577', 'SAM domain of Ph (polyhomeotic) proteins of Polycomb group'), ('G3DSA:1.10.150.50', 'Transcription Factor, Ets-1'), ('G3DSA:3.30.60.160', None), ('IPR001660', 'Sterile alpha motif domain'), ('IPR012313', 'Zinc finger, FCS-type'), ('IPR013761', 'Sterile alpha motif/pointed domain superfamily'), ('IPR038603', 'FCS-type zinc finger superfamily'), ('IPR050548', 'Polycomb group and chromatin remodeling factors'), ('PF00536', 'SAM domain (Sterile alpha motif)'), ('PF16616', 'Unstructured region on Polyhomeotic-like protein 1 and 2'), ('PF21319', 'Zinc finger, FCS-type'), ('PS50105', 'SAM domain profile'), ('PS51024', 'Zinc finger FCS-type profile'), ('PTHR12247', 'Polycomb group and chromatin remodeling factors'), ('SM00454', 'Sterile alpha motif.'), ('SSF47769', 'SAM/Pointed domain')]",,"""ENSG00000134686; Low tissue specificity."";",,,,,ENST00000257118.5 [Q8IXK0-1];ENST00000373418.7 [Q8IXK0-2];ENST00000683057.1 [Q8IXK0-5];,PHC2,ENSG00000134686,0.0,,,,,,0.089,0.887,0.397,PHC2
Q8IXV0,,Q8IXV0_HUMAN,regulation of DNA-templated transcription [GO:0006355],nucleus [GO:0005634],DNA binding [GO:0003677]; protein dimerization activity [GO:0046983],,,"DOMAIN 31..88; /note=""BHLH""; /evidence=""ECO:0000259|PROSITE:PS50888""; DOMAIN 107..140; /note=""Orange""; /evidence=""ECO:0000259|PROSITE:PS51054""",,,,"cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",unreviewed,HES1,HES1 protein,Homo sapiens (Human),277.0,29271.0,MPADIMEKNSSSPVAASVNTTPDKPKTASEHRKSSKPIMEKRRRARINESLSQLKTLILDALKKDSSRHSKLEKADILEMTVKHLRNLQRAQMTAALSTDPSVLGKYRAGFSECMNEVTRFLSTCEGVNTEVRTRLLGHLANCMTQINAMTYPGQPHPALQAPPPPPPGPGGPQHAPFAPPPPLVPIPGGAAPPPGGAPCKLGSQAGEAAKVFGGFQVVPAPDGQFAFLIPNGAFAHSGPVIPVYTSNSGTSVGPNAVSPSSGPSLTADSMWRPWRN,True,False,False,,,,,,,,,,,,,,,,,,,,,
Q8IZH2,ENSG00000114127,XRN1_HUMAN,cellular response to cycloheximide [GO:0071409]; cellular response to puromycin [GO:1905795]; histone mRNA catabolic process [GO:0071044]; negative regulation of telomere maintenance via telomerase [GO:0032211]; negative regulation of translation [GO:0017148]; nuclear mRNA surveillance [GO:0071028]; nuclear-transcribed mRNA catabolic process [GO:0000956]; response to testosterone [GO:0033574]; rRNA catabolic process [GO:0016075],cytosol [GO:0005829]; dendrite [GO:0030425]; membrane [GO:0016020]; neuronal cell body [GO:0043025]; nucleus [GO:0005634]; P-body [GO:0000932]; plasma membrane [GO:0005886],5'-3' RNA exonuclease activity [GO:0004534]; G-quadruplex DNA binding [GO:0051880]; G-quadruplex RNA binding [GO:0002151]; RNA binding [GO:0003723]; telomerase RNA binding [GO:0070034],,,,,,,"cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,XRN1 SEP1,5'-3' exoribonuclease 1 (EC 3.1.13.-) (Strand-exchange protein 1 homolog),Homo sapiens (Human),1706.0,194107.0,MGVPKFYRWISERYPCLSEVVKEHQIPEFDNLYLDMNGIIHQCSHPNDDDVHFRISDDKIFTDIFHYLEVLFRIIKPRKVFFMAVDGVAPRAKMNQQRGRRFRSAKEAEDKIKKAIEKGETLPTEARFDSNCITPGTEFMARLHEHLKYFVNMKISTDKSWQGVTIYFSGHETPGEGEHKIMEFIRSEKAKPDHDPNTRHCLYGLDADLIMLGLTSHEAHFSLLREEVRFGGKKTQRVCAPEETTFHLLHLSLMREYIDYEFSVLKEKITFKYDIERIIDDWILMGFLVGNDFIPHLPHLHINHDALPLLYGTYVTILPELGGYINESGHLNLPRFEKYLVKLSDFDREHFSEVFVDLKWFESKVGNKYLNEAAGVAAEEARNYKEKKKLKGQENSLCWTALDKNEGEMITSKDNLEDETEDDDLFETEFRQYKRTYYMTKMGVDVVSDDFLADQAACYVQAIQWILHYYYHGVQSWSWYYPYHYAPFLSDIHNISTLKIHFELGKPFKPFEQLLAVLPAASKNLLPACYQHLMTNEDSPIIEYYPPDFKTDLNGKQQEWEAVVLIPFIDEKRLLEAMETCNHSLKKEERKRNQHSECLMCWYDRDTEFIYPSPWPEKFPAIERCCTRYKIISLDAWRVDINKNKITRIDQKALYFCGFPTLKHIRHKFFLKKSGVQVFQQSSRGENMMLEILVDAESDELTVENVASSVLGKSVFVNWPHLEEARVVAVSDGETKFYLEEPPGTQKLYSGRTAPPSKVVHLGDKEQSNWAKEVQGISEHYLRRKGIIINETSAVVYAQLLTGRKYQINQNGEVRLEKQWSKQVVPFVYQTIVKDIRAFDSRFSNIKTLDDLFPLRSMVFMLGTPYYGCTGEVQDSGDVITEGRIRVIFSIPCEPNLDALIQNQHKYSIKYNPGYVLASRLGVSGYLVSRFTGSIFIGRGSRRNPHGDHKANVGLNLKFNKKNEEVPGYTKKVGSEWMYSSAAEQLLAEYLERAPELFSYIAKNSQEDVFYEDDIWPGENENGAEKVQEIITWLKGHPVSTLSRSSCDLQILDAAIVEKIEEEVEKCKQRKNNKKVRVTVKPHLLYRPLEQQHGVIPDRDAEFCLFDRVVNVRENFSVPVGLRGTIIGIKGANREADVLFEVLFDEEFPGGLTIRCSPGRGYRLPTSALVNLSHGSRSETGNQKLTAIVKPQPAVHQHSSSSSVSSGHLGALNHSPQSLFVPTQVPTKDDDEFCNIWQSLQGSGKMQYFQPTIQEKGAVLPQEISQVNQHHKSGFNDNSVKYQQRKHDPHRKFKEECKSPKAECWSQKMSNKQPNSGIENFLASLNISKENEVQSSHHGEPPSEEHLSPQSFAMGTRMLKEILKIDGSNTVDHKNEIKQIANEIPVSSNRRDEYGLPSQPKQNKKLASYMNKPHSANEYHNVQSMDNMCWPAPSQIPPVSTPVTELSRICSLVGMPQPDFSFLRMPQTMTVCQVKLSNGLLVHGPQCHSENEAKEKAALFALQQLGSLGMNFPLPSQVFANYPSAVPPGTIPPAFPPPTGWDHYGSNYALGAANIMPSSSHLFGSMPWGPSVPVPGKPFHHTLYSGTMPMAGGIPGGVHNQFIPLQVTKKRVANKKNFENKEAQSSQATPVQTSQPDSSNIVKVSPRESSSASLKSSPIAQPASSFQVETASQGHSISHHKSTPISSSRRKSRKLAVNFGVSKPSE,False,False,True,Q8IZH2,"[('cd18673', 'FEN-like PIN domains of XRN1, XRN2, and related proteins'), ('G3DSA:1.25.40.1050', None), ('G3DSA:2.170.260.40', None), ('G3DSA:2.30.30.750', None), ('G3DSA:3.40.50.12390', None), ('IPR004859', 'Xrn1, N-terminal'), ('IPR016494', ""5'-3' exoribonuclease 1""), ('IPR027073', ""5'-3' exoribonuclease""), ('IPR040992', ""5'-3' exoribonuclease 1, D1 domain""), ('IPR041106', 'Exoribonuclease Xrn1, D2/D3 domain'), ('IPR041385', ""5'-3' exoribonuclease 1, SH3-like domain""), ('IPR041412', 'Xrn1, helical domain'), ('IPR047007', ""5'-3' exoribonuclease 1, D1 domain superfamily""), ('IPR047008', ""5'-3' exoribonuclease 1, SH3-like domain superfamily""), ('PF03159', ""XRN 5'-3' exonuclease N-terminus""), ('PF17846', 'Xrn1 helical domain'), ('PF18129', 'Xrn1 SH3-like domain'), ('PF18332', 'Exoribonuclease Xrn1 D1 domain'), ('PF18334', 'Exoribonuclease Xrn1 D2/D3 domain'), ('PIRSF006743', ""5'-3' exonuclease, Xnr1 type"")]",,"""ENSG00000114127; Low tissue specificity."";",,3.1.13.-,,,ENST00000264951.8 [Q8IZH2-1];ENST00000392981.7 [Q8IZH2-2];ENST00000463916.5 [Q8IZH2-3];,XRN1,ENSG00000114127,0.0,XRN1,Canonical_RBPs,22.0,,,,0.297,0.052,XRN1
Q8IZU0,ENSG00000177138,FAM9B_HUMAN,meiotic cell cycle [GO:0051321]; spermatid development [GO:0007286],chromosome [GO:0005694]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; synaptonemal complex [GO:0000795],,,,,,,,"cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,FAM9B TEX39B,Protein FAM9B,Homo sapiens (Human),186.0,22438.0,MAAWGKKHAGKDPVRDECEERNRFTETREEDVTDEHGEREPFAETDEHTGANTKKPEDTAEDLTAKRKRMKMDKTCSKTKNKSKHALRKKQLKRQKRDYIHSLKLLNVLEEYITDEQKEEEEEEGEEEELIRIFQEQQKKWQQYRSVRRERLKEMKLLRDQFVKALEDFEDLCDRVFSDEDSELDN,False,False,True,Q8IZU0,"[('IPR006888', 'XLR/SYCP3/FAM9 domain'), ('IPR051443', 'X-linked Lymphocyte-regulated/Synaptonemal Complex Protein 3'), ('PF04803', 'Cor1/Xlr/Xmr conserved region'), ('PTHR19368', 'X-linked Lymphocyte-regulated/Synaptonemal Complex Protein 3')]",,"""ENSG00000177138; Tissue enhanced (liver, testis)."";",,,,,ENST00000327220.10 [Q8IZU0-1];ENST00000362066.7 [Q8IZU0-2];ENST00000428477.1 [Q8IZU0-1];ENST00000472522.6 [Q8IZU0-1];ENST00000651278.1 [Q8IZU0-1];,FAM9B,ENSG00000177138,0.0,,,,,,,0.731,0.5,FAM9B
Q8N0Z3,ENSG00000163611,SPICE_HUMAN,cell division [GO:0051301]; metaphase chromosome alignment [GO:0051310]; mitotic spindle assembly [GO:0090307]; regulation of centriole replication [GO:0046599],centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737]; spindle [GO:0005819],,,,,,,,"cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,SPICE1 CCDC52 SPICE,Spindle and centriole-associated protein 1 (Coiled-coil domain-containing protein 52) (Spindle and centriole-associated protein),Homo sapiens (Human),855.0,96264.0,MSFVRVNRCGPRVGVRKTPKVKKKKTSVKQEWDNTVTDLTVHRATPEDLVRRHEIHKSKNRALVHWELQEKALKRKWRKQKPETLNLEKRRLSIMKEILSDQYQMQDVLEKSDHLIAAAKELFPRRRTGFPNVTVAPDSSQGPIVVNQDPITQSIFNESVIEPQALNDVDGEEEGTVNSQSGESENENELDNSLNSQSNTNTDRFLQQLTEENFELISKLWTDIQQKIATQSQITPPGTPSSALSSGEQRAALNATNAVKRLQTRLQPEESTETLDSSYVVGHVLNSRKQKQLLNKVKRKPNLHALSKPKKNISSGSTTSADLPNRTNSNLDVLKHMIHEVEHEMEEYERWTGREVKGLQSSQGLTGFTLSLVSSLCRLVRYLKESEIQLRKEVETRQQLEQVLGDHRELIDALTAEILRLREENAATQARLQQYMVTTDEQLISLTHAIKNCPVINNRQEIQASESGATGRRVMDSPERPVVNANVSVPLMFREEVAEFPQEELPVKLSQVPDPPDNMNLAKNFPAHIFEPAVLLTPPRQKSNLKFSPLQDVLRRTVQTRPAPRLPPTVEIIEKEQNWEEKTLPIDTDIQNSSEENRLFTQRWRVSHMGEDLENKTQAPFVNLSQPLCNSHSNTQQSRSPTFSEELPVLGDGQQLRTNESLIQRKDIMTRIADLTLQNSAIKAHMNNIIEPRGEQGDGLRELNKQESASDMTSTFPVAQSLTPGSMEERIAELNRQSMEARGKLLQLIEQQKLVGLNLSPPMSPVQLPLRAWTEGAKRTIEVSIPGAEAPESSKCSTVSPVSGINTRRSSGATGNSCSPLNATSGSGRFTPLNPRAKIEKQNEEGWFALSTHVS,False,False,True,Q8N0Z3,"[('IPR031387', 'Spindle and centriole-associated protein 1'), ('PF15678', 'Centriole duplication and mitotic chromosome congression'), ('PTHR31167', 'SPINDLE AND CENTRIOLE ASSOCIATED PROTEIN 1 SPICE1')]",,"""ENSG00000163611; Low tissue specificity."";",,,,,ENST00000295872.8;,SPICE1,ENSG00000163611,0.0,,,,,,,0.858,0.138,SPICE1
Q8N165,ENSG00000175087,PDK1L_HUMAN,,cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],ATP binding [GO:0005524]; eukaryotic translation initiation factor 2alpha kinase activity [GO:0004694]; histone H2AS1 kinase activity [GO:0044024]; protein serine kinase activity [GO:0106310],,,"DOMAIN 8..334; /note=""Protein kinase""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00159""",,,,"cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,PDIK1L CLIK1L,Serine/threonine-protein kinase PDIK1L (EC 2.7.11.1) (PDLIM1-interacting kinase 1-like),Homo sapiens (Human),341.0,38546.0,MVSSQPKYDLIREVGRGSYGVVYEAVIRKTSARVAVKKIRCHAPENVELALREFWALSSIKSQHPNVIHLEECILQKDGMVQKMSHGSNSSLYLQLVETSLKGEIAFDPRSAYYLWFVMDFCDGGDMNEYLLSRKPNRKTNTSFMLQLSSALAFLHKNQIIHRDLKPDNILISQTRLDTSDLEPTLKVADFGLSKVCSASGQNPEEPVSVNKCFLSTACGTDFYMAPEVWEGHYTAKADIFALGIIIWAMLERITFIDTETKKELLGSYVKQGTEIVPVGEALLENPKMELLIPVKKKSMNGRMKQLIKEMLAANPQDRPDAFELELRLVQIAFKDSSWET,False,False,True,Q8N165,"[('cd13977', 'Catalytic domain of the Serine/Threonine kinase, PDLIM1 interacting kinase 1 like'), ('G3DSA:1.10.510.10', 'Transferase(Phosphotransferase) domain 1'), ('G3DSA:3.30.200.20', 'Phosphorylase Kinase; domain 1'), ('IPR000719', 'Protein kinase domain'), ('IPR008271', 'Serine/threonine-protein kinase, active site'), ('IPR011009', 'Protein kinase-like domain superfamily'), ('IPR017441', 'Protein kinase, ATP binding site'), ('IPR050339', 'Cell Cycle and Stress Response Kinase'), ('PF00069', 'Protein kinase domain'), ('PIRSF000654', 'Integrin-linked protein kinase'), ('PS00107', 'Protein kinases ATP-binding region signature'), ('PS00108', 'Serine/Threonine protein kinases active-site signature'), ('PS50011', 'Protein kinase domain profile'), ('PTHR11042', 'Cell Cycle and Stress Response Kinase'), ('SM00220', 'Serine/Threonine protein kinases, catalytic domain'), ('SSF56112', 'Protein kinase-like (PK-like)')]",,"""ENSG00000175087; Low tissue specificity."";","CATALYTIC ACTIVITY: Reaction=L-seryl-[protein] + ATP = O-phospho-L-seryl-[protein] + ADP + H(+); Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616, ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.1; CATALYTIC ACTIVITY: Reaction=L-threonyl-[protein] + ATP = O-phospho-L-threonyl-[protein] + ADP + H(+); Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060, Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013, ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216; EC=2.7.11.1;",2.7.11.1,,,ENST00000374269.2;ENST00000374271.8;ENST00000619836.4;,PDIK1L,ENSG00000175087,0.0,,,,,,,,,PDIK1L
Q8N3Y7,ENSG00000170786,RDHE2_HUMAN,"keratinocyte proliferation [GO:0043616]; negative regulation of gene expression, epigenetic [GO:0045814]; negative regulation of transcription by RNA polymerase II [GO:0000122]; retinal metabolic process [GO:0042574]; retinol metabolic process [GO:0042572]",chromatin [GO:0000785]; endoplasmic reticulum membrane [GO:0005789]; lipid droplet [GO:0005811]; nucleus [GO:0005634]; transcription repressor complex [GO:0017053],all-trans-retinol dehydrogenase (NAD+) activity [GO:0004745]; DNA-binding transcription factor binding [GO:0140297]; RNA polymerase II-specific DNA-binding transcription factor binding [GO:0061629]; transcription corepressor activity [GO:0003714],,,,,,,"cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,SDR16C5 RDHE2,Epidermal retinol dehydrogenase 2 (EPHD-2) (RDH-E2) (EC 1.1.1.105) (Retinal short-chain dehydrogenase reductase 2) (retSDR2) (Short-chain dehydrogenase/reductase family 16C member 5),Homo sapiens (Human),309.0,34095.0,MSFNLQSSKKLFIFLGKSLFSLLEAMIFALLPKPRKNVAGEIVLITGAGSGLGRLLALQFARLGSVLVLWDINKEGNEETCKMAREAGATRVHAYTCDCSQKEGVYRVADQVKKEVGDVSILINNAGIVTGKKFLDCPDELMEKSFDVNFKAHLWTYKAFLPAMIANDHGHLVCISSSAGLSGVNGLADYCASKFAAFGFAESVFVETFVQKQKGIKTTIVCPFFIKTGMFEGCTTGCPSLLPILEPKYAVEKIVEAILQEKMYLYMPKLLYFMMFLKSFLPLKTGLLIADYLGILHAMDGFVDQKKKL,False,True,False,Q8N3Y7,"[('cd05339', 'human 17-beta-hydroxysteroid dehydrogenase XI-like, classical (c) SDRs'), ('G3DSA:3.40.50.720', 'NAD(P)-binding Rossmann-like Domain'), ('IPR002347', 'Short-chain dehydrogenase/reductase SDR'), ('IPR036291', 'NAD(P)-binding domain superfamily'), ('PF00106', 'short chain dehydrogenase'), ('PR00080', 'SDRFAMILY'), ('PR00081', 'GDHRDH'), ('PTHR24322', 'Short-chain dehydrogenases/reductases'), ('SSF51735', 'NAD(P)-binding Rossmann-fold domains')]",,"""ENSG00000170786; Tissue enhanced (esophagus, lung, skin)."";","CATALYTIC ACTIVITY: Reaction=all-trans-retinol--[retinol-binding protein] + NAD(+) = all-trans-retinal--[retinol-binding protein] + NADH + H(+); Xref=Rhea:RHEA:48488, Rhea:RHEA-COMP:14428, Rhea:RHEA-COMP:14430, ChEBI:CHEBI:15378, ChEBI:CHEBI:17336, ChEBI:CHEBI:17898, ChEBI:CHEBI:57540, ChEBI:CHEBI:57945, ChEBI:CHEBI:83228; EC=1.1.1.105; Evidence={ECO:0000269|PubMed:18926804};",1.1.1.105,,PATHWAY: Cofactor metabolism; retinol metabolism. {ECO:0000269|PubMed:18926804}.,ENST00000303749.8 [Q8N3Y7-1];ENST00000396721.6 [Q8N3Y7-2];,SDR16C5,ENSG00000170786,0.0,,,,,,,0.081,,SDR16C5
Q8N448,ENSG00000139517,LNX2_HUMAN,neural precursor cell proliferation [GO:0061351]; neuron differentiation [GO:0030182],plasma membrane [GO:0005886],identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; PDZ domain binding [GO:0030165]; ubiquitin-protein transferase activity [GO:0004842],,DOMAIN: The NPXY motif is required for the interaction with the PID domain of NUMB. It is however not sufficient.,"DOMAIN 233..318; /note=""PDZ 1""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00143""; DOMAIN 339..422; /note=""PDZ 2""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00143""; DOMAIN 468..554; /note=""PDZ 3""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00143""; DOMAIN 600..688; /note=""PDZ 4""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00143""","STRAND 39..42; /evidence=""ECO:0007829|PDB:5DIN""; STRAND 58..62; /evidence=""ECO:0007829|PDB:5DIN""; STRAND 68..70; /evidence=""ECO:0007829|PDB:5DIN""; STRAND 111..113; /evidence=""ECO:0007829|PDB:5DIN""; STRAND 123..125; /evidence=""ECO:0007829|PDB:5DIN""; STRAND 336..343; /evidence=""ECO:0007829|PDB:5E1Y""; STRAND 353..356; /evidence=""ECO:0007829|PDB:5E1Y""; STRAND 359..361; /evidence=""ECO:0007829|PDB:5E1Y""; STRAND 363..369; /evidence=""ECO:0007829|PDB:5E1Y""; STRAND 386..390; /evidence=""ECO:0007829|PDB:5E1Y""; STRAND 412..422; /evidence=""ECO:0007829|PDB:5E1Y""","HELIX 46..48; /evidence=""ECO:0007829|PDB:5DIN""; HELIX 71..77; /evidence=""ECO:0007829|PDB:5DIN""; HELIX 93..95; /evidence=""ECO:0007829|PDB:5DIN""; HELIX 101..108; /evidence=""ECO:0007829|PDB:5DIN""; HELIX 126..128; /evidence=""ECO:0007829|PDB:5DIN""; HELIX 129..135; /evidence=""ECO:0007829|PDB:5DIN""; HELIX 374..378; /evidence=""ECO:0007829|PDB:5E1Y""; HELIX 400..408; /evidence=""ECO:0007829|PDB:5E1Y""","TURN 24..26; /evidence=""ECO:0007829|PDB:5DIN""; TURN 51..53; /evidence=""ECO:0007829|PDB:5DIN""; TURN 78..80; /evidence=""ECO:0007829|PDB:5DIN""; TURN 85..87; /evidence=""ECO:0007829|PDB:5DIN""; TURN 117..119; /evidence=""ECO:0007829|PDB:5DIN""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,LNX2 PDZRN1,Ligand of Numb protein X 2 (Numb-binding protein 2) (PDZ domain-containing RING finger protein 1),Homo sapiens (Human),690.0,76004.0,MGTTSDEMVSVEQTSSSSLNPLCFECGQQHWTRENHLYNYQNEVDDDLVCHICLQPLLQPLDTPCGHTFCYKCLRNFLQEKDFCPLDRKRLHFKLCKKSSILVHKLLDKLLVLCPFSSVCKDVMQRCDLEAHLKNRCPGASHRRVALERRKTSRTQAEIENENGPTLLDPAGTLSPEADCLGTGAVPVERHLTSASLSTWSEEPGLDNPAFEESAGADTTQQPLSLPEGEITTIEIHRSNPYIQLGISIVGGNETPLINIVIQEVYRDGVIARDGRLLAGDQILQVNNYNISNVSHNYARAVLSQPCNTLHLTVLRERRFGNRAHNHSDSNSPREEIFQVALHKRDSGEQLGIKLVRRTDEPGVFILDLLEGGLAAQDGRLSSNDRVLAINGHDLKYGTPELAAQIIQASGERVNLTIARPGKPQPGNTIREAGNHSSSSQHHTPPPYYSRPSSHKDLTQCVTCQEKHITVKKEPHESLGMTVAGGRGSKSGELPIFVTSVPPHGCLARDGRIKRGDVLLNINGIDLTNLSHSEAVAMLKASAASPAVALKALEVQIVEEATQNAEEQPSTFSENEYDASWSPSWVMWLGLPSTLHSCHDIVLRRSYLGSWGFSIVGGYEENHTNQPFFIKTIVLGTPAYYDGRLKCGDMIVAVNGLSTVGMSHSALVPMLKEQRNKVTLTVICWPGSLV,False,False,True,Q8N448,"[('cd00992', 'PDZ_signaling'), ('cd16780', 'Modified RING finger, HC subclass (C3HC3D-type), found in ligand of numb protein X 2 (LNX2)'), ('G3DSA:2.30.42.10', None), ('G3DSA:3.30.40.10', 'Zinc/RING finger domain, C3HC4 (zinc finger)'), ('IPR001478', 'PDZ domain'), ('IPR001841', 'Zinc finger, RING-type'), ('IPR013083', 'Zinc finger, RING/FYVE/PHD-type'), ('IPR017907', 'Zinc finger, RING-type, conserved site'), ('IPR036034', 'PDZ superfamily'), ('IPR051342', 'PDZ domain-containing scaffold protein'), ('PF00595', 'PDZ domain'), ('PF13923', 'Zinc finger, C3HC4 type (RING finger)'), ('PS00518', 'Zinc finger RING-type signature'), ('PS50089', 'Zinc finger RING-type profile'), ('PS50106', 'PDZ domain profile'), ('PTHR19964', 'PDZ domain-containing scaffold protein'), ('SM00184', 'Ring finger'), ('SM00228', 'Domain present in PSD-95, Dlg, and ZO-1/2.'), ('SSF50156', 'PDZ domain-like'), ('SSF57850', 'RING/U-box')]",,"""ENSG00000139517; Low tissue specificity."";",,,,,ENST00000316334.5;ENST00000649248.1;,LNX2,ENSG00000139517,0.0,,,,,,,0.232,0.094,LNX2
Q8N8N0,ENSG00000176641,RN152_HUMAN,apoptotic process [GO:0006915]; cellular response to amino acid starvation [GO:0034198]; negative regulation of TORC1 signaling [GO:1904262]; positive regulation of autophagy [GO:0010508]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked ubiquitination [GO:0070534]; protein monoubiquitination [GO:0006513]; protein ubiquitination [GO:0016567],lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; organelle membrane [GO:0031090],metal ion binding [GO:0046872]; small GTPase binding [GO:0031267]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842],"PTM: Ubiquitinated. Autoubiquitinated in vitro, leading to its degradation by the proteasome (Probable). {ECO:0000305|PubMed:21203937}.",,,,,,"cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,RNF152,E3 ubiquitin-protein ligase RNF152 (EC 2.3.2.27) (RING finger protein 152) (RING-type E3 ubiquitin transferase RNF152),Homo sapiens (Human),203.0,22357.0,METLSQDSLLECQICFNYYSPRRRPKLLDCKHTCCSVCLQQMRTSQKDVRCPWCRGVTKLPPGFSVSQLPDDPEVLAVIAIPHTSEHTPVFIKLPSNGCYMLPLPISKERALLPGDMGCRLLPGSQQKSVTVVTIPAEQQPLQGGAPQEAVEEEQDRRGVVKSSTWSGVCTVILVACVLVFLLGIVLHNMSCISKRFTVISCG,False,False,True,Q8N8N0,"[('cd16548', 'RING finger, HC subclass, found in RING finger protein 152 (RNF152) and similar proteins'), ('G3DSA:3.30.40.10', 'Zinc/RING finger domain, C3HC4 (zinc finger)'), ('IPR001841', 'Zinc finger, RING-type'), ('IPR013083', 'Zinc finger, RING/FYVE/PHD-type'), ('IPR033609', 'E3 ubiquitin-protein ligase RNF152, RING finger domain'), ('IPR045744', 'E3 ubiquitin-protein ligase RNF152, C-terminal'), ('PF14634', 'zinc-RING finger domain'), ('PF19325', 'E3 ubiquitin-protein ligase RNF152 C-terminus'), ('PS50089', 'Zinc finger RING-type profile'), ('PTHR25464', 'RNF152 and TRIM/RBCC E3 Ubiquitin Ligases'), ('SM00184', 'Ring finger'), ('SSF57850', 'RING/U-box')]",,"""ENSG00000176641; Tissue enhanced (kidney)."";","CATALYTIC ACTIVITY: Reaction=S-ubiquitinyl-[E2 ubiquitin-conjugating enzyme]-L-cysteine + [acceptor protein]-L-lysine = [E2 ubiquitin-conjugating enzyme]-L-cysteine + N(6)-ubiquitinyl-[acceptor protein]-L-lysine.; EC=2.3.2.27; Evidence={ECO:0000269|PubMed:25936802, ECO:0000269|PubMed:30514904};",2.3.2.27,,"PATHWAY: Protein modification; protein ubiquitination. {ECO:0000269|PubMed:25936802, ECO:0000269|PubMed:30514904}.",ENST00000312828.4;,RNF152,ENSG00000176641,0.0,,,,,,,0.527,,RNF152
Q8N960,ENSG00000168944,CE120_HUMAN,astral microtubule organization [GO:0030953]; centrosome cycle [GO:0007098]; cerebral cortex development [GO:0021987]; interkinetic nuclear migration [GO:0022027]; neurogenesis [GO:0022008]; positive regulation of centriole elongation [GO:1903724]; positive regulation of centrosome duplication [GO:0010825]; positive regulation of cilium assembly [GO:0045724]; positive regulation of establishment of protein localization [GO:1904951],centriole [GO:0005814]; centrosome [GO:0005813]; cytoplasm [GO:0005737],,,,"DOMAIN 1..112; /note=""C2 1""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00041""; DOMAIN 433..566; /note=""C2 2""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00041""","STRAND 8..19; /evidence=""ECO:0007829|PDB:6FLJ""; STRAND 27..34; /evidence=""ECO:0007829|PDB:6FLJ""; STRAND 37..40; /evidence=""ECO:0007829|PDB:6FLJ""; STRAND 47..49; /evidence=""ECO:0007829|PDB:6FLJ""; STRAND 51..60; /evidence=""ECO:0007829|PDB:6FLJ""; STRAND 74..83; /evidence=""ECO:0007829|PDB:6FLJ""; STRAND 88..98; /evidence=""ECO:0007829|PDB:6FLJ""; STRAND 110..113; /evidence=""ECO:0007829|PDB:6FLJ""; STRAND 125..134; /evidence=""ECO:0007829|PDB:6FLJ""; STRAND 452..465; /evidence=""ECO:0007829|PDB:6FLK""; STRAND 472..478; /evidence=""ECO:0007829|PDB:6FLK""; STRAND 495..497; /evidence=""ECO:0007829|PDB:6FLK""; STRAND 502..504; /evidence=""ECO:0007829|PDB:6FLK""; STRAND 509..516; /evidence=""ECO:0007829|PDB:6FLK""; STRAND 530..536; /evidence=""ECO:0007829|PDB:6FLK""; STRAND 544..551; /evidence=""ECO:0007829|PDB:6FLK""; STRAND 562..565; /evidence=""ECO:0007829|PDB:6FLK""; STRAND 569..584; /evidence=""ECO:0007829|PDB:6FLK""; STRAND 592..607; /evidence=""ECO:0007829|PDB:6FLK""","HELIX 4..6; /evidence=""ECO:0007829|PDB:4ICX""; HELIX 62..71; /evidence=""ECO:0007829|PDB:6FLJ""; HELIX 99..101; /evidence=""ECO:0007829|PDB:6FLJ""; HELIX 481..483; /evidence=""ECO:0007829|PDB:6FLK""; HELIX 518..527; /evidence=""ECO:0007829|PDB:6FLK""; HELIX 553..558; /evidence=""ECO:0007829|PDB:6FLK""","TURN 84..87; /evidence=""ECO:0007829|PDB:6FLJ""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,CEP120 CCDC100,Centrosomal protein of 120 kDa (Cep120) (Coiled-coil domain-containing protein 100),Homo sapiens (Human),986.0,112640.0,MVSKSDQLLIVVSILEGRHFPKRPKHMLVVEAKFDGEQLATDPVDHTDQPEFATELAWEIDRKALHQHRLQRTPIKLQCFALDPVTSAKETIGYIVLDLRTAQETKQAPKWYQLLSNKYTKFKSEIQISIALETDTKPPVDSFKAKGAPPRDGKVPAILAGLDPRDIVAVLNEEGGYHQIGPAEYCTDSFIMSVTIAFATQLEQLIPCTMKLPERQPEFFFYYSLLGNDVTNEPFNDLINPNFEPERASVRIRSSVEILRVYLALQSKLQIHLCCGDQSLGSTEIPLTGLLKKGSTEINQHPVTVEGAFTLDPPNRAKQKLAPIPVELAPTVGVSVALQREGIDSQSLIELKTQNEHEPEHSKKKVLTPIKEKTLTGPKSPTVSPVPSHNQSPPTKDDATESEVESLQYDKDTKPNPKASSSVPASLAQLVTTSNASEVASGQKIAVPATSHHFCFSIDLRSIHALEIGFPINCILRYSYPFFGSAAPIMTNPPVEVRKNMEVFLPQSYCAFDFATMPHQLQDTFLRIPLLVELWHKDKMSKDLLLGIARIQLSNILSSEKTRFLGSNGEQCWRQTYSESVPVIAAQGSNNRIADLSYTVTLEDYGLVKMREIFISDSSQGVSAVQQKPSSLPPAPCPSEIQTEPRETLEYKAALELEMWKEMQEDIFENQLKQKELAHMQALAEEWKKRDRERESLVKKKVAEYTILEGKLQKTLIDLEKREQQLASVESELQREKKELQSERQRNLQELQDSIRRAKEDCIHQVELERLKIKQLEEDKHRLQQQLNDAENKYKILEKEFQQFKDQQNNKPEIRLQSEINLLTLEKVELERKLESATKSKLHYKQQWGRALKELARLKQREQESQMARLKKQQEELEQMRLRYLAAEEKDTVKTERQELLDIRNELNRLRQQEQKQYQDSTEIASGKKDGPHGSVLEEGLDDYLTRLIEERDTLMRTGVYNHEDRIISELDRQIREILAKSNASN,False,False,True,Q8N960,"[('cd00030', 'C2 domain'), ('G3DSA:2.60.40.150', 'C2 domain'), ('IPR000008', 'C2 domain'), ('IPR022136', 'Domain of unknown function DUF3668'), ('IPR035892', 'C2 domain superfamily'), ('IPR039893', 'Centrosomal protein of 120kDa-like'), ('PF00168', 'C2 domain'), ('PF12416', 'Cep120 protein'), ('PS50004', 'C2 domain profile'), ('PTHR21574', 'CENTROSOMAL PROTEIN OF 120 KDA'), ('SSF49562', 'C2 domain (Calcium/lipid-binding domain, CaLB)')]",,"""ENSG00000168944; Low tissue specificity."";",,,,,ENST00000306467.10 [Q8N960-1];ENST00000306481.11 [Q8N960-2];ENST00000328236.10 [Q8N960-1];ENST00000508442.7 [Q8N960-2];ENST00000513565.6 [Q8N960-3];,CEP120,ENSG00000168944,0.0,,,,,,,0.277,0.1,CEP120
Q8NEU8,ENSG00000136044,DP13B_HUMAN,"adiponectin-activated signaling pathway [GO:0033211]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; cold acclimation [GO:0009631]; diet induced thermogenesis [GO:0002024]; glucose homeostasis [GO:0042593]; negative regulation of cellular response to insulin stimulus [GO:1900077]; negative regulation of cytokine production involved in inflammatory response [GO:1900016]; negative regulation of fatty acid oxidation [GO:0046322]; negative regulation of glucose import [GO:0046325]; negative regulation of neural precursor cell proliferation [GO:2000178]; negative regulation of neurogenesis [GO:0050768]; positive regulation of cold-induced thermogenesis [GO:0120162]; positive regulation of Fc-gamma receptor signaling pathway involved in phagocytosis [GO:1905451]; positive regulation of macropinocytosis [GO:1905303]; positive regulation of phagocytosis, engulfment [GO:0060100]; protein homotetramerization [GO:0051289]; protein import into nucleus [GO:0006606]; regulation of fibroblast migration [GO:0010762]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of innate immune response [GO:0045088]; regulation of toll-like receptor 4 signaling pathway [GO:0034143]; signal transduction [GO:0007165]; signaling [GO:0023052]; transforming growth factor beta receptor signaling pathway [GO:0007179]",cytoplasmic vesicle [GO:0031410]; early endosome membrane [GO:0031901]; early phagosome [GO:0032009]; early phagosome membrane [GO:0036186]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; macropinosome [GO:0044354]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ruffle [GO:0001726]; ruffle membrane [GO:0032587]; vesicle [GO:0031982],identical protein binding [GO:0042802]; phosphatidylinositol binding [GO:0035091]; phosphatidylserine binding [GO:0001786]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877],,"DOMAIN: The BAR domain is necessary and sufficient for mediating homotypic and heterotypic interactions; associates with cytoplasmic membrane structures; mediates interaction with TBC1D1 and ADIPOR1 (By similarity) (PubMed:18034774). The PH and PID domains mediate phosphoinositide binding (PubMed:18034774). The PID domain mediates phosphatidylserine binding and allows localization to cytosolic membrane structures and nucleus (PubMed:18034774). The PH domain allows localization to the plasma membrane, cytosolic vesicles and distinct nuclear and perinuclear structures and is sufficient for RUVBL2 interaction (PubMed:18034774, PubMed:19433865). {ECO:0000250|UniProtKB:Q8K3G9, ECO:0000269|PubMed:18034774, ECO:0000269|PubMed:19433865}.","DOMAIN 3..268; /note=""BAR""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00361""; DOMAIN 277..375; /note=""PH""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00145""; DOMAIN 488..637; /note=""PID""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00148""","STRAND 152..154; /evidence=""ECO:0007829|PDB:5C5B""; STRAND 281..288; /evidence=""ECO:0007829|PDB:5C5B""; STRAND 291..293; /evidence=""ECO:0007829|PDB:5C5B""; STRAND 296..305; /evidence=""ECO:0007829|PDB:5C5B""; STRAND 308..312; /evidence=""ECO:0007829|PDB:5C5B""; STRAND 320..324; /evidence=""ECO:0007829|PDB:5C5B""; STRAND 329..333; /evidence=""ECO:0007829|PDB:5C5B""; STRAND 341..345; /evidence=""ECO:0007829|PDB:5C5B""; STRAND 351..356; /evidence=""ECO:0007829|PDB:5C5B""","HELIX 9..11; /evidence=""ECO:0007829|PDB:5C5B""; HELIX 17..70; /evidence=""ECO:0007829|PDB:5C5B""; HELIX 80..110; /evidence=""ECO:0007829|PDB:5C5B""; HELIX 112..148; /evidence=""ECO:0007829|PDB:5C5B""; HELIX 157..217; /evidence=""ECO:0007829|PDB:5C5B""; HELIX 220..254; /evidence=""ECO:0007829|PDB:5C5B""; HELIX 259..261; /evidence=""ECO:0007829|PDB:5C5B""; HELIX 266..269; /evidence=""ECO:0007829|PDB:5C5B""; HELIX 360..373; /evidence=""ECO:0007829|PDB:5C5B""","TURN 12..14; /evidence=""ECO:0007829|PDB:5C5B""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,APPL2 DIP13B,"DCC-interacting protein 13-beta (Dip13-beta) (Adapter protein containing PH domain, PTB domain and leucine zipper motif 2)",Homo sapiens (Human),664.0,74493.0,MPAVDKLLLEEALQDSPQTRSLLSVFEEDAGTLTDYTNQLLQAMQRVYGAQNEMCLATQQLSKQLLAYEKQNFALGKGDEEVISTLHYFSKVVDELNLLHTELAKQLADTMVLPIIQFREKDLTEVSTLKDLFGLASNEHDLSMAKYSRLPKKKENEKVKTEVGKEVAAARRKQHLSSLQYYCALNALQYRKQMAMMEPMIGFAHGQINFFKKGAEMFSKRMDSFLSSVADMVQSIQVELEAEAEKMRVSQQELLSVDESVYTPDSDVAAPQINRNLIQKAGYLNLRNKTGLVTTTWERLYFFTQGGNLMCQPRGAVAGGLIQDLDNCSVMAVDCEDRRYCFQITTPNGKSGIILQAESRKENEEWICAINNISRQIYLTDNPEAVAIKLNQTALQAVTPITSFGKKQESSCPSQNLKNSEMENENDKIVPKATASLPEAEELIAPGTPIQFDIVLPATEFLDQNRGSRRTNPFGETEDESFPEAEDSLLQQMFIVRFLGSMAVKTDSTTEVIYEAMRQVLAARAIHNIFRMTESHLMVTSQSLRLIDPQTQVSRANFELTSVTQFAAHQENKRLVGFVIRVPESTGEESLSTYIFESNSEGEKICYAINLGKEIIEVQKDPEALAQLMLSIPLTNDGKYVLLNDQPDDDDGNPNEHRGAESEA,False,False,True,Q8NEU8,"[('cd07632', 'The Bin/Amphiphysin/Rvs (BAR) domain of Adaptor protein, Phosphotyrosine interaction, PH domain and Leucine zipper containing 2'), ('cd13158', 'Adaptor protein containing PH domain, PTB domain, and Leucine zipper motif (APPL; also called DCC-interacting protein (DIP)-13alpha) Phosphotyrosine-binding (PTB) domain'), ('cd13247', 'Adaptor protein containing PH domain, PTB domain, and Leucine zipper motif Bin1/amphiphysin/Rvs167 (BAR)-Pleckstrin homology (PH) domain'), ('G3DSA:1.20.1270.60', 'Arfaptin homology (AH) domain/BAR domain'), ('G3DSA:2.30.29.30', 'Pleckstrin-homology domain (PH domain)/Phosphotyrosine-binding domain (PTB)'), ('IPR001849', 'Pleckstrin homology domain'), ('IPR004148', 'BAR domain'), ('IPR006020', 'PTB/PI domain'), ('IPR011993', 'PH-like domain superfamily'), ('IPR027267', 'AH/BAR domain superfamily'), ('IPR047181', 'DCC-interacting protein 13-alpha/beta'), ('IPR047236', 'DCC-interacting protein 13-alpha/beta, PH domain'), ('IPR047237', 'DCC-interacting protein 13-alpha/beta, PTB domain'), ('IPR047239', 'DCC-interacting protein 13-beta, BAR domain'), ('PF00169', 'PH domain'), ('PF00640', 'Phosphotyrosine interaction domain (PTB/PID)'), ('PF16746', 'BAR domain of APPL family'), ('PS01179', 'Phosphotyrosine interaction domain (PID) profile'), ('PS50003', 'PH domain profile'), ('PTHR46415', 'ADAPTOR PROTEIN, PHOSPHOTYROSINE INTERACTION, PH DOMAIN AND LEUCINE ZIPPER-CONTAINING 2')]",,"""ENSG00000136044; Low tissue specificity."";",,,,,ENST00000258530.8 [Q8NEU8-1];ENST00000539978.6 [Q8NEU8-2];ENST00000551662.5 [Q8NEU8-3];,APPL2,ENSG00000136044,0.0,,,,,,,0.176,0.033,APPL2
Q8TAD8,ENSG00000163877,SNIP1_HUMAN,"miRNA processing [GO:0035196]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of canonical NF-kappaB signal transduction [GO:0043124]; U2-type prespliceosome assembly [GO:1903241]",cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; spliceosomal complex [GO:0005681]; U2 snRNP [GO:0005686]; U2-type precatalytic spliceosome [GO:0071005],mRNA binding [GO:0003729]; RNA binding [GO:0003723]; transcription regulator inhibitor activity [GO:0140416],PTM: Degraded by the proteasome upon binding to the SMAD1/OAZ1/PSMB4 complex.,,"DOMAIN 281..344; /note=""FHA""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00086""","STRAND 240..243; /evidence=""ECO:0007829|PDB:7DVQ""; STRAND 259..265; /evidence=""ECO:0007829|PDB:7DVQ""; STRAND 278..285; /evidence=""ECO:0007829|PDB:7DVQ""; STRAND 304..314; /evidence=""ECO:0007829|PDB:7DVQ""; STRAND 320..330; /evidence=""ECO:0007829|PDB:7DVQ""; STRAND 337..339; /evidence=""ECO:0007829|PDB:7DVQ""; STRAND 357..360; /evidence=""ECO:0007829|PDB:7DVQ""; STRAND 366..371; /evidence=""ECO:0007829|PDB:7DVQ""","HELIX 230..233; /evidence=""ECO:0007829|PDB:7DVQ""","TURN 234..236; /evidence=""ECO:0007829|PDB:7DVQ""; TURN 287..289; /evidence=""ECO:0007829|PDB:7DVQ""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,SNIP1,Smad nuclear-interacting protein 1 (FHA domain-containing protein SNIP1),Homo sapiens (Human),396.0,45778.0,MKAVKSERERGSRRRHRDGDVVLPAGVVVKQERLSPEVAPPAHRRPDHSGGSPSPPTSEPARSGHRGNRARGVSRSPPKKKNKASGRRSKSPRSKRNRSPHHSTVKVKQEREDHPRRGREDRQHREPSEQEHRRARNSDRDRHRGHSHQRRTSNERPGSGQGQGRDRDTQNLQAQEEEREFYNARRREHRQRNDVGGGGSESQELVPRPGGNNKEKEVPAKEKPSFELSGALLEDTNTFRGVVIKYSEPPEARIPKKRWRLYPFKNDEVLPVMYIHRQSAYLLGRHRRIADIPIDHPSCSKQHAVFQYRLVEYTRADGTVGRRVKPYIIDLGSGNGTFLNNKRIEPQRYYELKEKDVLKFGFSSREYVLLHESSDTSEIDRKDDEDEEEEEEVSDS,False,False,True,Q8TAD8,"[('cd22718', 'forkhead associated (FHA) domain found in Smad nuclear-interacting protein 1 (SNIP1) and similar proteins'), ('G3DSA:2.60.200.20', None), ('IPR000253', 'Forkhead-associated (FHA) domain'), ('IPR008984', 'SMAD/FHA domain superfamily'), ('IPR050923', 'Cellular Process Regulator and RNA Processing Protein'), ('PF00498', 'FHA domain'), ('PS50006', 'Forkhead-associated (FHA) domain profile'), ('PTHR23308', 'Cellular Process Regulator and RNA Processing Protein'), ('SM00240', 'Forkhead associated domain'), ('SSF49879', 'SMAD/FHA domain')]",,"""ENSG00000163877; Low tissue specificity."";",,,,,ENST00000296215.8;,SNIP1,ENSG00000163877,0.0,SNIP1,Non-canonical_RBPs,3.0,,,,0.634,0.634,SNIP1
Q8TAU3,ENSG00000173480,ZN417_HUMAN,regulation of transcription by RNA polymerase II [GO:0006357],nucleus [GO:0005634],"DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; metal ion binding [GO:0046872]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]",,,"DOMAIN 15..88; /note=""KRAB""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00119""",,,,"cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,ZNF417,Zinc finger protein 417,Homo sapiens (Human),575.0,65733.0,MAAAAPRRPTQQGTVTFEDVAVNFSQEEWCLLSEAQRCLYRDVMLENLALISSLGCWCGSKDEEAPCKQRISVQRESQSRTPRAGVSPKKAHPCEMCGLILEDVFHFADHQETHHKQKLNRSGACGKNLDDTAYLHQHQKQHIGEKFYRKSVREASFVKKRKLRVSQEPFVFREFGKDVLPSSGLCQEAAAVEKTDSETMHGPPFQEGKTNYSCGKRTKAFSTKHSVIPHQKLFTRDGCYVCSDCGKSFSRYVSFSNHQRDHTAKGPYDCGECGKSYSRKSSLIQHQRVHTGKTAYPCEECGKSFSQKGSLISHQRVHTGERPYECREYGKSFGQKGNLIQHQQGHTGERAYHCGECGKSFRQKFCFINHQRVHTGERPYKCGECGKSFGQKGNLVQHQRGHTGERPYECKECGKSFRYRSHLTEHQRLHTGERPYNCRECGKLFNRKYHLLVHERVHTGERPYACEVCGKLFGNKNCVTIHQRIHTGERPYECNECGKSFLSSSALHVHKRVHSGQKPYKCSECGKSFAECSSLIKHRRIHTGERPYECTKCGKTFQRSSTLLHHQSSHRRKAL,False,False,True,Q8TAU3,"[('cd07765', 'KRAB (Kruppel-associated box) domain -A box'), ('G3DSA:3.30.160.60', 'Classic Zinc Finger'), ('G3DSA:6.10.140.140', None), ('IPR001909', 'Krueppel-associated box'), ('IPR013087', 'Zinc finger C2H2-type'), ('IPR036051', 'KRAB domain superfamily'), ('IPR036236', 'Zinc finger C2H2 superfamily'), ('IPR050758', 'Zinc finger protein, C2H2-type'), ('PF00096', 'Zinc finger, C2H2 type'), ('PF01352', 'KRAB box'), ('PS00028', 'Zinc finger C2H2 type domain signature'), ('PS50157', 'Zinc finger C2H2 type domain profile'), ('PS50805', 'Krueppel-associated box (KRAB) profile'), ('PTHR23234', 'Zinc finger protein, C2H2-type'), ('SM00349', 'krueppel associated box'), ('SM00355', 'zinc finger'), ('SSF109640', 'KRAB domain (Kruppel-associated box)'), ('SSF57667', 'beta-beta-alpha zinc fingers')]",,"""ENSG00000173480; Low tissue specificity."";",,,,,ENST00000312026.6 [Q8TAU3-1];,ZNF417,ENSG00000173480,0.0,,,,,,,0.369,0.035,ZNF417
Q8TB24,ENSG00000100599,RIN3_HUMAN,endocytosis [GO:0006897]; negative regulation of mast cell chemotaxis [GO:0060755]; negative regulation of receptor internalization [GO:0002091]; regulation of vesicle size [GO:0097494]; signal transduction [GO:0007165],axon [GO:0030424]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; dendrite [GO:0030425]; early endosome [GO:0005769]; endocytic vesicle [GO:0030139]; neuronal cell body [GO:0043025]; vesicle [GO:0031982],GTPase activator activity [GO:0005096]; guanyl-nucleotide exchange factor activity [GO:0005085]; small GTPase binding [GO:0031267],,,"DOMAIN 63..158; /note=""SH2""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00191""; DOMAIN 703..846; /note=""VPS9""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00550""; DOMAIN 877..963; /note=""Ras-associating""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00166""",,,,"cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,RIN3,Ras and Rab interactor 3 (Ras interaction/interference protein 3),Homo sapiens (Human),985.0,107854.0,MIRHAGAPARGDPTGPVPVVGKGEEEEEEDGMRLCLPANPKNCLPHRRGISILEKLIKTCPVWLQLSLGQAEVARILHRVVAGMFLVRRDSSSKQLVLCVHFPSLNESSAEVLEYTIKEEKSILYLEGSALVFEDIFRLIAFYCVSRDLLPFTLRLPQAILEASSFTDLETIANLGLGFWDSSLNPPQERGKPAEPPRDRAPGFPLVSSLRPTAHDANCACEIELSVGNDRLWFVNPIFIEDCSSALPTDQPPLGNCPARPLPPTSDATSPTSRWAPRRPPPPPPVLPLQPCSPAQPPVLPALAPAPACPLPTSPPVPAPHVTPHAPGPPDHPNQPPMMTCERLPCPTAGLGPLREEAMKPGAASSPLQQVPAPPLPAKKNLPTAPPRRRVSERVSLEDQSPGMAAEGDQLSLPPQGTSDGPEDTPRESTEQGQDTEVKASDPHSMPELPRTAKQPPVPPPRKKRISRQLASTLPAPLENAELCTQAMALETPTPGPPREGQSPASQAGTQHPPAQATAHSQSSPEFKGSLASLSDSLGVSVMATDQDSYSTSSTEEELEQFSSPSVKKKPSMILGKARHRLSFASFSSMFHAFLSNNRKLYKKVVELAQDKGSYFGSLVQDYKVYSLEMMARQTSSTEMLQEIRTMMTQLKSYLLQSTELKALVDPALHSEEELEAIVESALYKCVLKPLKEAINSCLHQIHSKDGSLQQLKENQLVILATTTTDLGVTTSVPEVPMMEKILQKFTSMHKAYSPEKKISILLKTCKLIYDSMALGNPGKPYGADDFLPVLMYVLARSNLTEMLLNVEYMMELMDPALQLGEGSYYLTTTYGALEHIKSYDKITVTRQLSVEVQDSIHRWERRRTLNKARASRSSVQDFICVSYLEPEQQARTLASRADTQAQALCAQCAEKFAVERPQAHRLFVLVDGRCFQLADDALPHCIKGYLLRSEPKRDFHFVYRPLDGGGGGGGGSPPCLVVREPNFL,False,False,True,Q8TB24,"[('cd10395', 'Src homology 2 (SH2) domain found in Ras and Rab interactor 3 (RIN3)-like proteins'), ('cd16130', 'Ras-associating (RA) domain found in Ras and Rab interactor 3 (Rin3)'), ('G3DSA:1.20.1050.80', 'VPS9 domain'), ('G3DSA:3.30.505.10', 'SH2 domain'), ('IPR000159', 'Ras-associating domain'), ('IPR000980', 'SH2 domain'), ('IPR003123', 'VPS9 domain'), ('IPR035869', 'Ras and Rab interactor 3, SH2 domain'), ('IPR036860', 'SH2 domain superfamily'), ('IPR037191', 'VPS9 domain superfamily'), ('IPR045046', 'Vacuolar protein sorting-associated protein 9-like'), ('PF02204', 'Vacuolar sorting protein 9 (VPS9) domain'), ('PF23268', 'RIN1-like domain'), ('PS50001', 'Src homology 2 (SH2) domain profile'), ('PS50200', 'Ras-associating (RA) domain profile'), ('PS51205', 'VPS9 domain profile'), ('PTHR23101', 'RAB GDP/GTP EXCHANGE FACTOR'), ('SM00167', 'Domain present in VPS9'), ('SM00252', 'Src homology 2 domains'), ('SSF109993', 'VPS9 domain')]",,"""ENSG00000100599; Tissue enhanced (bone)."";",,,,,ENST00000216487.12 [Q8TB24-1];,RIN3,ENSG00000100599,0.0,,,,,,,0.462,0.309,RIN3
Q8TBB1,ENSG00000072201,LNX1_HUMAN,protein ubiquitination [GO:0016567]; synapse maturation [GO:0060074]; ubiquitin-dependent protein catabolic process [GO:0006511],cytoplasm [GO:0005737]; hippocampal mossy fiber to CA3 synapse [GO:0098686]; postsynapse [GO:0098794],identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; PDZ domain binding [GO:0030165]; ubiquitin-protein transferase activity [GO:0004842],,"DOMAIN: The NPXY motif is required for the interaction with the PID domain of NUMB. It is however not sufficient.; DOMAIN: The PDZ 1 domain participates in the interaction with the PID domain of NUMB, and participates in the isoform-specific ubiquitination of NUMB. The PDZ 2 domain of isoform 2 participates in the interaction with IGSF5/JAM4, other isoforms containing this domain may also interact with IGSF5/JAM4 (By similarity). {ECO:0000250}.","DOMAIN 274..359; /note=""PDZ 1""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00143""; DOMAIN 381..464; /note=""PDZ 2""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00143""; DOMAIN 507..593; /note=""PDZ 3""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00143""; DOMAIN 638..724; /note=""PDZ 4""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00143""","STRAND 45..47; /evidence=""ECO:0007829|PDB:5H7R""; STRAND 49..53; /evidence=""ECO:0007829|PDB:5H7R""; STRAND 59..61; /evidence=""ECO:0007829|PDB:5H7R""; STRAND 102..104; /evidence=""ECO:0007829|PDB:5H7R""; STRAND 114..116; /evidence=""ECO:0007829|PDB:5H7R""; STRAND 504..511; /evidence=""ECO:0007829|PDB:3B76""; STRAND 520..524; /evidence=""ECO:0007829|PDB:3B76""; STRAND 535..540; /evidence=""ECO:0007829|PDB:3B76""; STRAND 557..561; /evidence=""ECO:0007829|PDB:3B76""; STRAND 583..594; /evidence=""ECO:0007829|PDB:3B76""","HELIX 37..39; /evidence=""ECO:0007829|PDB:5H7R""; HELIX 62..71; /evidence=""ECO:0007829|PDB:5H7R""; HELIX 84..86; /evidence=""ECO:0007829|PDB:5H7R""; HELIX 92..99; /evidence=""ECO:0007829|PDB:5H7R""; HELIX 117..119; /evidence=""ECO:0007829|PDB:5H7R""; HELIX 120..126; /evidence=""ECO:0007829|PDB:5H7R""; HELIX 129..133; /evidence=""ECO:0007829|PDB:5H7R""; HELIX 545..549; /evidence=""ECO:0007829|PDB:3B76""; HELIX 566..568; /evidence=""ECO:0007829|PDB:3B76""; HELIX 571..579; /evidence=""ECO:0007829|PDB:3B76""","TURN 15..17; /evidence=""ECO:0007829|PDB:5H7R""; TURN 42..44; /evidence=""ECO:0007829|PDB:5H7R""; TURN 76..78; /evidence=""ECO:0007829|PDB:5H7R""; TURN 108..110; /evidence=""ECO:0007829|PDB:5H7R""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,LNX1 LNX PDZRN2 UNQ574/PRO1136,E3 ubiquitin-protein ligase LNX (EC 2.3.2.27) (Ligand of Numb-protein X 1) (Numb-binding protein 1) (PDZ domain-containing RING finger protein 2) (RING-type E3 ubiquitin transferase LNX),Homo sapiens (Human),728.0,80629.0,MNQPESANDPEPLCAVCGQAHSLEENHFYSYPEEVDDDLICHICLQALLDPLDTPCGHTYCTLCLTNFLVEKDFCPMDRKPLVLQHCKKSSILVNKLLNKLLVTCPFREHCTQVLQRCDLEHHFQTSCKGASHYGLTKDRKRRSQDGCPDGCASLTATAPSPEVSAAATISLMTDEPGLDNPAYVSSAEDGQPAISPVDSGRSNRTRARPFERSTIRSRSFKKINRALSVLRRTKSGSAVANHADQGRENSENTTAPEVFPRLYHLIPDGEITSIKINRVDPSESLSIRLVGGSETPLVHIIIQHIYRDGVIARDGRLLPGDIILKVNGMDISNVPHNYAVRLLRQPCQVLWLTVMREQKFRSRNNGQAPDAYRPRDDSFHVILNKSSPEEQLGIKLVRKVDEPGVFIFNVLDGGVAYRHGQLEENDRVLAINGHDLRYGSPESAAHLIQASERRVHLVVSRQVRQRSPDIFQEAGWNSNGSWSPGPGERSNTPKPLHPTITCHEKVVNIQKDPGESLGMTVAGGASHREWDLPIYVISVEPGGVISRDGRIKTGDILLNVDGVELTEVSRSEAVALLKRTSSSIVLKALEVKEYEPQEDCSSPAALDSNHNMAPPSDWSPSWVMWLELPRCLYNCKDIVLRRNTAGSLGFCIVGGYEEYNGNKPFFIKSIVEGTPAYNDGRIRCGDILLAVNGRSTSGMIHACLARLLKELKGRITLTIVSWPGTFL,False,False,True,Q8TBB1,"[('cd00992', 'PDZ_signaling'), ('cd16779', 'Modified RING finger, HC subclass (C3HC3D-type), found in ligand of numb protein X 1 (LNX1)'), ('G3DSA:2.30.42.10', None), ('G3DSA:3.30.40.10', 'Zinc/RING finger domain, C3HC4 (zinc finger)'), ('IPR001478', 'PDZ domain'), ('IPR001841', 'Zinc finger, RING-type'), ('IPR013083', 'Zinc finger, RING/FYVE/PHD-type'), ('IPR017907', 'Zinc finger, RING-type, conserved site'), ('IPR018957', 'Zinc finger, C3HC4 RING-type'), ('IPR036034', 'PDZ superfamily'), ('IPR051342', 'PDZ domain-containing scaffold protein'), ('PF00097', 'Zinc finger, C3HC4 type (RING finger)'), ('PF00595', 'PDZ domain'), ('PS00518', 'Zinc finger RING-type signature'), ('PS50089', 'Zinc finger RING-type profile'), ('PS50106', 'PDZ domain profile'), ('PTHR19964', 'PDZ domain-containing scaffold protein'), ('SM00184', 'Ring finger'), ('SM00228', 'Domain present in PSD-95, Dlg, and ZO-1/2.'), ('SSF50156', 'PDZ domain-like')]",Q8TBB1;,"""ENSG00000072201; Low tissue specificity."";",CATALYTIC ACTIVITY: Reaction=S-ubiquitinyl-[E2 ubiquitin-conjugating enzyme]-L-cysteine + [acceptor protein]-L-lysine = [E2 ubiquitin-conjugating enzyme]-L-cysteine + N(6)-ubiquitinyl-[acceptor protein]-L-lysine.; EC=2.3.2.27;,2.3.2.27,,PATHWAY: Protein modification; protein ubiquitination.,ENST00000263925.8 [Q8TBB1-1];ENST00000306888.6 [Q8TBB1-2];,LNX1,ENSG00000072201,0.0,,,,,,,0.284,0.078,LNX1
Q8TBC4,ENSG00000144744,UBA3_HUMAN,endomitotic cell cycle [GO:0007113]; post-translational protein modification [GO:0043687]; protein modification process [GO:0036211]; protein neddylation [GO:0045116]; proteolysis [GO:0006508]; regulation of cell cycle [GO:0051726],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; protein-containing complex [GO:0032991],ATP binding [GO:0005524]; identical protein binding [GO:0042802]; NEDD8 activating enzyme activity [GO:0019781]; NEDD8 transferase activity [GO:0019788]; protein heterodimerization activity [GO:0046982],,,,"STRAND 31..33; /evidence=""ECO:0007829|PDB:2NVU""; STRAND 72..75; /evidence=""ECO:0007829|PDB:1TT5""; STRAND 96..100; /evidence=""ECO:0007829|PDB:1TT5""; STRAND 142..146; /evidence=""ECO:0007829|PDB:1TT5""; STRAND 160..164; /evidence=""ECO:0007829|PDB:1TT5""; STRAND 185..188; /evidence=""ECO:0007829|PDB:1TT5""; STRAND 189..191; /evidence=""ECO:0007829|PDB:1R4M""; STRAND 198..204; /evidence=""ECO:0007829|PDB:1TT5""; STRAND 207..213; /evidence=""ECO:0007829|PDB:1TT5""; STRAND 341..346; /evidence=""ECO:0007829|PDB:1TT5""; STRAND 348..350; /evidence=""ECO:0007829|PDB:1TT5""; STRAND 352..356; /evidence=""ECO:0007829|PDB:1TT5""; STRAND 372..376; /evidence=""ECO:0007829|PDB:3FN1""; STRAND 377..379; /evidence=""ECO:0007829|PDB:1R4M""; STRAND 401..406; /evidence=""ECO:0007829|PDB:1Y8X""; STRAND 409..414; /evidence=""ECO:0007829|PDB:1Y8X""; STRAND 431..433; /evidence=""ECO:0007829|PDB:1Y8X""; STRAND 443..447; /evidence=""ECO:0007829|PDB:1Y8X""; STRAND 451..453; /evidence=""ECO:0007829|PDB:1YOV""; STRAND 455..460; /evidence=""ECO:0007829|PDB:1Y8X""","HELIX 39..46; /evidence=""ECO:0007829|PDB:1TT5""; HELIX 63..67; /evidence=""ECO:0007829|PDB:5JJM""; HELIX 80..90; /evidence=""ECO:0007829|PDB:1TT5""; HELIX 106..108; /evidence=""ECO:0007829|PDB:1TT5""; HELIX 117..119; /evidence=""ECO:0007829|PDB:1TT5""; HELIX 124..135; /evidence=""ECO:0007829|PDB:1TT5""; HELIX 148..150; /evidence=""ECO:0007829|PDB:1TT5""; HELIX 153..156; /evidence=""ECO:0007829|PDB:1TT5""; HELIX 169..181; /evidence=""ECO:0007829|PDB:1TT5""; HELIX 192..194; /evidence=""ECO:0007829|PDB:1TT5""; HELIX 221..227; /evidence=""ECO:0007829|PDB:1TT5""; HELIX 236..241; /evidence=""ECO:0007829|PDB:1TT5""; HELIX 246..255; /evidence=""ECO:0007829|PDB:1TT5""; HELIX 257..260; /evidence=""ECO:0007829|PDB:1TT5""; HELIX 275..291; /evidence=""ECO:0007829|PDB:1TT5""; HELIX 299..306; /evidence=""ECO:0007829|PDB:1TT5""; HELIX 314..333; /evidence=""ECO:0007829|PDB:1TT5""; HELIX 382..391; /evidence=""ECO:0007829|PDB:1Y8X""; HELIX 419..430; /evidence=""ECO:0007829|PDB:1Y8X""; HELIX 434..436; /evidence=""ECO:0007829|PDB:1Y8X""; HELIX 437..440; /evidence=""ECO:0007829|PDB:1R4M""","TURN 35..38; /evidence=""ECO:0007829|PDB:1TT5""; TURN 109..111; /evidence=""ECO:0007829|PDB:1TT5""; TURN 215..217; /evidence=""ECO:0007829|PDB:1TT5""; TURN 365..367; /evidence=""ECO:0007829|PDB:1TT5""; TURN 393..395; /evidence=""ECO:0007829|PDB:3FN1""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,UBA3 UBE1C,NEDD8-activating enzyme E1 catalytic subunit (EC 6.2.1.64) (NEDD8-activating enzyme E1C) (Ubiquitin-activating enzyme E1C) (Ubiquitin-like modifier-activating enzyme 3) (Ubiquitin-activating enzyme 3),Homo sapiens (Human),463.0,51852.0,MADGEEPEKKRRRIEELLAEKMAVDGGCGDTGDWEGRWNHVKKFLERSGPFTHPDFEPSTESLQFLLDTCKVLVIGAGGLGCELLKNLALSGFRQIHVIDMDTIDVSNLNRQFLFRPKDIGRPKAEVAAEFLNDRVPNCNVVPHFNKIQDFNDTFYRQFHIIVCGLDSIIARRWINGMLISLLNYEDGVLDPSSIVPLIDGGTEGFKGNARVILPGMTACIECTLELYPPQVNFPMCTIASMPRLPEHCIEYVRMLQWPKEQPFGEGVPLDGDDPEHIQWIFQKSLERASQYNIRGVTYRLTQGVVKRIIPAVASTNAVIAAVCATEVFKIATSAYIPLNNYLVFNDVDGLYTYTFEAERKENCPACSQLPQNIQFSPSAKLQEVLDYLTNSASLQMKSPAITATLEGKNRTLYLQSVTSIEERTRPNLSKTLKELGLVDGQELAVADVTTPQTVLFKLHFTS,False,False,True,Q8TBC4,"[('cd01488', 'Uba3_RUB'), ('G3DSA:1.10.10.520', 'Ubiquitin activating enzymes (Uba3). Chain: B, domain 2'), ('G3DSA:3.10.290.20', 'Ubiquitin-like 2 activating enzyme e1b. Chain: B, domain 3'), ('G3DSA:3.40.50.720', 'NAD(P)-binding Rossmann-like Domain'), ('IPR000594', 'THIF-type NAD/FAD binding fold'), ('IPR014929', 'E2 binding'), ('IPR023318', 'Ubiquitin activating enzyme, alpha domain superfamily'), ('IPR030468', 'NEDD8-activating enzyme E1 catalytic subunit, N-terminal domain'), ('IPR033127', 'Ubiquitin-activating enzyme E1, Cys active site'), ('IPR035985', 'Ubiquitin-activating enzyme'), ('IPR045886', 'ThiF/MoeB/HesA family'), ('PF00899', 'ThiF family'), ('PF08825', 'E2 binding domain'), ('PS00865', 'Ubiquitin-activating enzyme active site'), ('PTHR10953', 'UBIQUITIN-ACTIVATING ENZYME E1'), ('SM01181', 'E2_bind'), ('SSF69572', 'Activating enzymes of the ubiquitin-like proteins')]",,"""ENSG00000144744; Low tissue specificity."";",CATALYTIC ACTIVITY: [NEDD8-activating enzyme E1 catalytic subunit]: Reaction=ATP + [NEDD8 protein] + [E1 NEDD8-activating enzyme]-L-cysteine = AMP + diphosphate + [E1 NEDD8-activating enzyme]-S-[NEDD8 protein]-yl-L-cysteine.; EC=6.2.1.64; Evidence={ECO:0000269|PubMed:9694792};,6.2.1.64,ACTIVITY REGULATION: Binding of TP53BP2 to the regulatory subunit NAE1 decreases activity.,PATHWAY: Protein modification; protein neddylation.,ENST00000349511.8 [Q8TBC4-2];ENST00000361055.9 [Q8TBC4-1];,UBA3,ENSG00000144744,0.0,,,,,,,0.069,,UBA3
Q8WUM4,ENSG00000170248,PDC6I_HUMAN,actomyosin contractile ring assembly [GO:0000915]; apoptotic process [GO:0006915]; bicellular tight junction assembly [GO:0070830]; extracellular exosome biogenesis [GO:0097734]; macroautophagy [GO:0016236]; maintenance of epithelial cell apical/basal polarity [GO:0045199]; midbody abscission [GO:0061952]; mitotic cytokinesis [GO:0000281]; multivesicular body assembly [GO:0036258]; multivesicular body sorting pathway [GO:0071985]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of extracellular exosome assembly [GO:1903553]; protein homooligomerization [GO:0051260]; protein transport [GO:0015031]; regulation of centrosome duplication [GO:0010824]; regulation of extracellular exosome assembly [GO:1903551]; regulation of membrane permeability [GO:0090559]; ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway [GO:0090611]; viral budding [GO:0046755]; viral budding via host ESCRT complex [GO:0039702],actomyosin [GO:0042641]; bicellular tight junction [GO:0005923]; centrosome [GO:0005813]; cytosol [GO:0005829]; endoplasmic reticulum exit site [GO:0070971]; endosome [GO:0005768]; extracellular exosome [GO:0070062]; extracellular vesicle [GO:1903561]; Flemming body [GO:0090543]; focal adhesion [GO:0005925]; immunological synapse [GO:0001772]; melanosome [GO:0042470]; membrane [GO:0016020],calcium-dependent protein binding [GO:0048306]; protein homodimerization activity [GO:0042803]; proteinase activated receptor binding [GO:0031871],PTM: May be phosphorylated on tyrosine residues by activated PDGFRB. {ECO:0000269|PubMed:20494825}.,,"DOMAIN 3..392; /note=""BRO1""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00526""","STRAND 29..31; /evidence=""ECO:0007829|PDB:6KP3""; STRAND 32..34; /evidence=""ECO:0007829|PDB:2OEV""; STRAND 93..96; /evidence=""ECO:0007829|PDB:5WA1""; STRAND 98..100; /evidence=""ECO:0007829|PDB:2R05""; STRAND 110..114; /evidence=""ECO:0007829|PDB:5WA1""; STRAND 140..142; /evidence=""ECO:0007829|PDB:2OEV""; STRAND 171..173; /evidence=""ECO:0007829|PDB:2OEV""; STRAND 348..350; /evidence=""ECO:0007829|PDB:3C3R""; STRAND 408..412; /evidence=""ECO:0007829|PDB:2R05""; STRAND 591..593; /evidence=""ECO:0007829|PDB:2R05""; STRAND 802..805; /evidence=""ECO:0007829|PDB:3E1R""","HELIX 18..28; /evidence=""ECO:0007829|PDB:5WA1""; HELIX 35..54; /evidence=""ECO:0007829|PDB:5WA1""; HELIX 62..76; /evidence=""ECO:0007829|PDB:5WA1""; HELIX 116..136; /evidence=""ECO:0007829|PDB:5WA1""; HELIX 143..170; /evidence=""ECO:0007829|PDB:5WA1""; HELIX 177..179; /evidence=""ECO:0007829|PDB:5WA1""; HELIX 181..205; /evidence=""ECO:0007829|PDB:5WA1""; HELIX 210..231; /evidence=""ECO:0007829|PDB:5WA1""; HELIX 241..266; /evidence=""ECO:0007829|PDB:5WA1""; HELIX 270..290; /evidence=""ECO:0007829|PDB:5WA1""; HELIX 298..317; /evidence=""ECO:0007829|PDB:5WA1""; HELIX 326..328; /evidence=""ECO:0007829|PDB:5WA1""; HELIX 361..398; /evidence=""ECO:0007829|PDB:2XS1""; HELIX 403..406; /evidence=""ECO:0007829|PDB:2XS1""; HELIX 415..426; /evidence=""ECO:0007829|PDB:2XS1""; HELIX 430..471; /evidence=""ECO:0007829|PDB:2XS1""; HELIX 481..514; /evidence=""ECO:0007829|PDB:2XS1""; HELIX 517..523; /evidence=""ECO:0007829|PDB:2XS1""; HELIX 527..532; /evidence=""ECO:0007829|PDB:2XS1""; HELIX 541..543; /evidence=""ECO:0007829|PDB:2XS1""; HELIX 547..575; /evidence=""ECO:0007829|PDB:2XS1""; HELIX 581..590; /evidence=""ECO:0007829|PDB:2XS1""; HELIX 596..639; /evidence=""ECO:0007829|PDB:2XS1""; HELIX 644..697; /evidence=""ECO:0007829|PDB:2XS1""","TURN 77..88; /evidence=""ECO:0007829|PDB:5WA1""; TURN 104..106; /evidence=""ECO:0007829|PDB:5V3R""; TURN 292..294; /evidence=""ECO:0007829|PDB:5WA1""; TURN 354..357; /evidence=""ECO:0007829|PDB:5V3R""; TURN 399..402; /evidence=""ECO:0007829|PDB:2XS1""; TURN 427..429; /evidence=""ECO:0007829|PDB:2XS1""; TURN 473..475; /evidence=""ECO:0007829|PDB:2XS1""; TURN 810..813; /evidence=""ECO:0007829|PDB:2ZNE""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,PDCD6IP AIP1 ALIX KIAA1375,Programmed cell death 6-interacting protein (PDCD6-interacting protein) (ALG-2-interacting protein 1) (ALG-2-interacting protein X) (Hp95),Homo sapiens (Human),868.0,96023.0,MATFISVQLKKTSEVDLAKPLVKFIQQTYPSGGEEQAQYCRAAEELSKLRRAAVGRPLDKHEGALETLLRYYDQICSIEPKFPFSENQICLTFTWKDAFDKGSLFGGSVKLALASLGYEKSCVLFNCAALASQIAAEQNLDNDEGLKIAAKHYQFASGAFLHIKETVLSALSREPTVDISPDTVGTLSLIMLAQAQEVFFLKATRDKMKDAIIAKLANQAADYFGDAFKQCQYKDTLPKEVFPVLAAKHCIMQANAEYHQSILAKQQKKFGEEIARLQHAAELIKTVASRYDEYVNVKDFSDKINRALAAAKKDNDFIYHDRVPDLKDLDPIGKATLVKSTPVNVPISQKFTDLFEKMVPVSVQQSLAAYNQRKADLVNRSIAQMREATTLANGVLASLNLPAAIEDVSGDTVPQSILTKSRSVIEQGGIQTVDQLIKELPELLQRNREILDESLRLLDEEEATDNDLRAKFKERWQRTPSNELYKPLRAEGTNFRTVLDKAVQADGQVKECYQSHRDTIVLLCKPEPELNAAIPSANPAKTMQGSEVVNVLKSLLSNLDEVKKEREGLENDLKSVNFDMTSKFLTALAQDGVINEEALSVTELDRVYGGLTTKVQESLKKQEGLLKNIQVSHQEFSKMKQSNNEANLREEVLKNLATAYDNFVELVANLKEGTKFYNELTEILVRFQNKCSDIVFARKTERDELLKDLQQSIAREPSAPSIPTPAYQSSPAGGHAPTPPTPAPRTMPPTKPQPPARPPPPVLPANRAPSATAPSPVGAGTAAPAPSQTPGSAPPPQAQGPPYPTYPGYPGYCQMPMPMGYNPYAYGQYNMPYPPVYHQSPGQAPYPGPQQPSYPFPQPPQQSYYPQQ,False,False,True,Q8WUM4,"[('cd09235', 'Middle V-domain of mammalian Alix and related domains are dimerization and protein interaction modules'), ('cd09240', 'Protein-interacting, N-terminal, Bro1-like domain of mammalian Alix and related domains'), ('G3DSA:1.20.120.560', 'alix/aip1 in complex with the ypdl late domain'), ('G3DSA:1.20.140.50', 'alix/aip1 like domains'), ('G3DSA:1.25.40.280', 'alix/aip1 like domains'), ('IPR004328', 'BRO1 domain'), ('IPR025304', 'ALIX V-shaped domain'), ('IPR038499', 'BRO1 domain superfamily'), ('PF03097', 'BRO1-like domain'), ('PF13949', 'ALIX V-shaped domain binding to HIV'), ('PS51180', 'BRO1 domain profile'), ('PTHR23030', 'PCD6 INTERACTING PROTEIN-RELATED'), ('SM01041', 'BRO1-like domain')]",,"""ENSG00000170248; Low tissue specificity."";",,,,,ENST00000307296.8 [Q8WUM4-1];ENST00000457054.6 [Q8WUM4-2];,PDCD6IP,ENSG00000170248,0.0,PDCD6IP,Non-canonical_RBPs,16.0,,,,0.182,0.154,PDCD6IP
Q8WV44,ENSG00000146063,TRI41_HUMAN,cellular response to lipopolysaccharide [GO:0071222]; cellular response to muramyl dipeptide [GO:0071225]; defense response to virus [GO:0051607]; positive regulation of type I interferon-mediated signaling pathway [GO:0060340]; protein monoubiquitination [GO:0006513]; protein ubiquitination [GO:0016567],cytoplasm [GO:0005737]; nuclear body [GO:0016604]; nucleolus [GO:0005730],identical protein binding [GO:0042802]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270],PTM: Auto-ubiquitinated. {ECO:0000269|PubMed:17893151}.,,"DOMAIN 413..630; /note=""B30.2/SPRY""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00548""","STRAND 236..238; /evidence=""ECO:0007829|PDB:2EGM""; STRAND 243..245; /evidence=""ECO:0007829|PDB:2EGM""","HELIX 247..251; /evidence=""ECO:0007829|PDB:2EGM""; HELIX 253..256; /evidence=""ECO:0007829|PDB:2EGM""","TURN 228..230; /evidence=""ECO:0007829|PDB:2EGM""; TURN 239..242; /evidence=""ECO:0007829|PDB:2EGM""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,TRIM41 RINCK,E3 ubiquitin-protein ligase TRIM41 (EC 2.3.2.27) (RING finger-interacting protein with C kinase) (RINCK) (Tripartite motif-containing protein 41),Homo sapiens (Human),630.0,71670.0,MAAVAMTPNPVQTLQEEAVCAICLDYFTDPVSIGCGHNFCRVCVTQLWGGEDEEDRDELDREEEEEDGEEEEVEAVGAGAGWDTPMRDEDYEGDMEEEVEEEEEGVFWTSGMSRSSWDNMDYVWEEEDEEEDLDYYLGDMEEEDLRGEDEEDEEEVLEEVEEEDLDPVTPLPPPPAPRRCFTCPQCRKSFPRRSFRPNLQLANMVQVIRQMHPTPGRGSRVTDQGICPKHQEALKLFCEVDEEAICVVCRESRSHKQHSVVPLEEVVQEYKAKLQGHVEPLRKHLEAVQKMKAKEERRVTELKSQMKSELAAVASEFGRLTRFLAEEQAGLERRLREMHEAQLGRAGAAASRLAEQAAQLSRLLAEAQERSQQGGLRLLQDIKETFNRCEEVQLQPPEVWSPDPCQPHSHDFLTDAIVRKMSRMFCQAARVDLTLDPDTAHPALMLSPDRRGVRLAERRQEVADHPKRFSADCCVLGAQGFRSGRHYWEVEVGGRRGWAVGAARESTHHKEKVGPGGSSVGSGDASSSRHHHRRRRLHLPQQPLLQREVWCVGTNGKRYQAQSSTEQTLLSPSEKPRRFGVYLDYEAGRLGFYNAETLAHVHTFSAAFLGERVFPFFRVLSKGTRIKLCP,False,False,True,Q8WV44,"[('cd13741', 'PRY/SPRY domain in tripartite motif-binding protein 41 (TRIM41)'), ('cd19762', 'B-box-type 2 zinc finger found in tripartite motif-containing proteins TRIM7, TRIM27 and similar proteins'), ('G3DSA:2.60.120.920', None), ('G3DSA:3.30.160.60', 'Classic Zinc Finger'), ('G3DSA:3.30.40.10', 'Zinc/RING finger domain, C3HC4 (zinc finger)'), ('IPR000315', 'B-box-type zinc finger'), ('IPR001841', 'Zinc finger, RING-type'), ('IPR001870', 'B30.2/SPRY domain'), ('IPR003877', 'SPRY domain'), ('IPR003879', 'Butyrophylin-like, SPRY domain'), ('IPR006574', 'SPRY-associated'), ('IPR013083', 'Zinc finger, RING/FYVE/PHD-type'), ('IPR013320', 'Concanavalin A-like lectin/glucanase domain superfamily'), ('IPR017907', 'Zinc finger, RING-type, conserved site'), ('IPR042828', 'TRIM41, PRY/SPRY domain'), ('IPR043136', 'B30.2/SPRY domain superfamily'), ('IPR050143', 'Tripartite motif-containing'), ('PF00622', 'SPRY domain'), ('PF00643', 'B-box zinc finger'), ('PF13765', 'SPRY-associated domain')]",,"""ENSG00000146063; Tissue enhanced (brain)."";","CATALYTIC ACTIVITY: Reaction=S-ubiquitinyl-[E2 ubiquitin-conjugating enzyme]-L-cysteine + [acceptor protein]-L-lysine = [E2 ubiquitin-conjugating enzyme]-L-cysteine + N(6)-ubiquitinyl-[acceptor protein]-L-lysine.; EC=2.3.2.27; Evidence={ECO:0000269|PubMed:29760876, ECO:0000269|PubMed:29899090, ECO:0000269|PubMed:31979016};",2.3.2.27,,"PATHWAY: Protein modification; protein ubiquitination. {ECO:0000269|PubMed:29760876, ECO:0000269|PubMed:29899090, ECO:0000269|PubMed:31979016}.",ENST00000315073.10 [Q8WV44-1];ENST00000351937.9 [Q8WV44-2];,TRIM41,ENSG00000146063,0.0,TRIM41,Canonical_RBPs,0.0,,,,0.325,0.168,TRIM41
Q8WVT3,ENSG00000171853,TPC12_HUMAN,COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; Golgi organization [GO:0007030]; metaphase chromosome alignment [GO:0051310]; positive regulation of protein localization to kinetochore [GO:1905342]; regulation of kinetochore assembly [GO:0090234]; vesicle tethering [GO:0099022],cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum-Golgi intermediate compartment [GO:0005793]; Golgi apparatus [GO:0005794]; kinetochore [GO:0000776]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; TRAPP complex [GO:0030008]; TRAPPIII protein complex [GO:1990072],,PTM: Phosphorylated as the cells enter mitosis but is dephosphorylated at or before the onset of anaphase. The phosphorylated form recruits CENPE to kinetochores more efficiently than the non-phosphorylated form. {ECO:0000269|PubMed:25918224}.,,,,,,"cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,TRAPPC12 TRAMM TTC15 CGI-87,Trafficking protein particle complex subunit 12 (Tetratricopeptide repeat protein 15) (TPR repeat protein 15) (TTC-15) (Trafficking of membranes and mitosis),Homo sapiens (Human),735.0,79375.0,MEDAGGGEETPAPEAPHPPQLAPPEEQGLLFQEETIDLGGDEFGSEENETASEGSSPLADKLNEHMMESVLISDSPNSEGDAGDLGRVRDEAEPGGEGDPGPEPAGTPSPSGEADGDCAPEDAAPSSGGAPRQDAAREVPGSEAARPEQEPPVAEPVPVCTIFSQRAPPASGDGFEPQMVKSPSFGGASEASARTPPQVVQPSPSLSTFFGDTAASHSLASDFFDSFTTSAFISVSNPGAGSPAPASPPPLAVPGTEGRPEPVAMRGPQAAAPPASPEPFAHIQAVFAGSDDPFATALSMSEMDRRNDAWLPGEATRGVLRAVATQQRGAVFVDKENLTMPGLRFDNIQGDAVKDLMLRFLGEKAAAKRQVLNADSVEQSFVGLKQLISCRNWRAAVDLCGRLLTAHGQGYGKSGLLTSHTTDSLQLWFVRLALLVKLGLFQNAEMEFEPFGNLDQPDLYYEYYPHVYPGRRGSMVPFSMRILHAELQQYLGNPQESLDRLHKVKTVCSKILANLEQGLAEDGGMSSVTQEGRQASIRLWRSRLGRVMYSMANCLLLMKDYVLAVEAYHSVIKYYPEQEPQLLSGIGRISLQIGDIKTAEKYFQDVEKVTQKLDGLQGKIMVLMNSAFLHLGQNNFAEAHRFFTEILRMDPRNAVANNNAAVCLLYLGKLKDSLRQLEAMVQQDPRHYLHESVLFNLTTMYELESSRSMQKKQALLEAVAGKEGDSFNTQCLKLA,True,False,False,Q8WVT3,"[('G3DSA:1.25.40.10', 'Tetratricopeptide repeat domain'), ('IPR011990', 'Tetratricopeptide-like helical domain superfamily'), ('IPR019734', 'Tetratricopeptide repeat'), ('PF13174', 'Tetratricopeptide repeat'), ('PF14559', 'Tetratricopeptide repeat'), ('PS50005', 'TPR repeat profile'), ('PTHR21581', 'D-alanyl-D-alanine Carboxypeptidase'), ('SM00028', 'Tetratricopeptide repeats'), ('SSF48452', 'TPR-like')]",,"""ENSG00000171853; Tissue enhanced (testis)."";",,,,,ENST00000324266.10;ENST00000382110.6;,TRAPPC12,ENSG00000171853,0.0,,,,,,,0.328,0.332,TRAPPC12
Q8WWY3,ENSG00000105618|ENSG00000277154|ENSG00000276421|ENSG00000275885|ENSG00000274651|ENSG00000274144|ENSG00000274894|ENSG00000277953|ENSG00000275117|ENSG00000277707,PRP31_HUMAN,"mRNA splicing, via spliceosome [GO:0000398]; ribonucleoprotein complex localization [GO:0071166]; spliceosomal tri-snRNP complex assembly [GO:0000244]",Cajal body [GO:0015030]; MLL1 complex [GO:0071339]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; precatalytic spliceosome [GO:0071011]; spliceosomal tri-snRNP complex [GO:0097526]; U2-type precatalytic spliceosome [GO:0071005]; U2-type spliceosomal complex [GO:0005684]; U4 snRNP [GO:0005687]; U4/U6 x U5 tri-snRNP complex [GO:0046540]; U4atac snRNP [GO:0005690],identical protein binding [GO:0042802]; protein-macromolecule adaptor activity [GO:0030674]; ribonucleoprotein complex binding [GO:0043021]; RNA binding [GO:0003723]; snRNP binding [GO:0070990]; U4 snRNA binding [GO:0030621]; U4atac snRNA binding [GO:0030622],PTM: Phosphorylated by PRP4K during spliceosome assembly. {ECO:0000269|PubMed:20118938}.,"DOMAIN: Interacts with the snRNP via the Nop domain. {ECO:0000269|PubMed:17412961, ECO:0000269|PubMed:21784869}.; DOMAIN: The coiled coil domain is formed by two non-contiguous helices. {ECO:0000269|PubMed:17412961, ECO:0000269|PubMed:21784869}.","DOMAIN 215..333; /note=""Nop""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00690""",,"HELIX 89..118; /evidence=""ECO:0007829|PDB:2OZB""; HELIX 125..128; /evidence=""ECO:0007829|PDB:2OZB""; HELIX 132..142; /evidence=""ECO:0007829|PDB:2OZB""; HELIX 146..148; /evidence=""ECO:0007829|PDB:2OZB""; HELIX 149..151; /evidence=""ECO:0007829|PDB:3SIU""; HELIX 155..157; /evidence=""ECO:0007829|PDB:2OZB""; HELIX 161..172; /evidence=""ECO:0007829|PDB:2OZB""; HELIX 181..215; /evidence=""ECO:0007829|PDB:2OZB""; HELIX 217..235; /evidence=""ECO:0007829|PDB:2OZB""; HELIX 238..242; /evidence=""ECO:0007829|PDB:2OZB""; HELIX 246..249; /evidence=""ECO:0007829|PDB:2OZB""; HELIX 278..281; /evidence=""ECO:0007829|PDB:2OZB""; HELIX 285..287; /evidence=""ECO:0007829|PDB:2OZB""; HELIX 288..307; /evidence=""ECO:0007829|PDB:2OZB""; HELIX 315..331; /evidence=""ECO:0007829|PDB:2OZB""","TURN 119..121; /evidence=""ECO:0007829|PDB:2OZB""; TURN 250..253; /evidence=""ECO:0007829|PDB:2OZB""; TURN 273..276; /evidence=""ECO:0007829|PDB:2OZB""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,PRPF31 PRP31,U4/U6 small nuclear ribonucleoprotein Prp31 (Pre-mRNA-processing factor 31) (Serologically defined breast cancer antigen NY-BR-99) (U4/U6 snRNP 61 kDa protein) (Protein 61K) (hPrp31),Homo sapiens (Human),499.0,55456.0,MSLADELLADLEEAAEEEEGGSYGEEEEEPAIEDVQEETQLDLSGDSVKTIAKLWDSKMFAEIMMKIEEYISKQAKASEVMGPVEAAPEYRVIVDANNLTVEIENELNIIHKFIRDKYSKRFPELESLVPNALDYIRTVKELGNSLDKCKNNENLQQILTNATIMVVSVTASTTQGQQLSEEELERLEEACDMALELNASKHRIYEYVESRMSFIAPNLSIIIGASTAAKIMGVAGGLTNLSKMPACNIMLLGAQRKTLSGFSSTSVLPHTGYIYHSDIVQSLPPDLRRKAARLVAAKCTLAARVDSFHESTEGKVGYELKDEIERKFDKWQEPPPVKQVKPLPAPLDGQRKKRGGRRYRKMKERLGLTEIRKQANRMSFGEIEEDAYQEDLGFSLGHLGKSGSGRVRQTQVNEATKARISKTLQRTLQKQSVVYGGKSTIRDRSSGTASSVAFTPLQGLEIVNPQAAEKKVAEANQKYFSSMAEFLKVKGEKSGLMST,False,True,False,Q8WWY3,"[('G3DSA:1.10.246.90', 'Nop domain'), ('G3DSA:1.10.287.4070', None), ('IPR002687', 'Nop domain'), ('IPR012976', 'NOSIC'), ('IPR019175', 'Prp31 C-terminal'), ('IPR027105', 'U4/U6 small nuclear ribonucleoprotein Prp31'), ('IPR036070', 'Nop domain superfamily'), ('IPR042239', 'Nop, C-terminal domain'), ('PF01798', 'snoRNA binding domain, fibrillarin'), ('PF09785', 'Prp31 C terminal domain'), ('PS51358', 'Nop domain profile'), ('PTHR13904', 'PRE-MRNA SPLICING FACTOR PRP31'), ('SM00931', 'NOSIC (NUC001) domain'), ('SSF89124', 'Nop domain')]",,"""ENSG00000105618; Low tissue specificity."";",,,,,ENST00000321030.9 [Q8WWY3-1];ENST00000419967.5 [Q8WWY3-4];ENST00000610903.1 [Q8WWY3-1];ENST00000612749.4 [Q8WWY3-4];ENST00000613693.4 [Q8WWY3-1];ENST00000614518.4 [Q8WWY3-4];ENST00000615175.4 [Q8WWY3-4];ENST00000616732.1 [Q8WWY3-1];ENST00000618595.4 [Q8WWY3-4];ENST00000618937.1 [Q8WWY3-1];ENST00000619220.4 [Q8WWY3-4];ENST00000619391.1 [Q8WWY3-4];ENST00000619439.1 [Q8WWY3-1];ENST00000619956.1 [Q8WWY3-1];ENST00000620142.1 [Q8WWY3-1];ENST00000620861.1 [Q8WWY3-1];ENST00000621588.4 [Q8WWY3-4];ENST00000622300.1 [Q8WWY3-1];ENST00000622387.4 [Q8WWY3-4];ENST00000622636.4 [Q8WWY3-4];,PRPF31,ENSG00000105618,9.0,PRPF31,Canonical_RBPs,28.0,,,,0.415,0.122,PRPF31
Q8WYB5,ENSG00000156650|ENSG00000281813,KAT6B_HUMAN,negative regulation of DNA-templated transcription [GO:0045892]; nucleosome assembly [GO:0006334]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of developmental process [GO:0050793]; regulation of DNA-templated transcription [GO:0006355]; regulation of hemopoiesis [GO:1903706]; regulation of transcription by RNA polymerase II [GO:0006357],chromatin [GO:0000785]; MOZ/MORF histone acetyltransferase complex [GO:0070776]; nucleoplasm [GO:0005654]; nucleosome [GO:0000786]; nucleus [GO:0005634],chromatin binding [GO:0003682]; DNA binding [GO:0003677]; histone acetyltransferase activity [GO:0004402]; histone H3 acetyltransferase activity [GO:0010484]; histone H3K14 acetyltransferase activity [GO:0036408]; metal ion binding [GO:0046872]; peptide-lysine-N-acetyltransferase activity [GO:0061733]; protein-containing complex binding [GO:0044877]; transcription coactivator activity [GO:0003713]; transcription coregulator activity [GO:0003712],"PTM: Autoacetylated (PubMed:10497217, PubMed:11965546). Autoacetylation at Lys-815 is required for proper function. {ECO:0000250|UniProtKB:Q9H7Z6, ECO:0000269|PubMed:10497217, ECO:0000269|PubMed:11965546}.",DOMAIN: The N-terminus is involved in transcriptional activation while the C-terminus is involved in transcriptional repression. {ECO:0000269|PubMed:10497217}.,"DOMAIN 1..77; /note=""SAMD1-like winged helix (WH)""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU01358""; DOMAIN 103..176; /note=""H15""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00837""; DOMAIN 715..989; /note=""MYST-type HAT""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU01063""","STRAND 137..139; /evidence=""ECO:0007829|PDB:8E4V""; STRAND 164..168; /evidence=""ECO:0007829|PDB:8E4V""; STRAND 171..174; /evidence=""ECO:0007829|PDB:8E4V""; STRAND 214..216; /evidence=""ECO:0007829|PDB:5U2J""; STRAND 300..302; /evidence=""ECO:0007829|PDB:5U2J""","HELIX 107..118; /evidence=""ECO:0007829|PDB:8E4V""; HELIX 126..135; /evidence=""ECO:0007829|PDB:8E4V""; HELIX 140..144; /evidence=""ECO:0007829|PDB:8E4V""; HELIX 147..162; /evidence=""ECO:0007829|PDB:8E4V""; HELIX 246..249; /evidence=""ECO:0007829|PDB:5U2J""; HELIX 253..260; /evidence=""ECO:0007829|PDB:5U2J""; HELIX 282..284; /evidence=""ECO:0007829|PDB:5U2J""; HELIX 297..299; /evidence=""ECO:0007829|PDB:5U2J""","TURN 217..219; /evidence=""ECO:0007829|PDB:5U2J""; TURN 238..240; /evidence=""ECO:0007829|PDB:5U2J""; TURN 267..269; /evidence=""ECO:0007829|PDB:5U2J""; TURN 273..275; /evidence=""ECO:0007829|PDB:5U2J""; TURN 289..291; /evidence=""ECO:0007829|PDB:5U2J""; TURN 315..317; /evidence=""ECO:0007829|PDB:5U2J""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,KAT6B KIAA0383 MORF MOZ2 MYST4,"Histone acetyltransferase KAT6B (EC 2.3.1.48) (Histone acetyltransferase MOZ2) (MOZ, YBF2/SAS3, SAS2 and TIP60 protein 4) (MYST-4) (Monocytic leukemia zinc finger protein-related factor)",Homo sapiens (Human),2073.0,231378.0,MVKLANPLYTEWILEAIQKIKKQKQRPSEERICHAVSTSHGLDKKTVSEQLELSVQDGSVLKVTNKGLASYKDPDNPGRFSSVKPGTFPKSAKGSRGSCNDLRNVDWNKLLRRAIEGLEEPNGSSLKNIEKYLRSQSDLTSTTNNPAFQQRLRLGAKRAVNNGRLLKDGPQYRVNYGSLDGKGAPQYPSAFPSSLPPVSLLPHEKDQPRADPIPICSFCLGTKESNREKKPEELLSCADCGSSGHPSCLKFCPELTTNVKALRWQCIECKTCSACRVQGRNADNMLFCDSCDRGFHMECCDPPLSRMPKGMWICQVCRPKKKGRKLLHEKAAQIKRRYAKPIGRPKNKLKQRLLSVTSDEGSMNAFTGRGSPGRGQKTKVCTTPSSGHAASGKDSSSRLAVTDPTRPGATTKITTTSTYISASTLKVNKKTKGLIDGLTKFFTPSPDGRRSRGEIIDFSKHYRPRKKVSQKQSCTSHVLATGTTQKLKPPPSSLPPPTPISGQSPSSQKSSTATSSPSPQSSSSQCSVPSLSSLTTNSQLKALFDGLSHIYTTQGQSRKKGHPSYAPPKRMRRKTELSSTAKSKAHFFGKRDIRSRFISHSSSSSWGMARGSIFKAIAHFKRTTFLKKHRMLGRLKYKVTPQMGTPSPGKGSLTDGRIKPDQDDDTEIKINIKQESADVNVIGNKDVVTEEDLDVFKQAQELSWEKIECESGVEDCGRYPSVIEFGKYEIQTWYSSPYPQEYARLPKLYLCEFCLKYMKSKNILLRHSKKCGWFHPPANEIYRRKDLSVFEVDGNMSKIYCQNLCLLAKLFLDHKTLYYDVEPFLFYVLTKNDEKGCHLVGYFSKEKLCQQKYNVSCIMIMPQHQRQGFGRFLIDFSYLLSRREGQAGSPEKPLSDLGRLSYLAYWKSVILEYLYHHHERHISIKAISRATGMCPHDIATTLQHLHMIDKRDGRFVIIRREKLILSHMEKLKTCSRANELDPDSLRWTPILISNAAVSEEEREAEKEAERLMEQASCWEKEEQEILSTRANSRQSPAKVQSKNKYLHSPESRPVTGERGQLLELSKESSEEEEEEEDEEEEEEEEEEEEDEEEEEEEEEEEEEENIQSSPPRLTKPQSVAIKRKRPFVLKKKRGRKRRRINSSVTTETISETTEVLNEPFDNSDEERPMPQLEPTCEIEVEEDGRKPVLRKAFQHQPGKKRQTEEEEGKDNHCFKNADPCRNNMNDDSSNLKEGSKDNPEPLKCKQVWPKGTKRGLSKWRQNKERKTGFKLNLYTPPETPMEPDEQVTVEEQKETSEGKTSPSPIRIEEEVKETGEALLPQEENRREETCAPVSPNTSPGEKPEDDLIKPEEEEEEEEEEEEEEEEEEGEEEEGGGNVEKDPDGAKSQEKEEPEISTEKEDSARLDDHEEEEEEDEEPSHNEDHDADDEDDSHMESAEVEKEELPRESFKEVLENQETFLDLNVQPGHSNPEVLMDCGVDLTASCNSEPKELAGDPEAVPESDEEPPPGEQAQKQDQKNSKEVDTEFKEGNPATMEIDSETVQAVQSLTQESSEQDDTFQDCAETQEACRSLQNYTRADQSPQIATTLDDCQQSDHSSPVSSVHSHPGQSVRSVNSPSVPALENSYAQISPDQSAISVPSLQNMETSPMMDVPSVSDHSQQVVDSGFSDLGSIESTTENYENPSSYDSTMGGSICGNGSSQNSCSYSNLTSSSLTQSSCAVTQQMSNISGSCSMLQQTSISSPPTCSVKSPQGCVVERPPSSSQQLAQCSMAANFTPPMQLAEIPETSNANIGLYERMGQSDFGAGHYPQPSATFSLAKLQQLTNTLIDHSLPYSHSAAVTSYANSASLSTPLSNTGLVQLSQSPHSVPGGPQAQATMTPPPNLTPPPMNLPPPLLQRNMAASNIGISHSQRLQTQIASKGHISMRTKSASLSPAAATHQSQIYGRSQTVAMQGPARTLTMQRGMNMSVNLMPAPAYNVNSVNMNMNTLNAMNGYSMSQPMMNSGYHSNHGYMNQTPQYPMQMQMGMMGTQPYAQQPMQTPPHGNMMYTAPGHHGYMNTGMSKQSLNGSYMRR,False,False,True,Q8WYB5,"[('cd15527', 'PHD finger 2 found in monocytic leukemia zinc-finger protein (MOZ) and its factor (MORF)'), ('cd15618', 'PHD finger 1 found in monocytic leukemia zinc-finger protein (MOZ) and its factor (MORF)'), ('G3DSA:1.10.10.10', 'Winged helix-like DNA-binding domain superfamily/Winged helix DNA-binding domain'), ('G3DSA:3.30.40.10', 'Zinc/RING finger domain, C3HC4 (zinc finger)'), ('G3DSA:3.30.60.60', 'N-acetyl transferase-like'), ('G3DSA:3.40.630.30', None), ('IPR001965', 'Zinc finger, PHD-type'), ('IPR002717', 'Histone acetyltransferase domain, MYST-type'), ('IPR005818', 'Linker histone H1/H5, domain H15'), ('IPR011011', 'Zinc finger, FYVE/PHD-type'), ('IPR013083', 'Zinc finger, RING/FYVE/PHD-type'), ('IPR016181', 'Acyl-CoA N-acyltransferase'), ('IPR019787', 'Zinc finger, PHD-finger'), ('IPR036388', 'Winged helix-like DNA-binding domain superfamily'), ('IPR036390', 'Winged helix DNA-binding domain superfamily'), ('IPR040706', 'MYST, zinc finger domain'), ('IPR048589', 'SAM domain-containing protein 1-like, WH domain'), ('IPR050603', 'MYST family histone acetyltransferases'), ('PF00628', 'PHD-finger'), ('PF01853', 'MOZ/SAS family')]",,"""ENSG00000156650; Low tissue specificity."";","CATALYTIC ACTIVITY: Reaction=L-lysyl-[protein] + acetyl-CoA = N(6)-acetyl-L-lysyl-[protein] + CoA + H(+); Xref=Rhea:RHEA:45948, Rhea:RHEA-COMP:9752, Rhea:RHEA-COMP:10731, ChEBI:CHEBI:15378, ChEBI:CHEBI:29969, ChEBI:CHEBI:57287, ChEBI:CHEBI:57288, ChEBI:CHEBI:61930; EC=2.3.1.48; Evidence={ECO:0000269|PubMed:10497217};",2.3.1.48,,,ENST00000287239.10 [Q8WYB5-1];ENST00000372711.2 [Q8WYB5-2];ENST00000372714.6 [Q8WYB5-3];ENST00000372724.6 [Q8WYB5-2];ENST00000372725.6 [Q8WYB5-3];ENST00000628038.3 [Q8WYB5-3];ENST00000628523.3 [Q8WYB5-2];ENST00000629233.3 [Q8WYB5-3];ENST00000629879.2 [Q8WYB5-2];ENST00000630001.4 [Q8WYB5-1];ENST00000647630.1 [Q8WYB5-1];ENST00000648605.1 [Q8WYB5-1];ENST00000648725.1 [Q8WYB5-1];ENST00000648892.1 [Q8WYB5-3];ENST00000649006.1 [Q8WYB5-3];ENST00000649463.1 [Q8WYB5-1];ENST00000649574.1 [Q8WYB5-3];ENST00000650575.1 [Q8WYB5-3];,KAT6B,ENSG00000156650,1.0,,,,,,,0.717,0.361,KAT6B
Q8WZ42,ENSG00000155657,TITIN_HUMAN,cardiac muscle cell development [GO:0055013]; cardiac muscle contraction [GO:0060048]; cardiac muscle hypertrophy [GO:0003300]; cardiac muscle tissue morphogenesis [GO:0055008]; cardiac myofibril assembly [GO:0055003]; detection of muscle stretch [GO:0035995]; mitotic chromosome condensation [GO:0007076]; muscle contraction [GO:0006936]; positive regulation of gene expression [GO:0010628]; positive regulation of protein secretion [GO:0050714]; protein kinase A signaling [GO:0010737]; protein phosphorylation [GO:0006468]; response to calcium ion [GO:0051592]; sarcomere organization [GO:0045214]; sarcomerogenesis [GO:0048769]; skeletal muscle myosin thick filament assembly [GO:0030241]; skeletal muscle thin filament assembly [GO:0030240]; striated muscle contraction [GO:0006941],condensed nuclear chromosome [GO:0000794]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; I band [GO:0031674]; M band [GO:0031430]; striated muscle thin filament [GO:0005865]; Z disc [GO:0030018],actin filament binding [GO:0051015]; actinin binding [GO:0042805]; ATP binding [GO:0005524]; calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; histone H2AS1 kinase activity [GO:0044024]; identical protein binding [GO:0042802]; muscle alpha-actinin binding [GO:0051371]; protease binding [GO:0002020]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein kinase regulator activity [GO:0019887]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; protein tyrosine kinase activity [GO:0004713]; structural constituent of muscle [GO:0008307]; structural molecule activity conferring elasticity [GO:0097493]; telethonin binding [GO:0031433],PTM: Autophosphorylated. {ECO:0000250}.,DOMAIN: ZIS1 and ZIS5 regions contain multiple SPXR consensus sites for ERK- and CDK-like protein kinases as well as multiple SP motifs. ZIS1 could adopt a closed conformation which would block the TCAP-binding site.; DOMAIN: The PEVK region may serve as an entropic spring of a chain of structural folds and may also be an interaction site to other myofilament proteins to form interfilament connectivity in the sarcomere.,"DOMAIN 6..96; /note=""Ig-like 1""; DOMAIN 104..192; /note=""Ig-like 2""; DOMAIN 943..1031; /note=""Ig-like 3""; DOMAIN 1082..1172; /note=""Ig-like 4""; DOMAIN 1291..1382; /note=""Ig-like 5""; DOMAIN 1457..1546; /note=""Ig-like 6""; DOMAIN 1556..1646; /note=""Ig-like 7""; DOMAIN 1703..1793; /note=""Ig-like 8""; DOMAIN 1841..1928; /note=""Ig-like 9""; DOMAIN 2078..2167; /note=""Ig-like 10""; DOMAIN 2171..2262; /note=""Ig-like 11""; DOMAIN 2264..2354; /note=""Ig-like 12""; DOMAIN 2353..2443; /note=""Ig-like 13""; DOMAIN 2430..2529; /note=""Ig-like 14""; DOMAIN 2620..2703; /note=""Ig-like 15""; DOMAIN 2880..2965; /note=""Ig-like 16""; DOMAIN 2968..3050; /note=""Ig-like 17""; DOMAIN 3058..3141; /note=""Ig-like 18""; DOMAIN 3239..3327; /note=""Ig-like 19""; DOMAIN 3344..3432; /note=""Ig-like 20""; DOMAIN 3503..3586; /note=""Ig-like 21""; DOMAIN 3621..3712; /note=""Ig-like 22""; DOMAIN 4289..4376; /note=""Ig-like 23""; DOMAIN 4383..4471; /note=""Ig-like 24""; DOMAIN 4478..4566; /note=""Ig-like 25""; DOMAIN 4571..4659; /note=""Ig-like 26""; DOMAIN 4664..4753; /note=""Ig-like 27""; DOMAIN 4758..4846; /note=""Ig-like 28""; DOMAIN 4851..4936; /note=""Ig-like 29""; DOMAIN 4943..5032; /note=""Ig-like 30""; DOMAIN 5040..5128; /note=""Ig-like 31""; DOMAIN 5133..5221; /note=""Ig-like 32""; DOMAIN 5225..5314; /note=""Ig-like 33""; DOMAIN 5320..5408; /note=""Ig-like 34""; DOMAIN 5413..5501; /note=""Ig-like 35""; DOMAIN 5505..5594; /note=""Ig-like 36""; DOMAIN 5602..5690; /note=""Ig-like 37""; DOMAIN 5695..5783; /note=""Ig-like 38""; DOMAIN 5788..5877; /note=""Ig-like 39""; DOMAIN 5882..5970; /note=""Ig-like 40""; DOMAIN 5975..6063; /note=""Ig-like 41""; DOMAIN 6067..6156; /note=""Ig-like 42""; DOMAIN 6164..6252; /note=""Ig-like 43""; DOMAIN 6257..6347; /note=""Ig-like 44""; DOMAIN 6350..6440; /note=""Ig-like 45""; DOMAIN 6444..6534; /note=""Ig-like 46""; DOMAIN 6537..6626; /note=""Ig-like 47""; DOMAIN 6630..6721; /note=""Ig-like 48""; DOMAIN 6727..6815; /note=""Ig-like 49""; DOMAIN 6820..6908; /note=""Ig-like 50""; DOMAIN 6912..7001; /note=""Ig-like 51""; DOMAIN 7005..7093; /note=""Ig-like 52""; DOMAIN 7102..7190; /note=""Ig-like 53""; DOMAIN 7198..7286; /note=""Ig-like 54""; DOMAIN 7291..7380; /note=""Ig-like 55""; DOMAIN 7385..7473; /note=""Ig-like 56""; DOMAIN 7478..7567; /note=""Ig-like 57""; DOMAIN 7571..7662; /note=""Ig-like 58""; DOMAIN 7668..7756; /note=""Ig-like 59""; DOMAIN 7761..7849; /note=""Ig-like 60""; DOMAIN 7853..7942; /note=""Ig-like 61""; DOMAIN 7946..8035; /note=""Ig-like 62""; DOMAIN 8042..8133; /note=""Ig-like 63""; DOMAIN 8138..8229; /note=""Ig-like 64""; DOMAIN 8232..8321; /note=""Ig-like 65""; DOMAIN 8326..8414; /note=""Ig-like 66""; DOMAIN 8419..8508; /note=""Ig-like 67""; DOMAIN 8512..8603; /note=""Ig-like 68""; DOMAIN 8609..8697; /note=""Ig-like 69""; DOMAIN 8702..8790; /note=""Ig-like 70""; DOMAIN 8794..8883; /note=""Ig-like 71""; DOMAIN 8888..8976; /note=""Ig-like 72""; DOMAIN 8984..9074; /note=""Ig-like 73""; DOMAIN 9079..9168; /note=""Ig-like 74""; DOMAIN 9176..9265; /note=""Ig-like 75""; DOMAIN 9272..9361; /note=""Ig-like 76""; DOMAIN 9366..9470; /note=""Ig-like 77""; DOMAIN 9660..9755; /note=""Ig-like 78""; DOMAIN 9760..9851; /note=""Ig-like 79""; DOMAIN 12041..12133; /note=""Ig-like 80""; DOMAIN 12138..12222; /note=""Ig-like 81""; DOMAIN 12233..12318; /note=""Ig-like 82""; DOMAIN 12499..12584; /note=""Ig-like 83""; DOMAIN 12590..12672; /note=""Ig-like 84""; DOMAIN 12766..12850; /note=""Ig-like 85""; DOMAIN 12945..13032; /note=""Ig-like 86""; DOMAIN 13120..13206; /note=""Ig-like 87""; DOMAIN 13210..13295; /note=""Ig-like 88""; DOMAIN 13299..13384; /note=""Ig-like 89""; DOMAIN 13388..13478; /note=""Ig-like 90""; DOMAIN 13479..13562; /note=""Ig-like 91""; DOMAIN 13565..13655; /note=""Ig-like 92""; DOMAIN 13659..13748; /note=""Ig-like 93""; DOMAIN 13749..13833; /note=""Ig-like 94""; DOMAIN 13927..14012; /note=""Ig-like 95""; DOMAIN 14019..14114; /note=""Fibronectin type-III 1""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00316""; DOMAIN 14120..14215; /note=""Fibronectin type-III 2""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00316""; DOMAIN 14221..14316; /note=""Fibronectin type-III 3""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00316""; DOMAIN 14417..14513; /note=""Fibronectin type-III 4""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00316""; DOMAIN 14517..14614; /note=""Fibronectin type-III 5""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00316""; DOMAIN 14615..14708; /note=""Ig-like 96""; DOMAIN 14713..14806; /note=""Fibronectin type-III 6""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00316""; DOMAIN 14812..14907; /note=""Fibronectin type-III 7""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00316""; DOMAIN 14913..15007; /note=""Fibronectin type-III 8""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00316""; DOMAIN 15010..15107; /note=""Fibronectin type-III 9""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00316""; DOMAIN 15113..15207; /note=""Fibronectin type-III 10""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00316""; DOMAIN 15214..15310; /note=""Fibronectin type-III 11""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00316""; DOMAIN 15314..15402; /note=""Ig-like 97""; DOMAIN 15409..15503; /note=""Fibronectin type-III 12""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00316""; DOMAIN 15509..15604; /note=""Fibronectin type-III 13""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00316""; DOMAIN 15608..15724; /note=""Ig-like 98""; DOMAIN 15731..15826; /note=""Fibronectin type-III 14""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00316""; DOMAIN 15832..15926; /note=""Fibronectin type-III 15""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00316""; DOMAIN 15929..16025; /note=""Fibronectin type-III 16""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00316""; DOMAIN 16029..16119; /note=""Ig-like 99""; DOMAIN 16126..16218; /note=""Fibronectin type-III 17""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00316""; DOMAIN 16224..16318; /note=""Fibronectin type-III 18""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00316""; DOMAIN 16322..16420; /note=""Ig-like 100""; DOMAIN 16427..16522; /note=""Fibronectin type-III 19""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00316""; DOMAIN 16528..16628; /note=""Fibronectin type-III 20""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00316""; DOMAIN 16634..16734; /note=""Fibronectin type-III 21""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00316""; DOMAIN 16727..16834; /note=""Ig-like 101""; DOMAIN 16841..16934; /note=""Fibronectin type-III 22""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00316""; DOMAIN 16941..17041; /note=""Fibronectin type-III 23""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00316""; DOMAIN 17044..17139; /note=""Ig-like 102""; DOMAIN 17147..17240; /note=""Fibronectin type-III 24""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00316""; DOMAIN 17246..17345; /note=""Fibronectin type-III 25""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00316""; DOMAIN 17348..17445; /note=""Fibronectin type-III 26""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00316""; DOMAIN 17449..17536; /note=""Ig-like 103""; DOMAIN 17545..17640; /note=""Fibronectin type-III 27""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00316""; DOMAIN 17646..17741; /note=""Fibronectin type-III 28""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00316""; DOMAIN 17745..17834; /note=""Ig-like 104""; DOMAIN 17842..17935; /note=""Fibronectin type-III 29""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00316""; DOMAIN 17941..18036; /note=""Fibronectin type-III 30""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00316""; DOMAIN 18042..18139; /note=""Fibronectin type-III 31""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00316""; DOMAIN 18143..18228; /note=""Ig-like 105""; DOMAIN 18239..18333; /note=""Fibronectin type-III 32""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00316""; DOMAIN 18339..18431; /note=""Fibronectin type-III 33""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00316""; DOMAIN 18435..18526; /note=""Ig-like 106""; DOMAIN 18533..18632; /note=""Fibronectin type-III 34""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00316""; DOMAIN 18633..18727; /note=""Fibronectin type-III 35""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00316""; DOMAIN 18733..18829; /note=""Fibronectin type-III 36""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00316""; DOMAIN 18833..18924; /note=""Ig-like 107""; DOMAIN 18931..19025; /note=""Fibronectin type-III 37""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00316""; DOMAIN 19030..19124; /note=""Fibronectin type-III 38""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00316""; DOMAIN 19128..19219; /note=""Ig-like 108""; DOMAIN 19226..19321; /note=""Fibronectin type-III 39""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00316""; DOMAIN 19325..19420; /note=""Fibronectin type-III 40""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00316""; DOMAIN 19426..19527; /note=""Fibronectin type-III 41""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00316""; DOMAIN 19531..19617; /note=""Ig-like 109""; DOMAIN 19628..19722; /note=""Fibronectin type-III 42""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00316""; DOMAIN 19728..19823; /note=""Fibronectin type-III 43""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00316""; DOMAIN 19826..19914; /note=""Ig-like 110""; DOMAIN 19921..20017; /note=""Fibronectin type-III 44""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00316""; DOMAIN 20018..20116; /note=""Fibronectin type-III 45""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00316""; DOMAIN 20119..20217; /note=""Fibronectin type-III 46""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00316""; DOMAIN 20220..20311; /note=""Ig-like 111""; DOMAIN 20318..20411; /note=""Fibronectin type-III 47""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00316""; DOMAIN 20417..20512; /note=""Fibronectin type-III 48""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00316""; DOMAIN 20518..20613; /note=""Fibronectin type-III 49""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00316""; DOMAIN 20716..20813; /note=""Fibronectin type-III 50""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00316""; DOMAIN 20814..20908; /note=""Fibronectin type-III 51""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00316""; DOMAIN 20893..20996; /note=""Ig-like 112""; DOMAIN 21006..21101; /note=""Fibronectin type-III 52""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00316""; DOMAIN 21105..21200; /note=""Fibronectin type-III 53""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00316""; DOMAIN 21203..21299; /note=""Fibronectin type-III 54""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00316""; DOMAIN 21303..21395; /note=""Ig-like 113""; DOMAIN 21402..21495; /note=""Fibronectin type-III 55""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00316""; DOMAIN 21501..21596; /note=""Fibronectin type-III 56""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00316""; DOMAIN 21602..21697; /note=""Fibronectin type-III 57""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00316""; DOMAIN 21701..21793; /note=""Ig-like 114""; DOMAIN 21797..21891; /note=""Fibronectin type-III 58""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00316""; DOMAIN 21894..21986; /note=""Fibronectin type-III 59""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00316""; DOMAIN 21990..22083; /note=""Ig-like 115""; DOMAIN 22088..22182; /note=""Fibronectin type-III 60""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00316""; DOMAIN 22188..22283; /note=""Fibronectin type-III 61""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00316""; DOMAIN 22286..22382; /note=""Fibronectin type-III 62""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00316""; DOMAIN 22386..22477; /note=""Ig-like 116""; DOMAIN 22484..22578; /note=""Fibronectin type-III 63""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00316""; DOMAIN 22584..22679; /note=""Fibronectin type-III 64""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00316""; DOMAIN 22685..22781; /note=""Fibronectin type-III 65""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00316""; DOMAIN 22785..22874; /note=""Ig-like 117""; DOMAIN 22881..22976; /note=""Fibronectin type-III 66""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00316""; DOMAIN 22978..23071; /note=""Fibronectin type-III 67""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00316""; DOMAIN 23075..23163; /note=""Ig-like 118""; DOMAIN 23170..23264; /note=""Fibronectin type-III 68""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00316""; DOMAIN 23270..23364; /note=""Fibronectin type-III 69""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00316""; DOMAIN 23368..23463; /note=""Fibronectin type-III 70""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00316""; DOMAIN 23468..23555; /note=""Ig-like 119""; DOMAIN 23566..23660; /note=""Fibronectin type-III 71""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00316""; DOMAIN 23666..23761; /note=""Fibronectin type-III 72""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00316""; DOMAIN 23767..23863; /note=""Fibronectin type-III 73""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00316""; DOMAIN 23867..23954; /note=""Ig-like 120""; DOMAIN 23963..24057; /note=""Fibronectin type-III 74""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00316""; DOMAIN 24060..24153; /note=""Fibronectin type-III 75""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00316""; DOMAIN 24157..24241; /note=""Ig-like 121""; DOMAIN 24252..24346; /note=""Fibronectin type-III 76""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00316""; DOMAIN 24352..24446; /note=""Fibronectin type-III 77""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00316""; DOMAIN 24450..24546; /note=""Fibronectin type-III 78""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00316""; DOMAIN 24550..24641; /note=""Ig-like 122""; DOMAIN 24648..24742; /note=""Fibronectin type-III 79""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00316""; DOMAIN 24748..24843; /note=""Fibronectin type-III 80""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00316""; DOMAIN 24849..24945; /note=""Fibronectin type-III 81""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00316""; DOMAIN 24949..25038; /note=""Ig-like 123""; DOMAIN 25045..25139; /note=""Fibronectin type-III 82""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00316""; DOMAIN 25142..25235; /note=""Fibronectin type-III 83""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00316""; DOMAIN 25239..25325; /note=""Ig-like 124""; DOMAIN 25335..25428; /note=""Fibronectin type-III 84""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00316""; DOMAIN 25434..25529; /note=""Fibronectin type-III 85""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00316""; DOMAIN 25532..25627; /note=""Fibronectin type-III 86""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00316""; DOMAIN 25632..25722; /note=""Ig-like 125""; DOMAIN 25731..25825; /note=""Fibronectin type-III 87""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00316""; DOMAIN 25831..25926; /note=""Fibronectin type-III 88""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00316""; DOMAIN 25932..26028; /note=""Fibronectin type-III 89""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00316""; DOMAIN 26032..26121; /note=""Ig-like 126""; DOMAIN 26128..26222; /note=""Fibronectin type-III 90""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00316""; DOMAIN 26225..26318; /note=""Fibronectin type-III 91""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00316""; DOMAIN 26322..26410; /note=""Ig-like 127""; DOMAIN 26417..26510; /note=""Fibronectin type-III 92""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00316""; DOMAIN 26516..26611; /note=""Fibronectin type-III 93""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00316""; DOMAIN 26614..26710; /note=""Fibronectin type-III 94""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00316""; DOMAIN 26714..26801; /note=""Ig-like 128""; DOMAIN 26812..26906; /note=""Fibronectin type-III 95""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00316""; DOMAIN 26912..27007; /note=""Fibronectin type-III 96""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00316""; DOMAIN 27013..27107; /note=""Fibronectin type-III 97""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00316""; DOMAIN 27101..27196; /note=""Ig-like 129""; DOMAIN 27205..27296; /note=""Fibronectin type-III 98""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00316""; DOMAIN 27302..27392; /note=""Fibronectin type-III 99""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00316""; DOMAIN 27499..27593; /note=""Fibronectin type-III 100""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00316""; DOMAIN 27599..27694; /note=""Fibronectin type-III 101""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00316""; DOMAIN 27697..27793; /note=""Fibronectin type-III 102""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00316""; DOMAIN 27797..27888; /note=""Ig-like 130""; DOMAIN 27895..27989; /note=""Fibronectin type-III 103""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00316""; DOMAIN 27995..28090; /note=""Fibronectin type-III 104""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00316""; DOMAIN 28096..28192; /note=""Fibronectin type-III 105""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00316""; DOMAIN 28196..28286; /note=""Ig-like 131""; DOMAIN 28295..28389; /note=""Fibronectin type-III 106""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00316""; DOMAIN 28392..28484; /note=""Fibronectin type-III 107""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00316""; DOMAIN 28488..28577; /note=""Ig-like 132""; DOMAIN 28583..28680; /note=""Fibronectin type-III 108""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00316""; DOMAIN 28686..28781; /note=""Fibronectin type-III 109""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00316""; DOMAIN 28784..28879; /note=""Fibronectin type-III 110""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00316""; DOMAIN 28882..28974; /note=""Ig-like 133""; DOMAIN 28979..29071; /note=""Fibronectin type-III 111""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00316""; DOMAIN 29081..29177; /note=""Fibronectin type-III 112""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00316""; DOMAIN 29180..29278; /note=""Fibronectin type-III 113""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00316""; DOMAIN 29282..29367; /note=""Ig-like 134""; DOMAIN 29378..29473; /note=""Fibronectin type-III 114""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00316""; DOMAIN 29475..29568; /note=""Fibronectin type-III 115""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00316""; DOMAIN 29568..29663; /note=""Ig-like 135""; DOMAIN 29670..29764; /note=""Fibronectin type-III 116""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00316""; DOMAIN 29770..29865; /note=""Fibronectin type-III 117""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00316""; DOMAIN 29868..29967; /note=""Fibronectin type-III 118""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00316""; DOMAIN 29971..30059; /note=""Ig-like 136""; DOMAIN 30070..30163; /note=""Fibronectin type-III 119""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00316""; DOMAIN 30169..30265; /note=""Fibronectin type-III 120""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00316""; DOMAIN 30271..30367; /note=""Fibronectin type-III 121""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00316""; DOMAIN 30371..30460; /note=""Ig-like 137""; DOMAIN 30467..30561; /note=""Fibronectin type-III 122""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00316""; DOMAIN 30564..30658; /note=""Fibronectin type-III 123""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00316""; DOMAIN 30663..30754; /note=""Ig-like 138""; DOMAIN 30761..30855; /note=""Fibronectin type-III 124""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00316""; DOMAIN 30861..30956; /note=""Fibronectin type-III 125""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00316""; DOMAIN 30962..31058; /note=""Fibronectin type-III 126""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00316""; DOMAIN 31061..31150; /note=""Ig-like 139""; DOMAIN 31158..31254; /note=""Fibronectin type-III 127""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00316""; DOMAIN 31258..31354; /note=""Fibronectin type-III 128""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00316""; DOMAIN 31360..31455; /note=""Fibronectin type-III 129""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00316""; DOMAIN 31460..31548; /note=""Ig-like 140""; DOMAIN 31653..31748; /note=""Fibronectin type-III 130""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00316""; DOMAIN 31754..31849; /note=""Fibronectin type-III 131""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00316""; DOMAIN 31855..31945; /note=""Ig-like 141""; DOMAIN 31955..32046; /note=""Ig-like 142""; DOMAIN 32051..32144; /note=""Fibronectin type-III 132""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00316""; DOMAIN 32178..32432; /note=""Protein kinase""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00159""; DOMAIN 32496..32584; /note=""Ig-like 143""; DOMAIN 32617..32710; /note=""Ig-like 144""; DOMAIN 32722..32811; /note=""Ig-like 145""; DOMAIN 33301..33391; /note=""Ig-like 146""; DOMAIN 33488..33576; /note=""Ig-like 147""; DOMAIN 33645..33732; /note=""Ig-like 148""; DOMAIN 33779..33867; /note=""Ig-like 149""; DOMAIN 33963..34052; /note=""Ig-like 150""; DOMAIN 34061..34149; /note=""Ig-like 151""; DOMAIN 34256..34344; /note=""Ig-like 152""","STRAND 4..10; /evidence=""ECO:0007829|PDB:2A38""; STRAND 15..18; /evidence=""ECO:0007829|PDB:2A38""; STRAND 23..33; /evidence=""ECO:0007829|PDB:2A38""; STRAND 36..45; /evidence=""ECO:0007829|PDB:2A38""; STRAND 55..59; /evidence=""ECO:0007829|PDB:2A38""; STRAND 62..69; /evidence=""ECO:0007829|PDB:2A38""; STRAND 76..84; /evidence=""ECO:0007829|PDB:2A38""; STRAND 87..98; /evidence=""ECO:0007829|PDB:2A38""; STRAND 102..108; /evidence=""ECO:0007829|PDB:2A38""; STRAND 113..116; /evidence=""ECO:0007829|PDB:2A38""; STRAND 119..131; /evidence=""ECO:0007829|PDB:2A38""; STRAND 134..139; /evidence=""ECO:0007829|PDB:2A38""; STRAND 142..144; /evidence=""ECO:0007829|PDB:1YA5""; STRAND 147..155; /evidence=""ECO:0007829|PDB:2A38""; STRAND 158..166; /evidence=""ECO:0007829|PDB:2A38""; STRAND 172..180; /evidence=""ECO:0007829|PDB:2A38""; STRAND 183..194; /evidence=""ECO:0007829|PDB:2A38""; STRAND 199..205; /evidence=""ECO:0007829|PDB:6FWX""; STRAND 209..213; /evidence=""ECO:0007829|PDB:6FWX""; STRAND 225..233; /evidence=""ECO:0007829|PDB:6FWX""; STRAND 236..241; /evidence=""ECO:0007829|PDB:6FWX""; STRAND 1850..1852; /evidence=""ECO:0007829|PDB:6DL4""; STRAND 1858..1863; /evidence=""ECO:0007829|PDB:6DL4""; STRAND 1866..1869; /evidence=""ECO:0007829|PDB:6DL4""; STRAND 1871..1876; /evidence=""ECO:0007829|PDB:6DL4""; STRAND 1894..1899; /evidence=""ECO:0007829|PDB:6DL4""; STRAND 1908..1916; /evidence=""ECO:0007829|PDB:6DL4""; STRAND 1919..1929; /evidence=""ECO:0007829|PDB:6DL4""; STRAND 2076..2082; /evidence=""ECO:0007829|PDB:1G1C""; STRAND 2087..2090; /evidence=""ECO:0007829|PDB:1G1C""; STRAND 2095..2105; /evidence=""ECO:0007829|PDB:1G1C""; STRAND 2108..2113; /evidence=""ECO:0007829|PDB:1G1C""; STRAND 2122..2130; /evidence=""ECO:0007829|PDB:1G1C""; STRAND 2133..2138; /evidence=""ECO:0007829|PDB:1G1C""; STRAND 2147..2155; /evidence=""ECO:0007829|PDB:1G1C""; STRAND 2158..2169; /evidence=""ECO:0007829|PDB:1G1C""; STRAND 2797..2799; /evidence=""ECO:0007829|PDB:5JDD""; STRAND 2804..2807; /evidence=""ECO:0007829|PDB:5JDD""; STRAND 2812..2820; /evidence=""ECO:0007829|PDB:5JDD""; STRAND 2826..2829; /evidence=""ECO:0007829|PDB:5JDD""; STRAND 2838..2845; /evidence=""ECO:0007829|PDB:5JDD""; STRAND 2848..2853; /evidence=""ECO:0007829|PDB:5JDD""; STRAND 2862..2868; /evidence=""ECO:0007829|PDB:5JDD""; STRAND 2871..2880; /evidence=""ECO:0007829|PDB:5JDD""; STRAND 2884..2886; /evidence=""ECO:0007829|PDB:5JDD""; STRAND 2891..2894; /evidence=""ECO:0007829|PDB:5JDD""; STRAND 2899..2907; /evidence=""ECO:0007829|PDB:5JDD""; STRAND 2914..2916; /evidence=""ECO:0007829|PDB:5JDD""; STRAND 2924..2932; /evidence=""ECO:0007829|PDB:5JDD""; STRAND 2935..2940; /evidence=""ECO:0007829|PDB:5JDD""; STRAND 2949..2955; /evidence=""ECO:0007829|PDB:5JDD""; STRAND 2958..2967; /evidence=""ECO:0007829|PDB:5JDD""; STRAND 2971..2973; /evidence=""ECO:0007829|PDB:5JDD""; STRAND 2978..2981; /evidence=""ECO:0007829|PDB:5JDD""; STRAND 2986..2994; /evidence=""ECO:0007829|PDB:5JDD""; STRAND 3000..3003; /evidence=""ECO:0007829|PDB:5JDD""; STRAND 3012..3019; /evidence=""ECO:0007829|PDB:5JDD""; STRAND 3022..3027; /evidence=""ECO:0007829|PDB:5JDD""; STRAND 3036..3042; /evidence=""ECO:0007829|PDB:5JDD""; STRAND 3045..3053; /evidence=""ECO:0007829|PDB:5JDD""; STRAND 3504..3507; /evidence=""ECO:0007829|PDB:8OVU""; STRAND 3512..3515; /evidence=""ECO:0007829|PDB:8OVU""; STRAND 3520..3527; /evidence=""ECO:0007829|PDB:8OVU""; STRAND 3533..3538; /evidence=""ECO:0007829|PDB:8OVU""; STRAND 3547..3554; /evidence=""ECO:0007829|PDB:8OVU""; STRAND 3557..3562; /evidence=""ECO:0007829|PDB:8OVU""; STRAND 3571..3579; /evidence=""ECO:0007829|PDB:8OVU""; STRAND 3582..3593; /evidence=""ECO:0007829|PDB:8OVU""; STRAND 9582..9587; /evidence=""ECO:0007829|PDB:5JOE""; STRAND 9592..9595; /evidence=""ECO:0007829|PDB:5JOE""; STRAND 9600..9608; /evidence=""ECO:0007829|PDB:5JOE""; STRAND 9616..9619; /evidence=""ECO:0007829|PDB:5JOE""; STRAND 9628..9635; /evidence=""ECO:0007829|PDB:5JOE""; STRAND 9638..9643; /evidence=""ECO:0007829|PDB:5JOE""; STRAND 9652..9658; /evidence=""ECO:0007829|PDB:5JOE""; STRAND 9661..9670; /evidence=""ECO:0007829|PDB:5JOE""; STRAND 9674..9676; /evidence=""ECO:0007829|PDB:7AHS""; STRAND 9681..9684; /evidence=""ECO:0007829|PDB:7AHS""; STRAND 9689..9697; /evidence=""ECO:0007829|PDB:7AHS""; STRAND 9703..9706; /evidence=""ECO:0007829|PDB:7AHS""; STRAND 9717..9722; /evidence=""ECO:0007829|PDB:7AHS""; STRAND 9725..9732; /evidence=""ECO:0007829|PDB:7AHS""; STRAND 9739..9745; /evidence=""ECO:0007829|PDB:7AHS""; STRAND 9748..9757; /evidence=""ECO:0007829|PDB:7AHS""; STRAND 9763..9765; /evidence=""ECO:0007829|PDB:7AHS""; STRAND 9770..9772; /evidence=""ECO:0007829|PDB:7AHS""; STRAND 9778..9786; /evidence=""ECO:0007829|PDB:7AHS""; STRAND 9790..9795; /evidence=""ECO:0007829|PDB:7AHS""; STRAND 9803..9811; /evidence=""ECO:0007829|PDB:7AHS""; STRAND 9814..9819; /evidence=""ECO:0007829|PDB:7AHS""; STRAND 9828..9835; /evidence=""ECO:0007829|PDB:7AHS""; STRAND 9841..9850; /evidence=""ECO:0007829|PDB:7AHS""; STRAND 12680..12682; /evidence=""ECO:0007829|PDB:1WAA""; STRAND 12687..12690; /evidence=""ECO:0007829|PDB:1WAA""; STRAND 12691..12693; /evidence=""ECO:0007829|PDB:6I0Y""; STRAND 12695..12705; /evidence=""ECO:0007829|PDB:1WAA""; STRAND 12709..12712; /evidence=""ECO:0007829|PDB:1WAA""; STRAND 12719..12722; /evidence=""ECO:0007829|PDB:1TIU""; STRAND 12723..12728; /evidence=""ECO:0007829|PDB:1WAA""; STRAND 12731..12736; /evidence=""ECO:0007829|PDB:1WAA""; STRAND 12745..12751; /evidence=""ECO:0007829|PDB:1WAA""; STRAND 12754..12763; /evidence=""ECO:0007829|PDB:1WAA""; STRAND 14223..14228; /evidence=""ECO:0007829|PDB:4O00""; STRAND 14232..14240; /evidence=""ECO:0007829|PDB:4O00""; STRAND 14252..14259; /evidence=""ECO:0007829|PDB:4O00""; STRAND 14275..14281; /evidence=""ECO:0007829|PDB:4O00""; STRAND 14288..14296; /evidence=""ECO:0007829|PDB:4O00""; STRAND 14308..14314; /evidence=""ECO:0007829|PDB:4O00""; STRAND 14319..14322; /evidence=""ECO:0007829|PDB:8BXR""; STRAND 14331..14334; /evidence=""ECO:0007829|PDB:8BXR""; STRAND 14339..14349; /evidence=""ECO:0007829|PDB:8BXR""; STRAND 14352..14357; /evidence=""ECO:0007829|PDB:8BXR""; STRAND 14368..14372; /evidence=""ECO:0007829|PDB:8BXR""; STRAND 14374..14381; /evidence=""ECO:0007829|PDB:8BXR""; STRAND 14390..14397; /evidence=""ECO:0007829|PDB:8BXR""; STRAND 14402..14412; /evidence=""ECO:0007829|PDB:8BXR""; STRAND 14419..14424; /evidence=""ECO:0007829|PDB:8BW6""; STRAND 14431..14436; /evidence=""ECO:0007829|PDB:8BW6""; STRAND 14446..14455; /evidence=""ECO:0007829|PDB:8BW6""; STRAND 14462..14468; /evidence=""ECO:0007829|PDB:8BW6""; STRAND 14470..14475; /evidence=""ECO:0007829|PDB:8BW6""; STRAND 14484..14492; /evidence=""ECO:0007829|PDB:8BW6""; STRAND 14506..14509; /evidence=""ECO:0007829|PDB:8BXR""; STRAND 14522..14524; /evidence=""ECO:0007829|PDB:8BVO""; STRAND 14528..14534; /evidence=""ECO:0007829|PDB:8BVO""; STRAND 14549..14555; /evidence=""ECO:0007829|PDB:8BVO""; STRAND 14568..14576; /evidence=""ECO:0007829|PDB:8BVO""; STRAND 14584..14592; /evidence=""ECO:0007829|PDB:8BVO""; STRAND 15216..15224; /evidence=""ECO:0007829|PDB:8OS3""; STRAND 15227..15233; /evidence=""ECO:0007829|PDB:8OS3""; STRAND 15245..15252; /evidence=""ECO:0007829|PDB:8OS3""; STRAND 15268..15273; /evidence=""ECO:0007829|PDB:8OS3""; STRAND 15282..15290; /evidence=""ECO:0007829|PDB:8OS3""; STRAND 15305..15307; /evidence=""ECO:0007829|PDB:8OS3""; STRAND 16533..16538; /evidence=""ECO:0007829|PDB:8OMW""; STRAND 16541..16546; /evidence=""ECO:0007829|PDB:8OMW""; STRAND 16559..16566; /evidence=""ECO:0007829|PDB:8OMW""; STRAND 16585..16592; /evidence=""ECO:0007829|PDB:8OMW""; STRAND 16600..16609; /evidence=""ECO:0007829|PDB:8OMW""; STRAND 16623..16626; /evidence=""ECO:0007829|PDB:8OMW""; STRAND 20520..20528; /evidence=""ECO:0007829|PDB:8OSD""; STRAND 20531..20537; /evidence=""ECO:0007829|PDB:8OSD""; STRAND 20549..20556; /evidence=""ECO:0007829|PDB:8OSD""; STRAND 20573..20580; /evidence=""ECO:0007829|PDB:8OSD""; STRAND 20587..20594; /evidence=""ECO:0007829|PDB:8OSD""; STRAND 21506..21509; /evidence=""ECO:0007829|PDB:8ORL""; STRAND 21515..21518; /evidence=""ECO:0007829|PDB:8ORL""; STRAND 21532..21539; /evidence=""ECO:0007829|PDB:8ORL""; STRAND 21546..21551; /evidence=""ECO:0007829|PDB:8ORL""; STRAND 21553..21560; /evidence=""ECO:0007829|PDB:8ORL""; STRAND 21568..21577; /evidence=""ECO:0007829|PDB:8ORL""; STRAND 22291..22296; /evidence=""ECO:0007829|PDB:1BPV""; STRAND 22299..22303; /evidence=""ECO:0007829|PDB:1BPV""; STRAND 22319..22324; /evidence=""ECO:0007829|PDB:1BPV""; STRAND 22340..22345; /evidence=""ECO:0007829|PDB:1BPV""; STRAND 22354..22361; /evidence=""ECO:0007829|PDB:1BPV""; STRAND 22367..22377; /evidence=""ECO:0007829|PDB:1BPV""; STRAND 22883..22890; /evidence=""ECO:0007829|PDB:3LPW""; STRAND 22895..22900; /evidence=""ECO:0007829|PDB:3LPW""; STRAND 22912..22919; /evidence=""ECO:0007829|PDB:3LPW""; STRAND 22926..22932; /evidence=""ECO:0007829|PDB:3LPW""; STRAND 22934..22939; /evidence=""ECO:0007829|PDB:3LPW""; STRAND 22947..22956; /evidence=""ECO:0007829|PDB:3LPW""; STRAND 22970..22972; /evidence=""ECO:0007829|PDB:3LPW""; STRAND 22982..22987; /evidence=""ECO:0007829|PDB:3LPW""; STRAND 22992..22996; /evidence=""ECO:0007829|PDB:3LPW""; STRAND 23009..23016; /evidence=""ECO:0007829|PDB:3LPW""; STRAND 23023..23035; /evidence=""ECO:0007829|PDB:3LPW""; STRAND 23043..23052; /evidence=""ECO:0007829|PDB:3LPW""; STRAND 23568..23575; /evidence=""ECO:0007829|PDB:8BNQ""; STRAND 23581..23586; /evidence=""ECO:0007829|PDB:8BNQ""; STRAND 23596..23605; /evidence=""ECO:0007829|PDB:8BNQ""; STRAND 23612..23618; /evidence=""ECO:0007829|PDB:8BNQ""; STRAND 23620..23625; /evidence=""ECO:0007829|PDB:8BNQ""; STRAND 23633..23642; /evidence=""ECO:0007829|PDB:8BNQ""; STRAND 23671..23676; /evidence=""ECO:0007829|PDB:8BNQ""; STRAND 23679..23683; /evidence=""ECO:0007829|PDB:8BNQ""; STRAND 23697..23704; /evidence=""ECO:0007829|PDB:8BNQ""; STRAND 23711..23716; /evidence=""ECO:0007829|PDB:8BNQ""; STRAND 23720..23725; /evidence=""ECO:0007829|PDB:8BNQ""; STRAND 23733..23742; /evidence=""ECO:0007829|PDB:8BNQ""; STRAND 23769..23776; /evidence=""ECO:0007829|PDB:8BNQ""; STRAND 23781..23786; /evidence=""ECO:0007829|PDB:8BNQ""; STRAND 23798..23805; /evidence=""ECO:0007829|PDB:8BNQ""; STRAND 23811..23815; /evidence=""ECO:0007829|PDB:8BNQ""; STRAND 23820..23827; /evidence=""ECO:0007829|PDB:8BNQ""; STRAND 23835..23843; /evidence=""ECO:0007829|PDB:8BNQ""; STRAND 25439..25443; /evidence=""ECO:0007829|PDB:8OT5""; STRAND 25448..25451; /evidence=""ECO:0007829|PDB:8OT5""; STRAND 25465..25472; /evidence=""ECO:0007829|PDB:8OT5""; STRAND 25479..25481; /evidence=""ECO:0007829|PDB:8OT5""; STRAND 25486..25493; /evidence=""ECO:0007829|PDB:8OT5""; STRAND 25501..25509; /evidence=""ECO:0007829|PDB:8OT5""; STRAND 25514..25517; /evidence=""ECO:0007829|PDB:8OT5""; STRAND 26130..26137; /evidence=""ECO:0007829|PDB:8OTY""; STRAND 26142..26147; /evidence=""ECO:0007829|PDB:8OTY""; STRAND 26157..26166; /evidence=""ECO:0007829|PDB:8OTY""; STRAND 26173..26179; /evidence=""ECO:0007829|PDB:8OTY""; STRAND 26181..26186; /evidence=""ECO:0007829|PDB:8OTY""; STRAND 26194..26203; /evidence=""ECO:0007829|PDB:8OTY""; STRAND 26206..26212; /evidence=""ECO:0007829|PDB:8OTY""; STRAND 31458..31464; /evidence=""ECO:0007829|PDB:3LCY""; STRAND 31469..31472; /evidence=""ECO:0007829|PDB:3LCY""; STRAND 31475..31487; /evidence=""ECO:0007829|PDB:3LCY""; STRAND 31490..31495; /evidence=""ECO:0007829|PDB:3LCY""; STRAND 31498..31500; /evidence=""ECO:0007829|PDB:3LCY""; STRAND 31504..31520; /evidence=""ECO:0007829|PDB:3LCY""; STRAND 31528..31535; /evidence=""ECO:0007829|PDB:3LCY""; STRAND 31540..31555; /evidence=""ECO:0007829|PDB:3LCY""; STRAND 31563..31568; /evidence=""ECO:0007829|PDB:3LCY""; STRAND 31573..31583; /evidence=""ECO:0007829|PDB:3LCY""; STRAND 31586..31591; /evidence=""ECO:0007829|PDB:3LCY""; STRAND 31600..31606; /evidence=""ECO:0007829|PDB:3LCY""; STRAND 31608..31617; /evidence=""ECO:0007829|PDB:3LCY""; STRAND 31625..31632; /evidence=""ECO:0007829|PDB:3LCY""; STRAND 31637..31647; /evidence=""ECO:0007829|PDB:3LCY""; STRAND 31856..31859; /evidence=""ECO:0007829|PDB:2J8H""; STRAND 31864..31867; /evidence=""ECO:0007829|PDB:2J8H""; STRAND 31872..31879; /evidence=""ECO:0007829|PDB:2J8H""; STRAND 31885..31890; /evidence=""ECO:0007829|PDB:2J8H""; STRAND 31893..31895; /evidence=""ECO:0007829|PDB:2J8O""; STRAND 31899..31907; /evidence=""ECO:0007829|PDB:2J8H""; STRAND 31911..31916; /evidence=""ECO:0007829|PDB:2J8H""; STRAND 31925..31933; /evidence=""ECO:0007829|PDB:2J8H""; STRAND 31936..31952; /evidence=""ECO:0007829|PDB:2J8H""; STRAND 31961..31967; /evidence=""ECO:0007829|PDB:2J8H""; STRAND 31973..31982; /evidence=""ECO:0007829|PDB:2J8H""; STRAND 31985..31992; /evidence=""ECO:0007829|PDB:2J8H""; STRAND 31997..32000; /evidence=""ECO:0007829|PDB:2J8H""; STRAND 32002..32005; /evidence=""ECO:0007829|PDB:2J8H""; STRAND 32007..32013; /evidence=""ECO:0007829|PDB:2J8H""; STRAND 32024..32032; /evidence=""ECO:0007829|PDB:2J8H""; STRAND 32035..32046; /evidence=""ECO:0007829|PDB:2J8H""; STRAND 32053..32061; /evidence=""ECO:0007829|PDB:6YGN""; STRAND 32063..32070; /evidence=""ECO:0007829|PDB:6YGN""; STRAND 32076..32078; /evidence=""ECO:0007829|PDB:2NZI""; STRAND 32082..32089; /evidence=""ECO:0007829|PDB:6YGN""; STRAND 32095..32111; /evidence=""ECO:0007829|PDB:6YGN""; STRAND 32117..32125; /evidence=""ECO:0007829|PDB:6YGN""; STRAND 32167..32170; /evidence=""ECO:0007829|PDB:6YGN""; STRAND 32178..32186; /evidence=""ECO:0007829|PDB:1TKI""; STRAND 32188..32197; /evidence=""ECO:0007829|PDB:1TKI""; STRAND 32202..32209; /evidence=""ECO:0007829|PDB:1TKI""; STRAND 32237..32243; /evidence=""ECO:0007829|PDB:1TKI""; STRAND 32246..32251; /evidence=""ECO:0007829|PDB:1TKI""; STRAND 32265..32267; /evidence=""ECO:0007829|PDB:1TKI""; STRAND 32304..32310; /evidence=""ECO:0007829|PDB:1TKI""; STRAND 32314..32316; /evidence=""ECO:0007829|PDB:1TKI""; STRAND 32330..32336; /evidence=""ECO:0007829|PDB:1TKI""; STRAND 32474..32476; /evidence=""ECO:0007829|PDB:1TKI""; STRAND 32483..32489; /evidence=""ECO:0007829|PDB:1TKI""; STRAND 32504..32506; /evidence=""ECO:0007829|PDB:2BK8""; STRAND 32512..32520; /evidence=""ECO:0007829|PDB:2BK8""; STRAND 32526..32531; /evidence=""ECO:0007829|PDB:2BK8""; STRAND 32538..32547; /evidence=""ECO:0007829|PDB:2BK8""; STRAND 32550..32555; /evidence=""ECO:0007829|PDB:2BK8""; STRAND 32564..32571; /evidence=""ECO:0007829|PDB:2BK8""; STRAND 32576..32585; /evidence=""ECO:0007829|PDB:2BK8""; STRAND 32720..32726; /evidence=""ECO:0007829|PDB:6HCI""; STRAND 32731..32734; /evidence=""ECO:0007829|PDB:6HCI""; STRAND 32739..32749; /evidence=""ECO:0007829|PDB:6HCI""; STRAND 32752..32757; /evidence=""ECO:0007829|PDB:6HCI""; STRAND 32768..32773; /evidence=""ECO:0007829|PDB:6HCI""; STRAND 32777..32784; /evidence=""ECO:0007829|PDB:6HCI""; STRAND 32791..32799; /evidence=""ECO:0007829|PDB:6HCI""; STRAND 32802..32813; /evidence=""ECO:0007829|PDB:6HCI""; STRAND 33299..33305; /evidence=""ECO:0007829|PDB:6H4L""; STRAND 33310..33313; /evidence=""ECO:0007829|PDB:6H4L""; STRAND 33318..33328; /evidence=""ECO:0007829|PDB:6H4L""; STRAND 33331..33336; /evidence=""ECO:0007829|PDB:6H4L""; STRAND 33345..33352; /evidence=""ECO:0007829|PDB:6H4L""; STRAND 33355..33360; /evidence=""ECO:0007829|PDB:6H4L""; STRAND 33369..33377; /evidence=""ECO:0007829|PDB:6H4L""; STRAND 33380..33391; /evidence=""ECO:0007829|PDB:6H4L""; STRAND 33489..33492; /evidence=""ECO:0007829|PDB:1NCT""; STRAND 33497..33503; /evidence=""ECO:0007829|PDB:1NCT""; STRAND 33509..33512; /evidence=""ECO:0007829|PDB:1NCT""; STRAND 33514..33516; /evidence=""ECO:0007829|PDB:1TNM""; STRAND 33523..33526; /evidence=""ECO:0007829|PDB:1NCT""; STRAND 33532..33538; /evidence=""ECO:0007829|PDB:1NCT""; STRAND 33540..33547; /evidence=""ECO:0007829|PDB:1NCT""; STRAND 33556..33560; /evidence=""ECO:0007829|PDB:1NCT""; STRAND 33571..33577; /evidence=""ECO:0007829|PDB:1NCT""; STRAND 33777..33783; /evidence=""ECO:0007829|PDB:3PUC""; STRAND 33788..33794; /evidence=""ECO:0007829|PDB:3PUC""; STRAND 33796..33806; /evidence=""ECO:0007829|PDB:3PUC""; STRAND 33809..33814; /evidence=""ECO:0007829|PDB:3PUC""; STRAND 33821..33830; /evidence=""ECO:0007829|PDB:3PUC""; STRAND 33833..33838; /evidence=""ECO:0007829|PDB:3PUC""; STRAND 33847..33855; /evidence=""ECO:0007829|PDB:3PUC""; STRAND 33858..33869; /evidence=""ECO:0007829|PDB:3PUC""; STRAND 34060..34071; /evidence=""ECO:0007829|PDB:4UOW""; STRAND 34078..34088; /evidence=""ECO:0007829|PDB:4UOW""; STRAND 34091..34096; /evidence=""ECO:0007829|PDB:4UOW""; STRAND 34107..34112; /evidence=""ECO:0007829|PDB:4UOW""; STRAND 34115..34122; /evidence=""ECO:0007829|PDB:4UOW""; STRAND 34129..34136; /evidence=""ECO:0007829|PDB:4UOW""; STRAND 34138..34148; /evidence=""ECO:0007829|PDB:4UOW""; STRAND 34254..34258; /evidence=""ECO:0007829|PDB:3KNB""; STRAND 34263..34268; /evidence=""ECO:0007829|PDB:3KNB""; STRAND 34271..34283; /evidence=""ECO:0007829|PDB:3KNB""; STRAND 34286..34291; /evidence=""ECO:0007829|PDB:3KNB""; STRAND 34304..34308; /evidence=""ECO:0007829|PDB:3KNB""; STRAND 34310..34319; /evidence=""ECO:0007829|PDB:3KNB""; STRAND 34326..34334; /evidence=""ECO:0007829|PDB:3KNB""; STRAND 34337..34348; /evidence=""ECO:0007829|PDB:3KNB""","HELIX 72..74; /evidence=""ECO:0007829|PDB:2A38""; HELIX 168..170; /evidence=""ECO:0007829|PDB:2A38""; HELIX 2143..2145; /evidence=""ECO:0007829|PDB:1G1C""; HELIX 2858..2860; /evidence=""ECO:0007829|PDB:5JDD""; HELIX 2945..2947; /evidence=""ECO:0007829|PDB:5JDD""; HELIX 3032..3034; /evidence=""ECO:0007829|PDB:5JDD""; HELIX 3567..3569; /evidence=""ECO:0007829|PDB:8OVU""; HELIX 9506..9510; /evidence=""ECO:0007829|PDB:7NIP""; HELIX 9518..9525; /evidence=""ECO:0007829|PDB:7NIP""; HELIX 9530..9543; /evidence=""ECO:0007829|PDB:7NIP""; HELIX 9648..9650; /evidence=""ECO:0007829|PDB:5JOE""; HELIX 9735..9737; /evidence=""ECO:0007829|PDB:7AHS""; HELIX 9824..9826; /evidence=""ECO:0007829|PDB:7AHS""; HELIX 12741..12743; /evidence=""ECO:0007829|PDB:1WAA""; HELIX 14325..14327; /evidence=""ECO:0007829|PDB:8BXR""; HELIX 14386..14388; /evidence=""ECO:0007829|PDB:8BXR""; HELIX 20568..20570; /evidence=""ECO:0007829|PDB:8OSD""; HELIX 22381..22384; /evidence=""ECO:0007829|PDB:1BPV""; HELIX 31524..31526; /evidence=""ECO:0007829|PDB:3LCY""; HELIX 31620..31623; /evidence=""ECO:0007829|PDB:3LCY""; HELIX 31921..31923; /evidence=""ECO:0007829|PDB:2J8H""; HELIX 31956..31959; /evidence=""ECO:0007829|PDB:2NZI""; HELIX 32020..32022; /evidence=""ECO:0007829|PDB:2J8H""; HELIX 32142..32154; /evidence=""ECO:0007829|PDB:6YGN""; HELIX 32214..32228; /evidence=""ECO:0007829|PDB:1TKI""; HELIX 32259..32263; /evidence=""ECO:0007829|PDB:1TKI""; HELIX 32272..32291; /evidence=""ECO:0007829|PDB:1TKI""; HELIX 32301..32303; /evidence=""ECO:0007829|PDB:1TKI""; HELIX 32338..32340; /evidence=""ECO:0007829|PDB:1TKI""; HELIX 32343..32346; /evidence=""ECO:0007829|PDB:1TKI""; HELIX 32353..32369; /evidence=""ECO:0007829|PDB:1TKI""; HELIX 32379..32388; /evidence=""ECO:0007829|PDB:1TKI""; HELIX 32395..32398; /evidence=""ECO:0007829|PDB:1TKI""; HELIX 32403..32410; /evidence=""ECO:0007829|PDB:1TKI""; HELIX 32417..32419; /evidence=""ECO:0007829|PDB:1TKI""; HELIX 32423..32428; /evidence=""ECO:0007829|PDB:1TKI""; HELIX 32430..32433; /evidence=""ECO:0007829|PDB:1TKI""; HELIX 32436..32438; /evidence=""ECO:0007829|PDB:1TKI""; HELIX 32447..32457; /evidence=""ECO:0007829|PDB:1TKI""; HELIX 32466..32472; /evidence=""ECO:0007829|PDB:1TKI""; HELIX 32560..32562; /evidence=""ECO:0007829|PDB:2BK8""; HELIX 32787..32789; /evidence=""ECO:0007829|PDB:6HCI""; HELIX 33365..33367; /evidence=""ECO:0007829|PDB:6H4L""; HELIX 33843..33845; /evidence=""ECO:0007829|PDB:3PUC""; HELIX 34125..34127; /evidence=""ECO:0007829|PDB:4UOW""; HELIX 34300..34302; /evidence=""ECO:0007829|PDB:3KNB""; HELIX 34322..34324; /evidence=""ECO:0007829|PDB:3KNB""","TURN 48..50; /evidence=""ECO:0007829|PDB:2A38""; TURN 1891..1893; /evidence=""ECO:0007829|PDB:6DL4""; TURN 23806..23808; /evidence=""ECO:0007829|PDB:8BNQ""; TURN 31908..31910; /evidence=""ECO:0007829|PDB:2J8H""; TURN 32175..32177; /evidence=""ECO:0007829|PDB:1TKI""; TURN 32198..32201; /evidence=""ECO:0007829|PDB:1TKI""; TURN 32586..32588; /evidence=""ECO:0007829|PDB:2BK8""; TURN 32765..32767; /evidence=""ECO:0007829|PDB:6HCI""; TURN 32774..32776; /evidence=""ECO:0007829|PDB:6HCI""; TURN 33294..33297; /evidence=""ECO:0007829|PDB:3QP3""; TURN 34104..34106; /evidence=""ECO:0007829|PDB:4UOW""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,TTN,Titin (EC 2.7.11.1) (Connectin) (Rhabdomyosarcoma antigen MU-RMS-40.14),Homo sapiens (Human),34350.0,3816030.0,MTTQAPTFTQPLQSVVVLEGSTATFEAHISGFPVPEVSWFRDGQVISTSTLPGVQISFSDGRAKLTIPAVTKANSGRYSLKATNGSGQATSTAELLVKAETAPPNFVQRLQSMTVRQGSQVRLQVRVTGIPTPVVKFYRDGAEIQSSLDFQISQEGDLYSLLIAEAYPEDSGTYSVNATNSVGRATSTAELLVQGEEEVPAKKTKTIVSTAQISESRQTRIEKKIEAHFDARSIATVEMVIDGAAGQQLPHKTPPRIPPKPKSRSPTPPSIAAKAQLARQQSPSPIRHSPSPVRHVRAPTPSPVRSVSPAARISTSPIRSVRSPLLMRKTQASTVATGPEVPPPWKQEGYVASSSEAEMRETTLTTSTQIRTEERWEGRYGVQEQVTISGAAGAAASVSASASYAAEAVATGAKEVKQDADKSAAVATVVAAVDMARVREPVISAVEQTAQRTTTTAVHIQPAQEQVRKEAEKTAVTKVVVAADKAKEQELKSRTKEVITTKQEQMHVTHEQIRKETEKTFVPKVVISAAKAKEQETRISEEITKKQKQVTQEAIRQETEITAASMVVVATAKSTKLETVPGAQEETTTQQDQMHLSYEKIMKETRKTVVPKVIVATPKVKEQDLVSRGREGITTKREQVQITQEKMRKEAEKTALSTIAVATAKAKEQETILRTRETMATRQEQIQVTHGKVDVGKKAEAVATVVAAVDQARVREPREPGHLEESYAQQTTLEYGYKERISAAKVAEPPQRPASEPHVVPKAVKPRVIQAPSETHIKTTDQKGMHISSQIKKTTDLTTERLVHVDKRPRTASPHFTVSKISVPKTEHGYEASIAGSAIATLQKELSATSSAQKITKSVKAPTVKPSETRVRAEPTPLPQFPFADTPDTYKSEAGVEVKKEVGVSITGTTVREERFEVLHGREAKVTETARVPAPVEIPVTPPTLVSGLKNVTVIEGESVTLECHISGYPSPTVTWYREDYQIESSIDFQITFQSGIARLMIREAFAEDSGRFTCSAVNEAGTVSTSCYLAVQVSEEFEKETTAVTEKFTTEEKRFVESRDVVMTDTSLTEEQAGPGEPAAPYFITKPVVQKLVEGGSVVFGCQVGGNPKPHVYWKKSGVPLTTGYRYKVSYNKQTGECKLVISMTFADDAGEYTIVVRNKHGETSASASLLEEADYELLMKSQQEMLYQTQVTAFVQEPKVGETAPGFVYSEYEKEYEKEQALIRKKMAKDTVVVRTYVEDQEFHISSFEERLIKEIEYRIIKTTLEELLEEDGEEKMAVDISESEAVESGFDSRIKNYRILEGMGVTFHCKMSGYPLPKIAWYKDGKRIKHGERYQMDFLQDGRASLRIPVVLPEDEGIYTAFASNIKGNAICSGKLYVEPAAPLGAPTYIPTLEPVSRIRSLSPRSVSRSPIRMSPARMSPARMSPARMSPARMSPGRRLEETDESQLERLYKPVFVLKPVSFKCLEGQTARFDLKVVGRPMPETFWFHDGQQIVNDYTHKVVIKEDGTQSLIIVPATPSDSGEWTVVAQNRAGRSSISVILTVEAVEHQVKPMFVEKLKNVNIKEGSRLEMKVRATGNPNPDIVWLKNSDIIVPHKYPKIRIEGTKGEAALKIDSTVSQDSAWYTATAINKAGRDTTRCKVNVEVEFAEPEPERKLIIPRGTYRAKEIAAPELEPLHLRYGQEQWEEGDLYDKEKQQKPFFKKKLTSLRLKRFGPAHFECRLTPIGDPTMVVEWLHDGKPLEAANRLRMINEFGYCSLDYGVAYSRDSGIITCRATNKYGTDHTSATLIVKDEKSLVEESQLPEGRKGLQRIEELERMAHEGALTGVTTDQKEKQKPDIVLYPEPVRVLEGETARFRCRVTGYPQPKVNWYLNGQLIRKSKRFRVRYDGIHYLDIVDCKSYDTGEVKVTAENPEGVIEHKVKLEIQQREDFRSVLRRAPEPRPEFHVHEPGKLQFEVQKVDRPVDTTETKEVVKLKRAERITHEKVPEESEELRSKFKRRTEEGYYEAITAVELKSRKKDESYEELLRKTKDELLHWTKELTEEEKKALAEEGKITIPTFKPDKIELSPSMEAPKIFERIQSQTVGQGSDAHFRVRVVGKPDPECEWYKNGVKIERSDRIYWYWPEDNVCELVIRDVTAEDSASIMVKAINIAGETSSHAFLLVQAKQLITFTQELQDVVAKEKDTMATFECETSEPFVKVKWYKDGMEVHEGDKYRMHSDRKVHFLSILTIDTSDAEDYSCVLVEDENVKTTAKLIVEGAVVEFVKELQDIEVPESYSGELECIVSPENIEGKWYHNDVELKSNGKYTITSRRGRQNLTVKDVTKEDQGEYSFVIDGKKTTCKLKMKPRPIAILQGLSDQKVCEGDIVQLEVKVSLESVEGVWMKDGQEVQPSDRVHIVIDKQSHMLLIEDMTKEDAGNYSFTIPALGLSTSGRVSVYSVDVITPLKDVNVIEGTKAVLECKVSVPDVTSVKWYLNDEQIKPDDRVQAIVKGTKQRLVINRTHASDEGPYKLIVGRVETNCNLSVEKIKIIRGLRDLTCTETQNVVFEVELSHSGIDVLWNFKDKEIKPSSKYKIEAHGKIYKLTVLNMMKDDEGKYTFYAGENMTSGKLTVAGGAISKPLTDQTVAESQEAVFECEVANPDSKGEWLRDGKHLPLTNNIRSESDGHKRRLIIAATKLDDIGEYTYKVATSKTSAKLKVEAVKIKKTLKNLTVTETQDAVFTVELTHPNVKGVQWIKNGVVLESNEKYAISVKGTIYSLRIKNCAIVDESVYGFRLGRLGASARLHVETVKIIKKPKDVTALENATVAFEVSVSHDTVPVKWFHKSVEIKPSDKHRLVSERKVHKLMLQNISPSDAGEYTAVVGQLECKAKLFVETLHITKTMKNIEVPETKTASFECEVSHFNVPSMWLKNGVEIEMSEKFKIVVQGKLHQLIIMNTSTEDSAEYTFVCGNDQVSATLTVTPIMITSMLKDINAEEKDTITFEVTVNYEGISYKWLKNGVEIKSTDKCQMRTKKLTHSLNIRNVHFGDAADYTFVAGKATSTATLYVEARHIEFRKHIKDIKVLEKKRAMFECEVSEPDITVQWMKDDQELQITDRIKIQKEKYVHRLLIPSTRMSDAGKYTVVAGGNVSTAKLFVEGRDVRIRSIKKEVQVIEKQRAVVEFEVNEDDVDAHWYKDGIEINFQVQERHKYVVERRIHRMFISETRQSDAGEYTFVAGRNRSSVTLYVNAPEPPQVLQELQPVTVQSGKPARFCAVISGRPQPKISWYKEEQLLSTGFKCKFLHDGQEYTLLLIEAFPEDAAVYTCEAKNDYGVATTSASLSVEVPEVVSPDQEMPVYPPAIITPLQDTVTSEGQPARFQCRVSGTDLKVSWYSKDKKIKPSRFFRMTQFEDTYQLEIAEAYPEDEGTYTFVASNAVGQVSSTANLSLEAPESILHERIEQEIEMEMKEFSSSFLSAEEEGLHSAELQLSKINETLELLSESPVYPTKFDSEKEGTGPIFIKEVSNADISMGDVATLSVTVIGIPKPKIQWFFNGVLLTPSADYKFVFDGDDHSLIILFTKLEDEGEYTCMASNDYGKTICSAYLKINSKGEGHKDTETESAVAKSLEKLGGPCPPHFLKELKPIRCAQGLPAIFEYTVVGEPAPTVTWFKENKQLCTSVYYTIIHNPNGSGTFIVNDPQREDSGLYICKAENMLGESTCAAELLVLLEDTDMTDTPCKAKSTPEAPEDFPQTPLKGPAVEALDSEQEIATFVKDTILKAALITEENQQLSYEHIAKANELSSQLPLGAQELQSILEQDKLTPESTREFLCINGSIHFQPLKEPSPNLQLQIVQSQKTFSKEGILMPEEPETQAVLSDTEKIFPSAMSIEQINSLTVEPLKTLLAEPEGNYPQSSIEPPMHSYLTSVAEEVLSPKEKTVSDTNREQRVTLQKQEAQSALILSQSLAEGHVESLQSPDVMISQVNYEPLVPSEHSCTEGGKILIESANPLENAGQDSAVRIEEGKSLRFPLALEEKQVLLKEEHSDNVVMPPDQIIESKREPVAIKKVQEVQGRDLLSKESLLSGIPEEQRLNLKIQICRALQAAVASEQPGLFSEWLRNIEKVEVEAVNITQEPRHIMCMYLVTSAKSVTEEVTIIIEDVDPQMANLKMELRDALCAIIYEEIDILTAEGPRIQQGAKTSLQEEMDSFSGSQKVEPITEPEVESKYLISTEEVSYFNVQSRVKYLDATPVTKGVASAVVSDEKQDESLKPSEEKEESSSESGTEEVATVKIQEAEGGLIKEDGPMIHTPLVDTVSEEGDIVHLTTSITNAKEVNWYFENKLVPSDEKFKCLQDQNTYTLVIDKVNTEDHQGEYVCEALNDSGKTATSAKLTVVKRAAPVIKRKIEPLEVALGHLAKFTCEIQSAPNVRFQWFKAGREIYESDKCSIRSSKYISSLEILRTQVVDCGEYTCKASNEYGSVSCTATLTVTEAYPPTFLSRPKSLTTFVGKAAKFICTVTGTPVIETIWQKDGAALSPSPNWRISDAENKHILELSNLTIQDRGVYSCKASNKFGADICQAELIIIDKPHFIKELEPVQSAINKKVHLECQVDEDRKVTVTWSKDGQKLPPGKDYKICFEDKIATLEIPLAKLKDSGTYVCTASNEAGSSSCSATVTVREPPSFVKKVDPSYLMLPGESARLHCKLKGSPVIQVTWFKNNKELSESNTVRMYFVNSEAILDITDVKVEDSGSYSCEAVNDVGSDSCSTEIVIKEPPSFIKTLEPADIVRGTNALLQCEVSGTGPFEISWFKDKKQIRSSKKYRLFSQKSLVCLEIFSFNSADVGEYECVVANEVGKCGCMATHLLKEPPTFVKKVDDLIALGGQTVTLQAAVRGSEPISVTWMKGQEVIREDGKIKMSFSNGVAVLIIPDVQISFGGKYTCLAENEAGSQTSVGELIVKEPAKIIERAELIQVTAGDPATLEYTVAGTPELKPKWYKDGRPLVASKKYRISFKNNVAQLKFYSAELHDSGQYTFEISNEVGSSSCETTFTVLDRDIAPFFTKPLRNVDSVVNGTCRLDCKIAGSLPMRVSWFKDGKEIAASDRYRIAFVEGTASLEIIRVDMNDAGNFTCRATNSVGSKDSSGALIVQEPPSFVTKPGSKDVLPGSAVCLKSTFQGSTPLTIRWFKGNKELVSGGSCYITKEALESSLELYLVKTSDSGTYTCKVSNVAGGVECSANLFVKEPATFVEKLEPSQLLKKGDATQLACKVTGTPPIKITWFANDREIKESSKHRMSFVESTAVLRLTDVGIEDSGEYMCEAQNEAGSDHCSSIVIVKESPYFTKEFKPIEVLKEYDVMLLAEVAGTPPFEITWFKDNTILRSGRKYKTFIQDHLVSLQILKFVAADAGEYQCRVTNEVGSSICSARVTLREPPSFIKKIESTSSLRGGTAAFQATLKGSLPITVTWLKDSDEITEDDNIRMTFENNVASLYLSGIEVKHDGKYVCQAKNDAGIQRCSALLSVKEPATITEEAVSIDVTQGDPATLQVKFSGTKEITAKWFKDGQELTLGSKYKISVTDTVSILKIISTEKKDSGEYTFEVQNDVGRSSCKARINVLDLIIPPSFTKKLKKMDSIKGSFIDLECIVAGSHPISIQWFKDDQEISASEKYKFSFHDNTAFLEISQLEGTDSGTYTCSATNKAGHNQCSGHLTVKEPPYFVEKPQSQDVNPNTRVQLKALVGGTAPMTIKWFKDNKELHSGAARSVWKDDTSTSLELFAAKATDSGTYICQLSNDVGTATSKATLFVKEPPQFIKKPSPVLVLRNGQSTTFECQITGTPKIRVSWYLDGNEITAIQKHGISFIDGLATFQISGARVENSGTYVCEARNDAGTASCSIELKVKEPPTFIRELKPVEVVKYSDVELECEVTGTPPFEVTWLKNNREIRSSKKYTLTDRVSVFNLHITKCDPSDTGEYQCIVSNEGGSCSCSTRVALKEPPSFIKKIENTTTVLKSSATFQSTVAGSPPISITWLKDDQILDEDDNVYISFVDSVATLQIRSVDNGHSGRYTCQAKNESGVERCYAFLLVQEPAQIVEKAKSVDVTEKDPMTLECVVAGTPELKVKWLKDGKQIVPSRYFSMSFENNVASFRIQSVMKQDSGQYTFKVENDFGSSSCDAYLRVLDQNIPPSFTKKLTKMDKVLGSSIHMECKVSGSLPISAQWFKDGKEISTSAKYRLVCHERSVSLEVNNLELEDTANYTCKVSNVAGDDACSGILTVKEPPSFLVKPGRQQAIPDSTVEFKAILKGTPPFKIKWFKDDVELVSGPKCFIGLEGSTSFLNLYSVDASKTGQYTCHVTNDVGSDSCTTMLLVTEPPKFVKKLEASKIVKAGDSSRLECKIAGSPEIRVVWFRNEHELPASDKYRMTFIDSVAVIQMNNLSTEDSGDFICEAQNPAGSTSCSTKVIVKEPPVFSSFPPIVETLKNAEVSLECELSGTPPFEVVWYKDKRQLRSSKKYKIASKNFHTSIHILNVDTSDIGEYHCKAQNEVGSDTCVCTVKLKEPPRFVSKLNSLTVVAGEPAELQASIEGAQPIFVQWLKEKEEVIRESENIRITFVENVATLQFAKAEPANAGKYICQIKNDGGMRENMATLMVLEPAVIVEKAGPMTVTVGETCTLECKVAGTPELSVEWYKDGKLLTSSQKHKFSFYNKISSLRILSVERQDAGTYTFQVQNNVGKSSCTAVVDVSDRAVPPSFTRRLKNTGGVLGASCILECKVAGSSPISVAWFHEKTKIVSGAKYQTTFSDNVCTLQLNSLDSSDMGNYTCVAANVAGSDECRAVLTVQEPPSFVKEPEPLEVLPGKNVTFTSVIRGTPPFKVNWFRGARELVKGDRCNIYFEDTVAELELFNIDISQSGEYTCVVSNNAGQASCTTRLFVKEPAAFLKRLSDHSVEPGKSIILESTYTGTLPISVTWKKDGFNITTSEKCNIVTTEKTCILEILNSTKRDAGQYSCEIENEAGRDVCGALVSTLEPPYFVTELEPLEAAVGDSVSLQCQVAGTPEITVSWYKGDTKLRPTPEYRTYFTNNVATLVFNKVNINDSGEYTCKAENSIGTASSKTVFRIQERQLPPSFARQLKDIEQTVGLPVTLTCRLNGSAPIQVCWYRDGVLLRDDENLQTSFVDNVATLKILQTDLSHSGQYSCSASNPLGTASSSARLTAREPKKSPFFDIKPVSIDVIAGESADFECHVTGAQPMRITWSKDNKEIRPGGNYTITCVGNTPHLRILKVGKGDSGQYTCQATNDVGKDMCSAQLSVKEPPKFVKKLEASKVAKQGESIQLECKISGSPEIKVSWFRNDSELHESWKYNMSFINSVALLTINEASAEDSGDYICEAHNGVGDASCSTALTVKAPPVFTQKPSPVGALKGSDVILQCEISGTPPFEVVWVKDRKQVRNSKKFKITSKHFDTSLHILNLEASDVGEYHCKATNEVGSDTCSCSVKFKEPPRFVKKLSDTSTLIGDAVELRAIVEGFQPISVVWLKDRGEVIRESENTRISFIDNIATLQLGSPEASNSGKYICQIKNDAGMRECSAVLTVLEPARIIEKPEPMTVTTGNPFALECVVTGTPELSAKWFKDGRELSADSKHHITFINKVASLKIPCAEMSDKGLYSFEVKNSVGKSNCTVSVHVSDRIVPPSFIRKLKDVNAILGASVVLECRVSGSAPISVGWFQDGNEIVSGPKCQSSFSENVCTLNLSLLEPSDTGIYTCVAANVAGSDECSAVLTVQEPPSFEQTPDSVEVLPGMSLTFTSVIRGTPPFKVKWFKGSRELVPGESCNISLEDFVTELELFEVQPLESGDYSCLVTNDAGSASCTTHLFVKEPATFVKRLADFSVETGSPIVLEATYTGTPPISVSWIKDEYLISQSERCSITMTEKSTILEILESTIEDYAQYSCLIENEAGQDICEALVSVLEPPYFIEPLEHVEAVIGEPATLQCKVDGTPEIRISWYKEHTKLRSAPAYKMQFKNNVASLVINKVDHSDVGEYSCKADNSVGAVASSAVLVIKARKLPPFFARKLKDVHETLGFPVAFECRINGSEPLQVSWYKDGVLLKDDANLQTSFVHNVATLQILQTDQSHIGQYNCSASNPLGTASSSAKLILSEHEVPPFFDLKPVSVDLALGESGTFKCHVTGTAPIKITWAKDNREIRPGGNYKMTLVENTATLTVLKVGKGDAGQYTCYASNIAGKDSCSAQLGVQEPPRFIKKLEPSRIVKQDEFTRYECKIGGSPEIKVLWYKDETEIQESSKFRMSFVDSVAVLEMHNLSVEDSGDYTCEAHNAAGSASSSTSLKVKEPPIFRKKPHPIETLKGADVHLECELQGTPPFHVSWYKDKRELRSGKKYKIMSENFLTSIHILNVDAADIGEYQCKATNDVGSDTCVGSIALKAPPRFVKKLSDISTVVGKEVQLQTTIEGAEPISVVWFKDKGEIVRESDNIWISYSENIATLQFSRVEPANAGKYTCQIKNDAGMQECFATLSVLEPATIVEKPESIKVTTGDTCTLECTVAGTPELSTKWFKDGKELTSDNKYKISFFNKVSGLKIINVAPSDSGVYSFEVQNPVGKDSCTASLQVSDRTVPPSFTRKLKETNGLSGSSVVMECKVYGSPPISVSWFHEGNEISSGRKYQTTLTDNTCALTVNMLEESDSGDYTCIATNMAGSDECSAPLTVREPPSFVQKPDPMDVLTGTNVTFTSIVKGTPPFSVSWFKGSSELVPGDRCNVSLEDSVAELELFDVDTSQSGEYTCIVSNEAGKASCTTHLYIKAPAKFVKRLNDYSIEKGKPLILEGTFTGTPPISVTWKKNGINVTPSQRCNITTTEKSAILEIPSSTVEDAGQYNCYIENASGKDSCSAQILILEPPYFVKQLEPVKVSVGDSASLQCQLAGTPEIGVSWYKGDTKLRPTTTYKMHFRNNVATLVFNQVDINDSGEYICKAENSVGEVSASTFLTVQEQKLPPSFSRQLRDVQETVGLPVVFDCAISGSEPISVSWYKDGKPLKDSPNVQTSFLDNTATLNIFKTDRSLAGQYSCTATNPIGSASSSARLILTEGKNPPFFDIRLAPVDAVVGESADFECHVTGTQPIKVSWAKDSREIRSGGKYQISYLENSAHLTVLKVDKGDSGQYTCYAVNEVGKDSCTAQLNIKERLIPPSFTKRLSETVEETEGNSFKLEGRVAGSQPITVAWYKNNIEIQPTSNCEITFKNNTLVLQVRKAGMNDAGLYTCKVSNDAGSALCTSSIVIKEPKKPPVFDQHLTPVTVSEGEYVQLSCHVQGSEPIRIQWLKAGREIKPSDRCSFSFASGTAVLELRDVAKADSGDYVCKASNVAGSDTTKSKVTIKDKPAVAPATKKAAVDGRLFFVSEPQSIRVVEKTTATFIAKVGGDPIPNVKWTKGKWRQLNQGGRVFIHQKGDEAKLEIRDTTKTDSGLYRCVAFNEHGEIESNVNLQVDERKKQEKIEGDLRAMLKKTPILKKGAGEEEEIDIMELLKNVDPKEYEKYARMYGITDFRGLLQAFELLKQSQEEETHRLEIEEIERSERDEKEFEELVSFIQQRLSQTEPVTLIKDIENQTVLKDNDAVFEIDIKINYPEIKLSWYKGTEKLEPSDKFEISIDGDRHTLRVKNCQLKDQGNYRLVCGPHIASAKLTVIEPAWERHLQDVTLKEGQTCTMTCQFSVPNVKSEWFRNGRILKPQGRHKTEVEHKVHKLTIADVRAEDQGQYTCKYEDLETSAELRIEAEPIQFTKRIQNIVVSEHQSATFECEVSFDDAIVTWYKGPTELTESQKYNFRNDGRCHYMTIHNVTPDDEGVYSVIARLEPRGEARSTAELYLTTKEIKLELKPPDIPDSRVPIPTMPIRAVPPEEIPPVVAPPIPLLLPTPEEKKPPPKRIEVTKKAVKKDAKKVVAKPKEMTPREEIVKKPPPPTTLIPAKAPEIIDVSSKAEEVKIMTITRKKEVQKEKEAVYEKKQAVHKEKRVFIESFEEPYDELEVEPYTEPFEQPYYEEPDEDYEEIKVEAKKEVHEEWEEDFEEGQEYYEREEGYDEGEEEWEEAYQEREVIQVQKEVYEESHERKVPAKVPEKKAPPPPKVIKKPVIEKIEKTSRRMEEEKVQVTKVPEVSKKIVPQKPSRTPVQEEVIEVKVPAVHTKKMVISEEKMFFASHTEEEVSVTVPEVQKEIVTEEKIHVAISKRVEPPPKVPELPEKPAPEEVAPVPIPKKVEPPAPKVPEVPKKPVPEEKKPVPVPKKEPAAPPKVPEVPKKPVPEEKIPVPVAKKKEAPPAKVPEVQKGVVTEEKITIVTQREESPPPAVPEIPKKKVPEERKPVPRKEEEVPPPPKVPALPKKPVPEEKVAVPVPVAKKAPPPRAEVSKKTVVEEKRFVAEEKLSFAVPQRVEVTRHEVSAEEEWSYSEEEEGVSISVYREEEREEEEEAEVTEYEVMEEPEEYVVEEKLHIISKRVEAEPAEVTERQEKKIVLKPKIPAKIEEPPPAKVPEAPKKIVPEKKVPAPVPKKEKVPPPKVPEEPKKPVPEKKVPPKVIKMEEPLPAKVTERHMQITQEEKVLVAVTKKEAPPKARVPEEPKRAVPEEKVLKLKPKREEEPPAKVTEFRKRVVKEEKVSIEAPKREPQPIKEVTIMEEKERAYTLEEEAVSVQREEEYEEYEEYDYKEFEEYEPTEEYDQYEEYEEREYERYEEHEEYITEPEKPIPVKPVPEEPVPTKPKAPPAKVLKKAVPEEKVPVPIPKKLKPPPPKVPEEPKKVFEEKIRISITKREKEQVTEPAAKVPMKPKRVVAEEKVPVPRKEVAPPVRVPEVPKELEPEEVAFEEEVVTHVEEYLVEEEEEYIHEEEEFITEEEVVPVIPVKVPEVPRKPVPEEKKPVPVPKKKEAPPAKVPEVPKKPEEKVPVLIPKKEKPPPAKVPEVPKKPVPEEKVPVPVPKKVEAPPAKVPEVPKKPVPEKKVPVPAPKKVEAPPAKVPEVPKKLIPEEKKPTPVPKKVEAPPPKVPKKREPVPVPVALPQEEEVLFEEEIVPEEEVLPEEEEVLPEEEEVLPEEEEVLPEEEEIPPEEEEVPPEEEYVPEEEEFVPEEEVLPEVKPKVPVPAPVPEIKKKVTEKKVVIPKKEEAPPAKVPEVPKKVEEKRIILPKEEEVLPVEVTEEPEEEPISEEEIPEEPPSIEEVEEVAPPRVPEVIKKAVPEAPTPVPKKVEAPPAKVSKKIPEEKVPVPVQKKEAPPAKVPEVPKKVPEKKVLVPKKEAVPPAKGRTVLEEKVSVAFRQEVVVKERLELEVVEAEVEEIPEEEEFHEVEEYFEEGEFHEVEEFIKLEQHRVEEEHRVEKVHRVIEVFEAEEVEVFEKPKAPPKGPEISEKIIPPKKPPTKVVPRKEPPAKVPEVPKKIVVEEKVRVPEEPRVPPTKVPEVLPPKEVVPEKKVPVPPAKKPEAPPPKVPEAPKEVVPEKKVPVPPPKKPEVPPTKVPEVPKAAVPEKKVPEAIPPKPESPPPEVPEAPKEVVPEKKVPAAPPKKPEVTPVKVPEAPKEVVPEKKVPVPPPKKPEVPPTKVPEVPKVAVPEKKVPEAIPPKPESPPPEVFEEPEEVALEEPPAEVVEEPEPAAPPQVTVPPKKPVPEKKAPAVVAKKPELPPVKVPEVPKEVVPEKKVPLVVPKKPEAPPAKVPEVPKEVVPEKKVAVPKKPEVPPAKVPEVPKKPVLEEKPAVPVPERAESPPPEVYEEPEEIAPEEEIAPEEEKPVPVAEEEEPEVPPPAVPEEPKKIIPEKKVPVIKKPEAPPPKEPEPEKVIEKPKLKPRPPPPPPAPPKEDVKEKIFQLKAIPKKKVPEKPQVPEKVELTPLKVPGGEKKVRKLLPERKPEPKEEVVLKSVLRKRPEEEEPKVEPKKLEKVKKPAVPEPPPPKPVEEVEVPTVTKRERKIPEPTKVPEIKPAIPLPAPEPKPKPEAEVKTIKPPPVEPEPTPIAAPVTVPVVGKKAEAKAPKEEAAKPKGPIKGVPKKTPSPIEAERRKLRPGSGGEKPPDEAPFTYQLKAVPLKFVKEIKDIILTESEFVGSSAIFECLVSPSTAITTWMKDGSNIRESPKHRFIADGKDRKLHIIDVQLSDAGEYTCVLRLGNKEKTSTAKLVVEELPVRFVKTLEEEVTVVKGQPLYLSCELNKERDVVWRKDGKIVVEKPGRIVPGVIGLMRALTINDADDTDAGTYTVTVENANNLECSSCVKVVEVIRDWLVKPIRDQHVKPKGTAIFACDIAKDTPNIKWFKGYDEIPAEPNDKTEILRDGNHLYLKIKNAMPEDIAEYAVEIEGKRYPAKLTLGEREVELLKPIEDVTIYEKESASFDAEISEADIPGQWKLKGELLRPSPTCEIKAEGGKRFLTLHKVKLDQAGEVLYQALNAITTAILTVKEIELDFAVPLKDVTVPERRQARFECVLTREANVIWSKGPDIIKSSDKFDIIADGKKHILVINDSQFDDEGVYTAEVEGKKTSARLFVTGIRLKFMSPLEDQTVKEGETATFVCELSHEKMHVVWFKNDAKLHTSRTVLISSEGKTHKLEMKEVTLDDISQIKAQVKELSSTAQLKVLEADPYFTVKLHDKTAVEKDEITLKCEVSKDVPVKWFKDGEEIVPSPKYSIKADGLRRILKIKKADLKDKGEYVCDCGTDKTKANVTVEARLIKVEKPLYGVEVFVGETAHFEIELSEPDVHGQWKLKGQPLTASPDCEIIEDGKKHILILHNCQLGMTGEVSFQAANAKSAANLKVKELPLIFITPLSDVKVFEKDEAKFECEVSREPKTFRWLKGTQEITGDDRFELIKDGTKHSMVIKSAAFEDEAKYMFEAEDKHTSGKLIIEGIRLKFLTPLKDVTAKEKESAVFTVELSHDNIRVKWFKNDQRLHTTRSVSMQDEGKTHSITFKDLSIDDTSQIRVEAMGMSSEAKLTVLEGDPYFTGKLQDYTGVEKDEVILQCEISKADAPVKWFKDGKEIKPSKNAVIKADGKKRMLILKKALKSDIGQYTCDCGTDKTSGKLDIEDREIKLVRPLHSVEVMETETARFETEISEDDIHANWKLKGEALLQTPDCEIKEEGKIHSLVLHNCRLDQTGGVDFQAANVKSSAHLRVKPRVIGLLRPLKDVTVTAGETATFDCELSYEDIPVEWYLKGKKLEPSDKVVPRSEGKVHTLTLRDVKLEDAGEVQLTAKDFKTHANLFVKEPPVEFTKPLEDQTVEEGATAVLECEVSRENAKVKWFKNGTEILKSKKYEIVADGRVRKLVIHDCTPEDIKTYTCDAKDFKTSCNLNVVPPHVEFLRPLTDLQVREKEMARFECELSRENAKVKWFKDGAEIKKGKKYDIISKGAVRILVINKCLLDDEAEYSCEVRTARTSGMLTVLEEEAVFTKNLANIEVSETDTIKLVCEVSKPGAEVIWYKGDEEIIETGRYEILTEGRKRILVIQNAHLEDAGNYNCRLPSSRTDGKVKVHELAAEFISKPQNLEILEGEKAEFVCSISKESFPVQWKRDDKTLESGDKYDVIADGKKRVLVVKDATLQDMGTYVVMVGAARAAAHLTVIEKLRIVVPLKDTRVKEQQEVVFNCEVNTEGAKAKWFRNEEAIFDSSKYIILQKDLVYTLRIRDAHLDDQANYNVSLTNHRGENVKSAANLIVEEEDLRIVEPLKDIETMEKKSVTFWCKVNRLNVTLKWTKNGEEVPFDNRVSYRVDKYKHMLTIKDCGFPDEGEYIVTAGQDKSVAELLIIEAPTEFVEHLEDQTVTEFDDAVFSCQLSREKANVKWYRNGREIKEGKKYKFEKDGSIHRLIIKDCRLDDECEYACGVEDRKSRARLFVEEIPVEIIRPPQDILEAPGADVVFLAELNKDKVEVQWLRNNMVVVQGDKHQMMSEGKIHRLQICDIKPRDQGEYRFIAKDKEARAKLELAAAPKIKTADQDLVVDVGKPLTMVVPYDAYPKAEAEWFKENEPLSTKTIDTTAEQTSFRILEAKKGDKGRYKIVLQNKHGKAEGFINLKVIDVPGPVRNLEVTETFDGEVSLAWEEPLTDGGSKIIGYVVERRDIKRKTWVLATDRAESCEFTVTGLQKGGVEYLFRVSARNRVGTGEPVETDNPVEARSKYDVPGPPLNVTITDVNRFGVSLTWEPPEYDGGAEITNYVIELRDKTSIRWDTAMTVRAEDLSATVTDVVEGQEYSFRVRAQNRIGVGKPSAATPFVKVADPIERPSPPVNLTSSDQTQSSVQLKWEPPLKDGGSPILGYIIERCEEGKDNWIRCNMKLVPELTYKVTGLEKGNKYLYRVSAENKAGVSDPSEILGPLTADDAFVEPTMDLSAFKDGLEVIVPNPITILVPSTGYPRPTATWCFGDKVLETGDRVKMKTLSAYAELVISPSERSDKGIYTLKLENRVKTISGEIDVNVIARPSAPKELKFGDITKDSVHLTWEPPDDDGGSPLTGYVVEKREVSRKTWTKVMDFVTDLEFTVPDLVQGKEYLFKVCARNKCGPGEPAYVDEPVNMSTPATVPDPPENVKWRDRTANSIFLTWDPPKNDGGSRIKGYIVERCPRGSDKWVACGEPVAETKMEVTGLEEGKWYAYRVKALNRQGASKPSRPTEEIQAVDTQEAPEIFLDVKLLAGLTVKAGTKIELPATVTGKPEPKITWTKADMILKQDKRITIENVPKKSTVTIVDSKRSDTGTYIIEAVNVCGRATAVVEVNVLDKPGPPAAFDITDVTNESCLLTWNPPRDDGGSKITNYVVERRATDSEVWHKLSSTVKDTNFKATKLIPNKEYIFRVAAENMYGVGEPVQASPITAKYQFDPPGPPTRLEPSDITKDAVTLTWCEPDDDGGSPITGYWVERLDPDTDKWVRCNKMPVKDTTYRVKGLTNKKKYRFRVLAENLAGPGKPSKSTEPILIKDPIDPPWPPGKPTVKDVGKTSVRLNWTKPEHDGGAKIESYVIEMLKTGTDEWVRVAEGVPTTQHLLPGLMEGQEYSFRVRAVNKAGESEPSEPSDPVLCREKLYPPSPPRWLEVINITKNTADLKWTVPEKDGGSPITNYIVEKRDVRRKGWQTVDTTVKDTKCTVTPLTEGSLYVFRVAAENAIGQSDYTEIEDSVLAKDTFTTPGPPYALAVVDVTKRHVDLKWEPPKNDGGRPIQRYVIEKKERLGTRWVKAGKTAGPDCNFRVTDVIEGTEVQFQVRAENEAGVGHPSEPTEILSIEDPTSPPSPPLDLHVTDAGRKHIAIAWKPPEKNGGSPIIGYHVEMCPVGTEKWMRVNSRPIKDLKFKVEEGVVPDKEYVLRVRAVNAIGVSEPSEISENVVAKDPDCKPTIDLETHDIIVIEGEKLSIPVPFRAVPVPTVSWHKDGKEVKASDRLTMKNDHISAHLEVPKSVRADAGIYTITLENKLGSATASINVKVIGLPGPCKDIKASDITKSSCKLTWEPPEFDGGTPILHYVLERREAGRRTYIPVMSGENKLSWTVKDLIPNGEYFFRVKAVNKVGGGEYIELKNPVIAQDPKQPPDPPVDVEVHNPTAEAMTITWKPPLYDGGSKIMGYIIEKIAKGEERWKRCNEHLVPILTYTAKGLEEGKEYQFRVRAENAAGISEPSRATPPTKAVDPIDAPKVILRTSLEVKRGDEIALDASISGSPYPTITWIKDENVIVPEEIKKRAAPLVRRRKGEVQEEEPFVLPLTQRLSIDNSKKGESQLRVRDSLRPDHGLYMIKVENDHGIAKAPCTVSVLDTPGPPINFVFEDIRKTSVLCKWEPPLDDGGSEIINYTLEKKDKTKPDSEWIVVTSTLRHCKYSVTKLIEGKEYLFRVRAENRFGPGPPCVSKPLVAKDPFGPPDAPDKPIVEDVTSNSMLVKWNEPKDNGSPILGYWLEKREVNSTHWSRVNKSLLNALKANVDGLLEGLTYVFRVCAENAAGPGKFSPPSDPKTAHDPISPPGPPIPRVTDTSSTTIELEWEPPAFNGGGEIVGYFVDKQLVGTNEWSRCTEKMIKVRQYTVKEIREGADYKLRVSAVNAAGEGPPGETQPVTVAEPQEPPAVELDVSVKGGIQIMAGKTLRIPAVVTGRPVPTKVWTKEEGELDKDRVVIDNVGTKSELIIKDALRKDHGRYVITATNSCGSKFAAARVEVFDVPGPVLDLKPVVTNRKMCLLNWSDPEDDGGSEITGFIIERKDAKMHTWRQPIETERSKCDITGLLEGQEYKFRVIAKNKFGCGPPVEIGPILAVDPLGPPTSPERLTYTERTKSTITLDWKEPRSNGGSPIQGYIIEKRRHDKPDFERVNKRLCPTTSFLVENLDEHQMYEFRVKAVNEIGESEPSLPLNVVIQDDEVPPTIKLRLSVRGDTIKVKAGEPVHIPADVTGLPMPKIEWSKNETVIEKPTDALQITKEEVSRSEAKTELSIPKAVREDKGTYTVTASNRLGSVFRNVHVEVYDRPSPPRNLAVTDIKAESCYLTWDAPLDNGGSEITHYVIDKRDASRKKAEWEEVTNTAVEKRYGIWKLIPNGQYEFRVRAVNKYGISDECKSDKVVIQDPYRLPGPPGKPKVLARTKGSMLVSWTPPLDNGGSPITGYWLEKREEGSPYWSRVSRAPITKVGLKGVEFNVPRLLEGVKYQFRAMAINAAGIGPPSEPSDPEVAGDPIFPPGPPSCPEVKDKTKSSISLGWKPPAKDGGSPIKGYIVEMQEEGTTDWKRVNEPDKLITTCECVVPNLKELRKYRFRVKAVNEAGESEPSDTTGEIPATDIQEEPEVFIDIGAQDCLVCKAGSQIRIPAVIKGRPTPKSSWEFDGKAKKAMKDGVHDIPEDAQLETAENSSVIIIPECKRSHTGKYSITAKNKAGQKTANCRVKVMDVPGPPKDLKVSDITRGSCRLSWKMPDDDGGDRIKGYVIEKRTIDGKAWTKVNPDCGSTTFVVPDLLSEQQYFFRVRAENRFGIGPPVETIQRTTARDPIYPPDPPIKLKIGLITKNTVHLSWKPPKNDGGSPVTHYIVECLAWDPTGTKKEAWRQCNKRDVEELQFTVEDLVEGGEYEFRVKAVNAAGVSKPSATVGPVTVKDQTCPPSIDLKEFMEVEEGTNVNIVAKIKGVPFPTLTWFKAPPKKPDNKEPVLYDTHVNKLVVDDTCTLVIPQSRRSDTGLYTITAVNNLGTASKEMRLNVLGRPGPPVGPIKFESVSADQMTLSWFPPKDDGGSKITNYVIEKREANRKTWVHVSSEPKECTYTIPKLLEGHEYVFRIMAQNKYGIGEPLDSEPETARNLFSVPGAPDKPTVSSVTRNSMTVNWEEPEYDGGSPVTGYWLEMKDTTSKRWKRVNRDPIKAMTLGVSYKVTGLIEGSDYQFRVYAINAAGVGPASLPSDPATARDPIAPPGPPFPKVTDWTKSSADLEWSPPLKDGGSKVTGYIVEYKEEGKEEWEKGKDKEVRGTKLVVTGLKEGAFYKFRVRAVNIAGIGEPGEVTDVIEMKDRLVSPDLQLDASVRDRIVVHAGGVIRIIAYVSGKPPPTVTWNMNERTLPQEATIETTAISSSMVIKNCQRSHQGVYSLLAKNEAGERKKTIIVDVLDVPGPVGTPFLAHNLTNESCKLTWFSPEDDGGSPITNYVIEKRESDRRAWTPVTYTVTRQNATVQGLIQGKAYFFRIAAENSIGMGPFVETSEALVIREPITVPERPEDLEVKEVTKNTVTLTWNPPKYDGGSEIINYVLESRLIGTEKFHKVTNDNLLSRKYTVKGLKEGDTYEYRVSAVNIVGQGKPSFCTKPITCKDELAPPTLHLDFRDKLTIRVGEAFALTGRYSGKPKPKVSWFKDEADVLEDDRTHIKTTPATLALEKIKAKRSDSGKYCVVVENSTGSRKGFCQVNVVDRPGPPVGPVSFDEVTKDYMVISWKPPLDDGGSKITNYIIEKKEVGKDVWMPVTSASAKTTCKVSKLLEGKDYIFRIHAENLYGISDPLVSDSMKAKDRFRVPDAPDQPIVTEVTKDSALVTWNKPHDGGKPITNYILEKRETMSKRWARVTKDPIHPYTKFRVPDLLEGCQYEFRVSAENEIGIGDPSPPSKPVFAKDPIAKPSPPVNPEAIDTTCNSVDLTWQPPRHDGGSKILGYIVEYQKVGDEEWRRANHTPESCPETKYKVTGLRDGQTYKFRVLAVNAAGESDPAHVPEPVLVKDRLEPPELILDANMAREQHIKVGDTLRLSAIIKGVPFPKVTWKKEDRDAPTKARIDVTPVGSKLEIRNAAHEDGGIYSLTVENPAGSKTVSVKVLVLDKPGPPRDLEVSEIRKDSCYLTWKEPLDDGGSVITNYVVERRDVASAQWSPLSATSKKKSHFAKHLNEGNQYLFRVAAENQYGRGPFVETPKPIKALDPLHPPGPPKDLHHVDVDKTEVSLVWNKPDRDGGSPITGYLVEYQEEGTQDWIKFKTVTNLECVVTGLQQGKTYRFRVKAENIVGLGLPDTTIPIECQEKLVPPSVELDVKLIEGLVVKAGTTVRFPAIIRGVPVPTAKWTTDGSEIKTDEHYTVETDNFSSVLTIKNCLRRDTGEYQITVSNAAGSKTVAVHLTVLDVPGPPTGPINILDVTPEHMTISWQPPKDDGGSPVINYIVEKQDTRKDTWGVVSSGSSKTKLKIPHLQKGCEYVFRVRAENKIGVGPPLDSTPTVAKHKFSPPSPPGKPVVTDITENAATVSWTLPKSDGGSPITGYYMERREVTGKWVRVNKTPIADLKFRVTGLYEGNTYEFRVFAENLAGLSKPSPSSDPIKACRPIKPPGPPINPKLKDKSRETADLVWTKPLSDGGSPILGYVVECQKPGTAQWNRINKDELIRQCAFRVPGLIEGNEYRFRIKAANIVGEGEPRELAESVIAKDILHPPEVELDVTCRDVITVRVGQTIRILARVKGRPEPDITWTKEGKVLVREKRVDLIQDLPRVELQIKEAVRADHGKYIISAKNSSGHAQGSAIVNVLDRPGPCQNLKVTNVTKENCTISWENPLDNGGSEITNFIVEYRKPNQKGWSIVASDVTKRLIKANLLANNEYYFRVCAENKVGVGPTIETKTPILAINPIDRPGEPENLHIADKGKTFVYLKWRRPDYDGGSPNLSYHVERRLKGSDDWERVHKGSIKETHYMVDRCVENQIYEFRVQTKNEGGESDWVKTEEVVVKEDLQKPVLDLKLSGVLTVKAGDTIRLEAGVRGKPFPEVAWTKDKDATDLTRSPRVKIDTRADSSKFSLTKAKRSDGGKYVVTATNTAGSFVAYATVNVLDKPGPVRNLKIVDVSSDRCTVCWDPPEDDGGCEIQNYILEKCETKRMVWSTYSATVLTPGTTVTRLIEGNEYIFRVRAENKIGTGPPTESKPVIAKTKYDKPGRPDPPEVTKVSKEEMTVVWNPPEYDGGKSITGYFLEKKEKHSTRWVPVNKSAIPERRMKVQNLLPDHEYQFRVKAENEIGIGEPSLPSRPVVAKDPIEPPGPPTNFRVVDTTKHSITLGWGKPVYDGGAPIIGYVVEMRPKIADASPDEGWKRCNAAAQLVRKEFTVTSLDENQEYEFRVCAQNQVGIGRPAELKEAIKPKEILEPPEIDLDASMRKLVIVRAGCPIRLFAIVRGRPAPKVTWRKVGIDNVVRKGQVDLVDTMAFLVIPNSTRDDSGKYSLTLVNPAGEKAVFVNVRVLDTPGPVSDLKVSDVTKTSCHVSWAPPENDGGSQVTHYIVEKREADRKTWSTVTPEVKKTSFHVTNLVPGNEYYFRVTAVNEYGPGVPTDVPKPVLASDPLSEPDPPRKLEVTEMTKNSATLAWLPPLRDGGAKIDGYITSYREEEQPADRWTEYSVVKDLSLVVTGLKEGKKYKFRVAARNAVGVSLPREAEGVYEAKEQLLPPKILMPEQITIKAGKKLRIEAHVYGKPHPTCKWKKGEDEVVTSSHLAVHKADSSSILIIKDVTRKDSGYYSLTAENSSGTDTQKIKVVVMDAPGPPQPPFDISDIDADACSLSWHIPLEDGGSNITNYIVEKCDVSRGDWVTALASVTKTSCRVGKLIPGQEYIFRVRAENRFGISEPLTSPKMVAQFPFGVPSEPKNARVTKVNKDCIFVAWDRPDSDGGSPIIGYLIERKERNSLLWVKANDTLVRSTEYPCAGLVEGLEYSFRIYALNKAGSSPPSKPTEYVTARMPVDPPGKPEVIDVTKSTVSLIWARPKHDGGSKIIGYFVEACKLPGDKWVRCNTAPHQIPQEEYTATGLEEKAQYQFRAIARTAVNISPPSEPSDPVTILAENVPPRIDLSVAMKSLLTVKAGTNVCLDATVFGKPMPTVSWKKDGTLLKPAEGIKMAMQRNLCTLELFSVNRKDSGDYTITAENSSGSKSATIKLKVLDKPGPPASVKINKMYSDRAMLSWEPPLEDGGSEITNYIVDKRETSRPNWAQVSATVPITSCSVEKLIEGHEYQFRICAENKYGVGDPVFTEPAIAKNPYDPPGRCDPPVISNITKDHMTVSWKPPADDGGSPITGYLLEKRETQAVNWTKVNRKPIIERTLKATGLQEGTEYEFRVTAINKAGPGKPSDASKAAYARDPQYPPGPPAFPKVYDTTRSSVSLSWGKPAYDGGSPIIGYLVEVKRADSDNWVRCNLPQNLQKTRFEVTGLMEDTQYQFRVYAVNKIGYSDPSDVPDKHYPKDILIPPEGELDADLRKTLILRAGVTMRLYVPVKGRPPPKITWSKPNVNLRDRIGLDIKSTDFDTFLRCENVNKYDAGKYILTLENSCGKKEYTIVVKVLDTPGPPVNVTVKEISKDSAYVTWEPPIIDGGSPIINYVVQKRDAERKSWSTVTTECSKTSFRVANLEEGKSYFFRVFAENEYGIGDPGETRDAVKASQTPGPVVDLKVRSVSKSSCSIGWKKPHSDGGSRIIGYVVDFLTEENKWQRVMKSLSLQYSAKDLTEGKEYTFRVSAENENGEGTPSEITVVARDDVVAPDLDLKGLPDLCYLAKENSNFRLKIPIKGKPAPSVSWKKGEDPLATDTRVSVESSAVNTTLIVYDCQKSDAGKYTITLKNVAGTKEGTISIKVVGKPGIPTGPIKFDEVTAEAMTLKWAPPKDDGGSEITNYILEKRDSVNNKWVTCASAVQKTTFRVTRLHEGMEYTFRVSAENKYGVGEGLKSEPIVARHPFDVPDAPPPPNIVDVRHDSVSLTWTDPKKTGGSPITGYHLEFKERNSLLWKRANKTPIRMRDFKVTGLTEGLEYEFRVMAINLAGVGKPSLPSEPVVALDPIDPPGKPEVINITRNSVTLIWTEPKYDGGHKLTGYIVEKRDLPSKSWMKANHVNVPECAFTVTDLVEGGKYEFRIRAKNTAGAISAPSESTETIICKDEYEAPTIVLDPTIKDGLTIKAGDTIVLNAISILGKPLPKSSWSKAGKDIRPSDITQITSTPTSSMLTIKYATRKDAGEYTITATNPFGTKVEHVKVTVLDVPGPPGPVEISNVSAEKATLTWTPPLEDGGSPIKSYILEKRETSRLLWTVVSEDIQSCRHVATKLIQGNEYIFRVSAVNHYGKGEPVQSEPVKMVDRFGPPGPPEKPEVSNVTKNTATVSWKRPVDDGGSEITGYHVERREKKSLRWVRAIKTPVSDLRCKVTGLQEGSTYEFRVSAENRAGIGPPSEASDSVLMKDAAYPPGPPSNPHVTDTTKKSASLAWGKPHYDGGLEITGYVVEHQKVGDEAWIKDTTGTALRITQFVVPDLQTKEKYNFRISAINDAGVGEPAVIPDVEIVEREMAPDFELDAELRRTLVVRAGLSIRIFVPIKGRPAPEVTWTKDNINLKNRANIENTESFTLLIIPECNRYDTGKFVMTIENPAGKKSGFVNVRVLDTPGPVLNLRPTDITKDSVTLHWDLPLIDGGSRITNYIVEKREATRKSYSTATTKCHKCTYKVTGLSEGCEYFFRVMAENEYGIGEPTETTEPVKASEAPSPPDSLNIMDITKSTVSLAWPKPKHDGGSKITGYVIEAQRKGSDQWTHITTVKGLECVVRNLTEGEEYTFQVMAVNSAGRSAPRESRPVIVKEQTMLPELDLRGIYQKLVIAKAGDNIKVEIPVLGRPKPTVTWKKGDQILKQTQRVNFETTATSTILNINECVRSDSGPYPLTARNIVGEVGDVITIQVHDIPGPPTGPIKFDEVSSDFVTFSWDPPENDGGVPISNYVVEMRQTDSTTWVELATTVIRTTYKATRLTTGLEYQFRVKAQNRYGVGPGITSACIVANYPFKVPGPPGTPQVTAVTKDSMTISWHEPLSDGGSPILGYHVERKERNGILWQTVSKALVPGNIFKSSGLTDGIAYEFRVIAENMAGKSKPSKPSEPMLALDPIDPPGKPVPLNITRHTVTLKWAKPEYTGGFKITSYIVEKRDLPNGRWLKANFSNILENEFTVSGLTEDAAYEFRVIAKNAAGAISPPSEPSDAITCRDDVEAPKIKVDVKFKDTVILKAGEAFRLEADVSGRPPPTMEWSKDGKELEGTAKLEIKIADFSTNLVNKDSTRRDSGAYTLTATNPGGFAKHIFNVKVLDRPGPPEGPLAVTEVTSEKCVLSWFPPLDDGGAKIDHYIVQKRETSRLAWTNVASEVQVTKLKVTKLLKGNEYIFRVMAVNKYGVGEPLESEPVLAVNPYGPPDPPKNPEVTTITKDSMVVCWGHPDSDGGSEIINYIVERRDKAGQRWIKCNKKTLTDLRYKVSGLTEGHEYEFRIMAENAAGISAPSPTSPFYKACDTVFKPGPPGNPRVLDTSRSSISIAWNKPIYDGGSEITGYMVEIALPEEDEWQIVTPPAGLKATSYTITGLTENQEYKIRIYAMNSEGLGEPALVPGTPKAEDRMLPPEIELDADLRKVVTIRACCTLRLFVPIKGRPAPEVKWARDHGESLDKASIESTSSYTLLIVGNVNRFDSGKYILTVENSSGSKSAFVNVRVLDTPGPPQDLKVKEVTKTSVTLTWDPPLLDGGSKIKNYIVEKRESTRKAYSTVATNCHKTSWKVDQLQEGCSYYFRVLAENEYGIGLPAETAESVKASERPLPPGKITLMDVTRNSVSLSWEKPEHDGGSRILGYIVEMQTKGSDKWATCATVKVTEATITGLIQGEEYSFRVSAQNEKGISDPRQLSVPVIAKDLVIPPAFKLLFNTFTVLAGEDLKVDVPFIGRPTPAVTWHKDNVPLKQTTRVNAESTENNSLLTIKDACREDVGHYVVKLTNSAGEAIETLNVIVLDKPGPPTGPVKMDEVTADSITLSWGPPKYDGGSSINNYIVEKRDTSTTTWQIVSATVARTTIKACRLKTGCEYQFRIAAENRYGKSTYLNSEPTVAQYPFKVPGPPGTPVVTLSSRDSMEVQWNEPISDGGSRVIGYHLERKERNSILWVKLNKTPIPQTKFKTTGLEEGVEYEFRVSAENIVGIGKPSKVSECYVARDPCDPPGRPEAIIVTRNSVTLQWKKPTYDGGSKITGYIVEKKELPEGRWMKASFTNIIDTHFEVTGLVEDHRYEFRVIARNAAGVFSEPSESTGAITARDEVDPPRISMDPKYKDTIVVHAGESFKVDADIYGKPIPTIQWIKGDQELSNTARLEIKSTDFATSLSVKDAVRVDSGNYILKAKNVAGERSVTVNVKVLDRPGPPEGPVVISGVTAEKCTLAWKPPLQDGGSDIINYIVERRETSRLVWTVVDANVQTLSCKVTKLLEGNEYTFRIMAVNKYGVGEPLESEPVVAKNPFVVPDAPKAPEVTTVTKDSMIVVWERPASDGGSEILGYVLEKRDKEGIRWTRCHKRLIGELRLRVTGLIENHDYEFRVSAENAAGLSEPSPPSAYQKACDPIYKPGPPNNPKVIDITRSSVFLSWSKPIYDGGCEIQGYIVEKCDVSVGEWTMCTPPTGINKTNIEVEKLLEKHEYNFRICAINKAGVGEHADVPGPIIVEEKLEAPDIDLDLELRKIINIRAGGSLRLFVPIKGRPTPEVKWGKVDGEIRDAAIIDVTSSFTSLVLDNVNRYDSGKYTLTLENSSGTKSAFVTVRVLDTPSPPVNLKVTEITKDSVSITWEPPLLDGGSKIKNYIVEKREATRKSYAAVVTNCHKNSWKIDQLQEGCSYYFRVTAENEYGIGLPAQTADPIKVAEVPQPPGKITVDDVTRNSVSLSWTKPEHDGGSKIIQYIVEMQAKHSEKWSECARVKSLQAVITNLTQGEEYLFRVVAVNEKGRSDPRSLAVPIVAKDLVIEPDVKPAFSSYSVQVGQDLKIEVPISGRPKPTITWTKDGLPLKQTTRINVTDSLDLTTLSIKETHKDDGGQYGITVANVVGQKTASIEIVTLDKPDPPKGPVKFDDVSAESITLSWNPPLYTGGCQITNYIVQKRDTTTTVWDVVSATVARTTLKVTKLKTGTEYQFRIFAENRYGQSFALESDPIVAQYPYKEPGPPGTPFATAISKDSMVIQWHEPVNNGGSPVIGYHLERKERNSILWTKVNKTIIHDTQFKAQNLEEGIEYEFRVYAENIVGVGKASKNSECYVARDPCDPPGTPEPIMVKRNEITLQWTKPVYDGGSMITGYIVEKRDLPDGRWMKASFTNVIETQFTVSGLTEDQRYEFRVIAKNAAGAISKPSDSTGPITAKDEVELPRISMDPKFRDTIVVNAGETFRLEADVHGKPLPTIEWLRGDKEIEESARCEIKNTDFKALLIVKDAIRIDGGQYILRASNVAGSKSFPVNVKVLDRPGPPEGPVQVTGVTSEKCSLTWSPPLQDGGSDISHYVVEKRETSRLAWTVVASEVVTNSLKVTKLLEGNEYVFRIMAVNKYGVGEPLESAPVLMKNPFVLPGPPKSLEVTNIAKDSMTVCWNRPDSDGGSEIIGYIVEKRDRSGIRWIKCNKRRITDLRLRVTGLTEDHEYEFRVSAENAAGVGEPSPATVYYKACDPVFKPGPPTNAHIVDTTKNSITLAWGKPIYDGGSEILGYVVEICKADEEEWQIVTPQTGLRVTRFEISKLTEHQEYKIRVCALNKVGLGEATSVPGTVKPEDKLEAPELDLDSELRKGIVVRAGGSARIHIPFKGRPTPEITWSREEGEFTDKVQIEKGVNYTQLSIDNCDRNDAGKYILKLENSSGSKSAFVTVKVLDTPGPPQNLAVKEVRKDSAFLVWEPPIIDGGAKVKNYVIDKRESTRKAYANVSSKCSKTSFKVENLTEGAIYYFRVMAENEFGVGVPVETVDAVKAAEPPSPPGKVTLTDVSQTSASLMWEKPEHDGGSRVLGYVVEMQPKGTEKWSIVAESKVCNAVVTGLSSGQEYQFRVKAYNEKGKSDPRVLGVPVIAKDLTIQPSLKLPFNTYSIQAGEDLKIEIPVIGRPRPNISWVKDGEPLKQTTRVNVEETATSTVLHIKEGNKDDFGKYTVTATNSAGTATENLSVIVLEKPGPPVGPVRFDEVSADFVVISWEPPAYTGGCQISNYIVEKRDTTTTTWHMVSATVARTTIKITKLKTGTEYQFRIFAENRYGKSAPLDSKAVIVQYPFKEPGPPGTPFVTSISKDQMLVQWHEPVNDGGTKIIGYHLEQKEKNSILWVKLNKTPIQDTKFKTTGLDEGLEYEFKVSAENIVGIGKPSKVSECFVARDPCDPPGRPEAIVITRNNVTLKWKKPAYDGGSKITGYIVEKKDLPDGRWMKASFTNVLETEFTVSGLVEDQRYEFRVIARNAAGNFSEPSDSSGAITARDEIDAPNASLDPKYKDVIVVHAGETFVLEADIRGKPIPDVVWSKDGKELEETAARMEIKSTIQKTTLVVKDCIRTDGGQYILKLSNVGGTKSIPITVKVLDRPGPPEGPLKVTGVTAEKCYLAWNPPLQDGGANISHYIIEKRETSRLSWTQVSTEVQALNYKVTKLLPGNEYIFRVMAVNKYGIGEPLESGPVTACNPYKPPGPPSTPEVSAITKDSMVVTWARPVDDGGTEIEGYILEKRDKEGVRWTKCNKKTLTDLRLRVTGLTEGHSYEFRVAAENAAGVGEPSEPSVFYRACDALYPPGPPSNPKVTDTSRSSVSLAWSKPIYDGGAPVKGYVVEVKEAAADEWTTCTPPTGLQGKQFTVTKLKENTEYNFRICAINSEGVGEPATLPGSVVAQERIEPPEIELDADLRKVVVLRASATLRLFVTIKGRPEPEVKWEKAEGILTDRAQIEVTSSFTMLVIDNVTRFDSGRYNLTLENNSGSKTAFVNVRVLDSPSAPVNLTIREVKKDSVTLSWEPPLIDGGAKITNYIVEKRETTRKAYATITNNCTKTTFRIENLQEGCSYYFRVLASNEYGIGLPAETTEPVKVSEPPLPPGRVTLVDVTRNTATIKWEKPESDGGSKITGYVVEMQTKGSEKWSTCTQVKTLEATISGLTAGEEYVFRVAAVNEKGRSDPRQLGVPVIARDIEIKPSVELPFHTFNVKAREQLKIDVPFKGRPQATVNWRKDGQTLKETTRVNVSSSKTVTSLSIKEASKEDVGTYELCVSNSAGSITVPITIIVLDRPGPPGPIRIDEVSCDSITISWNPPEYDGGCQISNYIVEKKETTSTTWHIVSQAVARTSIKIVRLTTGSEYQFRVCAENRYGKSSYSESSAVVAEYPFSPPGPPGTPKVVHATKSTMLVTWQVPVNDGGSRVIGYHLEYKERSSILWSKANKILIADTQMKVSGLDEGLMYEYRVYAENIAGIGKCSKSCEPVPARDPCDPPGQPEVTNITRKSVSLKWSKPHYDGGAKITGYIVERRELPDGRWLKCNYTNIQETYFEVTELTEDQRYEFRVFARNAADSVSEPSESTGPIIVKDDVEPPRVMMDVKFRDVIVVKAGEVLKINADIAGRPLPVISWAKDGIEIEERARTEIISTDNHTLLTVKDCIRRDTGQYVLTLKNVAGTRSVAVNCKVLDKPGPPAGPLEINGLTAEKCSLSWGRPQEDGGADIDYYIVEKRETSHLAWTICEGELQMTSCKVTKLLKGNEYIFRVTGVNKYGVGEPLESVAIKALDPFTVPSPPTSLEITSVTKESMTLCWSRPESDGGSEISGYIIERREKNSLRWVRVNKKPVYDLRVKSTGLREGCEYEYRVYAENAAGLSLPSETSPLIRAEDPVFLPSPPSKPKIVDSGKTTITIAWVKPLFDGGAPITGYTVEYKKSDDTDWKTSIQSLRGTEYTISGLTTGAEYVFRVKSVNKVGASDPSDSSDPQIAKEREEEPLFDIDSEMRKTLIVKAGASFTMTVPFRGRPVPNVLWSKPDTDLRTRAYVDTTDSRTSLTIENANRNDSGKYTLTIQNVLSAASLTLVVKVLDTPGPPTNITVQDVTKESAVLSWDVPENDGGAPVKNYHIEKREASKKAWVSVTNNCNRLSYKVTNLQEGAIYYFRVSGENEFGVGIPAETKEGVKITEKPSPPEKLGVTSISKDSVSLTWLKPEHDGGSRIVHYVVEALEKGQKNWVKCAVAKSTHHVVSGLRENSEYFFRVFAENQAGLSDPRELLLPVLIKEQLEPPEIDMKNFPSHTVYVRAGSNLKVDIPISGKPLPKVTLSRDGVPLKATMRFNTEITAENLTINLKESVTADAGRYEITAANSSGTTKAFINIVVLDRPGPPTGPVVISDITEESVTLKWEPPKYDGGSQVTNYILLKRETSTAVWTEVSATVARTMMKVMKLTTGEEYQFRIKAENRFGISDHIDSACVTVKLPYTTPGPPSTPWVTNVTRESITVGWHEPVSNGGSAVVGYHLEMKDRNSILWQKANKLVIRTTHFKVTTISAGLIYEFRVYAENAAGVGKPSHPSEPVLAIDACEPPRNVRITDISKNSVSLSWQQPAFDGGSKITGYIVERRDLPDGRWTKASFTNVTETQFIISGLTQNSQYEFRVFARNAVGSISNPSEVVGPITCIDSYGGPVIDLPLEYTEVVKYRAGTSVKLRAGISGKPAPTIEWYKDDKELQTNALVCVENTTDLASILIKDADRLNSGCYELKLRNAMGSASATIRVQILDKPGPPGGPIEFKTVTAEKITLLWRPPADDGGAKITHYIVEKRETSRVVWSMVSEHLEECIITTTKIIKGNEYIFRVRAVNKYGIGEPLESDSVVAKNAFVTPGPPGIPEVTKITKNSMTVVWSRPIADGGSDISGYFLEKRDKKSLGWFKVLKETIRDTRQKVTGLTENSDYQYRVCAVNAAGQGPFSEPSEFYKAADPIDPPGPPAKIRIADSTKSSITLGWSKPVYDGGSAVTGYVVEIRQGEEEEWTTVSTKGEVRTTEYVVSNLKPGVNYYFRVSAVNCAGQGEPIEMNEPVQAKDILEAPEIDLDVALRTSVIAKAGEDVQVLIPFKGRPPPTVTWRKDEKNLGSDARYSIENTDSSSLLTIPQVTRNDTGKYILTIENGVGEPKSSTVSVKVLDTPAACQKLQVKHVSRGTVTLLWDPPLIDGGSPIINYVIEKRDATKRTWSVVSHKCSSTSFKLIDLSEKTPFFFRVLAENEIGIGEPCETTEPVKAAEVPAPIRDLSMKDSTKTSVILSWTKPDFDGGSVITEYVVERKGKGEQTWSHAGISKTCEIEVSQLKEQSVLEFRVFAKNEKGLSDPVTIGPITVKELIITPEVDLSDIPGAQVTVRIGHNVHLELPYKGKPKPSISWLKDGLPLKESEFVRFSKTENKITLSIKNAKKEHGGKYTVILDNAVCRIAVPITVITLGPPSKPKGPIRFDEIKADSVILSWDVPEDNGGGEITCYSIEKRETSQTNWKMVCSSVARTTFKVPNLVKDAEYQFRVRAENRYGVSQPLVSSIIVAKHQFRIPGPPGKPVIYNVTSDGMSLTWDAPVYDGGSEVTGFHVEKKERNSILWQKVNTSPISGREYRATGLVEGLDYQFRVYAENSAGLSSPSDPSKFTLAVSPVDPPGTPDYIDVTRETITLKWNPPLRDGGSKIVGYSIEKRQGNERWVRCNFTDVSECQYTVTGLSPGDRYEFRIIARNAVGTISPPSQSSGIIMTRDENVPPIVEFGPEYFDGLIIKSGESLRIKALVQGRPVPRVTWFKDGVEIEKRMNMEITDVLGSTSLFVRDATRDHRGVYTVEAKNASGSAKAEIKVKVQDTPGKVVGPIRFTNITGEKMTLWWDAPLNDGCAPITHYIIEKRETSRLAWALIEDKCEAQSYTAIKLINGNEYQFRVSAVNKFGVGRPLDSDPVVAQIQYTVPDAPGIPEPSNITGNSITLTWARPESDGGSEIQQYILERREKKSTRWVKVISKRPISETRFKVTGLTEGNEYEFHVMAENAAGVGPASGISRLIKCREPVNPPGPPTVVKVTDTSKTTVSLEWSKPVFDGGMEIIGYIIEMCKADLGDWHKVNAEACVKTRYTVTDLQAGEEYKFRVSAINGAGKGDSCEVTGTIKAVDRLTAPELDIDANFKQTHVVRAGASIRLFIAYQGRPTPTAVWSKPDSNLSLRADIHTTDSFSTLTVENCNRNDAGKYTLTVENNSGSKSITFTVKVLDTPGPPGPITFKDVTRGSATLMWDAPLLDGGARIHHYVVEKREASRRSWQVISEKCTRQIFKVNDLAEGVPYYFRVSAVNEYGVGEPYEMPEPIVATEQPAPPRRLDVVDTSKSSAVLAWLKPDHDGGSRITGYLLEMRQKGSDFWVEAGHTKQLTFTVERLVEKTEYEFRVKAKNDAGYSEPREAFSSVIIKEPQIEPTADLTGITNQLITCKAGSPFTIDVPISGRPAPKVTWKLEEMRLKETDRVSITTTKDRTTLTVKDSMRGDSGRYFLTLENTAGVKTFSVTVVVIGRPGPVTGPIEVSSVSAESCVLSWGEPKDGGGTEITNYIVEKRESGTTAWQLVNSSVKRTQIKVTHLTKYMEYSFRVSSENRFGVSKPLESAPIIAEHPFVPPSAPTRPEVYHVSANAMSIRWEEPYHDGGSKIIGYWVEKKERNTILWVKENKVPCLECNYKVTGLVEGLEYQFRTYALNAAGVSKASEASRPIMAQNPVDAPGRPEVTDVTRSTVSLIWSAPAYDGGSKVVGYIIERKPVSEVGDGRWLKCNYTIVSDNFFTVTALSEGDTYEFRVLAKNAAGVISKGSESTGPVTCRDEYAPPKAELDARLHGDLVTIRAGSDLVLDAAVGGKPEPKIIWTKGDKELDLCEKVSLQYTGKRATAVIKFCDRSDSGKYTLTVKNASGTKAVSVMVKVLDSPGPCGKLTVSRVTQEKCTLAWSLPQEDGGAEITHYIVERRETSRLNWVIVEGECPTLSYVVTRLIKNNEYIFRVRAVNKYGPGVPVESEPIVARNSFTIPSPPGIPEEVGTGKEHIIIQWTKPESDGGNEISNYLVDKREKKSLRWTRVNKDYVVYDTRLKVTSLMEGCDYQFRVTAVNAAGNSEPSEASNFISCREPSYTPGPPSAPRVVDTTKHSISLAWTKPMYDGGTDIVGYVLEMQEKDTDQWYRVHTNATIRNTEFTVPDLKMGQKYSFRVAAVNVKGMSEYSESIAEIEPVERIEIPDLELADDLKKTVTIRAGASLRLMVSVSGRPPPVITWSKQGIDLASRAIIDTTESYSLLIVDKVNRYDAGKYTIEAENQSGKKSATVLVKVYDTPGPCPSVKVKEVSRDSVTITWEIPTIDGGAPVNNYIVEKREAAMRAFKTVTTKCSKTLYRISGLVEGTMYYFRVLPENIYGIGEPCETSDAVLVSEVPLVPAKLEVVDVTKSTVTLAWEKPLYDGGSRLTGYVLEACKAGTERWMKVVTLKPTVLEHTVTSLNEGEQYLFRIRAQNEKGVSEPRETVTAVTVQDLRVLPTIDLSTMPQKTIHVPAGRPVELVIPIAGRPPPAASWFFAGSKLRESERVTVETHTKVAKLTIRETTIRDTGEYTLELKNVTGTTSETIKVIILDKPGPPTGPIKIDEIDATSITISWEPPELDGGAPLSGYVVEQRDAHRPGWLPVSESVTRSTFKFTRLTEGNEYVFRVAATNRFGIGSYLQSEVIECRSSIRIPGPPETLQIFDVSRDGMTLTWYPPEDDGGSQVTGYIVERKEVRADRWVRVNKVPVTMTRYRSTGLTEGLEYEHRVTAINARGSGKPSRPSKPIVAMDPIAPPGKPQNPRVTDTTRTSVSLAWSVPEDEGGSKVTGYLIEMQKVDQHEWTKCNTTPTKIREYTLTHLPQGAEYRFRVLACNAGGPGEPAEVPGTVKVTEMLEYPDYELDERYQEGIFVRQGGVIRLTIPIKGKPFPICKWTKEGQDISKRAMIATSETHTELVIKEADRGDSGTYDLVLENKCGKKAVYIKVRVIGSPNSPEGPLEYDDIQVRSVRVSWRPPADDGGADILGYILERREVPKAAWYTIDSRVRGTSLVVKGLKENVEYHFRVSAENQFGISKPLKSEEPVTPKTPLNPPEPPSNPPEVLDVTKSSVSLSWSRPKDDGGSRVTGYYIERKETSTDKWVRHNKTQITTTMYTVTGLVPDAEYQFRIIAQNDVGLSETSPASEPVVCKDPFDKPSQPGELEILSISKDSVTLQWEKPECDGGKEILGYWVEYRQSGDSAWKKSNKERIKDKQFTIGGLLEATEYEFRVFAENETGLSRPRRTAMSIKTKLTSGEAPGIRKEMKDVTTKLGEAAQLSCQIVGRPLPDIKWYRFGKELIQSRKYKMSSDGRTHTLTVMTEEQEDEGVYTCIATNEVGEVETSSKLLLQATPQFHPGYPLKEKYYGAVGSTLRLHVMYIGRPVPAMTWFHGQKLLQNSENITIENTEHYTHLVMKNVQRKTHAGKYKVQLSNVFGTVDAILDVEIQDKPDKPTGPIVIEALLKNSAVISWKPPADDGGSWITNYVVEKCEAKEGAEWQLVSSAISVTTCRIVNLTENAGYYFRVSAQNTFGISDPLEVSSVVIIKSPFEKPGAPGKPTITAVTKDSCVVAWKPPASDGGAKIRNYYLEKREKKQNKWISVTTEEIRETVFSVKNLIEGLEYEFRVKCENLGGESEWSEISEPITPKSDVPIQAPHFKEELRNLNVRYQSNATLVCKVTGHPKPIVKWYRQGKEIIADGLKYRIQEFKGGYHQLIIASVTDDDATVYQVRATNQGGSVSGTASLEVEVPAKIHLPKTLEGMGAVHALRGEVVSIKIPFSGKPDPVITWQKGQDLIDNNGHYQVIVTRSFTSLVFPNGVERKDAGFYVVCAKNRFGIDQKTVELDVADVPDPPRGVKVSDVSRDSVNLTWTEPASDGGSKITNYIVEKCATTAERWLRVGQARETRYTVINLFGKTSYQFRVIAENKFGLSKPSEPSEPTITKEDKTRAMNYDEEVDETREVSMTKASHSSTKELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIERVSTKVIRTLKHRRYYHTLIKKDLNMVVSAARISCGGAIRSQKGVSVAKVKVASIEIGPVSGQIMHAVGEEGGHVKYVCKIENYDQSTQVTWYFGVRQLENSEKYEITYEDGVAILYVKDITKLDDGTYRCKVVNDYGEDSSYAELFVKGVREVYDYYCRRTMKKIKRRTDTMRLLERPPEFTLPLYNKTAYVGENVRFGVTITVHPEPHVTWYKSGQKIKPGDNDKKYTFESDKGLYQLTINSVTTDDDAEYTVVARNKYGEDSCKAKLTVTLHPPPTDSTLRPMFKRLLANAECQEGQSVCFEIRVSGIPPPTLKWEKDGQPLSLGPNIEIIHEGLDYYALHIRDTLPEDTGYYRVTATNTAGSTSCQAHLQVERLRYKKQEFKSKEEHERHVQKQIDKTLRMAEILSGTESVPLTQVAKEALREAAVLYKPAVSTKTVKGEFRLEIEEKKEERKLRMPYDVPEPRKYKQTTIEEDQRIKQFVPMSDMKWYKKIRDQYEMPGKLDRVVQKRPKRIRLSRWEQFYVMPLPRITDQYRPKWRIPKLSQDDLEIVRPARRRTPSPDYDFYYRPRRRSLGDISDEELLLPIDDYLAMKRTEEERLRLEEELELGFSASPPSRSPPHFELSSLRYSSPQAHVKVEETRKDFRYSTYHIPTKAEASTSYAELRERHAQAAYRQPKQRQRIMAEREDEELLRPVTTTQHLSEYKSELDFMSKEEKSRKKSRRQREVTEITEIEEEYEISKHAQRESSSSASRLLRRRRSLSPTYIELMRPVSELIRSRPQPAEEYEDDTERRSPTPERTRPRSPSPVSSERSLSRFERSARFDIFSRYESMKAALKTQKTSERKYEVLSQQPFTLDHAPRITLRMRSHRVPCGQNTRFILNVQSKPTAEVKWYHNGVELQESSKIHYTNTSGVLTLEILDCHTDDSGTYRAVCTNYKGEASDYATLDVTGGDYTTYASQRRDEEVPRSVFPELTRTEAYAVSSFKKTSEMEASSSVREVKSQMTETRESLSSYEHSASAEMKSAALEEKSLEEKSTTRKIKTTLAARILTKPRSMTVYEGESARFSCDTDGEPVPTVTWLRKGQVLSTSARHQVTTTKYKSTFEISSVQASDEGNYSVVVENSEGKQEAEFTLTIQKARVTEKAVTSPPRVKSPEPRVKSPEAVKSPKRVKSPEPSHPKAVSPTETKPTPTEKVQHLPVSAPPKITQFLKAEASKEIAKLTCVVESSVLRAKEVTWYKDGKKLKENGHFQFHYSADGTYELKINNLTESDQGEYVCEISGEGGTSKTNLQFMGQAFKSIHEKVSKISETKKSDQKTTESTVTRKTEPKAPEPISSKPVIVTGLQDTTVSSDSVAKFAVKATGEPRPTAIWTKDGKAITQGGKYKLSEDKGGFFLEIHKTDTSDSGLYTCTVKNSAGSVSSSCKLTIKAIKDTEAQKVSTQKTSEITPQKKAVVQEEISQKALRSEEIKMSEAKSQEKLALKEEASKVLISEEVKKSAATSLEKSIVHEEITKTSQASEEVRTHAEIKAFSTQMSINEGQRLVLKANIAGATDVKWVLNGVELTNSEEYRYGVSGSDQTLTIKQASHRDEGILTCISKTKEGIVKCQYDLTLSKELSDAPAFISQPRSQNINEGQNVLFTCEISGEPSPEIEWFKNNLPISISSNVSISRSRNVYSLEIRNASVSDSGKYTIKAKNFRGQCSATASLMVLPLVEEPSREVVLRTSGDTSLQGSFSSQSVQMSASKQEASFSSFSSSSASSMTEMKFASMSAQSMSSMQESFVEMSSSSFMGISNMTQLESSTSKMLKAGIRGIPPKIEALPSDISIDEGKVLTVACAFTGEPTPEVTWSCGGRKIHSQEQGRFHIENTDDLTTLIIMDVQKQDGGLYTLSLGNEFGSDSATVNIHIRSI,False,False,True,Q8WZ42,"[('cd00063', 'FN3'), ('cd00096', 'Immunoglobulin domain'), ('cd05747', 'Immunoglobulin (Ig)-like domain of human titin C terminus and similar proteins; member of the I-set of Ig superfamily (IgSF) domains'), ('cd05748', 'Immunoglobulin (Ig)-like domain of titin and similar proteins'), ('cd14104', 'Catalytic domain of the Giant Serine/Threonine Kinase Titin'), ('cd20927', 'Immunoglobulin-like M1 domain from Titin; a member of the I-set of IgSF domains'), ('cd20951', 'Immunoglobulin domain I1 of the titin I-band and similar proteins; a member of the I-set of IgSF domains'), ('cd20972', 'Second Ig-like domain of the giant muscle protein titin Z1z2 in the sarcomeric Z-disk, and similar domains; a member of the I-set of IgSF domains'), ('cd20974', 'First Ig-like domain of the giant muscle protein titin Z1z2 in the sarcomeric Z-disk and similar proteins; a member of the I-set of IgSF domains'), ('G3DSA:1.10.510.10', 'Transferase(Phosphotransferase) domain 1'), ('G3DSA:2.60.40.10', 'Immunoglobulins'), ('G3DSA:3.30.200.20', 'Phosphorylase Kinase; domain 1'), ('IPR000719', 'Protein kinase domain'), ('IPR003598', 'Immunoglobulin subtype 2'), ('IPR003599', 'Immunoglobulin domain subtype'), ('IPR003961', 'Fibronectin type III'), ('IPR004168', 'PPAK motif'), ('IPR007110', 'Immunoglobulin-like domain'), ('IPR008266', 'Tyrosine-protein kinase, active site'), ('IPR011009', 'Protein kinase-like domain superfamily')]",,"""ENSG00000155657; Tissue enhanced (heart muscle, skeletal muscle, tongue)."";","CATALYTIC ACTIVITY: Reaction=L-seryl-[protein] + ATP = O-phospho-L-seryl-[protein] + ADP + H(+); Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616, ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.1; CATALYTIC ACTIVITY: Reaction=L-threonyl-[protein] + ATP = O-phospho-L-threonyl-[protein] + ADP + H(+); Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060, Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013, ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216; EC=2.7.11.1;",2.7.11.1,"ACTIVITY REGULATION: Full activation of the protein kinase domain requires both phosphorylation of Tyr-32341, preventing it from blocking the catalytic aspartate residue, and binding of Ca/CALM to the C-terminal regulatory tail of the molecule which results in ATP binding to the kinase. {ECO:0000269|PubMed:9804419}.",,ENST00000342992.11 [Q8WZ42-11];ENST00000359218.11 [Q8WZ42-10];ENST00000360870.10 [Q8WZ42-6];ENST00000460472.6 [Q8WZ42-3];ENST00000591111.5 [Q8WZ42-1];,TTN,ENSG00000155657,0.0,,,,6.26,DP00072,0.063,,0.056,TTN
Q92569,ENSG00000117461,P55G_HUMAN,B cell differentiation [GO:0030183]; cell migration involved in sprouting angiogenesis [GO:0002042]; immune response [GO:0006955]; insulin receptor signaling pathway [GO:0008286]; negative regulation of anoikis [GO:2000811]; phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0043491]; phosphatidylinositol phosphate biosynthetic process [GO:0046854]; positive regulation of cell migration [GO:0030335]; positive regulation of gene expression [GO:0010628]; positive regulation of protein phosphorylation [GO:0001934]; T cell differentiation [GO:0030217],"cytosol [GO:0005829]; phosphatidylinositol 3-kinase complex [GO:0005942]; phosphatidylinositol 3-kinase complex, class IA [GO:0005943]",1-phosphatidylinositol-3-kinase activity [GO:0016303]; 1-phosphatidylinositol-3-kinase regulator activity [GO:0046935]; phosphotyrosine residue binding [GO:0001784],,,"DOMAIN 65..160; /note=""SH2 1""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00191""; DOMAIN 358..452; /note=""SH2 2""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00191""",,,,"cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,PIK3R3,Phosphatidylinositol 3-kinase regulatory subunit gamma (PI3-kinase regulatory subunit gamma) (PI3K regulatory subunit gamma) (PtdIns-3-kinase regulatory subunit gamma) (Phosphatidylinositol 3-kinase 55 kDa regulatory subunit gamma) (PI3-kinase subunit p55-gamma) (PtdIns-3-kinase regulatory subunit p55-gamma) (p55PIK),Homo sapiens (Human),461.0,54448.0,MYNTVWSMDRDDADWREVMMPYSTELIFYIEMDPPALPPKPPKPMTSAVPNGMKDSSVSLQDAEWYWGDISREEVNDKLRDMPDGTFLVRDASTKMQGDYTLTLRKGGNNKLIKIYHRDGKYGFSDPLTFNSVVELINHYHHESLAQYNPKLDVKLMYPVSRYQQDQLVKEDNIDAVGKKLQEYHSQYQEKSKEYDRLYEEYTRTSQEIQMKRTAIEAFNETIKIFEEQCHTQEQHSKEYIERFRREGNEKEIERIMMNYDKLKSRLGEIHDSKMRLEQDLKNQALDNREIDKKMNSIKPDLIQLRKIRDQHLVWLNHKGVRQKRLNVWLGIKNEDADENYFINEEDENLPHYDEKTWFVEDINRVQAEDLLYGKPDGAFLIRESSKKGCYACSVVADGEVKHCVIYSTARGYGFAEPYNLYSSLKELVLHYQQTSLVQHNDSLNVRLAYPVHAQMPSLCR,False,False,True,Q92569,"[('cd09930', 'C-terminal Src homology 2 (cSH2) domain found in p85'), ('cd09942', 'N-terminal Src homology 2 (nSH2) domain found in p85'), ('G3DSA:1.10.287.1490', None), ('G3DSA:3.30.505.10', 'SH2 domain'), ('IPR000980', 'SH2 domain'), ('IPR032498', 'PI3K regulatory subunit p85-related , inter-SH2 domain'), ('IPR035020', 'PI3K p85 subunit, C-terminal SH2 domain'), ('IPR035022', 'PI3K p85 subunit, N-terminal SH2 domain'), ('IPR036860', 'SH2 domain superfamily'), ('PF00017', 'SH2 domain'), ('PF16454', 'Phosphatidylinositol 3-kinase regulatory subunit P85 inter-SH2 domain'), ('PR00401', 'SH2DOMAIN'), ('PR00678', 'PI3KINASEP85'), ('PS50001', 'Src homology 2 (SH2) domain profile'), ('PTHR10155', 'PHOSPHATIDYLINOSITOL 3-KINASE REGULATORY SUBUNIT'), ('SM00252', 'Src homology 2 domains'), ('SSF55550', 'SH2 domain')]",,"""ENSG00000117461; Low tissue specificity."";",,,,,ENST00000262741.10 [Q92569-1];ENST00000372006.5 [Q92569-1];ENST00000420542.5 [Q92569-1];ENST00000423209.5 [Q92569-2];,PIK3R3,ENSG00000117461,0.0,,,,,,,0.176,,PIK3R3
Q92731,ENSG00000140009,ESR2_HUMAN,cell-cell signaling [GO:0007267]; cellular response to estradiol stimulus [GO:0071392]; cellular response to estrogen stimulus [GO:0071391]; estrogen receptor signaling pathway [GO:0030520]; negative regulation of cell growth [GO:0030308]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of DNA-templated transcription [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357]; signal transduction [GO:0007165],chromatin [GO:0000785]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],"DNA binding [GO:0003677]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; enzyme binding [GO:0019899]; estrogen response element binding [GO:0034056]; nuclear estrogen receptor activity [GO:0030284]; nuclear receptor activity [GO:0004879]; nuclear steroid receptor activity [GO:0003707]; receptor antagonist activity [GO:0048019]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; steroid binding [GO:0005496]; zinc ion binding [GO:0008270]",PTM: Phosphorylation at Ser-87 and Ser-105 recruits NCOA1. {ECO:0000269|PubMed:15862947}.,"DOMAIN: Composed of three domains: a modulating N-terminal domain, a DNA-binding domain and a C-terminal ligand-binding domain.","DOMAIN 264..498; /note=""NR LBD""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU01189""","STRAND 286..288; /evidence=""ECO:0007829|PDB:7XVY""; STRAND 348..350; /evidence=""ECO:0007829|PDB:1L2J""; STRAND 353..357; /evidence=""ECO:0007829|PDB:3OLL""; STRAND 359..363; /evidence=""ECO:0007829|PDB:3OLL""; STRAND 407..409; /evidence=""ECO:0007829|PDB:1NDE""; STRAND 484..486; /evidence=""ECO:0007829|PDB:5TOA""","HELIX 257..260; /evidence=""ECO:0007829|PDB:1L2J""; HELIX 261..263; /evidence=""ECO:0007829|PDB:2FSZ""; HELIX 265..275; /evidence=""ECO:0007829|PDB:3OLL""; HELIX 291..314; /evidence=""ECO:0007829|PDB:3OLL""; HELIX 319..321; /evidence=""ECO:0007829|PDB:3OLL""; HELIX 324..347; /evidence=""ECO:0007829|PDB:3OLL""; HELIX 364..369; /evidence=""ECO:0007829|PDB:3OLL""; HELIX 373..389; /evidence=""ECO:0007829|PDB:3OLL""; HELIX 394..406; /evidence=""ECO:0007829|PDB:3OLL""; HELIX 411..413; /evidence=""ECO:0007829|PDB:1QKM""; HELIX 417..419; /evidence=""ECO:0007829|PDB:1L2J""; HELIX 421..442; /evidence=""ECO:0007829|PDB:3OLL""; HELIX 448..481; /evidence=""ECO:0007829|PDB:3OLL""; HELIX 489..497; /evidence=""ECO:0007829|PDB:3OLL""; HELIX 498..501; /evidence=""ECO:0007829|PDB:4ZI1""","TURN 443..445; /evidence=""ECO:0007829|PDB:7XVZ""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,ESR2 ESTRB NR3A2,Estrogen receptor beta (ER-beta) (Nuclear receptor subfamily 3 group A member 2),Homo sapiens (Human),530.0,59216.0,MDIKNSPSSLNSPSSYNCSQSILPLEHGSIYIPSSYVDSHHEYPAMTFYSPAVMNYSIPSNVTNLEGGPGRQTTSPNVLWPTPGHLSPLVVHRQLSHLYAEPQKSPWCEARSLEHTLPVNRETLKRKVSGNRCASPVTGPGSKRDAHFCAVCSDYASGYHYGVWSCEGCKAFFKRSIQGHNDYICPATNQCTIDKNRRKSCQACRLRKCYEVGMVKCGSRRERCGYRLVRRQRSADEQLHCAGKAKRSGGHAPRVRELLLDALSPEQLVLTLLEAEPPHVLISRPSAPFTEASMMMSLTKLADKELVHMISWAKKIPGFVELSLFDQVRLLESCWMEVLMMGLMWRSIDHPGKLIFAPDLVLDRDEGKCVEGILEIFDMLLATTSRFRELKLQHKEYLCVKAMILLNSSMYPLVTATQDADSSRKLAHLLNAVTDALVWVIAKSGISSQQQSMRLANLLMLLSHVRHASNKGMEHLLNMKCKNVVPVYDLLLEMLNAHVLRGCKSSITGSECSPAEDSKSKEGSQNPQSQ,False,False,True,Q92731,"[('cd06949', 'Ligand binding domain of Estrogen receptor, which are activated by the hormone 17beta-estradiol (estrogen)'), ('cd07171', 'DNA-binding domain of estrogen receptors (ER) is composed of two C4-type zinc fingers'), ('G3DSA:1.10.565.10', 'Retinoid X Receptor'), ('G3DSA:3.30.50.10', 'Erythroid Transcription Factor GATA-1, subunit A'), ('IPR000536', 'Nuclear hormone receptor, ligand-binding domain'), ('IPR001628', 'Zinc finger, nuclear hormone receptor-type'), ('IPR001723', 'Nuclear hormone receptor'), ('IPR013088', 'Zinc finger, NHR/GATA-type'), ('IPR021064', 'Estrogen receptor beta-like, N-terminal'), ('IPR024178', 'Estrogen receptor/oestrogen-related receptor'), ('IPR028355', 'Estrogen receptor beta/gamma'), ('IPR035500', 'Nuclear hormone receptor-like domain superfamily'), ('IPR050200', 'Nuclear hormone receptor family NR3 subfamily'), ('PF00104', 'Ligand-binding domain of nuclear hormone receptor'), ('PF00105', 'Double treble clef zinc finger, C4 type'), ('PF12497', 'Estrogen receptor beta'), ('PIRSF002527', 'Estrogen receptor-like nuclear receptor'), ('PIRSF500102', 'Estrogen receptor beta'), ('PR00047', 'STROIDFINGER'), ('PR00398', 'STRDHORMONER')]",Q92731;,"""ENSG00000140009; Tissue enhanced (adrenal gland, testis)."";",,,,,ENST00000267525.10 [Q92731-7];ENST00000341099.6 [Q92731-1];ENST00000344288.10 [Q92731-3];ENST00000353772.7 [Q92731-2];ENST00000358599.9 [Q92731-2];ENST00000553796.5 [Q92731-9];ENST00000554572.5 [Q92731-2];ENST00000555278.5 [Q92731-5];ENST00000557772.5 [Q92731-6];,ESR2,ENSG00000140009,0.0,,,,19.43,DP00079,0.315,0.411,0.045,ESR2
Q92734,ENSG00000114354,TFG_HUMAN,COPII vesicle coating [GO:0048208]; endoplasmic reticulum to Golgi vesicle-mediated transport [GO:0006888]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123],cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum exit site [GO:0070971]; intracellular membrane-bounded organelle [GO:0043231],identical protein binding [GO:0042802],,,"DOMAIN 10..91; /note=""PB1""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU01081""","STRAND 266..274; /evidence=""ECO:0007829|PDB:8TER""; STRAND 276..279; /evidence=""ECO:0007829|PDB:8TER""; STRAND 283..293; /evidence=""ECO:0007829|PDB:8TER""; STRAND 296..298; /evidence=""ECO:0007829|PDB:8TER""",,,"cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,TFG,Protein TFG (TRK-fused gene protein),Homo sapiens (Human),400.0,43448.0,MNGQLDLSGKLIIKAQLGEDIRRIPIHNEDITYDELVLMMQRVFRGKLLSNDEVTIKYKDEDGDLITIFDSSDLSFAIQCSRILKLTLFVNGQPRPLESSQVKYLRRELIELRNKVNRLLDSLEPPGEPGPSTNIPENDTVDGREEKSASDSSGKQSTQVMAASMSAFDPLKNQDEINKNVMSAFGLTDDQVSGPPSAPAEDRSGTPDSIASSSSAAHPPGVQPQQPPYTGAQTQAGQIEGQMYQQYQQQAGYGAQQPQAPPQQPQQYGIQYSASYSQQTGPQQPQQFQGYGQQPTSQAPAPAFSGQPQQLPAQPPQQYQASNYPAQTYTAQTSQPTNYTVAPASQPGMAPSQPGAYQPRPGFTSLPGSTMTPPPSGPNPYARNRPPFGQGYTQPGPGYR,False,False,True,Q92734,"[('cd06401', 'PB1_TFG'), ('G3DSA:3.10.20.90', 'Phosphatidylinositol 3-kinase Catalytic Subunit; Chain A, domain 1'), ('IPR000270', 'PB1 domain'), ('IPR033512', 'Protein TFG'), ('IPR034857', 'TFG, PB1 domain'), ('IPR053793', 'PB1-like domain'), ('PF00564', 'PB1 domain'), ('PS51745', 'PB1 domain profile'), ('PTHR15335', 'PROTEIN TFG'), ('SM00666', 'PB1 domain'), ('SSF54277', 'CAD & PB1 domains')]",,"""ENSG00000114354; Low tissue specificity."";",,,,,ENST00000240851.9 [Q92734-1];ENST00000463568.6 [Q92734-2];ENST00000476228.5 [Q92734-2];ENST00000487505.6 [Q92734-1];ENST00000490574.6 [Q92734-1];ENST00000615993.2 [Q92734-4];ENST00000620299.5 [Q92734-3];ENST00000674615.1 [Q92734-1];ENST00000674645.1 [Q92734-2];ENST00000674758.1 [Q92734-2];ENST00000675047.1 [Q92734-2];ENST00000675243.1 [Q92734-1];ENST00000675420.1 [Q92734-2];ENST00000675499.1 [Q92734-1];ENST00000675543.1 [Q92734-3];ENST00000675553.1 [Q92734-1];ENST00000675586.1 [Q92734-4];ENST00000676111.1 [Q92734-4];ENST00000676308.1 [Q92734-4];ENST00000676395.1 [Q92734-1];ENST00000676431.1 [Q92734-2];,TFG,ENSG00000114354,0.0,,,,,,,0.73,0.637,TFG
Q92890,ENSG00000070010,UFD1_HUMAN,"cellular response to misfolded protein [GO:0071218]; ERAD pathway [GO:0036503]; negative regulation of RIG-I signaling pathway [GO:0039536]; negative regulation of type I interferon production [GO:0032480]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; retrograde protein transport, ER to cytosol [GO:0030970]; skeletal system development [GO:0001501]; ubiquitin-dependent protein catabolic process [GO:0006511]",cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; UFD1-NPL4 complex [GO:0036501]; VCP-NPL4-UFD1 AAA ATPase complex [GO:0034098],cysteine-type deubiquitinase activity [GO:0004843]; K48-linked polyubiquitin modification-dependent protein binding [GO:0036435]; polyubiquitin modification-dependent protein binding [GO:0031593],,,,"STRAND 16..18; /evidence=""ECO:0007829|PDB:2YUJ""; STRAND 20..26; /evidence=""ECO:0007829|PDB:2YUJ""; STRAND 31..35; /evidence=""ECO:0007829|PDB:2YUJ""; STRAND 45..47; /evidence=""ECO:0007829|PDB:2YUJ""; STRAND 66..71; /evidence=""ECO:0007829|PDB:2YUJ""; STRAND 76..84; /evidence=""ECO:0007829|PDB:2YUJ""; STRAND 91..93; /evidence=""ECO:0007829|PDB:2YUJ""; STRAND 108..115; /evidence=""ECO:0007829|PDB:2YUJ""; STRAND 121..129; /evidence=""ECO:0007829|PDB:2YUJ""; STRAND 157..164; /evidence=""ECO:0007829|PDB:2YUJ""; STRAND 166..181; /evidence=""ECO:0007829|PDB:2YUJ""; STRAND 188..191; /evidence=""ECO:0007829|PDB:2YUJ""; STRAND 267..269; /evidence=""ECO:0007829|PDB:7WWQ""","HELIX 50..58; /evidence=""ECO:0007829|PDB:2YUJ""; HELIX 97..102; /evidence=""ECO:0007829|PDB:2YUJ""; HELIX 130..134; /evidence=""ECO:0007829|PDB:2YUJ""; HELIX 138..146; /evidence=""ECO:0007829|PDB:2YUJ""","TURN 39..44; /evidence=""ECO:0007829|PDB:2YUJ""; TURN 72..75; /evidence=""ECO:0007829|PDB:2YUJ""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,UFD1 UFD1L,Ubiquitin recognition factor in ER-associated degradation protein 1 (Ubiquitin fusion degradation protein 1) (UB fusion protein 1),Homo sapiens (Human),307.0,34500.0,MFSFNMFDHPIPRVFQNRFSTQYRCFSVSMLAGPNDRSDVEKGGKIIMPPSALDQLSRLNITYPMLFKLTNKNSDRMTHCGVLEFVADEGICYLPHWMMQNLLLEEGGLVQVESVNLQVATYSKFQPQSPDFLDITNPKAVLENALRNFACLTTGDVIAINYNEKIYELRVMETKPDKAVSIIECDMNVDFDAPLGYKEPERQVQHEESTEGEADHSGYAGELGFRAFSGSGNRLDGKKKGVEPSPSPIKPGDIKRGIPNYEFKLGKITFIRNSRPLVKKVEEDEAGGRFVAFSGEGQSLRKKGRKP,False,False,True,Q92890,"[('G3DSA:2.40.40.50', 'Ubiquitin fusion degradation protein UFD1, N-terminal domain'), ('G3DSA:3.10.330.10', None), ('IPR004854', 'Ubiquitin fusion degradation protein Ufd1-like'), ('IPR042299', 'Ufd1-like, Nn domain'), ('IPR055417', 'Ubiquitin fusion degradation protein UFD1, N-terminal subdomain 1'), ('IPR055418', 'Ubiquitin fusion degradation protein UFD1, N-terminal subdomain 2'), ('PF03152', 'Ubiquitin fusion degradation protein UFD1, N-terminal subdomain 1'), ('PF24842', 'Ubiquitin fusion degradation protein UFD1, N-terminal subdomain 2'), ('PTHR12555', 'UBIQUITIN FUSION DEGRADATON PROTEIN 1')]",,"""ENSG00000070010; Low tissue specificity."";",,,,PATHWAY: Protein degradation; proteasomal ubiquitin-dependent pathway. {ECO:0000250|UniProtKB:Q9ES53}.,ENST00000263202.15 [Q92890-2];ENST00000399523.5 [Q92890-3];,UFD1,ENSG00000070010,0.0,,,,,,,0.417,0.15,UFD1
Q92997,ENSG00000161202,DVL3_HUMAN,"canonical Wnt signaling pathway [GO:0060070]; intracellular signal transduction [GO:0035556]; non-canonical Wnt signaling pathway [GO:0035567]; planar cell polarity pathway involved in neural tube closure [GO:0090179]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of GTPase activity [GO:0043547]; positive regulation of JNK cascade [GO:0046330]; positive regulation of neuron projection arborization [GO:0150012]; positive regulation of protein phosphorylation [GO:0001934]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein stabilization [GO:0050821]; regulation of actin cytoskeleton organization [GO:0032956]; regulation of protein localization [GO:0032880]; response to xenobiotic stimulus [GO:0009410]; Wnt signaling pathway, planar cell polarity pathway [GO:0060071]",chromatin [GO:0000785]; cytosol [GO:0005829],beta-catenin binding [GO:0008013]; frizzled binding [GO:0005109]; protease binding [GO:0002020]; signaling receptor binding [GO:0005102]; small GTPase binding [GO:0031267],"PTM: Ubiquitinated. Deubiquitinated by CYLD, which acts on 'Lys-63'-linked ubiquitin chains. {ECO:0000269|PubMed:20227366}.; PTM: Phosphorylated by CSNK1D. {ECO:0000269|PubMed:21422228, ECO:0000269|PubMed:22612246}.; PTM: Arginine methylation may function as a switch in regulation of function in Wnt signaling. {ECO:0000269|PubMed:22612246, ECO:0000269|PubMed:23150776}.",,"DOMAIN 1..82; /note=""DIX""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00069""; DOMAIN 249..321; /note=""PDZ""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00143""; DOMAIN 422..496; /note=""DEP""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00066""","STRAND 247..252; /evidence=""ECO:0007829|PDB:6ZBQ""; STRAND 262..266; /evidence=""ECO:0007829|PDB:6ZBQ""; STRAND 270..272; /evidence=""ECO:0007829|PDB:6ZBZ""; STRAND 276..281; /evidence=""ECO:0007829|PDB:6ZBQ""; STRAND 298..302; /evidence=""ECO:0007829|PDB:6ZBQ""; STRAND 325..327; /evidence=""ECO:0007829|PDB:6ZC6""; STRAND 329..334; /evidence=""ECO:0007829|PDB:6ZBQ""","HELIX 286..290; /evidence=""ECO:0007829|PDB:6ZBQ""; HELIX 312..324; /evidence=""ECO:0007829|PDB:6ZBQ""","TURN 254..256; /evidence=""ECO:0007829|PDB:6ZC8""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,DVL3 KIAA0208,Segment polarity protein dishevelled homolog DVL-3 (Dishevelled-3) (DSH homolog 3),Homo sapiens (Human),716.0,78055.0,MGETKIIYHLDGQETPYLVKLPLPAERVTLADFKGVLQRPSYKFFFKSMDDDFGVVKEEISDDNAKLPCFNGRVVSWLVSAEGSHPDPAPFCADNPSELPPPMERTGGIGDSRPPSFHPHAGGGSQENLDNDTETDSLVSAQRERPRRRDGPEHATRLNGTAKGERRREPGGYDSSSTLMSSELETTSFFDSDEDDSTSRFSSSTEQSSASRLMRRHKRRRRKQKVSRIERSSSFSSITDSTMSLNIITVTLNMEKYNFLGISIVGQSNERGDGGIYIGSIMKGGAVAADGRIEPGDMLLQVNEINFENMSNDDAVRVLREIVHKPGPITLTVAKCWDPSPRGCFTLPRSEPIRPIDPAAWVSHTAAMTGTFPAYGMSPSLSTITSTSSSITSSIPDTERLDDFHLSIHSDMAAIVKAMASPESGLEVRDRMWLKITIPNAFIGSDVVDWLYHNVEGFTDRREARKYASNLLKAGFIRHTVNKITFSEQCYYIFGDLCGNMANLSLHDHDGSSGASDQDTLAPLPHPGAAPWPMAFPYQYPPPPHPYNPHPGFPELGYSYGGGSASSQHSEGSRSSGSNRSGSDRRKEKDPKAGDSKSGGSGSESDHTTRSSLRGPRERAPSERSGPAASEHSHRSHHSLASSLRSHHTHPSYGPPGVPPLYGPPMLMMPPPPAAMGPPGAPPGRDLASVPPELTASRQSFRMAMGNPSEFFVDVM,False,False,True,Q92997,"[('cd00992', 'PDZ_signaling'), ('cd04438', 'DEP_dishevelled'), ('G3DSA:1.10.10.10', 'Winged helix-like DNA-binding domain superfamily/Winged helix DNA-binding domain'), ('G3DSA:2.30.42.10', None), ('G3DSA:2.40.240.130', None), ('IPR000591', 'DEP domain'), ('IPR001158', 'DIX domain'), ('IPR001478', 'PDZ domain'), ('IPR003351', 'Dishevelled protein domain'), ('IPR008339', 'Dishevelled family'), ('IPR008342', 'Dishevelled-3'), ('IPR015506', 'Dishevelled-related protein'), ('IPR024580', 'Dishevelled C-terminal'), ('IPR029071', 'Ubiquitin-like domain superfamily'), ('IPR036034', 'PDZ superfamily'), ('IPR036388', 'Winged helix-like DNA-binding domain superfamily'), ('IPR036390', 'Winged helix DNA-binding domain superfamily'), ('IPR038207', 'DIX domain superfamily'), ('PF00595', 'PDZ domain'), ('PF00610', 'Domain found in Dishevelled, Egl-10, and Pleckstrin (DEP)')]",,"""ENSG00000161202; Low tissue specificity."";",,,,,ENST00000313143.9 [Q92997-1];ENST00000431765.6 [Q92997-2];,DVL3,ENSG00000161202,0.0,,,,,,,0.608,0.415,DVL3
Q93062,ENSG00000157110,RBPMS_HUMAN,"protein-containing complex assembly [GO:0065003]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; response to oxidative stress [GO:0006979]; RNA processing [GO:0006396]; SMAD protein signal transduction [GO:0060395]",cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; P-body [GO:0000932],molecular adaptor activity [GO:0060090]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; mRNA CDS binding [GO:1990715]; pre-mRNA intronic binding [GO:0097157]; protein homodimerization activity [GO:0042803]; RNA binding [GO:0003723]; transcription coactivator activity [GO:0003713],,"DOMAIN: The RNA recognition motif (RRM) domain mediates homodimerization (PubMed:26347403). The RRM domain also mediates binding to tandem CAC trinucleotide motif-containing single-stranded RNA (PubMed:24860013, PubMed:26347403). The RRM domain is also necessary for interaction with SMAD4 and for TGFB1/Smad-mediated transactivation activity (PubMed:17099224). {ECO:0000269|PubMed:17099224, ECO:0000269|PubMed:24860013, ECO:0000269|PubMed:26347403}.; DOMAIN: [Isoform A]: The C-terminal 20 amino acids region, without homology to other proteins, is essential for higher-order oligomerization (By similarity). Also essential for RBPMS cooperative RNA binding (By similarity). {ECO:0000250|UniProtKB:A0A8I6G705}.; DOMAIN: [Isoform C]: The C-terminal is required for TGFB1/Smad-mediated transactivation activity. {ECO:0000269|PubMed:17099224}.","DOMAIN 24..101; /note=""RRM""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00176""","STRAND 25..29; /evidence=""ECO:0007829|PDB:5CYJ""; STRAND 50..56; /evidence=""ECO:0007829|PDB:5CYJ""; STRAND 59..61; /evidence=""ECO:0007829|PDB:5CYJ""; STRAND 63..70; /evidence=""ECO:0007829|PDB:5CYJ""; STRAND 85..87; /evidence=""ECO:0007829|PDB:5CYJ""; STRAND 95..98; /evidence=""ECO:0007829|PDB:5CYJ""","HELIX 37..44; /evidence=""ECO:0007829|PDB:5CYJ""; HELIX 71..81; /evidence=""ECO:0007829|PDB:5CYJ""; HELIX 107..109; /evidence=""ECO:0007829|PDB:5CYJ""",,"cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,RBPMS HERMES,RNA-binding protein with multiple splicing (RBP-MS) (RBPMS) (Heart and RRM expressed sequence) (Hermes),Homo sapiens (Human),196.0,21802.0,MNNGGKAEKENTPSEANLQEEEVRTLFVSGLPLDIKPRELYLLFRPFKGYEGSLIKLTSKQPVGFVSFDSRSEAEAAKNALNGIRFDPEIPQTLRLEFAKANTKMAKNKLVGTPNPSTPLPNTVPQFIAREPYELTVPALYPSSPEVWAPYPLYPAELAPALPPPAFTYPASLHAQMRWLPPSEATSQGWKSRQFC,False,False,True,Q93062,"[('cd12682', 'RNA recognition motif (RRM) found in vertebrate RNA-binding protein with multiple splicing (RBP-MS)'), ('G3DSA:3.30.70.330', None), ('IPR000504', 'RNA recognition motif domain'), ('IPR012677', 'Nucleotide-binding alpha-beta plait domain superfamily'), ('IPR035979', 'RNA-binding domain superfamily'), ('PF00076', 'RNA recognition motif'), ('PS50102', 'Eukaryotic RNA Recognition Motif (RRM) profile'), ('PTHR10501', 'U1 SMALL NUCLEAR RIBONUCLEOPROTEIN A/U2 SMALL NUCLEAR RIBONUCLEOPROTEIN B'), ('SM00360', 'RNA recognition motif'), ('SSF54928', 'RNA-binding domain, RBD')]",,"""ENSG00000157110; Low tissue specificity."";",,,,,ENST00000287771.9 [Q93062-2];ENST00000320203.8 [Q93062-1];ENST00000339877.8 [Q93062-3];ENST00000397323.9 [Q93062-1];,RBPMS,ENSG00000157110,0.0,RBPMS,Canonical_RBPs,8.0,,,,0.577,,RBPMS
Q969T4,ENSG00000170035,UB2E3_HUMAN,protein K11-linked ubiquitination [GO:0070979]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked ubiquitination [GO:0070534],cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842],,,"DOMAIN 61..207; /note=""UBC core""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00388""",,,,"cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,UBE2E3 UBCE4 UBCH9,Ubiquitin-conjugating enzyme E2 E3 (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme E3) (UbcH9) (Ubiquitin carrier protein E3) (Ubiquitin-conjugating enzyme E2-23 kDa) (Ubiquitin-protein ligase E3),Homo sapiens (Human),207.0,22913.0,MSSDRQRSDDESPSTSSGSSDADQRDPAAPEPEEQEERKPSATQQKKNTKLSSKTTAKLSTSAKRIQKELAEITLDPPPNCSAGPKGDNIYEWRSTILGPPGSVYEGGVFFLDITFSSDYPFKPPKVTFRTRIYHCNINSQGVICLDILKDNWSPALTISKVLLSICSLLTDCNPADPLVGSIATQYLTNRAEHDRIARQWTKRYAT,False,False,True,Q969T4,"[('cd00195', 'UBCc'), ('G3DSA:3.10.110.10', 'Ubiquitin Conjugating Enzyme'), ('IPR000608', 'Ubiquitin-conjugating enzyme E2'), ('IPR016135', 'Ubiquitin-conjugating enzyme/RWD-like'), ('IPR023313', 'Ubiquitin-conjugating enzyme, active site'), ('PF00179', 'Ubiquitin-conjugating enzyme'), ('PS00183', 'Ubiquitin-conjugating (UBC) active site signature'), ('PS50127', 'Ubiquitin-conjugating (UBC) core domain profile'), ('PTHR24068', 'Ubiquitin-conjugating enzyme'), ('SM00212', 'Ubiquitin-conjugating enzyme E2, catalytic domain homologues'), ('SSF54495', 'UBC-like')]",,"""ENSG00000170035; Low tissue specificity."";","CATALYTIC ACTIVITY: Reaction=S-ubiquitinyl-[E1 ubiquitin-activating enzyme]-L-cysteine + [E2 ubiquitin-conjugating enzyme]-L-cysteine = [E1 ubiquitin-activating enzyme]-L-cysteine + S-ubiquitinyl-[E2 ubiquitin-conjugating enzyme]-L-cysteine.; EC=2.3.2.23; Evidence={ECO:0000255|PROSITE-ProRule:PRU00388, ECO:0000255|PROSITE-ProRule:PRU10133, ECO:0000269|PubMed:20061386};",2.3.2.23,,PATHWAY: Protein modification; protein ubiquitination. {ECO:0000255|PROSITE-ProRule:PRU00388}.,ENST00000392415.6;ENST00000410062.9;ENST00000602710.5;ENST00000602959.5;,UBE2E3,ENSG00000170035,0.0,,,,,,,0.29,0.304,UBE2E3
Q96AP0,ENSG00000102977,ACD_HUMAN,"embryonic limb morphogenesis [GO:0030326]; establishment of protein localization to telomere [GO:0070200]; intracellular protein transport [GO:0006886]; negative regulation of telomere maintenance via telomerase [GO:0032211]; positive regulation of single-stranded telomeric DNA binding [GO:0060381]; positive regulation of telomere maintenance [GO:0032206]; protection from non-homologous end joining at telomere [GO:0031848]; protein localization to chromosome, telomeric region [GO:0070198]; regulation of establishment of protein localization to telomere [GO:0070203]; segmentation [GO:0035282]; skeletal system development [GO:0001501]; telomere assembly [GO:0032202]; telomere capping [GO:0016233]; telomere maintenance [GO:0000723]; telomere maintenance via telomerase [GO:0007004]; urogenital system development [GO:0001655]","chromosome, telomeric region [GO:0000781]; nuclear body [GO:0016604]; nuclear telomere cap complex [GO:0000783]; nucleoplasm [GO:0005654]; shelterin complex [GO:0070187]; telomerase holoenzyme complex [GO:0005697]",DNA polymerase binding [GO:0070182]; protein-containing complex binding [GO:0044877]; telomerase inhibitor activity [GO:0010521]; telomeric DNA binding [GO:0042162],,,,"STRAND 7..9; /evidence=""ECO:0007829|PDB:5I2X""; STRAND 19..21; /evidence=""ECO:0007829|PDB:2I46""; STRAND 27..36; /evidence=""ECO:0007829|PDB:2I46""; STRAND 56..61; /evidence=""ECO:0007829|PDB:2I46""; STRAND 66..71; /evidence=""ECO:0007829|PDB:2I46""; STRAND 80..83; /evidence=""ECO:0007829|PDB:7QXA""; STRAND 85..88; /evidence=""ECO:0007829|PDB:5I2X""; STRAND 94..106; /evidence=""ECO:0007829|PDB:2I46""; STRAND 115..129; /evidence=""ECO:0007829|PDB:2I46""; STRAND 196..198; /evidence=""ECO:0007829|PDB:5UN7""","HELIX 13..18; /evidence=""ECO:0007829|PDB:2I46""; HELIX 73..77; /evidence=""ECO:0007829|PDB:2I46""; HELIX 138..140; /evidence=""ECO:0007829|PDB:2I46""; HELIX 142..152; /evidence=""ECO:0007829|PDB:2I46""; HELIX 168..173; /evidence=""ECO:0007829|PDB:7S1T""; HELIX 180..192; /evidence=""ECO:0007829|PDB:5H65""; HELIX 206..213; /evidence=""ECO:0007829|PDB:5H65""; HELIX 224..226; /evidence=""ECO:0007829|PDB:5H65""; HELIX 231..238; /evidence=""ECO:0007829|PDB:5UN7""; HELIX 425..430; /evidence=""ECO:0007829|PDB:5XYF""; HELIX 436..446; /evidence=""ECO:0007829|PDB:5XYF""","TURN 214..216; /evidence=""ECO:0007829|PDB:5H65""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,ACD PIP1 PTOP TINT1 TPP1,Adrenocortical dysplasia protein homolog (POT1 and TIN2-interacting protein),Homo sapiens (Human),458.0,48967.0,MAGSGRLVLRPWIRELILGSETPSSPRAGQLLEVLQDAEAAVAGPSHAPDTSDVGATLLVSDGTHSVRCLVTREALDTSDWEEKEFGFRGTEGRLLLLQDCGVHVQVAEGGAPAEFYLQVDRFSLLPTEQPRLRVPGCNQDLDVQKKLYDCLEEHLSESTSSNAGLSLSQLLDEMREDQEHQGALVCLAESCLTLEGPCTAPPVTHWAASRCKATGEAVYTVPSSMLCISENDQLILSSLGPCQRTQGPELPPPDPALQDLSLTLIASPPSSPSSSGTPALPGHMSSEESGTSISLLPALSLAAPDPGQRSSSQPSPAICSAPATLTPRSPHASRTPSSPLQSCTPSLSPRSHVPSPHQALVTRPQKPSLEFKEFVGLPCKNRPPFPRTGATRGAQEPCSVWEPPKRHRDGSAFQYEYEPPCTSLCARVQAVRLPPQLMAWALHFLMDAQPGSEPTPM,False,False,True,Q96AP0,"[('G3DSA:2.40.50.960', None), ('IPR019437', 'Shelterin complex subunit TPP1/Est3'), ('IPR028631', 'Adrenocortical dysplasia protein'), ('PF10341', 'Shelterin complex subunit, TPP1/ACD'), ('PTHR14487', 'ADRENOCORTICAL DYSPLASIA PROTEIN ACD')]",,"""ENSG00000102977; Low tissue specificity."";",,,,,ENST00000219251.13 [Q96AP0-2];ENST00000620761.6 [Q96AP0-3];,ACD,ENSG00000102977,0.0,ACD,Canonical_RBPs,0.0,,,,0.607,0.271,ACD
Q96B02,ENSG00000104343,UBE2W_HUMAN,antiviral innate immune response [GO:0140374]; cellular response to misfolded protein [GO:0071218]; DNA repair [GO:0006281]; negative regulation of TORC1 signaling [GO:1904262]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein K11-linked ubiquitination [GO:0070979]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515],cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842],"PTM: Autoubiquitinated at Met-1. {ECO:0000269|PubMed:22496338, ECO:0000269|PubMed:23560854}.",,"DOMAIN 3..151; /note=""UBC core""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00388""","STRAND 23..26; /evidence=""ECO:0007829|PDB:8A58""; STRAND 35..42; /evidence=""ECO:0007829|PDB:2A7L""; STRAND 53..60; /evidence=""ECO:0007829|PDB:2A7L""; STRAND 70..76; /evidence=""ECO:0007829|PDB:2A7L""; STRAND 88..90; /evidence=""ECO:0007829|PDB:8A58""","HELIX 6..17; /evidence=""ECO:0007829|PDB:2A7L""; HELIX 93..95; /evidence=""ECO:0007829|PDB:2A7L""; HELIX 105..115; /evidence=""ECO:0007829|PDB:2A7L""; HELIX 128..135; /evidence=""ECO:0007829|PDB:8A58""","TURN 48..51; /evidence=""ECO:0007829|PDB:2A7L""; TURN 62..66; /evidence=""ECO:0007829|PDB:2A7L""; TURN 96..98; /evidence=""ECO:0007829|PDB:2A7L""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,UBE2W UBC16,Ubiquitin-conjugating enzyme E2 W (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme W) (N-terminal E2 ubiquitin-conjugating enzyme) (EC 2.3.2.25) (N-terminus-conjugating E2) (Ubiquitin carrier protein W) (Ubiquitin-conjugating enzyme 16) (UBC-16) (Ubiquitin-protein ligase W),Homo sapiens (Human),151.0,17331.0,MASMQKRLQKELLALQNDPPPGMTLNEKSVQNSITQWIVDMEGAPGTLYEGEKFQLLFKFSSRYPFDSPQVMFTGENIPVHPHVYSNGHICLSILTEDWSPALSVQSVCLSIISMLSSCKEKRRPPDNSFYVRTCNKNPKKTKWWYHDDTC,False,False,True,Q96B02,"[('cd00195', 'UBCc'), ('G3DSA:3.10.110.10', 'Ubiquitin Conjugating Enzyme'), ('IPR000608', 'Ubiquitin-conjugating enzyme E2'), ('IPR016135', 'Ubiquitin-conjugating enzyme/RWD-like'), ('IPR050113', 'Ubiquitin-conjugating enzyme'), ('PF00179', 'Ubiquitin-conjugating enzyme'), ('PS50127', 'Ubiquitin-conjugating (UBC) core domain profile'), ('PTHR24067', 'Ubiquitin-conjugating enzyme'), ('SM00212', 'Ubiquitin-conjugating enzyme E2, catalytic domain homologues'), ('SSF54495', 'UBC-like')]",,"""ENSG00000104343; Low tissue specificity."";","CATALYTIC ACTIVITY: Reaction=S-ubiquitinyl-[E1 ubiquitin-activating enzyme]-L-cysteine + [E2 ubiquitin-conjugating enzyme]-L-cysteine = [E1 ubiquitin-activating enzyme]-L-cysteine + S-ubiquitinyl-[E2 ubiquitin-conjugating enzyme]-L-cysteine.; EC=2.3.2.23; Evidence={ECO:0000255|PROSITE-ProRule:PRU00388, ECO:0000269|PubMed:20061386}; CATALYTIC ACTIVITY: Reaction=S-ubiquitinyl-[E1 ubiquitin-activating enzyme]-L-cysteine + [acceptor protein]-N-terminal-amino acid = [E1 ubiquitin-activating enzyme]-L-cysteine + N-terminal-ubiquitinyl-[acceptor protein].; EC=2.3.2.25; Evidence={ECO:0000269|PubMed:23560854, ECO:0000269|PubMed:23696636};",2.3.2.23; 2.3.2.25,,PATHWAY: Protein modification; protein ubiquitination. {ECO:0000255|PROSITE-ProRule:PRU00388}.,ENST00000517608.5 [Q96B02-3];ENST00000602593.6 [Q96B02-1];ENST00000651945.1 [Q96B02-2];,UBE2W,ENSG00000104343,0.0,,,,6.62,DP01337,0.066,0.066,,UBE2W
Q96CW1,ENSG00000161203,AP2M1_HUMAN,clathrin-dependent endocytosis [GO:0072583]; intracellular protein transport [GO:0006886]; negative regulation of protein localization to plasma membrane [GO:1903077]; positive regulation of receptor internalization [GO:0002092]; positive regulation of synaptic vesicle endocytosis [GO:1900244]; postsynaptic neurotransmitter receptor internalization [GO:0098884]; protein-containing complex assembly [GO:0065003]; receptor internalization [GO:0031623]; regulation of vesicle size [GO:0097494]; synaptic vesicle endocytosis [GO:0048488]; vesicle budding from membrane [GO:0006900]; vesicle-mediated transport [GO:0016192],AP-2 adaptor complex [GO:0030122]; clathrin-coated endocytic vesicle [GO:0045334]; clathrin-coated endocytic vesicle membrane [GO:0030669]; clathrin-coated pit [GO:0005905]; cytoplasmic side of plasma membrane [GO:0009898]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; endocytic vesicle membrane [GO:0030666]; endolysosome membrane [GO:0036020]; extracellular exosome [GO:0070062]; extrinsic component of presynaptic endocytic zone membrane [GO:0098894]; glutamatergic synapse [GO:0098978]; lysosomal membrane [GO:0005765]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; synaptic vesicle [GO:0008021],clathrin adaptor activity [GO:0035615]; disordered domain specific binding [GO:0097718]; lipid binding [GO:0008289]; low-density lipoprotein particle receptor binding [GO:0050750]; signal sequence binding [GO:0005048]; transmembrane transporter binding [GO:0044325],PTM: Phosphorylation at Thr-156 increases the affinity of the AP-2 complex for cargo membrane proteins during the initial stages of endocytosis. {ECO:0000269|PubMed:11877457}.,,"DOMAIN 170..434; /note=""MHD""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00404""","STRAND 4..8; /evidence=""ECO:0007829|PDB:6URI""; STRAND 14..22; /evidence=""ECO:0007829|PDB:6URI""; STRAND 45..50; /evidence=""ECO:0007829|PDB:6URI""; STRAND 53..60; /evidence=""ECO:0007829|PDB:6URI""; STRAND 63..71; /evidence=""ECO:0007829|PDB:6URI""; STRAND 172..185; /evidence=""ECO:0007829|PDB:6BNT""; STRAND 191..205; /evidence=""ECO:0007829|PDB:6BNT""; STRAND 207..209; /evidence=""ECO:0007829|PDB:6BNT""; STRAND 211..216; /evidence=""ECO:0007829|PDB:6BNT""; STRAND 245..248; /evidence=""ECO:0007829|PDB:6BNT""; STRAND 263..265; /evidence=""ECO:0007829|PDB:6BNT""; STRAND 269..279; /evidence=""ECO:0007829|PDB:6BNT""; STRAND 287..296; /evidence=""ECO:0007829|PDB:6BNT""; STRAND 300..309; /evidence=""ECO:0007829|PDB:6BNT""; STRAND 315..325; /evidence=""ECO:0007829|PDB:6BNT""; STRAND 330..345; /evidence=""ECO:0007829|PDB:6BNT""; STRAND 350..372; /evidence=""ECO:0007829|PDB:6BNT""; STRAND 386..394; /evidence=""ECO:0007829|PDB:6BNT""; STRAND 401..407; /evidence=""ECO:0007829|PDB:6BNT""; STRAND 409..412; /evidence=""ECO:0007829|PDB:6BNT""; STRAND 418..433; /evidence=""ECO:0007829|PDB:6BNT""","HELIX 28..35; /evidence=""ECO:0007829|PDB:6URI""; HELIX 75..93; /evidence=""ECO:0007829|PDB:6URI""; HELIX 98..103; /evidence=""ECO:0007829|PDB:6URI""; HELIX 106..115; /evidence=""ECO:0007829|PDB:6URI""; HELIX 415..417; /evidence=""ECO:0007829|PDB:6BNT""","TURN 297..299; /evidence=""ECO:0007829|PDB:6BNT""; TURN 346..349; /evidence=""ECO:0007829|PDB:6BNT""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,AP2M1 CLAPM1 KIAA0109,AP-2 complex subunit mu (AP-2 mu chain) (Adaptin-mu2) (Adaptor protein complex AP-2 subunit mu) (Adaptor-related protein complex 2 subunit mu) (Clathrin assembly protein complex 2 mu medium chain) (Clathrin coat assembly protein AP50) (Clathrin coat-associated protein AP50) (HA2 50 kDa subunit) (Plasma membrane adaptor AP-2 50 kDa protein),Homo sapiens (Human),435.0,49655.0,MIGGLFIYNHKGEVLISRVYRDDIGRNAVDAFRVNVIHARQQVRSPVTNIARTSFFHVKRSNIWLAAVTKQNVNAAMVFEFLYKMCDVMAAYFGKISEENIKNNFVLIYELLDEILDFGYPQNSETGALKTFITQQGIKSQHQTKEEQSQITSQVTGQIGWRREGIKYRRNELFLDVLESVNLLMSPQGQVLSAHVSGRVVMKSYLSGMPECKFGMNDKIVIEKQGKGTADETSKSGKQSIAIDDCTFHQCVRLSKFDSERSISFIPPDGEFELMRYRTTKDIILPFRVIPLVREVGRTKLEVKVVIKSNFKPSLLAQKIEVRIPTPLNTSGVQVICMKGKAKYKASENAIVWKIKRMAGMKESQISAEIELLPTNDKKKWARPPISMNFEVPFAPSGLKVRYLKVFEPKLNYSDHDVIKWVRYIGRSGIYETRC,True,False,False,Q96CW1,"[('cd09251', 'C-terminal domain of medium Mu2 subunit in ubiquitously expressed clathrin-associated adaptor protein (AP) complex AP-2'), ('cd14836', 'AP-2 complex subunit mu N-terminal domain'), ('G3DSA:2.60.40.1170', 'Mu homology domain, subdomain B'), ('G3DSA:3.30.450.60', None), ('IPR001392', 'Clathrin adaptor, mu subunit'), ('IPR011012', 'Longin-like domain superfamily'), ('IPR018240', 'Clathrin adaptor, mu subunit, conserved site'), ('IPR022775', 'AP complex, mu/sigma subunit'), ('IPR028565', 'Mu homology domain'), ('IPR036168', 'AP-2 complex subunit mu, C-terminal superfamily'), ('IPR043512', 'Mu2, C-terminal domain'), ('IPR043532', 'AP-2 complex subunit mu, N-terminal'), ('IPR050431', 'Adaptor complexes medium subunit'), ('PF00928', 'Adaptor complexes medium subunit family'), ('PF01217', 'Clathrin adaptor complex small chain'), ('PIRSF005992', 'Adaptor protein complex, mu subunit'), ('PR00314', 'CLATHRINADPT'), ('PS00990', 'Clathrin adaptor complexes medium chain signature 1'), ('PS00991', 'Clathrin adaptor complexes medium chain signature 2'), ('PS51072', 'Mu homology domain (MHD) profile')]",,"""ENSG00000161203; Low tissue specificity."";",,,,,ENST00000292807.9 [Q96CW1-1];ENST00000382456.7 [Q96CW1-2];ENST00000439647.5 [Q96CW1-2];ENST00000621863.5 [Q96CW1-2];,AP2M1,ENSG00000161203,0.0,,,,,,,0.028,,AP2M1
Q96D03,ENSG00000145358,DDT4L_HUMAN,negative regulation of signal transduction [GO:0009968],cytoplasm [GO:0005737],,,,,,,,"cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,DDIT4L REDD2 RTP801L,DNA damage-inducible transcript 4-like protein (HIF-1 responsive protein RTP801-like) (Protein regulated in development and DNA damage response 2) (REDD-2),Homo sapiens (Human),193.0,21740.0,MVATGSLSSKNPASISELLDCGYHPESLLSDFDYWDYVVPEPNLNEVIFEESTCQNLVKMLENCLSKSKQTKLGCSKVLVPEKLTQRIAQDVLRLSSTEPCGLRGCVMHVNLEIENVCKKLDRIVCDSSVVPTFELTLVFKQENCSWTSFRDFFFSRGRFSSGFRRTLILSSGFRLVKKKLYSLIGTTVIEGS,False,False,True,Q96D03,"[('G3DSA:3.90.470.40', 'RTP801-like'), ('IPR012918', 'RTP801-like'), ('IPR038281', 'RTP801-like, C-terminal domain superfamily'), ('PF07809', 'RTP801 C-terminal region'), ('PTHR12478', 'DNA-DAMAGE-INDUCIBLE TRANSCRIPT 4 PROTEIN DDIT4')]",,"""ENSG00000145358; Group enriched (skeletal muscle, tongue)."";",,,,,ENST00000273990.6;,DDIT4L,ENSG00000145358,0.0,,,,,,,0.321,,DDIT4L
Q96EZ8,ENSG00000187778,MCRS1_HUMAN,chromatin remodeling [GO:0006338]; DNA recombination [GO:0006310]; DNA repair [GO:0006281]; negative regulation of telomere maintenance via telomere lengthening [GO:1904357]; positive regulation of DNA repair [GO:0045739]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of protein localization to nucleolus [GO:1904751]; positive regulation of telomere maintenance in response to DNA damage [GO:1904507]; positive regulation of transcription by RNA polymerase II [GO:0045944]; protein modification process [GO:0036211]; regulation of cell cycle [GO:0051726]; regulation of chromosome organization [GO:0033044]; regulation of DNA repair [GO:0006282]; regulation of DNA replication [GO:0006275]; regulation of DNA strand elongation [GO:0060382]; regulation of embryonic development [GO:0045995]; telomere maintenance [GO:0000723],cytoplasm [GO:0005737]; dendrite [GO:0030425]; histone acetyltransferase complex [GO:0000123]; Ino80 complex [GO:0031011]; MLL1 complex [GO:0071339]; NSL complex [GO:0044545]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perikaryon [GO:0043204],G-quadruplex RNA binding [GO:0002151]; poly(G) binding [GO:0034046]; poly(U) RNA binding [GO:0008266]; telomerase inhibitor activity [GO:0010521],"PTM: Ubiquitinated by UBR5 when not assembled in the INO80 complex, leading to its degradation: UBR5 recognizes and binds a degron that is not accessible when MCRS1 is part of the INO80 complex. {ECO:0000269|PubMed:37478862}.",,"DOMAIN 363..419; /note=""FHA""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00086""",,,,"cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,MCRS1 INO80Q MSP58,Microspherule protein 1 (58 kDa microspherule protein) (Cell cycle-regulated factor p78) (INO80 complex subunit J) (MCRS2),Homo sapiens (Human),462.0,51803.0,MDKDSQGLLDSSLMASGTASRSEDEESLAGQKRASSQALGTIPKRRSSSRFIKRKKFDDELVESSLAKSSTRAKGASGVEPGRCSGSEPSSSEKKKVSKAPSTPVPPSPAPAPGLTKRVKKSKQPLQVTKDLGRWKPADDLLLINAVLQTNDLTSVHLGVKFSCRFTLREVQERWYALLYDPVISKLACQAMRQLHPEAIAAIQSKALFSKAEEQLLSKVGSTSQPTLETFQDLLHRHPDAFYLARTAKALQAHWQLMKQYYLLEDQTVQPLPKGDQVLNFSDAEDLIDDSKLKDMRDEVLEHELMVADRRQKREIRQLEQELHKWQVLVDSITGMSSPDFDNQTLAVLRGRMVRYLMRSREITLGRATKDNQIDVDLSLEGPAWKISRKQGVIKLKNNGDFFIANEGRRPIYIDGRPVLCGSKWRLSNNSVVEIASLRFVFLINQDLIALIRAEAAKITPQ,False,True,False,Q96EZ8,"[('cd22687', 'forkhead associated (FHA) domain found in microspherule protein 1 (MCRS1) and similar proteins'), ('G3DSA:2.60.200.20', None), ('IPR000253', 'Forkhead-associated (FHA) domain'), ('IPR008984', 'SMAD/FHA domain superfamily'), ('IPR025999', 'Microspherule protein, N-terminal domain'), ('IPR037912', 'Microspherule protein 1'), ('PF00498', 'FHA domain'), ('PF13325', 'N-terminal region of micro-spherule protein'), ('PS50006', 'Forkhead-associated (FHA) domain profile'), ('PTHR13233', 'MICROSPHERULE PROTEIN 1'), ('SM00240', 'Forkhead associated domain'), ('SSF49879', 'SMAD/FHA domain')]",,"""ENSG00000187778; Low tissue specificity."";",,,,,ENST00000343810.9 [Q96EZ8-1];ENST00000357123.8 [Q96EZ8-2];ENST00000546244.5 [Q96EZ8-4];ENST00000550165.5 [Q96EZ8-1];,MCRS1,ENSG00000187778,0.0,MCRS1,Non-canonical_RBPs,0.0,,,,0.372,0.281,MCRS1
Q96HA1,ENSG00000196313,P121A_HUMAN,mRNA transport [GO:0051028]; nucleocytoplasmic transport [GO:0006913]; protein import into nucleus [GO:0006606]; RNA export from nucleus [GO:0006405],endoplasmic reticulum membrane [GO:0005789]; nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654],nuclear localization sequence binding [GO:0008139]; structural constituent of nuclear pore [GO:0017056],,DOMAIN: Contains F-X-F-G repeats.,,,,,"cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,POM121 KIAA0618 NUP121 POM121A,Nuclear envelope pore membrane protein POM 121 (Nuclear envelope pore membrane protein POM 121A) (Nucleoporin Nup121) (Pore membrane protein of 121 kDa),Homo sapiens (Human),1249.0,127720.0,MSPAAAAAGAGERRRPIASVRDGRGRGCGGPARAVLLGLSLVGLLLYLVPAAAALAWLTVGATAAWWGLSREPRGSRPLSSFVRKARHRRPLSSFVRKARHRRTLFASPLAKSTANGNLLEPRTLLEGPDPAELLLMGSYLGKPGPPQPAAAPEGQDLRDRPGRRPPARPAPRSPPPRSPPPRSPPPSPPTHRAHHVYPSLPTPLLRPSRRPSPRDCGTLPNRFVITPRRRYPIHQAQYSCLGVLPTVCWNGYHKKAVLSPRNSRMVCSPVTVRIAPPDRRFSRSAIPEQIISSTLSSPSSNAPDPCAKETVLSALKEKEKKRTVEEEDQIFLDGQENKRRRHDSSGSGHSAFEPLVANGVPASFVPKPGSLKRGLNSQSSDDHLNKRSRSSSMSSLTGAYASGIPSSSRNAITSSYSSTRGISQLWKRNGPSSSPFSSPASSRSQTPERPAKKIREEELCHHSSSSTPLAADRESQGEKAADTTPRKKQNSNSQSTPGSSGQRKRKVQLLPSRRGEQLTLPPPPQLGYSITAEDLDLEKKASLQWFNQALEDKSDAASNSVTETPPITQPSFTFTLPAAAPASPPTSLLAPSTNPLLESLKKMQTPPSLPPCPESAGAATTEALSPPKTPSLLPPLGLSQSGPPGLLPSPSFDSKPPTTLLGLIPAPSMVPATDTKAPPTLQAETATKPQATSAPSPAPKQSFLFGTQNTSPSSPAAPAASSAPPMFKPIFTAPPKSEKEGPTPPGPSVTATAPSSSSLPTTTSTTAPTFQPVFSSMGPPASVPLPAPFFKQTTTPATAPTTTAPLFTGLASATSAVAPITSASPSTDSASKPAFGFGINSVSSSSVSTTTSTATAASQPFLFGAPQASAASFTPAMGSIFQFGKPPALPTTTTVTTFSQSLHTAVPTATSSSAADFSGFGSTLATSAPATSSQPTLTFSNTSTPTFNIPFGSSAKSPLPSYPGANPQPAFGAAEGQPPGAAKPALAPSFGSSFTFGNSAAPAAAPTPAPPSMIKVVPAYVPTPIHPIFGGATHSAFGLKATASAFGAPASSQPAFGGSTAVFFGAATSSGFGATTQTASSGSSSSVFGSTTPSPFTFGGSAAPAGSGSFGINVATPGSSTTTGAFSFGAGQSGSTATSTPFAGGLGQNALGTTGQSTPFAFNVSSTTESKPVFGGTATPTFGLNTPAPGVGTSGSSLSFGASSAPAQGFVGVAPFGSAALSFSIGAGSKTPGARQRLQARRQHTRKK,True,False,False,Q96HA1,"[('IPR026054', 'Nuclear pore complex protein'), ('PF15229', 'POM121 family'), ('PTHR23193', 'NUCLEAR PORE COMPLEX PROTEIN NUP')]",,"""ENSG00000196313; Low tissue specificity."";",,,,,ENST00000395270.5 [Q96HA1-3];ENST00000434423.5 [Q96HA1-1];ENST00000627934.3 [Q96HA1-2];,POM121,ENSG00000196313,0.0,POM121,Non-canonical_RBPs,2.0,,,,1.0,0.441,POM121
Q96HA8,ENSG00000156795,NTAQ1_HUMAN,protein modification process [GO:0036211],cytosol [GO:0005829]; nucleus [GO:0005634],protein-N-terminal asparagine amidohydrolase activity [GO:0008418]; protein-N-terminal glutamine amidohydrolase activity [GO:0070773],,,,"STRAND 42..45; /evidence=""ECO:0007829|PDB:3C9Q""; STRAND 50..56; /evidence=""ECO:0007829|PDB:3C9Q""; STRAND 62..67; /evidence=""ECO:0007829|PDB:3C9Q""; STRAND 70..74; /evidence=""ECO:0007829|PDB:6KGJ""; STRAND 76..79; /evidence=""ECO:0007829|PDB:3C9Q""; STRAND 81..88; /evidence=""ECO:0007829|PDB:3C9Q""; STRAND 92..96; /evidence=""ECO:0007829|PDB:3C9Q""; STRAND 100..102; /evidence=""ECO:0007829|PDB:3C9Q""; STRAND 104..107; /evidence=""ECO:0007829|PDB:3C9Q""; STRAND 129..134; /evidence=""ECO:0007829|PDB:3C9Q""; STRAND 152..154; /evidence=""ECO:0007829|PDB:3C9Q""; STRAND 156..158; /evidence=""ECO:0007829|PDB:3C9Q""; STRAND 185..192; /evidence=""ECO:0007829|PDB:3C9Q""","HELIX 6..8; /evidence=""ECO:0007829|PDB:6KGJ""; HELIX 18..20; /evidence=""ECO:0007829|PDB:3C9Q""; HELIX 28..41; /evidence=""ECO:0007829|PDB:3C9Q""; HELIX 47..49; /evidence=""ECO:0007829|PDB:3C9Q""; HELIX 108..114; /evidence=""ECO:0007829|PDB:3C9Q""; HELIX 124..126; /evidence=""ECO:0007829|PDB:3C9Q""; HELIX 135..141; /evidence=""ECO:0007829|PDB:3C9Q""; HELIX 147..149; /evidence=""ECO:0007829|PDB:3C9Q""; HELIX 176..179; /evidence=""ECO:0007829|PDB:3C9Q""; HELIX 193..200; /evidence=""ECO:0007829|PDB:3C9Q""","TURN 89..91; /evidence=""ECO:0007829|PDB:3C9Q""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,NTAQ1 C8orf32 WDYHV1,Protein N-terminal glutamine amidohydrolase (EC 3.5.1.122) (Protein NH2-terminal glutamine deamidase) (N-terminal Gln amidase) (Nt(Q)-amidase) (WDYHV motif-containing protein 1),Homo sapiens (Human),205.0,23680.0,MEGNGPAAVHYQPASPPRDACVYSSCYCEENIWKLCEYIKNHDQYPLEECYAVFISNERKMIPIWKQQARPGDGPVIWDYHVVLLHVSSGGQNFIYDLDTVLPFPCLFDTYVEDAFKSDDDIHPQFRRKFRVIRADSYLKNFASDRSHMKDSSGNWREPPPPYPCIETGDSKMNLNDFISMDPKVGWGAVYTLSEFTHRFGSKNC,False,False,True,Q96HA8,"[('G3DSA:3.10.620.10', 'Protein N-terminal glutamine amidohydrolase, alpha beta roll'), ('IPR023128', 'Protein N-terminal glutamine amidohydrolase, alpha beta roll'), ('IPR037132', 'Protein N-terminal glutamine amidohydrolase, alpha beta roll superfamily'), ('IPR039733', 'Protein N-terminal glutamine amidohydrolase'), ('PF09764', 'N-terminal glutamine amidase'), ('PTHR13035', 'PROTEIN N-TERMINAL GLUTAMINE AMIDOHYDROLASE')]",,"""ENSG00000156795; Low tissue specificity."";","CATALYTIC ACTIVITY: Reaction=N-terminal L-glutaminyl-[protein] + H2O = N-terminal L-glutamyl-[protein] + NH4(+); Xref=Rhea:RHEA:50680, Rhea:RHEA-COMP:12668, Rhea:RHEA-COMP:12777, ChEBI:CHEBI:15377, ChEBI:CHEBI:28938, ChEBI:CHEBI:64721, ChEBI:CHEBI:64722; EC=3.5.1.122; Evidence={ECO:0000250|UniProtKB:Q80WB5};",3.5.1.122,,,ENST00000287387.7 [Q96HA8-1];ENST00000523984.5 [Q96HA8-2];ENST00000524254.5 [Q96HA8-2];,NTAQ1,ENSG00000156795,0.0,,,,,,,0.059,,NTAQ1
Q96L73,ENSG00000165671,NSD1_HUMAN,methylation [GO:0032259]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of DNA-templated transcription [GO:0006355]; regulation of peptidyl-serine phosphorylation [GO:0033135]; regulation of RNA polymerase II regulatory region sequence-specific DNA binding [GO:1903025],chromatin [GO:0000785]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],chromatin binding [GO:0003682]; histone H3 methyltransferase activity [GO:0140938]; histone H3K36 dimethyltransferase activity [GO:0140954]; histone H3K36 methyltransferase activity [GO:0046975]; histone H4K20 methyltransferase activity [GO:0042799]; nuclear androgen receptor binding [GO:0050681]; nuclear estrogen receptor binding [GO:0030331]; nuclear retinoic acid receptor binding [GO:0042974]; nuclear retinoid X receptor binding [GO:0046965]; nuclear thyroid hormone receptor binding [GO:0046966]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; transcription coregulator activity [GO:0003712]; transcription corepressor activity [GO:0003714]; zinc ion binding [GO:0008270],,,"DOMAIN 323..388; /note=""PWWP 1""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00162""; DOMAIN 1756..1818; /note=""PWWP 2""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00162""; DOMAIN 1890..1940; /note=""AWS""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00562""; DOMAIN 1942..2059; /note=""SET""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00190""; DOMAIN 2066..2082; /note=""Post-SET""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00155""","STRAND 1901..1903; /evidence=""ECO:0007829|PDB:3OOI""; STRAND 1944..1948; /evidence=""ECO:0007829|PDB:3OOI""; STRAND 1950..1960; /evidence=""ECO:0007829|PDB:3OOI""; STRAND 1967..1970; /evidence=""ECO:0007829|PDB:3OOI""; STRAND 1973..1976; /evidence=""ECO:0007829|PDB:3OOI""; STRAND 1998..2002; /evidence=""ECO:0007829|PDB:3OOI""; STRAND 2005..2013; /evidence=""ECO:0007829|PDB:3OOI""; STRAND 2026..2034; /evidence=""ECO:0007829|PDB:3OOI""; STRAND 2037..2046; /evidence=""ECO:0007829|PDB:3OOI""; STRAND 2062..2064; /evidence=""ECO:0007829|PDB:6KQP""; STRAND 2079..2082; /evidence=""ECO:0007829|PDB:6KQQ""","HELIX 1852..1863; /evidence=""ECO:0007829|PDB:3OOI""; HELIX 1869..1871; /evidence=""ECO:0007829|PDB:6KQQ""; HELIX 1889..1891; /evidence=""ECO:0007829|PDB:3OOI""; HELIX 1912..1915; /evidence=""ECO:0007829|PDB:3OOI""; HELIX 1928..1930; /evidence=""ECO:0007829|PDB:3OOI""; HELIX 1935..1938; /evidence=""ECO:0007829|PDB:3OOI""; HELIX 1978..1990; /evidence=""ECO:0007829|PDB:3OOI""; HELIX 2015..2018; /evidence=""ECO:0007829|PDB:3OOI""; HELIX 2058..2060; /evidence=""ECO:0007829|PDB:6KQQ""","TURN 1922..1924; /evidence=""ECO:0007829|PDB:3OOI""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,NSD1 ARA267 KMT3B,"Histone-lysine N-methyltransferase, H3 lysine-36 specific (EC 2.1.1.357) (Androgen receptor coactivator 267 kDa protein) (Androgen receptor-associated protein of 267 kDa) (H3-K36-HMTase) (Lysine N-methyltransferase 3B) (Nuclear receptor-binding SET domain-containing protein 1) (NR-binding SET domain-containing protein)",Homo sapiens (Human),2696.0,296652.0,MDQTCELPRRNCLLPFSNPVNLDAPEDKDSPFGNGQSNFSEPLNGCTMQLSTVSGTSQNAYGQDSPSCYIPLRRLQDLASMINVEYLNGSADGSESFQDPEKSDSRAQTPIVCTSLSPGGPTALAMKQEPSCNNSPELQVKVTKTIKNGFLHFENFTCVDDADVDSEMDPEQPVTEDESIEEIFEETQTNATCNYETKSENGVKVAMGSEQDSTPESRHGAVKSPFLPLAPQTETQKNKQRNEVDGSNEKAALLPAPFSLGDTNITIEEQLNSINLSFQDDPDSSTSTLGNMLELPGTSSSSTSQELPFCQPKKKSTPLKYEVGDLIWAKFKRRPWWPCRICSDPLINTHSKMKVSNRRPYRQYYVEAFGDPSERAWVAGKAIVMFEGRHQFEELPVLRRRGKQKEKGYRHKVPQKILSKWEASVGLAEQYDVPKGSKNRKCIPGSIKLDSEEDMPFEDCTNDPESEHDLLLNGCLKSLAFDSEHSADEKEKPCAKSRARKSSDNPKRTSVKKGHIQFEAHKDERRGKIPENLGLNFISGDISDTQASNELSRIANSLTGSNTAPGSFLFSSCGKNTAKKEFETSNGDSLLGLPEGALISKCSREKNKPQRSLVCGSKVKLCYIGAGDEEKRSDSISICTTSDDGSSDLDPIEHSSESDNSVLEIPDAFDRTENMLSMQKNEKIKYSRFAATNTRVKAKQKPLISNSHTDHLMGCTKSAEPGTETSQVNLSDLKASTLVHKPQSDFTNDALSPKFNLSSSISSENSLIKGGAANQALLHSKSKQPKFRSIKCKHKENPVMAEPPVINEECSLKCCSSDTKGSPLASISKSGKVDGLKLLNNMHEKTRDSSDIETAVVKHVLSELKELSYRSLGEDVSDSGTSKPSKPLLFSSASSQNHIPIEPDYKFSTLLMMLKDMHDSKTKEQRLMTAQNLVSYRSPGRGDCSTNSPVGVSKVLVSGGSTHNSEKKGDGTQNSANPSPSGGDSALSGELSASLPGLLSDKRDLPASGKSRSDCVTRRNCGRSKPSSKLRDAFSAQMVKNTVNRKALKTERKRKLNQLPSVTLDAVLQGDRERGGSLRGGAEDPSKEDPLQIMGHLTSEDGDHFSDVHFDSKVKQSDPGKISEKGLSFENGKGPELDSVMNSENDELNGVNQVVPKKRWQRLNQRRTKPRKRMNRFKEKENSECAFRVLLPSDPVQEGRDEFPEHRTPSASILEEPLTEQNHADCLDSAGPRLNVCDKSSASIGDMEKEPGIPSLTPQAELPEPAVRSEKKRLRKPSKWLLEYTEEYDQIFAPKKKQKKVQEQVHKVSSRCEEESLLARGRSSAQNKQVDENSLISTKEEPPVLEREAPFLEGPLAQSELGGGHAELPQLTLSVPVAPEVSPRPALESEELLVKTPGNYESKRQRKPTKKLLESNDLDPGFMPKKGDLGLSKKCYEAGHLENGITESCATSYSKDFGGGTTKIFDKPRKRKRQRHAAAKMQCKKVKNDDSSKEIPGSEGELMPHRTATSPKETVEEGVEHDPGMPASKKMQGERGGGAALKENVCQNCEKLGELLLCEAQCCGAFHLECLGLTEMPRGKFICNECRTGIHTCFVCKQSGEDVKRCLLPLCGKFYHEECVQKYPPTVMQNKGFRCSLHICITCHAANPANVSASKGRLMRCVRCPVAYHANDFCLAAGSKILASNSIICPNHFTPRRGCRNHEHVNVSWCFVCSEGGSLLCCDSCPAAFHRECLNIDIPEGNWYCNDCKAGKKPHYREIVWVKVGRYRWWPAEICHPRAVPSNIDKMRHDVGEFPVLFFGSNDYLWTHQARVFPYMEGDVSSKDKMGKGVDGTYKKALQEAAARFEELKAQKELRQLQEDRKNDKKPPPYKHIKVNRPIGRVQIFTADLSEIPRCNCKATDENPCGIDSECINRMLLYECHPTVCPAGGRCQNQCFSKRQYPEVEIFRTLQRGWGLRTKTDIKKGEFVNEYVGELIDEEECRARIRYAQEHDITNFYMLTLDKDRIIDAGPKGNYARFMNHCCQPNCETQKWSVNGDTRVGLFALSDIKAGTELTFNYNLECLGNGKTVCKCGAPNCSGFLGVRPKNQPIATEEKSKKFKKKQQGKRRTQGEITKEREDECFSCGDAGQLVSCKKPGCPKVYHADCLNLTKRPAGKWECPWHQCDICGKEAASFCEMCPSSFCKQHREGMLFISKLDGRLSCTEHDPCGPNPLEPGEIREYVPPPVPLPPGPSTHLAEQSTGMAAQAPKMSDKPPADTNQMLSLSKKALAGTCQRPLLPERPLERTDSRPQPLDKVRDLAGSGTKSQSLVSSQRPLDRPPAVAGPRPQLSDKPSPVTSPSSSPSVRSQPLERPLGTADPRLDKSIGAASPRPQSLEKTSVPTGLRLPPPDRLLITSSPKPQTSDRPTDKPHASLSQRLPPPEKVLSAVVQTLVAKEKALRPVDQNTQSKNRAALVMDLIDLTPRQKERAASPHQVTPQADEKMPVLESSSWPASKGLGHMPRAVEKGCVSDPLQTSGKAAAPSEDPWQAVKSLTQARLLSQPPAKAFLYEPTTQASGRASAGAEQTPGPLSQSPGLVKQAKQMVGGQQLPALAAKSGQSFRSLGKAPASLPTEEKKLVTTEQSPWALGKASSRAGLWPIVAGQTLAQSCWSAGSTQTLAQTCWSLGRGQDPKPEQNTLPALNQAPSSHKCAESEQK,False,False,True,Q96L73,"[('cd15648', 'PHD finger 1 found in nuclear receptor-binding SET domain-containing protein NSD1 and NSD2'), ('cd15650', 'PHD finger 2 found in nuclear receptor-binding SET domain-containing protein 1 (NSD1)'), ('cd15653', 'PHD finger 3 found in nuclear receptor-binding SET domain-containing protein 1 (NSD1)'), ('cd15656', 'PHD finger 4 found in nuclear receptor-binding SET domain-containing protein 1 (NSD1)'), ('cd15659', 'PHD finger 5 found in nuclear receptor-binding SET domain-containing protein 1 (NSD1)'), ('cd19210', 'SET domain (including post-SET domain) found in nuclear receptor-binding SET domain-containing protein 1 (NSD1) and similar proteins'), ('cd20161', 'first PWWP domain found in nuclear receptor-binding SET domain-containing protein 1 (NSD1) and similar proteins'), ('cd20164', 'second PWWP domain found in nuclear receptor-binding SET domain-containing protein 1 (NSD1) and similar proteins'), ('G3DSA:2.170.270.10', 'SET domain'), ('G3DSA:2.30.30.140', None), ('G3DSA:3.30.40.10', 'Zinc/RING finger domain, C3HC4 (zinc finger)'), ('IPR000313', 'PWWP domain'), ('IPR001214', 'SET domain'), ('IPR001965', 'Zinc finger, PHD-type'), ('IPR003616', 'Post-SET domain'), ('IPR006560', 'AWS domain'), ('IPR011011', 'Zinc finger, FYVE/PHD-type'), ('IPR013083', 'Zinc finger, RING/FYVE/PHD-type'), ('IPR019786', 'Zinc finger, PHD-type, conserved site'), ('IPR019787', 'Zinc finger, PHD-finger')]",,"""ENSG00000165671; Low tissue specificity."";","CATALYTIC ACTIVITY: Reaction=L-lysyl(36)-[histone H3] + 2 S-adenosyl-L-methionine = N(6),N(6)-dimethyl-L-lysyl(36)-[histone H3] + 2 S-adenosyl-L-homocysteine + 2 H(+); Xref=Rhea:RHEA:60308, Rhea:RHEA-COMP:9785, Rhea:RHEA-COMP:9787, ChEBI:CHEBI:15378, ChEBI:CHEBI:29969, ChEBI:CHEBI:57856, ChEBI:CHEBI:59789, ChEBI:CHEBI:61976; EC=2.1.1.357; Evidence={ECO:0000269|PubMed:21196496};",2.1.1.357,,,ENST00000439151.7 [Q96L73-1];ENST00000687453.1 [Q96L73-3];,NSD1,ENSG00000165671,0.0,,,,,,,0.729,0.297,NSD1
Q96LK0,ENSG00000174007,CEP19_HUMAN,"cilium assembly [GO:0060271]; microtubule anchoring at centrosome [GO:0034454]; vesicle targeting, trans-Golgi to periciliary membrane compartment [GO:0097712]",centriole [GO:0005814]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; cilium [GO:0005929]; cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; spindle pole [GO:0000922],,,,,,,,"cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,CEP19 C3orf34 HSD5,Centrosomal protein of 19 kDa (Cep19),Homo sapiens (Human),163.0,19166.0,MMCTAKKCGIRFQPPAIILIYESEIKGKIRQRIMPVRNFSKFSDCTRAAEQLKNNPRHKSYLEQVSLRQLEKLFSFLRGYLSGQSLAETMEQIQRETTIDPEEDLNKLDDKELAKRKSIMDELFEKNQKKKDDPNFVYDIEVEFPQDDQLQSCGWDTESADEF,False,False,True,Q96LK0,"[('IPR029412', 'Centrosomal protein of 19kDa'), ('PF14933', 'CEP19-like protein'), ('PTHR31539', 'CENTROSOMAL PROTEIN OF 19K CEP19')]",,"""ENSG00000174007; Low tissue specificity."";",,,,,ENST00000409690.5;,CEP19,ENSG00000174007,0.0,,,,,,,0.215,,CEP19
Q96LR5,ENSG00000182247,UB2E2_HUMAN,DNA damage response [GO:0006974]; ISG15-protein conjugation [GO:0032020]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; protein K11-linked ubiquitination [GO:0070979]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked ubiquitination [GO:0070534],nucleus [GO:0005634],ATP binding [GO:0005524]; ISG15 transferase activity [GO:0042296]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin-protein transferase activity [GO:0004842],PTM: Autoubiquitinated in vitro. {ECO:0000269|PubMed:22496338}.,,"DOMAIN 55..201; /note=""UBC core""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00388""","STRAND 75..82; /evidence=""ECO:0007829|PDB:1Y6L""; STRAND 86..92; /evidence=""ECO:0007829|PDB:1Y6L""; STRAND 103..109; /evidence=""ECO:0007829|PDB:1Y6L""; STRAND 120..125; /evidence=""ECO:0007829|PDB:1Y6L""","HELIX 55..69; /evidence=""ECO:0007829|PDB:1Y6L""; HELIX 141..143; /evidence=""ECO:0007829|PDB:1Y6L""; HELIX 153..165; /evidence=""ECO:0007829|PDB:1Y6L""; HELIX 175..183; /evidence=""ECO:0007829|PDB:1Y6L""; HELIX 185..199; /evidence=""ECO:0007829|PDB:1Y6L""","TURN 98..101; /evidence=""ECO:0007829|PDB:1Y6L""; TURN 112..115; /evidence=""ECO:0007829|PDB:1Y6L""; TURN 144..146; /evidence=""ECO:0007829|PDB:1Y6L""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,UBE2E2 UBCH8,Ubiquitin-conjugating enzyme E2 E2 (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme E2) (UbcH8) (Ubiquitin carrier protein E2) (Ubiquitin-protein ligase E2),Homo sapiens (Human),201.0,22255.0,MSTEAQRVDDSPSTSGGSSDGDQRESVQQEPEREQVQPKKKEGKISSKTAAKLSTSAKRIQKELAEITLDPPPNCSAGPKGDNIYEWRSTILGPPGSVYEGGVFFLDITFSPDYPFKPPKVTFRTRIYHCNINSQGVICLDILKDNWSPALTISKVLLSICSLLTDCNPADPLVGSIATQYMTNRAEHDRMARQWTKRYAT,False,False,True,Q96LR5,"[('cd00195', 'UBCc'), ('G3DSA:3.10.110.10', 'Ubiquitin Conjugating Enzyme'), ('IPR000608', 'Ubiquitin-conjugating enzyme E2'), ('IPR016135', 'Ubiquitin-conjugating enzyme/RWD-like'), ('IPR023313', 'Ubiquitin-conjugating enzyme, active site'), ('PF00179', 'Ubiquitin-conjugating enzyme'), ('PS00183', 'Ubiquitin-conjugating (UBC) active site signature'), ('PS50127', 'Ubiquitin-conjugating (UBC) core domain profile'), ('PTHR24068', 'Ubiquitin-conjugating enzyme'), ('SM00212', 'Ubiquitin-conjugating enzyme E2, catalytic domain homologues'), ('SSF54495', 'UBC-like')]",,"""ENSG00000182247; Low tissue specificity."";","CATALYTIC ACTIVITY: Reaction=S-ubiquitinyl-[E1 ubiquitin-activating enzyme]-L-cysteine + [E2 ubiquitin-conjugating enzyme]-L-cysteine = [E1 ubiquitin-activating enzyme]-L-cysteine + S-ubiquitinyl-[E2 ubiquitin-conjugating enzyme]-L-cysteine.; EC=2.3.2.23; Evidence={ECO:0000255|PROSITE-ProRule:PRU00388, ECO:0000255|PROSITE-ProRule:PRU10133, ECO:0000269|PubMed:20061386};",2.3.2.23,,PATHWAY: Protein modification; protein ubiquitination. {ECO:0000255|PROSITE-ProRule:PRU00388}.,ENST00000396703.6;ENST00000425792.5;,UBE2E2,ENSG00000182247,0.0,,,,,,,0.269,0.274,UBE2E2
Q96Q45,ENSG00000155755,TM237_HUMAN,cilium assembly [GO:0060271]; regulation of Wnt signaling pathway [GO:0030111],ciliary transition zone [GO:0035869]; cone photoreceptor outer segment [GO:0120199]; membrane [GO:0016020]; photoreceptor connecting cilium [GO:0032391]; rod photoreceptor outer segment [GO:0120200],,,,,,,,"cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,TMEM237 ALS2CR4,Transmembrane protein 237 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 4 protein),Homo sapiens (Human),408.0,45526.0,MRTDSGARLEEGHLRPPRALPPVPSQDDIPLSRPKKKKPRTKNTPASASLEGLAQTAGRRPSEGNEPSTKELKEHPEAPVQRRQKKTRLPLELETSSTQKKSSSSSLLRNENGIDAEPAEEAVIQKPRRKTKKTQPAELQYANELGVEDEDIITDEQTTVEQQSVFTAPTGISQPVGKVFVEKSRRFQAADRSELIKTTENIDVSMDVKPSWTTRDVALTVHRAFRMIGLFSHGFLAGCAVWNIVVIYVLAGDQLSNLSNLLQQYKTLAYPFQSLLYLLLALSTISAFDRIDFAKISVAIRNFLALDPTALASFLYFTALILSLSQQMTSDRIHLYTPSSVNGSLWEAGIEEQILQPWIVVNLVVALLVGLSWLFLSYRPGMDLSEELMFSSEVEEYPDKEKEIKASS,False,False,True,Q96Q45,"[('IPR029409', 'Transmembrane protein 237'), ('PF15383', 'Transmembrane protein 237'), ('PTHR28388', 'TRANSMEMBRANE PROTEIN 237')]",,"""ENSG00000155755; Tissue enriched (retina)."";",,,,,ENST00000409444.6 [Q96Q45-2];ENST00000409883.7 [Q96Q45-1];,TMEM237,ENSG00000155755,0.0,,,,,,,0.581,0.336,TMEM237
Q96RG2,ENSG00000115687,PASK_HUMAN,energy homeostasis [GO:0097009]; intracellular signal transduction [GO:0035556]; negative regulation of glycogen biosynthetic process [GO:0045719]; positive regulation of translation [GO:0045727]; protein autophosphorylation [GO:0046777]; protein phosphorylation [GO:0006468]; regulation of glucagon secretion [GO:0070092]; regulation of respiratory gaseous exchange [GO:0043576],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634],ATP binding [GO:0005524]; histone H2AS1 kinase activity [GO:0044024]; phosphatidylinositol binding [GO:0035091]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],PTM: Autophosphorylated on Thr-1161 and Thr-1165. Autophosphorylation is activated by phospholipids. {ECO:0000269|PubMed:11459942}.,DOMAIN: The protein kinase domain mediates binding to phosphatidylinositol. {ECO:0000269|PubMed:21418524}.,"DOMAIN 119..190; /note=""PAS 1""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00140""; DOMAIN 335..402; /note=""PAS 2""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00140""; DOMAIN 999..1251; /note=""Protein kinase""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00159""","STRAND 133..141; /evidence=""ECO:0007829|PDB:1LL8""; STRAND 144..147; /evidence=""ECO:0007829|PDB:1LL8""; STRAND 188..191; /evidence=""ECO:0007829|PDB:1LL8""; STRAND 193..195; /evidence=""ECO:0007829|PDB:1LL8""; STRAND 198..203; /evidence=""ECO:0007829|PDB:1LL8""; STRAND 211..214; /evidence=""ECO:0007829|PDB:1LL8""; STRAND 217..219; /evidence=""ECO:0007829|PDB:1LL8""; STRAND 222..225; /evidence=""ECO:0007829|PDB:1LL8""; STRAND 227..234; /evidence=""ECO:0007829|PDB:1LL8""; STRAND 999..1004; /evidence=""ECO:0007829|PDB:3DLS""; STRAND 1006..1010; /evidence=""ECO:0007829|PDB:3DLS""; STRAND 1012..1018; /evidence=""ECO:0007829|PDB:3DLS""; STRAND 1023..1032; /evidence=""ECO:0007829|PDB:3DLS""; STRAND 1039..1043; /evidence=""ECO:0007829|PDB:3DLS""; STRAND 1047..1050; /evidence=""ECO:0007829|PDB:3DLS""; STRAND 1067..1072; /evidence=""ECO:0007829|PDB:3DLS""; STRAND 1074..1082; /evidence=""ECO:0007829|PDB:3DLS""; STRAND 1134..1136; /evidence=""ECO:0007829|PDB:3DLS""; STRAND 1142..1144; /evidence=""ECO:0007829|PDB:3DLS""","HELIX 151..155; /evidence=""ECO:0007829|PDB:1LL8""; HELIX 167..170; /evidence=""ECO:0007829|PDB:1LL8""; HELIX 177..181; /evidence=""ECO:0007829|PDB:1LL8""; HELIX 987..991; /evidence=""ECO:0007829|PDB:3DLS""; HELIX 994..998; /evidence=""ECO:0007829|PDB:3DLS""; HELIX 1051..1056; /evidence=""ECO:0007829|PDB:3DLS""; HELIX 1090..1095; /evidence=""ECO:0007829|PDB:3DLS""; HELIX 1102..1121; /evidence=""ECO:0007829|PDB:3DLS""; HELIX 1131..1133; /evidence=""ECO:0007829|PDB:3DLS""; HELIX 1166..1168; /evidence=""ECO:0007829|PDB:3DLS""; HELIX 1171..1174; /evidence=""ECO:0007829|PDB:3DLS""; HELIX 1182..1198; /evidence=""ECO:0007829|PDB:3DLS""; HELIX 1206..1209; /evidence=""ECO:0007829|PDB:3DLS""; HELIX 1222..1231; /evidence=""ECO:0007829|PDB:3DLS""; HELIX 1236..1238; /evidence=""ECO:0007829|PDB:3DLS""; HELIX 1242..1247; /evidence=""ECO:0007829|PDB:3DLS""; HELIX 1257..1259; /evidence=""ECO:0007829|PDB:3DLS""; HELIX 1262..1265; /evidence=""ECO:0007829|PDB:3DLS""","TURN 159..161; /evidence=""ECO:0007829|PDB:1LL8""; TURN 174..176; /evidence=""ECO:0007829|PDB:1LL8""; TURN 182..184; /evidence=""ECO:0007829|PDB:1LL8""; TURN 1019..1022; /evidence=""ECO:0007829|PDB:3DLS""; TURN 1044..1046; /evidence=""ECO:0007829|PDB:3DLS""; TURN 1210..1212; /evidence=""ECO:0007829|PDB:3DLS""; TURN 1249..1252; /evidence=""ECO:0007829|PDB:3DLS""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,PASK KIAA0135,PAS domain-containing serine/threonine-protein kinase (PAS-kinase) (PASKIN) (hPASK) (EC 2.7.11.1),Homo sapiens (Human),1323.0,142929.0,MEDGGLTAFEEDQRCLSQSLPLPVSAEGPAAQTTAEPSRSFSSAHRHLSRRNGLSRLCQSRTALSEDRWSSYCLSSLAAQNICTSKLHCPAAPEHTDPSEPRGSVSCCSLLRGLSSGWSSPLLPAPVCNPNKAIFTVDAKTTEILVANDKACGLLGYSSQDLIGQKLTQFFLRSDSDVVEALSEEHMEADGHAAVVFGTVVDIISRSGEKIPVSVWMKRMRQERRLCCVVVLEPVERVSTWVAFQSDGTVTSCDSLFAHLHGYVSGEDVAGQHITDLIPSVQLPPSGQHIPKNLKIQRSVGRARDGTTFPLSLKLKSQPSSEEATTGEAAPVSGYRASVWVFCTISGLITLLPDGTIHGINHSFALTLFGYGKTELLGKNITFLIPGFYSYMDLAYNSSLQLPDLASCLDVGNESGCGERTLDPWQGQDPAEGGQDPRINVVLAGGHVVPRDEIRKLMESQDIFTGTQTELIAGGQLLSCLSPQPAPGVDNVPEGSLPVHGEQALPKDQQITALGREEPVAIESPGQDLLGESRSEPVDVKPFASCEDSEAPVPAEDGGSDAGMCGLCQKAQLERMGVSGPSGSDLWAGAAVAKPQAKGQLAGGSLLMHCPCYGSEWGLWWRSQDLAPSPSGMAGLSFGTPTLDEPWLGVENDREELQTCLIKEQLSQLSLAGALDVPHAELVPTECQAVTAPVSSCDLGGRDLCGGCTGSSSACYALATDLPGGLEAVEAQEVDVNSFSWNLKELFFSDQTDQTSSNCSCATSELRETPSSLAVGSDPDVGSLQEQGSCVLDDRELLLLTGTCVDLGQGRRFRESCVGHDPTEPLEVCLVSSEHYAASDRESPGHVPSTLDAGPEDTCPSAEEPRLNVQVTSTPVIVMRGAAGLQREIQEGAYSGSCYHRDGLRLSIQFEVRRVELQGPTPLFCCWLVKDLLHSQRDSAARTRLFLASLPGSTHSTAAELTGPSLVEVLRARPWFEEPPKAVELEGLAACEGEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETVEAAIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQPVNLADYTWEEVFRVNKPESGVLSAASLEMGNRSLSDVAQAQELCGGPVPGEAPNGQGCLHPGDPRLLTS,False,False,True,Q96RG2,"[('cd00130', 'PAS'), ('cd14004', 'Catalytic domain of the Serine/Threonine kinase, Per-ARNT-Sim (PAS) domain Kinase'), ('G3DSA:1.10.510.10', 'Transferase(Phosphotransferase) domain 1'), ('G3DSA:3.30.200.20', 'Phosphorylase Kinase; domain 1'), ('G3DSA:3.30.450.20', 'PAS domain'), ('IPR000014', 'PAS domain'), ('IPR000719', 'Protein kinase domain'), ('IPR008271', 'Serine/threonine-protein kinase, active site'), ('IPR011009', 'Protein kinase-like domain superfamily'), ('IPR017441', 'Protein kinase, ATP binding site'), ('IPR035965', 'PAS domain superfamily'), ('PF00069', 'Protein kinase domain'), ('PF13426', 'PAS domain'), ('PS00107', 'Protein kinases ATP-binding region signature'), ('PS00108', 'Serine/Threonine protein kinases active-site signature'), ('PS50011', 'Protein kinase domain profile'), ('PS50112', 'PAS repeat profile'), ('PTHR24346', 'MAP/MICROTUBULE AFFINITY-REGULATING KINASE'), ('SM00091', 'PAS domain'), ('SM00220', 'Serine/Threonine protein kinases, catalytic domain')]",,"""ENSG00000115687; Tissue enhanced (lymphoid)."";","CATALYTIC ACTIVITY: Reaction=L-seryl-[protein] + ATP = O-phospho-L-seryl-[protein] + ADP + H(+); Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616, ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.1; CATALYTIC ACTIVITY: Reaction=L-threonyl-[protein] + ATP = O-phospho-L-threonyl-[protein] + ADP + H(+); Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060, Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013, ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216; EC=2.7.11.1;",2.7.11.1,"ACTIVITY REGULATION: Protein kinase activity is inhibited by the first PAS domain: binding of an unidentified ligand desinhibits the protein kinase activity. May be activated by autophosphorylation on Thr-1161 and Thr-1165 (PubMed:11459942). The activating role of autophosphorylation at Thr-1161 is unclear: according to a report, autophosphorylation at Thr-1161 does not play a major role in activation (PubMed:20943661). Autophosphorylation is enhanced upon phosphatidylinositol monophosphate (phosphatidylinositol 4-phosphate) binding and inhibited upon phosphatidylinositol bi- and tri-phosphate binding. In contrast, phosphorylation of target proteins is inhibited upon all phosphatidylinositol-binding (phosphatidylinositol mono- bi- and tri-phosphate). {ECO:0000269|PubMed:11459942, ECO:0000269|PubMed:20943661, ECO:0000269|PubMed:21418524}.",,ENST00000234040.9 [Q96RG2-1];ENST00000358649.8 [Q96RG2-2];ENST00000403638.7 [Q96RG2-4];ENST00000405260.5 [Q96RG2-1];ENST00000544142.5 [Q96RG2-1];,PASK,ENSG00000115687,0.0,,,,,,,0.537,0.057,PASK
Q96SB4,ENSG00000096063,SRPK1_HUMAN,"chromosome segregation [GO:0007059]; innate immune response [GO:0045087]; intracellular signal transduction [GO:0035556]; negative regulation of viral genome replication [GO:0045071]; positive regulation of viral genome replication [GO:0045070]; protein phosphorylation [GO:0006468]; regulation of mRNA processing [GO:0050684]; regulation of mRNA splicing, via spliceosome [GO:0048024]; RNA splicing [GO:0008380]; sperm DNA condensation [GO:0035092]; spliceosomal complex assembly [GO:0000245]",chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; nuclear matrix [GO:0016363]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; plasma membrane [GO:0005886],ATP binding [GO:0005524]; histone H2AS1 kinase activity [GO:0044024]; magnesium ion binding [GO:0000287]; protein kinase activity [GO:0004672]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674]; RNA binding [GO:0003723],,,"DOMAIN 80..653; /note=""Protein kinase""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00159""","STRAND 80..88; /evidence=""ECO:0007829|PDB:5MY8""; STRAND 90..99; /evidence=""ECO:0007829|PDB:5MY8""; STRAND 104..111; /evidence=""ECO:0007829|PDB:5MY8""; STRAND 147..154; /evidence=""ECO:0007829|PDB:5MY8""; STRAND 159..166; /evidence=""ECO:0007829|PDB:5MY8""; STRAND 168..171; /evidence=""ECO:0007829|PDB:1WBP""; STRAND 219..221; /evidence=""ECO:0007829|PDB:5MY8""; STRAND 493..495; /evidence=""ECO:0007829|PDB:5MY8""; STRAND 557..559; /evidence=""ECO:0007829|PDB:5MY8""; STRAND 595..599; /evidence=""ECO:0007829|PDB:5MY8""","HELIX 59..61; /evidence=""ECO:0007829|PDB:5MXX""; HELIX 115..133; /evidence=""ECO:0007829|PDB:5MY8""; HELIX 139..143; /evidence=""ECO:0007829|PDB:5MY8""; HELIX 172..178; /evidence=""ECO:0007829|PDB:5MY8""; HELIX 186..205; /evidence=""ECO:0007829|PDB:5MY8""; HELIX 216..218; /evidence=""ECO:0007829|PDB:5MY8""; HELIX 225..238; /evidence=""ECO:0007829|PDB:5MY8""; HELIX 485..490; /evidence=""ECO:0007829|PDB:5MY8""; HELIX 498..500; /evidence=""ECO:0007829|PDB:1WAK""; HELIX 515..517; /evidence=""ECO:0007829|PDB:5MY8""; HELIX 520..524; /evidence=""ECO:0007829|PDB:5MY8""; HELIX 531..546; /evidence=""ECO:0007829|PDB:5MY8""; HELIX 561..573; /evidence=""ECO:0007829|PDB:5MY8""; HELIX 578..583; /evidence=""ECO:0007829|PDB:5MY8""; HELIX 587..589; /evidence=""ECO:0007829|PDB:5MY8""; HELIX 608..614; /evidence=""ECO:0007829|PDB:5MY8""; HELIX 620..630; /evidence=""ECO:0007829|PDB:5MY8""; HELIX 631..634; /evidence=""ECO:0007829|PDB:5MY8""; HELIX 638..640; /evidence=""ECO:0007829|PDB:5MY8""; HELIX 644..648; /evidence=""ECO:0007829|PDB:5MY8""; HELIX 651..654; /evidence=""ECO:0007829|PDB:5MY8""","TURN 77..79; /evidence=""ECO:0007829|PDB:5MY8""; TURN 100..103; /evidence=""ECO:0007829|PDB:5MY8""; TURN 179..181; /evidence=""ECO:0007829|PDB:5MY8""; TURN 504..506; /evidence=""ECO:0007829|PDB:5MXX""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,SRPK1,SRSF protein kinase 1 (EC 2.7.11.1) (SFRS protein kinase 1) (Serine/arginine-rich protein-specific kinase 1) (SR-protein-specific kinase 1),Homo sapiens (Human),655.0,74325.0,MERKVLALQARKKRTKAKKDKAQRKSETQHRGSAPHSESDLPEQEEEILGSDDDEQEDPNDYCKGGYHLVKIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPQPKPADKMSKNKKKKLKKKQKRQAELLEKRMQEIEEMEKESGPGQKRPNKQEESESPVERPLKENPPNKMTQEKLEESSTIGQDQTLMERDTEGGAAEINCNGVIEVINYTQNSNNETLRHKEDLHNANDCDVQNLNQESSFLSSQNGDSSTSQETDSCTPITSEVSDTMVCQSSSTVGQSFSEQHISQLQESIRAEIPCEDEQEQEHNGPLDNKGKSTAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS,False,False,True,Q96SB4,"[('G3DSA:1.10.510.10', 'Transferase(Phosphotransferase) domain 1'), ('G3DSA:3.30.200.20', 'Phosphorylase Kinase; domain 1'), ('IPR000719', 'Protein kinase domain'), ('IPR008271', 'Serine/threonine-protein kinase, active site'), ('IPR011009', 'Protein kinase-like domain superfamily'), ('IPR017441', 'Protein kinase, ATP binding site'), ('IPR051334', 'Serine/Arginine-Rich Protein Kinases'), ('PF00069', 'Protein kinase domain'), ('PS00107', 'Protein kinases ATP-binding region signature'), ('PS00108', 'Serine/Threonine protein kinases active-site signature'), ('PS50011', 'Protein kinase domain profile'), ('PTHR47634', 'Serine/Arginine-Rich Protein Kinases'), ('SM00220', 'Serine/Threonine protein kinases, catalytic domain'), ('SSF56112', 'Protein kinase-like (PK-like)')]",,"""ENSG00000096063; Low tissue specificity."";","CATALYTIC ACTIVITY: Reaction=L-seryl-[protein] + ATP = O-phospho-L-seryl-[protein] + ADP + H(+); Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616, ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.1; Evidence={ECO:0000269|PubMed:11509566, ECO:0000269|PubMed:12134018, ECO:0000269|PubMed:12565829, ECO:0000269|PubMed:14555757, ECO:0000269|PubMed:15034300, ECO:0000269|PubMed:8208298}; CATALYTIC ACTIVITY: Reaction=L-threonyl-[protein] + ATP = O-phospho-L-threonyl-[protein] + ADP + H(+); Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060, Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013, ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216; EC=2.7.11.1; Evidence={ECO:0000269|PubMed:11509566, ECO:0000269|PubMed:12134018, ECO:0000269|PubMed:12565829, ECO:0000269|PubMed:14555757, ECO:0000269|PubMed:15034300, ECO:0000269|PubMed:8208298};",2.7.11.1,ACTIVITY REGULATION: Activated by phosphorylation on Ser-51 and Ser-555. {ECO:0000269|PubMed:12565829}.,,ENST00000373825.7 [Q96SB4-2];ENST00000423325.6 [Q96SB4-4];,SRPK1,ENSG00000096063,0.0,SRPK1,Non-canonical_RBPs,22.0,,,,0.336,0.278,SRPK1
Q99217,ENSG00000125363,AMELX_HUMAN,amelogenesis [GO:0097186]; biomineral tissue development [GO:0031214]; cell adhesion [GO:0007155]; chondrocyte differentiation [GO:0002062]; enamel mineralization [GO:0070166]; epithelial to mesenchymal transition [GO:0001837]; odontogenesis of dentin-containing tooth [GO:0042475]; osteoblast differentiation [GO:0001649]; positive regulation of collagen biosynthetic process [GO:0032967]; positive regulation of tooth mineralization [GO:0070172]; regulation of cell population proliferation [GO:0042127]; response to calcium ion [GO:0051592]; response to nutrient [GO:0007584]; response to xenobiotic stimulus [GO:0009410]; signal transduction [GO:0007165]; tooth mineralization [GO:0034505],cell surface [GO:0009986]; collagen-containing extracellular matrix [GO:0062023]; endocytic vesicle [GO:0030139]; endoplasmic reticulum lumen [GO:0005788]; extracellular region [GO:0005576],growth factor activity [GO:0008083]; hydroxyapatite binding [GO:0046848]; identical protein binding [GO:0042802]; structural constituent of tooth enamel [GO:0030345],PTM: Phosphorylated by FAM20C in vitro. {ECO:0000269|PubMed:25789606}.,,,,,,"cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,AMELX AMG AMGX,"Amelogenin, X isoform",Homo sapiens (Human),191.0,21603.0,MGTWILFACLLGAAFAMPLPPHPGHPGYINFSYEVLTPLKWYQSIRPPYPSYGYEPMGGWLHHQIIPVLSQQHPPTHTLQPHHHIPVVPAQQPVIPQQPMMPVPGQHSMTPIQHHQPNLPPPAQQPYQPQPVQPQPHQPMQPQPPVHPMQPLPPQPPLPPMFPMQPLPPMLPDLTLEAWPSTDKTKREEVD,True,False,False,Q99217,"[('IPR004116', 'Amelogenin'), ('PF02948', 'Amelogenin'), ('PR01757', 'AMELOGENIN'), ('PTHR46794', 'AMELOGENIN, Y ISOFORM'), ('SM00818', 'Amelogenin')]",,"""ENSG00000125363; Not detected."";",,,,,ENST00000348912.4 [Q99217-2];ENST00000380712.7 [Q99217-3];ENST00000380714.7 [Q99217-1];,AMELX,ENSG00000125363,0.0,,,,,,,0.974,0.508,AMELX
Q99714,ENSG00000072506,HCD2_HUMAN,androgen metabolic process [GO:0008209]; bile acid biosynthetic process [GO:0006699]; brexanolone metabolic process [GO:0062173]; C21-steroid hormone metabolic process [GO:0008207]; estrogen metabolic process [GO:0008210]; fatty acid beta-oxidation [GO:0006635]; fatty acid metabolic process [GO:0006631]; isoleucine catabolic process [GO:0006550]; lipid metabolic process [GO:0006629]; mitochondrial tRNA 3'-end processing [GO:1990180]; mitochondrial tRNA 5'-end processing [GO:0097745]; mitochondrial tRNA methylation [GO:0070901]; mitochondrion organization [GO:0007005]; protein homotetramerization [GO:0051289],cytoplasm [GO:0005737]; mitochondrial matrix [GO:0005759]; mitochondrial nucleoid [GO:0042645]; mitochondrial ribonuclease P complex [GO:0030678]; mitochondrion [GO:0005739]; plasma membrane [GO:0005886]; tRNA methyltransferase complex [GO:0043527],"17-beta-hydroxysteroid dehydrogenase (NAD+) activity [GO:0044594]; 3-hydroxy-2-methylbutyryl-CoA dehydrogenase activity [GO:0047015]; 3-hydroxyacyl-CoA dehydrogenase activity [GO:0003857]; androstan-3-alpha,17-beta-diol dehydrogenase activity [GO:0047044]; chenodeoxycholate 7-alpha-dehydrogenase (NAD+) activity [GO:0106281]; cholate 7-alpha-dehydrogenase activity [GO:0008709]; estradiol 17-beta-dehydrogenase [NAD(P)+] activity [GO:0004303]; isoursodeoxycholate 7-beta-dehydrogenase (NAD+) activity [GO:0106282]; RNA binding [GO:0003723]; testosterone dehydrogenase (NAD+) activity [GO:0047035]; testosterone dehydrogenase [NAD(P)+] activity [GO:0030283]; tRNA binding [GO:0000049]; ursodeoxycholate 7-beta-dehydrogenase (NAD+) activity [GO:0106283]",,,,"STRAND 12..16; /evidence=""ECO:0007829|PDB:2O23""; STRAND 36..41; /evidence=""ECO:0007829|PDB:2O23""; STRAND 58..62; /evidence=""ECO:0007829|PDB:2O23""; STRAND 87..90; /evidence=""ECO:0007829|PDB:2O23""; STRAND 100..102; /evidence=""ECO:0007829|PDB:2O23""; STRAND 148..153; /evidence=""ECO:0007829|PDB:2O23""; STRAND 191..198; /evidence=""ECO:0007829|PDB:2O23""; STRAND 222..224; /evidence=""ECO:0007829|PDB:2O23""; STRAND 250..254; /evidence=""ECO:0007829|PDB:2O23""","HELIX 21..32; /evidence=""ECO:0007829|PDB:2O23""; HELIX 47..54; /evidence=""ECO:0007829|PDB:2O23""; HELIX 68..82; /evidence=""ECO:0007829|PDB:2O23""; HELIX 111..121; /evidence=""ECO:0007829|PDB:2O23""; HELIX 123..136; /evidence=""ECO:0007829|PDB:2O23""; HELIX 157..160; /evidence=""ECO:0007829|PDB:2O23""; HELIX 166..186; /evidence=""ECO:0007829|PDB:2O23""; HELIX 187..189; /evidence=""ECO:0007829|PDB:2O23""; HELIX 204..208; /evidence=""ECO:0007829|PDB:1U7T""; HELIX 216..219; /evidence=""ECO:0007829|PDB:2O23""; HELIX 230..242; /evidence=""ECO:0007829|PDB:2O23""","TURN 17..19; /evidence=""ECO:0007829|PDB:2O23""; TURN 103..106; /evidence=""ECO:0007829|PDB:2O23""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,HSD17B10 ERAB HADH2 MRPP2 SCHAD SDR5C1 XH98G2,3-hydroxyacyl-CoA dehydrogenase type-2 (EC 1.1.1.35) (17-beta-estradiol 17-dehydrogenase) (EC 1.1.1.62) (2-methyl-3-hydroxybutyryl-CoA dehydrogenase) (MHBD) (3-alpha-(17-beta)-hydroxysteroid dehydrogenase (NAD(+))) (EC 1.1.1.239) (3-hydroxy-2-methylbutyryl-CoA dehydrogenase) (EC 1.1.1.178) (3-hydroxyacyl-CoA dehydrogenase type II) (3alpha(or 20beta)-hydroxysteroid dehydrogenase) (EC 1.1.1.53) (7-alpha-hydroxysteroid dehydrogenase) (EC 1.1.1.159) (Endoplasmic reticulum-associated amyloid beta-peptide-binding protein) (Mitochondrial ribonuclease P protein 2) (Mitochondrial RNase P protein 2) (Short chain dehydrogenase/reductase family 5C member 1) (Short-chain type dehydrogenase/reductase XH98G2) (Type II HADH),Homo sapiens (Human),261.0,26923.0,MAAACRSVKGLVAVITGGASGLGLATAERLVGQGASAVLLDLPNSGGEAQAKKLGNNCVFAPADVTSEKDVQTALALAKGKFGRVDVAVNCAGIAVASKTYNLKKGQTHTLEDFQRVLDVNLMGTFNVIRLVAGEMGQNEPDQGGQRGVIINTASVAAFEGQVGQAAYSASKGGIVGMTLPIARDLAPIGIRVMTIAPGLFGTPLLTSLPEKVCNFLASQVPFPSRLGDPAEYAHLVQAIIENPFLNGEVIRLDGAIRMQP,True,False,False,Q99714,"[('cd05371', '17hydroxysteroid dehydrogenase type 10 (HSD10)-like, classical (c) SDRs'), ('G3DSA:3.40.50.720', 'NAD(P)-binding Rossmann-like Domain'), ('IPR002347', 'Short-chain dehydrogenase/reductase SDR'), ('IPR020904', 'Short-chain dehydrogenase/reductase, conserved site'), ('IPR036291', 'NAD(P)-binding domain superfamily'), ('PF00106', 'short chain dehydrogenase'), ('PR00080', 'SDRFAMILY'), ('PR00081', 'GDHRDH'), ('PS00061', 'Short-chain dehydrogenases/reductases family signature'), ('PTHR43658', 'Short-chain dehydrogenases/reductases'), ('SSF51735', 'NAD(P)-binding Rossmann-fold domains')]",,"""ENSG00000072506; Low tissue specificity."";","CATALYTIC ACTIVITY: Reaction=a (3S)-3-hydroxyacyl-CoA + NAD(+) = a 3-oxoacyl-CoA + NADH + H(+); Xref=Rhea:RHEA:22432, ChEBI:CHEBI:15378, ChEBI:CHEBI:57318, ChEBI:CHEBI:57540, ChEBI:CHEBI:57945, ChEBI:CHEBI:90726; EC=1.1.1.35; Evidence={ECO:0000269|PubMed:10600649, ECO:0000269|PubMed:12917011, ECO:0000269|PubMed:25925575, ECO:0000269|PubMed:26950678, ECO:0000269|PubMed:9553139}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:22433; Evidence={ECO:0000305|PubMed:12917011}; PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:22434; Evidence={ECO:0000305|PubMed:10600649, ECO:0000305|PubMed:12917011, ECO:0000305|PubMed:25925575, ECO:0000305|PubMed:26950678, ECO:0000305|PubMed:9553139}; CATALYTIC ACTIVITY: Reaction=(2S,3S)-3-hydroxy-2-methylbutanoyl-CoA + NAD(+) = 2-methyl-3-oxobutanoyl-CoA + NADH + H(+); Xref=Rhea:RHEA:13281, ChEBI:CHEBI:15378, ChEBI:CHEBI:57312, ChEBI:CHEBI:57335, ChEBI:CHEBI:57540, ChEBI:CHEBI:57945; EC=1.1.1.178; Evidence={ECO:0000269|PubMed:18996107, ECO:0000269|PubMed:19706438, ECO:0000269|PubMed:20077426}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:13282; Evidence={ECO:0000305|PubMed:18996107, ECO:0000305|PubMed:19706438, ECO:0000305|PubMed:20077426}; CATALYTIC ACTIVITY: Reaction=testosterone + NAD(+) = androst-4-ene-3,17-dione + NADH + H(+); Xref=Rhea:RHEA:14929, ChEBI:CHEBI:15378, ChEBI:CHEBI:16422, ChEBI:CHEBI:17347, ChEBI:CHEBI:57540, ChEBI:CHEBI:57945; EC=1.1.1.239; Evidence={ECO:0000269|PubMed:12917011}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:14930; Evidence={ECO:0000305|PubMed:12917011}; CATALYTIC ACTIVITY: Reaction=5alpha-androstane-3alpha,17beta-diol + NAD(+) = 17beta-hydroxy-5alpha-androstan-3-one + NADH + H(+); Xref=Rhea:RHEA:42004, ChEBI:CHEBI:15378, ChEBI:CHEBI:16330, ChEBI:CHEBI:36713, ChEBI:CHEBI:57540, ChEBI:CHEBI:57945; EC=1.1.1.53; Evidence={ECO:0000269|PubMed:12917011}; PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:42006; Evidence={ECO:0000305|PubMed:12917011}; CATALYTIC ACTIVITY: Reaction=17beta-estradiol + NAD(+) = estrone + NADH + H(+); Xref=Rhea:RHEA:24612, ChEBI:CHEBI:15378, ChEBI:CHEBI:16469, ChEBI:CHEBI:17263, ChEBI:CHEBI:57540, ChEBI:CHEBI:57945; EC=1.1.1.62; Evidence={ECO:0000269|PubMed:10600649, ECO:0000269|PubMed:12917011}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:24613; Evidence={ECO:0000305|PubMed:10600649, ECO:0000305|PubMed:12917011}; CATALYTIC ACTIVITY: Reaction=cholate + NAD(+) = 3alpha,12alpha-dihydroxy-7-oxo-5beta-cholanate + NADH + H(+); Xref=Rhea:RHEA:19409, ChEBI:CHEBI:11893, ChEBI:CHEBI:15378, ChEBI:CHEBI:29747, ChEBI:CHEBI:57540, ChEBI:CHEBI:57945; EC=1.1.1.159; Evidence={ECO:0000269|PubMed:12917011}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:19410; Evidence={ECO:0000305|PubMed:12917011}; CATALYTIC ACTIVITY: Reaction=(3S)-3-hydroxybutanoyl-CoA + NAD(+) = acetoacetyl-CoA + NADH + H(+); Xref=Rhea:RHEA:30799, ChEBI:CHEBI:15378, ChEBI:CHEBI:57286, ChEBI:CHEBI:57316, ChEBI:CHEBI:57540, ChEBI:CHEBI:57945; Evidence={ECO:0000269|PubMed:10600649, ECO:0000269|PubMed:12917011, ECO:0000269|PubMed:9553139}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:30800; Evidence={ECO:0000305|PubMed:12917011}; PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:30801; Evidence={ECO:0000305|PubMed:10600649, ECO:0000305|PubMed:25925575, ECO:0000305|PubMed:9553139}; CATALYTIC ACTIVITY: Reaction=(3S)-hydroxyoctanoyl-CoA + NAD(+) = 3-oxooctanoyl-CoA + NADH + H(+); Xref=Rhea:RHEA:31195, ChEBI:CHEBI:15378, ChEBI:CHEBI:57540, ChEBI:CHEBI:57945, ChEBI:CHEBI:62617, ChEBI:CHEBI:62619; Evidence={ECO:0000269|PubMed:9553139}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:31196; Evidence={ECO:0000305}; PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:31197; Evidence={ECO:0000305|PubMed:9553139}; CATALYTIC ACTIVITY: Reaction=(3S)-hydroxyhexadecanoyl-CoA + NAD(+) = 3-oxohexadecanoyl-CoA + NADH + H(+); Xref=Rhea:RHEA:31159, ChEBI:CHEBI:15378, ChEBI:CHEBI:57349, ChEBI:CHEBI:57540, ChEBI:CHEBI:57945, ChEBI:CHEBI:62613; Evidence={ECO:0000269|PubMed:9553139}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:31160; Evidence={ECO:0000305}; PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:31161; Evidence={ECO:0000305|PubMed:9553139}; CATALYTIC ACTIVITY: Reaction=17beta-hydroxy-5alpha-androstan-3-one + NAD(+) = 5alpha-androstan-3,17-dione + NADH + H(+); Xref=Rhea:RHEA:41992, ChEBI:CHEBI:15378, ChEBI:CHEBI:15994, ChEBI:CHEBI:16330, ChEBI:CHEBI:57540, ChEBI:CHEBI:57945; Evidence={ECO:0000269|PubMed:12917011}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:41993; Evidence={ECO:0000305|PubMed:12917011}; CATALYTIC ACTIVITY: Reaction=5alpha-pregnan-20beta-ol-3-one + NAD(+) = 5alpha-pregnane-3,20-dione + NADH + H(+); Xref=Rhea:RHEA:42008, ChEBI:CHEBI:15378, ChEBI:CHEBI:28952, ChEBI:CHEBI:57540, ChEBI:CHEBI:57945, ChEBI:CHEBI:78594; Evidence={ECO:0000269|PubMed:12917011}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:42009; Evidence={ECO:0000305|PubMed:12917011}; CATALYTIC ACTIVITY: Reaction=3alpha-hydroxy-5alpha-pregnan-20-one + NAD(+) = 5alpha-pregnane-3,20-dione + NADH + H(+); Xref=Rhea:RHEA:41980, ChEBI:CHEBI:15378, ChEBI:CHEBI:28952, ChEBI:CHEBI:50169, ChEBI:CHEBI:57540, ChEBI:CHEBI:57945; Evidence={ECO:0000269|PubMed:19706438, ECO:0000269|PubMed:28888424}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:41981; Evidence={ECO:0000305|PubMed:19706438, ECO:0000305|PubMed:28888424}; CATALYTIC ACTIVITY: Reaction=cortisone + NAD(+) = 17alpha-hydroxypregn-4-en-3,11,20-trione-21-al + NADH + H(+); Xref=Rhea:RHEA:42016, ChEBI:CHEBI:15378, ChEBI:CHEBI:16962, ChEBI:CHEBI:57540, ChEBI:CHEBI:57945, ChEBI:CHEBI:78596; Evidence={ECO:0000269|PubMed:12917011}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:42017; Evidence={ECO:0000305|PubMed:12917011}; CATALYTIC ACTIVITY: Reaction=11-dehydrocorticosterone + NAD(+) = pregn-4-ene-3,11,20,21-tetraone + NADH + H(+); Xref=Rhea:RHEA:42020, ChEBI:CHEBI:15378, ChEBI:CHEBI:57540, ChEBI:CHEBI:57945, ChEBI:CHEBI:78600, ChEBI:CHEBI:78601; Evidence={ECO:0000269|PubMed:12917011}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:42021; Evidence={ECO:0000305|PubMed:12917011}; CATALYTIC ACTIVITY: Reaction=cortisol + NAD(+) = 11beta,17alpha-dihydroxypregn-4-ene-3,20,21-trione + NADH + H(+); Xref=Rhea:RHEA:42012, ChEBI:CHEBI:15378, ChEBI:CHEBI:17650, ChEBI:CHEBI:57540, ChEBI:CHEBI:57945, ChEBI:CHEBI:78595; Evidence={ECO:0000269|PubMed:12917011}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:42013; Evidence={ECO:0000305|PubMed:12917011}; CATALYTIC ACTIVITY: Reaction=chenodeoxycholate + NAD(+) = 7-oxolithocholate + NADH + H(+); Xref=Rhea:RHEA:42036, ChEBI:CHEBI:15378, ChEBI:CHEBI:36234, ChEBI:CHEBI:57540, ChEBI:CHEBI:57945, ChEBI:CHEBI:78605; Evidence={ECO:0000269|PubMed:12917011}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:42037; Evidence={ECO:0000305|PubMed:12917011}; CATALYTIC ACTIVITY: Reaction=ursodeoxycholate + NAD(+) = 7-oxolithocholate + NADH + H(+); Xref=Rhea:RHEA:42028, ChEBI:CHEBI:15378, ChEBI:CHEBI:57540, ChEBI:CHEBI:57945, ChEBI:CHEBI:78604, ChEBI:CHEBI:78605; Evidence={ECO:0000269|PubMed:12917011}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:42029; Evidence={ECO:0000305|PubMed:12917011}; CATALYTIC ACTIVITY: Reaction=3beta,7beta-dihydroxy-5beta-cholan-24-oate + NAD(+) = 3beta-hydroxy-7-oxo-5beta-cholan-24-oate + NADH + H(+); Xref=Rhea:RHEA:42024, ChEBI:CHEBI:15378, ChEBI:CHEBI:57540, ChEBI:CHEBI:57945, ChEBI:CHEBI:78602, ChEBI:CHEBI:78603; Evidence={ECO:0000269|PubMed:12917011}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:42025; Evidence={ECO:0000305|PubMed:12917011};",1.1.1.159; 1.1.1.178; 1.1.1.239; 1.1.1.35; 1.1.1.53; 1.1.1.62,ACTIVITY REGULATION: The phospholipase C-like activity toward cardiolipin is inhibited by amyloid-beta peptide. {ECO:0000269|PubMed:26338420}.,"PATHWAY: Amino-acid degradation; L-isoleucine degradation. {ECO:0000269|PubMed:19706438}.; PATHWAY: Lipid metabolism; fatty acid beta-oxidation. {ECO:0000269|PubMed:10600649, ECO:0000269|PubMed:12917011, ECO:0000269|PubMed:9553139}.; PATHWAY: Steroid metabolism. {ECO:0000269|PubMed:10600649, ECO:0000269|PubMed:12917011}.; PATHWAY: Lipid metabolism; bile acid biosynthesis. {ECO:0000269|PubMed:12917011}.",ENST00000168216.11 [Q99714-1];ENST00000375304.9 [Q99714-2];,HSD17B10,ENSG00000072506,0.0,HSD17B10,Non-canonical_RBPs,10.0,15.33,DP03854,0.153,,,HSD17B10
Q99816,ENSG00000074319,TS101_HUMAN,autophagosome maturation [GO:0097352]; cell division [GO:0051301]; endosome to lysosome transport [GO:0008333]; exosomal secretion [GO:1990182]; extracellular transport [GO:0006858]; keratinocyte differentiation [GO:0030216]; macroautophagy [GO:0016236]; membrane fission [GO:0090148]; multivesicular body assembly [GO:0036258]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of epidermal growth factor-activated receptor activity [GO:0007175]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of exosomal secretion [GO:1903543]; positive regulation of ubiquitin-dependent endocytosis [GO:2000397]; positive regulation of viral budding via host ESCRT complex [GO:1903774]; protein modification process [GO:0036211]; protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043328]; regulation of cell cycle [GO:0051726]; regulation of cell growth [GO:0001558]; regulation of extracellular exosome assembly [GO:1903551]; regulation of MAP kinase activity [GO:0043405]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; viral budding [GO:0046755]; viral budding via host ESCRT complex [GO:0039702]; viral release from host cell [GO:0019076],centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; endosome [GO:0005768]; endosome membrane [GO:0010008]; ESCRT I complex [GO:0000813]; extracellular exosome [GO:0070062]; Flemming body [GO:0090543]; late endosome [GO:0005770]; late endosome membrane [GO:0031902]; multivesicular body [GO:0005771]; nucleolus [GO:0005730]; plasma membrane [GO:0005886],calcium-dependent protein binding [GO:0048306]; DNA binding [GO:0003677]; protein homodimerization activity [GO:0042803]; protein-containing complex binding [GO:0044877]; transcription corepressor activity [GO:0003714]; ubiquitin binding [GO:0043130]; ubiquitin protein ligase binding [GO:0031625]; virion binding [GO:0046790],"PTM: Monoubiquitinated at multiple sites by LRSAM1 and by MGRN1. Ubiquitination inactivates it, possibly by regulating its shuttling between an active membrane-bound protein and an inactive soluble form. Ubiquitination by MGRN1 requires the presence of UBE2D1. {ECO:0000269|PubMed:15256501, ECO:0000269|PubMed:17229889, ECO:0000269|PubMed:19703557}.",DOMAIN: The UEV domain is required for the interaction of the complex with ubiquitin. It also mediates the interaction with PTAP/PSAP motifs of HIV-1 P6 protein and human spumaretrovirus Gag protein.; DOMAIN: The coiled coil domain may interact with stathmin.; DOMAIN: The UEV domain binds ubiquitin and P-[ST]-A-P peptide motif independently.,"DOMAIN 2..145; /note=""UEV""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00652""; DOMAIN 322..390; /note=""SB""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00644""","STRAND 35..43; /evidence=""ECO:0007829|PDB:7NLC""; STRAND 45..47; /evidence=""ECO:0007829|PDB:4ZNY""; STRAND 49..63; /evidence=""ECO:0007829|PDB:7NLC""; STRAND 66..75; /evidence=""ECO:0007829|PDB:7NLC""; STRAND 86..89; /evidence=""ECO:0007829|PDB:7NLC""; STRAND 95..97; /evidence=""ECO:0007829|PDB:7NLC""; STRAND 100..103; /evidence=""ECO:0007829|PDB:1S1Q""; STRAND 107..109; /evidence=""ECO:0007829|PDB:1KPP""; STRAND 140..143; /evidence=""ECO:0007829|PDB:7NLC""; STRAND 317..322; /evidence=""ECO:0007829|PDB:6VME""","HELIX 5..11; /evidence=""ECO:0007829|PDB:7NLC""; HELIX 18..29; /evidence=""ECO:0007829|PDB:7NLC""; HELIX 112..115; /evidence=""ECO:0007829|PDB:7NLC""; HELIX 124..137; /evidence=""ECO:0007829|PDB:7NLC""; HELIX 230..299; /evidence=""ECO:0007829|PDB:3IV1""; HELIX 314..316; /evidence=""ECO:0007829|PDB:6VME""; HELIX 323..350; /evidence=""ECO:0007829|PDB:6VME""; HELIX 356..383; /evidence=""ECO:0007829|PDB:6VME""","TURN 12..14; /evidence=""ECO:0007829|PDB:7NLC""; TURN 78..81; /evidence=""ECO:0007829|PDB:7NLC""; TURN 119..121; /evidence=""ECO:0007829|PDB:7NLC""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,TSG101,Tumor susceptibility gene 101 protein (ESCRT-I complex subunit TSG101),Homo sapiens (Human),390.0,43944.0,MAVSESQLKKMVSKYKYRDLTVRETVNVITLYKDLKPVLDSYVFNDGSSRELMNLTGTIPVPYRGNTYNIPICLWLLDTYPYNPPICFVKPTSSMTIKTGKHVDANGKIYLPYLHEWKHPQSDLLGLIQVMIVVFGDEPPVFSRPISASYPPYQATGPPNTSYMPGMPGGISPYPSGYPPNPSGYPGCPYPPGGPYPATTSSQYPSQPPVTTVGPSRDGTISEDTIRASLISAVSDKLRWRMKEEMDRAQAELNALKRTEEDLKKGHQKLEEMVTRLDQEVAEVDKNIELLKKKDEELSSALEKMENQSENNDIDEVIIPTAPLYKQILNLYAEENAIEDTIFYLGEALRRGVIDLDVFLKHVRLLSRKQFQLRALMQKARKTAGLSDLY,False,False,True,Q99816,"[('G3DSA:3.10.110.10', 'Ubiquitin Conjugating Enzyme'), ('G3DSA:6.10.140.820', None), ('G3DSA:6.10.250.370', None), ('IPR008883', 'Ubiquitin E2 variant, N-terminal'), ('IPR016135', 'Ubiquitin-conjugating enzyme/RWD-like'), ('IPR017916', 'Steadiness box (SB) domain'), ('IPR037202', 'ESCRT assembly domain'), ('IPR052070', 'ESCRT-I complex UEV domain-containing protein'), ('PF05743', 'UEV domain'), ('PF09454', 'Vps23 core domain'), ('PS51312', 'Steadiness box (SB) domain profile'), ('PS51322', 'UEV domain profile'), ('PTHR23306', 'ESCRT-I complex UEV domain-containing protein'), ('SM00212', 'Ubiquitin-conjugating enzyme E2, catalytic domain homologues'), ('SSF140111', 'Endosomal sorting complex assembly domain'), ('SSF54495', 'UBC-like')]",Q99816;,"""ENSG00000074319; Low tissue specificity."";",,,,,ENST00000251968.4 [Q99816-1];,TSG101,ENSG00000074319,0.0,,,,,,,0.415,0.059,TSG101
Q99973,ENSG00000129566|ENSG00000291791,TEP1_HUMAN,telomere maintenance via recombination [GO:0000722],"chromosome, telomeric region [GO:0000781]; cytoplasm [GO:0005737]; nuclear matrix [GO:0016363]; ribonucleoprotein complex [GO:1990904]; telomerase holoenzyme complex [GO:0005697]",ATP binding [GO:0005524]; enzyme binding [GO:0019899]; p53 binding [GO:0002039]; RNA binding [GO:0003723]; telomerase activity [GO:0003720]; telomerase RNA binding [GO:0070034],,,"DOMAIN 223..676; /note=""TROVE""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00343""; DOMAIN 1162..1490; /note=""NACHT""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00136""",,,,"cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,TEP1 TLP1 TP1,Telomerase protein component 1 (Telomerase-associated protein 1) (Telomerase protein 1) (p240) (p80 telomerase homolog),Homo sapiens (Human),2627.0,290490.0,MEKLHGHVSAHPDILSLENRCLAMLPDLQPLEKLHQHVSTHSDILSLKNQCLATLPDLKTMEKPHGYVSAHPDILSLENQCLATLSDLKTMEKPHGHVSAHPDILSLENRCLATLSSLKSTVSASPLFQSLQISHMTQADLYRVNNSNCLLSEPPSWRAQHFSKGLDLSTCPIALKSISATETAQEATLGRWFDSEEKKGAETQMPSYSLSLGEEEEVEDLAVKLTSGDSESHPEPTDHVLQEKKMALLSLLCSTLVSEVNMNNTSDPTLAAIFEICRELALLEPEFILKASLYARQQLNVRNVANNILAIAAFLPACRPHLRRYFCAIVQLPSDWIQVAELYQSLAEGDKNKLVPLPACLRTAMTDKFAQFDEYQLAKYNPRKHRAKRHPRRPPRSPGMEPPFSHRCFPRYIGFLREEQRKFEKAGDTVSEKKNPPRFTLKKLVQRLHIHKPAQHVQALLGYRYPSNLQLFSRSRLPGPWDSSRAGKRMKLSRPETWERELSLRGNKASVWEELIENGKLPFMAMLRNLCNLLRVGISSRHHELILQRLQHAKSVIHSRQFPFRFLNAHDAIDALEAQLRNQALPFPSNITLMRRILTRNEKNRPRRRFLCHLSRQQLRMAMRIPVLYEQLKREKLRVHKARQWKYDGEMLNRYRQALETAVNLSVKHSLPLLPGRTVLVYLTDANADRLCPKSNPQGPPLNYALLLIGMMITRAEQVDVVLCGGDTLKTAVLKAEEGILKTAIKLQAQVQEFDENDGWSLNTFGKYLLSLAGQRVPVDRVILLGQSMDDGMINVAKQLYWQRVNSKCLFVGILLRRVQYLSTDLNPNDVTLSGCTDAILKFIAEHGASHLLEHVGQMDKIFKIPPPPGKTGVQSLRPLEEDTPSPLAPVSQQGWRSIRLFISSTFRDMHGERDLLLRSVLPALQARAAPHRISLHGIDLRWGVTEEETRRNRQLEVCLGEVENAQLFVGILGSRYGYIPPSYNLPDHPHFHWAQQYPSGRSVTEMEVMQFLNRNQRLQPSAQALIYFRDSSFLSSVPDAWKSDFVSESEEAARRISELKSYLSRQKGITCRRYPCEWGGVAAGRPYVGGLEEFGQLVLQDVWNMIQKLYLQPGALLEQPVSIPDDDLVQATFQQLQKPPSPARPRLLQDTVQRLMLPHGRLSLVTGQSGQGKTAFLASLVSALQAPDGAKVASLVFFHFSGARPDQGLALTLLRRLCTYLRGQLKEPGALPSTYRSLVWELQQRLLPKSAESLHPGQTQVLIIDGADRLVDQNGQLISDWIPKKLPRCVHLVLSVSSDAGLGETLEQSQGAHVLALGPLEASARARLVREELALYGKRLEESPFNNQMRLLLVKRESGRPLYLRLVTDHLRLFTLYEQVSERLRTLPATVPLLLQHILSTLEKEHGPDVLPQALTALEVTRSGLTVDQLHGVLSVWRTLPKGTKSWEEAVAAGNSGDPYPMGPFACLVQSLRSLLGEGPLERPGARLCLPDGPLRTAAKRCYGKRPGLEDTAHILIAAQLWKTCDADASGTFRSCPPEALGDLPYHLLQSGNRGLLSKFLTNLHVVAAHLELGLVSRLLEAHALYASSVPKEEQKLPEADVAVFRTFLRQQASILSQYPRLLPQQAANQPLDSPLCHQASLLSRRWHLQHTLRWLNKPRTMKNQQSSSLSLAVSSSPTAVAFSTNGQRAAVGTANGTVYLLDLRTWQEEKSVVSGCDGISACLFLSDDTLFLTAFDGLLELWDLQHGCRVLQTKAHQYQITGCCLSPDCRLLATVCLGGCLKLWDTVRGQLAFQHTYPKSLNCVAFHPEGQVIATGSWAGSISFFQVDGLKVTKDLGAPGASIRTLAFNVPGGVVAVGRLDSMVELWAWREGARLAAFPAHHGFVAAALFLHAGCQLLTAGEDGKVQVWSGSLGRPRGHLGSLSLSPALSVALSPDGDRVAVGYRADGIRIYKISSGSQGAQGQALDVAVSALAWLSPKVLVSGAEDGSLQGWALKECSLQSLWLLSRFQKPVLGLATSQELLASASEDFTVQLWPRQLLTRPHKAEDFPCGTELRGHEGPVSCCSFSTDGGSLATGGRDRSLLCWDVRTPKTPVLIHSFPACHRDWVTGCAWTKDNLLISCSSDGSVGLWDPESGQRLGQFLGHQSAVSAVAAVEEHVVSVSRDGTLKVWDHQGVELTSIPAHSGPISHCAAAMEPRAAGQPGSELLVVTVGLDGATRLWHPLLVCQTHTLLGHSGPVRAAAVSETSGLMLTASEDGSVRLWQVPKEADDTCIPRSSAAVTAVAWAPDGSMAVSGNQAGELILWQEAKAVATAQAPGHIGALIWSSAHTFFVLSADEKISEWQVKLRKGSAPGNLSLHLNRILQEDLGVLTSLDWAPDGHFLILAKADLKLLCMKPGDAPSEIWSSYTENPMILSTHKEYGIFVLQPKDPGVLSFLRQKESGEFEERLNFDINLENPSRTLISITQAKPESESSFLCASSDGILWNLAKCSPEGEWTTGNMWQKKANTPETQTPGTDPSTCRESDASMDSDASMDSEPTPHLKTRQRRKIHSGSVTALHVLPELLVTASKDRDVKLWERPSMQLLGLFRCEGSVSCLEPWLGANSTLQLAVGDVQGNVYFLNWE,True,False,False,Q99973,"[('cd00200', 'WD40'), ('G3DSA:1.25.40.370', None), ('G3DSA:2.130.10.10', 'YVTN repeat-like/Quinoprotein amine dehydrogenase'), ('G3DSA:3.40.50.300', 'P-loop containing nucleotide triphosphate hydrolases'), ('IPR001680', 'WD40 repeat'), ('IPR007111', 'NACHT nucleoside triphosphatase'), ('IPR008850', 'TEP1, N-terminal'), ('IPR008858', 'TROVE domain'), ('IPR015943', 'WD40/YVTN repeat-like-containing domain superfamily'), ('IPR025139', 'Domain of unknown function DUF4062'), ('IPR027417', 'P-loop containing nucleoside triphosphate hydrolase'), ('IPR036322', 'WD40-repeat-containing domain superfamily'), ('IPR037214', 'TROVE domain superfamily'), ('IPR045804', 'Domain of unknown function DUF5920'), ('IPR052652', 'Telomerase Complex Component'), ('PF00400', 'WD domain, G-beta repeat'), ('PF05386', 'TEP1 N-terminal domain'), ('PF05729', 'NACHT domain'), ('PF05731', 'TROVE domain'), ('PF13271', 'Domain of unknown function (DUF4062)')]",,"""ENSG00000129566; Low tissue specificity."";",,,,,ENST00000262715.10 [Q99973-1];ENST00000708760.1 [Q99973-1];,TEP1,ENSG00000129566,1.0,TEP1,Canonical_RBPs,2.0,,,,0.123,0.033,TEP1
Q99988,ENSG00000130513,GDF15_HUMAN,cell-cell signaling [GO:0007267]; cellular response to chemical stress [GO:0062197]; GDF15-GFRAL signaling pathway [GO:0160144]; negative regulation of appetite [GO:0032099]; negative regulation of growth hormone receptor signaling pathway [GO:0060400]; negative regulation of leukocyte migration [GO:0002686]; negative regulation of multicellular organism growth [GO:0040015]; negative regulation of SMAD protein signal transduction [GO:0060392]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of fatty acid oxidation [GO:0046321]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of myoblast fusion [GO:1901741]; positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction [GO:0051897]; reduction of food intake in response to dietary excess [GO:0002023]; response to metformin [GO:1901558]; signal transduction [GO:0007165]; transforming growth factor beta receptor signaling pathway [GO:0007179],cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634],cytokine activity [GO:0005125]; growth factor activity [GO:0008083]; hormone activity [GO:0005179]; protein homodimerization activity [GO:0042803],,,,"STRAND 204..219; /evidence=""ECO:0007829|PDB:5VZ3""; STRAND 229..231; /evidence=""ECO:0007829|PDB:5VZ3""; STRAND 233..243; /evidence=""ECO:0007829|PDB:5VZ3""; STRAND 248..250; /evidence=""ECO:0007829|PDB:5VZ3""; STRAND 273..287; /evidence=""ECO:0007829|PDB:5VZ3""; STRAND 289..308; /evidence=""ECO:0007829|PDB:5VZ3""","HELIX 253..264; /evidence=""ECO:0007829|PDB:5VZ3""","TURN 220..224; /evidence=""ECO:0007829|PDB:5VZ3""; TURN 226..228; /evidence=""ECO:0007829|PDB:5VZ3""; TURN 266..268; /evidence=""ECO:0007829|PDB:5VZ3""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,GDF15 MIC1 PDF PLAB PTGFB,Growth/differentiation factor 15 (GDF-15) (Macrophage inhibitory cytokine 1) (MIC-1) (NSAID-activated gene 1 protein) (NAG-1) (NSAID-regulated gene 1 protein) (NRG-1) (Placental TGF-beta) (Placental bone morphogenetic protein) (Prostate differentiation factor),Homo sapiens (Human),308.0,34140.0,MPGQELRTVNGSQMLLVLLVLSWLPHGGALSLAEASRASFPGPSELHSEDSRFRELRKRYEDLLTRLRANQSWEDSNTDLVPAPAVRILTPEVRLGSGGHLHLRISRAALPEGLPEASRLHRALFRLSPTASRSWDVTRPLRRQLSLARPQAPALHLRLSPPPSQSDQLLAESSSARPQLELHLRPQAARGRRRARARNGDHCPLGPGRCCRLHTVRASLEDLGWADWVLSPREVQVTMCIGACPSQFRAANMHAQIKTSLHRLKPDTVPAPCCVPASYNPMVLIQKTDTGVSLQTYDDLLAKDCHCI,True,False,False,Q99988,"[('cd19376', 'transforming growth factor beta (TGF-beta) like domain found in mammalian growth/differentiation factor 15 (GDF-15) and similar proteins'), ('G3DSA:2.10.90.10', 'Cystine-knot cytokines'), ('IPR001839', 'Transforming growth factor-beta, C-terminal'), ('IPR015615', 'Transforming growth factor-beta-related'), ('IPR029034', 'Cystine-knot cytokine'), ('PF00019', 'Transforming growth factor beta like domain'), ('PS51362', 'TGF-beta family profile'), ('PTHR11848', 'TGF-BETA FAMILY'), ('SM00204', 'Transforming growth factor-beta (TGF-beta) family'), ('SSF57501', 'Cystine-knot cytokines')]",,"""ENSG00000130513; Tissue enhanced (kidney, urinary bladder)."";",,,,,ENST00000252809.3;ENST00000595973.3;ENST00000597765.2;,GDF15,ENSG00000130513,0.0,,,,,,,0.286,0.084,GDF15
Q9BPW9,ENSG00000073737,DHRS9_HUMAN,9-cis-retinoic acid biosynthetic process [GO:0042904]; androgen metabolic process [GO:0008209]; epithelial cell differentiation [GO:0030855]; progesterone metabolic process [GO:0042448]; retinol metabolic process [GO:0042572]; steroid metabolic process [GO:0008202],endoplasmic reticulum membrane [GO:0005789]; intracellular membrane-bounded organelle [GO:0043231],"alcohol dehydrogenase (NAD+) activity [GO:0004022]; all-trans-retinol dehydrogenase (NAD+) activity [GO:0004745]; androstan-3-alpha,17-beta-diol dehydrogenase activity [GO:0047044]; androsterone dehydrogenase activity [GO:0047023]; racemase and epimerase activity [GO:0016854]; testosterone dehydrogenase (NAD+) activity [GO:0047035]",,,,,,,"cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,DHRS9 RDH15 SDR9C4 UNQ835/PRO1773,Dehydrogenase/reductase SDR family member 9 (EC 1.1.1.209) (EC 1.1.1.53) (3-alpha hydroxysteroid dehydrogenase) (3-alpha-HSD) (NADP-dependent retinol dehydrogenase/reductase) (RDH-E2) (RDHL) (Retinol dehydrogenase 15) (EC 1.1.1.105) (Short chain dehydrogenase/reductase family 9C member 4) (Short-chain dehydrogenase/reductase retSDR8) (Tracheobronchial epithelial cell-specific retinol dehydrogenase) (RDH-TBE),Homo sapiens (Human),319.0,35227.0,MLFWVLGLLILCGFLWTRKGKLKIEDITDKYIFITGCDSGFGNLAARTFDKKGFHVIAACLTESGSTALKAETSERLRTVLLDVTDPENVKRTAQWVKNQVGEKGLWGLINNAGVPGVLAPTDWLTLEDYREPIEVNLFGLISVTLNMLPLVKKAQGRVINVSSVGGRLAIVGGGYTPSKYAVEGFNDSLRRDMKAFGVHVSCIEPGLFKTNLADPVKVIEKKLAIWEQLSPDIKQQYGEGYIEKSLDKLKGNKSYVNMDLSPVVECMDHALTSLFPKTHYAAGKDAKIFWIPLSHMPAALQDFLLLKQKAELANPKAV,True,False,False,Q9BPW9,"[('cd09805', 'human 17beta-hydroxysteroid dehydrogenase type 2 (type 2 17beta-HSD)-like, classical (c) SDRs'), ('G3DSA:3.40.50.720', 'NAD(P)-binding Rossmann-like Domain'), ('IPR002347', 'Short-chain dehydrogenase/reductase SDR'), ('IPR036291', 'NAD(P)-binding domain superfamily'), ('PF00106', 'short chain dehydrogenase'), ('PR00080', 'SDRFAMILY'), ('PR00081', 'GDHRDH'), ('PTHR43313', 'Short-chain dehydrogenases/reductases'), ('SSF51735', 'NAD(P)-binding Rossmann-fold domains')]",,"""ENSG00000073737; Tissue enhanced (heart muscle, intestine)."";","CATALYTIC ACTIVITY: Reaction=3beta-hydroxy-5alpha-pregnane-20-one + NAD(+) = 5alpha-pregnane-3,20-dione + NADH + H(+); Xref=Rhea:RHEA:41988, ChEBI:CHEBI:11909, ChEBI:CHEBI:15378, ChEBI:CHEBI:28952, ChEBI:CHEBI:57540, ChEBI:CHEBI:57945; Evidence={ECO:0000269|PubMed:11294878}; CATALYTIC ACTIVITY: Reaction=17beta-hydroxy-5alpha-androstan-3-one + NAD(+) = 5alpha-androstan-3,17-dione + NADH + H(+); Xref=Rhea:RHEA:41992, ChEBI:CHEBI:15378, ChEBI:CHEBI:15994, ChEBI:CHEBI:16330, ChEBI:CHEBI:57540, ChEBI:CHEBI:57945; Evidence={ECO:0000269|PubMed:11294878}; CATALYTIC ACTIVITY: Reaction=androsterone + NAD(+) = 5alpha-androstan-3,17-dione + NADH + H(+); Xref=Rhea:RHEA:20381, ChEBI:CHEBI:15378, ChEBI:CHEBI:15994, ChEBI:CHEBI:16032, ChEBI:CHEBI:57540, ChEBI:CHEBI:57945; EC=1.1.1.209; Evidence={ECO:0000269|PubMed:11294878, ECO:0000269|PubMed:29541409}; CATALYTIC ACTIVITY: Reaction=5alpha-androstane-3alpha,17beta-diol + NAD(+) = 17beta-hydroxy-5alpha-androstan-3-one + NADH + H(+); Xref=Rhea:RHEA:42004, ChEBI:CHEBI:15378, ChEBI:CHEBI:16330, ChEBI:CHEBI:36713, ChEBI:CHEBI:57540, ChEBI:CHEBI:57945; EC=1.1.1.53; Evidence={ECO:0000269|PubMed:11294878}; CATALYTIC ACTIVITY: Reaction=all-trans-retinol + NAD(+) = all-trans-retinal + NADH + H(+); Xref=Rhea:RHEA:21284, ChEBI:CHEBI:15378, ChEBI:CHEBI:17336, ChEBI:CHEBI:17898, ChEBI:CHEBI:57540, ChEBI:CHEBI:57945; EC=1.1.1.105; Evidence={ECO:0000269|PubMed:11304534}; CATALYTIC ACTIVITY: Reaction=3alpha-hydroxy-5alpha-pregnan-20-one + NAD(+) = 5alpha-pregnane-3,20-dione + NADH + H(+); Xref=Rhea:RHEA:41980, ChEBI:CHEBI:15378, ChEBI:CHEBI:28952, ChEBI:CHEBI:50169, ChEBI:CHEBI:57540, ChEBI:CHEBI:57945; Evidence={ECO:0000269|PubMed:11294878};",1.1.1.105; 1.1.1.209; 1.1.1.53,,,ENST00000357546.6 [Q9BPW9-1];ENST00000412271.1 [Q9BPW9-1];ENST00000421653.5 [Q9BPW9-2];ENST00000428522.5 [Q9BPW9-1];ENST00000432060.6 [Q9BPW9-4];ENST00000436483.6 [Q9BPW9-1];ENST00000602501.5 [Q9BPW9-1];ENST00000674881.1 [Q9BPW9-1];,DHRS9,ENSG00000073737,0.0,,,,,,,0.047,,DHRS9
Q9BPZ3,ENSG00000120727,PAIP2_HUMAN,memory [GO:0007613]; negative regulation of translation [GO:0017148]; negative regulation of translational initiation [GO:0045947]; regulation of long-term synaptic potentiation [GO:1900271]; spermatogenesis [GO:0007283]; translation [GO:0006412],cytoplasm [GO:0005737],mRNA binding [GO:0003729]; mRNA regulatory element binding translation repressor activity [GO:0000900]; translation repressor activity [GO:0030371],"PTM: Ubiquitinated, leading to its degradation by the proteasome. {ECO:0000269|PubMed:16804161}.",DOMAIN: Only the PABPC1-interacting motif-1 (PAM1) interferes with the binding of PABPC1 to poly(A) RNA and translation initiation.,,,,,"cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,PAIP2 PAIP2A HSPC218,Polyadenylate-binding protein-interacting protein 2 (PABP-interacting protein 2) (PAIP-2) (Poly(A)-binding protein-interacting protein 2),Homo sapiens (Human),127.0,14984.0,MKDPSRSSTSPSIINEDVIINGHSHEDDNPFAEYMWMENEEEFNRQIEEELWEEEFIERCFQEMLEEEEEHEWFIPARDLPQTMDQIQDQFNDLVISDGSSLEDLVVKSNLNPNAKEFVPGVKYGNI,False,False,True,Q9BPZ3,"[('IPR009818', 'PAM2 motif'), ('IPR040396', 'Polyadenylate-binding protein-interacting protein 2-like'), ('PF07145', 'Ataxin-2 C-terminal region'), ('PTHR13154', 'POLYADENYLATE-BINDING PROTEIN-INTERACTING PROTEIN 2')]",Q9BPZ3;,"""ENSG00000120727; Low tissue specificity."";",,,,,ENST00000265192.9;ENST00000394795.6;ENST00000510080.1;,PAIP2,ENSG00000120727,0.0,PAIP2,Canonical_RBPs,1.0,,,0.173,0.866,0.189,PAIP2
Q9BQB6,ENSG00000167397,VKOR1_HUMAN,blood coagulation [GO:0007596]; bone development [GO:0060348]; peptidyl-glutamic acid carboxylation [GO:0017187]; positive regulation of coagulation [GO:0050820]; regulation of blood coagulation [GO:0030193]; response to organic cyclic compound [GO:0014070]; vitamin K metabolic process [GO:0042373]; xenobiotic metabolic process [GO:0006805],endoplasmic reticulum [GO:0005783]; endoplasmic reticulum membrane [GO:0005789],quinone binding [GO:0048038]; vitamin-K-epoxide reductase (warfarin-insensitive) activity [GO:0047058]; vitamin-K-epoxide reductase (warfarin-sensitive) activity [GO:0047057],,"DOMAIN: Partially oxidized VKORC1 forms a cysteine adduct with substrates, vitamin K 2,3-epoxide, inducing a closed conformation, juxtaposing all cysteines (S-S or SH) for unimpeded electron transfer (PubMed:33154105). VKOR becomes fully oxidized with an open conformation that releases reaction products, vitamin K quinone, or hydroquinone (PubMed:33154105). Cys-132 and Cys-135 constitute the catalytic redox-active center (PubMed:33154105). Cys-43 and Cys-51 are the cysteine pair that mediates transfer of reducing equivalents during catalysis (PubMed:33154105). {ECO:0000269|PubMed:33154105}.",,"STRAND 44..46; /evidence=""ECO:0007829|PDB:6WVH""","HELIX 10..15; /evidence=""ECO:0007829|PDB:6WVH""; HELIX 19..35; /evidence=""ECO:0007829|PDB:6WVH""; HELIX 51..56; /evidence=""ECO:0007829|PDB:6WVH""; HELIX 58..60; /evidence=""ECO:0007829|PDB:6WVH""; HELIX 62..64; /evidence=""ECO:0007829|PDB:6WVH""; HELIX 67..70; /evidence=""ECO:0007829|PDB:6WVH""; HELIX 80..95; /evidence=""ECO:0007829|PDB:6WVH""; HELIX 100..126; /evidence=""ECO:0007829|PDB:6WVH""; HELIX 133..154; /evidence=""ECO:0007829|PDB:6WVH""",,"cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,VKORC1 VKOR MSTP134 MSTP576 UNQ308/PRO351,"Vitamin K epoxide reductase complex subunit 1 (EC 1.17.4.4) (Vitamin K1 2,3-epoxide reductase subunit 1)",Homo sapiens (Human),163.0,18235.0,MGSTWGSPGWVRLALCLTGLVLSLYALHVKAARARDRDYRALCDVGTAISCSRVFSSRWGRGFGLVEHVLGQDSILNQSNSIFGCIFYTLQLLLGCLRTRWASVLMLLSSLVSLAGSVYLAWILFFVLYDFCIVCITTYAINVSLMWLSFRKVQEPQGKAKRH,False,False,True,Q9BQB6,"[('cd12917', 'Vitamin K epoxide reductase family in eukaryotes, excluding plants'), ('G3DSA:1.20.1440.130', 'VKOR domain'), ('IPR012932', 'Vitamin K epoxide reductase'), ('IPR038354', 'VKOR domain superfamily'), ('IPR042406', 'Vitamin K epoxide reductase complex subunit 1'), ('PF07884', 'Vitamin K epoxide reductase family'), ('PTHR14519', 'VITAMIN K EPOXIDE REDUCTASE COMPLEX, SUBUNIT 1'), ('SM00756', 'VKc')]",,"""ENSG00000167397; Tissue enhanced (liver)."";","CATALYTIC ACTIVITY: Reaction=phylloquinone + [protein]-disulfide + H2O = 2,3-epoxyphylloquinone + [protein]-dithiol; Xref=Rhea:RHEA:13817, Rhea:RHEA-COMP:10593, Rhea:RHEA-COMP:10594, ChEBI:CHEBI:15377, ChEBI:CHEBI:15759, ChEBI:CHEBI:18067, ChEBI:CHEBI:29950, ChEBI:CHEBI:50058; EC=1.17.4.4; Evidence={ECO:0000269|PubMed:15879509, ECO:0000269|PubMed:16270630, ECO:0000269|PubMed:20978134, ECO:0000269|PubMed:22923610, ECO:0000269|PubMed:33154105}; PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:13819; Evidence={ECO:0000269|PubMed:15879509, ECO:0000269|PubMed:16270630, ECO:0000269|PubMed:20978134, ECO:0000269|PubMed:22923610, ECO:0000269|PubMed:33154105}; CATALYTIC ACTIVITY: Reaction=phylloquinol + [protein]-disulfide = phylloquinone + [protein]-dithiol; Xref=Rhea:RHEA:57744, Rhea:RHEA-COMP:10593, Rhea:RHEA-COMP:10594, ChEBI:CHEBI:18067, ChEBI:CHEBI:28433, ChEBI:CHEBI:29950, ChEBI:CHEBI:50058; EC=1.17.4.4; Evidence={ECO:0000269|PubMed:15879509, ECO:0000269|PubMed:16270630, ECO:0000269|PubMed:20978134, ECO:0000269|PubMed:22923610, ECO:0000269|PubMed:33154105}; PhysiologicalDirection=right-to-left; Xref=Rhea:RHEA:57746; Evidence={ECO:0000269|PubMed:15879509, ECO:0000269|PubMed:16270630, ECO:0000269|PubMed:20978134, ECO:0000269|PubMed:22923610, ECO:0000269|PubMed:33154105};",1.17.4.4,"ACTIVITY REGULATION: Inhibited by warfarin (coumadin) (PubMed:15879509, PubMed:16270630, PubMed:22923610, PubMed:33154105). Warfarin locks VKORC1 in both redox states into the closed conformation (PubMed:33154105). Inhibited by warfarin analogs phenindione, brodifacoum and chlorophacinone (PubMed:33154105). {ECO:0000269|PubMed:15879509, ECO:0000269|PubMed:16270630, ECO:0000269|PubMed:22923610, ECO:0000269|PubMed:33154105}.",,ENST00000319788.11 [Q9BQB6-2];ENST00000354895.4 [Q9BQB6-3];ENST00000394975.3 [Q9BQB6-1];,VKORC1,ENSG00000167397,0.0,,,,,,,0.061,,VKORC1
Q9BRJ7,ENSG00000168101,TIRR_HUMAN,negative regulation of double-strand break repair via nonhomologous end joining [GO:2001033],nucleus [GO:0005634],RNA binding [GO:0003723]; snoRNA binding [GO:0030515],,,,"STRAND 10..12; /evidence=""ECO:0007829|PDB:6D0L""; STRAND 25..40; /evidence=""ECO:0007829|PDB:3KVH""; STRAND 44..55; /evidence=""ECO:0007829|PDB:3KVH""; STRAND 63..67; /evidence=""ECO:0007829|PDB:3KVH""; STRAND 96..101; /evidence=""ECO:0007829|PDB:3KVH""; STRAND 103..106; /evidence=""ECO:0007829|PDB:5ZCJ""; STRAND 108..116; /evidence=""ECO:0007829|PDB:3KVH""; STRAND 139..145; /evidence=""ECO:0007829|PDB:3KVH""","HELIX 14..17; /evidence=""ECO:0007829|PDB:3KVH""; HELIX 74..80; /evidence=""ECO:0007829|PDB:3KVH""; HELIX 93..95; /evidence=""ECO:0007829|PDB:3KVH""; HELIX 119..130; /evidence=""ECO:0007829|PDB:3KVH""; HELIX 157..161; /evidence=""ECO:0007829|PDB:3KVH""; HELIX 169..179; /evidence=""ECO:0007829|PDB:3KVH""; HELIX 185..206; /evidence=""ECO:0007829|PDB:3KVH""","TURN 41..43; /evidence=""ECO:0007829|PDB:3KVH""; TURN 69..71; /evidence=""ECO:0007829|PDB:3KVH""; TURN 136..138; /evidence=""ECO:0007829|PDB:3KVH""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,NUDT16L1 SDOS TIRR,Tudor-interacting repair regulator protein (NUDT16-like protein 1) (Protein syndesmos),Homo sapiens (Human),211.0,23338.0,MSTAAVPELKQISRVEAMRLGPGWSHSCHAMLYAANPGQLFGRIPMRFSVLMQMRFDGLLGFPGGFVDRRFWSLEDGLNRVLGLGLGCLRLTEADYLSSHLTEGPHRVVAHLYARQLTLEQLHAVEISAVHSRDHGLEVLGLVRVPLYTQKDRVGGFPNFLSNAFVSTAKCQLLFALKVLNMMPEEKLVEALAAATEKQKKALEKLLPASS,False,True,False,Q9BRJ7,"[('G3DSA:3.90.79.10', 'Nucleoside Triphosphate Pyrophosphohydrolase'), ('IPR015797', 'NUDIX hydrolase-like domain superfamily'), ('IPR054754', 'U8 snoRNA-decapping enzyme NudT16'), ('PF22327', 'U8 snoRNA-decapping enzyme-like'), ('PTHR31699', 'NUDIX T16 FAMILY MEMBER'), ('SSF55811', 'Nudix')]",,"""ENSG00000168101; Low tissue specificity."";",,,,,ENST00000304301.11 [Q9BRJ7-1];ENST00000405142.1 [Q9BRJ7-2];,NUDT16L1,ENSG00000168101,0.0,NUDT16L1,Non-canonical_RBPs,12.0,,,,0.047,,NUDT16L1
Q9BSI4,ENSG00000092330|ENSG00000284915,TINF2_HUMAN,"negative regulation of epithelial cell proliferation [GO:0050680]; negative regulation of protein ADP-ribosylation [GO:0010836]; negative regulation of telomere maintenance via telomerase [GO:0032211]; positive regulation of telomere maintenance [GO:0032206]; protein localization to chromosome, telomeric region [GO:0070198]; regulation of telomere maintenance via telomere lengthening [GO:1904356]; telomere assembly [GO:0032202]; telomere capping [GO:0016233]","chromosome, telomeric region [GO:0000781]; nuclear body [GO:0016604]; nuclear matrix [GO:0016363]; nuclear telomere cap complex [GO:0000783]; nucleoplasm [GO:0005654]; perinucleolar chromocenter [GO:0010370]; shelterin complex [GO:0070187]",telomeric DNA binding [GO:0042162],,DOMAIN: The TBM domain mediates interaction with TERF1. {ECO:0000269|PubMed:18202258}.,,"STRAND 263..265; /evidence=""ECO:0007829|PDB:3BQO""","HELIX 8..24; /evidence=""ECO:0007829|PDB:5XYF""; HELIX 28..30; /evidence=""ECO:0007829|PDB:5XYF""; HELIX 31..44; /evidence=""ECO:0007829|PDB:5XYF""; HELIX 51..71; /evidence=""ECO:0007829|PDB:5XYF""; HELIX 76..86; /evidence=""ECO:0007829|PDB:5XYF""; HELIX 101..122; /evidence=""ECO:0007829|PDB:5XYF""; HELIX 128..138; /evidence=""ECO:0007829|PDB:5XYF""; HELIX 141..160; /evidence=""ECO:0007829|PDB:5XYF""; HELIX 169..177; /evidence=""ECO:0007829|PDB:5XYF""; HELIX 187..195; /evidence=""ECO:0007829|PDB:5XYF""",,"cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,TINF2 TIN2,TERF1-interacting nuclear factor 2 (TRF1-interacting nuclear protein 2),Homo sapiens (Human),451.0,50023.0,MATPLVAGPAALRFAAAASWQVVRGRCVEHFPRVLEFLRSLRAVAPGLVRYRHHERLCMGLKAKVVVELILQGRPWAQVLKALNHHFPESGPIVRDPKATKQDLRKILEAQETFYQQVKQLSEAPVDLASKLQELEQEYGEPFLAAMEKLLFEYLCQLEKALPTPQAQQLQDVLSWMQPGVSITSSLAWRQYGVDMGWLLPECSVTDSVNLAEPMEQNPPQQQRLALHNPLPKAKPGTHLPQGPSSRTHPEPLAGRHFNLAPLGRRRVQSQWASTRGGHKERPTVMLFPFRNLGSPTQVISKPESKEEHAIYTADLAMGTRAASTGKSKSPCQTLGGRALKENPVDLPATEQKENCLDCYMDPLRLSLLPPRARKPVCPPSLCSSVITIGDLVLDSDEEENGQGEGKESLENYQKTKFDTLIPTLCEYLPPSGHGAIPVSSCDCRDSSRPL,False,False,True,Q9BSI4,"[('cd11657', 'N-terminal domain of TRF-interacting nuclear factor 2; shelterin complex protein of telomeres'), ('cd11741', 'TRF-binding motif region of TRF-Interacting Nuclear factor 2'), ('IPR029400', 'TERF1-interacting nuclear factor 2, N-terminal domain'), ('IPR039098', 'TERF1-interacting nuclear factor 2'), ('PF14973', 'TERF1-interacting nuclear factor 2 N-terminus'), ('PTHR15512', 'TERF1-INTERACTING NUCLEAR FACTOR 2')]",Q9BSI4;,"""ENSG00000092330; Tissue enriched (parathyroid)."";",,,,,ENST00000267415.12 [Q9BSI4-1];ENST00000399423.8 [Q9BSI4-2];ENST00000642983.1 [Q9BSI4-2];ENST00000646576.2 [Q9BSI4-1];,TINF2,ENSG00000092330,1.0,,,,,,0.022,0.545,0.064,TINF2
Q9BWF3,ENSG00000173933,RBM4_HUMAN,"cap-independent translational initiation [GO:0002190]; circadian regulation of gene expression [GO:0032922]; circadian regulation of translation [GO:0097167]; enteroendocrine cell differentiation [GO:0035883]; entrainment of circadian clock by photoperiod [GO:0043153]; insulin secretion involved in cellular response to glucose stimulus [GO:0035773]; IRES-dependent translational initiation of linear mRNA [GO:0002192]; miRNA-mediated gene silencing by inhibition of translation [GO:0035278]; mRNA splicing, via spliceosome [GO:0000398]; negative regulation of translation [GO:0017148]; negative regulation of translation in response to stress [GO:0032055]; negative regulation of translational initiation [GO:0045947]; pancreas development [GO:0031016]; positive regulation of muscle cell differentiation [GO:0051149]; positive regulation of translation [GO:0045727]; regulation of alternative mRNA splicing, via spliceosome [GO:0000381]; regulation of insulin receptor signaling pathway [GO:0046626]; regulation of nucleocytoplasmic transport [GO:0046822]; response to arsenic-containing substance [GO:0046685]; RNA processing [GO:0006396]",cytoplasm [GO:0005737]; cytoplasmic stress granule [GO:0010494]; cytosol [GO:0005829]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471],cyclin binding [GO:0030332]; miRNA binding [GO:0035198]; mRNA 3'-UTR binding [GO:0003730]; mRNA binding [GO:0003729]; pre-mRNA intronic binding [GO:0097157]; pre-mRNA intronic pyrimidine-rich binding [GO:0097158]; RNA binding [GO:0003723]; zinc ion binding [GO:0008270],"PTM: Phosphorylation on Ser-309 is induced upon cell muscle differentiation (By similarity). Phosphorylated. Phosphorylated in vitro on Ser-309 by SRPK1. Phosphorylation on Ser-309 is induced upon cell stress signaling, which alters its subcellular localization and may modulate its activity on IRES-mediated mRNA translation. {ECO:0000250, ECO:0000269|PubMed:17284590}.",,"DOMAIN 2..72; /note=""RRM 1""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00176""; DOMAIN 78..148; /note=""RRM 2""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00176""","STRAND 2..8; /evidence=""ECO:0007829|PDB:2DNQ""; STRAND 28..34; /evidence=""ECO:0007829|PDB:2DNQ""; STRAND 37..44; /evidence=""ECO:0007829|PDB:2DNQ""; STRAND 66..68; /evidence=""ECO:0007829|PDB:2DNQ""","HELIX 15..23; /evidence=""ECO:0007829|PDB:2DNQ""; HELIX 45..55; /evidence=""ECO:0007829|PDB:2DNQ""",,"cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,RBM4 RBM4A,RNA-binding protein 4 (Lark homolog) (hLark) (RNA-binding motif protein 4) (RNA-binding motif protein 4a),Homo sapiens (Human),364.0,40314.0,MVKLFIGNLPREATEQEIRSLFEQYGKVLECDIIKNYGFVHIEDKTAAEDAIRNLHHYKLHGVNINVEASKNKSKTSTKLHVGNISPTCTNKELRAKFEEYGPVIECDIVKDYAFVHMERAEDAVEAIRGLDNTEFQGKRMHVQLSTSRLRTAPGMGDQSGCYRCGKEGHWSKECPIDRSGRVADLTEQYNEQYGAVRTPYTMSYGDSLYYNNAYGALDAYYKRCRAARSYEAVAAAAASVYNYAEQTLSQLPQVQNTAMASHLTSTSLDPYDRHLLPTSGAAATAAAAAAAAAAVTAASTSYYGRDRSPLRRATAPVPTVGEGYGYGHESELSQASAAARNSLYDMARYEREQYADRARYSAF,False,False,True,Q9BWF3,"[('cd12606', 'RNA recognition motif 1 (RRM1) found in vertebrate RNA-binding protein 4 (RBM4)'), ('cd12607', 'RNA recognition motif 2 (RRM2) found in vertebrate RNA-binding protein 4 (RBM4)'), ('G3DSA:3.30.70.330', None), ('G3DSA:4.10.60.10', 'Zinc finger, CCHC-type'), ('IPR000504', 'RNA recognition motif domain'), ('IPR001878', 'Zinc finger, CCHC-type'), ('IPR012677', 'Nucleotide-binding alpha-beta plait domain superfamily'), ('IPR034897', 'RBM4, RNA recognition motif 1'), ('IPR034898', 'RBM4, RNA recognition motif 2'), ('IPR035979', 'RNA-binding domain superfamily'), ('IPR050502', 'Eukaryotic RNA-binding'), ('PF00076', 'RNA recognition motif'), ('PF00098', 'Zinc knuckle'), ('PS50102', 'Eukaryotic RNA Recognition Motif (RRM) profile'), ('PS50158', 'Zinc finger CCHC-type profile'), ('PTHR48025', 'Eukaryotic RNA-binding'), ('SM00343', 'zinc finger'), ('SM00360', 'RNA recognition motif'), ('SSF54928', 'RNA-binding domain, RBD')]",,"""ENSG00000173933; Low tissue specificity."";",,,,,ENST00000310092.12 [Q9BWF3-1];ENST00000396053.9 [Q9BWF3-4];ENST00000398692.8 [Q9BWF3-3];ENST00000408993.6 [Q9BWF3-1];ENST00000409406.1 [Q9BWF3-1];ENST00000483858.5 [Q9BWF3-2];ENST00000530235.1 [Q9BWF3-3];ENST00000532968.1 [Q9BWF3-2];,RBM4,ENSG00000173933,0.0,RBM4,Canonical_RBPs,19.0,,,,0.53,,RBM4
Q9BYE9,ENSG00000074276,CDHR2_HUMAN,brush border assembly [GO:1904970]; cell-cell adhesion [GO:0098609]; cell-cell adhesion mediated by cadherin [GO:0044331]; epithelial cell differentiation [GO:0030855]; homophilic cell adhesion via plasma membrane adhesion molecules [GO:0007156]; intermicrovillar adhesion [GO:0090675]; negative regulation of cell growth involved in contact inhibition [GO:0060243]; regulation of microvillus length [GO:0032532],anchoring junction [GO:0070161]; apical plasma membrane [GO:0016324]; brush border [GO:0005903]; brush border membrane [GO:0031526]; extracellular exosome [GO:0070062]; microvillus [GO:0005902]; microvillus membrane [GO:0031528]; plasma membrane [GO:0005886],calcium ion binding [GO:0005509]; cell adhesion molecule binding [GO:0050839],,DOMAIN: The cadherin 1 domain is required for binding to CDHR5. {ECO:0000269|PubMed:24725409}.,"DOMAIN 27..124; /note=""Cadherin 1""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00043""; DOMAIN 125..241; /note=""Cadherin 2""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00043""; DOMAIN 242..353; /note=""Cadherin 3""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00043""; DOMAIN 368..480; /note=""Cadherin 4""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00043""; DOMAIN 481..586; /note=""Cadherin 5""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00043""; DOMAIN 586..695; /note=""Cadherin 6""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00043""; DOMAIN 696..808; /note=""Cadherin 7""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00043""; DOMAIN 810..928; /note=""Cadherin 8""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00043""; DOMAIN 930..1058; /note=""Cadherin 9""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00043""","STRAND 32..36; /evidence=""ECO:0007829|PDB:5CZR""; STRAND 43..47; /evidence=""ECO:0007829|PDB:5CZR""; STRAND 59..64; /evidence=""ECO:0007829|PDB:5CZR""; STRAND 70..72; /evidence=""ECO:0007829|PDB:5CZR""; STRAND 78..81; /evidence=""ECO:0007829|PDB:5CZR""; STRAND 91..100; /evidence=""ECO:0007829|PDB:5CZR""; STRAND 105..115; /evidence=""ECO:0007829|PDB:5CZR""; STRAND 123..125; /evidence=""ECO:0007829|PDB:7N86""; STRAND 130..134; /evidence=""ECO:0007829|PDB:5CZR""; STRAND 142..145; /evidence=""ECO:0007829|PDB:5CZR""; STRAND 159..168; /evidence=""ECO:0007829|PDB:5CZR""; STRAND 170..172; /evidence=""ECO:0007829|PDB:5CZR""; STRAND 176..179; /evidence=""ECO:0007829|PDB:5CZR""; STRAND 183..187; /evidence=""ECO:0007829|PDB:5CZR""; STRAND 198..208; /evidence=""ECO:0007829|PDB:5CZR""; STRAND 211..213; /evidence=""ECO:0007829|PDB:5CZR""; STRAND 216..218; /evidence=""ECO:0007829|PDB:5CZR""; STRAND 225..232; /evidence=""ECO:0007829|PDB:5CZR""","HELIX 28..31; /evidence=""ECO:0007829|PDB:5CZR""; HELIX 67..69; /evidence=""ECO:0007829|PDB:5CZR""; HELIX 154..157; /evidence=""ECO:0007829|PDB:5CZR""; HELIX 173..175; /evidence=""ECO:0007829|PDB:5CZR""","TURN 74..76; /evidence=""ECO:0007829|PDB:5CZR""; TURN 87..89; /evidence=""ECO:0007829|PDB:5CZR""; TURN 193..196; /evidence=""ECO:0007829|PDB:5CZR""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,CDHR2 PCDH24 PCLKC,Cadherin-related family member 2 (Protocadherin LKC) (PC-LKC) (Protocadherin-24),Homo sapiens (Human),1310.0,141543.0,MAQLWLSCFLLPALVVSVAANVAPKFLANMTSVILPEDLPVGAQAFWLVAEDQDNDPLTYGMSGPNAYFFAVTPKTGEVKLASALDYETLYTFKVTISVSDPYIQVQREMLVIVEDRNDNAPVFQNTAFSTSINETLPVGSVVFSVLAVDKDMGSAGMVVYSIEKVIPSTGDSEHLFRILANGSIVLNGSLSYNNKSAFYQLELKACDLGGMYHNTFTIQCSLPVFLSISVVDQPDLDPQFVREFYSASVAEDAAKGTSVLTVEAVDGDKGINDPVIYSISYSTRPGWFDIGADGVIRVNGSLDREQLLEADEEVQLQVTATETHLNIYGQEAKVSIWVTVRVMDVNDHKPEFYNCSLPACTFTPEEAQVNFTGYVDEHASPRIPIDDLTMVVYDPDKGSNGTFLLSLGGPDAEAFSVSPERAVGSASVQVLVRVSALVDYERQTAMAVQVVATDSVSQNFSVAMVTIHLRDINDHRPTFPQSLYVLTVPEHSATGSVVTDSIHATDPDTGAWGQITYSLLPGNGADLFQVDPVSGTVTVRNGELLDRESQAVYYLTLQATDGGNLSSSTTLQIHLLDINDNAPVVSGSYNIFVQEEEGNVSVTIQAHDNDEPGTNNSRLLFNLLPGPYSHNFSLDPDTGLLRNLGPLDREAIDPALEGRIVLTVLVSDCGEPVLGTKVNVTITVEDINDNLPIFNQSSYNFTVKEEDPGVLVGVVKAWDADQTEANNRISFSLSGSGANYFMIRGLVLGAGWAEGYLRLPPDVSLDYETQPVFNLTVSAENPDPQGGETIVDVCVNVKDVNDNPPTLDVASLRGIRVAENGSQHGQVAVVVASDVDTSAQLEIQLVNILCTKAGVDVGSLCWGWFSVAANGSVYINQSKAIDYEACDLVTLVVRACDLATDPGFQAYSNNGSLLITIEDVNDNAPYFLPENKTFVIIPELVLPNREVASVRARDDDSGNNGVILFSILRVDFISKDGATIPFQGVFSIFTSSEADVFAGSIQPVTSLDSTLQGTYQVTVQARDRPSLGPFLEATTTLNLFTVDQSYRSRLQFSTPKEEVGANRQAINAALTQATRTTVYIVDIQDIDSAARARPHSYLDAYFVFPNGSALTLDELSVMIRNDQDSLTQLLQLGLVVLGSQESQESDLSKQLISVIIGLGVALLLVLVIMTMAFVCVRKSYNRKLQAMKAAKEARKTAAGVMPSAPAIPGTNMYNTERANPMLNLPNKDLGLEYLSPSNDLDSVSVNSLDDNSVDVDKNSQEIKEHRPPHTPPEPDPEPLSVVLLGRQAGASGQLEGPSYTNAGLDTTDL,False,False,True,Q9BYE9,"[('cd11304', 'Cadherin tandem repeat domain'), ('G3DSA:2.60.40.60', 'Cadherins'), ('IPR002126', 'Cadherin-like'), ('IPR015919', 'Cadherin-like superfamily'), ('IPR020894', 'Cadherin conserved site'), ('PF00028', 'Cadherin domain'), ('PR00205', 'CADHERIN'), ('PS00232', 'Cadherin domain signature'), ('PS50268', 'Cadherins domain profile'), ('PTHR24026', 'Calcium-Dependent Cadherin'), ('SM00112', 'Cadherin repeats.'), ('SSF49313', 'Cadherin-like')]",,"""ENSG00000074276; Tissue enriched (intestine)."";",,,,,ENST00000261944.10;ENST00000510636.5;,CDHR2,ENSG00000074276,0.0,,,,,,,0.146,0.04,CDHR2
Q9BYF1,ENSG00000130234,ACE2_HUMAN,angiotensin maturation [GO:0002003]; angiotensin-mediated drinking behavior [GO:0003051]; blood vessel diameter maintenance [GO:0097746]; entry receptor-mediated virion attachment to host cell [GO:0098670]; maternal process involved in female pregnancy [GO:0060135]; membrane fusion [GO:0061025]; negative regulation of ERK1 and ERK2 cascade [GO:0070373]; negative regulation of signaling receptor activity [GO:2000272]; negative regulation of smooth muscle cell proliferation [GO:0048662]; positive regulation of amino acid transport [GO:0051957]; positive regulation of cardiac muscle contraction [GO:0060452]; positive regulation of gap junction assembly [GO:1903598]; positive regulation of L-proline import across plasma membrane [GO:1905737]; positive regulation of reactive oxygen species metabolic process [GO:2000379]; receptor-mediated endocytosis of virus by host cell [GO:0019065]; receptor-mediated virion attachment to host cell [GO:0046813]; regulation of cardiac conduction [GO:1903779]; regulation of cell population proliferation [GO:0042127]; regulation of cytokine production [GO:0001817]; regulation of inflammatory response [GO:0050727]; regulation of systemic arterial blood pressure by renin-angiotensin [GO:0003081]; regulation of transmembrane transporter activity [GO:0022898]; regulation of vasoconstriction [GO:0019229]; symbiont entry into host cell [GO:0046718]; tryptophan transport [GO:0015827]; viral life cycle [GO:0019058],apical plasma membrane [GO:0016324]; brush border membrane [GO:0031526]; cell surface [GO:0009986]; cilium [GO:0005929]; endocytic vesicle membrane [GO:0030666]; endoplasmic reticulum lumen [GO:0005788]; extracellular exosome [GO:0070062]; extracellular region [GO:0005576]; extracellular space [GO:0005615]; membrane [GO:0016020]; membrane raft [GO:0045121]; plasma membrane [GO:0005886],carboxypeptidase activity [GO:0004180]; endopeptidase activity [GO:0004175]; identical protein binding [GO:0042802]; metallopeptidase activity [GO:0008237]; peptidyl-dipeptidase activity [GO:0008241]; virus receptor activity [GO:0001618]; zinc ion binding [GO:0008270],"PTM: N-glycosylation on Asn-90 may limit SARS infectivity. {ECO:0000269|PubMed:10924499, ECO:0000269|PubMed:14647384, ECO:0000269|PubMed:14754895, ECO:0000269|PubMed:15084671, ECO:0000269|PubMed:19159218}.; PTM: Proteolytic cleavage by ADAM17 generates a secreted form (PubMed:15983030, PubMed:33713620). Also cleaved by serine proteases: TMPRSS2, TMPRSS11D and HPN/TMPRSS1. {ECO:0000269|PubMed:15983030, ECO:0000269|PubMed:21068237, ECO:0000269|PubMed:21563828, ECO:0000269|PubMed:24227843, ECO:0000269|PubMed:32132184, ECO:0000269|PubMed:33713620}.; PTM: Phosphorylated. Phosphorylation at Tyr-781 probably inhibits interaction with AP2M1 and enables interactions with proteins containing SH2 domains. {ECO:0000305|PubMed:33436497, ECO:0000305|PubMed:33436498}.; PTM: Ubiquitinated. Ubiquitinated on Lys-788 via 'Lys-48'-linked ubiquitin (PubMed:36876523). 'Lys-48'-linked deubiquitinated by USP50 on the Lys-788; leading to its stabilization (PubMed:36876523). {ECO:0000269|PubMed:36876523}.","DOMAIN: The extracellular region of the ACE2 enzyme is composed of two domains. The first is a zinc metallopeptidase domain (residues 19-611). The second domain is located at the C-terminus (residues 612-740) and is 48% identical to human collectrin. {ECO:0000269|PubMed:14754895}.; DOMAIN: The cytoplasmic tail contains several linear motifs such as LIR, PDZ-binding, PTB and endocytic sorting signal motifs that would allow interaction with proteins that mediate endocytic trafficking and autophagy. {ECO:0000305|PubMed:33436497, ECO:0000305|PubMed:33436498}.","DOMAIN 19..607; /note=""Peptidase M2""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU01355""; DOMAIN 614..805; /note=""Collectrin-like""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU01354""","STRAND 101..103; /evidence=""ECO:0007829|PDB:8IF2""; STRAND 131..134; /evidence=""ECO:0007829|PDB:1R42""; STRAND 137..143; /evidence=""ECO:0007829|PDB:1R42""; STRAND 196..198; /evidence=""ECO:0007829|PDB:7WPB""; STRAND 258..260; /evidence=""ECO:0007829|PDB:7UFK""; STRAND 267..271; /evidence=""ECO:0007829|PDB:1R42""; STRAND 338..340; /evidence=""ECO:0007829|PDB:8BFW""; STRAND 347..352; /evidence=""ECO:0007829|PDB:1R42""; STRAND 355..359; /evidence=""ECO:0007829|PDB:1R42""; STRAND 396..399; /evidence=""ECO:0007829|PDB:7WPC""; STRAND 422..424; /evidence=""ECO:0007829|PDB:8BFW""; STRAND 466..468; /evidence=""ECO:0007829|PDB:8WGW""; STRAND 486..488; /evidence=""ECO:0007829|PDB:3D0G""; STRAND 494..496; /evidence=""ECO:0007829|PDB:7V8A""; STRAND 575..578; /evidence=""ECO:0007829|PDB:1R42""; STRAND 600..602; /evidence=""ECO:0007829|PDB:1R42""; STRAND 607..609; /evidence=""ECO:0007829|PDB:1R42""; STRAND 618..622; /evidence=""ECO:0007829|PDB:6M17""; STRAND 629..631; /evidence=""ECO:0007829|PDB:6M18""; STRAND 670..673; /evidence=""ECO:0007829|PDB:6M17""; STRAND 677..686; /evidence=""ECO:0007829|PDB:6M17""; STRAND 690..694; /evidence=""ECO:0007829|PDB:6M18""; STRAND 719..724; /evidence=""ECO:0007829|PDB:6M17""","HELIX 23..52; /evidence=""ECO:0007829|PDB:1R42""; HELIX 56..77; /evidence=""ECO:0007829|PDB:1R42""; HELIX 85..87; /evidence=""ECO:0007829|PDB:7UFK""; HELIX 91..100; /evidence=""ECO:0007829|PDB:1R42""; HELIX 104..107; /evidence=""ECO:0007829|PDB:1R42""; HELIX 110..129; /evidence=""ECO:0007829|PDB:1R42""; HELIX 148..154; /evidence=""ECO:0007829|PDB:1R42""; HELIX 158..171; /evidence=""ECO:0007829|PDB:1R42""; HELIX 173..193; /evidence=""ECO:0007829|PDB:1R42""; HELIX 199..204; /evidence=""ECO:0007829|PDB:1R42""; HELIX 220..251; /evidence=""ECO:0007829|PDB:1R42""; HELIX 264..266; /evidence=""ECO:0007829|PDB:1R42""; HELIX 276..278; /evidence=""ECO:0007829|PDB:1R42""; HELIX 279..282; /evidence=""ECO:0007829|PDB:1R42""; HELIX 298..300; /evidence=""ECO:0007829|PDB:1R42""; HELIX 304..316; /evidence=""ECO:0007829|PDB:1R42""; HELIX 327..330; /evidence=""ECO:0007829|PDB:1R42""; HELIX 366..384; /evidence=""ECO:0007829|PDB:1R42""; HELIX 390..392; /evidence=""ECO:0007829|PDB:1R42""; HELIX 400..413; /evidence=""ECO:0007829|PDB:1R42""; HELIX 415..420; /evidence=""ECO:0007829|PDB:1R42""; HELIX 432..446; /evidence=""ECO:0007829|PDB:1R42""; HELIX 449..465; /evidence=""ECO:0007829|PDB:1R42""; HELIX 470..472; /evidence=""ECO:0007829|PDB:1R42""; HELIX 473..483; /evidence=""ECO:0007829|PDB:1R42""; HELIX 499..502; /evidence=""ECO:0007829|PDB:1R42""; HELIX 504..507; /evidence=""ECO:0007829|PDB:1R42""; HELIX 514..531; /evidence=""ECO:0007829|PDB:1R42""; HELIX 539..541; /evidence=""ECO:0007829|PDB:1R42""; HELIX 548..558; /evidence=""ECO:0007829|PDB:1R42""; HELIX 566..574; /evidence=""ECO:0007829|PDB:1R42""; HELIX 582..598; /evidence=""ECO:0007829|PDB:1R42""; HELIX 624..627; /evidence=""ECO:0007829|PDB:6M17""; HELIX 637..657; /evidence=""ECO:0007829|PDB:6M17""; HELIX 667..669; /evidence=""ECO:0007829|PDB:6M17""; HELIX 697..706; /evidence=""ECO:0007829|PDB:6M17""; HELIX 708..715; /evidence=""ECO:0007829|PDB:6M17""; HELIX 741..765; /evidence=""ECO:0007829|PDB:6M17""","TURN 78..82; /evidence=""ECO:0007829|PDB:1R42""; TURN 144..146; /evidence=""ECO:0007829|PDB:1R42""; TURN 205..207; /evidence=""ECO:0007829|PDB:1R42""; TURN 213..215; /evidence=""ECO:0007829|PDB:1R42""; TURN 253..255; /evidence=""ECO:0007829|PDB:1R42""; TURN 284..287; /evidence=""ECO:0007829|PDB:1R42""; TURN 294..297; /evidence=""ECO:0007829|PDB:1R42""; TURN 317..319; /evidence=""ECO:0007829|PDB:1R42""; TURN 385..387; /evidence=""ECO:0007829|PDB:1R42""; TURN 426..428; /evidence=""ECO:0007829|PDB:7YR2""; TURN 532..534; /evidence=""ECO:0007829|PDB:1R42""; TURN 559..562; /evidence=""ECO:0007829|PDB:1R42""; TURN 612..615; /evidence=""ECO:0007829|PDB:6M17""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,ACE2 UNQ868/PRO1885,Angiotensin-converting enzyme 2 (EC 3.4.17.23) (Angiotensin-converting enzyme homolog) (ACEH) (Angiotensin-converting enzyme-related carboxypeptidase) (ACE-related carboxypeptidase) (EC 3.4.17.-) (Metalloprotease MPROT15) [Cleaved into: Processed angiotensin-converting enzyme 2],Homo sapiens (Human),805.0,92463.0,MSSSSWLLLSLVAVTAAQSTIEEQAKTFLDKFNHEAEDLFYQSSLASWNYNTNITEENVQNMNNAGDKWSAFLKEQSTLAQMYPLQEIQNLTVKLQLQALQQNGSSVLSEDKSKRLNTILNTMSTIYSTGKVCNPDNPQECLLLEPGLNEIMANSLDYNERLWAWESWRSEVGKQLRPLYEEYVVLKNEMARANHYEDYGDYWRGDYEVNGVDGYDYSRGQLIEDVEHTFEEIKPLYEHLHAYVRAKLMNAYPSYISPIGCLPAHLLGDMWGRFWTNLYSLTVPFGQKPNIDVTDAMVDQAWDAQRIFKEAEKFFVSVGLPNMTQGFWENSMLTDPGNVQKAVCHPTAWDLGKGDFRILMCTKVTMDDFLTAHHEMGHIQYDMAYAAQPFLLRNGANEGFHEAVGEIMSLSAATPKHLKSIGLLSPDFQEDNETEINFLLKQALTIVGTLPFTYMLEKWRWMVFKGEIPKDQWMKKWWEMKREIVGVVEPVPHDETYCDPASLFHVSNDYSFIRYYTRTLYQFQFQEALCQAAKHEGPLHKCDISNSTEAGQKLFNMLRLGKSEPWTLALENVVGAKNMNVRPLLNYFEPLFTWLKDQNKNSFVGWSTDWSPYADQSIKVRISLKSALGDKAYEWNDNEMYLFRSSVAYAMRQYFLKVKNQMILFGEEDVRVANLKPRISFNFFVTAPKNVSDIIPRTEVEKAIRMSRSRINDAFRLNDNSLEFLGIQPTLGPPNQPPVSIWLIVFGVVMGVIVVGIVILIFTGIRDRKKKNKARSGENPYASIDISKGENNPGFQNTDDVQTSF,False,True,False,Q9BYF1,"[('cd06461', 'Peptidase family M2, angiotensin converting enzyme (ACE)'), ('G3DSA:1.10.1370.30', None), ('IPR001548', 'Peptidase M2, peptidyl-dipeptidase A'), ('IPR031588', 'Collectrin domain'), ('PF01401', 'Angiotensin-converting enzyme'), ('PF16959', 'Renal amino acid transporter'), ('PR00791', 'PEPDIPTASEA'), ('PS52010', 'Collectrin-like domain profile'), ('PS52011', 'Peptidase family M2 domain profile'), ('PTHR10514', 'ANGIOTENSIN-CONVERTING ENZYME'), ('SSF55486', 'Metalloproteases (""zincins""), catalytic domain')]",,"""ENSG00000130234; Tissue enhanced (gallbladder, intestine, kidney)."";","CATALYTIC ACTIVITY: Reaction=angiotensin II + H2O = angiotensin-(1-7) + L-phenylalanine; Xref=Rhea:RHEA:26554, ChEBI:CHEBI:15377, ChEBI:CHEBI:58095, ChEBI:CHEBI:58506, ChEBI:CHEBI:58922; EC=3.4.17.23; Evidence={ECO:0000269|PubMed:10924499, ECO:0000269|PubMed:11815627, ECO:0000269|PubMed:19021774, ECO:0000305|PubMed:14504186}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:26555; Evidence={ECO:0000269|PubMed:14504186}; CATALYTIC ACTIVITY: Reaction=angiotensin I + H2O = angiotensin-(1-9) + L-leucine; Xref=Rhea:RHEA:63532, ChEBI:CHEBI:15377, ChEBI:CHEBI:57427, ChEBI:CHEBI:147350, ChEBI:CHEBI:147351; Evidence={ECO:0000269|PubMed:10924499, ECO:0000269|PubMed:10969042, ECO:0000269|PubMed:11815627, ECO:0000269|PubMed:19021774}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:63533; Evidence={ECO:0000305|PubMed:10924499, ECO:0000305|PubMed:10969042, ECO:0000305|PubMed:11815627, ECO:0000305|PubMed:19021774}; CATALYTIC ACTIVITY: Reaction=bradykinin(1-8) + H2O = bradykinin(1-7) + L-phenylalanine; Xref=Rhea:RHEA:63536, ChEBI:CHEBI:15377, ChEBI:CHEBI:58095, ChEBI:CHEBI:133069, ChEBI:CHEBI:147352; Evidence={ECO:0000269|PubMed:10969042, ECO:0000269|PubMed:11815627}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:63537; Evidence={ECO:0000305|PubMed:10969042, ECO:0000305|PubMed:11815627}; CATALYTIC ACTIVITY: Reaction=neurotensin + H2O = neurotensin-(1-12) + L-leucine; Xref=Rhea:RHEA:63540, ChEBI:CHEBI:15377, ChEBI:CHEBI:57427, ChEBI:CHEBI:147362, ChEBI:CHEBI:147363; Evidence={ECO:0000269|PubMed:10969042}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:63541; Evidence={ECO:0000305|PubMed:10969042}; CATALYTIC ACTIVITY: Reaction=neurotensin-(1-8) + H2O = neurotensin-(1-7) + L-arginine; Xref=Rhea:RHEA:63572, ChEBI:CHEBI:15377, ChEBI:CHEBI:32682, ChEBI:CHEBI:147393, ChEBI:CHEBI:147394; Evidence={ECO:0000269|PubMed:11815627}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:63573; Evidence={ECO:0000305|PubMed:11815627}; CATALYTIC ACTIVITY: Reaction=kinetensin + H2O = kinetensin-(1-8) + L-leucine; Xref=Rhea:RHEA:63544, ChEBI:CHEBI:15377, ChEBI:CHEBI:57427, ChEBI:CHEBI:147364, ChEBI:CHEBI:147365; Evidence={ECO:0000269|PubMed:10969042}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:63545; Evidence={ECO:0000305|PubMed:10969042}; CATALYTIC ACTIVITY: Reaction=dynorphin A-(1-13) + H2O = dynorphin A-(1-12) + L-lysine; Xref=Rhea:RHEA:63556, ChEBI:CHEBI:15377, ChEBI:CHEBI:32551, ChEBI:CHEBI:147381, ChEBI:CHEBI:147383; Evidence={ECO:0000269|PubMed:11815627}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:63557; Evidence={ECO:0000305|PubMed:11815627}; CATALYTIC ACTIVITY: Reaction=apelin-13 + H2O = apelin-12 + L-phenylalanine; Xref=Rhea:RHEA:63564, ChEBI:CHEBI:15377, ChEBI:CHEBI:58095, ChEBI:CHEBI:147395, ChEBI:CHEBI:147396; Evidence={ECO:0000269|PubMed:11815627}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:63565; Evidence={ECO:0000305|PubMed:11815627}; CATALYTIC ACTIVITY: Reaction=[Pyr1]apelin-13 + H2O = [Pyr1]apelin-12 + L-phenylalanine; Xref=Rhea:RHEA:63604, ChEBI:CHEBI:15377, ChEBI:CHEBI:58095, ChEBI:CHEBI:147415, ChEBI:CHEBI:147416; Evidence={ECO:0000269|PubMed:27217402, ECO:0000269|PubMed:28293165}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:63605; Evidence={ECO:0000269|PubMed:27217402}; CATALYTIC ACTIVITY: Reaction=apelin-17 + H2O = apelin-16 + L-phenylalanine; Xref=Rhea:RHEA:63608, ChEBI:CHEBI:15377, ChEBI:CHEBI:58095, ChEBI:CHEBI:147421, ChEBI:CHEBI:147422; Evidence={ECO:0000269|PubMed:27217402}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:63609; Evidence={ECO:0000269|PubMed:27217402}; CATALYTIC ACTIVITY: Reaction=beta-casomorphin-7 + H2O = beta-casomorphin-6 + L-isoleucine; Xref=Rhea:RHEA:63568, ChEBI:CHEBI:15377, ChEBI:CHEBI:58045, ChEBI:CHEBI:147390, ChEBI:CHEBI:147391; Evidence={ECO:0000269|PubMed:11815627}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:63569; Evidence={ECO:0000305|PubMed:11815627}; CATALYTIC ACTIVITY: Reaction=neocasomorphin + H2O = neocasomorphin-(1-5) + L-isoleucine; Xref=Rhea:RHEA:63600, ChEBI:CHEBI:15377, ChEBI:CHEBI:58045, ChEBI:CHEBI:147417, ChEBI:CHEBI:147418; Evidence={ECO:0000269|PubMed:11815627}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:63601; Evidence={ECO:0000305|PubMed:11815627};",3.4.17.-; 3.4.17.23,"ACTIVITY REGULATION: Regulated by chloride and fluoride, but not bromide (PubMed:11815627). Chloride increases angiotensin I and decreases angiotensin II cleavage (PubMed:19021774). Inhibited by MLN-4760, cFP_Leu, and EDTA (PubMed:15231706, PubMed:10924499), but not by the ACE inhibitors lisinopril, captopril and enalaprilat (PubMed:10924499, PubMed:10969042). Highly potent and selective in vitro ACE2 inhibitors were identified (PubMed:12358520). {ECO:0000269|PubMed:10924499, ECO:0000269|PubMed:10969042, ECO:0000269|PubMed:11815627, ECO:0000269|PubMed:12358520, ECO:0000269|PubMed:15231706, ECO:0000269|PubMed:19021774}.",,ENST00000252519.8 [Q9BYF1-1];ENST00000427411.2 [Q9BYF1-1];ENST00000677282.1 [Q9BYF1-3];ENST00000678073.1 [Q9BYF1-1];ENST00000680121.1 [Q9BYF1-1];,ACE2,ENSG00000130234,0.0,,,,4.6,DP02854,0.046,0.092,0.042,ACE2
Q9BZR9,ENSG00000171206,TRIM8_HUMAN,canonical NF-kappaB signal transduction [GO:0007249]; innate immune response [GO:0045087]; negative regulation of viral entry into host cell [GO:0046597]; negative regulation of viral transcription [GO:0032897]; positive regulation of autophagy [GO:0010508]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of protein localization to nucleus [GO:1900182]; protein K63-linked ubiquitination [GO:0070534]; stem cell population maintenance [GO:0019827]; suppression of viral release by host [GO:0044790],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleus [GO:0005634]; PML body [GO:0016605],identical protein binding [GO:0042802]; mitogen-activated protein kinase kinase kinase binding [GO:0031435]; protein homodimerization activity [GO:0042803]; transcription coactivator activity [GO:0003713]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270],,DOMAIN: The coiled coil domain is required for homodimerization.; DOMAIN: The region immediately C-terminal to the RING motif is sufficient to mediate the interaction with SOCS1. {ECO:0000250|UniProtKB:Q99PJ2}.,,,,,"cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,TRIM8 GERP RNF27,E3 ubiquitin-protein ligase TRIM8 (EC 2.3.2.27) (Glioblastoma-expressed RING finger protein) (RING finger protein 27) (RING-type E3 ubiquitin transferase TRIM8) (Tripartite motif-containing protein 8),Homo sapiens (Human),551.0,61489.0,MAENWKNCFEEELICPICLHVFVEPVQLPCKHNFCRGCIGEAWAKDSGLVRCPECNQAYNQKPGLEKNLKLTNIVEKFNALHVEKPPAALHCVFCRRGPPLPAQKVCLRCEAPCCQSHVQTHLQQPSTARGHLLVEADDVRAWSCPQHNAYRLYHCEAEQVAVCQYCCYYSGAHQGHSVCDVEIRRNEIRKMLMKQQDRLEEREQDIEDQLYKLESDKRLVEEKVNQLKEEVRLQYEKLHQLLDEDLRQTVEVLDKAQAKFCSENAAQALHLGERMQEAKKLLGSLQLLFDKTEDVSFMKNTKSVKILMDRTQTCTSSSLSPTKIGHLNSKLFLNEVAKKEKQLRKMLEGPFSTPVPFLQSVPLYPCGVSSSGAEKRKHSTAFPEASFLETSSGPVGGQYGAAGTASGEGQSGQPLGPCSSTQHLVALPGGAQPVHSSPVFPPSQYPNGSAAQQPMLPQYGGRKILVCSVDNCYCSSVANHGGHQPYPRSGHFPWTVPSQEYSHPLPPTPSVPQSLPSLAVRDWLDASQQPGHQDFYRVYGQPSTKHYVTS,False,False,True,Q9BZR9,"[('cd16580', 'RING finger, HC subclass, found in tripartite motif-containing protein 8 (TRIM8) and similar proteins'), ('cd19763', 'B-box-type 2 zinc finger found in tripartite motif-containing protein 8 (TRIM8) and similar proteins'), ('cd19838', 'B-box-type 1 zinc finger found in tripartite motif-containing protein 8 (TRIM8) and similar proteins'), ('G3DSA:3.30.160.60', 'Classic Zinc Finger'), ('G3DSA:3.30.40.10', 'Zinc/RING finger domain, C3HC4 (zinc finger)'), ('IPR001841', 'Zinc finger, RING-type'), ('IPR013083', 'Zinc finger, RING/FYVE/PHD-type'), ('IPR017907', 'Zinc finger, RING-type, conserved site'), ('IPR027370', 'Zinc finger, RING-type, eukaryotic'), ('IPR051051', 'E3 ubiquitin-protein ligase TRIM/RNF'), ('PF13445', 'RING-type zinc-finger'), ('PS00518', 'Zinc finger RING-type signature'), ('PS50089', 'Zinc finger RING-type profile'), ('PTHR25465', 'E3 ubiquitin-protein ligase TRIM/RNF'), ('SM00184', 'Ring finger'), ('SSF57845', 'B-box zinc-binding domain'), ('SSF57850', 'RING/U-box')]",,"""ENSG00000171206; Low tissue specificity."";",CATALYTIC ACTIVITY: Reaction=S-ubiquitinyl-[E2 ubiquitin-conjugating enzyme]-L-cysteine + [acceptor protein]-L-lysine = [E2 ubiquitin-conjugating enzyme]-L-cysteine + N(6)-ubiquitinyl-[acceptor protein]-L-lysine.; EC=2.3.2.27;,2.3.2.27,,PATHWAY: Protein modification; protein ubiquitination.,ENST00000643721.2;ENST00000710327.1;,TRIM8,ENSG00000171206,0.0,,,,,,,0.439,,TRIM8
Q9C019,ENSG00000137384|ENSG00000204610|ENSG00000235259|ENSG00000227147|ENSG00000235960|ENSG00000233599|ENSG00000235905|ENSG00000224145,TRI15_HUMAN,innate immune response [GO:0045087]; mesodermal cell fate determination [GO:0007500]; negative regulation of intracellular transport of viral material [GO:1901253]; negative regulation of non-canonical NF-kappaB signal transduction [GO:1901223]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of RIG-I signaling pathway [GO:1900246]; positive regulation of type I interferon production [GO:0032481]; protein ubiquitination [GO:0016567]; suppression of viral release by host [GO:0044790],cytoplasm [GO:0005737]; focal adhesion [GO:0005925]; nucleus [GO:0005634],molecular sequestering activity [GO:0140313]; transcription coactivator activity [GO:0003713]; ubiquitin protein ligase activity [GO:0061630]; zinc ion binding [GO:0008270],,,"DOMAIN 276..465; /note=""B30.2/SPRY""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00548""","STRAND 307..309; /evidence=""ECO:0007829|PDB:7QS2""; STRAND 313..318; /evidence=""ECO:0007829|PDB:7QS2""; STRAND 333..335; /evidence=""ECO:0007829|PDB:7QS2""; STRAND 337..342; /evidence=""ECO:0007829|PDB:7QS2""; STRAND 344..356; /evidence=""ECO:0007829|PDB:7QS2""; STRAND 362..369; /evidence=""ECO:0007829|PDB:7QS2""; STRAND 375..377; /evidence=""ECO:0007829|PDB:7QS2""; STRAND 386..394; /evidence=""ECO:0007829|PDB:7QS2""; STRAND 396..398; /evidence=""ECO:0007829|PDB:7QS2""; STRAND 404..406; /evidence=""ECO:0007829|PDB:7QS2""; STRAND 413..420; /evidence=""ECO:0007829|PDB:7QS2""; STRAND 425..430; /evidence=""ECO:0007829|PDB:7QS2""; STRAND 436..441; /evidence=""ECO:0007829|PDB:7QS2""; STRAND 448..456; /evidence=""ECO:0007829|PDB:7QS2""; STRAND 460..464; /evidence=""ECO:0007829|PDB:7QS2""","HELIX 382..384; /evidence=""ECO:0007829|PDB:7QS2""","TURN 300..302; /evidence=""ECO:0007829|PDB:7QS2""; TURN 421..424; /evidence=""ECO:0007829|PDB:7QS2""; TURN 431..433; /evidence=""ECO:0007829|PDB:7QS2""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,TRIM15 RNF93 ZNF178 ZNFB7,E3 ubiquitin-protein ligase TRIM15 (EC 2.3.2.27) (RING finger protein 93) (Zinc finger protein 178) (Zinc finger protein B7),Homo sapiens (Human),465.0,52113.0,MPATPSLKVVHELPACTLCAGPLEDAVTIPCGHTFCRLCLPALSQMGAQSSGKILLCPLCQEEEQAETPMAPVPLGPLGETYCEEHGEKIYFFCENDAEFLCVFCREGPTHQAHTVGFLDEAIQPYRDRLRSRLEALSTERDEIEDVKCQEDQKLQVLLTQIESKKHQVETAFERLQQELEQQRCLLLARLRELEQQIWKERDEYITKVSEEVTRLGAQVKELEEKCQQPASELLQDVRVNQSRCEMKTFVSPEAISPDLVKKIRDFHRKILTLPEMMRMFSENLAHHLEIDSGVITLDPQTASRSLVLSEDRKSVRYTRQKKSLPDSPLRFDGLPAVLGFPGFSSGRHRWQVDLQLGDGGGCTVGVAGEGVRRKGEMGLSAEDGVWAVIISHQQCWASTSPGTDLPLSEIPRGVRVALDYEAGQVTLHNAQTQEPIFTFTASFSGKVFPFFAVWKKGSCLTLKG,False,False,True,Q9C019,"[('cd15826', 'PRY/SPRY domain in tripartite motif-binding protein 15 (TRIM15)'), ('cd16569', 'RING finger, HC subclass, found in SNF2 histone-linker PHD finger RING finger helicase (SHPRH) and similar proteins'), ('cd19765', 'B-box-type 2 zinc finger found in tripartite motif-containing proteins, TRIM10, TRIM15, TRIM26, TRIM31 and similar proteins'), ('G3DSA:2.60.120.920', None), ('G3DSA:3.30.160.60', 'Classic Zinc Finger'), ('G3DSA:3.30.40.10', 'Zinc/RING finger domain, C3HC4 (zinc finger)'), ('IPR000315', 'B-box-type zinc finger'), ('IPR001841', 'Zinc finger, RING-type'), ('IPR001870', 'B30.2/SPRY domain'), ('IPR003877', 'SPRY domain'), ('IPR003879', 'Butyrophylin-like, SPRY domain'), ('IPR006574', 'SPRY-associated'), ('IPR013083', 'Zinc finger, RING/FYVE/PHD-type'), ('IPR013320', 'Concanavalin A-like lectin/glucanase domain superfamily'), ('IPR017907', 'Zinc finger, RING-type, conserved site'), ('IPR018957', 'Zinc finger, C3HC4 RING-type'), ('IPR043136', 'B30.2/SPRY domain superfamily'), ('IPR050143', 'Tripartite motif-containing'), ('PF00097', 'Zinc finger, C3HC4 type (RING finger)'), ('PF00622', 'SPRY domain')]",,"""ENSG00000204610; Group enriched (intestine, kidney, liver)."";",CATALYTIC ACTIVITY: Reaction=S-ubiquitinyl-[E2 ubiquitin-conjugating enzyme]-L-cysteine + [acceptor protein]-L-lysine = [E2 ubiquitin-conjugating enzyme]-L-cysteine + N(6)-ubiquitinyl-[acceptor protein]-L-lysine.; EC=2.3.2.27; Evidence={ECO:0000269|PubMed:34497368};,2.3.2.27,,,ENST00000259930.10 [Q9C019-1];ENST00000376694.9 [Q9C019-1];ENST00000414873.6 [Q9C019-1];ENST00000421984.6 [Q9C019-1];ENST00000427091.6 [Q9C019-1];ENST00000431059.6 [Q9C019-1];ENST00000550400.2 [Q9C019-2];ENST00000552676.2 [Q9C019-2];ENST00000552836.2 [Q9C019-2];,TRIM15,ENSG00000204610,7.0,,,,,,,0.161,,TRIM15
Q9C035,ENSG00000132256,TRIM5_HUMAN,activation of innate immune response [GO:0002218]; autophagy [GO:0006914]; defense response to virus [GO:0051607]; innate immune response [GO:0045087]; negative regulation of viral entry into host cell [GO:0046597]; positive regulation of autophagy [GO:0010508]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of MAPK cascade [GO:0043410]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; regulation of lipopolysaccharide-mediated signaling pathway [GO:0031664]; regulation of protein localization [GO:0032880]; regulation of viral entry into host cell [GO:0046596]; suppression of viral release by host [GO:0044790],cytoplasm [GO:0005737]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; P-body [GO:0000932],identical protein binding [GO:0042802]; pattern recognition receptor activity [GO:0038187]; protein homodimerization activity [GO:0042803]; protein kinase binding [GO:0019901]; protein-macromolecule adaptor activity [GO:0030674]; transcription coactivator activity [GO:0003713]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],PTM: Degraded in a proteasome-independent fashion in the absence of viral infection but in a proteasome-dependent fashion following exposure to restriction sensitive virus.; PTM: Autoubiquitinated in a RING finger- and UBE2D2-dependent manner. Monoubiquitinated by TRIM21. Deubiquitinated by Yersinia YopJ. Ubiquitination may not lead to proteasomal degradation. {ECO:0000269|PubMed:18312418}.,"DOMAIN: The B box-type zinc finger domain and the coiled-coil domain contribute to the higher and low order multimerization respectively which is essential for restriction activity (PubMed:22482711). The coiled coil domain is important for higher order multimerization by promoting the initial dimerization (By similarity). {ECO:0000250|UniProtKB:Q0PF16, ECO:0000269|PubMed:22482711}.; DOMAIN: The B30.2/SPRY domain acts as a capsid recognition domain. Polymorphisms in this domain explain the observed species-specific differences among orthologs (PubMed:22482711). {ECO:0000269|PubMed:22482711}.; DOMAIN: The RING-type zinc finger domain confers E3 ubiquitin ligase activity and is essential for retrovirus restriction activity, autoubiquitination and higher-order multimerization. {ECO:0000269|PubMed:22482711}.","DOMAIN 281..493; /note=""B30.2/SPRY""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00548""","STRAND 29..31; /evidence=""ECO:0007829|PDB:2ECV""; STRAND 64..66; /evidence=""ECO:0007829|PDB:2ECV""; STRAND 92..94; /evidence=""ECO:0007829|PDB:2YRG""; STRAND 104..106; /evidence=""ECO:0007829|PDB:2YRG""; STRAND 111..113; /evidence=""ECO:0007829|PDB:2YRG""; STRAND 128..130; /evidence=""ECO:0007829|PDB:2YRG""","HELIX 38..45; /evidence=""ECO:0007829|PDB:2ECV""; HELIX 115..118; /evidence=""ECO:0007829|PDB:2YRG""","TURN 16..18; /evidence=""ECO:0007829|PDB:2ECV""; TURN 46..50; /evidence=""ECO:0007829|PDB:2ECV""; TURN 56..58; /evidence=""ECO:0007829|PDB:2ECV""; TURN 96..98; /evidence=""ECO:0007829|PDB:2YRG""; TURN 107..109; /evidence=""ECO:0007829|PDB:2YRG""; TURN 121..125; /evidence=""ECO:0007829|PDB:2YRG""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,TRIM5 RNF88,Tripartite motif-containing protein 5 (EC 2.3.2.27) (RING finger protein 88) (RING-type E3 ubiquitin transferase TRIM5),Homo sapiens (Human),493.0,56338.0,MASGILVNVKEEVTCPICLELLTQPLSLDCGHSFCQACLTANHKKSMLDKGESSCPVCRISYQPENIRPNRHVANIVEKLREVKLSPEGQKVDHCARHGEKLLLFCQEDGKVICWLCERSQEHRGHHTFLTEEVAREYQVKLQAALEMLRQKQQEAEELEADIREEKASWKTQIQYDKTNVLADFEQLRDILDWEESNELQNLEKEEEDILKSLTNSETEMVQQTQSLRELISDLEHRLQGSVMELLQGVDGVIKRTENVTLKKPETFPKNQRRVFRAPDLKGMLEVFRELTDVRRYWVDVTVAPNNISCAVISEDKRQVSSPKPQIIYGARGTRYQTFVNFNYCTGILGSQSITSGKHYWEVDVSKKTAWILGVCAGFQPDAMCNIEKNENYQPKYGYWVIGLEEGVKCSAFQDSSFHTPSVPFIVPLSVIICPDRVGVFLDYEACTVSFFNITNHGFLIYKFSHCSFSQPVFPYLNPRKCGVPMTLCSPSS,False,False,True,Q9C035,"[('cd15822', 'PRY/SPRY domain in tripartite motif-binding protein 5 (TRIM5), also known as RING finger protein 88 (RNF88)'), ('cd16591', 'RING finger, HC subclass, found in tripartite motif-containing proteins TRIM5, TRIM6, TRIM22, TRIM34 and similar proteins'), ('cd19761', 'B-box-type 2 zinc finger found in tripartite motif-containing proteins, TRIM5, TRIM6, TRIM22, TRIM34, TRIM38 and similar proteins'), ('G3DSA:2.60.120.920', None), ('G3DSA:3.30.160.60', 'Classic Zinc Finger'), ('G3DSA:3.30.40.10', 'Zinc/RING finger domain, C3HC4 (zinc finger)'), ('IPR000315', 'B-box-type zinc finger'), ('IPR001841', 'Zinc finger, RING-type'), ('IPR001870', 'B30.2/SPRY domain'), ('IPR003877', 'SPRY domain'), ('IPR003879', 'Butyrophylin-like, SPRY domain'), ('IPR013083', 'Zinc finger, RING/FYVE/PHD-type'), ('IPR013320', 'Concanavalin A-like lectin/glucanase domain superfamily'), ('IPR017907', 'Zinc finger, RING-type, conserved site'), ('IPR027370', 'Zinc finger, RING-type, eukaryotic'), ('IPR043136', 'B30.2/SPRY domain superfamily'), ('IPR050143', 'Tripartite motif-containing'), ('PF00622', 'SPRY domain'), ('PF00643', 'B-box zinc finger'), ('PF13445', 'RING-type zinc-finger')]",Q9C035;,"""ENSG00000132256; Low tissue specificity."";",CATALYTIC ACTIVITY: Reaction=S-ubiquitinyl-[E2 ubiquitin-conjugating enzyme]-L-cysteine + [acceptor protein]-L-lysine = [E2 ubiquitin-conjugating enzyme]-L-cysteine + N(6)-ubiquitinyl-[acceptor protein]-L-lysine.; EC=2.3.2.27;,2.3.2.27,,PATHWAY: Protein modification; protein ubiquitination.,ENST00000380027.5 [Q9C035-4];ENST00000380034.8 [Q9C035-1];ENST00000396847.7 [Q9C035-3];ENST00000433961.5 [Q9C035-5];ENST00000684655.1 [Q9C035-1];,TRIM5,ENSG00000132256,0.0,TRIM5,Canonical_RBPs,0.0,,,,0.041,,TRIM5
Q9C0C9,ENSG00000175931,UBE2O_HUMAN,"positive regulation of BMP signaling pathway [GO:0030513]; protein K63-linked ubiquitination [GO:0070534]; protein monoubiquitination [GO:0006513]; retrograde transport, endosome to Golgi [GO:0042147]",cytoplasm [GO:0005737]; cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],ATP binding [GO:0005524]; RNA binding [GO:0003723]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842],"PTM: Phosphorylated. Phosphorylation affects subcellular location. {ECO:0000269|PubMed:24703950}.; PTM: Ubiquitinated: autoubiquitinates, possibly affecting its subcellular location. {ECO:0000269|PubMed:24703950}.",,"DOMAIN 953..1113; /note=""UBC core""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00388""","STRAND 65..79; /evidence=""ECO:0007829|PDB:7UN6""; STRAND 123..129; /evidence=""ECO:0007829|PDB:7UN6""; STRAND 132..134; /evidence=""ECO:0007829|PDB:7UN3""; STRAND 140..144; /evidence=""ECO:0007829|PDB:7UN6""; STRAND 152..159; /evidence=""ECO:0007829|PDB:7UN6""; STRAND 163..177; /evidence=""ECO:0007829|PDB:7UN6""; STRAND 183..188; /evidence=""ECO:0007829|PDB:7UN6""; STRAND 195..197; /evidence=""ECO:0007829|PDB:7UN6""; STRAND 203..205; /evidence=""ECO:0007829|PDB:7UN6""; STRAND 210..224; /evidence=""ECO:0007829|PDB:7UN6""; STRAND 229..233; /evidence=""ECO:0007829|PDB:7UN6""; STRAND 265..269; /evidence=""ECO:0007829|PDB:7UN6""; STRAND 275..281; /evidence=""ECO:0007829|PDB:7UN6""; STRAND 288..306; /evidence=""ECO:0007829|PDB:7UN6""; STRAND 326..328; /evidence=""ECO:0007829|PDB:7UN6""; STRAND 352..356; /evidence=""ECO:0007829|PDB:7UN6""; STRAND 543..559; /evidence=""ECO:0007829|PDB:7UN6""; STRAND 564..569; /evidence=""ECO:0007829|PDB:7UN6""; STRAND 573..575; /evidence=""ECO:0007829|PDB:7UN6""; STRAND 589..592; /evidence=""ECO:0007829|PDB:7UN6""; STRAND 595..597; /evidence=""ECO:0007829|PDB:7UN6""; STRAND 601..611; /evidence=""ECO:0007829|PDB:7UN6""; STRAND 616..624; /evidence=""ECO:0007829|PDB:7UN6""; STRAND 626..629; /evidence=""ECO:0007829|PDB:7UN6""; STRAND 631..635; /evidence=""ECO:0007829|PDB:7UN6""; STRAND 639..641; /evidence=""ECO:0007829|PDB:7UN6""; STRAND 645..647; /evidence=""ECO:0007829|PDB:7UN6""; STRAND 657..661; /evidence=""ECO:0007829|PDB:7UN6""; STRAND 678..684; /evidence=""ECO:0007829|PDB:7UN3""; STRAND 686..688; /evidence=""ECO:0007829|PDB:7UN3""; STRAND 694..697; /evidence=""ECO:0007829|PDB:7UN6""; STRAND 698..702; /evidence=""ECO:0007829|PDB:7UN3""; STRAND 707..709; /evidence=""ECO:0007829|PDB:7UN6""; STRAND 931..934; /evidence=""ECO:0007829|PDB:7UN6""; STRAND 971..979; /evidence=""ECO:0007829|PDB:7UN6""; STRAND 984..991; /evidence=""ECO:0007829|PDB:7UN6""; STRAND 993..995; /evidence=""ECO:0007829|PDB:7UN3""; STRAND 999..1007; /evidence=""ECO:0007829|PDB:7UN6""; STRAND 1018..1021; /evidence=""ECO:0007829|PDB:7UN6""; STRAND 1024..1027; /evidence=""ECO:0007829|PDB:7UN6""; STRAND 1029..1033; /evidence=""ECO:0007829|PDB:7UN6""; STRAND 1078..1083; /evidence=""ECO:0007829|PDB:7UN6""; STRAND 1255..1257; /evidence=""ECO:0007829|PDB:7UN3""","HELIX 189..191; /evidence=""ECO:0007829|PDB:7UN6""; HELIX 234..237; /evidence=""ECO:0007829|PDB:7UN6""; HELIX 270..274; /evidence=""ECO:0007829|PDB:7UN6""; HELIX 330..333; /evidence=""ECO:0007829|PDB:7UN6""; HELIX 340..342; /evidence=""ECO:0007829|PDB:7UN6""; HELIX 570..572; /evidence=""ECO:0007829|PDB:7UN6""; HELIX 642..644; /evidence=""ECO:0007829|PDB:7UN6""; HELIX 704..706; /evidence=""ECO:0007829|PDB:7UN6""; HELIX 951..967; /evidence=""ECO:0007829|PDB:7UN6""; HELIX 1061..1070; /evidence=""ECO:0007829|PDB:7UN6""; HELIX 1084..1087; /evidence=""ECO:0007829|PDB:7UN6""; HELIX 1091..1117; /evidence=""ECO:0007829|PDB:7UN6""; HELIX 1124..1145; /evidence=""ECO:0007829|PDB:7UN6""; HELIX 1263..1282; /evidence=""ECO:0007829|PDB:7UN6""","TURN 137..139; /evidence=""ECO:0007829|PDB:7UN6""; TURN 612..615; /evidence=""ECO:0007829|PDB:7UN6""; TURN 980..983; /evidence=""ECO:0007829|PDB:7UN6""; TURN 1010..1013; /evidence=""ECO:0007829|PDB:7UN6""; TURN 1042..1045; /evidence=""ECO:0007829|PDB:7UN6""; TURN 1121..1123; /evidence=""ECO:0007829|PDB:7UN6""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,UBE2O KIAA1734,(E3-independent) E2 ubiquitin-conjugating enzyme (EC 2.3.2.24) (E2/E3 hybrid ubiquitin-protein ligase UBE2O) (Ubiquitin carrier protein O) (Ubiquitin-conjugating enzyme E2 O) (Ubiquitin-conjugating enzyme E2 of 230 kDa) (Ubiquitin-conjugating enzyme E2-230K) (Ubiquitin-protein ligase O),Homo sapiens (Human),1292.0,141293.0,MADPAAPTPAAPAPAQAPAPAPEAVPAPAAAPVPAPAPASDSASGPSSDSGPEAGSQRLLFSHDLVSGRYRGSVHFGLVRLIHGEDSDSEGEEEGRGSSGCSEAGGAGHEEGRASPLRRGYVRVQWYPEGVKQHVKETKLKLEDRSVVPRDVVRHMRSTDSQCGTVIDVNIDCAVKLIGTNCIIYPVNSKDLQHIWPFMYGDYIAYDCWLGKVYDLKNQIILKLSNGARCSMNTEDGAKLYDVCPHVSDSGLFFDDSYGFYPGQVLIGPAKIFSSVQWLSGVKPVLSTKSKFRVVVEEVQVVELKVTWITKSFCPGGTDSVSPPPSVITQENLGRVKRLGCFDHAQRQLGERCLYVFPAKVEPAKIAWECPEKNCAQGEGSMAKKVKRLLKKQVVRIMSCSPDTQCSRDHSMEDPDKKGESKTKSEAESASPEETPDGSASPVEMQDEGAEEPHEAGEQLPPFLLKEGRDDRLHSAEQDADDEAADDTDDTSSVTSSASSTTSSQSGSGTSRKKSIPLSIKNLKRKHKRKKNKITRDFKPGDRVAVEVVTTMTSADVMWQDGSVECNIRSNDLFPVHHLDNNEFCPGDFVVDKRVQSCPDPAVYGVVQSGDHIGRTCMVKWFKLRPSGDDVELIGEEEDVSVYDIADHPDFRFRTTDIVIRIGNTEDGAPHKEDEPSVGQVARVDVSSKVEVVWADNSKTIILPQHLYNIESEIEESDYDSVEGSTSGASSDEWEDDSDSWETDNGLVEDEHPKIEEPPIPPLEQPVAPEDKGVVISEEAATAAVQGAVAMAAPMAGLMEKAGKDGPPKSFRELKEAIKILESLKNMTVEQLLTGSPTSPTVEPEKPTREKKFLDDIKKLQENLKKTLDNVAIVEEEKMEAVPDVERKEDKPEGQSPVKAEWPSETPVLCQQCGGKPGVTFTSAKGEVFSVLEFAPSNHSFKKIEFQPPEAKKFFSTVRKEMALLATSLPEGIMVKTFEDRMDLFSALIKGPTRTPYEDGLYLFDIQLPNIYPAVPPHFCYLSQCSGRLNPNLYDNGKVCVSLLGTWIGKGTERWTSKSSLLQVLISIQGLILVNEPYYNEAGFDSDRGLQEGYENSRCYNEMALIRVVQSMTQLVRRPPEVFEQEIRQHFSTGGWRLVNRIESWLETHALLEKAQALPNGVPKASSSPEPPAVAELSDSGQQEPEDGGPAPGEASQGSDSEGGAQGLASASRDHTDQTSETAPDASVPPSVKPKKRRKSYRSFLPEKSGYPDIGFPLFPLSKGFIKSIRGVLTQFRAALLEAGMPECTEDK,False,False,True,Q9C0C9,"[('cd00195', 'UBCc'), ('G3DSA:3.10.110.10', 'Ubiquitin Conjugating Enzyme'), ('IPR000608', 'Ubiquitin-conjugating enzyme E2'), ('IPR016135', 'Ubiquitin-conjugating enzyme/RWD-like'), ('PF00179', 'Ubiquitin-conjugating enzyme'), ('PF23043', 'UBE2O, SH3-B domain'), ('PF23044', 'UBE2O, ubiquitin binding SH3-C domain'), ('PF23046', 'UBE2O, tandem tSH3-B domain'), ('PF23048', 'UBE2O, N-terminal SH3-A domain'), ('PS50127', 'Ubiquitin-conjugating (UBC) core domain profile'), ('PTHR46116', 'Ubiquitin-Conjugating Enzyme'), ('SM00212', 'Ubiquitin-conjugating enzyme E2, catalytic domain homologues'), ('SSF54495', 'UBC-like')]",,"""ENSG00000175931; Low tissue specificity."";","CATALYTIC ACTIVITY: Reaction=S-ubiquitinyl-[E1 ubiquitin-activating enzyme]-L-cysteine + [acceptor protein]-L-lysine = [E1 ubiquitin-activating enzyme]-L-cysteine + N(6)-monoubiquitinyl-[acceptor protein]-L-lysine.; EC=2.3.2.24; Evidence={ECO:0000255|PROSITE-ProRule:PRU00388, ECO:0000269|PubMed:23455153, ECO:0000269|PubMed:24703950};",2.3.2.24,ACTIVITY REGULATION: inhibited by phenylarsine oxide (PAO). {ECO:0000269|PubMed:24703950}.,PATHWAY: Protein modification; protein ubiquitination. {ECO:0000255|PROSITE-ProRule:PRU00388}.,ENST00000319380.12;,UBE2O,ENSG00000175931,0.0,UBE2O,Non-canonical_RBPs,9.0,,,,0.405,0.261,UBE2O
Q9GZM8,ENSG00000166579,NDEL1_HUMAN,cell migration [GO:0016477]; central nervous system neuron axonogenesis [GO:0021955]; centrosome localization [GO:0051642]; cerebral cortex radially oriented cell migration [GO:0021799]; chromosome segregation [GO:0007059]; establishment of chromosome localization [GO:0051303]; establishment of mitotic spindle orientation [GO:0000132]; inner cell mass cell proliferation [GO:0001833]; insulin receptor signaling pathway [GO:0008286]; lysosome localization [GO:0032418]; microtubule nucleation [GO:0007020]; mitotic centrosome separation [GO:0007100]; neurofilament cytoskeleton organization [GO:0060052]; neuron projection extension [GO:1990138]; positive regulation of GTPase activity [GO:0043547]; positive regulation of ruffle assembly [GO:1900029]; radial glia-guided pyramidal neuron migration [GO:0140650]; regulation of intracellular protein transport [GO:0033157]; regulation of neuron projection development [GO:0010975]; retrograde axonal transport [GO:0008090]; vesicle transport along microtubule [GO:0047496],axon cytoplasm [GO:1904115]; axon hillock [GO:0043203]; cell leading edge [GO:0031252]; centrosome [GO:0005813]; cytosol [GO:0005829]; kinesin complex [GO:0005871]; kinetochore [GO:0000776]; microtubule [GO:0005874]; neurofilament cytoskeleton [GO:0060053]; spindle [GO:0005819]; synaptic vesicle [GO:0008021],alpha-tubulin binding [GO:0043014]; beta-tubulin binding [GO:0048487]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017],"PTM: Phosphorylated in mitosis. Can be phosphorylated by CDK1, CDK5 and MAPK1. Phosphorylation by CDK5 promotes interaction with KATNA1 and YWHAE. {ECO:0000269|PubMed:11163260, ECO:0000269|PubMed:12556484, ECO:0000269|PubMed:16203747}.; PTM: Palmitoylation at Cys-273 reduces affinity for dynein. {ECO:0000269|PubMed:19927128}.",,,,"HELIX 59..165; /evidence=""ECO:0007829|PDB:2V66""",,"cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,NDEL1 EOPA MITAP1 NUDEL,Nuclear distribution protein nudE-like 1 (Protein Nudel) (Mitosin-associated protein 1),Homo sapiens (Human),345.0,38375.0,MDGEDIPDFSSLKEETAYWKELSLKYKQSFQEARDELVEFQEGSRELEAELEAQLVQAEQRNRDLQADNQRLKYEVEALKEKLEHQYAQSYKQVSVLEDDLSQTRAIKEQLHKYVRELEQANDDLERAKRATIVSLEDFEQRLNQAIERNAFLESELDEKESLLVSVQRLKDEARDLRQELAVRERQQEVTRKSAPSSPTLDCEKMDSAVQASLSLPATPVGKGTENTFPSPKAIPNGFGTSPLTPSARISALNIVGDLLRKVGALESKLAACRNFAKDQASRKSYISGNVNCGVLNGNGTKFSRSGHTSFFDKGAVNGFDPAPPPPGLGSSRPSSAPGMLPLSV,False,False,True,Q9GZM8,"[('G3DSA:6.10.250.1080', None), ('IPR006964', 'NUDE domain'), ('IPR033494', 'NUDE family'), ('PF04880', 'NUDE protein, C-terminal conserved region'), ('PTHR10921', 'NUCLEAR DISTRIBUTION PROTEIN NUDE HOMOLOG 1')]",,"""ENSG00000166579; Low tissue specificity."";",,,,,ENST00000334527.12 [Q9GZM8-1];ENST00000402554.7 [Q9GZM8-3];,NDEL1,ENSG00000166579,0.0,,,,,,,0.565,0.09,NDEL1
Q9H009,ENSG00000253506,NACA2_HUMAN,protein targeting to membrane [GO:0006612]; protein transport [GO:0015031],cytoplasm [GO:0005737]; nascent polypeptide-associated complex [GO:0005854]; nucleus [GO:0005634],unfolded protein binding [GO:0051082],,,"DOMAIN 70..135; /note=""NAC-A/B""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00507""; DOMAIN 176..213; /note=""UBA""",,,,"cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,NACA2 NACAL,Nascent polypeptide-associated complex subunit alpha-2 (Alpha-NAC-like) (Hom s 2.01) (Nascent polypeptide-associated complex subunit alpha-like) (NAC-alpha-like),Homo sapiens (Human),215.0,23223.0,MPGEATETVPATEQELPQSQAETGSGTASDSGESVPGIEEQDSTQTTTQKAWLVAAAEIDEEPVGKAKQSRSEKRARKAMSKLGLLQVTGVTRVTIWKSKNILFVITKLDVYKSPASDAYIVFGEAKIQDLSQQAQLAAAEKFRVQGEAVGNIQENTQTPTVQEESEEEEVDETGVEVKDVKLVMSQANVSRAKAVRALKNNSNDIVNAIMELTV,True,False,False,Q9H009,"[('cd14415', 'UBA-like domain found in nascent polypeptide-associated complex subunit alpha (NACA) and putative NACA-like protein (NACP1)'), ('cd22054', 'nascent polypeptide-associated complex (NAC), alpha subunit'), ('G3DSA:1.10.8.10', 'DNA helicase RuvA subunit, C-terminal domain'), ('G3DSA:2.20.70.30', 'Nascent polypeptide-associated complex domain'), ('IPR002715', 'Nascent polypeptide-associated complex NAC domain'), ('IPR016641', 'Nascent polypeptide-associated complex subunit alpha-like'), ('IPR038187', 'NAC A/B domain superfamily'), ('IPR044034', 'Nascent polypeptide-associated complex subunit alpha-like, UBA domain'), ('PF01849', 'NAC domain'), ('PF19026', 'HYPK UBA domain'), ('PIRSF015901', 'Nascent polypeptide-associated complex, alpha subunit'), ('PS51151', 'NAC A/B domain profile'), ('PTHR21713', 'NASCENT POLYPEPTIDE ASSOCIATED COMPLEX ALPHA SUBUNIT-RELATED'), ('SM01407', 'NAC')]",,"""ENSG00000253506; Tissue enriched (testis)."";",,,,,ENST00000521764.3;,NACA2,ENSG00000253506,0.0,,,,,,,0.535,0.237,NACA2
Q9H0A6,ENSG00000105982,RNF32_HUMAN,,aggresome [GO:0016235]; cytosol [GO:0005829]; endosome [GO:0005768]; nuclear body [GO:0016604],metal ion binding [GO:0046872],,,"DOMAIN 186..215; /note=""IQ""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00116""",,,,"cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,RNF32 FKSG33 HSD15,RING finger protein 32,Homo sapiens (Human),362.0,41516.0,MLKNKGHSSKKDNLAVNAVALQDHILHDLQLRNLSVADHSKTQVQKKENKSLKRDTKAIIDTGLKKTTQCPKLEDSEKEYVLDPKPPPLTLAQKLGLIGPPPPPLSSDEWEKVKQRSLLQGDSVQPCPICKEEFELRPQVLLSCSHVFHKACLQAFEKFTNKKTCPLCRKNQYQTRVIHDGARLFRIKCVTRIQAYWRGCVVRKWYRNLRKTVPPTDAKLRKKFFEKKFTEISHRILCSYNTNIEELFAEIDQCLAINRSVLQQLEEKCGHEITEEEWEKIQVQALRRETHECSICLAPLSAAGGQRVGAGRRSREMALLSCSHVFHHACLLALEEFSVGDRPPFHACPLCRSCYQKKILEC,False,False,True,Q9H0A6,"[('cd16677', 'first RING finger, H2 subclass, found in RING finger protein 32 (RNF32) and similar proteins'), ('cd16678', 'second RING finger, H2 subclass, found in RING finger protein 32 (RNF32) and similar proteins'), ('G3DSA:1.20.5.190', None), ('G3DSA:3.30.40.10', 'Zinc/RING finger domain, C3HC4 (zinc finger)'), ('IPR000048', 'IQ motif, EF-hand binding site'), ('IPR001841', 'Zinc finger, RING-type'), ('IPR013083', 'Zinc finger, RING/FYVE/PHD-type'), ('IPR027370', 'Zinc finger, RING-type, eukaryotic'), ('IPR042862', 'RING finger protein 32'), ('PF00612', 'IQ calmodulin-binding motif'), ('PF13445', 'RING-type zinc-finger'), ('PF13639', 'Ring finger domain'), ('PS50089', 'Zinc finger RING-type profile'), ('PS50096', 'IQ motif profile'), ('PTHR14991', 'RING FINGER PROTEIN 32'), ('SM00184', 'Ring finger'), ('SSF57850', 'RING/U-box')]",,"""ENSG00000105982; Tissue enriched (testis)."";",,,,,ENST00000317955.10 [Q9H0A6-1];ENST00000392741.6 [Q9H0A6-4];ENST00000392743.6 [Q9H0A6-1];ENST00000392747.6 [Q9H0A6-6];ENST00000405335.5 [Q9H0A6-1];ENST00000432459.6 [Q9H0A6-1];,RNF32,ENSG00000105982,0.0,,,,,,,0.279,,RNF32
Q9H0M0,ENSG00000123124,WWP1_HUMAN,central nervous system development [GO:0007417]; monoatomic ion transmembrane transport [GO:0034220]; negative regulation of DNA-templated transcription [GO:0045892]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein ubiquitination [GO:0016567]; signal transduction [GO:0007165]; symbiont entry into host cell [GO:0046718],anchoring junction [GO:0070161]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; ubiquitin ligase complex [GO:0000151],ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842],"PTM: Auto-ubiquitinated and ubiquitinated by RNF11. {ECO:0000269|PubMed:15359284, ECO:0000269|PubMed:18724389, ECO:0000269|PubMed:19343052}.",DOMAIN: The WW domains mediate interaction with PPxY motif-containing proteins. {ECO:0000269|PubMed:21191027}.,"DOMAIN 1..116; /note=""C2""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00041""; DOMAIN 349..382; /note=""WW 1""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00224""; DOMAIN 381..414; /note=""WW 2""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00224""; DOMAIN 456..489; /note=""WW 3""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00224""; DOMAIN 496..529; /note=""WW 4""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00224""; DOMAIN 588..922; /note=""HECT""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00104""","STRAND 387..391; /evidence=""ECO:0007829|PDB:6J1X""; STRAND 397..401; /evidence=""ECO:0007829|PDB:6J1X""; STRAND 407..410; /evidence=""ECO:0007829|PDB:6J1X""; STRAND 452..455; /evidence=""ECO:0007829|PDB:6J1Y""; STRAND 462..466; /evidence=""ECO:0007829|PDB:6J1Y""; STRAND 472..476; /evidence=""ECO:0007829|PDB:6J1Y""; STRAND 481..485; /evidence=""ECO:0007829|PDB:6J1Y""; STRAND 502..506; /evidence=""ECO:0007829|PDB:6J1X""; STRAND 512..516; /evidence=""ECO:0007829|PDB:6J1X""; STRAND 521..525; /evidence=""ECO:0007829|PDB:6J1X""; STRAND 564..571; /evidence=""ECO:0007829|PDB:5HPS""; STRAND 594..600; /evidence=""ECO:0007829|PDB:5HPS""; STRAND 629..636; /evidence=""ECO:0007829|PDB:5HPS""; STRAND 641..643; /evidence=""ECO:0007829|PDB:5HPS""; STRAND 723..730; /evidence=""ECO:0007829|PDB:5HPS""; STRAND 733..740; /evidence=""ECO:0007829|PDB:5HPS""; STRAND 817..820; /evidence=""ECO:0007829|PDB:5HPS""; STRAND 867..870; /evidence=""ECO:0007829|PDB:8EI4""; STRAND 874..876; /evidence=""ECO:0007829|PDB:5HPS""; STRAND 881..883; /evidence=""ECO:0007829|PDB:5HPT""; STRAND 886..888; /evidence=""ECO:0007829|PDB:5HPS""; STRAND 893..895; /evidence=""ECO:0007829|PDB:5HPS""","HELIX 414..423; /evidence=""ECO:0007829|PDB:6J1X""; HELIX 434..443; /evidence=""ECO:0007829|PDB:6J1X""; HELIX 445..448; /evidence=""ECO:0007829|PDB:6J1Y""; HELIX 487..490; /evidence=""ECO:0007829|PDB:6J1Y""; HELIX 547..559; /evidence=""ECO:0007829|PDB:5HPS""; HELIX 576..586; /evidence=""ECO:0007829|PDB:5HPS""; HELIX 589..593; /evidence=""ECO:0007829|PDB:5HPS""; HELIX 611..623; /evidence=""ECO:0007829|PDB:5HPS""; HELIX 626..628; /evidence=""ECO:0007829|PDB:5HPS""; HELIX 645..649; /evidence=""ECO:0007829|PDB:5HPS""; HELIX 653..669; /evidence=""ECO:0007829|PDB:5HPS""; HELIX 680..686; /evidence=""ECO:0007829|PDB:5HPS""; HELIX 693..699; /evidence=""ECO:0007829|PDB:5HPS""; HELIX 701..712; /evidence=""ECO:0007829|PDB:5HPS""; HELIX 715..718; /evidence=""ECO:0007829|PDB:5HPS""; HELIX 743..745; /evidence=""ECO:0007829|PDB:1ND7""; HELIX 752..765; /evidence=""ECO:0007829|PDB:5HPS""; HELIX 770..783; /evidence=""ECO:0007829|PDB:5HPS""; HELIX 786..791; /evidence=""ECO:0007829|PDB:5HPS""; HELIX 794..802; /evidence=""ECO:0007829|PDB:5HPS""; HELIX 809..814; /evidence=""ECO:0007829|PDB:5HPS""; HELIX 826..837; /evidence=""ECO:0007829|PDB:5HPS""; HELIX 840..851; /evidence=""ECO:0007829|PDB:5HPS""; HELIX 860..863; /evidence=""ECO:0007829|PDB:5HPS""; HELIX 889..891; /evidence=""ECO:0007829|PDB:5HPS""; HELIX 902..914; /evidence=""ECO:0007829|PDB:5HPS""","TURN 402..404; /evidence=""ECO:0007829|PDB:6J1X""; TURN 427..429; /evidence=""ECO:0007829|PDB:6J1Y""; TURN 477..480; /evidence=""ECO:0007829|PDB:6J1Y""; TURN 509..511; /evidence=""ECO:0007829|PDB:2OP7""; TURN 517..520; /evidence=""ECO:0007829|PDB:6J1X""; TURN 527..529; /evidence=""ECO:0007829|PDB:6J1X""; TURN 573..575; /evidence=""ECO:0007829|PDB:1ND7""; TURN 601..603; /evidence=""ECO:0007829|PDB:1ND7""; TURN 749..751; /evidence=""ECO:0007829|PDB:5HPS""; TURN 766..769; /evidence=""ECO:0007829|PDB:5HPS""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,WWP1,NEDD4-like E3 ubiquitin-protein ligase WWP1 (EC 2.3.2.26) (Atrophin-1-interacting protein 5) (AIP5) (HECT-type E3 ubiquitin transferase WWP1) (TGIF-interacting ubiquitin ligase 1) (Tiul1) (WW domain-containing protein 1),Homo sapiens (Human),922.0,105202.0,MATASPRSDTSNNHSGRLQLQVTVSSAKLKRKKNWFGTAIYTEVVVDGEITKTAKSSSSSNPKWDEQLTVNVTPQTTLEFQVWSHRTLKADALLGKATIDLKQALLIHNRKLERVKEQLKLSLENKNGIAQTGELTVVLDGLVIEQENITNCSSSPTIEIQENGDALHENGEPSARTTARLAVEGTNGIDNHVPTSTLVQNSCCSYVVNGDNTPSSPSQVAARPKNTPAPKPLASEPADDTVNGESSSFAPTDNASVTGTPVVSEENALSPNCTSTTVEDPPVQEILTSSENNECIPSTSAELESEARSILEPDTSNSRSSSAFEAAKSRQPDGCMDPVRQQSGNANTETLPSGWEQRKDPHGRTYYVDHNTRTTTWERPQPLPPGWERRVDDRRRVYYVDHNTRTTTWQRPTMESVRNFEQWQSQRNQLQGAMQQFNQRYLYSASMLAAENDPYGPLPPGWEKRVDSTDRVYFVNHNTKTTQWEDPRTQGLQNEEPLPEGWEIRYTREGVRYFVDHNTRTTTFKDPRNGKSSVTKGGPQIAYERGFRWKLAHFRYLCQSNALPSHVKINVSRQTLFEDSFQQIMALKPYDLRRRLYVIFRGEEGLDYGGLAREWFFLLSHEVLNPMYCLFEYAGKNNYCLQINPASTINPDHLSYFCFIGRFIAMALFHGKFIDTGFSLPFYKRMLSKKLTIKDLESIDTEFYNSLIWIRDNNIEECGLEMYFSVDMEILGKVTSHDLKLGGSNILVTEENKDEYIGLMTEWRFSRGVQEQTKAFLDGFNEVVPLQWLQYFDEKELEVMLCGMQEVDLADWQRNTVYRHYTRNSKQIIWFWQFVKETDNEVRMRLLQFVTGTCRLPLGGFAELMGSNGPQKFCIEKVGKDTWLPRSHTCFNRLDLPPYKSYEQLKEKLLFAIEETEGFGQE,False,False,True,Q9H0M0,"[('cd00078', 'HECTc'), ('cd00201', 'WW'), ('cd04021', 'C2 domain present in E3 ubiquitin ligase'), ('G3DSA:2.20.70.10', None), ('G3DSA:2.60.40.150', 'C2 domain'), ('G3DSA:3.30.2160.10', 'Hect, E3 ligase catalytic domain'), ('G3DSA:3.30.2410.10', 'Hect, E3 ligase catalytic domain'), ('G3DSA:3.90.1750.10', 'Hect, E3 ligase catalytic domains'), ('IPR000008', 'C2 domain'), ('IPR000569', 'HECT domain'), ('IPR001202', 'WW domain'), ('IPR024928', 'E3 ubiquitin-protein ligase, SMURF1 type'), ('IPR035892', 'C2 domain superfamily'), ('IPR035983', 'HECT, E3 ligase catalytic domain'), ('IPR036020', 'WW domain superfamily'), ('IPR050409', 'E3 ubiquitin-protein ligase'), ('PF00168', 'C2 domain'), ('PF00397', 'WW domain'), ('PF00632', 'HECT-domain (ubiquitin-transferase)'), ('PIRSF001569', 'E3 ubiquitin-protein ligase, SMURF1 type')]",,"""ENSG00000123124; Tissue enhanced (skeletal)."";",CATALYTIC ACTIVITY: Reaction=S-ubiquitinyl-[E2 ubiquitin-conjugating enzyme]-L-cysteine + [acceptor protein]-L-lysine = [E2 ubiquitin-conjugating enzyme]-L-cysteine + N(6)-ubiquitinyl-[acceptor protein]-L-lysine.; EC=2.3.2.26; Evidence={ECO:0000269|PubMed:34404733};,2.3.2.26,ACTIVITY REGULATION: Activated by NDFIP1- and NDFIP2-binding.,PATHWAY: Protein modification; protein ubiquitination.,ENST00000265428.4 [Q9H0M0-1];ENST00000517970.6 [Q9H0M0-1];,WWP1,ENSG00000123124,0.0,,,,,,,0.244,0.194,WWP1
Q9H190,ENSG00000125775,SDCB2_HUMAN,cell population proliferation [GO:0008283]; intracellular signal transduction [GO:0035556]; intracellular transport [GO:0046907]; nervous system development [GO:0007399],cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; Golgi apparatus [GO:0005794]; nuclear speck [GO:0016607]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886],"identical protein binding [GO:0042802]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]",,"DOMAIN: Binds phosphatidylinositol 4,5-bisphosphate (PIP2) via its two PDZ domains. These domains target SDCBP2 to the plasma membranes and nucleoli, two PIP2-rich regions. {ECO:0000269|PubMed:15961997}.","DOMAIN 108..187; /note=""PDZ 1""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00143""; DOMAIN 192..267; /note=""PDZ 2""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00143""",,,,"cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,SDCBP2 SITAC18,Syntenin-2 (Similar to TACIP18) (SITAC) (Syndecan-binding protein 2),Homo sapiens (Human),292.0,31594.0,MSSLYPSLEDLKVDQAIQAQVRASPKMPALPVQATAISPPPVLYPNLAELENYMGLSLSSQEVQESLLQIPEGDSTAVSGPGPGQMVAPVTGYSLGVRRAEIKPGVREIHLCKDERGKTGLRLRKVDQGLFVQLVQANTPASLVGLRFGDQLLQIDGRDCAGWSSHKAHQVVKKASGDKIVVVVRDRPFQRTVTMHKDSMGHVGFVIKKGKIVSLVKGSSAARNGLLTNHYVCEVDGQNVIGLKDKKIMEILATAGNVVTLTIIPSVIYEHMVKKLPPVLLHHTMDHSIPDA,False,False,True,Q9H190,"[('cd00136', 'PDZ'), ('cd00992', 'PDZ_signaling'), ('G3DSA:2.30.42.10', None), ('IPR001478', 'PDZ domain'), ('IPR036034', 'PDZ superfamily'), ('IPR051230', 'Amyloid-beta A4 Precursor Protein-Binding'), ('PF00595', 'PDZ domain'), ('PS50106', 'PDZ domain profile'), ('PTHR12345', 'Amyloid-beta A4 Precursor Protein-Binding'), ('SM00228', 'Domain present in PSD-95, Dlg, and ZO-1/2.'), ('SSF50156', 'PDZ domain-like')]",,"""ENSG00000125775; Tissue enhanced (esophagus, intestine, stomach)."";",,,,,ENST00000339987.7 [Q9H190-1];ENST00000360779.4 [Q9H190-1];ENST00000381808.7 [Q9H190-3];ENST00000381812.5 [Q9H190-1];,SDCBP2,ENSG00000125775,0.0,,,,,,,0.223,,SDCBP2
Q9H211,ENSG00000167513,CDT1_HUMAN,attachment of mitotic spindle microtubules to kinetochore [GO:0051315]; cell division [GO:0051301]; DNA replication checkpoint signaling [GO:0000076]; DNA replication preinitiation complex assembly [GO:0071163]; mitotic cell cycle [GO:0000278]; negative regulation of cell cycle [GO:0045786]; negative regulation of DNA-templated DNA replication [GO:2000104]; positive regulation of chromatin binding [GO:0035563]; positive regulation of DNA replication [GO:0045740]; positive regulation of DNA-templated DNA replication [GO:2000105]; regulation of DNA-templated DNA replication initiation [GO:0030174]; regulation of nuclear cell cycle DNA replication [GO:0033262]; response to sorbitol [GO:0072708],kinetochore [GO:0000776]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],chromatin binding [GO:0003682]; DNA binding [GO:0003677]; DNA polymerase binding [GO:0070182],"PTM: Two independent E3 ubiquitin ligase complexes, SCF(SKP2) and the DCX(DTL) complex, mediated CDT1 degradation in S phase. Ubiquitinated by the DCX(DTL) complex, in response to DNA damage, leading to its degradation. Ubiquitination by the DCX(DTL) complex is necessary to ensure proper cell cycle regulation and is PCNA-dependent: interacts with PCNA via its PIP-box, while the presence of the containing the 'K+4' motif in the PIP box, recruit the DCX(DTL) complex, leading to its degradation. Phosphorylation at Thr-29 by CDK2 targets CDT1 for ubiquitination by SCF(SKP2) E3 ubiquitin ligase and subsequent degradation (PubMed:14993212). The interaction with GMNN protects it against ubiquitination. Deubiquitinated by USP37 (PubMed:27296872). {ECO:0000269|PubMed:14993212, ECO:0000269|PubMed:15257290, ECO:0000269|PubMed:16861906, ECO:0000269|PubMed:16949367, ECO:0000269|PubMed:17085480, ECO:0000269|PubMed:27296872}.; PTM: Phosphorylation by cyclin A-dependent kinases at Thr-29 targets CDT1 for ubiquitynation by SCF(SKP2) E3 ubiquitin ligase and subsequent degradation (PubMed:14993212). Phosphorylated at Thr-29 by MAPK8/JNK1, which blocks replication licensing in response to stress (PubMed:21856198). Binding to GMNN is not affected by phosphorylation. {ECO:0000250|UniProtKB:Q8R4E9, ECO:0000269|PubMed:14993212, ECO:0000269|PubMed:21856198, ECO:0000269|PubMed:22645314}.","DOMAIN: The PIP-box K+4 motif mediates both the interaction with PCNA and the recruitment of the DCX(DTL) complex: while the PIP-box interacts with PCNA, the presence of the K+4 submotif, recruits the DCX(DTL) complex, leading to its ubiquitination. {ECO:0000250|UniProtKB:Q9I9A7}.",,"STRAND 180..182; /evidence=""ECO:0007829|PDB:2WVR""; STRAND 247..251; /evidence=""ECO:0007829|PDB:2WVR""; STRAND 269..273; /evidence=""ECO:0007829|PDB:2WVR""","HELIX 169..172; /evidence=""ECO:0007829|PDB:2WVR""; HELIX 174..177; /evidence=""ECO:0007829|PDB:2WVR""; HELIX 188..209; /evidence=""ECO:0007829|PDB:2WVR""; HELIX 216..227; /evidence=""ECO:0007829|PDB:2WVR""; HELIX 233..242; /evidence=""ECO:0007829|PDB:2WVR""; HELIX 244..246; /evidence=""ECO:0007829|PDB:2WVR""; HELIX 288..314; /evidence=""ECO:0007829|PDB:2WVR""; HELIX 325..327; /evidence=""ECO:0007829|PDB:2WVR""; HELIX 420..423; /evidence=""ECO:0007829|PDB:2LE8""; HELIX 425..435; /evidence=""ECO:0007829|PDB:2LE8""","TURN 6..9; /evidence=""ECO:0007829|PDB:6QCG""; TURN 315..319; /evidence=""ECO:0007829|PDB:2WVR""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,CDT1,DNA replication factor Cdt1 (Double parked homolog) (DUP),Homo sapiens (Human),546.0,60390.0,MEQRRVTDFFARRRPGPPRIAPPKLACRTPSPARPALRAPASATSGSRKRARPPAAPGRDQARPPARRRLRLSVDEVSSPSTPEAPDIPACPSPGQKIKKSTPAAGQPPHLTSAQDQDTISELASCLQRARELGARVRALKASAQDAGESCTPEAEGRPEEPCGEKAPAYQRFHALAQPGLPGLVLPYKYQVLAEMFRSMDTIVGMLHNRSETPTFAKVQRGVQDMMRRRFEECNVGQIKTVYPASYRFRQERSVPTFKDGTRRSDYQLTIEPLLEQEADGAAPQLTASRLLQRRQIFSQKLVEHVKEHHKAFLASLSPAMVVPEDQLTRWHPRFNVDEVPDIEPAALPQPPATEKLTTAQEVLARARNLISPRMEKALSQLALRSAAPSSPGSPRPALPATPPATPPAASPSALKGVSQDLLERIRAKEAQKQLAQMTRCPEQEQRLQRLERLPELARVLRSVFVSERKPALSMEVACARMVGSCCTIMSPGEMEKHLLLLSELLPDWLSLHRIRTDTYVKLDKAADLAHITARLAHQTRAEEGL,True,True,False,Q9H211,"[('cd08674', 'The middle winged helix fold of replication licensing factor Cdt1 binds geminin to inhibit binding of the MCM complex to origins of replication and DNA'), ('cd08767', 'The C-terminal fold of replication licensing factor Cdt1 is essential for Cdt1 activity and directly interacts with MCM2-7 helicase'), ('G3DSA:1.10.10.1420', 'DNA replication factor Cdt1, C-terminal WH domain'), ('IPR014939', 'CDT1 Geminin-binding domain-like'), ('IPR032054', 'DNA replication factor Cdt1, C-terminal'), ('IPR036390', 'Winged helix DNA-binding domain superfamily'), ('IPR038090', 'DNA replication factor Cdt1, C-terminal WH domain superfamily'), ('IPR045173', 'DNA replication factor Cdt1'), ('PF08839', 'DNA replication factor CDT1 like'), ('PF16679', 'DNA replication factor Cdt1 C-terminal domain'), ('PTHR28637', 'DNA REPLICATION FACTOR CDT1'), ('SM01075', 'DNA replication factor CDT1 like'), ('SSF46785', '""Winged helix"" DNA-binding domain')]",,"""ENSG00000167513; Tissue enriched (bone)."";",,,,,ENST00000301019.9;,CDT1,ENSG00000167513,0.0,,,,22.53,DP01193,,0.432,0.319,CDT1
Q9H2X9,ENSG00000124140,S12A5_HUMAN,cell volume homeostasis [GO:0006884]; chemical synaptic transmission [GO:0007268]; chloride ion homeostasis [GO:0055064]; chloride transmembrane transport [GO:1902476]; dendritic spine development [GO:0060996]; hypotonic response [GO:0006971]; intracellular chloride ion homeostasis [GO:0030644]; intracellular pH reduction [GO:0051452]; learning [GO:0007612]; monoatomic ion transport [GO:0006811]; multicellular organism growth [GO:0035264]; postsynaptic neurotransmitter receptor diffusion trapping [GO:0098970]; potassium ion homeostasis [GO:0055075]; potassium ion import across plasma membrane [GO:1990573]; regulation of postsynapse assembly [GO:0150052]; response to xenobiotic stimulus [GO:0009410]; thermosensory behavior [GO:0040040],cell periphery [GO:0071944]; dendrite membrane [GO:0032590]; glutamatergic synapse [GO:0098978]; membrane [GO:0016020]; neuron projection [GO:0043005]; neuronal cell body [GO:0043025]; perikaryon [GO:0043204]; plasma membrane [GO:0005886]; postsynaptic specialization membrane [GO:0099634],ammonium channel activity [GO:0008519]; chloride transmembrane transporter activity [GO:0015108]; metal ion binding [GO:0046872]; potassium:chloride symporter activity [GO:0015379]; protein kinase binding [GO:0019901],"PTM: Phosphorylated at Thr-929 and Thr-1030 by OXSR1/OSR1 and STK39/SPAK downstream of WNK kinases (WNK1, WNK2, WNK3 or WNK4), inhibiting the potassium-chloride cotransport activity. {ECO:0000269|PubMed:19665974}.",,,"STRAND 241..243; /evidence=""ECO:0007829|PDB:6M23""; STRAND 308..314; /evidence=""ECO:0007829|PDB:6M23""; STRAND 326..328; /evidence=""ECO:0007829|PDB:6M23""; STRAND 332..334; /evidence=""ECO:0007829|PDB:6M23""; STRAND 348..352; /evidence=""ECO:0007829|PDB:6M23""; STRAND 364..369; /evidence=""ECO:0007829|PDB:6M23""; STRAND 395..397; /evidence=""ECO:0007829|PDB:6M23""; STRAND 412..414; /evidence=""ECO:0007829|PDB:6M23""; STRAND 442..446; /evidence=""ECO:0007829|PDB:6M23""; STRAND 503..505; /evidence=""ECO:0007829|PDB:6M23""; STRAND 555..558; /evidence=""ECO:0007829|PDB:6M23""; STRAND 614..616; /evidence=""ECO:0007829|PDB:6M23""; STRAND 664..666; /evidence=""ECO:0007829|PDB:7D8Z""; STRAND 685..687; /evidence=""ECO:0007829|PDB:6M23""; STRAND 688..691; /evidence=""ECO:0007829|PDB:7D8Z""; STRAND 698..700; /evidence=""ECO:0007829|PDB:6M23""; STRAND 729..736; /evidence=""ECO:0007829|PDB:6M23""; STRAND 763..772; /evidence=""ECO:0007829|PDB:6M23""; STRAND 793..796; /evidence=""ECO:0007829|PDB:6M23""; STRAND 803..806; /evidence=""ECO:0007829|PDB:6M23""; STRAND 827..832; /evidence=""ECO:0007829|PDB:6M23""; STRAND 850..852; /evidence=""ECO:0007829|PDB:6M23""; STRAND 854..856; /evidence=""ECO:0007829|PDB:6M23""; STRAND 871..876; /evidence=""ECO:0007829|PDB:6M23""; STRAND 880..885; /evidence=""ECO:0007829|PDB:6M23""; STRAND 887..889; /evidence=""ECO:0007829|PDB:6M23""; STRAND 910..915; /evidence=""ECO:0007829|PDB:6M23""; STRAND 949..951; /evidence=""ECO:0007829|PDB:6M23""; STRAND 1088..1091; /evidence=""ECO:0007829|PDB:6M23""; STRAND 1093..1096; /evidence=""ECO:0007829|PDB:6M23""; STRAND 1122..1128; /evidence=""ECO:0007829|PDB:6M23""","HELIX 82..88; /evidence=""ECO:0007829|PDB:7D8Z""; HELIX 99..102; /evidence=""ECO:0007829|PDB:6M23""; HELIX 103..105; /evidence=""ECO:0007829|PDB:6M23""; HELIX 122..125; /evidence=""ECO:0007829|PDB:6M23""; HELIX 127..133; /evidence=""ECO:0007829|PDB:6M23""; HELIX 137..141; /evidence=""ECO:0007829|PDB:6M23""; HELIX 143..149; /evidence=""ECO:0007829|PDB:6M23""; HELIX 163..177; /evidence=""ECO:0007829|PDB:6M23""; HELIX 188..191; /evidence=""ECO:0007829|PDB:6M23""; HELIX 198..201; /evidence=""ECO:0007829|PDB:6M23""; HELIX 203..228; /evidence=""ECO:0007829|PDB:6M23""; HELIX 245..270; /evidence=""ECO:0007829|PDB:6M23""; HELIX 272..277; /evidence=""ECO:0007829|PDB:6M23""; HELIX 279..299; /evidence=""ECO:0007829|PDB:6M23""; HELIX 341..344; /evidence=""ECO:0007829|PDB:6M23""; HELIX 356..359; /evidence=""ECO:0007829|PDB:6M23""; HELIX 378..380; /evidence=""ECO:0007829|PDB:6M23""; HELIX 423..430; /evidence=""ECO:0007829|PDB:6M23""; HELIX 431..433; /evidence=""ECO:0007829|PDB:6M23""; HELIX 437..441; /evidence=""ECO:0007829|PDB:6M23""; HELIX 450..463; /evidence=""ECO:0007829|PDB:6M23""; HELIX 466..476; /evidence=""ECO:0007829|PDB:6M23""; HELIX 482..485; /evidence=""ECO:0007829|PDB:6M23""; HELIX 500..502; /evidence=""ECO:0007829|PDB:6M23""; HELIX 508..520; /evidence=""ECO:0007829|PDB:6M23""; HELIX 525..538; /evidence=""ECO:0007829|PDB:6M23""; HELIX 543..549; /evidence=""ECO:0007829|PDB:6M23""; HELIX 559..567; /evidence=""ECO:0007829|PDB:6M23""; HELIX 569..571; /evidence=""ECO:0007829|PDB:6M23""; HELIX 581..605; /evidence=""ECO:0007829|PDB:6M23""; HELIX 621..634; /evidence=""ECO:0007829|PDB:6M23""; HELIX 638..644; /evidence=""ECO:0007829|PDB:6M23""; HELIX 646..663; /evidence=""ECO:0007829|PDB:6M23""; HELIX 667..681; /evidence=""ECO:0007829|PDB:6M23""; HELIX 713..722; /evidence=""ECO:0007829|PDB:6M23""; HELIX 738..741; /evidence=""ECO:0007829|PDB:6M23""; HELIX 743..756; /evidence=""ECO:0007829|PDB:6M23""; HELIX 773..782; /evidence=""ECO:0007829|PDB:6M23""; HELIX 812..823; /evidence=""ECO:0007829|PDB:6M23""; HELIX 834..836; /evidence=""ECO:0007829|PDB:6M23""; HELIX 859..868; /evidence=""ECO:0007829|PDB:6M23""; HELIX 894..903; /evidence=""ECO:0007829|PDB:6M23""; HELIX 931..940; /evidence=""ECO:0007829|PDB:6M23""; HELIX 1078..1087; /evidence=""ECO:0007829|PDB:6M23""; HELIX 1104..1106; /evidence=""ECO:0007829|PDB:6M23""; HELIX 1111..1117; /evidence=""ECO:0007829|PDB:6M23""","TURN 152..154; /evidence=""ECO:0007829|PDB:6M23""; TURN 156..162; /evidence=""ECO:0007829|PDB:6M23""; TURN 192..194; /evidence=""ECO:0007829|PDB:6M23""; TURN 300..302; /evidence=""ECO:0007829|PDB:6M23""; TURN 371..373; /evidence=""ECO:0007829|PDB:6M23""; TURN 477..479; /evidence=""ECO:0007829|PDB:6M23""; TURN 489..495; /evidence=""ECO:0007829|PDB:6M23""; TURN 521..524; /evidence=""ECO:0007829|PDB:6M23""; TURN 572..574; /evidence=""ECO:0007829|PDB:6M23""; TURN 577..579; /evidence=""ECO:0007829|PDB:6M23""; TURN 618..620; /evidence=""ECO:0007829|PDB:6M23""; TURN 757..760; /evidence=""ECO:0007829|PDB:6M23""; TURN 808..810; /evidence=""ECO:0007829|PDB:6M23""; TURN 904..906; /evidence=""ECO:0007829|PDB:6M23""; TURN 923..927; /evidence=""ECO:0007829|PDB:6M23""; TURN 946..948; /evidence=""ECO:0007829|PDB:6M23""; TURN 953..957; /evidence=""ECO:0007829|PDB:6M23""; TURN 1107..1110; /evidence=""ECO:0007829|PDB:6M23""; TURN 1118..1120; /evidence=""ECO:0007829|PDB:6M23""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,SLC12A5 KCC2 KIAA1176,Solute carrier family 12 member 5 (Electroneutral potassium-chloride cotransporter 2) (K-Cl cotransporter 2) (hKCC2) (Neuronal K-Cl cotransporter),Homo sapiens (Human),1139.0,126184.0,MSRRFTVTSLPPAGPARSPDPESRRHSVADPRHLPGEDVKGDGNPKESSPFINSTDTEKGKEYDGKNMALFEEEMDTSPMVSSLLSGLANYTNLPQGSREHEEAENNEGGKKKPVQAPRMGTFMGVYLPCLQNIFGVILFLRLTWVVGIAGIMESFCMVFICCSCTMLTAISMSAIATNGVVPAGGSYYMISRSLGPEFGGAVGLCFYLGTTFAGAMYILGTIEILLAYLFPAMAIFKAEDASGEAAAMLNNMRVYGTCVLTCMATVVFVGVKYVNKFALVFLGCVILSILAIYAGVIKSAFDPPNFPICLLGNRTLSRHGFDVCAKLAWEGNETVTTRLWGLFCSSRFLNATCDEYFTRNNVTEIQGIPGAASGLIKENLWSSYLTKGVIVERSGMTSVGLADGTPIDMDHPYVFSDMTSYFTLLVGIYFPSVTGIMAGSNRSGDLRDAQKSIPTGTILAIATTSAVYISSVVLFGACIEGVVLRDKFGEAVNGNLVVGTLAWPSPWVIVIGSFFSTCGAGLQSLTGAPRLLQAISRDGIVPFLQVFGHGKANGEPTWALLLTACICEIGILIASLDEVAPILSMFFLMCYMFVNLACAVQTLLRTPNWRPRFRYYHWTLSFLGMSLCLALMFICSWYYALVAMLIAGLIYKYIEYRGAEKEWGDGIRGLSLSAARYALLRLEEGPPHTKNWRPQLLVLVRVDQDQNVVHPQLLSLTSQLKAGKGLTIVGSVLEGTFLENHPQAQRAEESIRRLMEAEKVKGFCQVVISSNLRDGVSHLIQSGGLGGLQHNTVLVGWPRNWRQKEDHQTWRNFIELVRETTAGHLALLVTKNVSMFPGNPERFSEGSIDVWWIVHDGGMLMLLPFLLRHHKVWRKCKMRIFTVAQMDDNSIQMKKDLTTFLYHLRITAEVEVVEMHESDISAYTYEKTLVMEQRSQILKQMHLTKNEREREIQSITDESRGSIRRKNPANTRLRLNVPEETAGDSEEKPEEEVQLIHDQSAPSCPSSSPSPGEEPEGEGETDPEKVHLTWTKDKSVAEKNKGPSPVSSEGIKDFFSMKPEWENLNQSNVRRMHTAVRLNEVIVKKSRDAKLVLLNMPGPPRNRNGDENYMEFLEVLTEHLDRVMLVRGGGREVITIYS,True,False,False,Q9H2X9,"[('G3DSA:1.20.1740.10', 'Amino acid/polyamine transporter I'), ('IPR000076', 'K/Cl co-transporter'), ('IPR004841', 'Amino acid permease/ SLC12A domain'), ('IPR004842', 'SLC12A transporter family'), ('IPR018491', 'SLC12A transporter, C-terminal'), ('PF00324', 'Amino acid permease'), ('PF03522', 'Solute carrier family 12'), ('PR01081', 'KCLTRNSPORT'), ('PTHR11827', 'SOLUTE CARRIER FAMILY 12, CATION COTRANSPORTERS'), ('TIGR00930', 'K-Cl cotransporter')]",,"""ENSG00000124140; Tissue enhanced (brain, retina)."";","CATALYTIC ACTIVITY: Reaction=K(+)(in) + chloride(in) = K(+)(out) + chloride(out); Xref=Rhea:RHEA:72427, ChEBI:CHEBI:17996, ChEBI:CHEBI:29103; Evidence={ECO:0000269|PubMed:12106695};",,"ACTIVITY REGULATION: Inhibited following phosphorylation by OXSR1/OSR1 and STK39/SPAK: phosphorylation takes place downstream of WNK kinases (WNK1, WNK2, WNK3 or WNK4) in response to hyperosmotic stress and subsequent cell shrinkage. {ECO:0000269|PubMed:19665974, ECO:0000269|PubMed:21613606}.",,ENST00000243964.7 [Q9H2X9-2];ENST00000454036.6 [Q9H2X9-1];,SLC12A5,ENSG00000124140,0.0,,,,,,,0.161,0.175,SLC12A5
Q9H307,ENSG00000100941,PININ_HUMAN,"cell adhesion [GO:0007155]; mRNA splicing, via spliceosome [GO:0000398]",catalytic step 2 spliceosome [GO:0071013]; cell-cell junction [GO:0005911]; desmosome [GO:0030057]; intermediate filament [GO:0005882]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; plasma membrane [GO:0005886],DNA binding [GO:0003677]; RNA binding [GO:0003723]; structural molecule activity [GO:0005198],,,,,,,"cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,PNN DRS MEMA,Pinin (140 kDa nuclear and cell adhesion-related phosphoprotein) (Desmosome-associated protein) (Domain-rich serine protein) (DRS protein) (DRSP) (Melanoma metastasis clone A protein) (Nuclear protein SDK3) (SR-like protein),Homo sapiens (Human),717.0,81628.0,MAVAVRTLQEQLEKAKESLKNVDENIRKLTGRDPNDVRPIQARLLALSGPGGGRGRGSLLLRRGFSDSGGGPPAKQRDLEGAVSRLGGERRTRRESRQESDPEDDDVKKPALQSSVVATSKERTRRDLIQDQNMDEKGKQRNRRIFGLLMGTLQKFKQESTVATERQKRRQEIEQKLEVQAEEERKQVENERRELFEERRAKQTELRLLEQKVELAQLQEEWNEHNAKIIKYIRTKTKPHLFYIPGRMCPATQKLIEESQRKMNALFEGRRIEFAEQINKMEARPRRQSMKEKEHQVVRNEEQKAEQEEGKVAQREEELEETGNQHNDVEIEEAGEEEEKEIAIVHSDAEKEQEEEEQKQEMEVKMEEETEVRESEKQQDSQPEEVMDVLEMVENVKHVIADQEVMETNRVESVEPSENEASKELEPEMEFEIEPDKECKTLSPGKENVSALDMEKESEEKEEKESEPQPEPVAQPQPQSQPQLQLQSQSQPVLQSQPPSQPEDLSLAVLQPTPQVTQEQGHLLPERKDFPVESVKLTEVPVEPVLTVHPESKSKTKTRSRSRGRARNKTSKSRSRSSSSSSSSSSSTSSSSGSSSSSGSSSSRSSSSSSSSTSGSSSRDSSSSTSSSSESRSRSRGRGHNRDRKHRRSVDRKRRDTSGLERSHKSSKGGSSRDTKGSKDKNSRSDRKRSISESSRSGKRSSRSERDRKSDRKDKRR,False,True,False,Q9H307,"[('IPR006786', 'Pinin/SDK/MemA protein'), ('IPR006787', 'Pinin/SDK'), ('IPR039853', 'Pinin'), ('PF04696', 'pinin/SDK/memA/ protein conserved region'), ('PF04697', 'pinin/SDK conserved region'), ('PTHR12707', 'PINN')]",,"""ENSG00000100941; Low tissue specificity."";",,,,,ENST00000216832.9;,PNN,ENSG00000100941,0.0,PNN,Non-canonical_RBPs,27.0,,,,0.763,0.743,PNN
Q9H4A3,ENSG00000060237,WNK1_HUMAN,cell volume homeostasis [GO:0006884]; cellular hyperosmotic response [GO:0071474]; cellular response to chemokine [GO:1990869]; chemokine (C-C motif) ligand 21 signaling pathway [GO:0038116]; heart development [GO:0007507]; intracellular chloride ion homeostasis [GO:0030644]; intracellular signal transduction [GO:0035556]; lymphocyte migration into lymph node [GO:0097022]; monoatomic cation homeostasis [GO:0055080]; monoatomic ion transport [GO:0006811]; negative regulation of autophagy [GO:0010507]; negative regulation of cell-cell adhesion mediated by integrin [GO:0033633]; negative regulation of GTPase activity [GO:0034260]; negative regulation of heterotypic cell-cell adhesion [GO:0034115]; negative regulation of leukocyte cell-cell adhesion [GO:1903038]; negative regulation of pancreatic juice secretion [GO:0090188]; negative regulation of protein localization to plasma membrane [GO:1903077]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of sodium ion transport [GO:0010766]; neuron development [GO:0048666]; non-membrane-bounded organelle assembly [GO:0140694]; peptidyl-serine phosphorylation [GO:0018105]; peptidyl-threonine phosphorylation [GO:0018107]; positive regulation of angiogenesis [GO:0045766]; positive regulation of canonical Wnt signaling pathway [GO:0090263]; positive regulation of mitotic cytokinesis [GO:1903490]; positive regulation of systemic arterial blood pressure [GO:0003084]; positive regulation of T cell chemotaxis [GO:0010820]; positive regulation of termination of RNA polymerase II transcription [GO:1904595]; potassium ion homeostasis [GO:0055075]; protein insertion into ER membrane by stop-transfer membrane-anchor sequence [GO:0045050]; protein phosphorylation [GO:0006468]; regulation of monoatomic cation transmembrane transport [GO:1904062]; regulation of mRNA export from nucleus [GO:0010793]; regulation of sodium ion transmembrane transport [GO:1902305]; regulation of sodium ion transport [GO:0002028]; signal transduction [GO:0007165]; sodium ion transmembrane transport [GO:0035725]; T cell receptor signaling pathway [GO:0050852],cytoplasm [GO:0005737]; cytosol [GO:0005829]; intracellular non-membrane-bounded organelle [GO:0043232]; membrane [GO:0016020]; mitotic spindle [GO:0072686]; nucleus [GO:0005634]; protein-containing complex [GO:0032991],ATP binding [GO:0005524]; histone H2AS1 kinase activity [GO:0044024]; molecular condensate scaffold activity [GO:0140693]; phosphatase binding [GO:0019902]; protein kinase activator activity [GO:0030295]; protein kinase activity [GO:0004672]; protein kinase binding [GO:0019901]; protein serine kinase activity [GO:0106310]; protein serine/threonine kinase activity [GO:0004674],"PTM: Autophosphorylated at Ser-378 and Ser-382, promoting its activity (PubMed:15883153, PubMed:16263722, PubMed:16832045, PubMed:17190791, PubMed:31656913, PubMed:34289367). Autophosphorylation at Ser-382 is inhibited by intracellular calcium (By similarity). Phosphorylation at Thr-60 increases ability to activate SGK1 (By similarity). {ECO:0000250|UniProtKB:Q9JIH7, ECO:0000269|PubMed:15883153, ECO:0000269|PubMed:16263722, ECO:0000269|PubMed:16832045, ECO:0000269|PubMed:17190791, ECO:0000269|PubMed:31656913, ECO:0000269|PubMed:34289367}.; PTM: Ubiquitinated by the BCR(KLHL3) complex, leading to its degradation (PubMed:23387299, PubMed:23576762). Also ubiquitinated by the BCR(KLHL2) complex (PubMed:23838290). {ECO:0000269|PubMed:23387299, ECO:0000269|PubMed:23576762, ECO:0000269|PubMed:23838290}.; PTM: May be O-glycosylated. {ECO:0000269|PubMed:2507249}.","DOMAIN: Disordered regions undergo liquid-liquid phase separation (LLPS) for the formation of a cytoplasmic membraneless compartment that concentrates WNK1 with its substrates, OXSR1/OSR1 and STK39/SPAK. {ECO:0000269|PubMed:36318922}.; DOMAIN: The RFXV motifs mediate recognition with downstream kinases OXSR1/OSR1 and STK39/SPAK. {ECO:0000269|PubMed:16263722, ECO:0000269|PubMed:22989884}.","DOMAIN 221..479; /note=""Protein kinase""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00159""","STRAND 211..214; /evidence=""ECO:0007829|PDB:4PWN""; STRAND 216..218; /evidence=""ECO:0007829|PDB:4PWN""; STRAND 220..228; /evidence=""ECO:0007829|PDB:4PWN""; STRAND 231..240; /evidence=""ECO:0007829|PDB:4PWN""; STRAND 245..252; /evidence=""ECO:0007829|PDB:4PWN""; STRAND 283..288; /evidence=""ECO:0007829|PDB:4PWN""; STRAND 291..295; /evidence=""ECO:0007829|PDB:5WDY""; STRAND 297..302; /evidence=""ECO:0007829|PDB:4PWN""; STRAND 341..343; /evidence=""ECO:0007829|PDB:4PWN""; STRAND 355..358; /evidence=""ECO:0007829|PDB:4PWN""; STRAND 364..366; /evidence=""ECO:0007829|PDB:4PWN""; STRAND 377..380; /evidence=""ECO:0007829|PDB:5WE8""; STRAND 1248..1251; /evidence=""ECO:0007829|PDB:6FBK""; STRAND 1257..1261; /evidence=""ECO:0007829|PDB:6FBK""","HELIX 266..273; /evidence=""ECO:0007829|PDB:4PWN""; HELIX 309..316; /evidence=""ECO:0007829|PDB:4PWN""; HELIX 321..340; /evidence=""ECO:0007829|PDB:4PWN""; HELIX 352..354; /evidence=""ECO:0007829|PDB:4PWN""; HELIX 369..371; /evidence=""ECO:0007829|PDB:4PWN""; HELIX 392..396; /evidence=""ECO:0007829|PDB:4PWN""; HELIX 402..417; /evidence=""ECO:0007829|PDB:4PWN""; HELIX 428..435; /evidence=""ECO:0007829|PDB:4PWN""; HELIX 442..446; /evidence=""ECO:0007829|PDB:4PWN""; HELIX 450..459; /evidence=""ECO:0007829|PDB:4PWN""; HELIX 464..466; /evidence=""ECO:0007829|PDB:4PWN""; HELIX 470..474; /evidence=""ECO:0007829|PDB:4PWN""; HELIX 477..481; /evidence=""ECO:0007829|PDB:4PWN""","TURN 241..244; /evidence=""ECO:0007829|PDB:4PWN""; TURN 359..362; /evidence=""ECO:0007829|PDB:5WE8""; TURN 421..424; /evidence=""ECO:0007829|PDB:4PWN""; TURN 436..438; /evidence=""ECO:0007829|PDB:4PWN""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,WNK1 HSN2 KDP KIAA0344 PRKWNK1,Serine/threonine-protein kinase WNK1 (EC 2.7.11.1) (Erythrocyte 65 kDa protein) (p65) (Kinase deficient protein) (Protein kinase lysine-deficient 1) (Protein kinase with no lysine 1) (hWNK1),Homo sapiens (Human),2382.0,250794.0,MSGGAAEKQSSTPGSLFLSPPAPAPKNGSSSDSSVGEKLGAAAADAVTGRTEEYRRRRHTMDKDSRGAAATTTTTEHRFFRRSVICDSNATALELPGLPLSLPQPSIPAAVPQSAPPEPHREETVTATATSQVAQQPPAAAAPGEQAVAGPAPSTVPSSTSKDRPVSQPSLVGSKEEPPPARSGSGGGSAKEPQEERSQQQDDIEELETKAVGMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKSVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQEETGVRVELAEEDDGEKIAIKLWLRIEDIKKLKGKYKDNEAIEFSFDLERDVPEDVAQEMVESGYVCEGDHKTMAKAIKDRVSLIKRKREQRQLVREEQEKKKQEESSLKQQVEQSSASQTGIKQLPSASTGIPTASTTSASVSTQVEPEEPEADQHQQLQYQQPSISVLSDGTVDSGQGSSVFTESRVSSQQTVSYGSQHEQAHSTGTVPGHIPSTVQAQSQPHGVYPPSSVAQGQSQGQPSSSSLTGVSSSQPIQHPQQQQGIQQTAPPQQTVQYSLSQTSTSSEATTAQPVSQPQAPQVLPQVSAGKQLPVSQPVPTIQGEPQIPVATQPSVVPVHSGAHFLPVGQPLPTPLLPQYPVSQIPISTPHVSTAQTGFSSLPITMAAGITQPLLTLASSATTAAIPGVSTVVPSQLPTLLQPVTQLPSQVHPQLLQPAVQSMGIPANLGQAAEVPLSSGDVLYQGFPPRLPPQYPGDSNIAPSSNVASVCIHSTVLSPPMPTEVLATPGYFPTVVQPYVESNLLVPMGGVGGQVQVSQPGGSLAQAPTTSSQQAVLESTQGVSQVAPAEPVAVAQTQATQPTTLASSVDSAHSDVASGMSDGNENVPSSSGRHEGRTTKRHYRKSVRSRSRHEKTSRPKLRILNVSNKGDRVVECQLETHNRKMVTFKFDLDGDNPEEIATIMVNNDFILAIERESFVDQVREIIEKADEMLSEDVSVEPEGDQGLESLQGKDDYGFSGSQKLEGEFKQPIPASSMPQQIGIPTSSLTQVVHSAGRRFIVSPVPESRLRESKVFPSEITDTVAASTAQSPGMNLSHSASSLSLQQAFSELRRAQMTEGPNTAPPNFSHTGPTFPVVPPFLSSIAGVPTTAAATAPVPATSSPPNDISTSVIQSEVTVPTEEGIAGVATSTGVVTSGGLPIPPVSESPVLSSVVSSITIPAVVSISTTSPSLQVPTSTSEIVVSSTALYPSVTVSATSASAGGSTATPGPKPPAVVSQQAAGSTTVGATLTSVSTTTSFPSTASQLCIQLSSSTSTPTLAETVVVSAHSLDKTSHSSTTGLAFSLSAPSSSSSPGAGVSSYISQPGGLHPLVIPSVIASTPILPQAAGPTSTPLLPQVPSIPPLVQPVANVPAVQQTLIHSQPQPALLPNQPHTHCPEVDSDTQPKAPGIDDIKTLEEKLRSLFSEHSSSGAQHASVSLETSLVIESTVTPGIPTTAVAPSKLLTSTTSTCLPPTNLPLGTVALPVTPVVTPGQVSTPVSTTTSGVKPGTAPSKPPLTKAPVLPVGTELPAGTLPSEQLPPFPGPSLTQSQQPLEDLDAQLRRTLSPEMITVTSAVGPVSMAAPTAITEAGTQPQKGVSQVKEGPVLATSSGAGVFKMGRFQVSVAADGAQKEGKNKSEDAKSVHFESSTSESSVLSSSSPESTLVKPEPNGITIPGISSDVPESAHKTTASEAKSDTGQPTKVGRFQVTTTANKVGRFSVSKTEDKITDTKKEGPVASPPFMDLEQAVLPAVIPKKEKPELSEPSHLNGPSSDPEAAFLSRDVDDGSGSPHSPHQLSSKSLPSQNLSQSLSNSFNSSYMSSDNESDIEDEDLKLELRRLRDKHLKEIQDLQSRQKHEIESLYTKLGKVPPAVIIPPAAPLSGRRRRPTKSKGSKSSRSSSLGNKSPQLSGNLSGQSAASVLHPQQTLHPPGNIPESGQNQLLQPLKPSPSSDNLYSAFTSDGAISVPSLSAPGQGTSSTNTVGATVNSQAAQAQPPAMTSSRKGTFTDDLHKLVDNWARDAMNLSGRRGSKGHMNYEGPGMARKFSAPGQLCISMTSNLGGSAPISAASATSLGHFTKSMCPPQQYGFPATPFGAQWSGTGGPAPQPLGQFQPVGTASLQNFNISNLQKSISNPPGSNLRTT,False,False,True,Q9H4A3,"[('cd14030', 'Catalytic domain of the Serine/Threonine protein kinase, With No Lysine (WNK) 1'), ('G3DSA:1.10.510.10', 'Transferase(Phosphotransferase) domain 1'), ('G3DSA:3.10.20.90', 'Phosphatidylinositol 3-kinase Catalytic Subunit; Chain A, domain 1'), ('G3DSA:3.30.200.20', 'Phosphorylase Kinase; domain 1'), ('IPR000719', 'Protein kinase domain'), ('IPR008271', 'Serine/threonine-protein kinase, active site'), ('IPR011009', 'Protein kinase-like domain superfamily'), ('IPR024678', 'Serine/threonine-protein kinase OSR1/WNK, CCT domain'), ('IPR050588', 'With No Lysine (K) Ser/Thr Protein Kinase'), ('PF00069', 'Protein kinase domain'), ('PF12202', 'Oxidative-stress-responsive kinase 1 C-terminal domain'), ('PS00108', 'Serine/Threonine protein kinases active-site signature'), ('PS50011', 'Protein kinase domain profile'), ('PTHR13902', 'With No Lysine (K) Ser/Thr Protein Kinase'), ('SM00220', 'Serine/Threonine protein kinases, catalytic domain'), ('SSF56112', 'Protein kinase-like (PK-like)')]",Q9H4A3;,"""ENSG00000060237; Low tissue specificity."";","CATALYTIC ACTIVITY: Reaction=L-seryl-[protein] + ATP = O-phospho-L-seryl-[protein] + ADP + H(+); Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616, ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.1; Evidence={ECO:0000269|PubMed:10660600, ECO:0000269|PubMed:15883153, ECO:0000269|PubMed:16263722, ECO:0000269|PubMed:17190791, ECO:0000269|PubMed:19739668, ECO:0000269|PubMed:29196535, ECO:0000269|PubMed:31656913}; CATALYTIC ACTIVITY: Reaction=L-threonyl-[protein] + ATP = O-phospho-L-threonyl-[protein] + ADP + H(+); Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060, Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013, ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216; EC=2.7.11.1; Evidence={ECO:0000269|PubMed:10660600, ECO:0000269|PubMed:16263722, ECO:0000269|PubMed:16832045, ECO:0000269|PubMed:19739668, ECO:0000269|PubMed:21321328, ECO:0000269|PubMed:29196535};",2.7.11.1,"ACTIVITY REGULATION: Activated in response to hyperosmotic stress: cell shrinkage promotes formation of a membraneless compartment that concentrates WNK1 with its substrates, OXSR1/OSR1 and STK39/SPAK (PubMed:36318922). Activation requires autophosphorylation of Ser-382 and, to a lower extent, Ser-378 (PubMed:15883153, PubMed:16263722, PubMed:16832045, PubMed:17190791, PubMed:31656913, PubMed:34289367). Autophosphorylation and subsequent activation is inhibited by increases in intracellular ionic strength: Cl(-) potently inhibits WNK1 kinase activity via direct binding (By similarity). Also inhibited by K(+) ions (By similarity). Inhibited by small compounds staurosporine, tyrphostin 47, as well as Src tyrosine kinase inhibitors PP1 and PP2 (PubMed:19739668). {ECO:0000250|UniProtKB:Q9JIH7, ECO:0000269|PubMed:15883153, ECO:0000269|PubMed:16263722, ECO:0000269|PubMed:16832045, ECO:0000269|PubMed:17190791, ECO:0000269|PubMed:19739668, ECO:0000269|PubMed:31656913, ECO:0000269|PubMed:34289367, ECO:0000269|PubMed:36318922}.",,ENST00000315939.11 [Q9H4A3-1];ENST00000340908.9 [Q9H4A3-5];ENST00000530271.6 [Q9H4A3-7];ENST00000537687.5 [Q9H4A3-6];ENST00000675631.1 [Q9H4A3-4];,WNK1,ENSG00000060237,0.0,,,,,,,0.794,0.353,WNK1
Q9H6Y7,ENSG00000108523,RN167_HUMAN,"cellular response to leucine starvation [GO:1990253]; lysosome localization [GO:0032418]; negative regulation of cell cycle [GO:0045786]; negative regulation of TORC1 signaling [GO:1904262]; organelle localization [GO:0051640]; positive regulation of TORC1 signaling [GO:1904263]; protein K29-linked ubiquitination [GO:0035519]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; regulation of synaptic transmission, glutamatergic [GO:0051966]; ubiquitin-dependent protein catabolic process [GO:0006511]",cytoplasm [GO:0005737]; cytosol [GO:0005829]; endolysosome membrane [GO:0036020]; endosome [GO:0005768]; lysosomal membrane [GO:0005765]; lysosome [GO:0005764]; plasma membrane [GO:0005886],ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; zinc ion binding [GO:0008270],"PTM: Autoubiquitinated in vitro in the presence of UBE2D1 and UBE2E1. {ECO:0000269|PubMed:16314844, ECO:0000269|PubMed:33650289}.",,"DOMAIN 49..152; /note=""PA""; /evidence=""ECO:0000255""",,,,"cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,RNF167 RING105 LP2254,E3 ubiquitin-protein ligase RNF167 (EC 2.3.2.27) (RING finger protein 167),Homo sapiens (Human),350.0,38299.0,MHPAAFPLPVVVAAVLWGAAPTRGLIRATSDHNASMDFADLPALFGATLSQEGLQGFLVEAHPDNACSPIAPPPPAPVNGSVFIALLRRFDCNFDLKVLNAQKAGYGAAVVHNVNSNELLNMVWNSEEIQQQIWIPSVFIGERSSEYLRALFVYEKGARVLLVPDNTFPLGYYLIPFTGIVGLLVLAMGAVMIARCIQHRKRLQRNRLTKEQLKQIPTHDYQKGDQYDVCAICLDEYEDGDKLRVLPCAHAYHSRCVDPWLTQTRKTCPICKQPVHRGPGDEDQEEETQGQEEGDEGEPRDHPASERTPLLGSSPTLPTSFGSLAPAPLVFPGPSTDPPLSPPSSPVILV,False,False,True,Q9H6Y7,"[('cd02123', 'PA_C_RZF_like'), ('cd16797', 'RING finger, H2 subclass, found in RING finger protein 167 (RNF167) and similar proteins'), ('G3DSA:3.30.40.10', 'Zinc/RING finger domain, C3HC4 (zinc finger)'), ('G3DSA:3.50.30.30', None), ('IPR001841', 'Zinc finger, RING-type'), ('IPR003137', 'PA domain'), ('IPR011016', 'Zinc finger, RING-CH-type'), ('IPR013083', 'Zinc finger, RING/FYVE/PHD-type'), ('IPR044744', 'ZNRF4 /RNF13/RNF167, PA domain'), ('IPR046450', 'PA domain superfamily'), ('IPR051834', 'RING finger E3 ubiquitin-protein ligase'), ('PF02225', 'PA domain'), ('PF13639', 'Ring finger domain'), ('PS50089', 'Zinc finger RING-type profile'), ('PTHR45931', 'RING finger E3 ubiquitin-protein ligase'), ('SM00184', 'Ring finger'), ('SM00744', 'The RING-variant domain is a C4HC3 zinc-finger like motif found in a number of cellular and viral proteins. Some of these proteins have been shown both in vivo and in vitro to have ubiquitin E3 ligase activity.'), ('SSF52025', 'PA domain'), ('SSF57850', 'RING/U-box')]",,"""ENSG00000108523; Low tissue specificity."";","CATALYTIC ACTIVITY: Reaction=S-ubiquitinyl-[E2 ubiquitin-conjugating enzyme]-L-cysteine + [acceptor protein]-L-lysine = [E2 ubiquitin-conjugating enzyme]-L-cysteine + N(6)-ubiquitinyl-[acceptor protein]-L-lysine.; EC=2.3.2.27; Evidence={ECO:0000269|PubMed:23129617, ECO:0000269|PubMed:23353890, ECO:0000269|PubMed:27808481, ECO:0000269|PubMed:33594058, ECO:0000269|PubMed:33650289, ECO:0000269|PubMed:35114100};",2.3.2.27,,"PATHWAY: Protein modification; protein ubiquitination. {ECO:0000269|PubMed:23129617, ECO:0000269|PubMed:23353890, ECO:0000269|PubMed:27808481, ECO:0000269|PubMed:33594058, ECO:0000269|PubMed:33650289, ECO:0000269|PubMed:35114100}.",ENST00000262482.11 [Q9H6Y7-1];ENST00000571816.5 [Q9H6Y7-1];ENST00000572430.5 [Q9H6Y7-1];ENST00000575111.5 [Q9H6Y7-1];ENST00000576229.5 [Q9H6Y7-2];,RNF167,ENSG00000108523,0.0,,,,,,,0.3,0.229,RNF167
Q9H8X2,ENSG00000127080,IPPK_HUMAN,inositol phosphate biosynthetic process [GO:0032958]; inositol phosphate metabolic process [GO:0043647]; phosphorylation [GO:0016310]; positive regulation of transcription of nucleolar large rRNA by RNA polymerase I [GO:1901838],cytosol [GO:0005829]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],"ATP binding [GO:0005524]; inositol-1,3,4,5,6-pentakisphosphate 2-kinase activity [GO:0035299]; molecular adaptor activity [GO:0060090]",,DOMAIN: The EXKPK motif is conserved in inositol-pentakisphosphate 2-kinases of both family 1 and 2.,,,,,"cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,IPPK C9orf12,"Inositol-pentakisphosphate 2-kinase (EC 2.7.1.158) (IPK1 homolog) (Inositol-1,3,4,5,6-pentakisphosphate 2-kinase) (Ins(1,3,4,5,6)P5 2-kinase) (InsP5 2-kinase)",Homo sapiens (Human),491.0,56017.0,MEEGKMDENEWGYHGEGNKSLVVAHAQRCVVLRFLKFPPNRKKTSEEIFQHLQNIVDFGKNVMKEFLGENYVHYGEVVQLPLEFVKQLCLKIQSERPESRCDKDLDTLSGYAMCLPNLTRLQTYRFAEHRPILCVEIKPKCGFIPFSSDVTHEMKHKVCRYCMHQHLKVATGKWKQISKYCPLDLYSGNKQRMHFALKSLLQEAQNNLKIFKNGELIYGCKDARSPVADWSELAHHLKPFFFPSNGLASGPHCTRAVIRELVHVITRVLLSGSDKGRAGTLSPGLGPQGPRVCEASPFSRSLRCQGKNTPERSGLPKGCLLYKTLQVQMLDLLDIEGLYPLYNRVERYLEEFPEERKTLQIDGPYDEAFYQKLLDLSTEDDGTVAFALTKVQQYRVAMTAKDCSIMIALSPCLQDASSDQRPVVPSSRSRFAFSVSVLDLDLKPYESIPHQYKLDGKIVNYYSKTVRAKDNAVMSTRFKESEDCTLVLHKV,True,True,False,Q9H8X2,"[('G3DSA:3.30.200.110', 'Inositol-pentakisphosphate 2-kinase, N-lobe'), ('IPR009286', 'Inositol-pentakisphosphate 2-kinase'), ('IPR043001', 'Inositol-pentakisphosphate 2-kinase, N-terminal lobe'), ('PF06090', 'Inositol-pentakisphosphate 2-kinase'), ('PTHR14456', 'INOSITOL POLYPHOSPHATE KINASE 1')]",,"""ENSG00000127080; Low tissue specificity."";","CATALYTIC ACTIVITY: Reaction=1D-myo-inositol 1,3,4,5,6-pentakisphosphate + ATP = 1D-myo-inositol hexakisphosphate + ADP + H(+); Xref=Rhea:RHEA:20313, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616, ChEBI:CHEBI:57733, ChEBI:CHEBI:58130, ChEBI:CHEBI:456216; EC=2.7.1.158; Evidence={ECO:0000269|PubMed:12084730};",2.7.1.158,,,ENST00000287996.8;,IPPK,ENSG00000127080,0.0,,,,,,,0.037,,IPPK
Q9HAU5,ENSG00000151461,RENT2_HUMAN,"animal organ regeneration [GO:0031100]; liver development [GO:0001889]; mRNA export from nucleus [GO:0006406]; nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184]",cytoplasm [GO:0005737]; cytoplasmic ribonucleoprotein granule [GO:0036464]; cytosol [GO:0005829]; exon-exon junction complex [GO:0035145]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471],RNA binding [GO:0003723]; telomeric DNA binding [GO:0042162],,,"DOMAIN 168..431; /note=""MIF4G 1""; DOMAIN 569..758; /note=""MIF4G 2""; DOMAIN 773..986; /note=""MIF4G 3""","STRAND 299..301; /evidence=""ECO:0007829|PDB:4CEM""; STRAND 460..462; /evidence=""ECO:0007829|PDB:4CEK""; STRAND 909..911; /evidence=""ECO:0007829|PDB:1UW4""; STRAND 964..966; /evidence=""ECO:0007829|PDB:1UW4""; STRAND 1168..1174; /evidence=""ECO:0007829|PDB:2WJV""; STRAND 1183..1192; /evidence=""ECO:0007829|PDB:2WJV""","HELIX 122..149; /evidence=""ECO:0007829|PDB:4CEM""; HELIX 152..154; /evidence=""ECO:0007829|PDB:4CEM""; HELIX 158..162; /evidence=""ECO:0007829|PDB:4CEM""; HELIX 168..177; /evidence=""ECO:0007829|PDB:4CEM""; HELIX 178..180; /evidence=""ECO:0007829|PDB:4CEM""; HELIX 183..185; /evidence=""ECO:0007829|PDB:4CEM""; HELIX 186..195; /evidence=""ECO:0007829|PDB:4CEM""; HELIX 202..211; /evidence=""ECO:0007829|PDB:4CEM""; HELIX 216..218; /evidence=""ECO:0007829|PDB:4CEM""; HELIX 219..232; /evidence=""ECO:0007829|PDB:4CEM""; HELIX 236..253; /evidence=""ECO:0007829|PDB:4CEM""; HELIX 259..274; /evidence=""ECO:0007829|PDB:4CEM""; HELIX 280..297; /evidence=""ECO:0007829|PDB:4CEM""; HELIX 305..320; /evidence=""ECO:0007829|PDB:4CEM""; HELIX 325..334; /evidence=""ECO:0007829|PDB:4CEM""; HELIX 346..375; /evidence=""ECO:0007829|PDB:4CEM""; HELIX 383..386; /evidence=""ECO:0007829|PDB:4CEM""; HELIX 399..419; /evidence=""ECO:0007829|PDB:4CEM""; HELIX 463..469; /evidence=""ECO:0007829|PDB:4CEK""; HELIX 474..476; /evidence=""ECO:0007829|PDB:4CEK""; HELIX 539..549; /evidence=""ECO:0007829|PDB:4CEK""; HELIX 560..574; /evidence=""ECO:0007829|PDB:4CEK""; HELIX 575..577; /evidence=""ECO:0007829|PDB:4CEK""; HELIX 581..594; /evidence=""ECO:0007829|PDB:4CEK""; HELIX 598..609; /evidence=""ECO:0007829|PDB:4CEK""; HELIX 613..618; /evidence=""ECO:0007829|PDB:4CEK""; HELIX 619..629; /evidence=""ECO:0007829|PDB:4CEK""; HELIX 635..653; /evidence=""ECO:0007829|PDB:4CEK""; HELIX 660..675; /evidence=""ECO:0007829|PDB:4CEK""; HELIX 681..693; /evidence=""ECO:0007829|PDB:4CEK""; HELIX 697..716; /evidence=""ECO:0007829|PDB:4CEK""; HELIX 718..737; /evidence=""ECO:0007829|PDB:4CEK""; HELIX 742..755; /evidence=""ECO:0007829|PDB:4CEK""; HELIX 770..780; /evidence=""ECO:0007829|PDB:1UW4""; HELIX 782..785; /evidence=""ECO:0007829|PDB:7NWU""; HELIX 788..796; /evidence=""ECO:0007829|PDB:1UW4""; HELIX 803..814; /evidence=""ECO:0007829|PDB:1UW4""; HELIX 816..818; /evidence=""ECO:0007829|PDB:1UW4""; HELIX 821..823; /evidence=""ECO:0007829|PDB:1UW4""; HELIX 824..834; /evidence=""ECO:0007829|PDB:1UW4""; HELIX 839..859; /evidence=""ECO:0007829|PDB:1UW4""; HELIX 862..864; /evidence=""ECO:0007829|PDB:1UW4""; HELIX 865..880; /evidence=""ECO:0007829|PDB:1UW4""; HELIX 886..898; /evidence=""ECO:0007829|PDB:1UW4""; HELIX 917..929; /evidence=""ECO:0007829|PDB:1UW4""; HELIX 930..932; /evidence=""ECO:0007829|PDB:1UW4""; HELIX 936..957; /evidence=""ECO:0007829|PDB:1UW4""; HELIX 970..983; /evidence=""ECO:0007829|PDB:1UW4""; HELIX 993..1011; /evidence=""ECO:0007829|PDB:1UW4""; HELIX 1108..1126; /evidence=""ECO:0007829|PDB:2WJV""; HELIX 1193..1197; /evidence=""ECO:0007829|PDB:2WJV""","TURN 376..382; /evidence=""ECO:0007829|PDB:4CEM""; TURN 387..389; /evidence=""ECO:0007829|PDB:4CEM""; TURN 395..398; /evidence=""ECO:0007829|PDB:4CEM""; TURN 630..632; /evidence=""ECO:0007829|PDB:4CEK""; TURN 835..837; /evidence=""ECO:0007829|PDB:1UW4""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,UPF2 KIAA1408 RENT2,Regulator of nonsense transcripts 2 (Up-frameshift suppressor 2 homolog) (hUpf2),Homo sapiens (Human),1272.0,147810.0,MPAERKKPASMEEKDSLPNNKEKDCSERRTVSSKERPKDDIKLTAKKEVSKAPEDKKKRLEDDKRKKEDKERKKKDEEKVKAEEESKKKEEEEKKKHQEEERKKQEEQAKRQQEEEAAAQMKEKEESIQLHQEAWERHHLRKELRSKNQNAPDSRPEENFFSRLDSSLKKNTAFVKKLKTITEQQRDSLSHDFNGLNLSKYIAEAVASIVEAKLKISDVNCAVHLCSLFHQRYADFAPSLLQVWKKHFEARKEEKTPNITKLRTDLRFIAELTIVGIFTDKEGLSLIYEQLKNIINADRESHTHVSVVISFCRHCGDDIAGLVPRKVKSAAEKFNLSFPPSEIISPEKQQPFQNLLKEYFTSLTKHLKRDHRELQNTERQNRRILHSKGELSEDRHKQYEEFAMSYQKLLANSQSLADLLDENMPDLPQDKPTPEEHGPGIDIFTPGKPGEYDLEGGIWEDEDARNFYENLIDLKAFVPAILFKDNEKSCQNKESNKDDTKEAKESKENKEVSSPDDLELELENLEINDDTLELEGGDEAEDLTKKLLDEQEQEDEEASTGSHLKLIVDAFLQQLPNCVNRDLIDKAAMDFCMNMNTKANRKKLVRALFIVPRQRLDLLPFYARLVATLHPCMSDVAEDLCSMLRGDFRFHVRKKDQINIETKNKTVRFIGELTKFKMFTKNDTLHCLKMLLSDFSHHHIEMACTLLETCGRFLFRSPESHLRTSVLLEQMMRKKQAMHLDARYVTMVENAYYYCNPPPAEKTVKKKRPPLQEYVRKLLYKDLSKVTTEKVLRQMRKLPWQDQEVKDYVICCMINIWNVKYNSIHCVANLLAGLVLYQEDVGIHVVDGVLEDIRLGMEVNQPKFNQRRISSAKFLGELYNYRMVESAVIFRTLYSFTSFGVNPDGSPSSLDPPEHLFRIRLVCTILDTCGQYFDRGSSKRKLDCFLVYFQRYVWWKKSLEVWTKDHPFPIDIDYMISDTLELLRPKIKLCNSLEESIRQVQDLEREFLIKLGLVNDKDSKDSMTEGENLEEDEEEEEGGAETEEQSGNESEVNEPEEEEGSDNDDDEGEEEEEENTDYLTDSNKENETDEENTEVMIKGGGLKHVPCVEDEDFIQALDKMMLENLQQRSGESVKVHQLDVAIPLHLKSQLRKGPPLGGGEGEAESADTMPFVMLTRKGNKQQFKILNVPMSSQLAANHWNQQQAEQEERMRMKKLTLDINERQEQEDYQEMLQSLAQRPAPANTNRERRPRYQHPKGAPNADLIFKTGGRRR,False,False,True,Q9HAU5,"[('G3DSA:1.25.40.180', None), ('G3DSA:4.10.80.160', None), ('G3DSA:6.10.250.770', None), ('IPR003890', 'MIF4G-like, type 3'), ('IPR007193', 'Up-frameshift suppressor 2, C-terminal'), ('IPR016024', 'Armadillo-type fold'), ('IPR039762', 'Nonsense-mediated mRNA decay protein Nmd2/UPF2'), ('PF02854', 'MIF4G domain'), ('PF04050', 'Up-frameshift suppressor 2'), ('PTHR12839', 'NONSENSE-MEDIATED MRNA DECAY PROTEIN 2 UP-FRAMESHIFT SUPPRESSOR 2'), ('SM00543', 'Middle domain of eukaryotic initiation factor 4G (eIF4G)'), ('SSF48371', 'ARM repeat')]",,"""ENSG00000151461; Low tissue specificity."";",,,,,ENST00000356352.6;ENST00000357604.10;ENST00000397053.6;,UPF2,ENSG00000151461,0.0,UPF2,Canonical_RBPs,19.0,23.98,DP00949,0.241,0.32,0.26,UPF2
Q9HD42,ENSG00000131165,CHM1A_HUMAN,autophagosome maturation [GO:0097352]; autophagy [GO:0006914]; cell division [GO:0051301]; endosome transport via multivesicular body sorting pathway [GO:0032509]; ESCRT III complex disassembly [GO:1904903]; late endosome to lysosome transport [GO:1902774]; late endosome to vacuole transport [GO:0045324]; membrane fission [GO:0090148]; midbody abscission [GO:0061952]; mitotic chromosome condensation [GO:0007076]; mitotic metaphase chromosome alignment [GO:0007080]; multivesicular body assembly [GO:0036258]; multivesicular body sorting pathway [GO:0071985]; multivesicular body-lysosome fusion [GO:0061763]; negative regulation of gene expression [GO:0010629]; nuclear membrane reassembly [GO:0031468]; nucleus organization [GO:0006997]; plasma membrane repair [GO:0001778]; protein transport [GO:0015031]; regulation of centrosome duplication [GO:0010824]; regulation of mitotic spindle assembly [GO:1901673]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162]; vesicle fusion with vacuole [GO:0051469]; vesicle-mediated transport [GO:0016192]; viral budding from plasma membrane [GO:0046761]; viral budding via host ESCRT complex [GO:0039702],amphisome membrane [GO:1904930]; autophagosome membrane [GO:0000421]; condensed nuclear chromosome [GO:0000794]; cytosol [GO:0005829]; early endosome [GO:0005769]; endomembrane system [GO:0012505]; ESCRT III complex [GO:0000815]; extracellular exosome [GO:0070062]; kinetochore [GO:0000776]; kinetochore microtubule [GO:0005828]; lysosomal membrane [GO:0005765]; microtubule organizing center [GO:0005815]; midbody [GO:0030496]; multivesicular body [GO:0005771]; multivesicular body membrane [GO:0032585]; nuclear matrix [GO:0016363]; nuclear pore [GO:0005643]; plasma membrane [GO:0005886],identical protein binding [GO:0042802]; metallopeptidase activity [GO:0008237]; protein domain specific binding [GO:0019904]; protein homodimerization activity [GO:0042803]; zinc ion binding [GO:0008270],,,,,"HELIX 184..195; /evidence=""ECO:0007829|PDB:4A5X""",,"cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,CHMP1A CHMP1 KIAA0047 PCOLN3 PRSM1,Charged multivesicular body protein 1a (Chromatin-modifying protein 1a) (CHMP1a) (Vacuolar protein sorting-associated protein 46-1) (Vps46-1) (hVps46-1),Homo sapiens (Human),196.0,21703.0,MDDTLFQLKFTAKQLEKLAKKAEKDSKAEQAKVKKALLQKNVECARVYAENAIRKKNEGVNWLRMASRVDAVASKVQTAVTMKGVTKNMAQVTKALDKALSTMDLQKVSSVMDRFEQQVQNLDVHTSVMEDSMSSATTLTTPQEQVDSLIMQIAEENGLEVLDQLSQLPEGASAVGESSVRSQEDQLSRRLAALRN,False,False,True,Q9HD42,"[('G3DSA:6.10.140.1230', None), ('IPR005024', 'Snf7 family'), ('PF03357', 'Snf7'), ('PTHR10476', 'CHARGED MULTIVESICULAR BODY PROTEIN')]",,"""ENSG00000131165; Low tissue specificity."";",,,,,ENST00000397901.8 [Q9HD42-1];,CHMP1A,ENSG00000131165,0.0,,,,,,,0.189,0.122,CHMP1A
Q9NP31,ENSG00000027869,SH22A_HUMAN,angiogenesis [GO:0001525]; cell differentiation [GO:0030154]; signal transduction [GO:0007165]; T cell proliferation [GO:0042098],cytoplasm [GO:0005737]; cytosol [GO:0005829],SH3 domain binding [GO:0017124],PTM: Phosphorylated on tyrosine residues.,,"DOMAIN 95..186; /note=""SH2""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00191""",,,,"cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,SH2D2A SCAP TSAD VRAP,SH2 domain-containing protein 2A (SH2 domain-containing adapter protein) (T cell-specific adapter protein) (TSAd) (VEGF receptor-associated protein),Homo sapiens (Human),389.0,42934.0,MEFPLAQICPQGSHEAPIPTFSTFQITDMTRRSCQNLGYTAASPQAPEAASNTGNAERAEEVPGEGSLFLQAETRAWFQKTQAHWLLQHGAAPAWFHGFITRREAERLLEPKPQGCYLVRFSESAVTFVLTYRSRTCCRHFLLAQLRDGRHVVLGEDSAHARLQDLLLHYTAHPLSPYGETLTEPLARQTPEPAGLSLRTEESNFGSKSQDPNPQYSPIIKQGQAPVPMQKEGAGEKEPSQLLRPKPPIPAKPQLPPEVYTIPVPRHRPAPRPKPSNPIYNEPDEPIAFYAMGRGSPGEAPSNIYVEVEDEGLPATLGHPVLRKSWSRPVPGGQNTGGSQLHSENSVIGQGPPLPHQPPPAWRHTLPHNLSRQVLQDRGQAWLPLGPPQ,False,False,True,Q9NP31,"[('cd10416', 'Src homology 2 domain found in the SH2 domain containing protein 2A (SH2D2A)'), ('G3DSA:3.30.505.10', 'SH2 domain'), ('IPR000980', 'SH2 domain'), ('IPR035884', 'SH2D2A, SH2 domain'), ('IPR036860', 'SH2 domain superfamily'), ('PF00017', 'SH2 domain'), ('PR00401', 'SH2DOMAIN'), ('PS50001', 'Src homology 2 (SH2) domain profile'), ('PTHR14388', 'SH2 Domain-Containing'), ('SM00252', 'Src homology 2 domains'), ('SSF55550', 'SH2 domain')]",,"""ENSG00000027869; Tissue enhanced (lymphoid)."";",,,,,ENST00000368198.7 [Q9NP31-4];ENST00000368199.8 [Q9NP31-1];ENST00000392306.2 [Q9NP31-2];,SH2D2A,ENSG00000027869,0.0,,,,,,,0.668,0.501,SH2D2A
Q9NPD3,ENSG00000178896,EXOS4_HUMAN,defense response to virus [GO:0051607]; DNA deamination [GO:0045006]; histone mRNA catabolic process [GO:0071044]; maturation of 5.8S rRNA [GO:0000460]; nuclear mRNA surveillance [GO:0071028]; nuclear-transcribed mRNA catabolic process [GO:0000956]; poly(A)-dependent snoRNA 3'-end processing [GO:0071051]; positive regulation of cell growth [GO:0030307]; RNA catabolic process [GO:0006401]; RNA processing [GO:0006396]; rRNA catabolic process [GO:0016075]; rRNA processing [GO:0006364]; U4 snRNA 3'-end processing [GO:0034475],cytoplasm [GO:0005737]; cytoplasmic exosome (RNase complex) [GO:0000177]; cytosol [GO:0005829]; euchromatin [GO:0000791]; exosome (RNase complex) [GO:0000178]; intracellular membrane-bounded organelle [GO:0043231]; nuclear exosome (RNase complex) [GO:0000176]; nucleolar exosome (RNase complex) [GO:0101019]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],3'-5'-RNA exonuclease activity [GO:0000175]; mRNA 3'-UTR AU-rich region binding [GO:0035925]; RNA binding [GO:0003723],,,,"STRAND 14..17; /evidence=""ECO:0007829|PDB:2NN6""; STRAND 25..30; /evidence=""ECO:0007829|PDB:2NN6""; STRAND 32..45; /evidence=""ECO:0007829|PDB:2NN6""; STRAND 47..57; /evidence=""ECO:0007829|PDB:2NN6""; STRAND 60..62; /evidence=""ECO:0007829|PDB:2NN6""; STRAND 67..69; /evidence=""ECO:0007829|PDB:6D6Q""; STRAND 72..78; /evidence=""ECO:0007829|PDB:2NN6""; STRAND 83..85; /evidence=""ECO:0007829|PDB:2NN6""; STRAND 119..129; /evidence=""ECO:0007829|PDB:2NN6""; STRAND 158..165; /evidence=""ECO:0007829|PDB:2NN6""; STRAND 168..172; /evidence=""ECO:0007829|PDB:2NN6""; STRAND 185..189; /evidence=""ECO:0007829|PDB:2NN6""; STRAND 198..201; /evidence=""ECO:0007829|PDB:2NN6""","HELIX 94..109; /evidence=""ECO:0007829|PDB:2NN6""; HELIX 113..115; /evidence=""ECO:0007829|PDB:2NN6""; HELIX 134..148; /evidence=""ECO:0007829|PDB:2NN6""; HELIX 175..178; /evidence=""ECO:0007829|PDB:2NN6""; HELIX 210..239; /evidence=""ECO:0007829|PDB:2NN6""","TURN 80..82; /evidence=""ECO:0007829|PDB:2NN6""; TURN 89..91; /evidence=""ECO:0007829|PDB:2NN6""; TURN 191..193; /evidence=""ECO:0007829|PDB:2NN6""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,EXOSC4 RRP41 SKI6,Exosome complex component RRP41 (Exosome component 4) (Ribosomal RNA-processing protein 41) (p12A),Homo sapiens (Human),245.0,26383.0,MAGLELLSDQGYRVDGRRAGELRKIQARMGVFAQADGSAYIEQGNTKALAVVYGPHEIRGSRARALPDRALVNCQYSSATFSTGERKRRPHGDRKSCEMGLQLRQTFEAAILTQLHPRSQIDIYVQVLQADGGTYAACVNAATLAVLDAGIPMRDFVCACSAGFVDGTALADLSHVEEAAGGPQLALALLPASGQIALLEMDARLHEDHLERVLEAAAQAARDVHTLLDRVVRQHVREASILLGD,False,False,True,Q9NPD3,"[('cd11370', 'RRP41 subunit of eukaryotic exosome'), ('G3DSA:3.30.230.70', 'GHMP Kinase, N-terminal domain'), ('IPR001247', 'Exoribonuclease, phosphorolytic domain 1'), ('IPR015847', 'Exoribonuclease, phosphorolytic domain 2'), ('IPR020568', 'Ribosomal protein uS5 domain 2-type superfamily'), ('IPR027408', 'PNPase/RNase PH domain superfamily'), ('IPR036345', 'Exoribonuclease, PH domain 2 superfamily'), ('IPR050080', 'Ribonuclease PH'), ('PF01138', ""3' exoribonuclease family, domain 1""), ('PF03725', ""3' exoribonuclease family, domain 2""), ('PTHR11953', 'Ribonuclease PH'), ('SSF54211', 'Ribosomal protein S5 domain 2-like'), ('SSF55666', 'Ribonuclease PH domain 2-like')]",,"""ENSG00000178896; Tissue enhanced (testis)."";",,,,,ENST00000316052.6;,EXOSC4,ENSG00000178896,0.0,EXOSC4,Canonical_RBPs,8.0,,,,0.037,,EXOSC4
Q9NPI8,ENSG00000183161,FANCF_HUMAN,DNA damage response [GO:0006974]; interstrand cross-link repair [GO:0036297],chromatin [GO:0000785]; cytosol [GO:0005829]; Fanconi anaemia nuclear complex [GO:0043240]; nucleoplasm [GO:0005654],,,,,"STRAND 286..288; /evidence=""ECO:0007829|PDB:2IQC""; STRAND 293..295; /evidence=""ECO:0007829|PDB:2IQC""","HELIX 160..174; /evidence=""ECO:0007829|PDB:2IQC""; HELIX 186..195; /evidence=""ECO:0007829|PDB:2IQC""; HELIX 198..209; /evidence=""ECO:0007829|PDB:2IQC""; HELIX 235..243; /evidence=""ECO:0007829|PDB:2IQC""; HELIX 245..254; /evidence=""ECO:0007829|PDB:2IQC""; HELIX 257..266; /evidence=""ECO:0007829|PDB:2IQC""; HELIX 268..270; /evidence=""ECO:0007829|PDB:2IQC""; HELIX 271..283; /evidence=""ECO:0007829|PDB:2IQC""; HELIX 304..315; /evidence=""ECO:0007829|PDB:2IQC""; HELIX 319..335; /evidence=""ECO:0007829|PDB:2IQC""; HELIX 346..354; /evidence=""ECO:0007829|PDB:2IQC""","TURN 289..292; /evidence=""ECO:0007829|PDB:2IQC""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,FANCF,Fanconi anemia group F protein (Protein FACF),Homo sapiens (Human),374.0,42254.0,MESLLQHLDRFSELLAVSSTTYVSTWDPATVRRALQWARYLRHIHRRFGRHGPIRTALERRLHNQWRQEGGFGRGPVPGLANFQALGHCDVLLSLRLLENRALGDAARYHLVQQLFPGPGVRDADEETLQESLARLARRRSAVHMLRFNGYRENPNLQEDSLMKTQAELLLERLQEVGKAEAERPARFLSSLWERLPQNNFLKVIAVALLQPPLSRRPQEELEPGIHKSPGEGSQVLVHWLLGNSEVFAAFCRALPAGLLTLVTSRHPALSPVYLGLLTDWGQRLHYDLQKGIWVGTESQDVPWEELHNRFQSLCQAPPPLKDKVLTALETCKAQDGDFEVPGLSIWTDLLLALRSGAFRKRQVLGLSAGLSSV,False,False,True,Q9NPI8,"[('G3DSA:1.25.40.490', None), ('IPR035428', 'Fanconi anemia group F protein'), ('IPR038505', 'FANCF, C-terminal domain superfamily'), ('PF11107', 'Fanconi anemia group F protein (FANCF)'), ('PTHR14449', 'FANCONI ANEMIA GROUP F PROTEIN FANCF')]",,"""ENSG00000183161; Low tissue specificity."";",,,,,ENST00000327470.6;,FANCF,ENSG00000183161,0.0,,,,9.63,DP02782,0.096,0.08,,FANCF
Q9NQ66,ENSG00000182621,PLCB1_HUMAN,"activation of meiosis involved in egg activation [GO:0060466]; cellular response to fluoride [GO:1902618]; cellular response to glyceraldehyde [GO:1905631]; cellular response to ionomycin [GO:1904637]; cellular response to vasopressin [GO:1904117]; cerebral cortex development [GO:0021987]; fat cell differentiation [GO:0045444]; G protein-coupled acetylcholine receptor signaling pathway [GO:0007213]; G protein-coupled receptor signaling pathway [GO:0007186]; G2/M transition of mitotic cell cycle [GO:0000086]; glutamate receptor signaling pathway [GO:0007215]; inositol trisphosphate metabolic process [GO:0032957]; insulin-like growth factor receptor signaling pathway [GO:0048009]; interleukin-1-mediated signaling pathway [GO:0070498]; interleukin-12-mediated signaling pathway [GO:0035722]; interleukin-15-mediated signaling pathway [GO:0035723]; ion channel modulating, G protein-coupled receptor signaling pathway [GO:0099105]; learning [GO:0007612]; ligand-gated ion channel signaling pathway [GO:1990806]; memory [GO:0007613]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of monocyte extravasation [GO:2000438]; phosphatidylinositol catabolic process [GO:0031161]; phosphatidylinositol metabolic process [GO:0046488]; phosphatidylinositol-mediated signaling [GO:0048015]; phospholipase C-activating G protein-coupled acetylcholine receptor signaling pathway [GO:0007207]; positive regulation of acrosome reaction [GO:2000344]; positive regulation of CD24 production [GO:2000560]; positive regulation of developmental growth [GO:0048639]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of embryonic development [GO:0040019]; positive regulation of G1/S transition of mitotic cell cycle [GO:1900087]; positive regulation of insulin secretion [GO:0032024]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of JNK cascade [GO:0046330]; positive regulation of myoblast differentiation [GO:0045663]; postsynaptic modulation of chemical synaptic transmission [GO:0099170]; regulation of establishment of endothelial barrier [GO:1903140]; regulation of fertilization [GO:0080154]; regulation of G protein-coupled receptor signaling pathway [GO:0008277]; regulation of retrograde trans-synaptic signaling by endocanabinoid [GO:0099178]; release of sequestered calcium ion into cytosol [GO:0051209]; signal transduction [GO:0007165]",chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; nuclear membrane [GO:0031965]; nuclear speck [GO:0016607]; nucleus [GO:0005634]; postsynaptic cytosol [GO:0099524]; protein-containing complex [GO:0032991],"calcium ion binding [GO:0005509]; calmodulin binding [GO:0005516]; enzyme binding [GO:0019899]; GTPase activator activity [GO:0005096]; identical protein binding [GO:0042802]; lamin binding [GO:0005521]; phosphatidylinositol phospholipase C activity [GO:0004435]; phosphatidylinositol-4,5-bisphosphate binding [GO:0005546]; phospholipase C activity [GO:0004629]",PTM: Palmitoylated. Palmitoylation at Cys-17 by ZDHHC21 regulates the signaling activity of PLCB1 and the function of the endothelial barrier. Palmitoylation by ZDHHC21 is stimulated by inflammation. {ECO:0000250|UniProtKB:Q9Z1B3}.,,"DOMAIN 316..467; /note=""PI-PLC X-box""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00270""; DOMAIN 540..656; /note=""PI-PLC Y-box""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00271""; DOMAIN 656..786; /note=""C2""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00041""",,,,"cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,PLCB1 KIAA0581,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1 (EC 3.1.4.11) (PLC-154) (Phosphoinositide phospholipase C-beta-1) (Phospholipase C-I) (PLC-I) (Phospholipase C-beta-1) (PLC-beta-1)",Homo sapiens (Human),1216.0,138567.0,MAGAQPGVHALQLKPVCVSDSLKKGTKFVKWDDDSTIVTPIILRTDPQGFFFYWTDQNKETELLDLSLVKDARCGRHAKAPKDPKLRELLDVGNIGRLEQRMITVVYGPDLVNISHLNLVAFQEEVAKEWTNEVFSLATNLLAQNMSRDAFLEKAYTKLKLQVTPEGRIPLKNIYRLFSADRKRVETALEACSLPSSRNDSIPQEDFTPEVYRVFLNNLCPRPEIDNIFSEFGAKSKPYLTVDQMMDFINLKQRDPRLNEILYPPLKQEQVQVLIEKYEPNNSLARKGQISVDGFMRYLSGEENGVVSPEKLDLNEDMSQPLSHYFINSSHNTYLTAGQLAGNSSVEMYRQVLLSGCRCVELDCWKGRTAEEEPVITHGFTMTTEISFKEVIEAIAECAFKTSPFPILLSFENHVDSPKQQAKMAEYCRLIFGDALLMEPLEKYPLESGVPLPSPMDLMYKILVKNKKKSHKSSEGSGKKKLSEQASNTYSDSSSMFEPSSPGAGEADTESDDDDDDDDCKKSSMDEGTAGSEAMATEEMSNLVNYIQPVKFESFEISKKRNKSFEMSSFVETKGLEQLTKSPVEFVEYNKMQLSRIYPKGTRVDSSNYMPQLFWNAGCQMVALNFQTMDLAMQINMGMYEYNGKSGYRLKPEFMRRPDKHFDPFTEGIVDGIVANTLSVKIISGQFLSDKKVGTYVEVDMFGLPVDTRRKAFKTKTSQGNAVNPVWEEEPIVFKKVVLPTLACLRIAVYEEGGKFIGHRILPVQAIRPGYHYICLRNERNQPLTLPAVFVYIEVKDYVPDTYADVIEALSNPIRYVNLMEQRAKQLAALTLEDEEEVKKEADPGETPSEAPSEARTTPAENGVNHTTTLTPKPPSQALHSQPAPGSVKAPAKTEDLIQSVLTEVEAQTIEELKQQKSFVKLQKKHYKEMKDLVKRHHKKTTDLIKEHTTKYNEIQNDYLRRRAALEKSAKKDSKKKSEPSSPDHGSSTIEQDLAALDAEMTQKLIDLKDKQQQQLLNLRQEQYYSEKYQKREHIKLLIQKLTDVAEECQNNQLKKLKEICEKEKKELKKKMDKKRQEKITEAKSKDKSQMEEEKTEMIRSYIQEVVQYIKRLEEAQSKRQEKLVEKHKEIRQQILDEKPKLQVELEQEYQDKFKRLPLEILEFVQEAMKGKISEDSNHGSAPLSLSSDPGKVNHKTPSSEELGGDIPGKEFDTPL,False,True,False,Q9NQ66,"[('cd00275', 'C2 domain present in Phosphoinositide-specific phospholipases C (PLC)'), ('cd08591', 'Catalytic domain of metazoan phosphoinositide-specific phospholipase C-beta'), ('cd13361', 'Phospholipase C-beta (PLC-beta) pleckstrin homology (PH) domain'), ('cd16208', 'EF-hand motif found in phosphoinositide phospholipase C beta 1 (PI-PLC-beta1)'), ('G3DSA:1.10.238.10', 'EF-hand'), ('G3DSA:1.20.1230.10', 'Phospholipase C beta, distal C-terminal domain'), ('G3DSA:2.30.29.240', None), ('G3DSA:2.60.40.150', 'C2 domain'), ('G3DSA:3.20.20.190', 'Phosphatidylinositol (PI) phosphodiesterase'), ('IPR000008', 'C2 domain'), ('IPR000909', 'Phosphatidylinositol-specific phospholipase C, X domain'), ('IPR001192', 'Phosphoinositide phospholipase C family'), ('IPR001711', 'Phospholipase C, phosphatidylinositol-specific, Y domain'), ('IPR011992', 'EF-hand domain pair'), ('IPR014815', 'Phospholipase C-beta, C-terminal domain'), ('IPR016280', 'Phosphatidylinositol-4, 5-bisphosphate phosphodiesterase beta'), ('IPR017946', 'PLC-like phosphodiesterase, TIM beta/alpha-barrel domain superfamily'), ('IPR028400', '1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1, EF hand motif'), ('IPR035892', 'C2 domain superfamily'), ('IPR037862', 'PLC-beta, PH domain')]",,"""ENSG00000182621; Tissue enhanced (brain)."";","CATALYTIC ACTIVITY: Reaction=a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-4,5-bisphosphate) + H2O = 1D-myo-inositol 1,4,5-trisphosphate + a 1,2-diacyl-sn-glycerol + H(+); Xref=Rhea:RHEA:33179, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:17815, ChEBI:CHEBI:58456, ChEBI:CHEBI:203600; EC=3.1.4.11; Evidence={ECO:0000269|PubMed:9188725}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:33180; Evidence={ECO:0000305|PubMed:9188725}; CATALYTIC ACTIVITY: Reaction=a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol) + H2O = 1D-myo-inositol 1-phosphate + a 1,2-diacyl-sn-glycerol + H(+); Xref=Rhea:RHEA:43484, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:17815, ChEBI:CHEBI:57880, ChEBI:CHEBI:58433; Evidence={ECO:0000250|UniProtKB:P10687}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:43485; Evidence={ECO:0000250|UniProtKB:P10687};",3.1.4.11,,,ENST00000338037.11 [Q9NQ66-1];ENST00000378637.6 [Q9NQ66-2];ENST00000378641.7 [Q9NQ66-2];,PLCB1,ENSG00000182621,0.0,,,,,,,0.174,0.185,PLCB1
Q9NQX1,ENSG00000138738,PRDM5_HUMAN,cellular response to leukemia inhibitory factor [GO:1990830]; chromatin organization [GO:0006325]; methylation [GO:0032259]; mitotic cell cycle [GO:0000278]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of extracellular matrix organization [GO:1903053],nuclear body [GO:0016604]; nucleolus [GO:0005730]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],"DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor binding [GO:0140297]; DNA-binding transcription repressor activity, RNA polymerase II-specific [GO:0001227]; metal ion binding [GO:0046872]; methyltransferase activity [GO:0008168]; RNA polymerase II cis-regulatory region sequence-specific DNA binding [GO:0000978]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; transcription cis-regulatory region binding [GO:0000976]",,,"DOMAIN 8..124; /note=""SET""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00190""","STRAND 4..6; /evidence=""ECO:0007829|PDB:6XAZ""; STRAND 10..14; /evidence=""ECO:0007829|PDB:6XAZ""; STRAND 16..27; /evidence=""ECO:0007829|PDB:6XAZ""; STRAND 41..43; /evidence=""ECO:0007829|PDB:6XAZ""; STRAND 57..61; /evidence=""ECO:0007829|PDB:6XAZ""; STRAND 67..72; /evidence=""ECO:0007829|PDB:6XAZ""; STRAND 96..101; /evidence=""ECO:0007829|PDB:6XAZ""; STRAND 104..109; /evidence=""ECO:0007829|PDB:6XAZ""; STRAND 120..122; /evidence=""ECO:0007829|PDB:6XAZ""","HELIX 76..78; /evidence=""ECO:0007829|PDB:6XAZ""; HELIX 81..84; /evidence=""ECO:0007829|PDB:6XAZ""","TURN 91..93; /evidence=""ECO:0007829|PDB:6XAZ""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,PRDM5 PFM2,PR domain zinc finger protein 5 (EC 2.1.1.-) (PR domain-containing protein 5),Homo sapiens (Human),630.0,73090.0,MLGMYVPDRFSLKSSRVQDGMGLYTARRVRKGEKFGPFAGEKRMPEDLDENMDYRLMWEVRGSKGEVLYILDATNPRHSNWLRFVHEAPSQEQKNLAAIQEGENIFYLAVEDIETDTELLIGYLDSDMEAEEEEQQIMTVIKEGEVENSRRQSTAGRKDRLGCKEDYACPQCESSFTSEDILAEHLQTLHQKPTEEKEFKCKNCGKKFPVKQALQRHVLQCTAKSSLKESSRSFQCSVCNSSFSSASSFEQHQETCRGDARFVCKADSCGKRLKSKDALKRHQENVHTGDPKKKLICSVCNKKCSSASSLQEHRKIHEIFDCQECMKKFISANQLKRHMITHSEKRPYNCEICNKSFKRLDQVGAHKVIHSEDKPYKCKLCGKGFAHRNVYKNHKKTHSEERPFQCEECKALFRTPFSLQRHLLIHNSERTFKCHHCDATFKRKDTLNVHVQVVHERHKKYRCELCNKAFVTPSVLRSHKKTHTGEKEKICPYCGQKFASSGTLRVHIRSHTGERPYQCPYCEKGFSKNDGLKMHIRTHTREKPYKCSECSKAFSQKRGLDEHKRTHTGEKPFQCDVCDLAFSLKKMLIRHKMTHNPNRPLAECQFCHKKFTRNDYLKVHMDNIHGVADS,False,False,True,Q9NQX1,"[('cd19190', 'PR-SET domain found in PR domain zinc finger protein 5 (PRDM5) and similar proteins'), ('G3DSA:2.170.270.10', 'SET domain'), ('G3DSA:3.30.160.60', 'Classic Zinc Finger'), ('IPR001214', 'SET domain'), ('IPR013087', 'Zinc finger C2H2-type'), ('IPR017125', 'PR-domain zinc finger protein PRDM5-like'), ('IPR036236', 'Zinc finger C2H2 superfamily'), ('IPR044415', 'PRDM5, PR/SET domain'), ('IPR046341', 'SET domain superfamily'), ('IPR050331', 'Zinc finger'), ('PF00096', 'Zinc finger, C2H2 type'), ('PF12874', 'Zinc-finger of C2H2 type'), ('PF13912', 'C2H2-type zinc finger'), ('PF21549', 'PR domain zinc finger protein 2, PR domain'), ('PIRSF037162', 'PR-domain zinc finger protein PRDM5'), ('PS00028', 'Zinc finger C2H2 type domain signature'), ('PS50157', 'Zinc finger C2H2 type domain profile'), ('PS50280', 'SET domain profile'), ('PTHR16515', 'Zinc finger'), ('SM00317', 'SET (Su(var)3-9, Enhancer-of-zeste, Trithorax) domain')]",,"""ENSG00000138738; Low tissue specificity."";",,2.1.1.-,,,ENST00000264808.8 [Q9NQX1-1];ENST00000394435.2 [Q9NQX1-3];ENST00000428209.6 [Q9NQX1-2];ENST00000515109.5 [Q9NQX1-4];,PRDM5,ENSG00000138738,0.0,PRDM5,Canonical_RBPs,0.0,,,,0.127,,PRDM5
Q9NQX3,ENSG00000171723,GEPH_HUMAN,establishment of synaptic specificity at neuromuscular junction [GO:0007529]; gamma-aminobutyric acid receptor clustering [GO:0097112]; glycine receptor clustering [GO:0072579]; Mo-molybdopterin cofactor biosynthetic process [GO:0006777]; molybdopterin cofactor biosynthetic process [GO:0032324]; postsynaptic neurotransmitter receptor diffusion trapping [GO:0098970]; response to metal ion [GO:0010038],cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendrite [GO:0030425]; dendritic spine [GO:0043197]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic membrane [GO:0045211]; postsynaptic specialization [GO:0099572]; postsynaptic specialization membrane [GO:0099634]; synaptic membrane [GO:0097060],ATP binding [GO:0005524]; identical protein binding [GO:0042802]; metal ion binding [GO:0046872]; molybdopterin adenylyltransferase activity [GO:0061598]; molybdopterin cofactor binding [GO:0043546]; molybdopterin molybdotransferase activity [GO:0061599]; nitrate reductase activity [GO:0008940]; protein-macromolecule adaptor activity [GO:0030674],"PTM: Palmitoylated (PubMed:25025157). Palmitoylation is stimulated by GABA type A receptors activity (By similarity). Palmitoylation by ZDHHC12 regulates clustering at synapses (PubMed:25025157). {ECO:0000250|UniProtKB:Q8BUV3, ECO:0000269|PubMed:25025157}.",,,"STRAND 16..22; /evidence=""ECO:0007829|PDB:1JLJ""; STRAND 52..59; /evidence=""ECO:0007829|PDB:1JLJ""; STRAND 80..86; /evidence=""ECO:0007829|PDB:1JLJ""; STRAND 89..91; /evidence=""ECO:0007829|PDB:1JLJ""; STRAND 105..107; /evidence=""ECO:0007829|PDB:1JLJ""; STRAND 133..136; /evidence=""ECO:0007829|PDB:1JLJ""; STRAND 139..144; /evidence=""ECO:0007829|PDB:1JLJ""","HELIX 24..27; /evidence=""ECO:0007829|PDB:1JLJ""; HELIX 34..44; /evidence=""ECO:0007829|PDB:1JLJ""; HELIX 63..75; /evidence=""ECO:0007829|PDB:1JLJ""; HELIX 96..103; /evidence=""ECO:0007829|PDB:1JLJ""; HELIX 109..122; /evidence=""ECO:0007829|PDB:1JLJ""; HELIX 124..128; /evidence=""ECO:0007829|PDB:1JLJ""; HELIX 148..158; /evidence=""ECO:0007829|PDB:1JLJ""; HELIX 159..161; /evidence=""ECO:0007829|PDB:1JLJ""; HELIX 162..169; /evidence=""ECO:0007829|PDB:1JLJ""; HELIX 175..178; /evidence=""ECO:0007829|PDB:1JLJ""","TURN 46..49; /evidence=""ECO:0007829|PDB:1JLJ""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,GPHN GPH KIAA1385,Gephyrin [Includes: Molybdopterin adenylyltransferase (MPT adenylyltransferase) (EC 2.7.7.75) (Domain G); Molybdopterin molybdenumtransferase (MPT Mo-transferase) (EC 2.10.1.1) (Domain E)],Homo sapiens (Human),736.0,79748.0,MATEGMILTNHDHQIRVGVLTVSDSCFRNLAEDRSGINLKDLVQDPSLLGGTISAYKIVPDEIEEIKETLIDWCDEKELNLILTTGGTGFAPRDVTPEATKEVIEREAPGMALAMLMGSLNVTPLGMLSRPVCGIRGKTLIINLPGSKKGSQECFQFILPALPHAIDLLRDAIVKVKEVHDELEDLPSPPPPLSPPPTTSPHKQTEDKGVQCEEEEEEKKDSGVASTEDSSSSHITAAAIAAKIPDSIISRGVQVLPRDTASLSTTPSESPRAQATSRLSTASCPTPKVQSRCSSKENILRASHSAVDITKVARRHRMSPFPLTSMDKAFITVLEMTPVLGTEIINYRDGMGRVLAQDVYAKDNLPPFPASVKDGYAVRAADGPGDRFIIGESQAGEQPTQTVMPGQVMRVTTGAPIPCGADAVVQVEDTELIRESDDGTEELEVRILVQARPGQDIRPIGHDIKRGECVLAKGTHMGPSEIGLLATVGVTEVEVNKFPVVAVMSTGNELLNPEDDLLPGKIRDSNRSTLLATIQEHGYPTINLGIVGDNPDDLLNALNEGISRADVIITSGGVSMGEKDYLKQVLDIDLHAQIHFGRVFMKPGLPTTFATLDIDGVRKIIFALPGNPVSAVVTCNLFVVPALRKMQGILDPRPTIIKARLSCDVKLDPRPEYHRCILTWHHQEPLPWAQSTGNQMSSRLMSMRSANGLLMLPPKTEQYVELHKGEVVDVMVIGRL,True,True,True,Q9NQX3,"[('cd00886', 'MogA_MoaB'), ('cd00887', 'MoeA'), ('G3DSA:2.170.190.11', 'Molybdopterin biosynthesis moea protein, domain 3.'), ('G3DSA:2.40.340.10', 'MoeA, C-terminal, domain IV'), ('G3DSA:3.40.980.10', 'MoaB/Mog-like domain'), ('G3DSA:3.90.105.10', 'Molybdopterin biosynthesis moea protein, domain 2'), ('IPR001453', 'MoaB/Mog domain'), ('IPR005110', 'MoeA, N-terminal and linker domain'), ('IPR005111', 'MoeA, C-terminal, domain IV'), ('IPR008284', 'Molybdenum cofactor biosynthesis, conserved site'), ('IPR036135', 'MoeA, N-terminal and linker domain superfamily'), ('IPR036425', 'MoaB/Mog-like domain superfamily'), ('IPR036688', 'MoeA, C-terminal, domain IV superfamily'), ('IPR038987', 'Molybdopterin biosynthesis protein MoeA-like'), ('NF045515', 'gephyrin-like molybdotransferase Glp'), ('PF00994', 'Probable molybdopterin binding domain'), ('PF03453', 'MoeA N-terminal region (domain I and II)'), ('PF03454', 'MoeA C-terminal region (domain IV)'), ('PS01078', 'Molybdenum cofactor biosynthesis proteins signature 1'), ('PS01079', 'Molybdenum cofactor biosynthesis proteins signature 2')]",,"""ENSG00000171723; Tissue enhanced (brain, liver)."";","CATALYTIC ACTIVITY: Reaction=molybdopterin + ATP + H(+) = adenylyl-molybdopterin + diphosphate; Xref=Rhea:RHEA:31331, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616, ChEBI:CHEBI:33019, ChEBI:CHEBI:58698, ChEBI:CHEBI:62727; EC=2.7.7.75; Evidence={ECO:0000305|PubMed:26613940}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:31332; Evidence={ECO:0000305|PubMed:26613940}; CATALYTIC ACTIVITY: Reaction=adenylyl-molybdopterin + molybdate = Mo-molybdopterin + AMP + H(+); Xref=Rhea:RHEA:35047, ChEBI:CHEBI:15378, ChEBI:CHEBI:36264, ChEBI:CHEBI:62727, ChEBI:CHEBI:71302, ChEBI:CHEBI:456215; EC=2.10.1.1; Evidence={ECO:0000305|PubMed:22040219, ECO:0000305|PubMed:26613940}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:35048; Evidence={ECO:0000305|PubMed:22040219, ECO:0000305|PubMed:26613940};",2.10.1.1; 2.7.7.75,ACTIVITY REGULATION: Inhibited by copper and tungsten. {ECO:0000250}.,"PATHWAY: Cofactor biosynthesis; molybdopterin biosynthesis. {ECO:0000269|PubMed:11095995, ECO:0000269|PubMed:22040219, ECO:0000269|PubMed:26613940}.",ENST00000315266.9 [Q9NQX3-1];ENST00000478722.6 [Q9NQX3-2];,GPHN,ENSG00000171723,0.0,,,,1.63,DP03848,0.016,0.19,0.113,GPHN
Q9NR28,ENSG00000184047,DBLOH_HUMAN,activation of cysteine-type endopeptidase activity involved in apoptotic process [GO:0006919]; activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c [GO:0008635]; apoptotic process [GO:0006915]; extrinsic apoptotic signaling pathway via death domain receptors [GO:0008625]; intrinsic apoptotic signaling pathway [GO:0097193]; intrinsic apoptotic signaling pathway in response to oxidative stress [GO:0008631]; neuron apoptotic process [GO:0051402]; positive regulation of apoptotic process [GO:0043065],CD40 receptor complex [GO:0035631]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; mitochondrial intermembrane space [GO:0005758]; mitochondrion [GO:0005739],,"PTM: Ubiquitinated by BIRC7/livin (PubMed:16729033). Ubiquitinated by BIRC6 (PubMed:36758104, PubMed:36758105, PubMed:36758106). {ECO:0000269|PubMed:16729033, ECO:0000269|PubMed:36758104, ECO:0000269|PubMed:36758105, ECO:0000269|PubMed:36758106}.; PTM: The precursor form is proteolytically cleaved by mitochondrial processing peptidase MPP to remove the transit peptide and produce an intermediate form. This is then processed by PARL to produce the mature cleaved form which is released from mitochondria into the cytosol in apoptotic cells. {ECO:0000269|PubMed:28288130}.",DOMAIN: The mature N-terminus mediates interaction with XIAP/BIRC4.,,"STRAND 57..59; /evidence=""ECO:0007829|PDB:1XB0""; STRAND 123..125; /evidence=""ECO:0007829|PDB:1FEW""","HELIX 71..120; /evidence=""ECO:0007829|PDB:4TX5""; HELIX 126..173; /evidence=""ECO:0007829|PDB:4TX5""; HELIX 177..239; /evidence=""ECO:0007829|PDB:4TX5""",,"cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,DIABLO SMAC,"Diablo IAP-binding mitochondrial protein (Diablo homolog, mitochondrial) (Direct IAP-binding protein with low pI) (Second mitochondria-derived activator of caspases) (SMAC) [Cleaved into: Diablo IAP-binding mitochondrial protein, cleaved form]",Homo sapiens (Human),239.0,27131.0,MAALKSWLSRSVTSFFRYRQCLCVPVVANFKKRCFSELIRPWHKTVTIGFGVTLCAVPIAQKSEPHSLSSEALMRRAVSLVTDSTSTFLSQTTYALIEAITEYTKAVYTLTSLYRQYTSLLGKMNSEEEDEVWQVIIGARAEMTSKHQEYLKLETTWMTAVGLSEMAAEAAYQTGADQASITARNHIQLVKLQVEEVHQLSRKAETKLAEAQIEELRQKTQEEGEERAESEQEAYLRED,False,False,True,Q9NR28,"[('G3DSA:1.20.58.70', None), ('IPR009062', 'Smac/DIABLO-like superfamily'), ('IPR015142', 'Smac/DIABLO protein'), ('PF09057', 'Second Mitochondria-derived Activator of Caspases'), ('PTHR32247', 'DIABLO HOMOLOG, MITOCHONDRIAL'), ('SSF46984', 'Smac/diablo')]",,"""ENSG00000184047; Low tissue specificity."";",,,,,ENST00000353548.11 [Q9NR28-3];ENST00000464942.7 [Q9NR28-1];,DIABLO,ENSG00000184047,0.0,,,,6.28,DP01619,0.063,0.31,0.096,DIABLO
Q9NRD5,ENSG00000100151,PICK1_HUMAN,cellular response to decreased oxygen levels [GO:0036294]; cellular response to glucose starvation [GO:0042149]; dendritic spine maintenance [GO:0097062]; dendritic spine organization [GO:0097061]; glial cell development [GO:0021782]; intracellular protein transport [GO:0006886]; long-term synaptic depression [GO:0060292]; monoamine transport [GO:0015844]; negative regulation of Arp2/3 complex-mediated actin nucleation [GO:0034316]; neuronal ion channel clustering [GO:0045161]; positive regulation of receptor internalization [GO:0002092]; protein phosphorylation [GO:0006468]; receptor clustering [GO:0043113]; regulation of Arp2/3 complex-mediated actin nucleation [GO:0034315]; regulation of insulin secretion [GO:0050796],cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; endocytic vesicle membrane [GO:0030666]; Golgi apparatus [GO:0005794]; neuron projection [GO:0043005]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; postsynaptic density [GO:0014069]; postsynaptic early endosome [GO:0098842]; presynaptic membrane [GO:0042734]; synapse [GO:0045202]; synaptic vesicle [GO:0008021]; trans-Golgi network membrane [GO:0032588],actin filament binding [GO:0051015]; Arp2/3 complex binding [GO:0071933]; G protein-coupled receptor binding [GO:0001664]; identical protein binding [GO:0042802]; membrane curvature sensor activity [GO:0140090]; metal ion binding [GO:0046872]; phospholipid binding [GO:0005543]; protein domain specific binding [GO:0019904]; protein kinase C binding [GO:0005080]; signaling receptor binding [GO:0005102],PTM: Phosphorylation at Thr-82 appears to inhibit the interaction with AMPA receptors. {ECO:0000269|PubMed:20403402}.; PTM: Palmitoylation on Cys-413 is essential for long-term synaptic depression (LTD). {ECO:0000250}.,"DOMAIN: The AH domain mediates binding to F-actin. {ECO:0000250}.; DOMAIN: The unoccupied PDZ domain is probably involved in allosteric modulation by forming an intramolecular bridge with the AH domain leading to a 'closed' formation. Binding of a PDZ ligand, such as GRIA2, allows enhanced interactions with F-actin and the Arp2/3 complex thus enhanced inhibition of actin polymerization (By similarity). {ECO:0000250}.","DOMAIN 22..105; /note=""PDZ""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00143""; DOMAIN 144..357; /note=""AH""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00294""","STRAND 21..26; /evidence=""ECO:0007829|PDB:2GZV""; STRAND 34..39; /evidence=""ECO:0007829|PDB:2GZV""; STRAND 47..52; /evidence=""ECO:0007829|PDB:2GZV""; STRAND 69..73; /evidence=""ECO:0007829|PDB:2GZV""; STRAND 95..102; /evidence=""ECO:0007829|PDB:2GZV""","HELIX 57..61; /evidence=""ECO:0007829|PDB:2GZV""; HELIX 83..92; /evidence=""ECO:0007829|PDB:2GZV""",,"cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,PICK1 PRKCABP,PRKCA-binding protein (Protein interacting with C kinase 1) (Protein kinase C-alpha-binding protein),Homo sapiens (Human),415.0,46600.0,MFADLDYDIEEDKLGIPTVPGKVTLQKDAQNLIGISIGGGAQYCPCLYIVQVFDNTPAALDGTVAAGDEITGVNGRSIKGKTKVEVAKMIQEVKGEVTIHYNKLQADPKQGMSLDIVLKKVKHRLVENMSSGTADALGLSRAILCNDGLVKRLEELERTAELYKGMTEHTKNLLRAFYELSQTHRAFGDVFSVIGVREPQPAASEAFVKFADAHRSIEKFGIRLLKTIKPMLTDLNTYLNKAIPDTRLTIKKYLDVKFEYLSYCLKVKEMDDEEYSCIALGEPLYRVSTGNYEYRLILRCRQEARARFSQMRKDVLEKMELLDQKHVQDIVFQLQRLVSTMSKYYNDCYAVLRDADVFPIEVDLAHTTLAYGLNQEEFTDGEEEEEEEDTAAGEPSRDTRGAAGPLDKGGSWCDS,False,False,True,Q9NRD5,"[('cd00992', 'PDZ_signaling'), ('cd07659', 'The Bin/Amphiphysin/Rvs (BAR) domain of Protein Interacting with C Kinase 1'), ('G3DSA:1.20.1270.60', 'Arfaptin homology (AH) domain/BAR domain'), ('G3DSA:2.30.42.10', None), ('IPR001478', 'PDZ domain'), ('IPR010504', 'Arfaptin homology (AH) domain'), ('IPR027267', 'AH/BAR domain superfamily'), ('IPR030798', 'Arfaptin family'), ('IPR036034', 'PDZ superfamily'), ('IPR037959', 'PICK1, BAR domain'), ('PF00595', 'PDZ domain'), ('PF06456', 'Arfaptin-like domain'), ('PS50106', 'PDZ domain profile'), ('PS50870', 'Arfaptin homology (AH) domain profile'), ('PTHR12141', 'ARFAPTIN-RELATED'), ('SM00228', 'Domain present in PSD-95, Dlg, and ZO-1/2.'), ('SM01015', 'Arfaptin-like domain'), ('SSF103657', 'BAR/IMD domain-like'), ('SSF50156', 'PDZ domain-like')]",,"""ENSG00000100151; Low tissue specificity."";",,,,,ENST00000356976.8 [Q9NRD5-1];ENST00000404072.7 [Q9NRD5-1];,PICK1,ENSG00000100151,0.0,,,,,,,0.159,0.096,PICK1
Q9NRI5,ENSG00000162946,DISC1_HUMAN,"canonical Wnt signaling pathway [GO:0060070]; cell proliferation in forebrain [GO:0021846]; cilium assembly [GO:0060271]; detection of temperature stimulus involved in sensory perception of pain [GO:0050965]; microtubule cytoskeleton organization [GO:0000226]; mitochondrial calcium ion homeostasis [GO:0051560]; neuron cellular homeostasis [GO:0070050]; neuron migration [GO:0001764]; non-motile cilium assembly [GO:1905515]; positive regulation of axon extension [GO:0045773]; positive regulation of cell-matrix adhesion [GO:0001954]; positive regulation of neuroblast proliferation [GO:0002052]; positive regulation of neuron projection development [GO:0010976]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; positive regulation of Wnt signaling pathway [GO:0030177]; protein localization to centrosome [GO:0071539]; pyramidal neuron migration to cerebral cortex [GO:0021852]; regulation of dendritic spine development [GO:0060998]; regulation of postsynapse organization [GO:0099175]; regulation of synapse maturation [GO:0090128]; regulation of synaptic transmission, glutamatergic [GO:0051966]; response to electrical stimulus [GO:0051602]; TOR signaling [GO:0031929]; ubiquitin-dependent protein catabolic process [GO:0006511]",cell body [GO:0044297]; central region of growth cone [GO:0090724]; centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary base [GO:0097546]; cytosol [GO:0005829]; dynein complex [GO:0030286]; GABA-ergic synapse [GO:0098982]; glutamatergic synapse [GO:0098978]; intermediate filament cytoskeleton [GO:0045111]; kinesin complex [GO:0005871]; microtubule [GO:0005874]; mitochondrion [GO:0005739]; perinuclear region of cytoplasm [GO:0048471]; postsynaptic density [GO:0014069]; presynapse [GO:0098793]; synaptic vesicle [GO:0008021],identical protein binding [GO:0042802]; kinesin binding [GO:0019894]; molecular adaptor activity [GO:0060090]; protein-containing complex binding [GO:0044877],PTM: Ubiquitinated. Ubiquitination with 'Lys-48'-linked polyubiquitin chains leads to its proteasomal degradation. {ECO:0000269|PubMed:28727686}.,,,,,,"cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,DISC1 KIAA0457,Disrupted in schizophrenia 1 protein,Homo sapiens (Human),854.0,93611.0,MPGGGPQGAPAAAGGGGVSHRAGSRDCLPPAACFRRRRLARRPGYMRSSTGPGIGFLSPAVGTLFRFPGGVSGEESHHSESRARQCGLDSRGLLVRSPVSKSAAAPTVTSVRGTSAHFGIQLRGGTRLPDRLSWPCGPGSAGWQQEFAAMDSSETLDASWEAACSDGARRVRAAGSLPSAELSSNSCSPGCGPEVPPTPPGSHSAFTSSFSFIRLSLGSAGERGEAEGCPPSREAESHCQSPQEMGAKAASLDGPHEDPRCLSRPFSLLATRVSADLAQAARNSSRPERDMHSLPDMDPGSSSSLDPSLAGCGGDGSSGSGDAHSWDTLLRKWEPVLRDCLLRNRRQMEVISLRLKLQKLQEDAVENDDYDKAETLQQRLEDLEQEKISLHFQLPSRQPALSSFLGHLAAQVQAALRRGATQQASGDDTHTPLRMEPRLLEPTAQDSLHVSITRRDWLLQEKQQLQKEIEALQARMFVLEAKDQQLRREIEEQEQQLQWQGCDLTPLVGQLSLGQLQEVSKALQDTLASAGQIPFHAEPPETIRSLQERIKSLNLSLKEITTKVCMSEKFCSTLRKKVNDIETQLPALLEAKMHAISGNHFWTAKDLTEEIRSLTSEREGLEGLLSKLLVLSSRNVKKLGSVKEDYNRLRREVEHQETAYETSVKENTMKYMETLKNKLCSCKCPLLGKVWEADLEACRLLIQSLQLQEARGSLSVEDERQMDDLEGAAPPIPPRLHSEDKRKTPLKVLEEWKTHLIPSLHCAGGEQKEESYILSAELGEKCEDIGKKLLYLEDQLHTAIHSHDEDLIQSLRRELQMVKETLQAMILQLQPAKEAGEREAAASCMTAGVHEAQA,False,False,True,Q9NRI5,"[('IPR026081', 'Disrupted in schizophrenia 1'), ('PTHR14332', 'DISRUPTED IN SCHIZOPHRENIA 1 PROTEIN'), ('SSF46579', 'Prefoldin')]",Q9NRI5;,"""ENSG00000162946; Tissue enhanced (retina)."";",,,,,ENST00000317586.8 [Q9NRI5-4];ENST00000366633.7 [Q9NRI5-5];ENST00000366636.8 [Q9NRI5-3];ENST00000366637.8 [Q9NRI5-2];ENST00000439617.8 [Q9NRI5-1];ENST00000535983.5 [Q9NRI5-8];ENST00000539444.5 [Q9NRI5-6];ENST00000602281.5 [Q9NRI5-9];ENST00000602700.5 [Q9NRI5-10];ENST00000602713.5 [Q9NRI5-10];ENST00000602822.5 [Q9NRI5-10];ENST00000602873.5 [Q9NRI5-11];ENST00000628350.2 [Q9NRI5-7];,DISC1,ENSG00000162946,0.0,,,,6.32,DP03931,0.063,0.534,0.185,DISC1
Q9NUX5,ENSG00000128513,POTE1_HUMAN,DNA duplex unwinding [GO:0032508]; establishment of protein localization to telomere [GO:0070200]; negative regulation of telomere maintenance via telomerase [GO:0032211]; positive regulation of DNA helicase activity [GO:1905776]; positive regulation of DNA strand elongation [GO:0060383]; positive regulation of helicase activity [GO:0051096]; positive regulation of telomere maintenance [GO:0032206]; positive regulation of telomere maintenance via telomerase [GO:0032212]; regulation of DNA helicase activity [GO:1905774]; regulation of double-strand break repair via nonhomologous end joining [GO:2001032]; regulation of telomere maintenance via telomerase [GO:0032210]; telomere assembly [GO:0032202]; telomere capping [GO:0016233]; telomere maintenance via telomerase [GO:0007004]; telomeric D-loop disassembly [GO:0061820],"chromosome, telomeric region [GO:0000781]; nuclear telomere cap complex [GO:0000783]; nucleoplasm [GO:0005654]; shelterin complex [GO:0070187]",8-hydroxy-2'-deoxyguanosine DNA binding [GO:1905773]; DEAD/H-box RNA helicase binding [GO:0017151]; G-rich single-stranded DNA binding [GO:1990955]; G-rich strand telomeric DNA binding [GO:0098505]; single-stranded telomeric DNA binding [GO:0043047]; telomerase inhibitor activity [GO:0010521]; telomeric D-loop binding [GO:0061821]; telomeric DNA binding [GO:0042162],,,,"STRAND 19..37; /evidence=""ECO:0007829|PDB:1XJV""; STRAND 39..50; /evidence=""ECO:0007829|PDB:1XJV""; STRAND 56..65; /evidence=""ECO:0007829|PDB:1XJV""; STRAND 78..89; /evidence=""ECO:0007829|PDB:1XJV""; STRAND 92..106; /evidence=""ECO:0007829|PDB:1XJV""; STRAND 161..173; /evidence=""ECO:0007829|PDB:1XJV""; STRAND 175..184; /evidence=""ECO:0007829|PDB:1XJV""; STRAND 217..223; /evidence=""ECO:0007829|PDB:1XJV""; STRAND 238..251; /evidence=""ECO:0007829|PDB:1XJV""; STRAND 257..265; /evidence=""ECO:0007829|PDB:1XJV""; STRAND 274..278; /evidence=""ECO:0007829|PDB:1XJV""; STRAND 334..339; /evidence=""ECO:0007829|PDB:5UN7""; STRAND 359..370; /evidence=""ECO:0007829|PDB:5H65""; STRAND 378..381; /evidence=""ECO:0007829|PDB:5H65""; STRAND 388..390; /evidence=""ECO:0007829|PDB:5H65""; STRAND 417..425; /evidence=""ECO:0007829|PDB:5H65""; STRAND 427..429; /evidence=""ECO:0007829|PDB:5H65""; STRAND 433..439; /evidence=""ECO:0007829|PDB:5H65""; STRAND 452..457; /evidence=""ECO:0007829|PDB:5H65""; STRAND 470..478; /evidence=""ECO:0007829|PDB:5H65""; STRAND 480..486; /evidence=""ECO:0007829|PDB:5H65""; STRAND 492..495; /evidence=""ECO:0007829|PDB:5H65""; STRAND 498..500; /evidence=""ECO:0007829|PDB:5H65""; STRAND 521..523; /evidence=""ECO:0007829|PDB:5H65""; STRAND 539..549; /evidence=""ECO:0007829|PDB:5H65""; STRAND 554..563; /evidence=""ECO:0007829|PDB:5H65""; STRAND 593..595; /evidence=""ECO:0007829|PDB:5H65""; STRAND 603..611; /evidence=""ECO:0007829|PDB:5H65""; STRAND 614..616; /evidence=""ECO:0007829|PDB:7S1T""; STRAND 620..626; /evidence=""ECO:0007829|PDB:5H65""","HELIX 14..16; /evidence=""ECO:0007829|PDB:1XJV""; HELIX 66..68; /evidence=""ECO:0007829|PDB:1XJV""; HELIX 127..143; /evidence=""ECO:0007829|PDB:1XJV""; HELIX 153..155; /evidence=""ECO:0007829|PDB:1XJV""; HELIX 207..213; /evidence=""ECO:0007829|PDB:1XJV""; HELIX 214..216; /evidence=""ECO:0007829|PDB:1XJV""; HELIX 226..232; /evidence=""ECO:0007829|PDB:1XJV""; HELIX 270..272; /evidence=""ECO:0007829|PDB:1XJV""; HELIX 283..297; /evidence=""ECO:0007829|PDB:1XJV""; HELIX 348..352; /evidence=""ECO:0007829|PDB:5H65""; HELIX 374..377; /evidence=""ECO:0007829|PDB:5H65""; HELIX 394..404; /evidence=""ECO:0007829|PDB:5H65""; HELIX 411..413; /evidence=""ECO:0007829|PDB:5H65""; HELIX 448..450; /evidence=""ECO:0007829|PDB:5H65""; HELIX 460..469; /evidence=""ECO:0007829|PDB:5H65""; HELIX 512..517; /evidence=""ECO:0007829|PDB:5H65""; HELIX 526..532; /evidence=""ECO:0007829|PDB:5H65""; HELIX 570..573; /evidence=""ECO:0007829|PDB:5H65""; HELIX 577..590; /evidence=""ECO:0007829|PDB:5H65""; HELIX 597..599; /evidence=""ECO:0007829|PDB:5H65""","TURN 200..202; /evidence=""ECO:0007829|PDB:3KJP""; TURN 383..385; /evidence=""ECO:0007829|PDB:5H65""; TURN 504..506; /evidence=""ECO:0007829|PDB:5H65""; TURN 564..566; /evidence=""ECO:0007829|PDB:5H65""; TURN 630..632; /evidence=""ECO:0007829|PDB:5H65""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,POT1,Protection of telomeres protein 1 (hPot1) (POT1-like telomere end-binding protein),Homo sapiens (Human),634.0,71442.0,MSLVPATNYIYTPLNQLKGGTIVNVYGVVKFFKPPYLSKGTDYCSVVTIVDQTNVKLTCLLFSGNYEALPIIYKNGDIVRFHRLKIQVYKKETQGITSSGFASLTFEGTLGAPIIPRTSSKYFNFTTEDHKMVEALRVWASTHMSPSWTLLKLCDVQPMQYFDLTCQLLGKAEVDGASFLLKVWDGTRTPFPSWRVLIQDLVLEGDLSHIHRLQNLTIDILVYDNHVHVARSLKVGSFLRIYSLHTKLQSMNSENQTMLSLEFHLHGGTSYGRGIRVLPESNSDVDQLKKDLESANLTANQHSDVICQSEPDDSFPSSGSVSLYEVERCQQLSATILTDHQYLERTPLCAILKQKAPQQYRIRAKLRSYKPRRLFQSVKLHCPKCHLLQEVPHEGDLDIIFQDGATKTPDVKLQNTSLYDSKIWTTKNQKGRKVAVHFVKNNGILPLSNECLLLIEGGTLSEICKLSNKFNSVIPVRSGHEDLELLDLSAPFLIQGTIHHYGCKQCSSLRSIQNLNSLVDKTSWIPSSVAEALGIVPLQYVFVMTFTLDDGTGVLEAYLMDSDKFFQIPASEVLMDDDLQKSVDMIMDMFCPPGIKIDAYPWLECFIKSYNVTNGTDNQICYQIFDTTVAEDVI,False,False,True,Q9NUX5,"[('cd04497', 'hPOT1_OB1_like'), ('cd04498', 'hPOT1_OB2'), ('cd20374', 'Protection Of Telomeres Protein 1 (POT1) C-terminal region'), ('G3DSA:2.40.50.140', 'Nucleic acid-binding proteins'), ('IPR011564', 'Telomeric single stranded DNA binding POT1/Cdc13'), ('IPR012340', 'Nucleic acid-binding, OB-fold'), ('IPR028389', 'Protection of telomeres protein 1'), ('IPR032042', 'Protection of telomeres protein 1, ssDNA-binding domain'), ('IPR048953', 'Protection of telomeres protein 1, C-terminal insertion domain'), ('PF02765', 'Telomeric single stranded DNA binding POT1/CDC13'), ('PF16686', 'ssDNA-binding domain of telomere protection protein'), ('PF21375', 'Protection of telomeres protein 1 (POT1), C-terminal insertion domain'), ('PTHR14513', 'PROTECTION OF TELOMERES 1'), ('SM00976', 'Telomeric single stranded DNA binding POT1/CDC13'), ('SSF50249', 'Nucleic acid-binding proteins')]",,"""ENSG00000128513; Low tissue specificity."";",,,,,ENST00000357628.8 [Q9NUX5-1];ENST00000653241.1 [Q9NUX5-1];ENST00000655761.1 [Q9NUX5-1];ENST00000664366.1 [Q9NUX5-1];ENST00000668382.1 [Q9NUX5-1];,POT1,ENSG00000128513,0.0,,,,,,,0.074,,POT1
Q9NYB9,ENSG00000138443,ABI2_HUMAN,actin polymerization or depolymerization [GO:0008154]; cell migration [GO:0016477]; cytoskeleton organization [GO:0007010]; lens fiber cell morphogenesis [GO:0070309]; mitophagy [GO:0000423]; neuron migration [GO:0001764]; peptidyl-tyrosine phosphorylation [GO:0018108]; positive regulation of Arp2/3 complex-mediated actin nucleation [GO:2000601]; positive regulation of lamellipodium assembly [GO:0010592]; Rac protein signal transduction [GO:0016601]; regulation of dendritic spine morphogenesis [GO:0061001]; zonula adherens assembly [GO:0045186],actin-based cell projection [GO:0098858]; adherens junction [GO:0005912]; cytoplasm [GO:0005737]; cytoskeleton [GO:0005856]; cytosol [GO:0005829]; dendritic spine [GO:0043197]; filopodium tip [GO:0032433]; lamellipodium [GO:0030027]; nucleus [GO:0005634]; SCAR complex [GO:0031209],cytoskeletal anchor activity [GO:0008093]; identical protein binding [GO:0042802]; kinase binding [GO:0019900]; proline-rich region binding [GO:0070064]; SH3 domain binding [GO:0017124]; signaling adaptor activity [GO:0035591]; ubiquitin protein ligase binding [GO:0031625],PTM: Phosphorylated by ABL1. {ECO:0000269|PubMed:7590236}.,"DOMAIN: The SH3 domain is critical for binding to ABL1 and ABL2. {ECO:0000269|PubMed:7590236, ECO:0000269|PubMed:8649853}.","DOMAIN 45..107; /note=""t-SNARE coiled-coil homology""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00202""; DOMAIN 451..510; /note=""SH3""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00192""","STRAND 123..125; /evidence=""ECO:0007829|PDB:3P8C""; STRAND 453..458; /evidence=""ECO:0007829|PDB:2ED0""; STRAND 477..483; /evidence=""ECO:0007829|PDB:2ED0""; STRAND 485..493; /evidence=""ECO:0007829|PDB:2ED0""; STRAND 496..501; /evidence=""ECO:0007829|PDB:2ED0""; STRAND 504..507; /evidence=""ECO:0007829|PDB:2ED0""","HELIX 1..9; /evidence=""ECO:0007829|PDB:3P8C""; HELIX 11..39; /evidence=""ECO:0007829|PDB:3P8C""; HELIX 43..110; /evidence=""ECO:0007829|PDB:3P8C""","TURN 143..151; /evidence=""ECO:0007829|PDB:3P8C""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,ABI2 ARGBPIA,Abl interactor 2 (Abelson interactor 2) (Abi-2) (Abl-binding protein 3) (AblBP3) (Arg-binding protein 1) (ArgBP1),Homo sapiens (Human),513.0,55663.0,MAELQMLLEEEIPGGRRALFDSYTNLERVADYCENNYIQSADKQRALEETKAYTTQSLASVAYLINTLANNVLQMLDIQASQLRRMESSINHISQTVDIHKEKVARREIGILTTNKNTSRTHKIIAPANLERPVRYIRKPIDYTILDDIGHGVKWLLRFKVSTQNMKMGGLPRTTPPTQKPPSPPMSGKGTLGRHSPYRTLEPVRPPVVPNDYVPSPTRNMAPSQQSPVRTASVNQRNRTYSSSGSSGGSHPSSRSSSRENSGSGSVGVPIAVPTPSPPSVFPAPAGSAGTPPLPATSASAPAPLVPATVPSSTAPNAAAGGAPNLADGFTSPTPPVVSSTPPTGHPVQFYSMNRPASRHTPPTIGGSLPYRRPPSITSQTSLQNQMNGGPFYSQNPVSDTPPPPPPVEEPVFDESPPPPPPPEDYEEEEAAVVEYSDPYAEEDPPWAPRSYLEKVVAIYDYTKDKEDELSFQEGAIIYVIKKNDDGWYEGVMNGVTGLFPGNYVESIMHYSE,False,False,True,Q9NYB9,"[('cd11972', 'Src homology 3 domain of Abl Interactor 2'), ('G3DSA:2.30.30.40', 'SH3 Domains'), ('G3DSA:6.10.140.1620', None), ('IPR000727', 'Target SNARE coiled-coil homology domain'), ('IPR001452', 'SH3 domain'), ('IPR012849', 'Abl-interactor, homeo-domain homologous domain'), ('IPR028457', 'ABI family'), ('IPR035726', 'Abl interactor 2, SH3 domain'), ('IPR036028', 'SH3-like domain superfamily'), ('PF00018', 'SH3 domain'), ('PF07815', 'Abl-interactor HHR'), ('PR00452', 'SH3DOMAIN'), ('PR01217', 'PRICHEXTENSN'), ('PS50002', 'Src homology 3 (SH3) domain profile'), ('PS50192', 't-SNARE coiled-coil homology domain profile'), ('PTHR10460', 'ABL INTERACTOR FAMILY MEMBER'), ('SM00326', 'Src homology 3 domains'), ('SSF50044', 'SH3-domain')]",,"""ENSG00000138443; Low tissue specificity."";",,,,,ENST00000261017.9 [Q9NYB9-2];,ABI2,ENSG00000138443,0.0,,,,69.79,DP02386,0.698,0.665,0.517,ABI2
Q9P2J5,ENSG00000133706,SYLC_HUMAN,cellular response to amino acid starvation [GO:0034198]; cellular response to amino acid stimulus [GO:0071230]; cellular response to L-leucine [GO:0071233]; cellular response to leucine starvation [GO:1990253]; glutaminyl-tRNA aminoacylation [GO:0006425]; leucyl-tRNA aminoacylation [GO:0006429]; positive regulation of GTPase activity [GO:0043547]; positive regulation of TOR signaling [GO:0032008]; positive regulation of TORC1 signaling [GO:1904263]; regulation of cell size [GO:0008361]; tRNA aminoacylation for protein translation [GO:0006418],aminoacyl-tRNA synthetase multienzyme complex [GO:0017101]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; endomembrane system [GO:0012505]; endoplasmic reticulum [GO:0005783]; lysosome [GO:0005764]; nuclear body [GO:0016604],aminoacyl-tRNA editing activity [GO:0002161]; ATP binding [GO:0005524]; glutamine-tRNA ligase activity [GO:0004819]; GTPase activator activity [GO:0005096]; leucine-tRNA ligase activity [GO:0004823],,"DOMAIN: The structure of cytoplasmic leucine-tRNA ligase includes four main functional domains: the Rossmann-fold aminoacylation domain, the editing domain known as connective peptide 1 (CP1), the anticodon binding domain for tRNA recognition, and the vertebrate C-terminal (VC) domain for tRNA binding. {ECO:0000269|PubMed:32232361}.",,"STRAND 45..49; /evidence=""ECO:0007829|PDB:6LPF""; STRAND 56..58; /evidence=""ECO:0007829|PDB:6KID""; STRAND 83..85; /evidence=""ECO:0007829|PDB:6LPF""; STRAND 89..91; /evidence=""ECO:0007829|PDB:6KIE""; STRAND 93..95; /evidence=""ECO:0007829|PDB:6KIE""; STRAND 231..241; /evidence=""ECO:0007829|PDB:6LPF""; STRAND 253..255; /evidence=""ECO:0007829|PDB:6LPF""; STRAND 261..271; /evidence=""ECO:0007829|PDB:6LPF""; STRAND 287..294; /evidence=""ECO:0007829|PDB:6LPF""; STRAND 304..307; /evidence=""ECO:0007829|PDB:6LPF""; STRAND 311..317; /evidence=""ECO:0007829|PDB:6LPF""; STRAND 319..321; /evidence=""ECO:0007829|PDB:6KID""; STRAND 323..326; /evidence=""ECO:0007829|PDB:6LPF""; STRAND 340..342; /evidence=""ECO:0007829|PDB:6LPF""; STRAND 348..353; /evidence=""ECO:0007829|PDB:6LPF""; STRAND 361..363; /evidence=""ECO:0007829|PDB:6LPF""; STRAND 368..370; /evidence=""ECO:0007829|PDB:2WFD""; STRAND 372..376; /evidence=""ECO:0007829|PDB:6LPF""; STRAND 382..384; /evidence=""ECO:0007829|PDB:6LPF""; STRAND 387..391; /evidence=""ECO:0007829|PDB:6LPF""; STRAND 432..434; /evidence=""ECO:0007829|PDB:6LPF""; STRAND 438..440; /evidence=""ECO:0007829|PDB:6LPF""; STRAND 467..469; /evidence=""ECO:0007829|PDB:6KQY""; STRAND 479..482; /evidence=""ECO:0007829|PDB:6KIE""; STRAND 503..512; /evidence=""ECO:0007829|PDB:6LPF""; STRAND 516..519; /evidence=""ECO:0007829|PDB:6KQY""; STRAND 523..533; /evidence=""ECO:0007829|PDB:6LPF""; STRAND 550..554; /evidence=""ECO:0007829|PDB:6LPF""; STRAND 570..572; /evidence=""ECO:0007829|PDB:6LPF""; STRAND 574..580; /evidence=""ECO:0007829|PDB:6LPF""; STRAND 596..599; /evidence=""ECO:0007829|PDB:6LPF""; STRAND 640..643; /evidence=""ECO:0007829|PDB:6KQY""; STRAND 670..674; /evidence=""ECO:0007829|PDB:6LPF""; STRAND 693..695; /evidence=""ECO:0007829|PDB:6KID""; STRAND 703..707; /evidence=""ECO:0007829|PDB:6LPF""; STRAND 710..712; /evidence=""ECO:0007829|PDB:6LPF""; STRAND 748..751; /evidence=""ECO:0007829|PDB:6LPF""; STRAND 753..755; /evidence=""ECO:0007829|PDB:6LPF""; STRAND 935..939; /evidence=""ECO:0007829|PDB:6LPF""; STRAND 962..964; /evidence=""ECO:0007829|PDB:6KQY""; STRAND 1009..1011; /evidence=""ECO:0007829|PDB:6KIE""; STRAND 1034..1039; /evidence=""ECO:0007829|PDB:6LPF""; STRAND 1041..1044; /evidence=""ECO:0007829|PDB:6LPF""; STRAND 1058..1060; /evidence=""ECO:0007829|PDB:6LPF""","HELIX 8..27; /evidence=""ECO:0007829|PDB:6LPF""; HELIX 34..37; /evidence=""ECO:0007829|PDB:6LPF""; HELIX 61..79; /evidence=""ECO:0007829|PDB:6LPF""; HELIX 96..110; /evidence=""ECO:0007829|PDB:6LPF""; HELIX 157..163; /evidence=""ECO:0007829|PDB:6LPF""; HELIX 168..171; /evidence=""ECO:0007829|PDB:6LPF""; HELIX 172..175; /evidence=""ECO:0007829|PDB:6LPF""; HELIX 177..195; /evidence=""ECO:0007829|PDB:6LPF""; HELIX 201..203; /evidence=""ECO:0007829|PDB:6LPF""; HELIX 212..227; /evidence=""ECO:0007829|PDB:6LPF""; HELIX 250..252; /evidence=""ECO:0007829|PDB:6KID""; HELIX 277..282; /evidence=""ECO:0007829|PDB:6LPF""; HELIX 296..301; /evidence=""ECO:0007829|PDB:6LPF""; HELIX 328..336; /evidence=""ECO:0007829|PDB:6LPF""; HELIX 354..357; /evidence=""ECO:0007829|PDB:6LPF""; HELIX 397..408; /evidence=""ECO:0007829|PDB:6LPF""; HELIX 410..415; /evidence=""ECO:0007829|PDB:6LPF""; HELIX 420..422; /evidence=""ECO:0007829|PDB:6LPF""; HELIX 441..448; /evidence=""ECO:0007829|PDB:6LPF""; HELIX 457..466; /evidence=""ECO:0007829|PDB:6LPF""; HELIX 487..489; /evidence=""ECO:0007829|PDB:6LPF""; HELIX 491..500; /evidence=""ECO:0007829|PDB:6LPF""; HELIX 537..549; /evidence=""ECO:0007829|PDB:6LPF""; HELIX 555..567; /evidence=""ECO:0007829|PDB:6LPF""; HELIX 601..610; /evidence=""ECO:0007829|PDB:6LPF""; HELIX 627..629; /evidence=""ECO:0007829|PDB:6KID""; HELIX 632..639; /evidence=""ECO:0007829|PDB:6LPF""; HELIX 652..665; /evidence=""ECO:0007829|PDB:6LPF""; HELIX 675..677; /evidence=""ECO:0007829|PDB:6LPF""; HELIX 681..692; /evidence=""ECO:0007829|PDB:6LPF""; HELIX 697..699; /evidence=""ECO:0007829|PDB:6LPF""; HELIX 719..721; /evidence=""ECO:0007829|PDB:6LPF""; HELIX 727..744; /evidence=""ECO:0007829|PDB:6LPF""; HELIX 757..779; /evidence=""ECO:0007829|PDB:6LPF""; HELIX 781..783; /evidence=""ECO:0007829|PDB:6LR6""; HELIX 792..813; /evidence=""ECO:0007829|PDB:6LPF""; HELIX 817..824; /evidence=""ECO:0007829|PDB:6LPF""; HELIX 826..838; /evidence=""ECO:0007829|PDB:6LPF""; HELIX 845..859; /evidence=""ECO:0007829|PDB:6LPF""; HELIX 864..873; /evidence=""ECO:0007829|PDB:6LPF""; HELIX 880..882; /evidence=""ECO:0007829|PDB:6LPF""; HELIX 893..912; /evidence=""ECO:0007829|PDB:6LPF""; HELIX 946..961; /evidence=""ECO:0007829|PDB:6LPF""; HELIX 969..977; /evidence=""ECO:0007829|PDB:6LPF""; HELIX 980..985; /evidence=""ECO:0007829|PDB:6LPF""; HELIX 986..1003; /evidence=""ECO:0007829|PDB:6LPF""; HELIX 1004..1008; /evidence=""ECO:0007829|PDB:6LPF""; HELIX 1016..1021; /evidence=""ECO:0007829|PDB:6LPF""; HELIX 1024..1031; /evidence=""ECO:0007829|PDB:6LPF""; HELIX 1046..1051; /evidence=""ECO:0007829|PDB:6LPF""","TURN 28..30; /evidence=""ECO:0007829|PDB:6LPF""; TURN 112..115; /evidence=""ECO:0007829|PDB:6KID""; TURN 242..245; /evidence=""ECO:0007829|PDB:6LPF""; TURN 393..395; /evidence=""ECO:0007829|PDB:6LPF""; TURN 423..425; /evidence=""ECO:0007829|PDB:6LPF""; TURN 435..437; /evidence=""ECO:0007829|PDB:6LPF""; TURN 470..472; /evidence=""ECO:0007829|PDB:6LPF""; TURN 593..595; /evidence=""ECO:0007829|PDB:6LPF""; TURN 611..613; /evidence=""ECO:0007829|PDB:6LPF""; TURN 678..680; /evidence=""ECO:0007829|PDB:6LPF""; TURN 860..862; /evidence=""ECO:0007829|PDB:6LPF""; TURN 913..915; /evidence=""ECO:0007829|PDB:6KQY""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,LARS1 KIAA1352 LARS,"Leucine--tRNA ligase, cytoplasmic (EC 6.1.1.4) (Leucyl-tRNA synthetase) (LeuRS) (cLRS)",Homo sapiens (Human),1176.0,134466.0,MAERKGTAKVDFLKKIEKEIQQKWDTERVFEVNASNLEKQTSKGKYFVTFPYPYMNGRLHLGHTFSLSKCEFAVGYQRLKGKCCLFPFGLHCTGMPIKACADKLKREIELYGCPPDFPDEEEEEEETSVKTEDIIIKDKAKGKKSKAAAKAGSSKYQWGIMKSLGLSDEEIVKFSEAEHWLDYFPPLAIQDLKRMGLKVDWRRSFITTDVNPYYDSFVRWQFLTLRERNKIKFGKRYTIYSPKDGQPCMDHDRQTGEGVGPQEYTLLKLKVLEPYPSKLSGLKGKNIFLVAATLRPETMFGQTNCWVRPDMKYIGFETVNGDIFICTQKAARNMSYQGFTKDNGVVPVVKELMGEEILGASLSAPLTSYKVIYVLPMLTIKEDKGTGVVTSVPSDSPDDIAALRDLKKKQALRAKYGIRDDMVLPFEPVPVIEIPGFGNLSAVTICDELKIQSQNDREKLAEAKEKIYLKGFYEGIMLVDGFKGQKVQDVKKTIQKKMIDAGDALIYMEPEKQVMSRSSDECVVALCDQWYLDYGEENWKKQTSQCLKNLETFCEETRRNFEATLGWLQEHACSRTYGLGTHLPWDEQWLIESLSDSTIYMAFYTVAHLLQGGNLHGQAESPLGIRPQQMTKEVWDYVFFKEAPFPKTQIAKEKLDQLKQEFEFWYPVDLRVSGKDLVPNHLSYYLYNHVAMWPEQSDKWPTAVRANGHLLLNSEKMSKSTGNFLTLTQAIDKFSADGMRLALADAGDTVEDANFVEAMADAGILRLYTWVEWVKEMVANWDSLRSGPASTFNDRVFASELNAGIIKTDQNYEKMMFKEALKTGFFEFQAAKDKYRELAVEGMHRELVFRFIEVQTLLLAPFCPHLCEHIWTLLGKPDSIMNASWPVAGPVNEVLIHSSQYLMEVTHDLRLRLKNYMMPAKGKKTDKQPLQKPSHCTIYVAKNYPPWQHTTLSVLRKHFEANNGKLPDNKVIASELGSMPELKKYMKKVMPFVAMIKENLEKMGPRILDLQLEFDEKAVLMENIVYLTNSLELEHIEVKFASEAEDKIREDCCPGKPLNVFRIEPGVSVSLVNPQPSNGHFSTKIEIRQGDNCDSIIRRLMKMNRGIKDLSKVKLMRFDDPLLGPRRVPVLGKEYTEKTPISEHAVFNVDLMSKKIHLTENGIRVDIGDTIIYLVH,True,True,False,Q9P2J5,"[('cd07959', 'Anticodon-binding domain of archaeal and eukaryotic cytoplasmic leucyl tRNA synthetases'), ('G3DSA:1.10.730.10', 'Isoleucyl-tRNA Synthetase; Domain 1'), ('G3DSA:3.40.50.620', 'HUPs'), ('G3DSA:3.90.740.10', 'Valyl/Leucyl/Isoleucyl-tRNA synthetase, editing domain'), ('IPR001412', 'Aminoacyl-tRNA synthetase, class I, conserved site'), ('IPR002300', 'Aminoacyl-tRNA synthetase, class Ia'), ('IPR004493', 'Leucyl-tRNA synthetase, class Ia, archaeal/eukaryotic cytosolic'), ('IPR009008', 'Valyl/Leucyl/Isoleucyl-tRNA synthetase, editing domain'), ('IPR009080', 'Aminoacyl-tRNA synthetase, class Ia, anticodon-binding'), ('IPR013155', 'Methionyl/Valyl/Leucyl/Isoleucyl-tRNA synthetase, anticodon-binding'), ('IPR014729', 'Rossmann-like alpha/beta/alpha sandwich fold'), ('IPR054509', 'Leucine--tRNA ligase, ubiquitin-like domain'), ('IPR055416', 'Leucine--tRNA ligase, RagD-binding domain'), ('PF00133', 'tRNA synthetases class I (I, L, M and V)'), ('PF08264', 'Anticodon-binding domain of tRNA ligase'), ('PF22947', 'Leucine--tRNA ligase, ubiquitin-like domain'), ('PF24810', 'Leucine--tRNA ligase, RagD-binding domain'), ('PS00178', 'Aminoacyl-transfer RNA synthetases class-I signature'), ('PTHR45794', 'LEUCYL-TRNA SYNTHETASE'), ('SSF47323', 'Anticodon-binding domain of a subclass of class I aminoacyl-tRNA synthetases')]",,"""ENSG00000133706; Low tissue specificity."";","CATALYTIC ACTIVITY: Reaction=tRNA(Leu) + L-leucine + ATP = L-leucyl-tRNA(Leu) + AMP + diphosphate; Xref=Rhea:RHEA:11688, Rhea:RHEA-COMP:9613, Rhea:RHEA-COMP:9622, ChEBI:CHEBI:30616, ChEBI:CHEBI:33019, ChEBI:CHEBI:57427, ChEBI:CHEBI:78442, ChEBI:CHEBI:78494, ChEBI:CHEBI:456215; EC=6.1.1.4; Evidence={ECO:0000269|PubMed:25051973}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:11689; Evidence={ECO:0000305}; CATALYTIC ACTIVITY: Reaction=L-methionyl-tRNA(Leu) + H2O = tRNA(Leu) + L-methionine + H(+); Xref=Rhea:RHEA:77535, Rhea:RHEA-COMP:9613, Rhea:RHEA-COMP:18931, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:57844, ChEBI:CHEBI:78442, ChEBI:CHEBI:78530; Evidence={ECO:0000269|PubMed:25051973}; PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:77536; Evidence={ECO:0000269|PubMed:25051973};",6.1.1.4,"ACTIVITY REGULATION: 5-fluoro-1,3-dihydro-1-hydroxy-1,2-benzoxaborole inhibits LARS1 by forming a covalent adduct with the 3' adenosine of tRNA(Leu) at the editing site, thus locking the enzyme in an inactive conformation.",,ENST00000394434.7 [Q9P2J5-1];ENST00000510191.5 [Q9P2J5-2];ENST00000674174.1 [Q9P2J5-2];,LARS1,ENSG00000133706,0.0,LARS1,Canonical_RBPs,9.0,,,,0.038,,LARS1
Q9P2N6,ENSG00000114982,KANL3_HUMAN,chromatin organization [GO:0006325]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; regulation of mitochondrial transcription [GO:1903108],histone acetyltransferase complex [GO:0000123]; intracellular membrane-bounded organelle [GO:0043231]; mitochondrion [GO:0005739]; NSL complex [GO:0044545]; nucleoplasm [GO:0005654],,,,,,,,"cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,KANSL3 KIAA1310 NSL3 PRTD SI1,KAT8 regulatory NSL complex subunit 3 (NSL complex protein NSL3) (Non-specific lethal 3 homolog) (Serum inhibited-related protein) (Testis development protein PRTD),Homo sapiens (Human),904.0,95992.0,MAHRGGERDFQTSARRMGTSLLFQLSVHERELDLVFLDHSYAKPWSAHPDASSARPTRMLFVTPRRQHESTIESDVPIDVETVTSTPMPLYDNQKARSVMNECERHVIFARTDADAPPPPEDWEEHVNRTGWTMAQNKLFNKILKALQSDRLARLANEGACNEPVLRRVAVDKCARRVRQALASVSWDTKLIQWLHTTLVETLSLPMLAAYLDALQTLKGKIPTLIDRMLVSSNTKTGAAGAEALSLLLKRPWDPAVGVLSHNKPSKLPGSPLILIASSGPSSSVFPTSRRHRFWQSQLSCLGKVIPVATHLLNNGSGVGVLQCLEHMIGAVRSKVLEIHSHFPHKPIILIGWNTGALVACHVSVMEYVTAVVCLGFPLLTVDGPRGDVDDPLLDMKTPVLFVIGQNSLQCHPEAMEDFREKIRAENSLVVVGGADDNLRISKAKKKSEGLTQSMVDRCIQDEIVDFLTGVLTRAEGHMGSEPRDQDAEKKKKPRDVARRDLAFEVPERGSRPASPAAKLPASPSGSEDLSSVSSSPTSSPKTKVTTVTSAQKSSQIGSSQLLKRHVQRTEAVLTHKQAQAQFAAFLKQNMLVRKALPPGTSSCLFVPISSEPPEEGEKEDLRVQLKRHHPSSPLPGSKTSKRPKIKVSLISQGDTAGGPCAPSQGSAPEAAGGKPITMTLGQASAGAKELTGLLTTAKSSSSEGGVSASPVPSVVSSSTAPSALHTLQSRLVATSPGSSLPGATSASSLLQGLSFSLQDISSKTSGLPANPSPGPAPQATSVKLPTPMQSLGAITTGTSTIVRTIPVATTLSSLGATPGGKPTAIHQLLTNGGLAKLASSLPGLAQISNQASGLKVPTTITLTLRGQPSRITTLSPMGSGAAPSEESSSQVLPSSSQRLPPAP,False,True,False,Q9P2N6,"[('G3DSA:3.40.50.1820', 'alpha/beta hydrolase'), ('IPR026555', 'KAT8 regulatory NSL complex subunit 3/Testis-expressed sequence 30 protein'), ('IPR029058', 'Alpha/Beta hydrolase fold'), ('IPR046879', 'KANL3/Tex30, alpha/beta hydrolase-like domain'), ('PF20408', 'Alpha/beta hydrolase domain'), ('PF23154', 'KANSL3, helical domain'), ('PTHR13136', 'TESTIS DEVELOPMENT PROTEIN PRTD'), ('SSF53474', 'alpha/beta-Hydrolases')]",,"""ENSG00000114982; Low tissue specificity."";",,,,,ENST00000420155.5 [Q9P2N6-2];ENST00000431828.6 [Q9P2N6-3];ENST00000666923.1 [Q9P2N6-1];,KANSL3,ENSG00000114982,0.0,,,,,,,0.493,0.264,KANSL3
Q9UBC2,ENSG00000127527,EP15R_HUMAN,endocytosis [GO:0006897]; endosomal transport [GO:0016197],clathrin coat of coated pit [GO:0030132]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886],cadherin binding [GO:0045296]; calcium ion binding [GO:0005509],PTM: Phosphorylated on tyrosine residues by EGFR. {ECO:0000250}.,,"DOMAIN 15..104; /note=""EH 1""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00077""; DOMAIN 48..83; /note=""EF-hand 1""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00448""; DOMAIN 127..215; /note=""EH 2""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00077""; DOMAIN 159..194; /note=""EF-hand 2""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00448""; DOMAIN 274..309; /note=""EF-hand 3""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00448""; DOMAIN 275..365; /note=""EH 3""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00077""; DOMAIN 310..343; /note=""EF-hand 4""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00448""",,,,"cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,EPS15L1 EPS15R,Epidermal growth factor receptor substrate 15-like 1 (Eps15-related protein) (Eps15R),Homo sapiens (Human),864.0,94255.0,MAAPLIPLSQQIPTGNSLYESYYKQVDPAYTGRVGASEAALFLKKSGLSDIILGKIWDLADPEGKGFLDKQGFYVALRLVACAQSGHEVTLSNLNLSMPPPKFHDTSSPLMVTPPSAEAHWAVRVEEKAKFDGIFESLLPINGLLSGDKVKPVLMNSKLPLDVLGRVWDLSDIDKDGHLDRDEFAVAMHLVYRALEKEPVPSALPPSLIPPSKRKKTVFPGAVPVLPASPPPKDSLRSTPSHGSVSSLNSTGSLSPKHSLKQTQPTVNWVVPVADKMRFDEIFLKTDLDLDGYVSGQEVKEIFMHSGLTQNLLAHIWALADTRQTGKLSKDQFALAMYFIQQKVSKGIDPPQVLSPDMVPPSERGTPGPDSSGSLGSGEFTGVKELDDISQEIAQLQREKYSLEQDIREKEEAIRQKTSEVQELQNDLDRETSSLQELEAQKQDAQDRLDEMDQQKAKLRDMLSDVRQKCQDETQMISSLKTQIQSQESDLKSQEDDLNRAKSELNRLQQEETQLEQSIQAGRVQLETIIKSLKSTQDEINQARSKLSQLHESRQEAHRSLEQYDQVLDGAHGASLTDLANLSEGVSLAERGSFGAMDDPFKNKALLFSNNTQELHPDPFQTEDPFKSDPFKGADPFKGDPFQNDPFAEQQTTSTDPFGGDPFKESDPFRGSATDDFFKKQTKNDPFTSDPFTKNPSLPSKLDPFESSDPFSSSSVSSKGSDPFGTLDPFGSGSFNSAEGFADFSQMSKPPPSGPFTSSLGGAGFSDDPFKSKQDTPALPPKKPAPPRPKPPSGKSTPVSQLGSADFPEAPDPFQPLGADSGDPFQSKKGFGDPFSGKDPFVPSSAAKPSKASASGFADFTSVS,False,False,True,Q9UBC2,"[('cd00052', 'EH'), ('cd00176', 'SPEC'), ('G3DSA:1.10.238.10', 'EF-hand'), ('G3DSA:1.10.287.1490', None), ('IPR000261', 'EH domain'), ('IPR002048', 'EF-hand domain'), ('IPR011992', 'EF-hand domain pair'), ('IPR018159', 'Spectrin/alpha-actinin'), ('IPR018247', 'EF-Hand 1, calcium-binding site'), ('PF12763', 'Cytoskeletal-regulatory complex EF hand'), ('PS00018', 'EF-hand calcium-binding domain'), ('PS50031', 'EH domain profile'), ('PS50222', 'EF-hand calcium-binding domain profile'), ('PTHR11216', 'PAN1/END3 actin cytoskeleton-regulatory complex'), ('SM00027', 'Eps15 homology domain'), ('SM00054', 'EF-hand, calcium binding motif'), ('SSF47473', 'EF-hand'), ('SSF90257', 'Myosin rod fragments')]",Q9UBC2;,"""ENSG00000127527; Low tissue specificity."";",,,,,ENST00000248070.10 [Q9UBC2-1];ENST00000455140.7 [Q9UBC2-2];ENST00000535753.6 [Q9UBC2-3];ENST00000597937.5 [Q9UBC2-4];ENST00000602022.5 [Q9UBC2-3];,EPS15L1,ENSG00000127527,0.0,,,,,,,0.509,0.376,EPS15L1
Q9UH91,,Q9UH91_HUMAN,,,,,,,,,,"cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",unreviewed,,Xanthine oxidoreductase,Homo sapiens (Human),14.0,1626.0,MTADKLVFFVNGRK,True,False,False,,,,,,,,,,,,,,,,,,,,,
Q9UHD9,ENSG00000188021,UBQL2_HUMAN,autophagosome assembly [GO:0000045]; ERAD pathway [GO:0036503]; negative regulation of clathrin-dependent endocytosis [GO:1900186]; negative regulation of G protein-coupled receptor internalization [GO:1904021]; positive regulation of ERAD pathway [GO:1904294]; regulation of autophagosome assembly [GO:2000785]; regulation of macroautophagy [GO:0016241]; ubiquitin-dependent protein catabolic process [GO:0006511],autophagosome [GO:0005776]; cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; nucleus [GO:0005634]; plasma membrane [GO:0005886],identical protein binding [GO:0042802]; molecular condensate scaffold activity [GO:0140693]; polyubiquitin modification-dependent protein binding [GO:0031593],PTM: Degraded during macroautophagy. {ECO:0000269|PubMed:20529957}.,"DOMAIN: The ubiquitin-like domain is essential for its inhibitory effect on GPCR endocytosis. Mediates its association with the subunits of the proteasome. {ECO:0000269|PubMed:18199683, ECO:0000303|PubMed:24589709}.; DOMAIN: The UBA domain is essential for its association with microtubule-associated protein 1 light chain 3 (MAP1LC3). Mediates its association with ubiquitinated substrates. {ECO:0000269|PubMed:19148225, ECO:0000303|PubMed:24589709}.; DOMAIN: Dimerization is dependent upon the central region of the protein containing the STI1 domains and is independent of its ubiquitin-like and UBA domains. {ECO:0000269|PubMed:16813565}.","DOMAIN 33..107; /note=""Ubiquitin-like""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00214""; DOMAIN 178..206; /note=""STI1 1""; /evidence=""ECO:0000255""; DOMAIN 208..247; /note=""STI1 2""; /evidence=""ECO:0000255""; DOMAIN 379..426; /note=""STI1 3""; /evidence=""ECO:0000255""; DOMAIN 430..462; /note=""STI1 4""; /evidence=""ECO:0000255""; DOMAIN 581..621; /note=""UBA""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00212""","STRAND 23..25; /evidence=""ECO:0007829|PDB:1J8C""; STRAND 33..38; /evidence=""ECO:0007829|PDB:1J8C""; STRAND 43..48; /evidence=""ECO:0007829|PDB:1J8C""; STRAND 69..76; /evidence=""ECO:0007829|PDB:1J8C""; STRAND 79..82; /evidence=""ECO:0007829|PDB:1J8C""; STRAND 93..102; /evidence=""ECO:0007829|PDB:1J8C""","HELIX 54..65; /evidence=""ECO:0007829|PDB:1J8C""; HELIX 87..91; /evidence=""ECO:0007829|PDB:1J8C""; HELIX 579..591; /evidence=""ECO:0007829|PDB:7F7X""; HELIX 597..605; /evidence=""ECO:0007829|PDB:7F7X""; HELIX 612..618; /evidence=""ECO:0007829|PDB:7F7X""","TURN 606..608; /evidence=""ECO:0007829|PDB:7F7X""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,UBQLN2 N4BP4 PLIC2 HRIHFB2157,Ubiquilin-2 (Chap1) (DSK2 homolog) (Protein linking IAP with cytoskeleton 2) (PLIC-2) (hPLIC-2) (Ubiquitin-like product Chap1/Dsk2),Homo sapiens (Human),624.0,65696.0,MAENGESSGPPRPSRGPAAAQGSAAAPAEPKIIKVTVKTPKEKEEFAVPENSSVQQFKEAISKRFKSQTDQLVLIFAGKILKDQDTLIQHGIHDGLTVHLVIKSQNRPQGQSTQPSNAAGTNTTSASTPRSNSTPISTNSNPFGLGSLGGLAGLSSLGLSSTNFSELQSQMQQQLMASPEMMIQIMENPFVQSMLSNPDLMRQLIMANPQMQQLIQRNPEISHLLNNPDIMRQTLEIARNPAMMQEMMRNQDLALSNLESIPGGYNALRRMYTDIQEPMLNAAQEQFGGNPFASVGSSSSSGEGTQPSRTENRDPLPNPWAPPPATQSSATTSTTTSTGSGSGNSSSNATGNTVAAANYVASIFSTPGMQSLLQQITENPQLIQNMLSAPYMRSMMQSLSQNPDLAAQMMLNSPLFTANPQLQEQMRPQLPAFLQQMQNPDTLSAMSNPRAMQALMQIQQGLQTLATEAPGLIPSFTPGVGVGVLGTAIGPVGPVTPIGPIGPIVPFTPIGPIGPIGPTGPAAPPGSTGSGGPTGPTVSSAAPSETTSPTSESGPNQQFIQQMVQALAGANAPQLPNPEVRFQQQLEQLNAMGFLNREANLQALIATGGDINAAIERLLGSQPS,False,False,True,Q9UHD9,"[('cd01808', 'ubiquitin-like (Ubl) domain found in eukaryotic protein linking integrin-associated protein (IAP, also known as CD47) with cytoskeleton (PLIC) proteins'), ('cd14399', 'UBA domain of eukaryotic protein linking integrin-associated protein (IAP, also known as CD47) with cytoskeleton (PLIC) proteins'), ('G3DSA:1.10.260.100', None), ('G3DSA:1.10.8.10', 'DNA helicase RuvA subunit, C-terminal domain'), ('G3DSA:3.10.20.90', 'Phosphatidylinositol 3-kinase Catalytic Subunit; Chain A, domain 1'), ('IPR000626', 'Ubiquitin-like domain'), ('IPR006636', 'Heat shock chaperonin-binding'), ('IPR009060', 'UBA-like superfamily'), ('IPR015496', 'Ubiquilin'), ('IPR015940', 'Ubiquitin-associated domain'), ('IPR016024', 'Armadillo-type fold'), ('IPR029071', 'Ubiquitin-like domain superfamily'), ('PF00240', 'Ubiquitin family'), ('PF00627', 'UBA/TS-N domain'), ('PF23195', 'Ubiquilin-1-like domain'), ('PS50030', 'Ubiquitin-associated domain (UBA) profile'), ('PS50053', 'Ubiquitin domain profile'), ('PTHR10677', 'UBIQUILIN'), ('SM00165', 'Ubiquitin associated domain'), ('SM00213', 'Ubiquitin homologues')]",,"""ENSG00000188021; Low tissue specificity."";",,,,,ENST00000338222.7;,UBQLN2,ENSG00000188021,0.0,,,,20.35,DP01110,0.204,0.534,0.282,UBQLN2
Q9UIU0,,Q9UIU0_HUMAN,,monoatomic ion channel complex [GO:0034702],calcium channel activity [GO:0005262],,,"DOMAIN 253..430; /note=""VWFA""; /evidence=""ECO:0000259|PROSITE:PS50234""",,,,"cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",unreviewed,CACNA2D1,Dihydropyridine receptor alpha 2 subunit,Homo sapiens (Human),1110.0,125308.0,MAAGCLLALTLTLFQSLLIGPSSEEPFPSAVTIKSWVDKMQEDLVTLAKTASGVNQLVDIYEKYQDLYTVEPNNARQLVEIAARDIEKLLSNRSKALVRLALEAEKVQAAHQWREDFASNEVVYYNAKDDLDPEKNDSEPGSQRIKPVFIEDANFGRQISYQHAAVHIPTDIYEGSTIVLNELNWTSALDEVFKKNREEDPSLLWQVFGSATGLARYYPASPWVDNSRTPNKIDLYDVRRRPWYIQGAASPKDMLILVDVSGSVSGLTLKLIRTSVSEMLETLSDDDFVNVASFNSNAQDVSCFQHLVQANVRNKKVLKDAVNNITAKGITDYKKGFSFAFEQLLNYNVSRANCNKIIMLFTDGGEERAQEIFNKYNKDKKVRVFTFSVGQHNYDRGPIQWMACENKGYYYEIPSIGAIRINTQEYLDVLGRPMVLAGDKAKQVQWTNVYLDALELGLVITGTLPVFNITGQFENKTNLKNQLILGVMGVDVSLEDIKRLTPRFTLCPNGYYFAIDPNGYVLLHPNLQPKPIGVGIPTINLRKRRPNIQNPKSQEPVTLDFLDAELENDIKVEIRNKMIDGESGEKTFRTLVKSQDERYIDKGNRTYTWTPVNGTDYSLALVLPTYSFYYIKAKLEETITQARSKKGKMKDSETLKPDNFEESGYTFIAPRDYCNDLKISDNNTEFLLNFNEFIDRKTPNNPSCNADLINRVLLDAGFTNELVQNYWSKQKNIKGVKARFVVTDGGITRVYPKEAGENWQENPETYEDSFYKRSLDNDNYVFTAPYFNKSGPGAYESGIMVSKAVEIYIQGKLLKPAVVGIKIDVNSWIENFTKTSIRDPCAGPVCDCKRNSDVMDCVILDDGGFLLMANHDDYTNQIGRFFGEIDPSLMRHLVNISVYAFNKSYDYQSVCEPGAAPKQGAGHRSAYVPSVADILQIGWWATAAAWSILQQFLLSLTFPRLLEAVEMEDDDFTASLSKQSCITEQTQYFFDNDSKSFSGVLDCGNCSRIFHGEKLMNTNLIFIMVESKGTCPCDTRLLIQAEQTSDGPNPCDMVKQPRYRKGPDVCFDNNVLEDYTDCGGVSGLNPSLWYIIGIQFLLLWLVSGSTHRLL,True,False,False,,,,,,,,,,,,,,,,,,,,,
Q9UJV3,ENSG00000080561,TRIM1_HUMAN,innate immune response [GO:0045087]; negative regulation of viral entry into host cell [GO:0046597]; negative regulation of viral transcription [GO:0032897]; positive regulation of autophagy [GO:0010508]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; protein localization to microtubule [GO:0035372]; protein ubiquitination [GO:0016567]; suppression of viral release by host [GO:0044790],cytoplasm [GO:0005737]; extracellular exosome [GO:0070062]; microtubule [GO:0005874],enzyme binding [GO:0019899]; identical protein binding [GO:0042802]; microtubule binding [GO:0008017]; phosphoprotein binding [GO:0051219]; protein homodimerization activity [GO:0042803]; transcription coactivator activity [GO:0003713]; transferase activity [GO:0016740]; zinc ion binding [GO:0008270],PTM: Phosphorylated on serine and threonine residues. {ECO:0000269|PubMed:11806752}.,DOMAIN: The tripartite motif (RBCC; RING- and B box-type zinc fingers and coiled coil domains) mediates dimerization. {ECO:0000250}.; DOMAIN: Associates with microtubules in a manner that is dependent on the C-terminal B30.2 domain.,"DOMAIN 340..399; /note=""COS""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00586""; DOMAIN 398..531; /note=""Fibronectin type-III""; DOMAIN 516..709; /note=""B30.2/SPRY""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00548""","STRAND 199..201; /evidence=""ECO:0007829|PDB:2DJA""; STRAND 205..207; /evidence=""ECO:0007829|PDB:2DJA""; STRAND 212..214; /evidence=""ECO:0007829|PDB:2DJA""; STRAND 406..415; /evidence=""ECO:0007829|PDB:2DMK""; STRAND 418..424; /evidence=""ECO:0007829|PDB:2DMK""; STRAND 429..442; /evidence=""ECO:0007829|PDB:2DMK""; STRAND 487..493; /evidence=""ECO:0007829|PDB:2DMK""; STRAND 495..502; /evidence=""ECO:0007829|PDB:2DMK""; STRAND 508..519; /evidence=""ECO:0007829|PDB:2DMK""; STRAND 521..523; /evidence=""ECO:0007829|PDB:2DMK""; STRAND 527..530; /evidence=""ECO:0007829|PDB:2DMK""; STRAND 547..549; /evidence=""ECO:0007829|PDB:7QRZ""; STRAND 555..558; /evidence=""ECO:0007829|PDB:7QRZ""; STRAND 578..583; /evidence=""ECO:0007829|PDB:7QRZ""; STRAND 588..596; /evidence=""ECO:0007829|PDB:7QRZ""; STRAND 601..608; /evidence=""ECO:0007829|PDB:7QRZ""; STRAND 624..630; /evidence=""ECO:0007829|PDB:7QRZ""; STRAND 633..638; /evidence=""ECO:0007829|PDB:7QRZ""; STRAND 641..644; /evidence=""ECO:0007829|PDB:7QRZ""; STRAND 653..659; /evidence=""ECO:0007829|PDB:7QRZ""; STRAND 664..669; /evidence=""ECO:0007829|PDB:7QRZ""; STRAND 674..680; /evidence=""ECO:0007829|PDB:7QRZ""; STRAND 687..701; /evidence=""ECO:0007829|PDB:7QRZ""","HELIX 216..220; /evidence=""ECO:0007829|PDB:2DJA""; HELIX 483..486; /evidence=""ECO:0007829|PDB:2DMK""; HELIX 540..542; /evidence=""ECO:0007829|PDB:7QRZ""; HELIX 670..672; /evidence=""ECO:0007829|PDB:7QRZ""","TURN 208..211; /evidence=""ECO:0007829|PDB:2DJA""; TURN 223..226; /evidence=""ECO:0007829|PDB:2DJA""; TURN 660..663; /evidence=""ECO:0007829|PDB:7QRZ""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,MID2 FXY2 RNF60 TRIM1,Probable E3 ubiquitin-protein ligase MID2 (EC 2.3.2.27) (Midin-2) (Midline defect 2) (Midline-2) (RING finger protein 60) (RING-type E3 ubiquitin transferase MID2) (Tripartite motif-containing protein 1),Homo sapiens (Human),735.0,83210.0,MGESPASVVLNASGGLFSLKMETLESELTCPICLELFEDPLLLPCAHSLCFSCAHRILVSSCSSGESIEPITAFQCPTCRYVISLNHRGLDGLKRNVTLQNIIDRFQKASVSGPNSPSESRRERTYRPTTAMSSERIACQFCEQDPPRDAVKTCITCEVSYCDRCLRATHPNKKPFTSHRLVEPVPDTHLRGITCLDHENEKVNMYCVSDDQLICALCKLVGRHRDHQVASLNDRFEKLKQTLEMNLTNLVKRNSELENQMAKLIQICQQVEVNTAMHEAKLMEECDELVEIIQQRKQMIAVKIKETKVMKLRKLAQQVANCRQCLERSTVLINQAEHILKENDQARFLQSAKNIAERVAMATASSQVLIPDINFNDAFENFALDFSREKKLLEGLDYLTAPNPPSIREELCTASHDTITVHWISDDEFSISSYELQYTIFTGQANFISKSWCSWGLWPEIRKCKEAVSCSRLAGAPRGLYNSVDSWMIVPNIKQNHYTVHGLQSGTRYIFIVKAINQAGSRNSEPTRLKTNSQPFKLDPKMTHKKLKISNDGLQMEKDESSLKKSHTPERFSGTGCYGAAGNIFIDSGCHYWEVVMGSSTWYAIGIAYKSAPKNEWIGKNASSWVFSRCNSNFVVRHNNKEMLVDVPPHLKRLGVLLDYDNNMLSFYDPANSLHLHTFDVTFILPVCPTFTIWNKSLMILSGLPAPDFIDYPERQECNCRPQESPYVSGMKTCH,False,False,True,Q9UJV3,"[('cd00063', 'FN3'), ('cd13739', 'PRY/SPRY domain of tripartite motif-binding protein 1 (TRIM1) or MID2'), ('cd16754', 'RING finger, HC subclass, found in midline-2 (MID2) and similar proteins'), ('cd19823', 'B-box-type 2 zinc finger found in midline-2 (MID2) and similar proteins'), ('cd19837', 'B-box-type 1 zinc finger found in midline-2 (MID2) and similar proteins'), ('G3DSA:2.60.120.920', None), ('G3DSA:2.60.40.10', 'Immunoglobulins'), ('G3DSA:3.30.160.60', 'Classic Zinc Finger'), ('G3DSA:3.30.40.10', 'Zinc/RING finger domain, C3HC4 (zinc finger)'), ('G3DSA:4.10.830.40', None), ('IPR000315', 'B-box-type zinc finger'), ('IPR001841', 'Zinc finger, RING-type'), ('IPR001870', 'B30.2/SPRY domain'), ('IPR003649', 'B-box, C-terminal'), ('IPR003877', 'SPRY domain'), ('IPR003879', 'Butyrophylin-like, SPRY domain'), ('IPR003961', 'Fibronectin type III'), ('IPR013083', 'Zinc finger, RING/FYVE/PHD-type'), ('IPR013320', 'Concanavalin A-like lectin/glucanase domain superfamily'), ('IPR013783', 'Immunoglobulin-like fold')]",,"""ENSG00000080561; Low tissue specificity."";",CATALYTIC ACTIVITY: Reaction=S-ubiquitinyl-[E2 ubiquitin-conjugating enzyme]-L-cysteine + [acceptor protein]-L-lysine = [E2 ubiquitin-conjugating enzyme]-L-cysteine + N(6)-ubiquitinyl-[acceptor protein]-L-lysine.; EC=2.3.2.27; Evidence={ECO:0000269|PubMed:35266954};,2.3.2.27,,PATHWAY: Protein modification; protein ubiquitination.,ENST00000262843.11 [Q9UJV3-1];ENST00000443968.2 [Q9UJV3-2];,MID2,ENSG00000080561,0.0,MID2,Canonical_RBPs,0.0,,,,0.193,,MID2
Q9UKG1,ENSG00000157500,DP13A_HUMAN,adiponectin-activated signaling pathway [GO:0033211]; cellular response to hepatocyte growth factor stimulus [GO:0035729]; insulin receptor signaling pathway [GO:0008286]; maintenance of synapse structure [GO:0099558]; negative regulation of Fc-gamma receptor signaling pathway involved in phagocytosis [GO:1905450]; positive regulation of cytokine production involved in inflammatory response [GO:1900017]; positive regulation of glucose import [GO:0046326]; positive regulation of macropinocytosis [GO:1905303]; positive regulation of melanin biosynthetic process [GO:0048023]; protein import into nucleus [GO:0006606]; regulation of fibroblast migration [GO:0010762]; regulation of G1/S transition of mitotic cell cycle [GO:2000045]; regulation of glucose import [GO:0046324]; regulation of innate immune response [GO:0045088]; regulation of protein localization to plasma membrane [GO:1903076]; regulation of toll-like receptor 4 signaling pathway [GO:0034143]; signal transduction [GO:0007165]; signaling [GO:0023052]; transforming growth factor beta receptor signaling pathway [GO:0007179],cytoplasm [GO:0005737]; cytoplasmic vesicle [GO:0031410]; cytosol [GO:0005829]; early endosome [GO:0005769]; early endosome membrane [GO:0031901]; early phagosome [GO:0032009]; endosome [GO:0005768]; endosome membrane [GO:0010008]; extracellular exosome [GO:0070062]; glutamatergic synapse [GO:0098978]; intracellular vesicle [GO:0097708]; macropinosome [GO:0044354]; membrane [GO:0016020]; nucleus [GO:0005634]; plasma membrane [GO:0005886]; postsynapse [GO:0098794]; presynapse [GO:0098793]; ruffle [GO:0001726]; vesicle membrane [GO:0012506],beta-tubulin binding [GO:0048487]; identical protein binding [GO:0042802]; phosphatidylinositol binding [GO:0035091]; phosphatidylserine binding [GO:0001786]; protein homodimerization activity [GO:0042803]; protein kinase B binding [GO:0043422]; protein-containing complex binding [GO:0044877],PTM: Phosphorylation at Ser-410 by PKA severely impairs binding to OCRL. {ECO:0000269|PubMed:17765681}.,"DOMAIN: Overexpression of an N-terminal domain (residues 1-319) or a C-terminal region (residues 273-709) has a proapoptotic effect. {ECO:0000269|PubMed:15016378}.; DOMAIN: The F&H motif, an approximately 12-13 amino-acid sequence centered around Phe and His residues, is essential for binding to OCRL and INPP5B. {ECO:0000269|PubMed:21666675}.","DOMAIN 3..268; /note=""BAR""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00361""; DOMAIN 277..375; /note=""PH""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00145""; DOMAIN 496..656; /note=""PID""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00148""","STRAND 152..154; /evidence=""ECO:0007829|PDB:2Q13""; STRAND 262..265; /evidence=""ECO:0007829|PDB:2Q13""; STRAND 281..286; /evidence=""ECO:0007829|PDB:2Q13""; STRAND 298..305; /evidence=""ECO:0007829|PDB:2Q13""; STRAND 308..312; /evidence=""ECO:0007829|PDB:2Q13""; STRAND 320..324; /evidence=""ECO:0007829|PDB:2Q13""; STRAND 329..333; /evidence=""ECO:0007829|PDB:2Q13""; STRAND 339..345; /evidence=""ECO:0007829|PDB:2Q13""; STRAND 348..350; /evidence=""ECO:0007829|PDB:2ELB""; STRAND 354..356; /evidence=""ECO:0007829|PDB:5C5B""; STRAND 499..512; /evidence=""ECO:0007829|PDB:2EJ8""; STRAND 542..555; /evidence=""ECO:0007829|PDB:2EJ8""; STRAND 562..567; /evidence=""ECO:0007829|PDB:2EJ8""; STRAND 571..577; /evidence=""ECO:0007829|PDB:2EJ8""; STRAND 580..590; /evidence=""ECO:0007829|PDB:2EJ8""; STRAND 600..610; /evidence=""ECO:0007829|PDB:2EJ8""","HELIX 9..11; /evidence=""ECO:0007829|PDB:2Q13""; HELIX 16..66; /evidence=""ECO:0007829|PDB:2Q12""; HELIX 67..70; /evidence=""ECO:0007829|PDB:2Q12""; HELIX 81..110; /evidence=""ECO:0007829|PDB:2Q12""; HELIX 112..120; /evidence=""ECO:0007829|PDB:2Q12""; HELIX 122..151; /evidence=""ECO:0007829|PDB:2Q12""; HELIX 157..217; /evidence=""ECO:0007829|PDB:2Q12""; HELIX 220..257; /evidence=""ECO:0007829|PDB:2Q12""; HELIX 259..261; /evidence=""ECO:0007829|PDB:2Q13""; HELIX 360..374; /evidence=""ECO:0007829|PDB:2Q13""; HELIX 519..534; /evidence=""ECO:0007829|PDB:2EJ8""; HELIX 568..570; /evidence=""ECO:0007829|PDB:2EJ8""; HELIX 612..629; /evidence=""ECO:0007829|PDB:2EJ8""; HELIX 634..643; /evidence=""ECO:0007829|PDB:2ELA""","TURN 12..14; /evidence=""ECO:0007829|PDB:2Q13""; TURN 268..270; /evidence=""ECO:0007829|PDB:2Q13""; TURN 557..559; /evidence=""ECO:0007829|PDB:2EJ8""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,APPL1 APPL DIP13A KIAA1428,"DCC-interacting protein 13-alpha (Dip13-alpha) (Adapter protein containing PH domain, PTB domain and leucine zipper motif 1)",Homo sapiens (Human),709.0,79663.0,MPGIDKLPIEETLEDSPQTRSLLGVFEEDATAISNYMNQLYQAMHRIYDAQNELSAATHLTSKLLKEYEKQRFPLGGDDEVMSSTLQQFSKVIDELSSCHAVLSTQLADAMMFPITQFKERDLKEILTLKEVFQIASNDHDAAINRYSRLSKKRENDKVKYEVTEDVYTSRKKQHQTMMHYFCALNTLQYKKKIALLEPLLGYMQAQISFFKMGSENLNEQLEEFLANIGTSVQNVRREMDSDIETMQQTIEDLEVASDPLYVPDPDPTKFPVNRNLTRKAGYLNARNKTGLVSSTWDRQFYFTQGGNLMSQARGDVAGGLAMDIDNCSVMAVDCEDRRYCFQITSFDGKKSSILQAESKKDHEEWICTINNISKQIYLSENPEETAARVNQSALEAVTPSPSFQQRHESLRPAAGQSRPPTARTSSSGSLGSESTNLAALSLDSLVAPDTPIQFDIISPVCEDQPGQAKAFGQGGRRTNPFGESGGSTKSETEDSILHQLFIVRFLGSMEVKSDDHPDVVYETMRQILAARAIHNIFRMTESHLLVTCDCLKLIDPQTQVTRLTFPLPCVVLYATHQENKRLFGFVLRTSSGRSESNLSSVCYIFESNNEGEKICDSVGLAKQIALHAELDRRASEKQKEIERVKEKQQKELNKQKQIEKDLEEQSRLIAASSRPNQASSEGQFVVLSSSQSEESDLGEGGKKRESEA,False,False,True,Q9UKG1,"[('cd07631', 'The Bin/Amphiphysin/Rvs (BAR) domain of Adaptor protein, Phosphotyrosine interaction, PH domain and Leucine zipper containing 1'), ('cd13158', 'Adaptor protein containing PH domain, PTB domain, and Leucine zipper motif (APPL; also called DCC-interacting protein (DIP)-13alpha) Phosphotyrosine-binding (PTB) domain'), ('cd13247', 'Adaptor protein containing PH domain, PTB domain, and Leucine zipper motif Bin1/amphiphysin/Rvs167 (BAR)-Pleckstrin homology (PH) domain'), ('G3DSA:1.20.1270.60', 'Arfaptin homology (AH) domain/BAR domain'), ('G3DSA:2.30.29.30', 'Pleckstrin-homology domain (PH domain)/Phosphotyrosine-binding domain (PTB)'), ('IPR001849', 'Pleckstrin homology domain'), ('IPR004148', 'BAR domain'), ('IPR006020', 'PTB/PI domain'), ('IPR011993', 'PH-like domain superfamily'), ('IPR027267', 'AH/BAR domain superfamily'), ('IPR037929', 'DCC-interacting protein 13-alpha, BAR domain'), ('IPR047181', 'DCC-interacting protein 13-alpha/beta'), ('IPR047236', 'DCC-interacting protein 13-alpha/beta, PH domain'), ('IPR047237', 'DCC-interacting protein 13-alpha/beta, PTB domain'), ('PF00169', 'PH domain'), ('PF00640', 'Phosphotyrosine interaction domain (PTB/PID)'), ('PF16746', 'BAR domain of APPL family'), ('PS01179', 'Phosphotyrosine interaction domain (PID) profile'), ('PS50003', 'PH domain profile'), ('PTHR46415', 'ADAPTOR PROTEIN, PHOSPHOTYROSINE INTERACTION, PH DOMAIN AND LEUCINE ZIPPER-CONTAINING 2')]",Q9UKG1;,"""ENSG00000157500; Low tissue specificity."";",,,,,ENST00000288266.8;ENST00000650354.1;,APPL1,ENSG00000157500,0.0,,,,,,,0.185,0.181,APPL1
Q9UKX7,ENSG00000093000,NUP50_HUMAN,mRNA transport [GO:0051028]; nucleocytoplasmic transport [GO:0006913]; protein import into nucleus [GO:0006606],nuclear envelope [GO:0005635]; nuclear membrane [GO:0031965]; nuclear pore [GO:0005643]; nucleoplasm [GO:0005654],,,"DOMAIN: Contains FG repeats. FG repeats are interaction sites for karyopherins (importins, exportins) and form probably an affinity gradient, guiding the transport proteins unidirectionally with their cargo through the NPC. FG repeat regions are highly flexible and lack ordered secondary structure. The overall conservation of FG repeats regarding exact sequence, spacing, and repeat unit length is limited. {ECO:0000305}.","DOMAIN 335..468; /note=""RanBD1""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00164""","STRAND 15..17; /evidence=""ECO:0007829|PDB:3TJ3""; STRAND 358..369; /evidence=""ECO:0007829|PDB:7MO0""; STRAND 372..385; /evidence=""ECO:0007829|PDB:7MO0""; STRAND 387..389; /evidence=""ECO:0007829|PDB:7MO0""; STRAND 391..399; /evidence=""ECO:0007829|PDB:7MO0""; STRAND 404..409; /evidence=""ECO:0007829|PDB:7MO0""; STRAND 416..419; /evidence=""ECO:0007829|PDB:7MO0""; STRAND 423..428; /evidence=""ECO:0007829|PDB:7MO0""; STRAND 434..436; /evidence=""ECO:0007829|PDB:7MO0""; STRAND 443..448; /evidence=""ECO:0007829|PDB:7MO0""","HELIX 32..37; /evidence=""ECO:0007829|PDB:3TJ3""; HELIX 452..467; /evidence=""ECO:0007829|PDB:7MO0""","TURN 12..14; /evidence=""ECO:0007829|PDB:3TJ3""; TURN 420..422; /evidence=""ECO:0007829|PDB:7MO0""; TURN 437..440; /evidence=""ECO:0007829|PDB:7MO0""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,NUP50 NPAP60L PRO1146,Nuclear pore complex protein Nup50 (50 kDa nucleoporin) (Nuclear pore-associated protein 60 kDa-like) (Nucleoporin Nup50),Homo sapiens (Human),468.0,50144.0,MAKRNAEKELTDRNWDQEDEAEEVGTFSMASEEVLKNRAIKKAKRRNVGFESDTGGAFKGFKGLVVPSGGGRFSGFGSGAGGKPLEGLSNGNNITSAPPFASAKAAADPKVAFGSLAANGPTTLVDKVSNPKTNGDSQQPSSSGLASSKACVGNAYHKQLAALNCSVRDWIVKHVNTNPLCDLTPIFKDYEKYLANIEQQHGNSGRNSESESNKVAAETQSPSLFGSTKLQQESTFLFHGNKTEDTPDKKMEVASEKKTDPSSLGATSASFNFGKKVDSSVLGSLSSVPLTGFSFSPGNSSLFGKDTTQSKPVSSPFPTKPLEGQAEGDSGECKGGDEEENDEPPKVVVTEVKEEDAFYSKKCKLFYKKDNEFKEKGIGTLHLKPTANQKTQLLVRADTNLGNILLNVLIPPNMPCTRTGKNNVLIVCVPNPPIDEKNATMPVTMLIRVKTSEDADELHKILLEKKDA,True,False,False,Q9UKX7,"[('cd13170', 'Nucleoporin 50 Ran-binding domain'), ('G3DSA:2.30.29.30', 'Pleckstrin-homology domain (PH domain)/Phosphotyrosine-binding domain (PTB)'), ('IPR000156', 'Ran binding domain'), ('IPR011993', 'PH-like domain superfamily'), ('IPR015007', 'Nuclear pore complex, NUP2/50/61'), ('IPR045255', 'Ran binding protein RanBP1-like'), ('PF00638', 'RanBP1 domain'), ('PF08911', 'NUP50 (Nucleoporin 50 kDa)'), ('PS50196', 'Ran binding domain type 1 profile'), ('PTHR23138', 'RAN BINDING PROTEIN'), ('SM00160', 'Ran-binding domain'), ('SSF50729', 'PH domain-like')]",,"""ENSG00000093000; Low tissue specificity."";",,,,,ENST00000347635.9 [Q9UKX7-1];ENST00000396096.6 [Q9UKX7-2];ENST00000407019.6 [Q9UKX7-2];,NUP50,ENSG00000093000,0.0,NUP50,Non-canonical_RBPs,4.0,13.25,DP02455,0.132,0.66,0.323,NUP50
Q9UMS4,ENSG00000110107,PRP19_HUMAN,"DNA damage checkpoint signaling [GO:0000077]; double-strand break repair via nonhomologous end joining [GO:0006303]; inner cell mass cell proliferation [GO:0001833]; lipid biosynthetic process [GO:0008610]; mRNA splicing, via spliceosome [GO:0000398]; positive regulation of mRNA splicing, via spliceosome [GO:0048026]; proteasomal protein catabolic process [GO:0010498]; protein K63-linked ubiquitination [GO:0070534]; protein localization [GO:0008104]; protein polyubiquitination [GO:0000209]; spliceosomal complex assembly [GO:0000245]; spliceosomal tri-snRNP complex assembly [GO:0000244]",catalytic step 2 spliceosome [GO:0071013]; cytoplasm [GO:0005737]; lipid droplet [GO:0005811]; membrane [GO:0016020]; nuclear speck [GO:0016607]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; Prp19 complex [GO:0000974]; site of double-strand break [GO:0035861]; spindle [GO:0005819]; spliceosomal complex [GO:0005681]; U2-type catalytic step 1 spliceosome [GO:0071006]; U2-type catalytic step 2 spliceosome [GO:0071007],identical protein binding [GO:0042802]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; ubiquitin-ubiquitin ligase activity [GO:0034450],,DOMAIN: The 7 WD repeats are necessary and sufficient to support interaction with the RPA complex. {ECO:0000269|PubMed:24332808}.,"DOMAIN 2..73; /note=""U-box""","STRAND 13..17; /evidence=""ECO:0007829|PDB:6ID1""; STRAND 19..21; /evidence=""ECO:0007829|PDB:6ID1""; STRAND 24..26; /evidence=""ECO:0007829|PDB:6ID1""; STRAND 37..39; /evidence=""ECO:0007829|PDB:6ID1""; STRAND 53..56; /evidence=""ECO:0007829|PDB:6ID1""; STRAND 59..61; /evidence=""ECO:0007829|PDB:6ID0""; STRAND 208..213; /evidence=""ECO:0007829|PDB:4LG8""; STRAND 219..221; /evidence=""ECO:0007829|PDB:4LG8""; STRAND 224..230; /evidence=""ECO:0007829|PDB:4LG8""; STRAND 233..241; /evidence=""ECO:0007829|PDB:4LG8""; STRAND 246..250; /evidence=""ECO:0007829|PDB:4LG8""; STRAND 255..260; /evidence=""ECO:0007829|PDB:4LG8""; STRAND 269..272; /evidence=""ECO:0007829|PDB:4LG8""; STRAND 276..282; /evidence=""ECO:0007829|PDB:4LG8""; STRAND 288..292; /evidence=""ECO:0007829|PDB:4LG8""; STRAND 297..302; /evidence=""ECO:0007829|PDB:4LG8""; STRAND 309..314; /evidence=""ECO:0007829|PDB:4LG8""; STRAND 318..325; /evidence=""ECO:0007829|PDB:4LG8""; STRAND 328..334; /evidence=""ECO:0007829|PDB:4LG8""; STRAND 340..345; /evidence=""ECO:0007829|PDB:4LG8""; STRAND 353..358; /evidence=""ECO:0007829|PDB:4LG8""; STRAND 362..369; /evidence=""ECO:0007829|PDB:4LG8""; STRAND 374..378; /evidence=""ECO:0007829|PDB:4LG8""; STRAND 383..388; /evidence=""ECO:0007829|PDB:4LG8""; STRAND 395..400; /evidence=""ECO:0007829|PDB:4LG8""; STRAND 404..411; /evidence=""ECO:0007829|PDB:4LG8""; STRAND 414..420; /evidence=""ECO:0007829|PDB:4LG8""; STRAND 425..431; /evidence=""ECO:0007829|PDB:4LG8""; STRAND 438..443; /evidence=""ECO:0007829|PDB:4LG8""; STRAND 447..461; /evidence=""ECO:0007829|PDB:4LG8""; STRAND 466..471; /evidence=""ECO:0007829|PDB:4LG8""; STRAND 474..476; /evidence=""ECO:0007829|PDB:4LG8""; STRAND 478..483; /evidence=""ECO:0007829|PDB:4LG8""; STRAND 490..494; /evidence=""ECO:0007829|PDB:4LG8""; STRAND 499..503; /evidence=""ECO:0007829|PDB:4LG8""","HELIX 27..36; /evidence=""ECO:0007829|PDB:6ID1""; HELIX 70..74; /evidence=""ECO:0007829|PDB:6ID1""; HELIX 76..132; /evidence=""ECO:0007829|PDB:6ID1""; HELIX 201..204; /evidence=""ECO:0007829|PDB:4LG8""; HELIX 485..487; /evidence=""ECO:0007829|PDB:4LG8""","TURN 6..8; /evidence=""ECO:0007829|PDB:6ID1""; TURN 41..43; /evidence=""ECO:0007829|PDB:6ID1""; TURN 49..51; /evidence=""ECO:0007829|PDB:6ID1""; TURN 251..254; /evidence=""ECO:0007829|PDB:4LG8""; TURN 293..296; /evidence=""ECO:0007829|PDB:4LG8""; TURN 335..337; /evidence=""ECO:0007829|PDB:4LG8""; TURN 347..349; /evidence=""ECO:0007829|PDB:4LG8""; TURN 379..382; /evidence=""ECO:0007829|PDB:4LG8""; TURN 421..424; /evidence=""ECO:0007829|PDB:4LG8""; TURN 462..465; /evidence=""ECO:0007829|PDB:4LG8""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,PRPF19 NMP200 PRP19 SNEV,Pre-mRNA-processing factor 19 (EC 2.3.2.27) (Nuclear matrix protein 200) (PRP19/PSO4 homolog) (hPso4) (RING-type E3 ubiquitin transferase PRP19) (Senescence evasion factor),Homo sapiens (Human),504.0,55181.0,MSLICSISNEVPEHPCVSPVSNHVYERRLIEKYIAENGTDPINNQPLSEEQLIDIKVAHPIRPKPPSATSIPAILKALQDEWDAVMLHSFTLRQQLQTTRQELSHALYQHDAACRVIARLTKEVTAAREALATLKPQAGLIVPQAVPSSQPSVVGAGEPMDLGELVGMTPEIIQKLQDKATVLTTERKKRGKTVPEELVKPEELSKYRQVASHVGLHSASIPGILALDLCPSDTNKILTGGADKNVVVFDKSSEQILATLKGHTKKVTSVVFHPSQDLVFSASPDATIRIWSVPNASCVQVVRAHESAVTGLSLHATGDYLLSSSDDQYWAFSDIQTGRVLTKVTDETSGCSLTCAQFHPDGLIFGTGTMDSQIKIWDLKERTNVANFPGHSGPITSIAFSENGYYLATAADDSSVKLWDLRKLKNFKTLQLDNNFEVKSLIFDQSGTYLALGGTDVQIYICKQWTEILHFTEHSGLTTGVAFGHHAKFIASTGMDRSLKFYSL,False,False,True,Q9UMS4,"[('cd00200', 'WD40'), ('cd16656', 'U-box domain, a modified RING finger, found in pre-mRNA-processing factor 19 (Prp19) and similar proteins'), ('G3DSA:2.130.10.10', 'YVTN repeat-like/Quinoprotein amine dehydrogenase'), ('G3DSA:3.30.40.10', 'Zinc/RING finger domain, C3HC4 (zinc finger)'), ('IPR001680', 'WD40 repeat'), ('IPR003613', 'U-box domain'), ('IPR013083', 'Zinc finger, RING/FYVE/PHD-type'), ('IPR013915', 'Pre-mRNA-splicing factor 19, coiled-coil region'), ('IPR015943', 'WD40/YVTN repeat-like-containing domain superfamily'), ('IPR019775', 'WD40 repeat, conserved site'), ('IPR020472', 'G-protein beta WD-40 repeat'), ('IPR036322', 'WD40-repeat-containing domain superfamily'), ('IPR038959', 'Pre-mRNA-processing factor 19'), ('IPR055340', 'Pre-mRNA-processing factor 19, U-box domain'), ('PF04564', 'U-box domain'), ('PF08606', 'Prp19/Pso4-like'), ('PF24814', 'Prp19 WD40 domain'), ('PR00320', 'GPROTEINBRPT'), ('PS00678', 'Trp-Asp (WD) repeats signature'), ('PS50082', 'Trp-Asp (WD) repeats profile')]",,"""ENSG00000110107; Low tissue specificity."";",CATALYTIC ACTIVITY: Reaction=S-ubiquitinyl-[E2 ubiquitin-conjugating enzyme]-L-cysteine + [acceptor protein]-L-lysine = [E2 ubiquitin-conjugating enzyme]-L-cysteine + N(6)-ubiquitinyl-[acceptor protein]-L-lysine.; EC=2.3.2.27; Evidence={ECO:0000269|PubMed:11435423};,2.3.2.27,,PATHWAY: Protein modification; protein ubiquitination. {ECO:0000269|PubMed:11435423}.,ENST00000227524.9;,PRPF19,ENSG00000110107,0.0,PRPF19,Canonical_RBPs,15.0,5.16,DP01161,0.052,0.133,,PRPF19
Q9UNE7,ENSG00000103266,CHIP_HUMAN,cellular response to heat [GO:0034605]; cellular response to hypoxia [GO:0071456]; cellular response to misfolded protein [GO:0071218]; chaperone-mediated autophagy [GO:0061684]; DNA repair [GO:0006281]; endoplasmic reticulum unfolded protein response [GO:0030968]; ERAD pathway [GO:0036503]; ERBB2 signaling pathway [GO:0038128]; MAPK cascade [GO:0000165]; negative regulation of smooth muscle cell apoptotic process [GO:0034392]; negative regulation of transforming growth factor beta receptor signaling pathway [GO:0030512]; positive regulation of chaperone-mediated protein complex assembly [GO:0090035]; positive regulation of ERAD pathway [GO:1904294]; positive regulation of mitophagy [GO:1901526]; positive regulation of proteasomal ubiquitin-dependent protein catabolic process [GO:0032436]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of proteolysis [GO:0045862]; positive regulation of smooth muscle cell apoptotic process [GO:0034393]; positive regulation of ubiquitin-protein transferase activity [GO:0051443]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein autoubiquitination [GO:0051865]; protein K63-linked ubiquitination [GO:0070534]; protein maturation [GO:0051604]; protein monoubiquitination [GO:0006513]; protein polyubiquitination [GO:0000209]; protein quality control for misfolded or incompletely synthesized proteins [GO:0006515]; protein stabilization [GO:0050821]; protein ubiquitination [GO:0016567]; regulation of glucocorticoid metabolic process [GO:0031943]; regulation of protein stability [GO:0031647]; response to ischemia [GO:0002931]; ubiquitin-dependent protein catabolic process [GO:0006511],cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; mitochondrion [GO:0005739]; nuclear inclusion body [GO:0042405]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein folding chaperone complex [GO:0101031]; ubiquitin conjugating enzyme complex [GO:0031371]; ubiquitin ligase complex [GO:0000151]; Z disc [GO:0030018],enzyme binding [GO:0019899]; G protein-coupled receptor binding [GO:0001664]; heat shock protein binding [GO:0031072]; Hsp70 protein binding [GO:0030544]; Hsp90 protein binding [GO:0051879]; kinase binding [GO:0019900]; misfolded protein binding [GO:0051787]; protein homodimerization activity [GO:0042803]; protein-folding chaperone binding [GO:0051087]; protein-macromolecule adaptor activity [GO:0030674]; R-SMAD binding [GO:0070412]; SMAD binding [GO:0046332]; tau protein binding [GO:0048156]; TPR domain binding [GO:0030911]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842]; ubiquitin-ubiquitin ligase activity [GO:0034450],"PTM: Monoubiquitinated at Lys-2 following cell stress by UBE2W, promoting the interaction with ATXN3 (By similarity). Auto-ubiquitinated; mediated by UBE2D1 and UBE2D2 and enhanced in the presence of MAP2K5 (PubMed:20724525). {ECO:0000250, ECO:0000250|UniProtKB:Q9WUD1, ECO:0000269|PubMed:18042044, ECO:0000269|PubMed:20724525, ECO:0000269|PubMed:23560854}.",DOMAIN: The U-box domain is required for the ubiquitin protein ligase activity. {ECO:0000250|UniProtKB:Q9WUD1}.; DOMAIN: The TPR domain is essential for ubiquitination mediated by UBE2D1. {ECO:0000269|PubMed:18042044}.,"DOMAIN 226..300; /note=""U-box""",,"HELIX 26..38; /evidence=""ECO:0007829|PDB:6NSV""; HELIX 42..55; /evidence=""ECO:0007829|PDB:6NSV""; HELIX 60..72; /evidence=""ECO:0007829|PDB:6NSV""; HELIX 76..89; /evidence=""ECO:0007829|PDB:6NSV""; HELIX 94..106; /evidence=""ECO:0007829|PDB:6NSV""; HELIX 110..126; /evidence=""ECO:0007829|PDB:6NSV""; HELIX 134..149; /evidence=""ECO:0007829|PDB:6NSV""",,"cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,STUB1 CHIP PP1131,E3 ubiquitin-protein ligase CHIP (EC 2.3.2.27) (Antigen NY-CO-7) (CLL-associated antigen KW-8) (Carboxy terminus of Hsp70-interacting protein) (RING-type E3 ubiquitin transferase CHIP) (STIP1 homology and U box-containing protein 1),Homo sapiens (Human),303.0,34856.0,MKGKEEKEGGARLGAGGGSPEKSPSAQELKEQGNRLFVGRKYPEAAACYGRAITRNPLVAVYYTNRALCYLKMQQHEQALADCRRALELDGQSVKAHFFLGQCQLEMESYDEAIANLQRAYSLAKEQRLNFGDDIPSALRIAKKKRWNSIEERRIHQESELHSYLSRLIAAERERELEECQRNHEGDEDDSHVRAQQACIEAKHDKYMADMDELFSQVDEKRKKRDIPDYLCGKISFELMREPCITPSGITYDRKDIEEHLQRVGHFDPVTRSPLTQEQLIPNLAMKEVIDAFISENGWVEDY,False,False,True,Q9UNE7,"[('cd16654', 'U-box domain, a modified RING finger, found in carboxyl terminus of HSP70-interacting protein (CHIP) and similar proteins'), ('G3DSA:1.25.40.10', 'Tetratricopeptide repeat domain'), ('G3DSA:3.30.40.10', 'Zinc/RING finger domain, C3HC4 (zinc finger)'), ('G3DSA:6.10.140.2020', None), ('IPR003613', 'U-box domain'), ('IPR011990', 'Tetratricopeptide-like helical domain superfamily'), ('IPR013083', 'Zinc finger, RING/FYVE/PHD-type'), ('IPR019734', 'Tetratricopeptide repeat'), ('IPR041312', 'CHIP, N-terminal tetratricopeptide repeat domain'), ('IPR045202', 'CHIP , U-box domain'), ('PF04564', 'U-box domain'), ('PF12895', 'Anaphase-promoting complex, cyclosome, subunit 3'), ('PF18391', 'CHIP N-terminal tetratricopeptide repeat domain'), ('PS50005', 'TPR repeat profile'), ('PS51698', 'U-box domain profile'), ('PTHR46803', 'E3 UBIQUITIN-PROTEIN LIGASE CHIP'), ('SM00028', 'Tetratricopeptide repeats'), ('SM00504', 'Modified RING finger domain'), ('SSF48452', 'TPR-like'), ('SSF57850', 'RING/U-box')]",,"""ENSG00000103266; Low tissue specificity."";","CATALYTIC ACTIVITY: Reaction=S-ubiquitinyl-[E2 ubiquitin-conjugating enzyme]-L-cysteine + [acceptor protein]-L-lysine = [E2 ubiquitin-conjugating enzyme]-L-cysteine + N(6)-ubiquitinyl-[acceptor protein]-L-lysine.; EC=2.3.2.27; Evidence={ECO:0000269|PubMed:11557750, ECO:0000269|PubMed:15466472, ECO:0000269|PubMed:24043303};",2.3.2.27,,"PATHWAY: Protein modification; protein ubiquitination. {ECO:0000269|PubMed:11557750, ECO:0000269|PubMed:15466472}.",ENST00000219548.9 [Q9UNE7-1];ENST00000564370.5 [Q9UNE7-2];ENST00000565677.5 [Q9UNE7-2];,STUB1,ENSG00000103266,0.0,,,,,,,0.079,0.099,STUB1
Q9UQE7,ENSG00000108055,SMC3_HUMAN,cell division [GO:0051301]; DNA repair [GO:0006281]; establishment of meiotic sister chromatid cohesion [GO:0034089]; establishment of mitotic sister chromatid cohesion [GO:0034087]; meiotic cell cycle [GO:0051321]; mitotic cell cycle [GO:0000278]; mitotic sister chromatid cohesion [GO:0007064]; mitotic spindle assembly [GO:0090307]; regulation of DNA replication [GO:0006275]; sister chromatid cohesion [GO:0007062]; stem cell population maintenance [GO:0019827],"chromatin [GO:0000785]; chromosome [GO:0005694]; chromosome, centromeric region [GO:0000775]; cohesin complex [GO:0008278]; cytosol [GO:0005829]; lateral element [GO:0000800]; meiotic cohesin complex [GO:0030893]; mitotic cohesin complex [GO:0030892]; mitotic spindle pole [GO:0097431]; nuclear matrix [GO:0016363]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]",ATP binding [GO:0005524]; ATP hydrolysis activity [GO:0016887]; beta-tubulin binding [GO:0048487]; chromatin binding [GO:0003682]; double-stranded DNA binding [GO:0003690]; dynein complex binding [GO:0070840]; mediator complex binding [GO:0036033]; microtubule motor activity [GO:0003777]; protein heterodimerization activity [GO:0046982],"PTM: Ubiquitinated by the DCX(DCAF15) complex, leading to its degradation. {ECO:0000269|PubMed:31452512}.; PTM: Phosphorylated at Ser-1083 in a SPO11-dependent manner. {ECO:0000250|UniProtKB:Q9CW03}.; PTM: Acetylation at Lys-105 and Lys-106 by ESCO1 is important for genome stability and S phase sister chromatid cohesion. Regulated by DSCC1, it is required for processive DNA synthesis, coupling sister chromatid cohesion establishment during S phase to DNA replication. Deacetylation by HDAC8, regulates release of the cohesin complex from chromatin. {ECO:0000269|PubMed:18614053, ECO:0000269|PubMed:19907496, ECO:0000269|PubMed:22885700}.","DOMAIN: The flexible SMC hinge domain, which separates the large intramolecular coiled coil regions, allows the heterotypic interaction with the corresponding domain of SMC1A or SMC1B, forming a V-shaped heterodimer. The two heads of the heterodimer are then connected by different ends of the cleavable RAD21 protein, forming a ring structure (By similarity). {ECO:0000250}.","DOMAIN 530..642; /note=""SMC hinge""","STRAND 532..535; /evidence=""ECO:0007829|PDB:6WG4""; STRAND 561..564; /evidence=""ECO:0007829|PDB:6WG4""; STRAND 585..589; /evidence=""ECO:0007829|PDB:6WG4""; STRAND 604..608; /evidence=""ECO:0007829|PDB:6WG4""; STRAND 630..634; /evidence=""ECO:0007829|PDB:6WG4""; STRAND 649..652; /evidence=""ECO:0007829|PDB:6WG4""; STRAND 660..662; /evidence=""ECO:0007829|PDB:6WG4""","HELIX 501..522; /evidence=""ECO:0007829|PDB:6WG4""; HELIX 526..531; /evidence=""ECO:0007829|PDB:6WG4""; HELIX 536..539; /evidence=""ECO:0007829|PDB:6WG4""; HELIX 544..546; /evidence=""ECO:0007829|PDB:6WG4""; HELIX 547..554; /evidence=""ECO:0007829|PDB:6WG4""; HELIX 555..559; /evidence=""ECO:0007829|PDB:6WG4""; HELIX 566..578; /evidence=""ECO:0007829|PDB:6WG4""; HELIX 609..612; /evidence=""ECO:0007829|PDB:6WG4""; HELIX 617..619; /evidence=""ECO:0007829|PDB:6WG4""; HELIX 620..627; /evidence=""ECO:0007829|PDB:6WG4""; HELIX 636..645; /evidence=""ECO:0007829|PDB:6WG4""","TURN 590..592; /evidence=""ECO:0007829|PDB:6WG4""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,SMC3 BAM BMH CSPG6 SMC3L1,Structural maintenance of chromosomes protein 3 (SMC protein 3) (SMC-3) (Basement membrane-associated chondroitin proteoglycan) (Bamacan) (Chondroitin sulfate proteoglycan 6) (Chromosome-associated polypeptide) (hCAP),Homo sapiens (Human),1217.0,141542.0,MYIKQVIIQGFRSYRDQTIVDPFSSKHNVIVGRNGSGKSNFFYAIQFVLSDEFSHLRPEQRLALLHEGTGPRVISAFVEIIFDNSDNRLPIDKEEVSLRRVIGAKKDQYFLDKKMVTKNDVMNLLESAGFSRSNPYYIVKQGKINQMATAPDSQRLKLLREVAGTRVYDERKEESISLMKETEGKREKINELLKYIEERLHTLEEEKEELAQYQKWDKMRRALEYTIYNQELNETRAKLDELSAKRETSGEKSRQLRDAQQDARDKMEDIERQVRELKTKISAMKEEKEQLSAERQEQIKQRTKLELKAKDLQDELAGNSEQRKRLLKERQKLLEKIEEKQKELAETEPKFNSVKEKEERGIARLAQATQERTDLYAKQGRGSQFTSKEERDKWIKKELKSLDQAINDKKRQIAAIHKDLEDTEANKEKNLEQYNKLDQDLNEVKARVEELDRKYYEVKNKKDELQSERNYLWREENAEQQALAAKREDLEKKQQLLRAATGKAILNGIDSINKVLDHFRRKGINQHVQNGYHGIVMNNFECEPAFYTCVEVTAGNRLFYHIVDSDEVSTKILMEFNKMNLPGEVTFLPLNKLDVRDTAYPETNDAIPMISKLRYNPRFDKAFKHVFGKTLICRSMEVSTQLARAFTMDCITLEGDQVSHRGALTGGYYDTRKSRLELQKDVRKAEEELGELEAKLNENLRRNIERINNEIDQLMNQMQQIETQQRKFKASRDSILSEMKMLKEKRQQSEKTFMPKQRSLQSLEASLHAMESTRESLKAELGTDLLSQLSLEDQKRVDALNDEIRQLQQENRQLLNERIKLEGIITRVETYLNENLRKRLDQVEQELNELRETEGGTVLTATTSELEAINKRVKDTMARSEDLDNSIDKTEAGIKELQKSMERWKNMEKEHMDAINHDTKELEKMTNRQGMLLKKKEECMKKIRELGSLPQEAFEKYQTLSLKQLFRKLEQCNTELKKYSHVNKKALDQFVNFSEQKEKLIKRQEELDRGYKSIMELMNVLELRKYEAIQLTFKQVSKNFSEVFQKLVPGGKATLVMKKGDVEGSQSQDEGEGSGESERGSGSQSSVPSVDQFTGVGIRVSFTGKQGEMREMQQLSGGQKSLVALALIFAIQKCDPAPFYLFDEIDQALDAQHRKAVSDMIMELAVHAQFITTTFRPELLESADKFYGVKFRNKVSHIDVITAEMAKDFVEDDTTHG,True,False,True,Q9UQE7,"[('cd03272', 'ATP-binding cassette domain of eukaryotic SMC3 proteins'), ('G3DSA:1.10.287.1490', None), ('G3DSA:1.20.1060.20', None), ('G3DSA:3.30.70.1620', None), ('G3DSA:3.40.50.300', 'P-loop containing nucleotide triphosphate hydrolases'), ('IPR003395', 'RecF/RecN/SMC, N-terminal'), ('IPR010935', 'SMCs flexible hinge'), ('IPR024704', 'Structural maintenance of chromosomes protein'), ('IPR027417', 'P-loop containing nucleoside triphosphate hydrolase'), ('IPR036277', 'SMCs flexible hinge superfamily'), ('IPR041741', 'Structural maintenance of chromosomes 3, ABC domain, eukaryotic'), ('PF02463', 'RecF/RecN/SMC N terminal domain'), ('PF06470', 'SMC proteins Flexible Hinge Domain'), ('PIRSF005719', 'Structural maintenance of chromosomes protein'), ('PTHR43977', 'Structural Maintenance of Chromosomes (SMC)'), ('SM00968', 'SMC proteins Flexible Hinge Domain'), ('SSF52540', 'P-loop containing nucleoside triphosphate hydrolases'), ('SSF75553', 'Smc hinge domain')]",,"""ENSG00000108055; Low tissue specificity."";",,,,,ENST00000361804.5;,SMC3,ENSG00000108055,0.0,SMC3,Non-canonical_RBPs,11.0,,,,0.022,0.048,SMC3
Q9Y2D1,ENSG00000169136,ATF5_HUMAN,cerebellar granule cell precursor proliferation [GO:0021930]; circadian rhythm [GO:0007623]; fat cell differentiation [GO:0045444]; multicellular organism growth [GO:0035264]; negative regulation of apoptotic process [GO:0043066]; negative regulation of cell cycle G2/M phase transition [GO:1902750]; negative regulation of cell population proliferation [GO:0008285]; negative regulation of DNA-templated transcription [GO:0045892]; olfactory bulb interneuron development [GO:0021891]; positive regulation of DNA-templated transcription [GO:0045893]; positive regulation of transcription by RNA polymerase II [GO:0045944]; post-embryonic development [GO:0009791]; regulation of centrosome cycle [GO:0046605]; regulation of DNA-templated transcription [GO:0006355]; regulation of transcription by RNA polymerase II [GO:0006357],centrosome [GO:0005813]; chromatin [GO:0000785]; cytosol [GO:0005829]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; RNA polymerase II transcription regulator complex [GO:0090575],"chromatin binding [GO:0003682]; DNA-binding transcription activator activity, RNA polymerase II-specific [GO:0001228]; DNA-binding transcription factor activity [GO:0003700]; DNA-binding transcription factor activity, RNA polymerase II-specific [GO:0000981]; kinase binding [GO:0019900]; RNA polymerase II transcription regulatory region sequence-specific DNA binding [GO:0000977]; sequence-specific DNA binding [GO:0043565]; transcription cis-regulatory region binding [GO:0000976]; tubulin binding [GO:0015631]","PTM: Ubiquitinated by CDC34 and UBE2B in order to be degraded by the proteasome. Cisplatin inhibits ubiquitination and proteasome-mediated degradation by inhibiting the interaction with CDC34 (PubMed:18458088). Ubiquitination and degradation by the proteasome are inhibited by NLK in a kinase-independent manner (PubMed:25512613). {ECO:0000269|PubMed:10373550, ECO:0000269|PubMed:18458088, ECO:0000269|PubMed:22528486, ECO:0000269|PubMed:25512613}.; PTM: Phosphorylated by NLK, probably at Ser-92, Thr-94, Ser-126 and Ser-190. {ECO:0000269|PubMed:25512613}.; PTM: Acetylated at Lys-29 by EP300, the acetylation enhances the interaction with CEBPB, DNA-binding and transactivation activity. {ECO:0000250|UniProtKB:O70191, ECO:0000250|UniProtKB:Q6P788}.",,"DOMAIN 208..271; /note=""bZIP""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00978""",,,,"cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,ATF5 ATFX,Cyclic AMP-dependent transcription factor ATF-5 (cAMP-dependent transcription factor ATF-5) (Activating transcription factor 5) (Transcription factor ATFx),Homo sapiens (Human),282.0,30674.0,MSLLATLGLELDRALLPASGLGWLVDYGKLPPAPAPLAPYEVLGGALEGGLPVGGEPLAGDGFSDWMTERVDFTALLPLEPPLPPGTLPQPSPTPPDLEAMASLLKKELEQMEDFFLDAPPLPPPSPPPLPPPPLPPAPSLPLSLPSFDLPQPPVLDTLDLLAIYCRNEAGQEEVGMPPLPPPQQPPPPSPPQPSRLAPYPHPATTRGDRKQKKRDQNKSAALRYRQRKRAEGEALEGECQGLEARNRELKERAESVEREIQYVKDLLIEVYKARSQRTRSC,False,True,False,Q9Y2D1,"[('cd14692', 'Basic leucine zipper (bZIP) domain of Activating Transcription Factor-4 (ATF-4) and similar proteins: a DNA-binding and dimerization domain'), ('G3DSA:1.20.5.170', None), ('IPR004827', 'Basic-leucine zipper domain'), ('IPR046347', 'Basic-leucine zipper domain superfamily'), ('PF00170', 'bZIP transcription factor'), ('PS50217', 'Basic-leucine zipper (bZIP) domain profile'), ('PTHR13044', 'Basic leucine zipper (bZIP) transcription factors'), ('SM00338', 'basic region leucin zipper'), ('SSF57959', 'Leucine zipper domain')]",,"""ENSG00000169136; Tissue enriched (liver)."";",,,,,ENST00000423777.7;ENST00000595125.5;,ATF5,ENSG00000169136,0.0,,,,,,,0.819,0.365,ATF5
Q9Y2D8,ENSG00000117155,ADIP_HUMAN,cell adhesion [GO:0007155]; centrosome cycle [GO:0007098]; cilium assembly [GO:0060271]; intraciliary transport involved in cilium assembly [GO:0035735]; regulation of cell motility [GO:2000145]; regulation of Rac protein signal transduction [GO:0035020],adherens junction [GO:0005912]; cell leading edge [GO:0031252]; centriolar satellite [GO:0034451]; ciliary basal body [GO:0036064]; cytoplasm [GO:0005737]; nucleus [GO:0005634]; protein-containing complex [GO:0032991],,,DOMAIN: Both the N-terminal (up to position 79) and the C-terminal (from position 304) sequences are required for interaction with SSX2.,,,,,"cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,SSX2IP KIAA0923,Afadin- and alpha-actinin-binding protein (ADIP) (Afadin DIL domain-interacting protein) (SSX2-interacting protein),Homo sapiens (Human),614.0,71236.0,MGDWMTVTDPGLSSESKTISQYTSETKMSPSSLYSQQVLCSSIPLSKNVHSFFSAFCTEDNIEQSISYLDQELTTFGFPSLYEESKGKETKRELNIVAVLNCMNELLVLQRKNLLAQENVETQNLKLGSDMDHLQSCYSKLKEQLETSRREMIGLQERDRQLQCKNRNLHQLLKNEKDEVQKLQNIIASRATQYNHDMKRKEREYNKLKERLHQLVMNKKDKKIAMDILNYVGRADGKRGSWRTGKTEARNEDEMYKILLNDYEYRQKQILMENAELKKVLQQMKKEMISLLSPQKKKPRERVDDSTGTVISDVEEDAGELSRESMWDLSCETVREQLTNSIRKQWRILKSHVEKLDNQVSKVHLEGFNDEDVISRQDHEQETEKLELEIQQCKEMIKTQQQLLQQQLATAYDDDTTSLLRDCYLLEEKERLKEEWSLFKEQKKNFERERRSFTEAAIRLGLERKAFEEERASWLKQQFLNMTTFDHQNSENVKLFSAFSGSSDWDNLIVHSRQPQKKPHSVSNGSPVCMSKLTKSLPASPSTSDFCQTRSCISEHSSINVLNITAEEIKPNQVGGECTNQKWSVASRPGSQEGCYSGCSLSYTNSHVEKDDLP,False,False,True,Q9Y2D8,"[('IPR021622', 'Afadin/alpha-actinin-binding'), ('IPR052300', 'Adhesion and Centrosome-associated Protein'), ('PF11559', 'Afadin- and alpha -actinin-Binding'), ('PTHR46507', 'Adhesion and Centrosome-associated Protein')]",,"""ENSG00000117155; Tissue enhanced (retina, testis)."";",,,,,ENST00000342203.8 [Q9Y2D8-1];ENST00000437941.6 [Q9Y2D8-3];ENST00000481102.5 [Q9Y2D8-2];ENST00000605755.5 [Q9Y2D8-3];,SSX2IP,ENSG00000117155,0.0,,,,,,,0.697,0.042,SSX2IP
Q9Y2X8,ENSG00000078967,UB2D4_HUMAN,protein K11-linked ubiquitination [GO:0070979]; protein K27-linked ubiquitination [GO:0044314]; protein K29-linked ubiquitination [GO:0035519]; protein K48-linked ubiquitination [GO:0070936]; protein K6-linked ubiquitination [GO:0085020]; protein K63-linked ubiquitination [GO:0070534]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process [GO:0006511],nucleus [GO:0005634]; ubiquitin ligase complex [GO:0000151],ATP binding [GO:0005524]; ubiquitin conjugating enzyme activity [GO:0061631]; ubiquitin protein ligase binding [GO:0031625]; ubiquitin-protein transferase activity [GO:0004842],,,"DOMAIN 1..147; /note=""UBC core""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00388""",,,,"cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,UBE2D4 UBCH5D,Ubiquitin-conjugating enzyme E2 D4 (EC 2.3.2.23) (E2 ubiquitin-conjugating enzyme D4) (HBUCE1) (Ubiquitin carrier protein D4) (Ubiquitin-protein ligase D4),Homo sapiens (Human),147.0,16649.0,MALKRIQKELTDLQRDPPAQCSAGPVGDDLFHWQATIMGPNDSPYQGGVFFLTIHFPTDYPFKPPKVAFTTKIYHPNINSNGSICLDILRSQWSPALTVSKVLLSICSLLCDPNPDDPLVPEIAHTYKADREKYNRLAREWTQKYAM,False,False,True,Q9Y2X8,"[('cd00195', 'UBCc'), ('G3DSA:3.10.110.10', 'Ubiquitin Conjugating Enzyme'), ('IPR000608', 'Ubiquitin-conjugating enzyme E2'), ('IPR016135', 'Ubiquitin-conjugating enzyme/RWD-like'), ('IPR023313', 'Ubiquitin-conjugating enzyme, active site'), ('PF00179', 'Ubiquitin-conjugating enzyme'), ('PS00183', 'Ubiquitin-conjugating (UBC) active site signature'), ('PS50127', 'Ubiquitin-conjugating (UBC) core domain profile'), ('PTHR24068', 'Ubiquitin-conjugating enzyme'), ('SM00212', 'Ubiquitin-conjugating enzyme E2, catalytic domain homologues'), ('SSF54495', 'UBC-like')]",,"""ENSG00000078967; Tissue enhanced (skeletal)."";","CATALYTIC ACTIVITY: Reaction=S-ubiquitinyl-[E1 ubiquitin-activating enzyme]-L-cysteine + [E2 ubiquitin-conjugating enzyme]-L-cysteine = [E1 ubiquitin-activating enzyme]-L-cysteine + S-ubiquitinyl-[E2 ubiquitin-conjugating enzyme]-L-cysteine.; EC=2.3.2.23; Evidence={ECO:0000255|PROSITE-ProRule:PRU00388, ECO:0000255|PROSITE-ProRule:PRU10133, ECO:0000269|PubMed:20061386};",2.3.2.23,,PATHWAY: Protein modification; protein ubiquitination. {ECO:0000255|PROSITE-ProRule:PRU00388}.,ENST00000222402.8;,UBE2D4,ENSG00000078967,0.0,,,,,,,,,UBE2D4
Q9Y3E5,ENSG00000141378,PTH2_HUMAN,apoptotic process [GO:0006915]; negative regulation of anoikis [GO:2000811]; negative regulation of gene expression [GO:0010629]; positive regulation of anoikis [GO:2000210],cytosol [GO:0005829]; membrane [GO:0016020]; mitochondrial outer membrane [GO:0005741]; mitochondrion [GO:0005739],aminoacyl-tRNA hydrolase activity [GO:0004045],"PTM: Ubiquitinated by PRKN during mitophagy, leading to its degradation and enhancement of mitophagy. Deubiquitinated by USP30. {ECO:0000269|PubMed:25621951}.",,,"STRAND 65..72; /evidence=""ECO:0007829|PDB:1Q7S""; STRAND 115..122; /evidence=""ECO:0007829|PDB:1Q7S""; STRAND 140..145; /evidence=""ECO:0007829|PDB:1Q7S""; STRAND 147..151; /evidence=""ECO:0007829|PDB:1Q7S""; STRAND 153..165; /evidence=""ECO:0007829|PDB:1Q7S""","HELIX 73..75; /evidence=""ECO:0007829|PDB:1Q7S""; HELIX 79..100; /evidence=""ECO:0007829|PDB:1Q7S""; HELIX 102..110; /evidence=""ECO:0007829|PDB:1Q7S""; HELIX 123..135; /evidence=""ECO:0007829|PDB:1Q7S""; HELIX 166..173; /evidence=""ECO:0007829|PDB:1Q7S""",,"cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,PTRH2 BIT1 PTH2 CGI-147,"Peptidyl-tRNA hydrolase 2, mitochondrial (PTH 2) (EC 3.1.1.29) (Bcl-2 inhibitor of transcription 1)",Homo sapiens (Human),179.0,19194.0,MPSKSLVMEYLAHPSTLGLAVGVACGMCLGWSLRVCFGMLPKSKTSKTHTDTESEASILGDSGEYKMILVVRNDLKMGKGKVAAQCSHAAVSAYKQIQRRNPEMLKQWEYCGQPKVVVKAPDEETLIALLAHAKMLGLTVSLIQDAGRTQIAPGSQTVLGIGPGPADLIDKVTGHLKLY,True,True,True,Q9Y3E5,"[('cd02430', 'PTH2'), ('G3DSA:3.40.1490.10', 'Bit1'), ('IPR002833', 'Peptidyl-tRNA hydrolase, PTH2'), ('IPR023476', 'Peptidyl-tRNA hydrolase II domain superfamily'), ('PF01981', 'Peptidyl-tRNA hydrolase PTH2'), ('PS51257', 'Prokaryotic membrane lipoprotein lipid attachment site profile'), ('PTHR12649', 'PEPTIDYL-TRNA HYDROLASE 2'), ('SSF102462', 'Peptidyl-tRNA hydrolase II'), ('TIGR00283', 'aminoacyl-tRNA hydrolase')]",,"""ENSG00000141378; Low tissue specificity."";","CATALYTIC ACTIVITY: Reaction=an N-acyl-L-alpha-aminoacyl-tRNA + H2O = an N-acyl-L-amino acid + a tRNA + H(+); Xref=Rhea:RHEA:54448, Rhea:RHEA-COMP:10123, Rhea:RHEA-COMP:13883, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:59874, ChEBI:CHEBI:78442, ChEBI:CHEBI:138191; EC=3.1.1.29; Evidence={ECO:0000269|PubMed:14660562};",3.1.1.29,,,ENST00000393038.3;ENST00000470557.2;,PTRH2,ENSG00000141378,0.0,PTRH2,Canonical_RBPs,12.0,,,,0.33,,PTRH2
Q9Y4K3,ENSG00000175104,TRAF6_HUMAN,activation of protein kinase activity [GO:0032147]; antigen processing and presentation of exogenous peptide antigen via MHC class II [GO:0019886]; antiviral innate immune response [GO:0140374]; autophagosome assembly [GO:0000045]; bone resorption [GO:0045453]; canonical NF-kappaB signal transduction [GO:0007249]; CD40 signaling pathway [GO:0023035]; cellular response to cytokine stimulus [GO:0071345]; cellular response to lipopolysaccharide [GO:0071222]; cytoplasmic pattern recognition receptor signaling pathway [GO:0002753]; DNA damage response [GO:0006974]; Fc-epsilon receptor signaling pathway [GO:0038095]; in utero embryonic development [GO:0001701]; innate immune response [GO:0045087]; interleukin-1-mediated signaling pathway [GO:0070498]; interleukin-17-mediated signaling pathway [GO:0097400]; interleukin-17A-mediated signaling pathway [GO:0038173]; interleukin-33-mediated signaling pathway [GO:0038172]; lipopolysaccharide-mediated signaling pathway [GO:0031663]; MyD88-dependent toll-like receptor signaling pathway [GO:0002755]; myeloid dendritic cell differentiation [GO:0043011]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of transcription by RNA polymerase II [GO:0000122]; neural tube closure [GO:0001843]; non-canonical NF-kappaB signal transduction [GO:0038061]; odontogenesis of dentin-containing tooth [GO:0042475]; ossification [GO:0001503]; osteoclast differentiation [GO:0030316]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of interleukin-12 production [GO:0032735]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of interleukin-6 production [GO:0032755]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of leukocyte adhesion to vascular endothelial cell [GO:1904996]; positive regulation of lipopolysaccharide-mediated signaling pathway [GO:0031666]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of osteoclast differentiation [GO:0045672]; positive regulation of protein ubiquitination [GO:0031398]; positive regulation of T cell cytokine production [GO:0002726]; positive regulation of T cell proliferation [GO:0042102]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of transcription regulatory region DNA binding [GO:2000679]; positive regulation of type I interferon production [GO:0032481]; protein autoubiquitination [GO:0051865]; protein K63-linked ubiquitination [GO:0070534]; protein polyubiquitination [GO:0000209]; regulation of apoptotic process [GO:0042981]; regulation of canonical NF-kappaB signal transduction [GO:0043122]; regulation of immunoglobulin production [GO:0002637]; regulation of neurotransmitter receptor localization to postsynaptic specialization membrane [GO:0098696]; response to interleukin-1 [GO:0070555]; stimulatory C-type lectin receptor signaling pathway [GO:0002223]; T cell receptor signaling pathway [GO:0050852]; T-helper 1 type immune response [GO:0042088]; toll-like receptor 3 signaling pathway [GO:0034138]; toll-like receptor 4 signaling pathway [GO:0034142]; TRIF-dependent toll-like receptor signaling pathway [GO:0035666]; tumor necrosis factor-mediated signaling pathway [GO:0033209],CD40 receptor complex [GO:0035631]; cell cortex [GO:0005938]; cytoplasm [GO:0005737]; cytoplasmic side of plasma membrane [GO:0009898]; cytosol [GO:0005829]; endosome membrane [GO:0010008]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; glutamatergic synapse [GO:0098978]; lipid droplet [GO:0005811]; nucleus [GO:0005634]; perinuclear region of cytoplasm [GO:0048471]; plasma membrane [GO:0005886]; protein-containing complex [GO:0032991],histone deacetylase binding [GO:0042826]; identical protein binding [GO:0042802]; protein kinase B binding [GO:0043422]; protein-macromolecule adaptor activity [GO:0030674]; tumor necrosis factor receptor binding [GO:0005164]; ubiquitin conjugating enzyme binding [GO:0031624]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842]; ubiquitin-ubiquitin ligase activity [GO:0034450]; zinc ion binding [GO:0008270],"PTM: Sumoylated on Lys-124, Lys-142 and Lys-453 with SUMO1. {ECO:0000269|PubMed:18093978}.; PTM: Polyubiquitinated on Lys-124 by TRAF3IP2; after cell stimulation with IL17A (PubMed:19825828). Polyubiquitinated on Lys-124; after cell stimulation with IL1B or TGFB. This ligand-induced cell stimulation leads to dimerization/oligomerization of TRAF6 molecules, followed by auto-ubiquitination which involves UBE2N and UBE2V1 and leads to TRAF6 activation. This 'Lys-63' site-specific poly-ubiquitination appears to be associated with the activation of signaling molecules. Endogenous autoubiquitination occurs only for the cytoplasmic form. Deubiquitinated by USP10 in a TANK-dependent manner, leading to the negative regulation of NF-kappaB signaling upon DNA damage (PubMed:25861989). LRRC19 induces 'Lys-63' ubiquitination (PubMed:25026888). Ubiquitinated at Lys-319 by the SCF(FBXL2) complex, leading to its degradation by the proteasome (By similarity). {ECO:0000250|UniProtKB:P70196, ECO:0000269|PubMed:11460167, ECO:0000269|PubMed:17135271, ECO:0000269|PubMed:18093978, ECO:0000269|PubMed:18758450, ECO:0000269|PubMed:19465916, ECO:0000269|PubMed:19675569, ECO:0000269|PubMed:19825828, ECO:0000269|PubMed:25026888, ECO:0000269|PubMed:25861989}.; PTM: (Microbial infection) Deubiquitinated by Epstein-Barr virus BPLF1 on both 'Lys-48' and 'Lys-63'-linked ubiquitin chains; leading to NF-kappa-B signaling inhibition. {ECO:0000269|PubMed:24586164}.",DOMAIN: The coiled coil domain mediates homo- and hetero-oligomerization.; DOMAIN: The MATH/TRAF domain binds to receptor cytoplasmic domains.,"DOMAIN 350..499; /note=""MATH""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00129""","STRAND 60..62; /evidence=""ECO:0007829|PDB:3HCT""; STRAND 74..76; /evidence=""ECO:0007829|PDB:8HZ2""; STRAND 78..82; /evidence=""ECO:0007829|PDB:3HCT""; STRAND 88..90; /evidence=""ECO:0007829|PDB:3HCT""; STRAND 130..133; /evidence=""ECO:0007829|PDB:3HCT""; STRAND 135..138; /evidence=""ECO:0007829|PDB:3HCU""; STRAND 142..144; /evidence=""ECO:0007829|PDB:3HCT""; STRAND 153..155; /evidence=""ECO:0007829|PDB:3HCT""; STRAND 158..161; /evidence=""ECO:0007829|PDB:3HCS""; STRAND 168..170; /evidence=""ECO:0007829|PDB:3HCS""; STRAND 186..188; /evidence=""ECO:0007829|PDB:3HCS""; STRAND 195..197; /evidence=""ECO:0007829|PDB:3HCS""; STRAND 351..357; /evidence=""ECO:0007829|PDB:1LB6""; STRAND 373..376; /evidence=""ECO:0007829|PDB:1LB6""; STRAND 380..385; /evidence=""ECO:0007829|PDB:1LB6""; STRAND 388..395; /evidence=""ECO:0007829|PDB:1LB6""; STRAND 406..414; /evidence=""ECO:0007829|PDB:1LB6""; STRAND 428..434; /evidence=""ECO:0007829|PDB:1LB6""; STRAND 446..451; /evidence=""ECO:0007829|PDB:1LB6""; STRAND 463..466; /evidence=""ECO:0007829|PDB:1LB6""; STRAND 468..478; /evidence=""ECO:0007829|PDB:1LB6""; STRAND 492..500; /evidence=""ECO:0007829|PDB:1LB6""","HELIX 66..68; /evidence=""ECO:0007829|PDB:3HCT""; HELIX 91..101; /evidence=""ECO:0007829|PDB:3HCT""; HELIX 114..116; /evidence=""ECO:0007829|PDB:3HCT""; HELIX 121..128; /evidence=""ECO:0007829|PDB:3HCT""; HELIX 145..147; /evidence=""ECO:0007829|PDB:3HCT""; HELIX 149..151; /evidence=""ECO:0007829|PDB:3HCT""; HELIX 171..173; /evidence=""ECO:0007829|PDB:3HCS""; HELIX 174..180; /evidence=""ECO:0007829|PDB:3HCS""; HELIX 198..200; /evidence=""ECO:0007829|PDB:3HCS""; HELIX 201..205; /evidence=""ECO:0007829|PDB:3HCS""; HELIX 360..368; /evidence=""ECO:0007829|PDB:1LB6""; HELIX 419..421; /evidence=""ECO:0007829|PDB:1LB6""; HELIX 440..442; /evidence=""ECO:0007829|PDB:6A33""; HELIX 457..459; /evidence=""ECO:0007829|PDB:1LB6""; HELIX 479..483; /evidence=""ECO:0007829|PDB:1LB6""","TURN 71..73; /evidence=""ECO:0007829|PDB:3HCT""; TURN 84..86; /evidence=""ECO:0007829|PDB:2ECI""; TURN 106..108; /evidence=""ECO:0007829|PDB:3HCT""; TURN 163..165; /evidence=""ECO:0007829|PDB:3HCS""; TURN 190..192; /evidence=""ECO:0007829|PDB:3HCS""; TURN 401..405; /evidence=""ECO:0007829|PDB:1LB6""; TURN 484..486; /evidence=""ECO:0007829|PDB:6A33""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,TRAF6 RNF85,TNF receptor-associated factor 6 (EC 2.3.2.27) (E3 ubiquitin-protein ligase TRAF6) (Interleukin-1 signal transducer) (RING finger protein 85) (RING-type E3 ubiquitin transferase TRAF6),Homo sapiens (Human),522.0,59573.0,MSLLNCENSCGSSQSESDCCVAMASSCSAVTKDDSVGGTASTGNLSSSFMEEIQGYDVEFDPPLESKYECPICLMALREAVQTPCGHRFCKACIIKSIRDAGHKCPVDNEILLENQLFPDNFAKREILSLMVKCPNEGCLHKMELRHLEDHQAHCEFALMDCPQCQRPFQKFHINIHILKDCPRRQVSCDNCAASMAFEDKEIHDQNCPLANVICEYCNTILIREQMPNHYDLDCPTAPIPCTFSTFGCHEKMQRNHLARHLQENTQSHMRMLAQAVHSLSVIPDSGYISEVRNFQETIHQLEGRLVRQDHQIRELTAKMETQSMYVSELKRTIRTLEDKVAEIEAQQCNGIYIWKIGNFGMHLKCQEEEKPVVIHSPGFYTGKPGYKLCMRLHLQLPTAQRCANYISLFVHTMQGEYDSHLPWPFQGTIRLTILDQSEAPVRQNHEEIMDAKPELLAFQRPTIPRNPKGFGYVTFMHLEALRQRTFIKDDTLLVRCEVSTRFDMGSLRREGFQPRSTDAGV,False,False,True,Q9Y4K3,"[('cd03776', 'MATH_TRAF6'), ('cd16643', 'Modified RING finger, HC subclass (C3HC3D-type), found in tumor necrosis factor (TNF) receptor-associated factor 6 (TRAF6) and similar proteins'), ('G3DSA:2.60.210.10', 'Apoptosis, Tumor Necrosis Factor Receptor Associated Protein 2; Chain A'), ('G3DSA:3.30.40.10', 'Zinc/RING finger domain, C3HC4 (zinc finger)'), ('IPR001293', 'Zinc finger, TRAF-type'), ('IPR001841', 'Zinc finger, RING-type'), ('IPR002083', 'MATH/TRAF domain'), ('IPR008974', 'TRAF-like'), ('IPR012227', 'TNF receptor-associated factor TRAF, metazoa'), ('IPR013083', 'Zinc finger, RING/FYVE/PHD-type'), ('IPR017907', 'Zinc finger, RING-type, conserved site'), ('IPR027139', 'TNF receptor-associated factor 6, C3HC3D-type RING zinc finger'), ('IPR037309', 'TNF receptor-associated factor 6, MATH domain'), ('IPR041310', 'TNF receptor-associated factor 6, zinc finger 2'), ('IPR049342', 'TRAF1-6, MATH domain'), ('PF02176', 'TRAF-type zinc finger'), ('PF13923', 'Zinc finger, C3HC4 type (RING finger)'), ('PF18048', 'TNF receptor-associated factor 6 zinc finger 2'), ('PF21355', 'TRAF/meprin, MATH domain'), ('PIRSF015614', 'TNF receptor-associated factor (TRAF)')]",Q9Y4K3;,"""ENSG00000175104; Low tissue specificity."";",CATALYTIC ACTIVITY: Reaction=S-ubiquitinyl-[E2 ubiquitin-conjugating enzyme]-L-cysteine + [acceptor protein]-L-lysine = [E2 ubiquitin-conjugating enzyme]-L-cysteine + N(6)-ubiquitinyl-[acceptor protein]-L-lysine.; EC=2.3.2.27; Evidence={ECO:0000269|PubMed:23514740};,2.3.2.27,,PATHWAY: Protein modification; protein ubiquitination. {ECO:0000269|PubMed:23514740}.,ENST00000348124.5;ENST00000526995.6;,TRAF6,ENSG00000175104,0.0,,,,,,,0.178,,TRAF6
Q9Y4L5,ENSG00000265491,RN115_HUMAN,negative regulation of epidermal growth factor receptor signaling pathway [GO:0042059]; negative regulation of toll-like receptor signaling pathway [GO:0034122]; protein autoubiquitination [GO:0051865]; protein K11-linked ubiquitination [GO:0070979]; protein K48-linked ubiquitination [GO:0070936]; protein K63-linked ubiquitination [GO:0070534]; protein ubiquitination [GO:0016567]; ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway [GO:0043162],cytoplasm [GO:0005737]; cytosol [GO:0005829]; endoplasmic reticulum [GO:0005783]; Golgi apparatus [GO:0005794]; nucleus [GO:0005634],metal ion binding [GO:0046872]; ubiquitin protein ligase activity [GO:0061630]; ubiquitin-protein transferase activity [GO:0004842],"PTM: Phosphorylated by AKT1, allowing association with the 14-3-3 chaperones that facilitates associating with TLRs. {ECO:0000269|PubMed:35343654}.; PTM: RING-type zinc finger-dependent and E2-dependent autoubiquitination. {ECO:0000269|PubMed:16288031, ECO:0000269|PubMed:18819927}.; PTM: Deubiquitinated by USP9X; antogonizing its autoubiquitination and subsequent proteasomal degradation. {ECO:0000269|PubMed:30689267}.",,,,,,"cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,RNF115 ZNF364,E3 ubiquitin-protein ligase RNF115 (EC 2.3.2.27) (RING finger protein 115) (RING-type E3 ubiquitin transferase RNF115) (Rab7-interacting RING finger protein) (Rabring 7) (Zinc finger protein 364),Homo sapiens (Human),304.0,33703.0,MAEASAAGADSGAAVAAHRFFCHFCKGEVSPKLPEYICPRCESGFIEEVTDDSSFLGGGGSRIDNTTTTHFAELWGHLDHTMFFQDFRPFLSSSPLDQDNRANERGHQTHTDFWGARPPRLPLGRRYRSRGSSRPDRSPAIEGILQHIFAGFFANSAIPGSPHPFSWSGMLHSNPGDYAWGQTGLDAIVTQLLGQLENTGPPPADKEKITSLPTVTVTQEQVDMGLECPVCKEDYTVEEEVRQLPCNHFFHSSCIVPWLELHDTCPVCRKSLNGEDSTRQSQSTEASASNRFSNDSQLHDRWTF,False,False,True,Q9Y4L5,"[('cd16800', 'RING finger, H2 subclass, found in RING finger protein 115 (RNF115) and similar proteins'), ('G3DSA:3.30.40.10', 'Zinc/RING finger domain, C3HC4 (zinc finger)'), ('IPR001841', 'Zinc finger, RING-type'), ('IPR013083', 'Zinc finger, RING/FYVE/PHD-type'), ('IPR051834', 'RING finger E3 ubiquitin-protein ligase'), ('PF13639', 'Ring finger domain'), ('PS50089', 'Zinc finger RING-type profile'), ('PTHR45931', 'RING finger E3 ubiquitin-protein ligase'), ('SM00184', 'Ring finger'), ('SSF57850', 'RING/U-box')]",,"""ENSG00000265491; Low tissue specificity."";",CATALYTIC ACTIVITY: Reaction=S-ubiquitinyl-[E2 ubiquitin-conjugating enzyme]-L-cysteine + [acceptor protein]-L-lysine = [E2 ubiquitin-conjugating enzyme]-L-cysteine + N(6)-ubiquitinyl-[acceptor protein]-L-lysine.; EC=2.3.2.27; Evidence={ECO:0000269|PubMed:18819927};,2.3.2.27,,PATHWAY: Protein modification; protein ubiquitination. {ECO:0000269|PubMed:18819927}.,ENST00000582693.5;,RNF115,ENSG00000265491,0.0,,,,,,,0.628,0.253,RNF115
Q9Y5Y2,ENSG00000095906,NUBP2_HUMAN,cell projection organization [GO:0030030]; iron-sulfur cluster assembly [GO:0016226],centriole [GO:0005814]; cilium [GO:0005929]; cytosol [GO:0005829]; nucleus [GO:0005634]; spindle pole centrosome [GO:0031616],"4 iron, 4 sulfur cluster binding [GO:0051539]; ATP binding [GO:0005524]; ATP-dependent FeS chaperone activity [GO:0140663]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; nucleotide binding [GO:0000166]",,,,,,,"cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,NUBP2,Cytosolic Fe-S cluster assembly factor NUBP2 (Nucleotide-binding protein 2) (NBP 2),Homo sapiens (Human),271.0,28825.0,MEAAAEPGNLAGVRHIILVLSGKGGVGKSTISTELALALRHAGKKVGILDVDLCGPSIPRMLGAQGRAVHQCDRGWAPVFLDREQSISLMSVGFLLEKPDEAVVWRGPKKNALIKQFVSDVAWGELDYLVVDTPPGTSDEHMATIEALRPYQPLGALVVTTPQAVSVGDVRRELTFCRKTGLRVMGIVENMSGFTCPHCTECTSVFSRGGGEELAQLAGVPFLGSVPLDPALMRTLEEGHDFIQEFPGSPAFAALTSIAQKILDATPACLP,True,False,False,Q9Y5Y2,"[('cd02037', 'Mrp/NBP35 ATP-binding protein family'), ('G3DSA:3.40.50.300', 'P-loop containing nucleotide triphosphate hydrolases'), ('IPR000808', 'Iron-sulfur cluster carrier protein-like, conserved site'), ('IPR019591', 'Mrp/NBP35 ATP-binding protein'), ('IPR027417', 'P-loop containing nucleoside triphosphate hydrolase'), ('IPR028600', 'Cytosolic Fe-S cluster assembly factor NUBP2/Cfd1, eukaryotes'), ('IPR033756', 'Flagellum site-determining protein YlxH/ Fe-S cluster assembling factor NBP35'), ('MF_02040', 'Iron-sulfur cluster carrier protein'), ('MF_03039', 'Cytosolic Fe-S cluster assembly factor NUBP2 [NUBP2]'), ('PF10609', 'NUBPL iron-transfer P-loop NTPase'), ('PS01215', 'Mrp family signature'), ('PTHR23264', 'NUCLEOTIDE-BINDING PROTEIN NBP35 YEAST -RELATED'), ('SSF52540', 'P-loop containing nucleoside triphosphate hydrolases')]",,"""ENSG00000095906; Low tissue specificity."";",,,,,ENST00000262302.14;,NUBP2,ENSG00000095906,0.0,,,,,,,,,NUBP2
Q9Y697,ENSG00000244005,NFS1_HUMAN,[2Fe-2S] cluster assembly [GO:0044571]; [4Fe-4S] cluster assembly [GO:0044572]; iron incorporation into metallo-sulfur cluster [GO:0018283]; iron-sulfur cluster assembly [GO:0016226]; Mo-molybdopterin cofactor biosynthetic process [GO:0006777]; molybdopterin cofactor metabolic process [GO:0043545],centrosome [GO:0005813]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; iron-sulfur cluster assembly complex [GO:1990229]; mitochondrial [2Fe-2S] assembly complex [GO:0099128]; mitochondrial matrix [GO:0005759]; mitochondrion [GO:0005739]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],cysteine desulfurase activity [GO:0031071]; iron-sulfur cluster binding [GO:0051536]; metal ion binding [GO:0046872]; protein homodimerization activity [GO:0042803]; pyridoxal phosphate binding [GO:0030170],PTM: N-gluconoylated. {ECO:0000250|UniProtKB:Q9Z1J3}.; PTM: Cysteine persulfide intermediate is reduced by thiol-containing molecules like glutathione and L-cysteine. Persulfide reduction is a rate-limiting step of cysteine desulfurase catalytic cycle. {ECO:0000250|UniProtKB:Q9Z1J3}.,,,"STRAND 121..125; /evidence=""ECO:0007829|PDB:6UXE""; STRAND 148..152; /evidence=""ECO:0007829|PDB:6UXE""; STRAND 172..176; /evidence=""ECO:0007829|PDB:6UXE""; STRAND 197..201; /evidence=""ECO:0007829|PDB:6UXE""; STRAND 228..232; /evidence=""ECO:0007829|PDB:6UXE""; STRAND 250..255; /evidence=""ECO:0007829|PDB:6UXE""; STRAND 266..270; /evidence=""ECO:0007829|PDB:6UXE""; STRAND 337..344; /evidence=""ECO:0007829|PDB:6UXE""; STRAND 353..358; /evidence=""ECO:0007829|PDB:6UXE""; STRAND 376..378; /evidence=""ECO:0007829|PDB:6UXE""; STRAND 405..409; /evidence=""ECO:0007829|PDB:6UXE""","HELIX 71..82; /evidence=""ECO:0007829|PDB:6UXE""; HELIX 94..114; /evidence=""ECO:0007829|PDB:6UXE""; HELIX 118..120; /evidence=""ECO:0007829|PDB:6UXE""; HELIX 127..141; /evidence=""ECO:0007829|PDB:6UXE""; HELIX 157..168; /evidence=""ECO:0007829|PDB:6UXE""; HELIX 186..192; /evidence=""ECO:0007829|PDB:6UXE""; HELIX 215..224; /evidence=""ECO:0007829|PDB:6UXE""; HELIX 256..258; /evidence=""ECO:0007829|PDB:6UXE""; HELIX 298..336; /evidence=""ECO:0007829|PDB:6UXE""; HELIX 346..348; /evidence=""ECO:0007829|PDB:7RTK""; HELIX 363..369; /evidence=""ECO:0007829|PDB:6UXE""; HELIX 380..382; /evidence=""ECO:0007829|PDB:6WIH""; HELIX 390..394; /evidence=""ECO:0007829|PDB:6UXE""; HELIX 399..402; /evidence=""ECO:0007829|PDB:6UXE""; HELIX 416..435; /evidence=""ECO:0007829|PDB:6UXE""; HELIX 438..444; /evidence=""ECO:0007829|PDB:6UXE""; HELIX 449..451; /evidence=""ECO:0007829|PDB:6UXE""","TURN 63..65; /evidence=""ECO:0007829|PDB:6UXE""; TURN 142..145; /evidence=""ECO:0007829|PDB:6UXE""; TURN 207..209; /evidence=""ECO:0007829|PDB:6UXE""; TURN 234..239; /evidence=""ECO:0007829|PDB:6UXE""; TURN 244..248; /evidence=""ECO:0007829|PDB:6UXE""; TURN 272..275; /evidence=""ECO:0007829|PDB:6UXE""; TURN 287..291; /evidence=""ECO:0007829|PDB:6UXE""; TURN 384..386; /evidence=""ECO:0007829|PDB:6WIH""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,NFS1 NIFS HUSSY-08,Cysteine desulfurase (EC 2.8.1.7),Homo sapiens (Human),457.0,50196.0,MLLRAAWRRAAVAVTAAPGPKPAAPTRGLRLRVGDRAPQSAVPADTAAAPEVGPVLRPLYMDVQATTPLDPRVLDAMLPYLINYYGNPHSRTHAYGWESEAAMERARQQVASLIGADPREIIFTSGATESNNIAIKGVARFYRSRKKHLITTQTEHKCVLDSCRSLEAEGFQVTYLPVQKSGIIDLKELEAAIQPDTSLVSVMTVNNEIGVKQPIAEIGRICSSRKVYFHTDAAQAVGKIPLDVNDMKIDLMSISGHKIYGPKGVGAIYIRRRPRVRVEALQSGGGQERGMRSGTVPTPLVVGLGAACEVAQQEMEYDHKRISKLSERLIQNIMKSLPDVVMNGDPKHHYPGCINLSFAYVEGESLLMALKDVALSSGSACTSASLEPSYVLRAIGTDEDLAHSSIRFGIGRFTTEEEVDYTVEKCIQHVKRLREMSPLWEMVQDGIDLKSIKWTQH,True,False,False,Q9Y697,"[('G3DSA:3.40.640.10', 'Type I PLP-dependent aspartate aminotransferase-like (Major domain)'), ('G3DSA:3.90.1150.10', 'Aspartate Aminotransferase, domain 1'), ('IPR000192', 'Aminotransferase class V domain'), ('IPR010240', 'Cysteine desulfurase IscS'), ('IPR015421', 'Pyridoxal phosphate-dependent transferase, major domain'), ('IPR015422', 'Pyridoxal phosphate-dependent transferase, small domain'), ('IPR015424', 'Pyridoxal phosphate-dependent transferase'), ('IPR016454', 'Cysteine desulfurase'), ('IPR020578', 'Aminotransferase class-V, pyridoxal-phosphate binding site'), ('MF_00331', 'Cysteine desulfurase IscS [iscS]'), ('PF00266', 'Aminotransferase class-V'), ('PIRSF005572', 'Cysteine desulphurase, NifS type'), ('PS00595', 'Aminotransferases class-V pyridoxal-phosphate attachment site'), ('PTHR11601', 'Cysteine desulfurase'), ('SSF53383', 'PLP-dependent transferases'), ('TIGR02006', 'IscS subfamily cysteine desulfurase')]",,"""ENSG00000244005; Low tissue specificity."";","CATALYTIC ACTIVITY: [Isoform Mitochondrial]: Reaction=[sulfur carrier]-H + L-cysteine = [sulfur carrier]-SH + L-alanine; Xref=Rhea:RHEA:43892, Rhea:RHEA-COMP:14737, Rhea:RHEA-COMP:14739, ChEBI:CHEBI:29917, ChEBI:CHEBI:35235, ChEBI:CHEBI:57972, ChEBI:CHEBI:64428; EC=2.8.1.7; Evidence={ECO:0000269|PubMed:18650437, ECO:0000269|PubMed:29097656, ECO:0000269|PubMed:31101807}; CATALYTIC ACTIVITY: [Isoform Cytoplasmic]: Reaction=[sulfur carrier]-H + L-cysteine = [sulfur carrier]-SH + L-alanine; Xref=Rhea:RHEA:43892, Rhea:RHEA-COMP:14737, Rhea:RHEA-COMP:14739, ChEBI:CHEBI:29917, ChEBI:CHEBI:35235, ChEBI:CHEBI:57972, ChEBI:CHEBI:64428; EC=2.8.1.7; Evidence={ECO:0000269|PubMed:16527810, ECO:0000305|PubMed:18650437}; CATALYTIC ACTIVITY: [Isoform Cytoplasmic]: Reaction=[sulfur-carrier protein]-L-cysteine + L-cysteine = [sulfur-carrier protein]-S-sulfanyl-L-cysteine + L-alanine; Xref=Rhea:RHEA:17457, Rhea:RHEA-COMP:10742, Rhea:RHEA-COMP:10744, ChEBI:CHEBI:29950, ChEBI:CHEBI:35235, ChEBI:CHEBI:57972, ChEBI:CHEBI:61963; Evidence={ECO:0000269|PubMed:18650437, ECO:0000269|PubMed:23593335};",2.8.1.7,ACTIVITY REGULATION: Active only in complex with LYRM4. {ECO:0000269|PubMed:18650437}.,,ENST00000374085.5 [Q9Y697-2];ENST00000374092.9 [Q9Y697-1];ENST00000397425.5 [Q9Y697-2];ENST00000541387.5 [Q9Y697-3];,NFS1,ENSG00000244005,0.0,,,,,,,0.147,,NFS1
Q9Y6I3,ENSG00000063245,EPN1_HUMAN,embryonic organ development [GO:0048568]; endocytosis [GO:0006897]; female pregnancy [GO:0007565]; in utero embryonic development [GO:0001701]; negative regulation of sprouting angiogenesis [GO:1903671]; Notch signaling pathway [GO:0007219],clathrin vesicle coat [GO:0030125]; clathrin-coated pit [GO:0005905]; cytosol [GO:0005829]; endosome [GO:0005768]; nucleus [GO:0005634]; plasma membrane [GO:0005886],clathrin binding [GO:0030276]; molecular sequestering activity [GO:0140313]; phospholipid binding [GO:0005543],"PTM: Phosphorylated on serine and/or threonine residues in mitotic cells. Phosphorylation reduces interaction with REPS2, AP-2 and the membrane fraction. Depolarization of synaptosomes results in dephosphorylation. {ECO:0000269|PubMed:10764745}.; PTM: Ubiquitinated. {ECO:0000250}.","DOMAIN: The NPF repeat domain is involved in EPS15 binding.; DOMAIN: The DPW repeat domain is involved in AP2A2 and clathrin binding.; DOMAIN: The [DE]-X(1,2)-F-X-X-[FL]-X-X-X-R motif mediates interaction with the AP-2 complex subunit AP2B1. {ECO:0000250}.","DOMAIN 12..144; /note=""ENTH""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00243""; DOMAIN 183..202; /note=""UIM 1""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00213""; DOMAIN 208..227; /note=""UIM 2""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00213""; DOMAIN 233..252; /note=""UIM 3""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00213""",,"HELIX 20..27; /evidence=""ECO:0007829|PDB:1INZ""; HELIX 39..47; /evidence=""ECO:0007829|PDB:1INZ""; HELIX 51..62; /evidence=""ECO:0007829|PDB:1INZ""; HELIX 63..65; /evidence=""ECO:0007829|PDB:1INZ""; HELIX 72..86; /evidence=""ECO:0007829|PDB:1INZ""; HELIX 90..98; /evidence=""ECO:0007829|PDB:1INZ""; HELIX 100..108; /evidence=""ECO:0007829|PDB:1INZ""; HELIX 121..134; /evidence=""ECO:0007829|PDB:1INZ""",,"cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,EPN1,Epsin-1 (EH domain-binding mitotic phosphoprotein) (EPS-15-interacting protein 1),Homo sapiens (Human),576.0,60293.0,MSTSSLRRQMKNIVHNYSEAEIKVREATSNDPWGPSSSLMSEIADLTYNVVAFSEIMSMIWKRLNDHGKNWRHVYKAMTLMEYLIKTGSERVSQQCKENMYAVQTLKDFQYVDRDGKDQGVNVREKAKQLVALLRDEDRLREERAHALKTKEKLAQTATASSAAVGSGPPPEAEQAWPQSSGEEELQLQLALAMSKEEADQPPSCGPEDDAQLQLALSLSREEHDKEERIRRGDDLRLQMAIEESKRETGGKEESSLMDLADVFTAPAPAPTTDPWGGPAPMAAAVPTAAPTSDPWGGPPVPPAADPWGGPAPTPASGDPWRPAAPAGPSVDPWGGTPAPAAGEGPTPDPWGSSDGGVPVSGPSASDPWTPAPAFSDPWGGSPAKPSTNGTTAAGGFDTEPDEFSDFDRLRTALPTSGSSAGELELLAGEVPARSPGAFDMSGVRGSLAEAVGSPPPAATPTPTPPTRKTPESFLGPNAALVDLDSLVSRPGPTPPGAKASNPFLPGGGPATGPSVTNPFQPAPPATLTLNQLRLSPVPPVPGAPPTYISPLGGGPGLPPMMPPGPPAPNTNPFLL,True,False,True,Q9Y6I3,"[('cd16990', 'Epsin N-Terminal Homology (ENTH) domain of Epsin family'), ('G3DSA:1.25.40.90', None), ('IPR003903', 'Ubiquitin interacting motif'), ('IPR008942', 'ENTH/VHS'), ('IPR013809', 'ENTH domain'), ('PF01417', 'ENTH domain'), ('PS50330', 'Ubiquitin-interacting motif (UIM) domain profile'), ('PS50942', 'ENTH domain profile'), ('PTHR12276', 'Epsin'), ('SM00273', 'Epsin N-terminal homology (ENTH) domain'), ('SM00726', 'Ubiquitin-interacting motif.'), ('SSF48464', 'ENTH/VHS domain')]",Q9Y6I3;,"""ENSG00000063245; Low tissue specificity."";",,,,,ENST00000085079.11 [Q9Y6I3-3];ENST00000270460.11 [Q9Y6I3-2];ENST00000411543.6 [Q9Y6I3-1];,EPN1,ENSG00000063245,0.0,,,,3.13,DP02930,0.031,0.698,0.531,EPN1
Q9Y6K9,ENSG00000269335,NEMO_HUMAN,anoikis [GO:0043276]; apoptotic process [GO:0006915]; canonical NF-kappaB signal transduction [GO:0007249]; defense response to bacterium [GO:0042742]; DNA damage response [GO:0006974]; establishment of vesicle localization [GO:0051650]; immune response [GO:0006955]; inflammatory response [GO:0006954]; innate immune response [GO:0045087]; positive regulation of canonical NF-kappaB signal transduction [GO:0043123]; positive regulation of macroautophagy [GO:0016239]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of T cell receptor signaling pathway [GO:0050862]; positive regulation of transcription by RNA polymerase II [GO:0045944]; positive regulation of ubiquitin-dependent protein catabolic process [GO:2000060]; protein-containing complex assembly [GO:0065003]; response to virus [GO:0009615]; T cell receptor signaling pathway [GO:0050852],cytoplasm [GO:0005737]; cytosol [GO:0005829]; IkappaB kinase complex [GO:0008385]; mitotic spindle [GO:0072686]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991]; spindle pole [GO:0000922]; ubiquitin ligase complex [GO:0000151],identical protein binding [GO:0042802]; K63-linked polyubiquitin modification-dependent protein binding [GO:0070530]; linear polyubiquitin binding [GO:1990450]; metal ion binding [GO:0046872]; polyubiquitin modification-dependent protein binding [GO:0031593]; protein domain specific binding [GO:0019904]; protein heterodimerization activity [GO:0046982]; protein homodimerization activity [GO:0042803]; signaling adaptor activity [GO:0035591]; transferrin receptor binding [GO:1990459]; ubiquitin protein ligase binding [GO:0031625],"PTM: Phosphorylation at Ser-68 attenuates aminoterminal homodimerization. {ECO:0000269|PubMed:17977820}.; PTM: Polyubiquitinated on Lys-285 via 'Lys-63'-linked ubiquitin; the ubiquitination is mediated downstream of NOD2 and RIPK2 and probably plays a role in signaling by facilitating interactions with ubiquitin domain-containing proteins and activates the NF-kappa-B pathway (PubMed:15620648, PubMed:17562858, PubMed:19136968). Polyubiquitinated on Lys-285 and Lys-399 through 'Lys-63'-linked ubiquitin; the ubiquitination is mediated by BCL10, MALT1 and TRAF6 and probably plays a role in signaling by facilitating interactions with ubiquitin domain-containing proteins and activates the NF-kappa-B pathway (PubMed:14695475, PubMed:17562858, PubMed:19136968). Monoubiquitinated on Lys-277 and Lys-309; promotes nuclear export (PubMed:14651848). Polyubiquitinated through 'Lys-27' by TRIM23; involved in antiviral innate and inflammatory responses (PubMed:20724660). Linear polyubiquitinated on Lys-111, Lys-143, Lys-226, Lys-246, Lys-264, Lys-277, Lys-285, Lys-292, Lys-302, Lys-309 and Lys-326; the head-to-tail polyubiquitination is mediated by the LUBAC complex and plays a key role in NF-kappa-B activation (PubMed:21455181). Deubiquitinated by USP10 in a TANK-dependent and -independent manner, leading to the negative regulation of NF-kappa-B signaling upon DNA damage (PubMed:25861989). Ubiquitinated at Lys-326 by MARCHF2 following bacterial and viral infection which leads to its degradation (PubMed:32935379). Polyubiquitinated via 'Lys-29'-linked ubiquitin; leading to lysosomal degradation (PubMed:21518757). {ECO:0000269|PubMed:14651848, ECO:0000269|PubMed:14695475, ECO:0000269|PubMed:15620648, ECO:0000269|PubMed:17562858, ECO:0000269|PubMed:19136968, ECO:0000269|PubMed:20724660, ECO:0000269|PubMed:21455181, ECO:0000269|PubMed:21518757, ECO:0000269|PubMed:25861989, ECO:0000269|PubMed:32935379}.; PTM: Sumoylated on Lys-277 and Lys-309 with SUMO1; the modification results in phosphorylation of Ser-85 by ATM leading to a replacement of the sumoylation by mono-ubiquitination on these residues. {ECO:0000269|PubMed:14651848, ECO:0000269|PubMed:16497931, ECO:0000269|PubMed:19136968, ECO:0000269|PubMed:20010814, ECO:0000269|PubMed:21455181}.; PTM: Neddylated by TRIM40, resulting in stabilization of NFKBIA and down-regulation of NF-kappa-B activity. {ECO:0000269|PubMed:21474709}.; PTM: (Microbial infection) Cleaved by hepatitis A virus (HAV) protease 3C allowing the virus to disrupt the host innate immune signaling. {ECO:0000269|PubMed:24920812}.; PTM: (Microbial infection) Deubiquitinated by Epstein-Barr virus BPLF1 on both 'Lys-48' and 'Lys-63'-linked ubiquitin chains; leading to NF-kappa-B signaling inhibition. {ECO:0000269|PubMed:24586164}.; PTM: (Microbial infection) Polyubiquitinated on Lys-309 and Lys-321 via 'Lys-27'-linked ubiquitin by Shigella flexneri E3 ubiquitin-protein ligase ipah9.8, leading to its degradation by the proteasome. {ECO:0000269|PubMed:20010814}.; PTM: (Microbial infection) Polyubiquitination through 'Lys-63' is interrupted by interaction with SARS coronavirus-2/SARS-CoV-2 virus protein ORF9B which inhibits the NF-kappa-B pathway. {ECO:0000269|PubMed:33567255}.","DOMAIN: The leucine-zipper domain and the CCHC NOA-type zinc-fingers constitute the UBAN region and are essential for polyubiquitin binding and for the activation of IRF3. {ECO:0000269|PubMed:18313693, ECO:0000269|PubMed:19854139}.",,"STRAND 394..396; /evidence=""ECO:0007829|PDB:2JVY""; STRAND 403..406; /evidence=""ECO:0007829|PDB:2JVX""","HELIX 38..129; /evidence=""ECO:0007829|PDB:6MI3""; HELIX 197..249; /evidence=""ECO:0007829|PDB:3CL3""; HELIX 260..268; /evidence=""ECO:0007829|PDB:4BWN""; HELIX 271..295; /evidence=""ECO:0007829|PDB:4BWN""; HELIX 297..341; /evidence=""ECO:0007829|PDB:4BWN""; HELIX 407..416; /evidence=""ECO:0007829|PDB:2JVX""","TURN 194..196; /evidence=""ECO:0007829|PDB:3CL3""; TURN 398..400; /evidence=""ECO:0007829|PDB:5AAY""","cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,IKBKG FIP3 NEMO,NF-kappa-B essential modulator (NEMO) (FIP-3) (IkB kinase-associated protein 1) (IKKAP1) (Inhibitor of nuclear factor kappa-B kinase subunit gamma) (I-kappa-B kinase subunit gamma) (IKK-gamma) (IKKG) (IkB kinase subunit gamma) (NF-kappa-B essential modifier),Homo sapiens (Human),419.0,48198.0,MNRHLWKSQLCEMVQPSGGPAADQDVLGEESPLGKPAMLHLPSEQGAPETLQRCLEENQELRDAIRQSNQILRERCEELLHFQASQREEKEFLMCKFQEARKLVERLGLEKLDLKRQKEQALREVEHLKRCQQQMAEDKASVKAQVTSLLGELQESQSRLEAATKECQALEGRARAASEQARQLESEREALQQQHSVQVDQLRMQGQSVEAALRMERQAASEEKRKLAQLQVAYHQLFQEYDNHIKSSVVGSERKRGMQLEDLKQQLQQAEEALVAKQEVIDKLKEEAEQHKIVMETVPVLKAQADIYKADFQAERQAREKLAEKKELLQEQLEQLQREYSKLKASCQESARIEDMRKRHVEVSQAPLPPAPAYLSSPLALPSQRRSPPEEPPDFCCPKCQYQAPDMDTLQIHVMECIE,False,False,True,Q9Y6K9,"[('G3DSA:1.20.5.390', 'L1 transposable element, trimerization domain'), ('G3DSA:1.20.5.990', 'Nemo cc2-lz domain - 1d5 darpin complex'), ('IPR021063', 'NF-kappa-B essential modulator NEMO, N-terminal'), ('IPR032419', 'NF-kappa-B essential modulator NEMO, CC2-LZ domain'), ('IPR034735', 'NEMO, Zinc finger'), ('IPR051301', 'Optineurin/NF-kappa-B Essential Modulator'), ('PF11577', 'NF-kappa-B essential modulator NEMO'), ('PF16516', 'Leucine zipper of domain CC2 of NEMO, NF-kappa-B essential modulator'), ('PF18414', 'C2H2 type zinc-finger'), ('PS51801', 'Zinc finger CCHC NOA-type profile'), ('PTHR31553', 'Optineurin/NF-kappa-B Essential Modulator')]",,"""ENSG00000269335; Low tissue specificity."";",,,,,ENST00000422680.6 [Q9Y6K9-1];ENST00000440286.6 [Q9Y6K9-1];ENST00000445622.6 [Q9Y6K9-1];ENST00000594239.6 [Q9Y6K9-1];ENST00000611071.4 [Q9Y6K9-1];ENST00000611176.4 [Q9Y6K9-3];ENST00000618670.4 [Q9Y6K9-2];,IKBKG,ENSG00000269335,0.0,,,,25.54,DP02269,0.439,0.42,0.091,IKBKG
Q9Y6Q9,ENSG00000124151,NCOA3_HUMAN,cell dedifferentiation [GO:0043697]; cellular response to estradiol stimulus [GO:0071392]; cellular response to hormone stimulus [GO:0032870]; positive regulation of keratinocyte differentiation [GO:0045618]; positive regulation of stem cell population maintenance [GO:1902459]; positive regulation of transcription by RNA polymerase II [GO:0045944]; receptor transactivation [GO:0035624]; regulation of stem cell division [GO:2000035]; retinoic acid receptor signaling pathway [GO:0048384]; vitamin D receptor signaling pathway [GO:0070561],chromatin [GO:0000785]; cytoplasm [GO:0005737]; cytosol [GO:0005829]; extracellular exosome [GO:0070062]; nucleoplasm [GO:0005654]; nucleus [GO:0005634]; protein-containing complex [GO:0032991],disordered domain specific binding [GO:0097718]; histone acetyltransferase activity [GO:0004402]; nuclear receptor binding [GO:0016922]; nuclear receptor coactivator activity [GO:0030374]; nuclear thyroid hormone receptor binding [GO:0046966]; protein dimerization activity [GO:0046983]; RNA polymerase II complex binding [GO:0000993]; transcription coactivator activity [GO:0003713],"PTM: Acetylated by CREBBP. Acetylation occurs in the RID domain, and disrupts the interaction with nuclear receptors and regulates its function. {ECO:0000269|PubMed:10490106}.; PTM: Methylated by CARM1. {ECO:0000250}.; PTM: Phosphorylated by IKK complex. Regulated its function. Phosphorylation at Ser-601 by CK1 promotes coactivator function. {ECO:0000269|PubMed:11971985, ECO:0000269|PubMed:19339517}.","DOMAIN: Contains three Leu-Xaa-Xaa-Leu-Leu (LXXLL) motifs. Motifs 1 and 2 are essential for the association with nuclear receptors, and constitute the RID domain (Receptor-interacting domain).","DOMAIN 25..82; /note=""bHLH""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00981""; DOMAIN 110..180; /note=""PAS""; /evidence=""ECO:0000255|PROSITE-ProRule:PRU00140""",,"HELIX 619..626; /evidence=""ECO:0007829|PDB:3L3X""; HELIX 736..743; /evidence=""ECO:0007829|PDB:3L3Z""; HELIX 1049..1063; /evidence=""ECO:0007829|PDB:6SQC""; HELIX 1067..1075; /evidence=""ECO:0007829|PDB:6SQC""; HELIX 1078..1085; /evidence=""ECO:0007829|PDB:6SQC""; HELIX 1086..1088; /evidence=""ECO:0007829|PDB:1KBH""",,"cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,NCOA3 AIB1 BHLHE42 RAC3 TRAM1,Nuclear receptor coactivator 3 (NCoA-3) (EC 2.3.1.48) (ACTR) (Amplified in breast cancer 1 protein) (AIB-1) (CBP-interacting protein) (pCIP) (Class E basic helix-loop-helix protein 42) (bHLHe42) (Receptor-associated coactivator 3) (RAC-3) (Steroid receptor coactivator protein 3) (SRC-3) (Thyroid hormone receptor activator molecule 1) (TRAM-1),Homo sapiens (Human),1424.0,155293.0,MSGLGENLDPLASDSRKRKLPCDTPGQGLTCSGEKRRREQESKYIEELAELISANLSDIDNFNVKPDKCAILKETVRQIRQIKEQGKTISNDDDVQKADVSSTGQGVIDKDSLGPLLLQALDGFLFVVNRDGNIVFVSENVTQYLQYKQEDLVNTSVYNILHEEDRKDFLKNLPKSTVNGVSWTNETQRQKSHTFNCRMLMKTPHDILEDINASPEMRQRYETMQCFALSQPRAMMEEGEDLQSCMICVARRITTGERTFPSNPESFITRHDLSGKVVNIDTNSLRSSMRPGFEDIIRRCIQRFFSLNDGQSWSQKRHYQEAYLNGHAETPVYRFSLADGTIVTAQTKSKLFRNPVTNDRHGFVSTHFLQREQNGYRPNPNPVGQGIRPPMAGCNSSVGGMSMSPNQGLQMPSSRAYGLADPSTTGQMSGARYGGSSNIASLTPGPGMQSPSSYQNNNYGLNMSSPPHGSPGLAPNQQNIMISPRNRGSPKIASHQFSPVAGVHSPMASSGNTGNHSFSSSSLSALQAISEGVGTSLLSTLSSPGPKLDNSPNMNITQPSKVSNQDSKSPLGFYCDQNPVESSMCQSNSRDHLSDKESKESSVEGAENQRGPLESKGHKKLLQLLTCSSDDRGHSSLTNSPLDSSCKESSVSVTSPSGVSSSTSGGVSSTSNMHGSLLQEKHRILHKLLQNGNSPAEVAKITAEATGKDTSSITSCGDGNVVKQEQLSPKKKENNALLRYLLDRDDPSDALSKELQPQVEGVDNKMSQCTSSTIPSSSQEKDPKIKTETSEEGSGDLDNLDAILGDLTSSDFYNNSISSNGSHLGTKQQVFQGTNSLGLKSSQSVQSIRPPYNRAVSLDSPVSVGSSPPVKNISAFPMLPKQPMLGGNPRMMDSQENYGSSMGGPNRNVTVTQTPSSGDWGLPNSKAGRMEPMNSNSMGRPGGDYNTSLPRPALGGSIPTLPLRSNSIPGARPVLQQQQQMLQMRPGEIPMGMGANPYGQAAASNQLGSWPDGMLSMEQVSHGTQNRPLLRNSLDDLVGPPSNLEGQSDERALLDQLHTLLSNTDATGLEEIDRALGIPELVNQGQALEPKQDAFQGQEAAVMMDQKAGLYGQTYPAQGPPMQGGFHLQGQSPSFNSMMNQMNQQGNFPLQGMHPRANIMRPRTNTPKQLRMQLQQRLQGQQFLNQSRQALELKMENPTAGGAAVMRPMMQPQVSSQQGFLNAQMVAQRSRELLSHHFRQQRVAMMMQQQQQQQQQQQQQQQQQQQQQQQQQQQQQTQAFSPPPNVTASPSMDGLLAGPTMPQAPPQQFPYQPNYGMGQQPDPAFGRVSSPPNAMMSSRMGPSQNPMMQHPQAASIYQSSEMKGWPSGNLARNSSFSQQQFAHQGNPAVYSMVHMNGSSGHMGQMNMNPMPMSGMPMGPDQKYC,False,False,True,Q9Y6Q9,"[('cd00130', 'PAS'), ('cd18949', 'basic helix-loop-helix-Per-ARNT-Sim (bHLH-PAS) domain found in nuclear receptor coactivator 3 (NCoA-3) and similar proteins'), ('G3DSA:3.30.450.20', 'PAS domain'), ('G3DSA:4.10.280.10', 'Helix-loop-helix DNA-binding domain'), ('G3DSA:6.10.140.410', None), ('IPR000014', 'PAS domain'), ('IPR009110', 'Nuclear receptor coactivator, interlocking'), ('IPR010011', 'Nuclear receptor coactivator, DUF1518'), ('IPR011598', 'Myc-type, basic helix-loop-helix (bHLH) domain'), ('IPR013767', 'PAS fold'), ('IPR014920', 'Nuclear receptor coactivator, Ncoa-type, interlocking'), ('IPR014935', 'Nuclear receptor coactivator, receptor-binding domain'), ('IPR017426', 'Nuclear receptor coactivator'), ('IPR032565', 'Nuclear receptor coactivator 2/3, DUF4927'), ('IPR035965', 'PAS domain superfamily'), ('IPR036638', 'Helix-loop-helix DNA-binding domain superfamily'), ('IPR037077', 'Nuclear receptor coactivator, Ncoa-type, interlocking domain superfamily'), ('IPR056193', 'Nuclear receptor coactivator 1-3, bHLH domain'), ('IPR056194', 'Nuclear receptor coactivator 3, basic helix-loop-helix'), ('PF00989', 'PAS fold')]",Q9Y6Q9;,"""ENSG00000124151; Low tissue specificity."";","CATALYTIC ACTIVITY: Reaction=L-lysyl-[protein] + acetyl-CoA = N(6)-acetyl-L-lysyl-[protein] + CoA + H(+); Xref=Rhea:RHEA:45948, Rhea:RHEA-COMP:9752, Rhea:RHEA-COMP:10731, ChEBI:CHEBI:15378, ChEBI:CHEBI:29969, ChEBI:CHEBI:57287, ChEBI:CHEBI:57288, ChEBI:CHEBI:61930; EC=2.3.1.48; Evidence={ECO:0000269|PubMed:9267036};",2.3.1.48,"ACTIVITY REGULATION: Coactivator activity on nuclear receptors and NF-kappa-B pathways is enhanced by various hormones, and the TNF cytokine, respectively. TNF stimulation probably enhances phosphorylation, which in turn activates coactivator function. In contrast, acetylation by CREBBP apparently suppresses coactivation of target genes by disrupting its association with nuclear receptors. Binds to CSNK1D.",,ENST00000371997.3 [Q9Y6Q9-3];ENST00000371998.8 [Q9Y6Q9-1];ENST00000372004.7 [Q9Y6Q9-5];,NCOA3,ENSG00000124151,0.0,,,,4.99,DP00343,0.05,0.791,0.303,NCOA3
Q9Y6X0,ENSG00000152217,SETBP_HUMAN,regulation of DNA-templated transcription [GO:0006355],cytosol [GO:0005829]; nuclear body [GO:0016604]; nucleoplasm [GO:0005654]; nucleus [GO:0005634],DNA binding [GO:0003677]; histone H3K4 methyltransferase activity [GO:0042800],,,,,,,"cellular organisms (no rank), Eukaryota (superkingdom), Opisthokonta (clade), Metazoa (kingdom), Eumetazoa (clade), Bilateria (clade), Deuterostomia (clade), Chordata (phylum), Craniata (subphylum), Vertebrata (clade), Gnathostomata (clade), Teleostomi (clade), Euteleostomi (clade), Sarcopterygii (superclass), Dipnotetrapodomorpha (clade), Tetrapoda (clade), Amniota (clade), Mammalia (class), Theria (clade), Eutheria (clade), Boreoeutheria (clade), Euarchontoglires (superorder), Primates (order), Haplorrhini (suborder), Simiiformes (infraorder), Catarrhini (parvorder), Hominoidea (superfamily), Hominidae (family), Homininae (subfamily), Homo (genus)",reviewed,SETBP1 KIAA0437,SET-binding protein (SEB),Homo sapiens (Human),1596.0,175008.0,MESRETLSSSRQRGGESDFLPVSSAKPPAAPGCAGEPLLSTPGPGKGIPVGGERMEPEEEDELGSGRDVDSNSNADSEKWVAGDGLEEQEFSIKEANFTEGSLKLKIQTTKRAKKPPKNLENYICPPEIKITIKQSGDQKVSRAGKNSKATKEEERSHSKKKLLTASDLAASDLKGFQPQAYERPQKHSTLHYDTGLPQDFTGDTLKPKHQQKSSSQNHMDWSTNSDSGPVTQNCFISPESGRETASTSKIPALEPVASFAKAQGKKGSAGNTWSQLSNNNKDLLLGGVAPSPSSHSSPAPPSSSAECNGLQPLVDQDGGGTKEPPEPPTVGSKKKSSKKDVISQTIPNPDLDWVKNAQKAFDNTEGKREGYSADSAQEASPARQNVSSASNPENDSSHVRITIPIKAPSLDPTNHKRKKRQSIKAVVEKIMPEKALASGITMSSEVVNRILSNSEGNKKDPRVPKLSKMIENESPSVGLETGGNAEKVIPGGVSKPRKPPMVMTPPTCTDHSPSRKLPEIQHPKFAAKRRWTCSKPKPSTMLREAVMATSDKLMLEPPSAYPITPSSPLYTNTDSLTVITPVKKKRGRPKKQPLLTVETIHEGTSTSPVSPISREFPGTKKRKRRRNLAKLAQLVPGEDKPMSEMKFHKKVGKLGVLDKKTIKTINKMKTLKRKNILNQILSCSSSVALKAKAPPETSPGAAAIESKLGKQINVSKRGTIYIGKKRGRKPRAELPPPSEEPKTAIKHPRPVSSQPDVPAVPSNFQSLVASSPAAMHPLSTQLGGSNGNLSPASTETNFSELKTMPNLQPISALPTKTQKGIHSGTWKLSPPRLMANSPSHLCEIGSLKEITLSPVSESHSEETIPSDSGIGTDNNSTSDQAEKSSESRRRYSFDFCSLDNPEAIPSDTSTKNRHGHRQKHLIVDNFLAHESLKKPKHKRKRKSLQNRDDLQFLADLEELITKFQVFRISHRSYTFYHENPYPSIFRINFDHYYPVPYIQYDPLLYLRRTSDLKSKKKRGRPAKTNDTMTKVPFLQGFSYPIPSGSYYAPYGMPYTSMPMMNLGYYGQYPAPLYLSHTLGAASPFMRPTVPPPQFHTNSHVKMSGAAKHKAKHGVHLQGPVSMGLGDMQPSLNPPKVGSASLSSGRLHKRKHKHKHKHKEDRILGTHDNLSGLFAGKATGFSSHILSERLSSADKELPLVSEKNKHKEKQKHQHSEAGHKASKNNFEVDTLSTLSLSDAQHWTQAKEKGDLSSEPVDSCTKRYSGSGGDGGSTRSENLDVFSEMNPSNDKWDSDVSGSKRRSYEGFGTYREKDIQAFKMNRKERSSYDSSMSPGMPSPHLKVDQTAVHSKNEGSVPTMMTRKKPAAVDSVTIPPAPVLSLLAASAATSDAVGSSLKKRFKRREIEAIQCEVRKMCNYTKILSTKKNLDHVNKILKAKRLQRQSKTGNNFVKKRRGRPRKQPTQFDEDSRDQMPVLEKCIDLPSKRGQKPSLSPLVLEPAASQDTIMATIEAVIHMAREAPPLPPPPPPPLPPPPPPPLPPPPPLPKTPRGGKRKHKPQAPAQPPQQSPPQQPLPQEEEVKAKRQRKSRGSESEVLP,False,False,True,Q9Y6X0,"[('IPR017956', 'AT hook, DNA-binding motif'), ('PTHR46147', 'Histone-lysine N-methyltransferase SET2 subfamily'), ('SM00384', 'DNA binding domain with preference for A/T rich regions')]",,"""ENSG00000152217; Low tissue specificity."";",,,,,ENST00000426838.8 [Q9Y6X0-2];ENST00000649279.2 [Q9Y6X0-1];ENST00000677068.1 [Q9Y6X0-1];ENST00000677077.1 [Q9Y6X0-1];ENST00000677130.1 [Q9Y6X0-1];ENST00000678152.1 [Q9Y6X0-1];,SETBP1,ENSG00000152217,0.0,,,,,,,0.977,0.491,SETBP1
